No articulo,Articulo,Palabra,Tipo entidad
0,0211-699501013259,Efecto,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,sobre,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,homocisteina,i
0,0211-699501013259,total,o
0,0211-699501013259,en,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,La,o
0,0211-699501013259,hiperhomocisteinemia,i
0,0211-699501013259,es,o
0,0211-699501013259,un,o
0,0211-699501013259,marcador,o
0,0211-699501013259,de,o
0,0211-699501013259,riesgo,o
0,0211-699501013259,independiente,o
0,0211-699501013259,de,o
0,0211-699501013259,morbimortalidad,o
0,0211-699501013259,cardiovascular,i
0,0211-699501013259,Hemos,o
0,0211-699501013259,intentado,o
0,0211-699501013259,prospectivamente,o
0,0211-699501013259,reducir,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,homocisteina,i
0,0211-699501013259,total,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,mediante,o
0,0211-699501013259,suplemento,o
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,y,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,pp,i
0,0211-699501013259,valorando,o
0,0211-699501013259,su,o
0,0211-699501013259,posible,o
0,0211-699501013259,correlacion,o
0,0211-699501013259,con,o
0,0211-699501013259,dosis,o
0,0211-699501013259,de,o
0,0211-699501013259,dialisis,i
0,0211-699501013259,funcion,i
0,0211-699501013259,residual,i
0,0211-699501013259,y,o
0,0211-699501013259,parametros,o
0,0211-699501013259,nutricionales,o
0,0211-699501013259,Metodos,o
0,0211-699501013259,Todos,o
0,0211-699501013259,los,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,al,o
0,0211-699501013259,comienzo,o
0,0211-699501013259,del,o
0,0211-699501013259,estudio,o
0,0211-699501013259,que,o
0,0211-699501013259,no,o
0,0211-699501013259,recibian,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,ni,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,asi,o
0,0211-699501013259,como,o
0,0211-699501013259,los,o
0,0211-699501013259,incorporados,o
0,0211-699501013259,posteriormente,o
0,0211-699501013259,a,o
0,0211-699501013259,partir,o
0,0211-699501013259,de,o
0,0211-699501013259,su,o
0,0211-699501013259,tercer,o
0,0211-699501013259,mes,o
0,0211-699501013259,en,o
0,0211-699501013259,hemodialisis,i
0,0211-699501013259,recibieron,o
0,0211-699501013259,5,o
0,0211-699501013259,mg,o
0,0211-699501013259,orales,o
0,0211-699501013259,de,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,cada,o
0,0211-699501013259,48,o
0,0211-699501013259,horas,o
0,0211-699501013259,y,o
0,0211-699501013259,40,o
0,0211-699501013259,mg,o
0,0211-699501013259,orales,o
0,0211-699501013259,de,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,cada,o
0,0211-699501013259,semana,o
0,0211-699501013259,Se,o
0,0211-699501013259,determinaron,o
0,0211-699501013259,al,o
0,0211-699501013259,comienzo,o
0,0211-699501013259,del,o
0,0211-699501013259,estudio,o
0,0211-699501013259,y,o
0,0211-699501013259,cada,o
0,0211-699501013259,2,o
0,0211-699501013259,meses,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,folato,i
0,0211-699501013259,vitamina,i
0,0211-699501013259,B12,i
0,0211-699501013259,inmunoensayo,i
0,0211-699501013259,albumina,i
0,0211-699501013259,y,o
0,0211-699501013259,cinetica,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,urea,i
0,0211-699501013259,KTV,o
0,0211-699501013259,KRU,o
0,0211-699501013259,PCRn,o
0,0211-699501013259,y,o
0,0211-699501013259,cada,o
0,0211-699501013259,6,o
0,0211-699501013259,meses,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,HPLC,i
0,0211-699501013259,y,o
0,0211-699501013259,pp,i
0,0211-699501013259,RIA,i
0,0211-699501013259,Resultados,o
0,0211-699501013259,80,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,fueron,o
0,0211-699501013259,incluidos,o
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,estudio,o
0,0211-699501013259,basal,o
0,0211-699501013259,con,o
0,0211-699501013259,una,o
0,0211-699501013259,prevalencia,o
0,0211-699501013259,de,o
0,0211-699501013259,hiperhomocisteinemia,i
0,0211-699501013259,del,o
0,0211-699501013259,844,o
0,0211-699501013259,deficit,i
0,0211-699501013259,de,i
0,0211-699501013259,pp,i
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,32,o
0,0211-699501013259,y,o
0,0211-699501013259,folato,i
0,0211-699501013259,en,o
0,0211-699501013259,el,o
0,0211-699501013259,rango,o
0,0211-699501013259,normal,o
0,0211-699501013259,bajo,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,tHcy,i
0,0211-699501013259,se,o
0,0211-699501013259,correlacionaban,o
0,0211-699501013259,inversamente,o
0,0211-699501013259,con,o
0,0211-699501013259,los,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,r,o
0,0211-699501013259,0336,o
0,0211-699501013259,p,o
0,0211-699501013259,001,o
0,0211-699501013259,pero,o
0,0211-699501013259,no,o
0,0211-699501013259,con,o
0,0211-699501013259,pp,i
0,0211-699501013259,B12,i
0,0211-699501013259,edad,o
0,0211-699501013259,albumina,i
0,0211-699501013259,KTV,o
0,0211-699501013259,KRU,o
0,0211-699501013259,PCRn,o
0,0211-699501013259,Cincuenta,o
0,0211-699501013259,y,o
0,0211-699501013259,ocho,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,recibieron,o
0,0211-699501013259,seis,o
0,0211-699501013259,meses,o
0,0211-699501013259,de,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,normalizacion,o
0,0211-699501013259,del,o
0,0211-699501013259,pp,i
0,0211-699501013259,aumento,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,703,o
0,0211-699501013259,IC,o
0,0211-699501013259,638,o
0,0211-699501013259,795,o
0,0211-699501013259,vs,o
0,0211-699501013259,6181,o
0,0211-699501013259,IC,o
0,0211-699501013259,4447,o
0,0211-699501013259,7811,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,y,o
0,0211-699501013259,descenso,o
0,0211-699501013259,de,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,240,o
0,0211-699501013259,IC,o
0,0211-699501013259,213,o
0,0211-699501013259,264,o
0,0211-699501013259,vs,o
0,0211-699501013259,199,o
0,0211-699501013259,IC,o
0,0211-699501013259,175,o
0,0211-699501013259,224,o
0,0211-699501013259,p,o
0,0211-699501013259,005,o
0,0211-699501013259,Han,o
0,0211-699501013259,recibido,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,durante,o
0,0211-699501013259,12,o
0,0211-699501013259,meses,o
0,0211-699501013259,33,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,pero,o
0,0211-699501013259,a,o
0,0211-699501013259,pesar,o
0,0211-699501013259,de,o
0,0211-699501013259,un,o
0,0211-699501013259,continuo,o
0,0211-699501013259,aumento,o
0,0211-699501013259,del,o
0,0211-699501013259,folato,i
0,0211-699501013259,10078,o
0,0211-699501013259,IC,o
0,0211-699501013259,7481,o
0,0211-699501013259,12674,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,solo,o
0,0211-699501013259,3,o
0,0211-699501013259,pacientes,o
0,0211-699501013259,presentan,o
0,0211-699501013259,niveles,o
0,0211-699501013259,normales,o
0,0211-699501013259,de,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,correlacionandose,o
0,0211-699501013259,directamente,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,con,o
0,0211-699501013259,la,o
0,0211-699501013259,albumina,i
0,0211-699501013259,r,o
0,0211-699501013259,056,o
0,0211-699501013259,p,o
0,0211-699501013259,0001,o
0,0211-699501013259,que,o
0,0211-699501013259,se,o
0,0211-699501013259,elevo,o
0,0211-699501013259,con,o
0,0211-699501013259,respecto,o
0,0211-699501013259,al,o
0,0211-699501013259,inicio,o
0,0211-699501013259,337,o
0,0211-699501013259,IC,o
0,0211-699501013259,327,o
0,0211-699501013259,346,o
0,0211-699501013259,vs,o
0,0211-699501013259,350,o
0,0211-699501013259,IC,o
0,0211-699501013259,337,o
0,0211-699501013259,363,o
0,0211-699501013259,p,o
0,0211-699501013259,005,o
0,0211-699501013259,Conclusion,o
0,0211-699501013259,Tras,o
0,0211-699501013259,suplementacion,i
0,0211-699501013259,con,o
0,0211-699501013259,acido,i
0,0211-699501013259,folico,i
0,0211-699501013259,y,o
0,0211-699501013259,vitamina,i
0,0211-699501013259,B6,i
0,0211-699501013259,aunque,o
0,0211-699501013259,inicialmente,o
0,0211-699501013259,se,o
0,0211-699501013259,reduce,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,esta,o
0,0211-699501013259,respuesta,o
0,0211-699501013259,se,o
0,0211-699501013259,hace,o
0,0211-699501013259,refractaria,o
0,0211-699501013259,correlacionandose,o
0,0211-699501013259,directamente,o
0,0211-699501013259,la,o
0,0211-699501013259,tHcy,i
0,0211-699501013259,con,o
0,0211-699501013259,la,o
0,0211-699501013259,albumina,i
0,0211-699501013259,plasmatica,i
0,0211-699501013259,La,o
0,0211-699501013259,interpretacion,o
0,0211-699501013259,de,o
0,0211-699501013259,los,o
0,0211-699501013259,niveles,i
0,0211-699501013259,de,i
0,0211-699501013259,tHcy,i
0,0211-699501013259,debe,o
0,0211-699501013259,tener,o
0,0211-699501013259,en,o
0,0211-699501013259,cuenta,o
0,0211-699501013259,la,o
0,0211-699501013259,concentracion,i
0,0211-699501013259,de,i
0,0211-699501013259,albumina,i
1,0211-699501013259,Efecto,o
1,0211-699501013259,de,o
1,0211-699501013259,la,o
1,0211-699501013259,suplementacion,i
1,0211-699501013259,con,o
1,0211-699501013259,acido,i
1,0211-699501013259,folico,i
1,0211-699501013259,sobre,o
1,0211-699501013259,los,o
1,0211-699501013259,niveles,i
1,0211-699501013259,de,i
1,0211-699501013259,homocisteina,i
1,0211-699501013259,total,o
1,0211-699501013259,en,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,en,o
1,0211-699501013259,hemodialisis,i
1,0211-699501013259,La,o
1,0211-699501013259,hiperhomocisteinemia,i
1,0211-699501013259,es,o
1,0211-699501013259,un,o
1,0211-699501013259,marcador,o
1,0211-699501013259,de,o
1,0211-699501013259,riesgo,o
1,0211-699501013259,independiente,o
1,0211-699501013259,de,o
1,0211-699501013259,morbimortalidad,o
1,0211-699501013259,cardiovascular,i
1,0211-699501013259,Hemos,o
1,0211-699501013259,intentado,o
1,0211-699501013259,prospectivamente,o
1,0211-699501013259,reducir,o
1,0211-699501013259,los,o
1,0211-699501013259,niveles,i
1,0211-699501013259,de,i
1,0211-699501013259,homocisteina,i
1,0211-699501013259,total,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,mediante,o
1,0211-699501013259,suplemento,o
1,0211-699501013259,con,o
1,0211-699501013259,acido,i
1,0211-699501013259,folico,i
1,0211-699501013259,y,o
1,0211-699501013259,vitamina,i
1,0211-699501013259,B6,i
1,0211-699501013259,pp,i
1,0211-699501013259,valorando,o
1,0211-699501013259,su,o
1,0211-699501013259,posible,o
1,0211-699501013259,correlacion,o
1,0211-699501013259,con,o
1,0211-699501013259,dosis,o
1,0211-699501013259,de,o
1,0211-699501013259,dialisis,i
1,0211-699501013259,funcion,i
1,0211-699501013259,residual,i
1,0211-699501013259,y,o
1,0211-699501013259,parametros,o
1,0211-699501013259,nutricionales,o
1,0211-699501013259,Metodos,o
1,0211-699501013259,Todos,o
1,0211-699501013259,los,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,en,o
1,0211-699501013259,hemodialisis,i
1,0211-699501013259,al,o
1,0211-699501013259,comienzo,o
1,0211-699501013259,del,o
1,0211-699501013259,estudio,o
1,0211-699501013259,que,o
1,0211-699501013259,no,o
1,0211-699501013259,recibian,o
1,0211-699501013259,acido,i
1,0211-699501013259,folico,i
1,0211-699501013259,ni,o
1,0211-699501013259,vitamina,i
1,0211-699501013259,B6,i
1,0211-699501013259,asi,o
1,0211-699501013259,como,o
1,0211-699501013259,los,o
1,0211-699501013259,incorporados,o
1,0211-699501013259,posteriormente,o
1,0211-699501013259,a,o
1,0211-699501013259,partir,o
1,0211-699501013259,de,o
1,0211-699501013259,su,o
1,0211-699501013259,tercer,o
1,0211-699501013259,mes,o
1,0211-699501013259,en,o
1,0211-699501013259,hemodialisis,i
1,0211-699501013259,recibieron,o
1,0211-699501013259,5,o
1,0211-699501013259,mg,o
1,0211-699501013259,orales,o
1,0211-699501013259,de,o
1,0211-699501013259,acido,i
1,0211-699501013259,folico,i
1,0211-699501013259,cada,o
1,0211-699501013259,48,o
1,0211-699501013259,horas,o
1,0211-699501013259,y,o
1,0211-699501013259,40,o
1,0211-699501013259,mg,o
1,0211-699501013259,orales,o
1,0211-699501013259,de,o
1,0211-699501013259,vitamina,i
1,0211-699501013259,B6,i
1,0211-699501013259,cada,o
1,0211-699501013259,semana,o
1,0211-699501013259,Se,o
1,0211-699501013259,determinaron,o
1,0211-699501013259,al,o
1,0211-699501013259,comienzo,o
1,0211-699501013259,del,o
1,0211-699501013259,estudio,o
1,0211-699501013259,y,o
1,0211-699501013259,cada,o
1,0211-699501013259,2,o
1,0211-699501013259,meses,o
1,0211-699501013259,niveles,i
1,0211-699501013259,de,i
1,0211-699501013259,folato,i
1,0211-699501013259,vitamina,i
1,0211-699501013259,B12,i
1,0211-699501013259,inmunoensayo,i
1,0211-699501013259,albumina,i
1,0211-699501013259,y,o
1,0211-699501013259,cinetica,o
1,0211-699501013259,de,o
1,0211-699501013259,la,o
1,0211-699501013259,urea,i
1,0211-699501013259,KTV,o
1,0211-699501013259,KRU,o
1,0211-699501013259,PCRn,o
1,0211-699501013259,y,o
1,0211-699501013259,cada,o
1,0211-699501013259,6,o
1,0211-699501013259,meses,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,HPLC,i
1,0211-699501013259,y,o
1,0211-699501013259,pp,i
1,0211-699501013259,RIA,i
1,0211-699501013259,Resultados,o
1,0211-699501013259,80,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,fueron,o
1,0211-699501013259,incluidos,o
1,0211-699501013259,en,o
1,0211-699501013259,el,o
1,0211-699501013259,estudio,o
1,0211-699501013259,basal,o
1,0211-699501013259,con,o
1,0211-699501013259,una,o
1,0211-699501013259,prevalencia,o
1,0211-699501013259,de,o
1,0211-699501013259,hiperhomocisteinemia,i
1,0211-699501013259,del,o
1,0211-699501013259,844,o
1,0211-699501013259,deficit,i
1,0211-699501013259,de,i
1,0211-699501013259,pp,i
1,0211-699501013259,en,o
1,0211-699501013259,el,o
1,0211-699501013259,32,o
1,0211-699501013259,y,o
1,0211-699501013259,folato,i
1,0211-699501013259,en,o
1,0211-699501013259,el,o
1,0211-699501013259,rango,o
1,0211-699501013259,normal,o
1,0211-699501013259,bajo,o
1,0211-699501013259,los,o
1,0211-699501013259,niveles,i
1,0211-699501013259,de,i
1,0211-699501013259,tHcy,i
1,0211-699501013259,se,o
1,0211-699501013259,correlacionaban,o
1,0211-699501013259,inversamente,o
1,0211-699501013259,con,o
1,0211-699501013259,los,o
1,0211-699501013259,del,o
1,0211-699501013259,folato,i
1,0211-699501013259,r,o
1,0211-699501013259,0336,o
1,0211-699501013259,p,o
1,0211-699501013259,001,o
1,0211-699501013259,pero,o
1,0211-699501013259,no,o
1,0211-699501013259,con,o
1,0211-699501013259,pp,i
1,0211-699501013259,B12,i
1,0211-699501013259,edad,o
1,0211-699501013259,albumina,i
1,0211-699501013259,KTV,o
1,0211-699501013259,KRU,o
1,0211-699501013259,PCRn,o
1,0211-699501013259,Cincuenta,o
1,0211-699501013259,y,o
1,0211-699501013259,ocho,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,recibieron,o
1,0211-699501013259,seis,o
1,0211-699501013259,meses,o
1,0211-699501013259,de,o
1,0211-699501013259,suplementacion,i
1,0211-699501013259,con,o
1,0211-699501013259,normalizacion,o
1,0211-699501013259,del,o
1,0211-699501013259,pp,i
1,0211-699501013259,aumento,o
1,0211-699501013259,del,o
1,0211-699501013259,folato,i
1,0211-699501013259,703,o
1,0211-699501013259,IC,o
1,0211-699501013259,638,o
1,0211-699501013259,795,o
1,0211-699501013259,vs,o
1,0211-699501013259,6181,o
1,0211-699501013259,IC,o
1,0211-699501013259,4447,o
1,0211-699501013259,7811,o
1,0211-699501013259,p,o
1,0211-699501013259,0001,o
1,0211-699501013259,y,o
1,0211-699501013259,descenso,o
1,0211-699501013259,de,o
1,0211-699501013259,la,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,240,o
1,0211-699501013259,IC,o
1,0211-699501013259,213,o
1,0211-699501013259,264,o
1,0211-699501013259,vs,o
1,0211-699501013259,199,o
1,0211-699501013259,IC,o
1,0211-699501013259,175,o
1,0211-699501013259,224,o
1,0211-699501013259,p,o
1,0211-699501013259,005,o
1,0211-699501013259,Han,o
1,0211-699501013259,recibido,o
1,0211-699501013259,suplementacion,i
1,0211-699501013259,durante,o
1,0211-699501013259,12,o
1,0211-699501013259,meses,o
1,0211-699501013259,33,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,pero,o
1,0211-699501013259,a,o
1,0211-699501013259,pesar,o
1,0211-699501013259,de,o
1,0211-699501013259,un,o
1,0211-699501013259,continuo,o
1,0211-699501013259,aumento,o
1,0211-699501013259,del,o
1,0211-699501013259,folato,i
1,0211-699501013259,10078,o
1,0211-699501013259,IC,o
1,0211-699501013259,7481,o
1,0211-699501013259,12674,o
1,0211-699501013259,p,o
1,0211-699501013259,0001,o
1,0211-699501013259,solo,o
1,0211-699501013259,3,o
1,0211-699501013259,pacientes,o
1,0211-699501013259,presentan,o
1,0211-699501013259,niveles,o
1,0211-699501013259,normales,o
1,0211-699501013259,de,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,correlacionandose,o
1,0211-699501013259,directamente,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,con,o
1,0211-699501013259,la,o
1,0211-699501013259,albumina,i
1,0211-699501013259,r,o
1,0211-699501013259,056,o
1,0211-699501013259,p,o
1,0211-699501013259,0001,o
1,0211-699501013259,que,o
1,0211-699501013259,se,o
1,0211-699501013259,elevo,o
1,0211-699501013259,con,o
1,0211-699501013259,respecto,o
1,0211-699501013259,al,o
1,0211-699501013259,inicio,o
1,0211-699501013259,337,o
1,0211-699501013259,IC,o
1,0211-699501013259,327,o
1,0211-699501013259,346,o
1,0211-699501013259,vs,o
1,0211-699501013259,350,o
1,0211-699501013259,IC,o
1,0211-699501013259,337,o
1,0211-699501013259,363,o
1,0211-699501013259,p,o
1,0211-699501013259,005,o
1,0211-699501013259,Conclusion,o
1,0211-699501013259,Tras,o
1,0211-699501013259,suplementacion,i
1,0211-699501013259,con,o
1,0211-699501013259,acido,i
1,0211-699501013259,folico,i
1,0211-699501013259,y,o
1,0211-699501013259,vitamina,i
1,0211-699501013259,B6,i
1,0211-699501013259,aunque,o
1,0211-699501013259,inicialmente,o
1,0211-699501013259,se,o
1,0211-699501013259,reduce,o
1,0211-699501013259,la,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,esta,o
1,0211-699501013259,respuesta,o
1,0211-699501013259,se,o
1,0211-699501013259,hace,o
1,0211-699501013259,refractaria,o
1,0211-699501013259,correlacionandose,o
1,0211-699501013259,directamente,o
1,0211-699501013259,la,o
1,0211-699501013259,tHcy,i
1,0211-699501013259,con,o
1,0211-699501013259,la,o
1,0211-699501013259,albumina,i
1,0211-699501013259,plasmatica,i
1,0211-699501013259,La,o
1,0211-699501013259,interpretacion,o
1,0211-699501013259,de,o
1,0211-699501013259,los,o
1,0211-699501013259,niveles,i
1,0211-699501013259,de,i
1,0211-699501013259,tHcy,i
1,0211-699501013259,debe,o
1,0211-699501013259,tener,o
1,0211-699501013259,en,o
1,0211-699501013259,cuenta,o
1,0211-699501013259,la,o
1,0211-699501013259,concentracion,i
1,0211-699501013259,de,i
1,0211-699501013259,albumina,i
2,0211-699501013259,Efecto,o
2,0211-699501013259,de,o
2,0211-699501013259,la,o
2,0211-699501013259,suplementacion,i
2,0211-699501013259,con,o
2,0211-699501013259,acido,i
2,0211-699501013259,folico,i
2,0211-699501013259,sobre,o
2,0211-699501013259,los,o
2,0211-699501013259,niveles,i
2,0211-699501013259,de,i
2,0211-699501013259,homocisteina,i
2,0211-699501013259,total,o
2,0211-699501013259,en,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,en,o
2,0211-699501013259,hemodialisis,i
2,0211-699501013259,La,o
2,0211-699501013259,hiperhomocisteinemia,i
2,0211-699501013259,es,o
2,0211-699501013259,un,o
2,0211-699501013259,marcador,o
2,0211-699501013259,de,o
2,0211-699501013259,riesgo,o
2,0211-699501013259,independiente,o
2,0211-699501013259,de,o
2,0211-699501013259,morbimortalidad,o
2,0211-699501013259,cardiovascular,i
2,0211-699501013259,Hemos,o
2,0211-699501013259,intentado,o
2,0211-699501013259,prospectivamente,o
2,0211-699501013259,reducir,o
2,0211-699501013259,los,o
2,0211-699501013259,niveles,i
2,0211-699501013259,de,i
2,0211-699501013259,homocisteina,i
2,0211-699501013259,total,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,mediante,o
2,0211-699501013259,suplemento,o
2,0211-699501013259,con,o
2,0211-699501013259,acido,i
2,0211-699501013259,folico,i
2,0211-699501013259,y,o
2,0211-699501013259,vitamina,i
2,0211-699501013259,B6,i
2,0211-699501013259,pp,i
2,0211-699501013259,valorando,o
2,0211-699501013259,su,o
2,0211-699501013259,posible,o
2,0211-699501013259,correlacion,o
2,0211-699501013259,con,o
2,0211-699501013259,dosis,o
2,0211-699501013259,de,o
2,0211-699501013259,dialisis,i
2,0211-699501013259,funcion,i
2,0211-699501013259,residual,i
2,0211-699501013259,y,o
2,0211-699501013259,parametros,o
2,0211-699501013259,nutricionales,o
2,0211-699501013259,Metodos,o
2,0211-699501013259,Todos,o
2,0211-699501013259,los,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,en,o
2,0211-699501013259,hemodialisis,i
2,0211-699501013259,al,o
2,0211-699501013259,comienzo,o
2,0211-699501013259,del,o
2,0211-699501013259,estudio,o
2,0211-699501013259,que,o
2,0211-699501013259,no,o
2,0211-699501013259,recibian,o
2,0211-699501013259,acido,i
2,0211-699501013259,folico,i
2,0211-699501013259,ni,o
2,0211-699501013259,vitamina,i
2,0211-699501013259,B6,i
2,0211-699501013259,asi,o
2,0211-699501013259,como,o
2,0211-699501013259,los,o
2,0211-699501013259,incorporados,o
2,0211-699501013259,posteriormente,o
2,0211-699501013259,a,o
2,0211-699501013259,partir,o
2,0211-699501013259,de,o
2,0211-699501013259,su,o
2,0211-699501013259,tercer,o
2,0211-699501013259,mes,o
2,0211-699501013259,en,o
2,0211-699501013259,hemodialisis,i
2,0211-699501013259,recibieron,o
2,0211-699501013259,5,o
2,0211-699501013259,mg,o
2,0211-699501013259,orales,o
2,0211-699501013259,de,o
2,0211-699501013259,acido,i
2,0211-699501013259,folico,i
2,0211-699501013259,cada,o
2,0211-699501013259,48,o
2,0211-699501013259,horas,o
2,0211-699501013259,y,o
2,0211-699501013259,40,o
2,0211-699501013259,mg,o
2,0211-699501013259,orales,o
2,0211-699501013259,de,o
2,0211-699501013259,vitamina,i
2,0211-699501013259,B6,i
2,0211-699501013259,cada,o
2,0211-699501013259,semana,o
2,0211-699501013259,Se,o
2,0211-699501013259,determinaron,o
2,0211-699501013259,al,o
2,0211-699501013259,comienzo,o
2,0211-699501013259,del,o
2,0211-699501013259,estudio,o
2,0211-699501013259,y,o
2,0211-699501013259,cada,o
2,0211-699501013259,2,o
2,0211-699501013259,meses,o
2,0211-699501013259,niveles,i
2,0211-699501013259,de,i
2,0211-699501013259,folato,i
2,0211-699501013259,vitamina,i
2,0211-699501013259,B12,i
2,0211-699501013259,inmunoensayo,i
2,0211-699501013259,albumina,i
2,0211-699501013259,y,o
2,0211-699501013259,cinetica,o
2,0211-699501013259,de,o
2,0211-699501013259,la,o
2,0211-699501013259,urea,i
2,0211-699501013259,KTV,o
2,0211-699501013259,KRU,o
2,0211-699501013259,PCRn,o
2,0211-699501013259,y,o
2,0211-699501013259,cada,o
2,0211-699501013259,6,o
2,0211-699501013259,meses,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,HPLC,i
2,0211-699501013259,y,o
2,0211-699501013259,pp,i
2,0211-699501013259,RIA,i
2,0211-699501013259,Resultados,o
2,0211-699501013259,80,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,fueron,o
2,0211-699501013259,incluidos,o
2,0211-699501013259,en,o
2,0211-699501013259,el,o
2,0211-699501013259,estudio,o
2,0211-699501013259,basal,o
2,0211-699501013259,con,o
2,0211-699501013259,una,o
2,0211-699501013259,prevalencia,o
2,0211-699501013259,de,o
2,0211-699501013259,hiperhomocisteinemia,i
2,0211-699501013259,del,o
2,0211-699501013259,844,o
2,0211-699501013259,deficit,i
2,0211-699501013259,de,i
2,0211-699501013259,pp,i
2,0211-699501013259,en,o
2,0211-699501013259,el,o
2,0211-699501013259,32,o
2,0211-699501013259,y,o
2,0211-699501013259,folato,i
2,0211-699501013259,en,o
2,0211-699501013259,el,o
2,0211-699501013259,rango,o
2,0211-699501013259,normal,o
2,0211-699501013259,bajo,o
2,0211-699501013259,los,o
2,0211-699501013259,niveles,i
2,0211-699501013259,de,i
2,0211-699501013259,tHcy,i
2,0211-699501013259,se,o
2,0211-699501013259,correlacionaban,o
2,0211-699501013259,inversamente,o
2,0211-699501013259,con,o
2,0211-699501013259,los,o
2,0211-699501013259,del,o
2,0211-699501013259,folato,i
2,0211-699501013259,r,o
2,0211-699501013259,0336,o
2,0211-699501013259,p,o
2,0211-699501013259,001,o
2,0211-699501013259,pero,o
2,0211-699501013259,no,o
2,0211-699501013259,con,o
2,0211-699501013259,pp,i
2,0211-699501013259,B12,i
2,0211-699501013259,edad,o
2,0211-699501013259,albumina,i
2,0211-699501013259,KTV,o
2,0211-699501013259,KRU,o
2,0211-699501013259,PCRn,o
2,0211-699501013259,Cincuenta,o
2,0211-699501013259,y,o
2,0211-699501013259,ocho,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,recibieron,o
2,0211-699501013259,seis,o
2,0211-699501013259,meses,o
2,0211-699501013259,de,o
2,0211-699501013259,suplementacion,i
2,0211-699501013259,con,o
2,0211-699501013259,normalizacion,o
2,0211-699501013259,del,o
2,0211-699501013259,pp,i
2,0211-699501013259,aumento,o
2,0211-699501013259,del,o
2,0211-699501013259,folato,i
2,0211-699501013259,703,o
2,0211-699501013259,IC,o
2,0211-699501013259,638,o
2,0211-699501013259,795,o
2,0211-699501013259,vs,o
2,0211-699501013259,6181,o
2,0211-699501013259,IC,o
2,0211-699501013259,4447,o
2,0211-699501013259,7811,o
2,0211-699501013259,p,o
2,0211-699501013259,0001,o
2,0211-699501013259,y,o
2,0211-699501013259,descenso,o
2,0211-699501013259,de,o
2,0211-699501013259,la,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,240,o
2,0211-699501013259,IC,o
2,0211-699501013259,213,o
2,0211-699501013259,264,o
2,0211-699501013259,vs,o
2,0211-699501013259,199,o
2,0211-699501013259,IC,o
2,0211-699501013259,175,o
2,0211-699501013259,224,o
2,0211-699501013259,p,o
2,0211-699501013259,005,o
2,0211-699501013259,Han,o
2,0211-699501013259,recibido,o
2,0211-699501013259,suplementacion,i
2,0211-699501013259,durante,o
2,0211-699501013259,12,o
2,0211-699501013259,meses,o
2,0211-699501013259,33,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,pero,o
2,0211-699501013259,a,o
2,0211-699501013259,pesar,o
2,0211-699501013259,de,o
2,0211-699501013259,un,o
2,0211-699501013259,continuo,o
2,0211-699501013259,aumento,o
2,0211-699501013259,del,o
2,0211-699501013259,folato,i
2,0211-699501013259,10078,o
2,0211-699501013259,IC,o
2,0211-699501013259,7481,o
2,0211-699501013259,12674,o
2,0211-699501013259,p,o
2,0211-699501013259,0001,o
2,0211-699501013259,solo,o
2,0211-699501013259,3,o
2,0211-699501013259,pacientes,o
2,0211-699501013259,presentan,o
2,0211-699501013259,niveles,o
2,0211-699501013259,normales,o
2,0211-699501013259,de,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,correlacionandose,o
2,0211-699501013259,directamente,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,con,o
2,0211-699501013259,la,o
2,0211-699501013259,albumina,i
2,0211-699501013259,r,o
2,0211-699501013259,056,o
2,0211-699501013259,p,o
2,0211-699501013259,0001,o
2,0211-699501013259,que,o
2,0211-699501013259,se,o
2,0211-699501013259,elevo,o
2,0211-699501013259,con,o
2,0211-699501013259,respecto,o
2,0211-699501013259,al,o
2,0211-699501013259,inicio,o
2,0211-699501013259,337,o
2,0211-699501013259,IC,o
2,0211-699501013259,327,o
2,0211-699501013259,346,o
2,0211-699501013259,vs,o
2,0211-699501013259,350,o
2,0211-699501013259,IC,o
2,0211-699501013259,337,o
2,0211-699501013259,363,o
2,0211-699501013259,p,o
2,0211-699501013259,005,o
2,0211-699501013259,Conclusion,o
2,0211-699501013259,Tras,o
2,0211-699501013259,suplementacion,i
2,0211-699501013259,con,o
2,0211-699501013259,acido,i
2,0211-699501013259,folico,i
2,0211-699501013259,y,o
2,0211-699501013259,vitamina,i
2,0211-699501013259,B6,i
2,0211-699501013259,aunque,o
2,0211-699501013259,inicialmente,o
2,0211-699501013259,se,o
2,0211-699501013259,reduce,o
2,0211-699501013259,la,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,esta,o
2,0211-699501013259,respuesta,o
2,0211-699501013259,se,o
2,0211-699501013259,hace,o
2,0211-699501013259,refractaria,o
2,0211-699501013259,correlacionandose,o
2,0211-699501013259,directamente,o
2,0211-699501013259,la,o
2,0211-699501013259,tHcy,i
2,0211-699501013259,con,o
2,0211-699501013259,la,o
2,0211-699501013259,albumina,i
2,0211-699501013259,plasmatica,i
2,0211-699501013259,La,o
2,0211-699501013259,interpretacion,o
2,0211-699501013259,de,o
2,0211-699501013259,los,o
2,0211-699501013259,niveles,i
2,0211-699501013259,de,i
2,0211-699501013259,tHcy,i
2,0211-699501013259,debe,o
2,0211-699501013259,tener,o
2,0211-699501013259,en,o
2,0211-699501013259,cuenta,o
2,0211-699501013259,la,o
2,0211-699501013259,concentracion,i
2,0211-699501013259,de,i
2,0211-699501013259,albumina,i
3,0211-699501013259,Efecto,o
3,0211-699501013259,de,o
3,0211-699501013259,la,o
3,0211-699501013259,suplementacion,i
3,0211-699501013259,con,o
3,0211-699501013259,acido,i
3,0211-699501013259,folico,i
3,0211-699501013259,sobre,o
3,0211-699501013259,los,o
3,0211-699501013259,niveles,i
3,0211-699501013259,de,i
3,0211-699501013259,homocisteina,i
3,0211-699501013259,total,o
3,0211-699501013259,en,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,en,o
3,0211-699501013259,hemodialisis,i
3,0211-699501013259,La,o
3,0211-699501013259,hiperhomocisteinemia,i
3,0211-699501013259,es,o
3,0211-699501013259,un,o
3,0211-699501013259,marcador,o
3,0211-699501013259,de,o
3,0211-699501013259,riesgo,o
3,0211-699501013259,independiente,o
3,0211-699501013259,de,o
3,0211-699501013259,morbimortalidad,o
3,0211-699501013259,cardiovascular,i
3,0211-699501013259,Hemos,o
3,0211-699501013259,intentado,o
3,0211-699501013259,prospectivamente,o
3,0211-699501013259,reducir,o
3,0211-699501013259,los,o
3,0211-699501013259,niveles,i
3,0211-699501013259,de,i
3,0211-699501013259,homocisteina,i
3,0211-699501013259,total,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,mediante,o
3,0211-699501013259,suplemento,o
3,0211-699501013259,con,o
3,0211-699501013259,acido,i
3,0211-699501013259,folico,i
3,0211-699501013259,y,o
3,0211-699501013259,vitamina,i
3,0211-699501013259,B6,i
3,0211-699501013259,pp,i
3,0211-699501013259,valorando,o
3,0211-699501013259,su,o
3,0211-699501013259,posible,o
3,0211-699501013259,correlacion,o
3,0211-699501013259,con,o
3,0211-699501013259,dosis,o
3,0211-699501013259,de,o
3,0211-699501013259,dialisis,i
3,0211-699501013259,funcion,i
3,0211-699501013259,residual,i
3,0211-699501013259,y,o
3,0211-699501013259,parametros,o
3,0211-699501013259,nutricionales,o
3,0211-699501013259,Metodos,o
3,0211-699501013259,Todos,o
3,0211-699501013259,los,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,en,o
3,0211-699501013259,hemodialisis,i
3,0211-699501013259,al,o
3,0211-699501013259,comienzo,o
3,0211-699501013259,del,o
3,0211-699501013259,estudio,o
3,0211-699501013259,que,o
3,0211-699501013259,no,o
3,0211-699501013259,recibian,o
3,0211-699501013259,acido,i
3,0211-699501013259,folico,i
3,0211-699501013259,ni,o
3,0211-699501013259,vitamina,i
3,0211-699501013259,B6,i
3,0211-699501013259,asi,o
3,0211-699501013259,como,o
3,0211-699501013259,los,o
3,0211-699501013259,incorporados,o
3,0211-699501013259,posteriormente,o
3,0211-699501013259,a,o
3,0211-699501013259,partir,o
3,0211-699501013259,de,o
3,0211-699501013259,su,o
3,0211-699501013259,tercer,o
3,0211-699501013259,mes,o
3,0211-699501013259,en,o
3,0211-699501013259,hemodialisis,i
3,0211-699501013259,recibieron,o
3,0211-699501013259,5,o
3,0211-699501013259,mg,o
3,0211-699501013259,orales,o
3,0211-699501013259,de,o
3,0211-699501013259,acido,i
3,0211-699501013259,folico,i
3,0211-699501013259,cada,o
3,0211-699501013259,48,o
3,0211-699501013259,horas,o
3,0211-699501013259,y,o
3,0211-699501013259,40,o
3,0211-699501013259,mg,o
3,0211-699501013259,orales,o
3,0211-699501013259,de,o
3,0211-699501013259,vitamina,i
3,0211-699501013259,B6,i
3,0211-699501013259,cada,o
3,0211-699501013259,semana,o
3,0211-699501013259,Se,o
3,0211-699501013259,determinaron,o
3,0211-699501013259,al,o
3,0211-699501013259,comienzo,o
3,0211-699501013259,del,o
3,0211-699501013259,estudio,o
3,0211-699501013259,y,o
3,0211-699501013259,cada,o
3,0211-699501013259,2,o
3,0211-699501013259,meses,o
3,0211-699501013259,niveles,i
3,0211-699501013259,de,i
3,0211-699501013259,folato,i
3,0211-699501013259,vitamina,i
3,0211-699501013259,B12,i
3,0211-699501013259,inmunoensayo,i
3,0211-699501013259,albumina,i
3,0211-699501013259,y,o
3,0211-699501013259,cinetica,o
3,0211-699501013259,de,o
3,0211-699501013259,la,o
3,0211-699501013259,urea,i
3,0211-699501013259,KTV,o
3,0211-699501013259,KRU,o
3,0211-699501013259,PCRn,o
3,0211-699501013259,y,o
3,0211-699501013259,cada,o
3,0211-699501013259,6,o
3,0211-699501013259,meses,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,HPLC,i
3,0211-699501013259,y,o
3,0211-699501013259,pp,i
3,0211-699501013259,RIA,i
3,0211-699501013259,Resultados,o
3,0211-699501013259,80,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,fueron,o
3,0211-699501013259,incluidos,o
3,0211-699501013259,en,o
3,0211-699501013259,el,o
3,0211-699501013259,estudio,o
3,0211-699501013259,basal,o
3,0211-699501013259,con,o
3,0211-699501013259,una,o
3,0211-699501013259,prevalencia,o
3,0211-699501013259,de,o
3,0211-699501013259,hiperhomocisteinemia,i
3,0211-699501013259,del,o
3,0211-699501013259,844,o
3,0211-699501013259,deficit,i
3,0211-699501013259,de,i
3,0211-699501013259,pp,i
3,0211-699501013259,en,o
3,0211-699501013259,el,o
3,0211-699501013259,32,o
3,0211-699501013259,y,o
3,0211-699501013259,folato,i
3,0211-699501013259,en,o
3,0211-699501013259,el,o
3,0211-699501013259,rango,o
3,0211-699501013259,normal,o
3,0211-699501013259,bajo,o
3,0211-699501013259,los,o
3,0211-699501013259,niveles,i
3,0211-699501013259,de,i
3,0211-699501013259,tHcy,i
3,0211-699501013259,se,o
3,0211-699501013259,correlacionaban,o
3,0211-699501013259,inversamente,o
3,0211-699501013259,con,o
3,0211-699501013259,los,o
3,0211-699501013259,del,o
3,0211-699501013259,folato,i
3,0211-699501013259,r,o
3,0211-699501013259,0336,o
3,0211-699501013259,p,o
3,0211-699501013259,001,o
3,0211-699501013259,pero,o
3,0211-699501013259,no,o
3,0211-699501013259,con,o
3,0211-699501013259,pp,i
3,0211-699501013259,B12,i
3,0211-699501013259,edad,o
3,0211-699501013259,albumina,i
3,0211-699501013259,KTV,o
3,0211-699501013259,KRU,o
3,0211-699501013259,PCRn,o
3,0211-699501013259,Cincuenta,o
3,0211-699501013259,y,o
3,0211-699501013259,ocho,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,recibieron,o
3,0211-699501013259,seis,o
3,0211-699501013259,meses,o
3,0211-699501013259,de,o
3,0211-699501013259,suplementacion,i
3,0211-699501013259,con,o
3,0211-699501013259,normalizacion,o
3,0211-699501013259,del,o
3,0211-699501013259,pp,i
3,0211-699501013259,aumento,o
3,0211-699501013259,del,o
3,0211-699501013259,folato,i
3,0211-699501013259,703,o
3,0211-699501013259,IC,o
3,0211-699501013259,638,o
3,0211-699501013259,795,o
3,0211-699501013259,vs,o
3,0211-699501013259,6181,o
3,0211-699501013259,IC,o
3,0211-699501013259,4447,o
3,0211-699501013259,7811,o
3,0211-699501013259,p,o
3,0211-699501013259,0001,o
3,0211-699501013259,y,o
3,0211-699501013259,descenso,o
3,0211-699501013259,de,o
3,0211-699501013259,la,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,240,o
3,0211-699501013259,IC,o
3,0211-699501013259,213,o
3,0211-699501013259,264,o
3,0211-699501013259,vs,o
3,0211-699501013259,199,o
3,0211-699501013259,IC,o
3,0211-699501013259,175,o
3,0211-699501013259,224,o
3,0211-699501013259,p,o
3,0211-699501013259,005,o
3,0211-699501013259,Han,o
3,0211-699501013259,recibido,o
3,0211-699501013259,suplementacion,i
3,0211-699501013259,durante,o
3,0211-699501013259,12,o
3,0211-699501013259,meses,o
3,0211-699501013259,33,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,pero,o
3,0211-699501013259,a,o
3,0211-699501013259,pesar,o
3,0211-699501013259,de,o
3,0211-699501013259,un,o
3,0211-699501013259,continuo,o
3,0211-699501013259,aumento,o
3,0211-699501013259,del,o
3,0211-699501013259,folato,i
3,0211-699501013259,10078,o
3,0211-699501013259,IC,o
3,0211-699501013259,7481,o
3,0211-699501013259,12674,o
3,0211-699501013259,p,o
3,0211-699501013259,0001,o
3,0211-699501013259,solo,o
3,0211-699501013259,3,o
3,0211-699501013259,pacientes,o
3,0211-699501013259,presentan,o
3,0211-699501013259,niveles,o
3,0211-699501013259,normales,o
3,0211-699501013259,de,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,correlacionandose,o
3,0211-699501013259,directamente,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,con,o
3,0211-699501013259,la,o
3,0211-699501013259,albumina,i
3,0211-699501013259,r,o
3,0211-699501013259,056,o
3,0211-699501013259,p,o
3,0211-699501013259,0001,o
3,0211-699501013259,que,o
3,0211-699501013259,se,o
3,0211-699501013259,elevo,o
3,0211-699501013259,con,o
3,0211-699501013259,respecto,o
3,0211-699501013259,al,o
3,0211-699501013259,inicio,o
3,0211-699501013259,337,o
3,0211-699501013259,IC,o
3,0211-699501013259,327,o
3,0211-699501013259,346,o
3,0211-699501013259,vs,o
3,0211-699501013259,350,o
3,0211-699501013259,IC,o
3,0211-699501013259,337,o
3,0211-699501013259,363,o
3,0211-699501013259,p,o
3,0211-699501013259,005,o
3,0211-699501013259,Conclusion,o
3,0211-699501013259,Tras,o
3,0211-699501013259,suplementacion,i
3,0211-699501013259,con,o
3,0211-699501013259,acido,i
3,0211-699501013259,folico,i
3,0211-699501013259,y,o
3,0211-699501013259,vitamina,i
3,0211-699501013259,B6,i
3,0211-699501013259,aunque,o
3,0211-699501013259,inicialmente,o
3,0211-699501013259,se,o
3,0211-699501013259,reduce,o
3,0211-699501013259,la,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,esta,o
3,0211-699501013259,respuesta,o
3,0211-699501013259,se,o
3,0211-699501013259,hace,o
3,0211-699501013259,refractaria,o
3,0211-699501013259,correlacionandose,o
3,0211-699501013259,directamente,o
3,0211-699501013259,la,o
3,0211-699501013259,tHcy,i
3,0211-699501013259,con,o
3,0211-699501013259,la,o
3,0211-699501013259,albumina,i
3,0211-699501013259,plasmatica,i
3,0211-699501013259,La,o
3,0211-699501013259,interpretacion,o
3,0211-699501013259,de,o
3,0211-699501013259,los,o
3,0211-699501013259,niveles,i
3,0211-699501013259,de,i
3,0211-699501013259,tHcy,i
3,0211-699501013259,debe,o
3,0211-699501013259,tener,o
3,0211-699501013259,en,o
3,0211-699501013259,cuenta,o
3,0211-699501013259,la,o
3,0211-699501013259,concentracion,i
3,0211-699501013259,de,i
3,0211-699501013259,albumina,i
4,0211-699501013259,Efecto,o
4,0211-699501013259,de,o
4,0211-699501013259,la,o
4,0211-699501013259,suplementacion,i
4,0211-699501013259,con,o
4,0211-699501013259,acido,i
4,0211-699501013259,folico,i
4,0211-699501013259,sobre,o
4,0211-699501013259,los,o
4,0211-699501013259,niveles,i
4,0211-699501013259,de,i
4,0211-699501013259,homocisteina,i
4,0211-699501013259,total,o
4,0211-699501013259,en,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,en,o
4,0211-699501013259,hemodialisis,i
4,0211-699501013259,La,o
4,0211-699501013259,hiperhomocisteinemia,i
4,0211-699501013259,es,o
4,0211-699501013259,un,o
4,0211-699501013259,marcador,o
4,0211-699501013259,de,o
4,0211-699501013259,riesgo,o
4,0211-699501013259,independiente,o
4,0211-699501013259,de,o
4,0211-699501013259,morbimortalidad,o
4,0211-699501013259,cardiovascular,i
4,0211-699501013259,Hemos,o
4,0211-699501013259,intentado,o
4,0211-699501013259,prospectivamente,o
4,0211-699501013259,reducir,o
4,0211-699501013259,los,o
4,0211-699501013259,niveles,i
4,0211-699501013259,de,i
4,0211-699501013259,homocisteina,i
4,0211-699501013259,total,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,mediante,o
4,0211-699501013259,suplemento,o
4,0211-699501013259,con,o
4,0211-699501013259,acido,i
4,0211-699501013259,folico,i
4,0211-699501013259,y,o
4,0211-699501013259,vitamina,i
4,0211-699501013259,B6,i
4,0211-699501013259,pp,i
4,0211-699501013259,valorando,o
4,0211-699501013259,su,o
4,0211-699501013259,posible,o
4,0211-699501013259,correlacion,o
4,0211-699501013259,con,o
4,0211-699501013259,dosis,o
4,0211-699501013259,de,o
4,0211-699501013259,dialisis,i
4,0211-699501013259,funcion,i
4,0211-699501013259,residual,i
4,0211-699501013259,y,o
4,0211-699501013259,parametros,o
4,0211-699501013259,nutricionales,o
4,0211-699501013259,Metodos,o
4,0211-699501013259,Todos,o
4,0211-699501013259,los,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,en,o
4,0211-699501013259,hemodialisis,i
4,0211-699501013259,al,o
4,0211-699501013259,comienzo,o
4,0211-699501013259,del,o
4,0211-699501013259,estudio,o
4,0211-699501013259,que,o
4,0211-699501013259,no,o
4,0211-699501013259,recibian,o
4,0211-699501013259,acido,i
4,0211-699501013259,folico,i
4,0211-699501013259,ni,o
4,0211-699501013259,vitamina,i
4,0211-699501013259,B6,i
4,0211-699501013259,asi,o
4,0211-699501013259,como,o
4,0211-699501013259,los,o
4,0211-699501013259,incorporados,o
4,0211-699501013259,posteriormente,o
4,0211-699501013259,a,o
4,0211-699501013259,partir,o
4,0211-699501013259,de,o
4,0211-699501013259,su,o
4,0211-699501013259,tercer,o
4,0211-699501013259,mes,o
4,0211-699501013259,en,o
4,0211-699501013259,hemodialisis,i
4,0211-699501013259,recibieron,o
4,0211-699501013259,5,o
4,0211-699501013259,mg,o
4,0211-699501013259,orales,o
4,0211-699501013259,de,o
4,0211-699501013259,acido,i
4,0211-699501013259,folico,i
4,0211-699501013259,cada,o
4,0211-699501013259,48,o
4,0211-699501013259,horas,o
4,0211-699501013259,y,o
4,0211-699501013259,40,o
4,0211-699501013259,mg,o
4,0211-699501013259,orales,o
4,0211-699501013259,de,o
4,0211-699501013259,vitamina,i
4,0211-699501013259,B6,i
4,0211-699501013259,cada,o
4,0211-699501013259,semana,o
4,0211-699501013259,Se,o
4,0211-699501013259,determinaron,o
4,0211-699501013259,al,o
4,0211-699501013259,comienzo,o
4,0211-699501013259,del,o
4,0211-699501013259,estudio,o
4,0211-699501013259,y,o
4,0211-699501013259,cada,o
4,0211-699501013259,2,o
4,0211-699501013259,meses,o
4,0211-699501013259,niveles,i
4,0211-699501013259,de,i
4,0211-699501013259,folato,i
4,0211-699501013259,vitamina,i
4,0211-699501013259,B12,i
4,0211-699501013259,inmunoensayo,i
4,0211-699501013259,albumina,i
4,0211-699501013259,y,o
4,0211-699501013259,cinetica,o
4,0211-699501013259,de,o
4,0211-699501013259,la,o
4,0211-699501013259,urea,i
4,0211-699501013259,KTV,o
4,0211-699501013259,KRU,o
4,0211-699501013259,PCRn,o
4,0211-699501013259,y,o
4,0211-699501013259,cada,o
4,0211-699501013259,6,o
4,0211-699501013259,meses,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,HPLC,i
4,0211-699501013259,y,o
4,0211-699501013259,pp,i
4,0211-699501013259,RIA,i
4,0211-699501013259,Resultados,o
4,0211-699501013259,80,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,fueron,o
4,0211-699501013259,incluidos,o
4,0211-699501013259,en,o
4,0211-699501013259,el,o
4,0211-699501013259,estudio,o
4,0211-699501013259,basal,o
4,0211-699501013259,con,o
4,0211-699501013259,una,o
4,0211-699501013259,prevalencia,o
4,0211-699501013259,de,o
4,0211-699501013259,hiperhomocisteinemia,i
4,0211-699501013259,del,o
4,0211-699501013259,844,o
4,0211-699501013259,deficit,i
4,0211-699501013259,de,i
4,0211-699501013259,pp,i
4,0211-699501013259,en,o
4,0211-699501013259,el,o
4,0211-699501013259,32,o
4,0211-699501013259,y,o
4,0211-699501013259,folato,i
4,0211-699501013259,en,o
4,0211-699501013259,el,o
4,0211-699501013259,rango,o
4,0211-699501013259,normal,o
4,0211-699501013259,bajo,o
4,0211-699501013259,los,o
4,0211-699501013259,niveles,i
4,0211-699501013259,de,i
4,0211-699501013259,tHcy,i
4,0211-699501013259,se,o
4,0211-699501013259,correlacionaban,o
4,0211-699501013259,inversamente,o
4,0211-699501013259,con,o
4,0211-699501013259,los,o
4,0211-699501013259,del,o
4,0211-699501013259,folato,i
4,0211-699501013259,r,o
4,0211-699501013259,0336,o
4,0211-699501013259,p,o
4,0211-699501013259,001,o
4,0211-699501013259,pero,o
4,0211-699501013259,no,o
4,0211-699501013259,con,o
4,0211-699501013259,pp,i
4,0211-699501013259,B12,i
4,0211-699501013259,edad,o
4,0211-699501013259,albumina,i
4,0211-699501013259,KTV,o
4,0211-699501013259,KRU,o
4,0211-699501013259,PCRn,o
4,0211-699501013259,Cincuenta,o
4,0211-699501013259,y,o
4,0211-699501013259,ocho,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,recibieron,o
4,0211-699501013259,seis,o
4,0211-699501013259,meses,o
4,0211-699501013259,de,o
4,0211-699501013259,suplementacion,i
4,0211-699501013259,con,o
4,0211-699501013259,normalizacion,o
4,0211-699501013259,del,o
4,0211-699501013259,pp,i
4,0211-699501013259,aumento,o
4,0211-699501013259,del,o
4,0211-699501013259,folato,i
4,0211-699501013259,703,o
4,0211-699501013259,IC,o
4,0211-699501013259,638,o
4,0211-699501013259,795,o
4,0211-699501013259,vs,o
4,0211-699501013259,6181,o
4,0211-699501013259,IC,o
4,0211-699501013259,4447,o
4,0211-699501013259,7811,o
4,0211-699501013259,p,o
4,0211-699501013259,0001,o
4,0211-699501013259,y,o
4,0211-699501013259,descenso,o
4,0211-699501013259,de,o
4,0211-699501013259,la,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,240,o
4,0211-699501013259,IC,o
4,0211-699501013259,213,o
4,0211-699501013259,264,o
4,0211-699501013259,vs,o
4,0211-699501013259,199,o
4,0211-699501013259,IC,o
4,0211-699501013259,175,o
4,0211-699501013259,224,o
4,0211-699501013259,p,o
4,0211-699501013259,005,o
4,0211-699501013259,Han,o
4,0211-699501013259,recibido,o
4,0211-699501013259,suplementacion,i
4,0211-699501013259,durante,o
4,0211-699501013259,12,o
4,0211-699501013259,meses,o
4,0211-699501013259,33,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,pero,o
4,0211-699501013259,a,o
4,0211-699501013259,pesar,o
4,0211-699501013259,de,o
4,0211-699501013259,un,o
4,0211-699501013259,continuo,o
4,0211-699501013259,aumento,o
4,0211-699501013259,del,o
4,0211-699501013259,folato,i
4,0211-699501013259,10078,o
4,0211-699501013259,IC,o
4,0211-699501013259,7481,o
4,0211-699501013259,12674,o
4,0211-699501013259,p,o
4,0211-699501013259,0001,o
4,0211-699501013259,solo,o
4,0211-699501013259,3,o
4,0211-699501013259,pacientes,o
4,0211-699501013259,presentan,o
4,0211-699501013259,niveles,o
4,0211-699501013259,normales,o
4,0211-699501013259,de,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,correlacionandose,o
4,0211-699501013259,directamente,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,con,o
4,0211-699501013259,la,o
4,0211-699501013259,albumina,i
4,0211-699501013259,r,o
4,0211-699501013259,056,o
4,0211-699501013259,p,o
4,0211-699501013259,0001,o
4,0211-699501013259,que,o
4,0211-699501013259,se,o
4,0211-699501013259,elevo,o
4,0211-699501013259,con,o
4,0211-699501013259,respecto,o
4,0211-699501013259,al,o
4,0211-699501013259,inicio,o
4,0211-699501013259,337,o
4,0211-699501013259,IC,o
4,0211-699501013259,327,o
4,0211-699501013259,346,o
4,0211-699501013259,vs,o
4,0211-699501013259,350,o
4,0211-699501013259,IC,o
4,0211-699501013259,337,o
4,0211-699501013259,363,o
4,0211-699501013259,p,o
4,0211-699501013259,005,o
4,0211-699501013259,Conclusion,o
4,0211-699501013259,Tras,o
4,0211-699501013259,suplementacion,i
4,0211-699501013259,con,o
4,0211-699501013259,acido,i
4,0211-699501013259,folico,i
4,0211-699501013259,y,o
4,0211-699501013259,vitamina,i
4,0211-699501013259,B6,i
4,0211-699501013259,aunque,o
4,0211-699501013259,inicialmente,o
4,0211-699501013259,se,o
4,0211-699501013259,reduce,o
4,0211-699501013259,la,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,esta,o
4,0211-699501013259,respuesta,o
4,0211-699501013259,se,o
4,0211-699501013259,hace,o
4,0211-699501013259,refractaria,o
4,0211-699501013259,correlacionandose,o
4,0211-699501013259,directamente,o
4,0211-699501013259,la,o
4,0211-699501013259,tHcy,i
4,0211-699501013259,con,o
4,0211-699501013259,la,o
4,0211-699501013259,albumina,i
4,0211-699501013259,plasmatica,i
4,0211-699501013259,La,o
4,0211-699501013259,interpretacion,o
4,0211-699501013259,de,o
4,0211-699501013259,los,o
4,0211-699501013259,niveles,i
4,0211-699501013259,de,i
4,0211-699501013259,tHcy,i
4,0211-699501013259,debe,o
4,0211-699501013259,tener,o
4,0211-699501013259,en,o
4,0211-699501013259,cuenta,o
4,0211-699501013259,la,o
4,0211-699501013259,concentracion,i
4,0211-699501013259,de,i
4,0211-699501013259,albumina,i
5,0211-699501013259,Efecto,o
5,0211-699501013259,de,o
5,0211-699501013259,la,o
5,0211-699501013259,suplementacion,i
5,0211-699501013259,con,o
5,0211-699501013259,acido,i
5,0211-699501013259,folico,i
5,0211-699501013259,sobre,o
5,0211-699501013259,los,o
5,0211-699501013259,niveles,i
5,0211-699501013259,de,i
5,0211-699501013259,homocisteina,i
5,0211-699501013259,total,o
5,0211-699501013259,en,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,en,o
5,0211-699501013259,hemodialisis,i
5,0211-699501013259,La,o
5,0211-699501013259,hiperhomocisteinemia,i
5,0211-699501013259,es,o
5,0211-699501013259,un,o
5,0211-699501013259,marcador,o
5,0211-699501013259,de,o
5,0211-699501013259,riesgo,o
5,0211-699501013259,independiente,o
5,0211-699501013259,de,o
5,0211-699501013259,morbimortalidad,o
5,0211-699501013259,cardiovascular,i
5,0211-699501013259,Hemos,o
5,0211-699501013259,intentado,o
5,0211-699501013259,prospectivamente,o
5,0211-699501013259,reducir,o
5,0211-699501013259,los,o
5,0211-699501013259,niveles,i
5,0211-699501013259,de,i
5,0211-699501013259,homocisteina,i
5,0211-699501013259,total,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,mediante,o
5,0211-699501013259,suplemento,o
5,0211-699501013259,con,o
5,0211-699501013259,acido,i
5,0211-699501013259,folico,i
5,0211-699501013259,y,o
5,0211-699501013259,vitamina,i
5,0211-699501013259,B6,i
5,0211-699501013259,pp,i
5,0211-699501013259,valorando,o
5,0211-699501013259,su,o
5,0211-699501013259,posible,o
5,0211-699501013259,correlacion,o
5,0211-699501013259,con,o
5,0211-699501013259,dosis,o
5,0211-699501013259,de,o
5,0211-699501013259,dialisis,i
5,0211-699501013259,funcion,i
5,0211-699501013259,residual,i
5,0211-699501013259,y,o
5,0211-699501013259,parametros,o
5,0211-699501013259,nutricionales,o
5,0211-699501013259,Metodos,o
5,0211-699501013259,Todos,o
5,0211-699501013259,los,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,en,o
5,0211-699501013259,hemodialisis,i
5,0211-699501013259,al,o
5,0211-699501013259,comienzo,o
5,0211-699501013259,del,o
5,0211-699501013259,estudio,o
5,0211-699501013259,que,o
5,0211-699501013259,no,o
5,0211-699501013259,recibian,o
5,0211-699501013259,acido,i
5,0211-699501013259,folico,i
5,0211-699501013259,ni,o
5,0211-699501013259,vitamina,i
5,0211-699501013259,B6,i
5,0211-699501013259,asi,o
5,0211-699501013259,como,o
5,0211-699501013259,los,o
5,0211-699501013259,incorporados,o
5,0211-699501013259,posteriormente,o
5,0211-699501013259,a,o
5,0211-699501013259,partir,o
5,0211-699501013259,de,o
5,0211-699501013259,su,o
5,0211-699501013259,tercer,o
5,0211-699501013259,mes,o
5,0211-699501013259,en,o
5,0211-699501013259,hemodialisis,i
5,0211-699501013259,recibieron,o
5,0211-699501013259,5,o
5,0211-699501013259,mg,o
5,0211-699501013259,orales,o
5,0211-699501013259,de,o
5,0211-699501013259,acido,i
5,0211-699501013259,folico,i
5,0211-699501013259,cada,o
5,0211-699501013259,48,o
5,0211-699501013259,horas,o
5,0211-699501013259,y,o
5,0211-699501013259,40,o
5,0211-699501013259,mg,o
5,0211-699501013259,orales,o
5,0211-699501013259,de,o
5,0211-699501013259,vitamina,i
5,0211-699501013259,B6,i
5,0211-699501013259,cada,o
5,0211-699501013259,semana,o
5,0211-699501013259,Se,o
5,0211-699501013259,determinaron,o
5,0211-699501013259,al,o
5,0211-699501013259,comienzo,o
5,0211-699501013259,del,o
5,0211-699501013259,estudio,o
5,0211-699501013259,y,o
5,0211-699501013259,cada,o
5,0211-699501013259,2,o
5,0211-699501013259,meses,o
5,0211-699501013259,niveles,i
5,0211-699501013259,de,i
5,0211-699501013259,folato,i
5,0211-699501013259,vitamina,i
5,0211-699501013259,B12,i
5,0211-699501013259,inmunoensayo,i
5,0211-699501013259,albumina,i
5,0211-699501013259,y,o
5,0211-699501013259,cinetica,o
5,0211-699501013259,de,o
5,0211-699501013259,la,o
5,0211-699501013259,urea,i
5,0211-699501013259,KTV,o
5,0211-699501013259,KRU,o
5,0211-699501013259,PCRn,o
5,0211-699501013259,y,o
5,0211-699501013259,cada,o
5,0211-699501013259,6,o
5,0211-699501013259,meses,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,HPLC,i
5,0211-699501013259,y,o
5,0211-699501013259,pp,i
5,0211-699501013259,RIA,i
5,0211-699501013259,Resultados,o
5,0211-699501013259,80,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,fueron,o
5,0211-699501013259,incluidos,o
5,0211-699501013259,en,o
5,0211-699501013259,el,o
5,0211-699501013259,estudio,o
5,0211-699501013259,basal,o
5,0211-699501013259,con,o
5,0211-699501013259,una,o
5,0211-699501013259,prevalencia,o
5,0211-699501013259,de,o
5,0211-699501013259,hiperhomocisteinemia,i
5,0211-699501013259,del,o
5,0211-699501013259,844,o
5,0211-699501013259,deficit,i
5,0211-699501013259,de,i
5,0211-699501013259,pp,i
5,0211-699501013259,en,o
5,0211-699501013259,el,o
5,0211-699501013259,32,o
5,0211-699501013259,y,o
5,0211-699501013259,folato,i
5,0211-699501013259,en,o
5,0211-699501013259,el,o
5,0211-699501013259,rango,o
5,0211-699501013259,normal,o
5,0211-699501013259,bajo,o
5,0211-699501013259,los,o
5,0211-699501013259,niveles,i
5,0211-699501013259,de,i
5,0211-699501013259,tHcy,i
5,0211-699501013259,se,o
5,0211-699501013259,correlacionaban,o
5,0211-699501013259,inversamente,o
5,0211-699501013259,con,o
5,0211-699501013259,los,o
5,0211-699501013259,del,o
5,0211-699501013259,folato,i
5,0211-699501013259,r,o
5,0211-699501013259,0336,o
5,0211-699501013259,p,o
5,0211-699501013259,001,o
5,0211-699501013259,pero,o
5,0211-699501013259,no,o
5,0211-699501013259,con,o
5,0211-699501013259,pp,i
5,0211-699501013259,B12,i
5,0211-699501013259,edad,o
5,0211-699501013259,albumina,i
5,0211-699501013259,KTV,o
5,0211-699501013259,KRU,o
5,0211-699501013259,PCRn,o
5,0211-699501013259,Cincuenta,o
5,0211-699501013259,y,o
5,0211-699501013259,ocho,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,recibieron,o
5,0211-699501013259,seis,o
5,0211-699501013259,meses,o
5,0211-699501013259,de,o
5,0211-699501013259,suplementacion,i
5,0211-699501013259,con,o
5,0211-699501013259,normalizacion,o
5,0211-699501013259,del,o
5,0211-699501013259,pp,i
5,0211-699501013259,aumento,o
5,0211-699501013259,del,o
5,0211-699501013259,folato,i
5,0211-699501013259,703,o
5,0211-699501013259,IC,o
5,0211-699501013259,638,o
5,0211-699501013259,795,o
5,0211-699501013259,vs,o
5,0211-699501013259,6181,o
5,0211-699501013259,IC,o
5,0211-699501013259,4447,o
5,0211-699501013259,7811,o
5,0211-699501013259,p,o
5,0211-699501013259,0001,o
5,0211-699501013259,y,o
5,0211-699501013259,descenso,o
5,0211-699501013259,de,o
5,0211-699501013259,la,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,240,o
5,0211-699501013259,IC,o
5,0211-699501013259,213,o
5,0211-699501013259,264,o
5,0211-699501013259,vs,o
5,0211-699501013259,199,o
5,0211-699501013259,IC,o
5,0211-699501013259,175,o
5,0211-699501013259,224,o
5,0211-699501013259,p,o
5,0211-699501013259,005,o
5,0211-699501013259,Han,o
5,0211-699501013259,recibido,o
5,0211-699501013259,suplementacion,i
5,0211-699501013259,durante,o
5,0211-699501013259,12,o
5,0211-699501013259,meses,o
5,0211-699501013259,33,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,pero,o
5,0211-699501013259,a,o
5,0211-699501013259,pesar,o
5,0211-699501013259,de,o
5,0211-699501013259,un,o
5,0211-699501013259,continuo,o
5,0211-699501013259,aumento,o
5,0211-699501013259,del,o
5,0211-699501013259,folato,i
5,0211-699501013259,10078,o
5,0211-699501013259,IC,o
5,0211-699501013259,7481,o
5,0211-699501013259,12674,o
5,0211-699501013259,p,o
5,0211-699501013259,0001,o
5,0211-699501013259,solo,o
5,0211-699501013259,3,o
5,0211-699501013259,pacientes,o
5,0211-699501013259,presentan,o
5,0211-699501013259,niveles,o
5,0211-699501013259,normales,o
5,0211-699501013259,de,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,correlacionandose,o
5,0211-699501013259,directamente,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,con,o
5,0211-699501013259,la,o
5,0211-699501013259,albumina,i
5,0211-699501013259,r,o
5,0211-699501013259,056,o
5,0211-699501013259,p,o
5,0211-699501013259,0001,o
5,0211-699501013259,que,o
5,0211-699501013259,se,o
5,0211-699501013259,elevo,o
5,0211-699501013259,con,o
5,0211-699501013259,respecto,o
5,0211-699501013259,al,o
5,0211-699501013259,inicio,o
5,0211-699501013259,337,o
5,0211-699501013259,IC,o
5,0211-699501013259,327,o
5,0211-699501013259,346,o
5,0211-699501013259,vs,o
5,0211-699501013259,350,o
5,0211-699501013259,IC,o
5,0211-699501013259,337,o
5,0211-699501013259,363,o
5,0211-699501013259,p,o
5,0211-699501013259,005,o
5,0211-699501013259,Conclusion,o
5,0211-699501013259,Tras,o
5,0211-699501013259,suplementacion,i
5,0211-699501013259,con,o
5,0211-699501013259,acido,i
5,0211-699501013259,folico,i
5,0211-699501013259,y,o
5,0211-699501013259,vitamina,i
5,0211-699501013259,B6,i
5,0211-699501013259,aunque,o
5,0211-699501013259,inicialmente,o
5,0211-699501013259,se,o
5,0211-699501013259,reduce,o
5,0211-699501013259,la,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,esta,o
5,0211-699501013259,respuesta,o
5,0211-699501013259,se,o
5,0211-699501013259,hace,o
5,0211-699501013259,refractaria,o
5,0211-699501013259,correlacionandose,o
5,0211-699501013259,directamente,o
5,0211-699501013259,la,o
5,0211-699501013259,tHcy,i
5,0211-699501013259,con,o
5,0211-699501013259,la,o
5,0211-699501013259,albumina,i
5,0211-699501013259,plasmatica,i
5,0211-699501013259,La,o
5,0211-699501013259,interpretacion,o
5,0211-699501013259,de,o
5,0211-699501013259,los,o
5,0211-699501013259,niveles,i
5,0211-699501013259,de,i
5,0211-699501013259,tHcy,i
5,0211-699501013259,debe,o
5,0211-699501013259,tener,o
5,0211-699501013259,en,o
5,0211-699501013259,cuenta,o
5,0211-699501013259,la,o
5,0211-699501013259,concentracion,i
5,0211-699501013259,de,i
5,0211-699501013259,albumina,i
6,0211-699501013259,Efecto,o
6,0211-699501013259,de,o
6,0211-699501013259,la,o
6,0211-699501013259,suplementacion,i
6,0211-699501013259,con,o
6,0211-699501013259,acido,i
6,0211-699501013259,folico,i
6,0211-699501013259,sobre,o
6,0211-699501013259,los,o
6,0211-699501013259,niveles,i
6,0211-699501013259,de,i
6,0211-699501013259,homocisteina,i
6,0211-699501013259,total,o
6,0211-699501013259,en,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,en,o
6,0211-699501013259,hemodialisis,i
6,0211-699501013259,La,o
6,0211-699501013259,hiperhomocisteinemia,i
6,0211-699501013259,es,o
6,0211-699501013259,un,o
6,0211-699501013259,marcador,o
6,0211-699501013259,de,o
6,0211-699501013259,riesgo,o
6,0211-699501013259,independiente,o
6,0211-699501013259,de,o
6,0211-699501013259,morbimortalidad,o
6,0211-699501013259,cardiovascular,i
6,0211-699501013259,Hemos,o
6,0211-699501013259,intentado,o
6,0211-699501013259,prospectivamente,o
6,0211-699501013259,reducir,o
6,0211-699501013259,los,o
6,0211-699501013259,niveles,i
6,0211-699501013259,de,i
6,0211-699501013259,homocisteina,i
6,0211-699501013259,total,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,mediante,o
6,0211-699501013259,suplemento,o
6,0211-699501013259,con,o
6,0211-699501013259,acido,i
6,0211-699501013259,folico,i
6,0211-699501013259,y,o
6,0211-699501013259,vitamina,i
6,0211-699501013259,B6,i
6,0211-699501013259,pp,i
6,0211-699501013259,valorando,o
6,0211-699501013259,su,o
6,0211-699501013259,posible,o
6,0211-699501013259,correlacion,o
6,0211-699501013259,con,o
6,0211-699501013259,dosis,o
6,0211-699501013259,de,o
6,0211-699501013259,dialisis,i
6,0211-699501013259,funcion,i
6,0211-699501013259,residual,i
6,0211-699501013259,y,o
6,0211-699501013259,parametros,o
6,0211-699501013259,nutricionales,o
6,0211-699501013259,Metodos,o
6,0211-699501013259,Todos,o
6,0211-699501013259,los,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,en,o
6,0211-699501013259,hemodialisis,i
6,0211-699501013259,al,o
6,0211-699501013259,comienzo,o
6,0211-699501013259,del,o
6,0211-699501013259,estudio,o
6,0211-699501013259,que,o
6,0211-699501013259,no,o
6,0211-699501013259,recibian,o
6,0211-699501013259,acido,i
6,0211-699501013259,folico,i
6,0211-699501013259,ni,o
6,0211-699501013259,vitamina,i
6,0211-699501013259,B6,i
6,0211-699501013259,asi,o
6,0211-699501013259,como,o
6,0211-699501013259,los,o
6,0211-699501013259,incorporados,o
6,0211-699501013259,posteriormente,o
6,0211-699501013259,a,o
6,0211-699501013259,partir,o
6,0211-699501013259,de,o
6,0211-699501013259,su,o
6,0211-699501013259,tercer,o
6,0211-699501013259,mes,o
6,0211-699501013259,en,o
6,0211-699501013259,hemodialisis,i
6,0211-699501013259,recibieron,o
6,0211-699501013259,5,o
6,0211-699501013259,mg,o
6,0211-699501013259,orales,o
6,0211-699501013259,de,o
6,0211-699501013259,acido,i
6,0211-699501013259,folico,i
6,0211-699501013259,cada,o
6,0211-699501013259,48,o
6,0211-699501013259,horas,o
6,0211-699501013259,y,o
6,0211-699501013259,40,o
6,0211-699501013259,mg,o
6,0211-699501013259,orales,o
6,0211-699501013259,de,o
6,0211-699501013259,vitamina,i
6,0211-699501013259,B6,i
6,0211-699501013259,cada,o
6,0211-699501013259,semana,o
6,0211-699501013259,Se,o
6,0211-699501013259,determinaron,o
6,0211-699501013259,al,o
6,0211-699501013259,comienzo,o
6,0211-699501013259,del,o
6,0211-699501013259,estudio,o
6,0211-699501013259,y,o
6,0211-699501013259,cada,o
6,0211-699501013259,2,o
6,0211-699501013259,meses,o
6,0211-699501013259,niveles,i
6,0211-699501013259,de,i
6,0211-699501013259,folato,i
6,0211-699501013259,vitamina,i
6,0211-699501013259,B12,i
6,0211-699501013259,inmunoensayo,i
6,0211-699501013259,albumina,i
6,0211-699501013259,y,o
6,0211-699501013259,cinetica,o
6,0211-699501013259,de,o
6,0211-699501013259,la,o
6,0211-699501013259,urea,i
6,0211-699501013259,KTV,o
6,0211-699501013259,KRU,o
6,0211-699501013259,PCRn,o
6,0211-699501013259,y,o
6,0211-699501013259,cada,o
6,0211-699501013259,6,o
6,0211-699501013259,meses,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,HPLC,i
6,0211-699501013259,y,o
6,0211-699501013259,pp,i
6,0211-699501013259,RIA,i
6,0211-699501013259,Resultados,o
6,0211-699501013259,80,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,fueron,o
6,0211-699501013259,incluidos,o
6,0211-699501013259,en,o
6,0211-699501013259,el,o
6,0211-699501013259,estudio,o
6,0211-699501013259,basal,o
6,0211-699501013259,con,o
6,0211-699501013259,una,o
6,0211-699501013259,prevalencia,o
6,0211-699501013259,de,o
6,0211-699501013259,hiperhomocisteinemia,i
6,0211-699501013259,del,o
6,0211-699501013259,844,o
6,0211-699501013259,deficit,i
6,0211-699501013259,de,i
6,0211-699501013259,pp,i
6,0211-699501013259,en,o
6,0211-699501013259,el,o
6,0211-699501013259,32,o
6,0211-699501013259,y,o
6,0211-699501013259,folato,i
6,0211-699501013259,en,o
6,0211-699501013259,el,o
6,0211-699501013259,rango,o
6,0211-699501013259,normal,o
6,0211-699501013259,bajo,o
6,0211-699501013259,los,o
6,0211-699501013259,niveles,i
6,0211-699501013259,de,i
6,0211-699501013259,tHcy,i
6,0211-699501013259,se,o
6,0211-699501013259,correlacionaban,o
6,0211-699501013259,inversamente,o
6,0211-699501013259,con,o
6,0211-699501013259,los,o
6,0211-699501013259,del,o
6,0211-699501013259,folato,i
6,0211-699501013259,r,o
6,0211-699501013259,0336,o
6,0211-699501013259,p,o
6,0211-699501013259,001,o
6,0211-699501013259,pero,o
6,0211-699501013259,no,o
6,0211-699501013259,con,o
6,0211-699501013259,pp,i
6,0211-699501013259,B12,i
6,0211-699501013259,edad,o
6,0211-699501013259,albumina,i
6,0211-699501013259,KTV,o
6,0211-699501013259,KRU,o
6,0211-699501013259,PCRn,o
6,0211-699501013259,Cincuenta,o
6,0211-699501013259,y,o
6,0211-699501013259,ocho,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,recibieron,o
6,0211-699501013259,seis,o
6,0211-699501013259,meses,o
6,0211-699501013259,de,o
6,0211-699501013259,suplementacion,i
6,0211-699501013259,con,o
6,0211-699501013259,normalizacion,o
6,0211-699501013259,del,o
6,0211-699501013259,pp,i
6,0211-699501013259,aumento,o
6,0211-699501013259,del,o
6,0211-699501013259,folato,i
6,0211-699501013259,703,o
6,0211-699501013259,IC,o
6,0211-699501013259,638,o
6,0211-699501013259,795,o
6,0211-699501013259,vs,o
6,0211-699501013259,6181,o
6,0211-699501013259,IC,o
6,0211-699501013259,4447,o
6,0211-699501013259,7811,o
6,0211-699501013259,p,o
6,0211-699501013259,0001,o
6,0211-699501013259,y,o
6,0211-699501013259,descenso,o
6,0211-699501013259,de,o
6,0211-699501013259,la,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,240,o
6,0211-699501013259,IC,o
6,0211-699501013259,213,o
6,0211-699501013259,264,o
6,0211-699501013259,vs,o
6,0211-699501013259,199,o
6,0211-699501013259,IC,o
6,0211-699501013259,175,o
6,0211-699501013259,224,o
6,0211-699501013259,p,o
6,0211-699501013259,005,o
6,0211-699501013259,Han,o
6,0211-699501013259,recibido,o
6,0211-699501013259,suplementacion,i
6,0211-699501013259,durante,o
6,0211-699501013259,12,o
6,0211-699501013259,meses,o
6,0211-699501013259,33,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,pero,o
6,0211-699501013259,a,o
6,0211-699501013259,pesar,o
6,0211-699501013259,de,o
6,0211-699501013259,un,o
6,0211-699501013259,continuo,o
6,0211-699501013259,aumento,o
6,0211-699501013259,del,o
6,0211-699501013259,folato,i
6,0211-699501013259,10078,o
6,0211-699501013259,IC,o
6,0211-699501013259,7481,o
6,0211-699501013259,12674,o
6,0211-699501013259,p,o
6,0211-699501013259,0001,o
6,0211-699501013259,solo,o
6,0211-699501013259,3,o
6,0211-699501013259,pacientes,o
6,0211-699501013259,presentan,o
6,0211-699501013259,niveles,o
6,0211-699501013259,normales,o
6,0211-699501013259,de,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,correlacionandose,o
6,0211-699501013259,directamente,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,con,o
6,0211-699501013259,la,o
6,0211-699501013259,albumina,i
6,0211-699501013259,r,o
6,0211-699501013259,056,o
6,0211-699501013259,p,o
6,0211-699501013259,0001,o
6,0211-699501013259,que,o
6,0211-699501013259,se,o
6,0211-699501013259,elevo,o
6,0211-699501013259,con,o
6,0211-699501013259,respecto,o
6,0211-699501013259,al,o
6,0211-699501013259,inicio,o
6,0211-699501013259,337,o
6,0211-699501013259,IC,o
6,0211-699501013259,327,o
6,0211-699501013259,346,o
6,0211-699501013259,vs,o
6,0211-699501013259,350,o
6,0211-699501013259,IC,o
6,0211-699501013259,337,o
6,0211-699501013259,363,o
6,0211-699501013259,p,o
6,0211-699501013259,005,o
6,0211-699501013259,Conclusion,o
6,0211-699501013259,Tras,o
6,0211-699501013259,suplementacion,i
6,0211-699501013259,con,o
6,0211-699501013259,acido,i
6,0211-699501013259,folico,i
6,0211-699501013259,y,o
6,0211-699501013259,vitamina,i
6,0211-699501013259,B6,i
6,0211-699501013259,aunque,o
6,0211-699501013259,inicialmente,o
6,0211-699501013259,se,o
6,0211-699501013259,reduce,o
6,0211-699501013259,la,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,esta,o
6,0211-699501013259,respuesta,o
6,0211-699501013259,se,o
6,0211-699501013259,hace,o
6,0211-699501013259,refractaria,o
6,0211-699501013259,correlacionandose,o
6,0211-699501013259,directamente,o
6,0211-699501013259,la,o
6,0211-699501013259,tHcy,i
6,0211-699501013259,con,o
6,0211-699501013259,la,o
6,0211-699501013259,albumina,i
6,0211-699501013259,plasmatica,i
6,0211-699501013259,La,o
6,0211-699501013259,interpretacion,o
6,0211-699501013259,de,o
6,0211-699501013259,los,o
6,0211-699501013259,niveles,i
6,0211-699501013259,de,i
6,0211-699501013259,tHcy,i
6,0211-699501013259,debe,o
6,0211-699501013259,tener,o
6,0211-699501013259,en,o
6,0211-699501013259,cuenta,o
6,0211-699501013259,la,o
6,0211-699501013259,concentracion,i
6,0211-699501013259,de,i
6,0211-699501013259,albumina,i
7,0211-699501013259,Efecto,o
7,0211-699501013259,de,o
7,0211-699501013259,la,o
7,0211-699501013259,suplementacion,i
7,0211-699501013259,con,o
7,0211-699501013259,acido,i
7,0211-699501013259,folico,i
7,0211-699501013259,sobre,o
7,0211-699501013259,los,o
7,0211-699501013259,niveles,i
7,0211-699501013259,de,i
7,0211-699501013259,homocisteina,i
7,0211-699501013259,total,o
7,0211-699501013259,en,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,en,o
7,0211-699501013259,hemodialisis,i
7,0211-699501013259,La,o
7,0211-699501013259,hiperhomocisteinemia,i
7,0211-699501013259,es,o
7,0211-699501013259,un,o
7,0211-699501013259,marcador,o
7,0211-699501013259,de,o
7,0211-699501013259,riesgo,o
7,0211-699501013259,independiente,o
7,0211-699501013259,de,o
7,0211-699501013259,morbimortalidad,o
7,0211-699501013259,cardiovascular,i
7,0211-699501013259,Hemos,o
7,0211-699501013259,intentado,o
7,0211-699501013259,prospectivamente,o
7,0211-699501013259,reducir,o
7,0211-699501013259,los,o
7,0211-699501013259,niveles,i
7,0211-699501013259,de,i
7,0211-699501013259,homocisteina,i
7,0211-699501013259,total,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,mediante,o
7,0211-699501013259,suplemento,o
7,0211-699501013259,con,o
7,0211-699501013259,acido,i
7,0211-699501013259,folico,i
7,0211-699501013259,y,o
7,0211-699501013259,vitamina,i
7,0211-699501013259,B6,i
7,0211-699501013259,pp,i
7,0211-699501013259,valorando,o
7,0211-699501013259,su,o
7,0211-699501013259,posible,o
7,0211-699501013259,correlacion,o
7,0211-699501013259,con,o
7,0211-699501013259,dosis,o
7,0211-699501013259,de,o
7,0211-699501013259,dialisis,i
7,0211-699501013259,funcion,i
7,0211-699501013259,residual,i
7,0211-699501013259,y,o
7,0211-699501013259,parametros,o
7,0211-699501013259,nutricionales,o
7,0211-699501013259,Metodos,o
7,0211-699501013259,Todos,o
7,0211-699501013259,los,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,en,o
7,0211-699501013259,hemodialisis,i
7,0211-699501013259,al,o
7,0211-699501013259,comienzo,o
7,0211-699501013259,del,o
7,0211-699501013259,estudio,o
7,0211-699501013259,que,o
7,0211-699501013259,no,o
7,0211-699501013259,recibian,o
7,0211-699501013259,acido,i
7,0211-699501013259,folico,i
7,0211-699501013259,ni,o
7,0211-699501013259,vitamina,i
7,0211-699501013259,B6,i
7,0211-699501013259,asi,o
7,0211-699501013259,como,o
7,0211-699501013259,los,o
7,0211-699501013259,incorporados,o
7,0211-699501013259,posteriormente,o
7,0211-699501013259,a,o
7,0211-699501013259,partir,o
7,0211-699501013259,de,o
7,0211-699501013259,su,o
7,0211-699501013259,tercer,o
7,0211-699501013259,mes,o
7,0211-699501013259,en,o
7,0211-699501013259,hemodialisis,i
7,0211-699501013259,recibieron,o
7,0211-699501013259,5,o
7,0211-699501013259,mg,o
7,0211-699501013259,orales,o
7,0211-699501013259,de,o
7,0211-699501013259,acido,i
7,0211-699501013259,folico,i
7,0211-699501013259,cada,o
7,0211-699501013259,48,o
7,0211-699501013259,horas,o
7,0211-699501013259,y,o
7,0211-699501013259,40,o
7,0211-699501013259,mg,o
7,0211-699501013259,orales,o
7,0211-699501013259,de,o
7,0211-699501013259,vitamina,i
7,0211-699501013259,B6,i
7,0211-699501013259,cada,o
7,0211-699501013259,semana,o
7,0211-699501013259,Se,o
7,0211-699501013259,determinaron,o
7,0211-699501013259,al,o
7,0211-699501013259,comienzo,o
7,0211-699501013259,del,o
7,0211-699501013259,estudio,o
7,0211-699501013259,y,o
7,0211-699501013259,cada,o
7,0211-699501013259,2,o
7,0211-699501013259,meses,o
7,0211-699501013259,niveles,i
7,0211-699501013259,de,i
7,0211-699501013259,folato,i
7,0211-699501013259,vitamina,i
7,0211-699501013259,B12,i
7,0211-699501013259,inmunoensayo,i
7,0211-699501013259,albumina,i
7,0211-699501013259,y,o
7,0211-699501013259,cinetica,o
7,0211-699501013259,de,o
7,0211-699501013259,la,o
7,0211-699501013259,urea,i
7,0211-699501013259,KTV,o
7,0211-699501013259,KRU,o
7,0211-699501013259,PCRn,o
7,0211-699501013259,y,o
7,0211-699501013259,cada,o
7,0211-699501013259,6,o
7,0211-699501013259,meses,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,HPLC,i
7,0211-699501013259,y,o
7,0211-699501013259,pp,i
7,0211-699501013259,RIA,i
7,0211-699501013259,Resultados,o
7,0211-699501013259,80,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,fueron,o
7,0211-699501013259,incluidos,o
7,0211-699501013259,en,o
7,0211-699501013259,el,o
7,0211-699501013259,estudio,o
7,0211-699501013259,basal,o
7,0211-699501013259,con,o
7,0211-699501013259,una,o
7,0211-699501013259,prevalencia,o
7,0211-699501013259,de,o
7,0211-699501013259,hiperhomocisteinemia,i
7,0211-699501013259,del,o
7,0211-699501013259,844,o
7,0211-699501013259,deficit,i
7,0211-699501013259,de,i
7,0211-699501013259,pp,i
7,0211-699501013259,en,o
7,0211-699501013259,el,o
7,0211-699501013259,32,o
7,0211-699501013259,y,o
7,0211-699501013259,folato,i
7,0211-699501013259,en,o
7,0211-699501013259,el,o
7,0211-699501013259,rango,o
7,0211-699501013259,normal,o
7,0211-699501013259,bajo,o
7,0211-699501013259,los,o
7,0211-699501013259,niveles,i
7,0211-699501013259,de,i
7,0211-699501013259,tHcy,i
7,0211-699501013259,se,o
7,0211-699501013259,correlacionaban,o
7,0211-699501013259,inversamente,o
7,0211-699501013259,con,o
7,0211-699501013259,los,o
7,0211-699501013259,del,o
7,0211-699501013259,folato,i
7,0211-699501013259,r,o
7,0211-699501013259,0336,o
7,0211-699501013259,p,o
7,0211-699501013259,001,o
7,0211-699501013259,pero,o
7,0211-699501013259,no,o
7,0211-699501013259,con,o
7,0211-699501013259,pp,i
7,0211-699501013259,B12,i
7,0211-699501013259,edad,o
7,0211-699501013259,albumina,i
7,0211-699501013259,KTV,o
7,0211-699501013259,KRU,o
7,0211-699501013259,PCRn,o
7,0211-699501013259,Cincuenta,o
7,0211-699501013259,y,o
7,0211-699501013259,ocho,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,recibieron,o
7,0211-699501013259,seis,o
7,0211-699501013259,meses,o
7,0211-699501013259,de,o
7,0211-699501013259,suplementacion,i
7,0211-699501013259,con,o
7,0211-699501013259,normalizacion,o
7,0211-699501013259,del,o
7,0211-699501013259,pp,i
7,0211-699501013259,aumento,o
7,0211-699501013259,del,o
7,0211-699501013259,folato,i
7,0211-699501013259,703,o
7,0211-699501013259,IC,o
7,0211-699501013259,638,o
7,0211-699501013259,795,o
7,0211-699501013259,vs,o
7,0211-699501013259,6181,o
7,0211-699501013259,IC,o
7,0211-699501013259,4447,o
7,0211-699501013259,7811,o
7,0211-699501013259,p,o
7,0211-699501013259,0001,o
7,0211-699501013259,y,o
7,0211-699501013259,descenso,o
7,0211-699501013259,de,o
7,0211-699501013259,la,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,240,o
7,0211-699501013259,IC,o
7,0211-699501013259,213,o
7,0211-699501013259,264,o
7,0211-699501013259,vs,o
7,0211-699501013259,199,o
7,0211-699501013259,IC,o
7,0211-699501013259,175,o
7,0211-699501013259,224,o
7,0211-699501013259,p,o
7,0211-699501013259,005,o
7,0211-699501013259,Han,o
7,0211-699501013259,recibido,o
7,0211-699501013259,suplementacion,i
7,0211-699501013259,durante,o
7,0211-699501013259,12,o
7,0211-699501013259,meses,o
7,0211-699501013259,33,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,pero,o
7,0211-699501013259,a,o
7,0211-699501013259,pesar,o
7,0211-699501013259,de,o
7,0211-699501013259,un,o
7,0211-699501013259,continuo,o
7,0211-699501013259,aumento,o
7,0211-699501013259,del,o
7,0211-699501013259,folato,i
7,0211-699501013259,10078,o
7,0211-699501013259,IC,o
7,0211-699501013259,7481,o
7,0211-699501013259,12674,o
7,0211-699501013259,p,o
7,0211-699501013259,0001,o
7,0211-699501013259,solo,o
7,0211-699501013259,3,o
7,0211-699501013259,pacientes,o
7,0211-699501013259,presentan,o
7,0211-699501013259,niveles,o
7,0211-699501013259,normales,o
7,0211-699501013259,de,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,correlacionandose,o
7,0211-699501013259,directamente,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,con,o
7,0211-699501013259,la,o
7,0211-699501013259,albumina,i
7,0211-699501013259,r,o
7,0211-699501013259,056,o
7,0211-699501013259,p,o
7,0211-699501013259,0001,o
7,0211-699501013259,que,o
7,0211-699501013259,se,o
7,0211-699501013259,elevo,o
7,0211-699501013259,con,o
7,0211-699501013259,respecto,o
7,0211-699501013259,al,o
7,0211-699501013259,inicio,o
7,0211-699501013259,337,o
7,0211-699501013259,IC,o
7,0211-699501013259,327,o
7,0211-699501013259,346,o
7,0211-699501013259,vs,o
7,0211-699501013259,350,o
7,0211-699501013259,IC,o
7,0211-699501013259,337,o
7,0211-699501013259,363,o
7,0211-699501013259,p,o
7,0211-699501013259,005,o
7,0211-699501013259,Conclusion,o
7,0211-699501013259,Tras,o
7,0211-699501013259,suplementacion,i
7,0211-699501013259,con,o
7,0211-699501013259,acido,i
7,0211-699501013259,folico,i
7,0211-699501013259,y,o
7,0211-699501013259,vitamina,i
7,0211-699501013259,B6,i
7,0211-699501013259,aunque,o
7,0211-699501013259,inicialmente,o
7,0211-699501013259,se,o
7,0211-699501013259,reduce,o
7,0211-699501013259,la,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,esta,o
7,0211-699501013259,respuesta,o
7,0211-699501013259,se,o
7,0211-699501013259,hace,o
7,0211-699501013259,refractaria,o
7,0211-699501013259,correlacionandose,o
7,0211-699501013259,directamente,o
7,0211-699501013259,la,o
7,0211-699501013259,tHcy,i
7,0211-699501013259,con,o
7,0211-699501013259,la,o
7,0211-699501013259,albumina,i
7,0211-699501013259,plasmatica,i
7,0211-699501013259,La,o
7,0211-699501013259,interpretacion,o
7,0211-699501013259,de,o
7,0211-699501013259,los,o
7,0211-699501013259,niveles,i
7,0211-699501013259,de,i
7,0211-699501013259,tHcy,i
7,0211-699501013259,debe,o
7,0211-699501013259,tener,o
7,0211-699501013259,en,o
7,0211-699501013259,cuenta,o
7,0211-699501013259,la,o
7,0211-699501013259,concentracion,i
7,0211-699501013259,de,i
7,0211-699501013259,albumina,i
8,0211-699501013259,Efecto,o
8,0211-699501013259,de,o
8,0211-699501013259,la,o
8,0211-699501013259,suplementacion,i
8,0211-699501013259,con,o
8,0211-699501013259,acido,i
8,0211-699501013259,folico,i
8,0211-699501013259,sobre,o
8,0211-699501013259,los,o
8,0211-699501013259,niveles,i
8,0211-699501013259,de,i
8,0211-699501013259,homocisteina,i
8,0211-699501013259,total,o
8,0211-699501013259,en,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,en,o
8,0211-699501013259,hemodialisis,i
8,0211-699501013259,La,o
8,0211-699501013259,hiperhomocisteinemia,i
8,0211-699501013259,es,o
8,0211-699501013259,un,o
8,0211-699501013259,marcador,o
8,0211-699501013259,de,o
8,0211-699501013259,riesgo,o
8,0211-699501013259,independiente,o
8,0211-699501013259,de,o
8,0211-699501013259,morbimortalidad,o
8,0211-699501013259,cardiovascular,i
8,0211-699501013259,Hemos,o
8,0211-699501013259,intentado,o
8,0211-699501013259,prospectivamente,o
8,0211-699501013259,reducir,o
8,0211-699501013259,los,o
8,0211-699501013259,niveles,i
8,0211-699501013259,de,i
8,0211-699501013259,homocisteina,i
8,0211-699501013259,total,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,mediante,o
8,0211-699501013259,suplemento,o
8,0211-699501013259,con,o
8,0211-699501013259,acido,i
8,0211-699501013259,folico,i
8,0211-699501013259,y,o
8,0211-699501013259,vitamina,i
8,0211-699501013259,B6,i
8,0211-699501013259,pp,i
8,0211-699501013259,valorando,o
8,0211-699501013259,su,o
8,0211-699501013259,posible,o
8,0211-699501013259,correlacion,o
8,0211-699501013259,con,o
8,0211-699501013259,dosis,o
8,0211-699501013259,de,o
8,0211-699501013259,dialisis,i
8,0211-699501013259,funcion,i
8,0211-699501013259,residual,i
8,0211-699501013259,y,o
8,0211-699501013259,parametros,o
8,0211-699501013259,nutricionales,o
8,0211-699501013259,Metodos,o
8,0211-699501013259,Todos,o
8,0211-699501013259,los,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,en,o
8,0211-699501013259,hemodialisis,i
8,0211-699501013259,al,o
8,0211-699501013259,comienzo,o
8,0211-699501013259,del,o
8,0211-699501013259,estudio,o
8,0211-699501013259,que,o
8,0211-699501013259,no,o
8,0211-699501013259,recibian,o
8,0211-699501013259,acido,i
8,0211-699501013259,folico,i
8,0211-699501013259,ni,o
8,0211-699501013259,vitamina,i
8,0211-699501013259,B6,i
8,0211-699501013259,asi,o
8,0211-699501013259,como,o
8,0211-699501013259,los,o
8,0211-699501013259,incorporados,o
8,0211-699501013259,posteriormente,o
8,0211-699501013259,a,o
8,0211-699501013259,partir,o
8,0211-699501013259,de,o
8,0211-699501013259,su,o
8,0211-699501013259,tercer,o
8,0211-699501013259,mes,o
8,0211-699501013259,en,o
8,0211-699501013259,hemodialisis,i
8,0211-699501013259,recibieron,o
8,0211-699501013259,5,o
8,0211-699501013259,mg,o
8,0211-699501013259,orales,o
8,0211-699501013259,de,o
8,0211-699501013259,acido,i
8,0211-699501013259,folico,i
8,0211-699501013259,cada,o
8,0211-699501013259,48,o
8,0211-699501013259,horas,o
8,0211-699501013259,y,o
8,0211-699501013259,40,o
8,0211-699501013259,mg,o
8,0211-699501013259,orales,o
8,0211-699501013259,de,o
8,0211-699501013259,vitamina,i
8,0211-699501013259,B6,i
8,0211-699501013259,cada,o
8,0211-699501013259,semana,o
8,0211-699501013259,Se,o
8,0211-699501013259,determinaron,o
8,0211-699501013259,al,o
8,0211-699501013259,comienzo,o
8,0211-699501013259,del,o
8,0211-699501013259,estudio,o
8,0211-699501013259,y,o
8,0211-699501013259,cada,o
8,0211-699501013259,2,o
8,0211-699501013259,meses,o
8,0211-699501013259,niveles,i
8,0211-699501013259,de,i
8,0211-699501013259,folato,i
8,0211-699501013259,vitamina,i
8,0211-699501013259,B12,i
8,0211-699501013259,inmunoensayo,i
8,0211-699501013259,albumina,i
8,0211-699501013259,y,o
8,0211-699501013259,cinetica,o
8,0211-699501013259,de,o
8,0211-699501013259,la,o
8,0211-699501013259,urea,i
8,0211-699501013259,KTV,o
8,0211-699501013259,KRU,o
8,0211-699501013259,PCRn,o
8,0211-699501013259,y,o
8,0211-699501013259,cada,o
8,0211-699501013259,6,o
8,0211-699501013259,meses,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,HPLC,i
8,0211-699501013259,y,o
8,0211-699501013259,pp,i
8,0211-699501013259,RIA,i
8,0211-699501013259,Resultados,o
8,0211-699501013259,80,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,fueron,o
8,0211-699501013259,incluidos,o
8,0211-699501013259,en,o
8,0211-699501013259,el,o
8,0211-699501013259,estudio,o
8,0211-699501013259,basal,o
8,0211-699501013259,con,o
8,0211-699501013259,una,o
8,0211-699501013259,prevalencia,o
8,0211-699501013259,de,o
8,0211-699501013259,hiperhomocisteinemia,i
8,0211-699501013259,del,o
8,0211-699501013259,844,o
8,0211-699501013259,deficit,i
8,0211-699501013259,de,i
8,0211-699501013259,pp,i
8,0211-699501013259,en,o
8,0211-699501013259,el,o
8,0211-699501013259,32,o
8,0211-699501013259,y,o
8,0211-699501013259,folato,i
8,0211-699501013259,en,o
8,0211-699501013259,el,o
8,0211-699501013259,rango,o
8,0211-699501013259,normal,o
8,0211-699501013259,bajo,o
8,0211-699501013259,los,o
8,0211-699501013259,niveles,i
8,0211-699501013259,de,i
8,0211-699501013259,tHcy,i
8,0211-699501013259,se,o
8,0211-699501013259,correlacionaban,o
8,0211-699501013259,inversamente,o
8,0211-699501013259,con,o
8,0211-699501013259,los,o
8,0211-699501013259,del,o
8,0211-699501013259,folato,i
8,0211-699501013259,r,o
8,0211-699501013259,0336,o
8,0211-699501013259,p,o
8,0211-699501013259,001,o
8,0211-699501013259,pero,o
8,0211-699501013259,no,o
8,0211-699501013259,con,o
8,0211-699501013259,pp,i
8,0211-699501013259,B12,i
8,0211-699501013259,edad,o
8,0211-699501013259,albumina,i
8,0211-699501013259,KTV,o
8,0211-699501013259,KRU,o
8,0211-699501013259,PCRn,o
8,0211-699501013259,Cincuenta,o
8,0211-699501013259,y,o
8,0211-699501013259,ocho,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,recibieron,o
8,0211-699501013259,seis,o
8,0211-699501013259,meses,o
8,0211-699501013259,de,o
8,0211-699501013259,suplementacion,i
8,0211-699501013259,con,o
8,0211-699501013259,normalizacion,o
8,0211-699501013259,del,o
8,0211-699501013259,pp,i
8,0211-699501013259,aumento,o
8,0211-699501013259,del,o
8,0211-699501013259,folato,i
8,0211-699501013259,703,o
8,0211-699501013259,IC,o
8,0211-699501013259,638,o
8,0211-699501013259,795,o
8,0211-699501013259,vs,o
8,0211-699501013259,6181,o
8,0211-699501013259,IC,o
8,0211-699501013259,4447,o
8,0211-699501013259,7811,o
8,0211-699501013259,p,o
8,0211-699501013259,0001,o
8,0211-699501013259,y,o
8,0211-699501013259,descenso,o
8,0211-699501013259,de,o
8,0211-699501013259,la,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,240,o
8,0211-699501013259,IC,o
8,0211-699501013259,213,o
8,0211-699501013259,264,o
8,0211-699501013259,vs,o
8,0211-699501013259,199,o
8,0211-699501013259,IC,o
8,0211-699501013259,175,o
8,0211-699501013259,224,o
8,0211-699501013259,p,o
8,0211-699501013259,005,o
8,0211-699501013259,Han,o
8,0211-699501013259,recibido,o
8,0211-699501013259,suplementacion,i
8,0211-699501013259,durante,o
8,0211-699501013259,12,o
8,0211-699501013259,meses,o
8,0211-699501013259,33,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,pero,o
8,0211-699501013259,a,o
8,0211-699501013259,pesar,o
8,0211-699501013259,de,o
8,0211-699501013259,un,o
8,0211-699501013259,continuo,o
8,0211-699501013259,aumento,o
8,0211-699501013259,del,o
8,0211-699501013259,folato,i
8,0211-699501013259,10078,o
8,0211-699501013259,IC,o
8,0211-699501013259,7481,o
8,0211-699501013259,12674,o
8,0211-699501013259,p,o
8,0211-699501013259,0001,o
8,0211-699501013259,solo,o
8,0211-699501013259,3,o
8,0211-699501013259,pacientes,o
8,0211-699501013259,presentan,o
8,0211-699501013259,niveles,o
8,0211-699501013259,normales,o
8,0211-699501013259,de,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,correlacionandose,o
8,0211-699501013259,directamente,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,con,o
8,0211-699501013259,la,o
8,0211-699501013259,albumina,i
8,0211-699501013259,r,o
8,0211-699501013259,056,o
8,0211-699501013259,p,o
8,0211-699501013259,0001,o
8,0211-699501013259,que,o
8,0211-699501013259,se,o
8,0211-699501013259,elevo,o
8,0211-699501013259,con,o
8,0211-699501013259,respecto,o
8,0211-699501013259,al,o
8,0211-699501013259,inicio,o
8,0211-699501013259,337,o
8,0211-699501013259,IC,o
8,0211-699501013259,327,o
8,0211-699501013259,346,o
8,0211-699501013259,vs,o
8,0211-699501013259,350,o
8,0211-699501013259,IC,o
8,0211-699501013259,337,o
8,0211-699501013259,363,o
8,0211-699501013259,p,o
8,0211-699501013259,005,o
8,0211-699501013259,Conclusion,o
8,0211-699501013259,Tras,o
8,0211-699501013259,suplementacion,i
8,0211-699501013259,con,o
8,0211-699501013259,acido,i
8,0211-699501013259,folico,i
8,0211-699501013259,y,o
8,0211-699501013259,vitamina,i
8,0211-699501013259,B6,i
8,0211-699501013259,aunque,o
8,0211-699501013259,inicialmente,o
8,0211-699501013259,se,o
8,0211-699501013259,reduce,o
8,0211-699501013259,la,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,esta,o
8,0211-699501013259,respuesta,o
8,0211-699501013259,se,o
8,0211-699501013259,hace,o
8,0211-699501013259,refractaria,o
8,0211-699501013259,correlacionandose,o
8,0211-699501013259,directamente,o
8,0211-699501013259,la,o
8,0211-699501013259,tHcy,i
8,0211-699501013259,con,o
8,0211-699501013259,la,o
8,0211-699501013259,albumina,i
8,0211-699501013259,plasmatica,i
8,0211-699501013259,La,o
8,0211-699501013259,interpretacion,o
8,0211-699501013259,de,o
8,0211-699501013259,los,o
8,0211-699501013259,niveles,i
8,0211-699501013259,de,i
8,0211-699501013259,tHcy,i
8,0211-699501013259,debe,o
8,0211-699501013259,tener,o
8,0211-699501013259,en,o
8,0211-699501013259,cuenta,o
8,0211-699501013259,la,o
8,0211-699501013259,concentracion,i
8,0211-699501013259,de,i
8,0211-699501013259,albumina,i
9,0211-699501013259,Efecto,o
9,0211-699501013259,de,o
9,0211-699501013259,la,o
9,0211-699501013259,suplementacion,i
9,0211-699501013259,con,o
9,0211-699501013259,acido,i
9,0211-699501013259,folico,i
9,0211-699501013259,sobre,o
9,0211-699501013259,los,o
9,0211-699501013259,niveles,i
9,0211-699501013259,de,i
9,0211-699501013259,homocisteina,i
9,0211-699501013259,total,o
9,0211-699501013259,en,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,en,o
9,0211-699501013259,hemodialisis,i
9,0211-699501013259,La,o
9,0211-699501013259,hiperhomocisteinemia,i
9,0211-699501013259,es,o
9,0211-699501013259,un,o
9,0211-699501013259,marcador,o
9,0211-699501013259,de,o
9,0211-699501013259,riesgo,o
9,0211-699501013259,independiente,o
9,0211-699501013259,de,o
9,0211-699501013259,morbimortalidad,o
9,0211-699501013259,cardiovascular,i
9,0211-699501013259,Hemos,o
9,0211-699501013259,intentado,o
9,0211-699501013259,prospectivamente,o
9,0211-699501013259,reducir,o
9,0211-699501013259,los,o
9,0211-699501013259,niveles,i
9,0211-699501013259,de,i
9,0211-699501013259,homocisteina,i
9,0211-699501013259,total,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,mediante,o
9,0211-699501013259,suplemento,o
9,0211-699501013259,con,o
9,0211-699501013259,acido,i
9,0211-699501013259,folico,i
9,0211-699501013259,y,o
9,0211-699501013259,vitamina,i
9,0211-699501013259,B6,i
9,0211-699501013259,pp,i
9,0211-699501013259,valorando,o
9,0211-699501013259,su,o
9,0211-699501013259,posible,o
9,0211-699501013259,correlacion,o
9,0211-699501013259,con,o
9,0211-699501013259,dosis,o
9,0211-699501013259,de,o
9,0211-699501013259,dialisis,i
9,0211-699501013259,funcion,i
9,0211-699501013259,residual,i
9,0211-699501013259,y,o
9,0211-699501013259,parametros,o
9,0211-699501013259,nutricionales,o
9,0211-699501013259,Metodos,o
9,0211-699501013259,Todos,o
9,0211-699501013259,los,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,en,o
9,0211-699501013259,hemodialisis,i
9,0211-699501013259,al,o
9,0211-699501013259,comienzo,o
9,0211-699501013259,del,o
9,0211-699501013259,estudio,o
9,0211-699501013259,que,o
9,0211-699501013259,no,o
9,0211-699501013259,recibian,o
9,0211-699501013259,acido,i
9,0211-699501013259,folico,i
9,0211-699501013259,ni,o
9,0211-699501013259,vitamina,i
9,0211-699501013259,B6,i
9,0211-699501013259,asi,o
9,0211-699501013259,como,o
9,0211-699501013259,los,o
9,0211-699501013259,incorporados,o
9,0211-699501013259,posteriormente,o
9,0211-699501013259,a,o
9,0211-699501013259,partir,o
9,0211-699501013259,de,o
9,0211-699501013259,su,o
9,0211-699501013259,tercer,o
9,0211-699501013259,mes,o
9,0211-699501013259,en,o
9,0211-699501013259,hemodialisis,i
9,0211-699501013259,recibieron,o
9,0211-699501013259,5,o
9,0211-699501013259,mg,o
9,0211-699501013259,orales,o
9,0211-699501013259,de,o
9,0211-699501013259,acido,i
9,0211-699501013259,folico,i
9,0211-699501013259,cada,o
9,0211-699501013259,48,o
9,0211-699501013259,horas,o
9,0211-699501013259,y,o
9,0211-699501013259,40,o
9,0211-699501013259,mg,o
9,0211-699501013259,orales,o
9,0211-699501013259,de,o
9,0211-699501013259,vitamina,i
9,0211-699501013259,B6,i
9,0211-699501013259,cada,o
9,0211-699501013259,semana,o
9,0211-699501013259,Se,o
9,0211-699501013259,determinaron,o
9,0211-699501013259,al,o
9,0211-699501013259,comienzo,o
9,0211-699501013259,del,o
9,0211-699501013259,estudio,o
9,0211-699501013259,y,o
9,0211-699501013259,cada,o
9,0211-699501013259,2,o
9,0211-699501013259,meses,o
9,0211-699501013259,niveles,i
9,0211-699501013259,de,i
9,0211-699501013259,folato,i
9,0211-699501013259,vitamina,i
9,0211-699501013259,B12,i
9,0211-699501013259,inmunoensayo,i
9,0211-699501013259,albumina,i
9,0211-699501013259,y,o
9,0211-699501013259,cinetica,o
9,0211-699501013259,de,o
9,0211-699501013259,la,o
9,0211-699501013259,urea,i
9,0211-699501013259,KTV,o
9,0211-699501013259,KRU,o
9,0211-699501013259,PCRn,o
9,0211-699501013259,y,o
9,0211-699501013259,cada,o
9,0211-699501013259,6,o
9,0211-699501013259,meses,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,HPLC,i
9,0211-699501013259,y,o
9,0211-699501013259,pp,i
9,0211-699501013259,RIA,i
9,0211-699501013259,Resultados,o
9,0211-699501013259,80,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,fueron,o
9,0211-699501013259,incluidos,o
9,0211-699501013259,en,o
9,0211-699501013259,el,o
9,0211-699501013259,estudio,o
9,0211-699501013259,basal,o
9,0211-699501013259,con,o
9,0211-699501013259,una,o
9,0211-699501013259,prevalencia,o
9,0211-699501013259,de,o
9,0211-699501013259,hiperhomocisteinemia,i
9,0211-699501013259,del,o
9,0211-699501013259,844,o
9,0211-699501013259,deficit,i
9,0211-699501013259,de,i
9,0211-699501013259,pp,i
9,0211-699501013259,en,o
9,0211-699501013259,el,o
9,0211-699501013259,32,o
9,0211-699501013259,y,o
9,0211-699501013259,folato,i
9,0211-699501013259,en,o
9,0211-699501013259,el,o
9,0211-699501013259,rango,o
9,0211-699501013259,normal,o
9,0211-699501013259,bajo,o
9,0211-699501013259,los,o
9,0211-699501013259,niveles,i
9,0211-699501013259,de,i
9,0211-699501013259,tHcy,i
9,0211-699501013259,se,o
9,0211-699501013259,correlacionaban,o
9,0211-699501013259,inversamente,o
9,0211-699501013259,con,o
9,0211-699501013259,los,o
9,0211-699501013259,del,o
9,0211-699501013259,folato,i
9,0211-699501013259,r,o
9,0211-699501013259,0336,o
9,0211-699501013259,p,o
9,0211-699501013259,001,o
9,0211-699501013259,pero,o
9,0211-699501013259,no,o
9,0211-699501013259,con,o
9,0211-699501013259,pp,i
9,0211-699501013259,B12,i
9,0211-699501013259,edad,o
9,0211-699501013259,albumina,i
9,0211-699501013259,KTV,o
9,0211-699501013259,KRU,o
9,0211-699501013259,PCRn,o
9,0211-699501013259,Cincuenta,o
9,0211-699501013259,y,o
9,0211-699501013259,ocho,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,recibieron,o
9,0211-699501013259,seis,o
9,0211-699501013259,meses,o
9,0211-699501013259,de,o
9,0211-699501013259,suplementacion,i
9,0211-699501013259,con,o
9,0211-699501013259,normalizacion,o
9,0211-699501013259,del,o
9,0211-699501013259,pp,i
9,0211-699501013259,aumento,o
9,0211-699501013259,del,o
9,0211-699501013259,folato,i
9,0211-699501013259,703,o
9,0211-699501013259,IC,o
9,0211-699501013259,638,o
9,0211-699501013259,795,o
9,0211-699501013259,vs,o
9,0211-699501013259,6181,o
9,0211-699501013259,IC,o
9,0211-699501013259,4447,o
9,0211-699501013259,7811,o
9,0211-699501013259,p,o
9,0211-699501013259,0001,o
9,0211-699501013259,y,o
9,0211-699501013259,descenso,o
9,0211-699501013259,de,o
9,0211-699501013259,la,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,240,o
9,0211-699501013259,IC,o
9,0211-699501013259,213,o
9,0211-699501013259,264,o
9,0211-699501013259,vs,o
9,0211-699501013259,199,o
9,0211-699501013259,IC,o
9,0211-699501013259,175,o
9,0211-699501013259,224,o
9,0211-699501013259,p,o
9,0211-699501013259,005,o
9,0211-699501013259,Han,o
9,0211-699501013259,recibido,o
9,0211-699501013259,suplementacion,i
9,0211-699501013259,durante,o
9,0211-699501013259,12,o
9,0211-699501013259,meses,o
9,0211-699501013259,33,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,pero,o
9,0211-699501013259,a,o
9,0211-699501013259,pesar,o
9,0211-699501013259,de,o
9,0211-699501013259,un,o
9,0211-699501013259,continuo,o
9,0211-699501013259,aumento,o
9,0211-699501013259,del,o
9,0211-699501013259,folato,i
9,0211-699501013259,10078,o
9,0211-699501013259,IC,o
9,0211-699501013259,7481,o
9,0211-699501013259,12674,o
9,0211-699501013259,p,o
9,0211-699501013259,0001,o
9,0211-699501013259,solo,o
9,0211-699501013259,3,o
9,0211-699501013259,pacientes,o
9,0211-699501013259,presentan,o
9,0211-699501013259,niveles,o
9,0211-699501013259,normales,o
9,0211-699501013259,de,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,correlacionandose,o
9,0211-699501013259,directamente,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,con,o
9,0211-699501013259,la,o
9,0211-699501013259,albumina,i
9,0211-699501013259,r,o
9,0211-699501013259,056,o
9,0211-699501013259,p,o
9,0211-699501013259,0001,o
9,0211-699501013259,que,o
9,0211-699501013259,se,o
9,0211-699501013259,elevo,o
9,0211-699501013259,con,o
9,0211-699501013259,respecto,o
9,0211-699501013259,al,o
9,0211-699501013259,inicio,o
9,0211-699501013259,337,o
9,0211-699501013259,IC,o
9,0211-699501013259,327,o
9,0211-699501013259,346,o
9,0211-699501013259,vs,o
9,0211-699501013259,350,o
9,0211-699501013259,IC,o
9,0211-699501013259,337,o
9,0211-699501013259,363,o
9,0211-699501013259,p,o
9,0211-699501013259,005,o
9,0211-699501013259,Conclusion,o
9,0211-699501013259,Tras,o
9,0211-699501013259,suplementacion,i
9,0211-699501013259,con,o
9,0211-699501013259,acido,i
9,0211-699501013259,folico,i
9,0211-699501013259,y,o
9,0211-699501013259,vitamina,i
9,0211-699501013259,B6,i
9,0211-699501013259,aunque,o
9,0211-699501013259,inicialmente,o
9,0211-699501013259,se,o
9,0211-699501013259,reduce,o
9,0211-699501013259,la,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,esta,o
9,0211-699501013259,respuesta,o
9,0211-699501013259,se,o
9,0211-699501013259,hace,o
9,0211-699501013259,refractaria,o
9,0211-699501013259,correlacionandose,o
9,0211-699501013259,directamente,o
9,0211-699501013259,la,o
9,0211-699501013259,tHcy,i
9,0211-699501013259,con,o
9,0211-699501013259,la,o
9,0211-699501013259,albumina,i
9,0211-699501013259,plasmatica,i
9,0211-699501013259,La,o
9,0211-699501013259,interpretacion,o
9,0211-699501013259,de,o
9,0211-699501013259,los,o
9,0211-699501013259,niveles,i
9,0211-699501013259,de,i
9,0211-699501013259,tHcy,i
9,0211-699501013259,debe,o
9,0211-699501013259,tener,o
9,0211-699501013259,en,o
9,0211-699501013259,cuenta,o
9,0211-699501013259,la,o
9,0211-699501013259,concentracion,i
9,0211-699501013259,de,i
9,0211-699501013259,albumina,i
10,0211-699501013259,Efecto,o
10,0211-699501013259,de,o
10,0211-699501013259,la,o
10,0211-699501013259,suplementacion,i
10,0211-699501013259,con,o
10,0211-699501013259,acido,i
10,0211-699501013259,folico,i
10,0211-699501013259,sobre,o
10,0211-699501013259,los,o
10,0211-699501013259,niveles,i
10,0211-699501013259,de,i
10,0211-699501013259,homocisteina,i
10,0211-699501013259,total,o
10,0211-699501013259,en,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,en,o
10,0211-699501013259,hemodialisis,i
10,0211-699501013259,La,o
10,0211-699501013259,hiperhomocisteinemia,i
10,0211-699501013259,es,o
10,0211-699501013259,un,o
10,0211-699501013259,marcador,o
10,0211-699501013259,de,o
10,0211-699501013259,riesgo,o
10,0211-699501013259,independiente,o
10,0211-699501013259,de,o
10,0211-699501013259,morbimortalidad,o
10,0211-699501013259,cardiovascular,i
10,0211-699501013259,Hemos,o
10,0211-699501013259,intentado,o
10,0211-699501013259,prospectivamente,o
10,0211-699501013259,reducir,o
10,0211-699501013259,los,o
10,0211-699501013259,niveles,i
10,0211-699501013259,de,i
10,0211-699501013259,homocisteina,i
10,0211-699501013259,total,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,mediante,o
10,0211-699501013259,suplemento,o
10,0211-699501013259,con,o
10,0211-699501013259,acido,i
10,0211-699501013259,folico,i
10,0211-699501013259,y,o
10,0211-699501013259,vitamina,i
10,0211-699501013259,B6,i
10,0211-699501013259,pp,i
10,0211-699501013259,valorando,o
10,0211-699501013259,su,o
10,0211-699501013259,posible,o
10,0211-699501013259,correlacion,o
10,0211-699501013259,con,o
10,0211-699501013259,dosis,o
10,0211-699501013259,de,o
10,0211-699501013259,dialisis,i
10,0211-699501013259,funcion,i
10,0211-699501013259,residual,i
10,0211-699501013259,y,o
10,0211-699501013259,parametros,o
10,0211-699501013259,nutricionales,o
10,0211-699501013259,Metodos,o
10,0211-699501013259,Todos,o
10,0211-699501013259,los,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,en,o
10,0211-699501013259,hemodialisis,i
10,0211-699501013259,al,o
10,0211-699501013259,comienzo,o
10,0211-699501013259,del,o
10,0211-699501013259,estudio,o
10,0211-699501013259,que,o
10,0211-699501013259,no,o
10,0211-699501013259,recibian,o
10,0211-699501013259,acido,i
10,0211-699501013259,folico,i
10,0211-699501013259,ni,o
10,0211-699501013259,vitamina,i
10,0211-699501013259,B6,i
10,0211-699501013259,asi,o
10,0211-699501013259,como,o
10,0211-699501013259,los,o
10,0211-699501013259,incorporados,o
10,0211-699501013259,posteriormente,o
10,0211-699501013259,a,o
10,0211-699501013259,partir,o
10,0211-699501013259,de,o
10,0211-699501013259,su,o
10,0211-699501013259,tercer,o
10,0211-699501013259,mes,o
10,0211-699501013259,en,o
10,0211-699501013259,hemodialisis,i
10,0211-699501013259,recibieron,o
10,0211-699501013259,5,o
10,0211-699501013259,mg,o
10,0211-699501013259,orales,o
10,0211-699501013259,de,o
10,0211-699501013259,acido,i
10,0211-699501013259,folico,i
10,0211-699501013259,cada,o
10,0211-699501013259,48,o
10,0211-699501013259,horas,o
10,0211-699501013259,y,o
10,0211-699501013259,40,o
10,0211-699501013259,mg,o
10,0211-699501013259,orales,o
10,0211-699501013259,de,o
10,0211-699501013259,vitamina,i
10,0211-699501013259,B6,i
10,0211-699501013259,cada,o
10,0211-699501013259,semana,o
10,0211-699501013259,Se,o
10,0211-699501013259,determinaron,o
10,0211-699501013259,al,o
10,0211-699501013259,comienzo,o
10,0211-699501013259,del,o
10,0211-699501013259,estudio,o
10,0211-699501013259,y,o
10,0211-699501013259,cada,o
10,0211-699501013259,2,o
10,0211-699501013259,meses,o
10,0211-699501013259,niveles,i
10,0211-699501013259,de,i
10,0211-699501013259,folato,i
10,0211-699501013259,vitamina,i
10,0211-699501013259,B12,i
10,0211-699501013259,inmunoensayo,i
10,0211-699501013259,albumina,i
10,0211-699501013259,y,o
10,0211-699501013259,cinetica,o
10,0211-699501013259,de,o
10,0211-699501013259,la,o
10,0211-699501013259,urea,i
10,0211-699501013259,KTV,o
10,0211-699501013259,KRU,o
10,0211-699501013259,PCRn,o
10,0211-699501013259,y,o
10,0211-699501013259,cada,o
10,0211-699501013259,6,o
10,0211-699501013259,meses,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,HPLC,i
10,0211-699501013259,y,o
10,0211-699501013259,pp,i
10,0211-699501013259,RIA,i
10,0211-699501013259,Resultados,o
10,0211-699501013259,80,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,fueron,o
10,0211-699501013259,incluidos,o
10,0211-699501013259,en,o
10,0211-699501013259,el,o
10,0211-699501013259,estudio,o
10,0211-699501013259,basal,o
10,0211-699501013259,con,o
10,0211-699501013259,una,o
10,0211-699501013259,prevalencia,o
10,0211-699501013259,de,o
10,0211-699501013259,hiperhomocisteinemia,i
10,0211-699501013259,del,o
10,0211-699501013259,844,o
10,0211-699501013259,deficit,i
10,0211-699501013259,de,i
10,0211-699501013259,pp,i
10,0211-699501013259,en,o
10,0211-699501013259,el,o
10,0211-699501013259,32,o
10,0211-699501013259,y,o
10,0211-699501013259,folato,i
10,0211-699501013259,en,o
10,0211-699501013259,el,o
10,0211-699501013259,rango,o
10,0211-699501013259,normal,o
10,0211-699501013259,bajo,o
10,0211-699501013259,los,o
10,0211-699501013259,niveles,i
10,0211-699501013259,de,i
10,0211-699501013259,tHcy,i
10,0211-699501013259,se,o
10,0211-699501013259,correlacionaban,o
10,0211-699501013259,inversamente,o
10,0211-699501013259,con,o
10,0211-699501013259,los,o
10,0211-699501013259,del,o
10,0211-699501013259,folato,i
10,0211-699501013259,r,o
10,0211-699501013259,0336,o
10,0211-699501013259,p,o
10,0211-699501013259,001,o
10,0211-699501013259,pero,o
10,0211-699501013259,no,o
10,0211-699501013259,con,o
10,0211-699501013259,pp,i
10,0211-699501013259,B12,i
10,0211-699501013259,edad,o
10,0211-699501013259,albumina,i
10,0211-699501013259,KTV,o
10,0211-699501013259,KRU,o
10,0211-699501013259,PCRn,o
10,0211-699501013259,Cincuenta,o
10,0211-699501013259,y,o
10,0211-699501013259,ocho,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,recibieron,o
10,0211-699501013259,seis,o
10,0211-699501013259,meses,o
10,0211-699501013259,de,o
10,0211-699501013259,suplementacion,i
10,0211-699501013259,con,o
10,0211-699501013259,normalizacion,o
10,0211-699501013259,del,o
10,0211-699501013259,pp,i
10,0211-699501013259,aumento,o
10,0211-699501013259,del,o
10,0211-699501013259,folato,i
10,0211-699501013259,703,o
10,0211-699501013259,IC,o
10,0211-699501013259,638,o
10,0211-699501013259,795,o
10,0211-699501013259,vs,o
10,0211-699501013259,6181,o
10,0211-699501013259,IC,o
10,0211-699501013259,4447,o
10,0211-699501013259,7811,o
10,0211-699501013259,p,o
10,0211-699501013259,0001,o
10,0211-699501013259,y,o
10,0211-699501013259,descenso,o
10,0211-699501013259,de,o
10,0211-699501013259,la,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,240,o
10,0211-699501013259,IC,o
10,0211-699501013259,213,o
10,0211-699501013259,264,o
10,0211-699501013259,vs,o
10,0211-699501013259,199,o
10,0211-699501013259,IC,o
10,0211-699501013259,175,o
10,0211-699501013259,224,o
10,0211-699501013259,p,o
10,0211-699501013259,005,o
10,0211-699501013259,Han,o
10,0211-699501013259,recibido,o
10,0211-699501013259,suplementacion,i
10,0211-699501013259,durante,o
10,0211-699501013259,12,o
10,0211-699501013259,meses,o
10,0211-699501013259,33,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,pero,o
10,0211-699501013259,a,o
10,0211-699501013259,pesar,o
10,0211-699501013259,de,o
10,0211-699501013259,un,o
10,0211-699501013259,continuo,o
10,0211-699501013259,aumento,o
10,0211-699501013259,del,o
10,0211-699501013259,folato,i
10,0211-699501013259,10078,o
10,0211-699501013259,IC,o
10,0211-699501013259,7481,o
10,0211-699501013259,12674,o
10,0211-699501013259,p,o
10,0211-699501013259,0001,o
10,0211-699501013259,solo,o
10,0211-699501013259,3,o
10,0211-699501013259,pacientes,o
10,0211-699501013259,presentan,o
10,0211-699501013259,niveles,o
10,0211-699501013259,normales,o
10,0211-699501013259,de,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,correlacionandose,o
10,0211-699501013259,directamente,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,con,o
10,0211-699501013259,la,o
10,0211-699501013259,albumina,i
10,0211-699501013259,r,o
10,0211-699501013259,056,o
10,0211-699501013259,p,o
10,0211-699501013259,0001,o
10,0211-699501013259,que,o
10,0211-699501013259,se,o
10,0211-699501013259,elevo,o
10,0211-699501013259,con,o
10,0211-699501013259,respecto,o
10,0211-699501013259,al,o
10,0211-699501013259,inicio,o
10,0211-699501013259,337,o
10,0211-699501013259,IC,o
10,0211-699501013259,327,o
10,0211-699501013259,346,o
10,0211-699501013259,vs,o
10,0211-699501013259,350,o
10,0211-699501013259,IC,o
10,0211-699501013259,337,o
10,0211-699501013259,363,o
10,0211-699501013259,p,o
10,0211-699501013259,005,o
10,0211-699501013259,Conclusion,o
10,0211-699501013259,Tras,o
10,0211-699501013259,suplementacion,i
10,0211-699501013259,con,o
10,0211-699501013259,acido,i
10,0211-699501013259,folico,i
10,0211-699501013259,y,o
10,0211-699501013259,vitamina,i
10,0211-699501013259,B6,i
10,0211-699501013259,aunque,o
10,0211-699501013259,inicialmente,o
10,0211-699501013259,se,o
10,0211-699501013259,reduce,o
10,0211-699501013259,la,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,esta,o
10,0211-699501013259,respuesta,o
10,0211-699501013259,se,o
10,0211-699501013259,hace,o
10,0211-699501013259,refractaria,o
10,0211-699501013259,correlacionandose,o
10,0211-699501013259,directamente,o
10,0211-699501013259,la,o
10,0211-699501013259,tHcy,i
10,0211-699501013259,con,o
10,0211-699501013259,la,o
10,0211-699501013259,albumina,i
10,0211-699501013259,plasmatica,i
10,0211-699501013259,La,o
10,0211-699501013259,interpretacion,o
10,0211-699501013259,de,o
10,0211-699501013259,los,o
10,0211-699501013259,niveles,i
10,0211-699501013259,de,i
10,0211-699501013259,tHcy,i
10,0211-699501013259,debe,o
10,0211-699501013259,tener,o
10,0211-699501013259,en,o
10,0211-699501013259,cuenta,o
10,0211-699501013259,la,o
10,0211-699501013259,concentracion,i
10,0211-699501013259,de,i
10,0211-699501013259,albumina,i
11,0211-699501013259,Efecto,o
11,0211-699501013259,de,o
11,0211-699501013259,la,o
11,0211-699501013259,suplementacion,i
11,0211-699501013259,con,o
11,0211-699501013259,acido,i
11,0211-699501013259,folico,i
11,0211-699501013259,sobre,o
11,0211-699501013259,los,o
11,0211-699501013259,niveles,i
11,0211-699501013259,de,i
11,0211-699501013259,homocisteina,i
11,0211-699501013259,total,o
11,0211-699501013259,en,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,en,o
11,0211-699501013259,hemodialisis,i
11,0211-699501013259,La,o
11,0211-699501013259,hiperhomocisteinemia,i
11,0211-699501013259,es,o
11,0211-699501013259,un,o
11,0211-699501013259,marcador,o
11,0211-699501013259,de,o
11,0211-699501013259,riesgo,o
11,0211-699501013259,independiente,o
11,0211-699501013259,de,o
11,0211-699501013259,morbimortalidad,o
11,0211-699501013259,cardiovascular,i
11,0211-699501013259,Hemos,o
11,0211-699501013259,intentado,o
11,0211-699501013259,prospectivamente,o
11,0211-699501013259,reducir,o
11,0211-699501013259,los,o
11,0211-699501013259,niveles,i
11,0211-699501013259,de,i
11,0211-699501013259,homocisteina,i
11,0211-699501013259,total,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,mediante,o
11,0211-699501013259,suplemento,o
11,0211-699501013259,con,o
11,0211-699501013259,acido,i
11,0211-699501013259,folico,i
11,0211-699501013259,y,o
11,0211-699501013259,vitamina,i
11,0211-699501013259,B6,i
11,0211-699501013259,pp,i
11,0211-699501013259,valorando,o
11,0211-699501013259,su,o
11,0211-699501013259,posible,o
11,0211-699501013259,correlacion,o
11,0211-699501013259,con,o
11,0211-699501013259,dosis,o
11,0211-699501013259,de,o
11,0211-699501013259,dialisis,i
11,0211-699501013259,funcion,i
11,0211-699501013259,residual,i
11,0211-699501013259,y,o
11,0211-699501013259,parametros,o
11,0211-699501013259,nutricionales,o
11,0211-699501013259,Metodos,o
11,0211-699501013259,Todos,o
11,0211-699501013259,los,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,en,o
11,0211-699501013259,hemodialisis,i
11,0211-699501013259,al,o
11,0211-699501013259,comienzo,o
11,0211-699501013259,del,o
11,0211-699501013259,estudio,o
11,0211-699501013259,que,o
11,0211-699501013259,no,o
11,0211-699501013259,recibian,o
11,0211-699501013259,acido,i
11,0211-699501013259,folico,i
11,0211-699501013259,ni,o
11,0211-699501013259,vitamina,i
11,0211-699501013259,B6,i
11,0211-699501013259,asi,o
11,0211-699501013259,como,o
11,0211-699501013259,los,o
11,0211-699501013259,incorporados,o
11,0211-699501013259,posteriormente,o
11,0211-699501013259,a,o
11,0211-699501013259,partir,o
11,0211-699501013259,de,o
11,0211-699501013259,su,o
11,0211-699501013259,tercer,o
11,0211-699501013259,mes,o
11,0211-699501013259,en,o
11,0211-699501013259,hemodialisis,i
11,0211-699501013259,recibieron,o
11,0211-699501013259,5,o
11,0211-699501013259,mg,o
11,0211-699501013259,orales,o
11,0211-699501013259,de,o
11,0211-699501013259,acido,i
11,0211-699501013259,folico,i
11,0211-699501013259,cada,o
11,0211-699501013259,48,o
11,0211-699501013259,horas,o
11,0211-699501013259,y,o
11,0211-699501013259,40,o
11,0211-699501013259,mg,o
11,0211-699501013259,orales,o
11,0211-699501013259,de,o
11,0211-699501013259,vitamina,i
11,0211-699501013259,B6,i
11,0211-699501013259,cada,o
11,0211-699501013259,semana,o
11,0211-699501013259,Se,o
11,0211-699501013259,determinaron,o
11,0211-699501013259,al,o
11,0211-699501013259,comienzo,o
11,0211-699501013259,del,o
11,0211-699501013259,estudio,o
11,0211-699501013259,y,o
11,0211-699501013259,cada,o
11,0211-699501013259,2,o
11,0211-699501013259,meses,o
11,0211-699501013259,niveles,i
11,0211-699501013259,de,i
11,0211-699501013259,folato,i
11,0211-699501013259,vitamina,i
11,0211-699501013259,B12,i
11,0211-699501013259,inmunoensayo,i
11,0211-699501013259,albumina,i
11,0211-699501013259,y,o
11,0211-699501013259,cinetica,o
11,0211-699501013259,de,o
11,0211-699501013259,la,o
11,0211-699501013259,urea,i
11,0211-699501013259,KTV,o
11,0211-699501013259,KRU,o
11,0211-699501013259,PCRn,o
11,0211-699501013259,y,o
11,0211-699501013259,cada,o
11,0211-699501013259,6,o
11,0211-699501013259,meses,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,HPLC,i
11,0211-699501013259,y,o
11,0211-699501013259,pp,i
11,0211-699501013259,RIA,i
11,0211-699501013259,Resultados,o
11,0211-699501013259,80,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,fueron,o
11,0211-699501013259,incluidos,o
11,0211-699501013259,en,o
11,0211-699501013259,el,o
11,0211-699501013259,estudio,o
11,0211-699501013259,basal,o
11,0211-699501013259,con,o
11,0211-699501013259,una,o
11,0211-699501013259,prevalencia,o
11,0211-699501013259,de,o
11,0211-699501013259,hiperhomocisteinemia,i
11,0211-699501013259,del,o
11,0211-699501013259,844,o
11,0211-699501013259,deficit,i
11,0211-699501013259,de,i
11,0211-699501013259,pp,i
11,0211-699501013259,en,o
11,0211-699501013259,el,o
11,0211-699501013259,32,o
11,0211-699501013259,y,o
11,0211-699501013259,folato,i
11,0211-699501013259,en,o
11,0211-699501013259,el,o
11,0211-699501013259,rango,o
11,0211-699501013259,normal,o
11,0211-699501013259,bajo,o
11,0211-699501013259,los,o
11,0211-699501013259,niveles,i
11,0211-699501013259,de,i
11,0211-699501013259,tHcy,i
11,0211-699501013259,se,o
11,0211-699501013259,correlacionaban,o
11,0211-699501013259,inversamente,o
11,0211-699501013259,con,o
11,0211-699501013259,los,o
11,0211-699501013259,del,o
11,0211-699501013259,folato,i
11,0211-699501013259,r,o
11,0211-699501013259,0336,o
11,0211-699501013259,p,o
11,0211-699501013259,001,o
11,0211-699501013259,pero,o
11,0211-699501013259,no,o
11,0211-699501013259,con,o
11,0211-699501013259,pp,i
11,0211-699501013259,B12,i
11,0211-699501013259,edad,o
11,0211-699501013259,albumina,i
11,0211-699501013259,KTV,o
11,0211-699501013259,KRU,o
11,0211-699501013259,PCRn,o
11,0211-699501013259,Cincuenta,o
11,0211-699501013259,y,o
11,0211-699501013259,ocho,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,recibieron,o
11,0211-699501013259,seis,o
11,0211-699501013259,meses,o
11,0211-699501013259,de,o
11,0211-699501013259,suplementacion,i
11,0211-699501013259,con,o
11,0211-699501013259,normalizacion,o
11,0211-699501013259,del,o
11,0211-699501013259,pp,i
11,0211-699501013259,aumento,o
11,0211-699501013259,del,o
11,0211-699501013259,folato,i
11,0211-699501013259,703,o
11,0211-699501013259,IC,o
11,0211-699501013259,638,o
11,0211-699501013259,795,o
11,0211-699501013259,vs,o
11,0211-699501013259,6181,o
11,0211-699501013259,IC,o
11,0211-699501013259,4447,o
11,0211-699501013259,7811,o
11,0211-699501013259,p,o
11,0211-699501013259,0001,o
11,0211-699501013259,y,o
11,0211-699501013259,descenso,o
11,0211-699501013259,de,o
11,0211-699501013259,la,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,240,o
11,0211-699501013259,IC,o
11,0211-699501013259,213,o
11,0211-699501013259,264,o
11,0211-699501013259,vs,o
11,0211-699501013259,199,o
11,0211-699501013259,IC,o
11,0211-699501013259,175,o
11,0211-699501013259,224,o
11,0211-699501013259,p,o
11,0211-699501013259,005,o
11,0211-699501013259,Han,o
11,0211-699501013259,recibido,o
11,0211-699501013259,suplementacion,i
11,0211-699501013259,durante,o
11,0211-699501013259,12,o
11,0211-699501013259,meses,o
11,0211-699501013259,33,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,pero,o
11,0211-699501013259,a,o
11,0211-699501013259,pesar,o
11,0211-699501013259,de,o
11,0211-699501013259,un,o
11,0211-699501013259,continuo,o
11,0211-699501013259,aumento,o
11,0211-699501013259,del,o
11,0211-699501013259,folato,i
11,0211-699501013259,10078,o
11,0211-699501013259,IC,o
11,0211-699501013259,7481,o
11,0211-699501013259,12674,o
11,0211-699501013259,p,o
11,0211-699501013259,0001,o
11,0211-699501013259,solo,o
11,0211-699501013259,3,o
11,0211-699501013259,pacientes,o
11,0211-699501013259,presentan,o
11,0211-699501013259,niveles,o
11,0211-699501013259,normales,o
11,0211-699501013259,de,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,correlacionandose,o
11,0211-699501013259,directamente,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,con,o
11,0211-699501013259,la,o
11,0211-699501013259,albumina,i
11,0211-699501013259,r,o
11,0211-699501013259,056,o
11,0211-699501013259,p,o
11,0211-699501013259,0001,o
11,0211-699501013259,que,o
11,0211-699501013259,se,o
11,0211-699501013259,elevo,o
11,0211-699501013259,con,o
11,0211-699501013259,respecto,o
11,0211-699501013259,al,o
11,0211-699501013259,inicio,o
11,0211-699501013259,337,o
11,0211-699501013259,IC,o
11,0211-699501013259,327,o
11,0211-699501013259,346,o
11,0211-699501013259,vs,o
11,0211-699501013259,350,o
11,0211-699501013259,IC,o
11,0211-699501013259,337,o
11,0211-699501013259,363,o
11,0211-699501013259,p,o
11,0211-699501013259,005,o
11,0211-699501013259,Conclusion,o
11,0211-699501013259,Tras,o
11,0211-699501013259,suplementacion,i
11,0211-699501013259,con,o
11,0211-699501013259,acido,i
11,0211-699501013259,folico,i
11,0211-699501013259,y,o
11,0211-699501013259,vitamina,i
11,0211-699501013259,B6,i
11,0211-699501013259,aunque,o
11,0211-699501013259,inicialmente,o
11,0211-699501013259,se,o
11,0211-699501013259,reduce,o
11,0211-699501013259,la,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,esta,o
11,0211-699501013259,respuesta,o
11,0211-699501013259,se,o
11,0211-699501013259,hace,o
11,0211-699501013259,refractaria,o
11,0211-699501013259,correlacionandose,o
11,0211-699501013259,directamente,o
11,0211-699501013259,la,o
11,0211-699501013259,tHcy,i
11,0211-699501013259,con,o
11,0211-699501013259,la,o
11,0211-699501013259,albumina,i
11,0211-699501013259,plasmatica,i
11,0211-699501013259,La,o
11,0211-699501013259,interpretacion,o
11,0211-699501013259,de,o
11,0211-699501013259,los,o
11,0211-699501013259,niveles,i
11,0211-699501013259,de,i
11,0211-699501013259,tHcy,i
11,0211-699501013259,debe,o
11,0211-699501013259,tener,o
11,0211-699501013259,en,o
11,0211-699501013259,cuenta,o
11,0211-699501013259,la,o
11,0211-699501013259,concentracion,i
11,0211-699501013259,de,i
11,0211-699501013259,albumina,i
12,0211-699501013259,Efecto,o
12,0211-699501013259,de,o
12,0211-699501013259,la,o
12,0211-699501013259,suplementacion,i
12,0211-699501013259,con,o
12,0211-699501013259,acido,i
12,0211-699501013259,folico,i
12,0211-699501013259,sobre,o
12,0211-699501013259,los,o
12,0211-699501013259,niveles,i
12,0211-699501013259,de,i
12,0211-699501013259,homocisteina,i
12,0211-699501013259,total,o
12,0211-699501013259,en,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,en,o
12,0211-699501013259,hemodialisis,i
12,0211-699501013259,La,o
12,0211-699501013259,hiperhomocisteinemia,i
12,0211-699501013259,es,o
12,0211-699501013259,un,o
12,0211-699501013259,marcador,o
12,0211-699501013259,de,o
12,0211-699501013259,riesgo,o
12,0211-699501013259,independiente,o
12,0211-699501013259,de,o
12,0211-699501013259,morbimortalidad,o
12,0211-699501013259,cardiovascular,i
12,0211-699501013259,Hemos,o
12,0211-699501013259,intentado,o
12,0211-699501013259,prospectivamente,o
12,0211-699501013259,reducir,o
12,0211-699501013259,los,o
12,0211-699501013259,niveles,i
12,0211-699501013259,de,i
12,0211-699501013259,homocisteina,i
12,0211-699501013259,total,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,mediante,o
12,0211-699501013259,suplemento,o
12,0211-699501013259,con,o
12,0211-699501013259,acido,i
12,0211-699501013259,folico,i
12,0211-699501013259,y,o
12,0211-699501013259,vitamina,i
12,0211-699501013259,B6,i
12,0211-699501013259,pp,i
12,0211-699501013259,valorando,o
12,0211-699501013259,su,o
12,0211-699501013259,posible,o
12,0211-699501013259,correlacion,o
12,0211-699501013259,con,o
12,0211-699501013259,dosis,o
12,0211-699501013259,de,o
12,0211-699501013259,dialisis,i
12,0211-699501013259,funcion,i
12,0211-699501013259,residual,i
12,0211-699501013259,y,o
12,0211-699501013259,parametros,o
12,0211-699501013259,nutricionales,o
12,0211-699501013259,Metodos,o
12,0211-699501013259,Todos,o
12,0211-699501013259,los,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,en,o
12,0211-699501013259,hemodialisis,i
12,0211-699501013259,al,o
12,0211-699501013259,comienzo,o
12,0211-699501013259,del,o
12,0211-699501013259,estudio,o
12,0211-699501013259,que,o
12,0211-699501013259,no,o
12,0211-699501013259,recibian,o
12,0211-699501013259,acido,i
12,0211-699501013259,folico,i
12,0211-699501013259,ni,o
12,0211-699501013259,vitamina,i
12,0211-699501013259,B6,i
12,0211-699501013259,asi,o
12,0211-699501013259,como,o
12,0211-699501013259,los,o
12,0211-699501013259,incorporados,o
12,0211-699501013259,posteriormente,o
12,0211-699501013259,a,o
12,0211-699501013259,partir,o
12,0211-699501013259,de,o
12,0211-699501013259,su,o
12,0211-699501013259,tercer,o
12,0211-699501013259,mes,o
12,0211-699501013259,en,o
12,0211-699501013259,hemodialisis,i
12,0211-699501013259,recibieron,o
12,0211-699501013259,5,o
12,0211-699501013259,mg,o
12,0211-699501013259,orales,o
12,0211-699501013259,de,o
12,0211-699501013259,acido,i
12,0211-699501013259,folico,i
12,0211-699501013259,cada,o
12,0211-699501013259,48,o
12,0211-699501013259,horas,o
12,0211-699501013259,y,o
12,0211-699501013259,40,o
12,0211-699501013259,mg,o
12,0211-699501013259,orales,o
12,0211-699501013259,de,o
12,0211-699501013259,vitamina,i
12,0211-699501013259,B6,i
12,0211-699501013259,cada,o
12,0211-699501013259,semana,o
12,0211-699501013259,Se,o
12,0211-699501013259,determinaron,o
12,0211-699501013259,al,o
12,0211-699501013259,comienzo,o
12,0211-699501013259,del,o
12,0211-699501013259,estudio,o
12,0211-699501013259,y,o
12,0211-699501013259,cada,o
12,0211-699501013259,2,o
12,0211-699501013259,meses,o
12,0211-699501013259,niveles,i
12,0211-699501013259,de,i
12,0211-699501013259,folato,i
12,0211-699501013259,vitamina,i
12,0211-699501013259,B12,i
12,0211-699501013259,inmunoensayo,i
12,0211-699501013259,albumina,i
12,0211-699501013259,y,o
12,0211-699501013259,cinetica,o
12,0211-699501013259,de,o
12,0211-699501013259,la,o
12,0211-699501013259,urea,i
12,0211-699501013259,KTV,o
12,0211-699501013259,KRU,o
12,0211-699501013259,PCRn,o
12,0211-699501013259,y,o
12,0211-699501013259,cada,o
12,0211-699501013259,6,o
12,0211-699501013259,meses,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,HPLC,i
12,0211-699501013259,y,o
12,0211-699501013259,pp,i
12,0211-699501013259,RIA,i
12,0211-699501013259,Resultados,o
12,0211-699501013259,80,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,fueron,o
12,0211-699501013259,incluidos,o
12,0211-699501013259,en,o
12,0211-699501013259,el,o
12,0211-699501013259,estudio,o
12,0211-699501013259,basal,o
12,0211-699501013259,con,o
12,0211-699501013259,una,o
12,0211-699501013259,prevalencia,o
12,0211-699501013259,de,o
12,0211-699501013259,hiperhomocisteinemia,i
12,0211-699501013259,del,o
12,0211-699501013259,844,o
12,0211-699501013259,deficit,i
12,0211-699501013259,de,i
12,0211-699501013259,pp,i
12,0211-699501013259,en,o
12,0211-699501013259,el,o
12,0211-699501013259,32,o
12,0211-699501013259,y,o
12,0211-699501013259,folato,i
12,0211-699501013259,en,o
12,0211-699501013259,el,o
12,0211-699501013259,rango,o
12,0211-699501013259,normal,o
12,0211-699501013259,bajo,o
12,0211-699501013259,los,o
12,0211-699501013259,niveles,i
12,0211-699501013259,de,i
12,0211-699501013259,tHcy,i
12,0211-699501013259,se,o
12,0211-699501013259,correlacionaban,o
12,0211-699501013259,inversamente,o
12,0211-699501013259,con,o
12,0211-699501013259,los,o
12,0211-699501013259,del,o
12,0211-699501013259,folato,i
12,0211-699501013259,r,o
12,0211-699501013259,0336,o
12,0211-699501013259,p,o
12,0211-699501013259,001,o
12,0211-699501013259,pero,o
12,0211-699501013259,no,o
12,0211-699501013259,con,o
12,0211-699501013259,pp,i
12,0211-699501013259,B12,i
12,0211-699501013259,edad,o
12,0211-699501013259,albumina,i
12,0211-699501013259,KTV,o
12,0211-699501013259,KRU,o
12,0211-699501013259,PCRn,o
12,0211-699501013259,Cincuenta,o
12,0211-699501013259,y,o
12,0211-699501013259,ocho,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,recibieron,o
12,0211-699501013259,seis,o
12,0211-699501013259,meses,o
12,0211-699501013259,de,o
12,0211-699501013259,suplementacion,i
12,0211-699501013259,con,o
12,0211-699501013259,normalizacion,o
12,0211-699501013259,del,o
12,0211-699501013259,pp,i
12,0211-699501013259,aumento,o
12,0211-699501013259,del,o
12,0211-699501013259,folato,i
12,0211-699501013259,703,o
12,0211-699501013259,IC,o
12,0211-699501013259,638,o
12,0211-699501013259,795,o
12,0211-699501013259,vs,o
12,0211-699501013259,6181,o
12,0211-699501013259,IC,o
12,0211-699501013259,4447,o
12,0211-699501013259,7811,o
12,0211-699501013259,p,o
12,0211-699501013259,0001,o
12,0211-699501013259,y,o
12,0211-699501013259,descenso,o
12,0211-699501013259,de,o
12,0211-699501013259,la,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,240,o
12,0211-699501013259,IC,o
12,0211-699501013259,213,o
12,0211-699501013259,264,o
12,0211-699501013259,vs,o
12,0211-699501013259,199,o
12,0211-699501013259,IC,o
12,0211-699501013259,175,o
12,0211-699501013259,224,o
12,0211-699501013259,p,o
12,0211-699501013259,005,o
12,0211-699501013259,Han,o
12,0211-699501013259,recibido,o
12,0211-699501013259,suplementacion,i
12,0211-699501013259,durante,o
12,0211-699501013259,12,o
12,0211-699501013259,meses,o
12,0211-699501013259,33,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,pero,o
12,0211-699501013259,a,o
12,0211-699501013259,pesar,o
12,0211-699501013259,de,o
12,0211-699501013259,un,o
12,0211-699501013259,continuo,o
12,0211-699501013259,aumento,o
12,0211-699501013259,del,o
12,0211-699501013259,folato,i
12,0211-699501013259,10078,o
12,0211-699501013259,IC,o
12,0211-699501013259,7481,o
12,0211-699501013259,12674,o
12,0211-699501013259,p,o
12,0211-699501013259,0001,o
12,0211-699501013259,solo,o
12,0211-699501013259,3,o
12,0211-699501013259,pacientes,o
12,0211-699501013259,presentan,o
12,0211-699501013259,niveles,o
12,0211-699501013259,normales,o
12,0211-699501013259,de,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,correlacionandose,o
12,0211-699501013259,directamente,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,con,o
12,0211-699501013259,la,o
12,0211-699501013259,albumina,i
12,0211-699501013259,r,o
12,0211-699501013259,056,o
12,0211-699501013259,p,o
12,0211-699501013259,0001,o
12,0211-699501013259,que,o
12,0211-699501013259,se,o
12,0211-699501013259,elevo,o
12,0211-699501013259,con,o
12,0211-699501013259,respecto,o
12,0211-699501013259,al,o
12,0211-699501013259,inicio,o
12,0211-699501013259,337,o
12,0211-699501013259,IC,o
12,0211-699501013259,327,o
12,0211-699501013259,346,o
12,0211-699501013259,vs,o
12,0211-699501013259,350,o
12,0211-699501013259,IC,o
12,0211-699501013259,337,o
12,0211-699501013259,363,o
12,0211-699501013259,p,o
12,0211-699501013259,005,o
12,0211-699501013259,Conclusion,o
12,0211-699501013259,Tras,o
12,0211-699501013259,suplementacion,i
12,0211-699501013259,con,o
12,0211-699501013259,acido,i
12,0211-699501013259,folico,i
12,0211-699501013259,y,o
12,0211-699501013259,vitamina,i
12,0211-699501013259,B6,i
12,0211-699501013259,aunque,o
12,0211-699501013259,inicialmente,o
12,0211-699501013259,se,o
12,0211-699501013259,reduce,o
12,0211-699501013259,la,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,esta,o
12,0211-699501013259,respuesta,o
12,0211-699501013259,se,o
12,0211-699501013259,hace,o
12,0211-699501013259,refractaria,o
12,0211-699501013259,correlacionandose,o
12,0211-699501013259,directamente,o
12,0211-699501013259,la,o
12,0211-699501013259,tHcy,i
12,0211-699501013259,con,o
12,0211-699501013259,la,o
12,0211-699501013259,albumina,i
12,0211-699501013259,plasmatica,i
12,0211-699501013259,La,o
12,0211-699501013259,interpretacion,o
12,0211-699501013259,de,o
12,0211-699501013259,los,o
12,0211-699501013259,niveles,i
12,0211-699501013259,de,i
12,0211-699501013259,tHcy,i
12,0211-699501013259,debe,o
12,0211-699501013259,tener,o
12,0211-699501013259,en,o
12,0211-699501013259,cuenta,o
12,0211-699501013259,la,o
12,0211-699501013259,concentracion,i
12,0211-699501013259,de,i
12,0211-699501013259,albumina,i
13,0211-699501013259,Efecto,o
13,0211-699501013259,de,o
13,0211-699501013259,la,o
13,0211-699501013259,suplementacion,i
13,0211-699501013259,con,o
13,0211-699501013259,acido,i
13,0211-699501013259,folico,i
13,0211-699501013259,sobre,o
13,0211-699501013259,los,o
13,0211-699501013259,niveles,i
13,0211-699501013259,de,i
13,0211-699501013259,homocisteina,i
13,0211-699501013259,total,o
13,0211-699501013259,en,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,en,o
13,0211-699501013259,hemodialisis,i
13,0211-699501013259,La,o
13,0211-699501013259,hiperhomocisteinemia,i
13,0211-699501013259,es,o
13,0211-699501013259,un,o
13,0211-699501013259,marcador,o
13,0211-699501013259,de,o
13,0211-699501013259,riesgo,o
13,0211-699501013259,independiente,o
13,0211-699501013259,de,o
13,0211-699501013259,morbimortalidad,o
13,0211-699501013259,cardiovascular,i
13,0211-699501013259,Hemos,o
13,0211-699501013259,intentado,o
13,0211-699501013259,prospectivamente,o
13,0211-699501013259,reducir,o
13,0211-699501013259,los,o
13,0211-699501013259,niveles,i
13,0211-699501013259,de,i
13,0211-699501013259,homocisteina,i
13,0211-699501013259,total,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,mediante,o
13,0211-699501013259,suplemento,o
13,0211-699501013259,con,o
13,0211-699501013259,acido,i
13,0211-699501013259,folico,i
13,0211-699501013259,y,o
13,0211-699501013259,vitamina,i
13,0211-699501013259,B6,i
13,0211-699501013259,pp,i
13,0211-699501013259,valorando,o
13,0211-699501013259,su,o
13,0211-699501013259,posible,o
13,0211-699501013259,correlacion,o
13,0211-699501013259,con,o
13,0211-699501013259,dosis,o
13,0211-699501013259,de,o
13,0211-699501013259,dialisis,i
13,0211-699501013259,funcion,i
13,0211-699501013259,residual,i
13,0211-699501013259,y,o
13,0211-699501013259,parametros,o
13,0211-699501013259,nutricionales,o
13,0211-699501013259,Metodos,o
13,0211-699501013259,Todos,o
13,0211-699501013259,los,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,en,o
13,0211-699501013259,hemodialisis,i
13,0211-699501013259,al,o
13,0211-699501013259,comienzo,o
13,0211-699501013259,del,o
13,0211-699501013259,estudio,o
13,0211-699501013259,que,o
13,0211-699501013259,no,o
13,0211-699501013259,recibian,o
13,0211-699501013259,acido,i
13,0211-699501013259,folico,i
13,0211-699501013259,ni,o
13,0211-699501013259,vitamina,i
13,0211-699501013259,B6,i
13,0211-699501013259,asi,o
13,0211-699501013259,como,o
13,0211-699501013259,los,o
13,0211-699501013259,incorporados,o
13,0211-699501013259,posteriormente,o
13,0211-699501013259,a,o
13,0211-699501013259,partir,o
13,0211-699501013259,de,o
13,0211-699501013259,su,o
13,0211-699501013259,tercer,o
13,0211-699501013259,mes,o
13,0211-699501013259,en,o
13,0211-699501013259,hemodialisis,i
13,0211-699501013259,recibieron,o
13,0211-699501013259,5,o
13,0211-699501013259,mg,o
13,0211-699501013259,orales,o
13,0211-699501013259,de,o
13,0211-699501013259,acido,i
13,0211-699501013259,folico,i
13,0211-699501013259,cada,o
13,0211-699501013259,48,o
13,0211-699501013259,horas,o
13,0211-699501013259,y,o
13,0211-699501013259,40,o
13,0211-699501013259,mg,o
13,0211-699501013259,orales,o
13,0211-699501013259,de,o
13,0211-699501013259,vitamina,i
13,0211-699501013259,B6,i
13,0211-699501013259,cada,o
13,0211-699501013259,semana,o
13,0211-699501013259,Se,o
13,0211-699501013259,determinaron,o
13,0211-699501013259,al,o
13,0211-699501013259,comienzo,o
13,0211-699501013259,del,o
13,0211-699501013259,estudio,o
13,0211-699501013259,y,o
13,0211-699501013259,cada,o
13,0211-699501013259,2,o
13,0211-699501013259,meses,o
13,0211-699501013259,niveles,i
13,0211-699501013259,de,i
13,0211-699501013259,folato,i
13,0211-699501013259,vitamina,i
13,0211-699501013259,B12,i
13,0211-699501013259,inmunoensayo,i
13,0211-699501013259,albumina,i
13,0211-699501013259,y,o
13,0211-699501013259,cinetica,o
13,0211-699501013259,de,o
13,0211-699501013259,la,o
13,0211-699501013259,urea,i
13,0211-699501013259,KTV,o
13,0211-699501013259,KRU,o
13,0211-699501013259,PCRn,o
13,0211-699501013259,y,o
13,0211-699501013259,cada,o
13,0211-699501013259,6,o
13,0211-699501013259,meses,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,HPLC,i
13,0211-699501013259,y,o
13,0211-699501013259,pp,i
13,0211-699501013259,RIA,i
13,0211-699501013259,Resultados,o
13,0211-699501013259,80,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,fueron,o
13,0211-699501013259,incluidos,o
13,0211-699501013259,en,o
13,0211-699501013259,el,o
13,0211-699501013259,estudio,o
13,0211-699501013259,basal,o
13,0211-699501013259,con,o
13,0211-699501013259,una,o
13,0211-699501013259,prevalencia,o
13,0211-699501013259,de,o
13,0211-699501013259,hiperhomocisteinemia,i
13,0211-699501013259,del,o
13,0211-699501013259,844,o
13,0211-699501013259,deficit,i
13,0211-699501013259,de,i
13,0211-699501013259,pp,i
13,0211-699501013259,en,o
13,0211-699501013259,el,o
13,0211-699501013259,32,o
13,0211-699501013259,y,o
13,0211-699501013259,folato,i
13,0211-699501013259,en,o
13,0211-699501013259,el,o
13,0211-699501013259,rango,o
13,0211-699501013259,normal,o
13,0211-699501013259,bajo,o
13,0211-699501013259,los,o
13,0211-699501013259,niveles,i
13,0211-699501013259,de,i
13,0211-699501013259,tHcy,i
13,0211-699501013259,se,o
13,0211-699501013259,correlacionaban,o
13,0211-699501013259,inversamente,o
13,0211-699501013259,con,o
13,0211-699501013259,los,o
13,0211-699501013259,del,o
13,0211-699501013259,folato,i
13,0211-699501013259,r,o
13,0211-699501013259,0336,o
13,0211-699501013259,p,o
13,0211-699501013259,001,o
13,0211-699501013259,pero,o
13,0211-699501013259,no,o
13,0211-699501013259,con,o
13,0211-699501013259,pp,i
13,0211-699501013259,B12,i
13,0211-699501013259,edad,o
13,0211-699501013259,albumina,i
13,0211-699501013259,KTV,o
13,0211-699501013259,KRU,o
13,0211-699501013259,PCRn,o
13,0211-699501013259,Cincuenta,o
13,0211-699501013259,y,o
13,0211-699501013259,ocho,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,recibieron,o
13,0211-699501013259,seis,o
13,0211-699501013259,meses,o
13,0211-699501013259,de,o
13,0211-699501013259,suplementacion,i
13,0211-699501013259,con,o
13,0211-699501013259,normalizacion,o
13,0211-699501013259,del,o
13,0211-699501013259,pp,i
13,0211-699501013259,aumento,o
13,0211-699501013259,del,o
13,0211-699501013259,folato,i
13,0211-699501013259,703,o
13,0211-699501013259,IC,o
13,0211-699501013259,638,o
13,0211-699501013259,795,o
13,0211-699501013259,vs,o
13,0211-699501013259,6181,o
13,0211-699501013259,IC,o
13,0211-699501013259,4447,o
13,0211-699501013259,7811,o
13,0211-699501013259,p,o
13,0211-699501013259,0001,o
13,0211-699501013259,y,o
13,0211-699501013259,descenso,o
13,0211-699501013259,de,o
13,0211-699501013259,la,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,240,o
13,0211-699501013259,IC,o
13,0211-699501013259,213,o
13,0211-699501013259,264,o
13,0211-699501013259,vs,o
13,0211-699501013259,199,o
13,0211-699501013259,IC,o
13,0211-699501013259,175,o
13,0211-699501013259,224,o
13,0211-699501013259,p,o
13,0211-699501013259,005,o
13,0211-699501013259,Han,o
13,0211-699501013259,recibido,o
13,0211-699501013259,suplementacion,i
13,0211-699501013259,durante,o
13,0211-699501013259,12,o
13,0211-699501013259,meses,o
13,0211-699501013259,33,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,pero,o
13,0211-699501013259,a,o
13,0211-699501013259,pesar,o
13,0211-699501013259,de,o
13,0211-699501013259,un,o
13,0211-699501013259,continuo,o
13,0211-699501013259,aumento,o
13,0211-699501013259,del,o
13,0211-699501013259,folato,i
13,0211-699501013259,10078,o
13,0211-699501013259,IC,o
13,0211-699501013259,7481,o
13,0211-699501013259,12674,o
13,0211-699501013259,p,o
13,0211-699501013259,0001,o
13,0211-699501013259,solo,o
13,0211-699501013259,3,o
13,0211-699501013259,pacientes,o
13,0211-699501013259,presentan,o
13,0211-699501013259,niveles,o
13,0211-699501013259,normales,o
13,0211-699501013259,de,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,correlacionandose,o
13,0211-699501013259,directamente,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,con,o
13,0211-699501013259,la,o
13,0211-699501013259,albumina,i
13,0211-699501013259,r,o
13,0211-699501013259,056,o
13,0211-699501013259,p,o
13,0211-699501013259,0001,o
13,0211-699501013259,que,o
13,0211-699501013259,se,o
13,0211-699501013259,elevo,o
13,0211-699501013259,con,o
13,0211-699501013259,respecto,o
13,0211-699501013259,al,o
13,0211-699501013259,inicio,o
13,0211-699501013259,337,o
13,0211-699501013259,IC,o
13,0211-699501013259,327,o
13,0211-699501013259,346,o
13,0211-699501013259,vs,o
13,0211-699501013259,350,o
13,0211-699501013259,IC,o
13,0211-699501013259,337,o
13,0211-699501013259,363,o
13,0211-699501013259,p,o
13,0211-699501013259,005,o
13,0211-699501013259,Conclusion,o
13,0211-699501013259,Tras,o
13,0211-699501013259,suplementacion,i
13,0211-699501013259,con,o
13,0211-699501013259,acido,i
13,0211-699501013259,folico,i
13,0211-699501013259,y,o
13,0211-699501013259,vitamina,i
13,0211-699501013259,B6,i
13,0211-699501013259,aunque,o
13,0211-699501013259,inicialmente,o
13,0211-699501013259,se,o
13,0211-699501013259,reduce,o
13,0211-699501013259,la,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,esta,o
13,0211-699501013259,respuesta,o
13,0211-699501013259,se,o
13,0211-699501013259,hace,o
13,0211-699501013259,refractaria,o
13,0211-699501013259,correlacionandose,o
13,0211-699501013259,directamente,o
13,0211-699501013259,la,o
13,0211-699501013259,tHcy,i
13,0211-699501013259,con,o
13,0211-699501013259,la,o
13,0211-699501013259,albumina,i
13,0211-699501013259,plasmatica,i
13,0211-699501013259,La,o
13,0211-699501013259,interpretacion,o
13,0211-699501013259,de,o
13,0211-699501013259,los,o
13,0211-699501013259,niveles,i
13,0211-699501013259,de,i
13,0211-699501013259,tHcy,i
13,0211-699501013259,debe,o
13,0211-699501013259,tener,o
13,0211-699501013259,en,o
13,0211-699501013259,cuenta,o
13,0211-699501013259,la,o
13,0211-699501013259,concentracion,i
13,0211-699501013259,de,i
13,0211-699501013259,albumina,i
14,0211-699501013259,Efecto,o
14,0211-699501013259,de,o
14,0211-699501013259,la,o
14,0211-699501013259,suplementacion,i
14,0211-699501013259,con,o
14,0211-699501013259,acido,i
14,0211-699501013259,folico,i
14,0211-699501013259,sobre,o
14,0211-699501013259,los,o
14,0211-699501013259,niveles,i
14,0211-699501013259,de,i
14,0211-699501013259,homocisteina,i
14,0211-699501013259,total,o
14,0211-699501013259,en,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,en,o
14,0211-699501013259,hemodialisis,i
14,0211-699501013259,La,o
14,0211-699501013259,hiperhomocisteinemia,i
14,0211-699501013259,es,o
14,0211-699501013259,un,o
14,0211-699501013259,marcador,o
14,0211-699501013259,de,o
14,0211-699501013259,riesgo,o
14,0211-699501013259,independiente,o
14,0211-699501013259,de,o
14,0211-699501013259,morbimortalidad,o
14,0211-699501013259,cardiovascular,i
14,0211-699501013259,Hemos,o
14,0211-699501013259,intentado,o
14,0211-699501013259,prospectivamente,o
14,0211-699501013259,reducir,o
14,0211-699501013259,los,o
14,0211-699501013259,niveles,i
14,0211-699501013259,de,i
14,0211-699501013259,homocisteina,i
14,0211-699501013259,total,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,mediante,o
14,0211-699501013259,suplemento,o
14,0211-699501013259,con,o
14,0211-699501013259,acido,i
14,0211-699501013259,folico,i
14,0211-699501013259,y,o
14,0211-699501013259,vitamina,i
14,0211-699501013259,B6,i
14,0211-699501013259,pp,i
14,0211-699501013259,valorando,o
14,0211-699501013259,su,o
14,0211-699501013259,posible,o
14,0211-699501013259,correlacion,o
14,0211-699501013259,con,o
14,0211-699501013259,dosis,o
14,0211-699501013259,de,o
14,0211-699501013259,dialisis,i
14,0211-699501013259,funcion,i
14,0211-699501013259,residual,i
14,0211-699501013259,y,o
14,0211-699501013259,parametros,o
14,0211-699501013259,nutricionales,o
14,0211-699501013259,Metodos,o
14,0211-699501013259,Todos,o
14,0211-699501013259,los,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,en,o
14,0211-699501013259,hemodialisis,i
14,0211-699501013259,al,o
14,0211-699501013259,comienzo,o
14,0211-699501013259,del,o
14,0211-699501013259,estudio,o
14,0211-699501013259,que,o
14,0211-699501013259,no,o
14,0211-699501013259,recibian,o
14,0211-699501013259,acido,i
14,0211-699501013259,folico,i
14,0211-699501013259,ni,o
14,0211-699501013259,vitamina,i
14,0211-699501013259,B6,i
14,0211-699501013259,asi,o
14,0211-699501013259,como,o
14,0211-699501013259,los,o
14,0211-699501013259,incorporados,o
14,0211-699501013259,posteriormente,o
14,0211-699501013259,a,o
14,0211-699501013259,partir,o
14,0211-699501013259,de,o
14,0211-699501013259,su,o
14,0211-699501013259,tercer,o
14,0211-699501013259,mes,o
14,0211-699501013259,en,o
14,0211-699501013259,hemodialisis,i
14,0211-699501013259,recibieron,o
14,0211-699501013259,5,o
14,0211-699501013259,mg,o
14,0211-699501013259,orales,o
14,0211-699501013259,de,o
14,0211-699501013259,acido,i
14,0211-699501013259,folico,i
14,0211-699501013259,cada,o
14,0211-699501013259,48,o
14,0211-699501013259,horas,o
14,0211-699501013259,y,o
14,0211-699501013259,40,o
14,0211-699501013259,mg,o
14,0211-699501013259,orales,o
14,0211-699501013259,de,o
14,0211-699501013259,vitamina,i
14,0211-699501013259,B6,i
14,0211-699501013259,cada,o
14,0211-699501013259,semana,o
14,0211-699501013259,Se,o
14,0211-699501013259,determinaron,o
14,0211-699501013259,al,o
14,0211-699501013259,comienzo,o
14,0211-699501013259,del,o
14,0211-699501013259,estudio,o
14,0211-699501013259,y,o
14,0211-699501013259,cada,o
14,0211-699501013259,2,o
14,0211-699501013259,meses,o
14,0211-699501013259,niveles,i
14,0211-699501013259,de,i
14,0211-699501013259,folato,i
14,0211-699501013259,vitamina,i
14,0211-699501013259,B12,i
14,0211-699501013259,inmunoensayo,i
14,0211-699501013259,albumina,i
14,0211-699501013259,y,o
14,0211-699501013259,cinetica,o
14,0211-699501013259,de,o
14,0211-699501013259,la,o
14,0211-699501013259,urea,i
14,0211-699501013259,KTV,o
14,0211-699501013259,KRU,o
14,0211-699501013259,PCRn,o
14,0211-699501013259,y,o
14,0211-699501013259,cada,o
14,0211-699501013259,6,o
14,0211-699501013259,meses,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,HPLC,i
14,0211-699501013259,y,o
14,0211-699501013259,pp,i
14,0211-699501013259,RIA,i
14,0211-699501013259,Resultados,o
14,0211-699501013259,80,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,fueron,o
14,0211-699501013259,incluidos,o
14,0211-699501013259,en,o
14,0211-699501013259,el,o
14,0211-699501013259,estudio,o
14,0211-699501013259,basal,o
14,0211-699501013259,con,o
14,0211-699501013259,una,o
14,0211-699501013259,prevalencia,o
14,0211-699501013259,de,o
14,0211-699501013259,hiperhomocisteinemia,i
14,0211-699501013259,del,o
14,0211-699501013259,844,o
14,0211-699501013259,deficit,i
14,0211-699501013259,de,i
14,0211-699501013259,pp,i
14,0211-699501013259,en,o
14,0211-699501013259,el,o
14,0211-699501013259,32,o
14,0211-699501013259,y,o
14,0211-699501013259,folato,i
14,0211-699501013259,en,o
14,0211-699501013259,el,o
14,0211-699501013259,rango,o
14,0211-699501013259,normal,o
14,0211-699501013259,bajo,o
14,0211-699501013259,los,o
14,0211-699501013259,niveles,i
14,0211-699501013259,de,i
14,0211-699501013259,tHcy,i
14,0211-699501013259,se,o
14,0211-699501013259,correlacionaban,o
14,0211-699501013259,inversamente,o
14,0211-699501013259,con,o
14,0211-699501013259,los,o
14,0211-699501013259,del,o
14,0211-699501013259,folato,i
14,0211-699501013259,r,o
14,0211-699501013259,0336,o
14,0211-699501013259,p,o
14,0211-699501013259,001,o
14,0211-699501013259,pero,o
14,0211-699501013259,no,o
14,0211-699501013259,con,o
14,0211-699501013259,pp,i
14,0211-699501013259,B12,i
14,0211-699501013259,edad,o
14,0211-699501013259,albumina,i
14,0211-699501013259,KTV,o
14,0211-699501013259,KRU,o
14,0211-699501013259,PCRn,o
14,0211-699501013259,Cincuenta,o
14,0211-699501013259,y,o
14,0211-699501013259,ocho,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,recibieron,o
14,0211-699501013259,seis,o
14,0211-699501013259,meses,o
14,0211-699501013259,de,o
14,0211-699501013259,suplementacion,i
14,0211-699501013259,con,o
14,0211-699501013259,normalizacion,o
14,0211-699501013259,del,o
14,0211-699501013259,pp,i
14,0211-699501013259,aumento,o
14,0211-699501013259,del,o
14,0211-699501013259,folato,i
14,0211-699501013259,703,o
14,0211-699501013259,IC,o
14,0211-699501013259,638,o
14,0211-699501013259,795,o
14,0211-699501013259,vs,o
14,0211-699501013259,6181,o
14,0211-699501013259,IC,o
14,0211-699501013259,4447,o
14,0211-699501013259,7811,o
14,0211-699501013259,p,o
14,0211-699501013259,0001,o
14,0211-699501013259,y,o
14,0211-699501013259,descenso,o
14,0211-699501013259,de,o
14,0211-699501013259,la,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,240,o
14,0211-699501013259,IC,o
14,0211-699501013259,213,o
14,0211-699501013259,264,o
14,0211-699501013259,vs,o
14,0211-699501013259,199,o
14,0211-699501013259,IC,o
14,0211-699501013259,175,o
14,0211-699501013259,224,o
14,0211-699501013259,p,o
14,0211-699501013259,005,o
14,0211-699501013259,Han,o
14,0211-699501013259,recibido,o
14,0211-699501013259,suplementacion,i
14,0211-699501013259,durante,o
14,0211-699501013259,12,o
14,0211-699501013259,meses,o
14,0211-699501013259,33,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,pero,o
14,0211-699501013259,a,o
14,0211-699501013259,pesar,o
14,0211-699501013259,de,o
14,0211-699501013259,un,o
14,0211-699501013259,continuo,o
14,0211-699501013259,aumento,o
14,0211-699501013259,del,o
14,0211-699501013259,folato,i
14,0211-699501013259,10078,o
14,0211-699501013259,IC,o
14,0211-699501013259,7481,o
14,0211-699501013259,12674,o
14,0211-699501013259,p,o
14,0211-699501013259,0001,o
14,0211-699501013259,solo,o
14,0211-699501013259,3,o
14,0211-699501013259,pacientes,o
14,0211-699501013259,presentan,o
14,0211-699501013259,niveles,o
14,0211-699501013259,normales,o
14,0211-699501013259,de,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,correlacionandose,o
14,0211-699501013259,directamente,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,con,o
14,0211-699501013259,la,o
14,0211-699501013259,albumina,i
14,0211-699501013259,r,o
14,0211-699501013259,056,o
14,0211-699501013259,p,o
14,0211-699501013259,0001,o
14,0211-699501013259,que,o
14,0211-699501013259,se,o
14,0211-699501013259,elevo,o
14,0211-699501013259,con,o
14,0211-699501013259,respecto,o
14,0211-699501013259,al,o
14,0211-699501013259,inicio,o
14,0211-699501013259,337,o
14,0211-699501013259,IC,o
14,0211-699501013259,327,o
14,0211-699501013259,346,o
14,0211-699501013259,vs,o
14,0211-699501013259,350,o
14,0211-699501013259,IC,o
14,0211-699501013259,337,o
14,0211-699501013259,363,o
14,0211-699501013259,p,o
14,0211-699501013259,005,o
14,0211-699501013259,Conclusion,o
14,0211-699501013259,Tras,o
14,0211-699501013259,suplementacion,i
14,0211-699501013259,con,o
14,0211-699501013259,acido,i
14,0211-699501013259,folico,i
14,0211-699501013259,y,o
14,0211-699501013259,vitamina,i
14,0211-699501013259,B6,i
14,0211-699501013259,aunque,o
14,0211-699501013259,inicialmente,o
14,0211-699501013259,se,o
14,0211-699501013259,reduce,o
14,0211-699501013259,la,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,esta,o
14,0211-699501013259,respuesta,o
14,0211-699501013259,se,o
14,0211-699501013259,hace,o
14,0211-699501013259,refractaria,o
14,0211-699501013259,correlacionandose,o
14,0211-699501013259,directamente,o
14,0211-699501013259,la,o
14,0211-699501013259,tHcy,i
14,0211-699501013259,con,o
14,0211-699501013259,la,o
14,0211-699501013259,albumina,i
14,0211-699501013259,plasmatica,i
14,0211-699501013259,La,o
14,0211-699501013259,interpretacion,o
14,0211-699501013259,de,o
14,0211-699501013259,los,o
14,0211-699501013259,niveles,i
14,0211-699501013259,de,i
14,0211-699501013259,tHcy,i
14,0211-699501013259,debe,o
14,0211-699501013259,tener,o
14,0211-699501013259,en,o
14,0211-699501013259,cuenta,o
14,0211-699501013259,la,o
14,0211-699501013259,concentracion,i
14,0211-699501013259,de,i
14,0211-699501013259,albumina,i
15,0211-699501013259,Efecto,o
15,0211-699501013259,de,o
15,0211-699501013259,la,o
15,0211-699501013259,suplementacion,i
15,0211-699501013259,con,o
15,0211-699501013259,acido,i
15,0211-699501013259,folico,i
15,0211-699501013259,sobre,o
15,0211-699501013259,los,o
15,0211-699501013259,niveles,i
15,0211-699501013259,de,i
15,0211-699501013259,homocisteina,i
15,0211-699501013259,total,o
15,0211-699501013259,en,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,en,o
15,0211-699501013259,hemodialisis,i
15,0211-699501013259,La,o
15,0211-699501013259,hiperhomocisteinemia,i
15,0211-699501013259,es,o
15,0211-699501013259,un,o
15,0211-699501013259,marcador,o
15,0211-699501013259,de,o
15,0211-699501013259,riesgo,o
15,0211-699501013259,independiente,o
15,0211-699501013259,de,o
15,0211-699501013259,morbimortalidad,o
15,0211-699501013259,cardiovascular,i
15,0211-699501013259,Hemos,o
15,0211-699501013259,intentado,o
15,0211-699501013259,prospectivamente,o
15,0211-699501013259,reducir,o
15,0211-699501013259,los,o
15,0211-699501013259,niveles,i
15,0211-699501013259,de,i
15,0211-699501013259,homocisteina,i
15,0211-699501013259,total,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,mediante,o
15,0211-699501013259,suplemento,o
15,0211-699501013259,con,o
15,0211-699501013259,acido,i
15,0211-699501013259,folico,i
15,0211-699501013259,y,o
15,0211-699501013259,vitamina,i
15,0211-699501013259,B6,i
15,0211-699501013259,pp,i
15,0211-699501013259,valorando,o
15,0211-699501013259,su,o
15,0211-699501013259,posible,o
15,0211-699501013259,correlacion,o
15,0211-699501013259,con,o
15,0211-699501013259,dosis,o
15,0211-699501013259,de,o
15,0211-699501013259,dialisis,i
15,0211-699501013259,funcion,i
15,0211-699501013259,residual,i
15,0211-699501013259,y,o
15,0211-699501013259,parametros,o
15,0211-699501013259,nutricionales,o
15,0211-699501013259,Metodos,o
15,0211-699501013259,Todos,o
15,0211-699501013259,los,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,en,o
15,0211-699501013259,hemodialisis,i
15,0211-699501013259,al,o
15,0211-699501013259,comienzo,o
15,0211-699501013259,del,o
15,0211-699501013259,estudio,o
15,0211-699501013259,que,o
15,0211-699501013259,no,o
15,0211-699501013259,recibian,o
15,0211-699501013259,acido,i
15,0211-699501013259,folico,i
15,0211-699501013259,ni,o
15,0211-699501013259,vitamina,i
15,0211-699501013259,B6,i
15,0211-699501013259,asi,o
15,0211-699501013259,como,o
15,0211-699501013259,los,o
15,0211-699501013259,incorporados,o
15,0211-699501013259,posteriormente,o
15,0211-699501013259,a,o
15,0211-699501013259,partir,o
15,0211-699501013259,de,o
15,0211-699501013259,su,o
15,0211-699501013259,tercer,o
15,0211-699501013259,mes,o
15,0211-699501013259,en,o
15,0211-699501013259,hemodialisis,i
15,0211-699501013259,recibieron,o
15,0211-699501013259,5,o
15,0211-699501013259,mg,o
15,0211-699501013259,orales,o
15,0211-699501013259,de,o
15,0211-699501013259,acido,i
15,0211-699501013259,folico,i
15,0211-699501013259,cada,o
15,0211-699501013259,48,o
15,0211-699501013259,horas,o
15,0211-699501013259,y,o
15,0211-699501013259,40,o
15,0211-699501013259,mg,o
15,0211-699501013259,orales,o
15,0211-699501013259,de,o
15,0211-699501013259,vitamina,i
15,0211-699501013259,B6,i
15,0211-699501013259,cada,o
15,0211-699501013259,semana,o
15,0211-699501013259,Se,o
15,0211-699501013259,determinaron,o
15,0211-699501013259,al,o
15,0211-699501013259,comienzo,o
15,0211-699501013259,del,o
15,0211-699501013259,estudio,o
15,0211-699501013259,y,o
15,0211-699501013259,cada,o
15,0211-699501013259,2,o
15,0211-699501013259,meses,o
15,0211-699501013259,niveles,i
15,0211-699501013259,de,i
15,0211-699501013259,folato,i
15,0211-699501013259,vitamina,i
15,0211-699501013259,B12,i
15,0211-699501013259,inmunoensayo,i
15,0211-699501013259,albumina,i
15,0211-699501013259,y,o
15,0211-699501013259,cinetica,o
15,0211-699501013259,de,o
15,0211-699501013259,la,o
15,0211-699501013259,urea,i
15,0211-699501013259,KTV,o
15,0211-699501013259,KRU,o
15,0211-699501013259,PCRn,o
15,0211-699501013259,y,o
15,0211-699501013259,cada,o
15,0211-699501013259,6,o
15,0211-699501013259,meses,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,HPLC,i
15,0211-699501013259,y,o
15,0211-699501013259,pp,i
15,0211-699501013259,RIA,i
15,0211-699501013259,Resultados,o
15,0211-699501013259,80,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,fueron,o
15,0211-699501013259,incluidos,o
15,0211-699501013259,en,o
15,0211-699501013259,el,o
15,0211-699501013259,estudio,o
15,0211-699501013259,basal,o
15,0211-699501013259,con,o
15,0211-699501013259,una,o
15,0211-699501013259,prevalencia,o
15,0211-699501013259,de,o
15,0211-699501013259,hiperhomocisteinemia,i
15,0211-699501013259,del,o
15,0211-699501013259,844,o
15,0211-699501013259,deficit,i
15,0211-699501013259,de,i
15,0211-699501013259,pp,i
15,0211-699501013259,en,o
15,0211-699501013259,el,o
15,0211-699501013259,32,o
15,0211-699501013259,y,o
15,0211-699501013259,folato,i
15,0211-699501013259,en,o
15,0211-699501013259,el,o
15,0211-699501013259,rango,o
15,0211-699501013259,normal,o
15,0211-699501013259,bajo,o
15,0211-699501013259,los,o
15,0211-699501013259,niveles,i
15,0211-699501013259,de,i
15,0211-699501013259,tHcy,i
15,0211-699501013259,se,o
15,0211-699501013259,correlacionaban,o
15,0211-699501013259,inversamente,o
15,0211-699501013259,con,o
15,0211-699501013259,los,o
15,0211-699501013259,del,o
15,0211-699501013259,folato,i
15,0211-699501013259,r,o
15,0211-699501013259,0336,o
15,0211-699501013259,p,o
15,0211-699501013259,001,o
15,0211-699501013259,pero,o
15,0211-699501013259,no,o
15,0211-699501013259,con,o
15,0211-699501013259,pp,i
15,0211-699501013259,B12,i
15,0211-699501013259,edad,o
15,0211-699501013259,albumina,i
15,0211-699501013259,KTV,o
15,0211-699501013259,KRU,o
15,0211-699501013259,PCRn,o
15,0211-699501013259,Cincuenta,o
15,0211-699501013259,y,o
15,0211-699501013259,ocho,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,recibieron,o
15,0211-699501013259,seis,o
15,0211-699501013259,meses,o
15,0211-699501013259,de,o
15,0211-699501013259,suplementacion,i
15,0211-699501013259,con,o
15,0211-699501013259,normalizacion,o
15,0211-699501013259,del,o
15,0211-699501013259,pp,i
15,0211-699501013259,aumento,o
15,0211-699501013259,del,o
15,0211-699501013259,folato,i
15,0211-699501013259,703,o
15,0211-699501013259,IC,o
15,0211-699501013259,638,o
15,0211-699501013259,795,o
15,0211-699501013259,vs,o
15,0211-699501013259,6181,o
15,0211-699501013259,IC,o
15,0211-699501013259,4447,o
15,0211-699501013259,7811,o
15,0211-699501013259,p,o
15,0211-699501013259,0001,o
15,0211-699501013259,y,o
15,0211-699501013259,descenso,o
15,0211-699501013259,de,o
15,0211-699501013259,la,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,240,o
15,0211-699501013259,IC,o
15,0211-699501013259,213,o
15,0211-699501013259,264,o
15,0211-699501013259,vs,o
15,0211-699501013259,199,o
15,0211-699501013259,IC,o
15,0211-699501013259,175,o
15,0211-699501013259,224,o
15,0211-699501013259,p,o
15,0211-699501013259,005,o
15,0211-699501013259,Han,o
15,0211-699501013259,recibido,o
15,0211-699501013259,suplementacion,i
15,0211-699501013259,durante,o
15,0211-699501013259,12,o
15,0211-699501013259,meses,o
15,0211-699501013259,33,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,pero,o
15,0211-699501013259,a,o
15,0211-699501013259,pesar,o
15,0211-699501013259,de,o
15,0211-699501013259,un,o
15,0211-699501013259,continuo,o
15,0211-699501013259,aumento,o
15,0211-699501013259,del,o
15,0211-699501013259,folato,i
15,0211-699501013259,10078,o
15,0211-699501013259,IC,o
15,0211-699501013259,7481,o
15,0211-699501013259,12674,o
15,0211-699501013259,p,o
15,0211-699501013259,0001,o
15,0211-699501013259,solo,o
15,0211-699501013259,3,o
15,0211-699501013259,pacientes,o
15,0211-699501013259,presentan,o
15,0211-699501013259,niveles,o
15,0211-699501013259,normales,o
15,0211-699501013259,de,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,correlacionandose,o
15,0211-699501013259,directamente,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,con,o
15,0211-699501013259,la,o
15,0211-699501013259,albumina,i
15,0211-699501013259,r,o
15,0211-699501013259,056,o
15,0211-699501013259,p,o
15,0211-699501013259,0001,o
15,0211-699501013259,que,o
15,0211-699501013259,se,o
15,0211-699501013259,elevo,o
15,0211-699501013259,con,o
15,0211-699501013259,respecto,o
15,0211-699501013259,al,o
15,0211-699501013259,inicio,o
15,0211-699501013259,337,o
15,0211-699501013259,IC,o
15,0211-699501013259,327,o
15,0211-699501013259,346,o
15,0211-699501013259,vs,o
15,0211-699501013259,350,o
15,0211-699501013259,IC,o
15,0211-699501013259,337,o
15,0211-699501013259,363,o
15,0211-699501013259,p,o
15,0211-699501013259,005,o
15,0211-699501013259,Conclusion,o
15,0211-699501013259,Tras,o
15,0211-699501013259,suplementacion,i
15,0211-699501013259,con,o
15,0211-699501013259,acido,i
15,0211-699501013259,folico,i
15,0211-699501013259,y,o
15,0211-699501013259,vitamina,i
15,0211-699501013259,B6,i
15,0211-699501013259,aunque,o
15,0211-699501013259,inicialmente,o
15,0211-699501013259,se,o
15,0211-699501013259,reduce,o
15,0211-699501013259,la,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,esta,o
15,0211-699501013259,respuesta,o
15,0211-699501013259,se,o
15,0211-699501013259,hace,o
15,0211-699501013259,refractaria,o
15,0211-699501013259,correlacionandose,o
15,0211-699501013259,directamente,o
15,0211-699501013259,la,o
15,0211-699501013259,tHcy,i
15,0211-699501013259,con,o
15,0211-699501013259,la,o
15,0211-699501013259,albumina,i
15,0211-699501013259,plasmatica,i
15,0211-699501013259,La,o
15,0211-699501013259,interpretacion,o
15,0211-699501013259,de,o
15,0211-699501013259,los,o
15,0211-699501013259,niveles,i
15,0211-699501013259,de,i
15,0211-699501013259,tHcy,i
15,0211-699501013259,debe,o
15,0211-699501013259,tener,o
15,0211-699501013259,en,o
15,0211-699501013259,cuenta,o
15,0211-699501013259,la,o
15,0211-699501013259,concentracion,i
15,0211-699501013259,de,i
15,0211-699501013259,albumina,i
16,0211-699501013259,Efecto,o
16,0211-699501013259,de,o
16,0211-699501013259,la,o
16,0211-699501013259,suplementacion,i
16,0211-699501013259,con,o
16,0211-699501013259,acido,i
16,0211-699501013259,folico,i
16,0211-699501013259,sobre,o
16,0211-699501013259,los,o
16,0211-699501013259,niveles,i
16,0211-699501013259,de,i
16,0211-699501013259,homocisteina,i
16,0211-699501013259,total,o
16,0211-699501013259,en,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,en,o
16,0211-699501013259,hemodialisis,i
16,0211-699501013259,La,o
16,0211-699501013259,hiperhomocisteinemia,i
16,0211-699501013259,es,o
16,0211-699501013259,un,o
16,0211-699501013259,marcador,o
16,0211-699501013259,de,o
16,0211-699501013259,riesgo,o
16,0211-699501013259,independiente,o
16,0211-699501013259,de,o
16,0211-699501013259,morbimortalidad,o
16,0211-699501013259,cardiovascular,i
16,0211-699501013259,Hemos,o
16,0211-699501013259,intentado,o
16,0211-699501013259,prospectivamente,o
16,0211-699501013259,reducir,o
16,0211-699501013259,los,o
16,0211-699501013259,niveles,i
16,0211-699501013259,de,i
16,0211-699501013259,homocisteina,i
16,0211-699501013259,total,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,mediante,o
16,0211-699501013259,suplemento,o
16,0211-699501013259,con,o
16,0211-699501013259,acido,i
16,0211-699501013259,folico,i
16,0211-699501013259,y,o
16,0211-699501013259,vitamina,i
16,0211-699501013259,B6,i
16,0211-699501013259,pp,i
16,0211-699501013259,valorando,o
16,0211-699501013259,su,o
16,0211-699501013259,posible,o
16,0211-699501013259,correlacion,o
16,0211-699501013259,con,o
16,0211-699501013259,dosis,o
16,0211-699501013259,de,o
16,0211-699501013259,dialisis,i
16,0211-699501013259,funcion,i
16,0211-699501013259,residual,i
16,0211-699501013259,y,o
16,0211-699501013259,parametros,o
16,0211-699501013259,nutricionales,o
16,0211-699501013259,Metodos,o
16,0211-699501013259,Todos,o
16,0211-699501013259,los,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,en,o
16,0211-699501013259,hemodialisis,i
16,0211-699501013259,al,o
16,0211-699501013259,comienzo,o
16,0211-699501013259,del,o
16,0211-699501013259,estudio,o
16,0211-699501013259,que,o
16,0211-699501013259,no,o
16,0211-699501013259,recibian,o
16,0211-699501013259,acido,i
16,0211-699501013259,folico,i
16,0211-699501013259,ni,o
16,0211-699501013259,vitamina,i
16,0211-699501013259,B6,i
16,0211-699501013259,asi,o
16,0211-699501013259,como,o
16,0211-699501013259,los,o
16,0211-699501013259,incorporados,o
16,0211-699501013259,posteriormente,o
16,0211-699501013259,a,o
16,0211-699501013259,partir,o
16,0211-699501013259,de,o
16,0211-699501013259,su,o
16,0211-699501013259,tercer,o
16,0211-699501013259,mes,o
16,0211-699501013259,en,o
16,0211-699501013259,hemodialisis,i
16,0211-699501013259,recibieron,o
16,0211-699501013259,5,o
16,0211-699501013259,mg,o
16,0211-699501013259,orales,o
16,0211-699501013259,de,o
16,0211-699501013259,acido,i
16,0211-699501013259,folico,i
16,0211-699501013259,cada,o
16,0211-699501013259,48,o
16,0211-699501013259,horas,o
16,0211-699501013259,y,o
16,0211-699501013259,40,o
16,0211-699501013259,mg,o
16,0211-699501013259,orales,o
16,0211-699501013259,de,o
16,0211-699501013259,vitamina,i
16,0211-699501013259,B6,i
16,0211-699501013259,cada,o
16,0211-699501013259,semana,o
16,0211-699501013259,Se,o
16,0211-699501013259,determinaron,o
16,0211-699501013259,al,o
16,0211-699501013259,comienzo,o
16,0211-699501013259,del,o
16,0211-699501013259,estudio,o
16,0211-699501013259,y,o
16,0211-699501013259,cada,o
16,0211-699501013259,2,o
16,0211-699501013259,meses,o
16,0211-699501013259,niveles,i
16,0211-699501013259,de,i
16,0211-699501013259,folato,i
16,0211-699501013259,vitamina,i
16,0211-699501013259,B12,i
16,0211-699501013259,inmunoensayo,i
16,0211-699501013259,albumina,i
16,0211-699501013259,y,o
16,0211-699501013259,cinetica,o
16,0211-699501013259,de,o
16,0211-699501013259,la,o
16,0211-699501013259,urea,i
16,0211-699501013259,KTV,o
16,0211-699501013259,KRU,o
16,0211-699501013259,PCRn,o
16,0211-699501013259,y,o
16,0211-699501013259,cada,o
16,0211-699501013259,6,o
16,0211-699501013259,meses,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,HPLC,i
16,0211-699501013259,y,o
16,0211-699501013259,pp,i
16,0211-699501013259,RIA,i
16,0211-699501013259,Resultados,o
16,0211-699501013259,80,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,fueron,o
16,0211-699501013259,incluidos,o
16,0211-699501013259,en,o
16,0211-699501013259,el,o
16,0211-699501013259,estudio,o
16,0211-699501013259,basal,o
16,0211-699501013259,con,o
16,0211-699501013259,una,o
16,0211-699501013259,prevalencia,o
16,0211-699501013259,de,o
16,0211-699501013259,hiperhomocisteinemia,i
16,0211-699501013259,del,o
16,0211-699501013259,844,o
16,0211-699501013259,deficit,i
16,0211-699501013259,de,i
16,0211-699501013259,pp,i
16,0211-699501013259,en,o
16,0211-699501013259,el,o
16,0211-699501013259,32,o
16,0211-699501013259,y,o
16,0211-699501013259,folato,i
16,0211-699501013259,en,o
16,0211-699501013259,el,o
16,0211-699501013259,rango,o
16,0211-699501013259,normal,o
16,0211-699501013259,bajo,o
16,0211-699501013259,los,o
16,0211-699501013259,niveles,i
16,0211-699501013259,de,i
16,0211-699501013259,tHcy,i
16,0211-699501013259,se,o
16,0211-699501013259,correlacionaban,o
16,0211-699501013259,inversamente,o
16,0211-699501013259,con,o
16,0211-699501013259,los,o
16,0211-699501013259,del,o
16,0211-699501013259,folato,i
16,0211-699501013259,r,o
16,0211-699501013259,0336,o
16,0211-699501013259,p,o
16,0211-699501013259,001,o
16,0211-699501013259,pero,o
16,0211-699501013259,no,o
16,0211-699501013259,con,o
16,0211-699501013259,pp,i
16,0211-699501013259,B12,i
16,0211-699501013259,edad,o
16,0211-699501013259,albumina,i
16,0211-699501013259,KTV,o
16,0211-699501013259,KRU,o
16,0211-699501013259,PCRn,o
16,0211-699501013259,Cincuenta,o
16,0211-699501013259,y,o
16,0211-699501013259,ocho,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,recibieron,o
16,0211-699501013259,seis,o
16,0211-699501013259,meses,o
16,0211-699501013259,de,o
16,0211-699501013259,suplementacion,i
16,0211-699501013259,con,o
16,0211-699501013259,normalizacion,o
16,0211-699501013259,del,o
16,0211-699501013259,pp,i
16,0211-699501013259,aumento,o
16,0211-699501013259,del,o
16,0211-699501013259,folato,i
16,0211-699501013259,703,o
16,0211-699501013259,IC,o
16,0211-699501013259,638,o
16,0211-699501013259,795,o
16,0211-699501013259,vs,o
16,0211-699501013259,6181,o
16,0211-699501013259,IC,o
16,0211-699501013259,4447,o
16,0211-699501013259,7811,o
16,0211-699501013259,p,o
16,0211-699501013259,0001,o
16,0211-699501013259,y,o
16,0211-699501013259,descenso,o
16,0211-699501013259,de,o
16,0211-699501013259,la,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,240,o
16,0211-699501013259,IC,o
16,0211-699501013259,213,o
16,0211-699501013259,264,o
16,0211-699501013259,vs,o
16,0211-699501013259,199,o
16,0211-699501013259,IC,o
16,0211-699501013259,175,o
16,0211-699501013259,224,o
16,0211-699501013259,p,o
16,0211-699501013259,005,o
16,0211-699501013259,Han,o
16,0211-699501013259,recibido,o
16,0211-699501013259,suplementacion,i
16,0211-699501013259,durante,o
16,0211-699501013259,12,o
16,0211-699501013259,meses,o
16,0211-699501013259,33,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,pero,o
16,0211-699501013259,a,o
16,0211-699501013259,pesar,o
16,0211-699501013259,de,o
16,0211-699501013259,un,o
16,0211-699501013259,continuo,o
16,0211-699501013259,aumento,o
16,0211-699501013259,del,o
16,0211-699501013259,folato,i
16,0211-699501013259,10078,o
16,0211-699501013259,IC,o
16,0211-699501013259,7481,o
16,0211-699501013259,12674,o
16,0211-699501013259,p,o
16,0211-699501013259,0001,o
16,0211-699501013259,solo,o
16,0211-699501013259,3,o
16,0211-699501013259,pacientes,o
16,0211-699501013259,presentan,o
16,0211-699501013259,niveles,o
16,0211-699501013259,normales,o
16,0211-699501013259,de,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,correlacionandose,o
16,0211-699501013259,directamente,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,con,o
16,0211-699501013259,la,o
16,0211-699501013259,albumina,i
16,0211-699501013259,r,o
16,0211-699501013259,056,o
16,0211-699501013259,p,o
16,0211-699501013259,0001,o
16,0211-699501013259,que,o
16,0211-699501013259,se,o
16,0211-699501013259,elevo,o
16,0211-699501013259,con,o
16,0211-699501013259,respecto,o
16,0211-699501013259,al,o
16,0211-699501013259,inicio,o
16,0211-699501013259,337,o
16,0211-699501013259,IC,o
16,0211-699501013259,327,o
16,0211-699501013259,346,o
16,0211-699501013259,vs,o
16,0211-699501013259,350,o
16,0211-699501013259,IC,o
16,0211-699501013259,337,o
16,0211-699501013259,363,o
16,0211-699501013259,p,o
16,0211-699501013259,005,o
16,0211-699501013259,Conclusion,o
16,0211-699501013259,Tras,o
16,0211-699501013259,suplementacion,i
16,0211-699501013259,con,o
16,0211-699501013259,acido,i
16,0211-699501013259,folico,i
16,0211-699501013259,y,o
16,0211-699501013259,vitamina,i
16,0211-699501013259,B6,i
16,0211-699501013259,aunque,o
16,0211-699501013259,inicialmente,o
16,0211-699501013259,se,o
16,0211-699501013259,reduce,o
16,0211-699501013259,la,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,esta,o
16,0211-699501013259,respuesta,o
16,0211-699501013259,se,o
16,0211-699501013259,hace,o
16,0211-699501013259,refractaria,o
16,0211-699501013259,correlacionandose,o
16,0211-699501013259,directamente,o
16,0211-699501013259,la,o
16,0211-699501013259,tHcy,i
16,0211-699501013259,con,o
16,0211-699501013259,la,o
16,0211-699501013259,albumina,i
16,0211-699501013259,plasmatica,i
16,0211-699501013259,La,o
16,0211-699501013259,interpretacion,o
16,0211-699501013259,de,o
16,0211-699501013259,los,o
16,0211-699501013259,niveles,i
16,0211-699501013259,de,i
16,0211-699501013259,tHcy,i
16,0211-699501013259,debe,o
16,0211-699501013259,tener,o
16,0211-699501013259,en,o
16,0211-699501013259,cuenta,o
16,0211-699501013259,la,o
16,0211-699501013259,concentracion,i
16,0211-699501013259,de,i
16,0211-699501013259,albumina,i
17,0211-699501013259,Efecto,o
17,0211-699501013259,de,o
17,0211-699501013259,la,o
17,0211-699501013259,suplementacion,i
17,0211-699501013259,con,o
17,0211-699501013259,acido,i
17,0211-699501013259,folico,i
17,0211-699501013259,sobre,o
17,0211-699501013259,los,o
17,0211-699501013259,niveles,i
17,0211-699501013259,de,i
17,0211-699501013259,homocisteina,i
17,0211-699501013259,total,o
17,0211-699501013259,en,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,en,o
17,0211-699501013259,hemodialisis,i
17,0211-699501013259,La,o
17,0211-699501013259,hiperhomocisteinemia,i
17,0211-699501013259,es,o
17,0211-699501013259,un,o
17,0211-699501013259,marcador,o
17,0211-699501013259,de,o
17,0211-699501013259,riesgo,o
17,0211-699501013259,independiente,o
17,0211-699501013259,de,o
17,0211-699501013259,morbimortalidad,o
17,0211-699501013259,cardiovascular,i
17,0211-699501013259,Hemos,o
17,0211-699501013259,intentado,o
17,0211-699501013259,prospectivamente,o
17,0211-699501013259,reducir,o
17,0211-699501013259,los,o
17,0211-699501013259,niveles,i
17,0211-699501013259,de,i
17,0211-699501013259,homocisteina,i
17,0211-699501013259,total,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,mediante,o
17,0211-699501013259,suplemento,o
17,0211-699501013259,con,o
17,0211-699501013259,acido,i
17,0211-699501013259,folico,i
17,0211-699501013259,y,o
17,0211-699501013259,vitamina,i
17,0211-699501013259,B6,i
17,0211-699501013259,pp,i
17,0211-699501013259,valorando,o
17,0211-699501013259,su,o
17,0211-699501013259,posible,o
17,0211-699501013259,correlacion,o
17,0211-699501013259,con,o
17,0211-699501013259,dosis,o
17,0211-699501013259,de,o
17,0211-699501013259,dialisis,i
17,0211-699501013259,funcion,i
17,0211-699501013259,residual,i
17,0211-699501013259,y,o
17,0211-699501013259,parametros,o
17,0211-699501013259,nutricionales,o
17,0211-699501013259,Metodos,o
17,0211-699501013259,Todos,o
17,0211-699501013259,los,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,en,o
17,0211-699501013259,hemodialisis,i
17,0211-699501013259,al,o
17,0211-699501013259,comienzo,o
17,0211-699501013259,del,o
17,0211-699501013259,estudio,o
17,0211-699501013259,que,o
17,0211-699501013259,no,o
17,0211-699501013259,recibian,o
17,0211-699501013259,acido,i
17,0211-699501013259,folico,i
17,0211-699501013259,ni,o
17,0211-699501013259,vitamina,i
17,0211-699501013259,B6,i
17,0211-699501013259,asi,o
17,0211-699501013259,como,o
17,0211-699501013259,los,o
17,0211-699501013259,incorporados,o
17,0211-699501013259,posteriormente,o
17,0211-699501013259,a,o
17,0211-699501013259,partir,o
17,0211-699501013259,de,o
17,0211-699501013259,su,o
17,0211-699501013259,tercer,o
17,0211-699501013259,mes,o
17,0211-699501013259,en,o
17,0211-699501013259,hemodialisis,i
17,0211-699501013259,recibieron,o
17,0211-699501013259,5,o
17,0211-699501013259,mg,o
17,0211-699501013259,orales,o
17,0211-699501013259,de,o
17,0211-699501013259,acido,i
17,0211-699501013259,folico,i
17,0211-699501013259,cada,o
17,0211-699501013259,48,o
17,0211-699501013259,horas,o
17,0211-699501013259,y,o
17,0211-699501013259,40,o
17,0211-699501013259,mg,o
17,0211-699501013259,orales,o
17,0211-699501013259,de,o
17,0211-699501013259,vitamina,i
17,0211-699501013259,B6,i
17,0211-699501013259,cada,o
17,0211-699501013259,semana,o
17,0211-699501013259,Se,o
17,0211-699501013259,determinaron,o
17,0211-699501013259,al,o
17,0211-699501013259,comienzo,o
17,0211-699501013259,del,o
17,0211-699501013259,estudio,o
17,0211-699501013259,y,o
17,0211-699501013259,cada,o
17,0211-699501013259,2,o
17,0211-699501013259,meses,o
17,0211-699501013259,niveles,i
17,0211-699501013259,de,i
17,0211-699501013259,folato,i
17,0211-699501013259,vitamina,i
17,0211-699501013259,B12,i
17,0211-699501013259,inmunoensayo,i
17,0211-699501013259,albumina,i
17,0211-699501013259,y,o
17,0211-699501013259,cinetica,o
17,0211-699501013259,de,o
17,0211-699501013259,la,o
17,0211-699501013259,urea,i
17,0211-699501013259,KTV,o
17,0211-699501013259,KRU,o
17,0211-699501013259,PCRn,o
17,0211-699501013259,y,o
17,0211-699501013259,cada,o
17,0211-699501013259,6,o
17,0211-699501013259,meses,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,HPLC,i
17,0211-699501013259,y,o
17,0211-699501013259,pp,i
17,0211-699501013259,RIA,i
17,0211-699501013259,Resultados,o
17,0211-699501013259,80,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,fueron,o
17,0211-699501013259,incluidos,o
17,0211-699501013259,en,o
17,0211-699501013259,el,o
17,0211-699501013259,estudio,o
17,0211-699501013259,basal,o
17,0211-699501013259,con,o
17,0211-699501013259,una,o
17,0211-699501013259,prevalencia,o
17,0211-699501013259,de,o
17,0211-699501013259,hiperhomocisteinemia,i
17,0211-699501013259,del,o
17,0211-699501013259,844,o
17,0211-699501013259,deficit,i
17,0211-699501013259,de,i
17,0211-699501013259,pp,i
17,0211-699501013259,en,o
17,0211-699501013259,el,o
17,0211-699501013259,32,o
17,0211-699501013259,y,o
17,0211-699501013259,folato,i
17,0211-699501013259,en,o
17,0211-699501013259,el,o
17,0211-699501013259,rango,o
17,0211-699501013259,normal,o
17,0211-699501013259,bajo,o
17,0211-699501013259,los,o
17,0211-699501013259,niveles,i
17,0211-699501013259,de,i
17,0211-699501013259,tHcy,i
17,0211-699501013259,se,o
17,0211-699501013259,correlacionaban,o
17,0211-699501013259,inversamente,o
17,0211-699501013259,con,o
17,0211-699501013259,los,o
17,0211-699501013259,del,o
17,0211-699501013259,folato,i
17,0211-699501013259,r,o
17,0211-699501013259,0336,o
17,0211-699501013259,p,o
17,0211-699501013259,001,o
17,0211-699501013259,pero,o
17,0211-699501013259,no,o
17,0211-699501013259,con,o
17,0211-699501013259,pp,i
17,0211-699501013259,B12,i
17,0211-699501013259,edad,o
17,0211-699501013259,albumina,i
17,0211-699501013259,KTV,o
17,0211-699501013259,KRU,o
17,0211-699501013259,PCRn,o
17,0211-699501013259,Cincuenta,o
17,0211-699501013259,y,o
17,0211-699501013259,ocho,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,recibieron,o
17,0211-699501013259,seis,o
17,0211-699501013259,meses,o
17,0211-699501013259,de,o
17,0211-699501013259,suplementacion,i
17,0211-699501013259,con,o
17,0211-699501013259,normalizacion,o
17,0211-699501013259,del,o
17,0211-699501013259,pp,i
17,0211-699501013259,aumento,o
17,0211-699501013259,del,o
17,0211-699501013259,folato,i
17,0211-699501013259,703,o
17,0211-699501013259,IC,o
17,0211-699501013259,638,o
17,0211-699501013259,795,o
17,0211-699501013259,vs,o
17,0211-699501013259,6181,o
17,0211-699501013259,IC,o
17,0211-699501013259,4447,o
17,0211-699501013259,7811,o
17,0211-699501013259,p,o
17,0211-699501013259,0001,o
17,0211-699501013259,y,o
17,0211-699501013259,descenso,o
17,0211-699501013259,de,o
17,0211-699501013259,la,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,240,o
17,0211-699501013259,IC,o
17,0211-699501013259,213,o
17,0211-699501013259,264,o
17,0211-699501013259,vs,o
17,0211-699501013259,199,o
17,0211-699501013259,IC,o
17,0211-699501013259,175,o
17,0211-699501013259,224,o
17,0211-699501013259,p,o
17,0211-699501013259,005,o
17,0211-699501013259,Han,o
17,0211-699501013259,recibido,o
17,0211-699501013259,suplementacion,i
17,0211-699501013259,durante,o
17,0211-699501013259,12,o
17,0211-699501013259,meses,o
17,0211-699501013259,33,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,pero,o
17,0211-699501013259,a,o
17,0211-699501013259,pesar,o
17,0211-699501013259,de,o
17,0211-699501013259,un,o
17,0211-699501013259,continuo,o
17,0211-699501013259,aumento,o
17,0211-699501013259,del,o
17,0211-699501013259,folato,i
17,0211-699501013259,10078,o
17,0211-699501013259,IC,o
17,0211-699501013259,7481,o
17,0211-699501013259,12674,o
17,0211-699501013259,p,o
17,0211-699501013259,0001,o
17,0211-699501013259,solo,o
17,0211-699501013259,3,o
17,0211-699501013259,pacientes,o
17,0211-699501013259,presentan,o
17,0211-699501013259,niveles,o
17,0211-699501013259,normales,o
17,0211-699501013259,de,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,correlacionandose,o
17,0211-699501013259,directamente,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,con,o
17,0211-699501013259,la,o
17,0211-699501013259,albumina,i
17,0211-699501013259,r,o
17,0211-699501013259,056,o
17,0211-699501013259,p,o
17,0211-699501013259,0001,o
17,0211-699501013259,que,o
17,0211-699501013259,se,o
17,0211-699501013259,elevo,o
17,0211-699501013259,con,o
17,0211-699501013259,respecto,o
17,0211-699501013259,al,o
17,0211-699501013259,inicio,o
17,0211-699501013259,337,o
17,0211-699501013259,IC,o
17,0211-699501013259,327,o
17,0211-699501013259,346,o
17,0211-699501013259,vs,o
17,0211-699501013259,350,o
17,0211-699501013259,IC,o
17,0211-699501013259,337,o
17,0211-699501013259,363,o
17,0211-699501013259,p,o
17,0211-699501013259,005,o
17,0211-699501013259,Conclusion,o
17,0211-699501013259,Tras,o
17,0211-699501013259,suplementacion,i
17,0211-699501013259,con,o
17,0211-699501013259,acido,i
17,0211-699501013259,folico,i
17,0211-699501013259,y,o
17,0211-699501013259,vitamina,i
17,0211-699501013259,B6,i
17,0211-699501013259,aunque,o
17,0211-699501013259,inicialmente,o
17,0211-699501013259,se,o
17,0211-699501013259,reduce,o
17,0211-699501013259,la,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,esta,o
17,0211-699501013259,respuesta,o
17,0211-699501013259,se,o
17,0211-699501013259,hace,o
17,0211-699501013259,refractaria,o
17,0211-699501013259,correlacionandose,o
17,0211-699501013259,directamente,o
17,0211-699501013259,la,o
17,0211-699501013259,tHcy,i
17,0211-699501013259,con,o
17,0211-699501013259,la,o
17,0211-699501013259,albumina,i
17,0211-699501013259,plasmatica,i
17,0211-699501013259,La,o
17,0211-699501013259,interpretacion,o
17,0211-699501013259,de,o
17,0211-699501013259,los,o
17,0211-699501013259,niveles,i
17,0211-699501013259,de,i
17,0211-699501013259,tHcy,i
17,0211-699501013259,debe,o
17,0211-699501013259,tener,o
17,0211-699501013259,en,o
17,0211-699501013259,cuenta,o
17,0211-699501013259,la,o
17,0211-699501013259,concentracion,i
17,0211-699501013259,de,i
17,0211-699501013259,albumina,i
18,0211-699501013259,Efecto,o
18,0211-699501013259,de,o
18,0211-699501013259,la,o
18,0211-699501013259,suplementacion,i
18,0211-699501013259,con,o
18,0211-699501013259,acido,i
18,0211-699501013259,folico,i
18,0211-699501013259,sobre,o
18,0211-699501013259,los,o
18,0211-699501013259,niveles,i
18,0211-699501013259,de,i
18,0211-699501013259,homocisteina,i
18,0211-699501013259,total,o
18,0211-699501013259,en,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,en,o
18,0211-699501013259,hemodialisis,i
18,0211-699501013259,La,o
18,0211-699501013259,hiperhomocisteinemia,i
18,0211-699501013259,es,o
18,0211-699501013259,un,o
18,0211-699501013259,marcador,o
18,0211-699501013259,de,o
18,0211-699501013259,riesgo,o
18,0211-699501013259,independiente,o
18,0211-699501013259,de,o
18,0211-699501013259,morbimortalidad,o
18,0211-699501013259,cardiovascular,i
18,0211-699501013259,Hemos,o
18,0211-699501013259,intentado,o
18,0211-699501013259,prospectivamente,o
18,0211-699501013259,reducir,o
18,0211-699501013259,los,o
18,0211-699501013259,niveles,i
18,0211-699501013259,de,i
18,0211-699501013259,homocisteina,i
18,0211-699501013259,total,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,mediante,o
18,0211-699501013259,suplemento,o
18,0211-699501013259,con,o
18,0211-699501013259,acido,i
18,0211-699501013259,folico,i
18,0211-699501013259,y,o
18,0211-699501013259,vitamina,i
18,0211-699501013259,B6,i
18,0211-699501013259,pp,i
18,0211-699501013259,valorando,o
18,0211-699501013259,su,o
18,0211-699501013259,posible,o
18,0211-699501013259,correlacion,o
18,0211-699501013259,con,o
18,0211-699501013259,dosis,o
18,0211-699501013259,de,o
18,0211-699501013259,dialisis,i
18,0211-699501013259,funcion,i
18,0211-699501013259,residual,i
18,0211-699501013259,y,o
18,0211-699501013259,parametros,o
18,0211-699501013259,nutricionales,o
18,0211-699501013259,Metodos,o
18,0211-699501013259,Todos,o
18,0211-699501013259,los,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,en,o
18,0211-699501013259,hemodialisis,i
18,0211-699501013259,al,o
18,0211-699501013259,comienzo,o
18,0211-699501013259,del,o
18,0211-699501013259,estudio,o
18,0211-699501013259,que,o
18,0211-699501013259,no,o
18,0211-699501013259,recibian,o
18,0211-699501013259,acido,i
18,0211-699501013259,folico,i
18,0211-699501013259,ni,o
18,0211-699501013259,vitamina,i
18,0211-699501013259,B6,i
18,0211-699501013259,asi,o
18,0211-699501013259,como,o
18,0211-699501013259,los,o
18,0211-699501013259,incorporados,o
18,0211-699501013259,posteriormente,o
18,0211-699501013259,a,o
18,0211-699501013259,partir,o
18,0211-699501013259,de,o
18,0211-699501013259,su,o
18,0211-699501013259,tercer,o
18,0211-699501013259,mes,o
18,0211-699501013259,en,o
18,0211-699501013259,hemodialisis,i
18,0211-699501013259,recibieron,o
18,0211-699501013259,5,o
18,0211-699501013259,mg,o
18,0211-699501013259,orales,o
18,0211-699501013259,de,o
18,0211-699501013259,acido,i
18,0211-699501013259,folico,i
18,0211-699501013259,cada,o
18,0211-699501013259,48,o
18,0211-699501013259,horas,o
18,0211-699501013259,y,o
18,0211-699501013259,40,o
18,0211-699501013259,mg,o
18,0211-699501013259,orales,o
18,0211-699501013259,de,o
18,0211-699501013259,vitamina,i
18,0211-699501013259,B6,i
18,0211-699501013259,cada,o
18,0211-699501013259,semana,o
18,0211-699501013259,Se,o
18,0211-699501013259,determinaron,o
18,0211-699501013259,al,o
18,0211-699501013259,comienzo,o
18,0211-699501013259,del,o
18,0211-699501013259,estudio,o
18,0211-699501013259,y,o
18,0211-699501013259,cada,o
18,0211-699501013259,2,o
18,0211-699501013259,meses,o
18,0211-699501013259,niveles,i
18,0211-699501013259,de,i
18,0211-699501013259,folato,i
18,0211-699501013259,vitamina,i
18,0211-699501013259,B12,i
18,0211-699501013259,inmunoensayo,i
18,0211-699501013259,albumina,i
18,0211-699501013259,y,o
18,0211-699501013259,cinetica,o
18,0211-699501013259,de,o
18,0211-699501013259,la,o
18,0211-699501013259,urea,i
18,0211-699501013259,KTV,o
18,0211-699501013259,KRU,o
18,0211-699501013259,PCRn,o
18,0211-699501013259,y,o
18,0211-699501013259,cada,o
18,0211-699501013259,6,o
18,0211-699501013259,meses,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,HPLC,i
18,0211-699501013259,y,o
18,0211-699501013259,pp,i
18,0211-699501013259,RIA,i
18,0211-699501013259,Resultados,o
18,0211-699501013259,80,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,fueron,o
18,0211-699501013259,incluidos,o
18,0211-699501013259,en,o
18,0211-699501013259,el,o
18,0211-699501013259,estudio,o
18,0211-699501013259,basal,o
18,0211-699501013259,con,o
18,0211-699501013259,una,o
18,0211-699501013259,prevalencia,o
18,0211-699501013259,de,o
18,0211-699501013259,hiperhomocisteinemia,i
18,0211-699501013259,del,o
18,0211-699501013259,844,o
18,0211-699501013259,deficit,i
18,0211-699501013259,de,i
18,0211-699501013259,pp,i
18,0211-699501013259,en,o
18,0211-699501013259,el,o
18,0211-699501013259,32,o
18,0211-699501013259,y,o
18,0211-699501013259,folato,i
18,0211-699501013259,en,o
18,0211-699501013259,el,o
18,0211-699501013259,rango,o
18,0211-699501013259,normal,o
18,0211-699501013259,bajo,o
18,0211-699501013259,los,o
18,0211-699501013259,niveles,i
18,0211-699501013259,de,i
18,0211-699501013259,tHcy,i
18,0211-699501013259,se,o
18,0211-699501013259,correlacionaban,o
18,0211-699501013259,inversamente,o
18,0211-699501013259,con,o
18,0211-699501013259,los,o
18,0211-699501013259,del,o
18,0211-699501013259,folato,i
18,0211-699501013259,r,o
18,0211-699501013259,0336,o
18,0211-699501013259,p,o
18,0211-699501013259,001,o
18,0211-699501013259,pero,o
18,0211-699501013259,no,o
18,0211-699501013259,con,o
18,0211-699501013259,pp,i
18,0211-699501013259,B12,i
18,0211-699501013259,edad,o
18,0211-699501013259,albumina,i
18,0211-699501013259,KTV,o
18,0211-699501013259,KRU,o
18,0211-699501013259,PCRn,o
18,0211-699501013259,Cincuenta,o
18,0211-699501013259,y,o
18,0211-699501013259,ocho,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,recibieron,o
18,0211-699501013259,seis,o
18,0211-699501013259,meses,o
18,0211-699501013259,de,o
18,0211-699501013259,suplementacion,i
18,0211-699501013259,con,o
18,0211-699501013259,normalizacion,o
18,0211-699501013259,del,o
18,0211-699501013259,pp,i
18,0211-699501013259,aumento,o
18,0211-699501013259,del,o
18,0211-699501013259,folato,i
18,0211-699501013259,703,o
18,0211-699501013259,IC,o
18,0211-699501013259,638,o
18,0211-699501013259,795,o
18,0211-699501013259,vs,o
18,0211-699501013259,6181,o
18,0211-699501013259,IC,o
18,0211-699501013259,4447,o
18,0211-699501013259,7811,o
18,0211-699501013259,p,o
18,0211-699501013259,0001,o
18,0211-699501013259,y,o
18,0211-699501013259,descenso,o
18,0211-699501013259,de,o
18,0211-699501013259,la,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,240,o
18,0211-699501013259,IC,o
18,0211-699501013259,213,o
18,0211-699501013259,264,o
18,0211-699501013259,vs,o
18,0211-699501013259,199,o
18,0211-699501013259,IC,o
18,0211-699501013259,175,o
18,0211-699501013259,224,o
18,0211-699501013259,p,o
18,0211-699501013259,005,o
18,0211-699501013259,Han,o
18,0211-699501013259,recibido,o
18,0211-699501013259,suplementacion,i
18,0211-699501013259,durante,o
18,0211-699501013259,12,o
18,0211-699501013259,meses,o
18,0211-699501013259,33,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,pero,o
18,0211-699501013259,a,o
18,0211-699501013259,pesar,o
18,0211-699501013259,de,o
18,0211-699501013259,un,o
18,0211-699501013259,continuo,o
18,0211-699501013259,aumento,o
18,0211-699501013259,del,o
18,0211-699501013259,folato,i
18,0211-699501013259,10078,o
18,0211-699501013259,IC,o
18,0211-699501013259,7481,o
18,0211-699501013259,12674,o
18,0211-699501013259,p,o
18,0211-699501013259,0001,o
18,0211-699501013259,solo,o
18,0211-699501013259,3,o
18,0211-699501013259,pacientes,o
18,0211-699501013259,presentan,o
18,0211-699501013259,niveles,o
18,0211-699501013259,normales,o
18,0211-699501013259,de,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,correlacionandose,o
18,0211-699501013259,directamente,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,con,o
18,0211-699501013259,la,o
18,0211-699501013259,albumina,i
18,0211-699501013259,r,o
18,0211-699501013259,056,o
18,0211-699501013259,p,o
18,0211-699501013259,0001,o
18,0211-699501013259,que,o
18,0211-699501013259,se,o
18,0211-699501013259,elevo,o
18,0211-699501013259,con,o
18,0211-699501013259,respecto,o
18,0211-699501013259,al,o
18,0211-699501013259,inicio,o
18,0211-699501013259,337,o
18,0211-699501013259,IC,o
18,0211-699501013259,327,o
18,0211-699501013259,346,o
18,0211-699501013259,vs,o
18,0211-699501013259,350,o
18,0211-699501013259,IC,o
18,0211-699501013259,337,o
18,0211-699501013259,363,o
18,0211-699501013259,p,o
18,0211-699501013259,005,o
18,0211-699501013259,Conclusion,o
18,0211-699501013259,Tras,o
18,0211-699501013259,suplementacion,i
18,0211-699501013259,con,o
18,0211-699501013259,acido,i
18,0211-699501013259,folico,i
18,0211-699501013259,y,o
18,0211-699501013259,vitamina,i
18,0211-699501013259,B6,i
18,0211-699501013259,aunque,o
18,0211-699501013259,inicialmente,o
18,0211-699501013259,se,o
18,0211-699501013259,reduce,o
18,0211-699501013259,la,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,esta,o
18,0211-699501013259,respuesta,o
18,0211-699501013259,se,o
18,0211-699501013259,hace,o
18,0211-699501013259,refractaria,o
18,0211-699501013259,correlacionandose,o
18,0211-699501013259,directamente,o
18,0211-699501013259,la,o
18,0211-699501013259,tHcy,i
18,0211-699501013259,con,o
18,0211-699501013259,la,o
18,0211-699501013259,albumina,i
18,0211-699501013259,plasmatica,i
18,0211-699501013259,La,o
18,0211-699501013259,interpretacion,o
18,0211-699501013259,de,o
18,0211-699501013259,los,o
18,0211-699501013259,niveles,i
18,0211-699501013259,de,i
18,0211-699501013259,tHcy,i
18,0211-699501013259,debe,o
18,0211-699501013259,tener,o
18,0211-699501013259,en,o
18,0211-699501013259,cuenta,o
18,0211-699501013259,la,o
18,0211-699501013259,concentracion,i
18,0211-699501013259,de,i
18,0211-699501013259,albumina,i
19,0211-699501013259,Efecto,o
19,0211-699501013259,de,o
19,0211-699501013259,la,o
19,0211-699501013259,suplementacion,i
19,0211-699501013259,con,o
19,0211-699501013259,acido,i
19,0211-699501013259,folico,i
19,0211-699501013259,sobre,o
19,0211-699501013259,los,o
19,0211-699501013259,niveles,i
19,0211-699501013259,de,i
19,0211-699501013259,homocisteina,i
19,0211-699501013259,total,o
19,0211-699501013259,en,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,en,o
19,0211-699501013259,hemodialisis,i
19,0211-699501013259,La,o
19,0211-699501013259,hiperhomocisteinemia,i
19,0211-699501013259,es,o
19,0211-699501013259,un,o
19,0211-699501013259,marcador,o
19,0211-699501013259,de,o
19,0211-699501013259,riesgo,o
19,0211-699501013259,independiente,o
19,0211-699501013259,de,o
19,0211-699501013259,morbimortalidad,o
19,0211-699501013259,cardiovascular,i
19,0211-699501013259,Hemos,o
19,0211-699501013259,intentado,o
19,0211-699501013259,prospectivamente,o
19,0211-699501013259,reducir,o
19,0211-699501013259,los,o
19,0211-699501013259,niveles,i
19,0211-699501013259,de,i
19,0211-699501013259,homocisteina,i
19,0211-699501013259,total,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,mediante,o
19,0211-699501013259,suplemento,o
19,0211-699501013259,con,o
19,0211-699501013259,acido,i
19,0211-699501013259,folico,i
19,0211-699501013259,y,o
19,0211-699501013259,vitamina,i
19,0211-699501013259,B6,i
19,0211-699501013259,pp,i
19,0211-699501013259,valorando,o
19,0211-699501013259,su,o
19,0211-699501013259,posible,o
19,0211-699501013259,correlacion,o
19,0211-699501013259,con,o
19,0211-699501013259,dosis,o
19,0211-699501013259,de,o
19,0211-699501013259,dialisis,i
19,0211-699501013259,funcion,i
19,0211-699501013259,residual,i
19,0211-699501013259,y,o
19,0211-699501013259,parametros,o
19,0211-699501013259,nutricionales,o
19,0211-699501013259,Metodos,o
19,0211-699501013259,Todos,o
19,0211-699501013259,los,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,en,o
19,0211-699501013259,hemodialisis,i
19,0211-699501013259,al,o
19,0211-699501013259,comienzo,o
19,0211-699501013259,del,o
19,0211-699501013259,estudio,o
19,0211-699501013259,que,o
19,0211-699501013259,no,o
19,0211-699501013259,recibian,o
19,0211-699501013259,acido,i
19,0211-699501013259,folico,i
19,0211-699501013259,ni,o
19,0211-699501013259,vitamina,i
19,0211-699501013259,B6,i
19,0211-699501013259,asi,o
19,0211-699501013259,como,o
19,0211-699501013259,los,o
19,0211-699501013259,incorporados,o
19,0211-699501013259,posteriormente,o
19,0211-699501013259,a,o
19,0211-699501013259,partir,o
19,0211-699501013259,de,o
19,0211-699501013259,su,o
19,0211-699501013259,tercer,o
19,0211-699501013259,mes,o
19,0211-699501013259,en,o
19,0211-699501013259,hemodialisis,i
19,0211-699501013259,recibieron,o
19,0211-699501013259,5,o
19,0211-699501013259,mg,o
19,0211-699501013259,orales,o
19,0211-699501013259,de,o
19,0211-699501013259,acido,i
19,0211-699501013259,folico,i
19,0211-699501013259,cada,o
19,0211-699501013259,48,o
19,0211-699501013259,horas,o
19,0211-699501013259,y,o
19,0211-699501013259,40,o
19,0211-699501013259,mg,o
19,0211-699501013259,orales,o
19,0211-699501013259,de,o
19,0211-699501013259,vitamina,i
19,0211-699501013259,B6,i
19,0211-699501013259,cada,o
19,0211-699501013259,semana,o
19,0211-699501013259,Se,o
19,0211-699501013259,determinaron,o
19,0211-699501013259,al,o
19,0211-699501013259,comienzo,o
19,0211-699501013259,del,o
19,0211-699501013259,estudio,o
19,0211-699501013259,y,o
19,0211-699501013259,cada,o
19,0211-699501013259,2,o
19,0211-699501013259,meses,o
19,0211-699501013259,niveles,i
19,0211-699501013259,de,i
19,0211-699501013259,folato,i
19,0211-699501013259,vitamina,i
19,0211-699501013259,B12,i
19,0211-699501013259,inmunoensayo,i
19,0211-699501013259,albumina,i
19,0211-699501013259,y,o
19,0211-699501013259,cinetica,o
19,0211-699501013259,de,o
19,0211-699501013259,la,o
19,0211-699501013259,urea,i
19,0211-699501013259,KTV,o
19,0211-699501013259,KRU,o
19,0211-699501013259,PCRn,o
19,0211-699501013259,y,o
19,0211-699501013259,cada,o
19,0211-699501013259,6,o
19,0211-699501013259,meses,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,HPLC,i
19,0211-699501013259,y,o
19,0211-699501013259,pp,i
19,0211-699501013259,RIA,i
19,0211-699501013259,Resultados,o
19,0211-699501013259,80,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,fueron,o
19,0211-699501013259,incluidos,o
19,0211-699501013259,en,o
19,0211-699501013259,el,o
19,0211-699501013259,estudio,o
19,0211-699501013259,basal,o
19,0211-699501013259,con,o
19,0211-699501013259,una,o
19,0211-699501013259,prevalencia,o
19,0211-699501013259,de,o
19,0211-699501013259,hiperhomocisteinemia,i
19,0211-699501013259,del,o
19,0211-699501013259,844,o
19,0211-699501013259,deficit,i
19,0211-699501013259,de,i
19,0211-699501013259,pp,i
19,0211-699501013259,en,o
19,0211-699501013259,el,o
19,0211-699501013259,32,o
19,0211-699501013259,y,o
19,0211-699501013259,folato,i
19,0211-699501013259,en,o
19,0211-699501013259,el,o
19,0211-699501013259,rango,o
19,0211-699501013259,normal,o
19,0211-699501013259,bajo,o
19,0211-699501013259,los,o
19,0211-699501013259,niveles,i
19,0211-699501013259,de,i
19,0211-699501013259,tHcy,i
19,0211-699501013259,se,o
19,0211-699501013259,correlacionaban,o
19,0211-699501013259,inversamente,o
19,0211-699501013259,con,o
19,0211-699501013259,los,o
19,0211-699501013259,del,o
19,0211-699501013259,folato,i
19,0211-699501013259,r,o
19,0211-699501013259,0336,o
19,0211-699501013259,p,o
19,0211-699501013259,001,o
19,0211-699501013259,pero,o
19,0211-699501013259,no,o
19,0211-699501013259,con,o
19,0211-699501013259,pp,i
19,0211-699501013259,B12,i
19,0211-699501013259,edad,o
19,0211-699501013259,albumina,i
19,0211-699501013259,KTV,o
19,0211-699501013259,KRU,o
19,0211-699501013259,PCRn,o
19,0211-699501013259,Cincuenta,o
19,0211-699501013259,y,o
19,0211-699501013259,ocho,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,recibieron,o
19,0211-699501013259,seis,o
19,0211-699501013259,meses,o
19,0211-699501013259,de,o
19,0211-699501013259,suplementacion,i
19,0211-699501013259,con,o
19,0211-699501013259,normalizacion,o
19,0211-699501013259,del,o
19,0211-699501013259,pp,i
19,0211-699501013259,aumento,o
19,0211-699501013259,del,o
19,0211-699501013259,folato,i
19,0211-699501013259,703,o
19,0211-699501013259,IC,o
19,0211-699501013259,638,o
19,0211-699501013259,795,o
19,0211-699501013259,vs,o
19,0211-699501013259,6181,o
19,0211-699501013259,IC,o
19,0211-699501013259,4447,o
19,0211-699501013259,7811,o
19,0211-699501013259,p,o
19,0211-699501013259,0001,o
19,0211-699501013259,y,o
19,0211-699501013259,descenso,o
19,0211-699501013259,de,o
19,0211-699501013259,la,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,240,o
19,0211-699501013259,IC,o
19,0211-699501013259,213,o
19,0211-699501013259,264,o
19,0211-699501013259,vs,o
19,0211-699501013259,199,o
19,0211-699501013259,IC,o
19,0211-699501013259,175,o
19,0211-699501013259,224,o
19,0211-699501013259,p,o
19,0211-699501013259,005,o
19,0211-699501013259,Han,o
19,0211-699501013259,recibido,o
19,0211-699501013259,suplementacion,i
19,0211-699501013259,durante,o
19,0211-699501013259,12,o
19,0211-699501013259,meses,o
19,0211-699501013259,33,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,pero,o
19,0211-699501013259,a,o
19,0211-699501013259,pesar,o
19,0211-699501013259,de,o
19,0211-699501013259,un,o
19,0211-699501013259,continuo,o
19,0211-699501013259,aumento,o
19,0211-699501013259,del,o
19,0211-699501013259,folato,i
19,0211-699501013259,10078,o
19,0211-699501013259,IC,o
19,0211-699501013259,7481,o
19,0211-699501013259,12674,o
19,0211-699501013259,p,o
19,0211-699501013259,0001,o
19,0211-699501013259,solo,o
19,0211-699501013259,3,o
19,0211-699501013259,pacientes,o
19,0211-699501013259,presentan,o
19,0211-699501013259,niveles,o
19,0211-699501013259,normales,o
19,0211-699501013259,de,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,correlacionandose,o
19,0211-699501013259,directamente,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,con,o
19,0211-699501013259,la,o
19,0211-699501013259,albumina,i
19,0211-699501013259,r,o
19,0211-699501013259,056,o
19,0211-699501013259,p,o
19,0211-699501013259,0001,o
19,0211-699501013259,que,o
19,0211-699501013259,se,o
19,0211-699501013259,elevo,o
19,0211-699501013259,con,o
19,0211-699501013259,respecto,o
19,0211-699501013259,al,o
19,0211-699501013259,inicio,o
19,0211-699501013259,337,o
19,0211-699501013259,IC,o
19,0211-699501013259,327,o
19,0211-699501013259,346,o
19,0211-699501013259,vs,o
19,0211-699501013259,350,o
19,0211-699501013259,IC,o
19,0211-699501013259,337,o
19,0211-699501013259,363,o
19,0211-699501013259,p,o
19,0211-699501013259,005,o
19,0211-699501013259,Conclusion,o
19,0211-699501013259,Tras,o
19,0211-699501013259,suplementacion,i
19,0211-699501013259,con,o
19,0211-699501013259,acido,i
19,0211-699501013259,folico,i
19,0211-699501013259,y,o
19,0211-699501013259,vitamina,i
19,0211-699501013259,B6,i
19,0211-699501013259,aunque,o
19,0211-699501013259,inicialmente,o
19,0211-699501013259,se,o
19,0211-699501013259,reduce,o
19,0211-699501013259,la,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,esta,o
19,0211-699501013259,respuesta,o
19,0211-699501013259,se,o
19,0211-699501013259,hace,o
19,0211-699501013259,refractaria,o
19,0211-699501013259,correlacionandose,o
19,0211-699501013259,directamente,o
19,0211-699501013259,la,o
19,0211-699501013259,tHcy,i
19,0211-699501013259,con,o
19,0211-699501013259,la,o
19,0211-699501013259,albumina,i
19,0211-699501013259,plasmatica,i
19,0211-699501013259,La,o
19,0211-699501013259,interpretacion,o
19,0211-699501013259,de,o
19,0211-699501013259,los,o
19,0211-699501013259,niveles,i
19,0211-699501013259,de,i
19,0211-699501013259,tHcy,i
19,0211-699501013259,debe,o
19,0211-699501013259,tener,o
19,0211-699501013259,en,o
19,0211-699501013259,cuenta,o
19,0211-699501013259,la,o
19,0211-699501013259,concentracion,i
19,0211-699501013259,de,i
19,0211-699501013259,albumina,i
20,0211-699501013259,Efecto,o
20,0211-699501013259,de,o
20,0211-699501013259,la,o
20,0211-699501013259,suplementacion,i
20,0211-699501013259,con,o
20,0211-699501013259,acido,i
20,0211-699501013259,folico,i
20,0211-699501013259,sobre,o
20,0211-699501013259,los,o
20,0211-699501013259,niveles,i
20,0211-699501013259,de,i
20,0211-699501013259,homocisteina,i
20,0211-699501013259,total,o
20,0211-699501013259,en,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,en,o
20,0211-699501013259,hemodialisis,i
20,0211-699501013259,La,o
20,0211-699501013259,hiperhomocisteinemia,i
20,0211-699501013259,es,o
20,0211-699501013259,un,o
20,0211-699501013259,marcador,o
20,0211-699501013259,de,o
20,0211-699501013259,riesgo,o
20,0211-699501013259,independiente,o
20,0211-699501013259,de,o
20,0211-699501013259,morbimortalidad,o
20,0211-699501013259,cardiovascular,i
20,0211-699501013259,Hemos,o
20,0211-699501013259,intentado,o
20,0211-699501013259,prospectivamente,o
20,0211-699501013259,reducir,o
20,0211-699501013259,los,o
20,0211-699501013259,niveles,i
20,0211-699501013259,de,i
20,0211-699501013259,homocisteina,i
20,0211-699501013259,total,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,mediante,o
20,0211-699501013259,suplemento,o
20,0211-699501013259,con,o
20,0211-699501013259,acido,i
20,0211-699501013259,folico,i
20,0211-699501013259,y,o
20,0211-699501013259,vitamina,i
20,0211-699501013259,B6,i
20,0211-699501013259,pp,i
20,0211-699501013259,valorando,o
20,0211-699501013259,su,o
20,0211-699501013259,posible,o
20,0211-699501013259,correlacion,o
20,0211-699501013259,con,o
20,0211-699501013259,dosis,o
20,0211-699501013259,de,o
20,0211-699501013259,dialisis,i
20,0211-699501013259,funcion,i
20,0211-699501013259,residual,i
20,0211-699501013259,y,o
20,0211-699501013259,parametros,o
20,0211-699501013259,nutricionales,o
20,0211-699501013259,Metodos,o
20,0211-699501013259,Todos,o
20,0211-699501013259,los,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,en,o
20,0211-699501013259,hemodialisis,i
20,0211-699501013259,al,o
20,0211-699501013259,comienzo,o
20,0211-699501013259,del,o
20,0211-699501013259,estudio,o
20,0211-699501013259,que,o
20,0211-699501013259,no,o
20,0211-699501013259,recibian,o
20,0211-699501013259,acido,i
20,0211-699501013259,folico,i
20,0211-699501013259,ni,o
20,0211-699501013259,vitamina,i
20,0211-699501013259,B6,i
20,0211-699501013259,asi,o
20,0211-699501013259,como,o
20,0211-699501013259,los,o
20,0211-699501013259,incorporados,o
20,0211-699501013259,posteriormente,o
20,0211-699501013259,a,o
20,0211-699501013259,partir,o
20,0211-699501013259,de,o
20,0211-699501013259,su,o
20,0211-699501013259,tercer,o
20,0211-699501013259,mes,o
20,0211-699501013259,en,o
20,0211-699501013259,hemodialisis,i
20,0211-699501013259,recibieron,o
20,0211-699501013259,5,o
20,0211-699501013259,mg,o
20,0211-699501013259,orales,o
20,0211-699501013259,de,o
20,0211-699501013259,acido,i
20,0211-699501013259,folico,i
20,0211-699501013259,cada,o
20,0211-699501013259,48,o
20,0211-699501013259,horas,o
20,0211-699501013259,y,o
20,0211-699501013259,40,o
20,0211-699501013259,mg,o
20,0211-699501013259,orales,o
20,0211-699501013259,de,o
20,0211-699501013259,vitamina,i
20,0211-699501013259,B6,i
20,0211-699501013259,cada,o
20,0211-699501013259,semana,o
20,0211-699501013259,Se,o
20,0211-699501013259,determinaron,o
20,0211-699501013259,al,o
20,0211-699501013259,comienzo,o
20,0211-699501013259,del,o
20,0211-699501013259,estudio,o
20,0211-699501013259,y,o
20,0211-699501013259,cada,o
20,0211-699501013259,2,o
20,0211-699501013259,meses,o
20,0211-699501013259,niveles,i
20,0211-699501013259,de,i
20,0211-699501013259,folato,i
20,0211-699501013259,vitamina,i
20,0211-699501013259,B12,i
20,0211-699501013259,inmunoensayo,i
20,0211-699501013259,albumina,i
20,0211-699501013259,y,o
20,0211-699501013259,cinetica,o
20,0211-699501013259,de,o
20,0211-699501013259,la,o
20,0211-699501013259,urea,i
20,0211-699501013259,KTV,o
20,0211-699501013259,KRU,o
20,0211-699501013259,PCRn,o
20,0211-699501013259,y,o
20,0211-699501013259,cada,o
20,0211-699501013259,6,o
20,0211-699501013259,meses,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,HPLC,i
20,0211-699501013259,y,o
20,0211-699501013259,pp,i
20,0211-699501013259,RIA,i
20,0211-699501013259,Resultados,o
20,0211-699501013259,80,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,fueron,o
20,0211-699501013259,incluidos,o
20,0211-699501013259,en,o
20,0211-699501013259,el,o
20,0211-699501013259,estudio,o
20,0211-699501013259,basal,o
20,0211-699501013259,con,o
20,0211-699501013259,una,o
20,0211-699501013259,prevalencia,o
20,0211-699501013259,de,o
20,0211-699501013259,hiperhomocisteinemia,i
20,0211-699501013259,del,o
20,0211-699501013259,844,o
20,0211-699501013259,deficit,i
20,0211-699501013259,de,i
20,0211-699501013259,pp,i
20,0211-699501013259,en,o
20,0211-699501013259,el,o
20,0211-699501013259,32,o
20,0211-699501013259,y,o
20,0211-699501013259,folato,i
20,0211-699501013259,en,o
20,0211-699501013259,el,o
20,0211-699501013259,rango,o
20,0211-699501013259,normal,o
20,0211-699501013259,bajo,o
20,0211-699501013259,los,o
20,0211-699501013259,niveles,i
20,0211-699501013259,de,i
20,0211-699501013259,tHcy,i
20,0211-699501013259,se,o
20,0211-699501013259,correlacionaban,o
20,0211-699501013259,inversamente,o
20,0211-699501013259,con,o
20,0211-699501013259,los,o
20,0211-699501013259,del,o
20,0211-699501013259,folato,i
20,0211-699501013259,r,o
20,0211-699501013259,0336,o
20,0211-699501013259,p,o
20,0211-699501013259,001,o
20,0211-699501013259,pero,o
20,0211-699501013259,no,o
20,0211-699501013259,con,o
20,0211-699501013259,pp,i
20,0211-699501013259,B12,i
20,0211-699501013259,edad,o
20,0211-699501013259,albumina,i
20,0211-699501013259,KTV,o
20,0211-699501013259,KRU,o
20,0211-699501013259,PCRn,o
20,0211-699501013259,Cincuenta,o
20,0211-699501013259,y,o
20,0211-699501013259,ocho,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,recibieron,o
20,0211-699501013259,seis,o
20,0211-699501013259,meses,o
20,0211-699501013259,de,o
20,0211-699501013259,suplementacion,i
20,0211-699501013259,con,o
20,0211-699501013259,normalizacion,o
20,0211-699501013259,del,o
20,0211-699501013259,pp,i
20,0211-699501013259,aumento,o
20,0211-699501013259,del,o
20,0211-699501013259,folato,i
20,0211-699501013259,703,o
20,0211-699501013259,IC,o
20,0211-699501013259,638,o
20,0211-699501013259,795,o
20,0211-699501013259,vs,o
20,0211-699501013259,6181,o
20,0211-699501013259,IC,o
20,0211-699501013259,4447,o
20,0211-699501013259,7811,o
20,0211-699501013259,p,o
20,0211-699501013259,0001,o
20,0211-699501013259,y,o
20,0211-699501013259,descenso,o
20,0211-699501013259,de,o
20,0211-699501013259,la,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,240,o
20,0211-699501013259,IC,o
20,0211-699501013259,213,o
20,0211-699501013259,264,o
20,0211-699501013259,vs,o
20,0211-699501013259,199,o
20,0211-699501013259,IC,o
20,0211-699501013259,175,o
20,0211-699501013259,224,o
20,0211-699501013259,p,o
20,0211-699501013259,005,o
20,0211-699501013259,Han,o
20,0211-699501013259,recibido,o
20,0211-699501013259,suplementacion,i
20,0211-699501013259,durante,o
20,0211-699501013259,12,o
20,0211-699501013259,meses,o
20,0211-699501013259,33,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,pero,o
20,0211-699501013259,a,o
20,0211-699501013259,pesar,o
20,0211-699501013259,de,o
20,0211-699501013259,un,o
20,0211-699501013259,continuo,o
20,0211-699501013259,aumento,o
20,0211-699501013259,del,o
20,0211-699501013259,folato,i
20,0211-699501013259,10078,o
20,0211-699501013259,IC,o
20,0211-699501013259,7481,o
20,0211-699501013259,12674,o
20,0211-699501013259,p,o
20,0211-699501013259,0001,o
20,0211-699501013259,solo,o
20,0211-699501013259,3,o
20,0211-699501013259,pacientes,o
20,0211-699501013259,presentan,o
20,0211-699501013259,niveles,o
20,0211-699501013259,normales,o
20,0211-699501013259,de,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,correlacionandose,o
20,0211-699501013259,directamente,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,con,o
20,0211-699501013259,la,o
20,0211-699501013259,albumina,i
20,0211-699501013259,r,o
20,0211-699501013259,056,o
20,0211-699501013259,p,o
20,0211-699501013259,0001,o
20,0211-699501013259,que,o
20,0211-699501013259,se,o
20,0211-699501013259,elevo,o
20,0211-699501013259,con,o
20,0211-699501013259,respecto,o
20,0211-699501013259,al,o
20,0211-699501013259,inicio,o
20,0211-699501013259,337,o
20,0211-699501013259,IC,o
20,0211-699501013259,327,o
20,0211-699501013259,346,o
20,0211-699501013259,vs,o
20,0211-699501013259,350,o
20,0211-699501013259,IC,o
20,0211-699501013259,337,o
20,0211-699501013259,363,o
20,0211-699501013259,p,o
20,0211-699501013259,005,o
20,0211-699501013259,Conclusion,o
20,0211-699501013259,Tras,o
20,0211-699501013259,suplementacion,i
20,0211-699501013259,con,o
20,0211-699501013259,acido,i
20,0211-699501013259,folico,i
20,0211-699501013259,y,o
20,0211-699501013259,vitamina,i
20,0211-699501013259,B6,i
20,0211-699501013259,aunque,o
20,0211-699501013259,inicialmente,o
20,0211-699501013259,se,o
20,0211-699501013259,reduce,o
20,0211-699501013259,la,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,esta,o
20,0211-699501013259,respuesta,o
20,0211-699501013259,se,o
20,0211-699501013259,hace,o
20,0211-699501013259,refractaria,o
20,0211-699501013259,correlacionandose,o
20,0211-699501013259,directamente,o
20,0211-699501013259,la,o
20,0211-699501013259,tHcy,i
20,0211-699501013259,con,o
20,0211-699501013259,la,o
20,0211-699501013259,albumina,i
20,0211-699501013259,plasmatica,i
20,0211-699501013259,La,o
20,0211-699501013259,interpretacion,o
20,0211-699501013259,de,o
20,0211-699501013259,los,o
20,0211-699501013259,niveles,i
20,0211-699501013259,de,i
20,0211-699501013259,tHcy,i
20,0211-699501013259,debe,o
20,0211-699501013259,tener,o
20,0211-699501013259,en,o
20,0211-699501013259,cuenta,o
20,0211-699501013259,la,o
20,0211-699501013259,concentracion,i
20,0211-699501013259,de,i
20,0211-699501013259,albumina,i
21,0211-699501013259,Efecto,o
21,0211-699501013259,de,o
21,0211-699501013259,la,o
21,0211-699501013259,suplementacion,i
21,0211-699501013259,con,o
21,0211-699501013259,acido,i
21,0211-699501013259,folico,i
21,0211-699501013259,sobre,o
21,0211-699501013259,los,o
21,0211-699501013259,niveles,i
21,0211-699501013259,de,i
21,0211-699501013259,homocisteina,i
21,0211-699501013259,total,o
21,0211-699501013259,en,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,en,o
21,0211-699501013259,hemodialisis,i
21,0211-699501013259,La,o
21,0211-699501013259,hiperhomocisteinemia,i
21,0211-699501013259,es,o
21,0211-699501013259,un,o
21,0211-699501013259,marcador,o
21,0211-699501013259,de,o
21,0211-699501013259,riesgo,o
21,0211-699501013259,independiente,o
21,0211-699501013259,de,o
21,0211-699501013259,morbimortalidad,o
21,0211-699501013259,cardiovascular,i
21,0211-699501013259,Hemos,o
21,0211-699501013259,intentado,o
21,0211-699501013259,prospectivamente,o
21,0211-699501013259,reducir,o
21,0211-699501013259,los,o
21,0211-699501013259,niveles,i
21,0211-699501013259,de,i
21,0211-699501013259,homocisteina,i
21,0211-699501013259,total,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,mediante,o
21,0211-699501013259,suplemento,o
21,0211-699501013259,con,o
21,0211-699501013259,acido,i
21,0211-699501013259,folico,i
21,0211-699501013259,y,o
21,0211-699501013259,vitamina,i
21,0211-699501013259,B6,i
21,0211-699501013259,pp,i
21,0211-699501013259,valorando,o
21,0211-699501013259,su,o
21,0211-699501013259,posible,o
21,0211-699501013259,correlacion,o
21,0211-699501013259,con,o
21,0211-699501013259,dosis,o
21,0211-699501013259,de,o
21,0211-699501013259,dialisis,i
21,0211-699501013259,funcion,i
21,0211-699501013259,residual,i
21,0211-699501013259,y,o
21,0211-699501013259,parametros,o
21,0211-699501013259,nutricionales,o
21,0211-699501013259,Metodos,o
21,0211-699501013259,Todos,o
21,0211-699501013259,los,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,en,o
21,0211-699501013259,hemodialisis,i
21,0211-699501013259,al,o
21,0211-699501013259,comienzo,o
21,0211-699501013259,del,o
21,0211-699501013259,estudio,o
21,0211-699501013259,que,o
21,0211-699501013259,no,o
21,0211-699501013259,recibian,o
21,0211-699501013259,acido,i
21,0211-699501013259,folico,i
21,0211-699501013259,ni,o
21,0211-699501013259,vitamina,i
21,0211-699501013259,B6,i
21,0211-699501013259,asi,o
21,0211-699501013259,como,o
21,0211-699501013259,los,o
21,0211-699501013259,incorporados,o
21,0211-699501013259,posteriormente,o
21,0211-699501013259,a,o
21,0211-699501013259,partir,o
21,0211-699501013259,de,o
21,0211-699501013259,su,o
21,0211-699501013259,tercer,o
21,0211-699501013259,mes,o
21,0211-699501013259,en,o
21,0211-699501013259,hemodialisis,i
21,0211-699501013259,recibieron,o
21,0211-699501013259,5,o
21,0211-699501013259,mg,o
21,0211-699501013259,orales,o
21,0211-699501013259,de,o
21,0211-699501013259,acido,i
21,0211-699501013259,folico,i
21,0211-699501013259,cada,o
21,0211-699501013259,48,o
21,0211-699501013259,horas,o
21,0211-699501013259,y,o
21,0211-699501013259,40,o
21,0211-699501013259,mg,o
21,0211-699501013259,orales,o
21,0211-699501013259,de,o
21,0211-699501013259,vitamina,i
21,0211-699501013259,B6,i
21,0211-699501013259,cada,o
21,0211-699501013259,semana,o
21,0211-699501013259,Se,o
21,0211-699501013259,determinaron,o
21,0211-699501013259,al,o
21,0211-699501013259,comienzo,o
21,0211-699501013259,del,o
21,0211-699501013259,estudio,o
21,0211-699501013259,y,o
21,0211-699501013259,cada,o
21,0211-699501013259,2,o
21,0211-699501013259,meses,o
21,0211-699501013259,niveles,i
21,0211-699501013259,de,i
21,0211-699501013259,folato,i
21,0211-699501013259,vitamina,i
21,0211-699501013259,B12,i
21,0211-699501013259,inmunoensayo,i
21,0211-699501013259,albumina,i
21,0211-699501013259,y,o
21,0211-699501013259,cinetica,o
21,0211-699501013259,de,o
21,0211-699501013259,la,o
21,0211-699501013259,urea,i
21,0211-699501013259,KTV,o
21,0211-699501013259,KRU,o
21,0211-699501013259,PCRn,o
21,0211-699501013259,y,o
21,0211-699501013259,cada,o
21,0211-699501013259,6,o
21,0211-699501013259,meses,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,HPLC,i
21,0211-699501013259,y,o
21,0211-699501013259,pp,i
21,0211-699501013259,RIA,i
21,0211-699501013259,Resultados,o
21,0211-699501013259,80,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,fueron,o
21,0211-699501013259,incluidos,o
21,0211-699501013259,en,o
21,0211-699501013259,el,o
21,0211-699501013259,estudio,o
21,0211-699501013259,basal,o
21,0211-699501013259,con,o
21,0211-699501013259,una,o
21,0211-699501013259,prevalencia,o
21,0211-699501013259,de,o
21,0211-699501013259,hiperhomocisteinemia,i
21,0211-699501013259,del,o
21,0211-699501013259,844,o
21,0211-699501013259,deficit,i
21,0211-699501013259,de,i
21,0211-699501013259,pp,i
21,0211-699501013259,en,o
21,0211-699501013259,el,o
21,0211-699501013259,32,o
21,0211-699501013259,y,o
21,0211-699501013259,folato,i
21,0211-699501013259,en,o
21,0211-699501013259,el,o
21,0211-699501013259,rango,o
21,0211-699501013259,normal,o
21,0211-699501013259,bajo,o
21,0211-699501013259,los,o
21,0211-699501013259,niveles,i
21,0211-699501013259,de,i
21,0211-699501013259,tHcy,i
21,0211-699501013259,se,o
21,0211-699501013259,correlacionaban,o
21,0211-699501013259,inversamente,o
21,0211-699501013259,con,o
21,0211-699501013259,los,o
21,0211-699501013259,del,o
21,0211-699501013259,folato,i
21,0211-699501013259,r,o
21,0211-699501013259,0336,o
21,0211-699501013259,p,o
21,0211-699501013259,001,o
21,0211-699501013259,pero,o
21,0211-699501013259,no,o
21,0211-699501013259,con,o
21,0211-699501013259,pp,i
21,0211-699501013259,B12,i
21,0211-699501013259,edad,o
21,0211-699501013259,albumina,i
21,0211-699501013259,KTV,o
21,0211-699501013259,KRU,o
21,0211-699501013259,PCRn,o
21,0211-699501013259,Cincuenta,o
21,0211-699501013259,y,o
21,0211-699501013259,ocho,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,recibieron,o
21,0211-699501013259,seis,o
21,0211-699501013259,meses,o
21,0211-699501013259,de,o
21,0211-699501013259,suplementacion,i
21,0211-699501013259,con,o
21,0211-699501013259,normalizacion,o
21,0211-699501013259,del,o
21,0211-699501013259,pp,i
21,0211-699501013259,aumento,o
21,0211-699501013259,del,o
21,0211-699501013259,folato,i
21,0211-699501013259,703,o
21,0211-699501013259,IC,o
21,0211-699501013259,638,o
21,0211-699501013259,795,o
21,0211-699501013259,vs,o
21,0211-699501013259,6181,o
21,0211-699501013259,IC,o
21,0211-699501013259,4447,o
21,0211-699501013259,7811,o
21,0211-699501013259,p,o
21,0211-699501013259,0001,o
21,0211-699501013259,y,o
21,0211-699501013259,descenso,o
21,0211-699501013259,de,o
21,0211-699501013259,la,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,240,o
21,0211-699501013259,IC,o
21,0211-699501013259,213,o
21,0211-699501013259,264,o
21,0211-699501013259,vs,o
21,0211-699501013259,199,o
21,0211-699501013259,IC,o
21,0211-699501013259,175,o
21,0211-699501013259,224,o
21,0211-699501013259,p,o
21,0211-699501013259,005,o
21,0211-699501013259,Han,o
21,0211-699501013259,recibido,o
21,0211-699501013259,suplementacion,i
21,0211-699501013259,durante,o
21,0211-699501013259,12,o
21,0211-699501013259,meses,o
21,0211-699501013259,33,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,pero,o
21,0211-699501013259,a,o
21,0211-699501013259,pesar,o
21,0211-699501013259,de,o
21,0211-699501013259,un,o
21,0211-699501013259,continuo,o
21,0211-699501013259,aumento,o
21,0211-699501013259,del,o
21,0211-699501013259,folato,i
21,0211-699501013259,10078,o
21,0211-699501013259,IC,o
21,0211-699501013259,7481,o
21,0211-699501013259,12674,o
21,0211-699501013259,p,o
21,0211-699501013259,0001,o
21,0211-699501013259,solo,o
21,0211-699501013259,3,o
21,0211-699501013259,pacientes,o
21,0211-699501013259,presentan,o
21,0211-699501013259,niveles,o
21,0211-699501013259,normales,o
21,0211-699501013259,de,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,correlacionandose,o
21,0211-699501013259,directamente,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,con,o
21,0211-699501013259,la,o
21,0211-699501013259,albumina,i
21,0211-699501013259,r,o
21,0211-699501013259,056,o
21,0211-699501013259,p,o
21,0211-699501013259,0001,o
21,0211-699501013259,que,o
21,0211-699501013259,se,o
21,0211-699501013259,elevo,o
21,0211-699501013259,con,o
21,0211-699501013259,respecto,o
21,0211-699501013259,al,o
21,0211-699501013259,inicio,o
21,0211-699501013259,337,o
21,0211-699501013259,IC,o
21,0211-699501013259,327,o
21,0211-699501013259,346,o
21,0211-699501013259,vs,o
21,0211-699501013259,350,o
21,0211-699501013259,IC,o
21,0211-699501013259,337,o
21,0211-699501013259,363,o
21,0211-699501013259,p,o
21,0211-699501013259,005,o
21,0211-699501013259,Conclusion,o
21,0211-699501013259,Tras,o
21,0211-699501013259,suplementacion,i
21,0211-699501013259,con,o
21,0211-699501013259,acido,i
21,0211-699501013259,folico,i
21,0211-699501013259,y,o
21,0211-699501013259,vitamina,i
21,0211-699501013259,B6,i
21,0211-699501013259,aunque,o
21,0211-699501013259,inicialmente,o
21,0211-699501013259,se,o
21,0211-699501013259,reduce,o
21,0211-699501013259,la,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,esta,o
21,0211-699501013259,respuesta,o
21,0211-699501013259,se,o
21,0211-699501013259,hace,o
21,0211-699501013259,refractaria,o
21,0211-699501013259,correlacionandose,o
21,0211-699501013259,directamente,o
21,0211-699501013259,la,o
21,0211-699501013259,tHcy,i
21,0211-699501013259,con,o
21,0211-699501013259,la,o
21,0211-699501013259,albumina,i
21,0211-699501013259,plasmatica,i
21,0211-699501013259,La,o
21,0211-699501013259,interpretacion,o
21,0211-699501013259,de,o
21,0211-699501013259,los,o
21,0211-699501013259,niveles,i
21,0211-699501013259,de,i
21,0211-699501013259,tHcy,i
21,0211-699501013259,debe,o
21,0211-699501013259,tener,o
21,0211-699501013259,en,o
21,0211-699501013259,cuenta,o
21,0211-699501013259,la,o
21,0211-699501013259,concentracion,i
21,0211-699501013259,de,i
21,0211-699501013259,albumina,i
22,0211-699501013259,Efecto,o
22,0211-699501013259,de,o
22,0211-699501013259,la,o
22,0211-699501013259,suplementacion,i
22,0211-699501013259,con,o
22,0211-699501013259,acido,i
22,0211-699501013259,folico,i
22,0211-699501013259,sobre,o
22,0211-699501013259,los,o
22,0211-699501013259,niveles,i
22,0211-699501013259,de,i
22,0211-699501013259,homocisteina,i
22,0211-699501013259,total,o
22,0211-699501013259,en,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,en,o
22,0211-699501013259,hemodialisis,i
22,0211-699501013259,La,o
22,0211-699501013259,hiperhomocisteinemia,i
22,0211-699501013259,es,o
22,0211-699501013259,un,o
22,0211-699501013259,marcador,o
22,0211-699501013259,de,o
22,0211-699501013259,riesgo,o
22,0211-699501013259,independiente,o
22,0211-699501013259,de,o
22,0211-699501013259,morbimortalidad,o
22,0211-699501013259,cardiovascular,i
22,0211-699501013259,Hemos,o
22,0211-699501013259,intentado,o
22,0211-699501013259,prospectivamente,o
22,0211-699501013259,reducir,o
22,0211-699501013259,los,o
22,0211-699501013259,niveles,i
22,0211-699501013259,de,i
22,0211-699501013259,homocisteina,i
22,0211-699501013259,total,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,mediante,o
22,0211-699501013259,suplemento,o
22,0211-699501013259,con,o
22,0211-699501013259,acido,i
22,0211-699501013259,folico,i
22,0211-699501013259,y,o
22,0211-699501013259,vitamina,i
22,0211-699501013259,B6,i
22,0211-699501013259,pp,i
22,0211-699501013259,valorando,o
22,0211-699501013259,su,o
22,0211-699501013259,posible,o
22,0211-699501013259,correlacion,o
22,0211-699501013259,con,o
22,0211-699501013259,dosis,o
22,0211-699501013259,de,o
22,0211-699501013259,dialisis,i
22,0211-699501013259,funcion,i
22,0211-699501013259,residual,i
22,0211-699501013259,y,o
22,0211-699501013259,parametros,o
22,0211-699501013259,nutricionales,o
22,0211-699501013259,Metodos,o
22,0211-699501013259,Todos,o
22,0211-699501013259,los,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,en,o
22,0211-699501013259,hemodialisis,i
22,0211-699501013259,al,o
22,0211-699501013259,comienzo,o
22,0211-699501013259,del,o
22,0211-699501013259,estudio,o
22,0211-699501013259,que,o
22,0211-699501013259,no,o
22,0211-699501013259,recibian,o
22,0211-699501013259,acido,i
22,0211-699501013259,folico,i
22,0211-699501013259,ni,o
22,0211-699501013259,vitamina,i
22,0211-699501013259,B6,i
22,0211-699501013259,asi,o
22,0211-699501013259,como,o
22,0211-699501013259,los,o
22,0211-699501013259,incorporados,o
22,0211-699501013259,posteriormente,o
22,0211-699501013259,a,o
22,0211-699501013259,partir,o
22,0211-699501013259,de,o
22,0211-699501013259,su,o
22,0211-699501013259,tercer,o
22,0211-699501013259,mes,o
22,0211-699501013259,en,o
22,0211-699501013259,hemodialisis,i
22,0211-699501013259,recibieron,o
22,0211-699501013259,5,o
22,0211-699501013259,mg,o
22,0211-699501013259,orales,o
22,0211-699501013259,de,o
22,0211-699501013259,acido,i
22,0211-699501013259,folico,i
22,0211-699501013259,cada,o
22,0211-699501013259,48,o
22,0211-699501013259,horas,o
22,0211-699501013259,y,o
22,0211-699501013259,40,o
22,0211-699501013259,mg,o
22,0211-699501013259,orales,o
22,0211-699501013259,de,o
22,0211-699501013259,vitamina,i
22,0211-699501013259,B6,i
22,0211-699501013259,cada,o
22,0211-699501013259,semana,o
22,0211-699501013259,Se,o
22,0211-699501013259,determinaron,o
22,0211-699501013259,al,o
22,0211-699501013259,comienzo,o
22,0211-699501013259,del,o
22,0211-699501013259,estudio,o
22,0211-699501013259,y,o
22,0211-699501013259,cada,o
22,0211-699501013259,2,o
22,0211-699501013259,meses,o
22,0211-699501013259,niveles,i
22,0211-699501013259,de,i
22,0211-699501013259,folato,i
22,0211-699501013259,vitamina,i
22,0211-699501013259,B12,i
22,0211-699501013259,inmunoensayo,i
22,0211-699501013259,albumina,i
22,0211-699501013259,y,o
22,0211-699501013259,cinetica,o
22,0211-699501013259,de,o
22,0211-699501013259,la,o
22,0211-699501013259,urea,i
22,0211-699501013259,KTV,o
22,0211-699501013259,KRU,o
22,0211-699501013259,PCRn,o
22,0211-699501013259,y,o
22,0211-699501013259,cada,o
22,0211-699501013259,6,o
22,0211-699501013259,meses,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,HPLC,i
22,0211-699501013259,y,o
22,0211-699501013259,pp,i
22,0211-699501013259,RIA,i
22,0211-699501013259,Resultados,o
22,0211-699501013259,80,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,fueron,o
22,0211-699501013259,incluidos,o
22,0211-699501013259,en,o
22,0211-699501013259,el,o
22,0211-699501013259,estudio,o
22,0211-699501013259,basal,o
22,0211-699501013259,con,o
22,0211-699501013259,una,o
22,0211-699501013259,prevalencia,o
22,0211-699501013259,de,o
22,0211-699501013259,hiperhomocisteinemia,i
22,0211-699501013259,del,o
22,0211-699501013259,844,o
22,0211-699501013259,deficit,i
22,0211-699501013259,de,i
22,0211-699501013259,pp,i
22,0211-699501013259,en,o
22,0211-699501013259,el,o
22,0211-699501013259,32,o
22,0211-699501013259,y,o
22,0211-699501013259,folato,i
22,0211-699501013259,en,o
22,0211-699501013259,el,o
22,0211-699501013259,rango,o
22,0211-699501013259,normal,o
22,0211-699501013259,bajo,o
22,0211-699501013259,los,o
22,0211-699501013259,niveles,i
22,0211-699501013259,de,i
22,0211-699501013259,tHcy,i
22,0211-699501013259,se,o
22,0211-699501013259,correlacionaban,o
22,0211-699501013259,inversamente,o
22,0211-699501013259,con,o
22,0211-699501013259,los,o
22,0211-699501013259,del,o
22,0211-699501013259,folato,i
22,0211-699501013259,r,o
22,0211-699501013259,0336,o
22,0211-699501013259,p,o
22,0211-699501013259,001,o
22,0211-699501013259,pero,o
22,0211-699501013259,no,o
22,0211-699501013259,con,o
22,0211-699501013259,pp,i
22,0211-699501013259,B12,i
22,0211-699501013259,edad,o
22,0211-699501013259,albumina,i
22,0211-699501013259,KTV,o
22,0211-699501013259,KRU,o
22,0211-699501013259,PCRn,o
22,0211-699501013259,Cincuenta,o
22,0211-699501013259,y,o
22,0211-699501013259,ocho,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,recibieron,o
22,0211-699501013259,seis,o
22,0211-699501013259,meses,o
22,0211-699501013259,de,o
22,0211-699501013259,suplementacion,i
22,0211-699501013259,con,o
22,0211-699501013259,normalizacion,o
22,0211-699501013259,del,o
22,0211-699501013259,pp,i
22,0211-699501013259,aumento,o
22,0211-699501013259,del,o
22,0211-699501013259,folato,i
22,0211-699501013259,703,o
22,0211-699501013259,IC,o
22,0211-699501013259,638,o
22,0211-699501013259,795,o
22,0211-699501013259,vs,o
22,0211-699501013259,6181,o
22,0211-699501013259,IC,o
22,0211-699501013259,4447,o
22,0211-699501013259,7811,o
22,0211-699501013259,p,o
22,0211-699501013259,0001,o
22,0211-699501013259,y,o
22,0211-699501013259,descenso,o
22,0211-699501013259,de,o
22,0211-699501013259,la,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,240,o
22,0211-699501013259,IC,o
22,0211-699501013259,213,o
22,0211-699501013259,264,o
22,0211-699501013259,vs,o
22,0211-699501013259,199,o
22,0211-699501013259,IC,o
22,0211-699501013259,175,o
22,0211-699501013259,224,o
22,0211-699501013259,p,o
22,0211-699501013259,005,o
22,0211-699501013259,Han,o
22,0211-699501013259,recibido,o
22,0211-699501013259,suplementacion,i
22,0211-699501013259,durante,o
22,0211-699501013259,12,o
22,0211-699501013259,meses,o
22,0211-699501013259,33,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,pero,o
22,0211-699501013259,a,o
22,0211-699501013259,pesar,o
22,0211-699501013259,de,o
22,0211-699501013259,un,o
22,0211-699501013259,continuo,o
22,0211-699501013259,aumento,o
22,0211-699501013259,del,o
22,0211-699501013259,folato,i
22,0211-699501013259,10078,o
22,0211-699501013259,IC,o
22,0211-699501013259,7481,o
22,0211-699501013259,12674,o
22,0211-699501013259,p,o
22,0211-699501013259,0001,o
22,0211-699501013259,solo,o
22,0211-699501013259,3,o
22,0211-699501013259,pacientes,o
22,0211-699501013259,presentan,o
22,0211-699501013259,niveles,o
22,0211-699501013259,normales,o
22,0211-699501013259,de,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,correlacionandose,o
22,0211-699501013259,directamente,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,con,o
22,0211-699501013259,la,o
22,0211-699501013259,albumina,i
22,0211-699501013259,r,o
22,0211-699501013259,056,o
22,0211-699501013259,p,o
22,0211-699501013259,0001,o
22,0211-699501013259,que,o
22,0211-699501013259,se,o
22,0211-699501013259,elevo,o
22,0211-699501013259,con,o
22,0211-699501013259,respecto,o
22,0211-699501013259,al,o
22,0211-699501013259,inicio,o
22,0211-699501013259,337,o
22,0211-699501013259,IC,o
22,0211-699501013259,327,o
22,0211-699501013259,346,o
22,0211-699501013259,vs,o
22,0211-699501013259,350,o
22,0211-699501013259,IC,o
22,0211-699501013259,337,o
22,0211-699501013259,363,o
22,0211-699501013259,p,o
22,0211-699501013259,005,o
22,0211-699501013259,Conclusion,o
22,0211-699501013259,Tras,o
22,0211-699501013259,suplementacion,i
22,0211-699501013259,con,o
22,0211-699501013259,acido,i
22,0211-699501013259,folico,i
22,0211-699501013259,y,o
22,0211-699501013259,vitamina,i
22,0211-699501013259,B6,i
22,0211-699501013259,aunque,o
22,0211-699501013259,inicialmente,o
22,0211-699501013259,se,o
22,0211-699501013259,reduce,o
22,0211-699501013259,la,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,esta,o
22,0211-699501013259,respuesta,o
22,0211-699501013259,se,o
22,0211-699501013259,hace,o
22,0211-699501013259,refractaria,o
22,0211-699501013259,correlacionandose,o
22,0211-699501013259,directamente,o
22,0211-699501013259,la,o
22,0211-699501013259,tHcy,i
22,0211-699501013259,con,o
22,0211-699501013259,la,o
22,0211-699501013259,albumina,i
22,0211-699501013259,plasmatica,i
22,0211-699501013259,La,o
22,0211-699501013259,interpretacion,o
22,0211-699501013259,de,o
22,0211-699501013259,los,o
22,0211-699501013259,niveles,i
22,0211-699501013259,de,i
22,0211-699501013259,tHcy,i
22,0211-699501013259,debe,o
22,0211-699501013259,tener,o
22,0211-699501013259,en,o
22,0211-699501013259,cuenta,o
22,0211-699501013259,la,o
22,0211-699501013259,concentracion,i
22,0211-699501013259,de,i
22,0211-699501013259,albumina,i
23,0211-699501013259,Efecto,o
23,0211-699501013259,de,o
23,0211-699501013259,la,o
23,0211-699501013259,suplementacion,i
23,0211-699501013259,con,o
23,0211-699501013259,acido,i
23,0211-699501013259,folico,i
23,0211-699501013259,sobre,o
23,0211-699501013259,los,o
23,0211-699501013259,niveles,i
23,0211-699501013259,de,i
23,0211-699501013259,homocisteina,i
23,0211-699501013259,total,o
23,0211-699501013259,en,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,en,o
23,0211-699501013259,hemodialisis,i
23,0211-699501013259,La,o
23,0211-699501013259,hiperhomocisteinemia,i
23,0211-699501013259,es,o
23,0211-699501013259,un,o
23,0211-699501013259,marcador,o
23,0211-699501013259,de,o
23,0211-699501013259,riesgo,o
23,0211-699501013259,independiente,o
23,0211-699501013259,de,o
23,0211-699501013259,morbimortalidad,o
23,0211-699501013259,cardiovascular,i
23,0211-699501013259,Hemos,o
23,0211-699501013259,intentado,o
23,0211-699501013259,prospectivamente,o
23,0211-699501013259,reducir,o
23,0211-699501013259,los,o
23,0211-699501013259,niveles,i
23,0211-699501013259,de,i
23,0211-699501013259,homocisteina,i
23,0211-699501013259,total,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,mediante,o
23,0211-699501013259,suplemento,o
23,0211-699501013259,con,o
23,0211-699501013259,acido,i
23,0211-699501013259,folico,i
23,0211-699501013259,y,o
23,0211-699501013259,vitamina,i
23,0211-699501013259,B6,i
23,0211-699501013259,pp,i
23,0211-699501013259,valorando,o
23,0211-699501013259,su,o
23,0211-699501013259,posible,o
23,0211-699501013259,correlacion,o
23,0211-699501013259,con,o
23,0211-699501013259,dosis,o
23,0211-699501013259,de,o
23,0211-699501013259,dialisis,i
23,0211-699501013259,funcion,i
23,0211-699501013259,residual,i
23,0211-699501013259,y,o
23,0211-699501013259,parametros,o
23,0211-699501013259,nutricionales,o
23,0211-699501013259,Metodos,o
23,0211-699501013259,Todos,o
23,0211-699501013259,los,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,en,o
23,0211-699501013259,hemodialisis,i
23,0211-699501013259,al,o
23,0211-699501013259,comienzo,o
23,0211-699501013259,del,o
23,0211-699501013259,estudio,o
23,0211-699501013259,que,o
23,0211-699501013259,no,o
23,0211-699501013259,recibian,o
23,0211-699501013259,acido,i
23,0211-699501013259,folico,i
23,0211-699501013259,ni,o
23,0211-699501013259,vitamina,i
23,0211-699501013259,B6,i
23,0211-699501013259,asi,o
23,0211-699501013259,como,o
23,0211-699501013259,los,o
23,0211-699501013259,incorporados,o
23,0211-699501013259,posteriormente,o
23,0211-699501013259,a,o
23,0211-699501013259,partir,o
23,0211-699501013259,de,o
23,0211-699501013259,su,o
23,0211-699501013259,tercer,o
23,0211-699501013259,mes,o
23,0211-699501013259,en,o
23,0211-699501013259,hemodialisis,i
23,0211-699501013259,recibieron,o
23,0211-699501013259,5,o
23,0211-699501013259,mg,o
23,0211-699501013259,orales,o
23,0211-699501013259,de,o
23,0211-699501013259,acido,i
23,0211-699501013259,folico,i
23,0211-699501013259,cada,o
23,0211-699501013259,48,o
23,0211-699501013259,horas,o
23,0211-699501013259,y,o
23,0211-699501013259,40,o
23,0211-699501013259,mg,o
23,0211-699501013259,orales,o
23,0211-699501013259,de,o
23,0211-699501013259,vitamina,i
23,0211-699501013259,B6,i
23,0211-699501013259,cada,o
23,0211-699501013259,semana,o
23,0211-699501013259,Se,o
23,0211-699501013259,determinaron,o
23,0211-699501013259,al,o
23,0211-699501013259,comienzo,o
23,0211-699501013259,del,o
23,0211-699501013259,estudio,o
23,0211-699501013259,y,o
23,0211-699501013259,cada,o
23,0211-699501013259,2,o
23,0211-699501013259,meses,o
23,0211-699501013259,niveles,i
23,0211-699501013259,de,i
23,0211-699501013259,folato,i
23,0211-699501013259,vitamina,i
23,0211-699501013259,B12,i
23,0211-699501013259,inmunoensayo,i
23,0211-699501013259,albumina,i
23,0211-699501013259,y,o
23,0211-699501013259,cinetica,o
23,0211-699501013259,de,o
23,0211-699501013259,la,o
23,0211-699501013259,urea,i
23,0211-699501013259,KTV,o
23,0211-699501013259,KRU,o
23,0211-699501013259,PCRn,o
23,0211-699501013259,y,o
23,0211-699501013259,cada,o
23,0211-699501013259,6,o
23,0211-699501013259,meses,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,HPLC,i
23,0211-699501013259,y,o
23,0211-699501013259,pp,i
23,0211-699501013259,RIA,i
23,0211-699501013259,Resultados,o
23,0211-699501013259,80,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,fueron,o
23,0211-699501013259,incluidos,o
23,0211-699501013259,en,o
23,0211-699501013259,el,o
23,0211-699501013259,estudio,o
23,0211-699501013259,basal,o
23,0211-699501013259,con,o
23,0211-699501013259,una,o
23,0211-699501013259,prevalencia,o
23,0211-699501013259,de,o
23,0211-699501013259,hiperhomocisteinemia,i
23,0211-699501013259,del,o
23,0211-699501013259,844,o
23,0211-699501013259,deficit,i
23,0211-699501013259,de,i
23,0211-699501013259,pp,i
23,0211-699501013259,en,o
23,0211-699501013259,el,o
23,0211-699501013259,32,o
23,0211-699501013259,y,o
23,0211-699501013259,folato,i
23,0211-699501013259,en,o
23,0211-699501013259,el,o
23,0211-699501013259,rango,o
23,0211-699501013259,normal,o
23,0211-699501013259,bajo,o
23,0211-699501013259,los,o
23,0211-699501013259,niveles,i
23,0211-699501013259,de,i
23,0211-699501013259,tHcy,i
23,0211-699501013259,se,o
23,0211-699501013259,correlacionaban,o
23,0211-699501013259,inversamente,o
23,0211-699501013259,con,o
23,0211-699501013259,los,o
23,0211-699501013259,del,o
23,0211-699501013259,folato,i
23,0211-699501013259,r,o
23,0211-699501013259,0336,o
23,0211-699501013259,p,o
23,0211-699501013259,001,o
23,0211-699501013259,pero,o
23,0211-699501013259,no,o
23,0211-699501013259,con,o
23,0211-699501013259,pp,i
23,0211-699501013259,B12,i
23,0211-699501013259,edad,o
23,0211-699501013259,albumina,i
23,0211-699501013259,KTV,o
23,0211-699501013259,KRU,o
23,0211-699501013259,PCRn,o
23,0211-699501013259,Cincuenta,o
23,0211-699501013259,y,o
23,0211-699501013259,ocho,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,recibieron,o
23,0211-699501013259,seis,o
23,0211-699501013259,meses,o
23,0211-699501013259,de,o
23,0211-699501013259,suplementacion,i
23,0211-699501013259,con,o
23,0211-699501013259,normalizacion,o
23,0211-699501013259,del,o
23,0211-699501013259,pp,i
23,0211-699501013259,aumento,o
23,0211-699501013259,del,o
23,0211-699501013259,folato,i
23,0211-699501013259,703,o
23,0211-699501013259,IC,o
23,0211-699501013259,638,o
23,0211-699501013259,795,o
23,0211-699501013259,vs,o
23,0211-699501013259,6181,o
23,0211-699501013259,IC,o
23,0211-699501013259,4447,o
23,0211-699501013259,7811,o
23,0211-699501013259,p,o
23,0211-699501013259,0001,o
23,0211-699501013259,y,o
23,0211-699501013259,descenso,o
23,0211-699501013259,de,o
23,0211-699501013259,la,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,240,o
23,0211-699501013259,IC,o
23,0211-699501013259,213,o
23,0211-699501013259,264,o
23,0211-699501013259,vs,o
23,0211-699501013259,199,o
23,0211-699501013259,IC,o
23,0211-699501013259,175,o
23,0211-699501013259,224,o
23,0211-699501013259,p,o
23,0211-699501013259,005,o
23,0211-699501013259,Han,o
23,0211-699501013259,recibido,o
23,0211-699501013259,suplementacion,i
23,0211-699501013259,durante,o
23,0211-699501013259,12,o
23,0211-699501013259,meses,o
23,0211-699501013259,33,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,pero,o
23,0211-699501013259,a,o
23,0211-699501013259,pesar,o
23,0211-699501013259,de,o
23,0211-699501013259,un,o
23,0211-699501013259,continuo,o
23,0211-699501013259,aumento,o
23,0211-699501013259,del,o
23,0211-699501013259,folato,i
23,0211-699501013259,10078,o
23,0211-699501013259,IC,o
23,0211-699501013259,7481,o
23,0211-699501013259,12674,o
23,0211-699501013259,p,o
23,0211-699501013259,0001,o
23,0211-699501013259,solo,o
23,0211-699501013259,3,o
23,0211-699501013259,pacientes,o
23,0211-699501013259,presentan,o
23,0211-699501013259,niveles,o
23,0211-699501013259,normales,o
23,0211-699501013259,de,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,correlacionandose,o
23,0211-699501013259,directamente,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,con,o
23,0211-699501013259,la,o
23,0211-699501013259,albumina,i
23,0211-699501013259,r,o
23,0211-699501013259,056,o
23,0211-699501013259,p,o
23,0211-699501013259,0001,o
23,0211-699501013259,que,o
23,0211-699501013259,se,o
23,0211-699501013259,elevo,o
23,0211-699501013259,con,o
23,0211-699501013259,respecto,o
23,0211-699501013259,al,o
23,0211-699501013259,inicio,o
23,0211-699501013259,337,o
23,0211-699501013259,IC,o
23,0211-699501013259,327,o
23,0211-699501013259,346,o
23,0211-699501013259,vs,o
23,0211-699501013259,350,o
23,0211-699501013259,IC,o
23,0211-699501013259,337,o
23,0211-699501013259,363,o
23,0211-699501013259,p,o
23,0211-699501013259,005,o
23,0211-699501013259,Conclusion,o
23,0211-699501013259,Tras,o
23,0211-699501013259,suplementacion,i
23,0211-699501013259,con,o
23,0211-699501013259,acido,i
23,0211-699501013259,folico,i
23,0211-699501013259,y,o
23,0211-699501013259,vitamina,i
23,0211-699501013259,B6,i
23,0211-699501013259,aunque,o
23,0211-699501013259,inicialmente,o
23,0211-699501013259,se,o
23,0211-699501013259,reduce,o
23,0211-699501013259,la,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,esta,o
23,0211-699501013259,respuesta,o
23,0211-699501013259,se,o
23,0211-699501013259,hace,o
23,0211-699501013259,refractaria,o
23,0211-699501013259,correlacionandose,o
23,0211-699501013259,directamente,o
23,0211-699501013259,la,o
23,0211-699501013259,tHcy,i
23,0211-699501013259,con,o
23,0211-699501013259,la,o
23,0211-699501013259,albumina,i
23,0211-699501013259,plasmatica,i
23,0211-699501013259,La,o
23,0211-699501013259,interpretacion,o
23,0211-699501013259,de,o
23,0211-699501013259,los,o
23,0211-699501013259,niveles,i
23,0211-699501013259,de,i
23,0211-699501013259,tHcy,i
23,0211-699501013259,debe,o
23,0211-699501013259,tener,o
23,0211-699501013259,en,o
23,0211-699501013259,cuenta,o
23,0211-699501013259,la,o
23,0211-699501013259,concentracion,i
23,0211-699501013259,de,i
23,0211-699501013259,albumina,i
24,0211-699501013259,Efecto,o
24,0211-699501013259,de,o
24,0211-699501013259,la,o
24,0211-699501013259,suplementacion,i
24,0211-699501013259,con,o
24,0211-699501013259,acido,i
24,0211-699501013259,folico,i
24,0211-699501013259,sobre,o
24,0211-699501013259,los,o
24,0211-699501013259,niveles,i
24,0211-699501013259,de,i
24,0211-699501013259,homocisteina,i
24,0211-699501013259,total,o
24,0211-699501013259,en,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,en,o
24,0211-699501013259,hemodialisis,i
24,0211-699501013259,La,o
24,0211-699501013259,hiperhomocisteinemia,i
24,0211-699501013259,es,o
24,0211-699501013259,un,o
24,0211-699501013259,marcador,o
24,0211-699501013259,de,o
24,0211-699501013259,riesgo,o
24,0211-699501013259,independiente,o
24,0211-699501013259,de,o
24,0211-699501013259,morbimortalidad,o
24,0211-699501013259,cardiovascular,i
24,0211-699501013259,Hemos,o
24,0211-699501013259,intentado,o
24,0211-699501013259,prospectivamente,o
24,0211-699501013259,reducir,o
24,0211-699501013259,los,o
24,0211-699501013259,niveles,i
24,0211-699501013259,de,i
24,0211-699501013259,homocisteina,i
24,0211-699501013259,total,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,mediante,o
24,0211-699501013259,suplemento,o
24,0211-699501013259,con,o
24,0211-699501013259,acido,i
24,0211-699501013259,folico,i
24,0211-699501013259,y,o
24,0211-699501013259,vitamina,i
24,0211-699501013259,B6,i
24,0211-699501013259,pp,i
24,0211-699501013259,valorando,o
24,0211-699501013259,su,o
24,0211-699501013259,posible,o
24,0211-699501013259,correlacion,o
24,0211-699501013259,con,o
24,0211-699501013259,dosis,o
24,0211-699501013259,de,o
24,0211-699501013259,dialisis,i
24,0211-699501013259,funcion,i
24,0211-699501013259,residual,i
24,0211-699501013259,y,o
24,0211-699501013259,parametros,o
24,0211-699501013259,nutricionales,o
24,0211-699501013259,Metodos,o
24,0211-699501013259,Todos,o
24,0211-699501013259,los,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,en,o
24,0211-699501013259,hemodialisis,i
24,0211-699501013259,al,o
24,0211-699501013259,comienzo,o
24,0211-699501013259,del,o
24,0211-699501013259,estudio,o
24,0211-699501013259,que,o
24,0211-699501013259,no,o
24,0211-699501013259,recibian,o
24,0211-699501013259,acido,i
24,0211-699501013259,folico,i
24,0211-699501013259,ni,o
24,0211-699501013259,vitamina,i
24,0211-699501013259,B6,i
24,0211-699501013259,asi,o
24,0211-699501013259,como,o
24,0211-699501013259,los,o
24,0211-699501013259,incorporados,o
24,0211-699501013259,posteriormente,o
24,0211-699501013259,a,o
24,0211-699501013259,partir,o
24,0211-699501013259,de,o
24,0211-699501013259,su,o
24,0211-699501013259,tercer,o
24,0211-699501013259,mes,o
24,0211-699501013259,en,o
24,0211-699501013259,hemodialisis,i
24,0211-699501013259,recibieron,o
24,0211-699501013259,5,o
24,0211-699501013259,mg,o
24,0211-699501013259,orales,o
24,0211-699501013259,de,o
24,0211-699501013259,acido,i
24,0211-699501013259,folico,i
24,0211-699501013259,cada,o
24,0211-699501013259,48,o
24,0211-699501013259,horas,o
24,0211-699501013259,y,o
24,0211-699501013259,40,o
24,0211-699501013259,mg,o
24,0211-699501013259,orales,o
24,0211-699501013259,de,o
24,0211-699501013259,vitamina,i
24,0211-699501013259,B6,i
24,0211-699501013259,cada,o
24,0211-699501013259,semana,o
24,0211-699501013259,Se,o
24,0211-699501013259,determinaron,o
24,0211-699501013259,al,o
24,0211-699501013259,comienzo,o
24,0211-699501013259,del,o
24,0211-699501013259,estudio,o
24,0211-699501013259,y,o
24,0211-699501013259,cada,o
24,0211-699501013259,2,o
24,0211-699501013259,meses,o
24,0211-699501013259,niveles,i
24,0211-699501013259,de,i
24,0211-699501013259,folato,i
24,0211-699501013259,vitamina,i
24,0211-699501013259,B12,i
24,0211-699501013259,inmunoensayo,i
24,0211-699501013259,albumina,i
24,0211-699501013259,y,o
24,0211-699501013259,cinetica,o
24,0211-699501013259,de,o
24,0211-699501013259,la,o
24,0211-699501013259,urea,i
24,0211-699501013259,KTV,o
24,0211-699501013259,KRU,o
24,0211-699501013259,PCRn,o
24,0211-699501013259,y,o
24,0211-699501013259,cada,o
24,0211-699501013259,6,o
24,0211-699501013259,meses,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,HPLC,i
24,0211-699501013259,y,o
24,0211-699501013259,pp,i
24,0211-699501013259,RIA,i
24,0211-699501013259,Resultados,o
24,0211-699501013259,80,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,fueron,o
24,0211-699501013259,incluidos,o
24,0211-699501013259,en,o
24,0211-699501013259,el,o
24,0211-699501013259,estudio,o
24,0211-699501013259,basal,o
24,0211-699501013259,con,o
24,0211-699501013259,una,o
24,0211-699501013259,prevalencia,o
24,0211-699501013259,de,o
24,0211-699501013259,hiperhomocisteinemia,i
24,0211-699501013259,del,o
24,0211-699501013259,844,o
24,0211-699501013259,deficit,i
24,0211-699501013259,de,i
24,0211-699501013259,pp,i
24,0211-699501013259,en,o
24,0211-699501013259,el,o
24,0211-699501013259,32,o
24,0211-699501013259,y,o
24,0211-699501013259,folato,i
24,0211-699501013259,en,o
24,0211-699501013259,el,o
24,0211-699501013259,rango,o
24,0211-699501013259,normal,o
24,0211-699501013259,bajo,o
24,0211-699501013259,los,o
24,0211-699501013259,niveles,i
24,0211-699501013259,de,i
24,0211-699501013259,tHcy,i
24,0211-699501013259,se,o
24,0211-699501013259,correlacionaban,o
24,0211-699501013259,inversamente,o
24,0211-699501013259,con,o
24,0211-699501013259,los,o
24,0211-699501013259,del,o
24,0211-699501013259,folato,i
24,0211-699501013259,r,o
24,0211-699501013259,0336,o
24,0211-699501013259,p,o
24,0211-699501013259,001,o
24,0211-699501013259,pero,o
24,0211-699501013259,no,o
24,0211-699501013259,con,o
24,0211-699501013259,pp,i
24,0211-699501013259,B12,i
24,0211-699501013259,edad,o
24,0211-699501013259,albumina,i
24,0211-699501013259,KTV,o
24,0211-699501013259,KRU,o
24,0211-699501013259,PCRn,o
24,0211-699501013259,Cincuenta,o
24,0211-699501013259,y,o
24,0211-699501013259,ocho,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,recibieron,o
24,0211-699501013259,seis,o
24,0211-699501013259,meses,o
24,0211-699501013259,de,o
24,0211-699501013259,suplementacion,i
24,0211-699501013259,con,o
24,0211-699501013259,normalizacion,o
24,0211-699501013259,del,o
24,0211-699501013259,pp,i
24,0211-699501013259,aumento,o
24,0211-699501013259,del,o
24,0211-699501013259,folato,i
24,0211-699501013259,703,o
24,0211-699501013259,IC,o
24,0211-699501013259,638,o
24,0211-699501013259,795,o
24,0211-699501013259,vs,o
24,0211-699501013259,6181,o
24,0211-699501013259,IC,o
24,0211-699501013259,4447,o
24,0211-699501013259,7811,o
24,0211-699501013259,p,o
24,0211-699501013259,0001,o
24,0211-699501013259,y,o
24,0211-699501013259,descenso,o
24,0211-699501013259,de,o
24,0211-699501013259,la,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,240,o
24,0211-699501013259,IC,o
24,0211-699501013259,213,o
24,0211-699501013259,264,o
24,0211-699501013259,vs,o
24,0211-699501013259,199,o
24,0211-699501013259,IC,o
24,0211-699501013259,175,o
24,0211-699501013259,224,o
24,0211-699501013259,p,o
24,0211-699501013259,005,o
24,0211-699501013259,Han,o
24,0211-699501013259,recibido,o
24,0211-699501013259,suplementacion,i
24,0211-699501013259,durante,o
24,0211-699501013259,12,o
24,0211-699501013259,meses,o
24,0211-699501013259,33,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,pero,o
24,0211-699501013259,a,o
24,0211-699501013259,pesar,o
24,0211-699501013259,de,o
24,0211-699501013259,un,o
24,0211-699501013259,continuo,o
24,0211-699501013259,aumento,o
24,0211-699501013259,del,o
24,0211-699501013259,folato,i
24,0211-699501013259,10078,o
24,0211-699501013259,IC,o
24,0211-699501013259,7481,o
24,0211-699501013259,12674,o
24,0211-699501013259,p,o
24,0211-699501013259,0001,o
24,0211-699501013259,solo,o
24,0211-699501013259,3,o
24,0211-699501013259,pacientes,o
24,0211-699501013259,presentan,o
24,0211-699501013259,niveles,o
24,0211-699501013259,normales,o
24,0211-699501013259,de,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,correlacionandose,o
24,0211-699501013259,directamente,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,con,o
24,0211-699501013259,la,o
24,0211-699501013259,albumina,i
24,0211-699501013259,r,o
24,0211-699501013259,056,o
24,0211-699501013259,p,o
24,0211-699501013259,0001,o
24,0211-699501013259,que,o
24,0211-699501013259,se,o
24,0211-699501013259,elevo,o
24,0211-699501013259,con,o
24,0211-699501013259,respecto,o
24,0211-699501013259,al,o
24,0211-699501013259,inicio,o
24,0211-699501013259,337,o
24,0211-699501013259,IC,o
24,0211-699501013259,327,o
24,0211-699501013259,346,o
24,0211-699501013259,vs,o
24,0211-699501013259,350,o
24,0211-699501013259,IC,o
24,0211-699501013259,337,o
24,0211-699501013259,363,o
24,0211-699501013259,p,o
24,0211-699501013259,005,o
24,0211-699501013259,Conclusion,o
24,0211-699501013259,Tras,o
24,0211-699501013259,suplementacion,i
24,0211-699501013259,con,o
24,0211-699501013259,acido,i
24,0211-699501013259,folico,i
24,0211-699501013259,y,o
24,0211-699501013259,vitamina,i
24,0211-699501013259,B6,i
24,0211-699501013259,aunque,o
24,0211-699501013259,inicialmente,o
24,0211-699501013259,se,o
24,0211-699501013259,reduce,o
24,0211-699501013259,la,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,esta,o
24,0211-699501013259,respuesta,o
24,0211-699501013259,se,o
24,0211-699501013259,hace,o
24,0211-699501013259,refractaria,o
24,0211-699501013259,correlacionandose,o
24,0211-699501013259,directamente,o
24,0211-699501013259,la,o
24,0211-699501013259,tHcy,i
24,0211-699501013259,con,o
24,0211-699501013259,la,o
24,0211-699501013259,albumina,i
24,0211-699501013259,plasmatica,i
24,0211-699501013259,La,o
24,0211-699501013259,interpretacion,o
24,0211-699501013259,de,o
24,0211-699501013259,los,o
24,0211-699501013259,niveles,i
24,0211-699501013259,de,i
24,0211-699501013259,tHcy,i
24,0211-699501013259,debe,o
24,0211-699501013259,tener,o
24,0211-699501013259,en,o
24,0211-699501013259,cuenta,o
24,0211-699501013259,la,o
24,0211-699501013259,concentracion,i
24,0211-699501013259,de,i
24,0211-699501013259,albumina,i
25,0211-699501013259,Efecto,o
25,0211-699501013259,de,o
25,0211-699501013259,la,o
25,0211-699501013259,suplementacion,i
25,0211-699501013259,con,o
25,0211-699501013259,acido,i
25,0211-699501013259,folico,i
25,0211-699501013259,sobre,o
25,0211-699501013259,los,o
25,0211-699501013259,niveles,i
25,0211-699501013259,de,i
25,0211-699501013259,homocisteina,i
25,0211-699501013259,total,o
25,0211-699501013259,en,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,en,o
25,0211-699501013259,hemodialisis,i
25,0211-699501013259,La,o
25,0211-699501013259,hiperhomocisteinemia,i
25,0211-699501013259,es,o
25,0211-699501013259,un,o
25,0211-699501013259,marcador,o
25,0211-699501013259,de,o
25,0211-699501013259,riesgo,o
25,0211-699501013259,independiente,o
25,0211-699501013259,de,o
25,0211-699501013259,morbimortalidad,o
25,0211-699501013259,cardiovascular,i
25,0211-699501013259,Hemos,o
25,0211-699501013259,intentado,o
25,0211-699501013259,prospectivamente,o
25,0211-699501013259,reducir,o
25,0211-699501013259,los,o
25,0211-699501013259,niveles,i
25,0211-699501013259,de,i
25,0211-699501013259,homocisteina,i
25,0211-699501013259,total,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,mediante,o
25,0211-699501013259,suplemento,o
25,0211-699501013259,con,o
25,0211-699501013259,acido,i
25,0211-699501013259,folico,i
25,0211-699501013259,y,o
25,0211-699501013259,vitamina,i
25,0211-699501013259,B6,i
25,0211-699501013259,pp,i
25,0211-699501013259,valorando,o
25,0211-699501013259,su,o
25,0211-699501013259,posible,o
25,0211-699501013259,correlacion,o
25,0211-699501013259,con,o
25,0211-699501013259,dosis,o
25,0211-699501013259,de,o
25,0211-699501013259,dialisis,i
25,0211-699501013259,funcion,i
25,0211-699501013259,residual,i
25,0211-699501013259,y,o
25,0211-699501013259,parametros,o
25,0211-699501013259,nutricionales,o
25,0211-699501013259,Metodos,o
25,0211-699501013259,Todos,o
25,0211-699501013259,los,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,en,o
25,0211-699501013259,hemodialisis,i
25,0211-699501013259,al,o
25,0211-699501013259,comienzo,o
25,0211-699501013259,del,o
25,0211-699501013259,estudio,o
25,0211-699501013259,que,o
25,0211-699501013259,no,o
25,0211-699501013259,recibian,o
25,0211-699501013259,acido,i
25,0211-699501013259,folico,i
25,0211-699501013259,ni,o
25,0211-699501013259,vitamina,i
25,0211-699501013259,B6,i
25,0211-699501013259,asi,o
25,0211-699501013259,como,o
25,0211-699501013259,los,o
25,0211-699501013259,incorporados,o
25,0211-699501013259,posteriormente,o
25,0211-699501013259,a,o
25,0211-699501013259,partir,o
25,0211-699501013259,de,o
25,0211-699501013259,su,o
25,0211-699501013259,tercer,o
25,0211-699501013259,mes,o
25,0211-699501013259,en,o
25,0211-699501013259,hemodialisis,i
25,0211-699501013259,recibieron,o
25,0211-699501013259,5,o
25,0211-699501013259,mg,o
25,0211-699501013259,orales,o
25,0211-699501013259,de,o
25,0211-699501013259,acido,i
25,0211-699501013259,folico,i
25,0211-699501013259,cada,o
25,0211-699501013259,48,o
25,0211-699501013259,horas,o
25,0211-699501013259,y,o
25,0211-699501013259,40,o
25,0211-699501013259,mg,o
25,0211-699501013259,orales,o
25,0211-699501013259,de,o
25,0211-699501013259,vitamina,i
25,0211-699501013259,B6,i
25,0211-699501013259,cada,o
25,0211-699501013259,semana,o
25,0211-699501013259,Se,o
25,0211-699501013259,determinaron,o
25,0211-699501013259,al,o
25,0211-699501013259,comienzo,o
25,0211-699501013259,del,o
25,0211-699501013259,estudio,o
25,0211-699501013259,y,o
25,0211-699501013259,cada,o
25,0211-699501013259,2,o
25,0211-699501013259,meses,o
25,0211-699501013259,niveles,i
25,0211-699501013259,de,i
25,0211-699501013259,folato,i
25,0211-699501013259,vitamina,i
25,0211-699501013259,B12,i
25,0211-699501013259,inmunoensayo,i
25,0211-699501013259,albumina,i
25,0211-699501013259,y,o
25,0211-699501013259,cinetica,o
25,0211-699501013259,de,o
25,0211-699501013259,la,o
25,0211-699501013259,urea,i
25,0211-699501013259,KTV,o
25,0211-699501013259,KRU,o
25,0211-699501013259,PCRn,o
25,0211-699501013259,y,o
25,0211-699501013259,cada,o
25,0211-699501013259,6,o
25,0211-699501013259,meses,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,HPLC,i
25,0211-699501013259,y,o
25,0211-699501013259,pp,i
25,0211-699501013259,RIA,i
25,0211-699501013259,Resultados,o
25,0211-699501013259,80,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,fueron,o
25,0211-699501013259,incluidos,o
25,0211-699501013259,en,o
25,0211-699501013259,el,o
25,0211-699501013259,estudio,o
25,0211-699501013259,basal,o
25,0211-699501013259,con,o
25,0211-699501013259,una,o
25,0211-699501013259,prevalencia,o
25,0211-699501013259,de,o
25,0211-699501013259,hiperhomocisteinemia,i
25,0211-699501013259,del,o
25,0211-699501013259,844,o
25,0211-699501013259,deficit,i
25,0211-699501013259,de,i
25,0211-699501013259,pp,i
25,0211-699501013259,en,o
25,0211-699501013259,el,o
25,0211-699501013259,32,o
25,0211-699501013259,y,o
25,0211-699501013259,folato,i
25,0211-699501013259,en,o
25,0211-699501013259,el,o
25,0211-699501013259,rango,o
25,0211-699501013259,normal,o
25,0211-699501013259,bajo,o
25,0211-699501013259,los,o
25,0211-699501013259,niveles,i
25,0211-699501013259,de,i
25,0211-699501013259,tHcy,i
25,0211-699501013259,se,o
25,0211-699501013259,correlacionaban,o
25,0211-699501013259,inversamente,o
25,0211-699501013259,con,o
25,0211-699501013259,los,o
25,0211-699501013259,del,o
25,0211-699501013259,folato,i
25,0211-699501013259,r,o
25,0211-699501013259,0336,o
25,0211-699501013259,p,o
25,0211-699501013259,001,o
25,0211-699501013259,pero,o
25,0211-699501013259,no,o
25,0211-699501013259,con,o
25,0211-699501013259,pp,i
25,0211-699501013259,B12,i
25,0211-699501013259,edad,o
25,0211-699501013259,albumina,i
25,0211-699501013259,KTV,o
25,0211-699501013259,KRU,o
25,0211-699501013259,PCRn,o
25,0211-699501013259,Cincuenta,o
25,0211-699501013259,y,o
25,0211-699501013259,ocho,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,recibieron,o
25,0211-699501013259,seis,o
25,0211-699501013259,meses,o
25,0211-699501013259,de,o
25,0211-699501013259,suplementacion,i
25,0211-699501013259,con,o
25,0211-699501013259,normalizacion,o
25,0211-699501013259,del,o
25,0211-699501013259,pp,i
25,0211-699501013259,aumento,o
25,0211-699501013259,del,o
25,0211-699501013259,folato,i
25,0211-699501013259,703,o
25,0211-699501013259,IC,o
25,0211-699501013259,638,o
25,0211-699501013259,795,o
25,0211-699501013259,vs,o
25,0211-699501013259,6181,o
25,0211-699501013259,IC,o
25,0211-699501013259,4447,o
25,0211-699501013259,7811,o
25,0211-699501013259,p,o
25,0211-699501013259,0001,o
25,0211-699501013259,y,o
25,0211-699501013259,descenso,o
25,0211-699501013259,de,o
25,0211-699501013259,la,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,240,o
25,0211-699501013259,IC,o
25,0211-699501013259,213,o
25,0211-699501013259,264,o
25,0211-699501013259,vs,o
25,0211-699501013259,199,o
25,0211-699501013259,IC,o
25,0211-699501013259,175,o
25,0211-699501013259,224,o
25,0211-699501013259,p,o
25,0211-699501013259,005,o
25,0211-699501013259,Han,o
25,0211-699501013259,recibido,o
25,0211-699501013259,suplementacion,i
25,0211-699501013259,durante,o
25,0211-699501013259,12,o
25,0211-699501013259,meses,o
25,0211-699501013259,33,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,pero,o
25,0211-699501013259,a,o
25,0211-699501013259,pesar,o
25,0211-699501013259,de,o
25,0211-699501013259,un,o
25,0211-699501013259,continuo,o
25,0211-699501013259,aumento,o
25,0211-699501013259,del,o
25,0211-699501013259,folato,i
25,0211-699501013259,10078,o
25,0211-699501013259,IC,o
25,0211-699501013259,7481,o
25,0211-699501013259,12674,o
25,0211-699501013259,p,o
25,0211-699501013259,0001,o
25,0211-699501013259,solo,o
25,0211-699501013259,3,o
25,0211-699501013259,pacientes,o
25,0211-699501013259,presentan,o
25,0211-699501013259,niveles,o
25,0211-699501013259,normales,o
25,0211-699501013259,de,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,correlacionandose,o
25,0211-699501013259,directamente,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,con,o
25,0211-699501013259,la,o
25,0211-699501013259,albumina,i
25,0211-699501013259,r,o
25,0211-699501013259,056,o
25,0211-699501013259,p,o
25,0211-699501013259,0001,o
25,0211-699501013259,que,o
25,0211-699501013259,se,o
25,0211-699501013259,elevo,o
25,0211-699501013259,con,o
25,0211-699501013259,respecto,o
25,0211-699501013259,al,o
25,0211-699501013259,inicio,o
25,0211-699501013259,337,o
25,0211-699501013259,IC,o
25,0211-699501013259,327,o
25,0211-699501013259,346,o
25,0211-699501013259,vs,o
25,0211-699501013259,350,o
25,0211-699501013259,IC,o
25,0211-699501013259,337,o
25,0211-699501013259,363,o
25,0211-699501013259,p,o
25,0211-699501013259,005,o
25,0211-699501013259,Conclusion,o
25,0211-699501013259,Tras,o
25,0211-699501013259,suplementacion,i
25,0211-699501013259,con,o
25,0211-699501013259,acido,i
25,0211-699501013259,folico,i
25,0211-699501013259,y,o
25,0211-699501013259,vitamina,i
25,0211-699501013259,B6,i
25,0211-699501013259,aunque,o
25,0211-699501013259,inicialmente,o
25,0211-699501013259,se,o
25,0211-699501013259,reduce,o
25,0211-699501013259,la,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,esta,o
25,0211-699501013259,respuesta,o
25,0211-699501013259,se,o
25,0211-699501013259,hace,o
25,0211-699501013259,refractaria,o
25,0211-699501013259,correlacionandose,o
25,0211-699501013259,directamente,o
25,0211-699501013259,la,o
25,0211-699501013259,tHcy,i
25,0211-699501013259,con,o
25,0211-699501013259,la,o
25,0211-699501013259,albumina,i
25,0211-699501013259,plasmatica,i
25,0211-699501013259,La,o
25,0211-699501013259,interpretacion,o
25,0211-699501013259,de,o
25,0211-699501013259,los,o
25,0211-699501013259,niveles,i
25,0211-699501013259,de,i
25,0211-699501013259,tHcy,i
25,0211-699501013259,debe,o
25,0211-699501013259,tener,o
25,0211-699501013259,en,o
25,0211-699501013259,cuenta,o
25,0211-699501013259,la,o
25,0211-699501013259,concentracion,i
25,0211-699501013259,de,i
25,0211-699501013259,albumina,i
26,0211-699501013259,Efecto,o
26,0211-699501013259,de,o
26,0211-699501013259,la,o
26,0211-699501013259,suplementacion,i
26,0211-699501013259,con,o
26,0211-699501013259,acido,i
26,0211-699501013259,folico,i
26,0211-699501013259,sobre,o
26,0211-699501013259,los,o
26,0211-699501013259,niveles,i
26,0211-699501013259,de,i
26,0211-699501013259,homocisteina,i
26,0211-699501013259,total,o
26,0211-699501013259,en,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,en,o
26,0211-699501013259,hemodialisis,i
26,0211-699501013259,La,o
26,0211-699501013259,hiperhomocisteinemia,i
26,0211-699501013259,es,o
26,0211-699501013259,un,o
26,0211-699501013259,marcador,o
26,0211-699501013259,de,o
26,0211-699501013259,riesgo,o
26,0211-699501013259,independiente,o
26,0211-699501013259,de,o
26,0211-699501013259,morbimortalidad,o
26,0211-699501013259,cardiovascular,i
26,0211-699501013259,Hemos,o
26,0211-699501013259,intentado,o
26,0211-699501013259,prospectivamente,o
26,0211-699501013259,reducir,o
26,0211-699501013259,los,o
26,0211-699501013259,niveles,i
26,0211-699501013259,de,i
26,0211-699501013259,homocisteina,i
26,0211-699501013259,total,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,mediante,o
26,0211-699501013259,suplemento,o
26,0211-699501013259,con,o
26,0211-699501013259,acido,i
26,0211-699501013259,folico,i
26,0211-699501013259,y,o
26,0211-699501013259,vitamina,i
26,0211-699501013259,B6,i
26,0211-699501013259,pp,i
26,0211-699501013259,valorando,o
26,0211-699501013259,su,o
26,0211-699501013259,posible,o
26,0211-699501013259,correlacion,o
26,0211-699501013259,con,o
26,0211-699501013259,dosis,o
26,0211-699501013259,de,o
26,0211-699501013259,dialisis,i
26,0211-699501013259,funcion,i
26,0211-699501013259,residual,i
26,0211-699501013259,y,o
26,0211-699501013259,parametros,o
26,0211-699501013259,nutricionales,o
26,0211-699501013259,Metodos,o
26,0211-699501013259,Todos,o
26,0211-699501013259,los,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,en,o
26,0211-699501013259,hemodialisis,i
26,0211-699501013259,al,o
26,0211-699501013259,comienzo,o
26,0211-699501013259,del,o
26,0211-699501013259,estudio,o
26,0211-699501013259,que,o
26,0211-699501013259,no,o
26,0211-699501013259,recibian,o
26,0211-699501013259,acido,i
26,0211-699501013259,folico,i
26,0211-699501013259,ni,o
26,0211-699501013259,vitamina,i
26,0211-699501013259,B6,i
26,0211-699501013259,asi,o
26,0211-699501013259,como,o
26,0211-699501013259,los,o
26,0211-699501013259,incorporados,o
26,0211-699501013259,posteriormente,o
26,0211-699501013259,a,o
26,0211-699501013259,partir,o
26,0211-699501013259,de,o
26,0211-699501013259,su,o
26,0211-699501013259,tercer,o
26,0211-699501013259,mes,o
26,0211-699501013259,en,o
26,0211-699501013259,hemodialisis,i
26,0211-699501013259,recibieron,o
26,0211-699501013259,5,o
26,0211-699501013259,mg,o
26,0211-699501013259,orales,o
26,0211-699501013259,de,o
26,0211-699501013259,acido,i
26,0211-699501013259,folico,i
26,0211-699501013259,cada,o
26,0211-699501013259,48,o
26,0211-699501013259,horas,o
26,0211-699501013259,y,o
26,0211-699501013259,40,o
26,0211-699501013259,mg,o
26,0211-699501013259,orales,o
26,0211-699501013259,de,o
26,0211-699501013259,vitamina,i
26,0211-699501013259,B6,i
26,0211-699501013259,cada,o
26,0211-699501013259,semana,o
26,0211-699501013259,Se,o
26,0211-699501013259,determinaron,o
26,0211-699501013259,al,o
26,0211-699501013259,comienzo,o
26,0211-699501013259,del,o
26,0211-699501013259,estudio,o
26,0211-699501013259,y,o
26,0211-699501013259,cada,o
26,0211-699501013259,2,o
26,0211-699501013259,meses,o
26,0211-699501013259,niveles,i
26,0211-699501013259,de,i
26,0211-699501013259,folato,i
26,0211-699501013259,vitamina,i
26,0211-699501013259,B12,i
26,0211-699501013259,inmunoensayo,i
26,0211-699501013259,albumina,i
26,0211-699501013259,y,o
26,0211-699501013259,cinetica,o
26,0211-699501013259,de,o
26,0211-699501013259,la,o
26,0211-699501013259,urea,i
26,0211-699501013259,KTV,o
26,0211-699501013259,KRU,o
26,0211-699501013259,PCRn,o
26,0211-699501013259,y,o
26,0211-699501013259,cada,o
26,0211-699501013259,6,o
26,0211-699501013259,meses,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,HPLC,i
26,0211-699501013259,y,o
26,0211-699501013259,pp,i
26,0211-699501013259,RIA,i
26,0211-699501013259,Resultados,o
26,0211-699501013259,80,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,fueron,o
26,0211-699501013259,incluidos,o
26,0211-699501013259,en,o
26,0211-699501013259,el,o
26,0211-699501013259,estudio,o
26,0211-699501013259,basal,o
26,0211-699501013259,con,o
26,0211-699501013259,una,o
26,0211-699501013259,prevalencia,o
26,0211-699501013259,de,o
26,0211-699501013259,hiperhomocisteinemia,i
26,0211-699501013259,del,o
26,0211-699501013259,844,o
26,0211-699501013259,deficit,i
26,0211-699501013259,de,i
26,0211-699501013259,pp,i
26,0211-699501013259,en,o
26,0211-699501013259,el,o
26,0211-699501013259,32,o
26,0211-699501013259,y,o
26,0211-699501013259,folato,i
26,0211-699501013259,en,o
26,0211-699501013259,el,o
26,0211-699501013259,rango,o
26,0211-699501013259,normal,o
26,0211-699501013259,bajo,o
26,0211-699501013259,los,o
26,0211-699501013259,niveles,i
26,0211-699501013259,de,i
26,0211-699501013259,tHcy,i
26,0211-699501013259,se,o
26,0211-699501013259,correlacionaban,o
26,0211-699501013259,inversamente,o
26,0211-699501013259,con,o
26,0211-699501013259,los,o
26,0211-699501013259,del,o
26,0211-699501013259,folato,i
26,0211-699501013259,r,o
26,0211-699501013259,0336,o
26,0211-699501013259,p,o
26,0211-699501013259,001,o
26,0211-699501013259,pero,o
26,0211-699501013259,no,o
26,0211-699501013259,con,o
26,0211-699501013259,pp,i
26,0211-699501013259,B12,i
26,0211-699501013259,edad,o
26,0211-699501013259,albumina,i
26,0211-699501013259,KTV,o
26,0211-699501013259,KRU,o
26,0211-699501013259,PCRn,o
26,0211-699501013259,Cincuenta,o
26,0211-699501013259,y,o
26,0211-699501013259,ocho,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,recibieron,o
26,0211-699501013259,seis,o
26,0211-699501013259,meses,o
26,0211-699501013259,de,o
26,0211-699501013259,suplementacion,i
26,0211-699501013259,con,o
26,0211-699501013259,normalizacion,o
26,0211-699501013259,del,o
26,0211-699501013259,pp,i
26,0211-699501013259,aumento,o
26,0211-699501013259,del,o
26,0211-699501013259,folato,i
26,0211-699501013259,703,o
26,0211-699501013259,IC,o
26,0211-699501013259,638,o
26,0211-699501013259,795,o
26,0211-699501013259,vs,o
26,0211-699501013259,6181,o
26,0211-699501013259,IC,o
26,0211-699501013259,4447,o
26,0211-699501013259,7811,o
26,0211-699501013259,p,o
26,0211-699501013259,0001,o
26,0211-699501013259,y,o
26,0211-699501013259,descenso,o
26,0211-699501013259,de,o
26,0211-699501013259,la,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,240,o
26,0211-699501013259,IC,o
26,0211-699501013259,213,o
26,0211-699501013259,264,o
26,0211-699501013259,vs,o
26,0211-699501013259,199,o
26,0211-699501013259,IC,o
26,0211-699501013259,175,o
26,0211-699501013259,224,o
26,0211-699501013259,p,o
26,0211-699501013259,005,o
26,0211-699501013259,Han,o
26,0211-699501013259,recibido,o
26,0211-699501013259,suplementacion,i
26,0211-699501013259,durante,o
26,0211-699501013259,12,o
26,0211-699501013259,meses,o
26,0211-699501013259,33,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,pero,o
26,0211-699501013259,a,o
26,0211-699501013259,pesar,o
26,0211-699501013259,de,o
26,0211-699501013259,un,o
26,0211-699501013259,continuo,o
26,0211-699501013259,aumento,o
26,0211-699501013259,del,o
26,0211-699501013259,folato,i
26,0211-699501013259,10078,o
26,0211-699501013259,IC,o
26,0211-699501013259,7481,o
26,0211-699501013259,12674,o
26,0211-699501013259,p,o
26,0211-699501013259,0001,o
26,0211-699501013259,solo,o
26,0211-699501013259,3,o
26,0211-699501013259,pacientes,o
26,0211-699501013259,presentan,o
26,0211-699501013259,niveles,o
26,0211-699501013259,normales,o
26,0211-699501013259,de,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,correlacionandose,o
26,0211-699501013259,directamente,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,con,o
26,0211-699501013259,la,o
26,0211-699501013259,albumina,i
26,0211-699501013259,r,o
26,0211-699501013259,056,o
26,0211-699501013259,p,o
26,0211-699501013259,0001,o
26,0211-699501013259,que,o
26,0211-699501013259,se,o
26,0211-699501013259,elevo,o
26,0211-699501013259,con,o
26,0211-699501013259,respecto,o
26,0211-699501013259,al,o
26,0211-699501013259,inicio,o
26,0211-699501013259,337,o
26,0211-699501013259,IC,o
26,0211-699501013259,327,o
26,0211-699501013259,346,o
26,0211-699501013259,vs,o
26,0211-699501013259,350,o
26,0211-699501013259,IC,o
26,0211-699501013259,337,o
26,0211-699501013259,363,o
26,0211-699501013259,p,o
26,0211-699501013259,005,o
26,0211-699501013259,Conclusion,o
26,0211-699501013259,Tras,o
26,0211-699501013259,suplementacion,i
26,0211-699501013259,con,o
26,0211-699501013259,acido,i
26,0211-699501013259,folico,i
26,0211-699501013259,y,o
26,0211-699501013259,vitamina,i
26,0211-699501013259,B6,i
26,0211-699501013259,aunque,o
26,0211-699501013259,inicialmente,o
26,0211-699501013259,se,o
26,0211-699501013259,reduce,o
26,0211-699501013259,la,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,esta,o
26,0211-699501013259,respuesta,o
26,0211-699501013259,se,o
26,0211-699501013259,hace,o
26,0211-699501013259,refractaria,o
26,0211-699501013259,correlacionandose,o
26,0211-699501013259,directamente,o
26,0211-699501013259,la,o
26,0211-699501013259,tHcy,i
26,0211-699501013259,con,o
26,0211-699501013259,la,o
26,0211-699501013259,albumina,i
26,0211-699501013259,plasmatica,i
26,0211-699501013259,La,o
26,0211-699501013259,interpretacion,o
26,0211-699501013259,de,o
26,0211-699501013259,los,o
26,0211-699501013259,niveles,i
26,0211-699501013259,de,i
26,0211-699501013259,tHcy,i
26,0211-699501013259,debe,o
26,0211-699501013259,tener,o
26,0211-699501013259,en,o
26,0211-699501013259,cuenta,o
26,0211-699501013259,la,o
26,0211-699501013259,concentracion,i
26,0211-699501013259,de,i
26,0211-699501013259,albumina,i
27,0211-699501013259,Efecto,o
27,0211-699501013259,de,o
27,0211-699501013259,la,o
27,0211-699501013259,suplementacion,i
27,0211-699501013259,con,o
27,0211-699501013259,acido,i
27,0211-699501013259,folico,i
27,0211-699501013259,sobre,o
27,0211-699501013259,los,o
27,0211-699501013259,niveles,i
27,0211-699501013259,de,i
27,0211-699501013259,homocisteina,i
27,0211-699501013259,total,o
27,0211-699501013259,en,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,en,o
27,0211-699501013259,hemodialisis,i
27,0211-699501013259,La,o
27,0211-699501013259,hiperhomocisteinemia,i
27,0211-699501013259,es,o
27,0211-699501013259,un,o
27,0211-699501013259,marcador,o
27,0211-699501013259,de,o
27,0211-699501013259,riesgo,o
27,0211-699501013259,independiente,o
27,0211-699501013259,de,o
27,0211-699501013259,morbimortalidad,o
27,0211-699501013259,cardiovascular,i
27,0211-699501013259,Hemos,o
27,0211-699501013259,intentado,o
27,0211-699501013259,prospectivamente,o
27,0211-699501013259,reducir,o
27,0211-699501013259,los,o
27,0211-699501013259,niveles,i
27,0211-699501013259,de,i
27,0211-699501013259,homocisteina,i
27,0211-699501013259,total,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,mediante,o
27,0211-699501013259,suplemento,o
27,0211-699501013259,con,o
27,0211-699501013259,acido,i
27,0211-699501013259,folico,i
27,0211-699501013259,y,o
27,0211-699501013259,vitamina,i
27,0211-699501013259,B6,i
27,0211-699501013259,pp,i
27,0211-699501013259,valorando,o
27,0211-699501013259,su,o
27,0211-699501013259,posible,o
27,0211-699501013259,correlacion,o
27,0211-699501013259,con,o
27,0211-699501013259,dosis,o
27,0211-699501013259,de,o
27,0211-699501013259,dialisis,i
27,0211-699501013259,funcion,i
27,0211-699501013259,residual,i
27,0211-699501013259,y,o
27,0211-699501013259,parametros,o
27,0211-699501013259,nutricionales,o
27,0211-699501013259,Metodos,o
27,0211-699501013259,Todos,o
27,0211-699501013259,los,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,en,o
27,0211-699501013259,hemodialisis,i
27,0211-699501013259,al,o
27,0211-699501013259,comienzo,o
27,0211-699501013259,del,o
27,0211-699501013259,estudio,o
27,0211-699501013259,que,o
27,0211-699501013259,no,o
27,0211-699501013259,recibian,o
27,0211-699501013259,acido,i
27,0211-699501013259,folico,i
27,0211-699501013259,ni,o
27,0211-699501013259,vitamina,i
27,0211-699501013259,B6,i
27,0211-699501013259,asi,o
27,0211-699501013259,como,o
27,0211-699501013259,los,o
27,0211-699501013259,incorporados,o
27,0211-699501013259,posteriormente,o
27,0211-699501013259,a,o
27,0211-699501013259,partir,o
27,0211-699501013259,de,o
27,0211-699501013259,su,o
27,0211-699501013259,tercer,o
27,0211-699501013259,mes,o
27,0211-699501013259,en,o
27,0211-699501013259,hemodialisis,i
27,0211-699501013259,recibieron,o
27,0211-699501013259,5,o
27,0211-699501013259,mg,o
27,0211-699501013259,orales,o
27,0211-699501013259,de,o
27,0211-699501013259,acido,i
27,0211-699501013259,folico,i
27,0211-699501013259,cada,o
27,0211-699501013259,48,o
27,0211-699501013259,horas,o
27,0211-699501013259,y,o
27,0211-699501013259,40,o
27,0211-699501013259,mg,o
27,0211-699501013259,orales,o
27,0211-699501013259,de,o
27,0211-699501013259,vitamina,i
27,0211-699501013259,B6,i
27,0211-699501013259,cada,o
27,0211-699501013259,semana,o
27,0211-699501013259,Se,o
27,0211-699501013259,determinaron,o
27,0211-699501013259,al,o
27,0211-699501013259,comienzo,o
27,0211-699501013259,del,o
27,0211-699501013259,estudio,o
27,0211-699501013259,y,o
27,0211-699501013259,cada,o
27,0211-699501013259,2,o
27,0211-699501013259,meses,o
27,0211-699501013259,niveles,i
27,0211-699501013259,de,i
27,0211-699501013259,folato,i
27,0211-699501013259,vitamina,i
27,0211-699501013259,B12,i
27,0211-699501013259,inmunoensayo,i
27,0211-699501013259,albumina,i
27,0211-699501013259,y,o
27,0211-699501013259,cinetica,o
27,0211-699501013259,de,o
27,0211-699501013259,la,o
27,0211-699501013259,urea,i
27,0211-699501013259,KTV,o
27,0211-699501013259,KRU,o
27,0211-699501013259,PCRn,o
27,0211-699501013259,y,o
27,0211-699501013259,cada,o
27,0211-699501013259,6,o
27,0211-699501013259,meses,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,HPLC,i
27,0211-699501013259,y,o
27,0211-699501013259,pp,i
27,0211-699501013259,RIA,i
27,0211-699501013259,Resultados,o
27,0211-699501013259,80,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,fueron,o
27,0211-699501013259,incluidos,o
27,0211-699501013259,en,o
27,0211-699501013259,el,o
27,0211-699501013259,estudio,o
27,0211-699501013259,basal,o
27,0211-699501013259,con,o
27,0211-699501013259,una,o
27,0211-699501013259,prevalencia,o
27,0211-699501013259,de,o
27,0211-699501013259,hiperhomocisteinemia,i
27,0211-699501013259,del,o
27,0211-699501013259,844,o
27,0211-699501013259,deficit,i
27,0211-699501013259,de,i
27,0211-699501013259,pp,i
27,0211-699501013259,en,o
27,0211-699501013259,el,o
27,0211-699501013259,32,o
27,0211-699501013259,y,o
27,0211-699501013259,folato,i
27,0211-699501013259,en,o
27,0211-699501013259,el,o
27,0211-699501013259,rango,o
27,0211-699501013259,normal,o
27,0211-699501013259,bajo,o
27,0211-699501013259,los,o
27,0211-699501013259,niveles,i
27,0211-699501013259,de,i
27,0211-699501013259,tHcy,i
27,0211-699501013259,se,o
27,0211-699501013259,correlacionaban,o
27,0211-699501013259,inversamente,o
27,0211-699501013259,con,o
27,0211-699501013259,los,o
27,0211-699501013259,del,o
27,0211-699501013259,folato,i
27,0211-699501013259,r,o
27,0211-699501013259,0336,o
27,0211-699501013259,p,o
27,0211-699501013259,001,o
27,0211-699501013259,pero,o
27,0211-699501013259,no,o
27,0211-699501013259,con,o
27,0211-699501013259,pp,i
27,0211-699501013259,B12,i
27,0211-699501013259,edad,o
27,0211-699501013259,albumina,i
27,0211-699501013259,KTV,o
27,0211-699501013259,KRU,o
27,0211-699501013259,PCRn,o
27,0211-699501013259,Cincuenta,o
27,0211-699501013259,y,o
27,0211-699501013259,ocho,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,recibieron,o
27,0211-699501013259,seis,o
27,0211-699501013259,meses,o
27,0211-699501013259,de,o
27,0211-699501013259,suplementacion,i
27,0211-699501013259,con,o
27,0211-699501013259,normalizacion,o
27,0211-699501013259,del,o
27,0211-699501013259,pp,i
27,0211-699501013259,aumento,o
27,0211-699501013259,del,o
27,0211-699501013259,folato,i
27,0211-699501013259,703,o
27,0211-699501013259,IC,o
27,0211-699501013259,638,o
27,0211-699501013259,795,o
27,0211-699501013259,vs,o
27,0211-699501013259,6181,o
27,0211-699501013259,IC,o
27,0211-699501013259,4447,o
27,0211-699501013259,7811,o
27,0211-699501013259,p,o
27,0211-699501013259,0001,o
27,0211-699501013259,y,o
27,0211-699501013259,descenso,o
27,0211-699501013259,de,o
27,0211-699501013259,la,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,240,o
27,0211-699501013259,IC,o
27,0211-699501013259,213,o
27,0211-699501013259,264,o
27,0211-699501013259,vs,o
27,0211-699501013259,199,o
27,0211-699501013259,IC,o
27,0211-699501013259,175,o
27,0211-699501013259,224,o
27,0211-699501013259,p,o
27,0211-699501013259,005,o
27,0211-699501013259,Han,o
27,0211-699501013259,recibido,o
27,0211-699501013259,suplementacion,i
27,0211-699501013259,durante,o
27,0211-699501013259,12,o
27,0211-699501013259,meses,o
27,0211-699501013259,33,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,pero,o
27,0211-699501013259,a,o
27,0211-699501013259,pesar,o
27,0211-699501013259,de,o
27,0211-699501013259,un,o
27,0211-699501013259,continuo,o
27,0211-699501013259,aumento,o
27,0211-699501013259,del,o
27,0211-699501013259,folato,i
27,0211-699501013259,10078,o
27,0211-699501013259,IC,o
27,0211-699501013259,7481,o
27,0211-699501013259,12674,o
27,0211-699501013259,p,o
27,0211-699501013259,0001,o
27,0211-699501013259,solo,o
27,0211-699501013259,3,o
27,0211-699501013259,pacientes,o
27,0211-699501013259,presentan,o
27,0211-699501013259,niveles,o
27,0211-699501013259,normales,o
27,0211-699501013259,de,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,correlacionandose,o
27,0211-699501013259,directamente,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,con,o
27,0211-699501013259,la,o
27,0211-699501013259,albumina,i
27,0211-699501013259,r,o
27,0211-699501013259,056,o
27,0211-699501013259,p,o
27,0211-699501013259,0001,o
27,0211-699501013259,que,o
27,0211-699501013259,se,o
27,0211-699501013259,elevo,o
27,0211-699501013259,con,o
27,0211-699501013259,respecto,o
27,0211-699501013259,al,o
27,0211-699501013259,inicio,o
27,0211-699501013259,337,o
27,0211-699501013259,IC,o
27,0211-699501013259,327,o
27,0211-699501013259,346,o
27,0211-699501013259,vs,o
27,0211-699501013259,350,o
27,0211-699501013259,IC,o
27,0211-699501013259,337,o
27,0211-699501013259,363,o
27,0211-699501013259,p,o
27,0211-699501013259,005,o
27,0211-699501013259,Conclusion,o
27,0211-699501013259,Tras,o
27,0211-699501013259,suplementacion,i
27,0211-699501013259,con,o
27,0211-699501013259,acido,i
27,0211-699501013259,folico,i
27,0211-699501013259,y,o
27,0211-699501013259,vitamina,i
27,0211-699501013259,B6,i
27,0211-699501013259,aunque,o
27,0211-699501013259,inicialmente,o
27,0211-699501013259,se,o
27,0211-699501013259,reduce,o
27,0211-699501013259,la,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,esta,o
27,0211-699501013259,respuesta,o
27,0211-699501013259,se,o
27,0211-699501013259,hace,o
27,0211-699501013259,refractaria,o
27,0211-699501013259,correlacionandose,o
27,0211-699501013259,directamente,o
27,0211-699501013259,la,o
27,0211-699501013259,tHcy,i
27,0211-699501013259,con,o
27,0211-699501013259,la,o
27,0211-699501013259,albumina,i
27,0211-699501013259,plasmatica,i
27,0211-699501013259,La,o
27,0211-699501013259,interpretacion,o
27,0211-699501013259,de,o
27,0211-699501013259,los,o
27,0211-699501013259,niveles,i
27,0211-699501013259,de,i
27,0211-699501013259,tHcy,i
27,0211-699501013259,debe,o
27,0211-699501013259,tener,o
27,0211-699501013259,en,o
27,0211-699501013259,cuenta,o
27,0211-699501013259,la,o
27,0211-699501013259,concentracion,i
27,0211-699501013259,de,i
27,0211-699501013259,albumina,i
28,0211-699501013259,Efecto,o
28,0211-699501013259,de,o
28,0211-699501013259,la,o
28,0211-699501013259,suplementacion,i
28,0211-699501013259,con,o
28,0211-699501013259,acido,i
28,0211-699501013259,folico,i
28,0211-699501013259,sobre,o
28,0211-699501013259,los,o
28,0211-699501013259,niveles,i
28,0211-699501013259,de,i
28,0211-699501013259,homocisteina,i
28,0211-699501013259,total,o
28,0211-699501013259,en,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,en,o
28,0211-699501013259,hemodialisis,i
28,0211-699501013259,La,o
28,0211-699501013259,hiperhomocisteinemia,i
28,0211-699501013259,es,o
28,0211-699501013259,un,o
28,0211-699501013259,marcador,o
28,0211-699501013259,de,o
28,0211-699501013259,riesgo,o
28,0211-699501013259,independiente,o
28,0211-699501013259,de,o
28,0211-699501013259,morbimortalidad,o
28,0211-699501013259,cardiovascular,i
28,0211-699501013259,Hemos,o
28,0211-699501013259,intentado,o
28,0211-699501013259,prospectivamente,o
28,0211-699501013259,reducir,o
28,0211-699501013259,los,o
28,0211-699501013259,niveles,i
28,0211-699501013259,de,i
28,0211-699501013259,homocisteina,i
28,0211-699501013259,total,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,mediante,o
28,0211-699501013259,suplemento,o
28,0211-699501013259,con,o
28,0211-699501013259,acido,i
28,0211-699501013259,folico,i
28,0211-699501013259,y,o
28,0211-699501013259,vitamina,i
28,0211-699501013259,B6,i
28,0211-699501013259,pp,i
28,0211-699501013259,valorando,o
28,0211-699501013259,su,o
28,0211-699501013259,posible,o
28,0211-699501013259,correlacion,o
28,0211-699501013259,con,o
28,0211-699501013259,dosis,o
28,0211-699501013259,de,o
28,0211-699501013259,dialisis,i
28,0211-699501013259,funcion,i
28,0211-699501013259,residual,i
28,0211-699501013259,y,o
28,0211-699501013259,parametros,o
28,0211-699501013259,nutricionales,o
28,0211-699501013259,Metodos,o
28,0211-699501013259,Todos,o
28,0211-699501013259,los,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,en,o
28,0211-699501013259,hemodialisis,i
28,0211-699501013259,al,o
28,0211-699501013259,comienzo,o
28,0211-699501013259,del,o
28,0211-699501013259,estudio,o
28,0211-699501013259,que,o
28,0211-699501013259,no,o
28,0211-699501013259,recibian,o
28,0211-699501013259,acido,i
28,0211-699501013259,folico,i
28,0211-699501013259,ni,o
28,0211-699501013259,vitamina,i
28,0211-699501013259,B6,i
28,0211-699501013259,asi,o
28,0211-699501013259,como,o
28,0211-699501013259,los,o
28,0211-699501013259,incorporados,o
28,0211-699501013259,posteriormente,o
28,0211-699501013259,a,o
28,0211-699501013259,partir,o
28,0211-699501013259,de,o
28,0211-699501013259,su,o
28,0211-699501013259,tercer,o
28,0211-699501013259,mes,o
28,0211-699501013259,en,o
28,0211-699501013259,hemodialisis,i
28,0211-699501013259,recibieron,o
28,0211-699501013259,5,o
28,0211-699501013259,mg,o
28,0211-699501013259,orales,o
28,0211-699501013259,de,o
28,0211-699501013259,acido,i
28,0211-699501013259,folico,i
28,0211-699501013259,cada,o
28,0211-699501013259,48,o
28,0211-699501013259,horas,o
28,0211-699501013259,y,o
28,0211-699501013259,40,o
28,0211-699501013259,mg,o
28,0211-699501013259,orales,o
28,0211-699501013259,de,o
28,0211-699501013259,vitamina,i
28,0211-699501013259,B6,i
28,0211-699501013259,cada,o
28,0211-699501013259,semana,o
28,0211-699501013259,Se,o
28,0211-699501013259,determinaron,o
28,0211-699501013259,al,o
28,0211-699501013259,comienzo,o
28,0211-699501013259,del,o
28,0211-699501013259,estudio,o
28,0211-699501013259,y,o
28,0211-699501013259,cada,o
28,0211-699501013259,2,o
28,0211-699501013259,meses,o
28,0211-699501013259,niveles,i
28,0211-699501013259,de,i
28,0211-699501013259,folato,i
28,0211-699501013259,vitamina,i
28,0211-699501013259,B12,i
28,0211-699501013259,inmunoensayo,i
28,0211-699501013259,albumina,i
28,0211-699501013259,y,o
28,0211-699501013259,cinetica,o
28,0211-699501013259,de,o
28,0211-699501013259,la,o
28,0211-699501013259,urea,i
28,0211-699501013259,KTV,o
28,0211-699501013259,KRU,o
28,0211-699501013259,PCRn,o
28,0211-699501013259,y,o
28,0211-699501013259,cada,o
28,0211-699501013259,6,o
28,0211-699501013259,meses,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,HPLC,i
28,0211-699501013259,y,o
28,0211-699501013259,pp,i
28,0211-699501013259,RIA,i
28,0211-699501013259,Resultados,o
28,0211-699501013259,80,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,fueron,o
28,0211-699501013259,incluidos,o
28,0211-699501013259,en,o
28,0211-699501013259,el,o
28,0211-699501013259,estudio,o
28,0211-699501013259,basal,o
28,0211-699501013259,con,o
28,0211-699501013259,una,o
28,0211-699501013259,prevalencia,o
28,0211-699501013259,de,o
28,0211-699501013259,hiperhomocisteinemia,i
28,0211-699501013259,del,o
28,0211-699501013259,844,o
28,0211-699501013259,deficit,i
28,0211-699501013259,de,i
28,0211-699501013259,pp,i
28,0211-699501013259,en,o
28,0211-699501013259,el,o
28,0211-699501013259,32,o
28,0211-699501013259,y,o
28,0211-699501013259,folato,i
28,0211-699501013259,en,o
28,0211-699501013259,el,o
28,0211-699501013259,rango,o
28,0211-699501013259,normal,o
28,0211-699501013259,bajo,o
28,0211-699501013259,los,o
28,0211-699501013259,niveles,i
28,0211-699501013259,de,i
28,0211-699501013259,tHcy,i
28,0211-699501013259,se,o
28,0211-699501013259,correlacionaban,o
28,0211-699501013259,inversamente,o
28,0211-699501013259,con,o
28,0211-699501013259,los,o
28,0211-699501013259,del,o
28,0211-699501013259,folato,i
28,0211-699501013259,r,o
28,0211-699501013259,0336,o
28,0211-699501013259,p,o
28,0211-699501013259,001,o
28,0211-699501013259,pero,o
28,0211-699501013259,no,o
28,0211-699501013259,con,o
28,0211-699501013259,pp,i
28,0211-699501013259,B12,i
28,0211-699501013259,edad,o
28,0211-699501013259,albumina,i
28,0211-699501013259,KTV,o
28,0211-699501013259,KRU,o
28,0211-699501013259,PCRn,o
28,0211-699501013259,Cincuenta,o
28,0211-699501013259,y,o
28,0211-699501013259,ocho,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,recibieron,o
28,0211-699501013259,seis,o
28,0211-699501013259,meses,o
28,0211-699501013259,de,o
28,0211-699501013259,suplementacion,i
28,0211-699501013259,con,o
28,0211-699501013259,normalizacion,o
28,0211-699501013259,del,o
28,0211-699501013259,pp,i
28,0211-699501013259,aumento,o
28,0211-699501013259,del,o
28,0211-699501013259,folato,i
28,0211-699501013259,703,o
28,0211-699501013259,IC,o
28,0211-699501013259,638,o
28,0211-699501013259,795,o
28,0211-699501013259,vs,o
28,0211-699501013259,6181,o
28,0211-699501013259,IC,o
28,0211-699501013259,4447,o
28,0211-699501013259,7811,o
28,0211-699501013259,p,o
28,0211-699501013259,0001,o
28,0211-699501013259,y,o
28,0211-699501013259,descenso,o
28,0211-699501013259,de,o
28,0211-699501013259,la,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,240,o
28,0211-699501013259,IC,o
28,0211-699501013259,213,o
28,0211-699501013259,264,o
28,0211-699501013259,vs,o
28,0211-699501013259,199,o
28,0211-699501013259,IC,o
28,0211-699501013259,175,o
28,0211-699501013259,224,o
28,0211-699501013259,p,o
28,0211-699501013259,005,o
28,0211-699501013259,Han,o
28,0211-699501013259,recibido,o
28,0211-699501013259,suplementacion,i
28,0211-699501013259,durante,o
28,0211-699501013259,12,o
28,0211-699501013259,meses,o
28,0211-699501013259,33,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,pero,o
28,0211-699501013259,a,o
28,0211-699501013259,pesar,o
28,0211-699501013259,de,o
28,0211-699501013259,un,o
28,0211-699501013259,continuo,o
28,0211-699501013259,aumento,o
28,0211-699501013259,del,o
28,0211-699501013259,folato,i
28,0211-699501013259,10078,o
28,0211-699501013259,IC,o
28,0211-699501013259,7481,o
28,0211-699501013259,12674,o
28,0211-699501013259,p,o
28,0211-699501013259,0001,o
28,0211-699501013259,solo,o
28,0211-699501013259,3,o
28,0211-699501013259,pacientes,o
28,0211-699501013259,presentan,o
28,0211-699501013259,niveles,o
28,0211-699501013259,normales,o
28,0211-699501013259,de,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,correlacionandose,o
28,0211-699501013259,directamente,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,con,o
28,0211-699501013259,la,o
28,0211-699501013259,albumina,i
28,0211-699501013259,r,o
28,0211-699501013259,056,o
28,0211-699501013259,p,o
28,0211-699501013259,0001,o
28,0211-699501013259,que,o
28,0211-699501013259,se,o
28,0211-699501013259,elevo,o
28,0211-699501013259,con,o
28,0211-699501013259,respecto,o
28,0211-699501013259,al,o
28,0211-699501013259,inicio,o
28,0211-699501013259,337,o
28,0211-699501013259,IC,o
28,0211-699501013259,327,o
28,0211-699501013259,346,o
28,0211-699501013259,vs,o
28,0211-699501013259,350,o
28,0211-699501013259,IC,o
28,0211-699501013259,337,o
28,0211-699501013259,363,o
28,0211-699501013259,p,o
28,0211-699501013259,005,o
28,0211-699501013259,Conclusion,o
28,0211-699501013259,Tras,o
28,0211-699501013259,suplementacion,i
28,0211-699501013259,con,o
28,0211-699501013259,acido,i
28,0211-699501013259,folico,i
28,0211-699501013259,y,o
28,0211-699501013259,vitamina,i
28,0211-699501013259,B6,i
28,0211-699501013259,aunque,o
28,0211-699501013259,inicialmente,o
28,0211-699501013259,se,o
28,0211-699501013259,reduce,o
28,0211-699501013259,la,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,esta,o
28,0211-699501013259,respuesta,o
28,0211-699501013259,se,o
28,0211-699501013259,hace,o
28,0211-699501013259,refractaria,o
28,0211-699501013259,correlacionandose,o
28,0211-699501013259,directamente,o
28,0211-699501013259,la,o
28,0211-699501013259,tHcy,i
28,0211-699501013259,con,o
28,0211-699501013259,la,o
28,0211-699501013259,albumina,i
28,0211-699501013259,plasmatica,i
28,0211-699501013259,La,o
28,0211-699501013259,interpretacion,o
28,0211-699501013259,de,o
28,0211-699501013259,los,o
28,0211-699501013259,niveles,i
28,0211-699501013259,de,i
28,0211-699501013259,tHcy,i
28,0211-699501013259,debe,o
28,0211-699501013259,tener,o
28,0211-699501013259,en,o
28,0211-699501013259,cuenta,o
28,0211-699501013259,la,o
28,0211-699501013259,concentracion,i
28,0211-699501013259,de,i
28,0211-699501013259,albumina,i
29,0211-699501013259,Efecto,o
29,0211-699501013259,de,o
29,0211-699501013259,la,o
29,0211-699501013259,suplementacion,i
29,0211-699501013259,con,o
29,0211-699501013259,acido,i
29,0211-699501013259,folico,i
29,0211-699501013259,sobre,o
29,0211-699501013259,los,o
29,0211-699501013259,niveles,i
29,0211-699501013259,de,i
29,0211-699501013259,homocisteina,i
29,0211-699501013259,total,o
29,0211-699501013259,en,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,en,o
29,0211-699501013259,hemodialisis,i
29,0211-699501013259,La,o
29,0211-699501013259,hiperhomocisteinemia,i
29,0211-699501013259,es,o
29,0211-699501013259,un,o
29,0211-699501013259,marcador,o
29,0211-699501013259,de,o
29,0211-699501013259,riesgo,o
29,0211-699501013259,independiente,o
29,0211-699501013259,de,o
29,0211-699501013259,morbimortalidad,o
29,0211-699501013259,cardiovascular,i
29,0211-699501013259,Hemos,o
29,0211-699501013259,intentado,o
29,0211-699501013259,prospectivamente,o
29,0211-699501013259,reducir,o
29,0211-699501013259,los,o
29,0211-699501013259,niveles,i
29,0211-699501013259,de,i
29,0211-699501013259,homocisteina,i
29,0211-699501013259,total,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,mediante,o
29,0211-699501013259,suplemento,o
29,0211-699501013259,con,o
29,0211-699501013259,acido,i
29,0211-699501013259,folico,i
29,0211-699501013259,y,o
29,0211-699501013259,vitamina,i
29,0211-699501013259,B6,i
29,0211-699501013259,pp,i
29,0211-699501013259,valorando,o
29,0211-699501013259,su,o
29,0211-699501013259,posible,o
29,0211-699501013259,correlacion,o
29,0211-699501013259,con,o
29,0211-699501013259,dosis,o
29,0211-699501013259,de,o
29,0211-699501013259,dialisis,i
29,0211-699501013259,funcion,i
29,0211-699501013259,residual,i
29,0211-699501013259,y,o
29,0211-699501013259,parametros,o
29,0211-699501013259,nutricionales,o
29,0211-699501013259,Metodos,o
29,0211-699501013259,Todos,o
29,0211-699501013259,los,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,en,o
29,0211-699501013259,hemodialisis,i
29,0211-699501013259,al,o
29,0211-699501013259,comienzo,o
29,0211-699501013259,del,o
29,0211-699501013259,estudio,o
29,0211-699501013259,que,o
29,0211-699501013259,no,o
29,0211-699501013259,recibian,o
29,0211-699501013259,acido,i
29,0211-699501013259,folico,i
29,0211-699501013259,ni,o
29,0211-699501013259,vitamina,i
29,0211-699501013259,B6,i
29,0211-699501013259,asi,o
29,0211-699501013259,como,o
29,0211-699501013259,los,o
29,0211-699501013259,incorporados,o
29,0211-699501013259,posteriormente,o
29,0211-699501013259,a,o
29,0211-699501013259,partir,o
29,0211-699501013259,de,o
29,0211-699501013259,su,o
29,0211-699501013259,tercer,o
29,0211-699501013259,mes,o
29,0211-699501013259,en,o
29,0211-699501013259,hemodialisis,i
29,0211-699501013259,recibieron,o
29,0211-699501013259,5,o
29,0211-699501013259,mg,o
29,0211-699501013259,orales,o
29,0211-699501013259,de,o
29,0211-699501013259,acido,i
29,0211-699501013259,folico,i
29,0211-699501013259,cada,o
29,0211-699501013259,48,o
29,0211-699501013259,horas,o
29,0211-699501013259,y,o
29,0211-699501013259,40,o
29,0211-699501013259,mg,o
29,0211-699501013259,orales,o
29,0211-699501013259,de,o
29,0211-699501013259,vitamina,i
29,0211-699501013259,B6,i
29,0211-699501013259,cada,o
29,0211-699501013259,semana,o
29,0211-699501013259,Se,o
29,0211-699501013259,determinaron,o
29,0211-699501013259,al,o
29,0211-699501013259,comienzo,o
29,0211-699501013259,del,o
29,0211-699501013259,estudio,o
29,0211-699501013259,y,o
29,0211-699501013259,cada,o
29,0211-699501013259,2,o
29,0211-699501013259,meses,o
29,0211-699501013259,niveles,i
29,0211-699501013259,de,i
29,0211-699501013259,folato,i
29,0211-699501013259,vitamina,i
29,0211-699501013259,B12,i
29,0211-699501013259,inmunoensayo,i
29,0211-699501013259,albumina,i
29,0211-699501013259,y,o
29,0211-699501013259,cinetica,o
29,0211-699501013259,de,o
29,0211-699501013259,la,o
29,0211-699501013259,urea,i
29,0211-699501013259,KTV,o
29,0211-699501013259,KRU,o
29,0211-699501013259,PCRn,o
29,0211-699501013259,y,o
29,0211-699501013259,cada,o
29,0211-699501013259,6,o
29,0211-699501013259,meses,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,HPLC,i
29,0211-699501013259,y,o
29,0211-699501013259,pp,i
29,0211-699501013259,RIA,i
29,0211-699501013259,Resultados,o
29,0211-699501013259,80,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,fueron,o
29,0211-699501013259,incluidos,o
29,0211-699501013259,en,o
29,0211-699501013259,el,o
29,0211-699501013259,estudio,o
29,0211-699501013259,basal,o
29,0211-699501013259,con,o
29,0211-699501013259,una,o
29,0211-699501013259,prevalencia,o
29,0211-699501013259,de,o
29,0211-699501013259,hiperhomocisteinemia,i
29,0211-699501013259,del,o
29,0211-699501013259,844,o
29,0211-699501013259,deficit,i
29,0211-699501013259,de,i
29,0211-699501013259,pp,i
29,0211-699501013259,en,o
29,0211-699501013259,el,o
29,0211-699501013259,32,o
29,0211-699501013259,y,o
29,0211-699501013259,folato,i
29,0211-699501013259,en,o
29,0211-699501013259,el,o
29,0211-699501013259,rango,o
29,0211-699501013259,normal,o
29,0211-699501013259,bajo,o
29,0211-699501013259,los,o
29,0211-699501013259,niveles,i
29,0211-699501013259,de,i
29,0211-699501013259,tHcy,i
29,0211-699501013259,se,o
29,0211-699501013259,correlacionaban,o
29,0211-699501013259,inversamente,o
29,0211-699501013259,con,o
29,0211-699501013259,los,o
29,0211-699501013259,del,o
29,0211-699501013259,folato,i
29,0211-699501013259,r,o
29,0211-699501013259,0336,o
29,0211-699501013259,p,o
29,0211-699501013259,001,o
29,0211-699501013259,pero,o
29,0211-699501013259,no,o
29,0211-699501013259,con,o
29,0211-699501013259,pp,i
29,0211-699501013259,B12,i
29,0211-699501013259,edad,o
29,0211-699501013259,albumina,i
29,0211-699501013259,KTV,o
29,0211-699501013259,KRU,o
29,0211-699501013259,PCRn,o
29,0211-699501013259,Cincuenta,o
29,0211-699501013259,y,o
29,0211-699501013259,ocho,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,recibieron,o
29,0211-699501013259,seis,o
29,0211-699501013259,meses,o
29,0211-699501013259,de,o
29,0211-699501013259,suplementacion,i
29,0211-699501013259,con,o
29,0211-699501013259,normalizacion,o
29,0211-699501013259,del,o
29,0211-699501013259,pp,i
29,0211-699501013259,aumento,o
29,0211-699501013259,del,o
29,0211-699501013259,folato,i
29,0211-699501013259,703,o
29,0211-699501013259,IC,o
29,0211-699501013259,638,o
29,0211-699501013259,795,o
29,0211-699501013259,vs,o
29,0211-699501013259,6181,o
29,0211-699501013259,IC,o
29,0211-699501013259,4447,o
29,0211-699501013259,7811,o
29,0211-699501013259,p,o
29,0211-699501013259,0001,o
29,0211-699501013259,y,o
29,0211-699501013259,descenso,o
29,0211-699501013259,de,o
29,0211-699501013259,la,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,240,o
29,0211-699501013259,IC,o
29,0211-699501013259,213,o
29,0211-699501013259,264,o
29,0211-699501013259,vs,o
29,0211-699501013259,199,o
29,0211-699501013259,IC,o
29,0211-699501013259,175,o
29,0211-699501013259,224,o
29,0211-699501013259,p,o
29,0211-699501013259,005,o
29,0211-699501013259,Han,o
29,0211-699501013259,recibido,o
29,0211-699501013259,suplementacion,i
29,0211-699501013259,durante,o
29,0211-699501013259,12,o
29,0211-699501013259,meses,o
29,0211-699501013259,33,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,pero,o
29,0211-699501013259,a,o
29,0211-699501013259,pesar,o
29,0211-699501013259,de,o
29,0211-699501013259,un,o
29,0211-699501013259,continuo,o
29,0211-699501013259,aumento,o
29,0211-699501013259,del,o
29,0211-699501013259,folato,i
29,0211-699501013259,10078,o
29,0211-699501013259,IC,o
29,0211-699501013259,7481,o
29,0211-699501013259,12674,o
29,0211-699501013259,p,o
29,0211-699501013259,0001,o
29,0211-699501013259,solo,o
29,0211-699501013259,3,o
29,0211-699501013259,pacientes,o
29,0211-699501013259,presentan,o
29,0211-699501013259,niveles,o
29,0211-699501013259,normales,o
29,0211-699501013259,de,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,correlacionandose,o
29,0211-699501013259,directamente,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,con,o
29,0211-699501013259,la,o
29,0211-699501013259,albumina,i
29,0211-699501013259,r,o
29,0211-699501013259,056,o
29,0211-699501013259,p,o
29,0211-699501013259,0001,o
29,0211-699501013259,que,o
29,0211-699501013259,se,o
29,0211-699501013259,elevo,o
29,0211-699501013259,con,o
29,0211-699501013259,respecto,o
29,0211-699501013259,al,o
29,0211-699501013259,inicio,o
29,0211-699501013259,337,o
29,0211-699501013259,IC,o
29,0211-699501013259,327,o
29,0211-699501013259,346,o
29,0211-699501013259,vs,o
29,0211-699501013259,350,o
29,0211-699501013259,IC,o
29,0211-699501013259,337,o
29,0211-699501013259,363,o
29,0211-699501013259,p,o
29,0211-699501013259,005,o
29,0211-699501013259,Conclusion,o
29,0211-699501013259,Tras,o
29,0211-699501013259,suplementacion,i
29,0211-699501013259,con,o
29,0211-699501013259,acido,i
29,0211-699501013259,folico,i
29,0211-699501013259,y,o
29,0211-699501013259,vitamina,i
29,0211-699501013259,B6,i
29,0211-699501013259,aunque,o
29,0211-699501013259,inicialmente,o
29,0211-699501013259,se,o
29,0211-699501013259,reduce,o
29,0211-699501013259,la,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,esta,o
29,0211-699501013259,respuesta,o
29,0211-699501013259,se,o
29,0211-699501013259,hace,o
29,0211-699501013259,refractaria,o
29,0211-699501013259,correlacionandose,o
29,0211-699501013259,directamente,o
29,0211-699501013259,la,o
29,0211-699501013259,tHcy,i
29,0211-699501013259,con,o
29,0211-699501013259,la,o
29,0211-699501013259,albumina,i
29,0211-699501013259,plasmatica,i
29,0211-699501013259,La,o
29,0211-699501013259,interpretacion,o
29,0211-699501013259,de,o
29,0211-699501013259,los,o
29,0211-699501013259,niveles,i
29,0211-699501013259,de,i
29,0211-699501013259,tHcy,i
29,0211-699501013259,debe,o
29,0211-699501013259,tener,o
29,0211-699501013259,en,o
29,0211-699501013259,cuenta,o
29,0211-699501013259,la,o
29,0211-699501013259,concentracion,i
29,0211-699501013259,de,i
29,0211-699501013259,albumina,i
30,0211-699501013259,Efecto,o
30,0211-699501013259,de,o
30,0211-699501013259,la,o
30,0211-699501013259,suplementacion,i
30,0211-699501013259,con,o
30,0211-699501013259,acido,i
30,0211-699501013259,folico,i
30,0211-699501013259,sobre,o
30,0211-699501013259,los,o
30,0211-699501013259,niveles,i
30,0211-699501013259,de,i
30,0211-699501013259,homocisteina,i
30,0211-699501013259,total,o
30,0211-699501013259,en,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,en,o
30,0211-699501013259,hemodialisis,i
30,0211-699501013259,La,o
30,0211-699501013259,hiperhomocisteinemia,i
30,0211-699501013259,es,o
30,0211-699501013259,un,o
30,0211-699501013259,marcador,o
30,0211-699501013259,de,o
30,0211-699501013259,riesgo,o
30,0211-699501013259,independiente,o
30,0211-699501013259,de,o
30,0211-699501013259,morbimortalidad,o
30,0211-699501013259,cardiovascular,i
30,0211-699501013259,Hemos,o
30,0211-699501013259,intentado,o
30,0211-699501013259,prospectivamente,o
30,0211-699501013259,reducir,o
30,0211-699501013259,los,o
30,0211-699501013259,niveles,i
30,0211-699501013259,de,i
30,0211-699501013259,homocisteina,i
30,0211-699501013259,total,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,mediante,o
30,0211-699501013259,suplemento,o
30,0211-699501013259,con,o
30,0211-699501013259,acido,i
30,0211-699501013259,folico,i
30,0211-699501013259,y,o
30,0211-699501013259,vitamina,i
30,0211-699501013259,B6,i
30,0211-699501013259,pp,i
30,0211-699501013259,valorando,o
30,0211-699501013259,su,o
30,0211-699501013259,posible,o
30,0211-699501013259,correlacion,o
30,0211-699501013259,con,o
30,0211-699501013259,dosis,o
30,0211-699501013259,de,o
30,0211-699501013259,dialisis,i
30,0211-699501013259,funcion,i
30,0211-699501013259,residual,i
30,0211-699501013259,y,o
30,0211-699501013259,parametros,o
30,0211-699501013259,nutricionales,o
30,0211-699501013259,Metodos,o
30,0211-699501013259,Todos,o
30,0211-699501013259,los,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,en,o
30,0211-699501013259,hemodialisis,i
30,0211-699501013259,al,o
30,0211-699501013259,comienzo,o
30,0211-699501013259,del,o
30,0211-699501013259,estudio,o
30,0211-699501013259,que,o
30,0211-699501013259,no,o
30,0211-699501013259,recibian,o
30,0211-699501013259,acido,i
30,0211-699501013259,folico,i
30,0211-699501013259,ni,o
30,0211-699501013259,vitamina,i
30,0211-699501013259,B6,i
30,0211-699501013259,asi,o
30,0211-699501013259,como,o
30,0211-699501013259,los,o
30,0211-699501013259,incorporados,o
30,0211-699501013259,posteriormente,o
30,0211-699501013259,a,o
30,0211-699501013259,partir,o
30,0211-699501013259,de,o
30,0211-699501013259,su,o
30,0211-699501013259,tercer,o
30,0211-699501013259,mes,o
30,0211-699501013259,en,o
30,0211-699501013259,hemodialisis,i
30,0211-699501013259,recibieron,o
30,0211-699501013259,5,o
30,0211-699501013259,mg,o
30,0211-699501013259,orales,o
30,0211-699501013259,de,o
30,0211-699501013259,acido,i
30,0211-699501013259,folico,i
30,0211-699501013259,cada,o
30,0211-699501013259,48,o
30,0211-699501013259,horas,o
30,0211-699501013259,y,o
30,0211-699501013259,40,o
30,0211-699501013259,mg,o
30,0211-699501013259,orales,o
30,0211-699501013259,de,o
30,0211-699501013259,vitamina,i
30,0211-699501013259,B6,i
30,0211-699501013259,cada,o
30,0211-699501013259,semana,o
30,0211-699501013259,Se,o
30,0211-699501013259,determinaron,o
30,0211-699501013259,al,o
30,0211-699501013259,comienzo,o
30,0211-699501013259,del,o
30,0211-699501013259,estudio,o
30,0211-699501013259,y,o
30,0211-699501013259,cada,o
30,0211-699501013259,2,o
30,0211-699501013259,meses,o
30,0211-699501013259,niveles,i
30,0211-699501013259,de,i
30,0211-699501013259,folato,i
30,0211-699501013259,vitamina,i
30,0211-699501013259,B12,i
30,0211-699501013259,inmunoensayo,i
30,0211-699501013259,albumina,i
30,0211-699501013259,y,o
30,0211-699501013259,cinetica,o
30,0211-699501013259,de,o
30,0211-699501013259,la,o
30,0211-699501013259,urea,i
30,0211-699501013259,KTV,o
30,0211-699501013259,KRU,o
30,0211-699501013259,PCRn,o
30,0211-699501013259,y,o
30,0211-699501013259,cada,o
30,0211-699501013259,6,o
30,0211-699501013259,meses,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,HPLC,i
30,0211-699501013259,y,o
30,0211-699501013259,pp,i
30,0211-699501013259,RIA,i
30,0211-699501013259,Resultados,o
30,0211-699501013259,80,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,fueron,o
30,0211-699501013259,incluidos,o
30,0211-699501013259,en,o
30,0211-699501013259,el,o
30,0211-699501013259,estudio,o
30,0211-699501013259,basal,o
30,0211-699501013259,con,o
30,0211-699501013259,una,o
30,0211-699501013259,prevalencia,o
30,0211-699501013259,de,o
30,0211-699501013259,hiperhomocisteinemia,i
30,0211-699501013259,del,o
30,0211-699501013259,844,o
30,0211-699501013259,deficit,i
30,0211-699501013259,de,i
30,0211-699501013259,pp,i
30,0211-699501013259,en,o
30,0211-699501013259,el,o
30,0211-699501013259,32,o
30,0211-699501013259,y,o
30,0211-699501013259,folato,i
30,0211-699501013259,en,o
30,0211-699501013259,el,o
30,0211-699501013259,rango,o
30,0211-699501013259,normal,o
30,0211-699501013259,bajo,o
30,0211-699501013259,los,o
30,0211-699501013259,niveles,i
30,0211-699501013259,de,i
30,0211-699501013259,tHcy,i
30,0211-699501013259,se,o
30,0211-699501013259,correlacionaban,o
30,0211-699501013259,inversamente,o
30,0211-699501013259,con,o
30,0211-699501013259,los,o
30,0211-699501013259,del,o
30,0211-699501013259,folato,i
30,0211-699501013259,r,o
30,0211-699501013259,0336,o
30,0211-699501013259,p,o
30,0211-699501013259,001,o
30,0211-699501013259,pero,o
30,0211-699501013259,no,o
30,0211-699501013259,con,o
30,0211-699501013259,pp,i
30,0211-699501013259,B12,i
30,0211-699501013259,edad,o
30,0211-699501013259,albumina,i
30,0211-699501013259,KTV,o
30,0211-699501013259,KRU,o
30,0211-699501013259,PCRn,o
30,0211-699501013259,Cincuenta,o
30,0211-699501013259,y,o
30,0211-699501013259,ocho,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,recibieron,o
30,0211-699501013259,seis,o
30,0211-699501013259,meses,o
30,0211-699501013259,de,o
30,0211-699501013259,suplementacion,i
30,0211-699501013259,con,o
30,0211-699501013259,normalizacion,o
30,0211-699501013259,del,o
30,0211-699501013259,pp,i
30,0211-699501013259,aumento,o
30,0211-699501013259,del,o
30,0211-699501013259,folato,i
30,0211-699501013259,703,o
30,0211-699501013259,IC,o
30,0211-699501013259,638,o
30,0211-699501013259,795,o
30,0211-699501013259,vs,o
30,0211-699501013259,6181,o
30,0211-699501013259,IC,o
30,0211-699501013259,4447,o
30,0211-699501013259,7811,o
30,0211-699501013259,p,o
30,0211-699501013259,0001,o
30,0211-699501013259,y,o
30,0211-699501013259,descenso,o
30,0211-699501013259,de,o
30,0211-699501013259,la,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,240,o
30,0211-699501013259,IC,o
30,0211-699501013259,213,o
30,0211-699501013259,264,o
30,0211-699501013259,vs,o
30,0211-699501013259,199,o
30,0211-699501013259,IC,o
30,0211-699501013259,175,o
30,0211-699501013259,224,o
30,0211-699501013259,p,o
30,0211-699501013259,005,o
30,0211-699501013259,Han,o
30,0211-699501013259,recibido,o
30,0211-699501013259,suplementacion,i
30,0211-699501013259,durante,o
30,0211-699501013259,12,o
30,0211-699501013259,meses,o
30,0211-699501013259,33,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,pero,o
30,0211-699501013259,a,o
30,0211-699501013259,pesar,o
30,0211-699501013259,de,o
30,0211-699501013259,un,o
30,0211-699501013259,continuo,o
30,0211-699501013259,aumento,o
30,0211-699501013259,del,o
30,0211-699501013259,folato,i
30,0211-699501013259,10078,o
30,0211-699501013259,IC,o
30,0211-699501013259,7481,o
30,0211-699501013259,12674,o
30,0211-699501013259,p,o
30,0211-699501013259,0001,o
30,0211-699501013259,solo,o
30,0211-699501013259,3,o
30,0211-699501013259,pacientes,o
30,0211-699501013259,presentan,o
30,0211-699501013259,niveles,o
30,0211-699501013259,normales,o
30,0211-699501013259,de,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,correlacionandose,o
30,0211-699501013259,directamente,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,con,o
30,0211-699501013259,la,o
30,0211-699501013259,albumina,i
30,0211-699501013259,r,o
30,0211-699501013259,056,o
30,0211-699501013259,p,o
30,0211-699501013259,0001,o
30,0211-699501013259,que,o
30,0211-699501013259,se,o
30,0211-699501013259,elevo,o
30,0211-699501013259,con,o
30,0211-699501013259,respecto,o
30,0211-699501013259,al,o
30,0211-699501013259,inicio,o
30,0211-699501013259,337,o
30,0211-699501013259,IC,o
30,0211-699501013259,327,o
30,0211-699501013259,346,o
30,0211-699501013259,vs,o
30,0211-699501013259,350,o
30,0211-699501013259,IC,o
30,0211-699501013259,337,o
30,0211-699501013259,363,o
30,0211-699501013259,p,o
30,0211-699501013259,005,o
30,0211-699501013259,Conclusion,o
30,0211-699501013259,Tras,o
30,0211-699501013259,suplementacion,i
30,0211-699501013259,con,o
30,0211-699501013259,acido,i
30,0211-699501013259,folico,i
30,0211-699501013259,y,o
30,0211-699501013259,vitamina,i
30,0211-699501013259,B6,i
30,0211-699501013259,aunque,o
30,0211-699501013259,inicialmente,o
30,0211-699501013259,se,o
30,0211-699501013259,reduce,o
30,0211-699501013259,la,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,esta,o
30,0211-699501013259,respuesta,o
30,0211-699501013259,se,o
30,0211-699501013259,hace,o
30,0211-699501013259,refractaria,o
30,0211-699501013259,correlacionandose,o
30,0211-699501013259,directamente,o
30,0211-699501013259,la,o
30,0211-699501013259,tHcy,i
30,0211-699501013259,con,o
30,0211-699501013259,la,o
30,0211-699501013259,albumina,i
30,0211-699501013259,plasmatica,i
30,0211-699501013259,La,o
30,0211-699501013259,interpretacion,o
30,0211-699501013259,de,o
30,0211-699501013259,los,o
30,0211-699501013259,niveles,i
30,0211-699501013259,de,i
30,0211-699501013259,tHcy,i
30,0211-699501013259,debe,o
30,0211-699501013259,tener,o
30,0211-699501013259,en,o
30,0211-699501013259,cuenta,o
30,0211-699501013259,la,o
30,0211-699501013259,concentracion,i
30,0211-699501013259,de,i
30,0211-699501013259,albumina,i
31,0211-699501013259,Efecto,o
31,0211-699501013259,de,o
31,0211-699501013259,la,o
31,0211-699501013259,suplementacion,i
31,0211-699501013259,con,o
31,0211-699501013259,acido,i
31,0211-699501013259,folico,i
31,0211-699501013259,sobre,o
31,0211-699501013259,los,o
31,0211-699501013259,niveles,i
31,0211-699501013259,de,i
31,0211-699501013259,homocisteina,i
31,0211-699501013259,total,o
31,0211-699501013259,en,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,en,o
31,0211-699501013259,hemodialisis,i
31,0211-699501013259,La,o
31,0211-699501013259,hiperhomocisteinemia,i
31,0211-699501013259,es,o
31,0211-699501013259,un,o
31,0211-699501013259,marcador,o
31,0211-699501013259,de,o
31,0211-699501013259,riesgo,o
31,0211-699501013259,independiente,o
31,0211-699501013259,de,o
31,0211-699501013259,morbimortalidad,o
31,0211-699501013259,cardiovascular,i
31,0211-699501013259,Hemos,o
31,0211-699501013259,intentado,o
31,0211-699501013259,prospectivamente,o
31,0211-699501013259,reducir,o
31,0211-699501013259,los,o
31,0211-699501013259,niveles,i
31,0211-699501013259,de,i
31,0211-699501013259,homocisteina,i
31,0211-699501013259,total,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,mediante,o
31,0211-699501013259,suplemento,o
31,0211-699501013259,con,o
31,0211-699501013259,acido,i
31,0211-699501013259,folico,i
31,0211-699501013259,y,o
31,0211-699501013259,vitamina,i
31,0211-699501013259,B6,i
31,0211-699501013259,pp,i
31,0211-699501013259,valorando,o
31,0211-699501013259,su,o
31,0211-699501013259,posible,o
31,0211-699501013259,correlacion,o
31,0211-699501013259,con,o
31,0211-699501013259,dosis,o
31,0211-699501013259,de,o
31,0211-699501013259,dialisis,i
31,0211-699501013259,funcion,i
31,0211-699501013259,residual,i
31,0211-699501013259,y,o
31,0211-699501013259,parametros,o
31,0211-699501013259,nutricionales,o
31,0211-699501013259,Metodos,o
31,0211-699501013259,Todos,o
31,0211-699501013259,los,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,en,o
31,0211-699501013259,hemodialisis,i
31,0211-699501013259,al,o
31,0211-699501013259,comienzo,o
31,0211-699501013259,del,o
31,0211-699501013259,estudio,o
31,0211-699501013259,que,o
31,0211-699501013259,no,o
31,0211-699501013259,recibian,o
31,0211-699501013259,acido,i
31,0211-699501013259,folico,i
31,0211-699501013259,ni,o
31,0211-699501013259,vitamina,i
31,0211-699501013259,B6,i
31,0211-699501013259,asi,o
31,0211-699501013259,como,o
31,0211-699501013259,los,o
31,0211-699501013259,incorporados,o
31,0211-699501013259,posteriormente,o
31,0211-699501013259,a,o
31,0211-699501013259,partir,o
31,0211-699501013259,de,o
31,0211-699501013259,su,o
31,0211-699501013259,tercer,o
31,0211-699501013259,mes,o
31,0211-699501013259,en,o
31,0211-699501013259,hemodialisis,i
31,0211-699501013259,recibieron,o
31,0211-699501013259,5,o
31,0211-699501013259,mg,o
31,0211-699501013259,orales,o
31,0211-699501013259,de,o
31,0211-699501013259,acido,i
31,0211-699501013259,folico,i
31,0211-699501013259,cada,o
31,0211-699501013259,48,o
31,0211-699501013259,horas,o
31,0211-699501013259,y,o
31,0211-699501013259,40,o
31,0211-699501013259,mg,o
31,0211-699501013259,orales,o
31,0211-699501013259,de,o
31,0211-699501013259,vitamina,i
31,0211-699501013259,B6,i
31,0211-699501013259,cada,o
31,0211-699501013259,semana,o
31,0211-699501013259,Se,o
31,0211-699501013259,determinaron,o
31,0211-699501013259,al,o
31,0211-699501013259,comienzo,o
31,0211-699501013259,del,o
31,0211-699501013259,estudio,o
31,0211-699501013259,y,o
31,0211-699501013259,cada,o
31,0211-699501013259,2,o
31,0211-699501013259,meses,o
31,0211-699501013259,niveles,i
31,0211-699501013259,de,i
31,0211-699501013259,folato,i
31,0211-699501013259,vitamina,i
31,0211-699501013259,B12,i
31,0211-699501013259,inmunoensayo,i
31,0211-699501013259,albumina,i
31,0211-699501013259,y,o
31,0211-699501013259,cinetica,o
31,0211-699501013259,de,o
31,0211-699501013259,la,o
31,0211-699501013259,urea,i
31,0211-699501013259,KTV,o
31,0211-699501013259,KRU,o
31,0211-699501013259,PCRn,o
31,0211-699501013259,y,o
31,0211-699501013259,cada,o
31,0211-699501013259,6,o
31,0211-699501013259,meses,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,HPLC,i
31,0211-699501013259,y,o
31,0211-699501013259,pp,i
31,0211-699501013259,RIA,i
31,0211-699501013259,Resultados,o
31,0211-699501013259,80,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,fueron,o
31,0211-699501013259,incluidos,o
31,0211-699501013259,en,o
31,0211-699501013259,el,o
31,0211-699501013259,estudio,o
31,0211-699501013259,basal,o
31,0211-699501013259,con,o
31,0211-699501013259,una,o
31,0211-699501013259,prevalencia,o
31,0211-699501013259,de,o
31,0211-699501013259,hiperhomocisteinemia,i
31,0211-699501013259,del,o
31,0211-699501013259,844,o
31,0211-699501013259,deficit,i
31,0211-699501013259,de,i
31,0211-699501013259,pp,i
31,0211-699501013259,en,o
31,0211-699501013259,el,o
31,0211-699501013259,32,o
31,0211-699501013259,y,o
31,0211-699501013259,folato,i
31,0211-699501013259,en,o
31,0211-699501013259,el,o
31,0211-699501013259,rango,o
31,0211-699501013259,normal,o
31,0211-699501013259,bajo,o
31,0211-699501013259,los,o
31,0211-699501013259,niveles,i
31,0211-699501013259,de,i
31,0211-699501013259,tHcy,i
31,0211-699501013259,se,o
31,0211-699501013259,correlacionaban,o
31,0211-699501013259,inversamente,o
31,0211-699501013259,con,o
31,0211-699501013259,los,o
31,0211-699501013259,del,o
31,0211-699501013259,folato,i
31,0211-699501013259,r,o
31,0211-699501013259,0336,o
31,0211-699501013259,p,o
31,0211-699501013259,001,o
31,0211-699501013259,pero,o
31,0211-699501013259,no,o
31,0211-699501013259,con,o
31,0211-699501013259,pp,i
31,0211-699501013259,B12,i
31,0211-699501013259,edad,o
31,0211-699501013259,albumina,i
31,0211-699501013259,KTV,o
31,0211-699501013259,KRU,o
31,0211-699501013259,PCRn,o
31,0211-699501013259,Cincuenta,o
31,0211-699501013259,y,o
31,0211-699501013259,ocho,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,recibieron,o
31,0211-699501013259,seis,o
31,0211-699501013259,meses,o
31,0211-699501013259,de,o
31,0211-699501013259,suplementacion,i
31,0211-699501013259,con,o
31,0211-699501013259,normalizacion,o
31,0211-699501013259,del,o
31,0211-699501013259,pp,i
31,0211-699501013259,aumento,o
31,0211-699501013259,del,o
31,0211-699501013259,folato,i
31,0211-699501013259,703,o
31,0211-699501013259,IC,o
31,0211-699501013259,638,o
31,0211-699501013259,795,o
31,0211-699501013259,vs,o
31,0211-699501013259,6181,o
31,0211-699501013259,IC,o
31,0211-699501013259,4447,o
31,0211-699501013259,7811,o
31,0211-699501013259,p,o
31,0211-699501013259,0001,o
31,0211-699501013259,y,o
31,0211-699501013259,descenso,o
31,0211-699501013259,de,o
31,0211-699501013259,la,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,240,o
31,0211-699501013259,IC,o
31,0211-699501013259,213,o
31,0211-699501013259,264,o
31,0211-699501013259,vs,o
31,0211-699501013259,199,o
31,0211-699501013259,IC,o
31,0211-699501013259,175,o
31,0211-699501013259,224,o
31,0211-699501013259,p,o
31,0211-699501013259,005,o
31,0211-699501013259,Han,o
31,0211-699501013259,recibido,o
31,0211-699501013259,suplementacion,i
31,0211-699501013259,durante,o
31,0211-699501013259,12,o
31,0211-699501013259,meses,o
31,0211-699501013259,33,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,pero,o
31,0211-699501013259,a,o
31,0211-699501013259,pesar,o
31,0211-699501013259,de,o
31,0211-699501013259,un,o
31,0211-699501013259,continuo,o
31,0211-699501013259,aumento,o
31,0211-699501013259,del,o
31,0211-699501013259,folato,i
31,0211-699501013259,10078,o
31,0211-699501013259,IC,o
31,0211-699501013259,7481,o
31,0211-699501013259,12674,o
31,0211-699501013259,p,o
31,0211-699501013259,0001,o
31,0211-699501013259,solo,o
31,0211-699501013259,3,o
31,0211-699501013259,pacientes,o
31,0211-699501013259,presentan,o
31,0211-699501013259,niveles,o
31,0211-699501013259,normales,o
31,0211-699501013259,de,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,correlacionandose,o
31,0211-699501013259,directamente,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,con,o
31,0211-699501013259,la,o
31,0211-699501013259,albumina,i
31,0211-699501013259,r,o
31,0211-699501013259,056,o
31,0211-699501013259,p,o
31,0211-699501013259,0001,o
31,0211-699501013259,que,o
31,0211-699501013259,se,o
31,0211-699501013259,elevo,o
31,0211-699501013259,con,o
31,0211-699501013259,respecto,o
31,0211-699501013259,al,o
31,0211-699501013259,inicio,o
31,0211-699501013259,337,o
31,0211-699501013259,IC,o
31,0211-699501013259,327,o
31,0211-699501013259,346,o
31,0211-699501013259,vs,o
31,0211-699501013259,350,o
31,0211-699501013259,IC,o
31,0211-699501013259,337,o
31,0211-699501013259,363,o
31,0211-699501013259,p,o
31,0211-699501013259,005,o
31,0211-699501013259,Conclusion,o
31,0211-699501013259,Tras,o
31,0211-699501013259,suplementacion,i
31,0211-699501013259,con,o
31,0211-699501013259,acido,i
31,0211-699501013259,folico,i
31,0211-699501013259,y,o
31,0211-699501013259,vitamina,i
31,0211-699501013259,B6,i
31,0211-699501013259,aunque,o
31,0211-699501013259,inicialmente,o
31,0211-699501013259,se,o
31,0211-699501013259,reduce,o
31,0211-699501013259,la,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,esta,o
31,0211-699501013259,respuesta,o
31,0211-699501013259,se,o
31,0211-699501013259,hace,o
31,0211-699501013259,refractaria,o
31,0211-699501013259,correlacionandose,o
31,0211-699501013259,directamente,o
31,0211-699501013259,la,o
31,0211-699501013259,tHcy,i
31,0211-699501013259,con,o
31,0211-699501013259,la,o
31,0211-699501013259,albumina,i
31,0211-699501013259,plasmatica,i
31,0211-699501013259,La,o
31,0211-699501013259,interpretacion,o
31,0211-699501013259,de,o
31,0211-699501013259,los,o
31,0211-699501013259,niveles,i
31,0211-699501013259,de,i
31,0211-699501013259,tHcy,i
31,0211-699501013259,debe,o
31,0211-699501013259,tener,o
31,0211-699501013259,en,o
31,0211-699501013259,cuenta,o
31,0211-699501013259,la,o
31,0211-699501013259,concentracion,i
31,0211-699501013259,de,i
31,0211-699501013259,albumina,i
32,0211-699501013259,Efecto,o
32,0211-699501013259,de,o
32,0211-699501013259,la,o
32,0211-699501013259,suplementacion,i
32,0211-699501013259,con,o
32,0211-699501013259,acido,i
32,0211-699501013259,folico,i
32,0211-699501013259,sobre,o
32,0211-699501013259,los,o
32,0211-699501013259,niveles,i
32,0211-699501013259,de,i
32,0211-699501013259,homocisteina,i
32,0211-699501013259,total,o
32,0211-699501013259,en,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,en,o
32,0211-699501013259,hemodialisis,i
32,0211-699501013259,La,o
32,0211-699501013259,hiperhomocisteinemia,i
32,0211-699501013259,es,o
32,0211-699501013259,un,o
32,0211-699501013259,marcador,o
32,0211-699501013259,de,o
32,0211-699501013259,riesgo,o
32,0211-699501013259,independiente,o
32,0211-699501013259,de,o
32,0211-699501013259,morbimortalidad,o
32,0211-699501013259,cardiovascular,i
32,0211-699501013259,Hemos,o
32,0211-699501013259,intentado,o
32,0211-699501013259,prospectivamente,o
32,0211-699501013259,reducir,o
32,0211-699501013259,los,o
32,0211-699501013259,niveles,i
32,0211-699501013259,de,i
32,0211-699501013259,homocisteina,i
32,0211-699501013259,total,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,mediante,o
32,0211-699501013259,suplemento,o
32,0211-699501013259,con,o
32,0211-699501013259,acido,i
32,0211-699501013259,folico,i
32,0211-699501013259,y,o
32,0211-699501013259,vitamina,i
32,0211-699501013259,B6,i
32,0211-699501013259,pp,i
32,0211-699501013259,valorando,o
32,0211-699501013259,su,o
32,0211-699501013259,posible,o
32,0211-699501013259,correlacion,o
32,0211-699501013259,con,o
32,0211-699501013259,dosis,o
32,0211-699501013259,de,o
32,0211-699501013259,dialisis,i
32,0211-699501013259,funcion,i
32,0211-699501013259,residual,i
32,0211-699501013259,y,o
32,0211-699501013259,parametros,o
32,0211-699501013259,nutricionales,o
32,0211-699501013259,Metodos,o
32,0211-699501013259,Todos,o
32,0211-699501013259,los,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,en,o
32,0211-699501013259,hemodialisis,i
32,0211-699501013259,al,o
32,0211-699501013259,comienzo,o
32,0211-699501013259,del,o
32,0211-699501013259,estudio,o
32,0211-699501013259,que,o
32,0211-699501013259,no,o
32,0211-699501013259,recibian,o
32,0211-699501013259,acido,i
32,0211-699501013259,folico,i
32,0211-699501013259,ni,o
32,0211-699501013259,vitamina,i
32,0211-699501013259,B6,i
32,0211-699501013259,asi,o
32,0211-699501013259,como,o
32,0211-699501013259,los,o
32,0211-699501013259,incorporados,o
32,0211-699501013259,posteriormente,o
32,0211-699501013259,a,o
32,0211-699501013259,partir,o
32,0211-699501013259,de,o
32,0211-699501013259,su,o
32,0211-699501013259,tercer,o
32,0211-699501013259,mes,o
32,0211-699501013259,en,o
32,0211-699501013259,hemodialisis,i
32,0211-699501013259,recibieron,o
32,0211-699501013259,5,o
32,0211-699501013259,mg,o
32,0211-699501013259,orales,o
32,0211-699501013259,de,o
32,0211-699501013259,acido,i
32,0211-699501013259,folico,i
32,0211-699501013259,cada,o
32,0211-699501013259,48,o
32,0211-699501013259,horas,o
32,0211-699501013259,y,o
32,0211-699501013259,40,o
32,0211-699501013259,mg,o
32,0211-699501013259,orales,o
32,0211-699501013259,de,o
32,0211-699501013259,vitamina,i
32,0211-699501013259,B6,i
32,0211-699501013259,cada,o
32,0211-699501013259,semana,o
32,0211-699501013259,Se,o
32,0211-699501013259,determinaron,o
32,0211-699501013259,al,o
32,0211-699501013259,comienzo,o
32,0211-699501013259,del,o
32,0211-699501013259,estudio,o
32,0211-699501013259,y,o
32,0211-699501013259,cada,o
32,0211-699501013259,2,o
32,0211-699501013259,meses,o
32,0211-699501013259,niveles,i
32,0211-699501013259,de,i
32,0211-699501013259,folato,i
32,0211-699501013259,vitamina,i
32,0211-699501013259,B12,i
32,0211-699501013259,inmunoensayo,i
32,0211-699501013259,albumina,i
32,0211-699501013259,y,o
32,0211-699501013259,cinetica,o
32,0211-699501013259,de,o
32,0211-699501013259,la,o
32,0211-699501013259,urea,i
32,0211-699501013259,KTV,o
32,0211-699501013259,KRU,o
32,0211-699501013259,PCRn,o
32,0211-699501013259,y,o
32,0211-699501013259,cada,o
32,0211-699501013259,6,o
32,0211-699501013259,meses,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,HPLC,i
32,0211-699501013259,y,o
32,0211-699501013259,pp,i
32,0211-699501013259,RIA,i
32,0211-699501013259,Resultados,o
32,0211-699501013259,80,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,fueron,o
32,0211-699501013259,incluidos,o
32,0211-699501013259,en,o
32,0211-699501013259,el,o
32,0211-699501013259,estudio,o
32,0211-699501013259,basal,o
32,0211-699501013259,con,o
32,0211-699501013259,una,o
32,0211-699501013259,prevalencia,o
32,0211-699501013259,de,o
32,0211-699501013259,hiperhomocisteinemia,i
32,0211-699501013259,del,o
32,0211-699501013259,844,o
32,0211-699501013259,deficit,i
32,0211-699501013259,de,i
32,0211-699501013259,pp,i
32,0211-699501013259,en,o
32,0211-699501013259,el,o
32,0211-699501013259,32,o
32,0211-699501013259,y,o
32,0211-699501013259,folato,i
32,0211-699501013259,en,o
32,0211-699501013259,el,o
32,0211-699501013259,rango,o
32,0211-699501013259,normal,o
32,0211-699501013259,bajo,o
32,0211-699501013259,los,o
32,0211-699501013259,niveles,i
32,0211-699501013259,de,i
32,0211-699501013259,tHcy,i
32,0211-699501013259,se,o
32,0211-699501013259,correlacionaban,o
32,0211-699501013259,inversamente,o
32,0211-699501013259,con,o
32,0211-699501013259,los,o
32,0211-699501013259,del,o
32,0211-699501013259,folato,i
32,0211-699501013259,r,o
32,0211-699501013259,0336,o
32,0211-699501013259,p,o
32,0211-699501013259,001,o
32,0211-699501013259,pero,o
32,0211-699501013259,no,o
32,0211-699501013259,con,o
32,0211-699501013259,pp,i
32,0211-699501013259,B12,i
32,0211-699501013259,edad,o
32,0211-699501013259,albumina,i
32,0211-699501013259,KTV,o
32,0211-699501013259,KRU,o
32,0211-699501013259,PCRn,o
32,0211-699501013259,Cincuenta,o
32,0211-699501013259,y,o
32,0211-699501013259,ocho,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,recibieron,o
32,0211-699501013259,seis,o
32,0211-699501013259,meses,o
32,0211-699501013259,de,o
32,0211-699501013259,suplementacion,i
32,0211-699501013259,con,o
32,0211-699501013259,normalizacion,o
32,0211-699501013259,del,o
32,0211-699501013259,pp,i
32,0211-699501013259,aumento,o
32,0211-699501013259,del,o
32,0211-699501013259,folato,i
32,0211-699501013259,703,o
32,0211-699501013259,IC,o
32,0211-699501013259,638,o
32,0211-699501013259,795,o
32,0211-699501013259,vs,o
32,0211-699501013259,6181,o
32,0211-699501013259,IC,o
32,0211-699501013259,4447,o
32,0211-699501013259,7811,o
32,0211-699501013259,p,o
32,0211-699501013259,0001,o
32,0211-699501013259,y,o
32,0211-699501013259,descenso,o
32,0211-699501013259,de,o
32,0211-699501013259,la,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,240,o
32,0211-699501013259,IC,o
32,0211-699501013259,213,o
32,0211-699501013259,264,o
32,0211-699501013259,vs,o
32,0211-699501013259,199,o
32,0211-699501013259,IC,o
32,0211-699501013259,175,o
32,0211-699501013259,224,o
32,0211-699501013259,p,o
32,0211-699501013259,005,o
32,0211-699501013259,Han,o
32,0211-699501013259,recibido,o
32,0211-699501013259,suplementacion,i
32,0211-699501013259,durante,o
32,0211-699501013259,12,o
32,0211-699501013259,meses,o
32,0211-699501013259,33,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,pero,o
32,0211-699501013259,a,o
32,0211-699501013259,pesar,o
32,0211-699501013259,de,o
32,0211-699501013259,un,o
32,0211-699501013259,continuo,o
32,0211-699501013259,aumento,o
32,0211-699501013259,del,o
32,0211-699501013259,folato,i
32,0211-699501013259,10078,o
32,0211-699501013259,IC,o
32,0211-699501013259,7481,o
32,0211-699501013259,12674,o
32,0211-699501013259,p,o
32,0211-699501013259,0001,o
32,0211-699501013259,solo,o
32,0211-699501013259,3,o
32,0211-699501013259,pacientes,o
32,0211-699501013259,presentan,o
32,0211-699501013259,niveles,o
32,0211-699501013259,normales,o
32,0211-699501013259,de,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,correlacionandose,o
32,0211-699501013259,directamente,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,con,o
32,0211-699501013259,la,o
32,0211-699501013259,albumina,i
32,0211-699501013259,r,o
32,0211-699501013259,056,o
32,0211-699501013259,p,o
32,0211-699501013259,0001,o
32,0211-699501013259,que,o
32,0211-699501013259,se,o
32,0211-699501013259,elevo,o
32,0211-699501013259,con,o
32,0211-699501013259,respecto,o
32,0211-699501013259,al,o
32,0211-699501013259,inicio,o
32,0211-699501013259,337,o
32,0211-699501013259,IC,o
32,0211-699501013259,327,o
32,0211-699501013259,346,o
32,0211-699501013259,vs,o
32,0211-699501013259,350,o
32,0211-699501013259,IC,o
32,0211-699501013259,337,o
32,0211-699501013259,363,o
32,0211-699501013259,p,o
32,0211-699501013259,005,o
32,0211-699501013259,Conclusion,o
32,0211-699501013259,Tras,o
32,0211-699501013259,suplementacion,i
32,0211-699501013259,con,o
32,0211-699501013259,acido,i
32,0211-699501013259,folico,i
32,0211-699501013259,y,o
32,0211-699501013259,vitamina,i
32,0211-699501013259,B6,i
32,0211-699501013259,aunque,o
32,0211-699501013259,inicialmente,o
32,0211-699501013259,se,o
32,0211-699501013259,reduce,o
32,0211-699501013259,la,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,esta,o
32,0211-699501013259,respuesta,o
32,0211-699501013259,se,o
32,0211-699501013259,hace,o
32,0211-699501013259,refractaria,o
32,0211-699501013259,correlacionandose,o
32,0211-699501013259,directamente,o
32,0211-699501013259,la,o
32,0211-699501013259,tHcy,i
32,0211-699501013259,con,o
32,0211-699501013259,la,o
32,0211-699501013259,albumina,i
32,0211-699501013259,plasmatica,i
32,0211-699501013259,La,o
32,0211-699501013259,interpretacion,o
32,0211-699501013259,de,o
32,0211-699501013259,los,o
32,0211-699501013259,niveles,i
32,0211-699501013259,de,i
32,0211-699501013259,tHcy,i
32,0211-699501013259,debe,o
32,0211-699501013259,tener,o
32,0211-699501013259,en,o
32,0211-699501013259,cuenta,o
32,0211-699501013259,la,o
32,0211-699501013259,concentracion,i
32,0211-699501013259,de,i
32,0211-699501013259,albumina,i
33,0211-699501013259,Efecto,o
33,0211-699501013259,de,o
33,0211-699501013259,la,o
33,0211-699501013259,suplementacion,i
33,0211-699501013259,con,o
33,0211-699501013259,acido,i
33,0211-699501013259,folico,i
33,0211-699501013259,sobre,o
33,0211-699501013259,los,o
33,0211-699501013259,niveles,i
33,0211-699501013259,de,i
33,0211-699501013259,homocisteina,i
33,0211-699501013259,total,o
33,0211-699501013259,en,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,en,o
33,0211-699501013259,hemodialisis,i
33,0211-699501013259,La,o
33,0211-699501013259,hiperhomocisteinemia,i
33,0211-699501013259,es,o
33,0211-699501013259,un,o
33,0211-699501013259,marcador,o
33,0211-699501013259,de,o
33,0211-699501013259,riesgo,o
33,0211-699501013259,independiente,o
33,0211-699501013259,de,o
33,0211-699501013259,morbimortalidad,o
33,0211-699501013259,cardiovascular,i
33,0211-699501013259,Hemos,o
33,0211-699501013259,intentado,o
33,0211-699501013259,prospectivamente,o
33,0211-699501013259,reducir,o
33,0211-699501013259,los,o
33,0211-699501013259,niveles,i
33,0211-699501013259,de,i
33,0211-699501013259,homocisteina,i
33,0211-699501013259,total,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,mediante,o
33,0211-699501013259,suplemento,o
33,0211-699501013259,con,o
33,0211-699501013259,acido,i
33,0211-699501013259,folico,i
33,0211-699501013259,y,o
33,0211-699501013259,vitamina,i
33,0211-699501013259,B6,i
33,0211-699501013259,pp,i
33,0211-699501013259,valorando,o
33,0211-699501013259,su,o
33,0211-699501013259,posible,o
33,0211-699501013259,correlacion,o
33,0211-699501013259,con,o
33,0211-699501013259,dosis,o
33,0211-699501013259,de,o
33,0211-699501013259,dialisis,i
33,0211-699501013259,funcion,i
33,0211-699501013259,residual,i
33,0211-699501013259,y,o
33,0211-699501013259,parametros,o
33,0211-699501013259,nutricionales,o
33,0211-699501013259,Metodos,o
33,0211-699501013259,Todos,o
33,0211-699501013259,los,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,en,o
33,0211-699501013259,hemodialisis,i
33,0211-699501013259,al,o
33,0211-699501013259,comienzo,o
33,0211-699501013259,del,o
33,0211-699501013259,estudio,o
33,0211-699501013259,que,o
33,0211-699501013259,no,o
33,0211-699501013259,recibian,o
33,0211-699501013259,acido,i
33,0211-699501013259,folico,i
33,0211-699501013259,ni,o
33,0211-699501013259,vitamina,i
33,0211-699501013259,B6,i
33,0211-699501013259,asi,o
33,0211-699501013259,como,o
33,0211-699501013259,los,o
33,0211-699501013259,incorporados,o
33,0211-699501013259,posteriormente,o
33,0211-699501013259,a,o
33,0211-699501013259,partir,o
33,0211-699501013259,de,o
33,0211-699501013259,su,o
33,0211-699501013259,tercer,o
33,0211-699501013259,mes,o
33,0211-699501013259,en,o
33,0211-699501013259,hemodialisis,i
33,0211-699501013259,recibieron,o
33,0211-699501013259,5,o
33,0211-699501013259,mg,o
33,0211-699501013259,orales,o
33,0211-699501013259,de,o
33,0211-699501013259,acido,i
33,0211-699501013259,folico,i
33,0211-699501013259,cada,o
33,0211-699501013259,48,o
33,0211-699501013259,horas,o
33,0211-699501013259,y,o
33,0211-699501013259,40,o
33,0211-699501013259,mg,o
33,0211-699501013259,orales,o
33,0211-699501013259,de,o
33,0211-699501013259,vitamina,i
33,0211-699501013259,B6,i
33,0211-699501013259,cada,o
33,0211-699501013259,semana,o
33,0211-699501013259,Se,o
33,0211-699501013259,determinaron,o
33,0211-699501013259,al,o
33,0211-699501013259,comienzo,o
33,0211-699501013259,del,o
33,0211-699501013259,estudio,o
33,0211-699501013259,y,o
33,0211-699501013259,cada,o
33,0211-699501013259,2,o
33,0211-699501013259,meses,o
33,0211-699501013259,niveles,i
33,0211-699501013259,de,i
33,0211-699501013259,folato,i
33,0211-699501013259,vitamina,i
33,0211-699501013259,B12,i
33,0211-699501013259,inmunoensayo,i
33,0211-699501013259,albumina,i
33,0211-699501013259,y,o
33,0211-699501013259,cinetica,o
33,0211-699501013259,de,o
33,0211-699501013259,la,o
33,0211-699501013259,urea,i
33,0211-699501013259,KTV,o
33,0211-699501013259,KRU,o
33,0211-699501013259,PCRn,o
33,0211-699501013259,y,o
33,0211-699501013259,cada,o
33,0211-699501013259,6,o
33,0211-699501013259,meses,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,HPLC,i
33,0211-699501013259,y,o
33,0211-699501013259,pp,i
33,0211-699501013259,RIA,i
33,0211-699501013259,Resultados,o
33,0211-699501013259,80,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,fueron,o
33,0211-699501013259,incluidos,o
33,0211-699501013259,en,o
33,0211-699501013259,el,o
33,0211-699501013259,estudio,o
33,0211-699501013259,basal,o
33,0211-699501013259,con,o
33,0211-699501013259,una,o
33,0211-699501013259,prevalencia,o
33,0211-699501013259,de,o
33,0211-699501013259,hiperhomocisteinemia,i
33,0211-699501013259,del,o
33,0211-699501013259,844,o
33,0211-699501013259,deficit,i
33,0211-699501013259,de,i
33,0211-699501013259,pp,i
33,0211-699501013259,en,o
33,0211-699501013259,el,o
33,0211-699501013259,32,o
33,0211-699501013259,y,o
33,0211-699501013259,folato,i
33,0211-699501013259,en,o
33,0211-699501013259,el,o
33,0211-699501013259,rango,o
33,0211-699501013259,normal,o
33,0211-699501013259,bajo,o
33,0211-699501013259,los,o
33,0211-699501013259,niveles,i
33,0211-699501013259,de,i
33,0211-699501013259,tHcy,i
33,0211-699501013259,se,o
33,0211-699501013259,correlacionaban,o
33,0211-699501013259,inversamente,o
33,0211-699501013259,con,o
33,0211-699501013259,los,o
33,0211-699501013259,del,o
33,0211-699501013259,folato,i
33,0211-699501013259,r,o
33,0211-699501013259,0336,o
33,0211-699501013259,p,o
33,0211-699501013259,001,o
33,0211-699501013259,pero,o
33,0211-699501013259,no,o
33,0211-699501013259,con,o
33,0211-699501013259,pp,i
33,0211-699501013259,B12,i
33,0211-699501013259,edad,o
33,0211-699501013259,albumina,i
33,0211-699501013259,KTV,o
33,0211-699501013259,KRU,o
33,0211-699501013259,PCRn,o
33,0211-699501013259,Cincuenta,o
33,0211-699501013259,y,o
33,0211-699501013259,ocho,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,recibieron,o
33,0211-699501013259,seis,o
33,0211-699501013259,meses,o
33,0211-699501013259,de,o
33,0211-699501013259,suplementacion,i
33,0211-699501013259,con,o
33,0211-699501013259,normalizacion,o
33,0211-699501013259,del,o
33,0211-699501013259,pp,i
33,0211-699501013259,aumento,o
33,0211-699501013259,del,o
33,0211-699501013259,folato,i
33,0211-699501013259,703,o
33,0211-699501013259,IC,o
33,0211-699501013259,638,o
33,0211-699501013259,795,o
33,0211-699501013259,vs,o
33,0211-699501013259,6181,o
33,0211-699501013259,IC,o
33,0211-699501013259,4447,o
33,0211-699501013259,7811,o
33,0211-699501013259,p,o
33,0211-699501013259,0001,o
33,0211-699501013259,y,o
33,0211-699501013259,descenso,o
33,0211-699501013259,de,o
33,0211-699501013259,la,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,240,o
33,0211-699501013259,IC,o
33,0211-699501013259,213,o
33,0211-699501013259,264,o
33,0211-699501013259,vs,o
33,0211-699501013259,199,o
33,0211-699501013259,IC,o
33,0211-699501013259,175,o
33,0211-699501013259,224,o
33,0211-699501013259,p,o
33,0211-699501013259,005,o
33,0211-699501013259,Han,o
33,0211-699501013259,recibido,o
33,0211-699501013259,suplementacion,i
33,0211-699501013259,durante,o
33,0211-699501013259,12,o
33,0211-699501013259,meses,o
33,0211-699501013259,33,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,pero,o
33,0211-699501013259,a,o
33,0211-699501013259,pesar,o
33,0211-699501013259,de,o
33,0211-699501013259,un,o
33,0211-699501013259,continuo,o
33,0211-699501013259,aumento,o
33,0211-699501013259,del,o
33,0211-699501013259,folato,i
33,0211-699501013259,10078,o
33,0211-699501013259,IC,o
33,0211-699501013259,7481,o
33,0211-699501013259,12674,o
33,0211-699501013259,p,o
33,0211-699501013259,0001,o
33,0211-699501013259,solo,o
33,0211-699501013259,3,o
33,0211-699501013259,pacientes,o
33,0211-699501013259,presentan,o
33,0211-699501013259,niveles,o
33,0211-699501013259,normales,o
33,0211-699501013259,de,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,correlacionandose,o
33,0211-699501013259,directamente,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,con,o
33,0211-699501013259,la,o
33,0211-699501013259,albumina,i
33,0211-699501013259,r,o
33,0211-699501013259,056,o
33,0211-699501013259,p,o
33,0211-699501013259,0001,o
33,0211-699501013259,que,o
33,0211-699501013259,se,o
33,0211-699501013259,elevo,o
33,0211-699501013259,con,o
33,0211-699501013259,respecto,o
33,0211-699501013259,al,o
33,0211-699501013259,inicio,o
33,0211-699501013259,337,o
33,0211-699501013259,IC,o
33,0211-699501013259,327,o
33,0211-699501013259,346,o
33,0211-699501013259,vs,o
33,0211-699501013259,350,o
33,0211-699501013259,IC,o
33,0211-699501013259,337,o
33,0211-699501013259,363,o
33,0211-699501013259,p,o
33,0211-699501013259,005,o
33,0211-699501013259,Conclusion,o
33,0211-699501013259,Tras,o
33,0211-699501013259,suplementacion,i
33,0211-699501013259,con,o
33,0211-699501013259,acido,i
33,0211-699501013259,folico,i
33,0211-699501013259,y,o
33,0211-699501013259,vitamina,i
33,0211-699501013259,B6,i
33,0211-699501013259,aunque,o
33,0211-699501013259,inicialmente,o
33,0211-699501013259,se,o
33,0211-699501013259,reduce,o
33,0211-699501013259,la,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,esta,o
33,0211-699501013259,respuesta,o
33,0211-699501013259,se,o
33,0211-699501013259,hace,o
33,0211-699501013259,refractaria,o
33,0211-699501013259,correlacionandose,o
33,0211-699501013259,directamente,o
33,0211-699501013259,la,o
33,0211-699501013259,tHcy,i
33,0211-699501013259,con,o
33,0211-699501013259,la,o
33,0211-699501013259,albumina,i
33,0211-699501013259,plasmatica,i
33,0211-699501013259,La,o
33,0211-699501013259,interpretacion,o
33,0211-699501013259,de,o
33,0211-699501013259,los,o
33,0211-699501013259,niveles,i
33,0211-699501013259,de,i
33,0211-699501013259,tHcy,i
33,0211-699501013259,debe,o
33,0211-699501013259,tener,o
33,0211-699501013259,en,o
33,0211-699501013259,cuenta,o
33,0211-699501013259,la,o
33,0211-699501013259,concentracion,i
33,0211-699501013259,de,i
33,0211-699501013259,albumina,i
34,0211-699501013259,Efecto,o
34,0211-699501013259,de,o
34,0211-699501013259,la,o
34,0211-699501013259,suplementacion,i
34,0211-699501013259,con,o
34,0211-699501013259,acido,i
34,0211-699501013259,folico,i
34,0211-699501013259,sobre,o
34,0211-699501013259,los,o
34,0211-699501013259,niveles,i
34,0211-699501013259,de,i
34,0211-699501013259,homocisteina,i
34,0211-699501013259,total,o
34,0211-699501013259,en,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,en,o
34,0211-699501013259,hemodialisis,i
34,0211-699501013259,La,o
34,0211-699501013259,hiperhomocisteinemia,i
34,0211-699501013259,es,o
34,0211-699501013259,un,o
34,0211-699501013259,marcador,o
34,0211-699501013259,de,o
34,0211-699501013259,riesgo,o
34,0211-699501013259,independiente,o
34,0211-699501013259,de,o
34,0211-699501013259,morbimortalidad,o
34,0211-699501013259,cardiovascular,i
34,0211-699501013259,Hemos,o
34,0211-699501013259,intentado,o
34,0211-699501013259,prospectivamente,o
34,0211-699501013259,reducir,o
34,0211-699501013259,los,o
34,0211-699501013259,niveles,i
34,0211-699501013259,de,i
34,0211-699501013259,homocisteina,i
34,0211-699501013259,total,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,mediante,o
34,0211-699501013259,suplemento,o
34,0211-699501013259,con,o
34,0211-699501013259,acido,i
34,0211-699501013259,folico,i
34,0211-699501013259,y,o
34,0211-699501013259,vitamina,i
34,0211-699501013259,B6,i
34,0211-699501013259,pp,i
34,0211-699501013259,valorando,o
34,0211-699501013259,su,o
34,0211-699501013259,posible,o
34,0211-699501013259,correlacion,o
34,0211-699501013259,con,o
34,0211-699501013259,dosis,o
34,0211-699501013259,de,o
34,0211-699501013259,dialisis,i
34,0211-699501013259,funcion,i
34,0211-699501013259,residual,i
34,0211-699501013259,y,o
34,0211-699501013259,parametros,o
34,0211-699501013259,nutricionales,o
34,0211-699501013259,Metodos,o
34,0211-699501013259,Todos,o
34,0211-699501013259,los,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,en,o
34,0211-699501013259,hemodialisis,i
34,0211-699501013259,al,o
34,0211-699501013259,comienzo,o
34,0211-699501013259,del,o
34,0211-699501013259,estudio,o
34,0211-699501013259,que,o
34,0211-699501013259,no,o
34,0211-699501013259,recibian,o
34,0211-699501013259,acido,i
34,0211-699501013259,folico,i
34,0211-699501013259,ni,o
34,0211-699501013259,vitamina,i
34,0211-699501013259,B6,i
34,0211-699501013259,asi,o
34,0211-699501013259,como,o
34,0211-699501013259,los,o
34,0211-699501013259,incorporados,o
34,0211-699501013259,posteriormente,o
34,0211-699501013259,a,o
34,0211-699501013259,partir,o
34,0211-699501013259,de,o
34,0211-699501013259,su,o
34,0211-699501013259,tercer,o
34,0211-699501013259,mes,o
34,0211-699501013259,en,o
34,0211-699501013259,hemodialisis,i
34,0211-699501013259,recibieron,o
34,0211-699501013259,5,o
34,0211-699501013259,mg,o
34,0211-699501013259,orales,o
34,0211-699501013259,de,o
34,0211-699501013259,acido,i
34,0211-699501013259,folico,i
34,0211-699501013259,cada,o
34,0211-699501013259,48,o
34,0211-699501013259,horas,o
34,0211-699501013259,y,o
34,0211-699501013259,40,o
34,0211-699501013259,mg,o
34,0211-699501013259,orales,o
34,0211-699501013259,de,o
34,0211-699501013259,vitamina,i
34,0211-699501013259,B6,i
34,0211-699501013259,cada,o
34,0211-699501013259,semana,o
34,0211-699501013259,Se,o
34,0211-699501013259,determinaron,o
34,0211-699501013259,al,o
34,0211-699501013259,comienzo,o
34,0211-699501013259,del,o
34,0211-699501013259,estudio,o
34,0211-699501013259,y,o
34,0211-699501013259,cada,o
34,0211-699501013259,2,o
34,0211-699501013259,meses,o
34,0211-699501013259,niveles,i
34,0211-699501013259,de,i
34,0211-699501013259,folato,i
34,0211-699501013259,vitamina,i
34,0211-699501013259,B12,i
34,0211-699501013259,inmunoensayo,i
34,0211-699501013259,albumina,i
34,0211-699501013259,y,o
34,0211-699501013259,cinetica,o
34,0211-699501013259,de,o
34,0211-699501013259,la,o
34,0211-699501013259,urea,i
34,0211-699501013259,KTV,o
34,0211-699501013259,KRU,o
34,0211-699501013259,PCRn,o
34,0211-699501013259,y,o
34,0211-699501013259,cada,o
34,0211-699501013259,6,o
34,0211-699501013259,meses,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,HPLC,i
34,0211-699501013259,y,o
34,0211-699501013259,pp,i
34,0211-699501013259,RIA,i
34,0211-699501013259,Resultados,o
34,0211-699501013259,80,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,fueron,o
34,0211-699501013259,incluidos,o
34,0211-699501013259,en,o
34,0211-699501013259,el,o
34,0211-699501013259,estudio,o
34,0211-699501013259,basal,o
34,0211-699501013259,con,o
34,0211-699501013259,una,o
34,0211-699501013259,prevalencia,o
34,0211-699501013259,de,o
34,0211-699501013259,hiperhomocisteinemia,i
34,0211-699501013259,del,o
34,0211-699501013259,844,o
34,0211-699501013259,deficit,i
34,0211-699501013259,de,i
34,0211-699501013259,pp,i
34,0211-699501013259,en,o
34,0211-699501013259,el,o
34,0211-699501013259,32,o
34,0211-699501013259,y,o
34,0211-699501013259,folato,i
34,0211-699501013259,en,o
34,0211-699501013259,el,o
34,0211-699501013259,rango,o
34,0211-699501013259,normal,o
34,0211-699501013259,bajo,o
34,0211-699501013259,los,o
34,0211-699501013259,niveles,i
34,0211-699501013259,de,i
34,0211-699501013259,tHcy,i
34,0211-699501013259,se,o
34,0211-699501013259,correlacionaban,o
34,0211-699501013259,inversamente,o
34,0211-699501013259,con,o
34,0211-699501013259,los,o
34,0211-699501013259,del,o
34,0211-699501013259,folato,i
34,0211-699501013259,r,o
34,0211-699501013259,0336,o
34,0211-699501013259,p,o
34,0211-699501013259,001,o
34,0211-699501013259,pero,o
34,0211-699501013259,no,o
34,0211-699501013259,con,o
34,0211-699501013259,pp,i
34,0211-699501013259,B12,i
34,0211-699501013259,edad,o
34,0211-699501013259,albumina,i
34,0211-699501013259,KTV,o
34,0211-699501013259,KRU,o
34,0211-699501013259,PCRn,o
34,0211-699501013259,Cincuenta,o
34,0211-699501013259,y,o
34,0211-699501013259,ocho,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,recibieron,o
34,0211-699501013259,seis,o
34,0211-699501013259,meses,o
34,0211-699501013259,de,o
34,0211-699501013259,suplementacion,i
34,0211-699501013259,con,o
34,0211-699501013259,normalizacion,o
34,0211-699501013259,del,o
34,0211-699501013259,pp,i
34,0211-699501013259,aumento,o
34,0211-699501013259,del,o
34,0211-699501013259,folato,i
34,0211-699501013259,703,o
34,0211-699501013259,IC,o
34,0211-699501013259,638,o
34,0211-699501013259,795,o
34,0211-699501013259,vs,o
34,0211-699501013259,6181,o
34,0211-699501013259,IC,o
34,0211-699501013259,4447,o
34,0211-699501013259,7811,o
34,0211-699501013259,p,o
34,0211-699501013259,0001,o
34,0211-699501013259,y,o
34,0211-699501013259,descenso,o
34,0211-699501013259,de,o
34,0211-699501013259,la,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,240,o
34,0211-699501013259,IC,o
34,0211-699501013259,213,o
34,0211-699501013259,264,o
34,0211-699501013259,vs,o
34,0211-699501013259,199,o
34,0211-699501013259,IC,o
34,0211-699501013259,175,o
34,0211-699501013259,224,o
34,0211-699501013259,p,o
34,0211-699501013259,005,o
34,0211-699501013259,Han,o
34,0211-699501013259,recibido,o
34,0211-699501013259,suplementacion,i
34,0211-699501013259,durante,o
34,0211-699501013259,12,o
34,0211-699501013259,meses,o
34,0211-699501013259,33,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,pero,o
34,0211-699501013259,a,o
34,0211-699501013259,pesar,o
34,0211-699501013259,de,o
34,0211-699501013259,un,o
34,0211-699501013259,continuo,o
34,0211-699501013259,aumento,o
34,0211-699501013259,del,o
34,0211-699501013259,folato,i
34,0211-699501013259,10078,o
34,0211-699501013259,IC,o
34,0211-699501013259,7481,o
34,0211-699501013259,12674,o
34,0211-699501013259,p,o
34,0211-699501013259,0001,o
34,0211-699501013259,solo,o
34,0211-699501013259,3,o
34,0211-699501013259,pacientes,o
34,0211-699501013259,presentan,o
34,0211-699501013259,niveles,o
34,0211-699501013259,normales,o
34,0211-699501013259,de,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,correlacionandose,o
34,0211-699501013259,directamente,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,con,o
34,0211-699501013259,la,o
34,0211-699501013259,albumina,i
34,0211-699501013259,r,o
34,0211-699501013259,056,o
34,0211-699501013259,p,o
34,0211-699501013259,0001,o
34,0211-699501013259,que,o
34,0211-699501013259,se,o
34,0211-699501013259,elevo,o
34,0211-699501013259,con,o
34,0211-699501013259,respecto,o
34,0211-699501013259,al,o
34,0211-699501013259,inicio,o
34,0211-699501013259,337,o
34,0211-699501013259,IC,o
34,0211-699501013259,327,o
34,0211-699501013259,346,o
34,0211-699501013259,vs,o
34,0211-699501013259,350,o
34,0211-699501013259,IC,o
34,0211-699501013259,337,o
34,0211-699501013259,363,o
34,0211-699501013259,p,o
34,0211-699501013259,005,o
34,0211-699501013259,Conclusion,o
34,0211-699501013259,Tras,o
34,0211-699501013259,suplementacion,i
34,0211-699501013259,con,o
34,0211-699501013259,acido,i
34,0211-699501013259,folico,i
34,0211-699501013259,y,o
34,0211-699501013259,vitamina,i
34,0211-699501013259,B6,i
34,0211-699501013259,aunque,o
34,0211-699501013259,inicialmente,o
34,0211-699501013259,se,o
34,0211-699501013259,reduce,o
34,0211-699501013259,la,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,esta,o
34,0211-699501013259,respuesta,o
34,0211-699501013259,se,o
34,0211-699501013259,hace,o
34,0211-699501013259,refractaria,o
34,0211-699501013259,correlacionandose,o
34,0211-699501013259,directamente,o
34,0211-699501013259,la,o
34,0211-699501013259,tHcy,i
34,0211-699501013259,con,o
34,0211-699501013259,la,o
34,0211-699501013259,albumina,i
34,0211-699501013259,plasmatica,i
34,0211-699501013259,La,o
34,0211-699501013259,interpretacion,o
34,0211-699501013259,de,o
34,0211-699501013259,los,o
34,0211-699501013259,niveles,i
34,0211-699501013259,de,i
34,0211-699501013259,tHcy,i
34,0211-699501013259,debe,o
34,0211-699501013259,tener,o
34,0211-699501013259,en,o
34,0211-699501013259,cuenta,o
34,0211-699501013259,la,o
34,0211-699501013259,concentracion,i
34,0211-699501013259,de,i
34,0211-699501013259,albumina,i
35,0211-699501013259,Efecto,o
35,0211-699501013259,de,o
35,0211-699501013259,la,o
35,0211-699501013259,suplementacion,i
35,0211-699501013259,con,o
35,0211-699501013259,acido,i
35,0211-699501013259,folico,i
35,0211-699501013259,sobre,o
35,0211-699501013259,los,o
35,0211-699501013259,niveles,i
35,0211-699501013259,de,i
35,0211-699501013259,homocisteina,i
35,0211-699501013259,total,o
35,0211-699501013259,en,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,en,o
35,0211-699501013259,hemodialisis,i
35,0211-699501013259,La,o
35,0211-699501013259,hiperhomocisteinemia,i
35,0211-699501013259,es,o
35,0211-699501013259,un,o
35,0211-699501013259,marcador,o
35,0211-699501013259,de,o
35,0211-699501013259,riesgo,o
35,0211-699501013259,independiente,o
35,0211-699501013259,de,o
35,0211-699501013259,morbimortalidad,o
35,0211-699501013259,cardiovascular,i
35,0211-699501013259,Hemos,o
35,0211-699501013259,intentado,o
35,0211-699501013259,prospectivamente,o
35,0211-699501013259,reducir,o
35,0211-699501013259,los,o
35,0211-699501013259,niveles,i
35,0211-699501013259,de,i
35,0211-699501013259,homocisteina,i
35,0211-699501013259,total,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,mediante,o
35,0211-699501013259,suplemento,o
35,0211-699501013259,con,o
35,0211-699501013259,acido,i
35,0211-699501013259,folico,i
35,0211-699501013259,y,o
35,0211-699501013259,vitamina,i
35,0211-699501013259,B6,i
35,0211-699501013259,pp,i
35,0211-699501013259,valorando,o
35,0211-699501013259,su,o
35,0211-699501013259,posible,o
35,0211-699501013259,correlacion,o
35,0211-699501013259,con,o
35,0211-699501013259,dosis,o
35,0211-699501013259,de,o
35,0211-699501013259,dialisis,i
35,0211-699501013259,funcion,i
35,0211-699501013259,residual,i
35,0211-699501013259,y,o
35,0211-699501013259,parametros,o
35,0211-699501013259,nutricionales,o
35,0211-699501013259,Metodos,o
35,0211-699501013259,Todos,o
35,0211-699501013259,los,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,en,o
35,0211-699501013259,hemodialisis,i
35,0211-699501013259,al,o
35,0211-699501013259,comienzo,o
35,0211-699501013259,del,o
35,0211-699501013259,estudio,o
35,0211-699501013259,que,o
35,0211-699501013259,no,o
35,0211-699501013259,recibian,o
35,0211-699501013259,acido,i
35,0211-699501013259,folico,i
35,0211-699501013259,ni,o
35,0211-699501013259,vitamina,i
35,0211-699501013259,B6,i
35,0211-699501013259,asi,o
35,0211-699501013259,como,o
35,0211-699501013259,los,o
35,0211-699501013259,incorporados,o
35,0211-699501013259,posteriormente,o
35,0211-699501013259,a,o
35,0211-699501013259,partir,o
35,0211-699501013259,de,o
35,0211-699501013259,su,o
35,0211-699501013259,tercer,o
35,0211-699501013259,mes,o
35,0211-699501013259,en,o
35,0211-699501013259,hemodialisis,i
35,0211-699501013259,recibieron,o
35,0211-699501013259,5,o
35,0211-699501013259,mg,o
35,0211-699501013259,orales,o
35,0211-699501013259,de,o
35,0211-699501013259,acido,i
35,0211-699501013259,folico,i
35,0211-699501013259,cada,o
35,0211-699501013259,48,o
35,0211-699501013259,horas,o
35,0211-699501013259,y,o
35,0211-699501013259,40,o
35,0211-699501013259,mg,o
35,0211-699501013259,orales,o
35,0211-699501013259,de,o
35,0211-699501013259,vitamina,i
35,0211-699501013259,B6,i
35,0211-699501013259,cada,o
35,0211-699501013259,semana,o
35,0211-699501013259,Se,o
35,0211-699501013259,determinaron,o
35,0211-699501013259,al,o
35,0211-699501013259,comienzo,o
35,0211-699501013259,del,o
35,0211-699501013259,estudio,o
35,0211-699501013259,y,o
35,0211-699501013259,cada,o
35,0211-699501013259,2,o
35,0211-699501013259,meses,o
35,0211-699501013259,niveles,i
35,0211-699501013259,de,i
35,0211-699501013259,folato,i
35,0211-699501013259,vitamina,i
35,0211-699501013259,B12,i
35,0211-699501013259,inmunoensayo,i
35,0211-699501013259,albumina,i
35,0211-699501013259,y,o
35,0211-699501013259,cinetica,o
35,0211-699501013259,de,o
35,0211-699501013259,la,o
35,0211-699501013259,urea,i
35,0211-699501013259,KTV,o
35,0211-699501013259,KRU,o
35,0211-699501013259,PCRn,o
35,0211-699501013259,y,o
35,0211-699501013259,cada,o
35,0211-699501013259,6,o
35,0211-699501013259,meses,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,HPLC,i
35,0211-699501013259,y,o
35,0211-699501013259,pp,i
35,0211-699501013259,RIA,i
35,0211-699501013259,Resultados,o
35,0211-699501013259,80,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,fueron,o
35,0211-699501013259,incluidos,o
35,0211-699501013259,en,o
35,0211-699501013259,el,o
35,0211-699501013259,estudio,o
35,0211-699501013259,basal,o
35,0211-699501013259,con,o
35,0211-699501013259,una,o
35,0211-699501013259,prevalencia,o
35,0211-699501013259,de,o
35,0211-699501013259,hiperhomocisteinemia,i
35,0211-699501013259,del,o
35,0211-699501013259,844,o
35,0211-699501013259,deficit,i
35,0211-699501013259,de,i
35,0211-699501013259,pp,i
35,0211-699501013259,en,o
35,0211-699501013259,el,o
35,0211-699501013259,32,o
35,0211-699501013259,y,o
35,0211-699501013259,folato,i
35,0211-699501013259,en,o
35,0211-699501013259,el,o
35,0211-699501013259,rango,o
35,0211-699501013259,normal,o
35,0211-699501013259,bajo,o
35,0211-699501013259,los,o
35,0211-699501013259,niveles,i
35,0211-699501013259,de,i
35,0211-699501013259,tHcy,i
35,0211-699501013259,se,o
35,0211-699501013259,correlacionaban,o
35,0211-699501013259,inversamente,o
35,0211-699501013259,con,o
35,0211-699501013259,los,o
35,0211-699501013259,del,o
35,0211-699501013259,folato,i
35,0211-699501013259,r,o
35,0211-699501013259,0336,o
35,0211-699501013259,p,o
35,0211-699501013259,001,o
35,0211-699501013259,pero,o
35,0211-699501013259,no,o
35,0211-699501013259,con,o
35,0211-699501013259,pp,i
35,0211-699501013259,B12,i
35,0211-699501013259,edad,o
35,0211-699501013259,albumina,i
35,0211-699501013259,KTV,o
35,0211-699501013259,KRU,o
35,0211-699501013259,PCRn,o
35,0211-699501013259,Cincuenta,o
35,0211-699501013259,y,o
35,0211-699501013259,ocho,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,recibieron,o
35,0211-699501013259,seis,o
35,0211-699501013259,meses,o
35,0211-699501013259,de,o
35,0211-699501013259,suplementacion,i
35,0211-699501013259,con,o
35,0211-699501013259,normalizacion,o
35,0211-699501013259,del,o
35,0211-699501013259,pp,i
35,0211-699501013259,aumento,o
35,0211-699501013259,del,o
35,0211-699501013259,folato,i
35,0211-699501013259,703,o
35,0211-699501013259,IC,o
35,0211-699501013259,638,o
35,0211-699501013259,795,o
35,0211-699501013259,vs,o
35,0211-699501013259,6181,o
35,0211-699501013259,IC,o
35,0211-699501013259,4447,o
35,0211-699501013259,7811,o
35,0211-699501013259,p,o
35,0211-699501013259,0001,o
35,0211-699501013259,y,o
35,0211-699501013259,descenso,o
35,0211-699501013259,de,o
35,0211-699501013259,la,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,240,o
35,0211-699501013259,IC,o
35,0211-699501013259,213,o
35,0211-699501013259,264,o
35,0211-699501013259,vs,o
35,0211-699501013259,199,o
35,0211-699501013259,IC,o
35,0211-699501013259,175,o
35,0211-699501013259,224,o
35,0211-699501013259,p,o
35,0211-699501013259,005,o
35,0211-699501013259,Han,o
35,0211-699501013259,recibido,o
35,0211-699501013259,suplementacion,i
35,0211-699501013259,durante,o
35,0211-699501013259,12,o
35,0211-699501013259,meses,o
35,0211-699501013259,33,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,pero,o
35,0211-699501013259,a,o
35,0211-699501013259,pesar,o
35,0211-699501013259,de,o
35,0211-699501013259,un,o
35,0211-699501013259,continuo,o
35,0211-699501013259,aumento,o
35,0211-699501013259,del,o
35,0211-699501013259,folato,i
35,0211-699501013259,10078,o
35,0211-699501013259,IC,o
35,0211-699501013259,7481,o
35,0211-699501013259,12674,o
35,0211-699501013259,p,o
35,0211-699501013259,0001,o
35,0211-699501013259,solo,o
35,0211-699501013259,3,o
35,0211-699501013259,pacientes,o
35,0211-699501013259,presentan,o
35,0211-699501013259,niveles,o
35,0211-699501013259,normales,o
35,0211-699501013259,de,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,correlacionandose,o
35,0211-699501013259,directamente,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,con,o
35,0211-699501013259,la,o
35,0211-699501013259,albumina,i
35,0211-699501013259,r,o
35,0211-699501013259,056,o
35,0211-699501013259,p,o
35,0211-699501013259,0001,o
35,0211-699501013259,que,o
35,0211-699501013259,se,o
35,0211-699501013259,elevo,o
35,0211-699501013259,con,o
35,0211-699501013259,respecto,o
35,0211-699501013259,al,o
35,0211-699501013259,inicio,o
35,0211-699501013259,337,o
35,0211-699501013259,IC,o
35,0211-699501013259,327,o
35,0211-699501013259,346,o
35,0211-699501013259,vs,o
35,0211-699501013259,350,o
35,0211-699501013259,IC,o
35,0211-699501013259,337,o
35,0211-699501013259,363,o
35,0211-699501013259,p,o
35,0211-699501013259,005,o
35,0211-699501013259,Conclusion,o
35,0211-699501013259,Tras,o
35,0211-699501013259,suplementacion,i
35,0211-699501013259,con,o
35,0211-699501013259,acido,i
35,0211-699501013259,folico,i
35,0211-699501013259,y,o
35,0211-699501013259,vitamina,i
35,0211-699501013259,B6,i
35,0211-699501013259,aunque,o
35,0211-699501013259,inicialmente,o
35,0211-699501013259,se,o
35,0211-699501013259,reduce,o
35,0211-699501013259,la,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,esta,o
35,0211-699501013259,respuesta,o
35,0211-699501013259,se,o
35,0211-699501013259,hace,o
35,0211-699501013259,refractaria,o
35,0211-699501013259,correlacionandose,o
35,0211-699501013259,directamente,o
35,0211-699501013259,la,o
35,0211-699501013259,tHcy,i
35,0211-699501013259,con,o
35,0211-699501013259,la,o
35,0211-699501013259,albumina,i
35,0211-699501013259,plasmatica,i
35,0211-699501013259,La,o
35,0211-699501013259,interpretacion,o
35,0211-699501013259,de,o
35,0211-699501013259,los,o
35,0211-699501013259,niveles,i
35,0211-699501013259,de,i
35,0211-699501013259,tHcy,i
35,0211-699501013259,debe,o
35,0211-699501013259,tener,o
35,0211-699501013259,en,o
35,0211-699501013259,cuenta,o
35,0211-699501013259,la,o
35,0211-699501013259,concentracion,i
35,0211-699501013259,de,i
35,0211-699501013259,albumina,i
36,0211-699501013259,Efecto,o
36,0211-699501013259,de,o
36,0211-699501013259,la,o
36,0211-699501013259,suplementacion,i
36,0211-699501013259,con,o
36,0211-699501013259,acido,i
36,0211-699501013259,folico,i
36,0211-699501013259,sobre,o
36,0211-699501013259,los,o
36,0211-699501013259,niveles,i
36,0211-699501013259,de,i
36,0211-699501013259,homocisteina,i
36,0211-699501013259,total,o
36,0211-699501013259,en,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,en,o
36,0211-699501013259,hemodialisis,i
36,0211-699501013259,La,o
36,0211-699501013259,hiperhomocisteinemia,i
36,0211-699501013259,es,o
36,0211-699501013259,un,o
36,0211-699501013259,marcador,o
36,0211-699501013259,de,o
36,0211-699501013259,riesgo,o
36,0211-699501013259,independiente,o
36,0211-699501013259,de,o
36,0211-699501013259,morbimortalidad,o
36,0211-699501013259,cardiovascular,i
36,0211-699501013259,Hemos,o
36,0211-699501013259,intentado,o
36,0211-699501013259,prospectivamente,o
36,0211-699501013259,reducir,o
36,0211-699501013259,los,o
36,0211-699501013259,niveles,i
36,0211-699501013259,de,i
36,0211-699501013259,homocisteina,i
36,0211-699501013259,total,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,mediante,o
36,0211-699501013259,suplemento,o
36,0211-699501013259,con,o
36,0211-699501013259,acido,i
36,0211-699501013259,folico,i
36,0211-699501013259,y,o
36,0211-699501013259,vitamina,i
36,0211-699501013259,B6,i
36,0211-699501013259,pp,i
36,0211-699501013259,valorando,o
36,0211-699501013259,su,o
36,0211-699501013259,posible,o
36,0211-699501013259,correlacion,o
36,0211-699501013259,con,o
36,0211-699501013259,dosis,o
36,0211-699501013259,de,o
36,0211-699501013259,dialisis,i
36,0211-699501013259,funcion,i
36,0211-699501013259,residual,i
36,0211-699501013259,y,o
36,0211-699501013259,parametros,o
36,0211-699501013259,nutricionales,o
36,0211-699501013259,Metodos,o
36,0211-699501013259,Todos,o
36,0211-699501013259,los,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,en,o
36,0211-699501013259,hemodialisis,i
36,0211-699501013259,al,o
36,0211-699501013259,comienzo,o
36,0211-699501013259,del,o
36,0211-699501013259,estudio,o
36,0211-699501013259,que,o
36,0211-699501013259,no,o
36,0211-699501013259,recibian,o
36,0211-699501013259,acido,i
36,0211-699501013259,folico,i
36,0211-699501013259,ni,o
36,0211-699501013259,vitamina,i
36,0211-699501013259,B6,i
36,0211-699501013259,asi,o
36,0211-699501013259,como,o
36,0211-699501013259,los,o
36,0211-699501013259,incorporados,o
36,0211-699501013259,posteriormente,o
36,0211-699501013259,a,o
36,0211-699501013259,partir,o
36,0211-699501013259,de,o
36,0211-699501013259,su,o
36,0211-699501013259,tercer,o
36,0211-699501013259,mes,o
36,0211-699501013259,en,o
36,0211-699501013259,hemodialisis,i
36,0211-699501013259,recibieron,o
36,0211-699501013259,5,o
36,0211-699501013259,mg,o
36,0211-699501013259,orales,o
36,0211-699501013259,de,o
36,0211-699501013259,acido,i
36,0211-699501013259,folico,i
36,0211-699501013259,cada,o
36,0211-699501013259,48,o
36,0211-699501013259,horas,o
36,0211-699501013259,y,o
36,0211-699501013259,40,o
36,0211-699501013259,mg,o
36,0211-699501013259,orales,o
36,0211-699501013259,de,o
36,0211-699501013259,vitamina,i
36,0211-699501013259,B6,i
36,0211-699501013259,cada,o
36,0211-699501013259,semana,o
36,0211-699501013259,Se,o
36,0211-699501013259,determinaron,o
36,0211-699501013259,al,o
36,0211-699501013259,comienzo,o
36,0211-699501013259,del,o
36,0211-699501013259,estudio,o
36,0211-699501013259,y,o
36,0211-699501013259,cada,o
36,0211-699501013259,2,o
36,0211-699501013259,meses,o
36,0211-699501013259,niveles,i
36,0211-699501013259,de,i
36,0211-699501013259,folato,i
36,0211-699501013259,vitamina,i
36,0211-699501013259,B12,i
36,0211-699501013259,inmunoensayo,i
36,0211-699501013259,albumina,i
36,0211-699501013259,y,o
36,0211-699501013259,cinetica,o
36,0211-699501013259,de,o
36,0211-699501013259,la,o
36,0211-699501013259,urea,i
36,0211-699501013259,KTV,o
36,0211-699501013259,KRU,o
36,0211-699501013259,PCRn,o
36,0211-699501013259,y,o
36,0211-699501013259,cada,o
36,0211-699501013259,6,o
36,0211-699501013259,meses,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,HPLC,i
36,0211-699501013259,y,o
36,0211-699501013259,pp,i
36,0211-699501013259,RIA,i
36,0211-699501013259,Resultados,o
36,0211-699501013259,80,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,fueron,o
36,0211-699501013259,incluidos,o
36,0211-699501013259,en,o
36,0211-699501013259,el,o
36,0211-699501013259,estudio,o
36,0211-699501013259,basal,o
36,0211-699501013259,con,o
36,0211-699501013259,una,o
36,0211-699501013259,prevalencia,o
36,0211-699501013259,de,o
36,0211-699501013259,hiperhomocisteinemia,i
36,0211-699501013259,del,o
36,0211-699501013259,844,o
36,0211-699501013259,deficit,i
36,0211-699501013259,de,i
36,0211-699501013259,pp,i
36,0211-699501013259,en,o
36,0211-699501013259,el,o
36,0211-699501013259,32,o
36,0211-699501013259,y,o
36,0211-699501013259,folato,i
36,0211-699501013259,en,o
36,0211-699501013259,el,o
36,0211-699501013259,rango,o
36,0211-699501013259,normal,o
36,0211-699501013259,bajo,o
36,0211-699501013259,los,o
36,0211-699501013259,niveles,i
36,0211-699501013259,de,i
36,0211-699501013259,tHcy,i
36,0211-699501013259,se,o
36,0211-699501013259,correlacionaban,o
36,0211-699501013259,inversamente,o
36,0211-699501013259,con,o
36,0211-699501013259,los,o
36,0211-699501013259,del,o
36,0211-699501013259,folato,i
36,0211-699501013259,r,o
36,0211-699501013259,0336,o
36,0211-699501013259,p,o
36,0211-699501013259,001,o
36,0211-699501013259,pero,o
36,0211-699501013259,no,o
36,0211-699501013259,con,o
36,0211-699501013259,pp,i
36,0211-699501013259,B12,i
36,0211-699501013259,edad,o
36,0211-699501013259,albumina,i
36,0211-699501013259,KTV,o
36,0211-699501013259,KRU,o
36,0211-699501013259,PCRn,o
36,0211-699501013259,Cincuenta,o
36,0211-699501013259,y,o
36,0211-699501013259,ocho,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,recibieron,o
36,0211-699501013259,seis,o
36,0211-699501013259,meses,o
36,0211-699501013259,de,o
36,0211-699501013259,suplementacion,i
36,0211-699501013259,con,o
36,0211-699501013259,normalizacion,o
36,0211-699501013259,del,o
36,0211-699501013259,pp,i
36,0211-699501013259,aumento,o
36,0211-699501013259,del,o
36,0211-699501013259,folato,i
36,0211-699501013259,703,o
36,0211-699501013259,IC,o
36,0211-699501013259,638,o
36,0211-699501013259,795,o
36,0211-699501013259,vs,o
36,0211-699501013259,6181,o
36,0211-699501013259,IC,o
36,0211-699501013259,4447,o
36,0211-699501013259,7811,o
36,0211-699501013259,p,o
36,0211-699501013259,0001,o
36,0211-699501013259,y,o
36,0211-699501013259,descenso,o
36,0211-699501013259,de,o
36,0211-699501013259,la,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,240,o
36,0211-699501013259,IC,o
36,0211-699501013259,213,o
36,0211-699501013259,264,o
36,0211-699501013259,vs,o
36,0211-699501013259,199,o
36,0211-699501013259,IC,o
36,0211-699501013259,175,o
36,0211-699501013259,224,o
36,0211-699501013259,p,o
36,0211-699501013259,005,o
36,0211-699501013259,Han,o
36,0211-699501013259,recibido,o
36,0211-699501013259,suplementacion,i
36,0211-699501013259,durante,o
36,0211-699501013259,12,o
36,0211-699501013259,meses,o
36,0211-699501013259,33,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,pero,o
36,0211-699501013259,a,o
36,0211-699501013259,pesar,o
36,0211-699501013259,de,o
36,0211-699501013259,un,o
36,0211-699501013259,continuo,o
36,0211-699501013259,aumento,o
36,0211-699501013259,del,o
36,0211-699501013259,folato,i
36,0211-699501013259,10078,o
36,0211-699501013259,IC,o
36,0211-699501013259,7481,o
36,0211-699501013259,12674,o
36,0211-699501013259,p,o
36,0211-699501013259,0001,o
36,0211-699501013259,solo,o
36,0211-699501013259,3,o
36,0211-699501013259,pacientes,o
36,0211-699501013259,presentan,o
36,0211-699501013259,niveles,o
36,0211-699501013259,normales,o
36,0211-699501013259,de,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,correlacionandose,o
36,0211-699501013259,directamente,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,con,o
36,0211-699501013259,la,o
36,0211-699501013259,albumina,i
36,0211-699501013259,r,o
36,0211-699501013259,056,o
36,0211-699501013259,p,o
36,0211-699501013259,0001,o
36,0211-699501013259,que,o
36,0211-699501013259,se,o
36,0211-699501013259,elevo,o
36,0211-699501013259,con,o
36,0211-699501013259,respecto,o
36,0211-699501013259,al,o
36,0211-699501013259,inicio,o
36,0211-699501013259,337,o
36,0211-699501013259,IC,o
36,0211-699501013259,327,o
36,0211-699501013259,346,o
36,0211-699501013259,vs,o
36,0211-699501013259,350,o
36,0211-699501013259,IC,o
36,0211-699501013259,337,o
36,0211-699501013259,363,o
36,0211-699501013259,p,o
36,0211-699501013259,005,o
36,0211-699501013259,Conclusion,o
36,0211-699501013259,Tras,o
36,0211-699501013259,suplementacion,i
36,0211-699501013259,con,o
36,0211-699501013259,acido,i
36,0211-699501013259,folico,i
36,0211-699501013259,y,o
36,0211-699501013259,vitamina,i
36,0211-699501013259,B6,i
36,0211-699501013259,aunque,o
36,0211-699501013259,inicialmente,o
36,0211-699501013259,se,o
36,0211-699501013259,reduce,o
36,0211-699501013259,la,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,esta,o
36,0211-699501013259,respuesta,o
36,0211-699501013259,se,o
36,0211-699501013259,hace,o
36,0211-699501013259,refractaria,o
36,0211-699501013259,correlacionandose,o
36,0211-699501013259,directamente,o
36,0211-699501013259,la,o
36,0211-699501013259,tHcy,i
36,0211-699501013259,con,o
36,0211-699501013259,la,o
36,0211-699501013259,albumina,i
36,0211-699501013259,plasmatica,i
36,0211-699501013259,La,o
36,0211-699501013259,interpretacion,o
36,0211-699501013259,de,o
36,0211-699501013259,los,o
36,0211-699501013259,niveles,i
36,0211-699501013259,de,i
36,0211-699501013259,tHcy,i
36,0211-699501013259,debe,o
36,0211-699501013259,tener,o
36,0211-699501013259,en,o
36,0211-699501013259,cuenta,o
36,0211-699501013259,la,o
36,0211-699501013259,concentracion,i
36,0211-699501013259,de,i
36,0211-699501013259,albumina,i
37,0211-699501013259,Efecto,o
37,0211-699501013259,de,o
37,0211-699501013259,la,o
37,0211-699501013259,suplementacion,i
37,0211-699501013259,con,o
37,0211-699501013259,acido,i
37,0211-699501013259,folico,i
37,0211-699501013259,sobre,o
37,0211-699501013259,los,o
37,0211-699501013259,niveles,i
37,0211-699501013259,de,i
37,0211-699501013259,homocisteina,i
37,0211-699501013259,total,o
37,0211-699501013259,en,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,en,o
37,0211-699501013259,hemodialisis,i
37,0211-699501013259,La,o
37,0211-699501013259,hiperhomocisteinemia,i
37,0211-699501013259,es,o
37,0211-699501013259,un,o
37,0211-699501013259,marcador,o
37,0211-699501013259,de,o
37,0211-699501013259,riesgo,o
37,0211-699501013259,independiente,o
37,0211-699501013259,de,o
37,0211-699501013259,morbimortalidad,o
37,0211-699501013259,cardiovascular,i
37,0211-699501013259,Hemos,o
37,0211-699501013259,intentado,o
37,0211-699501013259,prospectivamente,o
37,0211-699501013259,reducir,o
37,0211-699501013259,los,o
37,0211-699501013259,niveles,i
37,0211-699501013259,de,i
37,0211-699501013259,homocisteina,i
37,0211-699501013259,total,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,mediante,o
37,0211-699501013259,suplemento,o
37,0211-699501013259,con,o
37,0211-699501013259,acido,i
37,0211-699501013259,folico,i
37,0211-699501013259,y,o
37,0211-699501013259,vitamina,i
37,0211-699501013259,B6,i
37,0211-699501013259,pp,i
37,0211-699501013259,valorando,o
37,0211-699501013259,su,o
37,0211-699501013259,posible,o
37,0211-699501013259,correlacion,o
37,0211-699501013259,con,o
37,0211-699501013259,dosis,o
37,0211-699501013259,de,o
37,0211-699501013259,dialisis,i
37,0211-699501013259,funcion,i
37,0211-699501013259,residual,i
37,0211-699501013259,y,o
37,0211-699501013259,parametros,o
37,0211-699501013259,nutricionales,o
37,0211-699501013259,Metodos,o
37,0211-699501013259,Todos,o
37,0211-699501013259,los,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,en,o
37,0211-699501013259,hemodialisis,i
37,0211-699501013259,al,o
37,0211-699501013259,comienzo,o
37,0211-699501013259,del,o
37,0211-699501013259,estudio,o
37,0211-699501013259,que,o
37,0211-699501013259,no,o
37,0211-699501013259,recibian,o
37,0211-699501013259,acido,i
37,0211-699501013259,folico,i
37,0211-699501013259,ni,o
37,0211-699501013259,vitamina,i
37,0211-699501013259,B6,i
37,0211-699501013259,asi,o
37,0211-699501013259,como,o
37,0211-699501013259,los,o
37,0211-699501013259,incorporados,o
37,0211-699501013259,posteriormente,o
37,0211-699501013259,a,o
37,0211-699501013259,partir,o
37,0211-699501013259,de,o
37,0211-699501013259,su,o
37,0211-699501013259,tercer,o
37,0211-699501013259,mes,o
37,0211-699501013259,en,o
37,0211-699501013259,hemodialisis,i
37,0211-699501013259,recibieron,o
37,0211-699501013259,5,o
37,0211-699501013259,mg,o
37,0211-699501013259,orales,o
37,0211-699501013259,de,o
37,0211-699501013259,acido,i
37,0211-699501013259,folico,i
37,0211-699501013259,cada,o
37,0211-699501013259,48,o
37,0211-699501013259,horas,o
37,0211-699501013259,y,o
37,0211-699501013259,40,o
37,0211-699501013259,mg,o
37,0211-699501013259,orales,o
37,0211-699501013259,de,o
37,0211-699501013259,vitamina,i
37,0211-699501013259,B6,i
37,0211-699501013259,cada,o
37,0211-699501013259,semana,o
37,0211-699501013259,Se,o
37,0211-699501013259,determinaron,o
37,0211-699501013259,al,o
37,0211-699501013259,comienzo,o
37,0211-699501013259,del,o
37,0211-699501013259,estudio,o
37,0211-699501013259,y,o
37,0211-699501013259,cada,o
37,0211-699501013259,2,o
37,0211-699501013259,meses,o
37,0211-699501013259,niveles,i
37,0211-699501013259,de,i
37,0211-699501013259,folato,i
37,0211-699501013259,vitamina,i
37,0211-699501013259,B12,i
37,0211-699501013259,inmunoensayo,i
37,0211-699501013259,albumina,i
37,0211-699501013259,y,o
37,0211-699501013259,cinetica,o
37,0211-699501013259,de,o
37,0211-699501013259,la,o
37,0211-699501013259,urea,i
37,0211-699501013259,KTV,o
37,0211-699501013259,KRU,o
37,0211-699501013259,PCRn,o
37,0211-699501013259,y,o
37,0211-699501013259,cada,o
37,0211-699501013259,6,o
37,0211-699501013259,meses,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,HPLC,i
37,0211-699501013259,y,o
37,0211-699501013259,pp,i
37,0211-699501013259,RIA,i
37,0211-699501013259,Resultados,o
37,0211-699501013259,80,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,fueron,o
37,0211-699501013259,incluidos,o
37,0211-699501013259,en,o
37,0211-699501013259,el,o
37,0211-699501013259,estudio,o
37,0211-699501013259,basal,o
37,0211-699501013259,con,o
37,0211-699501013259,una,o
37,0211-699501013259,prevalencia,o
37,0211-699501013259,de,o
37,0211-699501013259,hiperhomocisteinemia,i
37,0211-699501013259,del,o
37,0211-699501013259,844,o
37,0211-699501013259,deficit,i
37,0211-699501013259,de,i
37,0211-699501013259,pp,i
37,0211-699501013259,en,o
37,0211-699501013259,el,o
37,0211-699501013259,32,o
37,0211-699501013259,y,o
37,0211-699501013259,folato,i
37,0211-699501013259,en,o
37,0211-699501013259,el,o
37,0211-699501013259,rango,o
37,0211-699501013259,normal,o
37,0211-699501013259,bajo,o
37,0211-699501013259,los,o
37,0211-699501013259,niveles,i
37,0211-699501013259,de,i
37,0211-699501013259,tHcy,i
37,0211-699501013259,se,o
37,0211-699501013259,correlacionaban,o
37,0211-699501013259,inversamente,o
37,0211-699501013259,con,o
37,0211-699501013259,los,o
37,0211-699501013259,del,o
37,0211-699501013259,folato,i
37,0211-699501013259,r,o
37,0211-699501013259,0336,o
37,0211-699501013259,p,o
37,0211-699501013259,001,o
37,0211-699501013259,pero,o
37,0211-699501013259,no,o
37,0211-699501013259,con,o
37,0211-699501013259,pp,i
37,0211-699501013259,B12,i
37,0211-699501013259,edad,o
37,0211-699501013259,albumina,i
37,0211-699501013259,KTV,o
37,0211-699501013259,KRU,o
37,0211-699501013259,PCRn,o
37,0211-699501013259,Cincuenta,o
37,0211-699501013259,y,o
37,0211-699501013259,ocho,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,recibieron,o
37,0211-699501013259,seis,o
37,0211-699501013259,meses,o
37,0211-699501013259,de,o
37,0211-699501013259,suplementacion,i
37,0211-699501013259,con,o
37,0211-699501013259,normalizacion,o
37,0211-699501013259,del,o
37,0211-699501013259,pp,i
37,0211-699501013259,aumento,o
37,0211-699501013259,del,o
37,0211-699501013259,folato,i
37,0211-699501013259,703,o
37,0211-699501013259,IC,o
37,0211-699501013259,638,o
37,0211-699501013259,795,o
37,0211-699501013259,vs,o
37,0211-699501013259,6181,o
37,0211-699501013259,IC,o
37,0211-699501013259,4447,o
37,0211-699501013259,7811,o
37,0211-699501013259,p,o
37,0211-699501013259,0001,o
37,0211-699501013259,y,o
37,0211-699501013259,descenso,o
37,0211-699501013259,de,o
37,0211-699501013259,la,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,240,o
37,0211-699501013259,IC,o
37,0211-699501013259,213,o
37,0211-699501013259,264,o
37,0211-699501013259,vs,o
37,0211-699501013259,199,o
37,0211-699501013259,IC,o
37,0211-699501013259,175,o
37,0211-699501013259,224,o
37,0211-699501013259,p,o
37,0211-699501013259,005,o
37,0211-699501013259,Han,o
37,0211-699501013259,recibido,o
37,0211-699501013259,suplementacion,i
37,0211-699501013259,durante,o
37,0211-699501013259,12,o
37,0211-699501013259,meses,o
37,0211-699501013259,33,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,pero,o
37,0211-699501013259,a,o
37,0211-699501013259,pesar,o
37,0211-699501013259,de,o
37,0211-699501013259,un,o
37,0211-699501013259,continuo,o
37,0211-699501013259,aumento,o
37,0211-699501013259,del,o
37,0211-699501013259,folato,i
37,0211-699501013259,10078,o
37,0211-699501013259,IC,o
37,0211-699501013259,7481,o
37,0211-699501013259,12674,o
37,0211-699501013259,p,o
37,0211-699501013259,0001,o
37,0211-699501013259,solo,o
37,0211-699501013259,3,o
37,0211-699501013259,pacientes,o
37,0211-699501013259,presentan,o
37,0211-699501013259,niveles,o
37,0211-699501013259,normales,o
37,0211-699501013259,de,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,correlacionandose,o
37,0211-699501013259,directamente,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,con,o
37,0211-699501013259,la,o
37,0211-699501013259,albumina,i
37,0211-699501013259,r,o
37,0211-699501013259,056,o
37,0211-699501013259,p,o
37,0211-699501013259,0001,o
37,0211-699501013259,que,o
37,0211-699501013259,se,o
37,0211-699501013259,elevo,o
37,0211-699501013259,con,o
37,0211-699501013259,respecto,o
37,0211-699501013259,al,o
37,0211-699501013259,inicio,o
37,0211-699501013259,337,o
37,0211-699501013259,IC,o
37,0211-699501013259,327,o
37,0211-699501013259,346,o
37,0211-699501013259,vs,o
37,0211-699501013259,350,o
37,0211-699501013259,IC,o
37,0211-699501013259,337,o
37,0211-699501013259,363,o
37,0211-699501013259,p,o
37,0211-699501013259,005,o
37,0211-699501013259,Conclusion,o
37,0211-699501013259,Tras,o
37,0211-699501013259,suplementacion,i
37,0211-699501013259,con,o
37,0211-699501013259,acido,i
37,0211-699501013259,folico,i
37,0211-699501013259,y,o
37,0211-699501013259,vitamina,i
37,0211-699501013259,B6,i
37,0211-699501013259,aunque,o
37,0211-699501013259,inicialmente,o
37,0211-699501013259,se,o
37,0211-699501013259,reduce,o
37,0211-699501013259,la,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,esta,o
37,0211-699501013259,respuesta,o
37,0211-699501013259,se,o
37,0211-699501013259,hace,o
37,0211-699501013259,refractaria,o
37,0211-699501013259,correlacionandose,o
37,0211-699501013259,directamente,o
37,0211-699501013259,la,o
37,0211-699501013259,tHcy,i
37,0211-699501013259,con,o
37,0211-699501013259,la,o
37,0211-699501013259,albumina,i
37,0211-699501013259,plasmatica,i
37,0211-699501013259,La,o
37,0211-699501013259,interpretacion,o
37,0211-699501013259,de,o
37,0211-699501013259,los,o
37,0211-699501013259,niveles,i
37,0211-699501013259,de,i
37,0211-699501013259,tHcy,i
37,0211-699501013259,debe,o
37,0211-699501013259,tener,o
37,0211-699501013259,en,o
37,0211-699501013259,cuenta,o
37,0211-699501013259,la,o
37,0211-699501013259,concentracion,i
37,0211-699501013259,de,i
37,0211-699501013259,albumina,i
38,0211-699501013259,Efecto,o
38,0211-699501013259,de,o
38,0211-699501013259,la,o
38,0211-699501013259,suplementacion,i
38,0211-699501013259,con,o
38,0211-699501013259,acido,i
38,0211-699501013259,folico,i
38,0211-699501013259,sobre,o
38,0211-699501013259,los,o
38,0211-699501013259,niveles,i
38,0211-699501013259,de,i
38,0211-699501013259,homocisteina,i
38,0211-699501013259,total,o
38,0211-699501013259,en,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,en,o
38,0211-699501013259,hemodialisis,i
38,0211-699501013259,La,o
38,0211-699501013259,hiperhomocisteinemia,i
38,0211-699501013259,es,o
38,0211-699501013259,un,o
38,0211-699501013259,marcador,o
38,0211-699501013259,de,o
38,0211-699501013259,riesgo,o
38,0211-699501013259,independiente,o
38,0211-699501013259,de,o
38,0211-699501013259,morbimortalidad,o
38,0211-699501013259,cardiovascular,i
38,0211-699501013259,Hemos,o
38,0211-699501013259,intentado,o
38,0211-699501013259,prospectivamente,o
38,0211-699501013259,reducir,o
38,0211-699501013259,los,o
38,0211-699501013259,niveles,i
38,0211-699501013259,de,i
38,0211-699501013259,homocisteina,i
38,0211-699501013259,total,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,mediante,o
38,0211-699501013259,suplemento,o
38,0211-699501013259,con,o
38,0211-699501013259,acido,i
38,0211-699501013259,folico,i
38,0211-699501013259,y,o
38,0211-699501013259,vitamina,i
38,0211-699501013259,B6,i
38,0211-699501013259,pp,i
38,0211-699501013259,valorando,o
38,0211-699501013259,su,o
38,0211-699501013259,posible,o
38,0211-699501013259,correlacion,o
38,0211-699501013259,con,o
38,0211-699501013259,dosis,o
38,0211-699501013259,de,o
38,0211-699501013259,dialisis,i
38,0211-699501013259,funcion,i
38,0211-699501013259,residual,i
38,0211-699501013259,y,o
38,0211-699501013259,parametros,o
38,0211-699501013259,nutricionales,o
38,0211-699501013259,Metodos,o
38,0211-699501013259,Todos,o
38,0211-699501013259,los,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,en,o
38,0211-699501013259,hemodialisis,i
38,0211-699501013259,al,o
38,0211-699501013259,comienzo,o
38,0211-699501013259,del,o
38,0211-699501013259,estudio,o
38,0211-699501013259,que,o
38,0211-699501013259,no,o
38,0211-699501013259,recibian,o
38,0211-699501013259,acido,i
38,0211-699501013259,folico,i
38,0211-699501013259,ni,o
38,0211-699501013259,vitamina,i
38,0211-699501013259,B6,i
38,0211-699501013259,asi,o
38,0211-699501013259,como,o
38,0211-699501013259,los,o
38,0211-699501013259,incorporados,o
38,0211-699501013259,posteriormente,o
38,0211-699501013259,a,o
38,0211-699501013259,partir,o
38,0211-699501013259,de,o
38,0211-699501013259,su,o
38,0211-699501013259,tercer,o
38,0211-699501013259,mes,o
38,0211-699501013259,en,o
38,0211-699501013259,hemodialisis,i
38,0211-699501013259,recibieron,o
38,0211-699501013259,5,o
38,0211-699501013259,mg,o
38,0211-699501013259,orales,o
38,0211-699501013259,de,o
38,0211-699501013259,acido,i
38,0211-699501013259,folico,i
38,0211-699501013259,cada,o
38,0211-699501013259,48,o
38,0211-699501013259,horas,o
38,0211-699501013259,y,o
38,0211-699501013259,40,o
38,0211-699501013259,mg,o
38,0211-699501013259,orales,o
38,0211-699501013259,de,o
38,0211-699501013259,vitamina,i
38,0211-699501013259,B6,i
38,0211-699501013259,cada,o
38,0211-699501013259,semana,o
38,0211-699501013259,Se,o
38,0211-699501013259,determinaron,o
38,0211-699501013259,al,o
38,0211-699501013259,comienzo,o
38,0211-699501013259,del,o
38,0211-699501013259,estudio,o
38,0211-699501013259,y,o
38,0211-699501013259,cada,o
38,0211-699501013259,2,o
38,0211-699501013259,meses,o
38,0211-699501013259,niveles,i
38,0211-699501013259,de,i
38,0211-699501013259,folato,i
38,0211-699501013259,vitamina,i
38,0211-699501013259,B12,i
38,0211-699501013259,inmunoensayo,i
38,0211-699501013259,albumina,i
38,0211-699501013259,y,o
38,0211-699501013259,cinetica,o
38,0211-699501013259,de,o
38,0211-699501013259,la,o
38,0211-699501013259,urea,i
38,0211-699501013259,KTV,o
38,0211-699501013259,KRU,o
38,0211-699501013259,PCRn,o
38,0211-699501013259,y,o
38,0211-699501013259,cada,o
38,0211-699501013259,6,o
38,0211-699501013259,meses,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,HPLC,i
38,0211-699501013259,y,o
38,0211-699501013259,pp,i
38,0211-699501013259,RIA,i
38,0211-699501013259,Resultados,o
38,0211-699501013259,80,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,fueron,o
38,0211-699501013259,incluidos,o
38,0211-699501013259,en,o
38,0211-699501013259,el,o
38,0211-699501013259,estudio,o
38,0211-699501013259,basal,o
38,0211-699501013259,con,o
38,0211-699501013259,una,o
38,0211-699501013259,prevalencia,o
38,0211-699501013259,de,o
38,0211-699501013259,hiperhomocisteinemia,i
38,0211-699501013259,del,o
38,0211-699501013259,844,o
38,0211-699501013259,deficit,i
38,0211-699501013259,de,i
38,0211-699501013259,pp,i
38,0211-699501013259,en,o
38,0211-699501013259,el,o
38,0211-699501013259,32,o
38,0211-699501013259,y,o
38,0211-699501013259,folato,i
38,0211-699501013259,en,o
38,0211-699501013259,el,o
38,0211-699501013259,rango,o
38,0211-699501013259,normal,o
38,0211-699501013259,bajo,o
38,0211-699501013259,los,o
38,0211-699501013259,niveles,i
38,0211-699501013259,de,i
38,0211-699501013259,tHcy,i
38,0211-699501013259,se,o
38,0211-699501013259,correlacionaban,o
38,0211-699501013259,inversamente,o
38,0211-699501013259,con,o
38,0211-699501013259,los,o
38,0211-699501013259,del,o
38,0211-699501013259,folato,i
38,0211-699501013259,r,o
38,0211-699501013259,0336,o
38,0211-699501013259,p,o
38,0211-699501013259,001,o
38,0211-699501013259,pero,o
38,0211-699501013259,no,o
38,0211-699501013259,con,o
38,0211-699501013259,pp,i
38,0211-699501013259,B12,i
38,0211-699501013259,edad,o
38,0211-699501013259,albumina,i
38,0211-699501013259,KTV,o
38,0211-699501013259,KRU,o
38,0211-699501013259,PCRn,o
38,0211-699501013259,Cincuenta,o
38,0211-699501013259,y,o
38,0211-699501013259,ocho,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,recibieron,o
38,0211-699501013259,seis,o
38,0211-699501013259,meses,o
38,0211-699501013259,de,o
38,0211-699501013259,suplementacion,i
38,0211-699501013259,con,o
38,0211-699501013259,normalizacion,o
38,0211-699501013259,del,o
38,0211-699501013259,pp,i
38,0211-699501013259,aumento,o
38,0211-699501013259,del,o
38,0211-699501013259,folato,i
38,0211-699501013259,703,o
38,0211-699501013259,IC,o
38,0211-699501013259,638,o
38,0211-699501013259,795,o
38,0211-699501013259,vs,o
38,0211-699501013259,6181,o
38,0211-699501013259,IC,o
38,0211-699501013259,4447,o
38,0211-699501013259,7811,o
38,0211-699501013259,p,o
38,0211-699501013259,0001,o
38,0211-699501013259,y,o
38,0211-699501013259,descenso,o
38,0211-699501013259,de,o
38,0211-699501013259,la,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,240,o
38,0211-699501013259,IC,o
38,0211-699501013259,213,o
38,0211-699501013259,264,o
38,0211-699501013259,vs,o
38,0211-699501013259,199,o
38,0211-699501013259,IC,o
38,0211-699501013259,175,o
38,0211-699501013259,224,o
38,0211-699501013259,p,o
38,0211-699501013259,005,o
38,0211-699501013259,Han,o
38,0211-699501013259,recibido,o
38,0211-699501013259,suplementacion,i
38,0211-699501013259,durante,o
38,0211-699501013259,12,o
38,0211-699501013259,meses,o
38,0211-699501013259,33,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,pero,o
38,0211-699501013259,a,o
38,0211-699501013259,pesar,o
38,0211-699501013259,de,o
38,0211-699501013259,un,o
38,0211-699501013259,continuo,o
38,0211-699501013259,aumento,o
38,0211-699501013259,del,o
38,0211-699501013259,folato,i
38,0211-699501013259,10078,o
38,0211-699501013259,IC,o
38,0211-699501013259,7481,o
38,0211-699501013259,12674,o
38,0211-699501013259,p,o
38,0211-699501013259,0001,o
38,0211-699501013259,solo,o
38,0211-699501013259,3,o
38,0211-699501013259,pacientes,o
38,0211-699501013259,presentan,o
38,0211-699501013259,niveles,o
38,0211-699501013259,normales,o
38,0211-699501013259,de,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,correlacionandose,o
38,0211-699501013259,directamente,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,con,o
38,0211-699501013259,la,o
38,0211-699501013259,albumina,i
38,0211-699501013259,r,o
38,0211-699501013259,056,o
38,0211-699501013259,p,o
38,0211-699501013259,0001,o
38,0211-699501013259,que,o
38,0211-699501013259,se,o
38,0211-699501013259,elevo,o
38,0211-699501013259,con,o
38,0211-699501013259,respecto,o
38,0211-699501013259,al,o
38,0211-699501013259,inicio,o
38,0211-699501013259,337,o
38,0211-699501013259,IC,o
38,0211-699501013259,327,o
38,0211-699501013259,346,o
38,0211-699501013259,vs,o
38,0211-699501013259,350,o
38,0211-699501013259,IC,o
38,0211-699501013259,337,o
38,0211-699501013259,363,o
38,0211-699501013259,p,o
38,0211-699501013259,005,o
38,0211-699501013259,Conclusion,o
38,0211-699501013259,Tras,o
38,0211-699501013259,suplementacion,i
38,0211-699501013259,con,o
38,0211-699501013259,acido,i
38,0211-699501013259,folico,i
38,0211-699501013259,y,o
38,0211-699501013259,vitamina,i
38,0211-699501013259,B6,i
38,0211-699501013259,aunque,o
38,0211-699501013259,inicialmente,o
38,0211-699501013259,se,o
38,0211-699501013259,reduce,o
38,0211-699501013259,la,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,esta,o
38,0211-699501013259,respuesta,o
38,0211-699501013259,se,o
38,0211-699501013259,hace,o
38,0211-699501013259,refractaria,o
38,0211-699501013259,correlacionandose,o
38,0211-699501013259,directamente,o
38,0211-699501013259,la,o
38,0211-699501013259,tHcy,i
38,0211-699501013259,con,o
38,0211-699501013259,la,o
38,0211-699501013259,albumina,i
38,0211-699501013259,plasmatica,i
38,0211-699501013259,La,o
38,0211-699501013259,interpretacion,o
38,0211-699501013259,de,o
38,0211-699501013259,los,o
38,0211-699501013259,niveles,i
38,0211-699501013259,de,i
38,0211-699501013259,tHcy,i
38,0211-699501013259,debe,o
38,0211-699501013259,tener,o
38,0211-699501013259,en,o
38,0211-699501013259,cuenta,o
38,0211-699501013259,la,o
38,0211-699501013259,concentracion,i
38,0211-699501013259,de,i
38,0211-699501013259,albumina,i
39,0211-699501013259,Efecto,o
39,0211-699501013259,de,o
39,0211-699501013259,la,o
39,0211-699501013259,suplementacion,i
39,0211-699501013259,con,o
39,0211-699501013259,acido,i
39,0211-699501013259,folico,i
39,0211-699501013259,sobre,o
39,0211-699501013259,los,o
39,0211-699501013259,niveles,i
39,0211-699501013259,de,i
39,0211-699501013259,homocisteina,i
39,0211-699501013259,total,o
39,0211-699501013259,en,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,en,o
39,0211-699501013259,hemodialisis,i
39,0211-699501013259,La,o
39,0211-699501013259,hiperhomocisteinemia,i
39,0211-699501013259,es,o
39,0211-699501013259,un,o
39,0211-699501013259,marcador,o
39,0211-699501013259,de,o
39,0211-699501013259,riesgo,o
39,0211-699501013259,independiente,o
39,0211-699501013259,de,o
39,0211-699501013259,morbimortalidad,o
39,0211-699501013259,cardiovascular,i
39,0211-699501013259,Hemos,o
39,0211-699501013259,intentado,o
39,0211-699501013259,prospectivamente,o
39,0211-699501013259,reducir,o
39,0211-699501013259,los,o
39,0211-699501013259,niveles,i
39,0211-699501013259,de,i
39,0211-699501013259,homocisteina,i
39,0211-699501013259,total,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,mediante,o
39,0211-699501013259,suplemento,o
39,0211-699501013259,con,o
39,0211-699501013259,acido,i
39,0211-699501013259,folico,i
39,0211-699501013259,y,o
39,0211-699501013259,vitamina,i
39,0211-699501013259,B6,i
39,0211-699501013259,pp,i
39,0211-699501013259,valorando,o
39,0211-699501013259,su,o
39,0211-699501013259,posible,o
39,0211-699501013259,correlacion,o
39,0211-699501013259,con,o
39,0211-699501013259,dosis,o
39,0211-699501013259,de,o
39,0211-699501013259,dialisis,i
39,0211-699501013259,funcion,i
39,0211-699501013259,residual,i
39,0211-699501013259,y,o
39,0211-699501013259,parametros,o
39,0211-699501013259,nutricionales,o
39,0211-699501013259,Metodos,o
39,0211-699501013259,Todos,o
39,0211-699501013259,los,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,en,o
39,0211-699501013259,hemodialisis,i
39,0211-699501013259,al,o
39,0211-699501013259,comienzo,o
39,0211-699501013259,del,o
39,0211-699501013259,estudio,o
39,0211-699501013259,que,o
39,0211-699501013259,no,o
39,0211-699501013259,recibian,o
39,0211-699501013259,acido,i
39,0211-699501013259,folico,i
39,0211-699501013259,ni,o
39,0211-699501013259,vitamina,i
39,0211-699501013259,B6,i
39,0211-699501013259,asi,o
39,0211-699501013259,como,o
39,0211-699501013259,los,o
39,0211-699501013259,incorporados,o
39,0211-699501013259,posteriormente,o
39,0211-699501013259,a,o
39,0211-699501013259,partir,o
39,0211-699501013259,de,o
39,0211-699501013259,su,o
39,0211-699501013259,tercer,o
39,0211-699501013259,mes,o
39,0211-699501013259,en,o
39,0211-699501013259,hemodialisis,i
39,0211-699501013259,recibieron,o
39,0211-699501013259,5,o
39,0211-699501013259,mg,o
39,0211-699501013259,orales,o
39,0211-699501013259,de,o
39,0211-699501013259,acido,i
39,0211-699501013259,folico,i
39,0211-699501013259,cada,o
39,0211-699501013259,48,o
39,0211-699501013259,horas,o
39,0211-699501013259,y,o
39,0211-699501013259,40,o
39,0211-699501013259,mg,o
39,0211-699501013259,orales,o
39,0211-699501013259,de,o
39,0211-699501013259,vitamina,i
39,0211-699501013259,B6,i
39,0211-699501013259,cada,o
39,0211-699501013259,semana,o
39,0211-699501013259,Se,o
39,0211-699501013259,determinaron,o
39,0211-699501013259,al,o
39,0211-699501013259,comienzo,o
39,0211-699501013259,del,o
39,0211-699501013259,estudio,o
39,0211-699501013259,y,o
39,0211-699501013259,cada,o
39,0211-699501013259,2,o
39,0211-699501013259,meses,o
39,0211-699501013259,niveles,i
39,0211-699501013259,de,i
39,0211-699501013259,folato,i
39,0211-699501013259,vitamina,i
39,0211-699501013259,B12,i
39,0211-699501013259,inmunoensayo,i
39,0211-699501013259,albumina,i
39,0211-699501013259,y,o
39,0211-699501013259,cinetica,o
39,0211-699501013259,de,o
39,0211-699501013259,la,o
39,0211-699501013259,urea,i
39,0211-699501013259,KTV,o
39,0211-699501013259,KRU,o
39,0211-699501013259,PCRn,o
39,0211-699501013259,y,o
39,0211-699501013259,cada,o
39,0211-699501013259,6,o
39,0211-699501013259,meses,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,HPLC,i
39,0211-699501013259,y,o
39,0211-699501013259,pp,i
39,0211-699501013259,RIA,i
39,0211-699501013259,Resultados,o
39,0211-699501013259,80,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,fueron,o
39,0211-699501013259,incluidos,o
39,0211-699501013259,en,o
39,0211-699501013259,el,o
39,0211-699501013259,estudio,o
39,0211-699501013259,basal,o
39,0211-699501013259,con,o
39,0211-699501013259,una,o
39,0211-699501013259,prevalencia,o
39,0211-699501013259,de,o
39,0211-699501013259,hiperhomocisteinemia,i
39,0211-699501013259,del,o
39,0211-699501013259,844,o
39,0211-699501013259,deficit,i
39,0211-699501013259,de,i
39,0211-699501013259,pp,i
39,0211-699501013259,en,o
39,0211-699501013259,el,o
39,0211-699501013259,32,o
39,0211-699501013259,y,o
39,0211-699501013259,folato,i
39,0211-699501013259,en,o
39,0211-699501013259,el,o
39,0211-699501013259,rango,o
39,0211-699501013259,normal,o
39,0211-699501013259,bajo,o
39,0211-699501013259,los,o
39,0211-699501013259,niveles,i
39,0211-699501013259,de,i
39,0211-699501013259,tHcy,i
39,0211-699501013259,se,o
39,0211-699501013259,correlacionaban,o
39,0211-699501013259,inversamente,o
39,0211-699501013259,con,o
39,0211-699501013259,los,o
39,0211-699501013259,del,o
39,0211-699501013259,folato,i
39,0211-699501013259,r,o
39,0211-699501013259,0336,o
39,0211-699501013259,p,o
39,0211-699501013259,001,o
39,0211-699501013259,pero,o
39,0211-699501013259,no,o
39,0211-699501013259,con,o
39,0211-699501013259,pp,i
39,0211-699501013259,B12,i
39,0211-699501013259,edad,o
39,0211-699501013259,albumina,i
39,0211-699501013259,KTV,o
39,0211-699501013259,KRU,o
39,0211-699501013259,PCRn,o
39,0211-699501013259,Cincuenta,o
39,0211-699501013259,y,o
39,0211-699501013259,ocho,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,recibieron,o
39,0211-699501013259,seis,o
39,0211-699501013259,meses,o
39,0211-699501013259,de,o
39,0211-699501013259,suplementacion,i
39,0211-699501013259,con,o
39,0211-699501013259,normalizacion,o
39,0211-699501013259,del,o
39,0211-699501013259,pp,i
39,0211-699501013259,aumento,o
39,0211-699501013259,del,o
39,0211-699501013259,folato,i
39,0211-699501013259,703,o
39,0211-699501013259,IC,o
39,0211-699501013259,638,o
39,0211-699501013259,795,o
39,0211-699501013259,vs,o
39,0211-699501013259,6181,o
39,0211-699501013259,IC,o
39,0211-699501013259,4447,o
39,0211-699501013259,7811,o
39,0211-699501013259,p,o
39,0211-699501013259,0001,o
39,0211-699501013259,y,o
39,0211-699501013259,descenso,o
39,0211-699501013259,de,o
39,0211-699501013259,la,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,240,o
39,0211-699501013259,IC,o
39,0211-699501013259,213,o
39,0211-699501013259,264,o
39,0211-699501013259,vs,o
39,0211-699501013259,199,o
39,0211-699501013259,IC,o
39,0211-699501013259,175,o
39,0211-699501013259,224,o
39,0211-699501013259,p,o
39,0211-699501013259,005,o
39,0211-699501013259,Han,o
39,0211-699501013259,recibido,o
39,0211-699501013259,suplementacion,i
39,0211-699501013259,durante,o
39,0211-699501013259,12,o
39,0211-699501013259,meses,o
39,0211-699501013259,33,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,pero,o
39,0211-699501013259,a,o
39,0211-699501013259,pesar,o
39,0211-699501013259,de,o
39,0211-699501013259,un,o
39,0211-699501013259,continuo,o
39,0211-699501013259,aumento,o
39,0211-699501013259,del,o
39,0211-699501013259,folato,i
39,0211-699501013259,10078,o
39,0211-699501013259,IC,o
39,0211-699501013259,7481,o
39,0211-699501013259,12674,o
39,0211-699501013259,p,o
39,0211-699501013259,0001,o
39,0211-699501013259,solo,o
39,0211-699501013259,3,o
39,0211-699501013259,pacientes,o
39,0211-699501013259,presentan,o
39,0211-699501013259,niveles,o
39,0211-699501013259,normales,o
39,0211-699501013259,de,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,correlacionandose,o
39,0211-699501013259,directamente,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,con,o
39,0211-699501013259,la,o
39,0211-699501013259,albumina,i
39,0211-699501013259,r,o
39,0211-699501013259,056,o
39,0211-699501013259,p,o
39,0211-699501013259,0001,o
39,0211-699501013259,que,o
39,0211-699501013259,se,o
39,0211-699501013259,elevo,o
39,0211-699501013259,con,o
39,0211-699501013259,respecto,o
39,0211-699501013259,al,o
39,0211-699501013259,inicio,o
39,0211-699501013259,337,o
39,0211-699501013259,IC,o
39,0211-699501013259,327,o
39,0211-699501013259,346,o
39,0211-699501013259,vs,o
39,0211-699501013259,350,o
39,0211-699501013259,IC,o
39,0211-699501013259,337,o
39,0211-699501013259,363,o
39,0211-699501013259,p,o
39,0211-699501013259,005,o
39,0211-699501013259,Conclusion,o
39,0211-699501013259,Tras,o
39,0211-699501013259,suplementacion,i
39,0211-699501013259,con,o
39,0211-699501013259,acido,i
39,0211-699501013259,folico,i
39,0211-699501013259,y,o
39,0211-699501013259,vitamina,i
39,0211-699501013259,B6,i
39,0211-699501013259,aunque,o
39,0211-699501013259,inicialmente,o
39,0211-699501013259,se,o
39,0211-699501013259,reduce,o
39,0211-699501013259,la,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,esta,o
39,0211-699501013259,respuesta,o
39,0211-699501013259,se,o
39,0211-699501013259,hace,o
39,0211-699501013259,refractaria,o
39,0211-699501013259,correlacionandose,o
39,0211-699501013259,directamente,o
39,0211-699501013259,la,o
39,0211-699501013259,tHcy,i
39,0211-699501013259,con,o
39,0211-699501013259,la,o
39,0211-699501013259,albumina,i
39,0211-699501013259,plasmatica,i
39,0211-699501013259,La,o
39,0211-699501013259,interpretacion,o
39,0211-699501013259,de,o
39,0211-699501013259,los,o
39,0211-699501013259,niveles,i
39,0211-699501013259,de,i
39,0211-699501013259,tHcy,i
39,0211-699501013259,debe,o
39,0211-699501013259,tener,o
39,0211-699501013259,en,o
39,0211-699501013259,cuenta,o
39,0211-699501013259,la,o
39,0211-699501013259,concentracion,i
39,0211-699501013259,de,i
39,0211-699501013259,albumina,i
40,0211-699501013259,Efecto,o
40,0211-699501013259,de,o
40,0211-699501013259,la,o
40,0211-699501013259,suplementacion,i
40,0211-699501013259,con,o
40,0211-699501013259,acido,i
40,0211-699501013259,folico,i
40,0211-699501013259,sobre,o
40,0211-699501013259,los,o
40,0211-699501013259,niveles,i
40,0211-699501013259,de,i
40,0211-699501013259,homocisteina,i
40,0211-699501013259,total,o
40,0211-699501013259,en,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,en,o
40,0211-699501013259,hemodialisis,i
40,0211-699501013259,La,o
40,0211-699501013259,hiperhomocisteinemia,i
40,0211-699501013259,es,o
40,0211-699501013259,un,o
40,0211-699501013259,marcador,o
40,0211-699501013259,de,o
40,0211-699501013259,riesgo,o
40,0211-699501013259,independiente,o
40,0211-699501013259,de,o
40,0211-699501013259,morbimortalidad,o
40,0211-699501013259,cardiovascular,i
40,0211-699501013259,Hemos,o
40,0211-699501013259,intentado,o
40,0211-699501013259,prospectivamente,o
40,0211-699501013259,reducir,o
40,0211-699501013259,los,o
40,0211-699501013259,niveles,i
40,0211-699501013259,de,i
40,0211-699501013259,homocisteina,i
40,0211-699501013259,total,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,mediante,o
40,0211-699501013259,suplemento,o
40,0211-699501013259,con,o
40,0211-699501013259,acido,i
40,0211-699501013259,folico,i
40,0211-699501013259,y,o
40,0211-699501013259,vitamina,i
40,0211-699501013259,B6,i
40,0211-699501013259,pp,i
40,0211-699501013259,valorando,o
40,0211-699501013259,su,o
40,0211-699501013259,posible,o
40,0211-699501013259,correlacion,o
40,0211-699501013259,con,o
40,0211-699501013259,dosis,o
40,0211-699501013259,de,o
40,0211-699501013259,dialisis,i
40,0211-699501013259,funcion,i
40,0211-699501013259,residual,i
40,0211-699501013259,y,o
40,0211-699501013259,parametros,o
40,0211-699501013259,nutricionales,o
40,0211-699501013259,Metodos,o
40,0211-699501013259,Todos,o
40,0211-699501013259,los,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,en,o
40,0211-699501013259,hemodialisis,i
40,0211-699501013259,al,o
40,0211-699501013259,comienzo,o
40,0211-699501013259,del,o
40,0211-699501013259,estudio,o
40,0211-699501013259,que,o
40,0211-699501013259,no,o
40,0211-699501013259,recibian,o
40,0211-699501013259,acido,i
40,0211-699501013259,folico,i
40,0211-699501013259,ni,o
40,0211-699501013259,vitamina,i
40,0211-699501013259,B6,i
40,0211-699501013259,asi,o
40,0211-699501013259,como,o
40,0211-699501013259,los,o
40,0211-699501013259,incorporados,o
40,0211-699501013259,posteriormente,o
40,0211-699501013259,a,o
40,0211-699501013259,partir,o
40,0211-699501013259,de,o
40,0211-699501013259,su,o
40,0211-699501013259,tercer,o
40,0211-699501013259,mes,o
40,0211-699501013259,en,o
40,0211-699501013259,hemodialisis,i
40,0211-699501013259,recibieron,o
40,0211-699501013259,5,o
40,0211-699501013259,mg,o
40,0211-699501013259,orales,o
40,0211-699501013259,de,o
40,0211-699501013259,acido,i
40,0211-699501013259,folico,i
40,0211-699501013259,cada,o
40,0211-699501013259,48,o
40,0211-699501013259,horas,o
40,0211-699501013259,y,o
40,0211-699501013259,40,o
40,0211-699501013259,mg,o
40,0211-699501013259,orales,o
40,0211-699501013259,de,o
40,0211-699501013259,vitamina,i
40,0211-699501013259,B6,i
40,0211-699501013259,cada,o
40,0211-699501013259,semana,o
40,0211-699501013259,Se,o
40,0211-699501013259,determinaron,o
40,0211-699501013259,al,o
40,0211-699501013259,comienzo,o
40,0211-699501013259,del,o
40,0211-699501013259,estudio,o
40,0211-699501013259,y,o
40,0211-699501013259,cada,o
40,0211-699501013259,2,o
40,0211-699501013259,meses,o
40,0211-699501013259,niveles,i
40,0211-699501013259,de,i
40,0211-699501013259,folato,i
40,0211-699501013259,vitamina,i
40,0211-699501013259,B12,i
40,0211-699501013259,inmunoensayo,i
40,0211-699501013259,albumina,i
40,0211-699501013259,y,o
40,0211-699501013259,cinetica,o
40,0211-699501013259,de,o
40,0211-699501013259,la,o
40,0211-699501013259,urea,i
40,0211-699501013259,KTV,o
40,0211-699501013259,KRU,o
40,0211-699501013259,PCRn,o
40,0211-699501013259,y,o
40,0211-699501013259,cada,o
40,0211-699501013259,6,o
40,0211-699501013259,meses,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,HPLC,i
40,0211-699501013259,y,o
40,0211-699501013259,pp,i
40,0211-699501013259,RIA,i
40,0211-699501013259,Resultados,o
40,0211-699501013259,80,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,fueron,o
40,0211-699501013259,incluidos,o
40,0211-699501013259,en,o
40,0211-699501013259,el,o
40,0211-699501013259,estudio,o
40,0211-699501013259,basal,o
40,0211-699501013259,con,o
40,0211-699501013259,una,o
40,0211-699501013259,prevalencia,o
40,0211-699501013259,de,o
40,0211-699501013259,hiperhomocisteinemia,i
40,0211-699501013259,del,o
40,0211-699501013259,844,o
40,0211-699501013259,deficit,i
40,0211-699501013259,de,i
40,0211-699501013259,pp,i
40,0211-699501013259,en,o
40,0211-699501013259,el,o
40,0211-699501013259,32,o
40,0211-699501013259,y,o
40,0211-699501013259,folato,i
40,0211-699501013259,en,o
40,0211-699501013259,el,o
40,0211-699501013259,rango,o
40,0211-699501013259,normal,o
40,0211-699501013259,bajo,o
40,0211-699501013259,los,o
40,0211-699501013259,niveles,i
40,0211-699501013259,de,i
40,0211-699501013259,tHcy,i
40,0211-699501013259,se,o
40,0211-699501013259,correlacionaban,o
40,0211-699501013259,inversamente,o
40,0211-699501013259,con,o
40,0211-699501013259,los,o
40,0211-699501013259,del,o
40,0211-699501013259,folato,i
40,0211-699501013259,r,o
40,0211-699501013259,0336,o
40,0211-699501013259,p,o
40,0211-699501013259,001,o
40,0211-699501013259,pero,o
40,0211-699501013259,no,o
40,0211-699501013259,con,o
40,0211-699501013259,pp,i
40,0211-699501013259,B12,i
40,0211-699501013259,edad,o
40,0211-699501013259,albumina,i
40,0211-699501013259,KTV,o
40,0211-699501013259,KRU,o
40,0211-699501013259,PCRn,o
40,0211-699501013259,Cincuenta,o
40,0211-699501013259,y,o
40,0211-699501013259,ocho,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,recibieron,o
40,0211-699501013259,seis,o
40,0211-699501013259,meses,o
40,0211-699501013259,de,o
40,0211-699501013259,suplementacion,i
40,0211-699501013259,con,o
40,0211-699501013259,normalizacion,o
40,0211-699501013259,del,o
40,0211-699501013259,pp,i
40,0211-699501013259,aumento,o
40,0211-699501013259,del,o
40,0211-699501013259,folato,i
40,0211-699501013259,703,o
40,0211-699501013259,IC,o
40,0211-699501013259,638,o
40,0211-699501013259,795,o
40,0211-699501013259,vs,o
40,0211-699501013259,6181,o
40,0211-699501013259,IC,o
40,0211-699501013259,4447,o
40,0211-699501013259,7811,o
40,0211-699501013259,p,o
40,0211-699501013259,0001,o
40,0211-699501013259,y,o
40,0211-699501013259,descenso,o
40,0211-699501013259,de,o
40,0211-699501013259,la,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,240,o
40,0211-699501013259,IC,o
40,0211-699501013259,213,o
40,0211-699501013259,264,o
40,0211-699501013259,vs,o
40,0211-699501013259,199,o
40,0211-699501013259,IC,o
40,0211-699501013259,175,o
40,0211-699501013259,224,o
40,0211-699501013259,p,o
40,0211-699501013259,005,o
40,0211-699501013259,Han,o
40,0211-699501013259,recibido,o
40,0211-699501013259,suplementacion,i
40,0211-699501013259,durante,o
40,0211-699501013259,12,o
40,0211-699501013259,meses,o
40,0211-699501013259,33,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,pero,o
40,0211-699501013259,a,o
40,0211-699501013259,pesar,o
40,0211-699501013259,de,o
40,0211-699501013259,un,o
40,0211-699501013259,continuo,o
40,0211-699501013259,aumento,o
40,0211-699501013259,del,o
40,0211-699501013259,folato,i
40,0211-699501013259,10078,o
40,0211-699501013259,IC,o
40,0211-699501013259,7481,o
40,0211-699501013259,12674,o
40,0211-699501013259,p,o
40,0211-699501013259,0001,o
40,0211-699501013259,solo,o
40,0211-699501013259,3,o
40,0211-699501013259,pacientes,o
40,0211-699501013259,presentan,o
40,0211-699501013259,niveles,o
40,0211-699501013259,normales,o
40,0211-699501013259,de,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,correlacionandose,o
40,0211-699501013259,directamente,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,con,o
40,0211-699501013259,la,o
40,0211-699501013259,albumina,i
40,0211-699501013259,r,o
40,0211-699501013259,056,o
40,0211-699501013259,p,o
40,0211-699501013259,0001,o
40,0211-699501013259,que,o
40,0211-699501013259,se,o
40,0211-699501013259,elevo,o
40,0211-699501013259,con,o
40,0211-699501013259,respecto,o
40,0211-699501013259,al,o
40,0211-699501013259,inicio,o
40,0211-699501013259,337,o
40,0211-699501013259,IC,o
40,0211-699501013259,327,o
40,0211-699501013259,346,o
40,0211-699501013259,vs,o
40,0211-699501013259,350,o
40,0211-699501013259,IC,o
40,0211-699501013259,337,o
40,0211-699501013259,363,o
40,0211-699501013259,p,o
40,0211-699501013259,005,o
40,0211-699501013259,Conclusion,o
40,0211-699501013259,Tras,o
40,0211-699501013259,suplementacion,i
40,0211-699501013259,con,o
40,0211-699501013259,acido,i
40,0211-699501013259,folico,i
40,0211-699501013259,y,o
40,0211-699501013259,vitamina,i
40,0211-699501013259,B6,i
40,0211-699501013259,aunque,o
40,0211-699501013259,inicialmente,o
40,0211-699501013259,se,o
40,0211-699501013259,reduce,o
40,0211-699501013259,la,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,esta,o
40,0211-699501013259,respuesta,o
40,0211-699501013259,se,o
40,0211-699501013259,hace,o
40,0211-699501013259,refractaria,o
40,0211-699501013259,correlacionandose,o
40,0211-699501013259,directamente,o
40,0211-699501013259,la,o
40,0211-699501013259,tHcy,i
40,0211-699501013259,con,o
40,0211-699501013259,la,o
40,0211-699501013259,albumina,i
40,0211-699501013259,plasmatica,i
40,0211-699501013259,La,o
40,0211-699501013259,interpretacion,o
40,0211-699501013259,de,o
40,0211-699501013259,los,o
40,0211-699501013259,niveles,i
40,0211-699501013259,de,i
40,0211-699501013259,tHcy,i
40,0211-699501013259,debe,o
40,0211-699501013259,tener,o
40,0211-699501013259,en,o
40,0211-699501013259,cuenta,o
40,0211-699501013259,la,o
40,0211-699501013259,concentracion,i
40,0211-699501013259,de,i
40,0211-699501013259,albumina,i
41,0211-699501013259,Efecto,o
41,0211-699501013259,de,o
41,0211-699501013259,la,o
41,0211-699501013259,suplementacion,i
41,0211-699501013259,con,o
41,0211-699501013259,acido,i
41,0211-699501013259,folico,i
41,0211-699501013259,sobre,o
41,0211-699501013259,los,o
41,0211-699501013259,niveles,i
41,0211-699501013259,de,i
41,0211-699501013259,homocisteina,i
41,0211-699501013259,total,o
41,0211-699501013259,en,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,en,o
41,0211-699501013259,hemodialisis,i
41,0211-699501013259,La,o
41,0211-699501013259,hiperhomocisteinemia,i
41,0211-699501013259,es,o
41,0211-699501013259,un,o
41,0211-699501013259,marcador,o
41,0211-699501013259,de,o
41,0211-699501013259,riesgo,o
41,0211-699501013259,independiente,o
41,0211-699501013259,de,o
41,0211-699501013259,morbimortalidad,o
41,0211-699501013259,cardiovascular,i
41,0211-699501013259,Hemos,o
41,0211-699501013259,intentado,o
41,0211-699501013259,prospectivamente,o
41,0211-699501013259,reducir,o
41,0211-699501013259,los,o
41,0211-699501013259,niveles,i
41,0211-699501013259,de,i
41,0211-699501013259,homocisteina,i
41,0211-699501013259,total,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,mediante,o
41,0211-699501013259,suplemento,o
41,0211-699501013259,con,o
41,0211-699501013259,acido,i
41,0211-699501013259,folico,i
41,0211-699501013259,y,o
41,0211-699501013259,vitamina,i
41,0211-699501013259,B6,i
41,0211-699501013259,pp,i
41,0211-699501013259,valorando,o
41,0211-699501013259,su,o
41,0211-699501013259,posible,o
41,0211-699501013259,correlacion,o
41,0211-699501013259,con,o
41,0211-699501013259,dosis,o
41,0211-699501013259,de,o
41,0211-699501013259,dialisis,i
41,0211-699501013259,funcion,i
41,0211-699501013259,residual,i
41,0211-699501013259,y,o
41,0211-699501013259,parametros,o
41,0211-699501013259,nutricionales,o
41,0211-699501013259,Metodos,o
41,0211-699501013259,Todos,o
41,0211-699501013259,los,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,en,o
41,0211-699501013259,hemodialisis,i
41,0211-699501013259,al,o
41,0211-699501013259,comienzo,o
41,0211-699501013259,del,o
41,0211-699501013259,estudio,o
41,0211-699501013259,que,o
41,0211-699501013259,no,o
41,0211-699501013259,recibian,o
41,0211-699501013259,acido,i
41,0211-699501013259,folico,i
41,0211-699501013259,ni,o
41,0211-699501013259,vitamina,i
41,0211-699501013259,B6,i
41,0211-699501013259,asi,o
41,0211-699501013259,como,o
41,0211-699501013259,los,o
41,0211-699501013259,incorporados,o
41,0211-699501013259,posteriormente,o
41,0211-699501013259,a,o
41,0211-699501013259,partir,o
41,0211-699501013259,de,o
41,0211-699501013259,su,o
41,0211-699501013259,tercer,o
41,0211-699501013259,mes,o
41,0211-699501013259,en,o
41,0211-699501013259,hemodialisis,i
41,0211-699501013259,recibieron,o
41,0211-699501013259,5,o
41,0211-699501013259,mg,o
41,0211-699501013259,orales,o
41,0211-699501013259,de,o
41,0211-699501013259,acido,i
41,0211-699501013259,folico,i
41,0211-699501013259,cada,o
41,0211-699501013259,48,o
41,0211-699501013259,horas,o
41,0211-699501013259,y,o
41,0211-699501013259,40,o
41,0211-699501013259,mg,o
41,0211-699501013259,orales,o
41,0211-699501013259,de,o
41,0211-699501013259,vitamina,i
41,0211-699501013259,B6,i
41,0211-699501013259,cada,o
41,0211-699501013259,semana,o
41,0211-699501013259,Se,o
41,0211-699501013259,determinaron,o
41,0211-699501013259,al,o
41,0211-699501013259,comienzo,o
41,0211-699501013259,del,o
41,0211-699501013259,estudio,o
41,0211-699501013259,y,o
41,0211-699501013259,cada,o
41,0211-699501013259,2,o
41,0211-699501013259,meses,o
41,0211-699501013259,niveles,i
41,0211-699501013259,de,i
41,0211-699501013259,folato,i
41,0211-699501013259,vitamina,i
41,0211-699501013259,B12,i
41,0211-699501013259,inmunoensayo,i
41,0211-699501013259,albumina,i
41,0211-699501013259,y,o
41,0211-699501013259,cinetica,o
41,0211-699501013259,de,o
41,0211-699501013259,la,o
41,0211-699501013259,urea,i
41,0211-699501013259,KTV,o
41,0211-699501013259,KRU,o
41,0211-699501013259,PCRn,o
41,0211-699501013259,y,o
41,0211-699501013259,cada,o
41,0211-699501013259,6,o
41,0211-699501013259,meses,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,HPLC,i
41,0211-699501013259,y,o
41,0211-699501013259,pp,i
41,0211-699501013259,RIA,i
41,0211-699501013259,Resultados,o
41,0211-699501013259,80,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,fueron,o
41,0211-699501013259,incluidos,o
41,0211-699501013259,en,o
41,0211-699501013259,el,o
41,0211-699501013259,estudio,o
41,0211-699501013259,basal,o
41,0211-699501013259,con,o
41,0211-699501013259,una,o
41,0211-699501013259,prevalencia,o
41,0211-699501013259,de,o
41,0211-699501013259,hiperhomocisteinemia,i
41,0211-699501013259,del,o
41,0211-699501013259,844,o
41,0211-699501013259,deficit,i
41,0211-699501013259,de,i
41,0211-699501013259,pp,i
41,0211-699501013259,en,o
41,0211-699501013259,el,o
41,0211-699501013259,32,o
41,0211-699501013259,y,o
41,0211-699501013259,folato,i
41,0211-699501013259,en,o
41,0211-699501013259,el,o
41,0211-699501013259,rango,o
41,0211-699501013259,normal,o
41,0211-699501013259,bajo,o
41,0211-699501013259,los,o
41,0211-699501013259,niveles,i
41,0211-699501013259,de,i
41,0211-699501013259,tHcy,i
41,0211-699501013259,se,o
41,0211-699501013259,correlacionaban,o
41,0211-699501013259,inversamente,o
41,0211-699501013259,con,o
41,0211-699501013259,los,o
41,0211-699501013259,del,o
41,0211-699501013259,folato,i
41,0211-699501013259,r,o
41,0211-699501013259,0336,o
41,0211-699501013259,p,o
41,0211-699501013259,001,o
41,0211-699501013259,pero,o
41,0211-699501013259,no,o
41,0211-699501013259,con,o
41,0211-699501013259,pp,i
41,0211-699501013259,B12,i
41,0211-699501013259,edad,o
41,0211-699501013259,albumina,i
41,0211-699501013259,KTV,o
41,0211-699501013259,KRU,o
41,0211-699501013259,PCRn,o
41,0211-699501013259,Cincuenta,o
41,0211-699501013259,y,o
41,0211-699501013259,ocho,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,recibieron,o
41,0211-699501013259,seis,o
41,0211-699501013259,meses,o
41,0211-699501013259,de,o
41,0211-699501013259,suplementacion,i
41,0211-699501013259,con,o
41,0211-699501013259,normalizacion,o
41,0211-699501013259,del,o
41,0211-699501013259,pp,i
41,0211-699501013259,aumento,o
41,0211-699501013259,del,o
41,0211-699501013259,folato,i
41,0211-699501013259,703,o
41,0211-699501013259,IC,o
41,0211-699501013259,638,o
41,0211-699501013259,795,o
41,0211-699501013259,vs,o
41,0211-699501013259,6181,o
41,0211-699501013259,IC,o
41,0211-699501013259,4447,o
41,0211-699501013259,7811,o
41,0211-699501013259,p,o
41,0211-699501013259,0001,o
41,0211-699501013259,y,o
41,0211-699501013259,descenso,o
41,0211-699501013259,de,o
41,0211-699501013259,la,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,240,o
41,0211-699501013259,IC,o
41,0211-699501013259,213,o
41,0211-699501013259,264,o
41,0211-699501013259,vs,o
41,0211-699501013259,199,o
41,0211-699501013259,IC,o
41,0211-699501013259,175,o
41,0211-699501013259,224,o
41,0211-699501013259,p,o
41,0211-699501013259,005,o
41,0211-699501013259,Han,o
41,0211-699501013259,recibido,o
41,0211-699501013259,suplementacion,i
41,0211-699501013259,durante,o
41,0211-699501013259,12,o
41,0211-699501013259,meses,o
41,0211-699501013259,33,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,pero,o
41,0211-699501013259,a,o
41,0211-699501013259,pesar,o
41,0211-699501013259,de,o
41,0211-699501013259,un,o
41,0211-699501013259,continuo,o
41,0211-699501013259,aumento,o
41,0211-699501013259,del,o
41,0211-699501013259,folato,i
41,0211-699501013259,10078,o
41,0211-699501013259,IC,o
41,0211-699501013259,7481,o
41,0211-699501013259,12674,o
41,0211-699501013259,p,o
41,0211-699501013259,0001,o
41,0211-699501013259,solo,o
41,0211-699501013259,3,o
41,0211-699501013259,pacientes,o
41,0211-699501013259,presentan,o
41,0211-699501013259,niveles,o
41,0211-699501013259,normales,o
41,0211-699501013259,de,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,correlacionandose,o
41,0211-699501013259,directamente,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,con,o
41,0211-699501013259,la,o
41,0211-699501013259,albumina,i
41,0211-699501013259,r,o
41,0211-699501013259,056,o
41,0211-699501013259,p,o
41,0211-699501013259,0001,o
41,0211-699501013259,que,o
41,0211-699501013259,se,o
41,0211-699501013259,elevo,o
41,0211-699501013259,con,o
41,0211-699501013259,respecto,o
41,0211-699501013259,al,o
41,0211-699501013259,inicio,o
41,0211-699501013259,337,o
41,0211-699501013259,IC,o
41,0211-699501013259,327,o
41,0211-699501013259,346,o
41,0211-699501013259,vs,o
41,0211-699501013259,350,o
41,0211-699501013259,IC,o
41,0211-699501013259,337,o
41,0211-699501013259,363,o
41,0211-699501013259,p,o
41,0211-699501013259,005,o
41,0211-699501013259,Conclusion,o
41,0211-699501013259,Tras,o
41,0211-699501013259,suplementacion,i
41,0211-699501013259,con,o
41,0211-699501013259,acido,i
41,0211-699501013259,folico,i
41,0211-699501013259,y,o
41,0211-699501013259,vitamina,i
41,0211-699501013259,B6,i
41,0211-699501013259,aunque,o
41,0211-699501013259,inicialmente,o
41,0211-699501013259,se,o
41,0211-699501013259,reduce,o
41,0211-699501013259,la,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,esta,o
41,0211-699501013259,respuesta,o
41,0211-699501013259,se,o
41,0211-699501013259,hace,o
41,0211-699501013259,refractaria,o
41,0211-699501013259,correlacionandose,o
41,0211-699501013259,directamente,o
41,0211-699501013259,la,o
41,0211-699501013259,tHcy,i
41,0211-699501013259,con,o
41,0211-699501013259,la,o
41,0211-699501013259,albumina,i
41,0211-699501013259,plasmatica,i
41,0211-699501013259,La,o
41,0211-699501013259,interpretacion,o
41,0211-699501013259,de,o
41,0211-699501013259,los,o
41,0211-699501013259,niveles,i
41,0211-699501013259,de,i
41,0211-699501013259,tHcy,i
41,0211-699501013259,debe,o
41,0211-699501013259,tener,o
41,0211-699501013259,en,o
41,0211-699501013259,cuenta,o
41,0211-699501013259,la,o
41,0211-699501013259,concentracion,i
41,0211-699501013259,de,i
41,0211-699501013259,albumina,i
42,0211-699501013259,Efecto,o
42,0211-699501013259,de,o
42,0211-699501013259,la,o
42,0211-699501013259,suplementacion,i
42,0211-699501013259,con,o
42,0211-699501013259,acido,i
42,0211-699501013259,folico,i
42,0211-699501013259,sobre,o
42,0211-699501013259,los,o
42,0211-699501013259,niveles,i
42,0211-699501013259,de,i
42,0211-699501013259,homocisteina,i
42,0211-699501013259,total,o
42,0211-699501013259,en,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,en,o
42,0211-699501013259,hemodialisis,i
42,0211-699501013259,La,o
42,0211-699501013259,hiperhomocisteinemia,i
42,0211-699501013259,es,o
42,0211-699501013259,un,o
42,0211-699501013259,marcador,o
42,0211-699501013259,de,o
42,0211-699501013259,riesgo,o
42,0211-699501013259,independiente,o
42,0211-699501013259,de,o
42,0211-699501013259,morbimortalidad,o
42,0211-699501013259,cardiovascular,i
42,0211-699501013259,Hemos,o
42,0211-699501013259,intentado,o
42,0211-699501013259,prospectivamente,o
42,0211-699501013259,reducir,o
42,0211-699501013259,los,o
42,0211-699501013259,niveles,i
42,0211-699501013259,de,i
42,0211-699501013259,homocisteina,i
42,0211-699501013259,total,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,mediante,o
42,0211-699501013259,suplemento,o
42,0211-699501013259,con,o
42,0211-699501013259,acido,i
42,0211-699501013259,folico,i
42,0211-699501013259,y,o
42,0211-699501013259,vitamina,i
42,0211-699501013259,B6,i
42,0211-699501013259,pp,i
42,0211-699501013259,valorando,o
42,0211-699501013259,su,o
42,0211-699501013259,posible,o
42,0211-699501013259,correlacion,o
42,0211-699501013259,con,o
42,0211-699501013259,dosis,o
42,0211-699501013259,de,o
42,0211-699501013259,dialisis,i
42,0211-699501013259,funcion,i
42,0211-699501013259,residual,i
42,0211-699501013259,y,o
42,0211-699501013259,parametros,o
42,0211-699501013259,nutricionales,o
42,0211-699501013259,Metodos,o
42,0211-699501013259,Todos,o
42,0211-699501013259,los,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,en,o
42,0211-699501013259,hemodialisis,i
42,0211-699501013259,al,o
42,0211-699501013259,comienzo,o
42,0211-699501013259,del,o
42,0211-699501013259,estudio,o
42,0211-699501013259,que,o
42,0211-699501013259,no,o
42,0211-699501013259,recibian,o
42,0211-699501013259,acido,i
42,0211-699501013259,folico,i
42,0211-699501013259,ni,o
42,0211-699501013259,vitamina,i
42,0211-699501013259,B6,i
42,0211-699501013259,asi,o
42,0211-699501013259,como,o
42,0211-699501013259,los,o
42,0211-699501013259,incorporados,o
42,0211-699501013259,posteriormente,o
42,0211-699501013259,a,o
42,0211-699501013259,partir,o
42,0211-699501013259,de,o
42,0211-699501013259,su,o
42,0211-699501013259,tercer,o
42,0211-699501013259,mes,o
42,0211-699501013259,en,o
42,0211-699501013259,hemodialisis,i
42,0211-699501013259,recibieron,o
42,0211-699501013259,5,o
42,0211-699501013259,mg,o
42,0211-699501013259,orales,o
42,0211-699501013259,de,o
42,0211-699501013259,acido,i
42,0211-699501013259,folico,i
42,0211-699501013259,cada,o
42,0211-699501013259,48,o
42,0211-699501013259,horas,o
42,0211-699501013259,y,o
42,0211-699501013259,40,o
42,0211-699501013259,mg,o
42,0211-699501013259,orales,o
42,0211-699501013259,de,o
42,0211-699501013259,vitamina,i
42,0211-699501013259,B6,i
42,0211-699501013259,cada,o
42,0211-699501013259,semana,o
42,0211-699501013259,Se,o
42,0211-699501013259,determinaron,o
42,0211-699501013259,al,o
42,0211-699501013259,comienzo,o
42,0211-699501013259,del,o
42,0211-699501013259,estudio,o
42,0211-699501013259,y,o
42,0211-699501013259,cada,o
42,0211-699501013259,2,o
42,0211-699501013259,meses,o
42,0211-699501013259,niveles,i
42,0211-699501013259,de,i
42,0211-699501013259,folato,i
42,0211-699501013259,vitamina,i
42,0211-699501013259,B12,i
42,0211-699501013259,inmunoensayo,i
42,0211-699501013259,albumina,i
42,0211-699501013259,y,o
42,0211-699501013259,cinetica,o
42,0211-699501013259,de,o
42,0211-699501013259,la,o
42,0211-699501013259,urea,i
42,0211-699501013259,KTV,o
42,0211-699501013259,KRU,o
42,0211-699501013259,PCRn,o
42,0211-699501013259,y,o
42,0211-699501013259,cada,o
42,0211-699501013259,6,o
42,0211-699501013259,meses,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,HPLC,i
42,0211-699501013259,y,o
42,0211-699501013259,pp,i
42,0211-699501013259,RIA,i
42,0211-699501013259,Resultados,o
42,0211-699501013259,80,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,fueron,o
42,0211-699501013259,incluidos,o
42,0211-699501013259,en,o
42,0211-699501013259,el,o
42,0211-699501013259,estudio,o
42,0211-699501013259,basal,o
42,0211-699501013259,con,o
42,0211-699501013259,una,o
42,0211-699501013259,prevalencia,o
42,0211-699501013259,de,o
42,0211-699501013259,hiperhomocisteinemia,i
42,0211-699501013259,del,o
42,0211-699501013259,844,o
42,0211-699501013259,deficit,i
42,0211-699501013259,de,i
42,0211-699501013259,pp,i
42,0211-699501013259,en,o
42,0211-699501013259,el,o
42,0211-699501013259,32,o
42,0211-699501013259,y,o
42,0211-699501013259,folato,i
42,0211-699501013259,en,o
42,0211-699501013259,el,o
42,0211-699501013259,rango,o
42,0211-699501013259,normal,o
42,0211-699501013259,bajo,o
42,0211-699501013259,los,o
42,0211-699501013259,niveles,i
42,0211-699501013259,de,i
42,0211-699501013259,tHcy,i
42,0211-699501013259,se,o
42,0211-699501013259,correlacionaban,o
42,0211-699501013259,inversamente,o
42,0211-699501013259,con,o
42,0211-699501013259,los,o
42,0211-699501013259,del,o
42,0211-699501013259,folato,i
42,0211-699501013259,r,o
42,0211-699501013259,0336,o
42,0211-699501013259,p,o
42,0211-699501013259,001,o
42,0211-699501013259,pero,o
42,0211-699501013259,no,o
42,0211-699501013259,con,o
42,0211-699501013259,pp,i
42,0211-699501013259,B12,i
42,0211-699501013259,edad,o
42,0211-699501013259,albumina,i
42,0211-699501013259,KTV,o
42,0211-699501013259,KRU,o
42,0211-699501013259,PCRn,o
42,0211-699501013259,Cincuenta,o
42,0211-699501013259,y,o
42,0211-699501013259,ocho,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,recibieron,o
42,0211-699501013259,seis,o
42,0211-699501013259,meses,o
42,0211-699501013259,de,o
42,0211-699501013259,suplementacion,i
42,0211-699501013259,con,o
42,0211-699501013259,normalizacion,o
42,0211-699501013259,del,o
42,0211-699501013259,pp,i
42,0211-699501013259,aumento,o
42,0211-699501013259,del,o
42,0211-699501013259,folato,i
42,0211-699501013259,703,o
42,0211-699501013259,IC,o
42,0211-699501013259,638,o
42,0211-699501013259,795,o
42,0211-699501013259,vs,o
42,0211-699501013259,6181,o
42,0211-699501013259,IC,o
42,0211-699501013259,4447,o
42,0211-699501013259,7811,o
42,0211-699501013259,p,o
42,0211-699501013259,0001,o
42,0211-699501013259,y,o
42,0211-699501013259,descenso,o
42,0211-699501013259,de,o
42,0211-699501013259,la,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,240,o
42,0211-699501013259,IC,o
42,0211-699501013259,213,o
42,0211-699501013259,264,o
42,0211-699501013259,vs,o
42,0211-699501013259,199,o
42,0211-699501013259,IC,o
42,0211-699501013259,175,o
42,0211-699501013259,224,o
42,0211-699501013259,p,o
42,0211-699501013259,005,o
42,0211-699501013259,Han,o
42,0211-699501013259,recibido,o
42,0211-699501013259,suplementacion,i
42,0211-699501013259,durante,o
42,0211-699501013259,12,o
42,0211-699501013259,meses,o
42,0211-699501013259,33,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,pero,o
42,0211-699501013259,a,o
42,0211-699501013259,pesar,o
42,0211-699501013259,de,o
42,0211-699501013259,un,o
42,0211-699501013259,continuo,o
42,0211-699501013259,aumento,o
42,0211-699501013259,del,o
42,0211-699501013259,folato,i
42,0211-699501013259,10078,o
42,0211-699501013259,IC,o
42,0211-699501013259,7481,o
42,0211-699501013259,12674,o
42,0211-699501013259,p,o
42,0211-699501013259,0001,o
42,0211-699501013259,solo,o
42,0211-699501013259,3,o
42,0211-699501013259,pacientes,o
42,0211-699501013259,presentan,o
42,0211-699501013259,niveles,o
42,0211-699501013259,normales,o
42,0211-699501013259,de,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,correlacionandose,o
42,0211-699501013259,directamente,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,con,o
42,0211-699501013259,la,o
42,0211-699501013259,albumina,i
42,0211-699501013259,r,o
42,0211-699501013259,056,o
42,0211-699501013259,p,o
42,0211-699501013259,0001,o
42,0211-699501013259,que,o
42,0211-699501013259,se,o
42,0211-699501013259,elevo,o
42,0211-699501013259,con,o
42,0211-699501013259,respecto,o
42,0211-699501013259,al,o
42,0211-699501013259,inicio,o
42,0211-699501013259,337,o
42,0211-699501013259,IC,o
42,0211-699501013259,327,o
42,0211-699501013259,346,o
42,0211-699501013259,vs,o
42,0211-699501013259,350,o
42,0211-699501013259,IC,o
42,0211-699501013259,337,o
42,0211-699501013259,363,o
42,0211-699501013259,p,o
42,0211-699501013259,005,o
42,0211-699501013259,Conclusion,o
42,0211-699501013259,Tras,o
42,0211-699501013259,suplementacion,i
42,0211-699501013259,con,o
42,0211-699501013259,acido,i
42,0211-699501013259,folico,i
42,0211-699501013259,y,o
42,0211-699501013259,vitamina,i
42,0211-699501013259,B6,i
42,0211-699501013259,aunque,o
42,0211-699501013259,inicialmente,o
42,0211-699501013259,se,o
42,0211-699501013259,reduce,o
42,0211-699501013259,la,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,esta,o
42,0211-699501013259,respuesta,o
42,0211-699501013259,se,o
42,0211-699501013259,hace,o
42,0211-699501013259,refractaria,o
42,0211-699501013259,correlacionandose,o
42,0211-699501013259,directamente,o
42,0211-699501013259,la,o
42,0211-699501013259,tHcy,i
42,0211-699501013259,con,o
42,0211-699501013259,la,o
42,0211-699501013259,albumina,i
42,0211-699501013259,plasmatica,i
42,0211-699501013259,La,o
42,0211-699501013259,interpretacion,o
42,0211-699501013259,de,o
42,0211-699501013259,los,o
42,0211-699501013259,niveles,i
42,0211-699501013259,de,i
42,0211-699501013259,tHcy,i
42,0211-699501013259,debe,o
42,0211-699501013259,tener,o
42,0211-699501013259,en,o
42,0211-699501013259,cuenta,o
42,0211-699501013259,la,o
42,0211-699501013259,concentracion,i
42,0211-699501013259,de,i
42,0211-699501013259,albumina,i
43,0211-699501013259,Efecto,o
43,0211-699501013259,de,o
43,0211-699501013259,la,o
43,0211-699501013259,suplementacion,i
43,0211-699501013259,con,o
43,0211-699501013259,acido,i
43,0211-699501013259,folico,i
43,0211-699501013259,sobre,o
43,0211-699501013259,los,o
43,0211-699501013259,niveles,i
43,0211-699501013259,de,i
43,0211-699501013259,homocisteina,i
43,0211-699501013259,total,o
43,0211-699501013259,en,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,en,o
43,0211-699501013259,hemodialisis,i
43,0211-699501013259,La,o
43,0211-699501013259,hiperhomocisteinemia,i
43,0211-699501013259,es,o
43,0211-699501013259,un,o
43,0211-699501013259,marcador,o
43,0211-699501013259,de,o
43,0211-699501013259,riesgo,o
43,0211-699501013259,independiente,o
43,0211-699501013259,de,o
43,0211-699501013259,morbimortalidad,o
43,0211-699501013259,cardiovascular,i
43,0211-699501013259,Hemos,o
43,0211-699501013259,intentado,o
43,0211-699501013259,prospectivamente,o
43,0211-699501013259,reducir,o
43,0211-699501013259,los,o
43,0211-699501013259,niveles,i
43,0211-699501013259,de,i
43,0211-699501013259,homocisteina,i
43,0211-699501013259,total,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,mediante,o
43,0211-699501013259,suplemento,o
43,0211-699501013259,con,o
43,0211-699501013259,acido,i
43,0211-699501013259,folico,i
43,0211-699501013259,y,o
43,0211-699501013259,vitamina,i
43,0211-699501013259,B6,i
43,0211-699501013259,pp,i
43,0211-699501013259,valorando,o
43,0211-699501013259,su,o
43,0211-699501013259,posible,o
43,0211-699501013259,correlacion,o
43,0211-699501013259,con,o
43,0211-699501013259,dosis,o
43,0211-699501013259,de,o
43,0211-699501013259,dialisis,i
43,0211-699501013259,funcion,i
43,0211-699501013259,residual,i
43,0211-699501013259,y,o
43,0211-699501013259,parametros,o
43,0211-699501013259,nutricionales,o
43,0211-699501013259,Metodos,o
43,0211-699501013259,Todos,o
43,0211-699501013259,los,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,en,o
43,0211-699501013259,hemodialisis,i
43,0211-699501013259,al,o
43,0211-699501013259,comienzo,o
43,0211-699501013259,del,o
43,0211-699501013259,estudio,o
43,0211-699501013259,que,o
43,0211-699501013259,no,o
43,0211-699501013259,recibian,o
43,0211-699501013259,acido,i
43,0211-699501013259,folico,i
43,0211-699501013259,ni,o
43,0211-699501013259,vitamina,i
43,0211-699501013259,B6,i
43,0211-699501013259,asi,o
43,0211-699501013259,como,o
43,0211-699501013259,los,o
43,0211-699501013259,incorporados,o
43,0211-699501013259,posteriormente,o
43,0211-699501013259,a,o
43,0211-699501013259,partir,o
43,0211-699501013259,de,o
43,0211-699501013259,su,o
43,0211-699501013259,tercer,o
43,0211-699501013259,mes,o
43,0211-699501013259,en,o
43,0211-699501013259,hemodialisis,i
43,0211-699501013259,recibieron,o
43,0211-699501013259,5,o
43,0211-699501013259,mg,o
43,0211-699501013259,orales,o
43,0211-699501013259,de,o
43,0211-699501013259,acido,i
43,0211-699501013259,folico,i
43,0211-699501013259,cada,o
43,0211-699501013259,48,o
43,0211-699501013259,horas,o
43,0211-699501013259,y,o
43,0211-699501013259,40,o
43,0211-699501013259,mg,o
43,0211-699501013259,orales,o
43,0211-699501013259,de,o
43,0211-699501013259,vitamina,i
43,0211-699501013259,B6,i
43,0211-699501013259,cada,o
43,0211-699501013259,semana,o
43,0211-699501013259,Se,o
43,0211-699501013259,determinaron,o
43,0211-699501013259,al,o
43,0211-699501013259,comienzo,o
43,0211-699501013259,del,o
43,0211-699501013259,estudio,o
43,0211-699501013259,y,o
43,0211-699501013259,cada,o
43,0211-699501013259,2,o
43,0211-699501013259,meses,o
43,0211-699501013259,niveles,i
43,0211-699501013259,de,i
43,0211-699501013259,folato,i
43,0211-699501013259,vitamina,i
43,0211-699501013259,B12,i
43,0211-699501013259,inmunoensayo,i
43,0211-699501013259,albumina,i
43,0211-699501013259,y,o
43,0211-699501013259,cinetica,o
43,0211-699501013259,de,o
43,0211-699501013259,la,o
43,0211-699501013259,urea,i
43,0211-699501013259,KTV,o
43,0211-699501013259,KRU,o
43,0211-699501013259,PCRn,o
43,0211-699501013259,y,o
43,0211-699501013259,cada,o
43,0211-699501013259,6,o
43,0211-699501013259,meses,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,HPLC,i
43,0211-699501013259,y,o
43,0211-699501013259,pp,i
43,0211-699501013259,RIA,i
43,0211-699501013259,Resultados,o
43,0211-699501013259,80,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,fueron,o
43,0211-699501013259,incluidos,o
43,0211-699501013259,en,o
43,0211-699501013259,el,o
43,0211-699501013259,estudio,o
43,0211-699501013259,basal,o
43,0211-699501013259,con,o
43,0211-699501013259,una,o
43,0211-699501013259,prevalencia,o
43,0211-699501013259,de,o
43,0211-699501013259,hiperhomocisteinemia,i
43,0211-699501013259,del,o
43,0211-699501013259,844,o
43,0211-699501013259,deficit,i
43,0211-699501013259,de,i
43,0211-699501013259,pp,i
43,0211-699501013259,en,o
43,0211-699501013259,el,o
43,0211-699501013259,32,o
43,0211-699501013259,y,o
43,0211-699501013259,folato,i
43,0211-699501013259,en,o
43,0211-699501013259,el,o
43,0211-699501013259,rango,o
43,0211-699501013259,normal,o
43,0211-699501013259,bajo,o
43,0211-699501013259,los,o
43,0211-699501013259,niveles,i
43,0211-699501013259,de,i
43,0211-699501013259,tHcy,i
43,0211-699501013259,se,o
43,0211-699501013259,correlacionaban,o
43,0211-699501013259,inversamente,o
43,0211-699501013259,con,o
43,0211-699501013259,los,o
43,0211-699501013259,del,o
43,0211-699501013259,folato,i
43,0211-699501013259,r,o
43,0211-699501013259,0336,o
43,0211-699501013259,p,o
43,0211-699501013259,001,o
43,0211-699501013259,pero,o
43,0211-699501013259,no,o
43,0211-699501013259,con,o
43,0211-699501013259,pp,i
43,0211-699501013259,B12,i
43,0211-699501013259,edad,o
43,0211-699501013259,albumina,i
43,0211-699501013259,KTV,o
43,0211-699501013259,KRU,o
43,0211-699501013259,PCRn,o
43,0211-699501013259,Cincuenta,o
43,0211-699501013259,y,o
43,0211-699501013259,ocho,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,recibieron,o
43,0211-699501013259,seis,o
43,0211-699501013259,meses,o
43,0211-699501013259,de,o
43,0211-699501013259,suplementacion,i
43,0211-699501013259,con,o
43,0211-699501013259,normalizacion,o
43,0211-699501013259,del,o
43,0211-699501013259,pp,i
43,0211-699501013259,aumento,o
43,0211-699501013259,del,o
43,0211-699501013259,folato,i
43,0211-699501013259,703,o
43,0211-699501013259,IC,o
43,0211-699501013259,638,o
43,0211-699501013259,795,o
43,0211-699501013259,vs,o
43,0211-699501013259,6181,o
43,0211-699501013259,IC,o
43,0211-699501013259,4447,o
43,0211-699501013259,7811,o
43,0211-699501013259,p,o
43,0211-699501013259,0001,o
43,0211-699501013259,y,o
43,0211-699501013259,descenso,o
43,0211-699501013259,de,o
43,0211-699501013259,la,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,240,o
43,0211-699501013259,IC,o
43,0211-699501013259,213,o
43,0211-699501013259,264,o
43,0211-699501013259,vs,o
43,0211-699501013259,199,o
43,0211-699501013259,IC,o
43,0211-699501013259,175,o
43,0211-699501013259,224,o
43,0211-699501013259,p,o
43,0211-699501013259,005,o
43,0211-699501013259,Han,o
43,0211-699501013259,recibido,o
43,0211-699501013259,suplementacion,i
43,0211-699501013259,durante,o
43,0211-699501013259,12,o
43,0211-699501013259,meses,o
43,0211-699501013259,33,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,pero,o
43,0211-699501013259,a,o
43,0211-699501013259,pesar,o
43,0211-699501013259,de,o
43,0211-699501013259,un,o
43,0211-699501013259,continuo,o
43,0211-699501013259,aumento,o
43,0211-699501013259,del,o
43,0211-699501013259,folato,i
43,0211-699501013259,10078,o
43,0211-699501013259,IC,o
43,0211-699501013259,7481,o
43,0211-699501013259,12674,o
43,0211-699501013259,p,o
43,0211-699501013259,0001,o
43,0211-699501013259,solo,o
43,0211-699501013259,3,o
43,0211-699501013259,pacientes,o
43,0211-699501013259,presentan,o
43,0211-699501013259,niveles,o
43,0211-699501013259,normales,o
43,0211-699501013259,de,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,correlacionandose,o
43,0211-699501013259,directamente,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,con,o
43,0211-699501013259,la,o
43,0211-699501013259,albumina,i
43,0211-699501013259,r,o
43,0211-699501013259,056,o
43,0211-699501013259,p,o
43,0211-699501013259,0001,o
43,0211-699501013259,que,o
43,0211-699501013259,se,o
43,0211-699501013259,elevo,o
43,0211-699501013259,con,o
43,0211-699501013259,respecto,o
43,0211-699501013259,al,o
43,0211-699501013259,inicio,o
43,0211-699501013259,337,o
43,0211-699501013259,IC,o
43,0211-699501013259,327,o
43,0211-699501013259,346,o
43,0211-699501013259,vs,o
43,0211-699501013259,350,o
43,0211-699501013259,IC,o
43,0211-699501013259,337,o
43,0211-699501013259,363,o
43,0211-699501013259,p,o
43,0211-699501013259,005,o
43,0211-699501013259,Conclusion,o
43,0211-699501013259,Tras,o
43,0211-699501013259,suplementacion,i
43,0211-699501013259,con,o
43,0211-699501013259,acido,i
43,0211-699501013259,folico,i
43,0211-699501013259,y,o
43,0211-699501013259,vitamina,i
43,0211-699501013259,B6,i
43,0211-699501013259,aunque,o
43,0211-699501013259,inicialmente,o
43,0211-699501013259,se,o
43,0211-699501013259,reduce,o
43,0211-699501013259,la,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,esta,o
43,0211-699501013259,respuesta,o
43,0211-699501013259,se,o
43,0211-699501013259,hace,o
43,0211-699501013259,refractaria,o
43,0211-699501013259,correlacionandose,o
43,0211-699501013259,directamente,o
43,0211-699501013259,la,o
43,0211-699501013259,tHcy,i
43,0211-699501013259,con,o
43,0211-699501013259,la,o
43,0211-699501013259,albumina,i
43,0211-699501013259,plasmatica,i
43,0211-699501013259,La,o
43,0211-699501013259,interpretacion,o
43,0211-699501013259,de,o
43,0211-699501013259,los,o
43,0211-699501013259,niveles,i
43,0211-699501013259,de,i
43,0211-699501013259,tHcy,i
43,0211-699501013259,debe,o
43,0211-699501013259,tener,o
43,0211-699501013259,en,o
43,0211-699501013259,cuenta,o
43,0211-699501013259,la,o
43,0211-699501013259,concentracion,i
43,0211-699501013259,de,i
43,0211-699501013259,albumina,i
44,0211-699501013259,Efecto,o
44,0211-699501013259,de,o
44,0211-699501013259,la,o
44,0211-699501013259,suplementacion,i
44,0211-699501013259,con,o
44,0211-699501013259,acido,i
44,0211-699501013259,folico,i
44,0211-699501013259,sobre,o
44,0211-699501013259,los,o
44,0211-699501013259,niveles,i
44,0211-699501013259,de,i
44,0211-699501013259,homocisteina,i
44,0211-699501013259,total,o
44,0211-699501013259,en,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,en,o
44,0211-699501013259,hemodialisis,i
44,0211-699501013259,La,o
44,0211-699501013259,hiperhomocisteinemia,i
44,0211-699501013259,es,o
44,0211-699501013259,un,o
44,0211-699501013259,marcador,o
44,0211-699501013259,de,o
44,0211-699501013259,riesgo,o
44,0211-699501013259,independiente,o
44,0211-699501013259,de,o
44,0211-699501013259,morbimortalidad,o
44,0211-699501013259,cardiovascular,i
44,0211-699501013259,Hemos,o
44,0211-699501013259,intentado,o
44,0211-699501013259,prospectivamente,o
44,0211-699501013259,reducir,o
44,0211-699501013259,los,o
44,0211-699501013259,niveles,i
44,0211-699501013259,de,i
44,0211-699501013259,homocisteina,i
44,0211-699501013259,total,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,mediante,o
44,0211-699501013259,suplemento,o
44,0211-699501013259,con,o
44,0211-699501013259,acido,i
44,0211-699501013259,folico,i
44,0211-699501013259,y,o
44,0211-699501013259,vitamina,i
44,0211-699501013259,B6,i
44,0211-699501013259,pp,i
44,0211-699501013259,valorando,o
44,0211-699501013259,su,o
44,0211-699501013259,posible,o
44,0211-699501013259,correlacion,o
44,0211-699501013259,con,o
44,0211-699501013259,dosis,o
44,0211-699501013259,de,o
44,0211-699501013259,dialisis,i
44,0211-699501013259,funcion,i
44,0211-699501013259,residual,i
44,0211-699501013259,y,o
44,0211-699501013259,parametros,o
44,0211-699501013259,nutricionales,o
44,0211-699501013259,Metodos,o
44,0211-699501013259,Todos,o
44,0211-699501013259,los,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,en,o
44,0211-699501013259,hemodialisis,i
44,0211-699501013259,al,o
44,0211-699501013259,comienzo,o
44,0211-699501013259,del,o
44,0211-699501013259,estudio,o
44,0211-699501013259,que,o
44,0211-699501013259,no,o
44,0211-699501013259,recibian,o
44,0211-699501013259,acido,i
44,0211-699501013259,folico,i
44,0211-699501013259,ni,o
44,0211-699501013259,vitamina,i
44,0211-699501013259,B6,i
44,0211-699501013259,asi,o
44,0211-699501013259,como,o
44,0211-699501013259,los,o
44,0211-699501013259,incorporados,o
44,0211-699501013259,posteriormente,o
44,0211-699501013259,a,o
44,0211-699501013259,partir,o
44,0211-699501013259,de,o
44,0211-699501013259,su,o
44,0211-699501013259,tercer,o
44,0211-699501013259,mes,o
44,0211-699501013259,en,o
44,0211-699501013259,hemodialisis,i
44,0211-699501013259,recibieron,o
44,0211-699501013259,5,o
44,0211-699501013259,mg,o
44,0211-699501013259,orales,o
44,0211-699501013259,de,o
44,0211-699501013259,acido,i
44,0211-699501013259,folico,i
44,0211-699501013259,cada,o
44,0211-699501013259,48,o
44,0211-699501013259,horas,o
44,0211-699501013259,y,o
44,0211-699501013259,40,o
44,0211-699501013259,mg,o
44,0211-699501013259,orales,o
44,0211-699501013259,de,o
44,0211-699501013259,vitamina,i
44,0211-699501013259,B6,i
44,0211-699501013259,cada,o
44,0211-699501013259,semana,o
44,0211-699501013259,Se,o
44,0211-699501013259,determinaron,o
44,0211-699501013259,al,o
44,0211-699501013259,comienzo,o
44,0211-699501013259,del,o
44,0211-699501013259,estudio,o
44,0211-699501013259,y,o
44,0211-699501013259,cada,o
44,0211-699501013259,2,o
44,0211-699501013259,meses,o
44,0211-699501013259,niveles,i
44,0211-699501013259,de,i
44,0211-699501013259,folato,i
44,0211-699501013259,vitamina,i
44,0211-699501013259,B12,i
44,0211-699501013259,inmunoensayo,i
44,0211-699501013259,albumina,i
44,0211-699501013259,y,o
44,0211-699501013259,cinetica,o
44,0211-699501013259,de,o
44,0211-699501013259,la,o
44,0211-699501013259,urea,i
44,0211-699501013259,KTV,o
44,0211-699501013259,KRU,o
44,0211-699501013259,PCRn,o
44,0211-699501013259,y,o
44,0211-699501013259,cada,o
44,0211-699501013259,6,o
44,0211-699501013259,meses,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,HPLC,i
44,0211-699501013259,y,o
44,0211-699501013259,pp,i
44,0211-699501013259,RIA,i
44,0211-699501013259,Resultados,o
44,0211-699501013259,80,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,fueron,o
44,0211-699501013259,incluidos,o
44,0211-699501013259,en,o
44,0211-699501013259,el,o
44,0211-699501013259,estudio,o
44,0211-699501013259,basal,o
44,0211-699501013259,con,o
44,0211-699501013259,una,o
44,0211-699501013259,prevalencia,o
44,0211-699501013259,de,o
44,0211-699501013259,hiperhomocisteinemia,i
44,0211-699501013259,del,o
44,0211-699501013259,844,o
44,0211-699501013259,deficit,i
44,0211-699501013259,de,i
44,0211-699501013259,pp,i
44,0211-699501013259,en,o
44,0211-699501013259,el,o
44,0211-699501013259,32,o
44,0211-699501013259,y,o
44,0211-699501013259,folato,i
44,0211-699501013259,en,o
44,0211-699501013259,el,o
44,0211-699501013259,rango,o
44,0211-699501013259,normal,o
44,0211-699501013259,bajo,o
44,0211-699501013259,los,o
44,0211-699501013259,niveles,i
44,0211-699501013259,de,i
44,0211-699501013259,tHcy,i
44,0211-699501013259,se,o
44,0211-699501013259,correlacionaban,o
44,0211-699501013259,inversamente,o
44,0211-699501013259,con,o
44,0211-699501013259,los,o
44,0211-699501013259,del,o
44,0211-699501013259,folato,i
44,0211-699501013259,r,o
44,0211-699501013259,0336,o
44,0211-699501013259,p,o
44,0211-699501013259,001,o
44,0211-699501013259,pero,o
44,0211-699501013259,no,o
44,0211-699501013259,con,o
44,0211-699501013259,pp,i
44,0211-699501013259,B12,i
44,0211-699501013259,edad,o
44,0211-699501013259,albumina,i
44,0211-699501013259,KTV,o
44,0211-699501013259,KRU,o
44,0211-699501013259,PCRn,o
44,0211-699501013259,Cincuenta,o
44,0211-699501013259,y,o
44,0211-699501013259,ocho,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,recibieron,o
44,0211-699501013259,seis,o
44,0211-699501013259,meses,o
44,0211-699501013259,de,o
44,0211-699501013259,suplementacion,i
44,0211-699501013259,con,o
44,0211-699501013259,normalizacion,o
44,0211-699501013259,del,o
44,0211-699501013259,pp,i
44,0211-699501013259,aumento,o
44,0211-699501013259,del,o
44,0211-699501013259,folato,i
44,0211-699501013259,703,o
44,0211-699501013259,IC,o
44,0211-699501013259,638,o
44,0211-699501013259,795,o
44,0211-699501013259,vs,o
44,0211-699501013259,6181,o
44,0211-699501013259,IC,o
44,0211-699501013259,4447,o
44,0211-699501013259,7811,o
44,0211-699501013259,p,o
44,0211-699501013259,0001,o
44,0211-699501013259,y,o
44,0211-699501013259,descenso,o
44,0211-699501013259,de,o
44,0211-699501013259,la,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,240,o
44,0211-699501013259,IC,o
44,0211-699501013259,213,o
44,0211-699501013259,264,o
44,0211-699501013259,vs,o
44,0211-699501013259,199,o
44,0211-699501013259,IC,o
44,0211-699501013259,175,o
44,0211-699501013259,224,o
44,0211-699501013259,p,o
44,0211-699501013259,005,o
44,0211-699501013259,Han,o
44,0211-699501013259,recibido,o
44,0211-699501013259,suplementacion,i
44,0211-699501013259,durante,o
44,0211-699501013259,12,o
44,0211-699501013259,meses,o
44,0211-699501013259,33,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,pero,o
44,0211-699501013259,a,o
44,0211-699501013259,pesar,o
44,0211-699501013259,de,o
44,0211-699501013259,un,o
44,0211-699501013259,continuo,o
44,0211-699501013259,aumento,o
44,0211-699501013259,del,o
44,0211-699501013259,folato,i
44,0211-699501013259,10078,o
44,0211-699501013259,IC,o
44,0211-699501013259,7481,o
44,0211-699501013259,12674,o
44,0211-699501013259,p,o
44,0211-699501013259,0001,o
44,0211-699501013259,solo,o
44,0211-699501013259,3,o
44,0211-699501013259,pacientes,o
44,0211-699501013259,presentan,o
44,0211-699501013259,niveles,o
44,0211-699501013259,normales,o
44,0211-699501013259,de,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,correlacionandose,o
44,0211-699501013259,directamente,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,con,o
44,0211-699501013259,la,o
44,0211-699501013259,albumina,i
44,0211-699501013259,r,o
44,0211-699501013259,056,o
44,0211-699501013259,p,o
44,0211-699501013259,0001,o
44,0211-699501013259,que,o
44,0211-699501013259,se,o
44,0211-699501013259,elevo,o
44,0211-699501013259,con,o
44,0211-699501013259,respecto,o
44,0211-699501013259,al,o
44,0211-699501013259,inicio,o
44,0211-699501013259,337,o
44,0211-699501013259,IC,o
44,0211-699501013259,327,o
44,0211-699501013259,346,o
44,0211-699501013259,vs,o
44,0211-699501013259,350,o
44,0211-699501013259,IC,o
44,0211-699501013259,337,o
44,0211-699501013259,363,o
44,0211-699501013259,p,o
44,0211-699501013259,005,o
44,0211-699501013259,Conclusion,o
44,0211-699501013259,Tras,o
44,0211-699501013259,suplementacion,i
44,0211-699501013259,con,o
44,0211-699501013259,acido,i
44,0211-699501013259,folico,i
44,0211-699501013259,y,o
44,0211-699501013259,vitamina,i
44,0211-699501013259,B6,i
44,0211-699501013259,aunque,o
44,0211-699501013259,inicialmente,o
44,0211-699501013259,se,o
44,0211-699501013259,reduce,o
44,0211-699501013259,la,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,esta,o
44,0211-699501013259,respuesta,o
44,0211-699501013259,se,o
44,0211-699501013259,hace,o
44,0211-699501013259,refractaria,o
44,0211-699501013259,correlacionandose,o
44,0211-699501013259,directamente,o
44,0211-699501013259,la,o
44,0211-699501013259,tHcy,i
44,0211-699501013259,con,o
44,0211-699501013259,la,o
44,0211-699501013259,albumina,i
44,0211-699501013259,plasmatica,i
44,0211-699501013259,La,o
44,0211-699501013259,interpretacion,o
44,0211-699501013259,de,o
44,0211-699501013259,los,o
44,0211-699501013259,niveles,i
44,0211-699501013259,de,i
44,0211-699501013259,tHcy,i
44,0211-699501013259,debe,o
44,0211-699501013259,tener,o
44,0211-699501013259,en,o
44,0211-699501013259,cuenta,o
44,0211-699501013259,la,o
44,0211-699501013259,concentracion,i
44,0211-699501013259,de,i
44,0211-699501013259,albumina,i
45,0211-699501013259,Efecto,o
45,0211-699501013259,de,o
45,0211-699501013259,la,o
45,0211-699501013259,suplementacion,i
45,0211-699501013259,con,o
45,0211-699501013259,acido,i
45,0211-699501013259,folico,i
45,0211-699501013259,sobre,o
45,0211-699501013259,los,o
45,0211-699501013259,niveles,i
45,0211-699501013259,de,i
45,0211-699501013259,homocisteina,i
45,0211-699501013259,total,o
45,0211-699501013259,en,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,en,o
45,0211-699501013259,hemodialisis,i
45,0211-699501013259,La,o
45,0211-699501013259,hiperhomocisteinemia,i
45,0211-699501013259,es,o
45,0211-699501013259,un,o
45,0211-699501013259,marcador,o
45,0211-699501013259,de,o
45,0211-699501013259,riesgo,o
45,0211-699501013259,independiente,o
45,0211-699501013259,de,o
45,0211-699501013259,morbimortalidad,o
45,0211-699501013259,cardiovascular,i
45,0211-699501013259,Hemos,o
45,0211-699501013259,intentado,o
45,0211-699501013259,prospectivamente,o
45,0211-699501013259,reducir,o
45,0211-699501013259,los,o
45,0211-699501013259,niveles,i
45,0211-699501013259,de,i
45,0211-699501013259,homocisteina,i
45,0211-699501013259,total,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,mediante,o
45,0211-699501013259,suplemento,o
45,0211-699501013259,con,o
45,0211-699501013259,acido,i
45,0211-699501013259,folico,i
45,0211-699501013259,y,o
45,0211-699501013259,vitamina,i
45,0211-699501013259,B6,i
45,0211-699501013259,pp,i
45,0211-699501013259,valorando,o
45,0211-699501013259,su,o
45,0211-699501013259,posible,o
45,0211-699501013259,correlacion,o
45,0211-699501013259,con,o
45,0211-699501013259,dosis,o
45,0211-699501013259,de,o
45,0211-699501013259,dialisis,i
45,0211-699501013259,funcion,i
45,0211-699501013259,residual,i
45,0211-699501013259,y,o
45,0211-699501013259,parametros,o
45,0211-699501013259,nutricionales,o
45,0211-699501013259,Metodos,o
45,0211-699501013259,Todos,o
45,0211-699501013259,los,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,en,o
45,0211-699501013259,hemodialisis,i
45,0211-699501013259,al,o
45,0211-699501013259,comienzo,o
45,0211-699501013259,del,o
45,0211-699501013259,estudio,o
45,0211-699501013259,que,o
45,0211-699501013259,no,o
45,0211-699501013259,recibian,o
45,0211-699501013259,acido,i
45,0211-699501013259,folico,i
45,0211-699501013259,ni,o
45,0211-699501013259,vitamina,i
45,0211-699501013259,B6,i
45,0211-699501013259,asi,o
45,0211-699501013259,como,o
45,0211-699501013259,los,o
45,0211-699501013259,incorporados,o
45,0211-699501013259,posteriormente,o
45,0211-699501013259,a,o
45,0211-699501013259,partir,o
45,0211-699501013259,de,o
45,0211-699501013259,su,o
45,0211-699501013259,tercer,o
45,0211-699501013259,mes,o
45,0211-699501013259,en,o
45,0211-699501013259,hemodialisis,i
45,0211-699501013259,recibieron,o
45,0211-699501013259,5,o
45,0211-699501013259,mg,o
45,0211-699501013259,orales,o
45,0211-699501013259,de,o
45,0211-699501013259,acido,i
45,0211-699501013259,folico,i
45,0211-699501013259,cada,o
45,0211-699501013259,48,o
45,0211-699501013259,horas,o
45,0211-699501013259,y,o
45,0211-699501013259,40,o
45,0211-699501013259,mg,o
45,0211-699501013259,orales,o
45,0211-699501013259,de,o
45,0211-699501013259,vitamina,i
45,0211-699501013259,B6,i
45,0211-699501013259,cada,o
45,0211-699501013259,semana,o
45,0211-699501013259,Se,o
45,0211-699501013259,determinaron,o
45,0211-699501013259,al,o
45,0211-699501013259,comienzo,o
45,0211-699501013259,del,o
45,0211-699501013259,estudio,o
45,0211-699501013259,y,o
45,0211-699501013259,cada,o
45,0211-699501013259,2,o
45,0211-699501013259,meses,o
45,0211-699501013259,niveles,i
45,0211-699501013259,de,i
45,0211-699501013259,folato,i
45,0211-699501013259,vitamina,i
45,0211-699501013259,B12,i
45,0211-699501013259,inmunoensayo,i
45,0211-699501013259,albumina,i
45,0211-699501013259,y,o
45,0211-699501013259,cinetica,o
45,0211-699501013259,de,o
45,0211-699501013259,la,o
45,0211-699501013259,urea,i
45,0211-699501013259,KTV,o
45,0211-699501013259,KRU,o
45,0211-699501013259,PCRn,o
45,0211-699501013259,y,o
45,0211-699501013259,cada,o
45,0211-699501013259,6,o
45,0211-699501013259,meses,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,HPLC,i
45,0211-699501013259,y,o
45,0211-699501013259,pp,i
45,0211-699501013259,RIA,i
45,0211-699501013259,Resultados,o
45,0211-699501013259,80,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,fueron,o
45,0211-699501013259,incluidos,o
45,0211-699501013259,en,o
45,0211-699501013259,el,o
45,0211-699501013259,estudio,o
45,0211-699501013259,basal,o
45,0211-699501013259,con,o
45,0211-699501013259,una,o
45,0211-699501013259,prevalencia,o
45,0211-699501013259,de,o
45,0211-699501013259,hiperhomocisteinemia,i
45,0211-699501013259,del,o
45,0211-699501013259,844,o
45,0211-699501013259,deficit,i
45,0211-699501013259,de,i
45,0211-699501013259,pp,i
45,0211-699501013259,en,o
45,0211-699501013259,el,o
45,0211-699501013259,32,o
45,0211-699501013259,y,o
45,0211-699501013259,folato,i
45,0211-699501013259,en,o
45,0211-699501013259,el,o
45,0211-699501013259,rango,o
45,0211-699501013259,normal,o
45,0211-699501013259,bajo,o
45,0211-699501013259,los,o
45,0211-699501013259,niveles,i
45,0211-699501013259,de,i
45,0211-699501013259,tHcy,i
45,0211-699501013259,se,o
45,0211-699501013259,correlacionaban,o
45,0211-699501013259,inversamente,o
45,0211-699501013259,con,o
45,0211-699501013259,los,o
45,0211-699501013259,del,o
45,0211-699501013259,folato,i
45,0211-699501013259,r,o
45,0211-699501013259,0336,o
45,0211-699501013259,p,o
45,0211-699501013259,001,o
45,0211-699501013259,pero,o
45,0211-699501013259,no,o
45,0211-699501013259,con,o
45,0211-699501013259,pp,i
45,0211-699501013259,B12,i
45,0211-699501013259,edad,o
45,0211-699501013259,albumina,i
45,0211-699501013259,KTV,o
45,0211-699501013259,KRU,o
45,0211-699501013259,PCRn,o
45,0211-699501013259,Cincuenta,o
45,0211-699501013259,y,o
45,0211-699501013259,ocho,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,recibieron,o
45,0211-699501013259,seis,o
45,0211-699501013259,meses,o
45,0211-699501013259,de,o
45,0211-699501013259,suplementacion,i
45,0211-699501013259,con,o
45,0211-699501013259,normalizacion,o
45,0211-699501013259,del,o
45,0211-699501013259,pp,i
45,0211-699501013259,aumento,o
45,0211-699501013259,del,o
45,0211-699501013259,folato,i
45,0211-699501013259,703,o
45,0211-699501013259,IC,o
45,0211-699501013259,638,o
45,0211-699501013259,795,o
45,0211-699501013259,vs,o
45,0211-699501013259,6181,o
45,0211-699501013259,IC,o
45,0211-699501013259,4447,o
45,0211-699501013259,7811,o
45,0211-699501013259,p,o
45,0211-699501013259,0001,o
45,0211-699501013259,y,o
45,0211-699501013259,descenso,o
45,0211-699501013259,de,o
45,0211-699501013259,la,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,240,o
45,0211-699501013259,IC,o
45,0211-699501013259,213,o
45,0211-699501013259,264,o
45,0211-699501013259,vs,o
45,0211-699501013259,199,o
45,0211-699501013259,IC,o
45,0211-699501013259,175,o
45,0211-699501013259,224,o
45,0211-699501013259,p,o
45,0211-699501013259,005,o
45,0211-699501013259,Han,o
45,0211-699501013259,recibido,o
45,0211-699501013259,suplementacion,i
45,0211-699501013259,durante,o
45,0211-699501013259,12,o
45,0211-699501013259,meses,o
45,0211-699501013259,33,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,pero,o
45,0211-699501013259,a,o
45,0211-699501013259,pesar,o
45,0211-699501013259,de,o
45,0211-699501013259,un,o
45,0211-699501013259,continuo,o
45,0211-699501013259,aumento,o
45,0211-699501013259,del,o
45,0211-699501013259,folato,i
45,0211-699501013259,10078,o
45,0211-699501013259,IC,o
45,0211-699501013259,7481,o
45,0211-699501013259,12674,o
45,0211-699501013259,p,o
45,0211-699501013259,0001,o
45,0211-699501013259,solo,o
45,0211-699501013259,3,o
45,0211-699501013259,pacientes,o
45,0211-699501013259,presentan,o
45,0211-699501013259,niveles,o
45,0211-699501013259,normales,o
45,0211-699501013259,de,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,correlacionandose,o
45,0211-699501013259,directamente,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,con,o
45,0211-699501013259,la,o
45,0211-699501013259,albumina,i
45,0211-699501013259,r,o
45,0211-699501013259,056,o
45,0211-699501013259,p,o
45,0211-699501013259,0001,o
45,0211-699501013259,que,o
45,0211-699501013259,se,o
45,0211-699501013259,elevo,o
45,0211-699501013259,con,o
45,0211-699501013259,respecto,o
45,0211-699501013259,al,o
45,0211-699501013259,inicio,o
45,0211-699501013259,337,o
45,0211-699501013259,IC,o
45,0211-699501013259,327,o
45,0211-699501013259,346,o
45,0211-699501013259,vs,o
45,0211-699501013259,350,o
45,0211-699501013259,IC,o
45,0211-699501013259,337,o
45,0211-699501013259,363,o
45,0211-699501013259,p,o
45,0211-699501013259,005,o
45,0211-699501013259,Conclusion,o
45,0211-699501013259,Tras,o
45,0211-699501013259,suplementacion,i
45,0211-699501013259,con,o
45,0211-699501013259,acido,i
45,0211-699501013259,folico,i
45,0211-699501013259,y,o
45,0211-699501013259,vitamina,i
45,0211-699501013259,B6,i
45,0211-699501013259,aunque,o
45,0211-699501013259,inicialmente,o
45,0211-699501013259,se,o
45,0211-699501013259,reduce,o
45,0211-699501013259,la,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,esta,o
45,0211-699501013259,respuesta,o
45,0211-699501013259,se,o
45,0211-699501013259,hace,o
45,0211-699501013259,refractaria,o
45,0211-699501013259,correlacionandose,o
45,0211-699501013259,directamente,o
45,0211-699501013259,la,o
45,0211-699501013259,tHcy,i
45,0211-699501013259,con,o
45,0211-699501013259,la,o
45,0211-699501013259,albumina,i
45,0211-699501013259,plasmatica,i
45,0211-699501013259,La,o
45,0211-699501013259,interpretacion,o
45,0211-699501013259,de,o
45,0211-699501013259,los,o
45,0211-699501013259,niveles,i
45,0211-699501013259,de,i
45,0211-699501013259,tHcy,i
45,0211-699501013259,debe,o
45,0211-699501013259,tener,o
45,0211-699501013259,en,o
45,0211-699501013259,cuenta,o
45,0211-699501013259,la,o
45,0211-699501013259,concentracion,i
45,0211-699501013259,de,i
45,0211-699501013259,albumina,i
46,0211-699501013259,Efecto,o
46,0211-699501013259,de,o
46,0211-699501013259,la,o
46,0211-699501013259,suplementacion,i
46,0211-699501013259,con,o
46,0211-699501013259,acido,i
46,0211-699501013259,folico,i
46,0211-699501013259,sobre,o
46,0211-699501013259,los,o
46,0211-699501013259,niveles,i
46,0211-699501013259,de,i
46,0211-699501013259,homocisteina,i
46,0211-699501013259,total,o
46,0211-699501013259,en,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,en,o
46,0211-699501013259,hemodialisis,i
46,0211-699501013259,La,o
46,0211-699501013259,hiperhomocisteinemia,i
46,0211-699501013259,es,o
46,0211-699501013259,un,o
46,0211-699501013259,marcador,o
46,0211-699501013259,de,o
46,0211-699501013259,riesgo,o
46,0211-699501013259,independiente,o
46,0211-699501013259,de,o
46,0211-699501013259,morbimortalidad,o
46,0211-699501013259,cardiovascular,i
46,0211-699501013259,Hemos,o
46,0211-699501013259,intentado,o
46,0211-699501013259,prospectivamente,o
46,0211-699501013259,reducir,o
46,0211-699501013259,los,o
46,0211-699501013259,niveles,i
46,0211-699501013259,de,i
46,0211-699501013259,homocisteina,i
46,0211-699501013259,total,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,mediante,o
46,0211-699501013259,suplemento,o
46,0211-699501013259,con,o
46,0211-699501013259,acido,i
46,0211-699501013259,folico,i
46,0211-699501013259,y,o
46,0211-699501013259,vitamina,i
46,0211-699501013259,B6,i
46,0211-699501013259,pp,i
46,0211-699501013259,valorando,o
46,0211-699501013259,su,o
46,0211-699501013259,posible,o
46,0211-699501013259,correlacion,o
46,0211-699501013259,con,o
46,0211-699501013259,dosis,o
46,0211-699501013259,de,o
46,0211-699501013259,dialisis,i
46,0211-699501013259,funcion,i
46,0211-699501013259,residual,i
46,0211-699501013259,y,o
46,0211-699501013259,parametros,o
46,0211-699501013259,nutricionales,o
46,0211-699501013259,Metodos,o
46,0211-699501013259,Todos,o
46,0211-699501013259,los,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,en,o
46,0211-699501013259,hemodialisis,i
46,0211-699501013259,al,o
46,0211-699501013259,comienzo,o
46,0211-699501013259,del,o
46,0211-699501013259,estudio,o
46,0211-699501013259,que,o
46,0211-699501013259,no,o
46,0211-699501013259,recibian,o
46,0211-699501013259,acido,i
46,0211-699501013259,folico,i
46,0211-699501013259,ni,o
46,0211-699501013259,vitamina,i
46,0211-699501013259,B6,i
46,0211-699501013259,asi,o
46,0211-699501013259,como,o
46,0211-699501013259,los,o
46,0211-699501013259,incorporados,o
46,0211-699501013259,posteriormente,o
46,0211-699501013259,a,o
46,0211-699501013259,partir,o
46,0211-699501013259,de,o
46,0211-699501013259,su,o
46,0211-699501013259,tercer,o
46,0211-699501013259,mes,o
46,0211-699501013259,en,o
46,0211-699501013259,hemodialisis,i
46,0211-699501013259,recibieron,o
46,0211-699501013259,5,o
46,0211-699501013259,mg,o
46,0211-699501013259,orales,o
46,0211-699501013259,de,o
46,0211-699501013259,acido,i
46,0211-699501013259,folico,i
46,0211-699501013259,cada,o
46,0211-699501013259,48,o
46,0211-699501013259,horas,o
46,0211-699501013259,y,o
46,0211-699501013259,40,o
46,0211-699501013259,mg,o
46,0211-699501013259,orales,o
46,0211-699501013259,de,o
46,0211-699501013259,vitamina,i
46,0211-699501013259,B6,i
46,0211-699501013259,cada,o
46,0211-699501013259,semana,o
46,0211-699501013259,Se,o
46,0211-699501013259,determinaron,o
46,0211-699501013259,al,o
46,0211-699501013259,comienzo,o
46,0211-699501013259,del,o
46,0211-699501013259,estudio,o
46,0211-699501013259,y,o
46,0211-699501013259,cada,o
46,0211-699501013259,2,o
46,0211-699501013259,meses,o
46,0211-699501013259,niveles,i
46,0211-699501013259,de,i
46,0211-699501013259,folato,i
46,0211-699501013259,vitamina,i
46,0211-699501013259,B12,i
46,0211-699501013259,inmunoensayo,i
46,0211-699501013259,albumina,i
46,0211-699501013259,y,o
46,0211-699501013259,cinetica,o
46,0211-699501013259,de,o
46,0211-699501013259,la,o
46,0211-699501013259,urea,i
46,0211-699501013259,KTV,o
46,0211-699501013259,KRU,o
46,0211-699501013259,PCRn,o
46,0211-699501013259,y,o
46,0211-699501013259,cada,o
46,0211-699501013259,6,o
46,0211-699501013259,meses,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,HPLC,i
46,0211-699501013259,y,o
46,0211-699501013259,pp,i
46,0211-699501013259,RIA,i
46,0211-699501013259,Resultados,o
46,0211-699501013259,80,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,fueron,o
46,0211-699501013259,incluidos,o
46,0211-699501013259,en,o
46,0211-699501013259,el,o
46,0211-699501013259,estudio,o
46,0211-699501013259,basal,o
46,0211-699501013259,con,o
46,0211-699501013259,una,o
46,0211-699501013259,prevalencia,o
46,0211-699501013259,de,o
46,0211-699501013259,hiperhomocisteinemia,i
46,0211-699501013259,del,o
46,0211-699501013259,844,o
46,0211-699501013259,deficit,i
46,0211-699501013259,de,i
46,0211-699501013259,pp,i
46,0211-699501013259,en,o
46,0211-699501013259,el,o
46,0211-699501013259,32,o
46,0211-699501013259,y,o
46,0211-699501013259,folato,i
46,0211-699501013259,en,o
46,0211-699501013259,el,o
46,0211-699501013259,rango,o
46,0211-699501013259,normal,o
46,0211-699501013259,bajo,o
46,0211-699501013259,los,o
46,0211-699501013259,niveles,i
46,0211-699501013259,de,i
46,0211-699501013259,tHcy,i
46,0211-699501013259,se,o
46,0211-699501013259,correlacionaban,o
46,0211-699501013259,inversamente,o
46,0211-699501013259,con,o
46,0211-699501013259,los,o
46,0211-699501013259,del,o
46,0211-699501013259,folato,i
46,0211-699501013259,r,o
46,0211-699501013259,0336,o
46,0211-699501013259,p,o
46,0211-699501013259,001,o
46,0211-699501013259,pero,o
46,0211-699501013259,no,o
46,0211-699501013259,con,o
46,0211-699501013259,pp,i
46,0211-699501013259,B12,i
46,0211-699501013259,edad,o
46,0211-699501013259,albumina,i
46,0211-699501013259,KTV,o
46,0211-699501013259,KRU,o
46,0211-699501013259,PCRn,o
46,0211-699501013259,Cincuenta,o
46,0211-699501013259,y,o
46,0211-699501013259,ocho,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,recibieron,o
46,0211-699501013259,seis,o
46,0211-699501013259,meses,o
46,0211-699501013259,de,o
46,0211-699501013259,suplementacion,i
46,0211-699501013259,con,o
46,0211-699501013259,normalizacion,o
46,0211-699501013259,del,o
46,0211-699501013259,pp,i
46,0211-699501013259,aumento,o
46,0211-699501013259,del,o
46,0211-699501013259,folato,i
46,0211-699501013259,703,o
46,0211-699501013259,IC,o
46,0211-699501013259,638,o
46,0211-699501013259,795,o
46,0211-699501013259,vs,o
46,0211-699501013259,6181,o
46,0211-699501013259,IC,o
46,0211-699501013259,4447,o
46,0211-699501013259,7811,o
46,0211-699501013259,p,o
46,0211-699501013259,0001,o
46,0211-699501013259,y,o
46,0211-699501013259,descenso,o
46,0211-699501013259,de,o
46,0211-699501013259,la,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,240,o
46,0211-699501013259,IC,o
46,0211-699501013259,213,o
46,0211-699501013259,264,o
46,0211-699501013259,vs,o
46,0211-699501013259,199,o
46,0211-699501013259,IC,o
46,0211-699501013259,175,o
46,0211-699501013259,224,o
46,0211-699501013259,p,o
46,0211-699501013259,005,o
46,0211-699501013259,Han,o
46,0211-699501013259,recibido,o
46,0211-699501013259,suplementacion,i
46,0211-699501013259,durante,o
46,0211-699501013259,12,o
46,0211-699501013259,meses,o
46,0211-699501013259,33,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,pero,o
46,0211-699501013259,a,o
46,0211-699501013259,pesar,o
46,0211-699501013259,de,o
46,0211-699501013259,un,o
46,0211-699501013259,continuo,o
46,0211-699501013259,aumento,o
46,0211-699501013259,del,o
46,0211-699501013259,folato,i
46,0211-699501013259,10078,o
46,0211-699501013259,IC,o
46,0211-699501013259,7481,o
46,0211-699501013259,12674,o
46,0211-699501013259,p,o
46,0211-699501013259,0001,o
46,0211-699501013259,solo,o
46,0211-699501013259,3,o
46,0211-699501013259,pacientes,o
46,0211-699501013259,presentan,o
46,0211-699501013259,niveles,o
46,0211-699501013259,normales,o
46,0211-699501013259,de,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,correlacionandose,o
46,0211-699501013259,directamente,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,con,o
46,0211-699501013259,la,o
46,0211-699501013259,albumina,i
46,0211-699501013259,r,o
46,0211-699501013259,056,o
46,0211-699501013259,p,o
46,0211-699501013259,0001,o
46,0211-699501013259,que,o
46,0211-699501013259,se,o
46,0211-699501013259,elevo,o
46,0211-699501013259,con,o
46,0211-699501013259,respecto,o
46,0211-699501013259,al,o
46,0211-699501013259,inicio,o
46,0211-699501013259,337,o
46,0211-699501013259,IC,o
46,0211-699501013259,327,o
46,0211-699501013259,346,o
46,0211-699501013259,vs,o
46,0211-699501013259,350,o
46,0211-699501013259,IC,o
46,0211-699501013259,337,o
46,0211-699501013259,363,o
46,0211-699501013259,p,o
46,0211-699501013259,005,o
46,0211-699501013259,Conclusion,o
46,0211-699501013259,Tras,o
46,0211-699501013259,suplementacion,i
46,0211-699501013259,con,o
46,0211-699501013259,acido,i
46,0211-699501013259,folico,i
46,0211-699501013259,y,o
46,0211-699501013259,vitamina,i
46,0211-699501013259,B6,i
46,0211-699501013259,aunque,o
46,0211-699501013259,inicialmente,o
46,0211-699501013259,se,o
46,0211-699501013259,reduce,o
46,0211-699501013259,la,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,esta,o
46,0211-699501013259,respuesta,o
46,0211-699501013259,se,o
46,0211-699501013259,hace,o
46,0211-699501013259,refractaria,o
46,0211-699501013259,correlacionandose,o
46,0211-699501013259,directamente,o
46,0211-699501013259,la,o
46,0211-699501013259,tHcy,i
46,0211-699501013259,con,o
46,0211-699501013259,la,o
46,0211-699501013259,albumina,i
46,0211-699501013259,plasmatica,i
46,0211-699501013259,La,o
46,0211-699501013259,interpretacion,o
46,0211-699501013259,de,o
46,0211-699501013259,los,o
46,0211-699501013259,niveles,i
46,0211-699501013259,de,i
46,0211-699501013259,tHcy,i
46,0211-699501013259,debe,o
46,0211-699501013259,tener,o
46,0211-699501013259,en,o
46,0211-699501013259,cuenta,o
46,0211-699501013259,la,o
46,0211-699501013259,concentracion,i
46,0211-699501013259,de,i
46,0211-699501013259,albumina,i
47,0211-699501013259,Efecto,o
47,0211-699501013259,de,o
47,0211-699501013259,la,o
47,0211-699501013259,suplementacion,i
47,0211-699501013259,con,o
47,0211-699501013259,acido,i
47,0211-699501013259,folico,i
47,0211-699501013259,sobre,o
47,0211-699501013259,los,o
47,0211-699501013259,niveles,i
47,0211-699501013259,de,i
47,0211-699501013259,homocisteina,i
47,0211-699501013259,total,o
47,0211-699501013259,en,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,en,o
47,0211-699501013259,hemodialisis,i
47,0211-699501013259,La,o
47,0211-699501013259,hiperhomocisteinemia,i
47,0211-699501013259,es,o
47,0211-699501013259,un,o
47,0211-699501013259,marcador,o
47,0211-699501013259,de,o
47,0211-699501013259,riesgo,o
47,0211-699501013259,independiente,o
47,0211-699501013259,de,o
47,0211-699501013259,morbimortalidad,o
47,0211-699501013259,cardiovascular,i
47,0211-699501013259,Hemos,o
47,0211-699501013259,intentado,o
47,0211-699501013259,prospectivamente,o
47,0211-699501013259,reducir,o
47,0211-699501013259,los,o
47,0211-699501013259,niveles,i
47,0211-699501013259,de,i
47,0211-699501013259,homocisteina,i
47,0211-699501013259,total,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,mediante,o
47,0211-699501013259,suplemento,o
47,0211-699501013259,con,o
47,0211-699501013259,acido,i
47,0211-699501013259,folico,i
47,0211-699501013259,y,o
47,0211-699501013259,vitamina,i
47,0211-699501013259,B6,i
47,0211-699501013259,pp,i
47,0211-699501013259,valorando,o
47,0211-699501013259,su,o
47,0211-699501013259,posible,o
47,0211-699501013259,correlacion,o
47,0211-699501013259,con,o
47,0211-699501013259,dosis,o
47,0211-699501013259,de,o
47,0211-699501013259,dialisis,i
47,0211-699501013259,funcion,i
47,0211-699501013259,residual,i
47,0211-699501013259,y,o
47,0211-699501013259,parametros,o
47,0211-699501013259,nutricionales,o
47,0211-699501013259,Metodos,o
47,0211-699501013259,Todos,o
47,0211-699501013259,los,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,en,o
47,0211-699501013259,hemodialisis,i
47,0211-699501013259,al,o
47,0211-699501013259,comienzo,o
47,0211-699501013259,del,o
47,0211-699501013259,estudio,o
47,0211-699501013259,que,o
47,0211-699501013259,no,o
47,0211-699501013259,recibian,o
47,0211-699501013259,acido,i
47,0211-699501013259,folico,i
47,0211-699501013259,ni,o
47,0211-699501013259,vitamina,i
47,0211-699501013259,B6,i
47,0211-699501013259,asi,o
47,0211-699501013259,como,o
47,0211-699501013259,los,o
47,0211-699501013259,incorporados,o
47,0211-699501013259,posteriormente,o
47,0211-699501013259,a,o
47,0211-699501013259,partir,o
47,0211-699501013259,de,o
47,0211-699501013259,su,o
47,0211-699501013259,tercer,o
47,0211-699501013259,mes,o
47,0211-699501013259,en,o
47,0211-699501013259,hemodialisis,i
47,0211-699501013259,recibieron,o
47,0211-699501013259,5,o
47,0211-699501013259,mg,o
47,0211-699501013259,orales,o
47,0211-699501013259,de,o
47,0211-699501013259,acido,i
47,0211-699501013259,folico,i
47,0211-699501013259,cada,o
47,0211-699501013259,48,o
47,0211-699501013259,horas,o
47,0211-699501013259,y,o
47,0211-699501013259,40,o
47,0211-699501013259,mg,o
47,0211-699501013259,orales,o
47,0211-699501013259,de,o
47,0211-699501013259,vitamina,i
47,0211-699501013259,B6,i
47,0211-699501013259,cada,o
47,0211-699501013259,semana,o
47,0211-699501013259,Se,o
47,0211-699501013259,determinaron,o
47,0211-699501013259,al,o
47,0211-699501013259,comienzo,o
47,0211-699501013259,del,o
47,0211-699501013259,estudio,o
47,0211-699501013259,y,o
47,0211-699501013259,cada,o
47,0211-699501013259,2,o
47,0211-699501013259,meses,o
47,0211-699501013259,niveles,i
47,0211-699501013259,de,i
47,0211-699501013259,folato,i
47,0211-699501013259,vitamina,i
47,0211-699501013259,B12,i
47,0211-699501013259,inmunoensayo,i
47,0211-699501013259,albumina,i
47,0211-699501013259,y,o
47,0211-699501013259,cinetica,o
47,0211-699501013259,de,o
47,0211-699501013259,la,o
47,0211-699501013259,urea,i
47,0211-699501013259,KTV,o
47,0211-699501013259,KRU,o
47,0211-699501013259,PCRn,o
47,0211-699501013259,y,o
47,0211-699501013259,cada,o
47,0211-699501013259,6,o
47,0211-699501013259,meses,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,HPLC,i
47,0211-699501013259,y,o
47,0211-699501013259,pp,i
47,0211-699501013259,RIA,i
47,0211-699501013259,Resultados,o
47,0211-699501013259,80,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,fueron,o
47,0211-699501013259,incluidos,o
47,0211-699501013259,en,o
47,0211-699501013259,el,o
47,0211-699501013259,estudio,o
47,0211-699501013259,basal,o
47,0211-699501013259,con,o
47,0211-699501013259,una,o
47,0211-699501013259,prevalencia,o
47,0211-699501013259,de,o
47,0211-699501013259,hiperhomocisteinemia,i
47,0211-699501013259,del,o
47,0211-699501013259,844,o
47,0211-699501013259,deficit,i
47,0211-699501013259,de,i
47,0211-699501013259,pp,i
47,0211-699501013259,en,o
47,0211-699501013259,el,o
47,0211-699501013259,32,o
47,0211-699501013259,y,o
47,0211-699501013259,folato,i
47,0211-699501013259,en,o
47,0211-699501013259,el,o
47,0211-699501013259,rango,o
47,0211-699501013259,normal,o
47,0211-699501013259,bajo,o
47,0211-699501013259,los,o
47,0211-699501013259,niveles,i
47,0211-699501013259,de,i
47,0211-699501013259,tHcy,i
47,0211-699501013259,se,o
47,0211-699501013259,correlacionaban,o
47,0211-699501013259,inversamente,o
47,0211-699501013259,con,o
47,0211-699501013259,los,o
47,0211-699501013259,del,o
47,0211-699501013259,folato,i
47,0211-699501013259,r,o
47,0211-699501013259,0336,o
47,0211-699501013259,p,o
47,0211-699501013259,001,o
47,0211-699501013259,pero,o
47,0211-699501013259,no,o
47,0211-699501013259,con,o
47,0211-699501013259,pp,i
47,0211-699501013259,B12,i
47,0211-699501013259,edad,o
47,0211-699501013259,albumina,i
47,0211-699501013259,KTV,o
47,0211-699501013259,KRU,o
47,0211-699501013259,PCRn,o
47,0211-699501013259,Cincuenta,o
47,0211-699501013259,y,o
47,0211-699501013259,ocho,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,recibieron,o
47,0211-699501013259,seis,o
47,0211-699501013259,meses,o
47,0211-699501013259,de,o
47,0211-699501013259,suplementacion,i
47,0211-699501013259,con,o
47,0211-699501013259,normalizacion,o
47,0211-699501013259,del,o
47,0211-699501013259,pp,i
47,0211-699501013259,aumento,o
47,0211-699501013259,del,o
47,0211-699501013259,folato,i
47,0211-699501013259,703,o
47,0211-699501013259,IC,o
47,0211-699501013259,638,o
47,0211-699501013259,795,o
47,0211-699501013259,vs,o
47,0211-699501013259,6181,o
47,0211-699501013259,IC,o
47,0211-699501013259,4447,o
47,0211-699501013259,7811,o
47,0211-699501013259,p,o
47,0211-699501013259,0001,o
47,0211-699501013259,y,o
47,0211-699501013259,descenso,o
47,0211-699501013259,de,o
47,0211-699501013259,la,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,240,o
47,0211-699501013259,IC,o
47,0211-699501013259,213,o
47,0211-699501013259,264,o
47,0211-699501013259,vs,o
47,0211-699501013259,199,o
47,0211-699501013259,IC,o
47,0211-699501013259,175,o
47,0211-699501013259,224,o
47,0211-699501013259,p,o
47,0211-699501013259,005,o
47,0211-699501013259,Han,o
47,0211-699501013259,recibido,o
47,0211-699501013259,suplementacion,i
47,0211-699501013259,durante,o
47,0211-699501013259,12,o
47,0211-699501013259,meses,o
47,0211-699501013259,33,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,pero,o
47,0211-699501013259,a,o
47,0211-699501013259,pesar,o
47,0211-699501013259,de,o
47,0211-699501013259,un,o
47,0211-699501013259,continuo,o
47,0211-699501013259,aumento,o
47,0211-699501013259,del,o
47,0211-699501013259,folato,i
47,0211-699501013259,10078,o
47,0211-699501013259,IC,o
47,0211-699501013259,7481,o
47,0211-699501013259,12674,o
47,0211-699501013259,p,o
47,0211-699501013259,0001,o
47,0211-699501013259,solo,o
47,0211-699501013259,3,o
47,0211-699501013259,pacientes,o
47,0211-699501013259,presentan,o
47,0211-699501013259,niveles,o
47,0211-699501013259,normales,o
47,0211-699501013259,de,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,correlacionandose,o
47,0211-699501013259,directamente,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,con,o
47,0211-699501013259,la,o
47,0211-699501013259,albumina,i
47,0211-699501013259,r,o
47,0211-699501013259,056,o
47,0211-699501013259,p,o
47,0211-699501013259,0001,o
47,0211-699501013259,que,o
47,0211-699501013259,se,o
47,0211-699501013259,elevo,o
47,0211-699501013259,con,o
47,0211-699501013259,respecto,o
47,0211-699501013259,al,o
47,0211-699501013259,inicio,o
47,0211-699501013259,337,o
47,0211-699501013259,IC,o
47,0211-699501013259,327,o
47,0211-699501013259,346,o
47,0211-699501013259,vs,o
47,0211-699501013259,350,o
47,0211-699501013259,IC,o
47,0211-699501013259,337,o
47,0211-699501013259,363,o
47,0211-699501013259,p,o
47,0211-699501013259,005,o
47,0211-699501013259,Conclusion,o
47,0211-699501013259,Tras,o
47,0211-699501013259,suplementacion,i
47,0211-699501013259,con,o
47,0211-699501013259,acido,i
47,0211-699501013259,folico,i
47,0211-699501013259,y,o
47,0211-699501013259,vitamina,i
47,0211-699501013259,B6,i
47,0211-699501013259,aunque,o
47,0211-699501013259,inicialmente,o
47,0211-699501013259,se,o
47,0211-699501013259,reduce,o
47,0211-699501013259,la,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,esta,o
47,0211-699501013259,respuesta,o
47,0211-699501013259,se,o
47,0211-699501013259,hace,o
47,0211-699501013259,refractaria,o
47,0211-699501013259,correlacionandose,o
47,0211-699501013259,directamente,o
47,0211-699501013259,la,o
47,0211-699501013259,tHcy,i
47,0211-699501013259,con,o
47,0211-699501013259,la,o
47,0211-699501013259,albumina,i
47,0211-699501013259,plasmatica,i
47,0211-699501013259,La,o
47,0211-699501013259,interpretacion,o
47,0211-699501013259,de,o
47,0211-699501013259,los,o
47,0211-699501013259,niveles,i
47,0211-699501013259,de,i
47,0211-699501013259,tHcy,i
47,0211-699501013259,debe,o
47,0211-699501013259,tener,o
47,0211-699501013259,en,o
47,0211-699501013259,cuenta,o
47,0211-699501013259,la,o
47,0211-699501013259,concentracion,i
47,0211-699501013259,de,i
47,0211-699501013259,albumina,i
48,0211-699501013259,Efecto,o
48,0211-699501013259,de,o
48,0211-699501013259,la,o
48,0211-699501013259,suplementacion,i
48,0211-699501013259,con,o
48,0211-699501013259,acido,i
48,0211-699501013259,folico,i
48,0211-699501013259,sobre,o
48,0211-699501013259,los,o
48,0211-699501013259,niveles,i
48,0211-699501013259,de,i
48,0211-699501013259,homocisteina,i
48,0211-699501013259,total,o
48,0211-699501013259,en,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,en,o
48,0211-699501013259,hemodialisis,i
48,0211-699501013259,La,o
48,0211-699501013259,hiperhomocisteinemia,i
48,0211-699501013259,es,o
48,0211-699501013259,un,o
48,0211-699501013259,marcador,o
48,0211-699501013259,de,o
48,0211-699501013259,riesgo,o
48,0211-699501013259,independiente,o
48,0211-699501013259,de,o
48,0211-699501013259,morbimortalidad,o
48,0211-699501013259,cardiovascular,i
48,0211-699501013259,Hemos,o
48,0211-699501013259,intentado,o
48,0211-699501013259,prospectivamente,o
48,0211-699501013259,reducir,o
48,0211-699501013259,los,o
48,0211-699501013259,niveles,i
48,0211-699501013259,de,i
48,0211-699501013259,homocisteina,i
48,0211-699501013259,total,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,mediante,o
48,0211-699501013259,suplemento,o
48,0211-699501013259,con,o
48,0211-699501013259,acido,i
48,0211-699501013259,folico,i
48,0211-699501013259,y,o
48,0211-699501013259,vitamina,i
48,0211-699501013259,B6,i
48,0211-699501013259,pp,i
48,0211-699501013259,valorando,o
48,0211-699501013259,su,o
48,0211-699501013259,posible,o
48,0211-699501013259,correlacion,o
48,0211-699501013259,con,o
48,0211-699501013259,dosis,o
48,0211-699501013259,de,o
48,0211-699501013259,dialisis,i
48,0211-699501013259,funcion,i
48,0211-699501013259,residual,i
48,0211-699501013259,y,o
48,0211-699501013259,parametros,o
48,0211-699501013259,nutricionales,o
48,0211-699501013259,Metodos,o
48,0211-699501013259,Todos,o
48,0211-699501013259,los,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,en,o
48,0211-699501013259,hemodialisis,i
48,0211-699501013259,al,o
48,0211-699501013259,comienzo,o
48,0211-699501013259,del,o
48,0211-699501013259,estudio,o
48,0211-699501013259,que,o
48,0211-699501013259,no,o
48,0211-699501013259,recibian,o
48,0211-699501013259,acido,i
48,0211-699501013259,folico,i
48,0211-699501013259,ni,o
48,0211-699501013259,vitamina,i
48,0211-699501013259,B6,i
48,0211-699501013259,asi,o
48,0211-699501013259,como,o
48,0211-699501013259,los,o
48,0211-699501013259,incorporados,o
48,0211-699501013259,posteriormente,o
48,0211-699501013259,a,o
48,0211-699501013259,partir,o
48,0211-699501013259,de,o
48,0211-699501013259,su,o
48,0211-699501013259,tercer,o
48,0211-699501013259,mes,o
48,0211-699501013259,en,o
48,0211-699501013259,hemodialisis,i
48,0211-699501013259,recibieron,o
48,0211-699501013259,5,o
48,0211-699501013259,mg,o
48,0211-699501013259,orales,o
48,0211-699501013259,de,o
48,0211-699501013259,acido,i
48,0211-699501013259,folico,i
48,0211-699501013259,cada,o
48,0211-699501013259,48,o
48,0211-699501013259,horas,o
48,0211-699501013259,y,o
48,0211-699501013259,40,o
48,0211-699501013259,mg,o
48,0211-699501013259,orales,o
48,0211-699501013259,de,o
48,0211-699501013259,vitamina,i
48,0211-699501013259,B6,i
48,0211-699501013259,cada,o
48,0211-699501013259,semana,o
48,0211-699501013259,Se,o
48,0211-699501013259,determinaron,o
48,0211-699501013259,al,o
48,0211-699501013259,comienzo,o
48,0211-699501013259,del,o
48,0211-699501013259,estudio,o
48,0211-699501013259,y,o
48,0211-699501013259,cada,o
48,0211-699501013259,2,o
48,0211-699501013259,meses,o
48,0211-699501013259,niveles,i
48,0211-699501013259,de,i
48,0211-699501013259,folato,i
48,0211-699501013259,vitamina,i
48,0211-699501013259,B12,i
48,0211-699501013259,inmunoensayo,i
48,0211-699501013259,albumina,i
48,0211-699501013259,y,o
48,0211-699501013259,cinetica,o
48,0211-699501013259,de,o
48,0211-699501013259,la,o
48,0211-699501013259,urea,i
48,0211-699501013259,KTV,o
48,0211-699501013259,KRU,o
48,0211-699501013259,PCRn,o
48,0211-699501013259,y,o
48,0211-699501013259,cada,o
48,0211-699501013259,6,o
48,0211-699501013259,meses,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,HPLC,i
48,0211-699501013259,y,o
48,0211-699501013259,pp,i
48,0211-699501013259,RIA,i
48,0211-699501013259,Resultados,o
48,0211-699501013259,80,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,fueron,o
48,0211-699501013259,incluidos,o
48,0211-699501013259,en,o
48,0211-699501013259,el,o
48,0211-699501013259,estudio,o
48,0211-699501013259,basal,o
48,0211-699501013259,con,o
48,0211-699501013259,una,o
48,0211-699501013259,prevalencia,o
48,0211-699501013259,de,o
48,0211-699501013259,hiperhomocisteinemia,i
48,0211-699501013259,del,o
48,0211-699501013259,844,o
48,0211-699501013259,deficit,i
48,0211-699501013259,de,i
48,0211-699501013259,pp,i
48,0211-699501013259,en,o
48,0211-699501013259,el,o
48,0211-699501013259,32,o
48,0211-699501013259,y,o
48,0211-699501013259,folato,i
48,0211-699501013259,en,o
48,0211-699501013259,el,o
48,0211-699501013259,rango,o
48,0211-699501013259,normal,o
48,0211-699501013259,bajo,o
48,0211-699501013259,los,o
48,0211-699501013259,niveles,i
48,0211-699501013259,de,i
48,0211-699501013259,tHcy,i
48,0211-699501013259,se,o
48,0211-699501013259,correlacionaban,o
48,0211-699501013259,inversamente,o
48,0211-699501013259,con,o
48,0211-699501013259,los,o
48,0211-699501013259,del,o
48,0211-699501013259,folato,i
48,0211-699501013259,r,o
48,0211-699501013259,0336,o
48,0211-699501013259,p,o
48,0211-699501013259,001,o
48,0211-699501013259,pero,o
48,0211-699501013259,no,o
48,0211-699501013259,con,o
48,0211-699501013259,pp,i
48,0211-699501013259,B12,i
48,0211-699501013259,edad,o
48,0211-699501013259,albumina,i
48,0211-699501013259,KTV,o
48,0211-699501013259,KRU,o
48,0211-699501013259,PCRn,o
48,0211-699501013259,Cincuenta,o
48,0211-699501013259,y,o
48,0211-699501013259,ocho,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,recibieron,o
48,0211-699501013259,seis,o
48,0211-699501013259,meses,o
48,0211-699501013259,de,o
48,0211-699501013259,suplementacion,i
48,0211-699501013259,con,o
48,0211-699501013259,normalizacion,o
48,0211-699501013259,del,o
48,0211-699501013259,pp,i
48,0211-699501013259,aumento,o
48,0211-699501013259,del,o
48,0211-699501013259,folato,i
48,0211-699501013259,703,o
48,0211-699501013259,IC,o
48,0211-699501013259,638,o
48,0211-699501013259,795,o
48,0211-699501013259,vs,o
48,0211-699501013259,6181,o
48,0211-699501013259,IC,o
48,0211-699501013259,4447,o
48,0211-699501013259,7811,o
48,0211-699501013259,p,o
48,0211-699501013259,0001,o
48,0211-699501013259,y,o
48,0211-699501013259,descenso,o
48,0211-699501013259,de,o
48,0211-699501013259,la,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,240,o
48,0211-699501013259,IC,o
48,0211-699501013259,213,o
48,0211-699501013259,264,o
48,0211-699501013259,vs,o
48,0211-699501013259,199,o
48,0211-699501013259,IC,o
48,0211-699501013259,175,o
48,0211-699501013259,224,o
48,0211-699501013259,p,o
48,0211-699501013259,005,o
48,0211-699501013259,Han,o
48,0211-699501013259,recibido,o
48,0211-699501013259,suplementacion,i
48,0211-699501013259,durante,o
48,0211-699501013259,12,o
48,0211-699501013259,meses,o
48,0211-699501013259,33,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,pero,o
48,0211-699501013259,a,o
48,0211-699501013259,pesar,o
48,0211-699501013259,de,o
48,0211-699501013259,un,o
48,0211-699501013259,continuo,o
48,0211-699501013259,aumento,o
48,0211-699501013259,del,o
48,0211-699501013259,folato,i
48,0211-699501013259,10078,o
48,0211-699501013259,IC,o
48,0211-699501013259,7481,o
48,0211-699501013259,12674,o
48,0211-699501013259,p,o
48,0211-699501013259,0001,o
48,0211-699501013259,solo,o
48,0211-699501013259,3,o
48,0211-699501013259,pacientes,o
48,0211-699501013259,presentan,o
48,0211-699501013259,niveles,o
48,0211-699501013259,normales,o
48,0211-699501013259,de,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,correlacionandose,o
48,0211-699501013259,directamente,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,con,o
48,0211-699501013259,la,o
48,0211-699501013259,albumina,i
48,0211-699501013259,r,o
48,0211-699501013259,056,o
48,0211-699501013259,p,o
48,0211-699501013259,0001,o
48,0211-699501013259,que,o
48,0211-699501013259,se,o
48,0211-699501013259,elevo,o
48,0211-699501013259,con,o
48,0211-699501013259,respecto,o
48,0211-699501013259,al,o
48,0211-699501013259,inicio,o
48,0211-699501013259,337,o
48,0211-699501013259,IC,o
48,0211-699501013259,327,o
48,0211-699501013259,346,o
48,0211-699501013259,vs,o
48,0211-699501013259,350,o
48,0211-699501013259,IC,o
48,0211-699501013259,337,o
48,0211-699501013259,363,o
48,0211-699501013259,p,o
48,0211-699501013259,005,o
48,0211-699501013259,Conclusion,o
48,0211-699501013259,Tras,o
48,0211-699501013259,suplementacion,i
48,0211-699501013259,con,o
48,0211-699501013259,acido,i
48,0211-699501013259,folico,i
48,0211-699501013259,y,o
48,0211-699501013259,vitamina,i
48,0211-699501013259,B6,i
48,0211-699501013259,aunque,o
48,0211-699501013259,inicialmente,o
48,0211-699501013259,se,o
48,0211-699501013259,reduce,o
48,0211-699501013259,la,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,esta,o
48,0211-699501013259,respuesta,o
48,0211-699501013259,se,o
48,0211-699501013259,hace,o
48,0211-699501013259,refractaria,o
48,0211-699501013259,correlacionandose,o
48,0211-699501013259,directamente,o
48,0211-699501013259,la,o
48,0211-699501013259,tHcy,i
48,0211-699501013259,con,o
48,0211-699501013259,la,o
48,0211-699501013259,albumina,i
48,0211-699501013259,plasmatica,i
48,0211-699501013259,La,o
48,0211-699501013259,interpretacion,o
48,0211-699501013259,de,o
48,0211-699501013259,los,o
48,0211-699501013259,niveles,i
48,0211-699501013259,de,i
48,0211-699501013259,tHcy,i
48,0211-699501013259,debe,o
48,0211-699501013259,tener,o
48,0211-699501013259,en,o
48,0211-699501013259,cuenta,o
48,0211-699501013259,la,o
48,0211-699501013259,concentracion,i
48,0211-699501013259,de,i
48,0211-699501013259,albumina,i
49,0211-699501013259,Efecto,o
49,0211-699501013259,de,o
49,0211-699501013259,la,o
49,0211-699501013259,suplementacion,i
49,0211-699501013259,con,o
49,0211-699501013259,acido,i
49,0211-699501013259,folico,i
49,0211-699501013259,sobre,o
49,0211-699501013259,los,o
49,0211-699501013259,niveles,i
49,0211-699501013259,de,i
49,0211-699501013259,homocisteina,i
49,0211-699501013259,total,o
49,0211-699501013259,en,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,en,o
49,0211-699501013259,hemodialisis,i
49,0211-699501013259,La,o
49,0211-699501013259,hiperhomocisteinemia,i
49,0211-699501013259,es,o
49,0211-699501013259,un,o
49,0211-699501013259,marcador,o
49,0211-699501013259,de,o
49,0211-699501013259,riesgo,o
49,0211-699501013259,independiente,o
49,0211-699501013259,de,o
49,0211-699501013259,morbimortalidad,o
49,0211-699501013259,cardiovascular,i
49,0211-699501013259,Hemos,o
49,0211-699501013259,intentado,o
49,0211-699501013259,prospectivamente,o
49,0211-699501013259,reducir,o
49,0211-699501013259,los,o
49,0211-699501013259,niveles,i
49,0211-699501013259,de,i
49,0211-699501013259,homocisteina,i
49,0211-699501013259,total,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,mediante,o
49,0211-699501013259,suplemento,o
49,0211-699501013259,con,o
49,0211-699501013259,acido,i
49,0211-699501013259,folico,i
49,0211-699501013259,y,o
49,0211-699501013259,vitamina,i
49,0211-699501013259,B6,i
49,0211-699501013259,pp,i
49,0211-699501013259,valorando,o
49,0211-699501013259,su,o
49,0211-699501013259,posible,o
49,0211-699501013259,correlacion,o
49,0211-699501013259,con,o
49,0211-699501013259,dosis,o
49,0211-699501013259,de,o
49,0211-699501013259,dialisis,i
49,0211-699501013259,funcion,i
49,0211-699501013259,residual,i
49,0211-699501013259,y,o
49,0211-699501013259,parametros,o
49,0211-699501013259,nutricionales,o
49,0211-699501013259,Metodos,o
49,0211-699501013259,Todos,o
49,0211-699501013259,los,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,en,o
49,0211-699501013259,hemodialisis,i
49,0211-699501013259,al,o
49,0211-699501013259,comienzo,o
49,0211-699501013259,del,o
49,0211-699501013259,estudio,o
49,0211-699501013259,que,o
49,0211-699501013259,no,o
49,0211-699501013259,recibian,o
49,0211-699501013259,acido,i
49,0211-699501013259,folico,i
49,0211-699501013259,ni,o
49,0211-699501013259,vitamina,i
49,0211-699501013259,B6,i
49,0211-699501013259,asi,o
49,0211-699501013259,como,o
49,0211-699501013259,los,o
49,0211-699501013259,incorporados,o
49,0211-699501013259,posteriormente,o
49,0211-699501013259,a,o
49,0211-699501013259,partir,o
49,0211-699501013259,de,o
49,0211-699501013259,su,o
49,0211-699501013259,tercer,o
49,0211-699501013259,mes,o
49,0211-699501013259,en,o
49,0211-699501013259,hemodialisis,i
49,0211-699501013259,recibieron,o
49,0211-699501013259,5,o
49,0211-699501013259,mg,o
49,0211-699501013259,orales,o
49,0211-699501013259,de,o
49,0211-699501013259,acido,i
49,0211-699501013259,folico,i
49,0211-699501013259,cada,o
49,0211-699501013259,48,o
49,0211-699501013259,horas,o
49,0211-699501013259,y,o
49,0211-699501013259,40,o
49,0211-699501013259,mg,o
49,0211-699501013259,orales,o
49,0211-699501013259,de,o
49,0211-699501013259,vitamina,i
49,0211-699501013259,B6,i
49,0211-699501013259,cada,o
49,0211-699501013259,semana,o
49,0211-699501013259,Se,o
49,0211-699501013259,determinaron,o
49,0211-699501013259,al,o
49,0211-699501013259,comienzo,o
49,0211-699501013259,del,o
49,0211-699501013259,estudio,o
49,0211-699501013259,y,o
49,0211-699501013259,cada,o
49,0211-699501013259,2,o
49,0211-699501013259,meses,o
49,0211-699501013259,niveles,i
49,0211-699501013259,de,i
49,0211-699501013259,folato,i
49,0211-699501013259,vitamina,i
49,0211-699501013259,B12,i
49,0211-699501013259,inmunoensayo,i
49,0211-699501013259,albumina,i
49,0211-699501013259,y,o
49,0211-699501013259,cinetica,o
49,0211-699501013259,de,o
49,0211-699501013259,la,o
49,0211-699501013259,urea,i
49,0211-699501013259,KTV,o
49,0211-699501013259,KRU,o
49,0211-699501013259,PCRn,o
49,0211-699501013259,y,o
49,0211-699501013259,cada,o
49,0211-699501013259,6,o
49,0211-699501013259,meses,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,HPLC,i
49,0211-699501013259,y,o
49,0211-699501013259,pp,i
49,0211-699501013259,RIA,i
49,0211-699501013259,Resultados,o
49,0211-699501013259,80,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,fueron,o
49,0211-699501013259,incluidos,o
49,0211-699501013259,en,o
49,0211-699501013259,el,o
49,0211-699501013259,estudio,o
49,0211-699501013259,basal,o
49,0211-699501013259,con,o
49,0211-699501013259,una,o
49,0211-699501013259,prevalencia,o
49,0211-699501013259,de,o
49,0211-699501013259,hiperhomocisteinemia,i
49,0211-699501013259,del,o
49,0211-699501013259,844,o
49,0211-699501013259,deficit,i
49,0211-699501013259,de,i
49,0211-699501013259,pp,i
49,0211-699501013259,en,o
49,0211-699501013259,el,o
49,0211-699501013259,32,o
49,0211-699501013259,y,o
49,0211-699501013259,folato,i
49,0211-699501013259,en,o
49,0211-699501013259,el,o
49,0211-699501013259,rango,o
49,0211-699501013259,normal,o
49,0211-699501013259,bajo,o
49,0211-699501013259,los,o
49,0211-699501013259,niveles,i
49,0211-699501013259,de,i
49,0211-699501013259,tHcy,i
49,0211-699501013259,se,o
49,0211-699501013259,correlacionaban,o
49,0211-699501013259,inversamente,o
49,0211-699501013259,con,o
49,0211-699501013259,los,o
49,0211-699501013259,del,o
49,0211-699501013259,folato,i
49,0211-699501013259,r,o
49,0211-699501013259,0336,o
49,0211-699501013259,p,o
49,0211-699501013259,001,o
49,0211-699501013259,pero,o
49,0211-699501013259,no,o
49,0211-699501013259,con,o
49,0211-699501013259,pp,i
49,0211-699501013259,B12,i
49,0211-699501013259,edad,o
49,0211-699501013259,albumina,i
49,0211-699501013259,KTV,o
49,0211-699501013259,KRU,o
49,0211-699501013259,PCRn,o
49,0211-699501013259,Cincuenta,o
49,0211-699501013259,y,o
49,0211-699501013259,ocho,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,recibieron,o
49,0211-699501013259,seis,o
49,0211-699501013259,meses,o
49,0211-699501013259,de,o
49,0211-699501013259,suplementacion,i
49,0211-699501013259,con,o
49,0211-699501013259,normalizacion,o
49,0211-699501013259,del,o
49,0211-699501013259,pp,i
49,0211-699501013259,aumento,o
49,0211-699501013259,del,o
49,0211-699501013259,folato,i
49,0211-699501013259,703,o
49,0211-699501013259,IC,o
49,0211-699501013259,638,o
49,0211-699501013259,795,o
49,0211-699501013259,vs,o
49,0211-699501013259,6181,o
49,0211-699501013259,IC,o
49,0211-699501013259,4447,o
49,0211-699501013259,7811,o
49,0211-699501013259,p,o
49,0211-699501013259,0001,o
49,0211-699501013259,y,o
49,0211-699501013259,descenso,o
49,0211-699501013259,de,o
49,0211-699501013259,la,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,240,o
49,0211-699501013259,IC,o
49,0211-699501013259,213,o
49,0211-699501013259,264,o
49,0211-699501013259,vs,o
49,0211-699501013259,199,o
49,0211-699501013259,IC,o
49,0211-699501013259,175,o
49,0211-699501013259,224,o
49,0211-699501013259,p,o
49,0211-699501013259,005,o
49,0211-699501013259,Han,o
49,0211-699501013259,recibido,o
49,0211-699501013259,suplementacion,i
49,0211-699501013259,durante,o
49,0211-699501013259,12,o
49,0211-699501013259,meses,o
49,0211-699501013259,33,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,pero,o
49,0211-699501013259,a,o
49,0211-699501013259,pesar,o
49,0211-699501013259,de,o
49,0211-699501013259,un,o
49,0211-699501013259,continuo,o
49,0211-699501013259,aumento,o
49,0211-699501013259,del,o
49,0211-699501013259,folato,i
49,0211-699501013259,10078,o
49,0211-699501013259,IC,o
49,0211-699501013259,7481,o
49,0211-699501013259,12674,o
49,0211-699501013259,p,o
49,0211-699501013259,0001,o
49,0211-699501013259,solo,o
49,0211-699501013259,3,o
49,0211-699501013259,pacientes,o
49,0211-699501013259,presentan,o
49,0211-699501013259,niveles,o
49,0211-699501013259,normales,o
49,0211-699501013259,de,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,correlacionandose,o
49,0211-699501013259,directamente,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,con,o
49,0211-699501013259,la,o
49,0211-699501013259,albumina,i
49,0211-699501013259,r,o
49,0211-699501013259,056,o
49,0211-699501013259,p,o
49,0211-699501013259,0001,o
49,0211-699501013259,que,o
49,0211-699501013259,se,o
49,0211-699501013259,elevo,o
49,0211-699501013259,con,o
49,0211-699501013259,respecto,o
49,0211-699501013259,al,o
49,0211-699501013259,inicio,o
49,0211-699501013259,337,o
49,0211-699501013259,IC,o
49,0211-699501013259,327,o
49,0211-699501013259,346,o
49,0211-699501013259,vs,o
49,0211-699501013259,350,o
49,0211-699501013259,IC,o
49,0211-699501013259,337,o
49,0211-699501013259,363,o
49,0211-699501013259,p,o
49,0211-699501013259,005,o
49,0211-699501013259,Conclusion,o
49,0211-699501013259,Tras,o
49,0211-699501013259,suplementacion,i
49,0211-699501013259,con,o
49,0211-699501013259,acido,i
49,0211-699501013259,folico,i
49,0211-699501013259,y,o
49,0211-699501013259,vitamina,i
49,0211-699501013259,B6,i
49,0211-699501013259,aunque,o
49,0211-699501013259,inicialmente,o
49,0211-699501013259,se,o
49,0211-699501013259,reduce,o
49,0211-699501013259,la,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,esta,o
49,0211-699501013259,respuesta,o
49,0211-699501013259,se,o
49,0211-699501013259,hace,o
49,0211-699501013259,refractaria,o
49,0211-699501013259,correlacionandose,o
49,0211-699501013259,directamente,o
49,0211-699501013259,la,o
49,0211-699501013259,tHcy,i
49,0211-699501013259,con,o
49,0211-699501013259,la,o
49,0211-699501013259,albumina,i
49,0211-699501013259,plasmatica,i
49,0211-699501013259,La,o
49,0211-699501013259,interpretacion,o
49,0211-699501013259,de,o
49,0211-699501013259,los,o
49,0211-699501013259,niveles,i
49,0211-699501013259,de,i
49,0211-699501013259,tHcy,i
49,0211-699501013259,debe,o
49,0211-699501013259,tener,o
49,0211-699501013259,en,o
49,0211-699501013259,cuenta,o
49,0211-699501013259,la,o
49,0211-699501013259,concentracion,i
49,0211-699501013259,de,i
49,0211-699501013259,albumina,i
50,0211-699501013259,Efecto,o
50,0211-699501013259,de,o
50,0211-699501013259,la,o
50,0211-699501013259,suplementacion,i
50,0211-699501013259,con,o
50,0211-699501013259,acido,i
50,0211-699501013259,folico,i
50,0211-699501013259,sobre,o
50,0211-699501013259,los,o
50,0211-699501013259,niveles,i
50,0211-699501013259,de,i
50,0211-699501013259,homocisteina,i
50,0211-699501013259,total,o
50,0211-699501013259,en,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,en,o
50,0211-699501013259,hemodialisis,i
50,0211-699501013259,La,o
50,0211-699501013259,hiperhomocisteinemia,i
50,0211-699501013259,es,o
50,0211-699501013259,un,o
50,0211-699501013259,marcador,o
50,0211-699501013259,de,o
50,0211-699501013259,riesgo,o
50,0211-699501013259,independiente,o
50,0211-699501013259,de,o
50,0211-699501013259,morbimortalidad,o
50,0211-699501013259,cardiovascular,i
50,0211-699501013259,Hemos,o
50,0211-699501013259,intentado,o
50,0211-699501013259,prospectivamente,o
50,0211-699501013259,reducir,o
50,0211-699501013259,los,o
50,0211-699501013259,niveles,i
50,0211-699501013259,de,i
50,0211-699501013259,homocisteina,i
50,0211-699501013259,total,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,mediante,o
50,0211-699501013259,suplemento,o
50,0211-699501013259,con,o
50,0211-699501013259,acido,i
50,0211-699501013259,folico,i
50,0211-699501013259,y,o
50,0211-699501013259,vitamina,i
50,0211-699501013259,B6,i
50,0211-699501013259,pp,i
50,0211-699501013259,valorando,o
50,0211-699501013259,su,o
50,0211-699501013259,posible,o
50,0211-699501013259,correlacion,o
50,0211-699501013259,con,o
50,0211-699501013259,dosis,o
50,0211-699501013259,de,o
50,0211-699501013259,dialisis,i
50,0211-699501013259,funcion,i
50,0211-699501013259,residual,i
50,0211-699501013259,y,o
50,0211-699501013259,parametros,o
50,0211-699501013259,nutricionales,o
50,0211-699501013259,Metodos,o
50,0211-699501013259,Todos,o
50,0211-699501013259,los,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,en,o
50,0211-699501013259,hemodialisis,i
50,0211-699501013259,al,o
50,0211-699501013259,comienzo,o
50,0211-699501013259,del,o
50,0211-699501013259,estudio,o
50,0211-699501013259,que,o
50,0211-699501013259,no,o
50,0211-699501013259,recibian,o
50,0211-699501013259,acido,i
50,0211-699501013259,folico,i
50,0211-699501013259,ni,o
50,0211-699501013259,vitamina,i
50,0211-699501013259,B6,i
50,0211-699501013259,asi,o
50,0211-699501013259,como,o
50,0211-699501013259,los,o
50,0211-699501013259,incorporados,o
50,0211-699501013259,posteriormente,o
50,0211-699501013259,a,o
50,0211-699501013259,partir,o
50,0211-699501013259,de,o
50,0211-699501013259,su,o
50,0211-699501013259,tercer,o
50,0211-699501013259,mes,o
50,0211-699501013259,en,o
50,0211-699501013259,hemodialisis,i
50,0211-699501013259,recibieron,o
50,0211-699501013259,5,o
50,0211-699501013259,mg,o
50,0211-699501013259,orales,o
50,0211-699501013259,de,o
50,0211-699501013259,acido,i
50,0211-699501013259,folico,i
50,0211-699501013259,cada,o
50,0211-699501013259,48,o
50,0211-699501013259,horas,o
50,0211-699501013259,y,o
50,0211-699501013259,40,o
50,0211-699501013259,mg,o
50,0211-699501013259,orales,o
50,0211-699501013259,de,o
50,0211-699501013259,vitamina,i
50,0211-699501013259,B6,i
50,0211-699501013259,cada,o
50,0211-699501013259,semana,o
50,0211-699501013259,Se,o
50,0211-699501013259,determinaron,o
50,0211-699501013259,al,o
50,0211-699501013259,comienzo,o
50,0211-699501013259,del,o
50,0211-699501013259,estudio,o
50,0211-699501013259,y,o
50,0211-699501013259,cada,o
50,0211-699501013259,2,o
50,0211-699501013259,meses,o
50,0211-699501013259,niveles,i
50,0211-699501013259,de,i
50,0211-699501013259,folato,i
50,0211-699501013259,vitamina,i
50,0211-699501013259,B12,i
50,0211-699501013259,inmunoensayo,i
50,0211-699501013259,albumina,i
50,0211-699501013259,y,o
50,0211-699501013259,cinetica,o
50,0211-699501013259,de,o
50,0211-699501013259,la,o
50,0211-699501013259,urea,i
50,0211-699501013259,KTV,o
50,0211-699501013259,KRU,o
50,0211-699501013259,PCRn,o
50,0211-699501013259,y,o
50,0211-699501013259,cada,o
50,0211-699501013259,6,o
50,0211-699501013259,meses,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,HPLC,i
50,0211-699501013259,y,o
50,0211-699501013259,pp,i
50,0211-699501013259,RIA,i
50,0211-699501013259,Resultados,o
50,0211-699501013259,80,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,fueron,o
50,0211-699501013259,incluidos,o
50,0211-699501013259,en,o
50,0211-699501013259,el,o
50,0211-699501013259,estudio,o
50,0211-699501013259,basal,o
50,0211-699501013259,con,o
50,0211-699501013259,una,o
50,0211-699501013259,prevalencia,o
50,0211-699501013259,de,o
50,0211-699501013259,hiperhomocisteinemia,i
50,0211-699501013259,del,o
50,0211-699501013259,844,o
50,0211-699501013259,deficit,i
50,0211-699501013259,de,i
50,0211-699501013259,pp,i
50,0211-699501013259,en,o
50,0211-699501013259,el,o
50,0211-699501013259,32,o
50,0211-699501013259,y,o
50,0211-699501013259,folato,i
50,0211-699501013259,en,o
50,0211-699501013259,el,o
50,0211-699501013259,rango,o
50,0211-699501013259,normal,o
50,0211-699501013259,bajo,o
50,0211-699501013259,los,o
50,0211-699501013259,niveles,i
50,0211-699501013259,de,i
50,0211-699501013259,tHcy,i
50,0211-699501013259,se,o
50,0211-699501013259,correlacionaban,o
50,0211-699501013259,inversamente,o
50,0211-699501013259,con,o
50,0211-699501013259,los,o
50,0211-699501013259,del,o
50,0211-699501013259,folato,i
50,0211-699501013259,r,o
50,0211-699501013259,0336,o
50,0211-699501013259,p,o
50,0211-699501013259,001,o
50,0211-699501013259,pero,o
50,0211-699501013259,no,o
50,0211-699501013259,con,o
50,0211-699501013259,pp,i
50,0211-699501013259,B12,i
50,0211-699501013259,edad,o
50,0211-699501013259,albumina,i
50,0211-699501013259,KTV,o
50,0211-699501013259,KRU,o
50,0211-699501013259,PCRn,o
50,0211-699501013259,Cincuenta,o
50,0211-699501013259,y,o
50,0211-699501013259,ocho,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,recibieron,o
50,0211-699501013259,seis,o
50,0211-699501013259,meses,o
50,0211-699501013259,de,o
50,0211-699501013259,suplementacion,i
50,0211-699501013259,con,o
50,0211-699501013259,normalizacion,o
50,0211-699501013259,del,o
50,0211-699501013259,pp,i
50,0211-699501013259,aumento,o
50,0211-699501013259,del,o
50,0211-699501013259,folato,i
50,0211-699501013259,703,o
50,0211-699501013259,IC,o
50,0211-699501013259,638,o
50,0211-699501013259,795,o
50,0211-699501013259,vs,o
50,0211-699501013259,6181,o
50,0211-699501013259,IC,o
50,0211-699501013259,4447,o
50,0211-699501013259,7811,o
50,0211-699501013259,p,o
50,0211-699501013259,0001,o
50,0211-699501013259,y,o
50,0211-699501013259,descenso,o
50,0211-699501013259,de,o
50,0211-699501013259,la,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,240,o
50,0211-699501013259,IC,o
50,0211-699501013259,213,o
50,0211-699501013259,264,o
50,0211-699501013259,vs,o
50,0211-699501013259,199,o
50,0211-699501013259,IC,o
50,0211-699501013259,175,o
50,0211-699501013259,224,o
50,0211-699501013259,p,o
50,0211-699501013259,005,o
50,0211-699501013259,Han,o
50,0211-699501013259,recibido,o
50,0211-699501013259,suplementacion,i
50,0211-699501013259,durante,o
50,0211-699501013259,12,o
50,0211-699501013259,meses,o
50,0211-699501013259,33,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,pero,o
50,0211-699501013259,a,o
50,0211-699501013259,pesar,o
50,0211-699501013259,de,o
50,0211-699501013259,un,o
50,0211-699501013259,continuo,o
50,0211-699501013259,aumento,o
50,0211-699501013259,del,o
50,0211-699501013259,folato,i
50,0211-699501013259,10078,o
50,0211-699501013259,IC,o
50,0211-699501013259,7481,o
50,0211-699501013259,12674,o
50,0211-699501013259,p,o
50,0211-699501013259,0001,o
50,0211-699501013259,solo,o
50,0211-699501013259,3,o
50,0211-699501013259,pacientes,o
50,0211-699501013259,presentan,o
50,0211-699501013259,niveles,o
50,0211-699501013259,normales,o
50,0211-699501013259,de,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,correlacionandose,o
50,0211-699501013259,directamente,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,con,o
50,0211-699501013259,la,o
50,0211-699501013259,albumina,i
50,0211-699501013259,r,o
50,0211-699501013259,056,o
50,0211-699501013259,p,o
50,0211-699501013259,0001,o
50,0211-699501013259,que,o
50,0211-699501013259,se,o
50,0211-699501013259,elevo,o
50,0211-699501013259,con,o
50,0211-699501013259,respecto,o
50,0211-699501013259,al,o
50,0211-699501013259,inicio,o
50,0211-699501013259,337,o
50,0211-699501013259,IC,o
50,0211-699501013259,327,o
50,0211-699501013259,346,o
50,0211-699501013259,vs,o
50,0211-699501013259,350,o
50,0211-699501013259,IC,o
50,0211-699501013259,337,o
50,0211-699501013259,363,o
50,0211-699501013259,p,o
50,0211-699501013259,005,o
50,0211-699501013259,Conclusion,o
50,0211-699501013259,Tras,o
50,0211-699501013259,suplementacion,i
50,0211-699501013259,con,o
50,0211-699501013259,acido,i
50,0211-699501013259,folico,i
50,0211-699501013259,y,o
50,0211-699501013259,vitamina,i
50,0211-699501013259,B6,i
50,0211-699501013259,aunque,o
50,0211-699501013259,inicialmente,o
50,0211-699501013259,se,o
50,0211-699501013259,reduce,o
50,0211-699501013259,la,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,esta,o
50,0211-699501013259,respuesta,o
50,0211-699501013259,se,o
50,0211-699501013259,hace,o
50,0211-699501013259,refractaria,o
50,0211-699501013259,correlacionandose,o
50,0211-699501013259,directamente,o
50,0211-699501013259,la,o
50,0211-699501013259,tHcy,i
50,0211-699501013259,con,o
50,0211-699501013259,la,o
50,0211-699501013259,albumina,i
50,0211-699501013259,plasmatica,i
50,0211-699501013259,La,o
50,0211-699501013259,interpretacion,o
50,0211-699501013259,de,o
50,0211-699501013259,los,o
50,0211-699501013259,niveles,i
50,0211-699501013259,de,i
50,0211-699501013259,tHcy,i
50,0211-699501013259,debe,o
50,0211-699501013259,tener,o
50,0211-699501013259,en,o
50,0211-699501013259,cuenta,o
50,0211-699501013259,la,o
50,0211-699501013259,concentracion,i
50,0211-699501013259,de,i
50,0211-699501013259,albumina,i
51,0211-699501013259,Efecto,o
51,0211-699501013259,de,o
51,0211-699501013259,la,o
51,0211-699501013259,suplementacion,i
51,0211-699501013259,con,o
51,0211-699501013259,acido,i
51,0211-699501013259,folico,i
51,0211-699501013259,sobre,o
51,0211-699501013259,los,o
51,0211-699501013259,niveles,i
51,0211-699501013259,de,i
51,0211-699501013259,homocisteina,i
51,0211-699501013259,total,o
51,0211-699501013259,en,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,en,o
51,0211-699501013259,hemodialisis,i
51,0211-699501013259,La,o
51,0211-699501013259,hiperhomocisteinemia,i
51,0211-699501013259,es,o
51,0211-699501013259,un,o
51,0211-699501013259,marcador,o
51,0211-699501013259,de,o
51,0211-699501013259,riesgo,o
51,0211-699501013259,independiente,o
51,0211-699501013259,de,o
51,0211-699501013259,morbimortalidad,o
51,0211-699501013259,cardiovascular,i
51,0211-699501013259,Hemos,o
51,0211-699501013259,intentado,o
51,0211-699501013259,prospectivamente,o
51,0211-699501013259,reducir,o
51,0211-699501013259,los,o
51,0211-699501013259,niveles,i
51,0211-699501013259,de,i
51,0211-699501013259,homocisteina,i
51,0211-699501013259,total,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,mediante,o
51,0211-699501013259,suplemento,o
51,0211-699501013259,con,o
51,0211-699501013259,acido,i
51,0211-699501013259,folico,i
51,0211-699501013259,y,o
51,0211-699501013259,vitamina,i
51,0211-699501013259,B6,i
51,0211-699501013259,pp,i
51,0211-699501013259,valorando,o
51,0211-699501013259,su,o
51,0211-699501013259,posible,o
51,0211-699501013259,correlacion,o
51,0211-699501013259,con,o
51,0211-699501013259,dosis,o
51,0211-699501013259,de,o
51,0211-699501013259,dialisis,i
51,0211-699501013259,funcion,i
51,0211-699501013259,residual,i
51,0211-699501013259,y,o
51,0211-699501013259,parametros,o
51,0211-699501013259,nutricionales,o
51,0211-699501013259,Metodos,o
51,0211-699501013259,Todos,o
51,0211-699501013259,los,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,en,o
51,0211-699501013259,hemodialisis,i
51,0211-699501013259,al,o
51,0211-699501013259,comienzo,o
51,0211-699501013259,del,o
51,0211-699501013259,estudio,o
51,0211-699501013259,que,o
51,0211-699501013259,no,o
51,0211-699501013259,recibian,o
51,0211-699501013259,acido,i
51,0211-699501013259,folico,i
51,0211-699501013259,ni,o
51,0211-699501013259,vitamina,i
51,0211-699501013259,B6,i
51,0211-699501013259,asi,o
51,0211-699501013259,como,o
51,0211-699501013259,los,o
51,0211-699501013259,incorporados,o
51,0211-699501013259,posteriormente,o
51,0211-699501013259,a,o
51,0211-699501013259,partir,o
51,0211-699501013259,de,o
51,0211-699501013259,su,o
51,0211-699501013259,tercer,o
51,0211-699501013259,mes,o
51,0211-699501013259,en,o
51,0211-699501013259,hemodialisis,i
51,0211-699501013259,recibieron,o
51,0211-699501013259,5,o
51,0211-699501013259,mg,o
51,0211-699501013259,orales,o
51,0211-699501013259,de,o
51,0211-699501013259,acido,i
51,0211-699501013259,folico,i
51,0211-699501013259,cada,o
51,0211-699501013259,48,o
51,0211-699501013259,horas,o
51,0211-699501013259,y,o
51,0211-699501013259,40,o
51,0211-699501013259,mg,o
51,0211-699501013259,orales,o
51,0211-699501013259,de,o
51,0211-699501013259,vitamina,i
51,0211-699501013259,B6,i
51,0211-699501013259,cada,o
51,0211-699501013259,semana,o
51,0211-699501013259,Se,o
51,0211-699501013259,determinaron,o
51,0211-699501013259,al,o
51,0211-699501013259,comienzo,o
51,0211-699501013259,del,o
51,0211-699501013259,estudio,o
51,0211-699501013259,y,o
51,0211-699501013259,cada,o
51,0211-699501013259,2,o
51,0211-699501013259,meses,o
51,0211-699501013259,niveles,i
51,0211-699501013259,de,i
51,0211-699501013259,folato,i
51,0211-699501013259,vitamina,i
51,0211-699501013259,B12,i
51,0211-699501013259,inmunoensayo,i
51,0211-699501013259,albumina,i
51,0211-699501013259,y,o
51,0211-699501013259,cinetica,o
51,0211-699501013259,de,o
51,0211-699501013259,la,o
51,0211-699501013259,urea,i
51,0211-699501013259,KTV,o
51,0211-699501013259,KRU,o
51,0211-699501013259,PCRn,o
51,0211-699501013259,y,o
51,0211-699501013259,cada,o
51,0211-699501013259,6,o
51,0211-699501013259,meses,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,HPLC,i
51,0211-699501013259,y,o
51,0211-699501013259,pp,i
51,0211-699501013259,RIA,i
51,0211-699501013259,Resultados,o
51,0211-699501013259,80,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,fueron,o
51,0211-699501013259,incluidos,o
51,0211-699501013259,en,o
51,0211-699501013259,el,o
51,0211-699501013259,estudio,o
51,0211-699501013259,basal,o
51,0211-699501013259,con,o
51,0211-699501013259,una,o
51,0211-699501013259,prevalencia,o
51,0211-699501013259,de,o
51,0211-699501013259,hiperhomocisteinemia,i
51,0211-699501013259,del,o
51,0211-699501013259,844,o
51,0211-699501013259,deficit,i
51,0211-699501013259,de,i
51,0211-699501013259,pp,i
51,0211-699501013259,en,o
51,0211-699501013259,el,o
51,0211-699501013259,32,o
51,0211-699501013259,y,o
51,0211-699501013259,folato,i
51,0211-699501013259,en,o
51,0211-699501013259,el,o
51,0211-699501013259,rango,o
51,0211-699501013259,normal,o
51,0211-699501013259,bajo,o
51,0211-699501013259,los,o
51,0211-699501013259,niveles,i
51,0211-699501013259,de,i
51,0211-699501013259,tHcy,i
51,0211-699501013259,se,o
51,0211-699501013259,correlacionaban,o
51,0211-699501013259,inversamente,o
51,0211-699501013259,con,o
51,0211-699501013259,los,o
51,0211-699501013259,del,o
51,0211-699501013259,folato,i
51,0211-699501013259,r,o
51,0211-699501013259,0336,o
51,0211-699501013259,p,o
51,0211-699501013259,001,o
51,0211-699501013259,pero,o
51,0211-699501013259,no,o
51,0211-699501013259,con,o
51,0211-699501013259,pp,i
51,0211-699501013259,B12,i
51,0211-699501013259,edad,o
51,0211-699501013259,albumina,i
51,0211-699501013259,KTV,o
51,0211-699501013259,KRU,o
51,0211-699501013259,PCRn,o
51,0211-699501013259,Cincuenta,o
51,0211-699501013259,y,o
51,0211-699501013259,ocho,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,recibieron,o
51,0211-699501013259,seis,o
51,0211-699501013259,meses,o
51,0211-699501013259,de,o
51,0211-699501013259,suplementacion,i
51,0211-699501013259,con,o
51,0211-699501013259,normalizacion,o
51,0211-699501013259,del,o
51,0211-699501013259,pp,i
51,0211-699501013259,aumento,o
51,0211-699501013259,del,o
51,0211-699501013259,folato,i
51,0211-699501013259,703,o
51,0211-699501013259,IC,o
51,0211-699501013259,638,o
51,0211-699501013259,795,o
51,0211-699501013259,vs,o
51,0211-699501013259,6181,o
51,0211-699501013259,IC,o
51,0211-699501013259,4447,o
51,0211-699501013259,7811,o
51,0211-699501013259,p,o
51,0211-699501013259,0001,o
51,0211-699501013259,y,o
51,0211-699501013259,descenso,o
51,0211-699501013259,de,o
51,0211-699501013259,la,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,240,o
51,0211-699501013259,IC,o
51,0211-699501013259,213,o
51,0211-699501013259,264,o
51,0211-699501013259,vs,o
51,0211-699501013259,199,o
51,0211-699501013259,IC,o
51,0211-699501013259,175,o
51,0211-699501013259,224,o
51,0211-699501013259,p,o
51,0211-699501013259,005,o
51,0211-699501013259,Han,o
51,0211-699501013259,recibido,o
51,0211-699501013259,suplementacion,i
51,0211-699501013259,durante,o
51,0211-699501013259,12,o
51,0211-699501013259,meses,o
51,0211-699501013259,33,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,pero,o
51,0211-699501013259,a,o
51,0211-699501013259,pesar,o
51,0211-699501013259,de,o
51,0211-699501013259,un,o
51,0211-699501013259,continuo,o
51,0211-699501013259,aumento,o
51,0211-699501013259,del,o
51,0211-699501013259,folato,i
51,0211-699501013259,10078,o
51,0211-699501013259,IC,o
51,0211-699501013259,7481,o
51,0211-699501013259,12674,o
51,0211-699501013259,p,o
51,0211-699501013259,0001,o
51,0211-699501013259,solo,o
51,0211-699501013259,3,o
51,0211-699501013259,pacientes,o
51,0211-699501013259,presentan,o
51,0211-699501013259,niveles,o
51,0211-699501013259,normales,o
51,0211-699501013259,de,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,correlacionandose,o
51,0211-699501013259,directamente,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,con,o
51,0211-699501013259,la,o
51,0211-699501013259,albumina,i
51,0211-699501013259,r,o
51,0211-699501013259,056,o
51,0211-699501013259,p,o
51,0211-699501013259,0001,o
51,0211-699501013259,que,o
51,0211-699501013259,se,o
51,0211-699501013259,elevo,o
51,0211-699501013259,con,o
51,0211-699501013259,respecto,o
51,0211-699501013259,al,o
51,0211-699501013259,inicio,o
51,0211-699501013259,337,o
51,0211-699501013259,IC,o
51,0211-699501013259,327,o
51,0211-699501013259,346,o
51,0211-699501013259,vs,o
51,0211-699501013259,350,o
51,0211-699501013259,IC,o
51,0211-699501013259,337,o
51,0211-699501013259,363,o
51,0211-699501013259,p,o
51,0211-699501013259,005,o
51,0211-699501013259,Conclusion,o
51,0211-699501013259,Tras,o
51,0211-699501013259,suplementacion,i
51,0211-699501013259,con,o
51,0211-699501013259,acido,i
51,0211-699501013259,folico,i
51,0211-699501013259,y,o
51,0211-699501013259,vitamina,i
51,0211-699501013259,B6,i
51,0211-699501013259,aunque,o
51,0211-699501013259,inicialmente,o
51,0211-699501013259,se,o
51,0211-699501013259,reduce,o
51,0211-699501013259,la,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,esta,o
51,0211-699501013259,respuesta,o
51,0211-699501013259,se,o
51,0211-699501013259,hace,o
51,0211-699501013259,refractaria,o
51,0211-699501013259,correlacionandose,o
51,0211-699501013259,directamente,o
51,0211-699501013259,la,o
51,0211-699501013259,tHcy,i
51,0211-699501013259,con,o
51,0211-699501013259,la,o
51,0211-699501013259,albumina,i
51,0211-699501013259,plasmatica,i
51,0211-699501013259,La,o
51,0211-699501013259,interpretacion,o
51,0211-699501013259,de,o
51,0211-699501013259,los,o
51,0211-699501013259,niveles,i
51,0211-699501013259,de,i
51,0211-699501013259,tHcy,i
51,0211-699501013259,debe,o
51,0211-699501013259,tener,o
51,0211-699501013259,en,o
51,0211-699501013259,cuenta,o
51,0211-699501013259,la,o
51,0211-699501013259,concentracion,i
51,0211-699501013259,de,i
51,0211-699501013259,albumina,i
52,0211-699501013259,Efecto,o
52,0211-699501013259,de,o
52,0211-699501013259,la,o
52,0211-699501013259,suplementacion,i
52,0211-699501013259,con,o
52,0211-699501013259,acido,i
52,0211-699501013259,folico,i
52,0211-699501013259,sobre,o
52,0211-699501013259,los,o
52,0211-699501013259,niveles,i
52,0211-699501013259,de,i
52,0211-699501013259,homocisteina,i
52,0211-699501013259,total,o
52,0211-699501013259,en,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,en,o
52,0211-699501013259,hemodialisis,i
52,0211-699501013259,La,o
52,0211-699501013259,hiperhomocisteinemia,i
52,0211-699501013259,es,o
52,0211-699501013259,un,o
52,0211-699501013259,marcador,o
52,0211-699501013259,de,o
52,0211-699501013259,riesgo,o
52,0211-699501013259,independiente,o
52,0211-699501013259,de,o
52,0211-699501013259,morbimortalidad,o
52,0211-699501013259,cardiovascular,i
52,0211-699501013259,Hemos,o
52,0211-699501013259,intentado,o
52,0211-699501013259,prospectivamente,o
52,0211-699501013259,reducir,o
52,0211-699501013259,los,o
52,0211-699501013259,niveles,i
52,0211-699501013259,de,i
52,0211-699501013259,homocisteina,i
52,0211-699501013259,total,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,mediante,o
52,0211-699501013259,suplemento,o
52,0211-699501013259,con,o
52,0211-699501013259,acido,i
52,0211-699501013259,folico,i
52,0211-699501013259,y,o
52,0211-699501013259,vitamina,i
52,0211-699501013259,B6,i
52,0211-699501013259,pp,i
52,0211-699501013259,valorando,o
52,0211-699501013259,su,o
52,0211-699501013259,posible,o
52,0211-699501013259,correlacion,o
52,0211-699501013259,con,o
52,0211-699501013259,dosis,o
52,0211-699501013259,de,o
52,0211-699501013259,dialisis,i
52,0211-699501013259,funcion,i
52,0211-699501013259,residual,i
52,0211-699501013259,y,o
52,0211-699501013259,parametros,o
52,0211-699501013259,nutricionales,o
52,0211-699501013259,Metodos,o
52,0211-699501013259,Todos,o
52,0211-699501013259,los,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,en,o
52,0211-699501013259,hemodialisis,i
52,0211-699501013259,al,o
52,0211-699501013259,comienzo,o
52,0211-699501013259,del,o
52,0211-699501013259,estudio,o
52,0211-699501013259,que,o
52,0211-699501013259,no,o
52,0211-699501013259,recibian,o
52,0211-699501013259,acido,i
52,0211-699501013259,folico,i
52,0211-699501013259,ni,o
52,0211-699501013259,vitamina,i
52,0211-699501013259,B6,i
52,0211-699501013259,asi,o
52,0211-699501013259,como,o
52,0211-699501013259,los,o
52,0211-699501013259,incorporados,o
52,0211-699501013259,posteriormente,o
52,0211-699501013259,a,o
52,0211-699501013259,partir,o
52,0211-699501013259,de,o
52,0211-699501013259,su,o
52,0211-699501013259,tercer,o
52,0211-699501013259,mes,o
52,0211-699501013259,en,o
52,0211-699501013259,hemodialisis,i
52,0211-699501013259,recibieron,o
52,0211-699501013259,5,o
52,0211-699501013259,mg,o
52,0211-699501013259,orales,o
52,0211-699501013259,de,o
52,0211-699501013259,acido,i
52,0211-699501013259,folico,i
52,0211-699501013259,cada,o
52,0211-699501013259,48,o
52,0211-699501013259,horas,o
52,0211-699501013259,y,o
52,0211-699501013259,40,o
52,0211-699501013259,mg,o
52,0211-699501013259,orales,o
52,0211-699501013259,de,o
52,0211-699501013259,vitamina,i
52,0211-699501013259,B6,i
52,0211-699501013259,cada,o
52,0211-699501013259,semana,o
52,0211-699501013259,Se,o
52,0211-699501013259,determinaron,o
52,0211-699501013259,al,o
52,0211-699501013259,comienzo,o
52,0211-699501013259,del,o
52,0211-699501013259,estudio,o
52,0211-699501013259,y,o
52,0211-699501013259,cada,o
52,0211-699501013259,2,o
52,0211-699501013259,meses,o
52,0211-699501013259,niveles,i
52,0211-699501013259,de,i
52,0211-699501013259,folato,i
52,0211-699501013259,vitamina,i
52,0211-699501013259,B12,i
52,0211-699501013259,inmunoensayo,i
52,0211-699501013259,albumina,i
52,0211-699501013259,y,o
52,0211-699501013259,cinetica,o
52,0211-699501013259,de,o
52,0211-699501013259,la,o
52,0211-699501013259,urea,i
52,0211-699501013259,KTV,o
52,0211-699501013259,KRU,o
52,0211-699501013259,PCRn,o
52,0211-699501013259,y,o
52,0211-699501013259,cada,o
52,0211-699501013259,6,o
52,0211-699501013259,meses,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,HPLC,i
52,0211-699501013259,y,o
52,0211-699501013259,pp,i
52,0211-699501013259,RIA,i
52,0211-699501013259,Resultados,o
52,0211-699501013259,80,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,fueron,o
52,0211-699501013259,incluidos,o
52,0211-699501013259,en,o
52,0211-699501013259,el,o
52,0211-699501013259,estudio,o
52,0211-699501013259,basal,o
52,0211-699501013259,con,o
52,0211-699501013259,una,o
52,0211-699501013259,prevalencia,o
52,0211-699501013259,de,o
52,0211-699501013259,hiperhomocisteinemia,i
52,0211-699501013259,del,o
52,0211-699501013259,844,o
52,0211-699501013259,deficit,i
52,0211-699501013259,de,i
52,0211-699501013259,pp,i
52,0211-699501013259,en,o
52,0211-699501013259,el,o
52,0211-699501013259,32,o
52,0211-699501013259,y,o
52,0211-699501013259,folato,i
52,0211-699501013259,en,o
52,0211-699501013259,el,o
52,0211-699501013259,rango,o
52,0211-699501013259,normal,o
52,0211-699501013259,bajo,o
52,0211-699501013259,los,o
52,0211-699501013259,niveles,i
52,0211-699501013259,de,i
52,0211-699501013259,tHcy,i
52,0211-699501013259,se,o
52,0211-699501013259,correlacionaban,o
52,0211-699501013259,inversamente,o
52,0211-699501013259,con,o
52,0211-699501013259,los,o
52,0211-699501013259,del,o
52,0211-699501013259,folato,i
52,0211-699501013259,r,o
52,0211-699501013259,0336,o
52,0211-699501013259,p,o
52,0211-699501013259,001,o
52,0211-699501013259,pero,o
52,0211-699501013259,no,o
52,0211-699501013259,con,o
52,0211-699501013259,pp,i
52,0211-699501013259,B12,i
52,0211-699501013259,edad,o
52,0211-699501013259,albumina,i
52,0211-699501013259,KTV,o
52,0211-699501013259,KRU,o
52,0211-699501013259,PCRn,o
52,0211-699501013259,Cincuenta,o
52,0211-699501013259,y,o
52,0211-699501013259,ocho,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,recibieron,o
52,0211-699501013259,seis,o
52,0211-699501013259,meses,o
52,0211-699501013259,de,o
52,0211-699501013259,suplementacion,i
52,0211-699501013259,con,o
52,0211-699501013259,normalizacion,o
52,0211-699501013259,del,o
52,0211-699501013259,pp,i
52,0211-699501013259,aumento,o
52,0211-699501013259,del,o
52,0211-699501013259,folato,i
52,0211-699501013259,703,o
52,0211-699501013259,IC,o
52,0211-699501013259,638,o
52,0211-699501013259,795,o
52,0211-699501013259,vs,o
52,0211-699501013259,6181,o
52,0211-699501013259,IC,o
52,0211-699501013259,4447,o
52,0211-699501013259,7811,o
52,0211-699501013259,p,o
52,0211-699501013259,0001,o
52,0211-699501013259,y,o
52,0211-699501013259,descenso,o
52,0211-699501013259,de,o
52,0211-699501013259,la,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,240,o
52,0211-699501013259,IC,o
52,0211-699501013259,213,o
52,0211-699501013259,264,o
52,0211-699501013259,vs,o
52,0211-699501013259,199,o
52,0211-699501013259,IC,o
52,0211-699501013259,175,o
52,0211-699501013259,224,o
52,0211-699501013259,p,o
52,0211-699501013259,005,o
52,0211-699501013259,Han,o
52,0211-699501013259,recibido,o
52,0211-699501013259,suplementacion,i
52,0211-699501013259,durante,o
52,0211-699501013259,12,o
52,0211-699501013259,meses,o
52,0211-699501013259,33,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,pero,o
52,0211-699501013259,a,o
52,0211-699501013259,pesar,o
52,0211-699501013259,de,o
52,0211-699501013259,un,o
52,0211-699501013259,continuo,o
52,0211-699501013259,aumento,o
52,0211-699501013259,del,o
52,0211-699501013259,folato,i
52,0211-699501013259,10078,o
52,0211-699501013259,IC,o
52,0211-699501013259,7481,o
52,0211-699501013259,12674,o
52,0211-699501013259,p,o
52,0211-699501013259,0001,o
52,0211-699501013259,solo,o
52,0211-699501013259,3,o
52,0211-699501013259,pacientes,o
52,0211-699501013259,presentan,o
52,0211-699501013259,niveles,o
52,0211-699501013259,normales,o
52,0211-699501013259,de,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,correlacionandose,o
52,0211-699501013259,directamente,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,con,o
52,0211-699501013259,la,o
52,0211-699501013259,albumina,i
52,0211-699501013259,r,o
52,0211-699501013259,056,o
52,0211-699501013259,p,o
52,0211-699501013259,0001,o
52,0211-699501013259,que,o
52,0211-699501013259,se,o
52,0211-699501013259,elevo,o
52,0211-699501013259,con,o
52,0211-699501013259,respecto,o
52,0211-699501013259,al,o
52,0211-699501013259,inicio,o
52,0211-699501013259,337,o
52,0211-699501013259,IC,o
52,0211-699501013259,327,o
52,0211-699501013259,346,o
52,0211-699501013259,vs,o
52,0211-699501013259,350,o
52,0211-699501013259,IC,o
52,0211-699501013259,337,o
52,0211-699501013259,363,o
52,0211-699501013259,p,o
52,0211-699501013259,005,o
52,0211-699501013259,Conclusion,o
52,0211-699501013259,Tras,o
52,0211-699501013259,suplementacion,i
52,0211-699501013259,con,o
52,0211-699501013259,acido,i
52,0211-699501013259,folico,i
52,0211-699501013259,y,o
52,0211-699501013259,vitamina,i
52,0211-699501013259,B6,i
52,0211-699501013259,aunque,o
52,0211-699501013259,inicialmente,o
52,0211-699501013259,se,o
52,0211-699501013259,reduce,o
52,0211-699501013259,la,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,esta,o
52,0211-699501013259,respuesta,o
52,0211-699501013259,se,o
52,0211-699501013259,hace,o
52,0211-699501013259,refractaria,o
52,0211-699501013259,correlacionandose,o
52,0211-699501013259,directamente,o
52,0211-699501013259,la,o
52,0211-699501013259,tHcy,i
52,0211-699501013259,con,o
52,0211-699501013259,la,o
52,0211-699501013259,albumina,i
52,0211-699501013259,plasmatica,i
52,0211-699501013259,La,o
52,0211-699501013259,interpretacion,o
52,0211-699501013259,de,o
52,0211-699501013259,los,o
52,0211-699501013259,niveles,i
52,0211-699501013259,de,i
52,0211-699501013259,tHcy,i
52,0211-699501013259,debe,o
52,0211-699501013259,tener,o
52,0211-699501013259,en,o
52,0211-699501013259,cuenta,o
52,0211-699501013259,la,o
52,0211-699501013259,concentracion,i
52,0211-699501013259,de,i
52,0211-699501013259,albumina,i
53,0211-699501013259,Efecto,o
53,0211-699501013259,de,o
53,0211-699501013259,la,o
53,0211-699501013259,suplementacion,i
53,0211-699501013259,con,o
53,0211-699501013259,acido,i
53,0211-699501013259,folico,i
53,0211-699501013259,sobre,o
53,0211-699501013259,los,o
53,0211-699501013259,niveles,i
53,0211-699501013259,de,i
53,0211-699501013259,homocisteina,i
53,0211-699501013259,total,o
53,0211-699501013259,en,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,en,o
53,0211-699501013259,hemodialisis,i
53,0211-699501013259,La,o
53,0211-699501013259,hiperhomocisteinemia,i
53,0211-699501013259,es,o
53,0211-699501013259,un,o
53,0211-699501013259,marcador,o
53,0211-699501013259,de,o
53,0211-699501013259,riesgo,o
53,0211-699501013259,independiente,o
53,0211-699501013259,de,o
53,0211-699501013259,morbimortalidad,o
53,0211-699501013259,cardiovascular,i
53,0211-699501013259,Hemos,o
53,0211-699501013259,intentado,o
53,0211-699501013259,prospectivamente,o
53,0211-699501013259,reducir,o
53,0211-699501013259,los,o
53,0211-699501013259,niveles,i
53,0211-699501013259,de,i
53,0211-699501013259,homocisteina,i
53,0211-699501013259,total,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,mediante,o
53,0211-699501013259,suplemento,o
53,0211-699501013259,con,o
53,0211-699501013259,acido,i
53,0211-699501013259,folico,i
53,0211-699501013259,y,o
53,0211-699501013259,vitamina,i
53,0211-699501013259,B6,i
53,0211-699501013259,pp,i
53,0211-699501013259,valorando,o
53,0211-699501013259,su,o
53,0211-699501013259,posible,o
53,0211-699501013259,correlacion,o
53,0211-699501013259,con,o
53,0211-699501013259,dosis,o
53,0211-699501013259,de,o
53,0211-699501013259,dialisis,i
53,0211-699501013259,funcion,i
53,0211-699501013259,residual,i
53,0211-699501013259,y,o
53,0211-699501013259,parametros,o
53,0211-699501013259,nutricionales,o
53,0211-699501013259,Metodos,o
53,0211-699501013259,Todos,o
53,0211-699501013259,los,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,en,o
53,0211-699501013259,hemodialisis,i
53,0211-699501013259,al,o
53,0211-699501013259,comienzo,o
53,0211-699501013259,del,o
53,0211-699501013259,estudio,o
53,0211-699501013259,que,o
53,0211-699501013259,no,o
53,0211-699501013259,recibian,o
53,0211-699501013259,acido,i
53,0211-699501013259,folico,i
53,0211-699501013259,ni,o
53,0211-699501013259,vitamina,i
53,0211-699501013259,B6,i
53,0211-699501013259,asi,o
53,0211-699501013259,como,o
53,0211-699501013259,los,o
53,0211-699501013259,incorporados,o
53,0211-699501013259,posteriormente,o
53,0211-699501013259,a,o
53,0211-699501013259,partir,o
53,0211-699501013259,de,o
53,0211-699501013259,su,o
53,0211-699501013259,tercer,o
53,0211-699501013259,mes,o
53,0211-699501013259,en,o
53,0211-699501013259,hemodialisis,i
53,0211-699501013259,recibieron,o
53,0211-699501013259,5,o
53,0211-699501013259,mg,o
53,0211-699501013259,orales,o
53,0211-699501013259,de,o
53,0211-699501013259,acido,i
53,0211-699501013259,folico,i
53,0211-699501013259,cada,o
53,0211-699501013259,48,o
53,0211-699501013259,horas,o
53,0211-699501013259,y,o
53,0211-699501013259,40,o
53,0211-699501013259,mg,o
53,0211-699501013259,orales,o
53,0211-699501013259,de,o
53,0211-699501013259,vitamina,i
53,0211-699501013259,B6,i
53,0211-699501013259,cada,o
53,0211-699501013259,semana,o
53,0211-699501013259,Se,o
53,0211-699501013259,determinaron,o
53,0211-699501013259,al,o
53,0211-699501013259,comienzo,o
53,0211-699501013259,del,o
53,0211-699501013259,estudio,o
53,0211-699501013259,y,o
53,0211-699501013259,cada,o
53,0211-699501013259,2,o
53,0211-699501013259,meses,o
53,0211-699501013259,niveles,i
53,0211-699501013259,de,i
53,0211-699501013259,folato,i
53,0211-699501013259,vitamina,i
53,0211-699501013259,B12,i
53,0211-699501013259,inmunoensayo,i
53,0211-699501013259,albumina,i
53,0211-699501013259,y,o
53,0211-699501013259,cinetica,o
53,0211-699501013259,de,o
53,0211-699501013259,la,o
53,0211-699501013259,urea,i
53,0211-699501013259,KTV,o
53,0211-699501013259,KRU,o
53,0211-699501013259,PCRn,o
53,0211-699501013259,y,o
53,0211-699501013259,cada,o
53,0211-699501013259,6,o
53,0211-699501013259,meses,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,HPLC,i
53,0211-699501013259,y,o
53,0211-699501013259,pp,i
53,0211-699501013259,RIA,i
53,0211-699501013259,Resultados,o
53,0211-699501013259,80,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,fueron,o
53,0211-699501013259,incluidos,o
53,0211-699501013259,en,o
53,0211-699501013259,el,o
53,0211-699501013259,estudio,o
53,0211-699501013259,basal,o
53,0211-699501013259,con,o
53,0211-699501013259,una,o
53,0211-699501013259,prevalencia,o
53,0211-699501013259,de,o
53,0211-699501013259,hiperhomocisteinemia,i
53,0211-699501013259,del,o
53,0211-699501013259,844,o
53,0211-699501013259,deficit,i
53,0211-699501013259,de,i
53,0211-699501013259,pp,i
53,0211-699501013259,en,o
53,0211-699501013259,el,o
53,0211-699501013259,32,o
53,0211-699501013259,y,o
53,0211-699501013259,folato,i
53,0211-699501013259,en,o
53,0211-699501013259,el,o
53,0211-699501013259,rango,o
53,0211-699501013259,normal,o
53,0211-699501013259,bajo,o
53,0211-699501013259,los,o
53,0211-699501013259,niveles,i
53,0211-699501013259,de,i
53,0211-699501013259,tHcy,i
53,0211-699501013259,se,o
53,0211-699501013259,correlacionaban,o
53,0211-699501013259,inversamente,o
53,0211-699501013259,con,o
53,0211-699501013259,los,o
53,0211-699501013259,del,o
53,0211-699501013259,folato,i
53,0211-699501013259,r,o
53,0211-699501013259,0336,o
53,0211-699501013259,p,o
53,0211-699501013259,001,o
53,0211-699501013259,pero,o
53,0211-699501013259,no,o
53,0211-699501013259,con,o
53,0211-699501013259,pp,i
53,0211-699501013259,B12,i
53,0211-699501013259,edad,o
53,0211-699501013259,albumina,i
53,0211-699501013259,KTV,o
53,0211-699501013259,KRU,o
53,0211-699501013259,PCRn,o
53,0211-699501013259,Cincuenta,o
53,0211-699501013259,y,o
53,0211-699501013259,ocho,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,recibieron,o
53,0211-699501013259,seis,o
53,0211-699501013259,meses,o
53,0211-699501013259,de,o
53,0211-699501013259,suplementacion,i
53,0211-699501013259,con,o
53,0211-699501013259,normalizacion,o
53,0211-699501013259,del,o
53,0211-699501013259,pp,i
53,0211-699501013259,aumento,o
53,0211-699501013259,del,o
53,0211-699501013259,folato,i
53,0211-699501013259,703,o
53,0211-699501013259,IC,o
53,0211-699501013259,638,o
53,0211-699501013259,795,o
53,0211-699501013259,vs,o
53,0211-699501013259,6181,o
53,0211-699501013259,IC,o
53,0211-699501013259,4447,o
53,0211-699501013259,7811,o
53,0211-699501013259,p,o
53,0211-699501013259,0001,o
53,0211-699501013259,y,o
53,0211-699501013259,descenso,o
53,0211-699501013259,de,o
53,0211-699501013259,la,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,240,o
53,0211-699501013259,IC,o
53,0211-699501013259,213,o
53,0211-699501013259,264,o
53,0211-699501013259,vs,o
53,0211-699501013259,199,o
53,0211-699501013259,IC,o
53,0211-699501013259,175,o
53,0211-699501013259,224,o
53,0211-699501013259,p,o
53,0211-699501013259,005,o
53,0211-699501013259,Han,o
53,0211-699501013259,recibido,o
53,0211-699501013259,suplementacion,i
53,0211-699501013259,durante,o
53,0211-699501013259,12,o
53,0211-699501013259,meses,o
53,0211-699501013259,33,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,pero,o
53,0211-699501013259,a,o
53,0211-699501013259,pesar,o
53,0211-699501013259,de,o
53,0211-699501013259,un,o
53,0211-699501013259,continuo,o
53,0211-699501013259,aumento,o
53,0211-699501013259,del,o
53,0211-699501013259,folato,i
53,0211-699501013259,10078,o
53,0211-699501013259,IC,o
53,0211-699501013259,7481,o
53,0211-699501013259,12674,o
53,0211-699501013259,p,o
53,0211-699501013259,0001,o
53,0211-699501013259,solo,o
53,0211-699501013259,3,o
53,0211-699501013259,pacientes,o
53,0211-699501013259,presentan,o
53,0211-699501013259,niveles,o
53,0211-699501013259,normales,o
53,0211-699501013259,de,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,correlacionandose,o
53,0211-699501013259,directamente,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,con,o
53,0211-699501013259,la,o
53,0211-699501013259,albumina,i
53,0211-699501013259,r,o
53,0211-699501013259,056,o
53,0211-699501013259,p,o
53,0211-699501013259,0001,o
53,0211-699501013259,que,o
53,0211-699501013259,se,o
53,0211-699501013259,elevo,o
53,0211-699501013259,con,o
53,0211-699501013259,respecto,o
53,0211-699501013259,al,o
53,0211-699501013259,inicio,o
53,0211-699501013259,337,o
53,0211-699501013259,IC,o
53,0211-699501013259,327,o
53,0211-699501013259,346,o
53,0211-699501013259,vs,o
53,0211-699501013259,350,o
53,0211-699501013259,IC,o
53,0211-699501013259,337,o
53,0211-699501013259,363,o
53,0211-699501013259,p,o
53,0211-699501013259,005,o
53,0211-699501013259,Conclusion,o
53,0211-699501013259,Tras,o
53,0211-699501013259,suplementacion,i
53,0211-699501013259,con,o
53,0211-699501013259,acido,i
53,0211-699501013259,folico,i
53,0211-699501013259,y,o
53,0211-699501013259,vitamina,i
53,0211-699501013259,B6,i
53,0211-699501013259,aunque,o
53,0211-699501013259,inicialmente,o
53,0211-699501013259,se,o
53,0211-699501013259,reduce,o
53,0211-699501013259,la,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,esta,o
53,0211-699501013259,respuesta,o
53,0211-699501013259,se,o
53,0211-699501013259,hace,o
53,0211-699501013259,refractaria,o
53,0211-699501013259,correlacionandose,o
53,0211-699501013259,directamente,o
53,0211-699501013259,la,o
53,0211-699501013259,tHcy,i
53,0211-699501013259,con,o
53,0211-699501013259,la,o
53,0211-699501013259,albumina,i
53,0211-699501013259,plasmatica,i
53,0211-699501013259,La,o
53,0211-699501013259,interpretacion,o
53,0211-699501013259,de,o
53,0211-699501013259,los,o
53,0211-699501013259,niveles,i
53,0211-699501013259,de,i
53,0211-699501013259,tHcy,i
53,0211-699501013259,debe,o
53,0211-699501013259,tener,o
53,0211-699501013259,en,o
53,0211-699501013259,cuenta,o
53,0211-699501013259,la,o
53,0211-699501013259,concentracion,i
53,0211-699501013259,de,i
53,0211-699501013259,albumina,i
54,0211-699501013259,Efecto,o
54,0211-699501013259,de,o
54,0211-699501013259,la,o
54,0211-699501013259,suplementacion,i
54,0211-699501013259,con,o
54,0211-699501013259,acido,i
54,0211-699501013259,folico,i
54,0211-699501013259,sobre,o
54,0211-699501013259,los,o
54,0211-699501013259,niveles,i
54,0211-699501013259,de,i
54,0211-699501013259,homocisteina,i
54,0211-699501013259,total,o
54,0211-699501013259,en,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,en,o
54,0211-699501013259,hemodialisis,i
54,0211-699501013259,La,o
54,0211-699501013259,hiperhomocisteinemia,i
54,0211-699501013259,es,o
54,0211-699501013259,un,o
54,0211-699501013259,marcador,o
54,0211-699501013259,de,o
54,0211-699501013259,riesgo,o
54,0211-699501013259,independiente,o
54,0211-699501013259,de,o
54,0211-699501013259,morbimortalidad,o
54,0211-699501013259,cardiovascular,i
54,0211-699501013259,Hemos,o
54,0211-699501013259,intentado,o
54,0211-699501013259,prospectivamente,o
54,0211-699501013259,reducir,o
54,0211-699501013259,los,o
54,0211-699501013259,niveles,i
54,0211-699501013259,de,i
54,0211-699501013259,homocisteina,i
54,0211-699501013259,total,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,mediante,o
54,0211-699501013259,suplemento,o
54,0211-699501013259,con,o
54,0211-699501013259,acido,i
54,0211-699501013259,folico,i
54,0211-699501013259,y,o
54,0211-699501013259,vitamina,i
54,0211-699501013259,B6,i
54,0211-699501013259,pp,i
54,0211-699501013259,valorando,o
54,0211-699501013259,su,o
54,0211-699501013259,posible,o
54,0211-699501013259,correlacion,o
54,0211-699501013259,con,o
54,0211-699501013259,dosis,o
54,0211-699501013259,de,o
54,0211-699501013259,dialisis,i
54,0211-699501013259,funcion,i
54,0211-699501013259,residual,i
54,0211-699501013259,y,o
54,0211-699501013259,parametros,o
54,0211-699501013259,nutricionales,o
54,0211-699501013259,Metodos,o
54,0211-699501013259,Todos,o
54,0211-699501013259,los,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,en,o
54,0211-699501013259,hemodialisis,i
54,0211-699501013259,al,o
54,0211-699501013259,comienzo,o
54,0211-699501013259,del,o
54,0211-699501013259,estudio,o
54,0211-699501013259,que,o
54,0211-699501013259,no,o
54,0211-699501013259,recibian,o
54,0211-699501013259,acido,i
54,0211-699501013259,folico,i
54,0211-699501013259,ni,o
54,0211-699501013259,vitamina,i
54,0211-699501013259,B6,i
54,0211-699501013259,asi,o
54,0211-699501013259,como,o
54,0211-699501013259,los,o
54,0211-699501013259,incorporados,o
54,0211-699501013259,posteriormente,o
54,0211-699501013259,a,o
54,0211-699501013259,partir,o
54,0211-699501013259,de,o
54,0211-699501013259,su,o
54,0211-699501013259,tercer,o
54,0211-699501013259,mes,o
54,0211-699501013259,en,o
54,0211-699501013259,hemodialisis,i
54,0211-699501013259,recibieron,o
54,0211-699501013259,5,o
54,0211-699501013259,mg,o
54,0211-699501013259,orales,o
54,0211-699501013259,de,o
54,0211-699501013259,acido,i
54,0211-699501013259,folico,i
54,0211-699501013259,cada,o
54,0211-699501013259,48,o
54,0211-699501013259,horas,o
54,0211-699501013259,y,o
54,0211-699501013259,40,o
54,0211-699501013259,mg,o
54,0211-699501013259,orales,o
54,0211-699501013259,de,o
54,0211-699501013259,vitamina,i
54,0211-699501013259,B6,i
54,0211-699501013259,cada,o
54,0211-699501013259,semana,o
54,0211-699501013259,Se,o
54,0211-699501013259,determinaron,o
54,0211-699501013259,al,o
54,0211-699501013259,comienzo,o
54,0211-699501013259,del,o
54,0211-699501013259,estudio,o
54,0211-699501013259,y,o
54,0211-699501013259,cada,o
54,0211-699501013259,2,o
54,0211-699501013259,meses,o
54,0211-699501013259,niveles,i
54,0211-699501013259,de,i
54,0211-699501013259,folato,i
54,0211-699501013259,vitamina,i
54,0211-699501013259,B12,i
54,0211-699501013259,inmunoensayo,i
54,0211-699501013259,albumina,i
54,0211-699501013259,y,o
54,0211-699501013259,cinetica,o
54,0211-699501013259,de,o
54,0211-699501013259,la,o
54,0211-699501013259,urea,i
54,0211-699501013259,KTV,o
54,0211-699501013259,KRU,o
54,0211-699501013259,PCRn,o
54,0211-699501013259,y,o
54,0211-699501013259,cada,o
54,0211-699501013259,6,o
54,0211-699501013259,meses,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,HPLC,i
54,0211-699501013259,y,o
54,0211-699501013259,pp,i
54,0211-699501013259,RIA,i
54,0211-699501013259,Resultados,o
54,0211-699501013259,80,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,fueron,o
54,0211-699501013259,incluidos,o
54,0211-699501013259,en,o
54,0211-699501013259,el,o
54,0211-699501013259,estudio,o
54,0211-699501013259,basal,o
54,0211-699501013259,con,o
54,0211-699501013259,una,o
54,0211-699501013259,prevalencia,o
54,0211-699501013259,de,o
54,0211-699501013259,hiperhomocisteinemia,i
54,0211-699501013259,del,o
54,0211-699501013259,844,o
54,0211-699501013259,deficit,i
54,0211-699501013259,de,i
54,0211-699501013259,pp,i
54,0211-699501013259,en,o
54,0211-699501013259,el,o
54,0211-699501013259,32,o
54,0211-699501013259,y,o
54,0211-699501013259,folato,i
54,0211-699501013259,en,o
54,0211-699501013259,el,o
54,0211-699501013259,rango,o
54,0211-699501013259,normal,o
54,0211-699501013259,bajo,o
54,0211-699501013259,los,o
54,0211-699501013259,niveles,i
54,0211-699501013259,de,i
54,0211-699501013259,tHcy,i
54,0211-699501013259,se,o
54,0211-699501013259,correlacionaban,o
54,0211-699501013259,inversamente,o
54,0211-699501013259,con,o
54,0211-699501013259,los,o
54,0211-699501013259,del,o
54,0211-699501013259,folato,i
54,0211-699501013259,r,o
54,0211-699501013259,0336,o
54,0211-699501013259,p,o
54,0211-699501013259,001,o
54,0211-699501013259,pero,o
54,0211-699501013259,no,o
54,0211-699501013259,con,o
54,0211-699501013259,pp,i
54,0211-699501013259,B12,i
54,0211-699501013259,edad,o
54,0211-699501013259,albumina,i
54,0211-699501013259,KTV,o
54,0211-699501013259,KRU,o
54,0211-699501013259,PCRn,o
54,0211-699501013259,Cincuenta,o
54,0211-699501013259,y,o
54,0211-699501013259,ocho,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,recibieron,o
54,0211-699501013259,seis,o
54,0211-699501013259,meses,o
54,0211-699501013259,de,o
54,0211-699501013259,suplementacion,i
54,0211-699501013259,con,o
54,0211-699501013259,normalizacion,o
54,0211-699501013259,del,o
54,0211-699501013259,pp,i
54,0211-699501013259,aumento,o
54,0211-699501013259,del,o
54,0211-699501013259,folato,i
54,0211-699501013259,703,o
54,0211-699501013259,IC,o
54,0211-699501013259,638,o
54,0211-699501013259,795,o
54,0211-699501013259,vs,o
54,0211-699501013259,6181,o
54,0211-699501013259,IC,o
54,0211-699501013259,4447,o
54,0211-699501013259,7811,o
54,0211-699501013259,p,o
54,0211-699501013259,0001,o
54,0211-699501013259,y,o
54,0211-699501013259,descenso,o
54,0211-699501013259,de,o
54,0211-699501013259,la,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,240,o
54,0211-699501013259,IC,o
54,0211-699501013259,213,o
54,0211-699501013259,264,o
54,0211-699501013259,vs,o
54,0211-699501013259,199,o
54,0211-699501013259,IC,o
54,0211-699501013259,175,o
54,0211-699501013259,224,o
54,0211-699501013259,p,o
54,0211-699501013259,005,o
54,0211-699501013259,Han,o
54,0211-699501013259,recibido,o
54,0211-699501013259,suplementacion,i
54,0211-699501013259,durante,o
54,0211-699501013259,12,o
54,0211-699501013259,meses,o
54,0211-699501013259,33,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,pero,o
54,0211-699501013259,a,o
54,0211-699501013259,pesar,o
54,0211-699501013259,de,o
54,0211-699501013259,un,o
54,0211-699501013259,continuo,o
54,0211-699501013259,aumento,o
54,0211-699501013259,del,o
54,0211-699501013259,folato,i
54,0211-699501013259,10078,o
54,0211-699501013259,IC,o
54,0211-699501013259,7481,o
54,0211-699501013259,12674,o
54,0211-699501013259,p,o
54,0211-699501013259,0001,o
54,0211-699501013259,solo,o
54,0211-699501013259,3,o
54,0211-699501013259,pacientes,o
54,0211-699501013259,presentan,o
54,0211-699501013259,niveles,o
54,0211-699501013259,normales,o
54,0211-699501013259,de,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,correlacionandose,o
54,0211-699501013259,directamente,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,con,o
54,0211-699501013259,la,o
54,0211-699501013259,albumina,i
54,0211-699501013259,r,o
54,0211-699501013259,056,o
54,0211-699501013259,p,o
54,0211-699501013259,0001,o
54,0211-699501013259,que,o
54,0211-699501013259,se,o
54,0211-699501013259,elevo,o
54,0211-699501013259,con,o
54,0211-699501013259,respecto,o
54,0211-699501013259,al,o
54,0211-699501013259,inicio,o
54,0211-699501013259,337,o
54,0211-699501013259,IC,o
54,0211-699501013259,327,o
54,0211-699501013259,346,o
54,0211-699501013259,vs,o
54,0211-699501013259,350,o
54,0211-699501013259,IC,o
54,0211-699501013259,337,o
54,0211-699501013259,363,o
54,0211-699501013259,p,o
54,0211-699501013259,005,o
54,0211-699501013259,Conclusion,o
54,0211-699501013259,Tras,o
54,0211-699501013259,suplementacion,i
54,0211-699501013259,con,o
54,0211-699501013259,acido,i
54,0211-699501013259,folico,i
54,0211-699501013259,y,o
54,0211-699501013259,vitamina,i
54,0211-699501013259,B6,i
54,0211-699501013259,aunque,o
54,0211-699501013259,inicialmente,o
54,0211-699501013259,se,o
54,0211-699501013259,reduce,o
54,0211-699501013259,la,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,esta,o
54,0211-699501013259,respuesta,o
54,0211-699501013259,se,o
54,0211-699501013259,hace,o
54,0211-699501013259,refractaria,o
54,0211-699501013259,correlacionandose,o
54,0211-699501013259,directamente,o
54,0211-699501013259,la,o
54,0211-699501013259,tHcy,i
54,0211-699501013259,con,o
54,0211-699501013259,la,o
54,0211-699501013259,albumina,i
54,0211-699501013259,plasmatica,i
54,0211-699501013259,La,o
54,0211-699501013259,interpretacion,o
54,0211-699501013259,de,o
54,0211-699501013259,los,o
54,0211-699501013259,niveles,i
54,0211-699501013259,de,i
54,0211-699501013259,tHcy,i
54,0211-699501013259,debe,o
54,0211-699501013259,tener,o
54,0211-699501013259,en,o
54,0211-699501013259,cuenta,o
54,0211-699501013259,la,o
54,0211-699501013259,concentracion,i
54,0211-699501013259,de,i
54,0211-699501013259,albumina,i
55,0211-699501013259,Efecto,o
55,0211-699501013259,de,o
55,0211-699501013259,la,o
55,0211-699501013259,suplementacion,i
55,0211-699501013259,con,o
55,0211-699501013259,acido,i
55,0211-699501013259,folico,i
55,0211-699501013259,sobre,o
55,0211-699501013259,los,o
55,0211-699501013259,niveles,i
55,0211-699501013259,de,i
55,0211-699501013259,homocisteina,i
55,0211-699501013259,total,o
55,0211-699501013259,en,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,en,o
55,0211-699501013259,hemodialisis,i
55,0211-699501013259,La,o
55,0211-699501013259,hiperhomocisteinemia,i
55,0211-699501013259,es,o
55,0211-699501013259,un,o
55,0211-699501013259,marcador,o
55,0211-699501013259,de,o
55,0211-699501013259,riesgo,o
55,0211-699501013259,independiente,o
55,0211-699501013259,de,o
55,0211-699501013259,morbimortalidad,o
55,0211-699501013259,cardiovascular,i
55,0211-699501013259,Hemos,o
55,0211-699501013259,intentado,o
55,0211-699501013259,prospectivamente,o
55,0211-699501013259,reducir,o
55,0211-699501013259,los,o
55,0211-699501013259,niveles,i
55,0211-699501013259,de,i
55,0211-699501013259,homocisteina,i
55,0211-699501013259,total,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,mediante,o
55,0211-699501013259,suplemento,o
55,0211-699501013259,con,o
55,0211-699501013259,acido,i
55,0211-699501013259,folico,i
55,0211-699501013259,y,o
55,0211-699501013259,vitamina,i
55,0211-699501013259,B6,i
55,0211-699501013259,pp,i
55,0211-699501013259,valorando,o
55,0211-699501013259,su,o
55,0211-699501013259,posible,o
55,0211-699501013259,correlacion,o
55,0211-699501013259,con,o
55,0211-699501013259,dosis,o
55,0211-699501013259,de,o
55,0211-699501013259,dialisis,i
55,0211-699501013259,funcion,i
55,0211-699501013259,residual,i
55,0211-699501013259,y,o
55,0211-699501013259,parametros,o
55,0211-699501013259,nutricionales,o
55,0211-699501013259,Metodos,o
55,0211-699501013259,Todos,o
55,0211-699501013259,los,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,en,o
55,0211-699501013259,hemodialisis,i
55,0211-699501013259,al,o
55,0211-699501013259,comienzo,o
55,0211-699501013259,del,o
55,0211-699501013259,estudio,o
55,0211-699501013259,que,o
55,0211-699501013259,no,o
55,0211-699501013259,recibian,o
55,0211-699501013259,acido,i
55,0211-699501013259,folico,i
55,0211-699501013259,ni,o
55,0211-699501013259,vitamina,i
55,0211-699501013259,B6,i
55,0211-699501013259,asi,o
55,0211-699501013259,como,o
55,0211-699501013259,los,o
55,0211-699501013259,incorporados,o
55,0211-699501013259,posteriormente,o
55,0211-699501013259,a,o
55,0211-699501013259,partir,o
55,0211-699501013259,de,o
55,0211-699501013259,su,o
55,0211-699501013259,tercer,o
55,0211-699501013259,mes,o
55,0211-699501013259,en,o
55,0211-699501013259,hemodialisis,i
55,0211-699501013259,recibieron,o
55,0211-699501013259,5,o
55,0211-699501013259,mg,o
55,0211-699501013259,orales,o
55,0211-699501013259,de,o
55,0211-699501013259,acido,i
55,0211-699501013259,folico,i
55,0211-699501013259,cada,o
55,0211-699501013259,48,o
55,0211-699501013259,horas,o
55,0211-699501013259,y,o
55,0211-699501013259,40,o
55,0211-699501013259,mg,o
55,0211-699501013259,orales,o
55,0211-699501013259,de,o
55,0211-699501013259,vitamina,i
55,0211-699501013259,B6,i
55,0211-699501013259,cada,o
55,0211-699501013259,semana,o
55,0211-699501013259,Se,o
55,0211-699501013259,determinaron,o
55,0211-699501013259,al,o
55,0211-699501013259,comienzo,o
55,0211-699501013259,del,o
55,0211-699501013259,estudio,o
55,0211-699501013259,y,o
55,0211-699501013259,cada,o
55,0211-699501013259,2,o
55,0211-699501013259,meses,o
55,0211-699501013259,niveles,i
55,0211-699501013259,de,i
55,0211-699501013259,folato,i
55,0211-699501013259,vitamina,i
55,0211-699501013259,B12,i
55,0211-699501013259,inmunoensayo,i
55,0211-699501013259,albumina,i
55,0211-699501013259,y,o
55,0211-699501013259,cinetica,o
55,0211-699501013259,de,o
55,0211-699501013259,la,o
55,0211-699501013259,urea,i
55,0211-699501013259,KTV,o
55,0211-699501013259,KRU,o
55,0211-699501013259,PCRn,o
55,0211-699501013259,y,o
55,0211-699501013259,cada,o
55,0211-699501013259,6,o
55,0211-699501013259,meses,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,HPLC,i
55,0211-699501013259,y,o
55,0211-699501013259,pp,i
55,0211-699501013259,RIA,i
55,0211-699501013259,Resultados,o
55,0211-699501013259,80,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,fueron,o
55,0211-699501013259,incluidos,o
55,0211-699501013259,en,o
55,0211-699501013259,el,o
55,0211-699501013259,estudio,o
55,0211-699501013259,basal,o
55,0211-699501013259,con,o
55,0211-699501013259,una,o
55,0211-699501013259,prevalencia,o
55,0211-699501013259,de,o
55,0211-699501013259,hiperhomocisteinemia,i
55,0211-699501013259,del,o
55,0211-699501013259,844,o
55,0211-699501013259,deficit,i
55,0211-699501013259,de,i
55,0211-699501013259,pp,i
55,0211-699501013259,en,o
55,0211-699501013259,el,o
55,0211-699501013259,32,o
55,0211-699501013259,y,o
55,0211-699501013259,folato,i
55,0211-699501013259,en,o
55,0211-699501013259,el,o
55,0211-699501013259,rango,o
55,0211-699501013259,normal,o
55,0211-699501013259,bajo,o
55,0211-699501013259,los,o
55,0211-699501013259,niveles,i
55,0211-699501013259,de,i
55,0211-699501013259,tHcy,i
55,0211-699501013259,se,o
55,0211-699501013259,correlacionaban,o
55,0211-699501013259,inversamente,o
55,0211-699501013259,con,o
55,0211-699501013259,los,o
55,0211-699501013259,del,o
55,0211-699501013259,folato,i
55,0211-699501013259,r,o
55,0211-699501013259,0336,o
55,0211-699501013259,p,o
55,0211-699501013259,001,o
55,0211-699501013259,pero,o
55,0211-699501013259,no,o
55,0211-699501013259,con,o
55,0211-699501013259,pp,i
55,0211-699501013259,B12,i
55,0211-699501013259,edad,o
55,0211-699501013259,albumina,i
55,0211-699501013259,KTV,o
55,0211-699501013259,KRU,o
55,0211-699501013259,PCRn,o
55,0211-699501013259,Cincuenta,o
55,0211-699501013259,y,o
55,0211-699501013259,ocho,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,recibieron,o
55,0211-699501013259,seis,o
55,0211-699501013259,meses,o
55,0211-699501013259,de,o
55,0211-699501013259,suplementacion,i
55,0211-699501013259,con,o
55,0211-699501013259,normalizacion,o
55,0211-699501013259,del,o
55,0211-699501013259,pp,i
55,0211-699501013259,aumento,o
55,0211-699501013259,del,o
55,0211-699501013259,folato,i
55,0211-699501013259,703,o
55,0211-699501013259,IC,o
55,0211-699501013259,638,o
55,0211-699501013259,795,o
55,0211-699501013259,vs,o
55,0211-699501013259,6181,o
55,0211-699501013259,IC,o
55,0211-699501013259,4447,o
55,0211-699501013259,7811,o
55,0211-699501013259,p,o
55,0211-699501013259,0001,o
55,0211-699501013259,y,o
55,0211-699501013259,descenso,o
55,0211-699501013259,de,o
55,0211-699501013259,la,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,240,o
55,0211-699501013259,IC,o
55,0211-699501013259,213,o
55,0211-699501013259,264,o
55,0211-699501013259,vs,o
55,0211-699501013259,199,o
55,0211-699501013259,IC,o
55,0211-699501013259,175,o
55,0211-699501013259,224,o
55,0211-699501013259,p,o
55,0211-699501013259,005,o
55,0211-699501013259,Han,o
55,0211-699501013259,recibido,o
55,0211-699501013259,suplementacion,i
55,0211-699501013259,durante,o
55,0211-699501013259,12,o
55,0211-699501013259,meses,o
55,0211-699501013259,33,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,pero,o
55,0211-699501013259,a,o
55,0211-699501013259,pesar,o
55,0211-699501013259,de,o
55,0211-699501013259,un,o
55,0211-699501013259,continuo,o
55,0211-699501013259,aumento,o
55,0211-699501013259,del,o
55,0211-699501013259,folato,i
55,0211-699501013259,10078,o
55,0211-699501013259,IC,o
55,0211-699501013259,7481,o
55,0211-699501013259,12674,o
55,0211-699501013259,p,o
55,0211-699501013259,0001,o
55,0211-699501013259,solo,o
55,0211-699501013259,3,o
55,0211-699501013259,pacientes,o
55,0211-699501013259,presentan,o
55,0211-699501013259,niveles,o
55,0211-699501013259,normales,o
55,0211-699501013259,de,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,correlacionandose,o
55,0211-699501013259,directamente,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,con,o
55,0211-699501013259,la,o
55,0211-699501013259,albumina,i
55,0211-699501013259,r,o
55,0211-699501013259,056,o
55,0211-699501013259,p,o
55,0211-699501013259,0001,o
55,0211-699501013259,que,o
55,0211-699501013259,se,o
55,0211-699501013259,elevo,o
55,0211-699501013259,con,o
55,0211-699501013259,respecto,o
55,0211-699501013259,al,o
55,0211-699501013259,inicio,o
55,0211-699501013259,337,o
55,0211-699501013259,IC,o
55,0211-699501013259,327,o
55,0211-699501013259,346,o
55,0211-699501013259,vs,o
55,0211-699501013259,350,o
55,0211-699501013259,IC,o
55,0211-699501013259,337,o
55,0211-699501013259,363,o
55,0211-699501013259,p,o
55,0211-699501013259,005,o
55,0211-699501013259,Conclusion,o
55,0211-699501013259,Tras,o
55,0211-699501013259,suplementacion,i
55,0211-699501013259,con,o
55,0211-699501013259,acido,i
55,0211-699501013259,folico,i
55,0211-699501013259,y,o
55,0211-699501013259,vitamina,i
55,0211-699501013259,B6,i
55,0211-699501013259,aunque,o
55,0211-699501013259,inicialmente,o
55,0211-699501013259,se,o
55,0211-699501013259,reduce,o
55,0211-699501013259,la,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,esta,o
55,0211-699501013259,respuesta,o
55,0211-699501013259,se,o
55,0211-699501013259,hace,o
55,0211-699501013259,refractaria,o
55,0211-699501013259,correlacionandose,o
55,0211-699501013259,directamente,o
55,0211-699501013259,la,o
55,0211-699501013259,tHcy,i
55,0211-699501013259,con,o
55,0211-699501013259,la,o
55,0211-699501013259,albumina,i
55,0211-699501013259,plasmatica,i
55,0211-699501013259,La,o
55,0211-699501013259,interpretacion,o
55,0211-699501013259,de,o
55,0211-699501013259,los,o
55,0211-699501013259,niveles,i
55,0211-699501013259,de,i
55,0211-699501013259,tHcy,i
55,0211-699501013259,debe,o
55,0211-699501013259,tener,o
55,0211-699501013259,en,o
55,0211-699501013259,cuenta,o
55,0211-699501013259,la,o
55,0211-699501013259,concentracion,i
55,0211-699501013259,de,i
55,0211-699501013259,albumina,i
56,0211-699501013259,Efecto,o
56,0211-699501013259,de,o
56,0211-699501013259,la,o
56,0211-699501013259,suplementacion,i
56,0211-699501013259,con,o
56,0211-699501013259,acido,i
56,0211-699501013259,folico,i
56,0211-699501013259,sobre,o
56,0211-699501013259,los,o
56,0211-699501013259,niveles,i
56,0211-699501013259,de,i
56,0211-699501013259,homocisteina,i
56,0211-699501013259,total,o
56,0211-699501013259,en,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,en,o
56,0211-699501013259,hemodialisis,i
56,0211-699501013259,La,o
56,0211-699501013259,hiperhomocisteinemia,i
56,0211-699501013259,es,o
56,0211-699501013259,un,o
56,0211-699501013259,marcador,o
56,0211-699501013259,de,o
56,0211-699501013259,riesgo,o
56,0211-699501013259,independiente,o
56,0211-699501013259,de,o
56,0211-699501013259,morbimortalidad,o
56,0211-699501013259,cardiovascular,i
56,0211-699501013259,Hemos,o
56,0211-699501013259,intentado,o
56,0211-699501013259,prospectivamente,o
56,0211-699501013259,reducir,o
56,0211-699501013259,los,o
56,0211-699501013259,niveles,i
56,0211-699501013259,de,i
56,0211-699501013259,homocisteina,i
56,0211-699501013259,total,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,mediante,o
56,0211-699501013259,suplemento,o
56,0211-699501013259,con,o
56,0211-699501013259,acido,i
56,0211-699501013259,folico,i
56,0211-699501013259,y,o
56,0211-699501013259,vitamina,i
56,0211-699501013259,B6,i
56,0211-699501013259,pp,i
56,0211-699501013259,valorando,o
56,0211-699501013259,su,o
56,0211-699501013259,posible,o
56,0211-699501013259,correlacion,o
56,0211-699501013259,con,o
56,0211-699501013259,dosis,o
56,0211-699501013259,de,o
56,0211-699501013259,dialisis,i
56,0211-699501013259,funcion,i
56,0211-699501013259,residual,i
56,0211-699501013259,y,o
56,0211-699501013259,parametros,o
56,0211-699501013259,nutricionales,o
56,0211-699501013259,Metodos,o
56,0211-699501013259,Todos,o
56,0211-699501013259,los,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,en,o
56,0211-699501013259,hemodialisis,i
56,0211-699501013259,al,o
56,0211-699501013259,comienzo,o
56,0211-699501013259,del,o
56,0211-699501013259,estudio,o
56,0211-699501013259,que,o
56,0211-699501013259,no,o
56,0211-699501013259,recibian,o
56,0211-699501013259,acido,i
56,0211-699501013259,folico,i
56,0211-699501013259,ni,o
56,0211-699501013259,vitamina,i
56,0211-699501013259,B6,i
56,0211-699501013259,asi,o
56,0211-699501013259,como,o
56,0211-699501013259,los,o
56,0211-699501013259,incorporados,o
56,0211-699501013259,posteriormente,o
56,0211-699501013259,a,o
56,0211-699501013259,partir,o
56,0211-699501013259,de,o
56,0211-699501013259,su,o
56,0211-699501013259,tercer,o
56,0211-699501013259,mes,o
56,0211-699501013259,en,o
56,0211-699501013259,hemodialisis,i
56,0211-699501013259,recibieron,o
56,0211-699501013259,5,o
56,0211-699501013259,mg,o
56,0211-699501013259,orales,o
56,0211-699501013259,de,o
56,0211-699501013259,acido,i
56,0211-699501013259,folico,i
56,0211-699501013259,cada,o
56,0211-699501013259,48,o
56,0211-699501013259,horas,o
56,0211-699501013259,y,o
56,0211-699501013259,40,o
56,0211-699501013259,mg,o
56,0211-699501013259,orales,o
56,0211-699501013259,de,o
56,0211-699501013259,vitamina,i
56,0211-699501013259,B6,i
56,0211-699501013259,cada,o
56,0211-699501013259,semana,o
56,0211-699501013259,Se,o
56,0211-699501013259,determinaron,o
56,0211-699501013259,al,o
56,0211-699501013259,comienzo,o
56,0211-699501013259,del,o
56,0211-699501013259,estudio,o
56,0211-699501013259,y,o
56,0211-699501013259,cada,o
56,0211-699501013259,2,o
56,0211-699501013259,meses,o
56,0211-699501013259,niveles,i
56,0211-699501013259,de,i
56,0211-699501013259,folato,i
56,0211-699501013259,vitamina,i
56,0211-699501013259,B12,i
56,0211-699501013259,inmunoensayo,i
56,0211-699501013259,albumina,i
56,0211-699501013259,y,o
56,0211-699501013259,cinetica,o
56,0211-699501013259,de,o
56,0211-699501013259,la,o
56,0211-699501013259,urea,i
56,0211-699501013259,KTV,o
56,0211-699501013259,KRU,o
56,0211-699501013259,PCRn,o
56,0211-699501013259,y,o
56,0211-699501013259,cada,o
56,0211-699501013259,6,o
56,0211-699501013259,meses,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,HPLC,i
56,0211-699501013259,y,o
56,0211-699501013259,pp,i
56,0211-699501013259,RIA,i
56,0211-699501013259,Resultados,o
56,0211-699501013259,80,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,fueron,o
56,0211-699501013259,incluidos,o
56,0211-699501013259,en,o
56,0211-699501013259,el,o
56,0211-699501013259,estudio,o
56,0211-699501013259,basal,o
56,0211-699501013259,con,o
56,0211-699501013259,una,o
56,0211-699501013259,prevalencia,o
56,0211-699501013259,de,o
56,0211-699501013259,hiperhomocisteinemia,i
56,0211-699501013259,del,o
56,0211-699501013259,844,o
56,0211-699501013259,deficit,i
56,0211-699501013259,de,i
56,0211-699501013259,pp,i
56,0211-699501013259,en,o
56,0211-699501013259,el,o
56,0211-699501013259,32,o
56,0211-699501013259,y,o
56,0211-699501013259,folato,i
56,0211-699501013259,en,o
56,0211-699501013259,el,o
56,0211-699501013259,rango,o
56,0211-699501013259,normal,o
56,0211-699501013259,bajo,o
56,0211-699501013259,los,o
56,0211-699501013259,niveles,i
56,0211-699501013259,de,i
56,0211-699501013259,tHcy,i
56,0211-699501013259,se,o
56,0211-699501013259,correlacionaban,o
56,0211-699501013259,inversamente,o
56,0211-699501013259,con,o
56,0211-699501013259,los,o
56,0211-699501013259,del,o
56,0211-699501013259,folato,i
56,0211-699501013259,r,o
56,0211-699501013259,0336,o
56,0211-699501013259,p,o
56,0211-699501013259,001,o
56,0211-699501013259,pero,o
56,0211-699501013259,no,o
56,0211-699501013259,con,o
56,0211-699501013259,pp,i
56,0211-699501013259,B12,i
56,0211-699501013259,edad,o
56,0211-699501013259,albumina,i
56,0211-699501013259,KTV,o
56,0211-699501013259,KRU,o
56,0211-699501013259,PCRn,o
56,0211-699501013259,Cincuenta,o
56,0211-699501013259,y,o
56,0211-699501013259,ocho,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,recibieron,o
56,0211-699501013259,seis,o
56,0211-699501013259,meses,o
56,0211-699501013259,de,o
56,0211-699501013259,suplementacion,i
56,0211-699501013259,con,o
56,0211-699501013259,normalizacion,o
56,0211-699501013259,del,o
56,0211-699501013259,pp,i
56,0211-699501013259,aumento,o
56,0211-699501013259,del,o
56,0211-699501013259,folato,i
56,0211-699501013259,703,o
56,0211-699501013259,IC,o
56,0211-699501013259,638,o
56,0211-699501013259,795,o
56,0211-699501013259,vs,o
56,0211-699501013259,6181,o
56,0211-699501013259,IC,o
56,0211-699501013259,4447,o
56,0211-699501013259,7811,o
56,0211-699501013259,p,o
56,0211-699501013259,0001,o
56,0211-699501013259,y,o
56,0211-699501013259,descenso,o
56,0211-699501013259,de,o
56,0211-699501013259,la,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,240,o
56,0211-699501013259,IC,o
56,0211-699501013259,213,o
56,0211-699501013259,264,o
56,0211-699501013259,vs,o
56,0211-699501013259,199,o
56,0211-699501013259,IC,o
56,0211-699501013259,175,o
56,0211-699501013259,224,o
56,0211-699501013259,p,o
56,0211-699501013259,005,o
56,0211-699501013259,Han,o
56,0211-699501013259,recibido,o
56,0211-699501013259,suplementacion,i
56,0211-699501013259,durante,o
56,0211-699501013259,12,o
56,0211-699501013259,meses,o
56,0211-699501013259,33,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,pero,o
56,0211-699501013259,a,o
56,0211-699501013259,pesar,o
56,0211-699501013259,de,o
56,0211-699501013259,un,o
56,0211-699501013259,continuo,o
56,0211-699501013259,aumento,o
56,0211-699501013259,del,o
56,0211-699501013259,folato,i
56,0211-699501013259,10078,o
56,0211-699501013259,IC,o
56,0211-699501013259,7481,o
56,0211-699501013259,12674,o
56,0211-699501013259,p,o
56,0211-699501013259,0001,o
56,0211-699501013259,solo,o
56,0211-699501013259,3,o
56,0211-699501013259,pacientes,o
56,0211-699501013259,presentan,o
56,0211-699501013259,niveles,o
56,0211-699501013259,normales,o
56,0211-699501013259,de,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,correlacionandose,o
56,0211-699501013259,directamente,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,con,o
56,0211-699501013259,la,o
56,0211-699501013259,albumina,i
56,0211-699501013259,r,o
56,0211-699501013259,056,o
56,0211-699501013259,p,o
56,0211-699501013259,0001,o
56,0211-699501013259,que,o
56,0211-699501013259,se,o
56,0211-699501013259,elevo,o
56,0211-699501013259,con,o
56,0211-699501013259,respecto,o
56,0211-699501013259,al,o
56,0211-699501013259,inicio,o
56,0211-699501013259,337,o
56,0211-699501013259,IC,o
56,0211-699501013259,327,o
56,0211-699501013259,346,o
56,0211-699501013259,vs,o
56,0211-699501013259,350,o
56,0211-699501013259,IC,o
56,0211-699501013259,337,o
56,0211-699501013259,363,o
56,0211-699501013259,p,o
56,0211-699501013259,005,o
56,0211-699501013259,Conclusion,o
56,0211-699501013259,Tras,o
56,0211-699501013259,suplementacion,i
56,0211-699501013259,con,o
56,0211-699501013259,acido,i
56,0211-699501013259,folico,i
56,0211-699501013259,y,o
56,0211-699501013259,vitamina,i
56,0211-699501013259,B6,i
56,0211-699501013259,aunque,o
56,0211-699501013259,inicialmente,o
56,0211-699501013259,se,o
56,0211-699501013259,reduce,o
56,0211-699501013259,la,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,esta,o
56,0211-699501013259,respuesta,o
56,0211-699501013259,se,o
56,0211-699501013259,hace,o
56,0211-699501013259,refractaria,o
56,0211-699501013259,correlacionandose,o
56,0211-699501013259,directamente,o
56,0211-699501013259,la,o
56,0211-699501013259,tHcy,i
56,0211-699501013259,con,o
56,0211-699501013259,la,o
56,0211-699501013259,albumina,i
56,0211-699501013259,plasmatica,i
56,0211-699501013259,La,o
56,0211-699501013259,interpretacion,o
56,0211-699501013259,de,o
56,0211-699501013259,los,o
56,0211-699501013259,niveles,i
56,0211-699501013259,de,i
56,0211-699501013259,tHcy,i
56,0211-699501013259,debe,o
56,0211-699501013259,tener,o
56,0211-699501013259,en,o
56,0211-699501013259,cuenta,o
56,0211-699501013259,la,o
56,0211-699501013259,concentracion,i
56,0211-699501013259,de,i
56,0211-699501013259,albumina,i
57,0211-699501013259,Efecto,o
57,0211-699501013259,de,o
57,0211-699501013259,la,o
57,0211-699501013259,suplementacion,i
57,0211-699501013259,con,o
57,0211-699501013259,acido,i
57,0211-699501013259,folico,i
57,0211-699501013259,sobre,o
57,0211-699501013259,los,o
57,0211-699501013259,niveles,i
57,0211-699501013259,de,i
57,0211-699501013259,homocisteina,i
57,0211-699501013259,total,o
57,0211-699501013259,en,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,en,o
57,0211-699501013259,hemodialisis,i
57,0211-699501013259,La,o
57,0211-699501013259,hiperhomocisteinemia,i
57,0211-699501013259,es,o
57,0211-699501013259,un,o
57,0211-699501013259,marcador,o
57,0211-699501013259,de,o
57,0211-699501013259,riesgo,o
57,0211-699501013259,independiente,o
57,0211-699501013259,de,o
57,0211-699501013259,morbimortalidad,o
57,0211-699501013259,cardiovascular,i
57,0211-699501013259,Hemos,o
57,0211-699501013259,intentado,o
57,0211-699501013259,prospectivamente,o
57,0211-699501013259,reducir,o
57,0211-699501013259,los,o
57,0211-699501013259,niveles,i
57,0211-699501013259,de,i
57,0211-699501013259,homocisteina,i
57,0211-699501013259,total,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,mediante,o
57,0211-699501013259,suplemento,o
57,0211-699501013259,con,o
57,0211-699501013259,acido,i
57,0211-699501013259,folico,i
57,0211-699501013259,y,o
57,0211-699501013259,vitamina,i
57,0211-699501013259,B6,i
57,0211-699501013259,pp,i
57,0211-699501013259,valorando,o
57,0211-699501013259,su,o
57,0211-699501013259,posible,o
57,0211-699501013259,correlacion,o
57,0211-699501013259,con,o
57,0211-699501013259,dosis,o
57,0211-699501013259,de,o
57,0211-699501013259,dialisis,i
57,0211-699501013259,funcion,i
57,0211-699501013259,residual,i
57,0211-699501013259,y,o
57,0211-699501013259,parametros,o
57,0211-699501013259,nutricionales,o
57,0211-699501013259,Metodos,o
57,0211-699501013259,Todos,o
57,0211-699501013259,los,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,en,o
57,0211-699501013259,hemodialisis,i
57,0211-699501013259,al,o
57,0211-699501013259,comienzo,o
57,0211-699501013259,del,o
57,0211-699501013259,estudio,o
57,0211-699501013259,que,o
57,0211-699501013259,no,o
57,0211-699501013259,recibian,o
57,0211-699501013259,acido,i
57,0211-699501013259,folico,i
57,0211-699501013259,ni,o
57,0211-699501013259,vitamina,i
57,0211-699501013259,B6,i
57,0211-699501013259,asi,o
57,0211-699501013259,como,o
57,0211-699501013259,los,o
57,0211-699501013259,incorporados,o
57,0211-699501013259,posteriormente,o
57,0211-699501013259,a,o
57,0211-699501013259,partir,o
57,0211-699501013259,de,o
57,0211-699501013259,su,o
57,0211-699501013259,tercer,o
57,0211-699501013259,mes,o
57,0211-699501013259,en,o
57,0211-699501013259,hemodialisis,i
57,0211-699501013259,recibieron,o
57,0211-699501013259,5,o
57,0211-699501013259,mg,o
57,0211-699501013259,orales,o
57,0211-699501013259,de,o
57,0211-699501013259,acido,i
57,0211-699501013259,folico,i
57,0211-699501013259,cada,o
57,0211-699501013259,48,o
57,0211-699501013259,horas,o
57,0211-699501013259,y,o
57,0211-699501013259,40,o
57,0211-699501013259,mg,o
57,0211-699501013259,orales,o
57,0211-699501013259,de,o
57,0211-699501013259,vitamina,i
57,0211-699501013259,B6,i
57,0211-699501013259,cada,o
57,0211-699501013259,semana,o
57,0211-699501013259,Se,o
57,0211-699501013259,determinaron,o
57,0211-699501013259,al,o
57,0211-699501013259,comienzo,o
57,0211-699501013259,del,o
57,0211-699501013259,estudio,o
57,0211-699501013259,y,o
57,0211-699501013259,cada,o
57,0211-699501013259,2,o
57,0211-699501013259,meses,o
57,0211-699501013259,niveles,i
57,0211-699501013259,de,i
57,0211-699501013259,folato,i
57,0211-699501013259,vitamina,i
57,0211-699501013259,B12,i
57,0211-699501013259,inmunoensayo,i
57,0211-699501013259,albumina,i
57,0211-699501013259,y,o
57,0211-699501013259,cinetica,o
57,0211-699501013259,de,o
57,0211-699501013259,la,o
57,0211-699501013259,urea,i
57,0211-699501013259,KTV,o
57,0211-699501013259,KRU,o
57,0211-699501013259,PCRn,o
57,0211-699501013259,y,o
57,0211-699501013259,cada,o
57,0211-699501013259,6,o
57,0211-699501013259,meses,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,HPLC,i
57,0211-699501013259,y,o
57,0211-699501013259,pp,i
57,0211-699501013259,RIA,i
57,0211-699501013259,Resultados,o
57,0211-699501013259,80,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,fueron,o
57,0211-699501013259,incluidos,o
57,0211-699501013259,en,o
57,0211-699501013259,el,o
57,0211-699501013259,estudio,o
57,0211-699501013259,basal,o
57,0211-699501013259,con,o
57,0211-699501013259,una,o
57,0211-699501013259,prevalencia,o
57,0211-699501013259,de,o
57,0211-699501013259,hiperhomocisteinemia,i
57,0211-699501013259,del,o
57,0211-699501013259,844,o
57,0211-699501013259,deficit,i
57,0211-699501013259,de,i
57,0211-699501013259,pp,i
57,0211-699501013259,en,o
57,0211-699501013259,el,o
57,0211-699501013259,32,o
57,0211-699501013259,y,o
57,0211-699501013259,folato,i
57,0211-699501013259,en,o
57,0211-699501013259,el,o
57,0211-699501013259,rango,o
57,0211-699501013259,normal,o
57,0211-699501013259,bajo,o
57,0211-699501013259,los,o
57,0211-699501013259,niveles,i
57,0211-699501013259,de,i
57,0211-699501013259,tHcy,i
57,0211-699501013259,se,o
57,0211-699501013259,correlacionaban,o
57,0211-699501013259,inversamente,o
57,0211-699501013259,con,o
57,0211-699501013259,los,o
57,0211-699501013259,del,o
57,0211-699501013259,folato,i
57,0211-699501013259,r,o
57,0211-699501013259,0336,o
57,0211-699501013259,p,o
57,0211-699501013259,001,o
57,0211-699501013259,pero,o
57,0211-699501013259,no,o
57,0211-699501013259,con,o
57,0211-699501013259,pp,i
57,0211-699501013259,B12,i
57,0211-699501013259,edad,o
57,0211-699501013259,albumina,i
57,0211-699501013259,KTV,o
57,0211-699501013259,KRU,o
57,0211-699501013259,PCRn,o
57,0211-699501013259,Cincuenta,o
57,0211-699501013259,y,o
57,0211-699501013259,ocho,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,recibieron,o
57,0211-699501013259,seis,o
57,0211-699501013259,meses,o
57,0211-699501013259,de,o
57,0211-699501013259,suplementacion,i
57,0211-699501013259,con,o
57,0211-699501013259,normalizacion,o
57,0211-699501013259,del,o
57,0211-699501013259,pp,i
57,0211-699501013259,aumento,o
57,0211-699501013259,del,o
57,0211-699501013259,folato,i
57,0211-699501013259,703,o
57,0211-699501013259,IC,o
57,0211-699501013259,638,o
57,0211-699501013259,795,o
57,0211-699501013259,vs,o
57,0211-699501013259,6181,o
57,0211-699501013259,IC,o
57,0211-699501013259,4447,o
57,0211-699501013259,7811,o
57,0211-699501013259,p,o
57,0211-699501013259,0001,o
57,0211-699501013259,y,o
57,0211-699501013259,descenso,o
57,0211-699501013259,de,o
57,0211-699501013259,la,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,240,o
57,0211-699501013259,IC,o
57,0211-699501013259,213,o
57,0211-699501013259,264,o
57,0211-699501013259,vs,o
57,0211-699501013259,199,o
57,0211-699501013259,IC,o
57,0211-699501013259,175,o
57,0211-699501013259,224,o
57,0211-699501013259,p,o
57,0211-699501013259,005,o
57,0211-699501013259,Han,o
57,0211-699501013259,recibido,o
57,0211-699501013259,suplementacion,i
57,0211-699501013259,durante,o
57,0211-699501013259,12,o
57,0211-699501013259,meses,o
57,0211-699501013259,33,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,pero,o
57,0211-699501013259,a,o
57,0211-699501013259,pesar,o
57,0211-699501013259,de,o
57,0211-699501013259,un,o
57,0211-699501013259,continuo,o
57,0211-699501013259,aumento,o
57,0211-699501013259,del,o
57,0211-699501013259,folato,i
57,0211-699501013259,10078,o
57,0211-699501013259,IC,o
57,0211-699501013259,7481,o
57,0211-699501013259,12674,o
57,0211-699501013259,p,o
57,0211-699501013259,0001,o
57,0211-699501013259,solo,o
57,0211-699501013259,3,o
57,0211-699501013259,pacientes,o
57,0211-699501013259,presentan,o
57,0211-699501013259,niveles,o
57,0211-699501013259,normales,o
57,0211-699501013259,de,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,correlacionandose,o
57,0211-699501013259,directamente,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,con,o
57,0211-699501013259,la,o
57,0211-699501013259,albumina,i
57,0211-699501013259,r,o
57,0211-699501013259,056,o
57,0211-699501013259,p,o
57,0211-699501013259,0001,o
57,0211-699501013259,que,o
57,0211-699501013259,se,o
57,0211-699501013259,elevo,o
57,0211-699501013259,con,o
57,0211-699501013259,respecto,o
57,0211-699501013259,al,o
57,0211-699501013259,inicio,o
57,0211-699501013259,337,o
57,0211-699501013259,IC,o
57,0211-699501013259,327,o
57,0211-699501013259,346,o
57,0211-699501013259,vs,o
57,0211-699501013259,350,o
57,0211-699501013259,IC,o
57,0211-699501013259,337,o
57,0211-699501013259,363,o
57,0211-699501013259,p,o
57,0211-699501013259,005,o
57,0211-699501013259,Conclusion,o
57,0211-699501013259,Tras,o
57,0211-699501013259,suplementacion,i
57,0211-699501013259,con,o
57,0211-699501013259,acido,i
57,0211-699501013259,folico,i
57,0211-699501013259,y,o
57,0211-699501013259,vitamina,i
57,0211-699501013259,B6,i
57,0211-699501013259,aunque,o
57,0211-699501013259,inicialmente,o
57,0211-699501013259,se,o
57,0211-699501013259,reduce,o
57,0211-699501013259,la,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,esta,o
57,0211-699501013259,respuesta,o
57,0211-699501013259,se,o
57,0211-699501013259,hace,o
57,0211-699501013259,refractaria,o
57,0211-699501013259,correlacionandose,o
57,0211-699501013259,directamente,o
57,0211-699501013259,la,o
57,0211-699501013259,tHcy,i
57,0211-699501013259,con,o
57,0211-699501013259,la,o
57,0211-699501013259,albumina,i
57,0211-699501013259,plasmatica,i
57,0211-699501013259,La,o
57,0211-699501013259,interpretacion,o
57,0211-699501013259,de,o
57,0211-699501013259,los,o
57,0211-699501013259,niveles,i
57,0211-699501013259,de,i
57,0211-699501013259,tHcy,i
57,0211-699501013259,debe,o
57,0211-699501013259,tener,o
57,0211-699501013259,en,o
57,0211-699501013259,cuenta,o
57,0211-699501013259,la,o
57,0211-699501013259,concentracion,i
57,0211-699501013259,de,i
57,0211-699501013259,albumina,i
58,0211-699501013259,Efecto,o
58,0211-699501013259,de,o
58,0211-699501013259,la,o
58,0211-699501013259,suplementacion,i
58,0211-699501013259,con,o
58,0211-699501013259,acido,i
58,0211-699501013259,folico,i
58,0211-699501013259,sobre,o
58,0211-699501013259,los,o
58,0211-699501013259,niveles,i
58,0211-699501013259,de,i
58,0211-699501013259,homocisteina,i
58,0211-699501013259,total,o
58,0211-699501013259,en,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,en,o
58,0211-699501013259,hemodialisis,i
58,0211-699501013259,La,o
58,0211-699501013259,hiperhomocisteinemia,i
58,0211-699501013259,es,o
58,0211-699501013259,un,o
58,0211-699501013259,marcador,o
58,0211-699501013259,de,o
58,0211-699501013259,riesgo,o
58,0211-699501013259,independiente,o
58,0211-699501013259,de,o
58,0211-699501013259,morbimortalidad,o
58,0211-699501013259,cardiovascular,i
58,0211-699501013259,Hemos,o
58,0211-699501013259,intentado,o
58,0211-699501013259,prospectivamente,o
58,0211-699501013259,reducir,o
58,0211-699501013259,los,o
58,0211-699501013259,niveles,i
58,0211-699501013259,de,i
58,0211-699501013259,homocisteina,i
58,0211-699501013259,total,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,mediante,o
58,0211-699501013259,suplemento,o
58,0211-699501013259,con,o
58,0211-699501013259,acido,i
58,0211-699501013259,folico,i
58,0211-699501013259,y,o
58,0211-699501013259,vitamina,i
58,0211-699501013259,B6,i
58,0211-699501013259,pp,i
58,0211-699501013259,valorando,o
58,0211-699501013259,su,o
58,0211-699501013259,posible,o
58,0211-699501013259,correlacion,o
58,0211-699501013259,con,o
58,0211-699501013259,dosis,o
58,0211-699501013259,de,o
58,0211-699501013259,dialisis,i
58,0211-699501013259,funcion,i
58,0211-699501013259,residual,i
58,0211-699501013259,y,o
58,0211-699501013259,parametros,o
58,0211-699501013259,nutricionales,o
58,0211-699501013259,Metodos,o
58,0211-699501013259,Todos,o
58,0211-699501013259,los,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,en,o
58,0211-699501013259,hemodialisis,i
58,0211-699501013259,al,o
58,0211-699501013259,comienzo,o
58,0211-699501013259,del,o
58,0211-699501013259,estudio,o
58,0211-699501013259,que,o
58,0211-699501013259,no,o
58,0211-699501013259,recibian,o
58,0211-699501013259,acido,i
58,0211-699501013259,folico,i
58,0211-699501013259,ni,o
58,0211-699501013259,vitamina,i
58,0211-699501013259,B6,i
58,0211-699501013259,asi,o
58,0211-699501013259,como,o
58,0211-699501013259,los,o
58,0211-699501013259,incorporados,o
58,0211-699501013259,posteriormente,o
58,0211-699501013259,a,o
58,0211-699501013259,partir,o
58,0211-699501013259,de,o
58,0211-699501013259,su,o
58,0211-699501013259,tercer,o
58,0211-699501013259,mes,o
58,0211-699501013259,en,o
58,0211-699501013259,hemodialisis,i
58,0211-699501013259,recibieron,o
58,0211-699501013259,5,o
58,0211-699501013259,mg,o
58,0211-699501013259,orales,o
58,0211-699501013259,de,o
58,0211-699501013259,acido,i
58,0211-699501013259,folico,i
58,0211-699501013259,cada,o
58,0211-699501013259,48,o
58,0211-699501013259,horas,o
58,0211-699501013259,y,o
58,0211-699501013259,40,o
58,0211-699501013259,mg,o
58,0211-699501013259,orales,o
58,0211-699501013259,de,o
58,0211-699501013259,vitamina,i
58,0211-699501013259,B6,i
58,0211-699501013259,cada,o
58,0211-699501013259,semana,o
58,0211-699501013259,Se,o
58,0211-699501013259,determinaron,o
58,0211-699501013259,al,o
58,0211-699501013259,comienzo,o
58,0211-699501013259,del,o
58,0211-699501013259,estudio,o
58,0211-699501013259,y,o
58,0211-699501013259,cada,o
58,0211-699501013259,2,o
58,0211-699501013259,meses,o
58,0211-699501013259,niveles,i
58,0211-699501013259,de,i
58,0211-699501013259,folato,i
58,0211-699501013259,vitamina,i
58,0211-699501013259,B12,i
58,0211-699501013259,inmunoensayo,i
58,0211-699501013259,albumina,i
58,0211-699501013259,y,o
58,0211-699501013259,cinetica,o
58,0211-699501013259,de,o
58,0211-699501013259,la,o
58,0211-699501013259,urea,i
58,0211-699501013259,KTV,o
58,0211-699501013259,KRU,o
58,0211-699501013259,PCRn,o
58,0211-699501013259,y,o
58,0211-699501013259,cada,o
58,0211-699501013259,6,o
58,0211-699501013259,meses,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,HPLC,i
58,0211-699501013259,y,o
58,0211-699501013259,pp,i
58,0211-699501013259,RIA,i
58,0211-699501013259,Resultados,o
58,0211-699501013259,80,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,fueron,o
58,0211-699501013259,incluidos,o
58,0211-699501013259,en,o
58,0211-699501013259,el,o
58,0211-699501013259,estudio,o
58,0211-699501013259,basal,o
58,0211-699501013259,con,o
58,0211-699501013259,una,o
58,0211-699501013259,prevalencia,o
58,0211-699501013259,de,o
58,0211-699501013259,hiperhomocisteinemia,i
58,0211-699501013259,del,o
58,0211-699501013259,844,o
58,0211-699501013259,deficit,i
58,0211-699501013259,de,i
58,0211-699501013259,pp,i
58,0211-699501013259,en,o
58,0211-699501013259,el,o
58,0211-699501013259,32,o
58,0211-699501013259,y,o
58,0211-699501013259,folato,i
58,0211-699501013259,en,o
58,0211-699501013259,el,o
58,0211-699501013259,rango,o
58,0211-699501013259,normal,o
58,0211-699501013259,bajo,o
58,0211-699501013259,los,o
58,0211-699501013259,niveles,i
58,0211-699501013259,de,i
58,0211-699501013259,tHcy,i
58,0211-699501013259,se,o
58,0211-699501013259,correlacionaban,o
58,0211-699501013259,inversamente,o
58,0211-699501013259,con,o
58,0211-699501013259,los,o
58,0211-699501013259,del,o
58,0211-699501013259,folato,i
58,0211-699501013259,r,o
58,0211-699501013259,0336,o
58,0211-699501013259,p,o
58,0211-699501013259,001,o
58,0211-699501013259,pero,o
58,0211-699501013259,no,o
58,0211-699501013259,con,o
58,0211-699501013259,pp,i
58,0211-699501013259,B12,i
58,0211-699501013259,edad,o
58,0211-699501013259,albumina,i
58,0211-699501013259,KTV,o
58,0211-699501013259,KRU,o
58,0211-699501013259,PCRn,o
58,0211-699501013259,Cincuenta,o
58,0211-699501013259,y,o
58,0211-699501013259,ocho,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,recibieron,o
58,0211-699501013259,seis,o
58,0211-699501013259,meses,o
58,0211-699501013259,de,o
58,0211-699501013259,suplementacion,i
58,0211-699501013259,con,o
58,0211-699501013259,normalizacion,o
58,0211-699501013259,del,o
58,0211-699501013259,pp,i
58,0211-699501013259,aumento,o
58,0211-699501013259,del,o
58,0211-699501013259,folato,i
58,0211-699501013259,703,o
58,0211-699501013259,IC,o
58,0211-699501013259,638,o
58,0211-699501013259,795,o
58,0211-699501013259,vs,o
58,0211-699501013259,6181,o
58,0211-699501013259,IC,o
58,0211-699501013259,4447,o
58,0211-699501013259,7811,o
58,0211-699501013259,p,o
58,0211-699501013259,0001,o
58,0211-699501013259,y,o
58,0211-699501013259,descenso,o
58,0211-699501013259,de,o
58,0211-699501013259,la,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,240,o
58,0211-699501013259,IC,o
58,0211-699501013259,213,o
58,0211-699501013259,264,o
58,0211-699501013259,vs,o
58,0211-699501013259,199,o
58,0211-699501013259,IC,o
58,0211-699501013259,175,o
58,0211-699501013259,224,o
58,0211-699501013259,p,o
58,0211-699501013259,005,o
58,0211-699501013259,Han,o
58,0211-699501013259,recibido,o
58,0211-699501013259,suplementacion,i
58,0211-699501013259,durante,o
58,0211-699501013259,12,o
58,0211-699501013259,meses,o
58,0211-699501013259,33,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,pero,o
58,0211-699501013259,a,o
58,0211-699501013259,pesar,o
58,0211-699501013259,de,o
58,0211-699501013259,un,o
58,0211-699501013259,continuo,o
58,0211-699501013259,aumento,o
58,0211-699501013259,del,o
58,0211-699501013259,folato,i
58,0211-699501013259,10078,o
58,0211-699501013259,IC,o
58,0211-699501013259,7481,o
58,0211-699501013259,12674,o
58,0211-699501013259,p,o
58,0211-699501013259,0001,o
58,0211-699501013259,solo,o
58,0211-699501013259,3,o
58,0211-699501013259,pacientes,o
58,0211-699501013259,presentan,o
58,0211-699501013259,niveles,o
58,0211-699501013259,normales,o
58,0211-699501013259,de,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,correlacionandose,o
58,0211-699501013259,directamente,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,con,o
58,0211-699501013259,la,o
58,0211-699501013259,albumina,i
58,0211-699501013259,r,o
58,0211-699501013259,056,o
58,0211-699501013259,p,o
58,0211-699501013259,0001,o
58,0211-699501013259,que,o
58,0211-699501013259,se,o
58,0211-699501013259,elevo,o
58,0211-699501013259,con,o
58,0211-699501013259,respecto,o
58,0211-699501013259,al,o
58,0211-699501013259,inicio,o
58,0211-699501013259,337,o
58,0211-699501013259,IC,o
58,0211-699501013259,327,o
58,0211-699501013259,346,o
58,0211-699501013259,vs,o
58,0211-699501013259,350,o
58,0211-699501013259,IC,o
58,0211-699501013259,337,o
58,0211-699501013259,363,o
58,0211-699501013259,p,o
58,0211-699501013259,005,o
58,0211-699501013259,Conclusion,o
58,0211-699501013259,Tras,o
58,0211-699501013259,suplementacion,i
58,0211-699501013259,con,o
58,0211-699501013259,acido,i
58,0211-699501013259,folico,i
58,0211-699501013259,y,o
58,0211-699501013259,vitamina,i
58,0211-699501013259,B6,i
58,0211-699501013259,aunque,o
58,0211-699501013259,inicialmente,o
58,0211-699501013259,se,o
58,0211-699501013259,reduce,o
58,0211-699501013259,la,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,esta,o
58,0211-699501013259,respuesta,o
58,0211-699501013259,se,o
58,0211-699501013259,hace,o
58,0211-699501013259,refractaria,o
58,0211-699501013259,correlacionandose,o
58,0211-699501013259,directamente,o
58,0211-699501013259,la,o
58,0211-699501013259,tHcy,i
58,0211-699501013259,con,o
58,0211-699501013259,la,o
58,0211-699501013259,albumina,i
58,0211-699501013259,plasmatica,i
58,0211-699501013259,La,o
58,0211-699501013259,interpretacion,o
58,0211-699501013259,de,o
58,0211-699501013259,los,o
58,0211-699501013259,niveles,i
58,0211-699501013259,de,i
58,0211-699501013259,tHcy,i
58,0211-699501013259,debe,o
58,0211-699501013259,tener,o
58,0211-699501013259,en,o
58,0211-699501013259,cuenta,o
58,0211-699501013259,la,o
58,0211-699501013259,concentracion,i
58,0211-699501013259,de,i
58,0211-699501013259,albumina,i
59,0211-699501013259,Efecto,o
59,0211-699501013259,de,o
59,0211-699501013259,la,o
59,0211-699501013259,suplementacion,i
59,0211-699501013259,con,o
59,0211-699501013259,acido,i
59,0211-699501013259,folico,i
59,0211-699501013259,sobre,o
59,0211-699501013259,los,o
59,0211-699501013259,niveles,i
59,0211-699501013259,de,i
59,0211-699501013259,homocisteina,i
59,0211-699501013259,total,o
59,0211-699501013259,en,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,en,o
59,0211-699501013259,hemodialisis,i
59,0211-699501013259,La,o
59,0211-699501013259,hiperhomocisteinemia,i
59,0211-699501013259,es,o
59,0211-699501013259,un,o
59,0211-699501013259,marcador,o
59,0211-699501013259,de,o
59,0211-699501013259,riesgo,o
59,0211-699501013259,independiente,o
59,0211-699501013259,de,o
59,0211-699501013259,morbimortalidad,o
59,0211-699501013259,cardiovascular,i
59,0211-699501013259,Hemos,o
59,0211-699501013259,intentado,o
59,0211-699501013259,prospectivamente,o
59,0211-699501013259,reducir,o
59,0211-699501013259,los,o
59,0211-699501013259,niveles,i
59,0211-699501013259,de,i
59,0211-699501013259,homocisteina,i
59,0211-699501013259,total,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,mediante,o
59,0211-699501013259,suplemento,o
59,0211-699501013259,con,o
59,0211-699501013259,acido,i
59,0211-699501013259,folico,i
59,0211-699501013259,y,o
59,0211-699501013259,vitamina,i
59,0211-699501013259,B6,i
59,0211-699501013259,pp,i
59,0211-699501013259,valorando,o
59,0211-699501013259,su,o
59,0211-699501013259,posible,o
59,0211-699501013259,correlacion,o
59,0211-699501013259,con,o
59,0211-699501013259,dosis,o
59,0211-699501013259,de,o
59,0211-699501013259,dialisis,i
59,0211-699501013259,funcion,i
59,0211-699501013259,residual,i
59,0211-699501013259,y,o
59,0211-699501013259,parametros,o
59,0211-699501013259,nutricionales,o
59,0211-699501013259,Metodos,o
59,0211-699501013259,Todos,o
59,0211-699501013259,los,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,en,o
59,0211-699501013259,hemodialisis,i
59,0211-699501013259,al,o
59,0211-699501013259,comienzo,o
59,0211-699501013259,del,o
59,0211-699501013259,estudio,o
59,0211-699501013259,que,o
59,0211-699501013259,no,o
59,0211-699501013259,recibian,o
59,0211-699501013259,acido,i
59,0211-699501013259,folico,i
59,0211-699501013259,ni,o
59,0211-699501013259,vitamina,i
59,0211-699501013259,B6,i
59,0211-699501013259,asi,o
59,0211-699501013259,como,o
59,0211-699501013259,los,o
59,0211-699501013259,incorporados,o
59,0211-699501013259,posteriormente,o
59,0211-699501013259,a,o
59,0211-699501013259,partir,o
59,0211-699501013259,de,o
59,0211-699501013259,su,o
59,0211-699501013259,tercer,o
59,0211-699501013259,mes,o
59,0211-699501013259,en,o
59,0211-699501013259,hemodialisis,i
59,0211-699501013259,recibieron,o
59,0211-699501013259,5,o
59,0211-699501013259,mg,o
59,0211-699501013259,orales,o
59,0211-699501013259,de,o
59,0211-699501013259,acido,i
59,0211-699501013259,folico,i
59,0211-699501013259,cada,o
59,0211-699501013259,48,o
59,0211-699501013259,horas,o
59,0211-699501013259,y,o
59,0211-699501013259,40,o
59,0211-699501013259,mg,o
59,0211-699501013259,orales,o
59,0211-699501013259,de,o
59,0211-699501013259,vitamina,i
59,0211-699501013259,B6,i
59,0211-699501013259,cada,o
59,0211-699501013259,semana,o
59,0211-699501013259,Se,o
59,0211-699501013259,determinaron,o
59,0211-699501013259,al,o
59,0211-699501013259,comienzo,o
59,0211-699501013259,del,o
59,0211-699501013259,estudio,o
59,0211-699501013259,y,o
59,0211-699501013259,cada,o
59,0211-699501013259,2,o
59,0211-699501013259,meses,o
59,0211-699501013259,niveles,i
59,0211-699501013259,de,i
59,0211-699501013259,folato,i
59,0211-699501013259,vitamina,i
59,0211-699501013259,B12,i
59,0211-699501013259,inmunoensayo,i
59,0211-699501013259,albumina,i
59,0211-699501013259,y,o
59,0211-699501013259,cinetica,o
59,0211-699501013259,de,o
59,0211-699501013259,la,o
59,0211-699501013259,urea,i
59,0211-699501013259,KTV,o
59,0211-699501013259,KRU,o
59,0211-699501013259,PCRn,o
59,0211-699501013259,y,o
59,0211-699501013259,cada,o
59,0211-699501013259,6,o
59,0211-699501013259,meses,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,HPLC,i
59,0211-699501013259,y,o
59,0211-699501013259,pp,i
59,0211-699501013259,RIA,i
59,0211-699501013259,Resultados,o
59,0211-699501013259,80,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,fueron,o
59,0211-699501013259,incluidos,o
59,0211-699501013259,en,o
59,0211-699501013259,el,o
59,0211-699501013259,estudio,o
59,0211-699501013259,basal,o
59,0211-699501013259,con,o
59,0211-699501013259,una,o
59,0211-699501013259,prevalencia,o
59,0211-699501013259,de,o
59,0211-699501013259,hiperhomocisteinemia,i
59,0211-699501013259,del,o
59,0211-699501013259,844,o
59,0211-699501013259,deficit,i
59,0211-699501013259,de,i
59,0211-699501013259,pp,i
59,0211-699501013259,en,o
59,0211-699501013259,el,o
59,0211-699501013259,32,o
59,0211-699501013259,y,o
59,0211-699501013259,folato,i
59,0211-699501013259,en,o
59,0211-699501013259,el,o
59,0211-699501013259,rango,o
59,0211-699501013259,normal,o
59,0211-699501013259,bajo,o
59,0211-699501013259,los,o
59,0211-699501013259,niveles,i
59,0211-699501013259,de,i
59,0211-699501013259,tHcy,i
59,0211-699501013259,se,o
59,0211-699501013259,correlacionaban,o
59,0211-699501013259,inversamente,o
59,0211-699501013259,con,o
59,0211-699501013259,los,o
59,0211-699501013259,del,o
59,0211-699501013259,folato,i
59,0211-699501013259,r,o
59,0211-699501013259,0336,o
59,0211-699501013259,p,o
59,0211-699501013259,001,o
59,0211-699501013259,pero,o
59,0211-699501013259,no,o
59,0211-699501013259,con,o
59,0211-699501013259,pp,i
59,0211-699501013259,B12,i
59,0211-699501013259,edad,o
59,0211-699501013259,albumina,i
59,0211-699501013259,KTV,o
59,0211-699501013259,KRU,o
59,0211-699501013259,PCRn,o
59,0211-699501013259,Cincuenta,o
59,0211-699501013259,y,o
59,0211-699501013259,ocho,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,recibieron,o
59,0211-699501013259,seis,o
59,0211-699501013259,meses,o
59,0211-699501013259,de,o
59,0211-699501013259,suplementacion,i
59,0211-699501013259,con,o
59,0211-699501013259,normalizacion,o
59,0211-699501013259,del,o
59,0211-699501013259,pp,i
59,0211-699501013259,aumento,o
59,0211-699501013259,del,o
59,0211-699501013259,folato,i
59,0211-699501013259,703,o
59,0211-699501013259,IC,o
59,0211-699501013259,638,o
59,0211-699501013259,795,o
59,0211-699501013259,vs,o
59,0211-699501013259,6181,o
59,0211-699501013259,IC,o
59,0211-699501013259,4447,o
59,0211-699501013259,7811,o
59,0211-699501013259,p,o
59,0211-699501013259,0001,o
59,0211-699501013259,y,o
59,0211-699501013259,descenso,o
59,0211-699501013259,de,o
59,0211-699501013259,la,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,240,o
59,0211-699501013259,IC,o
59,0211-699501013259,213,o
59,0211-699501013259,264,o
59,0211-699501013259,vs,o
59,0211-699501013259,199,o
59,0211-699501013259,IC,o
59,0211-699501013259,175,o
59,0211-699501013259,224,o
59,0211-699501013259,p,o
59,0211-699501013259,005,o
59,0211-699501013259,Han,o
59,0211-699501013259,recibido,o
59,0211-699501013259,suplementacion,i
59,0211-699501013259,durante,o
59,0211-699501013259,12,o
59,0211-699501013259,meses,o
59,0211-699501013259,33,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,pero,o
59,0211-699501013259,a,o
59,0211-699501013259,pesar,o
59,0211-699501013259,de,o
59,0211-699501013259,un,o
59,0211-699501013259,continuo,o
59,0211-699501013259,aumento,o
59,0211-699501013259,del,o
59,0211-699501013259,folato,i
59,0211-699501013259,10078,o
59,0211-699501013259,IC,o
59,0211-699501013259,7481,o
59,0211-699501013259,12674,o
59,0211-699501013259,p,o
59,0211-699501013259,0001,o
59,0211-699501013259,solo,o
59,0211-699501013259,3,o
59,0211-699501013259,pacientes,o
59,0211-699501013259,presentan,o
59,0211-699501013259,niveles,o
59,0211-699501013259,normales,o
59,0211-699501013259,de,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,correlacionandose,o
59,0211-699501013259,directamente,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,con,o
59,0211-699501013259,la,o
59,0211-699501013259,albumina,i
59,0211-699501013259,r,o
59,0211-699501013259,056,o
59,0211-699501013259,p,o
59,0211-699501013259,0001,o
59,0211-699501013259,que,o
59,0211-699501013259,se,o
59,0211-699501013259,elevo,o
59,0211-699501013259,con,o
59,0211-699501013259,respecto,o
59,0211-699501013259,al,o
59,0211-699501013259,inicio,o
59,0211-699501013259,337,o
59,0211-699501013259,IC,o
59,0211-699501013259,327,o
59,0211-699501013259,346,o
59,0211-699501013259,vs,o
59,0211-699501013259,350,o
59,0211-699501013259,IC,o
59,0211-699501013259,337,o
59,0211-699501013259,363,o
59,0211-699501013259,p,o
59,0211-699501013259,005,o
59,0211-699501013259,Conclusion,o
59,0211-699501013259,Tras,o
59,0211-699501013259,suplementacion,i
59,0211-699501013259,con,o
59,0211-699501013259,acido,i
59,0211-699501013259,folico,i
59,0211-699501013259,y,o
59,0211-699501013259,vitamina,i
59,0211-699501013259,B6,i
59,0211-699501013259,aunque,o
59,0211-699501013259,inicialmente,o
59,0211-699501013259,se,o
59,0211-699501013259,reduce,o
59,0211-699501013259,la,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,esta,o
59,0211-699501013259,respuesta,o
59,0211-699501013259,se,o
59,0211-699501013259,hace,o
59,0211-699501013259,refractaria,o
59,0211-699501013259,correlacionandose,o
59,0211-699501013259,directamente,o
59,0211-699501013259,la,o
59,0211-699501013259,tHcy,i
59,0211-699501013259,con,o
59,0211-699501013259,la,o
59,0211-699501013259,albumina,i
59,0211-699501013259,plasmatica,i
59,0211-699501013259,La,o
59,0211-699501013259,interpretacion,o
59,0211-699501013259,de,o
59,0211-699501013259,los,o
59,0211-699501013259,niveles,i
59,0211-699501013259,de,i
59,0211-699501013259,tHcy,i
59,0211-699501013259,debe,o
59,0211-699501013259,tener,o
59,0211-699501013259,en,o
59,0211-699501013259,cuenta,o
59,0211-699501013259,la,o
59,0211-699501013259,concentracion,i
59,0211-699501013259,de,i
59,0211-699501013259,albumina,i
60,0211-699501013259,Efecto,o
60,0211-699501013259,de,o
60,0211-699501013259,la,o
60,0211-699501013259,suplementacion,i
60,0211-699501013259,con,o
60,0211-699501013259,acido,i
60,0211-699501013259,folico,i
60,0211-699501013259,sobre,o
60,0211-699501013259,los,o
60,0211-699501013259,niveles,i
60,0211-699501013259,de,i
60,0211-699501013259,homocisteina,i
60,0211-699501013259,total,o
60,0211-699501013259,en,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,en,o
60,0211-699501013259,hemodialisis,i
60,0211-699501013259,La,o
60,0211-699501013259,hiperhomocisteinemia,i
60,0211-699501013259,es,o
60,0211-699501013259,un,o
60,0211-699501013259,marcador,o
60,0211-699501013259,de,o
60,0211-699501013259,riesgo,o
60,0211-699501013259,independiente,o
60,0211-699501013259,de,o
60,0211-699501013259,morbimortalidad,o
60,0211-699501013259,cardiovascular,i
60,0211-699501013259,Hemos,o
60,0211-699501013259,intentado,o
60,0211-699501013259,prospectivamente,o
60,0211-699501013259,reducir,o
60,0211-699501013259,los,o
60,0211-699501013259,niveles,i
60,0211-699501013259,de,i
60,0211-699501013259,homocisteina,i
60,0211-699501013259,total,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,mediante,o
60,0211-699501013259,suplemento,o
60,0211-699501013259,con,o
60,0211-699501013259,acido,i
60,0211-699501013259,folico,i
60,0211-699501013259,y,o
60,0211-699501013259,vitamina,i
60,0211-699501013259,B6,i
60,0211-699501013259,pp,i
60,0211-699501013259,valorando,o
60,0211-699501013259,su,o
60,0211-699501013259,posible,o
60,0211-699501013259,correlacion,o
60,0211-699501013259,con,o
60,0211-699501013259,dosis,o
60,0211-699501013259,de,o
60,0211-699501013259,dialisis,i
60,0211-699501013259,funcion,i
60,0211-699501013259,residual,i
60,0211-699501013259,y,o
60,0211-699501013259,parametros,o
60,0211-699501013259,nutricionales,o
60,0211-699501013259,Metodos,o
60,0211-699501013259,Todos,o
60,0211-699501013259,los,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,en,o
60,0211-699501013259,hemodialisis,i
60,0211-699501013259,al,o
60,0211-699501013259,comienzo,o
60,0211-699501013259,del,o
60,0211-699501013259,estudio,o
60,0211-699501013259,que,o
60,0211-699501013259,no,o
60,0211-699501013259,recibian,o
60,0211-699501013259,acido,i
60,0211-699501013259,folico,i
60,0211-699501013259,ni,o
60,0211-699501013259,vitamina,i
60,0211-699501013259,B6,i
60,0211-699501013259,asi,o
60,0211-699501013259,como,o
60,0211-699501013259,los,o
60,0211-699501013259,incorporados,o
60,0211-699501013259,posteriormente,o
60,0211-699501013259,a,o
60,0211-699501013259,partir,o
60,0211-699501013259,de,o
60,0211-699501013259,su,o
60,0211-699501013259,tercer,o
60,0211-699501013259,mes,o
60,0211-699501013259,en,o
60,0211-699501013259,hemodialisis,i
60,0211-699501013259,recibieron,o
60,0211-699501013259,5,o
60,0211-699501013259,mg,o
60,0211-699501013259,orales,o
60,0211-699501013259,de,o
60,0211-699501013259,acido,i
60,0211-699501013259,folico,i
60,0211-699501013259,cada,o
60,0211-699501013259,48,o
60,0211-699501013259,horas,o
60,0211-699501013259,y,o
60,0211-699501013259,40,o
60,0211-699501013259,mg,o
60,0211-699501013259,orales,o
60,0211-699501013259,de,o
60,0211-699501013259,vitamina,i
60,0211-699501013259,B6,i
60,0211-699501013259,cada,o
60,0211-699501013259,semana,o
60,0211-699501013259,Se,o
60,0211-699501013259,determinaron,o
60,0211-699501013259,al,o
60,0211-699501013259,comienzo,o
60,0211-699501013259,del,o
60,0211-699501013259,estudio,o
60,0211-699501013259,y,o
60,0211-699501013259,cada,o
60,0211-699501013259,2,o
60,0211-699501013259,meses,o
60,0211-699501013259,niveles,i
60,0211-699501013259,de,i
60,0211-699501013259,folato,i
60,0211-699501013259,vitamina,i
60,0211-699501013259,B12,i
60,0211-699501013259,inmunoensayo,i
60,0211-699501013259,albumina,i
60,0211-699501013259,y,o
60,0211-699501013259,cinetica,o
60,0211-699501013259,de,o
60,0211-699501013259,la,o
60,0211-699501013259,urea,i
60,0211-699501013259,KTV,o
60,0211-699501013259,KRU,o
60,0211-699501013259,PCRn,o
60,0211-699501013259,y,o
60,0211-699501013259,cada,o
60,0211-699501013259,6,o
60,0211-699501013259,meses,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,HPLC,i
60,0211-699501013259,y,o
60,0211-699501013259,pp,i
60,0211-699501013259,RIA,i
60,0211-699501013259,Resultados,o
60,0211-699501013259,80,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,fueron,o
60,0211-699501013259,incluidos,o
60,0211-699501013259,en,o
60,0211-699501013259,el,o
60,0211-699501013259,estudio,o
60,0211-699501013259,basal,o
60,0211-699501013259,con,o
60,0211-699501013259,una,o
60,0211-699501013259,prevalencia,o
60,0211-699501013259,de,o
60,0211-699501013259,hiperhomocisteinemia,i
60,0211-699501013259,del,o
60,0211-699501013259,844,o
60,0211-699501013259,deficit,i
60,0211-699501013259,de,i
60,0211-699501013259,pp,i
60,0211-699501013259,en,o
60,0211-699501013259,el,o
60,0211-699501013259,32,o
60,0211-699501013259,y,o
60,0211-699501013259,folato,i
60,0211-699501013259,en,o
60,0211-699501013259,el,o
60,0211-699501013259,rango,o
60,0211-699501013259,normal,o
60,0211-699501013259,bajo,o
60,0211-699501013259,los,o
60,0211-699501013259,niveles,i
60,0211-699501013259,de,i
60,0211-699501013259,tHcy,i
60,0211-699501013259,se,o
60,0211-699501013259,correlacionaban,o
60,0211-699501013259,inversamente,o
60,0211-699501013259,con,o
60,0211-699501013259,los,o
60,0211-699501013259,del,o
60,0211-699501013259,folato,i
60,0211-699501013259,r,o
60,0211-699501013259,0336,o
60,0211-699501013259,p,o
60,0211-699501013259,001,o
60,0211-699501013259,pero,o
60,0211-699501013259,no,o
60,0211-699501013259,con,o
60,0211-699501013259,pp,i
60,0211-699501013259,B12,i
60,0211-699501013259,edad,o
60,0211-699501013259,albumina,i
60,0211-699501013259,KTV,o
60,0211-699501013259,KRU,o
60,0211-699501013259,PCRn,o
60,0211-699501013259,Cincuenta,o
60,0211-699501013259,y,o
60,0211-699501013259,ocho,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,recibieron,o
60,0211-699501013259,seis,o
60,0211-699501013259,meses,o
60,0211-699501013259,de,o
60,0211-699501013259,suplementacion,i
60,0211-699501013259,con,o
60,0211-699501013259,normalizacion,o
60,0211-699501013259,del,o
60,0211-699501013259,pp,i
60,0211-699501013259,aumento,o
60,0211-699501013259,del,o
60,0211-699501013259,folato,i
60,0211-699501013259,703,o
60,0211-699501013259,IC,o
60,0211-699501013259,638,o
60,0211-699501013259,795,o
60,0211-699501013259,vs,o
60,0211-699501013259,6181,o
60,0211-699501013259,IC,o
60,0211-699501013259,4447,o
60,0211-699501013259,7811,o
60,0211-699501013259,p,o
60,0211-699501013259,0001,o
60,0211-699501013259,y,o
60,0211-699501013259,descenso,o
60,0211-699501013259,de,o
60,0211-699501013259,la,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,240,o
60,0211-699501013259,IC,o
60,0211-699501013259,213,o
60,0211-699501013259,264,o
60,0211-699501013259,vs,o
60,0211-699501013259,199,o
60,0211-699501013259,IC,o
60,0211-699501013259,175,o
60,0211-699501013259,224,o
60,0211-699501013259,p,o
60,0211-699501013259,005,o
60,0211-699501013259,Han,o
60,0211-699501013259,recibido,o
60,0211-699501013259,suplementacion,i
60,0211-699501013259,durante,o
60,0211-699501013259,12,o
60,0211-699501013259,meses,o
60,0211-699501013259,33,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,pero,o
60,0211-699501013259,a,o
60,0211-699501013259,pesar,o
60,0211-699501013259,de,o
60,0211-699501013259,un,o
60,0211-699501013259,continuo,o
60,0211-699501013259,aumento,o
60,0211-699501013259,del,o
60,0211-699501013259,folato,i
60,0211-699501013259,10078,o
60,0211-699501013259,IC,o
60,0211-699501013259,7481,o
60,0211-699501013259,12674,o
60,0211-699501013259,p,o
60,0211-699501013259,0001,o
60,0211-699501013259,solo,o
60,0211-699501013259,3,o
60,0211-699501013259,pacientes,o
60,0211-699501013259,presentan,o
60,0211-699501013259,niveles,o
60,0211-699501013259,normales,o
60,0211-699501013259,de,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,correlacionandose,o
60,0211-699501013259,directamente,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,con,o
60,0211-699501013259,la,o
60,0211-699501013259,albumina,i
60,0211-699501013259,r,o
60,0211-699501013259,056,o
60,0211-699501013259,p,o
60,0211-699501013259,0001,o
60,0211-699501013259,que,o
60,0211-699501013259,se,o
60,0211-699501013259,elevo,o
60,0211-699501013259,con,o
60,0211-699501013259,respecto,o
60,0211-699501013259,al,o
60,0211-699501013259,inicio,o
60,0211-699501013259,337,o
60,0211-699501013259,IC,o
60,0211-699501013259,327,o
60,0211-699501013259,346,o
60,0211-699501013259,vs,o
60,0211-699501013259,350,o
60,0211-699501013259,IC,o
60,0211-699501013259,337,o
60,0211-699501013259,363,o
60,0211-699501013259,p,o
60,0211-699501013259,005,o
60,0211-699501013259,Conclusion,o
60,0211-699501013259,Tras,o
60,0211-699501013259,suplementacion,i
60,0211-699501013259,con,o
60,0211-699501013259,acido,i
60,0211-699501013259,folico,i
60,0211-699501013259,y,o
60,0211-699501013259,vitamina,i
60,0211-699501013259,B6,i
60,0211-699501013259,aunque,o
60,0211-699501013259,inicialmente,o
60,0211-699501013259,se,o
60,0211-699501013259,reduce,o
60,0211-699501013259,la,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,esta,o
60,0211-699501013259,respuesta,o
60,0211-699501013259,se,o
60,0211-699501013259,hace,o
60,0211-699501013259,refractaria,o
60,0211-699501013259,correlacionandose,o
60,0211-699501013259,directamente,o
60,0211-699501013259,la,o
60,0211-699501013259,tHcy,i
60,0211-699501013259,con,o
60,0211-699501013259,la,o
60,0211-699501013259,albumina,i
60,0211-699501013259,plasmatica,i
60,0211-699501013259,La,o
60,0211-699501013259,interpretacion,o
60,0211-699501013259,de,o
60,0211-699501013259,los,o
60,0211-699501013259,niveles,i
60,0211-699501013259,de,i
60,0211-699501013259,tHcy,i
60,0211-699501013259,debe,o
60,0211-699501013259,tener,o
60,0211-699501013259,en,o
60,0211-699501013259,cuenta,o
60,0211-699501013259,la,o
60,0211-699501013259,concentracion,i
60,0211-699501013259,de,i
60,0211-699501013259,albumina,i
61,0211-699501013259,Efecto,o
61,0211-699501013259,de,o
61,0211-699501013259,la,o
61,0211-699501013259,suplementacion,i
61,0211-699501013259,con,o
61,0211-699501013259,acido,i
61,0211-699501013259,folico,i
61,0211-699501013259,sobre,o
61,0211-699501013259,los,o
61,0211-699501013259,niveles,i
61,0211-699501013259,de,i
61,0211-699501013259,homocisteina,i
61,0211-699501013259,total,o
61,0211-699501013259,en,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,en,o
61,0211-699501013259,hemodialisis,i
61,0211-699501013259,La,o
61,0211-699501013259,hiperhomocisteinemia,i
61,0211-699501013259,es,o
61,0211-699501013259,un,o
61,0211-699501013259,marcador,o
61,0211-699501013259,de,o
61,0211-699501013259,riesgo,o
61,0211-699501013259,independiente,o
61,0211-699501013259,de,o
61,0211-699501013259,morbimortalidad,o
61,0211-699501013259,cardiovascular,i
61,0211-699501013259,Hemos,o
61,0211-699501013259,intentado,o
61,0211-699501013259,prospectivamente,o
61,0211-699501013259,reducir,o
61,0211-699501013259,los,o
61,0211-699501013259,niveles,i
61,0211-699501013259,de,i
61,0211-699501013259,homocisteina,i
61,0211-699501013259,total,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,mediante,o
61,0211-699501013259,suplemento,o
61,0211-699501013259,con,o
61,0211-699501013259,acido,i
61,0211-699501013259,folico,i
61,0211-699501013259,y,o
61,0211-699501013259,vitamina,i
61,0211-699501013259,B6,i
61,0211-699501013259,pp,i
61,0211-699501013259,valorando,o
61,0211-699501013259,su,o
61,0211-699501013259,posible,o
61,0211-699501013259,correlacion,o
61,0211-699501013259,con,o
61,0211-699501013259,dosis,o
61,0211-699501013259,de,o
61,0211-699501013259,dialisis,i
61,0211-699501013259,funcion,i
61,0211-699501013259,residual,i
61,0211-699501013259,y,o
61,0211-699501013259,parametros,o
61,0211-699501013259,nutricionales,o
61,0211-699501013259,Metodos,o
61,0211-699501013259,Todos,o
61,0211-699501013259,los,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,en,o
61,0211-699501013259,hemodialisis,i
61,0211-699501013259,al,o
61,0211-699501013259,comienzo,o
61,0211-699501013259,del,o
61,0211-699501013259,estudio,o
61,0211-699501013259,que,o
61,0211-699501013259,no,o
61,0211-699501013259,recibian,o
61,0211-699501013259,acido,i
61,0211-699501013259,folico,i
61,0211-699501013259,ni,o
61,0211-699501013259,vitamina,i
61,0211-699501013259,B6,i
61,0211-699501013259,asi,o
61,0211-699501013259,como,o
61,0211-699501013259,los,o
61,0211-699501013259,incorporados,o
61,0211-699501013259,posteriormente,o
61,0211-699501013259,a,o
61,0211-699501013259,partir,o
61,0211-699501013259,de,o
61,0211-699501013259,su,o
61,0211-699501013259,tercer,o
61,0211-699501013259,mes,o
61,0211-699501013259,en,o
61,0211-699501013259,hemodialisis,i
61,0211-699501013259,recibieron,o
61,0211-699501013259,5,o
61,0211-699501013259,mg,o
61,0211-699501013259,orales,o
61,0211-699501013259,de,o
61,0211-699501013259,acido,i
61,0211-699501013259,folico,i
61,0211-699501013259,cada,o
61,0211-699501013259,48,o
61,0211-699501013259,horas,o
61,0211-699501013259,y,o
61,0211-699501013259,40,o
61,0211-699501013259,mg,o
61,0211-699501013259,orales,o
61,0211-699501013259,de,o
61,0211-699501013259,vitamina,i
61,0211-699501013259,B6,i
61,0211-699501013259,cada,o
61,0211-699501013259,semana,o
61,0211-699501013259,Se,o
61,0211-699501013259,determinaron,o
61,0211-699501013259,al,o
61,0211-699501013259,comienzo,o
61,0211-699501013259,del,o
61,0211-699501013259,estudio,o
61,0211-699501013259,y,o
61,0211-699501013259,cada,o
61,0211-699501013259,2,o
61,0211-699501013259,meses,o
61,0211-699501013259,niveles,i
61,0211-699501013259,de,i
61,0211-699501013259,folato,i
61,0211-699501013259,vitamina,i
61,0211-699501013259,B12,i
61,0211-699501013259,inmunoensayo,i
61,0211-699501013259,albumina,i
61,0211-699501013259,y,o
61,0211-699501013259,cinetica,o
61,0211-699501013259,de,o
61,0211-699501013259,la,o
61,0211-699501013259,urea,i
61,0211-699501013259,KTV,o
61,0211-699501013259,KRU,o
61,0211-699501013259,PCRn,o
61,0211-699501013259,y,o
61,0211-699501013259,cada,o
61,0211-699501013259,6,o
61,0211-699501013259,meses,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,HPLC,i
61,0211-699501013259,y,o
61,0211-699501013259,pp,i
61,0211-699501013259,RIA,i
61,0211-699501013259,Resultados,o
61,0211-699501013259,80,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,fueron,o
61,0211-699501013259,incluidos,o
61,0211-699501013259,en,o
61,0211-699501013259,el,o
61,0211-699501013259,estudio,o
61,0211-699501013259,basal,o
61,0211-699501013259,con,o
61,0211-699501013259,una,o
61,0211-699501013259,prevalencia,o
61,0211-699501013259,de,o
61,0211-699501013259,hiperhomocisteinemia,i
61,0211-699501013259,del,o
61,0211-699501013259,844,o
61,0211-699501013259,deficit,i
61,0211-699501013259,de,i
61,0211-699501013259,pp,i
61,0211-699501013259,en,o
61,0211-699501013259,el,o
61,0211-699501013259,32,o
61,0211-699501013259,y,o
61,0211-699501013259,folato,i
61,0211-699501013259,en,o
61,0211-699501013259,el,o
61,0211-699501013259,rango,o
61,0211-699501013259,normal,o
61,0211-699501013259,bajo,o
61,0211-699501013259,los,o
61,0211-699501013259,niveles,i
61,0211-699501013259,de,i
61,0211-699501013259,tHcy,i
61,0211-699501013259,se,o
61,0211-699501013259,correlacionaban,o
61,0211-699501013259,inversamente,o
61,0211-699501013259,con,o
61,0211-699501013259,los,o
61,0211-699501013259,del,o
61,0211-699501013259,folato,i
61,0211-699501013259,r,o
61,0211-699501013259,0336,o
61,0211-699501013259,p,o
61,0211-699501013259,001,o
61,0211-699501013259,pero,o
61,0211-699501013259,no,o
61,0211-699501013259,con,o
61,0211-699501013259,pp,i
61,0211-699501013259,B12,i
61,0211-699501013259,edad,o
61,0211-699501013259,albumina,i
61,0211-699501013259,KTV,o
61,0211-699501013259,KRU,o
61,0211-699501013259,PCRn,o
61,0211-699501013259,Cincuenta,o
61,0211-699501013259,y,o
61,0211-699501013259,ocho,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,recibieron,o
61,0211-699501013259,seis,o
61,0211-699501013259,meses,o
61,0211-699501013259,de,o
61,0211-699501013259,suplementacion,i
61,0211-699501013259,con,o
61,0211-699501013259,normalizacion,o
61,0211-699501013259,del,o
61,0211-699501013259,pp,i
61,0211-699501013259,aumento,o
61,0211-699501013259,del,o
61,0211-699501013259,folato,i
61,0211-699501013259,703,o
61,0211-699501013259,IC,o
61,0211-699501013259,638,o
61,0211-699501013259,795,o
61,0211-699501013259,vs,o
61,0211-699501013259,6181,o
61,0211-699501013259,IC,o
61,0211-699501013259,4447,o
61,0211-699501013259,7811,o
61,0211-699501013259,p,o
61,0211-699501013259,0001,o
61,0211-699501013259,y,o
61,0211-699501013259,descenso,o
61,0211-699501013259,de,o
61,0211-699501013259,la,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,240,o
61,0211-699501013259,IC,o
61,0211-699501013259,213,o
61,0211-699501013259,264,o
61,0211-699501013259,vs,o
61,0211-699501013259,199,o
61,0211-699501013259,IC,o
61,0211-699501013259,175,o
61,0211-699501013259,224,o
61,0211-699501013259,p,o
61,0211-699501013259,005,o
61,0211-699501013259,Han,o
61,0211-699501013259,recibido,o
61,0211-699501013259,suplementacion,i
61,0211-699501013259,durante,o
61,0211-699501013259,12,o
61,0211-699501013259,meses,o
61,0211-699501013259,33,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,pero,o
61,0211-699501013259,a,o
61,0211-699501013259,pesar,o
61,0211-699501013259,de,o
61,0211-699501013259,un,o
61,0211-699501013259,continuo,o
61,0211-699501013259,aumento,o
61,0211-699501013259,del,o
61,0211-699501013259,folato,i
61,0211-699501013259,10078,o
61,0211-699501013259,IC,o
61,0211-699501013259,7481,o
61,0211-699501013259,12674,o
61,0211-699501013259,p,o
61,0211-699501013259,0001,o
61,0211-699501013259,solo,o
61,0211-699501013259,3,o
61,0211-699501013259,pacientes,o
61,0211-699501013259,presentan,o
61,0211-699501013259,niveles,o
61,0211-699501013259,normales,o
61,0211-699501013259,de,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,correlacionandose,o
61,0211-699501013259,directamente,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,con,o
61,0211-699501013259,la,o
61,0211-699501013259,albumina,i
61,0211-699501013259,r,o
61,0211-699501013259,056,o
61,0211-699501013259,p,o
61,0211-699501013259,0001,o
61,0211-699501013259,que,o
61,0211-699501013259,se,o
61,0211-699501013259,elevo,o
61,0211-699501013259,con,o
61,0211-699501013259,respecto,o
61,0211-699501013259,al,o
61,0211-699501013259,inicio,o
61,0211-699501013259,337,o
61,0211-699501013259,IC,o
61,0211-699501013259,327,o
61,0211-699501013259,346,o
61,0211-699501013259,vs,o
61,0211-699501013259,350,o
61,0211-699501013259,IC,o
61,0211-699501013259,337,o
61,0211-699501013259,363,o
61,0211-699501013259,p,o
61,0211-699501013259,005,o
61,0211-699501013259,Conclusion,o
61,0211-699501013259,Tras,o
61,0211-699501013259,suplementacion,i
61,0211-699501013259,con,o
61,0211-699501013259,acido,i
61,0211-699501013259,folico,i
61,0211-699501013259,y,o
61,0211-699501013259,vitamina,i
61,0211-699501013259,B6,i
61,0211-699501013259,aunque,o
61,0211-699501013259,inicialmente,o
61,0211-699501013259,se,o
61,0211-699501013259,reduce,o
61,0211-699501013259,la,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,esta,o
61,0211-699501013259,respuesta,o
61,0211-699501013259,se,o
61,0211-699501013259,hace,o
61,0211-699501013259,refractaria,o
61,0211-699501013259,correlacionandose,o
61,0211-699501013259,directamente,o
61,0211-699501013259,la,o
61,0211-699501013259,tHcy,i
61,0211-699501013259,con,o
61,0211-699501013259,la,o
61,0211-699501013259,albumina,i
61,0211-699501013259,plasmatica,i
61,0211-699501013259,La,o
61,0211-699501013259,interpretacion,o
61,0211-699501013259,de,o
61,0211-699501013259,los,o
61,0211-699501013259,niveles,i
61,0211-699501013259,de,i
61,0211-699501013259,tHcy,i
61,0211-699501013259,debe,o
61,0211-699501013259,tener,o
61,0211-699501013259,en,o
61,0211-699501013259,cuenta,o
61,0211-699501013259,la,o
61,0211-699501013259,concentracion,i
61,0211-699501013259,de,i
61,0211-699501013259,albumina,i
62,0211-699501013259,Efecto,o
62,0211-699501013259,de,o
62,0211-699501013259,la,o
62,0211-699501013259,suplementacion,i
62,0211-699501013259,con,o
62,0211-699501013259,acido,i
62,0211-699501013259,folico,i
62,0211-699501013259,sobre,o
62,0211-699501013259,los,o
62,0211-699501013259,niveles,i
62,0211-699501013259,de,i
62,0211-699501013259,homocisteina,i
62,0211-699501013259,total,o
62,0211-699501013259,en,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,en,o
62,0211-699501013259,hemodialisis,i
62,0211-699501013259,La,o
62,0211-699501013259,hiperhomocisteinemia,i
62,0211-699501013259,es,o
62,0211-699501013259,un,o
62,0211-699501013259,marcador,o
62,0211-699501013259,de,o
62,0211-699501013259,riesgo,o
62,0211-699501013259,independiente,o
62,0211-699501013259,de,o
62,0211-699501013259,morbimortalidad,o
62,0211-699501013259,cardiovascular,i
62,0211-699501013259,Hemos,o
62,0211-699501013259,intentado,o
62,0211-699501013259,prospectivamente,o
62,0211-699501013259,reducir,o
62,0211-699501013259,los,o
62,0211-699501013259,niveles,i
62,0211-699501013259,de,i
62,0211-699501013259,homocisteina,i
62,0211-699501013259,total,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,mediante,o
62,0211-699501013259,suplemento,o
62,0211-699501013259,con,o
62,0211-699501013259,acido,i
62,0211-699501013259,folico,i
62,0211-699501013259,y,o
62,0211-699501013259,vitamina,i
62,0211-699501013259,B6,i
62,0211-699501013259,pp,i
62,0211-699501013259,valorando,o
62,0211-699501013259,su,o
62,0211-699501013259,posible,o
62,0211-699501013259,correlacion,o
62,0211-699501013259,con,o
62,0211-699501013259,dosis,o
62,0211-699501013259,de,o
62,0211-699501013259,dialisis,i
62,0211-699501013259,funcion,i
62,0211-699501013259,residual,i
62,0211-699501013259,y,o
62,0211-699501013259,parametros,o
62,0211-699501013259,nutricionales,o
62,0211-699501013259,Metodos,o
62,0211-699501013259,Todos,o
62,0211-699501013259,los,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,en,o
62,0211-699501013259,hemodialisis,i
62,0211-699501013259,al,o
62,0211-699501013259,comienzo,o
62,0211-699501013259,del,o
62,0211-699501013259,estudio,o
62,0211-699501013259,que,o
62,0211-699501013259,no,o
62,0211-699501013259,recibian,o
62,0211-699501013259,acido,i
62,0211-699501013259,folico,i
62,0211-699501013259,ni,o
62,0211-699501013259,vitamina,i
62,0211-699501013259,B6,i
62,0211-699501013259,asi,o
62,0211-699501013259,como,o
62,0211-699501013259,los,o
62,0211-699501013259,incorporados,o
62,0211-699501013259,posteriormente,o
62,0211-699501013259,a,o
62,0211-699501013259,partir,o
62,0211-699501013259,de,o
62,0211-699501013259,su,o
62,0211-699501013259,tercer,o
62,0211-699501013259,mes,o
62,0211-699501013259,en,o
62,0211-699501013259,hemodialisis,i
62,0211-699501013259,recibieron,o
62,0211-699501013259,5,o
62,0211-699501013259,mg,o
62,0211-699501013259,orales,o
62,0211-699501013259,de,o
62,0211-699501013259,acido,i
62,0211-699501013259,folico,i
62,0211-699501013259,cada,o
62,0211-699501013259,48,o
62,0211-699501013259,horas,o
62,0211-699501013259,y,o
62,0211-699501013259,40,o
62,0211-699501013259,mg,o
62,0211-699501013259,orales,o
62,0211-699501013259,de,o
62,0211-699501013259,vitamina,i
62,0211-699501013259,B6,i
62,0211-699501013259,cada,o
62,0211-699501013259,semana,o
62,0211-699501013259,Se,o
62,0211-699501013259,determinaron,o
62,0211-699501013259,al,o
62,0211-699501013259,comienzo,o
62,0211-699501013259,del,o
62,0211-699501013259,estudio,o
62,0211-699501013259,y,o
62,0211-699501013259,cada,o
62,0211-699501013259,2,o
62,0211-699501013259,meses,o
62,0211-699501013259,niveles,i
62,0211-699501013259,de,i
62,0211-699501013259,folato,i
62,0211-699501013259,vitamina,i
62,0211-699501013259,B12,i
62,0211-699501013259,inmunoensayo,i
62,0211-699501013259,albumina,i
62,0211-699501013259,y,o
62,0211-699501013259,cinetica,o
62,0211-699501013259,de,o
62,0211-699501013259,la,o
62,0211-699501013259,urea,i
62,0211-699501013259,KTV,o
62,0211-699501013259,KRU,o
62,0211-699501013259,PCRn,o
62,0211-699501013259,y,o
62,0211-699501013259,cada,o
62,0211-699501013259,6,o
62,0211-699501013259,meses,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,HPLC,i
62,0211-699501013259,y,o
62,0211-699501013259,pp,i
62,0211-699501013259,RIA,i
62,0211-699501013259,Resultados,o
62,0211-699501013259,80,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,fueron,o
62,0211-699501013259,incluidos,o
62,0211-699501013259,en,o
62,0211-699501013259,el,o
62,0211-699501013259,estudio,o
62,0211-699501013259,basal,o
62,0211-699501013259,con,o
62,0211-699501013259,una,o
62,0211-699501013259,prevalencia,o
62,0211-699501013259,de,o
62,0211-699501013259,hiperhomocisteinemia,i
62,0211-699501013259,del,o
62,0211-699501013259,844,o
62,0211-699501013259,deficit,i
62,0211-699501013259,de,i
62,0211-699501013259,pp,i
62,0211-699501013259,en,o
62,0211-699501013259,el,o
62,0211-699501013259,32,o
62,0211-699501013259,y,o
62,0211-699501013259,folato,i
62,0211-699501013259,en,o
62,0211-699501013259,el,o
62,0211-699501013259,rango,o
62,0211-699501013259,normal,o
62,0211-699501013259,bajo,o
62,0211-699501013259,los,o
62,0211-699501013259,niveles,i
62,0211-699501013259,de,i
62,0211-699501013259,tHcy,i
62,0211-699501013259,se,o
62,0211-699501013259,correlacionaban,o
62,0211-699501013259,inversamente,o
62,0211-699501013259,con,o
62,0211-699501013259,los,o
62,0211-699501013259,del,o
62,0211-699501013259,folato,i
62,0211-699501013259,r,o
62,0211-699501013259,0336,o
62,0211-699501013259,p,o
62,0211-699501013259,001,o
62,0211-699501013259,pero,o
62,0211-699501013259,no,o
62,0211-699501013259,con,o
62,0211-699501013259,pp,i
62,0211-699501013259,B12,i
62,0211-699501013259,edad,o
62,0211-699501013259,albumina,i
62,0211-699501013259,KTV,o
62,0211-699501013259,KRU,o
62,0211-699501013259,PCRn,o
62,0211-699501013259,Cincuenta,o
62,0211-699501013259,y,o
62,0211-699501013259,ocho,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,recibieron,o
62,0211-699501013259,seis,o
62,0211-699501013259,meses,o
62,0211-699501013259,de,o
62,0211-699501013259,suplementacion,i
62,0211-699501013259,con,o
62,0211-699501013259,normalizacion,o
62,0211-699501013259,del,o
62,0211-699501013259,pp,i
62,0211-699501013259,aumento,o
62,0211-699501013259,del,o
62,0211-699501013259,folato,i
62,0211-699501013259,703,o
62,0211-699501013259,IC,o
62,0211-699501013259,638,o
62,0211-699501013259,795,o
62,0211-699501013259,vs,o
62,0211-699501013259,6181,o
62,0211-699501013259,IC,o
62,0211-699501013259,4447,o
62,0211-699501013259,7811,o
62,0211-699501013259,p,o
62,0211-699501013259,0001,o
62,0211-699501013259,y,o
62,0211-699501013259,descenso,o
62,0211-699501013259,de,o
62,0211-699501013259,la,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,240,o
62,0211-699501013259,IC,o
62,0211-699501013259,213,o
62,0211-699501013259,264,o
62,0211-699501013259,vs,o
62,0211-699501013259,199,o
62,0211-699501013259,IC,o
62,0211-699501013259,175,o
62,0211-699501013259,224,o
62,0211-699501013259,p,o
62,0211-699501013259,005,o
62,0211-699501013259,Han,o
62,0211-699501013259,recibido,o
62,0211-699501013259,suplementacion,i
62,0211-699501013259,durante,o
62,0211-699501013259,12,o
62,0211-699501013259,meses,o
62,0211-699501013259,33,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,pero,o
62,0211-699501013259,a,o
62,0211-699501013259,pesar,o
62,0211-699501013259,de,o
62,0211-699501013259,un,o
62,0211-699501013259,continuo,o
62,0211-699501013259,aumento,o
62,0211-699501013259,del,o
62,0211-699501013259,folato,i
62,0211-699501013259,10078,o
62,0211-699501013259,IC,o
62,0211-699501013259,7481,o
62,0211-699501013259,12674,o
62,0211-699501013259,p,o
62,0211-699501013259,0001,o
62,0211-699501013259,solo,o
62,0211-699501013259,3,o
62,0211-699501013259,pacientes,o
62,0211-699501013259,presentan,o
62,0211-699501013259,niveles,o
62,0211-699501013259,normales,o
62,0211-699501013259,de,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,correlacionandose,o
62,0211-699501013259,directamente,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,con,o
62,0211-699501013259,la,o
62,0211-699501013259,albumina,i
62,0211-699501013259,r,o
62,0211-699501013259,056,o
62,0211-699501013259,p,o
62,0211-699501013259,0001,o
62,0211-699501013259,que,o
62,0211-699501013259,se,o
62,0211-699501013259,elevo,o
62,0211-699501013259,con,o
62,0211-699501013259,respecto,o
62,0211-699501013259,al,o
62,0211-699501013259,inicio,o
62,0211-699501013259,337,o
62,0211-699501013259,IC,o
62,0211-699501013259,327,o
62,0211-699501013259,346,o
62,0211-699501013259,vs,o
62,0211-699501013259,350,o
62,0211-699501013259,IC,o
62,0211-699501013259,337,o
62,0211-699501013259,363,o
62,0211-699501013259,p,o
62,0211-699501013259,005,o
62,0211-699501013259,Conclusion,o
62,0211-699501013259,Tras,o
62,0211-699501013259,suplementacion,i
62,0211-699501013259,con,o
62,0211-699501013259,acido,i
62,0211-699501013259,folico,i
62,0211-699501013259,y,o
62,0211-699501013259,vitamina,i
62,0211-699501013259,B6,i
62,0211-699501013259,aunque,o
62,0211-699501013259,inicialmente,o
62,0211-699501013259,se,o
62,0211-699501013259,reduce,o
62,0211-699501013259,la,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,esta,o
62,0211-699501013259,respuesta,o
62,0211-699501013259,se,o
62,0211-699501013259,hace,o
62,0211-699501013259,refractaria,o
62,0211-699501013259,correlacionandose,o
62,0211-699501013259,directamente,o
62,0211-699501013259,la,o
62,0211-699501013259,tHcy,i
62,0211-699501013259,con,o
62,0211-699501013259,la,o
62,0211-699501013259,albumina,i
62,0211-699501013259,plasmatica,i
62,0211-699501013259,La,o
62,0211-699501013259,interpretacion,o
62,0211-699501013259,de,o
62,0211-699501013259,los,o
62,0211-699501013259,niveles,i
62,0211-699501013259,de,i
62,0211-699501013259,tHcy,i
62,0211-699501013259,debe,o
62,0211-699501013259,tener,o
62,0211-699501013259,en,o
62,0211-699501013259,cuenta,o
62,0211-699501013259,la,o
62,0211-699501013259,concentracion,i
62,0211-699501013259,de,i
62,0211-699501013259,albumina,i
63,0211-699501013259,Efecto,o
63,0211-699501013259,de,o
63,0211-699501013259,la,o
63,0211-699501013259,suplementacion,i
63,0211-699501013259,con,o
63,0211-699501013259,acido,i
63,0211-699501013259,folico,i
63,0211-699501013259,sobre,o
63,0211-699501013259,los,o
63,0211-699501013259,niveles,i
63,0211-699501013259,de,i
63,0211-699501013259,homocisteina,i
63,0211-699501013259,total,o
63,0211-699501013259,en,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,en,o
63,0211-699501013259,hemodialisis,i
63,0211-699501013259,La,o
63,0211-699501013259,hiperhomocisteinemia,i
63,0211-699501013259,es,o
63,0211-699501013259,un,o
63,0211-699501013259,marcador,o
63,0211-699501013259,de,o
63,0211-699501013259,riesgo,o
63,0211-699501013259,independiente,o
63,0211-699501013259,de,o
63,0211-699501013259,morbimortalidad,o
63,0211-699501013259,cardiovascular,i
63,0211-699501013259,Hemos,o
63,0211-699501013259,intentado,o
63,0211-699501013259,prospectivamente,o
63,0211-699501013259,reducir,o
63,0211-699501013259,los,o
63,0211-699501013259,niveles,i
63,0211-699501013259,de,i
63,0211-699501013259,homocisteina,i
63,0211-699501013259,total,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,mediante,o
63,0211-699501013259,suplemento,o
63,0211-699501013259,con,o
63,0211-699501013259,acido,i
63,0211-699501013259,folico,i
63,0211-699501013259,y,o
63,0211-699501013259,vitamina,i
63,0211-699501013259,B6,i
63,0211-699501013259,pp,i
63,0211-699501013259,valorando,o
63,0211-699501013259,su,o
63,0211-699501013259,posible,o
63,0211-699501013259,correlacion,o
63,0211-699501013259,con,o
63,0211-699501013259,dosis,o
63,0211-699501013259,de,o
63,0211-699501013259,dialisis,i
63,0211-699501013259,funcion,i
63,0211-699501013259,residual,i
63,0211-699501013259,y,o
63,0211-699501013259,parametros,o
63,0211-699501013259,nutricionales,o
63,0211-699501013259,Metodos,o
63,0211-699501013259,Todos,o
63,0211-699501013259,los,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,en,o
63,0211-699501013259,hemodialisis,i
63,0211-699501013259,al,o
63,0211-699501013259,comienzo,o
63,0211-699501013259,del,o
63,0211-699501013259,estudio,o
63,0211-699501013259,que,o
63,0211-699501013259,no,o
63,0211-699501013259,recibian,o
63,0211-699501013259,acido,i
63,0211-699501013259,folico,i
63,0211-699501013259,ni,o
63,0211-699501013259,vitamina,i
63,0211-699501013259,B6,i
63,0211-699501013259,asi,o
63,0211-699501013259,como,o
63,0211-699501013259,los,o
63,0211-699501013259,incorporados,o
63,0211-699501013259,posteriormente,o
63,0211-699501013259,a,o
63,0211-699501013259,partir,o
63,0211-699501013259,de,o
63,0211-699501013259,su,o
63,0211-699501013259,tercer,o
63,0211-699501013259,mes,o
63,0211-699501013259,en,o
63,0211-699501013259,hemodialisis,i
63,0211-699501013259,recibieron,o
63,0211-699501013259,5,o
63,0211-699501013259,mg,o
63,0211-699501013259,orales,o
63,0211-699501013259,de,o
63,0211-699501013259,acido,i
63,0211-699501013259,folico,i
63,0211-699501013259,cada,o
63,0211-699501013259,48,o
63,0211-699501013259,horas,o
63,0211-699501013259,y,o
63,0211-699501013259,40,o
63,0211-699501013259,mg,o
63,0211-699501013259,orales,o
63,0211-699501013259,de,o
63,0211-699501013259,vitamina,i
63,0211-699501013259,B6,i
63,0211-699501013259,cada,o
63,0211-699501013259,semana,o
63,0211-699501013259,Se,o
63,0211-699501013259,determinaron,o
63,0211-699501013259,al,o
63,0211-699501013259,comienzo,o
63,0211-699501013259,del,o
63,0211-699501013259,estudio,o
63,0211-699501013259,y,o
63,0211-699501013259,cada,o
63,0211-699501013259,2,o
63,0211-699501013259,meses,o
63,0211-699501013259,niveles,i
63,0211-699501013259,de,i
63,0211-699501013259,folato,i
63,0211-699501013259,vitamina,i
63,0211-699501013259,B12,i
63,0211-699501013259,inmunoensayo,i
63,0211-699501013259,albumina,i
63,0211-699501013259,y,o
63,0211-699501013259,cinetica,o
63,0211-699501013259,de,o
63,0211-699501013259,la,o
63,0211-699501013259,urea,i
63,0211-699501013259,KTV,o
63,0211-699501013259,KRU,o
63,0211-699501013259,PCRn,o
63,0211-699501013259,y,o
63,0211-699501013259,cada,o
63,0211-699501013259,6,o
63,0211-699501013259,meses,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,HPLC,i
63,0211-699501013259,y,o
63,0211-699501013259,pp,i
63,0211-699501013259,RIA,i
63,0211-699501013259,Resultados,o
63,0211-699501013259,80,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,fueron,o
63,0211-699501013259,incluidos,o
63,0211-699501013259,en,o
63,0211-699501013259,el,o
63,0211-699501013259,estudio,o
63,0211-699501013259,basal,o
63,0211-699501013259,con,o
63,0211-699501013259,una,o
63,0211-699501013259,prevalencia,o
63,0211-699501013259,de,o
63,0211-699501013259,hiperhomocisteinemia,i
63,0211-699501013259,del,o
63,0211-699501013259,844,o
63,0211-699501013259,deficit,i
63,0211-699501013259,de,i
63,0211-699501013259,pp,i
63,0211-699501013259,en,o
63,0211-699501013259,el,o
63,0211-699501013259,32,o
63,0211-699501013259,y,o
63,0211-699501013259,folato,i
63,0211-699501013259,en,o
63,0211-699501013259,el,o
63,0211-699501013259,rango,o
63,0211-699501013259,normal,o
63,0211-699501013259,bajo,o
63,0211-699501013259,los,o
63,0211-699501013259,niveles,i
63,0211-699501013259,de,i
63,0211-699501013259,tHcy,i
63,0211-699501013259,se,o
63,0211-699501013259,correlacionaban,o
63,0211-699501013259,inversamente,o
63,0211-699501013259,con,o
63,0211-699501013259,los,o
63,0211-699501013259,del,o
63,0211-699501013259,folato,i
63,0211-699501013259,r,o
63,0211-699501013259,0336,o
63,0211-699501013259,p,o
63,0211-699501013259,001,o
63,0211-699501013259,pero,o
63,0211-699501013259,no,o
63,0211-699501013259,con,o
63,0211-699501013259,pp,i
63,0211-699501013259,B12,i
63,0211-699501013259,edad,o
63,0211-699501013259,albumina,i
63,0211-699501013259,KTV,o
63,0211-699501013259,KRU,o
63,0211-699501013259,PCRn,o
63,0211-699501013259,Cincuenta,o
63,0211-699501013259,y,o
63,0211-699501013259,ocho,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,recibieron,o
63,0211-699501013259,seis,o
63,0211-699501013259,meses,o
63,0211-699501013259,de,o
63,0211-699501013259,suplementacion,i
63,0211-699501013259,con,o
63,0211-699501013259,normalizacion,o
63,0211-699501013259,del,o
63,0211-699501013259,pp,i
63,0211-699501013259,aumento,o
63,0211-699501013259,del,o
63,0211-699501013259,folato,i
63,0211-699501013259,703,o
63,0211-699501013259,IC,o
63,0211-699501013259,638,o
63,0211-699501013259,795,o
63,0211-699501013259,vs,o
63,0211-699501013259,6181,o
63,0211-699501013259,IC,o
63,0211-699501013259,4447,o
63,0211-699501013259,7811,o
63,0211-699501013259,p,o
63,0211-699501013259,0001,o
63,0211-699501013259,y,o
63,0211-699501013259,descenso,o
63,0211-699501013259,de,o
63,0211-699501013259,la,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,240,o
63,0211-699501013259,IC,o
63,0211-699501013259,213,o
63,0211-699501013259,264,o
63,0211-699501013259,vs,o
63,0211-699501013259,199,o
63,0211-699501013259,IC,o
63,0211-699501013259,175,o
63,0211-699501013259,224,o
63,0211-699501013259,p,o
63,0211-699501013259,005,o
63,0211-699501013259,Han,o
63,0211-699501013259,recibido,o
63,0211-699501013259,suplementacion,i
63,0211-699501013259,durante,o
63,0211-699501013259,12,o
63,0211-699501013259,meses,o
63,0211-699501013259,33,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,pero,o
63,0211-699501013259,a,o
63,0211-699501013259,pesar,o
63,0211-699501013259,de,o
63,0211-699501013259,un,o
63,0211-699501013259,continuo,o
63,0211-699501013259,aumento,o
63,0211-699501013259,del,o
63,0211-699501013259,folato,i
63,0211-699501013259,10078,o
63,0211-699501013259,IC,o
63,0211-699501013259,7481,o
63,0211-699501013259,12674,o
63,0211-699501013259,p,o
63,0211-699501013259,0001,o
63,0211-699501013259,solo,o
63,0211-699501013259,3,o
63,0211-699501013259,pacientes,o
63,0211-699501013259,presentan,o
63,0211-699501013259,niveles,o
63,0211-699501013259,normales,o
63,0211-699501013259,de,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,correlacionandose,o
63,0211-699501013259,directamente,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,con,o
63,0211-699501013259,la,o
63,0211-699501013259,albumina,i
63,0211-699501013259,r,o
63,0211-699501013259,056,o
63,0211-699501013259,p,o
63,0211-699501013259,0001,o
63,0211-699501013259,que,o
63,0211-699501013259,se,o
63,0211-699501013259,elevo,o
63,0211-699501013259,con,o
63,0211-699501013259,respecto,o
63,0211-699501013259,al,o
63,0211-699501013259,inicio,o
63,0211-699501013259,337,o
63,0211-699501013259,IC,o
63,0211-699501013259,327,o
63,0211-699501013259,346,o
63,0211-699501013259,vs,o
63,0211-699501013259,350,o
63,0211-699501013259,IC,o
63,0211-699501013259,337,o
63,0211-699501013259,363,o
63,0211-699501013259,p,o
63,0211-699501013259,005,o
63,0211-699501013259,Conclusion,o
63,0211-699501013259,Tras,o
63,0211-699501013259,suplementacion,i
63,0211-699501013259,con,o
63,0211-699501013259,acido,i
63,0211-699501013259,folico,i
63,0211-699501013259,y,o
63,0211-699501013259,vitamina,i
63,0211-699501013259,B6,i
63,0211-699501013259,aunque,o
63,0211-699501013259,inicialmente,o
63,0211-699501013259,se,o
63,0211-699501013259,reduce,o
63,0211-699501013259,la,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,esta,o
63,0211-699501013259,respuesta,o
63,0211-699501013259,se,o
63,0211-699501013259,hace,o
63,0211-699501013259,refractaria,o
63,0211-699501013259,correlacionandose,o
63,0211-699501013259,directamente,o
63,0211-699501013259,la,o
63,0211-699501013259,tHcy,i
63,0211-699501013259,con,o
63,0211-699501013259,la,o
63,0211-699501013259,albumina,i
63,0211-699501013259,plasmatica,i
63,0211-699501013259,La,o
63,0211-699501013259,interpretacion,o
63,0211-699501013259,de,o
63,0211-699501013259,los,o
63,0211-699501013259,niveles,i
63,0211-699501013259,de,i
63,0211-699501013259,tHcy,i
63,0211-699501013259,debe,o
63,0211-699501013259,tener,o
63,0211-699501013259,en,o
63,0211-699501013259,cuenta,o
63,0211-699501013259,la,o
63,0211-699501013259,concentracion,i
63,0211-699501013259,de,i
63,0211-699501013259,albumina,i
64,0211-699501013259,Efecto,o
64,0211-699501013259,de,o
64,0211-699501013259,la,o
64,0211-699501013259,suplementacion,i
64,0211-699501013259,con,o
64,0211-699501013259,acido,i
64,0211-699501013259,folico,i
64,0211-699501013259,sobre,o
64,0211-699501013259,los,o
64,0211-699501013259,niveles,i
64,0211-699501013259,de,i
64,0211-699501013259,homocisteina,i
64,0211-699501013259,total,o
64,0211-699501013259,en,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,en,o
64,0211-699501013259,hemodialisis,i
64,0211-699501013259,La,o
64,0211-699501013259,hiperhomocisteinemia,i
64,0211-699501013259,es,o
64,0211-699501013259,un,o
64,0211-699501013259,marcador,o
64,0211-699501013259,de,o
64,0211-699501013259,riesgo,o
64,0211-699501013259,independiente,o
64,0211-699501013259,de,o
64,0211-699501013259,morbimortalidad,o
64,0211-699501013259,cardiovascular,i
64,0211-699501013259,Hemos,o
64,0211-699501013259,intentado,o
64,0211-699501013259,prospectivamente,o
64,0211-699501013259,reducir,o
64,0211-699501013259,los,o
64,0211-699501013259,niveles,i
64,0211-699501013259,de,i
64,0211-699501013259,homocisteina,i
64,0211-699501013259,total,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,mediante,o
64,0211-699501013259,suplemento,o
64,0211-699501013259,con,o
64,0211-699501013259,acido,i
64,0211-699501013259,folico,i
64,0211-699501013259,y,o
64,0211-699501013259,vitamina,i
64,0211-699501013259,B6,i
64,0211-699501013259,pp,i
64,0211-699501013259,valorando,o
64,0211-699501013259,su,o
64,0211-699501013259,posible,o
64,0211-699501013259,correlacion,o
64,0211-699501013259,con,o
64,0211-699501013259,dosis,o
64,0211-699501013259,de,o
64,0211-699501013259,dialisis,i
64,0211-699501013259,funcion,i
64,0211-699501013259,residual,i
64,0211-699501013259,y,o
64,0211-699501013259,parametros,o
64,0211-699501013259,nutricionales,o
64,0211-699501013259,Metodos,o
64,0211-699501013259,Todos,o
64,0211-699501013259,los,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,en,o
64,0211-699501013259,hemodialisis,i
64,0211-699501013259,al,o
64,0211-699501013259,comienzo,o
64,0211-699501013259,del,o
64,0211-699501013259,estudio,o
64,0211-699501013259,que,o
64,0211-699501013259,no,o
64,0211-699501013259,recibian,o
64,0211-699501013259,acido,i
64,0211-699501013259,folico,i
64,0211-699501013259,ni,o
64,0211-699501013259,vitamina,i
64,0211-699501013259,B6,i
64,0211-699501013259,asi,o
64,0211-699501013259,como,o
64,0211-699501013259,los,o
64,0211-699501013259,incorporados,o
64,0211-699501013259,posteriormente,o
64,0211-699501013259,a,o
64,0211-699501013259,partir,o
64,0211-699501013259,de,o
64,0211-699501013259,su,o
64,0211-699501013259,tercer,o
64,0211-699501013259,mes,o
64,0211-699501013259,en,o
64,0211-699501013259,hemodialisis,i
64,0211-699501013259,recibieron,o
64,0211-699501013259,5,o
64,0211-699501013259,mg,o
64,0211-699501013259,orales,o
64,0211-699501013259,de,o
64,0211-699501013259,acido,i
64,0211-699501013259,folico,i
64,0211-699501013259,cada,o
64,0211-699501013259,48,o
64,0211-699501013259,horas,o
64,0211-699501013259,y,o
64,0211-699501013259,40,o
64,0211-699501013259,mg,o
64,0211-699501013259,orales,o
64,0211-699501013259,de,o
64,0211-699501013259,vitamina,i
64,0211-699501013259,B6,i
64,0211-699501013259,cada,o
64,0211-699501013259,semana,o
64,0211-699501013259,Se,o
64,0211-699501013259,determinaron,o
64,0211-699501013259,al,o
64,0211-699501013259,comienzo,o
64,0211-699501013259,del,o
64,0211-699501013259,estudio,o
64,0211-699501013259,y,o
64,0211-699501013259,cada,o
64,0211-699501013259,2,o
64,0211-699501013259,meses,o
64,0211-699501013259,niveles,i
64,0211-699501013259,de,i
64,0211-699501013259,folato,i
64,0211-699501013259,vitamina,i
64,0211-699501013259,B12,i
64,0211-699501013259,inmunoensayo,i
64,0211-699501013259,albumina,i
64,0211-699501013259,y,o
64,0211-699501013259,cinetica,o
64,0211-699501013259,de,o
64,0211-699501013259,la,o
64,0211-699501013259,urea,i
64,0211-699501013259,KTV,o
64,0211-699501013259,KRU,o
64,0211-699501013259,PCRn,o
64,0211-699501013259,y,o
64,0211-699501013259,cada,o
64,0211-699501013259,6,o
64,0211-699501013259,meses,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,HPLC,i
64,0211-699501013259,y,o
64,0211-699501013259,pp,i
64,0211-699501013259,RIA,i
64,0211-699501013259,Resultados,o
64,0211-699501013259,80,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,fueron,o
64,0211-699501013259,incluidos,o
64,0211-699501013259,en,o
64,0211-699501013259,el,o
64,0211-699501013259,estudio,o
64,0211-699501013259,basal,o
64,0211-699501013259,con,o
64,0211-699501013259,una,o
64,0211-699501013259,prevalencia,o
64,0211-699501013259,de,o
64,0211-699501013259,hiperhomocisteinemia,i
64,0211-699501013259,del,o
64,0211-699501013259,844,o
64,0211-699501013259,deficit,i
64,0211-699501013259,de,i
64,0211-699501013259,pp,i
64,0211-699501013259,en,o
64,0211-699501013259,el,o
64,0211-699501013259,32,o
64,0211-699501013259,y,o
64,0211-699501013259,folato,i
64,0211-699501013259,en,o
64,0211-699501013259,el,o
64,0211-699501013259,rango,o
64,0211-699501013259,normal,o
64,0211-699501013259,bajo,o
64,0211-699501013259,los,o
64,0211-699501013259,niveles,i
64,0211-699501013259,de,i
64,0211-699501013259,tHcy,i
64,0211-699501013259,se,o
64,0211-699501013259,correlacionaban,o
64,0211-699501013259,inversamente,o
64,0211-699501013259,con,o
64,0211-699501013259,los,o
64,0211-699501013259,del,o
64,0211-699501013259,folato,i
64,0211-699501013259,r,o
64,0211-699501013259,0336,o
64,0211-699501013259,p,o
64,0211-699501013259,001,o
64,0211-699501013259,pero,o
64,0211-699501013259,no,o
64,0211-699501013259,con,o
64,0211-699501013259,pp,i
64,0211-699501013259,B12,i
64,0211-699501013259,edad,o
64,0211-699501013259,albumina,i
64,0211-699501013259,KTV,o
64,0211-699501013259,KRU,o
64,0211-699501013259,PCRn,o
64,0211-699501013259,Cincuenta,o
64,0211-699501013259,y,o
64,0211-699501013259,ocho,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,recibieron,o
64,0211-699501013259,seis,o
64,0211-699501013259,meses,o
64,0211-699501013259,de,o
64,0211-699501013259,suplementacion,i
64,0211-699501013259,con,o
64,0211-699501013259,normalizacion,o
64,0211-699501013259,del,o
64,0211-699501013259,pp,i
64,0211-699501013259,aumento,o
64,0211-699501013259,del,o
64,0211-699501013259,folato,i
64,0211-699501013259,703,o
64,0211-699501013259,IC,o
64,0211-699501013259,638,o
64,0211-699501013259,795,o
64,0211-699501013259,vs,o
64,0211-699501013259,6181,o
64,0211-699501013259,IC,o
64,0211-699501013259,4447,o
64,0211-699501013259,7811,o
64,0211-699501013259,p,o
64,0211-699501013259,0001,o
64,0211-699501013259,y,o
64,0211-699501013259,descenso,o
64,0211-699501013259,de,o
64,0211-699501013259,la,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,240,o
64,0211-699501013259,IC,o
64,0211-699501013259,213,o
64,0211-699501013259,264,o
64,0211-699501013259,vs,o
64,0211-699501013259,199,o
64,0211-699501013259,IC,o
64,0211-699501013259,175,o
64,0211-699501013259,224,o
64,0211-699501013259,p,o
64,0211-699501013259,005,o
64,0211-699501013259,Han,o
64,0211-699501013259,recibido,o
64,0211-699501013259,suplementacion,i
64,0211-699501013259,durante,o
64,0211-699501013259,12,o
64,0211-699501013259,meses,o
64,0211-699501013259,33,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,pero,o
64,0211-699501013259,a,o
64,0211-699501013259,pesar,o
64,0211-699501013259,de,o
64,0211-699501013259,un,o
64,0211-699501013259,continuo,o
64,0211-699501013259,aumento,o
64,0211-699501013259,del,o
64,0211-699501013259,folato,i
64,0211-699501013259,10078,o
64,0211-699501013259,IC,o
64,0211-699501013259,7481,o
64,0211-699501013259,12674,o
64,0211-699501013259,p,o
64,0211-699501013259,0001,o
64,0211-699501013259,solo,o
64,0211-699501013259,3,o
64,0211-699501013259,pacientes,o
64,0211-699501013259,presentan,o
64,0211-699501013259,niveles,o
64,0211-699501013259,normales,o
64,0211-699501013259,de,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,correlacionandose,o
64,0211-699501013259,directamente,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,con,o
64,0211-699501013259,la,o
64,0211-699501013259,albumina,i
64,0211-699501013259,r,o
64,0211-699501013259,056,o
64,0211-699501013259,p,o
64,0211-699501013259,0001,o
64,0211-699501013259,que,o
64,0211-699501013259,se,o
64,0211-699501013259,elevo,o
64,0211-699501013259,con,o
64,0211-699501013259,respecto,o
64,0211-699501013259,al,o
64,0211-699501013259,inicio,o
64,0211-699501013259,337,o
64,0211-699501013259,IC,o
64,0211-699501013259,327,o
64,0211-699501013259,346,o
64,0211-699501013259,vs,o
64,0211-699501013259,350,o
64,0211-699501013259,IC,o
64,0211-699501013259,337,o
64,0211-699501013259,363,o
64,0211-699501013259,p,o
64,0211-699501013259,005,o
64,0211-699501013259,Conclusion,o
64,0211-699501013259,Tras,o
64,0211-699501013259,suplementacion,i
64,0211-699501013259,con,o
64,0211-699501013259,acido,i
64,0211-699501013259,folico,i
64,0211-699501013259,y,o
64,0211-699501013259,vitamina,i
64,0211-699501013259,B6,i
64,0211-699501013259,aunque,o
64,0211-699501013259,inicialmente,o
64,0211-699501013259,se,o
64,0211-699501013259,reduce,o
64,0211-699501013259,la,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,esta,o
64,0211-699501013259,respuesta,o
64,0211-699501013259,se,o
64,0211-699501013259,hace,o
64,0211-699501013259,refractaria,o
64,0211-699501013259,correlacionandose,o
64,0211-699501013259,directamente,o
64,0211-699501013259,la,o
64,0211-699501013259,tHcy,i
64,0211-699501013259,con,o
64,0211-699501013259,la,o
64,0211-699501013259,albumina,i
64,0211-699501013259,plasmatica,i
64,0211-699501013259,La,o
64,0211-699501013259,interpretacion,o
64,0211-699501013259,de,o
64,0211-699501013259,los,o
64,0211-699501013259,niveles,i
64,0211-699501013259,de,i
64,0211-699501013259,tHcy,i
64,0211-699501013259,debe,o
64,0211-699501013259,tener,o
64,0211-699501013259,en,o
64,0211-699501013259,cuenta,o
64,0211-699501013259,la,o
64,0211-699501013259,concentracion,i
64,0211-699501013259,de,i
64,0211-699501013259,albumina,i
65,0211-699501013259,Efecto,o
65,0211-699501013259,de,o
65,0211-699501013259,la,o
65,0211-699501013259,suplementacion,i
65,0211-699501013259,con,o
65,0211-699501013259,acido,i
65,0211-699501013259,folico,i
65,0211-699501013259,sobre,o
65,0211-699501013259,los,o
65,0211-699501013259,niveles,i
65,0211-699501013259,de,i
65,0211-699501013259,homocisteina,i
65,0211-699501013259,total,o
65,0211-699501013259,en,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,en,o
65,0211-699501013259,hemodialisis,i
65,0211-699501013259,La,o
65,0211-699501013259,hiperhomocisteinemia,i
65,0211-699501013259,es,o
65,0211-699501013259,un,o
65,0211-699501013259,marcador,o
65,0211-699501013259,de,o
65,0211-699501013259,riesgo,o
65,0211-699501013259,independiente,o
65,0211-699501013259,de,o
65,0211-699501013259,morbimortalidad,o
65,0211-699501013259,cardiovascular,i
65,0211-699501013259,Hemos,o
65,0211-699501013259,intentado,o
65,0211-699501013259,prospectivamente,o
65,0211-699501013259,reducir,o
65,0211-699501013259,los,o
65,0211-699501013259,niveles,i
65,0211-699501013259,de,i
65,0211-699501013259,homocisteina,i
65,0211-699501013259,total,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,mediante,o
65,0211-699501013259,suplemento,o
65,0211-699501013259,con,o
65,0211-699501013259,acido,i
65,0211-699501013259,folico,i
65,0211-699501013259,y,o
65,0211-699501013259,vitamina,i
65,0211-699501013259,B6,i
65,0211-699501013259,pp,i
65,0211-699501013259,valorando,o
65,0211-699501013259,su,o
65,0211-699501013259,posible,o
65,0211-699501013259,correlacion,o
65,0211-699501013259,con,o
65,0211-699501013259,dosis,o
65,0211-699501013259,de,o
65,0211-699501013259,dialisis,i
65,0211-699501013259,funcion,i
65,0211-699501013259,residual,i
65,0211-699501013259,y,o
65,0211-699501013259,parametros,o
65,0211-699501013259,nutricionales,o
65,0211-699501013259,Metodos,o
65,0211-699501013259,Todos,o
65,0211-699501013259,los,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,en,o
65,0211-699501013259,hemodialisis,i
65,0211-699501013259,al,o
65,0211-699501013259,comienzo,o
65,0211-699501013259,del,o
65,0211-699501013259,estudio,o
65,0211-699501013259,que,o
65,0211-699501013259,no,o
65,0211-699501013259,recibian,o
65,0211-699501013259,acido,i
65,0211-699501013259,folico,i
65,0211-699501013259,ni,o
65,0211-699501013259,vitamina,i
65,0211-699501013259,B6,i
65,0211-699501013259,asi,o
65,0211-699501013259,como,o
65,0211-699501013259,los,o
65,0211-699501013259,incorporados,o
65,0211-699501013259,posteriormente,o
65,0211-699501013259,a,o
65,0211-699501013259,partir,o
65,0211-699501013259,de,o
65,0211-699501013259,su,o
65,0211-699501013259,tercer,o
65,0211-699501013259,mes,o
65,0211-699501013259,en,o
65,0211-699501013259,hemodialisis,i
65,0211-699501013259,recibieron,o
65,0211-699501013259,5,o
65,0211-699501013259,mg,o
65,0211-699501013259,orales,o
65,0211-699501013259,de,o
65,0211-699501013259,acido,i
65,0211-699501013259,folico,i
65,0211-699501013259,cada,o
65,0211-699501013259,48,o
65,0211-699501013259,horas,o
65,0211-699501013259,y,o
65,0211-699501013259,40,o
65,0211-699501013259,mg,o
65,0211-699501013259,orales,o
65,0211-699501013259,de,o
65,0211-699501013259,vitamina,i
65,0211-699501013259,B6,i
65,0211-699501013259,cada,o
65,0211-699501013259,semana,o
65,0211-699501013259,Se,o
65,0211-699501013259,determinaron,o
65,0211-699501013259,al,o
65,0211-699501013259,comienzo,o
65,0211-699501013259,del,o
65,0211-699501013259,estudio,o
65,0211-699501013259,y,o
65,0211-699501013259,cada,o
65,0211-699501013259,2,o
65,0211-699501013259,meses,o
65,0211-699501013259,niveles,i
65,0211-699501013259,de,i
65,0211-699501013259,folato,i
65,0211-699501013259,vitamina,i
65,0211-699501013259,B12,i
65,0211-699501013259,inmunoensayo,i
65,0211-699501013259,albumina,i
65,0211-699501013259,y,o
65,0211-699501013259,cinetica,o
65,0211-699501013259,de,o
65,0211-699501013259,la,o
65,0211-699501013259,urea,i
65,0211-699501013259,KTV,o
65,0211-699501013259,KRU,o
65,0211-699501013259,PCRn,o
65,0211-699501013259,y,o
65,0211-699501013259,cada,o
65,0211-699501013259,6,o
65,0211-699501013259,meses,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,HPLC,i
65,0211-699501013259,y,o
65,0211-699501013259,pp,i
65,0211-699501013259,RIA,i
65,0211-699501013259,Resultados,o
65,0211-699501013259,80,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,fueron,o
65,0211-699501013259,incluidos,o
65,0211-699501013259,en,o
65,0211-699501013259,el,o
65,0211-699501013259,estudio,o
65,0211-699501013259,basal,o
65,0211-699501013259,con,o
65,0211-699501013259,una,o
65,0211-699501013259,prevalencia,o
65,0211-699501013259,de,o
65,0211-699501013259,hiperhomocisteinemia,i
65,0211-699501013259,del,o
65,0211-699501013259,844,o
65,0211-699501013259,deficit,i
65,0211-699501013259,de,i
65,0211-699501013259,pp,i
65,0211-699501013259,en,o
65,0211-699501013259,el,o
65,0211-699501013259,32,o
65,0211-699501013259,y,o
65,0211-699501013259,folato,i
65,0211-699501013259,en,o
65,0211-699501013259,el,o
65,0211-699501013259,rango,o
65,0211-699501013259,normal,o
65,0211-699501013259,bajo,o
65,0211-699501013259,los,o
65,0211-699501013259,niveles,i
65,0211-699501013259,de,i
65,0211-699501013259,tHcy,i
65,0211-699501013259,se,o
65,0211-699501013259,correlacionaban,o
65,0211-699501013259,inversamente,o
65,0211-699501013259,con,o
65,0211-699501013259,los,o
65,0211-699501013259,del,o
65,0211-699501013259,folato,i
65,0211-699501013259,r,o
65,0211-699501013259,0336,o
65,0211-699501013259,p,o
65,0211-699501013259,001,o
65,0211-699501013259,pero,o
65,0211-699501013259,no,o
65,0211-699501013259,con,o
65,0211-699501013259,pp,i
65,0211-699501013259,B12,i
65,0211-699501013259,edad,o
65,0211-699501013259,albumina,i
65,0211-699501013259,KTV,o
65,0211-699501013259,KRU,o
65,0211-699501013259,PCRn,o
65,0211-699501013259,Cincuenta,o
65,0211-699501013259,y,o
65,0211-699501013259,ocho,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,recibieron,o
65,0211-699501013259,seis,o
65,0211-699501013259,meses,o
65,0211-699501013259,de,o
65,0211-699501013259,suplementacion,i
65,0211-699501013259,con,o
65,0211-699501013259,normalizacion,o
65,0211-699501013259,del,o
65,0211-699501013259,pp,i
65,0211-699501013259,aumento,o
65,0211-699501013259,del,o
65,0211-699501013259,folato,i
65,0211-699501013259,703,o
65,0211-699501013259,IC,o
65,0211-699501013259,638,o
65,0211-699501013259,795,o
65,0211-699501013259,vs,o
65,0211-699501013259,6181,o
65,0211-699501013259,IC,o
65,0211-699501013259,4447,o
65,0211-699501013259,7811,o
65,0211-699501013259,p,o
65,0211-699501013259,0001,o
65,0211-699501013259,y,o
65,0211-699501013259,descenso,o
65,0211-699501013259,de,o
65,0211-699501013259,la,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,240,o
65,0211-699501013259,IC,o
65,0211-699501013259,213,o
65,0211-699501013259,264,o
65,0211-699501013259,vs,o
65,0211-699501013259,199,o
65,0211-699501013259,IC,o
65,0211-699501013259,175,o
65,0211-699501013259,224,o
65,0211-699501013259,p,o
65,0211-699501013259,005,o
65,0211-699501013259,Han,o
65,0211-699501013259,recibido,o
65,0211-699501013259,suplementacion,i
65,0211-699501013259,durante,o
65,0211-699501013259,12,o
65,0211-699501013259,meses,o
65,0211-699501013259,33,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,pero,o
65,0211-699501013259,a,o
65,0211-699501013259,pesar,o
65,0211-699501013259,de,o
65,0211-699501013259,un,o
65,0211-699501013259,continuo,o
65,0211-699501013259,aumento,o
65,0211-699501013259,del,o
65,0211-699501013259,folato,i
65,0211-699501013259,10078,o
65,0211-699501013259,IC,o
65,0211-699501013259,7481,o
65,0211-699501013259,12674,o
65,0211-699501013259,p,o
65,0211-699501013259,0001,o
65,0211-699501013259,solo,o
65,0211-699501013259,3,o
65,0211-699501013259,pacientes,o
65,0211-699501013259,presentan,o
65,0211-699501013259,niveles,o
65,0211-699501013259,normales,o
65,0211-699501013259,de,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,correlacionandose,o
65,0211-699501013259,directamente,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,con,o
65,0211-699501013259,la,o
65,0211-699501013259,albumina,i
65,0211-699501013259,r,o
65,0211-699501013259,056,o
65,0211-699501013259,p,o
65,0211-699501013259,0001,o
65,0211-699501013259,que,o
65,0211-699501013259,se,o
65,0211-699501013259,elevo,o
65,0211-699501013259,con,o
65,0211-699501013259,respecto,o
65,0211-699501013259,al,o
65,0211-699501013259,inicio,o
65,0211-699501013259,337,o
65,0211-699501013259,IC,o
65,0211-699501013259,327,o
65,0211-699501013259,346,o
65,0211-699501013259,vs,o
65,0211-699501013259,350,o
65,0211-699501013259,IC,o
65,0211-699501013259,337,o
65,0211-699501013259,363,o
65,0211-699501013259,p,o
65,0211-699501013259,005,o
65,0211-699501013259,Conclusion,o
65,0211-699501013259,Tras,o
65,0211-699501013259,suplementacion,i
65,0211-699501013259,con,o
65,0211-699501013259,acido,i
65,0211-699501013259,folico,i
65,0211-699501013259,y,o
65,0211-699501013259,vitamina,i
65,0211-699501013259,B6,i
65,0211-699501013259,aunque,o
65,0211-699501013259,inicialmente,o
65,0211-699501013259,se,o
65,0211-699501013259,reduce,o
65,0211-699501013259,la,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,esta,o
65,0211-699501013259,respuesta,o
65,0211-699501013259,se,o
65,0211-699501013259,hace,o
65,0211-699501013259,refractaria,o
65,0211-699501013259,correlacionandose,o
65,0211-699501013259,directamente,o
65,0211-699501013259,la,o
65,0211-699501013259,tHcy,i
65,0211-699501013259,con,o
65,0211-699501013259,la,o
65,0211-699501013259,albumina,i
65,0211-699501013259,plasmatica,i
65,0211-699501013259,La,o
65,0211-699501013259,interpretacion,o
65,0211-699501013259,de,o
65,0211-699501013259,los,o
65,0211-699501013259,niveles,i
65,0211-699501013259,de,i
65,0211-699501013259,tHcy,i
65,0211-699501013259,debe,o
65,0211-699501013259,tener,o
65,0211-699501013259,en,o
65,0211-699501013259,cuenta,o
65,0211-699501013259,la,o
65,0211-699501013259,concentracion,i
65,0211-699501013259,de,i
65,0211-699501013259,albumina,i
66,0211-699501013259,Efecto,o
66,0211-699501013259,de,o
66,0211-699501013259,la,o
66,0211-699501013259,suplementacion,i
66,0211-699501013259,con,o
66,0211-699501013259,acido,i
66,0211-699501013259,folico,i
66,0211-699501013259,sobre,o
66,0211-699501013259,los,o
66,0211-699501013259,niveles,i
66,0211-699501013259,de,i
66,0211-699501013259,homocisteina,i
66,0211-699501013259,total,o
66,0211-699501013259,en,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,en,o
66,0211-699501013259,hemodialisis,i
66,0211-699501013259,La,o
66,0211-699501013259,hiperhomocisteinemia,i
66,0211-699501013259,es,o
66,0211-699501013259,un,o
66,0211-699501013259,marcador,o
66,0211-699501013259,de,o
66,0211-699501013259,riesgo,o
66,0211-699501013259,independiente,o
66,0211-699501013259,de,o
66,0211-699501013259,morbimortalidad,o
66,0211-699501013259,cardiovascular,i
66,0211-699501013259,Hemos,o
66,0211-699501013259,intentado,o
66,0211-699501013259,prospectivamente,o
66,0211-699501013259,reducir,o
66,0211-699501013259,los,o
66,0211-699501013259,niveles,i
66,0211-699501013259,de,i
66,0211-699501013259,homocisteina,i
66,0211-699501013259,total,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,mediante,o
66,0211-699501013259,suplemento,o
66,0211-699501013259,con,o
66,0211-699501013259,acido,i
66,0211-699501013259,folico,i
66,0211-699501013259,y,o
66,0211-699501013259,vitamina,i
66,0211-699501013259,B6,i
66,0211-699501013259,pp,i
66,0211-699501013259,valorando,o
66,0211-699501013259,su,o
66,0211-699501013259,posible,o
66,0211-699501013259,correlacion,o
66,0211-699501013259,con,o
66,0211-699501013259,dosis,o
66,0211-699501013259,de,o
66,0211-699501013259,dialisis,i
66,0211-699501013259,funcion,i
66,0211-699501013259,residual,i
66,0211-699501013259,y,o
66,0211-699501013259,parametros,o
66,0211-699501013259,nutricionales,o
66,0211-699501013259,Metodos,o
66,0211-699501013259,Todos,o
66,0211-699501013259,los,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,en,o
66,0211-699501013259,hemodialisis,i
66,0211-699501013259,al,o
66,0211-699501013259,comienzo,o
66,0211-699501013259,del,o
66,0211-699501013259,estudio,o
66,0211-699501013259,que,o
66,0211-699501013259,no,o
66,0211-699501013259,recibian,o
66,0211-699501013259,acido,i
66,0211-699501013259,folico,i
66,0211-699501013259,ni,o
66,0211-699501013259,vitamina,i
66,0211-699501013259,B6,i
66,0211-699501013259,asi,o
66,0211-699501013259,como,o
66,0211-699501013259,los,o
66,0211-699501013259,incorporados,o
66,0211-699501013259,posteriormente,o
66,0211-699501013259,a,o
66,0211-699501013259,partir,o
66,0211-699501013259,de,o
66,0211-699501013259,su,o
66,0211-699501013259,tercer,o
66,0211-699501013259,mes,o
66,0211-699501013259,en,o
66,0211-699501013259,hemodialisis,i
66,0211-699501013259,recibieron,o
66,0211-699501013259,5,o
66,0211-699501013259,mg,o
66,0211-699501013259,orales,o
66,0211-699501013259,de,o
66,0211-699501013259,acido,i
66,0211-699501013259,folico,i
66,0211-699501013259,cada,o
66,0211-699501013259,48,o
66,0211-699501013259,horas,o
66,0211-699501013259,y,o
66,0211-699501013259,40,o
66,0211-699501013259,mg,o
66,0211-699501013259,orales,o
66,0211-699501013259,de,o
66,0211-699501013259,vitamina,i
66,0211-699501013259,B6,i
66,0211-699501013259,cada,o
66,0211-699501013259,semana,o
66,0211-699501013259,Se,o
66,0211-699501013259,determinaron,o
66,0211-699501013259,al,o
66,0211-699501013259,comienzo,o
66,0211-699501013259,del,o
66,0211-699501013259,estudio,o
66,0211-699501013259,y,o
66,0211-699501013259,cada,o
66,0211-699501013259,2,o
66,0211-699501013259,meses,o
66,0211-699501013259,niveles,i
66,0211-699501013259,de,i
66,0211-699501013259,folato,i
66,0211-699501013259,vitamina,i
66,0211-699501013259,B12,i
66,0211-699501013259,inmunoensayo,i
66,0211-699501013259,albumina,i
66,0211-699501013259,y,o
66,0211-699501013259,cinetica,o
66,0211-699501013259,de,o
66,0211-699501013259,la,o
66,0211-699501013259,urea,i
66,0211-699501013259,KTV,o
66,0211-699501013259,KRU,o
66,0211-699501013259,PCRn,o
66,0211-699501013259,y,o
66,0211-699501013259,cada,o
66,0211-699501013259,6,o
66,0211-699501013259,meses,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,HPLC,i
66,0211-699501013259,y,o
66,0211-699501013259,pp,i
66,0211-699501013259,RIA,i
66,0211-699501013259,Resultados,o
66,0211-699501013259,80,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,fueron,o
66,0211-699501013259,incluidos,o
66,0211-699501013259,en,o
66,0211-699501013259,el,o
66,0211-699501013259,estudio,o
66,0211-699501013259,basal,o
66,0211-699501013259,con,o
66,0211-699501013259,una,o
66,0211-699501013259,prevalencia,o
66,0211-699501013259,de,o
66,0211-699501013259,hiperhomocisteinemia,i
66,0211-699501013259,del,o
66,0211-699501013259,844,o
66,0211-699501013259,deficit,i
66,0211-699501013259,de,i
66,0211-699501013259,pp,i
66,0211-699501013259,en,o
66,0211-699501013259,el,o
66,0211-699501013259,32,o
66,0211-699501013259,y,o
66,0211-699501013259,folato,i
66,0211-699501013259,en,o
66,0211-699501013259,el,o
66,0211-699501013259,rango,o
66,0211-699501013259,normal,o
66,0211-699501013259,bajo,o
66,0211-699501013259,los,o
66,0211-699501013259,niveles,i
66,0211-699501013259,de,i
66,0211-699501013259,tHcy,i
66,0211-699501013259,se,o
66,0211-699501013259,correlacionaban,o
66,0211-699501013259,inversamente,o
66,0211-699501013259,con,o
66,0211-699501013259,los,o
66,0211-699501013259,del,o
66,0211-699501013259,folato,i
66,0211-699501013259,r,o
66,0211-699501013259,0336,o
66,0211-699501013259,p,o
66,0211-699501013259,001,o
66,0211-699501013259,pero,o
66,0211-699501013259,no,o
66,0211-699501013259,con,o
66,0211-699501013259,pp,i
66,0211-699501013259,B12,i
66,0211-699501013259,edad,o
66,0211-699501013259,albumina,i
66,0211-699501013259,KTV,o
66,0211-699501013259,KRU,o
66,0211-699501013259,PCRn,o
66,0211-699501013259,Cincuenta,o
66,0211-699501013259,y,o
66,0211-699501013259,ocho,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,recibieron,o
66,0211-699501013259,seis,o
66,0211-699501013259,meses,o
66,0211-699501013259,de,o
66,0211-699501013259,suplementacion,i
66,0211-699501013259,con,o
66,0211-699501013259,normalizacion,o
66,0211-699501013259,del,o
66,0211-699501013259,pp,i
66,0211-699501013259,aumento,o
66,0211-699501013259,del,o
66,0211-699501013259,folato,i
66,0211-699501013259,703,o
66,0211-699501013259,IC,o
66,0211-699501013259,638,o
66,0211-699501013259,795,o
66,0211-699501013259,vs,o
66,0211-699501013259,6181,o
66,0211-699501013259,IC,o
66,0211-699501013259,4447,o
66,0211-699501013259,7811,o
66,0211-699501013259,p,o
66,0211-699501013259,0001,o
66,0211-699501013259,y,o
66,0211-699501013259,descenso,o
66,0211-699501013259,de,o
66,0211-699501013259,la,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,240,o
66,0211-699501013259,IC,o
66,0211-699501013259,213,o
66,0211-699501013259,264,o
66,0211-699501013259,vs,o
66,0211-699501013259,199,o
66,0211-699501013259,IC,o
66,0211-699501013259,175,o
66,0211-699501013259,224,o
66,0211-699501013259,p,o
66,0211-699501013259,005,o
66,0211-699501013259,Han,o
66,0211-699501013259,recibido,o
66,0211-699501013259,suplementacion,i
66,0211-699501013259,durante,o
66,0211-699501013259,12,o
66,0211-699501013259,meses,o
66,0211-699501013259,33,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,pero,o
66,0211-699501013259,a,o
66,0211-699501013259,pesar,o
66,0211-699501013259,de,o
66,0211-699501013259,un,o
66,0211-699501013259,continuo,o
66,0211-699501013259,aumento,o
66,0211-699501013259,del,o
66,0211-699501013259,folato,i
66,0211-699501013259,10078,o
66,0211-699501013259,IC,o
66,0211-699501013259,7481,o
66,0211-699501013259,12674,o
66,0211-699501013259,p,o
66,0211-699501013259,0001,o
66,0211-699501013259,solo,o
66,0211-699501013259,3,o
66,0211-699501013259,pacientes,o
66,0211-699501013259,presentan,o
66,0211-699501013259,niveles,o
66,0211-699501013259,normales,o
66,0211-699501013259,de,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,correlacionandose,o
66,0211-699501013259,directamente,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,con,o
66,0211-699501013259,la,o
66,0211-699501013259,albumina,i
66,0211-699501013259,r,o
66,0211-699501013259,056,o
66,0211-699501013259,p,o
66,0211-699501013259,0001,o
66,0211-699501013259,que,o
66,0211-699501013259,se,o
66,0211-699501013259,elevo,o
66,0211-699501013259,con,o
66,0211-699501013259,respecto,o
66,0211-699501013259,al,o
66,0211-699501013259,inicio,o
66,0211-699501013259,337,o
66,0211-699501013259,IC,o
66,0211-699501013259,327,o
66,0211-699501013259,346,o
66,0211-699501013259,vs,o
66,0211-699501013259,350,o
66,0211-699501013259,IC,o
66,0211-699501013259,337,o
66,0211-699501013259,363,o
66,0211-699501013259,p,o
66,0211-699501013259,005,o
66,0211-699501013259,Conclusion,o
66,0211-699501013259,Tras,o
66,0211-699501013259,suplementacion,i
66,0211-699501013259,con,o
66,0211-699501013259,acido,i
66,0211-699501013259,folico,i
66,0211-699501013259,y,o
66,0211-699501013259,vitamina,i
66,0211-699501013259,B6,i
66,0211-699501013259,aunque,o
66,0211-699501013259,inicialmente,o
66,0211-699501013259,se,o
66,0211-699501013259,reduce,o
66,0211-699501013259,la,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,esta,o
66,0211-699501013259,respuesta,o
66,0211-699501013259,se,o
66,0211-699501013259,hace,o
66,0211-699501013259,refractaria,o
66,0211-699501013259,correlacionandose,o
66,0211-699501013259,directamente,o
66,0211-699501013259,la,o
66,0211-699501013259,tHcy,i
66,0211-699501013259,con,o
66,0211-699501013259,la,o
66,0211-699501013259,albumina,i
66,0211-699501013259,plasmatica,i
66,0211-699501013259,La,o
66,0211-699501013259,interpretacion,o
66,0211-699501013259,de,o
66,0211-699501013259,los,o
66,0211-699501013259,niveles,i
66,0211-699501013259,de,i
66,0211-699501013259,tHcy,i
66,0211-699501013259,debe,o
66,0211-699501013259,tener,o
66,0211-699501013259,en,o
66,0211-699501013259,cuenta,o
66,0211-699501013259,la,o
66,0211-699501013259,concentracion,i
66,0211-699501013259,de,i
66,0211-699501013259,albumina,i
67,0211-699501013259,Efecto,o
67,0211-699501013259,de,o
67,0211-699501013259,la,o
67,0211-699501013259,suplementacion,i
67,0211-699501013259,con,o
67,0211-699501013259,acido,i
67,0211-699501013259,folico,i
67,0211-699501013259,sobre,o
67,0211-699501013259,los,o
67,0211-699501013259,niveles,i
67,0211-699501013259,de,i
67,0211-699501013259,homocisteina,i
67,0211-699501013259,total,o
67,0211-699501013259,en,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,en,o
67,0211-699501013259,hemodialisis,i
67,0211-699501013259,La,o
67,0211-699501013259,hiperhomocisteinemia,i
67,0211-699501013259,es,o
67,0211-699501013259,un,o
67,0211-699501013259,marcador,o
67,0211-699501013259,de,o
67,0211-699501013259,riesgo,o
67,0211-699501013259,independiente,o
67,0211-699501013259,de,o
67,0211-699501013259,morbimortalidad,o
67,0211-699501013259,cardiovascular,i
67,0211-699501013259,Hemos,o
67,0211-699501013259,intentado,o
67,0211-699501013259,prospectivamente,o
67,0211-699501013259,reducir,o
67,0211-699501013259,los,o
67,0211-699501013259,niveles,i
67,0211-699501013259,de,i
67,0211-699501013259,homocisteina,i
67,0211-699501013259,total,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,mediante,o
67,0211-699501013259,suplemento,o
67,0211-699501013259,con,o
67,0211-699501013259,acido,i
67,0211-699501013259,folico,i
67,0211-699501013259,y,o
67,0211-699501013259,vitamina,i
67,0211-699501013259,B6,i
67,0211-699501013259,pp,i
67,0211-699501013259,valorando,o
67,0211-699501013259,su,o
67,0211-699501013259,posible,o
67,0211-699501013259,correlacion,o
67,0211-699501013259,con,o
67,0211-699501013259,dosis,o
67,0211-699501013259,de,o
67,0211-699501013259,dialisis,i
67,0211-699501013259,funcion,i
67,0211-699501013259,residual,i
67,0211-699501013259,y,o
67,0211-699501013259,parametros,o
67,0211-699501013259,nutricionales,o
67,0211-699501013259,Metodos,o
67,0211-699501013259,Todos,o
67,0211-699501013259,los,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,en,o
67,0211-699501013259,hemodialisis,i
67,0211-699501013259,al,o
67,0211-699501013259,comienzo,o
67,0211-699501013259,del,o
67,0211-699501013259,estudio,o
67,0211-699501013259,que,o
67,0211-699501013259,no,o
67,0211-699501013259,recibian,o
67,0211-699501013259,acido,i
67,0211-699501013259,folico,i
67,0211-699501013259,ni,o
67,0211-699501013259,vitamina,i
67,0211-699501013259,B6,i
67,0211-699501013259,asi,o
67,0211-699501013259,como,o
67,0211-699501013259,los,o
67,0211-699501013259,incorporados,o
67,0211-699501013259,posteriormente,o
67,0211-699501013259,a,o
67,0211-699501013259,partir,o
67,0211-699501013259,de,o
67,0211-699501013259,su,o
67,0211-699501013259,tercer,o
67,0211-699501013259,mes,o
67,0211-699501013259,en,o
67,0211-699501013259,hemodialisis,i
67,0211-699501013259,recibieron,o
67,0211-699501013259,5,o
67,0211-699501013259,mg,o
67,0211-699501013259,orales,o
67,0211-699501013259,de,o
67,0211-699501013259,acido,i
67,0211-699501013259,folico,i
67,0211-699501013259,cada,o
67,0211-699501013259,48,o
67,0211-699501013259,horas,o
67,0211-699501013259,y,o
67,0211-699501013259,40,o
67,0211-699501013259,mg,o
67,0211-699501013259,orales,o
67,0211-699501013259,de,o
67,0211-699501013259,vitamina,i
67,0211-699501013259,B6,i
67,0211-699501013259,cada,o
67,0211-699501013259,semana,o
67,0211-699501013259,Se,o
67,0211-699501013259,determinaron,o
67,0211-699501013259,al,o
67,0211-699501013259,comienzo,o
67,0211-699501013259,del,o
67,0211-699501013259,estudio,o
67,0211-699501013259,y,o
67,0211-699501013259,cada,o
67,0211-699501013259,2,o
67,0211-699501013259,meses,o
67,0211-699501013259,niveles,i
67,0211-699501013259,de,i
67,0211-699501013259,folato,i
67,0211-699501013259,vitamina,i
67,0211-699501013259,B12,i
67,0211-699501013259,inmunoensayo,i
67,0211-699501013259,albumina,i
67,0211-699501013259,y,o
67,0211-699501013259,cinetica,o
67,0211-699501013259,de,o
67,0211-699501013259,la,o
67,0211-699501013259,urea,i
67,0211-699501013259,KTV,o
67,0211-699501013259,KRU,o
67,0211-699501013259,PCRn,o
67,0211-699501013259,y,o
67,0211-699501013259,cada,o
67,0211-699501013259,6,o
67,0211-699501013259,meses,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,HPLC,i
67,0211-699501013259,y,o
67,0211-699501013259,pp,i
67,0211-699501013259,RIA,i
67,0211-699501013259,Resultados,o
67,0211-699501013259,80,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,fueron,o
67,0211-699501013259,incluidos,o
67,0211-699501013259,en,o
67,0211-699501013259,el,o
67,0211-699501013259,estudio,o
67,0211-699501013259,basal,o
67,0211-699501013259,con,o
67,0211-699501013259,una,o
67,0211-699501013259,prevalencia,o
67,0211-699501013259,de,o
67,0211-699501013259,hiperhomocisteinemia,i
67,0211-699501013259,del,o
67,0211-699501013259,844,o
67,0211-699501013259,deficit,i
67,0211-699501013259,de,i
67,0211-699501013259,pp,i
67,0211-699501013259,en,o
67,0211-699501013259,el,o
67,0211-699501013259,32,o
67,0211-699501013259,y,o
67,0211-699501013259,folato,i
67,0211-699501013259,en,o
67,0211-699501013259,el,o
67,0211-699501013259,rango,o
67,0211-699501013259,normal,o
67,0211-699501013259,bajo,o
67,0211-699501013259,los,o
67,0211-699501013259,niveles,i
67,0211-699501013259,de,i
67,0211-699501013259,tHcy,i
67,0211-699501013259,se,o
67,0211-699501013259,correlacionaban,o
67,0211-699501013259,inversamente,o
67,0211-699501013259,con,o
67,0211-699501013259,los,o
67,0211-699501013259,del,o
67,0211-699501013259,folato,i
67,0211-699501013259,r,o
67,0211-699501013259,0336,o
67,0211-699501013259,p,o
67,0211-699501013259,001,o
67,0211-699501013259,pero,o
67,0211-699501013259,no,o
67,0211-699501013259,con,o
67,0211-699501013259,pp,i
67,0211-699501013259,B12,i
67,0211-699501013259,edad,o
67,0211-699501013259,albumina,i
67,0211-699501013259,KTV,o
67,0211-699501013259,KRU,o
67,0211-699501013259,PCRn,o
67,0211-699501013259,Cincuenta,o
67,0211-699501013259,y,o
67,0211-699501013259,ocho,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,recibieron,o
67,0211-699501013259,seis,o
67,0211-699501013259,meses,o
67,0211-699501013259,de,o
67,0211-699501013259,suplementacion,i
67,0211-699501013259,con,o
67,0211-699501013259,normalizacion,o
67,0211-699501013259,del,o
67,0211-699501013259,pp,i
67,0211-699501013259,aumento,o
67,0211-699501013259,del,o
67,0211-699501013259,folato,i
67,0211-699501013259,703,o
67,0211-699501013259,IC,o
67,0211-699501013259,638,o
67,0211-699501013259,795,o
67,0211-699501013259,vs,o
67,0211-699501013259,6181,o
67,0211-699501013259,IC,o
67,0211-699501013259,4447,o
67,0211-699501013259,7811,o
67,0211-699501013259,p,o
67,0211-699501013259,0001,o
67,0211-699501013259,y,o
67,0211-699501013259,descenso,o
67,0211-699501013259,de,o
67,0211-699501013259,la,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,240,o
67,0211-699501013259,IC,o
67,0211-699501013259,213,o
67,0211-699501013259,264,o
67,0211-699501013259,vs,o
67,0211-699501013259,199,o
67,0211-699501013259,IC,o
67,0211-699501013259,175,o
67,0211-699501013259,224,o
67,0211-699501013259,p,o
67,0211-699501013259,005,o
67,0211-699501013259,Han,o
67,0211-699501013259,recibido,o
67,0211-699501013259,suplementacion,i
67,0211-699501013259,durante,o
67,0211-699501013259,12,o
67,0211-699501013259,meses,o
67,0211-699501013259,33,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,pero,o
67,0211-699501013259,a,o
67,0211-699501013259,pesar,o
67,0211-699501013259,de,o
67,0211-699501013259,un,o
67,0211-699501013259,continuo,o
67,0211-699501013259,aumento,o
67,0211-699501013259,del,o
67,0211-699501013259,folato,i
67,0211-699501013259,10078,o
67,0211-699501013259,IC,o
67,0211-699501013259,7481,o
67,0211-699501013259,12674,o
67,0211-699501013259,p,o
67,0211-699501013259,0001,o
67,0211-699501013259,solo,o
67,0211-699501013259,3,o
67,0211-699501013259,pacientes,o
67,0211-699501013259,presentan,o
67,0211-699501013259,niveles,o
67,0211-699501013259,normales,o
67,0211-699501013259,de,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,correlacionandose,o
67,0211-699501013259,directamente,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,con,o
67,0211-699501013259,la,o
67,0211-699501013259,albumina,i
67,0211-699501013259,r,o
67,0211-699501013259,056,o
67,0211-699501013259,p,o
67,0211-699501013259,0001,o
67,0211-699501013259,que,o
67,0211-699501013259,se,o
67,0211-699501013259,elevo,o
67,0211-699501013259,con,o
67,0211-699501013259,respecto,o
67,0211-699501013259,al,o
67,0211-699501013259,inicio,o
67,0211-699501013259,337,o
67,0211-699501013259,IC,o
67,0211-699501013259,327,o
67,0211-699501013259,346,o
67,0211-699501013259,vs,o
67,0211-699501013259,350,o
67,0211-699501013259,IC,o
67,0211-699501013259,337,o
67,0211-699501013259,363,o
67,0211-699501013259,p,o
67,0211-699501013259,005,o
67,0211-699501013259,Conclusion,o
67,0211-699501013259,Tras,o
67,0211-699501013259,suplementacion,i
67,0211-699501013259,con,o
67,0211-699501013259,acido,i
67,0211-699501013259,folico,i
67,0211-699501013259,y,o
67,0211-699501013259,vitamina,i
67,0211-699501013259,B6,i
67,0211-699501013259,aunque,o
67,0211-699501013259,inicialmente,o
67,0211-699501013259,se,o
67,0211-699501013259,reduce,o
67,0211-699501013259,la,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,esta,o
67,0211-699501013259,respuesta,o
67,0211-699501013259,se,o
67,0211-699501013259,hace,o
67,0211-699501013259,refractaria,o
67,0211-699501013259,correlacionandose,o
67,0211-699501013259,directamente,o
67,0211-699501013259,la,o
67,0211-699501013259,tHcy,i
67,0211-699501013259,con,o
67,0211-699501013259,la,o
67,0211-699501013259,albumina,i
67,0211-699501013259,plasmatica,i
67,0211-699501013259,La,o
67,0211-699501013259,interpretacion,o
67,0211-699501013259,de,o
67,0211-699501013259,los,o
67,0211-699501013259,niveles,i
67,0211-699501013259,de,i
67,0211-699501013259,tHcy,i
67,0211-699501013259,debe,o
67,0211-699501013259,tener,o
67,0211-699501013259,en,o
67,0211-699501013259,cuenta,o
67,0211-699501013259,la,o
67,0211-699501013259,concentracion,i
67,0211-699501013259,de,i
67,0211-699501013259,albumina,i
68,0211-699501013259,Efecto,o
68,0211-699501013259,de,o
68,0211-699501013259,la,o
68,0211-699501013259,suplementacion,i
68,0211-699501013259,con,o
68,0211-699501013259,acido,i
68,0211-699501013259,folico,i
68,0211-699501013259,sobre,o
68,0211-699501013259,los,o
68,0211-699501013259,niveles,i
68,0211-699501013259,de,i
68,0211-699501013259,homocisteina,i
68,0211-699501013259,total,o
68,0211-699501013259,en,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,en,o
68,0211-699501013259,hemodialisis,i
68,0211-699501013259,La,o
68,0211-699501013259,hiperhomocisteinemia,i
68,0211-699501013259,es,o
68,0211-699501013259,un,o
68,0211-699501013259,marcador,o
68,0211-699501013259,de,o
68,0211-699501013259,riesgo,o
68,0211-699501013259,independiente,o
68,0211-699501013259,de,o
68,0211-699501013259,morbimortalidad,o
68,0211-699501013259,cardiovascular,i
68,0211-699501013259,Hemos,o
68,0211-699501013259,intentado,o
68,0211-699501013259,prospectivamente,o
68,0211-699501013259,reducir,o
68,0211-699501013259,los,o
68,0211-699501013259,niveles,i
68,0211-699501013259,de,i
68,0211-699501013259,homocisteina,i
68,0211-699501013259,total,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,mediante,o
68,0211-699501013259,suplemento,o
68,0211-699501013259,con,o
68,0211-699501013259,acido,i
68,0211-699501013259,folico,i
68,0211-699501013259,y,o
68,0211-699501013259,vitamina,i
68,0211-699501013259,B6,i
68,0211-699501013259,pp,i
68,0211-699501013259,valorando,o
68,0211-699501013259,su,o
68,0211-699501013259,posible,o
68,0211-699501013259,correlacion,o
68,0211-699501013259,con,o
68,0211-699501013259,dosis,o
68,0211-699501013259,de,o
68,0211-699501013259,dialisis,i
68,0211-699501013259,funcion,i
68,0211-699501013259,residual,i
68,0211-699501013259,y,o
68,0211-699501013259,parametros,o
68,0211-699501013259,nutricionales,o
68,0211-699501013259,Metodos,o
68,0211-699501013259,Todos,o
68,0211-699501013259,los,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,en,o
68,0211-699501013259,hemodialisis,i
68,0211-699501013259,al,o
68,0211-699501013259,comienzo,o
68,0211-699501013259,del,o
68,0211-699501013259,estudio,o
68,0211-699501013259,que,o
68,0211-699501013259,no,o
68,0211-699501013259,recibian,o
68,0211-699501013259,acido,i
68,0211-699501013259,folico,i
68,0211-699501013259,ni,o
68,0211-699501013259,vitamina,i
68,0211-699501013259,B6,i
68,0211-699501013259,asi,o
68,0211-699501013259,como,o
68,0211-699501013259,los,o
68,0211-699501013259,incorporados,o
68,0211-699501013259,posteriormente,o
68,0211-699501013259,a,o
68,0211-699501013259,partir,o
68,0211-699501013259,de,o
68,0211-699501013259,su,o
68,0211-699501013259,tercer,o
68,0211-699501013259,mes,o
68,0211-699501013259,en,o
68,0211-699501013259,hemodialisis,i
68,0211-699501013259,recibieron,o
68,0211-699501013259,5,o
68,0211-699501013259,mg,o
68,0211-699501013259,orales,o
68,0211-699501013259,de,o
68,0211-699501013259,acido,i
68,0211-699501013259,folico,i
68,0211-699501013259,cada,o
68,0211-699501013259,48,o
68,0211-699501013259,horas,o
68,0211-699501013259,y,o
68,0211-699501013259,40,o
68,0211-699501013259,mg,o
68,0211-699501013259,orales,o
68,0211-699501013259,de,o
68,0211-699501013259,vitamina,i
68,0211-699501013259,B6,i
68,0211-699501013259,cada,o
68,0211-699501013259,semana,o
68,0211-699501013259,Se,o
68,0211-699501013259,determinaron,o
68,0211-699501013259,al,o
68,0211-699501013259,comienzo,o
68,0211-699501013259,del,o
68,0211-699501013259,estudio,o
68,0211-699501013259,y,o
68,0211-699501013259,cada,o
68,0211-699501013259,2,o
68,0211-699501013259,meses,o
68,0211-699501013259,niveles,i
68,0211-699501013259,de,i
68,0211-699501013259,folato,i
68,0211-699501013259,vitamina,i
68,0211-699501013259,B12,i
68,0211-699501013259,inmunoensayo,i
68,0211-699501013259,albumina,i
68,0211-699501013259,y,o
68,0211-699501013259,cinetica,o
68,0211-699501013259,de,o
68,0211-699501013259,la,o
68,0211-699501013259,urea,i
68,0211-699501013259,KTV,o
68,0211-699501013259,KRU,o
68,0211-699501013259,PCRn,o
68,0211-699501013259,y,o
68,0211-699501013259,cada,o
68,0211-699501013259,6,o
68,0211-699501013259,meses,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,HPLC,i
68,0211-699501013259,y,o
68,0211-699501013259,pp,i
68,0211-699501013259,RIA,i
68,0211-699501013259,Resultados,o
68,0211-699501013259,80,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,fueron,o
68,0211-699501013259,incluidos,o
68,0211-699501013259,en,o
68,0211-699501013259,el,o
68,0211-699501013259,estudio,o
68,0211-699501013259,basal,o
68,0211-699501013259,con,o
68,0211-699501013259,una,o
68,0211-699501013259,prevalencia,o
68,0211-699501013259,de,o
68,0211-699501013259,hiperhomocisteinemia,i
68,0211-699501013259,del,o
68,0211-699501013259,844,o
68,0211-699501013259,deficit,i
68,0211-699501013259,de,i
68,0211-699501013259,pp,i
68,0211-699501013259,en,o
68,0211-699501013259,el,o
68,0211-699501013259,32,o
68,0211-699501013259,y,o
68,0211-699501013259,folato,i
68,0211-699501013259,en,o
68,0211-699501013259,el,o
68,0211-699501013259,rango,o
68,0211-699501013259,normal,o
68,0211-699501013259,bajo,o
68,0211-699501013259,los,o
68,0211-699501013259,niveles,i
68,0211-699501013259,de,i
68,0211-699501013259,tHcy,i
68,0211-699501013259,se,o
68,0211-699501013259,correlacionaban,o
68,0211-699501013259,inversamente,o
68,0211-699501013259,con,o
68,0211-699501013259,los,o
68,0211-699501013259,del,o
68,0211-699501013259,folato,i
68,0211-699501013259,r,o
68,0211-699501013259,0336,o
68,0211-699501013259,p,o
68,0211-699501013259,001,o
68,0211-699501013259,pero,o
68,0211-699501013259,no,o
68,0211-699501013259,con,o
68,0211-699501013259,pp,i
68,0211-699501013259,B12,i
68,0211-699501013259,edad,o
68,0211-699501013259,albumina,i
68,0211-699501013259,KTV,o
68,0211-699501013259,KRU,o
68,0211-699501013259,PCRn,o
68,0211-699501013259,Cincuenta,o
68,0211-699501013259,y,o
68,0211-699501013259,ocho,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,recibieron,o
68,0211-699501013259,seis,o
68,0211-699501013259,meses,o
68,0211-699501013259,de,o
68,0211-699501013259,suplementacion,i
68,0211-699501013259,con,o
68,0211-699501013259,normalizacion,o
68,0211-699501013259,del,o
68,0211-699501013259,pp,i
68,0211-699501013259,aumento,o
68,0211-699501013259,del,o
68,0211-699501013259,folato,i
68,0211-699501013259,703,o
68,0211-699501013259,IC,o
68,0211-699501013259,638,o
68,0211-699501013259,795,o
68,0211-699501013259,vs,o
68,0211-699501013259,6181,o
68,0211-699501013259,IC,o
68,0211-699501013259,4447,o
68,0211-699501013259,7811,o
68,0211-699501013259,p,o
68,0211-699501013259,0001,o
68,0211-699501013259,y,o
68,0211-699501013259,descenso,o
68,0211-699501013259,de,o
68,0211-699501013259,la,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,240,o
68,0211-699501013259,IC,o
68,0211-699501013259,213,o
68,0211-699501013259,264,o
68,0211-699501013259,vs,o
68,0211-699501013259,199,o
68,0211-699501013259,IC,o
68,0211-699501013259,175,o
68,0211-699501013259,224,o
68,0211-699501013259,p,o
68,0211-699501013259,005,o
68,0211-699501013259,Han,o
68,0211-699501013259,recibido,o
68,0211-699501013259,suplementacion,i
68,0211-699501013259,durante,o
68,0211-699501013259,12,o
68,0211-699501013259,meses,o
68,0211-699501013259,33,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,pero,o
68,0211-699501013259,a,o
68,0211-699501013259,pesar,o
68,0211-699501013259,de,o
68,0211-699501013259,un,o
68,0211-699501013259,continuo,o
68,0211-699501013259,aumento,o
68,0211-699501013259,del,o
68,0211-699501013259,folato,i
68,0211-699501013259,10078,o
68,0211-699501013259,IC,o
68,0211-699501013259,7481,o
68,0211-699501013259,12674,o
68,0211-699501013259,p,o
68,0211-699501013259,0001,o
68,0211-699501013259,solo,o
68,0211-699501013259,3,o
68,0211-699501013259,pacientes,o
68,0211-699501013259,presentan,o
68,0211-699501013259,niveles,o
68,0211-699501013259,normales,o
68,0211-699501013259,de,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,correlacionandose,o
68,0211-699501013259,directamente,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,con,o
68,0211-699501013259,la,o
68,0211-699501013259,albumina,i
68,0211-699501013259,r,o
68,0211-699501013259,056,o
68,0211-699501013259,p,o
68,0211-699501013259,0001,o
68,0211-699501013259,que,o
68,0211-699501013259,se,o
68,0211-699501013259,elevo,o
68,0211-699501013259,con,o
68,0211-699501013259,respecto,o
68,0211-699501013259,al,o
68,0211-699501013259,inicio,o
68,0211-699501013259,337,o
68,0211-699501013259,IC,o
68,0211-699501013259,327,o
68,0211-699501013259,346,o
68,0211-699501013259,vs,o
68,0211-699501013259,350,o
68,0211-699501013259,IC,o
68,0211-699501013259,337,o
68,0211-699501013259,363,o
68,0211-699501013259,p,o
68,0211-699501013259,005,o
68,0211-699501013259,Conclusion,o
68,0211-699501013259,Tras,o
68,0211-699501013259,suplementacion,i
68,0211-699501013259,con,o
68,0211-699501013259,acido,i
68,0211-699501013259,folico,i
68,0211-699501013259,y,o
68,0211-699501013259,vitamina,i
68,0211-699501013259,B6,i
68,0211-699501013259,aunque,o
68,0211-699501013259,inicialmente,o
68,0211-699501013259,se,o
68,0211-699501013259,reduce,o
68,0211-699501013259,la,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,esta,o
68,0211-699501013259,respuesta,o
68,0211-699501013259,se,o
68,0211-699501013259,hace,o
68,0211-699501013259,refractaria,o
68,0211-699501013259,correlacionandose,o
68,0211-699501013259,directamente,o
68,0211-699501013259,la,o
68,0211-699501013259,tHcy,i
68,0211-699501013259,con,o
68,0211-699501013259,la,o
68,0211-699501013259,albumina,i
68,0211-699501013259,plasmatica,i
68,0211-699501013259,La,o
68,0211-699501013259,interpretacion,o
68,0211-699501013259,de,o
68,0211-699501013259,los,o
68,0211-699501013259,niveles,i
68,0211-699501013259,de,i
68,0211-699501013259,tHcy,i
68,0211-699501013259,debe,o
68,0211-699501013259,tener,o
68,0211-699501013259,en,o
68,0211-699501013259,cuenta,o
68,0211-699501013259,la,o
68,0211-699501013259,concentracion,i
68,0211-699501013259,de,i
68,0211-699501013259,albumina,i
69,0211-699501013259,Efecto,o
69,0211-699501013259,de,o
69,0211-699501013259,la,o
69,0211-699501013259,suplementacion,i
69,0211-699501013259,con,o
69,0211-699501013259,acido,i
69,0211-699501013259,folico,i
69,0211-699501013259,sobre,o
69,0211-699501013259,los,o
69,0211-699501013259,niveles,i
69,0211-699501013259,de,i
69,0211-699501013259,homocisteina,i
69,0211-699501013259,total,o
69,0211-699501013259,en,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,en,o
69,0211-699501013259,hemodialisis,i
69,0211-699501013259,La,o
69,0211-699501013259,hiperhomocisteinemia,i
69,0211-699501013259,es,o
69,0211-699501013259,un,o
69,0211-699501013259,marcador,o
69,0211-699501013259,de,o
69,0211-699501013259,riesgo,o
69,0211-699501013259,independiente,o
69,0211-699501013259,de,o
69,0211-699501013259,morbimortalidad,o
69,0211-699501013259,cardiovascular,i
69,0211-699501013259,Hemos,o
69,0211-699501013259,intentado,o
69,0211-699501013259,prospectivamente,o
69,0211-699501013259,reducir,o
69,0211-699501013259,los,o
69,0211-699501013259,niveles,i
69,0211-699501013259,de,i
69,0211-699501013259,homocisteina,i
69,0211-699501013259,total,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,mediante,o
69,0211-699501013259,suplemento,o
69,0211-699501013259,con,o
69,0211-699501013259,acido,i
69,0211-699501013259,folico,i
69,0211-699501013259,y,o
69,0211-699501013259,vitamina,i
69,0211-699501013259,B6,i
69,0211-699501013259,pp,i
69,0211-699501013259,valorando,o
69,0211-699501013259,su,o
69,0211-699501013259,posible,o
69,0211-699501013259,correlacion,o
69,0211-699501013259,con,o
69,0211-699501013259,dosis,o
69,0211-699501013259,de,o
69,0211-699501013259,dialisis,i
69,0211-699501013259,funcion,i
69,0211-699501013259,residual,i
69,0211-699501013259,y,o
69,0211-699501013259,parametros,o
69,0211-699501013259,nutricionales,o
69,0211-699501013259,Metodos,o
69,0211-699501013259,Todos,o
69,0211-699501013259,los,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,en,o
69,0211-699501013259,hemodialisis,i
69,0211-699501013259,al,o
69,0211-699501013259,comienzo,o
69,0211-699501013259,del,o
69,0211-699501013259,estudio,o
69,0211-699501013259,que,o
69,0211-699501013259,no,o
69,0211-699501013259,recibian,o
69,0211-699501013259,acido,i
69,0211-699501013259,folico,i
69,0211-699501013259,ni,o
69,0211-699501013259,vitamina,i
69,0211-699501013259,B6,i
69,0211-699501013259,asi,o
69,0211-699501013259,como,o
69,0211-699501013259,los,o
69,0211-699501013259,incorporados,o
69,0211-699501013259,posteriormente,o
69,0211-699501013259,a,o
69,0211-699501013259,partir,o
69,0211-699501013259,de,o
69,0211-699501013259,su,o
69,0211-699501013259,tercer,o
69,0211-699501013259,mes,o
69,0211-699501013259,en,o
69,0211-699501013259,hemodialisis,i
69,0211-699501013259,recibieron,o
69,0211-699501013259,5,o
69,0211-699501013259,mg,o
69,0211-699501013259,orales,o
69,0211-699501013259,de,o
69,0211-699501013259,acido,i
69,0211-699501013259,folico,i
69,0211-699501013259,cada,o
69,0211-699501013259,48,o
69,0211-699501013259,horas,o
69,0211-699501013259,y,o
69,0211-699501013259,40,o
69,0211-699501013259,mg,o
69,0211-699501013259,orales,o
69,0211-699501013259,de,o
69,0211-699501013259,vitamina,i
69,0211-699501013259,B6,i
69,0211-699501013259,cada,o
69,0211-699501013259,semana,o
69,0211-699501013259,Se,o
69,0211-699501013259,determinaron,o
69,0211-699501013259,al,o
69,0211-699501013259,comienzo,o
69,0211-699501013259,del,o
69,0211-699501013259,estudio,o
69,0211-699501013259,y,o
69,0211-699501013259,cada,o
69,0211-699501013259,2,o
69,0211-699501013259,meses,o
69,0211-699501013259,niveles,i
69,0211-699501013259,de,i
69,0211-699501013259,folato,i
69,0211-699501013259,vitamina,i
69,0211-699501013259,B12,i
69,0211-699501013259,inmunoensayo,i
69,0211-699501013259,albumina,i
69,0211-699501013259,y,o
69,0211-699501013259,cinetica,o
69,0211-699501013259,de,o
69,0211-699501013259,la,o
69,0211-699501013259,urea,i
69,0211-699501013259,KTV,o
69,0211-699501013259,KRU,o
69,0211-699501013259,PCRn,o
69,0211-699501013259,y,o
69,0211-699501013259,cada,o
69,0211-699501013259,6,o
69,0211-699501013259,meses,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,HPLC,i
69,0211-699501013259,y,o
69,0211-699501013259,pp,i
69,0211-699501013259,RIA,i
69,0211-699501013259,Resultados,o
69,0211-699501013259,80,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,fueron,o
69,0211-699501013259,incluidos,o
69,0211-699501013259,en,o
69,0211-699501013259,el,o
69,0211-699501013259,estudio,o
69,0211-699501013259,basal,o
69,0211-699501013259,con,o
69,0211-699501013259,una,o
69,0211-699501013259,prevalencia,o
69,0211-699501013259,de,o
69,0211-699501013259,hiperhomocisteinemia,i
69,0211-699501013259,del,o
69,0211-699501013259,844,o
69,0211-699501013259,deficit,i
69,0211-699501013259,de,i
69,0211-699501013259,pp,i
69,0211-699501013259,en,o
69,0211-699501013259,el,o
69,0211-699501013259,32,o
69,0211-699501013259,y,o
69,0211-699501013259,folato,i
69,0211-699501013259,en,o
69,0211-699501013259,el,o
69,0211-699501013259,rango,o
69,0211-699501013259,normal,o
69,0211-699501013259,bajo,o
69,0211-699501013259,los,o
69,0211-699501013259,niveles,i
69,0211-699501013259,de,i
69,0211-699501013259,tHcy,i
69,0211-699501013259,se,o
69,0211-699501013259,correlacionaban,o
69,0211-699501013259,inversamente,o
69,0211-699501013259,con,o
69,0211-699501013259,los,o
69,0211-699501013259,del,o
69,0211-699501013259,folato,i
69,0211-699501013259,r,o
69,0211-699501013259,0336,o
69,0211-699501013259,p,o
69,0211-699501013259,001,o
69,0211-699501013259,pero,o
69,0211-699501013259,no,o
69,0211-699501013259,con,o
69,0211-699501013259,pp,i
69,0211-699501013259,B12,i
69,0211-699501013259,edad,o
69,0211-699501013259,albumina,i
69,0211-699501013259,KTV,o
69,0211-699501013259,KRU,o
69,0211-699501013259,PCRn,o
69,0211-699501013259,Cincuenta,o
69,0211-699501013259,y,o
69,0211-699501013259,ocho,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,recibieron,o
69,0211-699501013259,seis,o
69,0211-699501013259,meses,o
69,0211-699501013259,de,o
69,0211-699501013259,suplementacion,i
69,0211-699501013259,con,o
69,0211-699501013259,normalizacion,o
69,0211-699501013259,del,o
69,0211-699501013259,pp,i
69,0211-699501013259,aumento,o
69,0211-699501013259,del,o
69,0211-699501013259,folato,i
69,0211-699501013259,703,o
69,0211-699501013259,IC,o
69,0211-699501013259,638,o
69,0211-699501013259,795,o
69,0211-699501013259,vs,o
69,0211-699501013259,6181,o
69,0211-699501013259,IC,o
69,0211-699501013259,4447,o
69,0211-699501013259,7811,o
69,0211-699501013259,p,o
69,0211-699501013259,0001,o
69,0211-699501013259,y,o
69,0211-699501013259,descenso,o
69,0211-699501013259,de,o
69,0211-699501013259,la,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,240,o
69,0211-699501013259,IC,o
69,0211-699501013259,213,o
69,0211-699501013259,264,o
69,0211-699501013259,vs,o
69,0211-699501013259,199,o
69,0211-699501013259,IC,o
69,0211-699501013259,175,o
69,0211-699501013259,224,o
69,0211-699501013259,p,o
69,0211-699501013259,005,o
69,0211-699501013259,Han,o
69,0211-699501013259,recibido,o
69,0211-699501013259,suplementacion,i
69,0211-699501013259,durante,o
69,0211-699501013259,12,o
69,0211-699501013259,meses,o
69,0211-699501013259,33,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,pero,o
69,0211-699501013259,a,o
69,0211-699501013259,pesar,o
69,0211-699501013259,de,o
69,0211-699501013259,un,o
69,0211-699501013259,continuo,o
69,0211-699501013259,aumento,o
69,0211-699501013259,del,o
69,0211-699501013259,folato,i
69,0211-699501013259,10078,o
69,0211-699501013259,IC,o
69,0211-699501013259,7481,o
69,0211-699501013259,12674,o
69,0211-699501013259,p,o
69,0211-699501013259,0001,o
69,0211-699501013259,solo,o
69,0211-699501013259,3,o
69,0211-699501013259,pacientes,o
69,0211-699501013259,presentan,o
69,0211-699501013259,niveles,o
69,0211-699501013259,normales,o
69,0211-699501013259,de,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,correlacionandose,o
69,0211-699501013259,directamente,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,con,o
69,0211-699501013259,la,o
69,0211-699501013259,albumina,i
69,0211-699501013259,r,o
69,0211-699501013259,056,o
69,0211-699501013259,p,o
69,0211-699501013259,0001,o
69,0211-699501013259,que,o
69,0211-699501013259,se,o
69,0211-699501013259,elevo,o
69,0211-699501013259,con,o
69,0211-699501013259,respecto,o
69,0211-699501013259,al,o
69,0211-699501013259,inicio,o
69,0211-699501013259,337,o
69,0211-699501013259,IC,o
69,0211-699501013259,327,o
69,0211-699501013259,346,o
69,0211-699501013259,vs,o
69,0211-699501013259,350,o
69,0211-699501013259,IC,o
69,0211-699501013259,337,o
69,0211-699501013259,363,o
69,0211-699501013259,p,o
69,0211-699501013259,005,o
69,0211-699501013259,Conclusion,o
69,0211-699501013259,Tras,o
69,0211-699501013259,suplementacion,i
69,0211-699501013259,con,o
69,0211-699501013259,acido,i
69,0211-699501013259,folico,i
69,0211-699501013259,y,o
69,0211-699501013259,vitamina,i
69,0211-699501013259,B6,i
69,0211-699501013259,aunque,o
69,0211-699501013259,inicialmente,o
69,0211-699501013259,se,o
69,0211-699501013259,reduce,o
69,0211-699501013259,la,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,esta,o
69,0211-699501013259,respuesta,o
69,0211-699501013259,se,o
69,0211-699501013259,hace,o
69,0211-699501013259,refractaria,o
69,0211-699501013259,correlacionandose,o
69,0211-699501013259,directamente,o
69,0211-699501013259,la,o
69,0211-699501013259,tHcy,i
69,0211-699501013259,con,o
69,0211-699501013259,la,o
69,0211-699501013259,albumina,i
69,0211-699501013259,plasmatica,i
69,0211-699501013259,La,o
69,0211-699501013259,interpretacion,o
69,0211-699501013259,de,o
69,0211-699501013259,los,o
69,0211-699501013259,niveles,i
69,0211-699501013259,de,i
69,0211-699501013259,tHcy,i
69,0211-699501013259,debe,o
69,0211-699501013259,tener,o
69,0211-699501013259,en,o
69,0211-699501013259,cuenta,o
69,0211-699501013259,la,o
69,0211-699501013259,concentracion,i
69,0211-699501013259,de,i
69,0211-699501013259,albumina,i
70,0211-699501013259,Efecto,o
70,0211-699501013259,de,o
70,0211-699501013259,la,o
70,0211-699501013259,suplementacion,i
70,0211-699501013259,con,o
70,0211-699501013259,acido,i
70,0211-699501013259,folico,i
70,0211-699501013259,sobre,o
70,0211-699501013259,los,o
70,0211-699501013259,niveles,i
70,0211-699501013259,de,i
70,0211-699501013259,homocisteina,i
70,0211-699501013259,total,o
70,0211-699501013259,en,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,en,o
70,0211-699501013259,hemodialisis,i
70,0211-699501013259,La,o
70,0211-699501013259,hiperhomocisteinemia,i
70,0211-699501013259,es,o
70,0211-699501013259,un,o
70,0211-699501013259,marcador,o
70,0211-699501013259,de,o
70,0211-699501013259,riesgo,o
70,0211-699501013259,independiente,o
70,0211-699501013259,de,o
70,0211-699501013259,morbimortalidad,o
70,0211-699501013259,cardiovascular,i
70,0211-699501013259,Hemos,o
70,0211-699501013259,intentado,o
70,0211-699501013259,prospectivamente,o
70,0211-699501013259,reducir,o
70,0211-699501013259,los,o
70,0211-699501013259,niveles,i
70,0211-699501013259,de,i
70,0211-699501013259,homocisteina,i
70,0211-699501013259,total,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,mediante,o
70,0211-699501013259,suplemento,o
70,0211-699501013259,con,o
70,0211-699501013259,acido,i
70,0211-699501013259,folico,i
70,0211-699501013259,y,o
70,0211-699501013259,vitamina,i
70,0211-699501013259,B6,i
70,0211-699501013259,pp,i
70,0211-699501013259,valorando,o
70,0211-699501013259,su,o
70,0211-699501013259,posible,o
70,0211-699501013259,correlacion,o
70,0211-699501013259,con,o
70,0211-699501013259,dosis,o
70,0211-699501013259,de,o
70,0211-699501013259,dialisis,i
70,0211-699501013259,funcion,i
70,0211-699501013259,residual,i
70,0211-699501013259,y,o
70,0211-699501013259,parametros,o
70,0211-699501013259,nutricionales,o
70,0211-699501013259,Metodos,o
70,0211-699501013259,Todos,o
70,0211-699501013259,los,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,en,o
70,0211-699501013259,hemodialisis,i
70,0211-699501013259,al,o
70,0211-699501013259,comienzo,o
70,0211-699501013259,del,o
70,0211-699501013259,estudio,o
70,0211-699501013259,que,o
70,0211-699501013259,no,o
70,0211-699501013259,recibian,o
70,0211-699501013259,acido,i
70,0211-699501013259,folico,i
70,0211-699501013259,ni,o
70,0211-699501013259,vitamina,i
70,0211-699501013259,B6,i
70,0211-699501013259,asi,o
70,0211-699501013259,como,o
70,0211-699501013259,los,o
70,0211-699501013259,incorporados,o
70,0211-699501013259,posteriormente,o
70,0211-699501013259,a,o
70,0211-699501013259,partir,o
70,0211-699501013259,de,o
70,0211-699501013259,su,o
70,0211-699501013259,tercer,o
70,0211-699501013259,mes,o
70,0211-699501013259,en,o
70,0211-699501013259,hemodialisis,i
70,0211-699501013259,recibieron,o
70,0211-699501013259,5,o
70,0211-699501013259,mg,o
70,0211-699501013259,orales,o
70,0211-699501013259,de,o
70,0211-699501013259,acido,i
70,0211-699501013259,folico,i
70,0211-699501013259,cada,o
70,0211-699501013259,48,o
70,0211-699501013259,horas,o
70,0211-699501013259,y,o
70,0211-699501013259,40,o
70,0211-699501013259,mg,o
70,0211-699501013259,orales,o
70,0211-699501013259,de,o
70,0211-699501013259,vitamina,i
70,0211-699501013259,B6,i
70,0211-699501013259,cada,o
70,0211-699501013259,semana,o
70,0211-699501013259,Se,o
70,0211-699501013259,determinaron,o
70,0211-699501013259,al,o
70,0211-699501013259,comienzo,o
70,0211-699501013259,del,o
70,0211-699501013259,estudio,o
70,0211-699501013259,y,o
70,0211-699501013259,cada,o
70,0211-699501013259,2,o
70,0211-699501013259,meses,o
70,0211-699501013259,niveles,i
70,0211-699501013259,de,i
70,0211-699501013259,folato,i
70,0211-699501013259,vitamina,i
70,0211-699501013259,B12,i
70,0211-699501013259,inmunoensayo,i
70,0211-699501013259,albumina,i
70,0211-699501013259,y,o
70,0211-699501013259,cinetica,o
70,0211-699501013259,de,o
70,0211-699501013259,la,o
70,0211-699501013259,urea,i
70,0211-699501013259,KTV,o
70,0211-699501013259,KRU,o
70,0211-699501013259,PCRn,o
70,0211-699501013259,y,o
70,0211-699501013259,cada,o
70,0211-699501013259,6,o
70,0211-699501013259,meses,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,HPLC,i
70,0211-699501013259,y,o
70,0211-699501013259,pp,i
70,0211-699501013259,RIA,i
70,0211-699501013259,Resultados,o
70,0211-699501013259,80,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,fueron,o
70,0211-699501013259,incluidos,o
70,0211-699501013259,en,o
70,0211-699501013259,el,o
70,0211-699501013259,estudio,o
70,0211-699501013259,basal,o
70,0211-699501013259,con,o
70,0211-699501013259,una,o
70,0211-699501013259,prevalencia,o
70,0211-699501013259,de,o
70,0211-699501013259,hiperhomocisteinemia,i
70,0211-699501013259,del,o
70,0211-699501013259,844,o
70,0211-699501013259,deficit,i
70,0211-699501013259,de,i
70,0211-699501013259,pp,i
70,0211-699501013259,en,o
70,0211-699501013259,el,o
70,0211-699501013259,32,o
70,0211-699501013259,y,o
70,0211-699501013259,folato,i
70,0211-699501013259,en,o
70,0211-699501013259,el,o
70,0211-699501013259,rango,o
70,0211-699501013259,normal,o
70,0211-699501013259,bajo,o
70,0211-699501013259,los,o
70,0211-699501013259,niveles,i
70,0211-699501013259,de,i
70,0211-699501013259,tHcy,i
70,0211-699501013259,se,o
70,0211-699501013259,correlacionaban,o
70,0211-699501013259,inversamente,o
70,0211-699501013259,con,o
70,0211-699501013259,los,o
70,0211-699501013259,del,o
70,0211-699501013259,folato,i
70,0211-699501013259,r,o
70,0211-699501013259,0336,o
70,0211-699501013259,p,o
70,0211-699501013259,001,o
70,0211-699501013259,pero,o
70,0211-699501013259,no,o
70,0211-699501013259,con,o
70,0211-699501013259,pp,i
70,0211-699501013259,B12,i
70,0211-699501013259,edad,o
70,0211-699501013259,albumina,i
70,0211-699501013259,KTV,o
70,0211-699501013259,KRU,o
70,0211-699501013259,PCRn,o
70,0211-699501013259,Cincuenta,o
70,0211-699501013259,y,o
70,0211-699501013259,ocho,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,recibieron,o
70,0211-699501013259,seis,o
70,0211-699501013259,meses,o
70,0211-699501013259,de,o
70,0211-699501013259,suplementacion,i
70,0211-699501013259,con,o
70,0211-699501013259,normalizacion,o
70,0211-699501013259,del,o
70,0211-699501013259,pp,i
70,0211-699501013259,aumento,o
70,0211-699501013259,del,o
70,0211-699501013259,folato,i
70,0211-699501013259,703,o
70,0211-699501013259,IC,o
70,0211-699501013259,638,o
70,0211-699501013259,795,o
70,0211-699501013259,vs,o
70,0211-699501013259,6181,o
70,0211-699501013259,IC,o
70,0211-699501013259,4447,o
70,0211-699501013259,7811,o
70,0211-699501013259,p,o
70,0211-699501013259,0001,o
70,0211-699501013259,y,o
70,0211-699501013259,descenso,o
70,0211-699501013259,de,o
70,0211-699501013259,la,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,240,o
70,0211-699501013259,IC,o
70,0211-699501013259,213,o
70,0211-699501013259,264,o
70,0211-699501013259,vs,o
70,0211-699501013259,199,o
70,0211-699501013259,IC,o
70,0211-699501013259,175,o
70,0211-699501013259,224,o
70,0211-699501013259,p,o
70,0211-699501013259,005,o
70,0211-699501013259,Han,o
70,0211-699501013259,recibido,o
70,0211-699501013259,suplementacion,i
70,0211-699501013259,durante,o
70,0211-699501013259,12,o
70,0211-699501013259,meses,o
70,0211-699501013259,33,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,pero,o
70,0211-699501013259,a,o
70,0211-699501013259,pesar,o
70,0211-699501013259,de,o
70,0211-699501013259,un,o
70,0211-699501013259,continuo,o
70,0211-699501013259,aumento,o
70,0211-699501013259,del,o
70,0211-699501013259,folato,i
70,0211-699501013259,10078,o
70,0211-699501013259,IC,o
70,0211-699501013259,7481,o
70,0211-699501013259,12674,o
70,0211-699501013259,p,o
70,0211-699501013259,0001,o
70,0211-699501013259,solo,o
70,0211-699501013259,3,o
70,0211-699501013259,pacientes,o
70,0211-699501013259,presentan,o
70,0211-699501013259,niveles,o
70,0211-699501013259,normales,o
70,0211-699501013259,de,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,correlacionandose,o
70,0211-699501013259,directamente,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,con,o
70,0211-699501013259,la,o
70,0211-699501013259,albumina,i
70,0211-699501013259,r,o
70,0211-699501013259,056,o
70,0211-699501013259,p,o
70,0211-699501013259,0001,o
70,0211-699501013259,que,o
70,0211-699501013259,se,o
70,0211-699501013259,elevo,o
70,0211-699501013259,con,o
70,0211-699501013259,respecto,o
70,0211-699501013259,al,o
70,0211-699501013259,inicio,o
70,0211-699501013259,337,o
70,0211-699501013259,IC,o
70,0211-699501013259,327,o
70,0211-699501013259,346,o
70,0211-699501013259,vs,o
70,0211-699501013259,350,o
70,0211-699501013259,IC,o
70,0211-699501013259,337,o
70,0211-699501013259,363,o
70,0211-699501013259,p,o
70,0211-699501013259,005,o
70,0211-699501013259,Conclusion,o
70,0211-699501013259,Tras,o
70,0211-699501013259,suplementacion,i
70,0211-699501013259,con,o
70,0211-699501013259,acido,i
70,0211-699501013259,folico,i
70,0211-699501013259,y,o
70,0211-699501013259,vitamina,i
70,0211-699501013259,B6,i
70,0211-699501013259,aunque,o
70,0211-699501013259,inicialmente,o
70,0211-699501013259,se,o
70,0211-699501013259,reduce,o
70,0211-699501013259,la,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,esta,o
70,0211-699501013259,respuesta,o
70,0211-699501013259,se,o
70,0211-699501013259,hace,o
70,0211-699501013259,refractaria,o
70,0211-699501013259,correlacionandose,o
70,0211-699501013259,directamente,o
70,0211-699501013259,la,o
70,0211-699501013259,tHcy,i
70,0211-699501013259,con,o
70,0211-699501013259,la,o
70,0211-699501013259,albumina,i
70,0211-699501013259,plasmatica,i
70,0211-699501013259,La,o
70,0211-699501013259,interpretacion,o
70,0211-699501013259,de,o
70,0211-699501013259,los,o
70,0211-699501013259,niveles,i
70,0211-699501013259,de,i
70,0211-699501013259,tHcy,i
70,0211-699501013259,debe,o
70,0211-699501013259,tener,o
70,0211-699501013259,en,o
70,0211-699501013259,cuenta,o
70,0211-699501013259,la,o
70,0211-699501013259,concentracion,i
70,0211-699501013259,de,i
70,0211-699501013259,albumina,i
71,0211-699501013259,Efecto,o
71,0211-699501013259,de,o
71,0211-699501013259,la,o
71,0211-699501013259,suplementacion,i
71,0211-699501013259,con,o
71,0211-699501013259,acido,i
71,0211-699501013259,folico,i
71,0211-699501013259,sobre,o
71,0211-699501013259,los,o
71,0211-699501013259,niveles,i
71,0211-699501013259,de,i
71,0211-699501013259,homocisteina,i
71,0211-699501013259,total,o
71,0211-699501013259,en,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,en,o
71,0211-699501013259,hemodialisis,i
71,0211-699501013259,La,o
71,0211-699501013259,hiperhomocisteinemia,i
71,0211-699501013259,es,o
71,0211-699501013259,un,o
71,0211-699501013259,marcador,o
71,0211-699501013259,de,o
71,0211-699501013259,riesgo,o
71,0211-699501013259,independiente,o
71,0211-699501013259,de,o
71,0211-699501013259,morbimortalidad,o
71,0211-699501013259,cardiovascular,i
71,0211-699501013259,Hemos,o
71,0211-699501013259,intentado,o
71,0211-699501013259,prospectivamente,o
71,0211-699501013259,reducir,o
71,0211-699501013259,los,o
71,0211-699501013259,niveles,i
71,0211-699501013259,de,i
71,0211-699501013259,homocisteina,i
71,0211-699501013259,total,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,mediante,o
71,0211-699501013259,suplemento,o
71,0211-699501013259,con,o
71,0211-699501013259,acido,i
71,0211-699501013259,folico,i
71,0211-699501013259,y,o
71,0211-699501013259,vitamina,i
71,0211-699501013259,B6,i
71,0211-699501013259,pp,i
71,0211-699501013259,valorando,o
71,0211-699501013259,su,o
71,0211-699501013259,posible,o
71,0211-699501013259,correlacion,o
71,0211-699501013259,con,o
71,0211-699501013259,dosis,o
71,0211-699501013259,de,o
71,0211-699501013259,dialisis,i
71,0211-699501013259,funcion,i
71,0211-699501013259,residual,i
71,0211-699501013259,y,o
71,0211-699501013259,parametros,o
71,0211-699501013259,nutricionales,o
71,0211-699501013259,Metodos,o
71,0211-699501013259,Todos,o
71,0211-699501013259,los,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,en,o
71,0211-699501013259,hemodialisis,i
71,0211-699501013259,al,o
71,0211-699501013259,comienzo,o
71,0211-699501013259,del,o
71,0211-699501013259,estudio,o
71,0211-699501013259,que,o
71,0211-699501013259,no,o
71,0211-699501013259,recibian,o
71,0211-699501013259,acido,i
71,0211-699501013259,folico,i
71,0211-699501013259,ni,o
71,0211-699501013259,vitamina,i
71,0211-699501013259,B6,i
71,0211-699501013259,asi,o
71,0211-699501013259,como,o
71,0211-699501013259,los,o
71,0211-699501013259,incorporados,o
71,0211-699501013259,posteriormente,o
71,0211-699501013259,a,o
71,0211-699501013259,partir,o
71,0211-699501013259,de,o
71,0211-699501013259,su,o
71,0211-699501013259,tercer,o
71,0211-699501013259,mes,o
71,0211-699501013259,en,o
71,0211-699501013259,hemodialisis,i
71,0211-699501013259,recibieron,o
71,0211-699501013259,5,o
71,0211-699501013259,mg,o
71,0211-699501013259,orales,o
71,0211-699501013259,de,o
71,0211-699501013259,acido,i
71,0211-699501013259,folico,i
71,0211-699501013259,cada,o
71,0211-699501013259,48,o
71,0211-699501013259,horas,o
71,0211-699501013259,y,o
71,0211-699501013259,40,o
71,0211-699501013259,mg,o
71,0211-699501013259,orales,o
71,0211-699501013259,de,o
71,0211-699501013259,vitamina,i
71,0211-699501013259,B6,i
71,0211-699501013259,cada,o
71,0211-699501013259,semana,o
71,0211-699501013259,Se,o
71,0211-699501013259,determinaron,o
71,0211-699501013259,al,o
71,0211-699501013259,comienzo,o
71,0211-699501013259,del,o
71,0211-699501013259,estudio,o
71,0211-699501013259,y,o
71,0211-699501013259,cada,o
71,0211-699501013259,2,o
71,0211-699501013259,meses,o
71,0211-699501013259,niveles,i
71,0211-699501013259,de,i
71,0211-699501013259,folato,i
71,0211-699501013259,vitamina,i
71,0211-699501013259,B12,i
71,0211-699501013259,inmunoensayo,i
71,0211-699501013259,albumina,i
71,0211-699501013259,y,o
71,0211-699501013259,cinetica,o
71,0211-699501013259,de,o
71,0211-699501013259,la,o
71,0211-699501013259,urea,i
71,0211-699501013259,KTV,o
71,0211-699501013259,KRU,o
71,0211-699501013259,PCRn,o
71,0211-699501013259,y,o
71,0211-699501013259,cada,o
71,0211-699501013259,6,o
71,0211-699501013259,meses,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,HPLC,i
71,0211-699501013259,y,o
71,0211-699501013259,pp,i
71,0211-699501013259,RIA,i
71,0211-699501013259,Resultados,o
71,0211-699501013259,80,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,fueron,o
71,0211-699501013259,incluidos,o
71,0211-699501013259,en,o
71,0211-699501013259,el,o
71,0211-699501013259,estudio,o
71,0211-699501013259,basal,o
71,0211-699501013259,con,o
71,0211-699501013259,una,o
71,0211-699501013259,prevalencia,o
71,0211-699501013259,de,o
71,0211-699501013259,hiperhomocisteinemia,i
71,0211-699501013259,del,o
71,0211-699501013259,844,o
71,0211-699501013259,deficit,i
71,0211-699501013259,de,i
71,0211-699501013259,pp,i
71,0211-699501013259,en,o
71,0211-699501013259,el,o
71,0211-699501013259,32,o
71,0211-699501013259,y,o
71,0211-699501013259,folato,i
71,0211-699501013259,en,o
71,0211-699501013259,el,o
71,0211-699501013259,rango,o
71,0211-699501013259,normal,o
71,0211-699501013259,bajo,o
71,0211-699501013259,los,o
71,0211-699501013259,niveles,i
71,0211-699501013259,de,i
71,0211-699501013259,tHcy,i
71,0211-699501013259,se,o
71,0211-699501013259,correlacionaban,o
71,0211-699501013259,inversamente,o
71,0211-699501013259,con,o
71,0211-699501013259,los,o
71,0211-699501013259,del,o
71,0211-699501013259,folato,i
71,0211-699501013259,r,o
71,0211-699501013259,0336,o
71,0211-699501013259,p,o
71,0211-699501013259,001,o
71,0211-699501013259,pero,o
71,0211-699501013259,no,o
71,0211-699501013259,con,o
71,0211-699501013259,pp,i
71,0211-699501013259,B12,i
71,0211-699501013259,edad,o
71,0211-699501013259,albumina,i
71,0211-699501013259,KTV,o
71,0211-699501013259,KRU,o
71,0211-699501013259,PCRn,o
71,0211-699501013259,Cincuenta,o
71,0211-699501013259,y,o
71,0211-699501013259,ocho,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,recibieron,o
71,0211-699501013259,seis,o
71,0211-699501013259,meses,o
71,0211-699501013259,de,o
71,0211-699501013259,suplementacion,i
71,0211-699501013259,con,o
71,0211-699501013259,normalizacion,o
71,0211-699501013259,del,o
71,0211-699501013259,pp,i
71,0211-699501013259,aumento,o
71,0211-699501013259,del,o
71,0211-699501013259,folato,i
71,0211-699501013259,703,o
71,0211-699501013259,IC,o
71,0211-699501013259,638,o
71,0211-699501013259,795,o
71,0211-699501013259,vs,o
71,0211-699501013259,6181,o
71,0211-699501013259,IC,o
71,0211-699501013259,4447,o
71,0211-699501013259,7811,o
71,0211-699501013259,p,o
71,0211-699501013259,0001,o
71,0211-699501013259,y,o
71,0211-699501013259,descenso,o
71,0211-699501013259,de,o
71,0211-699501013259,la,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,240,o
71,0211-699501013259,IC,o
71,0211-699501013259,213,o
71,0211-699501013259,264,o
71,0211-699501013259,vs,o
71,0211-699501013259,199,o
71,0211-699501013259,IC,o
71,0211-699501013259,175,o
71,0211-699501013259,224,o
71,0211-699501013259,p,o
71,0211-699501013259,005,o
71,0211-699501013259,Han,o
71,0211-699501013259,recibido,o
71,0211-699501013259,suplementacion,i
71,0211-699501013259,durante,o
71,0211-699501013259,12,o
71,0211-699501013259,meses,o
71,0211-699501013259,33,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,pero,o
71,0211-699501013259,a,o
71,0211-699501013259,pesar,o
71,0211-699501013259,de,o
71,0211-699501013259,un,o
71,0211-699501013259,continuo,o
71,0211-699501013259,aumento,o
71,0211-699501013259,del,o
71,0211-699501013259,folato,i
71,0211-699501013259,10078,o
71,0211-699501013259,IC,o
71,0211-699501013259,7481,o
71,0211-699501013259,12674,o
71,0211-699501013259,p,o
71,0211-699501013259,0001,o
71,0211-699501013259,solo,o
71,0211-699501013259,3,o
71,0211-699501013259,pacientes,o
71,0211-699501013259,presentan,o
71,0211-699501013259,niveles,o
71,0211-699501013259,normales,o
71,0211-699501013259,de,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,correlacionandose,o
71,0211-699501013259,directamente,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,con,o
71,0211-699501013259,la,o
71,0211-699501013259,albumina,i
71,0211-699501013259,r,o
71,0211-699501013259,056,o
71,0211-699501013259,p,o
71,0211-699501013259,0001,o
71,0211-699501013259,que,o
71,0211-699501013259,se,o
71,0211-699501013259,elevo,o
71,0211-699501013259,con,o
71,0211-699501013259,respecto,o
71,0211-699501013259,al,o
71,0211-699501013259,inicio,o
71,0211-699501013259,337,o
71,0211-699501013259,IC,o
71,0211-699501013259,327,o
71,0211-699501013259,346,o
71,0211-699501013259,vs,o
71,0211-699501013259,350,o
71,0211-699501013259,IC,o
71,0211-699501013259,337,o
71,0211-699501013259,363,o
71,0211-699501013259,p,o
71,0211-699501013259,005,o
71,0211-699501013259,Conclusion,o
71,0211-699501013259,Tras,o
71,0211-699501013259,suplementacion,i
71,0211-699501013259,con,o
71,0211-699501013259,acido,i
71,0211-699501013259,folico,i
71,0211-699501013259,y,o
71,0211-699501013259,vitamina,i
71,0211-699501013259,B6,i
71,0211-699501013259,aunque,o
71,0211-699501013259,inicialmente,o
71,0211-699501013259,se,o
71,0211-699501013259,reduce,o
71,0211-699501013259,la,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,esta,o
71,0211-699501013259,respuesta,o
71,0211-699501013259,se,o
71,0211-699501013259,hace,o
71,0211-699501013259,refractaria,o
71,0211-699501013259,correlacionandose,o
71,0211-699501013259,directamente,o
71,0211-699501013259,la,o
71,0211-699501013259,tHcy,i
71,0211-699501013259,con,o
71,0211-699501013259,la,o
71,0211-699501013259,albumina,i
71,0211-699501013259,plasmatica,i
71,0211-699501013259,La,o
71,0211-699501013259,interpretacion,o
71,0211-699501013259,de,o
71,0211-699501013259,los,o
71,0211-699501013259,niveles,i
71,0211-699501013259,de,i
71,0211-699501013259,tHcy,i
71,0211-699501013259,debe,o
71,0211-699501013259,tener,o
71,0211-699501013259,en,o
71,0211-699501013259,cuenta,o
71,0211-699501013259,la,o
71,0211-699501013259,concentracion,i
71,0211-699501013259,de,i
71,0211-699501013259,albumina,i
72,0211-699501013259,Efecto,o
72,0211-699501013259,de,o
72,0211-699501013259,la,o
72,0211-699501013259,suplementacion,i
72,0211-699501013259,con,o
72,0211-699501013259,acido,i
72,0211-699501013259,folico,i
72,0211-699501013259,sobre,o
72,0211-699501013259,los,o
72,0211-699501013259,niveles,i
72,0211-699501013259,de,i
72,0211-699501013259,homocisteina,i
72,0211-699501013259,total,o
72,0211-699501013259,en,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,en,o
72,0211-699501013259,hemodialisis,i
72,0211-699501013259,La,o
72,0211-699501013259,hiperhomocisteinemia,i
72,0211-699501013259,es,o
72,0211-699501013259,un,o
72,0211-699501013259,marcador,o
72,0211-699501013259,de,o
72,0211-699501013259,riesgo,o
72,0211-699501013259,independiente,o
72,0211-699501013259,de,o
72,0211-699501013259,morbimortalidad,o
72,0211-699501013259,cardiovascular,i
72,0211-699501013259,Hemos,o
72,0211-699501013259,intentado,o
72,0211-699501013259,prospectivamente,o
72,0211-699501013259,reducir,o
72,0211-699501013259,los,o
72,0211-699501013259,niveles,i
72,0211-699501013259,de,i
72,0211-699501013259,homocisteina,i
72,0211-699501013259,total,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,mediante,o
72,0211-699501013259,suplemento,o
72,0211-699501013259,con,o
72,0211-699501013259,acido,i
72,0211-699501013259,folico,i
72,0211-699501013259,y,o
72,0211-699501013259,vitamina,i
72,0211-699501013259,B6,i
72,0211-699501013259,pp,i
72,0211-699501013259,valorando,o
72,0211-699501013259,su,o
72,0211-699501013259,posible,o
72,0211-699501013259,correlacion,o
72,0211-699501013259,con,o
72,0211-699501013259,dosis,o
72,0211-699501013259,de,o
72,0211-699501013259,dialisis,i
72,0211-699501013259,funcion,i
72,0211-699501013259,residual,i
72,0211-699501013259,y,o
72,0211-699501013259,parametros,o
72,0211-699501013259,nutricionales,o
72,0211-699501013259,Metodos,o
72,0211-699501013259,Todos,o
72,0211-699501013259,los,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,en,o
72,0211-699501013259,hemodialisis,i
72,0211-699501013259,al,o
72,0211-699501013259,comienzo,o
72,0211-699501013259,del,o
72,0211-699501013259,estudio,o
72,0211-699501013259,que,o
72,0211-699501013259,no,o
72,0211-699501013259,recibian,o
72,0211-699501013259,acido,i
72,0211-699501013259,folico,i
72,0211-699501013259,ni,o
72,0211-699501013259,vitamina,i
72,0211-699501013259,B6,i
72,0211-699501013259,asi,o
72,0211-699501013259,como,o
72,0211-699501013259,los,o
72,0211-699501013259,incorporados,o
72,0211-699501013259,posteriormente,o
72,0211-699501013259,a,o
72,0211-699501013259,partir,o
72,0211-699501013259,de,o
72,0211-699501013259,su,o
72,0211-699501013259,tercer,o
72,0211-699501013259,mes,o
72,0211-699501013259,en,o
72,0211-699501013259,hemodialisis,i
72,0211-699501013259,recibieron,o
72,0211-699501013259,5,o
72,0211-699501013259,mg,o
72,0211-699501013259,orales,o
72,0211-699501013259,de,o
72,0211-699501013259,acido,i
72,0211-699501013259,folico,i
72,0211-699501013259,cada,o
72,0211-699501013259,48,o
72,0211-699501013259,horas,o
72,0211-699501013259,y,o
72,0211-699501013259,40,o
72,0211-699501013259,mg,o
72,0211-699501013259,orales,o
72,0211-699501013259,de,o
72,0211-699501013259,vitamina,i
72,0211-699501013259,B6,i
72,0211-699501013259,cada,o
72,0211-699501013259,semana,o
72,0211-699501013259,Se,o
72,0211-699501013259,determinaron,o
72,0211-699501013259,al,o
72,0211-699501013259,comienzo,o
72,0211-699501013259,del,o
72,0211-699501013259,estudio,o
72,0211-699501013259,y,o
72,0211-699501013259,cada,o
72,0211-699501013259,2,o
72,0211-699501013259,meses,o
72,0211-699501013259,niveles,i
72,0211-699501013259,de,i
72,0211-699501013259,folato,i
72,0211-699501013259,vitamina,i
72,0211-699501013259,B12,i
72,0211-699501013259,inmunoensayo,i
72,0211-699501013259,albumina,i
72,0211-699501013259,y,o
72,0211-699501013259,cinetica,o
72,0211-699501013259,de,o
72,0211-699501013259,la,o
72,0211-699501013259,urea,i
72,0211-699501013259,KTV,o
72,0211-699501013259,KRU,o
72,0211-699501013259,PCRn,o
72,0211-699501013259,y,o
72,0211-699501013259,cada,o
72,0211-699501013259,6,o
72,0211-699501013259,meses,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,HPLC,i
72,0211-699501013259,y,o
72,0211-699501013259,pp,i
72,0211-699501013259,RIA,i
72,0211-699501013259,Resultados,o
72,0211-699501013259,80,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,fueron,o
72,0211-699501013259,incluidos,o
72,0211-699501013259,en,o
72,0211-699501013259,el,o
72,0211-699501013259,estudio,o
72,0211-699501013259,basal,o
72,0211-699501013259,con,o
72,0211-699501013259,una,o
72,0211-699501013259,prevalencia,o
72,0211-699501013259,de,o
72,0211-699501013259,hiperhomocisteinemia,i
72,0211-699501013259,del,o
72,0211-699501013259,844,o
72,0211-699501013259,deficit,i
72,0211-699501013259,de,i
72,0211-699501013259,pp,i
72,0211-699501013259,en,o
72,0211-699501013259,el,o
72,0211-699501013259,32,o
72,0211-699501013259,y,o
72,0211-699501013259,folato,i
72,0211-699501013259,en,o
72,0211-699501013259,el,o
72,0211-699501013259,rango,o
72,0211-699501013259,normal,o
72,0211-699501013259,bajo,o
72,0211-699501013259,los,o
72,0211-699501013259,niveles,i
72,0211-699501013259,de,i
72,0211-699501013259,tHcy,i
72,0211-699501013259,se,o
72,0211-699501013259,correlacionaban,o
72,0211-699501013259,inversamente,o
72,0211-699501013259,con,o
72,0211-699501013259,los,o
72,0211-699501013259,del,o
72,0211-699501013259,folato,i
72,0211-699501013259,r,o
72,0211-699501013259,0336,o
72,0211-699501013259,p,o
72,0211-699501013259,001,o
72,0211-699501013259,pero,o
72,0211-699501013259,no,o
72,0211-699501013259,con,o
72,0211-699501013259,pp,i
72,0211-699501013259,B12,i
72,0211-699501013259,edad,o
72,0211-699501013259,albumina,i
72,0211-699501013259,KTV,o
72,0211-699501013259,KRU,o
72,0211-699501013259,PCRn,o
72,0211-699501013259,Cincuenta,o
72,0211-699501013259,y,o
72,0211-699501013259,ocho,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,recibieron,o
72,0211-699501013259,seis,o
72,0211-699501013259,meses,o
72,0211-699501013259,de,o
72,0211-699501013259,suplementacion,i
72,0211-699501013259,con,o
72,0211-699501013259,normalizacion,o
72,0211-699501013259,del,o
72,0211-699501013259,pp,i
72,0211-699501013259,aumento,o
72,0211-699501013259,del,o
72,0211-699501013259,folato,i
72,0211-699501013259,703,o
72,0211-699501013259,IC,o
72,0211-699501013259,638,o
72,0211-699501013259,795,o
72,0211-699501013259,vs,o
72,0211-699501013259,6181,o
72,0211-699501013259,IC,o
72,0211-699501013259,4447,o
72,0211-699501013259,7811,o
72,0211-699501013259,p,o
72,0211-699501013259,0001,o
72,0211-699501013259,y,o
72,0211-699501013259,descenso,o
72,0211-699501013259,de,o
72,0211-699501013259,la,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,240,o
72,0211-699501013259,IC,o
72,0211-699501013259,213,o
72,0211-699501013259,264,o
72,0211-699501013259,vs,o
72,0211-699501013259,199,o
72,0211-699501013259,IC,o
72,0211-699501013259,175,o
72,0211-699501013259,224,o
72,0211-699501013259,p,o
72,0211-699501013259,005,o
72,0211-699501013259,Han,o
72,0211-699501013259,recibido,o
72,0211-699501013259,suplementacion,i
72,0211-699501013259,durante,o
72,0211-699501013259,12,o
72,0211-699501013259,meses,o
72,0211-699501013259,33,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,pero,o
72,0211-699501013259,a,o
72,0211-699501013259,pesar,o
72,0211-699501013259,de,o
72,0211-699501013259,un,o
72,0211-699501013259,continuo,o
72,0211-699501013259,aumento,o
72,0211-699501013259,del,o
72,0211-699501013259,folato,i
72,0211-699501013259,10078,o
72,0211-699501013259,IC,o
72,0211-699501013259,7481,o
72,0211-699501013259,12674,o
72,0211-699501013259,p,o
72,0211-699501013259,0001,o
72,0211-699501013259,solo,o
72,0211-699501013259,3,o
72,0211-699501013259,pacientes,o
72,0211-699501013259,presentan,o
72,0211-699501013259,niveles,o
72,0211-699501013259,normales,o
72,0211-699501013259,de,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,correlacionandose,o
72,0211-699501013259,directamente,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,con,o
72,0211-699501013259,la,o
72,0211-699501013259,albumina,i
72,0211-699501013259,r,o
72,0211-699501013259,056,o
72,0211-699501013259,p,o
72,0211-699501013259,0001,o
72,0211-699501013259,que,o
72,0211-699501013259,se,o
72,0211-699501013259,elevo,o
72,0211-699501013259,con,o
72,0211-699501013259,respecto,o
72,0211-699501013259,al,o
72,0211-699501013259,inicio,o
72,0211-699501013259,337,o
72,0211-699501013259,IC,o
72,0211-699501013259,327,o
72,0211-699501013259,346,o
72,0211-699501013259,vs,o
72,0211-699501013259,350,o
72,0211-699501013259,IC,o
72,0211-699501013259,337,o
72,0211-699501013259,363,o
72,0211-699501013259,p,o
72,0211-699501013259,005,o
72,0211-699501013259,Conclusion,o
72,0211-699501013259,Tras,o
72,0211-699501013259,suplementacion,i
72,0211-699501013259,con,o
72,0211-699501013259,acido,i
72,0211-699501013259,folico,i
72,0211-699501013259,y,o
72,0211-699501013259,vitamina,i
72,0211-699501013259,B6,i
72,0211-699501013259,aunque,o
72,0211-699501013259,inicialmente,o
72,0211-699501013259,se,o
72,0211-699501013259,reduce,o
72,0211-699501013259,la,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,esta,o
72,0211-699501013259,respuesta,o
72,0211-699501013259,se,o
72,0211-699501013259,hace,o
72,0211-699501013259,refractaria,o
72,0211-699501013259,correlacionandose,o
72,0211-699501013259,directamente,o
72,0211-699501013259,la,o
72,0211-699501013259,tHcy,i
72,0211-699501013259,con,o
72,0211-699501013259,la,o
72,0211-699501013259,albumina,i
72,0211-699501013259,plasmatica,i
72,0211-699501013259,La,o
72,0211-699501013259,interpretacion,o
72,0211-699501013259,de,o
72,0211-699501013259,los,o
72,0211-699501013259,niveles,i
72,0211-699501013259,de,i
72,0211-699501013259,tHcy,i
72,0211-699501013259,debe,o
72,0211-699501013259,tener,o
72,0211-699501013259,en,o
72,0211-699501013259,cuenta,o
72,0211-699501013259,la,o
72,0211-699501013259,concentracion,i
72,0211-699501013259,de,i
72,0211-699501013259,albumina,i
73,0211-699501013259,Efecto,o
73,0211-699501013259,de,o
73,0211-699501013259,la,o
73,0211-699501013259,suplementacion,i
73,0211-699501013259,con,o
73,0211-699501013259,acido,i
73,0211-699501013259,folico,i
73,0211-699501013259,sobre,o
73,0211-699501013259,los,o
73,0211-699501013259,niveles,i
73,0211-699501013259,de,i
73,0211-699501013259,homocisteina,i
73,0211-699501013259,total,o
73,0211-699501013259,en,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,en,o
73,0211-699501013259,hemodialisis,i
73,0211-699501013259,La,o
73,0211-699501013259,hiperhomocisteinemia,i
73,0211-699501013259,es,o
73,0211-699501013259,un,o
73,0211-699501013259,marcador,o
73,0211-699501013259,de,o
73,0211-699501013259,riesgo,o
73,0211-699501013259,independiente,o
73,0211-699501013259,de,o
73,0211-699501013259,morbimortalidad,o
73,0211-699501013259,cardiovascular,i
73,0211-699501013259,Hemos,o
73,0211-699501013259,intentado,o
73,0211-699501013259,prospectivamente,o
73,0211-699501013259,reducir,o
73,0211-699501013259,los,o
73,0211-699501013259,niveles,i
73,0211-699501013259,de,i
73,0211-699501013259,homocisteina,i
73,0211-699501013259,total,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,mediante,o
73,0211-699501013259,suplemento,o
73,0211-699501013259,con,o
73,0211-699501013259,acido,i
73,0211-699501013259,folico,i
73,0211-699501013259,y,o
73,0211-699501013259,vitamina,i
73,0211-699501013259,B6,i
73,0211-699501013259,pp,i
73,0211-699501013259,valorando,o
73,0211-699501013259,su,o
73,0211-699501013259,posible,o
73,0211-699501013259,correlacion,o
73,0211-699501013259,con,o
73,0211-699501013259,dosis,o
73,0211-699501013259,de,o
73,0211-699501013259,dialisis,i
73,0211-699501013259,funcion,i
73,0211-699501013259,residual,i
73,0211-699501013259,y,o
73,0211-699501013259,parametros,o
73,0211-699501013259,nutricionales,o
73,0211-699501013259,Metodos,o
73,0211-699501013259,Todos,o
73,0211-699501013259,los,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,en,o
73,0211-699501013259,hemodialisis,i
73,0211-699501013259,al,o
73,0211-699501013259,comienzo,o
73,0211-699501013259,del,o
73,0211-699501013259,estudio,o
73,0211-699501013259,que,o
73,0211-699501013259,no,o
73,0211-699501013259,recibian,o
73,0211-699501013259,acido,i
73,0211-699501013259,folico,i
73,0211-699501013259,ni,o
73,0211-699501013259,vitamina,i
73,0211-699501013259,B6,i
73,0211-699501013259,asi,o
73,0211-699501013259,como,o
73,0211-699501013259,los,o
73,0211-699501013259,incorporados,o
73,0211-699501013259,posteriormente,o
73,0211-699501013259,a,o
73,0211-699501013259,partir,o
73,0211-699501013259,de,o
73,0211-699501013259,su,o
73,0211-699501013259,tercer,o
73,0211-699501013259,mes,o
73,0211-699501013259,en,o
73,0211-699501013259,hemodialisis,i
73,0211-699501013259,recibieron,o
73,0211-699501013259,5,o
73,0211-699501013259,mg,o
73,0211-699501013259,orales,o
73,0211-699501013259,de,o
73,0211-699501013259,acido,i
73,0211-699501013259,folico,i
73,0211-699501013259,cada,o
73,0211-699501013259,48,o
73,0211-699501013259,horas,o
73,0211-699501013259,y,o
73,0211-699501013259,40,o
73,0211-699501013259,mg,o
73,0211-699501013259,orales,o
73,0211-699501013259,de,o
73,0211-699501013259,vitamina,i
73,0211-699501013259,B6,i
73,0211-699501013259,cada,o
73,0211-699501013259,semana,o
73,0211-699501013259,Se,o
73,0211-699501013259,determinaron,o
73,0211-699501013259,al,o
73,0211-699501013259,comienzo,o
73,0211-699501013259,del,o
73,0211-699501013259,estudio,o
73,0211-699501013259,y,o
73,0211-699501013259,cada,o
73,0211-699501013259,2,o
73,0211-699501013259,meses,o
73,0211-699501013259,niveles,i
73,0211-699501013259,de,i
73,0211-699501013259,folato,i
73,0211-699501013259,vitamina,i
73,0211-699501013259,B12,i
73,0211-699501013259,inmunoensayo,i
73,0211-699501013259,albumina,i
73,0211-699501013259,y,o
73,0211-699501013259,cinetica,o
73,0211-699501013259,de,o
73,0211-699501013259,la,o
73,0211-699501013259,urea,i
73,0211-699501013259,KTV,o
73,0211-699501013259,KRU,o
73,0211-699501013259,PCRn,o
73,0211-699501013259,y,o
73,0211-699501013259,cada,o
73,0211-699501013259,6,o
73,0211-699501013259,meses,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,HPLC,i
73,0211-699501013259,y,o
73,0211-699501013259,pp,i
73,0211-699501013259,RIA,i
73,0211-699501013259,Resultados,o
73,0211-699501013259,80,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,fueron,o
73,0211-699501013259,incluidos,o
73,0211-699501013259,en,o
73,0211-699501013259,el,o
73,0211-699501013259,estudio,o
73,0211-699501013259,basal,o
73,0211-699501013259,con,o
73,0211-699501013259,una,o
73,0211-699501013259,prevalencia,o
73,0211-699501013259,de,o
73,0211-699501013259,hiperhomocisteinemia,i
73,0211-699501013259,del,o
73,0211-699501013259,844,o
73,0211-699501013259,deficit,i
73,0211-699501013259,de,i
73,0211-699501013259,pp,i
73,0211-699501013259,en,o
73,0211-699501013259,el,o
73,0211-699501013259,32,o
73,0211-699501013259,y,o
73,0211-699501013259,folato,i
73,0211-699501013259,en,o
73,0211-699501013259,el,o
73,0211-699501013259,rango,o
73,0211-699501013259,normal,o
73,0211-699501013259,bajo,o
73,0211-699501013259,los,o
73,0211-699501013259,niveles,i
73,0211-699501013259,de,i
73,0211-699501013259,tHcy,i
73,0211-699501013259,se,o
73,0211-699501013259,correlacionaban,o
73,0211-699501013259,inversamente,o
73,0211-699501013259,con,o
73,0211-699501013259,los,o
73,0211-699501013259,del,o
73,0211-699501013259,folato,i
73,0211-699501013259,r,o
73,0211-699501013259,0336,o
73,0211-699501013259,p,o
73,0211-699501013259,001,o
73,0211-699501013259,pero,o
73,0211-699501013259,no,o
73,0211-699501013259,con,o
73,0211-699501013259,pp,i
73,0211-699501013259,B12,i
73,0211-699501013259,edad,o
73,0211-699501013259,albumina,i
73,0211-699501013259,KTV,o
73,0211-699501013259,KRU,o
73,0211-699501013259,PCRn,o
73,0211-699501013259,Cincuenta,o
73,0211-699501013259,y,o
73,0211-699501013259,ocho,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,recibieron,o
73,0211-699501013259,seis,o
73,0211-699501013259,meses,o
73,0211-699501013259,de,o
73,0211-699501013259,suplementacion,i
73,0211-699501013259,con,o
73,0211-699501013259,normalizacion,o
73,0211-699501013259,del,o
73,0211-699501013259,pp,i
73,0211-699501013259,aumento,o
73,0211-699501013259,del,o
73,0211-699501013259,folato,i
73,0211-699501013259,703,o
73,0211-699501013259,IC,o
73,0211-699501013259,638,o
73,0211-699501013259,795,o
73,0211-699501013259,vs,o
73,0211-699501013259,6181,o
73,0211-699501013259,IC,o
73,0211-699501013259,4447,o
73,0211-699501013259,7811,o
73,0211-699501013259,p,o
73,0211-699501013259,0001,o
73,0211-699501013259,y,o
73,0211-699501013259,descenso,o
73,0211-699501013259,de,o
73,0211-699501013259,la,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,240,o
73,0211-699501013259,IC,o
73,0211-699501013259,213,o
73,0211-699501013259,264,o
73,0211-699501013259,vs,o
73,0211-699501013259,199,o
73,0211-699501013259,IC,o
73,0211-699501013259,175,o
73,0211-699501013259,224,o
73,0211-699501013259,p,o
73,0211-699501013259,005,o
73,0211-699501013259,Han,o
73,0211-699501013259,recibido,o
73,0211-699501013259,suplementacion,i
73,0211-699501013259,durante,o
73,0211-699501013259,12,o
73,0211-699501013259,meses,o
73,0211-699501013259,33,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,pero,o
73,0211-699501013259,a,o
73,0211-699501013259,pesar,o
73,0211-699501013259,de,o
73,0211-699501013259,un,o
73,0211-699501013259,continuo,o
73,0211-699501013259,aumento,o
73,0211-699501013259,del,o
73,0211-699501013259,folato,i
73,0211-699501013259,10078,o
73,0211-699501013259,IC,o
73,0211-699501013259,7481,o
73,0211-699501013259,12674,o
73,0211-699501013259,p,o
73,0211-699501013259,0001,o
73,0211-699501013259,solo,o
73,0211-699501013259,3,o
73,0211-699501013259,pacientes,o
73,0211-699501013259,presentan,o
73,0211-699501013259,niveles,o
73,0211-699501013259,normales,o
73,0211-699501013259,de,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,correlacionandose,o
73,0211-699501013259,directamente,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,con,o
73,0211-699501013259,la,o
73,0211-699501013259,albumina,i
73,0211-699501013259,r,o
73,0211-699501013259,056,o
73,0211-699501013259,p,o
73,0211-699501013259,0001,o
73,0211-699501013259,que,o
73,0211-699501013259,se,o
73,0211-699501013259,elevo,o
73,0211-699501013259,con,o
73,0211-699501013259,respecto,o
73,0211-699501013259,al,o
73,0211-699501013259,inicio,o
73,0211-699501013259,337,o
73,0211-699501013259,IC,o
73,0211-699501013259,327,o
73,0211-699501013259,346,o
73,0211-699501013259,vs,o
73,0211-699501013259,350,o
73,0211-699501013259,IC,o
73,0211-699501013259,337,o
73,0211-699501013259,363,o
73,0211-699501013259,p,o
73,0211-699501013259,005,o
73,0211-699501013259,Conclusion,o
73,0211-699501013259,Tras,o
73,0211-699501013259,suplementacion,i
73,0211-699501013259,con,o
73,0211-699501013259,acido,i
73,0211-699501013259,folico,i
73,0211-699501013259,y,o
73,0211-699501013259,vitamina,i
73,0211-699501013259,B6,i
73,0211-699501013259,aunque,o
73,0211-699501013259,inicialmente,o
73,0211-699501013259,se,o
73,0211-699501013259,reduce,o
73,0211-699501013259,la,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,esta,o
73,0211-699501013259,respuesta,o
73,0211-699501013259,se,o
73,0211-699501013259,hace,o
73,0211-699501013259,refractaria,o
73,0211-699501013259,correlacionandose,o
73,0211-699501013259,directamente,o
73,0211-699501013259,la,o
73,0211-699501013259,tHcy,i
73,0211-699501013259,con,o
73,0211-699501013259,la,o
73,0211-699501013259,albumina,i
73,0211-699501013259,plasmatica,i
73,0211-699501013259,La,o
73,0211-699501013259,interpretacion,o
73,0211-699501013259,de,o
73,0211-699501013259,los,o
73,0211-699501013259,niveles,i
73,0211-699501013259,de,i
73,0211-699501013259,tHcy,i
73,0211-699501013259,debe,o
73,0211-699501013259,tener,o
73,0211-699501013259,en,o
73,0211-699501013259,cuenta,o
73,0211-699501013259,la,o
73,0211-699501013259,concentracion,i
73,0211-699501013259,de,i
73,0211-699501013259,albumina,i
74,0211-699501013259,Efecto,o
74,0211-699501013259,de,o
74,0211-699501013259,la,o
74,0211-699501013259,suplementacion,i
74,0211-699501013259,con,o
74,0211-699501013259,acido,i
74,0211-699501013259,folico,i
74,0211-699501013259,sobre,o
74,0211-699501013259,los,o
74,0211-699501013259,niveles,i
74,0211-699501013259,de,i
74,0211-699501013259,homocisteina,i
74,0211-699501013259,total,o
74,0211-699501013259,en,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,en,o
74,0211-699501013259,hemodialisis,i
74,0211-699501013259,La,o
74,0211-699501013259,hiperhomocisteinemia,i
74,0211-699501013259,es,o
74,0211-699501013259,un,o
74,0211-699501013259,marcador,o
74,0211-699501013259,de,o
74,0211-699501013259,riesgo,o
74,0211-699501013259,independiente,o
74,0211-699501013259,de,o
74,0211-699501013259,morbimortalidad,o
74,0211-699501013259,cardiovascular,i
74,0211-699501013259,Hemos,o
74,0211-699501013259,intentado,o
74,0211-699501013259,prospectivamente,o
74,0211-699501013259,reducir,o
74,0211-699501013259,los,o
74,0211-699501013259,niveles,i
74,0211-699501013259,de,i
74,0211-699501013259,homocisteina,i
74,0211-699501013259,total,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,mediante,o
74,0211-699501013259,suplemento,o
74,0211-699501013259,con,o
74,0211-699501013259,acido,i
74,0211-699501013259,folico,i
74,0211-699501013259,y,o
74,0211-699501013259,vitamina,i
74,0211-699501013259,B6,i
74,0211-699501013259,pp,i
74,0211-699501013259,valorando,o
74,0211-699501013259,su,o
74,0211-699501013259,posible,o
74,0211-699501013259,correlacion,o
74,0211-699501013259,con,o
74,0211-699501013259,dosis,o
74,0211-699501013259,de,o
74,0211-699501013259,dialisis,i
74,0211-699501013259,funcion,i
74,0211-699501013259,residual,i
74,0211-699501013259,y,o
74,0211-699501013259,parametros,o
74,0211-699501013259,nutricionales,o
74,0211-699501013259,Metodos,o
74,0211-699501013259,Todos,o
74,0211-699501013259,los,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,en,o
74,0211-699501013259,hemodialisis,i
74,0211-699501013259,al,o
74,0211-699501013259,comienzo,o
74,0211-699501013259,del,o
74,0211-699501013259,estudio,o
74,0211-699501013259,que,o
74,0211-699501013259,no,o
74,0211-699501013259,recibian,o
74,0211-699501013259,acido,i
74,0211-699501013259,folico,i
74,0211-699501013259,ni,o
74,0211-699501013259,vitamina,i
74,0211-699501013259,B6,i
74,0211-699501013259,asi,o
74,0211-699501013259,como,o
74,0211-699501013259,los,o
74,0211-699501013259,incorporados,o
74,0211-699501013259,posteriormente,o
74,0211-699501013259,a,o
74,0211-699501013259,partir,o
74,0211-699501013259,de,o
74,0211-699501013259,su,o
74,0211-699501013259,tercer,o
74,0211-699501013259,mes,o
74,0211-699501013259,en,o
74,0211-699501013259,hemodialisis,i
74,0211-699501013259,recibieron,o
74,0211-699501013259,5,o
74,0211-699501013259,mg,o
74,0211-699501013259,orales,o
74,0211-699501013259,de,o
74,0211-699501013259,acido,i
74,0211-699501013259,folico,i
74,0211-699501013259,cada,o
74,0211-699501013259,48,o
74,0211-699501013259,horas,o
74,0211-699501013259,y,o
74,0211-699501013259,40,o
74,0211-699501013259,mg,o
74,0211-699501013259,orales,o
74,0211-699501013259,de,o
74,0211-699501013259,vitamina,i
74,0211-699501013259,B6,i
74,0211-699501013259,cada,o
74,0211-699501013259,semana,o
74,0211-699501013259,Se,o
74,0211-699501013259,determinaron,o
74,0211-699501013259,al,o
74,0211-699501013259,comienzo,o
74,0211-699501013259,del,o
74,0211-699501013259,estudio,o
74,0211-699501013259,y,o
74,0211-699501013259,cada,o
74,0211-699501013259,2,o
74,0211-699501013259,meses,o
74,0211-699501013259,niveles,i
74,0211-699501013259,de,i
74,0211-699501013259,folato,i
74,0211-699501013259,vitamina,i
74,0211-699501013259,B12,i
74,0211-699501013259,inmunoensayo,i
74,0211-699501013259,albumina,i
74,0211-699501013259,y,o
74,0211-699501013259,cinetica,o
74,0211-699501013259,de,o
74,0211-699501013259,la,o
74,0211-699501013259,urea,i
74,0211-699501013259,KTV,o
74,0211-699501013259,KRU,o
74,0211-699501013259,PCRn,o
74,0211-699501013259,y,o
74,0211-699501013259,cada,o
74,0211-699501013259,6,o
74,0211-699501013259,meses,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,HPLC,i
74,0211-699501013259,y,o
74,0211-699501013259,pp,i
74,0211-699501013259,RIA,i
74,0211-699501013259,Resultados,o
74,0211-699501013259,80,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,fueron,o
74,0211-699501013259,incluidos,o
74,0211-699501013259,en,o
74,0211-699501013259,el,o
74,0211-699501013259,estudio,o
74,0211-699501013259,basal,o
74,0211-699501013259,con,o
74,0211-699501013259,una,o
74,0211-699501013259,prevalencia,o
74,0211-699501013259,de,o
74,0211-699501013259,hiperhomocisteinemia,i
74,0211-699501013259,del,o
74,0211-699501013259,844,o
74,0211-699501013259,deficit,i
74,0211-699501013259,de,i
74,0211-699501013259,pp,i
74,0211-699501013259,en,o
74,0211-699501013259,el,o
74,0211-699501013259,32,o
74,0211-699501013259,y,o
74,0211-699501013259,folato,i
74,0211-699501013259,en,o
74,0211-699501013259,el,o
74,0211-699501013259,rango,o
74,0211-699501013259,normal,o
74,0211-699501013259,bajo,o
74,0211-699501013259,los,o
74,0211-699501013259,niveles,i
74,0211-699501013259,de,i
74,0211-699501013259,tHcy,i
74,0211-699501013259,se,o
74,0211-699501013259,correlacionaban,o
74,0211-699501013259,inversamente,o
74,0211-699501013259,con,o
74,0211-699501013259,los,o
74,0211-699501013259,del,o
74,0211-699501013259,folato,i
74,0211-699501013259,r,o
74,0211-699501013259,0336,o
74,0211-699501013259,p,o
74,0211-699501013259,001,o
74,0211-699501013259,pero,o
74,0211-699501013259,no,o
74,0211-699501013259,con,o
74,0211-699501013259,pp,i
74,0211-699501013259,B12,i
74,0211-699501013259,edad,o
74,0211-699501013259,albumina,i
74,0211-699501013259,KTV,o
74,0211-699501013259,KRU,o
74,0211-699501013259,PCRn,o
74,0211-699501013259,Cincuenta,o
74,0211-699501013259,y,o
74,0211-699501013259,ocho,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,recibieron,o
74,0211-699501013259,seis,o
74,0211-699501013259,meses,o
74,0211-699501013259,de,o
74,0211-699501013259,suplementacion,i
74,0211-699501013259,con,o
74,0211-699501013259,normalizacion,o
74,0211-699501013259,del,o
74,0211-699501013259,pp,i
74,0211-699501013259,aumento,o
74,0211-699501013259,del,o
74,0211-699501013259,folato,i
74,0211-699501013259,703,o
74,0211-699501013259,IC,o
74,0211-699501013259,638,o
74,0211-699501013259,795,o
74,0211-699501013259,vs,o
74,0211-699501013259,6181,o
74,0211-699501013259,IC,o
74,0211-699501013259,4447,o
74,0211-699501013259,7811,o
74,0211-699501013259,p,o
74,0211-699501013259,0001,o
74,0211-699501013259,y,o
74,0211-699501013259,descenso,o
74,0211-699501013259,de,o
74,0211-699501013259,la,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,240,o
74,0211-699501013259,IC,o
74,0211-699501013259,213,o
74,0211-699501013259,264,o
74,0211-699501013259,vs,o
74,0211-699501013259,199,o
74,0211-699501013259,IC,o
74,0211-699501013259,175,o
74,0211-699501013259,224,o
74,0211-699501013259,p,o
74,0211-699501013259,005,o
74,0211-699501013259,Han,o
74,0211-699501013259,recibido,o
74,0211-699501013259,suplementacion,i
74,0211-699501013259,durante,o
74,0211-699501013259,12,o
74,0211-699501013259,meses,o
74,0211-699501013259,33,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,pero,o
74,0211-699501013259,a,o
74,0211-699501013259,pesar,o
74,0211-699501013259,de,o
74,0211-699501013259,un,o
74,0211-699501013259,continuo,o
74,0211-699501013259,aumento,o
74,0211-699501013259,del,o
74,0211-699501013259,folato,i
74,0211-699501013259,10078,o
74,0211-699501013259,IC,o
74,0211-699501013259,7481,o
74,0211-699501013259,12674,o
74,0211-699501013259,p,o
74,0211-699501013259,0001,o
74,0211-699501013259,solo,o
74,0211-699501013259,3,o
74,0211-699501013259,pacientes,o
74,0211-699501013259,presentan,o
74,0211-699501013259,niveles,o
74,0211-699501013259,normales,o
74,0211-699501013259,de,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,correlacionandose,o
74,0211-699501013259,directamente,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,con,o
74,0211-699501013259,la,o
74,0211-699501013259,albumina,i
74,0211-699501013259,r,o
74,0211-699501013259,056,o
74,0211-699501013259,p,o
74,0211-699501013259,0001,o
74,0211-699501013259,que,o
74,0211-699501013259,se,o
74,0211-699501013259,elevo,o
74,0211-699501013259,con,o
74,0211-699501013259,respecto,o
74,0211-699501013259,al,o
74,0211-699501013259,inicio,o
74,0211-699501013259,337,o
74,0211-699501013259,IC,o
74,0211-699501013259,327,o
74,0211-699501013259,346,o
74,0211-699501013259,vs,o
74,0211-699501013259,350,o
74,0211-699501013259,IC,o
74,0211-699501013259,337,o
74,0211-699501013259,363,o
74,0211-699501013259,p,o
74,0211-699501013259,005,o
74,0211-699501013259,Conclusion,o
74,0211-699501013259,Tras,o
74,0211-699501013259,suplementacion,i
74,0211-699501013259,con,o
74,0211-699501013259,acido,i
74,0211-699501013259,folico,i
74,0211-699501013259,y,o
74,0211-699501013259,vitamina,i
74,0211-699501013259,B6,i
74,0211-699501013259,aunque,o
74,0211-699501013259,inicialmente,o
74,0211-699501013259,se,o
74,0211-699501013259,reduce,o
74,0211-699501013259,la,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,esta,o
74,0211-699501013259,respuesta,o
74,0211-699501013259,se,o
74,0211-699501013259,hace,o
74,0211-699501013259,refractaria,o
74,0211-699501013259,correlacionandose,o
74,0211-699501013259,directamente,o
74,0211-699501013259,la,o
74,0211-699501013259,tHcy,i
74,0211-699501013259,con,o
74,0211-699501013259,la,o
74,0211-699501013259,albumina,i
74,0211-699501013259,plasmatica,i
74,0211-699501013259,La,o
74,0211-699501013259,interpretacion,o
74,0211-699501013259,de,o
74,0211-699501013259,los,o
74,0211-699501013259,niveles,i
74,0211-699501013259,de,i
74,0211-699501013259,tHcy,i
74,0211-699501013259,debe,o
74,0211-699501013259,tener,o
74,0211-699501013259,en,o
74,0211-699501013259,cuenta,o
74,0211-699501013259,la,o
74,0211-699501013259,concentracion,i
74,0211-699501013259,de,i
74,0211-699501013259,albumina,i
75,0211-699501013259,Efecto,o
75,0211-699501013259,de,o
75,0211-699501013259,la,o
75,0211-699501013259,suplementacion,i
75,0211-699501013259,con,o
75,0211-699501013259,acido,i
75,0211-699501013259,folico,i
75,0211-699501013259,sobre,o
75,0211-699501013259,los,o
75,0211-699501013259,niveles,i
75,0211-699501013259,de,i
75,0211-699501013259,homocisteina,i
75,0211-699501013259,total,o
75,0211-699501013259,en,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,en,o
75,0211-699501013259,hemodialisis,i
75,0211-699501013259,La,o
75,0211-699501013259,hiperhomocisteinemia,i
75,0211-699501013259,es,o
75,0211-699501013259,un,o
75,0211-699501013259,marcador,o
75,0211-699501013259,de,o
75,0211-699501013259,riesgo,o
75,0211-699501013259,independiente,o
75,0211-699501013259,de,o
75,0211-699501013259,morbimortalidad,o
75,0211-699501013259,cardiovascular,i
75,0211-699501013259,Hemos,o
75,0211-699501013259,intentado,o
75,0211-699501013259,prospectivamente,o
75,0211-699501013259,reducir,o
75,0211-699501013259,los,o
75,0211-699501013259,niveles,i
75,0211-699501013259,de,i
75,0211-699501013259,homocisteina,i
75,0211-699501013259,total,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,mediante,o
75,0211-699501013259,suplemento,o
75,0211-699501013259,con,o
75,0211-699501013259,acido,i
75,0211-699501013259,folico,i
75,0211-699501013259,y,o
75,0211-699501013259,vitamina,i
75,0211-699501013259,B6,i
75,0211-699501013259,pp,i
75,0211-699501013259,valorando,o
75,0211-699501013259,su,o
75,0211-699501013259,posible,o
75,0211-699501013259,correlacion,o
75,0211-699501013259,con,o
75,0211-699501013259,dosis,o
75,0211-699501013259,de,o
75,0211-699501013259,dialisis,i
75,0211-699501013259,funcion,i
75,0211-699501013259,residual,i
75,0211-699501013259,y,o
75,0211-699501013259,parametros,o
75,0211-699501013259,nutricionales,o
75,0211-699501013259,Metodos,o
75,0211-699501013259,Todos,o
75,0211-699501013259,los,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,en,o
75,0211-699501013259,hemodialisis,i
75,0211-699501013259,al,o
75,0211-699501013259,comienzo,o
75,0211-699501013259,del,o
75,0211-699501013259,estudio,o
75,0211-699501013259,que,o
75,0211-699501013259,no,o
75,0211-699501013259,recibian,o
75,0211-699501013259,acido,i
75,0211-699501013259,folico,i
75,0211-699501013259,ni,o
75,0211-699501013259,vitamina,i
75,0211-699501013259,B6,i
75,0211-699501013259,asi,o
75,0211-699501013259,como,o
75,0211-699501013259,los,o
75,0211-699501013259,incorporados,o
75,0211-699501013259,posteriormente,o
75,0211-699501013259,a,o
75,0211-699501013259,partir,o
75,0211-699501013259,de,o
75,0211-699501013259,su,o
75,0211-699501013259,tercer,o
75,0211-699501013259,mes,o
75,0211-699501013259,en,o
75,0211-699501013259,hemodialisis,i
75,0211-699501013259,recibieron,o
75,0211-699501013259,5,o
75,0211-699501013259,mg,o
75,0211-699501013259,orales,o
75,0211-699501013259,de,o
75,0211-699501013259,acido,i
75,0211-699501013259,folico,i
75,0211-699501013259,cada,o
75,0211-699501013259,48,o
75,0211-699501013259,horas,o
75,0211-699501013259,y,o
75,0211-699501013259,40,o
75,0211-699501013259,mg,o
75,0211-699501013259,orales,o
75,0211-699501013259,de,o
75,0211-699501013259,vitamina,i
75,0211-699501013259,B6,i
75,0211-699501013259,cada,o
75,0211-699501013259,semana,o
75,0211-699501013259,Se,o
75,0211-699501013259,determinaron,o
75,0211-699501013259,al,o
75,0211-699501013259,comienzo,o
75,0211-699501013259,del,o
75,0211-699501013259,estudio,o
75,0211-699501013259,y,o
75,0211-699501013259,cada,o
75,0211-699501013259,2,o
75,0211-699501013259,meses,o
75,0211-699501013259,niveles,i
75,0211-699501013259,de,i
75,0211-699501013259,folato,i
75,0211-699501013259,vitamina,i
75,0211-699501013259,B12,i
75,0211-699501013259,inmunoensayo,i
75,0211-699501013259,albumina,i
75,0211-699501013259,y,o
75,0211-699501013259,cinetica,o
75,0211-699501013259,de,o
75,0211-699501013259,la,o
75,0211-699501013259,urea,i
75,0211-699501013259,KTV,o
75,0211-699501013259,KRU,o
75,0211-699501013259,PCRn,o
75,0211-699501013259,y,o
75,0211-699501013259,cada,o
75,0211-699501013259,6,o
75,0211-699501013259,meses,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,HPLC,i
75,0211-699501013259,y,o
75,0211-699501013259,pp,i
75,0211-699501013259,RIA,i
75,0211-699501013259,Resultados,o
75,0211-699501013259,80,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,fueron,o
75,0211-699501013259,incluidos,o
75,0211-699501013259,en,o
75,0211-699501013259,el,o
75,0211-699501013259,estudio,o
75,0211-699501013259,basal,o
75,0211-699501013259,con,o
75,0211-699501013259,una,o
75,0211-699501013259,prevalencia,o
75,0211-699501013259,de,o
75,0211-699501013259,hiperhomocisteinemia,i
75,0211-699501013259,del,o
75,0211-699501013259,844,o
75,0211-699501013259,deficit,i
75,0211-699501013259,de,i
75,0211-699501013259,pp,i
75,0211-699501013259,en,o
75,0211-699501013259,el,o
75,0211-699501013259,32,o
75,0211-699501013259,y,o
75,0211-699501013259,folato,i
75,0211-699501013259,en,o
75,0211-699501013259,el,o
75,0211-699501013259,rango,o
75,0211-699501013259,normal,o
75,0211-699501013259,bajo,o
75,0211-699501013259,los,o
75,0211-699501013259,niveles,i
75,0211-699501013259,de,i
75,0211-699501013259,tHcy,i
75,0211-699501013259,se,o
75,0211-699501013259,correlacionaban,o
75,0211-699501013259,inversamente,o
75,0211-699501013259,con,o
75,0211-699501013259,los,o
75,0211-699501013259,del,o
75,0211-699501013259,folato,i
75,0211-699501013259,r,o
75,0211-699501013259,0336,o
75,0211-699501013259,p,o
75,0211-699501013259,001,o
75,0211-699501013259,pero,o
75,0211-699501013259,no,o
75,0211-699501013259,con,o
75,0211-699501013259,pp,i
75,0211-699501013259,B12,i
75,0211-699501013259,edad,o
75,0211-699501013259,albumina,i
75,0211-699501013259,KTV,o
75,0211-699501013259,KRU,o
75,0211-699501013259,PCRn,o
75,0211-699501013259,Cincuenta,o
75,0211-699501013259,y,o
75,0211-699501013259,ocho,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,recibieron,o
75,0211-699501013259,seis,o
75,0211-699501013259,meses,o
75,0211-699501013259,de,o
75,0211-699501013259,suplementacion,i
75,0211-699501013259,con,o
75,0211-699501013259,normalizacion,o
75,0211-699501013259,del,o
75,0211-699501013259,pp,i
75,0211-699501013259,aumento,o
75,0211-699501013259,del,o
75,0211-699501013259,folato,i
75,0211-699501013259,703,o
75,0211-699501013259,IC,o
75,0211-699501013259,638,o
75,0211-699501013259,795,o
75,0211-699501013259,vs,o
75,0211-699501013259,6181,o
75,0211-699501013259,IC,o
75,0211-699501013259,4447,o
75,0211-699501013259,7811,o
75,0211-699501013259,p,o
75,0211-699501013259,0001,o
75,0211-699501013259,y,o
75,0211-699501013259,descenso,o
75,0211-699501013259,de,o
75,0211-699501013259,la,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,240,o
75,0211-699501013259,IC,o
75,0211-699501013259,213,o
75,0211-699501013259,264,o
75,0211-699501013259,vs,o
75,0211-699501013259,199,o
75,0211-699501013259,IC,o
75,0211-699501013259,175,o
75,0211-699501013259,224,o
75,0211-699501013259,p,o
75,0211-699501013259,005,o
75,0211-699501013259,Han,o
75,0211-699501013259,recibido,o
75,0211-699501013259,suplementacion,i
75,0211-699501013259,durante,o
75,0211-699501013259,12,o
75,0211-699501013259,meses,o
75,0211-699501013259,33,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,pero,o
75,0211-699501013259,a,o
75,0211-699501013259,pesar,o
75,0211-699501013259,de,o
75,0211-699501013259,un,o
75,0211-699501013259,continuo,o
75,0211-699501013259,aumento,o
75,0211-699501013259,del,o
75,0211-699501013259,folato,i
75,0211-699501013259,10078,o
75,0211-699501013259,IC,o
75,0211-699501013259,7481,o
75,0211-699501013259,12674,o
75,0211-699501013259,p,o
75,0211-699501013259,0001,o
75,0211-699501013259,solo,o
75,0211-699501013259,3,o
75,0211-699501013259,pacientes,o
75,0211-699501013259,presentan,o
75,0211-699501013259,niveles,o
75,0211-699501013259,normales,o
75,0211-699501013259,de,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,correlacionandose,o
75,0211-699501013259,directamente,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,con,o
75,0211-699501013259,la,o
75,0211-699501013259,albumina,i
75,0211-699501013259,r,o
75,0211-699501013259,056,o
75,0211-699501013259,p,o
75,0211-699501013259,0001,o
75,0211-699501013259,que,o
75,0211-699501013259,se,o
75,0211-699501013259,elevo,o
75,0211-699501013259,con,o
75,0211-699501013259,respecto,o
75,0211-699501013259,al,o
75,0211-699501013259,inicio,o
75,0211-699501013259,337,o
75,0211-699501013259,IC,o
75,0211-699501013259,327,o
75,0211-699501013259,346,o
75,0211-699501013259,vs,o
75,0211-699501013259,350,o
75,0211-699501013259,IC,o
75,0211-699501013259,337,o
75,0211-699501013259,363,o
75,0211-699501013259,p,o
75,0211-699501013259,005,o
75,0211-699501013259,Conclusion,o
75,0211-699501013259,Tras,o
75,0211-699501013259,suplementacion,i
75,0211-699501013259,con,o
75,0211-699501013259,acido,i
75,0211-699501013259,folico,i
75,0211-699501013259,y,o
75,0211-699501013259,vitamina,i
75,0211-699501013259,B6,i
75,0211-699501013259,aunque,o
75,0211-699501013259,inicialmente,o
75,0211-699501013259,se,o
75,0211-699501013259,reduce,o
75,0211-699501013259,la,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,esta,o
75,0211-699501013259,respuesta,o
75,0211-699501013259,se,o
75,0211-699501013259,hace,o
75,0211-699501013259,refractaria,o
75,0211-699501013259,correlacionandose,o
75,0211-699501013259,directamente,o
75,0211-699501013259,la,o
75,0211-699501013259,tHcy,i
75,0211-699501013259,con,o
75,0211-699501013259,la,o
75,0211-699501013259,albumina,i
75,0211-699501013259,plasmatica,i
75,0211-699501013259,La,o
75,0211-699501013259,interpretacion,o
75,0211-699501013259,de,o
75,0211-699501013259,los,o
75,0211-699501013259,niveles,i
75,0211-699501013259,de,i
75,0211-699501013259,tHcy,i
75,0211-699501013259,debe,o
75,0211-699501013259,tener,o
75,0211-699501013259,en,o
75,0211-699501013259,cuenta,o
75,0211-699501013259,la,o
75,0211-699501013259,concentracion,i
75,0211-699501013259,de,i
75,0211-699501013259,albumina,i
76,0211-699501013259,Efecto,o
76,0211-699501013259,de,o
76,0211-699501013259,la,o
76,0211-699501013259,suplementacion,i
76,0211-699501013259,con,o
76,0211-699501013259,acido,i
76,0211-699501013259,folico,i
76,0211-699501013259,sobre,o
76,0211-699501013259,los,o
76,0211-699501013259,niveles,i
76,0211-699501013259,de,i
76,0211-699501013259,homocisteina,i
76,0211-699501013259,total,o
76,0211-699501013259,en,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,en,o
76,0211-699501013259,hemodialisis,i
76,0211-699501013259,La,o
76,0211-699501013259,hiperhomocisteinemia,i
76,0211-699501013259,es,o
76,0211-699501013259,un,o
76,0211-699501013259,marcador,o
76,0211-699501013259,de,o
76,0211-699501013259,riesgo,o
76,0211-699501013259,independiente,o
76,0211-699501013259,de,o
76,0211-699501013259,morbimortalidad,o
76,0211-699501013259,cardiovascular,i
76,0211-699501013259,Hemos,o
76,0211-699501013259,intentado,o
76,0211-699501013259,prospectivamente,o
76,0211-699501013259,reducir,o
76,0211-699501013259,los,o
76,0211-699501013259,niveles,i
76,0211-699501013259,de,i
76,0211-699501013259,homocisteina,i
76,0211-699501013259,total,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,mediante,o
76,0211-699501013259,suplemento,o
76,0211-699501013259,con,o
76,0211-699501013259,acido,i
76,0211-699501013259,folico,i
76,0211-699501013259,y,o
76,0211-699501013259,vitamina,i
76,0211-699501013259,B6,i
76,0211-699501013259,pp,i
76,0211-699501013259,valorando,o
76,0211-699501013259,su,o
76,0211-699501013259,posible,o
76,0211-699501013259,correlacion,o
76,0211-699501013259,con,o
76,0211-699501013259,dosis,o
76,0211-699501013259,de,o
76,0211-699501013259,dialisis,i
76,0211-699501013259,funcion,i
76,0211-699501013259,residual,i
76,0211-699501013259,y,o
76,0211-699501013259,parametros,o
76,0211-699501013259,nutricionales,o
76,0211-699501013259,Metodos,o
76,0211-699501013259,Todos,o
76,0211-699501013259,los,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,en,o
76,0211-699501013259,hemodialisis,i
76,0211-699501013259,al,o
76,0211-699501013259,comienzo,o
76,0211-699501013259,del,o
76,0211-699501013259,estudio,o
76,0211-699501013259,que,o
76,0211-699501013259,no,o
76,0211-699501013259,recibian,o
76,0211-699501013259,acido,i
76,0211-699501013259,folico,i
76,0211-699501013259,ni,o
76,0211-699501013259,vitamina,i
76,0211-699501013259,B6,i
76,0211-699501013259,asi,o
76,0211-699501013259,como,o
76,0211-699501013259,los,o
76,0211-699501013259,incorporados,o
76,0211-699501013259,posteriormente,o
76,0211-699501013259,a,o
76,0211-699501013259,partir,o
76,0211-699501013259,de,o
76,0211-699501013259,su,o
76,0211-699501013259,tercer,o
76,0211-699501013259,mes,o
76,0211-699501013259,en,o
76,0211-699501013259,hemodialisis,i
76,0211-699501013259,recibieron,o
76,0211-699501013259,5,o
76,0211-699501013259,mg,o
76,0211-699501013259,orales,o
76,0211-699501013259,de,o
76,0211-699501013259,acido,i
76,0211-699501013259,folico,i
76,0211-699501013259,cada,o
76,0211-699501013259,48,o
76,0211-699501013259,horas,o
76,0211-699501013259,y,o
76,0211-699501013259,40,o
76,0211-699501013259,mg,o
76,0211-699501013259,orales,o
76,0211-699501013259,de,o
76,0211-699501013259,vitamina,i
76,0211-699501013259,B6,i
76,0211-699501013259,cada,o
76,0211-699501013259,semana,o
76,0211-699501013259,Se,o
76,0211-699501013259,determinaron,o
76,0211-699501013259,al,o
76,0211-699501013259,comienzo,o
76,0211-699501013259,del,o
76,0211-699501013259,estudio,o
76,0211-699501013259,y,o
76,0211-699501013259,cada,o
76,0211-699501013259,2,o
76,0211-699501013259,meses,o
76,0211-699501013259,niveles,i
76,0211-699501013259,de,i
76,0211-699501013259,folato,i
76,0211-699501013259,vitamina,i
76,0211-699501013259,B12,i
76,0211-699501013259,inmunoensayo,i
76,0211-699501013259,albumina,i
76,0211-699501013259,y,o
76,0211-699501013259,cinetica,o
76,0211-699501013259,de,o
76,0211-699501013259,la,o
76,0211-699501013259,urea,i
76,0211-699501013259,KTV,o
76,0211-699501013259,KRU,o
76,0211-699501013259,PCRn,o
76,0211-699501013259,y,o
76,0211-699501013259,cada,o
76,0211-699501013259,6,o
76,0211-699501013259,meses,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,HPLC,i
76,0211-699501013259,y,o
76,0211-699501013259,pp,i
76,0211-699501013259,RIA,i
76,0211-699501013259,Resultados,o
76,0211-699501013259,80,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,fueron,o
76,0211-699501013259,incluidos,o
76,0211-699501013259,en,o
76,0211-699501013259,el,o
76,0211-699501013259,estudio,o
76,0211-699501013259,basal,o
76,0211-699501013259,con,o
76,0211-699501013259,una,o
76,0211-699501013259,prevalencia,o
76,0211-699501013259,de,o
76,0211-699501013259,hiperhomocisteinemia,i
76,0211-699501013259,del,o
76,0211-699501013259,844,o
76,0211-699501013259,deficit,i
76,0211-699501013259,de,i
76,0211-699501013259,pp,i
76,0211-699501013259,en,o
76,0211-699501013259,el,o
76,0211-699501013259,32,o
76,0211-699501013259,y,o
76,0211-699501013259,folato,i
76,0211-699501013259,en,o
76,0211-699501013259,el,o
76,0211-699501013259,rango,o
76,0211-699501013259,normal,o
76,0211-699501013259,bajo,o
76,0211-699501013259,los,o
76,0211-699501013259,niveles,i
76,0211-699501013259,de,i
76,0211-699501013259,tHcy,i
76,0211-699501013259,se,o
76,0211-699501013259,correlacionaban,o
76,0211-699501013259,inversamente,o
76,0211-699501013259,con,o
76,0211-699501013259,los,o
76,0211-699501013259,del,o
76,0211-699501013259,folato,i
76,0211-699501013259,r,o
76,0211-699501013259,0336,o
76,0211-699501013259,p,o
76,0211-699501013259,001,o
76,0211-699501013259,pero,o
76,0211-699501013259,no,o
76,0211-699501013259,con,o
76,0211-699501013259,pp,i
76,0211-699501013259,B12,i
76,0211-699501013259,edad,o
76,0211-699501013259,albumina,i
76,0211-699501013259,KTV,o
76,0211-699501013259,KRU,o
76,0211-699501013259,PCRn,o
76,0211-699501013259,Cincuenta,o
76,0211-699501013259,y,o
76,0211-699501013259,ocho,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,recibieron,o
76,0211-699501013259,seis,o
76,0211-699501013259,meses,o
76,0211-699501013259,de,o
76,0211-699501013259,suplementacion,i
76,0211-699501013259,con,o
76,0211-699501013259,normalizacion,o
76,0211-699501013259,del,o
76,0211-699501013259,pp,i
76,0211-699501013259,aumento,o
76,0211-699501013259,del,o
76,0211-699501013259,folato,i
76,0211-699501013259,703,o
76,0211-699501013259,IC,o
76,0211-699501013259,638,o
76,0211-699501013259,795,o
76,0211-699501013259,vs,o
76,0211-699501013259,6181,o
76,0211-699501013259,IC,o
76,0211-699501013259,4447,o
76,0211-699501013259,7811,o
76,0211-699501013259,p,o
76,0211-699501013259,0001,o
76,0211-699501013259,y,o
76,0211-699501013259,descenso,o
76,0211-699501013259,de,o
76,0211-699501013259,la,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,240,o
76,0211-699501013259,IC,o
76,0211-699501013259,213,o
76,0211-699501013259,264,o
76,0211-699501013259,vs,o
76,0211-699501013259,199,o
76,0211-699501013259,IC,o
76,0211-699501013259,175,o
76,0211-699501013259,224,o
76,0211-699501013259,p,o
76,0211-699501013259,005,o
76,0211-699501013259,Han,o
76,0211-699501013259,recibido,o
76,0211-699501013259,suplementacion,i
76,0211-699501013259,durante,o
76,0211-699501013259,12,o
76,0211-699501013259,meses,o
76,0211-699501013259,33,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,pero,o
76,0211-699501013259,a,o
76,0211-699501013259,pesar,o
76,0211-699501013259,de,o
76,0211-699501013259,un,o
76,0211-699501013259,continuo,o
76,0211-699501013259,aumento,o
76,0211-699501013259,del,o
76,0211-699501013259,folato,i
76,0211-699501013259,10078,o
76,0211-699501013259,IC,o
76,0211-699501013259,7481,o
76,0211-699501013259,12674,o
76,0211-699501013259,p,o
76,0211-699501013259,0001,o
76,0211-699501013259,solo,o
76,0211-699501013259,3,o
76,0211-699501013259,pacientes,o
76,0211-699501013259,presentan,o
76,0211-699501013259,niveles,o
76,0211-699501013259,normales,o
76,0211-699501013259,de,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,correlacionandose,o
76,0211-699501013259,directamente,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,con,o
76,0211-699501013259,la,o
76,0211-699501013259,albumina,i
76,0211-699501013259,r,o
76,0211-699501013259,056,o
76,0211-699501013259,p,o
76,0211-699501013259,0001,o
76,0211-699501013259,que,o
76,0211-699501013259,se,o
76,0211-699501013259,elevo,o
76,0211-699501013259,con,o
76,0211-699501013259,respecto,o
76,0211-699501013259,al,o
76,0211-699501013259,inicio,o
76,0211-699501013259,337,o
76,0211-699501013259,IC,o
76,0211-699501013259,327,o
76,0211-699501013259,346,o
76,0211-699501013259,vs,o
76,0211-699501013259,350,o
76,0211-699501013259,IC,o
76,0211-699501013259,337,o
76,0211-699501013259,363,o
76,0211-699501013259,p,o
76,0211-699501013259,005,o
76,0211-699501013259,Conclusion,o
76,0211-699501013259,Tras,o
76,0211-699501013259,suplementacion,i
76,0211-699501013259,con,o
76,0211-699501013259,acido,i
76,0211-699501013259,folico,i
76,0211-699501013259,y,o
76,0211-699501013259,vitamina,i
76,0211-699501013259,B6,i
76,0211-699501013259,aunque,o
76,0211-699501013259,inicialmente,o
76,0211-699501013259,se,o
76,0211-699501013259,reduce,o
76,0211-699501013259,la,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,esta,o
76,0211-699501013259,respuesta,o
76,0211-699501013259,se,o
76,0211-699501013259,hace,o
76,0211-699501013259,refractaria,o
76,0211-699501013259,correlacionandose,o
76,0211-699501013259,directamente,o
76,0211-699501013259,la,o
76,0211-699501013259,tHcy,i
76,0211-699501013259,con,o
76,0211-699501013259,la,o
76,0211-699501013259,albumina,i
76,0211-699501013259,plasmatica,i
76,0211-699501013259,La,o
76,0211-699501013259,interpretacion,o
76,0211-699501013259,de,o
76,0211-699501013259,los,o
76,0211-699501013259,niveles,i
76,0211-699501013259,de,i
76,0211-699501013259,tHcy,i
76,0211-699501013259,debe,o
76,0211-699501013259,tener,o
76,0211-699501013259,en,o
76,0211-699501013259,cuenta,o
76,0211-699501013259,la,o
76,0211-699501013259,concentracion,i
76,0211-699501013259,de,i
76,0211-699501013259,albumina,i
77,0211-699501013259,Efecto,o
77,0211-699501013259,de,o
77,0211-699501013259,la,o
77,0211-699501013259,suplementacion,i
77,0211-699501013259,con,o
77,0211-699501013259,acido,i
77,0211-699501013259,folico,i
77,0211-699501013259,sobre,o
77,0211-699501013259,los,o
77,0211-699501013259,niveles,i
77,0211-699501013259,de,i
77,0211-699501013259,homocisteina,i
77,0211-699501013259,total,o
77,0211-699501013259,en,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,en,o
77,0211-699501013259,hemodialisis,i
77,0211-699501013259,La,o
77,0211-699501013259,hiperhomocisteinemia,i
77,0211-699501013259,es,o
77,0211-699501013259,un,o
77,0211-699501013259,marcador,o
77,0211-699501013259,de,o
77,0211-699501013259,riesgo,o
77,0211-699501013259,independiente,o
77,0211-699501013259,de,o
77,0211-699501013259,morbimortalidad,o
77,0211-699501013259,cardiovascular,i
77,0211-699501013259,Hemos,o
77,0211-699501013259,intentado,o
77,0211-699501013259,prospectivamente,o
77,0211-699501013259,reducir,o
77,0211-699501013259,los,o
77,0211-699501013259,niveles,i
77,0211-699501013259,de,i
77,0211-699501013259,homocisteina,i
77,0211-699501013259,total,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,mediante,o
77,0211-699501013259,suplemento,o
77,0211-699501013259,con,o
77,0211-699501013259,acido,i
77,0211-699501013259,folico,i
77,0211-699501013259,y,o
77,0211-699501013259,vitamina,i
77,0211-699501013259,B6,i
77,0211-699501013259,pp,i
77,0211-699501013259,valorando,o
77,0211-699501013259,su,o
77,0211-699501013259,posible,o
77,0211-699501013259,correlacion,o
77,0211-699501013259,con,o
77,0211-699501013259,dosis,o
77,0211-699501013259,de,o
77,0211-699501013259,dialisis,i
77,0211-699501013259,funcion,i
77,0211-699501013259,residual,i
77,0211-699501013259,y,o
77,0211-699501013259,parametros,o
77,0211-699501013259,nutricionales,o
77,0211-699501013259,Metodos,o
77,0211-699501013259,Todos,o
77,0211-699501013259,los,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,en,o
77,0211-699501013259,hemodialisis,i
77,0211-699501013259,al,o
77,0211-699501013259,comienzo,o
77,0211-699501013259,del,o
77,0211-699501013259,estudio,o
77,0211-699501013259,que,o
77,0211-699501013259,no,o
77,0211-699501013259,recibian,o
77,0211-699501013259,acido,i
77,0211-699501013259,folico,i
77,0211-699501013259,ni,o
77,0211-699501013259,vitamina,i
77,0211-699501013259,B6,i
77,0211-699501013259,asi,o
77,0211-699501013259,como,o
77,0211-699501013259,los,o
77,0211-699501013259,incorporados,o
77,0211-699501013259,posteriormente,o
77,0211-699501013259,a,o
77,0211-699501013259,partir,o
77,0211-699501013259,de,o
77,0211-699501013259,su,o
77,0211-699501013259,tercer,o
77,0211-699501013259,mes,o
77,0211-699501013259,en,o
77,0211-699501013259,hemodialisis,i
77,0211-699501013259,recibieron,o
77,0211-699501013259,5,o
77,0211-699501013259,mg,o
77,0211-699501013259,orales,o
77,0211-699501013259,de,o
77,0211-699501013259,acido,i
77,0211-699501013259,folico,i
77,0211-699501013259,cada,o
77,0211-699501013259,48,o
77,0211-699501013259,horas,o
77,0211-699501013259,y,o
77,0211-699501013259,40,o
77,0211-699501013259,mg,o
77,0211-699501013259,orales,o
77,0211-699501013259,de,o
77,0211-699501013259,vitamina,i
77,0211-699501013259,B6,i
77,0211-699501013259,cada,o
77,0211-699501013259,semana,o
77,0211-699501013259,Se,o
77,0211-699501013259,determinaron,o
77,0211-699501013259,al,o
77,0211-699501013259,comienzo,o
77,0211-699501013259,del,o
77,0211-699501013259,estudio,o
77,0211-699501013259,y,o
77,0211-699501013259,cada,o
77,0211-699501013259,2,o
77,0211-699501013259,meses,o
77,0211-699501013259,niveles,i
77,0211-699501013259,de,i
77,0211-699501013259,folato,i
77,0211-699501013259,vitamina,i
77,0211-699501013259,B12,i
77,0211-699501013259,inmunoensayo,i
77,0211-699501013259,albumina,i
77,0211-699501013259,y,o
77,0211-699501013259,cinetica,o
77,0211-699501013259,de,o
77,0211-699501013259,la,o
77,0211-699501013259,urea,i
77,0211-699501013259,KTV,o
77,0211-699501013259,KRU,o
77,0211-699501013259,PCRn,o
77,0211-699501013259,y,o
77,0211-699501013259,cada,o
77,0211-699501013259,6,o
77,0211-699501013259,meses,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,HPLC,i
77,0211-699501013259,y,o
77,0211-699501013259,pp,i
77,0211-699501013259,RIA,i
77,0211-699501013259,Resultados,o
77,0211-699501013259,80,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,fueron,o
77,0211-699501013259,incluidos,o
77,0211-699501013259,en,o
77,0211-699501013259,el,o
77,0211-699501013259,estudio,o
77,0211-699501013259,basal,o
77,0211-699501013259,con,o
77,0211-699501013259,una,o
77,0211-699501013259,prevalencia,o
77,0211-699501013259,de,o
77,0211-699501013259,hiperhomocisteinemia,i
77,0211-699501013259,del,o
77,0211-699501013259,844,o
77,0211-699501013259,deficit,i
77,0211-699501013259,de,i
77,0211-699501013259,pp,i
77,0211-699501013259,en,o
77,0211-699501013259,el,o
77,0211-699501013259,32,o
77,0211-699501013259,y,o
77,0211-699501013259,folato,i
77,0211-699501013259,en,o
77,0211-699501013259,el,o
77,0211-699501013259,rango,o
77,0211-699501013259,normal,o
77,0211-699501013259,bajo,o
77,0211-699501013259,los,o
77,0211-699501013259,niveles,i
77,0211-699501013259,de,i
77,0211-699501013259,tHcy,i
77,0211-699501013259,se,o
77,0211-699501013259,correlacionaban,o
77,0211-699501013259,inversamente,o
77,0211-699501013259,con,o
77,0211-699501013259,los,o
77,0211-699501013259,del,o
77,0211-699501013259,folato,i
77,0211-699501013259,r,o
77,0211-699501013259,0336,o
77,0211-699501013259,p,o
77,0211-699501013259,001,o
77,0211-699501013259,pero,o
77,0211-699501013259,no,o
77,0211-699501013259,con,o
77,0211-699501013259,pp,i
77,0211-699501013259,B12,i
77,0211-699501013259,edad,o
77,0211-699501013259,albumina,i
77,0211-699501013259,KTV,o
77,0211-699501013259,KRU,o
77,0211-699501013259,PCRn,o
77,0211-699501013259,Cincuenta,o
77,0211-699501013259,y,o
77,0211-699501013259,ocho,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,recibieron,o
77,0211-699501013259,seis,o
77,0211-699501013259,meses,o
77,0211-699501013259,de,o
77,0211-699501013259,suplementacion,i
77,0211-699501013259,con,o
77,0211-699501013259,normalizacion,o
77,0211-699501013259,del,o
77,0211-699501013259,pp,i
77,0211-699501013259,aumento,o
77,0211-699501013259,del,o
77,0211-699501013259,folato,i
77,0211-699501013259,703,o
77,0211-699501013259,IC,o
77,0211-699501013259,638,o
77,0211-699501013259,795,o
77,0211-699501013259,vs,o
77,0211-699501013259,6181,o
77,0211-699501013259,IC,o
77,0211-699501013259,4447,o
77,0211-699501013259,7811,o
77,0211-699501013259,p,o
77,0211-699501013259,0001,o
77,0211-699501013259,y,o
77,0211-699501013259,descenso,o
77,0211-699501013259,de,o
77,0211-699501013259,la,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,240,o
77,0211-699501013259,IC,o
77,0211-699501013259,213,o
77,0211-699501013259,264,o
77,0211-699501013259,vs,o
77,0211-699501013259,199,o
77,0211-699501013259,IC,o
77,0211-699501013259,175,o
77,0211-699501013259,224,o
77,0211-699501013259,p,o
77,0211-699501013259,005,o
77,0211-699501013259,Han,o
77,0211-699501013259,recibido,o
77,0211-699501013259,suplementacion,i
77,0211-699501013259,durante,o
77,0211-699501013259,12,o
77,0211-699501013259,meses,o
77,0211-699501013259,33,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,pero,o
77,0211-699501013259,a,o
77,0211-699501013259,pesar,o
77,0211-699501013259,de,o
77,0211-699501013259,un,o
77,0211-699501013259,continuo,o
77,0211-699501013259,aumento,o
77,0211-699501013259,del,o
77,0211-699501013259,folato,i
77,0211-699501013259,10078,o
77,0211-699501013259,IC,o
77,0211-699501013259,7481,o
77,0211-699501013259,12674,o
77,0211-699501013259,p,o
77,0211-699501013259,0001,o
77,0211-699501013259,solo,o
77,0211-699501013259,3,o
77,0211-699501013259,pacientes,o
77,0211-699501013259,presentan,o
77,0211-699501013259,niveles,o
77,0211-699501013259,normales,o
77,0211-699501013259,de,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,correlacionandose,o
77,0211-699501013259,directamente,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,con,o
77,0211-699501013259,la,o
77,0211-699501013259,albumina,i
77,0211-699501013259,r,o
77,0211-699501013259,056,o
77,0211-699501013259,p,o
77,0211-699501013259,0001,o
77,0211-699501013259,que,o
77,0211-699501013259,se,o
77,0211-699501013259,elevo,o
77,0211-699501013259,con,o
77,0211-699501013259,respecto,o
77,0211-699501013259,al,o
77,0211-699501013259,inicio,o
77,0211-699501013259,337,o
77,0211-699501013259,IC,o
77,0211-699501013259,327,o
77,0211-699501013259,346,o
77,0211-699501013259,vs,o
77,0211-699501013259,350,o
77,0211-699501013259,IC,o
77,0211-699501013259,337,o
77,0211-699501013259,363,o
77,0211-699501013259,p,o
77,0211-699501013259,005,o
77,0211-699501013259,Conclusion,o
77,0211-699501013259,Tras,o
77,0211-699501013259,suplementacion,i
77,0211-699501013259,con,o
77,0211-699501013259,acido,i
77,0211-699501013259,folico,i
77,0211-699501013259,y,o
77,0211-699501013259,vitamina,i
77,0211-699501013259,B6,i
77,0211-699501013259,aunque,o
77,0211-699501013259,inicialmente,o
77,0211-699501013259,se,o
77,0211-699501013259,reduce,o
77,0211-699501013259,la,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,esta,o
77,0211-699501013259,respuesta,o
77,0211-699501013259,se,o
77,0211-699501013259,hace,o
77,0211-699501013259,refractaria,o
77,0211-699501013259,correlacionandose,o
77,0211-699501013259,directamente,o
77,0211-699501013259,la,o
77,0211-699501013259,tHcy,i
77,0211-699501013259,con,o
77,0211-699501013259,la,o
77,0211-699501013259,albumina,i
77,0211-699501013259,plasmatica,i
77,0211-699501013259,La,o
77,0211-699501013259,interpretacion,o
77,0211-699501013259,de,o
77,0211-699501013259,los,o
77,0211-699501013259,niveles,i
77,0211-699501013259,de,i
77,0211-699501013259,tHcy,i
77,0211-699501013259,debe,o
77,0211-699501013259,tener,o
77,0211-699501013259,en,o
77,0211-699501013259,cuenta,o
77,0211-699501013259,la,o
77,0211-699501013259,concentracion,i
77,0211-699501013259,de,i
77,0211-699501013259,albumina,i
78,0211-699501013259,Efecto,o
78,0211-699501013259,de,o
78,0211-699501013259,la,o
78,0211-699501013259,suplementacion,i
78,0211-699501013259,con,o
78,0211-699501013259,acido,i
78,0211-699501013259,folico,i
78,0211-699501013259,sobre,o
78,0211-699501013259,los,o
78,0211-699501013259,niveles,i
78,0211-699501013259,de,i
78,0211-699501013259,homocisteina,i
78,0211-699501013259,total,o
78,0211-699501013259,en,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,en,o
78,0211-699501013259,hemodialisis,i
78,0211-699501013259,La,o
78,0211-699501013259,hiperhomocisteinemia,i
78,0211-699501013259,es,o
78,0211-699501013259,un,o
78,0211-699501013259,marcador,o
78,0211-699501013259,de,o
78,0211-699501013259,riesgo,o
78,0211-699501013259,independiente,o
78,0211-699501013259,de,o
78,0211-699501013259,morbimortalidad,o
78,0211-699501013259,cardiovascular,i
78,0211-699501013259,Hemos,o
78,0211-699501013259,intentado,o
78,0211-699501013259,prospectivamente,o
78,0211-699501013259,reducir,o
78,0211-699501013259,los,o
78,0211-699501013259,niveles,i
78,0211-699501013259,de,i
78,0211-699501013259,homocisteina,i
78,0211-699501013259,total,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,mediante,o
78,0211-699501013259,suplemento,o
78,0211-699501013259,con,o
78,0211-699501013259,acido,i
78,0211-699501013259,folico,i
78,0211-699501013259,y,o
78,0211-699501013259,vitamina,i
78,0211-699501013259,B6,i
78,0211-699501013259,pp,i
78,0211-699501013259,valorando,o
78,0211-699501013259,su,o
78,0211-699501013259,posible,o
78,0211-699501013259,correlacion,o
78,0211-699501013259,con,o
78,0211-699501013259,dosis,o
78,0211-699501013259,de,o
78,0211-699501013259,dialisis,i
78,0211-699501013259,funcion,i
78,0211-699501013259,residual,i
78,0211-699501013259,y,o
78,0211-699501013259,parametros,o
78,0211-699501013259,nutricionales,o
78,0211-699501013259,Metodos,o
78,0211-699501013259,Todos,o
78,0211-699501013259,los,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,en,o
78,0211-699501013259,hemodialisis,i
78,0211-699501013259,al,o
78,0211-699501013259,comienzo,o
78,0211-699501013259,del,o
78,0211-699501013259,estudio,o
78,0211-699501013259,que,o
78,0211-699501013259,no,o
78,0211-699501013259,recibian,o
78,0211-699501013259,acido,i
78,0211-699501013259,folico,i
78,0211-699501013259,ni,o
78,0211-699501013259,vitamina,i
78,0211-699501013259,B6,i
78,0211-699501013259,asi,o
78,0211-699501013259,como,o
78,0211-699501013259,los,o
78,0211-699501013259,incorporados,o
78,0211-699501013259,posteriormente,o
78,0211-699501013259,a,o
78,0211-699501013259,partir,o
78,0211-699501013259,de,o
78,0211-699501013259,su,o
78,0211-699501013259,tercer,o
78,0211-699501013259,mes,o
78,0211-699501013259,en,o
78,0211-699501013259,hemodialisis,i
78,0211-699501013259,recibieron,o
78,0211-699501013259,5,o
78,0211-699501013259,mg,o
78,0211-699501013259,orales,o
78,0211-699501013259,de,o
78,0211-699501013259,acido,i
78,0211-699501013259,folico,i
78,0211-699501013259,cada,o
78,0211-699501013259,48,o
78,0211-699501013259,horas,o
78,0211-699501013259,y,o
78,0211-699501013259,40,o
78,0211-699501013259,mg,o
78,0211-699501013259,orales,o
78,0211-699501013259,de,o
78,0211-699501013259,vitamina,i
78,0211-699501013259,B6,i
78,0211-699501013259,cada,o
78,0211-699501013259,semana,o
78,0211-699501013259,Se,o
78,0211-699501013259,determinaron,o
78,0211-699501013259,al,o
78,0211-699501013259,comienzo,o
78,0211-699501013259,del,o
78,0211-699501013259,estudio,o
78,0211-699501013259,y,o
78,0211-699501013259,cada,o
78,0211-699501013259,2,o
78,0211-699501013259,meses,o
78,0211-699501013259,niveles,i
78,0211-699501013259,de,i
78,0211-699501013259,folato,i
78,0211-699501013259,vitamina,i
78,0211-699501013259,B12,i
78,0211-699501013259,inmunoensayo,i
78,0211-699501013259,albumina,i
78,0211-699501013259,y,o
78,0211-699501013259,cinetica,o
78,0211-699501013259,de,o
78,0211-699501013259,la,o
78,0211-699501013259,urea,i
78,0211-699501013259,KTV,o
78,0211-699501013259,KRU,o
78,0211-699501013259,PCRn,o
78,0211-699501013259,y,o
78,0211-699501013259,cada,o
78,0211-699501013259,6,o
78,0211-699501013259,meses,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,HPLC,i
78,0211-699501013259,y,o
78,0211-699501013259,pp,i
78,0211-699501013259,RIA,i
78,0211-699501013259,Resultados,o
78,0211-699501013259,80,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,fueron,o
78,0211-699501013259,incluidos,o
78,0211-699501013259,en,o
78,0211-699501013259,el,o
78,0211-699501013259,estudio,o
78,0211-699501013259,basal,o
78,0211-699501013259,con,o
78,0211-699501013259,una,o
78,0211-699501013259,prevalencia,o
78,0211-699501013259,de,o
78,0211-699501013259,hiperhomocisteinemia,i
78,0211-699501013259,del,o
78,0211-699501013259,844,o
78,0211-699501013259,deficit,i
78,0211-699501013259,de,i
78,0211-699501013259,pp,i
78,0211-699501013259,en,o
78,0211-699501013259,el,o
78,0211-699501013259,32,o
78,0211-699501013259,y,o
78,0211-699501013259,folato,i
78,0211-699501013259,en,o
78,0211-699501013259,el,o
78,0211-699501013259,rango,o
78,0211-699501013259,normal,o
78,0211-699501013259,bajo,o
78,0211-699501013259,los,o
78,0211-699501013259,niveles,i
78,0211-699501013259,de,i
78,0211-699501013259,tHcy,i
78,0211-699501013259,se,o
78,0211-699501013259,correlacionaban,o
78,0211-699501013259,inversamente,o
78,0211-699501013259,con,o
78,0211-699501013259,los,o
78,0211-699501013259,del,o
78,0211-699501013259,folato,i
78,0211-699501013259,r,o
78,0211-699501013259,0336,o
78,0211-699501013259,p,o
78,0211-699501013259,001,o
78,0211-699501013259,pero,o
78,0211-699501013259,no,o
78,0211-699501013259,con,o
78,0211-699501013259,pp,i
78,0211-699501013259,B12,i
78,0211-699501013259,edad,o
78,0211-699501013259,albumina,i
78,0211-699501013259,KTV,o
78,0211-699501013259,KRU,o
78,0211-699501013259,PCRn,o
78,0211-699501013259,Cincuenta,o
78,0211-699501013259,y,o
78,0211-699501013259,ocho,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,recibieron,o
78,0211-699501013259,seis,o
78,0211-699501013259,meses,o
78,0211-699501013259,de,o
78,0211-699501013259,suplementacion,i
78,0211-699501013259,con,o
78,0211-699501013259,normalizacion,o
78,0211-699501013259,del,o
78,0211-699501013259,pp,i
78,0211-699501013259,aumento,o
78,0211-699501013259,del,o
78,0211-699501013259,folato,i
78,0211-699501013259,703,o
78,0211-699501013259,IC,o
78,0211-699501013259,638,o
78,0211-699501013259,795,o
78,0211-699501013259,vs,o
78,0211-699501013259,6181,o
78,0211-699501013259,IC,o
78,0211-699501013259,4447,o
78,0211-699501013259,7811,o
78,0211-699501013259,p,o
78,0211-699501013259,0001,o
78,0211-699501013259,y,o
78,0211-699501013259,descenso,o
78,0211-699501013259,de,o
78,0211-699501013259,la,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,240,o
78,0211-699501013259,IC,o
78,0211-699501013259,213,o
78,0211-699501013259,264,o
78,0211-699501013259,vs,o
78,0211-699501013259,199,o
78,0211-699501013259,IC,o
78,0211-699501013259,175,o
78,0211-699501013259,224,o
78,0211-699501013259,p,o
78,0211-699501013259,005,o
78,0211-699501013259,Han,o
78,0211-699501013259,recibido,o
78,0211-699501013259,suplementacion,i
78,0211-699501013259,durante,o
78,0211-699501013259,12,o
78,0211-699501013259,meses,o
78,0211-699501013259,33,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,pero,o
78,0211-699501013259,a,o
78,0211-699501013259,pesar,o
78,0211-699501013259,de,o
78,0211-699501013259,un,o
78,0211-699501013259,continuo,o
78,0211-699501013259,aumento,o
78,0211-699501013259,del,o
78,0211-699501013259,folato,i
78,0211-699501013259,10078,o
78,0211-699501013259,IC,o
78,0211-699501013259,7481,o
78,0211-699501013259,12674,o
78,0211-699501013259,p,o
78,0211-699501013259,0001,o
78,0211-699501013259,solo,o
78,0211-699501013259,3,o
78,0211-699501013259,pacientes,o
78,0211-699501013259,presentan,o
78,0211-699501013259,niveles,o
78,0211-699501013259,normales,o
78,0211-699501013259,de,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,correlacionandose,o
78,0211-699501013259,directamente,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,con,o
78,0211-699501013259,la,o
78,0211-699501013259,albumina,i
78,0211-699501013259,r,o
78,0211-699501013259,056,o
78,0211-699501013259,p,o
78,0211-699501013259,0001,o
78,0211-699501013259,que,o
78,0211-699501013259,se,o
78,0211-699501013259,elevo,o
78,0211-699501013259,con,o
78,0211-699501013259,respecto,o
78,0211-699501013259,al,o
78,0211-699501013259,inicio,o
78,0211-699501013259,337,o
78,0211-699501013259,IC,o
78,0211-699501013259,327,o
78,0211-699501013259,346,o
78,0211-699501013259,vs,o
78,0211-699501013259,350,o
78,0211-699501013259,IC,o
78,0211-699501013259,337,o
78,0211-699501013259,363,o
78,0211-699501013259,p,o
78,0211-699501013259,005,o
78,0211-699501013259,Conclusion,o
78,0211-699501013259,Tras,o
78,0211-699501013259,suplementacion,i
78,0211-699501013259,con,o
78,0211-699501013259,acido,i
78,0211-699501013259,folico,i
78,0211-699501013259,y,o
78,0211-699501013259,vitamina,i
78,0211-699501013259,B6,i
78,0211-699501013259,aunque,o
78,0211-699501013259,inicialmente,o
78,0211-699501013259,se,o
78,0211-699501013259,reduce,o
78,0211-699501013259,la,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,esta,o
78,0211-699501013259,respuesta,o
78,0211-699501013259,se,o
78,0211-699501013259,hace,o
78,0211-699501013259,refractaria,o
78,0211-699501013259,correlacionandose,o
78,0211-699501013259,directamente,o
78,0211-699501013259,la,o
78,0211-699501013259,tHcy,i
78,0211-699501013259,con,o
78,0211-699501013259,la,o
78,0211-699501013259,albumina,i
78,0211-699501013259,plasmatica,i
78,0211-699501013259,La,o
78,0211-699501013259,interpretacion,o
78,0211-699501013259,de,o
78,0211-699501013259,los,o
78,0211-699501013259,niveles,i
78,0211-699501013259,de,i
78,0211-699501013259,tHcy,i
78,0211-699501013259,debe,o
78,0211-699501013259,tener,o
78,0211-699501013259,en,o
78,0211-699501013259,cuenta,o
78,0211-699501013259,la,o
78,0211-699501013259,concentracion,i
78,0211-699501013259,de,i
78,0211-699501013259,albumina,i
79,0211-699501013259,Efecto,o
79,0211-699501013259,de,o
79,0211-699501013259,la,o
79,0211-699501013259,suplementacion,i
79,0211-699501013259,con,o
79,0211-699501013259,acido,i
79,0211-699501013259,folico,i
79,0211-699501013259,sobre,o
79,0211-699501013259,los,o
79,0211-699501013259,niveles,i
79,0211-699501013259,de,i
79,0211-699501013259,homocisteina,i
79,0211-699501013259,total,o
79,0211-699501013259,en,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,en,o
79,0211-699501013259,hemodialisis,i
79,0211-699501013259,La,o
79,0211-699501013259,hiperhomocisteinemia,i
79,0211-699501013259,es,o
79,0211-699501013259,un,o
79,0211-699501013259,marcador,o
79,0211-699501013259,de,o
79,0211-699501013259,riesgo,o
79,0211-699501013259,independiente,o
79,0211-699501013259,de,o
79,0211-699501013259,morbimortalidad,o
79,0211-699501013259,cardiovascular,i
79,0211-699501013259,Hemos,o
79,0211-699501013259,intentado,o
79,0211-699501013259,prospectivamente,o
79,0211-699501013259,reducir,o
79,0211-699501013259,los,o
79,0211-699501013259,niveles,i
79,0211-699501013259,de,i
79,0211-699501013259,homocisteina,i
79,0211-699501013259,total,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,mediante,o
79,0211-699501013259,suplemento,o
79,0211-699501013259,con,o
79,0211-699501013259,acido,i
79,0211-699501013259,folico,i
79,0211-699501013259,y,o
79,0211-699501013259,vitamina,i
79,0211-699501013259,B6,i
79,0211-699501013259,pp,i
79,0211-699501013259,valorando,o
79,0211-699501013259,su,o
79,0211-699501013259,posible,o
79,0211-699501013259,correlacion,o
79,0211-699501013259,con,o
79,0211-699501013259,dosis,o
79,0211-699501013259,de,o
79,0211-699501013259,dialisis,i
79,0211-699501013259,funcion,i
79,0211-699501013259,residual,i
79,0211-699501013259,y,o
79,0211-699501013259,parametros,o
79,0211-699501013259,nutricionales,o
79,0211-699501013259,Metodos,o
79,0211-699501013259,Todos,o
79,0211-699501013259,los,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,en,o
79,0211-699501013259,hemodialisis,i
79,0211-699501013259,al,o
79,0211-699501013259,comienzo,o
79,0211-699501013259,del,o
79,0211-699501013259,estudio,o
79,0211-699501013259,que,o
79,0211-699501013259,no,o
79,0211-699501013259,recibian,o
79,0211-699501013259,acido,i
79,0211-699501013259,folico,i
79,0211-699501013259,ni,o
79,0211-699501013259,vitamina,i
79,0211-699501013259,B6,i
79,0211-699501013259,asi,o
79,0211-699501013259,como,o
79,0211-699501013259,los,o
79,0211-699501013259,incorporados,o
79,0211-699501013259,posteriormente,o
79,0211-699501013259,a,o
79,0211-699501013259,partir,o
79,0211-699501013259,de,o
79,0211-699501013259,su,o
79,0211-699501013259,tercer,o
79,0211-699501013259,mes,o
79,0211-699501013259,en,o
79,0211-699501013259,hemodialisis,i
79,0211-699501013259,recibieron,o
79,0211-699501013259,5,o
79,0211-699501013259,mg,o
79,0211-699501013259,orales,o
79,0211-699501013259,de,o
79,0211-699501013259,acido,i
79,0211-699501013259,folico,i
79,0211-699501013259,cada,o
79,0211-699501013259,48,o
79,0211-699501013259,horas,o
79,0211-699501013259,y,o
79,0211-699501013259,40,o
79,0211-699501013259,mg,o
79,0211-699501013259,orales,o
79,0211-699501013259,de,o
79,0211-699501013259,vitamina,i
79,0211-699501013259,B6,i
79,0211-699501013259,cada,o
79,0211-699501013259,semana,o
79,0211-699501013259,Se,o
79,0211-699501013259,determinaron,o
79,0211-699501013259,al,o
79,0211-699501013259,comienzo,o
79,0211-699501013259,del,o
79,0211-699501013259,estudio,o
79,0211-699501013259,y,o
79,0211-699501013259,cada,o
79,0211-699501013259,2,o
79,0211-699501013259,meses,o
79,0211-699501013259,niveles,i
79,0211-699501013259,de,i
79,0211-699501013259,folato,i
79,0211-699501013259,vitamina,i
79,0211-699501013259,B12,i
79,0211-699501013259,inmunoensayo,i
79,0211-699501013259,albumina,i
79,0211-699501013259,y,o
79,0211-699501013259,cinetica,o
79,0211-699501013259,de,o
79,0211-699501013259,la,o
79,0211-699501013259,urea,i
79,0211-699501013259,KTV,o
79,0211-699501013259,KRU,o
79,0211-699501013259,PCRn,o
79,0211-699501013259,y,o
79,0211-699501013259,cada,o
79,0211-699501013259,6,o
79,0211-699501013259,meses,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,HPLC,i
79,0211-699501013259,y,o
79,0211-699501013259,pp,i
79,0211-699501013259,RIA,i
79,0211-699501013259,Resultados,o
79,0211-699501013259,80,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,fueron,o
79,0211-699501013259,incluidos,o
79,0211-699501013259,en,o
79,0211-699501013259,el,o
79,0211-699501013259,estudio,o
79,0211-699501013259,basal,o
79,0211-699501013259,con,o
79,0211-699501013259,una,o
79,0211-699501013259,prevalencia,o
79,0211-699501013259,de,o
79,0211-699501013259,hiperhomocisteinemia,i
79,0211-699501013259,del,o
79,0211-699501013259,844,o
79,0211-699501013259,deficit,i
79,0211-699501013259,de,i
79,0211-699501013259,pp,i
79,0211-699501013259,en,o
79,0211-699501013259,el,o
79,0211-699501013259,32,o
79,0211-699501013259,y,o
79,0211-699501013259,folato,i
79,0211-699501013259,en,o
79,0211-699501013259,el,o
79,0211-699501013259,rango,o
79,0211-699501013259,normal,o
79,0211-699501013259,bajo,o
79,0211-699501013259,los,o
79,0211-699501013259,niveles,i
79,0211-699501013259,de,i
79,0211-699501013259,tHcy,i
79,0211-699501013259,se,o
79,0211-699501013259,correlacionaban,o
79,0211-699501013259,inversamente,o
79,0211-699501013259,con,o
79,0211-699501013259,los,o
79,0211-699501013259,del,o
79,0211-699501013259,folato,i
79,0211-699501013259,r,o
79,0211-699501013259,0336,o
79,0211-699501013259,p,o
79,0211-699501013259,001,o
79,0211-699501013259,pero,o
79,0211-699501013259,no,o
79,0211-699501013259,con,o
79,0211-699501013259,pp,i
79,0211-699501013259,B12,i
79,0211-699501013259,edad,o
79,0211-699501013259,albumina,i
79,0211-699501013259,KTV,o
79,0211-699501013259,KRU,o
79,0211-699501013259,PCRn,o
79,0211-699501013259,Cincuenta,o
79,0211-699501013259,y,o
79,0211-699501013259,ocho,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,recibieron,o
79,0211-699501013259,seis,o
79,0211-699501013259,meses,o
79,0211-699501013259,de,o
79,0211-699501013259,suplementacion,i
79,0211-699501013259,con,o
79,0211-699501013259,normalizacion,o
79,0211-699501013259,del,o
79,0211-699501013259,pp,i
79,0211-699501013259,aumento,o
79,0211-699501013259,del,o
79,0211-699501013259,folato,i
79,0211-699501013259,703,o
79,0211-699501013259,IC,o
79,0211-699501013259,638,o
79,0211-699501013259,795,o
79,0211-699501013259,vs,o
79,0211-699501013259,6181,o
79,0211-699501013259,IC,o
79,0211-699501013259,4447,o
79,0211-699501013259,7811,o
79,0211-699501013259,p,o
79,0211-699501013259,0001,o
79,0211-699501013259,y,o
79,0211-699501013259,descenso,o
79,0211-699501013259,de,o
79,0211-699501013259,la,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,240,o
79,0211-699501013259,IC,o
79,0211-699501013259,213,o
79,0211-699501013259,264,o
79,0211-699501013259,vs,o
79,0211-699501013259,199,o
79,0211-699501013259,IC,o
79,0211-699501013259,175,o
79,0211-699501013259,224,o
79,0211-699501013259,p,o
79,0211-699501013259,005,o
79,0211-699501013259,Han,o
79,0211-699501013259,recibido,o
79,0211-699501013259,suplementacion,i
79,0211-699501013259,durante,o
79,0211-699501013259,12,o
79,0211-699501013259,meses,o
79,0211-699501013259,33,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,pero,o
79,0211-699501013259,a,o
79,0211-699501013259,pesar,o
79,0211-699501013259,de,o
79,0211-699501013259,un,o
79,0211-699501013259,continuo,o
79,0211-699501013259,aumento,o
79,0211-699501013259,del,o
79,0211-699501013259,folato,i
79,0211-699501013259,10078,o
79,0211-699501013259,IC,o
79,0211-699501013259,7481,o
79,0211-699501013259,12674,o
79,0211-699501013259,p,o
79,0211-699501013259,0001,o
79,0211-699501013259,solo,o
79,0211-699501013259,3,o
79,0211-699501013259,pacientes,o
79,0211-699501013259,presentan,o
79,0211-699501013259,niveles,o
79,0211-699501013259,normales,o
79,0211-699501013259,de,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,correlacionandose,o
79,0211-699501013259,directamente,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,con,o
79,0211-699501013259,la,o
79,0211-699501013259,albumina,i
79,0211-699501013259,r,o
79,0211-699501013259,056,o
79,0211-699501013259,p,o
79,0211-699501013259,0001,o
79,0211-699501013259,que,o
79,0211-699501013259,se,o
79,0211-699501013259,elevo,o
79,0211-699501013259,con,o
79,0211-699501013259,respecto,o
79,0211-699501013259,al,o
79,0211-699501013259,inicio,o
79,0211-699501013259,337,o
79,0211-699501013259,IC,o
79,0211-699501013259,327,o
79,0211-699501013259,346,o
79,0211-699501013259,vs,o
79,0211-699501013259,350,o
79,0211-699501013259,IC,o
79,0211-699501013259,337,o
79,0211-699501013259,363,o
79,0211-699501013259,p,o
79,0211-699501013259,005,o
79,0211-699501013259,Conclusion,o
79,0211-699501013259,Tras,o
79,0211-699501013259,suplementacion,i
79,0211-699501013259,con,o
79,0211-699501013259,acido,i
79,0211-699501013259,folico,i
79,0211-699501013259,y,o
79,0211-699501013259,vitamina,i
79,0211-699501013259,B6,i
79,0211-699501013259,aunque,o
79,0211-699501013259,inicialmente,o
79,0211-699501013259,se,o
79,0211-699501013259,reduce,o
79,0211-699501013259,la,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,esta,o
79,0211-699501013259,respuesta,o
79,0211-699501013259,se,o
79,0211-699501013259,hace,o
79,0211-699501013259,refractaria,o
79,0211-699501013259,correlacionandose,o
79,0211-699501013259,directamente,o
79,0211-699501013259,la,o
79,0211-699501013259,tHcy,i
79,0211-699501013259,con,o
79,0211-699501013259,la,o
79,0211-699501013259,albumina,i
79,0211-699501013259,plasmatica,i
79,0211-699501013259,La,o
79,0211-699501013259,interpretacion,o
79,0211-699501013259,de,o
79,0211-699501013259,los,o
79,0211-699501013259,niveles,i
79,0211-699501013259,de,i
79,0211-699501013259,tHcy,i
79,0211-699501013259,debe,o
79,0211-699501013259,tener,o
79,0211-699501013259,en,o
79,0211-699501013259,cuenta,o
79,0211-699501013259,la,o
79,0211-699501013259,concentracion,i
79,0211-699501013259,de,i
79,0211-699501013259,albumina,i
80,0211-699501013259,Efecto,o
80,0211-699501013259,de,o
80,0211-699501013259,la,o
80,0211-699501013259,suplementacion,i
80,0211-699501013259,con,o
80,0211-699501013259,acido,i
80,0211-699501013259,folico,i
80,0211-699501013259,sobre,o
80,0211-699501013259,los,o
80,0211-699501013259,niveles,i
80,0211-699501013259,de,i
80,0211-699501013259,homocisteina,i
80,0211-699501013259,total,o
80,0211-699501013259,en,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,en,o
80,0211-699501013259,hemodialisis,i
80,0211-699501013259,La,o
80,0211-699501013259,hiperhomocisteinemia,i
80,0211-699501013259,es,o
80,0211-699501013259,un,o
80,0211-699501013259,marcador,o
80,0211-699501013259,de,o
80,0211-699501013259,riesgo,o
80,0211-699501013259,independiente,o
80,0211-699501013259,de,o
80,0211-699501013259,morbimortalidad,o
80,0211-699501013259,cardiovascular,i
80,0211-699501013259,Hemos,o
80,0211-699501013259,intentado,o
80,0211-699501013259,prospectivamente,o
80,0211-699501013259,reducir,o
80,0211-699501013259,los,o
80,0211-699501013259,niveles,i
80,0211-699501013259,de,i
80,0211-699501013259,homocisteina,i
80,0211-699501013259,total,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,mediante,o
80,0211-699501013259,suplemento,o
80,0211-699501013259,con,o
80,0211-699501013259,acido,i
80,0211-699501013259,folico,i
80,0211-699501013259,y,o
80,0211-699501013259,vitamina,i
80,0211-699501013259,B6,i
80,0211-699501013259,pp,i
80,0211-699501013259,valorando,o
80,0211-699501013259,su,o
80,0211-699501013259,posible,o
80,0211-699501013259,correlacion,o
80,0211-699501013259,con,o
80,0211-699501013259,dosis,o
80,0211-699501013259,de,o
80,0211-699501013259,dialisis,i
80,0211-699501013259,funcion,i
80,0211-699501013259,residual,i
80,0211-699501013259,y,o
80,0211-699501013259,parametros,o
80,0211-699501013259,nutricionales,o
80,0211-699501013259,Metodos,o
80,0211-699501013259,Todos,o
80,0211-699501013259,los,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,en,o
80,0211-699501013259,hemodialisis,i
80,0211-699501013259,al,o
80,0211-699501013259,comienzo,o
80,0211-699501013259,del,o
80,0211-699501013259,estudio,o
80,0211-699501013259,que,o
80,0211-699501013259,no,o
80,0211-699501013259,recibian,o
80,0211-699501013259,acido,i
80,0211-699501013259,folico,i
80,0211-699501013259,ni,o
80,0211-699501013259,vitamina,i
80,0211-699501013259,B6,i
80,0211-699501013259,asi,o
80,0211-699501013259,como,o
80,0211-699501013259,los,o
80,0211-699501013259,incorporados,o
80,0211-699501013259,posteriormente,o
80,0211-699501013259,a,o
80,0211-699501013259,partir,o
80,0211-699501013259,de,o
80,0211-699501013259,su,o
80,0211-699501013259,tercer,o
80,0211-699501013259,mes,o
80,0211-699501013259,en,o
80,0211-699501013259,hemodialisis,i
80,0211-699501013259,recibieron,o
80,0211-699501013259,5,o
80,0211-699501013259,mg,o
80,0211-699501013259,orales,o
80,0211-699501013259,de,o
80,0211-699501013259,acido,i
80,0211-699501013259,folico,i
80,0211-699501013259,cada,o
80,0211-699501013259,48,o
80,0211-699501013259,horas,o
80,0211-699501013259,y,o
80,0211-699501013259,40,o
80,0211-699501013259,mg,o
80,0211-699501013259,orales,o
80,0211-699501013259,de,o
80,0211-699501013259,vitamina,i
80,0211-699501013259,B6,i
80,0211-699501013259,cada,o
80,0211-699501013259,semana,o
80,0211-699501013259,Se,o
80,0211-699501013259,determinaron,o
80,0211-699501013259,al,o
80,0211-699501013259,comienzo,o
80,0211-699501013259,del,o
80,0211-699501013259,estudio,o
80,0211-699501013259,y,o
80,0211-699501013259,cada,o
80,0211-699501013259,2,o
80,0211-699501013259,meses,o
80,0211-699501013259,niveles,i
80,0211-699501013259,de,i
80,0211-699501013259,folato,i
80,0211-699501013259,vitamina,i
80,0211-699501013259,B12,i
80,0211-699501013259,inmunoensayo,i
80,0211-699501013259,albumina,i
80,0211-699501013259,y,o
80,0211-699501013259,cinetica,o
80,0211-699501013259,de,o
80,0211-699501013259,la,o
80,0211-699501013259,urea,i
80,0211-699501013259,KTV,o
80,0211-699501013259,KRU,o
80,0211-699501013259,PCRn,o
80,0211-699501013259,y,o
80,0211-699501013259,cada,o
80,0211-699501013259,6,o
80,0211-699501013259,meses,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,HPLC,i
80,0211-699501013259,y,o
80,0211-699501013259,pp,i
80,0211-699501013259,RIA,i
80,0211-699501013259,Resultados,o
80,0211-699501013259,80,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,fueron,o
80,0211-699501013259,incluidos,o
80,0211-699501013259,en,o
80,0211-699501013259,el,o
80,0211-699501013259,estudio,o
80,0211-699501013259,basal,o
80,0211-699501013259,con,o
80,0211-699501013259,una,o
80,0211-699501013259,prevalencia,o
80,0211-699501013259,de,o
80,0211-699501013259,hiperhomocisteinemia,i
80,0211-699501013259,del,o
80,0211-699501013259,844,o
80,0211-699501013259,deficit,i
80,0211-699501013259,de,i
80,0211-699501013259,pp,i
80,0211-699501013259,en,o
80,0211-699501013259,el,o
80,0211-699501013259,32,o
80,0211-699501013259,y,o
80,0211-699501013259,folato,i
80,0211-699501013259,en,o
80,0211-699501013259,el,o
80,0211-699501013259,rango,o
80,0211-699501013259,normal,o
80,0211-699501013259,bajo,o
80,0211-699501013259,los,o
80,0211-699501013259,niveles,i
80,0211-699501013259,de,i
80,0211-699501013259,tHcy,i
80,0211-699501013259,se,o
80,0211-699501013259,correlacionaban,o
80,0211-699501013259,inversamente,o
80,0211-699501013259,con,o
80,0211-699501013259,los,o
80,0211-699501013259,del,o
80,0211-699501013259,folato,i
80,0211-699501013259,r,o
80,0211-699501013259,0336,o
80,0211-699501013259,p,o
80,0211-699501013259,001,o
80,0211-699501013259,pero,o
80,0211-699501013259,no,o
80,0211-699501013259,con,o
80,0211-699501013259,pp,i
80,0211-699501013259,B12,i
80,0211-699501013259,edad,o
80,0211-699501013259,albumina,i
80,0211-699501013259,KTV,o
80,0211-699501013259,KRU,o
80,0211-699501013259,PCRn,o
80,0211-699501013259,Cincuenta,o
80,0211-699501013259,y,o
80,0211-699501013259,ocho,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,recibieron,o
80,0211-699501013259,seis,o
80,0211-699501013259,meses,o
80,0211-699501013259,de,o
80,0211-699501013259,suplementacion,i
80,0211-699501013259,con,o
80,0211-699501013259,normalizacion,o
80,0211-699501013259,del,o
80,0211-699501013259,pp,i
80,0211-699501013259,aumento,o
80,0211-699501013259,del,o
80,0211-699501013259,folato,i
80,0211-699501013259,703,o
80,0211-699501013259,IC,o
80,0211-699501013259,638,o
80,0211-699501013259,795,o
80,0211-699501013259,vs,o
80,0211-699501013259,6181,o
80,0211-699501013259,IC,o
80,0211-699501013259,4447,o
80,0211-699501013259,7811,o
80,0211-699501013259,p,o
80,0211-699501013259,0001,o
80,0211-699501013259,y,o
80,0211-699501013259,descenso,o
80,0211-699501013259,de,o
80,0211-699501013259,la,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,240,o
80,0211-699501013259,IC,o
80,0211-699501013259,213,o
80,0211-699501013259,264,o
80,0211-699501013259,vs,o
80,0211-699501013259,199,o
80,0211-699501013259,IC,o
80,0211-699501013259,175,o
80,0211-699501013259,224,o
80,0211-699501013259,p,o
80,0211-699501013259,005,o
80,0211-699501013259,Han,o
80,0211-699501013259,recibido,o
80,0211-699501013259,suplementacion,i
80,0211-699501013259,durante,o
80,0211-699501013259,12,o
80,0211-699501013259,meses,o
80,0211-699501013259,33,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,pero,o
80,0211-699501013259,a,o
80,0211-699501013259,pesar,o
80,0211-699501013259,de,o
80,0211-699501013259,un,o
80,0211-699501013259,continuo,o
80,0211-699501013259,aumento,o
80,0211-699501013259,del,o
80,0211-699501013259,folato,i
80,0211-699501013259,10078,o
80,0211-699501013259,IC,o
80,0211-699501013259,7481,o
80,0211-699501013259,12674,o
80,0211-699501013259,p,o
80,0211-699501013259,0001,o
80,0211-699501013259,solo,o
80,0211-699501013259,3,o
80,0211-699501013259,pacientes,o
80,0211-699501013259,presentan,o
80,0211-699501013259,niveles,o
80,0211-699501013259,normales,o
80,0211-699501013259,de,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,correlacionandose,o
80,0211-699501013259,directamente,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,con,o
80,0211-699501013259,la,o
80,0211-699501013259,albumina,i
80,0211-699501013259,r,o
80,0211-699501013259,056,o
80,0211-699501013259,p,o
80,0211-699501013259,0001,o
80,0211-699501013259,que,o
80,0211-699501013259,se,o
80,0211-699501013259,elevo,o
80,0211-699501013259,con,o
80,0211-699501013259,respecto,o
80,0211-699501013259,al,o
80,0211-699501013259,inicio,o
80,0211-699501013259,337,o
80,0211-699501013259,IC,o
80,0211-699501013259,327,o
80,0211-699501013259,346,o
80,0211-699501013259,vs,o
80,0211-699501013259,350,o
80,0211-699501013259,IC,o
80,0211-699501013259,337,o
80,0211-699501013259,363,o
80,0211-699501013259,p,o
80,0211-699501013259,005,o
80,0211-699501013259,Conclusion,o
80,0211-699501013259,Tras,o
80,0211-699501013259,suplementacion,i
80,0211-699501013259,con,o
80,0211-699501013259,acido,i
80,0211-699501013259,folico,i
80,0211-699501013259,y,o
80,0211-699501013259,vitamina,i
80,0211-699501013259,B6,i
80,0211-699501013259,aunque,o
80,0211-699501013259,inicialmente,o
80,0211-699501013259,se,o
80,0211-699501013259,reduce,o
80,0211-699501013259,la,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,esta,o
80,0211-699501013259,respuesta,o
80,0211-699501013259,se,o
80,0211-699501013259,hace,o
80,0211-699501013259,refractaria,o
80,0211-699501013259,correlacionandose,o
80,0211-699501013259,directamente,o
80,0211-699501013259,la,o
80,0211-699501013259,tHcy,i
80,0211-699501013259,con,o
80,0211-699501013259,la,o
80,0211-699501013259,albumina,i
80,0211-699501013259,plasmatica,i
80,0211-699501013259,La,o
80,0211-699501013259,interpretacion,o
80,0211-699501013259,de,o
80,0211-699501013259,los,o
80,0211-699501013259,niveles,i
80,0211-699501013259,de,i
80,0211-699501013259,tHcy,i
80,0211-699501013259,debe,o
80,0211-699501013259,tener,o
80,0211-699501013259,en,o
80,0211-699501013259,cuenta,o
80,0211-699501013259,la,o
80,0211-699501013259,concentracion,i
80,0211-699501013259,de,i
80,0211-699501013259,albumina,i
81,0211-699501013259,Efecto,o
81,0211-699501013259,de,o
81,0211-699501013259,la,o
81,0211-699501013259,suplementacion,i
81,0211-699501013259,con,o
81,0211-699501013259,acido,i
81,0211-699501013259,folico,i
81,0211-699501013259,sobre,o
81,0211-699501013259,los,o
81,0211-699501013259,niveles,i
81,0211-699501013259,de,i
81,0211-699501013259,homocisteina,i
81,0211-699501013259,total,o
81,0211-699501013259,en,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,en,o
81,0211-699501013259,hemodialisis,i
81,0211-699501013259,La,o
81,0211-699501013259,hiperhomocisteinemia,i
81,0211-699501013259,es,o
81,0211-699501013259,un,o
81,0211-699501013259,marcador,o
81,0211-699501013259,de,o
81,0211-699501013259,riesgo,o
81,0211-699501013259,independiente,o
81,0211-699501013259,de,o
81,0211-699501013259,morbimortalidad,o
81,0211-699501013259,cardiovascular,i
81,0211-699501013259,Hemos,o
81,0211-699501013259,intentado,o
81,0211-699501013259,prospectivamente,o
81,0211-699501013259,reducir,o
81,0211-699501013259,los,o
81,0211-699501013259,niveles,i
81,0211-699501013259,de,i
81,0211-699501013259,homocisteina,i
81,0211-699501013259,total,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,mediante,o
81,0211-699501013259,suplemento,o
81,0211-699501013259,con,o
81,0211-699501013259,acido,i
81,0211-699501013259,folico,i
81,0211-699501013259,y,o
81,0211-699501013259,vitamina,i
81,0211-699501013259,B6,i
81,0211-699501013259,pp,i
81,0211-699501013259,valorando,o
81,0211-699501013259,su,o
81,0211-699501013259,posible,o
81,0211-699501013259,correlacion,o
81,0211-699501013259,con,o
81,0211-699501013259,dosis,o
81,0211-699501013259,de,o
81,0211-699501013259,dialisis,i
81,0211-699501013259,funcion,i
81,0211-699501013259,residual,i
81,0211-699501013259,y,o
81,0211-699501013259,parametros,o
81,0211-699501013259,nutricionales,o
81,0211-699501013259,Metodos,o
81,0211-699501013259,Todos,o
81,0211-699501013259,los,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,en,o
81,0211-699501013259,hemodialisis,i
81,0211-699501013259,al,o
81,0211-699501013259,comienzo,o
81,0211-699501013259,del,o
81,0211-699501013259,estudio,o
81,0211-699501013259,que,o
81,0211-699501013259,no,o
81,0211-699501013259,recibian,o
81,0211-699501013259,acido,i
81,0211-699501013259,folico,i
81,0211-699501013259,ni,o
81,0211-699501013259,vitamina,i
81,0211-699501013259,B6,i
81,0211-699501013259,asi,o
81,0211-699501013259,como,o
81,0211-699501013259,los,o
81,0211-699501013259,incorporados,o
81,0211-699501013259,posteriormente,o
81,0211-699501013259,a,o
81,0211-699501013259,partir,o
81,0211-699501013259,de,o
81,0211-699501013259,su,o
81,0211-699501013259,tercer,o
81,0211-699501013259,mes,o
81,0211-699501013259,en,o
81,0211-699501013259,hemodialisis,i
81,0211-699501013259,recibieron,o
81,0211-699501013259,5,o
81,0211-699501013259,mg,o
81,0211-699501013259,orales,o
81,0211-699501013259,de,o
81,0211-699501013259,acido,i
81,0211-699501013259,folico,i
81,0211-699501013259,cada,o
81,0211-699501013259,48,o
81,0211-699501013259,horas,o
81,0211-699501013259,y,o
81,0211-699501013259,40,o
81,0211-699501013259,mg,o
81,0211-699501013259,orales,o
81,0211-699501013259,de,o
81,0211-699501013259,vitamina,i
81,0211-699501013259,B6,i
81,0211-699501013259,cada,o
81,0211-699501013259,semana,o
81,0211-699501013259,Se,o
81,0211-699501013259,determinaron,o
81,0211-699501013259,al,o
81,0211-699501013259,comienzo,o
81,0211-699501013259,del,o
81,0211-699501013259,estudio,o
81,0211-699501013259,y,o
81,0211-699501013259,cada,o
81,0211-699501013259,2,o
81,0211-699501013259,meses,o
81,0211-699501013259,niveles,i
81,0211-699501013259,de,i
81,0211-699501013259,folato,i
81,0211-699501013259,vitamina,i
81,0211-699501013259,B12,i
81,0211-699501013259,inmunoensayo,i
81,0211-699501013259,albumina,i
81,0211-699501013259,y,o
81,0211-699501013259,cinetica,o
81,0211-699501013259,de,o
81,0211-699501013259,la,o
81,0211-699501013259,urea,i
81,0211-699501013259,KTV,o
81,0211-699501013259,KRU,o
81,0211-699501013259,PCRn,o
81,0211-699501013259,y,o
81,0211-699501013259,cada,o
81,0211-699501013259,6,o
81,0211-699501013259,meses,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,HPLC,i
81,0211-699501013259,y,o
81,0211-699501013259,pp,i
81,0211-699501013259,RIA,i
81,0211-699501013259,Resultados,o
81,0211-699501013259,80,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,fueron,o
81,0211-699501013259,incluidos,o
81,0211-699501013259,en,o
81,0211-699501013259,el,o
81,0211-699501013259,estudio,o
81,0211-699501013259,basal,o
81,0211-699501013259,con,o
81,0211-699501013259,una,o
81,0211-699501013259,prevalencia,o
81,0211-699501013259,de,o
81,0211-699501013259,hiperhomocisteinemia,i
81,0211-699501013259,del,o
81,0211-699501013259,844,o
81,0211-699501013259,deficit,i
81,0211-699501013259,de,i
81,0211-699501013259,pp,i
81,0211-699501013259,en,o
81,0211-699501013259,el,o
81,0211-699501013259,32,o
81,0211-699501013259,y,o
81,0211-699501013259,folato,i
81,0211-699501013259,en,o
81,0211-699501013259,el,o
81,0211-699501013259,rango,o
81,0211-699501013259,normal,o
81,0211-699501013259,bajo,o
81,0211-699501013259,los,o
81,0211-699501013259,niveles,i
81,0211-699501013259,de,i
81,0211-699501013259,tHcy,i
81,0211-699501013259,se,o
81,0211-699501013259,correlacionaban,o
81,0211-699501013259,inversamente,o
81,0211-699501013259,con,o
81,0211-699501013259,los,o
81,0211-699501013259,del,o
81,0211-699501013259,folato,i
81,0211-699501013259,r,o
81,0211-699501013259,0336,o
81,0211-699501013259,p,o
81,0211-699501013259,001,o
81,0211-699501013259,pero,o
81,0211-699501013259,no,o
81,0211-699501013259,con,o
81,0211-699501013259,pp,i
81,0211-699501013259,B12,i
81,0211-699501013259,edad,o
81,0211-699501013259,albumina,i
81,0211-699501013259,KTV,o
81,0211-699501013259,KRU,o
81,0211-699501013259,PCRn,o
81,0211-699501013259,Cincuenta,o
81,0211-699501013259,y,o
81,0211-699501013259,ocho,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,recibieron,o
81,0211-699501013259,seis,o
81,0211-699501013259,meses,o
81,0211-699501013259,de,o
81,0211-699501013259,suplementacion,i
81,0211-699501013259,con,o
81,0211-699501013259,normalizacion,o
81,0211-699501013259,del,o
81,0211-699501013259,pp,i
81,0211-699501013259,aumento,o
81,0211-699501013259,del,o
81,0211-699501013259,folato,i
81,0211-699501013259,703,o
81,0211-699501013259,IC,o
81,0211-699501013259,638,o
81,0211-699501013259,795,o
81,0211-699501013259,vs,o
81,0211-699501013259,6181,o
81,0211-699501013259,IC,o
81,0211-699501013259,4447,o
81,0211-699501013259,7811,o
81,0211-699501013259,p,o
81,0211-699501013259,0001,o
81,0211-699501013259,y,o
81,0211-699501013259,descenso,o
81,0211-699501013259,de,o
81,0211-699501013259,la,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,240,o
81,0211-699501013259,IC,o
81,0211-699501013259,213,o
81,0211-699501013259,264,o
81,0211-699501013259,vs,o
81,0211-699501013259,199,o
81,0211-699501013259,IC,o
81,0211-699501013259,175,o
81,0211-699501013259,224,o
81,0211-699501013259,p,o
81,0211-699501013259,005,o
81,0211-699501013259,Han,o
81,0211-699501013259,recibido,o
81,0211-699501013259,suplementacion,i
81,0211-699501013259,durante,o
81,0211-699501013259,12,o
81,0211-699501013259,meses,o
81,0211-699501013259,33,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,pero,o
81,0211-699501013259,a,o
81,0211-699501013259,pesar,o
81,0211-699501013259,de,o
81,0211-699501013259,un,o
81,0211-699501013259,continuo,o
81,0211-699501013259,aumento,o
81,0211-699501013259,del,o
81,0211-699501013259,folato,i
81,0211-699501013259,10078,o
81,0211-699501013259,IC,o
81,0211-699501013259,7481,o
81,0211-699501013259,12674,o
81,0211-699501013259,p,o
81,0211-699501013259,0001,o
81,0211-699501013259,solo,o
81,0211-699501013259,3,o
81,0211-699501013259,pacientes,o
81,0211-699501013259,presentan,o
81,0211-699501013259,niveles,o
81,0211-699501013259,normales,o
81,0211-699501013259,de,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,correlacionandose,o
81,0211-699501013259,directamente,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,con,o
81,0211-699501013259,la,o
81,0211-699501013259,albumina,i
81,0211-699501013259,r,o
81,0211-699501013259,056,o
81,0211-699501013259,p,o
81,0211-699501013259,0001,o
81,0211-699501013259,que,o
81,0211-699501013259,se,o
81,0211-699501013259,elevo,o
81,0211-699501013259,con,o
81,0211-699501013259,respecto,o
81,0211-699501013259,al,o
81,0211-699501013259,inicio,o
81,0211-699501013259,337,o
81,0211-699501013259,IC,o
81,0211-699501013259,327,o
81,0211-699501013259,346,o
81,0211-699501013259,vs,o
81,0211-699501013259,350,o
81,0211-699501013259,IC,o
81,0211-699501013259,337,o
81,0211-699501013259,363,o
81,0211-699501013259,p,o
81,0211-699501013259,005,o
81,0211-699501013259,Conclusion,o
81,0211-699501013259,Tras,o
81,0211-699501013259,suplementacion,i
81,0211-699501013259,con,o
81,0211-699501013259,acido,i
81,0211-699501013259,folico,i
81,0211-699501013259,y,o
81,0211-699501013259,vitamina,i
81,0211-699501013259,B6,i
81,0211-699501013259,aunque,o
81,0211-699501013259,inicialmente,o
81,0211-699501013259,se,o
81,0211-699501013259,reduce,o
81,0211-699501013259,la,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,esta,o
81,0211-699501013259,respuesta,o
81,0211-699501013259,se,o
81,0211-699501013259,hace,o
81,0211-699501013259,refractaria,o
81,0211-699501013259,correlacionandose,o
81,0211-699501013259,directamente,o
81,0211-699501013259,la,o
81,0211-699501013259,tHcy,i
81,0211-699501013259,con,o
81,0211-699501013259,la,o
81,0211-699501013259,albumina,i
81,0211-699501013259,plasmatica,i
81,0211-699501013259,La,o
81,0211-699501013259,interpretacion,o
81,0211-699501013259,de,o
81,0211-699501013259,los,o
81,0211-699501013259,niveles,i
81,0211-699501013259,de,i
81,0211-699501013259,tHcy,i
81,0211-699501013259,debe,o
81,0211-699501013259,tener,o
81,0211-699501013259,en,o
81,0211-699501013259,cuenta,o
81,0211-699501013259,la,o
81,0211-699501013259,concentracion,i
81,0211-699501013259,de,i
81,0211-699501013259,albumina,i
82,0211-699501013259,Efecto,o
82,0211-699501013259,de,o
82,0211-699501013259,la,o
82,0211-699501013259,suplementacion,i
82,0211-699501013259,con,o
82,0211-699501013259,acido,i
82,0211-699501013259,folico,i
82,0211-699501013259,sobre,o
82,0211-699501013259,los,o
82,0211-699501013259,niveles,i
82,0211-699501013259,de,i
82,0211-699501013259,homocisteina,i
82,0211-699501013259,total,o
82,0211-699501013259,en,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,en,o
82,0211-699501013259,hemodialisis,i
82,0211-699501013259,La,o
82,0211-699501013259,hiperhomocisteinemia,i
82,0211-699501013259,es,o
82,0211-699501013259,un,o
82,0211-699501013259,marcador,o
82,0211-699501013259,de,o
82,0211-699501013259,riesgo,o
82,0211-699501013259,independiente,o
82,0211-699501013259,de,o
82,0211-699501013259,morbimortalidad,o
82,0211-699501013259,cardiovascular,i
82,0211-699501013259,Hemos,o
82,0211-699501013259,intentado,o
82,0211-699501013259,prospectivamente,o
82,0211-699501013259,reducir,o
82,0211-699501013259,los,o
82,0211-699501013259,niveles,i
82,0211-699501013259,de,i
82,0211-699501013259,homocisteina,i
82,0211-699501013259,total,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,mediante,o
82,0211-699501013259,suplemento,o
82,0211-699501013259,con,o
82,0211-699501013259,acido,i
82,0211-699501013259,folico,i
82,0211-699501013259,y,o
82,0211-699501013259,vitamina,i
82,0211-699501013259,B6,i
82,0211-699501013259,pp,i
82,0211-699501013259,valorando,o
82,0211-699501013259,su,o
82,0211-699501013259,posible,o
82,0211-699501013259,correlacion,o
82,0211-699501013259,con,o
82,0211-699501013259,dosis,o
82,0211-699501013259,de,o
82,0211-699501013259,dialisis,i
82,0211-699501013259,funcion,i
82,0211-699501013259,residual,i
82,0211-699501013259,y,o
82,0211-699501013259,parametros,o
82,0211-699501013259,nutricionales,o
82,0211-699501013259,Metodos,o
82,0211-699501013259,Todos,o
82,0211-699501013259,los,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,en,o
82,0211-699501013259,hemodialisis,i
82,0211-699501013259,al,o
82,0211-699501013259,comienzo,o
82,0211-699501013259,del,o
82,0211-699501013259,estudio,o
82,0211-699501013259,que,o
82,0211-699501013259,no,o
82,0211-699501013259,recibian,o
82,0211-699501013259,acido,i
82,0211-699501013259,folico,i
82,0211-699501013259,ni,o
82,0211-699501013259,vitamina,i
82,0211-699501013259,B6,i
82,0211-699501013259,asi,o
82,0211-699501013259,como,o
82,0211-699501013259,los,o
82,0211-699501013259,incorporados,o
82,0211-699501013259,posteriormente,o
82,0211-699501013259,a,o
82,0211-699501013259,partir,o
82,0211-699501013259,de,o
82,0211-699501013259,su,o
82,0211-699501013259,tercer,o
82,0211-699501013259,mes,o
82,0211-699501013259,en,o
82,0211-699501013259,hemodialisis,i
82,0211-699501013259,recibieron,o
82,0211-699501013259,5,o
82,0211-699501013259,mg,o
82,0211-699501013259,orales,o
82,0211-699501013259,de,o
82,0211-699501013259,acido,i
82,0211-699501013259,folico,i
82,0211-699501013259,cada,o
82,0211-699501013259,48,o
82,0211-699501013259,horas,o
82,0211-699501013259,y,o
82,0211-699501013259,40,o
82,0211-699501013259,mg,o
82,0211-699501013259,orales,o
82,0211-699501013259,de,o
82,0211-699501013259,vitamina,i
82,0211-699501013259,B6,i
82,0211-699501013259,cada,o
82,0211-699501013259,semana,o
82,0211-699501013259,Se,o
82,0211-699501013259,determinaron,o
82,0211-699501013259,al,o
82,0211-699501013259,comienzo,o
82,0211-699501013259,del,o
82,0211-699501013259,estudio,o
82,0211-699501013259,y,o
82,0211-699501013259,cada,o
82,0211-699501013259,2,o
82,0211-699501013259,meses,o
82,0211-699501013259,niveles,i
82,0211-699501013259,de,i
82,0211-699501013259,folato,i
82,0211-699501013259,vitamina,i
82,0211-699501013259,B12,i
82,0211-699501013259,inmunoensayo,i
82,0211-699501013259,albumina,i
82,0211-699501013259,y,o
82,0211-699501013259,cinetica,o
82,0211-699501013259,de,o
82,0211-699501013259,la,o
82,0211-699501013259,urea,i
82,0211-699501013259,KTV,o
82,0211-699501013259,KRU,o
82,0211-699501013259,PCRn,o
82,0211-699501013259,y,o
82,0211-699501013259,cada,o
82,0211-699501013259,6,o
82,0211-699501013259,meses,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,HPLC,i
82,0211-699501013259,y,o
82,0211-699501013259,pp,i
82,0211-699501013259,RIA,i
82,0211-699501013259,Resultados,o
82,0211-699501013259,80,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,fueron,o
82,0211-699501013259,incluidos,o
82,0211-699501013259,en,o
82,0211-699501013259,el,o
82,0211-699501013259,estudio,o
82,0211-699501013259,basal,o
82,0211-699501013259,con,o
82,0211-699501013259,una,o
82,0211-699501013259,prevalencia,o
82,0211-699501013259,de,o
82,0211-699501013259,hiperhomocisteinemia,i
82,0211-699501013259,del,o
82,0211-699501013259,844,o
82,0211-699501013259,deficit,i
82,0211-699501013259,de,i
82,0211-699501013259,pp,i
82,0211-699501013259,en,o
82,0211-699501013259,el,o
82,0211-699501013259,32,o
82,0211-699501013259,y,o
82,0211-699501013259,folato,i
82,0211-699501013259,en,o
82,0211-699501013259,el,o
82,0211-699501013259,rango,o
82,0211-699501013259,normal,o
82,0211-699501013259,bajo,o
82,0211-699501013259,los,o
82,0211-699501013259,niveles,i
82,0211-699501013259,de,i
82,0211-699501013259,tHcy,i
82,0211-699501013259,se,o
82,0211-699501013259,correlacionaban,o
82,0211-699501013259,inversamente,o
82,0211-699501013259,con,o
82,0211-699501013259,los,o
82,0211-699501013259,del,o
82,0211-699501013259,folato,i
82,0211-699501013259,r,o
82,0211-699501013259,0336,o
82,0211-699501013259,p,o
82,0211-699501013259,001,o
82,0211-699501013259,pero,o
82,0211-699501013259,no,o
82,0211-699501013259,con,o
82,0211-699501013259,pp,i
82,0211-699501013259,B12,i
82,0211-699501013259,edad,o
82,0211-699501013259,albumina,i
82,0211-699501013259,KTV,o
82,0211-699501013259,KRU,o
82,0211-699501013259,PCRn,o
82,0211-699501013259,Cincuenta,o
82,0211-699501013259,y,o
82,0211-699501013259,ocho,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,recibieron,o
82,0211-699501013259,seis,o
82,0211-699501013259,meses,o
82,0211-699501013259,de,o
82,0211-699501013259,suplementacion,i
82,0211-699501013259,con,o
82,0211-699501013259,normalizacion,o
82,0211-699501013259,del,o
82,0211-699501013259,pp,i
82,0211-699501013259,aumento,o
82,0211-699501013259,del,o
82,0211-699501013259,folato,i
82,0211-699501013259,703,o
82,0211-699501013259,IC,o
82,0211-699501013259,638,o
82,0211-699501013259,795,o
82,0211-699501013259,vs,o
82,0211-699501013259,6181,o
82,0211-699501013259,IC,o
82,0211-699501013259,4447,o
82,0211-699501013259,7811,o
82,0211-699501013259,p,o
82,0211-699501013259,0001,o
82,0211-699501013259,y,o
82,0211-699501013259,descenso,o
82,0211-699501013259,de,o
82,0211-699501013259,la,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,240,o
82,0211-699501013259,IC,o
82,0211-699501013259,213,o
82,0211-699501013259,264,o
82,0211-699501013259,vs,o
82,0211-699501013259,199,o
82,0211-699501013259,IC,o
82,0211-699501013259,175,o
82,0211-699501013259,224,o
82,0211-699501013259,p,o
82,0211-699501013259,005,o
82,0211-699501013259,Han,o
82,0211-699501013259,recibido,o
82,0211-699501013259,suplementacion,i
82,0211-699501013259,durante,o
82,0211-699501013259,12,o
82,0211-699501013259,meses,o
82,0211-699501013259,33,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,pero,o
82,0211-699501013259,a,o
82,0211-699501013259,pesar,o
82,0211-699501013259,de,o
82,0211-699501013259,un,o
82,0211-699501013259,continuo,o
82,0211-699501013259,aumento,o
82,0211-699501013259,del,o
82,0211-699501013259,folato,i
82,0211-699501013259,10078,o
82,0211-699501013259,IC,o
82,0211-699501013259,7481,o
82,0211-699501013259,12674,o
82,0211-699501013259,p,o
82,0211-699501013259,0001,o
82,0211-699501013259,solo,o
82,0211-699501013259,3,o
82,0211-699501013259,pacientes,o
82,0211-699501013259,presentan,o
82,0211-699501013259,niveles,o
82,0211-699501013259,normales,o
82,0211-699501013259,de,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,correlacionandose,o
82,0211-699501013259,directamente,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,con,o
82,0211-699501013259,la,o
82,0211-699501013259,albumina,i
82,0211-699501013259,r,o
82,0211-699501013259,056,o
82,0211-699501013259,p,o
82,0211-699501013259,0001,o
82,0211-699501013259,que,o
82,0211-699501013259,se,o
82,0211-699501013259,elevo,o
82,0211-699501013259,con,o
82,0211-699501013259,respecto,o
82,0211-699501013259,al,o
82,0211-699501013259,inicio,o
82,0211-699501013259,337,o
82,0211-699501013259,IC,o
82,0211-699501013259,327,o
82,0211-699501013259,346,o
82,0211-699501013259,vs,o
82,0211-699501013259,350,o
82,0211-699501013259,IC,o
82,0211-699501013259,337,o
82,0211-699501013259,363,o
82,0211-699501013259,p,o
82,0211-699501013259,005,o
82,0211-699501013259,Conclusion,o
82,0211-699501013259,Tras,o
82,0211-699501013259,suplementacion,i
82,0211-699501013259,con,o
82,0211-699501013259,acido,i
82,0211-699501013259,folico,i
82,0211-699501013259,y,o
82,0211-699501013259,vitamina,i
82,0211-699501013259,B6,i
82,0211-699501013259,aunque,o
82,0211-699501013259,inicialmente,o
82,0211-699501013259,se,o
82,0211-699501013259,reduce,o
82,0211-699501013259,la,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,esta,o
82,0211-699501013259,respuesta,o
82,0211-699501013259,se,o
82,0211-699501013259,hace,o
82,0211-699501013259,refractaria,o
82,0211-699501013259,correlacionandose,o
82,0211-699501013259,directamente,o
82,0211-699501013259,la,o
82,0211-699501013259,tHcy,i
82,0211-699501013259,con,o
82,0211-699501013259,la,o
82,0211-699501013259,albumina,i
82,0211-699501013259,plasmatica,i
82,0211-699501013259,La,o
82,0211-699501013259,interpretacion,o
82,0211-699501013259,de,o
82,0211-699501013259,los,o
82,0211-699501013259,niveles,i
82,0211-699501013259,de,i
82,0211-699501013259,tHcy,i
82,0211-699501013259,debe,o
82,0211-699501013259,tener,o
82,0211-699501013259,en,o
82,0211-699501013259,cuenta,o
82,0211-699501013259,la,o
82,0211-699501013259,concentracion,i
82,0211-699501013259,de,i
82,0211-699501013259,albumina,i
83,0211-699501013259,Efecto,o
83,0211-699501013259,de,o
83,0211-699501013259,la,o
83,0211-699501013259,suplementacion,i
83,0211-699501013259,con,o
83,0211-699501013259,acido,i
83,0211-699501013259,folico,i
83,0211-699501013259,sobre,o
83,0211-699501013259,los,o
83,0211-699501013259,niveles,i
83,0211-699501013259,de,i
83,0211-699501013259,homocisteina,i
83,0211-699501013259,total,o
83,0211-699501013259,en,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,en,o
83,0211-699501013259,hemodialisis,i
83,0211-699501013259,La,o
83,0211-699501013259,hiperhomocisteinemia,i
83,0211-699501013259,es,o
83,0211-699501013259,un,o
83,0211-699501013259,marcador,o
83,0211-699501013259,de,o
83,0211-699501013259,riesgo,o
83,0211-699501013259,independiente,o
83,0211-699501013259,de,o
83,0211-699501013259,morbimortalidad,o
83,0211-699501013259,cardiovascular,i
83,0211-699501013259,Hemos,o
83,0211-699501013259,intentado,o
83,0211-699501013259,prospectivamente,o
83,0211-699501013259,reducir,o
83,0211-699501013259,los,o
83,0211-699501013259,niveles,i
83,0211-699501013259,de,i
83,0211-699501013259,homocisteina,i
83,0211-699501013259,total,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,mediante,o
83,0211-699501013259,suplemento,o
83,0211-699501013259,con,o
83,0211-699501013259,acido,i
83,0211-699501013259,folico,i
83,0211-699501013259,y,o
83,0211-699501013259,vitamina,i
83,0211-699501013259,B6,i
83,0211-699501013259,pp,i
83,0211-699501013259,valorando,o
83,0211-699501013259,su,o
83,0211-699501013259,posible,o
83,0211-699501013259,correlacion,o
83,0211-699501013259,con,o
83,0211-699501013259,dosis,o
83,0211-699501013259,de,o
83,0211-699501013259,dialisis,i
83,0211-699501013259,funcion,i
83,0211-699501013259,residual,i
83,0211-699501013259,y,o
83,0211-699501013259,parametros,o
83,0211-699501013259,nutricionales,o
83,0211-699501013259,Metodos,o
83,0211-699501013259,Todos,o
83,0211-699501013259,los,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,en,o
83,0211-699501013259,hemodialisis,i
83,0211-699501013259,al,o
83,0211-699501013259,comienzo,o
83,0211-699501013259,del,o
83,0211-699501013259,estudio,o
83,0211-699501013259,que,o
83,0211-699501013259,no,o
83,0211-699501013259,recibian,o
83,0211-699501013259,acido,i
83,0211-699501013259,folico,i
83,0211-699501013259,ni,o
83,0211-699501013259,vitamina,i
83,0211-699501013259,B6,i
83,0211-699501013259,asi,o
83,0211-699501013259,como,o
83,0211-699501013259,los,o
83,0211-699501013259,incorporados,o
83,0211-699501013259,posteriormente,o
83,0211-699501013259,a,o
83,0211-699501013259,partir,o
83,0211-699501013259,de,o
83,0211-699501013259,su,o
83,0211-699501013259,tercer,o
83,0211-699501013259,mes,o
83,0211-699501013259,en,o
83,0211-699501013259,hemodialisis,i
83,0211-699501013259,recibieron,o
83,0211-699501013259,5,o
83,0211-699501013259,mg,o
83,0211-699501013259,orales,o
83,0211-699501013259,de,o
83,0211-699501013259,acido,i
83,0211-699501013259,folico,i
83,0211-699501013259,cada,o
83,0211-699501013259,48,o
83,0211-699501013259,horas,o
83,0211-699501013259,y,o
83,0211-699501013259,40,o
83,0211-699501013259,mg,o
83,0211-699501013259,orales,o
83,0211-699501013259,de,o
83,0211-699501013259,vitamina,i
83,0211-699501013259,B6,i
83,0211-699501013259,cada,o
83,0211-699501013259,semana,o
83,0211-699501013259,Se,o
83,0211-699501013259,determinaron,o
83,0211-699501013259,al,o
83,0211-699501013259,comienzo,o
83,0211-699501013259,del,o
83,0211-699501013259,estudio,o
83,0211-699501013259,y,o
83,0211-699501013259,cada,o
83,0211-699501013259,2,o
83,0211-699501013259,meses,o
83,0211-699501013259,niveles,i
83,0211-699501013259,de,i
83,0211-699501013259,folato,i
83,0211-699501013259,vitamina,i
83,0211-699501013259,B12,i
83,0211-699501013259,inmunoensayo,i
83,0211-699501013259,albumina,i
83,0211-699501013259,y,o
83,0211-699501013259,cinetica,o
83,0211-699501013259,de,o
83,0211-699501013259,la,o
83,0211-699501013259,urea,i
83,0211-699501013259,KTV,o
83,0211-699501013259,KRU,o
83,0211-699501013259,PCRn,o
83,0211-699501013259,y,o
83,0211-699501013259,cada,o
83,0211-699501013259,6,o
83,0211-699501013259,meses,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,HPLC,i
83,0211-699501013259,y,o
83,0211-699501013259,pp,i
83,0211-699501013259,RIA,i
83,0211-699501013259,Resultados,o
83,0211-699501013259,80,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,fueron,o
83,0211-699501013259,incluidos,o
83,0211-699501013259,en,o
83,0211-699501013259,el,o
83,0211-699501013259,estudio,o
83,0211-699501013259,basal,o
83,0211-699501013259,con,o
83,0211-699501013259,una,o
83,0211-699501013259,prevalencia,o
83,0211-699501013259,de,o
83,0211-699501013259,hiperhomocisteinemia,i
83,0211-699501013259,del,o
83,0211-699501013259,844,o
83,0211-699501013259,deficit,i
83,0211-699501013259,de,i
83,0211-699501013259,pp,i
83,0211-699501013259,en,o
83,0211-699501013259,el,o
83,0211-699501013259,32,o
83,0211-699501013259,y,o
83,0211-699501013259,folato,i
83,0211-699501013259,en,o
83,0211-699501013259,el,o
83,0211-699501013259,rango,o
83,0211-699501013259,normal,o
83,0211-699501013259,bajo,o
83,0211-699501013259,los,o
83,0211-699501013259,niveles,i
83,0211-699501013259,de,i
83,0211-699501013259,tHcy,i
83,0211-699501013259,se,o
83,0211-699501013259,correlacionaban,o
83,0211-699501013259,inversamente,o
83,0211-699501013259,con,o
83,0211-699501013259,los,o
83,0211-699501013259,del,o
83,0211-699501013259,folato,i
83,0211-699501013259,r,o
83,0211-699501013259,0336,o
83,0211-699501013259,p,o
83,0211-699501013259,001,o
83,0211-699501013259,pero,o
83,0211-699501013259,no,o
83,0211-699501013259,con,o
83,0211-699501013259,pp,i
83,0211-699501013259,B12,i
83,0211-699501013259,edad,o
83,0211-699501013259,albumina,i
83,0211-699501013259,KTV,o
83,0211-699501013259,KRU,o
83,0211-699501013259,PCRn,o
83,0211-699501013259,Cincuenta,o
83,0211-699501013259,y,o
83,0211-699501013259,ocho,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,recibieron,o
83,0211-699501013259,seis,o
83,0211-699501013259,meses,o
83,0211-699501013259,de,o
83,0211-699501013259,suplementacion,i
83,0211-699501013259,con,o
83,0211-699501013259,normalizacion,o
83,0211-699501013259,del,o
83,0211-699501013259,pp,i
83,0211-699501013259,aumento,o
83,0211-699501013259,del,o
83,0211-699501013259,folato,i
83,0211-699501013259,703,o
83,0211-699501013259,IC,o
83,0211-699501013259,638,o
83,0211-699501013259,795,o
83,0211-699501013259,vs,o
83,0211-699501013259,6181,o
83,0211-699501013259,IC,o
83,0211-699501013259,4447,o
83,0211-699501013259,7811,o
83,0211-699501013259,p,o
83,0211-699501013259,0001,o
83,0211-699501013259,y,o
83,0211-699501013259,descenso,o
83,0211-699501013259,de,o
83,0211-699501013259,la,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,240,o
83,0211-699501013259,IC,o
83,0211-699501013259,213,o
83,0211-699501013259,264,o
83,0211-699501013259,vs,o
83,0211-699501013259,199,o
83,0211-699501013259,IC,o
83,0211-699501013259,175,o
83,0211-699501013259,224,o
83,0211-699501013259,p,o
83,0211-699501013259,005,o
83,0211-699501013259,Han,o
83,0211-699501013259,recibido,o
83,0211-699501013259,suplementacion,i
83,0211-699501013259,durante,o
83,0211-699501013259,12,o
83,0211-699501013259,meses,o
83,0211-699501013259,33,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,pero,o
83,0211-699501013259,a,o
83,0211-699501013259,pesar,o
83,0211-699501013259,de,o
83,0211-699501013259,un,o
83,0211-699501013259,continuo,o
83,0211-699501013259,aumento,o
83,0211-699501013259,del,o
83,0211-699501013259,folato,i
83,0211-699501013259,10078,o
83,0211-699501013259,IC,o
83,0211-699501013259,7481,o
83,0211-699501013259,12674,o
83,0211-699501013259,p,o
83,0211-699501013259,0001,o
83,0211-699501013259,solo,o
83,0211-699501013259,3,o
83,0211-699501013259,pacientes,o
83,0211-699501013259,presentan,o
83,0211-699501013259,niveles,o
83,0211-699501013259,normales,o
83,0211-699501013259,de,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,correlacionandose,o
83,0211-699501013259,directamente,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,con,o
83,0211-699501013259,la,o
83,0211-699501013259,albumina,i
83,0211-699501013259,r,o
83,0211-699501013259,056,o
83,0211-699501013259,p,o
83,0211-699501013259,0001,o
83,0211-699501013259,que,o
83,0211-699501013259,se,o
83,0211-699501013259,elevo,o
83,0211-699501013259,con,o
83,0211-699501013259,respecto,o
83,0211-699501013259,al,o
83,0211-699501013259,inicio,o
83,0211-699501013259,337,o
83,0211-699501013259,IC,o
83,0211-699501013259,327,o
83,0211-699501013259,346,o
83,0211-699501013259,vs,o
83,0211-699501013259,350,o
83,0211-699501013259,IC,o
83,0211-699501013259,337,o
83,0211-699501013259,363,o
83,0211-699501013259,p,o
83,0211-699501013259,005,o
83,0211-699501013259,Conclusion,o
83,0211-699501013259,Tras,o
83,0211-699501013259,suplementacion,i
83,0211-699501013259,con,o
83,0211-699501013259,acido,i
83,0211-699501013259,folico,i
83,0211-699501013259,y,o
83,0211-699501013259,vitamina,i
83,0211-699501013259,B6,i
83,0211-699501013259,aunque,o
83,0211-699501013259,inicialmente,o
83,0211-699501013259,se,o
83,0211-699501013259,reduce,o
83,0211-699501013259,la,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,esta,o
83,0211-699501013259,respuesta,o
83,0211-699501013259,se,o
83,0211-699501013259,hace,o
83,0211-699501013259,refractaria,o
83,0211-699501013259,correlacionandose,o
83,0211-699501013259,directamente,o
83,0211-699501013259,la,o
83,0211-699501013259,tHcy,i
83,0211-699501013259,con,o
83,0211-699501013259,la,o
83,0211-699501013259,albumina,i
83,0211-699501013259,plasmatica,i
83,0211-699501013259,La,o
83,0211-699501013259,interpretacion,o
83,0211-699501013259,de,o
83,0211-699501013259,los,o
83,0211-699501013259,niveles,i
83,0211-699501013259,de,i
83,0211-699501013259,tHcy,i
83,0211-699501013259,debe,o
83,0211-699501013259,tener,o
83,0211-699501013259,en,o
83,0211-699501013259,cuenta,o
83,0211-699501013259,la,o
83,0211-699501013259,concentracion,i
83,0211-699501013259,de,i
83,0211-699501013259,albumina,i
84,0211-699501013259,Efecto,o
84,0211-699501013259,de,o
84,0211-699501013259,la,o
84,0211-699501013259,suplementacion,i
84,0211-699501013259,con,o
84,0211-699501013259,acido,i
84,0211-699501013259,folico,i
84,0211-699501013259,sobre,o
84,0211-699501013259,los,o
84,0211-699501013259,niveles,i
84,0211-699501013259,de,i
84,0211-699501013259,homocisteina,i
84,0211-699501013259,total,o
84,0211-699501013259,en,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,en,o
84,0211-699501013259,hemodialisis,i
84,0211-699501013259,La,o
84,0211-699501013259,hiperhomocisteinemia,i
84,0211-699501013259,es,o
84,0211-699501013259,un,o
84,0211-699501013259,marcador,o
84,0211-699501013259,de,o
84,0211-699501013259,riesgo,o
84,0211-699501013259,independiente,o
84,0211-699501013259,de,o
84,0211-699501013259,morbimortalidad,o
84,0211-699501013259,cardiovascular,i
84,0211-699501013259,Hemos,o
84,0211-699501013259,intentado,o
84,0211-699501013259,prospectivamente,o
84,0211-699501013259,reducir,o
84,0211-699501013259,los,o
84,0211-699501013259,niveles,i
84,0211-699501013259,de,i
84,0211-699501013259,homocisteina,i
84,0211-699501013259,total,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,mediante,o
84,0211-699501013259,suplemento,o
84,0211-699501013259,con,o
84,0211-699501013259,acido,i
84,0211-699501013259,folico,i
84,0211-699501013259,y,o
84,0211-699501013259,vitamina,i
84,0211-699501013259,B6,i
84,0211-699501013259,pp,i
84,0211-699501013259,valorando,o
84,0211-699501013259,su,o
84,0211-699501013259,posible,o
84,0211-699501013259,correlacion,o
84,0211-699501013259,con,o
84,0211-699501013259,dosis,o
84,0211-699501013259,de,o
84,0211-699501013259,dialisis,i
84,0211-699501013259,funcion,i
84,0211-699501013259,residual,i
84,0211-699501013259,y,o
84,0211-699501013259,parametros,o
84,0211-699501013259,nutricionales,o
84,0211-699501013259,Metodos,o
84,0211-699501013259,Todos,o
84,0211-699501013259,los,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,en,o
84,0211-699501013259,hemodialisis,i
84,0211-699501013259,al,o
84,0211-699501013259,comienzo,o
84,0211-699501013259,del,o
84,0211-699501013259,estudio,o
84,0211-699501013259,que,o
84,0211-699501013259,no,o
84,0211-699501013259,recibian,o
84,0211-699501013259,acido,i
84,0211-699501013259,folico,i
84,0211-699501013259,ni,o
84,0211-699501013259,vitamina,i
84,0211-699501013259,B6,i
84,0211-699501013259,asi,o
84,0211-699501013259,como,o
84,0211-699501013259,los,o
84,0211-699501013259,incorporados,o
84,0211-699501013259,posteriormente,o
84,0211-699501013259,a,o
84,0211-699501013259,partir,o
84,0211-699501013259,de,o
84,0211-699501013259,su,o
84,0211-699501013259,tercer,o
84,0211-699501013259,mes,o
84,0211-699501013259,en,o
84,0211-699501013259,hemodialisis,i
84,0211-699501013259,recibieron,o
84,0211-699501013259,5,o
84,0211-699501013259,mg,o
84,0211-699501013259,orales,o
84,0211-699501013259,de,o
84,0211-699501013259,acido,i
84,0211-699501013259,folico,i
84,0211-699501013259,cada,o
84,0211-699501013259,48,o
84,0211-699501013259,horas,o
84,0211-699501013259,y,o
84,0211-699501013259,40,o
84,0211-699501013259,mg,o
84,0211-699501013259,orales,o
84,0211-699501013259,de,o
84,0211-699501013259,vitamina,i
84,0211-699501013259,B6,i
84,0211-699501013259,cada,o
84,0211-699501013259,semana,o
84,0211-699501013259,Se,o
84,0211-699501013259,determinaron,o
84,0211-699501013259,al,o
84,0211-699501013259,comienzo,o
84,0211-699501013259,del,o
84,0211-699501013259,estudio,o
84,0211-699501013259,y,o
84,0211-699501013259,cada,o
84,0211-699501013259,2,o
84,0211-699501013259,meses,o
84,0211-699501013259,niveles,i
84,0211-699501013259,de,i
84,0211-699501013259,folato,i
84,0211-699501013259,vitamina,i
84,0211-699501013259,B12,i
84,0211-699501013259,inmunoensayo,i
84,0211-699501013259,albumina,i
84,0211-699501013259,y,o
84,0211-699501013259,cinetica,o
84,0211-699501013259,de,o
84,0211-699501013259,la,o
84,0211-699501013259,urea,i
84,0211-699501013259,KTV,o
84,0211-699501013259,KRU,o
84,0211-699501013259,PCRn,o
84,0211-699501013259,y,o
84,0211-699501013259,cada,o
84,0211-699501013259,6,o
84,0211-699501013259,meses,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,HPLC,i
84,0211-699501013259,y,o
84,0211-699501013259,pp,i
84,0211-699501013259,RIA,i
84,0211-699501013259,Resultados,o
84,0211-699501013259,80,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,fueron,o
84,0211-699501013259,incluidos,o
84,0211-699501013259,en,o
84,0211-699501013259,el,o
84,0211-699501013259,estudio,o
84,0211-699501013259,basal,o
84,0211-699501013259,con,o
84,0211-699501013259,una,o
84,0211-699501013259,prevalencia,o
84,0211-699501013259,de,o
84,0211-699501013259,hiperhomocisteinemia,i
84,0211-699501013259,del,o
84,0211-699501013259,844,o
84,0211-699501013259,deficit,i
84,0211-699501013259,de,i
84,0211-699501013259,pp,i
84,0211-699501013259,en,o
84,0211-699501013259,el,o
84,0211-699501013259,32,o
84,0211-699501013259,y,o
84,0211-699501013259,folato,i
84,0211-699501013259,en,o
84,0211-699501013259,el,o
84,0211-699501013259,rango,o
84,0211-699501013259,normal,o
84,0211-699501013259,bajo,o
84,0211-699501013259,los,o
84,0211-699501013259,niveles,i
84,0211-699501013259,de,i
84,0211-699501013259,tHcy,i
84,0211-699501013259,se,o
84,0211-699501013259,correlacionaban,o
84,0211-699501013259,inversamente,o
84,0211-699501013259,con,o
84,0211-699501013259,los,o
84,0211-699501013259,del,o
84,0211-699501013259,folato,i
84,0211-699501013259,r,o
84,0211-699501013259,0336,o
84,0211-699501013259,p,o
84,0211-699501013259,001,o
84,0211-699501013259,pero,o
84,0211-699501013259,no,o
84,0211-699501013259,con,o
84,0211-699501013259,pp,i
84,0211-699501013259,B12,i
84,0211-699501013259,edad,o
84,0211-699501013259,albumina,i
84,0211-699501013259,KTV,o
84,0211-699501013259,KRU,o
84,0211-699501013259,PCRn,o
84,0211-699501013259,Cincuenta,o
84,0211-699501013259,y,o
84,0211-699501013259,ocho,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,recibieron,o
84,0211-699501013259,seis,o
84,0211-699501013259,meses,o
84,0211-699501013259,de,o
84,0211-699501013259,suplementacion,i
84,0211-699501013259,con,o
84,0211-699501013259,normalizacion,o
84,0211-699501013259,del,o
84,0211-699501013259,pp,i
84,0211-699501013259,aumento,o
84,0211-699501013259,del,o
84,0211-699501013259,folato,i
84,0211-699501013259,703,o
84,0211-699501013259,IC,o
84,0211-699501013259,638,o
84,0211-699501013259,795,o
84,0211-699501013259,vs,o
84,0211-699501013259,6181,o
84,0211-699501013259,IC,o
84,0211-699501013259,4447,o
84,0211-699501013259,7811,o
84,0211-699501013259,p,o
84,0211-699501013259,0001,o
84,0211-699501013259,y,o
84,0211-699501013259,descenso,o
84,0211-699501013259,de,o
84,0211-699501013259,la,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,240,o
84,0211-699501013259,IC,o
84,0211-699501013259,213,o
84,0211-699501013259,264,o
84,0211-699501013259,vs,o
84,0211-699501013259,199,o
84,0211-699501013259,IC,o
84,0211-699501013259,175,o
84,0211-699501013259,224,o
84,0211-699501013259,p,o
84,0211-699501013259,005,o
84,0211-699501013259,Han,o
84,0211-699501013259,recibido,o
84,0211-699501013259,suplementacion,i
84,0211-699501013259,durante,o
84,0211-699501013259,12,o
84,0211-699501013259,meses,o
84,0211-699501013259,33,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,pero,o
84,0211-699501013259,a,o
84,0211-699501013259,pesar,o
84,0211-699501013259,de,o
84,0211-699501013259,un,o
84,0211-699501013259,continuo,o
84,0211-699501013259,aumento,o
84,0211-699501013259,del,o
84,0211-699501013259,folato,i
84,0211-699501013259,10078,o
84,0211-699501013259,IC,o
84,0211-699501013259,7481,o
84,0211-699501013259,12674,o
84,0211-699501013259,p,o
84,0211-699501013259,0001,o
84,0211-699501013259,solo,o
84,0211-699501013259,3,o
84,0211-699501013259,pacientes,o
84,0211-699501013259,presentan,o
84,0211-699501013259,niveles,o
84,0211-699501013259,normales,o
84,0211-699501013259,de,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,correlacionandose,o
84,0211-699501013259,directamente,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,con,o
84,0211-699501013259,la,o
84,0211-699501013259,albumina,i
84,0211-699501013259,r,o
84,0211-699501013259,056,o
84,0211-699501013259,p,o
84,0211-699501013259,0001,o
84,0211-699501013259,que,o
84,0211-699501013259,se,o
84,0211-699501013259,elevo,o
84,0211-699501013259,con,o
84,0211-699501013259,respecto,o
84,0211-699501013259,al,o
84,0211-699501013259,inicio,o
84,0211-699501013259,337,o
84,0211-699501013259,IC,o
84,0211-699501013259,327,o
84,0211-699501013259,346,o
84,0211-699501013259,vs,o
84,0211-699501013259,350,o
84,0211-699501013259,IC,o
84,0211-699501013259,337,o
84,0211-699501013259,363,o
84,0211-699501013259,p,o
84,0211-699501013259,005,o
84,0211-699501013259,Conclusion,o
84,0211-699501013259,Tras,o
84,0211-699501013259,suplementacion,i
84,0211-699501013259,con,o
84,0211-699501013259,acido,i
84,0211-699501013259,folico,i
84,0211-699501013259,y,o
84,0211-699501013259,vitamina,i
84,0211-699501013259,B6,i
84,0211-699501013259,aunque,o
84,0211-699501013259,inicialmente,o
84,0211-699501013259,se,o
84,0211-699501013259,reduce,o
84,0211-699501013259,la,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,esta,o
84,0211-699501013259,respuesta,o
84,0211-699501013259,se,o
84,0211-699501013259,hace,o
84,0211-699501013259,refractaria,o
84,0211-699501013259,correlacionandose,o
84,0211-699501013259,directamente,o
84,0211-699501013259,la,o
84,0211-699501013259,tHcy,i
84,0211-699501013259,con,o
84,0211-699501013259,la,o
84,0211-699501013259,albumina,i
84,0211-699501013259,plasmatica,i
84,0211-699501013259,La,o
84,0211-699501013259,interpretacion,o
84,0211-699501013259,de,o
84,0211-699501013259,los,o
84,0211-699501013259,niveles,i
84,0211-699501013259,de,i
84,0211-699501013259,tHcy,i
84,0211-699501013259,debe,o
84,0211-699501013259,tener,o
84,0211-699501013259,en,o
84,0211-699501013259,cuenta,o
84,0211-699501013259,la,o
84,0211-699501013259,concentracion,i
84,0211-699501013259,de,i
84,0211-699501013259,albumina,i
85,0211-699501013259,Efecto,o
85,0211-699501013259,de,o
85,0211-699501013259,la,o
85,0211-699501013259,suplementacion,i
85,0211-699501013259,con,o
85,0211-699501013259,acido,i
85,0211-699501013259,folico,i
85,0211-699501013259,sobre,o
85,0211-699501013259,los,o
85,0211-699501013259,niveles,i
85,0211-699501013259,de,i
85,0211-699501013259,homocisteina,i
85,0211-699501013259,total,o
85,0211-699501013259,en,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,en,o
85,0211-699501013259,hemodialisis,i
85,0211-699501013259,La,o
85,0211-699501013259,hiperhomocisteinemia,i
85,0211-699501013259,es,o
85,0211-699501013259,un,o
85,0211-699501013259,marcador,o
85,0211-699501013259,de,o
85,0211-699501013259,riesgo,o
85,0211-699501013259,independiente,o
85,0211-699501013259,de,o
85,0211-699501013259,morbimortalidad,o
85,0211-699501013259,cardiovascular,i
85,0211-699501013259,Hemos,o
85,0211-699501013259,intentado,o
85,0211-699501013259,prospectivamente,o
85,0211-699501013259,reducir,o
85,0211-699501013259,los,o
85,0211-699501013259,niveles,i
85,0211-699501013259,de,i
85,0211-699501013259,homocisteina,i
85,0211-699501013259,total,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,mediante,o
85,0211-699501013259,suplemento,o
85,0211-699501013259,con,o
85,0211-699501013259,acido,i
85,0211-699501013259,folico,i
85,0211-699501013259,y,o
85,0211-699501013259,vitamina,i
85,0211-699501013259,B6,i
85,0211-699501013259,pp,i
85,0211-699501013259,valorando,o
85,0211-699501013259,su,o
85,0211-699501013259,posible,o
85,0211-699501013259,correlacion,o
85,0211-699501013259,con,o
85,0211-699501013259,dosis,o
85,0211-699501013259,de,o
85,0211-699501013259,dialisis,i
85,0211-699501013259,funcion,i
85,0211-699501013259,residual,i
85,0211-699501013259,y,o
85,0211-699501013259,parametros,o
85,0211-699501013259,nutricionales,o
85,0211-699501013259,Metodos,o
85,0211-699501013259,Todos,o
85,0211-699501013259,los,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,en,o
85,0211-699501013259,hemodialisis,i
85,0211-699501013259,al,o
85,0211-699501013259,comienzo,o
85,0211-699501013259,del,o
85,0211-699501013259,estudio,o
85,0211-699501013259,que,o
85,0211-699501013259,no,o
85,0211-699501013259,recibian,o
85,0211-699501013259,acido,i
85,0211-699501013259,folico,i
85,0211-699501013259,ni,o
85,0211-699501013259,vitamina,i
85,0211-699501013259,B6,i
85,0211-699501013259,asi,o
85,0211-699501013259,como,o
85,0211-699501013259,los,o
85,0211-699501013259,incorporados,o
85,0211-699501013259,posteriormente,o
85,0211-699501013259,a,o
85,0211-699501013259,partir,o
85,0211-699501013259,de,o
85,0211-699501013259,su,o
85,0211-699501013259,tercer,o
85,0211-699501013259,mes,o
85,0211-699501013259,en,o
85,0211-699501013259,hemodialisis,i
85,0211-699501013259,recibieron,o
85,0211-699501013259,5,o
85,0211-699501013259,mg,o
85,0211-699501013259,orales,o
85,0211-699501013259,de,o
85,0211-699501013259,acido,i
85,0211-699501013259,folico,i
85,0211-699501013259,cada,o
85,0211-699501013259,48,o
85,0211-699501013259,horas,o
85,0211-699501013259,y,o
85,0211-699501013259,40,o
85,0211-699501013259,mg,o
85,0211-699501013259,orales,o
85,0211-699501013259,de,o
85,0211-699501013259,vitamina,i
85,0211-699501013259,B6,i
85,0211-699501013259,cada,o
85,0211-699501013259,semana,o
85,0211-699501013259,Se,o
85,0211-699501013259,determinaron,o
85,0211-699501013259,al,o
85,0211-699501013259,comienzo,o
85,0211-699501013259,del,o
85,0211-699501013259,estudio,o
85,0211-699501013259,y,o
85,0211-699501013259,cada,o
85,0211-699501013259,2,o
85,0211-699501013259,meses,o
85,0211-699501013259,niveles,i
85,0211-699501013259,de,i
85,0211-699501013259,folato,i
85,0211-699501013259,vitamina,i
85,0211-699501013259,B12,i
85,0211-699501013259,inmunoensayo,i
85,0211-699501013259,albumina,i
85,0211-699501013259,y,o
85,0211-699501013259,cinetica,o
85,0211-699501013259,de,o
85,0211-699501013259,la,o
85,0211-699501013259,urea,i
85,0211-699501013259,KTV,o
85,0211-699501013259,KRU,o
85,0211-699501013259,PCRn,o
85,0211-699501013259,y,o
85,0211-699501013259,cada,o
85,0211-699501013259,6,o
85,0211-699501013259,meses,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,HPLC,i
85,0211-699501013259,y,o
85,0211-699501013259,pp,i
85,0211-699501013259,RIA,i
85,0211-699501013259,Resultados,o
85,0211-699501013259,80,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,fueron,o
85,0211-699501013259,incluidos,o
85,0211-699501013259,en,o
85,0211-699501013259,el,o
85,0211-699501013259,estudio,o
85,0211-699501013259,basal,o
85,0211-699501013259,con,o
85,0211-699501013259,una,o
85,0211-699501013259,prevalencia,o
85,0211-699501013259,de,o
85,0211-699501013259,hiperhomocisteinemia,i
85,0211-699501013259,del,o
85,0211-699501013259,844,o
85,0211-699501013259,deficit,i
85,0211-699501013259,de,i
85,0211-699501013259,pp,i
85,0211-699501013259,en,o
85,0211-699501013259,el,o
85,0211-699501013259,32,o
85,0211-699501013259,y,o
85,0211-699501013259,folato,i
85,0211-699501013259,en,o
85,0211-699501013259,el,o
85,0211-699501013259,rango,o
85,0211-699501013259,normal,o
85,0211-699501013259,bajo,o
85,0211-699501013259,los,o
85,0211-699501013259,niveles,i
85,0211-699501013259,de,i
85,0211-699501013259,tHcy,i
85,0211-699501013259,se,o
85,0211-699501013259,correlacionaban,o
85,0211-699501013259,inversamente,o
85,0211-699501013259,con,o
85,0211-699501013259,los,o
85,0211-699501013259,del,o
85,0211-699501013259,folato,i
85,0211-699501013259,r,o
85,0211-699501013259,0336,o
85,0211-699501013259,p,o
85,0211-699501013259,001,o
85,0211-699501013259,pero,o
85,0211-699501013259,no,o
85,0211-699501013259,con,o
85,0211-699501013259,pp,i
85,0211-699501013259,B12,i
85,0211-699501013259,edad,o
85,0211-699501013259,albumina,i
85,0211-699501013259,KTV,o
85,0211-699501013259,KRU,o
85,0211-699501013259,PCRn,o
85,0211-699501013259,Cincuenta,o
85,0211-699501013259,y,o
85,0211-699501013259,ocho,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,recibieron,o
85,0211-699501013259,seis,o
85,0211-699501013259,meses,o
85,0211-699501013259,de,o
85,0211-699501013259,suplementacion,i
85,0211-699501013259,con,o
85,0211-699501013259,normalizacion,o
85,0211-699501013259,del,o
85,0211-699501013259,pp,i
85,0211-699501013259,aumento,o
85,0211-699501013259,del,o
85,0211-699501013259,folato,i
85,0211-699501013259,703,o
85,0211-699501013259,IC,o
85,0211-699501013259,638,o
85,0211-699501013259,795,o
85,0211-699501013259,vs,o
85,0211-699501013259,6181,o
85,0211-699501013259,IC,o
85,0211-699501013259,4447,o
85,0211-699501013259,7811,o
85,0211-699501013259,p,o
85,0211-699501013259,0001,o
85,0211-699501013259,y,o
85,0211-699501013259,descenso,o
85,0211-699501013259,de,o
85,0211-699501013259,la,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,240,o
85,0211-699501013259,IC,o
85,0211-699501013259,213,o
85,0211-699501013259,264,o
85,0211-699501013259,vs,o
85,0211-699501013259,199,o
85,0211-699501013259,IC,o
85,0211-699501013259,175,o
85,0211-699501013259,224,o
85,0211-699501013259,p,o
85,0211-699501013259,005,o
85,0211-699501013259,Han,o
85,0211-699501013259,recibido,o
85,0211-699501013259,suplementacion,i
85,0211-699501013259,durante,o
85,0211-699501013259,12,o
85,0211-699501013259,meses,o
85,0211-699501013259,33,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,pero,o
85,0211-699501013259,a,o
85,0211-699501013259,pesar,o
85,0211-699501013259,de,o
85,0211-699501013259,un,o
85,0211-699501013259,continuo,o
85,0211-699501013259,aumento,o
85,0211-699501013259,del,o
85,0211-699501013259,folato,i
85,0211-699501013259,10078,o
85,0211-699501013259,IC,o
85,0211-699501013259,7481,o
85,0211-699501013259,12674,o
85,0211-699501013259,p,o
85,0211-699501013259,0001,o
85,0211-699501013259,solo,o
85,0211-699501013259,3,o
85,0211-699501013259,pacientes,o
85,0211-699501013259,presentan,o
85,0211-699501013259,niveles,o
85,0211-699501013259,normales,o
85,0211-699501013259,de,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,correlacionandose,o
85,0211-699501013259,directamente,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,con,o
85,0211-699501013259,la,o
85,0211-699501013259,albumina,i
85,0211-699501013259,r,o
85,0211-699501013259,056,o
85,0211-699501013259,p,o
85,0211-699501013259,0001,o
85,0211-699501013259,que,o
85,0211-699501013259,se,o
85,0211-699501013259,elevo,o
85,0211-699501013259,con,o
85,0211-699501013259,respecto,o
85,0211-699501013259,al,o
85,0211-699501013259,inicio,o
85,0211-699501013259,337,o
85,0211-699501013259,IC,o
85,0211-699501013259,327,o
85,0211-699501013259,346,o
85,0211-699501013259,vs,o
85,0211-699501013259,350,o
85,0211-699501013259,IC,o
85,0211-699501013259,337,o
85,0211-699501013259,363,o
85,0211-699501013259,p,o
85,0211-699501013259,005,o
85,0211-699501013259,Conclusion,o
85,0211-699501013259,Tras,o
85,0211-699501013259,suplementacion,i
85,0211-699501013259,con,o
85,0211-699501013259,acido,i
85,0211-699501013259,folico,i
85,0211-699501013259,y,o
85,0211-699501013259,vitamina,i
85,0211-699501013259,B6,i
85,0211-699501013259,aunque,o
85,0211-699501013259,inicialmente,o
85,0211-699501013259,se,o
85,0211-699501013259,reduce,o
85,0211-699501013259,la,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,esta,o
85,0211-699501013259,respuesta,o
85,0211-699501013259,se,o
85,0211-699501013259,hace,o
85,0211-699501013259,refractaria,o
85,0211-699501013259,correlacionandose,o
85,0211-699501013259,directamente,o
85,0211-699501013259,la,o
85,0211-699501013259,tHcy,i
85,0211-699501013259,con,o
85,0211-699501013259,la,o
85,0211-699501013259,albumina,i
85,0211-699501013259,plasmatica,i
85,0211-699501013259,La,o
85,0211-699501013259,interpretacion,o
85,0211-699501013259,de,o
85,0211-699501013259,los,o
85,0211-699501013259,niveles,i
85,0211-699501013259,de,i
85,0211-699501013259,tHcy,i
85,0211-699501013259,debe,o
85,0211-699501013259,tener,o
85,0211-699501013259,en,o
85,0211-699501013259,cuenta,o
85,0211-699501013259,la,o
85,0211-699501013259,concentracion,i
85,0211-699501013259,de,i
85,0211-699501013259,albumina,i
86,0211-699501013259,Efecto,o
86,0211-699501013259,de,o
86,0211-699501013259,la,o
86,0211-699501013259,suplementacion,i
86,0211-699501013259,con,o
86,0211-699501013259,acido,i
86,0211-699501013259,folico,i
86,0211-699501013259,sobre,o
86,0211-699501013259,los,o
86,0211-699501013259,niveles,i
86,0211-699501013259,de,i
86,0211-699501013259,homocisteina,i
86,0211-699501013259,total,o
86,0211-699501013259,en,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,en,o
86,0211-699501013259,hemodialisis,i
86,0211-699501013259,La,o
86,0211-699501013259,hiperhomocisteinemia,i
86,0211-699501013259,es,o
86,0211-699501013259,un,o
86,0211-699501013259,marcador,o
86,0211-699501013259,de,o
86,0211-699501013259,riesgo,o
86,0211-699501013259,independiente,o
86,0211-699501013259,de,o
86,0211-699501013259,morbimortalidad,o
86,0211-699501013259,cardiovascular,i
86,0211-699501013259,Hemos,o
86,0211-699501013259,intentado,o
86,0211-699501013259,prospectivamente,o
86,0211-699501013259,reducir,o
86,0211-699501013259,los,o
86,0211-699501013259,niveles,i
86,0211-699501013259,de,i
86,0211-699501013259,homocisteina,i
86,0211-699501013259,total,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,mediante,o
86,0211-699501013259,suplemento,o
86,0211-699501013259,con,o
86,0211-699501013259,acido,i
86,0211-699501013259,folico,i
86,0211-699501013259,y,o
86,0211-699501013259,vitamina,i
86,0211-699501013259,B6,i
86,0211-699501013259,pp,i
86,0211-699501013259,valorando,o
86,0211-699501013259,su,o
86,0211-699501013259,posible,o
86,0211-699501013259,correlacion,o
86,0211-699501013259,con,o
86,0211-699501013259,dosis,o
86,0211-699501013259,de,o
86,0211-699501013259,dialisis,i
86,0211-699501013259,funcion,i
86,0211-699501013259,residual,i
86,0211-699501013259,y,o
86,0211-699501013259,parametros,o
86,0211-699501013259,nutricionales,o
86,0211-699501013259,Metodos,o
86,0211-699501013259,Todos,o
86,0211-699501013259,los,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,en,o
86,0211-699501013259,hemodialisis,i
86,0211-699501013259,al,o
86,0211-699501013259,comienzo,o
86,0211-699501013259,del,o
86,0211-699501013259,estudio,o
86,0211-699501013259,que,o
86,0211-699501013259,no,o
86,0211-699501013259,recibian,o
86,0211-699501013259,acido,i
86,0211-699501013259,folico,i
86,0211-699501013259,ni,o
86,0211-699501013259,vitamina,i
86,0211-699501013259,B6,i
86,0211-699501013259,asi,o
86,0211-699501013259,como,o
86,0211-699501013259,los,o
86,0211-699501013259,incorporados,o
86,0211-699501013259,posteriormente,o
86,0211-699501013259,a,o
86,0211-699501013259,partir,o
86,0211-699501013259,de,o
86,0211-699501013259,su,o
86,0211-699501013259,tercer,o
86,0211-699501013259,mes,o
86,0211-699501013259,en,o
86,0211-699501013259,hemodialisis,i
86,0211-699501013259,recibieron,o
86,0211-699501013259,5,o
86,0211-699501013259,mg,o
86,0211-699501013259,orales,o
86,0211-699501013259,de,o
86,0211-699501013259,acido,i
86,0211-699501013259,folico,i
86,0211-699501013259,cada,o
86,0211-699501013259,48,o
86,0211-699501013259,horas,o
86,0211-699501013259,y,o
86,0211-699501013259,40,o
86,0211-699501013259,mg,o
86,0211-699501013259,orales,o
86,0211-699501013259,de,o
86,0211-699501013259,vitamina,i
86,0211-699501013259,B6,i
86,0211-699501013259,cada,o
86,0211-699501013259,semana,o
86,0211-699501013259,Se,o
86,0211-699501013259,determinaron,o
86,0211-699501013259,al,o
86,0211-699501013259,comienzo,o
86,0211-699501013259,del,o
86,0211-699501013259,estudio,o
86,0211-699501013259,y,o
86,0211-699501013259,cada,o
86,0211-699501013259,2,o
86,0211-699501013259,meses,o
86,0211-699501013259,niveles,i
86,0211-699501013259,de,i
86,0211-699501013259,folato,i
86,0211-699501013259,vitamina,i
86,0211-699501013259,B12,i
86,0211-699501013259,inmunoensayo,i
86,0211-699501013259,albumina,i
86,0211-699501013259,y,o
86,0211-699501013259,cinetica,o
86,0211-699501013259,de,o
86,0211-699501013259,la,o
86,0211-699501013259,urea,i
86,0211-699501013259,KTV,o
86,0211-699501013259,KRU,o
86,0211-699501013259,PCRn,o
86,0211-699501013259,y,o
86,0211-699501013259,cada,o
86,0211-699501013259,6,o
86,0211-699501013259,meses,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,HPLC,i
86,0211-699501013259,y,o
86,0211-699501013259,pp,i
86,0211-699501013259,RIA,i
86,0211-699501013259,Resultados,o
86,0211-699501013259,80,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,fueron,o
86,0211-699501013259,incluidos,o
86,0211-699501013259,en,o
86,0211-699501013259,el,o
86,0211-699501013259,estudio,o
86,0211-699501013259,basal,o
86,0211-699501013259,con,o
86,0211-699501013259,una,o
86,0211-699501013259,prevalencia,o
86,0211-699501013259,de,o
86,0211-699501013259,hiperhomocisteinemia,i
86,0211-699501013259,del,o
86,0211-699501013259,844,o
86,0211-699501013259,deficit,i
86,0211-699501013259,de,i
86,0211-699501013259,pp,i
86,0211-699501013259,en,o
86,0211-699501013259,el,o
86,0211-699501013259,32,o
86,0211-699501013259,y,o
86,0211-699501013259,folato,i
86,0211-699501013259,en,o
86,0211-699501013259,el,o
86,0211-699501013259,rango,o
86,0211-699501013259,normal,o
86,0211-699501013259,bajo,o
86,0211-699501013259,los,o
86,0211-699501013259,niveles,i
86,0211-699501013259,de,i
86,0211-699501013259,tHcy,i
86,0211-699501013259,se,o
86,0211-699501013259,correlacionaban,o
86,0211-699501013259,inversamente,o
86,0211-699501013259,con,o
86,0211-699501013259,los,o
86,0211-699501013259,del,o
86,0211-699501013259,folato,i
86,0211-699501013259,r,o
86,0211-699501013259,0336,o
86,0211-699501013259,p,o
86,0211-699501013259,001,o
86,0211-699501013259,pero,o
86,0211-699501013259,no,o
86,0211-699501013259,con,o
86,0211-699501013259,pp,i
86,0211-699501013259,B12,i
86,0211-699501013259,edad,o
86,0211-699501013259,albumina,i
86,0211-699501013259,KTV,o
86,0211-699501013259,KRU,o
86,0211-699501013259,PCRn,o
86,0211-699501013259,Cincuenta,o
86,0211-699501013259,y,o
86,0211-699501013259,ocho,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,recibieron,o
86,0211-699501013259,seis,o
86,0211-699501013259,meses,o
86,0211-699501013259,de,o
86,0211-699501013259,suplementacion,i
86,0211-699501013259,con,o
86,0211-699501013259,normalizacion,o
86,0211-699501013259,del,o
86,0211-699501013259,pp,i
86,0211-699501013259,aumento,o
86,0211-699501013259,del,o
86,0211-699501013259,folato,i
86,0211-699501013259,703,o
86,0211-699501013259,IC,o
86,0211-699501013259,638,o
86,0211-699501013259,795,o
86,0211-699501013259,vs,o
86,0211-699501013259,6181,o
86,0211-699501013259,IC,o
86,0211-699501013259,4447,o
86,0211-699501013259,7811,o
86,0211-699501013259,p,o
86,0211-699501013259,0001,o
86,0211-699501013259,y,o
86,0211-699501013259,descenso,o
86,0211-699501013259,de,o
86,0211-699501013259,la,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,240,o
86,0211-699501013259,IC,o
86,0211-699501013259,213,o
86,0211-699501013259,264,o
86,0211-699501013259,vs,o
86,0211-699501013259,199,o
86,0211-699501013259,IC,o
86,0211-699501013259,175,o
86,0211-699501013259,224,o
86,0211-699501013259,p,o
86,0211-699501013259,005,o
86,0211-699501013259,Han,o
86,0211-699501013259,recibido,o
86,0211-699501013259,suplementacion,i
86,0211-699501013259,durante,o
86,0211-699501013259,12,o
86,0211-699501013259,meses,o
86,0211-699501013259,33,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,pero,o
86,0211-699501013259,a,o
86,0211-699501013259,pesar,o
86,0211-699501013259,de,o
86,0211-699501013259,un,o
86,0211-699501013259,continuo,o
86,0211-699501013259,aumento,o
86,0211-699501013259,del,o
86,0211-699501013259,folato,i
86,0211-699501013259,10078,o
86,0211-699501013259,IC,o
86,0211-699501013259,7481,o
86,0211-699501013259,12674,o
86,0211-699501013259,p,o
86,0211-699501013259,0001,o
86,0211-699501013259,solo,o
86,0211-699501013259,3,o
86,0211-699501013259,pacientes,o
86,0211-699501013259,presentan,o
86,0211-699501013259,niveles,o
86,0211-699501013259,normales,o
86,0211-699501013259,de,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,correlacionandose,o
86,0211-699501013259,directamente,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,con,o
86,0211-699501013259,la,o
86,0211-699501013259,albumina,i
86,0211-699501013259,r,o
86,0211-699501013259,056,o
86,0211-699501013259,p,o
86,0211-699501013259,0001,o
86,0211-699501013259,que,o
86,0211-699501013259,se,o
86,0211-699501013259,elevo,o
86,0211-699501013259,con,o
86,0211-699501013259,respecto,o
86,0211-699501013259,al,o
86,0211-699501013259,inicio,o
86,0211-699501013259,337,o
86,0211-699501013259,IC,o
86,0211-699501013259,327,o
86,0211-699501013259,346,o
86,0211-699501013259,vs,o
86,0211-699501013259,350,o
86,0211-699501013259,IC,o
86,0211-699501013259,337,o
86,0211-699501013259,363,o
86,0211-699501013259,p,o
86,0211-699501013259,005,o
86,0211-699501013259,Conclusion,o
86,0211-699501013259,Tras,o
86,0211-699501013259,suplementacion,i
86,0211-699501013259,con,o
86,0211-699501013259,acido,i
86,0211-699501013259,folico,i
86,0211-699501013259,y,o
86,0211-699501013259,vitamina,i
86,0211-699501013259,B6,i
86,0211-699501013259,aunque,o
86,0211-699501013259,inicialmente,o
86,0211-699501013259,se,o
86,0211-699501013259,reduce,o
86,0211-699501013259,la,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,esta,o
86,0211-699501013259,respuesta,o
86,0211-699501013259,se,o
86,0211-699501013259,hace,o
86,0211-699501013259,refractaria,o
86,0211-699501013259,correlacionandose,o
86,0211-699501013259,directamente,o
86,0211-699501013259,la,o
86,0211-699501013259,tHcy,i
86,0211-699501013259,con,o
86,0211-699501013259,la,o
86,0211-699501013259,albumina,i
86,0211-699501013259,plasmatica,i
86,0211-699501013259,La,o
86,0211-699501013259,interpretacion,o
86,0211-699501013259,de,o
86,0211-699501013259,los,o
86,0211-699501013259,niveles,i
86,0211-699501013259,de,i
86,0211-699501013259,tHcy,i
86,0211-699501013259,debe,o
86,0211-699501013259,tener,o
86,0211-699501013259,en,o
86,0211-699501013259,cuenta,o
86,0211-699501013259,la,o
86,0211-699501013259,concentracion,i
86,0211-699501013259,de,i
86,0211-699501013259,albumina,i
87,0211-699501013259,Efecto,o
87,0211-699501013259,de,o
87,0211-699501013259,la,o
87,0211-699501013259,suplementacion,i
87,0211-699501013259,con,o
87,0211-699501013259,acido,i
87,0211-699501013259,folico,i
87,0211-699501013259,sobre,o
87,0211-699501013259,los,o
87,0211-699501013259,niveles,i
87,0211-699501013259,de,i
87,0211-699501013259,homocisteina,i
87,0211-699501013259,total,o
87,0211-699501013259,en,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,en,o
87,0211-699501013259,hemodialisis,i
87,0211-699501013259,La,o
87,0211-699501013259,hiperhomocisteinemia,i
87,0211-699501013259,es,o
87,0211-699501013259,un,o
87,0211-699501013259,marcador,o
87,0211-699501013259,de,o
87,0211-699501013259,riesgo,o
87,0211-699501013259,independiente,o
87,0211-699501013259,de,o
87,0211-699501013259,morbimortalidad,o
87,0211-699501013259,cardiovascular,i
87,0211-699501013259,Hemos,o
87,0211-699501013259,intentado,o
87,0211-699501013259,prospectivamente,o
87,0211-699501013259,reducir,o
87,0211-699501013259,los,o
87,0211-699501013259,niveles,i
87,0211-699501013259,de,i
87,0211-699501013259,homocisteina,i
87,0211-699501013259,total,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,mediante,o
87,0211-699501013259,suplemento,o
87,0211-699501013259,con,o
87,0211-699501013259,acido,i
87,0211-699501013259,folico,i
87,0211-699501013259,y,o
87,0211-699501013259,vitamina,i
87,0211-699501013259,B6,i
87,0211-699501013259,pp,i
87,0211-699501013259,valorando,o
87,0211-699501013259,su,o
87,0211-699501013259,posible,o
87,0211-699501013259,correlacion,o
87,0211-699501013259,con,o
87,0211-699501013259,dosis,o
87,0211-699501013259,de,o
87,0211-699501013259,dialisis,i
87,0211-699501013259,funcion,i
87,0211-699501013259,residual,i
87,0211-699501013259,y,o
87,0211-699501013259,parametros,o
87,0211-699501013259,nutricionales,o
87,0211-699501013259,Metodos,o
87,0211-699501013259,Todos,o
87,0211-699501013259,los,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,en,o
87,0211-699501013259,hemodialisis,i
87,0211-699501013259,al,o
87,0211-699501013259,comienzo,o
87,0211-699501013259,del,o
87,0211-699501013259,estudio,o
87,0211-699501013259,que,o
87,0211-699501013259,no,o
87,0211-699501013259,recibian,o
87,0211-699501013259,acido,i
87,0211-699501013259,folico,i
87,0211-699501013259,ni,o
87,0211-699501013259,vitamina,i
87,0211-699501013259,B6,i
87,0211-699501013259,asi,o
87,0211-699501013259,como,o
87,0211-699501013259,los,o
87,0211-699501013259,incorporados,o
87,0211-699501013259,posteriormente,o
87,0211-699501013259,a,o
87,0211-699501013259,partir,o
87,0211-699501013259,de,o
87,0211-699501013259,su,o
87,0211-699501013259,tercer,o
87,0211-699501013259,mes,o
87,0211-699501013259,en,o
87,0211-699501013259,hemodialisis,i
87,0211-699501013259,recibieron,o
87,0211-699501013259,5,o
87,0211-699501013259,mg,o
87,0211-699501013259,orales,o
87,0211-699501013259,de,o
87,0211-699501013259,acido,i
87,0211-699501013259,folico,i
87,0211-699501013259,cada,o
87,0211-699501013259,48,o
87,0211-699501013259,horas,o
87,0211-699501013259,y,o
87,0211-699501013259,40,o
87,0211-699501013259,mg,o
87,0211-699501013259,orales,o
87,0211-699501013259,de,o
87,0211-699501013259,vitamina,i
87,0211-699501013259,B6,i
87,0211-699501013259,cada,o
87,0211-699501013259,semana,o
87,0211-699501013259,Se,o
87,0211-699501013259,determinaron,o
87,0211-699501013259,al,o
87,0211-699501013259,comienzo,o
87,0211-699501013259,del,o
87,0211-699501013259,estudio,o
87,0211-699501013259,y,o
87,0211-699501013259,cada,o
87,0211-699501013259,2,o
87,0211-699501013259,meses,o
87,0211-699501013259,niveles,i
87,0211-699501013259,de,i
87,0211-699501013259,folato,i
87,0211-699501013259,vitamina,i
87,0211-699501013259,B12,i
87,0211-699501013259,inmunoensayo,i
87,0211-699501013259,albumina,i
87,0211-699501013259,y,o
87,0211-699501013259,cinetica,o
87,0211-699501013259,de,o
87,0211-699501013259,la,o
87,0211-699501013259,urea,i
87,0211-699501013259,KTV,o
87,0211-699501013259,KRU,o
87,0211-699501013259,PCRn,o
87,0211-699501013259,y,o
87,0211-699501013259,cada,o
87,0211-699501013259,6,o
87,0211-699501013259,meses,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,HPLC,i
87,0211-699501013259,y,o
87,0211-699501013259,pp,i
87,0211-699501013259,RIA,i
87,0211-699501013259,Resultados,o
87,0211-699501013259,80,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,fueron,o
87,0211-699501013259,incluidos,o
87,0211-699501013259,en,o
87,0211-699501013259,el,o
87,0211-699501013259,estudio,o
87,0211-699501013259,basal,o
87,0211-699501013259,con,o
87,0211-699501013259,una,o
87,0211-699501013259,prevalencia,o
87,0211-699501013259,de,o
87,0211-699501013259,hiperhomocisteinemia,i
87,0211-699501013259,del,o
87,0211-699501013259,844,o
87,0211-699501013259,deficit,i
87,0211-699501013259,de,i
87,0211-699501013259,pp,i
87,0211-699501013259,en,o
87,0211-699501013259,el,o
87,0211-699501013259,32,o
87,0211-699501013259,y,o
87,0211-699501013259,folato,i
87,0211-699501013259,en,o
87,0211-699501013259,el,o
87,0211-699501013259,rango,o
87,0211-699501013259,normal,o
87,0211-699501013259,bajo,o
87,0211-699501013259,los,o
87,0211-699501013259,niveles,i
87,0211-699501013259,de,i
87,0211-699501013259,tHcy,i
87,0211-699501013259,se,o
87,0211-699501013259,correlacionaban,o
87,0211-699501013259,inversamente,o
87,0211-699501013259,con,o
87,0211-699501013259,los,o
87,0211-699501013259,del,o
87,0211-699501013259,folato,i
87,0211-699501013259,r,o
87,0211-699501013259,0336,o
87,0211-699501013259,p,o
87,0211-699501013259,001,o
87,0211-699501013259,pero,o
87,0211-699501013259,no,o
87,0211-699501013259,con,o
87,0211-699501013259,pp,i
87,0211-699501013259,B12,i
87,0211-699501013259,edad,o
87,0211-699501013259,albumina,i
87,0211-699501013259,KTV,o
87,0211-699501013259,KRU,o
87,0211-699501013259,PCRn,o
87,0211-699501013259,Cincuenta,o
87,0211-699501013259,y,o
87,0211-699501013259,ocho,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,recibieron,o
87,0211-699501013259,seis,o
87,0211-699501013259,meses,o
87,0211-699501013259,de,o
87,0211-699501013259,suplementacion,i
87,0211-699501013259,con,o
87,0211-699501013259,normalizacion,o
87,0211-699501013259,del,o
87,0211-699501013259,pp,i
87,0211-699501013259,aumento,o
87,0211-699501013259,del,o
87,0211-699501013259,folato,i
87,0211-699501013259,703,o
87,0211-699501013259,IC,o
87,0211-699501013259,638,o
87,0211-699501013259,795,o
87,0211-699501013259,vs,o
87,0211-699501013259,6181,o
87,0211-699501013259,IC,o
87,0211-699501013259,4447,o
87,0211-699501013259,7811,o
87,0211-699501013259,p,o
87,0211-699501013259,0001,o
87,0211-699501013259,y,o
87,0211-699501013259,descenso,o
87,0211-699501013259,de,o
87,0211-699501013259,la,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,240,o
87,0211-699501013259,IC,o
87,0211-699501013259,213,o
87,0211-699501013259,264,o
87,0211-699501013259,vs,o
87,0211-699501013259,199,o
87,0211-699501013259,IC,o
87,0211-699501013259,175,o
87,0211-699501013259,224,o
87,0211-699501013259,p,o
87,0211-699501013259,005,o
87,0211-699501013259,Han,o
87,0211-699501013259,recibido,o
87,0211-699501013259,suplementacion,i
87,0211-699501013259,durante,o
87,0211-699501013259,12,o
87,0211-699501013259,meses,o
87,0211-699501013259,33,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,pero,o
87,0211-699501013259,a,o
87,0211-699501013259,pesar,o
87,0211-699501013259,de,o
87,0211-699501013259,un,o
87,0211-699501013259,continuo,o
87,0211-699501013259,aumento,o
87,0211-699501013259,del,o
87,0211-699501013259,folato,i
87,0211-699501013259,10078,o
87,0211-699501013259,IC,o
87,0211-699501013259,7481,o
87,0211-699501013259,12674,o
87,0211-699501013259,p,o
87,0211-699501013259,0001,o
87,0211-699501013259,solo,o
87,0211-699501013259,3,o
87,0211-699501013259,pacientes,o
87,0211-699501013259,presentan,o
87,0211-699501013259,niveles,o
87,0211-699501013259,normales,o
87,0211-699501013259,de,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,correlacionandose,o
87,0211-699501013259,directamente,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,con,o
87,0211-699501013259,la,o
87,0211-699501013259,albumina,i
87,0211-699501013259,r,o
87,0211-699501013259,056,o
87,0211-699501013259,p,o
87,0211-699501013259,0001,o
87,0211-699501013259,que,o
87,0211-699501013259,se,o
87,0211-699501013259,elevo,o
87,0211-699501013259,con,o
87,0211-699501013259,respecto,o
87,0211-699501013259,al,o
87,0211-699501013259,inicio,o
87,0211-699501013259,337,o
87,0211-699501013259,IC,o
87,0211-699501013259,327,o
87,0211-699501013259,346,o
87,0211-699501013259,vs,o
87,0211-699501013259,350,o
87,0211-699501013259,IC,o
87,0211-699501013259,337,o
87,0211-699501013259,363,o
87,0211-699501013259,p,o
87,0211-699501013259,005,o
87,0211-699501013259,Conclusion,o
87,0211-699501013259,Tras,o
87,0211-699501013259,suplementacion,i
87,0211-699501013259,con,o
87,0211-699501013259,acido,i
87,0211-699501013259,folico,i
87,0211-699501013259,y,o
87,0211-699501013259,vitamina,i
87,0211-699501013259,B6,i
87,0211-699501013259,aunque,o
87,0211-699501013259,inicialmente,o
87,0211-699501013259,se,o
87,0211-699501013259,reduce,o
87,0211-699501013259,la,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,esta,o
87,0211-699501013259,respuesta,o
87,0211-699501013259,se,o
87,0211-699501013259,hace,o
87,0211-699501013259,refractaria,o
87,0211-699501013259,correlacionandose,o
87,0211-699501013259,directamente,o
87,0211-699501013259,la,o
87,0211-699501013259,tHcy,i
87,0211-699501013259,con,o
87,0211-699501013259,la,o
87,0211-699501013259,albumina,i
87,0211-699501013259,plasmatica,i
87,0211-699501013259,La,o
87,0211-699501013259,interpretacion,o
87,0211-699501013259,de,o
87,0211-699501013259,los,o
87,0211-699501013259,niveles,i
87,0211-699501013259,de,i
87,0211-699501013259,tHcy,i
87,0211-699501013259,debe,o
87,0211-699501013259,tener,o
87,0211-699501013259,en,o
87,0211-699501013259,cuenta,o
87,0211-699501013259,la,o
87,0211-699501013259,concentracion,i
87,0211-699501013259,de,i
87,0211-699501013259,albumina,i
88,0211-699501013259,Efecto,o
88,0211-699501013259,de,o
88,0211-699501013259,la,o
88,0211-699501013259,suplementacion,i
88,0211-699501013259,con,o
88,0211-699501013259,acido,i
88,0211-699501013259,folico,i
88,0211-699501013259,sobre,o
88,0211-699501013259,los,o
88,0211-699501013259,niveles,i
88,0211-699501013259,de,i
88,0211-699501013259,homocisteina,i
88,0211-699501013259,total,o
88,0211-699501013259,en,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,en,o
88,0211-699501013259,hemodialisis,i
88,0211-699501013259,La,o
88,0211-699501013259,hiperhomocisteinemia,i
88,0211-699501013259,es,o
88,0211-699501013259,un,o
88,0211-699501013259,marcador,o
88,0211-699501013259,de,o
88,0211-699501013259,riesgo,o
88,0211-699501013259,independiente,o
88,0211-699501013259,de,o
88,0211-699501013259,morbimortalidad,o
88,0211-699501013259,cardiovascular,i
88,0211-699501013259,Hemos,o
88,0211-699501013259,intentado,o
88,0211-699501013259,prospectivamente,o
88,0211-699501013259,reducir,o
88,0211-699501013259,los,o
88,0211-699501013259,niveles,i
88,0211-699501013259,de,i
88,0211-699501013259,homocisteina,i
88,0211-699501013259,total,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,mediante,o
88,0211-699501013259,suplemento,o
88,0211-699501013259,con,o
88,0211-699501013259,acido,i
88,0211-699501013259,folico,i
88,0211-699501013259,y,o
88,0211-699501013259,vitamina,i
88,0211-699501013259,B6,i
88,0211-699501013259,pp,i
88,0211-699501013259,valorando,o
88,0211-699501013259,su,o
88,0211-699501013259,posible,o
88,0211-699501013259,correlacion,o
88,0211-699501013259,con,o
88,0211-699501013259,dosis,o
88,0211-699501013259,de,o
88,0211-699501013259,dialisis,i
88,0211-699501013259,funcion,i
88,0211-699501013259,residual,i
88,0211-699501013259,y,o
88,0211-699501013259,parametros,o
88,0211-699501013259,nutricionales,o
88,0211-699501013259,Metodos,o
88,0211-699501013259,Todos,o
88,0211-699501013259,los,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,en,o
88,0211-699501013259,hemodialisis,i
88,0211-699501013259,al,o
88,0211-699501013259,comienzo,o
88,0211-699501013259,del,o
88,0211-699501013259,estudio,o
88,0211-699501013259,que,o
88,0211-699501013259,no,o
88,0211-699501013259,recibian,o
88,0211-699501013259,acido,i
88,0211-699501013259,folico,i
88,0211-699501013259,ni,o
88,0211-699501013259,vitamina,i
88,0211-699501013259,B6,i
88,0211-699501013259,asi,o
88,0211-699501013259,como,o
88,0211-699501013259,los,o
88,0211-699501013259,incorporados,o
88,0211-699501013259,posteriormente,o
88,0211-699501013259,a,o
88,0211-699501013259,partir,o
88,0211-699501013259,de,o
88,0211-699501013259,su,o
88,0211-699501013259,tercer,o
88,0211-699501013259,mes,o
88,0211-699501013259,en,o
88,0211-699501013259,hemodialisis,i
88,0211-699501013259,recibieron,o
88,0211-699501013259,5,o
88,0211-699501013259,mg,o
88,0211-699501013259,orales,o
88,0211-699501013259,de,o
88,0211-699501013259,acido,i
88,0211-699501013259,folico,i
88,0211-699501013259,cada,o
88,0211-699501013259,48,o
88,0211-699501013259,horas,o
88,0211-699501013259,y,o
88,0211-699501013259,40,o
88,0211-699501013259,mg,o
88,0211-699501013259,orales,o
88,0211-699501013259,de,o
88,0211-699501013259,vitamina,i
88,0211-699501013259,B6,i
88,0211-699501013259,cada,o
88,0211-699501013259,semana,o
88,0211-699501013259,Se,o
88,0211-699501013259,determinaron,o
88,0211-699501013259,al,o
88,0211-699501013259,comienzo,o
88,0211-699501013259,del,o
88,0211-699501013259,estudio,o
88,0211-699501013259,y,o
88,0211-699501013259,cada,o
88,0211-699501013259,2,o
88,0211-699501013259,meses,o
88,0211-699501013259,niveles,i
88,0211-699501013259,de,i
88,0211-699501013259,folato,i
88,0211-699501013259,vitamina,i
88,0211-699501013259,B12,i
88,0211-699501013259,inmunoensayo,i
88,0211-699501013259,albumina,i
88,0211-699501013259,y,o
88,0211-699501013259,cinetica,o
88,0211-699501013259,de,o
88,0211-699501013259,la,o
88,0211-699501013259,urea,i
88,0211-699501013259,KTV,o
88,0211-699501013259,KRU,o
88,0211-699501013259,PCRn,o
88,0211-699501013259,y,o
88,0211-699501013259,cada,o
88,0211-699501013259,6,o
88,0211-699501013259,meses,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,HPLC,i
88,0211-699501013259,y,o
88,0211-699501013259,pp,i
88,0211-699501013259,RIA,i
88,0211-699501013259,Resultados,o
88,0211-699501013259,80,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,fueron,o
88,0211-699501013259,incluidos,o
88,0211-699501013259,en,o
88,0211-699501013259,el,o
88,0211-699501013259,estudio,o
88,0211-699501013259,basal,o
88,0211-699501013259,con,o
88,0211-699501013259,una,o
88,0211-699501013259,prevalencia,o
88,0211-699501013259,de,o
88,0211-699501013259,hiperhomocisteinemia,i
88,0211-699501013259,del,o
88,0211-699501013259,844,o
88,0211-699501013259,deficit,i
88,0211-699501013259,de,i
88,0211-699501013259,pp,i
88,0211-699501013259,en,o
88,0211-699501013259,el,o
88,0211-699501013259,32,o
88,0211-699501013259,y,o
88,0211-699501013259,folato,i
88,0211-699501013259,en,o
88,0211-699501013259,el,o
88,0211-699501013259,rango,o
88,0211-699501013259,normal,o
88,0211-699501013259,bajo,o
88,0211-699501013259,los,o
88,0211-699501013259,niveles,i
88,0211-699501013259,de,i
88,0211-699501013259,tHcy,i
88,0211-699501013259,se,o
88,0211-699501013259,correlacionaban,o
88,0211-699501013259,inversamente,o
88,0211-699501013259,con,o
88,0211-699501013259,los,o
88,0211-699501013259,del,o
88,0211-699501013259,folato,i
88,0211-699501013259,r,o
88,0211-699501013259,0336,o
88,0211-699501013259,p,o
88,0211-699501013259,001,o
88,0211-699501013259,pero,o
88,0211-699501013259,no,o
88,0211-699501013259,con,o
88,0211-699501013259,pp,i
88,0211-699501013259,B12,i
88,0211-699501013259,edad,o
88,0211-699501013259,albumina,i
88,0211-699501013259,KTV,o
88,0211-699501013259,KRU,o
88,0211-699501013259,PCRn,o
88,0211-699501013259,Cincuenta,o
88,0211-699501013259,y,o
88,0211-699501013259,ocho,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,recibieron,o
88,0211-699501013259,seis,o
88,0211-699501013259,meses,o
88,0211-699501013259,de,o
88,0211-699501013259,suplementacion,i
88,0211-699501013259,con,o
88,0211-699501013259,normalizacion,o
88,0211-699501013259,del,o
88,0211-699501013259,pp,i
88,0211-699501013259,aumento,o
88,0211-699501013259,del,o
88,0211-699501013259,folato,i
88,0211-699501013259,703,o
88,0211-699501013259,IC,o
88,0211-699501013259,638,o
88,0211-699501013259,795,o
88,0211-699501013259,vs,o
88,0211-699501013259,6181,o
88,0211-699501013259,IC,o
88,0211-699501013259,4447,o
88,0211-699501013259,7811,o
88,0211-699501013259,p,o
88,0211-699501013259,0001,o
88,0211-699501013259,y,o
88,0211-699501013259,descenso,o
88,0211-699501013259,de,o
88,0211-699501013259,la,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,240,o
88,0211-699501013259,IC,o
88,0211-699501013259,213,o
88,0211-699501013259,264,o
88,0211-699501013259,vs,o
88,0211-699501013259,199,o
88,0211-699501013259,IC,o
88,0211-699501013259,175,o
88,0211-699501013259,224,o
88,0211-699501013259,p,o
88,0211-699501013259,005,o
88,0211-699501013259,Han,o
88,0211-699501013259,recibido,o
88,0211-699501013259,suplementacion,i
88,0211-699501013259,durante,o
88,0211-699501013259,12,o
88,0211-699501013259,meses,o
88,0211-699501013259,33,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,pero,o
88,0211-699501013259,a,o
88,0211-699501013259,pesar,o
88,0211-699501013259,de,o
88,0211-699501013259,un,o
88,0211-699501013259,continuo,o
88,0211-699501013259,aumento,o
88,0211-699501013259,del,o
88,0211-699501013259,folato,i
88,0211-699501013259,10078,o
88,0211-699501013259,IC,o
88,0211-699501013259,7481,o
88,0211-699501013259,12674,o
88,0211-699501013259,p,o
88,0211-699501013259,0001,o
88,0211-699501013259,solo,o
88,0211-699501013259,3,o
88,0211-699501013259,pacientes,o
88,0211-699501013259,presentan,o
88,0211-699501013259,niveles,o
88,0211-699501013259,normales,o
88,0211-699501013259,de,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,correlacionandose,o
88,0211-699501013259,directamente,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,con,o
88,0211-699501013259,la,o
88,0211-699501013259,albumina,i
88,0211-699501013259,r,o
88,0211-699501013259,056,o
88,0211-699501013259,p,o
88,0211-699501013259,0001,o
88,0211-699501013259,que,o
88,0211-699501013259,se,o
88,0211-699501013259,elevo,o
88,0211-699501013259,con,o
88,0211-699501013259,respecto,o
88,0211-699501013259,al,o
88,0211-699501013259,inicio,o
88,0211-699501013259,337,o
88,0211-699501013259,IC,o
88,0211-699501013259,327,o
88,0211-699501013259,346,o
88,0211-699501013259,vs,o
88,0211-699501013259,350,o
88,0211-699501013259,IC,o
88,0211-699501013259,337,o
88,0211-699501013259,363,o
88,0211-699501013259,p,o
88,0211-699501013259,005,o
88,0211-699501013259,Conclusion,o
88,0211-699501013259,Tras,o
88,0211-699501013259,suplementacion,i
88,0211-699501013259,con,o
88,0211-699501013259,acido,i
88,0211-699501013259,folico,i
88,0211-699501013259,y,o
88,0211-699501013259,vitamina,i
88,0211-699501013259,B6,i
88,0211-699501013259,aunque,o
88,0211-699501013259,inicialmente,o
88,0211-699501013259,se,o
88,0211-699501013259,reduce,o
88,0211-699501013259,la,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,esta,o
88,0211-699501013259,respuesta,o
88,0211-699501013259,se,o
88,0211-699501013259,hace,o
88,0211-699501013259,refractaria,o
88,0211-699501013259,correlacionandose,o
88,0211-699501013259,directamente,o
88,0211-699501013259,la,o
88,0211-699501013259,tHcy,i
88,0211-699501013259,con,o
88,0211-699501013259,la,o
88,0211-699501013259,albumina,i
88,0211-699501013259,plasmatica,i
88,0211-699501013259,La,o
88,0211-699501013259,interpretacion,o
88,0211-699501013259,de,o
88,0211-699501013259,los,o
88,0211-699501013259,niveles,i
88,0211-699501013259,de,i
88,0211-699501013259,tHcy,i
88,0211-699501013259,debe,o
88,0211-699501013259,tener,o
88,0211-699501013259,en,o
88,0211-699501013259,cuenta,o
88,0211-699501013259,la,o
88,0211-699501013259,concentracion,i
88,0211-699501013259,de,i
88,0211-699501013259,albumina,i
89,0211-699501013259,Efecto,o
89,0211-699501013259,de,o
89,0211-699501013259,la,o
89,0211-699501013259,suplementacion,i
89,0211-699501013259,con,o
89,0211-699501013259,acido,i
89,0211-699501013259,folico,i
89,0211-699501013259,sobre,o
89,0211-699501013259,los,o
89,0211-699501013259,niveles,i
89,0211-699501013259,de,i
89,0211-699501013259,homocisteina,i
89,0211-699501013259,total,o
89,0211-699501013259,en,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,en,o
89,0211-699501013259,hemodialisis,i
89,0211-699501013259,La,o
89,0211-699501013259,hiperhomocisteinemia,i
89,0211-699501013259,es,o
89,0211-699501013259,un,o
89,0211-699501013259,marcador,o
89,0211-699501013259,de,o
89,0211-699501013259,riesgo,o
89,0211-699501013259,independiente,o
89,0211-699501013259,de,o
89,0211-699501013259,morbimortalidad,o
89,0211-699501013259,cardiovascular,i
89,0211-699501013259,Hemos,o
89,0211-699501013259,intentado,o
89,0211-699501013259,prospectivamente,o
89,0211-699501013259,reducir,o
89,0211-699501013259,los,o
89,0211-699501013259,niveles,i
89,0211-699501013259,de,i
89,0211-699501013259,homocisteina,i
89,0211-699501013259,total,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,mediante,o
89,0211-699501013259,suplemento,o
89,0211-699501013259,con,o
89,0211-699501013259,acido,i
89,0211-699501013259,folico,i
89,0211-699501013259,y,o
89,0211-699501013259,vitamina,i
89,0211-699501013259,B6,i
89,0211-699501013259,pp,i
89,0211-699501013259,valorando,o
89,0211-699501013259,su,o
89,0211-699501013259,posible,o
89,0211-699501013259,correlacion,o
89,0211-699501013259,con,o
89,0211-699501013259,dosis,o
89,0211-699501013259,de,o
89,0211-699501013259,dialisis,i
89,0211-699501013259,funcion,i
89,0211-699501013259,residual,i
89,0211-699501013259,y,o
89,0211-699501013259,parametros,o
89,0211-699501013259,nutricionales,o
89,0211-699501013259,Metodos,o
89,0211-699501013259,Todos,o
89,0211-699501013259,los,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,en,o
89,0211-699501013259,hemodialisis,i
89,0211-699501013259,al,o
89,0211-699501013259,comienzo,o
89,0211-699501013259,del,o
89,0211-699501013259,estudio,o
89,0211-699501013259,que,o
89,0211-699501013259,no,o
89,0211-699501013259,recibian,o
89,0211-699501013259,acido,i
89,0211-699501013259,folico,i
89,0211-699501013259,ni,o
89,0211-699501013259,vitamina,i
89,0211-699501013259,B6,i
89,0211-699501013259,asi,o
89,0211-699501013259,como,o
89,0211-699501013259,los,o
89,0211-699501013259,incorporados,o
89,0211-699501013259,posteriormente,o
89,0211-699501013259,a,o
89,0211-699501013259,partir,o
89,0211-699501013259,de,o
89,0211-699501013259,su,o
89,0211-699501013259,tercer,o
89,0211-699501013259,mes,o
89,0211-699501013259,en,o
89,0211-699501013259,hemodialisis,i
89,0211-699501013259,recibieron,o
89,0211-699501013259,5,o
89,0211-699501013259,mg,o
89,0211-699501013259,orales,o
89,0211-699501013259,de,o
89,0211-699501013259,acido,i
89,0211-699501013259,folico,i
89,0211-699501013259,cada,o
89,0211-699501013259,48,o
89,0211-699501013259,horas,o
89,0211-699501013259,y,o
89,0211-699501013259,40,o
89,0211-699501013259,mg,o
89,0211-699501013259,orales,o
89,0211-699501013259,de,o
89,0211-699501013259,vitamina,i
89,0211-699501013259,B6,i
89,0211-699501013259,cada,o
89,0211-699501013259,semana,o
89,0211-699501013259,Se,o
89,0211-699501013259,determinaron,o
89,0211-699501013259,al,o
89,0211-699501013259,comienzo,o
89,0211-699501013259,del,o
89,0211-699501013259,estudio,o
89,0211-699501013259,y,o
89,0211-699501013259,cada,o
89,0211-699501013259,2,o
89,0211-699501013259,meses,o
89,0211-699501013259,niveles,i
89,0211-699501013259,de,i
89,0211-699501013259,folato,i
89,0211-699501013259,vitamina,i
89,0211-699501013259,B12,i
89,0211-699501013259,inmunoensayo,i
89,0211-699501013259,albumina,i
89,0211-699501013259,y,o
89,0211-699501013259,cinetica,o
89,0211-699501013259,de,o
89,0211-699501013259,la,o
89,0211-699501013259,urea,i
89,0211-699501013259,KTV,o
89,0211-699501013259,KRU,o
89,0211-699501013259,PCRn,o
89,0211-699501013259,y,o
89,0211-699501013259,cada,o
89,0211-699501013259,6,o
89,0211-699501013259,meses,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,HPLC,i
89,0211-699501013259,y,o
89,0211-699501013259,pp,i
89,0211-699501013259,RIA,i
89,0211-699501013259,Resultados,o
89,0211-699501013259,80,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,fueron,o
89,0211-699501013259,incluidos,o
89,0211-699501013259,en,o
89,0211-699501013259,el,o
89,0211-699501013259,estudio,o
89,0211-699501013259,basal,o
89,0211-699501013259,con,o
89,0211-699501013259,una,o
89,0211-699501013259,prevalencia,o
89,0211-699501013259,de,o
89,0211-699501013259,hiperhomocisteinemia,i
89,0211-699501013259,del,o
89,0211-699501013259,844,o
89,0211-699501013259,deficit,i
89,0211-699501013259,de,i
89,0211-699501013259,pp,i
89,0211-699501013259,en,o
89,0211-699501013259,el,o
89,0211-699501013259,32,o
89,0211-699501013259,y,o
89,0211-699501013259,folato,i
89,0211-699501013259,en,o
89,0211-699501013259,el,o
89,0211-699501013259,rango,o
89,0211-699501013259,normal,o
89,0211-699501013259,bajo,o
89,0211-699501013259,los,o
89,0211-699501013259,niveles,i
89,0211-699501013259,de,i
89,0211-699501013259,tHcy,i
89,0211-699501013259,se,o
89,0211-699501013259,correlacionaban,o
89,0211-699501013259,inversamente,o
89,0211-699501013259,con,o
89,0211-699501013259,los,o
89,0211-699501013259,del,o
89,0211-699501013259,folato,i
89,0211-699501013259,r,o
89,0211-699501013259,0336,o
89,0211-699501013259,p,o
89,0211-699501013259,001,o
89,0211-699501013259,pero,o
89,0211-699501013259,no,o
89,0211-699501013259,con,o
89,0211-699501013259,pp,i
89,0211-699501013259,B12,i
89,0211-699501013259,edad,o
89,0211-699501013259,albumina,i
89,0211-699501013259,KTV,o
89,0211-699501013259,KRU,o
89,0211-699501013259,PCRn,o
89,0211-699501013259,Cincuenta,o
89,0211-699501013259,y,o
89,0211-699501013259,ocho,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,recibieron,o
89,0211-699501013259,seis,o
89,0211-699501013259,meses,o
89,0211-699501013259,de,o
89,0211-699501013259,suplementacion,i
89,0211-699501013259,con,o
89,0211-699501013259,normalizacion,o
89,0211-699501013259,del,o
89,0211-699501013259,pp,i
89,0211-699501013259,aumento,o
89,0211-699501013259,del,o
89,0211-699501013259,folato,i
89,0211-699501013259,703,o
89,0211-699501013259,IC,o
89,0211-699501013259,638,o
89,0211-699501013259,795,o
89,0211-699501013259,vs,o
89,0211-699501013259,6181,o
89,0211-699501013259,IC,o
89,0211-699501013259,4447,o
89,0211-699501013259,7811,o
89,0211-699501013259,p,o
89,0211-699501013259,0001,o
89,0211-699501013259,y,o
89,0211-699501013259,descenso,o
89,0211-699501013259,de,o
89,0211-699501013259,la,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,240,o
89,0211-699501013259,IC,o
89,0211-699501013259,213,o
89,0211-699501013259,264,o
89,0211-699501013259,vs,o
89,0211-699501013259,199,o
89,0211-699501013259,IC,o
89,0211-699501013259,175,o
89,0211-699501013259,224,o
89,0211-699501013259,p,o
89,0211-699501013259,005,o
89,0211-699501013259,Han,o
89,0211-699501013259,recibido,o
89,0211-699501013259,suplementacion,i
89,0211-699501013259,durante,o
89,0211-699501013259,12,o
89,0211-699501013259,meses,o
89,0211-699501013259,33,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,pero,o
89,0211-699501013259,a,o
89,0211-699501013259,pesar,o
89,0211-699501013259,de,o
89,0211-699501013259,un,o
89,0211-699501013259,continuo,o
89,0211-699501013259,aumento,o
89,0211-699501013259,del,o
89,0211-699501013259,folato,i
89,0211-699501013259,10078,o
89,0211-699501013259,IC,o
89,0211-699501013259,7481,o
89,0211-699501013259,12674,o
89,0211-699501013259,p,o
89,0211-699501013259,0001,o
89,0211-699501013259,solo,o
89,0211-699501013259,3,o
89,0211-699501013259,pacientes,o
89,0211-699501013259,presentan,o
89,0211-699501013259,niveles,o
89,0211-699501013259,normales,o
89,0211-699501013259,de,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,correlacionandose,o
89,0211-699501013259,directamente,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,con,o
89,0211-699501013259,la,o
89,0211-699501013259,albumina,i
89,0211-699501013259,r,o
89,0211-699501013259,056,o
89,0211-699501013259,p,o
89,0211-699501013259,0001,o
89,0211-699501013259,que,o
89,0211-699501013259,se,o
89,0211-699501013259,elevo,o
89,0211-699501013259,con,o
89,0211-699501013259,respecto,o
89,0211-699501013259,al,o
89,0211-699501013259,inicio,o
89,0211-699501013259,337,o
89,0211-699501013259,IC,o
89,0211-699501013259,327,o
89,0211-699501013259,346,o
89,0211-699501013259,vs,o
89,0211-699501013259,350,o
89,0211-699501013259,IC,o
89,0211-699501013259,337,o
89,0211-699501013259,363,o
89,0211-699501013259,p,o
89,0211-699501013259,005,o
89,0211-699501013259,Conclusion,o
89,0211-699501013259,Tras,o
89,0211-699501013259,suplementacion,i
89,0211-699501013259,con,o
89,0211-699501013259,acido,i
89,0211-699501013259,folico,i
89,0211-699501013259,y,o
89,0211-699501013259,vitamina,i
89,0211-699501013259,B6,i
89,0211-699501013259,aunque,o
89,0211-699501013259,inicialmente,o
89,0211-699501013259,se,o
89,0211-699501013259,reduce,o
89,0211-699501013259,la,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,esta,o
89,0211-699501013259,respuesta,o
89,0211-699501013259,se,o
89,0211-699501013259,hace,o
89,0211-699501013259,refractaria,o
89,0211-699501013259,correlacionandose,o
89,0211-699501013259,directamente,o
89,0211-699501013259,la,o
89,0211-699501013259,tHcy,i
89,0211-699501013259,con,o
89,0211-699501013259,la,o
89,0211-699501013259,albumina,i
89,0211-699501013259,plasmatica,i
89,0211-699501013259,La,o
89,0211-699501013259,interpretacion,o
89,0211-699501013259,de,o
89,0211-699501013259,los,o
89,0211-699501013259,niveles,i
89,0211-699501013259,de,i
89,0211-699501013259,tHcy,i
89,0211-699501013259,debe,o
89,0211-699501013259,tener,o
89,0211-699501013259,en,o
89,0211-699501013259,cuenta,o
89,0211-699501013259,la,o
89,0211-699501013259,concentracion,i
89,0211-699501013259,de,i
89,0211-699501013259,albumina,i
90,0211-699501013259,Efecto,o
90,0211-699501013259,de,o
90,0211-699501013259,la,o
90,0211-699501013259,suplementacion,i
90,0211-699501013259,con,o
90,0211-699501013259,acido,i
90,0211-699501013259,folico,i
90,0211-699501013259,sobre,o
90,0211-699501013259,los,o
90,0211-699501013259,niveles,i
90,0211-699501013259,de,i
90,0211-699501013259,homocisteina,i
90,0211-699501013259,total,o
90,0211-699501013259,en,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,en,o
90,0211-699501013259,hemodialisis,i
90,0211-699501013259,La,o
90,0211-699501013259,hiperhomocisteinemia,i
90,0211-699501013259,es,o
90,0211-699501013259,un,o
90,0211-699501013259,marcador,o
90,0211-699501013259,de,o
90,0211-699501013259,riesgo,o
90,0211-699501013259,independiente,o
90,0211-699501013259,de,o
90,0211-699501013259,morbimortalidad,o
90,0211-699501013259,cardiovascular,i
90,0211-699501013259,Hemos,o
90,0211-699501013259,intentado,o
90,0211-699501013259,prospectivamente,o
90,0211-699501013259,reducir,o
90,0211-699501013259,los,o
90,0211-699501013259,niveles,i
90,0211-699501013259,de,i
90,0211-699501013259,homocisteina,i
90,0211-699501013259,total,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,mediante,o
90,0211-699501013259,suplemento,o
90,0211-699501013259,con,o
90,0211-699501013259,acido,i
90,0211-699501013259,folico,i
90,0211-699501013259,y,o
90,0211-699501013259,vitamina,i
90,0211-699501013259,B6,i
90,0211-699501013259,pp,i
90,0211-699501013259,valorando,o
90,0211-699501013259,su,o
90,0211-699501013259,posible,o
90,0211-699501013259,correlacion,o
90,0211-699501013259,con,o
90,0211-699501013259,dosis,o
90,0211-699501013259,de,o
90,0211-699501013259,dialisis,i
90,0211-699501013259,funcion,i
90,0211-699501013259,residual,i
90,0211-699501013259,y,o
90,0211-699501013259,parametros,o
90,0211-699501013259,nutricionales,o
90,0211-699501013259,Metodos,o
90,0211-699501013259,Todos,o
90,0211-699501013259,los,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,en,o
90,0211-699501013259,hemodialisis,i
90,0211-699501013259,al,o
90,0211-699501013259,comienzo,o
90,0211-699501013259,del,o
90,0211-699501013259,estudio,o
90,0211-699501013259,que,o
90,0211-699501013259,no,o
90,0211-699501013259,recibian,o
90,0211-699501013259,acido,i
90,0211-699501013259,folico,i
90,0211-699501013259,ni,o
90,0211-699501013259,vitamina,i
90,0211-699501013259,B6,i
90,0211-699501013259,asi,o
90,0211-699501013259,como,o
90,0211-699501013259,los,o
90,0211-699501013259,incorporados,o
90,0211-699501013259,posteriormente,o
90,0211-699501013259,a,o
90,0211-699501013259,partir,o
90,0211-699501013259,de,o
90,0211-699501013259,su,o
90,0211-699501013259,tercer,o
90,0211-699501013259,mes,o
90,0211-699501013259,en,o
90,0211-699501013259,hemodialisis,i
90,0211-699501013259,recibieron,o
90,0211-699501013259,5,o
90,0211-699501013259,mg,o
90,0211-699501013259,orales,o
90,0211-699501013259,de,o
90,0211-699501013259,acido,i
90,0211-699501013259,folico,i
90,0211-699501013259,cada,o
90,0211-699501013259,48,o
90,0211-699501013259,horas,o
90,0211-699501013259,y,o
90,0211-699501013259,40,o
90,0211-699501013259,mg,o
90,0211-699501013259,orales,o
90,0211-699501013259,de,o
90,0211-699501013259,vitamina,i
90,0211-699501013259,B6,i
90,0211-699501013259,cada,o
90,0211-699501013259,semana,o
90,0211-699501013259,Se,o
90,0211-699501013259,determinaron,o
90,0211-699501013259,al,o
90,0211-699501013259,comienzo,o
90,0211-699501013259,del,o
90,0211-699501013259,estudio,o
90,0211-699501013259,y,o
90,0211-699501013259,cada,o
90,0211-699501013259,2,o
90,0211-699501013259,meses,o
90,0211-699501013259,niveles,i
90,0211-699501013259,de,i
90,0211-699501013259,folato,i
90,0211-699501013259,vitamina,i
90,0211-699501013259,B12,i
90,0211-699501013259,inmunoensayo,i
90,0211-699501013259,albumina,i
90,0211-699501013259,y,o
90,0211-699501013259,cinetica,o
90,0211-699501013259,de,o
90,0211-699501013259,la,o
90,0211-699501013259,urea,i
90,0211-699501013259,KTV,o
90,0211-699501013259,KRU,o
90,0211-699501013259,PCRn,o
90,0211-699501013259,y,o
90,0211-699501013259,cada,o
90,0211-699501013259,6,o
90,0211-699501013259,meses,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,HPLC,i
90,0211-699501013259,y,o
90,0211-699501013259,pp,i
90,0211-699501013259,RIA,i
90,0211-699501013259,Resultados,o
90,0211-699501013259,80,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,fueron,o
90,0211-699501013259,incluidos,o
90,0211-699501013259,en,o
90,0211-699501013259,el,o
90,0211-699501013259,estudio,o
90,0211-699501013259,basal,o
90,0211-699501013259,con,o
90,0211-699501013259,una,o
90,0211-699501013259,prevalencia,o
90,0211-699501013259,de,o
90,0211-699501013259,hiperhomocisteinemia,i
90,0211-699501013259,del,o
90,0211-699501013259,844,o
90,0211-699501013259,deficit,i
90,0211-699501013259,de,i
90,0211-699501013259,pp,i
90,0211-699501013259,en,o
90,0211-699501013259,el,o
90,0211-699501013259,32,o
90,0211-699501013259,y,o
90,0211-699501013259,folato,i
90,0211-699501013259,en,o
90,0211-699501013259,el,o
90,0211-699501013259,rango,o
90,0211-699501013259,normal,o
90,0211-699501013259,bajo,o
90,0211-699501013259,los,o
90,0211-699501013259,niveles,i
90,0211-699501013259,de,i
90,0211-699501013259,tHcy,i
90,0211-699501013259,se,o
90,0211-699501013259,correlacionaban,o
90,0211-699501013259,inversamente,o
90,0211-699501013259,con,o
90,0211-699501013259,los,o
90,0211-699501013259,del,o
90,0211-699501013259,folato,i
90,0211-699501013259,r,o
90,0211-699501013259,0336,o
90,0211-699501013259,p,o
90,0211-699501013259,001,o
90,0211-699501013259,pero,o
90,0211-699501013259,no,o
90,0211-699501013259,con,o
90,0211-699501013259,pp,i
90,0211-699501013259,B12,i
90,0211-699501013259,edad,o
90,0211-699501013259,albumina,i
90,0211-699501013259,KTV,o
90,0211-699501013259,KRU,o
90,0211-699501013259,PCRn,o
90,0211-699501013259,Cincuenta,o
90,0211-699501013259,y,o
90,0211-699501013259,ocho,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,recibieron,o
90,0211-699501013259,seis,o
90,0211-699501013259,meses,o
90,0211-699501013259,de,o
90,0211-699501013259,suplementacion,i
90,0211-699501013259,con,o
90,0211-699501013259,normalizacion,o
90,0211-699501013259,del,o
90,0211-699501013259,pp,i
90,0211-699501013259,aumento,o
90,0211-699501013259,del,o
90,0211-699501013259,folato,i
90,0211-699501013259,703,o
90,0211-699501013259,IC,o
90,0211-699501013259,638,o
90,0211-699501013259,795,o
90,0211-699501013259,vs,o
90,0211-699501013259,6181,o
90,0211-699501013259,IC,o
90,0211-699501013259,4447,o
90,0211-699501013259,7811,o
90,0211-699501013259,p,o
90,0211-699501013259,0001,o
90,0211-699501013259,y,o
90,0211-699501013259,descenso,o
90,0211-699501013259,de,o
90,0211-699501013259,la,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,240,o
90,0211-699501013259,IC,o
90,0211-699501013259,213,o
90,0211-699501013259,264,o
90,0211-699501013259,vs,o
90,0211-699501013259,199,o
90,0211-699501013259,IC,o
90,0211-699501013259,175,o
90,0211-699501013259,224,o
90,0211-699501013259,p,o
90,0211-699501013259,005,o
90,0211-699501013259,Han,o
90,0211-699501013259,recibido,o
90,0211-699501013259,suplementacion,i
90,0211-699501013259,durante,o
90,0211-699501013259,12,o
90,0211-699501013259,meses,o
90,0211-699501013259,33,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,pero,o
90,0211-699501013259,a,o
90,0211-699501013259,pesar,o
90,0211-699501013259,de,o
90,0211-699501013259,un,o
90,0211-699501013259,continuo,o
90,0211-699501013259,aumento,o
90,0211-699501013259,del,o
90,0211-699501013259,folato,i
90,0211-699501013259,10078,o
90,0211-699501013259,IC,o
90,0211-699501013259,7481,o
90,0211-699501013259,12674,o
90,0211-699501013259,p,o
90,0211-699501013259,0001,o
90,0211-699501013259,solo,o
90,0211-699501013259,3,o
90,0211-699501013259,pacientes,o
90,0211-699501013259,presentan,o
90,0211-699501013259,niveles,o
90,0211-699501013259,normales,o
90,0211-699501013259,de,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,correlacionandose,o
90,0211-699501013259,directamente,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,con,o
90,0211-699501013259,la,o
90,0211-699501013259,albumina,i
90,0211-699501013259,r,o
90,0211-699501013259,056,o
90,0211-699501013259,p,o
90,0211-699501013259,0001,o
90,0211-699501013259,que,o
90,0211-699501013259,se,o
90,0211-699501013259,elevo,o
90,0211-699501013259,con,o
90,0211-699501013259,respecto,o
90,0211-699501013259,al,o
90,0211-699501013259,inicio,o
90,0211-699501013259,337,o
90,0211-699501013259,IC,o
90,0211-699501013259,327,o
90,0211-699501013259,346,o
90,0211-699501013259,vs,o
90,0211-699501013259,350,o
90,0211-699501013259,IC,o
90,0211-699501013259,337,o
90,0211-699501013259,363,o
90,0211-699501013259,p,o
90,0211-699501013259,005,o
90,0211-699501013259,Conclusion,o
90,0211-699501013259,Tras,o
90,0211-699501013259,suplementacion,i
90,0211-699501013259,con,o
90,0211-699501013259,acido,i
90,0211-699501013259,folico,i
90,0211-699501013259,y,o
90,0211-699501013259,vitamina,i
90,0211-699501013259,B6,i
90,0211-699501013259,aunque,o
90,0211-699501013259,inicialmente,o
90,0211-699501013259,se,o
90,0211-699501013259,reduce,o
90,0211-699501013259,la,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,esta,o
90,0211-699501013259,respuesta,o
90,0211-699501013259,se,o
90,0211-699501013259,hace,o
90,0211-699501013259,refractaria,o
90,0211-699501013259,correlacionandose,o
90,0211-699501013259,directamente,o
90,0211-699501013259,la,o
90,0211-699501013259,tHcy,i
90,0211-699501013259,con,o
90,0211-699501013259,la,o
90,0211-699501013259,albumina,i
90,0211-699501013259,plasmatica,i
90,0211-699501013259,La,o
90,0211-699501013259,interpretacion,o
90,0211-699501013259,de,o
90,0211-699501013259,los,o
90,0211-699501013259,niveles,i
90,0211-699501013259,de,i
90,0211-699501013259,tHcy,i
90,0211-699501013259,debe,o
90,0211-699501013259,tener,o
90,0211-699501013259,en,o
90,0211-699501013259,cuenta,o
90,0211-699501013259,la,o
90,0211-699501013259,concentracion,i
90,0211-699501013259,de,i
90,0211-699501013259,albumina,i
91,0211-699501013259,Efecto,o
91,0211-699501013259,de,o
91,0211-699501013259,la,o
91,0211-699501013259,suplementacion,i
91,0211-699501013259,con,o
91,0211-699501013259,acido,i
91,0211-699501013259,folico,i
91,0211-699501013259,sobre,o
91,0211-699501013259,los,o
91,0211-699501013259,niveles,i
91,0211-699501013259,de,i
91,0211-699501013259,homocisteina,i
91,0211-699501013259,total,o
91,0211-699501013259,en,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,en,o
91,0211-699501013259,hemodialisis,i
91,0211-699501013259,La,o
91,0211-699501013259,hiperhomocisteinemia,i
91,0211-699501013259,es,o
91,0211-699501013259,un,o
91,0211-699501013259,marcador,o
91,0211-699501013259,de,o
91,0211-699501013259,riesgo,o
91,0211-699501013259,independiente,o
91,0211-699501013259,de,o
91,0211-699501013259,morbimortalidad,o
91,0211-699501013259,cardiovascular,i
91,0211-699501013259,Hemos,o
91,0211-699501013259,intentado,o
91,0211-699501013259,prospectivamente,o
91,0211-699501013259,reducir,o
91,0211-699501013259,los,o
91,0211-699501013259,niveles,i
91,0211-699501013259,de,i
91,0211-699501013259,homocisteina,i
91,0211-699501013259,total,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,mediante,o
91,0211-699501013259,suplemento,o
91,0211-699501013259,con,o
91,0211-699501013259,acido,i
91,0211-699501013259,folico,i
91,0211-699501013259,y,o
91,0211-699501013259,vitamina,i
91,0211-699501013259,B6,i
91,0211-699501013259,pp,i
91,0211-699501013259,valorando,o
91,0211-699501013259,su,o
91,0211-699501013259,posible,o
91,0211-699501013259,correlacion,o
91,0211-699501013259,con,o
91,0211-699501013259,dosis,o
91,0211-699501013259,de,o
91,0211-699501013259,dialisis,i
91,0211-699501013259,funcion,i
91,0211-699501013259,residual,i
91,0211-699501013259,y,o
91,0211-699501013259,parametros,o
91,0211-699501013259,nutricionales,o
91,0211-699501013259,Metodos,o
91,0211-699501013259,Todos,o
91,0211-699501013259,los,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,en,o
91,0211-699501013259,hemodialisis,i
91,0211-699501013259,al,o
91,0211-699501013259,comienzo,o
91,0211-699501013259,del,o
91,0211-699501013259,estudio,o
91,0211-699501013259,que,o
91,0211-699501013259,no,o
91,0211-699501013259,recibian,o
91,0211-699501013259,acido,i
91,0211-699501013259,folico,i
91,0211-699501013259,ni,o
91,0211-699501013259,vitamina,i
91,0211-699501013259,B6,i
91,0211-699501013259,asi,o
91,0211-699501013259,como,o
91,0211-699501013259,los,o
91,0211-699501013259,incorporados,o
91,0211-699501013259,posteriormente,o
91,0211-699501013259,a,o
91,0211-699501013259,partir,o
91,0211-699501013259,de,o
91,0211-699501013259,su,o
91,0211-699501013259,tercer,o
91,0211-699501013259,mes,o
91,0211-699501013259,en,o
91,0211-699501013259,hemodialisis,i
91,0211-699501013259,recibieron,o
91,0211-699501013259,5,o
91,0211-699501013259,mg,o
91,0211-699501013259,orales,o
91,0211-699501013259,de,o
91,0211-699501013259,acido,i
91,0211-699501013259,folico,i
91,0211-699501013259,cada,o
91,0211-699501013259,48,o
91,0211-699501013259,horas,o
91,0211-699501013259,y,o
91,0211-699501013259,40,o
91,0211-699501013259,mg,o
91,0211-699501013259,orales,o
91,0211-699501013259,de,o
91,0211-699501013259,vitamina,i
91,0211-699501013259,B6,i
91,0211-699501013259,cada,o
91,0211-699501013259,semana,o
91,0211-699501013259,Se,o
91,0211-699501013259,determinaron,o
91,0211-699501013259,al,o
91,0211-699501013259,comienzo,o
91,0211-699501013259,del,o
91,0211-699501013259,estudio,o
91,0211-699501013259,y,o
91,0211-699501013259,cada,o
91,0211-699501013259,2,o
91,0211-699501013259,meses,o
91,0211-699501013259,niveles,i
91,0211-699501013259,de,i
91,0211-699501013259,folato,i
91,0211-699501013259,vitamina,i
91,0211-699501013259,B12,i
91,0211-699501013259,inmunoensayo,i
91,0211-699501013259,albumina,i
91,0211-699501013259,y,o
91,0211-699501013259,cinetica,o
91,0211-699501013259,de,o
91,0211-699501013259,la,o
91,0211-699501013259,urea,i
91,0211-699501013259,KTV,o
91,0211-699501013259,KRU,o
91,0211-699501013259,PCRn,o
91,0211-699501013259,y,o
91,0211-699501013259,cada,o
91,0211-699501013259,6,o
91,0211-699501013259,meses,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,HPLC,i
91,0211-699501013259,y,o
91,0211-699501013259,pp,i
91,0211-699501013259,RIA,i
91,0211-699501013259,Resultados,o
91,0211-699501013259,80,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,fueron,o
91,0211-699501013259,incluidos,o
91,0211-699501013259,en,o
91,0211-699501013259,el,o
91,0211-699501013259,estudio,o
91,0211-699501013259,basal,o
91,0211-699501013259,con,o
91,0211-699501013259,una,o
91,0211-699501013259,prevalencia,o
91,0211-699501013259,de,o
91,0211-699501013259,hiperhomocisteinemia,i
91,0211-699501013259,del,o
91,0211-699501013259,844,o
91,0211-699501013259,deficit,i
91,0211-699501013259,de,i
91,0211-699501013259,pp,i
91,0211-699501013259,en,o
91,0211-699501013259,el,o
91,0211-699501013259,32,o
91,0211-699501013259,y,o
91,0211-699501013259,folato,i
91,0211-699501013259,en,o
91,0211-699501013259,el,o
91,0211-699501013259,rango,o
91,0211-699501013259,normal,o
91,0211-699501013259,bajo,o
91,0211-699501013259,los,o
91,0211-699501013259,niveles,i
91,0211-699501013259,de,i
91,0211-699501013259,tHcy,i
91,0211-699501013259,se,o
91,0211-699501013259,correlacionaban,o
91,0211-699501013259,inversamente,o
91,0211-699501013259,con,o
91,0211-699501013259,los,o
91,0211-699501013259,del,o
91,0211-699501013259,folato,i
91,0211-699501013259,r,o
91,0211-699501013259,0336,o
91,0211-699501013259,p,o
91,0211-699501013259,001,o
91,0211-699501013259,pero,o
91,0211-699501013259,no,o
91,0211-699501013259,con,o
91,0211-699501013259,pp,i
91,0211-699501013259,B12,i
91,0211-699501013259,edad,o
91,0211-699501013259,albumina,i
91,0211-699501013259,KTV,o
91,0211-699501013259,KRU,o
91,0211-699501013259,PCRn,o
91,0211-699501013259,Cincuenta,o
91,0211-699501013259,y,o
91,0211-699501013259,ocho,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,recibieron,o
91,0211-699501013259,seis,o
91,0211-699501013259,meses,o
91,0211-699501013259,de,o
91,0211-699501013259,suplementacion,i
91,0211-699501013259,con,o
91,0211-699501013259,normalizacion,o
91,0211-699501013259,del,o
91,0211-699501013259,pp,i
91,0211-699501013259,aumento,o
91,0211-699501013259,del,o
91,0211-699501013259,folato,i
91,0211-699501013259,703,o
91,0211-699501013259,IC,o
91,0211-699501013259,638,o
91,0211-699501013259,795,o
91,0211-699501013259,vs,o
91,0211-699501013259,6181,o
91,0211-699501013259,IC,o
91,0211-699501013259,4447,o
91,0211-699501013259,7811,o
91,0211-699501013259,p,o
91,0211-699501013259,0001,o
91,0211-699501013259,y,o
91,0211-699501013259,descenso,o
91,0211-699501013259,de,o
91,0211-699501013259,la,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,240,o
91,0211-699501013259,IC,o
91,0211-699501013259,213,o
91,0211-699501013259,264,o
91,0211-699501013259,vs,o
91,0211-699501013259,199,o
91,0211-699501013259,IC,o
91,0211-699501013259,175,o
91,0211-699501013259,224,o
91,0211-699501013259,p,o
91,0211-699501013259,005,o
91,0211-699501013259,Han,o
91,0211-699501013259,recibido,o
91,0211-699501013259,suplementacion,i
91,0211-699501013259,durante,o
91,0211-699501013259,12,o
91,0211-699501013259,meses,o
91,0211-699501013259,33,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,pero,o
91,0211-699501013259,a,o
91,0211-699501013259,pesar,o
91,0211-699501013259,de,o
91,0211-699501013259,un,o
91,0211-699501013259,continuo,o
91,0211-699501013259,aumento,o
91,0211-699501013259,del,o
91,0211-699501013259,folato,i
91,0211-699501013259,10078,o
91,0211-699501013259,IC,o
91,0211-699501013259,7481,o
91,0211-699501013259,12674,o
91,0211-699501013259,p,o
91,0211-699501013259,0001,o
91,0211-699501013259,solo,o
91,0211-699501013259,3,o
91,0211-699501013259,pacientes,o
91,0211-699501013259,presentan,o
91,0211-699501013259,niveles,o
91,0211-699501013259,normales,o
91,0211-699501013259,de,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,correlacionandose,o
91,0211-699501013259,directamente,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,con,o
91,0211-699501013259,la,o
91,0211-699501013259,albumina,i
91,0211-699501013259,r,o
91,0211-699501013259,056,o
91,0211-699501013259,p,o
91,0211-699501013259,0001,o
91,0211-699501013259,que,o
91,0211-699501013259,se,o
91,0211-699501013259,elevo,o
91,0211-699501013259,con,o
91,0211-699501013259,respecto,o
91,0211-699501013259,al,o
91,0211-699501013259,inicio,o
91,0211-699501013259,337,o
91,0211-699501013259,IC,o
91,0211-699501013259,327,o
91,0211-699501013259,346,o
91,0211-699501013259,vs,o
91,0211-699501013259,350,o
91,0211-699501013259,IC,o
91,0211-699501013259,337,o
91,0211-699501013259,363,o
91,0211-699501013259,p,o
91,0211-699501013259,005,o
91,0211-699501013259,Conclusion,o
91,0211-699501013259,Tras,o
91,0211-699501013259,suplementacion,i
91,0211-699501013259,con,o
91,0211-699501013259,acido,i
91,0211-699501013259,folico,i
91,0211-699501013259,y,o
91,0211-699501013259,vitamina,i
91,0211-699501013259,B6,i
91,0211-699501013259,aunque,o
91,0211-699501013259,inicialmente,o
91,0211-699501013259,se,o
91,0211-699501013259,reduce,o
91,0211-699501013259,la,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,esta,o
91,0211-699501013259,respuesta,o
91,0211-699501013259,se,o
91,0211-699501013259,hace,o
91,0211-699501013259,refractaria,o
91,0211-699501013259,correlacionandose,o
91,0211-699501013259,directamente,o
91,0211-699501013259,la,o
91,0211-699501013259,tHcy,i
91,0211-699501013259,con,o
91,0211-699501013259,la,o
91,0211-699501013259,albumina,i
91,0211-699501013259,plasmatica,i
91,0211-699501013259,La,o
91,0211-699501013259,interpretacion,o
91,0211-699501013259,de,o
91,0211-699501013259,los,o
91,0211-699501013259,niveles,i
91,0211-699501013259,de,i
91,0211-699501013259,tHcy,i
91,0211-699501013259,debe,o
91,0211-699501013259,tener,o
91,0211-699501013259,en,o
91,0211-699501013259,cuenta,o
91,0211-699501013259,la,o
91,0211-699501013259,concentracion,i
91,0211-699501013259,de,i
91,0211-699501013259,albumina,i
92,0211-699501013259,Efecto,o
92,0211-699501013259,de,o
92,0211-699501013259,la,o
92,0211-699501013259,suplementacion,i
92,0211-699501013259,con,o
92,0211-699501013259,acido,i
92,0211-699501013259,folico,i
92,0211-699501013259,sobre,o
92,0211-699501013259,los,o
92,0211-699501013259,niveles,i
92,0211-699501013259,de,i
92,0211-699501013259,homocisteina,i
92,0211-699501013259,total,o
92,0211-699501013259,en,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,en,o
92,0211-699501013259,hemodialisis,i
92,0211-699501013259,La,o
92,0211-699501013259,hiperhomocisteinemia,i
92,0211-699501013259,es,o
92,0211-699501013259,un,o
92,0211-699501013259,marcador,o
92,0211-699501013259,de,o
92,0211-699501013259,riesgo,o
92,0211-699501013259,independiente,o
92,0211-699501013259,de,o
92,0211-699501013259,morbimortalidad,o
92,0211-699501013259,cardiovascular,i
92,0211-699501013259,Hemos,o
92,0211-699501013259,intentado,o
92,0211-699501013259,prospectivamente,o
92,0211-699501013259,reducir,o
92,0211-699501013259,los,o
92,0211-699501013259,niveles,i
92,0211-699501013259,de,i
92,0211-699501013259,homocisteina,i
92,0211-699501013259,total,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,mediante,o
92,0211-699501013259,suplemento,o
92,0211-699501013259,con,o
92,0211-699501013259,acido,i
92,0211-699501013259,folico,i
92,0211-699501013259,y,o
92,0211-699501013259,vitamina,i
92,0211-699501013259,B6,i
92,0211-699501013259,pp,i
92,0211-699501013259,valorando,o
92,0211-699501013259,su,o
92,0211-699501013259,posible,o
92,0211-699501013259,correlacion,o
92,0211-699501013259,con,o
92,0211-699501013259,dosis,o
92,0211-699501013259,de,o
92,0211-699501013259,dialisis,i
92,0211-699501013259,funcion,i
92,0211-699501013259,residual,i
92,0211-699501013259,y,o
92,0211-699501013259,parametros,o
92,0211-699501013259,nutricionales,o
92,0211-699501013259,Metodos,o
92,0211-699501013259,Todos,o
92,0211-699501013259,los,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,en,o
92,0211-699501013259,hemodialisis,i
92,0211-699501013259,al,o
92,0211-699501013259,comienzo,o
92,0211-699501013259,del,o
92,0211-699501013259,estudio,o
92,0211-699501013259,que,o
92,0211-699501013259,no,o
92,0211-699501013259,recibian,o
92,0211-699501013259,acido,i
92,0211-699501013259,folico,i
92,0211-699501013259,ni,o
92,0211-699501013259,vitamina,i
92,0211-699501013259,B6,i
92,0211-699501013259,asi,o
92,0211-699501013259,como,o
92,0211-699501013259,los,o
92,0211-699501013259,incorporados,o
92,0211-699501013259,posteriormente,o
92,0211-699501013259,a,o
92,0211-699501013259,partir,o
92,0211-699501013259,de,o
92,0211-699501013259,su,o
92,0211-699501013259,tercer,o
92,0211-699501013259,mes,o
92,0211-699501013259,en,o
92,0211-699501013259,hemodialisis,i
92,0211-699501013259,recibieron,o
92,0211-699501013259,5,o
92,0211-699501013259,mg,o
92,0211-699501013259,orales,o
92,0211-699501013259,de,o
92,0211-699501013259,acido,i
92,0211-699501013259,folico,i
92,0211-699501013259,cada,o
92,0211-699501013259,48,o
92,0211-699501013259,horas,o
92,0211-699501013259,y,o
92,0211-699501013259,40,o
92,0211-699501013259,mg,o
92,0211-699501013259,orales,o
92,0211-699501013259,de,o
92,0211-699501013259,vitamina,i
92,0211-699501013259,B6,i
92,0211-699501013259,cada,o
92,0211-699501013259,semana,o
92,0211-699501013259,Se,o
92,0211-699501013259,determinaron,o
92,0211-699501013259,al,o
92,0211-699501013259,comienzo,o
92,0211-699501013259,del,o
92,0211-699501013259,estudio,o
92,0211-699501013259,y,o
92,0211-699501013259,cada,o
92,0211-699501013259,2,o
92,0211-699501013259,meses,o
92,0211-699501013259,niveles,i
92,0211-699501013259,de,i
92,0211-699501013259,folato,i
92,0211-699501013259,vitamina,i
92,0211-699501013259,B12,i
92,0211-699501013259,inmunoensayo,i
92,0211-699501013259,albumina,i
92,0211-699501013259,y,o
92,0211-699501013259,cinetica,o
92,0211-699501013259,de,o
92,0211-699501013259,la,o
92,0211-699501013259,urea,i
92,0211-699501013259,KTV,o
92,0211-699501013259,KRU,o
92,0211-699501013259,PCRn,o
92,0211-699501013259,y,o
92,0211-699501013259,cada,o
92,0211-699501013259,6,o
92,0211-699501013259,meses,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,HPLC,i
92,0211-699501013259,y,o
92,0211-699501013259,pp,i
92,0211-699501013259,RIA,i
92,0211-699501013259,Resultados,o
92,0211-699501013259,80,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,fueron,o
92,0211-699501013259,incluidos,o
92,0211-699501013259,en,o
92,0211-699501013259,el,o
92,0211-699501013259,estudio,o
92,0211-699501013259,basal,o
92,0211-699501013259,con,o
92,0211-699501013259,una,o
92,0211-699501013259,prevalencia,o
92,0211-699501013259,de,o
92,0211-699501013259,hiperhomocisteinemia,i
92,0211-699501013259,del,o
92,0211-699501013259,844,o
92,0211-699501013259,deficit,i
92,0211-699501013259,de,i
92,0211-699501013259,pp,i
92,0211-699501013259,en,o
92,0211-699501013259,el,o
92,0211-699501013259,32,o
92,0211-699501013259,y,o
92,0211-699501013259,folato,i
92,0211-699501013259,en,o
92,0211-699501013259,el,o
92,0211-699501013259,rango,o
92,0211-699501013259,normal,o
92,0211-699501013259,bajo,o
92,0211-699501013259,los,o
92,0211-699501013259,niveles,i
92,0211-699501013259,de,i
92,0211-699501013259,tHcy,i
92,0211-699501013259,se,o
92,0211-699501013259,correlacionaban,o
92,0211-699501013259,inversamente,o
92,0211-699501013259,con,o
92,0211-699501013259,los,o
92,0211-699501013259,del,o
92,0211-699501013259,folato,i
92,0211-699501013259,r,o
92,0211-699501013259,0336,o
92,0211-699501013259,p,o
92,0211-699501013259,001,o
92,0211-699501013259,pero,o
92,0211-699501013259,no,o
92,0211-699501013259,con,o
92,0211-699501013259,pp,i
92,0211-699501013259,B12,i
92,0211-699501013259,edad,o
92,0211-699501013259,albumina,i
92,0211-699501013259,KTV,o
92,0211-699501013259,KRU,o
92,0211-699501013259,PCRn,o
92,0211-699501013259,Cincuenta,o
92,0211-699501013259,y,o
92,0211-699501013259,ocho,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,recibieron,o
92,0211-699501013259,seis,o
92,0211-699501013259,meses,o
92,0211-699501013259,de,o
92,0211-699501013259,suplementacion,i
92,0211-699501013259,con,o
92,0211-699501013259,normalizacion,o
92,0211-699501013259,del,o
92,0211-699501013259,pp,i
92,0211-699501013259,aumento,o
92,0211-699501013259,del,o
92,0211-699501013259,folato,i
92,0211-699501013259,703,o
92,0211-699501013259,IC,o
92,0211-699501013259,638,o
92,0211-699501013259,795,o
92,0211-699501013259,vs,o
92,0211-699501013259,6181,o
92,0211-699501013259,IC,o
92,0211-699501013259,4447,o
92,0211-699501013259,7811,o
92,0211-699501013259,p,o
92,0211-699501013259,0001,o
92,0211-699501013259,y,o
92,0211-699501013259,descenso,o
92,0211-699501013259,de,o
92,0211-699501013259,la,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,240,o
92,0211-699501013259,IC,o
92,0211-699501013259,213,o
92,0211-699501013259,264,o
92,0211-699501013259,vs,o
92,0211-699501013259,199,o
92,0211-699501013259,IC,o
92,0211-699501013259,175,o
92,0211-699501013259,224,o
92,0211-699501013259,p,o
92,0211-699501013259,005,o
92,0211-699501013259,Han,o
92,0211-699501013259,recibido,o
92,0211-699501013259,suplementacion,i
92,0211-699501013259,durante,o
92,0211-699501013259,12,o
92,0211-699501013259,meses,o
92,0211-699501013259,33,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,pero,o
92,0211-699501013259,a,o
92,0211-699501013259,pesar,o
92,0211-699501013259,de,o
92,0211-699501013259,un,o
92,0211-699501013259,continuo,o
92,0211-699501013259,aumento,o
92,0211-699501013259,del,o
92,0211-699501013259,folato,i
92,0211-699501013259,10078,o
92,0211-699501013259,IC,o
92,0211-699501013259,7481,o
92,0211-699501013259,12674,o
92,0211-699501013259,p,o
92,0211-699501013259,0001,o
92,0211-699501013259,solo,o
92,0211-699501013259,3,o
92,0211-699501013259,pacientes,o
92,0211-699501013259,presentan,o
92,0211-699501013259,niveles,o
92,0211-699501013259,normales,o
92,0211-699501013259,de,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,correlacionandose,o
92,0211-699501013259,directamente,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,con,o
92,0211-699501013259,la,o
92,0211-699501013259,albumina,i
92,0211-699501013259,r,o
92,0211-699501013259,056,o
92,0211-699501013259,p,o
92,0211-699501013259,0001,o
92,0211-699501013259,que,o
92,0211-699501013259,se,o
92,0211-699501013259,elevo,o
92,0211-699501013259,con,o
92,0211-699501013259,respecto,o
92,0211-699501013259,al,o
92,0211-699501013259,inicio,o
92,0211-699501013259,337,o
92,0211-699501013259,IC,o
92,0211-699501013259,327,o
92,0211-699501013259,346,o
92,0211-699501013259,vs,o
92,0211-699501013259,350,o
92,0211-699501013259,IC,o
92,0211-699501013259,337,o
92,0211-699501013259,363,o
92,0211-699501013259,p,o
92,0211-699501013259,005,o
92,0211-699501013259,Conclusion,o
92,0211-699501013259,Tras,o
92,0211-699501013259,suplementacion,i
92,0211-699501013259,con,o
92,0211-699501013259,acido,i
92,0211-699501013259,folico,i
92,0211-699501013259,y,o
92,0211-699501013259,vitamina,i
92,0211-699501013259,B6,i
92,0211-699501013259,aunque,o
92,0211-699501013259,inicialmente,o
92,0211-699501013259,se,o
92,0211-699501013259,reduce,o
92,0211-699501013259,la,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,esta,o
92,0211-699501013259,respuesta,o
92,0211-699501013259,se,o
92,0211-699501013259,hace,o
92,0211-699501013259,refractaria,o
92,0211-699501013259,correlacionandose,o
92,0211-699501013259,directamente,o
92,0211-699501013259,la,o
92,0211-699501013259,tHcy,i
92,0211-699501013259,con,o
92,0211-699501013259,la,o
92,0211-699501013259,albumina,i
92,0211-699501013259,plasmatica,i
92,0211-699501013259,La,o
92,0211-699501013259,interpretacion,o
92,0211-699501013259,de,o
92,0211-699501013259,los,o
92,0211-699501013259,niveles,i
92,0211-699501013259,de,i
92,0211-699501013259,tHcy,i
92,0211-699501013259,debe,o
92,0211-699501013259,tener,o
92,0211-699501013259,en,o
92,0211-699501013259,cuenta,o
92,0211-699501013259,la,o
92,0211-699501013259,concentracion,i
92,0211-699501013259,de,i
92,0211-699501013259,albumina,i
93,0211-699501013259,Efecto,o
93,0211-699501013259,de,o
93,0211-699501013259,la,o
93,0211-699501013259,suplementacion,i
93,0211-699501013259,con,o
93,0211-699501013259,acido,i
93,0211-699501013259,folico,i
93,0211-699501013259,sobre,o
93,0211-699501013259,los,o
93,0211-699501013259,niveles,i
93,0211-699501013259,de,i
93,0211-699501013259,homocisteina,i
93,0211-699501013259,total,o
93,0211-699501013259,en,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,en,o
93,0211-699501013259,hemodialisis,i
93,0211-699501013259,La,o
93,0211-699501013259,hiperhomocisteinemia,i
93,0211-699501013259,es,o
93,0211-699501013259,un,o
93,0211-699501013259,marcador,o
93,0211-699501013259,de,o
93,0211-699501013259,riesgo,o
93,0211-699501013259,independiente,o
93,0211-699501013259,de,o
93,0211-699501013259,morbimortalidad,o
93,0211-699501013259,cardiovascular,i
93,0211-699501013259,Hemos,o
93,0211-699501013259,intentado,o
93,0211-699501013259,prospectivamente,o
93,0211-699501013259,reducir,o
93,0211-699501013259,los,o
93,0211-699501013259,niveles,i
93,0211-699501013259,de,i
93,0211-699501013259,homocisteina,i
93,0211-699501013259,total,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,mediante,o
93,0211-699501013259,suplemento,o
93,0211-699501013259,con,o
93,0211-699501013259,acido,i
93,0211-699501013259,folico,i
93,0211-699501013259,y,o
93,0211-699501013259,vitamina,i
93,0211-699501013259,B6,i
93,0211-699501013259,pp,i
93,0211-699501013259,valorando,o
93,0211-699501013259,su,o
93,0211-699501013259,posible,o
93,0211-699501013259,correlacion,o
93,0211-699501013259,con,o
93,0211-699501013259,dosis,o
93,0211-699501013259,de,o
93,0211-699501013259,dialisis,i
93,0211-699501013259,funcion,i
93,0211-699501013259,residual,i
93,0211-699501013259,y,o
93,0211-699501013259,parametros,o
93,0211-699501013259,nutricionales,o
93,0211-699501013259,Metodos,o
93,0211-699501013259,Todos,o
93,0211-699501013259,los,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,en,o
93,0211-699501013259,hemodialisis,i
93,0211-699501013259,al,o
93,0211-699501013259,comienzo,o
93,0211-699501013259,del,o
93,0211-699501013259,estudio,o
93,0211-699501013259,que,o
93,0211-699501013259,no,o
93,0211-699501013259,recibian,o
93,0211-699501013259,acido,i
93,0211-699501013259,folico,i
93,0211-699501013259,ni,o
93,0211-699501013259,vitamina,i
93,0211-699501013259,B6,i
93,0211-699501013259,asi,o
93,0211-699501013259,como,o
93,0211-699501013259,los,o
93,0211-699501013259,incorporados,o
93,0211-699501013259,posteriormente,o
93,0211-699501013259,a,o
93,0211-699501013259,partir,o
93,0211-699501013259,de,o
93,0211-699501013259,su,o
93,0211-699501013259,tercer,o
93,0211-699501013259,mes,o
93,0211-699501013259,en,o
93,0211-699501013259,hemodialisis,i
93,0211-699501013259,recibieron,o
93,0211-699501013259,5,o
93,0211-699501013259,mg,o
93,0211-699501013259,orales,o
93,0211-699501013259,de,o
93,0211-699501013259,acido,i
93,0211-699501013259,folico,i
93,0211-699501013259,cada,o
93,0211-699501013259,48,o
93,0211-699501013259,horas,o
93,0211-699501013259,y,o
93,0211-699501013259,40,o
93,0211-699501013259,mg,o
93,0211-699501013259,orales,o
93,0211-699501013259,de,o
93,0211-699501013259,vitamina,i
93,0211-699501013259,B6,i
93,0211-699501013259,cada,o
93,0211-699501013259,semana,o
93,0211-699501013259,Se,o
93,0211-699501013259,determinaron,o
93,0211-699501013259,al,o
93,0211-699501013259,comienzo,o
93,0211-699501013259,del,o
93,0211-699501013259,estudio,o
93,0211-699501013259,y,o
93,0211-699501013259,cada,o
93,0211-699501013259,2,o
93,0211-699501013259,meses,o
93,0211-699501013259,niveles,i
93,0211-699501013259,de,i
93,0211-699501013259,folato,i
93,0211-699501013259,vitamina,i
93,0211-699501013259,B12,i
93,0211-699501013259,inmunoensayo,i
93,0211-699501013259,albumina,i
93,0211-699501013259,y,o
93,0211-699501013259,cinetica,o
93,0211-699501013259,de,o
93,0211-699501013259,la,o
93,0211-699501013259,urea,i
93,0211-699501013259,KTV,o
93,0211-699501013259,KRU,o
93,0211-699501013259,PCRn,o
93,0211-699501013259,y,o
93,0211-699501013259,cada,o
93,0211-699501013259,6,o
93,0211-699501013259,meses,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,HPLC,i
93,0211-699501013259,y,o
93,0211-699501013259,pp,i
93,0211-699501013259,RIA,i
93,0211-699501013259,Resultados,o
93,0211-699501013259,80,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,fueron,o
93,0211-699501013259,incluidos,o
93,0211-699501013259,en,o
93,0211-699501013259,el,o
93,0211-699501013259,estudio,o
93,0211-699501013259,basal,o
93,0211-699501013259,con,o
93,0211-699501013259,una,o
93,0211-699501013259,prevalencia,o
93,0211-699501013259,de,o
93,0211-699501013259,hiperhomocisteinemia,i
93,0211-699501013259,del,o
93,0211-699501013259,844,o
93,0211-699501013259,deficit,i
93,0211-699501013259,de,i
93,0211-699501013259,pp,i
93,0211-699501013259,en,o
93,0211-699501013259,el,o
93,0211-699501013259,32,o
93,0211-699501013259,y,o
93,0211-699501013259,folato,i
93,0211-699501013259,en,o
93,0211-699501013259,el,o
93,0211-699501013259,rango,o
93,0211-699501013259,normal,o
93,0211-699501013259,bajo,o
93,0211-699501013259,los,o
93,0211-699501013259,niveles,i
93,0211-699501013259,de,i
93,0211-699501013259,tHcy,i
93,0211-699501013259,se,o
93,0211-699501013259,correlacionaban,o
93,0211-699501013259,inversamente,o
93,0211-699501013259,con,o
93,0211-699501013259,los,o
93,0211-699501013259,del,o
93,0211-699501013259,folato,i
93,0211-699501013259,r,o
93,0211-699501013259,0336,o
93,0211-699501013259,p,o
93,0211-699501013259,001,o
93,0211-699501013259,pero,o
93,0211-699501013259,no,o
93,0211-699501013259,con,o
93,0211-699501013259,pp,i
93,0211-699501013259,B12,i
93,0211-699501013259,edad,o
93,0211-699501013259,albumina,i
93,0211-699501013259,KTV,o
93,0211-699501013259,KRU,o
93,0211-699501013259,PCRn,o
93,0211-699501013259,Cincuenta,o
93,0211-699501013259,y,o
93,0211-699501013259,ocho,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,recibieron,o
93,0211-699501013259,seis,o
93,0211-699501013259,meses,o
93,0211-699501013259,de,o
93,0211-699501013259,suplementacion,i
93,0211-699501013259,con,o
93,0211-699501013259,normalizacion,o
93,0211-699501013259,del,o
93,0211-699501013259,pp,i
93,0211-699501013259,aumento,o
93,0211-699501013259,del,o
93,0211-699501013259,folato,i
93,0211-699501013259,703,o
93,0211-699501013259,IC,o
93,0211-699501013259,638,o
93,0211-699501013259,795,o
93,0211-699501013259,vs,o
93,0211-699501013259,6181,o
93,0211-699501013259,IC,o
93,0211-699501013259,4447,o
93,0211-699501013259,7811,o
93,0211-699501013259,p,o
93,0211-699501013259,0001,o
93,0211-699501013259,y,o
93,0211-699501013259,descenso,o
93,0211-699501013259,de,o
93,0211-699501013259,la,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,240,o
93,0211-699501013259,IC,o
93,0211-699501013259,213,o
93,0211-699501013259,264,o
93,0211-699501013259,vs,o
93,0211-699501013259,199,o
93,0211-699501013259,IC,o
93,0211-699501013259,175,o
93,0211-699501013259,224,o
93,0211-699501013259,p,o
93,0211-699501013259,005,o
93,0211-699501013259,Han,o
93,0211-699501013259,recibido,o
93,0211-699501013259,suplementacion,i
93,0211-699501013259,durante,o
93,0211-699501013259,12,o
93,0211-699501013259,meses,o
93,0211-699501013259,33,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,pero,o
93,0211-699501013259,a,o
93,0211-699501013259,pesar,o
93,0211-699501013259,de,o
93,0211-699501013259,un,o
93,0211-699501013259,continuo,o
93,0211-699501013259,aumento,o
93,0211-699501013259,del,o
93,0211-699501013259,folato,i
93,0211-699501013259,10078,o
93,0211-699501013259,IC,o
93,0211-699501013259,7481,o
93,0211-699501013259,12674,o
93,0211-699501013259,p,o
93,0211-699501013259,0001,o
93,0211-699501013259,solo,o
93,0211-699501013259,3,o
93,0211-699501013259,pacientes,o
93,0211-699501013259,presentan,o
93,0211-699501013259,niveles,o
93,0211-699501013259,normales,o
93,0211-699501013259,de,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,correlacionandose,o
93,0211-699501013259,directamente,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,con,o
93,0211-699501013259,la,o
93,0211-699501013259,albumina,i
93,0211-699501013259,r,o
93,0211-699501013259,056,o
93,0211-699501013259,p,o
93,0211-699501013259,0001,o
93,0211-699501013259,que,o
93,0211-699501013259,se,o
93,0211-699501013259,elevo,o
93,0211-699501013259,con,o
93,0211-699501013259,respecto,o
93,0211-699501013259,al,o
93,0211-699501013259,inicio,o
93,0211-699501013259,337,o
93,0211-699501013259,IC,o
93,0211-699501013259,327,o
93,0211-699501013259,346,o
93,0211-699501013259,vs,o
93,0211-699501013259,350,o
93,0211-699501013259,IC,o
93,0211-699501013259,337,o
93,0211-699501013259,363,o
93,0211-699501013259,p,o
93,0211-699501013259,005,o
93,0211-699501013259,Conclusion,o
93,0211-699501013259,Tras,o
93,0211-699501013259,suplementacion,i
93,0211-699501013259,con,o
93,0211-699501013259,acido,i
93,0211-699501013259,folico,i
93,0211-699501013259,y,o
93,0211-699501013259,vitamina,i
93,0211-699501013259,B6,i
93,0211-699501013259,aunque,o
93,0211-699501013259,inicialmente,o
93,0211-699501013259,se,o
93,0211-699501013259,reduce,o
93,0211-699501013259,la,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,esta,o
93,0211-699501013259,respuesta,o
93,0211-699501013259,se,o
93,0211-699501013259,hace,o
93,0211-699501013259,refractaria,o
93,0211-699501013259,correlacionandose,o
93,0211-699501013259,directamente,o
93,0211-699501013259,la,o
93,0211-699501013259,tHcy,i
93,0211-699501013259,con,o
93,0211-699501013259,la,o
93,0211-699501013259,albumina,i
93,0211-699501013259,plasmatica,i
93,0211-699501013259,La,o
93,0211-699501013259,interpretacion,o
93,0211-699501013259,de,o
93,0211-699501013259,los,o
93,0211-699501013259,niveles,i
93,0211-699501013259,de,i
93,0211-699501013259,tHcy,i
93,0211-699501013259,debe,o
93,0211-699501013259,tener,o
93,0211-699501013259,en,o
93,0211-699501013259,cuenta,o
93,0211-699501013259,la,o
93,0211-699501013259,concentracion,i
93,0211-699501013259,de,i
93,0211-699501013259,albumina,i
94,0211-699501013259,Efecto,o
94,0211-699501013259,de,o
94,0211-699501013259,la,o
94,0211-699501013259,suplementacion,i
94,0211-699501013259,con,o
94,0211-699501013259,acido,i
94,0211-699501013259,folico,i
94,0211-699501013259,sobre,o
94,0211-699501013259,los,o
94,0211-699501013259,niveles,i
94,0211-699501013259,de,i
94,0211-699501013259,homocisteina,i
94,0211-699501013259,total,o
94,0211-699501013259,en,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,en,o
94,0211-699501013259,hemodialisis,i
94,0211-699501013259,La,o
94,0211-699501013259,hiperhomocisteinemia,i
94,0211-699501013259,es,o
94,0211-699501013259,un,o
94,0211-699501013259,marcador,o
94,0211-699501013259,de,o
94,0211-699501013259,riesgo,o
94,0211-699501013259,independiente,o
94,0211-699501013259,de,o
94,0211-699501013259,morbimortalidad,o
94,0211-699501013259,cardiovascular,i
94,0211-699501013259,Hemos,o
94,0211-699501013259,intentado,o
94,0211-699501013259,prospectivamente,o
94,0211-699501013259,reducir,o
94,0211-699501013259,los,o
94,0211-699501013259,niveles,i
94,0211-699501013259,de,i
94,0211-699501013259,homocisteina,i
94,0211-699501013259,total,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,mediante,o
94,0211-699501013259,suplemento,o
94,0211-699501013259,con,o
94,0211-699501013259,acido,i
94,0211-699501013259,folico,i
94,0211-699501013259,y,o
94,0211-699501013259,vitamina,i
94,0211-699501013259,B6,i
94,0211-699501013259,pp,i
94,0211-699501013259,valorando,o
94,0211-699501013259,su,o
94,0211-699501013259,posible,o
94,0211-699501013259,correlacion,o
94,0211-699501013259,con,o
94,0211-699501013259,dosis,o
94,0211-699501013259,de,o
94,0211-699501013259,dialisis,i
94,0211-699501013259,funcion,i
94,0211-699501013259,residual,i
94,0211-699501013259,y,o
94,0211-699501013259,parametros,o
94,0211-699501013259,nutricionales,o
94,0211-699501013259,Metodos,o
94,0211-699501013259,Todos,o
94,0211-699501013259,los,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,en,o
94,0211-699501013259,hemodialisis,i
94,0211-699501013259,al,o
94,0211-699501013259,comienzo,o
94,0211-699501013259,del,o
94,0211-699501013259,estudio,o
94,0211-699501013259,que,o
94,0211-699501013259,no,o
94,0211-699501013259,recibian,o
94,0211-699501013259,acido,i
94,0211-699501013259,folico,i
94,0211-699501013259,ni,o
94,0211-699501013259,vitamina,i
94,0211-699501013259,B6,i
94,0211-699501013259,asi,o
94,0211-699501013259,como,o
94,0211-699501013259,los,o
94,0211-699501013259,incorporados,o
94,0211-699501013259,posteriormente,o
94,0211-699501013259,a,o
94,0211-699501013259,partir,o
94,0211-699501013259,de,o
94,0211-699501013259,su,o
94,0211-699501013259,tercer,o
94,0211-699501013259,mes,o
94,0211-699501013259,en,o
94,0211-699501013259,hemodialisis,i
94,0211-699501013259,recibieron,o
94,0211-699501013259,5,o
94,0211-699501013259,mg,o
94,0211-699501013259,orales,o
94,0211-699501013259,de,o
94,0211-699501013259,acido,i
94,0211-699501013259,folico,i
94,0211-699501013259,cada,o
94,0211-699501013259,48,o
94,0211-699501013259,horas,o
94,0211-699501013259,y,o
94,0211-699501013259,40,o
94,0211-699501013259,mg,o
94,0211-699501013259,orales,o
94,0211-699501013259,de,o
94,0211-699501013259,vitamina,i
94,0211-699501013259,B6,i
94,0211-699501013259,cada,o
94,0211-699501013259,semana,o
94,0211-699501013259,Se,o
94,0211-699501013259,determinaron,o
94,0211-699501013259,al,o
94,0211-699501013259,comienzo,o
94,0211-699501013259,del,o
94,0211-699501013259,estudio,o
94,0211-699501013259,y,o
94,0211-699501013259,cada,o
94,0211-699501013259,2,o
94,0211-699501013259,meses,o
94,0211-699501013259,niveles,i
94,0211-699501013259,de,i
94,0211-699501013259,folato,i
94,0211-699501013259,vitamina,i
94,0211-699501013259,B12,i
94,0211-699501013259,inmunoensayo,i
94,0211-699501013259,albumina,i
94,0211-699501013259,y,o
94,0211-699501013259,cinetica,o
94,0211-699501013259,de,o
94,0211-699501013259,la,o
94,0211-699501013259,urea,i
94,0211-699501013259,KTV,o
94,0211-699501013259,KRU,o
94,0211-699501013259,PCRn,o
94,0211-699501013259,y,o
94,0211-699501013259,cada,o
94,0211-699501013259,6,o
94,0211-699501013259,meses,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,HPLC,i
94,0211-699501013259,y,o
94,0211-699501013259,pp,i
94,0211-699501013259,RIA,i
94,0211-699501013259,Resultados,o
94,0211-699501013259,80,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,fueron,o
94,0211-699501013259,incluidos,o
94,0211-699501013259,en,o
94,0211-699501013259,el,o
94,0211-699501013259,estudio,o
94,0211-699501013259,basal,o
94,0211-699501013259,con,o
94,0211-699501013259,una,o
94,0211-699501013259,prevalencia,o
94,0211-699501013259,de,o
94,0211-699501013259,hiperhomocisteinemia,i
94,0211-699501013259,del,o
94,0211-699501013259,844,o
94,0211-699501013259,deficit,i
94,0211-699501013259,de,i
94,0211-699501013259,pp,i
94,0211-699501013259,en,o
94,0211-699501013259,el,o
94,0211-699501013259,32,o
94,0211-699501013259,y,o
94,0211-699501013259,folato,i
94,0211-699501013259,en,o
94,0211-699501013259,el,o
94,0211-699501013259,rango,o
94,0211-699501013259,normal,o
94,0211-699501013259,bajo,o
94,0211-699501013259,los,o
94,0211-699501013259,niveles,i
94,0211-699501013259,de,i
94,0211-699501013259,tHcy,i
94,0211-699501013259,se,o
94,0211-699501013259,correlacionaban,o
94,0211-699501013259,inversamente,o
94,0211-699501013259,con,o
94,0211-699501013259,los,o
94,0211-699501013259,del,o
94,0211-699501013259,folato,i
94,0211-699501013259,r,o
94,0211-699501013259,0336,o
94,0211-699501013259,p,o
94,0211-699501013259,001,o
94,0211-699501013259,pero,o
94,0211-699501013259,no,o
94,0211-699501013259,con,o
94,0211-699501013259,pp,i
94,0211-699501013259,B12,i
94,0211-699501013259,edad,o
94,0211-699501013259,albumina,i
94,0211-699501013259,KTV,o
94,0211-699501013259,KRU,o
94,0211-699501013259,PCRn,o
94,0211-699501013259,Cincuenta,o
94,0211-699501013259,y,o
94,0211-699501013259,ocho,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,recibieron,o
94,0211-699501013259,seis,o
94,0211-699501013259,meses,o
94,0211-699501013259,de,o
94,0211-699501013259,suplementacion,i
94,0211-699501013259,con,o
94,0211-699501013259,normalizacion,o
94,0211-699501013259,del,o
94,0211-699501013259,pp,i
94,0211-699501013259,aumento,o
94,0211-699501013259,del,o
94,0211-699501013259,folato,i
94,0211-699501013259,703,o
94,0211-699501013259,IC,o
94,0211-699501013259,638,o
94,0211-699501013259,795,o
94,0211-699501013259,vs,o
94,0211-699501013259,6181,o
94,0211-699501013259,IC,o
94,0211-699501013259,4447,o
94,0211-699501013259,7811,o
94,0211-699501013259,p,o
94,0211-699501013259,0001,o
94,0211-699501013259,y,o
94,0211-699501013259,descenso,o
94,0211-699501013259,de,o
94,0211-699501013259,la,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,240,o
94,0211-699501013259,IC,o
94,0211-699501013259,213,o
94,0211-699501013259,264,o
94,0211-699501013259,vs,o
94,0211-699501013259,199,o
94,0211-699501013259,IC,o
94,0211-699501013259,175,o
94,0211-699501013259,224,o
94,0211-699501013259,p,o
94,0211-699501013259,005,o
94,0211-699501013259,Han,o
94,0211-699501013259,recibido,o
94,0211-699501013259,suplementacion,i
94,0211-699501013259,durante,o
94,0211-699501013259,12,o
94,0211-699501013259,meses,o
94,0211-699501013259,33,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,pero,o
94,0211-699501013259,a,o
94,0211-699501013259,pesar,o
94,0211-699501013259,de,o
94,0211-699501013259,un,o
94,0211-699501013259,continuo,o
94,0211-699501013259,aumento,o
94,0211-699501013259,del,o
94,0211-699501013259,folato,i
94,0211-699501013259,10078,o
94,0211-699501013259,IC,o
94,0211-699501013259,7481,o
94,0211-699501013259,12674,o
94,0211-699501013259,p,o
94,0211-699501013259,0001,o
94,0211-699501013259,solo,o
94,0211-699501013259,3,o
94,0211-699501013259,pacientes,o
94,0211-699501013259,presentan,o
94,0211-699501013259,niveles,o
94,0211-699501013259,normales,o
94,0211-699501013259,de,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,correlacionandose,o
94,0211-699501013259,directamente,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,con,o
94,0211-699501013259,la,o
94,0211-699501013259,albumina,i
94,0211-699501013259,r,o
94,0211-699501013259,056,o
94,0211-699501013259,p,o
94,0211-699501013259,0001,o
94,0211-699501013259,que,o
94,0211-699501013259,se,o
94,0211-699501013259,elevo,o
94,0211-699501013259,con,o
94,0211-699501013259,respecto,o
94,0211-699501013259,al,o
94,0211-699501013259,inicio,o
94,0211-699501013259,337,o
94,0211-699501013259,IC,o
94,0211-699501013259,327,o
94,0211-699501013259,346,o
94,0211-699501013259,vs,o
94,0211-699501013259,350,o
94,0211-699501013259,IC,o
94,0211-699501013259,337,o
94,0211-699501013259,363,o
94,0211-699501013259,p,o
94,0211-699501013259,005,o
94,0211-699501013259,Conclusion,o
94,0211-699501013259,Tras,o
94,0211-699501013259,suplementacion,i
94,0211-699501013259,con,o
94,0211-699501013259,acido,i
94,0211-699501013259,folico,i
94,0211-699501013259,y,o
94,0211-699501013259,vitamina,i
94,0211-699501013259,B6,i
94,0211-699501013259,aunque,o
94,0211-699501013259,inicialmente,o
94,0211-699501013259,se,o
94,0211-699501013259,reduce,o
94,0211-699501013259,la,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,esta,o
94,0211-699501013259,respuesta,o
94,0211-699501013259,se,o
94,0211-699501013259,hace,o
94,0211-699501013259,refractaria,o
94,0211-699501013259,correlacionandose,o
94,0211-699501013259,directamente,o
94,0211-699501013259,la,o
94,0211-699501013259,tHcy,i
94,0211-699501013259,con,o
94,0211-699501013259,la,o
94,0211-699501013259,albumina,i
94,0211-699501013259,plasmatica,i
94,0211-699501013259,La,o
94,0211-699501013259,interpretacion,o
94,0211-699501013259,de,o
94,0211-699501013259,los,o
94,0211-699501013259,niveles,i
94,0211-699501013259,de,i
94,0211-699501013259,tHcy,i
94,0211-699501013259,debe,o
94,0211-699501013259,tener,o
94,0211-699501013259,en,o
94,0211-699501013259,cuenta,o
94,0211-699501013259,la,o
94,0211-699501013259,concentracion,i
94,0211-699501013259,de,i
94,0211-699501013259,albumina,i
95,0211-699501013259,Efecto,o
95,0211-699501013259,de,o
95,0211-699501013259,la,o
95,0211-699501013259,suplementacion,i
95,0211-699501013259,con,o
95,0211-699501013259,acido,i
95,0211-699501013259,folico,i
95,0211-699501013259,sobre,o
95,0211-699501013259,los,o
95,0211-699501013259,niveles,i
95,0211-699501013259,de,i
95,0211-699501013259,homocisteina,i
95,0211-699501013259,total,o
95,0211-699501013259,en,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,en,o
95,0211-699501013259,hemodialisis,i
95,0211-699501013259,La,o
95,0211-699501013259,hiperhomocisteinemia,i
95,0211-699501013259,es,o
95,0211-699501013259,un,o
95,0211-699501013259,marcador,o
95,0211-699501013259,de,o
95,0211-699501013259,riesgo,o
95,0211-699501013259,independiente,o
95,0211-699501013259,de,o
95,0211-699501013259,morbimortalidad,o
95,0211-699501013259,cardiovascular,i
95,0211-699501013259,Hemos,o
95,0211-699501013259,intentado,o
95,0211-699501013259,prospectivamente,o
95,0211-699501013259,reducir,o
95,0211-699501013259,los,o
95,0211-699501013259,niveles,i
95,0211-699501013259,de,i
95,0211-699501013259,homocisteina,i
95,0211-699501013259,total,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,mediante,o
95,0211-699501013259,suplemento,o
95,0211-699501013259,con,o
95,0211-699501013259,acido,i
95,0211-699501013259,folico,i
95,0211-699501013259,y,o
95,0211-699501013259,vitamina,i
95,0211-699501013259,B6,i
95,0211-699501013259,pp,i
95,0211-699501013259,valorando,o
95,0211-699501013259,su,o
95,0211-699501013259,posible,o
95,0211-699501013259,correlacion,o
95,0211-699501013259,con,o
95,0211-699501013259,dosis,o
95,0211-699501013259,de,o
95,0211-699501013259,dialisis,i
95,0211-699501013259,funcion,i
95,0211-699501013259,residual,i
95,0211-699501013259,y,o
95,0211-699501013259,parametros,o
95,0211-699501013259,nutricionales,o
95,0211-699501013259,Metodos,o
95,0211-699501013259,Todos,o
95,0211-699501013259,los,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,en,o
95,0211-699501013259,hemodialisis,i
95,0211-699501013259,al,o
95,0211-699501013259,comienzo,o
95,0211-699501013259,del,o
95,0211-699501013259,estudio,o
95,0211-699501013259,que,o
95,0211-699501013259,no,o
95,0211-699501013259,recibian,o
95,0211-699501013259,acido,i
95,0211-699501013259,folico,i
95,0211-699501013259,ni,o
95,0211-699501013259,vitamina,i
95,0211-699501013259,B6,i
95,0211-699501013259,asi,o
95,0211-699501013259,como,o
95,0211-699501013259,los,o
95,0211-699501013259,incorporados,o
95,0211-699501013259,posteriormente,o
95,0211-699501013259,a,o
95,0211-699501013259,partir,o
95,0211-699501013259,de,o
95,0211-699501013259,su,o
95,0211-699501013259,tercer,o
95,0211-699501013259,mes,o
95,0211-699501013259,en,o
95,0211-699501013259,hemodialisis,i
95,0211-699501013259,recibieron,o
95,0211-699501013259,5,o
95,0211-699501013259,mg,o
95,0211-699501013259,orales,o
95,0211-699501013259,de,o
95,0211-699501013259,acido,i
95,0211-699501013259,folico,i
95,0211-699501013259,cada,o
95,0211-699501013259,48,o
95,0211-699501013259,horas,o
95,0211-699501013259,y,o
95,0211-699501013259,40,o
95,0211-699501013259,mg,o
95,0211-699501013259,orales,o
95,0211-699501013259,de,o
95,0211-699501013259,vitamina,i
95,0211-699501013259,B6,i
95,0211-699501013259,cada,o
95,0211-699501013259,semana,o
95,0211-699501013259,Se,o
95,0211-699501013259,determinaron,o
95,0211-699501013259,al,o
95,0211-699501013259,comienzo,o
95,0211-699501013259,del,o
95,0211-699501013259,estudio,o
95,0211-699501013259,y,o
95,0211-699501013259,cada,o
95,0211-699501013259,2,o
95,0211-699501013259,meses,o
95,0211-699501013259,niveles,i
95,0211-699501013259,de,i
95,0211-699501013259,folato,i
95,0211-699501013259,vitamina,i
95,0211-699501013259,B12,i
95,0211-699501013259,inmunoensayo,i
95,0211-699501013259,albumina,i
95,0211-699501013259,y,o
95,0211-699501013259,cinetica,o
95,0211-699501013259,de,o
95,0211-699501013259,la,o
95,0211-699501013259,urea,i
95,0211-699501013259,KTV,o
95,0211-699501013259,KRU,o
95,0211-699501013259,PCRn,o
95,0211-699501013259,y,o
95,0211-699501013259,cada,o
95,0211-699501013259,6,o
95,0211-699501013259,meses,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,HPLC,i
95,0211-699501013259,y,o
95,0211-699501013259,pp,i
95,0211-699501013259,RIA,i
95,0211-699501013259,Resultados,o
95,0211-699501013259,80,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,fueron,o
95,0211-699501013259,incluidos,o
95,0211-699501013259,en,o
95,0211-699501013259,el,o
95,0211-699501013259,estudio,o
95,0211-699501013259,basal,o
95,0211-699501013259,con,o
95,0211-699501013259,una,o
95,0211-699501013259,prevalencia,o
95,0211-699501013259,de,o
95,0211-699501013259,hiperhomocisteinemia,i
95,0211-699501013259,del,o
95,0211-699501013259,844,o
95,0211-699501013259,deficit,i
95,0211-699501013259,de,i
95,0211-699501013259,pp,i
95,0211-699501013259,en,o
95,0211-699501013259,el,o
95,0211-699501013259,32,o
95,0211-699501013259,y,o
95,0211-699501013259,folato,i
95,0211-699501013259,en,o
95,0211-699501013259,el,o
95,0211-699501013259,rango,o
95,0211-699501013259,normal,o
95,0211-699501013259,bajo,o
95,0211-699501013259,los,o
95,0211-699501013259,niveles,i
95,0211-699501013259,de,i
95,0211-699501013259,tHcy,i
95,0211-699501013259,se,o
95,0211-699501013259,correlacionaban,o
95,0211-699501013259,inversamente,o
95,0211-699501013259,con,o
95,0211-699501013259,los,o
95,0211-699501013259,del,o
95,0211-699501013259,folato,i
95,0211-699501013259,r,o
95,0211-699501013259,0336,o
95,0211-699501013259,p,o
95,0211-699501013259,001,o
95,0211-699501013259,pero,o
95,0211-699501013259,no,o
95,0211-699501013259,con,o
95,0211-699501013259,pp,i
95,0211-699501013259,B12,i
95,0211-699501013259,edad,o
95,0211-699501013259,albumina,i
95,0211-699501013259,KTV,o
95,0211-699501013259,KRU,o
95,0211-699501013259,PCRn,o
95,0211-699501013259,Cincuenta,o
95,0211-699501013259,y,o
95,0211-699501013259,ocho,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,recibieron,o
95,0211-699501013259,seis,o
95,0211-699501013259,meses,o
95,0211-699501013259,de,o
95,0211-699501013259,suplementacion,i
95,0211-699501013259,con,o
95,0211-699501013259,normalizacion,o
95,0211-699501013259,del,o
95,0211-699501013259,pp,i
95,0211-699501013259,aumento,o
95,0211-699501013259,del,o
95,0211-699501013259,folato,i
95,0211-699501013259,703,o
95,0211-699501013259,IC,o
95,0211-699501013259,638,o
95,0211-699501013259,795,o
95,0211-699501013259,vs,o
95,0211-699501013259,6181,o
95,0211-699501013259,IC,o
95,0211-699501013259,4447,o
95,0211-699501013259,7811,o
95,0211-699501013259,p,o
95,0211-699501013259,0001,o
95,0211-699501013259,y,o
95,0211-699501013259,descenso,o
95,0211-699501013259,de,o
95,0211-699501013259,la,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,240,o
95,0211-699501013259,IC,o
95,0211-699501013259,213,o
95,0211-699501013259,264,o
95,0211-699501013259,vs,o
95,0211-699501013259,199,o
95,0211-699501013259,IC,o
95,0211-699501013259,175,o
95,0211-699501013259,224,o
95,0211-699501013259,p,o
95,0211-699501013259,005,o
95,0211-699501013259,Han,o
95,0211-699501013259,recibido,o
95,0211-699501013259,suplementacion,i
95,0211-699501013259,durante,o
95,0211-699501013259,12,o
95,0211-699501013259,meses,o
95,0211-699501013259,33,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,pero,o
95,0211-699501013259,a,o
95,0211-699501013259,pesar,o
95,0211-699501013259,de,o
95,0211-699501013259,un,o
95,0211-699501013259,continuo,o
95,0211-699501013259,aumento,o
95,0211-699501013259,del,o
95,0211-699501013259,folato,i
95,0211-699501013259,10078,o
95,0211-699501013259,IC,o
95,0211-699501013259,7481,o
95,0211-699501013259,12674,o
95,0211-699501013259,p,o
95,0211-699501013259,0001,o
95,0211-699501013259,solo,o
95,0211-699501013259,3,o
95,0211-699501013259,pacientes,o
95,0211-699501013259,presentan,o
95,0211-699501013259,niveles,o
95,0211-699501013259,normales,o
95,0211-699501013259,de,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,correlacionandose,o
95,0211-699501013259,directamente,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,con,o
95,0211-699501013259,la,o
95,0211-699501013259,albumina,i
95,0211-699501013259,r,o
95,0211-699501013259,056,o
95,0211-699501013259,p,o
95,0211-699501013259,0001,o
95,0211-699501013259,que,o
95,0211-699501013259,se,o
95,0211-699501013259,elevo,o
95,0211-699501013259,con,o
95,0211-699501013259,respecto,o
95,0211-699501013259,al,o
95,0211-699501013259,inicio,o
95,0211-699501013259,337,o
95,0211-699501013259,IC,o
95,0211-699501013259,327,o
95,0211-699501013259,346,o
95,0211-699501013259,vs,o
95,0211-699501013259,350,o
95,0211-699501013259,IC,o
95,0211-699501013259,337,o
95,0211-699501013259,363,o
95,0211-699501013259,p,o
95,0211-699501013259,005,o
95,0211-699501013259,Conclusion,o
95,0211-699501013259,Tras,o
95,0211-699501013259,suplementacion,i
95,0211-699501013259,con,o
95,0211-699501013259,acido,i
95,0211-699501013259,folico,i
95,0211-699501013259,y,o
95,0211-699501013259,vitamina,i
95,0211-699501013259,B6,i
95,0211-699501013259,aunque,o
95,0211-699501013259,inicialmente,o
95,0211-699501013259,se,o
95,0211-699501013259,reduce,o
95,0211-699501013259,la,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,esta,o
95,0211-699501013259,respuesta,o
95,0211-699501013259,se,o
95,0211-699501013259,hace,o
95,0211-699501013259,refractaria,o
95,0211-699501013259,correlacionandose,o
95,0211-699501013259,directamente,o
95,0211-699501013259,la,o
95,0211-699501013259,tHcy,i
95,0211-699501013259,con,o
95,0211-699501013259,la,o
95,0211-699501013259,albumina,i
95,0211-699501013259,plasmatica,i
95,0211-699501013259,La,o
95,0211-699501013259,interpretacion,o
95,0211-699501013259,de,o
95,0211-699501013259,los,o
95,0211-699501013259,niveles,i
95,0211-699501013259,de,i
95,0211-699501013259,tHcy,i
95,0211-699501013259,debe,o
95,0211-699501013259,tener,o
95,0211-699501013259,en,o
95,0211-699501013259,cuenta,o
95,0211-699501013259,la,o
95,0211-699501013259,concentracion,i
95,0211-699501013259,de,i
95,0211-699501013259,albumina,i
96,0211-699501013259,Efecto,o
96,0211-699501013259,de,o
96,0211-699501013259,la,o
96,0211-699501013259,suplementacion,i
96,0211-699501013259,con,o
96,0211-699501013259,acido,i
96,0211-699501013259,folico,i
96,0211-699501013259,sobre,o
96,0211-699501013259,los,o
96,0211-699501013259,niveles,i
96,0211-699501013259,de,i
96,0211-699501013259,homocisteina,i
96,0211-699501013259,total,o
96,0211-699501013259,en,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,en,o
96,0211-699501013259,hemodialisis,i
96,0211-699501013259,La,o
96,0211-699501013259,hiperhomocisteinemia,i
96,0211-699501013259,es,o
96,0211-699501013259,un,o
96,0211-699501013259,marcador,o
96,0211-699501013259,de,o
96,0211-699501013259,riesgo,o
96,0211-699501013259,independiente,o
96,0211-699501013259,de,o
96,0211-699501013259,morbimortalidad,o
96,0211-699501013259,cardiovascular,i
96,0211-699501013259,Hemos,o
96,0211-699501013259,intentado,o
96,0211-699501013259,prospectivamente,o
96,0211-699501013259,reducir,o
96,0211-699501013259,los,o
96,0211-699501013259,niveles,i
96,0211-699501013259,de,i
96,0211-699501013259,homocisteina,i
96,0211-699501013259,total,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,mediante,o
96,0211-699501013259,suplemento,o
96,0211-699501013259,con,o
96,0211-699501013259,acido,i
96,0211-699501013259,folico,i
96,0211-699501013259,y,o
96,0211-699501013259,vitamina,i
96,0211-699501013259,B6,i
96,0211-699501013259,pp,i
96,0211-699501013259,valorando,o
96,0211-699501013259,su,o
96,0211-699501013259,posible,o
96,0211-699501013259,correlacion,o
96,0211-699501013259,con,o
96,0211-699501013259,dosis,o
96,0211-699501013259,de,o
96,0211-699501013259,dialisis,i
96,0211-699501013259,funcion,i
96,0211-699501013259,residual,i
96,0211-699501013259,y,o
96,0211-699501013259,parametros,o
96,0211-699501013259,nutricionales,o
96,0211-699501013259,Metodos,o
96,0211-699501013259,Todos,o
96,0211-699501013259,los,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,en,o
96,0211-699501013259,hemodialisis,i
96,0211-699501013259,al,o
96,0211-699501013259,comienzo,o
96,0211-699501013259,del,o
96,0211-699501013259,estudio,o
96,0211-699501013259,que,o
96,0211-699501013259,no,o
96,0211-699501013259,recibian,o
96,0211-699501013259,acido,i
96,0211-699501013259,folico,i
96,0211-699501013259,ni,o
96,0211-699501013259,vitamina,i
96,0211-699501013259,B6,i
96,0211-699501013259,asi,o
96,0211-699501013259,como,o
96,0211-699501013259,los,o
96,0211-699501013259,incorporados,o
96,0211-699501013259,posteriormente,o
96,0211-699501013259,a,o
96,0211-699501013259,partir,o
96,0211-699501013259,de,o
96,0211-699501013259,su,o
96,0211-699501013259,tercer,o
96,0211-699501013259,mes,o
96,0211-699501013259,en,o
96,0211-699501013259,hemodialisis,i
96,0211-699501013259,recibieron,o
96,0211-699501013259,5,o
96,0211-699501013259,mg,o
96,0211-699501013259,orales,o
96,0211-699501013259,de,o
96,0211-699501013259,acido,i
96,0211-699501013259,folico,i
96,0211-699501013259,cada,o
96,0211-699501013259,48,o
96,0211-699501013259,horas,o
96,0211-699501013259,y,o
96,0211-699501013259,40,o
96,0211-699501013259,mg,o
96,0211-699501013259,orales,o
96,0211-699501013259,de,o
96,0211-699501013259,vitamina,i
96,0211-699501013259,B6,i
96,0211-699501013259,cada,o
96,0211-699501013259,semana,o
96,0211-699501013259,Se,o
96,0211-699501013259,determinaron,o
96,0211-699501013259,al,o
96,0211-699501013259,comienzo,o
96,0211-699501013259,del,o
96,0211-699501013259,estudio,o
96,0211-699501013259,y,o
96,0211-699501013259,cada,o
96,0211-699501013259,2,o
96,0211-699501013259,meses,o
96,0211-699501013259,niveles,i
96,0211-699501013259,de,i
96,0211-699501013259,folato,i
96,0211-699501013259,vitamina,i
96,0211-699501013259,B12,i
96,0211-699501013259,inmunoensayo,i
96,0211-699501013259,albumina,i
96,0211-699501013259,y,o
96,0211-699501013259,cinetica,o
96,0211-699501013259,de,o
96,0211-699501013259,la,o
96,0211-699501013259,urea,i
96,0211-699501013259,KTV,o
96,0211-699501013259,KRU,o
96,0211-699501013259,PCRn,o
96,0211-699501013259,y,o
96,0211-699501013259,cada,o
96,0211-699501013259,6,o
96,0211-699501013259,meses,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,HPLC,i
96,0211-699501013259,y,o
96,0211-699501013259,pp,i
96,0211-699501013259,RIA,i
96,0211-699501013259,Resultados,o
96,0211-699501013259,80,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,fueron,o
96,0211-699501013259,incluidos,o
96,0211-699501013259,en,o
96,0211-699501013259,el,o
96,0211-699501013259,estudio,o
96,0211-699501013259,basal,o
96,0211-699501013259,con,o
96,0211-699501013259,una,o
96,0211-699501013259,prevalencia,o
96,0211-699501013259,de,o
96,0211-699501013259,hiperhomocisteinemia,i
96,0211-699501013259,del,o
96,0211-699501013259,844,o
96,0211-699501013259,deficit,i
96,0211-699501013259,de,i
96,0211-699501013259,pp,i
96,0211-699501013259,en,o
96,0211-699501013259,el,o
96,0211-699501013259,32,o
96,0211-699501013259,y,o
96,0211-699501013259,folato,i
96,0211-699501013259,en,o
96,0211-699501013259,el,o
96,0211-699501013259,rango,o
96,0211-699501013259,normal,o
96,0211-699501013259,bajo,o
96,0211-699501013259,los,o
96,0211-699501013259,niveles,i
96,0211-699501013259,de,i
96,0211-699501013259,tHcy,i
96,0211-699501013259,se,o
96,0211-699501013259,correlacionaban,o
96,0211-699501013259,inversamente,o
96,0211-699501013259,con,o
96,0211-699501013259,los,o
96,0211-699501013259,del,o
96,0211-699501013259,folato,i
96,0211-699501013259,r,o
96,0211-699501013259,0336,o
96,0211-699501013259,p,o
96,0211-699501013259,001,o
96,0211-699501013259,pero,o
96,0211-699501013259,no,o
96,0211-699501013259,con,o
96,0211-699501013259,pp,i
96,0211-699501013259,B12,i
96,0211-699501013259,edad,o
96,0211-699501013259,albumina,i
96,0211-699501013259,KTV,o
96,0211-699501013259,KRU,o
96,0211-699501013259,PCRn,o
96,0211-699501013259,Cincuenta,o
96,0211-699501013259,y,o
96,0211-699501013259,ocho,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,recibieron,o
96,0211-699501013259,seis,o
96,0211-699501013259,meses,o
96,0211-699501013259,de,o
96,0211-699501013259,suplementacion,i
96,0211-699501013259,con,o
96,0211-699501013259,normalizacion,o
96,0211-699501013259,del,o
96,0211-699501013259,pp,i
96,0211-699501013259,aumento,o
96,0211-699501013259,del,o
96,0211-699501013259,folato,i
96,0211-699501013259,703,o
96,0211-699501013259,IC,o
96,0211-699501013259,638,o
96,0211-699501013259,795,o
96,0211-699501013259,vs,o
96,0211-699501013259,6181,o
96,0211-699501013259,IC,o
96,0211-699501013259,4447,o
96,0211-699501013259,7811,o
96,0211-699501013259,p,o
96,0211-699501013259,0001,o
96,0211-699501013259,y,o
96,0211-699501013259,descenso,o
96,0211-699501013259,de,o
96,0211-699501013259,la,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,240,o
96,0211-699501013259,IC,o
96,0211-699501013259,213,o
96,0211-699501013259,264,o
96,0211-699501013259,vs,o
96,0211-699501013259,199,o
96,0211-699501013259,IC,o
96,0211-699501013259,175,o
96,0211-699501013259,224,o
96,0211-699501013259,p,o
96,0211-699501013259,005,o
96,0211-699501013259,Han,o
96,0211-699501013259,recibido,o
96,0211-699501013259,suplementacion,i
96,0211-699501013259,durante,o
96,0211-699501013259,12,o
96,0211-699501013259,meses,o
96,0211-699501013259,33,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,pero,o
96,0211-699501013259,a,o
96,0211-699501013259,pesar,o
96,0211-699501013259,de,o
96,0211-699501013259,un,o
96,0211-699501013259,continuo,o
96,0211-699501013259,aumento,o
96,0211-699501013259,del,o
96,0211-699501013259,folato,i
96,0211-699501013259,10078,o
96,0211-699501013259,IC,o
96,0211-699501013259,7481,o
96,0211-699501013259,12674,o
96,0211-699501013259,p,o
96,0211-699501013259,0001,o
96,0211-699501013259,solo,o
96,0211-699501013259,3,o
96,0211-699501013259,pacientes,o
96,0211-699501013259,presentan,o
96,0211-699501013259,niveles,o
96,0211-699501013259,normales,o
96,0211-699501013259,de,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,correlacionandose,o
96,0211-699501013259,directamente,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,con,o
96,0211-699501013259,la,o
96,0211-699501013259,albumina,i
96,0211-699501013259,r,o
96,0211-699501013259,056,o
96,0211-699501013259,p,o
96,0211-699501013259,0001,o
96,0211-699501013259,que,o
96,0211-699501013259,se,o
96,0211-699501013259,elevo,o
96,0211-699501013259,con,o
96,0211-699501013259,respecto,o
96,0211-699501013259,al,o
96,0211-699501013259,inicio,o
96,0211-699501013259,337,o
96,0211-699501013259,IC,o
96,0211-699501013259,327,o
96,0211-699501013259,346,o
96,0211-699501013259,vs,o
96,0211-699501013259,350,o
96,0211-699501013259,IC,o
96,0211-699501013259,337,o
96,0211-699501013259,363,o
96,0211-699501013259,p,o
96,0211-699501013259,005,o
96,0211-699501013259,Conclusion,o
96,0211-699501013259,Tras,o
96,0211-699501013259,suplementacion,i
96,0211-699501013259,con,o
96,0211-699501013259,acido,i
96,0211-699501013259,folico,i
96,0211-699501013259,y,o
96,0211-699501013259,vitamina,i
96,0211-699501013259,B6,i
96,0211-699501013259,aunque,o
96,0211-699501013259,inicialmente,o
96,0211-699501013259,se,o
96,0211-699501013259,reduce,o
96,0211-699501013259,la,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,esta,o
96,0211-699501013259,respuesta,o
96,0211-699501013259,se,o
96,0211-699501013259,hace,o
96,0211-699501013259,refractaria,o
96,0211-699501013259,correlacionandose,o
96,0211-699501013259,directamente,o
96,0211-699501013259,la,o
96,0211-699501013259,tHcy,i
96,0211-699501013259,con,o
96,0211-699501013259,la,o
96,0211-699501013259,albumina,i
96,0211-699501013259,plasmatica,i
96,0211-699501013259,La,o
96,0211-699501013259,interpretacion,o
96,0211-699501013259,de,o
96,0211-699501013259,los,o
96,0211-699501013259,niveles,i
96,0211-699501013259,de,i
96,0211-699501013259,tHcy,i
96,0211-699501013259,debe,o
96,0211-699501013259,tener,o
96,0211-699501013259,en,o
96,0211-699501013259,cuenta,o
96,0211-699501013259,la,o
96,0211-699501013259,concentracion,i
96,0211-699501013259,de,i
96,0211-699501013259,albumina,i
97,0211-699501013259,Efecto,o
97,0211-699501013259,de,o
97,0211-699501013259,la,o
97,0211-699501013259,suplementacion,i
97,0211-699501013259,con,o
97,0211-699501013259,acido,i
97,0211-699501013259,folico,i
97,0211-699501013259,sobre,o
97,0211-699501013259,los,o
97,0211-699501013259,niveles,i
97,0211-699501013259,de,i
97,0211-699501013259,homocisteina,i
97,0211-699501013259,total,o
97,0211-699501013259,en,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,en,o
97,0211-699501013259,hemodialisis,i
97,0211-699501013259,La,o
97,0211-699501013259,hiperhomocisteinemia,i
97,0211-699501013259,es,o
97,0211-699501013259,un,o
97,0211-699501013259,marcador,o
97,0211-699501013259,de,o
97,0211-699501013259,riesgo,o
97,0211-699501013259,independiente,o
97,0211-699501013259,de,o
97,0211-699501013259,morbimortalidad,o
97,0211-699501013259,cardiovascular,i
97,0211-699501013259,Hemos,o
97,0211-699501013259,intentado,o
97,0211-699501013259,prospectivamente,o
97,0211-699501013259,reducir,o
97,0211-699501013259,los,o
97,0211-699501013259,niveles,i
97,0211-699501013259,de,i
97,0211-699501013259,homocisteina,i
97,0211-699501013259,total,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,mediante,o
97,0211-699501013259,suplemento,o
97,0211-699501013259,con,o
97,0211-699501013259,acido,i
97,0211-699501013259,folico,i
97,0211-699501013259,y,o
97,0211-699501013259,vitamina,i
97,0211-699501013259,B6,i
97,0211-699501013259,pp,i
97,0211-699501013259,valorando,o
97,0211-699501013259,su,o
97,0211-699501013259,posible,o
97,0211-699501013259,correlacion,o
97,0211-699501013259,con,o
97,0211-699501013259,dosis,o
97,0211-699501013259,de,o
97,0211-699501013259,dialisis,i
97,0211-699501013259,funcion,i
97,0211-699501013259,residual,i
97,0211-699501013259,y,o
97,0211-699501013259,parametros,o
97,0211-699501013259,nutricionales,o
97,0211-699501013259,Metodos,o
97,0211-699501013259,Todos,o
97,0211-699501013259,los,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,en,o
97,0211-699501013259,hemodialisis,i
97,0211-699501013259,al,o
97,0211-699501013259,comienzo,o
97,0211-699501013259,del,o
97,0211-699501013259,estudio,o
97,0211-699501013259,que,o
97,0211-699501013259,no,o
97,0211-699501013259,recibian,o
97,0211-699501013259,acido,i
97,0211-699501013259,folico,i
97,0211-699501013259,ni,o
97,0211-699501013259,vitamina,i
97,0211-699501013259,B6,i
97,0211-699501013259,asi,o
97,0211-699501013259,como,o
97,0211-699501013259,los,o
97,0211-699501013259,incorporados,o
97,0211-699501013259,posteriormente,o
97,0211-699501013259,a,o
97,0211-699501013259,partir,o
97,0211-699501013259,de,o
97,0211-699501013259,su,o
97,0211-699501013259,tercer,o
97,0211-699501013259,mes,o
97,0211-699501013259,en,o
97,0211-699501013259,hemodialisis,i
97,0211-699501013259,recibieron,o
97,0211-699501013259,5,o
97,0211-699501013259,mg,o
97,0211-699501013259,orales,o
97,0211-699501013259,de,o
97,0211-699501013259,acido,i
97,0211-699501013259,folico,i
97,0211-699501013259,cada,o
97,0211-699501013259,48,o
97,0211-699501013259,horas,o
97,0211-699501013259,y,o
97,0211-699501013259,40,o
97,0211-699501013259,mg,o
97,0211-699501013259,orales,o
97,0211-699501013259,de,o
97,0211-699501013259,vitamina,i
97,0211-699501013259,B6,i
97,0211-699501013259,cada,o
97,0211-699501013259,semana,o
97,0211-699501013259,Se,o
97,0211-699501013259,determinaron,o
97,0211-699501013259,al,o
97,0211-699501013259,comienzo,o
97,0211-699501013259,del,o
97,0211-699501013259,estudio,o
97,0211-699501013259,y,o
97,0211-699501013259,cada,o
97,0211-699501013259,2,o
97,0211-699501013259,meses,o
97,0211-699501013259,niveles,i
97,0211-699501013259,de,i
97,0211-699501013259,folato,i
97,0211-699501013259,vitamina,i
97,0211-699501013259,B12,i
97,0211-699501013259,inmunoensayo,i
97,0211-699501013259,albumina,i
97,0211-699501013259,y,o
97,0211-699501013259,cinetica,o
97,0211-699501013259,de,o
97,0211-699501013259,la,o
97,0211-699501013259,urea,i
97,0211-699501013259,KTV,o
97,0211-699501013259,KRU,o
97,0211-699501013259,PCRn,o
97,0211-699501013259,y,o
97,0211-699501013259,cada,o
97,0211-699501013259,6,o
97,0211-699501013259,meses,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,HPLC,i
97,0211-699501013259,y,o
97,0211-699501013259,pp,i
97,0211-699501013259,RIA,i
97,0211-699501013259,Resultados,o
97,0211-699501013259,80,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,fueron,o
97,0211-699501013259,incluidos,o
97,0211-699501013259,en,o
97,0211-699501013259,el,o
97,0211-699501013259,estudio,o
97,0211-699501013259,basal,o
97,0211-699501013259,con,o
97,0211-699501013259,una,o
97,0211-699501013259,prevalencia,o
97,0211-699501013259,de,o
97,0211-699501013259,hiperhomocisteinemia,i
97,0211-699501013259,del,o
97,0211-699501013259,844,o
97,0211-699501013259,deficit,i
97,0211-699501013259,de,i
97,0211-699501013259,pp,i
97,0211-699501013259,en,o
97,0211-699501013259,el,o
97,0211-699501013259,32,o
97,0211-699501013259,y,o
97,0211-699501013259,folato,i
97,0211-699501013259,en,o
97,0211-699501013259,el,o
97,0211-699501013259,rango,o
97,0211-699501013259,normal,o
97,0211-699501013259,bajo,o
97,0211-699501013259,los,o
97,0211-699501013259,niveles,i
97,0211-699501013259,de,i
97,0211-699501013259,tHcy,i
97,0211-699501013259,se,o
97,0211-699501013259,correlacionaban,o
97,0211-699501013259,inversamente,o
97,0211-699501013259,con,o
97,0211-699501013259,los,o
97,0211-699501013259,del,o
97,0211-699501013259,folato,i
97,0211-699501013259,r,o
97,0211-699501013259,0336,o
97,0211-699501013259,p,o
97,0211-699501013259,001,o
97,0211-699501013259,pero,o
97,0211-699501013259,no,o
97,0211-699501013259,con,o
97,0211-699501013259,pp,i
97,0211-699501013259,B12,i
97,0211-699501013259,edad,o
97,0211-699501013259,albumina,i
97,0211-699501013259,KTV,o
97,0211-699501013259,KRU,o
97,0211-699501013259,PCRn,o
97,0211-699501013259,Cincuenta,o
97,0211-699501013259,y,o
97,0211-699501013259,ocho,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,recibieron,o
97,0211-699501013259,seis,o
97,0211-699501013259,meses,o
97,0211-699501013259,de,o
97,0211-699501013259,suplementacion,i
97,0211-699501013259,con,o
97,0211-699501013259,normalizacion,o
97,0211-699501013259,del,o
97,0211-699501013259,pp,i
97,0211-699501013259,aumento,o
97,0211-699501013259,del,o
97,0211-699501013259,folato,i
97,0211-699501013259,703,o
97,0211-699501013259,IC,o
97,0211-699501013259,638,o
97,0211-699501013259,795,o
97,0211-699501013259,vs,o
97,0211-699501013259,6181,o
97,0211-699501013259,IC,o
97,0211-699501013259,4447,o
97,0211-699501013259,7811,o
97,0211-699501013259,p,o
97,0211-699501013259,0001,o
97,0211-699501013259,y,o
97,0211-699501013259,descenso,o
97,0211-699501013259,de,o
97,0211-699501013259,la,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,240,o
97,0211-699501013259,IC,o
97,0211-699501013259,213,o
97,0211-699501013259,264,o
97,0211-699501013259,vs,o
97,0211-699501013259,199,o
97,0211-699501013259,IC,o
97,0211-699501013259,175,o
97,0211-699501013259,224,o
97,0211-699501013259,p,o
97,0211-699501013259,005,o
97,0211-699501013259,Han,o
97,0211-699501013259,recibido,o
97,0211-699501013259,suplementacion,i
97,0211-699501013259,durante,o
97,0211-699501013259,12,o
97,0211-699501013259,meses,o
97,0211-699501013259,33,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,pero,o
97,0211-699501013259,a,o
97,0211-699501013259,pesar,o
97,0211-699501013259,de,o
97,0211-699501013259,un,o
97,0211-699501013259,continuo,o
97,0211-699501013259,aumento,o
97,0211-699501013259,del,o
97,0211-699501013259,folato,i
97,0211-699501013259,10078,o
97,0211-699501013259,IC,o
97,0211-699501013259,7481,o
97,0211-699501013259,12674,o
97,0211-699501013259,p,o
97,0211-699501013259,0001,o
97,0211-699501013259,solo,o
97,0211-699501013259,3,o
97,0211-699501013259,pacientes,o
97,0211-699501013259,presentan,o
97,0211-699501013259,niveles,o
97,0211-699501013259,normales,o
97,0211-699501013259,de,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,correlacionandose,o
97,0211-699501013259,directamente,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,con,o
97,0211-699501013259,la,o
97,0211-699501013259,albumina,i
97,0211-699501013259,r,o
97,0211-699501013259,056,o
97,0211-699501013259,p,o
97,0211-699501013259,0001,o
97,0211-699501013259,que,o
97,0211-699501013259,se,o
97,0211-699501013259,elevo,o
97,0211-699501013259,con,o
97,0211-699501013259,respecto,o
97,0211-699501013259,al,o
97,0211-699501013259,inicio,o
97,0211-699501013259,337,o
97,0211-699501013259,IC,o
97,0211-699501013259,327,o
97,0211-699501013259,346,o
97,0211-699501013259,vs,o
97,0211-699501013259,350,o
97,0211-699501013259,IC,o
97,0211-699501013259,337,o
97,0211-699501013259,363,o
97,0211-699501013259,p,o
97,0211-699501013259,005,o
97,0211-699501013259,Conclusion,o
97,0211-699501013259,Tras,o
97,0211-699501013259,suplementacion,i
97,0211-699501013259,con,o
97,0211-699501013259,acido,i
97,0211-699501013259,folico,i
97,0211-699501013259,y,o
97,0211-699501013259,vitamina,i
97,0211-699501013259,B6,i
97,0211-699501013259,aunque,o
97,0211-699501013259,inicialmente,o
97,0211-699501013259,se,o
97,0211-699501013259,reduce,o
97,0211-699501013259,la,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,esta,o
97,0211-699501013259,respuesta,o
97,0211-699501013259,se,o
97,0211-699501013259,hace,o
97,0211-699501013259,refractaria,o
97,0211-699501013259,correlacionandose,o
97,0211-699501013259,directamente,o
97,0211-699501013259,la,o
97,0211-699501013259,tHcy,i
97,0211-699501013259,con,o
97,0211-699501013259,la,o
97,0211-699501013259,albumina,i
97,0211-699501013259,plasmatica,i
97,0211-699501013259,La,o
97,0211-699501013259,interpretacion,o
97,0211-699501013259,de,o
97,0211-699501013259,los,o
97,0211-699501013259,niveles,i
97,0211-699501013259,de,i
97,0211-699501013259,tHcy,i
97,0211-699501013259,debe,o
97,0211-699501013259,tener,o
97,0211-699501013259,en,o
97,0211-699501013259,cuenta,o
97,0211-699501013259,la,o
97,0211-699501013259,concentracion,i
97,0211-699501013259,de,i
97,0211-699501013259,albumina,i
98,0211-699501013259,Efecto,o
98,0211-699501013259,de,o
98,0211-699501013259,la,o
98,0211-699501013259,suplementacion,i
98,0211-699501013259,con,o
98,0211-699501013259,acido,i
98,0211-699501013259,folico,i
98,0211-699501013259,sobre,o
98,0211-699501013259,los,o
98,0211-699501013259,niveles,i
98,0211-699501013259,de,i
98,0211-699501013259,homocisteina,i
98,0211-699501013259,total,o
98,0211-699501013259,en,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,en,o
98,0211-699501013259,hemodialisis,i
98,0211-699501013259,La,o
98,0211-699501013259,hiperhomocisteinemia,i
98,0211-699501013259,es,o
98,0211-699501013259,un,o
98,0211-699501013259,marcador,o
98,0211-699501013259,de,o
98,0211-699501013259,riesgo,o
98,0211-699501013259,independiente,o
98,0211-699501013259,de,o
98,0211-699501013259,morbimortalidad,o
98,0211-699501013259,cardiovascular,i
98,0211-699501013259,Hemos,o
98,0211-699501013259,intentado,o
98,0211-699501013259,prospectivamente,o
98,0211-699501013259,reducir,o
98,0211-699501013259,los,o
98,0211-699501013259,niveles,i
98,0211-699501013259,de,i
98,0211-699501013259,homocisteina,i
98,0211-699501013259,total,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,mediante,o
98,0211-699501013259,suplemento,o
98,0211-699501013259,con,o
98,0211-699501013259,acido,i
98,0211-699501013259,folico,i
98,0211-699501013259,y,o
98,0211-699501013259,vitamina,i
98,0211-699501013259,B6,i
98,0211-699501013259,pp,i
98,0211-699501013259,valorando,o
98,0211-699501013259,su,o
98,0211-699501013259,posible,o
98,0211-699501013259,correlacion,o
98,0211-699501013259,con,o
98,0211-699501013259,dosis,o
98,0211-699501013259,de,o
98,0211-699501013259,dialisis,i
98,0211-699501013259,funcion,i
98,0211-699501013259,residual,i
98,0211-699501013259,y,o
98,0211-699501013259,parametros,o
98,0211-699501013259,nutricionales,o
98,0211-699501013259,Metodos,o
98,0211-699501013259,Todos,o
98,0211-699501013259,los,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,en,o
98,0211-699501013259,hemodialisis,i
98,0211-699501013259,al,o
98,0211-699501013259,comienzo,o
98,0211-699501013259,del,o
98,0211-699501013259,estudio,o
98,0211-699501013259,que,o
98,0211-699501013259,no,o
98,0211-699501013259,recibian,o
98,0211-699501013259,acido,i
98,0211-699501013259,folico,i
98,0211-699501013259,ni,o
98,0211-699501013259,vitamina,i
98,0211-699501013259,B6,i
98,0211-699501013259,asi,o
98,0211-699501013259,como,o
98,0211-699501013259,los,o
98,0211-699501013259,incorporados,o
98,0211-699501013259,posteriormente,o
98,0211-699501013259,a,o
98,0211-699501013259,partir,o
98,0211-699501013259,de,o
98,0211-699501013259,su,o
98,0211-699501013259,tercer,o
98,0211-699501013259,mes,o
98,0211-699501013259,en,o
98,0211-699501013259,hemodialisis,i
98,0211-699501013259,recibieron,o
98,0211-699501013259,5,o
98,0211-699501013259,mg,o
98,0211-699501013259,orales,o
98,0211-699501013259,de,o
98,0211-699501013259,acido,i
98,0211-699501013259,folico,i
98,0211-699501013259,cada,o
98,0211-699501013259,48,o
98,0211-699501013259,horas,o
98,0211-699501013259,y,o
98,0211-699501013259,40,o
98,0211-699501013259,mg,o
98,0211-699501013259,orales,o
98,0211-699501013259,de,o
98,0211-699501013259,vitamina,i
98,0211-699501013259,B6,i
98,0211-699501013259,cada,o
98,0211-699501013259,semana,o
98,0211-699501013259,Se,o
98,0211-699501013259,determinaron,o
98,0211-699501013259,al,o
98,0211-699501013259,comienzo,o
98,0211-699501013259,del,o
98,0211-699501013259,estudio,o
98,0211-699501013259,y,o
98,0211-699501013259,cada,o
98,0211-699501013259,2,o
98,0211-699501013259,meses,o
98,0211-699501013259,niveles,i
98,0211-699501013259,de,i
98,0211-699501013259,folato,i
98,0211-699501013259,vitamina,i
98,0211-699501013259,B12,i
98,0211-699501013259,inmunoensayo,i
98,0211-699501013259,albumina,i
98,0211-699501013259,y,o
98,0211-699501013259,cinetica,o
98,0211-699501013259,de,o
98,0211-699501013259,la,o
98,0211-699501013259,urea,i
98,0211-699501013259,KTV,o
98,0211-699501013259,KRU,o
98,0211-699501013259,PCRn,o
98,0211-699501013259,y,o
98,0211-699501013259,cada,o
98,0211-699501013259,6,o
98,0211-699501013259,meses,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,HPLC,i
98,0211-699501013259,y,o
98,0211-699501013259,pp,i
98,0211-699501013259,RIA,i
98,0211-699501013259,Resultados,o
98,0211-699501013259,80,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,fueron,o
98,0211-699501013259,incluidos,o
98,0211-699501013259,en,o
98,0211-699501013259,el,o
98,0211-699501013259,estudio,o
98,0211-699501013259,basal,o
98,0211-699501013259,con,o
98,0211-699501013259,una,o
98,0211-699501013259,prevalencia,o
98,0211-699501013259,de,o
98,0211-699501013259,hiperhomocisteinemia,i
98,0211-699501013259,del,o
98,0211-699501013259,844,o
98,0211-699501013259,deficit,i
98,0211-699501013259,de,i
98,0211-699501013259,pp,i
98,0211-699501013259,en,o
98,0211-699501013259,el,o
98,0211-699501013259,32,o
98,0211-699501013259,y,o
98,0211-699501013259,folato,i
98,0211-699501013259,en,o
98,0211-699501013259,el,o
98,0211-699501013259,rango,o
98,0211-699501013259,normal,o
98,0211-699501013259,bajo,o
98,0211-699501013259,los,o
98,0211-699501013259,niveles,i
98,0211-699501013259,de,i
98,0211-699501013259,tHcy,i
98,0211-699501013259,se,o
98,0211-699501013259,correlacionaban,o
98,0211-699501013259,inversamente,o
98,0211-699501013259,con,o
98,0211-699501013259,los,o
98,0211-699501013259,del,o
98,0211-699501013259,folato,i
98,0211-699501013259,r,o
98,0211-699501013259,0336,o
98,0211-699501013259,p,o
98,0211-699501013259,001,o
98,0211-699501013259,pero,o
98,0211-699501013259,no,o
98,0211-699501013259,con,o
98,0211-699501013259,pp,i
98,0211-699501013259,B12,i
98,0211-699501013259,edad,o
98,0211-699501013259,albumina,i
98,0211-699501013259,KTV,o
98,0211-699501013259,KRU,o
98,0211-699501013259,PCRn,o
98,0211-699501013259,Cincuenta,o
98,0211-699501013259,y,o
98,0211-699501013259,ocho,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,recibieron,o
98,0211-699501013259,seis,o
98,0211-699501013259,meses,o
98,0211-699501013259,de,o
98,0211-699501013259,suplementacion,i
98,0211-699501013259,con,o
98,0211-699501013259,normalizacion,o
98,0211-699501013259,del,o
98,0211-699501013259,pp,i
98,0211-699501013259,aumento,o
98,0211-699501013259,del,o
98,0211-699501013259,folato,i
98,0211-699501013259,703,o
98,0211-699501013259,IC,o
98,0211-699501013259,638,o
98,0211-699501013259,795,o
98,0211-699501013259,vs,o
98,0211-699501013259,6181,o
98,0211-699501013259,IC,o
98,0211-699501013259,4447,o
98,0211-699501013259,7811,o
98,0211-699501013259,p,o
98,0211-699501013259,0001,o
98,0211-699501013259,y,o
98,0211-699501013259,descenso,o
98,0211-699501013259,de,o
98,0211-699501013259,la,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,240,o
98,0211-699501013259,IC,o
98,0211-699501013259,213,o
98,0211-699501013259,264,o
98,0211-699501013259,vs,o
98,0211-699501013259,199,o
98,0211-699501013259,IC,o
98,0211-699501013259,175,o
98,0211-699501013259,224,o
98,0211-699501013259,p,o
98,0211-699501013259,005,o
98,0211-699501013259,Han,o
98,0211-699501013259,recibido,o
98,0211-699501013259,suplementacion,i
98,0211-699501013259,durante,o
98,0211-699501013259,12,o
98,0211-699501013259,meses,o
98,0211-699501013259,33,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,pero,o
98,0211-699501013259,a,o
98,0211-699501013259,pesar,o
98,0211-699501013259,de,o
98,0211-699501013259,un,o
98,0211-699501013259,continuo,o
98,0211-699501013259,aumento,o
98,0211-699501013259,del,o
98,0211-699501013259,folato,i
98,0211-699501013259,10078,o
98,0211-699501013259,IC,o
98,0211-699501013259,7481,o
98,0211-699501013259,12674,o
98,0211-699501013259,p,o
98,0211-699501013259,0001,o
98,0211-699501013259,solo,o
98,0211-699501013259,3,o
98,0211-699501013259,pacientes,o
98,0211-699501013259,presentan,o
98,0211-699501013259,niveles,o
98,0211-699501013259,normales,o
98,0211-699501013259,de,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,correlacionandose,o
98,0211-699501013259,directamente,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,con,o
98,0211-699501013259,la,o
98,0211-699501013259,albumina,i
98,0211-699501013259,r,o
98,0211-699501013259,056,o
98,0211-699501013259,p,o
98,0211-699501013259,0001,o
98,0211-699501013259,que,o
98,0211-699501013259,se,o
98,0211-699501013259,elevo,o
98,0211-699501013259,con,o
98,0211-699501013259,respecto,o
98,0211-699501013259,al,o
98,0211-699501013259,inicio,o
98,0211-699501013259,337,o
98,0211-699501013259,IC,o
98,0211-699501013259,327,o
98,0211-699501013259,346,o
98,0211-699501013259,vs,o
98,0211-699501013259,350,o
98,0211-699501013259,IC,o
98,0211-699501013259,337,o
98,0211-699501013259,363,o
98,0211-699501013259,p,o
98,0211-699501013259,005,o
98,0211-699501013259,Conclusion,o
98,0211-699501013259,Tras,o
98,0211-699501013259,suplementacion,i
98,0211-699501013259,con,o
98,0211-699501013259,acido,i
98,0211-699501013259,folico,i
98,0211-699501013259,y,o
98,0211-699501013259,vitamina,i
98,0211-699501013259,B6,i
98,0211-699501013259,aunque,o
98,0211-699501013259,inicialmente,o
98,0211-699501013259,se,o
98,0211-699501013259,reduce,o
98,0211-699501013259,la,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,esta,o
98,0211-699501013259,respuesta,o
98,0211-699501013259,se,o
98,0211-699501013259,hace,o
98,0211-699501013259,refractaria,o
98,0211-699501013259,correlacionandose,o
98,0211-699501013259,directamente,o
98,0211-699501013259,la,o
98,0211-699501013259,tHcy,i
98,0211-699501013259,con,o
98,0211-699501013259,la,o
98,0211-699501013259,albumina,i
98,0211-699501013259,plasmatica,i
98,0211-699501013259,La,o
98,0211-699501013259,interpretacion,o
98,0211-699501013259,de,o
98,0211-699501013259,los,o
98,0211-699501013259,niveles,i
98,0211-699501013259,de,i
98,0211-699501013259,tHcy,i
98,0211-699501013259,debe,o
98,0211-699501013259,tener,o
98,0211-699501013259,en,o
98,0211-699501013259,cuenta,o
98,0211-699501013259,la,o
98,0211-699501013259,concentracion,i
98,0211-699501013259,de,i
98,0211-699501013259,albumina,i
99,0211-699501013259,Efecto,o
99,0211-699501013259,de,o
99,0211-699501013259,la,o
99,0211-699501013259,suplementacion,i
99,0211-699501013259,con,o
99,0211-699501013259,acido,i
99,0211-699501013259,folico,i
99,0211-699501013259,sobre,o
99,0211-699501013259,los,o
99,0211-699501013259,niveles,i
99,0211-699501013259,de,i
99,0211-699501013259,homocisteina,i
99,0211-699501013259,total,o
99,0211-699501013259,en,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,en,o
99,0211-699501013259,hemodialisis,i
99,0211-699501013259,La,o
99,0211-699501013259,hiperhomocisteinemia,i
99,0211-699501013259,es,o
99,0211-699501013259,un,o
99,0211-699501013259,marcador,o
99,0211-699501013259,de,o
99,0211-699501013259,riesgo,o
99,0211-699501013259,independiente,o
99,0211-699501013259,de,o
99,0211-699501013259,morbimortalidad,o
99,0211-699501013259,cardiovascular,i
99,0211-699501013259,Hemos,o
99,0211-699501013259,intentado,o
99,0211-699501013259,prospectivamente,o
99,0211-699501013259,reducir,o
99,0211-699501013259,los,o
99,0211-699501013259,niveles,i
99,0211-699501013259,de,i
99,0211-699501013259,homocisteina,i
99,0211-699501013259,total,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,mediante,o
99,0211-699501013259,suplemento,o
99,0211-699501013259,con,o
99,0211-699501013259,acido,i
99,0211-699501013259,folico,i
99,0211-699501013259,y,o
99,0211-699501013259,vitamina,i
99,0211-699501013259,B6,i
99,0211-699501013259,pp,i
99,0211-699501013259,valorando,o
99,0211-699501013259,su,o
99,0211-699501013259,posible,o
99,0211-699501013259,correlacion,o
99,0211-699501013259,con,o
99,0211-699501013259,dosis,o
99,0211-699501013259,de,o
99,0211-699501013259,dialisis,i
99,0211-699501013259,funcion,i
99,0211-699501013259,residual,i
99,0211-699501013259,y,o
99,0211-699501013259,parametros,o
99,0211-699501013259,nutricionales,o
99,0211-699501013259,Metodos,o
99,0211-699501013259,Todos,o
99,0211-699501013259,los,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,en,o
99,0211-699501013259,hemodialisis,i
99,0211-699501013259,al,o
99,0211-699501013259,comienzo,o
99,0211-699501013259,del,o
99,0211-699501013259,estudio,o
99,0211-699501013259,que,o
99,0211-699501013259,no,o
99,0211-699501013259,recibian,o
99,0211-699501013259,acido,i
99,0211-699501013259,folico,i
99,0211-699501013259,ni,o
99,0211-699501013259,vitamina,i
99,0211-699501013259,B6,i
99,0211-699501013259,asi,o
99,0211-699501013259,como,o
99,0211-699501013259,los,o
99,0211-699501013259,incorporados,o
99,0211-699501013259,posteriormente,o
99,0211-699501013259,a,o
99,0211-699501013259,partir,o
99,0211-699501013259,de,o
99,0211-699501013259,su,o
99,0211-699501013259,tercer,o
99,0211-699501013259,mes,o
99,0211-699501013259,en,o
99,0211-699501013259,hemodialisis,i
99,0211-699501013259,recibieron,o
99,0211-699501013259,5,o
99,0211-699501013259,mg,o
99,0211-699501013259,orales,o
99,0211-699501013259,de,o
99,0211-699501013259,acido,i
99,0211-699501013259,folico,i
99,0211-699501013259,cada,o
99,0211-699501013259,48,o
99,0211-699501013259,horas,o
99,0211-699501013259,y,o
99,0211-699501013259,40,o
99,0211-699501013259,mg,o
99,0211-699501013259,orales,o
99,0211-699501013259,de,o
99,0211-699501013259,vitamina,i
99,0211-699501013259,B6,i
99,0211-699501013259,cada,o
99,0211-699501013259,semana,o
99,0211-699501013259,Se,o
99,0211-699501013259,determinaron,o
99,0211-699501013259,al,o
99,0211-699501013259,comienzo,o
99,0211-699501013259,del,o
99,0211-699501013259,estudio,o
99,0211-699501013259,y,o
99,0211-699501013259,cada,o
99,0211-699501013259,2,o
99,0211-699501013259,meses,o
99,0211-699501013259,niveles,i
99,0211-699501013259,de,i
99,0211-699501013259,folato,i
99,0211-699501013259,vitamina,i
99,0211-699501013259,B12,i
99,0211-699501013259,inmunoensayo,i
99,0211-699501013259,albumina,i
99,0211-699501013259,y,o
99,0211-699501013259,cinetica,o
99,0211-699501013259,de,o
99,0211-699501013259,la,o
99,0211-699501013259,urea,i
99,0211-699501013259,KTV,o
99,0211-699501013259,KRU,o
99,0211-699501013259,PCRn,o
99,0211-699501013259,y,o
99,0211-699501013259,cada,o
99,0211-699501013259,6,o
99,0211-699501013259,meses,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,HPLC,i
99,0211-699501013259,y,o
99,0211-699501013259,pp,i
99,0211-699501013259,RIA,i
99,0211-699501013259,Resultados,o
99,0211-699501013259,80,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,fueron,o
99,0211-699501013259,incluidos,o
99,0211-699501013259,en,o
99,0211-699501013259,el,o
99,0211-699501013259,estudio,o
99,0211-699501013259,basal,o
99,0211-699501013259,con,o
99,0211-699501013259,una,o
99,0211-699501013259,prevalencia,o
99,0211-699501013259,de,o
99,0211-699501013259,hiperhomocisteinemia,i
99,0211-699501013259,del,o
99,0211-699501013259,844,o
99,0211-699501013259,deficit,i
99,0211-699501013259,de,i
99,0211-699501013259,pp,i
99,0211-699501013259,en,o
99,0211-699501013259,el,o
99,0211-699501013259,32,o
99,0211-699501013259,y,o
99,0211-699501013259,folato,i
99,0211-699501013259,en,o
99,0211-699501013259,el,o
99,0211-699501013259,rango,o
99,0211-699501013259,normal,o
99,0211-699501013259,bajo,o
99,0211-699501013259,los,o
99,0211-699501013259,niveles,i
99,0211-699501013259,de,i
99,0211-699501013259,tHcy,i
99,0211-699501013259,se,o
99,0211-699501013259,correlacionaban,o
99,0211-699501013259,inversamente,o
99,0211-699501013259,con,o
99,0211-699501013259,los,o
99,0211-699501013259,del,o
99,0211-699501013259,folato,i
99,0211-699501013259,r,o
99,0211-699501013259,0336,o
99,0211-699501013259,p,o
99,0211-699501013259,001,o
99,0211-699501013259,pero,o
99,0211-699501013259,no,o
99,0211-699501013259,con,o
99,0211-699501013259,pp,i
99,0211-699501013259,B12,i
99,0211-699501013259,edad,o
99,0211-699501013259,albumina,i
99,0211-699501013259,KTV,o
99,0211-699501013259,KRU,o
99,0211-699501013259,PCRn,o
99,0211-699501013259,Cincuenta,o
99,0211-699501013259,y,o
99,0211-699501013259,ocho,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,recibieron,o
99,0211-699501013259,seis,o
99,0211-699501013259,meses,o
99,0211-699501013259,de,o
99,0211-699501013259,suplementacion,i
99,0211-699501013259,con,o
99,0211-699501013259,normalizacion,o
99,0211-699501013259,del,o
99,0211-699501013259,pp,i
99,0211-699501013259,aumento,o
99,0211-699501013259,del,o
99,0211-699501013259,folato,i
99,0211-699501013259,703,o
99,0211-699501013259,IC,o
99,0211-699501013259,638,o
99,0211-699501013259,795,o
99,0211-699501013259,vs,o
99,0211-699501013259,6181,o
99,0211-699501013259,IC,o
99,0211-699501013259,4447,o
99,0211-699501013259,7811,o
99,0211-699501013259,p,o
99,0211-699501013259,0001,o
99,0211-699501013259,y,o
99,0211-699501013259,descenso,o
99,0211-699501013259,de,o
99,0211-699501013259,la,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,240,o
99,0211-699501013259,IC,o
99,0211-699501013259,213,o
99,0211-699501013259,264,o
99,0211-699501013259,vs,o
99,0211-699501013259,199,o
99,0211-699501013259,IC,o
99,0211-699501013259,175,o
99,0211-699501013259,224,o
99,0211-699501013259,p,o
99,0211-699501013259,005,o
99,0211-699501013259,Han,o
99,0211-699501013259,recibido,o
99,0211-699501013259,suplementacion,i
99,0211-699501013259,durante,o
99,0211-699501013259,12,o
99,0211-699501013259,meses,o
99,0211-699501013259,33,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,pero,o
99,0211-699501013259,a,o
99,0211-699501013259,pesar,o
99,0211-699501013259,de,o
99,0211-699501013259,un,o
99,0211-699501013259,continuo,o
99,0211-699501013259,aumento,o
99,0211-699501013259,del,o
99,0211-699501013259,folato,i
99,0211-699501013259,10078,o
99,0211-699501013259,IC,o
99,0211-699501013259,7481,o
99,0211-699501013259,12674,o
99,0211-699501013259,p,o
99,0211-699501013259,0001,o
99,0211-699501013259,solo,o
99,0211-699501013259,3,o
99,0211-699501013259,pacientes,o
99,0211-699501013259,presentan,o
99,0211-699501013259,niveles,o
99,0211-699501013259,normales,o
99,0211-699501013259,de,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,correlacionandose,o
99,0211-699501013259,directamente,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,con,o
99,0211-699501013259,la,o
99,0211-699501013259,albumina,i
99,0211-699501013259,r,o
99,0211-699501013259,056,o
99,0211-699501013259,p,o
99,0211-699501013259,0001,o
99,0211-699501013259,que,o
99,0211-699501013259,se,o
99,0211-699501013259,elevo,o
99,0211-699501013259,con,o
99,0211-699501013259,respecto,o
99,0211-699501013259,al,o
99,0211-699501013259,inicio,o
99,0211-699501013259,337,o
99,0211-699501013259,IC,o
99,0211-699501013259,327,o
99,0211-699501013259,346,o
99,0211-699501013259,vs,o
99,0211-699501013259,350,o
99,0211-699501013259,IC,o
99,0211-699501013259,337,o
99,0211-699501013259,363,o
99,0211-699501013259,p,o
99,0211-699501013259,005,o
99,0211-699501013259,Conclusion,o
99,0211-699501013259,Tras,o
99,0211-699501013259,suplementacion,i
99,0211-699501013259,con,o
99,0211-699501013259,acido,i
99,0211-699501013259,folico,i
99,0211-699501013259,y,o
99,0211-699501013259,vitamina,i
99,0211-699501013259,B6,i
99,0211-699501013259,aunque,o
99,0211-699501013259,inicialmente,o
99,0211-699501013259,se,o
99,0211-699501013259,reduce,o
99,0211-699501013259,la,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,esta,o
99,0211-699501013259,respuesta,o
99,0211-699501013259,se,o
99,0211-699501013259,hace,o
99,0211-699501013259,refractaria,o
99,0211-699501013259,correlacionandose,o
99,0211-699501013259,directamente,o
99,0211-699501013259,la,o
99,0211-699501013259,tHcy,i
99,0211-699501013259,con,o
99,0211-699501013259,la,o
99,0211-699501013259,albumina,i
99,0211-699501013259,plasmatica,i
99,0211-699501013259,La,o
99,0211-699501013259,interpretacion,o
99,0211-699501013259,de,o
99,0211-699501013259,los,o
99,0211-699501013259,niveles,i
99,0211-699501013259,de,i
99,0211-699501013259,tHcy,i
99,0211-699501013259,debe,o
99,0211-699501013259,tener,o
99,0211-699501013259,en,o
99,0211-699501013259,cuenta,o
99,0211-699501013259,la,o
99,0211-699501013259,concentracion,i
99,0211-699501013259,de,i
99,0211-699501013259,albumina,i
100,0211-699501013259,Efecto,o
100,0211-699501013259,de,o
100,0211-699501013259,la,o
100,0211-699501013259,suplementacion,i
100,0211-699501013259,con,o
100,0211-699501013259,acido,i
100,0211-699501013259,folico,i
100,0211-699501013259,sobre,o
100,0211-699501013259,los,o
100,0211-699501013259,niveles,i
100,0211-699501013259,de,i
100,0211-699501013259,homocisteina,i
100,0211-699501013259,total,o
100,0211-699501013259,en,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,en,o
100,0211-699501013259,hemodialisis,i
100,0211-699501013259,La,o
100,0211-699501013259,hiperhomocisteinemia,i
100,0211-699501013259,es,o
100,0211-699501013259,un,o
100,0211-699501013259,marcador,o
100,0211-699501013259,de,o
100,0211-699501013259,riesgo,o
100,0211-699501013259,independiente,o
100,0211-699501013259,de,o
100,0211-699501013259,morbimortalidad,o
100,0211-699501013259,cardiovascular,i
100,0211-699501013259,Hemos,o
100,0211-699501013259,intentado,o
100,0211-699501013259,prospectivamente,o
100,0211-699501013259,reducir,o
100,0211-699501013259,los,o
100,0211-699501013259,niveles,i
100,0211-699501013259,de,i
100,0211-699501013259,homocisteina,i
100,0211-699501013259,total,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,mediante,o
100,0211-699501013259,suplemento,o
100,0211-699501013259,con,o
100,0211-699501013259,acido,i
100,0211-699501013259,folico,i
100,0211-699501013259,y,o
100,0211-699501013259,vitamina,i
100,0211-699501013259,B6,i
100,0211-699501013259,pp,i
100,0211-699501013259,valorando,o
100,0211-699501013259,su,o
100,0211-699501013259,posible,o
100,0211-699501013259,correlacion,o
100,0211-699501013259,con,o
100,0211-699501013259,dosis,o
100,0211-699501013259,de,o
100,0211-699501013259,dialisis,i
100,0211-699501013259,funcion,i
100,0211-699501013259,residual,i
100,0211-699501013259,y,o
100,0211-699501013259,parametros,o
100,0211-699501013259,nutricionales,o
100,0211-699501013259,Metodos,o
100,0211-699501013259,Todos,o
100,0211-699501013259,los,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,en,o
100,0211-699501013259,hemodialisis,i
100,0211-699501013259,al,o
100,0211-699501013259,comienzo,o
100,0211-699501013259,del,o
100,0211-699501013259,estudio,o
100,0211-699501013259,que,o
100,0211-699501013259,no,o
100,0211-699501013259,recibian,o
100,0211-699501013259,acido,i
100,0211-699501013259,folico,i
100,0211-699501013259,ni,o
100,0211-699501013259,vitamina,i
100,0211-699501013259,B6,i
100,0211-699501013259,asi,o
100,0211-699501013259,como,o
100,0211-699501013259,los,o
100,0211-699501013259,incorporados,o
100,0211-699501013259,posteriormente,o
100,0211-699501013259,a,o
100,0211-699501013259,partir,o
100,0211-699501013259,de,o
100,0211-699501013259,su,o
100,0211-699501013259,tercer,o
100,0211-699501013259,mes,o
100,0211-699501013259,en,o
100,0211-699501013259,hemodialisis,i
100,0211-699501013259,recibieron,o
100,0211-699501013259,5,o
100,0211-699501013259,mg,o
100,0211-699501013259,orales,o
100,0211-699501013259,de,o
100,0211-699501013259,acido,i
100,0211-699501013259,folico,i
100,0211-699501013259,cada,o
100,0211-699501013259,48,o
100,0211-699501013259,horas,o
100,0211-699501013259,y,o
100,0211-699501013259,40,o
100,0211-699501013259,mg,o
100,0211-699501013259,orales,o
100,0211-699501013259,de,o
100,0211-699501013259,vitamina,i
100,0211-699501013259,B6,i
100,0211-699501013259,cada,o
100,0211-699501013259,semana,o
100,0211-699501013259,Se,o
100,0211-699501013259,determinaron,o
100,0211-699501013259,al,o
100,0211-699501013259,comienzo,o
100,0211-699501013259,del,o
100,0211-699501013259,estudio,o
100,0211-699501013259,y,o
100,0211-699501013259,cada,o
100,0211-699501013259,2,o
100,0211-699501013259,meses,o
100,0211-699501013259,niveles,i
100,0211-699501013259,de,i
100,0211-699501013259,folato,i
100,0211-699501013259,vitamina,i
100,0211-699501013259,B12,i
100,0211-699501013259,inmunoensayo,i
100,0211-699501013259,albumina,i
100,0211-699501013259,y,o
100,0211-699501013259,cinetica,o
100,0211-699501013259,de,o
100,0211-699501013259,la,o
100,0211-699501013259,urea,i
100,0211-699501013259,KTV,o
100,0211-699501013259,KRU,o
100,0211-699501013259,PCRn,o
100,0211-699501013259,y,o
100,0211-699501013259,cada,o
100,0211-699501013259,6,o
100,0211-699501013259,meses,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,HPLC,i
100,0211-699501013259,y,o
100,0211-699501013259,pp,i
100,0211-699501013259,RIA,i
100,0211-699501013259,Resultados,o
100,0211-699501013259,80,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,fueron,o
100,0211-699501013259,incluidos,o
100,0211-699501013259,en,o
100,0211-699501013259,el,o
100,0211-699501013259,estudio,o
100,0211-699501013259,basal,o
100,0211-699501013259,con,o
100,0211-699501013259,una,o
100,0211-699501013259,prevalencia,o
100,0211-699501013259,de,o
100,0211-699501013259,hiperhomocisteinemia,i
100,0211-699501013259,del,o
100,0211-699501013259,844,o
100,0211-699501013259,deficit,i
100,0211-699501013259,de,i
100,0211-699501013259,pp,i
100,0211-699501013259,en,o
100,0211-699501013259,el,o
100,0211-699501013259,32,o
100,0211-699501013259,y,o
100,0211-699501013259,folato,i
100,0211-699501013259,en,o
100,0211-699501013259,el,o
100,0211-699501013259,rango,o
100,0211-699501013259,normal,o
100,0211-699501013259,bajo,o
100,0211-699501013259,los,o
100,0211-699501013259,niveles,i
100,0211-699501013259,de,i
100,0211-699501013259,tHcy,i
100,0211-699501013259,se,o
100,0211-699501013259,correlacionaban,o
100,0211-699501013259,inversamente,o
100,0211-699501013259,con,o
100,0211-699501013259,los,o
100,0211-699501013259,del,o
100,0211-699501013259,folato,i
100,0211-699501013259,r,o
100,0211-699501013259,0336,o
100,0211-699501013259,p,o
100,0211-699501013259,001,o
100,0211-699501013259,pero,o
100,0211-699501013259,no,o
100,0211-699501013259,con,o
100,0211-699501013259,pp,i
100,0211-699501013259,B12,i
100,0211-699501013259,edad,o
100,0211-699501013259,albumina,i
100,0211-699501013259,KTV,o
100,0211-699501013259,KRU,o
100,0211-699501013259,PCRn,o
100,0211-699501013259,Cincuenta,o
100,0211-699501013259,y,o
100,0211-699501013259,ocho,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,recibieron,o
100,0211-699501013259,seis,o
100,0211-699501013259,meses,o
100,0211-699501013259,de,o
100,0211-699501013259,suplementacion,i
100,0211-699501013259,con,o
100,0211-699501013259,normalizacion,o
100,0211-699501013259,del,o
100,0211-699501013259,pp,i
100,0211-699501013259,aumento,o
100,0211-699501013259,del,o
100,0211-699501013259,folato,i
100,0211-699501013259,703,o
100,0211-699501013259,IC,o
100,0211-699501013259,638,o
100,0211-699501013259,795,o
100,0211-699501013259,vs,o
100,0211-699501013259,6181,o
100,0211-699501013259,IC,o
100,0211-699501013259,4447,o
100,0211-699501013259,7811,o
100,0211-699501013259,p,o
100,0211-699501013259,0001,o
100,0211-699501013259,y,o
100,0211-699501013259,descenso,o
100,0211-699501013259,de,o
100,0211-699501013259,la,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,240,o
100,0211-699501013259,IC,o
100,0211-699501013259,213,o
100,0211-699501013259,264,o
100,0211-699501013259,vs,o
100,0211-699501013259,199,o
100,0211-699501013259,IC,o
100,0211-699501013259,175,o
100,0211-699501013259,224,o
100,0211-699501013259,p,o
100,0211-699501013259,005,o
100,0211-699501013259,Han,o
100,0211-699501013259,recibido,o
100,0211-699501013259,suplementacion,i
100,0211-699501013259,durante,o
100,0211-699501013259,12,o
100,0211-699501013259,meses,o
100,0211-699501013259,33,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,pero,o
100,0211-699501013259,a,o
100,0211-699501013259,pesar,o
100,0211-699501013259,de,o
100,0211-699501013259,un,o
100,0211-699501013259,continuo,o
100,0211-699501013259,aumento,o
100,0211-699501013259,del,o
100,0211-699501013259,folato,i
100,0211-699501013259,10078,o
100,0211-699501013259,IC,o
100,0211-699501013259,7481,o
100,0211-699501013259,12674,o
100,0211-699501013259,p,o
100,0211-699501013259,0001,o
100,0211-699501013259,solo,o
100,0211-699501013259,3,o
100,0211-699501013259,pacientes,o
100,0211-699501013259,presentan,o
100,0211-699501013259,niveles,o
100,0211-699501013259,normales,o
100,0211-699501013259,de,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,correlacionandose,o
100,0211-699501013259,directamente,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,con,o
100,0211-699501013259,la,o
100,0211-699501013259,albumina,i
100,0211-699501013259,r,o
100,0211-699501013259,056,o
100,0211-699501013259,p,o
100,0211-699501013259,0001,o
100,0211-699501013259,que,o
100,0211-699501013259,se,o
100,0211-699501013259,elevo,o
100,0211-699501013259,con,o
100,0211-699501013259,respecto,o
100,0211-699501013259,al,o
100,0211-699501013259,inicio,o
100,0211-699501013259,337,o
100,0211-699501013259,IC,o
100,0211-699501013259,327,o
100,0211-699501013259,346,o
100,0211-699501013259,vs,o
100,0211-699501013259,350,o
100,0211-699501013259,IC,o
100,0211-699501013259,337,o
100,0211-699501013259,363,o
100,0211-699501013259,p,o
100,0211-699501013259,005,o
100,0211-699501013259,Conclusion,o
100,0211-699501013259,Tras,o
100,0211-699501013259,suplementacion,i
100,0211-699501013259,con,o
100,0211-699501013259,acido,i
100,0211-699501013259,folico,i
100,0211-699501013259,y,o
100,0211-699501013259,vitamina,i
100,0211-699501013259,B6,i
100,0211-699501013259,aunque,o
100,0211-699501013259,inicialmente,o
100,0211-699501013259,se,o
100,0211-699501013259,reduce,o
100,0211-699501013259,la,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,esta,o
100,0211-699501013259,respuesta,o
100,0211-699501013259,se,o
100,0211-699501013259,hace,o
100,0211-699501013259,refractaria,o
100,0211-699501013259,correlacionandose,o
100,0211-699501013259,directamente,o
100,0211-699501013259,la,o
100,0211-699501013259,tHcy,i
100,0211-699501013259,con,o
100,0211-699501013259,la,o
100,0211-699501013259,albumina,i
100,0211-699501013259,plasmatica,i
100,0211-699501013259,La,o
100,0211-699501013259,interpretacion,o
100,0211-699501013259,de,o
100,0211-699501013259,los,o
100,0211-699501013259,niveles,i
100,0211-699501013259,de,i
100,0211-699501013259,tHcy,i
100,0211-699501013259,debe,o
100,0211-699501013259,tener,o
100,0211-699501013259,en,o
100,0211-699501013259,cuenta,o
100,0211-699501013259,la,o
100,0211-699501013259,concentracion,i
100,0211-699501013259,de,i
100,0211-699501013259,albumina,i
101,0211-699501013259,Efecto,o
101,0211-699501013259,de,o
101,0211-699501013259,la,o
101,0211-699501013259,suplementacion,i
101,0211-699501013259,con,o
101,0211-699501013259,acido,i
101,0211-699501013259,folico,i
101,0211-699501013259,sobre,o
101,0211-699501013259,los,o
101,0211-699501013259,niveles,i
101,0211-699501013259,de,i
101,0211-699501013259,homocisteina,i
101,0211-699501013259,total,o
101,0211-699501013259,en,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,en,o
101,0211-699501013259,hemodialisis,i
101,0211-699501013259,La,o
101,0211-699501013259,hiperhomocisteinemia,i
101,0211-699501013259,es,o
101,0211-699501013259,un,o
101,0211-699501013259,marcador,o
101,0211-699501013259,de,o
101,0211-699501013259,riesgo,o
101,0211-699501013259,independiente,o
101,0211-699501013259,de,o
101,0211-699501013259,morbimortalidad,o
101,0211-699501013259,cardiovascular,i
101,0211-699501013259,Hemos,o
101,0211-699501013259,intentado,o
101,0211-699501013259,prospectivamente,o
101,0211-699501013259,reducir,o
101,0211-699501013259,los,o
101,0211-699501013259,niveles,i
101,0211-699501013259,de,i
101,0211-699501013259,homocisteina,i
101,0211-699501013259,total,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,mediante,o
101,0211-699501013259,suplemento,o
101,0211-699501013259,con,o
101,0211-699501013259,acido,i
101,0211-699501013259,folico,i
101,0211-699501013259,y,o
101,0211-699501013259,vitamina,i
101,0211-699501013259,B6,i
101,0211-699501013259,pp,i
101,0211-699501013259,valorando,o
101,0211-699501013259,su,o
101,0211-699501013259,posible,o
101,0211-699501013259,correlacion,o
101,0211-699501013259,con,o
101,0211-699501013259,dosis,o
101,0211-699501013259,de,o
101,0211-699501013259,dialisis,i
101,0211-699501013259,funcion,i
101,0211-699501013259,residual,i
101,0211-699501013259,y,o
101,0211-699501013259,parametros,o
101,0211-699501013259,nutricionales,o
101,0211-699501013259,Metodos,o
101,0211-699501013259,Todos,o
101,0211-699501013259,los,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,en,o
101,0211-699501013259,hemodialisis,i
101,0211-699501013259,al,o
101,0211-699501013259,comienzo,o
101,0211-699501013259,del,o
101,0211-699501013259,estudio,o
101,0211-699501013259,que,o
101,0211-699501013259,no,o
101,0211-699501013259,recibian,o
101,0211-699501013259,acido,i
101,0211-699501013259,folico,i
101,0211-699501013259,ni,o
101,0211-699501013259,vitamina,i
101,0211-699501013259,B6,i
101,0211-699501013259,asi,o
101,0211-699501013259,como,o
101,0211-699501013259,los,o
101,0211-699501013259,incorporados,o
101,0211-699501013259,posteriormente,o
101,0211-699501013259,a,o
101,0211-699501013259,partir,o
101,0211-699501013259,de,o
101,0211-699501013259,su,o
101,0211-699501013259,tercer,o
101,0211-699501013259,mes,o
101,0211-699501013259,en,o
101,0211-699501013259,hemodialisis,i
101,0211-699501013259,recibieron,o
101,0211-699501013259,5,o
101,0211-699501013259,mg,o
101,0211-699501013259,orales,o
101,0211-699501013259,de,o
101,0211-699501013259,acido,i
101,0211-699501013259,folico,i
101,0211-699501013259,cada,o
101,0211-699501013259,48,o
101,0211-699501013259,horas,o
101,0211-699501013259,y,o
101,0211-699501013259,40,o
101,0211-699501013259,mg,o
101,0211-699501013259,orales,o
101,0211-699501013259,de,o
101,0211-699501013259,vitamina,i
101,0211-699501013259,B6,i
101,0211-699501013259,cada,o
101,0211-699501013259,semana,o
101,0211-699501013259,Se,o
101,0211-699501013259,determinaron,o
101,0211-699501013259,al,o
101,0211-699501013259,comienzo,o
101,0211-699501013259,del,o
101,0211-699501013259,estudio,o
101,0211-699501013259,y,o
101,0211-699501013259,cada,o
101,0211-699501013259,2,o
101,0211-699501013259,meses,o
101,0211-699501013259,niveles,i
101,0211-699501013259,de,i
101,0211-699501013259,folato,i
101,0211-699501013259,vitamina,i
101,0211-699501013259,B12,i
101,0211-699501013259,inmunoensayo,i
101,0211-699501013259,albumina,i
101,0211-699501013259,y,o
101,0211-699501013259,cinetica,o
101,0211-699501013259,de,o
101,0211-699501013259,la,o
101,0211-699501013259,urea,i
101,0211-699501013259,KTV,o
101,0211-699501013259,KRU,o
101,0211-699501013259,PCRn,o
101,0211-699501013259,y,o
101,0211-699501013259,cada,o
101,0211-699501013259,6,o
101,0211-699501013259,meses,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,HPLC,i
101,0211-699501013259,y,o
101,0211-699501013259,pp,i
101,0211-699501013259,RIA,i
101,0211-699501013259,Resultados,o
101,0211-699501013259,80,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,fueron,o
101,0211-699501013259,incluidos,o
101,0211-699501013259,en,o
101,0211-699501013259,el,o
101,0211-699501013259,estudio,o
101,0211-699501013259,basal,o
101,0211-699501013259,con,o
101,0211-699501013259,una,o
101,0211-699501013259,prevalencia,o
101,0211-699501013259,de,o
101,0211-699501013259,hiperhomocisteinemia,i
101,0211-699501013259,del,o
101,0211-699501013259,844,o
101,0211-699501013259,deficit,i
101,0211-699501013259,de,i
101,0211-699501013259,pp,i
101,0211-699501013259,en,o
101,0211-699501013259,el,o
101,0211-699501013259,32,o
101,0211-699501013259,y,o
101,0211-699501013259,folato,i
101,0211-699501013259,en,o
101,0211-699501013259,el,o
101,0211-699501013259,rango,o
101,0211-699501013259,normal,o
101,0211-699501013259,bajo,o
101,0211-699501013259,los,o
101,0211-699501013259,niveles,i
101,0211-699501013259,de,i
101,0211-699501013259,tHcy,i
101,0211-699501013259,se,o
101,0211-699501013259,correlacionaban,o
101,0211-699501013259,inversamente,o
101,0211-699501013259,con,o
101,0211-699501013259,los,o
101,0211-699501013259,del,o
101,0211-699501013259,folato,i
101,0211-699501013259,r,o
101,0211-699501013259,0336,o
101,0211-699501013259,p,o
101,0211-699501013259,001,o
101,0211-699501013259,pero,o
101,0211-699501013259,no,o
101,0211-699501013259,con,o
101,0211-699501013259,pp,i
101,0211-699501013259,B12,i
101,0211-699501013259,edad,o
101,0211-699501013259,albumina,i
101,0211-699501013259,KTV,o
101,0211-699501013259,KRU,o
101,0211-699501013259,PCRn,o
101,0211-699501013259,Cincuenta,o
101,0211-699501013259,y,o
101,0211-699501013259,ocho,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,recibieron,o
101,0211-699501013259,seis,o
101,0211-699501013259,meses,o
101,0211-699501013259,de,o
101,0211-699501013259,suplementacion,i
101,0211-699501013259,con,o
101,0211-699501013259,normalizacion,o
101,0211-699501013259,del,o
101,0211-699501013259,pp,i
101,0211-699501013259,aumento,o
101,0211-699501013259,del,o
101,0211-699501013259,folato,i
101,0211-699501013259,703,o
101,0211-699501013259,IC,o
101,0211-699501013259,638,o
101,0211-699501013259,795,o
101,0211-699501013259,vs,o
101,0211-699501013259,6181,o
101,0211-699501013259,IC,o
101,0211-699501013259,4447,o
101,0211-699501013259,7811,o
101,0211-699501013259,p,o
101,0211-699501013259,0001,o
101,0211-699501013259,y,o
101,0211-699501013259,descenso,o
101,0211-699501013259,de,o
101,0211-699501013259,la,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,240,o
101,0211-699501013259,IC,o
101,0211-699501013259,213,o
101,0211-699501013259,264,o
101,0211-699501013259,vs,o
101,0211-699501013259,199,o
101,0211-699501013259,IC,o
101,0211-699501013259,175,o
101,0211-699501013259,224,o
101,0211-699501013259,p,o
101,0211-699501013259,005,o
101,0211-699501013259,Han,o
101,0211-699501013259,recibido,o
101,0211-699501013259,suplementacion,i
101,0211-699501013259,durante,o
101,0211-699501013259,12,o
101,0211-699501013259,meses,o
101,0211-699501013259,33,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,pero,o
101,0211-699501013259,a,o
101,0211-699501013259,pesar,o
101,0211-699501013259,de,o
101,0211-699501013259,un,o
101,0211-699501013259,continuo,o
101,0211-699501013259,aumento,o
101,0211-699501013259,del,o
101,0211-699501013259,folato,i
101,0211-699501013259,10078,o
101,0211-699501013259,IC,o
101,0211-699501013259,7481,o
101,0211-699501013259,12674,o
101,0211-699501013259,p,o
101,0211-699501013259,0001,o
101,0211-699501013259,solo,o
101,0211-699501013259,3,o
101,0211-699501013259,pacientes,o
101,0211-699501013259,presentan,o
101,0211-699501013259,niveles,o
101,0211-699501013259,normales,o
101,0211-699501013259,de,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,correlacionandose,o
101,0211-699501013259,directamente,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,con,o
101,0211-699501013259,la,o
101,0211-699501013259,albumina,i
101,0211-699501013259,r,o
101,0211-699501013259,056,o
101,0211-699501013259,p,o
101,0211-699501013259,0001,o
101,0211-699501013259,que,o
101,0211-699501013259,se,o
101,0211-699501013259,elevo,o
101,0211-699501013259,con,o
101,0211-699501013259,respecto,o
101,0211-699501013259,al,o
101,0211-699501013259,inicio,o
101,0211-699501013259,337,o
101,0211-699501013259,IC,o
101,0211-699501013259,327,o
101,0211-699501013259,346,o
101,0211-699501013259,vs,o
101,0211-699501013259,350,o
101,0211-699501013259,IC,o
101,0211-699501013259,337,o
101,0211-699501013259,363,o
101,0211-699501013259,p,o
101,0211-699501013259,005,o
101,0211-699501013259,Conclusion,o
101,0211-699501013259,Tras,o
101,0211-699501013259,suplementacion,i
101,0211-699501013259,con,o
101,0211-699501013259,acido,i
101,0211-699501013259,folico,i
101,0211-699501013259,y,o
101,0211-699501013259,vitamina,i
101,0211-699501013259,B6,i
101,0211-699501013259,aunque,o
101,0211-699501013259,inicialmente,o
101,0211-699501013259,se,o
101,0211-699501013259,reduce,o
101,0211-699501013259,la,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,esta,o
101,0211-699501013259,respuesta,o
101,0211-699501013259,se,o
101,0211-699501013259,hace,o
101,0211-699501013259,refractaria,o
101,0211-699501013259,correlacionandose,o
101,0211-699501013259,directamente,o
101,0211-699501013259,la,o
101,0211-699501013259,tHcy,i
101,0211-699501013259,con,o
101,0211-699501013259,la,o
101,0211-699501013259,albumina,i
101,0211-699501013259,plasmatica,i
101,0211-699501013259,La,o
101,0211-699501013259,interpretacion,o
101,0211-699501013259,de,o
101,0211-699501013259,los,o
101,0211-699501013259,niveles,i
101,0211-699501013259,de,i
101,0211-699501013259,tHcy,i
101,0211-699501013259,debe,o
101,0211-699501013259,tener,o
101,0211-699501013259,en,o
101,0211-699501013259,cuenta,o
101,0211-699501013259,la,o
101,0211-699501013259,concentracion,i
101,0211-699501013259,de,i
101,0211-699501013259,albumina,i
102,0211-699501013259,Efecto,o
102,0211-699501013259,de,o
102,0211-699501013259,la,o
102,0211-699501013259,suplementacion,i
102,0211-699501013259,con,o
102,0211-699501013259,acido,i
102,0211-699501013259,folico,i
102,0211-699501013259,sobre,o
102,0211-699501013259,los,o
102,0211-699501013259,niveles,i
102,0211-699501013259,de,i
102,0211-699501013259,homocisteina,i
102,0211-699501013259,total,o
102,0211-699501013259,en,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,en,o
102,0211-699501013259,hemodialisis,i
102,0211-699501013259,La,o
102,0211-699501013259,hiperhomocisteinemia,i
102,0211-699501013259,es,o
102,0211-699501013259,un,o
102,0211-699501013259,marcador,o
102,0211-699501013259,de,o
102,0211-699501013259,riesgo,o
102,0211-699501013259,independiente,o
102,0211-699501013259,de,o
102,0211-699501013259,morbimortalidad,o
102,0211-699501013259,cardiovascular,i
102,0211-699501013259,Hemos,o
102,0211-699501013259,intentado,o
102,0211-699501013259,prospectivamente,o
102,0211-699501013259,reducir,o
102,0211-699501013259,los,o
102,0211-699501013259,niveles,i
102,0211-699501013259,de,i
102,0211-699501013259,homocisteina,i
102,0211-699501013259,total,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,mediante,o
102,0211-699501013259,suplemento,o
102,0211-699501013259,con,o
102,0211-699501013259,acido,i
102,0211-699501013259,folico,i
102,0211-699501013259,y,o
102,0211-699501013259,vitamina,i
102,0211-699501013259,B6,i
102,0211-699501013259,pp,i
102,0211-699501013259,valorando,o
102,0211-699501013259,su,o
102,0211-699501013259,posible,o
102,0211-699501013259,correlacion,o
102,0211-699501013259,con,o
102,0211-699501013259,dosis,o
102,0211-699501013259,de,o
102,0211-699501013259,dialisis,i
102,0211-699501013259,funcion,i
102,0211-699501013259,residual,i
102,0211-699501013259,y,o
102,0211-699501013259,parametros,o
102,0211-699501013259,nutricionales,o
102,0211-699501013259,Metodos,o
102,0211-699501013259,Todos,o
102,0211-699501013259,los,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,en,o
102,0211-699501013259,hemodialisis,i
102,0211-699501013259,al,o
102,0211-699501013259,comienzo,o
102,0211-699501013259,del,o
102,0211-699501013259,estudio,o
102,0211-699501013259,que,o
102,0211-699501013259,no,o
102,0211-699501013259,recibian,o
102,0211-699501013259,acido,i
102,0211-699501013259,folico,i
102,0211-699501013259,ni,o
102,0211-699501013259,vitamina,i
102,0211-699501013259,B6,i
102,0211-699501013259,asi,o
102,0211-699501013259,como,o
102,0211-699501013259,los,o
102,0211-699501013259,incorporados,o
102,0211-699501013259,posteriormente,o
102,0211-699501013259,a,o
102,0211-699501013259,partir,o
102,0211-699501013259,de,o
102,0211-699501013259,su,o
102,0211-699501013259,tercer,o
102,0211-699501013259,mes,o
102,0211-699501013259,en,o
102,0211-699501013259,hemodialisis,i
102,0211-699501013259,recibieron,o
102,0211-699501013259,5,o
102,0211-699501013259,mg,o
102,0211-699501013259,orales,o
102,0211-699501013259,de,o
102,0211-699501013259,acido,i
102,0211-699501013259,folico,i
102,0211-699501013259,cada,o
102,0211-699501013259,48,o
102,0211-699501013259,horas,o
102,0211-699501013259,y,o
102,0211-699501013259,40,o
102,0211-699501013259,mg,o
102,0211-699501013259,orales,o
102,0211-699501013259,de,o
102,0211-699501013259,vitamina,i
102,0211-699501013259,B6,i
102,0211-699501013259,cada,o
102,0211-699501013259,semana,o
102,0211-699501013259,Se,o
102,0211-699501013259,determinaron,o
102,0211-699501013259,al,o
102,0211-699501013259,comienzo,o
102,0211-699501013259,del,o
102,0211-699501013259,estudio,o
102,0211-699501013259,y,o
102,0211-699501013259,cada,o
102,0211-699501013259,2,o
102,0211-699501013259,meses,o
102,0211-699501013259,niveles,i
102,0211-699501013259,de,i
102,0211-699501013259,folato,i
102,0211-699501013259,vitamina,i
102,0211-699501013259,B12,i
102,0211-699501013259,inmunoensayo,i
102,0211-699501013259,albumina,i
102,0211-699501013259,y,o
102,0211-699501013259,cinetica,o
102,0211-699501013259,de,o
102,0211-699501013259,la,o
102,0211-699501013259,urea,i
102,0211-699501013259,KTV,o
102,0211-699501013259,KRU,o
102,0211-699501013259,PCRn,o
102,0211-699501013259,y,o
102,0211-699501013259,cada,o
102,0211-699501013259,6,o
102,0211-699501013259,meses,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,HPLC,i
102,0211-699501013259,y,o
102,0211-699501013259,pp,i
102,0211-699501013259,RIA,i
102,0211-699501013259,Resultados,o
102,0211-699501013259,80,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,fueron,o
102,0211-699501013259,incluidos,o
102,0211-699501013259,en,o
102,0211-699501013259,el,o
102,0211-699501013259,estudio,o
102,0211-699501013259,basal,o
102,0211-699501013259,con,o
102,0211-699501013259,una,o
102,0211-699501013259,prevalencia,o
102,0211-699501013259,de,o
102,0211-699501013259,hiperhomocisteinemia,i
102,0211-699501013259,del,o
102,0211-699501013259,844,o
102,0211-699501013259,deficit,i
102,0211-699501013259,de,i
102,0211-699501013259,pp,i
102,0211-699501013259,en,o
102,0211-699501013259,el,o
102,0211-699501013259,32,o
102,0211-699501013259,y,o
102,0211-699501013259,folato,i
102,0211-699501013259,en,o
102,0211-699501013259,el,o
102,0211-699501013259,rango,o
102,0211-699501013259,normal,o
102,0211-699501013259,bajo,o
102,0211-699501013259,los,o
102,0211-699501013259,niveles,i
102,0211-699501013259,de,i
102,0211-699501013259,tHcy,i
102,0211-699501013259,se,o
102,0211-699501013259,correlacionaban,o
102,0211-699501013259,inversamente,o
102,0211-699501013259,con,o
102,0211-699501013259,los,o
102,0211-699501013259,del,o
102,0211-699501013259,folato,i
102,0211-699501013259,r,o
102,0211-699501013259,0336,o
102,0211-699501013259,p,o
102,0211-699501013259,001,o
102,0211-699501013259,pero,o
102,0211-699501013259,no,o
102,0211-699501013259,con,o
102,0211-699501013259,pp,i
102,0211-699501013259,B12,i
102,0211-699501013259,edad,o
102,0211-699501013259,albumina,i
102,0211-699501013259,KTV,o
102,0211-699501013259,KRU,o
102,0211-699501013259,PCRn,o
102,0211-699501013259,Cincuenta,o
102,0211-699501013259,y,o
102,0211-699501013259,ocho,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,recibieron,o
102,0211-699501013259,seis,o
102,0211-699501013259,meses,o
102,0211-699501013259,de,o
102,0211-699501013259,suplementacion,i
102,0211-699501013259,con,o
102,0211-699501013259,normalizacion,o
102,0211-699501013259,del,o
102,0211-699501013259,pp,i
102,0211-699501013259,aumento,o
102,0211-699501013259,del,o
102,0211-699501013259,folato,i
102,0211-699501013259,703,o
102,0211-699501013259,IC,o
102,0211-699501013259,638,o
102,0211-699501013259,795,o
102,0211-699501013259,vs,o
102,0211-699501013259,6181,o
102,0211-699501013259,IC,o
102,0211-699501013259,4447,o
102,0211-699501013259,7811,o
102,0211-699501013259,p,o
102,0211-699501013259,0001,o
102,0211-699501013259,y,o
102,0211-699501013259,descenso,o
102,0211-699501013259,de,o
102,0211-699501013259,la,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,240,o
102,0211-699501013259,IC,o
102,0211-699501013259,213,o
102,0211-699501013259,264,o
102,0211-699501013259,vs,o
102,0211-699501013259,199,o
102,0211-699501013259,IC,o
102,0211-699501013259,175,o
102,0211-699501013259,224,o
102,0211-699501013259,p,o
102,0211-699501013259,005,o
102,0211-699501013259,Han,o
102,0211-699501013259,recibido,o
102,0211-699501013259,suplementacion,i
102,0211-699501013259,durante,o
102,0211-699501013259,12,o
102,0211-699501013259,meses,o
102,0211-699501013259,33,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,pero,o
102,0211-699501013259,a,o
102,0211-699501013259,pesar,o
102,0211-699501013259,de,o
102,0211-699501013259,un,o
102,0211-699501013259,continuo,o
102,0211-699501013259,aumento,o
102,0211-699501013259,del,o
102,0211-699501013259,folato,i
102,0211-699501013259,10078,o
102,0211-699501013259,IC,o
102,0211-699501013259,7481,o
102,0211-699501013259,12674,o
102,0211-699501013259,p,o
102,0211-699501013259,0001,o
102,0211-699501013259,solo,o
102,0211-699501013259,3,o
102,0211-699501013259,pacientes,o
102,0211-699501013259,presentan,o
102,0211-699501013259,niveles,o
102,0211-699501013259,normales,o
102,0211-699501013259,de,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,correlacionandose,o
102,0211-699501013259,directamente,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,con,o
102,0211-699501013259,la,o
102,0211-699501013259,albumina,i
102,0211-699501013259,r,o
102,0211-699501013259,056,o
102,0211-699501013259,p,o
102,0211-699501013259,0001,o
102,0211-699501013259,que,o
102,0211-699501013259,se,o
102,0211-699501013259,elevo,o
102,0211-699501013259,con,o
102,0211-699501013259,respecto,o
102,0211-699501013259,al,o
102,0211-699501013259,inicio,o
102,0211-699501013259,337,o
102,0211-699501013259,IC,o
102,0211-699501013259,327,o
102,0211-699501013259,346,o
102,0211-699501013259,vs,o
102,0211-699501013259,350,o
102,0211-699501013259,IC,o
102,0211-699501013259,337,o
102,0211-699501013259,363,o
102,0211-699501013259,p,o
102,0211-699501013259,005,o
102,0211-699501013259,Conclusion,o
102,0211-699501013259,Tras,o
102,0211-699501013259,suplementacion,i
102,0211-699501013259,con,o
102,0211-699501013259,acido,i
102,0211-699501013259,folico,i
102,0211-699501013259,y,o
102,0211-699501013259,vitamina,i
102,0211-699501013259,B6,i
102,0211-699501013259,aunque,o
102,0211-699501013259,inicialmente,o
102,0211-699501013259,se,o
102,0211-699501013259,reduce,o
102,0211-699501013259,la,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,esta,o
102,0211-699501013259,respuesta,o
102,0211-699501013259,se,o
102,0211-699501013259,hace,o
102,0211-699501013259,refractaria,o
102,0211-699501013259,correlacionandose,o
102,0211-699501013259,directamente,o
102,0211-699501013259,la,o
102,0211-699501013259,tHcy,i
102,0211-699501013259,con,o
102,0211-699501013259,la,o
102,0211-699501013259,albumina,i
102,0211-699501013259,plasmatica,i
102,0211-699501013259,La,o
102,0211-699501013259,interpretacion,o
102,0211-699501013259,de,o
102,0211-699501013259,los,o
102,0211-699501013259,niveles,i
102,0211-699501013259,de,i
102,0211-699501013259,tHcy,i
102,0211-699501013259,debe,o
102,0211-699501013259,tener,o
102,0211-699501013259,en,o
102,0211-699501013259,cuenta,o
102,0211-699501013259,la,o
102,0211-699501013259,concentracion,i
102,0211-699501013259,de,i
102,0211-699501013259,albumina,i
103,0211-699501013259,Efecto,o
103,0211-699501013259,de,o
103,0211-699501013259,la,o
103,0211-699501013259,suplementacion,i
103,0211-699501013259,con,o
103,0211-699501013259,acido,i
103,0211-699501013259,folico,i
103,0211-699501013259,sobre,o
103,0211-699501013259,los,o
103,0211-699501013259,niveles,i
103,0211-699501013259,de,i
103,0211-699501013259,homocisteina,i
103,0211-699501013259,total,o
103,0211-699501013259,en,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,en,o
103,0211-699501013259,hemodialisis,i
103,0211-699501013259,La,o
103,0211-699501013259,hiperhomocisteinemia,i
103,0211-699501013259,es,o
103,0211-699501013259,un,o
103,0211-699501013259,marcador,o
103,0211-699501013259,de,o
103,0211-699501013259,riesgo,o
103,0211-699501013259,independiente,o
103,0211-699501013259,de,o
103,0211-699501013259,morbimortalidad,o
103,0211-699501013259,cardiovascular,i
103,0211-699501013259,Hemos,o
103,0211-699501013259,intentado,o
103,0211-699501013259,prospectivamente,o
103,0211-699501013259,reducir,o
103,0211-699501013259,los,o
103,0211-699501013259,niveles,i
103,0211-699501013259,de,i
103,0211-699501013259,homocisteina,i
103,0211-699501013259,total,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,mediante,o
103,0211-699501013259,suplemento,o
103,0211-699501013259,con,o
103,0211-699501013259,acido,i
103,0211-699501013259,folico,i
103,0211-699501013259,y,o
103,0211-699501013259,vitamina,i
103,0211-699501013259,B6,i
103,0211-699501013259,pp,i
103,0211-699501013259,valorando,o
103,0211-699501013259,su,o
103,0211-699501013259,posible,o
103,0211-699501013259,correlacion,o
103,0211-699501013259,con,o
103,0211-699501013259,dosis,o
103,0211-699501013259,de,o
103,0211-699501013259,dialisis,i
103,0211-699501013259,funcion,i
103,0211-699501013259,residual,i
103,0211-699501013259,y,o
103,0211-699501013259,parametros,o
103,0211-699501013259,nutricionales,o
103,0211-699501013259,Metodos,o
103,0211-699501013259,Todos,o
103,0211-699501013259,los,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,en,o
103,0211-699501013259,hemodialisis,i
103,0211-699501013259,al,o
103,0211-699501013259,comienzo,o
103,0211-699501013259,del,o
103,0211-699501013259,estudio,o
103,0211-699501013259,que,o
103,0211-699501013259,no,o
103,0211-699501013259,recibian,o
103,0211-699501013259,acido,i
103,0211-699501013259,folico,i
103,0211-699501013259,ni,o
103,0211-699501013259,vitamina,i
103,0211-699501013259,B6,i
103,0211-699501013259,asi,o
103,0211-699501013259,como,o
103,0211-699501013259,los,o
103,0211-699501013259,incorporados,o
103,0211-699501013259,posteriormente,o
103,0211-699501013259,a,o
103,0211-699501013259,partir,o
103,0211-699501013259,de,o
103,0211-699501013259,su,o
103,0211-699501013259,tercer,o
103,0211-699501013259,mes,o
103,0211-699501013259,en,o
103,0211-699501013259,hemodialisis,i
103,0211-699501013259,recibieron,o
103,0211-699501013259,5,o
103,0211-699501013259,mg,o
103,0211-699501013259,orales,o
103,0211-699501013259,de,o
103,0211-699501013259,acido,i
103,0211-699501013259,folico,i
103,0211-699501013259,cada,o
103,0211-699501013259,48,o
103,0211-699501013259,horas,o
103,0211-699501013259,y,o
103,0211-699501013259,40,o
103,0211-699501013259,mg,o
103,0211-699501013259,orales,o
103,0211-699501013259,de,o
103,0211-699501013259,vitamina,i
103,0211-699501013259,B6,i
103,0211-699501013259,cada,o
103,0211-699501013259,semana,o
103,0211-699501013259,Se,o
103,0211-699501013259,determinaron,o
103,0211-699501013259,al,o
103,0211-699501013259,comienzo,o
103,0211-699501013259,del,o
103,0211-699501013259,estudio,o
103,0211-699501013259,y,o
103,0211-699501013259,cada,o
103,0211-699501013259,2,o
103,0211-699501013259,meses,o
103,0211-699501013259,niveles,i
103,0211-699501013259,de,i
103,0211-699501013259,folato,i
103,0211-699501013259,vitamina,i
103,0211-699501013259,B12,i
103,0211-699501013259,inmunoensayo,i
103,0211-699501013259,albumina,i
103,0211-699501013259,y,o
103,0211-699501013259,cinetica,o
103,0211-699501013259,de,o
103,0211-699501013259,la,o
103,0211-699501013259,urea,i
103,0211-699501013259,KTV,o
103,0211-699501013259,KRU,o
103,0211-699501013259,PCRn,o
103,0211-699501013259,y,o
103,0211-699501013259,cada,o
103,0211-699501013259,6,o
103,0211-699501013259,meses,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,HPLC,i
103,0211-699501013259,y,o
103,0211-699501013259,pp,i
103,0211-699501013259,RIA,i
103,0211-699501013259,Resultados,o
103,0211-699501013259,80,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,fueron,o
103,0211-699501013259,incluidos,o
103,0211-699501013259,en,o
103,0211-699501013259,el,o
103,0211-699501013259,estudio,o
103,0211-699501013259,basal,o
103,0211-699501013259,con,o
103,0211-699501013259,una,o
103,0211-699501013259,prevalencia,o
103,0211-699501013259,de,o
103,0211-699501013259,hiperhomocisteinemia,i
103,0211-699501013259,del,o
103,0211-699501013259,844,o
103,0211-699501013259,deficit,i
103,0211-699501013259,de,i
103,0211-699501013259,pp,i
103,0211-699501013259,en,o
103,0211-699501013259,el,o
103,0211-699501013259,32,o
103,0211-699501013259,y,o
103,0211-699501013259,folato,i
103,0211-699501013259,en,o
103,0211-699501013259,el,o
103,0211-699501013259,rango,o
103,0211-699501013259,normal,o
103,0211-699501013259,bajo,o
103,0211-699501013259,los,o
103,0211-699501013259,niveles,i
103,0211-699501013259,de,i
103,0211-699501013259,tHcy,i
103,0211-699501013259,se,o
103,0211-699501013259,correlacionaban,o
103,0211-699501013259,inversamente,o
103,0211-699501013259,con,o
103,0211-699501013259,los,o
103,0211-699501013259,del,o
103,0211-699501013259,folato,i
103,0211-699501013259,r,o
103,0211-699501013259,0336,o
103,0211-699501013259,p,o
103,0211-699501013259,001,o
103,0211-699501013259,pero,o
103,0211-699501013259,no,o
103,0211-699501013259,con,o
103,0211-699501013259,pp,i
103,0211-699501013259,B12,i
103,0211-699501013259,edad,o
103,0211-699501013259,albumina,i
103,0211-699501013259,KTV,o
103,0211-699501013259,KRU,o
103,0211-699501013259,PCRn,o
103,0211-699501013259,Cincuenta,o
103,0211-699501013259,y,o
103,0211-699501013259,ocho,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,recibieron,o
103,0211-699501013259,seis,o
103,0211-699501013259,meses,o
103,0211-699501013259,de,o
103,0211-699501013259,suplementacion,i
103,0211-699501013259,con,o
103,0211-699501013259,normalizacion,o
103,0211-699501013259,del,o
103,0211-699501013259,pp,i
103,0211-699501013259,aumento,o
103,0211-699501013259,del,o
103,0211-699501013259,folato,i
103,0211-699501013259,703,o
103,0211-699501013259,IC,o
103,0211-699501013259,638,o
103,0211-699501013259,795,o
103,0211-699501013259,vs,o
103,0211-699501013259,6181,o
103,0211-699501013259,IC,o
103,0211-699501013259,4447,o
103,0211-699501013259,7811,o
103,0211-699501013259,p,o
103,0211-699501013259,0001,o
103,0211-699501013259,y,o
103,0211-699501013259,descenso,o
103,0211-699501013259,de,o
103,0211-699501013259,la,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,240,o
103,0211-699501013259,IC,o
103,0211-699501013259,213,o
103,0211-699501013259,264,o
103,0211-699501013259,vs,o
103,0211-699501013259,199,o
103,0211-699501013259,IC,o
103,0211-699501013259,175,o
103,0211-699501013259,224,o
103,0211-699501013259,p,o
103,0211-699501013259,005,o
103,0211-699501013259,Han,o
103,0211-699501013259,recibido,o
103,0211-699501013259,suplementacion,i
103,0211-699501013259,durante,o
103,0211-699501013259,12,o
103,0211-699501013259,meses,o
103,0211-699501013259,33,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,pero,o
103,0211-699501013259,a,o
103,0211-699501013259,pesar,o
103,0211-699501013259,de,o
103,0211-699501013259,un,o
103,0211-699501013259,continuo,o
103,0211-699501013259,aumento,o
103,0211-699501013259,del,o
103,0211-699501013259,folato,i
103,0211-699501013259,10078,o
103,0211-699501013259,IC,o
103,0211-699501013259,7481,o
103,0211-699501013259,12674,o
103,0211-699501013259,p,o
103,0211-699501013259,0001,o
103,0211-699501013259,solo,o
103,0211-699501013259,3,o
103,0211-699501013259,pacientes,o
103,0211-699501013259,presentan,o
103,0211-699501013259,niveles,o
103,0211-699501013259,normales,o
103,0211-699501013259,de,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,correlacionandose,o
103,0211-699501013259,directamente,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,con,o
103,0211-699501013259,la,o
103,0211-699501013259,albumina,i
103,0211-699501013259,r,o
103,0211-699501013259,056,o
103,0211-699501013259,p,o
103,0211-699501013259,0001,o
103,0211-699501013259,que,o
103,0211-699501013259,se,o
103,0211-699501013259,elevo,o
103,0211-699501013259,con,o
103,0211-699501013259,respecto,o
103,0211-699501013259,al,o
103,0211-699501013259,inicio,o
103,0211-699501013259,337,o
103,0211-699501013259,IC,o
103,0211-699501013259,327,o
103,0211-699501013259,346,o
103,0211-699501013259,vs,o
103,0211-699501013259,350,o
103,0211-699501013259,IC,o
103,0211-699501013259,337,o
103,0211-699501013259,363,o
103,0211-699501013259,p,o
103,0211-699501013259,005,o
103,0211-699501013259,Conclusion,o
103,0211-699501013259,Tras,o
103,0211-699501013259,suplementacion,i
103,0211-699501013259,con,o
103,0211-699501013259,acido,i
103,0211-699501013259,folico,i
103,0211-699501013259,y,o
103,0211-699501013259,vitamina,i
103,0211-699501013259,B6,i
103,0211-699501013259,aunque,o
103,0211-699501013259,inicialmente,o
103,0211-699501013259,se,o
103,0211-699501013259,reduce,o
103,0211-699501013259,la,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,esta,o
103,0211-699501013259,respuesta,o
103,0211-699501013259,se,o
103,0211-699501013259,hace,o
103,0211-699501013259,refractaria,o
103,0211-699501013259,correlacionandose,o
103,0211-699501013259,directamente,o
103,0211-699501013259,la,o
103,0211-699501013259,tHcy,i
103,0211-699501013259,con,o
103,0211-699501013259,la,o
103,0211-699501013259,albumina,i
103,0211-699501013259,plasmatica,i
103,0211-699501013259,La,o
103,0211-699501013259,interpretacion,o
103,0211-699501013259,de,o
103,0211-699501013259,los,o
103,0211-699501013259,niveles,i
103,0211-699501013259,de,i
103,0211-699501013259,tHcy,i
103,0211-699501013259,debe,o
103,0211-699501013259,tener,o
103,0211-699501013259,en,o
103,0211-699501013259,cuenta,o
103,0211-699501013259,la,o
103,0211-699501013259,concentracion,i
103,0211-699501013259,de,i
103,0211-699501013259,albumina,i
104,0211-699501013259,Efecto,o
104,0211-699501013259,de,o
104,0211-699501013259,la,o
104,0211-699501013259,suplementacion,i
104,0211-699501013259,con,o
104,0211-699501013259,acido,i
104,0211-699501013259,folico,i
104,0211-699501013259,sobre,o
104,0211-699501013259,los,o
104,0211-699501013259,niveles,i
104,0211-699501013259,de,i
104,0211-699501013259,homocisteina,i
104,0211-699501013259,total,o
104,0211-699501013259,en,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,en,o
104,0211-699501013259,hemodialisis,i
104,0211-699501013259,La,o
104,0211-699501013259,hiperhomocisteinemia,i
104,0211-699501013259,es,o
104,0211-699501013259,un,o
104,0211-699501013259,marcador,o
104,0211-699501013259,de,o
104,0211-699501013259,riesgo,o
104,0211-699501013259,independiente,o
104,0211-699501013259,de,o
104,0211-699501013259,morbimortalidad,o
104,0211-699501013259,cardiovascular,i
104,0211-699501013259,Hemos,o
104,0211-699501013259,intentado,o
104,0211-699501013259,prospectivamente,o
104,0211-699501013259,reducir,o
104,0211-699501013259,los,o
104,0211-699501013259,niveles,i
104,0211-699501013259,de,i
104,0211-699501013259,homocisteina,i
104,0211-699501013259,total,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,mediante,o
104,0211-699501013259,suplemento,o
104,0211-699501013259,con,o
104,0211-699501013259,acido,i
104,0211-699501013259,folico,i
104,0211-699501013259,y,o
104,0211-699501013259,vitamina,i
104,0211-699501013259,B6,i
104,0211-699501013259,pp,i
104,0211-699501013259,valorando,o
104,0211-699501013259,su,o
104,0211-699501013259,posible,o
104,0211-699501013259,correlacion,o
104,0211-699501013259,con,o
104,0211-699501013259,dosis,o
104,0211-699501013259,de,o
104,0211-699501013259,dialisis,i
104,0211-699501013259,funcion,i
104,0211-699501013259,residual,i
104,0211-699501013259,y,o
104,0211-699501013259,parametros,o
104,0211-699501013259,nutricionales,o
104,0211-699501013259,Metodos,o
104,0211-699501013259,Todos,o
104,0211-699501013259,los,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,en,o
104,0211-699501013259,hemodialisis,i
104,0211-699501013259,al,o
104,0211-699501013259,comienzo,o
104,0211-699501013259,del,o
104,0211-699501013259,estudio,o
104,0211-699501013259,que,o
104,0211-699501013259,no,o
104,0211-699501013259,recibian,o
104,0211-699501013259,acido,i
104,0211-699501013259,folico,i
104,0211-699501013259,ni,o
104,0211-699501013259,vitamina,i
104,0211-699501013259,B6,i
104,0211-699501013259,asi,o
104,0211-699501013259,como,o
104,0211-699501013259,los,o
104,0211-699501013259,incorporados,o
104,0211-699501013259,posteriormente,o
104,0211-699501013259,a,o
104,0211-699501013259,partir,o
104,0211-699501013259,de,o
104,0211-699501013259,su,o
104,0211-699501013259,tercer,o
104,0211-699501013259,mes,o
104,0211-699501013259,en,o
104,0211-699501013259,hemodialisis,i
104,0211-699501013259,recibieron,o
104,0211-699501013259,5,o
104,0211-699501013259,mg,o
104,0211-699501013259,orales,o
104,0211-699501013259,de,o
104,0211-699501013259,acido,i
104,0211-699501013259,folico,i
104,0211-699501013259,cada,o
104,0211-699501013259,48,o
104,0211-699501013259,horas,o
104,0211-699501013259,y,o
104,0211-699501013259,40,o
104,0211-699501013259,mg,o
104,0211-699501013259,orales,o
104,0211-699501013259,de,o
104,0211-699501013259,vitamina,i
104,0211-699501013259,B6,i
104,0211-699501013259,cada,o
104,0211-699501013259,semana,o
104,0211-699501013259,Se,o
104,0211-699501013259,determinaron,o
104,0211-699501013259,al,o
104,0211-699501013259,comienzo,o
104,0211-699501013259,del,o
104,0211-699501013259,estudio,o
104,0211-699501013259,y,o
104,0211-699501013259,cada,o
104,0211-699501013259,2,o
104,0211-699501013259,meses,o
104,0211-699501013259,niveles,i
104,0211-699501013259,de,i
104,0211-699501013259,folato,i
104,0211-699501013259,vitamina,i
104,0211-699501013259,B12,i
104,0211-699501013259,inmunoensayo,i
104,0211-699501013259,albumina,i
104,0211-699501013259,y,o
104,0211-699501013259,cinetica,o
104,0211-699501013259,de,o
104,0211-699501013259,la,o
104,0211-699501013259,urea,i
104,0211-699501013259,KTV,o
104,0211-699501013259,KRU,o
104,0211-699501013259,PCRn,o
104,0211-699501013259,y,o
104,0211-699501013259,cada,o
104,0211-699501013259,6,o
104,0211-699501013259,meses,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,HPLC,i
104,0211-699501013259,y,o
104,0211-699501013259,pp,i
104,0211-699501013259,RIA,i
104,0211-699501013259,Resultados,o
104,0211-699501013259,80,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,fueron,o
104,0211-699501013259,incluidos,o
104,0211-699501013259,en,o
104,0211-699501013259,el,o
104,0211-699501013259,estudio,o
104,0211-699501013259,basal,o
104,0211-699501013259,con,o
104,0211-699501013259,una,o
104,0211-699501013259,prevalencia,o
104,0211-699501013259,de,o
104,0211-699501013259,hiperhomocisteinemia,i
104,0211-699501013259,del,o
104,0211-699501013259,844,o
104,0211-699501013259,deficit,i
104,0211-699501013259,de,i
104,0211-699501013259,pp,i
104,0211-699501013259,en,o
104,0211-699501013259,el,o
104,0211-699501013259,32,o
104,0211-699501013259,y,o
104,0211-699501013259,folato,i
104,0211-699501013259,en,o
104,0211-699501013259,el,o
104,0211-699501013259,rango,o
104,0211-699501013259,normal,o
104,0211-699501013259,bajo,o
104,0211-699501013259,los,o
104,0211-699501013259,niveles,i
104,0211-699501013259,de,i
104,0211-699501013259,tHcy,i
104,0211-699501013259,se,o
104,0211-699501013259,correlacionaban,o
104,0211-699501013259,inversamente,o
104,0211-699501013259,con,o
104,0211-699501013259,los,o
104,0211-699501013259,del,o
104,0211-699501013259,folato,i
104,0211-699501013259,r,o
104,0211-699501013259,0336,o
104,0211-699501013259,p,o
104,0211-699501013259,001,o
104,0211-699501013259,pero,o
104,0211-699501013259,no,o
104,0211-699501013259,con,o
104,0211-699501013259,pp,i
104,0211-699501013259,B12,i
104,0211-699501013259,edad,o
104,0211-699501013259,albumina,i
104,0211-699501013259,KTV,o
104,0211-699501013259,KRU,o
104,0211-699501013259,PCRn,o
104,0211-699501013259,Cincuenta,o
104,0211-699501013259,y,o
104,0211-699501013259,ocho,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,recibieron,o
104,0211-699501013259,seis,o
104,0211-699501013259,meses,o
104,0211-699501013259,de,o
104,0211-699501013259,suplementacion,i
104,0211-699501013259,con,o
104,0211-699501013259,normalizacion,o
104,0211-699501013259,del,o
104,0211-699501013259,pp,i
104,0211-699501013259,aumento,o
104,0211-699501013259,del,o
104,0211-699501013259,folato,i
104,0211-699501013259,703,o
104,0211-699501013259,IC,o
104,0211-699501013259,638,o
104,0211-699501013259,795,o
104,0211-699501013259,vs,o
104,0211-699501013259,6181,o
104,0211-699501013259,IC,o
104,0211-699501013259,4447,o
104,0211-699501013259,7811,o
104,0211-699501013259,p,o
104,0211-699501013259,0001,o
104,0211-699501013259,y,o
104,0211-699501013259,descenso,o
104,0211-699501013259,de,o
104,0211-699501013259,la,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,240,o
104,0211-699501013259,IC,o
104,0211-699501013259,213,o
104,0211-699501013259,264,o
104,0211-699501013259,vs,o
104,0211-699501013259,199,o
104,0211-699501013259,IC,o
104,0211-699501013259,175,o
104,0211-699501013259,224,o
104,0211-699501013259,p,o
104,0211-699501013259,005,o
104,0211-699501013259,Han,o
104,0211-699501013259,recibido,o
104,0211-699501013259,suplementacion,i
104,0211-699501013259,durante,o
104,0211-699501013259,12,o
104,0211-699501013259,meses,o
104,0211-699501013259,33,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,pero,o
104,0211-699501013259,a,o
104,0211-699501013259,pesar,o
104,0211-699501013259,de,o
104,0211-699501013259,un,o
104,0211-699501013259,continuo,o
104,0211-699501013259,aumento,o
104,0211-699501013259,del,o
104,0211-699501013259,folato,i
104,0211-699501013259,10078,o
104,0211-699501013259,IC,o
104,0211-699501013259,7481,o
104,0211-699501013259,12674,o
104,0211-699501013259,p,o
104,0211-699501013259,0001,o
104,0211-699501013259,solo,o
104,0211-699501013259,3,o
104,0211-699501013259,pacientes,o
104,0211-699501013259,presentan,o
104,0211-699501013259,niveles,o
104,0211-699501013259,normales,o
104,0211-699501013259,de,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,correlacionandose,o
104,0211-699501013259,directamente,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,con,o
104,0211-699501013259,la,o
104,0211-699501013259,albumina,i
104,0211-699501013259,r,o
104,0211-699501013259,056,o
104,0211-699501013259,p,o
104,0211-699501013259,0001,o
104,0211-699501013259,que,o
104,0211-699501013259,se,o
104,0211-699501013259,elevo,o
104,0211-699501013259,con,o
104,0211-699501013259,respecto,o
104,0211-699501013259,al,o
104,0211-699501013259,inicio,o
104,0211-699501013259,337,o
104,0211-699501013259,IC,o
104,0211-699501013259,327,o
104,0211-699501013259,346,o
104,0211-699501013259,vs,o
104,0211-699501013259,350,o
104,0211-699501013259,IC,o
104,0211-699501013259,337,o
104,0211-699501013259,363,o
104,0211-699501013259,p,o
104,0211-699501013259,005,o
104,0211-699501013259,Conclusion,o
104,0211-699501013259,Tras,o
104,0211-699501013259,suplementacion,i
104,0211-699501013259,con,o
104,0211-699501013259,acido,i
104,0211-699501013259,folico,i
104,0211-699501013259,y,o
104,0211-699501013259,vitamina,i
104,0211-699501013259,B6,i
104,0211-699501013259,aunque,o
104,0211-699501013259,inicialmente,o
104,0211-699501013259,se,o
104,0211-699501013259,reduce,o
104,0211-699501013259,la,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,esta,o
104,0211-699501013259,respuesta,o
104,0211-699501013259,se,o
104,0211-699501013259,hace,o
104,0211-699501013259,refractaria,o
104,0211-699501013259,correlacionandose,o
104,0211-699501013259,directamente,o
104,0211-699501013259,la,o
104,0211-699501013259,tHcy,i
104,0211-699501013259,con,o
104,0211-699501013259,la,o
104,0211-699501013259,albumina,i
104,0211-699501013259,plasmatica,i
104,0211-699501013259,La,o
104,0211-699501013259,interpretacion,o
104,0211-699501013259,de,o
104,0211-699501013259,los,o
104,0211-699501013259,niveles,i
104,0211-699501013259,de,i
104,0211-699501013259,tHcy,i
104,0211-699501013259,debe,o
104,0211-699501013259,tener,o
104,0211-699501013259,en,o
104,0211-699501013259,cuenta,o
104,0211-699501013259,la,o
104,0211-699501013259,concentracion,i
104,0211-699501013259,de,i
104,0211-699501013259,albumina,i
105,0211-699501013259,Efecto,o
105,0211-699501013259,de,o
105,0211-699501013259,la,o
105,0211-699501013259,suplementacion,i
105,0211-699501013259,con,o
105,0211-699501013259,acido,i
105,0211-699501013259,folico,i
105,0211-699501013259,sobre,o
105,0211-699501013259,los,o
105,0211-699501013259,niveles,i
105,0211-699501013259,de,i
105,0211-699501013259,homocisteina,i
105,0211-699501013259,total,o
105,0211-699501013259,en,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,en,o
105,0211-699501013259,hemodialisis,i
105,0211-699501013259,La,o
105,0211-699501013259,hiperhomocisteinemia,i
105,0211-699501013259,es,o
105,0211-699501013259,un,o
105,0211-699501013259,marcador,o
105,0211-699501013259,de,o
105,0211-699501013259,riesgo,o
105,0211-699501013259,independiente,o
105,0211-699501013259,de,o
105,0211-699501013259,morbimortalidad,o
105,0211-699501013259,cardiovascular,i
105,0211-699501013259,Hemos,o
105,0211-699501013259,intentado,o
105,0211-699501013259,prospectivamente,o
105,0211-699501013259,reducir,o
105,0211-699501013259,los,o
105,0211-699501013259,niveles,i
105,0211-699501013259,de,i
105,0211-699501013259,homocisteina,i
105,0211-699501013259,total,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,mediante,o
105,0211-699501013259,suplemento,o
105,0211-699501013259,con,o
105,0211-699501013259,acido,i
105,0211-699501013259,folico,i
105,0211-699501013259,y,o
105,0211-699501013259,vitamina,i
105,0211-699501013259,B6,i
105,0211-699501013259,pp,i
105,0211-699501013259,valorando,o
105,0211-699501013259,su,o
105,0211-699501013259,posible,o
105,0211-699501013259,correlacion,o
105,0211-699501013259,con,o
105,0211-699501013259,dosis,o
105,0211-699501013259,de,o
105,0211-699501013259,dialisis,i
105,0211-699501013259,funcion,i
105,0211-699501013259,residual,i
105,0211-699501013259,y,o
105,0211-699501013259,parametros,o
105,0211-699501013259,nutricionales,o
105,0211-699501013259,Metodos,o
105,0211-699501013259,Todos,o
105,0211-699501013259,los,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,en,o
105,0211-699501013259,hemodialisis,i
105,0211-699501013259,al,o
105,0211-699501013259,comienzo,o
105,0211-699501013259,del,o
105,0211-699501013259,estudio,o
105,0211-699501013259,que,o
105,0211-699501013259,no,o
105,0211-699501013259,recibian,o
105,0211-699501013259,acido,i
105,0211-699501013259,folico,i
105,0211-699501013259,ni,o
105,0211-699501013259,vitamina,i
105,0211-699501013259,B6,i
105,0211-699501013259,asi,o
105,0211-699501013259,como,o
105,0211-699501013259,los,o
105,0211-699501013259,incorporados,o
105,0211-699501013259,posteriormente,o
105,0211-699501013259,a,o
105,0211-699501013259,partir,o
105,0211-699501013259,de,o
105,0211-699501013259,su,o
105,0211-699501013259,tercer,o
105,0211-699501013259,mes,o
105,0211-699501013259,en,o
105,0211-699501013259,hemodialisis,i
105,0211-699501013259,recibieron,o
105,0211-699501013259,5,o
105,0211-699501013259,mg,o
105,0211-699501013259,orales,o
105,0211-699501013259,de,o
105,0211-699501013259,acido,i
105,0211-699501013259,folico,i
105,0211-699501013259,cada,o
105,0211-699501013259,48,o
105,0211-699501013259,horas,o
105,0211-699501013259,y,o
105,0211-699501013259,40,o
105,0211-699501013259,mg,o
105,0211-699501013259,orales,o
105,0211-699501013259,de,o
105,0211-699501013259,vitamina,i
105,0211-699501013259,B6,i
105,0211-699501013259,cada,o
105,0211-699501013259,semana,o
105,0211-699501013259,Se,o
105,0211-699501013259,determinaron,o
105,0211-699501013259,al,o
105,0211-699501013259,comienzo,o
105,0211-699501013259,del,o
105,0211-699501013259,estudio,o
105,0211-699501013259,y,o
105,0211-699501013259,cada,o
105,0211-699501013259,2,o
105,0211-699501013259,meses,o
105,0211-699501013259,niveles,i
105,0211-699501013259,de,i
105,0211-699501013259,folato,i
105,0211-699501013259,vitamina,i
105,0211-699501013259,B12,i
105,0211-699501013259,inmunoensayo,i
105,0211-699501013259,albumina,i
105,0211-699501013259,y,o
105,0211-699501013259,cinetica,o
105,0211-699501013259,de,o
105,0211-699501013259,la,o
105,0211-699501013259,urea,i
105,0211-699501013259,KTV,o
105,0211-699501013259,KRU,o
105,0211-699501013259,PCRn,o
105,0211-699501013259,y,o
105,0211-699501013259,cada,o
105,0211-699501013259,6,o
105,0211-699501013259,meses,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,HPLC,i
105,0211-699501013259,y,o
105,0211-699501013259,pp,i
105,0211-699501013259,RIA,i
105,0211-699501013259,Resultados,o
105,0211-699501013259,80,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,fueron,o
105,0211-699501013259,incluidos,o
105,0211-699501013259,en,o
105,0211-699501013259,el,o
105,0211-699501013259,estudio,o
105,0211-699501013259,basal,o
105,0211-699501013259,con,o
105,0211-699501013259,una,o
105,0211-699501013259,prevalencia,o
105,0211-699501013259,de,o
105,0211-699501013259,hiperhomocisteinemia,i
105,0211-699501013259,del,o
105,0211-699501013259,844,o
105,0211-699501013259,deficit,i
105,0211-699501013259,de,i
105,0211-699501013259,pp,i
105,0211-699501013259,en,o
105,0211-699501013259,el,o
105,0211-699501013259,32,o
105,0211-699501013259,y,o
105,0211-699501013259,folato,i
105,0211-699501013259,en,o
105,0211-699501013259,el,o
105,0211-699501013259,rango,o
105,0211-699501013259,normal,o
105,0211-699501013259,bajo,o
105,0211-699501013259,los,o
105,0211-699501013259,niveles,i
105,0211-699501013259,de,i
105,0211-699501013259,tHcy,i
105,0211-699501013259,se,o
105,0211-699501013259,correlacionaban,o
105,0211-699501013259,inversamente,o
105,0211-699501013259,con,o
105,0211-699501013259,los,o
105,0211-699501013259,del,o
105,0211-699501013259,folato,i
105,0211-699501013259,r,o
105,0211-699501013259,0336,o
105,0211-699501013259,p,o
105,0211-699501013259,001,o
105,0211-699501013259,pero,o
105,0211-699501013259,no,o
105,0211-699501013259,con,o
105,0211-699501013259,pp,i
105,0211-699501013259,B12,i
105,0211-699501013259,edad,o
105,0211-699501013259,albumina,i
105,0211-699501013259,KTV,o
105,0211-699501013259,KRU,o
105,0211-699501013259,PCRn,o
105,0211-699501013259,Cincuenta,o
105,0211-699501013259,y,o
105,0211-699501013259,ocho,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,recibieron,o
105,0211-699501013259,seis,o
105,0211-699501013259,meses,o
105,0211-699501013259,de,o
105,0211-699501013259,suplementacion,i
105,0211-699501013259,con,o
105,0211-699501013259,normalizacion,o
105,0211-699501013259,del,o
105,0211-699501013259,pp,i
105,0211-699501013259,aumento,o
105,0211-699501013259,del,o
105,0211-699501013259,folato,i
105,0211-699501013259,703,o
105,0211-699501013259,IC,o
105,0211-699501013259,638,o
105,0211-699501013259,795,o
105,0211-699501013259,vs,o
105,0211-699501013259,6181,o
105,0211-699501013259,IC,o
105,0211-699501013259,4447,o
105,0211-699501013259,7811,o
105,0211-699501013259,p,o
105,0211-699501013259,0001,o
105,0211-699501013259,y,o
105,0211-699501013259,descenso,o
105,0211-699501013259,de,o
105,0211-699501013259,la,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,240,o
105,0211-699501013259,IC,o
105,0211-699501013259,213,o
105,0211-699501013259,264,o
105,0211-699501013259,vs,o
105,0211-699501013259,199,o
105,0211-699501013259,IC,o
105,0211-699501013259,175,o
105,0211-699501013259,224,o
105,0211-699501013259,p,o
105,0211-699501013259,005,o
105,0211-699501013259,Han,o
105,0211-699501013259,recibido,o
105,0211-699501013259,suplementacion,i
105,0211-699501013259,durante,o
105,0211-699501013259,12,o
105,0211-699501013259,meses,o
105,0211-699501013259,33,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,pero,o
105,0211-699501013259,a,o
105,0211-699501013259,pesar,o
105,0211-699501013259,de,o
105,0211-699501013259,un,o
105,0211-699501013259,continuo,o
105,0211-699501013259,aumento,o
105,0211-699501013259,del,o
105,0211-699501013259,folato,i
105,0211-699501013259,10078,o
105,0211-699501013259,IC,o
105,0211-699501013259,7481,o
105,0211-699501013259,12674,o
105,0211-699501013259,p,o
105,0211-699501013259,0001,o
105,0211-699501013259,solo,o
105,0211-699501013259,3,o
105,0211-699501013259,pacientes,o
105,0211-699501013259,presentan,o
105,0211-699501013259,niveles,o
105,0211-699501013259,normales,o
105,0211-699501013259,de,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,correlacionandose,o
105,0211-699501013259,directamente,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,con,o
105,0211-699501013259,la,o
105,0211-699501013259,albumina,i
105,0211-699501013259,r,o
105,0211-699501013259,056,o
105,0211-699501013259,p,o
105,0211-699501013259,0001,o
105,0211-699501013259,que,o
105,0211-699501013259,se,o
105,0211-699501013259,elevo,o
105,0211-699501013259,con,o
105,0211-699501013259,respecto,o
105,0211-699501013259,al,o
105,0211-699501013259,inicio,o
105,0211-699501013259,337,o
105,0211-699501013259,IC,o
105,0211-699501013259,327,o
105,0211-699501013259,346,o
105,0211-699501013259,vs,o
105,0211-699501013259,350,o
105,0211-699501013259,IC,o
105,0211-699501013259,337,o
105,0211-699501013259,363,o
105,0211-699501013259,p,o
105,0211-699501013259,005,o
105,0211-699501013259,Conclusion,o
105,0211-699501013259,Tras,o
105,0211-699501013259,suplementacion,i
105,0211-699501013259,con,o
105,0211-699501013259,acido,i
105,0211-699501013259,folico,i
105,0211-699501013259,y,o
105,0211-699501013259,vitamina,i
105,0211-699501013259,B6,i
105,0211-699501013259,aunque,o
105,0211-699501013259,inicialmente,o
105,0211-699501013259,se,o
105,0211-699501013259,reduce,o
105,0211-699501013259,la,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,esta,o
105,0211-699501013259,respuesta,o
105,0211-699501013259,se,o
105,0211-699501013259,hace,o
105,0211-699501013259,refractaria,o
105,0211-699501013259,correlacionandose,o
105,0211-699501013259,directamente,o
105,0211-699501013259,la,o
105,0211-699501013259,tHcy,i
105,0211-699501013259,con,o
105,0211-699501013259,la,o
105,0211-699501013259,albumina,i
105,0211-699501013259,plasmatica,i
105,0211-699501013259,La,o
105,0211-699501013259,interpretacion,o
105,0211-699501013259,de,o
105,0211-699501013259,los,o
105,0211-699501013259,niveles,i
105,0211-699501013259,de,i
105,0211-699501013259,tHcy,i
105,0211-699501013259,debe,o
105,0211-699501013259,tener,o
105,0211-699501013259,en,o
105,0211-699501013259,cuenta,o
105,0211-699501013259,la,o
105,0211-699501013259,concentracion,i
105,0211-699501013259,de,i
105,0211-699501013259,albumina,i
106,0211-699501013259,Efecto,o
106,0211-699501013259,de,o
106,0211-699501013259,la,o
106,0211-699501013259,suplementacion,i
106,0211-699501013259,con,o
106,0211-699501013259,acido,i
106,0211-699501013259,folico,i
106,0211-699501013259,sobre,o
106,0211-699501013259,los,o
106,0211-699501013259,niveles,i
106,0211-699501013259,de,i
106,0211-699501013259,homocisteina,i
106,0211-699501013259,total,o
106,0211-699501013259,en,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,en,o
106,0211-699501013259,hemodialisis,i
106,0211-699501013259,La,o
106,0211-699501013259,hiperhomocisteinemia,i
106,0211-699501013259,es,o
106,0211-699501013259,un,o
106,0211-699501013259,marcador,o
106,0211-699501013259,de,o
106,0211-699501013259,riesgo,o
106,0211-699501013259,independiente,o
106,0211-699501013259,de,o
106,0211-699501013259,morbimortalidad,o
106,0211-699501013259,cardiovascular,i
106,0211-699501013259,Hemos,o
106,0211-699501013259,intentado,o
106,0211-699501013259,prospectivamente,o
106,0211-699501013259,reducir,o
106,0211-699501013259,los,o
106,0211-699501013259,niveles,i
106,0211-699501013259,de,i
106,0211-699501013259,homocisteina,i
106,0211-699501013259,total,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,mediante,o
106,0211-699501013259,suplemento,o
106,0211-699501013259,con,o
106,0211-699501013259,acido,i
106,0211-699501013259,folico,i
106,0211-699501013259,y,o
106,0211-699501013259,vitamina,i
106,0211-699501013259,B6,i
106,0211-699501013259,pp,i
106,0211-699501013259,valorando,o
106,0211-699501013259,su,o
106,0211-699501013259,posible,o
106,0211-699501013259,correlacion,o
106,0211-699501013259,con,o
106,0211-699501013259,dosis,o
106,0211-699501013259,de,o
106,0211-699501013259,dialisis,i
106,0211-699501013259,funcion,i
106,0211-699501013259,residual,i
106,0211-699501013259,y,o
106,0211-699501013259,parametros,o
106,0211-699501013259,nutricionales,o
106,0211-699501013259,Metodos,o
106,0211-699501013259,Todos,o
106,0211-699501013259,los,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,en,o
106,0211-699501013259,hemodialisis,i
106,0211-699501013259,al,o
106,0211-699501013259,comienzo,o
106,0211-699501013259,del,o
106,0211-699501013259,estudio,o
106,0211-699501013259,que,o
106,0211-699501013259,no,o
106,0211-699501013259,recibian,o
106,0211-699501013259,acido,i
106,0211-699501013259,folico,i
106,0211-699501013259,ni,o
106,0211-699501013259,vitamina,i
106,0211-699501013259,B6,i
106,0211-699501013259,asi,o
106,0211-699501013259,como,o
106,0211-699501013259,los,o
106,0211-699501013259,incorporados,o
106,0211-699501013259,posteriormente,o
106,0211-699501013259,a,o
106,0211-699501013259,partir,o
106,0211-699501013259,de,o
106,0211-699501013259,su,o
106,0211-699501013259,tercer,o
106,0211-699501013259,mes,o
106,0211-699501013259,en,o
106,0211-699501013259,hemodialisis,i
106,0211-699501013259,recibieron,o
106,0211-699501013259,5,o
106,0211-699501013259,mg,o
106,0211-699501013259,orales,o
106,0211-699501013259,de,o
106,0211-699501013259,acido,i
106,0211-699501013259,folico,i
106,0211-699501013259,cada,o
106,0211-699501013259,48,o
106,0211-699501013259,horas,o
106,0211-699501013259,y,o
106,0211-699501013259,40,o
106,0211-699501013259,mg,o
106,0211-699501013259,orales,o
106,0211-699501013259,de,o
106,0211-699501013259,vitamina,i
106,0211-699501013259,B6,i
106,0211-699501013259,cada,o
106,0211-699501013259,semana,o
106,0211-699501013259,Se,o
106,0211-699501013259,determinaron,o
106,0211-699501013259,al,o
106,0211-699501013259,comienzo,o
106,0211-699501013259,del,o
106,0211-699501013259,estudio,o
106,0211-699501013259,y,o
106,0211-699501013259,cada,o
106,0211-699501013259,2,o
106,0211-699501013259,meses,o
106,0211-699501013259,niveles,i
106,0211-699501013259,de,i
106,0211-699501013259,folato,i
106,0211-699501013259,vitamina,i
106,0211-699501013259,B12,i
106,0211-699501013259,inmunoensayo,i
106,0211-699501013259,albumina,i
106,0211-699501013259,y,o
106,0211-699501013259,cinetica,o
106,0211-699501013259,de,o
106,0211-699501013259,la,o
106,0211-699501013259,urea,i
106,0211-699501013259,KTV,o
106,0211-699501013259,KRU,o
106,0211-699501013259,PCRn,o
106,0211-699501013259,y,o
106,0211-699501013259,cada,o
106,0211-699501013259,6,o
106,0211-699501013259,meses,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,HPLC,i
106,0211-699501013259,y,o
106,0211-699501013259,pp,i
106,0211-699501013259,RIA,i
106,0211-699501013259,Resultados,o
106,0211-699501013259,80,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,fueron,o
106,0211-699501013259,incluidos,o
106,0211-699501013259,en,o
106,0211-699501013259,el,o
106,0211-699501013259,estudio,o
106,0211-699501013259,basal,o
106,0211-699501013259,con,o
106,0211-699501013259,una,o
106,0211-699501013259,prevalencia,o
106,0211-699501013259,de,o
106,0211-699501013259,hiperhomocisteinemia,i
106,0211-699501013259,del,o
106,0211-699501013259,844,o
106,0211-699501013259,deficit,i
106,0211-699501013259,de,i
106,0211-699501013259,pp,i
106,0211-699501013259,en,o
106,0211-699501013259,el,o
106,0211-699501013259,32,o
106,0211-699501013259,y,o
106,0211-699501013259,folato,i
106,0211-699501013259,en,o
106,0211-699501013259,el,o
106,0211-699501013259,rango,o
106,0211-699501013259,normal,o
106,0211-699501013259,bajo,o
106,0211-699501013259,los,o
106,0211-699501013259,niveles,i
106,0211-699501013259,de,i
106,0211-699501013259,tHcy,i
106,0211-699501013259,se,o
106,0211-699501013259,correlacionaban,o
106,0211-699501013259,inversamente,o
106,0211-699501013259,con,o
106,0211-699501013259,los,o
106,0211-699501013259,del,o
106,0211-699501013259,folato,i
106,0211-699501013259,r,o
106,0211-699501013259,0336,o
106,0211-699501013259,p,o
106,0211-699501013259,001,o
106,0211-699501013259,pero,o
106,0211-699501013259,no,o
106,0211-699501013259,con,o
106,0211-699501013259,pp,i
106,0211-699501013259,B12,i
106,0211-699501013259,edad,o
106,0211-699501013259,albumina,i
106,0211-699501013259,KTV,o
106,0211-699501013259,KRU,o
106,0211-699501013259,PCRn,o
106,0211-699501013259,Cincuenta,o
106,0211-699501013259,y,o
106,0211-699501013259,ocho,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,recibieron,o
106,0211-699501013259,seis,o
106,0211-699501013259,meses,o
106,0211-699501013259,de,o
106,0211-699501013259,suplementacion,i
106,0211-699501013259,con,o
106,0211-699501013259,normalizacion,o
106,0211-699501013259,del,o
106,0211-699501013259,pp,i
106,0211-699501013259,aumento,o
106,0211-699501013259,del,o
106,0211-699501013259,folato,i
106,0211-699501013259,703,o
106,0211-699501013259,IC,o
106,0211-699501013259,638,o
106,0211-699501013259,795,o
106,0211-699501013259,vs,o
106,0211-699501013259,6181,o
106,0211-699501013259,IC,o
106,0211-699501013259,4447,o
106,0211-699501013259,7811,o
106,0211-699501013259,p,o
106,0211-699501013259,0001,o
106,0211-699501013259,y,o
106,0211-699501013259,descenso,o
106,0211-699501013259,de,o
106,0211-699501013259,la,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,240,o
106,0211-699501013259,IC,o
106,0211-699501013259,213,o
106,0211-699501013259,264,o
106,0211-699501013259,vs,o
106,0211-699501013259,199,o
106,0211-699501013259,IC,o
106,0211-699501013259,175,o
106,0211-699501013259,224,o
106,0211-699501013259,p,o
106,0211-699501013259,005,o
106,0211-699501013259,Han,o
106,0211-699501013259,recibido,o
106,0211-699501013259,suplementacion,i
106,0211-699501013259,durante,o
106,0211-699501013259,12,o
106,0211-699501013259,meses,o
106,0211-699501013259,33,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,pero,o
106,0211-699501013259,a,o
106,0211-699501013259,pesar,o
106,0211-699501013259,de,o
106,0211-699501013259,un,o
106,0211-699501013259,continuo,o
106,0211-699501013259,aumento,o
106,0211-699501013259,del,o
106,0211-699501013259,folato,i
106,0211-699501013259,10078,o
106,0211-699501013259,IC,o
106,0211-699501013259,7481,o
106,0211-699501013259,12674,o
106,0211-699501013259,p,o
106,0211-699501013259,0001,o
106,0211-699501013259,solo,o
106,0211-699501013259,3,o
106,0211-699501013259,pacientes,o
106,0211-699501013259,presentan,o
106,0211-699501013259,niveles,o
106,0211-699501013259,normales,o
106,0211-699501013259,de,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,correlacionandose,o
106,0211-699501013259,directamente,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,con,o
106,0211-699501013259,la,o
106,0211-699501013259,albumina,i
106,0211-699501013259,r,o
106,0211-699501013259,056,o
106,0211-699501013259,p,o
106,0211-699501013259,0001,o
106,0211-699501013259,que,o
106,0211-699501013259,se,o
106,0211-699501013259,elevo,o
106,0211-699501013259,con,o
106,0211-699501013259,respecto,o
106,0211-699501013259,al,o
106,0211-699501013259,inicio,o
106,0211-699501013259,337,o
106,0211-699501013259,IC,o
106,0211-699501013259,327,o
106,0211-699501013259,346,o
106,0211-699501013259,vs,o
106,0211-699501013259,350,o
106,0211-699501013259,IC,o
106,0211-699501013259,337,o
106,0211-699501013259,363,o
106,0211-699501013259,p,o
106,0211-699501013259,005,o
106,0211-699501013259,Conclusion,o
106,0211-699501013259,Tras,o
106,0211-699501013259,suplementacion,i
106,0211-699501013259,con,o
106,0211-699501013259,acido,i
106,0211-699501013259,folico,i
106,0211-699501013259,y,o
106,0211-699501013259,vitamina,i
106,0211-699501013259,B6,i
106,0211-699501013259,aunque,o
106,0211-699501013259,inicialmente,o
106,0211-699501013259,se,o
106,0211-699501013259,reduce,o
106,0211-699501013259,la,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,esta,o
106,0211-699501013259,respuesta,o
106,0211-699501013259,se,o
106,0211-699501013259,hace,o
106,0211-699501013259,refractaria,o
106,0211-699501013259,correlacionandose,o
106,0211-699501013259,directamente,o
106,0211-699501013259,la,o
106,0211-699501013259,tHcy,i
106,0211-699501013259,con,o
106,0211-699501013259,la,o
106,0211-699501013259,albumina,i
106,0211-699501013259,plasmatica,i
106,0211-699501013259,La,o
106,0211-699501013259,interpretacion,o
106,0211-699501013259,de,o
106,0211-699501013259,los,o
106,0211-699501013259,niveles,i
106,0211-699501013259,de,i
106,0211-699501013259,tHcy,i
106,0211-699501013259,debe,o
106,0211-699501013259,tener,o
106,0211-699501013259,en,o
106,0211-699501013259,cuenta,o
106,0211-699501013259,la,o
106,0211-699501013259,concentracion,i
106,0211-699501013259,de,i
106,0211-699501013259,albumina,i
107,0211-699501013259,Efecto,o
107,0211-699501013259,de,o
107,0211-699501013259,la,o
107,0211-699501013259,suplementacion,i
107,0211-699501013259,con,o
107,0211-699501013259,acido,i
107,0211-699501013259,folico,i
107,0211-699501013259,sobre,o
107,0211-699501013259,los,o
107,0211-699501013259,niveles,i
107,0211-699501013259,de,i
107,0211-699501013259,homocisteina,i
107,0211-699501013259,total,o
107,0211-699501013259,en,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,en,o
107,0211-699501013259,hemodialisis,i
107,0211-699501013259,La,o
107,0211-699501013259,hiperhomocisteinemia,i
107,0211-699501013259,es,o
107,0211-699501013259,un,o
107,0211-699501013259,marcador,o
107,0211-699501013259,de,o
107,0211-699501013259,riesgo,o
107,0211-699501013259,independiente,o
107,0211-699501013259,de,o
107,0211-699501013259,morbimortalidad,o
107,0211-699501013259,cardiovascular,i
107,0211-699501013259,Hemos,o
107,0211-699501013259,intentado,o
107,0211-699501013259,prospectivamente,o
107,0211-699501013259,reducir,o
107,0211-699501013259,los,o
107,0211-699501013259,niveles,i
107,0211-699501013259,de,i
107,0211-699501013259,homocisteina,i
107,0211-699501013259,total,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,mediante,o
107,0211-699501013259,suplemento,o
107,0211-699501013259,con,o
107,0211-699501013259,acido,i
107,0211-699501013259,folico,i
107,0211-699501013259,y,o
107,0211-699501013259,vitamina,i
107,0211-699501013259,B6,i
107,0211-699501013259,pp,i
107,0211-699501013259,valorando,o
107,0211-699501013259,su,o
107,0211-699501013259,posible,o
107,0211-699501013259,correlacion,o
107,0211-699501013259,con,o
107,0211-699501013259,dosis,o
107,0211-699501013259,de,o
107,0211-699501013259,dialisis,i
107,0211-699501013259,funcion,i
107,0211-699501013259,residual,i
107,0211-699501013259,y,o
107,0211-699501013259,parametros,o
107,0211-699501013259,nutricionales,o
107,0211-699501013259,Metodos,o
107,0211-699501013259,Todos,o
107,0211-699501013259,los,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,en,o
107,0211-699501013259,hemodialisis,i
107,0211-699501013259,al,o
107,0211-699501013259,comienzo,o
107,0211-699501013259,del,o
107,0211-699501013259,estudio,o
107,0211-699501013259,que,o
107,0211-699501013259,no,o
107,0211-699501013259,recibian,o
107,0211-699501013259,acido,i
107,0211-699501013259,folico,i
107,0211-699501013259,ni,o
107,0211-699501013259,vitamina,i
107,0211-699501013259,B6,i
107,0211-699501013259,asi,o
107,0211-699501013259,como,o
107,0211-699501013259,los,o
107,0211-699501013259,incorporados,o
107,0211-699501013259,posteriormente,o
107,0211-699501013259,a,o
107,0211-699501013259,partir,o
107,0211-699501013259,de,o
107,0211-699501013259,su,o
107,0211-699501013259,tercer,o
107,0211-699501013259,mes,o
107,0211-699501013259,en,o
107,0211-699501013259,hemodialisis,i
107,0211-699501013259,recibieron,o
107,0211-699501013259,5,o
107,0211-699501013259,mg,o
107,0211-699501013259,orales,o
107,0211-699501013259,de,o
107,0211-699501013259,acido,i
107,0211-699501013259,folico,i
107,0211-699501013259,cada,o
107,0211-699501013259,48,o
107,0211-699501013259,horas,o
107,0211-699501013259,y,o
107,0211-699501013259,40,o
107,0211-699501013259,mg,o
107,0211-699501013259,orales,o
107,0211-699501013259,de,o
107,0211-699501013259,vitamina,i
107,0211-699501013259,B6,i
107,0211-699501013259,cada,o
107,0211-699501013259,semana,o
107,0211-699501013259,Se,o
107,0211-699501013259,determinaron,o
107,0211-699501013259,al,o
107,0211-699501013259,comienzo,o
107,0211-699501013259,del,o
107,0211-699501013259,estudio,o
107,0211-699501013259,y,o
107,0211-699501013259,cada,o
107,0211-699501013259,2,o
107,0211-699501013259,meses,o
107,0211-699501013259,niveles,i
107,0211-699501013259,de,i
107,0211-699501013259,folato,i
107,0211-699501013259,vitamina,i
107,0211-699501013259,B12,i
107,0211-699501013259,inmunoensayo,i
107,0211-699501013259,albumina,i
107,0211-699501013259,y,o
107,0211-699501013259,cinetica,o
107,0211-699501013259,de,o
107,0211-699501013259,la,o
107,0211-699501013259,urea,i
107,0211-699501013259,KTV,o
107,0211-699501013259,KRU,o
107,0211-699501013259,PCRn,o
107,0211-699501013259,y,o
107,0211-699501013259,cada,o
107,0211-699501013259,6,o
107,0211-699501013259,meses,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,HPLC,i
107,0211-699501013259,y,o
107,0211-699501013259,pp,i
107,0211-699501013259,RIA,i
107,0211-699501013259,Resultados,o
107,0211-699501013259,80,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,fueron,o
107,0211-699501013259,incluidos,o
107,0211-699501013259,en,o
107,0211-699501013259,el,o
107,0211-699501013259,estudio,o
107,0211-699501013259,basal,o
107,0211-699501013259,con,o
107,0211-699501013259,una,o
107,0211-699501013259,prevalencia,o
107,0211-699501013259,de,o
107,0211-699501013259,hiperhomocisteinemia,i
107,0211-699501013259,del,o
107,0211-699501013259,844,o
107,0211-699501013259,deficit,i
107,0211-699501013259,de,i
107,0211-699501013259,pp,i
107,0211-699501013259,en,o
107,0211-699501013259,el,o
107,0211-699501013259,32,o
107,0211-699501013259,y,o
107,0211-699501013259,folato,i
107,0211-699501013259,en,o
107,0211-699501013259,el,o
107,0211-699501013259,rango,o
107,0211-699501013259,normal,o
107,0211-699501013259,bajo,o
107,0211-699501013259,los,o
107,0211-699501013259,niveles,i
107,0211-699501013259,de,i
107,0211-699501013259,tHcy,i
107,0211-699501013259,se,o
107,0211-699501013259,correlacionaban,o
107,0211-699501013259,inversamente,o
107,0211-699501013259,con,o
107,0211-699501013259,los,o
107,0211-699501013259,del,o
107,0211-699501013259,folato,i
107,0211-699501013259,r,o
107,0211-699501013259,0336,o
107,0211-699501013259,p,o
107,0211-699501013259,001,o
107,0211-699501013259,pero,o
107,0211-699501013259,no,o
107,0211-699501013259,con,o
107,0211-699501013259,pp,i
107,0211-699501013259,B12,i
107,0211-699501013259,edad,o
107,0211-699501013259,albumina,i
107,0211-699501013259,KTV,o
107,0211-699501013259,KRU,o
107,0211-699501013259,PCRn,o
107,0211-699501013259,Cincuenta,o
107,0211-699501013259,y,o
107,0211-699501013259,ocho,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,recibieron,o
107,0211-699501013259,seis,o
107,0211-699501013259,meses,o
107,0211-699501013259,de,o
107,0211-699501013259,suplementacion,i
107,0211-699501013259,con,o
107,0211-699501013259,normalizacion,o
107,0211-699501013259,del,o
107,0211-699501013259,pp,i
107,0211-699501013259,aumento,o
107,0211-699501013259,del,o
107,0211-699501013259,folato,i
107,0211-699501013259,703,o
107,0211-699501013259,IC,o
107,0211-699501013259,638,o
107,0211-699501013259,795,o
107,0211-699501013259,vs,o
107,0211-699501013259,6181,o
107,0211-699501013259,IC,o
107,0211-699501013259,4447,o
107,0211-699501013259,7811,o
107,0211-699501013259,p,o
107,0211-699501013259,0001,o
107,0211-699501013259,y,o
107,0211-699501013259,descenso,o
107,0211-699501013259,de,o
107,0211-699501013259,la,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,240,o
107,0211-699501013259,IC,o
107,0211-699501013259,213,o
107,0211-699501013259,264,o
107,0211-699501013259,vs,o
107,0211-699501013259,199,o
107,0211-699501013259,IC,o
107,0211-699501013259,175,o
107,0211-699501013259,224,o
107,0211-699501013259,p,o
107,0211-699501013259,005,o
107,0211-699501013259,Han,o
107,0211-699501013259,recibido,o
107,0211-699501013259,suplementacion,i
107,0211-699501013259,durante,o
107,0211-699501013259,12,o
107,0211-699501013259,meses,o
107,0211-699501013259,33,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,pero,o
107,0211-699501013259,a,o
107,0211-699501013259,pesar,o
107,0211-699501013259,de,o
107,0211-699501013259,un,o
107,0211-699501013259,continuo,o
107,0211-699501013259,aumento,o
107,0211-699501013259,del,o
107,0211-699501013259,folato,i
107,0211-699501013259,10078,o
107,0211-699501013259,IC,o
107,0211-699501013259,7481,o
107,0211-699501013259,12674,o
107,0211-699501013259,p,o
107,0211-699501013259,0001,o
107,0211-699501013259,solo,o
107,0211-699501013259,3,o
107,0211-699501013259,pacientes,o
107,0211-699501013259,presentan,o
107,0211-699501013259,niveles,o
107,0211-699501013259,normales,o
107,0211-699501013259,de,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,correlacionandose,o
107,0211-699501013259,directamente,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,con,o
107,0211-699501013259,la,o
107,0211-699501013259,albumina,i
107,0211-699501013259,r,o
107,0211-699501013259,056,o
107,0211-699501013259,p,o
107,0211-699501013259,0001,o
107,0211-699501013259,que,o
107,0211-699501013259,se,o
107,0211-699501013259,elevo,o
107,0211-699501013259,con,o
107,0211-699501013259,respecto,o
107,0211-699501013259,al,o
107,0211-699501013259,inicio,o
107,0211-699501013259,337,o
107,0211-699501013259,IC,o
107,0211-699501013259,327,o
107,0211-699501013259,346,o
107,0211-699501013259,vs,o
107,0211-699501013259,350,o
107,0211-699501013259,IC,o
107,0211-699501013259,337,o
107,0211-699501013259,363,o
107,0211-699501013259,p,o
107,0211-699501013259,005,o
107,0211-699501013259,Conclusion,o
107,0211-699501013259,Tras,o
107,0211-699501013259,suplementacion,i
107,0211-699501013259,con,o
107,0211-699501013259,acido,i
107,0211-699501013259,folico,i
107,0211-699501013259,y,o
107,0211-699501013259,vitamina,i
107,0211-699501013259,B6,i
107,0211-699501013259,aunque,o
107,0211-699501013259,inicialmente,o
107,0211-699501013259,se,o
107,0211-699501013259,reduce,o
107,0211-699501013259,la,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,esta,o
107,0211-699501013259,respuesta,o
107,0211-699501013259,se,o
107,0211-699501013259,hace,o
107,0211-699501013259,refractaria,o
107,0211-699501013259,correlacionandose,o
107,0211-699501013259,directamente,o
107,0211-699501013259,la,o
107,0211-699501013259,tHcy,i
107,0211-699501013259,con,o
107,0211-699501013259,la,o
107,0211-699501013259,albumina,i
107,0211-699501013259,plasmatica,i
107,0211-699501013259,La,o
107,0211-699501013259,interpretacion,o
107,0211-699501013259,de,o
107,0211-699501013259,los,o
107,0211-699501013259,niveles,i
107,0211-699501013259,de,i
107,0211-699501013259,tHcy,i
107,0211-699501013259,debe,o
107,0211-699501013259,tener,o
107,0211-699501013259,en,o
107,0211-699501013259,cuenta,o
107,0211-699501013259,la,o
107,0211-699501013259,concentracion,i
107,0211-699501013259,de,i
107,0211-699501013259,albumina,i
108,0211-699501013259,Efecto,o
108,0211-699501013259,de,o
108,0211-699501013259,la,o
108,0211-699501013259,suplementacion,i
108,0211-699501013259,con,o
108,0211-699501013259,acido,i
108,0211-699501013259,folico,i
108,0211-699501013259,sobre,o
108,0211-699501013259,los,o
108,0211-699501013259,niveles,i
108,0211-699501013259,de,i
108,0211-699501013259,homocisteina,i
108,0211-699501013259,total,o
108,0211-699501013259,en,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,en,o
108,0211-699501013259,hemodialisis,i
108,0211-699501013259,La,o
108,0211-699501013259,hiperhomocisteinemia,i
108,0211-699501013259,es,o
108,0211-699501013259,un,o
108,0211-699501013259,marcador,o
108,0211-699501013259,de,o
108,0211-699501013259,riesgo,o
108,0211-699501013259,independiente,o
108,0211-699501013259,de,o
108,0211-699501013259,morbimortalidad,o
108,0211-699501013259,cardiovascular,i
108,0211-699501013259,Hemos,o
108,0211-699501013259,intentado,o
108,0211-699501013259,prospectivamente,o
108,0211-699501013259,reducir,o
108,0211-699501013259,los,o
108,0211-699501013259,niveles,i
108,0211-699501013259,de,i
108,0211-699501013259,homocisteina,i
108,0211-699501013259,total,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,mediante,o
108,0211-699501013259,suplemento,o
108,0211-699501013259,con,o
108,0211-699501013259,acido,i
108,0211-699501013259,folico,i
108,0211-699501013259,y,o
108,0211-699501013259,vitamina,i
108,0211-699501013259,B6,i
108,0211-699501013259,pp,i
108,0211-699501013259,valorando,o
108,0211-699501013259,su,o
108,0211-699501013259,posible,o
108,0211-699501013259,correlacion,o
108,0211-699501013259,con,o
108,0211-699501013259,dosis,o
108,0211-699501013259,de,o
108,0211-699501013259,dialisis,i
108,0211-699501013259,funcion,i
108,0211-699501013259,residual,i
108,0211-699501013259,y,o
108,0211-699501013259,parametros,o
108,0211-699501013259,nutricionales,o
108,0211-699501013259,Metodos,o
108,0211-699501013259,Todos,o
108,0211-699501013259,los,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,en,o
108,0211-699501013259,hemodialisis,i
108,0211-699501013259,al,o
108,0211-699501013259,comienzo,o
108,0211-699501013259,del,o
108,0211-699501013259,estudio,o
108,0211-699501013259,que,o
108,0211-699501013259,no,o
108,0211-699501013259,recibian,o
108,0211-699501013259,acido,i
108,0211-699501013259,folico,i
108,0211-699501013259,ni,o
108,0211-699501013259,vitamina,i
108,0211-699501013259,B6,i
108,0211-699501013259,asi,o
108,0211-699501013259,como,o
108,0211-699501013259,los,o
108,0211-699501013259,incorporados,o
108,0211-699501013259,posteriormente,o
108,0211-699501013259,a,o
108,0211-699501013259,partir,o
108,0211-699501013259,de,o
108,0211-699501013259,su,o
108,0211-699501013259,tercer,o
108,0211-699501013259,mes,o
108,0211-699501013259,en,o
108,0211-699501013259,hemodialisis,i
108,0211-699501013259,recibieron,o
108,0211-699501013259,5,o
108,0211-699501013259,mg,o
108,0211-699501013259,orales,o
108,0211-699501013259,de,o
108,0211-699501013259,acido,i
108,0211-699501013259,folico,i
108,0211-699501013259,cada,o
108,0211-699501013259,48,o
108,0211-699501013259,horas,o
108,0211-699501013259,y,o
108,0211-699501013259,40,o
108,0211-699501013259,mg,o
108,0211-699501013259,orales,o
108,0211-699501013259,de,o
108,0211-699501013259,vitamina,i
108,0211-699501013259,B6,i
108,0211-699501013259,cada,o
108,0211-699501013259,semana,o
108,0211-699501013259,Se,o
108,0211-699501013259,determinaron,o
108,0211-699501013259,al,o
108,0211-699501013259,comienzo,o
108,0211-699501013259,del,o
108,0211-699501013259,estudio,o
108,0211-699501013259,y,o
108,0211-699501013259,cada,o
108,0211-699501013259,2,o
108,0211-699501013259,meses,o
108,0211-699501013259,niveles,i
108,0211-699501013259,de,i
108,0211-699501013259,folato,i
108,0211-699501013259,vitamina,i
108,0211-699501013259,B12,i
108,0211-699501013259,inmunoensayo,i
108,0211-699501013259,albumina,i
108,0211-699501013259,y,o
108,0211-699501013259,cinetica,o
108,0211-699501013259,de,o
108,0211-699501013259,la,o
108,0211-699501013259,urea,i
108,0211-699501013259,KTV,o
108,0211-699501013259,KRU,o
108,0211-699501013259,PCRn,o
108,0211-699501013259,y,o
108,0211-699501013259,cada,o
108,0211-699501013259,6,o
108,0211-699501013259,meses,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,HPLC,i
108,0211-699501013259,y,o
108,0211-699501013259,pp,i
108,0211-699501013259,RIA,i
108,0211-699501013259,Resultados,o
108,0211-699501013259,80,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,fueron,o
108,0211-699501013259,incluidos,o
108,0211-699501013259,en,o
108,0211-699501013259,el,o
108,0211-699501013259,estudio,o
108,0211-699501013259,basal,o
108,0211-699501013259,con,o
108,0211-699501013259,una,o
108,0211-699501013259,prevalencia,o
108,0211-699501013259,de,o
108,0211-699501013259,hiperhomocisteinemia,i
108,0211-699501013259,del,o
108,0211-699501013259,844,o
108,0211-699501013259,deficit,i
108,0211-699501013259,de,i
108,0211-699501013259,pp,i
108,0211-699501013259,en,o
108,0211-699501013259,el,o
108,0211-699501013259,32,o
108,0211-699501013259,y,o
108,0211-699501013259,folato,i
108,0211-699501013259,en,o
108,0211-699501013259,el,o
108,0211-699501013259,rango,o
108,0211-699501013259,normal,o
108,0211-699501013259,bajo,o
108,0211-699501013259,los,o
108,0211-699501013259,niveles,i
108,0211-699501013259,de,i
108,0211-699501013259,tHcy,i
108,0211-699501013259,se,o
108,0211-699501013259,correlacionaban,o
108,0211-699501013259,inversamente,o
108,0211-699501013259,con,o
108,0211-699501013259,los,o
108,0211-699501013259,del,o
108,0211-699501013259,folato,i
108,0211-699501013259,r,o
108,0211-699501013259,0336,o
108,0211-699501013259,p,o
108,0211-699501013259,001,o
108,0211-699501013259,pero,o
108,0211-699501013259,no,o
108,0211-699501013259,con,o
108,0211-699501013259,pp,i
108,0211-699501013259,B12,i
108,0211-699501013259,edad,o
108,0211-699501013259,albumina,i
108,0211-699501013259,KTV,o
108,0211-699501013259,KRU,o
108,0211-699501013259,PCRn,o
108,0211-699501013259,Cincuenta,o
108,0211-699501013259,y,o
108,0211-699501013259,ocho,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,recibieron,o
108,0211-699501013259,seis,o
108,0211-699501013259,meses,o
108,0211-699501013259,de,o
108,0211-699501013259,suplementacion,i
108,0211-699501013259,con,o
108,0211-699501013259,normalizacion,o
108,0211-699501013259,del,o
108,0211-699501013259,pp,i
108,0211-699501013259,aumento,o
108,0211-699501013259,del,o
108,0211-699501013259,folato,i
108,0211-699501013259,703,o
108,0211-699501013259,IC,o
108,0211-699501013259,638,o
108,0211-699501013259,795,o
108,0211-699501013259,vs,o
108,0211-699501013259,6181,o
108,0211-699501013259,IC,o
108,0211-699501013259,4447,o
108,0211-699501013259,7811,o
108,0211-699501013259,p,o
108,0211-699501013259,0001,o
108,0211-699501013259,y,o
108,0211-699501013259,descenso,o
108,0211-699501013259,de,o
108,0211-699501013259,la,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,240,o
108,0211-699501013259,IC,o
108,0211-699501013259,213,o
108,0211-699501013259,264,o
108,0211-699501013259,vs,o
108,0211-699501013259,199,o
108,0211-699501013259,IC,o
108,0211-699501013259,175,o
108,0211-699501013259,224,o
108,0211-699501013259,p,o
108,0211-699501013259,005,o
108,0211-699501013259,Han,o
108,0211-699501013259,recibido,o
108,0211-699501013259,suplementacion,i
108,0211-699501013259,durante,o
108,0211-699501013259,12,o
108,0211-699501013259,meses,o
108,0211-699501013259,33,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,pero,o
108,0211-699501013259,a,o
108,0211-699501013259,pesar,o
108,0211-699501013259,de,o
108,0211-699501013259,un,o
108,0211-699501013259,continuo,o
108,0211-699501013259,aumento,o
108,0211-699501013259,del,o
108,0211-699501013259,folato,i
108,0211-699501013259,10078,o
108,0211-699501013259,IC,o
108,0211-699501013259,7481,o
108,0211-699501013259,12674,o
108,0211-699501013259,p,o
108,0211-699501013259,0001,o
108,0211-699501013259,solo,o
108,0211-699501013259,3,o
108,0211-699501013259,pacientes,o
108,0211-699501013259,presentan,o
108,0211-699501013259,niveles,o
108,0211-699501013259,normales,o
108,0211-699501013259,de,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,correlacionandose,o
108,0211-699501013259,directamente,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,con,o
108,0211-699501013259,la,o
108,0211-699501013259,albumina,i
108,0211-699501013259,r,o
108,0211-699501013259,056,o
108,0211-699501013259,p,o
108,0211-699501013259,0001,o
108,0211-699501013259,que,o
108,0211-699501013259,se,o
108,0211-699501013259,elevo,o
108,0211-699501013259,con,o
108,0211-699501013259,respecto,o
108,0211-699501013259,al,o
108,0211-699501013259,inicio,o
108,0211-699501013259,337,o
108,0211-699501013259,IC,o
108,0211-699501013259,327,o
108,0211-699501013259,346,o
108,0211-699501013259,vs,o
108,0211-699501013259,350,o
108,0211-699501013259,IC,o
108,0211-699501013259,337,o
108,0211-699501013259,363,o
108,0211-699501013259,p,o
108,0211-699501013259,005,o
108,0211-699501013259,Conclusion,o
108,0211-699501013259,Tras,o
108,0211-699501013259,suplementacion,i
108,0211-699501013259,con,o
108,0211-699501013259,acido,i
108,0211-699501013259,folico,i
108,0211-699501013259,y,o
108,0211-699501013259,vitamina,i
108,0211-699501013259,B6,i
108,0211-699501013259,aunque,o
108,0211-699501013259,inicialmente,o
108,0211-699501013259,se,o
108,0211-699501013259,reduce,o
108,0211-699501013259,la,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,esta,o
108,0211-699501013259,respuesta,o
108,0211-699501013259,se,o
108,0211-699501013259,hace,o
108,0211-699501013259,refractaria,o
108,0211-699501013259,correlacionandose,o
108,0211-699501013259,directamente,o
108,0211-699501013259,la,o
108,0211-699501013259,tHcy,i
108,0211-699501013259,con,o
108,0211-699501013259,la,o
108,0211-699501013259,albumina,i
108,0211-699501013259,plasmatica,i
108,0211-699501013259,La,o
108,0211-699501013259,interpretacion,o
108,0211-699501013259,de,o
108,0211-699501013259,los,o
108,0211-699501013259,niveles,i
108,0211-699501013259,de,i
108,0211-699501013259,tHcy,i
108,0211-699501013259,debe,o
108,0211-699501013259,tener,o
108,0211-699501013259,en,o
108,0211-699501013259,cuenta,o
108,0211-699501013259,la,o
108,0211-699501013259,concentracion,i
108,0211-699501013259,de,i
108,0211-699501013259,albumina,i
109,0211-699501013259,Efecto,o
109,0211-699501013259,de,o
109,0211-699501013259,la,o
109,0211-699501013259,suplementacion,i
109,0211-699501013259,con,o
109,0211-699501013259,acido,i
109,0211-699501013259,folico,i
109,0211-699501013259,sobre,o
109,0211-699501013259,los,o
109,0211-699501013259,niveles,i
109,0211-699501013259,de,i
109,0211-699501013259,homocisteina,i
109,0211-699501013259,total,o
109,0211-699501013259,en,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,en,o
109,0211-699501013259,hemodialisis,i
109,0211-699501013259,La,o
109,0211-699501013259,hiperhomocisteinemia,i
109,0211-699501013259,es,o
109,0211-699501013259,un,o
109,0211-699501013259,marcador,o
109,0211-699501013259,de,o
109,0211-699501013259,riesgo,o
109,0211-699501013259,independiente,o
109,0211-699501013259,de,o
109,0211-699501013259,morbimortalidad,o
109,0211-699501013259,cardiovascular,i
109,0211-699501013259,Hemos,o
109,0211-699501013259,intentado,o
109,0211-699501013259,prospectivamente,o
109,0211-699501013259,reducir,o
109,0211-699501013259,los,o
109,0211-699501013259,niveles,i
109,0211-699501013259,de,i
109,0211-699501013259,homocisteina,i
109,0211-699501013259,total,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,mediante,o
109,0211-699501013259,suplemento,o
109,0211-699501013259,con,o
109,0211-699501013259,acido,i
109,0211-699501013259,folico,i
109,0211-699501013259,y,o
109,0211-699501013259,vitamina,i
109,0211-699501013259,B6,i
109,0211-699501013259,pp,i
109,0211-699501013259,valorando,o
109,0211-699501013259,su,o
109,0211-699501013259,posible,o
109,0211-699501013259,correlacion,o
109,0211-699501013259,con,o
109,0211-699501013259,dosis,o
109,0211-699501013259,de,o
109,0211-699501013259,dialisis,i
109,0211-699501013259,funcion,i
109,0211-699501013259,residual,i
109,0211-699501013259,y,o
109,0211-699501013259,parametros,o
109,0211-699501013259,nutricionales,o
109,0211-699501013259,Metodos,o
109,0211-699501013259,Todos,o
109,0211-699501013259,los,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,en,o
109,0211-699501013259,hemodialisis,i
109,0211-699501013259,al,o
109,0211-699501013259,comienzo,o
109,0211-699501013259,del,o
109,0211-699501013259,estudio,o
109,0211-699501013259,que,o
109,0211-699501013259,no,o
109,0211-699501013259,recibian,o
109,0211-699501013259,acido,i
109,0211-699501013259,folico,i
109,0211-699501013259,ni,o
109,0211-699501013259,vitamina,i
109,0211-699501013259,B6,i
109,0211-699501013259,asi,o
109,0211-699501013259,como,o
109,0211-699501013259,los,o
109,0211-699501013259,incorporados,o
109,0211-699501013259,posteriormente,o
109,0211-699501013259,a,o
109,0211-699501013259,partir,o
109,0211-699501013259,de,o
109,0211-699501013259,su,o
109,0211-699501013259,tercer,o
109,0211-699501013259,mes,o
109,0211-699501013259,en,o
109,0211-699501013259,hemodialisis,i
109,0211-699501013259,recibieron,o
109,0211-699501013259,5,o
109,0211-699501013259,mg,o
109,0211-699501013259,orales,o
109,0211-699501013259,de,o
109,0211-699501013259,acido,i
109,0211-699501013259,folico,i
109,0211-699501013259,cada,o
109,0211-699501013259,48,o
109,0211-699501013259,horas,o
109,0211-699501013259,y,o
109,0211-699501013259,40,o
109,0211-699501013259,mg,o
109,0211-699501013259,orales,o
109,0211-699501013259,de,o
109,0211-699501013259,vitamina,i
109,0211-699501013259,B6,i
109,0211-699501013259,cada,o
109,0211-699501013259,semana,o
109,0211-699501013259,Se,o
109,0211-699501013259,determinaron,o
109,0211-699501013259,al,o
109,0211-699501013259,comienzo,o
109,0211-699501013259,del,o
109,0211-699501013259,estudio,o
109,0211-699501013259,y,o
109,0211-699501013259,cada,o
109,0211-699501013259,2,o
109,0211-699501013259,meses,o
109,0211-699501013259,niveles,i
109,0211-699501013259,de,i
109,0211-699501013259,folato,i
109,0211-699501013259,vitamina,i
109,0211-699501013259,B12,i
109,0211-699501013259,inmunoensayo,i
109,0211-699501013259,albumina,i
109,0211-699501013259,y,o
109,0211-699501013259,cinetica,o
109,0211-699501013259,de,o
109,0211-699501013259,la,o
109,0211-699501013259,urea,i
109,0211-699501013259,KTV,o
109,0211-699501013259,KRU,o
109,0211-699501013259,PCRn,o
109,0211-699501013259,y,o
109,0211-699501013259,cada,o
109,0211-699501013259,6,o
109,0211-699501013259,meses,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,HPLC,i
109,0211-699501013259,y,o
109,0211-699501013259,pp,i
109,0211-699501013259,RIA,i
109,0211-699501013259,Resultados,o
109,0211-699501013259,80,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,fueron,o
109,0211-699501013259,incluidos,o
109,0211-699501013259,en,o
109,0211-699501013259,el,o
109,0211-699501013259,estudio,o
109,0211-699501013259,basal,o
109,0211-699501013259,con,o
109,0211-699501013259,una,o
109,0211-699501013259,prevalencia,o
109,0211-699501013259,de,o
109,0211-699501013259,hiperhomocisteinemia,i
109,0211-699501013259,del,o
109,0211-699501013259,844,o
109,0211-699501013259,deficit,i
109,0211-699501013259,de,i
109,0211-699501013259,pp,i
109,0211-699501013259,en,o
109,0211-699501013259,el,o
109,0211-699501013259,32,o
109,0211-699501013259,y,o
109,0211-699501013259,folato,i
109,0211-699501013259,en,o
109,0211-699501013259,el,o
109,0211-699501013259,rango,o
109,0211-699501013259,normal,o
109,0211-699501013259,bajo,o
109,0211-699501013259,los,o
109,0211-699501013259,niveles,i
109,0211-699501013259,de,i
109,0211-699501013259,tHcy,i
109,0211-699501013259,se,o
109,0211-699501013259,correlacionaban,o
109,0211-699501013259,inversamente,o
109,0211-699501013259,con,o
109,0211-699501013259,los,o
109,0211-699501013259,del,o
109,0211-699501013259,folato,i
109,0211-699501013259,r,o
109,0211-699501013259,0336,o
109,0211-699501013259,p,o
109,0211-699501013259,001,o
109,0211-699501013259,pero,o
109,0211-699501013259,no,o
109,0211-699501013259,con,o
109,0211-699501013259,pp,i
109,0211-699501013259,B12,i
109,0211-699501013259,edad,o
109,0211-699501013259,albumina,i
109,0211-699501013259,KTV,o
109,0211-699501013259,KRU,o
109,0211-699501013259,PCRn,o
109,0211-699501013259,Cincuenta,o
109,0211-699501013259,y,o
109,0211-699501013259,ocho,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,recibieron,o
109,0211-699501013259,seis,o
109,0211-699501013259,meses,o
109,0211-699501013259,de,o
109,0211-699501013259,suplementacion,i
109,0211-699501013259,con,o
109,0211-699501013259,normalizacion,o
109,0211-699501013259,del,o
109,0211-699501013259,pp,i
109,0211-699501013259,aumento,o
109,0211-699501013259,del,o
109,0211-699501013259,folato,i
109,0211-699501013259,703,o
109,0211-699501013259,IC,o
109,0211-699501013259,638,o
109,0211-699501013259,795,o
109,0211-699501013259,vs,o
109,0211-699501013259,6181,o
109,0211-699501013259,IC,o
109,0211-699501013259,4447,o
109,0211-699501013259,7811,o
109,0211-699501013259,p,o
109,0211-699501013259,0001,o
109,0211-699501013259,y,o
109,0211-699501013259,descenso,o
109,0211-699501013259,de,o
109,0211-699501013259,la,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,240,o
109,0211-699501013259,IC,o
109,0211-699501013259,213,o
109,0211-699501013259,264,o
109,0211-699501013259,vs,o
109,0211-699501013259,199,o
109,0211-699501013259,IC,o
109,0211-699501013259,175,o
109,0211-699501013259,224,o
109,0211-699501013259,p,o
109,0211-699501013259,005,o
109,0211-699501013259,Han,o
109,0211-699501013259,recibido,o
109,0211-699501013259,suplementacion,i
109,0211-699501013259,durante,o
109,0211-699501013259,12,o
109,0211-699501013259,meses,o
109,0211-699501013259,33,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,pero,o
109,0211-699501013259,a,o
109,0211-699501013259,pesar,o
109,0211-699501013259,de,o
109,0211-699501013259,un,o
109,0211-699501013259,continuo,o
109,0211-699501013259,aumento,o
109,0211-699501013259,del,o
109,0211-699501013259,folato,i
109,0211-699501013259,10078,o
109,0211-699501013259,IC,o
109,0211-699501013259,7481,o
109,0211-699501013259,12674,o
109,0211-699501013259,p,o
109,0211-699501013259,0001,o
109,0211-699501013259,solo,o
109,0211-699501013259,3,o
109,0211-699501013259,pacientes,o
109,0211-699501013259,presentan,o
109,0211-699501013259,niveles,o
109,0211-699501013259,normales,o
109,0211-699501013259,de,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,correlacionandose,o
109,0211-699501013259,directamente,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,con,o
109,0211-699501013259,la,o
109,0211-699501013259,albumina,i
109,0211-699501013259,r,o
109,0211-699501013259,056,o
109,0211-699501013259,p,o
109,0211-699501013259,0001,o
109,0211-699501013259,que,o
109,0211-699501013259,se,o
109,0211-699501013259,elevo,o
109,0211-699501013259,con,o
109,0211-699501013259,respecto,o
109,0211-699501013259,al,o
109,0211-699501013259,inicio,o
109,0211-699501013259,337,o
109,0211-699501013259,IC,o
109,0211-699501013259,327,o
109,0211-699501013259,346,o
109,0211-699501013259,vs,o
109,0211-699501013259,350,o
109,0211-699501013259,IC,o
109,0211-699501013259,337,o
109,0211-699501013259,363,o
109,0211-699501013259,p,o
109,0211-699501013259,005,o
109,0211-699501013259,Conclusion,o
109,0211-699501013259,Tras,o
109,0211-699501013259,suplementacion,i
109,0211-699501013259,con,o
109,0211-699501013259,acido,i
109,0211-699501013259,folico,i
109,0211-699501013259,y,o
109,0211-699501013259,vitamina,i
109,0211-699501013259,B6,i
109,0211-699501013259,aunque,o
109,0211-699501013259,inicialmente,o
109,0211-699501013259,se,o
109,0211-699501013259,reduce,o
109,0211-699501013259,la,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,esta,o
109,0211-699501013259,respuesta,o
109,0211-699501013259,se,o
109,0211-699501013259,hace,o
109,0211-699501013259,refractaria,o
109,0211-699501013259,correlacionandose,o
109,0211-699501013259,directamente,o
109,0211-699501013259,la,o
109,0211-699501013259,tHcy,i
109,0211-699501013259,con,o
109,0211-699501013259,la,o
109,0211-699501013259,albumina,i
109,0211-699501013259,plasmatica,i
109,0211-699501013259,La,o
109,0211-699501013259,interpretacion,o
109,0211-699501013259,de,o
109,0211-699501013259,los,o
109,0211-699501013259,niveles,i
109,0211-699501013259,de,i
109,0211-699501013259,tHcy,i
109,0211-699501013259,debe,o
109,0211-699501013259,tener,o
109,0211-699501013259,en,o
109,0211-699501013259,cuenta,o
109,0211-699501013259,la,o
109,0211-699501013259,concentracion,i
109,0211-699501013259,de,i
109,0211-699501013259,albumina,i
110,0211-699501013259,Efecto,o
110,0211-699501013259,de,o
110,0211-699501013259,la,o
110,0211-699501013259,suplementacion,i
110,0211-699501013259,con,o
110,0211-699501013259,acido,i
110,0211-699501013259,folico,i
110,0211-699501013259,sobre,o
110,0211-699501013259,los,o
110,0211-699501013259,niveles,i
110,0211-699501013259,de,i
110,0211-699501013259,homocisteina,i
110,0211-699501013259,total,o
110,0211-699501013259,en,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,en,o
110,0211-699501013259,hemodialisis,i
110,0211-699501013259,La,o
110,0211-699501013259,hiperhomocisteinemia,i
110,0211-699501013259,es,o
110,0211-699501013259,un,o
110,0211-699501013259,marcador,o
110,0211-699501013259,de,o
110,0211-699501013259,riesgo,o
110,0211-699501013259,independiente,o
110,0211-699501013259,de,o
110,0211-699501013259,morbimortalidad,o
110,0211-699501013259,cardiovascular,i
110,0211-699501013259,Hemos,o
110,0211-699501013259,intentado,o
110,0211-699501013259,prospectivamente,o
110,0211-699501013259,reducir,o
110,0211-699501013259,los,o
110,0211-699501013259,niveles,i
110,0211-699501013259,de,i
110,0211-699501013259,homocisteina,i
110,0211-699501013259,total,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,mediante,o
110,0211-699501013259,suplemento,o
110,0211-699501013259,con,o
110,0211-699501013259,acido,i
110,0211-699501013259,folico,i
110,0211-699501013259,y,o
110,0211-699501013259,vitamina,i
110,0211-699501013259,B6,i
110,0211-699501013259,pp,i
110,0211-699501013259,valorando,o
110,0211-699501013259,su,o
110,0211-699501013259,posible,o
110,0211-699501013259,correlacion,o
110,0211-699501013259,con,o
110,0211-699501013259,dosis,o
110,0211-699501013259,de,o
110,0211-699501013259,dialisis,i
110,0211-699501013259,funcion,i
110,0211-699501013259,residual,i
110,0211-699501013259,y,o
110,0211-699501013259,parametros,o
110,0211-699501013259,nutricionales,o
110,0211-699501013259,Metodos,o
110,0211-699501013259,Todos,o
110,0211-699501013259,los,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,en,o
110,0211-699501013259,hemodialisis,i
110,0211-699501013259,al,o
110,0211-699501013259,comienzo,o
110,0211-699501013259,del,o
110,0211-699501013259,estudio,o
110,0211-699501013259,que,o
110,0211-699501013259,no,o
110,0211-699501013259,recibian,o
110,0211-699501013259,acido,i
110,0211-699501013259,folico,i
110,0211-699501013259,ni,o
110,0211-699501013259,vitamina,i
110,0211-699501013259,B6,i
110,0211-699501013259,asi,o
110,0211-699501013259,como,o
110,0211-699501013259,los,o
110,0211-699501013259,incorporados,o
110,0211-699501013259,posteriormente,o
110,0211-699501013259,a,o
110,0211-699501013259,partir,o
110,0211-699501013259,de,o
110,0211-699501013259,su,o
110,0211-699501013259,tercer,o
110,0211-699501013259,mes,o
110,0211-699501013259,en,o
110,0211-699501013259,hemodialisis,i
110,0211-699501013259,recibieron,o
110,0211-699501013259,5,o
110,0211-699501013259,mg,o
110,0211-699501013259,orales,o
110,0211-699501013259,de,o
110,0211-699501013259,acido,i
110,0211-699501013259,folico,i
110,0211-699501013259,cada,o
110,0211-699501013259,48,o
110,0211-699501013259,horas,o
110,0211-699501013259,y,o
110,0211-699501013259,40,o
110,0211-699501013259,mg,o
110,0211-699501013259,orales,o
110,0211-699501013259,de,o
110,0211-699501013259,vitamina,i
110,0211-699501013259,B6,i
110,0211-699501013259,cada,o
110,0211-699501013259,semana,o
110,0211-699501013259,Se,o
110,0211-699501013259,determinaron,o
110,0211-699501013259,al,o
110,0211-699501013259,comienzo,o
110,0211-699501013259,del,o
110,0211-699501013259,estudio,o
110,0211-699501013259,y,o
110,0211-699501013259,cada,o
110,0211-699501013259,2,o
110,0211-699501013259,meses,o
110,0211-699501013259,niveles,i
110,0211-699501013259,de,i
110,0211-699501013259,folato,i
110,0211-699501013259,vitamina,i
110,0211-699501013259,B12,i
110,0211-699501013259,inmunoensayo,i
110,0211-699501013259,albumina,i
110,0211-699501013259,y,o
110,0211-699501013259,cinetica,o
110,0211-699501013259,de,o
110,0211-699501013259,la,o
110,0211-699501013259,urea,i
110,0211-699501013259,KTV,o
110,0211-699501013259,KRU,o
110,0211-699501013259,PCRn,o
110,0211-699501013259,y,o
110,0211-699501013259,cada,o
110,0211-699501013259,6,o
110,0211-699501013259,meses,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,HPLC,i
110,0211-699501013259,y,o
110,0211-699501013259,pp,i
110,0211-699501013259,RIA,i
110,0211-699501013259,Resultados,o
110,0211-699501013259,80,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,fueron,o
110,0211-699501013259,incluidos,o
110,0211-699501013259,en,o
110,0211-699501013259,el,o
110,0211-699501013259,estudio,o
110,0211-699501013259,basal,o
110,0211-699501013259,con,o
110,0211-699501013259,una,o
110,0211-699501013259,prevalencia,o
110,0211-699501013259,de,o
110,0211-699501013259,hiperhomocisteinemia,i
110,0211-699501013259,del,o
110,0211-699501013259,844,o
110,0211-699501013259,deficit,i
110,0211-699501013259,de,i
110,0211-699501013259,pp,i
110,0211-699501013259,en,o
110,0211-699501013259,el,o
110,0211-699501013259,32,o
110,0211-699501013259,y,o
110,0211-699501013259,folato,i
110,0211-699501013259,en,o
110,0211-699501013259,el,o
110,0211-699501013259,rango,o
110,0211-699501013259,normal,o
110,0211-699501013259,bajo,o
110,0211-699501013259,los,o
110,0211-699501013259,niveles,i
110,0211-699501013259,de,i
110,0211-699501013259,tHcy,i
110,0211-699501013259,se,o
110,0211-699501013259,correlacionaban,o
110,0211-699501013259,inversamente,o
110,0211-699501013259,con,o
110,0211-699501013259,los,o
110,0211-699501013259,del,o
110,0211-699501013259,folato,i
110,0211-699501013259,r,o
110,0211-699501013259,0336,o
110,0211-699501013259,p,o
110,0211-699501013259,001,o
110,0211-699501013259,pero,o
110,0211-699501013259,no,o
110,0211-699501013259,con,o
110,0211-699501013259,pp,i
110,0211-699501013259,B12,i
110,0211-699501013259,edad,o
110,0211-699501013259,albumina,i
110,0211-699501013259,KTV,o
110,0211-699501013259,KRU,o
110,0211-699501013259,PCRn,o
110,0211-699501013259,Cincuenta,o
110,0211-699501013259,y,o
110,0211-699501013259,ocho,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,recibieron,o
110,0211-699501013259,seis,o
110,0211-699501013259,meses,o
110,0211-699501013259,de,o
110,0211-699501013259,suplementacion,i
110,0211-699501013259,con,o
110,0211-699501013259,normalizacion,o
110,0211-699501013259,del,o
110,0211-699501013259,pp,i
110,0211-699501013259,aumento,o
110,0211-699501013259,del,o
110,0211-699501013259,folato,i
110,0211-699501013259,703,o
110,0211-699501013259,IC,o
110,0211-699501013259,638,o
110,0211-699501013259,795,o
110,0211-699501013259,vs,o
110,0211-699501013259,6181,o
110,0211-699501013259,IC,o
110,0211-699501013259,4447,o
110,0211-699501013259,7811,o
110,0211-699501013259,p,o
110,0211-699501013259,0001,o
110,0211-699501013259,y,o
110,0211-699501013259,descenso,o
110,0211-699501013259,de,o
110,0211-699501013259,la,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,240,o
110,0211-699501013259,IC,o
110,0211-699501013259,213,o
110,0211-699501013259,264,o
110,0211-699501013259,vs,o
110,0211-699501013259,199,o
110,0211-699501013259,IC,o
110,0211-699501013259,175,o
110,0211-699501013259,224,o
110,0211-699501013259,p,o
110,0211-699501013259,005,o
110,0211-699501013259,Han,o
110,0211-699501013259,recibido,o
110,0211-699501013259,suplementacion,i
110,0211-699501013259,durante,o
110,0211-699501013259,12,o
110,0211-699501013259,meses,o
110,0211-699501013259,33,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,pero,o
110,0211-699501013259,a,o
110,0211-699501013259,pesar,o
110,0211-699501013259,de,o
110,0211-699501013259,un,o
110,0211-699501013259,continuo,o
110,0211-699501013259,aumento,o
110,0211-699501013259,del,o
110,0211-699501013259,folato,i
110,0211-699501013259,10078,o
110,0211-699501013259,IC,o
110,0211-699501013259,7481,o
110,0211-699501013259,12674,o
110,0211-699501013259,p,o
110,0211-699501013259,0001,o
110,0211-699501013259,solo,o
110,0211-699501013259,3,o
110,0211-699501013259,pacientes,o
110,0211-699501013259,presentan,o
110,0211-699501013259,niveles,o
110,0211-699501013259,normales,o
110,0211-699501013259,de,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,correlacionandose,o
110,0211-699501013259,directamente,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,con,o
110,0211-699501013259,la,o
110,0211-699501013259,albumina,i
110,0211-699501013259,r,o
110,0211-699501013259,056,o
110,0211-699501013259,p,o
110,0211-699501013259,0001,o
110,0211-699501013259,que,o
110,0211-699501013259,se,o
110,0211-699501013259,elevo,o
110,0211-699501013259,con,o
110,0211-699501013259,respecto,o
110,0211-699501013259,al,o
110,0211-699501013259,inicio,o
110,0211-699501013259,337,o
110,0211-699501013259,IC,o
110,0211-699501013259,327,o
110,0211-699501013259,346,o
110,0211-699501013259,vs,o
110,0211-699501013259,350,o
110,0211-699501013259,IC,o
110,0211-699501013259,337,o
110,0211-699501013259,363,o
110,0211-699501013259,p,o
110,0211-699501013259,005,o
110,0211-699501013259,Conclusion,o
110,0211-699501013259,Tras,o
110,0211-699501013259,suplementacion,i
110,0211-699501013259,con,o
110,0211-699501013259,acido,i
110,0211-699501013259,folico,i
110,0211-699501013259,y,o
110,0211-699501013259,vitamina,i
110,0211-699501013259,B6,i
110,0211-699501013259,aunque,o
110,0211-699501013259,inicialmente,o
110,0211-699501013259,se,o
110,0211-699501013259,reduce,o
110,0211-699501013259,la,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,esta,o
110,0211-699501013259,respuesta,o
110,0211-699501013259,se,o
110,0211-699501013259,hace,o
110,0211-699501013259,refractaria,o
110,0211-699501013259,correlacionandose,o
110,0211-699501013259,directamente,o
110,0211-699501013259,la,o
110,0211-699501013259,tHcy,i
110,0211-699501013259,con,o
110,0211-699501013259,la,o
110,0211-699501013259,albumina,i
110,0211-699501013259,plasmatica,i
110,0211-699501013259,La,o
110,0211-699501013259,interpretacion,o
110,0211-699501013259,de,o
110,0211-699501013259,los,o
110,0211-699501013259,niveles,i
110,0211-699501013259,de,i
110,0211-699501013259,tHcy,i
110,0211-699501013259,debe,o
110,0211-699501013259,tener,o
110,0211-699501013259,en,o
110,0211-699501013259,cuenta,o
110,0211-699501013259,la,o
110,0211-699501013259,concentracion,i
110,0211-699501013259,de,i
110,0211-699501013259,albumina,i
111,0211-699501013259,Efecto,o
111,0211-699501013259,de,o
111,0211-699501013259,la,o
111,0211-699501013259,suplementacion,i
111,0211-699501013259,con,o
111,0211-699501013259,acido,i
111,0211-699501013259,folico,i
111,0211-699501013259,sobre,o
111,0211-699501013259,los,o
111,0211-699501013259,niveles,i
111,0211-699501013259,de,i
111,0211-699501013259,homocisteina,i
111,0211-699501013259,total,o
111,0211-699501013259,en,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,en,o
111,0211-699501013259,hemodialisis,i
111,0211-699501013259,La,o
111,0211-699501013259,hiperhomocisteinemia,i
111,0211-699501013259,es,o
111,0211-699501013259,un,o
111,0211-699501013259,marcador,o
111,0211-699501013259,de,o
111,0211-699501013259,riesgo,o
111,0211-699501013259,independiente,o
111,0211-699501013259,de,o
111,0211-699501013259,morbimortalidad,o
111,0211-699501013259,cardiovascular,i
111,0211-699501013259,Hemos,o
111,0211-699501013259,intentado,o
111,0211-699501013259,prospectivamente,o
111,0211-699501013259,reducir,o
111,0211-699501013259,los,o
111,0211-699501013259,niveles,i
111,0211-699501013259,de,i
111,0211-699501013259,homocisteina,i
111,0211-699501013259,total,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,mediante,o
111,0211-699501013259,suplemento,o
111,0211-699501013259,con,o
111,0211-699501013259,acido,i
111,0211-699501013259,folico,i
111,0211-699501013259,y,o
111,0211-699501013259,vitamina,i
111,0211-699501013259,B6,i
111,0211-699501013259,pp,i
111,0211-699501013259,valorando,o
111,0211-699501013259,su,o
111,0211-699501013259,posible,o
111,0211-699501013259,correlacion,o
111,0211-699501013259,con,o
111,0211-699501013259,dosis,o
111,0211-699501013259,de,o
111,0211-699501013259,dialisis,i
111,0211-699501013259,funcion,i
111,0211-699501013259,residual,i
111,0211-699501013259,y,o
111,0211-699501013259,parametros,o
111,0211-699501013259,nutricionales,o
111,0211-699501013259,Metodos,o
111,0211-699501013259,Todos,o
111,0211-699501013259,los,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,en,o
111,0211-699501013259,hemodialisis,i
111,0211-699501013259,al,o
111,0211-699501013259,comienzo,o
111,0211-699501013259,del,o
111,0211-699501013259,estudio,o
111,0211-699501013259,que,o
111,0211-699501013259,no,o
111,0211-699501013259,recibian,o
111,0211-699501013259,acido,i
111,0211-699501013259,folico,i
111,0211-699501013259,ni,o
111,0211-699501013259,vitamina,i
111,0211-699501013259,B6,i
111,0211-699501013259,asi,o
111,0211-699501013259,como,o
111,0211-699501013259,los,o
111,0211-699501013259,incorporados,o
111,0211-699501013259,posteriormente,o
111,0211-699501013259,a,o
111,0211-699501013259,partir,o
111,0211-699501013259,de,o
111,0211-699501013259,su,o
111,0211-699501013259,tercer,o
111,0211-699501013259,mes,o
111,0211-699501013259,en,o
111,0211-699501013259,hemodialisis,i
111,0211-699501013259,recibieron,o
111,0211-699501013259,5,o
111,0211-699501013259,mg,o
111,0211-699501013259,orales,o
111,0211-699501013259,de,o
111,0211-699501013259,acido,i
111,0211-699501013259,folico,i
111,0211-699501013259,cada,o
111,0211-699501013259,48,o
111,0211-699501013259,horas,o
111,0211-699501013259,y,o
111,0211-699501013259,40,o
111,0211-699501013259,mg,o
111,0211-699501013259,orales,o
111,0211-699501013259,de,o
111,0211-699501013259,vitamina,i
111,0211-699501013259,B6,i
111,0211-699501013259,cada,o
111,0211-699501013259,semana,o
111,0211-699501013259,Se,o
111,0211-699501013259,determinaron,o
111,0211-699501013259,al,o
111,0211-699501013259,comienzo,o
111,0211-699501013259,del,o
111,0211-699501013259,estudio,o
111,0211-699501013259,y,o
111,0211-699501013259,cada,o
111,0211-699501013259,2,o
111,0211-699501013259,meses,o
111,0211-699501013259,niveles,i
111,0211-699501013259,de,i
111,0211-699501013259,folato,i
111,0211-699501013259,vitamina,i
111,0211-699501013259,B12,i
111,0211-699501013259,inmunoensayo,i
111,0211-699501013259,albumina,i
111,0211-699501013259,y,o
111,0211-699501013259,cinetica,o
111,0211-699501013259,de,o
111,0211-699501013259,la,o
111,0211-699501013259,urea,i
111,0211-699501013259,KTV,o
111,0211-699501013259,KRU,o
111,0211-699501013259,PCRn,o
111,0211-699501013259,y,o
111,0211-699501013259,cada,o
111,0211-699501013259,6,o
111,0211-699501013259,meses,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,HPLC,i
111,0211-699501013259,y,o
111,0211-699501013259,pp,i
111,0211-699501013259,RIA,i
111,0211-699501013259,Resultados,o
111,0211-699501013259,80,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,fueron,o
111,0211-699501013259,incluidos,o
111,0211-699501013259,en,o
111,0211-699501013259,el,o
111,0211-699501013259,estudio,o
111,0211-699501013259,basal,o
111,0211-699501013259,con,o
111,0211-699501013259,una,o
111,0211-699501013259,prevalencia,o
111,0211-699501013259,de,o
111,0211-699501013259,hiperhomocisteinemia,i
111,0211-699501013259,del,o
111,0211-699501013259,844,o
111,0211-699501013259,deficit,i
111,0211-699501013259,de,i
111,0211-699501013259,pp,i
111,0211-699501013259,en,o
111,0211-699501013259,el,o
111,0211-699501013259,32,o
111,0211-699501013259,y,o
111,0211-699501013259,folato,i
111,0211-699501013259,en,o
111,0211-699501013259,el,o
111,0211-699501013259,rango,o
111,0211-699501013259,normal,o
111,0211-699501013259,bajo,o
111,0211-699501013259,los,o
111,0211-699501013259,niveles,i
111,0211-699501013259,de,i
111,0211-699501013259,tHcy,i
111,0211-699501013259,se,o
111,0211-699501013259,correlacionaban,o
111,0211-699501013259,inversamente,o
111,0211-699501013259,con,o
111,0211-699501013259,los,o
111,0211-699501013259,del,o
111,0211-699501013259,folato,i
111,0211-699501013259,r,o
111,0211-699501013259,0336,o
111,0211-699501013259,p,o
111,0211-699501013259,001,o
111,0211-699501013259,pero,o
111,0211-699501013259,no,o
111,0211-699501013259,con,o
111,0211-699501013259,pp,i
111,0211-699501013259,B12,i
111,0211-699501013259,edad,o
111,0211-699501013259,albumina,i
111,0211-699501013259,KTV,o
111,0211-699501013259,KRU,o
111,0211-699501013259,PCRn,o
111,0211-699501013259,Cincuenta,o
111,0211-699501013259,y,o
111,0211-699501013259,ocho,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,recibieron,o
111,0211-699501013259,seis,o
111,0211-699501013259,meses,o
111,0211-699501013259,de,o
111,0211-699501013259,suplementacion,i
111,0211-699501013259,con,o
111,0211-699501013259,normalizacion,o
111,0211-699501013259,del,o
111,0211-699501013259,pp,i
111,0211-699501013259,aumento,o
111,0211-699501013259,del,o
111,0211-699501013259,folato,i
111,0211-699501013259,703,o
111,0211-699501013259,IC,o
111,0211-699501013259,638,o
111,0211-699501013259,795,o
111,0211-699501013259,vs,o
111,0211-699501013259,6181,o
111,0211-699501013259,IC,o
111,0211-699501013259,4447,o
111,0211-699501013259,7811,o
111,0211-699501013259,p,o
111,0211-699501013259,0001,o
111,0211-699501013259,y,o
111,0211-699501013259,descenso,o
111,0211-699501013259,de,o
111,0211-699501013259,la,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,240,o
111,0211-699501013259,IC,o
111,0211-699501013259,213,o
111,0211-699501013259,264,o
111,0211-699501013259,vs,o
111,0211-699501013259,199,o
111,0211-699501013259,IC,o
111,0211-699501013259,175,o
111,0211-699501013259,224,o
111,0211-699501013259,p,o
111,0211-699501013259,005,o
111,0211-699501013259,Han,o
111,0211-699501013259,recibido,o
111,0211-699501013259,suplementacion,i
111,0211-699501013259,durante,o
111,0211-699501013259,12,o
111,0211-699501013259,meses,o
111,0211-699501013259,33,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,pero,o
111,0211-699501013259,a,o
111,0211-699501013259,pesar,o
111,0211-699501013259,de,o
111,0211-699501013259,un,o
111,0211-699501013259,continuo,o
111,0211-699501013259,aumento,o
111,0211-699501013259,del,o
111,0211-699501013259,folato,i
111,0211-699501013259,10078,o
111,0211-699501013259,IC,o
111,0211-699501013259,7481,o
111,0211-699501013259,12674,o
111,0211-699501013259,p,o
111,0211-699501013259,0001,o
111,0211-699501013259,solo,o
111,0211-699501013259,3,o
111,0211-699501013259,pacientes,o
111,0211-699501013259,presentan,o
111,0211-699501013259,niveles,o
111,0211-699501013259,normales,o
111,0211-699501013259,de,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,correlacionandose,o
111,0211-699501013259,directamente,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,con,o
111,0211-699501013259,la,o
111,0211-699501013259,albumina,i
111,0211-699501013259,r,o
111,0211-699501013259,056,o
111,0211-699501013259,p,o
111,0211-699501013259,0001,o
111,0211-699501013259,que,o
111,0211-699501013259,se,o
111,0211-699501013259,elevo,o
111,0211-699501013259,con,o
111,0211-699501013259,respecto,o
111,0211-699501013259,al,o
111,0211-699501013259,inicio,o
111,0211-699501013259,337,o
111,0211-699501013259,IC,o
111,0211-699501013259,327,o
111,0211-699501013259,346,o
111,0211-699501013259,vs,o
111,0211-699501013259,350,o
111,0211-699501013259,IC,o
111,0211-699501013259,337,o
111,0211-699501013259,363,o
111,0211-699501013259,p,o
111,0211-699501013259,005,o
111,0211-699501013259,Conclusion,o
111,0211-699501013259,Tras,o
111,0211-699501013259,suplementacion,i
111,0211-699501013259,con,o
111,0211-699501013259,acido,i
111,0211-699501013259,folico,i
111,0211-699501013259,y,o
111,0211-699501013259,vitamina,i
111,0211-699501013259,B6,i
111,0211-699501013259,aunque,o
111,0211-699501013259,inicialmente,o
111,0211-699501013259,se,o
111,0211-699501013259,reduce,o
111,0211-699501013259,la,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,esta,o
111,0211-699501013259,respuesta,o
111,0211-699501013259,se,o
111,0211-699501013259,hace,o
111,0211-699501013259,refractaria,o
111,0211-699501013259,correlacionandose,o
111,0211-699501013259,directamente,o
111,0211-699501013259,la,o
111,0211-699501013259,tHcy,i
111,0211-699501013259,con,o
111,0211-699501013259,la,o
111,0211-699501013259,albumina,i
111,0211-699501013259,plasmatica,i
111,0211-699501013259,La,o
111,0211-699501013259,interpretacion,o
111,0211-699501013259,de,o
111,0211-699501013259,los,o
111,0211-699501013259,niveles,i
111,0211-699501013259,de,i
111,0211-699501013259,tHcy,i
111,0211-699501013259,debe,o
111,0211-699501013259,tener,o
111,0211-699501013259,en,o
111,0211-699501013259,cuenta,o
111,0211-699501013259,la,o
111,0211-699501013259,concentracion,i
111,0211-699501013259,de,i
111,0211-699501013259,albumina,i
112,0211-699501013259,Efecto,o
112,0211-699501013259,de,o
112,0211-699501013259,la,o
112,0211-699501013259,suplementacion,i
112,0211-699501013259,con,o
112,0211-699501013259,acido,i
112,0211-699501013259,folico,i
112,0211-699501013259,sobre,o
112,0211-699501013259,los,o
112,0211-699501013259,niveles,i
112,0211-699501013259,de,i
112,0211-699501013259,homocisteina,i
112,0211-699501013259,total,o
112,0211-699501013259,en,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,en,o
112,0211-699501013259,hemodialisis,i
112,0211-699501013259,La,o
112,0211-699501013259,hiperhomocisteinemia,i
112,0211-699501013259,es,o
112,0211-699501013259,un,o
112,0211-699501013259,marcador,o
112,0211-699501013259,de,o
112,0211-699501013259,riesgo,o
112,0211-699501013259,independiente,o
112,0211-699501013259,de,o
112,0211-699501013259,morbimortalidad,o
112,0211-699501013259,cardiovascular,i
112,0211-699501013259,Hemos,o
112,0211-699501013259,intentado,o
112,0211-699501013259,prospectivamente,o
112,0211-699501013259,reducir,o
112,0211-699501013259,los,o
112,0211-699501013259,niveles,i
112,0211-699501013259,de,i
112,0211-699501013259,homocisteina,i
112,0211-699501013259,total,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,mediante,o
112,0211-699501013259,suplemento,o
112,0211-699501013259,con,o
112,0211-699501013259,acido,i
112,0211-699501013259,folico,i
112,0211-699501013259,y,o
112,0211-699501013259,vitamina,i
112,0211-699501013259,B6,i
112,0211-699501013259,pp,i
112,0211-699501013259,valorando,o
112,0211-699501013259,su,o
112,0211-699501013259,posible,o
112,0211-699501013259,correlacion,o
112,0211-699501013259,con,o
112,0211-699501013259,dosis,o
112,0211-699501013259,de,o
112,0211-699501013259,dialisis,i
112,0211-699501013259,funcion,i
112,0211-699501013259,residual,i
112,0211-699501013259,y,o
112,0211-699501013259,parametros,o
112,0211-699501013259,nutricionales,o
112,0211-699501013259,Metodos,o
112,0211-699501013259,Todos,o
112,0211-699501013259,los,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,en,o
112,0211-699501013259,hemodialisis,i
112,0211-699501013259,al,o
112,0211-699501013259,comienzo,o
112,0211-699501013259,del,o
112,0211-699501013259,estudio,o
112,0211-699501013259,que,o
112,0211-699501013259,no,o
112,0211-699501013259,recibian,o
112,0211-699501013259,acido,i
112,0211-699501013259,folico,i
112,0211-699501013259,ni,o
112,0211-699501013259,vitamina,i
112,0211-699501013259,B6,i
112,0211-699501013259,asi,o
112,0211-699501013259,como,o
112,0211-699501013259,los,o
112,0211-699501013259,incorporados,o
112,0211-699501013259,posteriormente,o
112,0211-699501013259,a,o
112,0211-699501013259,partir,o
112,0211-699501013259,de,o
112,0211-699501013259,su,o
112,0211-699501013259,tercer,o
112,0211-699501013259,mes,o
112,0211-699501013259,en,o
112,0211-699501013259,hemodialisis,i
112,0211-699501013259,recibieron,o
112,0211-699501013259,5,o
112,0211-699501013259,mg,o
112,0211-699501013259,orales,o
112,0211-699501013259,de,o
112,0211-699501013259,acido,i
112,0211-699501013259,folico,i
112,0211-699501013259,cada,o
112,0211-699501013259,48,o
112,0211-699501013259,horas,o
112,0211-699501013259,y,o
112,0211-699501013259,40,o
112,0211-699501013259,mg,o
112,0211-699501013259,orales,o
112,0211-699501013259,de,o
112,0211-699501013259,vitamina,i
112,0211-699501013259,B6,i
112,0211-699501013259,cada,o
112,0211-699501013259,semana,o
112,0211-699501013259,Se,o
112,0211-699501013259,determinaron,o
112,0211-699501013259,al,o
112,0211-699501013259,comienzo,o
112,0211-699501013259,del,o
112,0211-699501013259,estudio,o
112,0211-699501013259,y,o
112,0211-699501013259,cada,o
112,0211-699501013259,2,o
112,0211-699501013259,meses,o
112,0211-699501013259,niveles,i
112,0211-699501013259,de,i
112,0211-699501013259,folato,i
112,0211-699501013259,vitamina,i
112,0211-699501013259,B12,i
112,0211-699501013259,inmunoensayo,i
112,0211-699501013259,albumina,i
112,0211-699501013259,y,o
112,0211-699501013259,cinetica,o
112,0211-699501013259,de,o
112,0211-699501013259,la,o
112,0211-699501013259,urea,i
112,0211-699501013259,KTV,o
112,0211-699501013259,KRU,o
112,0211-699501013259,PCRn,o
112,0211-699501013259,y,o
112,0211-699501013259,cada,o
112,0211-699501013259,6,o
112,0211-699501013259,meses,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,HPLC,i
112,0211-699501013259,y,o
112,0211-699501013259,pp,i
112,0211-699501013259,RIA,i
112,0211-699501013259,Resultados,o
112,0211-699501013259,80,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,fueron,o
112,0211-699501013259,incluidos,o
112,0211-699501013259,en,o
112,0211-699501013259,el,o
112,0211-699501013259,estudio,o
112,0211-699501013259,basal,o
112,0211-699501013259,con,o
112,0211-699501013259,una,o
112,0211-699501013259,prevalencia,o
112,0211-699501013259,de,o
112,0211-699501013259,hiperhomocisteinemia,i
112,0211-699501013259,del,o
112,0211-699501013259,844,o
112,0211-699501013259,deficit,i
112,0211-699501013259,de,i
112,0211-699501013259,pp,i
112,0211-699501013259,en,o
112,0211-699501013259,el,o
112,0211-699501013259,32,o
112,0211-699501013259,y,o
112,0211-699501013259,folato,i
112,0211-699501013259,en,o
112,0211-699501013259,el,o
112,0211-699501013259,rango,o
112,0211-699501013259,normal,o
112,0211-699501013259,bajo,o
112,0211-699501013259,los,o
112,0211-699501013259,niveles,i
112,0211-699501013259,de,i
112,0211-699501013259,tHcy,i
112,0211-699501013259,se,o
112,0211-699501013259,correlacionaban,o
112,0211-699501013259,inversamente,o
112,0211-699501013259,con,o
112,0211-699501013259,los,o
112,0211-699501013259,del,o
112,0211-699501013259,folato,i
112,0211-699501013259,r,o
112,0211-699501013259,0336,o
112,0211-699501013259,p,o
112,0211-699501013259,001,o
112,0211-699501013259,pero,o
112,0211-699501013259,no,o
112,0211-699501013259,con,o
112,0211-699501013259,pp,i
112,0211-699501013259,B12,i
112,0211-699501013259,edad,o
112,0211-699501013259,albumina,i
112,0211-699501013259,KTV,o
112,0211-699501013259,KRU,o
112,0211-699501013259,PCRn,o
112,0211-699501013259,Cincuenta,o
112,0211-699501013259,y,o
112,0211-699501013259,ocho,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,recibieron,o
112,0211-699501013259,seis,o
112,0211-699501013259,meses,o
112,0211-699501013259,de,o
112,0211-699501013259,suplementacion,i
112,0211-699501013259,con,o
112,0211-699501013259,normalizacion,o
112,0211-699501013259,del,o
112,0211-699501013259,pp,i
112,0211-699501013259,aumento,o
112,0211-699501013259,del,o
112,0211-699501013259,folato,i
112,0211-699501013259,703,o
112,0211-699501013259,IC,o
112,0211-699501013259,638,o
112,0211-699501013259,795,o
112,0211-699501013259,vs,o
112,0211-699501013259,6181,o
112,0211-699501013259,IC,o
112,0211-699501013259,4447,o
112,0211-699501013259,7811,o
112,0211-699501013259,p,o
112,0211-699501013259,0001,o
112,0211-699501013259,y,o
112,0211-699501013259,descenso,o
112,0211-699501013259,de,o
112,0211-699501013259,la,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,240,o
112,0211-699501013259,IC,o
112,0211-699501013259,213,o
112,0211-699501013259,264,o
112,0211-699501013259,vs,o
112,0211-699501013259,199,o
112,0211-699501013259,IC,o
112,0211-699501013259,175,o
112,0211-699501013259,224,o
112,0211-699501013259,p,o
112,0211-699501013259,005,o
112,0211-699501013259,Han,o
112,0211-699501013259,recibido,o
112,0211-699501013259,suplementacion,i
112,0211-699501013259,durante,o
112,0211-699501013259,12,o
112,0211-699501013259,meses,o
112,0211-699501013259,33,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,pero,o
112,0211-699501013259,a,o
112,0211-699501013259,pesar,o
112,0211-699501013259,de,o
112,0211-699501013259,un,o
112,0211-699501013259,continuo,o
112,0211-699501013259,aumento,o
112,0211-699501013259,del,o
112,0211-699501013259,folato,i
112,0211-699501013259,10078,o
112,0211-699501013259,IC,o
112,0211-699501013259,7481,o
112,0211-699501013259,12674,o
112,0211-699501013259,p,o
112,0211-699501013259,0001,o
112,0211-699501013259,solo,o
112,0211-699501013259,3,o
112,0211-699501013259,pacientes,o
112,0211-699501013259,presentan,o
112,0211-699501013259,niveles,o
112,0211-699501013259,normales,o
112,0211-699501013259,de,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,correlacionandose,o
112,0211-699501013259,directamente,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,con,o
112,0211-699501013259,la,o
112,0211-699501013259,albumina,i
112,0211-699501013259,r,o
112,0211-699501013259,056,o
112,0211-699501013259,p,o
112,0211-699501013259,0001,o
112,0211-699501013259,que,o
112,0211-699501013259,se,o
112,0211-699501013259,elevo,o
112,0211-699501013259,con,o
112,0211-699501013259,respecto,o
112,0211-699501013259,al,o
112,0211-699501013259,inicio,o
112,0211-699501013259,337,o
112,0211-699501013259,IC,o
112,0211-699501013259,327,o
112,0211-699501013259,346,o
112,0211-699501013259,vs,o
112,0211-699501013259,350,o
112,0211-699501013259,IC,o
112,0211-699501013259,337,o
112,0211-699501013259,363,o
112,0211-699501013259,p,o
112,0211-699501013259,005,o
112,0211-699501013259,Conclusion,o
112,0211-699501013259,Tras,o
112,0211-699501013259,suplementacion,i
112,0211-699501013259,con,o
112,0211-699501013259,acido,i
112,0211-699501013259,folico,i
112,0211-699501013259,y,o
112,0211-699501013259,vitamina,i
112,0211-699501013259,B6,i
112,0211-699501013259,aunque,o
112,0211-699501013259,inicialmente,o
112,0211-699501013259,se,o
112,0211-699501013259,reduce,o
112,0211-699501013259,la,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,esta,o
112,0211-699501013259,respuesta,o
112,0211-699501013259,se,o
112,0211-699501013259,hace,o
112,0211-699501013259,refractaria,o
112,0211-699501013259,correlacionandose,o
112,0211-699501013259,directamente,o
112,0211-699501013259,la,o
112,0211-699501013259,tHcy,i
112,0211-699501013259,con,o
112,0211-699501013259,la,o
112,0211-699501013259,albumina,i
112,0211-699501013259,plasmatica,i
112,0211-699501013259,La,o
112,0211-699501013259,interpretacion,o
112,0211-699501013259,de,o
112,0211-699501013259,los,o
112,0211-699501013259,niveles,i
112,0211-699501013259,de,i
112,0211-699501013259,tHcy,i
112,0211-699501013259,debe,o
112,0211-699501013259,tener,o
112,0211-699501013259,en,o
112,0211-699501013259,cuenta,o
112,0211-699501013259,la,o
112,0211-699501013259,concentracion,i
112,0211-699501013259,de,i
112,0211-699501013259,albumina,i
113,0211-699501013259,Efecto,o
113,0211-699501013259,de,o
113,0211-699501013259,la,o
113,0211-699501013259,suplementacion,i
113,0211-699501013259,con,o
113,0211-699501013259,acido,i
113,0211-699501013259,folico,i
113,0211-699501013259,sobre,o
113,0211-699501013259,los,o
113,0211-699501013259,niveles,i
113,0211-699501013259,de,i
113,0211-699501013259,homocisteina,i
113,0211-699501013259,total,o
113,0211-699501013259,en,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,en,o
113,0211-699501013259,hemodialisis,i
113,0211-699501013259,La,o
113,0211-699501013259,hiperhomocisteinemia,i
113,0211-699501013259,es,o
113,0211-699501013259,un,o
113,0211-699501013259,marcador,o
113,0211-699501013259,de,o
113,0211-699501013259,riesgo,o
113,0211-699501013259,independiente,o
113,0211-699501013259,de,o
113,0211-699501013259,morbimortalidad,o
113,0211-699501013259,cardiovascular,i
113,0211-699501013259,Hemos,o
113,0211-699501013259,intentado,o
113,0211-699501013259,prospectivamente,o
113,0211-699501013259,reducir,o
113,0211-699501013259,los,o
113,0211-699501013259,niveles,i
113,0211-699501013259,de,i
113,0211-699501013259,homocisteina,i
113,0211-699501013259,total,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,mediante,o
113,0211-699501013259,suplemento,o
113,0211-699501013259,con,o
113,0211-699501013259,acido,i
113,0211-699501013259,folico,i
113,0211-699501013259,y,o
113,0211-699501013259,vitamina,i
113,0211-699501013259,B6,i
113,0211-699501013259,pp,i
113,0211-699501013259,valorando,o
113,0211-699501013259,su,o
113,0211-699501013259,posible,o
113,0211-699501013259,correlacion,o
113,0211-699501013259,con,o
113,0211-699501013259,dosis,o
113,0211-699501013259,de,o
113,0211-699501013259,dialisis,i
113,0211-699501013259,funcion,i
113,0211-699501013259,residual,i
113,0211-699501013259,y,o
113,0211-699501013259,parametros,o
113,0211-699501013259,nutricionales,o
113,0211-699501013259,Metodos,o
113,0211-699501013259,Todos,o
113,0211-699501013259,los,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,en,o
113,0211-699501013259,hemodialisis,i
113,0211-699501013259,al,o
113,0211-699501013259,comienzo,o
113,0211-699501013259,del,o
113,0211-699501013259,estudio,o
113,0211-699501013259,que,o
113,0211-699501013259,no,o
113,0211-699501013259,recibian,o
113,0211-699501013259,acido,i
113,0211-699501013259,folico,i
113,0211-699501013259,ni,o
113,0211-699501013259,vitamina,i
113,0211-699501013259,B6,i
113,0211-699501013259,asi,o
113,0211-699501013259,como,o
113,0211-699501013259,los,o
113,0211-699501013259,incorporados,o
113,0211-699501013259,posteriormente,o
113,0211-699501013259,a,o
113,0211-699501013259,partir,o
113,0211-699501013259,de,o
113,0211-699501013259,su,o
113,0211-699501013259,tercer,o
113,0211-699501013259,mes,o
113,0211-699501013259,en,o
113,0211-699501013259,hemodialisis,i
113,0211-699501013259,recibieron,o
113,0211-699501013259,5,o
113,0211-699501013259,mg,o
113,0211-699501013259,orales,o
113,0211-699501013259,de,o
113,0211-699501013259,acido,i
113,0211-699501013259,folico,i
113,0211-699501013259,cada,o
113,0211-699501013259,48,o
113,0211-699501013259,horas,o
113,0211-699501013259,y,o
113,0211-699501013259,40,o
113,0211-699501013259,mg,o
113,0211-699501013259,orales,o
113,0211-699501013259,de,o
113,0211-699501013259,vitamina,i
113,0211-699501013259,B6,i
113,0211-699501013259,cada,o
113,0211-699501013259,semana,o
113,0211-699501013259,Se,o
113,0211-699501013259,determinaron,o
113,0211-699501013259,al,o
113,0211-699501013259,comienzo,o
113,0211-699501013259,del,o
113,0211-699501013259,estudio,o
113,0211-699501013259,y,o
113,0211-699501013259,cada,o
113,0211-699501013259,2,o
113,0211-699501013259,meses,o
113,0211-699501013259,niveles,i
113,0211-699501013259,de,i
113,0211-699501013259,folato,i
113,0211-699501013259,vitamina,i
113,0211-699501013259,B12,i
113,0211-699501013259,inmunoensayo,i
113,0211-699501013259,albumina,i
113,0211-699501013259,y,o
113,0211-699501013259,cinetica,o
113,0211-699501013259,de,o
113,0211-699501013259,la,o
113,0211-699501013259,urea,i
113,0211-699501013259,KTV,o
113,0211-699501013259,KRU,o
113,0211-699501013259,PCRn,o
113,0211-699501013259,y,o
113,0211-699501013259,cada,o
113,0211-699501013259,6,o
113,0211-699501013259,meses,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,HPLC,i
113,0211-699501013259,y,o
113,0211-699501013259,pp,i
113,0211-699501013259,RIA,i
113,0211-699501013259,Resultados,o
113,0211-699501013259,80,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,fueron,o
113,0211-699501013259,incluidos,o
113,0211-699501013259,en,o
113,0211-699501013259,el,o
113,0211-699501013259,estudio,o
113,0211-699501013259,basal,o
113,0211-699501013259,con,o
113,0211-699501013259,una,o
113,0211-699501013259,prevalencia,o
113,0211-699501013259,de,o
113,0211-699501013259,hiperhomocisteinemia,i
113,0211-699501013259,del,o
113,0211-699501013259,844,o
113,0211-699501013259,deficit,i
113,0211-699501013259,de,i
113,0211-699501013259,pp,i
113,0211-699501013259,en,o
113,0211-699501013259,el,o
113,0211-699501013259,32,o
113,0211-699501013259,y,o
113,0211-699501013259,folato,i
113,0211-699501013259,en,o
113,0211-699501013259,el,o
113,0211-699501013259,rango,o
113,0211-699501013259,normal,o
113,0211-699501013259,bajo,o
113,0211-699501013259,los,o
113,0211-699501013259,niveles,i
113,0211-699501013259,de,i
113,0211-699501013259,tHcy,i
113,0211-699501013259,se,o
113,0211-699501013259,correlacionaban,o
113,0211-699501013259,inversamente,o
113,0211-699501013259,con,o
113,0211-699501013259,los,o
113,0211-699501013259,del,o
113,0211-699501013259,folato,i
113,0211-699501013259,r,o
113,0211-699501013259,0336,o
113,0211-699501013259,p,o
113,0211-699501013259,001,o
113,0211-699501013259,pero,o
113,0211-699501013259,no,o
113,0211-699501013259,con,o
113,0211-699501013259,pp,i
113,0211-699501013259,B12,i
113,0211-699501013259,edad,o
113,0211-699501013259,albumina,i
113,0211-699501013259,KTV,o
113,0211-699501013259,KRU,o
113,0211-699501013259,PCRn,o
113,0211-699501013259,Cincuenta,o
113,0211-699501013259,y,o
113,0211-699501013259,ocho,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,recibieron,o
113,0211-699501013259,seis,o
113,0211-699501013259,meses,o
113,0211-699501013259,de,o
113,0211-699501013259,suplementacion,i
113,0211-699501013259,con,o
113,0211-699501013259,normalizacion,o
113,0211-699501013259,del,o
113,0211-699501013259,pp,i
113,0211-699501013259,aumento,o
113,0211-699501013259,del,o
113,0211-699501013259,folato,i
113,0211-699501013259,703,o
113,0211-699501013259,IC,o
113,0211-699501013259,638,o
113,0211-699501013259,795,o
113,0211-699501013259,vs,o
113,0211-699501013259,6181,o
113,0211-699501013259,IC,o
113,0211-699501013259,4447,o
113,0211-699501013259,7811,o
113,0211-699501013259,p,o
113,0211-699501013259,0001,o
113,0211-699501013259,y,o
113,0211-699501013259,descenso,o
113,0211-699501013259,de,o
113,0211-699501013259,la,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,240,o
113,0211-699501013259,IC,o
113,0211-699501013259,213,o
113,0211-699501013259,264,o
113,0211-699501013259,vs,o
113,0211-699501013259,199,o
113,0211-699501013259,IC,o
113,0211-699501013259,175,o
113,0211-699501013259,224,o
113,0211-699501013259,p,o
113,0211-699501013259,005,o
113,0211-699501013259,Han,o
113,0211-699501013259,recibido,o
113,0211-699501013259,suplementacion,i
113,0211-699501013259,durante,o
113,0211-699501013259,12,o
113,0211-699501013259,meses,o
113,0211-699501013259,33,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,pero,o
113,0211-699501013259,a,o
113,0211-699501013259,pesar,o
113,0211-699501013259,de,o
113,0211-699501013259,un,o
113,0211-699501013259,continuo,o
113,0211-699501013259,aumento,o
113,0211-699501013259,del,o
113,0211-699501013259,folato,i
113,0211-699501013259,10078,o
113,0211-699501013259,IC,o
113,0211-699501013259,7481,o
113,0211-699501013259,12674,o
113,0211-699501013259,p,o
113,0211-699501013259,0001,o
113,0211-699501013259,solo,o
113,0211-699501013259,3,o
113,0211-699501013259,pacientes,o
113,0211-699501013259,presentan,o
113,0211-699501013259,niveles,o
113,0211-699501013259,normales,o
113,0211-699501013259,de,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,correlacionandose,o
113,0211-699501013259,directamente,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,con,o
113,0211-699501013259,la,o
113,0211-699501013259,albumina,i
113,0211-699501013259,r,o
113,0211-699501013259,056,o
113,0211-699501013259,p,o
113,0211-699501013259,0001,o
113,0211-699501013259,que,o
113,0211-699501013259,se,o
113,0211-699501013259,elevo,o
113,0211-699501013259,con,o
113,0211-699501013259,respecto,o
113,0211-699501013259,al,o
113,0211-699501013259,inicio,o
113,0211-699501013259,337,o
113,0211-699501013259,IC,o
113,0211-699501013259,327,o
113,0211-699501013259,346,o
113,0211-699501013259,vs,o
113,0211-699501013259,350,o
113,0211-699501013259,IC,o
113,0211-699501013259,337,o
113,0211-699501013259,363,o
113,0211-699501013259,p,o
113,0211-699501013259,005,o
113,0211-699501013259,Conclusion,o
113,0211-699501013259,Tras,o
113,0211-699501013259,suplementacion,i
113,0211-699501013259,con,o
113,0211-699501013259,acido,i
113,0211-699501013259,folico,i
113,0211-699501013259,y,o
113,0211-699501013259,vitamina,i
113,0211-699501013259,B6,i
113,0211-699501013259,aunque,o
113,0211-699501013259,inicialmente,o
113,0211-699501013259,se,o
113,0211-699501013259,reduce,o
113,0211-699501013259,la,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,esta,o
113,0211-699501013259,respuesta,o
113,0211-699501013259,se,o
113,0211-699501013259,hace,o
113,0211-699501013259,refractaria,o
113,0211-699501013259,correlacionandose,o
113,0211-699501013259,directamente,o
113,0211-699501013259,la,o
113,0211-699501013259,tHcy,i
113,0211-699501013259,con,o
113,0211-699501013259,la,o
113,0211-699501013259,albumina,i
113,0211-699501013259,plasmatica,i
113,0211-699501013259,La,o
113,0211-699501013259,interpretacion,o
113,0211-699501013259,de,o
113,0211-699501013259,los,o
113,0211-699501013259,niveles,i
113,0211-699501013259,de,i
113,0211-699501013259,tHcy,i
113,0211-699501013259,debe,o
113,0211-699501013259,tener,o
113,0211-699501013259,en,o
113,0211-699501013259,cuenta,o
113,0211-699501013259,la,o
113,0211-699501013259,concentracion,i
113,0211-699501013259,de,i
113,0211-699501013259,albumina,i
114,0211-699501013259,Efecto,o
114,0211-699501013259,de,o
114,0211-699501013259,la,o
114,0211-699501013259,suplementacion,i
114,0211-699501013259,con,o
114,0211-699501013259,acido,i
114,0211-699501013259,folico,i
114,0211-699501013259,sobre,o
114,0211-699501013259,los,o
114,0211-699501013259,niveles,i
114,0211-699501013259,de,i
114,0211-699501013259,homocisteina,i
114,0211-699501013259,total,o
114,0211-699501013259,en,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,en,o
114,0211-699501013259,hemodialisis,i
114,0211-699501013259,La,o
114,0211-699501013259,hiperhomocisteinemia,i
114,0211-699501013259,es,o
114,0211-699501013259,un,o
114,0211-699501013259,marcador,o
114,0211-699501013259,de,o
114,0211-699501013259,riesgo,o
114,0211-699501013259,independiente,o
114,0211-699501013259,de,o
114,0211-699501013259,morbimortalidad,o
114,0211-699501013259,cardiovascular,i
114,0211-699501013259,Hemos,o
114,0211-699501013259,intentado,o
114,0211-699501013259,prospectivamente,o
114,0211-699501013259,reducir,o
114,0211-699501013259,los,o
114,0211-699501013259,niveles,i
114,0211-699501013259,de,i
114,0211-699501013259,homocisteina,i
114,0211-699501013259,total,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,mediante,o
114,0211-699501013259,suplemento,o
114,0211-699501013259,con,o
114,0211-699501013259,acido,i
114,0211-699501013259,folico,i
114,0211-699501013259,y,o
114,0211-699501013259,vitamina,i
114,0211-699501013259,B6,i
114,0211-699501013259,pp,i
114,0211-699501013259,valorando,o
114,0211-699501013259,su,o
114,0211-699501013259,posible,o
114,0211-699501013259,correlacion,o
114,0211-699501013259,con,o
114,0211-699501013259,dosis,o
114,0211-699501013259,de,o
114,0211-699501013259,dialisis,i
114,0211-699501013259,funcion,i
114,0211-699501013259,residual,i
114,0211-699501013259,y,o
114,0211-699501013259,parametros,o
114,0211-699501013259,nutricionales,o
114,0211-699501013259,Metodos,o
114,0211-699501013259,Todos,o
114,0211-699501013259,los,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,en,o
114,0211-699501013259,hemodialisis,i
114,0211-699501013259,al,o
114,0211-699501013259,comienzo,o
114,0211-699501013259,del,o
114,0211-699501013259,estudio,o
114,0211-699501013259,que,o
114,0211-699501013259,no,o
114,0211-699501013259,recibian,o
114,0211-699501013259,acido,i
114,0211-699501013259,folico,i
114,0211-699501013259,ni,o
114,0211-699501013259,vitamina,i
114,0211-699501013259,B6,i
114,0211-699501013259,asi,o
114,0211-699501013259,como,o
114,0211-699501013259,los,o
114,0211-699501013259,incorporados,o
114,0211-699501013259,posteriormente,o
114,0211-699501013259,a,o
114,0211-699501013259,partir,o
114,0211-699501013259,de,o
114,0211-699501013259,su,o
114,0211-699501013259,tercer,o
114,0211-699501013259,mes,o
114,0211-699501013259,en,o
114,0211-699501013259,hemodialisis,i
114,0211-699501013259,recibieron,o
114,0211-699501013259,5,o
114,0211-699501013259,mg,o
114,0211-699501013259,orales,o
114,0211-699501013259,de,o
114,0211-699501013259,acido,i
114,0211-699501013259,folico,i
114,0211-699501013259,cada,o
114,0211-699501013259,48,o
114,0211-699501013259,horas,o
114,0211-699501013259,y,o
114,0211-699501013259,40,o
114,0211-699501013259,mg,o
114,0211-699501013259,orales,o
114,0211-699501013259,de,o
114,0211-699501013259,vitamina,i
114,0211-699501013259,B6,i
114,0211-699501013259,cada,o
114,0211-699501013259,semana,o
114,0211-699501013259,Se,o
114,0211-699501013259,determinaron,o
114,0211-699501013259,al,o
114,0211-699501013259,comienzo,o
114,0211-699501013259,del,o
114,0211-699501013259,estudio,o
114,0211-699501013259,y,o
114,0211-699501013259,cada,o
114,0211-699501013259,2,o
114,0211-699501013259,meses,o
114,0211-699501013259,niveles,i
114,0211-699501013259,de,i
114,0211-699501013259,folato,i
114,0211-699501013259,vitamina,i
114,0211-699501013259,B12,i
114,0211-699501013259,inmunoensayo,i
114,0211-699501013259,albumina,i
114,0211-699501013259,y,o
114,0211-699501013259,cinetica,o
114,0211-699501013259,de,o
114,0211-699501013259,la,o
114,0211-699501013259,urea,i
114,0211-699501013259,KTV,o
114,0211-699501013259,KRU,o
114,0211-699501013259,PCRn,o
114,0211-699501013259,y,o
114,0211-699501013259,cada,o
114,0211-699501013259,6,o
114,0211-699501013259,meses,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,HPLC,i
114,0211-699501013259,y,o
114,0211-699501013259,pp,i
114,0211-699501013259,RIA,i
114,0211-699501013259,Resultados,o
114,0211-699501013259,80,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,fueron,o
114,0211-699501013259,incluidos,o
114,0211-699501013259,en,o
114,0211-699501013259,el,o
114,0211-699501013259,estudio,o
114,0211-699501013259,basal,o
114,0211-699501013259,con,o
114,0211-699501013259,una,o
114,0211-699501013259,prevalencia,o
114,0211-699501013259,de,o
114,0211-699501013259,hiperhomocisteinemia,i
114,0211-699501013259,del,o
114,0211-699501013259,844,o
114,0211-699501013259,deficit,i
114,0211-699501013259,de,i
114,0211-699501013259,pp,i
114,0211-699501013259,en,o
114,0211-699501013259,el,o
114,0211-699501013259,32,o
114,0211-699501013259,y,o
114,0211-699501013259,folato,i
114,0211-699501013259,en,o
114,0211-699501013259,el,o
114,0211-699501013259,rango,o
114,0211-699501013259,normal,o
114,0211-699501013259,bajo,o
114,0211-699501013259,los,o
114,0211-699501013259,niveles,i
114,0211-699501013259,de,i
114,0211-699501013259,tHcy,i
114,0211-699501013259,se,o
114,0211-699501013259,correlacionaban,o
114,0211-699501013259,inversamente,o
114,0211-699501013259,con,o
114,0211-699501013259,los,o
114,0211-699501013259,del,o
114,0211-699501013259,folato,i
114,0211-699501013259,r,o
114,0211-699501013259,0336,o
114,0211-699501013259,p,o
114,0211-699501013259,001,o
114,0211-699501013259,pero,o
114,0211-699501013259,no,o
114,0211-699501013259,con,o
114,0211-699501013259,pp,i
114,0211-699501013259,B12,i
114,0211-699501013259,edad,o
114,0211-699501013259,albumina,i
114,0211-699501013259,KTV,o
114,0211-699501013259,KRU,o
114,0211-699501013259,PCRn,o
114,0211-699501013259,Cincuenta,o
114,0211-699501013259,y,o
114,0211-699501013259,ocho,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,recibieron,o
114,0211-699501013259,seis,o
114,0211-699501013259,meses,o
114,0211-699501013259,de,o
114,0211-699501013259,suplementacion,i
114,0211-699501013259,con,o
114,0211-699501013259,normalizacion,o
114,0211-699501013259,del,o
114,0211-699501013259,pp,i
114,0211-699501013259,aumento,o
114,0211-699501013259,del,o
114,0211-699501013259,folato,i
114,0211-699501013259,703,o
114,0211-699501013259,IC,o
114,0211-699501013259,638,o
114,0211-699501013259,795,o
114,0211-699501013259,vs,o
114,0211-699501013259,6181,o
114,0211-699501013259,IC,o
114,0211-699501013259,4447,o
114,0211-699501013259,7811,o
114,0211-699501013259,p,o
114,0211-699501013259,0001,o
114,0211-699501013259,y,o
114,0211-699501013259,descenso,o
114,0211-699501013259,de,o
114,0211-699501013259,la,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,240,o
114,0211-699501013259,IC,o
114,0211-699501013259,213,o
114,0211-699501013259,264,o
114,0211-699501013259,vs,o
114,0211-699501013259,199,o
114,0211-699501013259,IC,o
114,0211-699501013259,175,o
114,0211-699501013259,224,o
114,0211-699501013259,p,o
114,0211-699501013259,005,o
114,0211-699501013259,Han,o
114,0211-699501013259,recibido,o
114,0211-699501013259,suplementacion,i
114,0211-699501013259,durante,o
114,0211-699501013259,12,o
114,0211-699501013259,meses,o
114,0211-699501013259,33,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,pero,o
114,0211-699501013259,a,o
114,0211-699501013259,pesar,o
114,0211-699501013259,de,o
114,0211-699501013259,un,o
114,0211-699501013259,continuo,o
114,0211-699501013259,aumento,o
114,0211-699501013259,del,o
114,0211-699501013259,folato,i
114,0211-699501013259,10078,o
114,0211-699501013259,IC,o
114,0211-699501013259,7481,o
114,0211-699501013259,12674,o
114,0211-699501013259,p,o
114,0211-699501013259,0001,o
114,0211-699501013259,solo,o
114,0211-699501013259,3,o
114,0211-699501013259,pacientes,o
114,0211-699501013259,presentan,o
114,0211-699501013259,niveles,o
114,0211-699501013259,normales,o
114,0211-699501013259,de,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,correlacionandose,o
114,0211-699501013259,directamente,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,con,o
114,0211-699501013259,la,o
114,0211-699501013259,albumina,i
114,0211-699501013259,r,o
114,0211-699501013259,056,o
114,0211-699501013259,p,o
114,0211-699501013259,0001,o
114,0211-699501013259,que,o
114,0211-699501013259,se,o
114,0211-699501013259,elevo,o
114,0211-699501013259,con,o
114,0211-699501013259,respecto,o
114,0211-699501013259,al,o
114,0211-699501013259,inicio,o
114,0211-699501013259,337,o
114,0211-699501013259,IC,o
114,0211-699501013259,327,o
114,0211-699501013259,346,o
114,0211-699501013259,vs,o
114,0211-699501013259,350,o
114,0211-699501013259,IC,o
114,0211-699501013259,337,o
114,0211-699501013259,363,o
114,0211-699501013259,p,o
114,0211-699501013259,005,o
114,0211-699501013259,Conclusion,o
114,0211-699501013259,Tras,o
114,0211-699501013259,suplementacion,i
114,0211-699501013259,con,o
114,0211-699501013259,acido,i
114,0211-699501013259,folico,i
114,0211-699501013259,y,o
114,0211-699501013259,vitamina,i
114,0211-699501013259,B6,i
114,0211-699501013259,aunque,o
114,0211-699501013259,inicialmente,o
114,0211-699501013259,se,o
114,0211-699501013259,reduce,o
114,0211-699501013259,la,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,esta,o
114,0211-699501013259,respuesta,o
114,0211-699501013259,se,o
114,0211-699501013259,hace,o
114,0211-699501013259,refractaria,o
114,0211-699501013259,correlacionandose,o
114,0211-699501013259,directamente,o
114,0211-699501013259,la,o
114,0211-699501013259,tHcy,i
114,0211-699501013259,con,o
114,0211-699501013259,la,o
114,0211-699501013259,albumina,i
114,0211-699501013259,plasmatica,i
114,0211-699501013259,La,o
114,0211-699501013259,interpretacion,o
114,0211-699501013259,de,o
114,0211-699501013259,los,o
114,0211-699501013259,niveles,i
114,0211-699501013259,de,i
114,0211-699501013259,tHcy,i
114,0211-699501013259,debe,o
114,0211-699501013259,tener,o
114,0211-699501013259,en,o
114,0211-699501013259,cuenta,o
114,0211-699501013259,la,o
114,0211-699501013259,concentracion,i
114,0211-699501013259,de,i
114,0211-699501013259,albumina,i
115,0211-699501013259,Efecto,o
115,0211-699501013259,de,o
115,0211-699501013259,la,o
115,0211-699501013259,suplementacion,i
115,0211-699501013259,con,o
115,0211-699501013259,acido,i
115,0211-699501013259,folico,i
115,0211-699501013259,sobre,o
115,0211-699501013259,los,o
115,0211-699501013259,niveles,i
115,0211-699501013259,de,i
115,0211-699501013259,homocisteina,i
115,0211-699501013259,total,o
115,0211-699501013259,en,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,en,o
115,0211-699501013259,hemodialisis,i
115,0211-699501013259,La,o
115,0211-699501013259,hiperhomocisteinemia,i
115,0211-699501013259,es,o
115,0211-699501013259,un,o
115,0211-699501013259,marcador,o
115,0211-699501013259,de,o
115,0211-699501013259,riesgo,o
115,0211-699501013259,independiente,o
115,0211-699501013259,de,o
115,0211-699501013259,morbimortalidad,o
115,0211-699501013259,cardiovascular,i
115,0211-699501013259,Hemos,o
115,0211-699501013259,intentado,o
115,0211-699501013259,prospectivamente,o
115,0211-699501013259,reducir,o
115,0211-699501013259,los,o
115,0211-699501013259,niveles,i
115,0211-699501013259,de,i
115,0211-699501013259,homocisteina,i
115,0211-699501013259,total,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,mediante,o
115,0211-699501013259,suplemento,o
115,0211-699501013259,con,o
115,0211-699501013259,acido,i
115,0211-699501013259,folico,i
115,0211-699501013259,y,o
115,0211-699501013259,vitamina,i
115,0211-699501013259,B6,i
115,0211-699501013259,pp,i
115,0211-699501013259,valorando,o
115,0211-699501013259,su,o
115,0211-699501013259,posible,o
115,0211-699501013259,correlacion,o
115,0211-699501013259,con,o
115,0211-699501013259,dosis,o
115,0211-699501013259,de,o
115,0211-699501013259,dialisis,i
115,0211-699501013259,funcion,i
115,0211-699501013259,residual,i
115,0211-699501013259,y,o
115,0211-699501013259,parametros,o
115,0211-699501013259,nutricionales,o
115,0211-699501013259,Metodos,o
115,0211-699501013259,Todos,o
115,0211-699501013259,los,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,en,o
115,0211-699501013259,hemodialisis,i
115,0211-699501013259,al,o
115,0211-699501013259,comienzo,o
115,0211-699501013259,del,o
115,0211-699501013259,estudio,o
115,0211-699501013259,que,o
115,0211-699501013259,no,o
115,0211-699501013259,recibian,o
115,0211-699501013259,acido,i
115,0211-699501013259,folico,i
115,0211-699501013259,ni,o
115,0211-699501013259,vitamina,i
115,0211-699501013259,B6,i
115,0211-699501013259,asi,o
115,0211-699501013259,como,o
115,0211-699501013259,los,o
115,0211-699501013259,incorporados,o
115,0211-699501013259,posteriormente,o
115,0211-699501013259,a,o
115,0211-699501013259,partir,o
115,0211-699501013259,de,o
115,0211-699501013259,su,o
115,0211-699501013259,tercer,o
115,0211-699501013259,mes,o
115,0211-699501013259,en,o
115,0211-699501013259,hemodialisis,i
115,0211-699501013259,recibieron,o
115,0211-699501013259,5,o
115,0211-699501013259,mg,o
115,0211-699501013259,orales,o
115,0211-699501013259,de,o
115,0211-699501013259,acido,i
115,0211-699501013259,folico,i
115,0211-699501013259,cada,o
115,0211-699501013259,48,o
115,0211-699501013259,horas,o
115,0211-699501013259,y,o
115,0211-699501013259,40,o
115,0211-699501013259,mg,o
115,0211-699501013259,orales,o
115,0211-699501013259,de,o
115,0211-699501013259,vitamina,i
115,0211-699501013259,B6,i
115,0211-699501013259,cada,o
115,0211-699501013259,semana,o
115,0211-699501013259,Se,o
115,0211-699501013259,determinaron,o
115,0211-699501013259,al,o
115,0211-699501013259,comienzo,o
115,0211-699501013259,del,o
115,0211-699501013259,estudio,o
115,0211-699501013259,y,o
115,0211-699501013259,cada,o
115,0211-699501013259,2,o
115,0211-699501013259,meses,o
115,0211-699501013259,niveles,i
115,0211-699501013259,de,i
115,0211-699501013259,folato,i
115,0211-699501013259,vitamina,i
115,0211-699501013259,B12,i
115,0211-699501013259,inmunoensayo,i
115,0211-699501013259,albumina,i
115,0211-699501013259,y,o
115,0211-699501013259,cinetica,o
115,0211-699501013259,de,o
115,0211-699501013259,la,o
115,0211-699501013259,urea,i
115,0211-699501013259,KTV,o
115,0211-699501013259,KRU,o
115,0211-699501013259,PCRn,o
115,0211-699501013259,y,o
115,0211-699501013259,cada,o
115,0211-699501013259,6,o
115,0211-699501013259,meses,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,HPLC,i
115,0211-699501013259,y,o
115,0211-699501013259,pp,i
115,0211-699501013259,RIA,i
115,0211-699501013259,Resultados,o
115,0211-699501013259,80,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,fueron,o
115,0211-699501013259,incluidos,o
115,0211-699501013259,en,o
115,0211-699501013259,el,o
115,0211-699501013259,estudio,o
115,0211-699501013259,basal,o
115,0211-699501013259,con,o
115,0211-699501013259,una,o
115,0211-699501013259,prevalencia,o
115,0211-699501013259,de,o
115,0211-699501013259,hiperhomocisteinemia,i
115,0211-699501013259,del,o
115,0211-699501013259,844,o
115,0211-699501013259,deficit,i
115,0211-699501013259,de,i
115,0211-699501013259,pp,i
115,0211-699501013259,en,o
115,0211-699501013259,el,o
115,0211-699501013259,32,o
115,0211-699501013259,y,o
115,0211-699501013259,folato,i
115,0211-699501013259,en,o
115,0211-699501013259,el,o
115,0211-699501013259,rango,o
115,0211-699501013259,normal,o
115,0211-699501013259,bajo,o
115,0211-699501013259,los,o
115,0211-699501013259,niveles,i
115,0211-699501013259,de,i
115,0211-699501013259,tHcy,i
115,0211-699501013259,se,o
115,0211-699501013259,correlacionaban,o
115,0211-699501013259,inversamente,o
115,0211-699501013259,con,o
115,0211-699501013259,los,o
115,0211-699501013259,del,o
115,0211-699501013259,folato,i
115,0211-699501013259,r,o
115,0211-699501013259,0336,o
115,0211-699501013259,p,o
115,0211-699501013259,001,o
115,0211-699501013259,pero,o
115,0211-699501013259,no,o
115,0211-699501013259,con,o
115,0211-699501013259,pp,i
115,0211-699501013259,B12,i
115,0211-699501013259,edad,o
115,0211-699501013259,albumina,i
115,0211-699501013259,KTV,o
115,0211-699501013259,KRU,o
115,0211-699501013259,PCRn,o
115,0211-699501013259,Cincuenta,o
115,0211-699501013259,y,o
115,0211-699501013259,ocho,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,recibieron,o
115,0211-699501013259,seis,o
115,0211-699501013259,meses,o
115,0211-699501013259,de,o
115,0211-699501013259,suplementacion,i
115,0211-699501013259,con,o
115,0211-699501013259,normalizacion,o
115,0211-699501013259,del,o
115,0211-699501013259,pp,i
115,0211-699501013259,aumento,o
115,0211-699501013259,del,o
115,0211-699501013259,folato,i
115,0211-699501013259,703,o
115,0211-699501013259,IC,o
115,0211-699501013259,638,o
115,0211-699501013259,795,o
115,0211-699501013259,vs,o
115,0211-699501013259,6181,o
115,0211-699501013259,IC,o
115,0211-699501013259,4447,o
115,0211-699501013259,7811,o
115,0211-699501013259,p,o
115,0211-699501013259,0001,o
115,0211-699501013259,y,o
115,0211-699501013259,descenso,o
115,0211-699501013259,de,o
115,0211-699501013259,la,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,240,o
115,0211-699501013259,IC,o
115,0211-699501013259,213,o
115,0211-699501013259,264,o
115,0211-699501013259,vs,o
115,0211-699501013259,199,o
115,0211-699501013259,IC,o
115,0211-699501013259,175,o
115,0211-699501013259,224,o
115,0211-699501013259,p,o
115,0211-699501013259,005,o
115,0211-699501013259,Han,o
115,0211-699501013259,recibido,o
115,0211-699501013259,suplementacion,i
115,0211-699501013259,durante,o
115,0211-699501013259,12,o
115,0211-699501013259,meses,o
115,0211-699501013259,33,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,pero,o
115,0211-699501013259,a,o
115,0211-699501013259,pesar,o
115,0211-699501013259,de,o
115,0211-699501013259,un,o
115,0211-699501013259,continuo,o
115,0211-699501013259,aumento,o
115,0211-699501013259,del,o
115,0211-699501013259,folato,i
115,0211-699501013259,10078,o
115,0211-699501013259,IC,o
115,0211-699501013259,7481,o
115,0211-699501013259,12674,o
115,0211-699501013259,p,o
115,0211-699501013259,0001,o
115,0211-699501013259,solo,o
115,0211-699501013259,3,o
115,0211-699501013259,pacientes,o
115,0211-699501013259,presentan,o
115,0211-699501013259,niveles,o
115,0211-699501013259,normales,o
115,0211-699501013259,de,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,correlacionandose,o
115,0211-699501013259,directamente,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,con,o
115,0211-699501013259,la,o
115,0211-699501013259,albumina,i
115,0211-699501013259,r,o
115,0211-699501013259,056,o
115,0211-699501013259,p,o
115,0211-699501013259,0001,o
115,0211-699501013259,que,o
115,0211-699501013259,se,o
115,0211-699501013259,elevo,o
115,0211-699501013259,con,o
115,0211-699501013259,respecto,o
115,0211-699501013259,al,o
115,0211-699501013259,inicio,o
115,0211-699501013259,337,o
115,0211-699501013259,IC,o
115,0211-699501013259,327,o
115,0211-699501013259,346,o
115,0211-699501013259,vs,o
115,0211-699501013259,350,o
115,0211-699501013259,IC,o
115,0211-699501013259,337,o
115,0211-699501013259,363,o
115,0211-699501013259,p,o
115,0211-699501013259,005,o
115,0211-699501013259,Conclusion,o
115,0211-699501013259,Tras,o
115,0211-699501013259,suplementacion,i
115,0211-699501013259,con,o
115,0211-699501013259,acido,i
115,0211-699501013259,folico,i
115,0211-699501013259,y,o
115,0211-699501013259,vitamina,i
115,0211-699501013259,B6,i
115,0211-699501013259,aunque,o
115,0211-699501013259,inicialmente,o
115,0211-699501013259,se,o
115,0211-699501013259,reduce,o
115,0211-699501013259,la,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,esta,o
115,0211-699501013259,respuesta,o
115,0211-699501013259,se,o
115,0211-699501013259,hace,o
115,0211-699501013259,refractaria,o
115,0211-699501013259,correlacionandose,o
115,0211-699501013259,directamente,o
115,0211-699501013259,la,o
115,0211-699501013259,tHcy,i
115,0211-699501013259,con,o
115,0211-699501013259,la,o
115,0211-699501013259,albumina,i
115,0211-699501013259,plasmatica,i
115,0211-699501013259,La,o
115,0211-699501013259,interpretacion,o
115,0211-699501013259,de,o
115,0211-699501013259,los,o
115,0211-699501013259,niveles,i
115,0211-699501013259,de,i
115,0211-699501013259,tHcy,i
115,0211-699501013259,debe,o
115,0211-699501013259,tener,o
115,0211-699501013259,en,o
115,0211-699501013259,cuenta,o
115,0211-699501013259,la,o
115,0211-699501013259,concentracion,i
115,0211-699501013259,de,i
115,0211-699501013259,albumina,i
116,0211-699501013259,Efecto,o
116,0211-699501013259,de,o
116,0211-699501013259,la,o
116,0211-699501013259,suplementacion,i
116,0211-699501013259,con,o
116,0211-699501013259,acido,i
116,0211-699501013259,folico,i
116,0211-699501013259,sobre,o
116,0211-699501013259,los,o
116,0211-699501013259,niveles,i
116,0211-699501013259,de,i
116,0211-699501013259,homocisteina,i
116,0211-699501013259,total,o
116,0211-699501013259,en,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,en,o
116,0211-699501013259,hemodialisis,i
116,0211-699501013259,La,o
116,0211-699501013259,hiperhomocisteinemia,i
116,0211-699501013259,es,o
116,0211-699501013259,un,o
116,0211-699501013259,marcador,o
116,0211-699501013259,de,o
116,0211-699501013259,riesgo,o
116,0211-699501013259,independiente,o
116,0211-699501013259,de,o
116,0211-699501013259,morbimortalidad,o
116,0211-699501013259,cardiovascular,i
116,0211-699501013259,Hemos,o
116,0211-699501013259,intentado,o
116,0211-699501013259,prospectivamente,o
116,0211-699501013259,reducir,o
116,0211-699501013259,los,o
116,0211-699501013259,niveles,i
116,0211-699501013259,de,i
116,0211-699501013259,homocisteina,i
116,0211-699501013259,total,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,mediante,o
116,0211-699501013259,suplemento,o
116,0211-699501013259,con,o
116,0211-699501013259,acido,i
116,0211-699501013259,folico,i
116,0211-699501013259,y,o
116,0211-699501013259,vitamina,i
116,0211-699501013259,B6,i
116,0211-699501013259,pp,i
116,0211-699501013259,valorando,o
116,0211-699501013259,su,o
116,0211-699501013259,posible,o
116,0211-699501013259,correlacion,o
116,0211-699501013259,con,o
116,0211-699501013259,dosis,o
116,0211-699501013259,de,o
116,0211-699501013259,dialisis,i
116,0211-699501013259,funcion,i
116,0211-699501013259,residual,i
116,0211-699501013259,y,o
116,0211-699501013259,parametros,o
116,0211-699501013259,nutricionales,o
116,0211-699501013259,Metodos,o
116,0211-699501013259,Todos,o
116,0211-699501013259,los,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,en,o
116,0211-699501013259,hemodialisis,i
116,0211-699501013259,al,o
116,0211-699501013259,comienzo,o
116,0211-699501013259,del,o
116,0211-699501013259,estudio,o
116,0211-699501013259,que,o
116,0211-699501013259,no,o
116,0211-699501013259,recibian,o
116,0211-699501013259,acido,i
116,0211-699501013259,folico,i
116,0211-699501013259,ni,o
116,0211-699501013259,vitamina,i
116,0211-699501013259,B6,i
116,0211-699501013259,asi,o
116,0211-699501013259,como,o
116,0211-699501013259,los,o
116,0211-699501013259,incorporados,o
116,0211-699501013259,posteriormente,o
116,0211-699501013259,a,o
116,0211-699501013259,partir,o
116,0211-699501013259,de,o
116,0211-699501013259,su,o
116,0211-699501013259,tercer,o
116,0211-699501013259,mes,o
116,0211-699501013259,en,o
116,0211-699501013259,hemodialisis,i
116,0211-699501013259,recibieron,o
116,0211-699501013259,5,o
116,0211-699501013259,mg,o
116,0211-699501013259,orales,o
116,0211-699501013259,de,o
116,0211-699501013259,acido,i
116,0211-699501013259,folico,i
116,0211-699501013259,cada,o
116,0211-699501013259,48,o
116,0211-699501013259,horas,o
116,0211-699501013259,y,o
116,0211-699501013259,40,o
116,0211-699501013259,mg,o
116,0211-699501013259,orales,o
116,0211-699501013259,de,o
116,0211-699501013259,vitamina,i
116,0211-699501013259,B6,i
116,0211-699501013259,cada,o
116,0211-699501013259,semana,o
116,0211-699501013259,Se,o
116,0211-699501013259,determinaron,o
116,0211-699501013259,al,o
116,0211-699501013259,comienzo,o
116,0211-699501013259,del,o
116,0211-699501013259,estudio,o
116,0211-699501013259,y,o
116,0211-699501013259,cada,o
116,0211-699501013259,2,o
116,0211-699501013259,meses,o
116,0211-699501013259,niveles,i
116,0211-699501013259,de,i
116,0211-699501013259,folato,i
116,0211-699501013259,vitamina,i
116,0211-699501013259,B12,i
116,0211-699501013259,inmunoensayo,i
116,0211-699501013259,albumina,i
116,0211-699501013259,y,o
116,0211-699501013259,cinetica,o
116,0211-699501013259,de,o
116,0211-699501013259,la,o
116,0211-699501013259,urea,i
116,0211-699501013259,KTV,o
116,0211-699501013259,KRU,o
116,0211-699501013259,PCRn,o
116,0211-699501013259,y,o
116,0211-699501013259,cada,o
116,0211-699501013259,6,o
116,0211-699501013259,meses,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,HPLC,i
116,0211-699501013259,y,o
116,0211-699501013259,pp,i
116,0211-699501013259,RIA,i
116,0211-699501013259,Resultados,o
116,0211-699501013259,80,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,fueron,o
116,0211-699501013259,incluidos,o
116,0211-699501013259,en,o
116,0211-699501013259,el,o
116,0211-699501013259,estudio,o
116,0211-699501013259,basal,o
116,0211-699501013259,con,o
116,0211-699501013259,una,o
116,0211-699501013259,prevalencia,o
116,0211-699501013259,de,o
116,0211-699501013259,hiperhomocisteinemia,i
116,0211-699501013259,del,o
116,0211-699501013259,844,o
116,0211-699501013259,deficit,i
116,0211-699501013259,de,i
116,0211-699501013259,pp,i
116,0211-699501013259,en,o
116,0211-699501013259,el,o
116,0211-699501013259,32,o
116,0211-699501013259,y,o
116,0211-699501013259,folato,i
116,0211-699501013259,en,o
116,0211-699501013259,el,o
116,0211-699501013259,rango,o
116,0211-699501013259,normal,o
116,0211-699501013259,bajo,o
116,0211-699501013259,los,o
116,0211-699501013259,niveles,i
116,0211-699501013259,de,i
116,0211-699501013259,tHcy,i
116,0211-699501013259,se,o
116,0211-699501013259,correlacionaban,o
116,0211-699501013259,inversamente,o
116,0211-699501013259,con,o
116,0211-699501013259,los,o
116,0211-699501013259,del,o
116,0211-699501013259,folato,i
116,0211-699501013259,r,o
116,0211-699501013259,0336,o
116,0211-699501013259,p,o
116,0211-699501013259,001,o
116,0211-699501013259,pero,o
116,0211-699501013259,no,o
116,0211-699501013259,con,o
116,0211-699501013259,pp,i
116,0211-699501013259,B12,i
116,0211-699501013259,edad,o
116,0211-699501013259,albumina,i
116,0211-699501013259,KTV,o
116,0211-699501013259,KRU,o
116,0211-699501013259,PCRn,o
116,0211-699501013259,Cincuenta,o
116,0211-699501013259,y,o
116,0211-699501013259,ocho,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,recibieron,o
116,0211-699501013259,seis,o
116,0211-699501013259,meses,o
116,0211-699501013259,de,o
116,0211-699501013259,suplementacion,i
116,0211-699501013259,con,o
116,0211-699501013259,normalizacion,o
116,0211-699501013259,del,o
116,0211-699501013259,pp,i
116,0211-699501013259,aumento,o
116,0211-699501013259,del,o
116,0211-699501013259,folato,i
116,0211-699501013259,703,o
116,0211-699501013259,IC,o
116,0211-699501013259,638,o
116,0211-699501013259,795,o
116,0211-699501013259,vs,o
116,0211-699501013259,6181,o
116,0211-699501013259,IC,o
116,0211-699501013259,4447,o
116,0211-699501013259,7811,o
116,0211-699501013259,p,o
116,0211-699501013259,0001,o
116,0211-699501013259,y,o
116,0211-699501013259,descenso,o
116,0211-699501013259,de,o
116,0211-699501013259,la,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,240,o
116,0211-699501013259,IC,o
116,0211-699501013259,213,o
116,0211-699501013259,264,o
116,0211-699501013259,vs,o
116,0211-699501013259,199,o
116,0211-699501013259,IC,o
116,0211-699501013259,175,o
116,0211-699501013259,224,o
116,0211-699501013259,p,o
116,0211-699501013259,005,o
116,0211-699501013259,Han,o
116,0211-699501013259,recibido,o
116,0211-699501013259,suplementacion,i
116,0211-699501013259,durante,o
116,0211-699501013259,12,o
116,0211-699501013259,meses,o
116,0211-699501013259,33,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,pero,o
116,0211-699501013259,a,o
116,0211-699501013259,pesar,o
116,0211-699501013259,de,o
116,0211-699501013259,un,o
116,0211-699501013259,continuo,o
116,0211-699501013259,aumento,o
116,0211-699501013259,del,o
116,0211-699501013259,folato,i
116,0211-699501013259,10078,o
116,0211-699501013259,IC,o
116,0211-699501013259,7481,o
116,0211-699501013259,12674,o
116,0211-699501013259,p,o
116,0211-699501013259,0001,o
116,0211-699501013259,solo,o
116,0211-699501013259,3,o
116,0211-699501013259,pacientes,o
116,0211-699501013259,presentan,o
116,0211-699501013259,niveles,o
116,0211-699501013259,normales,o
116,0211-699501013259,de,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,correlacionandose,o
116,0211-699501013259,directamente,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,con,o
116,0211-699501013259,la,o
116,0211-699501013259,albumina,i
116,0211-699501013259,r,o
116,0211-699501013259,056,o
116,0211-699501013259,p,o
116,0211-699501013259,0001,o
116,0211-699501013259,que,o
116,0211-699501013259,se,o
116,0211-699501013259,elevo,o
116,0211-699501013259,con,o
116,0211-699501013259,respecto,o
116,0211-699501013259,al,o
116,0211-699501013259,inicio,o
116,0211-699501013259,337,o
116,0211-699501013259,IC,o
116,0211-699501013259,327,o
116,0211-699501013259,346,o
116,0211-699501013259,vs,o
116,0211-699501013259,350,o
116,0211-699501013259,IC,o
116,0211-699501013259,337,o
116,0211-699501013259,363,o
116,0211-699501013259,p,o
116,0211-699501013259,005,o
116,0211-699501013259,Conclusion,o
116,0211-699501013259,Tras,o
116,0211-699501013259,suplementacion,i
116,0211-699501013259,con,o
116,0211-699501013259,acido,i
116,0211-699501013259,folico,i
116,0211-699501013259,y,o
116,0211-699501013259,vitamina,i
116,0211-699501013259,B6,i
116,0211-699501013259,aunque,o
116,0211-699501013259,inicialmente,o
116,0211-699501013259,se,o
116,0211-699501013259,reduce,o
116,0211-699501013259,la,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,esta,o
116,0211-699501013259,respuesta,o
116,0211-699501013259,se,o
116,0211-699501013259,hace,o
116,0211-699501013259,refractaria,o
116,0211-699501013259,correlacionandose,o
116,0211-699501013259,directamente,o
116,0211-699501013259,la,o
116,0211-699501013259,tHcy,i
116,0211-699501013259,con,o
116,0211-699501013259,la,o
116,0211-699501013259,albumina,i
116,0211-699501013259,plasmatica,i
116,0211-699501013259,La,o
116,0211-699501013259,interpretacion,o
116,0211-699501013259,de,o
116,0211-699501013259,los,o
116,0211-699501013259,niveles,i
116,0211-699501013259,de,i
116,0211-699501013259,tHcy,i
116,0211-699501013259,debe,o
116,0211-699501013259,tener,o
116,0211-699501013259,en,o
116,0211-699501013259,cuenta,o
116,0211-699501013259,la,o
116,0211-699501013259,concentracion,i
116,0211-699501013259,de,i
116,0211-699501013259,albumina,i
117,0211-699501013259,Efecto,o
117,0211-699501013259,de,o
117,0211-699501013259,la,o
117,0211-699501013259,suplementacion,i
117,0211-699501013259,con,o
117,0211-699501013259,acido,i
117,0211-699501013259,folico,i
117,0211-699501013259,sobre,o
117,0211-699501013259,los,o
117,0211-699501013259,niveles,i
117,0211-699501013259,de,i
117,0211-699501013259,homocisteina,i
117,0211-699501013259,total,o
117,0211-699501013259,en,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,en,o
117,0211-699501013259,hemodialisis,i
117,0211-699501013259,La,o
117,0211-699501013259,hiperhomocisteinemia,i
117,0211-699501013259,es,o
117,0211-699501013259,un,o
117,0211-699501013259,marcador,o
117,0211-699501013259,de,o
117,0211-699501013259,riesgo,o
117,0211-699501013259,independiente,o
117,0211-699501013259,de,o
117,0211-699501013259,morbimortalidad,o
117,0211-699501013259,cardiovascular,i
117,0211-699501013259,Hemos,o
117,0211-699501013259,intentado,o
117,0211-699501013259,prospectivamente,o
117,0211-699501013259,reducir,o
117,0211-699501013259,los,o
117,0211-699501013259,niveles,i
117,0211-699501013259,de,i
117,0211-699501013259,homocisteina,i
117,0211-699501013259,total,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,mediante,o
117,0211-699501013259,suplemento,o
117,0211-699501013259,con,o
117,0211-699501013259,acido,i
117,0211-699501013259,folico,i
117,0211-699501013259,y,o
117,0211-699501013259,vitamina,i
117,0211-699501013259,B6,i
117,0211-699501013259,pp,i
117,0211-699501013259,valorando,o
117,0211-699501013259,su,o
117,0211-699501013259,posible,o
117,0211-699501013259,correlacion,o
117,0211-699501013259,con,o
117,0211-699501013259,dosis,o
117,0211-699501013259,de,o
117,0211-699501013259,dialisis,i
117,0211-699501013259,funcion,i
117,0211-699501013259,residual,i
117,0211-699501013259,y,o
117,0211-699501013259,parametros,o
117,0211-699501013259,nutricionales,o
117,0211-699501013259,Metodos,o
117,0211-699501013259,Todos,o
117,0211-699501013259,los,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,en,o
117,0211-699501013259,hemodialisis,i
117,0211-699501013259,al,o
117,0211-699501013259,comienzo,o
117,0211-699501013259,del,o
117,0211-699501013259,estudio,o
117,0211-699501013259,que,o
117,0211-699501013259,no,o
117,0211-699501013259,recibian,o
117,0211-699501013259,acido,i
117,0211-699501013259,folico,i
117,0211-699501013259,ni,o
117,0211-699501013259,vitamina,i
117,0211-699501013259,B6,i
117,0211-699501013259,asi,o
117,0211-699501013259,como,o
117,0211-699501013259,los,o
117,0211-699501013259,incorporados,o
117,0211-699501013259,posteriormente,o
117,0211-699501013259,a,o
117,0211-699501013259,partir,o
117,0211-699501013259,de,o
117,0211-699501013259,su,o
117,0211-699501013259,tercer,o
117,0211-699501013259,mes,o
117,0211-699501013259,en,o
117,0211-699501013259,hemodialisis,i
117,0211-699501013259,recibieron,o
117,0211-699501013259,5,o
117,0211-699501013259,mg,o
117,0211-699501013259,orales,o
117,0211-699501013259,de,o
117,0211-699501013259,acido,i
117,0211-699501013259,folico,i
117,0211-699501013259,cada,o
117,0211-699501013259,48,o
117,0211-699501013259,horas,o
117,0211-699501013259,y,o
117,0211-699501013259,40,o
117,0211-699501013259,mg,o
117,0211-699501013259,orales,o
117,0211-699501013259,de,o
117,0211-699501013259,vitamina,i
117,0211-699501013259,B6,i
117,0211-699501013259,cada,o
117,0211-699501013259,semana,o
117,0211-699501013259,Se,o
117,0211-699501013259,determinaron,o
117,0211-699501013259,al,o
117,0211-699501013259,comienzo,o
117,0211-699501013259,del,o
117,0211-699501013259,estudio,o
117,0211-699501013259,y,o
117,0211-699501013259,cada,o
117,0211-699501013259,2,o
117,0211-699501013259,meses,o
117,0211-699501013259,niveles,i
117,0211-699501013259,de,i
117,0211-699501013259,folato,i
117,0211-699501013259,vitamina,i
117,0211-699501013259,B12,i
117,0211-699501013259,inmunoensayo,i
117,0211-699501013259,albumina,i
117,0211-699501013259,y,o
117,0211-699501013259,cinetica,o
117,0211-699501013259,de,o
117,0211-699501013259,la,o
117,0211-699501013259,urea,i
117,0211-699501013259,KTV,o
117,0211-699501013259,KRU,o
117,0211-699501013259,PCRn,o
117,0211-699501013259,y,o
117,0211-699501013259,cada,o
117,0211-699501013259,6,o
117,0211-699501013259,meses,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,HPLC,i
117,0211-699501013259,y,o
117,0211-699501013259,pp,i
117,0211-699501013259,RIA,i
117,0211-699501013259,Resultados,o
117,0211-699501013259,80,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,fueron,o
117,0211-699501013259,incluidos,o
117,0211-699501013259,en,o
117,0211-699501013259,el,o
117,0211-699501013259,estudio,o
117,0211-699501013259,basal,o
117,0211-699501013259,con,o
117,0211-699501013259,una,o
117,0211-699501013259,prevalencia,o
117,0211-699501013259,de,o
117,0211-699501013259,hiperhomocisteinemia,i
117,0211-699501013259,del,o
117,0211-699501013259,844,o
117,0211-699501013259,deficit,i
117,0211-699501013259,de,i
117,0211-699501013259,pp,i
117,0211-699501013259,en,o
117,0211-699501013259,el,o
117,0211-699501013259,32,o
117,0211-699501013259,y,o
117,0211-699501013259,folato,i
117,0211-699501013259,en,o
117,0211-699501013259,el,o
117,0211-699501013259,rango,o
117,0211-699501013259,normal,o
117,0211-699501013259,bajo,o
117,0211-699501013259,los,o
117,0211-699501013259,niveles,i
117,0211-699501013259,de,i
117,0211-699501013259,tHcy,i
117,0211-699501013259,se,o
117,0211-699501013259,correlacionaban,o
117,0211-699501013259,inversamente,o
117,0211-699501013259,con,o
117,0211-699501013259,los,o
117,0211-699501013259,del,o
117,0211-699501013259,folato,i
117,0211-699501013259,r,o
117,0211-699501013259,0336,o
117,0211-699501013259,p,o
117,0211-699501013259,001,o
117,0211-699501013259,pero,o
117,0211-699501013259,no,o
117,0211-699501013259,con,o
117,0211-699501013259,pp,i
117,0211-699501013259,B12,i
117,0211-699501013259,edad,o
117,0211-699501013259,albumina,i
117,0211-699501013259,KTV,o
117,0211-699501013259,KRU,o
117,0211-699501013259,PCRn,o
117,0211-699501013259,Cincuenta,o
117,0211-699501013259,y,o
117,0211-699501013259,ocho,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,recibieron,o
117,0211-699501013259,seis,o
117,0211-699501013259,meses,o
117,0211-699501013259,de,o
117,0211-699501013259,suplementacion,i
117,0211-699501013259,con,o
117,0211-699501013259,normalizacion,o
117,0211-699501013259,del,o
117,0211-699501013259,pp,i
117,0211-699501013259,aumento,o
117,0211-699501013259,del,o
117,0211-699501013259,folato,i
117,0211-699501013259,703,o
117,0211-699501013259,IC,o
117,0211-699501013259,638,o
117,0211-699501013259,795,o
117,0211-699501013259,vs,o
117,0211-699501013259,6181,o
117,0211-699501013259,IC,o
117,0211-699501013259,4447,o
117,0211-699501013259,7811,o
117,0211-699501013259,p,o
117,0211-699501013259,0001,o
117,0211-699501013259,y,o
117,0211-699501013259,descenso,o
117,0211-699501013259,de,o
117,0211-699501013259,la,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,240,o
117,0211-699501013259,IC,o
117,0211-699501013259,213,o
117,0211-699501013259,264,o
117,0211-699501013259,vs,o
117,0211-699501013259,199,o
117,0211-699501013259,IC,o
117,0211-699501013259,175,o
117,0211-699501013259,224,o
117,0211-699501013259,p,o
117,0211-699501013259,005,o
117,0211-699501013259,Han,o
117,0211-699501013259,recibido,o
117,0211-699501013259,suplementacion,i
117,0211-699501013259,durante,o
117,0211-699501013259,12,o
117,0211-699501013259,meses,o
117,0211-699501013259,33,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,pero,o
117,0211-699501013259,a,o
117,0211-699501013259,pesar,o
117,0211-699501013259,de,o
117,0211-699501013259,un,o
117,0211-699501013259,continuo,o
117,0211-699501013259,aumento,o
117,0211-699501013259,del,o
117,0211-699501013259,folato,i
117,0211-699501013259,10078,o
117,0211-699501013259,IC,o
117,0211-699501013259,7481,o
117,0211-699501013259,12674,o
117,0211-699501013259,p,o
117,0211-699501013259,0001,o
117,0211-699501013259,solo,o
117,0211-699501013259,3,o
117,0211-699501013259,pacientes,o
117,0211-699501013259,presentan,o
117,0211-699501013259,niveles,o
117,0211-699501013259,normales,o
117,0211-699501013259,de,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,correlacionandose,o
117,0211-699501013259,directamente,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,con,o
117,0211-699501013259,la,o
117,0211-699501013259,albumina,i
117,0211-699501013259,r,o
117,0211-699501013259,056,o
117,0211-699501013259,p,o
117,0211-699501013259,0001,o
117,0211-699501013259,que,o
117,0211-699501013259,se,o
117,0211-699501013259,elevo,o
117,0211-699501013259,con,o
117,0211-699501013259,respecto,o
117,0211-699501013259,al,o
117,0211-699501013259,inicio,o
117,0211-699501013259,337,o
117,0211-699501013259,IC,o
117,0211-699501013259,327,o
117,0211-699501013259,346,o
117,0211-699501013259,vs,o
117,0211-699501013259,350,o
117,0211-699501013259,IC,o
117,0211-699501013259,337,o
117,0211-699501013259,363,o
117,0211-699501013259,p,o
117,0211-699501013259,005,o
117,0211-699501013259,Conclusion,o
117,0211-699501013259,Tras,o
117,0211-699501013259,suplementacion,i
117,0211-699501013259,con,o
117,0211-699501013259,acido,i
117,0211-699501013259,folico,i
117,0211-699501013259,y,o
117,0211-699501013259,vitamina,i
117,0211-699501013259,B6,i
117,0211-699501013259,aunque,o
117,0211-699501013259,inicialmente,o
117,0211-699501013259,se,o
117,0211-699501013259,reduce,o
117,0211-699501013259,la,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,esta,o
117,0211-699501013259,respuesta,o
117,0211-699501013259,se,o
117,0211-699501013259,hace,o
117,0211-699501013259,refractaria,o
117,0211-699501013259,correlacionandose,o
117,0211-699501013259,directamente,o
117,0211-699501013259,la,o
117,0211-699501013259,tHcy,i
117,0211-699501013259,con,o
117,0211-699501013259,la,o
117,0211-699501013259,albumina,i
117,0211-699501013259,plasmatica,i
117,0211-699501013259,La,o
117,0211-699501013259,interpretacion,o
117,0211-699501013259,de,o
117,0211-699501013259,los,o
117,0211-699501013259,niveles,i
117,0211-699501013259,de,i
117,0211-699501013259,tHcy,i
117,0211-699501013259,debe,o
117,0211-699501013259,tener,o
117,0211-699501013259,en,o
117,0211-699501013259,cuenta,o
117,0211-699501013259,la,o
117,0211-699501013259,concentracion,i
117,0211-699501013259,de,i
117,0211-699501013259,albumina,i
118,0211-699501013259,Efecto,o
118,0211-699501013259,de,o
118,0211-699501013259,la,o
118,0211-699501013259,suplementacion,i
118,0211-699501013259,con,o
118,0211-699501013259,acido,i
118,0211-699501013259,folico,i
118,0211-699501013259,sobre,o
118,0211-699501013259,los,o
118,0211-699501013259,niveles,i
118,0211-699501013259,de,i
118,0211-699501013259,homocisteina,i
118,0211-699501013259,total,o
118,0211-699501013259,en,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,en,o
118,0211-699501013259,hemodialisis,i
118,0211-699501013259,La,o
118,0211-699501013259,hiperhomocisteinemia,i
118,0211-699501013259,es,o
118,0211-699501013259,un,o
118,0211-699501013259,marcador,o
118,0211-699501013259,de,o
118,0211-699501013259,riesgo,o
118,0211-699501013259,independiente,o
118,0211-699501013259,de,o
118,0211-699501013259,morbimortalidad,o
118,0211-699501013259,cardiovascular,i
118,0211-699501013259,Hemos,o
118,0211-699501013259,intentado,o
118,0211-699501013259,prospectivamente,o
118,0211-699501013259,reducir,o
118,0211-699501013259,los,o
118,0211-699501013259,niveles,i
118,0211-699501013259,de,i
118,0211-699501013259,homocisteina,i
118,0211-699501013259,total,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,mediante,o
118,0211-699501013259,suplemento,o
118,0211-699501013259,con,o
118,0211-699501013259,acido,i
118,0211-699501013259,folico,i
118,0211-699501013259,y,o
118,0211-699501013259,vitamina,i
118,0211-699501013259,B6,i
118,0211-699501013259,pp,i
118,0211-699501013259,valorando,o
118,0211-699501013259,su,o
118,0211-699501013259,posible,o
118,0211-699501013259,correlacion,o
118,0211-699501013259,con,o
118,0211-699501013259,dosis,o
118,0211-699501013259,de,o
118,0211-699501013259,dialisis,i
118,0211-699501013259,funcion,i
118,0211-699501013259,residual,i
118,0211-699501013259,y,o
118,0211-699501013259,parametros,o
118,0211-699501013259,nutricionales,o
118,0211-699501013259,Metodos,o
118,0211-699501013259,Todos,o
118,0211-699501013259,los,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,en,o
118,0211-699501013259,hemodialisis,i
118,0211-699501013259,al,o
118,0211-699501013259,comienzo,o
118,0211-699501013259,del,o
118,0211-699501013259,estudio,o
118,0211-699501013259,que,o
118,0211-699501013259,no,o
118,0211-699501013259,recibian,o
118,0211-699501013259,acido,i
118,0211-699501013259,folico,i
118,0211-699501013259,ni,o
118,0211-699501013259,vitamina,i
118,0211-699501013259,B6,i
118,0211-699501013259,asi,o
118,0211-699501013259,como,o
118,0211-699501013259,los,o
118,0211-699501013259,incorporados,o
118,0211-699501013259,posteriormente,o
118,0211-699501013259,a,o
118,0211-699501013259,partir,o
118,0211-699501013259,de,o
118,0211-699501013259,su,o
118,0211-699501013259,tercer,o
118,0211-699501013259,mes,o
118,0211-699501013259,en,o
118,0211-699501013259,hemodialisis,i
118,0211-699501013259,recibieron,o
118,0211-699501013259,5,o
118,0211-699501013259,mg,o
118,0211-699501013259,orales,o
118,0211-699501013259,de,o
118,0211-699501013259,acido,i
118,0211-699501013259,folico,i
118,0211-699501013259,cada,o
118,0211-699501013259,48,o
118,0211-699501013259,horas,o
118,0211-699501013259,y,o
118,0211-699501013259,40,o
118,0211-699501013259,mg,o
118,0211-699501013259,orales,o
118,0211-699501013259,de,o
118,0211-699501013259,vitamina,i
118,0211-699501013259,B6,i
118,0211-699501013259,cada,o
118,0211-699501013259,semana,o
118,0211-699501013259,Se,o
118,0211-699501013259,determinaron,o
118,0211-699501013259,al,o
118,0211-699501013259,comienzo,o
118,0211-699501013259,del,o
118,0211-699501013259,estudio,o
118,0211-699501013259,y,o
118,0211-699501013259,cada,o
118,0211-699501013259,2,o
118,0211-699501013259,meses,o
118,0211-699501013259,niveles,i
118,0211-699501013259,de,i
118,0211-699501013259,folato,i
118,0211-699501013259,vitamina,i
118,0211-699501013259,B12,i
118,0211-699501013259,inmunoensayo,i
118,0211-699501013259,albumina,i
118,0211-699501013259,y,o
118,0211-699501013259,cinetica,o
118,0211-699501013259,de,o
118,0211-699501013259,la,o
118,0211-699501013259,urea,i
118,0211-699501013259,KTV,o
118,0211-699501013259,KRU,o
118,0211-699501013259,PCRn,o
118,0211-699501013259,y,o
118,0211-699501013259,cada,o
118,0211-699501013259,6,o
118,0211-699501013259,meses,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,HPLC,i
118,0211-699501013259,y,o
118,0211-699501013259,pp,i
118,0211-699501013259,RIA,i
118,0211-699501013259,Resultados,o
118,0211-699501013259,80,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,fueron,o
118,0211-699501013259,incluidos,o
118,0211-699501013259,en,o
118,0211-699501013259,el,o
118,0211-699501013259,estudio,o
118,0211-699501013259,basal,o
118,0211-699501013259,con,o
118,0211-699501013259,una,o
118,0211-699501013259,prevalencia,o
118,0211-699501013259,de,o
118,0211-699501013259,hiperhomocisteinemia,i
118,0211-699501013259,del,o
118,0211-699501013259,844,o
118,0211-699501013259,deficit,i
118,0211-699501013259,de,i
118,0211-699501013259,pp,i
118,0211-699501013259,en,o
118,0211-699501013259,el,o
118,0211-699501013259,32,o
118,0211-699501013259,y,o
118,0211-699501013259,folato,i
118,0211-699501013259,en,o
118,0211-699501013259,el,o
118,0211-699501013259,rango,o
118,0211-699501013259,normal,o
118,0211-699501013259,bajo,o
118,0211-699501013259,los,o
118,0211-699501013259,niveles,i
118,0211-699501013259,de,i
118,0211-699501013259,tHcy,i
118,0211-699501013259,se,o
118,0211-699501013259,correlacionaban,o
118,0211-699501013259,inversamente,o
118,0211-699501013259,con,o
118,0211-699501013259,los,o
118,0211-699501013259,del,o
118,0211-699501013259,folato,i
118,0211-699501013259,r,o
118,0211-699501013259,0336,o
118,0211-699501013259,p,o
118,0211-699501013259,001,o
118,0211-699501013259,pero,o
118,0211-699501013259,no,o
118,0211-699501013259,con,o
118,0211-699501013259,pp,i
118,0211-699501013259,B12,i
118,0211-699501013259,edad,o
118,0211-699501013259,albumina,i
118,0211-699501013259,KTV,o
118,0211-699501013259,KRU,o
118,0211-699501013259,PCRn,o
118,0211-699501013259,Cincuenta,o
118,0211-699501013259,y,o
118,0211-699501013259,ocho,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,recibieron,o
118,0211-699501013259,seis,o
118,0211-699501013259,meses,o
118,0211-699501013259,de,o
118,0211-699501013259,suplementacion,i
118,0211-699501013259,con,o
118,0211-699501013259,normalizacion,o
118,0211-699501013259,del,o
118,0211-699501013259,pp,i
118,0211-699501013259,aumento,o
118,0211-699501013259,del,o
118,0211-699501013259,folato,i
118,0211-699501013259,703,o
118,0211-699501013259,IC,o
118,0211-699501013259,638,o
118,0211-699501013259,795,o
118,0211-699501013259,vs,o
118,0211-699501013259,6181,o
118,0211-699501013259,IC,o
118,0211-699501013259,4447,o
118,0211-699501013259,7811,o
118,0211-699501013259,p,o
118,0211-699501013259,0001,o
118,0211-699501013259,y,o
118,0211-699501013259,descenso,o
118,0211-699501013259,de,o
118,0211-699501013259,la,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,240,o
118,0211-699501013259,IC,o
118,0211-699501013259,213,o
118,0211-699501013259,264,o
118,0211-699501013259,vs,o
118,0211-699501013259,199,o
118,0211-699501013259,IC,o
118,0211-699501013259,175,o
118,0211-699501013259,224,o
118,0211-699501013259,p,o
118,0211-699501013259,005,o
118,0211-699501013259,Han,o
118,0211-699501013259,recibido,o
118,0211-699501013259,suplementacion,i
118,0211-699501013259,durante,o
118,0211-699501013259,12,o
118,0211-699501013259,meses,o
118,0211-699501013259,33,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,pero,o
118,0211-699501013259,a,o
118,0211-699501013259,pesar,o
118,0211-699501013259,de,o
118,0211-699501013259,un,o
118,0211-699501013259,continuo,o
118,0211-699501013259,aumento,o
118,0211-699501013259,del,o
118,0211-699501013259,folato,i
118,0211-699501013259,10078,o
118,0211-699501013259,IC,o
118,0211-699501013259,7481,o
118,0211-699501013259,12674,o
118,0211-699501013259,p,o
118,0211-699501013259,0001,o
118,0211-699501013259,solo,o
118,0211-699501013259,3,o
118,0211-699501013259,pacientes,o
118,0211-699501013259,presentan,o
118,0211-699501013259,niveles,o
118,0211-699501013259,normales,o
118,0211-699501013259,de,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,correlacionandose,o
118,0211-699501013259,directamente,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,con,o
118,0211-699501013259,la,o
118,0211-699501013259,albumina,i
118,0211-699501013259,r,o
118,0211-699501013259,056,o
118,0211-699501013259,p,o
118,0211-699501013259,0001,o
118,0211-699501013259,que,o
118,0211-699501013259,se,o
118,0211-699501013259,elevo,o
118,0211-699501013259,con,o
118,0211-699501013259,respecto,o
118,0211-699501013259,al,o
118,0211-699501013259,inicio,o
118,0211-699501013259,337,o
118,0211-699501013259,IC,o
118,0211-699501013259,327,o
118,0211-699501013259,346,o
118,0211-699501013259,vs,o
118,0211-699501013259,350,o
118,0211-699501013259,IC,o
118,0211-699501013259,337,o
118,0211-699501013259,363,o
118,0211-699501013259,p,o
118,0211-699501013259,005,o
118,0211-699501013259,Conclusion,o
118,0211-699501013259,Tras,o
118,0211-699501013259,suplementacion,i
118,0211-699501013259,con,o
118,0211-699501013259,acido,i
118,0211-699501013259,folico,i
118,0211-699501013259,y,o
118,0211-699501013259,vitamina,i
118,0211-699501013259,B6,i
118,0211-699501013259,aunque,o
118,0211-699501013259,inicialmente,o
118,0211-699501013259,se,o
118,0211-699501013259,reduce,o
118,0211-699501013259,la,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,esta,o
118,0211-699501013259,respuesta,o
118,0211-699501013259,se,o
118,0211-699501013259,hace,o
118,0211-699501013259,refractaria,o
118,0211-699501013259,correlacionandose,o
118,0211-699501013259,directamente,o
118,0211-699501013259,la,o
118,0211-699501013259,tHcy,i
118,0211-699501013259,con,o
118,0211-699501013259,la,o
118,0211-699501013259,albumina,i
118,0211-699501013259,plasmatica,i
118,0211-699501013259,La,o
118,0211-699501013259,interpretacion,o
118,0211-699501013259,de,o
118,0211-699501013259,los,o
118,0211-699501013259,niveles,i
118,0211-699501013259,de,i
118,0211-699501013259,tHcy,i
118,0211-699501013259,debe,o
118,0211-699501013259,tener,o
118,0211-699501013259,en,o
118,0211-699501013259,cuenta,o
118,0211-699501013259,la,o
118,0211-699501013259,concentracion,i
118,0211-699501013259,de,i
118,0211-699501013259,albumina,i
119,0211-699501013259,Efecto,o
119,0211-699501013259,de,o
119,0211-699501013259,la,o
119,0211-699501013259,suplementacion,i
119,0211-699501013259,con,o
119,0211-699501013259,acido,i
119,0211-699501013259,folico,i
119,0211-699501013259,sobre,o
119,0211-699501013259,los,o
119,0211-699501013259,niveles,i
119,0211-699501013259,de,i
119,0211-699501013259,homocisteina,i
119,0211-699501013259,total,o
119,0211-699501013259,en,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,en,o
119,0211-699501013259,hemodialisis,i
119,0211-699501013259,La,o
119,0211-699501013259,hiperhomocisteinemia,i
119,0211-699501013259,es,o
119,0211-699501013259,un,o
119,0211-699501013259,marcador,o
119,0211-699501013259,de,o
119,0211-699501013259,riesgo,o
119,0211-699501013259,independiente,o
119,0211-699501013259,de,o
119,0211-699501013259,morbimortalidad,o
119,0211-699501013259,cardiovascular,i
119,0211-699501013259,Hemos,o
119,0211-699501013259,intentado,o
119,0211-699501013259,prospectivamente,o
119,0211-699501013259,reducir,o
119,0211-699501013259,los,o
119,0211-699501013259,niveles,i
119,0211-699501013259,de,i
119,0211-699501013259,homocisteina,i
119,0211-699501013259,total,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,mediante,o
119,0211-699501013259,suplemento,o
119,0211-699501013259,con,o
119,0211-699501013259,acido,i
119,0211-699501013259,folico,i
119,0211-699501013259,y,o
119,0211-699501013259,vitamina,i
119,0211-699501013259,B6,i
119,0211-699501013259,pp,i
119,0211-699501013259,valorando,o
119,0211-699501013259,su,o
119,0211-699501013259,posible,o
119,0211-699501013259,correlacion,o
119,0211-699501013259,con,o
119,0211-699501013259,dosis,o
119,0211-699501013259,de,o
119,0211-699501013259,dialisis,i
119,0211-699501013259,funcion,i
119,0211-699501013259,residual,i
119,0211-699501013259,y,o
119,0211-699501013259,parametros,o
119,0211-699501013259,nutricionales,o
119,0211-699501013259,Metodos,o
119,0211-699501013259,Todos,o
119,0211-699501013259,los,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,en,o
119,0211-699501013259,hemodialisis,i
119,0211-699501013259,al,o
119,0211-699501013259,comienzo,o
119,0211-699501013259,del,o
119,0211-699501013259,estudio,o
119,0211-699501013259,que,o
119,0211-699501013259,no,o
119,0211-699501013259,recibian,o
119,0211-699501013259,acido,i
119,0211-699501013259,folico,i
119,0211-699501013259,ni,o
119,0211-699501013259,vitamina,i
119,0211-699501013259,B6,i
119,0211-699501013259,asi,o
119,0211-699501013259,como,o
119,0211-699501013259,los,o
119,0211-699501013259,incorporados,o
119,0211-699501013259,posteriormente,o
119,0211-699501013259,a,o
119,0211-699501013259,partir,o
119,0211-699501013259,de,o
119,0211-699501013259,su,o
119,0211-699501013259,tercer,o
119,0211-699501013259,mes,o
119,0211-699501013259,en,o
119,0211-699501013259,hemodialisis,i
119,0211-699501013259,recibieron,o
119,0211-699501013259,5,o
119,0211-699501013259,mg,o
119,0211-699501013259,orales,o
119,0211-699501013259,de,o
119,0211-699501013259,acido,i
119,0211-699501013259,folico,i
119,0211-699501013259,cada,o
119,0211-699501013259,48,o
119,0211-699501013259,horas,o
119,0211-699501013259,y,o
119,0211-699501013259,40,o
119,0211-699501013259,mg,o
119,0211-699501013259,orales,o
119,0211-699501013259,de,o
119,0211-699501013259,vitamina,i
119,0211-699501013259,B6,i
119,0211-699501013259,cada,o
119,0211-699501013259,semana,o
119,0211-699501013259,Se,o
119,0211-699501013259,determinaron,o
119,0211-699501013259,al,o
119,0211-699501013259,comienzo,o
119,0211-699501013259,del,o
119,0211-699501013259,estudio,o
119,0211-699501013259,y,o
119,0211-699501013259,cada,o
119,0211-699501013259,2,o
119,0211-699501013259,meses,o
119,0211-699501013259,niveles,i
119,0211-699501013259,de,i
119,0211-699501013259,folato,i
119,0211-699501013259,vitamina,i
119,0211-699501013259,B12,i
119,0211-699501013259,inmunoensayo,i
119,0211-699501013259,albumina,i
119,0211-699501013259,y,o
119,0211-699501013259,cinetica,o
119,0211-699501013259,de,o
119,0211-699501013259,la,o
119,0211-699501013259,urea,i
119,0211-699501013259,KTV,o
119,0211-699501013259,KRU,o
119,0211-699501013259,PCRn,o
119,0211-699501013259,y,o
119,0211-699501013259,cada,o
119,0211-699501013259,6,o
119,0211-699501013259,meses,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,HPLC,i
119,0211-699501013259,y,o
119,0211-699501013259,pp,i
119,0211-699501013259,RIA,i
119,0211-699501013259,Resultados,o
119,0211-699501013259,80,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,fueron,o
119,0211-699501013259,incluidos,o
119,0211-699501013259,en,o
119,0211-699501013259,el,o
119,0211-699501013259,estudio,o
119,0211-699501013259,basal,o
119,0211-699501013259,con,o
119,0211-699501013259,una,o
119,0211-699501013259,prevalencia,o
119,0211-699501013259,de,o
119,0211-699501013259,hiperhomocisteinemia,i
119,0211-699501013259,del,o
119,0211-699501013259,844,o
119,0211-699501013259,deficit,i
119,0211-699501013259,de,i
119,0211-699501013259,pp,i
119,0211-699501013259,en,o
119,0211-699501013259,el,o
119,0211-699501013259,32,o
119,0211-699501013259,y,o
119,0211-699501013259,folato,i
119,0211-699501013259,en,o
119,0211-699501013259,el,o
119,0211-699501013259,rango,o
119,0211-699501013259,normal,o
119,0211-699501013259,bajo,o
119,0211-699501013259,los,o
119,0211-699501013259,niveles,i
119,0211-699501013259,de,i
119,0211-699501013259,tHcy,i
119,0211-699501013259,se,o
119,0211-699501013259,correlacionaban,o
119,0211-699501013259,inversamente,o
119,0211-699501013259,con,o
119,0211-699501013259,los,o
119,0211-699501013259,del,o
119,0211-699501013259,folato,i
119,0211-699501013259,r,o
119,0211-699501013259,0336,o
119,0211-699501013259,p,o
119,0211-699501013259,001,o
119,0211-699501013259,pero,o
119,0211-699501013259,no,o
119,0211-699501013259,con,o
119,0211-699501013259,pp,i
119,0211-699501013259,B12,i
119,0211-699501013259,edad,o
119,0211-699501013259,albumina,i
119,0211-699501013259,KTV,o
119,0211-699501013259,KRU,o
119,0211-699501013259,PCRn,o
119,0211-699501013259,Cincuenta,o
119,0211-699501013259,y,o
119,0211-699501013259,ocho,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,recibieron,o
119,0211-699501013259,seis,o
119,0211-699501013259,meses,o
119,0211-699501013259,de,o
119,0211-699501013259,suplementacion,i
119,0211-699501013259,con,o
119,0211-699501013259,normalizacion,o
119,0211-699501013259,del,o
119,0211-699501013259,pp,i
119,0211-699501013259,aumento,o
119,0211-699501013259,del,o
119,0211-699501013259,folato,i
119,0211-699501013259,703,o
119,0211-699501013259,IC,o
119,0211-699501013259,638,o
119,0211-699501013259,795,o
119,0211-699501013259,vs,o
119,0211-699501013259,6181,o
119,0211-699501013259,IC,o
119,0211-699501013259,4447,o
119,0211-699501013259,7811,o
119,0211-699501013259,p,o
119,0211-699501013259,0001,o
119,0211-699501013259,y,o
119,0211-699501013259,descenso,o
119,0211-699501013259,de,o
119,0211-699501013259,la,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,240,o
119,0211-699501013259,IC,o
119,0211-699501013259,213,o
119,0211-699501013259,264,o
119,0211-699501013259,vs,o
119,0211-699501013259,199,o
119,0211-699501013259,IC,o
119,0211-699501013259,175,o
119,0211-699501013259,224,o
119,0211-699501013259,p,o
119,0211-699501013259,005,o
119,0211-699501013259,Han,o
119,0211-699501013259,recibido,o
119,0211-699501013259,suplementacion,i
119,0211-699501013259,durante,o
119,0211-699501013259,12,o
119,0211-699501013259,meses,o
119,0211-699501013259,33,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,pero,o
119,0211-699501013259,a,o
119,0211-699501013259,pesar,o
119,0211-699501013259,de,o
119,0211-699501013259,un,o
119,0211-699501013259,continuo,o
119,0211-699501013259,aumento,o
119,0211-699501013259,del,o
119,0211-699501013259,folato,i
119,0211-699501013259,10078,o
119,0211-699501013259,IC,o
119,0211-699501013259,7481,o
119,0211-699501013259,12674,o
119,0211-699501013259,p,o
119,0211-699501013259,0001,o
119,0211-699501013259,solo,o
119,0211-699501013259,3,o
119,0211-699501013259,pacientes,o
119,0211-699501013259,presentan,o
119,0211-699501013259,niveles,o
119,0211-699501013259,normales,o
119,0211-699501013259,de,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,correlacionandose,o
119,0211-699501013259,directamente,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,con,o
119,0211-699501013259,la,o
119,0211-699501013259,albumina,i
119,0211-699501013259,r,o
119,0211-699501013259,056,o
119,0211-699501013259,p,o
119,0211-699501013259,0001,o
119,0211-699501013259,que,o
119,0211-699501013259,se,o
119,0211-699501013259,elevo,o
119,0211-699501013259,con,o
119,0211-699501013259,respecto,o
119,0211-699501013259,al,o
119,0211-699501013259,inicio,o
119,0211-699501013259,337,o
119,0211-699501013259,IC,o
119,0211-699501013259,327,o
119,0211-699501013259,346,o
119,0211-699501013259,vs,o
119,0211-699501013259,350,o
119,0211-699501013259,IC,o
119,0211-699501013259,337,o
119,0211-699501013259,363,o
119,0211-699501013259,p,o
119,0211-699501013259,005,o
119,0211-699501013259,Conclusion,o
119,0211-699501013259,Tras,o
119,0211-699501013259,suplementacion,i
119,0211-699501013259,con,o
119,0211-699501013259,acido,i
119,0211-699501013259,folico,i
119,0211-699501013259,y,o
119,0211-699501013259,vitamina,i
119,0211-699501013259,B6,i
119,0211-699501013259,aunque,o
119,0211-699501013259,inicialmente,o
119,0211-699501013259,se,o
119,0211-699501013259,reduce,o
119,0211-699501013259,la,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,esta,o
119,0211-699501013259,respuesta,o
119,0211-699501013259,se,o
119,0211-699501013259,hace,o
119,0211-699501013259,refractaria,o
119,0211-699501013259,correlacionandose,o
119,0211-699501013259,directamente,o
119,0211-699501013259,la,o
119,0211-699501013259,tHcy,i
119,0211-699501013259,con,o
119,0211-699501013259,la,o
119,0211-699501013259,albumina,i
119,0211-699501013259,plasmatica,i
119,0211-699501013259,La,o
119,0211-699501013259,interpretacion,o
119,0211-699501013259,de,o
119,0211-699501013259,los,o
119,0211-699501013259,niveles,i
119,0211-699501013259,de,i
119,0211-699501013259,tHcy,i
119,0211-699501013259,debe,o
119,0211-699501013259,tener,o
119,0211-699501013259,en,o
119,0211-699501013259,cuenta,o
119,0211-699501013259,la,o
119,0211-699501013259,concentracion,i
119,0211-699501013259,de,i
119,0211-699501013259,albumina,i
120,0211-699501013259,Efecto,o
120,0211-699501013259,de,o
120,0211-699501013259,la,o
120,0211-699501013259,suplementacion,i
120,0211-699501013259,con,o
120,0211-699501013259,acido,i
120,0211-699501013259,folico,i
120,0211-699501013259,sobre,o
120,0211-699501013259,los,o
120,0211-699501013259,niveles,i
120,0211-699501013259,de,i
120,0211-699501013259,homocisteina,i
120,0211-699501013259,total,o
120,0211-699501013259,en,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,en,o
120,0211-699501013259,hemodialisis,i
120,0211-699501013259,La,o
120,0211-699501013259,hiperhomocisteinemia,i
120,0211-699501013259,es,o
120,0211-699501013259,un,o
120,0211-699501013259,marcador,o
120,0211-699501013259,de,o
120,0211-699501013259,riesgo,o
120,0211-699501013259,independiente,o
120,0211-699501013259,de,o
120,0211-699501013259,morbimortalidad,o
120,0211-699501013259,cardiovascular,i
120,0211-699501013259,Hemos,o
120,0211-699501013259,intentado,o
120,0211-699501013259,prospectivamente,o
120,0211-699501013259,reducir,o
120,0211-699501013259,los,o
120,0211-699501013259,niveles,i
120,0211-699501013259,de,i
120,0211-699501013259,homocisteina,i
120,0211-699501013259,total,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,mediante,o
120,0211-699501013259,suplemento,o
120,0211-699501013259,con,o
120,0211-699501013259,acido,i
120,0211-699501013259,folico,i
120,0211-699501013259,y,o
120,0211-699501013259,vitamina,i
120,0211-699501013259,B6,i
120,0211-699501013259,pp,i
120,0211-699501013259,valorando,o
120,0211-699501013259,su,o
120,0211-699501013259,posible,o
120,0211-699501013259,correlacion,o
120,0211-699501013259,con,o
120,0211-699501013259,dosis,o
120,0211-699501013259,de,o
120,0211-699501013259,dialisis,i
120,0211-699501013259,funcion,i
120,0211-699501013259,residual,i
120,0211-699501013259,y,o
120,0211-699501013259,parametros,o
120,0211-699501013259,nutricionales,o
120,0211-699501013259,Metodos,o
120,0211-699501013259,Todos,o
120,0211-699501013259,los,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,en,o
120,0211-699501013259,hemodialisis,i
120,0211-699501013259,al,o
120,0211-699501013259,comienzo,o
120,0211-699501013259,del,o
120,0211-699501013259,estudio,o
120,0211-699501013259,que,o
120,0211-699501013259,no,o
120,0211-699501013259,recibian,o
120,0211-699501013259,acido,i
120,0211-699501013259,folico,i
120,0211-699501013259,ni,o
120,0211-699501013259,vitamina,i
120,0211-699501013259,B6,i
120,0211-699501013259,asi,o
120,0211-699501013259,como,o
120,0211-699501013259,los,o
120,0211-699501013259,incorporados,o
120,0211-699501013259,posteriormente,o
120,0211-699501013259,a,o
120,0211-699501013259,partir,o
120,0211-699501013259,de,o
120,0211-699501013259,su,o
120,0211-699501013259,tercer,o
120,0211-699501013259,mes,o
120,0211-699501013259,en,o
120,0211-699501013259,hemodialisis,i
120,0211-699501013259,recibieron,o
120,0211-699501013259,5,o
120,0211-699501013259,mg,o
120,0211-699501013259,orales,o
120,0211-699501013259,de,o
120,0211-699501013259,acido,i
120,0211-699501013259,folico,i
120,0211-699501013259,cada,o
120,0211-699501013259,48,o
120,0211-699501013259,horas,o
120,0211-699501013259,y,o
120,0211-699501013259,40,o
120,0211-699501013259,mg,o
120,0211-699501013259,orales,o
120,0211-699501013259,de,o
120,0211-699501013259,vitamina,i
120,0211-699501013259,B6,i
120,0211-699501013259,cada,o
120,0211-699501013259,semana,o
120,0211-699501013259,Se,o
120,0211-699501013259,determinaron,o
120,0211-699501013259,al,o
120,0211-699501013259,comienzo,o
120,0211-699501013259,del,o
120,0211-699501013259,estudio,o
120,0211-699501013259,y,o
120,0211-699501013259,cada,o
120,0211-699501013259,2,o
120,0211-699501013259,meses,o
120,0211-699501013259,niveles,i
120,0211-699501013259,de,i
120,0211-699501013259,folato,i
120,0211-699501013259,vitamina,i
120,0211-699501013259,B12,i
120,0211-699501013259,inmunoensayo,i
120,0211-699501013259,albumina,i
120,0211-699501013259,y,o
120,0211-699501013259,cinetica,o
120,0211-699501013259,de,o
120,0211-699501013259,la,o
120,0211-699501013259,urea,i
120,0211-699501013259,KTV,o
120,0211-699501013259,KRU,o
120,0211-699501013259,PCRn,o
120,0211-699501013259,y,o
120,0211-699501013259,cada,o
120,0211-699501013259,6,o
120,0211-699501013259,meses,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,HPLC,i
120,0211-699501013259,y,o
120,0211-699501013259,pp,i
120,0211-699501013259,RIA,i
120,0211-699501013259,Resultados,o
120,0211-699501013259,80,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,fueron,o
120,0211-699501013259,incluidos,o
120,0211-699501013259,en,o
120,0211-699501013259,el,o
120,0211-699501013259,estudio,o
120,0211-699501013259,basal,o
120,0211-699501013259,con,o
120,0211-699501013259,una,o
120,0211-699501013259,prevalencia,o
120,0211-699501013259,de,o
120,0211-699501013259,hiperhomocisteinemia,i
120,0211-699501013259,del,o
120,0211-699501013259,844,o
120,0211-699501013259,deficit,i
120,0211-699501013259,de,i
120,0211-699501013259,pp,i
120,0211-699501013259,en,o
120,0211-699501013259,el,o
120,0211-699501013259,32,o
120,0211-699501013259,y,o
120,0211-699501013259,folato,i
120,0211-699501013259,en,o
120,0211-699501013259,el,o
120,0211-699501013259,rango,o
120,0211-699501013259,normal,o
120,0211-699501013259,bajo,o
120,0211-699501013259,los,o
120,0211-699501013259,niveles,i
120,0211-699501013259,de,i
120,0211-699501013259,tHcy,i
120,0211-699501013259,se,o
120,0211-699501013259,correlacionaban,o
120,0211-699501013259,inversamente,o
120,0211-699501013259,con,o
120,0211-699501013259,los,o
120,0211-699501013259,del,o
120,0211-699501013259,folato,i
120,0211-699501013259,r,o
120,0211-699501013259,0336,o
120,0211-699501013259,p,o
120,0211-699501013259,001,o
120,0211-699501013259,pero,o
120,0211-699501013259,no,o
120,0211-699501013259,con,o
120,0211-699501013259,pp,i
120,0211-699501013259,B12,i
120,0211-699501013259,edad,o
120,0211-699501013259,albumina,i
120,0211-699501013259,KTV,o
120,0211-699501013259,KRU,o
120,0211-699501013259,PCRn,o
120,0211-699501013259,Cincuenta,o
120,0211-699501013259,y,o
120,0211-699501013259,ocho,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,recibieron,o
120,0211-699501013259,seis,o
120,0211-699501013259,meses,o
120,0211-699501013259,de,o
120,0211-699501013259,suplementacion,i
120,0211-699501013259,con,o
120,0211-699501013259,normalizacion,o
120,0211-699501013259,del,o
120,0211-699501013259,pp,i
120,0211-699501013259,aumento,o
120,0211-699501013259,del,o
120,0211-699501013259,folato,i
120,0211-699501013259,703,o
120,0211-699501013259,IC,o
120,0211-699501013259,638,o
120,0211-699501013259,795,o
120,0211-699501013259,vs,o
120,0211-699501013259,6181,o
120,0211-699501013259,IC,o
120,0211-699501013259,4447,o
120,0211-699501013259,7811,o
120,0211-699501013259,p,o
120,0211-699501013259,0001,o
120,0211-699501013259,y,o
120,0211-699501013259,descenso,o
120,0211-699501013259,de,o
120,0211-699501013259,la,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,240,o
120,0211-699501013259,IC,o
120,0211-699501013259,213,o
120,0211-699501013259,264,o
120,0211-699501013259,vs,o
120,0211-699501013259,199,o
120,0211-699501013259,IC,o
120,0211-699501013259,175,o
120,0211-699501013259,224,o
120,0211-699501013259,p,o
120,0211-699501013259,005,o
120,0211-699501013259,Han,o
120,0211-699501013259,recibido,o
120,0211-699501013259,suplementacion,i
120,0211-699501013259,durante,o
120,0211-699501013259,12,o
120,0211-699501013259,meses,o
120,0211-699501013259,33,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,pero,o
120,0211-699501013259,a,o
120,0211-699501013259,pesar,o
120,0211-699501013259,de,o
120,0211-699501013259,un,o
120,0211-699501013259,continuo,o
120,0211-699501013259,aumento,o
120,0211-699501013259,del,o
120,0211-699501013259,folato,i
120,0211-699501013259,10078,o
120,0211-699501013259,IC,o
120,0211-699501013259,7481,o
120,0211-699501013259,12674,o
120,0211-699501013259,p,o
120,0211-699501013259,0001,o
120,0211-699501013259,solo,o
120,0211-699501013259,3,o
120,0211-699501013259,pacientes,o
120,0211-699501013259,presentan,o
120,0211-699501013259,niveles,o
120,0211-699501013259,normales,o
120,0211-699501013259,de,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,correlacionandose,o
120,0211-699501013259,directamente,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,con,o
120,0211-699501013259,la,o
120,0211-699501013259,albumina,i
120,0211-699501013259,r,o
120,0211-699501013259,056,o
120,0211-699501013259,p,o
120,0211-699501013259,0001,o
120,0211-699501013259,que,o
120,0211-699501013259,se,o
120,0211-699501013259,elevo,o
120,0211-699501013259,con,o
120,0211-699501013259,respecto,o
120,0211-699501013259,al,o
120,0211-699501013259,inicio,o
120,0211-699501013259,337,o
120,0211-699501013259,IC,o
120,0211-699501013259,327,o
120,0211-699501013259,346,o
120,0211-699501013259,vs,o
120,0211-699501013259,350,o
120,0211-699501013259,IC,o
120,0211-699501013259,337,o
120,0211-699501013259,363,o
120,0211-699501013259,p,o
120,0211-699501013259,005,o
120,0211-699501013259,Conclusion,o
120,0211-699501013259,Tras,o
120,0211-699501013259,suplementacion,i
120,0211-699501013259,con,o
120,0211-699501013259,acido,i
120,0211-699501013259,folico,i
120,0211-699501013259,y,o
120,0211-699501013259,vitamina,i
120,0211-699501013259,B6,i
120,0211-699501013259,aunque,o
120,0211-699501013259,inicialmente,o
120,0211-699501013259,se,o
120,0211-699501013259,reduce,o
120,0211-699501013259,la,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,esta,o
120,0211-699501013259,respuesta,o
120,0211-699501013259,se,o
120,0211-699501013259,hace,o
120,0211-699501013259,refractaria,o
120,0211-699501013259,correlacionandose,o
120,0211-699501013259,directamente,o
120,0211-699501013259,la,o
120,0211-699501013259,tHcy,i
120,0211-699501013259,con,o
120,0211-699501013259,la,o
120,0211-699501013259,albumina,i
120,0211-699501013259,plasmatica,i
120,0211-699501013259,La,o
120,0211-699501013259,interpretacion,o
120,0211-699501013259,de,o
120,0211-699501013259,los,o
120,0211-699501013259,niveles,i
120,0211-699501013259,de,i
120,0211-699501013259,tHcy,i
120,0211-699501013259,debe,o
120,0211-699501013259,tener,o
120,0211-699501013259,en,o
120,0211-699501013259,cuenta,o
120,0211-699501013259,la,o
120,0211-699501013259,concentracion,i
120,0211-699501013259,de,i
120,0211-699501013259,albumina,i
121,0211-699501013259,Efecto,o
121,0211-699501013259,de,o
121,0211-699501013259,la,o
121,0211-699501013259,suplementacion,i
121,0211-699501013259,con,o
121,0211-699501013259,acido,i
121,0211-699501013259,folico,i
121,0211-699501013259,sobre,o
121,0211-699501013259,los,o
121,0211-699501013259,niveles,i
121,0211-699501013259,de,i
121,0211-699501013259,homocisteina,i
121,0211-699501013259,total,o
121,0211-699501013259,en,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,en,o
121,0211-699501013259,hemodialisis,i
121,0211-699501013259,La,o
121,0211-699501013259,hiperhomocisteinemia,i
121,0211-699501013259,es,o
121,0211-699501013259,un,o
121,0211-699501013259,marcador,o
121,0211-699501013259,de,o
121,0211-699501013259,riesgo,o
121,0211-699501013259,independiente,o
121,0211-699501013259,de,o
121,0211-699501013259,morbimortalidad,o
121,0211-699501013259,cardiovascular,i
121,0211-699501013259,Hemos,o
121,0211-699501013259,intentado,o
121,0211-699501013259,prospectivamente,o
121,0211-699501013259,reducir,o
121,0211-699501013259,los,o
121,0211-699501013259,niveles,i
121,0211-699501013259,de,i
121,0211-699501013259,homocisteina,i
121,0211-699501013259,total,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,mediante,o
121,0211-699501013259,suplemento,o
121,0211-699501013259,con,o
121,0211-699501013259,acido,i
121,0211-699501013259,folico,i
121,0211-699501013259,y,o
121,0211-699501013259,vitamina,i
121,0211-699501013259,B6,i
121,0211-699501013259,pp,i
121,0211-699501013259,valorando,o
121,0211-699501013259,su,o
121,0211-699501013259,posible,o
121,0211-699501013259,correlacion,o
121,0211-699501013259,con,o
121,0211-699501013259,dosis,o
121,0211-699501013259,de,o
121,0211-699501013259,dialisis,i
121,0211-699501013259,funcion,i
121,0211-699501013259,residual,i
121,0211-699501013259,y,o
121,0211-699501013259,parametros,o
121,0211-699501013259,nutricionales,o
121,0211-699501013259,Metodos,o
121,0211-699501013259,Todos,o
121,0211-699501013259,los,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,en,o
121,0211-699501013259,hemodialisis,i
121,0211-699501013259,al,o
121,0211-699501013259,comienzo,o
121,0211-699501013259,del,o
121,0211-699501013259,estudio,o
121,0211-699501013259,que,o
121,0211-699501013259,no,o
121,0211-699501013259,recibian,o
121,0211-699501013259,acido,i
121,0211-699501013259,folico,i
121,0211-699501013259,ni,o
121,0211-699501013259,vitamina,i
121,0211-699501013259,B6,i
121,0211-699501013259,asi,o
121,0211-699501013259,como,o
121,0211-699501013259,los,o
121,0211-699501013259,incorporados,o
121,0211-699501013259,posteriormente,o
121,0211-699501013259,a,o
121,0211-699501013259,partir,o
121,0211-699501013259,de,o
121,0211-699501013259,su,o
121,0211-699501013259,tercer,o
121,0211-699501013259,mes,o
121,0211-699501013259,en,o
121,0211-699501013259,hemodialisis,i
121,0211-699501013259,recibieron,o
121,0211-699501013259,5,o
121,0211-699501013259,mg,o
121,0211-699501013259,orales,o
121,0211-699501013259,de,o
121,0211-699501013259,acido,i
121,0211-699501013259,folico,i
121,0211-699501013259,cada,o
121,0211-699501013259,48,o
121,0211-699501013259,horas,o
121,0211-699501013259,y,o
121,0211-699501013259,40,o
121,0211-699501013259,mg,o
121,0211-699501013259,orales,o
121,0211-699501013259,de,o
121,0211-699501013259,vitamina,i
121,0211-699501013259,B6,i
121,0211-699501013259,cada,o
121,0211-699501013259,semana,o
121,0211-699501013259,Se,o
121,0211-699501013259,determinaron,o
121,0211-699501013259,al,o
121,0211-699501013259,comienzo,o
121,0211-699501013259,del,o
121,0211-699501013259,estudio,o
121,0211-699501013259,y,o
121,0211-699501013259,cada,o
121,0211-699501013259,2,o
121,0211-699501013259,meses,o
121,0211-699501013259,niveles,i
121,0211-699501013259,de,i
121,0211-699501013259,folato,i
121,0211-699501013259,vitamina,i
121,0211-699501013259,B12,i
121,0211-699501013259,inmunoensayo,i
121,0211-699501013259,albumina,i
121,0211-699501013259,y,o
121,0211-699501013259,cinetica,o
121,0211-699501013259,de,o
121,0211-699501013259,la,o
121,0211-699501013259,urea,i
121,0211-699501013259,KTV,o
121,0211-699501013259,KRU,o
121,0211-699501013259,PCRn,o
121,0211-699501013259,y,o
121,0211-699501013259,cada,o
121,0211-699501013259,6,o
121,0211-699501013259,meses,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,HPLC,i
121,0211-699501013259,y,o
121,0211-699501013259,pp,i
121,0211-699501013259,RIA,i
121,0211-699501013259,Resultados,o
121,0211-699501013259,80,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,fueron,o
121,0211-699501013259,incluidos,o
121,0211-699501013259,en,o
121,0211-699501013259,el,o
121,0211-699501013259,estudio,o
121,0211-699501013259,basal,o
121,0211-699501013259,con,o
121,0211-699501013259,una,o
121,0211-699501013259,prevalencia,o
121,0211-699501013259,de,o
121,0211-699501013259,hiperhomocisteinemia,i
121,0211-699501013259,del,o
121,0211-699501013259,844,o
121,0211-699501013259,deficit,i
121,0211-699501013259,de,i
121,0211-699501013259,pp,i
121,0211-699501013259,en,o
121,0211-699501013259,el,o
121,0211-699501013259,32,o
121,0211-699501013259,y,o
121,0211-699501013259,folato,i
121,0211-699501013259,en,o
121,0211-699501013259,el,o
121,0211-699501013259,rango,o
121,0211-699501013259,normal,o
121,0211-699501013259,bajo,o
121,0211-699501013259,los,o
121,0211-699501013259,niveles,i
121,0211-699501013259,de,i
121,0211-699501013259,tHcy,i
121,0211-699501013259,se,o
121,0211-699501013259,correlacionaban,o
121,0211-699501013259,inversamente,o
121,0211-699501013259,con,o
121,0211-699501013259,los,o
121,0211-699501013259,del,o
121,0211-699501013259,folato,i
121,0211-699501013259,r,o
121,0211-699501013259,0336,o
121,0211-699501013259,p,o
121,0211-699501013259,001,o
121,0211-699501013259,pero,o
121,0211-699501013259,no,o
121,0211-699501013259,con,o
121,0211-699501013259,pp,i
121,0211-699501013259,B12,i
121,0211-699501013259,edad,o
121,0211-699501013259,albumina,i
121,0211-699501013259,KTV,o
121,0211-699501013259,KRU,o
121,0211-699501013259,PCRn,o
121,0211-699501013259,Cincuenta,o
121,0211-699501013259,y,o
121,0211-699501013259,ocho,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,recibieron,o
121,0211-699501013259,seis,o
121,0211-699501013259,meses,o
121,0211-699501013259,de,o
121,0211-699501013259,suplementacion,i
121,0211-699501013259,con,o
121,0211-699501013259,normalizacion,o
121,0211-699501013259,del,o
121,0211-699501013259,pp,i
121,0211-699501013259,aumento,o
121,0211-699501013259,del,o
121,0211-699501013259,folato,i
121,0211-699501013259,703,o
121,0211-699501013259,IC,o
121,0211-699501013259,638,o
121,0211-699501013259,795,o
121,0211-699501013259,vs,o
121,0211-699501013259,6181,o
121,0211-699501013259,IC,o
121,0211-699501013259,4447,o
121,0211-699501013259,7811,o
121,0211-699501013259,p,o
121,0211-699501013259,0001,o
121,0211-699501013259,y,o
121,0211-699501013259,descenso,o
121,0211-699501013259,de,o
121,0211-699501013259,la,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,240,o
121,0211-699501013259,IC,o
121,0211-699501013259,213,o
121,0211-699501013259,264,o
121,0211-699501013259,vs,o
121,0211-699501013259,199,o
121,0211-699501013259,IC,o
121,0211-699501013259,175,o
121,0211-699501013259,224,o
121,0211-699501013259,p,o
121,0211-699501013259,005,o
121,0211-699501013259,Han,o
121,0211-699501013259,recibido,o
121,0211-699501013259,suplementacion,i
121,0211-699501013259,durante,o
121,0211-699501013259,12,o
121,0211-699501013259,meses,o
121,0211-699501013259,33,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,pero,o
121,0211-699501013259,a,o
121,0211-699501013259,pesar,o
121,0211-699501013259,de,o
121,0211-699501013259,un,o
121,0211-699501013259,continuo,o
121,0211-699501013259,aumento,o
121,0211-699501013259,del,o
121,0211-699501013259,folato,i
121,0211-699501013259,10078,o
121,0211-699501013259,IC,o
121,0211-699501013259,7481,o
121,0211-699501013259,12674,o
121,0211-699501013259,p,o
121,0211-699501013259,0001,o
121,0211-699501013259,solo,o
121,0211-699501013259,3,o
121,0211-699501013259,pacientes,o
121,0211-699501013259,presentan,o
121,0211-699501013259,niveles,o
121,0211-699501013259,normales,o
121,0211-699501013259,de,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,correlacionandose,o
121,0211-699501013259,directamente,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,con,o
121,0211-699501013259,la,o
121,0211-699501013259,albumina,i
121,0211-699501013259,r,o
121,0211-699501013259,056,o
121,0211-699501013259,p,o
121,0211-699501013259,0001,o
121,0211-699501013259,que,o
121,0211-699501013259,se,o
121,0211-699501013259,elevo,o
121,0211-699501013259,con,o
121,0211-699501013259,respecto,o
121,0211-699501013259,al,o
121,0211-699501013259,inicio,o
121,0211-699501013259,337,o
121,0211-699501013259,IC,o
121,0211-699501013259,327,o
121,0211-699501013259,346,o
121,0211-699501013259,vs,o
121,0211-699501013259,350,o
121,0211-699501013259,IC,o
121,0211-699501013259,337,o
121,0211-699501013259,363,o
121,0211-699501013259,p,o
121,0211-699501013259,005,o
121,0211-699501013259,Conclusion,o
121,0211-699501013259,Tras,o
121,0211-699501013259,suplementacion,i
121,0211-699501013259,con,o
121,0211-699501013259,acido,i
121,0211-699501013259,folico,i
121,0211-699501013259,y,o
121,0211-699501013259,vitamina,i
121,0211-699501013259,B6,i
121,0211-699501013259,aunque,o
121,0211-699501013259,inicialmente,o
121,0211-699501013259,se,o
121,0211-699501013259,reduce,o
121,0211-699501013259,la,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,esta,o
121,0211-699501013259,respuesta,o
121,0211-699501013259,se,o
121,0211-699501013259,hace,o
121,0211-699501013259,refractaria,o
121,0211-699501013259,correlacionandose,o
121,0211-699501013259,directamente,o
121,0211-699501013259,la,o
121,0211-699501013259,tHcy,i
121,0211-699501013259,con,o
121,0211-699501013259,la,o
121,0211-699501013259,albumina,i
121,0211-699501013259,plasmatica,i
121,0211-699501013259,La,o
121,0211-699501013259,interpretacion,o
121,0211-699501013259,de,o
121,0211-699501013259,los,o
121,0211-699501013259,niveles,i
121,0211-699501013259,de,i
121,0211-699501013259,tHcy,i
121,0211-699501013259,debe,o
121,0211-699501013259,tener,o
121,0211-699501013259,en,o
121,0211-699501013259,cuenta,o
121,0211-699501013259,la,o
121,0211-699501013259,concentracion,i
121,0211-699501013259,de,i
121,0211-699501013259,albumina,i
122,0211-699501013259,Efecto,o
122,0211-699501013259,de,o
122,0211-699501013259,la,o
122,0211-699501013259,suplementacion,i
122,0211-699501013259,con,o
122,0211-699501013259,acido,i
122,0211-699501013259,folico,i
122,0211-699501013259,sobre,o
122,0211-699501013259,los,o
122,0211-699501013259,niveles,i
122,0211-699501013259,de,i
122,0211-699501013259,homocisteina,i
122,0211-699501013259,total,o
122,0211-699501013259,en,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,en,o
122,0211-699501013259,hemodialisis,i
122,0211-699501013259,La,o
122,0211-699501013259,hiperhomocisteinemia,i
122,0211-699501013259,es,o
122,0211-699501013259,un,o
122,0211-699501013259,marcador,o
122,0211-699501013259,de,o
122,0211-699501013259,riesgo,o
122,0211-699501013259,independiente,o
122,0211-699501013259,de,o
122,0211-699501013259,morbimortalidad,o
122,0211-699501013259,cardiovascular,i
122,0211-699501013259,Hemos,o
122,0211-699501013259,intentado,o
122,0211-699501013259,prospectivamente,o
122,0211-699501013259,reducir,o
122,0211-699501013259,los,o
122,0211-699501013259,niveles,i
122,0211-699501013259,de,i
122,0211-699501013259,homocisteina,i
122,0211-699501013259,total,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,mediante,o
122,0211-699501013259,suplemento,o
122,0211-699501013259,con,o
122,0211-699501013259,acido,i
122,0211-699501013259,folico,i
122,0211-699501013259,y,o
122,0211-699501013259,vitamina,i
122,0211-699501013259,B6,i
122,0211-699501013259,pp,i
122,0211-699501013259,valorando,o
122,0211-699501013259,su,o
122,0211-699501013259,posible,o
122,0211-699501013259,correlacion,o
122,0211-699501013259,con,o
122,0211-699501013259,dosis,o
122,0211-699501013259,de,o
122,0211-699501013259,dialisis,i
122,0211-699501013259,funcion,i
122,0211-699501013259,residual,i
122,0211-699501013259,y,o
122,0211-699501013259,parametros,o
122,0211-699501013259,nutricionales,o
122,0211-699501013259,Metodos,o
122,0211-699501013259,Todos,o
122,0211-699501013259,los,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,en,o
122,0211-699501013259,hemodialisis,i
122,0211-699501013259,al,o
122,0211-699501013259,comienzo,o
122,0211-699501013259,del,o
122,0211-699501013259,estudio,o
122,0211-699501013259,que,o
122,0211-699501013259,no,o
122,0211-699501013259,recibian,o
122,0211-699501013259,acido,i
122,0211-699501013259,folico,i
122,0211-699501013259,ni,o
122,0211-699501013259,vitamina,i
122,0211-699501013259,B6,i
122,0211-699501013259,asi,o
122,0211-699501013259,como,o
122,0211-699501013259,los,o
122,0211-699501013259,incorporados,o
122,0211-699501013259,posteriormente,o
122,0211-699501013259,a,o
122,0211-699501013259,partir,o
122,0211-699501013259,de,o
122,0211-699501013259,su,o
122,0211-699501013259,tercer,o
122,0211-699501013259,mes,o
122,0211-699501013259,en,o
122,0211-699501013259,hemodialisis,i
122,0211-699501013259,recibieron,o
122,0211-699501013259,5,o
122,0211-699501013259,mg,o
122,0211-699501013259,orales,o
122,0211-699501013259,de,o
122,0211-699501013259,acido,i
122,0211-699501013259,folico,i
122,0211-699501013259,cada,o
122,0211-699501013259,48,o
122,0211-699501013259,horas,o
122,0211-699501013259,y,o
122,0211-699501013259,40,o
122,0211-699501013259,mg,o
122,0211-699501013259,orales,o
122,0211-699501013259,de,o
122,0211-699501013259,vitamina,i
122,0211-699501013259,B6,i
122,0211-699501013259,cada,o
122,0211-699501013259,semana,o
122,0211-699501013259,Se,o
122,0211-699501013259,determinaron,o
122,0211-699501013259,al,o
122,0211-699501013259,comienzo,o
122,0211-699501013259,del,o
122,0211-699501013259,estudio,o
122,0211-699501013259,y,o
122,0211-699501013259,cada,o
122,0211-699501013259,2,o
122,0211-699501013259,meses,o
122,0211-699501013259,niveles,i
122,0211-699501013259,de,i
122,0211-699501013259,folato,i
122,0211-699501013259,vitamina,i
122,0211-699501013259,B12,i
122,0211-699501013259,inmunoensayo,i
122,0211-699501013259,albumina,i
122,0211-699501013259,y,o
122,0211-699501013259,cinetica,o
122,0211-699501013259,de,o
122,0211-699501013259,la,o
122,0211-699501013259,urea,i
122,0211-699501013259,KTV,o
122,0211-699501013259,KRU,o
122,0211-699501013259,PCRn,o
122,0211-699501013259,y,o
122,0211-699501013259,cada,o
122,0211-699501013259,6,o
122,0211-699501013259,meses,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,HPLC,i
122,0211-699501013259,y,o
122,0211-699501013259,pp,i
122,0211-699501013259,RIA,i
122,0211-699501013259,Resultados,o
122,0211-699501013259,80,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,fueron,o
122,0211-699501013259,incluidos,o
122,0211-699501013259,en,o
122,0211-699501013259,el,o
122,0211-699501013259,estudio,o
122,0211-699501013259,basal,o
122,0211-699501013259,con,o
122,0211-699501013259,una,o
122,0211-699501013259,prevalencia,o
122,0211-699501013259,de,o
122,0211-699501013259,hiperhomocisteinemia,i
122,0211-699501013259,del,o
122,0211-699501013259,844,o
122,0211-699501013259,deficit,i
122,0211-699501013259,de,i
122,0211-699501013259,pp,i
122,0211-699501013259,en,o
122,0211-699501013259,el,o
122,0211-699501013259,32,o
122,0211-699501013259,y,o
122,0211-699501013259,folato,i
122,0211-699501013259,en,o
122,0211-699501013259,el,o
122,0211-699501013259,rango,o
122,0211-699501013259,normal,o
122,0211-699501013259,bajo,o
122,0211-699501013259,los,o
122,0211-699501013259,niveles,i
122,0211-699501013259,de,i
122,0211-699501013259,tHcy,i
122,0211-699501013259,se,o
122,0211-699501013259,correlacionaban,o
122,0211-699501013259,inversamente,o
122,0211-699501013259,con,o
122,0211-699501013259,los,o
122,0211-699501013259,del,o
122,0211-699501013259,folato,i
122,0211-699501013259,r,o
122,0211-699501013259,0336,o
122,0211-699501013259,p,o
122,0211-699501013259,001,o
122,0211-699501013259,pero,o
122,0211-699501013259,no,o
122,0211-699501013259,con,o
122,0211-699501013259,pp,i
122,0211-699501013259,B12,i
122,0211-699501013259,edad,o
122,0211-699501013259,albumina,i
122,0211-699501013259,KTV,o
122,0211-699501013259,KRU,o
122,0211-699501013259,PCRn,o
122,0211-699501013259,Cincuenta,o
122,0211-699501013259,y,o
122,0211-699501013259,ocho,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,recibieron,o
122,0211-699501013259,seis,o
122,0211-699501013259,meses,o
122,0211-699501013259,de,o
122,0211-699501013259,suplementacion,i
122,0211-699501013259,con,o
122,0211-699501013259,normalizacion,o
122,0211-699501013259,del,o
122,0211-699501013259,pp,i
122,0211-699501013259,aumento,o
122,0211-699501013259,del,o
122,0211-699501013259,folato,i
122,0211-699501013259,703,o
122,0211-699501013259,IC,o
122,0211-699501013259,638,o
122,0211-699501013259,795,o
122,0211-699501013259,vs,o
122,0211-699501013259,6181,o
122,0211-699501013259,IC,o
122,0211-699501013259,4447,o
122,0211-699501013259,7811,o
122,0211-699501013259,p,o
122,0211-699501013259,0001,o
122,0211-699501013259,y,o
122,0211-699501013259,descenso,o
122,0211-699501013259,de,o
122,0211-699501013259,la,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,240,o
122,0211-699501013259,IC,o
122,0211-699501013259,213,o
122,0211-699501013259,264,o
122,0211-699501013259,vs,o
122,0211-699501013259,199,o
122,0211-699501013259,IC,o
122,0211-699501013259,175,o
122,0211-699501013259,224,o
122,0211-699501013259,p,o
122,0211-699501013259,005,o
122,0211-699501013259,Han,o
122,0211-699501013259,recibido,o
122,0211-699501013259,suplementacion,i
122,0211-699501013259,durante,o
122,0211-699501013259,12,o
122,0211-699501013259,meses,o
122,0211-699501013259,33,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,pero,o
122,0211-699501013259,a,o
122,0211-699501013259,pesar,o
122,0211-699501013259,de,o
122,0211-699501013259,un,o
122,0211-699501013259,continuo,o
122,0211-699501013259,aumento,o
122,0211-699501013259,del,o
122,0211-699501013259,folato,i
122,0211-699501013259,10078,o
122,0211-699501013259,IC,o
122,0211-699501013259,7481,o
122,0211-699501013259,12674,o
122,0211-699501013259,p,o
122,0211-699501013259,0001,o
122,0211-699501013259,solo,o
122,0211-699501013259,3,o
122,0211-699501013259,pacientes,o
122,0211-699501013259,presentan,o
122,0211-699501013259,niveles,o
122,0211-699501013259,normales,o
122,0211-699501013259,de,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,correlacionandose,o
122,0211-699501013259,directamente,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,con,o
122,0211-699501013259,la,o
122,0211-699501013259,albumina,i
122,0211-699501013259,r,o
122,0211-699501013259,056,o
122,0211-699501013259,p,o
122,0211-699501013259,0001,o
122,0211-699501013259,que,o
122,0211-699501013259,se,o
122,0211-699501013259,elevo,o
122,0211-699501013259,con,o
122,0211-699501013259,respecto,o
122,0211-699501013259,al,o
122,0211-699501013259,inicio,o
122,0211-699501013259,337,o
122,0211-699501013259,IC,o
122,0211-699501013259,327,o
122,0211-699501013259,346,o
122,0211-699501013259,vs,o
122,0211-699501013259,350,o
122,0211-699501013259,IC,o
122,0211-699501013259,337,o
122,0211-699501013259,363,o
122,0211-699501013259,p,o
122,0211-699501013259,005,o
122,0211-699501013259,Conclusion,o
122,0211-699501013259,Tras,o
122,0211-699501013259,suplementacion,i
122,0211-699501013259,con,o
122,0211-699501013259,acido,i
122,0211-699501013259,folico,i
122,0211-699501013259,y,o
122,0211-699501013259,vitamina,i
122,0211-699501013259,B6,i
122,0211-699501013259,aunque,o
122,0211-699501013259,inicialmente,o
122,0211-699501013259,se,o
122,0211-699501013259,reduce,o
122,0211-699501013259,la,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,esta,o
122,0211-699501013259,respuesta,o
122,0211-699501013259,se,o
122,0211-699501013259,hace,o
122,0211-699501013259,refractaria,o
122,0211-699501013259,correlacionandose,o
122,0211-699501013259,directamente,o
122,0211-699501013259,la,o
122,0211-699501013259,tHcy,i
122,0211-699501013259,con,o
122,0211-699501013259,la,o
122,0211-699501013259,albumina,i
122,0211-699501013259,plasmatica,i
122,0211-699501013259,La,o
122,0211-699501013259,interpretacion,o
122,0211-699501013259,de,o
122,0211-699501013259,los,o
122,0211-699501013259,niveles,i
122,0211-699501013259,de,i
122,0211-699501013259,tHcy,i
122,0211-699501013259,debe,o
122,0211-699501013259,tener,o
122,0211-699501013259,en,o
122,0211-699501013259,cuenta,o
122,0211-699501013259,la,o
122,0211-699501013259,concentracion,i
122,0211-699501013259,de,i
122,0211-699501013259,albumina,i
123,0211-699501013259,Efecto,o
123,0211-699501013259,de,o
123,0211-699501013259,la,o
123,0211-699501013259,suplementacion,i
123,0211-699501013259,con,o
123,0211-699501013259,acido,i
123,0211-699501013259,folico,i
123,0211-699501013259,sobre,o
123,0211-699501013259,los,o
123,0211-699501013259,niveles,i
123,0211-699501013259,de,i
123,0211-699501013259,homocisteina,i
123,0211-699501013259,total,o
123,0211-699501013259,en,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,en,o
123,0211-699501013259,hemodialisis,i
123,0211-699501013259,La,o
123,0211-699501013259,hiperhomocisteinemia,i
123,0211-699501013259,es,o
123,0211-699501013259,un,o
123,0211-699501013259,marcador,o
123,0211-699501013259,de,o
123,0211-699501013259,riesgo,o
123,0211-699501013259,independiente,o
123,0211-699501013259,de,o
123,0211-699501013259,morbimortalidad,o
123,0211-699501013259,cardiovascular,i
123,0211-699501013259,Hemos,o
123,0211-699501013259,intentado,o
123,0211-699501013259,prospectivamente,o
123,0211-699501013259,reducir,o
123,0211-699501013259,los,o
123,0211-699501013259,niveles,i
123,0211-699501013259,de,i
123,0211-699501013259,homocisteina,i
123,0211-699501013259,total,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,mediante,o
123,0211-699501013259,suplemento,o
123,0211-699501013259,con,o
123,0211-699501013259,acido,i
123,0211-699501013259,folico,i
123,0211-699501013259,y,o
123,0211-699501013259,vitamina,i
123,0211-699501013259,B6,i
123,0211-699501013259,pp,i
123,0211-699501013259,valorando,o
123,0211-699501013259,su,o
123,0211-699501013259,posible,o
123,0211-699501013259,correlacion,o
123,0211-699501013259,con,o
123,0211-699501013259,dosis,o
123,0211-699501013259,de,o
123,0211-699501013259,dialisis,i
123,0211-699501013259,funcion,i
123,0211-699501013259,residual,i
123,0211-699501013259,y,o
123,0211-699501013259,parametros,o
123,0211-699501013259,nutricionales,o
123,0211-699501013259,Metodos,o
123,0211-699501013259,Todos,o
123,0211-699501013259,los,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,en,o
123,0211-699501013259,hemodialisis,i
123,0211-699501013259,al,o
123,0211-699501013259,comienzo,o
123,0211-699501013259,del,o
123,0211-699501013259,estudio,o
123,0211-699501013259,que,o
123,0211-699501013259,no,o
123,0211-699501013259,recibian,o
123,0211-699501013259,acido,i
123,0211-699501013259,folico,i
123,0211-699501013259,ni,o
123,0211-699501013259,vitamina,i
123,0211-699501013259,B6,i
123,0211-699501013259,asi,o
123,0211-699501013259,como,o
123,0211-699501013259,los,o
123,0211-699501013259,incorporados,o
123,0211-699501013259,posteriormente,o
123,0211-699501013259,a,o
123,0211-699501013259,partir,o
123,0211-699501013259,de,o
123,0211-699501013259,su,o
123,0211-699501013259,tercer,o
123,0211-699501013259,mes,o
123,0211-699501013259,en,o
123,0211-699501013259,hemodialisis,i
123,0211-699501013259,recibieron,o
123,0211-699501013259,5,o
123,0211-699501013259,mg,o
123,0211-699501013259,orales,o
123,0211-699501013259,de,o
123,0211-699501013259,acido,i
123,0211-699501013259,folico,i
123,0211-699501013259,cada,o
123,0211-699501013259,48,o
123,0211-699501013259,horas,o
123,0211-699501013259,y,o
123,0211-699501013259,40,o
123,0211-699501013259,mg,o
123,0211-699501013259,orales,o
123,0211-699501013259,de,o
123,0211-699501013259,vitamina,i
123,0211-699501013259,B6,i
123,0211-699501013259,cada,o
123,0211-699501013259,semana,o
123,0211-699501013259,Se,o
123,0211-699501013259,determinaron,o
123,0211-699501013259,al,o
123,0211-699501013259,comienzo,o
123,0211-699501013259,del,o
123,0211-699501013259,estudio,o
123,0211-699501013259,y,o
123,0211-699501013259,cada,o
123,0211-699501013259,2,o
123,0211-699501013259,meses,o
123,0211-699501013259,niveles,i
123,0211-699501013259,de,i
123,0211-699501013259,folato,i
123,0211-699501013259,vitamina,i
123,0211-699501013259,B12,i
123,0211-699501013259,inmunoensayo,i
123,0211-699501013259,albumina,i
123,0211-699501013259,y,o
123,0211-699501013259,cinetica,o
123,0211-699501013259,de,o
123,0211-699501013259,la,o
123,0211-699501013259,urea,i
123,0211-699501013259,KTV,o
123,0211-699501013259,KRU,o
123,0211-699501013259,PCRn,o
123,0211-699501013259,y,o
123,0211-699501013259,cada,o
123,0211-699501013259,6,o
123,0211-699501013259,meses,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,HPLC,i
123,0211-699501013259,y,o
123,0211-699501013259,pp,i
123,0211-699501013259,RIA,i
123,0211-699501013259,Resultados,o
123,0211-699501013259,80,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,fueron,o
123,0211-699501013259,incluidos,o
123,0211-699501013259,en,o
123,0211-699501013259,el,o
123,0211-699501013259,estudio,o
123,0211-699501013259,basal,o
123,0211-699501013259,con,o
123,0211-699501013259,una,o
123,0211-699501013259,prevalencia,o
123,0211-699501013259,de,o
123,0211-699501013259,hiperhomocisteinemia,i
123,0211-699501013259,del,o
123,0211-699501013259,844,o
123,0211-699501013259,deficit,i
123,0211-699501013259,de,i
123,0211-699501013259,pp,i
123,0211-699501013259,en,o
123,0211-699501013259,el,o
123,0211-699501013259,32,o
123,0211-699501013259,y,o
123,0211-699501013259,folato,i
123,0211-699501013259,en,o
123,0211-699501013259,el,o
123,0211-699501013259,rango,o
123,0211-699501013259,normal,o
123,0211-699501013259,bajo,o
123,0211-699501013259,los,o
123,0211-699501013259,niveles,i
123,0211-699501013259,de,i
123,0211-699501013259,tHcy,i
123,0211-699501013259,se,o
123,0211-699501013259,correlacionaban,o
123,0211-699501013259,inversamente,o
123,0211-699501013259,con,o
123,0211-699501013259,los,o
123,0211-699501013259,del,o
123,0211-699501013259,folato,i
123,0211-699501013259,r,o
123,0211-699501013259,0336,o
123,0211-699501013259,p,o
123,0211-699501013259,001,o
123,0211-699501013259,pero,o
123,0211-699501013259,no,o
123,0211-699501013259,con,o
123,0211-699501013259,pp,i
123,0211-699501013259,B12,i
123,0211-699501013259,edad,o
123,0211-699501013259,albumina,i
123,0211-699501013259,KTV,o
123,0211-699501013259,KRU,o
123,0211-699501013259,PCRn,o
123,0211-699501013259,Cincuenta,o
123,0211-699501013259,y,o
123,0211-699501013259,ocho,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,recibieron,o
123,0211-699501013259,seis,o
123,0211-699501013259,meses,o
123,0211-699501013259,de,o
123,0211-699501013259,suplementacion,i
123,0211-699501013259,con,o
123,0211-699501013259,normalizacion,o
123,0211-699501013259,del,o
123,0211-699501013259,pp,i
123,0211-699501013259,aumento,o
123,0211-699501013259,del,o
123,0211-699501013259,folato,i
123,0211-699501013259,703,o
123,0211-699501013259,IC,o
123,0211-699501013259,638,o
123,0211-699501013259,795,o
123,0211-699501013259,vs,o
123,0211-699501013259,6181,o
123,0211-699501013259,IC,o
123,0211-699501013259,4447,o
123,0211-699501013259,7811,o
123,0211-699501013259,p,o
123,0211-699501013259,0001,o
123,0211-699501013259,y,o
123,0211-699501013259,descenso,o
123,0211-699501013259,de,o
123,0211-699501013259,la,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,240,o
123,0211-699501013259,IC,o
123,0211-699501013259,213,o
123,0211-699501013259,264,o
123,0211-699501013259,vs,o
123,0211-699501013259,199,o
123,0211-699501013259,IC,o
123,0211-699501013259,175,o
123,0211-699501013259,224,o
123,0211-699501013259,p,o
123,0211-699501013259,005,o
123,0211-699501013259,Han,o
123,0211-699501013259,recibido,o
123,0211-699501013259,suplementacion,i
123,0211-699501013259,durante,o
123,0211-699501013259,12,o
123,0211-699501013259,meses,o
123,0211-699501013259,33,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,pero,o
123,0211-699501013259,a,o
123,0211-699501013259,pesar,o
123,0211-699501013259,de,o
123,0211-699501013259,un,o
123,0211-699501013259,continuo,o
123,0211-699501013259,aumento,o
123,0211-699501013259,del,o
123,0211-699501013259,folato,i
123,0211-699501013259,10078,o
123,0211-699501013259,IC,o
123,0211-699501013259,7481,o
123,0211-699501013259,12674,o
123,0211-699501013259,p,o
123,0211-699501013259,0001,o
123,0211-699501013259,solo,o
123,0211-699501013259,3,o
123,0211-699501013259,pacientes,o
123,0211-699501013259,presentan,o
123,0211-699501013259,niveles,o
123,0211-699501013259,normales,o
123,0211-699501013259,de,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,correlacionandose,o
123,0211-699501013259,directamente,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,con,o
123,0211-699501013259,la,o
123,0211-699501013259,albumina,i
123,0211-699501013259,r,o
123,0211-699501013259,056,o
123,0211-699501013259,p,o
123,0211-699501013259,0001,o
123,0211-699501013259,que,o
123,0211-699501013259,se,o
123,0211-699501013259,elevo,o
123,0211-699501013259,con,o
123,0211-699501013259,respecto,o
123,0211-699501013259,al,o
123,0211-699501013259,inicio,o
123,0211-699501013259,337,o
123,0211-699501013259,IC,o
123,0211-699501013259,327,o
123,0211-699501013259,346,o
123,0211-699501013259,vs,o
123,0211-699501013259,350,o
123,0211-699501013259,IC,o
123,0211-699501013259,337,o
123,0211-699501013259,363,o
123,0211-699501013259,p,o
123,0211-699501013259,005,o
123,0211-699501013259,Conclusion,o
123,0211-699501013259,Tras,o
123,0211-699501013259,suplementacion,i
123,0211-699501013259,con,o
123,0211-699501013259,acido,i
123,0211-699501013259,folico,i
123,0211-699501013259,y,o
123,0211-699501013259,vitamina,i
123,0211-699501013259,B6,i
123,0211-699501013259,aunque,o
123,0211-699501013259,inicialmente,o
123,0211-699501013259,se,o
123,0211-699501013259,reduce,o
123,0211-699501013259,la,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,esta,o
123,0211-699501013259,respuesta,o
123,0211-699501013259,se,o
123,0211-699501013259,hace,o
123,0211-699501013259,refractaria,o
123,0211-699501013259,correlacionandose,o
123,0211-699501013259,directamente,o
123,0211-699501013259,la,o
123,0211-699501013259,tHcy,i
123,0211-699501013259,con,o
123,0211-699501013259,la,o
123,0211-699501013259,albumina,i
123,0211-699501013259,plasmatica,i
123,0211-699501013259,La,o
123,0211-699501013259,interpretacion,o
123,0211-699501013259,de,o
123,0211-699501013259,los,o
123,0211-699501013259,niveles,i
123,0211-699501013259,de,i
123,0211-699501013259,tHcy,i
123,0211-699501013259,debe,o
123,0211-699501013259,tener,o
123,0211-699501013259,en,o
123,0211-699501013259,cuenta,o
123,0211-699501013259,la,o
123,0211-699501013259,concentracion,i
123,0211-699501013259,de,i
123,0211-699501013259,albumina,i
124,0211-699501013259,Efecto,o
124,0211-699501013259,de,o
124,0211-699501013259,la,o
124,0211-699501013259,suplementacion,i
124,0211-699501013259,con,o
124,0211-699501013259,acido,i
124,0211-699501013259,folico,i
124,0211-699501013259,sobre,o
124,0211-699501013259,los,o
124,0211-699501013259,niveles,i
124,0211-699501013259,de,i
124,0211-699501013259,homocisteina,i
124,0211-699501013259,total,o
124,0211-699501013259,en,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,en,o
124,0211-699501013259,hemodialisis,i
124,0211-699501013259,La,o
124,0211-699501013259,hiperhomocisteinemia,i
124,0211-699501013259,es,o
124,0211-699501013259,un,o
124,0211-699501013259,marcador,o
124,0211-699501013259,de,o
124,0211-699501013259,riesgo,o
124,0211-699501013259,independiente,o
124,0211-699501013259,de,o
124,0211-699501013259,morbimortalidad,o
124,0211-699501013259,cardiovascular,i
124,0211-699501013259,Hemos,o
124,0211-699501013259,intentado,o
124,0211-699501013259,prospectivamente,o
124,0211-699501013259,reducir,o
124,0211-699501013259,los,o
124,0211-699501013259,niveles,i
124,0211-699501013259,de,i
124,0211-699501013259,homocisteina,i
124,0211-699501013259,total,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,mediante,o
124,0211-699501013259,suplemento,o
124,0211-699501013259,con,o
124,0211-699501013259,acido,i
124,0211-699501013259,folico,i
124,0211-699501013259,y,o
124,0211-699501013259,vitamina,i
124,0211-699501013259,B6,i
124,0211-699501013259,pp,i
124,0211-699501013259,valorando,o
124,0211-699501013259,su,o
124,0211-699501013259,posible,o
124,0211-699501013259,correlacion,o
124,0211-699501013259,con,o
124,0211-699501013259,dosis,o
124,0211-699501013259,de,o
124,0211-699501013259,dialisis,i
124,0211-699501013259,funcion,i
124,0211-699501013259,residual,i
124,0211-699501013259,y,o
124,0211-699501013259,parametros,o
124,0211-699501013259,nutricionales,o
124,0211-699501013259,Metodos,o
124,0211-699501013259,Todos,o
124,0211-699501013259,los,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,en,o
124,0211-699501013259,hemodialisis,i
124,0211-699501013259,al,o
124,0211-699501013259,comienzo,o
124,0211-699501013259,del,o
124,0211-699501013259,estudio,o
124,0211-699501013259,que,o
124,0211-699501013259,no,o
124,0211-699501013259,recibian,o
124,0211-699501013259,acido,i
124,0211-699501013259,folico,i
124,0211-699501013259,ni,o
124,0211-699501013259,vitamina,i
124,0211-699501013259,B6,i
124,0211-699501013259,asi,o
124,0211-699501013259,como,o
124,0211-699501013259,los,o
124,0211-699501013259,incorporados,o
124,0211-699501013259,posteriormente,o
124,0211-699501013259,a,o
124,0211-699501013259,partir,o
124,0211-699501013259,de,o
124,0211-699501013259,su,o
124,0211-699501013259,tercer,o
124,0211-699501013259,mes,o
124,0211-699501013259,en,o
124,0211-699501013259,hemodialisis,i
124,0211-699501013259,recibieron,o
124,0211-699501013259,5,o
124,0211-699501013259,mg,o
124,0211-699501013259,orales,o
124,0211-699501013259,de,o
124,0211-699501013259,acido,i
124,0211-699501013259,folico,i
124,0211-699501013259,cada,o
124,0211-699501013259,48,o
124,0211-699501013259,horas,o
124,0211-699501013259,y,o
124,0211-699501013259,40,o
124,0211-699501013259,mg,o
124,0211-699501013259,orales,o
124,0211-699501013259,de,o
124,0211-699501013259,vitamina,i
124,0211-699501013259,B6,i
124,0211-699501013259,cada,o
124,0211-699501013259,semana,o
124,0211-699501013259,Se,o
124,0211-699501013259,determinaron,o
124,0211-699501013259,al,o
124,0211-699501013259,comienzo,o
124,0211-699501013259,del,o
124,0211-699501013259,estudio,o
124,0211-699501013259,y,o
124,0211-699501013259,cada,o
124,0211-699501013259,2,o
124,0211-699501013259,meses,o
124,0211-699501013259,niveles,i
124,0211-699501013259,de,i
124,0211-699501013259,folato,i
124,0211-699501013259,vitamina,i
124,0211-699501013259,B12,i
124,0211-699501013259,inmunoensayo,i
124,0211-699501013259,albumina,i
124,0211-699501013259,y,o
124,0211-699501013259,cinetica,o
124,0211-699501013259,de,o
124,0211-699501013259,la,o
124,0211-699501013259,urea,i
124,0211-699501013259,KTV,o
124,0211-699501013259,KRU,o
124,0211-699501013259,PCRn,o
124,0211-699501013259,y,o
124,0211-699501013259,cada,o
124,0211-699501013259,6,o
124,0211-699501013259,meses,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,HPLC,i
124,0211-699501013259,y,o
124,0211-699501013259,pp,i
124,0211-699501013259,RIA,i
124,0211-699501013259,Resultados,o
124,0211-699501013259,80,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,fueron,o
124,0211-699501013259,incluidos,o
124,0211-699501013259,en,o
124,0211-699501013259,el,o
124,0211-699501013259,estudio,o
124,0211-699501013259,basal,o
124,0211-699501013259,con,o
124,0211-699501013259,una,o
124,0211-699501013259,prevalencia,o
124,0211-699501013259,de,o
124,0211-699501013259,hiperhomocisteinemia,i
124,0211-699501013259,del,o
124,0211-699501013259,844,o
124,0211-699501013259,deficit,i
124,0211-699501013259,de,i
124,0211-699501013259,pp,i
124,0211-699501013259,en,o
124,0211-699501013259,el,o
124,0211-699501013259,32,o
124,0211-699501013259,y,o
124,0211-699501013259,folato,i
124,0211-699501013259,en,o
124,0211-699501013259,el,o
124,0211-699501013259,rango,o
124,0211-699501013259,normal,o
124,0211-699501013259,bajo,o
124,0211-699501013259,los,o
124,0211-699501013259,niveles,i
124,0211-699501013259,de,i
124,0211-699501013259,tHcy,i
124,0211-699501013259,se,o
124,0211-699501013259,correlacionaban,o
124,0211-699501013259,inversamente,o
124,0211-699501013259,con,o
124,0211-699501013259,los,o
124,0211-699501013259,del,o
124,0211-699501013259,folato,i
124,0211-699501013259,r,o
124,0211-699501013259,0336,o
124,0211-699501013259,p,o
124,0211-699501013259,001,o
124,0211-699501013259,pero,o
124,0211-699501013259,no,o
124,0211-699501013259,con,o
124,0211-699501013259,pp,i
124,0211-699501013259,B12,i
124,0211-699501013259,edad,o
124,0211-699501013259,albumina,i
124,0211-699501013259,KTV,o
124,0211-699501013259,KRU,o
124,0211-699501013259,PCRn,o
124,0211-699501013259,Cincuenta,o
124,0211-699501013259,y,o
124,0211-699501013259,ocho,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,recibieron,o
124,0211-699501013259,seis,o
124,0211-699501013259,meses,o
124,0211-699501013259,de,o
124,0211-699501013259,suplementacion,i
124,0211-699501013259,con,o
124,0211-699501013259,normalizacion,o
124,0211-699501013259,del,o
124,0211-699501013259,pp,i
124,0211-699501013259,aumento,o
124,0211-699501013259,del,o
124,0211-699501013259,folato,i
124,0211-699501013259,703,o
124,0211-699501013259,IC,o
124,0211-699501013259,638,o
124,0211-699501013259,795,o
124,0211-699501013259,vs,o
124,0211-699501013259,6181,o
124,0211-699501013259,IC,o
124,0211-699501013259,4447,o
124,0211-699501013259,7811,o
124,0211-699501013259,p,o
124,0211-699501013259,0001,o
124,0211-699501013259,y,o
124,0211-699501013259,descenso,o
124,0211-699501013259,de,o
124,0211-699501013259,la,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,240,o
124,0211-699501013259,IC,o
124,0211-699501013259,213,o
124,0211-699501013259,264,o
124,0211-699501013259,vs,o
124,0211-699501013259,199,o
124,0211-699501013259,IC,o
124,0211-699501013259,175,o
124,0211-699501013259,224,o
124,0211-699501013259,p,o
124,0211-699501013259,005,o
124,0211-699501013259,Han,o
124,0211-699501013259,recibido,o
124,0211-699501013259,suplementacion,i
124,0211-699501013259,durante,o
124,0211-699501013259,12,o
124,0211-699501013259,meses,o
124,0211-699501013259,33,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,pero,o
124,0211-699501013259,a,o
124,0211-699501013259,pesar,o
124,0211-699501013259,de,o
124,0211-699501013259,un,o
124,0211-699501013259,continuo,o
124,0211-699501013259,aumento,o
124,0211-699501013259,del,o
124,0211-699501013259,folato,i
124,0211-699501013259,10078,o
124,0211-699501013259,IC,o
124,0211-699501013259,7481,o
124,0211-699501013259,12674,o
124,0211-699501013259,p,o
124,0211-699501013259,0001,o
124,0211-699501013259,solo,o
124,0211-699501013259,3,o
124,0211-699501013259,pacientes,o
124,0211-699501013259,presentan,o
124,0211-699501013259,niveles,o
124,0211-699501013259,normales,o
124,0211-699501013259,de,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,correlacionandose,o
124,0211-699501013259,directamente,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,con,o
124,0211-699501013259,la,o
124,0211-699501013259,albumina,i
124,0211-699501013259,r,o
124,0211-699501013259,056,o
124,0211-699501013259,p,o
124,0211-699501013259,0001,o
124,0211-699501013259,que,o
124,0211-699501013259,se,o
124,0211-699501013259,elevo,o
124,0211-699501013259,con,o
124,0211-699501013259,respecto,o
124,0211-699501013259,al,o
124,0211-699501013259,inicio,o
124,0211-699501013259,337,o
124,0211-699501013259,IC,o
124,0211-699501013259,327,o
124,0211-699501013259,346,o
124,0211-699501013259,vs,o
124,0211-699501013259,350,o
124,0211-699501013259,IC,o
124,0211-699501013259,337,o
124,0211-699501013259,363,o
124,0211-699501013259,p,o
124,0211-699501013259,005,o
124,0211-699501013259,Conclusion,o
124,0211-699501013259,Tras,o
124,0211-699501013259,suplementacion,i
124,0211-699501013259,con,o
124,0211-699501013259,acido,i
124,0211-699501013259,folico,i
124,0211-699501013259,y,o
124,0211-699501013259,vitamina,i
124,0211-699501013259,B6,i
124,0211-699501013259,aunque,o
124,0211-699501013259,inicialmente,o
124,0211-699501013259,se,o
124,0211-699501013259,reduce,o
124,0211-699501013259,la,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,esta,o
124,0211-699501013259,respuesta,o
124,0211-699501013259,se,o
124,0211-699501013259,hace,o
124,0211-699501013259,refractaria,o
124,0211-699501013259,correlacionandose,o
124,0211-699501013259,directamente,o
124,0211-699501013259,la,o
124,0211-699501013259,tHcy,i
124,0211-699501013259,con,o
124,0211-699501013259,la,o
124,0211-699501013259,albumina,i
124,0211-699501013259,plasmatica,i
124,0211-699501013259,La,o
124,0211-699501013259,interpretacion,o
124,0211-699501013259,de,o
124,0211-699501013259,los,o
124,0211-699501013259,niveles,i
124,0211-699501013259,de,i
124,0211-699501013259,tHcy,i
124,0211-699501013259,debe,o
124,0211-699501013259,tener,o
124,0211-699501013259,en,o
124,0211-699501013259,cuenta,o
124,0211-699501013259,la,o
124,0211-699501013259,concentracion,i
124,0211-699501013259,de,i
124,0211-699501013259,albumina,i
125,0211-699501013259,Efecto,o
125,0211-699501013259,de,o
125,0211-699501013259,la,o
125,0211-699501013259,suplementacion,i
125,0211-699501013259,con,o
125,0211-699501013259,acido,i
125,0211-699501013259,folico,i
125,0211-699501013259,sobre,o
125,0211-699501013259,los,o
125,0211-699501013259,niveles,i
125,0211-699501013259,de,i
125,0211-699501013259,homocisteina,i
125,0211-699501013259,total,o
125,0211-699501013259,en,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,en,o
125,0211-699501013259,hemodialisis,i
125,0211-699501013259,La,o
125,0211-699501013259,hiperhomocisteinemia,i
125,0211-699501013259,es,o
125,0211-699501013259,un,o
125,0211-699501013259,marcador,o
125,0211-699501013259,de,o
125,0211-699501013259,riesgo,o
125,0211-699501013259,independiente,o
125,0211-699501013259,de,o
125,0211-699501013259,morbimortalidad,o
125,0211-699501013259,cardiovascular,i
125,0211-699501013259,Hemos,o
125,0211-699501013259,intentado,o
125,0211-699501013259,prospectivamente,o
125,0211-699501013259,reducir,o
125,0211-699501013259,los,o
125,0211-699501013259,niveles,i
125,0211-699501013259,de,i
125,0211-699501013259,homocisteina,i
125,0211-699501013259,total,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,mediante,o
125,0211-699501013259,suplemento,o
125,0211-699501013259,con,o
125,0211-699501013259,acido,i
125,0211-699501013259,folico,i
125,0211-699501013259,y,o
125,0211-699501013259,vitamina,i
125,0211-699501013259,B6,i
125,0211-699501013259,pp,i
125,0211-699501013259,valorando,o
125,0211-699501013259,su,o
125,0211-699501013259,posible,o
125,0211-699501013259,correlacion,o
125,0211-699501013259,con,o
125,0211-699501013259,dosis,o
125,0211-699501013259,de,o
125,0211-699501013259,dialisis,i
125,0211-699501013259,funcion,i
125,0211-699501013259,residual,i
125,0211-699501013259,y,o
125,0211-699501013259,parametros,o
125,0211-699501013259,nutricionales,o
125,0211-699501013259,Metodos,o
125,0211-699501013259,Todos,o
125,0211-699501013259,los,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,en,o
125,0211-699501013259,hemodialisis,i
125,0211-699501013259,al,o
125,0211-699501013259,comienzo,o
125,0211-699501013259,del,o
125,0211-699501013259,estudio,o
125,0211-699501013259,que,o
125,0211-699501013259,no,o
125,0211-699501013259,recibian,o
125,0211-699501013259,acido,i
125,0211-699501013259,folico,i
125,0211-699501013259,ni,o
125,0211-699501013259,vitamina,i
125,0211-699501013259,B6,i
125,0211-699501013259,asi,o
125,0211-699501013259,como,o
125,0211-699501013259,los,o
125,0211-699501013259,incorporados,o
125,0211-699501013259,posteriormente,o
125,0211-699501013259,a,o
125,0211-699501013259,partir,o
125,0211-699501013259,de,o
125,0211-699501013259,su,o
125,0211-699501013259,tercer,o
125,0211-699501013259,mes,o
125,0211-699501013259,en,o
125,0211-699501013259,hemodialisis,i
125,0211-699501013259,recibieron,o
125,0211-699501013259,5,o
125,0211-699501013259,mg,o
125,0211-699501013259,orales,o
125,0211-699501013259,de,o
125,0211-699501013259,acido,i
125,0211-699501013259,folico,i
125,0211-699501013259,cada,o
125,0211-699501013259,48,o
125,0211-699501013259,horas,o
125,0211-699501013259,y,o
125,0211-699501013259,40,o
125,0211-699501013259,mg,o
125,0211-699501013259,orales,o
125,0211-699501013259,de,o
125,0211-699501013259,vitamina,i
125,0211-699501013259,B6,i
125,0211-699501013259,cada,o
125,0211-699501013259,semana,o
125,0211-699501013259,Se,o
125,0211-699501013259,determinaron,o
125,0211-699501013259,al,o
125,0211-699501013259,comienzo,o
125,0211-699501013259,del,o
125,0211-699501013259,estudio,o
125,0211-699501013259,y,o
125,0211-699501013259,cada,o
125,0211-699501013259,2,o
125,0211-699501013259,meses,o
125,0211-699501013259,niveles,i
125,0211-699501013259,de,i
125,0211-699501013259,folato,i
125,0211-699501013259,vitamina,i
125,0211-699501013259,B12,i
125,0211-699501013259,inmunoensayo,i
125,0211-699501013259,albumina,i
125,0211-699501013259,y,o
125,0211-699501013259,cinetica,o
125,0211-699501013259,de,o
125,0211-699501013259,la,o
125,0211-699501013259,urea,i
125,0211-699501013259,KTV,o
125,0211-699501013259,KRU,o
125,0211-699501013259,PCRn,o
125,0211-699501013259,y,o
125,0211-699501013259,cada,o
125,0211-699501013259,6,o
125,0211-699501013259,meses,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,HPLC,i
125,0211-699501013259,y,o
125,0211-699501013259,pp,i
125,0211-699501013259,RIA,i
125,0211-699501013259,Resultados,o
125,0211-699501013259,80,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,fueron,o
125,0211-699501013259,incluidos,o
125,0211-699501013259,en,o
125,0211-699501013259,el,o
125,0211-699501013259,estudio,o
125,0211-699501013259,basal,o
125,0211-699501013259,con,o
125,0211-699501013259,una,o
125,0211-699501013259,prevalencia,o
125,0211-699501013259,de,o
125,0211-699501013259,hiperhomocisteinemia,i
125,0211-699501013259,del,o
125,0211-699501013259,844,o
125,0211-699501013259,deficit,i
125,0211-699501013259,de,i
125,0211-699501013259,pp,i
125,0211-699501013259,en,o
125,0211-699501013259,el,o
125,0211-699501013259,32,o
125,0211-699501013259,y,o
125,0211-699501013259,folato,i
125,0211-699501013259,en,o
125,0211-699501013259,el,o
125,0211-699501013259,rango,o
125,0211-699501013259,normal,o
125,0211-699501013259,bajo,o
125,0211-699501013259,los,o
125,0211-699501013259,niveles,i
125,0211-699501013259,de,i
125,0211-699501013259,tHcy,i
125,0211-699501013259,se,o
125,0211-699501013259,correlacionaban,o
125,0211-699501013259,inversamente,o
125,0211-699501013259,con,o
125,0211-699501013259,los,o
125,0211-699501013259,del,o
125,0211-699501013259,folato,i
125,0211-699501013259,r,o
125,0211-699501013259,0336,o
125,0211-699501013259,p,o
125,0211-699501013259,001,o
125,0211-699501013259,pero,o
125,0211-699501013259,no,o
125,0211-699501013259,con,o
125,0211-699501013259,pp,i
125,0211-699501013259,B12,i
125,0211-699501013259,edad,o
125,0211-699501013259,albumina,i
125,0211-699501013259,KTV,o
125,0211-699501013259,KRU,o
125,0211-699501013259,PCRn,o
125,0211-699501013259,Cincuenta,o
125,0211-699501013259,y,o
125,0211-699501013259,ocho,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,recibieron,o
125,0211-699501013259,seis,o
125,0211-699501013259,meses,o
125,0211-699501013259,de,o
125,0211-699501013259,suplementacion,i
125,0211-699501013259,con,o
125,0211-699501013259,normalizacion,o
125,0211-699501013259,del,o
125,0211-699501013259,pp,i
125,0211-699501013259,aumento,o
125,0211-699501013259,del,o
125,0211-699501013259,folato,i
125,0211-699501013259,703,o
125,0211-699501013259,IC,o
125,0211-699501013259,638,o
125,0211-699501013259,795,o
125,0211-699501013259,vs,o
125,0211-699501013259,6181,o
125,0211-699501013259,IC,o
125,0211-699501013259,4447,o
125,0211-699501013259,7811,o
125,0211-699501013259,p,o
125,0211-699501013259,0001,o
125,0211-699501013259,y,o
125,0211-699501013259,descenso,o
125,0211-699501013259,de,o
125,0211-699501013259,la,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,240,o
125,0211-699501013259,IC,o
125,0211-699501013259,213,o
125,0211-699501013259,264,o
125,0211-699501013259,vs,o
125,0211-699501013259,199,o
125,0211-699501013259,IC,o
125,0211-699501013259,175,o
125,0211-699501013259,224,o
125,0211-699501013259,p,o
125,0211-699501013259,005,o
125,0211-699501013259,Han,o
125,0211-699501013259,recibido,o
125,0211-699501013259,suplementacion,i
125,0211-699501013259,durante,o
125,0211-699501013259,12,o
125,0211-699501013259,meses,o
125,0211-699501013259,33,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,pero,o
125,0211-699501013259,a,o
125,0211-699501013259,pesar,o
125,0211-699501013259,de,o
125,0211-699501013259,un,o
125,0211-699501013259,continuo,o
125,0211-699501013259,aumento,o
125,0211-699501013259,del,o
125,0211-699501013259,folato,i
125,0211-699501013259,10078,o
125,0211-699501013259,IC,o
125,0211-699501013259,7481,o
125,0211-699501013259,12674,o
125,0211-699501013259,p,o
125,0211-699501013259,0001,o
125,0211-699501013259,solo,o
125,0211-699501013259,3,o
125,0211-699501013259,pacientes,o
125,0211-699501013259,presentan,o
125,0211-699501013259,niveles,o
125,0211-699501013259,normales,o
125,0211-699501013259,de,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,correlacionandose,o
125,0211-699501013259,directamente,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,con,o
125,0211-699501013259,la,o
125,0211-699501013259,albumina,i
125,0211-699501013259,r,o
125,0211-699501013259,056,o
125,0211-699501013259,p,o
125,0211-699501013259,0001,o
125,0211-699501013259,que,o
125,0211-699501013259,se,o
125,0211-699501013259,elevo,o
125,0211-699501013259,con,o
125,0211-699501013259,respecto,o
125,0211-699501013259,al,o
125,0211-699501013259,inicio,o
125,0211-699501013259,337,o
125,0211-699501013259,IC,o
125,0211-699501013259,327,o
125,0211-699501013259,346,o
125,0211-699501013259,vs,o
125,0211-699501013259,350,o
125,0211-699501013259,IC,o
125,0211-699501013259,337,o
125,0211-699501013259,363,o
125,0211-699501013259,p,o
125,0211-699501013259,005,o
125,0211-699501013259,Conclusion,o
125,0211-699501013259,Tras,o
125,0211-699501013259,suplementacion,i
125,0211-699501013259,con,o
125,0211-699501013259,acido,i
125,0211-699501013259,folico,i
125,0211-699501013259,y,o
125,0211-699501013259,vitamina,i
125,0211-699501013259,B6,i
125,0211-699501013259,aunque,o
125,0211-699501013259,inicialmente,o
125,0211-699501013259,se,o
125,0211-699501013259,reduce,o
125,0211-699501013259,la,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,esta,o
125,0211-699501013259,respuesta,o
125,0211-699501013259,se,o
125,0211-699501013259,hace,o
125,0211-699501013259,refractaria,o
125,0211-699501013259,correlacionandose,o
125,0211-699501013259,directamente,o
125,0211-699501013259,la,o
125,0211-699501013259,tHcy,i
125,0211-699501013259,con,o
125,0211-699501013259,la,o
125,0211-699501013259,albumina,i
125,0211-699501013259,plasmatica,i
125,0211-699501013259,La,o
125,0211-699501013259,interpretacion,o
125,0211-699501013259,de,o
125,0211-699501013259,los,o
125,0211-699501013259,niveles,i
125,0211-699501013259,de,i
125,0211-699501013259,tHcy,i
125,0211-699501013259,debe,o
125,0211-699501013259,tener,o
125,0211-699501013259,en,o
125,0211-699501013259,cuenta,o
125,0211-699501013259,la,o
125,0211-699501013259,concentracion,i
125,0211-699501013259,de,i
125,0211-699501013259,albumina,i
126,0211-699501013259,Efecto,o
126,0211-699501013259,de,o
126,0211-699501013259,la,o
126,0211-699501013259,suplementacion,i
126,0211-699501013259,con,o
126,0211-699501013259,acido,i
126,0211-699501013259,folico,i
126,0211-699501013259,sobre,o
126,0211-699501013259,los,o
126,0211-699501013259,niveles,i
126,0211-699501013259,de,i
126,0211-699501013259,homocisteina,i
126,0211-699501013259,total,o
126,0211-699501013259,en,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,en,o
126,0211-699501013259,hemodialisis,i
126,0211-699501013259,La,o
126,0211-699501013259,hiperhomocisteinemia,i
126,0211-699501013259,es,o
126,0211-699501013259,un,o
126,0211-699501013259,marcador,o
126,0211-699501013259,de,o
126,0211-699501013259,riesgo,o
126,0211-699501013259,independiente,o
126,0211-699501013259,de,o
126,0211-699501013259,morbimortalidad,o
126,0211-699501013259,cardiovascular,i
126,0211-699501013259,Hemos,o
126,0211-699501013259,intentado,o
126,0211-699501013259,prospectivamente,o
126,0211-699501013259,reducir,o
126,0211-699501013259,los,o
126,0211-699501013259,niveles,i
126,0211-699501013259,de,i
126,0211-699501013259,homocisteina,i
126,0211-699501013259,total,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,mediante,o
126,0211-699501013259,suplemento,o
126,0211-699501013259,con,o
126,0211-699501013259,acido,i
126,0211-699501013259,folico,i
126,0211-699501013259,y,o
126,0211-699501013259,vitamina,i
126,0211-699501013259,B6,i
126,0211-699501013259,pp,i
126,0211-699501013259,valorando,o
126,0211-699501013259,su,o
126,0211-699501013259,posible,o
126,0211-699501013259,correlacion,o
126,0211-699501013259,con,o
126,0211-699501013259,dosis,o
126,0211-699501013259,de,o
126,0211-699501013259,dialisis,i
126,0211-699501013259,funcion,i
126,0211-699501013259,residual,i
126,0211-699501013259,y,o
126,0211-699501013259,parametros,o
126,0211-699501013259,nutricionales,o
126,0211-699501013259,Metodos,o
126,0211-699501013259,Todos,o
126,0211-699501013259,los,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,en,o
126,0211-699501013259,hemodialisis,i
126,0211-699501013259,al,o
126,0211-699501013259,comienzo,o
126,0211-699501013259,del,o
126,0211-699501013259,estudio,o
126,0211-699501013259,que,o
126,0211-699501013259,no,o
126,0211-699501013259,recibian,o
126,0211-699501013259,acido,i
126,0211-699501013259,folico,i
126,0211-699501013259,ni,o
126,0211-699501013259,vitamina,i
126,0211-699501013259,B6,i
126,0211-699501013259,asi,o
126,0211-699501013259,como,o
126,0211-699501013259,los,o
126,0211-699501013259,incorporados,o
126,0211-699501013259,posteriormente,o
126,0211-699501013259,a,o
126,0211-699501013259,partir,o
126,0211-699501013259,de,o
126,0211-699501013259,su,o
126,0211-699501013259,tercer,o
126,0211-699501013259,mes,o
126,0211-699501013259,en,o
126,0211-699501013259,hemodialisis,i
126,0211-699501013259,recibieron,o
126,0211-699501013259,5,o
126,0211-699501013259,mg,o
126,0211-699501013259,orales,o
126,0211-699501013259,de,o
126,0211-699501013259,acido,i
126,0211-699501013259,folico,i
126,0211-699501013259,cada,o
126,0211-699501013259,48,o
126,0211-699501013259,horas,o
126,0211-699501013259,y,o
126,0211-699501013259,40,o
126,0211-699501013259,mg,o
126,0211-699501013259,orales,o
126,0211-699501013259,de,o
126,0211-699501013259,vitamina,i
126,0211-699501013259,B6,i
126,0211-699501013259,cada,o
126,0211-699501013259,semana,o
126,0211-699501013259,Se,o
126,0211-699501013259,determinaron,o
126,0211-699501013259,al,o
126,0211-699501013259,comienzo,o
126,0211-699501013259,del,o
126,0211-699501013259,estudio,o
126,0211-699501013259,y,o
126,0211-699501013259,cada,o
126,0211-699501013259,2,o
126,0211-699501013259,meses,o
126,0211-699501013259,niveles,i
126,0211-699501013259,de,i
126,0211-699501013259,folato,i
126,0211-699501013259,vitamina,i
126,0211-699501013259,B12,i
126,0211-699501013259,inmunoensayo,i
126,0211-699501013259,albumina,i
126,0211-699501013259,y,o
126,0211-699501013259,cinetica,o
126,0211-699501013259,de,o
126,0211-699501013259,la,o
126,0211-699501013259,urea,i
126,0211-699501013259,KTV,o
126,0211-699501013259,KRU,o
126,0211-699501013259,PCRn,o
126,0211-699501013259,y,o
126,0211-699501013259,cada,o
126,0211-699501013259,6,o
126,0211-699501013259,meses,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,HPLC,i
126,0211-699501013259,y,o
126,0211-699501013259,pp,i
126,0211-699501013259,RIA,i
126,0211-699501013259,Resultados,o
126,0211-699501013259,80,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,fueron,o
126,0211-699501013259,incluidos,o
126,0211-699501013259,en,o
126,0211-699501013259,el,o
126,0211-699501013259,estudio,o
126,0211-699501013259,basal,o
126,0211-699501013259,con,o
126,0211-699501013259,una,o
126,0211-699501013259,prevalencia,o
126,0211-699501013259,de,o
126,0211-699501013259,hiperhomocisteinemia,i
126,0211-699501013259,del,o
126,0211-699501013259,844,o
126,0211-699501013259,deficit,i
126,0211-699501013259,de,i
126,0211-699501013259,pp,i
126,0211-699501013259,en,o
126,0211-699501013259,el,o
126,0211-699501013259,32,o
126,0211-699501013259,y,o
126,0211-699501013259,folato,i
126,0211-699501013259,en,o
126,0211-699501013259,el,o
126,0211-699501013259,rango,o
126,0211-699501013259,normal,o
126,0211-699501013259,bajo,o
126,0211-699501013259,los,o
126,0211-699501013259,niveles,i
126,0211-699501013259,de,i
126,0211-699501013259,tHcy,i
126,0211-699501013259,se,o
126,0211-699501013259,correlacionaban,o
126,0211-699501013259,inversamente,o
126,0211-699501013259,con,o
126,0211-699501013259,los,o
126,0211-699501013259,del,o
126,0211-699501013259,folato,i
126,0211-699501013259,r,o
126,0211-699501013259,0336,o
126,0211-699501013259,p,o
126,0211-699501013259,001,o
126,0211-699501013259,pero,o
126,0211-699501013259,no,o
126,0211-699501013259,con,o
126,0211-699501013259,pp,i
126,0211-699501013259,B12,i
126,0211-699501013259,edad,o
126,0211-699501013259,albumina,i
126,0211-699501013259,KTV,o
126,0211-699501013259,KRU,o
126,0211-699501013259,PCRn,o
126,0211-699501013259,Cincuenta,o
126,0211-699501013259,y,o
126,0211-699501013259,ocho,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,recibieron,o
126,0211-699501013259,seis,o
126,0211-699501013259,meses,o
126,0211-699501013259,de,o
126,0211-699501013259,suplementacion,i
126,0211-699501013259,con,o
126,0211-699501013259,normalizacion,o
126,0211-699501013259,del,o
126,0211-699501013259,pp,i
126,0211-699501013259,aumento,o
126,0211-699501013259,del,o
126,0211-699501013259,folato,i
126,0211-699501013259,703,o
126,0211-699501013259,IC,o
126,0211-699501013259,638,o
126,0211-699501013259,795,o
126,0211-699501013259,vs,o
126,0211-699501013259,6181,o
126,0211-699501013259,IC,o
126,0211-699501013259,4447,o
126,0211-699501013259,7811,o
126,0211-699501013259,p,o
126,0211-699501013259,0001,o
126,0211-699501013259,y,o
126,0211-699501013259,descenso,o
126,0211-699501013259,de,o
126,0211-699501013259,la,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,240,o
126,0211-699501013259,IC,o
126,0211-699501013259,213,o
126,0211-699501013259,264,o
126,0211-699501013259,vs,o
126,0211-699501013259,199,o
126,0211-699501013259,IC,o
126,0211-699501013259,175,o
126,0211-699501013259,224,o
126,0211-699501013259,p,o
126,0211-699501013259,005,o
126,0211-699501013259,Han,o
126,0211-699501013259,recibido,o
126,0211-699501013259,suplementacion,i
126,0211-699501013259,durante,o
126,0211-699501013259,12,o
126,0211-699501013259,meses,o
126,0211-699501013259,33,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,pero,o
126,0211-699501013259,a,o
126,0211-699501013259,pesar,o
126,0211-699501013259,de,o
126,0211-699501013259,un,o
126,0211-699501013259,continuo,o
126,0211-699501013259,aumento,o
126,0211-699501013259,del,o
126,0211-699501013259,folato,i
126,0211-699501013259,10078,o
126,0211-699501013259,IC,o
126,0211-699501013259,7481,o
126,0211-699501013259,12674,o
126,0211-699501013259,p,o
126,0211-699501013259,0001,o
126,0211-699501013259,solo,o
126,0211-699501013259,3,o
126,0211-699501013259,pacientes,o
126,0211-699501013259,presentan,o
126,0211-699501013259,niveles,o
126,0211-699501013259,normales,o
126,0211-699501013259,de,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,correlacionandose,o
126,0211-699501013259,directamente,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,con,o
126,0211-699501013259,la,o
126,0211-699501013259,albumina,i
126,0211-699501013259,r,o
126,0211-699501013259,056,o
126,0211-699501013259,p,o
126,0211-699501013259,0001,o
126,0211-699501013259,que,o
126,0211-699501013259,se,o
126,0211-699501013259,elevo,o
126,0211-699501013259,con,o
126,0211-699501013259,respecto,o
126,0211-699501013259,al,o
126,0211-699501013259,inicio,o
126,0211-699501013259,337,o
126,0211-699501013259,IC,o
126,0211-699501013259,327,o
126,0211-699501013259,346,o
126,0211-699501013259,vs,o
126,0211-699501013259,350,o
126,0211-699501013259,IC,o
126,0211-699501013259,337,o
126,0211-699501013259,363,o
126,0211-699501013259,p,o
126,0211-699501013259,005,o
126,0211-699501013259,Conclusion,o
126,0211-699501013259,Tras,o
126,0211-699501013259,suplementacion,i
126,0211-699501013259,con,o
126,0211-699501013259,acido,i
126,0211-699501013259,folico,i
126,0211-699501013259,y,o
126,0211-699501013259,vitamina,i
126,0211-699501013259,B6,i
126,0211-699501013259,aunque,o
126,0211-699501013259,inicialmente,o
126,0211-699501013259,se,o
126,0211-699501013259,reduce,o
126,0211-699501013259,la,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,esta,o
126,0211-699501013259,respuesta,o
126,0211-699501013259,se,o
126,0211-699501013259,hace,o
126,0211-699501013259,refractaria,o
126,0211-699501013259,correlacionandose,o
126,0211-699501013259,directamente,o
126,0211-699501013259,la,o
126,0211-699501013259,tHcy,i
126,0211-699501013259,con,o
126,0211-699501013259,la,o
126,0211-699501013259,albumina,i
126,0211-699501013259,plasmatica,i
126,0211-699501013259,La,o
126,0211-699501013259,interpretacion,o
126,0211-699501013259,de,o
126,0211-699501013259,los,o
126,0211-699501013259,niveles,i
126,0211-699501013259,de,i
126,0211-699501013259,tHcy,i
126,0211-699501013259,debe,o
126,0211-699501013259,tener,o
126,0211-699501013259,en,o
126,0211-699501013259,cuenta,o
126,0211-699501013259,la,o
126,0211-699501013259,concentracion,i
126,0211-699501013259,de,i
126,0211-699501013259,albumina,i
127,0211-699501013259,Efecto,o
127,0211-699501013259,de,o
127,0211-699501013259,la,o
127,0211-699501013259,suplementacion,i
127,0211-699501013259,con,o
127,0211-699501013259,acido,i
127,0211-699501013259,folico,i
127,0211-699501013259,sobre,o
127,0211-699501013259,los,o
127,0211-699501013259,niveles,i
127,0211-699501013259,de,i
127,0211-699501013259,homocisteina,i
127,0211-699501013259,total,o
127,0211-699501013259,en,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,en,o
127,0211-699501013259,hemodialisis,i
127,0211-699501013259,La,o
127,0211-699501013259,hiperhomocisteinemia,i
127,0211-699501013259,es,o
127,0211-699501013259,un,o
127,0211-699501013259,marcador,o
127,0211-699501013259,de,o
127,0211-699501013259,riesgo,o
127,0211-699501013259,independiente,o
127,0211-699501013259,de,o
127,0211-699501013259,morbimortalidad,o
127,0211-699501013259,cardiovascular,i
127,0211-699501013259,Hemos,o
127,0211-699501013259,intentado,o
127,0211-699501013259,prospectivamente,o
127,0211-699501013259,reducir,o
127,0211-699501013259,los,o
127,0211-699501013259,niveles,i
127,0211-699501013259,de,i
127,0211-699501013259,homocisteina,i
127,0211-699501013259,total,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,mediante,o
127,0211-699501013259,suplemento,o
127,0211-699501013259,con,o
127,0211-699501013259,acido,i
127,0211-699501013259,folico,i
127,0211-699501013259,y,o
127,0211-699501013259,vitamina,i
127,0211-699501013259,B6,i
127,0211-699501013259,pp,i
127,0211-699501013259,valorando,o
127,0211-699501013259,su,o
127,0211-699501013259,posible,o
127,0211-699501013259,correlacion,o
127,0211-699501013259,con,o
127,0211-699501013259,dosis,o
127,0211-699501013259,de,o
127,0211-699501013259,dialisis,i
127,0211-699501013259,funcion,i
127,0211-699501013259,residual,i
127,0211-699501013259,y,o
127,0211-699501013259,parametros,o
127,0211-699501013259,nutricionales,o
127,0211-699501013259,Metodos,o
127,0211-699501013259,Todos,o
127,0211-699501013259,los,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,en,o
127,0211-699501013259,hemodialisis,i
127,0211-699501013259,al,o
127,0211-699501013259,comienzo,o
127,0211-699501013259,del,o
127,0211-699501013259,estudio,o
127,0211-699501013259,que,o
127,0211-699501013259,no,o
127,0211-699501013259,recibian,o
127,0211-699501013259,acido,i
127,0211-699501013259,folico,i
127,0211-699501013259,ni,o
127,0211-699501013259,vitamina,i
127,0211-699501013259,B6,i
127,0211-699501013259,asi,o
127,0211-699501013259,como,o
127,0211-699501013259,los,o
127,0211-699501013259,incorporados,o
127,0211-699501013259,posteriormente,o
127,0211-699501013259,a,o
127,0211-699501013259,partir,o
127,0211-699501013259,de,o
127,0211-699501013259,su,o
127,0211-699501013259,tercer,o
127,0211-699501013259,mes,o
127,0211-699501013259,en,o
127,0211-699501013259,hemodialisis,i
127,0211-699501013259,recibieron,o
127,0211-699501013259,5,o
127,0211-699501013259,mg,o
127,0211-699501013259,orales,o
127,0211-699501013259,de,o
127,0211-699501013259,acido,i
127,0211-699501013259,folico,i
127,0211-699501013259,cada,o
127,0211-699501013259,48,o
127,0211-699501013259,horas,o
127,0211-699501013259,y,o
127,0211-699501013259,40,o
127,0211-699501013259,mg,o
127,0211-699501013259,orales,o
127,0211-699501013259,de,o
127,0211-699501013259,vitamina,i
127,0211-699501013259,B6,i
127,0211-699501013259,cada,o
127,0211-699501013259,semana,o
127,0211-699501013259,Se,o
127,0211-699501013259,determinaron,o
127,0211-699501013259,al,o
127,0211-699501013259,comienzo,o
127,0211-699501013259,del,o
127,0211-699501013259,estudio,o
127,0211-699501013259,y,o
127,0211-699501013259,cada,o
127,0211-699501013259,2,o
127,0211-699501013259,meses,o
127,0211-699501013259,niveles,i
127,0211-699501013259,de,i
127,0211-699501013259,folato,i
127,0211-699501013259,vitamina,i
127,0211-699501013259,B12,i
127,0211-699501013259,inmunoensayo,i
127,0211-699501013259,albumina,i
127,0211-699501013259,y,o
127,0211-699501013259,cinetica,o
127,0211-699501013259,de,o
127,0211-699501013259,la,o
127,0211-699501013259,urea,i
127,0211-699501013259,KTV,o
127,0211-699501013259,KRU,o
127,0211-699501013259,PCRn,o
127,0211-699501013259,y,o
127,0211-699501013259,cada,o
127,0211-699501013259,6,o
127,0211-699501013259,meses,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,HPLC,i
127,0211-699501013259,y,o
127,0211-699501013259,pp,i
127,0211-699501013259,RIA,i
127,0211-699501013259,Resultados,o
127,0211-699501013259,80,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,fueron,o
127,0211-699501013259,incluidos,o
127,0211-699501013259,en,o
127,0211-699501013259,el,o
127,0211-699501013259,estudio,o
127,0211-699501013259,basal,o
127,0211-699501013259,con,o
127,0211-699501013259,una,o
127,0211-699501013259,prevalencia,o
127,0211-699501013259,de,o
127,0211-699501013259,hiperhomocisteinemia,i
127,0211-699501013259,del,o
127,0211-699501013259,844,o
127,0211-699501013259,deficit,i
127,0211-699501013259,de,i
127,0211-699501013259,pp,i
127,0211-699501013259,en,o
127,0211-699501013259,el,o
127,0211-699501013259,32,o
127,0211-699501013259,y,o
127,0211-699501013259,folato,i
127,0211-699501013259,en,o
127,0211-699501013259,el,o
127,0211-699501013259,rango,o
127,0211-699501013259,normal,o
127,0211-699501013259,bajo,o
127,0211-699501013259,los,o
127,0211-699501013259,niveles,i
127,0211-699501013259,de,i
127,0211-699501013259,tHcy,i
127,0211-699501013259,se,o
127,0211-699501013259,correlacionaban,o
127,0211-699501013259,inversamente,o
127,0211-699501013259,con,o
127,0211-699501013259,los,o
127,0211-699501013259,del,o
127,0211-699501013259,folato,i
127,0211-699501013259,r,o
127,0211-699501013259,0336,o
127,0211-699501013259,p,o
127,0211-699501013259,001,o
127,0211-699501013259,pero,o
127,0211-699501013259,no,o
127,0211-699501013259,con,o
127,0211-699501013259,pp,i
127,0211-699501013259,B12,i
127,0211-699501013259,edad,o
127,0211-699501013259,albumina,i
127,0211-699501013259,KTV,o
127,0211-699501013259,KRU,o
127,0211-699501013259,PCRn,o
127,0211-699501013259,Cincuenta,o
127,0211-699501013259,y,o
127,0211-699501013259,ocho,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,recibieron,o
127,0211-699501013259,seis,o
127,0211-699501013259,meses,o
127,0211-699501013259,de,o
127,0211-699501013259,suplementacion,i
127,0211-699501013259,con,o
127,0211-699501013259,normalizacion,o
127,0211-699501013259,del,o
127,0211-699501013259,pp,i
127,0211-699501013259,aumento,o
127,0211-699501013259,del,o
127,0211-699501013259,folato,i
127,0211-699501013259,703,o
127,0211-699501013259,IC,o
127,0211-699501013259,638,o
127,0211-699501013259,795,o
127,0211-699501013259,vs,o
127,0211-699501013259,6181,o
127,0211-699501013259,IC,o
127,0211-699501013259,4447,o
127,0211-699501013259,7811,o
127,0211-699501013259,p,o
127,0211-699501013259,0001,o
127,0211-699501013259,y,o
127,0211-699501013259,descenso,o
127,0211-699501013259,de,o
127,0211-699501013259,la,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,240,o
127,0211-699501013259,IC,o
127,0211-699501013259,213,o
127,0211-699501013259,264,o
127,0211-699501013259,vs,o
127,0211-699501013259,199,o
127,0211-699501013259,IC,o
127,0211-699501013259,175,o
127,0211-699501013259,224,o
127,0211-699501013259,p,o
127,0211-699501013259,005,o
127,0211-699501013259,Han,o
127,0211-699501013259,recibido,o
127,0211-699501013259,suplementacion,i
127,0211-699501013259,durante,o
127,0211-699501013259,12,o
127,0211-699501013259,meses,o
127,0211-699501013259,33,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,pero,o
127,0211-699501013259,a,o
127,0211-699501013259,pesar,o
127,0211-699501013259,de,o
127,0211-699501013259,un,o
127,0211-699501013259,continuo,o
127,0211-699501013259,aumento,o
127,0211-699501013259,del,o
127,0211-699501013259,folato,i
127,0211-699501013259,10078,o
127,0211-699501013259,IC,o
127,0211-699501013259,7481,o
127,0211-699501013259,12674,o
127,0211-699501013259,p,o
127,0211-699501013259,0001,o
127,0211-699501013259,solo,o
127,0211-699501013259,3,o
127,0211-699501013259,pacientes,o
127,0211-699501013259,presentan,o
127,0211-699501013259,niveles,o
127,0211-699501013259,normales,o
127,0211-699501013259,de,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,correlacionandose,o
127,0211-699501013259,directamente,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,con,o
127,0211-699501013259,la,o
127,0211-699501013259,albumina,i
127,0211-699501013259,r,o
127,0211-699501013259,056,o
127,0211-699501013259,p,o
127,0211-699501013259,0001,o
127,0211-699501013259,que,o
127,0211-699501013259,se,o
127,0211-699501013259,elevo,o
127,0211-699501013259,con,o
127,0211-699501013259,respecto,o
127,0211-699501013259,al,o
127,0211-699501013259,inicio,o
127,0211-699501013259,337,o
127,0211-699501013259,IC,o
127,0211-699501013259,327,o
127,0211-699501013259,346,o
127,0211-699501013259,vs,o
127,0211-699501013259,350,o
127,0211-699501013259,IC,o
127,0211-699501013259,337,o
127,0211-699501013259,363,o
127,0211-699501013259,p,o
127,0211-699501013259,005,o
127,0211-699501013259,Conclusion,o
127,0211-699501013259,Tras,o
127,0211-699501013259,suplementacion,i
127,0211-699501013259,con,o
127,0211-699501013259,acido,i
127,0211-699501013259,folico,i
127,0211-699501013259,y,o
127,0211-699501013259,vitamina,i
127,0211-699501013259,B6,i
127,0211-699501013259,aunque,o
127,0211-699501013259,inicialmente,o
127,0211-699501013259,se,o
127,0211-699501013259,reduce,o
127,0211-699501013259,la,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,esta,o
127,0211-699501013259,respuesta,o
127,0211-699501013259,se,o
127,0211-699501013259,hace,o
127,0211-699501013259,refractaria,o
127,0211-699501013259,correlacionandose,o
127,0211-699501013259,directamente,o
127,0211-699501013259,la,o
127,0211-699501013259,tHcy,i
127,0211-699501013259,con,o
127,0211-699501013259,la,o
127,0211-699501013259,albumina,i
127,0211-699501013259,plasmatica,i
127,0211-699501013259,La,o
127,0211-699501013259,interpretacion,o
127,0211-699501013259,de,o
127,0211-699501013259,los,o
127,0211-699501013259,niveles,i
127,0211-699501013259,de,i
127,0211-699501013259,tHcy,i
127,0211-699501013259,debe,o
127,0211-699501013259,tener,o
127,0211-699501013259,en,o
127,0211-699501013259,cuenta,o
127,0211-699501013259,la,o
127,0211-699501013259,concentracion,i
127,0211-699501013259,de,i
127,0211-699501013259,albumina,i
128,0211-699501013259,Efecto,o
128,0211-699501013259,de,o
128,0211-699501013259,la,o
128,0211-699501013259,suplementacion,i
128,0211-699501013259,con,o
128,0211-699501013259,acido,i
128,0211-699501013259,folico,i
128,0211-699501013259,sobre,o
128,0211-699501013259,los,o
128,0211-699501013259,niveles,i
128,0211-699501013259,de,i
128,0211-699501013259,homocisteina,i
128,0211-699501013259,total,o
128,0211-699501013259,en,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,en,o
128,0211-699501013259,hemodialisis,i
128,0211-699501013259,La,o
128,0211-699501013259,hiperhomocisteinemia,i
128,0211-699501013259,es,o
128,0211-699501013259,un,o
128,0211-699501013259,marcador,o
128,0211-699501013259,de,o
128,0211-699501013259,riesgo,o
128,0211-699501013259,independiente,o
128,0211-699501013259,de,o
128,0211-699501013259,morbimortalidad,o
128,0211-699501013259,cardiovascular,i
128,0211-699501013259,Hemos,o
128,0211-699501013259,intentado,o
128,0211-699501013259,prospectivamente,o
128,0211-699501013259,reducir,o
128,0211-699501013259,los,o
128,0211-699501013259,niveles,i
128,0211-699501013259,de,i
128,0211-699501013259,homocisteina,i
128,0211-699501013259,total,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,mediante,o
128,0211-699501013259,suplemento,o
128,0211-699501013259,con,o
128,0211-699501013259,acido,i
128,0211-699501013259,folico,i
128,0211-699501013259,y,o
128,0211-699501013259,vitamina,i
128,0211-699501013259,B6,i
128,0211-699501013259,pp,i
128,0211-699501013259,valorando,o
128,0211-699501013259,su,o
128,0211-699501013259,posible,o
128,0211-699501013259,correlacion,o
128,0211-699501013259,con,o
128,0211-699501013259,dosis,o
128,0211-699501013259,de,o
128,0211-699501013259,dialisis,i
128,0211-699501013259,funcion,i
128,0211-699501013259,residual,i
128,0211-699501013259,y,o
128,0211-699501013259,parametros,o
128,0211-699501013259,nutricionales,o
128,0211-699501013259,Metodos,o
128,0211-699501013259,Todos,o
128,0211-699501013259,los,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,en,o
128,0211-699501013259,hemodialisis,i
128,0211-699501013259,al,o
128,0211-699501013259,comienzo,o
128,0211-699501013259,del,o
128,0211-699501013259,estudio,o
128,0211-699501013259,que,o
128,0211-699501013259,no,o
128,0211-699501013259,recibian,o
128,0211-699501013259,acido,i
128,0211-699501013259,folico,i
128,0211-699501013259,ni,o
128,0211-699501013259,vitamina,i
128,0211-699501013259,B6,i
128,0211-699501013259,asi,o
128,0211-699501013259,como,o
128,0211-699501013259,los,o
128,0211-699501013259,incorporados,o
128,0211-699501013259,posteriormente,o
128,0211-699501013259,a,o
128,0211-699501013259,partir,o
128,0211-699501013259,de,o
128,0211-699501013259,su,o
128,0211-699501013259,tercer,o
128,0211-699501013259,mes,o
128,0211-699501013259,en,o
128,0211-699501013259,hemodialisis,i
128,0211-699501013259,recibieron,o
128,0211-699501013259,5,o
128,0211-699501013259,mg,o
128,0211-699501013259,orales,o
128,0211-699501013259,de,o
128,0211-699501013259,acido,i
128,0211-699501013259,folico,i
128,0211-699501013259,cada,o
128,0211-699501013259,48,o
128,0211-699501013259,horas,o
128,0211-699501013259,y,o
128,0211-699501013259,40,o
128,0211-699501013259,mg,o
128,0211-699501013259,orales,o
128,0211-699501013259,de,o
128,0211-699501013259,vitamina,i
128,0211-699501013259,B6,i
128,0211-699501013259,cada,o
128,0211-699501013259,semana,o
128,0211-699501013259,Se,o
128,0211-699501013259,determinaron,o
128,0211-699501013259,al,o
128,0211-699501013259,comienzo,o
128,0211-699501013259,del,o
128,0211-699501013259,estudio,o
128,0211-699501013259,y,o
128,0211-699501013259,cada,o
128,0211-699501013259,2,o
128,0211-699501013259,meses,o
128,0211-699501013259,niveles,i
128,0211-699501013259,de,i
128,0211-699501013259,folato,i
128,0211-699501013259,vitamina,i
128,0211-699501013259,B12,i
128,0211-699501013259,inmunoensayo,i
128,0211-699501013259,albumina,i
128,0211-699501013259,y,o
128,0211-699501013259,cinetica,o
128,0211-699501013259,de,o
128,0211-699501013259,la,o
128,0211-699501013259,urea,i
128,0211-699501013259,KTV,o
128,0211-699501013259,KRU,o
128,0211-699501013259,PCRn,o
128,0211-699501013259,y,o
128,0211-699501013259,cada,o
128,0211-699501013259,6,o
128,0211-699501013259,meses,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,HPLC,i
128,0211-699501013259,y,o
128,0211-699501013259,pp,i
128,0211-699501013259,RIA,i
128,0211-699501013259,Resultados,o
128,0211-699501013259,80,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,fueron,o
128,0211-699501013259,incluidos,o
128,0211-699501013259,en,o
128,0211-699501013259,el,o
128,0211-699501013259,estudio,o
128,0211-699501013259,basal,o
128,0211-699501013259,con,o
128,0211-699501013259,una,o
128,0211-699501013259,prevalencia,o
128,0211-699501013259,de,o
128,0211-699501013259,hiperhomocisteinemia,i
128,0211-699501013259,del,o
128,0211-699501013259,844,o
128,0211-699501013259,deficit,i
128,0211-699501013259,de,i
128,0211-699501013259,pp,i
128,0211-699501013259,en,o
128,0211-699501013259,el,o
128,0211-699501013259,32,o
128,0211-699501013259,y,o
128,0211-699501013259,folato,i
128,0211-699501013259,en,o
128,0211-699501013259,el,o
128,0211-699501013259,rango,o
128,0211-699501013259,normal,o
128,0211-699501013259,bajo,o
128,0211-699501013259,los,o
128,0211-699501013259,niveles,i
128,0211-699501013259,de,i
128,0211-699501013259,tHcy,i
128,0211-699501013259,se,o
128,0211-699501013259,correlacionaban,o
128,0211-699501013259,inversamente,o
128,0211-699501013259,con,o
128,0211-699501013259,los,o
128,0211-699501013259,del,o
128,0211-699501013259,folato,i
128,0211-699501013259,r,o
128,0211-699501013259,0336,o
128,0211-699501013259,p,o
128,0211-699501013259,001,o
128,0211-699501013259,pero,o
128,0211-699501013259,no,o
128,0211-699501013259,con,o
128,0211-699501013259,pp,i
128,0211-699501013259,B12,i
128,0211-699501013259,edad,o
128,0211-699501013259,albumina,i
128,0211-699501013259,KTV,o
128,0211-699501013259,KRU,o
128,0211-699501013259,PCRn,o
128,0211-699501013259,Cincuenta,o
128,0211-699501013259,y,o
128,0211-699501013259,ocho,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,recibieron,o
128,0211-699501013259,seis,o
128,0211-699501013259,meses,o
128,0211-699501013259,de,o
128,0211-699501013259,suplementacion,i
128,0211-699501013259,con,o
128,0211-699501013259,normalizacion,o
128,0211-699501013259,del,o
128,0211-699501013259,pp,i
128,0211-699501013259,aumento,o
128,0211-699501013259,del,o
128,0211-699501013259,folato,i
128,0211-699501013259,703,o
128,0211-699501013259,IC,o
128,0211-699501013259,638,o
128,0211-699501013259,795,o
128,0211-699501013259,vs,o
128,0211-699501013259,6181,o
128,0211-699501013259,IC,o
128,0211-699501013259,4447,o
128,0211-699501013259,7811,o
128,0211-699501013259,p,o
128,0211-699501013259,0001,o
128,0211-699501013259,y,o
128,0211-699501013259,descenso,o
128,0211-699501013259,de,o
128,0211-699501013259,la,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,240,o
128,0211-699501013259,IC,o
128,0211-699501013259,213,o
128,0211-699501013259,264,o
128,0211-699501013259,vs,o
128,0211-699501013259,199,o
128,0211-699501013259,IC,o
128,0211-699501013259,175,o
128,0211-699501013259,224,o
128,0211-699501013259,p,o
128,0211-699501013259,005,o
128,0211-699501013259,Han,o
128,0211-699501013259,recibido,o
128,0211-699501013259,suplementacion,i
128,0211-699501013259,durante,o
128,0211-699501013259,12,o
128,0211-699501013259,meses,o
128,0211-699501013259,33,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,pero,o
128,0211-699501013259,a,o
128,0211-699501013259,pesar,o
128,0211-699501013259,de,o
128,0211-699501013259,un,o
128,0211-699501013259,continuo,o
128,0211-699501013259,aumento,o
128,0211-699501013259,del,o
128,0211-699501013259,folato,i
128,0211-699501013259,10078,o
128,0211-699501013259,IC,o
128,0211-699501013259,7481,o
128,0211-699501013259,12674,o
128,0211-699501013259,p,o
128,0211-699501013259,0001,o
128,0211-699501013259,solo,o
128,0211-699501013259,3,o
128,0211-699501013259,pacientes,o
128,0211-699501013259,presentan,o
128,0211-699501013259,niveles,o
128,0211-699501013259,normales,o
128,0211-699501013259,de,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,correlacionandose,o
128,0211-699501013259,directamente,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,con,o
128,0211-699501013259,la,o
128,0211-699501013259,albumina,i
128,0211-699501013259,r,o
128,0211-699501013259,056,o
128,0211-699501013259,p,o
128,0211-699501013259,0001,o
128,0211-699501013259,que,o
128,0211-699501013259,se,o
128,0211-699501013259,elevo,o
128,0211-699501013259,con,o
128,0211-699501013259,respecto,o
128,0211-699501013259,al,o
128,0211-699501013259,inicio,o
128,0211-699501013259,337,o
128,0211-699501013259,IC,o
128,0211-699501013259,327,o
128,0211-699501013259,346,o
128,0211-699501013259,vs,o
128,0211-699501013259,350,o
128,0211-699501013259,IC,o
128,0211-699501013259,337,o
128,0211-699501013259,363,o
128,0211-699501013259,p,o
128,0211-699501013259,005,o
128,0211-699501013259,Conclusion,o
128,0211-699501013259,Tras,o
128,0211-699501013259,suplementacion,i
128,0211-699501013259,con,o
128,0211-699501013259,acido,i
128,0211-699501013259,folico,i
128,0211-699501013259,y,o
128,0211-699501013259,vitamina,i
128,0211-699501013259,B6,i
128,0211-699501013259,aunque,o
128,0211-699501013259,inicialmente,o
128,0211-699501013259,se,o
128,0211-699501013259,reduce,o
128,0211-699501013259,la,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,esta,o
128,0211-699501013259,respuesta,o
128,0211-699501013259,se,o
128,0211-699501013259,hace,o
128,0211-699501013259,refractaria,o
128,0211-699501013259,correlacionandose,o
128,0211-699501013259,directamente,o
128,0211-699501013259,la,o
128,0211-699501013259,tHcy,i
128,0211-699501013259,con,o
128,0211-699501013259,la,o
128,0211-699501013259,albumina,i
128,0211-699501013259,plasmatica,i
128,0211-699501013259,La,o
128,0211-699501013259,interpretacion,o
128,0211-699501013259,de,o
128,0211-699501013259,los,o
128,0211-699501013259,niveles,i
128,0211-699501013259,de,i
128,0211-699501013259,tHcy,i
128,0211-699501013259,debe,o
128,0211-699501013259,tener,o
128,0211-699501013259,en,o
128,0211-699501013259,cuenta,o
128,0211-699501013259,la,o
128,0211-699501013259,concentracion,i
128,0211-699501013259,de,i
128,0211-699501013259,albumina,i
129,0211-699501013259,Efecto,o
129,0211-699501013259,de,o
129,0211-699501013259,la,o
129,0211-699501013259,suplementacion,i
129,0211-699501013259,con,o
129,0211-699501013259,acido,i
129,0211-699501013259,folico,i
129,0211-699501013259,sobre,o
129,0211-699501013259,los,o
129,0211-699501013259,niveles,i
129,0211-699501013259,de,i
129,0211-699501013259,homocisteina,i
129,0211-699501013259,total,o
129,0211-699501013259,en,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,en,o
129,0211-699501013259,hemodialisis,i
129,0211-699501013259,La,o
129,0211-699501013259,hiperhomocisteinemia,i
129,0211-699501013259,es,o
129,0211-699501013259,un,o
129,0211-699501013259,marcador,o
129,0211-699501013259,de,o
129,0211-699501013259,riesgo,o
129,0211-699501013259,independiente,o
129,0211-699501013259,de,o
129,0211-699501013259,morbimortalidad,o
129,0211-699501013259,cardiovascular,i
129,0211-699501013259,Hemos,o
129,0211-699501013259,intentado,o
129,0211-699501013259,prospectivamente,o
129,0211-699501013259,reducir,o
129,0211-699501013259,los,o
129,0211-699501013259,niveles,i
129,0211-699501013259,de,i
129,0211-699501013259,homocisteina,i
129,0211-699501013259,total,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,mediante,o
129,0211-699501013259,suplemento,o
129,0211-699501013259,con,o
129,0211-699501013259,acido,i
129,0211-699501013259,folico,i
129,0211-699501013259,y,o
129,0211-699501013259,vitamina,i
129,0211-699501013259,B6,i
129,0211-699501013259,pp,i
129,0211-699501013259,valorando,o
129,0211-699501013259,su,o
129,0211-699501013259,posible,o
129,0211-699501013259,correlacion,o
129,0211-699501013259,con,o
129,0211-699501013259,dosis,o
129,0211-699501013259,de,o
129,0211-699501013259,dialisis,i
129,0211-699501013259,funcion,i
129,0211-699501013259,residual,i
129,0211-699501013259,y,o
129,0211-699501013259,parametros,o
129,0211-699501013259,nutricionales,o
129,0211-699501013259,Metodos,o
129,0211-699501013259,Todos,o
129,0211-699501013259,los,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,en,o
129,0211-699501013259,hemodialisis,i
129,0211-699501013259,al,o
129,0211-699501013259,comienzo,o
129,0211-699501013259,del,o
129,0211-699501013259,estudio,o
129,0211-699501013259,que,o
129,0211-699501013259,no,o
129,0211-699501013259,recibian,o
129,0211-699501013259,acido,i
129,0211-699501013259,folico,i
129,0211-699501013259,ni,o
129,0211-699501013259,vitamina,i
129,0211-699501013259,B6,i
129,0211-699501013259,asi,o
129,0211-699501013259,como,o
129,0211-699501013259,los,o
129,0211-699501013259,incorporados,o
129,0211-699501013259,posteriormente,o
129,0211-699501013259,a,o
129,0211-699501013259,partir,o
129,0211-699501013259,de,o
129,0211-699501013259,su,o
129,0211-699501013259,tercer,o
129,0211-699501013259,mes,o
129,0211-699501013259,en,o
129,0211-699501013259,hemodialisis,i
129,0211-699501013259,recibieron,o
129,0211-699501013259,5,o
129,0211-699501013259,mg,o
129,0211-699501013259,orales,o
129,0211-699501013259,de,o
129,0211-699501013259,acido,i
129,0211-699501013259,folico,i
129,0211-699501013259,cada,o
129,0211-699501013259,48,o
129,0211-699501013259,horas,o
129,0211-699501013259,y,o
129,0211-699501013259,40,o
129,0211-699501013259,mg,o
129,0211-699501013259,orales,o
129,0211-699501013259,de,o
129,0211-699501013259,vitamina,i
129,0211-699501013259,B6,i
129,0211-699501013259,cada,o
129,0211-699501013259,semana,o
129,0211-699501013259,Se,o
129,0211-699501013259,determinaron,o
129,0211-699501013259,al,o
129,0211-699501013259,comienzo,o
129,0211-699501013259,del,o
129,0211-699501013259,estudio,o
129,0211-699501013259,y,o
129,0211-699501013259,cada,o
129,0211-699501013259,2,o
129,0211-699501013259,meses,o
129,0211-699501013259,niveles,i
129,0211-699501013259,de,i
129,0211-699501013259,folato,i
129,0211-699501013259,vitamina,i
129,0211-699501013259,B12,i
129,0211-699501013259,inmunoensayo,i
129,0211-699501013259,albumina,i
129,0211-699501013259,y,o
129,0211-699501013259,cinetica,o
129,0211-699501013259,de,o
129,0211-699501013259,la,o
129,0211-699501013259,urea,i
129,0211-699501013259,KTV,o
129,0211-699501013259,KRU,o
129,0211-699501013259,PCRn,o
129,0211-699501013259,y,o
129,0211-699501013259,cada,o
129,0211-699501013259,6,o
129,0211-699501013259,meses,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,HPLC,i
129,0211-699501013259,y,o
129,0211-699501013259,pp,i
129,0211-699501013259,RIA,i
129,0211-699501013259,Resultados,o
129,0211-699501013259,80,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,fueron,o
129,0211-699501013259,incluidos,o
129,0211-699501013259,en,o
129,0211-699501013259,el,o
129,0211-699501013259,estudio,o
129,0211-699501013259,basal,o
129,0211-699501013259,con,o
129,0211-699501013259,una,o
129,0211-699501013259,prevalencia,o
129,0211-699501013259,de,o
129,0211-699501013259,hiperhomocisteinemia,i
129,0211-699501013259,del,o
129,0211-699501013259,844,o
129,0211-699501013259,deficit,i
129,0211-699501013259,de,i
129,0211-699501013259,pp,i
129,0211-699501013259,en,o
129,0211-699501013259,el,o
129,0211-699501013259,32,o
129,0211-699501013259,y,o
129,0211-699501013259,folato,i
129,0211-699501013259,en,o
129,0211-699501013259,el,o
129,0211-699501013259,rango,o
129,0211-699501013259,normal,o
129,0211-699501013259,bajo,o
129,0211-699501013259,los,o
129,0211-699501013259,niveles,i
129,0211-699501013259,de,i
129,0211-699501013259,tHcy,i
129,0211-699501013259,se,o
129,0211-699501013259,correlacionaban,o
129,0211-699501013259,inversamente,o
129,0211-699501013259,con,o
129,0211-699501013259,los,o
129,0211-699501013259,del,o
129,0211-699501013259,folato,i
129,0211-699501013259,r,o
129,0211-699501013259,0336,o
129,0211-699501013259,p,o
129,0211-699501013259,001,o
129,0211-699501013259,pero,o
129,0211-699501013259,no,o
129,0211-699501013259,con,o
129,0211-699501013259,pp,i
129,0211-699501013259,B12,i
129,0211-699501013259,edad,o
129,0211-699501013259,albumina,i
129,0211-699501013259,KTV,o
129,0211-699501013259,KRU,o
129,0211-699501013259,PCRn,o
129,0211-699501013259,Cincuenta,o
129,0211-699501013259,y,o
129,0211-699501013259,ocho,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,recibieron,o
129,0211-699501013259,seis,o
129,0211-699501013259,meses,o
129,0211-699501013259,de,o
129,0211-699501013259,suplementacion,i
129,0211-699501013259,con,o
129,0211-699501013259,normalizacion,o
129,0211-699501013259,del,o
129,0211-699501013259,pp,i
129,0211-699501013259,aumento,o
129,0211-699501013259,del,o
129,0211-699501013259,folato,i
129,0211-699501013259,703,o
129,0211-699501013259,IC,o
129,0211-699501013259,638,o
129,0211-699501013259,795,o
129,0211-699501013259,vs,o
129,0211-699501013259,6181,o
129,0211-699501013259,IC,o
129,0211-699501013259,4447,o
129,0211-699501013259,7811,o
129,0211-699501013259,p,o
129,0211-699501013259,0001,o
129,0211-699501013259,y,o
129,0211-699501013259,descenso,o
129,0211-699501013259,de,o
129,0211-699501013259,la,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,240,o
129,0211-699501013259,IC,o
129,0211-699501013259,213,o
129,0211-699501013259,264,o
129,0211-699501013259,vs,o
129,0211-699501013259,199,o
129,0211-699501013259,IC,o
129,0211-699501013259,175,o
129,0211-699501013259,224,o
129,0211-699501013259,p,o
129,0211-699501013259,005,o
129,0211-699501013259,Han,o
129,0211-699501013259,recibido,o
129,0211-699501013259,suplementacion,i
129,0211-699501013259,durante,o
129,0211-699501013259,12,o
129,0211-699501013259,meses,o
129,0211-699501013259,33,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,pero,o
129,0211-699501013259,a,o
129,0211-699501013259,pesar,o
129,0211-699501013259,de,o
129,0211-699501013259,un,o
129,0211-699501013259,continuo,o
129,0211-699501013259,aumento,o
129,0211-699501013259,del,o
129,0211-699501013259,folato,i
129,0211-699501013259,10078,o
129,0211-699501013259,IC,o
129,0211-699501013259,7481,o
129,0211-699501013259,12674,o
129,0211-699501013259,p,o
129,0211-699501013259,0001,o
129,0211-699501013259,solo,o
129,0211-699501013259,3,o
129,0211-699501013259,pacientes,o
129,0211-699501013259,presentan,o
129,0211-699501013259,niveles,o
129,0211-699501013259,normales,o
129,0211-699501013259,de,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,correlacionandose,o
129,0211-699501013259,directamente,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,con,o
129,0211-699501013259,la,o
129,0211-699501013259,albumina,i
129,0211-699501013259,r,o
129,0211-699501013259,056,o
129,0211-699501013259,p,o
129,0211-699501013259,0001,o
129,0211-699501013259,que,o
129,0211-699501013259,se,o
129,0211-699501013259,elevo,o
129,0211-699501013259,con,o
129,0211-699501013259,respecto,o
129,0211-699501013259,al,o
129,0211-699501013259,inicio,o
129,0211-699501013259,337,o
129,0211-699501013259,IC,o
129,0211-699501013259,327,o
129,0211-699501013259,346,o
129,0211-699501013259,vs,o
129,0211-699501013259,350,o
129,0211-699501013259,IC,o
129,0211-699501013259,337,o
129,0211-699501013259,363,o
129,0211-699501013259,p,o
129,0211-699501013259,005,o
129,0211-699501013259,Conclusion,o
129,0211-699501013259,Tras,o
129,0211-699501013259,suplementacion,i
129,0211-699501013259,con,o
129,0211-699501013259,acido,i
129,0211-699501013259,folico,i
129,0211-699501013259,y,o
129,0211-699501013259,vitamina,i
129,0211-699501013259,B6,i
129,0211-699501013259,aunque,o
129,0211-699501013259,inicialmente,o
129,0211-699501013259,se,o
129,0211-699501013259,reduce,o
129,0211-699501013259,la,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,esta,o
129,0211-699501013259,respuesta,o
129,0211-699501013259,se,o
129,0211-699501013259,hace,o
129,0211-699501013259,refractaria,o
129,0211-699501013259,correlacionandose,o
129,0211-699501013259,directamente,o
129,0211-699501013259,la,o
129,0211-699501013259,tHcy,i
129,0211-699501013259,con,o
129,0211-699501013259,la,o
129,0211-699501013259,albumina,i
129,0211-699501013259,plasmatica,i
129,0211-699501013259,La,o
129,0211-699501013259,interpretacion,o
129,0211-699501013259,de,o
129,0211-699501013259,los,o
129,0211-699501013259,niveles,i
129,0211-699501013259,de,i
129,0211-699501013259,tHcy,i
129,0211-699501013259,debe,o
129,0211-699501013259,tener,o
129,0211-699501013259,en,o
129,0211-699501013259,cuenta,o
129,0211-699501013259,la,o
129,0211-699501013259,concentracion,i
129,0211-699501013259,de,i
129,0211-699501013259,albumina,i
130,0211-699501013259,Efecto,o
130,0211-699501013259,de,o
130,0211-699501013259,la,o
130,0211-699501013259,suplementacion,i
130,0211-699501013259,con,o
130,0211-699501013259,acido,i
130,0211-699501013259,folico,i
130,0211-699501013259,sobre,o
130,0211-699501013259,los,o
130,0211-699501013259,niveles,i
130,0211-699501013259,de,i
130,0211-699501013259,homocisteina,i
130,0211-699501013259,total,o
130,0211-699501013259,en,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,en,o
130,0211-699501013259,hemodialisis,i
130,0211-699501013259,La,o
130,0211-699501013259,hiperhomocisteinemia,i
130,0211-699501013259,es,o
130,0211-699501013259,un,o
130,0211-699501013259,marcador,o
130,0211-699501013259,de,o
130,0211-699501013259,riesgo,o
130,0211-699501013259,independiente,o
130,0211-699501013259,de,o
130,0211-699501013259,morbimortalidad,o
130,0211-699501013259,cardiovascular,i
130,0211-699501013259,Hemos,o
130,0211-699501013259,intentado,o
130,0211-699501013259,prospectivamente,o
130,0211-699501013259,reducir,o
130,0211-699501013259,los,o
130,0211-699501013259,niveles,i
130,0211-699501013259,de,i
130,0211-699501013259,homocisteina,i
130,0211-699501013259,total,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,mediante,o
130,0211-699501013259,suplemento,o
130,0211-699501013259,con,o
130,0211-699501013259,acido,i
130,0211-699501013259,folico,i
130,0211-699501013259,y,o
130,0211-699501013259,vitamina,i
130,0211-699501013259,B6,i
130,0211-699501013259,pp,i
130,0211-699501013259,valorando,o
130,0211-699501013259,su,o
130,0211-699501013259,posible,o
130,0211-699501013259,correlacion,o
130,0211-699501013259,con,o
130,0211-699501013259,dosis,o
130,0211-699501013259,de,o
130,0211-699501013259,dialisis,i
130,0211-699501013259,funcion,i
130,0211-699501013259,residual,i
130,0211-699501013259,y,o
130,0211-699501013259,parametros,o
130,0211-699501013259,nutricionales,o
130,0211-699501013259,Metodos,o
130,0211-699501013259,Todos,o
130,0211-699501013259,los,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,en,o
130,0211-699501013259,hemodialisis,i
130,0211-699501013259,al,o
130,0211-699501013259,comienzo,o
130,0211-699501013259,del,o
130,0211-699501013259,estudio,o
130,0211-699501013259,que,o
130,0211-699501013259,no,o
130,0211-699501013259,recibian,o
130,0211-699501013259,acido,i
130,0211-699501013259,folico,i
130,0211-699501013259,ni,o
130,0211-699501013259,vitamina,i
130,0211-699501013259,B6,i
130,0211-699501013259,asi,o
130,0211-699501013259,como,o
130,0211-699501013259,los,o
130,0211-699501013259,incorporados,o
130,0211-699501013259,posteriormente,o
130,0211-699501013259,a,o
130,0211-699501013259,partir,o
130,0211-699501013259,de,o
130,0211-699501013259,su,o
130,0211-699501013259,tercer,o
130,0211-699501013259,mes,o
130,0211-699501013259,en,o
130,0211-699501013259,hemodialisis,i
130,0211-699501013259,recibieron,o
130,0211-699501013259,5,o
130,0211-699501013259,mg,o
130,0211-699501013259,orales,o
130,0211-699501013259,de,o
130,0211-699501013259,acido,i
130,0211-699501013259,folico,i
130,0211-699501013259,cada,o
130,0211-699501013259,48,o
130,0211-699501013259,horas,o
130,0211-699501013259,y,o
130,0211-699501013259,40,o
130,0211-699501013259,mg,o
130,0211-699501013259,orales,o
130,0211-699501013259,de,o
130,0211-699501013259,vitamina,i
130,0211-699501013259,B6,i
130,0211-699501013259,cada,o
130,0211-699501013259,semana,o
130,0211-699501013259,Se,o
130,0211-699501013259,determinaron,o
130,0211-699501013259,al,o
130,0211-699501013259,comienzo,o
130,0211-699501013259,del,o
130,0211-699501013259,estudio,o
130,0211-699501013259,y,o
130,0211-699501013259,cada,o
130,0211-699501013259,2,o
130,0211-699501013259,meses,o
130,0211-699501013259,niveles,i
130,0211-699501013259,de,i
130,0211-699501013259,folato,i
130,0211-699501013259,vitamina,i
130,0211-699501013259,B12,i
130,0211-699501013259,inmunoensayo,i
130,0211-699501013259,albumina,i
130,0211-699501013259,y,o
130,0211-699501013259,cinetica,o
130,0211-699501013259,de,o
130,0211-699501013259,la,o
130,0211-699501013259,urea,i
130,0211-699501013259,KTV,o
130,0211-699501013259,KRU,o
130,0211-699501013259,PCRn,o
130,0211-699501013259,y,o
130,0211-699501013259,cada,o
130,0211-699501013259,6,o
130,0211-699501013259,meses,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,HPLC,i
130,0211-699501013259,y,o
130,0211-699501013259,pp,i
130,0211-699501013259,RIA,i
130,0211-699501013259,Resultados,o
130,0211-699501013259,80,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,fueron,o
130,0211-699501013259,incluidos,o
130,0211-699501013259,en,o
130,0211-699501013259,el,o
130,0211-699501013259,estudio,o
130,0211-699501013259,basal,o
130,0211-699501013259,con,o
130,0211-699501013259,una,o
130,0211-699501013259,prevalencia,o
130,0211-699501013259,de,o
130,0211-699501013259,hiperhomocisteinemia,i
130,0211-699501013259,del,o
130,0211-699501013259,844,o
130,0211-699501013259,deficit,i
130,0211-699501013259,de,i
130,0211-699501013259,pp,i
130,0211-699501013259,en,o
130,0211-699501013259,el,o
130,0211-699501013259,32,o
130,0211-699501013259,y,o
130,0211-699501013259,folato,i
130,0211-699501013259,en,o
130,0211-699501013259,el,o
130,0211-699501013259,rango,o
130,0211-699501013259,normal,o
130,0211-699501013259,bajo,o
130,0211-699501013259,los,o
130,0211-699501013259,niveles,i
130,0211-699501013259,de,i
130,0211-699501013259,tHcy,i
130,0211-699501013259,se,o
130,0211-699501013259,correlacionaban,o
130,0211-699501013259,inversamente,o
130,0211-699501013259,con,o
130,0211-699501013259,los,o
130,0211-699501013259,del,o
130,0211-699501013259,folato,i
130,0211-699501013259,r,o
130,0211-699501013259,0336,o
130,0211-699501013259,p,o
130,0211-699501013259,001,o
130,0211-699501013259,pero,o
130,0211-699501013259,no,o
130,0211-699501013259,con,o
130,0211-699501013259,pp,i
130,0211-699501013259,B12,i
130,0211-699501013259,edad,o
130,0211-699501013259,albumina,i
130,0211-699501013259,KTV,o
130,0211-699501013259,KRU,o
130,0211-699501013259,PCRn,o
130,0211-699501013259,Cincuenta,o
130,0211-699501013259,y,o
130,0211-699501013259,ocho,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,recibieron,o
130,0211-699501013259,seis,o
130,0211-699501013259,meses,o
130,0211-699501013259,de,o
130,0211-699501013259,suplementacion,i
130,0211-699501013259,con,o
130,0211-699501013259,normalizacion,o
130,0211-699501013259,del,o
130,0211-699501013259,pp,i
130,0211-699501013259,aumento,o
130,0211-699501013259,del,o
130,0211-699501013259,folato,i
130,0211-699501013259,703,o
130,0211-699501013259,IC,o
130,0211-699501013259,638,o
130,0211-699501013259,795,o
130,0211-699501013259,vs,o
130,0211-699501013259,6181,o
130,0211-699501013259,IC,o
130,0211-699501013259,4447,o
130,0211-699501013259,7811,o
130,0211-699501013259,p,o
130,0211-699501013259,0001,o
130,0211-699501013259,y,o
130,0211-699501013259,descenso,o
130,0211-699501013259,de,o
130,0211-699501013259,la,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,240,o
130,0211-699501013259,IC,o
130,0211-699501013259,213,o
130,0211-699501013259,264,o
130,0211-699501013259,vs,o
130,0211-699501013259,199,o
130,0211-699501013259,IC,o
130,0211-699501013259,175,o
130,0211-699501013259,224,o
130,0211-699501013259,p,o
130,0211-699501013259,005,o
130,0211-699501013259,Han,o
130,0211-699501013259,recibido,o
130,0211-699501013259,suplementacion,i
130,0211-699501013259,durante,o
130,0211-699501013259,12,o
130,0211-699501013259,meses,o
130,0211-699501013259,33,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,pero,o
130,0211-699501013259,a,o
130,0211-699501013259,pesar,o
130,0211-699501013259,de,o
130,0211-699501013259,un,o
130,0211-699501013259,continuo,o
130,0211-699501013259,aumento,o
130,0211-699501013259,del,o
130,0211-699501013259,folato,i
130,0211-699501013259,10078,o
130,0211-699501013259,IC,o
130,0211-699501013259,7481,o
130,0211-699501013259,12674,o
130,0211-699501013259,p,o
130,0211-699501013259,0001,o
130,0211-699501013259,solo,o
130,0211-699501013259,3,o
130,0211-699501013259,pacientes,o
130,0211-699501013259,presentan,o
130,0211-699501013259,niveles,o
130,0211-699501013259,normales,o
130,0211-699501013259,de,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,correlacionandose,o
130,0211-699501013259,directamente,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,con,o
130,0211-699501013259,la,o
130,0211-699501013259,albumina,i
130,0211-699501013259,r,o
130,0211-699501013259,056,o
130,0211-699501013259,p,o
130,0211-699501013259,0001,o
130,0211-699501013259,que,o
130,0211-699501013259,se,o
130,0211-699501013259,elevo,o
130,0211-699501013259,con,o
130,0211-699501013259,respecto,o
130,0211-699501013259,al,o
130,0211-699501013259,inicio,o
130,0211-699501013259,337,o
130,0211-699501013259,IC,o
130,0211-699501013259,327,o
130,0211-699501013259,346,o
130,0211-699501013259,vs,o
130,0211-699501013259,350,o
130,0211-699501013259,IC,o
130,0211-699501013259,337,o
130,0211-699501013259,363,o
130,0211-699501013259,p,o
130,0211-699501013259,005,o
130,0211-699501013259,Conclusion,o
130,0211-699501013259,Tras,o
130,0211-699501013259,suplementacion,i
130,0211-699501013259,con,o
130,0211-699501013259,acido,i
130,0211-699501013259,folico,i
130,0211-699501013259,y,o
130,0211-699501013259,vitamina,i
130,0211-699501013259,B6,i
130,0211-699501013259,aunque,o
130,0211-699501013259,inicialmente,o
130,0211-699501013259,se,o
130,0211-699501013259,reduce,o
130,0211-699501013259,la,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,esta,o
130,0211-699501013259,respuesta,o
130,0211-699501013259,se,o
130,0211-699501013259,hace,o
130,0211-699501013259,refractaria,o
130,0211-699501013259,correlacionandose,o
130,0211-699501013259,directamente,o
130,0211-699501013259,la,o
130,0211-699501013259,tHcy,i
130,0211-699501013259,con,o
130,0211-699501013259,la,o
130,0211-699501013259,albumina,i
130,0211-699501013259,plasmatica,i
130,0211-699501013259,La,o
130,0211-699501013259,interpretacion,o
130,0211-699501013259,de,o
130,0211-699501013259,los,o
130,0211-699501013259,niveles,i
130,0211-699501013259,de,i
130,0211-699501013259,tHcy,i
130,0211-699501013259,debe,o
130,0211-699501013259,tener,o
130,0211-699501013259,en,o
130,0211-699501013259,cuenta,o
130,0211-699501013259,la,o
130,0211-699501013259,concentracion,i
130,0211-699501013259,de,i
130,0211-699501013259,albumina,i
131,0211-699501013259,Efecto,o
131,0211-699501013259,de,o
131,0211-699501013259,la,o
131,0211-699501013259,suplementacion,i
131,0211-699501013259,con,o
131,0211-699501013259,acido,i
131,0211-699501013259,folico,i
131,0211-699501013259,sobre,o
131,0211-699501013259,los,o
131,0211-699501013259,niveles,i
131,0211-699501013259,de,i
131,0211-699501013259,homocisteina,i
131,0211-699501013259,total,o
131,0211-699501013259,en,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,en,o
131,0211-699501013259,hemodialisis,i
131,0211-699501013259,La,o
131,0211-699501013259,hiperhomocisteinemia,i
131,0211-699501013259,es,o
131,0211-699501013259,un,o
131,0211-699501013259,marcador,o
131,0211-699501013259,de,o
131,0211-699501013259,riesgo,o
131,0211-699501013259,independiente,o
131,0211-699501013259,de,o
131,0211-699501013259,morbimortalidad,o
131,0211-699501013259,cardiovascular,i
131,0211-699501013259,Hemos,o
131,0211-699501013259,intentado,o
131,0211-699501013259,prospectivamente,o
131,0211-699501013259,reducir,o
131,0211-699501013259,los,o
131,0211-699501013259,niveles,i
131,0211-699501013259,de,i
131,0211-699501013259,homocisteina,i
131,0211-699501013259,total,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,mediante,o
131,0211-699501013259,suplemento,o
131,0211-699501013259,con,o
131,0211-699501013259,acido,i
131,0211-699501013259,folico,i
131,0211-699501013259,y,o
131,0211-699501013259,vitamina,i
131,0211-699501013259,B6,i
131,0211-699501013259,pp,i
131,0211-699501013259,valorando,o
131,0211-699501013259,su,o
131,0211-699501013259,posible,o
131,0211-699501013259,correlacion,o
131,0211-699501013259,con,o
131,0211-699501013259,dosis,o
131,0211-699501013259,de,o
131,0211-699501013259,dialisis,i
131,0211-699501013259,funcion,i
131,0211-699501013259,residual,i
131,0211-699501013259,y,o
131,0211-699501013259,parametros,o
131,0211-699501013259,nutricionales,o
131,0211-699501013259,Metodos,o
131,0211-699501013259,Todos,o
131,0211-699501013259,los,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,en,o
131,0211-699501013259,hemodialisis,i
131,0211-699501013259,al,o
131,0211-699501013259,comienzo,o
131,0211-699501013259,del,o
131,0211-699501013259,estudio,o
131,0211-699501013259,que,o
131,0211-699501013259,no,o
131,0211-699501013259,recibian,o
131,0211-699501013259,acido,i
131,0211-699501013259,folico,i
131,0211-699501013259,ni,o
131,0211-699501013259,vitamina,i
131,0211-699501013259,B6,i
131,0211-699501013259,asi,o
131,0211-699501013259,como,o
131,0211-699501013259,los,o
131,0211-699501013259,incorporados,o
131,0211-699501013259,posteriormente,o
131,0211-699501013259,a,o
131,0211-699501013259,partir,o
131,0211-699501013259,de,o
131,0211-699501013259,su,o
131,0211-699501013259,tercer,o
131,0211-699501013259,mes,o
131,0211-699501013259,en,o
131,0211-699501013259,hemodialisis,i
131,0211-699501013259,recibieron,o
131,0211-699501013259,5,o
131,0211-699501013259,mg,o
131,0211-699501013259,orales,o
131,0211-699501013259,de,o
131,0211-699501013259,acido,i
131,0211-699501013259,folico,i
131,0211-699501013259,cada,o
131,0211-699501013259,48,o
131,0211-699501013259,horas,o
131,0211-699501013259,y,o
131,0211-699501013259,40,o
131,0211-699501013259,mg,o
131,0211-699501013259,orales,o
131,0211-699501013259,de,o
131,0211-699501013259,vitamina,i
131,0211-699501013259,B6,i
131,0211-699501013259,cada,o
131,0211-699501013259,semana,o
131,0211-699501013259,Se,o
131,0211-699501013259,determinaron,o
131,0211-699501013259,al,o
131,0211-699501013259,comienzo,o
131,0211-699501013259,del,o
131,0211-699501013259,estudio,o
131,0211-699501013259,y,o
131,0211-699501013259,cada,o
131,0211-699501013259,2,o
131,0211-699501013259,meses,o
131,0211-699501013259,niveles,i
131,0211-699501013259,de,i
131,0211-699501013259,folato,i
131,0211-699501013259,vitamina,i
131,0211-699501013259,B12,i
131,0211-699501013259,inmunoensayo,i
131,0211-699501013259,albumina,i
131,0211-699501013259,y,o
131,0211-699501013259,cinetica,o
131,0211-699501013259,de,o
131,0211-699501013259,la,o
131,0211-699501013259,urea,i
131,0211-699501013259,KTV,o
131,0211-699501013259,KRU,o
131,0211-699501013259,PCRn,o
131,0211-699501013259,y,o
131,0211-699501013259,cada,o
131,0211-699501013259,6,o
131,0211-699501013259,meses,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,HPLC,i
131,0211-699501013259,y,o
131,0211-699501013259,pp,i
131,0211-699501013259,RIA,i
131,0211-699501013259,Resultados,o
131,0211-699501013259,80,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,fueron,o
131,0211-699501013259,incluidos,o
131,0211-699501013259,en,o
131,0211-699501013259,el,o
131,0211-699501013259,estudio,o
131,0211-699501013259,basal,o
131,0211-699501013259,con,o
131,0211-699501013259,una,o
131,0211-699501013259,prevalencia,o
131,0211-699501013259,de,o
131,0211-699501013259,hiperhomocisteinemia,i
131,0211-699501013259,del,o
131,0211-699501013259,844,o
131,0211-699501013259,deficit,i
131,0211-699501013259,de,i
131,0211-699501013259,pp,i
131,0211-699501013259,en,o
131,0211-699501013259,el,o
131,0211-699501013259,32,o
131,0211-699501013259,y,o
131,0211-699501013259,folato,i
131,0211-699501013259,en,o
131,0211-699501013259,el,o
131,0211-699501013259,rango,o
131,0211-699501013259,normal,o
131,0211-699501013259,bajo,o
131,0211-699501013259,los,o
131,0211-699501013259,niveles,i
131,0211-699501013259,de,i
131,0211-699501013259,tHcy,i
131,0211-699501013259,se,o
131,0211-699501013259,correlacionaban,o
131,0211-699501013259,inversamente,o
131,0211-699501013259,con,o
131,0211-699501013259,los,o
131,0211-699501013259,del,o
131,0211-699501013259,folato,i
131,0211-699501013259,r,o
131,0211-699501013259,0336,o
131,0211-699501013259,p,o
131,0211-699501013259,001,o
131,0211-699501013259,pero,o
131,0211-699501013259,no,o
131,0211-699501013259,con,o
131,0211-699501013259,pp,i
131,0211-699501013259,B12,i
131,0211-699501013259,edad,o
131,0211-699501013259,albumina,i
131,0211-699501013259,KTV,o
131,0211-699501013259,KRU,o
131,0211-699501013259,PCRn,o
131,0211-699501013259,Cincuenta,o
131,0211-699501013259,y,o
131,0211-699501013259,ocho,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,recibieron,o
131,0211-699501013259,seis,o
131,0211-699501013259,meses,o
131,0211-699501013259,de,o
131,0211-699501013259,suplementacion,i
131,0211-699501013259,con,o
131,0211-699501013259,normalizacion,o
131,0211-699501013259,del,o
131,0211-699501013259,pp,i
131,0211-699501013259,aumento,o
131,0211-699501013259,del,o
131,0211-699501013259,folato,i
131,0211-699501013259,703,o
131,0211-699501013259,IC,o
131,0211-699501013259,638,o
131,0211-699501013259,795,o
131,0211-699501013259,vs,o
131,0211-699501013259,6181,o
131,0211-699501013259,IC,o
131,0211-699501013259,4447,o
131,0211-699501013259,7811,o
131,0211-699501013259,p,o
131,0211-699501013259,0001,o
131,0211-699501013259,y,o
131,0211-699501013259,descenso,o
131,0211-699501013259,de,o
131,0211-699501013259,la,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,240,o
131,0211-699501013259,IC,o
131,0211-699501013259,213,o
131,0211-699501013259,264,o
131,0211-699501013259,vs,o
131,0211-699501013259,199,o
131,0211-699501013259,IC,o
131,0211-699501013259,175,o
131,0211-699501013259,224,o
131,0211-699501013259,p,o
131,0211-699501013259,005,o
131,0211-699501013259,Han,o
131,0211-699501013259,recibido,o
131,0211-699501013259,suplementacion,i
131,0211-699501013259,durante,o
131,0211-699501013259,12,o
131,0211-699501013259,meses,o
131,0211-699501013259,33,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,pero,o
131,0211-699501013259,a,o
131,0211-699501013259,pesar,o
131,0211-699501013259,de,o
131,0211-699501013259,un,o
131,0211-699501013259,continuo,o
131,0211-699501013259,aumento,o
131,0211-699501013259,del,o
131,0211-699501013259,folato,i
131,0211-699501013259,10078,o
131,0211-699501013259,IC,o
131,0211-699501013259,7481,o
131,0211-699501013259,12674,o
131,0211-699501013259,p,o
131,0211-699501013259,0001,o
131,0211-699501013259,solo,o
131,0211-699501013259,3,o
131,0211-699501013259,pacientes,o
131,0211-699501013259,presentan,o
131,0211-699501013259,niveles,o
131,0211-699501013259,normales,o
131,0211-699501013259,de,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,correlacionandose,o
131,0211-699501013259,directamente,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,con,o
131,0211-699501013259,la,o
131,0211-699501013259,albumina,i
131,0211-699501013259,r,o
131,0211-699501013259,056,o
131,0211-699501013259,p,o
131,0211-699501013259,0001,o
131,0211-699501013259,que,o
131,0211-699501013259,se,o
131,0211-699501013259,elevo,o
131,0211-699501013259,con,o
131,0211-699501013259,respecto,o
131,0211-699501013259,al,o
131,0211-699501013259,inicio,o
131,0211-699501013259,337,o
131,0211-699501013259,IC,o
131,0211-699501013259,327,o
131,0211-699501013259,346,o
131,0211-699501013259,vs,o
131,0211-699501013259,350,o
131,0211-699501013259,IC,o
131,0211-699501013259,337,o
131,0211-699501013259,363,o
131,0211-699501013259,p,o
131,0211-699501013259,005,o
131,0211-699501013259,Conclusion,o
131,0211-699501013259,Tras,o
131,0211-699501013259,suplementacion,i
131,0211-699501013259,con,o
131,0211-699501013259,acido,i
131,0211-699501013259,folico,i
131,0211-699501013259,y,o
131,0211-699501013259,vitamina,i
131,0211-699501013259,B6,i
131,0211-699501013259,aunque,o
131,0211-699501013259,inicialmente,o
131,0211-699501013259,se,o
131,0211-699501013259,reduce,o
131,0211-699501013259,la,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,esta,o
131,0211-699501013259,respuesta,o
131,0211-699501013259,se,o
131,0211-699501013259,hace,o
131,0211-699501013259,refractaria,o
131,0211-699501013259,correlacionandose,o
131,0211-699501013259,directamente,o
131,0211-699501013259,la,o
131,0211-699501013259,tHcy,i
131,0211-699501013259,con,o
131,0211-699501013259,la,o
131,0211-699501013259,albumina,i
131,0211-699501013259,plasmatica,i
131,0211-699501013259,La,o
131,0211-699501013259,interpretacion,o
131,0211-699501013259,de,o
131,0211-699501013259,los,o
131,0211-699501013259,niveles,i
131,0211-699501013259,de,i
131,0211-699501013259,tHcy,i
131,0211-699501013259,debe,o
131,0211-699501013259,tener,o
131,0211-699501013259,en,o
131,0211-699501013259,cuenta,o
131,0211-699501013259,la,o
131,0211-699501013259,concentracion,i
131,0211-699501013259,de,i
131,0211-699501013259,albumina,i
132,0211-699501013259,Efecto,o
132,0211-699501013259,de,o
132,0211-699501013259,la,o
132,0211-699501013259,suplementacion,i
132,0211-699501013259,con,o
132,0211-699501013259,acido,i
132,0211-699501013259,folico,i
132,0211-699501013259,sobre,o
132,0211-699501013259,los,o
132,0211-699501013259,niveles,i
132,0211-699501013259,de,i
132,0211-699501013259,homocisteina,i
132,0211-699501013259,total,o
132,0211-699501013259,en,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,en,o
132,0211-699501013259,hemodialisis,i
132,0211-699501013259,La,o
132,0211-699501013259,hiperhomocisteinemia,i
132,0211-699501013259,es,o
132,0211-699501013259,un,o
132,0211-699501013259,marcador,o
132,0211-699501013259,de,o
132,0211-699501013259,riesgo,o
132,0211-699501013259,independiente,o
132,0211-699501013259,de,o
132,0211-699501013259,morbimortalidad,o
132,0211-699501013259,cardiovascular,i
132,0211-699501013259,Hemos,o
132,0211-699501013259,intentado,o
132,0211-699501013259,prospectivamente,o
132,0211-699501013259,reducir,o
132,0211-699501013259,los,o
132,0211-699501013259,niveles,i
132,0211-699501013259,de,i
132,0211-699501013259,homocisteina,i
132,0211-699501013259,total,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,mediante,o
132,0211-699501013259,suplemento,o
132,0211-699501013259,con,o
132,0211-699501013259,acido,i
132,0211-699501013259,folico,i
132,0211-699501013259,y,o
132,0211-699501013259,vitamina,i
132,0211-699501013259,B6,i
132,0211-699501013259,pp,i
132,0211-699501013259,valorando,o
132,0211-699501013259,su,o
132,0211-699501013259,posible,o
132,0211-699501013259,correlacion,o
132,0211-699501013259,con,o
132,0211-699501013259,dosis,o
132,0211-699501013259,de,o
132,0211-699501013259,dialisis,i
132,0211-699501013259,funcion,i
132,0211-699501013259,residual,i
132,0211-699501013259,y,o
132,0211-699501013259,parametros,o
132,0211-699501013259,nutricionales,o
132,0211-699501013259,Metodos,o
132,0211-699501013259,Todos,o
132,0211-699501013259,los,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,en,o
132,0211-699501013259,hemodialisis,i
132,0211-699501013259,al,o
132,0211-699501013259,comienzo,o
132,0211-699501013259,del,o
132,0211-699501013259,estudio,o
132,0211-699501013259,que,o
132,0211-699501013259,no,o
132,0211-699501013259,recibian,o
132,0211-699501013259,acido,i
132,0211-699501013259,folico,i
132,0211-699501013259,ni,o
132,0211-699501013259,vitamina,i
132,0211-699501013259,B6,i
132,0211-699501013259,asi,o
132,0211-699501013259,como,o
132,0211-699501013259,los,o
132,0211-699501013259,incorporados,o
132,0211-699501013259,posteriormente,o
132,0211-699501013259,a,o
132,0211-699501013259,partir,o
132,0211-699501013259,de,o
132,0211-699501013259,su,o
132,0211-699501013259,tercer,o
132,0211-699501013259,mes,o
132,0211-699501013259,en,o
132,0211-699501013259,hemodialisis,i
132,0211-699501013259,recibieron,o
132,0211-699501013259,5,o
132,0211-699501013259,mg,o
132,0211-699501013259,orales,o
132,0211-699501013259,de,o
132,0211-699501013259,acido,i
132,0211-699501013259,folico,i
132,0211-699501013259,cada,o
132,0211-699501013259,48,o
132,0211-699501013259,horas,o
132,0211-699501013259,y,o
132,0211-699501013259,40,o
132,0211-699501013259,mg,o
132,0211-699501013259,orales,o
132,0211-699501013259,de,o
132,0211-699501013259,vitamina,i
132,0211-699501013259,B6,i
132,0211-699501013259,cada,o
132,0211-699501013259,semana,o
132,0211-699501013259,Se,o
132,0211-699501013259,determinaron,o
132,0211-699501013259,al,o
132,0211-699501013259,comienzo,o
132,0211-699501013259,del,o
132,0211-699501013259,estudio,o
132,0211-699501013259,y,o
132,0211-699501013259,cada,o
132,0211-699501013259,2,o
132,0211-699501013259,meses,o
132,0211-699501013259,niveles,i
132,0211-699501013259,de,i
132,0211-699501013259,folato,i
132,0211-699501013259,vitamina,i
132,0211-699501013259,B12,i
132,0211-699501013259,inmunoensayo,i
132,0211-699501013259,albumina,i
132,0211-699501013259,y,o
132,0211-699501013259,cinetica,o
132,0211-699501013259,de,o
132,0211-699501013259,la,o
132,0211-699501013259,urea,i
132,0211-699501013259,KTV,o
132,0211-699501013259,KRU,o
132,0211-699501013259,PCRn,o
132,0211-699501013259,y,o
132,0211-699501013259,cada,o
132,0211-699501013259,6,o
132,0211-699501013259,meses,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,HPLC,i
132,0211-699501013259,y,o
132,0211-699501013259,pp,i
132,0211-699501013259,RIA,i
132,0211-699501013259,Resultados,o
132,0211-699501013259,80,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,fueron,o
132,0211-699501013259,incluidos,o
132,0211-699501013259,en,o
132,0211-699501013259,el,o
132,0211-699501013259,estudio,o
132,0211-699501013259,basal,o
132,0211-699501013259,con,o
132,0211-699501013259,una,o
132,0211-699501013259,prevalencia,o
132,0211-699501013259,de,o
132,0211-699501013259,hiperhomocisteinemia,i
132,0211-699501013259,del,o
132,0211-699501013259,844,o
132,0211-699501013259,deficit,i
132,0211-699501013259,de,i
132,0211-699501013259,pp,i
132,0211-699501013259,en,o
132,0211-699501013259,el,o
132,0211-699501013259,32,o
132,0211-699501013259,y,o
132,0211-699501013259,folato,i
132,0211-699501013259,en,o
132,0211-699501013259,el,o
132,0211-699501013259,rango,o
132,0211-699501013259,normal,o
132,0211-699501013259,bajo,o
132,0211-699501013259,los,o
132,0211-699501013259,niveles,i
132,0211-699501013259,de,i
132,0211-699501013259,tHcy,i
132,0211-699501013259,se,o
132,0211-699501013259,correlacionaban,o
132,0211-699501013259,inversamente,o
132,0211-699501013259,con,o
132,0211-699501013259,los,o
132,0211-699501013259,del,o
132,0211-699501013259,folato,i
132,0211-699501013259,r,o
132,0211-699501013259,0336,o
132,0211-699501013259,p,o
132,0211-699501013259,001,o
132,0211-699501013259,pero,o
132,0211-699501013259,no,o
132,0211-699501013259,con,o
132,0211-699501013259,pp,i
132,0211-699501013259,B12,i
132,0211-699501013259,edad,o
132,0211-699501013259,albumina,i
132,0211-699501013259,KTV,o
132,0211-699501013259,KRU,o
132,0211-699501013259,PCRn,o
132,0211-699501013259,Cincuenta,o
132,0211-699501013259,y,o
132,0211-699501013259,ocho,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,recibieron,o
132,0211-699501013259,seis,o
132,0211-699501013259,meses,o
132,0211-699501013259,de,o
132,0211-699501013259,suplementacion,i
132,0211-699501013259,con,o
132,0211-699501013259,normalizacion,o
132,0211-699501013259,del,o
132,0211-699501013259,pp,i
132,0211-699501013259,aumento,o
132,0211-699501013259,del,o
132,0211-699501013259,folato,i
132,0211-699501013259,703,o
132,0211-699501013259,IC,o
132,0211-699501013259,638,o
132,0211-699501013259,795,o
132,0211-699501013259,vs,o
132,0211-699501013259,6181,o
132,0211-699501013259,IC,o
132,0211-699501013259,4447,o
132,0211-699501013259,7811,o
132,0211-699501013259,p,o
132,0211-699501013259,0001,o
132,0211-699501013259,y,o
132,0211-699501013259,descenso,o
132,0211-699501013259,de,o
132,0211-699501013259,la,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,240,o
132,0211-699501013259,IC,o
132,0211-699501013259,213,o
132,0211-699501013259,264,o
132,0211-699501013259,vs,o
132,0211-699501013259,199,o
132,0211-699501013259,IC,o
132,0211-699501013259,175,o
132,0211-699501013259,224,o
132,0211-699501013259,p,o
132,0211-699501013259,005,o
132,0211-699501013259,Han,o
132,0211-699501013259,recibido,o
132,0211-699501013259,suplementacion,i
132,0211-699501013259,durante,o
132,0211-699501013259,12,o
132,0211-699501013259,meses,o
132,0211-699501013259,33,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,pero,o
132,0211-699501013259,a,o
132,0211-699501013259,pesar,o
132,0211-699501013259,de,o
132,0211-699501013259,un,o
132,0211-699501013259,continuo,o
132,0211-699501013259,aumento,o
132,0211-699501013259,del,o
132,0211-699501013259,folato,i
132,0211-699501013259,10078,o
132,0211-699501013259,IC,o
132,0211-699501013259,7481,o
132,0211-699501013259,12674,o
132,0211-699501013259,p,o
132,0211-699501013259,0001,o
132,0211-699501013259,solo,o
132,0211-699501013259,3,o
132,0211-699501013259,pacientes,o
132,0211-699501013259,presentan,o
132,0211-699501013259,niveles,o
132,0211-699501013259,normales,o
132,0211-699501013259,de,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,correlacionandose,o
132,0211-699501013259,directamente,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,con,o
132,0211-699501013259,la,o
132,0211-699501013259,albumina,i
132,0211-699501013259,r,o
132,0211-699501013259,056,o
132,0211-699501013259,p,o
132,0211-699501013259,0001,o
132,0211-699501013259,que,o
132,0211-699501013259,se,o
132,0211-699501013259,elevo,o
132,0211-699501013259,con,o
132,0211-699501013259,respecto,o
132,0211-699501013259,al,o
132,0211-699501013259,inicio,o
132,0211-699501013259,337,o
132,0211-699501013259,IC,o
132,0211-699501013259,327,o
132,0211-699501013259,346,o
132,0211-699501013259,vs,o
132,0211-699501013259,350,o
132,0211-699501013259,IC,o
132,0211-699501013259,337,o
132,0211-699501013259,363,o
132,0211-699501013259,p,o
132,0211-699501013259,005,o
132,0211-699501013259,Conclusion,o
132,0211-699501013259,Tras,o
132,0211-699501013259,suplementacion,i
132,0211-699501013259,con,o
132,0211-699501013259,acido,i
132,0211-699501013259,folico,i
132,0211-699501013259,y,o
132,0211-699501013259,vitamina,i
132,0211-699501013259,B6,i
132,0211-699501013259,aunque,o
132,0211-699501013259,inicialmente,o
132,0211-699501013259,se,o
132,0211-699501013259,reduce,o
132,0211-699501013259,la,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,esta,o
132,0211-699501013259,respuesta,o
132,0211-699501013259,se,o
132,0211-699501013259,hace,o
132,0211-699501013259,refractaria,o
132,0211-699501013259,correlacionandose,o
132,0211-699501013259,directamente,o
132,0211-699501013259,la,o
132,0211-699501013259,tHcy,i
132,0211-699501013259,con,o
132,0211-699501013259,la,o
132,0211-699501013259,albumina,i
132,0211-699501013259,plasmatica,i
132,0211-699501013259,La,o
132,0211-699501013259,interpretacion,o
132,0211-699501013259,de,o
132,0211-699501013259,los,o
132,0211-699501013259,niveles,i
132,0211-699501013259,de,i
132,0211-699501013259,tHcy,i
132,0211-699501013259,debe,o
132,0211-699501013259,tener,o
132,0211-699501013259,en,o
132,0211-699501013259,cuenta,o
132,0211-699501013259,la,o
132,0211-699501013259,concentracion,i
132,0211-699501013259,de,i
132,0211-699501013259,albumina,i
133,0211-699501013259,Efecto,o
133,0211-699501013259,de,o
133,0211-699501013259,la,o
133,0211-699501013259,suplementacion,i
133,0211-699501013259,con,o
133,0211-699501013259,acido,i
133,0211-699501013259,folico,i
133,0211-699501013259,sobre,o
133,0211-699501013259,los,o
133,0211-699501013259,niveles,i
133,0211-699501013259,de,i
133,0211-699501013259,homocisteina,i
133,0211-699501013259,total,o
133,0211-699501013259,en,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,en,o
133,0211-699501013259,hemodialisis,i
133,0211-699501013259,La,o
133,0211-699501013259,hiperhomocisteinemia,i
133,0211-699501013259,es,o
133,0211-699501013259,un,o
133,0211-699501013259,marcador,o
133,0211-699501013259,de,o
133,0211-699501013259,riesgo,o
133,0211-699501013259,independiente,o
133,0211-699501013259,de,o
133,0211-699501013259,morbimortalidad,o
133,0211-699501013259,cardiovascular,i
133,0211-699501013259,Hemos,o
133,0211-699501013259,intentado,o
133,0211-699501013259,prospectivamente,o
133,0211-699501013259,reducir,o
133,0211-699501013259,los,o
133,0211-699501013259,niveles,i
133,0211-699501013259,de,i
133,0211-699501013259,homocisteina,i
133,0211-699501013259,total,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,mediante,o
133,0211-699501013259,suplemento,o
133,0211-699501013259,con,o
133,0211-699501013259,acido,i
133,0211-699501013259,folico,i
133,0211-699501013259,y,o
133,0211-699501013259,vitamina,i
133,0211-699501013259,B6,i
133,0211-699501013259,pp,i
133,0211-699501013259,valorando,o
133,0211-699501013259,su,o
133,0211-699501013259,posible,o
133,0211-699501013259,correlacion,o
133,0211-699501013259,con,o
133,0211-699501013259,dosis,o
133,0211-699501013259,de,o
133,0211-699501013259,dialisis,i
133,0211-699501013259,funcion,i
133,0211-699501013259,residual,i
133,0211-699501013259,y,o
133,0211-699501013259,parametros,o
133,0211-699501013259,nutricionales,o
133,0211-699501013259,Metodos,o
133,0211-699501013259,Todos,o
133,0211-699501013259,los,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,en,o
133,0211-699501013259,hemodialisis,i
133,0211-699501013259,al,o
133,0211-699501013259,comienzo,o
133,0211-699501013259,del,o
133,0211-699501013259,estudio,o
133,0211-699501013259,que,o
133,0211-699501013259,no,o
133,0211-699501013259,recibian,o
133,0211-699501013259,acido,i
133,0211-699501013259,folico,i
133,0211-699501013259,ni,o
133,0211-699501013259,vitamina,i
133,0211-699501013259,B6,i
133,0211-699501013259,asi,o
133,0211-699501013259,como,o
133,0211-699501013259,los,o
133,0211-699501013259,incorporados,o
133,0211-699501013259,posteriormente,o
133,0211-699501013259,a,o
133,0211-699501013259,partir,o
133,0211-699501013259,de,o
133,0211-699501013259,su,o
133,0211-699501013259,tercer,o
133,0211-699501013259,mes,o
133,0211-699501013259,en,o
133,0211-699501013259,hemodialisis,i
133,0211-699501013259,recibieron,o
133,0211-699501013259,5,o
133,0211-699501013259,mg,o
133,0211-699501013259,orales,o
133,0211-699501013259,de,o
133,0211-699501013259,acido,i
133,0211-699501013259,folico,i
133,0211-699501013259,cada,o
133,0211-699501013259,48,o
133,0211-699501013259,horas,o
133,0211-699501013259,y,o
133,0211-699501013259,40,o
133,0211-699501013259,mg,o
133,0211-699501013259,orales,o
133,0211-699501013259,de,o
133,0211-699501013259,vitamina,i
133,0211-699501013259,B6,i
133,0211-699501013259,cada,o
133,0211-699501013259,semana,o
133,0211-699501013259,Se,o
133,0211-699501013259,determinaron,o
133,0211-699501013259,al,o
133,0211-699501013259,comienzo,o
133,0211-699501013259,del,o
133,0211-699501013259,estudio,o
133,0211-699501013259,y,o
133,0211-699501013259,cada,o
133,0211-699501013259,2,o
133,0211-699501013259,meses,o
133,0211-699501013259,niveles,i
133,0211-699501013259,de,i
133,0211-699501013259,folato,i
133,0211-699501013259,vitamina,i
133,0211-699501013259,B12,i
133,0211-699501013259,inmunoensayo,i
133,0211-699501013259,albumina,i
133,0211-699501013259,y,o
133,0211-699501013259,cinetica,o
133,0211-699501013259,de,o
133,0211-699501013259,la,o
133,0211-699501013259,urea,i
133,0211-699501013259,KTV,o
133,0211-699501013259,KRU,o
133,0211-699501013259,PCRn,o
133,0211-699501013259,y,o
133,0211-699501013259,cada,o
133,0211-699501013259,6,o
133,0211-699501013259,meses,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,HPLC,i
133,0211-699501013259,y,o
133,0211-699501013259,pp,i
133,0211-699501013259,RIA,i
133,0211-699501013259,Resultados,o
133,0211-699501013259,80,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,fueron,o
133,0211-699501013259,incluidos,o
133,0211-699501013259,en,o
133,0211-699501013259,el,o
133,0211-699501013259,estudio,o
133,0211-699501013259,basal,o
133,0211-699501013259,con,o
133,0211-699501013259,una,o
133,0211-699501013259,prevalencia,o
133,0211-699501013259,de,o
133,0211-699501013259,hiperhomocisteinemia,i
133,0211-699501013259,del,o
133,0211-699501013259,844,o
133,0211-699501013259,deficit,i
133,0211-699501013259,de,i
133,0211-699501013259,pp,i
133,0211-699501013259,en,o
133,0211-699501013259,el,o
133,0211-699501013259,32,o
133,0211-699501013259,y,o
133,0211-699501013259,folato,i
133,0211-699501013259,en,o
133,0211-699501013259,el,o
133,0211-699501013259,rango,o
133,0211-699501013259,normal,o
133,0211-699501013259,bajo,o
133,0211-699501013259,los,o
133,0211-699501013259,niveles,i
133,0211-699501013259,de,i
133,0211-699501013259,tHcy,i
133,0211-699501013259,se,o
133,0211-699501013259,correlacionaban,o
133,0211-699501013259,inversamente,o
133,0211-699501013259,con,o
133,0211-699501013259,los,o
133,0211-699501013259,del,o
133,0211-699501013259,folato,i
133,0211-699501013259,r,o
133,0211-699501013259,0336,o
133,0211-699501013259,p,o
133,0211-699501013259,001,o
133,0211-699501013259,pero,o
133,0211-699501013259,no,o
133,0211-699501013259,con,o
133,0211-699501013259,pp,i
133,0211-699501013259,B12,i
133,0211-699501013259,edad,o
133,0211-699501013259,albumina,i
133,0211-699501013259,KTV,o
133,0211-699501013259,KRU,o
133,0211-699501013259,PCRn,o
133,0211-699501013259,Cincuenta,o
133,0211-699501013259,y,o
133,0211-699501013259,ocho,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,recibieron,o
133,0211-699501013259,seis,o
133,0211-699501013259,meses,o
133,0211-699501013259,de,o
133,0211-699501013259,suplementacion,i
133,0211-699501013259,con,o
133,0211-699501013259,normalizacion,o
133,0211-699501013259,del,o
133,0211-699501013259,pp,i
133,0211-699501013259,aumento,o
133,0211-699501013259,del,o
133,0211-699501013259,folato,i
133,0211-699501013259,703,o
133,0211-699501013259,IC,o
133,0211-699501013259,638,o
133,0211-699501013259,795,o
133,0211-699501013259,vs,o
133,0211-699501013259,6181,o
133,0211-699501013259,IC,o
133,0211-699501013259,4447,o
133,0211-699501013259,7811,o
133,0211-699501013259,p,o
133,0211-699501013259,0001,o
133,0211-699501013259,y,o
133,0211-699501013259,descenso,o
133,0211-699501013259,de,o
133,0211-699501013259,la,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,240,o
133,0211-699501013259,IC,o
133,0211-699501013259,213,o
133,0211-699501013259,264,o
133,0211-699501013259,vs,o
133,0211-699501013259,199,o
133,0211-699501013259,IC,o
133,0211-699501013259,175,o
133,0211-699501013259,224,o
133,0211-699501013259,p,o
133,0211-699501013259,005,o
133,0211-699501013259,Han,o
133,0211-699501013259,recibido,o
133,0211-699501013259,suplementacion,i
133,0211-699501013259,durante,o
133,0211-699501013259,12,o
133,0211-699501013259,meses,o
133,0211-699501013259,33,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,pero,o
133,0211-699501013259,a,o
133,0211-699501013259,pesar,o
133,0211-699501013259,de,o
133,0211-699501013259,un,o
133,0211-699501013259,continuo,o
133,0211-699501013259,aumento,o
133,0211-699501013259,del,o
133,0211-699501013259,folato,i
133,0211-699501013259,10078,o
133,0211-699501013259,IC,o
133,0211-699501013259,7481,o
133,0211-699501013259,12674,o
133,0211-699501013259,p,o
133,0211-699501013259,0001,o
133,0211-699501013259,solo,o
133,0211-699501013259,3,o
133,0211-699501013259,pacientes,o
133,0211-699501013259,presentan,o
133,0211-699501013259,niveles,o
133,0211-699501013259,normales,o
133,0211-699501013259,de,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,correlacionandose,o
133,0211-699501013259,directamente,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,con,o
133,0211-699501013259,la,o
133,0211-699501013259,albumina,i
133,0211-699501013259,r,o
133,0211-699501013259,056,o
133,0211-699501013259,p,o
133,0211-699501013259,0001,o
133,0211-699501013259,que,o
133,0211-699501013259,se,o
133,0211-699501013259,elevo,o
133,0211-699501013259,con,o
133,0211-699501013259,respecto,o
133,0211-699501013259,al,o
133,0211-699501013259,inicio,o
133,0211-699501013259,337,o
133,0211-699501013259,IC,o
133,0211-699501013259,327,o
133,0211-699501013259,346,o
133,0211-699501013259,vs,o
133,0211-699501013259,350,o
133,0211-699501013259,IC,o
133,0211-699501013259,337,o
133,0211-699501013259,363,o
133,0211-699501013259,p,o
133,0211-699501013259,005,o
133,0211-699501013259,Conclusion,o
133,0211-699501013259,Tras,o
133,0211-699501013259,suplementacion,i
133,0211-699501013259,con,o
133,0211-699501013259,acido,i
133,0211-699501013259,folico,i
133,0211-699501013259,y,o
133,0211-699501013259,vitamina,i
133,0211-699501013259,B6,i
133,0211-699501013259,aunque,o
133,0211-699501013259,inicialmente,o
133,0211-699501013259,se,o
133,0211-699501013259,reduce,o
133,0211-699501013259,la,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,esta,o
133,0211-699501013259,respuesta,o
133,0211-699501013259,se,o
133,0211-699501013259,hace,o
133,0211-699501013259,refractaria,o
133,0211-699501013259,correlacionandose,o
133,0211-699501013259,directamente,o
133,0211-699501013259,la,o
133,0211-699501013259,tHcy,i
133,0211-699501013259,con,o
133,0211-699501013259,la,o
133,0211-699501013259,albumina,i
133,0211-699501013259,plasmatica,i
133,0211-699501013259,La,o
133,0211-699501013259,interpretacion,o
133,0211-699501013259,de,o
133,0211-699501013259,los,o
133,0211-699501013259,niveles,i
133,0211-699501013259,de,i
133,0211-699501013259,tHcy,i
133,0211-699501013259,debe,o
133,0211-699501013259,tener,o
133,0211-699501013259,en,o
133,0211-699501013259,cuenta,o
133,0211-699501013259,la,o
133,0211-699501013259,concentracion,i
133,0211-699501013259,de,i
133,0211-699501013259,albumina,i
134,0211-699501013259,Efecto,o
134,0211-699501013259,de,o
134,0211-699501013259,la,o
134,0211-699501013259,suplementacion,i
134,0211-699501013259,con,o
134,0211-699501013259,acido,i
134,0211-699501013259,folico,i
134,0211-699501013259,sobre,o
134,0211-699501013259,los,o
134,0211-699501013259,niveles,i
134,0211-699501013259,de,i
134,0211-699501013259,homocisteina,i
134,0211-699501013259,total,o
134,0211-699501013259,en,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,en,o
134,0211-699501013259,hemodialisis,i
134,0211-699501013259,La,o
134,0211-699501013259,hiperhomocisteinemia,i
134,0211-699501013259,es,o
134,0211-699501013259,un,o
134,0211-699501013259,marcador,o
134,0211-699501013259,de,o
134,0211-699501013259,riesgo,o
134,0211-699501013259,independiente,o
134,0211-699501013259,de,o
134,0211-699501013259,morbimortalidad,o
134,0211-699501013259,cardiovascular,i
134,0211-699501013259,Hemos,o
134,0211-699501013259,intentado,o
134,0211-699501013259,prospectivamente,o
134,0211-699501013259,reducir,o
134,0211-699501013259,los,o
134,0211-699501013259,niveles,i
134,0211-699501013259,de,i
134,0211-699501013259,homocisteina,i
134,0211-699501013259,total,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,mediante,o
134,0211-699501013259,suplemento,o
134,0211-699501013259,con,o
134,0211-699501013259,acido,i
134,0211-699501013259,folico,i
134,0211-699501013259,y,o
134,0211-699501013259,vitamina,i
134,0211-699501013259,B6,i
134,0211-699501013259,pp,i
134,0211-699501013259,valorando,o
134,0211-699501013259,su,o
134,0211-699501013259,posible,o
134,0211-699501013259,correlacion,o
134,0211-699501013259,con,o
134,0211-699501013259,dosis,o
134,0211-699501013259,de,o
134,0211-699501013259,dialisis,i
134,0211-699501013259,funcion,i
134,0211-699501013259,residual,i
134,0211-699501013259,y,o
134,0211-699501013259,parametros,o
134,0211-699501013259,nutricionales,o
134,0211-699501013259,Metodos,o
134,0211-699501013259,Todos,o
134,0211-699501013259,los,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,en,o
134,0211-699501013259,hemodialisis,i
134,0211-699501013259,al,o
134,0211-699501013259,comienzo,o
134,0211-699501013259,del,o
134,0211-699501013259,estudio,o
134,0211-699501013259,que,o
134,0211-699501013259,no,o
134,0211-699501013259,recibian,o
134,0211-699501013259,acido,i
134,0211-699501013259,folico,i
134,0211-699501013259,ni,o
134,0211-699501013259,vitamina,i
134,0211-699501013259,B6,i
134,0211-699501013259,asi,o
134,0211-699501013259,como,o
134,0211-699501013259,los,o
134,0211-699501013259,incorporados,o
134,0211-699501013259,posteriormente,o
134,0211-699501013259,a,o
134,0211-699501013259,partir,o
134,0211-699501013259,de,o
134,0211-699501013259,su,o
134,0211-699501013259,tercer,o
134,0211-699501013259,mes,o
134,0211-699501013259,en,o
134,0211-699501013259,hemodialisis,i
134,0211-699501013259,recibieron,o
134,0211-699501013259,5,o
134,0211-699501013259,mg,o
134,0211-699501013259,orales,o
134,0211-699501013259,de,o
134,0211-699501013259,acido,i
134,0211-699501013259,folico,i
134,0211-699501013259,cada,o
134,0211-699501013259,48,o
134,0211-699501013259,horas,o
134,0211-699501013259,y,o
134,0211-699501013259,40,o
134,0211-699501013259,mg,o
134,0211-699501013259,orales,o
134,0211-699501013259,de,o
134,0211-699501013259,vitamina,i
134,0211-699501013259,B6,i
134,0211-699501013259,cada,o
134,0211-699501013259,semana,o
134,0211-699501013259,Se,o
134,0211-699501013259,determinaron,o
134,0211-699501013259,al,o
134,0211-699501013259,comienzo,o
134,0211-699501013259,del,o
134,0211-699501013259,estudio,o
134,0211-699501013259,y,o
134,0211-699501013259,cada,o
134,0211-699501013259,2,o
134,0211-699501013259,meses,o
134,0211-699501013259,niveles,i
134,0211-699501013259,de,i
134,0211-699501013259,folato,i
134,0211-699501013259,vitamina,i
134,0211-699501013259,B12,i
134,0211-699501013259,inmunoensayo,i
134,0211-699501013259,albumina,i
134,0211-699501013259,y,o
134,0211-699501013259,cinetica,o
134,0211-699501013259,de,o
134,0211-699501013259,la,o
134,0211-699501013259,urea,i
134,0211-699501013259,KTV,o
134,0211-699501013259,KRU,o
134,0211-699501013259,PCRn,o
134,0211-699501013259,y,o
134,0211-699501013259,cada,o
134,0211-699501013259,6,o
134,0211-699501013259,meses,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,HPLC,i
134,0211-699501013259,y,o
134,0211-699501013259,pp,i
134,0211-699501013259,RIA,i
134,0211-699501013259,Resultados,o
134,0211-699501013259,80,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,fueron,o
134,0211-699501013259,incluidos,o
134,0211-699501013259,en,o
134,0211-699501013259,el,o
134,0211-699501013259,estudio,o
134,0211-699501013259,basal,o
134,0211-699501013259,con,o
134,0211-699501013259,una,o
134,0211-699501013259,prevalencia,o
134,0211-699501013259,de,o
134,0211-699501013259,hiperhomocisteinemia,i
134,0211-699501013259,del,o
134,0211-699501013259,844,o
134,0211-699501013259,deficit,i
134,0211-699501013259,de,i
134,0211-699501013259,pp,i
134,0211-699501013259,en,o
134,0211-699501013259,el,o
134,0211-699501013259,32,o
134,0211-699501013259,y,o
134,0211-699501013259,folato,i
134,0211-699501013259,en,o
134,0211-699501013259,el,o
134,0211-699501013259,rango,o
134,0211-699501013259,normal,o
134,0211-699501013259,bajo,o
134,0211-699501013259,los,o
134,0211-699501013259,niveles,i
134,0211-699501013259,de,i
134,0211-699501013259,tHcy,i
134,0211-699501013259,se,o
134,0211-699501013259,correlacionaban,o
134,0211-699501013259,inversamente,o
134,0211-699501013259,con,o
134,0211-699501013259,los,o
134,0211-699501013259,del,o
134,0211-699501013259,folato,i
134,0211-699501013259,r,o
134,0211-699501013259,0336,o
134,0211-699501013259,p,o
134,0211-699501013259,001,o
134,0211-699501013259,pero,o
134,0211-699501013259,no,o
134,0211-699501013259,con,o
134,0211-699501013259,pp,i
134,0211-699501013259,B12,i
134,0211-699501013259,edad,o
134,0211-699501013259,albumina,i
134,0211-699501013259,KTV,o
134,0211-699501013259,KRU,o
134,0211-699501013259,PCRn,o
134,0211-699501013259,Cincuenta,o
134,0211-699501013259,y,o
134,0211-699501013259,ocho,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,recibieron,o
134,0211-699501013259,seis,o
134,0211-699501013259,meses,o
134,0211-699501013259,de,o
134,0211-699501013259,suplementacion,i
134,0211-699501013259,con,o
134,0211-699501013259,normalizacion,o
134,0211-699501013259,del,o
134,0211-699501013259,pp,i
134,0211-699501013259,aumento,o
134,0211-699501013259,del,o
134,0211-699501013259,folato,i
134,0211-699501013259,703,o
134,0211-699501013259,IC,o
134,0211-699501013259,638,o
134,0211-699501013259,795,o
134,0211-699501013259,vs,o
134,0211-699501013259,6181,o
134,0211-699501013259,IC,o
134,0211-699501013259,4447,o
134,0211-699501013259,7811,o
134,0211-699501013259,p,o
134,0211-699501013259,0001,o
134,0211-699501013259,y,o
134,0211-699501013259,descenso,o
134,0211-699501013259,de,o
134,0211-699501013259,la,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,240,o
134,0211-699501013259,IC,o
134,0211-699501013259,213,o
134,0211-699501013259,264,o
134,0211-699501013259,vs,o
134,0211-699501013259,199,o
134,0211-699501013259,IC,o
134,0211-699501013259,175,o
134,0211-699501013259,224,o
134,0211-699501013259,p,o
134,0211-699501013259,005,o
134,0211-699501013259,Han,o
134,0211-699501013259,recibido,o
134,0211-699501013259,suplementacion,i
134,0211-699501013259,durante,o
134,0211-699501013259,12,o
134,0211-699501013259,meses,o
134,0211-699501013259,33,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,pero,o
134,0211-699501013259,a,o
134,0211-699501013259,pesar,o
134,0211-699501013259,de,o
134,0211-699501013259,un,o
134,0211-699501013259,continuo,o
134,0211-699501013259,aumento,o
134,0211-699501013259,del,o
134,0211-699501013259,folato,i
134,0211-699501013259,10078,o
134,0211-699501013259,IC,o
134,0211-699501013259,7481,o
134,0211-699501013259,12674,o
134,0211-699501013259,p,o
134,0211-699501013259,0001,o
134,0211-699501013259,solo,o
134,0211-699501013259,3,o
134,0211-699501013259,pacientes,o
134,0211-699501013259,presentan,o
134,0211-699501013259,niveles,o
134,0211-699501013259,normales,o
134,0211-699501013259,de,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,correlacionandose,o
134,0211-699501013259,directamente,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,con,o
134,0211-699501013259,la,o
134,0211-699501013259,albumina,i
134,0211-699501013259,r,o
134,0211-699501013259,056,o
134,0211-699501013259,p,o
134,0211-699501013259,0001,o
134,0211-699501013259,que,o
134,0211-699501013259,se,o
134,0211-699501013259,elevo,o
134,0211-699501013259,con,o
134,0211-699501013259,respecto,o
134,0211-699501013259,al,o
134,0211-699501013259,inicio,o
134,0211-699501013259,337,o
134,0211-699501013259,IC,o
134,0211-699501013259,327,o
134,0211-699501013259,346,o
134,0211-699501013259,vs,o
134,0211-699501013259,350,o
134,0211-699501013259,IC,o
134,0211-699501013259,337,o
134,0211-699501013259,363,o
134,0211-699501013259,p,o
134,0211-699501013259,005,o
134,0211-699501013259,Conclusion,o
134,0211-699501013259,Tras,o
134,0211-699501013259,suplementacion,i
134,0211-699501013259,con,o
134,0211-699501013259,acido,i
134,0211-699501013259,folico,i
134,0211-699501013259,y,o
134,0211-699501013259,vitamina,i
134,0211-699501013259,B6,i
134,0211-699501013259,aunque,o
134,0211-699501013259,inicialmente,o
134,0211-699501013259,se,o
134,0211-699501013259,reduce,o
134,0211-699501013259,la,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,esta,o
134,0211-699501013259,respuesta,o
134,0211-699501013259,se,o
134,0211-699501013259,hace,o
134,0211-699501013259,refractaria,o
134,0211-699501013259,correlacionandose,o
134,0211-699501013259,directamente,o
134,0211-699501013259,la,o
134,0211-699501013259,tHcy,i
134,0211-699501013259,con,o
134,0211-699501013259,la,o
134,0211-699501013259,albumina,i
134,0211-699501013259,plasmatica,i
134,0211-699501013259,La,o
134,0211-699501013259,interpretacion,o
134,0211-699501013259,de,o
134,0211-699501013259,los,o
134,0211-699501013259,niveles,i
134,0211-699501013259,de,i
134,0211-699501013259,tHcy,i
134,0211-699501013259,debe,o
134,0211-699501013259,tener,o
134,0211-699501013259,en,o
134,0211-699501013259,cuenta,o
134,0211-699501013259,la,o
134,0211-699501013259,concentracion,i
134,0211-699501013259,de,i
134,0211-699501013259,albumina,i
135,0211-699501013259,Efecto,o
135,0211-699501013259,de,o
135,0211-699501013259,la,o
135,0211-699501013259,suplementacion,i
135,0211-699501013259,con,o
135,0211-699501013259,acido,i
135,0211-699501013259,folico,i
135,0211-699501013259,sobre,o
135,0211-699501013259,los,o
135,0211-699501013259,niveles,i
135,0211-699501013259,de,i
135,0211-699501013259,homocisteina,i
135,0211-699501013259,total,o
135,0211-699501013259,en,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,en,o
135,0211-699501013259,hemodialisis,i
135,0211-699501013259,La,o
135,0211-699501013259,hiperhomocisteinemia,i
135,0211-699501013259,es,o
135,0211-699501013259,un,o
135,0211-699501013259,marcador,o
135,0211-699501013259,de,o
135,0211-699501013259,riesgo,o
135,0211-699501013259,independiente,o
135,0211-699501013259,de,o
135,0211-699501013259,morbimortalidad,o
135,0211-699501013259,cardiovascular,i
135,0211-699501013259,Hemos,o
135,0211-699501013259,intentado,o
135,0211-699501013259,prospectivamente,o
135,0211-699501013259,reducir,o
135,0211-699501013259,los,o
135,0211-699501013259,niveles,i
135,0211-699501013259,de,i
135,0211-699501013259,homocisteina,i
135,0211-699501013259,total,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,mediante,o
135,0211-699501013259,suplemento,o
135,0211-699501013259,con,o
135,0211-699501013259,acido,i
135,0211-699501013259,folico,i
135,0211-699501013259,y,o
135,0211-699501013259,vitamina,i
135,0211-699501013259,B6,i
135,0211-699501013259,pp,i
135,0211-699501013259,valorando,o
135,0211-699501013259,su,o
135,0211-699501013259,posible,o
135,0211-699501013259,correlacion,o
135,0211-699501013259,con,o
135,0211-699501013259,dosis,o
135,0211-699501013259,de,o
135,0211-699501013259,dialisis,i
135,0211-699501013259,funcion,i
135,0211-699501013259,residual,i
135,0211-699501013259,y,o
135,0211-699501013259,parametros,o
135,0211-699501013259,nutricionales,o
135,0211-699501013259,Metodos,o
135,0211-699501013259,Todos,o
135,0211-699501013259,los,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,en,o
135,0211-699501013259,hemodialisis,i
135,0211-699501013259,al,o
135,0211-699501013259,comienzo,o
135,0211-699501013259,del,o
135,0211-699501013259,estudio,o
135,0211-699501013259,que,o
135,0211-699501013259,no,o
135,0211-699501013259,recibian,o
135,0211-699501013259,acido,i
135,0211-699501013259,folico,i
135,0211-699501013259,ni,o
135,0211-699501013259,vitamina,i
135,0211-699501013259,B6,i
135,0211-699501013259,asi,o
135,0211-699501013259,como,o
135,0211-699501013259,los,o
135,0211-699501013259,incorporados,o
135,0211-699501013259,posteriormente,o
135,0211-699501013259,a,o
135,0211-699501013259,partir,o
135,0211-699501013259,de,o
135,0211-699501013259,su,o
135,0211-699501013259,tercer,o
135,0211-699501013259,mes,o
135,0211-699501013259,en,o
135,0211-699501013259,hemodialisis,i
135,0211-699501013259,recibieron,o
135,0211-699501013259,5,o
135,0211-699501013259,mg,o
135,0211-699501013259,orales,o
135,0211-699501013259,de,o
135,0211-699501013259,acido,i
135,0211-699501013259,folico,i
135,0211-699501013259,cada,o
135,0211-699501013259,48,o
135,0211-699501013259,horas,o
135,0211-699501013259,y,o
135,0211-699501013259,40,o
135,0211-699501013259,mg,o
135,0211-699501013259,orales,o
135,0211-699501013259,de,o
135,0211-699501013259,vitamina,i
135,0211-699501013259,B6,i
135,0211-699501013259,cada,o
135,0211-699501013259,semana,o
135,0211-699501013259,Se,o
135,0211-699501013259,determinaron,o
135,0211-699501013259,al,o
135,0211-699501013259,comienzo,o
135,0211-699501013259,del,o
135,0211-699501013259,estudio,o
135,0211-699501013259,y,o
135,0211-699501013259,cada,o
135,0211-699501013259,2,o
135,0211-699501013259,meses,o
135,0211-699501013259,niveles,i
135,0211-699501013259,de,i
135,0211-699501013259,folato,i
135,0211-699501013259,vitamina,i
135,0211-699501013259,B12,i
135,0211-699501013259,inmunoensayo,i
135,0211-699501013259,albumina,i
135,0211-699501013259,y,o
135,0211-699501013259,cinetica,o
135,0211-699501013259,de,o
135,0211-699501013259,la,o
135,0211-699501013259,urea,i
135,0211-699501013259,KTV,o
135,0211-699501013259,KRU,o
135,0211-699501013259,PCRn,o
135,0211-699501013259,y,o
135,0211-699501013259,cada,o
135,0211-699501013259,6,o
135,0211-699501013259,meses,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,HPLC,i
135,0211-699501013259,y,o
135,0211-699501013259,pp,i
135,0211-699501013259,RIA,i
135,0211-699501013259,Resultados,o
135,0211-699501013259,80,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,fueron,o
135,0211-699501013259,incluidos,o
135,0211-699501013259,en,o
135,0211-699501013259,el,o
135,0211-699501013259,estudio,o
135,0211-699501013259,basal,o
135,0211-699501013259,con,o
135,0211-699501013259,una,o
135,0211-699501013259,prevalencia,o
135,0211-699501013259,de,o
135,0211-699501013259,hiperhomocisteinemia,i
135,0211-699501013259,del,o
135,0211-699501013259,844,o
135,0211-699501013259,deficit,i
135,0211-699501013259,de,i
135,0211-699501013259,pp,i
135,0211-699501013259,en,o
135,0211-699501013259,el,o
135,0211-699501013259,32,o
135,0211-699501013259,y,o
135,0211-699501013259,folato,i
135,0211-699501013259,en,o
135,0211-699501013259,el,o
135,0211-699501013259,rango,o
135,0211-699501013259,normal,o
135,0211-699501013259,bajo,o
135,0211-699501013259,los,o
135,0211-699501013259,niveles,i
135,0211-699501013259,de,i
135,0211-699501013259,tHcy,i
135,0211-699501013259,se,o
135,0211-699501013259,correlacionaban,o
135,0211-699501013259,inversamente,o
135,0211-699501013259,con,o
135,0211-699501013259,los,o
135,0211-699501013259,del,o
135,0211-699501013259,folato,i
135,0211-699501013259,r,o
135,0211-699501013259,0336,o
135,0211-699501013259,p,o
135,0211-699501013259,001,o
135,0211-699501013259,pero,o
135,0211-699501013259,no,o
135,0211-699501013259,con,o
135,0211-699501013259,pp,i
135,0211-699501013259,B12,i
135,0211-699501013259,edad,o
135,0211-699501013259,albumina,i
135,0211-699501013259,KTV,o
135,0211-699501013259,KRU,o
135,0211-699501013259,PCRn,o
135,0211-699501013259,Cincuenta,o
135,0211-699501013259,y,o
135,0211-699501013259,ocho,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,recibieron,o
135,0211-699501013259,seis,o
135,0211-699501013259,meses,o
135,0211-699501013259,de,o
135,0211-699501013259,suplementacion,i
135,0211-699501013259,con,o
135,0211-699501013259,normalizacion,o
135,0211-699501013259,del,o
135,0211-699501013259,pp,i
135,0211-699501013259,aumento,o
135,0211-699501013259,del,o
135,0211-699501013259,folato,i
135,0211-699501013259,703,o
135,0211-699501013259,IC,o
135,0211-699501013259,638,o
135,0211-699501013259,795,o
135,0211-699501013259,vs,o
135,0211-699501013259,6181,o
135,0211-699501013259,IC,o
135,0211-699501013259,4447,o
135,0211-699501013259,7811,o
135,0211-699501013259,p,o
135,0211-699501013259,0001,o
135,0211-699501013259,y,o
135,0211-699501013259,descenso,o
135,0211-699501013259,de,o
135,0211-699501013259,la,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,240,o
135,0211-699501013259,IC,o
135,0211-699501013259,213,o
135,0211-699501013259,264,o
135,0211-699501013259,vs,o
135,0211-699501013259,199,o
135,0211-699501013259,IC,o
135,0211-699501013259,175,o
135,0211-699501013259,224,o
135,0211-699501013259,p,o
135,0211-699501013259,005,o
135,0211-699501013259,Han,o
135,0211-699501013259,recibido,o
135,0211-699501013259,suplementacion,i
135,0211-699501013259,durante,o
135,0211-699501013259,12,o
135,0211-699501013259,meses,o
135,0211-699501013259,33,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,pero,o
135,0211-699501013259,a,o
135,0211-699501013259,pesar,o
135,0211-699501013259,de,o
135,0211-699501013259,un,o
135,0211-699501013259,continuo,o
135,0211-699501013259,aumento,o
135,0211-699501013259,del,o
135,0211-699501013259,folato,i
135,0211-699501013259,10078,o
135,0211-699501013259,IC,o
135,0211-699501013259,7481,o
135,0211-699501013259,12674,o
135,0211-699501013259,p,o
135,0211-699501013259,0001,o
135,0211-699501013259,solo,o
135,0211-699501013259,3,o
135,0211-699501013259,pacientes,o
135,0211-699501013259,presentan,o
135,0211-699501013259,niveles,o
135,0211-699501013259,normales,o
135,0211-699501013259,de,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,correlacionandose,o
135,0211-699501013259,directamente,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,con,o
135,0211-699501013259,la,o
135,0211-699501013259,albumina,i
135,0211-699501013259,r,o
135,0211-699501013259,056,o
135,0211-699501013259,p,o
135,0211-699501013259,0001,o
135,0211-699501013259,que,o
135,0211-699501013259,se,o
135,0211-699501013259,elevo,o
135,0211-699501013259,con,o
135,0211-699501013259,respecto,o
135,0211-699501013259,al,o
135,0211-699501013259,inicio,o
135,0211-699501013259,337,o
135,0211-699501013259,IC,o
135,0211-699501013259,327,o
135,0211-699501013259,346,o
135,0211-699501013259,vs,o
135,0211-699501013259,350,o
135,0211-699501013259,IC,o
135,0211-699501013259,337,o
135,0211-699501013259,363,o
135,0211-699501013259,p,o
135,0211-699501013259,005,o
135,0211-699501013259,Conclusion,o
135,0211-699501013259,Tras,o
135,0211-699501013259,suplementacion,i
135,0211-699501013259,con,o
135,0211-699501013259,acido,i
135,0211-699501013259,folico,i
135,0211-699501013259,y,o
135,0211-699501013259,vitamina,i
135,0211-699501013259,B6,i
135,0211-699501013259,aunque,o
135,0211-699501013259,inicialmente,o
135,0211-699501013259,se,o
135,0211-699501013259,reduce,o
135,0211-699501013259,la,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,esta,o
135,0211-699501013259,respuesta,o
135,0211-699501013259,se,o
135,0211-699501013259,hace,o
135,0211-699501013259,refractaria,o
135,0211-699501013259,correlacionandose,o
135,0211-699501013259,directamente,o
135,0211-699501013259,la,o
135,0211-699501013259,tHcy,i
135,0211-699501013259,con,o
135,0211-699501013259,la,o
135,0211-699501013259,albumina,i
135,0211-699501013259,plasmatica,i
135,0211-699501013259,La,o
135,0211-699501013259,interpretacion,o
135,0211-699501013259,de,o
135,0211-699501013259,los,o
135,0211-699501013259,niveles,i
135,0211-699501013259,de,i
135,0211-699501013259,tHcy,i
135,0211-699501013259,debe,o
135,0211-699501013259,tener,o
135,0211-699501013259,en,o
135,0211-699501013259,cuenta,o
135,0211-699501013259,la,o
135,0211-699501013259,concentracion,i
135,0211-699501013259,de,i
135,0211-699501013259,albumina,i
136,0211-699501013259,Efecto,o
136,0211-699501013259,de,o
136,0211-699501013259,la,o
136,0211-699501013259,suplementacion,i
136,0211-699501013259,con,o
136,0211-699501013259,acido,i
136,0211-699501013259,folico,i
136,0211-699501013259,sobre,o
136,0211-699501013259,los,o
136,0211-699501013259,niveles,i
136,0211-699501013259,de,i
136,0211-699501013259,homocisteina,i
136,0211-699501013259,total,o
136,0211-699501013259,en,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,en,o
136,0211-699501013259,hemodialisis,i
136,0211-699501013259,La,o
136,0211-699501013259,hiperhomocisteinemia,i
136,0211-699501013259,es,o
136,0211-699501013259,un,o
136,0211-699501013259,marcador,o
136,0211-699501013259,de,o
136,0211-699501013259,riesgo,o
136,0211-699501013259,independiente,o
136,0211-699501013259,de,o
136,0211-699501013259,morbimortalidad,o
136,0211-699501013259,cardiovascular,i
136,0211-699501013259,Hemos,o
136,0211-699501013259,intentado,o
136,0211-699501013259,prospectivamente,o
136,0211-699501013259,reducir,o
136,0211-699501013259,los,o
136,0211-699501013259,niveles,i
136,0211-699501013259,de,i
136,0211-699501013259,homocisteina,i
136,0211-699501013259,total,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,mediante,o
136,0211-699501013259,suplemento,o
136,0211-699501013259,con,o
136,0211-699501013259,acido,i
136,0211-699501013259,folico,i
136,0211-699501013259,y,o
136,0211-699501013259,vitamina,i
136,0211-699501013259,B6,i
136,0211-699501013259,pp,i
136,0211-699501013259,valorando,o
136,0211-699501013259,su,o
136,0211-699501013259,posible,o
136,0211-699501013259,correlacion,o
136,0211-699501013259,con,o
136,0211-699501013259,dosis,o
136,0211-699501013259,de,o
136,0211-699501013259,dialisis,i
136,0211-699501013259,funcion,i
136,0211-699501013259,residual,i
136,0211-699501013259,y,o
136,0211-699501013259,parametros,o
136,0211-699501013259,nutricionales,o
136,0211-699501013259,Metodos,o
136,0211-699501013259,Todos,o
136,0211-699501013259,los,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,en,o
136,0211-699501013259,hemodialisis,i
136,0211-699501013259,al,o
136,0211-699501013259,comienzo,o
136,0211-699501013259,del,o
136,0211-699501013259,estudio,o
136,0211-699501013259,que,o
136,0211-699501013259,no,o
136,0211-699501013259,recibian,o
136,0211-699501013259,acido,i
136,0211-699501013259,folico,i
136,0211-699501013259,ni,o
136,0211-699501013259,vitamina,i
136,0211-699501013259,B6,i
136,0211-699501013259,asi,o
136,0211-699501013259,como,o
136,0211-699501013259,los,o
136,0211-699501013259,incorporados,o
136,0211-699501013259,posteriormente,o
136,0211-699501013259,a,o
136,0211-699501013259,partir,o
136,0211-699501013259,de,o
136,0211-699501013259,su,o
136,0211-699501013259,tercer,o
136,0211-699501013259,mes,o
136,0211-699501013259,en,o
136,0211-699501013259,hemodialisis,i
136,0211-699501013259,recibieron,o
136,0211-699501013259,5,o
136,0211-699501013259,mg,o
136,0211-699501013259,orales,o
136,0211-699501013259,de,o
136,0211-699501013259,acido,i
136,0211-699501013259,folico,i
136,0211-699501013259,cada,o
136,0211-699501013259,48,o
136,0211-699501013259,horas,o
136,0211-699501013259,y,o
136,0211-699501013259,40,o
136,0211-699501013259,mg,o
136,0211-699501013259,orales,o
136,0211-699501013259,de,o
136,0211-699501013259,vitamina,i
136,0211-699501013259,B6,i
136,0211-699501013259,cada,o
136,0211-699501013259,semana,o
136,0211-699501013259,Se,o
136,0211-699501013259,determinaron,o
136,0211-699501013259,al,o
136,0211-699501013259,comienzo,o
136,0211-699501013259,del,o
136,0211-699501013259,estudio,o
136,0211-699501013259,y,o
136,0211-699501013259,cada,o
136,0211-699501013259,2,o
136,0211-699501013259,meses,o
136,0211-699501013259,niveles,i
136,0211-699501013259,de,i
136,0211-699501013259,folato,i
136,0211-699501013259,vitamina,i
136,0211-699501013259,B12,i
136,0211-699501013259,inmunoensayo,i
136,0211-699501013259,albumina,i
136,0211-699501013259,y,o
136,0211-699501013259,cinetica,o
136,0211-699501013259,de,o
136,0211-699501013259,la,o
136,0211-699501013259,urea,i
136,0211-699501013259,KTV,o
136,0211-699501013259,KRU,o
136,0211-699501013259,PCRn,o
136,0211-699501013259,y,o
136,0211-699501013259,cada,o
136,0211-699501013259,6,o
136,0211-699501013259,meses,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,HPLC,i
136,0211-699501013259,y,o
136,0211-699501013259,pp,i
136,0211-699501013259,RIA,i
136,0211-699501013259,Resultados,o
136,0211-699501013259,80,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,fueron,o
136,0211-699501013259,incluidos,o
136,0211-699501013259,en,o
136,0211-699501013259,el,o
136,0211-699501013259,estudio,o
136,0211-699501013259,basal,o
136,0211-699501013259,con,o
136,0211-699501013259,una,o
136,0211-699501013259,prevalencia,o
136,0211-699501013259,de,o
136,0211-699501013259,hiperhomocisteinemia,i
136,0211-699501013259,del,o
136,0211-699501013259,844,o
136,0211-699501013259,deficit,i
136,0211-699501013259,de,i
136,0211-699501013259,pp,i
136,0211-699501013259,en,o
136,0211-699501013259,el,o
136,0211-699501013259,32,o
136,0211-699501013259,y,o
136,0211-699501013259,folato,i
136,0211-699501013259,en,o
136,0211-699501013259,el,o
136,0211-699501013259,rango,o
136,0211-699501013259,normal,o
136,0211-699501013259,bajo,o
136,0211-699501013259,los,o
136,0211-699501013259,niveles,i
136,0211-699501013259,de,i
136,0211-699501013259,tHcy,i
136,0211-699501013259,se,o
136,0211-699501013259,correlacionaban,o
136,0211-699501013259,inversamente,o
136,0211-699501013259,con,o
136,0211-699501013259,los,o
136,0211-699501013259,del,o
136,0211-699501013259,folato,i
136,0211-699501013259,r,o
136,0211-699501013259,0336,o
136,0211-699501013259,p,o
136,0211-699501013259,001,o
136,0211-699501013259,pero,o
136,0211-699501013259,no,o
136,0211-699501013259,con,o
136,0211-699501013259,pp,i
136,0211-699501013259,B12,i
136,0211-699501013259,edad,o
136,0211-699501013259,albumina,i
136,0211-699501013259,KTV,o
136,0211-699501013259,KRU,o
136,0211-699501013259,PCRn,o
136,0211-699501013259,Cincuenta,o
136,0211-699501013259,y,o
136,0211-699501013259,ocho,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,recibieron,o
136,0211-699501013259,seis,o
136,0211-699501013259,meses,o
136,0211-699501013259,de,o
136,0211-699501013259,suplementacion,i
136,0211-699501013259,con,o
136,0211-699501013259,normalizacion,o
136,0211-699501013259,del,o
136,0211-699501013259,pp,i
136,0211-699501013259,aumento,o
136,0211-699501013259,del,o
136,0211-699501013259,folato,i
136,0211-699501013259,703,o
136,0211-699501013259,IC,o
136,0211-699501013259,638,o
136,0211-699501013259,795,o
136,0211-699501013259,vs,o
136,0211-699501013259,6181,o
136,0211-699501013259,IC,o
136,0211-699501013259,4447,o
136,0211-699501013259,7811,o
136,0211-699501013259,p,o
136,0211-699501013259,0001,o
136,0211-699501013259,y,o
136,0211-699501013259,descenso,o
136,0211-699501013259,de,o
136,0211-699501013259,la,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,240,o
136,0211-699501013259,IC,o
136,0211-699501013259,213,o
136,0211-699501013259,264,o
136,0211-699501013259,vs,o
136,0211-699501013259,199,o
136,0211-699501013259,IC,o
136,0211-699501013259,175,o
136,0211-699501013259,224,o
136,0211-699501013259,p,o
136,0211-699501013259,005,o
136,0211-699501013259,Han,o
136,0211-699501013259,recibido,o
136,0211-699501013259,suplementacion,i
136,0211-699501013259,durante,o
136,0211-699501013259,12,o
136,0211-699501013259,meses,o
136,0211-699501013259,33,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,pero,o
136,0211-699501013259,a,o
136,0211-699501013259,pesar,o
136,0211-699501013259,de,o
136,0211-699501013259,un,o
136,0211-699501013259,continuo,o
136,0211-699501013259,aumento,o
136,0211-699501013259,del,o
136,0211-699501013259,folato,i
136,0211-699501013259,10078,o
136,0211-699501013259,IC,o
136,0211-699501013259,7481,o
136,0211-699501013259,12674,o
136,0211-699501013259,p,o
136,0211-699501013259,0001,o
136,0211-699501013259,solo,o
136,0211-699501013259,3,o
136,0211-699501013259,pacientes,o
136,0211-699501013259,presentan,o
136,0211-699501013259,niveles,o
136,0211-699501013259,normales,o
136,0211-699501013259,de,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,correlacionandose,o
136,0211-699501013259,directamente,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,con,o
136,0211-699501013259,la,o
136,0211-699501013259,albumina,i
136,0211-699501013259,r,o
136,0211-699501013259,056,o
136,0211-699501013259,p,o
136,0211-699501013259,0001,o
136,0211-699501013259,que,o
136,0211-699501013259,se,o
136,0211-699501013259,elevo,o
136,0211-699501013259,con,o
136,0211-699501013259,respecto,o
136,0211-699501013259,al,o
136,0211-699501013259,inicio,o
136,0211-699501013259,337,o
136,0211-699501013259,IC,o
136,0211-699501013259,327,o
136,0211-699501013259,346,o
136,0211-699501013259,vs,o
136,0211-699501013259,350,o
136,0211-699501013259,IC,o
136,0211-699501013259,337,o
136,0211-699501013259,363,o
136,0211-699501013259,p,o
136,0211-699501013259,005,o
136,0211-699501013259,Conclusion,o
136,0211-699501013259,Tras,o
136,0211-699501013259,suplementacion,i
136,0211-699501013259,con,o
136,0211-699501013259,acido,i
136,0211-699501013259,folico,i
136,0211-699501013259,y,o
136,0211-699501013259,vitamina,i
136,0211-699501013259,B6,i
136,0211-699501013259,aunque,o
136,0211-699501013259,inicialmente,o
136,0211-699501013259,se,o
136,0211-699501013259,reduce,o
136,0211-699501013259,la,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,esta,o
136,0211-699501013259,respuesta,o
136,0211-699501013259,se,o
136,0211-699501013259,hace,o
136,0211-699501013259,refractaria,o
136,0211-699501013259,correlacionandose,o
136,0211-699501013259,directamente,o
136,0211-699501013259,la,o
136,0211-699501013259,tHcy,i
136,0211-699501013259,con,o
136,0211-699501013259,la,o
136,0211-699501013259,albumina,i
136,0211-699501013259,plasmatica,i
136,0211-699501013259,La,o
136,0211-699501013259,interpretacion,o
136,0211-699501013259,de,o
136,0211-699501013259,los,o
136,0211-699501013259,niveles,i
136,0211-699501013259,de,i
136,0211-699501013259,tHcy,i
136,0211-699501013259,debe,o
136,0211-699501013259,tener,o
136,0211-699501013259,en,o
136,0211-699501013259,cuenta,o
136,0211-699501013259,la,o
136,0211-699501013259,concentracion,i
136,0211-699501013259,de,i
136,0211-699501013259,albumina,i
137,0211-699501013259,Efecto,o
137,0211-699501013259,de,o
137,0211-699501013259,la,o
137,0211-699501013259,suplementacion,i
137,0211-699501013259,con,o
137,0211-699501013259,acido,i
137,0211-699501013259,folico,i
137,0211-699501013259,sobre,o
137,0211-699501013259,los,o
137,0211-699501013259,niveles,i
137,0211-699501013259,de,i
137,0211-699501013259,homocisteina,i
137,0211-699501013259,total,o
137,0211-699501013259,en,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,en,o
137,0211-699501013259,hemodialisis,i
137,0211-699501013259,La,o
137,0211-699501013259,hiperhomocisteinemia,i
137,0211-699501013259,es,o
137,0211-699501013259,un,o
137,0211-699501013259,marcador,o
137,0211-699501013259,de,o
137,0211-699501013259,riesgo,o
137,0211-699501013259,independiente,o
137,0211-699501013259,de,o
137,0211-699501013259,morbimortalidad,o
137,0211-699501013259,cardiovascular,i
137,0211-699501013259,Hemos,o
137,0211-699501013259,intentado,o
137,0211-699501013259,prospectivamente,o
137,0211-699501013259,reducir,o
137,0211-699501013259,los,o
137,0211-699501013259,niveles,i
137,0211-699501013259,de,i
137,0211-699501013259,homocisteina,i
137,0211-699501013259,total,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,mediante,o
137,0211-699501013259,suplemento,o
137,0211-699501013259,con,o
137,0211-699501013259,acido,i
137,0211-699501013259,folico,i
137,0211-699501013259,y,o
137,0211-699501013259,vitamina,i
137,0211-699501013259,B6,i
137,0211-699501013259,pp,i
137,0211-699501013259,valorando,o
137,0211-699501013259,su,o
137,0211-699501013259,posible,o
137,0211-699501013259,correlacion,o
137,0211-699501013259,con,o
137,0211-699501013259,dosis,o
137,0211-699501013259,de,o
137,0211-699501013259,dialisis,i
137,0211-699501013259,funcion,i
137,0211-699501013259,residual,i
137,0211-699501013259,y,o
137,0211-699501013259,parametros,o
137,0211-699501013259,nutricionales,o
137,0211-699501013259,Metodos,o
137,0211-699501013259,Todos,o
137,0211-699501013259,los,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,en,o
137,0211-699501013259,hemodialisis,i
137,0211-699501013259,al,o
137,0211-699501013259,comienzo,o
137,0211-699501013259,del,o
137,0211-699501013259,estudio,o
137,0211-699501013259,que,o
137,0211-699501013259,no,o
137,0211-699501013259,recibian,o
137,0211-699501013259,acido,i
137,0211-699501013259,folico,i
137,0211-699501013259,ni,o
137,0211-699501013259,vitamina,i
137,0211-699501013259,B6,i
137,0211-699501013259,asi,o
137,0211-699501013259,como,o
137,0211-699501013259,los,o
137,0211-699501013259,incorporados,o
137,0211-699501013259,posteriormente,o
137,0211-699501013259,a,o
137,0211-699501013259,partir,o
137,0211-699501013259,de,o
137,0211-699501013259,su,o
137,0211-699501013259,tercer,o
137,0211-699501013259,mes,o
137,0211-699501013259,en,o
137,0211-699501013259,hemodialisis,i
137,0211-699501013259,recibieron,o
137,0211-699501013259,5,o
137,0211-699501013259,mg,o
137,0211-699501013259,orales,o
137,0211-699501013259,de,o
137,0211-699501013259,acido,i
137,0211-699501013259,folico,i
137,0211-699501013259,cada,o
137,0211-699501013259,48,o
137,0211-699501013259,horas,o
137,0211-699501013259,y,o
137,0211-699501013259,40,o
137,0211-699501013259,mg,o
137,0211-699501013259,orales,o
137,0211-699501013259,de,o
137,0211-699501013259,vitamina,i
137,0211-699501013259,B6,i
137,0211-699501013259,cada,o
137,0211-699501013259,semana,o
137,0211-699501013259,Se,o
137,0211-699501013259,determinaron,o
137,0211-699501013259,al,o
137,0211-699501013259,comienzo,o
137,0211-699501013259,del,o
137,0211-699501013259,estudio,o
137,0211-699501013259,y,o
137,0211-699501013259,cada,o
137,0211-699501013259,2,o
137,0211-699501013259,meses,o
137,0211-699501013259,niveles,i
137,0211-699501013259,de,i
137,0211-699501013259,folato,i
137,0211-699501013259,vitamina,i
137,0211-699501013259,B12,i
137,0211-699501013259,inmunoensayo,i
137,0211-699501013259,albumina,i
137,0211-699501013259,y,o
137,0211-699501013259,cinetica,o
137,0211-699501013259,de,o
137,0211-699501013259,la,o
137,0211-699501013259,urea,i
137,0211-699501013259,KTV,o
137,0211-699501013259,KRU,o
137,0211-699501013259,PCRn,o
137,0211-699501013259,y,o
137,0211-699501013259,cada,o
137,0211-699501013259,6,o
137,0211-699501013259,meses,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,HPLC,i
137,0211-699501013259,y,o
137,0211-699501013259,pp,i
137,0211-699501013259,RIA,i
137,0211-699501013259,Resultados,o
137,0211-699501013259,80,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,fueron,o
137,0211-699501013259,incluidos,o
137,0211-699501013259,en,o
137,0211-699501013259,el,o
137,0211-699501013259,estudio,o
137,0211-699501013259,basal,o
137,0211-699501013259,con,o
137,0211-699501013259,una,o
137,0211-699501013259,prevalencia,o
137,0211-699501013259,de,o
137,0211-699501013259,hiperhomocisteinemia,i
137,0211-699501013259,del,o
137,0211-699501013259,844,o
137,0211-699501013259,deficit,i
137,0211-699501013259,de,i
137,0211-699501013259,pp,i
137,0211-699501013259,en,o
137,0211-699501013259,el,o
137,0211-699501013259,32,o
137,0211-699501013259,y,o
137,0211-699501013259,folato,i
137,0211-699501013259,en,o
137,0211-699501013259,el,o
137,0211-699501013259,rango,o
137,0211-699501013259,normal,o
137,0211-699501013259,bajo,o
137,0211-699501013259,los,o
137,0211-699501013259,niveles,i
137,0211-699501013259,de,i
137,0211-699501013259,tHcy,i
137,0211-699501013259,se,o
137,0211-699501013259,correlacionaban,o
137,0211-699501013259,inversamente,o
137,0211-699501013259,con,o
137,0211-699501013259,los,o
137,0211-699501013259,del,o
137,0211-699501013259,folato,i
137,0211-699501013259,r,o
137,0211-699501013259,0336,o
137,0211-699501013259,p,o
137,0211-699501013259,001,o
137,0211-699501013259,pero,o
137,0211-699501013259,no,o
137,0211-699501013259,con,o
137,0211-699501013259,pp,i
137,0211-699501013259,B12,i
137,0211-699501013259,edad,o
137,0211-699501013259,albumina,i
137,0211-699501013259,KTV,o
137,0211-699501013259,KRU,o
137,0211-699501013259,PCRn,o
137,0211-699501013259,Cincuenta,o
137,0211-699501013259,y,o
137,0211-699501013259,ocho,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,recibieron,o
137,0211-699501013259,seis,o
137,0211-699501013259,meses,o
137,0211-699501013259,de,o
137,0211-699501013259,suplementacion,i
137,0211-699501013259,con,o
137,0211-699501013259,normalizacion,o
137,0211-699501013259,del,o
137,0211-699501013259,pp,i
137,0211-699501013259,aumento,o
137,0211-699501013259,del,o
137,0211-699501013259,folato,i
137,0211-699501013259,703,o
137,0211-699501013259,IC,o
137,0211-699501013259,638,o
137,0211-699501013259,795,o
137,0211-699501013259,vs,o
137,0211-699501013259,6181,o
137,0211-699501013259,IC,o
137,0211-699501013259,4447,o
137,0211-699501013259,7811,o
137,0211-699501013259,p,o
137,0211-699501013259,0001,o
137,0211-699501013259,y,o
137,0211-699501013259,descenso,o
137,0211-699501013259,de,o
137,0211-699501013259,la,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,240,o
137,0211-699501013259,IC,o
137,0211-699501013259,213,o
137,0211-699501013259,264,o
137,0211-699501013259,vs,o
137,0211-699501013259,199,o
137,0211-699501013259,IC,o
137,0211-699501013259,175,o
137,0211-699501013259,224,o
137,0211-699501013259,p,o
137,0211-699501013259,005,o
137,0211-699501013259,Han,o
137,0211-699501013259,recibido,o
137,0211-699501013259,suplementacion,i
137,0211-699501013259,durante,o
137,0211-699501013259,12,o
137,0211-699501013259,meses,o
137,0211-699501013259,33,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,pero,o
137,0211-699501013259,a,o
137,0211-699501013259,pesar,o
137,0211-699501013259,de,o
137,0211-699501013259,un,o
137,0211-699501013259,continuo,o
137,0211-699501013259,aumento,o
137,0211-699501013259,del,o
137,0211-699501013259,folato,i
137,0211-699501013259,10078,o
137,0211-699501013259,IC,o
137,0211-699501013259,7481,o
137,0211-699501013259,12674,o
137,0211-699501013259,p,o
137,0211-699501013259,0001,o
137,0211-699501013259,solo,o
137,0211-699501013259,3,o
137,0211-699501013259,pacientes,o
137,0211-699501013259,presentan,o
137,0211-699501013259,niveles,o
137,0211-699501013259,normales,o
137,0211-699501013259,de,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,correlacionandose,o
137,0211-699501013259,directamente,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,con,o
137,0211-699501013259,la,o
137,0211-699501013259,albumina,i
137,0211-699501013259,r,o
137,0211-699501013259,056,o
137,0211-699501013259,p,o
137,0211-699501013259,0001,o
137,0211-699501013259,que,o
137,0211-699501013259,se,o
137,0211-699501013259,elevo,o
137,0211-699501013259,con,o
137,0211-699501013259,respecto,o
137,0211-699501013259,al,o
137,0211-699501013259,inicio,o
137,0211-699501013259,337,o
137,0211-699501013259,IC,o
137,0211-699501013259,327,o
137,0211-699501013259,346,o
137,0211-699501013259,vs,o
137,0211-699501013259,350,o
137,0211-699501013259,IC,o
137,0211-699501013259,337,o
137,0211-699501013259,363,o
137,0211-699501013259,p,o
137,0211-699501013259,005,o
137,0211-699501013259,Conclusion,o
137,0211-699501013259,Tras,o
137,0211-699501013259,suplementacion,i
137,0211-699501013259,con,o
137,0211-699501013259,acido,i
137,0211-699501013259,folico,i
137,0211-699501013259,y,o
137,0211-699501013259,vitamina,i
137,0211-699501013259,B6,i
137,0211-699501013259,aunque,o
137,0211-699501013259,inicialmente,o
137,0211-699501013259,se,o
137,0211-699501013259,reduce,o
137,0211-699501013259,la,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,esta,o
137,0211-699501013259,respuesta,o
137,0211-699501013259,se,o
137,0211-699501013259,hace,o
137,0211-699501013259,refractaria,o
137,0211-699501013259,correlacionandose,o
137,0211-699501013259,directamente,o
137,0211-699501013259,la,o
137,0211-699501013259,tHcy,i
137,0211-699501013259,con,o
137,0211-699501013259,la,o
137,0211-699501013259,albumina,i
137,0211-699501013259,plasmatica,i
137,0211-699501013259,La,o
137,0211-699501013259,interpretacion,o
137,0211-699501013259,de,o
137,0211-699501013259,los,o
137,0211-699501013259,niveles,i
137,0211-699501013259,de,i
137,0211-699501013259,tHcy,i
137,0211-699501013259,debe,o
137,0211-699501013259,tener,o
137,0211-699501013259,en,o
137,0211-699501013259,cuenta,o
137,0211-699501013259,la,o
137,0211-699501013259,concentracion,i
137,0211-699501013259,de,i
137,0211-699501013259,albumina,i
138,0211-699501013259,Efecto,o
138,0211-699501013259,de,o
138,0211-699501013259,la,o
138,0211-699501013259,suplementacion,i
138,0211-699501013259,con,o
138,0211-699501013259,acido,i
138,0211-699501013259,folico,i
138,0211-699501013259,sobre,o
138,0211-699501013259,los,o
138,0211-699501013259,niveles,i
138,0211-699501013259,de,i
138,0211-699501013259,homocisteina,i
138,0211-699501013259,total,o
138,0211-699501013259,en,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,en,o
138,0211-699501013259,hemodialisis,i
138,0211-699501013259,La,o
138,0211-699501013259,hiperhomocisteinemia,i
138,0211-699501013259,es,o
138,0211-699501013259,un,o
138,0211-699501013259,marcador,o
138,0211-699501013259,de,o
138,0211-699501013259,riesgo,o
138,0211-699501013259,independiente,o
138,0211-699501013259,de,o
138,0211-699501013259,morbimortalidad,o
138,0211-699501013259,cardiovascular,i
138,0211-699501013259,Hemos,o
138,0211-699501013259,intentado,o
138,0211-699501013259,prospectivamente,o
138,0211-699501013259,reducir,o
138,0211-699501013259,los,o
138,0211-699501013259,niveles,i
138,0211-699501013259,de,i
138,0211-699501013259,homocisteina,i
138,0211-699501013259,total,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,mediante,o
138,0211-699501013259,suplemento,o
138,0211-699501013259,con,o
138,0211-699501013259,acido,i
138,0211-699501013259,folico,i
138,0211-699501013259,y,o
138,0211-699501013259,vitamina,i
138,0211-699501013259,B6,i
138,0211-699501013259,pp,i
138,0211-699501013259,valorando,o
138,0211-699501013259,su,o
138,0211-699501013259,posible,o
138,0211-699501013259,correlacion,o
138,0211-699501013259,con,o
138,0211-699501013259,dosis,o
138,0211-699501013259,de,o
138,0211-699501013259,dialisis,i
138,0211-699501013259,funcion,i
138,0211-699501013259,residual,i
138,0211-699501013259,y,o
138,0211-699501013259,parametros,o
138,0211-699501013259,nutricionales,o
138,0211-699501013259,Metodos,o
138,0211-699501013259,Todos,o
138,0211-699501013259,los,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,en,o
138,0211-699501013259,hemodialisis,i
138,0211-699501013259,al,o
138,0211-699501013259,comienzo,o
138,0211-699501013259,del,o
138,0211-699501013259,estudio,o
138,0211-699501013259,que,o
138,0211-699501013259,no,o
138,0211-699501013259,recibian,o
138,0211-699501013259,acido,i
138,0211-699501013259,folico,i
138,0211-699501013259,ni,o
138,0211-699501013259,vitamina,i
138,0211-699501013259,B6,i
138,0211-699501013259,asi,o
138,0211-699501013259,como,o
138,0211-699501013259,los,o
138,0211-699501013259,incorporados,o
138,0211-699501013259,posteriormente,o
138,0211-699501013259,a,o
138,0211-699501013259,partir,o
138,0211-699501013259,de,o
138,0211-699501013259,su,o
138,0211-699501013259,tercer,o
138,0211-699501013259,mes,o
138,0211-699501013259,en,o
138,0211-699501013259,hemodialisis,i
138,0211-699501013259,recibieron,o
138,0211-699501013259,5,o
138,0211-699501013259,mg,o
138,0211-699501013259,orales,o
138,0211-699501013259,de,o
138,0211-699501013259,acido,i
138,0211-699501013259,folico,i
138,0211-699501013259,cada,o
138,0211-699501013259,48,o
138,0211-699501013259,horas,o
138,0211-699501013259,y,o
138,0211-699501013259,40,o
138,0211-699501013259,mg,o
138,0211-699501013259,orales,o
138,0211-699501013259,de,o
138,0211-699501013259,vitamina,i
138,0211-699501013259,B6,i
138,0211-699501013259,cada,o
138,0211-699501013259,semana,o
138,0211-699501013259,Se,o
138,0211-699501013259,determinaron,o
138,0211-699501013259,al,o
138,0211-699501013259,comienzo,o
138,0211-699501013259,del,o
138,0211-699501013259,estudio,o
138,0211-699501013259,y,o
138,0211-699501013259,cada,o
138,0211-699501013259,2,o
138,0211-699501013259,meses,o
138,0211-699501013259,niveles,i
138,0211-699501013259,de,i
138,0211-699501013259,folato,i
138,0211-699501013259,vitamina,i
138,0211-699501013259,B12,i
138,0211-699501013259,inmunoensayo,i
138,0211-699501013259,albumina,i
138,0211-699501013259,y,o
138,0211-699501013259,cinetica,o
138,0211-699501013259,de,o
138,0211-699501013259,la,o
138,0211-699501013259,urea,i
138,0211-699501013259,KTV,o
138,0211-699501013259,KRU,o
138,0211-699501013259,PCRn,o
138,0211-699501013259,y,o
138,0211-699501013259,cada,o
138,0211-699501013259,6,o
138,0211-699501013259,meses,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,HPLC,i
138,0211-699501013259,y,o
138,0211-699501013259,pp,i
138,0211-699501013259,RIA,i
138,0211-699501013259,Resultados,o
138,0211-699501013259,80,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,fueron,o
138,0211-699501013259,incluidos,o
138,0211-699501013259,en,o
138,0211-699501013259,el,o
138,0211-699501013259,estudio,o
138,0211-699501013259,basal,o
138,0211-699501013259,con,o
138,0211-699501013259,una,o
138,0211-699501013259,prevalencia,o
138,0211-699501013259,de,o
138,0211-699501013259,hiperhomocisteinemia,i
138,0211-699501013259,del,o
138,0211-699501013259,844,o
138,0211-699501013259,deficit,i
138,0211-699501013259,de,i
138,0211-699501013259,pp,i
138,0211-699501013259,en,o
138,0211-699501013259,el,o
138,0211-699501013259,32,o
138,0211-699501013259,y,o
138,0211-699501013259,folato,i
138,0211-699501013259,en,o
138,0211-699501013259,el,o
138,0211-699501013259,rango,o
138,0211-699501013259,normal,o
138,0211-699501013259,bajo,o
138,0211-699501013259,los,o
138,0211-699501013259,niveles,i
138,0211-699501013259,de,i
138,0211-699501013259,tHcy,i
138,0211-699501013259,se,o
138,0211-699501013259,correlacionaban,o
138,0211-699501013259,inversamente,o
138,0211-699501013259,con,o
138,0211-699501013259,los,o
138,0211-699501013259,del,o
138,0211-699501013259,folato,i
138,0211-699501013259,r,o
138,0211-699501013259,0336,o
138,0211-699501013259,p,o
138,0211-699501013259,001,o
138,0211-699501013259,pero,o
138,0211-699501013259,no,o
138,0211-699501013259,con,o
138,0211-699501013259,pp,i
138,0211-699501013259,B12,i
138,0211-699501013259,edad,o
138,0211-699501013259,albumina,i
138,0211-699501013259,KTV,o
138,0211-699501013259,KRU,o
138,0211-699501013259,PCRn,o
138,0211-699501013259,Cincuenta,o
138,0211-699501013259,y,o
138,0211-699501013259,ocho,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,recibieron,o
138,0211-699501013259,seis,o
138,0211-699501013259,meses,o
138,0211-699501013259,de,o
138,0211-699501013259,suplementacion,i
138,0211-699501013259,con,o
138,0211-699501013259,normalizacion,o
138,0211-699501013259,del,o
138,0211-699501013259,pp,i
138,0211-699501013259,aumento,o
138,0211-699501013259,del,o
138,0211-699501013259,folato,i
138,0211-699501013259,703,o
138,0211-699501013259,IC,o
138,0211-699501013259,638,o
138,0211-699501013259,795,o
138,0211-699501013259,vs,o
138,0211-699501013259,6181,o
138,0211-699501013259,IC,o
138,0211-699501013259,4447,o
138,0211-699501013259,7811,o
138,0211-699501013259,p,o
138,0211-699501013259,0001,o
138,0211-699501013259,y,o
138,0211-699501013259,descenso,o
138,0211-699501013259,de,o
138,0211-699501013259,la,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,240,o
138,0211-699501013259,IC,o
138,0211-699501013259,213,o
138,0211-699501013259,264,o
138,0211-699501013259,vs,o
138,0211-699501013259,199,o
138,0211-699501013259,IC,o
138,0211-699501013259,175,o
138,0211-699501013259,224,o
138,0211-699501013259,p,o
138,0211-699501013259,005,o
138,0211-699501013259,Han,o
138,0211-699501013259,recibido,o
138,0211-699501013259,suplementacion,i
138,0211-699501013259,durante,o
138,0211-699501013259,12,o
138,0211-699501013259,meses,o
138,0211-699501013259,33,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,pero,o
138,0211-699501013259,a,o
138,0211-699501013259,pesar,o
138,0211-699501013259,de,o
138,0211-699501013259,un,o
138,0211-699501013259,continuo,o
138,0211-699501013259,aumento,o
138,0211-699501013259,del,o
138,0211-699501013259,folato,i
138,0211-699501013259,10078,o
138,0211-699501013259,IC,o
138,0211-699501013259,7481,o
138,0211-699501013259,12674,o
138,0211-699501013259,p,o
138,0211-699501013259,0001,o
138,0211-699501013259,solo,o
138,0211-699501013259,3,o
138,0211-699501013259,pacientes,o
138,0211-699501013259,presentan,o
138,0211-699501013259,niveles,o
138,0211-699501013259,normales,o
138,0211-699501013259,de,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,correlacionandose,o
138,0211-699501013259,directamente,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,con,o
138,0211-699501013259,la,o
138,0211-699501013259,albumina,i
138,0211-699501013259,r,o
138,0211-699501013259,056,o
138,0211-699501013259,p,o
138,0211-699501013259,0001,o
138,0211-699501013259,que,o
138,0211-699501013259,se,o
138,0211-699501013259,elevo,o
138,0211-699501013259,con,o
138,0211-699501013259,respecto,o
138,0211-699501013259,al,o
138,0211-699501013259,inicio,o
138,0211-699501013259,337,o
138,0211-699501013259,IC,o
138,0211-699501013259,327,o
138,0211-699501013259,346,o
138,0211-699501013259,vs,o
138,0211-699501013259,350,o
138,0211-699501013259,IC,o
138,0211-699501013259,337,o
138,0211-699501013259,363,o
138,0211-699501013259,p,o
138,0211-699501013259,005,o
138,0211-699501013259,Conclusion,o
138,0211-699501013259,Tras,o
138,0211-699501013259,suplementacion,i
138,0211-699501013259,con,o
138,0211-699501013259,acido,i
138,0211-699501013259,folico,i
138,0211-699501013259,y,o
138,0211-699501013259,vitamina,i
138,0211-699501013259,B6,i
138,0211-699501013259,aunque,o
138,0211-699501013259,inicialmente,o
138,0211-699501013259,se,o
138,0211-699501013259,reduce,o
138,0211-699501013259,la,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,esta,o
138,0211-699501013259,respuesta,o
138,0211-699501013259,se,o
138,0211-699501013259,hace,o
138,0211-699501013259,refractaria,o
138,0211-699501013259,correlacionandose,o
138,0211-699501013259,directamente,o
138,0211-699501013259,la,o
138,0211-699501013259,tHcy,i
138,0211-699501013259,con,o
138,0211-699501013259,la,o
138,0211-699501013259,albumina,i
138,0211-699501013259,plasmatica,i
138,0211-699501013259,La,o
138,0211-699501013259,interpretacion,o
138,0211-699501013259,de,o
138,0211-699501013259,los,o
138,0211-699501013259,niveles,i
138,0211-699501013259,de,i
138,0211-699501013259,tHcy,i
138,0211-699501013259,debe,o
138,0211-699501013259,tener,o
138,0211-699501013259,en,o
138,0211-699501013259,cuenta,o
138,0211-699501013259,la,o
138,0211-699501013259,concentracion,i
138,0211-699501013259,de,i
138,0211-699501013259,albumina,i
139,0211-699501013259,Efecto,o
139,0211-699501013259,de,o
139,0211-699501013259,la,o
139,0211-699501013259,suplementacion,i
139,0211-699501013259,con,o
139,0211-699501013259,acido,i
139,0211-699501013259,folico,i
139,0211-699501013259,sobre,o
139,0211-699501013259,los,o
139,0211-699501013259,niveles,i
139,0211-699501013259,de,i
139,0211-699501013259,homocisteina,i
139,0211-699501013259,total,o
139,0211-699501013259,en,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,en,o
139,0211-699501013259,hemodialisis,i
139,0211-699501013259,La,o
139,0211-699501013259,hiperhomocisteinemia,i
139,0211-699501013259,es,o
139,0211-699501013259,un,o
139,0211-699501013259,marcador,o
139,0211-699501013259,de,o
139,0211-699501013259,riesgo,o
139,0211-699501013259,independiente,o
139,0211-699501013259,de,o
139,0211-699501013259,morbimortalidad,o
139,0211-699501013259,cardiovascular,i
139,0211-699501013259,Hemos,o
139,0211-699501013259,intentado,o
139,0211-699501013259,prospectivamente,o
139,0211-699501013259,reducir,o
139,0211-699501013259,los,o
139,0211-699501013259,niveles,i
139,0211-699501013259,de,i
139,0211-699501013259,homocisteina,i
139,0211-699501013259,total,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,mediante,o
139,0211-699501013259,suplemento,o
139,0211-699501013259,con,o
139,0211-699501013259,acido,i
139,0211-699501013259,folico,i
139,0211-699501013259,y,o
139,0211-699501013259,vitamina,i
139,0211-699501013259,B6,i
139,0211-699501013259,pp,i
139,0211-699501013259,valorando,o
139,0211-699501013259,su,o
139,0211-699501013259,posible,o
139,0211-699501013259,correlacion,o
139,0211-699501013259,con,o
139,0211-699501013259,dosis,o
139,0211-699501013259,de,o
139,0211-699501013259,dialisis,i
139,0211-699501013259,funcion,i
139,0211-699501013259,residual,i
139,0211-699501013259,y,o
139,0211-699501013259,parametros,o
139,0211-699501013259,nutricionales,o
139,0211-699501013259,Metodos,o
139,0211-699501013259,Todos,o
139,0211-699501013259,los,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,en,o
139,0211-699501013259,hemodialisis,i
139,0211-699501013259,al,o
139,0211-699501013259,comienzo,o
139,0211-699501013259,del,o
139,0211-699501013259,estudio,o
139,0211-699501013259,que,o
139,0211-699501013259,no,o
139,0211-699501013259,recibian,o
139,0211-699501013259,acido,i
139,0211-699501013259,folico,i
139,0211-699501013259,ni,o
139,0211-699501013259,vitamina,i
139,0211-699501013259,B6,i
139,0211-699501013259,asi,o
139,0211-699501013259,como,o
139,0211-699501013259,los,o
139,0211-699501013259,incorporados,o
139,0211-699501013259,posteriormente,o
139,0211-699501013259,a,o
139,0211-699501013259,partir,o
139,0211-699501013259,de,o
139,0211-699501013259,su,o
139,0211-699501013259,tercer,o
139,0211-699501013259,mes,o
139,0211-699501013259,en,o
139,0211-699501013259,hemodialisis,i
139,0211-699501013259,recibieron,o
139,0211-699501013259,5,o
139,0211-699501013259,mg,o
139,0211-699501013259,orales,o
139,0211-699501013259,de,o
139,0211-699501013259,acido,i
139,0211-699501013259,folico,i
139,0211-699501013259,cada,o
139,0211-699501013259,48,o
139,0211-699501013259,horas,o
139,0211-699501013259,y,o
139,0211-699501013259,40,o
139,0211-699501013259,mg,o
139,0211-699501013259,orales,o
139,0211-699501013259,de,o
139,0211-699501013259,vitamina,i
139,0211-699501013259,B6,i
139,0211-699501013259,cada,o
139,0211-699501013259,semana,o
139,0211-699501013259,Se,o
139,0211-699501013259,determinaron,o
139,0211-699501013259,al,o
139,0211-699501013259,comienzo,o
139,0211-699501013259,del,o
139,0211-699501013259,estudio,o
139,0211-699501013259,y,o
139,0211-699501013259,cada,o
139,0211-699501013259,2,o
139,0211-699501013259,meses,o
139,0211-699501013259,niveles,i
139,0211-699501013259,de,i
139,0211-699501013259,folato,i
139,0211-699501013259,vitamina,i
139,0211-699501013259,B12,i
139,0211-699501013259,inmunoensayo,i
139,0211-699501013259,albumina,i
139,0211-699501013259,y,o
139,0211-699501013259,cinetica,o
139,0211-699501013259,de,o
139,0211-699501013259,la,o
139,0211-699501013259,urea,i
139,0211-699501013259,KTV,o
139,0211-699501013259,KRU,o
139,0211-699501013259,PCRn,o
139,0211-699501013259,y,o
139,0211-699501013259,cada,o
139,0211-699501013259,6,o
139,0211-699501013259,meses,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,HPLC,i
139,0211-699501013259,y,o
139,0211-699501013259,pp,i
139,0211-699501013259,RIA,i
139,0211-699501013259,Resultados,o
139,0211-699501013259,80,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,fueron,o
139,0211-699501013259,incluidos,o
139,0211-699501013259,en,o
139,0211-699501013259,el,o
139,0211-699501013259,estudio,o
139,0211-699501013259,basal,o
139,0211-699501013259,con,o
139,0211-699501013259,una,o
139,0211-699501013259,prevalencia,o
139,0211-699501013259,de,o
139,0211-699501013259,hiperhomocisteinemia,i
139,0211-699501013259,del,o
139,0211-699501013259,844,o
139,0211-699501013259,deficit,i
139,0211-699501013259,de,i
139,0211-699501013259,pp,i
139,0211-699501013259,en,o
139,0211-699501013259,el,o
139,0211-699501013259,32,o
139,0211-699501013259,y,o
139,0211-699501013259,folato,i
139,0211-699501013259,en,o
139,0211-699501013259,el,o
139,0211-699501013259,rango,o
139,0211-699501013259,normal,o
139,0211-699501013259,bajo,o
139,0211-699501013259,los,o
139,0211-699501013259,niveles,i
139,0211-699501013259,de,i
139,0211-699501013259,tHcy,i
139,0211-699501013259,se,o
139,0211-699501013259,correlacionaban,o
139,0211-699501013259,inversamente,o
139,0211-699501013259,con,o
139,0211-699501013259,los,o
139,0211-699501013259,del,o
139,0211-699501013259,folato,i
139,0211-699501013259,r,o
139,0211-699501013259,0336,o
139,0211-699501013259,p,o
139,0211-699501013259,001,o
139,0211-699501013259,pero,o
139,0211-699501013259,no,o
139,0211-699501013259,con,o
139,0211-699501013259,pp,i
139,0211-699501013259,B12,i
139,0211-699501013259,edad,o
139,0211-699501013259,albumina,i
139,0211-699501013259,KTV,o
139,0211-699501013259,KRU,o
139,0211-699501013259,PCRn,o
139,0211-699501013259,Cincuenta,o
139,0211-699501013259,y,o
139,0211-699501013259,ocho,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,recibieron,o
139,0211-699501013259,seis,o
139,0211-699501013259,meses,o
139,0211-699501013259,de,o
139,0211-699501013259,suplementacion,i
139,0211-699501013259,con,o
139,0211-699501013259,normalizacion,o
139,0211-699501013259,del,o
139,0211-699501013259,pp,i
139,0211-699501013259,aumento,o
139,0211-699501013259,del,o
139,0211-699501013259,folato,i
139,0211-699501013259,703,o
139,0211-699501013259,IC,o
139,0211-699501013259,638,o
139,0211-699501013259,795,o
139,0211-699501013259,vs,o
139,0211-699501013259,6181,o
139,0211-699501013259,IC,o
139,0211-699501013259,4447,o
139,0211-699501013259,7811,o
139,0211-699501013259,p,o
139,0211-699501013259,0001,o
139,0211-699501013259,y,o
139,0211-699501013259,descenso,o
139,0211-699501013259,de,o
139,0211-699501013259,la,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,240,o
139,0211-699501013259,IC,o
139,0211-699501013259,213,o
139,0211-699501013259,264,o
139,0211-699501013259,vs,o
139,0211-699501013259,199,o
139,0211-699501013259,IC,o
139,0211-699501013259,175,o
139,0211-699501013259,224,o
139,0211-699501013259,p,o
139,0211-699501013259,005,o
139,0211-699501013259,Han,o
139,0211-699501013259,recibido,o
139,0211-699501013259,suplementacion,i
139,0211-699501013259,durante,o
139,0211-699501013259,12,o
139,0211-699501013259,meses,o
139,0211-699501013259,33,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,pero,o
139,0211-699501013259,a,o
139,0211-699501013259,pesar,o
139,0211-699501013259,de,o
139,0211-699501013259,un,o
139,0211-699501013259,continuo,o
139,0211-699501013259,aumento,o
139,0211-699501013259,del,o
139,0211-699501013259,folato,i
139,0211-699501013259,10078,o
139,0211-699501013259,IC,o
139,0211-699501013259,7481,o
139,0211-699501013259,12674,o
139,0211-699501013259,p,o
139,0211-699501013259,0001,o
139,0211-699501013259,solo,o
139,0211-699501013259,3,o
139,0211-699501013259,pacientes,o
139,0211-699501013259,presentan,o
139,0211-699501013259,niveles,o
139,0211-699501013259,normales,o
139,0211-699501013259,de,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,correlacionandose,o
139,0211-699501013259,directamente,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,con,o
139,0211-699501013259,la,o
139,0211-699501013259,albumina,i
139,0211-699501013259,r,o
139,0211-699501013259,056,o
139,0211-699501013259,p,o
139,0211-699501013259,0001,o
139,0211-699501013259,que,o
139,0211-699501013259,se,o
139,0211-699501013259,elevo,o
139,0211-699501013259,con,o
139,0211-699501013259,respecto,o
139,0211-699501013259,al,o
139,0211-699501013259,inicio,o
139,0211-699501013259,337,o
139,0211-699501013259,IC,o
139,0211-699501013259,327,o
139,0211-699501013259,346,o
139,0211-699501013259,vs,o
139,0211-699501013259,350,o
139,0211-699501013259,IC,o
139,0211-699501013259,337,o
139,0211-699501013259,363,o
139,0211-699501013259,p,o
139,0211-699501013259,005,o
139,0211-699501013259,Conclusion,o
139,0211-699501013259,Tras,o
139,0211-699501013259,suplementacion,i
139,0211-699501013259,con,o
139,0211-699501013259,acido,i
139,0211-699501013259,folico,i
139,0211-699501013259,y,o
139,0211-699501013259,vitamina,i
139,0211-699501013259,B6,i
139,0211-699501013259,aunque,o
139,0211-699501013259,inicialmente,o
139,0211-699501013259,se,o
139,0211-699501013259,reduce,o
139,0211-699501013259,la,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,esta,o
139,0211-699501013259,respuesta,o
139,0211-699501013259,se,o
139,0211-699501013259,hace,o
139,0211-699501013259,refractaria,o
139,0211-699501013259,correlacionandose,o
139,0211-699501013259,directamente,o
139,0211-699501013259,la,o
139,0211-699501013259,tHcy,i
139,0211-699501013259,con,o
139,0211-699501013259,la,o
139,0211-699501013259,albumina,i
139,0211-699501013259,plasmatica,i
139,0211-699501013259,La,o
139,0211-699501013259,interpretacion,o
139,0211-699501013259,de,o
139,0211-699501013259,los,o
139,0211-699501013259,niveles,i
139,0211-699501013259,de,i
139,0211-699501013259,tHcy,i
139,0211-699501013259,debe,o
139,0211-699501013259,tener,o
139,0211-699501013259,en,o
139,0211-699501013259,cuenta,o
139,0211-699501013259,la,o
139,0211-699501013259,concentracion,i
139,0211-699501013259,de,i
139,0211-699501013259,albumina,i
140,0211-699501013259,Efecto,o
140,0211-699501013259,de,o
140,0211-699501013259,la,o
140,0211-699501013259,suplementacion,i
140,0211-699501013259,con,o
140,0211-699501013259,acido,i
140,0211-699501013259,folico,i
140,0211-699501013259,sobre,o
140,0211-699501013259,los,o
140,0211-699501013259,niveles,i
140,0211-699501013259,de,i
140,0211-699501013259,homocisteina,i
140,0211-699501013259,total,o
140,0211-699501013259,en,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,en,o
140,0211-699501013259,hemodialisis,i
140,0211-699501013259,La,o
140,0211-699501013259,hiperhomocisteinemia,i
140,0211-699501013259,es,o
140,0211-699501013259,un,o
140,0211-699501013259,marcador,o
140,0211-699501013259,de,o
140,0211-699501013259,riesgo,o
140,0211-699501013259,independiente,o
140,0211-699501013259,de,o
140,0211-699501013259,morbimortalidad,o
140,0211-699501013259,cardiovascular,i
140,0211-699501013259,Hemos,o
140,0211-699501013259,intentado,o
140,0211-699501013259,prospectivamente,o
140,0211-699501013259,reducir,o
140,0211-699501013259,los,o
140,0211-699501013259,niveles,i
140,0211-699501013259,de,i
140,0211-699501013259,homocisteina,i
140,0211-699501013259,total,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,mediante,o
140,0211-699501013259,suplemento,o
140,0211-699501013259,con,o
140,0211-699501013259,acido,i
140,0211-699501013259,folico,i
140,0211-699501013259,y,o
140,0211-699501013259,vitamina,i
140,0211-699501013259,B6,i
140,0211-699501013259,pp,i
140,0211-699501013259,valorando,o
140,0211-699501013259,su,o
140,0211-699501013259,posible,o
140,0211-699501013259,correlacion,o
140,0211-699501013259,con,o
140,0211-699501013259,dosis,o
140,0211-699501013259,de,o
140,0211-699501013259,dialisis,i
140,0211-699501013259,funcion,i
140,0211-699501013259,residual,i
140,0211-699501013259,y,o
140,0211-699501013259,parametros,o
140,0211-699501013259,nutricionales,o
140,0211-699501013259,Metodos,o
140,0211-699501013259,Todos,o
140,0211-699501013259,los,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,en,o
140,0211-699501013259,hemodialisis,i
140,0211-699501013259,al,o
140,0211-699501013259,comienzo,o
140,0211-699501013259,del,o
140,0211-699501013259,estudio,o
140,0211-699501013259,que,o
140,0211-699501013259,no,o
140,0211-699501013259,recibian,o
140,0211-699501013259,acido,i
140,0211-699501013259,folico,i
140,0211-699501013259,ni,o
140,0211-699501013259,vitamina,i
140,0211-699501013259,B6,i
140,0211-699501013259,asi,o
140,0211-699501013259,como,o
140,0211-699501013259,los,o
140,0211-699501013259,incorporados,o
140,0211-699501013259,posteriormente,o
140,0211-699501013259,a,o
140,0211-699501013259,partir,o
140,0211-699501013259,de,o
140,0211-699501013259,su,o
140,0211-699501013259,tercer,o
140,0211-699501013259,mes,o
140,0211-699501013259,en,o
140,0211-699501013259,hemodialisis,i
140,0211-699501013259,recibieron,o
140,0211-699501013259,5,o
140,0211-699501013259,mg,o
140,0211-699501013259,orales,o
140,0211-699501013259,de,o
140,0211-699501013259,acido,i
140,0211-699501013259,folico,i
140,0211-699501013259,cada,o
140,0211-699501013259,48,o
140,0211-699501013259,horas,o
140,0211-699501013259,y,o
140,0211-699501013259,40,o
140,0211-699501013259,mg,o
140,0211-699501013259,orales,o
140,0211-699501013259,de,o
140,0211-699501013259,vitamina,i
140,0211-699501013259,B6,i
140,0211-699501013259,cada,o
140,0211-699501013259,semana,o
140,0211-699501013259,Se,o
140,0211-699501013259,determinaron,o
140,0211-699501013259,al,o
140,0211-699501013259,comienzo,o
140,0211-699501013259,del,o
140,0211-699501013259,estudio,o
140,0211-699501013259,y,o
140,0211-699501013259,cada,o
140,0211-699501013259,2,o
140,0211-699501013259,meses,o
140,0211-699501013259,niveles,i
140,0211-699501013259,de,i
140,0211-699501013259,folato,i
140,0211-699501013259,vitamina,i
140,0211-699501013259,B12,i
140,0211-699501013259,inmunoensayo,i
140,0211-699501013259,albumina,i
140,0211-699501013259,y,o
140,0211-699501013259,cinetica,o
140,0211-699501013259,de,o
140,0211-699501013259,la,o
140,0211-699501013259,urea,i
140,0211-699501013259,KTV,o
140,0211-699501013259,KRU,o
140,0211-699501013259,PCRn,o
140,0211-699501013259,y,o
140,0211-699501013259,cada,o
140,0211-699501013259,6,o
140,0211-699501013259,meses,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,HPLC,i
140,0211-699501013259,y,o
140,0211-699501013259,pp,i
140,0211-699501013259,RIA,i
140,0211-699501013259,Resultados,o
140,0211-699501013259,80,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,fueron,o
140,0211-699501013259,incluidos,o
140,0211-699501013259,en,o
140,0211-699501013259,el,o
140,0211-699501013259,estudio,o
140,0211-699501013259,basal,o
140,0211-699501013259,con,o
140,0211-699501013259,una,o
140,0211-699501013259,prevalencia,o
140,0211-699501013259,de,o
140,0211-699501013259,hiperhomocisteinemia,i
140,0211-699501013259,del,o
140,0211-699501013259,844,o
140,0211-699501013259,deficit,i
140,0211-699501013259,de,i
140,0211-699501013259,pp,i
140,0211-699501013259,en,o
140,0211-699501013259,el,o
140,0211-699501013259,32,o
140,0211-699501013259,y,o
140,0211-699501013259,folato,i
140,0211-699501013259,en,o
140,0211-699501013259,el,o
140,0211-699501013259,rango,o
140,0211-699501013259,normal,o
140,0211-699501013259,bajo,o
140,0211-699501013259,los,o
140,0211-699501013259,niveles,i
140,0211-699501013259,de,i
140,0211-699501013259,tHcy,i
140,0211-699501013259,se,o
140,0211-699501013259,correlacionaban,o
140,0211-699501013259,inversamente,o
140,0211-699501013259,con,o
140,0211-699501013259,los,o
140,0211-699501013259,del,o
140,0211-699501013259,folato,i
140,0211-699501013259,r,o
140,0211-699501013259,0336,o
140,0211-699501013259,p,o
140,0211-699501013259,001,o
140,0211-699501013259,pero,o
140,0211-699501013259,no,o
140,0211-699501013259,con,o
140,0211-699501013259,pp,i
140,0211-699501013259,B12,i
140,0211-699501013259,edad,o
140,0211-699501013259,albumina,i
140,0211-699501013259,KTV,o
140,0211-699501013259,KRU,o
140,0211-699501013259,PCRn,o
140,0211-699501013259,Cincuenta,o
140,0211-699501013259,y,o
140,0211-699501013259,ocho,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,recibieron,o
140,0211-699501013259,seis,o
140,0211-699501013259,meses,o
140,0211-699501013259,de,o
140,0211-699501013259,suplementacion,i
140,0211-699501013259,con,o
140,0211-699501013259,normalizacion,o
140,0211-699501013259,del,o
140,0211-699501013259,pp,i
140,0211-699501013259,aumento,o
140,0211-699501013259,del,o
140,0211-699501013259,folato,i
140,0211-699501013259,703,o
140,0211-699501013259,IC,o
140,0211-699501013259,638,o
140,0211-699501013259,795,o
140,0211-699501013259,vs,o
140,0211-699501013259,6181,o
140,0211-699501013259,IC,o
140,0211-699501013259,4447,o
140,0211-699501013259,7811,o
140,0211-699501013259,p,o
140,0211-699501013259,0001,o
140,0211-699501013259,y,o
140,0211-699501013259,descenso,o
140,0211-699501013259,de,o
140,0211-699501013259,la,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,240,o
140,0211-699501013259,IC,o
140,0211-699501013259,213,o
140,0211-699501013259,264,o
140,0211-699501013259,vs,o
140,0211-699501013259,199,o
140,0211-699501013259,IC,o
140,0211-699501013259,175,o
140,0211-699501013259,224,o
140,0211-699501013259,p,o
140,0211-699501013259,005,o
140,0211-699501013259,Han,o
140,0211-699501013259,recibido,o
140,0211-699501013259,suplementacion,i
140,0211-699501013259,durante,o
140,0211-699501013259,12,o
140,0211-699501013259,meses,o
140,0211-699501013259,33,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,pero,o
140,0211-699501013259,a,o
140,0211-699501013259,pesar,o
140,0211-699501013259,de,o
140,0211-699501013259,un,o
140,0211-699501013259,continuo,o
140,0211-699501013259,aumento,o
140,0211-699501013259,del,o
140,0211-699501013259,folato,i
140,0211-699501013259,10078,o
140,0211-699501013259,IC,o
140,0211-699501013259,7481,o
140,0211-699501013259,12674,o
140,0211-699501013259,p,o
140,0211-699501013259,0001,o
140,0211-699501013259,solo,o
140,0211-699501013259,3,o
140,0211-699501013259,pacientes,o
140,0211-699501013259,presentan,o
140,0211-699501013259,niveles,o
140,0211-699501013259,normales,o
140,0211-699501013259,de,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,correlacionandose,o
140,0211-699501013259,directamente,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,con,o
140,0211-699501013259,la,o
140,0211-699501013259,albumina,i
140,0211-699501013259,r,o
140,0211-699501013259,056,o
140,0211-699501013259,p,o
140,0211-699501013259,0001,o
140,0211-699501013259,que,o
140,0211-699501013259,se,o
140,0211-699501013259,elevo,o
140,0211-699501013259,con,o
140,0211-699501013259,respecto,o
140,0211-699501013259,al,o
140,0211-699501013259,inicio,o
140,0211-699501013259,337,o
140,0211-699501013259,IC,o
140,0211-699501013259,327,o
140,0211-699501013259,346,o
140,0211-699501013259,vs,o
140,0211-699501013259,350,o
140,0211-699501013259,IC,o
140,0211-699501013259,337,o
140,0211-699501013259,363,o
140,0211-699501013259,p,o
140,0211-699501013259,005,o
140,0211-699501013259,Conclusion,o
140,0211-699501013259,Tras,o
140,0211-699501013259,suplementacion,i
140,0211-699501013259,con,o
140,0211-699501013259,acido,i
140,0211-699501013259,folico,i
140,0211-699501013259,y,o
140,0211-699501013259,vitamina,i
140,0211-699501013259,B6,i
140,0211-699501013259,aunque,o
140,0211-699501013259,inicialmente,o
140,0211-699501013259,se,o
140,0211-699501013259,reduce,o
140,0211-699501013259,la,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,esta,o
140,0211-699501013259,respuesta,o
140,0211-699501013259,se,o
140,0211-699501013259,hace,o
140,0211-699501013259,refractaria,o
140,0211-699501013259,correlacionandose,o
140,0211-699501013259,directamente,o
140,0211-699501013259,la,o
140,0211-699501013259,tHcy,i
140,0211-699501013259,con,o
140,0211-699501013259,la,o
140,0211-699501013259,albumina,i
140,0211-699501013259,plasmatica,i
140,0211-699501013259,La,o
140,0211-699501013259,interpretacion,o
140,0211-699501013259,de,o
140,0211-699501013259,los,o
140,0211-699501013259,niveles,i
140,0211-699501013259,de,i
140,0211-699501013259,tHcy,i
140,0211-699501013259,debe,o
140,0211-699501013259,tener,o
140,0211-699501013259,en,o
140,0211-699501013259,cuenta,o
140,0211-699501013259,la,o
140,0211-699501013259,concentracion,i
140,0211-699501013259,de,i
140,0211-699501013259,albumina,i
141,0211-699501013259,Efecto,o
141,0211-699501013259,de,o
141,0211-699501013259,la,o
141,0211-699501013259,suplementacion,i
141,0211-699501013259,con,o
141,0211-699501013259,acido,i
141,0211-699501013259,folico,i
141,0211-699501013259,sobre,o
141,0211-699501013259,los,o
141,0211-699501013259,niveles,i
141,0211-699501013259,de,i
141,0211-699501013259,homocisteina,i
141,0211-699501013259,total,o
141,0211-699501013259,en,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,en,o
141,0211-699501013259,hemodialisis,i
141,0211-699501013259,La,o
141,0211-699501013259,hiperhomocisteinemia,i
141,0211-699501013259,es,o
141,0211-699501013259,un,o
141,0211-699501013259,marcador,o
141,0211-699501013259,de,o
141,0211-699501013259,riesgo,o
141,0211-699501013259,independiente,o
141,0211-699501013259,de,o
141,0211-699501013259,morbimortalidad,o
141,0211-699501013259,cardiovascular,i
141,0211-699501013259,Hemos,o
141,0211-699501013259,intentado,o
141,0211-699501013259,prospectivamente,o
141,0211-699501013259,reducir,o
141,0211-699501013259,los,o
141,0211-699501013259,niveles,i
141,0211-699501013259,de,i
141,0211-699501013259,homocisteina,i
141,0211-699501013259,total,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,mediante,o
141,0211-699501013259,suplemento,o
141,0211-699501013259,con,o
141,0211-699501013259,acido,i
141,0211-699501013259,folico,i
141,0211-699501013259,y,o
141,0211-699501013259,vitamina,i
141,0211-699501013259,B6,i
141,0211-699501013259,pp,i
141,0211-699501013259,valorando,o
141,0211-699501013259,su,o
141,0211-699501013259,posible,o
141,0211-699501013259,correlacion,o
141,0211-699501013259,con,o
141,0211-699501013259,dosis,o
141,0211-699501013259,de,o
141,0211-699501013259,dialisis,i
141,0211-699501013259,funcion,i
141,0211-699501013259,residual,i
141,0211-699501013259,y,o
141,0211-699501013259,parametros,o
141,0211-699501013259,nutricionales,o
141,0211-699501013259,Metodos,o
141,0211-699501013259,Todos,o
141,0211-699501013259,los,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,en,o
141,0211-699501013259,hemodialisis,i
141,0211-699501013259,al,o
141,0211-699501013259,comienzo,o
141,0211-699501013259,del,o
141,0211-699501013259,estudio,o
141,0211-699501013259,que,o
141,0211-699501013259,no,o
141,0211-699501013259,recibian,o
141,0211-699501013259,acido,i
141,0211-699501013259,folico,i
141,0211-699501013259,ni,o
141,0211-699501013259,vitamina,i
141,0211-699501013259,B6,i
141,0211-699501013259,asi,o
141,0211-699501013259,como,o
141,0211-699501013259,los,o
141,0211-699501013259,incorporados,o
141,0211-699501013259,posteriormente,o
141,0211-699501013259,a,o
141,0211-699501013259,partir,o
141,0211-699501013259,de,o
141,0211-699501013259,su,o
141,0211-699501013259,tercer,o
141,0211-699501013259,mes,o
141,0211-699501013259,en,o
141,0211-699501013259,hemodialisis,i
141,0211-699501013259,recibieron,o
141,0211-699501013259,5,o
141,0211-699501013259,mg,o
141,0211-699501013259,orales,o
141,0211-699501013259,de,o
141,0211-699501013259,acido,i
141,0211-699501013259,folico,i
141,0211-699501013259,cada,o
141,0211-699501013259,48,o
141,0211-699501013259,horas,o
141,0211-699501013259,y,o
141,0211-699501013259,40,o
141,0211-699501013259,mg,o
141,0211-699501013259,orales,o
141,0211-699501013259,de,o
141,0211-699501013259,vitamina,i
141,0211-699501013259,B6,i
141,0211-699501013259,cada,o
141,0211-699501013259,semana,o
141,0211-699501013259,Se,o
141,0211-699501013259,determinaron,o
141,0211-699501013259,al,o
141,0211-699501013259,comienzo,o
141,0211-699501013259,del,o
141,0211-699501013259,estudio,o
141,0211-699501013259,y,o
141,0211-699501013259,cada,o
141,0211-699501013259,2,o
141,0211-699501013259,meses,o
141,0211-699501013259,niveles,i
141,0211-699501013259,de,i
141,0211-699501013259,folato,i
141,0211-699501013259,vitamina,i
141,0211-699501013259,B12,i
141,0211-699501013259,inmunoensayo,i
141,0211-699501013259,albumina,i
141,0211-699501013259,y,o
141,0211-699501013259,cinetica,o
141,0211-699501013259,de,o
141,0211-699501013259,la,o
141,0211-699501013259,urea,i
141,0211-699501013259,KTV,o
141,0211-699501013259,KRU,o
141,0211-699501013259,PCRn,o
141,0211-699501013259,y,o
141,0211-699501013259,cada,o
141,0211-699501013259,6,o
141,0211-699501013259,meses,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,HPLC,i
141,0211-699501013259,y,o
141,0211-699501013259,pp,i
141,0211-699501013259,RIA,i
141,0211-699501013259,Resultados,o
141,0211-699501013259,80,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,fueron,o
141,0211-699501013259,incluidos,o
141,0211-699501013259,en,o
141,0211-699501013259,el,o
141,0211-699501013259,estudio,o
141,0211-699501013259,basal,o
141,0211-699501013259,con,o
141,0211-699501013259,una,o
141,0211-699501013259,prevalencia,o
141,0211-699501013259,de,o
141,0211-699501013259,hiperhomocisteinemia,i
141,0211-699501013259,del,o
141,0211-699501013259,844,o
141,0211-699501013259,deficit,i
141,0211-699501013259,de,i
141,0211-699501013259,pp,i
141,0211-699501013259,en,o
141,0211-699501013259,el,o
141,0211-699501013259,32,o
141,0211-699501013259,y,o
141,0211-699501013259,folato,i
141,0211-699501013259,en,o
141,0211-699501013259,el,o
141,0211-699501013259,rango,o
141,0211-699501013259,normal,o
141,0211-699501013259,bajo,o
141,0211-699501013259,los,o
141,0211-699501013259,niveles,i
141,0211-699501013259,de,i
141,0211-699501013259,tHcy,i
141,0211-699501013259,se,o
141,0211-699501013259,correlacionaban,o
141,0211-699501013259,inversamente,o
141,0211-699501013259,con,o
141,0211-699501013259,los,o
141,0211-699501013259,del,o
141,0211-699501013259,folato,i
141,0211-699501013259,r,o
141,0211-699501013259,0336,o
141,0211-699501013259,p,o
141,0211-699501013259,001,o
141,0211-699501013259,pero,o
141,0211-699501013259,no,o
141,0211-699501013259,con,o
141,0211-699501013259,pp,i
141,0211-699501013259,B12,i
141,0211-699501013259,edad,o
141,0211-699501013259,albumina,i
141,0211-699501013259,KTV,o
141,0211-699501013259,KRU,o
141,0211-699501013259,PCRn,o
141,0211-699501013259,Cincuenta,o
141,0211-699501013259,y,o
141,0211-699501013259,ocho,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,recibieron,o
141,0211-699501013259,seis,o
141,0211-699501013259,meses,o
141,0211-699501013259,de,o
141,0211-699501013259,suplementacion,i
141,0211-699501013259,con,o
141,0211-699501013259,normalizacion,o
141,0211-699501013259,del,o
141,0211-699501013259,pp,i
141,0211-699501013259,aumento,o
141,0211-699501013259,del,o
141,0211-699501013259,folato,i
141,0211-699501013259,703,o
141,0211-699501013259,IC,o
141,0211-699501013259,638,o
141,0211-699501013259,795,o
141,0211-699501013259,vs,o
141,0211-699501013259,6181,o
141,0211-699501013259,IC,o
141,0211-699501013259,4447,o
141,0211-699501013259,7811,o
141,0211-699501013259,p,o
141,0211-699501013259,0001,o
141,0211-699501013259,y,o
141,0211-699501013259,descenso,o
141,0211-699501013259,de,o
141,0211-699501013259,la,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,240,o
141,0211-699501013259,IC,o
141,0211-699501013259,213,o
141,0211-699501013259,264,o
141,0211-699501013259,vs,o
141,0211-699501013259,199,o
141,0211-699501013259,IC,o
141,0211-699501013259,175,o
141,0211-699501013259,224,o
141,0211-699501013259,p,o
141,0211-699501013259,005,o
141,0211-699501013259,Han,o
141,0211-699501013259,recibido,o
141,0211-699501013259,suplementacion,i
141,0211-699501013259,durante,o
141,0211-699501013259,12,o
141,0211-699501013259,meses,o
141,0211-699501013259,33,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,pero,o
141,0211-699501013259,a,o
141,0211-699501013259,pesar,o
141,0211-699501013259,de,o
141,0211-699501013259,un,o
141,0211-699501013259,continuo,o
141,0211-699501013259,aumento,o
141,0211-699501013259,del,o
141,0211-699501013259,folato,i
141,0211-699501013259,10078,o
141,0211-699501013259,IC,o
141,0211-699501013259,7481,o
141,0211-699501013259,12674,o
141,0211-699501013259,p,o
141,0211-699501013259,0001,o
141,0211-699501013259,solo,o
141,0211-699501013259,3,o
141,0211-699501013259,pacientes,o
141,0211-699501013259,presentan,o
141,0211-699501013259,niveles,o
141,0211-699501013259,normales,o
141,0211-699501013259,de,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,correlacionandose,o
141,0211-699501013259,directamente,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,con,o
141,0211-699501013259,la,o
141,0211-699501013259,albumina,i
141,0211-699501013259,r,o
141,0211-699501013259,056,o
141,0211-699501013259,p,o
141,0211-699501013259,0001,o
141,0211-699501013259,que,o
141,0211-699501013259,se,o
141,0211-699501013259,elevo,o
141,0211-699501013259,con,o
141,0211-699501013259,respecto,o
141,0211-699501013259,al,o
141,0211-699501013259,inicio,o
141,0211-699501013259,337,o
141,0211-699501013259,IC,o
141,0211-699501013259,327,o
141,0211-699501013259,346,o
141,0211-699501013259,vs,o
141,0211-699501013259,350,o
141,0211-699501013259,IC,o
141,0211-699501013259,337,o
141,0211-699501013259,363,o
141,0211-699501013259,p,o
141,0211-699501013259,005,o
141,0211-699501013259,Conclusion,o
141,0211-699501013259,Tras,o
141,0211-699501013259,suplementacion,i
141,0211-699501013259,con,o
141,0211-699501013259,acido,i
141,0211-699501013259,folico,i
141,0211-699501013259,y,o
141,0211-699501013259,vitamina,i
141,0211-699501013259,B6,i
141,0211-699501013259,aunque,o
141,0211-699501013259,inicialmente,o
141,0211-699501013259,se,o
141,0211-699501013259,reduce,o
141,0211-699501013259,la,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,esta,o
141,0211-699501013259,respuesta,o
141,0211-699501013259,se,o
141,0211-699501013259,hace,o
141,0211-699501013259,refractaria,o
141,0211-699501013259,correlacionandose,o
141,0211-699501013259,directamente,o
141,0211-699501013259,la,o
141,0211-699501013259,tHcy,i
141,0211-699501013259,con,o
141,0211-699501013259,la,o
141,0211-699501013259,albumina,i
141,0211-699501013259,plasmatica,i
141,0211-699501013259,La,o
141,0211-699501013259,interpretacion,o
141,0211-699501013259,de,o
141,0211-699501013259,los,o
141,0211-699501013259,niveles,i
141,0211-699501013259,de,i
141,0211-699501013259,tHcy,i
141,0211-699501013259,debe,o
141,0211-699501013259,tener,o
141,0211-699501013259,en,o
141,0211-699501013259,cuenta,o
141,0211-699501013259,la,o
141,0211-699501013259,concentracion,i
141,0211-699501013259,de,i
141,0211-699501013259,albumina,i
142,0211-699501013259,Efecto,o
142,0211-699501013259,de,o
142,0211-699501013259,la,o
142,0211-699501013259,suplementacion,i
142,0211-699501013259,con,o
142,0211-699501013259,acido,i
142,0211-699501013259,folico,i
142,0211-699501013259,sobre,o
142,0211-699501013259,los,o
142,0211-699501013259,niveles,i
142,0211-699501013259,de,i
142,0211-699501013259,homocisteina,i
142,0211-699501013259,total,o
142,0211-699501013259,en,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,en,o
142,0211-699501013259,hemodialisis,i
142,0211-699501013259,La,o
142,0211-699501013259,hiperhomocisteinemia,i
142,0211-699501013259,es,o
142,0211-699501013259,un,o
142,0211-699501013259,marcador,o
142,0211-699501013259,de,o
142,0211-699501013259,riesgo,o
142,0211-699501013259,independiente,o
142,0211-699501013259,de,o
142,0211-699501013259,morbimortalidad,o
142,0211-699501013259,cardiovascular,i
142,0211-699501013259,Hemos,o
142,0211-699501013259,intentado,o
142,0211-699501013259,prospectivamente,o
142,0211-699501013259,reducir,o
142,0211-699501013259,los,o
142,0211-699501013259,niveles,i
142,0211-699501013259,de,i
142,0211-699501013259,homocisteina,i
142,0211-699501013259,total,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,mediante,o
142,0211-699501013259,suplemento,o
142,0211-699501013259,con,o
142,0211-699501013259,acido,i
142,0211-699501013259,folico,i
142,0211-699501013259,y,o
142,0211-699501013259,vitamina,i
142,0211-699501013259,B6,i
142,0211-699501013259,pp,i
142,0211-699501013259,valorando,o
142,0211-699501013259,su,o
142,0211-699501013259,posible,o
142,0211-699501013259,correlacion,o
142,0211-699501013259,con,o
142,0211-699501013259,dosis,o
142,0211-699501013259,de,o
142,0211-699501013259,dialisis,i
142,0211-699501013259,funcion,i
142,0211-699501013259,residual,i
142,0211-699501013259,y,o
142,0211-699501013259,parametros,o
142,0211-699501013259,nutricionales,o
142,0211-699501013259,Metodos,o
142,0211-699501013259,Todos,o
142,0211-699501013259,los,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,en,o
142,0211-699501013259,hemodialisis,i
142,0211-699501013259,al,o
142,0211-699501013259,comienzo,o
142,0211-699501013259,del,o
142,0211-699501013259,estudio,o
142,0211-699501013259,que,o
142,0211-699501013259,no,o
142,0211-699501013259,recibian,o
142,0211-699501013259,acido,i
142,0211-699501013259,folico,i
142,0211-699501013259,ni,o
142,0211-699501013259,vitamina,i
142,0211-699501013259,B6,i
142,0211-699501013259,asi,o
142,0211-699501013259,como,o
142,0211-699501013259,los,o
142,0211-699501013259,incorporados,o
142,0211-699501013259,posteriormente,o
142,0211-699501013259,a,o
142,0211-699501013259,partir,o
142,0211-699501013259,de,o
142,0211-699501013259,su,o
142,0211-699501013259,tercer,o
142,0211-699501013259,mes,o
142,0211-699501013259,en,o
142,0211-699501013259,hemodialisis,i
142,0211-699501013259,recibieron,o
142,0211-699501013259,5,o
142,0211-699501013259,mg,o
142,0211-699501013259,orales,o
142,0211-699501013259,de,o
142,0211-699501013259,acido,i
142,0211-699501013259,folico,i
142,0211-699501013259,cada,o
142,0211-699501013259,48,o
142,0211-699501013259,horas,o
142,0211-699501013259,y,o
142,0211-699501013259,40,o
142,0211-699501013259,mg,o
142,0211-699501013259,orales,o
142,0211-699501013259,de,o
142,0211-699501013259,vitamina,i
142,0211-699501013259,B6,i
142,0211-699501013259,cada,o
142,0211-699501013259,semana,o
142,0211-699501013259,Se,o
142,0211-699501013259,determinaron,o
142,0211-699501013259,al,o
142,0211-699501013259,comienzo,o
142,0211-699501013259,del,o
142,0211-699501013259,estudio,o
142,0211-699501013259,y,o
142,0211-699501013259,cada,o
142,0211-699501013259,2,o
142,0211-699501013259,meses,o
142,0211-699501013259,niveles,i
142,0211-699501013259,de,i
142,0211-699501013259,folato,i
142,0211-699501013259,vitamina,i
142,0211-699501013259,B12,i
142,0211-699501013259,inmunoensayo,i
142,0211-699501013259,albumina,i
142,0211-699501013259,y,o
142,0211-699501013259,cinetica,o
142,0211-699501013259,de,o
142,0211-699501013259,la,o
142,0211-699501013259,urea,i
142,0211-699501013259,KTV,o
142,0211-699501013259,KRU,o
142,0211-699501013259,PCRn,o
142,0211-699501013259,y,o
142,0211-699501013259,cada,o
142,0211-699501013259,6,o
142,0211-699501013259,meses,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,HPLC,i
142,0211-699501013259,y,o
142,0211-699501013259,pp,i
142,0211-699501013259,RIA,i
142,0211-699501013259,Resultados,o
142,0211-699501013259,80,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,fueron,o
142,0211-699501013259,incluidos,o
142,0211-699501013259,en,o
142,0211-699501013259,el,o
142,0211-699501013259,estudio,o
142,0211-699501013259,basal,o
142,0211-699501013259,con,o
142,0211-699501013259,una,o
142,0211-699501013259,prevalencia,o
142,0211-699501013259,de,o
142,0211-699501013259,hiperhomocisteinemia,i
142,0211-699501013259,del,o
142,0211-699501013259,844,o
142,0211-699501013259,deficit,i
142,0211-699501013259,de,i
142,0211-699501013259,pp,i
142,0211-699501013259,en,o
142,0211-699501013259,el,o
142,0211-699501013259,32,o
142,0211-699501013259,y,o
142,0211-699501013259,folato,i
142,0211-699501013259,en,o
142,0211-699501013259,el,o
142,0211-699501013259,rango,o
142,0211-699501013259,normal,o
142,0211-699501013259,bajo,o
142,0211-699501013259,los,o
142,0211-699501013259,niveles,i
142,0211-699501013259,de,i
142,0211-699501013259,tHcy,i
142,0211-699501013259,se,o
142,0211-699501013259,correlacionaban,o
142,0211-699501013259,inversamente,o
142,0211-699501013259,con,o
142,0211-699501013259,los,o
142,0211-699501013259,del,o
142,0211-699501013259,folato,i
142,0211-699501013259,r,o
142,0211-699501013259,0336,o
142,0211-699501013259,p,o
142,0211-699501013259,001,o
142,0211-699501013259,pero,o
142,0211-699501013259,no,o
142,0211-699501013259,con,o
142,0211-699501013259,pp,i
142,0211-699501013259,B12,i
142,0211-699501013259,edad,o
142,0211-699501013259,albumina,i
142,0211-699501013259,KTV,o
142,0211-699501013259,KRU,o
142,0211-699501013259,PCRn,o
142,0211-699501013259,Cincuenta,o
142,0211-699501013259,y,o
142,0211-699501013259,ocho,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,recibieron,o
142,0211-699501013259,seis,o
142,0211-699501013259,meses,o
142,0211-699501013259,de,o
142,0211-699501013259,suplementacion,i
142,0211-699501013259,con,o
142,0211-699501013259,normalizacion,o
142,0211-699501013259,del,o
142,0211-699501013259,pp,i
142,0211-699501013259,aumento,o
142,0211-699501013259,del,o
142,0211-699501013259,folato,i
142,0211-699501013259,703,o
142,0211-699501013259,IC,o
142,0211-699501013259,638,o
142,0211-699501013259,795,o
142,0211-699501013259,vs,o
142,0211-699501013259,6181,o
142,0211-699501013259,IC,o
142,0211-699501013259,4447,o
142,0211-699501013259,7811,o
142,0211-699501013259,p,o
142,0211-699501013259,0001,o
142,0211-699501013259,y,o
142,0211-699501013259,descenso,o
142,0211-699501013259,de,o
142,0211-699501013259,la,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,240,o
142,0211-699501013259,IC,o
142,0211-699501013259,213,o
142,0211-699501013259,264,o
142,0211-699501013259,vs,o
142,0211-699501013259,199,o
142,0211-699501013259,IC,o
142,0211-699501013259,175,o
142,0211-699501013259,224,o
142,0211-699501013259,p,o
142,0211-699501013259,005,o
142,0211-699501013259,Han,o
142,0211-699501013259,recibido,o
142,0211-699501013259,suplementacion,i
142,0211-699501013259,durante,o
142,0211-699501013259,12,o
142,0211-699501013259,meses,o
142,0211-699501013259,33,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,pero,o
142,0211-699501013259,a,o
142,0211-699501013259,pesar,o
142,0211-699501013259,de,o
142,0211-699501013259,un,o
142,0211-699501013259,continuo,o
142,0211-699501013259,aumento,o
142,0211-699501013259,del,o
142,0211-699501013259,folato,i
142,0211-699501013259,10078,o
142,0211-699501013259,IC,o
142,0211-699501013259,7481,o
142,0211-699501013259,12674,o
142,0211-699501013259,p,o
142,0211-699501013259,0001,o
142,0211-699501013259,solo,o
142,0211-699501013259,3,o
142,0211-699501013259,pacientes,o
142,0211-699501013259,presentan,o
142,0211-699501013259,niveles,o
142,0211-699501013259,normales,o
142,0211-699501013259,de,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,correlacionandose,o
142,0211-699501013259,directamente,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,con,o
142,0211-699501013259,la,o
142,0211-699501013259,albumina,i
142,0211-699501013259,r,o
142,0211-699501013259,056,o
142,0211-699501013259,p,o
142,0211-699501013259,0001,o
142,0211-699501013259,que,o
142,0211-699501013259,se,o
142,0211-699501013259,elevo,o
142,0211-699501013259,con,o
142,0211-699501013259,respecto,o
142,0211-699501013259,al,o
142,0211-699501013259,inicio,o
142,0211-699501013259,337,o
142,0211-699501013259,IC,o
142,0211-699501013259,327,o
142,0211-699501013259,346,o
142,0211-699501013259,vs,o
142,0211-699501013259,350,o
142,0211-699501013259,IC,o
142,0211-699501013259,337,o
142,0211-699501013259,363,o
142,0211-699501013259,p,o
142,0211-699501013259,005,o
142,0211-699501013259,Conclusion,o
142,0211-699501013259,Tras,o
142,0211-699501013259,suplementacion,i
142,0211-699501013259,con,o
142,0211-699501013259,acido,i
142,0211-699501013259,folico,i
142,0211-699501013259,y,o
142,0211-699501013259,vitamina,i
142,0211-699501013259,B6,i
142,0211-699501013259,aunque,o
142,0211-699501013259,inicialmente,o
142,0211-699501013259,se,o
142,0211-699501013259,reduce,o
142,0211-699501013259,la,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,esta,o
142,0211-699501013259,respuesta,o
142,0211-699501013259,se,o
142,0211-699501013259,hace,o
142,0211-699501013259,refractaria,o
142,0211-699501013259,correlacionandose,o
142,0211-699501013259,directamente,o
142,0211-699501013259,la,o
142,0211-699501013259,tHcy,i
142,0211-699501013259,con,o
142,0211-699501013259,la,o
142,0211-699501013259,albumina,i
142,0211-699501013259,plasmatica,i
142,0211-699501013259,La,o
142,0211-699501013259,interpretacion,o
142,0211-699501013259,de,o
142,0211-699501013259,los,o
142,0211-699501013259,niveles,i
142,0211-699501013259,de,i
142,0211-699501013259,tHcy,i
142,0211-699501013259,debe,o
142,0211-699501013259,tener,o
142,0211-699501013259,en,o
142,0211-699501013259,cuenta,o
142,0211-699501013259,la,o
142,0211-699501013259,concentracion,i
142,0211-699501013259,de,i
142,0211-699501013259,albumina,i
143,0211-699501013259,Efecto,o
143,0211-699501013259,de,o
143,0211-699501013259,la,o
143,0211-699501013259,suplementacion,i
143,0211-699501013259,con,o
143,0211-699501013259,acido,i
143,0211-699501013259,folico,i
143,0211-699501013259,sobre,o
143,0211-699501013259,los,o
143,0211-699501013259,niveles,i
143,0211-699501013259,de,i
143,0211-699501013259,homocisteina,i
143,0211-699501013259,total,o
143,0211-699501013259,en,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,en,o
143,0211-699501013259,hemodialisis,i
143,0211-699501013259,La,o
143,0211-699501013259,hiperhomocisteinemia,i
143,0211-699501013259,es,o
143,0211-699501013259,un,o
143,0211-699501013259,marcador,o
143,0211-699501013259,de,o
143,0211-699501013259,riesgo,o
143,0211-699501013259,independiente,o
143,0211-699501013259,de,o
143,0211-699501013259,morbimortalidad,o
143,0211-699501013259,cardiovascular,i
143,0211-699501013259,Hemos,o
143,0211-699501013259,intentado,o
143,0211-699501013259,prospectivamente,o
143,0211-699501013259,reducir,o
143,0211-699501013259,los,o
143,0211-699501013259,niveles,i
143,0211-699501013259,de,i
143,0211-699501013259,homocisteina,i
143,0211-699501013259,total,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,mediante,o
143,0211-699501013259,suplemento,o
143,0211-699501013259,con,o
143,0211-699501013259,acido,i
143,0211-699501013259,folico,i
143,0211-699501013259,y,o
143,0211-699501013259,vitamina,i
143,0211-699501013259,B6,i
143,0211-699501013259,pp,i
143,0211-699501013259,valorando,o
143,0211-699501013259,su,o
143,0211-699501013259,posible,o
143,0211-699501013259,correlacion,o
143,0211-699501013259,con,o
143,0211-699501013259,dosis,o
143,0211-699501013259,de,o
143,0211-699501013259,dialisis,i
143,0211-699501013259,funcion,i
143,0211-699501013259,residual,i
143,0211-699501013259,y,o
143,0211-699501013259,parametros,o
143,0211-699501013259,nutricionales,o
143,0211-699501013259,Metodos,o
143,0211-699501013259,Todos,o
143,0211-699501013259,los,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,en,o
143,0211-699501013259,hemodialisis,i
143,0211-699501013259,al,o
143,0211-699501013259,comienzo,o
143,0211-699501013259,del,o
143,0211-699501013259,estudio,o
143,0211-699501013259,que,o
143,0211-699501013259,no,o
143,0211-699501013259,recibian,o
143,0211-699501013259,acido,i
143,0211-699501013259,folico,i
143,0211-699501013259,ni,o
143,0211-699501013259,vitamina,i
143,0211-699501013259,B6,i
143,0211-699501013259,asi,o
143,0211-699501013259,como,o
143,0211-699501013259,los,o
143,0211-699501013259,incorporados,o
143,0211-699501013259,posteriormente,o
143,0211-699501013259,a,o
143,0211-699501013259,partir,o
143,0211-699501013259,de,o
143,0211-699501013259,su,o
143,0211-699501013259,tercer,o
143,0211-699501013259,mes,o
143,0211-699501013259,en,o
143,0211-699501013259,hemodialisis,i
143,0211-699501013259,recibieron,o
143,0211-699501013259,5,o
143,0211-699501013259,mg,o
143,0211-699501013259,orales,o
143,0211-699501013259,de,o
143,0211-699501013259,acido,i
143,0211-699501013259,folico,i
143,0211-699501013259,cada,o
143,0211-699501013259,48,o
143,0211-699501013259,horas,o
143,0211-699501013259,y,o
143,0211-699501013259,40,o
143,0211-699501013259,mg,o
143,0211-699501013259,orales,o
143,0211-699501013259,de,o
143,0211-699501013259,vitamina,i
143,0211-699501013259,B6,i
143,0211-699501013259,cada,o
143,0211-699501013259,semana,o
143,0211-699501013259,Se,o
143,0211-699501013259,determinaron,o
143,0211-699501013259,al,o
143,0211-699501013259,comienzo,o
143,0211-699501013259,del,o
143,0211-699501013259,estudio,o
143,0211-699501013259,y,o
143,0211-699501013259,cada,o
143,0211-699501013259,2,o
143,0211-699501013259,meses,o
143,0211-699501013259,niveles,i
143,0211-699501013259,de,i
143,0211-699501013259,folato,i
143,0211-699501013259,vitamina,i
143,0211-699501013259,B12,i
143,0211-699501013259,inmunoensayo,i
143,0211-699501013259,albumina,i
143,0211-699501013259,y,o
143,0211-699501013259,cinetica,o
143,0211-699501013259,de,o
143,0211-699501013259,la,o
143,0211-699501013259,urea,i
143,0211-699501013259,KTV,o
143,0211-699501013259,KRU,o
143,0211-699501013259,PCRn,o
143,0211-699501013259,y,o
143,0211-699501013259,cada,o
143,0211-699501013259,6,o
143,0211-699501013259,meses,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,HPLC,i
143,0211-699501013259,y,o
143,0211-699501013259,pp,i
143,0211-699501013259,RIA,i
143,0211-699501013259,Resultados,o
143,0211-699501013259,80,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,fueron,o
143,0211-699501013259,incluidos,o
143,0211-699501013259,en,o
143,0211-699501013259,el,o
143,0211-699501013259,estudio,o
143,0211-699501013259,basal,o
143,0211-699501013259,con,o
143,0211-699501013259,una,o
143,0211-699501013259,prevalencia,o
143,0211-699501013259,de,o
143,0211-699501013259,hiperhomocisteinemia,i
143,0211-699501013259,del,o
143,0211-699501013259,844,o
143,0211-699501013259,deficit,i
143,0211-699501013259,de,i
143,0211-699501013259,pp,i
143,0211-699501013259,en,o
143,0211-699501013259,el,o
143,0211-699501013259,32,o
143,0211-699501013259,y,o
143,0211-699501013259,folato,i
143,0211-699501013259,en,o
143,0211-699501013259,el,o
143,0211-699501013259,rango,o
143,0211-699501013259,normal,o
143,0211-699501013259,bajo,o
143,0211-699501013259,los,o
143,0211-699501013259,niveles,i
143,0211-699501013259,de,i
143,0211-699501013259,tHcy,i
143,0211-699501013259,se,o
143,0211-699501013259,correlacionaban,o
143,0211-699501013259,inversamente,o
143,0211-699501013259,con,o
143,0211-699501013259,los,o
143,0211-699501013259,del,o
143,0211-699501013259,folato,i
143,0211-699501013259,r,o
143,0211-699501013259,0336,o
143,0211-699501013259,p,o
143,0211-699501013259,001,o
143,0211-699501013259,pero,o
143,0211-699501013259,no,o
143,0211-699501013259,con,o
143,0211-699501013259,pp,i
143,0211-699501013259,B12,i
143,0211-699501013259,edad,o
143,0211-699501013259,albumina,i
143,0211-699501013259,KTV,o
143,0211-699501013259,KRU,o
143,0211-699501013259,PCRn,o
143,0211-699501013259,Cincuenta,o
143,0211-699501013259,y,o
143,0211-699501013259,ocho,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,recibieron,o
143,0211-699501013259,seis,o
143,0211-699501013259,meses,o
143,0211-699501013259,de,o
143,0211-699501013259,suplementacion,i
143,0211-699501013259,con,o
143,0211-699501013259,normalizacion,o
143,0211-699501013259,del,o
143,0211-699501013259,pp,i
143,0211-699501013259,aumento,o
143,0211-699501013259,del,o
143,0211-699501013259,folato,i
143,0211-699501013259,703,o
143,0211-699501013259,IC,o
143,0211-699501013259,638,o
143,0211-699501013259,795,o
143,0211-699501013259,vs,o
143,0211-699501013259,6181,o
143,0211-699501013259,IC,o
143,0211-699501013259,4447,o
143,0211-699501013259,7811,o
143,0211-699501013259,p,o
143,0211-699501013259,0001,o
143,0211-699501013259,y,o
143,0211-699501013259,descenso,o
143,0211-699501013259,de,o
143,0211-699501013259,la,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,240,o
143,0211-699501013259,IC,o
143,0211-699501013259,213,o
143,0211-699501013259,264,o
143,0211-699501013259,vs,o
143,0211-699501013259,199,o
143,0211-699501013259,IC,o
143,0211-699501013259,175,o
143,0211-699501013259,224,o
143,0211-699501013259,p,o
143,0211-699501013259,005,o
143,0211-699501013259,Han,o
143,0211-699501013259,recibido,o
143,0211-699501013259,suplementacion,i
143,0211-699501013259,durante,o
143,0211-699501013259,12,o
143,0211-699501013259,meses,o
143,0211-699501013259,33,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,pero,o
143,0211-699501013259,a,o
143,0211-699501013259,pesar,o
143,0211-699501013259,de,o
143,0211-699501013259,un,o
143,0211-699501013259,continuo,o
143,0211-699501013259,aumento,o
143,0211-699501013259,del,o
143,0211-699501013259,folato,i
143,0211-699501013259,10078,o
143,0211-699501013259,IC,o
143,0211-699501013259,7481,o
143,0211-699501013259,12674,o
143,0211-699501013259,p,o
143,0211-699501013259,0001,o
143,0211-699501013259,solo,o
143,0211-699501013259,3,o
143,0211-699501013259,pacientes,o
143,0211-699501013259,presentan,o
143,0211-699501013259,niveles,o
143,0211-699501013259,normales,o
143,0211-699501013259,de,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,correlacionandose,o
143,0211-699501013259,directamente,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,con,o
143,0211-699501013259,la,o
143,0211-699501013259,albumina,i
143,0211-699501013259,r,o
143,0211-699501013259,056,o
143,0211-699501013259,p,o
143,0211-699501013259,0001,o
143,0211-699501013259,que,o
143,0211-699501013259,se,o
143,0211-699501013259,elevo,o
143,0211-699501013259,con,o
143,0211-699501013259,respecto,o
143,0211-699501013259,al,o
143,0211-699501013259,inicio,o
143,0211-699501013259,337,o
143,0211-699501013259,IC,o
143,0211-699501013259,327,o
143,0211-699501013259,346,o
143,0211-699501013259,vs,o
143,0211-699501013259,350,o
143,0211-699501013259,IC,o
143,0211-699501013259,337,o
143,0211-699501013259,363,o
143,0211-699501013259,p,o
143,0211-699501013259,005,o
143,0211-699501013259,Conclusion,o
143,0211-699501013259,Tras,o
143,0211-699501013259,suplementacion,i
143,0211-699501013259,con,o
143,0211-699501013259,acido,i
143,0211-699501013259,folico,i
143,0211-699501013259,y,o
143,0211-699501013259,vitamina,i
143,0211-699501013259,B6,i
143,0211-699501013259,aunque,o
143,0211-699501013259,inicialmente,o
143,0211-699501013259,se,o
143,0211-699501013259,reduce,o
143,0211-699501013259,la,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,esta,o
143,0211-699501013259,respuesta,o
143,0211-699501013259,se,o
143,0211-699501013259,hace,o
143,0211-699501013259,refractaria,o
143,0211-699501013259,correlacionandose,o
143,0211-699501013259,directamente,o
143,0211-699501013259,la,o
143,0211-699501013259,tHcy,i
143,0211-699501013259,con,o
143,0211-699501013259,la,o
143,0211-699501013259,albumina,i
143,0211-699501013259,plasmatica,i
143,0211-699501013259,La,o
143,0211-699501013259,interpretacion,o
143,0211-699501013259,de,o
143,0211-699501013259,los,o
143,0211-699501013259,niveles,i
143,0211-699501013259,de,i
143,0211-699501013259,tHcy,i
143,0211-699501013259,debe,o
143,0211-699501013259,tener,o
143,0211-699501013259,en,o
143,0211-699501013259,cuenta,o
143,0211-699501013259,la,o
143,0211-699501013259,concentracion,i
143,0211-699501013259,de,i
143,0211-699501013259,albumina,i
144,0211-699501013259,Efecto,o
144,0211-699501013259,de,o
144,0211-699501013259,la,o
144,0211-699501013259,suplementacion,i
144,0211-699501013259,con,o
144,0211-699501013259,acido,i
144,0211-699501013259,folico,i
144,0211-699501013259,sobre,o
144,0211-699501013259,los,o
144,0211-699501013259,niveles,i
144,0211-699501013259,de,i
144,0211-699501013259,homocisteina,i
144,0211-699501013259,total,o
144,0211-699501013259,en,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,en,o
144,0211-699501013259,hemodialisis,i
144,0211-699501013259,La,o
144,0211-699501013259,hiperhomocisteinemia,i
144,0211-699501013259,es,o
144,0211-699501013259,un,o
144,0211-699501013259,marcador,o
144,0211-699501013259,de,o
144,0211-699501013259,riesgo,o
144,0211-699501013259,independiente,o
144,0211-699501013259,de,o
144,0211-699501013259,morbimortalidad,o
144,0211-699501013259,cardiovascular,i
144,0211-699501013259,Hemos,o
144,0211-699501013259,intentado,o
144,0211-699501013259,prospectivamente,o
144,0211-699501013259,reducir,o
144,0211-699501013259,los,o
144,0211-699501013259,niveles,i
144,0211-699501013259,de,i
144,0211-699501013259,homocisteina,i
144,0211-699501013259,total,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,mediante,o
144,0211-699501013259,suplemento,o
144,0211-699501013259,con,o
144,0211-699501013259,acido,i
144,0211-699501013259,folico,i
144,0211-699501013259,y,o
144,0211-699501013259,vitamina,i
144,0211-699501013259,B6,i
144,0211-699501013259,pp,i
144,0211-699501013259,valorando,o
144,0211-699501013259,su,o
144,0211-699501013259,posible,o
144,0211-699501013259,correlacion,o
144,0211-699501013259,con,o
144,0211-699501013259,dosis,o
144,0211-699501013259,de,o
144,0211-699501013259,dialisis,i
144,0211-699501013259,funcion,i
144,0211-699501013259,residual,i
144,0211-699501013259,y,o
144,0211-699501013259,parametros,o
144,0211-699501013259,nutricionales,o
144,0211-699501013259,Metodos,o
144,0211-699501013259,Todos,o
144,0211-699501013259,los,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,en,o
144,0211-699501013259,hemodialisis,i
144,0211-699501013259,al,o
144,0211-699501013259,comienzo,o
144,0211-699501013259,del,o
144,0211-699501013259,estudio,o
144,0211-699501013259,que,o
144,0211-699501013259,no,o
144,0211-699501013259,recibian,o
144,0211-699501013259,acido,i
144,0211-699501013259,folico,i
144,0211-699501013259,ni,o
144,0211-699501013259,vitamina,i
144,0211-699501013259,B6,i
144,0211-699501013259,asi,o
144,0211-699501013259,como,o
144,0211-699501013259,los,o
144,0211-699501013259,incorporados,o
144,0211-699501013259,posteriormente,o
144,0211-699501013259,a,o
144,0211-699501013259,partir,o
144,0211-699501013259,de,o
144,0211-699501013259,su,o
144,0211-699501013259,tercer,o
144,0211-699501013259,mes,o
144,0211-699501013259,en,o
144,0211-699501013259,hemodialisis,i
144,0211-699501013259,recibieron,o
144,0211-699501013259,5,o
144,0211-699501013259,mg,o
144,0211-699501013259,orales,o
144,0211-699501013259,de,o
144,0211-699501013259,acido,i
144,0211-699501013259,folico,i
144,0211-699501013259,cada,o
144,0211-699501013259,48,o
144,0211-699501013259,horas,o
144,0211-699501013259,y,o
144,0211-699501013259,40,o
144,0211-699501013259,mg,o
144,0211-699501013259,orales,o
144,0211-699501013259,de,o
144,0211-699501013259,vitamina,i
144,0211-699501013259,B6,i
144,0211-699501013259,cada,o
144,0211-699501013259,semana,o
144,0211-699501013259,Se,o
144,0211-699501013259,determinaron,o
144,0211-699501013259,al,o
144,0211-699501013259,comienzo,o
144,0211-699501013259,del,o
144,0211-699501013259,estudio,o
144,0211-699501013259,y,o
144,0211-699501013259,cada,o
144,0211-699501013259,2,o
144,0211-699501013259,meses,o
144,0211-699501013259,niveles,i
144,0211-699501013259,de,i
144,0211-699501013259,folato,i
144,0211-699501013259,vitamina,i
144,0211-699501013259,B12,i
144,0211-699501013259,inmunoensayo,i
144,0211-699501013259,albumina,i
144,0211-699501013259,y,o
144,0211-699501013259,cinetica,o
144,0211-699501013259,de,o
144,0211-699501013259,la,o
144,0211-699501013259,urea,i
144,0211-699501013259,KTV,o
144,0211-699501013259,KRU,o
144,0211-699501013259,PCRn,o
144,0211-699501013259,y,o
144,0211-699501013259,cada,o
144,0211-699501013259,6,o
144,0211-699501013259,meses,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,HPLC,i
144,0211-699501013259,y,o
144,0211-699501013259,pp,i
144,0211-699501013259,RIA,i
144,0211-699501013259,Resultados,o
144,0211-699501013259,80,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,fueron,o
144,0211-699501013259,incluidos,o
144,0211-699501013259,en,o
144,0211-699501013259,el,o
144,0211-699501013259,estudio,o
144,0211-699501013259,basal,o
144,0211-699501013259,con,o
144,0211-699501013259,una,o
144,0211-699501013259,prevalencia,o
144,0211-699501013259,de,o
144,0211-699501013259,hiperhomocisteinemia,i
144,0211-699501013259,del,o
144,0211-699501013259,844,o
144,0211-699501013259,deficit,i
144,0211-699501013259,de,i
144,0211-699501013259,pp,i
144,0211-699501013259,en,o
144,0211-699501013259,el,o
144,0211-699501013259,32,o
144,0211-699501013259,y,o
144,0211-699501013259,folato,i
144,0211-699501013259,en,o
144,0211-699501013259,el,o
144,0211-699501013259,rango,o
144,0211-699501013259,normal,o
144,0211-699501013259,bajo,o
144,0211-699501013259,los,o
144,0211-699501013259,niveles,i
144,0211-699501013259,de,i
144,0211-699501013259,tHcy,i
144,0211-699501013259,se,o
144,0211-699501013259,correlacionaban,o
144,0211-699501013259,inversamente,o
144,0211-699501013259,con,o
144,0211-699501013259,los,o
144,0211-699501013259,del,o
144,0211-699501013259,folato,i
144,0211-699501013259,r,o
144,0211-699501013259,0336,o
144,0211-699501013259,p,o
144,0211-699501013259,001,o
144,0211-699501013259,pero,o
144,0211-699501013259,no,o
144,0211-699501013259,con,o
144,0211-699501013259,pp,i
144,0211-699501013259,B12,i
144,0211-699501013259,edad,o
144,0211-699501013259,albumina,i
144,0211-699501013259,KTV,o
144,0211-699501013259,KRU,o
144,0211-699501013259,PCRn,o
144,0211-699501013259,Cincuenta,o
144,0211-699501013259,y,o
144,0211-699501013259,ocho,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,recibieron,o
144,0211-699501013259,seis,o
144,0211-699501013259,meses,o
144,0211-699501013259,de,o
144,0211-699501013259,suplementacion,i
144,0211-699501013259,con,o
144,0211-699501013259,normalizacion,o
144,0211-699501013259,del,o
144,0211-699501013259,pp,i
144,0211-699501013259,aumento,o
144,0211-699501013259,del,o
144,0211-699501013259,folato,i
144,0211-699501013259,703,o
144,0211-699501013259,IC,o
144,0211-699501013259,638,o
144,0211-699501013259,795,o
144,0211-699501013259,vs,o
144,0211-699501013259,6181,o
144,0211-699501013259,IC,o
144,0211-699501013259,4447,o
144,0211-699501013259,7811,o
144,0211-699501013259,p,o
144,0211-699501013259,0001,o
144,0211-699501013259,y,o
144,0211-699501013259,descenso,o
144,0211-699501013259,de,o
144,0211-699501013259,la,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,240,o
144,0211-699501013259,IC,o
144,0211-699501013259,213,o
144,0211-699501013259,264,o
144,0211-699501013259,vs,o
144,0211-699501013259,199,o
144,0211-699501013259,IC,o
144,0211-699501013259,175,o
144,0211-699501013259,224,o
144,0211-699501013259,p,o
144,0211-699501013259,005,o
144,0211-699501013259,Han,o
144,0211-699501013259,recibido,o
144,0211-699501013259,suplementacion,i
144,0211-699501013259,durante,o
144,0211-699501013259,12,o
144,0211-699501013259,meses,o
144,0211-699501013259,33,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,pero,o
144,0211-699501013259,a,o
144,0211-699501013259,pesar,o
144,0211-699501013259,de,o
144,0211-699501013259,un,o
144,0211-699501013259,continuo,o
144,0211-699501013259,aumento,o
144,0211-699501013259,del,o
144,0211-699501013259,folato,i
144,0211-699501013259,10078,o
144,0211-699501013259,IC,o
144,0211-699501013259,7481,o
144,0211-699501013259,12674,o
144,0211-699501013259,p,o
144,0211-699501013259,0001,o
144,0211-699501013259,solo,o
144,0211-699501013259,3,o
144,0211-699501013259,pacientes,o
144,0211-699501013259,presentan,o
144,0211-699501013259,niveles,o
144,0211-699501013259,normales,o
144,0211-699501013259,de,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,correlacionandose,o
144,0211-699501013259,directamente,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,con,o
144,0211-699501013259,la,o
144,0211-699501013259,albumina,i
144,0211-699501013259,r,o
144,0211-699501013259,056,o
144,0211-699501013259,p,o
144,0211-699501013259,0001,o
144,0211-699501013259,que,o
144,0211-699501013259,se,o
144,0211-699501013259,elevo,o
144,0211-699501013259,con,o
144,0211-699501013259,respecto,o
144,0211-699501013259,al,o
144,0211-699501013259,inicio,o
144,0211-699501013259,337,o
144,0211-699501013259,IC,o
144,0211-699501013259,327,o
144,0211-699501013259,346,o
144,0211-699501013259,vs,o
144,0211-699501013259,350,o
144,0211-699501013259,IC,o
144,0211-699501013259,337,o
144,0211-699501013259,363,o
144,0211-699501013259,p,o
144,0211-699501013259,005,o
144,0211-699501013259,Conclusion,o
144,0211-699501013259,Tras,o
144,0211-699501013259,suplementacion,i
144,0211-699501013259,con,o
144,0211-699501013259,acido,i
144,0211-699501013259,folico,i
144,0211-699501013259,y,o
144,0211-699501013259,vitamina,i
144,0211-699501013259,B6,i
144,0211-699501013259,aunque,o
144,0211-699501013259,inicialmente,o
144,0211-699501013259,se,o
144,0211-699501013259,reduce,o
144,0211-699501013259,la,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,esta,o
144,0211-699501013259,respuesta,o
144,0211-699501013259,se,o
144,0211-699501013259,hace,o
144,0211-699501013259,refractaria,o
144,0211-699501013259,correlacionandose,o
144,0211-699501013259,directamente,o
144,0211-699501013259,la,o
144,0211-699501013259,tHcy,i
144,0211-699501013259,con,o
144,0211-699501013259,la,o
144,0211-699501013259,albumina,i
144,0211-699501013259,plasmatica,i
144,0211-699501013259,La,o
144,0211-699501013259,interpretacion,o
144,0211-699501013259,de,o
144,0211-699501013259,los,o
144,0211-699501013259,niveles,i
144,0211-699501013259,de,i
144,0211-699501013259,tHcy,i
144,0211-699501013259,debe,o
144,0211-699501013259,tener,o
144,0211-699501013259,en,o
144,0211-699501013259,cuenta,o
144,0211-699501013259,la,o
144,0211-699501013259,concentracion,i
144,0211-699501013259,de,i
144,0211-699501013259,albumina,i
145,0211-699501013259,Efecto,o
145,0211-699501013259,de,o
145,0211-699501013259,la,o
145,0211-699501013259,suplementacion,i
145,0211-699501013259,con,o
145,0211-699501013259,acido,i
145,0211-699501013259,folico,i
145,0211-699501013259,sobre,o
145,0211-699501013259,los,o
145,0211-699501013259,niveles,i
145,0211-699501013259,de,i
145,0211-699501013259,homocisteina,i
145,0211-699501013259,total,o
145,0211-699501013259,en,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,en,o
145,0211-699501013259,hemodialisis,i
145,0211-699501013259,La,o
145,0211-699501013259,hiperhomocisteinemia,i
145,0211-699501013259,es,o
145,0211-699501013259,un,o
145,0211-699501013259,marcador,o
145,0211-699501013259,de,o
145,0211-699501013259,riesgo,o
145,0211-699501013259,independiente,o
145,0211-699501013259,de,o
145,0211-699501013259,morbimortalidad,o
145,0211-699501013259,cardiovascular,i
145,0211-699501013259,Hemos,o
145,0211-699501013259,intentado,o
145,0211-699501013259,prospectivamente,o
145,0211-699501013259,reducir,o
145,0211-699501013259,los,o
145,0211-699501013259,niveles,i
145,0211-699501013259,de,i
145,0211-699501013259,homocisteina,i
145,0211-699501013259,total,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,mediante,o
145,0211-699501013259,suplemento,o
145,0211-699501013259,con,o
145,0211-699501013259,acido,i
145,0211-699501013259,folico,i
145,0211-699501013259,y,o
145,0211-699501013259,vitamina,i
145,0211-699501013259,B6,i
145,0211-699501013259,pp,i
145,0211-699501013259,valorando,o
145,0211-699501013259,su,o
145,0211-699501013259,posible,o
145,0211-699501013259,correlacion,o
145,0211-699501013259,con,o
145,0211-699501013259,dosis,o
145,0211-699501013259,de,o
145,0211-699501013259,dialisis,i
145,0211-699501013259,funcion,i
145,0211-699501013259,residual,i
145,0211-699501013259,y,o
145,0211-699501013259,parametros,o
145,0211-699501013259,nutricionales,o
145,0211-699501013259,Metodos,o
145,0211-699501013259,Todos,o
145,0211-699501013259,los,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,en,o
145,0211-699501013259,hemodialisis,i
145,0211-699501013259,al,o
145,0211-699501013259,comienzo,o
145,0211-699501013259,del,o
145,0211-699501013259,estudio,o
145,0211-699501013259,que,o
145,0211-699501013259,no,o
145,0211-699501013259,recibian,o
145,0211-699501013259,acido,i
145,0211-699501013259,folico,i
145,0211-699501013259,ni,o
145,0211-699501013259,vitamina,i
145,0211-699501013259,B6,i
145,0211-699501013259,asi,o
145,0211-699501013259,como,o
145,0211-699501013259,los,o
145,0211-699501013259,incorporados,o
145,0211-699501013259,posteriormente,o
145,0211-699501013259,a,o
145,0211-699501013259,partir,o
145,0211-699501013259,de,o
145,0211-699501013259,su,o
145,0211-699501013259,tercer,o
145,0211-699501013259,mes,o
145,0211-699501013259,en,o
145,0211-699501013259,hemodialisis,i
145,0211-699501013259,recibieron,o
145,0211-699501013259,5,o
145,0211-699501013259,mg,o
145,0211-699501013259,orales,o
145,0211-699501013259,de,o
145,0211-699501013259,acido,i
145,0211-699501013259,folico,i
145,0211-699501013259,cada,o
145,0211-699501013259,48,o
145,0211-699501013259,horas,o
145,0211-699501013259,y,o
145,0211-699501013259,40,o
145,0211-699501013259,mg,o
145,0211-699501013259,orales,o
145,0211-699501013259,de,o
145,0211-699501013259,vitamina,i
145,0211-699501013259,B6,i
145,0211-699501013259,cada,o
145,0211-699501013259,semana,o
145,0211-699501013259,Se,o
145,0211-699501013259,determinaron,o
145,0211-699501013259,al,o
145,0211-699501013259,comienzo,o
145,0211-699501013259,del,o
145,0211-699501013259,estudio,o
145,0211-699501013259,y,o
145,0211-699501013259,cada,o
145,0211-699501013259,2,o
145,0211-699501013259,meses,o
145,0211-699501013259,niveles,i
145,0211-699501013259,de,i
145,0211-699501013259,folato,i
145,0211-699501013259,vitamina,i
145,0211-699501013259,B12,i
145,0211-699501013259,inmunoensayo,i
145,0211-699501013259,albumina,i
145,0211-699501013259,y,o
145,0211-699501013259,cinetica,o
145,0211-699501013259,de,o
145,0211-699501013259,la,o
145,0211-699501013259,urea,i
145,0211-699501013259,KTV,o
145,0211-699501013259,KRU,o
145,0211-699501013259,PCRn,o
145,0211-699501013259,y,o
145,0211-699501013259,cada,o
145,0211-699501013259,6,o
145,0211-699501013259,meses,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,HPLC,i
145,0211-699501013259,y,o
145,0211-699501013259,pp,i
145,0211-699501013259,RIA,i
145,0211-699501013259,Resultados,o
145,0211-699501013259,80,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,fueron,o
145,0211-699501013259,incluidos,o
145,0211-699501013259,en,o
145,0211-699501013259,el,o
145,0211-699501013259,estudio,o
145,0211-699501013259,basal,o
145,0211-699501013259,con,o
145,0211-699501013259,una,o
145,0211-699501013259,prevalencia,o
145,0211-699501013259,de,o
145,0211-699501013259,hiperhomocisteinemia,i
145,0211-699501013259,del,o
145,0211-699501013259,844,o
145,0211-699501013259,deficit,i
145,0211-699501013259,de,i
145,0211-699501013259,pp,i
145,0211-699501013259,en,o
145,0211-699501013259,el,o
145,0211-699501013259,32,o
145,0211-699501013259,y,o
145,0211-699501013259,folato,i
145,0211-699501013259,en,o
145,0211-699501013259,el,o
145,0211-699501013259,rango,o
145,0211-699501013259,normal,o
145,0211-699501013259,bajo,o
145,0211-699501013259,los,o
145,0211-699501013259,niveles,i
145,0211-699501013259,de,i
145,0211-699501013259,tHcy,i
145,0211-699501013259,se,o
145,0211-699501013259,correlacionaban,o
145,0211-699501013259,inversamente,o
145,0211-699501013259,con,o
145,0211-699501013259,los,o
145,0211-699501013259,del,o
145,0211-699501013259,folato,i
145,0211-699501013259,r,o
145,0211-699501013259,0336,o
145,0211-699501013259,p,o
145,0211-699501013259,001,o
145,0211-699501013259,pero,o
145,0211-699501013259,no,o
145,0211-699501013259,con,o
145,0211-699501013259,pp,i
145,0211-699501013259,B12,i
145,0211-699501013259,edad,o
145,0211-699501013259,albumina,i
145,0211-699501013259,KTV,o
145,0211-699501013259,KRU,o
145,0211-699501013259,PCRn,o
145,0211-699501013259,Cincuenta,o
145,0211-699501013259,y,o
145,0211-699501013259,ocho,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,recibieron,o
145,0211-699501013259,seis,o
145,0211-699501013259,meses,o
145,0211-699501013259,de,o
145,0211-699501013259,suplementacion,i
145,0211-699501013259,con,o
145,0211-699501013259,normalizacion,o
145,0211-699501013259,del,o
145,0211-699501013259,pp,i
145,0211-699501013259,aumento,o
145,0211-699501013259,del,o
145,0211-699501013259,folato,i
145,0211-699501013259,703,o
145,0211-699501013259,IC,o
145,0211-699501013259,638,o
145,0211-699501013259,795,o
145,0211-699501013259,vs,o
145,0211-699501013259,6181,o
145,0211-699501013259,IC,o
145,0211-699501013259,4447,o
145,0211-699501013259,7811,o
145,0211-699501013259,p,o
145,0211-699501013259,0001,o
145,0211-699501013259,y,o
145,0211-699501013259,descenso,o
145,0211-699501013259,de,o
145,0211-699501013259,la,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,240,o
145,0211-699501013259,IC,o
145,0211-699501013259,213,o
145,0211-699501013259,264,o
145,0211-699501013259,vs,o
145,0211-699501013259,199,o
145,0211-699501013259,IC,o
145,0211-699501013259,175,o
145,0211-699501013259,224,o
145,0211-699501013259,p,o
145,0211-699501013259,005,o
145,0211-699501013259,Han,o
145,0211-699501013259,recibido,o
145,0211-699501013259,suplementacion,i
145,0211-699501013259,durante,o
145,0211-699501013259,12,o
145,0211-699501013259,meses,o
145,0211-699501013259,33,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,pero,o
145,0211-699501013259,a,o
145,0211-699501013259,pesar,o
145,0211-699501013259,de,o
145,0211-699501013259,un,o
145,0211-699501013259,continuo,o
145,0211-699501013259,aumento,o
145,0211-699501013259,del,o
145,0211-699501013259,folato,i
145,0211-699501013259,10078,o
145,0211-699501013259,IC,o
145,0211-699501013259,7481,o
145,0211-699501013259,12674,o
145,0211-699501013259,p,o
145,0211-699501013259,0001,o
145,0211-699501013259,solo,o
145,0211-699501013259,3,o
145,0211-699501013259,pacientes,o
145,0211-699501013259,presentan,o
145,0211-699501013259,niveles,o
145,0211-699501013259,normales,o
145,0211-699501013259,de,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,correlacionandose,o
145,0211-699501013259,directamente,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,con,o
145,0211-699501013259,la,o
145,0211-699501013259,albumina,i
145,0211-699501013259,r,o
145,0211-699501013259,056,o
145,0211-699501013259,p,o
145,0211-699501013259,0001,o
145,0211-699501013259,que,o
145,0211-699501013259,se,o
145,0211-699501013259,elevo,o
145,0211-699501013259,con,o
145,0211-699501013259,respecto,o
145,0211-699501013259,al,o
145,0211-699501013259,inicio,o
145,0211-699501013259,337,o
145,0211-699501013259,IC,o
145,0211-699501013259,327,o
145,0211-699501013259,346,o
145,0211-699501013259,vs,o
145,0211-699501013259,350,o
145,0211-699501013259,IC,o
145,0211-699501013259,337,o
145,0211-699501013259,363,o
145,0211-699501013259,p,o
145,0211-699501013259,005,o
145,0211-699501013259,Conclusion,o
145,0211-699501013259,Tras,o
145,0211-699501013259,suplementacion,i
145,0211-699501013259,con,o
145,0211-699501013259,acido,i
145,0211-699501013259,folico,i
145,0211-699501013259,y,o
145,0211-699501013259,vitamina,i
145,0211-699501013259,B6,i
145,0211-699501013259,aunque,o
145,0211-699501013259,inicialmente,o
145,0211-699501013259,se,o
145,0211-699501013259,reduce,o
145,0211-699501013259,la,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,esta,o
145,0211-699501013259,respuesta,o
145,0211-699501013259,se,o
145,0211-699501013259,hace,o
145,0211-699501013259,refractaria,o
145,0211-699501013259,correlacionandose,o
145,0211-699501013259,directamente,o
145,0211-699501013259,la,o
145,0211-699501013259,tHcy,i
145,0211-699501013259,con,o
145,0211-699501013259,la,o
145,0211-699501013259,albumina,i
145,0211-699501013259,plasmatica,i
145,0211-699501013259,La,o
145,0211-699501013259,interpretacion,o
145,0211-699501013259,de,o
145,0211-699501013259,los,o
145,0211-699501013259,niveles,i
145,0211-699501013259,de,i
145,0211-699501013259,tHcy,i
145,0211-699501013259,debe,o
145,0211-699501013259,tener,o
145,0211-699501013259,en,o
145,0211-699501013259,cuenta,o
145,0211-699501013259,la,o
145,0211-699501013259,concentracion,i
145,0211-699501013259,de,i
145,0211-699501013259,albumina,i
146,0211-699501013259,Efecto,o
146,0211-699501013259,de,o
146,0211-699501013259,la,o
146,0211-699501013259,suplementacion,i
146,0211-699501013259,con,o
146,0211-699501013259,acido,i
146,0211-699501013259,folico,i
146,0211-699501013259,sobre,o
146,0211-699501013259,los,o
146,0211-699501013259,niveles,i
146,0211-699501013259,de,i
146,0211-699501013259,homocisteina,i
146,0211-699501013259,total,o
146,0211-699501013259,en,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,en,o
146,0211-699501013259,hemodialisis,i
146,0211-699501013259,La,o
146,0211-699501013259,hiperhomocisteinemia,i
146,0211-699501013259,es,o
146,0211-699501013259,un,o
146,0211-699501013259,marcador,o
146,0211-699501013259,de,o
146,0211-699501013259,riesgo,o
146,0211-699501013259,independiente,o
146,0211-699501013259,de,o
146,0211-699501013259,morbimortalidad,o
146,0211-699501013259,cardiovascular,i
146,0211-699501013259,Hemos,o
146,0211-699501013259,intentado,o
146,0211-699501013259,prospectivamente,o
146,0211-699501013259,reducir,o
146,0211-699501013259,los,o
146,0211-699501013259,niveles,i
146,0211-699501013259,de,i
146,0211-699501013259,homocisteina,i
146,0211-699501013259,total,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,mediante,o
146,0211-699501013259,suplemento,o
146,0211-699501013259,con,o
146,0211-699501013259,acido,i
146,0211-699501013259,folico,i
146,0211-699501013259,y,o
146,0211-699501013259,vitamina,i
146,0211-699501013259,B6,i
146,0211-699501013259,pp,i
146,0211-699501013259,valorando,o
146,0211-699501013259,su,o
146,0211-699501013259,posible,o
146,0211-699501013259,correlacion,o
146,0211-699501013259,con,o
146,0211-699501013259,dosis,o
146,0211-699501013259,de,o
146,0211-699501013259,dialisis,i
146,0211-699501013259,funcion,i
146,0211-699501013259,residual,i
146,0211-699501013259,y,o
146,0211-699501013259,parametros,o
146,0211-699501013259,nutricionales,o
146,0211-699501013259,Metodos,o
146,0211-699501013259,Todos,o
146,0211-699501013259,los,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,en,o
146,0211-699501013259,hemodialisis,i
146,0211-699501013259,al,o
146,0211-699501013259,comienzo,o
146,0211-699501013259,del,o
146,0211-699501013259,estudio,o
146,0211-699501013259,que,o
146,0211-699501013259,no,o
146,0211-699501013259,recibian,o
146,0211-699501013259,acido,i
146,0211-699501013259,folico,i
146,0211-699501013259,ni,o
146,0211-699501013259,vitamina,i
146,0211-699501013259,B6,i
146,0211-699501013259,asi,o
146,0211-699501013259,como,o
146,0211-699501013259,los,o
146,0211-699501013259,incorporados,o
146,0211-699501013259,posteriormente,o
146,0211-699501013259,a,o
146,0211-699501013259,partir,o
146,0211-699501013259,de,o
146,0211-699501013259,su,o
146,0211-699501013259,tercer,o
146,0211-699501013259,mes,o
146,0211-699501013259,en,o
146,0211-699501013259,hemodialisis,i
146,0211-699501013259,recibieron,o
146,0211-699501013259,5,o
146,0211-699501013259,mg,o
146,0211-699501013259,orales,o
146,0211-699501013259,de,o
146,0211-699501013259,acido,i
146,0211-699501013259,folico,i
146,0211-699501013259,cada,o
146,0211-699501013259,48,o
146,0211-699501013259,horas,o
146,0211-699501013259,y,o
146,0211-699501013259,40,o
146,0211-699501013259,mg,o
146,0211-699501013259,orales,o
146,0211-699501013259,de,o
146,0211-699501013259,vitamina,i
146,0211-699501013259,B6,i
146,0211-699501013259,cada,o
146,0211-699501013259,semana,o
146,0211-699501013259,Se,o
146,0211-699501013259,determinaron,o
146,0211-699501013259,al,o
146,0211-699501013259,comienzo,o
146,0211-699501013259,del,o
146,0211-699501013259,estudio,o
146,0211-699501013259,y,o
146,0211-699501013259,cada,o
146,0211-699501013259,2,o
146,0211-699501013259,meses,o
146,0211-699501013259,niveles,i
146,0211-699501013259,de,i
146,0211-699501013259,folato,i
146,0211-699501013259,vitamina,i
146,0211-699501013259,B12,i
146,0211-699501013259,inmunoensayo,i
146,0211-699501013259,albumina,i
146,0211-699501013259,y,o
146,0211-699501013259,cinetica,o
146,0211-699501013259,de,o
146,0211-699501013259,la,o
146,0211-699501013259,urea,i
146,0211-699501013259,KTV,o
146,0211-699501013259,KRU,o
146,0211-699501013259,PCRn,o
146,0211-699501013259,y,o
146,0211-699501013259,cada,o
146,0211-699501013259,6,o
146,0211-699501013259,meses,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,HPLC,i
146,0211-699501013259,y,o
146,0211-699501013259,pp,i
146,0211-699501013259,RIA,i
146,0211-699501013259,Resultados,o
146,0211-699501013259,80,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,fueron,o
146,0211-699501013259,incluidos,o
146,0211-699501013259,en,o
146,0211-699501013259,el,o
146,0211-699501013259,estudio,o
146,0211-699501013259,basal,o
146,0211-699501013259,con,o
146,0211-699501013259,una,o
146,0211-699501013259,prevalencia,o
146,0211-699501013259,de,o
146,0211-699501013259,hiperhomocisteinemia,i
146,0211-699501013259,del,o
146,0211-699501013259,844,o
146,0211-699501013259,deficit,i
146,0211-699501013259,de,i
146,0211-699501013259,pp,i
146,0211-699501013259,en,o
146,0211-699501013259,el,o
146,0211-699501013259,32,o
146,0211-699501013259,y,o
146,0211-699501013259,folato,i
146,0211-699501013259,en,o
146,0211-699501013259,el,o
146,0211-699501013259,rango,o
146,0211-699501013259,normal,o
146,0211-699501013259,bajo,o
146,0211-699501013259,los,o
146,0211-699501013259,niveles,i
146,0211-699501013259,de,i
146,0211-699501013259,tHcy,i
146,0211-699501013259,se,o
146,0211-699501013259,correlacionaban,o
146,0211-699501013259,inversamente,o
146,0211-699501013259,con,o
146,0211-699501013259,los,o
146,0211-699501013259,del,o
146,0211-699501013259,folato,i
146,0211-699501013259,r,o
146,0211-699501013259,0336,o
146,0211-699501013259,p,o
146,0211-699501013259,001,o
146,0211-699501013259,pero,o
146,0211-699501013259,no,o
146,0211-699501013259,con,o
146,0211-699501013259,pp,i
146,0211-699501013259,B12,i
146,0211-699501013259,edad,o
146,0211-699501013259,albumina,i
146,0211-699501013259,KTV,o
146,0211-699501013259,KRU,o
146,0211-699501013259,PCRn,o
146,0211-699501013259,Cincuenta,o
146,0211-699501013259,y,o
146,0211-699501013259,ocho,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,recibieron,o
146,0211-699501013259,seis,o
146,0211-699501013259,meses,o
146,0211-699501013259,de,o
146,0211-699501013259,suplementacion,i
146,0211-699501013259,con,o
146,0211-699501013259,normalizacion,o
146,0211-699501013259,del,o
146,0211-699501013259,pp,i
146,0211-699501013259,aumento,o
146,0211-699501013259,del,o
146,0211-699501013259,folato,i
146,0211-699501013259,703,o
146,0211-699501013259,IC,o
146,0211-699501013259,638,o
146,0211-699501013259,795,o
146,0211-699501013259,vs,o
146,0211-699501013259,6181,o
146,0211-699501013259,IC,o
146,0211-699501013259,4447,o
146,0211-699501013259,7811,o
146,0211-699501013259,p,o
146,0211-699501013259,0001,o
146,0211-699501013259,y,o
146,0211-699501013259,descenso,o
146,0211-699501013259,de,o
146,0211-699501013259,la,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,240,o
146,0211-699501013259,IC,o
146,0211-699501013259,213,o
146,0211-699501013259,264,o
146,0211-699501013259,vs,o
146,0211-699501013259,199,o
146,0211-699501013259,IC,o
146,0211-699501013259,175,o
146,0211-699501013259,224,o
146,0211-699501013259,p,o
146,0211-699501013259,005,o
146,0211-699501013259,Han,o
146,0211-699501013259,recibido,o
146,0211-699501013259,suplementacion,i
146,0211-699501013259,durante,o
146,0211-699501013259,12,o
146,0211-699501013259,meses,o
146,0211-699501013259,33,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,pero,o
146,0211-699501013259,a,o
146,0211-699501013259,pesar,o
146,0211-699501013259,de,o
146,0211-699501013259,un,o
146,0211-699501013259,continuo,o
146,0211-699501013259,aumento,o
146,0211-699501013259,del,o
146,0211-699501013259,folato,i
146,0211-699501013259,10078,o
146,0211-699501013259,IC,o
146,0211-699501013259,7481,o
146,0211-699501013259,12674,o
146,0211-699501013259,p,o
146,0211-699501013259,0001,o
146,0211-699501013259,solo,o
146,0211-699501013259,3,o
146,0211-699501013259,pacientes,o
146,0211-699501013259,presentan,o
146,0211-699501013259,niveles,o
146,0211-699501013259,normales,o
146,0211-699501013259,de,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,correlacionandose,o
146,0211-699501013259,directamente,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,con,o
146,0211-699501013259,la,o
146,0211-699501013259,albumina,i
146,0211-699501013259,r,o
146,0211-699501013259,056,o
146,0211-699501013259,p,o
146,0211-699501013259,0001,o
146,0211-699501013259,que,o
146,0211-699501013259,se,o
146,0211-699501013259,elevo,o
146,0211-699501013259,con,o
146,0211-699501013259,respecto,o
146,0211-699501013259,al,o
146,0211-699501013259,inicio,o
146,0211-699501013259,337,o
146,0211-699501013259,IC,o
146,0211-699501013259,327,o
146,0211-699501013259,346,o
146,0211-699501013259,vs,o
146,0211-699501013259,350,o
146,0211-699501013259,IC,o
146,0211-699501013259,337,o
146,0211-699501013259,363,o
146,0211-699501013259,p,o
146,0211-699501013259,005,o
146,0211-699501013259,Conclusion,o
146,0211-699501013259,Tras,o
146,0211-699501013259,suplementacion,i
146,0211-699501013259,con,o
146,0211-699501013259,acido,i
146,0211-699501013259,folico,i
146,0211-699501013259,y,o
146,0211-699501013259,vitamina,i
146,0211-699501013259,B6,i
146,0211-699501013259,aunque,o
146,0211-699501013259,inicialmente,o
146,0211-699501013259,se,o
146,0211-699501013259,reduce,o
146,0211-699501013259,la,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,esta,o
146,0211-699501013259,respuesta,o
146,0211-699501013259,se,o
146,0211-699501013259,hace,o
146,0211-699501013259,refractaria,o
146,0211-699501013259,correlacionandose,o
146,0211-699501013259,directamente,o
146,0211-699501013259,la,o
146,0211-699501013259,tHcy,i
146,0211-699501013259,con,o
146,0211-699501013259,la,o
146,0211-699501013259,albumina,i
146,0211-699501013259,plasmatica,i
146,0211-699501013259,La,o
146,0211-699501013259,interpretacion,o
146,0211-699501013259,de,o
146,0211-699501013259,los,o
146,0211-699501013259,niveles,i
146,0211-699501013259,de,i
146,0211-699501013259,tHcy,i
146,0211-699501013259,debe,o
146,0211-699501013259,tener,o
146,0211-699501013259,en,o
146,0211-699501013259,cuenta,o
146,0211-699501013259,la,o
146,0211-699501013259,concentracion,i
146,0211-699501013259,de,i
146,0211-699501013259,albumina,i
147,0211-699501013259,Efecto,o
147,0211-699501013259,de,o
147,0211-699501013259,la,o
147,0211-699501013259,suplementacion,i
147,0211-699501013259,con,o
147,0211-699501013259,acido,i
147,0211-699501013259,folico,i
147,0211-699501013259,sobre,o
147,0211-699501013259,los,o
147,0211-699501013259,niveles,i
147,0211-699501013259,de,i
147,0211-699501013259,homocisteina,i
147,0211-699501013259,total,o
147,0211-699501013259,en,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,en,o
147,0211-699501013259,hemodialisis,i
147,0211-699501013259,La,o
147,0211-699501013259,hiperhomocisteinemia,i
147,0211-699501013259,es,o
147,0211-699501013259,un,o
147,0211-699501013259,marcador,o
147,0211-699501013259,de,o
147,0211-699501013259,riesgo,o
147,0211-699501013259,independiente,o
147,0211-699501013259,de,o
147,0211-699501013259,morbimortalidad,o
147,0211-699501013259,cardiovascular,i
147,0211-699501013259,Hemos,o
147,0211-699501013259,intentado,o
147,0211-699501013259,prospectivamente,o
147,0211-699501013259,reducir,o
147,0211-699501013259,los,o
147,0211-699501013259,niveles,i
147,0211-699501013259,de,i
147,0211-699501013259,homocisteina,i
147,0211-699501013259,total,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,mediante,o
147,0211-699501013259,suplemento,o
147,0211-699501013259,con,o
147,0211-699501013259,acido,i
147,0211-699501013259,folico,i
147,0211-699501013259,y,o
147,0211-699501013259,vitamina,i
147,0211-699501013259,B6,i
147,0211-699501013259,pp,i
147,0211-699501013259,valorando,o
147,0211-699501013259,su,o
147,0211-699501013259,posible,o
147,0211-699501013259,correlacion,o
147,0211-699501013259,con,o
147,0211-699501013259,dosis,o
147,0211-699501013259,de,o
147,0211-699501013259,dialisis,i
147,0211-699501013259,funcion,i
147,0211-699501013259,residual,i
147,0211-699501013259,y,o
147,0211-699501013259,parametros,o
147,0211-699501013259,nutricionales,o
147,0211-699501013259,Metodos,o
147,0211-699501013259,Todos,o
147,0211-699501013259,los,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,en,o
147,0211-699501013259,hemodialisis,i
147,0211-699501013259,al,o
147,0211-699501013259,comienzo,o
147,0211-699501013259,del,o
147,0211-699501013259,estudio,o
147,0211-699501013259,que,o
147,0211-699501013259,no,o
147,0211-699501013259,recibian,o
147,0211-699501013259,acido,i
147,0211-699501013259,folico,i
147,0211-699501013259,ni,o
147,0211-699501013259,vitamina,i
147,0211-699501013259,B6,i
147,0211-699501013259,asi,o
147,0211-699501013259,como,o
147,0211-699501013259,los,o
147,0211-699501013259,incorporados,o
147,0211-699501013259,posteriormente,o
147,0211-699501013259,a,o
147,0211-699501013259,partir,o
147,0211-699501013259,de,o
147,0211-699501013259,su,o
147,0211-699501013259,tercer,o
147,0211-699501013259,mes,o
147,0211-699501013259,en,o
147,0211-699501013259,hemodialisis,i
147,0211-699501013259,recibieron,o
147,0211-699501013259,5,o
147,0211-699501013259,mg,o
147,0211-699501013259,orales,o
147,0211-699501013259,de,o
147,0211-699501013259,acido,i
147,0211-699501013259,folico,i
147,0211-699501013259,cada,o
147,0211-699501013259,48,o
147,0211-699501013259,horas,o
147,0211-699501013259,y,o
147,0211-699501013259,40,o
147,0211-699501013259,mg,o
147,0211-699501013259,orales,o
147,0211-699501013259,de,o
147,0211-699501013259,vitamina,i
147,0211-699501013259,B6,i
147,0211-699501013259,cada,o
147,0211-699501013259,semana,o
147,0211-699501013259,Se,o
147,0211-699501013259,determinaron,o
147,0211-699501013259,al,o
147,0211-699501013259,comienzo,o
147,0211-699501013259,del,o
147,0211-699501013259,estudio,o
147,0211-699501013259,y,o
147,0211-699501013259,cada,o
147,0211-699501013259,2,o
147,0211-699501013259,meses,o
147,0211-699501013259,niveles,i
147,0211-699501013259,de,i
147,0211-699501013259,folato,i
147,0211-699501013259,vitamina,i
147,0211-699501013259,B12,i
147,0211-699501013259,inmunoensayo,i
147,0211-699501013259,albumina,i
147,0211-699501013259,y,o
147,0211-699501013259,cinetica,o
147,0211-699501013259,de,o
147,0211-699501013259,la,o
147,0211-699501013259,urea,i
147,0211-699501013259,KTV,o
147,0211-699501013259,KRU,o
147,0211-699501013259,PCRn,o
147,0211-699501013259,y,o
147,0211-699501013259,cada,o
147,0211-699501013259,6,o
147,0211-699501013259,meses,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,HPLC,i
147,0211-699501013259,y,o
147,0211-699501013259,pp,i
147,0211-699501013259,RIA,i
147,0211-699501013259,Resultados,o
147,0211-699501013259,80,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,fueron,o
147,0211-699501013259,incluidos,o
147,0211-699501013259,en,o
147,0211-699501013259,el,o
147,0211-699501013259,estudio,o
147,0211-699501013259,basal,o
147,0211-699501013259,con,o
147,0211-699501013259,una,o
147,0211-699501013259,prevalencia,o
147,0211-699501013259,de,o
147,0211-699501013259,hiperhomocisteinemia,i
147,0211-699501013259,del,o
147,0211-699501013259,844,o
147,0211-699501013259,deficit,i
147,0211-699501013259,de,i
147,0211-699501013259,pp,i
147,0211-699501013259,en,o
147,0211-699501013259,el,o
147,0211-699501013259,32,o
147,0211-699501013259,y,o
147,0211-699501013259,folato,i
147,0211-699501013259,en,o
147,0211-699501013259,el,o
147,0211-699501013259,rango,o
147,0211-699501013259,normal,o
147,0211-699501013259,bajo,o
147,0211-699501013259,los,o
147,0211-699501013259,niveles,i
147,0211-699501013259,de,i
147,0211-699501013259,tHcy,i
147,0211-699501013259,se,o
147,0211-699501013259,correlacionaban,o
147,0211-699501013259,inversamente,o
147,0211-699501013259,con,o
147,0211-699501013259,los,o
147,0211-699501013259,del,o
147,0211-699501013259,folato,i
147,0211-699501013259,r,o
147,0211-699501013259,0336,o
147,0211-699501013259,p,o
147,0211-699501013259,001,o
147,0211-699501013259,pero,o
147,0211-699501013259,no,o
147,0211-699501013259,con,o
147,0211-699501013259,pp,i
147,0211-699501013259,B12,i
147,0211-699501013259,edad,o
147,0211-699501013259,albumina,i
147,0211-699501013259,KTV,o
147,0211-699501013259,KRU,o
147,0211-699501013259,PCRn,o
147,0211-699501013259,Cincuenta,o
147,0211-699501013259,y,o
147,0211-699501013259,ocho,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,recibieron,o
147,0211-699501013259,seis,o
147,0211-699501013259,meses,o
147,0211-699501013259,de,o
147,0211-699501013259,suplementacion,i
147,0211-699501013259,con,o
147,0211-699501013259,normalizacion,o
147,0211-699501013259,del,o
147,0211-699501013259,pp,i
147,0211-699501013259,aumento,o
147,0211-699501013259,del,o
147,0211-699501013259,folato,i
147,0211-699501013259,703,o
147,0211-699501013259,IC,o
147,0211-699501013259,638,o
147,0211-699501013259,795,o
147,0211-699501013259,vs,o
147,0211-699501013259,6181,o
147,0211-699501013259,IC,o
147,0211-699501013259,4447,o
147,0211-699501013259,7811,o
147,0211-699501013259,p,o
147,0211-699501013259,0001,o
147,0211-699501013259,y,o
147,0211-699501013259,descenso,o
147,0211-699501013259,de,o
147,0211-699501013259,la,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,240,o
147,0211-699501013259,IC,o
147,0211-699501013259,213,o
147,0211-699501013259,264,o
147,0211-699501013259,vs,o
147,0211-699501013259,199,o
147,0211-699501013259,IC,o
147,0211-699501013259,175,o
147,0211-699501013259,224,o
147,0211-699501013259,p,o
147,0211-699501013259,005,o
147,0211-699501013259,Han,o
147,0211-699501013259,recibido,o
147,0211-699501013259,suplementacion,i
147,0211-699501013259,durante,o
147,0211-699501013259,12,o
147,0211-699501013259,meses,o
147,0211-699501013259,33,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,pero,o
147,0211-699501013259,a,o
147,0211-699501013259,pesar,o
147,0211-699501013259,de,o
147,0211-699501013259,un,o
147,0211-699501013259,continuo,o
147,0211-699501013259,aumento,o
147,0211-699501013259,del,o
147,0211-699501013259,folato,i
147,0211-699501013259,10078,o
147,0211-699501013259,IC,o
147,0211-699501013259,7481,o
147,0211-699501013259,12674,o
147,0211-699501013259,p,o
147,0211-699501013259,0001,o
147,0211-699501013259,solo,o
147,0211-699501013259,3,o
147,0211-699501013259,pacientes,o
147,0211-699501013259,presentan,o
147,0211-699501013259,niveles,o
147,0211-699501013259,normales,o
147,0211-699501013259,de,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,correlacionandose,o
147,0211-699501013259,directamente,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,con,o
147,0211-699501013259,la,o
147,0211-699501013259,albumina,i
147,0211-699501013259,r,o
147,0211-699501013259,056,o
147,0211-699501013259,p,o
147,0211-699501013259,0001,o
147,0211-699501013259,que,o
147,0211-699501013259,se,o
147,0211-699501013259,elevo,o
147,0211-699501013259,con,o
147,0211-699501013259,respecto,o
147,0211-699501013259,al,o
147,0211-699501013259,inicio,o
147,0211-699501013259,337,o
147,0211-699501013259,IC,o
147,0211-699501013259,327,o
147,0211-699501013259,346,o
147,0211-699501013259,vs,o
147,0211-699501013259,350,o
147,0211-699501013259,IC,o
147,0211-699501013259,337,o
147,0211-699501013259,363,o
147,0211-699501013259,p,o
147,0211-699501013259,005,o
147,0211-699501013259,Conclusion,o
147,0211-699501013259,Tras,o
147,0211-699501013259,suplementacion,i
147,0211-699501013259,con,o
147,0211-699501013259,acido,i
147,0211-699501013259,folico,i
147,0211-699501013259,y,o
147,0211-699501013259,vitamina,i
147,0211-699501013259,B6,i
147,0211-699501013259,aunque,o
147,0211-699501013259,inicialmente,o
147,0211-699501013259,se,o
147,0211-699501013259,reduce,o
147,0211-699501013259,la,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,esta,o
147,0211-699501013259,respuesta,o
147,0211-699501013259,se,o
147,0211-699501013259,hace,o
147,0211-699501013259,refractaria,o
147,0211-699501013259,correlacionandose,o
147,0211-699501013259,directamente,o
147,0211-699501013259,la,o
147,0211-699501013259,tHcy,i
147,0211-699501013259,con,o
147,0211-699501013259,la,o
147,0211-699501013259,albumina,i
147,0211-699501013259,plasmatica,i
147,0211-699501013259,La,o
147,0211-699501013259,interpretacion,o
147,0211-699501013259,de,o
147,0211-699501013259,los,o
147,0211-699501013259,niveles,i
147,0211-699501013259,de,i
147,0211-699501013259,tHcy,i
147,0211-699501013259,debe,o
147,0211-699501013259,tener,o
147,0211-699501013259,en,o
147,0211-699501013259,cuenta,o
147,0211-699501013259,la,o
147,0211-699501013259,concentracion,i
147,0211-699501013259,de,i
147,0211-699501013259,albumina,i
148,0211-699501013259,Efecto,o
148,0211-699501013259,de,o
148,0211-699501013259,la,o
148,0211-699501013259,suplementacion,i
148,0211-699501013259,con,o
148,0211-699501013259,acido,i
148,0211-699501013259,folico,i
148,0211-699501013259,sobre,o
148,0211-699501013259,los,o
148,0211-699501013259,niveles,i
148,0211-699501013259,de,i
148,0211-699501013259,homocisteina,i
148,0211-699501013259,total,o
148,0211-699501013259,en,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,en,o
148,0211-699501013259,hemodialisis,i
148,0211-699501013259,La,o
148,0211-699501013259,hiperhomocisteinemia,i
148,0211-699501013259,es,o
148,0211-699501013259,un,o
148,0211-699501013259,marcador,o
148,0211-699501013259,de,o
148,0211-699501013259,riesgo,o
148,0211-699501013259,independiente,o
148,0211-699501013259,de,o
148,0211-699501013259,morbimortalidad,o
148,0211-699501013259,cardiovascular,i
148,0211-699501013259,Hemos,o
148,0211-699501013259,intentado,o
148,0211-699501013259,prospectivamente,o
148,0211-699501013259,reducir,o
148,0211-699501013259,los,o
148,0211-699501013259,niveles,i
148,0211-699501013259,de,i
148,0211-699501013259,homocisteina,i
148,0211-699501013259,total,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,mediante,o
148,0211-699501013259,suplemento,o
148,0211-699501013259,con,o
148,0211-699501013259,acido,i
148,0211-699501013259,folico,i
148,0211-699501013259,y,o
148,0211-699501013259,vitamina,i
148,0211-699501013259,B6,i
148,0211-699501013259,pp,i
148,0211-699501013259,valorando,o
148,0211-699501013259,su,o
148,0211-699501013259,posible,o
148,0211-699501013259,correlacion,o
148,0211-699501013259,con,o
148,0211-699501013259,dosis,o
148,0211-699501013259,de,o
148,0211-699501013259,dialisis,i
148,0211-699501013259,funcion,i
148,0211-699501013259,residual,i
148,0211-699501013259,y,o
148,0211-699501013259,parametros,o
148,0211-699501013259,nutricionales,o
148,0211-699501013259,Metodos,o
148,0211-699501013259,Todos,o
148,0211-699501013259,los,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,en,o
148,0211-699501013259,hemodialisis,i
148,0211-699501013259,al,o
148,0211-699501013259,comienzo,o
148,0211-699501013259,del,o
148,0211-699501013259,estudio,o
148,0211-699501013259,que,o
148,0211-699501013259,no,o
148,0211-699501013259,recibian,o
148,0211-699501013259,acido,i
148,0211-699501013259,folico,i
148,0211-699501013259,ni,o
148,0211-699501013259,vitamina,i
148,0211-699501013259,B6,i
148,0211-699501013259,asi,o
148,0211-699501013259,como,o
148,0211-699501013259,los,o
148,0211-699501013259,incorporados,o
148,0211-699501013259,posteriormente,o
148,0211-699501013259,a,o
148,0211-699501013259,partir,o
148,0211-699501013259,de,o
148,0211-699501013259,su,o
148,0211-699501013259,tercer,o
148,0211-699501013259,mes,o
148,0211-699501013259,en,o
148,0211-699501013259,hemodialisis,i
148,0211-699501013259,recibieron,o
148,0211-699501013259,5,o
148,0211-699501013259,mg,o
148,0211-699501013259,orales,o
148,0211-699501013259,de,o
148,0211-699501013259,acido,i
148,0211-699501013259,folico,i
148,0211-699501013259,cada,o
148,0211-699501013259,48,o
148,0211-699501013259,horas,o
148,0211-699501013259,y,o
148,0211-699501013259,40,o
148,0211-699501013259,mg,o
148,0211-699501013259,orales,o
148,0211-699501013259,de,o
148,0211-699501013259,vitamina,i
148,0211-699501013259,B6,i
148,0211-699501013259,cada,o
148,0211-699501013259,semana,o
148,0211-699501013259,Se,o
148,0211-699501013259,determinaron,o
148,0211-699501013259,al,o
148,0211-699501013259,comienzo,o
148,0211-699501013259,del,o
148,0211-699501013259,estudio,o
148,0211-699501013259,y,o
148,0211-699501013259,cada,o
148,0211-699501013259,2,o
148,0211-699501013259,meses,o
148,0211-699501013259,niveles,i
148,0211-699501013259,de,i
148,0211-699501013259,folato,i
148,0211-699501013259,vitamina,i
148,0211-699501013259,B12,i
148,0211-699501013259,inmunoensayo,i
148,0211-699501013259,albumina,i
148,0211-699501013259,y,o
148,0211-699501013259,cinetica,o
148,0211-699501013259,de,o
148,0211-699501013259,la,o
148,0211-699501013259,urea,i
148,0211-699501013259,KTV,o
148,0211-699501013259,KRU,o
148,0211-699501013259,PCRn,o
148,0211-699501013259,y,o
148,0211-699501013259,cada,o
148,0211-699501013259,6,o
148,0211-699501013259,meses,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,HPLC,i
148,0211-699501013259,y,o
148,0211-699501013259,pp,i
148,0211-699501013259,RIA,i
148,0211-699501013259,Resultados,o
148,0211-699501013259,80,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,fueron,o
148,0211-699501013259,incluidos,o
148,0211-699501013259,en,o
148,0211-699501013259,el,o
148,0211-699501013259,estudio,o
148,0211-699501013259,basal,o
148,0211-699501013259,con,o
148,0211-699501013259,una,o
148,0211-699501013259,prevalencia,o
148,0211-699501013259,de,o
148,0211-699501013259,hiperhomocisteinemia,i
148,0211-699501013259,del,o
148,0211-699501013259,844,o
148,0211-699501013259,deficit,i
148,0211-699501013259,de,i
148,0211-699501013259,pp,i
148,0211-699501013259,en,o
148,0211-699501013259,el,o
148,0211-699501013259,32,o
148,0211-699501013259,y,o
148,0211-699501013259,folato,i
148,0211-699501013259,en,o
148,0211-699501013259,el,o
148,0211-699501013259,rango,o
148,0211-699501013259,normal,o
148,0211-699501013259,bajo,o
148,0211-699501013259,los,o
148,0211-699501013259,niveles,i
148,0211-699501013259,de,i
148,0211-699501013259,tHcy,i
148,0211-699501013259,se,o
148,0211-699501013259,correlacionaban,o
148,0211-699501013259,inversamente,o
148,0211-699501013259,con,o
148,0211-699501013259,los,o
148,0211-699501013259,del,o
148,0211-699501013259,folato,i
148,0211-699501013259,r,o
148,0211-699501013259,0336,o
148,0211-699501013259,p,o
148,0211-699501013259,001,o
148,0211-699501013259,pero,o
148,0211-699501013259,no,o
148,0211-699501013259,con,o
148,0211-699501013259,pp,i
148,0211-699501013259,B12,i
148,0211-699501013259,edad,o
148,0211-699501013259,albumina,i
148,0211-699501013259,KTV,o
148,0211-699501013259,KRU,o
148,0211-699501013259,PCRn,o
148,0211-699501013259,Cincuenta,o
148,0211-699501013259,y,o
148,0211-699501013259,ocho,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,recibieron,o
148,0211-699501013259,seis,o
148,0211-699501013259,meses,o
148,0211-699501013259,de,o
148,0211-699501013259,suplementacion,i
148,0211-699501013259,con,o
148,0211-699501013259,normalizacion,o
148,0211-699501013259,del,o
148,0211-699501013259,pp,i
148,0211-699501013259,aumento,o
148,0211-699501013259,del,o
148,0211-699501013259,folato,i
148,0211-699501013259,703,o
148,0211-699501013259,IC,o
148,0211-699501013259,638,o
148,0211-699501013259,795,o
148,0211-699501013259,vs,o
148,0211-699501013259,6181,o
148,0211-699501013259,IC,o
148,0211-699501013259,4447,o
148,0211-699501013259,7811,o
148,0211-699501013259,p,o
148,0211-699501013259,0001,o
148,0211-699501013259,y,o
148,0211-699501013259,descenso,o
148,0211-699501013259,de,o
148,0211-699501013259,la,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,240,o
148,0211-699501013259,IC,o
148,0211-699501013259,213,o
148,0211-699501013259,264,o
148,0211-699501013259,vs,o
148,0211-699501013259,199,o
148,0211-699501013259,IC,o
148,0211-699501013259,175,o
148,0211-699501013259,224,o
148,0211-699501013259,p,o
148,0211-699501013259,005,o
148,0211-699501013259,Han,o
148,0211-699501013259,recibido,o
148,0211-699501013259,suplementacion,i
148,0211-699501013259,durante,o
148,0211-699501013259,12,o
148,0211-699501013259,meses,o
148,0211-699501013259,33,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,pero,o
148,0211-699501013259,a,o
148,0211-699501013259,pesar,o
148,0211-699501013259,de,o
148,0211-699501013259,un,o
148,0211-699501013259,continuo,o
148,0211-699501013259,aumento,o
148,0211-699501013259,del,o
148,0211-699501013259,folato,i
148,0211-699501013259,10078,o
148,0211-699501013259,IC,o
148,0211-699501013259,7481,o
148,0211-699501013259,12674,o
148,0211-699501013259,p,o
148,0211-699501013259,0001,o
148,0211-699501013259,solo,o
148,0211-699501013259,3,o
148,0211-699501013259,pacientes,o
148,0211-699501013259,presentan,o
148,0211-699501013259,niveles,o
148,0211-699501013259,normales,o
148,0211-699501013259,de,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,correlacionandose,o
148,0211-699501013259,directamente,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,con,o
148,0211-699501013259,la,o
148,0211-699501013259,albumina,i
148,0211-699501013259,r,o
148,0211-699501013259,056,o
148,0211-699501013259,p,o
148,0211-699501013259,0001,o
148,0211-699501013259,que,o
148,0211-699501013259,se,o
148,0211-699501013259,elevo,o
148,0211-699501013259,con,o
148,0211-699501013259,respecto,o
148,0211-699501013259,al,o
148,0211-699501013259,inicio,o
148,0211-699501013259,337,o
148,0211-699501013259,IC,o
148,0211-699501013259,327,o
148,0211-699501013259,346,o
148,0211-699501013259,vs,o
148,0211-699501013259,350,o
148,0211-699501013259,IC,o
148,0211-699501013259,337,o
148,0211-699501013259,363,o
148,0211-699501013259,p,o
148,0211-699501013259,005,o
148,0211-699501013259,Conclusion,o
148,0211-699501013259,Tras,o
148,0211-699501013259,suplementacion,i
148,0211-699501013259,con,o
148,0211-699501013259,acido,i
148,0211-699501013259,folico,i
148,0211-699501013259,y,o
148,0211-699501013259,vitamina,i
148,0211-699501013259,B6,i
148,0211-699501013259,aunque,o
148,0211-699501013259,inicialmente,o
148,0211-699501013259,se,o
148,0211-699501013259,reduce,o
148,0211-699501013259,la,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,esta,o
148,0211-699501013259,respuesta,o
148,0211-699501013259,se,o
148,0211-699501013259,hace,o
148,0211-699501013259,refractaria,o
148,0211-699501013259,correlacionandose,o
148,0211-699501013259,directamente,o
148,0211-699501013259,la,o
148,0211-699501013259,tHcy,i
148,0211-699501013259,con,o
148,0211-699501013259,la,o
148,0211-699501013259,albumina,i
148,0211-699501013259,plasmatica,i
148,0211-699501013259,La,o
148,0211-699501013259,interpretacion,o
148,0211-699501013259,de,o
148,0211-699501013259,los,o
148,0211-699501013259,niveles,i
148,0211-699501013259,de,i
148,0211-699501013259,tHcy,i
148,0211-699501013259,debe,o
148,0211-699501013259,tener,o
148,0211-699501013259,en,o
148,0211-699501013259,cuenta,o
148,0211-699501013259,la,o
148,0211-699501013259,concentracion,i
148,0211-699501013259,de,i
148,0211-699501013259,albumina,i
149,0211-699501013259,Efecto,o
149,0211-699501013259,de,o
149,0211-699501013259,la,o
149,0211-699501013259,suplementacion,i
149,0211-699501013259,con,o
149,0211-699501013259,acido,i
149,0211-699501013259,folico,i
149,0211-699501013259,sobre,o
149,0211-699501013259,los,o
149,0211-699501013259,niveles,i
149,0211-699501013259,de,i
149,0211-699501013259,homocisteina,i
149,0211-699501013259,total,o
149,0211-699501013259,en,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,en,o
149,0211-699501013259,hemodialisis,i
149,0211-699501013259,La,o
149,0211-699501013259,hiperhomocisteinemia,i
149,0211-699501013259,es,o
149,0211-699501013259,un,o
149,0211-699501013259,marcador,o
149,0211-699501013259,de,o
149,0211-699501013259,riesgo,o
149,0211-699501013259,independiente,o
149,0211-699501013259,de,o
149,0211-699501013259,morbimortalidad,o
149,0211-699501013259,cardiovascular,i
149,0211-699501013259,Hemos,o
149,0211-699501013259,intentado,o
149,0211-699501013259,prospectivamente,o
149,0211-699501013259,reducir,o
149,0211-699501013259,los,o
149,0211-699501013259,niveles,i
149,0211-699501013259,de,i
149,0211-699501013259,homocisteina,i
149,0211-699501013259,total,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,mediante,o
149,0211-699501013259,suplemento,o
149,0211-699501013259,con,o
149,0211-699501013259,acido,i
149,0211-699501013259,folico,i
149,0211-699501013259,y,o
149,0211-699501013259,vitamina,i
149,0211-699501013259,B6,i
149,0211-699501013259,pp,i
149,0211-699501013259,valorando,o
149,0211-699501013259,su,o
149,0211-699501013259,posible,o
149,0211-699501013259,correlacion,o
149,0211-699501013259,con,o
149,0211-699501013259,dosis,o
149,0211-699501013259,de,o
149,0211-699501013259,dialisis,i
149,0211-699501013259,funcion,i
149,0211-699501013259,residual,i
149,0211-699501013259,y,o
149,0211-699501013259,parametros,o
149,0211-699501013259,nutricionales,o
149,0211-699501013259,Metodos,o
149,0211-699501013259,Todos,o
149,0211-699501013259,los,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,en,o
149,0211-699501013259,hemodialisis,i
149,0211-699501013259,al,o
149,0211-699501013259,comienzo,o
149,0211-699501013259,del,o
149,0211-699501013259,estudio,o
149,0211-699501013259,que,o
149,0211-699501013259,no,o
149,0211-699501013259,recibian,o
149,0211-699501013259,acido,i
149,0211-699501013259,folico,i
149,0211-699501013259,ni,o
149,0211-699501013259,vitamina,i
149,0211-699501013259,B6,i
149,0211-699501013259,asi,o
149,0211-699501013259,como,o
149,0211-699501013259,los,o
149,0211-699501013259,incorporados,o
149,0211-699501013259,posteriormente,o
149,0211-699501013259,a,o
149,0211-699501013259,partir,o
149,0211-699501013259,de,o
149,0211-699501013259,su,o
149,0211-699501013259,tercer,o
149,0211-699501013259,mes,o
149,0211-699501013259,en,o
149,0211-699501013259,hemodialisis,i
149,0211-699501013259,recibieron,o
149,0211-699501013259,5,o
149,0211-699501013259,mg,o
149,0211-699501013259,orales,o
149,0211-699501013259,de,o
149,0211-699501013259,acido,i
149,0211-699501013259,folico,i
149,0211-699501013259,cada,o
149,0211-699501013259,48,o
149,0211-699501013259,horas,o
149,0211-699501013259,y,o
149,0211-699501013259,40,o
149,0211-699501013259,mg,o
149,0211-699501013259,orales,o
149,0211-699501013259,de,o
149,0211-699501013259,vitamina,i
149,0211-699501013259,B6,i
149,0211-699501013259,cada,o
149,0211-699501013259,semana,o
149,0211-699501013259,Se,o
149,0211-699501013259,determinaron,o
149,0211-699501013259,al,o
149,0211-699501013259,comienzo,o
149,0211-699501013259,del,o
149,0211-699501013259,estudio,o
149,0211-699501013259,y,o
149,0211-699501013259,cada,o
149,0211-699501013259,2,o
149,0211-699501013259,meses,o
149,0211-699501013259,niveles,i
149,0211-699501013259,de,i
149,0211-699501013259,folato,i
149,0211-699501013259,vitamina,i
149,0211-699501013259,B12,i
149,0211-699501013259,inmunoensayo,i
149,0211-699501013259,albumina,i
149,0211-699501013259,y,o
149,0211-699501013259,cinetica,o
149,0211-699501013259,de,o
149,0211-699501013259,la,o
149,0211-699501013259,urea,i
149,0211-699501013259,KTV,o
149,0211-699501013259,KRU,o
149,0211-699501013259,PCRn,o
149,0211-699501013259,y,o
149,0211-699501013259,cada,o
149,0211-699501013259,6,o
149,0211-699501013259,meses,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,HPLC,i
149,0211-699501013259,y,o
149,0211-699501013259,pp,i
149,0211-699501013259,RIA,i
149,0211-699501013259,Resultados,o
149,0211-699501013259,80,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,fueron,o
149,0211-699501013259,incluidos,o
149,0211-699501013259,en,o
149,0211-699501013259,el,o
149,0211-699501013259,estudio,o
149,0211-699501013259,basal,o
149,0211-699501013259,con,o
149,0211-699501013259,una,o
149,0211-699501013259,prevalencia,o
149,0211-699501013259,de,o
149,0211-699501013259,hiperhomocisteinemia,i
149,0211-699501013259,del,o
149,0211-699501013259,844,o
149,0211-699501013259,deficit,i
149,0211-699501013259,de,i
149,0211-699501013259,pp,i
149,0211-699501013259,en,o
149,0211-699501013259,el,o
149,0211-699501013259,32,o
149,0211-699501013259,y,o
149,0211-699501013259,folato,i
149,0211-699501013259,en,o
149,0211-699501013259,el,o
149,0211-699501013259,rango,o
149,0211-699501013259,normal,o
149,0211-699501013259,bajo,o
149,0211-699501013259,los,o
149,0211-699501013259,niveles,i
149,0211-699501013259,de,i
149,0211-699501013259,tHcy,i
149,0211-699501013259,se,o
149,0211-699501013259,correlacionaban,o
149,0211-699501013259,inversamente,o
149,0211-699501013259,con,o
149,0211-699501013259,los,o
149,0211-699501013259,del,o
149,0211-699501013259,folato,i
149,0211-699501013259,r,o
149,0211-699501013259,0336,o
149,0211-699501013259,p,o
149,0211-699501013259,001,o
149,0211-699501013259,pero,o
149,0211-699501013259,no,o
149,0211-699501013259,con,o
149,0211-699501013259,pp,i
149,0211-699501013259,B12,i
149,0211-699501013259,edad,o
149,0211-699501013259,albumina,i
149,0211-699501013259,KTV,o
149,0211-699501013259,KRU,o
149,0211-699501013259,PCRn,o
149,0211-699501013259,Cincuenta,o
149,0211-699501013259,y,o
149,0211-699501013259,ocho,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,recibieron,o
149,0211-699501013259,seis,o
149,0211-699501013259,meses,o
149,0211-699501013259,de,o
149,0211-699501013259,suplementacion,i
149,0211-699501013259,con,o
149,0211-699501013259,normalizacion,o
149,0211-699501013259,del,o
149,0211-699501013259,pp,i
149,0211-699501013259,aumento,o
149,0211-699501013259,del,o
149,0211-699501013259,folato,i
149,0211-699501013259,703,o
149,0211-699501013259,IC,o
149,0211-699501013259,638,o
149,0211-699501013259,795,o
149,0211-699501013259,vs,o
149,0211-699501013259,6181,o
149,0211-699501013259,IC,o
149,0211-699501013259,4447,o
149,0211-699501013259,7811,o
149,0211-699501013259,p,o
149,0211-699501013259,0001,o
149,0211-699501013259,y,o
149,0211-699501013259,descenso,o
149,0211-699501013259,de,o
149,0211-699501013259,la,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,240,o
149,0211-699501013259,IC,o
149,0211-699501013259,213,o
149,0211-699501013259,264,o
149,0211-699501013259,vs,o
149,0211-699501013259,199,o
149,0211-699501013259,IC,o
149,0211-699501013259,175,o
149,0211-699501013259,224,o
149,0211-699501013259,p,o
149,0211-699501013259,005,o
149,0211-699501013259,Han,o
149,0211-699501013259,recibido,o
149,0211-699501013259,suplementacion,i
149,0211-699501013259,durante,o
149,0211-699501013259,12,o
149,0211-699501013259,meses,o
149,0211-699501013259,33,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,pero,o
149,0211-699501013259,a,o
149,0211-699501013259,pesar,o
149,0211-699501013259,de,o
149,0211-699501013259,un,o
149,0211-699501013259,continuo,o
149,0211-699501013259,aumento,o
149,0211-699501013259,del,o
149,0211-699501013259,folato,i
149,0211-699501013259,10078,o
149,0211-699501013259,IC,o
149,0211-699501013259,7481,o
149,0211-699501013259,12674,o
149,0211-699501013259,p,o
149,0211-699501013259,0001,o
149,0211-699501013259,solo,o
149,0211-699501013259,3,o
149,0211-699501013259,pacientes,o
149,0211-699501013259,presentan,o
149,0211-699501013259,niveles,o
149,0211-699501013259,normales,o
149,0211-699501013259,de,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,correlacionandose,o
149,0211-699501013259,directamente,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,con,o
149,0211-699501013259,la,o
149,0211-699501013259,albumina,i
149,0211-699501013259,r,o
149,0211-699501013259,056,o
149,0211-699501013259,p,o
149,0211-699501013259,0001,o
149,0211-699501013259,que,o
149,0211-699501013259,se,o
149,0211-699501013259,elevo,o
149,0211-699501013259,con,o
149,0211-699501013259,respecto,o
149,0211-699501013259,al,o
149,0211-699501013259,inicio,o
149,0211-699501013259,337,o
149,0211-699501013259,IC,o
149,0211-699501013259,327,o
149,0211-699501013259,346,o
149,0211-699501013259,vs,o
149,0211-699501013259,350,o
149,0211-699501013259,IC,o
149,0211-699501013259,337,o
149,0211-699501013259,363,o
149,0211-699501013259,p,o
149,0211-699501013259,005,o
149,0211-699501013259,Conclusion,o
149,0211-699501013259,Tras,o
149,0211-699501013259,suplementacion,i
149,0211-699501013259,con,o
149,0211-699501013259,acido,i
149,0211-699501013259,folico,i
149,0211-699501013259,y,o
149,0211-699501013259,vitamina,i
149,0211-699501013259,B6,i
149,0211-699501013259,aunque,o
149,0211-699501013259,inicialmente,o
149,0211-699501013259,se,o
149,0211-699501013259,reduce,o
149,0211-699501013259,la,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,esta,o
149,0211-699501013259,respuesta,o
149,0211-699501013259,se,o
149,0211-699501013259,hace,o
149,0211-699501013259,refractaria,o
149,0211-699501013259,correlacionandose,o
149,0211-699501013259,directamente,o
149,0211-699501013259,la,o
149,0211-699501013259,tHcy,i
149,0211-699501013259,con,o
149,0211-699501013259,la,o
149,0211-699501013259,albumina,i
149,0211-699501013259,plasmatica,i
149,0211-699501013259,La,o
149,0211-699501013259,interpretacion,o
149,0211-699501013259,de,o
149,0211-699501013259,los,o
149,0211-699501013259,niveles,i
149,0211-699501013259,de,i
149,0211-699501013259,tHcy,i
149,0211-699501013259,debe,o
149,0211-699501013259,tener,o
149,0211-699501013259,en,o
149,0211-699501013259,cuenta,o
149,0211-699501013259,la,o
149,0211-699501013259,concentracion,i
149,0211-699501013259,de,i
149,0211-699501013259,albumina,i
150,0211-699501013259,Efecto,o
150,0211-699501013259,de,o
150,0211-699501013259,la,o
150,0211-699501013259,suplementacion,i
150,0211-699501013259,con,o
150,0211-699501013259,acido,i
150,0211-699501013259,folico,i
150,0211-699501013259,sobre,o
150,0211-699501013259,los,o
150,0211-699501013259,niveles,i
150,0211-699501013259,de,i
150,0211-699501013259,homocisteina,i
150,0211-699501013259,total,o
150,0211-699501013259,en,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,en,o
150,0211-699501013259,hemodialisis,i
150,0211-699501013259,La,o
150,0211-699501013259,hiperhomocisteinemia,i
150,0211-699501013259,es,o
150,0211-699501013259,un,o
150,0211-699501013259,marcador,o
150,0211-699501013259,de,o
150,0211-699501013259,riesgo,o
150,0211-699501013259,independiente,o
150,0211-699501013259,de,o
150,0211-699501013259,morbimortalidad,o
150,0211-699501013259,cardiovascular,i
150,0211-699501013259,Hemos,o
150,0211-699501013259,intentado,o
150,0211-699501013259,prospectivamente,o
150,0211-699501013259,reducir,o
150,0211-699501013259,los,o
150,0211-699501013259,niveles,i
150,0211-699501013259,de,i
150,0211-699501013259,homocisteina,i
150,0211-699501013259,total,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,mediante,o
150,0211-699501013259,suplemento,o
150,0211-699501013259,con,o
150,0211-699501013259,acido,i
150,0211-699501013259,folico,i
150,0211-699501013259,y,o
150,0211-699501013259,vitamina,i
150,0211-699501013259,B6,i
150,0211-699501013259,pp,i
150,0211-699501013259,valorando,o
150,0211-699501013259,su,o
150,0211-699501013259,posible,o
150,0211-699501013259,correlacion,o
150,0211-699501013259,con,o
150,0211-699501013259,dosis,o
150,0211-699501013259,de,o
150,0211-699501013259,dialisis,i
150,0211-699501013259,funcion,i
150,0211-699501013259,residual,i
150,0211-699501013259,y,o
150,0211-699501013259,parametros,o
150,0211-699501013259,nutricionales,o
150,0211-699501013259,Metodos,o
150,0211-699501013259,Todos,o
150,0211-699501013259,los,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,en,o
150,0211-699501013259,hemodialisis,i
150,0211-699501013259,al,o
150,0211-699501013259,comienzo,o
150,0211-699501013259,del,o
150,0211-699501013259,estudio,o
150,0211-699501013259,que,o
150,0211-699501013259,no,o
150,0211-699501013259,recibian,o
150,0211-699501013259,acido,i
150,0211-699501013259,folico,i
150,0211-699501013259,ni,o
150,0211-699501013259,vitamina,i
150,0211-699501013259,B6,i
150,0211-699501013259,asi,o
150,0211-699501013259,como,o
150,0211-699501013259,los,o
150,0211-699501013259,incorporados,o
150,0211-699501013259,posteriormente,o
150,0211-699501013259,a,o
150,0211-699501013259,partir,o
150,0211-699501013259,de,o
150,0211-699501013259,su,o
150,0211-699501013259,tercer,o
150,0211-699501013259,mes,o
150,0211-699501013259,en,o
150,0211-699501013259,hemodialisis,i
150,0211-699501013259,recibieron,o
150,0211-699501013259,5,o
150,0211-699501013259,mg,o
150,0211-699501013259,orales,o
150,0211-699501013259,de,o
150,0211-699501013259,acido,i
150,0211-699501013259,folico,i
150,0211-699501013259,cada,o
150,0211-699501013259,48,o
150,0211-699501013259,horas,o
150,0211-699501013259,y,o
150,0211-699501013259,40,o
150,0211-699501013259,mg,o
150,0211-699501013259,orales,o
150,0211-699501013259,de,o
150,0211-699501013259,vitamina,i
150,0211-699501013259,B6,i
150,0211-699501013259,cada,o
150,0211-699501013259,semana,o
150,0211-699501013259,Se,o
150,0211-699501013259,determinaron,o
150,0211-699501013259,al,o
150,0211-699501013259,comienzo,o
150,0211-699501013259,del,o
150,0211-699501013259,estudio,o
150,0211-699501013259,y,o
150,0211-699501013259,cada,o
150,0211-699501013259,2,o
150,0211-699501013259,meses,o
150,0211-699501013259,niveles,i
150,0211-699501013259,de,i
150,0211-699501013259,folato,i
150,0211-699501013259,vitamina,i
150,0211-699501013259,B12,i
150,0211-699501013259,inmunoensayo,i
150,0211-699501013259,albumina,i
150,0211-699501013259,y,o
150,0211-699501013259,cinetica,o
150,0211-699501013259,de,o
150,0211-699501013259,la,o
150,0211-699501013259,urea,i
150,0211-699501013259,KTV,o
150,0211-699501013259,KRU,o
150,0211-699501013259,PCRn,o
150,0211-699501013259,y,o
150,0211-699501013259,cada,o
150,0211-699501013259,6,o
150,0211-699501013259,meses,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,HPLC,i
150,0211-699501013259,y,o
150,0211-699501013259,pp,i
150,0211-699501013259,RIA,i
150,0211-699501013259,Resultados,o
150,0211-699501013259,80,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,fueron,o
150,0211-699501013259,incluidos,o
150,0211-699501013259,en,o
150,0211-699501013259,el,o
150,0211-699501013259,estudio,o
150,0211-699501013259,basal,o
150,0211-699501013259,con,o
150,0211-699501013259,una,o
150,0211-699501013259,prevalencia,o
150,0211-699501013259,de,o
150,0211-699501013259,hiperhomocisteinemia,i
150,0211-699501013259,del,o
150,0211-699501013259,844,o
150,0211-699501013259,deficit,i
150,0211-699501013259,de,i
150,0211-699501013259,pp,i
150,0211-699501013259,en,o
150,0211-699501013259,el,o
150,0211-699501013259,32,o
150,0211-699501013259,y,o
150,0211-699501013259,folato,i
150,0211-699501013259,en,o
150,0211-699501013259,el,o
150,0211-699501013259,rango,o
150,0211-699501013259,normal,o
150,0211-699501013259,bajo,o
150,0211-699501013259,los,o
150,0211-699501013259,niveles,i
150,0211-699501013259,de,i
150,0211-699501013259,tHcy,i
150,0211-699501013259,se,o
150,0211-699501013259,correlacionaban,o
150,0211-699501013259,inversamente,o
150,0211-699501013259,con,o
150,0211-699501013259,los,o
150,0211-699501013259,del,o
150,0211-699501013259,folato,i
150,0211-699501013259,r,o
150,0211-699501013259,0336,o
150,0211-699501013259,p,o
150,0211-699501013259,001,o
150,0211-699501013259,pero,o
150,0211-699501013259,no,o
150,0211-699501013259,con,o
150,0211-699501013259,pp,i
150,0211-699501013259,B12,i
150,0211-699501013259,edad,o
150,0211-699501013259,albumina,i
150,0211-699501013259,KTV,o
150,0211-699501013259,KRU,o
150,0211-699501013259,PCRn,o
150,0211-699501013259,Cincuenta,o
150,0211-699501013259,y,o
150,0211-699501013259,ocho,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,recibieron,o
150,0211-699501013259,seis,o
150,0211-699501013259,meses,o
150,0211-699501013259,de,o
150,0211-699501013259,suplementacion,i
150,0211-699501013259,con,o
150,0211-699501013259,normalizacion,o
150,0211-699501013259,del,o
150,0211-699501013259,pp,i
150,0211-699501013259,aumento,o
150,0211-699501013259,del,o
150,0211-699501013259,folato,i
150,0211-699501013259,703,o
150,0211-699501013259,IC,o
150,0211-699501013259,638,o
150,0211-699501013259,795,o
150,0211-699501013259,vs,o
150,0211-699501013259,6181,o
150,0211-699501013259,IC,o
150,0211-699501013259,4447,o
150,0211-699501013259,7811,o
150,0211-699501013259,p,o
150,0211-699501013259,0001,o
150,0211-699501013259,y,o
150,0211-699501013259,descenso,o
150,0211-699501013259,de,o
150,0211-699501013259,la,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,240,o
150,0211-699501013259,IC,o
150,0211-699501013259,213,o
150,0211-699501013259,264,o
150,0211-699501013259,vs,o
150,0211-699501013259,199,o
150,0211-699501013259,IC,o
150,0211-699501013259,175,o
150,0211-699501013259,224,o
150,0211-699501013259,p,o
150,0211-699501013259,005,o
150,0211-699501013259,Han,o
150,0211-699501013259,recibido,o
150,0211-699501013259,suplementacion,i
150,0211-699501013259,durante,o
150,0211-699501013259,12,o
150,0211-699501013259,meses,o
150,0211-699501013259,33,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,pero,o
150,0211-699501013259,a,o
150,0211-699501013259,pesar,o
150,0211-699501013259,de,o
150,0211-699501013259,un,o
150,0211-699501013259,continuo,o
150,0211-699501013259,aumento,o
150,0211-699501013259,del,o
150,0211-699501013259,folato,i
150,0211-699501013259,10078,o
150,0211-699501013259,IC,o
150,0211-699501013259,7481,o
150,0211-699501013259,12674,o
150,0211-699501013259,p,o
150,0211-699501013259,0001,o
150,0211-699501013259,solo,o
150,0211-699501013259,3,o
150,0211-699501013259,pacientes,o
150,0211-699501013259,presentan,o
150,0211-699501013259,niveles,o
150,0211-699501013259,normales,o
150,0211-699501013259,de,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,correlacionandose,o
150,0211-699501013259,directamente,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,con,o
150,0211-699501013259,la,o
150,0211-699501013259,albumina,i
150,0211-699501013259,r,o
150,0211-699501013259,056,o
150,0211-699501013259,p,o
150,0211-699501013259,0001,o
150,0211-699501013259,que,o
150,0211-699501013259,se,o
150,0211-699501013259,elevo,o
150,0211-699501013259,con,o
150,0211-699501013259,respecto,o
150,0211-699501013259,al,o
150,0211-699501013259,inicio,o
150,0211-699501013259,337,o
150,0211-699501013259,IC,o
150,0211-699501013259,327,o
150,0211-699501013259,346,o
150,0211-699501013259,vs,o
150,0211-699501013259,350,o
150,0211-699501013259,IC,o
150,0211-699501013259,337,o
150,0211-699501013259,363,o
150,0211-699501013259,p,o
150,0211-699501013259,005,o
150,0211-699501013259,Conclusion,o
150,0211-699501013259,Tras,o
150,0211-699501013259,suplementacion,i
150,0211-699501013259,con,o
150,0211-699501013259,acido,i
150,0211-699501013259,folico,i
150,0211-699501013259,y,o
150,0211-699501013259,vitamina,i
150,0211-699501013259,B6,i
150,0211-699501013259,aunque,o
150,0211-699501013259,inicialmente,o
150,0211-699501013259,se,o
150,0211-699501013259,reduce,o
150,0211-699501013259,la,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,esta,o
150,0211-699501013259,respuesta,o
150,0211-699501013259,se,o
150,0211-699501013259,hace,o
150,0211-699501013259,refractaria,o
150,0211-699501013259,correlacionandose,o
150,0211-699501013259,directamente,o
150,0211-699501013259,la,o
150,0211-699501013259,tHcy,i
150,0211-699501013259,con,o
150,0211-699501013259,la,o
150,0211-699501013259,albumina,i
150,0211-699501013259,plasmatica,i
150,0211-699501013259,La,o
150,0211-699501013259,interpretacion,o
150,0211-699501013259,de,o
150,0211-699501013259,los,o
150,0211-699501013259,niveles,i
150,0211-699501013259,de,i
150,0211-699501013259,tHcy,i
150,0211-699501013259,debe,o
150,0211-699501013259,tener,o
150,0211-699501013259,en,o
150,0211-699501013259,cuenta,o
150,0211-699501013259,la,o
150,0211-699501013259,concentracion,i
150,0211-699501013259,de,i
150,0211-699501013259,albumina,i
151,0211-699501013259,Efecto,o
151,0211-699501013259,de,o
151,0211-699501013259,la,o
151,0211-699501013259,suplementacion,i
151,0211-699501013259,con,o
151,0211-699501013259,acido,i
151,0211-699501013259,folico,i
151,0211-699501013259,sobre,o
151,0211-699501013259,los,o
151,0211-699501013259,niveles,i
151,0211-699501013259,de,i
151,0211-699501013259,homocisteina,i
151,0211-699501013259,total,o
151,0211-699501013259,en,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,en,o
151,0211-699501013259,hemodialisis,i
151,0211-699501013259,La,o
151,0211-699501013259,hiperhomocisteinemia,i
151,0211-699501013259,es,o
151,0211-699501013259,un,o
151,0211-699501013259,marcador,o
151,0211-699501013259,de,o
151,0211-699501013259,riesgo,o
151,0211-699501013259,independiente,o
151,0211-699501013259,de,o
151,0211-699501013259,morbimortalidad,o
151,0211-699501013259,cardiovascular,i
151,0211-699501013259,Hemos,o
151,0211-699501013259,intentado,o
151,0211-699501013259,prospectivamente,o
151,0211-699501013259,reducir,o
151,0211-699501013259,los,o
151,0211-699501013259,niveles,i
151,0211-699501013259,de,i
151,0211-699501013259,homocisteina,i
151,0211-699501013259,total,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,mediante,o
151,0211-699501013259,suplemento,o
151,0211-699501013259,con,o
151,0211-699501013259,acido,i
151,0211-699501013259,folico,i
151,0211-699501013259,y,o
151,0211-699501013259,vitamina,i
151,0211-699501013259,B6,i
151,0211-699501013259,pp,i
151,0211-699501013259,valorando,o
151,0211-699501013259,su,o
151,0211-699501013259,posible,o
151,0211-699501013259,correlacion,o
151,0211-699501013259,con,o
151,0211-699501013259,dosis,o
151,0211-699501013259,de,o
151,0211-699501013259,dialisis,i
151,0211-699501013259,funcion,i
151,0211-699501013259,residual,i
151,0211-699501013259,y,o
151,0211-699501013259,parametros,o
151,0211-699501013259,nutricionales,o
151,0211-699501013259,Metodos,o
151,0211-699501013259,Todos,o
151,0211-699501013259,los,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,en,o
151,0211-699501013259,hemodialisis,i
151,0211-699501013259,al,o
151,0211-699501013259,comienzo,o
151,0211-699501013259,del,o
151,0211-699501013259,estudio,o
151,0211-699501013259,que,o
151,0211-699501013259,no,o
151,0211-699501013259,recibian,o
151,0211-699501013259,acido,i
151,0211-699501013259,folico,i
151,0211-699501013259,ni,o
151,0211-699501013259,vitamina,i
151,0211-699501013259,B6,i
151,0211-699501013259,asi,o
151,0211-699501013259,como,o
151,0211-699501013259,los,o
151,0211-699501013259,incorporados,o
151,0211-699501013259,posteriormente,o
151,0211-699501013259,a,o
151,0211-699501013259,partir,o
151,0211-699501013259,de,o
151,0211-699501013259,su,o
151,0211-699501013259,tercer,o
151,0211-699501013259,mes,o
151,0211-699501013259,en,o
151,0211-699501013259,hemodialisis,i
151,0211-699501013259,recibieron,o
151,0211-699501013259,5,o
151,0211-699501013259,mg,o
151,0211-699501013259,orales,o
151,0211-699501013259,de,o
151,0211-699501013259,acido,i
151,0211-699501013259,folico,i
151,0211-699501013259,cada,o
151,0211-699501013259,48,o
151,0211-699501013259,horas,o
151,0211-699501013259,y,o
151,0211-699501013259,40,o
151,0211-699501013259,mg,o
151,0211-699501013259,orales,o
151,0211-699501013259,de,o
151,0211-699501013259,vitamina,i
151,0211-699501013259,B6,i
151,0211-699501013259,cada,o
151,0211-699501013259,semana,o
151,0211-699501013259,Se,o
151,0211-699501013259,determinaron,o
151,0211-699501013259,al,o
151,0211-699501013259,comienzo,o
151,0211-699501013259,del,o
151,0211-699501013259,estudio,o
151,0211-699501013259,y,o
151,0211-699501013259,cada,o
151,0211-699501013259,2,o
151,0211-699501013259,meses,o
151,0211-699501013259,niveles,i
151,0211-699501013259,de,i
151,0211-699501013259,folato,i
151,0211-699501013259,vitamina,i
151,0211-699501013259,B12,i
151,0211-699501013259,inmunoensayo,i
151,0211-699501013259,albumina,i
151,0211-699501013259,y,o
151,0211-699501013259,cinetica,o
151,0211-699501013259,de,o
151,0211-699501013259,la,o
151,0211-699501013259,urea,i
151,0211-699501013259,KTV,o
151,0211-699501013259,KRU,o
151,0211-699501013259,PCRn,o
151,0211-699501013259,y,o
151,0211-699501013259,cada,o
151,0211-699501013259,6,o
151,0211-699501013259,meses,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,HPLC,i
151,0211-699501013259,y,o
151,0211-699501013259,pp,i
151,0211-699501013259,RIA,i
151,0211-699501013259,Resultados,o
151,0211-699501013259,80,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,fueron,o
151,0211-699501013259,incluidos,o
151,0211-699501013259,en,o
151,0211-699501013259,el,o
151,0211-699501013259,estudio,o
151,0211-699501013259,basal,o
151,0211-699501013259,con,o
151,0211-699501013259,una,o
151,0211-699501013259,prevalencia,o
151,0211-699501013259,de,o
151,0211-699501013259,hiperhomocisteinemia,i
151,0211-699501013259,del,o
151,0211-699501013259,844,o
151,0211-699501013259,deficit,i
151,0211-699501013259,de,i
151,0211-699501013259,pp,i
151,0211-699501013259,en,o
151,0211-699501013259,el,o
151,0211-699501013259,32,o
151,0211-699501013259,y,o
151,0211-699501013259,folato,i
151,0211-699501013259,en,o
151,0211-699501013259,el,o
151,0211-699501013259,rango,o
151,0211-699501013259,normal,o
151,0211-699501013259,bajo,o
151,0211-699501013259,los,o
151,0211-699501013259,niveles,i
151,0211-699501013259,de,i
151,0211-699501013259,tHcy,i
151,0211-699501013259,se,o
151,0211-699501013259,correlacionaban,o
151,0211-699501013259,inversamente,o
151,0211-699501013259,con,o
151,0211-699501013259,los,o
151,0211-699501013259,del,o
151,0211-699501013259,folato,i
151,0211-699501013259,r,o
151,0211-699501013259,0336,o
151,0211-699501013259,p,o
151,0211-699501013259,001,o
151,0211-699501013259,pero,o
151,0211-699501013259,no,o
151,0211-699501013259,con,o
151,0211-699501013259,pp,i
151,0211-699501013259,B12,i
151,0211-699501013259,edad,o
151,0211-699501013259,albumina,i
151,0211-699501013259,KTV,o
151,0211-699501013259,KRU,o
151,0211-699501013259,PCRn,o
151,0211-699501013259,Cincuenta,o
151,0211-699501013259,y,o
151,0211-699501013259,ocho,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,recibieron,o
151,0211-699501013259,seis,o
151,0211-699501013259,meses,o
151,0211-699501013259,de,o
151,0211-699501013259,suplementacion,i
151,0211-699501013259,con,o
151,0211-699501013259,normalizacion,o
151,0211-699501013259,del,o
151,0211-699501013259,pp,i
151,0211-699501013259,aumento,o
151,0211-699501013259,del,o
151,0211-699501013259,folato,i
151,0211-699501013259,703,o
151,0211-699501013259,IC,o
151,0211-699501013259,638,o
151,0211-699501013259,795,o
151,0211-699501013259,vs,o
151,0211-699501013259,6181,o
151,0211-699501013259,IC,o
151,0211-699501013259,4447,o
151,0211-699501013259,7811,o
151,0211-699501013259,p,o
151,0211-699501013259,0001,o
151,0211-699501013259,y,o
151,0211-699501013259,descenso,o
151,0211-699501013259,de,o
151,0211-699501013259,la,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,240,o
151,0211-699501013259,IC,o
151,0211-699501013259,213,o
151,0211-699501013259,264,o
151,0211-699501013259,vs,o
151,0211-699501013259,199,o
151,0211-699501013259,IC,o
151,0211-699501013259,175,o
151,0211-699501013259,224,o
151,0211-699501013259,p,o
151,0211-699501013259,005,o
151,0211-699501013259,Han,o
151,0211-699501013259,recibido,o
151,0211-699501013259,suplementacion,i
151,0211-699501013259,durante,o
151,0211-699501013259,12,o
151,0211-699501013259,meses,o
151,0211-699501013259,33,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,pero,o
151,0211-699501013259,a,o
151,0211-699501013259,pesar,o
151,0211-699501013259,de,o
151,0211-699501013259,un,o
151,0211-699501013259,continuo,o
151,0211-699501013259,aumento,o
151,0211-699501013259,del,o
151,0211-699501013259,folato,i
151,0211-699501013259,10078,o
151,0211-699501013259,IC,o
151,0211-699501013259,7481,o
151,0211-699501013259,12674,o
151,0211-699501013259,p,o
151,0211-699501013259,0001,o
151,0211-699501013259,solo,o
151,0211-699501013259,3,o
151,0211-699501013259,pacientes,o
151,0211-699501013259,presentan,o
151,0211-699501013259,niveles,o
151,0211-699501013259,normales,o
151,0211-699501013259,de,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,correlacionandose,o
151,0211-699501013259,directamente,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,con,o
151,0211-699501013259,la,o
151,0211-699501013259,albumina,i
151,0211-699501013259,r,o
151,0211-699501013259,056,o
151,0211-699501013259,p,o
151,0211-699501013259,0001,o
151,0211-699501013259,que,o
151,0211-699501013259,se,o
151,0211-699501013259,elevo,o
151,0211-699501013259,con,o
151,0211-699501013259,respecto,o
151,0211-699501013259,al,o
151,0211-699501013259,inicio,o
151,0211-699501013259,337,o
151,0211-699501013259,IC,o
151,0211-699501013259,327,o
151,0211-699501013259,346,o
151,0211-699501013259,vs,o
151,0211-699501013259,350,o
151,0211-699501013259,IC,o
151,0211-699501013259,337,o
151,0211-699501013259,363,o
151,0211-699501013259,p,o
151,0211-699501013259,005,o
151,0211-699501013259,Conclusion,o
151,0211-699501013259,Tras,o
151,0211-699501013259,suplementacion,i
151,0211-699501013259,con,o
151,0211-699501013259,acido,i
151,0211-699501013259,folico,i
151,0211-699501013259,y,o
151,0211-699501013259,vitamina,i
151,0211-699501013259,B6,i
151,0211-699501013259,aunque,o
151,0211-699501013259,inicialmente,o
151,0211-699501013259,se,o
151,0211-699501013259,reduce,o
151,0211-699501013259,la,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,esta,o
151,0211-699501013259,respuesta,o
151,0211-699501013259,se,o
151,0211-699501013259,hace,o
151,0211-699501013259,refractaria,o
151,0211-699501013259,correlacionandose,o
151,0211-699501013259,directamente,o
151,0211-699501013259,la,o
151,0211-699501013259,tHcy,i
151,0211-699501013259,con,o
151,0211-699501013259,la,o
151,0211-699501013259,albumina,i
151,0211-699501013259,plasmatica,i
151,0211-699501013259,La,o
151,0211-699501013259,interpretacion,o
151,0211-699501013259,de,o
151,0211-699501013259,los,o
151,0211-699501013259,niveles,i
151,0211-699501013259,de,i
151,0211-699501013259,tHcy,i
151,0211-699501013259,debe,o
151,0211-699501013259,tener,o
151,0211-699501013259,en,o
151,0211-699501013259,cuenta,o
151,0211-699501013259,la,o
151,0211-699501013259,concentracion,i
151,0211-699501013259,de,i
151,0211-699501013259,albumina,i
152,0211-699501013259,Efecto,o
152,0211-699501013259,de,o
152,0211-699501013259,la,o
152,0211-699501013259,suplementacion,i
152,0211-699501013259,con,o
152,0211-699501013259,acido,i
152,0211-699501013259,folico,i
152,0211-699501013259,sobre,o
152,0211-699501013259,los,o
152,0211-699501013259,niveles,i
152,0211-699501013259,de,i
152,0211-699501013259,homocisteina,i
152,0211-699501013259,total,o
152,0211-699501013259,en,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,en,o
152,0211-699501013259,hemodialisis,i
152,0211-699501013259,La,o
152,0211-699501013259,hiperhomocisteinemia,i
152,0211-699501013259,es,o
152,0211-699501013259,un,o
152,0211-699501013259,marcador,o
152,0211-699501013259,de,o
152,0211-699501013259,riesgo,o
152,0211-699501013259,independiente,o
152,0211-699501013259,de,o
152,0211-699501013259,morbimortalidad,o
152,0211-699501013259,cardiovascular,i
152,0211-699501013259,Hemos,o
152,0211-699501013259,intentado,o
152,0211-699501013259,prospectivamente,o
152,0211-699501013259,reducir,o
152,0211-699501013259,los,o
152,0211-699501013259,niveles,i
152,0211-699501013259,de,i
152,0211-699501013259,homocisteina,i
152,0211-699501013259,total,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,mediante,o
152,0211-699501013259,suplemento,o
152,0211-699501013259,con,o
152,0211-699501013259,acido,i
152,0211-699501013259,folico,i
152,0211-699501013259,y,o
152,0211-699501013259,vitamina,i
152,0211-699501013259,B6,i
152,0211-699501013259,pp,i
152,0211-699501013259,valorando,o
152,0211-699501013259,su,o
152,0211-699501013259,posible,o
152,0211-699501013259,correlacion,o
152,0211-699501013259,con,o
152,0211-699501013259,dosis,o
152,0211-699501013259,de,o
152,0211-699501013259,dialisis,i
152,0211-699501013259,funcion,i
152,0211-699501013259,residual,i
152,0211-699501013259,y,o
152,0211-699501013259,parametros,o
152,0211-699501013259,nutricionales,o
152,0211-699501013259,Metodos,o
152,0211-699501013259,Todos,o
152,0211-699501013259,los,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,en,o
152,0211-699501013259,hemodialisis,i
152,0211-699501013259,al,o
152,0211-699501013259,comienzo,o
152,0211-699501013259,del,o
152,0211-699501013259,estudio,o
152,0211-699501013259,que,o
152,0211-699501013259,no,o
152,0211-699501013259,recibian,o
152,0211-699501013259,acido,i
152,0211-699501013259,folico,i
152,0211-699501013259,ni,o
152,0211-699501013259,vitamina,i
152,0211-699501013259,B6,i
152,0211-699501013259,asi,o
152,0211-699501013259,como,o
152,0211-699501013259,los,o
152,0211-699501013259,incorporados,o
152,0211-699501013259,posteriormente,o
152,0211-699501013259,a,o
152,0211-699501013259,partir,o
152,0211-699501013259,de,o
152,0211-699501013259,su,o
152,0211-699501013259,tercer,o
152,0211-699501013259,mes,o
152,0211-699501013259,en,o
152,0211-699501013259,hemodialisis,i
152,0211-699501013259,recibieron,o
152,0211-699501013259,5,o
152,0211-699501013259,mg,o
152,0211-699501013259,orales,o
152,0211-699501013259,de,o
152,0211-699501013259,acido,i
152,0211-699501013259,folico,i
152,0211-699501013259,cada,o
152,0211-699501013259,48,o
152,0211-699501013259,horas,o
152,0211-699501013259,y,o
152,0211-699501013259,40,o
152,0211-699501013259,mg,o
152,0211-699501013259,orales,o
152,0211-699501013259,de,o
152,0211-699501013259,vitamina,i
152,0211-699501013259,B6,i
152,0211-699501013259,cada,o
152,0211-699501013259,semana,o
152,0211-699501013259,Se,o
152,0211-699501013259,determinaron,o
152,0211-699501013259,al,o
152,0211-699501013259,comienzo,o
152,0211-699501013259,del,o
152,0211-699501013259,estudio,o
152,0211-699501013259,y,o
152,0211-699501013259,cada,o
152,0211-699501013259,2,o
152,0211-699501013259,meses,o
152,0211-699501013259,niveles,i
152,0211-699501013259,de,i
152,0211-699501013259,folato,i
152,0211-699501013259,vitamina,i
152,0211-699501013259,B12,i
152,0211-699501013259,inmunoensayo,i
152,0211-699501013259,albumina,i
152,0211-699501013259,y,o
152,0211-699501013259,cinetica,o
152,0211-699501013259,de,o
152,0211-699501013259,la,o
152,0211-699501013259,urea,i
152,0211-699501013259,KTV,o
152,0211-699501013259,KRU,o
152,0211-699501013259,PCRn,o
152,0211-699501013259,y,o
152,0211-699501013259,cada,o
152,0211-699501013259,6,o
152,0211-699501013259,meses,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,HPLC,i
152,0211-699501013259,y,o
152,0211-699501013259,pp,i
152,0211-699501013259,RIA,i
152,0211-699501013259,Resultados,o
152,0211-699501013259,80,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,fueron,o
152,0211-699501013259,incluidos,o
152,0211-699501013259,en,o
152,0211-699501013259,el,o
152,0211-699501013259,estudio,o
152,0211-699501013259,basal,o
152,0211-699501013259,con,o
152,0211-699501013259,una,o
152,0211-699501013259,prevalencia,o
152,0211-699501013259,de,o
152,0211-699501013259,hiperhomocisteinemia,i
152,0211-699501013259,del,o
152,0211-699501013259,844,o
152,0211-699501013259,deficit,i
152,0211-699501013259,de,i
152,0211-699501013259,pp,i
152,0211-699501013259,en,o
152,0211-699501013259,el,o
152,0211-699501013259,32,o
152,0211-699501013259,y,o
152,0211-699501013259,folato,i
152,0211-699501013259,en,o
152,0211-699501013259,el,o
152,0211-699501013259,rango,o
152,0211-699501013259,normal,o
152,0211-699501013259,bajo,o
152,0211-699501013259,los,o
152,0211-699501013259,niveles,i
152,0211-699501013259,de,i
152,0211-699501013259,tHcy,i
152,0211-699501013259,se,o
152,0211-699501013259,correlacionaban,o
152,0211-699501013259,inversamente,o
152,0211-699501013259,con,o
152,0211-699501013259,los,o
152,0211-699501013259,del,o
152,0211-699501013259,folato,i
152,0211-699501013259,r,o
152,0211-699501013259,0336,o
152,0211-699501013259,p,o
152,0211-699501013259,001,o
152,0211-699501013259,pero,o
152,0211-699501013259,no,o
152,0211-699501013259,con,o
152,0211-699501013259,pp,i
152,0211-699501013259,B12,i
152,0211-699501013259,edad,o
152,0211-699501013259,albumina,i
152,0211-699501013259,KTV,o
152,0211-699501013259,KRU,o
152,0211-699501013259,PCRn,o
152,0211-699501013259,Cincuenta,o
152,0211-699501013259,y,o
152,0211-699501013259,ocho,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,recibieron,o
152,0211-699501013259,seis,o
152,0211-699501013259,meses,o
152,0211-699501013259,de,o
152,0211-699501013259,suplementacion,i
152,0211-699501013259,con,o
152,0211-699501013259,normalizacion,o
152,0211-699501013259,del,o
152,0211-699501013259,pp,i
152,0211-699501013259,aumento,o
152,0211-699501013259,del,o
152,0211-699501013259,folato,i
152,0211-699501013259,703,o
152,0211-699501013259,IC,o
152,0211-699501013259,638,o
152,0211-699501013259,795,o
152,0211-699501013259,vs,o
152,0211-699501013259,6181,o
152,0211-699501013259,IC,o
152,0211-699501013259,4447,o
152,0211-699501013259,7811,o
152,0211-699501013259,p,o
152,0211-699501013259,0001,o
152,0211-699501013259,y,o
152,0211-699501013259,descenso,o
152,0211-699501013259,de,o
152,0211-699501013259,la,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,240,o
152,0211-699501013259,IC,o
152,0211-699501013259,213,o
152,0211-699501013259,264,o
152,0211-699501013259,vs,o
152,0211-699501013259,199,o
152,0211-699501013259,IC,o
152,0211-699501013259,175,o
152,0211-699501013259,224,o
152,0211-699501013259,p,o
152,0211-699501013259,005,o
152,0211-699501013259,Han,o
152,0211-699501013259,recibido,o
152,0211-699501013259,suplementacion,i
152,0211-699501013259,durante,o
152,0211-699501013259,12,o
152,0211-699501013259,meses,o
152,0211-699501013259,33,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,pero,o
152,0211-699501013259,a,o
152,0211-699501013259,pesar,o
152,0211-699501013259,de,o
152,0211-699501013259,un,o
152,0211-699501013259,continuo,o
152,0211-699501013259,aumento,o
152,0211-699501013259,del,o
152,0211-699501013259,folato,i
152,0211-699501013259,10078,o
152,0211-699501013259,IC,o
152,0211-699501013259,7481,o
152,0211-699501013259,12674,o
152,0211-699501013259,p,o
152,0211-699501013259,0001,o
152,0211-699501013259,solo,o
152,0211-699501013259,3,o
152,0211-699501013259,pacientes,o
152,0211-699501013259,presentan,o
152,0211-699501013259,niveles,o
152,0211-699501013259,normales,o
152,0211-699501013259,de,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,correlacionandose,o
152,0211-699501013259,directamente,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,con,o
152,0211-699501013259,la,o
152,0211-699501013259,albumina,i
152,0211-699501013259,r,o
152,0211-699501013259,056,o
152,0211-699501013259,p,o
152,0211-699501013259,0001,o
152,0211-699501013259,que,o
152,0211-699501013259,se,o
152,0211-699501013259,elevo,o
152,0211-699501013259,con,o
152,0211-699501013259,respecto,o
152,0211-699501013259,al,o
152,0211-699501013259,inicio,o
152,0211-699501013259,337,o
152,0211-699501013259,IC,o
152,0211-699501013259,327,o
152,0211-699501013259,346,o
152,0211-699501013259,vs,o
152,0211-699501013259,350,o
152,0211-699501013259,IC,o
152,0211-699501013259,337,o
152,0211-699501013259,363,o
152,0211-699501013259,p,o
152,0211-699501013259,005,o
152,0211-699501013259,Conclusion,o
152,0211-699501013259,Tras,o
152,0211-699501013259,suplementacion,i
152,0211-699501013259,con,o
152,0211-699501013259,acido,i
152,0211-699501013259,folico,i
152,0211-699501013259,y,o
152,0211-699501013259,vitamina,i
152,0211-699501013259,B6,i
152,0211-699501013259,aunque,o
152,0211-699501013259,inicialmente,o
152,0211-699501013259,se,o
152,0211-699501013259,reduce,o
152,0211-699501013259,la,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,esta,o
152,0211-699501013259,respuesta,o
152,0211-699501013259,se,o
152,0211-699501013259,hace,o
152,0211-699501013259,refractaria,o
152,0211-699501013259,correlacionandose,o
152,0211-699501013259,directamente,o
152,0211-699501013259,la,o
152,0211-699501013259,tHcy,i
152,0211-699501013259,con,o
152,0211-699501013259,la,o
152,0211-699501013259,albumina,i
152,0211-699501013259,plasmatica,i
152,0211-699501013259,La,o
152,0211-699501013259,interpretacion,o
152,0211-699501013259,de,o
152,0211-699501013259,los,o
152,0211-699501013259,niveles,i
152,0211-699501013259,de,i
152,0211-699501013259,tHcy,i
152,0211-699501013259,debe,o
152,0211-699501013259,tener,o
152,0211-699501013259,en,o
152,0211-699501013259,cuenta,o
152,0211-699501013259,la,o
152,0211-699501013259,concentracion,i
152,0211-699501013259,de,i
152,0211-699501013259,albumina,i
153,0211-699501013259,Efecto,o
153,0211-699501013259,de,o
153,0211-699501013259,la,o
153,0211-699501013259,suplementacion,i
153,0211-699501013259,con,o
153,0211-699501013259,acido,i
153,0211-699501013259,folico,i
153,0211-699501013259,sobre,o
153,0211-699501013259,los,o
153,0211-699501013259,niveles,i
153,0211-699501013259,de,i
153,0211-699501013259,homocisteina,i
153,0211-699501013259,total,o
153,0211-699501013259,en,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,en,o
153,0211-699501013259,hemodialisis,i
153,0211-699501013259,La,o
153,0211-699501013259,hiperhomocisteinemia,i
153,0211-699501013259,es,o
153,0211-699501013259,un,o
153,0211-699501013259,marcador,o
153,0211-699501013259,de,o
153,0211-699501013259,riesgo,o
153,0211-699501013259,independiente,o
153,0211-699501013259,de,o
153,0211-699501013259,morbimortalidad,o
153,0211-699501013259,cardiovascular,i
153,0211-699501013259,Hemos,o
153,0211-699501013259,intentado,o
153,0211-699501013259,prospectivamente,o
153,0211-699501013259,reducir,o
153,0211-699501013259,los,o
153,0211-699501013259,niveles,i
153,0211-699501013259,de,i
153,0211-699501013259,homocisteina,i
153,0211-699501013259,total,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,mediante,o
153,0211-699501013259,suplemento,o
153,0211-699501013259,con,o
153,0211-699501013259,acido,i
153,0211-699501013259,folico,i
153,0211-699501013259,y,o
153,0211-699501013259,vitamina,i
153,0211-699501013259,B6,i
153,0211-699501013259,pp,i
153,0211-699501013259,valorando,o
153,0211-699501013259,su,o
153,0211-699501013259,posible,o
153,0211-699501013259,correlacion,o
153,0211-699501013259,con,o
153,0211-699501013259,dosis,o
153,0211-699501013259,de,o
153,0211-699501013259,dialisis,i
153,0211-699501013259,funcion,i
153,0211-699501013259,residual,i
153,0211-699501013259,y,o
153,0211-699501013259,parametros,o
153,0211-699501013259,nutricionales,o
153,0211-699501013259,Metodos,o
153,0211-699501013259,Todos,o
153,0211-699501013259,los,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,en,o
153,0211-699501013259,hemodialisis,i
153,0211-699501013259,al,o
153,0211-699501013259,comienzo,o
153,0211-699501013259,del,o
153,0211-699501013259,estudio,o
153,0211-699501013259,que,o
153,0211-699501013259,no,o
153,0211-699501013259,recibian,o
153,0211-699501013259,acido,i
153,0211-699501013259,folico,i
153,0211-699501013259,ni,o
153,0211-699501013259,vitamina,i
153,0211-699501013259,B6,i
153,0211-699501013259,asi,o
153,0211-699501013259,como,o
153,0211-699501013259,los,o
153,0211-699501013259,incorporados,o
153,0211-699501013259,posteriormente,o
153,0211-699501013259,a,o
153,0211-699501013259,partir,o
153,0211-699501013259,de,o
153,0211-699501013259,su,o
153,0211-699501013259,tercer,o
153,0211-699501013259,mes,o
153,0211-699501013259,en,o
153,0211-699501013259,hemodialisis,i
153,0211-699501013259,recibieron,o
153,0211-699501013259,5,o
153,0211-699501013259,mg,o
153,0211-699501013259,orales,o
153,0211-699501013259,de,o
153,0211-699501013259,acido,i
153,0211-699501013259,folico,i
153,0211-699501013259,cada,o
153,0211-699501013259,48,o
153,0211-699501013259,horas,o
153,0211-699501013259,y,o
153,0211-699501013259,40,o
153,0211-699501013259,mg,o
153,0211-699501013259,orales,o
153,0211-699501013259,de,o
153,0211-699501013259,vitamina,i
153,0211-699501013259,B6,i
153,0211-699501013259,cada,o
153,0211-699501013259,semana,o
153,0211-699501013259,Se,o
153,0211-699501013259,determinaron,o
153,0211-699501013259,al,o
153,0211-699501013259,comienzo,o
153,0211-699501013259,del,o
153,0211-699501013259,estudio,o
153,0211-699501013259,y,o
153,0211-699501013259,cada,o
153,0211-699501013259,2,o
153,0211-699501013259,meses,o
153,0211-699501013259,niveles,i
153,0211-699501013259,de,i
153,0211-699501013259,folato,i
153,0211-699501013259,vitamina,i
153,0211-699501013259,B12,i
153,0211-699501013259,inmunoensayo,i
153,0211-699501013259,albumina,i
153,0211-699501013259,y,o
153,0211-699501013259,cinetica,o
153,0211-699501013259,de,o
153,0211-699501013259,la,o
153,0211-699501013259,urea,i
153,0211-699501013259,KTV,o
153,0211-699501013259,KRU,o
153,0211-699501013259,PCRn,o
153,0211-699501013259,y,o
153,0211-699501013259,cada,o
153,0211-699501013259,6,o
153,0211-699501013259,meses,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,HPLC,i
153,0211-699501013259,y,o
153,0211-699501013259,pp,i
153,0211-699501013259,RIA,i
153,0211-699501013259,Resultados,o
153,0211-699501013259,80,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,fueron,o
153,0211-699501013259,incluidos,o
153,0211-699501013259,en,o
153,0211-699501013259,el,o
153,0211-699501013259,estudio,o
153,0211-699501013259,basal,o
153,0211-699501013259,con,o
153,0211-699501013259,una,o
153,0211-699501013259,prevalencia,o
153,0211-699501013259,de,o
153,0211-699501013259,hiperhomocisteinemia,i
153,0211-699501013259,del,o
153,0211-699501013259,844,o
153,0211-699501013259,deficit,i
153,0211-699501013259,de,i
153,0211-699501013259,pp,i
153,0211-699501013259,en,o
153,0211-699501013259,el,o
153,0211-699501013259,32,o
153,0211-699501013259,y,o
153,0211-699501013259,folato,i
153,0211-699501013259,en,o
153,0211-699501013259,el,o
153,0211-699501013259,rango,o
153,0211-699501013259,normal,o
153,0211-699501013259,bajo,o
153,0211-699501013259,los,o
153,0211-699501013259,niveles,i
153,0211-699501013259,de,i
153,0211-699501013259,tHcy,i
153,0211-699501013259,se,o
153,0211-699501013259,correlacionaban,o
153,0211-699501013259,inversamente,o
153,0211-699501013259,con,o
153,0211-699501013259,los,o
153,0211-699501013259,del,o
153,0211-699501013259,folato,i
153,0211-699501013259,r,o
153,0211-699501013259,0336,o
153,0211-699501013259,p,o
153,0211-699501013259,001,o
153,0211-699501013259,pero,o
153,0211-699501013259,no,o
153,0211-699501013259,con,o
153,0211-699501013259,pp,i
153,0211-699501013259,B12,i
153,0211-699501013259,edad,o
153,0211-699501013259,albumina,i
153,0211-699501013259,KTV,o
153,0211-699501013259,KRU,o
153,0211-699501013259,PCRn,o
153,0211-699501013259,Cincuenta,o
153,0211-699501013259,y,o
153,0211-699501013259,ocho,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,recibieron,o
153,0211-699501013259,seis,o
153,0211-699501013259,meses,o
153,0211-699501013259,de,o
153,0211-699501013259,suplementacion,i
153,0211-699501013259,con,o
153,0211-699501013259,normalizacion,o
153,0211-699501013259,del,o
153,0211-699501013259,pp,i
153,0211-699501013259,aumento,o
153,0211-699501013259,del,o
153,0211-699501013259,folato,i
153,0211-699501013259,703,o
153,0211-699501013259,IC,o
153,0211-699501013259,638,o
153,0211-699501013259,795,o
153,0211-699501013259,vs,o
153,0211-699501013259,6181,o
153,0211-699501013259,IC,o
153,0211-699501013259,4447,o
153,0211-699501013259,7811,o
153,0211-699501013259,p,o
153,0211-699501013259,0001,o
153,0211-699501013259,y,o
153,0211-699501013259,descenso,o
153,0211-699501013259,de,o
153,0211-699501013259,la,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,240,o
153,0211-699501013259,IC,o
153,0211-699501013259,213,o
153,0211-699501013259,264,o
153,0211-699501013259,vs,o
153,0211-699501013259,199,o
153,0211-699501013259,IC,o
153,0211-699501013259,175,o
153,0211-699501013259,224,o
153,0211-699501013259,p,o
153,0211-699501013259,005,o
153,0211-699501013259,Han,o
153,0211-699501013259,recibido,o
153,0211-699501013259,suplementacion,i
153,0211-699501013259,durante,o
153,0211-699501013259,12,o
153,0211-699501013259,meses,o
153,0211-699501013259,33,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,pero,o
153,0211-699501013259,a,o
153,0211-699501013259,pesar,o
153,0211-699501013259,de,o
153,0211-699501013259,un,o
153,0211-699501013259,continuo,o
153,0211-699501013259,aumento,o
153,0211-699501013259,del,o
153,0211-699501013259,folato,i
153,0211-699501013259,10078,o
153,0211-699501013259,IC,o
153,0211-699501013259,7481,o
153,0211-699501013259,12674,o
153,0211-699501013259,p,o
153,0211-699501013259,0001,o
153,0211-699501013259,solo,o
153,0211-699501013259,3,o
153,0211-699501013259,pacientes,o
153,0211-699501013259,presentan,o
153,0211-699501013259,niveles,o
153,0211-699501013259,normales,o
153,0211-699501013259,de,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,correlacionandose,o
153,0211-699501013259,directamente,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,con,o
153,0211-699501013259,la,o
153,0211-699501013259,albumina,i
153,0211-699501013259,r,o
153,0211-699501013259,056,o
153,0211-699501013259,p,o
153,0211-699501013259,0001,o
153,0211-699501013259,que,o
153,0211-699501013259,se,o
153,0211-699501013259,elevo,o
153,0211-699501013259,con,o
153,0211-699501013259,respecto,o
153,0211-699501013259,al,o
153,0211-699501013259,inicio,o
153,0211-699501013259,337,o
153,0211-699501013259,IC,o
153,0211-699501013259,327,o
153,0211-699501013259,346,o
153,0211-699501013259,vs,o
153,0211-699501013259,350,o
153,0211-699501013259,IC,o
153,0211-699501013259,337,o
153,0211-699501013259,363,o
153,0211-699501013259,p,o
153,0211-699501013259,005,o
153,0211-699501013259,Conclusion,o
153,0211-699501013259,Tras,o
153,0211-699501013259,suplementacion,i
153,0211-699501013259,con,o
153,0211-699501013259,acido,i
153,0211-699501013259,folico,i
153,0211-699501013259,y,o
153,0211-699501013259,vitamina,i
153,0211-699501013259,B6,i
153,0211-699501013259,aunque,o
153,0211-699501013259,inicialmente,o
153,0211-699501013259,se,o
153,0211-699501013259,reduce,o
153,0211-699501013259,la,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,esta,o
153,0211-699501013259,respuesta,o
153,0211-699501013259,se,o
153,0211-699501013259,hace,o
153,0211-699501013259,refractaria,o
153,0211-699501013259,correlacionandose,o
153,0211-699501013259,directamente,o
153,0211-699501013259,la,o
153,0211-699501013259,tHcy,i
153,0211-699501013259,con,o
153,0211-699501013259,la,o
153,0211-699501013259,albumina,i
153,0211-699501013259,plasmatica,i
153,0211-699501013259,La,o
153,0211-699501013259,interpretacion,o
153,0211-699501013259,de,o
153,0211-699501013259,los,o
153,0211-699501013259,niveles,i
153,0211-699501013259,de,i
153,0211-699501013259,tHcy,i
153,0211-699501013259,debe,o
153,0211-699501013259,tener,o
153,0211-699501013259,en,o
153,0211-699501013259,cuenta,o
153,0211-699501013259,la,o
153,0211-699501013259,concentracion,i
153,0211-699501013259,de,i
153,0211-699501013259,albumina,i
154,0211-699501013259,Efecto,o
154,0211-699501013259,de,o
154,0211-699501013259,la,o
154,0211-699501013259,suplementacion,i
154,0211-699501013259,con,o
154,0211-699501013259,acido,i
154,0211-699501013259,folico,i
154,0211-699501013259,sobre,o
154,0211-699501013259,los,o
154,0211-699501013259,niveles,i
154,0211-699501013259,de,i
154,0211-699501013259,homocisteina,i
154,0211-699501013259,total,o
154,0211-699501013259,en,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,en,o
154,0211-699501013259,hemodialisis,i
154,0211-699501013259,La,o
154,0211-699501013259,hiperhomocisteinemia,i
154,0211-699501013259,es,o
154,0211-699501013259,un,o
154,0211-699501013259,marcador,o
154,0211-699501013259,de,o
154,0211-699501013259,riesgo,o
154,0211-699501013259,independiente,o
154,0211-699501013259,de,o
154,0211-699501013259,morbimortalidad,o
154,0211-699501013259,cardiovascular,i
154,0211-699501013259,Hemos,o
154,0211-699501013259,intentado,o
154,0211-699501013259,prospectivamente,o
154,0211-699501013259,reducir,o
154,0211-699501013259,los,o
154,0211-699501013259,niveles,i
154,0211-699501013259,de,i
154,0211-699501013259,homocisteina,i
154,0211-699501013259,total,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,mediante,o
154,0211-699501013259,suplemento,o
154,0211-699501013259,con,o
154,0211-699501013259,acido,i
154,0211-699501013259,folico,i
154,0211-699501013259,y,o
154,0211-699501013259,vitamina,i
154,0211-699501013259,B6,i
154,0211-699501013259,pp,i
154,0211-699501013259,valorando,o
154,0211-699501013259,su,o
154,0211-699501013259,posible,o
154,0211-699501013259,correlacion,o
154,0211-699501013259,con,o
154,0211-699501013259,dosis,o
154,0211-699501013259,de,o
154,0211-699501013259,dialisis,i
154,0211-699501013259,funcion,i
154,0211-699501013259,residual,i
154,0211-699501013259,y,o
154,0211-699501013259,parametros,o
154,0211-699501013259,nutricionales,o
154,0211-699501013259,Metodos,o
154,0211-699501013259,Todos,o
154,0211-699501013259,los,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,en,o
154,0211-699501013259,hemodialisis,i
154,0211-699501013259,al,o
154,0211-699501013259,comienzo,o
154,0211-699501013259,del,o
154,0211-699501013259,estudio,o
154,0211-699501013259,que,o
154,0211-699501013259,no,o
154,0211-699501013259,recibian,o
154,0211-699501013259,acido,i
154,0211-699501013259,folico,i
154,0211-699501013259,ni,o
154,0211-699501013259,vitamina,i
154,0211-699501013259,B6,i
154,0211-699501013259,asi,o
154,0211-699501013259,como,o
154,0211-699501013259,los,o
154,0211-699501013259,incorporados,o
154,0211-699501013259,posteriormente,o
154,0211-699501013259,a,o
154,0211-699501013259,partir,o
154,0211-699501013259,de,o
154,0211-699501013259,su,o
154,0211-699501013259,tercer,o
154,0211-699501013259,mes,o
154,0211-699501013259,en,o
154,0211-699501013259,hemodialisis,i
154,0211-699501013259,recibieron,o
154,0211-699501013259,5,o
154,0211-699501013259,mg,o
154,0211-699501013259,orales,o
154,0211-699501013259,de,o
154,0211-699501013259,acido,i
154,0211-699501013259,folico,i
154,0211-699501013259,cada,o
154,0211-699501013259,48,o
154,0211-699501013259,horas,o
154,0211-699501013259,y,o
154,0211-699501013259,40,o
154,0211-699501013259,mg,o
154,0211-699501013259,orales,o
154,0211-699501013259,de,o
154,0211-699501013259,vitamina,i
154,0211-699501013259,B6,i
154,0211-699501013259,cada,o
154,0211-699501013259,semana,o
154,0211-699501013259,Se,o
154,0211-699501013259,determinaron,o
154,0211-699501013259,al,o
154,0211-699501013259,comienzo,o
154,0211-699501013259,del,o
154,0211-699501013259,estudio,o
154,0211-699501013259,y,o
154,0211-699501013259,cada,o
154,0211-699501013259,2,o
154,0211-699501013259,meses,o
154,0211-699501013259,niveles,i
154,0211-699501013259,de,i
154,0211-699501013259,folato,i
154,0211-699501013259,vitamina,i
154,0211-699501013259,B12,i
154,0211-699501013259,inmunoensayo,i
154,0211-699501013259,albumina,i
154,0211-699501013259,y,o
154,0211-699501013259,cinetica,o
154,0211-699501013259,de,o
154,0211-699501013259,la,o
154,0211-699501013259,urea,i
154,0211-699501013259,KTV,o
154,0211-699501013259,KRU,o
154,0211-699501013259,PCRn,o
154,0211-699501013259,y,o
154,0211-699501013259,cada,o
154,0211-699501013259,6,o
154,0211-699501013259,meses,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,HPLC,i
154,0211-699501013259,y,o
154,0211-699501013259,pp,i
154,0211-699501013259,RIA,i
154,0211-699501013259,Resultados,o
154,0211-699501013259,80,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,fueron,o
154,0211-699501013259,incluidos,o
154,0211-699501013259,en,o
154,0211-699501013259,el,o
154,0211-699501013259,estudio,o
154,0211-699501013259,basal,o
154,0211-699501013259,con,o
154,0211-699501013259,una,o
154,0211-699501013259,prevalencia,o
154,0211-699501013259,de,o
154,0211-699501013259,hiperhomocisteinemia,i
154,0211-699501013259,del,o
154,0211-699501013259,844,o
154,0211-699501013259,deficit,i
154,0211-699501013259,de,i
154,0211-699501013259,pp,i
154,0211-699501013259,en,o
154,0211-699501013259,el,o
154,0211-699501013259,32,o
154,0211-699501013259,y,o
154,0211-699501013259,folato,i
154,0211-699501013259,en,o
154,0211-699501013259,el,o
154,0211-699501013259,rango,o
154,0211-699501013259,normal,o
154,0211-699501013259,bajo,o
154,0211-699501013259,los,o
154,0211-699501013259,niveles,i
154,0211-699501013259,de,i
154,0211-699501013259,tHcy,i
154,0211-699501013259,se,o
154,0211-699501013259,correlacionaban,o
154,0211-699501013259,inversamente,o
154,0211-699501013259,con,o
154,0211-699501013259,los,o
154,0211-699501013259,del,o
154,0211-699501013259,folato,i
154,0211-699501013259,r,o
154,0211-699501013259,0336,o
154,0211-699501013259,p,o
154,0211-699501013259,001,o
154,0211-699501013259,pero,o
154,0211-699501013259,no,o
154,0211-699501013259,con,o
154,0211-699501013259,pp,i
154,0211-699501013259,B12,i
154,0211-699501013259,edad,o
154,0211-699501013259,albumina,i
154,0211-699501013259,KTV,o
154,0211-699501013259,KRU,o
154,0211-699501013259,PCRn,o
154,0211-699501013259,Cincuenta,o
154,0211-699501013259,y,o
154,0211-699501013259,ocho,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,recibieron,o
154,0211-699501013259,seis,o
154,0211-699501013259,meses,o
154,0211-699501013259,de,o
154,0211-699501013259,suplementacion,i
154,0211-699501013259,con,o
154,0211-699501013259,normalizacion,o
154,0211-699501013259,del,o
154,0211-699501013259,pp,i
154,0211-699501013259,aumento,o
154,0211-699501013259,del,o
154,0211-699501013259,folato,i
154,0211-699501013259,703,o
154,0211-699501013259,IC,o
154,0211-699501013259,638,o
154,0211-699501013259,795,o
154,0211-699501013259,vs,o
154,0211-699501013259,6181,o
154,0211-699501013259,IC,o
154,0211-699501013259,4447,o
154,0211-699501013259,7811,o
154,0211-699501013259,p,o
154,0211-699501013259,0001,o
154,0211-699501013259,y,o
154,0211-699501013259,descenso,o
154,0211-699501013259,de,o
154,0211-699501013259,la,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,240,o
154,0211-699501013259,IC,o
154,0211-699501013259,213,o
154,0211-699501013259,264,o
154,0211-699501013259,vs,o
154,0211-699501013259,199,o
154,0211-699501013259,IC,o
154,0211-699501013259,175,o
154,0211-699501013259,224,o
154,0211-699501013259,p,o
154,0211-699501013259,005,o
154,0211-699501013259,Han,o
154,0211-699501013259,recibido,o
154,0211-699501013259,suplementacion,i
154,0211-699501013259,durante,o
154,0211-699501013259,12,o
154,0211-699501013259,meses,o
154,0211-699501013259,33,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,pero,o
154,0211-699501013259,a,o
154,0211-699501013259,pesar,o
154,0211-699501013259,de,o
154,0211-699501013259,un,o
154,0211-699501013259,continuo,o
154,0211-699501013259,aumento,o
154,0211-699501013259,del,o
154,0211-699501013259,folato,i
154,0211-699501013259,10078,o
154,0211-699501013259,IC,o
154,0211-699501013259,7481,o
154,0211-699501013259,12674,o
154,0211-699501013259,p,o
154,0211-699501013259,0001,o
154,0211-699501013259,solo,o
154,0211-699501013259,3,o
154,0211-699501013259,pacientes,o
154,0211-699501013259,presentan,o
154,0211-699501013259,niveles,o
154,0211-699501013259,normales,o
154,0211-699501013259,de,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,correlacionandose,o
154,0211-699501013259,directamente,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,con,o
154,0211-699501013259,la,o
154,0211-699501013259,albumina,i
154,0211-699501013259,r,o
154,0211-699501013259,056,o
154,0211-699501013259,p,o
154,0211-699501013259,0001,o
154,0211-699501013259,que,o
154,0211-699501013259,se,o
154,0211-699501013259,elevo,o
154,0211-699501013259,con,o
154,0211-699501013259,respecto,o
154,0211-699501013259,al,o
154,0211-699501013259,inicio,o
154,0211-699501013259,337,o
154,0211-699501013259,IC,o
154,0211-699501013259,327,o
154,0211-699501013259,346,o
154,0211-699501013259,vs,o
154,0211-699501013259,350,o
154,0211-699501013259,IC,o
154,0211-699501013259,337,o
154,0211-699501013259,363,o
154,0211-699501013259,p,o
154,0211-699501013259,005,o
154,0211-699501013259,Conclusion,o
154,0211-699501013259,Tras,o
154,0211-699501013259,suplementacion,i
154,0211-699501013259,con,o
154,0211-699501013259,acido,i
154,0211-699501013259,folico,i
154,0211-699501013259,y,o
154,0211-699501013259,vitamina,i
154,0211-699501013259,B6,i
154,0211-699501013259,aunque,o
154,0211-699501013259,inicialmente,o
154,0211-699501013259,se,o
154,0211-699501013259,reduce,o
154,0211-699501013259,la,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,esta,o
154,0211-699501013259,respuesta,o
154,0211-699501013259,se,o
154,0211-699501013259,hace,o
154,0211-699501013259,refractaria,o
154,0211-699501013259,correlacionandose,o
154,0211-699501013259,directamente,o
154,0211-699501013259,la,o
154,0211-699501013259,tHcy,i
154,0211-699501013259,con,o
154,0211-699501013259,la,o
154,0211-699501013259,albumina,i
154,0211-699501013259,plasmatica,i
154,0211-699501013259,La,o
154,0211-699501013259,interpretacion,o
154,0211-699501013259,de,o
154,0211-699501013259,los,o
154,0211-699501013259,niveles,i
154,0211-699501013259,de,i
154,0211-699501013259,tHcy,i
154,0211-699501013259,debe,o
154,0211-699501013259,tener,o
154,0211-699501013259,en,o
154,0211-699501013259,cuenta,o
154,0211-699501013259,la,o
154,0211-699501013259,concentracion,i
154,0211-699501013259,de,i
154,0211-699501013259,albumina,i
155,0211-699501013259,Efecto,o
155,0211-699501013259,de,o
155,0211-699501013259,la,o
155,0211-699501013259,suplementacion,i
155,0211-699501013259,con,o
155,0211-699501013259,acido,i
155,0211-699501013259,folico,i
155,0211-699501013259,sobre,o
155,0211-699501013259,los,o
155,0211-699501013259,niveles,i
155,0211-699501013259,de,i
155,0211-699501013259,homocisteina,i
155,0211-699501013259,total,o
155,0211-699501013259,en,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,en,o
155,0211-699501013259,hemodialisis,i
155,0211-699501013259,La,o
155,0211-699501013259,hiperhomocisteinemia,i
155,0211-699501013259,es,o
155,0211-699501013259,un,o
155,0211-699501013259,marcador,o
155,0211-699501013259,de,o
155,0211-699501013259,riesgo,o
155,0211-699501013259,independiente,o
155,0211-699501013259,de,o
155,0211-699501013259,morbimortalidad,o
155,0211-699501013259,cardiovascular,i
155,0211-699501013259,Hemos,o
155,0211-699501013259,intentado,o
155,0211-699501013259,prospectivamente,o
155,0211-699501013259,reducir,o
155,0211-699501013259,los,o
155,0211-699501013259,niveles,i
155,0211-699501013259,de,i
155,0211-699501013259,homocisteina,i
155,0211-699501013259,total,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,mediante,o
155,0211-699501013259,suplemento,o
155,0211-699501013259,con,o
155,0211-699501013259,acido,i
155,0211-699501013259,folico,i
155,0211-699501013259,y,o
155,0211-699501013259,vitamina,i
155,0211-699501013259,B6,i
155,0211-699501013259,pp,i
155,0211-699501013259,valorando,o
155,0211-699501013259,su,o
155,0211-699501013259,posible,o
155,0211-699501013259,correlacion,o
155,0211-699501013259,con,o
155,0211-699501013259,dosis,o
155,0211-699501013259,de,o
155,0211-699501013259,dialisis,i
155,0211-699501013259,funcion,i
155,0211-699501013259,residual,i
155,0211-699501013259,y,o
155,0211-699501013259,parametros,o
155,0211-699501013259,nutricionales,o
155,0211-699501013259,Metodos,o
155,0211-699501013259,Todos,o
155,0211-699501013259,los,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,en,o
155,0211-699501013259,hemodialisis,i
155,0211-699501013259,al,o
155,0211-699501013259,comienzo,o
155,0211-699501013259,del,o
155,0211-699501013259,estudio,o
155,0211-699501013259,que,o
155,0211-699501013259,no,o
155,0211-699501013259,recibian,o
155,0211-699501013259,acido,i
155,0211-699501013259,folico,i
155,0211-699501013259,ni,o
155,0211-699501013259,vitamina,i
155,0211-699501013259,B6,i
155,0211-699501013259,asi,o
155,0211-699501013259,como,o
155,0211-699501013259,los,o
155,0211-699501013259,incorporados,o
155,0211-699501013259,posteriormente,o
155,0211-699501013259,a,o
155,0211-699501013259,partir,o
155,0211-699501013259,de,o
155,0211-699501013259,su,o
155,0211-699501013259,tercer,o
155,0211-699501013259,mes,o
155,0211-699501013259,en,o
155,0211-699501013259,hemodialisis,i
155,0211-699501013259,recibieron,o
155,0211-699501013259,5,o
155,0211-699501013259,mg,o
155,0211-699501013259,orales,o
155,0211-699501013259,de,o
155,0211-699501013259,acido,i
155,0211-699501013259,folico,i
155,0211-699501013259,cada,o
155,0211-699501013259,48,o
155,0211-699501013259,horas,o
155,0211-699501013259,y,o
155,0211-699501013259,40,o
155,0211-699501013259,mg,o
155,0211-699501013259,orales,o
155,0211-699501013259,de,o
155,0211-699501013259,vitamina,i
155,0211-699501013259,B6,i
155,0211-699501013259,cada,o
155,0211-699501013259,semana,o
155,0211-699501013259,Se,o
155,0211-699501013259,determinaron,o
155,0211-699501013259,al,o
155,0211-699501013259,comienzo,o
155,0211-699501013259,del,o
155,0211-699501013259,estudio,o
155,0211-699501013259,y,o
155,0211-699501013259,cada,o
155,0211-699501013259,2,o
155,0211-699501013259,meses,o
155,0211-699501013259,niveles,i
155,0211-699501013259,de,i
155,0211-699501013259,folato,i
155,0211-699501013259,vitamina,i
155,0211-699501013259,B12,i
155,0211-699501013259,inmunoensayo,i
155,0211-699501013259,albumina,i
155,0211-699501013259,y,o
155,0211-699501013259,cinetica,o
155,0211-699501013259,de,o
155,0211-699501013259,la,o
155,0211-699501013259,urea,i
155,0211-699501013259,KTV,o
155,0211-699501013259,KRU,o
155,0211-699501013259,PCRn,o
155,0211-699501013259,y,o
155,0211-699501013259,cada,o
155,0211-699501013259,6,o
155,0211-699501013259,meses,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,HPLC,i
155,0211-699501013259,y,o
155,0211-699501013259,pp,i
155,0211-699501013259,RIA,i
155,0211-699501013259,Resultados,o
155,0211-699501013259,80,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,fueron,o
155,0211-699501013259,incluidos,o
155,0211-699501013259,en,o
155,0211-699501013259,el,o
155,0211-699501013259,estudio,o
155,0211-699501013259,basal,o
155,0211-699501013259,con,o
155,0211-699501013259,una,o
155,0211-699501013259,prevalencia,o
155,0211-699501013259,de,o
155,0211-699501013259,hiperhomocisteinemia,i
155,0211-699501013259,del,o
155,0211-699501013259,844,o
155,0211-699501013259,deficit,i
155,0211-699501013259,de,i
155,0211-699501013259,pp,i
155,0211-699501013259,en,o
155,0211-699501013259,el,o
155,0211-699501013259,32,o
155,0211-699501013259,y,o
155,0211-699501013259,folato,i
155,0211-699501013259,en,o
155,0211-699501013259,el,o
155,0211-699501013259,rango,o
155,0211-699501013259,normal,o
155,0211-699501013259,bajo,o
155,0211-699501013259,los,o
155,0211-699501013259,niveles,i
155,0211-699501013259,de,i
155,0211-699501013259,tHcy,i
155,0211-699501013259,se,o
155,0211-699501013259,correlacionaban,o
155,0211-699501013259,inversamente,o
155,0211-699501013259,con,o
155,0211-699501013259,los,o
155,0211-699501013259,del,o
155,0211-699501013259,folato,i
155,0211-699501013259,r,o
155,0211-699501013259,0336,o
155,0211-699501013259,p,o
155,0211-699501013259,001,o
155,0211-699501013259,pero,o
155,0211-699501013259,no,o
155,0211-699501013259,con,o
155,0211-699501013259,pp,i
155,0211-699501013259,B12,i
155,0211-699501013259,edad,o
155,0211-699501013259,albumina,i
155,0211-699501013259,KTV,o
155,0211-699501013259,KRU,o
155,0211-699501013259,PCRn,o
155,0211-699501013259,Cincuenta,o
155,0211-699501013259,y,o
155,0211-699501013259,ocho,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,recibieron,o
155,0211-699501013259,seis,o
155,0211-699501013259,meses,o
155,0211-699501013259,de,o
155,0211-699501013259,suplementacion,i
155,0211-699501013259,con,o
155,0211-699501013259,normalizacion,o
155,0211-699501013259,del,o
155,0211-699501013259,pp,i
155,0211-699501013259,aumento,o
155,0211-699501013259,del,o
155,0211-699501013259,folato,i
155,0211-699501013259,703,o
155,0211-699501013259,IC,o
155,0211-699501013259,638,o
155,0211-699501013259,795,o
155,0211-699501013259,vs,o
155,0211-699501013259,6181,o
155,0211-699501013259,IC,o
155,0211-699501013259,4447,o
155,0211-699501013259,7811,o
155,0211-699501013259,p,o
155,0211-699501013259,0001,o
155,0211-699501013259,y,o
155,0211-699501013259,descenso,o
155,0211-699501013259,de,o
155,0211-699501013259,la,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,240,o
155,0211-699501013259,IC,o
155,0211-699501013259,213,o
155,0211-699501013259,264,o
155,0211-699501013259,vs,o
155,0211-699501013259,199,o
155,0211-699501013259,IC,o
155,0211-699501013259,175,o
155,0211-699501013259,224,o
155,0211-699501013259,p,o
155,0211-699501013259,005,o
155,0211-699501013259,Han,o
155,0211-699501013259,recibido,o
155,0211-699501013259,suplementacion,i
155,0211-699501013259,durante,o
155,0211-699501013259,12,o
155,0211-699501013259,meses,o
155,0211-699501013259,33,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,pero,o
155,0211-699501013259,a,o
155,0211-699501013259,pesar,o
155,0211-699501013259,de,o
155,0211-699501013259,un,o
155,0211-699501013259,continuo,o
155,0211-699501013259,aumento,o
155,0211-699501013259,del,o
155,0211-699501013259,folato,i
155,0211-699501013259,10078,o
155,0211-699501013259,IC,o
155,0211-699501013259,7481,o
155,0211-699501013259,12674,o
155,0211-699501013259,p,o
155,0211-699501013259,0001,o
155,0211-699501013259,solo,o
155,0211-699501013259,3,o
155,0211-699501013259,pacientes,o
155,0211-699501013259,presentan,o
155,0211-699501013259,niveles,o
155,0211-699501013259,normales,o
155,0211-699501013259,de,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,correlacionandose,o
155,0211-699501013259,directamente,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,con,o
155,0211-699501013259,la,o
155,0211-699501013259,albumina,i
155,0211-699501013259,r,o
155,0211-699501013259,056,o
155,0211-699501013259,p,o
155,0211-699501013259,0001,o
155,0211-699501013259,que,o
155,0211-699501013259,se,o
155,0211-699501013259,elevo,o
155,0211-699501013259,con,o
155,0211-699501013259,respecto,o
155,0211-699501013259,al,o
155,0211-699501013259,inicio,o
155,0211-699501013259,337,o
155,0211-699501013259,IC,o
155,0211-699501013259,327,o
155,0211-699501013259,346,o
155,0211-699501013259,vs,o
155,0211-699501013259,350,o
155,0211-699501013259,IC,o
155,0211-699501013259,337,o
155,0211-699501013259,363,o
155,0211-699501013259,p,o
155,0211-699501013259,005,o
155,0211-699501013259,Conclusion,o
155,0211-699501013259,Tras,o
155,0211-699501013259,suplementacion,i
155,0211-699501013259,con,o
155,0211-699501013259,acido,i
155,0211-699501013259,folico,i
155,0211-699501013259,y,o
155,0211-699501013259,vitamina,i
155,0211-699501013259,B6,i
155,0211-699501013259,aunque,o
155,0211-699501013259,inicialmente,o
155,0211-699501013259,se,o
155,0211-699501013259,reduce,o
155,0211-699501013259,la,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,esta,o
155,0211-699501013259,respuesta,o
155,0211-699501013259,se,o
155,0211-699501013259,hace,o
155,0211-699501013259,refractaria,o
155,0211-699501013259,correlacionandose,o
155,0211-699501013259,directamente,o
155,0211-699501013259,la,o
155,0211-699501013259,tHcy,i
155,0211-699501013259,con,o
155,0211-699501013259,la,o
155,0211-699501013259,albumina,i
155,0211-699501013259,plasmatica,i
155,0211-699501013259,La,o
155,0211-699501013259,interpretacion,o
155,0211-699501013259,de,o
155,0211-699501013259,los,o
155,0211-699501013259,niveles,i
155,0211-699501013259,de,i
155,0211-699501013259,tHcy,i
155,0211-699501013259,debe,o
155,0211-699501013259,tener,o
155,0211-699501013259,en,o
155,0211-699501013259,cuenta,o
155,0211-699501013259,la,o
155,0211-699501013259,concentracion,i
155,0211-699501013259,de,i
155,0211-699501013259,albumina,i
156,0211-699501013259,Efecto,o
156,0211-699501013259,de,o
156,0211-699501013259,la,o
156,0211-699501013259,suplementacion,i
156,0211-699501013259,con,o
156,0211-699501013259,acido,i
156,0211-699501013259,folico,i
156,0211-699501013259,sobre,o
156,0211-699501013259,los,o
156,0211-699501013259,niveles,i
156,0211-699501013259,de,i
156,0211-699501013259,homocisteina,i
156,0211-699501013259,total,o
156,0211-699501013259,en,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,en,o
156,0211-699501013259,hemodialisis,i
156,0211-699501013259,La,o
156,0211-699501013259,hiperhomocisteinemia,i
156,0211-699501013259,es,o
156,0211-699501013259,un,o
156,0211-699501013259,marcador,o
156,0211-699501013259,de,o
156,0211-699501013259,riesgo,o
156,0211-699501013259,independiente,o
156,0211-699501013259,de,o
156,0211-699501013259,morbimortalidad,o
156,0211-699501013259,cardiovascular,i
156,0211-699501013259,Hemos,o
156,0211-699501013259,intentado,o
156,0211-699501013259,prospectivamente,o
156,0211-699501013259,reducir,o
156,0211-699501013259,los,o
156,0211-699501013259,niveles,i
156,0211-699501013259,de,i
156,0211-699501013259,homocisteina,i
156,0211-699501013259,total,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,mediante,o
156,0211-699501013259,suplemento,o
156,0211-699501013259,con,o
156,0211-699501013259,acido,i
156,0211-699501013259,folico,i
156,0211-699501013259,y,o
156,0211-699501013259,vitamina,i
156,0211-699501013259,B6,i
156,0211-699501013259,pp,i
156,0211-699501013259,valorando,o
156,0211-699501013259,su,o
156,0211-699501013259,posible,o
156,0211-699501013259,correlacion,o
156,0211-699501013259,con,o
156,0211-699501013259,dosis,o
156,0211-699501013259,de,o
156,0211-699501013259,dialisis,i
156,0211-699501013259,funcion,i
156,0211-699501013259,residual,i
156,0211-699501013259,y,o
156,0211-699501013259,parametros,o
156,0211-699501013259,nutricionales,o
156,0211-699501013259,Metodos,o
156,0211-699501013259,Todos,o
156,0211-699501013259,los,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,en,o
156,0211-699501013259,hemodialisis,i
156,0211-699501013259,al,o
156,0211-699501013259,comienzo,o
156,0211-699501013259,del,o
156,0211-699501013259,estudio,o
156,0211-699501013259,que,o
156,0211-699501013259,no,o
156,0211-699501013259,recibian,o
156,0211-699501013259,acido,i
156,0211-699501013259,folico,i
156,0211-699501013259,ni,o
156,0211-699501013259,vitamina,i
156,0211-699501013259,B6,i
156,0211-699501013259,asi,o
156,0211-699501013259,como,o
156,0211-699501013259,los,o
156,0211-699501013259,incorporados,o
156,0211-699501013259,posteriormente,o
156,0211-699501013259,a,o
156,0211-699501013259,partir,o
156,0211-699501013259,de,o
156,0211-699501013259,su,o
156,0211-699501013259,tercer,o
156,0211-699501013259,mes,o
156,0211-699501013259,en,o
156,0211-699501013259,hemodialisis,i
156,0211-699501013259,recibieron,o
156,0211-699501013259,5,o
156,0211-699501013259,mg,o
156,0211-699501013259,orales,o
156,0211-699501013259,de,o
156,0211-699501013259,acido,i
156,0211-699501013259,folico,i
156,0211-699501013259,cada,o
156,0211-699501013259,48,o
156,0211-699501013259,horas,o
156,0211-699501013259,y,o
156,0211-699501013259,40,o
156,0211-699501013259,mg,o
156,0211-699501013259,orales,o
156,0211-699501013259,de,o
156,0211-699501013259,vitamina,i
156,0211-699501013259,B6,i
156,0211-699501013259,cada,o
156,0211-699501013259,semana,o
156,0211-699501013259,Se,o
156,0211-699501013259,determinaron,o
156,0211-699501013259,al,o
156,0211-699501013259,comienzo,o
156,0211-699501013259,del,o
156,0211-699501013259,estudio,o
156,0211-699501013259,y,o
156,0211-699501013259,cada,o
156,0211-699501013259,2,o
156,0211-699501013259,meses,o
156,0211-699501013259,niveles,i
156,0211-699501013259,de,i
156,0211-699501013259,folato,i
156,0211-699501013259,vitamina,i
156,0211-699501013259,B12,i
156,0211-699501013259,inmunoensayo,i
156,0211-699501013259,albumina,i
156,0211-699501013259,y,o
156,0211-699501013259,cinetica,o
156,0211-699501013259,de,o
156,0211-699501013259,la,o
156,0211-699501013259,urea,i
156,0211-699501013259,KTV,o
156,0211-699501013259,KRU,o
156,0211-699501013259,PCRn,o
156,0211-699501013259,y,o
156,0211-699501013259,cada,o
156,0211-699501013259,6,o
156,0211-699501013259,meses,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,HPLC,i
156,0211-699501013259,y,o
156,0211-699501013259,pp,i
156,0211-699501013259,RIA,i
156,0211-699501013259,Resultados,o
156,0211-699501013259,80,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,fueron,o
156,0211-699501013259,incluidos,o
156,0211-699501013259,en,o
156,0211-699501013259,el,o
156,0211-699501013259,estudio,o
156,0211-699501013259,basal,o
156,0211-699501013259,con,o
156,0211-699501013259,una,o
156,0211-699501013259,prevalencia,o
156,0211-699501013259,de,o
156,0211-699501013259,hiperhomocisteinemia,i
156,0211-699501013259,del,o
156,0211-699501013259,844,o
156,0211-699501013259,deficit,i
156,0211-699501013259,de,i
156,0211-699501013259,pp,i
156,0211-699501013259,en,o
156,0211-699501013259,el,o
156,0211-699501013259,32,o
156,0211-699501013259,y,o
156,0211-699501013259,folato,i
156,0211-699501013259,en,o
156,0211-699501013259,el,o
156,0211-699501013259,rango,o
156,0211-699501013259,normal,o
156,0211-699501013259,bajo,o
156,0211-699501013259,los,o
156,0211-699501013259,niveles,i
156,0211-699501013259,de,i
156,0211-699501013259,tHcy,i
156,0211-699501013259,se,o
156,0211-699501013259,correlacionaban,o
156,0211-699501013259,inversamente,o
156,0211-699501013259,con,o
156,0211-699501013259,los,o
156,0211-699501013259,del,o
156,0211-699501013259,folato,i
156,0211-699501013259,r,o
156,0211-699501013259,0336,o
156,0211-699501013259,p,o
156,0211-699501013259,001,o
156,0211-699501013259,pero,o
156,0211-699501013259,no,o
156,0211-699501013259,con,o
156,0211-699501013259,pp,i
156,0211-699501013259,B12,i
156,0211-699501013259,edad,o
156,0211-699501013259,albumina,i
156,0211-699501013259,KTV,o
156,0211-699501013259,KRU,o
156,0211-699501013259,PCRn,o
156,0211-699501013259,Cincuenta,o
156,0211-699501013259,y,o
156,0211-699501013259,ocho,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,recibieron,o
156,0211-699501013259,seis,o
156,0211-699501013259,meses,o
156,0211-699501013259,de,o
156,0211-699501013259,suplementacion,i
156,0211-699501013259,con,o
156,0211-699501013259,normalizacion,o
156,0211-699501013259,del,o
156,0211-699501013259,pp,i
156,0211-699501013259,aumento,o
156,0211-699501013259,del,o
156,0211-699501013259,folato,i
156,0211-699501013259,703,o
156,0211-699501013259,IC,o
156,0211-699501013259,638,o
156,0211-699501013259,795,o
156,0211-699501013259,vs,o
156,0211-699501013259,6181,o
156,0211-699501013259,IC,o
156,0211-699501013259,4447,o
156,0211-699501013259,7811,o
156,0211-699501013259,p,o
156,0211-699501013259,0001,o
156,0211-699501013259,y,o
156,0211-699501013259,descenso,o
156,0211-699501013259,de,o
156,0211-699501013259,la,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,240,o
156,0211-699501013259,IC,o
156,0211-699501013259,213,o
156,0211-699501013259,264,o
156,0211-699501013259,vs,o
156,0211-699501013259,199,o
156,0211-699501013259,IC,o
156,0211-699501013259,175,o
156,0211-699501013259,224,o
156,0211-699501013259,p,o
156,0211-699501013259,005,o
156,0211-699501013259,Han,o
156,0211-699501013259,recibido,o
156,0211-699501013259,suplementacion,i
156,0211-699501013259,durante,o
156,0211-699501013259,12,o
156,0211-699501013259,meses,o
156,0211-699501013259,33,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,pero,o
156,0211-699501013259,a,o
156,0211-699501013259,pesar,o
156,0211-699501013259,de,o
156,0211-699501013259,un,o
156,0211-699501013259,continuo,o
156,0211-699501013259,aumento,o
156,0211-699501013259,del,o
156,0211-699501013259,folato,i
156,0211-699501013259,10078,o
156,0211-699501013259,IC,o
156,0211-699501013259,7481,o
156,0211-699501013259,12674,o
156,0211-699501013259,p,o
156,0211-699501013259,0001,o
156,0211-699501013259,solo,o
156,0211-699501013259,3,o
156,0211-699501013259,pacientes,o
156,0211-699501013259,presentan,o
156,0211-699501013259,niveles,o
156,0211-699501013259,normales,o
156,0211-699501013259,de,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,correlacionandose,o
156,0211-699501013259,directamente,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,con,o
156,0211-699501013259,la,o
156,0211-699501013259,albumina,i
156,0211-699501013259,r,o
156,0211-699501013259,056,o
156,0211-699501013259,p,o
156,0211-699501013259,0001,o
156,0211-699501013259,que,o
156,0211-699501013259,se,o
156,0211-699501013259,elevo,o
156,0211-699501013259,con,o
156,0211-699501013259,respecto,o
156,0211-699501013259,al,o
156,0211-699501013259,inicio,o
156,0211-699501013259,337,o
156,0211-699501013259,IC,o
156,0211-699501013259,327,o
156,0211-699501013259,346,o
156,0211-699501013259,vs,o
156,0211-699501013259,350,o
156,0211-699501013259,IC,o
156,0211-699501013259,337,o
156,0211-699501013259,363,o
156,0211-699501013259,p,o
156,0211-699501013259,005,o
156,0211-699501013259,Conclusion,o
156,0211-699501013259,Tras,o
156,0211-699501013259,suplementacion,i
156,0211-699501013259,con,o
156,0211-699501013259,acido,i
156,0211-699501013259,folico,i
156,0211-699501013259,y,o
156,0211-699501013259,vitamina,i
156,0211-699501013259,B6,i
156,0211-699501013259,aunque,o
156,0211-699501013259,inicialmente,o
156,0211-699501013259,se,o
156,0211-699501013259,reduce,o
156,0211-699501013259,la,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,esta,o
156,0211-699501013259,respuesta,o
156,0211-699501013259,se,o
156,0211-699501013259,hace,o
156,0211-699501013259,refractaria,o
156,0211-699501013259,correlacionandose,o
156,0211-699501013259,directamente,o
156,0211-699501013259,la,o
156,0211-699501013259,tHcy,i
156,0211-699501013259,con,o
156,0211-699501013259,la,o
156,0211-699501013259,albumina,i
156,0211-699501013259,plasmatica,i
156,0211-699501013259,La,o
156,0211-699501013259,interpretacion,o
156,0211-699501013259,de,o
156,0211-699501013259,los,o
156,0211-699501013259,niveles,i
156,0211-699501013259,de,i
156,0211-699501013259,tHcy,i
156,0211-699501013259,debe,o
156,0211-699501013259,tener,o
156,0211-699501013259,en,o
156,0211-699501013259,cuenta,o
156,0211-699501013259,la,o
156,0211-699501013259,concentracion,i
156,0211-699501013259,de,i
156,0211-699501013259,albumina,i
157,0211-699501013259,Efecto,o
157,0211-699501013259,de,o
157,0211-699501013259,la,o
157,0211-699501013259,suplementacion,i
157,0211-699501013259,con,o
157,0211-699501013259,acido,i
157,0211-699501013259,folico,i
157,0211-699501013259,sobre,o
157,0211-699501013259,los,o
157,0211-699501013259,niveles,i
157,0211-699501013259,de,i
157,0211-699501013259,homocisteina,i
157,0211-699501013259,total,o
157,0211-699501013259,en,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,en,o
157,0211-699501013259,hemodialisis,i
157,0211-699501013259,La,o
157,0211-699501013259,hiperhomocisteinemia,i
157,0211-699501013259,es,o
157,0211-699501013259,un,o
157,0211-699501013259,marcador,o
157,0211-699501013259,de,o
157,0211-699501013259,riesgo,o
157,0211-699501013259,independiente,o
157,0211-699501013259,de,o
157,0211-699501013259,morbimortalidad,o
157,0211-699501013259,cardiovascular,i
157,0211-699501013259,Hemos,o
157,0211-699501013259,intentado,o
157,0211-699501013259,prospectivamente,o
157,0211-699501013259,reducir,o
157,0211-699501013259,los,o
157,0211-699501013259,niveles,i
157,0211-699501013259,de,i
157,0211-699501013259,homocisteina,i
157,0211-699501013259,total,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,mediante,o
157,0211-699501013259,suplemento,o
157,0211-699501013259,con,o
157,0211-699501013259,acido,i
157,0211-699501013259,folico,i
157,0211-699501013259,y,o
157,0211-699501013259,vitamina,i
157,0211-699501013259,B6,i
157,0211-699501013259,pp,i
157,0211-699501013259,valorando,o
157,0211-699501013259,su,o
157,0211-699501013259,posible,o
157,0211-699501013259,correlacion,o
157,0211-699501013259,con,o
157,0211-699501013259,dosis,o
157,0211-699501013259,de,o
157,0211-699501013259,dialisis,i
157,0211-699501013259,funcion,i
157,0211-699501013259,residual,i
157,0211-699501013259,y,o
157,0211-699501013259,parametros,o
157,0211-699501013259,nutricionales,o
157,0211-699501013259,Metodos,o
157,0211-699501013259,Todos,o
157,0211-699501013259,los,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,en,o
157,0211-699501013259,hemodialisis,i
157,0211-699501013259,al,o
157,0211-699501013259,comienzo,o
157,0211-699501013259,del,o
157,0211-699501013259,estudio,o
157,0211-699501013259,que,o
157,0211-699501013259,no,o
157,0211-699501013259,recibian,o
157,0211-699501013259,acido,i
157,0211-699501013259,folico,i
157,0211-699501013259,ni,o
157,0211-699501013259,vitamina,i
157,0211-699501013259,B6,i
157,0211-699501013259,asi,o
157,0211-699501013259,como,o
157,0211-699501013259,los,o
157,0211-699501013259,incorporados,o
157,0211-699501013259,posteriormente,o
157,0211-699501013259,a,o
157,0211-699501013259,partir,o
157,0211-699501013259,de,o
157,0211-699501013259,su,o
157,0211-699501013259,tercer,o
157,0211-699501013259,mes,o
157,0211-699501013259,en,o
157,0211-699501013259,hemodialisis,i
157,0211-699501013259,recibieron,o
157,0211-699501013259,5,o
157,0211-699501013259,mg,o
157,0211-699501013259,orales,o
157,0211-699501013259,de,o
157,0211-699501013259,acido,i
157,0211-699501013259,folico,i
157,0211-699501013259,cada,o
157,0211-699501013259,48,o
157,0211-699501013259,horas,o
157,0211-699501013259,y,o
157,0211-699501013259,40,o
157,0211-699501013259,mg,o
157,0211-699501013259,orales,o
157,0211-699501013259,de,o
157,0211-699501013259,vitamina,i
157,0211-699501013259,B6,i
157,0211-699501013259,cada,o
157,0211-699501013259,semana,o
157,0211-699501013259,Se,o
157,0211-699501013259,determinaron,o
157,0211-699501013259,al,o
157,0211-699501013259,comienzo,o
157,0211-699501013259,del,o
157,0211-699501013259,estudio,o
157,0211-699501013259,y,o
157,0211-699501013259,cada,o
157,0211-699501013259,2,o
157,0211-699501013259,meses,o
157,0211-699501013259,niveles,i
157,0211-699501013259,de,i
157,0211-699501013259,folato,i
157,0211-699501013259,vitamina,i
157,0211-699501013259,B12,i
157,0211-699501013259,inmunoensayo,i
157,0211-699501013259,albumina,i
157,0211-699501013259,y,o
157,0211-699501013259,cinetica,o
157,0211-699501013259,de,o
157,0211-699501013259,la,o
157,0211-699501013259,urea,i
157,0211-699501013259,KTV,o
157,0211-699501013259,KRU,o
157,0211-699501013259,PCRn,o
157,0211-699501013259,y,o
157,0211-699501013259,cada,o
157,0211-699501013259,6,o
157,0211-699501013259,meses,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,HPLC,i
157,0211-699501013259,y,o
157,0211-699501013259,pp,i
157,0211-699501013259,RIA,i
157,0211-699501013259,Resultados,o
157,0211-699501013259,80,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,fueron,o
157,0211-699501013259,incluidos,o
157,0211-699501013259,en,o
157,0211-699501013259,el,o
157,0211-699501013259,estudio,o
157,0211-699501013259,basal,o
157,0211-699501013259,con,o
157,0211-699501013259,una,o
157,0211-699501013259,prevalencia,o
157,0211-699501013259,de,o
157,0211-699501013259,hiperhomocisteinemia,i
157,0211-699501013259,del,o
157,0211-699501013259,844,o
157,0211-699501013259,deficit,i
157,0211-699501013259,de,i
157,0211-699501013259,pp,i
157,0211-699501013259,en,o
157,0211-699501013259,el,o
157,0211-699501013259,32,o
157,0211-699501013259,y,o
157,0211-699501013259,folato,i
157,0211-699501013259,en,o
157,0211-699501013259,el,o
157,0211-699501013259,rango,o
157,0211-699501013259,normal,o
157,0211-699501013259,bajo,o
157,0211-699501013259,los,o
157,0211-699501013259,niveles,i
157,0211-699501013259,de,i
157,0211-699501013259,tHcy,i
157,0211-699501013259,se,o
157,0211-699501013259,correlacionaban,o
157,0211-699501013259,inversamente,o
157,0211-699501013259,con,o
157,0211-699501013259,los,o
157,0211-699501013259,del,o
157,0211-699501013259,folato,i
157,0211-699501013259,r,o
157,0211-699501013259,0336,o
157,0211-699501013259,p,o
157,0211-699501013259,001,o
157,0211-699501013259,pero,o
157,0211-699501013259,no,o
157,0211-699501013259,con,o
157,0211-699501013259,pp,i
157,0211-699501013259,B12,i
157,0211-699501013259,edad,o
157,0211-699501013259,albumina,i
157,0211-699501013259,KTV,o
157,0211-699501013259,KRU,o
157,0211-699501013259,PCRn,o
157,0211-699501013259,Cincuenta,o
157,0211-699501013259,y,o
157,0211-699501013259,ocho,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,recibieron,o
157,0211-699501013259,seis,o
157,0211-699501013259,meses,o
157,0211-699501013259,de,o
157,0211-699501013259,suplementacion,i
157,0211-699501013259,con,o
157,0211-699501013259,normalizacion,o
157,0211-699501013259,del,o
157,0211-699501013259,pp,i
157,0211-699501013259,aumento,o
157,0211-699501013259,del,o
157,0211-699501013259,folato,i
157,0211-699501013259,703,o
157,0211-699501013259,IC,o
157,0211-699501013259,638,o
157,0211-699501013259,795,o
157,0211-699501013259,vs,o
157,0211-699501013259,6181,o
157,0211-699501013259,IC,o
157,0211-699501013259,4447,o
157,0211-699501013259,7811,o
157,0211-699501013259,p,o
157,0211-699501013259,0001,o
157,0211-699501013259,y,o
157,0211-699501013259,descenso,o
157,0211-699501013259,de,o
157,0211-699501013259,la,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,240,o
157,0211-699501013259,IC,o
157,0211-699501013259,213,o
157,0211-699501013259,264,o
157,0211-699501013259,vs,o
157,0211-699501013259,199,o
157,0211-699501013259,IC,o
157,0211-699501013259,175,o
157,0211-699501013259,224,o
157,0211-699501013259,p,o
157,0211-699501013259,005,o
157,0211-699501013259,Han,o
157,0211-699501013259,recibido,o
157,0211-699501013259,suplementacion,i
157,0211-699501013259,durante,o
157,0211-699501013259,12,o
157,0211-699501013259,meses,o
157,0211-699501013259,33,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,pero,o
157,0211-699501013259,a,o
157,0211-699501013259,pesar,o
157,0211-699501013259,de,o
157,0211-699501013259,un,o
157,0211-699501013259,continuo,o
157,0211-699501013259,aumento,o
157,0211-699501013259,del,o
157,0211-699501013259,folato,i
157,0211-699501013259,10078,o
157,0211-699501013259,IC,o
157,0211-699501013259,7481,o
157,0211-699501013259,12674,o
157,0211-699501013259,p,o
157,0211-699501013259,0001,o
157,0211-699501013259,solo,o
157,0211-699501013259,3,o
157,0211-699501013259,pacientes,o
157,0211-699501013259,presentan,o
157,0211-699501013259,niveles,o
157,0211-699501013259,normales,o
157,0211-699501013259,de,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,correlacionandose,o
157,0211-699501013259,directamente,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,con,o
157,0211-699501013259,la,o
157,0211-699501013259,albumina,i
157,0211-699501013259,r,o
157,0211-699501013259,056,o
157,0211-699501013259,p,o
157,0211-699501013259,0001,o
157,0211-699501013259,que,o
157,0211-699501013259,se,o
157,0211-699501013259,elevo,o
157,0211-699501013259,con,o
157,0211-699501013259,respecto,o
157,0211-699501013259,al,o
157,0211-699501013259,inicio,o
157,0211-699501013259,337,o
157,0211-699501013259,IC,o
157,0211-699501013259,327,o
157,0211-699501013259,346,o
157,0211-699501013259,vs,o
157,0211-699501013259,350,o
157,0211-699501013259,IC,o
157,0211-699501013259,337,o
157,0211-699501013259,363,o
157,0211-699501013259,p,o
157,0211-699501013259,005,o
157,0211-699501013259,Conclusion,o
157,0211-699501013259,Tras,o
157,0211-699501013259,suplementacion,i
157,0211-699501013259,con,o
157,0211-699501013259,acido,i
157,0211-699501013259,folico,i
157,0211-699501013259,y,o
157,0211-699501013259,vitamina,i
157,0211-699501013259,B6,i
157,0211-699501013259,aunque,o
157,0211-699501013259,inicialmente,o
157,0211-699501013259,se,o
157,0211-699501013259,reduce,o
157,0211-699501013259,la,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,esta,o
157,0211-699501013259,respuesta,o
157,0211-699501013259,se,o
157,0211-699501013259,hace,o
157,0211-699501013259,refractaria,o
157,0211-699501013259,correlacionandose,o
157,0211-699501013259,directamente,o
157,0211-699501013259,la,o
157,0211-699501013259,tHcy,i
157,0211-699501013259,con,o
157,0211-699501013259,la,o
157,0211-699501013259,albumina,i
157,0211-699501013259,plasmatica,i
157,0211-699501013259,La,o
157,0211-699501013259,interpretacion,o
157,0211-699501013259,de,o
157,0211-699501013259,los,o
157,0211-699501013259,niveles,i
157,0211-699501013259,de,i
157,0211-699501013259,tHcy,i
157,0211-699501013259,debe,o
157,0211-699501013259,tener,o
157,0211-699501013259,en,o
157,0211-699501013259,cuenta,o
157,0211-699501013259,la,o
157,0211-699501013259,concentracion,i
157,0211-699501013259,de,i
157,0211-699501013259,albumina,i
158,0211-699501013259,Efecto,o
158,0211-699501013259,de,o
158,0211-699501013259,la,o
158,0211-699501013259,suplementacion,i
158,0211-699501013259,con,o
158,0211-699501013259,acido,i
158,0211-699501013259,folico,i
158,0211-699501013259,sobre,o
158,0211-699501013259,los,o
158,0211-699501013259,niveles,i
158,0211-699501013259,de,i
158,0211-699501013259,homocisteina,i
158,0211-699501013259,total,o
158,0211-699501013259,en,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,en,o
158,0211-699501013259,hemodialisis,i
158,0211-699501013259,La,o
158,0211-699501013259,hiperhomocisteinemia,i
158,0211-699501013259,es,o
158,0211-699501013259,un,o
158,0211-699501013259,marcador,o
158,0211-699501013259,de,o
158,0211-699501013259,riesgo,o
158,0211-699501013259,independiente,o
158,0211-699501013259,de,o
158,0211-699501013259,morbimortalidad,o
158,0211-699501013259,cardiovascular,i
158,0211-699501013259,Hemos,o
158,0211-699501013259,intentado,o
158,0211-699501013259,prospectivamente,o
158,0211-699501013259,reducir,o
158,0211-699501013259,los,o
158,0211-699501013259,niveles,i
158,0211-699501013259,de,i
158,0211-699501013259,homocisteina,i
158,0211-699501013259,total,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,mediante,o
158,0211-699501013259,suplemento,o
158,0211-699501013259,con,o
158,0211-699501013259,acido,i
158,0211-699501013259,folico,i
158,0211-699501013259,y,o
158,0211-699501013259,vitamina,i
158,0211-699501013259,B6,i
158,0211-699501013259,pp,i
158,0211-699501013259,valorando,o
158,0211-699501013259,su,o
158,0211-699501013259,posible,o
158,0211-699501013259,correlacion,o
158,0211-699501013259,con,o
158,0211-699501013259,dosis,o
158,0211-699501013259,de,o
158,0211-699501013259,dialisis,i
158,0211-699501013259,funcion,i
158,0211-699501013259,residual,i
158,0211-699501013259,y,o
158,0211-699501013259,parametros,o
158,0211-699501013259,nutricionales,o
158,0211-699501013259,Metodos,o
158,0211-699501013259,Todos,o
158,0211-699501013259,los,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,en,o
158,0211-699501013259,hemodialisis,i
158,0211-699501013259,al,o
158,0211-699501013259,comienzo,o
158,0211-699501013259,del,o
158,0211-699501013259,estudio,o
158,0211-699501013259,que,o
158,0211-699501013259,no,o
158,0211-699501013259,recibian,o
158,0211-699501013259,acido,i
158,0211-699501013259,folico,i
158,0211-699501013259,ni,o
158,0211-699501013259,vitamina,i
158,0211-699501013259,B6,i
158,0211-699501013259,asi,o
158,0211-699501013259,como,o
158,0211-699501013259,los,o
158,0211-699501013259,incorporados,o
158,0211-699501013259,posteriormente,o
158,0211-699501013259,a,o
158,0211-699501013259,partir,o
158,0211-699501013259,de,o
158,0211-699501013259,su,o
158,0211-699501013259,tercer,o
158,0211-699501013259,mes,o
158,0211-699501013259,en,o
158,0211-699501013259,hemodialisis,i
158,0211-699501013259,recibieron,o
158,0211-699501013259,5,o
158,0211-699501013259,mg,o
158,0211-699501013259,orales,o
158,0211-699501013259,de,o
158,0211-699501013259,acido,i
158,0211-699501013259,folico,i
158,0211-699501013259,cada,o
158,0211-699501013259,48,o
158,0211-699501013259,horas,o
158,0211-699501013259,y,o
158,0211-699501013259,40,o
158,0211-699501013259,mg,o
158,0211-699501013259,orales,o
158,0211-699501013259,de,o
158,0211-699501013259,vitamina,i
158,0211-699501013259,B6,i
158,0211-699501013259,cada,o
158,0211-699501013259,semana,o
158,0211-699501013259,Se,o
158,0211-699501013259,determinaron,o
158,0211-699501013259,al,o
158,0211-699501013259,comienzo,o
158,0211-699501013259,del,o
158,0211-699501013259,estudio,o
158,0211-699501013259,y,o
158,0211-699501013259,cada,o
158,0211-699501013259,2,o
158,0211-699501013259,meses,o
158,0211-699501013259,niveles,i
158,0211-699501013259,de,i
158,0211-699501013259,folato,i
158,0211-699501013259,vitamina,i
158,0211-699501013259,B12,i
158,0211-699501013259,inmunoensayo,i
158,0211-699501013259,albumina,i
158,0211-699501013259,y,o
158,0211-699501013259,cinetica,o
158,0211-699501013259,de,o
158,0211-699501013259,la,o
158,0211-699501013259,urea,i
158,0211-699501013259,KTV,o
158,0211-699501013259,KRU,o
158,0211-699501013259,PCRn,o
158,0211-699501013259,y,o
158,0211-699501013259,cada,o
158,0211-699501013259,6,o
158,0211-699501013259,meses,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,HPLC,i
158,0211-699501013259,y,o
158,0211-699501013259,pp,i
158,0211-699501013259,RIA,i
158,0211-699501013259,Resultados,o
158,0211-699501013259,80,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,fueron,o
158,0211-699501013259,incluidos,o
158,0211-699501013259,en,o
158,0211-699501013259,el,o
158,0211-699501013259,estudio,o
158,0211-699501013259,basal,o
158,0211-699501013259,con,o
158,0211-699501013259,una,o
158,0211-699501013259,prevalencia,o
158,0211-699501013259,de,o
158,0211-699501013259,hiperhomocisteinemia,i
158,0211-699501013259,del,o
158,0211-699501013259,844,o
158,0211-699501013259,deficit,i
158,0211-699501013259,de,i
158,0211-699501013259,pp,i
158,0211-699501013259,en,o
158,0211-699501013259,el,o
158,0211-699501013259,32,o
158,0211-699501013259,y,o
158,0211-699501013259,folato,i
158,0211-699501013259,en,o
158,0211-699501013259,el,o
158,0211-699501013259,rango,o
158,0211-699501013259,normal,o
158,0211-699501013259,bajo,o
158,0211-699501013259,los,o
158,0211-699501013259,niveles,i
158,0211-699501013259,de,i
158,0211-699501013259,tHcy,i
158,0211-699501013259,se,o
158,0211-699501013259,correlacionaban,o
158,0211-699501013259,inversamente,o
158,0211-699501013259,con,o
158,0211-699501013259,los,o
158,0211-699501013259,del,o
158,0211-699501013259,folato,i
158,0211-699501013259,r,o
158,0211-699501013259,0336,o
158,0211-699501013259,p,o
158,0211-699501013259,001,o
158,0211-699501013259,pero,o
158,0211-699501013259,no,o
158,0211-699501013259,con,o
158,0211-699501013259,pp,i
158,0211-699501013259,B12,i
158,0211-699501013259,edad,o
158,0211-699501013259,albumina,i
158,0211-699501013259,KTV,o
158,0211-699501013259,KRU,o
158,0211-699501013259,PCRn,o
158,0211-699501013259,Cincuenta,o
158,0211-699501013259,y,o
158,0211-699501013259,ocho,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,recibieron,o
158,0211-699501013259,seis,o
158,0211-699501013259,meses,o
158,0211-699501013259,de,o
158,0211-699501013259,suplementacion,i
158,0211-699501013259,con,o
158,0211-699501013259,normalizacion,o
158,0211-699501013259,del,o
158,0211-699501013259,pp,i
158,0211-699501013259,aumento,o
158,0211-699501013259,del,o
158,0211-699501013259,folato,i
158,0211-699501013259,703,o
158,0211-699501013259,IC,o
158,0211-699501013259,638,o
158,0211-699501013259,795,o
158,0211-699501013259,vs,o
158,0211-699501013259,6181,o
158,0211-699501013259,IC,o
158,0211-699501013259,4447,o
158,0211-699501013259,7811,o
158,0211-699501013259,p,o
158,0211-699501013259,0001,o
158,0211-699501013259,y,o
158,0211-699501013259,descenso,o
158,0211-699501013259,de,o
158,0211-699501013259,la,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,240,o
158,0211-699501013259,IC,o
158,0211-699501013259,213,o
158,0211-699501013259,264,o
158,0211-699501013259,vs,o
158,0211-699501013259,199,o
158,0211-699501013259,IC,o
158,0211-699501013259,175,o
158,0211-699501013259,224,o
158,0211-699501013259,p,o
158,0211-699501013259,005,o
158,0211-699501013259,Han,o
158,0211-699501013259,recibido,o
158,0211-699501013259,suplementacion,i
158,0211-699501013259,durante,o
158,0211-699501013259,12,o
158,0211-699501013259,meses,o
158,0211-699501013259,33,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,pero,o
158,0211-699501013259,a,o
158,0211-699501013259,pesar,o
158,0211-699501013259,de,o
158,0211-699501013259,un,o
158,0211-699501013259,continuo,o
158,0211-699501013259,aumento,o
158,0211-699501013259,del,o
158,0211-699501013259,folato,i
158,0211-699501013259,10078,o
158,0211-699501013259,IC,o
158,0211-699501013259,7481,o
158,0211-699501013259,12674,o
158,0211-699501013259,p,o
158,0211-699501013259,0001,o
158,0211-699501013259,solo,o
158,0211-699501013259,3,o
158,0211-699501013259,pacientes,o
158,0211-699501013259,presentan,o
158,0211-699501013259,niveles,o
158,0211-699501013259,normales,o
158,0211-699501013259,de,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,correlacionandose,o
158,0211-699501013259,directamente,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,con,o
158,0211-699501013259,la,o
158,0211-699501013259,albumina,i
158,0211-699501013259,r,o
158,0211-699501013259,056,o
158,0211-699501013259,p,o
158,0211-699501013259,0001,o
158,0211-699501013259,que,o
158,0211-699501013259,se,o
158,0211-699501013259,elevo,o
158,0211-699501013259,con,o
158,0211-699501013259,respecto,o
158,0211-699501013259,al,o
158,0211-699501013259,inicio,o
158,0211-699501013259,337,o
158,0211-699501013259,IC,o
158,0211-699501013259,327,o
158,0211-699501013259,346,o
158,0211-699501013259,vs,o
158,0211-699501013259,350,o
158,0211-699501013259,IC,o
158,0211-699501013259,337,o
158,0211-699501013259,363,o
158,0211-699501013259,p,o
158,0211-699501013259,005,o
158,0211-699501013259,Conclusion,o
158,0211-699501013259,Tras,o
158,0211-699501013259,suplementacion,i
158,0211-699501013259,con,o
158,0211-699501013259,acido,i
158,0211-699501013259,folico,i
158,0211-699501013259,y,o
158,0211-699501013259,vitamina,i
158,0211-699501013259,B6,i
158,0211-699501013259,aunque,o
158,0211-699501013259,inicialmente,o
158,0211-699501013259,se,o
158,0211-699501013259,reduce,o
158,0211-699501013259,la,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,esta,o
158,0211-699501013259,respuesta,o
158,0211-699501013259,se,o
158,0211-699501013259,hace,o
158,0211-699501013259,refractaria,o
158,0211-699501013259,correlacionandose,o
158,0211-699501013259,directamente,o
158,0211-699501013259,la,o
158,0211-699501013259,tHcy,i
158,0211-699501013259,con,o
158,0211-699501013259,la,o
158,0211-699501013259,albumina,i
158,0211-699501013259,plasmatica,i
158,0211-699501013259,La,o
158,0211-699501013259,interpretacion,o
158,0211-699501013259,de,o
158,0211-699501013259,los,o
158,0211-699501013259,niveles,i
158,0211-699501013259,de,i
158,0211-699501013259,tHcy,i
158,0211-699501013259,debe,o
158,0211-699501013259,tener,o
158,0211-699501013259,en,o
158,0211-699501013259,cuenta,o
158,0211-699501013259,la,o
158,0211-699501013259,concentracion,i
158,0211-699501013259,de,i
158,0211-699501013259,albumina,i
159,0211-699501013259,Efecto,o
159,0211-699501013259,de,o
159,0211-699501013259,la,o
159,0211-699501013259,suplementacion,i
159,0211-699501013259,con,o
159,0211-699501013259,acido,i
159,0211-699501013259,folico,i
159,0211-699501013259,sobre,o
159,0211-699501013259,los,o
159,0211-699501013259,niveles,i
159,0211-699501013259,de,i
159,0211-699501013259,homocisteina,i
159,0211-699501013259,total,o
159,0211-699501013259,en,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,en,o
159,0211-699501013259,hemodialisis,i
159,0211-699501013259,La,o
159,0211-699501013259,hiperhomocisteinemia,i
159,0211-699501013259,es,o
159,0211-699501013259,un,o
159,0211-699501013259,marcador,o
159,0211-699501013259,de,o
159,0211-699501013259,riesgo,o
159,0211-699501013259,independiente,o
159,0211-699501013259,de,o
159,0211-699501013259,morbimortalidad,o
159,0211-699501013259,cardiovascular,i
159,0211-699501013259,Hemos,o
159,0211-699501013259,intentado,o
159,0211-699501013259,prospectivamente,o
159,0211-699501013259,reducir,o
159,0211-699501013259,los,o
159,0211-699501013259,niveles,i
159,0211-699501013259,de,i
159,0211-699501013259,homocisteina,i
159,0211-699501013259,total,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,mediante,o
159,0211-699501013259,suplemento,o
159,0211-699501013259,con,o
159,0211-699501013259,acido,i
159,0211-699501013259,folico,i
159,0211-699501013259,y,o
159,0211-699501013259,vitamina,i
159,0211-699501013259,B6,i
159,0211-699501013259,pp,i
159,0211-699501013259,valorando,o
159,0211-699501013259,su,o
159,0211-699501013259,posible,o
159,0211-699501013259,correlacion,o
159,0211-699501013259,con,o
159,0211-699501013259,dosis,o
159,0211-699501013259,de,o
159,0211-699501013259,dialisis,i
159,0211-699501013259,funcion,i
159,0211-699501013259,residual,i
159,0211-699501013259,y,o
159,0211-699501013259,parametros,o
159,0211-699501013259,nutricionales,o
159,0211-699501013259,Metodos,o
159,0211-699501013259,Todos,o
159,0211-699501013259,los,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,en,o
159,0211-699501013259,hemodialisis,i
159,0211-699501013259,al,o
159,0211-699501013259,comienzo,o
159,0211-699501013259,del,o
159,0211-699501013259,estudio,o
159,0211-699501013259,que,o
159,0211-699501013259,no,o
159,0211-699501013259,recibian,o
159,0211-699501013259,acido,i
159,0211-699501013259,folico,i
159,0211-699501013259,ni,o
159,0211-699501013259,vitamina,i
159,0211-699501013259,B6,i
159,0211-699501013259,asi,o
159,0211-699501013259,como,o
159,0211-699501013259,los,o
159,0211-699501013259,incorporados,o
159,0211-699501013259,posteriormente,o
159,0211-699501013259,a,o
159,0211-699501013259,partir,o
159,0211-699501013259,de,o
159,0211-699501013259,su,o
159,0211-699501013259,tercer,o
159,0211-699501013259,mes,o
159,0211-699501013259,en,o
159,0211-699501013259,hemodialisis,i
159,0211-699501013259,recibieron,o
159,0211-699501013259,5,o
159,0211-699501013259,mg,o
159,0211-699501013259,orales,o
159,0211-699501013259,de,o
159,0211-699501013259,acido,i
159,0211-699501013259,folico,i
159,0211-699501013259,cada,o
159,0211-699501013259,48,o
159,0211-699501013259,horas,o
159,0211-699501013259,y,o
159,0211-699501013259,40,o
159,0211-699501013259,mg,o
159,0211-699501013259,orales,o
159,0211-699501013259,de,o
159,0211-699501013259,vitamina,i
159,0211-699501013259,B6,i
159,0211-699501013259,cada,o
159,0211-699501013259,semana,o
159,0211-699501013259,Se,o
159,0211-699501013259,determinaron,o
159,0211-699501013259,al,o
159,0211-699501013259,comienzo,o
159,0211-699501013259,del,o
159,0211-699501013259,estudio,o
159,0211-699501013259,y,o
159,0211-699501013259,cada,o
159,0211-699501013259,2,o
159,0211-699501013259,meses,o
159,0211-699501013259,niveles,i
159,0211-699501013259,de,i
159,0211-699501013259,folato,i
159,0211-699501013259,vitamina,i
159,0211-699501013259,B12,i
159,0211-699501013259,inmunoensayo,i
159,0211-699501013259,albumina,i
159,0211-699501013259,y,o
159,0211-699501013259,cinetica,o
159,0211-699501013259,de,o
159,0211-699501013259,la,o
159,0211-699501013259,urea,i
159,0211-699501013259,KTV,o
159,0211-699501013259,KRU,o
159,0211-699501013259,PCRn,o
159,0211-699501013259,y,o
159,0211-699501013259,cada,o
159,0211-699501013259,6,o
159,0211-699501013259,meses,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,HPLC,i
159,0211-699501013259,y,o
159,0211-699501013259,pp,i
159,0211-699501013259,RIA,i
159,0211-699501013259,Resultados,o
159,0211-699501013259,80,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,fueron,o
159,0211-699501013259,incluidos,o
159,0211-699501013259,en,o
159,0211-699501013259,el,o
159,0211-699501013259,estudio,o
159,0211-699501013259,basal,o
159,0211-699501013259,con,o
159,0211-699501013259,una,o
159,0211-699501013259,prevalencia,o
159,0211-699501013259,de,o
159,0211-699501013259,hiperhomocisteinemia,i
159,0211-699501013259,del,o
159,0211-699501013259,844,o
159,0211-699501013259,deficit,i
159,0211-699501013259,de,i
159,0211-699501013259,pp,i
159,0211-699501013259,en,o
159,0211-699501013259,el,o
159,0211-699501013259,32,o
159,0211-699501013259,y,o
159,0211-699501013259,folato,i
159,0211-699501013259,en,o
159,0211-699501013259,el,o
159,0211-699501013259,rango,o
159,0211-699501013259,normal,o
159,0211-699501013259,bajo,o
159,0211-699501013259,los,o
159,0211-699501013259,niveles,i
159,0211-699501013259,de,i
159,0211-699501013259,tHcy,i
159,0211-699501013259,se,o
159,0211-699501013259,correlacionaban,o
159,0211-699501013259,inversamente,o
159,0211-699501013259,con,o
159,0211-699501013259,los,o
159,0211-699501013259,del,o
159,0211-699501013259,folato,i
159,0211-699501013259,r,o
159,0211-699501013259,0336,o
159,0211-699501013259,p,o
159,0211-699501013259,001,o
159,0211-699501013259,pero,o
159,0211-699501013259,no,o
159,0211-699501013259,con,o
159,0211-699501013259,pp,i
159,0211-699501013259,B12,i
159,0211-699501013259,edad,o
159,0211-699501013259,albumina,i
159,0211-699501013259,KTV,o
159,0211-699501013259,KRU,o
159,0211-699501013259,PCRn,o
159,0211-699501013259,Cincuenta,o
159,0211-699501013259,y,o
159,0211-699501013259,ocho,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,recibieron,o
159,0211-699501013259,seis,o
159,0211-699501013259,meses,o
159,0211-699501013259,de,o
159,0211-699501013259,suplementacion,i
159,0211-699501013259,con,o
159,0211-699501013259,normalizacion,o
159,0211-699501013259,del,o
159,0211-699501013259,pp,i
159,0211-699501013259,aumento,o
159,0211-699501013259,del,o
159,0211-699501013259,folato,i
159,0211-699501013259,703,o
159,0211-699501013259,IC,o
159,0211-699501013259,638,o
159,0211-699501013259,795,o
159,0211-699501013259,vs,o
159,0211-699501013259,6181,o
159,0211-699501013259,IC,o
159,0211-699501013259,4447,o
159,0211-699501013259,7811,o
159,0211-699501013259,p,o
159,0211-699501013259,0001,o
159,0211-699501013259,y,o
159,0211-699501013259,descenso,o
159,0211-699501013259,de,o
159,0211-699501013259,la,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,240,o
159,0211-699501013259,IC,o
159,0211-699501013259,213,o
159,0211-699501013259,264,o
159,0211-699501013259,vs,o
159,0211-699501013259,199,o
159,0211-699501013259,IC,o
159,0211-699501013259,175,o
159,0211-699501013259,224,o
159,0211-699501013259,p,o
159,0211-699501013259,005,o
159,0211-699501013259,Han,o
159,0211-699501013259,recibido,o
159,0211-699501013259,suplementacion,i
159,0211-699501013259,durante,o
159,0211-699501013259,12,o
159,0211-699501013259,meses,o
159,0211-699501013259,33,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,pero,o
159,0211-699501013259,a,o
159,0211-699501013259,pesar,o
159,0211-699501013259,de,o
159,0211-699501013259,un,o
159,0211-699501013259,continuo,o
159,0211-699501013259,aumento,o
159,0211-699501013259,del,o
159,0211-699501013259,folato,i
159,0211-699501013259,10078,o
159,0211-699501013259,IC,o
159,0211-699501013259,7481,o
159,0211-699501013259,12674,o
159,0211-699501013259,p,o
159,0211-699501013259,0001,o
159,0211-699501013259,solo,o
159,0211-699501013259,3,o
159,0211-699501013259,pacientes,o
159,0211-699501013259,presentan,o
159,0211-699501013259,niveles,o
159,0211-699501013259,normales,o
159,0211-699501013259,de,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,correlacionandose,o
159,0211-699501013259,directamente,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,con,o
159,0211-699501013259,la,o
159,0211-699501013259,albumina,i
159,0211-699501013259,r,o
159,0211-699501013259,056,o
159,0211-699501013259,p,o
159,0211-699501013259,0001,o
159,0211-699501013259,que,o
159,0211-699501013259,se,o
159,0211-699501013259,elevo,o
159,0211-699501013259,con,o
159,0211-699501013259,respecto,o
159,0211-699501013259,al,o
159,0211-699501013259,inicio,o
159,0211-699501013259,337,o
159,0211-699501013259,IC,o
159,0211-699501013259,327,o
159,0211-699501013259,346,o
159,0211-699501013259,vs,o
159,0211-699501013259,350,o
159,0211-699501013259,IC,o
159,0211-699501013259,337,o
159,0211-699501013259,363,o
159,0211-699501013259,p,o
159,0211-699501013259,005,o
159,0211-699501013259,Conclusion,o
159,0211-699501013259,Tras,o
159,0211-699501013259,suplementacion,i
159,0211-699501013259,con,o
159,0211-699501013259,acido,i
159,0211-699501013259,folico,i
159,0211-699501013259,y,o
159,0211-699501013259,vitamina,i
159,0211-699501013259,B6,i
159,0211-699501013259,aunque,o
159,0211-699501013259,inicialmente,o
159,0211-699501013259,se,o
159,0211-699501013259,reduce,o
159,0211-699501013259,la,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,esta,o
159,0211-699501013259,respuesta,o
159,0211-699501013259,se,o
159,0211-699501013259,hace,o
159,0211-699501013259,refractaria,o
159,0211-699501013259,correlacionandose,o
159,0211-699501013259,directamente,o
159,0211-699501013259,la,o
159,0211-699501013259,tHcy,i
159,0211-699501013259,con,o
159,0211-699501013259,la,o
159,0211-699501013259,albumina,i
159,0211-699501013259,plasmatica,i
159,0211-699501013259,La,o
159,0211-699501013259,interpretacion,o
159,0211-699501013259,de,o
159,0211-699501013259,los,o
159,0211-699501013259,niveles,i
159,0211-699501013259,de,i
159,0211-699501013259,tHcy,i
159,0211-699501013259,debe,o
159,0211-699501013259,tener,o
159,0211-699501013259,en,o
159,0211-699501013259,cuenta,o
159,0211-699501013259,la,o
159,0211-699501013259,concentracion,i
159,0211-699501013259,de,i
159,0211-699501013259,albumina,i
160,0211-699501013259,Efecto,o
160,0211-699501013259,de,o
160,0211-699501013259,la,o
160,0211-699501013259,suplementacion,i
160,0211-699501013259,con,o
160,0211-699501013259,acido,i
160,0211-699501013259,folico,i
160,0211-699501013259,sobre,o
160,0211-699501013259,los,o
160,0211-699501013259,niveles,i
160,0211-699501013259,de,i
160,0211-699501013259,homocisteina,i
160,0211-699501013259,total,o
160,0211-699501013259,en,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,en,o
160,0211-699501013259,hemodialisis,i
160,0211-699501013259,La,o
160,0211-699501013259,hiperhomocisteinemia,i
160,0211-699501013259,es,o
160,0211-699501013259,un,o
160,0211-699501013259,marcador,o
160,0211-699501013259,de,o
160,0211-699501013259,riesgo,o
160,0211-699501013259,independiente,o
160,0211-699501013259,de,o
160,0211-699501013259,morbimortalidad,o
160,0211-699501013259,cardiovascular,i
160,0211-699501013259,Hemos,o
160,0211-699501013259,intentado,o
160,0211-699501013259,prospectivamente,o
160,0211-699501013259,reducir,o
160,0211-699501013259,los,o
160,0211-699501013259,niveles,i
160,0211-699501013259,de,i
160,0211-699501013259,homocisteina,i
160,0211-699501013259,total,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,mediante,o
160,0211-699501013259,suplemento,o
160,0211-699501013259,con,o
160,0211-699501013259,acido,i
160,0211-699501013259,folico,i
160,0211-699501013259,y,o
160,0211-699501013259,vitamina,i
160,0211-699501013259,B6,i
160,0211-699501013259,pp,i
160,0211-699501013259,valorando,o
160,0211-699501013259,su,o
160,0211-699501013259,posible,o
160,0211-699501013259,correlacion,o
160,0211-699501013259,con,o
160,0211-699501013259,dosis,o
160,0211-699501013259,de,o
160,0211-699501013259,dialisis,i
160,0211-699501013259,funcion,i
160,0211-699501013259,residual,i
160,0211-699501013259,y,o
160,0211-699501013259,parametros,o
160,0211-699501013259,nutricionales,o
160,0211-699501013259,Metodos,o
160,0211-699501013259,Todos,o
160,0211-699501013259,los,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,en,o
160,0211-699501013259,hemodialisis,i
160,0211-699501013259,al,o
160,0211-699501013259,comienzo,o
160,0211-699501013259,del,o
160,0211-699501013259,estudio,o
160,0211-699501013259,que,o
160,0211-699501013259,no,o
160,0211-699501013259,recibian,o
160,0211-699501013259,acido,i
160,0211-699501013259,folico,i
160,0211-699501013259,ni,o
160,0211-699501013259,vitamina,i
160,0211-699501013259,B6,i
160,0211-699501013259,asi,o
160,0211-699501013259,como,o
160,0211-699501013259,los,o
160,0211-699501013259,incorporados,o
160,0211-699501013259,posteriormente,o
160,0211-699501013259,a,o
160,0211-699501013259,partir,o
160,0211-699501013259,de,o
160,0211-699501013259,su,o
160,0211-699501013259,tercer,o
160,0211-699501013259,mes,o
160,0211-699501013259,en,o
160,0211-699501013259,hemodialisis,i
160,0211-699501013259,recibieron,o
160,0211-699501013259,5,o
160,0211-699501013259,mg,o
160,0211-699501013259,orales,o
160,0211-699501013259,de,o
160,0211-699501013259,acido,i
160,0211-699501013259,folico,i
160,0211-699501013259,cada,o
160,0211-699501013259,48,o
160,0211-699501013259,horas,o
160,0211-699501013259,y,o
160,0211-699501013259,40,o
160,0211-699501013259,mg,o
160,0211-699501013259,orales,o
160,0211-699501013259,de,o
160,0211-699501013259,vitamina,i
160,0211-699501013259,B6,i
160,0211-699501013259,cada,o
160,0211-699501013259,semana,o
160,0211-699501013259,Se,o
160,0211-699501013259,determinaron,o
160,0211-699501013259,al,o
160,0211-699501013259,comienzo,o
160,0211-699501013259,del,o
160,0211-699501013259,estudio,o
160,0211-699501013259,y,o
160,0211-699501013259,cada,o
160,0211-699501013259,2,o
160,0211-699501013259,meses,o
160,0211-699501013259,niveles,i
160,0211-699501013259,de,i
160,0211-699501013259,folato,i
160,0211-699501013259,vitamina,i
160,0211-699501013259,B12,i
160,0211-699501013259,inmunoensayo,i
160,0211-699501013259,albumina,i
160,0211-699501013259,y,o
160,0211-699501013259,cinetica,o
160,0211-699501013259,de,o
160,0211-699501013259,la,o
160,0211-699501013259,urea,i
160,0211-699501013259,KTV,o
160,0211-699501013259,KRU,o
160,0211-699501013259,PCRn,o
160,0211-699501013259,y,o
160,0211-699501013259,cada,o
160,0211-699501013259,6,o
160,0211-699501013259,meses,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,HPLC,i
160,0211-699501013259,y,o
160,0211-699501013259,pp,i
160,0211-699501013259,RIA,i
160,0211-699501013259,Resultados,o
160,0211-699501013259,80,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,fueron,o
160,0211-699501013259,incluidos,o
160,0211-699501013259,en,o
160,0211-699501013259,el,o
160,0211-699501013259,estudio,o
160,0211-699501013259,basal,o
160,0211-699501013259,con,o
160,0211-699501013259,una,o
160,0211-699501013259,prevalencia,o
160,0211-699501013259,de,o
160,0211-699501013259,hiperhomocisteinemia,i
160,0211-699501013259,del,o
160,0211-699501013259,844,o
160,0211-699501013259,deficit,i
160,0211-699501013259,de,i
160,0211-699501013259,pp,i
160,0211-699501013259,en,o
160,0211-699501013259,el,o
160,0211-699501013259,32,o
160,0211-699501013259,y,o
160,0211-699501013259,folato,i
160,0211-699501013259,en,o
160,0211-699501013259,el,o
160,0211-699501013259,rango,o
160,0211-699501013259,normal,o
160,0211-699501013259,bajo,o
160,0211-699501013259,los,o
160,0211-699501013259,niveles,i
160,0211-699501013259,de,i
160,0211-699501013259,tHcy,i
160,0211-699501013259,se,o
160,0211-699501013259,correlacionaban,o
160,0211-699501013259,inversamente,o
160,0211-699501013259,con,o
160,0211-699501013259,los,o
160,0211-699501013259,del,o
160,0211-699501013259,folato,i
160,0211-699501013259,r,o
160,0211-699501013259,0336,o
160,0211-699501013259,p,o
160,0211-699501013259,001,o
160,0211-699501013259,pero,o
160,0211-699501013259,no,o
160,0211-699501013259,con,o
160,0211-699501013259,pp,i
160,0211-699501013259,B12,i
160,0211-699501013259,edad,o
160,0211-699501013259,albumina,i
160,0211-699501013259,KTV,o
160,0211-699501013259,KRU,o
160,0211-699501013259,PCRn,o
160,0211-699501013259,Cincuenta,o
160,0211-699501013259,y,o
160,0211-699501013259,ocho,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,recibieron,o
160,0211-699501013259,seis,o
160,0211-699501013259,meses,o
160,0211-699501013259,de,o
160,0211-699501013259,suplementacion,i
160,0211-699501013259,con,o
160,0211-699501013259,normalizacion,o
160,0211-699501013259,del,o
160,0211-699501013259,pp,i
160,0211-699501013259,aumento,o
160,0211-699501013259,del,o
160,0211-699501013259,folato,i
160,0211-699501013259,703,o
160,0211-699501013259,IC,o
160,0211-699501013259,638,o
160,0211-699501013259,795,o
160,0211-699501013259,vs,o
160,0211-699501013259,6181,o
160,0211-699501013259,IC,o
160,0211-699501013259,4447,o
160,0211-699501013259,7811,o
160,0211-699501013259,p,o
160,0211-699501013259,0001,o
160,0211-699501013259,y,o
160,0211-699501013259,descenso,o
160,0211-699501013259,de,o
160,0211-699501013259,la,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,240,o
160,0211-699501013259,IC,o
160,0211-699501013259,213,o
160,0211-699501013259,264,o
160,0211-699501013259,vs,o
160,0211-699501013259,199,o
160,0211-699501013259,IC,o
160,0211-699501013259,175,o
160,0211-699501013259,224,o
160,0211-699501013259,p,o
160,0211-699501013259,005,o
160,0211-699501013259,Han,o
160,0211-699501013259,recibido,o
160,0211-699501013259,suplementacion,i
160,0211-699501013259,durante,o
160,0211-699501013259,12,o
160,0211-699501013259,meses,o
160,0211-699501013259,33,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,pero,o
160,0211-699501013259,a,o
160,0211-699501013259,pesar,o
160,0211-699501013259,de,o
160,0211-699501013259,un,o
160,0211-699501013259,continuo,o
160,0211-699501013259,aumento,o
160,0211-699501013259,del,o
160,0211-699501013259,folato,i
160,0211-699501013259,10078,o
160,0211-699501013259,IC,o
160,0211-699501013259,7481,o
160,0211-699501013259,12674,o
160,0211-699501013259,p,o
160,0211-699501013259,0001,o
160,0211-699501013259,solo,o
160,0211-699501013259,3,o
160,0211-699501013259,pacientes,o
160,0211-699501013259,presentan,o
160,0211-699501013259,niveles,o
160,0211-699501013259,normales,o
160,0211-699501013259,de,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,correlacionandose,o
160,0211-699501013259,directamente,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,con,o
160,0211-699501013259,la,o
160,0211-699501013259,albumina,i
160,0211-699501013259,r,o
160,0211-699501013259,056,o
160,0211-699501013259,p,o
160,0211-699501013259,0001,o
160,0211-699501013259,que,o
160,0211-699501013259,se,o
160,0211-699501013259,elevo,o
160,0211-699501013259,con,o
160,0211-699501013259,respecto,o
160,0211-699501013259,al,o
160,0211-699501013259,inicio,o
160,0211-699501013259,337,o
160,0211-699501013259,IC,o
160,0211-699501013259,327,o
160,0211-699501013259,346,o
160,0211-699501013259,vs,o
160,0211-699501013259,350,o
160,0211-699501013259,IC,o
160,0211-699501013259,337,o
160,0211-699501013259,363,o
160,0211-699501013259,p,o
160,0211-699501013259,005,o
160,0211-699501013259,Conclusion,o
160,0211-699501013259,Tras,o
160,0211-699501013259,suplementacion,i
160,0211-699501013259,con,o
160,0211-699501013259,acido,i
160,0211-699501013259,folico,i
160,0211-699501013259,y,o
160,0211-699501013259,vitamina,i
160,0211-699501013259,B6,i
160,0211-699501013259,aunque,o
160,0211-699501013259,inicialmente,o
160,0211-699501013259,se,o
160,0211-699501013259,reduce,o
160,0211-699501013259,la,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,esta,o
160,0211-699501013259,respuesta,o
160,0211-699501013259,se,o
160,0211-699501013259,hace,o
160,0211-699501013259,refractaria,o
160,0211-699501013259,correlacionandose,o
160,0211-699501013259,directamente,o
160,0211-699501013259,la,o
160,0211-699501013259,tHcy,i
160,0211-699501013259,con,o
160,0211-699501013259,la,o
160,0211-699501013259,albumina,i
160,0211-699501013259,plasmatica,i
160,0211-699501013259,La,o
160,0211-699501013259,interpretacion,o
160,0211-699501013259,de,o
160,0211-699501013259,los,o
160,0211-699501013259,niveles,i
160,0211-699501013259,de,i
160,0211-699501013259,tHcy,i
160,0211-699501013259,debe,o
160,0211-699501013259,tener,o
160,0211-699501013259,en,o
160,0211-699501013259,cuenta,o
160,0211-699501013259,la,o
160,0211-699501013259,concentracion,i
160,0211-699501013259,de,i
160,0211-699501013259,albumina,i
161,0211-699501013259,Efecto,o
161,0211-699501013259,de,o
161,0211-699501013259,la,o
161,0211-699501013259,suplementacion,i
161,0211-699501013259,con,o
161,0211-699501013259,acido,i
161,0211-699501013259,folico,i
161,0211-699501013259,sobre,o
161,0211-699501013259,los,o
161,0211-699501013259,niveles,i
161,0211-699501013259,de,i
161,0211-699501013259,homocisteina,i
161,0211-699501013259,total,o
161,0211-699501013259,en,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,en,o
161,0211-699501013259,hemodialisis,i
161,0211-699501013259,La,o
161,0211-699501013259,hiperhomocisteinemia,i
161,0211-699501013259,es,o
161,0211-699501013259,un,o
161,0211-699501013259,marcador,o
161,0211-699501013259,de,o
161,0211-699501013259,riesgo,o
161,0211-699501013259,independiente,o
161,0211-699501013259,de,o
161,0211-699501013259,morbimortalidad,o
161,0211-699501013259,cardiovascular,i
161,0211-699501013259,Hemos,o
161,0211-699501013259,intentado,o
161,0211-699501013259,prospectivamente,o
161,0211-699501013259,reducir,o
161,0211-699501013259,los,o
161,0211-699501013259,niveles,i
161,0211-699501013259,de,i
161,0211-699501013259,homocisteina,i
161,0211-699501013259,total,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,mediante,o
161,0211-699501013259,suplemento,o
161,0211-699501013259,con,o
161,0211-699501013259,acido,i
161,0211-699501013259,folico,i
161,0211-699501013259,y,o
161,0211-699501013259,vitamina,i
161,0211-699501013259,B6,i
161,0211-699501013259,pp,i
161,0211-699501013259,valorando,o
161,0211-699501013259,su,o
161,0211-699501013259,posible,o
161,0211-699501013259,correlacion,o
161,0211-699501013259,con,o
161,0211-699501013259,dosis,o
161,0211-699501013259,de,o
161,0211-699501013259,dialisis,i
161,0211-699501013259,funcion,i
161,0211-699501013259,residual,i
161,0211-699501013259,y,o
161,0211-699501013259,parametros,o
161,0211-699501013259,nutricionales,o
161,0211-699501013259,Metodos,o
161,0211-699501013259,Todos,o
161,0211-699501013259,los,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,en,o
161,0211-699501013259,hemodialisis,i
161,0211-699501013259,al,o
161,0211-699501013259,comienzo,o
161,0211-699501013259,del,o
161,0211-699501013259,estudio,o
161,0211-699501013259,que,o
161,0211-699501013259,no,o
161,0211-699501013259,recibian,o
161,0211-699501013259,acido,i
161,0211-699501013259,folico,i
161,0211-699501013259,ni,o
161,0211-699501013259,vitamina,i
161,0211-699501013259,B6,i
161,0211-699501013259,asi,o
161,0211-699501013259,como,o
161,0211-699501013259,los,o
161,0211-699501013259,incorporados,o
161,0211-699501013259,posteriormente,o
161,0211-699501013259,a,o
161,0211-699501013259,partir,o
161,0211-699501013259,de,o
161,0211-699501013259,su,o
161,0211-699501013259,tercer,o
161,0211-699501013259,mes,o
161,0211-699501013259,en,o
161,0211-699501013259,hemodialisis,i
161,0211-699501013259,recibieron,o
161,0211-699501013259,5,o
161,0211-699501013259,mg,o
161,0211-699501013259,orales,o
161,0211-699501013259,de,o
161,0211-699501013259,acido,i
161,0211-699501013259,folico,i
161,0211-699501013259,cada,o
161,0211-699501013259,48,o
161,0211-699501013259,horas,o
161,0211-699501013259,y,o
161,0211-699501013259,40,o
161,0211-699501013259,mg,o
161,0211-699501013259,orales,o
161,0211-699501013259,de,o
161,0211-699501013259,vitamina,i
161,0211-699501013259,B6,i
161,0211-699501013259,cada,o
161,0211-699501013259,semana,o
161,0211-699501013259,Se,o
161,0211-699501013259,determinaron,o
161,0211-699501013259,al,o
161,0211-699501013259,comienzo,o
161,0211-699501013259,del,o
161,0211-699501013259,estudio,o
161,0211-699501013259,y,o
161,0211-699501013259,cada,o
161,0211-699501013259,2,o
161,0211-699501013259,meses,o
161,0211-699501013259,niveles,i
161,0211-699501013259,de,i
161,0211-699501013259,folato,i
161,0211-699501013259,vitamina,i
161,0211-699501013259,B12,i
161,0211-699501013259,inmunoensayo,i
161,0211-699501013259,albumina,i
161,0211-699501013259,y,o
161,0211-699501013259,cinetica,o
161,0211-699501013259,de,o
161,0211-699501013259,la,o
161,0211-699501013259,urea,i
161,0211-699501013259,KTV,o
161,0211-699501013259,KRU,o
161,0211-699501013259,PCRn,o
161,0211-699501013259,y,o
161,0211-699501013259,cada,o
161,0211-699501013259,6,o
161,0211-699501013259,meses,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,HPLC,i
161,0211-699501013259,y,o
161,0211-699501013259,pp,i
161,0211-699501013259,RIA,i
161,0211-699501013259,Resultados,o
161,0211-699501013259,80,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,fueron,o
161,0211-699501013259,incluidos,o
161,0211-699501013259,en,o
161,0211-699501013259,el,o
161,0211-699501013259,estudio,o
161,0211-699501013259,basal,o
161,0211-699501013259,con,o
161,0211-699501013259,una,o
161,0211-699501013259,prevalencia,o
161,0211-699501013259,de,o
161,0211-699501013259,hiperhomocisteinemia,i
161,0211-699501013259,del,o
161,0211-699501013259,844,o
161,0211-699501013259,deficit,i
161,0211-699501013259,de,i
161,0211-699501013259,pp,i
161,0211-699501013259,en,o
161,0211-699501013259,el,o
161,0211-699501013259,32,o
161,0211-699501013259,y,o
161,0211-699501013259,folato,i
161,0211-699501013259,en,o
161,0211-699501013259,el,o
161,0211-699501013259,rango,o
161,0211-699501013259,normal,o
161,0211-699501013259,bajo,o
161,0211-699501013259,los,o
161,0211-699501013259,niveles,i
161,0211-699501013259,de,i
161,0211-699501013259,tHcy,i
161,0211-699501013259,se,o
161,0211-699501013259,correlacionaban,o
161,0211-699501013259,inversamente,o
161,0211-699501013259,con,o
161,0211-699501013259,los,o
161,0211-699501013259,del,o
161,0211-699501013259,folato,i
161,0211-699501013259,r,o
161,0211-699501013259,0336,o
161,0211-699501013259,p,o
161,0211-699501013259,001,o
161,0211-699501013259,pero,o
161,0211-699501013259,no,o
161,0211-699501013259,con,o
161,0211-699501013259,pp,i
161,0211-699501013259,B12,i
161,0211-699501013259,edad,o
161,0211-699501013259,albumina,i
161,0211-699501013259,KTV,o
161,0211-699501013259,KRU,o
161,0211-699501013259,PCRn,o
161,0211-699501013259,Cincuenta,o
161,0211-699501013259,y,o
161,0211-699501013259,ocho,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,recibieron,o
161,0211-699501013259,seis,o
161,0211-699501013259,meses,o
161,0211-699501013259,de,o
161,0211-699501013259,suplementacion,i
161,0211-699501013259,con,o
161,0211-699501013259,normalizacion,o
161,0211-699501013259,del,o
161,0211-699501013259,pp,i
161,0211-699501013259,aumento,o
161,0211-699501013259,del,o
161,0211-699501013259,folato,i
161,0211-699501013259,703,o
161,0211-699501013259,IC,o
161,0211-699501013259,638,o
161,0211-699501013259,795,o
161,0211-699501013259,vs,o
161,0211-699501013259,6181,o
161,0211-699501013259,IC,o
161,0211-699501013259,4447,o
161,0211-699501013259,7811,o
161,0211-699501013259,p,o
161,0211-699501013259,0001,o
161,0211-699501013259,y,o
161,0211-699501013259,descenso,o
161,0211-699501013259,de,o
161,0211-699501013259,la,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,240,o
161,0211-699501013259,IC,o
161,0211-699501013259,213,o
161,0211-699501013259,264,o
161,0211-699501013259,vs,o
161,0211-699501013259,199,o
161,0211-699501013259,IC,o
161,0211-699501013259,175,o
161,0211-699501013259,224,o
161,0211-699501013259,p,o
161,0211-699501013259,005,o
161,0211-699501013259,Han,o
161,0211-699501013259,recibido,o
161,0211-699501013259,suplementacion,i
161,0211-699501013259,durante,o
161,0211-699501013259,12,o
161,0211-699501013259,meses,o
161,0211-699501013259,33,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,pero,o
161,0211-699501013259,a,o
161,0211-699501013259,pesar,o
161,0211-699501013259,de,o
161,0211-699501013259,un,o
161,0211-699501013259,continuo,o
161,0211-699501013259,aumento,o
161,0211-699501013259,del,o
161,0211-699501013259,folato,i
161,0211-699501013259,10078,o
161,0211-699501013259,IC,o
161,0211-699501013259,7481,o
161,0211-699501013259,12674,o
161,0211-699501013259,p,o
161,0211-699501013259,0001,o
161,0211-699501013259,solo,o
161,0211-699501013259,3,o
161,0211-699501013259,pacientes,o
161,0211-699501013259,presentan,o
161,0211-699501013259,niveles,o
161,0211-699501013259,normales,o
161,0211-699501013259,de,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,correlacionandose,o
161,0211-699501013259,directamente,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,con,o
161,0211-699501013259,la,o
161,0211-699501013259,albumina,i
161,0211-699501013259,r,o
161,0211-699501013259,056,o
161,0211-699501013259,p,o
161,0211-699501013259,0001,o
161,0211-699501013259,que,o
161,0211-699501013259,se,o
161,0211-699501013259,elevo,o
161,0211-699501013259,con,o
161,0211-699501013259,respecto,o
161,0211-699501013259,al,o
161,0211-699501013259,inicio,o
161,0211-699501013259,337,o
161,0211-699501013259,IC,o
161,0211-699501013259,327,o
161,0211-699501013259,346,o
161,0211-699501013259,vs,o
161,0211-699501013259,350,o
161,0211-699501013259,IC,o
161,0211-699501013259,337,o
161,0211-699501013259,363,o
161,0211-699501013259,p,o
161,0211-699501013259,005,o
161,0211-699501013259,Conclusion,o
161,0211-699501013259,Tras,o
161,0211-699501013259,suplementacion,i
161,0211-699501013259,con,o
161,0211-699501013259,acido,i
161,0211-699501013259,folico,i
161,0211-699501013259,y,o
161,0211-699501013259,vitamina,i
161,0211-699501013259,B6,i
161,0211-699501013259,aunque,o
161,0211-699501013259,inicialmente,o
161,0211-699501013259,se,o
161,0211-699501013259,reduce,o
161,0211-699501013259,la,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,esta,o
161,0211-699501013259,respuesta,o
161,0211-699501013259,se,o
161,0211-699501013259,hace,o
161,0211-699501013259,refractaria,o
161,0211-699501013259,correlacionandose,o
161,0211-699501013259,directamente,o
161,0211-699501013259,la,o
161,0211-699501013259,tHcy,i
161,0211-699501013259,con,o
161,0211-699501013259,la,o
161,0211-699501013259,albumina,i
161,0211-699501013259,plasmatica,i
161,0211-699501013259,La,o
161,0211-699501013259,interpretacion,o
161,0211-699501013259,de,o
161,0211-699501013259,los,o
161,0211-699501013259,niveles,i
161,0211-699501013259,de,i
161,0211-699501013259,tHcy,i
161,0211-699501013259,debe,o
161,0211-699501013259,tener,o
161,0211-699501013259,en,o
161,0211-699501013259,cuenta,o
161,0211-699501013259,la,o
161,0211-699501013259,concentracion,i
161,0211-699501013259,de,i
161,0211-699501013259,albumina,i
162,0211-699501013259,Efecto,o
162,0211-699501013259,de,o
162,0211-699501013259,la,o
162,0211-699501013259,suplementacion,i
162,0211-699501013259,con,o
162,0211-699501013259,acido,i
162,0211-699501013259,folico,i
162,0211-699501013259,sobre,o
162,0211-699501013259,los,o
162,0211-699501013259,niveles,i
162,0211-699501013259,de,i
162,0211-699501013259,homocisteina,i
162,0211-699501013259,total,o
162,0211-699501013259,en,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,en,o
162,0211-699501013259,hemodialisis,i
162,0211-699501013259,La,o
162,0211-699501013259,hiperhomocisteinemia,i
162,0211-699501013259,es,o
162,0211-699501013259,un,o
162,0211-699501013259,marcador,o
162,0211-699501013259,de,o
162,0211-699501013259,riesgo,o
162,0211-699501013259,independiente,o
162,0211-699501013259,de,o
162,0211-699501013259,morbimortalidad,o
162,0211-699501013259,cardiovascular,i
162,0211-699501013259,Hemos,o
162,0211-699501013259,intentado,o
162,0211-699501013259,prospectivamente,o
162,0211-699501013259,reducir,o
162,0211-699501013259,los,o
162,0211-699501013259,niveles,i
162,0211-699501013259,de,i
162,0211-699501013259,homocisteina,i
162,0211-699501013259,total,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,mediante,o
162,0211-699501013259,suplemento,o
162,0211-699501013259,con,o
162,0211-699501013259,acido,i
162,0211-699501013259,folico,i
162,0211-699501013259,y,o
162,0211-699501013259,vitamina,i
162,0211-699501013259,B6,i
162,0211-699501013259,pp,i
162,0211-699501013259,valorando,o
162,0211-699501013259,su,o
162,0211-699501013259,posible,o
162,0211-699501013259,correlacion,o
162,0211-699501013259,con,o
162,0211-699501013259,dosis,o
162,0211-699501013259,de,o
162,0211-699501013259,dialisis,i
162,0211-699501013259,funcion,i
162,0211-699501013259,residual,i
162,0211-699501013259,y,o
162,0211-699501013259,parametros,o
162,0211-699501013259,nutricionales,o
162,0211-699501013259,Metodos,o
162,0211-699501013259,Todos,o
162,0211-699501013259,los,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,en,o
162,0211-699501013259,hemodialisis,i
162,0211-699501013259,al,o
162,0211-699501013259,comienzo,o
162,0211-699501013259,del,o
162,0211-699501013259,estudio,o
162,0211-699501013259,que,o
162,0211-699501013259,no,o
162,0211-699501013259,recibian,o
162,0211-699501013259,acido,i
162,0211-699501013259,folico,i
162,0211-699501013259,ni,o
162,0211-699501013259,vitamina,i
162,0211-699501013259,B6,i
162,0211-699501013259,asi,o
162,0211-699501013259,como,o
162,0211-699501013259,los,o
162,0211-699501013259,incorporados,o
162,0211-699501013259,posteriormente,o
162,0211-699501013259,a,o
162,0211-699501013259,partir,o
162,0211-699501013259,de,o
162,0211-699501013259,su,o
162,0211-699501013259,tercer,o
162,0211-699501013259,mes,o
162,0211-699501013259,en,o
162,0211-699501013259,hemodialisis,i
162,0211-699501013259,recibieron,o
162,0211-699501013259,5,o
162,0211-699501013259,mg,o
162,0211-699501013259,orales,o
162,0211-699501013259,de,o
162,0211-699501013259,acido,i
162,0211-699501013259,folico,i
162,0211-699501013259,cada,o
162,0211-699501013259,48,o
162,0211-699501013259,horas,o
162,0211-699501013259,y,o
162,0211-699501013259,40,o
162,0211-699501013259,mg,o
162,0211-699501013259,orales,o
162,0211-699501013259,de,o
162,0211-699501013259,vitamina,i
162,0211-699501013259,B6,i
162,0211-699501013259,cada,o
162,0211-699501013259,semana,o
162,0211-699501013259,Se,o
162,0211-699501013259,determinaron,o
162,0211-699501013259,al,o
162,0211-699501013259,comienzo,o
162,0211-699501013259,del,o
162,0211-699501013259,estudio,o
162,0211-699501013259,y,o
162,0211-699501013259,cada,o
162,0211-699501013259,2,o
162,0211-699501013259,meses,o
162,0211-699501013259,niveles,i
162,0211-699501013259,de,i
162,0211-699501013259,folato,i
162,0211-699501013259,vitamina,i
162,0211-699501013259,B12,i
162,0211-699501013259,inmunoensayo,i
162,0211-699501013259,albumina,i
162,0211-699501013259,y,o
162,0211-699501013259,cinetica,o
162,0211-699501013259,de,o
162,0211-699501013259,la,o
162,0211-699501013259,urea,i
162,0211-699501013259,KTV,o
162,0211-699501013259,KRU,o
162,0211-699501013259,PCRn,o
162,0211-699501013259,y,o
162,0211-699501013259,cada,o
162,0211-699501013259,6,o
162,0211-699501013259,meses,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,HPLC,i
162,0211-699501013259,y,o
162,0211-699501013259,pp,i
162,0211-699501013259,RIA,i
162,0211-699501013259,Resultados,o
162,0211-699501013259,80,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,fueron,o
162,0211-699501013259,incluidos,o
162,0211-699501013259,en,o
162,0211-699501013259,el,o
162,0211-699501013259,estudio,o
162,0211-699501013259,basal,o
162,0211-699501013259,con,o
162,0211-699501013259,una,o
162,0211-699501013259,prevalencia,o
162,0211-699501013259,de,o
162,0211-699501013259,hiperhomocisteinemia,i
162,0211-699501013259,del,o
162,0211-699501013259,844,o
162,0211-699501013259,deficit,i
162,0211-699501013259,de,i
162,0211-699501013259,pp,i
162,0211-699501013259,en,o
162,0211-699501013259,el,o
162,0211-699501013259,32,o
162,0211-699501013259,y,o
162,0211-699501013259,folato,i
162,0211-699501013259,en,o
162,0211-699501013259,el,o
162,0211-699501013259,rango,o
162,0211-699501013259,normal,o
162,0211-699501013259,bajo,o
162,0211-699501013259,los,o
162,0211-699501013259,niveles,i
162,0211-699501013259,de,i
162,0211-699501013259,tHcy,i
162,0211-699501013259,se,o
162,0211-699501013259,correlacionaban,o
162,0211-699501013259,inversamente,o
162,0211-699501013259,con,o
162,0211-699501013259,los,o
162,0211-699501013259,del,o
162,0211-699501013259,folato,i
162,0211-699501013259,r,o
162,0211-699501013259,0336,o
162,0211-699501013259,p,o
162,0211-699501013259,001,o
162,0211-699501013259,pero,o
162,0211-699501013259,no,o
162,0211-699501013259,con,o
162,0211-699501013259,pp,i
162,0211-699501013259,B12,i
162,0211-699501013259,edad,o
162,0211-699501013259,albumina,i
162,0211-699501013259,KTV,o
162,0211-699501013259,KRU,o
162,0211-699501013259,PCRn,o
162,0211-699501013259,Cincuenta,o
162,0211-699501013259,y,o
162,0211-699501013259,ocho,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,recibieron,o
162,0211-699501013259,seis,o
162,0211-699501013259,meses,o
162,0211-699501013259,de,o
162,0211-699501013259,suplementacion,i
162,0211-699501013259,con,o
162,0211-699501013259,normalizacion,o
162,0211-699501013259,del,o
162,0211-699501013259,pp,i
162,0211-699501013259,aumento,o
162,0211-699501013259,del,o
162,0211-699501013259,folato,i
162,0211-699501013259,703,o
162,0211-699501013259,IC,o
162,0211-699501013259,638,o
162,0211-699501013259,795,o
162,0211-699501013259,vs,o
162,0211-699501013259,6181,o
162,0211-699501013259,IC,o
162,0211-699501013259,4447,o
162,0211-699501013259,7811,o
162,0211-699501013259,p,o
162,0211-699501013259,0001,o
162,0211-699501013259,y,o
162,0211-699501013259,descenso,o
162,0211-699501013259,de,o
162,0211-699501013259,la,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,240,o
162,0211-699501013259,IC,o
162,0211-699501013259,213,o
162,0211-699501013259,264,o
162,0211-699501013259,vs,o
162,0211-699501013259,199,o
162,0211-699501013259,IC,o
162,0211-699501013259,175,o
162,0211-699501013259,224,o
162,0211-699501013259,p,o
162,0211-699501013259,005,o
162,0211-699501013259,Han,o
162,0211-699501013259,recibido,o
162,0211-699501013259,suplementacion,i
162,0211-699501013259,durante,o
162,0211-699501013259,12,o
162,0211-699501013259,meses,o
162,0211-699501013259,33,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,pero,o
162,0211-699501013259,a,o
162,0211-699501013259,pesar,o
162,0211-699501013259,de,o
162,0211-699501013259,un,o
162,0211-699501013259,continuo,o
162,0211-699501013259,aumento,o
162,0211-699501013259,del,o
162,0211-699501013259,folato,i
162,0211-699501013259,10078,o
162,0211-699501013259,IC,o
162,0211-699501013259,7481,o
162,0211-699501013259,12674,o
162,0211-699501013259,p,o
162,0211-699501013259,0001,o
162,0211-699501013259,solo,o
162,0211-699501013259,3,o
162,0211-699501013259,pacientes,o
162,0211-699501013259,presentan,o
162,0211-699501013259,niveles,o
162,0211-699501013259,normales,o
162,0211-699501013259,de,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,correlacionandose,o
162,0211-699501013259,directamente,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,con,o
162,0211-699501013259,la,o
162,0211-699501013259,albumina,i
162,0211-699501013259,r,o
162,0211-699501013259,056,o
162,0211-699501013259,p,o
162,0211-699501013259,0001,o
162,0211-699501013259,que,o
162,0211-699501013259,se,o
162,0211-699501013259,elevo,o
162,0211-699501013259,con,o
162,0211-699501013259,respecto,o
162,0211-699501013259,al,o
162,0211-699501013259,inicio,o
162,0211-699501013259,337,o
162,0211-699501013259,IC,o
162,0211-699501013259,327,o
162,0211-699501013259,346,o
162,0211-699501013259,vs,o
162,0211-699501013259,350,o
162,0211-699501013259,IC,o
162,0211-699501013259,337,o
162,0211-699501013259,363,o
162,0211-699501013259,p,o
162,0211-699501013259,005,o
162,0211-699501013259,Conclusion,o
162,0211-699501013259,Tras,o
162,0211-699501013259,suplementacion,i
162,0211-699501013259,con,o
162,0211-699501013259,acido,i
162,0211-699501013259,folico,i
162,0211-699501013259,y,o
162,0211-699501013259,vitamina,i
162,0211-699501013259,B6,i
162,0211-699501013259,aunque,o
162,0211-699501013259,inicialmente,o
162,0211-699501013259,se,o
162,0211-699501013259,reduce,o
162,0211-699501013259,la,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,esta,o
162,0211-699501013259,respuesta,o
162,0211-699501013259,se,o
162,0211-699501013259,hace,o
162,0211-699501013259,refractaria,o
162,0211-699501013259,correlacionandose,o
162,0211-699501013259,directamente,o
162,0211-699501013259,la,o
162,0211-699501013259,tHcy,i
162,0211-699501013259,con,o
162,0211-699501013259,la,o
162,0211-699501013259,albumina,i
162,0211-699501013259,plasmatica,i
162,0211-699501013259,La,o
162,0211-699501013259,interpretacion,o
162,0211-699501013259,de,o
162,0211-699501013259,los,o
162,0211-699501013259,niveles,i
162,0211-699501013259,de,i
162,0211-699501013259,tHcy,i
162,0211-699501013259,debe,o
162,0211-699501013259,tener,o
162,0211-699501013259,en,o
162,0211-699501013259,cuenta,o
162,0211-699501013259,la,o
162,0211-699501013259,concentracion,i
162,0211-699501013259,de,i
162,0211-699501013259,albumina,i
163,0211-699501013259,Efecto,o
163,0211-699501013259,de,o
163,0211-699501013259,la,o
163,0211-699501013259,suplementacion,i
163,0211-699501013259,con,o
163,0211-699501013259,acido,i
163,0211-699501013259,folico,i
163,0211-699501013259,sobre,o
163,0211-699501013259,los,o
163,0211-699501013259,niveles,i
163,0211-699501013259,de,i
163,0211-699501013259,homocisteina,i
163,0211-699501013259,total,o
163,0211-699501013259,en,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,en,o
163,0211-699501013259,hemodialisis,i
163,0211-699501013259,La,o
163,0211-699501013259,hiperhomocisteinemia,i
163,0211-699501013259,es,o
163,0211-699501013259,un,o
163,0211-699501013259,marcador,o
163,0211-699501013259,de,o
163,0211-699501013259,riesgo,o
163,0211-699501013259,independiente,o
163,0211-699501013259,de,o
163,0211-699501013259,morbimortalidad,o
163,0211-699501013259,cardiovascular,i
163,0211-699501013259,Hemos,o
163,0211-699501013259,intentado,o
163,0211-699501013259,prospectivamente,o
163,0211-699501013259,reducir,o
163,0211-699501013259,los,o
163,0211-699501013259,niveles,i
163,0211-699501013259,de,i
163,0211-699501013259,homocisteina,i
163,0211-699501013259,total,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,mediante,o
163,0211-699501013259,suplemento,o
163,0211-699501013259,con,o
163,0211-699501013259,acido,i
163,0211-699501013259,folico,i
163,0211-699501013259,y,o
163,0211-699501013259,vitamina,i
163,0211-699501013259,B6,i
163,0211-699501013259,pp,i
163,0211-699501013259,valorando,o
163,0211-699501013259,su,o
163,0211-699501013259,posible,o
163,0211-699501013259,correlacion,o
163,0211-699501013259,con,o
163,0211-699501013259,dosis,o
163,0211-699501013259,de,o
163,0211-699501013259,dialisis,i
163,0211-699501013259,funcion,i
163,0211-699501013259,residual,i
163,0211-699501013259,y,o
163,0211-699501013259,parametros,o
163,0211-699501013259,nutricionales,o
163,0211-699501013259,Metodos,o
163,0211-699501013259,Todos,o
163,0211-699501013259,los,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,en,o
163,0211-699501013259,hemodialisis,i
163,0211-699501013259,al,o
163,0211-699501013259,comienzo,o
163,0211-699501013259,del,o
163,0211-699501013259,estudio,o
163,0211-699501013259,que,o
163,0211-699501013259,no,o
163,0211-699501013259,recibian,o
163,0211-699501013259,acido,i
163,0211-699501013259,folico,i
163,0211-699501013259,ni,o
163,0211-699501013259,vitamina,i
163,0211-699501013259,B6,i
163,0211-699501013259,asi,o
163,0211-699501013259,como,o
163,0211-699501013259,los,o
163,0211-699501013259,incorporados,o
163,0211-699501013259,posteriormente,o
163,0211-699501013259,a,o
163,0211-699501013259,partir,o
163,0211-699501013259,de,o
163,0211-699501013259,su,o
163,0211-699501013259,tercer,o
163,0211-699501013259,mes,o
163,0211-699501013259,en,o
163,0211-699501013259,hemodialisis,i
163,0211-699501013259,recibieron,o
163,0211-699501013259,5,o
163,0211-699501013259,mg,o
163,0211-699501013259,orales,o
163,0211-699501013259,de,o
163,0211-699501013259,acido,i
163,0211-699501013259,folico,i
163,0211-699501013259,cada,o
163,0211-699501013259,48,o
163,0211-699501013259,horas,o
163,0211-699501013259,y,o
163,0211-699501013259,40,o
163,0211-699501013259,mg,o
163,0211-699501013259,orales,o
163,0211-699501013259,de,o
163,0211-699501013259,vitamina,i
163,0211-699501013259,B6,i
163,0211-699501013259,cada,o
163,0211-699501013259,semana,o
163,0211-699501013259,Se,o
163,0211-699501013259,determinaron,o
163,0211-699501013259,al,o
163,0211-699501013259,comienzo,o
163,0211-699501013259,del,o
163,0211-699501013259,estudio,o
163,0211-699501013259,y,o
163,0211-699501013259,cada,o
163,0211-699501013259,2,o
163,0211-699501013259,meses,o
163,0211-699501013259,niveles,i
163,0211-699501013259,de,i
163,0211-699501013259,folato,i
163,0211-699501013259,vitamina,i
163,0211-699501013259,B12,i
163,0211-699501013259,inmunoensayo,i
163,0211-699501013259,albumina,i
163,0211-699501013259,y,o
163,0211-699501013259,cinetica,o
163,0211-699501013259,de,o
163,0211-699501013259,la,o
163,0211-699501013259,urea,i
163,0211-699501013259,KTV,o
163,0211-699501013259,KRU,o
163,0211-699501013259,PCRn,o
163,0211-699501013259,y,o
163,0211-699501013259,cada,o
163,0211-699501013259,6,o
163,0211-699501013259,meses,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,HPLC,i
163,0211-699501013259,y,o
163,0211-699501013259,pp,i
163,0211-699501013259,RIA,i
163,0211-699501013259,Resultados,o
163,0211-699501013259,80,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,fueron,o
163,0211-699501013259,incluidos,o
163,0211-699501013259,en,o
163,0211-699501013259,el,o
163,0211-699501013259,estudio,o
163,0211-699501013259,basal,o
163,0211-699501013259,con,o
163,0211-699501013259,una,o
163,0211-699501013259,prevalencia,o
163,0211-699501013259,de,o
163,0211-699501013259,hiperhomocisteinemia,i
163,0211-699501013259,del,o
163,0211-699501013259,844,o
163,0211-699501013259,deficit,i
163,0211-699501013259,de,i
163,0211-699501013259,pp,i
163,0211-699501013259,en,o
163,0211-699501013259,el,o
163,0211-699501013259,32,o
163,0211-699501013259,y,o
163,0211-699501013259,folato,i
163,0211-699501013259,en,o
163,0211-699501013259,el,o
163,0211-699501013259,rango,o
163,0211-699501013259,normal,o
163,0211-699501013259,bajo,o
163,0211-699501013259,los,o
163,0211-699501013259,niveles,i
163,0211-699501013259,de,i
163,0211-699501013259,tHcy,i
163,0211-699501013259,se,o
163,0211-699501013259,correlacionaban,o
163,0211-699501013259,inversamente,o
163,0211-699501013259,con,o
163,0211-699501013259,los,o
163,0211-699501013259,del,o
163,0211-699501013259,folato,i
163,0211-699501013259,r,o
163,0211-699501013259,0336,o
163,0211-699501013259,p,o
163,0211-699501013259,001,o
163,0211-699501013259,pero,o
163,0211-699501013259,no,o
163,0211-699501013259,con,o
163,0211-699501013259,pp,i
163,0211-699501013259,B12,i
163,0211-699501013259,edad,o
163,0211-699501013259,albumina,i
163,0211-699501013259,KTV,o
163,0211-699501013259,KRU,o
163,0211-699501013259,PCRn,o
163,0211-699501013259,Cincuenta,o
163,0211-699501013259,y,o
163,0211-699501013259,ocho,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,recibieron,o
163,0211-699501013259,seis,o
163,0211-699501013259,meses,o
163,0211-699501013259,de,o
163,0211-699501013259,suplementacion,i
163,0211-699501013259,con,o
163,0211-699501013259,normalizacion,o
163,0211-699501013259,del,o
163,0211-699501013259,pp,i
163,0211-699501013259,aumento,o
163,0211-699501013259,del,o
163,0211-699501013259,folato,i
163,0211-699501013259,703,o
163,0211-699501013259,IC,o
163,0211-699501013259,638,o
163,0211-699501013259,795,o
163,0211-699501013259,vs,o
163,0211-699501013259,6181,o
163,0211-699501013259,IC,o
163,0211-699501013259,4447,o
163,0211-699501013259,7811,o
163,0211-699501013259,p,o
163,0211-699501013259,0001,o
163,0211-699501013259,y,o
163,0211-699501013259,descenso,o
163,0211-699501013259,de,o
163,0211-699501013259,la,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,240,o
163,0211-699501013259,IC,o
163,0211-699501013259,213,o
163,0211-699501013259,264,o
163,0211-699501013259,vs,o
163,0211-699501013259,199,o
163,0211-699501013259,IC,o
163,0211-699501013259,175,o
163,0211-699501013259,224,o
163,0211-699501013259,p,o
163,0211-699501013259,005,o
163,0211-699501013259,Han,o
163,0211-699501013259,recibido,o
163,0211-699501013259,suplementacion,i
163,0211-699501013259,durante,o
163,0211-699501013259,12,o
163,0211-699501013259,meses,o
163,0211-699501013259,33,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,pero,o
163,0211-699501013259,a,o
163,0211-699501013259,pesar,o
163,0211-699501013259,de,o
163,0211-699501013259,un,o
163,0211-699501013259,continuo,o
163,0211-699501013259,aumento,o
163,0211-699501013259,del,o
163,0211-699501013259,folato,i
163,0211-699501013259,10078,o
163,0211-699501013259,IC,o
163,0211-699501013259,7481,o
163,0211-699501013259,12674,o
163,0211-699501013259,p,o
163,0211-699501013259,0001,o
163,0211-699501013259,solo,o
163,0211-699501013259,3,o
163,0211-699501013259,pacientes,o
163,0211-699501013259,presentan,o
163,0211-699501013259,niveles,o
163,0211-699501013259,normales,o
163,0211-699501013259,de,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,correlacionandose,o
163,0211-699501013259,directamente,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,con,o
163,0211-699501013259,la,o
163,0211-699501013259,albumina,i
163,0211-699501013259,r,o
163,0211-699501013259,056,o
163,0211-699501013259,p,o
163,0211-699501013259,0001,o
163,0211-699501013259,que,o
163,0211-699501013259,se,o
163,0211-699501013259,elevo,o
163,0211-699501013259,con,o
163,0211-699501013259,respecto,o
163,0211-699501013259,al,o
163,0211-699501013259,inicio,o
163,0211-699501013259,337,o
163,0211-699501013259,IC,o
163,0211-699501013259,327,o
163,0211-699501013259,346,o
163,0211-699501013259,vs,o
163,0211-699501013259,350,o
163,0211-699501013259,IC,o
163,0211-699501013259,337,o
163,0211-699501013259,363,o
163,0211-699501013259,p,o
163,0211-699501013259,005,o
163,0211-699501013259,Conclusion,o
163,0211-699501013259,Tras,o
163,0211-699501013259,suplementacion,i
163,0211-699501013259,con,o
163,0211-699501013259,acido,i
163,0211-699501013259,folico,i
163,0211-699501013259,y,o
163,0211-699501013259,vitamina,i
163,0211-699501013259,B6,i
163,0211-699501013259,aunque,o
163,0211-699501013259,inicialmente,o
163,0211-699501013259,se,o
163,0211-699501013259,reduce,o
163,0211-699501013259,la,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,esta,o
163,0211-699501013259,respuesta,o
163,0211-699501013259,se,o
163,0211-699501013259,hace,o
163,0211-699501013259,refractaria,o
163,0211-699501013259,correlacionandose,o
163,0211-699501013259,directamente,o
163,0211-699501013259,la,o
163,0211-699501013259,tHcy,i
163,0211-699501013259,con,o
163,0211-699501013259,la,o
163,0211-699501013259,albumina,i
163,0211-699501013259,plasmatica,i
163,0211-699501013259,La,o
163,0211-699501013259,interpretacion,o
163,0211-699501013259,de,o
163,0211-699501013259,los,o
163,0211-699501013259,niveles,i
163,0211-699501013259,de,i
163,0211-699501013259,tHcy,i
163,0211-699501013259,debe,o
163,0211-699501013259,tener,o
163,0211-699501013259,en,o
163,0211-699501013259,cuenta,o
163,0211-699501013259,la,o
163,0211-699501013259,concentracion,i
163,0211-699501013259,de,i
163,0211-699501013259,albumina,i
164,0211-699501013259,Efecto,o
164,0211-699501013259,de,o
164,0211-699501013259,la,o
164,0211-699501013259,suplementacion,i
164,0211-699501013259,con,o
164,0211-699501013259,acido,i
164,0211-699501013259,folico,i
164,0211-699501013259,sobre,o
164,0211-699501013259,los,o
164,0211-699501013259,niveles,i
164,0211-699501013259,de,i
164,0211-699501013259,homocisteina,i
164,0211-699501013259,total,o
164,0211-699501013259,en,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,en,o
164,0211-699501013259,hemodialisis,i
164,0211-699501013259,La,o
164,0211-699501013259,hiperhomocisteinemia,i
164,0211-699501013259,es,o
164,0211-699501013259,un,o
164,0211-699501013259,marcador,o
164,0211-699501013259,de,o
164,0211-699501013259,riesgo,o
164,0211-699501013259,independiente,o
164,0211-699501013259,de,o
164,0211-699501013259,morbimortalidad,o
164,0211-699501013259,cardiovascular,i
164,0211-699501013259,Hemos,o
164,0211-699501013259,intentado,o
164,0211-699501013259,prospectivamente,o
164,0211-699501013259,reducir,o
164,0211-699501013259,los,o
164,0211-699501013259,niveles,i
164,0211-699501013259,de,i
164,0211-699501013259,homocisteina,i
164,0211-699501013259,total,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,mediante,o
164,0211-699501013259,suplemento,o
164,0211-699501013259,con,o
164,0211-699501013259,acido,i
164,0211-699501013259,folico,i
164,0211-699501013259,y,o
164,0211-699501013259,vitamina,i
164,0211-699501013259,B6,i
164,0211-699501013259,pp,i
164,0211-699501013259,valorando,o
164,0211-699501013259,su,o
164,0211-699501013259,posible,o
164,0211-699501013259,correlacion,o
164,0211-699501013259,con,o
164,0211-699501013259,dosis,o
164,0211-699501013259,de,o
164,0211-699501013259,dialisis,i
164,0211-699501013259,funcion,i
164,0211-699501013259,residual,i
164,0211-699501013259,y,o
164,0211-699501013259,parametros,o
164,0211-699501013259,nutricionales,o
164,0211-699501013259,Metodos,o
164,0211-699501013259,Todos,o
164,0211-699501013259,los,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,en,o
164,0211-699501013259,hemodialisis,i
164,0211-699501013259,al,o
164,0211-699501013259,comienzo,o
164,0211-699501013259,del,o
164,0211-699501013259,estudio,o
164,0211-699501013259,que,o
164,0211-699501013259,no,o
164,0211-699501013259,recibian,o
164,0211-699501013259,acido,i
164,0211-699501013259,folico,i
164,0211-699501013259,ni,o
164,0211-699501013259,vitamina,i
164,0211-699501013259,B6,i
164,0211-699501013259,asi,o
164,0211-699501013259,como,o
164,0211-699501013259,los,o
164,0211-699501013259,incorporados,o
164,0211-699501013259,posteriormente,o
164,0211-699501013259,a,o
164,0211-699501013259,partir,o
164,0211-699501013259,de,o
164,0211-699501013259,su,o
164,0211-699501013259,tercer,o
164,0211-699501013259,mes,o
164,0211-699501013259,en,o
164,0211-699501013259,hemodialisis,i
164,0211-699501013259,recibieron,o
164,0211-699501013259,5,o
164,0211-699501013259,mg,o
164,0211-699501013259,orales,o
164,0211-699501013259,de,o
164,0211-699501013259,acido,i
164,0211-699501013259,folico,i
164,0211-699501013259,cada,o
164,0211-699501013259,48,o
164,0211-699501013259,horas,o
164,0211-699501013259,y,o
164,0211-699501013259,40,o
164,0211-699501013259,mg,o
164,0211-699501013259,orales,o
164,0211-699501013259,de,o
164,0211-699501013259,vitamina,i
164,0211-699501013259,B6,i
164,0211-699501013259,cada,o
164,0211-699501013259,semana,o
164,0211-699501013259,Se,o
164,0211-699501013259,determinaron,o
164,0211-699501013259,al,o
164,0211-699501013259,comienzo,o
164,0211-699501013259,del,o
164,0211-699501013259,estudio,o
164,0211-699501013259,y,o
164,0211-699501013259,cada,o
164,0211-699501013259,2,o
164,0211-699501013259,meses,o
164,0211-699501013259,niveles,i
164,0211-699501013259,de,i
164,0211-699501013259,folato,i
164,0211-699501013259,vitamina,i
164,0211-699501013259,B12,i
164,0211-699501013259,inmunoensayo,i
164,0211-699501013259,albumina,i
164,0211-699501013259,y,o
164,0211-699501013259,cinetica,o
164,0211-699501013259,de,o
164,0211-699501013259,la,o
164,0211-699501013259,urea,i
164,0211-699501013259,KTV,o
164,0211-699501013259,KRU,o
164,0211-699501013259,PCRn,o
164,0211-699501013259,y,o
164,0211-699501013259,cada,o
164,0211-699501013259,6,o
164,0211-699501013259,meses,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,HPLC,i
164,0211-699501013259,y,o
164,0211-699501013259,pp,i
164,0211-699501013259,RIA,i
164,0211-699501013259,Resultados,o
164,0211-699501013259,80,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,fueron,o
164,0211-699501013259,incluidos,o
164,0211-699501013259,en,o
164,0211-699501013259,el,o
164,0211-699501013259,estudio,o
164,0211-699501013259,basal,o
164,0211-699501013259,con,o
164,0211-699501013259,una,o
164,0211-699501013259,prevalencia,o
164,0211-699501013259,de,o
164,0211-699501013259,hiperhomocisteinemia,i
164,0211-699501013259,del,o
164,0211-699501013259,844,o
164,0211-699501013259,deficit,i
164,0211-699501013259,de,i
164,0211-699501013259,pp,i
164,0211-699501013259,en,o
164,0211-699501013259,el,o
164,0211-699501013259,32,o
164,0211-699501013259,y,o
164,0211-699501013259,folato,i
164,0211-699501013259,en,o
164,0211-699501013259,el,o
164,0211-699501013259,rango,o
164,0211-699501013259,normal,o
164,0211-699501013259,bajo,o
164,0211-699501013259,los,o
164,0211-699501013259,niveles,i
164,0211-699501013259,de,i
164,0211-699501013259,tHcy,i
164,0211-699501013259,se,o
164,0211-699501013259,correlacionaban,o
164,0211-699501013259,inversamente,o
164,0211-699501013259,con,o
164,0211-699501013259,los,o
164,0211-699501013259,del,o
164,0211-699501013259,folato,i
164,0211-699501013259,r,o
164,0211-699501013259,0336,o
164,0211-699501013259,p,o
164,0211-699501013259,001,o
164,0211-699501013259,pero,o
164,0211-699501013259,no,o
164,0211-699501013259,con,o
164,0211-699501013259,pp,i
164,0211-699501013259,B12,i
164,0211-699501013259,edad,o
164,0211-699501013259,albumina,i
164,0211-699501013259,KTV,o
164,0211-699501013259,KRU,o
164,0211-699501013259,PCRn,o
164,0211-699501013259,Cincuenta,o
164,0211-699501013259,y,o
164,0211-699501013259,ocho,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,recibieron,o
164,0211-699501013259,seis,o
164,0211-699501013259,meses,o
164,0211-699501013259,de,o
164,0211-699501013259,suplementacion,i
164,0211-699501013259,con,o
164,0211-699501013259,normalizacion,o
164,0211-699501013259,del,o
164,0211-699501013259,pp,i
164,0211-699501013259,aumento,o
164,0211-699501013259,del,o
164,0211-699501013259,folato,i
164,0211-699501013259,703,o
164,0211-699501013259,IC,o
164,0211-699501013259,638,o
164,0211-699501013259,795,o
164,0211-699501013259,vs,o
164,0211-699501013259,6181,o
164,0211-699501013259,IC,o
164,0211-699501013259,4447,o
164,0211-699501013259,7811,o
164,0211-699501013259,p,o
164,0211-699501013259,0001,o
164,0211-699501013259,y,o
164,0211-699501013259,descenso,o
164,0211-699501013259,de,o
164,0211-699501013259,la,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,240,o
164,0211-699501013259,IC,o
164,0211-699501013259,213,o
164,0211-699501013259,264,o
164,0211-699501013259,vs,o
164,0211-699501013259,199,o
164,0211-699501013259,IC,o
164,0211-699501013259,175,o
164,0211-699501013259,224,o
164,0211-699501013259,p,o
164,0211-699501013259,005,o
164,0211-699501013259,Han,o
164,0211-699501013259,recibido,o
164,0211-699501013259,suplementacion,i
164,0211-699501013259,durante,o
164,0211-699501013259,12,o
164,0211-699501013259,meses,o
164,0211-699501013259,33,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,pero,o
164,0211-699501013259,a,o
164,0211-699501013259,pesar,o
164,0211-699501013259,de,o
164,0211-699501013259,un,o
164,0211-699501013259,continuo,o
164,0211-699501013259,aumento,o
164,0211-699501013259,del,o
164,0211-699501013259,folato,i
164,0211-699501013259,10078,o
164,0211-699501013259,IC,o
164,0211-699501013259,7481,o
164,0211-699501013259,12674,o
164,0211-699501013259,p,o
164,0211-699501013259,0001,o
164,0211-699501013259,solo,o
164,0211-699501013259,3,o
164,0211-699501013259,pacientes,o
164,0211-699501013259,presentan,o
164,0211-699501013259,niveles,o
164,0211-699501013259,normales,o
164,0211-699501013259,de,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,correlacionandose,o
164,0211-699501013259,directamente,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,con,o
164,0211-699501013259,la,o
164,0211-699501013259,albumina,i
164,0211-699501013259,r,o
164,0211-699501013259,056,o
164,0211-699501013259,p,o
164,0211-699501013259,0001,o
164,0211-699501013259,que,o
164,0211-699501013259,se,o
164,0211-699501013259,elevo,o
164,0211-699501013259,con,o
164,0211-699501013259,respecto,o
164,0211-699501013259,al,o
164,0211-699501013259,inicio,o
164,0211-699501013259,337,o
164,0211-699501013259,IC,o
164,0211-699501013259,327,o
164,0211-699501013259,346,o
164,0211-699501013259,vs,o
164,0211-699501013259,350,o
164,0211-699501013259,IC,o
164,0211-699501013259,337,o
164,0211-699501013259,363,o
164,0211-699501013259,p,o
164,0211-699501013259,005,o
164,0211-699501013259,Conclusion,o
164,0211-699501013259,Tras,o
164,0211-699501013259,suplementacion,i
164,0211-699501013259,con,o
164,0211-699501013259,acido,i
164,0211-699501013259,folico,i
164,0211-699501013259,y,o
164,0211-699501013259,vitamina,i
164,0211-699501013259,B6,i
164,0211-699501013259,aunque,o
164,0211-699501013259,inicialmente,o
164,0211-699501013259,se,o
164,0211-699501013259,reduce,o
164,0211-699501013259,la,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,esta,o
164,0211-699501013259,respuesta,o
164,0211-699501013259,se,o
164,0211-699501013259,hace,o
164,0211-699501013259,refractaria,o
164,0211-699501013259,correlacionandose,o
164,0211-699501013259,directamente,o
164,0211-699501013259,la,o
164,0211-699501013259,tHcy,i
164,0211-699501013259,con,o
164,0211-699501013259,la,o
164,0211-699501013259,albumina,i
164,0211-699501013259,plasmatica,i
164,0211-699501013259,La,o
164,0211-699501013259,interpretacion,o
164,0211-699501013259,de,o
164,0211-699501013259,los,o
164,0211-699501013259,niveles,i
164,0211-699501013259,de,i
164,0211-699501013259,tHcy,i
164,0211-699501013259,debe,o
164,0211-699501013259,tener,o
164,0211-699501013259,en,o
164,0211-699501013259,cuenta,o
164,0211-699501013259,la,o
164,0211-699501013259,concentracion,i
164,0211-699501013259,de,i
164,0211-699501013259,albumina,i
165,0211-699501013259,Efecto,o
165,0211-699501013259,de,o
165,0211-699501013259,la,o
165,0211-699501013259,suplementacion,i
165,0211-699501013259,con,o
165,0211-699501013259,acido,i
165,0211-699501013259,folico,i
165,0211-699501013259,sobre,o
165,0211-699501013259,los,o
165,0211-699501013259,niveles,i
165,0211-699501013259,de,i
165,0211-699501013259,homocisteina,i
165,0211-699501013259,total,o
165,0211-699501013259,en,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,en,o
165,0211-699501013259,hemodialisis,i
165,0211-699501013259,La,o
165,0211-699501013259,hiperhomocisteinemia,i
165,0211-699501013259,es,o
165,0211-699501013259,un,o
165,0211-699501013259,marcador,o
165,0211-699501013259,de,o
165,0211-699501013259,riesgo,o
165,0211-699501013259,independiente,o
165,0211-699501013259,de,o
165,0211-699501013259,morbimortalidad,o
165,0211-699501013259,cardiovascular,i
165,0211-699501013259,Hemos,o
165,0211-699501013259,intentado,o
165,0211-699501013259,prospectivamente,o
165,0211-699501013259,reducir,o
165,0211-699501013259,los,o
165,0211-699501013259,niveles,i
165,0211-699501013259,de,i
165,0211-699501013259,homocisteina,i
165,0211-699501013259,total,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,mediante,o
165,0211-699501013259,suplemento,o
165,0211-699501013259,con,o
165,0211-699501013259,acido,i
165,0211-699501013259,folico,i
165,0211-699501013259,y,o
165,0211-699501013259,vitamina,i
165,0211-699501013259,B6,i
165,0211-699501013259,pp,i
165,0211-699501013259,valorando,o
165,0211-699501013259,su,o
165,0211-699501013259,posible,o
165,0211-699501013259,correlacion,o
165,0211-699501013259,con,o
165,0211-699501013259,dosis,o
165,0211-699501013259,de,o
165,0211-699501013259,dialisis,i
165,0211-699501013259,funcion,i
165,0211-699501013259,residual,i
165,0211-699501013259,y,o
165,0211-699501013259,parametros,o
165,0211-699501013259,nutricionales,o
165,0211-699501013259,Metodos,o
165,0211-699501013259,Todos,o
165,0211-699501013259,los,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,en,o
165,0211-699501013259,hemodialisis,i
165,0211-699501013259,al,o
165,0211-699501013259,comienzo,o
165,0211-699501013259,del,o
165,0211-699501013259,estudio,o
165,0211-699501013259,que,o
165,0211-699501013259,no,o
165,0211-699501013259,recibian,o
165,0211-699501013259,acido,i
165,0211-699501013259,folico,i
165,0211-699501013259,ni,o
165,0211-699501013259,vitamina,i
165,0211-699501013259,B6,i
165,0211-699501013259,asi,o
165,0211-699501013259,como,o
165,0211-699501013259,los,o
165,0211-699501013259,incorporados,o
165,0211-699501013259,posteriormente,o
165,0211-699501013259,a,o
165,0211-699501013259,partir,o
165,0211-699501013259,de,o
165,0211-699501013259,su,o
165,0211-699501013259,tercer,o
165,0211-699501013259,mes,o
165,0211-699501013259,en,o
165,0211-699501013259,hemodialisis,i
165,0211-699501013259,recibieron,o
165,0211-699501013259,5,o
165,0211-699501013259,mg,o
165,0211-699501013259,orales,o
165,0211-699501013259,de,o
165,0211-699501013259,acido,i
165,0211-699501013259,folico,i
165,0211-699501013259,cada,o
165,0211-699501013259,48,o
165,0211-699501013259,horas,o
165,0211-699501013259,y,o
165,0211-699501013259,40,o
165,0211-699501013259,mg,o
165,0211-699501013259,orales,o
165,0211-699501013259,de,o
165,0211-699501013259,vitamina,i
165,0211-699501013259,B6,i
165,0211-699501013259,cada,o
165,0211-699501013259,semana,o
165,0211-699501013259,Se,o
165,0211-699501013259,determinaron,o
165,0211-699501013259,al,o
165,0211-699501013259,comienzo,o
165,0211-699501013259,del,o
165,0211-699501013259,estudio,o
165,0211-699501013259,y,o
165,0211-699501013259,cada,o
165,0211-699501013259,2,o
165,0211-699501013259,meses,o
165,0211-699501013259,niveles,i
165,0211-699501013259,de,i
165,0211-699501013259,folato,i
165,0211-699501013259,vitamina,i
165,0211-699501013259,B12,i
165,0211-699501013259,inmunoensayo,i
165,0211-699501013259,albumina,i
165,0211-699501013259,y,o
165,0211-699501013259,cinetica,o
165,0211-699501013259,de,o
165,0211-699501013259,la,o
165,0211-699501013259,urea,i
165,0211-699501013259,KTV,o
165,0211-699501013259,KRU,o
165,0211-699501013259,PCRn,o
165,0211-699501013259,y,o
165,0211-699501013259,cada,o
165,0211-699501013259,6,o
165,0211-699501013259,meses,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,HPLC,i
165,0211-699501013259,y,o
165,0211-699501013259,pp,i
165,0211-699501013259,RIA,i
165,0211-699501013259,Resultados,o
165,0211-699501013259,80,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,fueron,o
165,0211-699501013259,incluidos,o
165,0211-699501013259,en,o
165,0211-699501013259,el,o
165,0211-699501013259,estudio,o
165,0211-699501013259,basal,o
165,0211-699501013259,con,o
165,0211-699501013259,una,o
165,0211-699501013259,prevalencia,o
165,0211-699501013259,de,o
165,0211-699501013259,hiperhomocisteinemia,i
165,0211-699501013259,del,o
165,0211-699501013259,844,o
165,0211-699501013259,deficit,i
165,0211-699501013259,de,i
165,0211-699501013259,pp,i
165,0211-699501013259,en,o
165,0211-699501013259,el,o
165,0211-699501013259,32,o
165,0211-699501013259,y,o
165,0211-699501013259,folato,i
165,0211-699501013259,en,o
165,0211-699501013259,el,o
165,0211-699501013259,rango,o
165,0211-699501013259,normal,o
165,0211-699501013259,bajo,o
165,0211-699501013259,los,o
165,0211-699501013259,niveles,i
165,0211-699501013259,de,i
165,0211-699501013259,tHcy,i
165,0211-699501013259,se,o
165,0211-699501013259,correlacionaban,o
165,0211-699501013259,inversamente,o
165,0211-699501013259,con,o
165,0211-699501013259,los,o
165,0211-699501013259,del,o
165,0211-699501013259,folato,i
165,0211-699501013259,r,o
165,0211-699501013259,0336,o
165,0211-699501013259,p,o
165,0211-699501013259,001,o
165,0211-699501013259,pero,o
165,0211-699501013259,no,o
165,0211-699501013259,con,o
165,0211-699501013259,pp,i
165,0211-699501013259,B12,i
165,0211-699501013259,edad,o
165,0211-699501013259,albumina,i
165,0211-699501013259,KTV,o
165,0211-699501013259,KRU,o
165,0211-699501013259,PCRn,o
165,0211-699501013259,Cincuenta,o
165,0211-699501013259,y,o
165,0211-699501013259,ocho,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,recibieron,o
165,0211-699501013259,seis,o
165,0211-699501013259,meses,o
165,0211-699501013259,de,o
165,0211-699501013259,suplementacion,i
165,0211-699501013259,con,o
165,0211-699501013259,normalizacion,o
165,0211-699501013259,del,o
165,0211-699501013259,pp,i
165,0211-699501013259,aumento,o
165,0211-699501013259,del,o
165,0211-699501013259,folato,i
165,0211-699501013259,703,o
165,0211-699501013259,IC,o
165,0211-699501013259,638,o
165,0211-699501013259,795,o
165,0211-699501013259,vs,o
165,0211-699501013259,6181,o
165,0211-699501013259,IC,o
165,0211-699501013259,4447,o
165,0211-699501013259,7811,o
165,0211-699501013259,p,o
165,0211-699501013259,0001,o
165,0211-699501013259,y,o
165,0211-699501013259,descenso,o
165,0211-699501013259,de,o
165,0211-699501013259,la,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,240,o
165,0211-699501013259,IC,o
165,0211-699501013259,213,o
165,0211-699501013259,264,o
165,0211-699501013259,vs,o
165,0211-699501013259,199,o
165,0211-699501013259,IC,o
165,0211-699501013259,175,o
165,0211-699501013259,224,o
165,0211-699501013259,p,o
165,0211-699501013259,005,o
165,0211-699501013259,Han,o
165,0211-699501013259,recibido,o
165,0211-699501013259,suplementacion,i
165,0211-699501013259,durante,o
165,0211-699501013259,12,o
165,0211-699501013259,meses,o
165,0211-699501013259,33,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,pero,o
165,0211-699501013259,a,o
165,0211-699501013259,pesar,o
165,0211-699501013259,de,o
165,0211-699501013259,un,o
165,0211-699501013259,continuo,o
165,0211-699501013259,aumento,o
165,0211-699501013259,del,o
165,0211-699501013259,folato,i
165,0211-699501013259,10078,o
165,0211-699501013259,IC,o
165,0211-699501013259,7481,o
165,0211-699501013259,12674,o
165,0211-699501013259,p,o
165,0211-699501013259,0001,o
165,0211-699501013259,solo,o
165,0211-699501013259,3,o
165,0211-699501013259,pacientes,o
165,0211-699501013259,presentan,o
165,0211-699501013259,niveles,o
165,0211-699501013259,normales,o
165,0211-699501013259,de,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,correlacionandose,o
165,0211-699501013259,directamente,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,con,o
165,0211-699501013259,la,o
165,0211-699501013259,albumina,i
165,0211-699501013259,r,o
165,0211-699501013259,056,o
165,0211-699501013259,p,o
165,0211-699501013259,0001,o
165,0211-699501013259,que,o
165,0211-699501013259,se,o
165,0211-699501013259,elevo,o
165,0211-699501013259,con,o
165,0211-699501013259,respecto,o
165,0211-699501013259,al,o
165,0211-699501013259,inicio,o
165,0211-699501013259,337,o
165,0211-699501013259,IC,o
165,0211-699501013259,327,o
165,0211-699501013259,346,o
165,0211-699501013259,vs,o
165,0211-699501013259,350,o
165,0211-699501013259,IC,o
165,0211-699501013259,337,o
165,0211-699501013259,363,o
165,0211-699501013259,p,o
165,0211-699501013259,005,o
165,0211-699501013259,Conclusion,o
165,0211-699501013259,Tras,o
165,0211-699501013259,suplementacion,i
165,0211-699501013259,con,o
165,0211-699501013259,acido,i
165,0211-699501013259,folico,i
165,0211-699501013259,y,o
165,0211-699501013259,vitamina,i
165,0211-699501013259,B6,i
165,0211-699501013259,aunque,o
165,0211-699501013259,inicialmente,o
165,0211-699501013259,se,o
165,0211-699501013259,reduce,o
165,0211-699501013259,la,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,esta,o
165,0211-699501013259,respuesta,o
165,0211-699501013259,se,o
165,0211-699501013259,hace,o
165,0211-699501013259,refractaria,o
165,0211-699501013259,correlacionandose,o
165,0211-699501013259,directamente,o
165,0211-699501013259,la,o
165,0211-699501013259,tHcy,i
165,0211-699501013259,con,o
165,0211-699501013259,la,o
165,0211-699501013259,albumina,i
165,0211-699501013259,plasmatica,i
165,0211-699501013259,La,o
165,0211-699501013259,interpretacion,o
165,0211-699501013259,de,o
165,0211-699501013259,los,o
165,0211-699501013259,niveles,i
165,0211-699501013259,de,i
165,0211-699501013259,tHcy,i
165,0211-699501013259,debe,o
165,0211-699501013259,tener,o
165,0211-699501013259,en,o
165,0211-699501013259,cuenta,o
165,0211-699501013259,la,o
165,0211-699501013259,concentracion,i
165,0211-699501013259,de,i
165,0211-699501013259,albumina,i
166,0211-699501013259,Efecto,o
166,0211-699501013259,de,o
166,0211-699501013259,la,o
166,0211-699501013259,suplementacion,i
166,0211-699501013259,con,o
166,0211-699501013259,acido,i
166,0211-699501013259,folico,i
166,0211-699501013259,sobre,o
166,0211-699501013259,los,o
166,0211-699501013259,niveles,i
166,0211-699501013259,de,i
166,0211-699501013259,homocisteina,i
166,0211-699501013259,total,o
166,0211-699501013259,en,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,en,o
166,0211-699501013259,hemodialisis,i
166,0211-699501013259,La,o
166,0211-699501013259,hiperhomocisteinemia,i
166,0211-699501013259,es,o
166,0211-699501013259,un,o
166,0211-699501013259,marcador,o
166,0211-699501013259,de,o
166,0211-699501013259,riesgo,o
166,0211-699501013259,independiente,o
166,0211-699501013259,de,o
166,0211-699501013259,morbimortalidad,o
166,0211-699501013259,cardiovascular,i
166,0211-699501013259,Hemos,o
166,0211-699501013259,intentado,o
166,0211-699501013259,prospectivamente,o
166,0211-699501013259,reducir,o
166,0211-699501013259,los,o
166,0211-699501013259,niveles,i
166,0211-699501013259,de,i
166,0211-699501013259,homocisteina,i
166,0211-699501013259,total,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,mediante,o
166,0211-699501013259,suplemento,o
166,0211-699501013259,con,o
166,0211-699501013259,acido,i
166,0211-699501013259,folico,i
166,0211-699501013259,y,o
166,0211-699501013259,vitamina,i
166,0211-699501013259,B6,i
166,0211-699501013259,pp,i
166,0211-699501013259,valorando,o
166,0211-699501013259,su,o
166,0211-699501013259,posible,o
166,0211-699501013259,correlacion,o
166,0211-699501013259,con,o
166,0211-699501013259,dosis,o
166,0211-699501013259,de,o
166,0211-699501013259,dialisis,i
166,0211-699501013259,funcion,i
166,0211-699501013259,residual,i
166,0211-699501013259,y,o
166,0211-699501013259,parametros,o
166,0211-699501013259,nutricionales,o
166,0211-699501013259,Metodos,o
166,0211-699501013259,Todos,o
166,0211-699501013259,los,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,en,o
166,0211-699501013259,hemodialisis,i
166,0211-699501013259,al,o
166,0211-699501013259,comienzo,o
166,0211-699501013259,del,o
166,0211-699501013259,estudio,o
166,0211-699501013259,que,o
166,0211-699501013259,no,o
166,0211-699501013259,recibian,o
166,0211-699501013259,acido,i
166,0211-699501013259,folico,i
166,0211-699501013259,ni,o
166,0211-699501013259,vitamina,i
166,0211-699501013259,B6,i
166,0211-699501013259,asi,o
166,0211-699501013259,como,o
166,0211-699501013259,los,o
166,0211-699501013259,incorporados,o
166,0211-699501013259,posteriormente,o
166,0211-699501013259,a,o
166,0211-699501013259,partir,o
166,0211-699501013259,de,o
166,0211-699501013259,su,o
166,0211-699501013259,tercer,o
166,0211-699501013259,mes,o
166,0211-699501013259,en,o
166,0211-699501013259,hemodialisis,i
166,0211-699501013259,recibieron,o
166,0211-699501013259,5,o
166,0211-699501013259,mg,o
166,0211-699501013259,orales,o
166,0211-699501013259,de,o
166,0211-699501013259,acido,i
166,0211-699501013259,folico,i
166,0211-699501013259,cada,o
166,0211-699501013259,48,o
166,0211-699501013259,horas,o
166,0211-699501013259,y,o
166,0211-699501013259,40,o
166,0211-699501013259,mg,o
166,0211-699501013259,orales,o
166,0211-699501013259,de,o
166,0211-699501013259,vitamina,i
166,0211-699501013259,B6,i
166,0211-699501013259,cada,o
166,0211-699501013259,semana,o
166,0211-699501013259,Se,o
166,0211-699501013259,determinaron,o
166,0211-699501013259,al,o
166,0211-699501013259,comienzo,o
166,0211-699501013259,del,o
166,0211-699501013259,estudio,o
166,0211-699501013259,y,o
166,0211-699501013259,cada,o
166,0211-699501013259,2,o
166,0211-699501013259,meses,o
166,0211-699501013259,niveles,i
166,0211-699501013259,de,i
166,0211-699501013259,folato,i
166,0211-699501013259,vitamina,i
166,0211-699501013259,B12,i
166,0211-699501013259,inmunoensayo,i
166,0211-699501013259,albumina,i
166,0211-699501013259,y,o
166,0211-699501013259,cinetica,o
166,0211-699501013259,de,o
166,0211-699501013259,la,o
166,0211-699501013259,urea,i
166,0211-699501013259,KTV,o
166,0211-699501013259,KRU,o
166,0211-699501013259,PCRn,o
166,0211-699501013259,y,o
166,0211-699501013259,cada,o
166,0211-699501013259,6,o
166,0211-699501013259,meses,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,HPLC,i
166,0211-699501013259,y,o
166,0211-699501013259,pp,i
166,0211-699501013259,RIA,i
166,0211-699501013259,Resultados,o
166,0211-699501013259,80,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,fueron,o
166,0211-699501013259,incluidos,o
166,0211-699501013259,en,o
166,0211-699501013259,el,o
166,0211-699501013259,estudio,o
166,0211-699501013259,basal,o
166,0211-699501013259,con,o
166,0211-699501013259,una,o
166,0211-699501013259,prevalencia,o
166,0211-699501013259,de,o
166,0211-699501013259,hiperhomocisteinemia,i
166,0211-699501013259,del,o
166,0211-699501013259,844,o
166,0211-699501013259,deficit,i
166,0211-699501013259,de,i
166,0211-699501013259,pp,i
166,0211-699501013259,en,o
166,0211-699501013259,el,o
166,0211-699501013259,32,o
166,0211-699501013259,y,o
166,0211-699501013259,folato,i
166,0211-699501013259,en,o
166,0211-699501013259,el,o
166,0211-699501013259,rango,o
166,0211-699501013259,normal,o
166,0211-699501013259,bajo,o
166,0211-699501013259,los,o
166,0211-699501013259,niveles,i
166,0211-699501013259,de,i
166,0211-699501013259,tHcy,i
166,0211-699501013259,se,o
166,0211-699501013259,correlacionaban,o
166,0211-699501013259,inversamente,o
166,0211-699501013259,con,o
166,0211-699501013259,los,o
166,0211-699501013259,del,o
166,0211-699501013259,folato,i
166,0211-699501013259,r,o
166,0211-699501013259,0336,o
166,0211-699501013259,p,o
166,0211-699501013259,001,o
166,0211-699501013259,pero,o
166,0211-699501013259,no,o
166,0211-699501013259,con,o
166,0211-699501013259,pp,i
166,0211-699501013259,B12,i
166,0211-699501013259,edad,o
166,0211-699501013259,albumina,i
166,0211-699501013259,KTV,o
166,0211-699501013259,KRU,o
166,0211-699501013259,PCRn,o
166,0211-699501013259,Cincuenta,o
166,0211-699501013259,y,o
166,0211-699501013259,ocho,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,recibieron,o
166,0211-699501013259,seis,o
166,0211-699501013259,meses,o
166,0211-699501013259,de,o
166,0211-699501013259,suplementacion,i
166,0211-699501013259,con,o
166,0211-699501013259,normalizacion,o
166,0211-699501013259,del,o
166,0211-699501013259,pp,i
166,0211-699501013259,aumento,o
166,0211-699501013259,del,o
166,0211-699501013259,folato,i
166,0211-699501013259,703,o
166,0211-699501013259,IC,o
166,0211-699501013259,638,o
166,0211-699501013259,795,o
166,0211-699501013259,vs,o
166,0211-699501013259,6181,o
166,0211-699501013259,IC,o
166,0211-699501013259,4447,o
166,0211-699501013259,7811,o
166,0211-699501013259,p,o
166,0211-699501013259,0001,o
166,0211-699501013259,y,o
166,0211-699501013259,descenso,o
166,0211-699501013259,de,o
166,0211-699501013259,la,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,240,o
166,0211-699501013259,IC,o
166,0211-699501013259,213,o
166,0211-699501013259,264,o
166,0211-699501013259,vs,o
166,0211-699501013259,199,o
166,0211-699501013259,IC,o
166,0211-699501013259,175,o
166,0211-699501013259,224,o
166,0211-699501013259,p,o
166,0211-699501013259,005,o
166,0211-699501013259,Han,o
166,0211-699501013259,recibido,o
166,0211-699501013259,suplementacion,i
166,0211-699501013259,durante,o
166,0211-699501013259,12,o
166,0211-699501013259,meses,o
166,0211-699501013259,33,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,pero,o
166,0211-699501013259,a,o
166,0211-699501013259,pesar,o
166,0211-699501013259,de,o
166,0211-699501013259,un,o
166,0211-699501013259,continuo,o
166,0211-699501013259,aumento,o
166,0211-699501013259,del,o
166,0211-699501013259,folato,i
166,0211-699501013259,10078,o
166,0211-699501013259,IC,o
166,0211-699501013259,7481,o
166,0211-699501013259,12674,o
166,0211-699501013259,p,o
166,0211-699501013259,0001,o
166,0211-699501013259,solo,o
166,0211-699501013259,3,o
166,0211-699501013259,pacientes,o
166,0211-699501013259,presentan,o
166,0211-699501013259,niveles,o
166,0211-699501013259,normales,o
166,0211-699501013259,de,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,correlacionandose,o
166,0211-699501013259,directamente,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,con,o
166,0211-699501013259,la,o
166,0211-699501013259,albumina,i
166,0211-699501013259,r,o
166,0211-699501013259,056,o
166,0211-699501013259,p,o
166,0211-699501013259,0001,o
166,0211-699501013259,que,o
166,0211-699501013259,se,o
166,0211-699501013259,elevo,o
166,0211-699501013259,con,o
166,0211-699501013259,respecto,o
166,0211-699501013259,al,o
166,0211-699501013259,inicio,o
166,0211-699501013259,337,o
166,0211-699501013259,IC,o
166,0211-699501013259,327,o
166,0211-699501013259,346,o
166,0211-699501013259,vs,o
166,0211-699501013259,350,o
166,0211-699501013259,IC,o
166,0211-699501013259,337,o
166,0211-699501013259,363,o
166,0211-699501013259,p,o
166,0211-699501013259,005,o
166,0211-699501013259,Conclusion,o
166,0211-699501013259,Tras,o
166,0211-699501013259,suplementacion,i
166,0211-699501013259,con,o
166,0211-699501013259,acido,i
166,0211-699501013259,folico,i
166,0211-699501013259,y,o
166,0211-699501013259,vitamina,i
166,0211-699501013259,B6,i
166,0211-699501013259,aunque,o
166,0211-699501013259,inicialmente,o
166,0211-699501013259,se,o
166,0211-699501013259,reduce,o
166,0211-699501013259,la,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,esta,o
166,0211-699501013259,respuesta,o
166,0211-699501013259,se,o
166,0211-699501013259,hace,o
166,0211-699501013259,refractaria,o
166,0211-699501013259,correlacionandose,o
166,0211-699501013259,directamente,o
166,0211-699501013259,la,o
166,0211-699501013259,tHcy,i
166,0211-699501013259,con,o
166,0211-699501013259,la,o
166,0211-699501013259,albumina,i
166,0211-699501013259,plasmatica,i
166,0211-699501013259,La,o
166,0211-699501013259,interpretacion,o
166,0211-699501013259,de,o
166,0211-699501013259,los,o
166,0211-699501013259,niveles,i
166,0211-699501013259,de,i
166,0211-699501013259,tHcy,i
166,0211-699501013259,debe,o
166,0211-699501013259,tener,o
166,0211-699501013259,en,o
166,0211-699501013259,cuenta,o
166,0211-699501013259,la,o
166,0211-699501013259,concentracion,i
166,0211-699501013259,de,i
166,0211-699501013259,albumina,i
167,0211-699501013259,Efecto,o
167,0211-699501013259,de,o
167,0211-699501013259,la,o
167,0211-699501013259,suplementacion,i
167,0211-699501013259,con,o
167,0211-699501013259,acido,i
167,0211-699501013259,folico,i
167,0211-699501013259,sobre,o
167,0211-699501013259,los,o
167,0211-699501013259,niveles,i
167,0211-699501013259,de,i
167,0211-699501013259,homocisteina,i
167,0211-699501013259,total,o
167,0211-699501013259,en,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,en,o
167,0211-699501013259,hemodialisis,i
167,0211-699501013259,La,o
167,0211-699501013259,hiperhomocisteinemia,i
167,0211-699501013259,es,o
167,0211-699501013259,un,o
167,0211-699501013259,marcador,o
167,0211-699501013259,de,o
167,0211-699501013259,riesgo,o
167,0211-699501013259,independiente,o
167,0211-699501013259,de,o
167,0211-699501013259,morbimortalidad,o
167,0211-699501013259,cardiovascular,i
167,0211-699501013259,Hemos,o
167,0211-699501013259,intentado,o
167,0211-699501013259,prospectivamente,o
167,0211-699501013259,reducir,o
167,0211-699501013259,los,o
167,0211-699501013259,niveles,i
167,0211-699501013259,de,i
167,0211-699501013259,homocisteina,i
167,0211-699501013259,total,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,mediante,o
167,0211-699501013259,suplemento,o
167,0211-699501013259,con,o
167,0211-699501013259,acido,i
167,0211-699501013259,folico,i
167,0211-699501013259,y,o
167,0211-699501013259,vitamina,i
167,0211-699501013259,B6,i
167,0211-699501013259,pp,i
167,0211-699501013259,valorando,o
167,0211-699501013259,su,o
167,0211-699501013259,posible,o
167,0211-699501013259,correlacion,o
167,0211-699501013259,con,o
167,0211-699501013259,dosis,o
167,0211-699501013259,de,o
167,0211-699501013259,dialisis,i
167,0211-699501013259,funcion,i
167,0211-699501013259,residual,i
167,0211-699501013259,y,o
167,0211-699501013259,parametros,o
167,0211-699501013259,nutricionales,o
167,0211-699501013259,Metodos,o
167,0211-699501013259,Todos,o
167,0211-699501013259,los,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,en,o
167,0211-699501013259,hemodialisis,i
167,0211-699501013259,al,o
167,0211-699501013259,comienzo,o
167,0211-699501013259,del,o
167,0211-699501013259,estudio,o
167,0211-699501013259,que,o
167,0211-699501013259,no,o
167,0211-699501013259,recibian,o
167,0211-699501013259,acido,i
167,0211-699501013259,folico,i
167,0211-699501013259,ni,o
167,0211-699501013259,vitamina,i
167,0211-699501013259,B6,i
167,0211-699501013259,asi,o
167,0211-699501013259,como,o
167,0211-699501013259,los,o
167,0211-699501013259,incorporados,o
167,0211-699501013259,posteriormente,o
167,0211-699501013259,a,o
167,0211-699501013259,partir,o
167,0211-699501013259,de,o
167,0211-699501013259,su,o
167,0211-699501013259,tercer,o
167,0211-699501013259,mes,o
167,0211-699501013259,en,o
167,0211-699501013259,hemodialisis,i
167,0211-699501013259,recibieron,o
167,0211-699501013259,5,o
167,0211-699501013259,mg,o
167,0211-699501013259,orales,o
167,0211-699501013259,de,o
167,0211-699501013259,acido,i
167,0211-699501013259,folico,i
167,0211-699501013259,cada,o
167,0211-699501013259,48,o
167,0211-699501013259,horas,o
167,0211-699501013259,y,o
167,0211-699501013259,40,o
167,0211-699501013259,mg,o
167,0211-699501013259,orales,o
167,0211-699501013259,de,o
167,0211-699501013259,vitamina,i
167,0211-699501013259,B6,i
167,0211-699501013259,cada,o
167,0211-699501013259,semana,o
167,0211-699501013259,Se,o
167,0211-699501013259,determinaron,o
167,0211-699501013259,al,o
167,0211-699501013259,comienzo,o
167,0211-699501013259,del,o
167,0211-699501013259,estudio,o
167,0211-699501013259,y,o
167,0211-699501013259,cada,o
167,0211-699501013259,2,o
167,0211-699501013259,meses,o
167,0211-699501013259,niveles,i
167,0211-699501013259,de,i
167,0211-699501013259,folato,i
167,0211-699501013259,vitamina,i
167,0211-699501013259,B12,i
167,0211-699501013259,inmunoensayo,i
167,0211-699501013259,albumina,i
167,0211-699501013259,y,o
167,0211-699501013259,cinetica,o
167,0211-699501013259,de,o
167,0211-699501013259,la,o
167,0211-699501013259,urea,i
167,0211-699501013259,KTV,o
167,0211-699501013259,KRU,o
167,0211-699501013259,PCRn,o
167,0211-699501013259,y,o
167,0211-699501013259,cada,o
167,0211-699501013259,6,o
167,0211-699501013259,meses,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,HPLC,i
167,0211-699501013259,y,o
167,0211-699501013259,pp,i
167,0211-699501013259,RIA,i
167,0211-699501013259,Resultados,o
167,0211-699501013259,80,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,fueron,o
167,0211-699501013259,incluidos,o
167,0211-699501013259,en,o
167,0211-699501013259,el,o
167,0211-699501013259,estudio,o
167,0211-699501013259,basal,o
167,0211-699501013259,con,o
167,0211-699501013259,una,o
167,0211-699501013259,prevalencia,o
167,0211-699501013259,de,o
167,0211-699501013259,hiperhomocisteinemia,i
167,0211-699501013259,del,o
167,0211-699501013259,844,o
167,0211-699501013259,deficit,i
167,0211-699501013259,de,i
167,0211-699501013259,pp,i
167,0211-699501013259,en,o
167,0211-699501013259,el,o
167,0211-699501013259,32,o
167,0211-699501013259,y,o
167,0211-699501013259,folato,i
167,0211-699501013259,en,o
167,0211-699501013259,el,o
167,0211-699501013259,rango,o
167,0211-699501013259,normal,o
167,0211-699501013259,bajo,o
167,0211-699501013259,los,o
167,0211-699501013259,niveles,i
167,0211-699501013259,de,i
167,0211-699501013259,tHcy,i
167,0211-699501013259,se,o
167,0211-699501013259,correlacionaban,o
167,0211-699501013259,inversamente,o
167,0211-699501013259,con,o
167,0211-699501013259,los,o
167,0211-699501013259,del,o
167,0211-699501013259,folato,i
167,0211-699501013259,r,o
167,0211-699501013259,0336,o
167,0211-699501013259,p,o
167,0211-699501013259,001,o
167,0211-699501013259,pero,o
167,0211-699501013259,no,o
167,0211-699501013259,con,o
167,0211-699501013259,pp,i
167,0211-699501013259,B12,i
167,0211-699501013259,edad,o
167,0211-699501013259,albumina,i
167,0211-699501013259,KTV,o
167,0211-699501013259,KRU,o
167,0211-699501013259,PCRn,o
167,0211-699501013259,Cincuenta,o
167,0211-699501013259,y,o
167,0211-699501013259,ocho,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,recibieron,o
167,0211-699501013259,seis,o
167,0211-699501013259,meses,o
167,0211-699501013259,de,o
167,0211-699501013259,suplementacion,i
167,0211-699501013259,con,o
167,0211-699501013259,normalizacion,o
167,0211-699501013259,del,o
167,0211-699501013259,pp,i
167,0211-699501013259,aumento,o
167,0211-699501013259,del,o
167,0211-699501013259,folato,i
167,0211-699501013259,703,o
167,0211-699501013259,IC,o
167,0211-699501013259,638,o
167,0211-699501013259,795,o
167,0211-699501013259,vs,o
167,0211-699501013259,6181,o
167,0211-699501013259,IC,o
167,0211-699501013259,4447,o
167,0211-699501013259,7811,o
167,0211-699501013259,p,o
167,0211-699501013259,0001,o
167,0211-699501013259,y,o
167,0211-699501013259,descenso,o
167,0211-699501013259,de,o
167,0211-699501013259,la,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,240,o
167,0211-699501013259,IC,o
167,0211-699501013259,213,o
167,0211-699501013259,264,o
167,0211-699501013259,vs,o
167,0211-699501013259,199,o
167,0211-699501013259,IC,o
167,0211-699501013259,175,o
167,0211-699501013259,224,o
167,0211-699501013259,p,o
167,0211-699501013259,005,o
167,0211-699501013259,Han,o
167,0211-699501013259,recibido,o
167,0211-699501013259,suplementacion,i
167,0211-699501013259,durante,o
167,0211-699501013259,12,o
167,0211-699501013259,meses,o
167,0211-699501013259,33,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,pero,o
167,0211-699501013259,a,o
167,0211-699501013259,pesar,o
167,0211-699501013259,de,o
167,0211-699501013259,un,o
167,0211-699501013259,continuo,o
167,0211-699501013259,aumento,o
167,0211-699501013259,del,o
167,0211-699501013259,folato,i
167,0211-699501013259,10078,o
167,0211-699501013259,IC,o
167,0211-699501013259,7481,o
167,0211-699501013259,12674,o
167,0211-699501013259,p,o
167,0211-699501013259,0001,o
167,0211-699501013259,solo,o
167,0211-699501013259,3,o
167,0211-699501013259,pacientes,o
167,0211-699501013259,presentan,o
167,0211-699501013259,niveles,o
167,0211-699501013259,normales,o
167,0211-699501013259,de,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,correlacionandose,o
167,0211-699501013259,directamente,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,con,o
167,0211-699501013259,la,o
167,0211-699501013259,albumina,i
167,0211-699501013259,r,o
167,0211-699501013259,056,o
167,0211-699501013259,p,o
167,0211-699501013259,0001,o
167,0211-699501013259,que,o
167,0211-699501013259,se,o
167,0211-699501013259,elevo,o
167,0211-699501013259,con,o
167,0211-699501013259,respecto,o
167,0211-699501013259,al,o
167,0211-699501013259,inicio,o
167,0211-699501013259,337,o
167,0211-699501013259,IC,o
167,0211-699501013259,327,o
167,0211-699501013259,346,o
167,0211-699501013259,vs,o
167,0211-699501013259,350,o
167,0211-699501013259,IC,o
167,0211-699501013259,337,o
167,0211-699501013259,363,o
167,0211-699501013259,p,o
167,0211-699501013259,005,o
167,0211-699501013259,Conclusion,o
167,0211-699501013259,Tras,o
167,0211-699501013259,suplementacion,i
167,0211-699501013259,con,o
167,0211-699501013259,acido,i
167,0211-699501013259,folico,i
167,0211-699501013259,y,o
167,0211-699501013259,vitamina,i
167,0211-699501013259,B6,i
167,0211-699501013259,aunque,o
167,0211-699501013259,inicialmente,o
167,0211-699501013259,se,o
167,0211-699501013259,reduce,o
167,0211-699501013259,la,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,esta,o
167,0211-699501013259,respuesta,o
167,0211-699501013259,se,o
167,0211-699501013259,hace,o
167,0211-699501013259,refractaria,o
167,0211-699501013259,correlacionandose,o
167,0211-699501013259,directamente,o
167,0211-699501013259,la,o
167,0211-699501013259,tHcy,i
167,0211-699501013259,con,o
167,0211-699501013259,la,o
167,0211-699501013259,albumina,i
167,0211-699501013259,plasmatica,i
167,0211-699501013259,La,o
167,0211-699501013259,interpretacion,o
167,0211-699501013259,de,o
167,0211-699501013259,los,o
167,0211-699501013259,niveles,i
167,0211-699501013259,de,i
167,0211-699501013259,tHcy,i
167,0211-699501013259,debe,o
167,0211-699501013259,tener,o
167,0211-699501013259,en,o
167,0211-699501013259,cuenta,o
167,0211-699501013259,la,o
167,0211-699501013259,concentracion,i
167,0211-699501013259,de,i
167,0211-699501013259,albumina,i
168,0211-699501013259,Efecto,o
168,0211-699501013259,de,o
168,0211-699501013259,la,o
168,0211-699501013259,suplementacion,i
168,0211-699501013259,con,o
168,0211-699501013259,acido,i
168,0211-699501013259,folico,i
168,0211-699501013259,sobre,o
168,0211-699501013259,los,o
168,0211-699501013259,niveles,i
168,0211-699501013259,de,i
168,0211-699501013259,homocisteina,i
168,0211-699501013259,total,o
168,0211-699501013259,en,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,en,o
168,0211-699501013259,hemodialisis,i
168,0211-699501013259,La,o
168,0211-699501013259,hiperhomocisteinemia,i
168,0211-699501013259,es,o
168,0211-699501013259,un,o
168,0211-699501013259,marcador,o
168,0211-699501013259,de,o
168,0211-699501013259,riesgo,o
168,0211-699501013259,independiente,o
168,0211-699501013259,de,o
168,0211-699501013259,morbimortalidad,o
168,0211-699501013259,cardiovascular,i
168,0211-699501013259,Hemos,o
168,0211-699501013259,intentado,o
168,0211-699501013259,prospectivamente,o
168,0211-699501013259,reducir,o
168,0211-699501013259,los,o
168,0211-699501013259,niveles,i
168,0211-699501013259,de,i
168,0211-699501013259,homocisteina,i
168,0211-699501013259,total,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,mediante,o
168,0211-699501013259,suplemento,o
168,0211-699501013259,con,o
168,0211-699501013259,acido,i
168,0211-699501013259,folico,i
168,0211-699501013259,y,o
168,0211-699501013259,vitamina,i
168,0211-699501013259,B6,i
168,0211-699501013259,pp,i
168,0211-699501013259,valorando,o
168,0211-699501013259,su,o
168,0211-699501013259,posible,o
168,0211-699501013259,correlacion,o
168,0211-699501013259,con,o
168,0211-699501013259,dosis,o
168,0211-699501013259,de,o
168,0211-699501013259,dialisis,i
168,0211-699501013259,funcion,i
168,0211-699501013259,residual,i
168,0211-699501013259,y,o
168,0211-699501013259,parametros,o
168,0211-699501013259,nutricionales,o
168,0211-699501013259,Metodos,o
168,0211-699501013259,Todos,o
168,0211-699501013259,los,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,en,o
168,0211-699501013259,hemodialisis,i
168,0211-699501013259,al,o
168,0211-699501013259,comienzo,o
168,0211-699501013259,del,o
168,0211-699501013259,estudio,o
168,0211-699501013259,que,o
168,0211-699501013259,no,o
168,0211-699501013259,recibian,o
168,0211-699501013259,acido,i
168,0211-699501013259,folico,i
168,0211-699501013259,ni,o
168,0211-699501013259,vitamina,i
168,0211-699501013259,B6,i
168,0211-699501013259,asi,o
168,0211-699501013259,como,o
168,0211-699501013259,los,o
168,0211-699501013259,incorporados,o
168,0211-699501013259,posteriormente,o
168,0211-699501013259,a,o
168,0211-699501013259,partir,o
168,0211-699501013259,de,o
168,0211-699501013259,su,o
168,0211-699501013259,tercer,o
168,0211-699501013259,mes,o
168,0211-699501013259,en,o
168,0211-699501013259,hemodialisis,i
168,0211-699501013259,recibieron,o
168,0211-699501013259,5,o
168,0211-699501013259,mg,o
168,0211-699501013259,orales,o
168,0211-699501013259,de,o
168,0211-699501013259,acido,i
168,0211-699501013259,folico,i
168,0211-699501013259,cada,o
168,0211-699501013259,48,o
168,0211-699501013259,horas,o
168,0211-699501013259,y,o
168,0211-699501013259,40,o
168,0211-699501013259,mg,o
168,0211-699501013259,orales,o
168,0211-699501013259,de,o
168,0211-699501013259,vitamina,i
168,0211-699501013259,B6,i
168,0211-699501013259,cada,o
168,0211-699501013259,semana,o
168,0211-699501013259,Se,o
168,0211-699501013259,determinaron,o
168,0211-699501013259,al,o
168,0211-699501013259,comienzo,o
168,0211-699501013259,del,o
168,0211-699501013259,estudio,o
168,0211-699501013259,y,o
168,0211-699501013259,cada,o
168,0211-699501013259,2,o
168,0211-699501013259,meses,o
168,0211-699501013259,niveles,i
168,0211-699501013259,de,i
168,0211-699501013259,folato,i
168,0211-699501013259,vitamina,i
168,0211-699501013259,B12,i
168,0211-699501013259,inmunoensayo,i
168,0211-699501013259,albumina,i
168,0211-699501013259,y,o
168,0211-699501013259,cinetica,o
168,0211-699501013259,de,o
168,0211-699501013259,la,o
168,0211-699501013259,urea,i
168,0211-699501013259,KTV,o
168,0211-699501013259,KRU,o
168,0211-699501013259,PCRn,o
168,0211-699501013259,y,o
168,0211-699501013259,cada,o
168,0211-699501013259,6,o
168,0211-699501013259,meses,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,HPLC,i
168,0211-699501013259,y,o
168,0211-699501013259,pp,i
168,0211-699501013259,RIA,i
168,0211-699501013259,Resultados,o
168,0211-699501013259,80,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,fueron,o
168,0211-699501013259,incluidos,o
168,0211-699501013259,en,o
168,0211-699501013259,el,o
168,0211-699501013259,estudio,o
168,0211-699501013259,basal,o
168,0211-699501013259,con,o
168,0211-699501013259,una,o
168,0211-699501013259,prevalencia,o
168,0211-699501013259,de,o
168,0211-699501013259,hiperhomocisteinemia,i
168,0211-699501013259,del,o
168,0211-699501013259,844,o
168,0211-699501013259,deficit,i
168,0211-699501013259,de,i
168,0211-699501013259,pp,i
168,0211-699501013259,en,o
168,0211-699501013259,el,o
168,0211-699501013259,32,o
168,0211-699501013259,y,o
168,0211-699501013259,folato,i
168,0211-699501013259,en,o
168,0211-699501013259,el,o
168,0211-699501013259,rango,o
168,0211-699501013259,normal,o
168,0211-699501013259,bajo,o
168,0211-699501013259,los,o
168,0211-699501013259,niveles,i
168,0211-699501013259,de,i
168,0211-699501013259,tHcy,i
168,0211-699501013259,se,o
168,0211-699501013259,correlacionaban,o
168,0211-699501013259,inversamente,o
168,0211-699501013259,con,o
168,0211-699501013259,los,o
168,0211-699501013259,del,o
168,0211-699501013259,folato,i
168,0211-699501013259,r,o
168,0211-699501013259,0336,o
168,0211-699501013259,p,o
168,0211-699501013259,001,o
168,0211-699501013259,pero,o
168,0211-699501013259,no,o
168,0211-699501013259,con,o
168,0211-699501013259,pp,i
168,0211-699501013259,B12,i
168,0211-699501013259,edad,o
168,0211-699501013259,albumina,i
168,0211-699501013259,KTV,o
168,0211-699501013259,KRU,o
168,0211-699501013259,PCRn,o
168,0211-699501013259,Cincuenta,o
168,0211-699501013259,y,o
168,0211-699501013259,ocho,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,recibieron,o
168,0211-699501013259,seis,o
168,0211-699501013259,meses,o
168,0211-699501013259,de,o
168,0211-699501013259,suplementacion,i
168,0211-699501013259,con,o
168,0211-699501013259,normalizacion,o
168,0211-699501013259,del,o
168,0211-699501013259,pp,i
168,0211-699501013259,aumento,o
168,0211-699501013259,del,o
168,0211-699501013259,folato,i
168,0211-699501013259,703,o
168,0211-699501013259,IC,o
168,0211-699501013259,638,o
168,0211-699501013259,795,o
168,0211-699501013259,vs,o
168,0211-699501013259,6181,o
168,0211-699501013259,IC,o
168,0211-699501013259,4447,o
168,0211-699501013259,7811,o
168,0211-699501013259,p,o
168,0211-699501013259,0001,o
168,0211-699501013259,y,o
168,0211-699501013259,descenso,o
168,0211-699501013259,de,o
168,0211-699501013259,la,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,240,o
168,0211-699501013259,IC,o
168,0211-699501013259,213,o
168,0211-699501013259,264,o
168,0211-699501013259,vs,o
168,0211-699501013259,199,o
168,0211-699501013259,IC,o
168,0211-699501013259,175,o
168,0211-699501013259,224,o
168,0211-699501013259,p,o
168,0211-699501013259,005,o
168,0211-699501013259,Han,o
168,0211-699501013259,recibido,o
168,0211-699501013259,suplementacion,i
168,0211-699501013259,durante,o
168,0211-699501013259,12,o
168,0211-699501013259,meses,o
168,0211-699501013259,33,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,pero,o
168,0211-699501013259,a,o
168,0211-699501013259,pesar,o
168,0211-699501013259,de,o
168,0211-699501013259,un,o
168,0211-699501013259,continuo,o
168,0211-699501013259,aumento,o
168,0211-699501013259,del,o
168,0211-699501013259,folato,i
168,0211-699501013259,10078,o
168,0211-699501013259,IC,o
168,0211-699501013259,7481,o
168,0211-699501013259,12674,o
168,0211-699501013259,p,o
168,0211-699501013259,0001,o
168,0211-699501013259,solo,o
168,0211-699501013259,3,o
168,0211-699501013259,pacientes,o
168,0211-699501013259,presentan,o
168,0211-699501013259,niveles,o
168,0211-699501013259,normales,o
168,0211-699501013259,de,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,correlacionandose,o
168,0211-699501013259,directamente,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,con,o
168,0211-699501013259,la,o
168,0211-699501013259,albumina,i
168,0211-699501013259,r,o
168,0211-699501013259,056,o
168,0211-699501013259,p,o
168,0211-699501013259,0001,o
168,0211-699501013259,que,o
168,0211-699501013259,se,o
168,0211-699501013259,elevo,o
168,0211-699501013259,con,o
168,0211-699501013259,respecto,o
168,0211-699501013259,al,o
168,0211-699501013259,inicio,o
168,0211-699501013259,337,o
168,0211-699501013259,IC,o
168,0211-699501013259,327,o
168,0211-699501013259,346,o
168,0211-699501013259,vs,o
168,0211-699501013259,350,o
168,0211-699501013259,IC,o
168,0211-699501013259,337,o
168,0211-699501013259,363,o
168,0211-699501013259,p,o
168,0211-699501013259,005,o
168,0211-699501013259,Conclusion,o
168,0211-699501013259,Tras,o
168,0211-699501013259,suplementacion,i
168,0211-699501013259,con,o
168,0211-699501013259,acido,i
168,0211-699501013259,folico,i
168,0211-699501013259,y,o
168,0211-699501013259,vitamina,i
168,0211-699501013259,B6,i
168,0211-699501013259,aunque,o
168,0211-699501013259,inicialmente,o
168,0211-699501013259,se,o
168,0211-699501013259,reduce,o
168,0211-699501013259,la,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,esta,o
168,0211-699501013259,respuesta,o
168,0211-699501013259,se,o
168,0211-699501013259,hace,o
168,0211-699501013259,refractaria,o
168,0211-699501013259,correlacionandose,o
168,0211-699501013259,directamente,o
168,0211-699501013259,la,o
168,0211-699501013259,tHcy,i
168,0211-699501013259,con,o
168,0211-699501013259,la,o
168,0211-699501013259,albumina,i
168,0211-699501013259,plasmatica,i
168,0211-699501013259,La,o
168,0211-699501013259,interpretacion,o
168,0211-699501013259,de,o
168,0211-699501013259,los,o
168,0211-699501013259,niveles,i
168,0211-699501013259,de,i
168,0211-699501013259,tHcy,i
168,0211-699501013259,debe,o
168,0211-699501013259,tener,o
168,0211-699501013259,en,o
168,0211-699501013259,cuenta,o
168,0211-699501013259,la,o
168,0211-699501013259,concentracion,i
168,0211-699501013259,de,i
168,0211-699501013259,albumina,i
169,0211-699501013259,Efecto,o
169,0211-699501013259,de,o
169,0211-699501013259,la,o
169,0211-699501013259,suplementacion,i
169,0211-699501013259,con,o
169,0211-699501013259,acido,i
169,0211-699501013259,folico,i
169,0211-699501013259,sobre,o
169,0211-699501013259,los,o
169,0211-699501013259,niveles,i
169,0211-699501013259,de,i
169,0211-699501013259,homocisteina,i
169,0211-699501013259,total,o
169,0211-699501013259,en,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,en,o
169,0211-699501013259,hemodialisis,i
169,0211-699501013259,La,o
169,0211-699501013259,hiperhomocisteinemia,i
169,0211-699501013259,es,o
169,0211-699501013259,un,o
169,0211-699501013259,marcador,o
169,0211-699501013259,de,o
169,0211-699501013259,riesgo,o
169,0211-699501013259,independiente,o
169,0211-699501013259,de,o
169,0211-699501013259,morbimortalidad,o
169,0211-699501013259,cardiovascular,i
169,0211-699501013259,Hemos,o
169,0211-699501013259,intentado,o
169,0211-699501013259,prospectivamente,o
169,0211-699501013259,reducir,o
169,0211-699501013259,los,o
169,0211-699501013259,niveles,i
169,0211-699501013259,de,i
169,0211-699501013259,homocisteina,i
169,0211-699501013259,total,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,mediante,o
169,0211-699501013259,suplemento,o
169,0211-699501013259,con,o
169,0211-699501013259,acido,i
169,0211-699501013259,folico,i
169,0211-699501013259,y,o
169,0211-699501013259,vitamina,i
169,0211-699501013259,B6,i
169,0211-699501013259,pp,i
169,0211-699501013259,valorando,o
169,0211-699501013259,su,o
169,0211-699501013259,posible,o
169,0211-699501013259,correlacion,o
169,0211-699501013259,con,o
169,0211-699501013259,dosis,o
169,0211-699501013259,de,o
169,0211-699501013259,dialisis,i
169,0211-699501013259,funcion,i
169,0211-699501013259,residual,i
169,0211-699501013259,y,o
169,0211-699501013259,parametros,o
169,0211-699501013259,nutricionales,o
169,0211-699501013259,Metodos,o
169,0211-699501013259,Todos,o
169,0211-699501013259,los,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,en,o
169,0211-699501013259,hemodialisis,i
169,0211-699501013259,al,o
169,0211-699501013259,comienzo,o
169,0211-699501013259,del,o
169,0211-699501013259,estudio,o
169,0211-699501013259,que,o
169,0211-699501013259,no,o
169,0211-699501013259,recibian,o
169,0211-699501013259,acido,i
169,0211-699501013259,folico,i
169,0211-699501013259,ni,o
169,0211-699501013259,vitamina,i
169,0211-699501013259,B6,i
169,0211-699501013259,asi,o
169,0211-699501013259,como,o
169,0211-699501013259,los,o
169,0211-699501013259,incorporados,o
169,0211-699501013259,posteriormente,o
169,0211-699501013259,a,o
169,0211-699501013259,partir,o
169,0211-699501013259,de,o
169,0211-699501013259,su,o
169,0211-699501013259,tercer,o
169,0211-699501013259,mes,o
169,0211-699501013259,en,o
169,0211-699501013259,hemodialisis,i
169,0211-699501013259,recibieron,o
169,0211-699501013259,5,o
169,0211-699501013259,mg,o
169,0211-699501013259,orales,o
169,0211-699501013259,de,o
169,0211-699501013259,acido,i
169,0211-699501013259,folico,i
169,0211-699501013259,cada,o
169,0211-699501013259,48,o
169,0211-699501013259,horas,o
169,0211-699501013259,y,o
169,0211-699501013259,40,o
169,0211-699501013259,mg,o
169,0211-699501013259,orales,o
169,0211-699501013259,de,o
169,0211-699501013259,vitamina,i
169,0211-699501013259,B6,i
169,0211-699501013259,cada,o
169,0211-699501013259,semana,o
169,0211-699501013259,Se,o
169,0211-699501013259,determinaron,o
169,0211-699501013259,al,o
169,0211-699501013259,comienzo,o
169,0211-699501013259,del,o
169,0211-699501013259,estudio,o
169,0211-699501013259,y,o
169,0211-699501013259,cada,o
169,0211-699501013259,2,o
169,0211-699501013259,meses,o
169,0211-699501013259,niveles,i
169,0211-699501013259,de,i
169,0211-699501013259,folato,i
169,0211-699501013259,vitamina,i
169,0211-699501013259,B12,i
169,0211-699501013259,inmunoensayo,i
169,0211-699501013259,albumina,i
169,0211-699501013259,y,o
169,0211-699501013259,cinetica,o
169,0211-699501013259,de,o
169,0211-699501013259,la,o
169,0211-699501013259,urea,i
169,0211-699501013259,KTV,o
169,0211-699501013259,KRU,o
169,0211-699501013259,PCRn,o
169,0211-699501013259,y,o
169,0211-699501013259,cada,o
169,0211-699501013259,6,o
169,0211-699501013259,meses,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,HPLC,i
169,0211-699501013259,y,o
169,0211-699501013259,pp,i
169,0211-699501013259,RIA,i
169,0211-699501013259,Resultados,o
169,0211-699501013259,80,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,fueron,o
169,0211-699501013259,incluidos,o
169,0211-699501013259,en,o
169,0211-699501013259,el,o
169,0211-699501013259,estudio,o
169,0211-699501013259,basal,o
169,0211-699501013259,con,o
169,0211-699501013259,una,o
169,0211-699501013259,prevalencia,o
169,0211-699501013259,de,o
169,0211-699501013259,hiperhomocisteinemia,i
169,0211-699501013259,del,o
169,0211-699501013259,844,o
169,0211-699501013259,deficit,i
169,0211-699501013259,de,i
169,0211-699501013259,pp,i
169,0211-699501013259,en,o
169,0211-699501013259,el,o
169,0211-699501013259,32,o
169,0211-699501013259,y,o
169,0211-699501013259,folato,i
169,0211-699501013259,en,o
169,0211-699501013259,el,o
169,0211-699501013259,rango,o
169,0211-699501013259,normal,o
169,0211-699501013259,bajo,o
169,0211-699501013259,los,o
169,0211-699501013259,niveles,i
169,0211-699501013259,de,i
169,0211-699501013259,tHcy,i
169,0211-699501013259,se,o
169,0211-699501013259,correlacionaban,o
169,0211-699501013259,inversamente,o
169,0211-699501013259,con,o
169,0211-699501013259,los,o
169,0211-699501013259,del,o
169,0211-699501013259,folato,i
169,0211-699501013259,r,o
169,0211-699501013259,0336,o
169,0211-699501013259,p,o
169,0211-699501013259,001,o
169,0211-699501013259,pero,o
169,0211-699501013259,no,o
169,0211-699501013259,con,o
169,0211-699501013259,pp,i
169,0211-699501013259,B12,i
169,0211-699501013259,edad,o
169,0211-699501013259,albumina,i
169,0211-699501013259,KTV,o
169,0211-699501013259,KRU,o
169,0211-699501013259,PCRn,o
169,0211-699501013259,Cincuenta,o
169,0211-699501013259,y,o
169,0211-699501013259,ocho,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,recibieron,o
169,0211-699501013259,seis,o
169,0211-699501013259,meses,o
169,0211-699501013259,de,o
169,0211-699501013259,suplementacion,i
169,0211-699501013259,con,o
169,0211-699501013259,normalizacion,o
169,0211-699501013259,del,o
169,0211-699501013259,pp,i
169,0211-699501013259,aumento,o
169,0211-699501013259,del,o
169,0211-699501013259,folato,i
169,0211-699501013259,703,o
169,0211-699501013259,IC,o
169,0211-699501013259,638,o
169,0211-699501013259,795,o
169,0211-699501013259,vs,o
169,0211-699501013259,6181,o
169,0211-699501013259,IC,o
169,0211-699501013259,4447,o
169,0211-699501013259,7811,o
169,0211-699501013259,p,o
169,0211-699501013259,0001,o
169,0211-699501013259,y,o
169,0211-699501013259,descenso,o
169,0211-699501013259,de,o
169,0211-699501013259,la,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,240,o
169,0211-699501013259,IC,o
169,0211-699501013259,213,o
169,0211-699501013259,264,o
169,0211-699501013259,vs,o
169,0211-699501013259,199,o
169,0211-699501013259,IC,o
169,0211-699501013259,175,o
169,0211-699501013259,224,o
169,0211-699501013259,p,o
169,0211-699501013259,005,o
169,0211-699501013259,Han,o
169,0211-699501013259,recibido,o
169,0211-699501013259,suplementacion,i
169,0211-699501013259,durante,o
169,0211-699501013259,12,o
169,0211-699501013259,meses,o
169,0211-699501013259,33,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,pero,o
169,0211-699501013259,a,o
169,0211-699501013259,pesar,o
169,0211-699501013259,de,o
169,0211-699501013259,un,o
169,0211-699501013259,continuo,o
169,0211-699501013259,aumento,o
169,0211-699501013259,del,o
169,0211-699501013259,folato,i
169,0211-699501013259,10078,o
169,0211-699501013259,IC,o
169,0211-699501013259,7481,o
169,0211-699501013259,12674,o
169,0211-699501013259,p,o
169,0211-699501013259,0001,o
169,0211-699501013259,solo,o
169,0211-699501013259,3,o
169,0211-699501013259,pacientes,o
169,0211-699501013259,presentan,o
169,0211-699501013259,niveles,o
169,0211-699501013259,normales,o
169,0211-699501013259,de,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,correlacionandose,o
169,0211-699501013259,directamente,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,con,o
169,0211-699501013259,la,o
169,0211-699501013259,albumina,i
169,0211-699501013259,r,o
169,0211-699501013259,056,o
169,0211-699501013259,p,o
169,0211-699501013259,0001,o
169,0211-699501013259,que,o
169,0211-699501013259,se,o
169,0211-699501013259,elevo,o
169,0211-699501013259,con,o
169,0211-699501013259,respecto,o
169,0211-699501013259,al,o
169,0211-699501013259,inicio,o
169,0211-699501013259,337,o
169,0211-699501013259,IC,o
169,0211-699501013259,327,o
169,0211-699501013259,346,o
169,0211-699501013259,vs,o
169,0211-699501013259,350,o
169,0211-699501013259,IC,o
169,0211-699501013259,337,o
169,0211-699501013259,363,o
169,0211-699501013259,p,o
169,0211-699501013259,005,o
169,0211-699501013259,Conclusion,o
169,0211-699501013259,Tras,o
169,0211-699501013259,suplementacion,i
169,0211-699501013259,con,o
169,0211-699501013259,acido,i
169,0211-699501013259,folico,i
169,0211-699501013259,y,o
169,0211-699501013259,vitamina,i
169,0211-699501013259,B6,i
169,0211-699501013259,aunque,o
169,0211-699501013259,inicialmente,o
169,0211-699501013259,se,o
169,0211-699501013259,reduce,o
169,0211-699501013259,la,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,esta,o
169,0211-699501013259,respuesta,o
169,0211-699501013259,se,o
169,0211-699501013259,hace,o
169,0211-699501013259,refractaria,o
169,0211-699501013259,correlacionandose,o
169,0211-699501013259,directamente,o
169,0211-699501013259,la,o
169,0211-699501013259,tHcy,i
169,0211-699501013259,con,o
169,0211-699501013259,la,o
169,0211-699501013259,albumina,i
169,0211-699501013259,plasmatica,i
169,0211-699501013259,La,o
169,0211-699501013259,interpretacion,o
169,0211-699501013259,de,o
169,0211-699501013259,los,o
169,0211-699501013259,niveles,i
169,0211-699501013259,de,i
169,0211-699501013259,tHcy,i
169,0211-699501013259,debe,o
169,0211-699501013259,tener,o
169,0211-699501013259,en,o
169,0211-699501013259,cuenta,o
169,0211-699501013259,la,o
169,0211-699501013259,concentracion,i
169,0211-699501013259,de,i
169,0211-699501013259,albumina,i
170,0211-699501013259,Efecto,o
170,0211-699501013259,de,o
170,0211-699501013259,la,o
170,0211-699501013259,suplementacion,i
170,0211-699501013259,con,o
170,0211-699501013259,acido,i
170,0211-699501013259,folico,i
170,0211-699501013259,sobre,o
170,0211-699501013259,los,o
170,0211-699501013259,niveles,i
170,0211-699501013259,de,i
170,0211-699501013259,homocisteina,i
170,0211-699501013259,total,o
170,0211-699501013259,en,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,en,o
170,0211-699501013259,hemodialisis,i
170,0211-699501013259,La,o
170,0211-699501013259,hiperhomocisteinemia,i
170,0211-699501013259,es,o
170,0211-699501013259,un,o
170,0211-699501013259,marcador,o
170,0211-699501013259,de,o
170,0211-699501013259,riesgo,o
170,0211-699501013259,independiente,o
170,0211-699501013259,de,o
170,0211-699501013259,morbimortalidad,o
170,0211-699501013259,cardiovascular,i
170,0211-699501013259,Hemos,o
170,0211-699501013259,intentado,o
170,0211-699501013259,prospectivamente,o
170,0211-699501013259,reducir,o
170,0211-699501013259,los,o
170,0211-699501013259,niveles,i
170,0211-699501013259,de,i
170,0211-699501013259,homocisteina,i
170,0211-699501013259,total,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,mediante,o
170,0211-699501013259,suplemento,o
170,0211-699501013259,con,o
170,0211-699501013259,acido,i
170,0211-699501013259,folico,i
170,0211-699501013259,y,o
170,0211-699501013259,vitamina,i
170,0211-699501013259,B6,i
170,0211-699501013259,pp,i
170,0211-699501013259,valorando,o
170,0211-699501013259,su,o
170,0211-699501013259,posible,o
170,0211-699501013259,correlacion,o
170,0211-699501013259,con,o
170,0211-699501013259,dosis,o
170,0211-699501013259,de,o
170,0211-699501013259,dialisis,i
170,0211-699501013259,funcion,i
170,0211-699501013259,residual,i
170,0211-699501013259,y,o
170,0211-699501013259,parametros,o
170,0211-699501013259,nutricionales,o
170,0211-699501013259,Metodos,o
170,0211-699501013259,Todos,o
170,0211-699501013259,los,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,en,o
170,0211-699501013259,hemodialisis,i
170,0211-699501013259,al,o
170,0211-699501013259,comienzo,o
170,0211-699501013259,del,o
170,0211-699501013259,estudio,o
170,0211-699501013259,que,o
170,0211-699501013259,no,o
170,0211-699501013259,recibian,o
170,0211-699501013259,acido,i
170,0211-699501013259,folico,i
170,0211-699501013259,ni,o
170,0211-699501013259,vitamina,i
170,0211-699501013259,B6,i
170,0211-699501013259,asi,o
170,0211-699501013259,como,o
170,0211-699501013259,los,o
170,0211-699501013259,incorporados,o
170,0211-699501013259,posteriormente,o
170,0211-699501013259,a,o
170,0211-699501013259,partir,o
170,0211-699501013259,de,o
170,0211-699501013259,su,o
170,0211-699501013259,tercer,o
170,0211-699501013259,mes,o
170,0211-699501013259,en,o
170,0211-699501013259,hemodialisis,i
170,0211-699501013259,recibieron,o
170,0211-699501013259,5,o
170,0211-699501013259,mg,o
170,0211-699501013259,orales,o
170,0211-699501013259,de,o
170,0211-699501013259,acido,i
170,0211-699501013259,folico,i
170,0211-699501013259,cada,o
170,0211-699501013259,48,o
170,0211-699501013259,horas,o
170,0211-699501013259,y,o
170,0211-699501013259,40,o
170,0211-699501013259,mg,o
170,0211-699501013259,orales,o
170,0211-699501013259,de,o
170,0211-699501013259,vitamina,i
170,0211-699501013259,B6,i
170,0211-699501013259,cada,o
170,0211-699501013259,semana,o
170,0211-699501013259,Se,o
170,0211-699501013259,determinaron,o
170,0211-699501013259,al,o
170,0211-699501013259,comienzo,o
170,0211-699501013259,del,o
170,0211-699501013259,estudio,o
170,0211-699501013259,y,o
170,0211-699501013259,cada,o
170,0211-699501013259,2,o
170,0211-699501013259,meses,o
170,0211-699501013259,niveles,i
170,0211-699501013259,de,i
170,0211-699501013259,folato,i
170,0211-699501013259,vitamina,i
170,0211-699501013259,B12,i
170,0211-699501013259,inmunoensayo,i
170,0211-699501013259,albumina,i
170,0211-699501013259,y,o
170,0211-699501013259,cinetica,o
170,0211-699501013259,de,o
170,0211-699501013259,la,o
170,0211-699501013259,urea,i
170,0211-699501013259,KTV,o
170,0211-699501013259,KRU,o
170,0211-699501013259,PCRn,o
170,0211-699501013259,y,o
170,0211-699501013259,cada,o
170,0211-699501013259,6,o
170,0211-699501013259,meses,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,HPLC,i
170,0211-699501013259,y,o
170,0211-699501013259,pp,i
170,0211-699501013259,RIA,i
170,0211-699501013259,Resultados,o
170,0211-699501013259,80,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,fueron,o
170,0211-699501013259,incluidos,o
170,0211-699501013259,en,o
170,0211-699501013259,el,o
170,0211-699501013259,estudio,o
170,0211-699501013259,basal,o
170,0211-699501013259,con,o
170,0211-699501013259,una,o
170,0211-699501013259,prevalencia,o
170,0211-699501013259,de,o
170,0211-699501013259,hiperhomocisteinemia,i
170,0211-699501013259,del,o
170,0211-699501013259,844,o
170,0211-699501013259,deficit,i
170,0211-699501013259,de,i
170,0211-699501013259,pp,i
170,0211-699501013259,en,o
170,0211-699501013259,el,o
170,0211-699501013259,32,o
170,0211-699501013259,y,o
170,0211-699501013259,folato,i
170,0211-699501013259,en,o
170,0211-699501013259,el,o
170,0211-699501013259,rango,o
170,0211-699501013259,normal,o
170,0211-699501013259,bajo,o
170,0211-699501013259,los,o
170,0211-699501013259,niveles,i
170,0211-699501013259,de,i
170,0211-699501013259,tHcy,i
170,0211-699501013259,se,o
170,0211-699501013259,correlacionaban,o
170,0211-699501013259,inversamente,o
170,0211-699501013259,con,o
170,0211-699501013259,los,o
170,0211-699501013259,del,o
170,0211-699501013259,folato,i
170,0211-699501013259,r,o
170,0211-699501013259,0336,o
170,0211-699501013259,p,o
170,0211-699501013259,001,o
170,0211-699501013259,pero,o
170,0211-699501013259,no,o
170,0211-699501013259,con,o
170,0211-699501013259,pp,i
170,0211-699501013259,B12,i
170,0211-699501013259,edad,o
170,0211-699501013259,albumina,i
170,0211-699501013259,KTV,o
170,0211-699501013259,KRU,o
170,0211-699501013259,PCRn,o
170,0211-699501013259,Cincuenta,o
170,0211-699501013259,y,o
170,0211-699501013259,ocho,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,recibieron,o
170,0211-699501013259,seis,o
170,0211-699501013259,meses,o
170,0211-699501013259,de,o
170,0211-699501013259,suplementacion,i
170,0211-699501013259,con,o
170,0211-699501013259,normalizacion,o
170,0211-699501013259,del,o
170,0211-699501013259,pp,i
170,0211-699501013259,aumento,o
170,0211-699501013259,del,o
170,0211-699501013259,folato,i
170,0211-699501013259,703,o
170,0211-699501013259,IC,o
170,0211-699501013259,638,o
170,0211-699501013259,795,o
170,0211-699501013259,vs,o
170,0211-699501013259,6181,o
170,0211-699501013259,IC,o
170,0211-699501013259,4447,o
170,0211-699501013259,7811,o
170,0211-699501013259,p,o
170,0211-699501013259,0001,o
170,0211-699501013259,y,o
170,0211-699501013259,descenso,o
170,0211-699501013259,de,o
170,0211-699501013259,la,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,240,o
170,0211-699501013259,IC,o
170,0211-699501013259,213,o
170,0211-699501013259,264,o
170,0211-699501013259,vs,o
170,0211-699501013259,199,o
170,0211-699501013259,IC,o
170,0211-699501013259,175,o
170,0211-699501013259,224,o
170,0211-699501013259,p,o
170,0211-699501013259,005,o
170,0211-699501013259,Han,o
170,0211-699501013259,recibido,o
170,0211-699501013259,suplementacion,i
170,0211-699501013259,durante,o
170,0211-699501013259,12,o
170,0211-699501013259,meses,o
170,0211-699501013259,33,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,pero,o
170,0211-699501013259,a,o
170,0211-699501013259,pesar,o
170,0211-699501013259,de,o
170,0211-699501013259,un,o
170,0211-699501013259,continuo,o
170,0211-699501013259,aumento,o
170,0211-699501013259,del,o
170,0211-699501013259,folato,i
170,0211-699501013259,10078,o
170,0211-699501013259,IC,o
170,0211-699501013259,7481,o
170,0211-699501013259,12674,o
170,0211-699501013259,p,o
170,0211-699501013259,0001,o
170,0211-699501013259,solo,o
170,0211-699501013259,3,o
170,0211-699501013259,pacientes,o
170,0211-699501013259,presentan,o
170,0211-699501013259,niveles,o
170,0211-699501013259,normales,o
170,0211-699501013259,de,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,correlacionandose,o
170,0211-699501013259,directamente,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,con,o
170,0211-699501013259,la,o
170,0211-699501013259,albumina,i
170,0211-699501013259,r,o
170,0211-699501013259,056,o
170,0211-699501013259,p,o
170,0211-699501013259,0001,o
170,0211-699501013259,que,o
170,0211-699501013259,se,o
170,0211-699501013259,elevo,o
170,0211-699501013259,con,o
170,0211-699501013259,respecto,o
170,0211-699501013259,al,o
170,0211-699501013259,inicio,o
170,0211-699501013259,337,o
170,0211-699501013259,IC,o
170,0211-699501013259,327,o
170,0211-699501013259,346,o
170,0211-699501013259,vs,o
170,0211-699501013259,350,o
170,0211-699501013259,IC,o
170,0211-699501013259,337,o
170,0211-699501013259,363,o
170,0211-699501013259,p,o
170,0211-699501013259,005,o
170,0211-699501013259,Conclusion,o
170,0211-699501013259,Tras,o
170,0211-699501013259,suplementacion,i
170,0211-699501013259,con,o
170,0211-699501013259,acido,i
170,0211-699501013259,folico,i
170,0211-699501013259,y,o
170,0211-699501013259,vitamina,i
170,0211-699501013259,B6,i
170,0211-699501013259,aunque,o
170,0211-699501013259,inicialmente,o
170,0211-699501013259,se,o
170,0211-699501013259,reduce,o
170,0211-699501013259,la,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,esta,o
170,0211-699501013259,respuesta,o
170,0211-699501013259,se,o
170,0211-699501013259,hace,o
170,0211-699501013259,refractaria,o
170,0211-699501013259,correlacionandose,o
170,0211-699501013259,directamente,o
170,0211-699501013259,la,o
170,0211-699501013259,tHcy,i
170,0211-699501013259,con,o
170,0211-699501013259,la,o
170,0211-699501013259,albumina,i
170,0211-699501013259,plasmatica,i
170,0211-699501013259,La,o
170,0211-699501013259,interpretacion,o
170,0211-699501013259,de,o
170,0211-699501013259,los,o
170,0211-699501013259,niveles,i
170,0211-699501013259,de,i
170,0211-699501013259,tHcy,i
170,0211-699501013259,debe,o
170,0211-699501013259,tener,o
170,0211-699501013259,en,o
170,0211-699501013259,cuenta,o
170,0211-699501013259,la,o
170,0211-699501013259,concentracion,i
170,0211-699501013259,de,i
170,0211-699501013259,albumina,i
171,0211-699501013259,Efecto,o
171,0211-699501013259,de,o
171,0211-699501013259,la,o
171,0211-699501013259,suplementacion,i
171,0211-699501013259,con,o
171,0211-699501013259,acido,i
171,0211-699501013259,folico,i
171,0211-699501013259,sobre,o
171,0211-699501013259,los,o
171,0211-699501013259,niveles,i
171,0211-699501013259,de,i
171,0211-699501013259,homocisteina,i
171,0211-699501013259,total,o
171,0211-699501013259,en,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,en,o
171,0211-699501013259,hemodialisis,i
171,0211-699501013259,La,o
171,0211-699501013259,hiperhomocisteinemia,i
171,0211-699501013259,es,o
171,0211-699501013259,un,o
171,0211-699501013259,marcador,o
171,0211-699501013259,de,o
171,0211-699501013259,riesgo,o
171,0211-699501013259,independiente,o
171,0211-699501013259,de,o
171,0211-699501013259,morbimortalidad,o
171,0211-699501013259,cardiovascular,i
171,0211-699501013259,Hemos,o
171,0211-699501013259,intentado,o
171,0211-699501013259,prospectivamente,o
171,0211-699501013259,reducir,o
171,0211-699501013259,los,o
171,0211-699501013259,niveles,i
171,0211-699501013259,de,i
171,0211-699501013259,homocisteina,i
171,0211-699501013259,total,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,mediante,o
171,0211-699501013259,suplemento,o
171,0211-699501013259,con,o
171,0211-699501013259,acido,i
171,0211-699501013259,folico,i
171,0211-699501013259,y,o
171,0211-699501013259,vitamina,i
171,0211-699501013259,B6,i
171,0211-699501013259,pp,i
171,0211-699501013259,valorando,o
171,0211-699501013259,su,o
171,0211-699501013259,posible,o
171,0211-699501013259,correlacion,o
171,0211-699501013259,con,o
171,0211-699501013259,dosis,o
171,0211-699501013259,de,o
171,0211-699501013259,dialisis,i
171,0211-699501013259,funcion,i
171,0211-699501013259,residual,i
171,0211-699501013259,y,o
171,0211-699501013259,parametros,o
171,0211-699501013259,nutricionales,o
171,0211-699501013259,Metodos,o
171,0211-699501013259,Todos,o
171,0211-699501013259,los,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,en,o
171,0211-699501013259,hemodialisis,i
171,0211-699501013259,al,o
171,0211-699501013259,comienzo,o
171,0211-699501013259,del,o
171,0211-699501013259,estudio,o
171,0211-699501013259,que,o
171,0211-699501013259,no,o
171,0211-699501013259,recibian,o
171,0211-699501013259,acido,i
171,0211-699501013259,folico,i
171,0211-699501013259,ni,o
171,0211-699501013259,vitamina,i
171,0211-699501013259,B6,i
171,0211-699501013259,asi,o
171,0211-699501013259,como,o
171,0211-699501013259,los,o
171,0211-699501013259,incorporados,o
171,0211-699501013259,posteriormente,o
171,0211-699501013259,a,o
171,0211-699501013259,partir,o
171,0211-699501013259,de,o
171,0211-699501013259,su,o
171,0211-699501013259,tercer,o
171,0211-699501013259,mes,o
171,0211-699501013259,en,o
171,0211-699501013259,hemodialisis,i
171,0211-699501013259,recibieron,o
171,0211-699501013259,5,o
171,0211-699501013259,mg,o
171,0211-699501013259,orales,o
171,0211-699501013259,de,o
171,0211-699501013259,acido,i
171,0211-699501013259,folico,i
171,0211-699501013259,cada,o
171,0211-699501013259,48,o
171,0211-699501013259,horas,o
171,0211-699501013259,y,o
171,0211-699501013259,40,o
171,0211-699501013259,mg,o
171,0211-699501013259,orales,o
171,0211-699501013259,de,o
171,0211-699501013259,vitamina,i
171,0211-699501013259,B6,i
171,0211-699501013259,cada,o
171,0211-699501013259,semana,o
171,0211-699501013259,Se,o
171,0211-699501013259,determinaron,o
171,0211-699501013259,al,o
171,0211-699501013259,comienzo,o
171,0211-699501013259,del,o
171,0211-699501013259,estudio,o
171,0211-699501013259,y,o
171,0211-699501013259,cada,o
171,0211-699501013259,2,o
171,0211-699501013259,meses,o
171,0211-699501013259,niveles,i
171,0211-699501013259,de,i
171,0211-699501013259,folato,i
171,0211-699501013259,vitamina,i
171,0211-699501013259,B12,i
171,0211-699501013259,inmunoensayo,i
171,0211-699501013259,albumina,i
171,0211-699501013259,y,o
171,0211-699501013259,cinetica,o
171,0211-699501013259,de,o
171,0211-699501013259,la,o
171,0211-699501013259,urea,i
171,0211-699501013259,KTV,o
171,0211-699501013259,KRU,o
171,0211-699501013259,PCRn,o
171,0211-699501013259,y,o
171,0211-699501013259,cada,o
171,0211-699501013259,6,o
171,0211-699501013259,meses,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,HPLC,i
171,0211-699501013259,y,o
171,0211-699501013259,pp,i
171,0211-699501013259,RIA,i
171,0211-699501013259,Resultados,o
171,0211-699501013259,80,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,fueron,o
171,0211-699501013259,incluidos,o
171,0211-699501013259,en,o
171,0211-699501013259,el,o
171,0211-699501013259,estudio,o
171,0211-699501013259,basal,o
171,0211-699501013259,con,o
171,0211-699501013259,una,o
171,0211-699501013259,prevalencia,o
171,0211-699501013259,de,o
171,0211-699501013259,hiperhomocisteinemia,i
171,0211-699501013259,del,o
171,0211-699501013259,844,o
171,0211-699501013259,deficit,i
171,0211-699501013259,de,i
171,0211-699501013259,pp,i
171,0211-699501013259,en,o
171,0211-699501013259,el,o
171,0211-699501013259,32,o
171,0211-699501013259,y,o
171,0211-699501013259,folato,i
171,0211-699501013259,en,o
171,0211-699501013259,el,o
171,0211-699501013259,rango,o
171,0211-699501013259,normal,o
171,0211-699501013259,bajo,o
171,0211-699501013259,los,o
171,0211-699501013259,niveles,i
171,0211-699501013259,de,i
171,0211-699501013259,tHcy,i
171,0211-699501013259,se,o
171,0211-699501013259,correlacionaban,o
171,0211-699501013259,inversamente,o
171,0211-699501013259,con,o
171,0211-699501013259,los,o
171,0211-699501013259,del,o
171,0211-699501013259,folato,i
171,0211-699501013259,r,o
171,0211-699501013259,0336,o
171,0211-699501013259,p,o
171,0211-699501013259,001,o
171,0211-699501013259,pero,o
171,0211-699501013259,no,o
171,0211-699501013259,con,o
171,0211-699501013259,pp,i
171,0211-699501013259,B12,i
171,0211-699501013259,edad,o
171,0211-699501013259,albumina,i
171,0211-699501013259,KTV,o
171,0211-699501013259,KRU,o
171,0211-699501013259,PCRn,o
171,0211-699501013259,Cincuenta,o
171,0211-699501013259,y,o
171,0211-699501013259,ocho,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,recibieron,o
171,0211-699501013259,seis,o
171,0211-699501013259,meses,o
171,0211-699501013259,de,o
171,0211-699501013259,suplementacion,i
171,0211-699501013259,con,o
171,0211-699501013259,normalizacion,o
171,0211-699501013259,del,o
171,0211-699501013259,pp,i
171,0211-699501013259,aumento,o
171,0211-699501013259,del,o
171,0211-699501013259,folato,i
171,0211-699501013259,703,o
171,0211-699501013259,IC,o
171,0211-699501013259,638,o
171,0211-699501013259,795,o
171,0211-699501013259,vs,o
171,0211-699501013259,6181,o
171,0211-699501013259,IC,o
171,0211-699501013259,4447,o
171,0211-699501013259,7811,o
171,0211-699501013259,p,o
171,0211-699501013259,0001,o
171,0211-699501013259,y,o
171,0211-699501013259,descenso,o
171,0211-699501013259,de,o
171,0211-699501013259,la,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,240,o
171,0211-699501013259,IC,o
171,0211-699501013259,213,o
171,0211-699501013259,264,o
171,0211-699501013259,vs,o
171,0211-699501013259,199,o
171,0211-699501013259,IC,o
171,0211-699501013259,175,o
171,0211-699501013259,224,o
171,0211-699501013259,p,o
171,0211-699501013259,005,o
171,0211-699501013259,Han,o
171,0211-699501013259,recibido,o
171,0211-699501013259,suplementacion,i
171,0211-699501013259,durante,o
171,0211-699501013259,12,o
171,0211-699501013259,meses,o
171,0211-699501013259,33,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,pero,o
171,0211-699501013259,a,o
171,0211-699501013259,pesar,o
171,0211-699501013259,de,o
171,0211-699501013259,un,o
171,0211-699501013259,continuo,o
171,0211-699501013259,aumento,o
171,0211-699501013259,del,o
171,0211-699501013259,folato,i
171,0211-699501013259,10078,o
171,0211-699501013259,IC,o
171,0211-699501013259,7481,o
171,0211-699501013259,12674,o
171,0211-699501013259,p,o
171,0211-699501013259,0001,o
171,0211-699501013259,solo,o
171,0211-699501013259,3,o
171,0211-699501013259,pacientes,o
171,0211-699501013259,presentan,o
171,0211-699501013259,niveles,o
171,0211-699501013259,normales,o
171,0211-699501013259,de,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,correlacionandose,o
171,0211-699501013259,directamente,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,con,o
171,0211-699501013259,la,o
171,0211-699501013259,albumina,i
171,0211-699501013259,r,o
171,0211-699501013259,056,o
171,0211-699501013259,p,o
171,0211-699501013259,0001,o
171,0211-699501013259,que,o
171,0211-699501013259,se,o
171,0211-699501013259,elevo,o
171,0211-699501013259,con,o
171,0211-699501013259,respecto,o
171,0211-699501013259,al,o
171,0211-699501013259,inicio,o
171,0211-699501013259,337,o
171,0211-699501013259,IC,o
171,0211-699501013259,327,o
171,0211-699501013259,346,o
171,0211-699501013259,vs,o
171,0211-699501013259,350,o
171,0211-699501013259,IC,o
171,0211-699501013259,337,o
171,0211-699501013259,363,o
171,0211-699501013259,p,o
171,0211-699501013259,005,o
171,0211-699501013259,Conclusion,o
171,0211-699501013259,Tras,o
171,0211-699501013259,suplementacion,i
171,0211-699501013259,con,o
171,0211-699501013259,acido,i
171,0211-699501013259,folico,i
171,0211-699501013259,y,o
171,0211-699501013259,vitamina,i
171,0211-699501013259,B6,i
171,0211-699501013259,aunque,o
171,0211-699501013259,inicialmente,o
171,0211-699501013259,se,o
171,0211-699501013259,reduce,o
171,0211-699501013259,la,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,esta,o
171,0211-699501013259,respuesta,o
171,0211-699501013259,se,o
171,0211-699501013259,hace,o
171,0211-699501013259,refractaria,o
171,0211-699501013259,correlacionandose,o
171,0211-699501013259,directamente,o
171,0211-699501013259,la,o
171,0211-699501013259,tHcy,i
171,0211-699501013259,con,o
171,0211-699501013259,la,o
171,0211-699501013259,albumina,i
171,0211-699501013259,plasmatica,i
171,0211-699501013259,La,o
171,0211-699501013259,interpretacion,o
171,0211-699501013259,de,o
171,0211-699501013259,los,o
171,0211-699501013259,niveles,i
171,0211-699501013259,de,i
171,0211-699501013259,tHcy,i
171,0211-699501013259,debe,o
171,0211-699501013259,tener,o
171,0211-699501013259,en,o
171,0211-699501013259,cuenta,o
171,0211-699501013259,la,o
171,0211-699501013259,concentracion,i
171,0211-699501013259,de,i
171,0211-699501013259,albumina,i
172,0211-699501013259,Efecto,o
172,0211-699501013259,de,o
172,0211-699501013259,la,o
172,0211-699501013259,suplementacion,i
172,0211-699501013259,con,o
172,0211-699501013259,acido,i
172,0211-699501013259,folico,i
172,0211-699501013259,sobre,o
172,0211-699501013259,los,o
172,0211-699501013259,niveles,i
172,0211-699501013259,de,i
172,0211-699501013259,homocisteina,i
172,0211-699501013259,total,o
172,0211-699501013259,en,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,en,o
172,0211-699501013259,hemodialisis,i
172,0211-699501013259,La,o
172,0211-699501013259,hiperhomocisteinemia,i
172,0211-699501013259,es,o
172,0211-699501013259,un,o
172,0211-699501013259,marcador,o
172,0211-699501013259,de,o
172,0211-699501013259,riesgo,o
172,0211-699501013259,independiente,o
172,0211-699501013259,de,o
172,0211-699501013259,morbimortalidad,o
172,0211-699501013259,cardiovascular,i
172,0211-699501013259,Hemos,o
172,0211-699501013259,intentado,o
172,0211-699501013259,prospectivamente,o
172,0211-699501013259,reducir,o
172,0211-699501013259,los,o
172,0211-699501013259,niveles,i
172,0211-699501013259,de,i
172,0211-699501013259,homocisteina,i
172,0211-699501013259,total,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,mediante,o
172,0211-699501013259,suplemento,o
172,0211-699501013259,con,o
172,0211-699501013259,acido,i
172,0211-699501013259,folico,i
172,0211-699501013259,y,o
172,0211-699501013259,vitamina,i
172,0211-699501013259,B6,i
172,0211-699501013259,pp,i
172,0211-699501013259,valorando,o
172,0211-699501013259,su,o
172,0211-699501013259,posible,o
172,0211-699501013259,correlacion,o
172,0211-699501013259,con,o
172,0211-699501013259,dosis,o
172,0211-699501013259,de,o
172,0211-699501013259,dialisis,i
172,0211-699501013259,funcion,i
172,0211-699501013259,residual,i
172,0211-699501013259,y,o
172,0211-699501013259,parametros,o
172,0211-699501013259,nutricionales,o
172,0211-699501013259,Metodos,o
172,0211-699501013259,Todos,o
172,0211-699501013259,los,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,en,o
172,0211-699501013259,hemodialisis,i
172,0211-699501013259,al,o
172,0211-699501013259,comienzo,o
172,0211-699501013259,del,o
172,0211-699501013259,estudio,o
172,0211-699501013259,que,o
172,0211-699501013259,no,o
172,0211-699501013259,recibian,o
172,0211-699501013259,acido,i
172,0211-699501013259,folico,i
172,0211-699501013259,ni,o
172,0211-699501013259,vitamina,i
172,0211-699501013259,B6,i
172,0211-699501013259,asi,o
172,0211-699501013259,como,o
172,0211-699501013259,los,o
172,0211-699501013259,incorporados,o
172,0211-699501013259,posteriormente,o
172,0211-699501013259,a,o
172,0211-699501013259,partir,o
172,0211-699501013259,de,o
172,0211-699501013259,su,o
172,0211-699501013259,tercer,o
172,0211-699501013259,mes,o
172,0211-699501013259,en,o
172,0211-699501013259,hemodialisis,i
172,0211-699501013259,recibieron,o
172,0211-699501013259,5,o
172,0211-699501013259,mg,o
172,0211-699501013259,orales,o
172,0211-699501013259,de,o
172,0211-699501013259,acido,i
172,0211-699501013259,folico,i
172,0211-699501013259,cada,o
172,0211-699501013259,48,o
172,0211-699501013259,horas,o
172,0211-699501013259,y,o
172,0211-699501013259,40,o
172,0211-699501013259,mg,o
172,0211-699501013259,orales,o
172,0211-699501013259,de,o
172,0211-699501013259,vitamina,i
172,0211-699501013259,B6,i
172,0211-699501013259,cada,o
172,0211-699501013259,semana,o
172,0211-699501013259,Se,o
172,0211-699501013259,determinaron,o
172,0211-699501013259,al,o
172,0211-699501013259,comienzo,o
172,0211-699501013259,del,o
172,0211-699501013259,estudio,o
172,0211-699501013259,y,o
172,0211-699501013259,cada,o
172,0211-699501013259,2,o
172,0211-699501013259,meses,o
172,0211-699501013259,niveles,i
172,0211-699501013259,de,i
172,0211-699501013259,folato,i
172,0211-699501013259,vitamina,i
172,0211-699501013259,B12,i
172,0211-699501013259,inmunoensayo,i
172,0211-699501013259,albumina,i
172,0211-699501013259,y,o
172,0211-699501013259,cinetica,o
172,0211-699501013259,de,o
172,0211-699501013259,la,o
172,0211-699501013259,urea,i
172,0211-699501013259,KTV,o
172,0211-699501013259,KRU,o
172,0211-699501013259,PCRn,o
172,0211-699501013259,y,o
172,0211-699501013259,cada,o
172,0211-699501013259,6,o
172,0211-699501013259,meses,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,HPLC,i
172,0211-699501013259,y,o
172,0211-699501013259,pp,i
172,0211-699501013259,RIA,i
172,0211-699501013259,Resultados,o
172,0211-699501013259,80,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,fueron,o
172,0211-699501013259,incluidos,o
172,0211-699501013259,en,o
172,0211-699501013259,el,o
172,0211-699501013259,estudio,o
172,0211-699501013259,basal,o
172,0211-699501013259,con,o
172,0211-699501013259,una,o
172,0211-699501013259,prevalencia,o
172,0211-699501013259,de,o
172,0211-699501013259,hiperhomocisteinemia,i
172,0211-699501013259,del,o
172,0211-699501013259,844,o
172,0211-699501013259,deficit,i
172,0211-699501013259,de,i
172,0211-699501013259,pp,i
172,0211-699501013259,en,o
172,0211-699501013259,el,o
172,0211-699501013259,32,o
172,0211-699501013259,y,o
172,0211-699501013259,folato,i
172,0211-699501013259,en,o
172,0211-699501013259,el,o
172,0211-699501013259,rango,o
172,0211-699501013259,normal,o
172,0211-699501013259,bajo,o
172,0211-699501013259,los,o
172,0211-699501013259,niveles,i
172,0211-699501013259,de,i
172,0211-699501013259,tHcy,i
172,0211-699501013259,se,o
172,0211-699501013259,correlacionaban,o
172,0211-699501013259,inversamente,o
172,0211-699501013259,con,o
172,0211-699501013259,los,o
172,0211-699501013259,del,o
172,0211-699501013259,folato,i
172,0211-699501013259,r,o
172,0211-699501013259,0336,o
172,0211-699501013259,p,o
172,0211-699501013259,001,o
172,0211-699501013259,pero,o
172,0211-699501013259,no,o
172,0211-699501013259,con,o
172,0211-699501013259,pp,i
172,0211-699501013259,B12,i
172,0211-699501013259,edad,o
172,0211-699501013259,albumina,i
172,0211-699501013259,KTV,o
172,0211-699501013259,KRU,o
172,0211-699501013259,PCRn,o
172,0211-699501013259,Cincuenta,o
172,0211-699501013259,y,o
172,0211-699501013259,ocho,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,recibieron,o
172,0211-699501013259,seis,o
172,0211-699501013259,meses,o
172,0211-699501013259,de,o
172,0211-699501013259,suplementacion,i
172,0211-699501013259,con,o
172,0211-699501013259,normalizacion,o
172,0211-699501013259,del,o
172,0211-699501013259,pp,i
172,0211-699501013259,aumento,o
172,0211-699501013259,del,o
172,0211-699501013259,folato,i
172,0211-699501013259,703,o
172,0211-699501013259,IC,o
172,0211-699501013259,638,o
172,0211-699501013259,795,o
172,0211-699501013259,vs,o
172,0211-699501013259,6181,o
172,0211-699501013259,IC,o
172,0211-699501013259,4447,o
172,0211-699501013259,7811,o
172,0211-699501013259,p,o
172,0211-699501013259,0001,o
172,0211-699501013259,y,o
172,0211-699501013259,descenso,o
172,0211-699501013259,de,o
172,0211-699501013259,la,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,240,o
172,0211-699501013259,IC,o
172,0211-699501013259,213,o
172,0211-699501013259,264,o
172,0211-699501013259,vs,o
172,0211-699501013259,199,o
172,0211-699501013259,IC,o
172,0211-699501013259,175,o
172,0211-699501013259,224,o
172,0211-699501013259,p,o
172,0211-699501013259,005,o
172,0211-699501013259,Han,o
172,0211-699501013259,recibido,o
172,0211-699501013259,suplementacion,i
172,0211-699501013259,durante,o
172,0211-699501013259,12,o
172,0211-699501013259,meses,o
172,0211-699501013259,33,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,pero,o
172,0211-699501013259,a,o
172,0211-699501013259,pesar,o
172,0211-699501013259,de,o
172,0211-699501013259,un,o
172,0211-699501013259,continuo,o
172,0211-699501013259,aumento,o
172,0211-699501013259,del,o
172,0211-699501013259,folato,i
172,0211-699501013259,10078,o
172,0211-699501013259,IC,o
172,0211-699501013259,7481,o
172,0211-699501013259,12674,o
172,0211-699501013259,p,o
172,0211-699501013259,0001,o
172,0211-699501013259,solo,o
172,0211-699501013259,3,o
172,0211-699501013259,pacientes,o
172,0211-699501013259,presentan,o
172,0211-699501013259,niveles,o
172,0211-699501013259,normales,o
172,0211-699501013259,de,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,correlacionandose,o
172,0211-699501013259,directamente,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,con,o
172,0211-699501013259,la,o
172,0211-699501013259,albumina,i
172,0211-699501013259,r,o
172,0211-699501013259,056,o
172,0211-699501013259,p,o
172,0211-699501013259,0001,o
172,0211-699501013259,que,o
172,0211-699501013259,se,o
172,0211-699501013259,elevo,o
172,0211-699501013259,con,o
172,0211-699501013259,respecto,o
172,0211-699501013259,al,o
172,0211-699501013259,inicio,o
172,0211-699501013259,337,o
172,0211-699501013259,IC,o
172,0211-699501013259,327,o
172,0211-699501013259,346,o
172,0211-699501013259,vs,o
172,0211-699501013259,350,o
172,0211-699501013259,IC,o
172,0211-699501013259,337,o
172,0211-699501013259,363,o
172,0211-699501013259,p,o
172,0211-699501013259,005,o
172,0211-699501013259,Conclusion,o
172,0211-699501013259,Tras,o
172,0211-699501013259,suplementacion,i
172,0211-699501013259,con,o
172,0211-699501013259,acido,i
172,0211-699501013259,folico,i
172,0211-699501013259,y,o
172,0211-699501013259,vitamina,i
172,0211-699501013259,B6,i
172,0211-699501013259,aunque,o
172,0211-699501013259,inicialmente,o
172,0211-699501013259,se,o
172,0211-699501013259,reduce,o
172,0211-699501013259,la,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,esta,o
172,0211-699501013259,respuesta,o
172,0211-699501013259,se,o
172,0211-699501013259,hace,o
172,0211-699501013259,refractaria,o
172,0211-699501013259,correlacionandose,o
172,0211-699501013259,directamente,o
172,0211-699501013259,la,o
172,0211-699501013259,tHcy,i
172,0211-699501013259,con,o
172,0211-699501013259,la,o
172,0211-699501013259,albumina,i
172,0211-699501013259,plasmatica,i
172,0211-699501013259,La,o
172,0211-699501013259,interpretacion,o
172,0211-699501013259,de,o
172,0211-699501013259,los,o
172,0211-699501013259,niveles,i
172,0211-699501013259,de,i
172,0211-699501013259,tHcy,i
172,0211-699501013259,debe,o
172,0211-699501013259,tener,o
172,0211-699501013259,en,o
172,0211-699501013259,cuenta,o
172,0211-699501013259,la,o
172,0211-699501013259,concentracion,i
172,0211-699501013259,de,i
172,0211-699501013259,albumina,i
173,0211-699501013259,Efecto,o
173,0211-699501013259,de,o
173,0211-699501013259,la,o
173,0211-699501013259,suplementacion,i
173,0211-699501013259,con,o
173,0211-699501013259,acido,i
173,0211-699501013259,folico,i
173,0211-699501013259,sobre,o
173,0211-699501013259,los,o
173,0211-699501013259,niveles,i
173,0211-699501013259,de,i
173,0211-699501013259,homocisteina,i
173,0211-699501013259,total,o
173,0211-699501013259,en,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,en,o
173,0211-699501013259,hemodialisis,i
173,0211-699501013259,La,o
173,0211-699501013259,hiperhomocisteinemia,i
173,0211-699501013259,es,o
173,0211-699501013259,un,o
173,0211-699501013259,marcador,o
173,0211-699501013259,de,o
173,0211-699501013259,riesgo,o
173,0211-699501013259,independiente,o
173,0211-699501013259,de,o
173,0211-699501013259,morbimortalidad,o
173,0211-699501013259,cardiovascular,i
173,0211-699501013259,Hemos,o
173,0211-699501013259,intentado,o
173,0211-699501013259,prospectivamente,o
173,0211-699501013259,reducir,o
173,0211-699501013259,los,o
173,0211-699501013259,niveles,i
173,0211-699501013259,de,i
173,0211-699501013259,homocisteina,i
173,0211-699501013259,total,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,mediante,o
173,0211-699501013259,suplemento,o
173,0211-699501013259,con,o
173,0211-699501013259,acido,i
173,0211-699501013259,folico,i
173,0211-699501013259,y,o
173,0211-699501013259,vitamina,i
173,0211-699501013259,B6,i
173,0211-699501013259,pp,i
173,0211-699501013259,valorando,o
173,0211-699501013259,su,o
173,0211-699501013259,posible,o
173,0211-699501013259,correlacion,o
173,0211-699501013259,con,o
173,0211-699501013259,dosis,o
173,0211-699501013259,de,o
173,0211-699501013259,dialisis,i
173,0211-699501013259,funcion,i
173,0211-699501013259,residual,i
173,0211-699501013259,y,o
173,0211-699501013259,parametros,o
173,0211-699501013259,nutricionales,o
173,0211-699501013259,Metodos,o
173,0211-699501013259,Todos,o
173,0211-699501013259,los,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,en,o
173,0211-699501013259,hemodialisis,i
173,0211-699501013259,al,o
173,0211-699501013259,comienzo,o
173,0211-699501013259,del,o
173,0211-699501013259,estudio,o
173,0211-699501013259,que,o
173,0211-699501013259,no,o
173,0211-699501013259,recibian,o
173,0211-699501013259,acido,i
173,0211-699501013259,folico,i
173,0211-699501013259,ni,o
173,0211-699501013259,vitamina,i
173,0211-699501013259,B6,i
173,0211-699501013259,asi,o
173,0211-699501013259,como,o
173,0211-699501013259,los,o
173,0211-699501013259,incorporados,o
173,0211-699501013259,posteriormente,o
173,0211-699501013259,a,o
173,0211-699501013259,partir,o
173,0211-699501013259,de,o
173,0211-699501013259,su,o
173,0211-699501013259,tercer,o
173,0211-699501013259,mes,o
173,0211-699501013259,en,o
173,0211-699501013259,hemodialisis,i
173,0211-699501013259,recibieron,o
173,0211-699501013259,5,o
173,0211-699501013259,mg,o
173,0211-699501013259,orales,o
173,0211-699501013259,de,o
173,0211-699501013259,acido,i
173,0211-699501013259,folico,i
173,0211-699501013259,cada,o
173,0211-699501013259,48,o
173,0211-699501013259,horas,o
173,0211-699501013259,y,o
173,0211-699501013259,40,o
173,0211-699501013259,mg,o
173,0211-699501013259,orales,o
173,0211-699501013259,de,o
173,0211-699501013259,vitamina,i
173,0211-699501013259,B6,i
173,0211-699501013259,cada,o
173,0211-699501013259,semana,o
173,0211-699501013259,Se,o
173,0211-699501013259,determinaron,o
173,0211-699501013259,al,o
173,0211-699501013259,comienzo,o
173,0211-699501013259,del,o
173,0211-699501013259,estudio,o
173,0211-699501013259,y,o
173,0211-699501013259,cada,o
173,0211-699501013259,2,o
173,0211-699501013259,meses,o
173,0211-699501013259,niveles,i
173,0211-699501013259,de,i
173,0211-699501013259,folato,i
173,0211-699501013259,vitamina,i
173,0211-699501013259,B12,i
173,0211-699501013259,inmunoensayo,i
173,0211-699501013259,albumina,i
173,0211-699501013259,y,o
173,0211-699501013259,cinetica,o
173,0211-699501013259,de,o
173,0211-699501013259,la,o
173,0211-699501013259,urea,i
173,0211-699501013259,KTV,o
173,0211-699501013259,KRU,o
173,0211-699501013259,PCRn,o
173,0211-699501013259,y,o
173,0211-699501013259,cada,o
173,0211-699501013259,6,o
173,0211-699501013259,meses,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,HPLC,i
173,0211-699501013259,y,o
173,0211-699501013259,pp,i
173,0211-699501013259,RIA,i
173,0211-699501013259,Resultados,o
173,0211-699501013259,80,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,fueron,o
173,0211-699501013259,incluidos,o
173,0211-699501013259,en,o
173,0211-699501013259,el,o
173,0211-699501013259,estudio,o
173,0211-699501013259,basal,o
173,0211-699501013259,con,o
173,0211-699501013259,una,o
173,0211-699501013259,prevalencia,o
173,0211-699501013259,de,o
173,0211-699501013259,hiperhomocisteinemia,i
173,0211-699501013259,del,o
173,0211-699501013259,844,o
173,0211-699501013259,deficit,i
173,0211-699501013259,de,i
173,0211-699501013259,pp,i
173,0211-699501013259,en,o
173,0211-699501013259,el,o
173,0211-699501013259,32,o
173,0211-699501013259,y,o
173,0211-699501013259,folato,i
173,0211-699501013259,en,o
173,0211-699501013259,el,o
173,0211-699501013259,rango,o
173,0211-699501013259,normal,o
173,0211-699501013259,bajo,o
173,0211-699501013259,los,o
173,0211-699501013259,niveles,i
173,0211-699501013259,de,i
173,0211-699501013259,tHcy,i
173,0211-699501013259,se,o
173,0211-699501013259,correlacionaban,o
173,0211-699501013259,inversamente,o
173,0211-699501013259,con,o
173,0211-699501013259,los,o
173,0211-699501013259,del,o
173,0211-699501013259,folato,i
173,0211-699501013259,r,o
173,0211-699501013259,0336,o
173,0211-699501013259,p,o
173,0211-699501013259,001,o
173,0211-699501013259,pero,o
173,0211-699501013259,no,o
173,0211-699501013259,con,o
173,0211-699501013259,pp,i
173,0211-699501013259,B12,i
173,0211-699501013259,edad,o
173,0211-699501013259,albumina,i
173,0211-699501013259,KTV,o
173,0211-699501013259,KRU,o
173,0211-699501013259,PCRn,o
173,0211-699501013259,Cincuenta,o
173,0211-699501013259,y,o
173,0211-699501013259,ocho,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,recibieron,o
173,0211-699501013259,seis,o
173,0211-699501013259,meses,o
173,0211-699501013259,de,o
173,0211-699501013259,suplementacion,i
173,0211-699501013259,con,o
173,0211-699501013259,normalizacion,o
173,0211-699501013259,del,o
173,0211-699501013259,pp,i
173,0211-699501013259,aumento,o
173,0211-699501013259,del,o
173,0211-699501013259,folato,i
173,0211-699501013259,703,o
173,0211-699501013259,IC,o
173,0211-699501013259,638,o
173,0211-699501013259,795,o
173,0211-699501013259,vs,o
173,0211-699501013259,6181,o
173,0211-699501013259,IC,o
173,0211-699501013259,4447,o
173,0211-699501013259,7811,o
173,0211-699501013259,p,o
173,0211-699501013259,0001,o
173,0211-699501013259,y,o
173,0211-699501013259,descenso,o
173,0211-699501013259,de,o
173,0211-699501013259,la,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,240,o
173,0211-699501013259,IC,o
173,0211-699501013259,213,o
173,0211-699501013259,264,o
173,0211-699501013259,vs,o
173,0211-699501013259,199,o
173,0211-699501013259,IC,o
173,0211-699501013259,175,o
173,0211-699501013259,224,o
173,0211-699501013259,p,o
173,0211-699501013259,005,o
173,0211-699501013259,Han,o
173,0211-699501013259,recibido,o
173,0211-699501013259,suplementacion,i
173,0211-699501013259,durante,o
173,0211-699501013259,12,o
173,0211-699501013259,meses,o
173,0211-699501013259,33,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,pero,o
173,0211-699501013259,a,o
173,0211-699501013259,pesar,o
173,0211-699501013259,de,o
173,0211-699501013259,un,o
173,0211-699501013259,continuo,o
173,0211-699501013259,aumento,o
173,0211-699501013259,del,o
173,0211-699501013259,folato,i
173,0211-699501013259,10078,o
173,0211-699501013259,IC,o
173,0211-699501013259,7481,o
173,0211-699501013259,12674,o
173,0211-699501013259,p,o
173,0211-699501013259,0001,o
173,0211-699501013259,solo,o
173,0211-699501013259,3,o
173,0211-699501013259,pacientes,o
173,0211-699501013259,presentan,o
173,0211-699501013259,niveles,o
173,0211-699501013259,normales,o
173,0211-699501013259,de,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,correlacionandose,o
173,0211-699501013259,directamente,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,con,o
173,0211-699501013259,la,o
173,0211-699501013259,albumina,i
173,0211-699501013259,r,o
173,0211-699501013259,056,o
173,0211-699501013259,p,o
173,0211-699501013259,0001,o
173,0211-699501013259,que,o
173,0211-699501013259,se,o
173,0211-699501013259,elevo,o
173,0211-699501013259,con,o
173,0211-699501013259,respecto,o
173,0211-699501013259,al,o
173,0211-699501013259,inicio,o
173,0211-699501013259,337,o
173,0211-699501013259,IC,o
173,0211-699501013259,327,o
173,0211-699501013259,346,o
173,0211-699501013259,vs,o
173,0211-699501013259,350,o
173,0211-699501013259,IC,o
173,0211-699501013259,337,o
173,0211-699501013259,363,o
173,0211-699501013259,p,o
173,0211-699501013259,005,o
173,0211-699501013259,Conclusion,o
173,0211-699501013259,Tras,o
173,0211-699501013259,suplementacion,i
173,0211-699501013259,con,o
173,0211-699501013259,acido,i
173,0211-699501013259,folico,i
173,0211-699501013259,y,o
173,0211-699501013259,vitamina,i
173,0211-699501013259,B6,i
173,0211-699501013259,aunque,o
173,0211-699501013259,inicialmente,o
173,0211-699501013259,se,o
173,0211-699501013259,reduce,o
173,0211-699501013259,la,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,esta,o
173,0211-699501013259,respuesta,o
173,0211-699501013259,se,o
173,0211-699501013259,hace,o
173,0211-699501013259,refractaria,o
173,0211-699501013259,correlacionandose,o
173,0211-699501013259,directamente,o
173,0211-699501013259,la,o
173,0211-699501013259,tHcy,i
173,0211-699501013259,con,o
173,0211-699501013259,la,o
173,0211-699501013259,albumina,i
173,0211-699501013259,plasmatica,i
173,0211-699501013259,La,o
173,0211-699501013259,interpretacion,o
173,0211-699501013259,de,o
173,0211-699501013259,los,o
173,0211-699501013259,niveles,i
173,0211-699501013259,de,i
173,0211-699501013259,tHcy,i
173,0211-699501013259,debe,o
173,0211-699501013259,tener,o
173,0211-699501013259,en,o
173,0211-699501013259,cuenta,o
173,0211-699501013259,la,o
173,0211-699501013259,concentracion,i
173,0211-699501013259,de,i
173,0211-699501013259,albumina,i
174,0211-699501013259,Efecto,o
174,0211-699501013259,de,o
174,0211-699501013259,la,o
174,0211-699501013259,suplementacion,i
174,0211-699501013259,con,o
174,0211-699501013259,acido,i
174,0211-699501013259,folico,i
174,0211-699501013259,sobre,o
174,0211-699501013259,los,o
174,0211-699501013259,niveles,i
174,0211-699501013259,de,i
174,0211-699501013259,homocisteina,i
174,0211-699501013259,total,o
174,0211-699501013259,en,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,en,o
174,0211-699501013259,hemodialisis,i
174,0211-699501013259,La,o
174,0211-699501013259,hiperhomocisteinemia,i
174,0211-699501013259,es,o
174,0211-699501013259,un,o
174,0211-699501013259,marcador,o
174,0211-699501013259,de,o
174,0211-699501013259,riesgo,o
174,0211-699501013259,independiente,o
174,0211-699501013259,de,o
174,0211-699501013259,morbimortalidad,o
174,0211-699501013259,cardiovascular,i
174,0211-699501013259,Hemos,o
174,0211-699501013259,intentado,o
174,0211-699501013259,prospectivamente,o
174,0211-699501013259,reducir,o
174,0211-699501013259,los,o
174,0211-699501013259,niveles,i
174,0211-699501013259,de,i
174,0211-699501013259,homocisteina,i
174,0211-699501013259,total,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,mediante,o
174,0211-699501013259,suplemento,o
174,0211-699501013259,con,o
174,0211-699501013259,acido,i
174,0211-699501013259,folico,i
174,0211-699501013259,y,o
174,0211-699501013259,vitamina,i
174,0211-699501013259,B6,i
174,0211-699501013259,pp,i
174,0211-699501013259,valorando,o
174,0211-699501013259,su,o
174,0211-699501013259,posible,o
174,0211-699501013259,correlacion,o
174,0211-699501013259,con,o
174,0211-699501013259,dosis,o
174,0211-699501013259,de,o
174,0211-699501013259,dialisis,i
174,0211-699501013259,funcion,i
174,0211-699501013259,residual,i
174,0211-699501013259,y,o
174,0211-699501013259,parametros,o
174,0211-699501013259,nutricionales,o
174,0211-699501013259,Metodos,o
174,0211-699501013259,Todos,o
174,0211-699501013259,los,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,en,o
174,0211-699501013259,hemodialisis,i
174,0211-699501013259,al,o
174,0211-699501013259,comienzo,o
174,0211-699501013259,del,o
174,0211-699501013259,estudio,o
174,0211-699501013259,que,o
174,0211-699501013259,no,o
174,0211-699501013259,recibian,o
174,0211-699501013259,acido,i
174,0211-699501013259,folico,i
174,0211-699501013259,ni,o
174,0211-699501013259,vitamina,i
174,0211-699501013259,B6,i
174,0211-699501013259,asi,o
174,0211-699501013259,como,o
174,0211-699501013259,los,o
174,0211-699501013259,incorporados,o
174,0211-699501013259,posteriormente,o
174,0211-699501013259,a,o
174,0211-699501013259,partir,o
174,0211-699501013259,de,o
174,0211-699501013259,su,o
174,0211-699501013259,tercer,o
174,0211-699501013259,mes,o
174,0211-699501013259,en,o
174,0211-699501013259,hemodialisis,i
174,0211-699501013259,recibieron,o
174,0211-699501013259,5,o
174,0211-699501013259,mg,o
174,0211-699501013259,orales,o
174,0211-699501013259,de,o
174,0211-699501013259,acido,i
174,0211-699501013259,folico,i
174,0211-699501013259,cada,o
174,0211-699501013259,48,o
174,0211-699501013259,horas,o
174,0211-699501013259,y,o
174,0211-699501013259,40,o
174,0211-699501013259,mg,o
174,0211-699501013259,orales,o
174,0211-699501013259,de,o
174,0211-699501013259,vitamina,i
174,0211-699501013259,B6,i
174,0211-699501013259,cada,o
174,0211-699501013259,semana,o
174,0211-699501013259,Se,o
174,0211-699501013259,determinaron,o
174,0211-699501013259,al,o
174,0211-699501013259,comienzo,o
174,0211-699501013259,del,o
174,0211-699501013259,estudio,o
174,0211-699501013259,y,o
174,0211-699501013259,cada,o
174,0211-699501013259,2,o
174,0211-699501013259,meses,o
174,0211-699501013259,niveles,i
174,0211-699501013259,de,i
174,0211-699501013259,folato,i
174,0211-699501013259,vitamina,i
174,0211-699501013259,B12,i
174,0211-699501013259,inmunoensayo,i
174,0211-699501013259,albumina,i
174,0211-699501013259,y,o
174,0211-699501013259,cinetica,o
174,0211-699501013259,de,o
174,0211-699501013259,la,o
174,0211-699501013259,urea,i
174,0211-699501013259,KTV,o
174,0211-699501013259,KRU,o
174,0211-699501013259,PCRn,o
174,0211-699501013259,y,o
174,0211-699501013259,cada,o
174,0211-699501013259,6,o
174,0211-699501013259,meses,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,HPLC,i
174,0211-699501013259,y,o
174,0211-699501013259,pp,i
174,0211-699501013259,RIA,i
174,0211-699501013259,Resultados,o
174,0211-699501013259,80,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,fueron,o
174,0211-699501013259,incluidos,o
174,0211-699501013259,en,o
174,0211-699501013259,el,o
174,0211-699501013259,estudio,o
174,0211-699501013259,basal,o
174,0211-699501013259,con,o
174,0211-699501013259,una,o
174,0211-699501013259,prevalencia,o
174,0211-699501013259,de,o
174,0211-699501013259,hiperhomocisteinemia,i
174,0211-699501013259,del,o
174,0211-699501013259,844,o
174,0211-699501013259,deficit,i
174,0211-699501013259,de,i
174,0211-699501013259,pp,i
174,0211-699501013259,en,o
174,0211-699501013259,el,o
174,0211-699501013259,32,o
174,0211-699501013259,y,o
174,0211-699501013259,folato,i
174,0211-699501013259,en,o
174,0211-699501013259,el,o
174,0211-699501013259,rango,o
174,0211-699501013259,normal,o
174,0211-699501013259,bajo,o
174,0211-699501013259,los,o
174,0211-699501013259,niveles,i
174,0211-699501013259,de,i
174,0211-699501013259,tHcy,i
174,0211-699501013259,se,o
174,0211-699501013259,correlacionaban,o
174,0211-699501013259,inversamente,o
174,0211-699501013259,con,o
174,0211-699501013259,los,o
174,0211-699501013259,del,o
174,0211-699501013259,folato,i
174,0211-699501013259,r,o
174,0211-699501013259,0336,o
174,0211-699501013259,p,o
174,0211-699501013259,001,o
174,0211-699501013259,pero,o
174,0211-699501013259,no,o
174,0211-699501013259,con,o
174,0211-699501013259,pp,i
174,0211-699501013259,B12,i
174,0211-699501013259,edad,o
174,0211-699501013259,albumina,i
174,0211-699501013259,KTV,o
174,0211-699501013259,KRU,o
174,0211-699501013259,PCRn,o
174,0211-699501013259,Cincuenta,o
174,0211-699501013259,y,o
174,0211-699501013259,ocho,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,recibieron,o
174,0211-699501013259,seis,o
174,0211-699501013259,meses,o
174,0211-699501013259,de,o
174,0211-699501013259,suplementacion,i
174,0211-699501013259,con,o
174,0211-699501013259,normalizacion,o
174,0211-699501013259,del,o
174,0211-699501013259,pp,i
174,0211-699501013259,aumento,o
174,0211-699501013259,del,o
174,0211-699501013259,folato,i
174,0211-699501013259,703,o
174,0211-699501013259,IC,o
174,0211-699501013259,638,o
174,0211-699501013259,795,o
174,0211-699501013259,vs,o
174,0211-699501013259,6181,o
174,0211-699501013259,IC,o
174,0211-699501013259,4447,o
174,0211-699501013259,7811,o
174,0211-699501013259,p,o
174,0211-699501013259,0001,o
174,0211-699501013259,y,o
174,0211-699501013259,descenso,o
174,0211-699501013259,de,o
174,0211-699501013259,la,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,240,o
174,0211-699501013259,IC,o
174,0211-699501013259,213,o
174,0211-699501013259,264,o
174,0211-699501013259,vs,o
174,0211-699501013259,199,o
174,0211-699501013259,IC,o
174,0211-699501013259,175,o
174,0211-699501013259,224,o
174,0211-699501013259,p,o
174,0211-699501013259,005,o
174,0211-699501013259,Han,o
174,0211-699501013259,recibido,o
174,0211-699501013259,suplementacion,i
174,0211-699501013259,durante,o
174,0211-699501013259,12,o
174,0211-699501013259,meses,o
174,0211-699501013259,33,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,pero,o
174,0211-699501013259,a,o
174,0211-699501013259,pesar,o
174,0211-699501013259,de,o
174,0211-699501013259,un,o
174,0211-699501013259,continuo,o
174,0211-699501013259,aumento,o
174,0211-699501013259,del,o
174,0211-699501013259,folato,i
174,0211-699501013259,10078,o
174,0211-699501013259,IC,o
174,0211-699501013259,7481,o
174,0211-699501013259,12674,o
174,0211-699501013259,p,o
174,0211-699501013259,0001,o
174,0211-699501013259,solo,o
174,0211-699501013259,3,o
174,0211-699501013259,pacientes,o
174,0211-699501013259,presentan,o
174,0211-699501013259,niveles,o
174,0211-699501013259,normales,o
174,0211-699501013259,de,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,correlacionandose,o
174,0211-699501013259,directamente,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,con,o
174,0211-699501013259,la,o
174,0211-699501013259,albumina,i
174,0211-699501013259,r,o
174,0211-699501013259,056,o
174,0211-699501013259,p,o
174,0211-699501013259,0001,o
174,0211-699501013259,que,o
174,0211-699501013259,se,o
174,0211-699501013259,elevo,o
174,0211-699501013259,con,o
174,0211-699501013259,respecto,o
174,0211-699501013259,al,o
174,0211-699501013259,inicio,o
174,0211-699501013259,337,o
174,0211-699501013259,IC,o
174,0211-699501013259,327,o
174,0211-699501013259,346,o
174,0211-699501013259,vs,o
174,0211-699501013259,350,o
174,0211-699501013259,IC,o
174,0211-699501013259,337,o
174,0211-699501013259,363,o
174,0211-699501013259,p,o
174,0211-699501013259,005,o
174,0211-699501013259,Conclusion,o
174,0211-699501013259,Tras,o
174,0211-699501013259,suplementacion,i
174,0211-699501013259,con,o
174,0211-699501013259,acido,i
174,0211-699501013259,folico,i
174,0211-699501013259,y,o
174,0211-699501013259,vitamina,i
174,0211-699501013259,B6,i
174,0211-699501013259,aunque,o
174,0211-699501013259,inicialmente,o
174,0211-699501013259,se,o
174,0211-699501013259,reduce,o
174,0211-699501013259,la,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,esta,o
174,0211-699501013259,respuesta,o
174,0211-699501013259,se,o
174,0211-699501013259,hace,o
174,0211-699501013259,refractaria,o
174,0211-699501013259,correlacionandose,o
174,0211-699501013259,directamente,o
174,0211-699501013259,la,o
174,0211-699501013259,tHcy,i
174,0211-699501013259,con,o
174,0211-699501013259,la,o
174,0211-699501013259,albumina,i
174,0211-699501013259,plasmatica,i
174,0211-699501013259,La,o
174,0211-699501013259,interpretacion,o
174,0211-699501013259,de,o
174,0211-699501013259,los,o
174,0211-699501013259,niveles,i
174,0211-699501013259,de,i
174,0211-699501013259,tHcy,i
174,0211-699501013259,debe,o
174,0211-699501013259,tener,o
174,0211-699501013259,en,o
174,0211-699501013259,cuenta,o
174,0211-699501013259,la,o
174,0211-699501013259,concentracion,i
174,0211-699501013259,de,i
174,0211-699501013259,albumina,i
175,0211-699501013259,Efecto,o
175,0211-699501013259,de,o
175,0211-699501013259,la,o
175,0211-699501013259,suplementacion,i
175,0211-699501013259,con,o
175,0211-699501013259,acido,i
175,0211-699501013259,folico,i
175,0211-699501013259,sobre,o
175,0211-699501013259,los,o
175,0211-699501013259,niveles,i
175,0211-699501013259,de,i
175,0211-699501013259,homocisteina,i
175,0211-699501013259,total,o
175,0211-699501013259,en,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,en,o
175,0211-699501013259,hemodialisis,i
175,0211-699501013259,La,o
175,0211-699501013259,hiperhomocisteinemia,i
175,0211-699501013259,es,o
175,0211-699501013259,un,o
175,0211-699501013259,marcador,o
175,0211-699501013259,de,o
175,0211-699501013259,riesgo,o
175,0211-699501013259,independiente,o
175,0211-699501013259,de,o
175,0211-699501013259,morbimortalidad,o
175,0211-699501013259,cardiovascular,i
175,0211-699501013259,Hemos,o
175,0211-699501013259,intentado,o
175,0211-699501013259,prospectivamente,o
175,0211-699501013259,reducir,o
175,0211-699501013259,los,o
175,0211-699501013259,niveles,i
175,0211-699501013259,de,i
175,0211-699501013259,homocisteina,i
175,0211-699501013259,total,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,mediante,o
175,0211-699501013259,suplemento,o
175,0211-699501013259,con,o
175,0211-699501013259,acido,i
175,0211-699501013259,folico,i
175,0211-699501013259,y,o
175,0211-699501013259,vitamina,i
175,0211-699501013259,B6,i
175,0211-699501013259,pp,i
175,0211-699501013259,valorando,o
175,0211-699501013259,su,o
175,0211-699501013259,posible,o
175,0211-699501013259,correlacion,o
175,0211-699501013259,con,o
175,0211-699501013259,dosis,o
175,0211-699501013259,de,o
175,0211-699501013259,dialisis,i
175,0211-699501013259,funcion,i
175,0211-699501013259,residual,i
175,0211-699501013259,y,o
175,0211-699501013259,parametros,o
175,0211-699501013259,nutricionales,o
175,0211-699501013259,Metodos,o
175,0211-699501013259,Todos,o
175,0211-699501013259,los,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,en,o
175,0211-699501013259,hemodialisis,i
175,0211-699501013259,al,o
175,0211-699501013259,comienzo,o
175,0211-699501013259,del,o
175,0211-699501013259,estudio,o
175,0211-699501013259,que,o
175,0211-699501013259,no,o
175,0211-699501013259,recibian,o
175,0211-699501013259,acido,i
175,0211-699501013259,folico,i
175,0211-699501013259,ni,o
175,0211-699501013259,vitamina,i
175,0211-699501013259,B6,i
175,0211-699501013259,asi,o
175,0211-699501013259,como,o
175,0211-699501013259,los,o
175,0211-699501013259,incorporados,o
175,0211-699501013259,posteriormente,o
175,0211-699501013259,a,o
175,0211-699501013259,partir,o
175,0211-699501013259,de,o
175,0211-699501013259,su,o
175,0211-699501013259,tercer,o
175,0211-699501013259,mes,o
175,0211-699501013259,en,o
175,0211-699501013259,hemodialisis,i
175,0211-699501013259,recibieron,o
175,0211-699501013259,5,o
175,0211-699501013259,mg,o
175,0211-699501013259,orales,o
175,0211-699501013259,de,o
175,0211-699501013259,acido,i
175,0211-699501013259,folico,i
175,0211-699501013259,cada,o
175,0211-699501013259,48,o
175,0211-699501013259,horas,o
175,0211-699501013259,y,o
175,0211-699501013259,40,o
175,0211-699501013259,mg,o
175,0211-699501013259,orales,o
175,0211-699501013259,de,o
175,0211-699501013259,vitamina,i
175,0211-699501013259,B6,i
175,0211-699501013259,cada,o
175,0211-699501013259,semana,o
175,0211-699501013259,Se,o
175,0211-699501013259,determinaron,o
175,0211-699501013259,al,o
175,0211-699501013259,comienzo,o
175,0211-699501013259,del,o
175,0211-699501013259,estudio,o
175,0211-699501013259,y,o
175,0211-699501013259,cada,o
175,0211-699501013259,2,o
175,0211-699501013259,meses,o
175,0211-699501013259,niveles,i
175,0211-699501013259,de,i
175,0211-699501013259,folato,i
175,0211-699501013259,vitamina,i
175,0211-699501013259,B12,i
175,0211-699501013259,inmunoensayo,i
175,0211-699501013259,albumina,i
175,0211-699501013259,y,o
175,0211-699501013259,cinetica,o
175,0211-699501013259,de,o
175,0211-699501013259,la,o
175,0211-699501013259,urea,i
175,0211-699501013259,KTV,o
175,0211-699501013259,KRU,o
175,0211-699501013259,PCRn,o
175,0211-699501013259,y,o
175,0211-699501013259,cada,o
175,0211-699501013259,6,o
175,0211-699501013259,meses,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,HPLC,i
175,0211-699501013259,y,o
175,0211-699501013259,pp,i
175,0211-699501013259,RIA,i
175,0211-699501013259,Resultados,o
175,0211-699501013259,80,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,fueron,o
175,0211-699501013259,incluidos,o
175,0211-699501013259,en,o
175,0211-699501013259,el,o
175,0211-699501013259,estudio,o
175,0211-699501013259,basal,o
175,0211-699501013259,con,o
175,0211-699501013259,una,o
175,0211-699501013259,prevalencia,o
175,0211-699501013259,de,o
175,0211-699501013259,hiperhomocisteinemia,i
175,0211-699501013259,del,o
175,0211-699501013259,844,o
175,0211-699501013259,deficit,i
175,0211-699501013259,de,i
175,0211-699501013259,pp,i
175,0211-699501013259,en,o
175,0211-699501013259,el,o
175,0211-699501013259,32,o
175,0211-699501013259,y,o
175,0211-699501013259,folato,i
175,0211-699501013259,en,o
175,0211-699501013259,el,o
175,0211-699501013259,rango,o
175,0211-699501013259,normal,o
175,0211-699501013259,bajo,o
175,0211-699501013259,los,o
175,0211-699501013259,niveles,i
175,0211-699501013259,de,i
175,0211-699501013259,tHcy,i
175,0211-699501013259,se,o
175,0211-699501013259,correlacionaban,o
175,0211-699501013259,inversamente,o
175,0211-699501013259,con,o
175,0211-699501013259,los,o
175,0211-699501013259,del,o
175,0211-699501013259,folato,i
175,0211-699501013259,r,o
175,0211-699501013259,0336,o
175,0211-699501013259,p,o
175,0211-699501013259,001,o
175,0211-699501013259,pero,o
175,0211-699501013259,no,o
175,0211-699501013259,con,o
175,0211-699501013259,pp,i
175,0211-699501013259,B12,i
175,0211-699501013259,edad,o
175,0211-699501013259,albumina,i
175,0211-699501013259,KTV,o
175,0211-699501013259,KRU,o
175,0211-699501013259,PCRn,o
175,0211-699501013259,Cincuenta,o
175,0211-699501013259,y,o
175,0211-699501013259,ocho,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,recibieron,o
175,0211-699501013259,seis,o
175,0211-699501013259,meses,o
175,0211-699501013259,de,o
175,0211-699501013259,suplementacion,i
175,0211-699501013259,con,o
175,0211-699501013259,normalizacion,o
175,0211-699501013259,del,o
175,0211-699501013259,pp,i
175,0211-699501013259,aumento,o
175,0211-699501013259,del,o
175,0211-699501013259,folato,i
175,0211-699501013259,703,o
175,0211-699501013259,IC,o
175,0211-699501013259,638,o
175,0211-699501013259,795,o
175,0211-699501013259,vs,o
175,0211-699501013259,6181,o
175,0211-699501013259,IC,o
175,0211-699501013259,4447,o
175,0211-699501013259,7811,o
175,0211-699501013259,p,o
175,0211-699501013259,0001,o
175,0211-699501013259,y,o
175,0211-699501013259,descenso,o
175,0211-699501013259,de,o
175,0211-699501013259,la,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,240,o
175,0211-699501013259,IC,o
175,0211-699501013259,213,o
175,0211-699501013259,264,o
175,0211-699501013259,vs,o
175,0211-699501013259,199,o
175,0211-699501013259,IC,o
175,0211-699501013259,175,o
175,0211-699501013259,224,o
175,0211-699501013259,p,o
175,0211-699501013259,005,o
175,0211-699501013259,Han,o
175,0211-699501013259,recibido,o
175,0211-699501013259,suplementacion,i
175,0211-699501013259,durante,o
175,0211-699501013259,12,o
175,0211-699501013259,meses,o
175,0211-699501013259,33,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,pero,o
175,0211-699501013259,a,o
175,0211-699501013259,pesar,o
175,0211-699501013259,de,o
175,0211-699501013259,un,o
175,0211-699501013259,continuo,o
175,0211-699501013259,aumento,o
175,0211-699501013259,del,o
175,0211-699501013259,folato,i
175,0211-699501013259,10078,o
175,0211-699501013259,IC,o
175,0211-699501013259,7481,o
175,0211-699501013259,12674,o
175,0211-699501013259,p,o
175,0211-699501013259,0001,o
175,0211-699501013259,solo,o
175,0211-699501013259,3,o
175,0211-699501013259,pacientes,o
175,0211-699501013259,presentan,o
175,0211-699501013259,niveles,o
175,0211-699501013259,normales,o
175,0211-699501013259,de,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,correlacionandose,o
175,0211-699501013259,directamente,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,con,o
175,0211-699501013259,la,o
175,0211-699501013259,albumina,i
175,0211-699501013259,r,o
175,0211-699501013259,056,o
175,0211-699501013259,p,o
175,0211-699501013259,0001,o
175,0211-699501013259,que,o
175,0211-699501013259,se,o
175,0211-699501013259,elevo,o
175,0211-699501013259,con,o
175,0211-699501013259,respecto,o
175,0211-699501013259,al,o
175,0211-699501013259,inicio,o
175,0211-699501013259,337,o
175,0211-699501013259,IC,o
175,0211-699501013259,327,o
175,0211-699501013259,346,o
175,0211-699501013259,vs,o
175,0211-699501013259,350,o
175,0211-699501013259,IC,o
175,0211-699501013259,337,o
175,0211-699501013259,363,o
175,0211-699501013259,p,o
175,0211-699501013259,005,o
175,0211-699501013259,Conclusion,o
175,0211-699501013259,Tras,o
175,0211-699501013259,suplementacion,i
175,0211-699501013259,con,o
175,0211-699501013259,acido,i
175,0211-699501013259,folico,i
175,0211-699501013259,y,o
175,0211-699501013259,vitamina,i
175,0211-699501013259,B6,i
175,0211-699501013259,aunque,o
175,0211-699501013259,inicialmente,o
175,0211-699501013259,se,o
175,0211-699501013259,reduce,o
175,0211-699501013259,la,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,esta,o
175,0211-699501013259,respuesta,o
175,0211-699501013259,se,o
175,0211-699501013259,hace,o
175,0211-699501013259,refractaria,o
175,0211-699501013259,correlacionandose,o
175,0211-699501013259,directamente,o
175,0211-699501013259,la,o
175,0211-699501013259,tHcy,i
175,0211-699501013259,con,o
175,0211-699501013259,la,o
175,0211-699501013259,albumina,i
175,0211-699501013259,plasmatica,i
175,0211-699501013259,La,o
175,0211-699501013259,interpretacion,o
175,0211-699501013259,de,o
175,0211-699501013259,los,o
175,0211-699501013259,niveles,i
175,0211-699501013259,de,i
175,0211-699501013259,tHcy,i
175,0211-699501013259,debe,o
175,0211-699501013259,tener,o
175,0211-699501013259,en,o
175,0211-699501013259,cuenta,o
175,0211-699501013259,la,o
175,0211-699501013259,concentracion,i
175,0211-699501013259,de,i
175,0211-699501013259,albumina,i
176,0211-699501013259,Efecto,o
176,0211-699501013259,de,o
176,0211-699501013259,la,o
176,0211-699501013259,suplementacion,i
176,0211-699501013259,con,o
176,0211-699501013259,acido,i
176,0211-699501013259,folico,i
176,0211-699501013259,sobre,o
176,0211-699501013259,los,o
176,0211-699501013259,niveles,i
176,0211-699501013259,de,i
176,0211-699501013259,homocisteina,i
176,0211-699501013259,total,o
176,0211-699501013259,en,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,en,o
176,0211-699501013259,hemodialisis,i
176,0211-699501013259,La,o
176,0211-699501013259,hiperhomocisteinemia,i
176,0211-699501013259,es,o
176,0211-699501013259,un,o
176,0211-699501013259,marcador,o
176,0211-699501013259,de,o
176,0211-699501013259,riesgo,o
176,0211-699501013259,independiente,o
176,0211-699501013259,de,o
176,0211-699501013259,morbimortalidad,o
176,0211-699501013259,cardiovascular,i
176,0211-699501013259,Hemos,o
176,0211-699501013259,intentado,o
176,0211-699501013259,prospectivamente,o
176,0211-699501013259,reducir,o
176,0211-699501013259,los,o
176,0211-699501013259,niveles,i
176,0211-699501013259,de,i
176,0211-699501013259,homocisteina,i
176,0211-699501013259,total,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,mediante,o
176,0211-699501013259,suplemento,o
176,0211-699501013259,con,o
176,0211-699501013259,acido,i
176,0211-699501013259,folico,i
176,0211-699501013259,y,o
176,0211-699501013259,vitamina,i
176,0211-699501013259,B6,i
176,0211-699501013259,pp,i
176,0211-699501013259,valorando,o
176,0211-699501013259,su,o
176,0211-699501013259,posible,o
176,0211-699501013259,correlacion,o
176,0211-699501013259,con,o
176,0211-699501013259,dosis,o
176,0211-699501013259,de,o
176,0211-699501013259,dialisis,i
176,0211-699501013259,funcion,i
176,0211-699501013259,residual,i
176,0211-699501013259,y,o
176,0211-699501013259,parametros,o
176,0211-699501013259,nutricionales,o
176,0211-699501013259,Metodos,o
176,0211-699501013259,Todos,o
176,0211-699501013259,los,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,en,o
176,0211-699501013259,hemodialisis,i
176,0211-699501013259,al,o
176,0211-699501013259,comienzo,o
176,0211-699501013259,del,o
176,0211-699501013259,estudio,o
176,0211-699501013259,que,o
176,0211-699501013259,no,o
176,0211-699501013259,recibian,o
176,0211-699501013259,acido,i
176,0211-699501013259,folico,i
176,0211-699501013259,ni,o
176,0211-699501013259,vitamina,i
176,0211-699501013259,B6,i
176,0211-699501013259,asi,o
176,0211-699501013259,como,o
176,0211-699501013259,los,o
176,0211-699501013259,incorporados,o
176,0211-699501013259,posteriormente,o
176,0211-699501013259,a,o
176,0211-699501013259,partir,o
176,0211-699501013259,de,o
176,0211-699501013259,su,o
176,0211-699501013259,tercer,o
176,0211-699501013259,mes,o
176,0211-699501013259,en,o
176,0211-699501013259,hemodialisis,i
176,0211-699501013259,recibieron,o
176,0211-699501013259,5,o
176,0211-699501013259,mg,o
176,0211-699501013259,orales,o
176,0211-699501013259,de,o
176,0211-699501013259,acido,i
176,0211-699501013259,folico,i
176,0211-699501013259,cada,o
176,0211-699501013259,48,o
176,0211-699501013259,horas,o
176,0211-699501013259,y,o
176,0211-699501013259,40,o
176,0211-699501013259,mg,o
176,0211-699501013259,orales,o
176,0211-699501013259,de,o
176,0211-699501013259,vitamina,i
176,0211-699501013259,B6,i
176,0211-699501013259,cada,o
176,0211-699501013259,semana,o
176,0211-699501013259,Se,o
176,0211-699501013259,determinaron,o
176,0211-699501013259,al,o
176,0211-699501013259,comienzo,o
176,0211-699501013259,del,o
176,0211-699501013259,estudio,o
176,0211-699501013259,y,o
176,0211-699501013259,cada,o
176,0211-699501013259,2,o
176,0211-699501013259,meses,o
176,0211-699501013259,niveles,i
176,0211-699501013259,de,i
176,0211-699501013259,folato,i
176,0211-699501013259,vitamina,i
176,0211-699501013259,B12,i
176,0211-699501013259,inmunoensayo,i
176,0211-699501013259,albumina,i
176,0211-699501013259,y,o
176,0211-699501013259,cinetica,o
176,0211-699501013259,de,o
176,0211-699501013259,la,o
176,0211-699501013259,urea,i
176,0211-699501013259,KTV,o
176,0211-699501013259,KRU,o
176,0211-699501013259,PCRn,o
176,0211-699501013259,y,o
176,0211-699501013259,cada,o
176,0211-699501013259,6,o
176,0211-699501013259,meses,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,HPLC,i
176,0211-699501013259,y,o
176,0211-699501013259,pp,i
176,0211-699501013259,RIA,i
176,0211-699501013259,Resultados,o
176,0211-699501013259,80,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,fueron,o
176,0211-699501013259,incluidos,o
176,0211-699501013259,en,o
176,0211-699501013259,el,o
176,0211-699501013259,estudio,o
176,0211-699501013259,basal,o
176,0211-699501013259,con,o
176,0211-699501013259,una,o
176,0211-699501013259,prevalencia,o
176,0211-699501013259,de,o
176,0211-699501013259,hiperhomocisteinemia,i
176,0211-699501013259,del,o
176,0211-699501013259,844,o
176,0211-699501013259,deficit,i
176,0211-699501013259,de,i
176,0211-699501013259,pp,i
176,0211-699501013259,en,o
176,0211-699501013259,el,o
176,0211-699501013259,32,o
176,0211-699501013259,y,o
176,0211-699501013259,folato,i
176,0211-699501013259,en,o
176,0211-699501013259,el,o
176,0211-699501013259,rango,o
176,0211-699501013259,normal,o
176,0211-699501013259,bajo,o
176,0211-699501013259,los,o
176,0211-699501013259,niveles,i
176,0211-699501013259,de,i
176,0211-699501013259,tHcy,i
176,0211-699501013259,se,o
176,0211-699501013259,correlacionaban,o
176,0211-699501013259,inversamente,o
176,0211-699501013259,con,o
176,0211-699501013259,los,o
176,0211-699501013259,del,o
176,0211-699501013259,folato,i
176,0211-699501013259,r,o
176,0211-699501013259,0336,o
176,0211-699501013259,p,o
176,0211-699501013259,001,o
176,0211-699501013259,pero,o
176,0211-699501013259,no,o
176,0211-699501013259,con,o
176,0211-699501013259,pp,i
176,0211-699501013259,B12,i
176,0211-699501013259,edad,o
176,0211-699501013259,albumina,i
176,0211-699501013259,KTV,o
176,0211-699501013259,KRU,o
176,0211-699501013259,PCRn,o
176,0211-699501013259,Cincuenta,o
176,0211-699501013259,y,o
176,0211-699501013259,ocho,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,recibieron,o
176,0211-699501013259,seis,o
176,0211-699501013259,meses,o
176,0211-699501013259,de,o
176,0211-699501013259,suplementacion,i
176,0211-699501013259,con,o
176,0211-699501013259,normalizacion,o
176,0211-699501013259,del,o
176,0211-699501013259,pp,i
176,0211-699501013259,aumento,o
176,0211-699501013259,del,o
176,0211-699501013259,folato,i
176,0211-699501013259,703,o
176,0211-699501013259,IC,o
176,0211-699501013259,638,o
176,0211-699501013259,795,o
176,0211-699501013259,vs,o
176,0211-699501013259,6181,o
176,0211-699501013259,IC,o
176,0211-699501013259,4447,o
176,0211-699501013259,7811,o
176,0211-699501013259,p,o
176,0211-699501013259,0001,o
176,0211-699501013259,y,o
176,0211-699501013259,descenso,o
176,0211-699501013259,de,o
176,0211-699501013259,la,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,240,o
176,0211-699501013259,IC,o
176,0211-699501013259,213,o
176,0211-699501013259,264,o
176,0211-699501013259,vs,o
176,0211-699501013259,199,o
176,0211-699501013259,IC,o
176,0211-699501013259,175,o
176,0211-699501013259,224,o
176,0211-699501013259,p,o
176,0211-699501013259,005,o
176,0211-699501013259,Han,o
176,0211-699501013259,recibido,o
176,0211-699501013259,suplementacion,i
176,0211-699501013259,durante,o
176,0211-699501013259,12,o
176,0211-699501013259,meses,o
176,0211-699501013259,33,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,pero,o
176,0211-699501013259,a,o
176,0211-699501013259,pesar,o
176,0211-699501013259,de,o
176,0211-699501013259,un,o
176,0211-699501013259,continuo,o
176,0211-699501013259,aumento,o
176,0211-699501013259,del,o
176,0211-699501013259,folato,i
176,0211-699501013259,10078,o
176,0211-699501013259,IC,o
176,0211-699501013259,7481,o
176,0211-699501013259,12674,o
176,0211-699501013259,p,o
176,0211-699501013259,0001,o
176,0211-699501013259,solo,o
176,0211-699501013259,3,o
176,0211-699501013259,pacientes,o
176,0211-699501013259,presentan,o
176,0211-699501013259,niveles,o
176,0211-699501013259,normales,o
176,0211-699501013259,de,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,correlacionandose,o
176,0211-699501013259,directamente,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,con,o
176,0211-699501013259,la,o
176,0211-699501013259,albumina,i
176,0211-699501013259,r,o
176,0211-699501013259,056,o
176,0211-699501013259,p,o
176,0211-699501013259,0001,o
176,0211-699501013259,que,o
176,0211-699501013259,se,o
176,0211-699501013259,elevo,o
176,0211-699501013259,con,o
176,0211-699501013259,respecto,o
176,0211-699501013259,al,o
176,0211-699501013259,inicio,o
176,0211-699501013259,337,o
176,0211-699501013259,IC,o
176,0211-699501013259,327,o
176,0211-699501013259,346,o
176,0211-699501013259,vs,o
176,0211-699501013259,350,o
176,0211-699501013259,IC,o
176,0211-699501013259,337,o
176,0211-699501013259,363,o
176,0211-699501013259,p,o
176,0211-699501013259,005,o
176,0211-699501013259,Conclusion,o
176,0211-699501013259,Tras,o
176,0211-699501013259,suplementacion,i
176,0211-699501013259,con,o
176,0211-699501013259,acido,i
176,0211-699501013259,folico,i
176,0211-699501013259,y,o
176,0211-699501013259,vitamina,i
176,0211-699501013259,B6,i
176,0211-699501013259,aunque,o
176,0211-699501013259,inicialmente,o
176,0211-699501013259,se,o
176,0211-699501013259,reduce,o
176,0211-699501013259,la,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,esta,o
176,0211-699501013259,respuesta,o
176,0211-699501013259,se,o
176,0211-699501013259,hace,o
176,0211-699501013259,refractaria,o
176,0211-699501013259,correlacionandose,o
176,0211-699501013259,directamente,o
176,0211-699501013259,la,o
176,0211-699501013259,tHcy,i
176,0211-699501013259,con,o
176,0211-699501013259,la,o
176,0211-699501013259,albumina,i
176,0211-699501013259,plasmatica,i
176,0211-699501013259,La,o
176,0211-699501013259,interpretacion,o
176,0211-699501013259,de,o
176,0211-699501013259,los,o
176,0211-699501013259,niveles,i
176,0211-699501013259,de,i
176,0211-699501013259,tHcy,i
176,0211-699501013259,debe,o
176,0211-699501013259,tener,o
176,0211-699501013259,en,o
176,0211-699501013259,cuenta,o
176,0211-699501013259,la,o
176,0211-699501013259,concentracion,i
176,0211-699501013259,de,i
176,0211-699501013259,albumina,i
177,0211-699501013259,Efecto,o
177,0211-699501013259,de,o
177,0211-699501013259,la,o
177,0211-699501013259,suplementacion,i
177,0211-699501013259,con,o
177,0211-699501013259,acido,i
177,0211-699501013259,folico,i
177,0211-699501013259,sobre,o
177,0211-699501013259,los,o
177,0211-699501013259,niveles,i
177,0211-699501013259,de,i
177,0211-699501013259,homocisteina,i
177,0211-699501013259,total,o
177,0211-699501013259,en,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,en,o
177,0211-699501013259,hemodialisis,i
177,0211-699501013259,La,o
177,0211-699501013259,hiperhomocisteinemia,i
177,0211-699501013259,es,o
177,0211-699501013259,un,o
177,0211-699501013259,marcador,o
177,0211-699501013259,de,o
177,0211-699501013259,riesgo,o
177,0211-699501013259,independiente,o
177,0211-699501013259,de,o
177,0211-699501013259,morbimortalidad,o
177,0211-699501013259,cardiovascular,i
177,0211-699501013259,Hemos,o
177,0211-699501013259,intentado,o
177,0211-699501013259,prospectivamente,o
177,0211-699501013259,reducir,o
177,0211-699501013259,los,o
177,0211-699501013259,niveles,i
177,0211-699501013259,de,i
177,0211-699501013259,homocisteina,i
177,0211-699501013259,total,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,mediante,o
177,0211-699501013259,suplemento,o
177,0211-699501013259,con,o
177,0211-699501013259,acido,i
177,0211-699501013259,folico,i
177,0211-699501013259,y,o
177,0211-699501013259,vitamina,i
177,0211-699501013259,B6,i
177,0211-699501013259,pp,i
177,0211-699501013259,valorando,o
177,0211-699501013259,su,o
177,0211-699501013259,posible,o
177,0211-699501013259,correlacion,o
177,0211-699501013259,con,o
177,0211-699501013259,dosis,o
177,0211-699501013259,de,o
177,0211-699501013259,dialisis,i
177,0211-699501013259,funcion,i
177,0211-699501013259,residual,i
177,0211-699501013259,y,o
177,0211-699501013259,parametros,o
177,0211-699501013259,nutricionales,o
177,0211-699501013259,Metodos,o
177,0211-699501013259,Todos,o
177,0211-699501013259,los,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,en,o
177,0211-699501013259,hemodialisis,i
177,0211-699501013259,al,o
177,0211-699501013259,comienzo,o
177,0211-699501013259,del,o
177,0211-699501013259,estudio,o
177,0211-699501013259,que,o
177,0211-699501013259,no,o
177,0211-699501013259,recibian,o
177,0211-699501013259,acido,i
177,0211-699501013259,folico,i
177,0211-699501013259,ni,o
177,0211-699501013259,vitamina,i
177,0211-699501013259,B6,i
177,0211-699501013259,asi,o
177,0211-699501013259,como,o
177,0211-699501013259,los,o
177,0211-699501013259,incorporados,o
177,0211-699501013259,posteriormente,o
177,0211-699501013259,a,o
177,0211-699501013259,partir,o
177,0211-699501013259,de,o
177,0211-699501013259,su,o
177,0211-699501013259,tercer,o
177,0211-699501013259,mes,o
177,0211-699501013259,en,o
177,0211-699501013259,hemodialisis,i
177,0211-699501013259,recibieron,o
177,0211-699501013259,5,o
177,0211-699501013259,mg,o
177,0211-699501013259,orales,o
177,0211-699501013259,de,o
177,0211-699501013259,acido,i
177,0211-699501013259,folico,i
177,0211-699501013259,cada,o
177,0211-699501013259,48,o
177,0211-699501013259,horas,o
177,0211-699501013259,y,o
177,0211-699501013259,40,o
177,0211-699501013259,mg,o
177,0211-699501013259,orales,o
177,0211-699501013259,de,o
177,0211-699501013259,vitamina,i
177,0211-699501013259,B6,i
177,0211-699501013259,cada,o
177,0211-699501013259,semana,o
177,0211-699501013259,Se,o
177,0211-699501013259,determinaron,o
177,0211-699501013259,al,o
177,0211-699501013259,comienzo,o
177,0211-699501013259,del,o
177,0211-699501013259,estudio,o
177,0211-699501013259,y,o
177,0211-699501013259,cada,o
177,0211-699501013259,2,o
177,0211-699501013259,meses,o
177,0211-699501013259,niveles,i
177,0211-699501013259,de,i
177,0211-699501013259,folato,i
177,0211-699501013259,vitamina,i
177,0211-699501013259,B12,i
177,0211-699501013259,inmunoensayo,i
177,0211-699501013259,albumina,i
177,0211-699501013259,y,o
177,0211-699501013259,cinetica,o
177,0211-699501013259,de,o
177,0211-699501013259,la,o
177,0211-699501013259,urea,i
177,0211-699501013259,KTV,o
177,0211-699501013259,KRU,o
177,0211-699501013259,PCRn,o
177,0211-699501013259,y,o
177,0211-699501013259,cada,o
177,0211-699501013259,6,o
177,0211-699501013259,meses,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,HPLC,i
177,0211-699501013259,y,o
177,0211-699501013259,pp,i
177,0211-699501013259,RIA,i
177,0211-699501013259,Resultados,o
177,0211-699501013259,80,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,fueron,o
177,0211-699501013259,incluidos,o
177,0211-699501013259,en,o
177,0211-699501013259,el,o
177,0211-699501013259,estudio,o
177,0211-699501013259,basal,o
177,0211-699501013259,con,o
177,0211-699501013259,una,o
177,0211-699501013259,prevalencia,o
177,0211-699501013259,de,o
177,0211-699501013259,hiperhomocisteinemia,i
177,0211-699501013259,del,o
177,0211-699501013259,844,o
177,0211-699501013259,deficit,i
177,0211-699501013259,de,i
177,0211-699501013259,pp,i
177,0211-699501013259,en,o
177,0211-699501013259,el,o
177,0211-699501013259,32,o
177,0211-699501013259,y,o
177,0211-699501013259,folato,i
177,0211-699501013259,en,o
177,0211-699501013259,el,o
177,0211-699501013259,rango,o
177,0211-699501013259,normal,o
177,0211-699501013259,bajo,o
177,0211-699501013259,los,o
177,0211-699501013259,niveles,i
177,0211-699501013259,de,i
177,0211-699501013259,tHcy,i
177,0211-699501013259,se,o
177,0211-699501013259,correlacionaban,o
177,0211-699501013259,inversamente,o
177,0211-699501013259,con,o
177,0211-699501013259,los,o
177,0211-699501013259,del,o
177,0211-699501013259,folato,i
177,0211-699501013259,r,o
177,0211-699501013259,0336,o
177,0211-699501013259,p,o
177,0211-699501013259,001,o
177,0211-699501013259,pero,o
177,0211-699501013259,no,o
177,0211-699501013259,con,o
177,0211-699501013259,pp,i
177,0211-699501013259,B12,i
177,0211-699501013259,edad,o
177,0211-699501013259,albumina,i
177,0211-699501013259,KTV,o
177,0211-699501013259,KRU,o
177,0211-699501013259,PCRn,o
177,0211-699501013259,Cincuenta,o
177,0211-699501013259,y,o
177,0211-699501013259,ocho,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,recibieron,o
177,0211-699501013259,seis,o
177,0211-699501013259,meses,o
177,0211-699501013259,de,o
177,0211-699501013259,suplementacion,i
177,0211-699501013259,con,o
177,0211-699501013259,normalizacion,o
177,0211-699501013259,del,o
177,0211-699501013259,pp,i
177,0211-699501013259,aumento,o
177,0211-699501013259,del,o
177,0211-699501013259,folato,i
177,0211-699501013259,703,o
177,0211-699501013259,IC,o
177,0211-699501013259,638,o
177,0211-699501013259,795,o
177,0211-699501013259,vs,o
177,0211-699501013259,6181,o
177,0211-699501013259,IC,o
177,0211-699501013259,4447,o
177,0211-699501013259,7811,o
177,0211-699501013259,p,o
177,0211-699501013259,0001,o
177,0211-699501013259,y,o
177,0211-699501013259,descenso,o
177,0211-699501013259,de,o
177,0211-699501013259,la,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,240,o
177,0211-699501013259,IC,o
177,0211-699501013259,213,o
177,0211-699501013259,264,o
177,0211-699501013259,vs,o
177,0211-699501013259,199,o
177,0211-699501013259,IC,o
177,0211-699501013259,175,o
177,0211-699501013259,224,o
177,0211-699501013259,p,o
177,0211-699501013259,005,o
177,0211-699501013259,Han,o
177,0211-699501013259,recibido,o
177,0211-699501013259,suplementacion,i
177,0211-699501013259,durante,o
177,0211-699501013259,12,o
177,0211-699501013259,meses,o
177,0211-699501013259,33,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,pero,o
177,0211-699501013259,a,o
177,0211-699501013259,pesar,o
177,0211-699501013259,de,o
177,0211-699501013259,un,o
177,0211-699501013259,continuo,o
177,0211-699501013259,aumento,o
177,0211-699501013259,del,o
177,0211-699501013259,folato,i
177,0211-699501013259,10078,o
177,0211-699501013259,IC,o
177,0211-699501013259,7481,o
177,0211-699501013259,12674,o
177,0211-699501013259,p,o
177,0211-699501013259,0001,o
177,0211-699501013259,solo,o
177,0211-699501013259,3,o
177,0211-699501013259,pacientes,o
177,0211-699501013259,presentan,o
177,0211-699501013259,niveles,o
177,0211-699501013259,normales,o
177,0211-699501013259,de,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,correlacionandose,o
177,0211-699501013259,directamente,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,con,o
177,0211-699501013259,la,o
177,0211-699501013259,albumina,i
177,0211-699501013259,r,o
177,0211-699501013259,056,o
177,0211-699501013259,p,o
177,0211-699501013259,0001,o
177,0211-699501013259,que,o
177,0211-699501013259,se,o
177,0211-699501013259,elevo,o
177,0211-699501013259,con,o
177,0211-699501013259,respecto,o
177,0211-699501013259,al,o
177,0211-699501013259,inicio,o
177,0211-699501013259,337,o
177,0211-699501013259,IC,o
177,0211-699501013259,327,o
177,0211-699501013259,346,o
177,0211-699501013259,vs,o
177,0211-699501013259,350,o
177,0211-699501013259,IC,o
177,0211-699501013259,337,o
177,0211-699501013259,363,o
177,0211-699501013259,p,o
177,0211-699501013259,005,o
177,0211-699501013259,Conclusion,o
177,0211-699501013259,Tras,o
177,0211-699501013259,suplementacion,i
177,0211-699501013259,con,o
177,0211-699501013259,acido,i
177,0211-699501013259,folico,i
177,0211-699501013259,y,o
177,0211-699501013259,vitamina,i
177,0211-699501013259,B6,i
177,0211-699501013259,aunque,o
177,0211-699501013259,inicialmente,o
177,0211-699501013259,se,o
177,0211-699501013259,reduce,o
177,0211-699501013259,la,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,esta,o
177,0211-699501013259,respuesta,o
177,0211-699501013259,se,o
177,0211-699501013259,hace,o
177,0211-699501013259,refractaria,o
177,0211-699501013259,correlacionandose,o
177,0211-699501013259,directamente,o
177,0211-699501013259,la,o
177,0211-699501013259,tHcy,i
177,0211-699501013259,con,o
177,0211-699501013259,la,o
177,0211-699501013259,albumina,i
177,0211-699501013259,plasmatica,i
177,0211-699501013259,La,o
177,0211-699501013259,interpretacion,o
177,0211-699501013259,de,o
177,0211-699501013259,los,o
177,0211-699501013259,niveles,i
177,0211-699501013259,de,i
177,0211-699501013259,tHcy,i
177,0211-699501013259,debe,o
177,0211-699501013259,tener,o
177,0211-699501013259,en,o
177,0211-699501013259,cuenta,o
177,0211-699501013259,la,o
177,0211-699501013259,concentracion,i
177,0211-699501013259,de,i
177,0211-699501013259,albumina,i
178,0211-699501013259,Efecto,o
178,0211-699501013259,de,o
178,0211-699501013259,la,o
178,0211-699501013259,suplementacion,i
178,0211-699501013259,con,o
178,0211-699501013259,acido,i
178,0211-699501013259,folico,i
178,0211-699501013259,sobre,o
178,0211-699501013259,los,o
178,0211-699501013259,niveles,i
178,0211-699501013259,de,i
178,0211-699501013259,homocisteina,i
178,0211-699501013259,total,o
178,0211-699501013259,en,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,en,o
178,0211-699501013259,hemodialisis,i
178,0211-699501013259,La,o
178,0211-699501013259,hiperhomocisteinemia,i
178,0211-699501013259,es,o
178,0211-699501013259,un,o
178,0211-699501013259,marcador,o
178,0211-699501013259,de,o
178,0211-699501013259,riesgo,o
178,0211-699501013259,independiente,o
178,0211-699501013259,de,o
178,0211-699501013259,morbimortalidad,o
178,0211-699501013259,cardiovascular,i
178,0211-699501013259,Hemos,o
178,0211-699501013259,intentado,o
178,0211-699501013259,prospectivamente,o
178,0211-699501013259,reducir,o
178,0211-699501013259,los,o
178,0211-699501013259,niveles,i
178,0211-699501013259,de,i
178,0211-699501013259,homocisteina,i
178,0211-699501013259,total,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,mediante,o
178,0211-699501013259,suplemento,o
178,0211-699501013259,con,o
178,0211-699501013259,acido,i
178,0211-699501013259,folico,i
178,0211-699501013259,y,o
178,0211-699501013259,vitamina,i
178,0211-699501013259,B6,i
178,0211-699501013259,pp,i
178,0211-699501013259,valorando,o
178,0211-699501013259,su,o
178,0211-699501013259,posible,o
178,0211-699501013259,correlacion,o
178,0211-699501013259,con,o
178,0211-699501013259,dosis,o
178,0211-699501013259,de,o
178,0211-699501013259,dialisis,i
178,0211-699501013259,funcion,i
178,0211-699501013259,residual,i
178,0211-699501013259,y,o
178,0211-699501013259,parametros,o
178,0211-699501013259,nutricionales,o
178,0211-699501013259,Metodos,o
178,0211-699501013259,Todos,o
178,0211-699501013259,los,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,en,o
178,0211-699501013259,hemodialisis,i
178,0211-699501013259,al,o
178,0211-699501013259,comienzo,o
178,0211-699501013259,del,o
178,0211-699501013259,estudio,o
178,0211-699501013259,que,o
178,0211-699501013259,no,o
178,0211-699501013259,recibian,o
178,0211-699501013259,acido,i
178,0211-699501013259,folico,i
178,0211-699501013259,ni,o
178,0211-699501013259,vitamina,i
178,0211-699501013259,B6,i
178,0211-699501013259,asi,o
178,0211-699501013259,como,o
178,0211-699501013259,los,o
178,0211-699501013259,incorporados,o
178,0211-699501013259,posteriormente,o
178,0211-699501013259,a,o
178,0211-699501013259,partir,o
178,0211-699501013259,de,o
178,0211-699501013259,su,o
178,0211-699501013259,tercer,o
178,0211-699501013259,mes,o
178,0211-699501013259,en,o
178,0211-699501013259,hemodialisis,i
178,0211-699501013259,recibieron,o
178,0211-699501013259,5,o
178,0211-699501013259,mg,o
178,0211-699501013259,orales,o
178,0211-699501013259,de,o
178,0211-699501013259,acido,i
178,0211-699501013259,folico,i
178,0211-699501013259,cada,o
178,0211-699501013259,48,o
178,0211-699501013259,horas,o
178,0211-699501013259,y,o
178,0211-699501013259,40,o
178,0211-699501013259,mg,o
178,0211-699501013259,orales,o
178,0211-699501013259,de,o
178,0211-699501013259,vitamina,i
178,0211-699501013259,B6,i
178,0211-699501013259,cada,o
178,0211-699501013259,semana,o
178,0211-699501013259,Se,o
178,0211-699501013259,determinaron,o
178,0211-699501013259,al,o
178,0211-699501013259,comienzo,o
178,0211-699501013259,del,o
178,0211-699501013259,estudio,o
178,0211-699501013259,y,o
178,0211-699501013259,cada,o
178,0211-699501013259,2,o
178,0211-699501013259,meses,o
178,0211-699501013259,niveles,i
178,0211-699501013259,de,i
178,0211-699501013259,folato,i
178,0211-699501013259,vitamina,i
178,0211-699501013259,B12,i
178,0211-699501013259,inmunoensayo,i
178,0211-699501013259,albumina,i
178,0211-699501013259,y,o
178,0211-699501013259,cinetica,o
178,0211-699501013259,de,o
178,0211-699501013259,la,o
178,0211-699501013259,urea,i
178,0211-699501013259,KTV,o
178,0211-699501013259,KRU,o
178,0211-699501013259,PCRn,o
178,0211-699501013259,y,o
178,0211-699501013259,cada,o
178,0211-699501013259,6,o
178,0211-699501013259,meses,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,HPLC,i
178,0211-699501013259,y,o
178,0211-699501013259,pp,i
178,0211-699501013259,RIA,i
178,0211-699501013259,Resultados,o
178,0211-699501013259,80,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,fueron,o
178,0211-699501013259,incluidos,o
178,0211-699501013259,en,o
178,0211-699501013259,el,o
178,0211-699501013259,estudio,o
178,0211-699501013259,basal,o
178,0211-699501013259,con,o
178,0211-699501013259,una,o
178,0211-699501013259,prevalencia,o
178,0211-699501013259,de,o
178,0211-699501013259,hiperhomocisteinemia,i
178,0211-699501013259,del,o
178,0211-699501013259,844,o
178,0211-699501013259,deficit,i
178,0211-699501013259,de,i
178,0211-699501013259,pp,i
178,0211-699501013259,en,o
178,0211-699501013259,el,o
178,0211-699501013259,32,o
178,0211-699501013259,y,o
178,0211-699501013259,folato,i
178,0211-699501013259,en,o
178,0211-699501013259,el,o
178,0211-699501013259,rango,o
178,0211-699501013259,normal,o
178,0211-699501013259,bajo,o
178,0211-699501013259,los,o
178,0211-699501013259,niveles,i
178,0211-699501013259,de,i
178,0211-699501013259,tHcy,i
178,0211-699501013259,se,o
178,0211-699501013259,correlacionaban,o
178,0211-699501013259,inversamente,o
178,0211-699501013259,con,o
178,0211-699501013259,los,o
178,0211-699501013259,del,o
178,0211-699501013259,folato,i
178,0211-699501013259,r,o
178,0211-699501013259,0336,o
178,0211-699501013259,p,o
178,0211-699501013259,001,o
178,0211-699501013259,pero,o
178,0211-699501013259,no,o
178,0211-699501013259,con,o
178,0211-699501013259,pp,i
178,0211-699501013259,B12,i
178,0211-699501013259,edad,o
178,0211-699501013259,albumina,i
178,0211-699501013259,KTV,o
178,0211-699501013259,KRU,o
178,0211-699501013259,PCRn,o
178,0211-699501013259,Cincuenta,o
178,0211-699501013259,y,o
178,0211-699501013259,ocho,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,recibieron,o
178,0211-699501013259,seis,o
178,0211-699501013259,meses,o
178,0211-699501013259,de,o
178,0211-699501013259,suplementacion,i
178,0211-699501013259,con,o
178,0211-699501013259,normalizacion,o
178,0211-699501013259,del,o
178,0211-699501013259,pp,i
178,0211-699501013259,aumento,o
178,0211-699501013259,del,o
178,0211-699501013259,folato,i
178,0211-699501013259,703,o
178,0211-699501013259,IC,o
178,0211-699501013259,638,o
178,0211-699501013259,795,o
178,0211-699501013259,vs,o
178,0211-699501013259,6181,o
178,0211-699501013259,IC,o
178,0211-699501013259,4447,o
178,0211-699501013259,7811,o
178,0211-699501013259,p,o
178,0211-699501013259,0001,o
178,0211-699501013259,y,o
178,0211-699501013259,descenso,o
178,0211-699501013259,de,o
178,0211-699501013259,la,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,240,o
178,0211-699501013259,IC,o
178,0211-699501013259,213,o
178,0211-699501013259,264,o
178,0211-699501013259,vs,o
178,0211-699501013259,199,o
178,0211-699501013259,IC,o
178,0211-699501013259,175,o
178,0211-699501013259,224,o
178,0211-699501013259,p,o
178,0211-699501013259,005,o
178,0211-699501013259,Han,o
178,0211-699501013259,recibido,o
178,0211-699501013259,suplementacion,i
178,0211-699501013259,durante,o
178,0211-699501013259,12,o
178,0211-699501013259,meses,o
178,0211-699501013259,33,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,pero,o
178,0211-699501013259,a,o
178,0211-699501013259,pesar,o
178,0211-699501013259,de,o
178,0211-699501013259,un,o
178,0211-699501013259,continuo,o
178,0211-699501013259,aumento,o
178,0211-699501013259,del,o
178,0211-699501013259,folato,i
178,0211-699501013259,10078,o
178,0211-699501013259,IC,o
178,0211-699501013259,7481,o
178,0211-699501013259,12674,o
178,0211-699501013259,p,o
178,0211-699501013259,0001,o
178,0211-699501013259,solo,o
178,0211-699501013259,3,o
178,0211-699501013259,pacientes,o
178,0211-699501013259,presentan,o
178,0211-699501013259,niveles,o
178,0211-699501013259,normales,o
178,0211-699501013259,de,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,correlacionandose,o
178,0211-699501013259,directamente,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,con,o
178,0211-699501013259,la,o
178,0211-699501013259,albumina,i
178,0211-699501013259,r,o
178,0211-699501013259,056,o
178,0211-699501013259,p,o
178,0211-699501013259,0001,o
178,0211-699501013259,que,o
178,0211-699501013259,se,o
178,0211-699501013259,elevo,o
178,0211-699501013259,con,o
178,0211-699501013259,respecto,o
178,0211-699501013259,al,o
178,0211-699501013259,inicio,o
178,0211-699501013259,337,o
178,0211-699501013259,IC,o
178,0211-699501013259,327,o
178,0211-699501013259,346,o
178,0211-699501013259,vs,o
178,0211-699501013259,350,o
178,0211-699501013259,IC,o
178,0211-699501013259,337,o
178,0211-699501013259,363,o
178,0211-699501013259,p,o
178,0211-699501013259,005,o
178,0211-699501013259,Conclusion,o
178,0211-699501013259,Tras,o
178,0211-699501013259,suplementacion,i
178,0211-699501013259,con,o
178,0211-699501013259,acido,i
178,0211-699501013259,folico,i
178,0211-699501013259,y,o
178,0211-699501013259,vitamina,i
178,0211-699501013259,B6,i
178,0211-699501013259,aunque,o
178,0211-699501013259,inicialmente,o
178,0211-699501013259,se,o
178,0211-699501013259,reduce,o
178,0211-699501013259,la,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,esta,o
178,0211-699501013259,respuesta,o
178,0211-699501013259,se,o
178,0211-699501013259,hace,o
178,0211-699501013259,refractaria,o
178,0211-699501013259,correlacionandose,o
178,0211-699501013259,directamente,o
178,0211-699501013259,la,o
178,0211-699501013259,tHcy,i
178,0211-699501013259,con,o
178,0211-699501013259,la,o
178,0211-699501013259,albumina,i
178,0211-699501013259,plasmatica,i
178,0211-699501013259,La,o
178,0211-699501013259,interpretacion,o
178,0211-699501013259,de,o
178,0211-699501013259,los,o
178,0211-699501013259,niveles,i
178,0211-699501013259,de,i
178,0211-699501013259,tHcy,i
178,0211-699501013259,debe,o
178,0211-699501013259,tener,o
178,0211-699501013259,en,o
178,0211-699501013259,cuenta,o
178,0211-699501013259,la,o
178,0211-699501013259,concentracion,i
178,0211-699501013259,de,i
178,0211-699501013259,albumina,i
179,0211-699501013259,Efecto,o
179,0211-699501013259,de,o
179,0211-699501013259,la,o
179,0211-699501013259,suplementacion,i
179,0211-699501013259,con,o
179,0211-699501013259,acido,i
179,0211-699501013259,folico,i
179,0211-699501013259,sobre,o
179,0211-699501013259,los,o
179,0211-699501013259,niveles,i
179,0211-699501013259,de,i
179,0211-699501013259,homocisteina,i
179,0211-699501013259,total,o
179,0211-699501013259,en,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,en,o
179,0211-699501013259,hemodialisis,i
179,0211-699501013259,La,o
179,0211-699501013259,hiperhomocisteinemia,i
179,0211-699501013259,es,o
179,0211-699501013259,un,o
179,0211-699501013259,marcador,o
179,0211-699501013259,de,o
179,0211-699501013259,riesgo,o
179,0211-699501013259,independiente,o
179,0211-699501013259,de,o
179,0211-699501013259,morbimortalidad,o
179,0211-699501013259,cardiovascular,i
179,0211-699501013259,Hemos,o
179,0211-699501013259,intentado,o
179,0211-699501013259,prospectivamente,o
179,0211-699501013259,reducir,o
179,0211-699501013259,los,o
179,0211-699501013259,niveles,i
179,0211-699501013259,de,i
179,0211-699501013259,homocisteina,i
179,0211-699501013259,total,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,mediante,o
179,0211-699501013259,suplemento,o
179,0211-699501013259,con,o
179,0211-699501013259,acido,i
179,0211-699501013259,folico,i
179,0211-699501013259,y,o
179,0211-699501013259,vitamina,i
179,0211-699501013259,B6,i
179,0211-699501013259,pp,i
179,0211-699501013259,valorando,o
179,0211-699501013259,su,o
179,0211-699501013259,posible,o
179,0211-699501013259,correlacion,o
179,0211-699501013259,con,o
179,0211-699501013259,dosis,o
179,0211-699501013259,de,o
179,0211-699501013259,dialisis,i
179,0211-699501013259,funcion,i
179,0211-699501013259,residual,i
179,0211-699501013259,y,o
179,0211-699501013259,parametros,o
179,0211-699501013259,nutricionales,o
179,0211-699501013259,Metodos,o
179,0211-699501013259,Todos,o
179,0211-699501013259,los,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,en,o
179,0211-699501013259,hemodialisis,i
179,0211-699501013259,al,o
179,0211-699501013259,comienzo,o
179,0211-699501013259,del,o
179,0211-699501013259,estudio,o
179,0211-699501013259,que,o
179,0211-699501013259,no,o
179,0211-699501013259,recibian,o
179,0211-699501013259,acido,i
179,0211-699501013259,folico,i
179,0211-699501013259,ni,o
179,0211-699501013259,vitamina,i
179,0211-699501013259,B6,i
179,0211-699501013259,asi,o
179,0211-699501013259,como,o
179,0211-699501013259,los,o
179,0211-699501013259,incorporados,o
179,0211-699501013259,posteriormente,o
179,0211-699501013259,a,o
179,0211-699501013259,partir,o
179,0211-699501013259,de,o
179,0211-699501013259,su,o
179,0211-699501013259,tercer,o
179,0211-699501013259,mes,o
179,0211-699501013259,en,o
179,0211-699501013259,hemodialisis,i
179,0211-699501013259,recibieron,o
179,0211-699501013259,5,o
179,0211-699501013259,mg,o
179,0211-699501013259,orales,o
179,0211-699501013259,de,o
179,0211-699501013259,acido,i
179,0211-699501013259,folico,i
179,0211-699501013259,cada,o
179,0211-699501013259,48,o
179,0211-699501013259,horas,o
179,0211-699501013259,y,o
179,0211-699501013259,40,o
179,0211-699501013259,mg,o
179,0211-699501013259,orales,o
179,0211-699501013259,de,o
179,0211-699501013259,vitamina,i
179,0211-699501013259,B6,i
179,0211-699501013259,cada,o
179,0211-699501013259,semana,o
179,0211-699501013259,Se,o
179,0211-699501013259,determinaron,o
179,0211-699501013259,al,o
179,0211-699501013259,comienzo,o
179,0211-699501013259,del,o
179,0211-699501013259,estudio,o
179,0211-699501013259,y,o
179,0211-699501013259,cada,o
179,0211-699501013259,2,o
179,0211-699501013259,meses,o
179,0211-699501013259,niveles,i
179,0211-699501013259,de,i
179,0211-699501013259,folato,i
179,0211-699501013259,vitamina,i
179,0211-699501013259,B12,i
179,0211-699501013259,inmunoensayo,i
179,0211-699501013259,albumina,i
179,0211-699501013259,y,o
179,0211-699501013259,cinetica,o
179,0211-699501013259,de,o
179,0211-699501013259,la,o
179,0211-699501013259,urea,i
179,0211-699501013259,KTV,o
179,0211-699501013259,KRU,o
179,0211-699501013259,PCRn,o
179,0211-699501013259,y,o
179,0211-699501013259,cada,o
179,0211-699501013259,6,o
179,0211-699501013259,meses,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,HPLC,i
179,0211-699501013259,y,o
179,0211-699501013259,pp,i
179,0211-699501013259,RIA,i
179,0211-699501013259,Resultados,o
179,0211-699501013259,80,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,fueron,o
179,0211-699501013259,incluidos,o
179,0211-699501013259,en,o
179,0211-699501013259,el,o
179,0211-699501013259,estudio,o
179,0211-699501013259,basal,o
179,0211-699501013259,con,o
179,0211-699501013259,una,o
179,0211-699501013259,prevalencia,o
179,0211-699501013259,de,o
179,0211-699501013259,hiperhomocisteinemia,i
179,0211-699501013259,del,o
179,0211-699501013259,844,o
179,0211-699501013259,deficit,i
179,0211-699501013259,de,i
179,0211-699501013259,pp,i
179,0211-699501013259,en,o
179,0211-699501013259,el,o
179,0211-699501013259,32,o
179,0211-699501013259,y,o
179,0211-699501013259,folato,i
179,0211-699501013259,en,o
179,0211-699501013259,el,o
179,0211-699501013259,rango,o
179,0211-699501013259,normal,o
179,0211-699501013259,bajo,o
179,0211-699501013259,los,o
179,0211-699501013259,niveles,i
179,0211-699501013259,de,i
179,0211-699501013259,tHcy,i
179,0211-699501013259,se,o
179,0211-699501013259,correlacionaban,o
179,0211-699501013259,inversamente,o
179,0211-699501013259,con,o
179,0211-699501013259,los,o
179,0211-699501013259,del,o
179,0211-699501013259,folato,i
179,0211-699501013259,r,o
179,0211-699501013259,0336,o
179,0211-699501013259,p,o
179,0211-699501013259,001,o
179,0211-699501013259,pero,o
179,0211-699501013259,no,o
179,0211-699501013259,con,o
179,0211-699501013259,pp,i
179,0211-699501013259,B12,i
179,0211-699501013259,edad,o
179,0211-699501013259,albumina,i
179,0211-699501013259,KTV,o
179,0211-699501013259,KRU,o
179,0211-699501013259,PCRn,o
179,0211-699501013259,Cincuenta,o
179,0211-699501013259,y,o
179,0211-699501013259,ocho,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,recibieron,o
179,0211-699501013259,seis,o
179,0211-699501013259,meses,o
179,0211-699501013259,de,o
179,0211-699501013259,suplementacion,i
179,0211-699501013259,con,o
179,0211-699501013259,normalizacion,o
179,0211-699501013259,del,o
179,0211-699501013259,pp,i
179,0211-699501013259,aumento,o
179,0211-699501013259,del,o
179,0211-699501013259,folato,i
179,0211-699501013259,703,o
179,0211-699501013259,IC,o
179,0211-699501013259,638,o
179,0211-699501013259,795,o
179,0211-699501013259,vs,o
179,0211-699501013259,6181,o
179,0211-699501013259,IC,o
179,0211-699501013259,4447,o
179,0211-699501013259,7811,o
179,0211-699501013259,p,o
179,0211-699501013259,0001,o
179,0211-699501013259,y,o
179,0211-699501013259,descenso,o
179,0211-699501013259,de,o
179,0211-699501013259,la,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,240,o
179,0211-699501013259,IC,o
179,0211-699501013259,213,o
179,0211-699501013259,264,o
179,0211-699501013259,vs,o
179,0211-699501013259,199,o
179,0211-699501013259,IC,o
179,0211-699501013259,175,o
179,0211-699501013259,224,o
179,0211-699501013259,p,o
179,0211-699501013259,005,o
179,0211-699501013259,Han,o
179,0211-699501013259,recibido,o
179,0211-699501013259,suplementacion,i
179,0211-699501013259,durante,o
179,0211-699501013259,12,o
179,0211-699501013259,meses,o
179,0211-699501013259,33,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,pero,o
179,0211-699501013259,a,o
179,0211-699501013259,pesar,o
179,0211-699501013259,de,o
179,0211-699501013259,un,o
179,0211-699501013259,continuo,o
179,0211-699501013259,aumento,o
179,0211-699501013259,del,o
179,0211-699501013259,folato,i
179,0211-699501013259,10078,o
179,0211-699501013259,IC,o
179,0211-699501013259,7481,o
179,0211-699501013259,12674,o
179,0211-699501013259,p,o
179,0211-699501013259,0001,o
179,0211-699501013259,solo,o
179,0211-699501013259,3,o
179,0211-699501013259,pacientes,o
179,0211-699501013259,presentan,o
179,0211-699501013259,niveles,o
179,0211-699501013259,normales,o
179,0211-699501013259,de,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,correlacionandose,o
179,0211-699501013259,directamente,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,con,o
179,0211-699501013259,la,o
179,0211-699501013259,albumina,i
179,0211-699501013259,r,o
179,0211-699501013259,056,o
179,0211-699501013259,p,o
179,0211-699501013259,0001,o
179,0211-699501013259,que,o
179,0211-699501013259,se,o
179,0211-699501013259,elevo,o
179,0211-699501013259,con,o
179,0211-699501013259,respecto,o
179,0211-699501013259,al,o
179,0211-699501013259,inicio,o
179,0211-699501013259,337,o
179,0211-699501013259,IC,o
179,0211-699501013259,327,o
179,0211-699501013259,346,o
179,0211-699501013259,vs,o
179,0211-699501013259,350,o
179,0211-699501013259,IC,o
179,0211-699501013259,337,o
179,0211-699501013259,363,o
179,0211-699501013259,p,o
179,0211-699501013259,005,o
179,0211-699501013259,Conclusion,o
179,0211-699501013259,Tras,o
179,0211-699501013259,suplementacion,i
179,0211-699501013259,con,o
179,0211-699501013259,acido,i
179,0211-699501013259,folico,i
179,0211-699501013259,y,o
179,0211-699501013259,vitamina,i
179,0211-699501013259,B6,i
179,0211-699501013259,aunque,o
179,0211-699501013259,inicialmente,o
179,0211-699501013259,se,o
179,0211-699501013259,reduce,o
179,0211-699501013259,la,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,esta,o
179,0211-699501013259,respuesta,o
179,0211-699501013259,se,o
179,0211-699501013259,hace,o
179,0211-699501013259,refractaria,o
179,0211-699501013259,correlacionandose,o
179,0211-699501013259,directamente,o
179,0211-699501013259,la,o
179,0211-699501013259,tHcy,i
179,0211-699501013259,con,o
179,0211-699501013259,la,o
179,0211-699501013259,albumina,i
179,0211-699501013259,plasmatica,i
179,0211-699501013259,La,o
179,0211-699501013259,interpretacion,o
179,0211-699501013259,de,o
179,0211-699501013259,los,o
179,0211-699501013259,niveles,i
179,0211-699501013259,de,i
179,0211-699501013259,tHcy,i
179,0211-699501013259,debe,o
179,0211-699501013259,tener,o
179,0211-699501013259,en,o
179,0211-699501013259,cuenta,o
179,0211-699501013259,la,o
179,0211-699501013259,concentracion,i
179,0211-699501013259,de,i
179,0211-699501013259,albumina,i
180,0211-699501013259,Efecto,o
180,0211-699501013259,de,o
180,0211-699501013259,la,o
180,0211-699501013259,suplementacion,i
180,0211-699501013259,con,o
180,0211-699501013259,acido,i
180,0211-699501013259,folico,i
180,0211-699501013259,sobre,o
180,0211-699501013259,los,o
180,0211-699501013259,niveles,i
180,0211-699501013259,de,i
180,0211-699501013259,homocisteina,i
180,0211-699501013259,total,o
180,0211-699501013259,en,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,en,o
180,0211-699501013259,hemodialisis,i
180,0211-699501013259,La,o
180,0211-699501013259,hiperhomocisteinemia,i
180,0211-699501013259,es,o
180,0211-699501013259,un,o
180,0211-699501013259,marcador,o
180,0211-699501013259,de,o
180,0211-699501013259,riesgo,o
180,0211-699501013259,independiente,o
180,0211-699501013259,de,o
180,0211-699501013259,morbimortalidad,o
180,0211-699501013259,cardiovascular,i
180,0211-699501013259,Hemos,o
180,0211-699501013259,intentado,o
180,0211-699501013259,prospectivamente,o
180,0211-699501013259,reducir,o
180,0211-699501013259,los,o
180,0211-699501013259,niveles,i
180,0211-699501013259,de,i
180,0211-699501013259,homocisteina,i
180,0211-699501013259,total,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,mediante,o
180,0211-699501013259,suplemento,o
180,0211-699501013259,con,o
180,0211-699501013259,acido,i
180,0211-699501013259,folico,i
180,0211-699501013259,y,o
180,0211-699501013259,vitamina,i
180,0211-699501013259,B6,i
180,0211-699501013259,pp,i
180,0211-699501013259,valorando,o
180,0211-699501013259,su,o
180,0211-699501013259,posible,o
180,0211-699501013259,correlacion,o
180,0211-699501013259,con,o
180,0211-699501013259,dosis,o
180,0211-699501013259,de,o
180,0211-699501013259,dialisis,i
180,0211-699501013259,funcion,i
180,0211-699501013259,residual,i
180,0211-699501013259,y,o
180,0211-699501013259,parametros,o
180,0211-699501013259,nutricionales,o
180,0211-699501013259,Metodos,o
180,0211-699501013259,Todos,o
180,0211-699501013259,los,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,en,o
180,0211-699501013259,hemodialisis,i
180,0211-699501013259,al,o
180,0211-699501013259,comienzo,o
180,0211-699501013259,del,o
180,0211-699501013259,estudio,o
180,0211-699501013259,que,o
180,0211-699501013259,no,o
180,0211-699501013259,recibian,o
180,0211-699501013259,acido,i
180,0211-699501013259,folico,i
180,0211-699501013259,ni,o
180,0211-699501013259,vitamina,i
180,0211-699501013259,B6,i
180,0211-699501013259,asi,o
180,0211-699501013259,como,o
180,0211-699501013259,los,o
180,0211-699501013259,incorporados,o
180,0211-699501013259,posteriormente,o
180,0211-699501013259,a,o
180,0211-699501013259,partir,o
180,0211-699501013259,de,o
180,0211-699501013259,su,o
180,0211-699501013259,tercer,o
180,0211-699501013259,mes,o
180,0211-699501013259,en,o
180,0211-699501013259,hemodialisis,i
180,0211-699501013259,recibieron,o
180,0211-699501013259,5,o
180,0211-699501013259,mg,o
180,0211-699501013259,orales,o
180,0211-699501013259,de,o
180,0211-699501013259,acido,i
180,0211-699501013259,folico,i
180,0211-699501013259,cada,o
180,0211-699501013259,48,o
180,0211-699501013259,horas,o
180,0211-699501013259,y,o
180,0211-699501013259,40,o
180,0211-699501013259,mg,o
180,0211-699501013259,orales,o
180,0211-699501013259,de,o
180,0211-699501013259,vitamina,i
180,0211-699501013259,B6,i
180,0211-699501013259,cada,o
180,0211-699501013259,semana,o
180,0211-699501013259,Se,o
180,0211-699501013259,determinaron,o
180,0211-699501013259,al,o
180,0211-699501013259,comienzo,o
180,0211-699501013259,del,o
180,0211-699501013259,estudio,o
180,0211-699501013259,y,o
180,0211-699501013259,cada,o
180,0211-699501013259,2,o
180,0211-699501013259,meses,o
180,0211-699501013259,niveles,i
180,0211-699501013259,de,i
180,0211-699501013259,folato,i
180,0211-699501013259,vitamina,i
180,0211-699501013259,B12,i
180,0211-699501013259,inmunoensayo,i
180,0211-699501013259,albumina,i
180,0211-699501013259,y,o
180,0211-699501013259,cinetica,o
180,0211-699501013259,de,o
180,0211-699501013259,la,o
180,0211-699501013259,urea,i
180,0211-699501013259,KTV,o
180,0211-699501013259,KRU,o
180,0211-699501013259,PCRn,o
180,0211-699501013259,y,o
180,0211-699501013259,cada,o
180,0211-699501013259,6,o
180,0211-699501013259,meses,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,HPLC,i
180,0211-699501013259,y,o
180,0211-699501013259,pp,i
180,0211-699501013259,RIA,i
180,0211-699501013259,Resultados,o
180,0211-699501013259,80,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,fueron,o
180,0211-699501013259,incluidos,o
180,0211-699501013259,en,o
180,0211-699501013259,el,o
180,0211-699501013259,estudio,o
180,0211-699501013259,basal,o
180,0211-699501013259,con,o
180,0211-699501013259,una,o
180,0211-699501013259,prevalencia,o
180,0211-699501013259,de,o
180,0211-699501013259,hiperhomocisteinemia,i
180,0211-699501013259,del,o
180,0211-699501013259,844,o
180,0211-699501013259,deficit,i
180,0211-699501013259,de,i
180,0211-699501013259,pp,i
180,0211-699501013259,en,o
180,0211-699501013259,el,o
180,0211-699501013259,32,o
180,0211-699501013259,y,o
180,0211-699501013259,folato,i
180,0211-699501013259,en,o
180,0211-699501013259,el,o
180,0211-699501013259,rango,o
180,0211-699501013259,normal,o
180,0211-699501013259,bajo,o
180,0211-699501013259,los,o
180,0211-699501013259,niveles,i
180,0211-699501013259,de,i
180,0211-699501013259,tHcy,i
180,0211-699501013259,se,o
180,0211-699501013259,correlacionaban,o
180,0211-699501013259,inversamente,o
180,0211-699501013259,con,o
180,0211-699501013259,los,o
180,0211-699501013259,del,o
180,0211-699501013259,folato,i
180,0211-699501013259,r,o
180,0211-699501013259,0336,o
180,0211-699501013259,p,o
180,0211-699501013259,001,o
180,0211-699501013259,pero,o
180,0211-699501013259,no,o
180,0211-699501013259,con,o
180,0211-699501013259,pp,i
180,0211-699501013259,B12,i
180,0211-699501013259,edad,o
180,0211-699501013259,albumina,i
180,0211-699501013259,KTV,o
180,0211-699501013259,KRU,o
180,0211-699501013259,PCRn,o
180,0211-699501013259,Cincuenta,o
180,0211-699501013259,y,o
180,0211-699501013259,ocho,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,recibieron,o
180,0211-699501013259,seis,o
180,0211-699501013259,meses,o
180,0211-699501013259,de,o
180,0211-699501013259,suplementacion,i
180,0211-699501013259,con,o
180,0211-699501013259,normalizacion,o
180,0211-699501013259,del,o
180,0211-699501013259,pp,i
180,0211-699501013259,aumento,o
180,0211-699501013259,del,o
180,0211-699501013259,folato,i
180,0211-699501013259,703,o
180,0211-699501013259,IC,o
180,0211-699501013259,638,o
180,0211-699501013259,795,o
180,0211-699501013259,vs,o
180,0211-699501013259,6181,o
180,0211-699501013259,IC,o
180,0211-699501013259,4447,o
180,0211-699501013259,7811,o
180,0211-699501013259,p,o
180,0211-699501013259,0001,o
180,0211-699501013259,y,o
180,0211-699501013259,descenso,o
180,0211-699501013259,de,o
180,0211-699501013259,la,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,240,o
180,0211-699501013259,IC,o
180,0211-699501013259,213,o
180,0211-699501013259,264,o
180,0211-699501013259,vs,o
180,0211-699501013259,199,o
180,0211-699501013259,IC,o
180,0211-699501013259,175,o
180,0211-699501013259,224,o
180,0211-699501013259,p,o
180,0211-699501013259,005,o
180,0211-699501013259,Han,o
180,0211-699501013259,recibido,o
180,0211-699501013259,suplementacion,i
180,0211-699501013259,durante,o
180,0211-699501013259,12,o
180,0211-699501013259,meses,o
180,0211-699501013259,33,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,pero,o
180,0211-699501013259,a,o
180,0211-699501013259,pesar,o
180,0211-699501013259,de,o
180,0211-699501013259,un,o
180,0211-699501013259,continuo,o
180,0211-699501013259,aumento,o
180,0211-699501013259,del,o
180,0211-699501013259,folato,i
180,0211-699501013259,10078,o
180,0211-699501013259,IC,o
180,0211-699501013259,7481,o
180,0211-699501013259,12674,o
180,0211-699501013259,p,o
180,0211-699501013259,0001,o
180,0211-699501013259,solo,o
180,0211-699501013259,3,o
180,0211-699501013259,pacientes,o
180,0211-699501013259,presentan,o
180,0211-699501013259,niveles,o
180,0211-699501013259,normales,o
180,0211-699501013259,de,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,correlacionandose,o
180,0211-699501013259,directamente,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,con,o
180,0211-699501013259,la,o
180,0211-699501013259,albumina,i
180,0211-699501013259,r,o
180,0211-699501013259,056,o
180,0211-699501013259,p,o
180,0211-699501013259,0001,o
180,0211-699501013259,que,o
180,0211-699501013259,se,o
180,0211-699501013259,elevo,o
180,0211-699501013259,con,o
180,0211-699501013259,respecto,o
180,0211-699501013259,al,o
180,0211-699501013259,inicio,o
180,0211-699501013259,337,o
180,0211-699501013259,IC,o
180,0211-699501013259,327,o
180,0211-699501013259,346,o
180,0211-699501013259,vs,o
180,0211-699501013259,350,o
180,0211-699501013259,IC,o
180,0211-699501013259,337,o
180,0211-699501013259,363,o
180,0211-699501013259,p,o
180,0211-699501013259,005,o
180,0211-699501013259,Conclusion,o
180,0211-699501013259,Tras,o
180,0211-699501013259,suplementacion,i
180,0211-699501013259,con,o
180,0211-699501013259,acido,i
180,0211-699501013259,folico,i
180,0211-699501013259,y,o
180,0211-699501013259,vitamina,i
180,0211-699501013259,B6,i
180,0211-699501013259,aunque,o
180,0211-699501013259,inicialmente,o
180,0211-699501013259,se,o
180,0211-699501013259,reduce,o
180,0211-699501013259,la,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,esta,o
180,0211-699501013259,respuesta,o
180,0211-699501013259,se,o
180,0211-699501013259,hace,o
180,0211-699501013259,refractaria,o
180,0211-699501013259,correlacionandose,o
180,0211-699501013259,directamente,o
180,0211-699501013259,la,o
180,0211-699501013259,tHcy,i
180,0211-699501013259,con,o
180,0211-699501013259,la,o
180,0211-699501013259,albumina,i
180,0211-699501013259,plasmatica,i
180,0211-699501013259,La,o
180,0211-699501013259,interpretacion,o
180,0211-699501013259,de,o
180,0211-699501013259,los,o
180,0211-699501013259,niveles,i
180,0211-699501013259,de,i
180,0211-699501013259,tHcy,i
180,0211-699501013259,debe,o
180,0211-699501013259,tener,o
180,0211-699501013259,en,o
180,0211-699501013259,cuenta,o
180,0211-699501013259,la,o
180,0211-699501013259,concentracion,i
180,0211-699501013259,de,i
180,0211-699501013259,albumina,i
181,0211-699501013259,Efecto,o
181,0211-699501013259,de,o
181,0211-699501013259,la,o
181,0211-699501013259,suplementacion,i
181,0211-699501013259,con,o
181,0211-699501013259,acido,i
181,0211-699501013259,folico,i
181,0211-699501013259,sobre,o
181,0211-699501013259,los,o
181,0211-699501013259,niveles,i
181,0211-699501013259,de,i
181,0211-699501013259,homocisteina,i
181,0211-699501013259,total,o
181,0211-699501013259,en,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,en,o
181,0211-699501013259,hemodialisis,i
181,0211-699501013259,La,o
181,0211-699501013259,hiperhomocisteinemia,i
181,0211-699501013259,es,o
181,0211-699501013259,un,o
181,0211-699501013259,marcador,o
181,0211-699501013259,de,o
181,0211-699501013259,riesgo,o
181,0211-699501013259,independiente,o
181,0211-699501013259,de,o
181,0211-699501013259,morbimortalidad,o
181,0211-699501013259,cardiovascular,i
181,0211-699501013259,Hemos,o
181,0211-699501013259,intentado,o
181,0211-699501013259,prospectivamente,o
181,0211-699501013259,reducir,o
181,0211-699501013259,los,o
181,0211-699501013259,niveles,i
181,0211-699501013259,de,i
181,0211-699501013259,homocisteina,i
181,0211-699501013259,total,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,mediante,o
181,0211-699501013259,suplemento,o
181,0211-699501013259,con,o
181,0211-699501013259,acido,i
181,0211-699501013259,folico,i
181,0211-699501013259,y,o
181,0211-699501013259,vitamina,i
181,0211-699501013259,B6,i
181,0211-699501013259,pp,i
181,0211-699501013259,valorando,o
181,0211-699501013259,su,o
181,0211-699501013259,posible,o
181,0211-699501013259,correlacion,o
181,0211-699501013259,con,o
181,0211-699501013259,dosis,o
181,0211-699501013259,de,o
181,0211-699501013259,dialisis,i
181,0211-699501013259,funcion,i
181,0211-699501013259,residual,i
181,0211-699501013259,y,o
181,0211-699501013259,parametros,o
181,0211-699501013259,nutricionales,o
181,0211-699501013259,Metodos,o
181,0211-699501013259,Todos,o
181,0211-699501013259,los,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,en,o
181,0211-699501013259,hemodialisis,i
181,0211-699501013259,al,o
181,0211-699501013259,comienzo,o
181,0211-699501013259,del,o
181,0211-699501013259,estudio,o
181,0211-699501013259,que,o
181,0211-699501013259,no,o
181,0211-699501013259,recibian,o
181,0211-699501013259,acido,i
181,0211-699501013259,folico,i
181,0211-699501013259,ni,o
181,0211-699501013259,vitamina,i
181,0211-699501013259,B6,i
181,0211-699501013259,asi,o
181,0211-699501013259,como,o
181,0211-699501013259,los,o
181,0211-699501013259,incorporados,o
181,0211-699501013259,posteriormente,o
181,0211-699501013259,a,o
181,0211-699501013259,partir,o
181,0211-699501013259,de,o
181,0211-699501013259,su,o
181,0211-699501013259,tercer,o
181,0211-699501013259,mes,o
181,0211-699501013259,en,o
181,0211-699501013259,hemodialisis,i
181,0211-699501013259,recibieron,o
181,0211-699501013259,5,o
181,0211-699501013259,mg,o
181,0211-699501013259,orales,o
181,0211-699501013259,de,o
181,0211-699501013259,acido,i
181,0211-699501013259,folico,i
181,0211-699501013259,cada,o
181,0211-699501013259,48,o
181,0211-699501013259,horas,o
181,0211-699501013259,y,o
181,0211-699501013259,40,o
181,0211-699501013259,mg,o
181,0211-699501013259,orales,o
181,0211-699501013259,de,o
181,0211-699501013259,vitamina,i
181,0211-699501013259,B6,i
181,0211-699501013259,cada,o
181,0211-699501013259,semana,o
181,0211-699501013259,Se,o
181,0211-699501013259,determinaron,o
181,0211-699501013259,al,o
181,0211-699501013259,comienzo,o
181,0211-699501013259,del,o
181,0211-699501013259,estudio,o
181,0211-699501013259,y,o
181,0211-699501013259,cada,o
181,0211-699501013259,2,o
181,0211-699501013259,meses,o
181,0211-699501013259,niveles,i
181,0211-699501013259,de,i
181,0211-699501013259,folato,i
181,0211-699501013259,vitamina,i
181,0211-699501013259,B12,i
181,0211-699501013259,inmunoensayo,i
181,0211-699501013259,albumina,i
181,0211-699501013259,y,o
181,0211-699501013259,cinetica,o
181,0211-699501013259,de,o
181,0211-699501013259,la,o
181,0211-699501013259,urea,i
181,0211-699501013259,KTV,o
181,0211-699501013259,KRU,o
181,0211-699501013259,PCRn,o
181,0211-699501013259,y,o
181,0211-699501013259,cada,o
181,0211-699501013259,6,o
181,0211-699501013259,meses,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,HPLC,i
181,0211-699501013259,y,o
181,0211-699501013259,pp,i
181,0211-699501013259,RIA,i
181,0211-699501013259,Resultados,o
181,0211-699501013259,80,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,fueron,o
181,0211-699501013259,incluidos,o
181,0211-699501013259,en,o
181,0211-699501013259,el,o
181,0211-699501013259,estudio,o
181,0211-699501013259,basal,o
181,0211-699501013259,con,o
181,0211-699501013259,una,o
181,0211-699501013259,prevalencia,o
181,0211-699501013259,de,o
181,0211-699501013259,hiperhomocisteinemia,i
181,0211-699501013259,del,o
181,0211-699501013259,844,o
181,0211-699501013259,deficit,i
181,0211-699501013259,de,i
181,0211-699501013259,pp,i
181,0211-699501013259,en,o
181,0211-699501013259,el,o
181,0211-699501013259,32,o
181,0211-699501013259,y,o
181,0211-699501013259,folato,i
181,0211-699501013259,en,o
181,0211-699501013259,el,o
181,0211-699501013259,rango,o
181,0211-699501013259,normal,o
181,0211-699501013259,bajo,o
181,0211-699501013259,los,o
181,0211-699501013259,niveles,i
181,0211-699501013259,de,i
181,0211-699501013259,tHcy,i
181,0211-699501013259,se,o
181,0211-699501013259,correlacionaban,o
181,0211-699501013259,inversamente,o
181,0211-699501013259,con,o
181,0211-699501013259,los,o
181,0211-699501013259,del,o
181,0211-699501013259,folato,i
181,0211-699501013259,r,o
181,0211-699501013259,0336,o
181,0211-699501013259,p,o
181,0211-699501013259,001,o
181,0211-699501013259,pero,o
181,0211-699501013259,no,o
181,0211-699501013259,con,o
181,0211-699501013259,pp,i
181,0211-699501013259,B12,i
181,0211-699501013259,edad,o
181,0211-699501013259,albumina,i
181,0211-699501013259,KTV,o
181,0211-699501013259,KRU,o
181,0211-699501013259,PCRn,o
181,0211-699501013259,Cincuenta,o
181,0211-699501013259,y,o
181,0211-699501013259,ocho,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,recibieron,o
181,0211-699501013259,seis,o
181,0211-699501013259,meses,o
181,0211-699501013259,de,o
181,0211-699501013259,suplementacion,i
181,0211-699501013259,con,o
181,0211-699501013259,normalizacion,o
181,0211-699501013259,del,o
181,0211-699501013259,pp,i
181,0211-699501013259,aumento,o
181,0211-699501013259,del,o
181,0211-699501013259,folato,i
181,0211-699501013259,703,o
181,0211-699501013259,IC,o
181,0211-699501013259,638,o
181,0211-699501013259,795,o
181,0211-699501013259,vs,o
181,0211-699501013259,6181,o
181,0211-699501013259,IC,o
181,0211-699501013259,4447,o
181,0211-699501013259,7811,o
181,0211-699501013259,p,o
181,0211-699501013259,0001,o
181,0211-699501013259,y,o
181,0211-699501013259,descenso,o
181,0211-699501013259,de,o
181,0211-699501013259,la,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,240,o
181,0211-699501013259,IC,o
181,0211-699501013259,213,o
181,0211-699501013259,264,o
181,0211-699501013259,vs,o
181,0211-699501013259,199,o
181,0211-699501013259,IC,o
181,0211-699501013259,175,o
181,0211-699501013259,224,o
181,0211-699501013259,p,o
181,0211-699501013259,005,o
181,0211-699501013259,Han,o
181,0211-699501013259,recibido,o
181,0211-699501013259,suplementacion,i
181,0211-699501013259,durante,o
181,0211-699501013259,12,o
181,0211-699501013259,meses,o
181,0211-699501013259,33,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,pero,o
181,0211-699501013259,a,o
181,0211-699501013259,pesar,o
181,0211-699501013259,de,o
181,0211-699501013259,un,o
181,0211-699501013259,continuo,o
181,0211-699501013259,aumento,o
181,0211-699501013259,del,o
181,0211-699501013259,folato,i
181,0211-699501013259,10078,o
181,0211-699501013259,IC,o
181,0211-699501013259,7481,o
181,0211-699501013259,12674,o
181,0211-699501013259,p,o
181,0211-699501013259,0001,o
181,0211-699501013259,solo,o
181,0211-699501013259,3,o
181,0211-699501013259,pacientes,o
181,0211-699501013259,presentan,o
181,0211-699501013259,niveles,o
181,0211-699501013259,normales,o
181,0211-699501013259,de,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,correlacionandose,o
181,0211-699501013259,directamente,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,con,o
181,0211-699501013259,la,o
181,0211-699501013259,albumina,i
181,0211-699501013259,r,o
181,0211-699501013259,056,o
181,0211-699501013259,p,o
181,0211-699501013259,0001,o
181,0211-699501013259,que,o
181,0211-699501013259,se,o
181,0211-699501013259,elevo,o
181,0211-699501013259,con,o
181,0211-699501013259,respecto,o
181,0211-699501013259,al,o
181,0211-699501013259,inicio,o
181,0211-699501013259,337,o
181,0211-699501013259,IC,o
181,0211-699501013259,327,o
181,0211-699501013259,346,o
181,0211-699501013259,vs,o
181,0211-699501013259,350,o
181,0211-699501013259,IC,o
181,0211-699501013259,337,o
181,0211-699501013259,363,o
181,0211-699501013259,p,o
181,0211-699501013259,005,o
181,0211-699501013259,Conclusion,o
181,0211-699501013259,Tras,o
181,0211-699501013259,suplementacion,i
181,0211-699501013259,con,o
181,0211-699501013259,acido,i
181,0211-699501013259,folico,i
181,0211-699501013259,y,o
181,0211-699501013259,vitamina,i
181,0211-699501013259,B6,i
181,0211-699501013259,aunque,o
181,0211-699501013259,inicialmente,o
181,0211-699501013259,se,o
181,0211-699501013259,reduce,o
181,0211-699501013259,la,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,esta,o
181,0211-699501013259,respuesta,o
181,0211-699501013259,se,o
181,0211-699501013259,hace,o
181,0211-699501013259,refractaria,o
181,0211-699501013259,correlacionandose,o
181,0211-699501013259,directamente,o
181,0211-699501013259,la,o
181,0211-699501013259,tHcy,i
181,0211-699501013259,con,o
181,0211-699501013259,la,o
181,0211-699501013259,albumina,i
181,0211-699501013259,plasmatica,i
181,0211-699501013259,La,o
181,0211-699501013259,interpretacion,o
181,0211-699501013259,de,o
181,0211-699501013259,los,o
181,0211-699501013259,niveles,i
181,0211-699501013259,de,i
181,0211-699501013259,tHcy,i
181,0211-699501013259,debe,o
181,0211-699501013259,tener,o
181,0211-699501013259,en,o
181,0211-699501013259,cuenta,o
181,0211-699501013259,la,o
181,0211-699501013259,concentracion,i
181,0211-699501013259,de,i
181,0211-699501013259,albumina,i
182,0211-699501013259,Efecto,o
182,0211-699501013259,de,o
182,0211-699501013259,la,o
182,0211-699501013259,suplementacion,i
182,0211-699501013259,con,o
182,0211-699501013259,acido,i
182,0211-699501013259,folico,i
182,0211-699501013259,sobre,o
182,0211-699501013259,los,o
182,0211-699501013259,niveles,i
182,0211-699501013259,de,i
182,0211-699501013259,homocisteina,i
182,0211-699501013259,total,o
182,0211-699501013259,en,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,en,o
182,0211-699501013259,hemodialisis,i
182,0211-699501013259,La,o
182,0211-699501013259,hiperhomocisteinemia,i
182,0211-699501013259,es,o
182,0211-699501013259,un,o
182,0211-699501013259,marcador,o
182,0211-699501013259,de,o
182,0211-699501013259,riesgo,o
182,0211-699501013259,independiente,o
182,0211-699501013259,de,o
182,0211-699501013259,morbimortalidad,o
182,0211-699501013259,cardiovascular,i
182,0211-699501013259,Hemos,o
182,0211-699501013259,intentado,o
182,0211-699501013259,prospectivamente,o
182,0211-699501013259,reducir,o
182,0211-699501013259,los,o
182,0211-699501013259,niveles,i
182,0211-699501013259,de,i
182,0211-699501013259,homocisteina,i
182,0211-699501013259,total,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,mediante,o
182,0211-699501013259,suplemento,o
182,0211-699501013259,con,o
182,0211-699501013259,acido,i
182,0211-699501013259,folico,i
182,0211-699501013259,y,o
182,0211-699501013259,vitamina,i
182,0211-699501013259,B6,i
182,0211-699501013259,pp,i
182,0211-699501013259,valorando,o
182,0211-699501013259,su,o
182,0211-699501013259,posible,o
182,0211-699501013259,correlacion,o
182,0211-699501013259,con,o
182,0211-699501013259,dosis,o
182,0211-699501013259,de,o
182,0211-699501013259,dialisis,i
182,0211-699501013259,funcion,i
182,0211-699501013259,residual,i
182,0211-699501013259,y,o
182,0211-699501013259,parametros,o
182,0211-699501013259,nutricionales,o
182,0211-699501013259,Metodos,o
182,0211-699501013259,Todos,o
182,0211-699501013259,los,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,en,o
182,0211-699501013259,hemodialisis,i
182,0211-699501013259,al,o
182,0211-699501013259,comienzo,o
182,0211-699501013259,del,o
182,0211-699501013259,estudio,o
182,0211-699501013259,que,o
182,0211-699501013259,no,o
182,0211-699501013259,recibian,o
182,0211-699501013259,acido,i
182,0211-699501013259,folico,i
182,0211-699501013259,ni,o
182,0211-699501013259,vitamina,i
182,0211-699501013259,B6,i
182,0211-699501013259,asi,o
182,0211-699501013259,como,o
182,0211-699501013259,los,o
182,0211-699501013259,incorporados,o
182,0211-699501013259,posteriormente,o
182,0211-699501013259,a,o
182,0211-699501013259,partir,o
182,0211-699501013259,de,o
182,0211-699501013259,su,o
182,0211-699501013259,tercer,o
182,0211-699501013259,mes,o
182,0211-699501013259,en,o
182,0211-699501013259,hemodialisis,i
182,0211-699501013259,recibieron,o
182,0211-699501013259,5,o
182,0211-699501013259,mg,o
182,0211-699501013259,orales,o
182,0211-699501013259,de,o
182,0211-699501013259,acido,i
182,0211-699501013259,folico,i
182,0211-699501013259,cada,o
182,0211-699501013259,48,o
182,0211-699501013259,horas,o
182,0211-699501013259,y,o
182,0211-699501013259,40,o
182,0211-699501013259,mg,o
182,0211-699501013259,orales,o
182,0211-699501013259,de,o
182,0211-699501013259,vitamina,i
182,0211-699501013259,B6,i
182,0211-699501013259,cada,o
182,0211-699501013259,semana,o
182,0211-699501013259,Se,o
182,0211-699501013259,determinaron,o
182,0211-699501013259,al,o
182,0211-699501013259,comienzo,o
182,0211-699501013259,del,o
182,0211-699501013259,estudio,o
182,0211-699501013259,y,o
182,0211-699501013259,cada,o
182,0211-699501013259,2,o
182,0211-699501013259,meses,o
182,0211-699501013259,niveles,i
182,0211-699501013259,de,i
182,0211-699501013259,folato,i
182,0211-699501013259,vitamina,i
182,0211-699501013259,B12,i
182,0211-699501013259,inmunoensayo,i
182,0211-699501013259,albumina,i
182,0211-699501013259,y,o
182,0211-699501013259,cinetica,o
182,0211-699501013259,de,o
182,0211-699501013259,la,o
182,0211-699501013259,urea,i
182,0211-699501013259,KTV,o
182,0211-699501013259,KRU,o
182,0211-699501013259,PCRn,o
182,0211-699501013259,y,o
182,0211-699501013259,cada,o
182,0211-699501013259,6,o
182,0211-699501013259,meses,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,HPLC,i
182,0211-699501013259,y,o
182,0211-699501013259,pp,i
182,0211-699501013259,RIA,i
182,0211-699501013259,Resultados,o
182,0211-699501013259,80,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,fueron,o
182,0211-699501013259,incluidos,o
182,0211-699501013259,en,o
182,0211-699501013259,el,o
182,0211-699501013259,estudio,o
182,0211-699501013259,basal,o
182,0211-699501013259,con,o
182,0211-699501013259,una,o
182,0211-699501013259,prevalencia,o
182,0211-699501013259,de,o
182,0211-699501013259,hiperhomocisteinemia,i
182,0211-699501013259,del,o
182,0211-699501013259,844,o
182,0211-699501013259,deficit,i
182,0211-699501013259,de,i
182,0211-699501013259,pp,i
182,0211-699501013259,en,o
182,0211-699501013259,el,o
182,0211-699501013259,32,o
182,0211-699501013259,y,o
182,0211-699501013259,folato,i
182,0211-699501013259,en,o
182,0211-699501013259,el,o
182,0211-699501013259,rango,o
182,0211-699501013259,normal,o
182,0211-699501013259,bajo,o
182,0211-699501013259,los,o
182,0211-699501013259,niveles,i
182,0211-699501013259,de,i
182,0211-699501013259,tHcy,i
182,0211-699501013259,se,o
182,0211-699501013259,correlacionaban,o
182,0211-699501013259,inversamente,o
182,0211-699501013259,con,o
182,0211-699501013259,los,o
182,0211-699501013259,del,o
182,0211-699501013259,folato,i
182,0211-699501013259,r,o
182,0211-699501013259,0336,o
182,0211-699501013259,p,o
182,0211-699501013259,001,o
182,0211-699501013259,pero,o
182,0211-699501013259,no,o
182,0211-699501013259,con,o
182,0211-699501013259,pp,i
182,0211-699501013259,B12,i
182,0211-699501013259,edad,o
182,0211-699501013259,albumina,i
182,0211-699501013259,KTV,o
182,0211-699501013259,KRU,o
182,0211-699501013259,PCRn,o
182,0211-699501013259,Cincuenta,o
182,0211-699501013259,y,o
182,0211-699501013259,ocho,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,recibieron,o
182,0211-699501013259,seis,o
182,0211-699501013259,meses,o
182,0211-699501013259,de,o
182,0211-699501013259,suplementacion,i
182,0211-699501013259,con,o
182,0211-699501013259,normalizacion,o
182,0211-699501013259,del,o
182,0211-699501013259,pp,i
182,0211-699501013259,aumento,o
182,0211-699501013259,del,o
182,0211-699501013259,folato,i
182,0211-699501013259,703,o
182,0211-699501013259,IC,o
182,0211-699501013259,638,o
182,0211-699501013259,795,o
182,0211-699501013259,vs,o
182,0211-699501013259,6181,o
182,0211-699501013259,IC,o
182,0211-699501013259,4447,o
182,0211-699501013259,7811,o
182,0211-699501013259,p,o
182,0211-699501013259,0001,o
182,0211-699501013259,y,o
182,0211-699501013259,descenso,o
182,0211-699501013259,de,o
182,0211-699501013259,la,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,240,o
182,0211-699501013259,IC,o
182,0211-699501013259,213,o
182,0211-699501013259,264,o
182,0211-699501013259,vs,o
182,0211-699501013259,199,o
182,0211-699501013259,IC,o
182,0211-699501013259,175,o
182,0211-699501013259,224,o
182,0211-699501013259,p,o
182,0211-699501013259,005,o
182,0211-699501013259,Han,o
182,0211-699501013259,recibido,o
182,0211-699501013259,suplementacion,i
182,0211-699501013259,durante,o
182,0211-699501013259,12,o
182,0211-699501013259,meses,o
182,0211-699501013259,33,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,pero,o
182,0211-699501013259,a,o
182,0211-699501013259,pesar,o
182,0211-699501013259,de,o
182,0211-699501013259,un,o
182,0211-699501013259,continuo,o
182,0211-699501013259,aumento,o
182,0211-699501013259,del,o
182,0211-699501013259,folato,i
182,0211-699501013259,10078,o
182,0211-699501013259,IC,o
182,0211-699501013259,7481,o
182,0211-699501013259,12674,o
182,0211-699501013259,p,o
182,0211-699501013259,0001,o
182,0211-699501013259,solo,o
182,0211-699501013259,3,o
182,0211-699501013259,pacientes,o
182,0211-699501013259,presentan,o
182,0211-699501013259,niveles,o
182,0211-699501013259,normales,o
182,0211-699501013259,de,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,correlacionandose,o
182,0211-699501013259,directamente,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,con,o
182,0211-699501013259,la,o
182,0211-699501013259,albumina,i
182,0211-699501013259,r,o
182,0211-699501013259,056,o
182,0211-699501013259,p,o
182,0211-699501013259,0001,o
182,0211-699501013259,que,o
182,0211-699501013259,se,o
182,0211-699501013259,elevo,o
182,0211-699501013259,con,o
182,0211-699501013259,respecto,o
182,0211-699501013259,al,o
182,0211-699501013259,inicio,o
182,0211-699501013259,337,o
182,0211-699501013259,IC,o
182,0211-699501013259,327,o
182,0211-699501013259,346,o
182,0211-699501013259,vs,o
182,0211-699501013259,350,o
182,0211-699501013259,IC,o
182,0211-699501013259,337,o
182,0211-699501013259,363,o
182,0211-699501013259,p,o
182,0211-699501013259,005,o
182,0211-699501013259,Conclusion,o
182,0211-699501013259,Tras,o
182,0211-699501013259,suplementacion,i
182,0211-699501013259,con,o
182,0211-699501013259,acido,i
182,0211-699501013259,folico,i
182,0211-699501013259,y,o
182,0211-699501013259,vitamina,i
182,0211-699501013259,B6,i
182,0211-699501013259,aunque,o
182,0211-699501013259,inicialmente,o
182,0211-699501013259,se,o
182,0211-699501013259,reduce,o
182,0211-699501013259,la,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,esta,o
182,0211-699501013259,respuesta,o
182,0211-699501013259,se,o
182,0211-699501013259,hace,o
182,0211-699501013259,refractaria,o
182,0211-699501013259,correlacionandose,o
182,0211-699501013259,directamente,o
182,0211-699501013259,la,o
182,0211-699501013259,tHcy,i
182,0211-699501013259,con,o
182,0211-699501013259,la,o
182,0211-699501013259,albumina,i
182,0211-699501013259,plasmatica,i
182,0211-699501013259,La,o
182,0211-699501013259,interpretacion,o
182,0211-699501013259,de,o
182,0211-699501013259,los,o
182,0211-699501013259,niveles,i
182,0211-699501013259,de,i
182,0211-699501013259,tHcy,i
182,0211-699501013259,debe,o
182,0211-699501013259,tener,o
182,0211-699501013259,en,o
182,0211-699501013259,cuenta,o
182,0211-699501013259,la,o
182,0211-699501013259,concentracion,i
182,0211-699501013259,de,i
182,0211-699501013259,albumina,i
183,0211-699501013259,Efecto,o
183,0211-699501013259,de,o
183,0211-699501013259,la,o
183,0211-699501013259,suplementacion,i
183,0211-699501013259,con,o
183,0211-699501013259,acido,i
183,0211-699501013259,folico,i
183,0211-699501013259,sobre,o
183,0211-699501013259,los,o
183,0211-699501013259,niveles,i
183,0211-699501013259,de,i
183,0211-699501013259,homocisteina,i
183,0211-699501013259,total,o
183,0211-699501013259,en,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,en,o
183,0211-699501013259,hemodialisis,i
183,0211-699501013259,La,o
183,0211-699501013259,hiperhomocisteinemia,i
183,0211-699501013259,es,o
183,0211-699501013259,un,o
183,0211-699501013259,marcador,o
183,0211-699501013259,de,o
183,0211-699501013259,riesgo,o
183,0211-699501013259,independiente,o
183,0211-699501013259,de,o
183,0211-699501013259,morbimortalidad,o
183,0211-699501013259,cardiovascular,i
183,0211-699501013259,Hemos,o
183,0211-699501013259,intentado,o
183,0211-699501013259,prospectivamente,o
183,0211-699501013259,reducir,o
183,0211-699501013259,los,o
183,0211-699501013259,niveles,i
183,0211-699501013259,de,i
183,0211-699501013259,homocisteina,i
183,0211-699501013259,total,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,mediante,o
183,0211-699501013259,suplemento,o
183,0211-699501013259,con,o
183,0211-699501013259,acido,i
183,0211-699501013259,folico,i
183,0211-699501013259,y,o
183,0211-699501013259,vitamina,i
183,0211-699501013259,B6,i
183,0211-699501013259,pp,i
183,0211-699501013259,valorando,o
183,0211-699501013259,su,o
183,0211-699501013259,posible,o
183,0211-699501013259,correlacion,o
183,0211-699501013259,con,o
183,0211-699501013259,dosis,o
183,0211-699501013259,de,o
183,0211-699501013259,dialisis,i
183,0211-699501013259,funcion,i
183,0211-699501013259,residual,i
183,0211-699501013259,y,o
183,0211-699501013259,parametros,o
183,0211-699501013259,nutricionales,o
183,0211-699501013259,Metodos,o
183,0211-699501013259,Todos,o
183,0211-699501013259,los,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,en,o
183,0211-699501013259,hemodialisis,i
183,0211-699501013259,al,o
183,0211-699501013259,comienzo,o
183,0211-699501013259,del,o
183,0211-699501013259,estudio,o
183,0211-699501013259,que,o
183,0211-699501013259,no,o
183,0211-699501013259,recibian,o
183,0211-699501013259,acido,i
183,0211-699501013259,folico,i
183,0211-699501013259,ni,o
183,0211-699501013259,vitamina,i
183,0211-699501013259,B6,i
183,0211-699501013259,asi,o
183,0211-699501013259,como,o
183,0211-699501013259,los,o
183,0211-699501013259,incorporados,o
183,0211-699501013259,posteriormente,o
183,0211-699501013259,a,o
183,0211-699501013259,partir,o
183,0211-699501013259,de,o
183,0211-699501013259,su,o
183,0211-699501013259,tercer,o
183,0211-699501013259,mes,o
183,0211-699501013259,en,o
183,0211-699501013259,hemodialisis,i
183,0211-699501013259,recibieron,o
183,0211-699501013259,5,o
183,0211-699501013259,mg,o
183,0211-699501013259,orales,o
183,0211-699501013259,de,o
183,0211-699501013259,acido,i
183,0211-699501013259,folico,i
183,0211-699501013259,cada,o
183,0211-699501013259,48,o
183,0211-699501013259,horas,o
183,0211-699501013259,y,o
183,0211-699501013259,40,o
183,0211-699501013259,mg,o
183,0211-699501013259,orales,o
183,0211-699501013259,de,o
183,0211-699501013259,vitamina,i
183,0211-699501013259,B6,i
183,0211-699501013259,cada,o
183,0211-699501013259,semana,o
183,0211-699501013259,Se,o
183,0211-699501013259,determinaron,o
183,0211-699501013259,al,o
183,0211-699501013259,comienzo,o
183,0211-699501013259,del,o
183,0211-699501013259,estudio,o
183,0211-699501013259,y,o
183,0211-699501013259,cada,o
183,0211-699501013259,2,o
183,0211-699501013259,meses,o
183,0211-699501013259,niveles,i
183,0211-699501013259,de,i
183,0211-699501013259,folato,i
183,0211-699501013259,vitamina,i
183,0211-699501013259,B12,i
183,0211-699501013259,inmunoensayo,i
183,0211-699501013259,albumina,i
183,0211-699501013259,y,o
183,0211-699501013259,cinetica,o
183,0211-699501013259,de,o
183,0211-699501013259,la,o
183,0211-699501013259,urea,i
183,0211-699501013259,KTV,o
183,0211-699501013259,KRU,o
183,0211-699501013259,PCRn,o
183,0211-699501013259,y,o
183,0211-699501013259,cada,o
183,0211-699501013259,6,o
183,0211-699501013259,meses,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,HPLC,i
183,0211-699501013259,y,o
183,0211-699501013259,pp,i
183,0211-699501013259,RIA,i
183,0211-699501013259,Resultados,o
183,0211-699501013259,80,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,fueron,o
183,0211-699501013259,incluidos,o
183,0211-699501013259,en,o
183,0211-699501013259,el,o
183,0211-699501013259,estudio,o
183,0211-699501013259,basal,o
183,0211-699501013259,con,o
183,0211-699501013259,una,o
183,0211-699501013259,prevalencia,o
183,0211-699501013259,de,o
183,0211-699501013259,hiperhomocisteinemia,i
183,0211-699501013259,del,o
183,0211-699501013259,844,o
183,0211-699501013259,deficit,i
183,0211-699501013259,de,i
183,0211-699501013259,pp,i
183,0211-699501013259,en,o
183,0211-699501013259,el,o
183,0211-699501013259,32,o
183,0211-699501013259,y,o
183,0211-699501013259,folato,i
183,0211-699501013259,en,o
183,0211-699501013259,el,o
183,0211-699501013259,rango,o
183,0211-699501013259,normal,o
183,0211-699501013259,bajo,o
183,0211-699501013259,los,o
183,0211-699501013259,niveles,i
183,0211-699501013259,de,i
183,0211-699501013259,tHcy,i
183,0211-699501013259,se,o
183,0211-699501013259,correlacionaban,o
183,0211-699501013259,inversamente,o
183,0211-699501013259,con,o
183,0211-699501013259,los,o
183,0211-699501013259,del,o
183,0211-699501013259,folato,i
183,0211-699501013259,r,o
183,0211-699501013259,0336,o
183,0211-699501013259,p,o
183,0211-699501013259,001,o
183,0211-699501013259,pero,o
183,0211-699501013259,no,o
183,0211-699501013259,con,o
183,0211-699501013259,pp,i
183,0211-699501013259,B12,i
183,0211-699501013259,edad,o
183,0211-699501013259,albumina,i
183,0211-699501013259,KTV,o
183,0211-699501013259,KRU,o
183,0211-699501013259,PCRn,o
183,0211-699501013259,Cincuenta,o
183,0211-699501013259,y,o
183,0211-699501013259,ocho,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,recibieron,o
183,0211-699501013259,seis,o
183,0211-699501013259,meses,o
183,0211-699501013259,de,o
183,0211-699501013259,suplementacion,i
183,0211-699501013259,con,o
183,0211-699501013259,normalizacion,o
183,0211-699501013259,del,o
183,0211-699501013259,pp,i
183,0211-699501013259,aumento,o
183,0211-699501013259,del,o
183,0211-699501013259,folato,i
183,0211-699501013259,703,o
183,0211-699501013259,IC,o
183,0211-699501013259,638,o
183,0211-699501013259,795,o
183,0211-699501013259,vs,o
183,0211-699501013259,6181,o
183,0211-699501013259,IC,o
183,0211-699501013259,4447,o
183,0211-699501013259,7811,o
183,0211-699501013259,p,o
183,0211-699501013259,0001,o
183,0211-699501013259,y,o
183,0211-699501013259,descenso,o
183,0211-699501013259,de,o
183,0211-699501013259,la,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,240,o
183,0211-699501013259,IC,o
183,0211-699501013259,213,o
183,0211-699501013259,264,o
183,0211-699501013259,vs,o
183,0211-699501013259,199,o
183,0211-699501013259,IC,o
183,0211-699501013259,175,o
183,0211-699501013259,224,o
183,0211-699501013259,p,o
183,0211-699501013259,005,o
183,0211-699501013259,Han,o
183,0211-699501013259,recibido,o
183,0211-699501013259,suplementacion,i
183,0211-699501013259,durante,o
183,0211-699501013259,12,o
183,0211-699501013259,meses,o
183,0211-699501013259,33,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,pero,o
183,0211-699501013259,a,o
183,0211-699501013259,pesar,o
183,0211-699501013259,de,o
183,0211-699501013259,un,o
183,0211-699501013259,continuo,o
183,0211-699501013259,aumento,o
183,0211-699501013259,del,o
183,0211-699501013259,folato,i
183,0211-699501013259,10078,o
183,0211-699501013259,IC,o
183,0211-699501013259,7481,o
183,0211-699501013259,12674,o
183,0211-699501013259,p,o
183,0211-699501013259,0001,o
183,0211-699501013259,solo,o
183,0211-699501013259,3,o
183,0211-699501013259,pacientes,o
183,0211-699501013259,presentan,o
183,0211-699501013259,niveles,o
183,0211-699501013259,normales,o
183,0211-699501013259,de,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,correlacionandose,o
183,0211-699501013259,directamente,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,con,o
183,0211-699501013259,la,o
183,0211-699501013259,albumina,i
183,0211-699501013259,r,o
183,0211-699501013259,056,o
183,0211-699501013259,p,o
183,0211-699501013259,0001,o
183,0211-699501013259,que,o
183,0211-699501013259,se,o
183,0211-699501013259,elevo,o
183,0211-699501013259,con,o
183,0211-699501013259,respecto,o
183,0211-699501013259,al,o
183,0211-699501013259,inicio,o
183,0211-699501013259,337,o
183,0211-699501013259,IC,o
183,0211-699501013259,327,o
183,0211-699501013259,346,o
183,0211-699501013259,vs,o
183,0211-699501013259,350,o
183,0211-699501013259,IC,o
183,0211-699501013259,337,o
183,0211-699501013259,363,o
183,0211-699501013259,p,o
183,0211-699501013259,005,o
183,0211-699501013259,Conclusion,o
183,0211-699501013259,Tras,o
183,0211-699501013259,suplementacion,i
183,0211-699501013259,con,o
183,0211-699501013259,acido,i
183,0211-699501013259,folico,i
183,0211-699501013259,y,o
183,0211-699501013259,vitamina,i
183,0211-699501013259,B6,i
183,0211-699501013259,aunque,o
183,0211-699501013259,inicialmente,o
183,0211-699501013259,se,o
183,0211-699501013259,reduce,o
183,0211-699501013259,la,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,esta,o
183,0211-699501013259,respuesta,o
183,0211-699501013259,se,o
183,0211-699501013259,hace,o
183,0211-699501013259,refractaria,o
183,0211-699501013259,correlacionandose,o
183,0211-699501013259,directamente,o
183,0211-699501013259,la,o
183,0211-699501013259,tHcy,i
183,0211-699501013259,con,o
183,0211-699501013259,la,o
183,0211-699501013259,albumina,i
183,0211-699501013259,plasmatica,i
183,0211-699501013259,La,o
183,0211-699501013259,interpretacion,o
183,0211-699501013259,de,o
183,0211-699501013259,los,o
183,0211-699501013259,niveles,i
183,0211-699501013259,de,i
183,0211-699501013259,tHcy,i
183,0211-699501013259,debe,o
183,0211-699501013259,tener,o
183,0211-699501013259,en,o
183,0211-699501013259,cuenta,o
183,0211-699501013259,la,o
183,0211-699501013259,concentracion,i
183,0211-699501013259,de,i
183,0211-699501013259,albumina,i
184,0211-699501013259,Efecto,o
184,0211-699501013259,de,o
184,0211-699501013259,la,o
184,0211-699501013259,suplementacion,i
184,0211-699501013259,con,o
184,0211-699501013259,acido,i
184,0211-699501013259,folico,i
184,0211-699501013259,sobre,o
184,0211-699501013259,los,o
184,0211-699501013259,niveles,i
184,0211-699501013259,de,i
184,0211-699501013259,homocisteina,i
184,0211-699501013259,total,o
184,0211-699501013259,en,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,en,o
184,0211-699501013259,hemodialisis,i
184,0211-699501013259,La,o
184,0211-699501013259,hiperhomocisteinemia,i
184,0211-699501013259,es,o
184,0211-699501013259,un,o
184,0211-699501013259,marcador,o
184,0211-699501013259,de,o
184,0211-699501013259,riesgo,o
184,0211-699501013259,independiente,o
184,0211-699501013259,de,o
184,0211-699501013259,morbimortalidad,o
184,0211-699501013259,cardiovascular,i
184,0211-699501013259,Hemos,o
184,0211-699501013259,intentado,o
184,0211-699501013259,prospectivamente,o
184,0211-699501013259,reducir,o
184,0211-699501013259,los,o
184,0211-699501013259,niveles,i
184,0211-699501013259,de,i
184,0211-699501013259,homocisteina,i
184,0211-699501013259,total,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,mediante,o
184,0211-699501013259,suplemento,o
184,0211-699501013259,con,o
184,0211-699501013259,acido,i
184,0211-699501013259,folico,i
184,0211-699501013259,y,o
184,0211-699501013259,vitamina,i
184,0211-699501013259,B6,i
184,0211-699501013259,pp,i
184,0211-699501013259,valorando,o
184,0211-699501013259,su,o
184,0211-699501013259,posible,o
184,0211-699501013259,correlacion,o
184,0211-699501013259,con,o
184,0211-699501013259,dosis,o
184,0211-699501013259,de,o
184,0211-699501013259,dialisis,i
184,0211-699501013259,funcion,i
184,0211-699501013259,residual,i
184,0211-699501013259,y,o
184,0211-699501013259,parametros,o
184,0211-699501013259,nutricionales,o
184,0211-699501013259,Metodos,o
184,0211-699501013259,Todos,o
184,0211-699501013259,los,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,en,o
184,0211-699501013259,hemodialisis,i
184,0211-699501013259,al,o
184,0211-699501013259,comienzo,o
184,0211-699501013259,del,o
184,0211-699501013259,estudio,o
184,0211-699501013259,que,o
184,0211-699501013259,no,o
184,0211-699501013259,recibian,o
184,0211-699501013259,acido,i
184,0211-699501013259,folico,i
184,0211-699501013259,ni,o
184,0211-699501013259,vitamina,i
184,0211-699501013259,B6,i
184,0211-699501013259,asi,o
184,0211-699501013259,como,o
184,0211-699501013259,los,o
184,0211-699501013259,incorporados,o
184,0211-699501013259,posteriormente,o
184,0211-699501013259,a,o
184,0211-699501013259,partir,o
184,0211-699501013259,de,o
184,0211-699501013259,su,o
184,0211-699501013259,tercer,o
184,0211-699501013259,mes,o
184,0211-699501013259,en,o
184,0211-699501013259,hemodialisis,i
184,0211-699501013259,recibieron,o
184,0211-699501013259,5,o
184,0211-699501013259,mg,o
184,0211-699501013259,orales,o
184,0211-699501013259,de,o
184,0211-699501013259,acido,i
184,0211-699501013259,folico,i
184,0211-699501013259,cada,o
184,0211-699501013259,48,o
184,0211-699501013259,horas,o
184,0211-699501013259,y,o
184,0211-699501013259,40,o
184,0211-699501013259,mg,o
184,0211-699501013259,orales,o
184,0211-699501013259,de,o
184,0211-699501013259,vitamina,i
184,0211-699501013259,B6,i
184,0211-699501013259,cada,o
184,0211-699501013259,semana,o
184,0211-699501013259,Se,o
184,0211-699501013259,determinaron,o
184,0211-699501013259,al,o
184,0211-699501013259,comienzo,o
184,0211-699501013259,del,o
184,0211-699501013259,estudio,o
184,0211-699501013259,y,o
184,0211-699501013259,cada,o
184,0211-699501013259,2,o
184,0211-699501013259,meses,o
184,0211-699501013259,niveles,i
184,0211-699501013259,de,i
184,0211-699501013259,folato,i
184,0211-699501013259,vitamina,i
184,0211-699501013259,B12,i
184,0211-699501013259,inmunoensayo,i
184,0211-699501013259,albumina,i
184,0211-699501013259,y,o
184,0211-699501013259,cinetica,o
184,0211-699501013259,de,o
184,0211-699501013259,la,o
184,0211-699501013259,urea,i
184,0211-699501013259,KTV,o
184,0211-699501013259,KRU,o
184,0211-699501013259,PCRn,o
184,0211-699501013259,y,o
184,0211-699501013259,cada,o
184,0211-699501013259,6,o
184,0211-699501013259,meses,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,HPLC,i
184,0211-699501013259,y,o
184,0211-699501013259,pp,i
184,0211-699501013259,RIA,i
184,0211-699501013259,Resultados,o
184,0211-699501013259,80,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,fueron,o
184,0211-699501013259,incluidos,o
184,0211-699501013259,en,o
184,0211-699501013259,el,o
184,0211-699501013259,estudio,o
184,0211-699501013259,basal,o
184,0211-699501013259,con,o
184,0211-699501013259,una,o
184,0211-699501013259,prevalencia,o
184,0211-699501013259,de,o
184,0211-699501013259,hiperhomocisteinemia,i
184,0211-699501013259,del,o
184,0211-699501013259,844,o
184,0211-699501013259,deficit,i
184,0211-699501013259,de,i
184,0211-699501013259,pp,i
184,0211-699501013259,en,o
184,0211-699501013259,el,o
184,0211-699501013259,32,o
184,0211-699501013259,y,o
184,0211-699501013259,folato,i
184,0211-699501013259,en,o
184,0211-699501013259,el,o
184,0211-699501013259,rango,o
184,0211-699501013259,normal,o
184,0211-699501013259,bajo,o
184,0211-699501013259,los,o
184,0211-699501013259,niveles,i
184,0211-699501013259,de,i
184,0211-699501013259,tHcy,i
184,0211-699501013259,se,o
184,0211-699501013259,correlacionaban,o
184,0211-699501013259,inversamente,o
184,0211-699501013259,con,o
184,0211-699501013259,los,o
184,0211-699501013259,del,o
184,0211-699501013259,folato,i
184,0211-699501013259,r,o
184,0211-699501013259,0336,o
184,0211-699501013259,p,o
184,0211-699501013259,001,o
184,0211-699501013259,pero,o
184,0211-699501013259,no,o
184,0211-699501013259,con,o
184,0211-699501013259,pp,i
184,0211-699501013259,B12,i
184,0211-699501013259,edad,o
184,0211-699501013259,albumina,i
184,0211-699501013259,KTV,o
184,0211-699501013259,KRU,o
184,0211-699501013259,PCRn,o
184,0211-699501013259,Cincuenta,o
184,0211-699501013259,y,o
184,0211-699501013259,ocho,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,recibieron,o
184,0211-699501013259,seis,o
184,0211-699501013259,meses,o
184,0211-699501013259,de,o
184,0211-699501013259,suplementacion,i
184,0211-699501013259,con,o
184,0211-699501013259,normalizacion,o
184,0211-699501013259,del,o
184,0211-699501013259,pp,i
184,0211-699501013259,aumento,o
184,0211-699501013259,del,o
184,0211-699501013259,folato,i
184,0211-699501013259,703,o
184,0211-699501013259,IC,o
184,0211-699501013259,638,o
184,0211-699501013259,795,o
184,0211-699501013259,vs,o
184,0211-699501013259,6181,o
184,0211-699501013259,IC,o
184,0211-699501013259,4447,o
184,0211-699501013259,7811,o
184,0211-699501013259,p,o
184,0211-699501013259,0001,o
184,0211-699501013259,y,o
184,0211-699501013259,descenso,o
184,0211-699501013259,de,o
184,0211-699501013259,la,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,240,o
184,0211-699501013259,IC,o
184,0211-699501013259,213,o
184,0211-699501013259,264,o
184,0211-699501013259,vs,o
184,0211-699501013259,199,o
184,0211-699501013259,IC,o
184,0211-699501013259,175,o
184,0211-699501013259,224,o
184,0211-699501013259,p,o
184,0211-699501013259,005,o
184,0211-699501013259,Han,o
184,0211-699501013259,recibido,o
184,0211-699501013259,suplementacion,i
184,0211-699501013259,durante,o
184,0211-699501013259,12,o
184,0211-699501013259,meses,o
184,0211-699501013259,33,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,pero,o
184,0211-699501013259,a,o
184,0211-699501013259,pesar,o
184,0211-699501013259,de,o
184,0211-699501013259,un,o
184,0211-699501013259,continuo,o
184,0211-699501013259,aumento,o
184,0211-699501013259,del,o
184,0211-699501013259,folato,i
184,0211-699501013259,10078,o
184,0211-699501013259,IC,o
184,0211-699501013259,7481,o
184,0211-699501013259,12674,o
184,0211-699501013259,p,o
184,0211-699501013259,0001,o
184,0211-699501013259,solo,o
184,0211-699501013259,3,o
184,0211-699501013259,pacientes,o
184,0211-699501013259,presentan,o
184,0211-699501013259,niveles,o
184,0211-699501013259,normales,o
184,0211-699501013259,de,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,correlacionandose,o
184,0211-699501013259,directamente,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,con,o
184,0211-699501013259,la,o
184,0211-699501013259,albumina,i
184,0211-699501013259,r,o
184,0211-699501013259,056,o
184,0211-699501013259,p,o
184,0211-699501013259,0001,o
184,0211-699501013259,que,o
184,0211-699501013259,se,o
184,0211-699501013259,elevo,o
184,0211-699501013259,con,o
184,0211-699501013259,respecto,o
184,0211-699501013259,al,o
184,0211-699501013259,inicio,o
184,0211-699501013259,337,o
184,0211-699501013259,IC,o
184,0211-699501013259,327,o
184,0211-699501013259,346,o
184,0211-699501013259,vs,o
184,0211-699501013259,350,o
184,0211-699501013259,IC,o
184,0211-699501013259,337,o
184,0211-699501013259,363,o
184,0211-699501013259,p,o
184,0211-699501013259,005,o
184,0211-699501013259,Conclusion,o
184,0211-699501013259,Tras,o
184,0211-699501013259,suplementacion,i
184,0211-699501013259,con,o
184,0211-699501013259,acido,i
184,0211-699501013259,folico,i
184,0211-699501013259,y,o
184,0211-699501013259,vitamina,i
184,0211-699501013259,B6,i
184,0211-699501013259,aunque,o
184,0211-699501013259,inicialmente,o
184,0211-699501013259,se,o
184,0211-699501013259,reduce,o
184,0211-699501013259,la,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,esta,o
184,0211-699501013259,respuesta,o
184,0211-699501013259,se,o
184,0211-699501013259,hace,o
184,0211-699501013259,refractaria,o
184,0211-699501013259,correlacionandose,o
184,0211-699501013259,directamente,o
184,0211-699501013259,la,o
184,0211-699501013259,tHcy,i
184,0211-699501013259,con,o
184,0211-699501013259,la,o
184,0211-699501013259,albumina,i
184,0211-699501013259,plasmatica,i
184,0211-699501013259,La,o
184,0211-699501013259,interpretacion,o
184,0211-699501013259,de,o
184,0211-699501013259,los,o
184,0211-699501013259,niveles,i
184,0211-699501013259,de,i
184,0211-699501013259,tHcy,i
184,0211-699501013259,debe,o
184,0211-699501013259,tener,o
184,0211-699501013259,en,o
184,0211-699501013259,cuenta,o
184,0211-699501013259,la,o
184,0211-699501013259,concentracion,i
184,0211-699501013259,de,i
184,0211-699501013259,albumina,i
185,0211-699501013259,Efecto,o
185,0211-699501013259,de,o
185,0211-699501013259,la,o
185,0211-699501013259,suplementacion,i
185,0211-699501013259,con,o
185,0211-699501013259,acido,i
185,0211-699501013259,folico,i
185,0211-699501013259,sobre,o
185,0211-699501013259,los,o
185,0211-699501013259,niveles,i
185,0211-699501013259,de,i
185,0211-699501013259,homocisteina,i
185,0211-699501013259,total,o
185,0211-699501013259,en,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,en,o
185,0211-699501013259,hemodialisis,i
185,0211-699501013259,La,o
185,0211-699501013259,hiperhomocisteinemia,i
185,0211-699501013259,es,o
185,0211-699501013259,un,o
185,0211-699501013259,marcador,o
185,0211-699501013259,de,o
185,0211-699501013259,riesgo,o
185,0211-699501013259,independiente,o
185,0211-699501013259,de,o
185,0211-699501013259,morbimortalidad,o
185,0211-699501013259,cardiovascular,i
185,0211-699501013259,Hemos,o
185,0211-699501013259,intentado,o
185,0211-699501013259,prospectivamente,o
185,0211-699501013259,reducir,o
185,0211-699501013259,los,o
185,0211-699501013259,niveles,i
185,0211-699501013259,de,i
185,0211-699501013259,homocisteina,i
185,0211-699501013259,total,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,mediante,o
185,0211-699501013259,suplemento,o
185,0211-699501013259,con,o
185,0211-699501013259,acido,i
185,0211-699501013259,folico,i
185,0211-699501013259,y,o
185,0211-699501013259,vitamina,i
185,0211-699501013259,B6,i
185,0211-699501013259,pp,i
185,0211-699501013259,valorando,o
185,0211-699501013259,su,o
185,0211-699501013259,posible,o
185,0211-699501013259,correlacion,o
185,0211-699501013259,con,o
185,0211-699501013259,dosis,o
185,0211-699501013259,de,o
185,0211-699501013259,dialisis,i
185,0211-699501013259,funcion,i
185,0211-699501013259,residual,i
185,0211-699501013259,y,o
185,0211-699501013259,parametros,o
185,0211-699501013259,nutricionales,o
185,0211-699501013259,Metodos,o
185,0211-699501013259,Todos,o
185,0211-699501013259,los,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,en,o
185,0211-699501013259,hemodialisis,i
185,0211-699501013259,al,o
185,0211-699501013259,comienzo,o
185,0211-699501013259,del,o
185,0211-699501013259,estudio,o
185,0211-699501013259,que,o
185,0211-699501013259,no,o
185,0211-699501013259,recibian,o
185,0211-699501013259,acido,i
185,0211-699501013259,folico,i
185,0211-699501013259,ni,o
185,0211-699501013259,vitamina,i
185,0211-699501013259,B6,i
185,0211-699501013259,asi,o
185,0211-699501013259,como,o
185,0211-699501013259,los,o
185,0211-699501013259,incorporados,o
185,0211-699501013259,posteriormente,o
185,0211-699501013259,a,o
185,0211-699501013259,partir,o
185,0211-699501013259,de,o
185,0211-699501013259,su,o
185,0211-699501013259,tercer,o
185,0211-699501013259,mes,o
185,0211-699501013259,en,o
185,0211-699501013259,hemodialisis,i
185,0211-699501013259,recibieron,o
185,0211-699501013259,5,o
185,0211-699501013259,mg,o
185,0211-699501013259,orales,o
185,0211-699501013259,de,o
185,0211-699501013259,acido,i
185,0211-699501013259,folico,i
185,0211-699501013259,cada,o
185,0211-699501013259,48,o
185,0211-699501013259,horas,o
185,0211-699501013259,y,o
185,0211-699501013259,40,o
185,0211-699501013259,mg,o
185,0211-699501013259,orales,o
185,0211-699501013259,de,o
185,0211-699501013259,vitamina,i
185,0211-699501013259,B6,i
185,0211-699501013259,cada,o
185,0211-699501013259,semana,o
185,0211-699501013259,Se,o
185,0211-699501013259,determinaron,o
185,0211-699501013259,al,o
185,0211-699501013259,comienzo,o
185,0211-699501013259,del,o
185,0211-699501013259,estudio,o
185,0211-699501013259,y,o
185,0211-699501013259,cada,o
185,0211-699501013259,2,o
185,0211-699501013259,meses,o
185,0211-699501013259,niveles,i
185,0211-699501013259,de,i
185,0211-699501013259,folato,i
185,0211-699501013259,vitamina,i
185,0211-699501013259,B12,i
185,0211-699501013259,inmunoensayo,i
185,0211-699501013259,albumina,i
185,0211-699501013259,y,o
185,0211-699501013259,cinetica,o
185,0211-699501013259,de,o
185,0211-699501013259,la,o
185,0211-699501013259,urea,i
185,0211-699501013259,KTV,o
185,0211-699501013259,KRU,o
185,0211-699501013259,PCRn,o
185,0211-699501013259,y,o
185,0211-699501013259,cada,o
185,0211-699501013259,6,o
185,0211-699501013259,meses,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,HPLC,i
185,0211-699501013259,y,o
185,0211-699501013259,pp,i
185,0211-699501013259,RIA,i
185,0211-699501013259,Resultados,o
185,0211-699501013259,80,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,fueron,o
185,0211-699501013259,incluidos,o
185,0211-699501013259,en,o
185,0211-699501013259,el,o
185,0211-699501013259,estudio,o
185,0211-699501013259,basal,o
185,0211-699501013259,con,o
185,0211-699501013259,una,o
185,0211-699501013259,prevalencia,o
185,0211-699501013259,de,o
185,0211-699501013259,hiperhomocisteinemia,i
185,0211-699501013259,del,o
185,0211-699501013259,844,o
185,0211-699501013259,deficit,i
185,0211-699501013259,de,i
185,0211-699501013259,pp,i
185,0211-699501013259,en,o
185,0211-699501013259,el,o
185,0211-699501013259,32,o
185,0211-699501013259,y,o
185,0211-699501013259,folato,i
185,0211-699501013259,en,o
185,0211-699501013259,el,o
185,0211-699501013259,rango,o
185,0211-699501013259,normal,o
185,0211-699501013259,bajo,o
185,0211-699501013259,los,o
185,0211-699501013259,niveles,i
185,0211-699501013259,de,i
185,0211-699501013259,tHcy,i
185,0211-699501013259,se,o
185,0211-699501013259,correlacionaban,o
185,0211-699501013259,inversamente,o
185,0211-699501013259,con,o
185,0211-699501013259,los,o
185,0211-699501013259,del,o
185,0211-699501013259,folato,i
185,0211-699501013259,r,o
185,0211-699501013259,0336,o
185,0211-699501013259,p,o
185,0211-699501013259,001,o
185,0211-699501013259,pero,o
185,0211-699501013259,no,o
185,0211-699501013259,con,o
185,0211-699501013259,pp,i
185,0211-699501013259,B12,i
185,0211-699501013259,edad,o
185,0211-699501013259,albumina,i
185,0211-699501013259,KTV,o
185,0211-699501013259,KRU,o
185,0211-699501013259,PCRn,o
185,0211-699501013259,Cincuenta,o
185,0211-699501013259,y,o
185,0211-699501013259,ocho,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,recibieron,o
185,0211-699501013259,seis,o
185,0211-699501013259,meses,o
185,0211-699501013259,de,o
185,0211-699501013259,suplementacion,i
185,0211-699501013259,con,o
185,0211-699501013259,normalizacion,o
185,0211-699501013259,del,o
185,0211-699501013259,pp,i
185,0211-699501013259,aumento,o
185,0211-699501013259,del,o
185,0211-699501013259,folato,i
185,0211-699501013259,703,o
185,0211-699501013259,IC,o
185,0211-699501013259,638,o
185,0211-699501013259,795,o
185,0211-699501013259,vs,o
185,0211-699501013259,6181,o
185,0211-699501013259,IC,o
185,0211-699501013259,4447,o
185,0211-699501013259,7811,o
185,0211-699501013259,p,o
185,0211-699501013259,0001,o
185,0211-699501013259,y,o
185,0211-699501013259,descenso,o
185,0211-699501013259,de,o
185,0211-699501013259,la,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,240,o
185,0211-699501013259,IC,o
185,0211-699501013259,213,o
185,0211-699501013259,264,o
185,0211-699501013259,vs,o
185,0211-699501013259,199,o
185,0211-699501013259,IC,o
185,0211-699501013259,175,o
185,0211-699501013259,224,o
185,0211-699501013259,p,o
185,0211-699501013259,005,o
185,0211-699501013259,Han,o
185,0211-699501013259,recibido,o
185,0211-699501013259,suplementacion,i
185,0211-699501013259,durante,o
185,0211-699501013259,12,o
185,0211-699501013259,meses,o
185,0211-699501013259,33,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,pero,o
185,0211-699501013259,a,o
185,0211-699501013259,pesar,o
185,0211-699501013259,de,o
185,0211-699501013259,un,o
185,0211-699501013259,continuo,o
185,0211-699501013259,aumento,o
185,0211-699501013259,del,o
185,0211-699501013259,folato,i
185,0211-699501013259,10078,o
185,0211-699501013259,IC,o
185,0211-699501013259,7481,o
185,0211-699501013259,12674,o
185,0211-699501013259,p,o
185,0211-699501013259,0001,o
185,0211-699501013259,solo,o
185,0211-699501013259,3,o
185,0211-699501013259,pacientes,o
185,0211-699501013259,presentan,o
185,0211-699501013259,niveles,o
185,0211-699501013259,normales,o
185,0211-699501013259,de,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,correlacionandose,o
185,0211-699501013259,directamente,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,con,o
185,0211-699501013259,la,o
185,0211-699501013259,albumina,i
185,0211-699501013259,r,o
185,0211-699501013259,056,o
185,0211-699501013259,p,o
185,0211-699501013259,0001,o
185,0211-699501013259,que,o
185,0211-699501013259,se,o
185,0211-699501013259,elevo,o
185,0211-699501013259,con,o
185,0211-699501013259,respecto,o
185,0211-699501013259,al,o
185,0211-699501013259,inicio,o
185,0211-699501013259,337,o
185,0211-699501013259,IC,o
185,0211-699501013259,327,o
185,0211-699501013259,346,o
185,0211-699501013259,vs,o
185,0211-699501013259,350,o
185,0211-699501013259,IC,o
185,0211-699501013259,337,o
185,0211-699501013259,363,o
185,0211-699501013259,p,o
185,0211-699501013259,005,o
185,0211-699501013259,Conclusion,o
185,0211-699501013259,Tras,o
185,0211-699501013259,suplementacion,i
185,0211-699501013259,con,o
185,0211-699501013259,acido,i
185,0211-699501013259,folico,i
185,0211-699501013259,y,o
185,0211-699501013259,vitamina,i
185,0211-699501013259,B6,i
185,0211-699501013259,aunque,o
185,0211-699501013259,inicialmente,o
185,0211-699501013259,se,o
185,0211-699501013259,reduce,o
185,0211-699501013259,la,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,esta,o
185,0211-699501013259,respuesta,o
185,0211-699501013259,se,o
185,0211-699501013259,hace,o
185,0211-699501013259,refractaria,o
185,0211-699501013259,correlacionandose,o
185,0211-699501013259,directamente,o
185,0211-699501013259,la,o
185,0211-699501013259,tHcy,i
185,0211-699501013259,con,o
185,0211-699501013259,la,o
185,0211-699501013259,albumina,i
185,0211-699501013259,plasmatica,i
185,0211-699501013259,La,o
185,0211-699501013259,interpretacion,o
185,0211-699501013259,de,o
185,0211-699501013259,los,o
185,0211-699501013259,niveles,i
185,0211-699501013259,de,i
185,0211-699501013259,tHcy,i
185,0211-699501013259,debe,o
185,0211-699501013259,tener,o
185,0211-699501013259,en,o
185,0211-699501013259,cuenta,o
185,0211-699501013259,la,o
185,0211-699501013259,concentracion,i
185,0211-699501013259,de,i
185,0211-699501013259,albumina,i
186,0211-699501013259,Efecto,o
186,0211-699501013259,de,o
186,0211-699501013259,la,o
186,0211-699501013259,suplementacion,i
186,0211-699501013259,con,o
186,0211-699501013259,acido,i
186,0211-699501013259,folico,i
186,0211-699501013259,sobre,o
186,0211-699501013259,los,o
186,0211-699501013259,niveles,i
186,0211-699501013259,de,i
186,0211-699501013259,homocisteina,i
186,0211-699501013259,total,o
186,0211-699501013259,en,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,en,o
186,0211-699501013259,hemodialisis,i
186,0211-699501013259,La,o
186,0211-699501013259,hiperhomocisteinemia,i
186,0211-699501013259,es,o
186,0211-699501013259,un,o
186,0211-699501013259,marcador,o
186,0211-699501013259,de,o
186,0211-699501013259,riesgo,o
186,0211-699501013259,independiente,o
186,0211-699501013259,de,o
186,0211-699501013259,morbimortalidad,o
186,0211-699501013259,cardiovascular,i
186,0211-699501013259,Hemos,o
186,0211-699501013259,intentado,o
186,0211-699501013259,prospectivamente,o
186,0211-699501013259,reducir,o
186,0211-699501013259,los,o
186,0211-699501013259,niveles,i
186,0211-699501013259,de,i
186,0211-699501013259,homocisteina,i
186,0211-699501013259,total,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,mediante,o
186,0211-699501013259,suplemento,o
186,0211-699501013259,con,o
186,0211-699501013259,acido,i
186,0211-699501013259,folico,i
186,0211-699501013259,y,o
186,0211-699501013259,vitamina,i
186,0211-699501013259,B6,i
186,0211-699501013259,pp,i
186,0211-699501013259,valorando,o
186,0211-699501013259,su,o
186,0211-699501013259,posible,o
186,0211-699501013259,correlacion,o
186,0211-699501013259,con,o
186,0211-699501013259,dosis,o
186,0211-699501013259,de,o
186,0211-699501013259,dialisis,i
186,0211-699501013259,funcion,i
186,0211-699501013259,residual,i
186,0211-699501013259,y,o
186,0211-699501013259,parametros,o
186,0211-699501013259,nutricionales,o
186,0211-699501013259,Metodos,o
186,0211-699501013259,Todos,o
186,0211-699501013259,los,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,en,o
186,0211-699501013259,hemodialisis,i
186,0211-699501013259,al,o
186,0211-699501013259,comienzo,o
186,0211-699501013259,del,o
186,0211-699501013259,estudio,o
186,0211-699501013259,que,o
186,0211-699501013259,no,o
186,0211-699501013259,recibian,o
186,0211-699501013259,acido,i
186,0211-699501013259,folico,i
186,0211-699501013259,ni,o
186,0211-699501013259,vitamina,i
186,0211-699501013259,B6,i
186,0211-699501013259,asi,o
186,0211-699501013259,como,o
186,0211-699501013259,los,o
186,0211-699501013259,incorporados,o
186,0211-699501013259,posteriormente,o
186,0211-699501013259,a,o
186,0211-699501013259,partir,o
186,0211-699501013259,de,o
186,0211-699501013259,su,o
186,0211-699501013259,tercer,o
186,0211-699501013259,mes,o
186,0211-699501013259,en,o
186,0211-699501013259,hemodialisis,i
186,0211-699501013259,recibieron,o
186,0211-699501013259,5,o
186,0211-699501013259,mg,o
186,0211-699501013259,orales,o
186,0211-699501013259,de,o
186,0211-699501013259,acido,i
186,0211-699501013259,folico,i
186,0211-699501013259,cada,o
186,0211-699501013259,48,o
186,0211-699501013259,horas,o
186,0211-699501013259,y,o
186,0211-699501013259,40,o
186,0211-699501013259,mg,o
186,0211-699501013259,orales,o
186,0211-699501013259,de,o
186,0211-699501013259,vitamina,i
186,0211-699501013259,B6,i
186,0211-699501013259,cada,o
186,0211-699501013259,semana,o
186,0211-699501013259,Se,o
186,0211-699501013259,determinaron,o
186,0211-699501013259,al,o
186,0211-699501013259,comienzo,o
186,0211-699501013259,del,o
186,0211-699501013259,estudio,o
186,0211-699501013259,y,o
186,0211-699501013259,cada,o
186,0211-699501013259,2,o
186,0211-699501013259,meses,o
186,0211-699501013259,niveles,i
186,0211-699501013259,de,i
186,0211-699501013259,folato,i
186,0211-699501013259,vitamina,i
186,0211-699501013259,B12,i
186,0211-699501013259,inmunoensayo,i
186,0211-699501013259,albumina,i
186,0211-699501013259,y,o
186,0211-699501013259,cinetica,o
186,0211-699501013259,de,o
186,0211-699501013259,la,o
186,0211-699501013259,urea,i
186,0211-699501013259,KTV,o
186,0211-699501013259,KRU,o
186,0211-699501013259,PCRn,o
186,0211-699501013259,y,o
186,0211-699501013259,cada,o
186,0211-699501013259,6,o
186,0211-699501013259,meses,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,HPLC,i
186,0211-699501013259,y,o
186,0211-699501013259,pp,i
186,0211-699501013259,RIA,i
186,0211-699501013259,Resultados,o
186,0211-699501013259,80,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,fueron,o
186,0211-699501013259,incluidos,o
186,0211-699501013259,en,o
186,0211-699501013259,el,o
186,0211-699501013259,estudio,o
186,0211-699501013259,basal,o
186,0211-699501013259,con,o
186,0211-699501013259,una,o
186,0211-699501013259,prevalencia,o
186,0211-699501013259,de,o
186,0211-699501013259,hiperhomocisteinemia,i
186,0211-699501013259,del,o
186,0211-699501013259,844,o
186,0211-699501013259,deficit,i
186,0211-699501013259,de,i
186,0211-699501013259,pp,i
186,0211-699501013259,en,o
186,0211-699501013259,el,o
186,0211-699501013259,32,o
186,0211-699501013259,y,o
186,0211-699501013259,folato,i
186,0211-699501013259,en,o
186,0211-699501013259,el,o
186,0211-699501013259,rango,o
186,0211-699501013259,normal,o
186,0211-699501013259,bajo,o
186,0211-699501013259,los,o
186,0211-699501013259,niveles,i
186,0211-699501013259,de,i
186,0211-699501013259,tHcy,i
186,0211-699501013259,se,o
186,0211-699501013259,correlacionaban,o
186,0211-699501013259,inversamente,o
186,0211-699501013259,con,o
186,0211-699501013259,los,o
186,0211-699501013259,del,o
186,0211-699501013259,folato,i
186,0211-699501013259,r,o
186,0211-699501013259,0336,o
186,0211-699501013259,p,o
186,0211-699501013259,001,o
186,0211-699501013259,pero,o
186,0211-699501013259,no,o
186,0211-699501013259,con,o
186,0211-699501013259,pp,i
186,0211-699501013259,B12,i
186,0211-699501013259,edad,o
186,0211-699501013259,albumina,i
186,0211-699501013259,KTV,o
186,0211-699501013259,KRU,o
186,0211-699501013259,PCRn,o
186,0211-699501013259,Cincuenta,o
186,0211-699501013259,y,o
186,0211-699501013259,ocho,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,recibieron,o
186,0211-699501013259,seis,o
186,0211-699501013259,meses,o
186,0211-699501013259,de,o
186,0211-699501013259,suplementacion,i
186,0211-699501013259,con,o
186,0211-699501013259,normalizacion,o
186,0211-699501013259,del,o
186,0211-699501013259,pp,i
186,0211-699501013259,aumento,o
186,0211-699501013259,del,o
186,0211-699501013259,folato,i
186,0211-699501013259,703,o
186,0211-699501013259,IC,o
186,0211-699501013259,638,o
186,0211-699501013259,795,o
186,0211-699501013259,vs,o
186,0211-699501013259,6181,o
186,0211-699501013259,IC,o
186,0211-699501013259,4447,o
186,0211-699501013259,7811,o
186,0211-699501013259,p,o
186,0211-699501013259,0001,o
186,0211-699501013259,y,o
186,0211-699501013259,descenso,o
186,0211-699501013259,de,o
186,0211-699501013259,la,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,240,o
186,0211-699501013259,IC,o
186,0211-699501013259,213,o
186,0211-699501013259,264,o
186,0211-699501013259,vs,o
186,0211-699501013259,199,o
186,0211-699501013259,IC,o
186,0211-699501013259,175,o
186,0211-699501013259,224,o
186,0211-699501013259,p,o
186,0211-699501013259,005,o
186,0211-699501013259,Han,o
186,0211-699501013259,recibido,o
186,0211-699501013259,suplementacion,i
186,0211-699501013259,durante,o
186,0211-699501013259,12,o
186,0211-699501013259,meses,o
186,0211-699501013259,33,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,pero,o
186,0211-699501013259,a,o
186,0211-699501013259,pesar,o
186,0211-699501013259,de,o
186,0211-699501013259,un,o
186,0211-699501013259,continuo,o
186,0211-699501013259,aumento,o
186,0211-699501013259,del,o
186,0211-699501013259,folato,i
186,0211-699501013259,10078,o
186,0211-699501013259,IC,o
186,0211-699501013259,7481,o
186,0211-699501013259,12674,o
186,0211-699501013259,p,o
186,0211-699501013259,0001,o
186,0211-699501013259,solo,o
186,0211-699501013259,3,o
186,0211-699501013259,pacientes,o
186,0211-699501013259,presentan,o
186,0211-699501013259,niveles,o
186,0211-699501013259,normales,o
186,0211-699501013259,de,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,correlacionandose,o
186,0211-699501013259,directamente,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,con,o
186,0211-699501013259,la,o
186,0211-699501013259,albumina,i
186,0211-699501013259,r,o
186,0211-699501013259,056,o
186,0211-699501013259,p,o
186,0211-699501013259,0001,o
186,0211-699501013259,que,o
186,0211-699501013259,se,o
186,0211-699501013259,elevo,o
186,0211-699501013259,con,o
186,0211-699501013259,respecto,o
186,0211-699501013259,al,o
186,0211-699501013259,inicio,o
186,0211-699501013259,337,o
186,0211-699501013259,IC,o
186,0211-699501013259,327,o
186,0211-699501013259,346,o
186,0211-699501013259,vs,o
186,0211-699501013259,350,o
186,0211-699501013259,IC,o
186,0211-699501013259,337,o
186,0211-699501013259,363,o
186,0211-699501013259,p,o
186,0211-699501013259,005,o
186,0211-699501013259,Conclusion,o
186,0211-699501013259,Tras,o
186,0211-699501013259,suplementacion,i
186,0211-699501013259,con,o
186,0211-699501013259,acido,i
186,0211-699501013259,folico,i
186,0211-699501013259,y,o
186,0211-699501013259,vitamina,i
186,0211-699501013259,B6,i
186,0211-699501013259,aunque,o
186,0211-699501013259,inicialmente,o
186,0211-699501013259,se,o
186,0211-699501013259,reduce,o
186,0211-699501013259,la,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,esta,o
186,0211-699501013259,respuesta,o
186,0211-699501013259,se,o
186,0211-699501013259,hace,o
186,0211-699501013259,refractaria,o
186,0211-699501013259,correlacionandose,o
186,0211-699501013259,directamente,o
186,0211-699501013259,la,o
186,0211-699501013259,tHcy,i
186,0211-699501013259,con,o
186,0211-699501013259,la,o
186,0211-699501013259,albumina,i
186,0211-699501013259,plasmatica,i
186,0211-699501013259,La,o
186,0211-699501013259,interpretacion,o
186,0211-699501013259,de,o
186,0211-699501013259,los,o
186,0211-699501013259,niveles,i
186,0211-699501013259,de,i
186,0211-699501013259,tHcy,i
186,0211-699501013259,debe,o
186,0211-699501013259,tener,o
186,0211-699501013259,en,o
186,0211-699501013259,cuenta,o
186,0211-699501013259,la,o
186,0211-699501013259,concentracion,i
186,0211-699501013259,de,i
186,0211-699501013259,albumina,i
187,0211-699501013259,Efecto,o
187,0211-699501013259,de,o
187,0211-699501013259,la,o
187,0211-699501013259,suplementacion,i
187,0211-699501013259,con,o
187,0211-699501013259,acido,i
187,0211-699501013259,folico,i
187,0211-699501013259,sobre,o
187,0211-699501013259,los,o
187,0211-699501013259,niveles,i
187,0211-699501013259,de,i
187,0211-699501013259,homocisteina,i
187,0211-699501013259,total,o
187,0211-699501013259,en,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,en,o
187,0211-699501013259,hemodialisis,i
187,0211-699501013259,La,o
187,0211-699501013259,hiperhomocisteinemia,i
187,0211-699501013259,es,o
187,0211-699501013259,un,o
187,0211-699501013259,marcador,o
187,0211-699501013259,de,o
187,0211-699501013259,riesgo,o
187,0211-699501013259,independiente,o
187,0211-699501013259,de,o
187,0211-699501013259,morbimortalidad,o
187,0211-699501013259,cardiovascular,i
187,0211-699501013259,Hemos,o
187,0211-699501013259,intentado,o
187,0211-699501013259,prospectivamente,o
187,0211-699501013259,reducir,o
187,0211-699501013259,los,o
187,0211-699501013259,niveles,i
187,0211-699501013259,de,i
187,0211-699501013259,homocisteina,i
187,0211-699501013259,total,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,mediante,o
187,0211-699501013259,suplemento,o
187,0211-699501013259,con,o
187,0211-699501013259,acido,i
187,0211-699501013259,folico,i
187,0211-699501013259,y,o
187,0211-699501013259,vitamina,i
187,0211-699501013259,B6,i
187,0211-699501013259,pp,i
187,0211-699501013259,valorando,o
187,0211-699501013259,su,o
187,0211-699501013259,posible,o
187,0211-699501013259,correlacion,o
187,0211-699501013259,con,o
187,0211-699501013259,dosis,o
187,0211-699501013259,de,o
187,0211-699501013259,dialisis,i
187,0211-699501013259,funcion,i
187,0211-699501013259,residual,i
187,0211-699501013259,y,o
187,0211-699501013259,parametros,o
187,0211-699501013259,nutricionales,o
187,0211-699501013259,Metodos,o
187,0211-699501013259,Todos,o
187,0211-699501013259,los,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,en,o
187,0211-699501013259,hemodialisis,i
187,0211-699501013259,al,o
187,0211-699501013259,comienzo,o
187,0211-699501013259,del,o
187,0211-699501013259,estudio,o
187,0211-699501013259,que,o
187,0211-699501013259,no,o
187,0211-699501013259,recibian,o
187,0211-699501013259,acido,i
187,0211-699501013259,folico,i
187,0211-699501013259,ni,o
187,0211-699501013259,vitamina,i
187,0211-699501013259,B6,i
187,0211-699501013259,asi,o
187,0211-699501013259,como,o
187,0211-699501013259,los,o
187,0211-699501013259,incorporados,o
187,0211-699501013259,posteriormente,o
187,0211-699501013259,a,o
187,0211-699501013259,partir,o
187,0211-699501013259,de,o
187,0211-699501013259,su,o
187,0211-699501013259,tercer,o
187,0211-699501013259,mes,o
187,0211-699501013259,en,o
187,0211-699501013259,hemodialisis,i
187,0211-699501013259,recibieron,o
187,0211-699501013259,5,o
187,0211-699501013259,mg,o
187,0211-699501013259,orales,o
187,0211-699501013259,de,o
187,0211-699501013259,acido,i
187,0211-699501013259,folico,i
187,0211-699501013259,cada,o
187,0211-699501013259,48,o
187,0211-699501013259,horas,o
187,0211-699501013259,y,o
187,0211-699501013259,40,o
187,0211-699501013259,mg,o
187,0211-699501013259,orales,o
187,0211-699501013259,de,o
187,0211-699501013259,vitamina,i
187,0211-699501013259,B6,i
187,0211-699501013259,cada,o
187,0211-699501013259,semana,o
187,0211-699501013259,Se,o
187,0211-699501013259,determinaron,o
187,0211-699501013259,al,o
187,0211-699501013259,comienzo,o
187,0211-699501013259,del,o
187,0211-699501013259,estudio,o
187,0211-699501013259,y,o
187,0211-699501013259,cada,o
187,0211-699501013259,2,o
187,0211-699501013259,meses,o
187,0211-699501013259,niveles,i
187,0211-699501013259,de,i
187,0211-699501013259,folato,i
187,0211-699501013259,vitamina,i
187,0211-699501013259,B12,i
187,0211-699501013259,inmunoensayo,i
187,0211-699501013259,albumina,i
187,0211-699501013259,y,o
187,0211-699501013259,cinetica,o
187,0211-699501013259,de,o
187,0211-699501013259,la,o
187,0211-699501013259,urea,i
187,0211-699501013259,KTV,o
187,0211-699501013259,KRU,o
187,0211-699501013259,PCRn,o
187,0211-699501013259,y,o
187,0211-699501013259,cada,o
187,0211-699501013259,6,o
187,0211-699501013259,meses,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,HPLC,i
187,0211-699501013259,y,o
187,0211-699501013259,pp,i
187,0211-699501013259,RIA,i
187,0211-699501013259,Resultados,o
187,0211-699501013259,80,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,fueron,o
187,0211-699501013259,incluidos,o
187,0211-699501013259,en,o
187,0211-699501013259,el,o
187,0211-699501013259,estudio,o
187,0211-699501013259,basal,o
187,0211-699501013259,con,o
187,0211-699501013259,una,o
187,0211-699501013259,prevalencia,o
187,0211-699501013259,de,o
187,0211-699501013259,hiperhomocisteinemia,i
187,0211-699501013259,del,o
187,0211-699501013259,844,o
187,0211-699501013259,deficit,i
187,0211-699501013259,de,i
187,0211-699501013259,pp,i
187,0211-699501013259,en,o
187,0211-699501013259,el,o
187,0211-699501013259,32,o
187,0211-699501013259,y,o
187,0211-699501013259,folato,i
187,0211-699501013259,en,o
187,0211-699501013259,el,o
187,0211-699501013259,rango,o
187,0211-699501013259,normal,o
187,0211-699501013259,bajo,o
187,0211-699501013259,los,o
187,0211-699501013259,niveles,i
187,0211-699501013259,de,i
187,0211-699501013259,tHcy,i
187,0211-699501013259,se,o
187,0211-699501013259,correlacionaban,o
187,0211-699501013259,inversamente,o
187,0211-699501013259,con,o
187,0211-699501013259,los,o
187,0211-699501013259,del,o
187,0211-699501013259,folato,i
187,0211-699501013259,r,o
187,0211-699501013259,0336,o
187,0211-699501013259,p,o
187,0211-699501013259,001,o
187,0211-699501013259,pero,o
187,0211-699501013259,no,o
187,0211-699501013259,con,o
187,0211-699501013259,pp,i
187,0211-699501013259,B12,i
187,0211-699501013259,edad,o
187,0211-699501013259,albumina,i
187,0211-699501013259,KTV,o
187,0211-699501013259,KRU,o
187,0211-699501013259,PCRn,o
187,0211-699501013259,Cincuenta,o
187,0211-699501013259,y,o
187,0211-699501013259,ocho,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,recibieron,o
187,0211-699501013259,seis,o
187,0211-699501013259,meses,o
187,0211-699501013259,de,o
187,0211-699501013259,suplementacion,i
187,0211-699501013259,con,o
187,0211-699501013259,normalizacion,o
187,0211-699501013259,del,o
187,0211-699501013259,pp,i
187,0211-699501013259,aumento,o
187,0211-699501013259,del,o
187,0211-699501013259,folato,i
187,0211-699501013259,703,o
187,0211-699501013259,IC,o
187,0211-699501013259,638,o
187,0211-699501013259,795,o
187,0211-699501013259,vs,o
187,0211-699501013259,6181,o
187,0211-699501013259,IC,o
187,0211-699501013259,4447,o
187,0211-699501013259,7811,o
187,0211-699501013259,p,o
187,0211-699501013259,0001,o
187,0211-699501013259,y,o
187,0211-699501013259,descenso,o
187,0211-699501013259,de,o
187,0211-699501013259,la,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,240,o
187,0211-699501013259,IC,o
187,0211-699501013259,213,o
187,0211-699501013259,264,o
187,0211-699501013259,vs,o
187,0211-699501013259,199,o
187,0211-699501013259,IC,o
187,0211-699501013259,175,o
187,0211-699501013259,224,o
187,0211-699501013259,p,o
187,0211-699501013259,005,o
187,0211-699501013259,Han,o
187,0211-699501013259,recibido,o
187,0211-699501013259,suplementacion,i
187,0211-699501013259,durante,o
187,0211-699501013259,12,o
187,0211-699501013259,meses,o
187,0211-699501013259,33,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,pero,o
187,0211-699501013259,a,o
187,0211-699501013259,pesar,o
187,0211-699501013259,de,o
187,0211-699501013259,un,o
187,0211-699501013259,continuo,o
187,0211-699501013259,aumento,o
187,0211-699501013259,del,o
187,0211-699501013259,folato,i
187,0211-699501013259,10078,o
187,0211-699501013259,IC,o
187,0211-699501013259,7481,o
187,0211-699501013259,12674,o
187,0211-699501013259,p,o
187,0211-699501013259,0001,o
187,0211-699501013259,solo,o
187,0211-699501013259,3,o
187,0211-699501013259,pacientes,o
187,0211-699501013259,presentan,o
187,0211-699501013259,niveles,o
187,0211-699501013259,normales,o
187,0211-699501013259,de,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,correlacionandose,o
187,0211-699501013259,directamente,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,con,o
187,0211-699501013259,la,o
187,0211-699501013259,albumina,i
187,0211-699501013259,r,o
187,0211-699501013259,056,o
187,0211-699501013259,p,o
187,0211-699501013259,0001,o
187,0211-699501013259,que,o
187,0211-699501013259,se,o
187,0211-699501013259,elevo,o
187,0211-699501013259,con,o
187,0211-699501013259,respecto,o
187,0211-699501013259,al,o
187,0211-699501013259,inicio,o
187,0211-699501013259,337,o
187,0211-699501013259,IC,o
187,0211-699501013259,327,o
187,0211-699501013259,346,o
187,0211-699501013259,vs,o
187,0211-699501013259,350,o
187,0211-699501013259,IC,o
187,0211-699501013259,337,o
187,0211-699501013259,363,o
187,0211-699501013259,p,o
187,0211-699501013259,005,o
187,0211-699501013259,Conclusion,o
187,0211-699501013259,Tras,o
187,0211-699501013259,suplementacion,i
187,0211-699501013259,con,o
187,0211-699501013259,acido,i
187,0211-699501013259,folico,i
187,0211-699501013259,y,o
187,0211-699501013259,vitamina,i
187,0211-699501013259,B6,i
187,0211-699501013259,aunque,o
187,0211-699501013259,inicialmente,o
187,0211-699501013259,se,o
187,0211-699501013259,reduce,o
187,0211-699501013259,la,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,esta,o
187,0211-699501013259,respuesta,o
187,0211-699501013259,se,o
187,0211-699501013259,hace,o
187,0211-699501013259,refractaria,o
187,0211-699501013259,correlacionandose,o
187,0211-699501013259,directamente,o
187,0211-699501013259,la,o
187,0211-699501013259,tHcy,i
187,0211-699501013259,con,o
187,0211-699501013259,la,o
187,0211-699501013259,albumina,i
187,0211-699501013259,plasmatica,i
187,0211-699501013259,La,o
187,0211-699501013259,interpretacion,o
187,0211-699501013259,de,o
187,0211-699501013259,los,o
187,0211-699501013259,niveles,i
187,0211-699501013259,de,i
187,0211-699501013259,tHcy,i
187,0211-699501013259,debe,o
187,0211-699501013259,tener,o
187,0211-699501013259,en,o
187,0211-699501013259,cuenta,o
187,0211-699501013259,la,o
187,0211-699501013259,concentracion,i
187,0211-699501013259,de,i
187,0211-699501013259,albumina,i
188,0211-699501013259,Efecto,o
188,0211-699501013259,de,o
188,0211-699501013259,la,o
188,0211-699501013259,suplementacion,i
188,0211-699501013259,con,o
188,0211-699501013259,acido,i
188,0211-699501013259,folico,i
188,0211-699501013259,sobre,o
188,0211-699501013259,los,o
188,0211-699501013259,niveles,i
188,0211-699501013259,de,i
188,0211-699501013259,homocisteina,i
188,0211-699501013259,total,o
188,0211-699501013259,en,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,en,o
188,0211-699501013259,hemodialisis,i
188,0211-699501013259,La,o
188,0211-699501013259,hiperhomocisteinemia,i
188,0211-699501013259,es,o
188,0211-699501013259,un,o
188,0211-699501013259,marcador,o
188,0211-699501013259,de,o
188,0211-699501013259,riesgo,o
188,0211-699501013259,independiente,o
188,0211-699501013259,de,o
188,0211-699501013259,morbimortalidad,o
188,0211-699501013259,cardiovascular,i
188,0211-699501013259,Hemos,o
188,0211-699501013259,intentado,o
188,0211-699501013259,prospectivamente,o
188,0211-699501013259,reducir,o
188,0211-699501013259,los,o
188,0211-699501013259,niveles,i
188,0211-699501013259,de,i
188,0211-699501013259,homocisteina,i
188,0211-699501013259,total,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,mediante,o
188,0211-699501013259,suplemento,o
188,0211-699501013259,con,o
188,0211-699501013259,acido,i
188,0211-699501013259,folico,i
188,0211-699501013259,y,o
188,0211-699501013259,vitamina,i
188,0211-699501013259,B6,i
188,0211-699501013259,pp,i
188,0211-699501013259,valorando,o
188,0211-699501013259,su,o
188,0211-699501013259,posible,o
188,0211-699501013259,correlacion,o
188,0211-699501013259,con,o
188,0211-699501013259,dosis,o
188,0211-699501013259,de,o
188,0211-699501013259,dialisis,i
188,0211-699501013259,funcion,i
188,0211-699501013259,residual,i
188,0211-699501013259,y,o
188,0211-699501013259,parametros,o
188,0211-699501013259,nutricionales,o
188,0211-699501013259,Metodos,o
188,0211-699501013259,Todos,o
188,0211-699501013259,los,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,en,o
188,0211-699501013259,hemodialisis,i
188,0211-699501013259,al,o
188,0211-699501013259,comienzo,o
188,0211-699501013259,del,o
188,0211-699501013259,estudio,o
188,0211-699501013259,que,o
188,0211-699501013259,no,o
188,0211-699501013259,recibian,o
188,0211-699501013259,acido,i
188,0211-699501013259,folico,i
188,0211-699501013259,ni,o
188,0211-699501013259,vitamina,i
188,0211-699501013259,B6,i
188,0211-699501013259,asi,o
188,0211-699501013259,como,o
188,0211-699501013259,los,o
188,0211-699501013259,incorporados,o
188,0211-699501013259,posteriormente,o
188,0211-699501013259,a,o
188,0211-699501013259,partir,o
188,0211-699501013259,de,o
188,0211-699501013259,su,o
188,0211-699501013259,tercer,o
188,0211-699501013259,mes,o
188,0211-699501013259,en,o
188,0211-699501013259,hemodialisis,i
188,0211-699501013259,recibieron,o
188,0211-699501013259,5,o
188,0211-699501013259,mg,o
188,0211-699501013259,orales,o
188,0211-699501013259,de,o
188,0211-699501013259,acido,i
188,0211-699501013259,folico,i
188,0211-699501013259,cada,o
188,0211-699501013259,48,o
188,0211-699501013259,horas,o
188,0211-699501013259,y,o
188,0211-699501013259,40,o
188,0211-699501013259,mg,o
188,0211-699501013259,orales,o
188,0211-699501013259,de,o
188,0211-699501013259,vitamina,i
188,0211-699501013259,B6,i
188,0211-699501013259,cada,o
188,0211-699501013259,semana,o
188,0211-699501013259,Se,o
188,0211-699501013259,determinaron,o
188,0211-699501013259,al,o
188,0211-699501013259,comienzo,o
188,0211-699501013259,del,o
188,0211-699501013259,estudio,o
188,0211-699501013259,y,o
188,0211-699501013259,cada,o
188,0211-699501013259,2,o
188,0211-699501013259,meses,o
188,0211-699501013259,niveles,i
188,0211-699501013259,de,i
188,0211-699501013259,folato,i
188,0211-699501013259,vitamina,i
188,0211-699501013259,B12,i
188,0211-699501013259,inmunoensayo,i
188,0211-699501013259,albumina,i
188,0211-699501013259,y,o
188,0211-699501013259,cinetica,o
188,0211-699501013259,de,o
188,0211-699501013259,la,o
188,0211-699501013259,urea,i
188,0211-699501013259,KTV,o
188,0211-699501013259,KRU,o
188,0211-699501013259,PCRn,o
188,0211-699501013259,y,o
188,0211-699501013259,cada,o
188,0211-699501013259,6,o
188,0211-699501013259,meses,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,HPLC,i
188,0211-699501013259,y,o
188,0211-699501013259,pp,i
188,0211-699501013259,RIA,i
188,0211-699501013259,Resultados,o
188,0211-699501013259,80,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,fueron,o
188,0211-699501013259,incluidos,o
188,0211-699501013259,en,o
188,0211-699501013259,el,o
188,0211-699501013259,estudio,o
188,0211-699501013259,basal,o
188,0211-699501013259,con,o
188,0211-699501013259,una,o
188,0211-699501013259,prevalencia,o
188,0211-699501013259,de,o
188,0211-699501013259,hiperhomocisteinemia,i
188,0211-699501013259,del,o
188,0211-699501013259,844,o
188,0211-699501013259,deficit,i
188,0211-699501013259,de,i
188,0211-699501013259,pp,i
188,0211-699501013259,en,o
188,0211-699501013259,el,o
188,0211-699501013259,32,o
188,0211-699501013259,y,o
188,0211-699501013259,folato,i
188,0211-699501013259,en,o
188,0211-699501013259,el,o
188,0211-699501013259,rango,o
188,0211-699501013259,normal,o
188,0211-699501013259,bajo,o
188,0211-699501013259,los,o
188,0211-699501013259,niveles,i
188,0211-699501013259,de,i
188,0211-699501013259,tHcy,i
188,0211-699501013259,se,o
188,0211-699501013259,correlacionaban,o
188,0211-699501013259,inversamente,o
188,0211-699501013259,con,o
188,0211-699501013259,los,o
188,0211-699501013259,del,o
188,0211-699501013259,folato,i
188,0211-699501013259,r,o
188,0211-699501013259,0336,o
188,0211-699501013259,p,o
188,0211-699501013259,001,o
188,0211-699501013259,pero,o
188,0211-699501013259,no,o
188,0211-699501013259,con,o
188,0211-699501013259,pp,i
188,0211-699501013259,B12,i
188,0211-699501013259,edad,o
188,0211-699501013259,albumina,i
188,0211-699501013259,KTV,o
188,0211-699501013259,KRU,o
188,0211-699501013259,PCRn,o
188,0211-699501013259,Cincuenta,o
188,0211-699501013259,y,o
188,0211-699501013259,ocho,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,recibieron,o
188,0211-699501013259,seis,o
188,0211-699501013259,meses,o
188,0211-699501013259,de,o
188,0211-699501013259,suplementacion,i
188,0211-699501013259,con,o
188,0211-699501013259,normalizacion,o
188,0211-699501013259,del,o
188,0211-699501013259,pp,i
188,0211-699501013259,aumento,o
188,0211-699501013259,del,o
188,0211-699501013259,folato,i
188,0211-699501013259,703,o
188,0211-699501013259,IC,o
188,0211-699501013259,638,o
188,0211-699501013259,795,o
188,0211-699501013259,vs,o
188,0211-699501013259,6181,o
188,0211-699501013259,IC,o
188,0211-699501013259,4447,o
188,0211-699501013259,7811,o
188,0211-699501013259,p,o
188,0211-699501013259,0001,o
188,0211-699501013259,y,o
188,0211-699501013259,descenso,o
188,0211-699501013259,de,o
188,0211-699501013259,la,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,240,o
188,0211-699501013259,IC,o
188,0211-699501013259,213,o
188,0211-699501013259,264,o
188,0211-699501013259,vs,o
188,0211-699501013259,199,o
188,0211-699501013259,IC,o
188,0211-699501013259,175,o
188,0211-699501013259,224,o
188,0211-699501013259,p,o
188,0211-699501013259,005,o
188,0211-699501013259,Han,o
188,0211-699501013259,recibido,o
188,0211-699501013259,suplementacion,i
188,0211-699501013259,durante,o
188,0211-699501013259,12,o
188,0211-699501013259,meses,o
188,0211-699501013259,33,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,pero,o
188,0211-699501013259,a,o
188,0211-699501013259,pesar,o
188,0211-699501013259,de,o
188,0211-699501013259,un,o
188,0211-699501013259,continuo,o
188,0211-699501013259,aumento,o
188,0211-699501013259,del,o
188,0211-699501013259,folato,i
188,0211-699501013259,10078,o
188,0211-699501013259,IC,o
188,0211-699501013259,7481,o
188,0211-699501013259,12674,o
188,0211-699501013259,p,o
188,0211-699501013259,0001,o
188,0211-699501013259,solo,o
188,0211-699501013259,3,o
188,0211-699501013259,pacientes,o
188,0211-699501013259,presentan,o
188,0211-699501013259,niveles,o
188,0211-699501013259,normales,o
188,0211-699501013259,de,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,correlacionandose,o
188,0211-699501013259,directamente,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,con,o
188,0211-699501013259,la,o
188,0211-699501013259,albumina,i
188,0211-699501013259,r,o
188,0211-699501013259,056,o
188,0211-699501013259,p,o
188,0211-699501013259,0001,o
188,0211-699501013259,que,o
188,0211-699501013259,se,o
188,0211-699501013259,elevo,o
188,0211-699501013259,con,o
188,0211-699501013259,respecto,o
188,0211-699501013259,al,o
188,0211-699501013259,inicio,o
188,0211-699501013259,337,o
188,0211-699501013259,IC,o
188,0211-699501013259,327,o
188,0211-699501013259,346,o
188,0211-699501013259,vs,o
188,0211-699501013259,350,o
188,0211-699501013259,IC,o
188,0211-699501013259,337,o
188,0211-699501013259,363,o
188,0211-699501013259,p,o
188,0211-699501013259,005,o
188,0211-699501013259,Conclusion,o
188,0211-699501013259,Tras,o
188,0211-699501013259,suplementacion,i
188,0211-699501013259,con,o
188,0211-699501013259,acido,i
188,0211-699501013259,folico,i
188,0211-699501013259,y,o
188,0211-699501013259,vitamina,i
188,0211-699501013259,B6,i
188,0211-699501013259,aunque,o
188,0211-699501013259,inicialmente,o
188,0211-699501013259,se,o
188,0211-699501013259,reduce,o
188,0211-699501013259,la,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,esta,o
188,0211-699501013259,respuesta,o
188,0211-699501013259,se,o
188,0211-699501013259,hace,o
188,0211-699501013259,refractaria,o
188,0211-699501013259,correlacionandose,o
188,0211-699501013259,directamente,o
188,0211-699501013259,la,o
188,0211-699501013259,tHcy,i
188,0211-699501013259,con,o
188,0211-699501013259,la,o
188,0211-699501013259,albumina,i
188,0211-699501013259,plasmatica,i
188,0211-699501013259,La,o
188,0211-699501013259,interpretacion,o
188,0211-699501013259,de,o
188,0211-699501013259,los,o
188,0211-699501013259,niveles,i
188,0211-699501013259,de,i
188,0211-699501013259,tHcy,i
188,0211-699501013259,debe,o
188,0211-699501013259,tener,o
188,0211-699501013259,en,o
188,0211-699501013259,cuenta,o
188,0211-699501013259,la,o
188,0211-699501013259,concentracion,i
188,0211-699501013259,de,i
188,0211-699501013259,albumina,i
189,0211-699501013259,Efecto,o
189,0211-699501013259,de,o
189,0211-699501013259,la,o
189,0211-699501013259,suplementacion,i
189,0211-699501013259,con,o
189,0211-699501013259,acido,i
189,0211-699501013259,folico,i
189,0211-699501013259,sobre,o
189,0211-699501013259,los,o
189,0211-699501013259,niveles,i
189,0211-699501013259,de,i
189,0211-699501013259,homocisteina,i
189,0211-699501013259,total,o
189,0211-699501013259,en,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,en,o
189,0211-699501013259,hemodialisis,i
189,0211-699501013259,La,o
189,0211-699501013259,hiperhomocisteinemia,i
189,0211-699501013259,es,o
189,0211-699501013259,un,o
189,0211-699501013259,marcador,o
189,0211-699501013259,de,o
189,0211-699501013259,riesgo,o
189,0211-699501013259,independiente,o
189,0211-699501013259,de,o
189,0211-699501013259,morbimortalidad,o
189,0211-699501013259,cardiovascular,i
189,0211-699501013259,Hemos,o
189,0211-699501013259,intentado,o
189,0211-699501013259,prospectivamente,o
189,0211-699501013259,reducir,o
189,0211-699501013259,los,o
189,0211-699501013259,niveles,i
189,0211-699501013259,de,i
189,0211-699501013259,homocisteina,i
189,0211-699501013259,total,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,mediante,o
189,0211-699501013259,suplemento,o
189,0211-699501013259,con,o
189,0211-699501013259,acido,i
189,0211-699501013259,folico,i
189,0211-699501013259,y,o
189,0211-699501013259,vitamina,i
189,0211-699501013259,B6,i
189,0211-699501013259,pp,i
189,0211-699501013259,valorando,o
189,0211-699501013259,su,o
189,0211-699501013259,posible,o
189,0211-699501013259,correlacion,o
189,0211-699501013259,con,o
189,0211-699501013259,dosis,o
189,0211-699501013259,de,o
189,0211-699501013259,dialisis,i
189,0211-699501013259,funcion,i
189,0211-699501013259,residual,i
189,0211-699501013259,y,o
189,0211-699501013259,parametros,o
189,0211-699501013259,nutricionales,o
189,0211-699501013259,Metodos,o
189,0211-699501013259,Todos,o
189,0211-699501013259,los,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,en,o
189,0211-699501013259,hemodialisis,i
189,0211-699501013259,al,o
189,0211-699501013259,comienzo,o
189,0211-699501013259,del,o
189,0211-699501013259,estudio,o
189,0211-699501013259,que,o
189,0211-699501013259,no,o
189,0211-699501013259,recibian,o
189,0211-699501013259,acido,i
189,0211-699501013259,folico,i
189,0211-699501013259,ni,o
189,0211-699501013259,vitamina,i
189,0211-699501013259,B6,i
189,0211-699501013259,asi,o
189,0211-699501013259,como,o
189,0211-699501013259,los,o
189,0211-699501013259,incorporados,o
189,0211-699501013259,posteriormente,o
189,0211-699501013259,a,o
189,0211-699501013259,partir,o
189,0211-699501013259,de,o
189,0211-699501013259,su,o
189,0211-699501013259,tercer,o
189,0211-699501013259,mes,o
189,0211-699501013259,en,o
189,0211-699501013259,hemodialisis,i
189,0211-699501013259,recibieron,o
189,0211-699501013259,5,o
189,0211-699501013259,mg,o
189,0211-699501013259,orales,o
189,0211-699501013259,de,o
189,0211-699501013259,acido,i
189,0211-699501013259,folico,i
189,0211-699501013259,cada,o
189,0211-699501013259,48,o
189,0211-699501013259,horas,o
189,0211-699501013259,y,o
189,0211-699501013259,40,o
189,0211-699501013259,mg,o
189,0211-699501013259,orales,o
189,0211-699501013259,de,o
189,0211-699501013259,vitamina,i
189,0211-699501013259,B6,i
189,0211-699501013259,cada,o
189,0211-699501013259,semana,o
189,0211-699501013259,Se,o
189,0211-699501013259,determinaron,o
189,0211-699501013259,al,o
189,0211-699501013259,comienzo,o
189,0211-699501013259,del,o
189,0211-699501013259,estudio,o
189,0211-699501013259,y,o
189,0211-699501013259,cada,o
189,0211-699501013259,2,o
189,0211-699501013259,meses,o
189,0211-699501013259,niveles,i
189,0211-699501013259,de,i
189,0211-699501013259,folato,i
189,0211-699501013259,vitamina,i
189,0211-699501013259,B12,i
189,0211-699501013259,inmunoensayo,i
189,0211-699501013259,albumina,i
189,0211-699501013259,y,o
189,0211-699501013259,cinetica,o
189,0211-699501013259,de,o
189,0211-699501013259,la,o
189,0211-699501013259,urea,i
189,0211-699501013259,KTV,o
189,0211-699501013259,KRU,o
189,0211-699501013259,PCRn,o
189,0211-699501013259,y,o
189,0211-699501013259,cada,o
189,0211-699501013259,6,o
189,0211-699501013259,meses,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,HPLC,i
189,0211-699501013259,y,o
189,0211-699501013259,pp,i
189,0211-699501013259,RIA,i
189,0211-699501013259,Resultados,o
189,0211-699501013259,80,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,fueron,o
189,0211-699501013259,incluidos,o
189,0211-699501013259,en,o
189,0211-699501013259,el,o
189,0211-699501013259,estudio,o
189,0211-699501013259,basal,o
189,0211-699501013259,con,o
189,0211-699501013259,una,o
189,0211-699501013259,prevalencia,o
189,0211-699501013259,de,o
189,0211-699501013259,hiperhomocisteinemia,i
189,0211-699501013259,del,o
189,0211-699501013259,844,o
189,0211-699501013259,deficit,i
189,0211-699501013259,de,i
189,0211-699501013259,pp,i
189,0211-699501013259,en,o
189,0211-699501013259,el,o
189,0211-699501013259,32,o
189,0211-699501013259,y,o
189,0211-699501013259,folato,i
189,0211-699501013259,en,o
189,0211-699501013259,el,o
189,0211-699501013259,rango,o
189,0211-699501013259,normal,o
189,0211-699501013259,bajo,o
189,0211-699501013259,los,o
189,0211-699501013259,niveles,i
189,0211-699501013259,de,i
189,0211-699501013259,tHcy,i
189,0211-699501013259,se,o
189,0211-699501013259,correlacionaban,o
189,0211-699501013259,inversamente,o
189,0211-699501013259,con,o
189,0211-699501013259,los,o
189,0211-699501013259,del,o
189,0211-699501013259,folato,i
189,0211-699501013259,r,o
189,0211-699501013259,0336,o
189,0211-699501013259,p,o
189,0211-699501013259,001,o
189,0211-699501013259,pero,o
189,0211-699501013259,no,o
189,0211-699501013259,con,o
189,0211-699501013259,pp,i
189,0211-699501013259,B12,i
189,0211-699501013259,edad,o
189,0211-699501013259,albumina,i
189,0211-699501013259,KTV,o
189,0211-699501013259,KRU,o
189,0211-699501013259,PCRn,o
189,0211-699501013259,Cincuenta,o
189,0211-699501013259,y,o
189,0211-699501013259,ocho,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,recibieron,o
189,0211-699501013259,seis,o
189,0211-699501013259,meses,o
189,0211-699501013259,de,o
189,0211-699501013259,suplementacion,i
189,0211-699501013259,con,o
189,0211-699501013259,normalizacion,o
189,0211-699501013259,del,o
189,0211-699501013259,pp,i
189,0211-699501013259,aumento,o
189,0211-699501013259,del,o
189,0211-699501013259,folato,i
189,0211-699501013259,703,o
189,0211-699501013259,IC,o
189,0211-699501013259,638,o
189,0211-699501013259,795,o
189,0211-699501013259,vs,o
189,0211-699501013259,6181,o
189,0211-699501013259,IC,o
189,0211-699501013259,4447,o
189,0211-699501013259,7811,o
189,0211-699501013259,p,o
189,0211-699501013259,0001,o
189,0211-699501013259,y,o
189,0211-699501013259,descenso,o
189,0211-699501013259,de,o
189,0211-699501013259,la,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,240,o
189,0211-699501013259,IC,o
189,0211-699501013259,213,o
189,0211-699501013259,264,o
189,0211-699501013259,vs,o
189,0211-699501013259,199,o
189,0211-699501013259,IC,o
189,0211-699501013259,175,o
189,0211-699501013259,224,o
189,0211-699501013259,p,o
189,0211-699501013259,005,o
189,0211-699501013259,Han,o
189,0211-699501013259,recibido,o
189,0211-699501013259,suplementacion,i
189,0211-699501013259,durante,o
189,0211-699501013259,12,o
189,0211-699501013259,meses,o
189,0211-699501013259,33,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,pero,o
189,0211-699501013259,a,o
189,0211-699501013259,pesar,o
189,0211-699501013259,de,o
189,0211-699501013259,un,o
189,0211-699501013259,continuo,o
189,0211-699501013259,aumento,o
189,0211-699501013259,del,o
189,0211-699501013259,folato,i
189,0211-699501013259,10078,o
189,0211-699501013259,IC,o
189,0211-699501013259,7481,o
189,0211-699501013259,12674,o
189,0211-699501013259,p,o
189,0211-699501013259,0001,o
189,0211-699501013259,solo,o
189,0211-699501013259,3,o
189,0211-699501013259,pacientes,o
189,0211-699501013259,presentan,o
189,0211-699501013259,niveles,o
189,0211-699501013259,normales,o
189,0211-699501013259,de,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,correlacionandose,o
189,0211-699501013259,directamente,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,con,o
189,0211-699501013259,la,o
189,0211-699501013259,albumina,i
189,0211-699501013259,r,o
189,0211-699501013259,056,o
189,0211-699501013259,p,o
189,0211-699501013259,0001,o
189,0211-699501013259,que,o
189,0211-699501013259,se,o
189,0211-699501013259,elevo,o
189,0211-699501013259,con,o
189,0211-699501013259,respecto,o
189,0211-699501013259,al,o
189,0211-699501013259,inicio,o
189,0211-699501013259,337,o
189,0211-699501013259,IC,o
189,0211-699501013259,327,o
189,0211-699501013259,346,o
189,0211-699501013259,vs,o
189,0211-699501013259,350,o
189,0211-699501013259,IC,o
189,0211-699501013259,337,o
189,0211-699501013259,363,o
189,0211-699501013259,p,o
189,0211-699501013259,005,o
189,0211-699501013259,Conclusion,o
189,0211-699501013259,Tras,o
189,0211-699501013259,suplementacion,i
189,0211-699501013259,con,o
189,0211-699501013259,acido,i
189,0211-699501013259,folico,i
189,0211-699501013259,y,o
189,0211-699501013259,vitamina,i
189,0211-699501013259,B6,i
189,0211-699501013259,aunque,o
189,0211-699501013259,inicialmente,o
189,0211-699501013259,se,o
189,0211-699501013259,reduce,o
189,0211-699501013259,la,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,esta,o
189,0211-699501013259,respuesta,o
189,0211-699501013259,se,o
189,0211-699501013259,hace,o
189,0211-699501013259,refractaria,o
189,0211-699501013259,correlacionandose,o
189,0211-699501013259,directamente,o
189,0211-699501013259,la,o
189,0211-699501013259,tHcy,i
189,0211-699501013259,con,o
189,0211-699501013259,la,o
189,0211-699501013259,albumina,i
189,0211-699501013259,plasmatica,i
189,0211-699501013259,La,o
189,0211-699501013259,interpretacion,o
189,0211-699501013259,de,o
189,0211-699501013259,los,o
189,0211-699501013259,niveles,i
189,0211-699501013259,de,i
189,0211-699501013259,tHcy,i
189,0211-699501013259,debe,o
189,0211-699501013259,tener,o
189,0211-699501013259,en,o
189,0211-699501013259,cuenta,o
189,0211-699501013259,la,o
189,0211-699501013259,concentracion,i
189,0211-699501013259,de,i
189,0211-699501013259,albumina,i
190,0211-699501013259,Efecto,o
190,0211-699501013259,de,o
190,0211-699501013259,la,o
190,0211-699501013259,suplementacion,i
190,0211-699501013259,con,o
190,0211-699501013259,acido,i
190,0211-699501013259,folico,i
190,0211-699501013259,sobre,o
190,0211-699501013259,los,o
190,0211-699501013259,niveles,i
190,0211-699501013259,de,i
190,0211-699501013259,homocisteina,i
190,0211-699501013259,total,o
190,0211-699501013259,en,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,en,o
190,0211-699501013259,hemodialisis,i
190,0211-699501013259,La,o
190,0211-699501013259,hiperhomocisteinemia,i
190,0211-699501013259,es,o
190,0211-699501013259,un,o
190,0211-699501013259,marcador,o
190,0211-699501013259,de,o
190,0211-699501013259,riesgo,o
190,0211-699501013259,independiente,o
190,0211-699501013259,de,o
190,0211-699501013259,morbimortalidad,o
190,0211-699501013259,cardiovascular,i
190,0211-699501013259,Hemos,o
190,0211-699501013259,intentado,o
190,0211-699501013259,prospectivamente,o
190,0211-699501013259,reducir,o
190,0211-699501013259,los,o
190,0211-699501013259,niveles,i
190,0211-699501013259,de,i
190,0211-699501013259,homocisteina,i
190,0211-699501013259,total,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,mediante,o
190,0211-699501013259,suplemento,o
190,0211-699501013259,con,o
190,0211-699501013259,acido,i
190,0211-699501013259,folico,i
190,0211-699501013259,y,o
190,0211-699501013259,vitamina,i
190,0211-699501013259,B6,i
190,0211-699501013259,pp,i
190,0211-699501013259,valorando,o
190,0211-699501013259,su,o
190,0211-699501013259,posible,o
190,0211-699501013259,correlacion,o
190,0211-699501013259,con,o
190,0211-699501013259,dosis,o
190,0211-699501013259,de,o
190,0211-699501013259,dialisis,i
190,0211-699501013259,funcion,i
190,0211-699501013259,residual,i
190,0211-699501013259,y,o
190,0211-699501013259,parametros,o
190,0211-699501013259,nutricionales,o
190,0211-699501013259,Metodos,o
190,0211-699501013259,Todos,o
190,0211-699501013259,los,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,en,o
190,0211-699501013259,hemodialisis,i
190,0211-699501013259,al,o
190,0211-699501013259,comienzo,o
190,0211-699501013259,del,o
190,0211-699501013259,estudio,o
190,0211-699501013259,que,o
190,0211-699501013259,no,o
190,0211-699501013259,recibian,o
190,0211-699501013259,acido,i
190,0211-699501013259,folico,i
190,0211-699501013259,ni,o
190,0211-699501013259,vitamina,i
190,0211-699501013259,B6,i
190,0211-699501013259,asi,o
190,0211-699501013259,como,o
190,0211-699501013259,los,o
190,0211-699501013259,incorporados,o
190,0211-699501013259,posteriormente,o
190,0211-699501013259,a,o
190,0211-699501013259,partir,o
190,0211-699501013259,de,o
190,0211-699501013259,su,o
190,0211-699501013259,tercer,o
190,0211-699501013259,mes,o
190,0211-699501013259,en,o
190,0211-699501013259,hemodialisis,i
190,0211-699501013259,recibieron,o
190,0211-699501013259,5,o
190,0211-699501013259,mg,o
190,0211-699501013259,orales,o
190,0211-699501013259,de,o
190,0211-699501013259,acido,i
190,0211-699501013259,folico,i
190,0211-699501013259,cada,o
190,0211-699501013259,48,o
190,0211-699501013259,horas,o
190,0211-699501013259,y,o
190,0211-699501013259,40,o
190,0211-699501013259,mg,o
190,0211-699501013259,orales,o
190,0211-699501013259,de,o
190,0211-699501013259,vitamina,i
190,0211-699501013259,B6,i
190,0211-699501013259,cada,o
190,0211-699501013259,semana,o
190,0211-699501013259,Se,o
190,0211-699501013259,determinaron,o
190,0211-699501013259,al,o
190,0211-699501013259,comienzo,o
190,0211-699501013259,del,o
190,0211-699501013259,estudio,o
190,0211-699501013259,y,o
190,0211-699501013259,cada,o
190,0211-699501013259,2,o
190,0211-699501013259,meses,o
190,0211-699501013259,niveles,i
190,0211-699501013259,de,i
190,0211-699501013259,folato,i
190,0211-699501013259,vitamina,i
190,0211-699501013259,B12,i
190,0211-699501013259,inmunoensayo,i
190,0211-699501013259,albumina,i
190,0211-699501013259,y,o
190,0211-699501013259,cinetica,o
190,0211-699501013259,de,o
190,0211-699501013259,la,o
190,0211-699501013259,urea,i
190,0211-699501013259,KTV,o
190,0211-699501013259,KRU,o
190,0211-699501013259,PCRn,o
190,0211-699501013259,y,o
190,0211-699501013259,cada,o
190,0211-699501013259,6,o
190,0211-699501013259,meses,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,HPLC,i
190,0211-699501013259,y,o
190,0211-699501013259,pp,i
190,0211-699501013259,RIA,i
190,0211-699501013259,Resultados,o
190,0211-699501013259,80,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,fueron,o
190,0211-699501013259,incluidos,o
190,0211-699501013259,en,o
190,0211-699501013259,el,o
190,0211-699501013259,estudio,o
190,0211-699501013259,basal,o
190,0211-699501013259,con,o
190,0211-699501013259,una,o
190,0211-699501013259,prevalencia,o
190,0211-699501013259,de,o
190,0211-699501013259,hiperhomocisteinemia,i
190,0211-699501013259,del,o
190,0211-699501013259,844,o
190,0211-699501013259,deficit,i
190,0211-699501013259,de,i
190,0211-699501013259,pp,i
190,0211-699501013259,en,o
190,0211-699501013259,el,o
190,0211-699501013259,32,o
190,0211-699501013259,y,o
190,0211-699501013259,folato,i
190,0211-699501013259,en,o
190,0211-699501013259,el,o
190,0211-699501013259,rango,o
190,0211-699501013259,normal,o
190,0211-699501013259,bajo,o
190,0211-699501013259,los,o
190,0211-699501013259,niveles,i
190,0211-699501013259,de,i
190,0211-699501013259,tHcy,i
190,0211-699501013259,se,o
190,0211-699501013259,correlacionaban,o
190,0211-699501013259,inversamente,o
190,0211-699501013259,con,o
190,0211-699501013259,los,o
190,0211-699501013259,del,o
190,0211-699501013259,folato,i
190,0211-699501013259,r,o
190,0211-699501013259,0336,o
190,0211-699501013259,p,o
190,0211-699501013259,001,o
190,0211-699501013259,pero,o
190,0211-699501013259,no,o
190,0211-699501013259,con,o
190,0211-699501013259,pp,i
190,0211-699501013259,B12,i
190,0211-699501013259,edad,o
190,0211-699501013259,albumina,i
190,0211-699501013259,KTV,o
190,0211-699501013259,KRU,o
190,0211-699501013259,PCRn,o
190,0211-699501013259,Cincuenta,o
190,0211-699501013259,y,o
190,0211-699501013259,ocho,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,recibieron,o
190,0211-699501013259,seis,o
190,0211-699501013259,meses,o
190,0211-699501013259,de,o
190,0211-699501013259,suplementacion,i
190,0211-699501013259,con,o
190,0211-699501013259,normalizacion,o
190,0211-699501013259,del,o
190,0211-699501013259,pp,i
190,0211-699501013259,aumento,o
190,0211-699501013259,del,o
190,0211-699501013259,folato,i
190,0211-699501013259,703,o
190,0211-699501013259,IC,o
190,0211-699501013259,638,o
190,0211-699501013259,795,o
190,0211-699501013259,vs,o
190,0211-699501013259,6181,o
190,0211-699501013259,IC,o
190,0211-699501013259,4447,o
190,0211-699501013259,7811,o
190,0211-699501013259,p,o
190,0211-699501013259,0001,o
190,0211-699501013259,y,o
190,0211-699501013259,descenso,o
190,0211-699501013259,de,o
190,0211-699501013259,la,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,240,o
190,0211-699501013259,IC,o
190,0211-699501013259,213,o
190,0211-699501013259,264,o
190,0211-699501013259,vs,o
190,0211-699501013259,199,o
190,0211-699501013259,IC,o
190,0211-699501013259,175,o
190,0211-699501013259,224,o
190,0211-699501013259,p,o
190,0211-699501013259,005,o
190,0211-699501013259,Han,o
190,0211-699501013259,recibido,o
190,0211-699501013259,suplementacion,i
190,0211-699501013259,durante,o
190,0211-699501013259,12,o
190,0211-699501013259,meses,o
190,0211-699501013259,33,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,pero,o
190,0211-699501013259,a,o
190,0211-699501013259,pesar,o
190,0211-699501013259,de,o
190,0211-699501013259,un,o
190,0211-699501013259,continuo,o
190,0211-699501013259,aumento,o
190,0211-699501013259,del,o
190,0211-699501013259,folato,i
190,0211-699501013259,10078,o
190,0211-699501013259,IC,o
190,0211-699501013259,7481,o
190,0211-699501013259,12674,o
190,0211-699501013259,p,o
190,0211-699501013259,0001,o
190,0211-699501013259,solo,o
190,0211-699501013259,3,o
190,0211-699501013259,pacientes,o
190,0211-699501013259,presentan,o
190,0211-699501013259,niveles,o
190,0211-699501013259,normales,o
190,0211-699501013259,de,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,correlacionandose,o
190,0211-699501013259,directamente,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,con,o
190,0211-699501013259,la,o
190,0211-699501013259,albumina,i
190,0211-699501013259,r,o
190,0211-699501013259,056,o
190,0211-699501013259,p,o
190,0211-699501013259,0001,o
190,0211-699501013259,que,o
190,0211-699501013259,se,o
190,0211-699501013259,elevo,o
190,0211-699501013259,con,o
190,0211-699501013259,respecto,o
190,0211-699501013259,al,o
190,0211-699501013259,inicio,o
190,0211-699501013259,337,o
190,0211-699501013259,IC,o
190,0211-699501013259,327,o
190,0211-699501013259,346,o
190,0211-699501013259,vs,o
190,0211-699501013259,350,o
190,0211-699501013259,IC,o
190,0211-699501013259,337,o
190,0211-699501013259,363,o
190,0211-699501013259,p,o
190,0211-699501013259,005,o
190,0211-699501013259,Conclusion,o
190,0211-699501013259,Tras,o
190,0211-699501013259,suplementacion,i
190,0211-699501013259,con,o
190,0211-699501013259,acido,i
190,0211-699501013259,folico,i
190,0211-699501013259,y,o
190,0211-699501013259,vitamina,i
190,0211-699501013259,B6,i
190,0211-699501013259,aunque,o
190,0211-699501013259,inicialmente,o
190,0211-699501013259,se,o
190,0211-699501013259,reduce,o
190,0211-699501013259,la,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,esta,o
190,0211-699501013259,respuesta,o
190,0211-699501013259,se,o
190,0211-699501013259,hace,o
190,0211-699501013259,refractaria,o
190,0211-699501013259,correlacionandose,o
190,0211-699501013259,directamente,o
190,0211-699501013259,la,o
190,0211-699501013259,tHcy,i
190,0211-699501013259,con,o
190,0211-699501013259,la,o
190,0211-699501013259,albumina,i
190,0211-699501013259,plasmatica,i
190,0211-699501013259,La,o
190,0211-699501013259,interpretacion,o
190,0211-699501013259,de,o
190,0211-699501013259,los,o
190,0211-699501013259,niveles,i
190,0211-699501013259,de,i
190,0211-699501013259,tHcy,i
190,0211-699501013259,debe,o
190,0211-699501013259,tener,o
190,0211-699501013259,en,o
190,0211-699501013259,cuenta,o
190,0211-699501013259,la,o
190,0211-699501013259,concentracion,i
190,0211-699501013259,de,i
190,0211-699501013259,albumina,i
191,0211-699501013259,Efecto,o
191,0211-699501013259,de,o
191,0211-699501013259,la,o
191,0211-699501013259,suplementacion,i
191,0211-699501013259,con,o
191,0211-699501013259,acido,i
191,0211-699501013259,folico,i
191,0211-699501013259,sobre,o
191,0211-699501013259,los,o
191,0211-699501013259,niveles,i
191,0211-699501013259,de,i
191,0211-699501013259,homocisteina,i
191,0211-699501013259,total,o
191,0211-699501013259,en,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,en,o
191,0211-699501013259,hemodialisis,i
191,0211-699501013259,La,o
191,0211-699501013259,hiperhomocisteinemia,i
191,0211-699501013259,es,o
191,0211-699501013259,un,o
191,0211-699501013259,marcador,o
191,0211-699501013259,de,o
191,0211-699501013259,riesgo,o
191,0211-699501013259,independiente,o
191,0211-699501013259,de,o
191,0211-699501013259,morbimortalidad,o
191,0211-699501013259,cardiovascular,i
191,0211-699501013259,Hemos,o
191,0211-699501013259,intentado,o
191,0211-699501013259,prospectivamente,o
191,0211-699501013259,reducir,o
191,0211-699501013259,los,o
191,0211-699501013259,niveles,i
191,0211-699501013259,de,i
191,0211-699501013259,homocisteina,i
191,0211-699501013259,total,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,mediante,o
191,0211-699501013259,suplemento,o
191,0211-699501013259,con,o
191,0211-699501013259,acido,i
191,0211-699501013259,folico,i
191,0211-699501013259,y,o
191,0211-699501013259,vitamina,i
191,0211-699501013259,B6,i
191,0211-699501013259,pp,i
191,0211-699501013259,valorando,o
191,0211-699501013259,su,o
191,0211-699501013259,posible,o
191,0211-699501013259,correlacion,o
191,0211-699501013259,con,o
191,0211-699501013259,dosis,o
191,0211-699501013259,de,o
191,0211-699501013259,dialisis,i
191,0211-699501013259,funcion,i
191,0211-699501013259,residual,i
191,0211-699501013259,y,o
191,0211-699501013259,parametros,o
191,0211-699501013259,nutricionales,o
191,0211-699501013259,Metodos,o
191,0211-699501013259,Todos,o
191,0211-699501013259,los,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,en,o
191,0211-699501013259,hemodialisis,i
191,0211-699501013259,al,o
191,0211-699501013259,comienzo,o
191,0211-699501013259,del,o
191,0211-699501013259,estudio,o
191,0211-699501013259,que,o
191,0211-699501013259,no,o
191,0211-699501013259,recibian,o
191,0211-699501013259,acido,i
191,0211-699501013259,folico,i
191,0211-699501013259,ni,o
191,0211-699501013259,vitamina,i
191,0211-699501013259,B6,i
191,0211-699501013259,asi,o
191,0211-699501013259,como,o
191,0211-699501013259,los,o
191,0211-699501013259,incorporados,o
191,0211-699501013259,posteriormente,o
191,0211-699501013259,a,o
191,0211-699501013259,partir,o
191,0211-699501013259,de,o
191,0211-699501013259,su,o
191,0211-699501013259,tercer,o
191,0211-699501013259,mes,o
191,0211-699501013259,en,o
191,0211-699501013259,hemodialisis,i
191,0211-699501013259,recibieron,o
191,0211-699501013259,5,o
191,0211-699501013259,mg,o
191,0211-699501013259,orales,o
191,0211-699501013259,de,o
191,0211-699501013259,acido,i
191,0211-699501013259,folico,i
191,0211-699501013259,cada,o
191,0211-699501013259,48,o
191,0211-699501013259,horas,o
191,0211-699501013259,y,o
191,0211-699501013259,40,o
191,0211-699501013259,mg,o
191,0211-699501013259,orales,o
191,0211-699501013259,de,o
191,0211-699501013259,vitamina,i
191,0211-699501013259,B6,i
191,0211-699501013259,cada,o
191,0211-699501013259,semana,o
191,0211-699501013259,Se,o
191,0211-699501013259,determinaron,o
191,0211-699501013259,al,o
191,0211-699501013259,comienzo,o
191,0211-699501013259,del,o
191,0211-699501013259,estudio,o
191,0211-699501013259,y,o
191,0211-699501013259,cada,o
191,0211-699501013259,2,o
191,0211-699501013259,meses,o
191,0211-699501013259,niveles,i
191,0211-699501013259,de,i
191,0211-699501013259,folato,i
191,0211-699501013259,vitamina,i
191,0211-699501013259,B12,i
191,0211-699501013259,inmunoensayo,i
191,0211-699501013259,albumina,i
191,0211-699501013259,y,o
191,0211-699501013259,cinetica,o
191,0211-699501013259,de,o
191,0211-699501013259,la,o
191,0211-699501013259,urea,i
191,0211-699501013259,KTV,o
191,0211-699501013259,KRU,o
191,0211-699501013259,PCRn,o
191,0211-699501013259,y,o
191,0211-699501013259,cada,o
191,0211-699501013259,6,o
191,0211-699501013259,meses,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,HPLC,i
191,0211-699501013259,y,o
191,0211-699501013259,pp,i
191,0211-699501013259,RIA,i
191,0211-699501013259,Resultados,o
191,0211-699501013259,80,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,fueron,o
191,0211-699501013259,incluidos,o
191,0211-699501013259,en,o
191,0211-699501013259,el,o
191,0211-699501013259,estudio,o
191,0211-699501013259,basal,o
191,0211-699501013259,con,o
191,0211-699501013259,una,o
191,0211-699501013259,prevalencia,o
191,0211-699501013259,de,o
191,0211-699501013259,hiperhomocisteinemia,i
191,0211-699501013259,del,o
191,0211-699501013259,844,o
191,0211-699501013259,deficit,i
191,0211-699501013259,de,i
191,0211-699501013259,pp,i
191,0211-699501013259,en,o
191,0211-699501013259,el,o
191,0211-699501013259,32,o
191,0211-699501013259,y,o
191,0211-699501013259,folato,i
191,0211-699501013259,en,o
191,0211-699501013259,el,o
191,0211-699501013259,rango,o
191,0211-699501013259,normal,o
191,0211-699501013259,bajo,o
191,0211-699501013259,los,o
191,0211-699501013259,niveles,i
191,0211-699501013259,de,i
191,0211-699501013259,tHcy,i
191,0211-699501013259,se,o
191,0211-699501013259,correlacionaban,o
191,0211-699501013259,inversamente,o
191,0211-699501013259,con,o
191,0211-699501013259,los,o
191,0211-699501013259,del,o
191,0211-699501013259,folato,i
191,0211-699501013259,r,o
191,0211-699501013259,0336,o
191,0211-699501013259,p,o
191,0211-699501013259,001,o
191,0211-699501013259,pero,o
191,0211-699501013259,no,o
191,0211-699501013259,con,o
191,0211-699501013259,pp,i
191,0211-699501013259,B12,i
191,0211-699501013259,edad,o
191,0211-699501013259,albumina,i
191,0211-699501013259,KTV,o
191,0211-699501013259,KRU,o
191,0211-699501013259,PCRn,o
191,0211-699501013259,Cincuenta,o
191,0211-699501013259,y,o
191,0211-699501013259,ocho,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,recibieron,o
191,0211-699501013259,seis,o
191,0211-699501013259,meses,o
191,0211-699501013259,de,o
191,0211-699501013259,suplementacion,i
191,0211-699501013259,con,o
191,0211-699501013259,normalizacion,o
191,0211-699501013259,del,o
191,0211-699501013259,pp,i
191,0211-699501013259,aumento,o
191,0211-699501013259,del,o
191,0211-699501013259,folato,i
191,0211-699501013259,703,o
191,0211-699501013259,IC,o
191,0211-699501013259,638,o
191,0211-699501013259,795,o
191,0211-699501013259,vs,o
191,0211-699501013259,6181,o
191,0211-699501013259,IC,o
191,0211-699501013259,4447,o
191,0211-699501013259,7811,o
191,0211-699501013259,p,o
191,0211-699501013259,0001,o
191,0211-699501013259,y,o
191,0211-699501013259,descenso,o
191,0211-699501013259,de,o
191,0211-699501013259,la,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,240,o
191,0211-699501013259,IC,o
191,0211-699501013259,213,o
191,0211-699501013259,264,o
191,0211-699501013259,vs,o
191,0211-699501013259,199,o
191,0211-699501013259,IC,o
191,0211-699501013259,175,o
191,0211-699501013259,224,o
191,0211-699501013259,p,o
191,0211-699501013259,005,o
191,0211-699501013259,Han,o
191,0211-699501013259,recibido,o
191,0211-699501013259,suplementacion,i
191,0211-699501013259,durante,o
191,0211-699501013259,12,o
191,0211-699501013259,meses,o
191,0211-699501013259,33,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,pero,o
191,0211-699501013259,a,o
191,0211-699501013259,pesar,o
191,0211-699501013259,de,o
191,0211-699501013259,un,o
191,0211-699501013259,continuo,o
191,0211-699501013259,aumento,o
191,0211-699501013259,del,o
191,0211-699501013259,folato,i
191,0211-699501013259,10078,o
191,0211-699501013259,IC,o
191,0211-699501013259,7481,o
191,0211-699501013259,12674,o
191,0211-699501013259,p,o
191,0211-699501013259,0001,o
191,0211-699501013259,solo,o
191,0211-699501013259,3,o
191,0211-699501013259,pacientes,o
191,0211-699501013259,presentan,o
191,0211-699501013259,niveles,o
191,0211-699501013259,normales,o
191,0211-699501013259,de,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,correlacionandose,o
191,0211-699501013259,directamente,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,con,o
191,0211-699501013259,la,o
191,0211-699501013259,albumina,i
191,0211-699501013259,r,o
191,0211-699501013259,056,o
191,0211-699501013259,p,o
191,0211-699501013259,0001,o
191,0211-699501013259,que,o
191,0211-699501013259,se,o
191,0211-699501013259,elevo,o
191,0211-699501013259,con,o
191,0211-699501013259,respecto,o
191,0211-699501013259,al,o
191,0211-699501013259,inicio,o
191,0211-699501013259,337,o
191,0211-699501013259,IC,o
191,0211-699501013259,327,o
191,0211-699501013259,346,o
191,0211-699501013259,vs,o
191,0211-699501013259,350,o
191,0211-699501013259,IC,o
191,0211-699501013259,337,o
191,0211-699501013259,363,o
191,0211-699501013259,p,o
191,0211-699501013259,005,o
191,0211-699501013259,Conclusion,o
191,0211-699501013259,Tras,o
191,0211-699501013259,suplementacion,i
191,0211-699501013259,con,o
191,0211-699501013259,acido,i
191,0211-699501013259,folico,i
191,0211-699501013259,y,o
191,0211-699501013259,vitamina,i
191,0211-699501013259,B6,i
191,0211-699501013259,aunque,o
191,0211-699501013259,inicialmente,o
191,0211-699501013259,se,o
191,0211-699501013259,reduce,o
191,0211-699501013259,la,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,esta,o
191,0211-699501013259,respuesta,o
191,0211-699501013259,se,o
191,0211-699501013259,hace,o
191,0211-699501013259,refractaria,o
191,0211-699501013259,correlacionandose,o
191,0211-699501013259,directamente,o
191,0211-699501013259,la,o
191,0211-699501013259,tHcy,i
191,0211-699501013259,con,o
191,0211-699501013259,la,o
191,0211-699501013259,albumina,i
191,0211-699501013259,plasmatica,i
191,0211-699501013259,La,o
191,0211-699501013259,interpretacion,o
191,0211-699501013259,de,o
191,0211-699501013259,los,o
191,0211-699501013259,niveles,i
191,0211-699501013259,de,i
191,0211-699501013259,tHcy,i
191,0211-699501013259,debe,o
191,0211-699501013259,tener,o
191,0211-699501013259,en,o
191,0211-699501013259,cuenta,o
191,0211-699501013259,la,o
191,0211-699501013259,concentracion,i
191,0211-699501013259,de,i
191,0211-699501013259,albumina,i
192,0211-699501013259,Efecto,o
192,0211-699501013259,de,o
192,0211-699501013259,la,o
192,0211-699501013259,suplementacion,i
192,0211-699501013259,con,o
192,0211-699501013259,acido,i
192,0211-699501013259,folico,i
192,0211-699501013259,sobre,o
192,0211-699501013259,los,o
192,0211-699501013259,niveles,i
192,0211-699501013259,de,i
192,0211-699501013259,homocisteina,i
192,0211-699501013259,total,o
192,0211-699501013259,en,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,en,o
192,0211-699501013259,hemodialisis,i
192,0211-699501013259,La,o
192,0211-699501013259,hiperhomocisteinemia,i
192,0211-699501013259,es,o
192,0211-699501013259,un,o
192,0211-699501013259,marcador,o
192,0211-699501013259,de,o
192,0211-699501013259,riesgo,o
192,0211-699501013259,independiente,o
192,0211-699501013259,de,o
192,0211-699501013259,morbimortalidad,o
192,0211-699501013259,cardiovascular,i
192,0211-699501013259,Hemos,o
192,0211-699501013259,intentado,o
192,0211-699501013259,prospectivamente,o
192,0211-699501013259,reducir,o
192,0211-699501013259,los,o
192,0211-699501013259,niveles,i
192,0211-699501013259,de,i
192,0211-699501013259,homocisteina,i
192,0211-699501013259,total,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,mediante,o
192,0211-699501013259,suplemento,o
192,0211-699501013259,con,o
192,0211-699501013259,acido,i
192,0211-699501013259,folico,i
192,0211-699501013259,y,o
192,0211-699501013259,vitamina,i
192,0211-699501013259,B6,i
192,0211-699501013259,pp,i
192,0211-699501013259,valorando,o
192,0211-699501013259,su,o
192,0211-699501013259,posible,o
192,0211-699501013259,correlacion,o
192,0211-699501013259,con,o
192,0211-699501013259,dosis,o
192,0211-699501013259,de,o
192,0211-699501013259,dialisis,i
192,0211-699501013259,funcion,i
192,0211-699501013259,residual,i
192,0211-699501013259,y,o
192,0211-699501013259,parametros,o
192,0211-699501013259,nutricionales,o
192,0211-699501013259,Metodos,o
192,0211-699501013259,Todos,o
192,0211-699501013259,los,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,en,o
192,0211-699501013259,hemodialisis,i
192,0211-699501013259,al,o
192,0211-699501013259,comienzo,o
192,0211-699501013259,del,o
192,0211-699501013259,estudio,o
192,0211-699501013259,que,o
192,0211-699501013259,no,o
192,0211-699501013259,recibian,o
192,0211-699501013259,acido,i
192,0211-699501013259,folico,i
192,0211-699501013259,ni,o
192,0211-699501013259,vitamina,i
192,0211-699501013259,B6,i
192,0211-699501013259,asi,o
192,0211-699501013259,como,o
192,0211-699501013259,los,o
192,0211-699501013259,incorporados,o
192,0211-699501013259,posteriormente,o
192,0211-699501013259,a,o
192,0211-699501013259,partir,o
192,0211-699501013259,de,o
192,0211-699501013259,su,o
192,0211-699501013259,tercer,o
192,0211-699501013259,mes,o
192,0211-699501013259,en,o
192,0211-699501013259,hemodialisis,i
192,0211-699501013259,recibieron,o
192,0211-699501013259,5,o
192,0211-699501013259,mg,o
192,0211-699501013259,orales,o
192,0211-699501013259,de,o
192,0211-699501013259,acido,i
192,0211-699501013259,folico,i
192,0211-699501013259,cada,o
192,0211-699501013259,48,o
192,0211-699501013259,horas,o
192,0211-699501013259,y,o
192,0211-699501013259,40,o
192,0211-699501013259,mg,o
192,0211-699501013259,orales,o
192,0211-699501013259,de,o
192,0211-699501013259,vitamina,i
192,0211-699501013259,B6,i
192,0211-699501013259,cada,o
192,0211-699501013259,semana,o
192,0211-699501013259,Se,o
192,0211-699501013259,determinaron,o
192,0211-699501013259,al,o
192,0211-699501013259,comienzo,o
192,0211-699501013259,del,o
192,0211-699501013259,estudio,o
192,0211-699501013259,y,o
192,0211-699501013259,cada,o
192,0211-699501013259,2,o
192,0211-699501013259,meses,o
192,0211-699501013259,niveles,i
192,0211-699501013259,de,i
192,0211-699501013259,folato,i
192,0211-699501013259,vitamina,i
192,0211-699501013259,B12,i
192,0211-699501013259,inmunoensayo,i
192,0211-699501013259,albumina,i
192,0211-699501013259,y,o
192,0211-699501013259,cinetica,o
192,0211-699501013259,de,o
192,0211-699501013259,la,o
192,0211-699501013259,urea,i
192,0211-699501013259,KTV,o
192,0211-699501013259,KRU,o
192,0211-699501013259,PCRn,o
192,0211-699501013259,y,o
192,0211-699501013259,cada,o
192,0211-699501013259,6,o
192,0211-699501013259,meses,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,HPLC,i
192,0211-699501013259,y,o
192,0211-699501013259,pp,i
192,0211-699501013259,RIA,i
192,0211-699501013259,Resultados,o
192,0211-699501013259,80,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,fueron,o
192,0211-699501013259,incluidos,o
192,0211-699501013259,en,o
192,0211-699501013259,el,o
192,0211-699501013259,estudio,o
192,0211-699501013259,basal,o
192,0211-699501013259,con,o
192,0211-699501013259,una,o
192,0211-699501013259,prevalencia,o
192,0211-699501013259,de,o
192,0211-699501013259,hiperhomocisteinemia,i
192,0211-699501013259,del,o
192,0211-699501013259,844,o
192,0211-699501013259,deficit,i
192,0211-699501013259,de,i
192,0211-699501013259,pp,i
192,0211-699501013259,en,o
192,0211-699501013259,el,o
192,0211-699501013259,32,o
192,0211-699501013259,y,o
192,0211-699501013259,folato,i
192,0211-699501013259,en,o
192,0211-699501013259,el,o
192,0211-699501013259,rango,o
192,0211-699501013259,normal,o
192,0211-699501013259,bajo,o
192,0211-699501013259,los,o
192,0211-699501013259,niveles,i
192,0211-699501013259,de,i
192,0211-699501013259,tHcy,i
192,0211-699501013259,se,o
192,0211-699501013259,correlacionaban,o
192,0211-699501013259,inversamente,o
192,0211-699501013259,con,o
192,0211-699501013259,los,o
192,0211-699501013259,del,o
192,0211-699501013259,folato,i
192,0211-699501013259,r,o
192,0211-699501013259,0336,o
192,0211-699501013259,p,o
192,0211-699501013259,001,o
192,0211-699501013259,pero,o
192,0211-699501013259,no,o
192,0211-699501013259,con,o
192,0211-699501013259,pp,i
192,0211-699501013259,B12,i
192,0211-699501013259,edad,o
192,0211-699501013259,albumina,i
192,0211-699501013259,KTV,o
192,0211-699501013259,KRU,o
192,0211-699501013259,PCRn,o
192,0211-699501013259,Cincuenta,o
192,0211-699501013259,y,o
192,0211-699501013259,ocho,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,recibieron,o
192,0211-699501013259,seis,o
192,0211-699501013259,meses,o
192,0211-699501013259,de,o
192,0211-699501013259,suplementacion,i
192,0211-699501013259,con,o
192,0211-699501013259,normalizacion,o
192,0211-699501013259,del,o
192,0211-699501013259,pp,i
192,0211-699501013259,aumento,o
192,0211-699501013259,del,o
192,0211-699501013259,folato,i
192,0211-699501013259,703,o
192,0211-699501013259,IC,o
192,0211-699501013259,638,o
192,0211-699501013259,795,o
192,0211-699501013259,vs,o
192,0211-699501013259,6181,o
192,0211-699501013259,IC,o
192,0211-699501013259,4447,o
192,0211-699501013259,7811,o
192,0211-699501013259,p,o
192,0211-699501013259,0001,o
192,0211-699501013259,y,o
192,0211-699501013259,descenso,o
192,0211-699501013259,de,o
192,0211-699501013259,la,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,240,o
192,0211-699501013259,IC,o
192,0211-699501013259,213,o
192,0211-699501013259,264,o
192,0211-699501013259,vs,o
192,0211-699501013259,199,o
192,0211-699501013259,IC,o
192,0211-699501013259,175,o
192,0211-699501013259,224,o
192,0211-699501013259,p,o
192,0211-699501013259,005,o
192,0211-699501013259,Han,o
192,0211-699501013259,recibido,o
192,0211-699501013259,suplementacion,i
192,0211-699501013259,durante,o
192,0211-699501013259,12,o
192,0211-699501013259,meses,o
192,0211-699501013259,33,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,pero,o
192,0211-699501013259,a,o
192,0211-699501013259,pesar,o
192,0211-699501013259,de,o
192,0211-699501013259,un,o
192,0211-699501013259,continuo,o
192,0211-699501013259,aumento,o
192,0211-699501013259,del,o
192,0211-699501013259,folato,i
192,0211-699501013259,10078,o
192,0211-699501013259,IC,o
192,0211-699501013259,7481,o
192,0211-699501013259,12674,o
192,0211-699501013259,p,o
192,0211-699501013259,0001,o
192,0211-699501013259,solo,o
192,0211-699501013259,3,o
192,0211-699501013259,pacientes,o
192,0211-699501013259,presentan,o
192,0211-699501013259,niveles,o
192,0211-699501013259,normales,o
192,0211-699501013259,de,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,correlacionandose,o
192,0211-699501013259,directamente,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,con,o
192,0211-699501013259,la,o
192,0211-699501013259,albumina,i
192,0211-699501013259,r,o
192,0211-699501013259,056,o
192,0211-699501013259,p,o
192,0211-699501013259,0001,o
192,0211-699501013259,que,o
192,0211-699501013259,se,o
192,0211-699501013259,elevo,o
192,0211-699501013259,con,o
192,0211-699501013259,respecto,o
192,0211-699501013259,al,o
192,0211-699501013259,inicio,o
192,0211-699501013259,337,o
192,0211-699501013259,IC,o
192,0211-699501013259,327,o
192,0211-699501013259,346,o
192,0211-699501013259,vs,o
192,0211-699501013259,350,o
192,0211-699501013259,IC,o
192,0211-699501013259,337,o
192,0211-699501013259,363,o
192,0211-699501013259,p,o
192,0211-699501013259,005,o
192,0211-699501013259,Conclusion,o
192,0211-699501013259,Tras,o
192,0211-699501013259,suplementacion,i
192,0211-699501013259,con,o
192,0211-699501013259,acido,i
192,0211-699501013259,folico,i
192,0211-699501013259,y,o
192,0211-699501013259,vitamina,i
192,0211-699501013259,B6,i
192,0211-699501013259,aunque,o
192,0211-699501013259,inicialmente,o
192,0211-699501013259,se,o
192,0211-699501013259,reduce,o
192,0211-699501013259,la,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,esta,o
192,0211-699501013259,respuesta,o
192,0211-699501013259,se,o
192,0211-699501013259,hace,o
192,0211-699501013259,refractaria,o
192,0211-699501013259,correlacionandose,o
192,0211-699501013259,directamente,o
192,0211-699501013259,la,o
192,0211-699501013259,tHcy,i
192,0211-699501013259,con,o
192,0211-699501013259,la,o
192,0211-699501013259,albumina,i
192,0211-699501013259,plasmatica,i
192,0211-699501013259,La,o
192,0211-699501013259,interpretacion,o
192,0211-699501013259,de,o
192,0211-699501013259,los,o
192,0211-699501013259,niveles,i
192,0211-699501013259,de,i
192,0211-699501013259,tHcy,i
192,0211-699501013259,debe,o
192,0211-699501013259,tener,o
192,0211-699501013259,en,o
192,0211-699501013259,cuenta,o
192,0211-699501013259,la,o
192,0211-699501013259,concentracion,i
192,0211-699501013259,de,i
192,0211-699501013259,albumina,i
193,0211-699501013259,Efecto,o
193,0211-699501013259,de,o
193,0211-699501013259,la,o
193,0211-699501013259,suplementacion,i
193,0211-699501013259,con,o
193,0211-699501013259,acido,i
193,0211-699501013259,folico,i
193,0211-699501013259,sobre,o
193,0211-699501013259,los,o
193,0211-699501013259,niveles,i
193,0211-699501013259,de,i
193,0211-699501013259,homocisteina,i
193,0211-699501013259,total,o
193,0211-699501013259,en,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,en,o
193,0211-699501013259,hemodialisis,i
193,0211-699501013259,La,o
193,0211-699501013259,hiperhomocisteinemia,i
193,0211-699501013259,es,o
193,0211-699501013259,un,o
193,0211-699501013259,marcador,o
193,0211-699501013259,de,o
193,0211-699501013259,riesgo,o
193,0211-699501013259,independiente,o
193,0211-699501013259,de,o
193,0211-699501013259,morbimortalidad,o
193,0211-699501013259,cardiovascular,i
193,0211-699501013259,Hemos,o
193,0211-699501013259,intentado,o
193,0211-699501013259,prospectivamente,o
193,0211-699501013259,reducir,o
193,0211-699501013259,los,o
193,0211-699501013259,niveles,i
193,0211-699501013259,de,i
193,0211-699501013259,homocisteina,i
193,0211-699501013259,total,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,mediante,o
193,0211-699501013259,suplemento,o
193,0211-699501013259,con,o
193,0211-699501013259,acido,i
193,0211-699501013259,folico,i
193,0211-699501013259,y,o
193,0211-699501013259,vitamina,i
193,0211-699501013259,B6,i
193,0211-699501013259,pp,i
193,0211-699501013259,valorando,o
193,0211-699501013259,su,o
193,0211-699501013259,posible,o
193,0211-699501013259,correlacion,o
193,0211-699501013259,con,o
193,0211-699501013259,dosis,o
193,0211-699501013259,de,o
193,0211-699501013259,dialisis,i
193,0211-699501013259,funcion,i
193,0211-699501013259,residual,i
193,0211-699501013259,y,o
193,0211-699501013259,parametros,o
193,0211-699501013259,nutricionales,o
193,0211-699501013259,Metodos,o
193,0211-699501013259,Todos,o
193,0211-699501013259,los,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,en,o
193,0211-699501013259,hemodialisis,i
193,0211-699501013259,al,o
193,0211-699501013259,comienzo,o
193,0211-699501013259,del,o
193,0211-699501013259,estudio,o
193,0211-699501013259,que,o
193,0211-699501013259,no,o
193,0211-699501013259,recibian,o
193,0211-699501013259,acido,i
193,0211-699501013259,folico,i
193,0211-699501013259,ni,o
193,0211-699501013259,vitamina,i
193,0211-699501013259,B6,i
193,0211-699501013259,asi,o
193,0211-699501013259,como,o
193,0211-699501013259,los,o
193,0211-699501013259,incorporados,o
193,0211-699501013259,posteriormente,o
193,0211-699501013259,a,o
193,0211-699501013259,partir,o
193,0211-699501013259,de,o
193,0211-699501013259,su,o
193,0211-699501013259,tercer,o
193,0211-699501013259,mes,o
193,0211-699501013259,en,o
193,0211-699501013259,hemodialisis,i
193,0211-699501013259,recibieron,o
193,0211-699501013259,5,o
193,0211-699501013259,mg,o
193,0211-699501013259,orales,o
193,0211-699501013259,de,o
193,0211-699501013259,acido,i
193,0211-699501013259,folico,i
193,0211-699501013259,cada,o
193,0211-699501013259,48,o
193,0211-699501013259,horas,o
193,0211-699501013259,y,o
193,0211-699501013259,40,o
193,0211-699501013259,mg,o
193,0211-699501013259,orales,o
193,0211-699501013259,de,o
193,0211-699501013259,vitamina,i
193,0211-699501013259,B6,i
193,0211-699501013259,cada,o
193,0211-699501013259,semana,o
193,0211-699501013259,Se,o
193,0211-699501013259,determinaron,o
193,0211-699501013259,al,o
193,0211-699501013259,comienzo,o
193,0211-699501013259,del,o
193,0211-699501013259,estudio,o
193,0211-699501013259,y,o
193,0211-699501013259,cada,o
193,0211-699501013259,2,o
193,0211-699501013259,meses,o
193,0211-699501013259,niveles,i
193,0211-699501013259,de,i
193,0211-699501013259,folato,i
193,0211-699501013259,vitamina,i
193,0211-699501013259,B12,i
193,0211-699501013259,inmunoensayo,i
193,0211-699501013259,albumina,i
193,0211-699501013259,y,o
193,0211-699501013259,cinetica,o
193,0211-699501013259,de,o
193,0211-699501013259,la,o
193,0211-699501013259,urea,i
193,0211-699501013259,KTV,o
193,0211-699501013259,KRU,o
193,0211-699501013259,PCRn,o
193,0211-699501013259,y,o
193,0211-699501013259,cada,o
193,0211-699501013259,6,o
193,0211-699501013259,meses,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,HPLC,i
193,0211-699501013259,y,o
193,0211-699501013259,pp,i
193,0211-699501013259,RIA,i
193,0211-699501013259,Resultados,o
193,0211-699501013259,80,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,fueron,o
193,0211-699501013259,incluidos,o
193,0211-699501013259,en,o
193,0211-699501013259,el,o
193,0211-699501013259,estudio,o
193,0211-699501013259,basal,o
193,0211-699501013259,con,o
193,0211-699501013259,una,o
193,0211-699501013259,prevalencia,o
193,0211-699501013259,de,o
193,0211-699501013259,hiperhomocisteinemia,i
193,0211-699501013259,del,o
193,0211-699501013259,844,o
193,0211-699501013259,deficit,i
193,0211-699501013259,de,i
193,0211-699501013259,pp,i
193,0211-699501013259,en,o
193,0211-699501013259,el,o
193,0211-699501013259,32,o
193,0211-699501013259,y,o
193,0211-699501013259,folato,i
193,0211-699501013259,en,o
193,0211-699501013259,el,o
193,0211-699501013259,rango,o
193,0211-699501013259,normal,o
193,0211-699501013259,bajo,o
193,0211-699501013259,los,o
193,0211-699501013259,niveles,i
193,0211-699501013259,de,i
193,0211-699501013259,tHcy,i
193,0211-699501013259,se,o
193,0211-699501013259,correlacionaban,o
193,0211-699501013259,inversamente,o
193,0211-699501013259,con,o
193,0211-699501013259,los,o
193,0211-699501013259,del,o
193,0211-699501013259,folato,i
193,0211-699501013259,r,o
193,0211-699501013259,0336,o
193,0211-699501013259,p,o
193,0211-699501013259,001,o
193,0211-699501013259,pero,o
193,0211-699501013259,no,o
193,0211-699501013259,con,o
193,0211-699501013259,pp,i
193,0211-699501013259,B12,i
193,0211-699501013259,edad,o
193,0211-699501013259,albumina,i
193,0211-699501013259,KTV,o
193,0211-699501013259,KRU,o
193,0211-699501013259,PCRn,o
193,0211-699501013259,Cincuenta,o
193,0211-699501013259,y,o
193,0211-699501013259,ocho,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,recibieron,o
193,0211-699501013259,seis,o
193,0211-699501013259,meses,o
193,0211-699501013259,de,o
193,0211-699501013259,suplementacion,i
193,0211-699501013259,con,o
193,0211-699501013259,normalizacion,o
193,0211-699501013259,del,o
193,0211-699501013259,pp,i
193,0211-699501013259,aumento,o
193,0211-699501013259,del,o
193,0211-699501013259,folato,i
193,0211-699501013259,703,o
193,0211-699501013259,IC,o
193,0211-699501013259,638,o
193,0211-699501013259,795,o
193,0211-699501013259,vs,o
193,0211-699501013259,6181,o
193,0211-699501013259,IC,o
193,0211-699501013259,4447,o
193,0211-699501013259,7811,o
193,0211-699501013259,p,o
193,0211-699501013259,0001,o
193,0211-699501013259,y,o
193,0211-699501013259,descenso,o
193,0211-699501013259,de,o
193,0211-699501013259,la,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,240,o
193,0211-699501013259,IC,o
193,0211-699501013259,213,o
193,0211-699501013259,264,o
193,0211-699501013259,vs,o
193,0211-699501013259,199,o
193,0211-699501013259,IC,o
193,0211-699501013259,175,o
193,0211-699501013259,224,o
193,0211-699501013259,p,o
193,0211-699501013259,005,o
193,0211-699501013259,Han,o
193,0211-699501013259,recibido,o
193,0211-699501013259,suplementacion,i
193,0211-699501013259,durante,o
193,0211-699501013259,12,o
193,0211-699501013259,meses,o
193,0211-699501013259,33,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,pero,o
193,0211-699501013259,a,o
193,0211-699501013259,pesar,o
193,0211-699501013259,de,o
193,0211-699501013259,un,o
193,0211-699501013259,continuo,o
193,0211-699501013259,aumento,o
193,0211-699501013259,del,o
193,0211-699501013259,folato,i
193,0211-699501013259,10078,o
193,0211-699501013259,IC,o
193,0211-699501013259,7481,o
193,0211-699501013259,12674,o
193,0211-699501013259,p,o
193,0211-699501013259,0001,o
193,0211-699501013259,solo,o
193,0211-699501013259,3,o
193,0211-699501013259,pacientes,o
193,0211-699501013259,presentan,o
193,0211-699501013259,niveles,o
193,0211-699501013259,normales,o
193,0211-699501013259,de,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,correlacionandose,o
193,0211-699501013259,directamente,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,con,o
193,0211-699501013259,la,o
193,0211-699501013259,albumina,i
193,0211-699501013259,r,o
193,0211-699501013259,056,o
193,0211-699501013259,p,o
193,0211-699501013259,0001,o
193,0211-699501013259,que,o
193,0211-699501013259,se,o
193,0211-699501013259,elevo,o
193,0211-699501013259,con,o
193,0211-699501013259,respecto,o
193,0211-699501013259,al,o
193,0211-699501013259,inicio,o
193,0211-699501013259,337,o
193,0211-699501013259,IC,o
193,0211-699501013259,327,o
193,0211-699501013259,346,o
193,0211-699501013259,vs,o
193,0211-699501013259,350,o
193,0211-699501013259,IC,o
193,0211-699501013259,337,o
193,0211-699501013259,363,o
193,0211-699501013259,p,o
193,0211-699501013259,005,o
193,0211-699501013259,Conclusion,o
193,0211-699501013259,Tras,o
193,0211-699501013259,suplementacion,i
193,0211-699501013259,con,o
193,0211-699501013259,acido,i
193,0211-699501013259,folico,i
193,0211-699501013259,y,o
193,0211-699501013259,vitamina,i
193,0211-699501013259,B6,i
193,0211-699501013259,aunque,o
193,0211-699501013259,inicialmente,o
193,0211-699501013259,se,o
193,0211-699501013259,reduce,o
193,0211-699501013259,la,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,esta,o
193,0211-699501013259,respuesta,o
193,0211-699501013259,se,o
193,0211-699501013259,hace,o
193,0211-699501013259,refractaria,o
193,0211-699501013259,correlacionandose,o
193,0211-699501013259,directamente,o
193,0211-699501013259,la,o
193,0211-699501013259,tHcy,i
193,0211-699501013259,con,o
193,0211-699501013259,la,o
193,0211-699501013259,albumina,i
193,0211-699501013259,plasmatica,i
193,0211-699501013259,La,o
193,0211-699501013259,interpretacion,o
193,0211-699501013259,de,o
193,0211-699501013259,los,o
193,0211-699501013259,niveles,i
193,0211-699501013259,de,i
193,0211-699501013259,tHcy,i
193,0211-699501013259,debe,o
193,0211-699501013259,tener,o
193,0211-699501013259,en,o
193,0211-699501013259,cuenta,o
193,0211-699501013259,la,o
193,0211-699501013259,concentracion,i
193,0211-699501013259,de,i
193,0211-699501013259,albumina,i
194,0211-699501013259,Efecto,o
194,0211-699501013259,de,o
194,0211-699501013259,la,o
194,0211-699501013259,suplementacion,i
194,0211-699501013259,con,o
194,0211-699501013259,acido,i
194,0211-699501013259,folico,i
194,0211-699501013259,sobre,o
194,0211-699501013259,los,o
194,0211-699501013259,niveles,i
194,0211-699501013259,de,i
194,0211-699501013259,homocisteina,i
194,0211-699501013259,total,o
194,0211-699501013259,en,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,en,o
194,0211-699501013259,hemodialisis,i
194,0211-699501013259,La,o
194,0211-699501013259,hiperhomocisteinemia,i
194,0211-699501013259,es,o
194,0211-699501013259,un,o
194,0211-699501013259,marcador,o
194,0211-699501013259,de,o
194,0211-699501013259,riesgo,o
194,0211-699501013259,independiente,o
194,0211-699501013259,de,o
194,0211-699501013259,morbimortalidad,o
194,0211-699501013259,cardiovascular,i
194,0211-699501013259,Hemos,o
194,0211-699501013259,intentado,o
194,0211-699501013259,prospectivamente,o
194,0211-699501013259,reducir,o
194,0211-699501013259,los,o
194,0211-699501013259,niveles,i
194,0211-699501013259,de,i
194,0211-699501013259,homocisteina,i
194,0211-699501013259,total,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,mediante,o
194,0211-699501013259,suplemento,o
194,0211-699501013259,con,o
194,0211-699501013259,acido,i
194,0211-699501013259,folico,i
194,0211-699501013259,y,o
194,0211-699501013259,vitamina,i
194,0211-699501013259,B6,i
194,0211-699501013259,pp,i
194,0211-699501013259,valorando,o
194,0211-699501013259,su,o
194,0211-699501013259,posible,o
194,0211-699501013259,correlacion,o
194,0211-699501013259,con,o
194,0211-699501013259,dosis,o
194,0211-699501013259,de,o
194,0211-699501013259,dialisis,i
194,0211-699501013259,funcion,i
194,0211-699501013259,residual,i
194,0211-699501013259,y,o
194,0211-699501013259,parametros,o
194,0211-699501013259,nutricionales,o
194,0211-699501013259,Metodos,o
194,0211-699501013259,Todos,o
194,0211-699501013259,los,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,en,o
194,0211-699501013259,hemodialisis,i
194,0211-699501013259,al,o
194,0211-699501013259,comienzo,o
194,0211-699501013259,del,o
194,0211-699501013259,estudio,o
194,0211-699501013259,que,o
194,0211-699501013259,no,o
194,0211-699501013259,recibian,o
194,0211-699501013259,acido,i
194,0211-699501013259,folico,i
194,0211-699501013259,ni,o
194,0211-699501013259,vitamina,i
194,0211-699501013259,B6,i
194,0211-699501013259,asi,o
194,0211-699501013259,como,o
194,0211-699501013259,los,o
194,0211-699501013259,incorporados,o
194,0211-699501013259,posteriormente,o
194,0211-699501013259,a,o
194,0211-699501013259,partir,o
194,0211-699501013259,de,o
194,0211-699501013259,su,o
194,0211-699501013259,tercer,o
194,0211-699501013259,mes,o
194,0211-699501013259,en,o
194,0211-699501013259,hemodialisis,i
194,0211-699501013259,recibieron,o
194,0211-699501013259,5,o
194,0211-699501013259,mg,o
194,0211-699501013259,orales,o
194,0211-699501013259,de,o
194,0211-699501013259,acido,i
194,0211-699501013259,folico,i
194,0211-699501013259,cada,o
194,0211-699501013259,48,o
194,0211-699501013259,horas,o
194,0211-699501013259,y,o
194,0211-699501013259,40,o
194,0211-699501013259,mg,o
194,0211-699501013259,orales,o
194,0211-699501013259,de,o
194,0211-699501013259,vitamina,i
194,0211-699501013259,B6,i
194,0211-699501013259,cada,o
194,0211-699501013259,semana,o
194,0211-699501013259,Se,o
194,0211-699501013259,determinaron,o
194,0211-699501013259,al,o
194,0211-699501013259,comienzo,o
194,0211-699501013259,del,o
194,0211-699501013259,estudio,o
194,0211-699501013259,y,o
194,0211-699501013259,cada,o
194,0211-699501013259,2,o
194,0211-699501013259,meses,o
194,0211-699501013259,niveles,i
194,0211-699501013259,de,i
194,0211-699501013259,folato,i
194,0211-699501013259,vitamina,i
194,0211-699501013259,B12,i
194,0211-699501013259,inmunoensayo,i
194,0211-699501013259,albumina,i
194,0211-699501013259,y,o
194,0211-699501013259,cinetica,o
194,0211-699501013259,de,o
194,0211-699501013259,la,o
194,0211-699501013259,urea,i
194,0211-699501013259,KTV,o
194,0211-699501013259,KRU,o
194,0211-699501013259,PCRn,o
194,0211-699501013259,y,o
194,0211-699501013259,cada,o
194,0211-699501013259,6,o
194,0211-699501013259,meses,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,HPLC,i
194,0211-699501013259,y,o
194,0211-699501013259,pp,i
194,0211-699501013259,RIA,i
194,0211-699501013259,Resultados,o
194,0211-699501013259,80,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,fueron,o
194,0211-699501013259,incluidos,o
194,0211-699501013259,en,o
194,0211-699501013259,el,o
194,0211-699501013259,estudio,o
194,0211-699501013259,basal,o
194,0211-699501013259,con,o
194,0211-699501013259,una,o
194,0211-699501013259,prevalencia,o
194,0211-699501013259,de,o
194,0211-699501013259,hiperhomocisteinemia,i
194,0211-699501013259,del,o
194,0211-699501013259,844,o
194,0211-699501013259,deficit,i
194,0211-699501013259,de,i
194,0211-699501013259,pp,i
194,0211-699501013259,en,o
194,0211-699501013259,el,o
194,0211-699501013259,32,o
194,0211-699501013259,y,o
194,0211-699501013259,folato,i
194,0211-699501013259,en,o
194,0211-699501013259,el,o
194,0211-699501013259,rango,o
194,0211-699501013259,normal,o
194,0211-699501013259,bajo,o
194,0211-699501013259,los,o
194,0211-699501013259,niveles,i
194,0211-699501013259,de,i
194,0211-699501013259,tHcy,i
194,0211-699501013259,se,o
194,0211-699501013259,correlacionaban,o
194,0211-699501013259,inversamente,o
194,0211-699501013259,con,o
194,0211-699501013259,los,o
194,0211-699501013259,del,o
194,0211-699501013259,folato,i
194,0211-699501013259,r,o
194,0211-699501013259,0336,o
194,0211-699501013259,p,o
194,0211-699501013259,001,o
194,0211-699501013259,pero,o
194,0211-699501013259,no,o
194,0211-699501013259,con,o
194,0211-699501013259,pp,i
194,0211-699501013259,B12,i
194,0211-699501013259,edad,o
194,0211-699501013259,albumina,i
194,0211-699501013259,KTV,o
194,0211-699501013259,KRU,o
194,0211-699501013259,PCRn,o
194,0211-699501013259,Cincuenta,o
194,0211-699501013259,y,o
194,0211-699501013259,ocho,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,recibieron,o
194,0211-699501013259,seis,o
194,0211-699501013259,meses,o
194,0211-699501013259,de,o
194,0211-699501013259,suplementacion,i
194,0211-699501013259,con,o
194,0211-699501013259,normalizacion,o
194,0211-699501013259,del,o
194,0211-699501013259,pp,i
194,0211-699501013259,aumento,o
194,0211-699501013259,del,o
194,0211-699501013259,folato,i
194,0211-699501013259,703,o
194,0211-699501013259,IC,o
194,0211-699501013259,638,o
194,0211-699501013259,795,o
194,0211-699501013259,vs,o
194,0211-699501013259,6181,o
194,0211-699501013259,IC,o
194,0211-699501013259,4447,o
194,0211-699501013259,7811,o
194,0211-699501013259,p,o
194,0211-699501013259,0001,o
194,0211-699501013259,y,o
194,0211-699501013259,descenso,o
194,0211-699501013259,de,o
194,0211-699501013259,la,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,240,o
194,0211-699501013259,IC,o
194,0211-699501013259,213,o
194,0211-699501013259,264,o
194,0211-699501013259,vs,o
194,0211-699501013259,199,o
194,0211-699501013259,IC,o
194,0211-699501013259,175,o
194,0211-699501013259,224,o
194,0211-699501013259,p,o
194,0211-699501013259,005,o
194,0211-699501013259,Han,o
194,0211-699501013259,recibido,o
194,0211-699501013259,suplementacion,i
194,0211-699501013259,durante,o
194,0211-699501013259,12,o
194,0211-699501013259,meses,o
194,0211-699501013259,33,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,pero,o
194,0211-699501013259,a,o
194,0211-699501013259,pesar,o
194,0211-699501013259,de,o
194,0211-699501013259,un,o
194,0211-699501013259,continuo,o
194,0211-699501013259,aumento,o
194,0211-699501013259,del,o
194,0211-699501013259,folato,i
194,0211-699501013259,10078,o
194,0211-699501013259,IC,o
194,0211-699501013259,7481,o
194,0211-699501013259,12674,o
194,0211-699501013259,p,o
194,0211-699501013259,0001,o
194,0211-699501013259,solo,o
194,0211-699501013259,3,o
194,0211-699501013259,pacientes,o
194,0211-699501013259,presentan,o
194,0211-699501013259,niveles,o
194,0211-699501013259,normales,o
194,0211-699501013259,de,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,correlacionandose,o
194,0211-699501013259,directamente,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,con,o
194,0211-699501013259,la,o
194,0211-699501013259,albumina,i
194,0211-699501013259,r,o
194,0211-699501013259,056,o
194,0211-699501013259,p,o
194,0211-699501013259,0001,o
194,0211-699501013259,que,o
194,0211-699501013259,se,o
194,0211-699501013259,elevo,o
194,0211-699501013259,con,o
194,0211-699501013259,respecto,o
194,0211-699501013259,al,o
194,0211-699501013259,inicio,o
194,0211-699501013259,337,o
194,0211-699501013259,IC,o
194,0211-699501013259,327,o
194,0211-699501013259,346,o
194,0211-699501013259,vs,o
194,0211-699501013259,350,o
194,0211-699501013259,IC,o
194,0211-699501013259,337,o
194,0211-699501013259,363,o
194,0211-699501013259,p,o
194,0211-699501013259,005,o
194,0211-699501013259,Conclusion,o
194,0211-699501013259,Tras,o
194,0211-699501013259,suplementacion,i
194,0211-699501013259,con,o
194,0211-699501013259,acido,i
194,0211-699501013259,folico,i
194,0211-699501013259,y,o
194,0211-699501013259,vitamina,i
194,0211-699501013259,B6,i
194,0211-699501013259,aunque,o
194,0211-699501013259,inicialmente,o
194,0211-699501013259,se,o
194,0211-699501013259,reduce,o
194,0211-699501013259,la,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,esta,o
194,0211-699501013259,respuesta,o
194,0211-699501013259,se,o
194,0211-699501013259,hace,o
194,0211-699501013259,refractaria,o
194,0211-699501013259,correlacionandose,o
194,0211-699501013259,directamente,o
194,0211-699501013259,la,o
194,0211-699501013259,tHcy,i
194,0211-699501013259,con,o
194,0211-699501013259,la,o
194,0211-699501013259,albumina,i
194,0211-699501013259,plasmatica,i
194,0211-699501013259,La,o
194,0211-699501013259,interpretacion,o
194,0211-699501013259,de,o
194,0211-699501013259,los,o
194,0211-699501013259,niveles,i
194,0211-699501013259,de,i
194,0211-699501013259,tHcy,i
194,0211-699501013259,debe,o
194,0211-699501013259,tener,o
194,0211-699501013259,en,o
194,0211-699501013259,cuenta,o
194,0211-699501013259,la,o
194,0211-699501013259,concentracion,i
194,0211-699501013259,de,i
194,0211-699501013259,albumina,i
195,0211-699501013259,Efecto,o
195,0211-699501013259,de,o
195,0211-699501013259,la,o
195,0211-699501013259,suplementacion,i
195,0211-699501013259,con,o
195,0211-699501013259,acido,i
195,0211-699501013259,folico,i
195,0211-699501013259,sobre,o
195,0211-699501013259,los,o
195,0211-699501013259,niveles,i
195,0211-699501013259,de,i
195,0211-699501013259,homocisteina,i
195,0211-699501013259,total,o
195,0211-699501013259,en,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,en,o
195,0211-699501013259,hemodialisis,i
195,0211-699501013259,La,o
195,0211-699501013259,hiperhomocisteinemia,i
195,0211-699501013259,es,o
195,0211-699501013259,un,o
195,0211-699501013259,marcador,o
195,0211-699501013259,de,o
195,0211-699501013259,riesgo,o
195,0211-699501013259,independiente,o
195,0211-699501013259,de,o
195,0211-699501013259,morbimortalidad,o
195,0211-699501013259,cardiovascular,i
195,0211-699501013259,Hemos,o
195,0211-699501013259,intentado,o
195,0211-699501013259,prospectivamente,o
195,0211-699501013259,reducir,o
195,0211-699501013259,los,o
195,0211-699501013259,niveles,i
195,0211-699501013259,de,i
195,0211-699501013259,homocisteina,i
195,0211-699501013259,total,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,mediante,o
195,0211-699501013259,suplemento,o
195,0211-699501013259,con,o
195,0211-699501013259,acido,i
195,0211-699501013259,folico,i
195,0211-699501013259,y,o
195,0211-699501013259,vitamina,i
195,0211-699501013259,B6,i
195,0211-699501013259,pp,i
195,0211-699501013259,valorando,o
195,0211-699501013259,su,o
195,0211-699501013259,posible,o
195,0211-699501013259,correlacion,o
195,0211-699501013259,con,o
195,0211-699501013259,dosis,o
195,0211-699501013259,de,o
195,0211-699501013259,dialisis,i
195,0211-699501013259,funcion,i
195,0211-699501013259,residual,i
195,0211-699501013259,y,o
195,0211-699501013259,parametros,o
195,0211-699501013259,nutricionales,o
195,0211-699501013259,Metodos,o
195,0211-699501013259,Todos,o
195,0211-699501013259,los,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,en,o
195,0211-699501013259,hemodialisis,i
195,0211-699501013259,al,o
195,0211-699501013259,comienzo,o
195,0211-699501013259,del,o
195,0211-699501013259,estudio,o
195,0211-699501013259,que,o
195,0211-699501013259,no,o
195,0211-699501013259,recibian,o
195,0211-699501013259,acido,i
195,0211-699501013259,folico,i
195,0211-699501013259,ni,o
195,0211-699501013259,vitamina,i
195,0211-699501013259,B6,i
195,0211-699501013259,asi,o
195,0211-699501013259,como,o
195,0211-699501013259,los,o
195,0211-699501013259,incorporados,o
195,0211-699501013259,posteriormente,o
195,0211-699501013259,a,o
195,0211-699501013259,partir,o
195,0211-699501013259,de,o
195,0211-699501013259,su,o
195,0211-699501013259,tercer,o
195,0211-699501013259,mes,o
195,0211-699501013259,en,o
195,0211-699501013259,hemodialisis,i
195,0211-699501013259,recibieron,o
195,0211-699501013259,5,o
195,0211-699501013259,mg,o
195,0211-699501013259,orales,o
195,0211-699501013259,de,o
195,0211-699501013259,acido,i
195,0211-699501013259,folico,i
195,0211-699501013259,cada,o
195,0211-699501013259,48,o
195,0211-699501013259,horas,o
195,0211-699501013259,y,o
195,0211-699501013259,40,o
195,0211-699501013259,mg,o
195,0211-699501013259,orales,o
195,0211-699501013259,de,o
195,0211-699501013259,vitamina,i
195,0211-699501013259,B6,i
195,0211-699501013259,cada,o
195,0211-699501013259,semana,o
195,0211-699501013259,Se,o
195,0211-699501013259,determinaron,o
195,0211-699501013259,al,o
195,0211-699501013259,comienzo,o
195,0211-699501013259,del,o
195,0211-699501013259,estudio,o
195,0211-699501013259,y,o
195,0211-699501013259,cada,o
195,0211-699501013259,2,o
195,0211-699501013259,meses,o
195,0211-699501013259,niveles,i
195,0211-699501013259,de,i
195,0211-699501013259,folato,i
195,0211-699501013259,vitamina,i
195,0211-699501013259,B12,i
195,0211-699501013259,inmunoensayo,i
195,0211-699501013259,albumina,i
195,0211-699501013259,y,o
195,0211-699501013259,cinetica,o
195,0211-699501013259,de,o
195,0211-699501013259,la,o
195,0211-699501013259,urea,i
195,0211-699501013259,KTV,o
195,0211-699501013259,KRU,o
195,0211-699501013259,PCRn,o
195,0211-699501013259,y,o
195,0211-699501013259,cada,o
195,0211-699501013259,6,o
195,0211-699501013259,meses,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,HPLC,i
195,0211-699501013259,y,o
195,0211-699501013259,pp,i
195,0211-699501013259,RIA,i
195,0211-699501013259,Resultados,o
195,0211-699501013259,80,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,fueron,o
195,0211-699501013259,incluidos,o
195,0211-699501013259,en,o
195,0211-699501013259,el,o
195,0211-699501013259,estudio,o
195,0211-699501013259,basal,o
195,0211-699501013259,con,o
195,0211-699501013259,una,o
195,0211-699501013259,prevalencia,o
195,0211-699501013259,de,o
195,0211-699501013259,hiperhomocisteinemia,i
195,0211-699501013259,del,o
195,0211-699501013259,844,o
195,0211-699501013259,deficit,i
195,0211-699501013259,de,i
195,0211-699501013259,pp,i
195,0211-699501013259,en,o
195,0211-699501013259,el,o
195,0211-699501013259,32,o
195,0211-699501013259,y,o
195,0211-699501013259,folato,i
195,0211-699501013259,en,o
195,0211-699501013259,el,o
195,0211-699501013259,rango,o
195,0211-699501013259,normal,o
195,0211-699501013259,bajo,o
195,0211-699501013259,los,o
195,0211-699501013259,niveles,i
195,0211-699501013259,de,i
195,0211-699501013259,tHcy,i
195,0211-699501013259,se,o
195,0211-699501013259,correlacionaban,o
195,0211-699501013259,inversamente,o
195,0211-699501013259,con,o
195,0211-699501013259,los,o
195,0211-699501013259,del,o
195,0211-699501013259,folato,i
195,0211-699501013259,r,o
195,0211-699501013259,0336,o
195,0211-699501013259,p,o
195,0211-699501013259,001,o
195,0211-699501013259,pero,o
195,0211-699501013259,no,o
195,0211-699501013259,con,o
195,0211-699501013259,pp,i
195,0211-699501013259,B12,i
195,0211-699501013259,edad,o
195,0211-699501013259,albumina,i
195,0211-699501013259,KTV,o
195,0211-699501013259,KRU,o
195,0211-699501013259,PCRn,o
195,0211-699501013259,Cincuenta,o
195,0211-699501013259,y,o
195,0211-699501013259,ocho,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,recibieron,o
195,0211-699501013259,seis,o
195,0211-699501013259,meses,o
195,0211-699501013259,de,o
195,0211-699501013259,suplementacion,i
195,0211-699501013259,con,o
195,0211-699501013259,normalizacion,o
195,0211-699501013259,del,o
195,0211-699501013259,pp,i
195,0211-699501013259,aumento,o
195,0211-699501013259,del,o
195,0211-699501013259,folato,i
195,0211-699501013259,703,o
195,0211-699501013259,IC,o
195,0211-699501013259,638,o
195,0211-699501013259,795,o
195,0211-699501013259,vs,o
195,0211-699501013259,6181,o
195,0211-699501013259,IC,o
195,0211-699501013259,4447,o
195,0211-699501013259,7811,o
195,0211-699501013259,p,o
195,0211-699501013259,0001,o
195,0211-699501013259,y,o
195,0211-699501013259,descenso,o
195,0211-699501013259,de,o
195,0211-699501013259,la,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,240,o
195,0211-699501013259,IC,o
195,0211-699501013259,213,o
195,0211-699501013259,264,o
195,0211-699501013259,vs,o
195,0211-699501013259,199,o
195,0211-699501013259,IC,o
195,0211-699501013259,175,o
195,0211-699501013259,224,o
195,0211-699501013259,p,o
195,0211-699501013259,005,o
195,0211-699501013259,Han,o
195,0211-699501013259,recibido,o
195,0211-699501013259,suplementacion,i
195,0211-699501013259,durante,o
195,0211-699501013259,12,o
195,0211-699501013259,meses,o
195,0211-699501013259,33,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,pero,o
195,0211-699501013259,a,o
195,0211-699501013259,pesar,o
195,0211-699501013259,de,o
195,0211-699501013259,un,o
195,0211-699501013259,continuo,o
195,0211-699501013259,aumento,o
195,0211-699501013259,del,o
195,0211-699501013259,folato,i
195,0211-699501013259,10078,o
195,0211-699501013259,IC,o
195,0211-699501013259,7481,o
195,0211-699501013259,12674,o
195,0211-699501013259,p,o
195,0211-699501013259,0001,o
195,0211-699501013259,solo,o
195,0211-699501013259,3,o
195,0211-699501013259,pacientes,o
195,0211-699501013259,presentan,o
195,0211-699501013259,niveles,o
195,0211-699501013259,normales,o
195,0211-699501013259,de,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,correlacionandose,o
195,0211-699501013259,directamente,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,con,o
195,0211-699501013259,la,o
195,0211-699501013259,albumina,i
195,0211-699501013259,r,o
195,0211-699501013259,056,o
195,0211-699501013259,p,o
195,0211-699501013259,0001,o
195,0211-699501013259,que,o
195,0211-699501013259,se,o
195,0211-699501013259,elevo,o
195,0211-699501013259,con,o
195,0211-699501013259,respecto,o
195,0211-699501013259,al,o
195,0211-699501013259,inicio,o
195,0211-699501013259,337,o
195,0211-699501013259,IC,o
195,0211-699501013259,327,o
195,0211-699501013259,346,o
195,0211-699501013259,vs,o
195,0211-699501013259,350,o
195,0211-699501013259,IC,o
195,0211-699501013259,337,o
195,0211-699501013259,363,o
195,0211-699501013259,p,o
195,0211-699501013259,005,o
195,0211-699501013259,Conclusion,o
195,0211-699501013259,Tras,o
195,0211-699501013259,suplementacion,i
195,0211-699501013259,con,o
195,0211-699501013259,acido,i
195,0211-699501013259,folico,i
195,0211-699501013259,y,o
195,0211-699501013259,vitamina,i
195,0211-699501013259,B6,i
195,0211-699501013259,aunque,o
195,0211-699501013259,inicialmente,o
195,0211-699501013259,se,o
195,0211-699501013259,reduce,o
195,0211-699501013259,la,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,esta,o
195,0211-699501013259,respuesta,o
195,0211-699501013259,se,o
195,0211-699501013259,hace,o
195,0211-699501013259,refractaria,o
195,0211-699501013259,correlacionandose,o
195,0211-699501013259,directamente,o
195,0211-699501013259,la,o
195,0211-699501013259,tHcy,i
195,0211-699501013259,con,o
195,0211-699501013259,la,o
195,0211-699501013259,albumina,i
195,0211-699501013259,plasmatica,i
195,0211-699501013259,La,o
195,0211-699501013259,interpretacion,o
195,0211-699501013259,de,o
195,0211-699501013259,los,o
195,0211-699501013259,niveles,i
195,0211-699501013259,de,i
195,0211-699501013259,tHcy,i
195,0211-699501013259,debe,o
195,0211-699501013259,tener,o
195,0211-699501013259,en,o
195,0211-699501013259,cuenta,o
195,0211-699501013259,la,o
195,0211-699501013259,concentracion,i
195,0211-699501013259,de,i
195,0211-699501013259,albumina,i
196,0211-699501013259,Efecto,o
196,0211-699501013259,de,o
196,0211-699501013259,la,o
196,0211-699501013259,suplementacion,i
196,0211-699501013259,con,o
196,0211-699501013259,acido,i
196,0211-699501013259,folico,i
196,0211-699501013259,sobre,o
196,0211-699501013259,los,o
196,0211-699501013259,niveles,i
196,0211-699501013259,de,i
196,0211-699501013259,homocisteina,i
196,0211-699501013259,total,o
196,0211-699501013259,en,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,en,o
196,0211-699501013259,hemodialisis,i
196,0211-699501013259,La,o
196,0211-699501013259,hiperhomocisteinemia,i
196,0211-699501013259,es,o
196,0211-699501013259,un,o
196,0211-699501013259,marcador,o
196,0211-699501013259,de,o
196,0211-699501013259,riesgo,o
196,0211-699501013259,independiente,o
196,0211-699501013259,de,o
196,0211-699501013259,morbimortalidad,o
196,0211-699501013259,cardiovascular,i
196,0211-699501013259,Hemos,o
196,0211-699501013259,intentado,o
196,0211-699501013259,prospectivamente,o
196,0211-699501013259,reducir,o
196,0211-699501013259,los,o
196,0211-699501013259,niveles,i
196,0211-699501013259,de,i
196,0211-699501013259,homocisteina,i
196,0211-699501013259,total,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,mediante,o
196,0211-699501013259,suplemento,o
196,0211-699501013259,con,o
196,0211-699501013259,acido,i
196,0211-699501013259,folico,i
196,0211-699501013259,y,o
196,0211-699501013259,vitamina,i
196,0211-699501013259,B6,i
196,0211-699501013259,pp,i
196,0211-699501013259,valorando,o
196,0211-699501013259,su,o
196,0211-699501013259,posible,o
196,0211-699501013259,correlacion,o
196,0211-699501013259,con,o
196,0211-699501013259,dosis,o
196,0211-699501013259,de,o
196,0211-699501013259,dialisis,i
196,0211-699501013259,funcion,i
196,0211-699501013259,residual,i
196,0211-699501013259,y,o
196,0211-699501013259,parametros,o
196,0211-699501013259,nutricionales,o
196,0211-699501013259,Metodos,o
196,0211-699501013259,Todos,o
196,0211-699501013259,los,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,en,o
196,0211-699501013259,hemodialisis,i
196,0211-699501013259,al,o
196,0211-699501013259,comienzo,o
196,0211-699501013259,del,o
196,0211-699501013259,estudio,o
196,0211-699501013259,que,o
196,0211-699501013259,no,o
196,0211-699501013259,recibian,o
196,0211-699501013259,acido,i
196,0211-699501013259,folico,i
196,0211-699501013259,ni,o
196,0211-699501013259,vitamina,i
196,0211-699501013259,B6,i
196,0211-699501013259,asi,o
196,0211-699501013259,como,o
196,0211-699501013259,los,o
196,0211-699501013259,incorporados,o
196,0211-699501013259,posteriormente,o
196,0211-699501013259,a,o
196,0211-699501013259,partir,o
196,0211-699501013259,de,o
196,0211-699501013259,su,o
196,0211-699501013259,tercer,o
196,0211-699501013259,mes,o
196,0211-699501013259,en,o
196,0211-699501013259,hemodialisis,i
196,0211-699501013259,recibieron,o
196,0211-699501013259,5,o
196,0211-699501013259,mg,o
196,0211-699501013259,orales,o
196,0211-699501013259,de,o
196,0211-699501013259,acido,i
196,0211-699501013259,folico,i
196,0211-699501013259,cada,o
196,0211-699501013259,48,o
196,0211-699501013259,horas,o
196,0211-699501013259,y,o
196,0211-699501013259,40,o
196,0211-699501013259,mg,o
196,0211-699501013259,orales,o
196,0211-699501013259,de,o
196,0211-699501013259,vitamina,i
196,0211-699501013259,B6,i
196,0211-699501013259,cada,o
196,0211-699501013259,semana,o
196,0211-699501013259,Se,o
196,0211-699501013259,determinaron,o
196,0211-699501013259,al,o
196,0211-699501013259,comienzo,o
196,0211-699501013259,del,o
196,0211-699501013259,estudio,o
196,0211-699501013259,y,o
196,0211-699501013259,cada,o
196,0211-699501013259,2,o
196,0211-699501013259,meses,o
196,0211-699501013259,niveles,i
196,0211-699501013259,de,i
196,0211-699501013259,folato,i
196,0211-699501013259,vitamina,i
196,0211-699501013259,B12,i
196,0211-699501013259,inmunoensayo,i
196,0211-699501013259,albumina,i
196,0211-699501013259,y,o
196,0211-699501013259,cinetica,o
196,0211-699501013259,de,o
196,0211-699501013259,la,o
196,0211-699501013259,urea,i
196,0211-699501013259,KTV,o
196,0211-699501013259,KRU,o
196,0211-699501013259,PCRn,o
196,0211-699501013259,y,o
196,0211-699501013259,cada,o
196,0211-699501013259,6,o
196,0211-699501013259,meses,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,HPLC,i
196,0211-699501013259,y,o
196,0211-699501013259,pp,i
196,0211-699501013259,RIA,i
196,0211-699501013259,Resultados,o
196,0211-699501013259,80,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,fueron,o
196,0211-699501013259,incluidos,o
196,0211-699501013259,en,o
196,0211-699501013259,el,o
196,0211-699501013259,estudio,o
196,0211-699501013259,basal,o
196,0211-699501013259,con,o
196,0211-699501013259,una,o
196,0211-699501013259,prevalencia,o
196,0211-699501013259,de,o
196,0211-699501013259,hiperhomocisteinemia,i
196,0211-699501013259,del,o
196,0211-699501013259,844,o
196,0211-699501013259,deficit,i
196,0211-699501013259,de,i
196,0211-699501013259,pp,i
196,0211-699501013259,en,o
196,0211-699501013259,el,o
196,0211-699501013259,32,o
196,0211-699501013259,y,o
196,0211-699501013259,folato,i
196,0211-699501013259,en,o
196,0211-699501013259,el,o
196,0211-699501013259,rango,o
196,0211-699501013259,normal,o
196,0211-699501013259,bajo,o
196,0211-699501013259,los,o
196,0211-699501013259,niveles,i
196,0211-699501013259,de,i
196,0211-699501013259,tHcy,i
196,0211-699501013259,se,o
196,0211-699501013259,correlacionaban,o
196,0211-699501013259,inversamente,o
196,0211-699501013259,con,o
196,0211-699501013259,los,o
196,0211-699501013259,del,o
196,0211-699501013259,folato,i
196,0211-699501013259,r,o
196,0211-699501013259,0336,o
196,0211-699501013259,p,o
196,0211-699501013259,001,o
196,0211-699501013259,pero,o
196,0211-699501013259,no,o
196,0211-699501013259,con,o
196,0211-699501013259,pp,i
196,0211-699501013259,B12,i
196,0211-699501013259,edad,o
196,0211-699501013259,albumina,i
196,0211-699501013259,KTV,o
196,0211-699501013259,KRU,o
196,0211-699501013259,PCRn,o
196,0211-699501013259,Cincuenta,o
196,0211-699501013259,y,o
196,0211-699501013259,ocho,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,recibieron,o
196,0211-699501013259,seis,o
196,0211-699501013259,meses,o
196,0211-699501013259,de,o
196,0211-699501013259,suplementacion,i
196,0211-699501013259,con,o
196,0211-699501013259,normalizacion,o
196,0211-699501013259,del,o
196,0211-699501013259,pp,i
196,0211-699501013259,aumento,o
196,0211-699501013259,del,o
196,0211-699501013259,folato,i
196,0211-699501013259,703,o
196,0211-699501013259,IC,o
196,0211-699501013259,638,o
196,0211-699501013259,795,o
196,0211-699501013259,vs,o
196,0211-699501013259,6181,o
196,0211-699501013259,IC,o
196,0211-699501013259,4447,o
196,0211-699501013259,7811,o
196,0211-699501013259,p,o
196,0211-699501013259,0001,o
196,0211-699501013259,y,o
196,0211-699501013259,descenso,o
196,0211-699501013259,de,o
196,0211-699501013259,la,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,240,o
196,0211-699501013259,IC,o
196,0211-699501013259,213,o
196,0211-699501013259,264,o
196,0211-699501013259,vs,o
196,0211-699501013259,199,o
196,0211-699501013259,IC,o
196,0211-699501013259,175,o
196,0211-699501013259,224,o
196,0211-699501013259,p,o
196,0211-699501013259,005,o
196,0211-699501013259,Han,o
196,0211-699501013259,recibido,o
196,0211-699501013259,suplementacion,i
196,0211-699501013259,durante,o
196,0211-699501013259,12,o
196,0211-699501013259,meses,o
196,0211-699501013259,33,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,pero,o
196,0211-699501013259,a,o
196,0211-699501013259,pesar,o
196,0211-699501013259,de,o
196,0211-699501013259,un,o
196,0211-699501013259,continuo,o
196,0211-699501013259,aumento,o
196,0211-699501013259,del,o
196,0211-699501013259,folato,i
196,0211-699501013259,10078,o
196,0211-699501013259,IC,o
196,0211-699501013259,7481,o
196,0211-699501013259,12674,o
196,0211-699501013259,p,o
196,0211-699501013259,0001,o
196,0211-699501013259,solo,o
196,0211-699501013259,3,o
196,0211-699501013259,pacientes,o
196,0211-699501013259,presentan,o
196,0211-699501013259,niveles,o
196,0211-699501013259,normales,o
196,0211-699501013259,de,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,correlacionandose,o
196,0211-699501013259,directamente,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,con,o
196,0211-699501013259,la,o
196,0211-699501013259,albumina,i
196,0211-699501013259,r,o
196,0211-699501013259,056,o
196,0211-699501013259,p,o
196,0211-699501013259,0001,o
196,0211-699501013259,que,o
196,0211-699501013259,se,o
196,0211-699501013259,elevo,o
196,0211-699501013259,con,o
196,0211-699501013259,respecto,o
196,0211-699501013259,al,o
196,0211-699501013259,inicio,o
196,0211-699501013259,337,o
196,0211-699501013259,IC,o
196,0211-699501013259,327,o
196,0211-699501013259,346,o
196,0211-699501013259,vs,o
196,0211-699501013259,350,o
196,0211-699501013259,IC,o
196,0211-699501013259,337,o
196,0211-699501013259,363,o
196,0211-699501013259,p,o
196,0211-699501013259,005,o
196,0211-699501013259,Conclusion,o
196,0211-699501013259,Tras,o
196,0211-699501013259,suplementacion,i
196,0211-699501013259,con,o
196,0211-699501013259,acido,i
196,0211-699501013259,folico,i
196,0211-699501013259,y,o
196,0211-699501013259,vitamina,i
196,0211-699501013259,B6,i
196,0211-699501013259,aunque,o
196,0211-699501013259,inicialmente,o
196,0211-699501013259,se,o
196,0211-699501013259,reduce,o
196,0211-699501013259,la,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,esta,o
196,0211-699501013259,respuesta,o
196,0211-699501013259,se,o
196,0211-699501013259,hace,o
196,0211-699501013259,refractaria,o
196,0211-699501013259,correlacionandose,o
196,0211-699501013259,directamente,o
196,0211-699501013259,la,o
196,0211-699501013259,tHcy,i
196,0211-699501013259,con,o
196,0211-699501013259,la,o
196,0211-699501013259,albumina,i
196,0211-699501013259,plasmatica,i
196,0211-699501013259,La,o
196,0211-699501013259,interpretacion,o
196,0211-699501013259,de,o
196,0211-699501013259,los,o
196,0211-699501013259,niveles,i
196,0211-699501013259,de,i
196,0211-699501013259,tHcy,i
196,0211-699501013259,debe,o
196,0211-699501013259,tener,o
196,0211-699501013259,en,o
196,0211-699501013259,cuenta,o
196,0211-699501013259,la,o
196,0211-699501013259,concentracion,i
196,0211-699501013259,de,i
196,0211-699501013259,albumina,i
197,0211-699501013259,Efecto,o
197,0211-699501013259,de,o
197,0211-699501013259,la,o
197,0211-699501013259,suplementacion,i
197,0211-699501013259,con,o
197,0211-699501013259,acido,i
197,0211-699501013259,folico,i
197,0211-699501013259,sobre,o
197,0211-699501013259,los,o
197,0211-699501013259,niveles,i
197,0211-699501013259,de,i
197,0211-699501013259,homocisteina,i
197,0211-699501013259,total,o
197,0211-699501013259,en,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,en,o
197,0211-699501013259,hemodialisis,i
197,0211-699501013259,La,o
197,0211-699501013259,hiperhomocisteinemia,i
197,0211-699501013259,es,o
197,0211-699501013259,un,o
197,0211-699501013259,marcador,o
197,0211-699501013259,de,o
197,0211-699501013259,riesgo,o
197,0211-699501013259,independiente,o
197,0211-699501013259,de,o
197,0211-699501013259,morbimortalidad,o
197,0211-699501013259,cardiovascular,i
197,0211-699501013259,Hemos,o
197,0211-699501013259,intentado,o
197,0211-699501013259,prospectivamente,o
197,0211-699501013259,reducir,o
197,0211-699501013259,los,o
197,0211-699501013259,niveles,i
197,0211-699501013259,de,i
197,0211-699501013259,homocisteina,i
197,0211-699501013259,total,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,mediante,o
197,0211-699501013259,suplemento,o
197,0211-699501013259,con,o
197,0211-699501013259,acido,i
197,0211-699501013259,folico,i
197,0211-699501013259,y,o
197,0211-699501013259,vitamina,i
197,0211-699501013259,B6,i
197,0211-699501013259,pp,i
197,0211-699501013259,valorando,o
197,0211-699501013259,su,o
197,0211-699501013259,posible,o
197,0211-699501013259,correlacion,o
197,0211-699501013259,con,o
197,0211-699501013259,dosis,o
197,0211-699501013259,de,o
197,0211-699501013259,dialisis,i
197,0211-699501013259,funcion,i
197,0211-699501013259,residual,i
197,0211-699501013259,y,o
197,0211-699501013259,parametros,o
197,0211-699501013259,nutricionales,o
197,0211-699501013259,Metodos,o
197,0211-699501013259,Todos,o
197,0211-699501013259,los,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,en,o
197,0211-699501013259,hemodialisis,i
197,0211-699501013259,al,o
197,0211-699501013259,comienzo,o
197,0211-699501013259,del,o
197,0211-699501013259,estudio,o
197,0211-699501013259,que,o
197,0211-699501013259,no,o
197,0211-699501013259,recibian,o
197,0211-699501013259,acido,i
197,0211-699501013259,folico,i
197,0211-699501013259,ni,o
197,0211-699501013259,vitamina,i
197,0211-699501013259,B6,i
197,0211-699501013259,asi,o
197,0211-699501013259,como,o
197,0211-699501013259,los,o
197,0211-699501013259,incorporados,o
197,0211-699501013259,posteriormente,o
197,0211-699501013259,a,o
197,0211-699501013259,partir,o
197,0211-699501013259,de,o
197,0211-699501013259,su,o
197,0211-699501013259,tercer,o
197,0211-699501013259,mes,o
197,0211-699501013259,en,o
197,0211-699501013259,hemodialisis,i
197,0211-699501013259,recibieron,o
197,0211-699501013259,5,o
197,0211-699501013259,mg,o
197,0211-699501013259,orales,o
197,0211-699501013259,de,o
197,0211-699501013259,acido,i
197,0211-699501013259,folico,i
197,0211-699501013259,cada,o
197,0211-699501013259,48,o
197,0211-699501013259,horas,o
197,0211-699501013259,y,o
197,0211-699501013259,40,o
197,0211-699501013259,mg,o
197,0211-699501013259,orales,o
197,0211-699501013259,de,o
197,0211-699501013259,vitamina,i
197,0211-699501013259,B6,i
197,0211-699501013259,cada,o
197,0211-699501013259,semana,o
197,0211-699501013259,Se,o
197,0211-699501013259,determinaron,o
197,0211-699501013259,al,o
197,0211-699501013259,comienzo,o
197,0211-699501013259,del,o
197,0211-699501013259,estudio,o
197,0211-699501013259,y,o
197,0211-699501013259,cada,o
197,0211-699501013259,2,o
197,0211-699501013259,meses,o
197,0211-699501013259,niveles,i
197,0211-699501013259,de,i
197,0211-699501013259,folato,i
197,0211-699501013259,vitamina,i
197,0211-699501013259,B12,i
197,0211-699501013259,inmunoensayo,i
197,0211-699501013259,albumina,i
197,0211-699501013259,y,o
197,0211-699501013259,cinetica,o
197,0211-699501013259,de,o
197,0211-699501013259,la,o
197,0211-699501013259,urea,i
197,0211-699501013259,KTV,o
197,0211-699501013259,KRU,o
197,0211-699501013259,PCRn,o
197,0211-699501013259,y,o
197,0211-699501013259,cada,o
197,0211-699501013259,6,o
197,0211-699501013259,meses,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,HPLC,i
197,0211-699501013259,y,o
197,0211-699501013259,pp,i
197,0211-699501013259,RIA,i
197,0211-699501013259,Resultados,o
197,0211-699501013259,80,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,fueron,o
197,0211-699501013259,incluidos,o
197,0211-699501013259,en,o
197,0211-699501013259,el,o
197,0211-699501013259,estudio,o
197,0211-699501013259,basal,o
197,0211-699501013259,con,o
197,0211-699501013259,una,o
197,0211-699501013259,prevalencia,o
197,0211-699501013259,de,o
197,0211-699501013259,hiperhomocisteinemia,i
197,0211-699501013259,del,o
197,0211-699501013259,844,o
197,0211-699501013259,deficit,i
197,0211-699501013259,de,i
197,0211-699501013259,pp,i
197,0211-699501013259,en,o
197,0211-699501013259,el,o
197,0211-699501013259,32,o
197,0211-699501013259,y,o
197,0211-699501013259,folato,i
197,0211-699501013259,en,o
197,0211-699501013259,el,o
197,0211-699501013259,rango,o
197,0211-699501013259,normal,o
197,0211-699501013259,bajo,o
197,0211-699501013259,los,o
197,0211-699501013259,niveles,i
197,0211-699501013259,de,i
197,0211-699501013259,tHcy,i
197,0211-699501013259,se,o
197,0211-699501013259,correlacionaban,o
197,0211-699501013259,inversamente,o
197,0211-699501013259,con,o
197,0211-699501013259,los,o
197,0211-699501013259,del,o
197,0211-699501013259,folato,i
197,0211-699501013259,r,o
197,0211-699501013259,0336,o
197,0211-699501013259,p,o
197,0211-699501013259,001,o
197,0211-699501013259,pero,o
197,0211-699501013259,no,o
197,0211-699501013259,con,o
197,0211-699501013259,pp,i
197,0211-699501013259,B12,i
197,0211-699501013259,edad,o
197,0211-699501013259,albumina,i
197,0211-699501013259,KTV,o
197,0211-699501013259,KRU,o
197,0211-699501013259,PCRn,o
197,0211-699501013259,Cincuenta,o
197,0211-699501013259,y,o
197,0211-699501013259,ocho,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,recibieron,o
197,0211-699501013259,seis,o
197,0211-699501013259,meses,o
197,0211-699501013259,de,o
197,0211-699501013259,suplementacion,i
197,0211-699501013259,con,o
197,0211-699501013259,normalizacion,o
197,0211-699501013259,del,o
197,0211-699501013259,pp,i
197,0211-699501013259,aumento,o
197,0211-699501013259,del,o
197,0211-699501013259,folato,i
197,0211-699501013259,703,o
197,0211-699501013259,IC,o
197,0211-699501013259,638,o
197,0211-699501013259,795,o
197,0211-699501013259,vs,o
197,0211-699501013259,6181,o
197,0211-699501013259,IC,o
197,0211-699501013259,4447,o
197,0211-699501013259,7811,o
197,0211-699501013259,p,o
197,0211-699501013259,0001,o
197,0211-699501013259,y,o
197,0211-699501013259,descenso,o
197,0211-699501013259,de,o
197,0211-699501013259,la,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,240,o
197,0211-699501013259,IC,o
197,0211-699501013259,213,o
197,0211-699501013259,264,o
197,0211-699501013259,vs,o
197,0211-699501013259,199,o
197,0211-699501013259,IC,o
197,0211-699501013259,175,o
197,0211-699501013259,224,o
197,0211-699501013259,p,o
197,0211-699501013259,005,o
197,0211-699501013259,Han,o
197,0211-699501013259,recibido,o
197,0211-699501013259,suplementacion,i
197,0211-699501013259,durante,o
197,0211-699501013259,12,o
197,0211-699501013259,meses,o
197,0211-699501013259,33,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,pero,o
197,0211-699501013259,a,o
197,0211-699501013259,pesar,o
197,0211-699501013259,de,o
197,0211-699501013259,un,o
197,0211-699501013259,continuo,o
197,0211-699501013259,aumento,o
197,0211-699501013259,del,o
197,0211-699501013259,folato,i
197,0211-699501013259,10078,o
197,0211-699501013259,IC,o
197,0211-699501013259,7481,o
197,0211-699501013259,12674,o
197,0211-699501013259,p,o
197,0211-699501013259,0001,o
197,0211-699501013259,solo,o
197,0211-699501013259,3,o
197,0211-699501013259,pacientes,o
197,0211-699501013259,presentan,o
197,0211-699501013259,niveles,o
197,0211-699501013259,normales,o
197,0211-699501013259,de,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,correlacionandose,o
197,0211-699501013259,directamente,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,con,o
197,0211-699501013259,la,o
197,0211-699501013259,albumina,i
197,0211-699501013259,r,o
197,0211-699501013259,056,o
197,0211-699501013259,p,o
197,0211-699501013259,0001,o
197,0211-699501013259,que,o
197,0211-699501013259,se,o
197,0211-699501013259,elevo,o
197,0211-699501013259,con,o
197,0211-699501013259,respecto,o
197,0211-699501013259,al,o
197,0211-699501013259,inicio,o
197,0211-699501013259,337,o
197,0211-699501013259,IC,o
197,0211-699501013259,327,o
197,0211-699501013259,346,o
197,0211-699501013259,vs,o
197,0211-699501013259,350,o
197,0211-699501013259,IC,o
197,0211-699501013259,337,o
197,0211-699501013259,363,o
197,0211-699501013259,p,o
197,0211-699501013259,005,o
197,0211-699501013259,Conclusion,o
197,0211-699501013259,Tras,o
197,0211-699501013259,suplementacion,i
197,0211-699501013259,con,o
197,0211-699501013259,acido,i
197,0211-699501013259,folico,i
197,0211-699501013259,y,o
197,0211-699501013259,vitamina,i
197,0211-699501013259,B6,i
197,0211-699501013259,aunque,o
197,0211-699501013259,inicialmente,o
197,0211-699501013259,se,o
197,0211-699501013259,reduce,o
197,0211-699501013259,la,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,esta,o
197,0211-699501013259,respuesta,o
197,0211-699501013259,se,o
197,0211-699501013259,hace,o
197,0211-699501013259,refractaria,o
197,0211-699501013259,correlacionandose,o
197,0211-699501013259,directamente,o
197,0211-699501013259,la,o
197,0211-699501013259,tHcy,i
197,0211-699501013259,con,o
197,0211-699501013259,la,o
197,0211-699501013259,albumina,i
197,0211-699501013259,plasmatica,i
197,0211-699501013259,La,o
197,0211-699501013259,interpretacion,o
197,0211-699501013259,de,o
197,0211-699501013259,los,o
197,0211-699501013259,niveles,i
197,0211-699501013259,de,i
197,0211-699501013259,tHcy,i
197,0211-699501013259,debe,o
197,0211-699501013259,tener,o
197,0211-699501013259,en,o
197,0211-699501013259,cuenta,o
197,0211-699501013259,la,o
197,0211-699501013259,concentracion,i
197,0211-699501013259,de,i
197,0211-699501013259,albumina,i
198,0211-699501013259,Efecto,o
198,0211-699501013259,de,o
198,0211-699501013259,la,o
198,0211-699501013259,suplementacion,i
198,0211-699501013259,con,o
198,0211-699501013259,acido,i
198,0211-699501013259,folico,i
198,0211-699501013259,sobre,o
198,0211-699501013259,los,o
198,0211-699501013259,niveles,i
198,0211-699501013259,de,i
198,0211-699501013259,homocisteina,i
198,0211-699501013259,total,o
198,0211-699501013259,en,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,en,o
198,0211-699501013259,hemodialisis,i
198,0211-699501013259,La,o
198,0211-699501013259,hiperhomocisteinemia,i
198,0211-699501013259,es,o
198,0211-699501013259,un,o
198,0211-699501013259,marcador,o
198,0211-699501013259,de,o
198,0211-699501013259,riesgo,o
198,0211-699501013259,independiente,o
198,0211-699501013259,de,o
198,0211-699501013259,morbimortalidad,o
198,0211-699501013259,cardiovascular,i
198,0211-699501013259,Hemos,o
198,0211-699501013259,intentado,o
198,0211-699501013259,prospectivamente,o
198,0211-699501013259,reducir,o
198,0211-699501013259,los,o
198,0211-699501013259,niveles,i
198,0211-699501013259,de,i
198,0211-699501013259,homocisteina,i
198,0211-699501013259,total,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,mediante,o
198,0211-699501013259,suplemento,o
198,0211-699501013259,con,o
198,0211-699501013259,acido,i
198,0211-699501013259,folico,i
198,0211-699501013259,y,o
198,0211-699501013259,vitamina,i
198,0211-699501013259,B6,i
198,0211-699501013259,pp,i
198,0211-699501013259,valorando,o
198,0211-699501013259,su,o
198,0211-699501013259,posible,o
198,0211-699501013259,correlacion,o
198,0211-699501013259,con,o
198,0211-699501013259,dosis,o
198,0211-699501013259,de,o
198,0211-699501013259,dialisis,i
198,0211-699501013259,funcion,i
198,0211-699501013259,residual,i
198,0211-699501013259,y,o
198,0211-699501013259,parametros,o
198,0211-699501013259,nutricionales,o
198,0211-699501013259,Metodos,o
198,0211-699501013259,Todos,o
198,0211-699501013259,los,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,en,o
198,0211-699501013259,hemodialisis,i
198,0211-699501013259,al,o
198,0211-699501013259,comienzo,o
198,0211-699501013259,del,o
198,0211-699501013259,estudio,o
198,0211-699501013259,que,o
198,0211-699501013259,no,o
198,0211-699501013259,recibian,o
198,0211-699501013259,acido,i
198,0211-699501013259,folico,i
198,0211-699501013259,ni,o
198,0211-699501013259,vitamina,i
198,0211-699501013259,B6,i
198,0211-699501013259,asi,o
198,0211-699501013259,como,o
198,0211-699501013259,los,o
198,0211-699501013259,incorporados,o
198,0211-699501013259,posteriormente,o
198,0211-699501013259,a,o
198,0211-699501013259,partir,o
198,0211-699501013259,de,o
198,0211-699501013259,su,o
198,0211-699501013259,tercer,o
198,0211-699501013259,mes,o
198,0211-699501013259,en,o
198,0211-699501013259,hemodialisis,i
198,0211-699501013259,recibieron,o
198,0211-699501013259,5,o
198,0211-699501013259,mg,o
198,0211-699501013259,orales,o
198,0211-699501013259,de,o
198,0211-699501013259,acido,i
198,0211-699501013259,folico,i
198,0211-699501013259,cada,o
198,0211-699501013259,48,o
198,0211-699501013259,horas,o
198,0211-699501013259,y,o
198,0211-699501013259,40,o
198,0211-699501013259,mg,o
198,0211-699501013259,orales,o
198,0211-699501013259,de,o
198,0211-699501013259,vitamina,i
198,0211-699501013259,B6,i
198,0211-699501013259,cada,o
198,0211-699501013259,semana,o
198,0211-699501013259,Se,o
198,0211-699501013259,determinaron,o
198,0211-699501013259,al,o
198,0211-699501013259,comienzo,o
198,0211-699501013259,del,o
198,0211-699501013259,estudio,o
198,0211-699501013259,y,o
198,0211-699501013259,cada,o
198,0211-699501013259,2,o
198,0211-699501013259,meses,o
198,0211-699501013259,niveles,i
198,0211-699501013259,de,i
198,0211-699501013259,folato,i
198,0211-699501013259,vitamina,i
198,0211-699501013259,B12,i
198,0211-699501013259,inmunoensayo,i
198,0211-699501013259,albumina,i
198,0211-699501013259,y,o
198,0211-699501013259,cinetica,o
198,0211-699501013259,de,o
198,0211-699501013259,la,o
198,0211-699501013259,urea,i
198,0211-699501013259,KTV,o
198,0211-699501013259,KRU,o
198,0211-699501013259,PCRn,o
198,0211-699501013259,y,o
198,0211-699501013259,cada,o
198,0211-699501013259,6,o
198,0211-699501013259,meses,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,HPLC,i
198,0211-699501013259,y,o
198,0211-699501013259,pp,i
198,0211-699501013259,RIA,i
198,0211-699501013259,Resultados,o
198,0211-699501013259,80,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,fueron,o
198,0211-699501013259,incluidos,o
198,0211-699501013259,en,o
198,0211-699501013259,el,o
198,0211-699501013259,estudio,o
198,0211-699501013259,basal,o
198,0211-699501013259,con,o
198,0211-699501013259,una,o
198,0211-699501013259,prevalencia,o
198,0211-699501013259,de,o
198,0211-699501013259,hiperhomocisteinemia,i
198,0211-699501013259,del,o
198,0211-699501013259,844,o
198,0211-699501013259,deficit,i
198,0211-699501013259,de,i
198,0211-699501013259,pp,i
198,0211-699501013259,en,o
198,0211-699501013259,el,o
198,0211-699501013259,32,o
198,0211-699501013259,y,o
198,0211-699501013259,folato,i
198,0211-699501013259,en,o
198,0211-699501013259,el,o
198,0211-699501013259,rango,o
198,0211-699501013259,normal,o
198,0211-699501013259,bajo,o
198,0211-699501013259,los,o
198,0211-699501013259,niveles,i
198,0211-699501013259,de,i
198,0211-699501013259,tHcy,i
198,0211-699501013259,se,o
198,0211-699501013259,correlacionaban,o
198,0211-699501013259,inversamente,o
198,0211-699501013259,con,o
198,0211-699501013259,los,o
198,0211-699501013259,del,o
198,0211-699501013259,folato,i
198,0211-699501013259,r,o
198,0211-699501013259,0336,o
198,0211-699501013259,p,o
198,0211-699501013259,001,o
198,0211-699501013259,pero,o
198,0211-699501013259,no,o
198,0211-699501013259,con,o
198,0211-699501013259,pp,i
198,0211-699501013259,B12,i
198,0211-699501013259,edad,o
198,0211-699501013259,albumina,i
198,0211-699501013259,KTV,o
198,0211-699501013259,KRU,o
198,0211-699501013259,PCRn,o
198,0211-699501013259,Cincuenta,o
198,0211-699501013259,y,o
198,0211-699501013259,ocho,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,recibieron,o
198,0211-699501013259,seis,o
198,0211-699501013259,meses,o
198,0211-699501013259,de,o
198,0211-699501013259,suplementacion,i
198,0211-699501013259,con,o
198,0211-699501013259,normalizacion,o
198,0211-699501013259,del,o
198,0211-699501013259,pp,i
198,0211-699501013259,aumento,o
198,0211-699501013259,del,o
198,0211-699501013259,folato,i
198,0211-699501013259,703,o
198,0211-699501013259,IC,o
198,0211-699501013259,638,o
198,0211-699501013259,795,o
198,0211-699501013259,vs,o
198,0211-699501013259,6181,o
198,0211-699501013259,IC,o
198,0211-699501013259,4447,o
198,0211-699501013259,7811,o
198,0211-699501013259,p,o
198,0211-699501013259,0001,o
198,0211-699501013259,y,o
198,0211-699501013259,descenso,o
198,0211-699501013259,de,o
198,0211-699501013259,la,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,240,o
198,0211-699501013259,IC,o
198,0211-699501013259,213,o
198,0211-699501013259,264,o
198,0211-699501013259,vs,o
198,0211-699501013259,199,o
198,0211-699501013259,IC,o
198,0211-699501013259,175,o
198,0211-699501013259,224,o
198,0211-699501013259,p,o
198,0211-699501013259,005,o
198,0211-699501013259,Han,o
198,0211-699501013259,recibido,o
198,0211-699501013259,suplementacion,i
198,0211-699501013259,durante,o
198,0211-699501013259,12,o
198,0211-699501013259,meses,o
198,0211-699501013259,33,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,pero,o
198,0211-699501013259,a,o
198,0211-699501013259,pesar,o
198,0211-699501013259,de,o
198,0211-699501013259,un,o
198,0211-699501013259,continuo,o
198,0211-699501013259,aumento,o
198,0211-699501013259,del,o
198,0211-699501013259,folato,i
198,0211-699501013259,10078,o
198,0211-699501013259,IC,o
198,0211-699501013259,7481,o
198,0211-699501013259,12674,o
198,0211-699501013259,p,o
198,0211-699501013259,0001,o
198,0211-699501013259,solo,o
198,0211-699501013259,3,o
198,0211-699501013259,pacientes,o
198,0211-699501013259,presentan,o
198,0211-699501013259,niveles,o
198,0211-699501013259,normales,o
198,0211-699501013259,de,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,correlacionandose,o
198,0211-699501013259,directamente,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,con,o
198,0211-699501013259,la,o
198,0211-699501013259,albumina,i
198,0211-699501013259,r,o
198,0211-699501013259,056,o
198,0211-699501013259,p,o
198,0211-699501013259,0001,o
198,0211-699501013259,que,o
198,0211-699501013259,se,o
198,0211-699501013259,elevo,o
198,0211-699501013259,con,o
198,0211-699501013259,respecto,o
198,0211-699501013259,al,o
198,0211-699501013259,inicio,o
198,0211-699501013259,337,o
198,0211-699501013259,IC,o
198,0211-699501013259,327,o
198,0211-699501013259,346,o
198,0211-699501013259,vs,o
198,0211-699501013259,350,o
198,0211-699501013259,IC,o
198,0211-699501013259,337,o
198,0211-699501013259,363,o
198,0211-699501013259,p,o
198,0211-699501013259,005,o
198,0211-699501013259,Conclusion,o
198,0211-699501013259,Tras,o
198,0211-699501013259,suplementacion,i
198,0211-699501013259,con,o
198,0211-699501013259,acido,i
198,0211-699501013259,folico,i
198,0211-699501013259,y,o
198,0211-699501013259,vitamina,i
198,0211-699501013259,B6,i
198,0211-699501013259,aunque,o
198,0211-699501013259,inicialmente,o
198,0211-699501013259,se,o
198,0211-699501013259,reduce,o
198,0211-699501013259,la,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,esta,o
198,0211-699501013259,respuesta,o
198,0211-699501013259,se,o
198,0211-699501013259,hace,o
198,0211-699501013259,refractaria,o
198,0211-699501013259,correlacionandose,o
198,0211-699501013259,directamente,o
198,0211-699501013259,la,o
198,0211-699501013259,tHcy,i
198,0211-699501013259,con,o
198,0211-699501013259,la,o
198,0211-699501013259,albumina,i
198,0211-699501013259,plasmatica,i
198,0211-699501013259,La,o
198,0211-699501013259,interpretacion,o
198,0211-699501013259,de,o
198,0211-699501013259,los,o
198,0211-699501013259,niveles,i
198,0211-699501013259,de,i
198,0211-699501013259,tHcy,i
198,0211-699501013259,debe,o
198,0211-699501013259,tener,o
198,0211-699501013259,en,o
198,0211-699501013259,cuenta,o
198,0211-699501013259,la,o
198,0211-699501013259,concentracion,i
198,0211-699501013259,de,i
198,0211-699501013259,albumina,i
199,0211-699501013259,Efecto,o
199,0211-699501013259,de,o
199,0211-699501013259,la,o
199,0211-699501013259,suplementacion,i
199,0211-699501013259,con,o
199,0211-699501013259,acido,i
199,0211-699501013259,folico,i
199,0211-699501013259,sobre,o
199,0211-699501013259,los,o
199,0211-699501013259,niveles,i
199,0211-699501013259,de,i
199,0211-699501013259,homocisteina,i
199,0211-699501013259,total,o
199,0211-699501013259,en,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,en,o
199,0211-699501013259,hemodialisis,i
199,0211-699501013259,La,o
199,0211-699501013259,hiperhomocisteinemia,i
199,0211-699501013259,es,o
199,0211-699501013259,un,o
199,0211-699501013259,marcador,o
199,0211-699501013259,de,o
199,0211-699501013259,riesgo,o
199,0211-699501013259,independiente,o
199,0211-699501013259,de,o
199,0211-699501013259,morbimortalidad,o
199,0211-699501013259,cardiovascular,i
199,0211-699501013259,Hemos,o
199,0211-699501013259,intentado,o
199,0211-699501013259,prospectivamente,o
199,0211-699501013259,reducir,o
199,0211-699501013259,los,o
199,0211-699501013259,niveles,i
199,0211-699501013259,de,i
199,0211-699501013259,homocisteina,i
199,0211-699501013259,total,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,mediante,o
199,0211-699501013259,suplemento,o
199,0211-699501013259,con,o
199,0211-699501013259,acido,i
199,0211-699501013259,folico,i
199,0211-699501013259,y,o
199,0211-699501013259,vitamina,i
199,0211-699501013259,B6,i
199,0211-699501013259,pp,i
199,0211-699501013259,valorando,o
199,0211-699501013259,su,o
199,0211-699501013259,posible,o
199,0211-699501013259,correlacion,o
199,0211-699501013259,con,o
199,0211-699501013259,dosis,o
199,0211-699501013259,de,o
199,0211-699501013259,dialisis,i
199,0211-699501013259,funcion,i
199,0211-699501013259,residual,i
199,0211-699501013259,y,o
199,0211-699501013259,parametros,o
199,0211-699501013259,nutricionales,o
199,0211-699501013259,Metodos,o
199,0211-699501013259,Todos,o
199,0211-699501013259,los,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,en,o
199,0211-699501013259,hemodialisis,i
199,0211-699501013259,al,o
199,0211-699501013259,comienzo,o
199,0211-699501013259,del,o
199,0211-699501013259,estudio,o
199,0211-699501013259,que,o
199,0211-699501013259,no,o
199,0211-699501013259,recibian,o
199,0211-699501013259,acido,i
199,0211-699501013259,folico,i
199,0211-699501013259,ni,o
199,0211-699501013259,vitamina,i
199,0211-699501013259,B6,i
199,0211-699501013259,asi,o
199,0211-699501013259,como,o
199,0211-699501013259,los,o
199,0211-699501013259,incorporados,o
199,0211-699501013259,posteriormente,o
199,0211-699501013259,a,o
199,0211-699501013259,partir,o
199,0211-699501013259,de,o
199,0211-699501013259,su,o
199,0211-699501013259,tercer,o
199,0211-699501013259,mes,o
199,0211-699501013259,en,o
199,0211-699501013259,hemodialisis,i
199,0211-699501013259,recibieron,o
199,0211-699501013259,5,o
199,0211-699501013259,mg,o
199,0211-699501013259,orales,o
199,0211-699501013259,de,o
199,0211-699501013259,acido,i
199,0211-699501013259,folico,i
199,0211-699501013259,cada,o
199,0211-699501013259,48,o
199,0211-699501013259,horas,o
199,0211-699501013259,y,o
199,0211-699501013259,40,o
199,0211-699501013259,mg,o
199,0211-699501013259,orales,o
199,0211-699501013259,de,o
199,0211-699501013259,vitamina,i
199,0211-699501013259,B6,i
199,0211-699501013259,cada,o
199,0211-699501013259,semana,o
199,0211-699501013259,Se,o
199,0211-699501013259,determinaron,o
199,0211-699501013259,al,o
199,0211-699501013259,comienzo,o
199,0211-699501013259,del,o
199,0211-699501013259,estudio,o
199,0211-699501013259,y,o
199,0211-699501013259,cada,o
199,0211-699501013259,2,o
199,0211-699501013259,meses,o
199,0211-699501013259,niveles,i
199,0211-699501013259,de,i
199,0211-699501013259,folato,i
199,0211-699501013259,vitamina,i
199,0211-699501013259,B12,i
199,0211-699501013259,inmunoensayo,i
199,0211-699501013259,albumina,i
199,0211-699501013259,y,o
199,0211-699501013259,cinetica,o
199,0211-699501013259,de,o
199,0211-699501013259,la,o
199,0211-699501013259,urea,i
199,0211-699501013259,KTV,o
199,0211-699501013259,KRU,o
199,0211-699501013259,PCRn,o
199,0211-699501013259,y,o
199,0211-699501013259,cada,o
199,0211-699501013259,6,o
199,0211-699501013259,meses,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,HPLC,i
199,0211-699501013259,y,o
199,0211-699501013259,pp,i
199,0211-699501013259,RIA,i
199,0211-699501013259,Resultados,o
199,0211-699501013259,80,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,fueron,o
199,0211-699501013259,incluidos,o
199,0211-699501013259,en,o
199,0211-699501013259,el,o
199,0211-699501013259,estudio,o
199,0211-699501013259,basal,o
199,0211-699501013259,con,o
199,0211-699501013259,una,o
199,0211-699501013259,prevalencia,o
199,0211-699501013259,de,o
199,0211-699501013259,hiperhomocisteinemia,i
199,0211-699501013259,del,o
199,0211-699501013259,844,o
199,0211-699501013259,deficit,i
199,0211-699501013259,de,i
199,0211-699501013259,pp,i
199,0211-699501013259,en,o
199,0211-699501013259,el,o
199,0211-699501013259,32,o
199,0211-699501013259,y,o
199,0211-699501013259,folato,i
199,0211-699501013259,en,o
199,0211-699501013259,el,o
199,0211-699501013259,rango,o
199,0211-699501013259,normal,o
199,0211-699501013259,bajo,o
199,0211-699501013259,los,o
199,0211-699501013259,niveles,i
199,0211-699501013259,de,i
199,0211-699501013259,tHcy,i
199,0211-699501013259,se,o
199,0211-699501013259,correlacionaban,o
199,0211-699501013259,inversamente,o
199,0211-699501013259,con,o
199,0211-699501013259,los,o
199,0211-699501013259,del,o
199,0211-699501013259,folato,i
199,0211-699501013259,r,o
199,0211-699501013259,0336,o
199,0211-699501013259,p,o
199,0211-699501013259,001,o
199,0211-699501013259,pero,o
199,0211-699501013259,no,o
199,0211-699501013259,con,o
199,0211-699501013259,pp,i
199,0211-699501013259,B12,i
199,0211-699501013259,edad,o
199,0211-699501013259,albumina,i
199,0211-699501013259,KTV,o
199,0211-699501013259,KRU,o
199,0211-699501013259,PCRn,o
199,0211-699501013259,Cincuenta,o
199,0211-699501013259,y,o
199,0211-699501013259,ocho,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,recibieron,o
199,0211-699501013259,seis,o
199,0211-699501013259,meses,o
199,0211-699501013259,de,o
199,0211-699501013259,suplementacion,i
199,0211-699501013259,con,o
199,0211-699501013259,normalizacion,o
199,0211-699501013259,del,o
199,0211-699501013259,pp,i
199,0211-699501013259,aumento,o
199,0211-699501013259,del,o
199,0211-699501013259,folato,i
199,0211-699501013259,703,o
199,0211-699501013259,IC,o
199,0211-699501013259,638,o
199,0211-699501013259,795,o
199,0211-699501013259,vs,o
199,0211-699501013259,6181,o
199,0211-699501013259,IC,o
199,0211-699501013259,4447,o
199,0211-699501013259,7811,o
199,0211-699501013259,p,o
199,0211-699501013259,0001,o
199,0211-699501013259,y,o
199,0211-699501013259,descenso,o
199,0211-699501013259,de,o
199,0211-699501013259,la,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,240,o
199,0211-699501013259,IC,o
199,0211-699501013259,213,o
199,0211-699501013259,264,o
199,0211-699501013259,vs,o
199,0211-699501013259,199,o
199,0211-699501013259,IC,o
199,0211-699501013259,175,o
199,0211-699501013259,224,o
199,0211-699501013259,p,o
199,0211-699501013259,005,o
199,0211-699501013259,Han,o
199,0211-699501013259,recibido,o
199,0211-699501013259,suplementacion,i
199,0211-699501013259,durante,o
199,0211-699501013259,12,o
199,0211-699501013259,meses,o
199,0211-699501013259,33,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,pero,o
199,0211-699501013259,a,o
199,0211-699501013259,pesar,o
199,0211-699501013259,de,o
199,0211-699501013259,un,o
199,0211-699501013259,continuo,o
199,0211-699501013259,aumento,o
199,0211-699501013259,del,o
199,0211-699501013259,folato,i
199,0211-699501013259,10078,o
199,0211-699501013259,IC,o
199,0211-699501013259,7481,o
199,0211-699501013259,12674,o
199,0211-699501013259,p,o
199,0211-699501013259,0001,o
199,0211-699501013259,solo,o
199,0211-699501013259,3,o
199,0211-699501013259,pacientes,o
199,0211-699501013259,presentan,o
199,0211-699501013259,niveles,o
199,0211-699501013259,normales,o
199,0211-699501013259,de,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,correlacionandose,o
199,0211-699501013259,directamente,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,con,o
199,0211-699501013259,la,o
199,0211-699501013259,albumina,i
199,0211-699501013259,r,o
199,0211-699501013259,056,o
199,0211-699501013259,p,o
199,0211-699501013259,0001,o
199,0211-699501013259,que,o
199,0211-699501013259,se,o
199,0211-699501013259,elevo,o
199,0211-699501013259,con,o
199,0211-699501013259,respecto,o
199,0211-699501013259,al,o
199,0211-699501013259,inicio,o
199,0211-699501013259,337,o
199,0211-699501013259,IC,o
199,0211-699501013259,327,o
199,0211-699501013259,346,o
199,0211-699501013259,vs,o
199,0211-699501013259,350,o
199,0211-699501013259,IC,o
199,0211-699501013259,337,o
199,0211-699501013259,363,o
199,0211-699501013259,p,o
199,0211-699501013259,005,o
199,0211-699501013259,Conclusion,o
199,0211-699501013259,Tras,o
199,0211-699501013259,suplementacion,i
199,0211-699501013259,con,o
199,0211-699501013259,acido,i
199,0211-699501013259,folico,i
199,0211-699501013259,y,o
199,0211-699501013259,vitamina,i
199,0211-699501013259,B6,i
199,0211-699501013259,aunque,o
199,0211-699501013259,inicialmente,o
199,0211-699501013259,se,o
199,0211-699501013259,reduce,o
199,0211-699501013259,la,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,esta,o
199,0211-699501013259,respuesta,o
199,0211-699501013259,se,o
199,0211-699501013259,hace,o
199,0211-699501013259,refractaria,o
199,0211-699501013259,correlacionandose,o
199,0211-699501013259,directamente,o
199,0211-699501013259,la,o
199,0211-699501013259,tHcy,i
199,0211-699501013259,con,o
199,0211-699501013259,la,o
199,0211-699501013259,albumina,i
199,0211-699501013259,plasmatica,i
199,0211-699501013259,La,o
199,0211-699501013259,interpretacion,o
199,0211-699501013259,de,o
199,0211-699501013259,los,o
199,0211-699501013259,niveles,i
199,0211-699501013259,de,i
199,0211-699501013259,tHcy,i
199,0211-699501013259,debe,o
199,0211-699501013259,tener,o
199,0211-699501013259,en,o
199,0211-699501013259,cuenta,o
199,0211-699501013259,la,o
199,0211-699501013259,concentracion,i
199,0211-699501013259,de,i
199,0211-699501013259,albumina,i
200,0211-699501013259,Efecto,o
200,0211-699501013259,de,o
200,0211-699501013259,la,o
200,0211-699501013259,suplementacion,i
200,0211-699501013259,con,o
200,0211-699501013259,acido,i
200,0211-699501013259,folico,i
200,0211-699501013259,sobre,o
200,0211-699501013259,los,o
200,0211-699501013259,niveles,i
200,0211-699501013259,de,i
200,0211-699501013259,homocisteina,i
200,0211-699501013259,total,o
200,0211-699501013259,en,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,en,o
200,0211-699501013259,hemodialisis,i
200,0211-699501013259,La,o
200,0211-699501013259,hiperhomocisteinemia,i
200,0211-699501013259,es,o
200,0211-699501013259,un,o
200,0211-699501013259,marcador,o
200,0211-699501013259,de,o
200,0211-699501013259,riesgo,o
200,0211-699501013259,independiente,o
200,0211-699501013259,de,o
200,0211-699501013259,morbimortalidad,o
200,0211-699501013259,cardiovascular,i
200,0211-699501013259,Hemos,o
200,0211-699501013259,intentado,o
200,0211-699501013259,prospectivamente,o
200,0211-699501013259,reducir,o
200,0211-699501013259,los,o
200,0211-699501013259,niveles,i
200,0211-699501013259,de,i
200,0211-699501013259,homocisteina,i
200,0211-699501013259,total,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,mediante,o
200,0211-699501013259,suplemento,o
200,0211-699501013259,con,o
200,0211-699501013259,acido,i
200,0211-699501013259,folico,i
200,0211-699501013259,y,o
200,0211-699501013259,vitamina,i
200,0211-699501013259,B6,i
200,0211-699501013259,pp,i
200,0211-699501013259,valorando,o
200,0211-699501013259,su,o
200,0211-699501013259,posible,o
200,0211-699501013259,correlacion,o
200,0211-699501013259,con,o
200,0211-699501013259,dosis,o
200,0211-699501013259,de,o
200,0211-699501013259,dialisis,i
200,0211-699501013259,funcion,i
200,0211-699501013259,residual,i
200,0211-699501013259,y,o
200,0211-699501013259,parametros,o
200,0211-699501013259,nutricionales,o
200,0211-699501013259,Metodos,o
200,0211-699501013259,Todos,o
200,0211-699501013259,los,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,en,o
200,0211-699501013259,hemodialisis,i
200,0211-699501013259,al,o
200,0211-699501013259,comienzo,o
200,0211-699501013259,del,o
200,0211-699501013259,estudio,o
200,0211-699501013259,que,o
200,0211-699501013259,no,o
200,0211-699501013259,recibian,o
200,0211-699501013259,acido,i
200,0211-699501013259,folico,i
200,0211-699501013259,ni,o
200,0211-699501013259,vitamina,i
200,0211-699501013259,B6,i
200,0211-699501013259,asi,o
200,0211-699501013259,como,o
200,0211-699501013259,los,o
200,0211-699501013259,incorporados,o
200,0211-699501013259,posteriormente,o
200,0211-699501013259,a,o
200,0211-699501013259,partir,o
200,0211-699501013259,de,o
200,0211-699501013259,su,o
200,0211-699501013259,tercer,o
200,0211-699501013259,mes,o
200,0211-699501013259,en,o
200,0211-699501013259,hemodialisis,i
200,0211-699501013259,recibieron,o
200,0211-699501013259,5,o
200,0211-699501013259,mg,o
200,0211-699501013259,orales,o
200,0211-699501013259,de,o
200,0211-699501013259,acido,i
200,0211-699501013259,folico,i
200,0211-699501013259,cada,o
200,0211-699501013259,48,o
200,0211-699501013259,horas,o
200,0211-699501013259,y,o
200,0211-699501013259,40,o
200,0211-699501013259,mg,o
200,0211-699501013259,orales,o
200,0211-699501013259,de,o
200,0211-699501013259,vitamina,i
200,0211-699501013259,B6,i
200,0211-699501013259,cada,o
200,0211-699501013259,semana,o
200,0211-699501013259,Se,o
200,0211-699501013259,determinaron,o
200,0211-699501013259,al,o
200,0211-699501013259,comienzo,o
200,0211-699501013259,del,o
200,0211-699501013259,estudio,o
200,0211-699501013259,y,o
200,0211-699501013259,cada,o
200,0211-699501013259,2,o
200,0211-699501013259,meses,o
200,0211-699501013259,niveles,i
200,0211-699501013259,de,i
200,0211-699501013259,folato,i
200,0211-699501013259,vitamina,i
200,0211-699501013259,B12,i
200,0211-699501013259,inmunoensayo,i
200,0211-699501013259,albumina,i
200,0211-699501013259,y,o
200,0211-699501013259,cinetica,o
200,0211-699501013259,de,o
200,0211-699501013259,la,o
200,0211-699501013259,urea,i
200,0211-699501013259,KTV,o
200,0211-699501013259,KRU,o
200,0211-699501013259,PCRn,o
200,0211-699501013259,y,o
200,0211-699501013259,cada,o
200,0211-699501013259,6,o
200,0211-699501013259,meses,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,HPLC,i
200,0211-699501013259,y,o
200,0211-699501013259,pp,i
200,0211-699501013259,RIA,i
200,0211-699501013259,Resultados,o
200,0211-699501013259,80,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,fueron,o
200,0211-699501013259,incluidos,o
200,0211-699501013259,en,o
200,0211-699501013259,el,o
200,0211-699501013259,estudio,o
200,0211-699501013259,basal,o
200,0211-699501013259,con,o
200,0211-699501013259,una,o
200,0211-699501013259,prevalencia,o
200,0211-699501013259,de,o
200,0211-699501013259,hiperhomocisteinemia,i
200,0211-699501013259,del,o
200,0211-699501013259,844,o
200,0211-699501013259,deficit,i
200,0211-699501013259,de,i
200,0211-699501013259,pp,i
200,0211-699501013259,en,o
200,0211-699501013259,el,o
200,0211-699501013259,32,o
200,0211-699501013259,y,o
200,0211-699501013259,folato,i
200,0211-699501013259,en,o
200,0211-699501013259,el,o
200,0211-699501013259,rango,o
200,0211-699501013259,normal,o
200,0211-699501013259,bajo,o
200,0211-699501013259,los,o
200,0211-699501013259,niveles,i
200,0211-699501013259,de,i
200,0211-699501013259,tHcy,i
200,0211-699501013259,se,o
200,0211-699501013259,correlacionaban,o
200,0211-699501013259,inversamente,o
200,0211-699501013259,con,o
200,0211-699501013259,los,o
200,0211-699501013259,del,o
200,0211-699501013259,folato,i
200,0211-699501013259,r,o
200,0211-699501013259,0336,o
200,0211-699501013259,p,o
200,0211-699501013259,001,o
200,0211-699501013259,pero,o
200,0211-699501013259,no,o
200,0211-699501013259,con,o
200,0211-699501013259,pp,i
200,0211-699501013259,B12,i
200,0211-699501013259,edad,o
200,0211-699501013259,albumina,i
200,0211-699501013259,KTV,o
200,0211-699501013259,KRU,o
200,0211-699501013259,PCRn,o
200,0211-699501013259,Cincuenta,o
200,0211-699501013259,y,o
200,0211-699501013259,ocho,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,recibieron,o
200,0211-699501013259,seis,o
200,0211-699501013259,meses,o
200,0211-699501013259,de,o
200,0211-699501013259,suplementacion,i
200,0211-699501013259,con,o
200,0211-699501013259,normalizacion,o
200,0211-699501013259,del,o
200,0211-699501013259,pp,i
200,0211-699501013259,aumento,o
200,0211-699501013259,del,o
200,0211-699501013259,folato,i
200,0211-699501013259,703,o
200,0211-699501013259,IC,o
200,0211-699501013259,638,o
200,0211-699501013259,795,o
200,0211-699501013259,vs,o
200,0211-699501013259,6181,o
200,0211-699501013259,IC,o
200,0211-699501013259,4447,o
200,0211-699501013259,7811,o
200,0211-699501013259,p,o
200,0211-699501013259,0001,o
200,0211-699501013259,y,o
200,0211-699501013259,descenso,o
200,0211-699501013259,de,o
200,0211-699501013259,la,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,240,o
200,0211-699501013259,IC,o
200,0211-699501013259,213,o
200,0211-699501013259,264,o
200,0211-699501013259,vs,o
200,0211-699501013259,199,o
200,0211-699501013259,IC,o
200,0211-699501013259,175,o
200,0211-699501013259,224,o
200,0211-699501013259,p,o
200,0211-699501013259,005,o
200,0211-699501013259,Han,o
200,0211-699501013259,recibido,o
200,0211-699501013259,suplementacion,i
200,0211-699501013259,durante,o
200,0211-699501013259,12,o
200,0211-699501013259,meses,o
200,0211-699501013259,33,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,pero,o
200,0211-699501013259,a,o
200,0211-699501013259,pesar,o
200,0211-699501013259,de,o
200,0211-699501013259,un,o
200,0211-699501013259,continuo,o
200,0211-699501013259,aumento,o
200,0211-699501013259,del,o
200,0211-699501013259,folato,i
200,0211-699501013259,10078,o
200,0211-699501013259,IC,o
200,0211-699501013259,7481,o
200,0211-699501013259,12674,o
200,0211-699501013259,p,o
200,0211-699501013259,0001,o
200,0211-699501013259,solo,o
200,0211-699501013259,3,o
200,0211-699501013259,pacientes,o
200,0211-699501013259,presentan,o
200,0211-699501013259,niveles,o
200,0211-699501013259,normales,o
200,0211-699501013259,de,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,correlacionandose,o
200,0211-699501013259,directamente,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,con,o
200,0211-699501013259,la,o
200,0211-699501013259,albumina,i
200,0211-699501013259,r,o
200,0211-699501013259,056,o
200,0211-699501013259,p,o
200,0211-699501013259,0001,o
200,0211-699501013259,que,o
200,0211-699501013259,se,o
200,0211-699501013259,elevo,o
200,0211-699501013259,con,o
200,0211-699501013259,respecto,o
200,0211-699501013259,al,o
200,0211-699501013259,inicio,o
200,0211-699501013259,337,o
200,0211-699501013259,IC,o
200,0211-699501013259,327,o
200,0211-699501013259,346,o
200,0211-699501013259,vs,o
200,0211-699501013259,350,o
200,0211-699501013259,IC,o
200,0211-699501013259,337,o
200,0211-699501013259,363,o
200,0211-699501013259,p,o
200,0211-699501013259,005,o
200,0211-699501013259,Conclusion,o
200,0211-699501013259,Tras,o
200,0211-699501013259,suplementacion,i
200,0211-699501013259,con,o
200,0211-699501013259,acido,i
200,0211-699501013259,folico,i
200,0211-699501013259,y,o
200,0211-699501013259,vitamina,i
200,0211-699501013259,B6,i
200,0211-699501013259,aunque,o
200,0211-699501013259,inicialmente,o
200,0211-699501013259,se,o
200,0211-699501013259,reduce,o
200,0211-699501013259,la,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,esta,o
200,0211-699501013259,respuesta,o
200,0211-699501013259,se,o
200,0211-699501013259,hace,o
200,0211-699501013259,refractaria,o
200,0211-699501013259,correlacionandose,o
200,0211-699501013259,directamente,o
200,0211-699501013259,la,o
200,0211-699501013259,tHcy,i
200,0211-699501013259,con,o
200,0211-699501013259,la,o
200,0211-699501013259,albumina,i
200,0211-699501013259,plasmatica,i
200,0211-699501013259,La,o
200,0211-699501013259,interpretacion,o
200,0211-699501013259,de,o
200,0211-699501013259,los,o
200,0211-699501013259,niveles,i
200,0211-699501013259,de,i
200,0211-699501013259,tHcy,i
200,0211-699501013259,debe,o
200,0211-699501013259,tener,o
200,0211-699501013259,en,o
200,0211-699501013259,cuenta,o
200,0211-699501013259,la,o
200,0211-699501013259,concentracion,i
200,0211-699501013259,de,i
200,0211-699501013259,albumina,i
201,0211-699501013259,Efecto,o
201,0211-699501013259,de,o
201,0211-699501013259,la,o
201,0211-699501013259,suplementacion,i
201,0211-699501013259,con,o
201,0211-699501013259,acido,i
201,0211-699501013259,folico,i
201,0211-699501013259,sobre,o
201,0211-699501013259,los,o
201,0211-699501013259,niveles,i
201,0211-699501013259,de,i
201,0211-699501013259,homocisteina,i
201,0211-699501013259,total,o
201,0211-699501013259,en,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,en,o
201,0211-699501013259,hemodialisis,i
201,0211-699501013259,La,o
201,0211-699501013259,hiperhomocisteinemia,i
201,0211-699501013259,es,o
201,0211-699501013259,un,o
201,0211-699501013259,marcador,o
201,0211-699501013259,de,o
201,0211-699501013259,riesgo,o
201,0211-699501013259,independiente,o
201,0211-699501013259,de,o
201,0211-699501013259,morbimortalidad,o
201,0211-699501013259,cardiovascular,i
201,0211-699501013259,Hemos,o
201,0211-699501013259,intentado,o
201,0211-699501013259,prospectivamente,o
201,0211-699501013259,reducir,o
201,0211-699501013259,los,o
201,0211-699501013259,niveles,i
201,0211-699501013259,de,i
201,0211-699501013259,homocisteina,i
201,0211-699501013259,total,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,mediante,o
201,0211-699501013259,suplemento,o
201,0211-699501013259,con,o
201,0211-699501013259,acido,i
201,0211-699501013259,folico,i
201,0211-699501013259,y,o
201,0211-699501013259,vitamina,i
201,0211-699501013259,B6,i
201,0211-699501013259,pp,i
201,0211-699501013259,valorando,o
201,0211-699501013259,su,o
201,0211-699501013259,posible,o
201,0211-699501013259,correlacion,o
201,0211-699501013259,con,o
201,0211-699501013259,dosis,o
201,0211-699501013259,de,o
201,0211-699501013259,dialisis,i
201,0211-699501013259,funcion,i
201,0211-699501013259,residual,i
201,0211-699501013259,y,o
201,0211-699501013259,parametros,o
201,0211-699501013259,nutricionales,o
201,0211-699501013259,Metodos,o
201,0211-699501013259,Todos,o
201,0211-699501013259,los,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,en,o
201,0211-699501013259,hemodialisis,i
201,0211-699501013259,al,o
201,0211-699501013259,comienzo,o
201,0211-699501013259,del,o
201,0211-699501013259,estudio,o
201,0211-699501013259,que,o
201,0211-699501013259,no,o
201,0211-699501013259,recibian,o
201,0211-699501013259,acido,i
201,0211-699501013259,folico,i
201,0211-699501013259,ni,o
201,0211-699501013259,vitamina,i
201,0211-699501013259,B6,i
201,0211-699501013259,asi,o
201,0211-699501013259,como,o
201,0211-699501013259,los,o
201,0211-699501013259,incorporados,o
201,0211-699501013259,posteriormente,o
201,0211-699501013259,a,o
201,0211-699501013259,partir,o
201,0211-699501013259,de,o
201,0211-699501013259,su,o
201,0211-699501013259,tercer,o
201,0211-699501013259,mes,o
201,0211-699501013259,en,o
201,0211-699501013259,hemodialisis,i
201,0211-699501013259,recibieron,o
201,0211-699501013259,5,o
201,0211-699501013259,mg,o
201,0211-699501013259,orales,o
201,0211-699501013259,de,o
201,0211-699501013259,acido,i
201,0211-699501013259,folico,i
201,0211-699501013259,cada,o
201,0211-699501013259,48,o
201,0211-699501013259,horas,o
201,0211-699501013259,y,o
201,0211-699501013259,40,o
201,0211-699501013259,mg,o
201,0211-699501013259,orales,o
201,0211-699501013259,de,o
201,0211-699501013259,vitamina,i
201,0211-699501013259,B6,i
201,0211-699501013259,cada,o
201,0211-699501013259,semana,o
201,0211-699501013259,Se,o
201,0211-699501013259,determinaron,o
201,0211-699501013259,al,o
201,0211-699501013259,comienzo,o
201,0211-699501013259,del,o
201,0211-699501013259,estudio,o
201,0211-699501013259,y,o
201,0211-699501013259,cada,o
201,0211-699501013259,2,o
201,0211-699501013259,meses,o
201,0211-699501013259,niveles,i
201,0211-699501013259,de,i
201,0211-699501013259,folato,i
201,0211-699501013259,vitamina,i
201,0211-699501013259,B12,i
201,0211-699501013259,inmunoensayo,i
201,0211-699501013259,albumina,i
201,0211-699501013259,y,o
201,0211-699501013259,cinetica,o
201,0211-699501013259,de,o
201,0211-699501013259,la,o
201,0211-699501013259,urea,i
201,0211-699501013259,KTV,o
201,0211-699501013259,KRU,o
201,0211-699501013259,PCRn,o
201,0211-699501013259,y,o
201,0211-699501013259,cada,o
201,0211-699501013259,6,o
201,0211-699501013259,meses,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,HPLC,i
201,0211-699501013259,y,o
201,0211-699501013259,pp,i
201,0211-699501013259,RIA,i
201,0211-699501013259,Resultados,o
201,0211-699501013259,80,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,fueron,o
201,0211-699501013259,incluidos,o
201,0211-699501013259,en,o
201,0211-699501013259,el,o
201,0211-699501013259,estudio,o
201,0211-699501013259,basal,o
201,0211-699501013259,con,o
201,0211-699501013259,una,o
201,0211-699501013259,prevalencia,o
201,0211-699501013259,de,o
201,0211-699501013259,hiperhomocisteinemia,i
201,0211-699501013259,del,o
201,0211-699501013259,844,o
201,0211-699501013259,deficit,i
201,0211-699501013259,de,i
201,0211-699501013259,pp,i
201,0211-699501013259,en,o
201,0211-699501013259,el,o
201,0211-699501013259,32,o
201,0211-699501013259,y,o
201,0211-699501013259,folato,i
201,0211-699501013259,en,o
201,0211-699501013259,el,o
201,0211-699501013259,rango,o
201,0211-699501013259,normal,o
201,0211-699501013259,bajo,o
201,0211-699501013259,los,o
201,0211-699501013259,niveles,i
201,0211-699501013259,de,i
201,0211-699501013259,tHcy,i
201,0211-699501013259,se,o
201,0211-699501013259,correlacionaban,o
201,0211-699501013259,inversamente,o
201,0211-699501013259,con,o
201,0211-699501013259,los,o
201,0211-699501013259,del,o
201,0211-699501013259,folato,i
201,0211-699501013259,r,o
201,0211-699501013259,0336,o
201,0211-699501013259,p,o
201,0211-699501013259,001,o
201,0211-699501013259,pero,o
201,0211-699501013259,no,o
201,0211-699501013259,con,o
201,0211-699501013259,pp,i
201,0211-699501013259,B12,i
201,0211-699501013259,edad,o
201,0211-699501013259,albumina,i
201,0211-699501013259,KTV,o
201,0211-699501013259,KRU,o
201,0211-699501013259,PCRn,o
201,0211-699501013259,Cincuenta,o
201,0211-699501013259,y,o
201,0211-699501013259,ocho,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,recibieron,o
201,0211-699501013259,seis,o
201,0211-699501013259,meses,o
201,0211-699501013259,de,o
201,0211-699501013259,suplementacion,i
201,0211-699501013259,con,o
201,0211-699501013259,normalizacion,o
201,0211-699501013259,del,o
201,0211-699501013259,pp,i
201,0211-699501013259,aumento,o
201,0211-699501013259,del,o
201,0211-699501013259,folato,i
201,0211-699501013259,703,o
201,0211-699501013259,IC,o
201,0211-699501013259,638,o
201,0211-699501013259,795,o
201,0211-699501013259,vs,o
201,0211-699501013259,6181,o
201,0211-699501013259,IC,o
201,0211-699501013259,4447,o
201,0211-699501013259,7811,o
201,0211-699501013259,p,o
201,0211-699501013259,0001,o
201,0211-699501013259,y,o
201,0211-699501013259,descenso,o
201,0211-699501013259,de,o
201,0211-699501013259,la,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,240,o
201,0211-699501013259,IC,o
201,0211-699501013259,213,o
201,0211-699501013259,264,o
201,0211-699501013259,vs,o
201,0211-699501013259,199,o
201,0211-699501013259,IC,o
201,0211-699501013259,175,o
201,0211-699501013259,224,o
201,0211-699501013259,p,o
201,0211-699501013259,005,o
201,0211-699501013259,Han,o
201,0211-699501013259,recibido,o
201,0211-699501013259,suplementacion,i
201,0211-699501013259,durante,o
201,0211-699501013259,12,o
201,0211-699501013259,meses,o
201,0211-699501013259,33,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,pero,o
201,0211-699501013259,a,o
201,0211-699501013259,pesar,o
201,0211-699501013259,de,o
201,0211-699501013259,un,o
201,0211-699501013259,continuo,o
201,0211-699501013259,aumento,o
201,0211-699501013259,del,o
201,0211-699501013259,folato,i
201,0211-699501013259,10078,o
201,0211-699501013259,IC,o
201,0211-699501013259,7481,o
201,0211-699501013259,12674,o
201,0211-699501013259,p,o
201,0211-699501013259,0001,o
201,0211-699501013259,solo,o
201,0211-699501013259,3,o
201,0211-699501013259,pacientes,o
201,0211-699501013259,presentan,o
201,0211-699501013259,niveles,o
201,0211-699501013259,normales,o
201,0211-699501013259,de,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,correlacionandose,o
201,0211-699501013259,directamente,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,con,o
201,0211-699501013259,la,o
201,0211-699501013259,albumina,i
201,0211-699501013259,r,o
201,0211-699501013259,056,o
201,0211-699501013259,p,o
201,0211-699501013259,0001,o
201,0211-699501013259,que,o
201,0211-699501013259,se,o
201,0211-699501013259,elevo,o
201,0211-699501013259,con,o
201,0211-699501013259,respecto,o
201,0211-699501013259,al,o
201,0211-699501013259,inicio,o
201,0211-699501013259,337,o
201,0211-699501013259,IC,o
201,0211-699501013259,327,o
201,0211-699501013259,346,o
201,0211-699501013259,vs,o
201,0211-699501013259,350,o
201,0211-699501013259,IC,o
201,0211-699501013259,337,o
201,0211-699501013259,363,o
201,0211-699501013259,p,o
201,0211-699501013259,005,o
201,0211-699501013259,Conclusion,o
201,0211-699501013259,Tras,o
201,0211-699501013259,suplementacion,i
201,0211-699501013259,con,o
201,0211-699501013259,acido,i
201,0211-699501013259,folico,i
201,0211-699501013259,y,o
201,0211-699501013259,vitamina,i
201,0211-699501013259,B6,i
201,0211-699501013259,aunque,o
201,0211-699501013259,inicialmente,o
201,0211-699501013259,se,o
201,0211-699501013259,reduce,o
201,0211-699501013259,la,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,esta,o
201,0211-699501013259,respuesta,o
201,0211-699501013259,se,o
201,0211-699501013259,hace,o
201,0211-699501013259,refractaria,o
201,0211-699501013259,correlacionandose,o
201,0211-699501013259,directamente,o
201,0211-699501013259,la,o
201,0211-699501013259,tHcy,i
201,0211-699501013259,con,o
201,0211-699501013259,la,o
201,0211-699501013259,albumina,i
201,0211-699501013259,plasmatica,i
201,0211-699501013259,La,o
201,0211-699501013259,interpretacion,o
201,0211-699501013259,de,o
201,0211-699501013259,los,o
201,0211-699501013259,niveles,i
201,0211-699501013259,de,i
201,0211-699501013259,tHcy,i
201,0211-699501013259,debe,o
201,0211-699501013259,tener,o
201,0211-699501013259,en,o
201,0211-699501013259,cuenta,o
201,0211-699501013259,la,o
201,0211-699501013259,concentracion,i
201,0211-699501013259,de,i
201,0211-699501013259,albumina,i
202,0211-699501013259,Efecto,o
202,0211-699501013259,de,o
202,0211-699501013259,la,o
202,0211-699501013259,suplementacion,i
202,0211-699501013259,con,o
202,0211-699501013259,acido,i
202,0211-699501013259,folico,i
202,0211-699501013259,sobre,o
202,0211-699501013259,los,o
202,0211-699501013259,niveles,i
202,0211-699501013259,de,i
202,0211-699501013259,homocisteina,i
202,0211-699501013259,total,o
202,0211-699501013259,en,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,en,o
202,0211-699501013259,hemodialisis,i
202,0211-699501013259,La,o
202,0211-699501013259,hiperhomocisteinemia,i
202,0211-699501013259,es,o
202,0211-699501013259,un,o
202,0211-699501013259,marcador,o
202,0211-699501013259,de,o
202,0211-699501013259,riesgo,o
202,0211-699501013259,independiente,o
202,0211-699501013259,de,o
202,0211-699501013259,morbimortalidad,o
202,0211-699501013259,cardiovascular,i
202,0211-699501013259,Hemos,o
202,0211-699501013259,intentado,o
202,0211-699501013259,prospectivamente,o
202,0211-699501013259,reducir,o
202,0211-699501013259,los,o
202,0211-699501013259,niveles,i
202,0211-699501013259,de,i
202,0211-699501013259,homocisteina,i
202,0211-699501013259,total,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,mediante,o
202,0211-699501013259,suplemento,o
202,0211-699501013259,con,o
202,0211-699501013259,acido,i
202,0211-699501013259,folico,i
202,0211-699501013259,y,o
202,0211-699501013259,vitamina,i
202,0211-699501013259,B6,i
202,0211-699501013259,pp,i
202,0211-699501013259,valorando,o
202,0211-699501013259,su,o
202,0211-699501013259,posible,o
202,0211-699501013259,correlacion,o
202,0211-699501013259,con,o
202,0211-699501013259,dosis,o
202,0211-699501013259,de,o
202,0211-699501013259,dialisis,i
202,0211-699501013259,funcion,i
202,0211-699501013259,residual,i
202,0211-699501013259,y,o
202,0211-699501013259,parametros,o
202,0211-699501013259,nutricionales,o
202,0211-699501013259,Metodos,o
202,0211-699501013259,Todos,o
202,0211-699501013259,los,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,en,o
202,0211-699501013259,hemodialisis,i
202,0211-699501013259,al,o
202,0211-699501013259,comienzo,o
202,0211-699501013259,del,o
202,0211-699501013259,estudio,o
202,0211-699501013259,que,o
202,0211-699501013259,no,o
202,0211-699501013259,recibian,o
202,0211-699501013259,acido,i
202,0211-699501013259,folico,i
202,0211-699501013259,ni,o
202,0211-699501013259,vitamina,i
202,0211-699501013259,B6,i
202,0211-699501013259,asi,o
202,0211-699501013259,como,o
202,0211-699501013259,los,o
202,0211-699501013259,incorporados,o
202,0211-699501013259,posteriormente,o
202,0211-699501013259,a,o
202,0211-699501013259,partir,o
202,0211-699501013259,de,o
202,0211-699501013259,su,o
202,0211-699501013259,tercer,o
202,0211-699501013259,mes,o
202,0211-699501013259,en,o
202,0211-699501013259,hemodialisis,i
202,0211-699501013259,recibieron,o
202,0211-699501013259,5,o
202,0211-699501013259,mg,o
202,0211-699501013259,orales,o
202,0211-699501013259,de,o
202,0211-699501013259,acido,i
202,0211-699501013259,folico,i
202,0211-699501013259,cada,o
202,0211-699501013259,48,o
202,0211-699501013259,horas,o
202,0211-699501013259,y,o
202,0211-699501013259,40,o
202,0211-699501013259,mg,o
202,0211-699501013259,orales,o
202,0211-699501013259,de,o
202,0211-699501013259,vitamina,i
202,0211-699501013259,B6,i
202,0211-699501013259,cada,o
202,0211-699501013259,semana,o
202,0211-699501013259,Se,o
202,0211-699501013259,determinaron,o
202,0211-699501013259,al,o
202,0211-699501013259,comienzo,o
202,0211-699501013259,del,o
202,0211-699501013259,estudio,o
202,0211-699501013259,y,o
202,0211-699501013259,cada,o
202,0211-699501013259,2,o
202,0211-699501013259,meses,o
202,0211-699501013259,niveles,i
202,0211-699501013259,de,i
202,0211-699501013259,folato,i
202,0211-699501013259,vitamina,i
202,0211-699501013259,B12,i
202,0211-699501013259,inmunoensayo,i
202,0211-699501013259,albumina,i
202,0211-699501013259,y,o
202,0211-699501013259,cinetica,o
202,0211-699501013259,de,o
202,0211-699501013259,la,o
202,0211-699501013259,urea,i
202,0211-699501013259,KTV,o
202,0211-699501013259,KRU,o
202,0211-699501013259,PCRn,o
202,0211-699501013259,y,o
202,0211-699501013259,cada,o
202,0211-699501013259,6,o
202,0211-699501013259,meses,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,HPLC,i
202,0211-699501013259,y,o
202,0211-699501013259,pp,i
202,0211-699501013259,RIA,i
202,0211-699501013259,Resultados,o
202,0211-699501013259,80,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,fueron,o
202,0211-699501013259,incluidos,o
202,0211-699501013259,en,o
202,0211-699501013259,el,o
202,0211-699501013259,estudio,o
202,0211-699501013259,basal,o
202,0211-699501013259,con,o
202,0211-699501013259,una,o
202,0211-699501013259,prevalencia,o
202,0211-699501013259,de,o
202,0211-699501013259,hiperhomocisteinemia,i
202,0211-699501013259,del,o
202,0211-699501013259,844,o
202,0211-699501013259,deficit,i
202,0211-699501013259,de,i
202,0211-699501013259,pp,i
202,0211-699501013259,en,o
202,0211-699501013259,el,o
202,0211-699501013259,32,o
202,0211-699501013259,y,o
202,0211-699501013259,folato,i
202,0211-699501013259,en,o
202,0211-699501013259,el,o
202,0211-699501013259,rango,o
202,0211-699501013259,normal,o
202,0211-699501013259,bajo,o
202,0211-699501013259,los,o
202,0211-699501013259,niveles,i
202,0211-699501013259,de,i
202,0211-699501013259,tHcy,i
202,0211-699501013259,se,o
202,0211-699501013259,correlacionaban,o
202,0211-699501013259,inversamente,o
202,0211-699501013259,con,o
202,0211-699501013259,los,o
202,0211-699501013259,del,o
202,0211-699501013259,folato,i
202,0211-699501013259,r,o
202,0211-699501013259,0336,o
202,0211-699501013259,p,o
202,0211-699501013259,001,o
202,0211-699501013259,pero,o
202,0211-699501013259,no,o
202,0211-699501013259,con,o
202,0211-699501013259,pp,i
202,0211-699501013259,B12,i
202,0211-699501013259,edad,o
202,0211-699501013259,albumina,i
202,0211-699501013259,KTV,o
202,0211-699501013259,KRU,o
202,0211-699501013259,PCRn,o
202,0211-699501013259,Cincuenta,o
202,0211-699501013259,y,o
202,0211-699501013259,ocho,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,recibieron,o
202,0211-699501013259,seis,o
202,0211-699501013259,meses,o
202,0211-699501013259,de,o
202,0211-699501013259,suplementacion,i
202,0211-699501013259,con,o
202,0211-699501013259,normalizacion,o
202,0211-699501013259,del,o
202,0211-699501013259,pp,i
202,0211-699501013259,aumento,o
202,0211-699501013259,del,o
202,0211-699501013259,folato,i
202,0211-699501013259,703,o
202,0211-699501013259,IC,o
202,0211-699501013259,638,o
202,0211-699501013259,795,o
202,0211-699501013259,vs,o
202,0211-699501013259,6181,o
202,0211-699501013259,IC,o
202,0211-699501013259,4447,o
202,0211-699501013259,7811,o
202,0211-699501013259,p,o
202,0211-699501013259,0001,o
202,0211-699501013259,y,o
202,0211-699501013259,descenso,o
202,0211-699501013259,de,o
202,0211-699501013259,la,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,240,o
202,0211-699501013259,IC,o
202,0211-699501013259,213,o
202,0211-699501013259,264,o
202,0211-699501013259,vs,o
202,0211-699501013259,199,o
202,0211-699501013259,IC,o
202,0211-699501013259,175,o
202,0211-699501013259,224,o
202,0211-699501013259,p,o
202,0211-699501013259,005,o
202,0211-699501013259,Han,o
202,0211-699501013259,recibido,o
202,0211-699501013259,suplementacion,i
202,0211-699501013259,durante,o
202,0211-699501013259,12,o
202,0211-699501013259,meses,o
202,0211-699501013259,33,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,pero,o
202,0211-699501013259,a,o
202,0211-699501013259,pesar,o
202,0211-699501013259,de,o
202,0211-699501013259,un,o
202,0211-699501013259,continuo,o
202,0211-699501013259,aumento,o
202,0211-699501013259,del,o
202,0211-699501013259,folato,i
202,0211-699501013259,10078,o
202,0211-699501013259,IC,o
202,0211-699501013259,7481,o
202,0211-699501013259,12674,o
202,0211-699501013259,p,o
202,0211-699501013259,0001,o
202,0211-699501013259,solo,o
202,0211-699501013259,3,o
202,0211-699501013259,pacientes,o
202,0211-699501013259,presentan,o
202,0211-699501013259,niveles,o
202,0211-699501013259,normales,o
202,0211-699501013259,de,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,correlacionandose,o
202,0211-699501013259,directamente,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,con,o
202,0211-699501013259,la,o
202,0211-699501013259,albumina,i
202,0211-699501013259,r,o
202,0211-699501013259,056,o
202,0211-699501013259,p,o
202,0211-699501013259,0001,o
202,0211-699501013259,que,o
202,0211-699501013259,se,o
202,0211-699501013259,elevo,o
202,0211-699501013259,con,o
202,0211-699501013259,respecto,o
202,0211-699501013259,al,o
202,0211-699501013259,inicio,o
202,0211-699501013259,337,o
202,0211-699501013259,IC,o
202,0211-699501013259,327,o
202,0211-699501013259,346,o
202,0211-699501013259,vs,o
202,0211-699501013259,350,o
202,0211-699501013259,IC,o
202,0211-699501013259,337,o
202,0211-699501013259,363,o
202,0211-699501013259,p,o
202,0211-699501013259,005,o
202,0211-699501013259,Conclusion,o
202,0211-699501013259,Tras,o
202,0211-699501013259,suplementacion,i
202,0211-699501013259,con,o
202,0211-699501013259,acido,i
202,0211-699501013259,folico,i
202,0211-699501013259,y,o
202,0211-699501013259,vitamina,i
202,0211-699501013259,B6,i
202,0211-699501013259,aunque,o
202,0211-699501013259,inicialmente,o
202,0211-699501013259,se,o
202,0211-699501013259,reduce,o
202,0211-699501013259,la,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,esta,o
202,0211-699501013259,respuesta,o
202,0211-699501013259,se,o
202,0211-699501013259,hace,o
202,0211-699501013259,refractaria,o
202,0211-699501013259,correlacionandose,o
202,0211-699501013259,directamente,o
202,0211-699501013259,la,o
202,0211-699501013259,tHcy,i
202,0211-699501013259,con,o
202,0211-699501013259,la,o
202,0211-699501013259,albumina,i
202,0211-699501013259,plasmatica,i
202,0211-699501013259,La,o
202,0211-699501013259,interpretacion,o
202,0211-699501013259,de,o
202,0211-699501013259,los,o
202,0211-699501013259,niveles,i
202,0211-699501013259,de,i
202,0211-699501013259,tHcy,i
202,0211-699501013259,debe,o
202,0211-699501013259,tener,o
202,0211-699501013259,en,o
202,0211-699501013259,cuenta,o
202,0211-699501013259,la,o
202,0211-699501013259,concentracion,i
202,0211-699501013259,de,i
202,0211-699501013259,albumina,i
203,0211-699501013259,Efecto,o
203,0211-699501013259,de,o
203,0211-699501013259,la,o
203,0211-699501013259,suplementacion,i
203,0211-699501013259,con,o
203,0211-699501013259,acido,i
203,0211-699501013259,folico,i
203,0211-699501013259,sobre,o
203,0211-699501013259,los,o
203,0211-699501013259,niveles,i
203,0211-699501013259,de,i
203,0211-699501013259,homocisteina,i
203,0211-699501013259,total,o
203,0211-699501013259,en,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,en,o
203,0211-699501013259,hemodialisis,i
203,0211-699501013259,La,o
203,0211-699501013259,hiperhomocisteinemia,i
203,0211-699501013259,es,o
203,0211-699501013259,un,o
203,0211-699501013259,marcador,o
203,0211-699501013259,de,o
203,0211-699501013259,riesgo,o
203,0211-699501013259,independiente,o
203,0211-699501013259,de,o
203,0211-699501013259,morbimortalidad,o
203,0211-699501013259,cardiovascular,i
203,0211-699501013259,Hemos,o
203,0211-699501013259,intentado,o
203,0211-699501013259,prospectivamente,o
203,0211-699501013259,reducir,o
203,0211-699501013259,los,o
203,0211-699501013259,niveles,i
203,0211-699501013259,de,i
203,0211-699501013259,homocisteina,i
203,0211-699501013259,total,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,mediante,o
203,0211-699501013259,suplemento,o
203,0211-699501013259,con,o
203,0211-699501013259,acido,i
203,0211-699501013259,folico,i
203,0211-699501013259,y,o
203,0211-699501013259,vitamina,i
203,0211-699501013259,B6,i
203,0211-699501013259,pp,i
203,0211-699501013259,valorando,o
203,0211-699501013259,su,o
203,0211-699501013259,posible,o
203,0211-699501013259,correlacion,o
203,0211-699501013259,con,o
203,0211-699501013259,dosis,o
203,0211-699501013259,de,o
203,0211-699501013259,dialisis,i
203,0211-699501013259,funcion,i
203,0211-699501013259,residual,i
203,0211-699501013259,y,o
203,0211-699501013259,parametros,o
203,0211-699501013259,nutricionales,o
203,0211-699501013259,Metodos,o
203,0211-699501013259,Todos,o
203,0211-699501013259,los,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,en,o
203,0211-699501013259,hemodialisis,i
203,0211-699501013259,al,o
203,0211-699501013259,comienzo,o
203,0211-699501013259,del,o
203,0211-699501013259,estudio,o
203,0211-699501013259,que,o
203,0211-699501013259,no,o
203,0211-699501013259,recibian,o
203,0211-699501013259,acido,i
203,0211-699501013259,folico,i
203,0211-699501013259,ni,o
203,0211-699501013259,vitamina,i
203,0211-699501013259,B6,i
203,0211-699501013259,asi,o
203,0211-699501013259,como,o
203,0211-699501013259,los,o
203,0211-699501013259,incorporados,o
203,0211-699501013259,posteriormente,o
203,0211-699501013259,a,o
203,0211-699501013259,partir,o
203,0211-699501013259,de,o
203,0211-699501013259,su,o
203,0211-699501013259,tercer,o
203,0211-699501013259,mes,o
203,0211-699501013259,en,o
203,0211-699501013259,hemodialisis,i
203,0211-699501013259,recibieron,o
203,0211-699501013259,5,o
203,0211-699501013259,mg,o
203,0211-699501013259,orales,o
203,0211-699501013259,de,o
203,0211-699501013259,acido,i
203,0211-699501013259,folico,i
203,0211-699501013259,cada,o
203,0211-699501013259,48,o
203,0211-699501013259,horas,o
203,0211-699501013259,y,o
203,0211-699501013259,40,o
203,0211-699501013259,mg,o
203,0211-699501013259,orales,o
203,0211-699501013259,de,o
203,0211-699501013259,vitamina,i
203,0211-699501013259,B6,i
203,0211-699501013259,cada,o
203,0211-699501013259,semana,o
203,0211-699501013259,Se,o
203,0211-699501013259,determinaron,o
203,0211-699501013259,al,o
203,0211-699501013259,comienzo,o
203,0211-699501013259,del,o
203,0211-699501013259,estudio,o
203,0211-699501013259,y,o
203,0211-699501013259,cada,o
203,0211-699501013259,2,o
203,0211-699501013259,meses,o
203,0211-699501013259,niveles,i
203,0211-699501013259,de,i
203,0211-699501013259,folato,i
203,0211-699501013259,vitamina,i
203,0211-699501013259,B12,i
203,0211-699501013259,inmunoensayo,i
203,0211-699501013259,albumina,i
203,0211-699501013259,y,o
203,0211-699501013259,cinetica,o
203,0211-699501013259,de,o
203,0211-699501013259,la,o
203,0211-699501013259,urea,i
203,0211-699501013259,KTV,o
203,0211-699501013259,KRU,o
203,0211-699501013259,PCRn,o
203,0211-699501013259,y,o
203,0211-699501013259,cada,o
203,0211-699501013259,6,o
203,0211-699501013259,meses,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,HPLC,i
203,0211-699501013259,y,o
203,0211-699501013259,pp,i
203,0211-699501013259,RIA,i
203,0211-699501013259,Resultados,o
203,0211-699501013259,80,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,fueron,o
203,0211-699501013259,incluidos,o
203,0211-699501013259,en,o
203,0211-699501013259,el,o
203,0211-699501013259,estudio,o
203,0211-699501013259,basal,o
203,0211-699501013259,con,o
203,0211-699501013259,una,o
203,0211-699501013259,prevalencia,o
203,0211-699501013259,de,o
203,0211-699501013259,hiperhomocisteinemia,i
203,0211-699501013259,del,o
203,0211-699501013259,844,o
203,0211-699501013259,deficit,i
203,0211-699501013259,de,i
203,0211-699501013259,pp,i
203,0211-699501013259,en,o
203,0211-699501013259,el,o
203,0211-699501013259,32,o
203,0211-699501013259,y,o
203,0211-699501013259,folato,i
203,0211-699501013259,en,o
203,0211-699501013259,el,o
203,0211-699501013259,rango,o
203,0211-699501013259,normal,o
203,0211-699501013259,bajo,o
203,0211-699501013259,los,o
203,0211-699501013259,niveles,i
203,0211-699501013259,de,i
203,0211-699501013259,tHcy,i
203,0211-699501013259,se,o
203,0211-699501013259,correlacionaban,o
203,0211-699501013259,inversamente,o
203,0211-699501013259,con,o
203,0211-699501013259,los,o
203,0211-699501013259,del,o
203,0211-699501013259,folato,i
203,0211-699501013259,r,o
203,0211-699501013259,0336,o
203,0211-699501013259,p,o
203,0211-699501013259,001,o
203,0211-699501013259,pero,o
203,0211-699501013259,no,o
203,0211-699501013259,con,o
203,0211-699501013259,pp,i
203,0211-699501013259,B12,i
203,0211-699501013259,edad,o
203,0211-699501013259,albumina,i
203,0211-699501013259,KTV,o
203,0211-699501013259,KRU,o
203,0211-699501013259,PCRn,o
203,0211-699501013259,Cincuenta,o
203,0211-699501013259,y,o
203,0211-699501013259,ocho,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,recibieron,o
203,0211-699501013259,seis,o
203,0211-699501013259,meses,o
203,0211-699501013259,de,o
203,0211-699501013259,suplementacion,i
203,0211-699501013259,con,o
203,0211-699501013259,normalizacion,o
203,0211-699501013259,del,o
203,0211-699501013259,pp,i
203,0211-699501013259,aumento,o
203,0211-699501013259,del,o
203,0211-699501013259,folato,i
203,0211-699501013259,703,o
203,0211-699501013259,IC,o
203,0211-699501013259,638,o
203,0211-699501013259,795,o
203,0211-699501013259,vs,o
203,0211-699501013259,6181,o
203,0211-699501013259,IC,o
203,0211-699501013259,4447,o
203,0211-699501013259,7811,o
203,0211-699501013259,p,o
203,0211-699501013259,0001,o
203,0211-699501013259,y,o
203,0211-699501013259,descenso,o
203,0211-699501013259,de,o
203,0211-699501013259,la,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,240,o
203,0211-699501013259,IC,o
203,0211-699501013259,213,o
203,0211-699501013259,264,o
203,0211-699501013259,vs,o
203,0211-699501013259,199,o
203,0211-699501013259,IC,o
203,0211-699501013259,175,o
203,0211-699501013259,224,o
203,0211-699501013259,p,o
203,0211-699501013259,005,o
203,0211-699501013259,Han,o
203,0211-699501013259,recibido,o
203,0211-699501013259,suplementacion,i
203,0211-699501013259,durante,o
203,0211-699501013259,12,o
203,0211-699501013259,meses,o
203,0211-699501013259,33,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,pero,o
203,0211-699501013259,a,o
203,0211-699501013259,pesar,o
203,0211-699501013259,de,o
203,0211-699501013259,un,o
203,0211-699501013259,continuo,o
203,0211-699501013259,aumento,o
203,0211-699501013259,del,o
203,0211-699501013259,folato,i
203,0211-699501013259,10078,o
203,0211-699501013259,IC,o
203,0211-699501013259,7481,o
203,0211-699501013259,12674,o
203,0211-699501013259,p,o
203,0211-699501013259,0001,o
203,0211-699501013259,solo,o
203,0211-699501013259,3,o
203,0211-699501013259,pacientes,o
203,0211-699501013259,presentan,o
203,0211-699501013259,niveles,o
203,0211-699501013259,normales,o
203,0211-699501013259,de,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,correlacionandose,o
203,0211-699501013259,directamente,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,con,o
203,0211-699501013259,la,o
203,0211-699501013259,albumina,i
203,0211-699501013259,r,o
203,0211-699501013259,056,o
203,0211-699501013259,p,o
203,0211-699501013259,0001,o
203,0211-699501013259,que,o
203,0211-699501013259,se,o
203,0211-699501013259,elevo,o
203,0211-699501013259,con,o
203,0211-699501013259,respecto,o
203,0211-699501013259,al,o
203,0211-699501013259,inicio,o
203,0211-699501013259,337,o
203,0211-699501013259,IC,o
203,0211-699501013259,327,o
203,0211-699501013259,346,o
203,0211-699501013259,vs,o
203,0211-699501013259,350,o
203,0211-699501013259,IC,o
203,0211-699501013259,337,o
203,0211-699501013259,363,o
203,0211-699501013259,p,o
203,0211-699501013259,005,o
203,0211-699501013259,Conclusion,o
203,0211-699501013259,Tras,o
203,0211-699501013259,suplementacion,i
203,0211-699501013259,con,o
203,0211-699501013259,acido,i
203,0211-699501013259,folico,i
203,0211-699501013259,y,o
203,0211-699501013259,vitamina,i
203,0211-699501013259,B6,i
203,0211-699501013259,aunque,o
203,0211-699501013259,inicialmente,o
203,0211-699501013259,se,o
203,0211-699501013259,reduce,o
203,0211-699501013259,la,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,esta,o
203,0211-699501013259,respuesta,o
203,0211-699501013259,se,o
203,0211-699501013259,hace,o
203,0211-699501013259,refractaria,o
203,0211-699501013259,correlacionandose,o
203,0211-699501013259,directamente,o
203,0211-699501013259,la,o
203,0211-699501013259,tHcy,i
203,0211-699501013259,con,o
203,0211-699501013259,la,o
203,0211-699501013259,albumina,i
203,0211-699501013259,plasmatica,i
203,0211-699501013259,La,o
203,0211-699501013259,interpretacion,o
203,0211-699501013259,de,o
203,0211-699501013259,los,o
203,0211-699501013259,niveles,i
203,0211-699501013259,de,i
203,0211-699501013259,tHcy,i
203,0211-699501013259,debe,o
203,0211-699501013259,tener,o
203,0211-699501013259,en,o
203,0211-699501013259,cuenta,o
203,0211-699501013259,la,o
203,0211-699501013259,concentracion,i
203,0211-699501013259,de,i
203,0211-699501013259,albumina,i
204,0211-699501013259,Efecto,o
204,0211-699501013259,de,o
204,0211-699501013259,la,o
204,0211-699501013259,suplementacion,i
204,0211-699501013259,con,o
204,0211-699501013259,acido,i
204,0211-699501013259,folico,i
204,0211-699501013259,sobre,o
204,0211-699501013259,los,o
204,0211-699501013259,niveles,i
204,0211-699501013259,de,i
204,0211-699501013259,homocisteina,i
204,0211-699501013259,total,o
204,0211-699501013259,en,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,en,o
204,0211-699501013259,hemodialisis,i
204,0211-699501013259,La,o
204,0211-699501013259,hiperhomocisteinemia,i
204,0211-699501013259,es,o
204,0211-699501013259,un,o
204,0211-699501013259,marcador,o
204,0211-699501013259,de,o
204,0211-699501013259,riesgo,o
204,0211-699501013259,independiente,o
204,0211-699501013259,de,o
204,0211-699501013259,morbimortalidad,o
204,0211-699501013259,cardiovascular,i
204,0211-699501013259,Hemos,o
204,0211-699501013259,intentado,o
204,0211-699501013259,prospectivamente,o
204,0211-699501013259,reducir,o
204,0211-699501013259,los,o
204,0211-699501013259,niveles,i
204,0211-699501013259,de,i
204,0211-699501013259,homocisteina,i
204,0211-699501013259,total,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,mediante,o
204,0211-699501013259,suplemento,o
204,0211-699501013259,con,o
204,0211-699501013259,acido,i
204,0211-699501013259,folico,i
204,0211-699501013259,y,o
204,0211-699501013259,vitamina,i
204,0211-699501013259,B6,i
204,0211-699501013259,pp,i
204,0211-699501013259,valorando,o
204,0211-699501013259,su,o
204,0211-699501013259,posible,o
204,0211-699501013259,correlacion,o
204,0211-699501013259,con,o
204,0211-699501013259,dosis,o
204,0211-699501013259,de,o
204,0211-699501013259,dialisis,i
204,0211-699501013259,funcion,i
204,0211-699501013259,residual,i
204,0211-699501013259,y,o
204,0211-699501013259,parametros,o
204,0211-699501013259,nutricionales,o
204,0211-699501013259,Metodos,o
204,0211-699501013259,Todos,o
204,0211-699501013259,los,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,en,o
204,0211-699501013259,hemodialisis,i
204,0211-699501013259,al,o
204,0211-699501013259,comienzo,o
204,0211-699501013259,del,o
204,0211-699501013259,estudio,o
204,0211-699501013259,que,o
204,0211-699501013259,no,o
204,0211-699501013259,recibian,o
204,0211-699501013259,acido,i
204,0211-699501013259,folico,i
204,0211-699501013259,ni,o
204,0211-699501013259,vitamina,i
204,0211-699501013259,B6,i
204,0211-699501013259,asi,o
204,0211-699501013259,como,o
204,0211-699501013259,los,o
204,0211-699501013259,incorporados,o
204,0211-699501013259,posteriormente,o
204,0211-699501013259,a,o
204,0211-699501013259,partir,o
204,0211-699501013259,de,o
204,0211-699501013259,su,o
204,0211-699501013259,tercer,o
204,0211-699501013259,mes,o
204,0211-699501013259,en,o
204,0211-699501013259,hemodialisis,i
204,0211-699501013259,recibieron,o
204,0211-699501013259,5,o
204,0211-699501013259,mg,o
204,0211-699501013259,orales,o
204,0211-699501013259,de,o
204,0211-699501013259,acido,i
204,0211-699501013259,folico,i
204,0211-699501013259,cada,o
204,0211-699501013259,48,o
204,0211-699501013259,horas,o
204,0211-699501013259,y,o
204,0211-699501013259,40,o
204,0211-699501013259,mg,o
204,0211-699501013259,orales,o
204,0211-699501013259,de,o
204,0211-699501013259,vitamina,i
204,0211-699501013259,B6,i
204,0211-699501013259,cada,o
204,0211-699501013259,semana,o
204,0211-699501013259,Se,o
204,0211-699501013259,determinaron,o
204,0211-699501013259,al,o
204,0211-699501013259,comienzo,o
204,0211-699501013259,del,o
204,0211-699501013259,estudio,o
204,0211-699501013259,y,o
204,0211-699501013259,cada,o
204,0211-699501013259,2,o
204,0211-699501013259,meses,o
204,0211-699501013259,niveles,i
204,0211-699501013259,de,i
204,0211-699501013259,folato,i
204,0211-699501013259,vitamina,i
204,0211-699501013259,B12,i
204,0211-699501013259,inmunoensayo,i
204,0211-699501013259,albumina,i
204,0211-699501013259,y,o
204,0211-699501013259,cinetica,o
204,0211-699501013259,de,o
204,0211-699501013259,la,o
204,0211-699501013259,urea,i
204,0211-699501013259,KTV,o
204,0211-699501013259,KRU,o
204,0211-699501013259,PCRn,o
204,0211-699501013259,y,o
204,0211-699501013259,cada,o
204,0211-699501013259,6,o
204,0211-699501013259,meses,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,HPLC,i
204,0211-699501013259,y,o
204,0211-699501013259,pp,i
204,0211-699501013259,RIA,i
204,0211-699501013259,Resultados,o
204,0211-699501013259,80,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,fueron,o
204,0211-699501013259,incluidos,o
204,0211-699501013259,en,o
204,0211-699501013259,el,o
204,0211-699501013259,estudio,o
204,0211-699501013259,basal,o
204,0211-699501013259,con,o
204,0211-699501013259,una,o
204,0211-699501013259,prevalencia,o
204,0211-699501013259,de,o
204,0211-699501013259,hiperhomocisteinemia,i
204,0211-699501013259,del,o
204,0211-699501013259,844,o
204,0211-699501013259,deficit,i
204,0211-699501013259,de,i
204,0211-699501013259,pp,i
204,0211-699501013259,en,o
204,0211-699501013259,el,o
204,0211-699501013259,32,o
204,0211-699501013259,y,o
204,0211-699501013259,folato,i
204,0211-699501013259,en,o
204,0211-699501013259,el,o
204,0211-699501013259,rango,o
204,0211-699501013259,normal,o
204,0211-699501013259,bajo,o
204,0211-699501013259,los,o
204,0211-699501013259,niveles,i
204,0211-699501013259,de,i
204,0211-699501013259,tHcy,i
204,0211-699501013259,se,o
204,0211-699501013259,correlacionaban,o
204,0211-699501013259,inversamente,o
204,0211-699501013259,con,o
204,0211-699501013259,los,o
204,0211-699501013259,del,o
204,0211-699501013259,folato,i
204,0211-699501013259,r,o
204,0211-699501013259,0336,o
204,0211-699501013259,p,o
204,0211-699501013259,001,o
204,0211-699501013259,pero,o
204,0211-699501013259,no,o
204,0211-699501013259,con,o
204,0211-699501013259,pp,i
204,0211-699501013259,B12,i
204,0211-699501013259,edad,o
204,0211-699501013259,albumina,i
204,0211-699501013259,KTV,o
204,0211-699501013259,KRU,o
204,0211-699501013259,PCRn,o
204,0211-699501013259,Cincuenta,o
204,0211-699501013259,y,o
204,0211-699501013259,ocho,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,recibieron,o
204,0211-699501013259,seis,o
204,0211-699501013259,meses,o
204,0211-699501013259,de,o
204,0211-699501013259,suplementacion,i
204,0211-699501013259,con,o
204,0211-699501013259,normalizacion,o
204,0211-699501013259,del,o
204,0211-699501013259,pp,i
204,0211-699501013259,aumento,o
204,0211-699501013259,del,o
204,0211-699501013259,folato,i
204,0211-699501013259,703,o
204,0211-699501013259,IC,o
204,0211-699501013259,638,o
204,0211-699501013259,795,o
204,0211-699501013259,vs,o
204,0211-699501013259,6181,o
204,0211-699501013259,IC,o
204,0211-699501013259,4447,o
204,0211-699501013259,7811,o
204,0211-699501013259,p,o
204,0211-699501013259,0001,o
204,0211-699501013259,y,o
204,0211-699501013259,descenso,o
204,0211-699501013259,de,o
204,0211-699501013259,la,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,240,o
204,0211-699501013259,IC,o
204,0211-699501013259,213,o
204,0211-699501013259,264,o
204,0211-699501013259,vs,o
204,0211-699501013259,199,o
204,0211-699501013259,IC,o
204,0211-699501013259,175,o
204,0211-699501013259,224,o
204,0211-699501013259,p,o
204,0211-699501013259,005,o
204,0211-699501013259,Han,o
204,0211-699501013259,recibido,o
204,0211-699501013259,suplementacion,i
204,0211-699501013259,durante,o
204,0211-699501013259,12,o
204,0211-699501013259,meses,o
204,0211-699501013259,33,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,pero,o
204,0211-699501013259,a,o
204,0211-699501013259,pesar,o
204,0211-699501013259,de,o
204,0211-699501013259,un,o
204,0211-699501013259,continuo,o
204,0211-699501013259,aumento,o
204,0211-699501013259,del,o
204,0211-699501013259,folato,i
204,0211-699501013259,10078,o
204,0211-699501013259,IC,o
204,0211-699501013259,7481,o
204,0211-699501013259,12674,o
204,0211-699501013259,p,o
204,0211-699501013259,0001,o
204,0211-699501013259,solo,o
204,0211-699501013259,3,o
204,0211-699501013259,pacientes,o
204,0211-699501013259,presentan,o
204,0211-699501013259,niveles,o
204,0211-699501013259,normales,o
204,0211-699501013259,de,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,correlacionandose,o
204,0211-699501013259,directamente,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,con,o
204,0211-699501013259,la,o
204,0211-699501013259,albumina,i
204,0211-699501013259,r,o
204,0211-699501013259,056,o
204,0211-699501013259,p,o
204,0211-699501013259,0001,o
204,0211-699501013259,que,o
204,0211-699501013259,se,o
204,0211-699501013259,elevo,o
204,0211-699501013259,con,o
204,0211-699501013259,respecto,o
204,0211-699501013259,al,o
204,0211-699501013259,inicio,o
204,0211-699501013259,337,o
204,0211-699501013259,IC,o
204,0211-699501013259,327,o
204,0211-699501013259,346,o
204,0211-699501013259,vs,o
204,0211-699501013259,350,o
204,0211-699501013259,IC,o
204,0211-699501013259,337,o
204,0211-699501013259,363,o
204,0211-699501013259,p,o
204,0211-699501013259,005,o
204,0211-699501013259,Conclusion,o
204,0211-699501013259,Tras,o
204,0211-699501013259,suplementacion,i
204,0211-699501013259,con,o
204,0211-699501013259,acido,i
204,0211-699501013259,folico,i
204,0211-699501013259,y,o
204,0211-699501013259,vitamina,i
204,0211-699501013259,B6,i
204,0211-699501013259,aunque,o
204,0211-699501013259,inicialmente,o
204,0211-699501013259,se,o
204,0211-699501013259,reduce,o
204,0211-699501013259,la,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,esta,o
204,0211-699501013259,respuesta,o
204,0211-699501013259,se,o
204,0211-699501013259,hace,o
204,0211-699501013259,refractaria,o
204,0211-699501013259,correlacionandose,o
204,0211-699501013259,directamente,o
204,0211-699501013259,la,o
204,0211-699501013259,tHcy,i
204,0211-699501013259,con,o
204,0211-699501013259,la,o
204,0211-699501013259,albumina,i
204,0211-699501013259,plasmatica,i
204,0211-699501013259,La,o
204,0211-699501013259,interpretacion,o
204,0211-699501013259,de,o
204,0211-699501013259,los,o
204,0211-699501013259,niveles,i
204,0211-699501013259,de,i
204,0211-699501013259,tHcy,i
204,0211-699501013259,debe,o
204,0211-699501013259,tener,o
204,0211-699501013259,en,o
204,0211-699501013259,cuenta,o
204,0211-699501013259,la,o
204,0211-699501013259,concentracion,i
204,0211-699501013259,de,i
204,0211-699501013259,albumina,i
205,0211-699501013259,Efecto,o
205,0211-699501013259,de,o
205,0211-699501013259,la,o
205,0211-699501013259,suplementacion,i
205,0211-699501013259,con,o
205,0211-699501013259,acido,i
205,0211-699501013259,folico,i
205,0211-699501013259,sobre,o
205,0211-699501013259,los,o
205,0211-699501013259,niveles,i
205,0211-699501013259,de,i
205,0211-699501013259,homocisteina,i
205,0211-699501013259,total,o
205,0211-699501013259,en,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,en,o
205,0211-699501013259,hemodialisis,i
205,0211-699501013259,La,o
205,0211-699501013259,hiperhomocisteinemia,i
205,0211-699501013259,es,o
205,0211-699501013259,un,o
205,0211-699501013259,marcador,o
205,0211-699501013259,de,o
205,0211-699501013259,riesgo,o
205,0211-699501013259,independiente,o
205,0211-699501013259,de,o
205,0211-699501013259,morbimortalidad,o
205,0211-699501013259,cardiovascular,i
205,0211-699501013259,Hemos,o
205,0211-699501013259,intentado,o
205,0211-699501013259,prospectivamente,o
205,0211-699501013259,reducir,o
205,0211-699501013259,los,o
205,0211-699501013259,niveles,i
205,0211-699501013259,de,i
205,0211-699501013259,homocisteina,i
205,0211-699501013259,total,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,mediante,o
205,0211-699501013259,suplemento,o
205,0211-699501013259,con,o
205,0211-699501013259,acido,i
205,0211-699501013259,folico,i
205,0211-699501013259,y,o
205,0211-699501013259,vitamina,i
205,0211-699501013259,B6,i
205,0211-699501013259,pp,i
205,0211-699501013259,valorando,o
205,0211-699501013259,su,o
205,0211-699501013259,posible,o
205,0211-699501013259,correlacion,o
205,0211-699501013259,con,o
205,0211-699501013259,dosis,o
205,0211-699501013259,de,o
205,0211-699501013259,dialisis,i
205,0211-699501013259,funcion,i
205,0211-699501013259,residual,i
205,0211-699501013259,y,o
205,0211-699501013259,parametros,o
205,0211-699501013259,nutricionales,o
205,0211-699501013259,Metodos,o
205,0211-699501013259,Todos,o
205,0211-699501013259,los,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,en,o
205,0211-699501013259,hemodialisis,i
205,0211-699501013259,al,o
205,0211-699501013259,comienzo,o
205,0211-699501013259,del,o
205,0211-699501013259,estudio,o
205,0211-699501013259,que,o
205,0211-699501013259,no,o
205,0211-699501013259,recibian,o
205,0211-699501013259,acido,i
205,0211-699501013259,folico,i
205,0211-699501013259,ni,o
205,0211-699501013259,vitamina,i
205,0211-699501013259,B6,i
205,0211-699501013259,asi,o
205,0211-699501013259,como,o
205,0211-699501013259,los,o
205,0211-699501013259,incorporados,o
205,0211-699501013259,posteriormente,o
205,0211-699501013259,a,o
205,0211-699501013259,partir,o
205,0211-699501013259,de,o
205,0211-699501013259,su,o
205,0211-699501013259,tercer,o
205,0211-699501013259,mes,o
205,0211-699501013259,en,o
205,0211-699501013259,hemodialisis,i
205,0211-699501013259,recibieron,o
205,0211-699501013259,5,o
205,0211-699501013259,mg,o
205,0211-699501013259,orales,o
205,0211-699501013259,de,o
205,0211-699501013259,acido,i
205,0211-699501013259,folico,i
205,0211-699501013259,cada,o
205,0211-699501013259,48,o
205,0211-699501013259,horas,o
205,0211-699501013259,y,o
205,0211-699501013259,40,o
205,0211-699501013259,mg,o
205,0211-699501013259,orales,o
205,0211-699501013259,de,o
205,0211-699501013259,vitamina,i
205,0211-699501013259,B6,i
205,0211-699501013259,cada,o
205,0211-699501013259,semana,o
205,0211-699501013259,Se,o
205,0211-699501013259,determinaron,o
205,0211-699501013259,al,o
205,0211-699501013259,comienzo,o
205,0211-699501013259,del,o
205,0211-699501013259,estudio,o
205,0211-699501013259,y,o
205,0211-699501013259,cada,o
205,0211-699501013259,2,o
205,0211-699501013259,meses,o
205,0211-699501013259,niveles,i
205,0211-699501013259,de,i
205,0211-699501013259,folato,i
205,0211-699501013259,vitamina,i
205,0211-699501013259,B12,i
205,0211-699501013259,inmunoensayo,i
205,0211-699501013259,albumina,i
205,0211-699501013259,y,o
205,0211-699501013259,cinetica,o
205,0211-699501013259,de,o
205,0211-699501013259,la,o
205,0211-699501013259,urea,i
205,0211-699501013259,KTV,o
205,0211-699501013259,KRU,o
205,0211-699501013259,PCRn,o
205,0211-699501013259,y,o
205,0211-699501013259,cada,o
205,0211-699501013259,6,o
205,0211-699501013259,meses,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,HPLC,i
205,0211-699501013259,y,o
205,0211-699501013259,pp,i
205,0211-699501013259,RIA,i
205,0211-699501013259,Resultados,o
205,0211-699501013259,80,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,fueron,o
205,0211-699501013259,incluidos,o
205,0211-699501013259,en,o
205,0211-699501013259,el,o
205,0211-699501013259,estudio,o
205,0211-699501013259,basal,o
205,0211-699501013259,con,o
205,0211-699501013259,una,o
205,0211-699501013259,prevalencia,o
205,0211-699501013259,de,o
205,0211-699501013259,hiperhomocisteinemia,i
205,0211-699501013259,del,o
205,0211-699501013259,844,o
205,0211-699501013259,deficit,i
205,0211-699501013259,de,i
205,0211-699501013259,pp,i
205,0211-699501013259,en,o
205,0211-699501013259,el,o
205,0211-699501013259,32,o
205,0211-699501013259,y,o
205,0211-699501013259,folato,i
205,0211-699501013259,en,o
205,0211-699501013259,el,o
205,0211-699501013259,rango,o
205,0211-699501013259,normal,o
205,0211-699501013259,bajo,o
205,0211-699501013259,los,o
205,0211-699501013259,niveles,i
205,0211-699501013259,de,i
205,0211-699501013259,tHcy,i
205,0211-699501013259,se,o
205,0211-699501013259,correlacionaban,o
205,0211-699501013259,inversamente,o
205,0211-699501013259,con,o
205,0211-699501013259,los,o
205,0211-699501013259,del,o
205,0211-699501013259,folato,i
205,0211-699501013259,r,o
205,0211-699501013259,0336,o
205,0211-699501013259,p,o
205,0211-699501013259,001,o
205,0211-699501013259,pero,o
205,0211-699501013259,no,o
205,0211-699501013259,con,o
205,0211-699501013259,pp,i
205,0211-699501013259,B12,i
205,0211-699501013259,edad,o
205,0211-699501013259,albumina,i
205,0211-699501013259,KTV,o
205,0211-699501013259,KRU,o
205,0211-699501013259,PCRn,o
205,0211-699501013259,Cincuenta,o
205,0211-699501013259,y,o
205,0211-699501013259,ocho,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,recibieron,o
205,0211-699501013259,seis,o
205,0211-699501013259,meses,o
205,0211-699501013259,de,o
205,0211-699501013259,suplementacion,i
205,0211-699501013259,con,o
205,0211-699501013259,normalizacion,o
205,0211-699501013259,del,o
205,0211-699501013259,pp,i
205,0211-699501013259,aumento,o
205,0211-699501013259,del,o
205,0211-699501013259,folato,i
205,0211-699501013259,703,o
205,0211-699501013259,IC,o
205,0211-699501013259,638,o
205,0211-699501013259,795,o
205,0211-699501013259,vs,o
205,0211-699501013259,6181,o
205,0211-699501013259,IC,o
205,0211-699501013259,4447,o
205,0211-699501013259,7811,o
205,0211-699501013259,p,o
205,0211-699501013259,0001,o
205,0211-699501013259,y,o
205,0211-699501013259,descenso,o
205,0211-699501013259,de,o
205,0211-699501013259,la,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,240,o
205,0211-699501013259,IC,o
205,0211-699501013259,213,o
205,0211-699501013259,264,o
205,0211-699501013259,vs,o
205,0211-699501013259,199,o
205,0211-699501013259,IC,o
205,0211-699501013259,175,o
205,0211-699501013259,224,o
205,0211-699501013259,p,o
205,0211-699501013259,005,o
205,0211-699501013259,Han,o
205,0211-699501013259,recibido,o
205,0211-699501013259,suplementacion,i
205,0211-699501013259,durante,o
205,0211-699501013259,12,o
205,0211-699501013259,meses,o
205,0211-699501013259,33,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,pero,o
205,0211-699501013259,a,o
205,0211-699501013259,pesar,o
205,0211-699501013259,de,o
205,0211-699501013259,un,o
205,0211-699501013259,continuo,o
205,0211-699501013259,aumento,o
205,0211-699501013259,del,o
205,0211-699501013259,folato,i
205,0211-699501013259,10078,o
205,0211-699501013259,IC,o
205,0211-699501013259,7481,o
205,0211-699501013259,12674,o
205,0211-699501013259,p,o
205,0211-699501013259,0001,o
205,0211-699501013259,solo,o
205,0211-699501013259,3,o
205,0211-699501013259,pacientes,o
205,0211-699501013259,presentan,o
205,0211-699501013259,niveles,o
205,0211-699501013259,normales,o
205,0211-699501013259,de,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,correlacionandose,o
205,0211-699501013259,directamente,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,con,o
205,0211-699501013259,la,o
205,0211-699501013259,albumina,i
205,0211-699501013259,r,o
205,0211-699501013259,056,o
205,0211-699501013259,p,o
205,0211-699501013259,0001,o
205,0211-699501013259,que,o
205,0211-699501013259,se,o
205,0211-699501013259,elevo,o
205,0211-699501013259,con,o
205,0211-699501013259,respecto,o
205,0211-699501013259,al,o
205,0211-699501013259,inicio,o
205,0211-699501013259,337,o
205,0211-699501013259,IC,o
205,0211-699501013259,327,o
205,0211-699501013259,346,o
205,0211-699501013259,vs,o
205,0211-699501013259,350,o
205,0211-699501013259,IC,o
205,0211-699501013259,337,o
205,0211-699501013259,363,o
205,0211-699501013259,p,o
205,0211-699501013259,005,o
205,0211-699501013259,Conclusion,o
205,0211-699501013259,Tras,o
205,0211-699501013259,suplementacion,i
205,0211-699501013259,con,o
205,0211-699501013259,acido,i
205,0211-699501013259,folico,i
205,0211-699501013259,y,o
205,0211-699501013259,vitamina,i
205,0211-699501013259,B6,i
205,0211-699501013259,aunque,o
205,0211-699501013259,inicialmente,o
205,0211-699501013259,se,o
205,0211-699501013259,reduce,o
205,0211-699501013259,la,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,esta,o
205,0211-699501013259,respuesta,o
205,0211-699501013259,se,o
205,0211-699501013259,hace,o
205,0211-699501013259,refractaria,o
205,0211-699501013259,correlacionandose,o
205,0211-699501013259,directamente,o
205,0211-699501013259,la,o
205,0211-699501013259,tHcy,i
205,0211-699501013259,con,o
205,0211-699501013259,la,o
205,0211-699501013259,albumina,i
205,0211-699501013259,plasmatica,i
205,0211-699501013259,La,o
205,0211-699501013259,interpretacion,o
205,0211-699501013259,de,o
205,0211-699501013259,los,o
205,0211-699501013259,niveles,i
205,0211-699501013259,de,i
205,0211-699501013259,tHcy,i
205,0211-699501013259,debe,o
205,0211-699501013259,tener,o
205,0211-699501013259,en,o
205,0211-699501013259,cuenta,o
205,0211-699501013259,la,o
205,0211-699501013259,concentracion,i
205,0211-699501013259,de,i
205,0211-699501013259,albumina,i
206,0211-699501013259,Efecto,o
206,0211-699501013259,de,o
206,0211-699501013259,la,o
206,0211-699501013259,suplementacion,i
206,0211-699501013259,con,o
206,0211-699501013259,acido,i
206,0211-699501013259,folico,i
206,0211-699501013259,sobre,o
206,0211-699501013259,los,o
206,0211-699501013259,niveles,i
206,0211-699501013259,de,i
206,0211-699501013259,homocisteina,i
206,0211-699501013259,total,o
206,0211-699501013259,en,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,en,o
206,0211-699501013259,hemodialisis,i
206,0211-699501013259,La,o
206,0211-699501013259,hiperhomocisteinemia,i
206,0211-699501013259,es,o
206,0211-699501013259,un,o
206,0211-699501013259,marcador,o
206,0211-699501013259,de,o
206,0211-699501013259,riesgo,o
206,0211-699501013259,independiente,o
206,0211-699501013259,de,o
206,0211-699501013259,morbimortalidad,o
206,0211-699501013259,cardiovascular,i
206,0211-699501013259,Hemos,o
206,0211-699501013259,intentado,o
206,0211-699501013259,prospectivamente,o
206,0211-699501013259,reducir,o
206,0211-699501013259,los,o
206,0211-699501013259,niveles,i
206,0211-699501013259,de,i
206,0211-699501013259,homocisteina,i
206,0211-699501013259,total,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,mediante,o
206,0211-699501013259,suplemento,o
206,0211-699501013259,con,o
206,0211-699501013259,acido,i
206,0211-699501013259,folico,i
206,0211-699501013259,y,o
206,0211-699501013259,vitamina,i
206,0211-699501013259,B6,i
206,0211-699501013259,pp,i
206,0211-699501013259,valorando,o
206,0211-699501013259,su,o
206,0211-699501013259,posible,o
206,0211-699501013259,correlacion,o
206,0211-699501013259,con,o
206,0211-699501013259,dosis,o
206,0211-699501013259,de,o
206,0211-699501013259,dialisis,i
206,0211-699501013259,funcion,i
206,0211-699501013259,residual,i
206,0211-699501013259,y,o
206,0211-699501013259,parametros,o
206,0211-699501013259,nutricionales,o
206,0211-699501013259,Metodos,o
206,0211-699501013259,Todos,o
206,0211-699501013259,los,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,en,o
206,0211-699501013259,hemodialisis,i
206,0211-699501013259,al,o
206,0211-699501013259,comienzo,o
206,0211-699501013259,del,o
206,0211-699501013259,estudio,o
206,0211-699501013259,que,o
206,0211-699501013259,no,o
206,0211-699501013259,recibian,o
206,0211-699501013259,acido,i
206,0211-699501013259,folico,i
206,0211-699501013259,ni,o
206,0211-699501013259,vitamina,i
206,0211-699501013259,B6,i
206,0211-699501013259,asi,o
206,0211-699501013259,como,o
206,0211-699501013259,los,o
206,0211-699501013259,incorporados,o
206,0211-699501013259,posteriormente,o
206,0211-699501013259,a,o
206,0211-699501013259,partir,o
206,0211-699501013259,de,o
206,0211-699501013259,su,o
206,0211-699501013259,tercer,o
206,0211-699501013259,mes,o
206,0211-699501013259,en,o
206,0211-699501013259,hemodialisis,i
206,0211-699501013259,recibieron,o
206,0211-699501013259,5,o
206,0211-699501013259,mg,o
206,0211-699501013259,orales,o
206,0211-699501013259,de,o
206,0211-699501013259,acido,i
206,0211-699501013259,folico,i
206,0211-699501013259,cada,o
206,0211-699501013259,48,o
206,0211-699501013259,horas,o
206,0211-699501013259,y,o
206,0211-699501013259,40,o
206,0211-699501013259,mg,o
206,0211-699501013259,orales,o
206,0211-699501013259,de,o
206,0211-699501013259,vitamina,i
206,0211-699501013259,B6,i
206,0211-699501013259,cada,o
206,0211-699501013259,semana,o
206,0211-699501013259,Se,o
206,0211-699501013259,determinaron,o
206,0211-699501013259,al,o
206,0211-699501013259,comienzo,o
206,0211-699501013259,del,o
206,0211-699501013259,estudio,o
206,0211-699501013259,y,o
206,0211-699501013259,cada,o
206,0211-699501013259,2,o
206,0211-699501013259,meses,o
206,0211-699501013259,niveles,i
206,0211-699501013259,de,i
206,0211-699501013259,folato,i
206,0211-699501013259,vitamina,i
206,0211-699501013259,B12,i
206,0211-699501013259,inmunoensayo,i
206,0211-699501013259,albumina,i
206,0211-699501013259,y,o
206,0211-699501013259,cinetica,o
206,0211-699501013259,de,o
206,0211-699501013259,la,o
206,0211-699501013259,urea,i
206,0211-699501013259,KTV,o
206,0211-699501013259,KRU,o
206,0211-699501013259,PCRn,o
206,0211-699501013259,y,o
206,0211-699501013259,cada,o
206,0211-699501013259,6,o
206,0211-699501013259,meses,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,HPLC,i
206,0211-699501013259,y,o
206,0211-699501013259,pp,i
206,0211-699501013259,RIA,i
206,0211-699501013259,Resultados,o
206,0211-699501013259,80,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,fueron,o
206,0211-699501013259,incluidos,o
206,0211-699501013259,en,o
206,0211-699501013259,el,o
206,0211-699501013259,estudio,o
206,0211-699501013259,basal,o
206,0211-699501013259,con,o
206,0211-699501013259,una,o
206,0211-699501013259,prevalencia,o
206,0211-699501013259,de,o
206,0211-699501013259,hiperhomocisteinemia,i
206,0211-699501013259,del,o
206,0211-699501013259,844,o
206,0211-699501013259,deficit,i
206,0211-699501013259,de,i
206,0211-699501013259,pp,i
206,0211-699501013259,en,o
206,0211-699501013259,el,o
206,0211-699501013259,32,o
206,0211-699501013259,y,o
206,0211-699501013259,folato,i
206,0211-699501013259,en,o
206,0211-699501013259,el,o
206,0211-699501013259,rango,o
206,0211-699501013259,normal,o
206,0211-699501013259,bajo,o
206,0211-699501013259,los,o
206,0211-699501013259,niveles,i
206,0211-699501013259,de,i
206,0211-699501013259,tHcy,i
206,0211-699501013259,se,o
206,0211-699501013259,correlacionaban,o
206,0211-699501013259,inversamente,o
206,0211-699501013259,con,o
206,0211-699501013259,los,o
206,0211-699501013259,del,o
206,0211-699501013259,folato,i
206,0211-699501013259,r,o
206,0211-699501013259,0336,o
206,0211-699501013259,p,o
206,0211-699501013259,001,o
206,0211-699501013259,pero,o
206,0211-699501013259,no,o
206,0211-699501013259,con,o
206,0211-699501013259,pp,i
206,0211-699501013259,B12,i
206,0211-699501013259,edad,o
206,0211-699501013259,albumina,i
206,0211-699501013259,KTV,o
206,0211-699501013259,KRU,o
206,0211-699501013259,PCRn,o
206,0211-699501013259,Cincuenta,o
206,0211-699501013259,y,o
206,0211-699501013259,ocho,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,recibieron,o
206,0211-699501013259,seis,o
206,0211-699501013259,meses,o
206,0211-699501013259,de,o
206,0211-699501013259,suplementacion,i
206,0211-699501013259,con,o
206,0211-699501013259,normalizacion,o
206,0211-699501013259,del,o
206,0211-699501013259,pp,i
206,0211-699501013259,aumento,o
206,0211-699501013259,del,o
206,0211-699501013259,folato,i
206,0211-699501013259,703,o
206,0211-699501013259,IC,o
206,0211-699501013259,638,o
206,0211-699501013259,795,o
206,0211-699501013259,vs,o
206,0211-699501013259,6181,o
206,0211-699501013259,IC,o
206,0211-699501013259,4447,o
206,0211-699501013259,7811,o
206,0211-699501013259,p,o
206,0211-699501013259,0001,o
206,0211-699501013259,y,o
206,0211-699501013259,descenso,o
206,0211-699501013259,de,o
206,0211-699501013259,la,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,240,o
206,0211-699501013259,IC,o
206,0211-699501013259,213,o
206,0211-699501013259,264,o
206,0211-699501013259,vs,o
206,0211-699501013259,199,o
206,0211-699501013259,IC,o
206,0211-699501013259,175,o
206,0211-699501013259,224,o
206,0211-699501013259,p,o
206,0211-699501013259,005,o
206,0211-699501013259,Han,o
206,0211-699501013259,recibido,o
206,0211-699501013259,suplementacion,i
206,0211-699501013259,durante,o
206,0211-699501013259,12,o
206,0211-699501013259,meses,o
206,0211-699501013259,33,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,pero,o
206,0211-699501013259,a,o
206,0211-699501013259,pesar,o
206,0211-699501013259,de,o
206,0211-699501013259,un,o
206,0211-699501013259,continuo,o
206,0211-699501013259,aumento,o
206,0211-699501013259,del,o
206,0211-699501013259,folato,i
206,0211-699501013259,10078,o
206,0211-699501013259,IC,o
206,0211-699501013259,7481,o
206,0211-699501013259,12674,o
206,0211-699501013259,p,o
206,0211-699501013259,0001,o
206,0211-699501013259,solo,o
206,0211-699501013259,3,o
206,0211-699501013259,pacientes,o
206,0211-699501013259,presentan,o
206,0211-699501013259,niveles,o
206,0211-699501013259,normales,o
206,0211-699501013259,de,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,correlacionandose,o
206,0211-699501013259,directamente,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,con,o
206,0211-699501013259,la,o
206,0211-699501013259,albumina,i
206,0211-699501013259,r,o
206,0211-699501013259,056,o
206,0211-699501013259,p,o
206,0211-699501013259,0001,o
206,0211-699501013259,que,o
206,0211-699501013259,se,o
206,0211-699501013259,elevo,o
206,0211-699501013259,con,o
206,0211-699501013259,respecto,o
206,0211-699501013259,al,o
206,0211-699501013259,inicio,o
206,0211-699501013259,337,o
206,0211-699501013259,IC,o
206,0211-699501013259,327,o
206,0211-699501013259,346,o
206,0211-699501013259,vs,o
206,0211-699501013259,350,o
206,0211-699501013259,IC,o
206,0211-699501013259,337,o
206,0211-699501013259,363,o
206,0211-699501013259,p,o
206,0211-699501013259,005,o
206,0211-699501013259,Conclusion,o
206,0211-699501013259,Tras,o
206,0211-699501013259,suplementacion,i
206,0211-699501013259,con,o
206,0211-699501013259,acido,i
206,0211-699501013259,folico,i
206,0211-699501013259,y,o
206,0211-699501013259,vitamina,i
206,0211-699501013259,B6,i
206,0211-699501013259,aunque,o
206,0211-699501013259,inicialmente,o
206,0211-699501013259,se,o
206,0211-699501013259,reduce,o
206,0211-699501013259,la,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,esta,o
206,0211-699501013259,respuesta,o
206,0211-699501013259,se,o
206,0211-699501013259,hace,o
206,0211-699501013259,refractaria,o
206,0211-699501013259,correlacionandose,o
206,0211-699501013259,directamente,o
206,0211-699501013259,la,o
206,0211-699501013259,tHcy,i
206,0211-699501013259,con,o
206,0211-699501013259,la,o
206,0211-699501013259,albumina,i
206,0211-699501013259,plasmatica,i
206,0211-699501013259,La,o
206,0211-699501013259,interpretacion,o
206,0211-699501013259,de,o
206,0211-699501013259,los,o
206,0211-699501013259,niveles,i
206,0211-699501013259,de,i
206,0211-699501013259,tHcy,i
206,0211-699501013259,debe,o
206,0211-699501013259,tener,o
206,0211-699501013259,en,o
206,0211-699501013259,cuenta,o
206,0211-699501013259,la,o
206,0211-699501013259,concentracion,i
206,0211-699501013259,de,i
206,0211-699501013259,albumina,i
207,0211-699501013259,Efecto,o
207,0211-699501013259,de,o
207,0211-699501013259,la,o
207,0211-699501013259,suplementacion,i
207,0211-699501013259,con,o
207,0211-699501013259,acido,i
207,0211-699501013259,folico,i
207,0211-699501013259,sobre,o
207,0211-699501013259,los,o
207,0211-699501013259,niveles,i
207,0211-699501013259,de,i
207,0211-699501013259,homocisteina,i
207,0211-699501013259,total,o
207,0211-699501013259,en,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,en,o
207,0211-699501013259,hemodialisis,i
207,0211-699501013259,La,o
207,0211-699501013259,hiperhomocisteinemia,i
207,0211-699501013259,es,o
207,0211-699501013259,un,o
207,0211-699501013259,marcador,o
207,0211-699501013259,de,o
207,0211-699501013259,riesgo,o
207,0211-699501013259,independiente,o
207,0211-699501013259,de,o
207,0211-699501013259,morbimortalidad,o
207,0211-699501013259,cardiovascular,i
207,0211-699501013259,Hemos,o
207,0211-699501013259,intentado,o
207,0211-699501013259,prospectivamente,o
207,0211-699501013259,reducir,o
207,0211-699501013259,los,o
207,0211-699501013259,niveles,i
207,0211-699501013259,de,i
207,0211-699501013259,homocisteina,i
207,0211-699501013259,total,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,mediante,o
207,0211-699501013259,suplemento,o
207,0211-699501013259,con,o
207,0211-699501013259,acido,i
207,0211-699501013259,folico,i
207,0211-699501013259,y,o
207,0211-699501013259,vitamina,i
207,0211-699501013259,B6,i
207,0211-699501013259,pp,i
207,0211-699501013259,valorando,o
207,0211-699501013259,su,o
207,0211-699501013259,posible,o
207,0211-699501013259,correlacion,o
207,0211-699501013259,con,o
207,0211-699501013259,dosis,o
207,0211-699501013259,de,o
207,0211-699501013259,dialisis,i
207,0211-699501013259,funcion,i
207,0211-699501013259,residual,i
207,0211-699501013259,y,o
207,0211-699501013259,parametros,o
207,0211-699501013259,nutricionales,o
207,0211-699501013259,Metodos,o
207,0211-699501013259,Todos,o
207,0211-699501013259,los,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,en,o
207,0211-699501013259,hemodialisis,i
207,0211-699501013259,al,o
207,0211-699501013259,comienzo,o
207,0211-699501013259,del,o
207,0211-699501013259,estudio,o
207,0211-699501013259,que,o
207,0211-699501013259,no,o
207,0211-699501013259,recibian,o
207,0211-699501013259,acido,i
207,0211-699501013259,folico,i
207,0211-699501013259,ni,o
207,0211-699501013259,vitamina,i
207,0211-699501013259,B6,i
207,0211-699501013259,asi,o
207,0211-699501013259,como,o
207,0211-699501013259,los,o
207,0211-699501013259,incorporados,o
207,0211-699501013259,posteriormente,o
207,0211-699501013259,a,o
207,0211-699501013259,partir,o
207,0211-699501013259,de,o
207,0211-699501013259,su,o
207,0211-699501013259,tercer,o
207,0211-699501013259,mes,o
207,0211-699501013259,en,o
207,0211-699501013259,hemodialisis,i
207,0211-699501013259,recibieron,o
207,0211-699501013259,5,o
207,0211-699501013259,mg,o
207,0211-699501013259,orales,o
207,0211-699501013259,de,o
207,0211-699501013259,acido,i
207,0211-699501013259,folico,i
207,0211-699501013259,cada,o
207,0211-699501013259,48,o
207,0211-699501013259,horas,o
207,0211-699501013259,y,o
207,0211-699501013259,40,o
207,0211-699501013259,mg,o
207,0211-699501013259,orales,o
207,0211-699501013259,de,o
207,0211-699501013259,vitamina,i
207,0211-699501013259,B6,i
207,0211-699501013259,cada,o
207,0211-699501013259,semana,o
207,0211-699501013259,Se,o
207,0211-699501013259,determinaron,o
207,0211-699501013259,al,o
207,0211-699501013259,comienzo,o
207,0211-699501013259,del,o
207,0211-699501013259,estudio,o
207,0211-699501013259,y,o
207,0211-699501013259,cada,o
207,0211-699501013259,2,o
207,0211-699501013259,meses,o
207,0211-699501013259,niveles,i
207,0211-699501013259,de,i
207,0211-699501013259,folato,i
207,0211-699501013259,vitamina,i
207,0211-699501013259,B12,i
207,0211-699501013259,inmunoensayo,i
207,0211-699501013259,albumina,i
207,0211-699501013259,y,o
207,0211-699501013259,cinetica,o
207,0211-699501013259,de,o
207,0211-699501013259,la,o
207,0211-699501013259,urea,i
207,0211-699501013259,KTV,o
207,0211-699501013259,KRU,o
207,0211-699501013259,PCRn,o
207,0211-699501013259,y,o
207,0211-699501013259,cada,o
207,0211-699501013259,6,o
207,0211-699501013259,meses,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,HPLC,i
207,0211-699501013259,y,o
207,0211-699501013259,pp,i
207,0211-699501013259,RIA,i
207,0211-699501013259,Resultados,o
207,0211-699501013259,80,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,fueron,o
207,0211-699501013259,incluidos,o
207,0211-699501013259,en,o
207,0211-699501013259,el,o
207,0211-699501013259,estudio,o
207,0211-699501013259,basal,o
207,0211-699501013259,con,o
207,0211-699501013259,una,o
207,0211-699501013259,prevalencia,o
207,0211-699501013259,de,o
207,0211-699501013259,hiperhomocisteinemia,i
207,0211-699501013259,del,o
207,0211-699501013259,844,o
207,0211-699501013259,deficit,i
207,0211-699501013259,de,i
207,0211-699501013259,pp,i
207,0211-699501013259,en,o
207,0211-699501013259,el,o
207,0211-699501013259,32,o
207,0211-699501013259,y,o
207,0211-699501013259,folato,i
207,0211-699501013259,en,o
207,0211-699501013259,el,o
207,0211-699501013259,rango,o
207,0211-699501013259,normal,o
207,0211-699501013259,bajo,o
207,0211-699501013259,los,o
207,0211-699501013259,niveles,i
207,0211-699501013259,de,i
207,0211-699501013259,tHcy,i
207,0211-699501013259,se,o
207,0211-699501013259,correlacionaban,o
207,0211-699501013259,inversamente,o
207,0211-699501013259,con,o
207,0211-699501013259,los,o
207,0211-699501013259,del,o
207,0211-699501013259,folato,i
207,0211-699501013259,r,o
207,0211-699501013259,0336,o
207,0211-699501013259,p,o
207,0211-699501013259,001,o
207,0211-699501013259,pero,o
207,0211-699501013259,no,o
207,0211-699501013259,con,o
207,0211-699501013259,pp,i
207,0211-699501013259,B12,i
207,0211-699501013259,edad,o
207,0211-699501013259,albumina,i
207,0211-699501013259,KTV,o
207,0211-699501013259,KRU,o
207,0211-699501013259,PCRn,o
207,0211-699501013259,Cincuenta,o
207,0211-699501013259,y,o
207,0211-699501013259,ocho,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,recibieron,o
207,0211-699501013259,seis,o
207,0211-699501013259,meses,o
207,0211-699501013259,de,o
207,0211-699501013259,suplementacion,i
207,0211-699501013259,con,o
207,0211-699501013259,normalizacion,o
207,0211-699501013259,del,o
207,0211-699501013259,pp,i
207,0211-699501013259,aumento,o
207,0211-699501013259,del,o
207,0211-699501013259,folato,i
207,0211-699501013259,703,o
207,0211-699501013259,IC,o
207,0211-699501013259,638,o
207,0211-699501013259,795,o
207,0211-699501013259,vs,o
207,0211-699501013259,6181,o
207,0211-699501013259,IC,o
207,0211-699501013259,4447,o
207,0211-699501013259,7811,o
207,0211-699501013259,p,o
207,0211-699501013259,0001,o
207,0211-699501013259,y,o
207,0211-699501013259,descenso,o
207,0211-699501013259,de,o
207,0211-699501013259,la,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,240,o
207,0211-699501013259,IC,o
207,0211-699501013259,213,o
207,0211-699501013259,264,o
207,0211-699501013259,vs,o
207,0211-699501013259,199,o
207,0211-699501013259,IC,o
207,0211-699501013259,175,o
207,0211-699501013259,224,o
207,0211-699501013259,p,o
207,0211-699501013259,005,o
207,0211-699501013259,Han,o
207,0211-699501013259,recibido,o
207,0211-699501013259,suplementacion,i
207,0211-699501013259,durante,o
207,0211-699501013259,12,o
207,0211-699501013259,meses,o
207,0211-699501013259,33,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,pero,o
207,0211-699501013259,a,o
207,0211-699501013259,pesar,o
207,0211-699501013259,de,o
207,0211-699501013259,un,o
207,0211-699501013259,continuo,o
207,0211-699501013259,aumento,o
207,0211-699501013259,del,o
207,0211-699501013259,folato,i
207,0211-699501013259,10078,o
207,0211-699501013259,IC,o
207,0211-699501013259,7481,o
207,0211-699501013259,12674,o
207,0211-699501013259,p,o
207,0211-699501013259,0001,o
207,0211-699501013259,solo,o
207,0211-699501013259,3,o
207,0211-699501013259,pacientes,o
207,0211-699501013259,presentan,o
207,0211-699501013259,niveles,o
207,0211-699501013259,normales,o
207,0211-699501013259,de,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,correlacionandose,o
207,0211-699501013259,directamente,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,con,o
207,0211-699501013259,la,o
207,0211-699501013259,albumina,i
207,0211-699501013259,r,o
207,0211-699501013259,056,o
207,0211-699501013259,p,o
207,0211-699501013259,0001,o
207,0211-699501013259,que,o
207,0211-699501013259,se,o
207,0211-699501013259,elevo,o
207,0211-699501013259,con,o
207,0211-699501013259,respecto,o
207,0211-699501013259,al,o
207,0211-699501013259,inicio,o
207,0211-699501013259,337,o
207,0211-699501013259,IC,o
207,0211-699501013259,327,o
207,0211-699501013259,346,o
207,0211-699501013259,vs,o
207,0211-699501013259,350,o
207,0211-699501013259,IC,o
207,0211-699501013259,337,o
207,0211-699501013259,363,o
207,0211-699501013259,p,o
207,0211-699501013259,005,o
207,0211-699501013259,Conclusion,o
207,0211-699501013259,Tras,o
207,0211-699501013259,suplementacion,i
207,0211-699501013259,con,o
207,0211-699501013259,acido,i
207,0211-699501013259,folico,i
207,0211-699501013259,y,o
207,0211-699501013259,vitamina,i
207,0211-699501013259,B6,i
207,0211-699501013259,aunque,o
207,0211-699501013259,inicialmente,o
207,0211-699501013259,se,o
207,0211-699501013259,reduce,o
207,0211-699501013259,la,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,esta,o
207,0211-699501013259,respuesta,o
207,0211-699501013259,se,o
207,0211-699501013259,hace,o
207,0211-699501013259,refractaria,o
207,0211-699501013259,correlacionandose,o
207,0211-699501013259,directamente,o
207,0211-699501013259,la,o
207,0211-699501013259,tHcy,i
207,0211-699501013259,con,o
207,0211-699501013259,la,o
207,0211-699501013259,albumina,i
207,0211-699501013259,plasmatica,i
207,0211-699501013259,La,o
207,0211-699501013259,interpretacion,o
207,0211-699501013259,de,o
207,0211-699501013259,los,o
207,0211-699501013259,niveles,i
207,0211-699501013259,de,i
207,0211-699501013259,tHcy,i
207,0211-699501013259,debe,o
207,0211-699501013259,tener,o
207,0211-699501013259,en,o
207,0211-699501013259,cuenta,o
207,0211-699501013259,la,o
207,0211-699501013259,concentracion,i
207,0211-699501013259,de,i
207,0211-699501013259,albumina,i
208,0211-699501013259,Efecto,o
208,0211-699501013259,de,o
208,0211-699501013259,la,o
208,0211-699501013259,suplementacion,i
208,0211-699501013259,con,o
208,0211-699501013259,acido,i
208,0211-699501013259,folico,i
208,0211-699501013259,sobre,o
208,0211-699501013259,los,o
208,0211-699501013259,niveles,i
208,0211-699501013259,de,i
208,0211-699501013259,homocisteina,i
208,0211-699501013259,total,o
208,0211-699501013259,en,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,en,o
208,0211-699501013259,hemodialisis,i
208,0211-699501013259,La,o
208,0211-699501013259,hiperhomocisteinemia,i
208,0211-699501013259,es,o
208,0211-699501013259,un,o
208,0211-699501013259,marcador,o
208,0211-699501013259,de,o
208,0211-699501013259,riesgo,o
208,0211-699501013259,independiente,o
208,0211-699501013259,de,o
208,0211-699501013259,morbimortalidad,o
208,0211-699501013259,cardiovascular,i
208,0211-699501013259,Hemos,o
208,0211-699501013259,intentado,o
208,0211-699501013259,prospectivamente,o
208,0211-699501013259,reducir,o
208,0211-699501013259,los,o
208,0211-699501013259,niveles,i
208,0211-699501013259,de,i
208,0211-699501013259,homocisteina,i
208,0211-699501013259,total,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,mediante,o
208,0211-699501013259,suplemento,o
208,0211-699501013259,con,o
208,0211-699501013259,acido,i
208,0211-699501013259,folico,i
208,0211-699501013259,y,o
208,0211-699501013259,vitamina,i
208,0211-699501013259,B6,i
208,0211-699501013259,pp,i
208,0211-699501013259,valorando,o
208,0211-699501013259,su,o
208,0211-699501013259,posible,o
208,0211-699501013259,correlacion,o
208,0211-699501013259,con,o
208,0211-699501013259,dosis,o
208,0211-699501013259,de,o
208,0211-699501013259,dialisis,i
208,0211-699501013259,funcion,i
208,0211-699501013259,residual,i
208,0211-699501013259,y,o
208,0211-699501013259,parametros,o
208,0211-699501013259,nutricionales,o
208,0211-699501013259,Metodos,o
208,0211-699501013259,Todos,o
208,0211-699501013259,los,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,en,o
208,0211-699501013259,hemodialisis,i
208,0211-699501013259,al,o
208,0211-699501013259,comienzo,o
208,0211-699501013259,del,o
208,0211-699501013259,estudio,o
208,0211-699501013259,que,o
208,0211-699501013259,no,o
208,0211-699501013259,recibian,o
208,0211-699501013259,acido,i
208,0211-699501013259,folico,i
208,0211-699501013259,ni,o
208,0211-699501013259,vitamina,i
208,0211-699501013259,B6,i
208,0211-699501013259,asi,o
208,0211-699501013259,como,o
208,0211-699501013259,los,o
208,0211-699501013259,incorporados,o
208,0211-699501013259,posteriormente,o
208,0211-699501013259,a,o
208,0211-699501013259,partir,o
208,0211-699501013259,de,o
208,0211-699501013259,su,o
208,0211-699501013259,tercer,o
208,0211-699501013259,mes,o
208,0211-699501013259,en,o
208,0211-699501013259,hemodialisis,i
208,0211-699501013259,recibieron,o
208,0211-699501013259,5,o
208,0211-699501013259,mg,o
208,0211-699501013259,orales,o
208,0211-699501013259,de,o
208,0211-699501013259,acido,i
208,0211-699501013259,folico,i
208,0211-699501013259,cada,o
208,0211-699501013259,48,o
208,0211-699501013259,horas,o
208,0211-699501013259,y,o
208,0211-699501013259,40,o
208,0211-699501013259,mg,o
208,0211-699501013259,orales,o
208,0211-699501013259,de,o
208,0211-699501013259,vitamina,i
208,0211-699501013259,B6,i
208,0211-699501013259,cada,o
208,0211-699501013259,semana,o
208,0211-699501013259,Se,o
208,0211-699501013259,determinaron,o
208,0211-699501013259,al,o
208,0211-699501013259,comienzo,o
208,0211-699501013259,del,o
208,0211-699501013259,estudio,o
208,0211-699501013259,y,o
208,0211-699501013259,cada,o
208,0211-699501013259,2,o
208,0211-699501013259,meses,o
208,0211-699501013259,niveles,i
208,0211-699501013259,de,i
208,0211-699501013259,folato,i
208,0211-699501013259,vitamina,i
208,0211-699501013259,B12,i
208,0211-699501013259,inmunoensayo,i
208,0211-699501013259,albumina,i
208,0211-699501013259,y,o
208,0211-699501013259,cinetica,o
208,0211-699501013259,de,o
208,0211-699501013259,la,o
208,0211-699501013259,urea,i
208,0211-699501013259,KTV,o
208,0211-699501013259,KRU,o
208,0211-699501013259,PCRn,o
208,0211-699501013259,y,o
208,0211-699501013259,cada,o
208,0211-699501013259,6,o
208,0211-699501013259,meses,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,HPLC,i
208,0211-699501013259,y,o
208,0211-699501013259,pp,i
208,0211-699501013259,RIA,i
208,0211-699501013259,Resultados,o
208,0211-699501013259,80,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,fueron,o
208,0211-699501013259,incluidos,o
208,0211-699501013259,en,o
208,0211-699501013259,el,o
208,0211-699501013259,estudio,o
208,0211-699501013259,basal,o
208,0211-699501013259,con,o
208,0211-699501013259,una,o
208,0211-699501013259,prevalencia,o
208,0211-699501013259,de,o
208,0211-699501013259,hiperhomocisteinemia,i
208,0211-699501013259,del,o
208,0211-699501013259,844,o
208,0211-699501013259,deficit,i
208,0211-699501013259,de,i
208,0211-699501013259,pp,i
208,0211-699501013259,en,o
208,0211-699501013259,el,o
208,0211-699501013259,32,o
208,0211-699501013259,y,o
208,0211-699501013259,folato,i
208,0211-699501013259,en,o
208,0211-699501013259,el,o
208,0211-699501013259,rango,o
208,0211-699501013259,normal,o
208,0211-699501013259,bajo,o
208,0211-699501013259,los,o
208,0211-699501013259,niveles,i
208,0211-699501013259,de,i
208,0211-699501013259,tHcy,i
208,0211-699501013259,se,o
208,0211-699501013259,correlacionaban,o
208,0211-699501013259,inversamente,o
208,0211-699501013259,con,o
208,0211-699501013259,los,o
208,0211-699501013259,del,o
208,0211-699501013259,folato,i
208,0211-699501013259,r,o
208,0211-699501013259,0336,o
208,0211-699501013259,p,o
208,0211-699501013259,001,o
208,0211-699501013259,pero,o
208,0211-699501013259,no,o
208,0211-699501013259,con,o
208,0211-699501013259,pp,i
208,0211-699501013259,B12,i
208,0211-699501013259,edad,o
208,0211-699501013259,albumina,i
208,0211-699501013259,KTV,o
208,0211-699501013259,KRU,o
208,0211-699501013259,PCRn,o
208,0211-699501013259,Cincuenta,o
208,0211-699501013259,y,o
208,0211-699501013259,ocho,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,recibieron,o
208,0211-699501013259,seis,o
208,0211-699501013259,meses,o
208,0211-699501013259,de,o
208,0211-699501013259,suplementacion,i
208,0211-699501013259,con,o
208,0211-699501013259,normalizacion,o
208,0211-699501013259,del,o
208,0211-699501013259,pp,i
208,0211-699501013259,aumento,o
208,0211-699501013259,del,o
208,0211-699501013259,folato,i
208,0211-699501013259,703,o
208,0211-699501013259,IC,o
208,0211-699501013259,638,o
208,0211-699501013259,795,o
208,0211-699501013259,vs,o
208,0211-699501013259,6181,o
208,0211-699501013259,IC,o
208,0211-699501013259,4447,o
208,0211-699501013259,7811,o
208,0211-699501013259,p,o
208,0211-699501013259,0001,o
208,0211-699501013259,y,o
208,0211-699501013259,descenso,o
208,0211-699501013259,de,o
208,0211-699501013259,la,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,240,o
208,0211-699501013259,IC,o
208,0211-699501013259,213,o
208,0211-699501013259,264,o
208,0211-699501013259,vs,o
208,0211-699501013259,199,o
208,0211-699501013259,IC,o
208,0211-699501013259,175,o
208,0211-699501013259,224,o
208,0211-699501013259,p,o
208,0211-699501013259,005,o
208,0211-699501013259,Han,o
208,0211-699501013259,recibido,o
208,0211-699501013259,suplementacion,i
208,0211-699501013259,durante,o
208,0211-699501013259,12,o
208,0211-699501013259,meses,o
208,0211-699501013259,33,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,pero,o
208,0211-699501013259,a,o
208,0211-699501013259,pesar,o
208,0211-699501013259,de,o
208,0211-699501013259,un,o
208,0211-699501013259,continuo,o
208,0211-699501013259,aumento,o
208,0211-699501013259,del,o
208,0211-699501013259,folato,i
208,0211-699501013259,10078,o
208,0211-699501013259,IC,o
208,0211-699501013259,7481,o
208,0211-699501013259,12674,o
208,0211-699501013259,p,o
208,0211-699501013259,0001,o
208,0211-699501013259,solo,o
208,0211-699501013259,3,o
208,0211-699501013259,pacientes,o
208,0211-699501013259,presentan,o
208,0211-699501013259,niveles,o
208,0211-699501013259,normales,o
208,0211-699501013259,de,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,correlacionandose,o
208,0211-699501013259,directamente,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,con,o
208,0211-699501013259,la,o
208,0211-699501013259,albumina,i
208,0211-699501013259,r,o
208,0211-699501013259,056,o
208,0211-699501013259,p,o
208,0211-699501013259,0001,o
208,0211-699501013259,que,o
208,0211-699501013259,se,o
208,0211-699501013259,elevo,o
208,0211-699501013259,con,o
208,0211-699501013259,respecto,o
208,0211-699501013259,al,o
208,0211-699501013259,inicio,o
208,0211-699501013259,337,o
208,0211-699501013259,IC,o
208,0211-699501013259,327,o
208,0211-699501013259,346,o
208,0211-699501013259,vs,o
208,0211-699501013259,350,o
208,0211-699501013259,IC,o
208,0211-699501013259,337,o
208,0211-699501013259,363,o
208,0211-699501013259,p,o
208,0211-699501013259,005,o
208,0211-699501013259,Conclusion,o
208,0211-699501013259,Tras,o
208,0211-699501013259,suplementacion,i
208,0211-699501013259,con,o
208,0211-699501013259,acido,i
208,0211-699501013259,folico,i
208,0211-699501013259,y,o
208,0211-699501013259,vitamina,i
208,0211-699501013259,B6,i
208,0211-699501013259,aunque,o
208,0211-699501013259,inicialmente,o
208,0211-699501013259,se,o
208,0211-699501013259,reduce,o
208,0211-699501013259,la,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,esta,o
208,0211-699501013259,respuesta,o
208,0211-699501013259,se,o
208,0211-699501013259,hace,o
208,0211-699501013259,refractaria,o
208,0211-699501013259,correlacionandose,o
208,0211-699501013259,directamente,o
208,0211-699501013259,la,o
208,0211-699501013259,tHcy,i
208,0211-699501013259,con,o
208,0211-699501013259,la,o
208,0211-699501013259,albumina,i
208,0211-699501013259,plasmatica,i
208,0211-699501013259,La,o
208,0211-699501013259,interpretacion,o
208,0211-699501013259,de,o
208,0211-699501013259,los,o
208,0211-699501013259,niveles,i
208,0211-699501013259,de,i
208,0211-699501013259,tHcy,i
208,0211-699501013259,debe,o
208,0211-699501013259,tener,o
208,0211-699501013259,en,o
208,0211-699501013259,cuenta,o
208,0211-699501013259,la,o
208,0211-699501013259,concentracion,i
208,0211-699501013259,de,i
208,0211-699501013259,albumina,i
209,0211-699501013259,Efecto,o
209,0211-699501013259,de,o
209,0211-699501013259,la,o
209,0211-699501013259,suplementacion,i
209,0211-699501013259,con,o
209,0211-699501013259,acido,i
209,0211-699501013259,folico,i
209,0211-699501013259,sobre,o
209,0211-699501013259,los,o
209,0211-699501013259,niveles,i
209,0211-699501013259,de,i
209,0211-699501013259,homocisteina,i
209,0211-699501013259,total,o
209,0211-699501013259,en,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,en,o
209,0211-699501013259,hemodialisis,i
209,0211-699501013259,La,o
209,0211-699501013259,hiperhomocisteinemia,i
209,0211-699501013259,es,o
209,0211-699501013259,un,o
209,0211-699501013259,marcador,o
209,0211-699501013259,de,o
209,0211-699501013259,riesgo,o
209,0211-699501013259,independiente,o
209,0211-699501013259,de,o
209,0211-699501013259,morbimortalidad,o
209,0211-699501013259,cardiovascular,i
209,0211-699501013259,Hemos,o
209,0211-699501013259,intentado,o
209,0211-699501013259,prospectivamente,o
209,0211-699501013259,reducir,o
209,0211-699501013259,los,o
209,0211-699501013259,niveles,i
209,0211-699501013259,de,i
209,0211-699501013259,homocisteina,i
209,0211-699501013259,total,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,mediante,o
209,0211-699501013259,suplemento,o
209,0211-699501013259,con,o
209,0211-699501013259,acido,i
209,0211-699501013259,folico,i
209,0211-699501013259,y,o
209,0211-699501013259,vitamina,i
209,0211-699501013259,B6,i
209,0211-699501013259,pp,i
209,0211-699501013259,valorando,o
209,0211-699501013259,su,o
209,0211-699501013259,posible,o
209,0211-699501013259,correlacion,o
209,0211-699501013259,con,o
209,0211-699501013259,dosis,o
209,0211-699501013259,de,o
209,0211-699501013259,dialisis,i
209,0211-699501013259,funcion,i
209,0211-699501013259,residual,i
209,0211-699501013259,y,o
209,0211-699501013259,parametros,o
209,0211-699501013259,nutricionales,o
209,0211-699501013259,Metodos,o
209,0211-699501013259,Todos,o
209,0211-699501013259,los,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,en,o
209,0211-699501013259,hemodialisis,i
209,0211-699501013259,al,o
209,0211-699501013259,comienzo,o
209,0211-699501013259,del,o
209,0211-699501013259,estudio,o
209,0211-699501013259,que,o
209,0211-699501013259,no,o
209,0211-699501013259,recibian,o
209,0211-699501013259,acido,i
209,0211-699501013259,folico,i
209,0211-699501013259,ni,o
209,0211-699501013259,vitamina,i
209,0211-699501013259,B6,i
209,0211-699501013259,asi,o
209,0211-699501013259,como,o
209,0211-699501013259,los,o
209,0211-699501013259,incorporados,o
209,0211-699501013259,posteriormente,o
209,0211-699501013259,a,o
209,0211-699501013259,partir,o
209,0211-699501013259,de,o
209,0211-699501013259,su,o
209,0211-699501013259,tercer,o
209,0211-699501013259,mes,o
209,0211-699501013259,en,o
209,0211-699501013259,hemodialisis,i
209,0211-699501013259,recibieron,o
209,0211-699501013259,5,o
209,0211-699501013259,mg,o
209,0211-699501013259,orales,o
209,0211-699501013259,de,o
209,0211-699501013259,acido,i
209,0211-699501013259,folico,i
209,0211-699501013259,cada,o
209,0211-699501013259,48,o
209,0211-699501013259,horas,o
209,0211-699501013259,y,o
209,0211-699501013259,40,o
209,0211-699501013259,mg,o
209,0211-699501013259,orales,o
209,0211-699501013259,de,o
209,0211-699501013259,vitamina,i
209,0211-699501013259,B6,i
209,0211-699501013259,cada,o
209,0211-699501013259,semana,o
209,0211-699501013259,Se,o
209,0211-699501013259,determinaron,o
209,0211-699501013259,al,o
209,0211-699501013259,comienzo,o
209,0211-699501013259,del,o
209,0211-699501013259,estudio,o
209,0211-699501013259,y,o
209,0211-699501013259,cada,o
209,0211-699501013259,2,o
209,0211-699501013259,meses,o
209,0211-699501013259,niveles,i
209,0211-699501013259,de,i
209,0211-699501013259,folato,i
209,0211-699501013259,vitamina,i
209,0211-699501013259,B12,i
209,0211-699501013259,inmunoensayo,i
209,0211-699501013259,albumina,i
209,0211-699501013259,y,o
209,0211-699501013259,cinetica,o
209,0211-699501013259,de,o
209,0211-699501013259,la,o
209,0211-699501013259,urea,i
209,0211-699501013259,KTV,o
209,0211-699501013259,KRU,o
209,0211-699501013259,PCRn,o
209,0211-699501013259,y,o
209,0211-699501013259,cada,o
209,0211-699501013259,6,o
209,0211-699501013259,meses,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,HPLC,i
209,0211-699501013259,y,o
209,0211-699501013259,pp,i
209,0211-699501013259,RIA,i
209,0211-699501013259,Resultados,o
209,0211-699501013259,80,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,fueron,o
209,0211-699501013259,incluidos,o
209,0211-699501013259,en,o
209,0211-699501013259,el,o
209,0211-699501013259,estudio,o
209,0211-699501013259,basal,o
209,0211-699501013259,con,o
209,0211-699501013259,una,o
209,0211-699501013259,prevalencia,o
209,0211-699501013259,de,o
209,0211-699501013259,hiperhomocisteinemia,i
209,0211-699501013259,del,o
209,0211-699501013259,844,o
209,0211-699501013259,deficit,i
209,0211-699501013259,de,i
209,0211-699501013259,pp,i
209,0211-699501013259,en,o
209,0211-699501013259,el,o
209,0211-699501013259,32,o
209,0211-699501013259,y,o
209,0211-699501013259,folato,i
209,0211-699501013259,en,o
209,0211-699501013259,el,o
209,0211-699501013259,rango,o
209,0211-699501013259,normal,o
209,0211-699501013259,bajo,o
209,0211-699501013259,los,o
209,0211-699501013259,niveles,i
209,0211-699501013259,de,i
209,0211-699501013259,tHcy,i
209,0211-699501013259,se,o
209,0211-699501013259,correlacionaban,o
209,0211-699501013259,inversamente,o
209,0211-699501013259,con,o
209,0211-699501013259,los,o
209,0211-699501013259,del,o
209,0211-699501013259,folato,i
209,0211-699501013259,r,o
209,0211-699501013259,0336,o
209,0211-699501013259,p,o
209,0211-699501013259,001,o
209,0211-699501013259,pero,o
209,0211-699501013259,no,o
209,0211-699501013259,con,o
209,0211-699501013259,pp,i
209,0211-699501013259,B12,i
209,0211-699501013259,edad,o
209,0211-699501013259,albumina,i
209,0211-699501013259,KTV,o
209,0211-699501013259,KRU,o
209,0211-699501013259,PCRn,o
209,0211-699501013259,Cincuenta,o
209,0211-699501013259,y,o
209,0211-699501013259,ocho,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,recibieron,o
209,0211-699501013259,seis,o
209,0211-699501013259,meses,o
209,0211-699501013259,de,o
209,0211-699501013259,suplementacion,i
209,0211-699501013259,con,o
209,0211-699501013259,normalizacion,o
209,0211-699501013259,del,o
209,0211-699501013259,pp,i
209,0211-699501013259,aumento,o
209,0211-699501013259,del,o
209,0211-699501013259,folato,i
209,0211-699501013259,703,o
209,0211-699501013259,IC,o
209,0211-699501013259,638,o
209,0211-699501013259,795,o
209,0211-699501013259,vs,o
209,0211-699501013259,6181,o
209,0211-699501013259,IC,o
209,0211-699501013259,4447,o
209,0211-699501013259,7811,o
209,0211-699501013259,p,o
209,0211-699501013259,0001,o
209,0211-699501013259,y,o
209,0211-699501013259,descenso,o
209,0211-699501013259,de,o
209,0211-699501013259,la,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,240,o
209,0211-699501013259,IC,o
209,0211-699501013259,213,o
209,0211-699501013259,264,o
209,0211-699501013259,vs,o
209,0211-699501013259,199,o
209,0211-699501013259,IC,o
209,0211-699501013259,175,o
209,0211-699501013259,224,o
209,0211-699501013259,p,o
209,0211-699501013259,005,o
209,0211-699501013259,Han,o
209,0211-699501013259,recibido,o
209,0211-699501013259,suplementacion,i
209,0211-699501013259,durante,o
209,0211-699501013259,12,o
209,0211-699501013259,meses,o
209,0211-699501013259,33,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,pero,o
209,0211-699501013259,a,o
209,0211-699501013259,pesar,o
209,0211-699501013259,de,o
209,0211-699501013259,un,o
209,0211-699501013259,continuo,o
209,0211-699501013259,aumento,o
209,0211-699501013259,del,o
209,0211-699501013259,folato,i
209,0211-699501013259,10078,o
209,0211-699501013259,IC,o
209,0211-699501013259,7481,o
209,0211-699501013259,12674,o
209,0211-699501013259,p,o
209,0211-699501013259,0001,o
209,0211-699501013259,solo,o
209,0211-699501013259,3,o
209,0211-699501013259,pacientes,o
209,0211-699501013259,presentan,o
209,0211-699501013259,niveles,o
209,0211-699501013259,normales,o
209,0211-699501013259,de,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,correlacionandose,o
209,0211-699501013259,directamente,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,con,o
209,0211-699501013259,la,o
209,0211-699501013259,albumina,i
209,0211-699501013259,r,o
209,0211-699501013259,056,o
209,0211-699501013259,p,o
209,0211-699501013259,0001,o
209,0211-699501013259,que,o
209,0211-699501013259,se,o
209,0211-699501013259,elevo,o
209,0211-699501013259,con,o
209,0211-699501013259,respecto,o
209,0211-699501013259,al,o
209,0211-699501013259,inicio,o
209,0211-699501013259,337,o
209,0211-699501013259,IC,o
209,0211-699501013259,327,o
209,0211-699501013259,346,o
209,0211-699501013259,vs,o
209,0211-699501013259,350,o
209,0211-699501013259,IC,o
209,0211-699501013259,337,o
209,0211-699501013259,363,o
209,0211-699501013259,p,o
209,0211-699501013259,005,o
209,0211-699501013259,Conclusion,o
209,0211-699501013259,Tras,o
209,0211-699501013259,suplementacion,i
209,0211-699501013259,con,o
209,0211-699501013259,acido,i
209,0211-699501013259,folico,i
209,0211-699501013259,y,o
209,0211-699501013259,vitamina,i
209,0211-699501013259,B6,i
209,0211-699501013259,aunque,o
209,0211-699501013259,inicialmente,o
209,0211-699501013259,se,o
209,0211-699501013259,reduce,o
209,0211-699501013259,la,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,esta,o
209,0211-699501013259,respuesta,o
209,0211-699501013259,se,o
209,0211-699501013259,hace,o
209,0211-699501013259,refractaria,o
209,0211-699501013259,correlacionandose,o
209,0211-699501013259,directamente,o
209,0211-699501013259,la,o
209,0211-699501013259,tHcy,i
209,0211-699501013259,con,o
209,0211-699501013259,la,o
209,0211-699501013259,albumina,i
209,0211-699501013259,plasmatica,i
209,0211-699501013259,La,o
209,0211-699501013259,interpretacion,o
209,0211-699501013259,de,o
209,0211-699501013259,los,o
209,0211-699501013259,niveles,i
209,0211-699501013259,de,i
209,0211-699501013259,tHcy,i
209,0211-699501013259,debe,o
209,0211-699501013259,tener,o
209,0211-699501013259,en,o
209,0211-699501013259,cuenta,o
209,0211-699501013259,la,o
209,0211-699501013259,concentracion,i
209,0211-699501013259,de,i
209,0211-699501013259,albumina,i
210,0211-699501013259,Efecto,o
210,0211-699501013259,de,o
210,0211-699501013259,la,o
210,0211-699501013259,suplementacion,i
210,0211-699501013259,con,o
210,0211-699501013259,acido,i
210,0211-699501013259,folico,i
210,0211-699501013259,sobre,o
210,0211-699501013259,los,o
210,0211-699501013259,niveles,i
210,0211-699501013259,de,i
210,0211-699501013259,homocisteina,i
210,0211-699501013259,total,o
210,0211-699501013259,en,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,en,o
210,0211-699501013259,hemodialisis,i
210,0211-699501013259,La,o
210,0211-699501013259,hiperhomocisteinemia,i
210,0211-699501013259,es,o
210,0211-699501013259,un,o
210,0211-699501013259,marcador,o
210,0211-699501013259,de,o
210,0211-699501013259,riesgo,o
210,0211-699501013259,independiente,o
210,0211-699501013259,de,o
210,0211-699501013259,morbimortalidad,o
210,0211-699501013259,cardiovascular,i
210,0211-699501013259,Hemos,o
210,0211-699501013259,intentado,o
210,0211-699501013259,prospectivamente,o
210,0211-699501013259,reducir,o
210,0211-699501013259,los,o
210,0211-699501013259,niveles,i
210,0211-699501013259,de,i
210,0211-699501013259,homocisteina,i
210,0211-699501013259,total,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,mediante,o
210,0211-699501013259,suplemento,o
210,0211-699501013259,con,o
210,0211-699501013259,acido,i
210,0211-699501013259,folico,i
210,0211-699501013259,y,o
210,0211-699501013259,vitamina,i
210,0211-699501013259,B6,i
210,0211-699501013259,pp,i
210,0211-699501013259,valorando,o
210,0211-699501013259,su,o
210,0211-699501013259,posible,o
210,0211-699501013259,correlacion,o
210,0211-699501013259,con,o
210,0211-699501013259,dosis,o
210,0211-699501013259,de,o
210,0211-699501013259,dialisis,i
210,0211-699501013259,funcion,i
210,0211-699501013259,residual,i
210,0211-699501013259,y,o
210,0211-699501013259,parametros,o
210,0211-699501013259,nutricionales,o
210,0211-699501013259,Metodos,o
210,0211-699501013259,Todos,o
210,0211-699501013259,los,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,en,o
210,0211-699501013259,hemodialisis,i
210,0211-699501013259,al,o
210,0211-699501013259,comienzo,o
210,0211-699501013259,del,o
210,0211-699501013259,estudio,o
210,0211-699501013259,que,o
210,0211-699501013259,no,o
210,0211-699501013259,recibian,o
210,0211-699501013259,acido,i
210,0211-699501013259,folico,i
210,0211-699501013259,ni,o
210,0211-699501013259,vitamina,i
210,0211-699501013259,B6,i
210,0211-699501013259,asi,o
210,0211-699501013259,como,o
210,0211-699501013259,los,o
210,0211-699501013259,incorporados,o
210,0211-699501013259,posteriormente,o
210,0211-699501013259,a,o
210,0211-699501013259,partir,o
210,0211-699501013259,de,o
210,0211-699501013259,su,o
210,0211-699501013259,tercer,o
210,0211-699501013259,mes,o
210,0211-699501013259,en,o
210,0211-699501013259,hemodialisis,i
210,0211-699501013259,recibieron,o
210,0211-699501013259,5,o
210,0211-699501013259,mg,o
210,0211-699501013259,orales,o
210,0211-699501013259,de,o
210,0211-699501013259,acido,i
210,0211-699501013259,folico,i
210,0211-699501013259,cada,o
210,0211-699501013259,48,o
210,0211-699501013259,horas,o
210,0211-699501013259,y,o
210,0211-699501013259,40,o
210,0211-699501013259,mg,o
210,0211-699501013259,orales,o
210,0211-699501013259,de,o
210,0211-699501013259,vitamina,i
210,0211-699501013259,B6,i
210,0211-699501013259,cada,o
210,0211-699501013259,semana,o
210,0211-699501013259,Se,o
210,0211-699501013259,determinaron,o
210,0211-699501013259,al,o
210,0211-699501013259,comienzo,o
210,0211-699501013259,del,o
210,0211-699501013259,estudio,o
210,0211-699501013259,y,o
210,0211-699501013259,cada,o
210,0211-699501013259,2,o
210,0211-699501013259,meses,o
210,0211-699501013259,niveles,i
210,0211-699501013259,de,i
210,0211-699501013259,folato,i
210,0211-699501013259,vitamina,i
210,0211-699501013259,B12,i
210,0211-699501013259,inmunoensayo,i
210,0211-699501013259,albumina,i
210,0211-699501013259,y,o
210,0211-699501013259,cinetica,o
210,0211-699501013259,de,o
210,0211-699501013259,la,o
210,0211-699501013259,urea,i
210,0211-699501013259,KTV,o
210,0211-699501013259,KRU,o
210,0211-699501013259,PCRn,o
210,0211-699501013259,y,o
210,0211-699501013259,cada,o
210,0211-699501013259,6,o
210,0211-699501013259,meses,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,HPLC,i
210,0211-699501013259,y,o
210,0211-699501013259,pp,i
210,0211-699501013259,RIA,i
210,0211-699501013259,Resultados,o
210,0211-699501013259,80,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,fueron,o
210,0211-699501013259,incluidos,o
210,0211-699501013259,en,o
210,0211-699501013259,el,o
210,0211-699501013259,estudio,o
210,0211-699501013259,basal,o
210,0211-699501013259,con,o
210,0211-699501013259,una,o
210,0211-699501013259,prevalencia,o
210,0211-699501013259,de,o
210,0211-699501013259,hiperhomocisteinemia,i
210,0211-699501013259,del,o
210,0211-699501013259,844,o
210,0211-699501013259,deficit,i
210,0211-699501013259,de,i
210,0211-699501013259,pp,i
210,0211-699501013259,en,o
210,0211-699501013259,el,o
210,0211-699501013259,32,o
210,0211-699501013259,y,o
210,0211-699501013259,folato,i
210,0211-699501013259,en,o
210,0211-699501013259,el,o
210,0211-699501013259,rango,o
210,0211-699501013259,normal,o
210,0211-699501013259,bajo,o
210,0211-699501013259,los,o
210,0211-699501013259,niveles,i
210,0211-699501013259,de,i
210,0211-699501013259,tHcy,i
210,0211-699501013259,se,o
210,0211-699501013259,correlacionaban,o
210,0211-699501013259,inversamente,o
210,0211-699501013259,con,o
210,0211-699501013259,los,o
210,0211-699501013259,del,o
210,0211-699501013259,folato,i
210,0211-699501013259,r,o
210,0211-699501013259,0336,o
210,0211-699501013259,p,o
210,0211-699501013259,001,o
210,0211-699501013259,pero,o
210,0211-699501013259,no,o
210,0211-699501013259,con,o
210,0211-699501013259,pp,i
210,0211-699501013259,B12,i
210,0211-699501013259,edad,o
210,0211-699501013259,albumina,i
210,0211-699501013259,KTV,o
210,0211-699501013259,KRU,o
210,0211-699501013259,PCRn,o
210,0211-699501013259,Cincuenta,o
210,0211-699501013259,y,o
210,0211-699501013259,ocho,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,recibieron,o
210,0211-699501013259,seis,o
210,0211-699501013259,meses,o
210,0211-699501013259,de,o
210,0211-699501013259,suplementacion,i
210,0211-699501013259,con,o
210,0211-699501013259,normalizacion,o
210,0211-699501013259,del,o
210,0211-699501013259,pp,i
210,0211-699501013259,aumento,o
210,0211-699501013259,del,o
210,0211-699501013259,folato,i
210,0211-699501013259,703,o
210,0211-699501013259,IC,o
210,0211-699501013259,638,o
210,0211-699501013259,795,o
210,0211-699501013259,vs,o
210,0211-699501013259,6181,o
210,0211-699501013259,IC,o
210,0211-699501013259,4447,o
210,0211-699501013259,7811,o
210,0211-699501013259,p,o
210,0211-699501013259,0001,o
210,0211-699501013259,y,o
210,0211-699501013259,descenso,o
210,0211-699501013259,de,o
210,0211-699501013259,la,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,240,o
210,0211-699501013259,IC,o
210,0211-699501013259,213,o
210,0211-699501013259,264,o
210,0211-699501013259,vs,o
210,0211-699501013259,199,o
210,0211-699501013259,IC,o
210,0211-699501013259,175,o
210,0211-699501013259,224,o
210,0211-699501013259,p,o
210,0211-699501013259,005,o
210,0211-699501013259,Han,o
210,0211-699501013259,recibido,o
210,0211-699501013259,suplementacion,i
210,0211-699501013259,durante,o
210,0211-699501013259,12,o
210,0211-699501013259,meses,o
210,0211-699501013259,33,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,pero,o
210,0211-699501013259,a,o
210,0211-699501013259,pesar,o
210,0211-699501013259,de,o
210,0211-699501013259,un,o
210,0211-699501013259,continuo,o
210,0211-699501013259,aumento,o
210,0211-699501013259,del,o
210,0211-699501013259,folato,i
210,0211-699501013259,10078,o
210,0211-699501013259,IC,o
210,0211-699501013259,7481,o
210,0211-699501013259,12674,o
210,0211-699501013259,p,o
210,0211-699501013259,0001,o
210,0211-699501013259,solo,o
210,0211-699501013259,3,o
210,0211-699501013259,pacientes,o
210,0211-699501013259,presentan,o
210,0211-699501013259,niveles,o
210,0211-699501013259,normales,o
210,0211-699501013259,de,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,correlacionandose,o
210,0211-699501013259,directamente,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,con,o
210,0211-699501013259,la,o
210,0211-699501013259,albumina,i
210,0211-699501013259,r,o
210,0211-699501013259,056,o
210,0211-699501013259,p,o
210,0211-699501013259,0001,o
210,0211-699501013259,que,o
210,0211-699501013259,se,o
210,0211-699501013259,elevo,o
210,0211-699501013259,con,o
210,0211-699501013259,respecto,o
210,0211-699501013259,al,o
210,0211-699501013259,inicio,o
210,0211-699501013259,337,o
210,0211-699501013259,IC,o
210,0211-699501013259,327,o
210,0211-699501013259,346,o
210,0211-699501013259,vs,o
210,0211-699501013259,350,o
210,0211-699501013259,IC,o
210,0211-699501013259,337,o
210,0211-699501013259,363,o
210,0211-699501013259,p,o
210,0211-699501013259,005,o
210,0211-699501013259,Conclusion,o
210,0211-699501013259,Tras,o
210,0211-699501013259,suplementacion,i
210,0211-699501013259,con,o
210,0211-699501013259,acido,i
210,0211-699501013259,folico,i
210,0211-699501013259,y,o
210,0211-699501013259,vitamina,i
210,0211-699501013259,B6,i
210,0211-699501013259,aunque,o
210,0211-699501013259,inicialmente,o
210,0211-699501013259,se,o
210,0211-699501013259,reduce,o
210,0211-699501013259,la,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,esta,o
210,0211-699501013259,respuesta,o
210,0211-699501013259,se,o
210,0211-699501013259,hace,o
210,0211-699501013259,refractaria,o
210,0211-699501013259,correlacionandose,o
210,0211-699501013259,directamente,o
210,0211-699501013259,la,o
210,0211-699501013259,tHcy,i
210,0211-699501013259,con,o
210,0211-699501013259,la,o
210,0211-699501013259,albumina,i
210,0211-699501013259,plasmatica,i
210,0211-699501013259,La,o
210,0211-699501013259,interpretacion,o
210,0211-699501013259,de,o
210,0211-699501013259,los,o
210,0211-699501013259,niveles,i
210,0211-699501013259,de,i
210,0211-699501013259,tHcy,i
210,0211-699501013259,debe,o
210,0211-699501013259,tener,o
210,0211-699501013259,en,o
210,0211-699501013259,cuenta,o
210,0211-699501013259,la,o
210,0211-699501013259,concentracion,i
210,0211-699501013259,de,i
210,0211-699501013259,albumina,i
211,0211-699501013259,Efecto,o
211,0211-699501013259,de,o
211,0211-699501013259,la,o
211,0211-699501013259,suplementacion,i
211,0211-699501013259,con,o
211,0211-699501013259,acido,i
211,0211-699501013259,folico,i
211,0211-699501013259,sobre,o
211,0211-699501013259,los,o
211,0211-699501013259,niveles,i
211,0211-699501013259,de,i
211,0211-699501013259,homocisteina,i
211,0211-699501013259,total,o
211,0211-699501013259,en,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,en,o
211,0211-699501013259,hemodialisis,i
211,0211-699501013259,La,o
211,0211-699501013259,hiperhomocisteinemia,i
211,0211-699501013259,es,o
211,0211-699501013259,un,o
211,0211-699501013259,marcador,o
211,0211-699501013259,de,o
211,0211-699501013259,riesgo,o
211,0211-699501013259,independiente,o
211,0211-699501013259,de,o
211,0211-699501013259,morbimortalidad,o
211,0211-699501013259,cardiovascular,i
211,0211-699501013259,Hemos,o
211,0211-699501013259,intentado,o
211,0211-699501013259,prospectivamente,o
211,0211-699501013259,reducir,o
211,0211-699501013259,los,o
211,0211-699501013259,niveles,i
211,0211-699501013259,de,i
211,0211-699501013259,homocisteina,i
211,0211-699501013259,total,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,mediante,o
211,0211-699501013259,suplemento,o
211,0211-699501013259,con,o
211,0211-699501013259,acido,i
211,0211-699501013259,folico,i
211,0211-699501013259,y,o
211,0211-699501013259,vitamina,i
211,0211-699501013259,B6,i
211,0211-699501013259,pp,i
211,0211-699501013259,valorando,o
211,0211-699501013259,su,o
211,0211-699501013259,posible,o
211,0211-699501013259,correlacion,o
211,0211-699501013259,con,o
211,0211-699501013259,dosis,o
211,0211-699501013259,de,o
211,0211-699501013259,dialisis,i
211,0211-699501013259,funcion,i
211,0211-699501013259,residual,i
211,0211-699501013259,y,o
211,0211-699501013259,parametros,o
211,0211-699501013259,nutricionales,o
211,0211-699501013259,Metodos,o
211,0211-699501013259,Todos,o
211,0211-699501013259,los,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,en,o
211,0211-699501013259,hemodialisis,i
211,0211-699501013259,al,o
211,0211-699501013259,comienzo,o
211,0211-699501013259,del,o
211,0211-699501013259,estudio,o
211,0211-699501013259,que,o
211,0211-699501013259,no,o
211,0211-699501013259,recibian,o
211,0211-699501013259,acido,i
211,0211-699501013259,folico,i
211,0211-699501013259,ni,o
211,0211-699501013259,vitamina,i
211,0211-699501013259,B6,i
211,0211-699501013259,asi,o
211,0211-699501013259,como,o
211,0211-699501013259,los,o
211,0211-699501013259,incorporados,o
211,0211-699501013259,posteriormente,o
211,0211-699501013259,a,o
211,0211-699501013259,partir,o
211,0211-699501013259,de,o
211,0211-699501013259,su,o
211,0211-699501013259,tercer,o
211,0211-699501013259,mes,o
211,0211-699501013259,en,o
211,0211-699501013259,hemodialisis,i
211,0211-699501013259,recibieron,o
211,0211-699501013259,5,o
211,0211-699501013259,mg,o
211,0211-699501013259,orales,o
211,0211-699501013259,de,o
211,0211-699501013259,acido,i
211,0211-699501013259,folico,i
211,0211-699501013259,cada,o
211,0211-699501013259,48,o
211,0211-699501013259,horas,o
211,0211-699501013259,y,o
211,0211-699501013259,40,o
211,0211-699501013259,mg,o
211,0211-699501013259,orales,o
211,0211-699501013259,de,o
211,0211-699501013259,vitamina,i
211,0211-699501013259,B6,i
211,0211-699501013259,cada,o
211,0211-699501013259,semana,o
211,0211-699501013259,Se,o
211,0211-699501013259,determinaron,o
211,0211-699501013259,al,o
211,0211-699501013259,comienzo,o
211,0211-699501013259,del,o
211,0211-699501013259,estudio,o
211,0211-699501013259,y,o
211,0211-699501013259,cada,o
211,0211-699501013259,2,o
211,0211-699501013259,meses,o
211,0211-699501013259,niveles,i
211,0211-699501013259,de,i
211,0211-699501013259,folato,i
211,0211-699501013259,vitamina,i
211,0211-699501013259,B12,i
211,0211-699501013259,inmunoensayo,i
211,0211-699501013259,albumina,i
211,0211-699501013259,y,o
211,0211-699501013259,cinetica,o
211,0211-699501013259,de,o
211,0211-699501013259,la,o
211,0211-699501013259,urea,i
211,0211-699501013259,KTV,o
211,0211-699501013259,KRU,o
211,0211-699501013259,PCRn,o
211,0211-699501013259,y,o
211,0211-699501013259,cada,o
211,0211-699501013259,6,o
211,0211-699501013259,meses,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,HPLC,i
211,0211-699501013259,y,o
211,0211-699501013259,pp,i
211,0211-699501013259,RIA,i
211,0211-699501013259,Resultados,o
211,0211-699501013259,80,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,fueron,o
211,0211-699501013259,incluidos,o
211,0211-699501013259,en,o
211,0211-699501013259,el,o
211,0211-699501013259,estudio,o
211,0211-699501013259,basal,o
211,0211-699501013259,con,o
211,0211-699501013259,una,o
211,0211-699501013259,prevalencia,o
211,0211-699501013259,de,o
211,0211-699501013259,hiperhomocisteinemia,i
211,0211-699501013259,del,o
211,0211-699501013259,844,o
211,0211-699501013259,deficit,i
211,0211-699501013259,de,i
211,0211-699501013259,pp,i
211,0211-699501013259,en,o
211,0211-699501013259,el,o
211,0211-699501013259,32,o
211,0211-699501013259,y,o
211,0211-699501013259,folato,i
211,0211-699501013259,en,o
211,0211-699501013259,el,o
211,0211-699501013259,rango,o
211,0211-699501013259,normal,o
211,0211-699501013259,bajo,o
211,0211-699501013259,los,o
211,0211-699501013259,niveles,i
211,0211-699501013259,de,i
211,0211-699501013259,tHcy,i
211,0211-699501013259,se,o
211,0211-699501013259,correlacionaban,o
211,0211-699501013259,inversamente,o
211,0211-699501013259,con,o
211,0211-699501013259,los,o
211,0211-699501013259,del,o
211,0211-699501013259,folato,i
211,0211-699501013259,r,o
211,0211-699501013259,0336,o
211,0211-699501013259,p,o
211,0211-699501013259,001,o
211,0211-699501013259,pero,o
211,0211-699501013259,no,o
211,0211-699501013259,con,o
211,0211-699501013259,pp,i
211,0211-699501013259,B12,i
211,0211-699501013259,edad,o
211,0211-699501013259,albumina,i
211,0211-699501013259,KTV,o
211,0211-699501013259,KRU,o
211,0211-699501013259,PCRn,o
211,0211-699501013259,Cincuenta,o
211,0211-699501013259,y,o
211,0211-699501013259,ocho,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,recibieron,o
211,0211-699501013259,seis,o
211,0211-699501013259,meses,o
211,0211-699501013259,de,o
211,0211-699501013259,suplementacion,i
211,0211-699501013259,con,o
211,0211-699501013259,normalizacion,o
211,0211-699501013259,del,o
211,0211-699501013259,pp,i
211,0211-699501013259,aumento,o
211,0211-699501013259,del,o
211,0211-699501013259,folato,i
211,0211-699501013259,703,o
211,0211-699501013259,IC,o
211,0211-699501013259,638,o
211,0211-699501013259,795,o
211,0211-699501013259,vs,o
211,0211-699501013259,6181,o
211,0211-699501013259,IC,o
211,0211-699501013259,4447,o
211,0211-699501013259,7811,o
211,0211-699501013259,p,o
211,0211-699501013259,0001,o
211,0211-699501013259,y,o
211,0211-699501013259,descenso,o
211,0211-699501013259,de,o
211,0211-699501013259,la,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,240,o
211,0211-699501013259,IC,o
211,0211-699501013259,213,o
211,0211-699501013259,264,o
211,0211-699501013259,vs,o
211,0211-699501013259,199,o
211,0211-699501013259,IC,o
211,0211-699501013259,175,o
211,0211-699501013259,224,o
211,0211-699501013259,p,o
211,0211-699501013259,005,o
211,0211-699501013259,Han,o
211,0211-699501013259,recibido,o
211,0211-699501013259,suplementacion,i
211,0211-699501013259,durante,o
211,0211-699501013259,12,o
211,0211-699501013259,meses,o
211,0211-699501013259,33,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,pero,o
211,0211-699501013259,a,o
211,0211-699501013259,pesar,o
211,0211-699501013259,de,o
211,0211-699501013259,un,o
211,0211-699501013259,continuo,o
211,0211-699501013259,aumento,o
211,0211-699501013259,del,o
211,0211-699501013259,folato,i
211,0211-699501013259,10078,o
211,0211-699501013259,IC,o
211,0211-699501013259,7481,o
211,0211-699501013259,12674,o
211,0211-699501013259,p,o
211,0211-699501013259,0001,o
211,0211-699501013259,solo,o
211,0211-699501013259,3,o
211,0211-699501013259,pacientes,o
211,0211-699501013259,presentan,o
211,0211-699501013259,niveles,o
211,0211-699501013259,normales,o
211,0211-699501013259,de,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,correlacionandose,o
211,0211-699501013259,directamente,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,con,o
211,0211-699501013259,la,o
211,0211-699501013259,albumina,i
211,0211-699501013259,r,o
211,0211-699501013259,056,o
211,0211-699501013259,p,o
211,0211-699501013259,0001,o
211,0211-699501013259,que,o
211,0211-699501013259,se,o
211,0211-699501013259,elevo,o
211,0211-699501013259,con,o
211,0211-699501013259,respecto,o
211,0211-699501013259,al,o
211,0211-699501013259,inicio,o
211,0211-699501013259,337,o
211,0211-699501013259,IC,o
211,0211-699501013259,327,o
211,0211-699501013259,346,o
211,0211-699501013259,vs,o
211,0211-699501013259,350,o
211,0211-699501013259,IC,o
211,0211-699501013259,337,o
211,0211-699501013259,363,o
211,0211-699501013259,p,o
211,0211-699501013259,005,o
211,0211-699501013259,Conclusion,o
211,0211-699501013259,Tras,o
211,0211-699501013259,suplementacion,i
211,0211-699501013259,con,o
211,0211-699501013259,acido,i
211,0211-699501013259,folico,i
211,0211-699501013259,y,o
211,0211-699501013259,vitamina,i
211,0211-699501013259,B6,i
211,0211-699501013259,aunque,o
211,0211-699501013259,inicialmente,o
211,0211-699501013259,se,o
211,0211-699501013259,reduce,o
211,0211-699501013259,la,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,esta,o
211,0211-699501013259,respuesta,o
211,0211-699501013259,se,o
211,0211-699501013259,hace,o
211,0211-699501013259,refractaria,o
211,0211-699501013259,correlacionandose,o
211,0211-699501013259,directamente,o
211,0211-699501013259,la,o
211,0211-699501013259,tHcy,i
211,0211-699501013259,con,o
211,0211-699501013259,la,o
211,0211-699501013259,albumina,i
211,0211-699501013259,plasmatica,i
211,0211-699501013259,La,o
211,0211-699501013259,interpretacion,o
211,0211-699501013259,de,o
211,0211-699501013259,los,o
211,0211-699501013259,niveles,i
211,0211-699501013259,de,i
211,0211-699501013259,tHcy,i
211,0211-699501013259,debe,o
211,0211-699501013259,tener,o
211,0211-699501013259,en,o
211,0211-699501013259,cuenta,o
211,0211-699501013259,la,o
211,0211-699501013259,concentracion,i
211,0211-699501013259,de,i
211,0211-699501013259,albumina,i
212,0211-699501013259,Efecto,o
212,0211-699501013259,de,o
212,0211-699501013259,la,o
212,0211-699501013259,suplementacion,i
212,0211-699501013259,con,o
212,0211-699501013259,acido,i
212,0211-699501013259,folico,i
212,0211-699501013259,sobre,o
212,0211-699501013259,los,o
212,0211-699501013259,niveles,i
212,0211-699501013259,de,i
212,0211-699501013259,homocisteina,i
212,0211-699501013259,total,o
212,0211-699501013259,en,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,en,o
212,0211-699501013259,hemodialisis,i
212,0211-699501013259,La,o
212,0211-699501013259,hiperhomocisteinemia,i
212,0211-699501013259,es,o
212,0211-699501013259,un,o
212,0211-699501013259,marcador,o
212,0211-699501013259,de,o
212,0211-699501013259,riesgo,o
212,0211-699501013259,independiente,o
212,0211-699501013259,de,o
212,0211-699501013259,morbimortalidad,o
212,0211-699501013259,cardiovascular,i
212,0211-699501013259,Hemos,o
212,0211-699501013259,intentado,o
212,0211-699501013259,prospectivamente,o
212,0211-699501013259,reducir,o
212,0211-699501013259,los,o
212,0211-699501013259,niveles,i
212,0211-699501013259,de,i
212,0211-699501013259,homocisteina,i
212,0211-699501013259,total,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,mediante,o
212,0211-699501013259,suplemento,o
212,0211-699501013259,con,o
212,0211-699501013259,acido,i
212,0211-699501013259,folico,i
212,0211-699501013259,y,o
212,0211-699501013259,vitamina,i
212,0211-699501013259,B6,i
212,0211-699501013259,pp,i
212,0211-699501013259,valorando,o
212,0211-699501013259,su,o
212,0211-699501013259,posible,o
212,0211-699501013259,correlacion,o
212,0211-699501013259,con,o
212,0211-699501013259,dosis,o
212,0211-699501013259,de,o
212,0211-699501013259,dialisis,i
212,0211-699501013259,funcion,i
212,0211-699501013259,residual,i
212,0211-699501013259,y,o
212,0211-699501013259,parametros,o
212,0211-699501013259,nutricionales,o
212,0211-699501013259,Metodos,o
212,0211-699501013259,Todos,o
212,0211-699501013259,los,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,en,o
212,0211-699501013259,hemodialisis,i
212,0211-699501013259,al,o
212,0211-699501013259,comienzo,o
212,0211-699501013259,del,o
212,0211-699501013259,estudio,o
212,0211-699501013259,que,o
212,0211-699501013259,no,o
212,0211-699501013259,recibian,o
212,0211-699501013259,acido,i
212,0211-699501013259,folico,i
212,0211-699501013259,ni,o
212,0211-699501013259,vitamina,i
212,0211-699501013259,B6,i
212,0211-699501013259,asi,o
212,0211-699501013259,como,o
212,0211-699501013259,los,o
212,0211-699501013259,incorporados,o
212,0211-699501013259,posteriormente,o
212,0211-699501013259,a,o
212,0211-699501013259,partir,o
212,0211-699501013259,de,o
212,0211-699501013259,su,o
212,0211-699501013259,tercer,o
212,0211-699501013259,mes,o
212,0211-699501013259,en,o
212,0211-699501013259,hemodialisis,i
212,0211-699501013259,recibieron,o
212,0211-699501013259,5,o
212,0211-699501013259,mg,o
212,0211-699501013259,orales,o
212,0211-699501013259,de,o
212,0211-699501013259,acido,i
212,0211-699501013259,folico,i
212,0211-699501013259,cada,o
212,0211-699501013259,48,o
212,0211-699501013259,horas,o
212,0211-699501013259,y,o
212,0211-699501013259,40,o
212,0211-699501013259,mg,o
212,0211-699501013259,orales,o
212,0211-699501013259,de,o
212,0211-699501013259,vitamina,i
212,0211-699501013259,B6,i
212,0211-699501013259,cada,o
212,0211-699501013259,semana,o
212,0211-699501013259,Se,o
212,0211-699501013259,determinaron,o
212,0211-699501013259,al,o
212,0211-699501013259,comienzo,o
212,0211-699501013259,del,o
212,0211-699501013259,estudio,o
212,0211-699501013259,y,o
212,0211-699501013259,cada,o
212,0211-699501013259,2,o
212,0211-699501013259,meses,o
212,0211-699501013259,niveles,i
212,0211-699501013259,de,i
212,0211-699501013259,folato,i
212,0211-699501013259,vitamina,i
212,0211-699501013259,B12,i
212,0211-699501013259,inmunoensayo,i
212,0211-699501013259,albumina,i
212,0211-699501013259,y,o
212,0211-699501013259,cinetica,o
212,0211-699501013259,de,o
212,0211-699501013259,la,o
212,0211-699501013259,urea,i
212,0211-699501013259,KTV,o
212,0211-699501013259,KRU,o
212,0211-699501013259,PCRn,o
212,0211-699501013259,y,o
212,0211-699501013259,cada,o
212,0211-699501013259,6,o
212,0211-699501013259,meses,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,HPLC,i
212,0211-699501013259,y,o
212,0211-699501013259,pp,i
212,0211-699501013259,RIA,i
212,0211-699501013259,Resultados,o
212,0211-699501013259,80,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,fueron,o
212,0211-699501013259,incluidos,o
212,0211-699501013259,en,o
212,0211-699501013259,el,o
212,0211-699501013259,estudio,o
212,0211-699501013259,basal,o
212,0211-699501013259,con,o
212,0211-699501013259,una,o
212,0211-699501013259,prevalencia,o
212,0211-699501013259,de,o
212,0211-699501013259,hiperhomocisteinemia,i
212,0211-699501013259,del,o
212,0211-699501013259,844,o
212,0211-699501013259,deficit,i
212,0211-699501013259,de,i
212,0211-699501013259,pp,i
212,0211-699501013259,en,o
212,0211-699501013259,el,o
212,0211-699501013259,32,o
212,0211-699501013259,y,o
212,0211-699501013259,folato,i
212,0211-699501013259,en,o
212,0211-699501013259,el,o
212,0211-699501013259,rango,o
212,0211-699501013259,normal,o
212,0211-699501013259,bajo,o
212,0211-699501013259,los,o
212,0211-699501013259,niveles,i
212,0211-699501013259,de,i
212,0211-699501013259,tHcy,i
212,0211-699501013259,se,o
212,0211-699501013259,correlacionaban,o
212,0211-699501013259,inversamente,o
212,0211-699501013259,con,o
212,0211-699501013259,los,o
212,0211-699501013259,del,o
212,0211-699501013259,folato,i
212,0211-699501013259,r,o
212,0211-699501013259,0336,o
212,0211-699501013259,p,o
212,0211-699501013259,001,o
212,0211-699501013259,pero,o
212,0211-699501013259,no,o
212,0211-699501013259,con,o
212,0211-699501013259,pp,i
212,0211-699501013259,B12,i
212,0211-699501013259,edad,o
212,0211-699501013259,albumina,i
212,0211-699501013259,KTV,o
212,0211-699501013259,KRU,o
212,0211-699501013259,PCRn,o
212,0211-699501013259,Cincuenta,o
212,0211-699501013259,y,o
212,0211-699501013259,ocho,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,recibieron,o
212,0211-699501013259,seis,o
212,0211-699501013259,meses,o
212,0211-699501013259,de,o
212,0211-699501013259,suplementacion,i
212,0211-699501013259,con,o
212,0211-699501013259,normalizacion,o
212,0211-699501013259,del,o
212,0211-699501013259,pp,i
212,0211-699501013259,aumento,o
212,0211-699501013259,del,o
212,0211-699501013259,folato,i
212,0211-699501013259,703,o
212,0211-699501013259,IC,o
212,0211-699501013259,638,o
212,0211-699501013259,795,o
212,0211-699501013259,vs,o
212,0211-699501013259,6181,o
212,0211-699501013259,IC,o
212,0211-699501013259,4447,o
212,0211-699501013259,7811,o
212,0211-699501013259,p,o
212,0211-699501013259,0001,o
212,0211-699501013259,y,o
212,0211-699501013259,descenso,o
212,0211-699501013259,de,o
212,0211-699501013259,la,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,240,o
212,0211-699501013259,IC,o
212,0211-699501013259,213,o
212,0211-699501013259,264,o
212,0211-699501013259,vs,o
212,0211-699501013259,199,o
212,0211-699501013259,IC,o
212,0211-699501013259,175,o
212,0211-699501013259,224,o
212,0211-699501013259,p,o
212,0211-699501013259,005,o
212,0211-699501013259,Han,o
212,0211-699501013259,recibido,o
212,0211-699501013259,suplementacion,i
212,0211-699501013259,durante,o
212,0211-699501013259,12,o
212,0211-699501013259,meses,o
212,0211-699501013259,33,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,pero,o
212,0211-699501013259,a,o
212,0211-699501013259,pesar,o
212,0211-699501013259,de,o
212,0211-699501013259,un,o
212,0211-699501013259,continuo,o
212,0211-699501013259,aumento,o
212,0211-699501013259,del,o
212,0211-699501013259,folato,i
212,0211-699501013259,10078,o
212,0211-699501013259,IC,o
212,0211-699501013259,7481,o
212,0211-699501013259,12674,o
212,0211-699501013259,p,o
212,0211-699501013259,0001,o
212,0211-699501013259,solo,o
212,0211-699501013259,3,o
212,0211-699501013259,pacientes,o
212,0211-699501013259,presentan,o
212,0211-699501013259,niveles,o
212,0211-699501013259,normales,o
212,0211-699501013259,de,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,correlacionandose,o
212,0211-699501013259,directamente,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,con,o
212,0211-699501013259,la,o
212,0211-699501013259,albumina,i
212,0211-699501013259,r,o
212,0211-699501013259,056,o
212,0211-699501013259,p,o
212,0211-699501013259,0001,o
212,0211-699501013259,que,o
212,0211-699501013259,se,o
212,0211-699501013259,elevo,o
212,0211-699501013259,con,o
212,0211-699501013259,respecto,o
212,0211-699501013259,al,o
212,0211-699501013259,inicio,o
212,0211-699501013259,337,o
212,0211-699501013259,IC,o
212,0211-699501013259,327,o
212,0211-699501013259,346,o
212,0211-699501013259,vs,o
212,0211-699501013259,350,o
212,0211-699501013259,IC,o
212,0211-699501013259,337,o
212,0211-699501013259,363,o
212,0211-699501013259,p,o
212,0211-699501013259,005,o
212,0211-699501013259,Conclusion,o
212,0211-699501013259,Tras,o
212,0211-699501013259,suplementacion,i
212,0211-699501013259,con,o
212,0211-699501013259,acido,i
212,0211-699501013259,folico,i
212,0211-699501013259,y,o
212,0211-699501013259,vitamina,i
212,0211-699501013259,B6,i
212,0211-699501013259,aunque,o
212,0211-699501013259,inicialmente,o
212,0211-699501013259,se,o
212,0211-699501013259,reduce,o
212,0211-699501013259,la,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,esta,o
212,0211-699501013259,respuesta,o
212,0211-699501013259,se,o
212,0211-699501013259,hace,o
212,0211-699501013259,refractaria,o
212,0211-699501013259,correlacionandose,o
212,0211-699501013259,directamente,o
212,0211-699501013259,la,o
212,0211-699501013259,tHcy,i
212,0211-699501013259,con,o
212,0211-699501013259,la,o
212,0211-699501013259,albumina,i
212,0211-699501013259,plasmatica,i
212,0211-699501013259,La,o
212,0211-699501013259,interpretacion,o
212,0211-699501013259,de,o
212,0211-699501013259,los,o
212,0211-699501013259,niveles,i
212,0211-699501013259,de,i
212,0211-699501013259,tHcy,i
212,0211-699501013259,debe,o
212,0211-699501013259,tener,o
212,0211-699501013259,en,o
212,0211-699501013259,cuenta,o
212,0211-699501013259,la,o
212,0211-699501013259,concentracion,i
212,0211-699501013259,de,i
212,0211-699501013259,albumina,i
213,0211-699501013259,Efecto,o
213,0211-699501013259,de,o
213,0211-699501013259,la,o
213,0211-699501013259,suplementacion,i
213,0211-699501013259,con,o
213,0211-699501013259,acido,i
213,0211-699501013259,folico,i
213,0211-699501013259,sobre,o
213,0211-699501013259,los,o
213,0211-699501013259,niveles,i
213,0211-699501013259,de,i
213,0211-699501013259,homocisteina,i
213,0211-699501013259,total,o
213,0211-699501013259,en,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,en,o
213,0211-699501013259,hemodialisis,i
213,0211-699501013259,La,o
213,0211-699501013259,hiperhomocisteinemia,i
213,0211-699501013259,es,o
213,0211-699501013259,un,o
213,0211-699501013259,marcador,o
213,0211-699501013259,de,o
213,0211-699501013259,riesgo,o
213,0211-699501013259,independiente,o
213,0211-699501013259,de,o
213,0211-699501013259,morbimortalidad,o
213,0211-699501013259,cardiovascular,i
213,0211-699501013259,Hemos,o
213,0211-699501013259,intentado,o
213,0211-699501013259,prospectivamente,o
213,0211-699501013259,reducir,o
213,0211-699501013259,los,o
213,0211-699501013259,niveles,i
213,0211-699501013259,de,i
213,0211-699501013259,homocisteina,i
213,0211-699501013259,total,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,mediante,o
213,0211-699501013259,suplemento,o
213,0211-699501013259,con,o
213,0211-699501013259,acido,i
213,0211-699501013259,folico,i
213,0211-699501013259,y,o
213,0211-699501013259,vitamina,i
213,0211-699501013259,B6,i
213,0211-699501013259,pp,i
213,0211-699501013259,valorando,o
213,0211-699501013259,su,o
213,0211-699501013259,posible,o
213,0211-699501013259,correlacion,o
213,0211-699501013259,con,o
213,0211-699501013259,dosis,o
213,0211-699501013259,de,o
213,0211-699501013259,dialisis,i
213,0211-699501013259,funcion,i
213,0211-699501013259,residual,i
213,0211-699501013259,y,o
213,0211-699501013259,parametros,o
213,0211-699501013259,nutricionales,o
213,0211-699501013259,Metodos,o
213,0211-699501013259,Todos,o
213,0211-699501013259,los,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,en,o
213,0211-699501013259,hemodialisis,i
213,0211-699501013259,al,o
213,0211-699501013259,comienzo,o
213,0211-699501013259,del,o
213,0211-699501013259,estudio,o
213,0211-699501013259,que,o
213,0211-699501013259,no,o
213,0211-699501013259,recibian,o
213,0211-699501013259,acido,i
213,0211-699501013259,folico,i
213,0211-699501013259,ni,o
213,0211-699501013259,vitamina,i
213,0211-699501013259,B6,i
213,0211-699501013259,asi,o
213,0211-699501013259,como,o
213,0211-699501013259,los,o
213,0211-699501013259,incorporados,o
213,0211-699501013259,posteriormente,o
213,0211-699501013259,a,o
213,0211-699501013259,partir,o
213,0211-699501013259,de,o
213,0211-699501013259,su,o
213,0211-699501013259,tercer,o
213,0211-699501013259,mes,o
213,0211-699501013259,en,o
213,0211-699501013259,hemodialisis,i
213,0211-699501013259,recibieron,o
213,0211-699501013259,5,o
213,0211-699501013259,mg,o
213,0211-699501013259,orales,o
213,0211-699501013259,de,o
213,0211-699501013259,acido,i
213,0211-699501013259,folico,i
213,0211-699501013259,cada,o
213,0211-699501013259,48,o
213,0211-699501013259,horas,o
213,0211-699501013259,y,o
213,0211-699501013259,40,o
213,0211-699501013259,mg,o
213,0211-699501013259,orales,o
213,0211-699501013259,de,o
213,0211-699501013259,vitamina,i
213,0211-699501013259,B6,i
213,0211-699501013259,cada,o
213,0211-699501013259,semana,o
213,0211-699501013259,Se,o
213,0211-699501013259,determinaron,o
213,0211-699501013259,al,o
213,0211-699501013259,comienzo,o
213,0211-699501013259,del,o
213,0211-699501013259,estudio,o
213,0211-699501013259,y,o
213,0211-699501013259,cada,o
213,0211-699501013259,2,o
213,0211-699501013259,meses,o
213,0211-699501013259,niveles,i
213,0211-699501013259,de,i
213,0211-699501013259,folato,i
213,0211-699501013259,vitamina,i
213,0211-699501013259,B12,i
213,0211-699501013259,inmunoensayo,i
213,0211-699501013259,albumina,i
213,0211-699501013259,y,o
213,0211-699501013259,cinetica,o
213,0211-699501013259,de,o
213,0211-699501013259,la,o
213,0211-699501013259,urea,i
213,0211-699501013259,KTV,o
213,0211-699501013259,KRU,o
213,0211-699501013259,PCRn,o
213,0211-699501013259,y,o
213,0211-699501013259,cada,o
213,0211-699501013259,6,o
213,0211-699501013259,meses,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,HPLC,i
213,0211-699501013259,y,o
213,0211-699501013259,pp,i
213,0211-699501013259,RIA,i
213,0211-699501013259,Resultados,o
213,0211-699501013259,80,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,fueron,o
213,0211-699501013259,incluidos,o
213,0211-699501013259,en,o
213,0211-699501013259,el,o
213,0211-699501013259,estudio,o
213,0211-699501013259,basal,o
213,0211-699501013259,con,o
213,0211-699501013259,una,o
213,0211-699501013259,prevalencia,o
213,0211-699501013259,de,o
213,0211-699501013259,hiperhomocisteinemia,i
213,0211-699501013259,del,o
213,0211-699501013259,844,o
213,0211-699501013259,deficit,i
213,0211-699501013259,de,i
213,0211-699501013259,pp,i
213,0211-699501013259,en,o
213,0211-699501013259,el,o
213,0211-699501013259,32,o
213,0211-699501013259,y,o
213,0211-699501013259,folato,i
213,0211-699501013259,en,o
213,0211-699501013259,el,o
213,0211-699501013259,rango,o
213,0211-699501013259,normal,o
213,0211-699501013259,bajo,o
213,0211-699501013259,los,o
213,0211-699501013259,niveles,i
213,0211-699501013259,de,i
213,0211-699501013259,tHcy,i
213,0211-699501013259,se,o
213,0211-699501013259,correlacionaban,o
213,0211-699501013259,inversamente,o
213,0211-699501013259,con,o
213,0211-699501013259,los,o
213,0211-699501013259,del,o
213,0211-699501013259,folato,i
213,0211-699501013259,r,o
213,0211-699501013259,0336,o
213,0211-699501013259,p,o
213,0211-699501013259,001,o
213,0211-699501013259,pero,o
213,0211-699501013259,no,o
213,0211-699501013259,con,o
213,0211-699501013259,pp,i
213,0211-699501013259,B12,i
213,0211-699501013259,edad,o
213,0211-699501013259,albumina,i
213,0211-699501013259,KTV,o
213,0211-699501013259,KRU,o
213,0211-699501013259,PCRn,o
213,0211-699501013259,Cincuenta,o
213,0211-699501013259,y,o
213,0211-699501013259,ocho,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,recibieron,o
213,0211-699501013259,seis,o
213,0211-699501013259,meses,o
213,0211-699501013259,de,o
213,0211-699501013259,suplementacion,i
213,0211-699501013259,con,o
213,0211-699501013259,normalizacion,o
213,0211-699501013259,del,o
213,0211-699501013259,pp,i
213,0211-699501013259,aumento,o
213,0211-699501013259,del,o
213,0211-699501013259,folato,i
213,0211-699501013259,703,o
213,0211-699501013259,IC,o
213,0211-699501013259,638,o
213,0211-699501013259,795,o
213,0211-699501013259,vs,o
213,0211-699501013259,6181,o
213,0211-699501013259,IC,o
213,0211-699501013259,4447,o
213,0211-699501013259,7811,o
213,0211-699501013259,p,o
213,0211-699501013259,0001,o
213,0211-699501013259,y,o
213,0211-699501013259,descenso,o
213,0211-699501013259,de,o
213,0211-699501013259,la,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,240,o
213,0211-699501013259,IC,o
213,0211-699501013259,213,o
213,0211-699501013259,264,o
213,0211-699501013259,vs,o
213,0211-699501013259,199,o
213,0211-699501013259,IC,o
213,0211-699501013259,175,o
213,0211-699501013259,224,o
213,0211-699501013259,p,o
213,0211-699501013259,005,o
213,0211-699501013259,Han,o
213,0211-699501013259,recibido,o
213,0211-699501013259,suplementacion,i
213,0211-699501013259,durante,o
213,0211-699501013259,12,o
213,0211-699501013259,meses,o
213,0211-699501013259,33,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,pero,o
213,0211-699501013259,a,o
213,0211-699501013259,pesar,o
213,0211-699501013259,de,o
213,0211-699501013259,un,o
213,0211-699501013259,continuo,o
213,0211-699501013259,aumento,o
213,0211-699501013259,del,o
213,0211-699501013259,folato,i
213,0211-699501013259,10078,o
213,0211-699501013259,IC,o
213,0211-699501013259,7481,o
213,0211-699501013259,12674,o
213,0211-699501013259,p,o
213,0211-699501013259,0001,o
213,0211-699501013259,solo,o
213,0211-699501013259,3,o
213,0211-699501013259,pacientes,o
213,0211-699501013259,presentan,o
213,0211-699501013259,niveles,o
213,0211-699501013259,normales,o
213,0211-699501013259,de,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,correlacionandose,o
213,0211-699501013259,directamente,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,con,o
213,0211-699501013259,la,o
213,0211-699501013259,albumina,i
213,0211-699501013259,r,o
213,0211-699501013259,056,o
213,0211-699501013259,p,o
213,0211-699501013259,0001,o
213,0211-699501013259,que,o
213,0211-699501013259,se,o
213,0211-699501013259,elevo,o
213,0211-699501013259,con,o
213,0211-699501013259,respecto,o
213,0211-699501013259,al,o
213,0211-699501013259,inicio,o
213,0211-699501013259,337,o
213,0211-699501013259,IC,o
213,0211-699501013259,327,o
213,0211-699501013259,346,o
213,0211-699501013259,vs,o
213,0211-699501013259,350,o
213,0211-699501013259,IC,o
213,0211-699501013259,337,o
213,0211-699501013259,363,o
213,0211-699501013259,p,o
213,0211-699501013259,005,o
213,0211-699501013259,Conclusion,o
213,0211-699501013259,Tras,o
213,0211-699501013259,suplementacion,i
213,0211-699501013259,con,o
213,0211-699501013259,acido,i
213,0211-699501013259,folico,i
213,0211-699501013259,y,o
213,0211-699501013259,vitamina,i
213,0211-699501013259,B6,i
213,0211-699501013259,aunque,o
213,0211-699501013259,inicialmente,o
213,0211-699501013259,se,o
213,0211-699501013259,reduce,o
213,0211-699501013259,la,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,esta,o
213,0211-699501013259,respuesta,o
213,0211-699501013259,se,o
213,0211-699501013259,hace,o
213,0211-699501013259,refractaria,o
213,0211-699501013259,correlacionandose,o
213,0211-699501013259,directamente,o
213,0211-699501013259,la,o
213,0211-699501013259,tHcy,i
213,0211-699501013259,con,o
213,0211-699501013259,la,o
213,0211-699501013259,albumina,i
213,0211-699501013259,plasmatica,i
213,0211-699501013259,La,o
213,0211-699501013259,interpretacion,o
213,0211-699501013259,de,o
213,0211-699501013259,los,o
213,0211-699501013259,niveles,i
213,0211-699501013259,de,i
213,0211-699501013259,tHcy,i
213,0211-699501013259,debe,o
213,0211-699501013259,tener,o
213,0211-699501013259,en,o
213,0211-699501013259,cuenta,o
213,0211-699501013259,la,o
213,0211-699501013259,concentracion,i
213,0211-699501013259,de,i
213,0211-699501013259,albumina,i
214,0211-699501013259,Efecto,o
214,0211-699501013259,de,o
214,0211-699501013259,la,o
214,0211-699501013259,suplementacion,i
214,0211-699501013259,con,o
214,0211-699501013259,acido,i
214,0211-699501013259,folico,i
214,0211-699501013259,sobre,o
214,0211-699501013259,los,o
214,0211-699501013259,niveles,i
214,0211-699501013259,de,i
214,0211-699501013259,homocisteina,i
214,0211-699501013259,total,o
214,0211-699501013259,en,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,en,o
214,0211-699501013259,hemodialisis,i
214,0211-699501013259,La,o
214,0211-699501013259,hiperhomocisteinemia,i
214,0211-699501013259,es,o
214,0211-699501013259,un,o
214,0211-699501013259,marcador,o
214,0211-699501013259,de,o
214,0211-699501013259,riesgo,o
214,0211-699501013259,independiente,o
214,0211-699501013259,de,o
214,0211-699501013259,morbimortalidad,o
214,0211-699501013259,cardiovascular,i
214,0211-699501013259,Hemos,o
214,0211-699501013259,intentado,o
214,0211-699501013259,prospectivamente,o
214,0211-699501013259,reducir,o
214,0211-699501013259,los,o
214,0211-699501013259,niveles,i
214,0211-699501013259,de,i
214,0211-699501013259,homocisteina,i
214,0211-699501013259,total,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,mediante,o
214,0211-699501013259,suplemento,o
214,0211-699501013259,con,o
214,0211-699501013259,acido,i
214,0211-699501013259,folico,i
214,0211-699501013259,y,o
214,0211-699501013259,vitamina,i
214,0211-699501013259,B6,i
214,0211-699501013259,pp,i
214,0211-699501013259,valorando,o
214,0211-699501013259,su,o
214,0211-699501013259,posible,o
214,0211-699501013259,correlacion,o
214,0211-699501013259,con,o
214,0211-699501013259,dosis,o
214,0211-699501013259,de,o
214,0211-699501013259,dialisis,i
214,0211-699501013259,funcion,i
214,0211-699501013259,residual,i
214,0211-699501013259,y,o
214,0211-699501013259,parametros,o
214,0211-699501013259,nutricionales,o
214,0211-699501013259,Metodos,o
214,0211-699501013259,Todos,o
214,0211-699501013259,los,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,en,o
214,0211-699501013259,hemodialisis,i
214,0211-699501013259,al,o
214,0211-699501013259,comienzo,o
214,0211-699501013259,del,o
214,0211-699501013259,estudio,o
214,0211-699501013259,que,o
214,0211-699501013259,no,o
214,0211-699501013259,recibian,o
214,0211-699501013259,acido,i
214,0211-699501013259,folico,i
214,0211-699501013259,ni,o
214,0211-699501013259,vitamina,i
214,0211-699501013259,B6,i
214,0211-699501013259,asi,o
214,0211-699501013259,como,o
214,0211-699501013259,los,o
214,0211-699501013259,incorporados,o
214,0211-699501013259,posteriormente,o
214,0211-699501013259,a,o
214,0211-699501013259,partir,o
214,0211-699501013259,de,o
214,0211-699501013259,su,o
214,0211-699501013259,tercer,o
214,0211-699501013259,mes,o
214,0211-699501013259,en,o
214,0211-699501013259,hemodialisis,i
214,0211-699501013259,recibieron,o
214,0211-699501013259,5,o
214,0211-699501013259,mg,o
214,0211-699501013259,orales,o
214,0211-699501013259,de,o
214,0211-699501013259,acido,i
214,0211-699501013259,folico,i
214,0211-699501013259,cada,o
214,0211-699501013259,48,o
214,0211-699501013259,horas,o
214,0211-699501013259,y,o
214,0211-699501013259,40,o
214,0211-699501013259,mg,o
214,0211-699501013259,orales,o
214,0211-699501013259,de,o
214,0211-699501013259,vitamina,i
214,0211-699501013259,B6,i
214,0211-699501013259,cada,o
214,0211-699501013259,semana,o
214,0211-699501013259,Se,o
214,0211-699501013259,determinaron,o
214,0211-699501013259,al,o
214,0211-699501013259,comienzo,o
214,0211-699501013259,del,o
214,0211-699501013259,estudio,o
214,0211-699501013259,y,o
214,0211-699501013259,cada,o
214,0211-699501013259,2,o
214,0211-699501013259,meses,o
214,0211-699501013259,niveles,i
214,0211-699501013259,de,i
214,0211-699501013259,folato,i
214,0211-699501013259,vitamina,i
214,0211-699501013259,B12,i
214,0211-699501013259,inmunoensayo,i
214,0211-699501013259,albumina,i
214,0211-699501013259,y,o
214,0211-699501013259,cinetica,o
214,0211-699501013259,de,o
214,0211-699501013259,la,o
214,0211-699501013259,urea,i
214,0211-699501013259,KTV,o
214,0211-699501013259,KRU,o
214,0211-699501013259,PCRn,o
214,0211-699501013259,y,o
214,0211-699501013259,cada,o
214,0211-699501013259,6,o
214,0211-699501013259,meses,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,HPLC,i
214,0211-699501013259,y,o
214,0211-699501013259,pp,i
214,0211-699501013259,RIA,i
214,0211-699501013259,Resultados,o
214,0211-699501013259,80,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,fueron,o
214,0211-699501013259,incluidos,o
214,0211-699501013259,en,o
214,0211-699501013259,el,o
214,0211-699501013259,estudio,o
214,0211-699501013259,basal,o
214,0211-699501013259,con,o
214,0211-699501013259,una,o
214,0211-699501013259,prevalencia,o
214,0211-699501013259,de,o
214,0211-699501013259,hiperhomocisteinemia,i
214,0211-699501013259,del,o
214,0211-699501013259,844,o
214,0211-699501013259,deficit,i
214,0211-699501013259,de,i
214,0211-699501013259,pp,i
214,0211-699501013259,en,o
214,0211-699501013259,el,o
214,0211-699501013259,32,o
214,0211-699501013259,y,o
214,0211-699501013259,folato,i
214,0211-699501013259,en,o
214,0211-699501013259,el,o
214,0211-699501013259,rango,o
214,0211-699501013259,normal,o
214,0211-699501013259,bajo,o
214,0211-699501013259,los,o
214,0211-699501013259,niveles,i
214,0211-699501013259,de,i
214,0211-699501013259,tHcy,i
214,0211-699501013259,se,o
214,0211-699501013259,correlacionaban,o
214,0211-699501013259,inversamente,o
214,0211-699501013259,con,o
214,0211-699501013259,los,o
214,0211-699501013259,del,o
214,0211-699501013259,folato,i
214,0211-699501013259,r,o
214,0211-699501013259,0336,o
214,0211-699501013259,p,o
214,0211-699501013259,001,o
214,0211-699501013259,pero,o
214,0211-699501013259,no,o
214,0211-699501013259,con,o
214,0211-699501013259,pp,i
214,0211-699501013259,B12,i
214,0211-699501013259,edad,o
214,0211-699501013259,albumina,i
214,0211-699501013259,KTV,o
214,0211-699501013259,KRU,o
214,0211-699501013259,PCRn,o
214,0211-699501013259,Cincuenta,o
214,0211-699501013259,y,o
214,0211-699501013259,ocho,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,recibieron,o
214,0211-699501013259,seis,o
214,0211-699501013259,meses,o
214,0211-699501013259,de,o
214,0211-699501013259,suplementacion,i
214,0211-699501013259,con,o
214,0211-699501013259,normalizacion,o
214,0211-699501013259,del,o
214,0211-699501013259,pp,i
214,0211-699501013259,aumento,o
214,0211-699501013259,del,o
214,0211-699501013259,folato,i
214,0211-699501013259,703,o
214,0211-699501013259,IC,o
214,0211-699501013259,638,o
214,0211-699501013259,795,o
214,0211-699501013259,vs,o
214,0211-699501013259,6181,o
214,0211-699501013259,IC,o
214,0211-699501013259,4447,o
214,0211-699501013259,7811,o
214,0211-699501013259,p,o
214,0211-699501013259,0001,o
214,0211-699501013259,y,o
214,0211-699501013259,descenso,o
214,0211-699501013259,de,o
214,0211-699501013259,la,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,240,o
214,0211-699501013259,IC,o
214,0211-699501013259,213,o
214,0211-699501013259,264,o
214,0211-699501013259,vs,o
214,0211-699501013259,199,o
214,0211-699501013259,IC,o
214,0211-699501013259,175,o
214,0211-699501013259,224,o
214,0211-699501013259,p,o
214,0211-699501013259,005,o
214,0211-699501013259,Han,o
214,0211-699501013259,recibido,o
214,0211-699501013259,suplementacion,i
214,0211-699501013259,durante,o
214,0211-699501013259,12,o
214,0211-699501013259,meses,o
214,0211-699501013259,33,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,pero,o
214,0211-699501013259,a,o
214,0211-699501013259,pesar,o
214,0211-699501013259,de,o
214,0211-699501013259,un,o
214,0211-699501013259,continuo,o
214,0211-699501013259,aumento,o
214,0211-699501013259,del,o
214,0211-699501013259,folato,i
214,0211-699501013259,10078,o
214,0211-699501013259,IC,o
214,0211-699501013259,7481,o
214,0211-699501013259,12674,o
214,0211-699501013259,p,o
214,0211-699501013259,0001,o
214,0211-699501013259,solo,o
214,0211-699501013259,3,o
214,0211-699501013259,pacientes,o
214,0211-699501013259,presentan,o
214,0211-699501013259,niveles,o
214,0211-699501013259,normales,o
214,0211-699501013259,de,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,correlacionandose,o
214,0211-699501013259,directamente,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,con,o
214,0211-699501013259,la,o
214,0211-699501013259,albumina,i
214,0211-699501013259,r,o
214,0211-699501013259,056,o
214,0211-699501013259,p,o
214,0211-699501013259,0001,o
214,0211-699501013259,que,o
214,0211-699501013259,se,o
214,0211-699501013259,elevo,o
214,0211-699501013259,con,o
214,0211-699501013259,respecto,o
214,0211-699501013259,al,o
214,0211-699501013259,inicio,o
214,0211-699501013259,337,o
214,0211-699501013259,IC,o
214,0211-699501013259,327,o
214,0211-699501013259,346,o
214,0211-699501013259,vs,o
214,0211-699501013259,350,o
214,0211-699501013259,IC,o
214,0211-699501013259,337,o
214,0211-699501013259,363,o
214,0211-699501013259,p,o
214,0211-699501013259,005,o
214,0211-699501013259,Conclusion,o
214,0211-699501013259,Tras,o
214,0211-699501013259,suplementacion,i
214,0211-699501013259,con,o
214,0211-699501013259,acido,i
214,0211-699501013259,folico,i
214,0211-699501013259,y,o
214,0211-699501013259,vitamina,i
214,0211-699501013259,B6,i
214,0211-699501013259,aunque,o
214,0211-699501013259,inicialmente,o
214,0211-699501013259,se,o
214,0211-699501013259,reduce,o
214,0211-699501013259,la,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,esta,o
214,0211-699501013259,respuesta,o
214,0211-699501013259,se,o
214,0211-699501013259,hace,o
214,0211-699501013259,refractaria,o
214,0211-699501013259,correlacionandose,o
214,0211-699501013259,directamente,o
214,0211-699501013259,la,o
214,0211-699501013259,tHcy,i
214,0211-699501013259,con,o
214,0211-699501013259,la,o
214,0211-699501013259,albumina,i
214,0211-699501013259,plasmatica,i
214,0211-699501013259,La,o
214,0211-699501013259,interpretacion,o
214,0211-699501013259,de,o
214,0211-699501013259,los,o
214,0211-699501013259,niveles,i
214,0211-699501013259,de,i
214,0211-699501013259,tHcy,i
214,0211-699501013259,debe,o
214,0211-699501013259,tener,o
214,0211-699501013259,en,o
214,0211-699501013259,cuenta,o
214,0211-699501013259,la,o
214,0211-699501013259,concentracion,i
214,0211-699501013259,de,i
214,0211-699501013259,albumina,i
215,0211-699501013259,Efecto,o
215,0211-699501013259,de,o
215,0211-699501013259,la,o
215,0211-699501013259,suplementacion,i
215,0211-699501013259,con,o
215,0211-699501013259,acido,i
215,0211-699501013259,folico,i
215,0211-699501013259,sobre,o
215,0211-699501013259,los,o
215,0211-699501013259,niveles,i
215,0211-699501013259,de,i
215,0211-699501013259,homocisteina,i
215,0211-699501013259,total,o
215,0211-699501013259,en,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,en,o
215,0211-699501013259,hemodialisis,i
215,0211-699501013259,La,o
215,0211-699501013259,hiperhomocisteinemia,i
215,0211-699501013259,es,o
215,0211-699501013259,un,o
215,0211-699501013259,marcador,o
215,0211-699501013259,de,o
215,0211-699501013259,riesgo,o
215,0211-699501013259,independiente,o
215,0211-699501013259,de,o
215,0211-699501013259,morbimortalidad,o
215,0211-699501013259,cardiovascular,i
215,0211-699501013259,Hemos,o
215,0211-699501013259,intentado,o
215,0211-699501013259,prospectivamente,o
215,0211-699501013259,reducir,o
215,0211-699501013259,los,o
215,0211-699501013259,niveles,i
215,0211-699501013259,de,i
215,0211-699501013259,homocisteina,i
215,0211-699501013259,total,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,mediante,o
215,0211-699501013259,suplemento,o
215,0211-699501013259,con,o
215,0211-699501013259,acido,i
215,0211-699501013259,folico,i
215,0211-699501013259,y,o
215,0211-699501013259,vitamina,i
215,0211-699501013259,B6,i
215,0211-699501013259,pp,i
215,0211-699501013259,valorando,o
215,0211-699501013259,su,o
215,0211-699501013259,posible,o
215,0211-699501013259,correlacion,o
215,0211-699501013259,con,o
215,0211-699501013259,dosis,o
215,0211-699501013259,de,o
215,0211-699501013259,dialisis,i
215,0211-699501013259,funcion,i
215,0211-699501013259,residual,i
215,0211-699501013259,y,o
215,0211-699501013259,parametros,o
215,0211-699501013259,nutricionales,o
215,0211-699501013259,Metodos,o
215,0211-699501013259,Todos,o
215,0211-699501013259,los,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,en,o
215,0211-699501013259,hemodialisis,i
215,0211-699501013259,al,o
215,0211-699501013259,comienzo,o
215,0211-699501013259,del,o
215,0211-699501013259,estudio,o
215,0211-699501013259,que,o
215,0211-699501013259,no,o
215,0211-699501013259,recibian,o
215,0211-699501013259,acido,i
215,0211-699501013259,folico,i
215,0211-699501013259,ni,o
215,0211-699501013259,vitamina,i
215,0211-699501013259,B6,i
215,0211-699501013259,asi,o
215,0211-699501013259,como,o
215,0211-699501013259,los,o
215,0211-699501013259,incorporados,o
215,0211-699501013259,posteriormente,o
215,0211-699501013259,a,o
215,0211-699501013259,partir,o
215,0211-699501013259,de,o
215,0211-699501013259,su,o
215,0211-699501013259,tercer,o
215,0211-699501013259,mes,o
215,0211-699501013259,en,o
215,0211-699501013259,hemodialisis,i
215,0211-699501013259,recibieron,o
215,0211-699501013259,5,o
215,0211-699501013259,mg,o
215,0211-699501013259,orales,o
215,0211-699501013259,de,o
215,0211-699501013259,acido,i
215,0211-699501013259,folico,i
215,0211-699501013259,cada,o
215,0211-699501013259,48,o
215,0211-699501013259,horas,o
215,0211-699501013259,y,o
215,0211-699501013259,40,o
215,0211-699501013259,mg,o
215,0211-699501013259,orales,o
215,0211-699501013259,de,o
215,0211-699501013259,vitamina,i
215,0211-699501013259,B6,i
215,0211-699501013259,cada,o
215,0211-699501013259,semana,o
215,0211-699501013259,Se,o
215,0211-699501013259,determinaron,o
215,0211-699501013259,al,o
215,0211-699501013259,comienzo,o
215,0211-699501013259,del,o
215,0211-699501013259,estudio,o
215,0211-699501013259,y,o
215,0211-699501013259,cada,o
215,0211-699501013259,2,o
215,0211-699501013259,meses,o
215,0211-699501013259,niveles,i
215,0211-699501013259,de,i
215,0211-699501013259,folato,i
215,0211-699501013259,vitamina,i
215,0211-699501013259,B12,i
215,0211-699501013259,inmunoensayo,i
215,0211-699501013259,albumina,i
215,0211-699501013259,y,o
215,0211-699501013259,cinetica,o
215,0211-699501013259,de,o
215,0211-699501013259,la,o
215,0211-699501013259,urea,i
215,0211-699501013259,KTV,o
215,0211-699501013259,KRU,o
215,0211-699501013259,PCRn,o
215,0211-699501013259,y,o
215,0211-699501013259,cada,o
215,0211-699501013259,6,o
215,0211-699501013259,meses,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,HPLC,i
215,0211-699501013259,y,o
215,0211-699501013259,pp,i
215,0211-699501013259,RIA,i
215,0211-699501013259,Resultados,o
215,0211-699501013259,80,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,fueron,o
215,0211-699501013259,incluidos,o
215,0211-699501013259,en,o
215,0211-699501013259,el,o
215,0211-699501013259,estudio,o
215,0211-699501013259,basal,o
215,0211-699501013259,con,o
215,0211-699501013259,una,o
215,0211-699501013259,prevalencia,o
215,0211-699501013259,de,o
215,0211-699501013259,hiperhomocisteinemia,i
215,0211-699501013259,del,o
215,0211-699501013259,844,o
215,0211-699501013259,deficit,i
215,0211-699501013259,de,i
215,0211-699501013259,pp,i
215,0211-699501013259,en,o
215,0211-699501013259,el,o
215,0211-699501013259,32,o
215,0211-699501013259,y,o
215,0211-699501013259,folato,i
215,0211-699501013259,en,o
215,0211-699501013259,el,o
215,0211-699501013259,rango,o
215,0211-699501013259,normal,o
215,0211-699501013259,bajo,o
215,0211-699501013259,los,o
215,0211-699501013259,niveles,i
215,0211-699501013259,de,i
215,0211-699501013259,tHcy,i
215,0211-699501013259,se,o
215,0211-699501013259,correlacionaban,o
215,0211-699501013259,inversamente,o
215,0211-699501013259,con,o
215,0211-699501013259,los,o
215,0211-699501013259,del,o
215,0211-699501013259,folato,i
215,0211-699501013259,r,o
215,0211-699501013259,0336,o
215,0211-699501013259,p,o
215,0211-699501013259,001,o
215,0211-699501013259,pero,o
215,0211-699501013259,no,o
215,0211-699501013259,con,o
215,0211-699501013259,pp,i
215,0211-699501013259,B12,i
215,0211-699501013259,edad,o
215,0211-699501013259,albumina,i
215,0211-699501013259,KTV,o
215,0211-699501013259,KRU,o
215,0211-699501013259,PCRn,o
215,0211-699501013259,Cincuenta,o
215,0211-699501013259,y,o
215,0211-699501013259,ocho,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,recibieron,o
215,0211-699501013259,seis,o
215,0211-699501013259,meses,o
215,0211-699501013259,de,o
215,0211-699501013259,suplementacion,i
215,0211-699501013259,con,o
215,0211-699501013259,normalizacion,o
215,0211-699501013259,del,o
215,0211-699501013259,pp,i
215,0211-699501013259,aumento,o
215,0211-699501013259,del,o
215,0211-699501013259,folato,i
215,0211-699501013259,703,o
215,0211-699501013259,IC,o
215,0211-699501013259,638,o
215,0211-699501013259,795,o
215,0211-699501013259,vs,o
215,0211-699501013259,6181,o
215,0211-699501013259,IC,o
215,0211-699501013259,4447,o
215,0211-699501013259,7811,o
215,0211-699501013259,p,o
215,0211-699501013259,0001,o
215,0211-699501013259,y,o
215,0211-699501013259,descenso,o
215,0211-699501013259,de,o
215,0211-699501013259,la,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,240,o
215,0211-699501013259,IC,o
215,0211-699501013259,213,o
215,0211-699501013259,264,o
215,0211-699501013259,vs,o
215,0211-699501013259,199,o
215,0211-699501013259,IC,o
215,0211-699501013259,175,o
215,0211-699501013259,224,o
215,0211-699501013259,p,o
215,0211-699501013259,005,o
215,0211-699501013259,Han,o
215,0211-699501013259,recibido,o
215,0211-699501013259,suplementacion,i
215,0211-699501013259,durante,o
215,0211-699501013259,12,o
215,0211-699501013259,meses,o
215,0211-699501013259,33,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,pero,o
215,0211-699501013259,a,o
215,0211-699501013259,pesar,o
215,0211-699501013259,de,o
215,0211-699501013259,un,o
215,0211-699501013259,continuo,o
215,0211-699501013259,aumento,o
215,0211-699501013259,del,o
215,0211-699501013259,folato,i
215,0211-699501013259,10078,o
215,0211-699501013259,IC,o
215,0211-699501013259,7481,o
215,0211-699501013259,12674,o
215,0211-699501013259,p,o
215,0211-699501013259,0001,o
215,0211-699501013259,solo,o
215,0211-699501013259,3,o
215,0211-699501013259,pacientes,o
215,0211-699501013259,presentan,o
215,0211-699501013259,niveles,o
215,0211-699501013259,normales,o
215,0211-699501013259,de,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,correlacionandose,o
215,0211-699501013259,directamente,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,con,o
215,0211-699501013259,la,o
215,0211-699501013259,albumina,i
215,0211-699501013259,r,o
215,0211-699501013259,056,o
215,0211-699501013259,p,o
215,0211-699501013259,0001,o
215,0211-699501013259,que,o
215,0211-699501013259,se,o
215,0211-699501013259,elevo,o
215,0211-699501013259,con,o
215,0211-699501013259,respecto,o
215,0211-699501013259,al,o
215,0211-699501013259,inicio,o
215,0211-699501013259,337,o
215,0211-699501013259,IC,o
215,0211-699501013259,327,o
215,0211-699501013259,346,o
215,0211-699501013259,vs,o
215,0211-699501013259,350,o
215,0211-699501013259,IC,o
215,0211-699501013259,337,o
215,0211-699501013259,363,o
215,0211-699501013259,p,o
215,0211-699501013259,005,o
215,0211-699501013259,Conclusion,o
215,0211-699501013259,Tras,o
215,0211-699501013259,suplementacion,i
215,0211-699501013259,con,o
215,0211-699501013259,acido,i
215,0211-699501013259,folico,i
215,0211-699501013259,y,o
215,0211-699501013259,vitamina,i
215,0211-699501013259,B6,i
215,0211-699501013259,aunque,o
215,0211-699501013259,inicialmente,o
215,0211-699501013259,se,o
215,0211-699501013259,reduce,o
215,0211-699501013259,la,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,esta,o
215,0211-699501013259,respuesta,o
215,0211-699501013259,se,o
215,0211-699501013259,hace,o
215,0211-699501013259,refractaria,o
215,0211-699501013259,correlacionandose,o
215,0211-699501013259,directamente,o
215,0211-699501013259,la,o
215,0211-699501013259,tHcy,i
215,0211-699501013259,con,o
215,0211-699501013259,la,o
215,0211-699501013259,albumina,i
215,0211-699501013259,plasmatica,i
215,0211-699501013259,La,o
215,0211-699501013259,interpretacion,o
215,0211-699501013259,de,o
215,0211-699501013259,los,o
215,0211-699501013259,niveles,i
215,0211-699501013259,de,i
215,0211-699501013259,tHcy,i
215,0211-699501013259,debe,o
215,0211-699501013259,tener,o
215,0211-699501013259,en,o
215,0211-699501013259,cuenta,o
215,0211-699501013259,la,o
215,0211-699501013259,concentracion,i
215,0211-699501013259,de,i
215,0211-699501013259,albumina,i
216,0211-699501013259,Efecto,o
216,0211-699501013259,de,o
216,0211-699501013259,la,o
216,0211-699501013259,suplementacion,i
216,0211-699501013259,con,o
216,0211-699501013259,acido,i
216,0211-699501013259,folico,i
216,0211-699501013259,sobre,o
216,0211-699501013259,los,o
216,0211-699501013259,niveles,i
216,0211-699501013259,de,i
216,0211-699501013259,homocisteina,i
216,0211-699501013259,total,o
216,0211-699501013259,en,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,en,o
216,0211-699501013259,hemodialisis,i
216,0211-699501013259,La,o
216,0211-699501013259,hiperhomocisteinemia,i
216,0211-699501013259,es,o
216,0211-699501013259,un,o
216,0211-699501013259,marcador,o
216,0211-699501013259,de,o
216,0211-699501013259,riesgo,o
216,0211-699501013259,independiente,o
216,0211-699501013259,de,o
216,0211-699501013259,morbimortalidad,o
216,0211-699501013259,cardiovascular,i
216,0211-699501013259,Hemos,o
216,0211-699501013259,intentado,o
216,0211-699501013259,prospectivamente,o
216,0211-699501013259,reducir,o
216,0211-699501013259,los,o
216,0211-699501013259,niveles,i
216,0211-699501013259,de,i
216,0211-699501013259,homocisteina,i
216,0211-699501013259,total,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,mediante,o
216,0211-699501013259,suplemento,o
216,0211-699501013259,con,o
216,0211-699501013259,acido,i
216,0211-699501013259,folico,i
216,0211-699501013259,y,o
216,0211-699501013259,vitamina,i
216,0211-699501013259,B6,i
216,0211-699501013259,pp,i
216,0211-699501013259,valorando,o
216,0211-699501013259,su,o
216,0211-699501013259,posible,o
216,0211-699501013259,correlacion,o
216,0211-699501013259,con,o
216,0211-699501013259,dosis,o
216,0211-699501013259,de,o
216,0211-699501013259,dialisis,i
216,0211-699501013259,funcion,i
216,0211-699501013259,residual,i
216,0211-699501013259,y,o
216,0211-699501013259,parametros,o
216,0211-699501013259,nutricionales,o
216,0211-699501013259,Metodos,o
216,0211-699501013259,Todos,o
216,0211-699501013259,los,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,en,o
216,0211-699501013259,hemodialisis,i
216,0211-699501013259,al,o
216,0211-699501013259,comienzo,o
216,0211-699501013259,del,o
216,0211-699501013259,estudio,o
216,0211-699501013259,que,o
216,0211-699501013259,no,o
216,0211-699501013259,recibian,o
216,0211-699501013259,acido,i
216,0211-699501013259,folico,i
216,0211-699501013259,ni,o
216,0211-699501013259,vitamina,i
216,0211-699501013259,B6,i
216,0211-699501013259,asi,o
216,0211-699501013259,como,o
216,0211-699501013259,los,o
216,0211-699501013259,incorporados,o
216,0211-699501013259,posteriormente,o
216,0211-699501013259,a,o
216,0211-699501013259,partir,o
216,0211-699501013259,de,o
216,0211-699501013259,su,o
216,0211-699501013259,tercer,o
216,0211-699501013259,mes,o
216,0211-699501013259,en,o
216,0211-699501013259,hemodialisis,i
216,0211-699501013259,recibieron,o
216,0211-699501013259,5,o
216,0211-699501013259,mg,o
216,0211-699501013259,orales,o
216,0211-699501013259,de,o
216,0211-699501013259,acido,i
216,0211-699501013259,folico,i
216,0211-699501013259,cada,o
216,0211-699501013259,48,o
216,0211-699501013259,horas,o
216,0211-699501013259,y,o
216,0211-699501013259,40,o
216,0211-699501013259,mg,o
216,0211-699501013259,orales,o
216,0211-699501013259,de,o
216,0211-699501013259,vitamina,i
216,0211-699501013259,B6,i
216,0211-699501013259,cada,o
216,0211-699501013259,semana,o
216,0211-699501013259,Se,o
216,0211-699501013259,determinaron,o
216,0211-699501013259,al,o
216,0211-699501013259,comienzo,o
216,0211-699501013259,del,o
216,0211-699501013259,estudio,o
216,0211-699501013259,y,o
216,0211-699501013259,cada,o
216,0211-699501013259,2,o
216,0211-699501013259,meses,o
216,0211-699501013259,niveles,i
216,0211-699501013259,de,i
216,0211-699501013259,folato,i
216,0211-699501013259,vitamina,i
216,0211-699501013259,B12,i
216,0211-699501013259,inmunoensayo,i
216,0211-699501013259,albumina,i
216,0211-699501013259,y,o
216,0211-699501013259,cinetica,o
216,0211-699501013259,de,o
216,0211-699501013259,la,o
216,0211-699501013259,urea,i
216,0211-699501013259,KTV,o
216,0211-699501013259,KRU,o
216,0211-699501013259,PCRn,o
216,0211-699501013259,y,o
216,0211-699501013259,cada,o
216,0211-699501013259,6,o
216,0211-699501013259,meses,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,HPLC,i
216,0211-699501013259,y,o
216,0211-699501013259,pp,i
216,0211-699501013259,RIA,i
216,0211-699501013259,Resultados,o
216,0211-699501013259,80,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,fueron,o
216,0211-699501013259,incluidos,o
216,0211-699501013259,en,o
216,0211-699501013259,el,o
216,0211-699501013259,estudio,o
216,0211-699501013259,basal,o
216,0211-699501013259,con,o
216,0211-699501013259,una,o
216,0211-699501013259,prevalencia,o
216,0211-699501013259,de,o
216,0211-699501013259,hiperhomocisteinemia,i
216,0211-699501013259,del,o
216,0211-699501013259,844,o
216,0211-699501013259,deficit,i
216,0211-699501013259,de,i
216,0211-699501013259,pp,i
216,0211-699501013259,en,o
216,0211-699501013259,el,o
216,0211-699501013259,32,o
216,0211-699501013259,y,o
216,0211-699501013259,folato,i
216,0211-699501013259,en,o
216,0211-699501013259,el,o
216,0211-699501013259,rango,o
216,0211-699501013259,normal,o
216,0211-699501013259,bajo,o
216,0211-699501013259,los,o
216,0211-699501013259,niveles,i
216,0211-699501013259,de,i
216,0211-699501013259,tHcy,i
216,0211-699501013259,se,o
216,0211-699501013259,correlacionaban,o
216,0211-699501013259,inversamente,o
216,0211-699501013259,con,o
216,0211-699501013259,los,o
216,0211-699501013259,del,o
216,0211-699501013259,folato,i
216,0211-699501013259,r,o
216,0211-699501013259,0336,o
216,0211-699501013259,p,o
216,0211-699501013259,001,o
216,0211-699501013259,pero,o
216,0211-699501013259,no,o
216,0211-699501013259,con,o
216,0211-699501013259,pp,i
216,0211-699501013259,B12,i
216,0211-699501013259,edad,o
216,0211-699501013259,albumina,i
216,0211-699501013259,KTV,o
216,0211-699501013259,KRU,o
216,0211-699501013259,PCRn,o
216,0211-699501013259,Cincuenta,o
216,0211-699501013259,y,o
216,0211-699501013259,ocho,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,recibieron,o
216,0211-699501013259,seis,o
216,0211-699501013259,meses,o
216,0211-699501013259,de,o
216,0211-699501013259,suplementacion,i
216,0211-699501013259,con,o
216,0211-699501013259,normalizacion,o
216,0211-699501013259,del,o
216,0211-699501013259,pp,i
216,0211-699501013259,aumento,o
216,0211-699501013259,del,o
216,0211-699501013259,folato,i
216,0211-699501013259,703,o
216,0211-699501013259,IC,o
216,0211-699501013259,638,o
216,0211-699501013259,795,o
216,0211-699501013259,vs,o
216,0211-699501013259,6181,o
216,0211-699501013259,IC,o
216,0211-699501013259,4447,o
216,0211-699501013259,7811,o
216,0211-699501013259,p,o
216,0211-699501013259,0001,o
216,0211-699501013259,y,o
216,0211-699501013259,descenso,o
216,0211-699501013259,de,o
216,0211-699501013259,la,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,240,o
216,0211-699501013259,IC,o
216,0211-699501013259,213,o
216,0211-699501013259,264,o
216,0211-699501013259,vs,o
216,0211-699501013259,199,o
216,0211-699501013259,IC,o
216,0211-699501013259,175,o
216,0211-699501013259,224,o
216,0211-699501013259,p,o
216,0211-699501013259,005,o
216,0211-699501013259,Han,o
216,0211-699501013259,recibido,o
216,0211-699501013259,suplementacion,i
216,0211-699501013259,durante,o
216,0211-699501013259,12,o
216,0211-699501013259,meses,o
216,0211-699501013259,33,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,pero,o
216,0211-699501013259,a,o
216,0211-699501013259,pesar,o
216,0211-699501013259,de,o
216,0211-699501013259,un,o
216,0211-699501013259,continuo,o
216,0211-699501013259,aumento,o
216,0211-699501013259,del,o
216,0211-699501013259,folato,i
216,0211-699501013259,10078,o
216,0211-699501013259,IC,o
216,0211-699501013259,7481,o
216,0211-699501013259,12674,o
216,0211-699501013259,p,o
216,0211-699501013259,0001,o
216,0211-699501013259,solo,o
216,0211-699501013259,3,o
216,0211-699501013259,pacientes,o
216,0211-699501013259,presentan,o
216,0211-699501013259,niveles,o
216,0211-699501013259,normales,o
216,0211-699501013259,de,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,correlacionandose,o
216,0211-699501013259,directamente,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,con,o
216,0211-699501013259,la,o
216,0211-699501013259,albumina,i
216,0211-699501013259,r,o
216,0211-699501013259,056,o
216,0211-699501013259,p,o
216,0211-699501013259,0001,o
216,0211-699501013259,que,o
216,0211-699501013259,se,o
216,0211-699501013259,elevo,o
216,0211-699501013259,con,o
216,0211-699501013259,respecto,o
216,0211-699501013259,al,o
216,0211-699501013259,inicio,o
216,0211-699501013259,337,o
216,0211-699501013259,IC,o
216,0211-699501013259,327,o
216,0211-699501013259,346,o
216,0211-699501013259,vs,o
216,0211-699501013259,350,o
216,0211-699501013259,IC,o
216,0211-699501013259,337,o
216,0211-699501013259,363,o
216,0211-699501013259,p,o
216,0211-699501013259,005,o
216,0211-699501013259,Conclusion,o
216,0211-699501013259,Tras,o
216,0211-699501013259,suplementacion,i
216,0211-699501013259,con,o
216,0211-699501013259,acido,i
216,0211-699501013259,folico,i
216,0211-699501013259,y,o
216,0211-699501013259,vitamina,i
216,0211-699501013259,B6,i
216,0211-699501013259,aunque,o
216,0211-699501013259,inicialmente,o
216,0211-699501013259,se,o
216,0211-699501013259,reduce,o
216,0211-699501013259,la,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,esta,o
216,0211-699501013259,respuesta,o
216,0211-699501013259,se,o
216,0211-699501013259,hace,o
216,0211-699501013259,refractaria,o
216,0211-699501013259,correlacionandose,o
216,0211-699501013259,directamente,o
216,0211-699501013259,la,o
216,0211-699501013259,tHcy,i
216,0211-699501013259,con,o
216,0211-699501013259,la,o
216,0211-699501013259,albumina,i
216,0211-699501013259,plasmatica,i
216,0211-699501013259,La,o
216,0211-699501013259,interpretacion,o
216,0211-699501013259,de,o
216,0211-699501013259,los,o
216,0211-699501013259,niveles,i
216,0211-699501013259,de,i
216,0211-699501013259,tHcy,i
216,0211-699501013259,debe,o
216,0211-699501013259,tener,o
216,0211-699501013259,en,o
216,0211-699501013259,cuenta,o
216,0211-699501013259,la,o
216,0211-699501013259,concentracion,i
216,0211-699501013259,de,i
216,0211-699501013259,albumina,i
217,0211-699501013259,Efecto,o
217,0211-699501013259,de,o
217,0211-699501013259,la,o
217,0211-699501013259,suplementacion,i
217,0211-699501013259,con,o
217,0211-699501013259,acido,i
217,0211-699501013259,folico,i
217,0211-699501013259,sobre,o
217,0211-699501013259,los,o
217,0211-699501013259,niveles,i
217,0211-699501013259,de,i
217,0211-699501013259,homocisteina,i
217,0211-699501013259,total,o
217,0211-699501013259,en,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,en,o
217,0211-699501013259,hemodialisis,i
217,0211-699501013259,La,o
217,0211-699501013259,hiperhomocisteinemia,i
217,0211-699501013259,es,o
217,0211-699501013259,un,o
217,0211-699501013259,marcador,o
217,0211-699501013259,de,o
217,0211-699501013259,riesgo,o
217,0211-699501013259,independiente,o
217,0211-699501013259,de,o
217,0211-699501013259,morbimortalidad,o
217,0211-699501013259,cardiovascular,i
217,0211-699501013259,Hemos,o
217,0211-699501013259,intentado,o
217,0211-699501013259,prospectivamente,o
217,0211-699501013259,reducir,o
217,0211-699501013259,los,o
217,0211-699501013259,niveles,i
217,0211-699501013259,de,i
217,0211-699501013259,homocisteina,i
217,0211-699501013259,total,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,mediante,o
217,0211-699501013259,suplemento,o
217,0211-699501013259,con,o
217,0211-699501013259,acido,i
217,0211-699501013259,folico,i
217,0211-699501013259,y,o
217,0211-699501013259,vitamina,i
217,0211-699501013259,B6,i
217,0211-699501013259,pp,i
217,0211-699501013259,valorando,o
217,0211-699501013259,su,o
217,0211-699501013259,posible,o
217,0211-699501013259,correlacion,o
217,0211-699501013259,con,o
217,0211-699501013259,dosis,o
217,0211-699501013259,de,o
217,0211-699501013259,dialisis,i
217,0211-699501013259,funcion,i
217,0211-699501013259,residual,i
217,0211-699501013259,y,o
217,0211-699501013259,parametros,o
217,0211-699501013259,nutricionales,o
217,0211-699501013259,Metodos,o
217,0211-699501013259,Todos,o
217,0211-699501013259,los,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,en,o
217,0211-699501013259,hemodialisis,i
217,0211-699501013259,al,o
217,0211-699501013259,comienzo,o
217,0211-699501013259,del,o
217,0211-699501013259,estudio,o
217,0211-699501013259,que,o
217,0211-699501013259,no,o
217,0211-699501013259,recibian,o
217,0211-699501013259,acido,i
217,0211-699501013259,folico,i
217,0211-699501013259,ni,o
217,0211-699501013259,vitamina,i
217,0211-699501013259,B6,i
217,0211-699501013259,asi,o
217,0211-699501013259,como,o
217,0211-699501013259,los,o
217,0211-699501013259,incorporados,o
217,0211-699501013259,posteriormente,o
217,0211-699501013259,a,o
217,0211-699501013259,partir,o
217,0211-699501013259,de,o
217,0211-699501013259,su,o
217,0211-699501013259,tercer,o
217,0211-699501013259,mes,o
217,0211-699501013259,en,o
217,0211-699501013259,hemodialisis,i
217,0211-699501013259,recibieron,o
217,0211-699501013259,5,o
217,0211-699501013259,mg,o
217,0211-699501013259,orales,o
217,0211-699501013259,de,o
217,0211-699501013259,acido,i
217,0211-699501013259,folico,i
217,0211-699501013259,cada,o
217,0211-699501013259,48,o
217,0211-699501013259,horas,o
217,0211-699501013259,y,o
217,0211-699501013259,40,o
217,0211-699501013259,mg,o
217,0211-699501013259,orales,o
217,0211-699501013259,de,o
217,0211-699501013259,vitamina,i
217,0211-699501013259,B6,i
217,0211-699501013259,cada,o
217,0211-699501013259,semana,o
217,0211-699501013259,Se,o
217,0211-699501013259,determinaron,o
217,0211-699501013259,al,o
217,0211-699501013259,comienzo,o
217,0211-699501013259,del,o
217,0211-699501013259,estudio,o
217,0211-699501013259,y,o
217,0211-699501013259,cada,o
217,0211-699501013259,2,o
217,0211-699501013259,meses,o
217,0211-699501013259,niveles,i
217,0211-699501013259,de,i
217,0211-699501013259,folato,i
217,0211-699501013259,vitamina,i
217,0211-699501013259,B12,i
217,0211-699501013259,inmunoensayo,i
217,0211-699501013259,albumina,i
217,0211-699501013259,y,o
217,0211-699501013259,cinetica,o
217,0211-699501013259,de,o
217,0211-699501013259,la,o
217,0211-699501013259,urea,i
217,0211-699501013259,KTV,o
217,0211-699501013259,KRU,o
217,0211-699501013259,PCRn,o
217,0211-699501013259,y,o
217,0211-699501013259,cada,o
217,0211-699501013259,6,o
217,0211-699501013259,meses,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,HPLC,i
217,0211-699501013259,y,o
217,0211-699501013259,pp,i
217,0211-699501013259,RIA,i
217,0211-699501013259,Resultados,o
217,0211-699501013259,80,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,fueron,o
217,0211-699501013259,incluidos,o
217,0211-699501013259,en,o
217,0211-699501013259,el,o
217,0211-699501013259,estudio,o
217,0211-699501013259,basal,o
217,0211-699501013259,con,o
217,0211-699501013259,una,o
217,0211-699501013259,prevalencia,o
217,0211-699501013259,de,o
217,0211-699501013259,hiperhomocisteinemia,i
217,0211-699501013259,del,o
217,0211-699501013259,844,o
217,0211-699501013259,deficit,i
217,0211-699501013259,de,i
217,0211-699501013259,pp,i
217,0211-699501013259,en,o
217,0211-699501013259,el,o
217,0211-699501013259,32,o
217,0211-699501013259,y,o
217,0211-699501013259,folato,i
217,0211-699501013259,en,o
217,0211-699501013259,el,o
217,0211-699501013259,rango,o
217,0211-699501013259,normal,o
217,0211-699501013259,bajo,o
217,0211-699501013259,los,o
217,0211-699501013259,niveles,i
217,0211-699501013259,de,i
217,0211-699501013259,tHcy,i
217,0211-699501013259,se,o
217,0211-699501013259,correlacionaban,o
217,0211-699501013259,inversamente,o
217,0211-699501013259,con,o
217,0211-699501013259,los,o
217,0211-699501013259,del,o
217,0211-699501013259,folato,i
217,0211-699501013259,r,o
217,0211-699501013259,0336,o
217,0211-699501013259,p,o
217,0211-699501013259,001,o
217,0211-699501013259,pero,o
217,0211-699501013259,no,o
217,0211-699501013259,con,o
217,0211-699501013259,pp,i
217,0211-699501013259,B12,i
217,0211-699501013259,edad,o
217,0211-699501013259,albumina,i
217,0211-699501013259,KTV,o
217,0211-699501013259,KRU,o
217,0211-699501013259,PCRn,o
217,0211-699501013259,Cincuenta,o
217,0211-699501013259,y,o
217,0211-699501013259,ocho,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,recibieron,o
217,0211-699501013259,seis,o
217,0211-699501013259,meses,o
217,0211-699501013259,de,o
217,0211-699501013259,suplementacion,i
217,0211-699501013259,con,o
217,0211-699501013259,normalizacion,o
217,0211-699501013259,del,o
217,0211-699501013259,pp,i
217,0211-699501013259,aumento,o
217,0211-699501013259,del,o
217,0211-699501013259,folato,i
217,0211-699501013259,703,o
217,0211-699501013259,IC,o
217,0211-699501013259,638,o
217,0211-699501013259,795,o
217,0211-699501013259,vs,o
217,0211-699501013259,6181,o
217,0211-699501013259,IC,o
217,0211-699501013259,4447,o
217,0211-699501013259,7811,o
217,0211-699501013259,p,o
217,0211-699501013259,0001,o
217,0211-699501013259,y,o
217,0211-699501013259,descenso,o
217,0211-699501013259,de,o
217,0211-699501013259,la,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,240,o
217,0211-699501013259,IC,o
217,0211-699501013259,213,o
217,0211-699501013259,264,o
217,0211-699501013259,vs,o
217,0211-699501013259,199,o
217,0211-699501013259,IC,o
217,0211-699501013259,175,o
217,0211-699501013259,224,o
217,0211-699501013259,p,o
217,0211-699501013259,005,o
217,0211-699501013259,Han,o
217,0211-699501013259,recibido,o
217,0211-699501013259,suplementacion,i
217,0211-699501013259,durante,o
217,0211-699501013259,12,o
217,0211-699501013259,meses,o
217,0211-699501013259,33,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,pero,o
217,0211-699501013259,a,o
217,0211-699501013259,pesar,o
217,0211-699501013259,de,o
217,0211-699501013259,un,o
217,0211-699501013259,continuo,o
217,0211-699501013259,aumento,o
217,0211-699501013259,del,o
217,0211-699501013259,folato,i
217,0211-699501013259,10078,o
217,0211-699501013259,IC,o
217,0211-699501013259,7481,o
217,0211-699501013259,12674,o
217,0211-699501013259,p,o
217,0211-699501013259,0001,o
217,0211-699501013259,solo,o
217,0211-699501013259,3,o
217,0211-699501013259,pacientes,o
217,0211-699501013259,presentan,o
217,0211-699501013259,niveles,o
217,0211-699501013259,normales,o
217,0211-699501013259,de,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,correlacionandose,o
217,0211-699501013259,directamente,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,con,o
217,0211-699501013259,la,o
217,0211-699501013259,albumina,i
217,0211-699501013259,r,o
217,0211-699501013259,056,o
217,0211-699501013259,p,o
217,0211-699501013259,0001,o
217,0211-699501013259,que,o
217,0211-699501013259,se,o
217,0211-699501013259,elevo,o
217,0211-699501013259,con,o
217,0211-699501013259,respecto,o
217,0211-699501013259,al,o
217,0211-699501013259,inicio,o
217,0211-699501013259,337,o
217,0211-699501013259,IC,o
217,0211-699501013259,327,o
217,0211-699501013259,346,o
217,0211-699501013259,vs,o
217,0211-699501013259,350,o
217,0211-699501013259,IC,o
217,0211-699501013259,337,o
217,0211-699501013259,363,o
217,0211-699501013259,p,o
217,0211-699501013259,005,o
217,0211-699501013259,Conclusion,o
217,0211-699501013259,Tras,o
217,0211-699501013259,suplementacion,i
217,0211-699501013259,con,o
217,0211-699501013259,acido,i
217,0211-699501013259,folico,i
217,0211-699501013259,y,o
217,0211-699501013259,vitamina,i
217,0211-699501013259,B6,i
217,0211-699501013259,aunque,o
217,0211-699501013259,inicialmente,o
217,0211-699501013259,se,o
217,0211-699501013259,reduce,o
217,0211-699501013259,la,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,esta,o
217,0211-699501013259,respuesta,o
217,0211-699501013259,se,o
217,0211-699501013259,hace,o
217,0211-699501013259,refractaria,o
217,0211-699501013259,correlacionandose,o
217,0211-699501013259,directamente,o
217,0211-699501013259,la,o
217,0211-699501013259,tHcy,i
217,0211-699501013259,con,o
217,0211-699501013259,la,o
217,0211-699501013259,albumina,i
217,0211-699501013259,plasmatica,i
217,0211-699501013259,La,o
217,0211-699501013259,interpretacion,o
217,0211-699501013259,de,o
217,0211-699501013259,los,o
217,0211-699501013259,niveles,i
217,0211-699501013259,de,i
217,0211-699501013259,tHcy,i
217,0211-699501013259,debe,o
217,0211-699501013259,tener,o
217,0211-699501013259,en,o
217,0211-699501013259,cuenta,o
217,0211-699501013259,la,o
217,0211-699501013259,concentracion,i
217,0211-699501013259,de,i
217,0211-699501013259,albumina,i
218,0211-699501013259,Efecto,o
218,0211-699501013259,de,o
218,0211-699501013259,la,o
218,0211-699501013259,suplementacion,i
218,0211-699501013259,con,o
218,0211-699501013259,acido,i
218,0211-699501013259,folico,i
218,0211-699501013259,sobre,o
218,0211-699501013259,los,o
218,0211-699501013259,niveles,i
218,0211-699501013259,de,i
218,0211-699501013259,homocisteina,i
218,0211-699501013259,total,o
218,0211-699501013259,en,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,en,o
218,0211-699501013259,hemodialisis,i
218,0211-699501013259,La,o
218,0211-699501013259,hiperhomocisteinemia,i
218,0211-699501013259,es,o
218,0211-699501013259,un,o
218,0211-699501013259,marcador,o
218,0211-699501013259,de,o
218,0211-699501013259,riesgo,o
218,0211-699501013259,independiente,o
218,0211-699501013259,de,o
218,0211-699501013259,morbimortalidad,o
218,0211-699501013259,cardiovascular,i
218,0211-699501013259,Hemos,o
218,0211-699501013259,intentado,o
218,0211-699501013259,prospectivamente,o
218,0211-699501013259,reducir,o
218,0211-699501013259,los,o
218,0211-699501013259,niveles,i
218,0211-699501013259,de,i
218,0211-699501013259,homocisteina,i
218,0211-699501013259,total,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,mediante,o
218,0211-699501013259,suplemento,o
218,0211-699501013259,con,o
218,0211-699501013259,acido,i
218,0211-699501013259,folico,i
218,0211-699501013259,y,o
218,0211-699501013259,vitamina,i
218,0211-699501013259,B6,i
218,0211-699501013259,pp,i
218,0211-699501013259,valorando,o
218,0211-699501013259,su,o
218,0211-699501013259,posible,o
218,0211-699501013259,correlacion,o
218,0211-699501013259,con,o
218,0211-699501013259,dosis,o
218,0211-699501013259,de,o
218,0211-699501013259,dialisis,i
218,0211-699501013259,funcion,i
218,0211-699501013259,residual,i
218,0211-699501013259,y,o
218,0211-699501013259,parametros,o
218,0211-699501013259,nutricionales,o
218,0211-699501013259,Metodos,o
218,0211-699501013259,Todos,o
218,0211-699501013259,los,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,en,o
218,0211-699501013259,hemodialisis,i
218,0211-699501013259,al,o
218,0211-699501013259,comienzo,o
218,0211-699501013259,del,o
218,0211-699501013259,estudio,o
218,0211-699501013259,que,o
218,0211-699501013259,no,o
218,0211-699501013259,recibian,o
218,0211-699501013259,acido,i
218,0211-699501013259,folico,i
218,0211-699501013259,ni,o
218,0211-699501013259,vitamina,i
218,0211-699501013259,B6,i
218,0211-699501013259,asi,o
218,0211-699501013259,como,o
218,0211-699501013259,los,o
218,0211-699501013259,incorporados,o
218,0211-699501013259,posteriormente,o
218,0211-699501013259,a,o
218,0211-699501013259,partir,o
218,0211-699501013259,de,o
218,0211-699501013259,su,o
218,0211-699501013259,tercer,o
218,0211-699501013259,mes,o
218,0211-699501013259,en,o
218,0211-699501013259,hemodialisis,i
218,0211-699501013259,recibieron,o
218,0211-699501013259,5,o
218,0211-699501013259,mg,o
218,0211-699501013259,orales,o
218,0211-699501013259,de,o
218,0211-699501013259,acido,i
218,0211-699501013259,folico,i
218,0211-699501013259,cada,o
218,0211-699501013259,48,o
218,0211-699501013259,horas,o
218,0211-699501013259,y,o
218,0211-699501013259,40,o
218,0211-699501013259,mg,o
218,0211-699501013259,orales,o
218,0211-699501013259,de,o
218,0211-699501013259,vitamina,i
218,0211-699501013259,B6,i
218,0211-699501013259,cada,o
218,0211-699501013259,semana,o
218,0211-699501013259,Se,o
218,0211-699501013259,determinaron,o
218,0211-699501013259,al,o
218,0211-699501013259,comienzo,o
218,0211-699501013259,del,o
218,0211-699501013259,estudio,o
218,0211-699501013259,y,o
218,0211-699501013259,cada,o
218,0211-699501013259,2,o
218,0211-699501013259,meses,o
218,0211-699501013259,niveles,i
218,0211-699501013259,de,i
218,0211-699501013259,folato,i
218,0211-699501013259,vitamina,i
218,0211-699501013259,B12,i
218,0211-699501013259,inmunoensayo,i
218,0211-699501013259,albumina,i
218,0211-699501013259,y,o
218,0211-699501013259,cinetica,o
218,0211-699501013259,de,o
218,0211-699501013259,la,o
218,0211-699501013259,urea,i
218,0211-699501013259,KTV,o
218,0211-699501013259,KRU,o
218,0211-699501013259,PCRn,o
218,0211-699501013259,y,o
218,0211-699501013259,cada,o
218,0211-699501013259,6,o
218,0211-699501013259,meses,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,HPLC,i
218,0211-699501013259,y,o
218,0211-699501013259,pp,i
218,0211-699501013259,RIA,i
218,0211-699501013259,Resultados,o
218,0211-699501013259,80,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,fueron,o
218,0211-699501013259,incluidos,o
218,0211-699501013259,en,o
218,0211-699501013259,el,o
218,0211-699501013259,estudio,o
218,0211-699501013259,basal,o
218,0211-699501013259,con,o
218,0211-699501013259,una,o
218,0211-699501013259,prevalencia,o
218,0211-699501013259,de,o
218,0211-699501013259,hiperhomocisteinemia,i
218,0211-699501013259,del,o
218,0211-699501013259,844,o
218,0211-699501013259,deficit,i
218,0211-699501013259,de,i
218,0211-699501013259,pp,i
218,0211-699501013259,en,o
218,0211-699501013259,el,o
218,0211-699501013259,32,o
218,0211-699501013259,y,o
218,0211-699501013259,folato,i
218,0211-699501013259,en,o
218,0211-699501013259,el,o
218,0211-699501013259,rango,o
218,0211-699501013259,normal,o
218,0211-699501013259,bajo,o
218,0211-699501013259,los,o
218,0211-699501013259,niveles,i
218,0211-699501013259,de,i
218,0211-699501013259,tHcy,i
218,0211-699501013259,se,o
218,0211-699501013259,correlacionaban,o
218,0211-699501013259,inversamente,o
218,0211-699501013259,con,o
218,0211-699501013259,los,o
218,0211-699501013259,del,o
218,0211-699501013259,folato,i
218,0211-699501013259,r,o
218,0211-699501013259,0336,o
218,0211-699501013259,p,o
218,0211-699501013259,001,o
218,0211-699501013259,pero,o
218,0211-699501013259,no,o
218,0211-699501013259,con,o
218,0211-699501013259,pp,i
218,0211-699501013259,B12,i
218,0211-699501013259,edad,o
218,0211-699501013259,albumina,i
218,0211-699501013259,KTV,o
218,0211-699501013259,KRU,o
218,0211-699501013259,PCRn,o
218,0211-699501013259,Cincuenta,o
218,0211-699501013259,y,o
218,0211-699501013259,ocho,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,recibieron,o
218,0211-699501013259,seis,o
218,0211-699501013259,meses,o
218,0211-699501013259,de,o
218,0211-699501013259,suplementacion,i
218,0211-699501013259,con,o
218,0211-699501013259,normalizacion,o
218,0211-699501013259,del,o
218,0211-699501013259,pp,i
218,0211-699501013259,aumento,o
218,0211-699501013259,del,o
218,0211-699501013259,folato,i
218,0211-699501013259,703,o
218,0211-699501013259,IC,o
218,0211-699501013259,638,o
218,0211-699501013259,795,o
218,0211-699501013259,vs,o
218,0211-699501013259,6181,o
218,0211-699501013259,IC,o
218,0211-699501013259,4447,o
218,0211-699501013259,7811,o
218,0211-699501013259,p,o
218,0211-699501013259,0001,o
218,0211-699501013259,y,o
218,0211-699501013259,descenso,o
218,0211-699501013259,de,o
218,0211-699501013259,la,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,240,o
218,0211-699501013259,IC,o
218,0211-699501013259,213,o
218,0211-699501013259,264,o
218,0211-699501013259,vs,o
218,0211-699501013259,199,o
218,0211-699501013259,IC,o
218,0211-699501013259,175,o
218,0211-699501013259,224,o
218,0211-699501013259,p,o
218,0211-699501013259,005,o
218,0211-699501013259,Han,o
218,0211-699501013259,recibido,o
218,0211-699501013259,suplementacion,i
218,0211-699501013259,durante,o
218,0211-699501013259,12,o
218,0211-699501013259,meses,o
218,0211-699501013259,33,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,pero,o
218,0211-699501013259,a,o
218,0211-699501013259,pesar,o
218,0211-699501013259,de,o
218,0211-699501013259,un,o
218,0211-699501013259,continuo,o
218,0211-699501013259,aumento,o
218,0211-699501013259,del,o
218,0211-699501013259,folato,i
218,0211-699501013259,10078,o
218,0211-699501013259,IC,o
218,0211-699501013259,7481,o
218,0211-699501013259,12674,o
218,0211-699501013259,p,o
218,0211-699501013259,0001,o
218,0211-699501013259,solo,o
218,0211-699501013259,3,o
218,0211-699501013259,pacientes,o
218,0211-699501013259,presentan,o
218,0211-699501013259,niveles,o
218,0211-699501013259,normales,o
218,0211-699501013259,de,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,correlacionandose,o
218,0211-699501013259,directamente,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,con,o
218,0211-699501013259,la,o
218,0211-699501013259,albumina,i
218,0211-699501013259,r,o
218,0211-699501013259,056,o
218,0211-699501013259,p,o
218,0211-699501013259,0001,o
218,0211-699501013259,que,o
218,0211-699501013259,se,o
218,0211-699501013259,elevo,o
218,0211-699501013259,con,o
218,0211-699501013259,respecto,o
218,0211-699501013259,al,o
218,0211-699501013259,inicio,o
218,0211-699501013259,337,o
218,0211-699501013259,IC,o
218,0211-699501013259,327,o
218,0211-699501013259,346,o
218,0211-699501013259,vs,o
218,0211-699501013259,350,o
218,0211-699501013259,IC,o
218,0211-699501013259,337,o
218,0211-699501013259,363,o
218,0211-699501013259,p,o
218,0211-699501013259,005,o
218,0211-699501013259,Conclusion,o
218,0211-699501013259,Tras,o
218,0211-699501013259,suplementacion,i
218,0211-699501013259,con,o
218,0211-699501013259,acido,i
218,0211-699501013259,folico,i
218,0211-699501013259,y,o
218,0211-699501013259,vitamina,i
218,0211-699501013259,B6,i
218,0211-699501013259,aunque,o
218,0211-699501013259,inicialmente,o
218,0211-699501013259,se,o
218,0211-699501013259,reduce,o
218,0211-699501013259,la,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,esta,o
218,0211-699501013259,respuesta,o
218,0211-699501013259,se,o
218,0211-699501013259,hace,o
218,0211-699501013259,refractaria,o
218,0211-699501013259,correlacionandose,o
218,0211-699501013259,directamente,o
218,0211-699501013259,la,o
218,0211-699501013259,tHcy,i
218,0211-699501013259,con,o
218,0211-699501013259,la,o
218,0211-699501013259,albumina,i
218,0211-699501013259,plasmatica,i
218,0211-699501013259,La,o
218,0211-699501013259,interpretacion,o
218,0211-699501013259,de,o
218,0211-699501013259,los,o
218,0211-699501013259,niveles,i
218,0211-699501013259,de,i
218,0211-699501013259,tHcy,i
218,0211-699501013259,debe,o
218,0211-699501013259,tener,o
218,0211-699501013259,en,o
218,0211-699501013259,cuenta,o
218,0211-699501013259,la,o
218,0211-699501013259,concentracion,i
218,0211-699501013259,de,i
218,0211-699501013259,albumina,i
219,0211-699501013259,Efecto,o
219,0211-699501013259,de,o
219,0211-699501013259,la,o
219,0211-699501013259,suplementacion,i
219,0211-699501013259,con,o
219,0211-699501013259,acido,i
219,0211-699501013259,folico,i
219,0211-699501013259,sobre,o
219,0211-699501013259,los,o
219,0211-699501013259,niveles,i
219,0211-699501013259,de,i
219,0211-699501013259,homocisteina,i
219,0211-699501013259,total,o
219,0211-699501013259,en,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,en,o
219,0211-699501013259,hemodialisis,i
219,0211-699501013259,La,o
219,0211-699501013259,hiperhomocisteinemia,i
219,0211-699501013259,es,o
219,0211-699501013259,un,o
219,0211-699501013259,marcador,o
219,0211-699501013259,de,o
219,0211-699501013259,riesgo,o
219,0211-699501013259,independiente,o
219,0211-699501013259,de,o
219,0211-699501013259,morbimortalidad,o
219,0211-699501013259,cardiovascular,i
219,0211-699501013259,Hemos,o
219,0211-699501013259,intentado,o
219,0211-699501013259,prospectivamente,o
219,0211-699501013259,reducir,o
219,0211-699501013259,los,o
219,0211-699501013259,niveles,i
219,0211-699501013259,de,i
219,0211-699501013259,homocisteina,i
219,0211-699501013259,total,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,mediante,o
219,0211-699501013259,suplemento,o
219,0211-699501013259,con,o
219,0211-699501013259,acido,i
219,0211-699501013259,folico,i
219,0211-699501013259,y,o
219,0211-699501013259,vitamina,i
219,0211-699501013259,B6,i
219,0211-699501013259,pp,i
219,0211-699501013259,valorando,o
219,0211-699501013259,su,o
219,0211-699501013259,posible,o
219,0211-699501013259,correlacion,o
219,0211-699501013259,con,o
219,0211-699501013259,dosis,o
219,0211-699501013259,de,o
219,0211-699501013259,dialisis,i
219,0211-699501013259,funcion,i
219,0211-699501013259,residual,i
219,0211-699501013259,y,o
219,0211-699501013259,parametros,o
219,0211-699501013259,nutricionales,o
219,0211-699501013259,Metodos,o
219,0211-699501013259,Todos,o
219,0211-699501013259,los,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,en,o
219,0211-699501013259,hemodialisis,i
219,0211-699501013259,al,o
219,0211-699501013259,comienzo,o
219,0211-699501013259,del,o
219,0211-699501013259,estudio,o
219,0211-699501013259,que,o
219,0211-699501013259,no,o
219,0211-699501013259,recibian,o
219,0211-699501013259,acido,i
219,0211-699501013259,folico,i
219,0211-699501013259,ni,o
219,0211-699501013259,vitamina,i
219,0211-699501013259,B6,i
219,0211-699501013259,asi,o
219,0211-699501013259,como,o
219,0211-699501013259,los,o
219,0211-699501013259,incorporados,o
219,0211-699501013259,posteriormente,o
219,0211-699501013259,a,o
219,0211-699501013259,partir,o
219,0211-699501013259,de,o
219,0211-699501013259,su,o
219,0211-699501013259,tercer,o
219,0211-699501013259,mes,o
219,0211-699501013259,en,o
219,0211-699501013259,hemodialisis,i
219,0211-699501013259,recibieron,o
219,0211-699501013259,5,o
219,0211-699501013259,mg,o
219,0211-699501013259,orales,o
219,0211-699501013259,de,o
219,0211-699501013259,acido,i
219,0211-699501013259,folico,i
219,0211-699501013259,cada,o
219,0211-699501013259,48,o
219,0211-699501013259,horas,o
219,0211-699501013259,y,o
219,0211-699501013259,40,o
219,0211-699501013259,mg,o
219,0211-699501013259,orales,o
219,0211-699501013259,de,o
219,0211-699501013259,vitamina,i
219,0211-699501013259,B6,i
219,0211-699501013259,cada,o
219,0211-699501013259,semana,o
219,0211-699501013259,Se,o
219,0211-699501013259,determinaron,o
219,0211-699501013259,al,o
219,0211-699501013259,comienzo,o
219,0211-699501013259,del,o
219,0211-699501013259,estudio,o
219,0211-699501013259,y,o
219,0211-699501013259,cada,o
219,0211-699501013259,2,o
219,0211-699501013259,meses,o
219,0211-699501013259,niveles,i
219,0211-699501013259,de,i
219,0211-699501013259,folato,i
219,0211-699501013259,vitamina,i
219,0211-699501013259,B12,i
219,0211-699501013259,inmunoensayo,i
219,0211-699501013259,albumina,i
219,0211-699501013259,y,o
219,0211-699501013259,cinetica,o
219,0211-699501013259,de,o
219,0211-699501013259,la,o
219,0211-699501013259,urea,i
219,0211-699501013259,KTV,o
219,0211-699501013259,KRU,o
219,0211-699501013259,PCRn,o
219,0211-699501013259,y,o
219,0211-699501013259,cada,o
219,0211-699501013259,6,o
219,0211-699501013259,meses,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,HPLC,i
219,0211-699501013259,y,o
219,0211-699501013259,pp,i
219,0211-699501013259,RIA,i
219,0211-699501013259,Resultados,o
219,0211-699501013259,80,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,fueron,o
219,0211-699501013259,incluidos,o
219,0211-699501013259,en,o
219,0211-699501013259,el,o
219,0211-699501013259,estudio,o
219,0211-699501013259,basal,o
219,0211-699501013259,con,o
219,0211-699501013259,una,o
219,0211-699501013259,prevalencia,o
219,0211-699501013259,de,o
219,0211-699501013259,hiperhomocisteinemia,i
219,0211-699501013259,del,o
219,0211-699501013259,844,o
219,0211-699501013259,deficit,i
219,0211-699501013259,de,i
219,0211-699501013259,pp,i
219,0211-699501013259,en,o
219,0211-699501013259,el,o
219,0211-699501013259,32,o
219,0211-699501013259,y,o
219,0211-699501013259,folato,i
219,0211-699501013259,en,o
219,0211-699501013259,el,o
219,0211-699501013259,rango,o
219,0211-699501013259,normal,o
219,0211-699501013259,bajo,o
219,0211-699501013259,los,o
219,0211-699501013259,niveles,i
219,0211-699501013259,de,i
219,0211-699501013259,tHcy,i
219,0211-699501013259,se,o
219,0211-699501013259,correlacionaban,o
219,0211-699501013259,inversamente,o
219,0211-699501013259,con,o
219,0211-699501013259,los,o
219,0211-699501013259,del,o
219,0211-699501013259,folato,i
219,0211-699501013259,r,o
219,0211-699501013259,0336,o
219,0211-699501013259,p,o
219,0211-699501013259,001,o
219,0211-699501013259,pero,o
219,0211-699501013259,no,o
219,0211-699501013259,con,o
219,0211-699501013259,pp,i
219,0211-699501013259,B12,i
219,0211-699501013259,edad,o
219,0211-699501013259,albumina,i
219,0211-699501013259,KTV,o
219,0211-699501013259,KRU,o
219,0211-699501013259,PCRn,o
219,0211-699501013259,Cincuenta,o
219,0211-699501013259,y,o
219,0211-699501013259,ocho,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,recibieron,o
219,0211-699501013259,seis,o
219,0211-699501013259,meses,o
219,0211-699501013259,de,o
219,0211-699501013259,suplementacion,i
219,0211-699501013259,con,o
219,0211-699501013259,normalizacion,o
219,0211-699501013259,del,o
219,0211-699501013259,pp,i
219,0211-699501013259,aumento,o
219,0211-699501013259,del,o
219,0211-699501013259,folato,i
219,0211-699501013259,703,o
219,0211-699501013259,IC,o
219,0211-699501013259,638,o
219,0211-699501013259,795,o
219,0211-699501013259,vs,o
219,0211-699501013259,6181,o
219,0211-699501013259,IC,o
219,0211-699501013259,4447,o
219,0211-699501013259,7811,o
219,0211-699501013259,p,o
219,0211-699501013259,0001,o
219,0211-699501013259,y,o
219,0211-699501013259,descenso,o
219,0211-699501013259,de,o
219,0211-699501013259,la,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,240,o
219,0211-699501013259,IC,o
219,0211-699501013259,213,o
219,0211-699501013259,264,o
219,0211-699501013259,vs,o
219,0211-699501013259,199,o
219,0211-699501013259,IC,o
219,0211-699501013259,175,o
219,0211-699501013259,224,o
219,0211-699501013259,p,o
219,0211-699501013259,005,o
219,0211-699501013259,Han,o
219,0211-699501013259,recibido,o
219,0211-699501013259,suplementacion,i
219,0211-699501013259,durante,o
219,0211-699501013259,12,o
219,0211-699501013259,meses,o
219,0211-699501013259,33,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,pero,o
219,0211-699501013259,a,o
219,0211-699501013259,pesar,o
219,0211-699501013259,de,o
219,0211-699501013259,un,o
219,0211-699501013259,continuo,o
219,0211-699501013259,aumento,o
219,0211-699501013259,del,o
219,0211-699501013259,folato,i
219,0211-699501013259,10078,o
219,0211-699501013259,IC,o
219,0211-699501013259,7481,o
219,0211-699501013259,12674,o
219,0211-699501013259,p,o
219,0211-699501013259,0001,o
219,0211-699501013259,solo,o
219,0211-699501013259,3,o
219,0211-699501013259,pacientes,o
219,0211-699501013259,presentan,o
219,0211-699501013259,niveles,o
219,0211-699501013259,normales,o
219,0211-699501013259,de,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,correlacionandose,o
219,0211-699501013259,directamente,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,con,o
219,0211-699501013259,la,o
219,0211-699501013259,albumina,i
219,0211-699501013259,r,o
219,0211-699501013259,056,o
219,0211-699501013259,p,o
219,0211-699501013259,0001,o
219,0211-699501013259,que,o
219,0211-699501013259,se,o
219,0211-699501013259,elevo,o
219,0211-699501013259,con,o
219,0211-699501013259,respecto,o
219,0211-699501013259,al,o
219,0211-699501013259,inicio,o
219,0211-699501013259,337,o
219,0211-699501013259,IC,o
219,0211-699501013259,327,o
219,0211-699501013259,346,o
219,0211-699501013259,vs,o
219,0211-699501013259,350,o
219,0211-699501013259,IC,o
219,0211-699501013259,337,o
219,0211-699501013259,363,o
219,0211-699501013259,p,o
219,0211-699501013259,005,o
219,0211-699501013259,Conclusion,o
219,0211-699501013259,Tras,o
219,0211-699501013259,suplementacion,i
219,0211-699501013259,con,o
219,0211-699501013259,acido,i
219,0211-699501013259,folico,i
219,0211-699501013259,y,o
219,0211-699501013259,vitamina,i
219,0211-699501013259,B6,i
219,0211-699501013259,aunque,o
219,0211-699501013259,inicialmente,o
219,0211-699501013259,se,o
219,0211-699501013259,reduce,o
219,0211-699501013259,la,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,esta,o
219,0211-699501013259,respuesta,o
219,0211-699501013259,se,o
219,0211-699501013259,hace,o
219,0211-699501013259,refractaria,o
219,0211-699501013259,correlacionandose,o
219,0211-699501013259,directamente,o
219,0211-699501013259,la,o
219,0211-699501013259,tHcy,i
219,0211-699501013259,con,o
219,0211-699501013259,la,o
219,0211-699501013259,albumina,i
219,0211-699501013259,plasmatica,i
219,0211-699501013259,La,o
219,0211-699501013259,interpretacion,o
219,0211-699501013259,de,o
219,0211-699501013259,los,o
219,0211-699501013259,niveles,i
219,0211-699501013259,de,i
219,0211-699501013259,tHcy,i
219,0211-699501013259,debe,o
219,0211-699501013259,tener,o
219,0211-699501013259,en,o
219,0211-699501013259,cuenta,o
219,0211-699501013259,la,o
219,0211-699501013259,concentracion,i
219,0211-699501013259,de,i
219,0211-699501013259,albumina,i
220,0211-699501013259,Efecto,o
220,0211-699501013259,de,o
220,0211-699501013259,la,o
220,0211-699501013259,suplementacion,i
220,0211-699501013259,con,o
220,0211-699501013259,acido,i
220,0211-699501013259,folico,i
220,0211-699501013259,sobre,o
220,0211-699501013259,los,o
220,0211-699501013259,niveles,i
220,0211-699501013259,de,i
220,0211-699501013259,homocisteina,i
220,0211-699501013259,total,o
220,0211-699501013259,en,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,en,o
220,0211-699501013259,hemodialisis,i
220,0211-699501013259,La,o
220,0211-699501013259,hiperhomocisteinemia,i
220,0211-699501013259,es,o
220,0211-699501013259,un,o
220,0211-699501013259,marcador,o
220,0211-699501013259,de,o
220,0211-699501013259,riesgo,o
220,0211-699501013259,independiente,o
220,0211-699501013259,de,o
220,0211-699501013259,morbimortalidad,o
220,0211-699501013259,cardiovascular,i
220,0211-699501013259,Hemos,o
220,0211-699501013259,intentado,o
220,0211-699501013259,prospectivamente,o
220,0211-699501013259,reducir,o
220,0211-699501013259,los,o
220,0211-699501013259,niveles,i
220,0211-699501013259,de,i
220,0211-699501013259,homocisteina,i
220,0211-699501013259,total,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,mediante,o
220,0211-699501013259,suplemento,o
220,0211-699501013259,con,o
220,0211-699501013259,acido,i
220,0211-699501013259,folico,i
220,0211-699501013259,y,o
220,0211-699501013259,vitamina,i
220,0211-699501013259,B6,i
220,0211-699501013259,pp,i
220,0211-699501013259,valorando,o
220,0211-699501013259,su,o
220,0211-699501013259,posible,o
220,0211-699501013259,correlacion,o
220,0211-699501013259,con,o
220,0211-699501013259,dosis,o
220,0211-699501013259,de,o
220,0211-699501013259,dialisis,i
220,0211-699501013259,funcion,i
220,0211-699501013259,residual,i
220,0211-699501013259,y,o
220,0211-699501013259,parametros,o
220,0211-699501013259,nutricionales,o
220,0211-699501013259,Metodos,o
220,0211-699501013259,Todos,o
220,0211-699501013259,los,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,en,o
220,0211-699501013259,hemodialisis,i
220,0211-699501013259,al,o
220,0211-699501013259,comienzo,o
220,0211-699501013259,del,o
220,0211-699501013259,estudio,o
220,0211-699501013259,que,o
220,0211-699501013259,no,o
220,0211-699501013259,recibian,o
220,0211-699501013259,acido,i
220,0211-699501013259,folico,i
220,0211-699501013259,ni,o
220,0211-699501013259,vitamina,i
220,0211-699501013259,B6,i
220,0211-699501013259,asi,o
220,0211-699501013259,como,o
220,0211-699501013259,los,o
220,0211-699501013259,incorporados,o
220,0211-699501013259,posteriormente,o
220,0211-699501013259,a,o
220,0211-699501013259,partir,o
220,0211-699501013259,de,o
220,0211-699501013259,su,o
220,0211-699501013259,tercer,o
220,0211-699501013259,mes,o
220,0211-699501013259,en,o
220,0211-699501013259,hemodialisis,i
220,0211-699501013259,recibieron,o
220,0211-699501013259,5,o
220,0211-699501013259,mg,o
220,0211-699501013259,orales,o
220,0211-699501013259,de,o
220,0211-699501013259,acido,i
220,0211-699501013259,folico,i
220,0211-699501013259,cada,o
220,0211-699501013259,48,o
220,0211-699501013259,horas,o
220,0211-699501013259,y,o
220,0211-699501013259,40,o
220,0211-699501013259,mg,o
220,0211-699501013259,orales,o
220,0211-699501013259,de,o
220,0211-699501013259,vitamina,i
220,0211-699501013259,B6,i
220,0211-699501013259,cada,o
220,0211-699501013259,semana,o
220,0211-699501013259,Se,o
220,0211-699501013259,determinaron,o
220,0211-699501013259,al,o
220,0211-699501013259,comienzo,o
220,0211-699501013259,del,o
220,0211-699501013259,estudio,o
220,0211-699501013259,y,o
220,0211-699501013259,cada,o
220,0211-699501013259,2,o
220,0211-699501013259,meses,o
220,0211-699501013259,niveles,i
220,0211-699501013259,de,i
220,0211-699501013259,folato,i
220,0211-699501013259,vitamina,i
220,0211-699501013259,B12,i
220,0211-699501013259,inmunoensayo,i
220,0211-699501013259,albumina,i
220,0211-699501013259,y,o
220,0211-699501013259,cinetica,o
220,0211-699501013259,de,o
220,0211-699501013259,la,o
220,0211-699501013259,urea,i
220,0211-699501013259,KTV,o
220,0211-699501013259,KRU,o
220,0211-699501013259,PCRn,o
220,0211-699501013259,y,o
220,0211-699501013259,cada,o
220,0211-699501013259,6,o
220,0211-699501013259,meses,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,HPLC,i
220,0211-699501013259,y,o
220,0211-699501013259,pp,i
220,0211-699501013259,RIA,i
220,0211-699501013259,Resultados,o
220,0211-699501013259,80,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,fueron,o
220,0211-699501013259,incluidos,o
220,0211-699501013259,en,o
220,0211-699501013259,el,o
220,0211-699501013259,estudio,o
220,0211-699501013259,basal,o
220,0211-699501013259,con,o
220,0211-699501013259,una,o
220,0211-699501013259,prevalencia,o
220,0211-699501013259,de,o
220,0211-699501013259,hiperhomocisteinemia,i
220,0211-699501013259,del,o
220,0211-699501013259,844,o
220,0211-699501013259,deficit,i
220,0211-699501013259,de,i
220,0211-699501013259,pp,i
220,0211-699501013259,en,o
220,0211-699501013259,el,o
220,0211-699501013259,32,o
220,0211-699501013259,y,o
220,0211-699501013259,folato,i
220,0211-699501013259,en,o
220,0211-699501013259,el,o
220,0211-699501013259,rango,o
220,0211-699501013259,normal,o
220,0211-699501013259,bajo,o
220,0211-699501013259,los,o
220,0211-699501013259,niveles,i
220,0211-699501013259,de,i
220,0211-699501013259,tHcy,i
220,0211-699501013259,se,o
220,0211-699501013259,correlacionaban,o
220,0211-699501013259,inversamente,o
220,0211-699501013259,con,o
220,0211-699501013259,los,o
220,0211-699501013259,del,o
220,0211-699501013259,folato,i
220,0211-699501013259,r,o
220,0211-699501013259,0336,o
220,0211-699501013259,p,o
220,0211-699501013259,001,o
220,0211-699501013259,pero,o
220,0211-699501013259,no,o
220,0211-699501013259,con,o
220,0211-699501013259,pp,i
220,0211-699501013259,B12,i
220,0211-699501013259,edad,o
220,0211-699501013259,albumina,i
220,0211-699501013259,KTV,o
220,0211-699501013259,KRU,o
220,0211-699501013259,PCRn,o
220,0211-699501013259,Cincuenta,o
220,0211-699501013259,y,o
220,0211-699501013259,ocho,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,recibieron,o
220,0211-699501013259,seis,o
220,0211-699501013259,meses,o
220,0211-699501013259,de,o
220,0211-699501013259,suplementacion,i
220,0211-699501013259,con,o
220,0211-699501013259,normalizacion,o
220,0211-699501013259,del,o
220,0211-699501013259,pp,i
220,0211-699501013259,aumento,o
220,0211-699501013259,del,o
220,0211-699501013259,folato,i
220,0211-699501013259,703,o
220,0211-699501013259,IC,o
220,0211-699501013259,638,o
220,0211-699501013259,795,o
220,0211-699501013259,vs,o
220,0211-699501013259,6181,o
220,0211-699501013259,IC,o
220,0211-699501013259,4447,o
220,0211-699501013259,7811,o
220,0211-699501013259,p,o
220,0211-699501013259,0001,o
220,0211-699501013259,y,o
220,0211-699501013259,descenso,o
220,0211-699501013259,de,o
220,0211-699501013259,la,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,240,o
220,0211-699501013259,IC,o
220,0211-699501013259,213,o
220,0211-699501013259,264,o
220,0211-699501013259,vs,o
220,0211-699501013259,199,o
220,0211-699501013259,IC,o
220,0211-699501013259,175,o
220,0211-699501013259,224,o
220,0211-699501013259,p,o
220,0211-699501013259,005,o
220,0211-699501013259,Han,o
220,0211-699501013259,recibido,o
220,0211-699501013259,suplementacion,i
220,0211-699501013259,durante,o
220,0211-699501013259,12,o
220,0211-699501013259,meses,o
220,0211-699501013259,33,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,pero,o
220,0211-699501013259,a,o
220,0211-699501013259,pesar,o
220,0211-699501013259,de,o
220,0211-699501013259,un,o
220,0211-699501013259,continuo,o
220,0211-699501013259,aumento,o
220,0211-699501013259,del,o
220,0211-699501013259,folato,i
220,0211-699501013259,10078,o
220,0211-699501013259,IC,o
220,0211-699501013259,7481,o
220,0211-699501013259,12674,o
220,0211-699501013259,p,o
220,0211-699501013259,0001,o
220,0211-699501013259,solo,o
220,0211-699501013259,3,o
220,0211-699501013259,pacientes,o
220,0211-699501013259,presentan,o
220,0211-699501013259,niveles,o
220,0211-699501013259,normales,o
220,0211-699501013259,de,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,correlacionandose,o
220,0211-699501013259,directamente,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,con,o
220,0211-699501013259,la,o
220,0211-699501013259,albumina,i
220,0211-699501013259,r,o
220,0211-699501013259,056,o
220,0211-699501013259,p,o
220,0211-699501013259,0001,o
220,0211-699501013259,que,o
220,0211-699501013259,se,o
220,0211-699501013259,elevo,o
220,0211-699501013259,con,o
220,0211-699501013259,respecto,o
220,0211-699501013259,al,o
220,0211-699501013259,inicio,o
220,0211-699501013259,337,o
220,0211-699501013259,IC,o
220,0211-699501013259,327,o
220,0211-699501013259,346,o
220,0211-699501013259,vs,o
220,0211-699501013259,350,o
220,0211-699501013259,IC,o
220,0211-699501013259,337,o
220,0211-699501013259,363,o
220,0211-699501013259,p,o
220,0211-699501013259,005,o
220,0211-699501013259,Conclusion,o
220,0211-699501013259,Tras,o
220,0211-699501013259,suplementacion,i
220,0211-699501013259,con,o
220,0211-699501013259,acido,i
220,0211-699501013259,folico,i
220,0211-699501013259,y,o
220,0211-699501013259,vitamina,i
220,0211-699501013259,B6,i
220,0211-699501013259,aunque,o
220,0211-699501013259,inicialmente,o
220,0211-699501013259,se,o
220,0211-699501013259,reduce,o
220,0211-699501013259,la,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,esta,o
220,0211-699501013259,respuesta,o
220,0211-699501013259,se,o
220,0211-699501013259,hace,o
220,0211-699501013259,refractaria,o
220,0211-699501013259,correlacionandose,o
220,0211-699501013259,directamente,o
220,0211-699501013259,la,o
220,0211-699501013259,tHcy,i
220,0211-699501013259,con,o
220,0211-699501013259,la,o
220,0211-699501013259,albumina,i
220,0211-699501013259,plasmatica,i
220,0211-699501013259,La,o
220,0211-699501013259,interpretacion,o
220,0211-699501013259,de,o
220,0211-699501013259,los,o
220,0211-699501013259,niveles,i
220,0211-699501013259,de,i
220,0211-699501013259,tHcy,i
220,0211-699501013259,debe,o
220,0211-699501013259,tener,o
220,0211-699501013259,en,o
220,0211-699501013259,cuenta,o
220,0211-699501013259,la,o
220,0211-699501013259,concentracion,i
220,0211-699501013259,de,i
220,0211-699501013259,albumina,i
221,0211-699501013259,Efecto,o
221,0211-699501013259,de,o
221,0211-699501013259,la,o
221,0211-699501013259,suplementacion,i
221,0211-699501013259,con,o
221,0211-699501013259,acido,i
221,0211-699501013259,folico,i
221,0211-699501013259,sobre,o
221,0211-699501013259,los,o
221,0211-699501013259,niveles,i
221,0211-699501013259,de,i
221,0211-699501013259,homocisteina,i
221,0211-699501013259,total,o
221,0211-699501013259,en,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,en,o
221,0211-699501013259,hemodialisis,i
221,0211-699501013259,La,o
221,0211-699501013259,hiperhomocisteinemia,i
221,0211-699501013259,es,o
221,0211-699501013259,un,o
221,0211-699501013259,marcador,o
221,0211-699501013259,de,o
221,0211-699501013259,riesgo,o
221,0211-699501013259,independiente,o
221,0211-699501013259,de,o
221,0211-699501013259,morbimortalidad,o
221,0211-699501013259,cardiovascular,i
221,0211-699501013259,Hemos,o
221,0211-699501013259,intentado,o
221,0211-699501013259,prospectivamente,o
221,0211-699501013259,reducir,o
221,0211-699501013259,los,o
221,0211-699501013259,niveles,i
221,0211-699501013259,de,i
221,0211-699501013259,homocisteina,i
221,0211-699501013259,total,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,mediante,o
221,0211-699501013259,suplemento,o
221,0211-699501013259,con,o
221,0211-699501013259,acido,i
221,0211-699501013259,folico,i
221,0211-699501013259,y,o
221,0211-699501013259,vitamina,i
221,0211-699501013259,B6,i
221,0211-699501013259,pp,i
221,0211-699501013259,valorando,o
221,0211-699501013259,su,o
221,0211-699501013259,posible,o
221,0211-699501013259,correlacion,o
221,0211-699501013259,con,o
221,0211-699501013259,dosis,o
221,0211-699501013259,de,o
221,0211-699501013259,dialisis,i
221,0211-699501013259,funcion,i
221,0211-699501013259,residual,i
221,0211-699501013259,y,o
221,0211-699501013259,parametros,o
221,0211-699501013259,nutricionales,o
221,0211-699501013259,Metodos,o
221,0211-699501013259,Todos,o
221,0211-699501013259,los,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,en,o
221,0211-699501013259,hemodialisis,i
221,0211-699501013259,al,o
221,0211-699501013259,comienzo,o
221,0211-699501013259,del,o
221,0211-699501013259,estudio,o
221,0211-699501013259,que,o
221,0211-699501013259,no,o
221,0211-699501013259,recibian,o
221,0211-699501013259,acido,i
221,0211-699501013259,folico,i
221,0211-699501013259,ni,o
221,0211-699501013259,vitamina,i
221,0211-699501013259,B6,i
221,0211-699501013259,asi,o
221,0211-699501013259,como,o
221,0211-699501013259,los,o
221,0211-699501013259,incorporados,o
221,0211-699501013259,posteriormente,o
221,0211-699501013259,a,o
221,0211-699501013259,partir,o
221,0211-699501013259,de,o
221,0211-699501013259,su,o
221,0211-699501013259,tercer,o
221,0211-699501013259,mes,o
221,0211-699501013259,en,o
221,0211-699501013259,hemodialisis,i
221,0211-699501013259,recibieron,o
221,0211-699501013259,5,o
221,0211-699501013259,mg,o
221,0211-699501013259,orales,o
221,0211-699501013259,de,o
221,0211-699501013259,acido,i
221,0211-699501013259,folico,i
221,0211-699501013259,cada,o
221,0211-699501013259,48,o
221,0211-699501013259,horas,o
221,0211-699501013259,y,o
221,0211-699501013259,40,o
221,0211-699501013259,mg,o
221,0211-699501013259,orales,o
221,0211-699501013259,de,o
221,0211-699501013259,vitamina,i
221,0211-699501013259,B6,i
221,0211-699501013259,cada,o
221,0211-699501013259,semana,o
221,0211-699501013259,Se,o
221,0211-699501013259,determinaron,o
221,0211-699501013259,al,o
221,0211-699501013259,comienzo,o
221,0211-699501013259,del,o
221,0211-699501013259,estudio,o
221,0211-699501013259,y,o
221,0211-699501013259,cada,o
221,0211-699501013259,2,o
221,0211-699501013259,meses,o
221,0211-699501013259,niveles,i
221,0211-699501013259,de,i
221,0211-699501013259,folato,i
221,0211-699501013259,vitamina,i
221,0211-699501013259,B12,i
221,0211-699501013259,inmunoensayo,i
221,0211-699501013259,albumina,i
221,0211-699501013259,y,o
221,0211-699501013259,cinetica,o
221,0211-699501013259,de,o
221,0211-699501013259,la,o
221,0211-699501013259,urea,i
221,0211-699501013259,KTV,o
221,0211-699501013259,KRU,o
221,0211-699501013259,PCRn,o
221,0211-699501013259,y,o
221,0211-699501013259,cada,o
221,0211-699501013259,6,o
221,0211-699501013259,meses,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,HPLC,i
221,0211-699501013259,y,o
221,0211-699501013259,pp,i
221,0211-699501013259,RIA,i
221,0211-699501013259,Resultados,o
221,0211-699501013259,80,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,fueron,o
221,0211-699501013259,incluidos,o
221,0211-699501013259,en,o
221,0211-699501013259,el,o
221,0211-699501013259,estudio,o
221,0211-699501013259,basal,o
221,0211-699501013259,con,o
221,0211-699501013259,una,o
221,0211-699501013259,prevalencia,o
221,0211-699501013259,de,o
221,0211-699501013259,hiperhomocisteinemia,i
221,0211-699501013259,del,o
221,0211-699501013259,844,o
221,0211-699501013259,deficit,i
221,0211-699501013259,de,i
221,0211-699501013259,pp,i
221,0211-699501013259,en,o
221,0211-699501013259,el,o
221,0211-699501013259,32,o
221,0211-699501013259,y,o
221,0211-699501013259,folato,i
221,0211-699501013259,en,o
221,0211-699501013259,el,o
221,0211-699501013259,rango,o
221,0211-699501013259,normal,o
221,0211-699501013259,bajo,o
221,0211-699501013259,los,o
221,0211-699501013259,niveles,i
221,0211-699501013259,de,i
221,0211-699501013259,tHcy,i
221,0211-699501013259,se,o
221,0211-699501013259,correlacionaban,o
221,0211-699501013259,inversamente,o
221,0211-699501013259,con,o
221,0211-699501013259,los,o
221,0211-699501013259,del,o
221,0211-699501013259,folato,i
221,0211-699501013259,r,o
221,0211-699501013259,0336,o
221,0211-699501013259,p,o
221,0211-699501013259,001,o
221,0211-699501013259,pero,o
221,0211-699501013259,no,o
221,0211-699501013259,con,o
221,0211-699501013259,pp,i
221,0211-699501013259,B12,i
221,0211-699501013259,edad,o
221,0211-699501013259,albumina,i
221,0211-699501013259,KTV,o
221,0211-699501013259,KRU,o
221,0211-699501013259,PCRn,o
221,0211-699501013259,Cincuenta,o
221,0211-699501013259,y,o
221,0211-699501013259,ocho,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,recibieron,o
221,0211-699501013259,seis,o
221,0211-699501013259,meses,o
221,0211-699501013259,de,o
221,0211-699501013259,suplementacion,i
221,0211-699501013259,con,o
221,0211-699501013259,normalizacion,o
221,0211-699501013259,del,o
221,0211-699501013259,pp,i
221,0211-699501013259,aumento,o
221,0211-699501013259,del,o
221,0211-699501013259,folato,i
221,0211-699501013259,703,o
221,0211-699501013259,IC,o
221,0211-699501013259,638,o
221,0211-699501013259,795,o
221,0211-699501013259,vs,o
221,0211-699501013259,6181,o
221,0211-699501013259,IC,o
221,0211-699501013259,4447,o
221,0211-699501013259,7811,o
221,0211-699501013259,p,o
221,0211-699501013259,0001,o
221,0211-699501013259,y,o
221,0211-699501013259,descenso,o
221,0211-699501013259,de,o
221,0211-699501013259,la,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,240,o
221,0211-699501013259,IC,o
221,0211-699501013259,213,o
221,0211-699501013259,264,o
221,0211-699501013259,vs,o
221,0211-699501013259,199,o
221,0211-699501013259,IC,o
221,0211-699501013259,175,o
221,0211-699501013259,224,o
221,0211-699501013259,p,o
221,0211-699501013259,005,o
221,0211-699501013259,Han,o
221,0211-699501013259,recibido,o
221,0211-699501013259,suplementacion,i
221,0211-699501013259,durante,o
221,0211-699501013259,12,o
221,0211-699501013259,meses,o
221,0211-699501013259,33,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,pero,o
221,0211-699501013259,a,o
221,0211-699501013259,pesar,o
221,0211-699501013259,de,o
221,0211-699501013259,un,o
221,0211-699501013259,continuo,o
221,0211-699501013259,aumento,o
221,0211-699501013259,del,o
221,0211-699501013259,folato,i
221,0211-699501013259,10078,o
221,0211-699501013259,IC,o
221,0211-699501013259,7481,o
221,0211-699501013259,12674,o
221,0211-699501013259,p,o
221,0211-699501013259,0001,o
221,0211-699501013259,solo,o
221,0211-699501013259,3,o
221,0211-699501013259,pacientes,o
221,0211-699501013259,presentan,o
221,0211-699501013259,niveles,o
221,0211-699501013259,normales,o
221,0211-699501013259,de,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,correlacionandose,o
221,0211-699501013259,directamente,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,con,o
221,0211-699501013259,la,o
221,0211-699501013259,albumina,i
221,0211-699501013259,r,o
221,0211-699501013259,056,o
221,0211-699501013259,p,o
221,0211-699501013259,0001,o
221,0211-699501013259,que,o
221,0211-699501013259,se,o
221,0211-699501013259,elevo,o
221,0211-699501013259,con,o
221,0211-699501013259,respecto,o
221,0211-699501013259,al,o
221,0211-699501013259,inicio,o
221,0211-699501013259,337,o
221,0211-699501013259,IC,o
221,0211-699501013259,327,o
221,0211-699501013259,346,o
221,0211-699501013259,vs,o
221,0211-699501013259,350,o
221,0211-699501013259,IC,o
221,0211-699501013259,337,o
221,0211-699501013259,363,o
221,0211-699501013259,p,o
221,0211-699501013259,005,o
221,0211-699501013259,Conclusion,o
221,0211-699501013259,Tras,o
221,0211-699501013259,suplementacion,i
221,0211-699501013259,con,o
221,0211-699501013259,acido,i
221,0211-699501013259,folico,i
221,0211-699501013259,y,o
221,0211-699501013259,vitamina,i
221,0211-699501013259,B6,i
221,0211-699501013259,aunque,o
221,0211-699501013259,inicialmente,o
221,0211-699501013259,se,o
221,0211-699501013259,reduce,o
221,0211-699501013259,la,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,esta,o
221,0211-699501013259,respuesta,o
221,0211-699501013259,se,o
221,0211-699501013259,hace,o
221,0211-699501013259,refractaria,o
221,0211-699501013259,correlacionandose,o
221,0211-699501013259,directamente,o
221,0211-699501013259,la,o
221,0211-699501013259,tHcy,i
221,0211-699501013259,con,o
221,0211-699501013259,la,o
221,0211-699501013259,albumina,i
221,0211-699501013259,plasmatica,i
221,0211-699501013259,La,o
221,0211-699501013259,interpretacion,o
221,0211-699501013259,de,o
221,0211-699501013259,los,o
221,0211-699501013259,niveles,i
221,0211-699501013259,de,i
221,0211-699501013259,tHcy,i
221,0211-699501013259,debe,o
221,0211-699501013259,tener,o
221,0211-699501013259,en,o
221,0211-699501013259,cuenta,o
221,0211-699501013259,la,o
221,0211-699501013259,concentracion,i
221,0211-699501013259,de,i
221,0211-699501013259,albumina,i
222,0211-699501013259,Efecto,o
222,0211-699501013259,de,o
222,0211-699501013259,la,o
222,0211-699501013259,suplementacion,i
222,0211-699501013259,con,o
222,0211-699501013259,acido,i
222,0211-699501013259,folico,i
222,0211-699501013259,sobre,o
222,0211-699501013259,los,o
222,0211-699501013259,niveles,i
222,0211-699501013259,de,i
222,0211-699501013259,homocisteina,i
222,0211-699501013259,total,o
222,0211-699501013259,en,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,en,o
222,0211-699501013259,hemodialisis,i
222,0211-699501013259,La,o
222,0211-699501013259,hiperhomocisteinemia,i
222,0211-699501013259,es,o
222,0211-699501013259,un,o
222,0211-699501013259,marcador,o
222,0211-699501013259,de,o
222,0211-699501013259,riesgo,o
222,0211-699501013259,independiente,o
222,0211-699501013259,de,o
222,0211-699501013259,morbimortalidad,o
222,0211-699501013259,cardiovascular,i
222,0211-699501013259,Hemos,o
222,0211-699501013259,intentado,o
222,0211-699501013259,prospectivamente,o
222,0211-699501013259,reducir,o
222,0211-699501013259,los,o
222,0211-699501013259,niveles,i
222,0211-699501013259,de,i
222,0211-699501013259,homocisteina,i
222,0211-699501013259,total,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,mediante,o
222,0211-699501013259,suplemento,o
222,0211-699501013259,con,o
222,0211-699501013259,acido,i
222,0211-699501013259,folico,i
222,0211-699501013259,y,o
222,0211-699501013259,vitamina,i
222,0211-699501013259,B6,i
222,0211-699501013259,pp,i
222,0211-699501013259,valorando,o
222,0211-699501013259,su,o
222,0211-699501013259,posible,o
222,0211-699501013259,correlacion,o
222,0211-699501013259,con,o
222,0211-699501013259,dosis,o
222,0211-699501013259,de,o
222,0211-699501013259,dialisis,i
222,0211-699501013259,funcion,i
222,0211-699501013259,residual,i
222,0211-699501013259,y,o
222,0211-699501013259,parametros,o
222,0211-699501013259,nutricionales,o
222,0211-699501013259,Metodos,o
222,0211-699501013259,Todos,o
222,0211-699501013259,los,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,en,o
222,0211-699501013259,hemodialisis,i
222,0211-699501013259,al,o
222,0211-699501013259,comienzo,o
222,0211-699501013259,del,o
222,0211-699501013259,estudio,o
222,0211-699501013259,que,o
222,0211-699501013259,no,o
222,0211-699501013259,recibian,o
222,0211-699501013259,acido,i
222,0211-699501013259,folico,i
222,0211-699501013259,ni,o
222,0211-699501013259,vitamina,i
222,0211-699501013259,B6,i
222,0211-699501013259,asi,o
222,0211-699501013259,como,o
222,0211-699501013259,los,o
222,0211-699501013259,incorporados,o
222,0211-699501013259,posteriormente,o
222,0211-699501013259,a,o
222,0211-699501013259,partir,o
222,0211-699501013259,de,o
222,0211-699501013259,su,o
222,0211-699501013259,tercer,o
222,0211-699501013259,mes,o
222,0211-699501013259,en,o
222,0211-699501013259,hemodialisis,i
222,0211-699501013259,recibieron,o
222,0211-699501013259,5,o
222,0211-699501013259,mg,o
222,0211-699501013259,orales,o
222,0211-699501013259,de,o
222,0211-699501013259,acido,i
222,0211-699501013259,folico,i
222,0211-699501013259,cada,o
222,0211-699501013259,48,o
222,0211-699501013259,horas,o
222,0211-699501013259,y,o
222,0211-699501013259,40,o
222,0211-699501013259,mg,o
222,0211-699501013259,orales,o
222,0211-699501013259,de,o
222,0211-699501013259,vitamina,i
222,0211-699501013259,B6,i
222,0211-699501013259,cada,o
222,0211-699501013259,semana,o
222,0211-699501013259,Se,o
222,0211-699501013259,determinaron,o
222,0211-699501013259,al,o
222,0211-699501013259,comienzo,o
222,0211-699501013259,del,o
222,0211-699501013259,estudio,o
222,0211-699501013259,y,o
222,0211-699501013259,cada,o
222,0211-699501013259,2,o
222,0211-699501013259,meses,o
222,0211-699501013259,niveles,i
222,0211-699501013259,de,i
222,0211-699501013259,folato,i
222,0211-699501013259,vitamina,i
222,0211-699501013259,B12,i
222,0211-699501013259,inmunoensayo,i
222,0211-699501013259,albumina,i
222,0211-699501013259,y,o
222,0211-699501013259,cinetica,o
222,0211-699501013259,de,o
222,0211-699501013259,la,o
222,0211-699501013259,urea,i
222,0211-699501013259,KTV,o
222,0211-699501013259,KRU,o
222,0211-699501013259,PCRn,o
222,0211-699501013259,y,o
222,0211-699501013259,cada,o
222,0211-699501013259,6,o
222,0211-699501013259,meses,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,HPLC,i
222,0211-699501013259,y,o
222,0211-699501013259,pp,i
222,0211-699501013259,RIA,i
222,0211-699501013259,Resultados,o
222,0211-699501013259,80,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,fueron,o
222,0211-699501013259,incluidos,o
222,0211-699501013259,en,o
222,0211-699501013259,el,o
222,0211-699501013259,estudio,o
222,0211-699501013259,basal,o
222,0211-699501013259,con,o
222,0211-699501013259,una,o
222,0211-699501013259,prevalencia,o
222,0211-699501013259,de,o
222,0211-699501013259,hiperhomocisteinemia,i
222,0211-699501013259,del,o
222,0211-699501013259,844,o
222,0211-699501013259,deficit,i
222,0211-699501013259,de,i
222,0211-699501013259,pp,i
222,0211-699501013259,en,o
222,0211-699501013259,el,o
222,0211-699501013259,32,o
222,0211-699501013259,y,o
222,0211-699501013259,folato,i
222,0211-699501013259,en,o
222,0211-699501013259,el,o
222,0211-699501013259,rango,o
222,0211-699501013259,normal,o
222,0211-699501013259,bajo,o
222,0211-699501013259,los,o
222,0211-699501013259,niveles,i
222,0211-699501013259,de,i
222,0211-699501013259,tHcy,i
222,0211-699501013259,se,o
222,0211-699501013259,correlacionaban,o
222,0211-699501013259,inversamente,o
222,0211-699501013259,con,o
222,0211-699501013259,los,o
222,0211-699501013259,del,o
222,0211-699501013259,folato,i
222,0211-699501013259,r,o
222,0211-699501013259,0336,o
222,0211-699501013259,p,o
222,0211-699501013259,001,o
222,0211-699501013259,pero,o
222,0211-699501013259,no,o
222,0211-699501013259,con,o
222,0211-699501013259,pp,i
222,0211-699501013259,B12,i
222,0211-699501013259,edad,o
222,0211-699501013259,albumina,i
222,0211-699501013259,KTV,o
222,0211-699501013259,KRU,o
222,0211-699501013259,PCRn,o
222,0211-699501013259,Cincuenta,o
222,0211-699501013259,y,o
222,0211-699501013259,ocho,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,recibieron,o
222,0211-699501013259,seis,o
222,0211-699501013259,meses,o
222,0211-699501013259,de,o
222,0211-699501013259,suplementacion,i
222,0211-699501013259,con,o
222,0211-699501013259,normalizacion,o
222,0211-699501013259,del,o
222,0211-699501013259,pp,i
222,0211-699501013259,aumento,o
222,0211-699501013259,del,o
222,0211-699501013259,folato,i
222,0211-699501013259,703,o
222,0211-699501013259,IC,o
222,0211-699501013259,638,o
222,0211-699501013259,795,o
222,0211-699501013259,vs,o
222,0211-699501013259,6181,o
222,0211-699501013259,IC,o
222,0211-699501013259,4447,o
222,0211-699501013259,7811,o
222,0211-699501013259,p,o
222,0211-699501013259,0001,o
222,0211-699501013259,y,o
222,0211-699501013259,descenso,o
222,0211-699501013259,de,o
222,0211-699501013259,la,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,240,o
222,0211-699501013259,IC,o
222,0211-699501013259,213,o
222,0211-699501013259,264,o
222,0211-699501013259,vs,o
222,0211-699501013259,199,o
222,0211-699501013259,IC,o
222,0211-699501013259,175,o
222,0211-699501013259,224,o
222,0211-699501013259,p,o
222,0211-699501013259,005,o
222,0211-699501013259,Han,o
222,0211-699501013259,recibido,o
222,0211-699501013259,suplementacion,i
222,0211-699501013259,durante,o
222,0211-699501013259,12,o
222,0211-699501013259,meses,o
222,0211-699501013259,33,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,pero,o
222,0211-699501013259,a,o
222,0211-699501013259,pesar,o
222,0211-699501013259,de,o
222,0211-699501013259,un,o
222,0211-699501013259,continuo,o
222,0211-699501013259,aumento,o
222,0211-699501013259,del,o
222,0211-699501013259,folato,i
222,0211-699501013259,10078,o
222,0211-699501013259,IC,o
222,0211-699501013259,7481,o
222,0211-699501013259,12674,o
222,0211-699501013259,p,o
222,0211-699501013259,0001,o
222,0211-699501013259,solo,o
222,0211-699501013259,3,o
222,0211-699501013259,pacientes,o
222,0211-699501013259,presentan,o
222,0211-699501013259,niveles,o
222,0211-699501013259,normales,o
222,0211-699501013259,de,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,correlacionandose,o
222,0211-699501013259,directamente,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,con,o
222,0211-699501013259,la,o
222,0211-699501013259,albumina,i
222,0211-699501013259,r,o
222,0211-699501013259,056,o
222,0211-699501013259,p,o
222,0211-699501013259,0001,o
222,0211-699501013259,que,o
222,0211-699501013259,se,o
222,0211-699501013259,elevo,o
222,0211-699501013259,con,o
222,0211-699501013259,respecto,o
222,0211-699501013259,al,o
222,0211-699501013259,inicio,o
222,0211-699501013259,337,o
222,0211-699501013259,IC,o
222,0211-699501013259,327,o
222,0211-699501013259,346,o
222,0211-699501013259,vs,o
222,0211-699501013259,350,o
222,0211-699501013259,IC,o
222,0211-699501013259,337,o
222,0211-699501013259,363,o
222,0211-699501013259,p,o
222,0211-699501013259,005,o
222,0211-699501013259,Conclusion,o
222,0211-699501013259,Tras,o
222,0211-699501013259,suplementacion,i
222,0211-699501013259,con,o
222,0211-699501013259,acido,i
222,0211-699501013259,folico,i
222,0211-699501013259,y,o
222,0211-699501013259,vitamina,i
222,0211-699501013259,B6,i
222,0211-699501013259,aunque,o
222,0211-699501013259,inicialmente,o
222,0211-699501013259,se,o
222,0211-699501013259,reduce,o
222,0211-699501013259,la,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,esta,o
222,0211-699501013259,respuesta,o
222,0211-699501013259,se,o
222,0211-699501013259,hace,o
222,0211-699501013259,refractaria,o
222,0211-699501013259,correlacionandose,o
222,0211-699501013259,directamente,o
222,0211-699501013259,la,o
222,0211-699501013259,tHcy,i
222,0211-699501013259,con,o
222,0211-699501013259,la,o
222,0211-699501013259,albumina,i
222,0211-699501013259,plasmatica,i
222,0211-699501013259,La,o
222,0211-699501013259,interpretacion,o
222,0211-699501013259,de,o
222,0211-699501013259,los,o
222,0211-699501013259,niveles,i
222,0211-699501013259,de,i
222,0211-699501013259,tHcy,i
222,0211-699501013259,debe,o
222,0211-699501013259,tener,o
222,0211-699501013259,en,o
222,0211-699501013259,cuenta,o
222,0211-699501013259,la,o
222,0211-699501013259,concentracion,i
222,0211-699501013259,de,i
222,0211-699501013259,albumina,i
223,0211-699501013259,Efecto,o
223,0211-699501013259,de,o
223,0211-699501013259,la,o
223,0211-699501013259,suplementacion,i
223,0211-699501013259,con,o
223,0211-699501013259,acido,i
223,0211-699501013259,folico,i
223,0211-699501013259,sobre,o
223,0211-699501013259,los,o
223,0211-699501013259,niveles,i
223,0211-699501013259,de,i
223,0211-699501013259,homocisteina,i
223,0211-699501013259,total,o
223,0211-699501013259,en,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,en,o
223,0211-699501013259,hemodialisis,i
223,0211-699501013259,La,o
223,0211-699501013259,hiperhomocisteinemia,i
223,0211-699501013259,es,o
223,0211-699501013259,un,o
223,0211-699501013259,marcador,o
223,0211-699501013259,de,o
223,0211-699501013259,riesgo,o
223,0211-699501013259,independiente,o
223,0211-699501013259,de,o
223,0211-699501013259,morbimortalidad,o
223,0211-699501013259,cardiovascular,i
223,0211-699501013259,Hemos,o
223,0211-699501013259,intentado,o
223,0211-699501013259,prospectivamente,o
223,0211-699501013259,reducir,o
223,0211-699501013259,los,o
223,0211-699501013259,niveles,i
223,0211-699501013259,de,i
223,0211-699501013259,homocisteina,i
223,0211-699501013259,total,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,mediante,o
223,0211-699501013259,suplemento,o
223,0211-699501013259,con,o
223,0211-699501013259,acido,i
223,0211-699501013259,folico,i
223,0211-699501013259,y,o
223,0211-699501013259,vitamina,i
223,0211-699501013259,B6,i
223,0211-699501013259,pp,i
223,0211-699501013259,valorando,o
223,0211-699501013259,su,o
223,0211-699501013259,posible,o
223,0211-699501013259,correlacion,o
223,0211-699501013259,con,o
223,0211-699501013259,dosis,o
223,0211-699501013259,de,o
223,0211-699501013259,dialisis,i
223,0211-699501013259,funcion,i
223,0211-699501013259,residual,i
223,0211-699501013259,y,o
223,0211-699501013259,parametros,o
223,0211-699501013259,nutricionales,o
223,0211-699501013259,Metodos,o
223,0211-699501013259,Todos,o
223,0211-699501013259,los,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,en,o
223,0211-699501013259,hemodialisis,i
223,0211-699501013259,al,o
223,0211-699501013259,comienzo,o
223,0211-699501013259,del,o
223,0211-699501013259,estudio,o
223,0211-699501013259,que,o
223,0211-699501013259,no,o
223,0211-699501013259,recibian,o
223,0211-699501013259,acido,i
223,0211-699501013259,folico,i
223,0211-699501013259,ni,o
223,0211-699501013259,vitamina,i
223,0211-699501013259,B6,i
223,0211-699501013259,asi,o
223,0211-699501013259,como,o
223,0211-699501013259,los,o
223,0211-699501013259,incorporados,o
223,0211-699501013259,posteriormente,o
223,0211-699501013259,a,o
223,0211-699501013259,partir,o
223,0211-699501013259,de,o
223,0211-699501013259,su,o
223,0211-699501013259,tercer,o
223,0211-699501013259,mes,o
223,0211-699501013259,en,o
223,0211-699501013259,hemodialisis,i
223,0211-699501013259,recibieron,o
223,0211-699501013259,5,o
223,0211-699501013259,mg,o
223,0211-699501013259,orales,o
223,0211-699501013259,de,o
223,0211-699501013259,acido,i
223,0211-699501013259,folico,i
223,0211-699501013259,cada,o
223,0211-699501013259,48,o
223,0211-699501013259,horas,o
223,0211-699501013259,y,o
223,0211-699501013259,40,o
223,0211-699501013259,mg,o
223,0211-699501013259,orales,o
223,0211-699501013259,de,o
223,0211-699501013259,vitamina,i
223,0211-699501013259,B6,i
223,0211-699501013259,cada,o
223,0211-699501013259,semana,o
223,0211-699501013259,Se,o
223,0211-699501013259,determinaron,o
223,0211-699501013259,al,o
223,0211-699501013259,comienzo,o
223,0211-699501013259,del,o
223,0211-699501013259,estudio,o
223,0211-699501013259,y,o
223,0211-699501013259,cada,o
223,0211-699501013259,2,o
223,0211-699501013259,meses,o
223,0211-699501013259,niveles,i
223,0211-699501013259,de,i
223,0211-699501013259,folato,i
223,0211-699501013259,vitamina,i
223,0211-699501013259,B12,i
223,0211-699501013259,inmunoensayo,i
223,0211-699501013259,albumina,i
223,0211-699501013259,y,o
223,0211-699501013259,cinetica,o
223,0211-699501013259,de,o
223,0211-699501013259,la,o
223,0211-699501013259,urea,i
223,0211-699501013259,KTV,o
223,0211-699501013259,KRU,o
223,0211-699501013259,PCRn,o
223,0211-699501013259,y,o
223,0211-699501013259,cada,o
223,0211-699501013259,6,o
223,0211-699501013259,meses,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,HPLC,i
223,0211-699501013259,y,o
223,0211-699501013259,pp,i
223,0211-699501013259,RIA,i
223,0211-699501013259,Resultados,o
223,0211-699501013259,80,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,fueron,o
223,0211-699501013259,incluidos,o
223,0211-699501013259,en,o
223,0211-699501013259,el,o
223,0211-699501013259,estudio,o
223,0211-699501013259,basal,o
223,0211-699501013259,con,o
223,0211-699501013259,una,o
223,0211-699501013259,prevalencia,o
223,0211-699501013259,de,o
223,0211-699501013259,hiperhomocisteinemia,i
223,0211-699501013259,del,o
223,0211-699501013259,844,o
223,0211-699501013259,deficit,i
223,0211-699501013259,de,i
223,0211-699501013259,pp,i
223,0211-699501013259,en,o
223,0211-699501013259,el,o
223,0211-699501013259,32,o
223,0211-699501013259,y,o
223,0211-699501013259,folato,i
223,0211-699501013259,en,o
223,0211-699501013259,el,o
223,0211-699501013259,rango,o
223,0211-699501013259,normal,o
223,0211-699501013259,bajo,o
223,0211-699501013259,los,o
223,0211-699501013259,niveles,i
223,0211-699501013259,de,i
223,0211-699501013259,tHcy,i
223,0211-699501013259,se,o
223,0211-699501013259,correlacionaban,o
223,0211-699501013259,inversamente,o
223,0211-699501013259,con,o
223,0211-699501013259,los,o
223,0211-699501013259,del,o
223,0211-699501013259,folato,i
223,0211-699501013259,r,o
223,0211-699501013259,0336,o
223,0211-699501013259,p,o
223,0211-699501013259,001,o
223,0211-699501013259,pero,o
223,0211-699501013259,no,o
223,0211-699501013259,con,o
223,0211-699501013259,pp,i
223,0211-699501013259,B12,i
223,0211-699501013259,edad,o
223,0211-699501013259,albumina,i
223,0211-699501013259,KTV,o
223,0211-699501013259,KRU,o
223,0211-699501013259,PCRn,o
223,0211-699501013259,Cincuenta,o
223,0211-699501013259,y,o
223,0211-699501013259,ocho,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,recibieron,o
223,0211-699501013259,seis,o
223,0211-699501013259,meses,o
223,0211-699501013259,de,o
223,0211-699501013259,suplementacion,i
223,0211-699501013259,con,o
223,0211-699501013259,normalizacion,o
223,0211-699501013259,del,o
223,0211-699501013259,pp,i
223,0211-699501013259,aumento,o
223,0211-699501013259,del,o
223,0211-699501013259,folato,i
223,0211-699501013259,703,o
223,0211-699501013259,IC,o
223,0211-699501013259,638,o
223,0211-699501013259,795,o
223,0211-699501013259,vs,o
223,0211-699501013259,6181,o
223,0211-699501013259,IC,o
223,0211-699501013259,4447,o
223,0211-699501013259,7811,o
223,0211-699501013259,p,o
223,0211-699501013259,0001,o
223,0211-699501013259,y,o
223,0211-699501013259,descenso,o
223,0211-699501013259,de,o
223,0211-699501013259,la,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,240,o
223,0211-699501013259,IC,o
223,0211-699501013259,213,o
223,0211-699501013259,264,o
223,0211-699501013259,vs,o
223,0211-699501013259,199,o
223,0211-699501013259,IC,o
223,0211-699501013259,175,o
223,0211-699501013259,224,o
223,0211-699501013259,p,o
223,0211-699501013259,005,o
223,0211-699501013259,Han,o
223,0211-699501013259,recibido,o
223,0211-699501013259,suplementacion,i
223,0211-699501013259,durante,o
223,0211-699501013259,12,o
223,0211-699501013259,meses,o
223,0211-699501013259,33,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,pero,o
223,0211-699501013259,a,o
223,0211-699501013259,pesar,o
223,0211-699501013259,de,o
223,0211-699501013259,un,o
223,0211-699501013259,continuo,o
223,0211-699501013259,aumento,o
223,0211-699501013259,del,o
223,0211-699501013259,folato,i
223,0211-699501013259,10078,o
223,0211-699501013259,IC,o
223,0211-699501013259,7481,o
223,0211-699501013259,12674,o
223,0211-699501013259,p,o
223,0211-699501013259,0001,o
223,0211-699501013259,solo,o
223,0211-699501013259,3,o
223,0211-699501013259,pacientes,o
223,0211-699501013259,presentan,o
223,0211-699501013259,niveles,o
223,0211-699501013259,normales,o
223,0211-699501013259,de,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,correlacionandose,o
223,0211-699501013259,directamente,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,con,o
223,0211-699501013259,la,o
223,0211-699501013259,albumina,i
223,0211-699501013259,r,o
223,0211-699501013259,056,o
223,0211-699501013259,p,o
223,0211-699501013259,0001,o
223,0211-699501013259,que,o
223,0211-699501013259,se,o
223,0211-699501013259,elevo,o
223,0211-699501013259,con,o
223,0211-699501013259,respecto,o
223,0211-699501013259,al,o
223,0211-699501013259,inicio,o
223,0211-699501013259,337,o
223,0211-699501013259,IC,o
223,0211-699501013259,327,o
223,0211-699501013259,346,o
223,0211-699501013259,vs,o
223,0211-699501013259,350,o
223,0211-699501013259,IC,o
223,0211-699501013259,337,o
223,0211-699501013259,363,o
223,0211-699501013259,p,o
223,0211-699501013259,005,o
223,0211-699501013259,Conclusion,o
223,0211-699501013259,Tras,o
223,0211-699501013259,suplementacion,i
223,0211-699501013259,con,o
223,0211-699501013259,acido,i
223,0211-699501013259,folico,i
223,0211-699501013259,y,o
223,0211-699501013259,vitamina,i
223,0211-699501013259,B6,i
223,0211-699501013259,aunque,o
223,0211-699501013259,inicialmente,o
223,0211-699501013259,se,o
223,0211-699501013259,reduce,o
223,0211-699501013259,la,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,esta,o
223,0211-699501013259,respuesta,o
223,0211-699501013259,se,o
223,0211-699501013259,hace,o
223,0211-699501013259,refractaria,o
223,0211-699501013259,correlacionandose,o
223,0211-699501013259,directamente,o
223,0211-699501013259,la,o
223,0211-699501013259,tHcy,i
223,0211-699501013259,con,o
223,0211-699501013259,la,o
223,0211-699501013259,albumina,i
223,0211-699501013259,plasmatica,i
223,0211-699501013259,La,o
223,0211-699501013259,interpretacion,o
223,0211-699501013259,de,o
223,0211-699501013259,los,o
223,0211-699501013259,niveles,i
223,0211-699501013259,de,i
223,0211-699501013259,tHcy,i
223,0211-699501013259,debe,o
223,0211-699501013259,tener,o
223,0211-699501013259,en,o
223,0211-699501013259,cuenta,o
223,0211-699501013259,la,o
223,0211-699501013259,concentracion,i
223,0211-699501013259,de,i
223,0211-699501013259,albumina,i
224,0211-699501013259,Efecto,o
224,0211-699501013259,de,o
224,0211-699501013259,la,o
224,0211-699501013259,suplementacion,i
224,0211-699501013259,con,o
224,0211-699501013259,acido,i
224,0211-699501013259,folico,i
224,0211-699501013259,sobre,o
224,0211-699501013259,los,o
224,0211-699501013259,niveles,i
224,0211-699501013259,de,i
224,0211-699501013259,homocisteina,i
224,0211-699501013259,total,o
224,0211-699501013259,en,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,en,o
224,0211-699501013259,hemodialisis,i
224,0211-699501013259,La,o
224,0211-699501013259,hiperhomocisteinemia,i
224,0211-699501013259,es,o
224,0211-699501013259,un,o
224,0211-699501013259,marcador,o
224,0211-699501013259,de,o
224,0211-699501013259,riesgo,o
224,0211-699501013259,independiente,o
224,0211-699501013259,de,o
224,0211-699501013259,morbimortalidad,o
224,0211-699501013259,cardiovascular,i
224,0211-699501013259,Hemos,o
224,0211-699501013259,intentado,o
224,0211-699501013259,prospectivamente,o
224,0211-699501013259,reducir,o
224,0211-699501013259,los,o
224,0211-699501013259,niveles,i
224,0211-699501013259,de,i
224,0211-699501013259,homocisteina,i
224,0211-699501013259,total,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,mediante,o
224,0211-699501013259,suplemento,o
224,0211-699501013259,con,o
224,0211-699501013259,acido,i
224,0211-699501013259,folico,i
224,0211-699501013259,y,o
224,0211-699501013259,vitamina,i
224,0211-699501013259,B6,i
224,0211-699501013259,pp,i
224,0211-699501013259,valorando,o
224,0211-699501013259,su,o
224,0211-699501013259,posible,o
224,0211-699501013259,correlacion,o
224,0211-699501013259,con,o
224,0211-699501013259,dosis,o
224,0211-699501013259,de,o
224,0211-699501013259,dialisis,i
224,0211-699501013259,funcion,i
224,0211-699501013259,residual,i
224,0211-699501013259,y,o
224,0211-699501013259,parametros,o
224,0211-699501013259,nutricionales,o
224,0211-699501013259,Metodos,o
224,0211-699501013259,Todos,o
224,0211-699501013259,los,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,en,o
224,0211-699501013259,hemodialisis,i
224,0211-699501013259,al,o
224,0211-699501013259,comienzo,o
224,0211-699501013259,del,o
224,0211-699501013259,estudio,o
224,0211-699501013259,que,o
224,0211-699501013259,no,o
224,0211-699501013259,recibian,o
224,0211-699501013259,acido,i
224,0211-699501013259,folico,i
224,0211-699501013259,ni,o
224,0211-699501013259,vitamina,i
224,0211-699501013259,B6,i
224,0211-699501013259,asi,o
224,0211-699501013259,como,o
224,0211-699501013259,los,o
224,0211-699501013259,incorporados,o
224,0211-699501013259,posteriormente,o
224,0211-699501013259,a,o
224,0211-699501013259,partir,o
224,0211-699501013259,de,o
224,0211-699501013259,su,o
224,0211-699501013259,tercer,o
224,0211-699501013259,mes,o
224,0211-699501013259,en,o
224,0211-699501013259,hemodialisis,i
224,0211-699501013259,recibieron,o
224,0211-699501013259,5,o
224,0211-699501013259,mg,o
224,0211-699501013259,orales,o
224,0211-699501013259,de,o
224,0211-699501013259,acido,i
224,0211-699501013259,folico,i
224,0211-699501013259,cada,o
224,0211-699501013259,48,o
224,0211-699501013259,horas,o
224,0211-699501013259,y,o
224,0211-699501013259,40,o
224,0211-699501013259,mg,o
224,0211-699501013259,orales,o
224,0211-699501013259,de,o
224,0211-699501013259,vitamina,i
224,0211-699501013259,B6,i
224,0211-699501013259,cada,o
224,0211-699501013259,semana,o
224,0211-699501013259,Se,o
224,0211-699501013259,determinaron,o
224,0211-699501013259,al,o
224,0211-699501013259,comienzo,o
224,0211-699501013259,del,o
224,0211-699501013259,estudio,o
224,0211-699501013259,y,o
224,0211-699501013259,cada,o
224,0211-699501013259,2,o
224,0211-699501013259,meses,o
224,0211-699501013259,niveles,i
224,0211-699501013259,de,i
224,0211-699501013259,folato,i
224,0211-699501013259,vitamina,i
224,0211-699501013259,B12,i
224,0211-699501013259,inmunoensayo,i
224,0211-699501013259,albumina,i
224,0211-699501013259,y,o
224,0211-699501013259,cinetica,o
224,0211-699501013259,de,o
224,0211-699501013259,la,o
224,0211-699501013259,urea,i
224,0211-699501013259,KTV,o
224,0211-699501013259,KRU,o
224,0211-699501013259,PCRn,o
224,0211-699501013259,y,o
224,0211-699501013259,cada,o
224,0211-699501013259,6,o
224,0211-699501013259,meses,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,HPLC,i
224,0211-699501013259,y,o
224,0211-699501013259,pp,i
224,0211-699501013259,RIA,i
224,0211-699501013259,Resultados,o
224,0211-699501013259,80,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,fueron,o
224,0211-699501013259,incluidos,o
224,0211-699501013259,en,o
224,0211-699501013259,el,o
224,0211-699501013259,estudio,o
224,0211-699501013259,basal,o
224,0211-699501013259,con,o
224,0211-699501013259,una,o
224,0211-699501013259,prevalencia,o
224,0211-699501013259,de,o
224,0211-699501013259,hiperhomocisteinemia,i
224,0211-699501013259,del,o
224,0211-699501013259,844,o
224,0211-699501013259,deficit,i
224,0211-699501013259,de,i
224,0211-699501013259,pp,i
224,0211-699501013259,en,o
224,0211-699501013259,el,o
224,0211-699501013259,32,o
224,0211-699501013259,y,o
224,0211-699501013259,folato,i
224,0211-699501013259,en,o
224,0211-699501013259,el,o
224,0211-699501013259,rango,o
224,0211-699501013259,normal,o
224,0211-699501013259,bajo,o
224,0211-699501013259,los,o
224,0211-699501013259,niveles,i
224,0211-699501013259,de,i
224,0211-699501013259,tHcy,i
224,0211-699501013259,se,o
224,0211-699501013259,correlacionaban,o
224,0211-699501013259,inversamente,o
224,0211-699501013259,con,o
224,0211-699501013259,los,o
224,0211-699501013259,del,o
224,0211-699501013259,folato,i
224,0211-699501013259,r,o
224,0211-699501013259,0336,o
224,0211-699501013259,p,o
224,0211-699501013259,001,o
224,0211-699501013259,pero,o
224,0211-699501013259,no,o
224,0211-699501013259,con,o
224,0211-699501013259,pp,i
224,0211-699501013259,B12,i
224,0211-699501013259,edad,o
224,0211-699501013259,albumina,i
224,0211-699501013259,KTV,o
224,0211-699501013259,KRU,o
224,0211-699501013259,PCRn,o
224,0211-699501013259,Cincuenta,o
224,0211-699501013259,y,o
224,0211-699501013259,ocho,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,recibieron,o
224,0211-699501013259,seis,o
224,0211-699501013259,meses,o
224,0211-699501013259,de,o
224,0211-699501013259,suplementacion,i
224,0211-699501013259,con,o
224,0211-699501013259,normalizacion,o
224,0211-699501013259,del,o
224,0211-699501013259,pp,i
224,0211-699501013259,aumento,o
224,0211-699501013259,del,o
224,0211-699501013259,folato,i
224,0211-699501013259,703,o
224,0211-699501013259,IC,o
224,0211-699501013259,638,o
224,0211-699501013259,795,o
224,0211-699501013259,vs,o
224,0211-699501013259,6181,o
224,0211-699501013259,IC,o
224,0211-699501013259,4447,o
224,0211-699501013259,7811,o
224,0211-699501013259,p,o
224,0211-699501013259,0001,o
224,0211-699501013259,y,o
224,0211-699501013259,descenso,o
224,0211-699501013259,de,o
224,0211-699501013259,la,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,240,o
224,0211-699501013259,IC,o
224,0211-699501013259,213,o
224,0211-699501013259,264,o
224,0211-699501013259,vs,o
224,0211-699501013259,199,o
224,0211-699501013259,IC,o
224,0211-699501013259,175,o
224,0211-699501013259,224,o
224,0211-699501013259,p,o
224,0211-699501013259,005,o
224,0211-699501013259,Han,o
224,0211-699501013259,recibido,o
224,0211-699501013259,suplementacion,i
224,0211-699501013259,durante,o
224,0211-699501013259,12,o
224,0211-699501013259,meses,o
224,0211-699501013259,33,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,pero,o
224,0211-699501013259,a,o
224,0211-699501013259,pesar,o
224,0211-699501013259,de,o
224,0211-699501013259,un,o
224,0211-699501013259,continuo,o
224,0211-699501013259,aumento,o
224,0211-699501013259,del,o
224,0211-699501013259,folato,i
224,0211-699501013259,10078,o
224,0211-699501013259,IC,o
224,0211-699501013259,7481,o
224,0211-699501013259,12674,o
224,0211-699501013259,p,o
224,0211-699501013259,0001,o
224,0211-699501013259,solo,o
224,0211-699501013259,3,o
224,0211-699501013259,pacientes,o
224,0211-699501013259,presentan,o
224,0211-699501013259,niveles,o
224,0211-699501013259,normales,o
224,0211-699501013259,de,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,correlacionandose,o
224,0211-699501013259,directamente,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,con,o
224,0211-699501013259,la,o
224,0211-699501013259,albumina,i
224,0211-699501013259,r,o
224,0211-699501013259,056,o
224,0211-699501013259,p,o
224,0211-699501013259,0001,o
224,0211-699501013259,que,o
224,0211-699501013259,se,o
224,0211-699501013259,elevo,o
224,0211-699501013259,con,o
224,0211-699501013259,respecto,o
224,0211-699501013259,al,o
224,0211-699501013259,inicio,o
224,0211-699501013259,337,o
224,0211-699501013259,IC,o
224,0211-699501013259,327,o
224,0211-699501013259,346,o
224,0211-699501013259,vs,o
224,0211-699501013259,350,o
224,0211-699501013259,IC,o
224,0211-699501013259,337,o
224,0211-699501013259,363,o
224,0211-699501013259,p,o
224,0211-699501013259,005,o
224,0211-699501013259,Conclusion,o
224,0211-699501013259,Tras,o
224,0211-699501013259,suplementacion,i
224,0211-699501013259,con,o
224,0211-699501013259,acido,i
224,0211-699501013259,folico,i
224,0211-699501013259,y,o
224,0211-699501013259,vitamina,i
224,0211-699501013259,B6,i
224,0211-699501013259,aunque,o
224,0211-699501013259,inicialmente,o
224,0211-699501013259,se,o
224,0211-699501013259,reduce,o
224,0211-699501013259,la,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,esta,o
224,0211-699501013259,respuesta,o
224,0211-699501013259,se,o
224,0211-699501013259,hace,o
224,0211-699501013259,refractaria,o
224,0211-699501013259,correlacionandose,o
224,0211-699501013259,directamente,o
224,0211-699501013259,la,o
224,0211-699501013259,tHcy,i
224,0211-699501013259,con,o
224,0211-699501013259,la,o
224,0211-699501013259,albumina,i
224,0211-699501013259,plasmatica,i
224,0211-699501013259,La,o
224,0211-699501013259,interpretacion,o
224,0211-699501013259,de,o
224,0211-699501013259,los,o
224,0211-699501013259,niveles,i
224,0211-699501013259,de,i
224,0211-699501013259,tHcy,i
224,0211-699501013259,debe,o
224,0211-699501013259,tener,o
224,0211-699501013259,en,o
224,0211-699501013259,cuenta,o
224,0211-699501013259,la,o
224,0211-699501013259,concentracion,i
224,0211-699501013259,de,i
224,0211-699501013259,albumina,i
225,0211-699501013259,Efecto,o
225,0211-699501013259,de,o
225,0211-699501013259,la,o
225,0211-699501013259,suplementacion,i
225,0211-699501013259,con,o
225,0211-699501013259,acido,i
225,0211-699501013259,folico,i
225,0211-699501013259,sobre,o
225,0211-699501013259,los,o
225,0211-699501013259,niveles,i
225,0211-699501013259,de,i
225,0211-699501013259,homocisteina,i
225,0211-699501013259,total,o
225,0211-699501013259,en,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,en,o
225,0211-699501013259,hemodialisis,i
225,0211-699501013259,La,o
225,0211-699501013259,hiperhomocisteinemia,i
225,0211-699501013259,es,o
225,0211-699501013259,un,o
225,0211-699501013259,marcador,o
225,0211-699501013259,de,o
225,0211-699501013259,riesgo,o
225,0211-699501013259,independiente,o
225,0211-699501013259,de,o
225,0211-699501013259,morbimortalidad,o
225,0211-699501013259,cardiovascular,i
225,0211-699501013259,Hemos,o
225,0211-699501013259,intentado,o
225,0211-699501013259,prospectivamente,o
225,0211-699501013259,reducir,o
225,0211-699501013259,los,o
225,0211-699501013259,niveles,i
225,0211-699501013259,de,i
225,0211-699501013259,homocisteina,i
225,0211-699501013259,total,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,mediante,o
225,0211-699501013259,suplemento,o
225,0211-699501013259,con,o
225,0211-699501013259,acido,i
225,0211-699501013259,folico,i
225,0211-699501013259,y,o
225,0211-699501013259,vitamina,i
225,0211-699501013259,B6,i
225,0211-699501013259,pp,i
225,0211-699501013259,valorando,o
225,0211-699501013259,su,o
225,0211-699501013259,posible,o
225,0211-699501013259,correlacion,o
225,0211-699501013259,con,o
225,0211-699501013259,dosis,o
225,0211-699501013259,de,o
225,0211-699501013259,dialisis,i
225,0211-699501013259,funcion,i
225,0211-699501013259,residual,i
225,0211-699501013259,y,o
225,0211-699501013259,parametros,o
225,0211-699501013259,nutricionales,o
225,0211-699501013259,Metodos,o
225,0211-699501013259,Todos,o
225,0211-699501013259,los,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,en,o
225,0211-699501013259,hemodialisis,i
225,0211-699501013259,al,o
225,0211-699501013259,comienzo,o
225,0211-699501013259,del,o
225,0211-699501013259,estudio,o
225,0211-699501013259,que,o
225,0211-699501013259,no,o
225,0211-699501013259,recibian,o
225,0211-699501013259,acido,i
225,0211-699501013259,folico,i
225,0211-699501013259,ni,o
225,0211-699501013259,vitamina,i
225,0211-699501013259,B6,i
225,0211-699501013259,asi,o
225,0211-699501013259,como,o
225,0211-699501013259,los,o
225,0211-699501013259,incorporados,o
225,0211-699501013259,posteriormente,o
225,0211-699501013259,a,o
225,0211-699501013259,partir,o
225,0211-699501013259,de,o
225,0211-699501013259,su,o
225,0211-699501013259,tercer,o
225,0211-699501013259,mes,o
225,0211-699501013259,en,o
225,0211-699501013259,hemodialisis,i
225,0211-699501013259,recibieron,o
225,0211-699501013259,5,o
225,0211-699501013259,mg,o
225,0211-699501013259,orales,o
225,0211-699501013259,de,o
225,0211-699501013259,acido,i
225,0211-699501013259,folico,i
225,0211-699501013259,cada,o
225,0211-699501013259,48,o
225,0211-699501013259,horas,o
225,0211-699501013259,y,o
225,0211-699501013259,40,o
225,0211-699501013259,mg,o
225,0211-699501013259,orales,o
225,0211-699501013259,de,o
225,0211-699501013259,vitamina,i
225,0211-699501013259,B6,i
225,0211-699501013259,cada,o
225,0211-699501013259,semana,o
225,0211-699501013259,Se,o
225,0211-699501013259,determinaron,o
225,0211-699501013259,al,o
225,0211-699501013259,comienzo,o
225,0211-699501013259,del,o
225,0211-699501013259,estudio,o
225,0211-699501013259,y,o
225,0211-699501013259,cada,o
225,0211-699501013259,2,o
225,0211-699501013259,meses,o
225,0211-699501013259,niveles,i
225,0211-699501013259,de,i
225,0211-699501013259,folato,i
225,0211-699501013259,vitamina,i
225,0211-699501013259,B12,i
225,0211-699501013259,inmunoensayo,i
225,0211-699501013259,albumina,i
225,0211-699501013259,y,o
225,0211-699501013259,cinetica,o
225,0211-699501013259,de,o
225,0211-699501013259,la,o
225,0211-699501013259,urea,i
225,0211-699501013259,KTV,o
225,0211-699501013259,KRU,o
225,0211-699501013259,PCRn,o
225,0211-699501013259,y,o
225,0211-699501013259,cada,o
225,0211-699501013259,6,o
225,0211-699501013259,meses,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,HPLC,i
225,0211-699501013259,y,o
225,0211-699501013259,pp,i
225,0211-699501013259,RIA,i
225,0211-699501013259,Resultados,o
225,0211-699501013259,80,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,fueron,o
225,0211-699501013259,incluidos,o
225,0211-699501013259,en,o
225,0211-699501013259,el,o
225,0211-699501013259,estudio,o
225,0211-699501013259,basal,o
225,0211-699501013259,con,o
225,0211-699501013259,una,o
225,0211-699501013259,prevalencia,o
225,0211-699501013259,de,o
225,0211-699501013259,hiperhomocisteinemia,i
225,0211-699501013259,del,o
225,0211-699501013259,844,o
225,0211-699501013259,deficit,i
225,0211-699501013259,de,i
225,0211-699501013259,pp,i
225,0211-699501013259,en,o
225,0211-699501013259,el,o
225,0211-699501013259,32,o
225,0211-699501013259,y,o
225,0211-699501013259,folato,i
225,0211-699501013259,en,o
225,0211-699501013259,el,o
225,0211-699501013259,rango,o
225,0211-699501013259,normal,o
225,0211-699501013259,bajo,o
225,0211-699501013259,los,o
225,0211-699501013259,niveles,i
225,0211-699501013259,de,i
225,0211-699501013259,tHcy,i
225,0211-699501013259,se,o
225,0211-699501013259,correlacionaban,o
225,0211-699501013259,inversamente,o
225,0211-699501013259,con,o
225,0211-699501013259,los,o
225,0211-699501013259,del,o
225,0211-699501013259,folato,i
225,0211-699501013259,r,o
225,0211-699501013259,0336,o
225,0211-699501013259,p,o
225,0211-699501013259,001,o
225,0211-699501013259,pero,o
225,0211-699501013259,no,o
225,0211-699501013259,con,o
225,0211-699501013259,pp,i
225,0211-699501013259,B12,i
225,0211-699501013259,edad,o
225,0211-699501013259,albumina,i
225,0211-699501013259,KTV,o
225,0211-699501013259,KRU,o
225,0211-699501013259,PCRn,o
225,0211-699501013259,Cincuenta,o
225,0211-699501013259,y,o
225,0211-699501013259,ocho,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,recibieron,o
225,0211-699501013259,seis,o
225,0211-699501013259,meses,o
225,0211-699501013259,de,o
225,0211-699501013259,suplementacion,i
225,0211-699501013259,con,o
225,0211-699501013259,normalizacion,o
225,0211-699501013259,del,o
225,0211-699501013259,pp,i
225,0211-699501013259,aumento,o
225,0211-699501013259,del,o
225,0211-699501013259,folato,i
225,0211-699501013259,703,o
225,0211-699501013259,IC,o
225,0211-699501013259,638,o
225,0211-699501013259,795,o
225,0211-699501013259,vs,o
225,0211-699501013259,6181,o
225,0211-699501013259,IC,o
225,0211-699501013259,4447,o
225,0211-699501013259,7811,o
225,0211-699501013259,p,o
225,0211-699501013259,0001,o
225,0211-699501013259,y,o
225,0211-699501013259,descenso,o
225,0211-699501013259,de,o
225,0211-699501013259,la,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,240,o
225,0211-699501013259,IC,o
225,0211-699501013259,213,o
225,0211-699501013259,264,o
225,0211-699501013259,vs,o
225,0211-699501013259,199,o
225,0211-699501013259,IC,o
225,0211-699501013259,175,o
225,0211-699501013259,224,o
225,0211-699501013259,p,o
225,0211-699501013259,005,o
225,0211-699501013259,Han,o
225,0211-699501013259,recibido,o
225,0211-699501013259,suplementacion,i
225,0211-699501013259,durante,o
225,0211-699501013259,12,o
225,0211-699501013259,meses,o
225,0211-699501013259,33,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,pero,o
225,0211-699501013259,a,o
225,0211-699501013259,pesar,o
225,0211-699501013259,de,o
225,0211-699501013259,un,o
225,0211-699501013259,continuo,o
225,0211-699501013259,aumento,o
225,0211-699501013259,del,o
225,0211-699501013259,folato,i
225,0211-699501013259,10078,o
225,0211-699501013259,IC,o
225,0211-699501013259,7481,o
225,0211-699501013259,12674,o
225,0211-699501013259,p,o
225,0211-699501013259,0001,o
225,0211-699501013259,solo,o
225,0211-699501013259,3,o
225,0211-699501013259,pacientes,o
225,0211-699501013259,presentan,o
225,0211-699501013259,niveles,o
225,0211-699501013259,normales,o
225,0211-699501013259,de,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,correlacionandose,o
225,0211-699501013259,directamente,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,con,o
225,0211-699501013259,la,o
225,0211-699501013259,albumina,i
225,0211-699501013259,r,o
225,0211-699501013259,056,o
225,0211-699501013259,p,o
225,0211-699501013259,0001,o
225,0211-699501013259,que,o
225,0211-699501013259,se,o
225,0211-699501013259,elevo,o
225,0211-699501013259,con,o
225,0211-699501013259,respecto,o
225,0211-699501013259,al,o
225,0211-699501013259,inicio,o
225,0211-699501013259,337,o
225,0211-699501013259,IC,o
225,0211-699501013259,327,o
225,0211-699501013259,346,o
225,0211-699501013259,vs,o
225,0211-699501013259,350,o
225,0211-699501013259,IC,o
225,0211-699501013259,337,o
225,0211-699501013259,363,o
225,0211-699501013259,p,o
225,0211-699501013259,005,o
225,0211-699501013259,Conclusion,o
225,0211-699501013259,Tras,o
225,0211-699501013259,suplementacion,i
225,0211-699501013259,con,o
225,0211-699501013259,acido,i
225,0211-699501013259,folico,i
225,0211-699501013259,y,o
225,0211-699501013259,vitamina,i
225,0211-699501013259,B6,i
225,0211-699501013259,aunque,o
225,0211-699501013259,inicialmente,o
225,0211-699501013259,se,o
225,0211-699501013259,reduce,o
225,0211-699501013259,la,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,esta,o
225,0211-699501013259,respuesta,o
225,0211-699501013259,se,o
225,0211-699501013259,hace,o
225,0211-699501013259,refractaria,o
225,0211-699501013259,correlacionandose,o
225,0211-699501013259,directamente,o
225,0211-699501013259,la,o
225,0211-699501013259,tHcy,i
225,0211-699501013259,con,o
225,0211-699501013259,la,o
225,0211-699501013259,albumina,i
225,0211-699501013259,plasmatica,i
225,0211-699501013259,La,o
225,0211-699501013259,interpretacion,o
225,0211-699501013259,de,o
225,0211-699501013259,los,o
225,0211-699501013259,niveles,i
225,0211-699501013259,de,i
225,0211-699501013259,tHcy,i
225,0211-699501013259,debe,o
225,0211-699501013259,tener,o
225,0211-699501013259,en,o
225,0211-699501013259,cuenta,o
225,0211-699501013259,la,o
225,0211-699501013259,concentracion,i
225,0211-699501013259,de,i
225,0211-699501013259,albumina,i
226,0211-699501013259,Efecto,o
226,0211-699501013259,de,o
226,0211-699501013259,la,o
226,0211-699501013259,suplementacion,i
226,0211-699501013259,con,o
226,0211-699501013259,acido,i
226,0211-699501013259,folico,i
226,0211-699501013259,sobre,o
226,0211-699501013259,los,o
226,0211-699501013259,niveles,i
226,0211-699501013259,de,i
226,0211-699501013259,homocisteina,i
226,0211-699501013259,total,o
226,0211-699501013259,en,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,en,o
226,0211-699501013259,hemodialisis,i
226,0211-699501013259,La,o
226,0211-699501013259,hiperhomocisteinemia,i
226,0211-699501013259,es,o
226,0211-699501013259,un,o
226,0211-699501013259,marcador,o
226,0211-699501013259,de,o
226,0211-699501013259,riesgo,o
226,0211-699501013259,independiente,o
226,0211-699501013259,de,o
226,0211-699501013259,morbimortalidad,o
226,0211-699501013259,cardiovascular,i
226,0211-699501013259,Hemos,o
226,0211-699501013259,intentado,o
226,0211-699501013259,prospectivamente,o
226,0211-699501013259,reducir,o
226,0211-699501013259,los,o
226,0211-699501013259,niveles,i
226,0211-699501013259,de,i
226,0211-699501013259,homocisteina,i
226,0211-699501013259,total,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,mediante,o
226,0211-699501013259,suplemento,o
226,0211-699501013259,con,o
226,0211-699501013259,acido,i
226,0211-699501013259,folico,i
226,0211-699501013259,y,o
226,0211-699501013259,vitamina,i
226,0211-699501013259,B6,i
226,0211-699501013259,pp,i
226,0211-699501013259,valorando,o
226,0211-699501013259,su,o
226,0211-699501013259,posible,o
226,0211-699501013259,correlacion,o
226,0211-699501013259,con,o
226,0211-699501013259,dosis,o
226,0211-699501013259,de,o
226,0211-699501013259,dialisis,i
226,0211-699501013259,funcion,i
226,0211-699501013259,residual,i
226,0211-699501013259,y,o
226,0211-699501013259,parametros,o
226,0211-699501013259,nutricionales,o
226,0211-699501013259,Metodos,o
226,0211-699501013259,Todos,o
226,0211-699501013259,los,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,en,o
226,0211-699501013259,hemodialisis,i
226,0211-699501013259,al,o
226,0211-699501013259,comienzo,o
226,0211-699501013259,del,o
226,0211-699501013259,estudio,o
226,0211-699501013259,que,o
226,0211-699501013259,no,o
226,0211-699501013259,recibian,o
226,0211-699501013259,acido,i
226,0211-699501013259,folico,i
226,0211-699501013259,ni,o
226,0211-699501013259,vitamina,i
226,0211-699501013259,B6,i
226,0211-699501013259,asi,o
226,0211-699501013259,como,o
226,0211-699501013259,los,o
226,0211-699501013259,incorporados,o
226,0211-699501013259,posteriormente,o
226,0211-699501013259,a,o
226,0211-699501013259,partir,o
226,0211-699501013259,de,o
226,0211-699501013259,su,o
226,0211-699501013259,tercer,o
226,0211-699501013259,mes,o
226,0211-699501013259,en,o
226,0211-699501013259,hemodialisis,i
226,0211-699501013259,recibieron,o
226,0211-699501013259,5,o
226,0211-699501013259,mg,o
226,0211-699501013259,orales,o
226,0211-699501013259,de,o
226,0211-699501013259,acido,i
226,0211-699501013259,folico,i
226,0211-699501013259,cada,o
226,0211-699501013259,48,o
226,0211-699501013259,horas,o
226,0211-699501013259,y,o
226,0211-699501013259,40,o
226,0211-699501013259,mg,o
226,0211-699501013259,orales,o
226,0211-699501013259,de,o
226,0211-699501013259,vitamina,i
226,0211-699501013259,B6,i
226,0211-699501013259,cada,o
226,0211-699501013259,semana,o
226,0211-699501013259,Se,o
226,0211-699501013259,determinaron,o
226,0211-699501013259,al,o
226,0211-699501013259,comienzo,o
226,0211-699501013259,del,o
226,0211-699501013259,estudio,o
226,0211-699501013259,y,o
226,0211-699501013259,cada,o
226,0211-699501013259,2,o
226,0211-699501013259,meses,o
226,0211-699501013259,niveles,i
226,0211-699501013259,de,i
226,0211-699501013259,folato,i
226,0211-699501013259,vitamina,i
226,0211-699501013259,B12,i
226,0211-699501013259,inmunoensayo,i
226,0211-699501013259,albumina,i
226,0211-699501013259,y,o
226,0211-699501013259,cinetica,o
226,0211-699501013259,de,o
226,0211-699501013259,la,o
226,0211-699501013259,urea,i
226,0211-699501013259,KTV,o
226,0211-699501013259,KRU,o
226,0211-699501013259,PCRn,o
226,0211-699501013259,y,o
226,0211-699501013259,cada,o
226,0211-699501013259,6,o
226,0211-699501013259,meses,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,HPLC,i
226,0211-699501013259,y,o
226,0211-699501013259,pp,i
226,0211-699501013259,RIA,i
226,0211-699501013259,Resultados,o
226,0211-699501013259,80,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,fueron,o
226,0211-699501013259,incluidos,o
226,0211-699501013259,en,o
226,0211-699501013259,el,o
226,0211-699501013259,estudio,o
226,0211-699501013259,basal,o
226,0211-699501013259,con,o
226,0211-699501013259,una,o
226,0211-699501013259,prevalencia,o
226,0211-699501013259,de,o
226,0211-699501013259,hiperhomocisteinemia,i
226,0211-699501013259,del,o
226,0211-699501013259,844,o
226,0211-699501013259,deficit,i
226,0211-699501013259,de,i
226,0211-699501013259,pp,i
226,0211-699501013259,en,o
226,0211-699501013259,el,o
226,0211-699501013259,32,o
226,0211-699501013259,y,o
226,0211-699501013259,folato,i
226,0211-699501013259,en,o
226,0211-699501013259,el,o
226,0211-699501013259,rango,o
226,0211-699501013259,normal,o
226,0211-699501013259,bajo,o
226,0211-699501013259,los,o
226,0211-699501013259,niveles,i
226,0211-699501013259,de,i
226,0211-699501013259,tHcy,i
226,0211-699501013259,se,o
226,0211-699501013259,correlacionaban,o
226,0211-699501013259,inversamente,o
226,0211-699501013259,con,o
226,0211-699501013259,los,o
226,0211-699501013259,del,o
226,0211-699501013259,folato,i
226,0211-699501013259,r,o
226,0211-699501013259,0336,o
226,0211-699501013259,p,o
226,0211-699501013259,001,o
226,0211-699501013259,pero,o
226,0211-699501013259,no,o
226,0211-699501013259,con,o
226,0211-699501013259,pp,i
226,0211-699501013259,B12,i
226,0211-699501013259,edad,o
226,0211-699501013259,albumina,i
226,0211-699501013259,KTV,o
226,0211-699501013259,KRU,o
226,0211-699501013259,PCRn,o
226,0211-699501013259,Cincuenta,o
226,0211-699501013259,y,o
226,0211-699501013259,ocho,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,recibieron,o
226,0211-699501013259,seis,o
226,0211-699501013259,meses,o
226,0211-699501013259,de,o
226,0211-699501013259,suplementacion,i
226,0211-699501013259,con,o
226,0211-699501013259,normalizacion,o
226,0211-699501013259,del,o
226,0211-699501013259,pp,i
226,0211-699501013259,aumento,o
226,0211-699501013259,del,o
226,0211-699501013259,folato,i
226,0211-699501013259,703,o
226,0211-699501013259,IC,o
226,0211-699501013259,638,o
226,0211-699501013259,795,o
226,0211-699501013259,vs,o
226,0211-699501013259,6181,o
226,0211-699501013259,IC,o
226,0211-699501013259,4447,o
226,0211-699501013259,7811,o
226,0211-699501013259,p,o
226,0211-699501013259,0001,o
226,0211-699501013259,y,o
226,0211-699501013259,descenso,o
226,0211-699501013259,de,o
226,0211-699501013259,la,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,240,o
226,0211-699501013259,IC,o
226,0211-699501013259,213,o
226,0211-699501013259,264,o
226,0211-699501013259,vs,o
226,0211-699501013259,199,o
226,0211-699501013259,IC,o
226,0211-699501013259,175,o
226,0211-699501013259,224,o
226,0211-699501013259,p,o
226,0211-699501013259,005,o
226,0211-699501013259,Han,o
226,0211-699501013259,recibido,o
226,0211-699501013259,suplementacion,i
226,0211-699501013259,durante,o
226,0211-699501013259,12,o
226,0211-699501013259,meses,o
226,0211-699501013259,33,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,pero,o
226,0211-699501013259,a,o
226,0211-699501013259,pesar,o
226,0211-699501013259,de,o
226,0211-699501013259,un,o
226,0211-699501013259,continuo,o
226,0211-699501013259,aumento,o
226,0211-699501013259,del,o
226,0211-699501013259,folato,i
226,0211-699501013259,10078,o
226,0211-699501013259,IC,o
226,0211-699501013259,7481,o
226,0211-699501013259,12674,o
226,0211-699501013259,p,o
226,0211-699501013259,0001,o
226,0211-699501013259,solo,o
226,0211-699501013259,3,o
226,0211-699501013259,pacientes,o
226,0211-699501013259,presentan,o
226,0211-699501013259,niveles,o
226,0211-699501013259,normales,o
226,0211-699501013259,de,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,correlacionandose,o
226,0211-699501013259,directamente,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,con,o
226,0211-699501013259,la,o
226,0211-699501013259,albumina,i
226,0211-699501013259,r,o
226,0211-699501013259,056,o
226,0211-699501013259,p,o
226,0211-699501013259,0001,o
226,0211-699501013259,que,o
226,0211-699501013259,se,o
226,0211-699501013259,elevo,o
226,0211-699501013259,con,o
226,0211-699501013259,respecto,o
226,0211-699501013259,al,o
226,0211-699501013259,inicio,o
226,0211-699501013259,337,o
226,0211-699501013259,IC,o
226,0211-699501013259,327,o
226,0211-699501013259,346,o
226,0211-699501013259,vs,o
226,0211-699501013259,350,o
226,0211-699501013259,IC,o
226,0211-699501013259,337,o
226,0211-699501013259,363,o
226,0211-699501013259,p,o
226,0211-699501013259,005,o
226,0211-699501013259,Conclusion,o
226,0211-699501013259,Tras,o
226,0211-699501013259,suplementacion,i
226,0211-699501013259,con,o
226,0211-699501013259,acido,i
226,0211-699501013259,folico,i
226,0211-699501013259,y,o
226,0211-699501013259,vitamina,i
226,0211-699501013259,B6,i
226,0211-699501013259,aunque,o
226,0211-699501013259,inicialmente,o
226,0211-699501013259,se,o
226,0211-699501013259,reduce,o
226,0211-699501013259,la,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,esta,o
226,0211-699501013259,respuesta,o
226,0211-699501013259,se,o
226,0211-699501013259,hace,o
226,0211-699501013259,refractaria,o
226,0211-699501013259,correlacionandose,o
226,0211-699501013259,directamente,o
226,0211-699501013259,la,o
226,0211-699501013259,tHcy,i
226,0211-699501013259,con,o
226,0211-699501013259,la,o
226,0211-699501013259,albumina,i
226,0211-699501013259,plasmatica,i
226,0211-699501013259,La,o
226,0211-699501013259,interpretacion,o
226,0211-699501013259,de,o
226,0211-699501013259,los,o
226,0211-699501013259,niveles,i
226,0211-699501013259,de,i
226,0211-699501013259,tHcy,i
226,0211-699501013259,debe,o
226,0211-699501013259,tener,o
226,0211-699501013259,en,o
226,0211-699501013259,cuenta,o
226,0211-699501013259,la,o
226,0211-699501013259,concentracion,i
226,0211-699501013259,de,i
226,0211-699501013259,albumina,i
227,0211-699501013259,Efecto,o
227,0211-699501013259,de,o
227,0211-699501013259,la,o
227,0211-699501013259,suplementacion,i
227,0211-699501013259,con,o
227,0211-699501013259,acido,i
227,0211-699501013259,folico,i
227,0211-699501013259,sobre,o
227,0211-699501013259,los,o
227,0211-699501013259,niveles,i
227,0211-699501013259,de,i
227,0211-699501013259,homocisteina,i
227,0211-699501013259,total,o
227,0211-699501013259,en,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,en,o
227,0211-699501013259,hemodialisis,i
227,0211-699501013259,La,o
227,0211-699501013259,hiperhomocisteinemia,i
227,0211-699501013259,es,o
227,0211-699501013259,un,o
227,0211-699501013259,marcador,o
227,0211-699501013259,de,o
227,0211-699501013259,riesgo,o
227,0211-699501013259,independiente,o
227,0211-699501013259,de,o
227,0211-699501013259,morbimortalidad,o
227,0211-699501013259,cardiovascular,i
227,0211-699501013259,Hemos,o
227,0211-699501013259,intentado,o
227,0211-699501013259,prospectivamente,o
227,0211-699501013259,reducir,o
227,0211-699501013259,los,o
227,0211-699501013259,niveles,i
227,0211-699501013259,de,i
227,0211-699501013259,homocisteina,i
227,0211-699501013259,total,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,mediante,o
227,0211-699501013259,suplemento,o
227,0211-699501013259,con,o
227,0211-699501013259,acido,i
227,0211-699501013259,folico,i
227,0211-699501013259,y,o
227,0211-699501013259,vitamina,i
227,0211-699501013259,B6,i
227,0211-699501013259,pp,i
227,0211-699501013259,valorando,o
227,0211-699501013259,su,o
227,0211-699501013259,posible,o
227,0211-699501013259,correlacion,o
227,0211-699501013259,con,o
227,0211-699501013259,dosis,o
227,0211-699501013259,de,o
227,0211-699501013259,dialisis,i
227,0211-699501013259,funcion,i
227,0211-699501013259,residual,i
227,0211-699501013259,y,o
227,0211-699501013259,parametros,o
227,0211-699501013259,nutricionales,o
227,0211-699501013259,Metodos,o
227,0211-699501013259,Todos,o
227,0211-699501013259,los,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,en,o
227,0211-699501013259,hemodialisis,i
227,0211-699501013259,al,o
227,0211-699501013259,comienzo,o
227,0211-699501013259,del,o
227,0211-699501013259,estudio,o
227,0211-699501013259,que,o
227,0211-699501013259,no,o
227,0211-699501013259,recibian,o
227,0211-699501013259,acido,i
227,0211-699501013259,folico,i
227,0211-699501013259,ni,o
227,0211-699501013259,vitamina,i
227,0211-699501013259,B6,i
227,0211-699501013259,asi,o
227,0211-699501013259,como,o
227,0211-699501013259,los,o
227,0211-699501013259,incorporados,o
227,0211-699501013259,posteriormente,o
227,0211-699501013259,a,o
227,0211-699501013259,partir,o
227,0211-699501013259,de,o
227,0211-699501013259,su,o
227,0211-699501013259,tercer,o
227,0211-699501013259,mes,o
227,0211-699501013259,en,o
227,0211-699501013259,hemodialisis,i
227,0211-699501013259,recibieron,o
227,0211-699501013259,5,o
227,0211-699501013259,mg,o
227,0211-699501013259,orales,o
227,0211-699501013259,de,o
227,0211-699501013259,acido,i
227,0211-699501013259,folico,i
227,0211-699501013259,cada,o
227,0211-699501013259,48,o
227,0211-699501013259,horas,o
227,0211-699501013259,y,o
227,0211-699501013259,40,o
227,0211-699501013259,mg,o
227,0211-699501013259,orales,o
227,0211-699501013259,de,o
227,0211-699501013259,vitamina,i
227,0211-699501013259,B6,i
227,0211-699501013259,cada,o
227,0211-699501013259,semana,o
227,0211-699501013259,Se,o
227,0211-699501013259,determinaron,o
227,0211-699501013259,al,o
227,0211-699501013259,comienzo,o
227,0211-699501013259,del,o
227,0211-699501013259,estudio,o
227,0211-699501013259,y,o
227,0211-699501013259,cada,o
227,0211-699501013259,2,o
227,0211-699501013259,meses,o
227,0211-699501013259,niveles,i
227,0211-699501013259,de,i
227,0211-699501013259,folato,i
227,0211-699501013259,vitamina,i
227,0211-699501013259,B12,i
227,0211-699501013259,inmunoensayo,i
227,0211-699501013259,albumina,i
227,0211-699501013259,y,o
227,0211-699501013259,cinetica,o
227,0211-699501013259,de,o
227,0211-699501013259,la,o
227,0211-699501013259,urea,i
227,0211-699501013259,KTV,o
227,0211-699501013259,KRU,o
227,0211-699501013259,PCRn,o
227,0211-699501013259,y,o
227,0211-699501013259,cada,o
227,0211-699501013259,6,o
227,0211-699501013259,meses,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,HPLC,i
227,0211-699501013259,y,o
227,0211-699501013259,pp,i
227,0211-699501013259,RIA,i
227,0211-699501013259,Resultados,o
227,0211-699501013259,80,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,fueron,o
227,0211-699501013259,incluidos,o
227,0211-699501013259,en,o
227,0211-699501013259,el,o
227,0211-699501013259,estudio,o
227,0211-699501013259,basal,o
227,0211-699501013259,con,o
227,0211-699501013259,una,o
227,0211-699501013259,prevalencia,o
227,0211-699501013259,de,o
227,0211-699501013259,hiperhomocisteinemia,i
227,0211-699501013259,del,o
227,0211-699501013259,844,o
227,0211-699501013259,deficit,i
227,0211-699501013259,de,i
227,0211-699501013259,pp,i
227,0211-699501013259,en,o
227,0211-699501013259,el,o
227,0211-699501013259,32,o
227,0211-699501013259,y,o
227,0211-699501013259,folato,i
227,0211-699501013259,en,o
227,0211-699501013259,el,o
227,0211-699501013259,rango,o
227,0211-699501013259,normal,o
227,0211-699501013259,bajo,o
227,0211-699501013259,los,o
227,0211-699501013259,niveles,i
227,0211-699501013259,de,i
227,0211-699501013259,tHcy,i
227,0211-699501013259,se,o
227,0211-699501013259,correlacionaban,o
227,0211-699501013259,inversamente,o
227,0211-699501013259,con,o
227,0211-699501013259,los,o
227,0211-699501013259,del,o
227,0211-699501013259,folato,i
227,0211-699501013259,r,o
227,0211-699501013259,0336,o
227,0211-699501013259,p,o
227,0211-699501013259,001,o
227,0211-699501013259,pero,o
227,0211-699501013259,no,o
227,0211-699501013259,con,o
227,0211-699501013259,pp,i
227,0211-699501013259,B12,i
227,0211-699501013259,edad,o
227,0211-699501013259,albumina,i
227,0211-699501013259,KTV,o
227,0211-699501013259,KRU,o
227,0211-699501013259,PCRn,o
227,0211-699501013259,Cincuenta,o
227,0211-699501013259,y,o
227,0211-699501013259,ocho,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,recibieron,o
227,0211-699501013259,seis,o
227,0211-699501013259,meses,o
227,0211-699501013259,de,o
227,0211-699501013259,suplementacion,i
227,0211-699501013259,con,o
227,0211-699501013259,normalizacion,o
227,0211-699501013259,del,o
227,0211-699501013259,pp,i
227,0211-699501013259,aumento,o
227,0211-699501013259,del,o
227,0211-699501013259,folato,i
227,0211-699501013259,703,o
227,0211-699501013259,IC,o
227,0211-699501013259,638,o
227,0211-699501013259,795,o
227,0211-699501013259,vs,o
227,0211-699501013259,6181,o
227,0211-699501013259,IC,o
227,0211-699501013259,4447,o
227,0211-699501013259,7811,o
227,0211-699501013259,p,o
227,0211-699501013259,0001,o
227,0211-699501013259,y,o
227,0211-699501013259,descenso,o
227,0211-699501013259,de,o
227,0211-699501013259,la,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,240,o
227,0211-699501013259,IC,o
227,0211-699501013259,213,o
227,0211-699501013259,264,o
227,0211-699501013259,vs,o
227,0211-699501013259,199,o
227,0211-699501013259,IC,o
227,0211-699501013259,175,o
227,0211-699501013259,224,o
227,0211-699501013259,p,o
227,0211-699501013259,005,o
227,0211-699501013259,Han,o
227,0211-699501013259,recibido,o
227,0211-699501013259,suplementacion,i
227,0211-699501013259,durante,o
227,0211-699501013259,12,o
227,0211-699501013259,meses,o
227,0211-699501013259,33,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,pero,o
227,0211-699501013259,a,o
227,0211-699501013259,pesar,o
227,0211-699501013259,de,o
227,0211-699501013259,un,o
227,0211-699501013259,continuo,o
227,0211-699501013259,aumento,o
227,0211-699501013259,del,o
227,0211-699501013259,folato,i
227,0211-699501013259,10078,o
227,0211-699501013259,IC,o
227,0211-699501013259,7481,o
227,0211-699501013259,12674,o
227,0211-699501013259,p,o
227,0211-699501013259,0001,o
227,0211-699501013259,solo,o
227,0211-699501013259,3,o
227,0211-699501013259,pacientes,o
227,0211-699501013259,presentan,o
227,0211-699501013259,niveles,o
227,0211-699501013259,normales,o
227,0211-699501013259,de,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,correlacionandose,o
227,0211-699501013259,directamente,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,con,o
227,0211-699501013259,la,o
227,0211-699501013259,albumina,i
227,0211-699501013259,r,o
227,0211-699501013259,056,o
227,0211-699501013259,p,o
227,0211-699501013259,0001,o
227,0211-699501013259,que,o
227,0211-699501013259,se,o
227,0211-699501013259,elevo,o
227,0211-699501013259,con,o
227,0211-699501013259,respecto,o
227,0211-699501013259,al,o
227,0211-699501013259,inicio,o
227,0211-699501013259,337,o
227,0211-699501013259,IC,o
227,0211-699501013259,327,o
227,0211-699501013259,346,o
227,0211-699501013259,vs,o
227,0211-699501013259,350,o
227,0211-699501013259,IC,o
227,0211-699501013259,337,o
227,0211-699501013259,363,o
227,0211-699501013259,p,o
227,0211-699501013259,005,o
227,0211-699501013259,Conclusion,o
227,0211-699501013259,Tras,o
227,0211-699501013259,suplementacion,i
227,0211-699501013259,con,o
227,0211-699501013259,acido,i
227,0211-699501013259,folico,i
227,0211-699501013259,y,o
227,0211-699501013259,vitamina,i
227,0211-699501013259,B6,i
227,0211-699501013259,aunque,o
227,0211-699501013259,inicialmente,o
227,0211-699501013259,se,o
227,0211-699501013259,reduce,o
227,0211-699501013259,la,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,esta,o
227,0211-699501013259,respuesta,o
227,0211-699501013259,se,o
227,0211-699501013259,hace,o
227,0211-699501013259,refractaria,o
227,0211-699501013259,correlacionandose,o
227,0211-699501013259,directamente,o
227,0211-699501013259,la,o
227,0211-699501013259,tHcy,i
227,0211-699501013259,con,o
227,0211-699501013259,la,o
227,0211-699501013259,albumina,i
227,0211-699501013259,plasmatica,i
227,0211-699501013259,La,o
227,0211-699501013259,interpretacion,o
227,0211-699501013259,de,o
227,0211-699501013259,los,o
227,0211-699501013259,niveles,i
227,0211-699501013259,de,i
227,0211-699501013259,tHcy,i
227,0211-699501013259,debe,o
227,0211-699501013259,tener,o
227,0211-699501013259,en,o
227,0211-699501013259,cuenta,o
227,0211-699501013259,la,o
227,0211-699501013259,concentracion,i
227,0211-699501013259,de,i
227,0211-699501013259,albumina,i
228,0211-699501013259,Efecto,o
228,0211-699501013259,de,o
228,0211-699501013259,la,o
228,0211-699501013259,suplementacion,i
228,0211-699501013259,con,o
228,0211-699501013259,acido,i
228,0211-699501013259,folico,i
228,0211-699501013259,sobre,o
228,0211-699501013259,los,o
228,0211-699501013259,niveles,i
228,0211-699501013259,de,i
228,0211-699501013259,homocisteina,i
228,0211-699501013259,total,o
228,0211-699501013259,en,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,en,o
228,0211-699501013259,hemodialisis,i
228,0211-699501013259,La,o
228,0211-699501013259,hiperhomocisteinemia,i
228,0211-699501013259,es,o
228,0211-699501013259,un,o
228,0211-699501013259,marcador,o
228,0211-699501013259,de,o
228,0211-699501013259,riesgo,o
228,0211-699501013259,independiente,o
228,0211-699501013259,de,o
228,0211-699501013259,morbimortalidad,o
228,0211-699501013259,cardiovascular,i
228,0211-699501013259,Hemos,o
228,0211-699501013259,intentado,o
228,0211-699501013259,prospectivamente,o
228,0211-699501013259,reducir,o
228,0211-699501013259,los,o
228,0211-699501013259,niveles,i
228,0211-699501013259,de,i
228,0211-699501013259,homocisteina,i
228,0211-699501013259,total,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,mediante,o
228,0211-699501013259,suplemento,o
228,0211-699501013259,con,o
228,0211-699501013259,acido,i
228,0211-699501013259,folico,i
228,0211-699501013259,y,o
228,0211-699501013259,vitamina,i
228,0211-699501013259,B6,i
228,0211-699501013259,pp,i
228,0211-699501013259,valorando,o
228,0211-699501013259,su,o
228,0211-699501013259,posible,o
228,0211-699501013259,correlacion,o
228,0211-699501013259,con,o
228,0211-699501013259,dosis,o
228,0211-699501013259,de,o
228,0211-699501013259,dialisis,i
228,0211-699501013259,funcion,i
228,0211-699501013259,residual,i
228,0211-699501013259,y,o
228,0211-699501013259,parametros,o
228,0211-699501013259,nutricionales,o
228,0211-699501013259,Metodos,o
228,0211-699501013259,Todos,o
228,0211-699501013259,los,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,en,o
228,0211-699501013259,hemodialisis,i
228,0211-699501013259,al,o
228,0211-699501013259,comienzo,o
228,0211-699501013259,del,o
228,0211-699501013259,estudio,o
228,0211-699501013259,que,o
228,0211-699501013259,no,o
228,0211-699501013259,recibian,o
228,0211-699501013259,acido,i
228,0211-699501013259,folico,i
228,0211-699501013259,ni,o
228,0211-699501013259,vitamina,i
228,0211-699501013259,B6,i
228,0211-699501013259,asi,o
228,0211-699501013259,como,o
228,0211-699501013259,los,o
228,0211-699501013259,incorporados,o
228,0211-699501013259,posteriormente,o
228,0211-699501013259,a,o
228,0211-699501013259,partir,o
228,0211-699501013259,de,o
228,0211-699501013259,su,o
228,0211-699501013259,tercer,o
228,0211-699501013259,mes,o
228,0211-699501013259,en,o
228,0211-699501013259,hemodialisis,i
228,0211-699501013259,recibieron,o
228,0211-699501013259,5,o
228,0211-699501013259,mg,o
228,0211-699501013259,orales,o
228,0211-699501013259,de,o
228,0211-699501013259,acido,i
228,0211-699501013259,folico,i
228,0211-699501013259,cada,o
228,0211-699501013259,48,o
228,0211-699501013259,horas,o
228,0211-699501013259,y,o
228,0211-699501013259,40,o
228,0211-699501013259,mg,o
228,0211-699501013259,orales,o
228,0211-699501013259,de,o
228,0211-699501013259,vitamina,i
228,0211-699501013259,B6,i
228,0211-699501013259,cada,o
228,0211-699501013259,semana,o
228,0211-699501013259,Se,o
228,0211-699501013259,determinaron,o
228,0211-699501013259,al,o
228,0211-699501013259,comienzo,o
228,0211-699501013259,del,o
228,0211-699501013259,estudio,o
228,0211-699501013259,y,o
228,0211-699501013259,cada,o
228,0211-699501013259,2,o
228,0211-699501013259,meses,o
228,0211-699501013259,niveles,i
228,0211-699501013259,de,i
228,0211-699501013259,folato,i
228,0211-699501013259,vitamina,i
228,0211-699501013259,B12,i
228,0211-699501013259,inmunoensayo,i
228,0211-699501013259,albumina,i
228,0211-699501013259,y,o
228,0211-699501013259,cinetica,o
228,0211-699501013259,de,o
228,0211-699501013259,la,o
228,0211-699501013259,urea,i
228,0211-699501013259,KTV,o
228,0211-699501013259,KRU,o
228,0211-699501013259,PCRn,o
228,0211-699501013259,y,o
228,0211-699501013259,cada,o
228,0211-699501013259,6,o
228,0211-699501013259,meses,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,HPLC,i
228,0211-699501013259,y,o
228,0211-699501013259,pp,i
228,0211-699501013259,RIA,i
228,0211-699501013259,Resultados,o
228,0211-699501013259,80,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,fueron,o
228,0211-699501013259,incluidos,o
228,0211-699501013259,en,o
228,0211-699501013259,el,o
228,0211-699501013259,estudio,o
228,0211-699501013259,basal,o
228,0211-699501013259,con,o
228,0211-699501013259,una,o
228,0211-699501013259,prevalencia,o
228,0211-699501013259,de,o
228,0211-699501013259,hiperhomocisteinemia,i
228,0211-699501013259,del,o
228,0211-699501013259,844,o
228,0211-699501013259,deficit,i
228,0211-699501013259,de,i
228,0211-699501013259,pp,i
228,0211-699501013259,en,o
228,0211-699501013259,el,o
228,0211-699501013259,32,o
228,0211-699501013259,y,o
228,0211-699501013259,folato,i
228,0211-699501013259,en,o
228,0211-699501013259,el,o
228,0211-699501013259,rango,o
228,0211-699501013259,normal,o
228,0211-699501013259,bajo,o
228,0211-699501013259,los,o
228,0211-699501013259,niveles,i
228,0211-699501013259,de,i
228,0211-699501013259,tHcy,i
228,0211-699501013259,se,o
228,0211-699501013259,correlacionaban,o
228,0211-699501013259,inversamente,o
228,0211-699501013259,con,o
228,0211-699501013259,los,o
228,0211-699501013259,del,o
228,0211-699501013259,folato,i
228,0211-699501013259,r,o
228,0211-699501013259,0336,o
228,0211-699501013259,p,o
228,0211-699501013259,001,o
228,0211-699501013259,pero,o
228,0211-699501013259,no,o
228,0211-699501013259,con,o
228,0211-699501013259,pp,i
228,0211-699501013259,B12,i
228,0211-699501013259,edad,o
228,0211-699501013259,albumina,i
228,0211-699501013259,KTV,o
228,0211-699501013259,KRU,o
228,0211-699501013259,PCRn,o
228,0211-699501013259,Cincuenta,o
228,0211-699501013259,y,o
228,0211-699501013259,ocho,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,recibieron,o
228,0211-699501013259,seis,o
228,0211-699501013259,meses,o
228,0211-699501013259,de,o
228,0211-699501013259,suplementacion,i
228,0211-699501013259,con,o
228,0211-699501013259,normalizacion,o
228,0211-699501013259,del,o
228,0211-699501013259,pp,i
228,0211-699501013259,aumento,o
228,0211-699501013259,del,o
228,0211-699501013259,folato,i
228,0211-699501013259,703,o
228,0211-699501013259,IC,o
228,0211-699501013259,638,o
228,0211-699501013259,795,o
228,0211-699501013259,vs,o
228,0211-699501013259,6181,o
228,0211-699501013259,IC,o
228,0211-699501013259,4447,o
228,0211-699501013259,7811,o
228,0211-699501013259,p,o
228,0211-699501013259,0001,o
228,0211-699501013259,y,o
228,0211-699501013259,descenso,o
228,0211-699501013259,de,o
228,0211-699501013259,la,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,240,o
228,0211-699501013259,IC,o
228,0211-699501013259,213,o
228,0211-699501013259,264,o
228,0211-699501013259,vs,o
228,0211-699501013259,199,o
228,0211-699501013259,IC,o
228,0211-699501013259,175,o
228,0211-699501013259,224,o
228,0211-699501013259,p,o
228,0211-699501013259,005,o
228,0211-699501013259,Han,o
228,0211-699501013259,recibido,o
228,0211-699501013259,suplementacion,i
228,0211-699501013259,durante,o
228,0211-699501013259,12,o
228,0211-699501013259,meses,o
228,0211-699501013259,33,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,pero,o
228,0211-699501013259,a,o
228,0211-699501013259,pesar,o
228,0211-699501013259,de,o
228,0211-699501013259,un,o
228,0211-699501013259,continuo,o
228,0211-699501013259,aumento,o
228,0211-699501013259,del,o
228,0211-699501013259,folato,i
228,0211-699501013259,10078,o
228,0211-699501013259,IC,o
228,0211-699501013259,7481,o
228,0211-699501013259,12674,o
228,0211-699501013259,p,o
228,0211-699501013259,0001,o
228,0211-699501013259,solo,o
228,0211-699501013259,3,o
228,0211-699501013259,pacientes,o
228,0211-699501013259,presentan,o
228,0211-699501013259,niveles,o
228,0211-699501013259,normales,o
228,0211-699501013259,de,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,correlacionandose,o
228,0211-699501013259,directamente,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,con,o
228,0211-699501013259,la,o
228,0211-699501013259,albumina,i
228,0211-699501013259,r,o
228,0211-699501013259,056,o
228,0211-699501013259,p,o
228,0211-699501013259,0001,o
228,0211-699501013259,que,o
228,0211-699501013259,se,o
228,0211-699501013259,elevo,o
228,0211-699501013259,con,o
228,0211-699501013259,respecto,o
228,0211-699501013259,al,o
228,0211-699501013259,inicio,o
228,0211-699501013259,337,o
228,0211-699501013259,IC,o
228,0211-699501013259,327,o
228,0211-699501013259,346,o
228,0211-699501013259,vs,o
228,0211-699501013259,350,o
228,0211-699501013259,IC,o
228,0211-699501013259,337,o
228,0211-699501013259,363,o
228,0211-699501013259,p,o
228,0211-699501013259,005,o
228,0211-699501013259,Conclusion,o
228,0211-699501013259,Tras,o
228,0211-699501013259,suplementacion,i
228,0211-699501013259,con,o
228,0211-699501013259,acido,i
228,0211-699501013259,folico,i
228,0211-699501013259,y,o
228,0211-699501013259,vitamina,i
228,0211-699501013259,B6,i
228,0211-699501013259,aunque,o
228,0211-699501013259,inicialmente,o
228,0211-699501013259,se,o
228,0211-699501013259,reduce,o
228,0211-699501013259,la,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,esta,o
228,0211-699501013259,respuesta,o
228,0211-699501013259,se,o
228,0211-699501013259,hace,o
228,0211-699501013259,refractaria,o
228,0211-699501013259,correlacionandose,o
228,0211-699501013259,directamente,o
228,0211-699501013259,la,o
228,0211-699501013259,tHcy,i
228,0211-699501013259,con,o
228,0211-699501013259,la,o
228,0211-699501013259,albumina,i
228,0211-699501013259,plasmatica,i
228,0211-699501013259,La,o
228,0211-699501013259,interpretacion,o
228,0211-699501013259,de,o
228,0211-699501013259,los,o
228,0211-699501013259,niveles,i
228,0211-699501013259,de,i
228,0211-699501013259,tHcy,i
228,0211-699501013259,debe,o
228,0211-699501013259,tener,o
228,0211-699501013259,en,o
228,0211-699501013259,cuenta,o
228,0211-699501013259,la,o
228,0211-699501013259,concentracion,i
228,0211-699501013259,de,i
228,0211-699501013259,albumina,i
229,0211-699501013259,Efecto,o
229,0211-699501013259,de,o
229,0211-699501013259,la,o
229,0211-699501013259,suplementacion,i
229,0211-699501013259,con,o
229,0211-699501013259,acido,i
229,0211-699501013259,folico,i
229,0211-699501013259,sobre,o
229,0211-699501013259,los,o
229,0211-699501013259,niveles,i
229,0211-699501013259,de,i
229,0211-699501013259,homocisteina,i
229,0211-699501013259,total,o
229,0211-699501013259,en,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,en,o
229,0211-699501013259,hemodialisis,i
229,0211-699501013259,La,o
229,0211-699501013259,hiperhomocisteinemia,i
229,0211-699501013259,es,o
229,0211-699501013259,un,o
229,0211-699501013259,marcador,o
229,0211-699501013259,de,o
229,0211-699501013259,riesgo,o
229,0211-699501013259,independiente,o
229,0211-699501013259,de,o
229,0211-699501013259,morbimortalidad,o
229,0211-699501013259,cardiovascular,i
229,0211-699501013259,Hemos,o
229,0211-699501013259,intentado,o
229,0211-699501013259,prospectivamente,o
229,0211-699501013259,reducir,o
229,0211-699501013259,los,o
229,0211-699501013259,niveles,i
229,0211-699501013259,de,i
229,0211-699501013259,homocisteina,i
229,0211-699501013259,total,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,mediante,o
229,0211-699501013259,suplemento,o
229,0211-699501013259,con,o
229,0211-699501013259,acido,i
229,0211-699501013259,folico,i
229,0211-699501013259,y,o
229,0211-699501013259,vitamina,i
229,0211-699501013259,B6,i
229,0211-699501013259,pp,i
229,0211-699501013259,valorando,o
229,0211-699501013259,su,o
229,0211-699501013259,posible,o
229,0211-699501013259,correlacion,o
229,0211-699501013259,con,o
229,0211-699501013259,dosis,o
229,0211-699501013259,de,o
229,0211-699501013259,dialisis,i
229,0211-699501013259,funcion,i
229,0211-699501013259,residual,i
229,0211-699501013259,y,o
229,0211-699501013259,parametros,o
229,0211-699501013259,nutricionales,o
229,0211-699501013259,Metodos,o
229,0211-699501013259,Todos,o
229,0211-699501013259,los,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,en,o
229,0211-699501013259,hemodialisis,i
229,0211-699501013259,al,o
229,0211-699501013259,comienzo,o
229,0211-699501013259,del,o
229,0211-699501013259,estudio,o
229,0211-699501013259,que,o
229,0211-699501013259,no,o
229,0211-699501013259,recibian,o
229,0211-699501013259,acido,i
229,0211-699501013259,folico,i
229,0211-699501013259,ni,o
229,0211-699501013259,vitamina,i
229,0211-699501013259,B6,i
229,0211-699501013259,asi,o
229,0211-699501013259,como,o
229,0211-699501013259,los,o
229,0211-699501013259,incorporados,o
229,0211-699501013259,posteriormente,o
229,0211-699501013259,a,o
229,0211-699501013259,partir,o
229,0211-699501013259,de,o
229,0211-699501013259,su,o
229,0211-699501013259,tercer,o
229,0211-699501013259,mes,o
229,0211-699501013259,en,o
229,0211-699501013259,hemodialisis,i
229,0211-699501013259,recibieron,o
229,0211-699501013259,5,o
229,0211-699501013259,mg,o
229,0211-699501013259,orales,o
229,0211-699501013259,de,o
229,0211-699501013259,acido,i
229,0211-699501013259,folico,i
229,0211-699501013259,cada,o
229,0211-699501013259,48,o
229,0211-699501013259,horas,o
229,0211-699501013259,y,o
229,0211-699501013259,40,o
229,0211-699501013259,mg,o
229,0211-699501013259,orales,o
229,0211-699501013259,de,o
229,0211-699501013259,vitamina,i
229,0211-699501013259,B6,i
229,0211-699501013259,cada,o
229,0211-699501013259,semana,o
229,0211-699501013259,Se,o
229,0211-699501013259,determinaron,o
229,0211-699501013259,al,o
229,0211-699501013259,comienzo,o
229,0211-699501013259,del,o
229,0211-699501013259,estudio,o
229,0211-699501013259,y,o
229,0211-699501013259,cada,o
229,0211-699501013259,2,o
229,0211-699501013259,meses,o
229,0211-699501013259,niveles,i
229,0211-699501013259,de,i
229,0211-699501013259,folato,i
229,0211-699501013259,vitamina,i
229,0211-699501013259,B12,i
229,0211-699501013259,inmunoensayo,i
229,0211-699501013259,albumina,i
229,0211-699501013259,y,o
229,0211-699501013259,cinetica,o
229,0211-699501013259,de,o
229,0211-699501013259,la,o
229,0211-699501013259,urea,i
229,0211-699501013259,KTV,o
229,0211-699501013259,KRU,o
229,0211-699501013259,PCRn,o
229,0211-699501013259,y,o
229,0211-699501013259,cada,o
229,0211-699501013259,6,o
229,0211-699501013259,meses,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,HPLC,i
229,0211-699501013259,y,o
229,0211-699501013259,pp,i
229,0211-699501013259,RIA,i
229,0211-699501013259,Resultados,o
229,0211-699501013259,80,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,fueron,o
229,0211-699501013259,incluidos,o
229,0211-699501013259,en,o
229,0211-699501013259,el,o
229,0211-699501013259,estudio,o
229,0211-699501013259,basal,o
229,0211-699501013259,con,o
229,0211-699501013259,una,o
229,0211-699501013259,prevalencia,o
229,0211-699501013259,de,o
229,0211-699501013259,hiperhomocisteinemia,i
229,0211-699501013259,del,o
229,0211-699501013259,844,o
229,0211-699501013259,deficit,i
229,0211-699501013259,de,i
229,0211-699501013259,pp,i
229,0211-699501013259,en,o
229,0211-699501013259,el,o
229,0211-699501013259,32,o
229,0211-699501013259,y,o
229,0211-699501013259,folato,i
229,0211-699501013259,en,o
229,0211-699501013259,el,o
229,0211-699501013259,rango,o
229,0211-699501013259,normal,o
229,0211-699501013259,bajo,o
229,0211-699501013259,los,o
229,0211-699501013259,niveles,i
229,0211-699501013259,de,i
229,0211-699501013259,tHcy,i
229,0211-699501013259,se,o
229,0211-699501013259,correlacionaban,o
229,0211-699501013259,inversamente,o
229,0211-699501013259,con,o
229,0211-699501013259,los,o
229,0211-699501013259,del,o
229,0211-699501013259,folato,i
229,0211-699501013259,r,o
229,0211-699501013259,0336,o
229,0211-699501013259,p,o
229,0211-699501013259,001,o
229,0211-699501013259,pero,o
229,0211-699501013259,no,o
229,0211-699501013259,con,o
229,0211-699501013259,pp,i
229,0211-699501013259,B12,i
229,0211-699501013259,edad,o
229,0211-699501013259,albumina,i
229,0211-699501013259,KTV,o
229,0211-699501013259,KRU,o
229,0211-699501013259,PCRn,o
229,0211-699501013259,Cincuenta,o
229,0211-699501013259,y,o
229,0211-699501013259,ocho,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,recibieron,o
229,0211-699501013259,seis,o
229,0211-699501013259,meses,o
229,0211-699501013259,de,o
229,0211-699501013259,suplementacion,i
229,0211-699501013259,con,o
229,0211-699501013259,normalizacion,o
229,0211-699501013259,del,o
229,0211-699501013259,pp,i
229,0211-699501013259,aumento,o
229,0211-699501013259,del,o
229,0211-699501013259,folato,i
229,0211-699501013259,703,o
229,0211-699501013259,IC,o
229,0211-699501013259,638,o
229,0211-699501013259,795,o
229,0211-699501013259,vs,o
229,0211-699501013259,6181,o
229,0211-699501013259,IC,o
229,0211-699501013259,4447,o
229,0211-699501013259,7811,o
229,0211-699501013259,p,o
229,0211-699501013259,0001,o
229,0211-699501013259,y,o
229,0211-699501013259,descenso,o
229,0211-699501013259,de,o
229,0211-699501013259,la,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,240,o
229,0211-699501013259,IC,o
229,0211-699501013259,213,o
229,0211-699501013259,264,o
229,0211-699501013259,vs,o
229,0211-699501013259,199,o
229,0211-699501013259,IC,o
229,0211-699501013259,175,o
229,0211-699501013259,224,o
229,0211-699501013259,p,o
229,0211-699501013259,005,o
229,0211-699501013259,Han,o
229,0211-699501013259,recibido,o
229,0211-699501013259,suplementacion,i
229,0211-699501013259,durante,o
229,0211-699501013259,12,o
229,0211-699501013259,meses,o
229,0211-699501013259,33,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,pero,o
229,0211-699501013259,a,o
229,0211-699501013259,pesar,o
229,0211-699501013259,de,o
229,0211-699501013259,un,o
229,0211-699501013259,continuo,o
229,0211-699501013259,aumento,o
229,0211-699501013259,del,o
229,0211-699501013259,folato,i
229,0211-699501013259,10078,o
229,0211-699501013259,IC,o
229,0211-699501013259,7481,o
229,0211-699501013259,12674,o
229,0211-699501013259,p,o
229,0211-699501013259,0001,o
229,0211-699501013259,solo,o
229,0211-699501013259,3,o
229,0211-699501013259,pacientes,o
229,0211-699501013259,presentan,o
229,0211-699501013259,niveles,o
229,0211-699501013259,normales,o
229,0211-699501013259,de,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,correlacionandose,o
229,0211-699501013259,directamente,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,con,o
229,0211-699501013259,la,o
229,0211-699501013259,albumina,i
229,0211-699501013259,r,o
229,0211-699501013259,056,o
229,0211-699501013259,p,o
229,0211-699501013259,0001,o
229,0211-699501013259,que,o
229,0211-699501013259,se,o
229,0211-699501013259,elevo,o
229,0211-699501013259,con,o
229,0211-699501013259,respecto,o
229,0211-699501013259,al,o
229,0211-699501013259,inicio,o
229,0211-699501013259,337,o
229,0211-699501013259,IC,o
229,0211-699501013259,327,o
229,0211-699501013259,346,o
229,0211-699501013259,vs,o
229,0211-699501013259,350,o
229,0211-699501013259,IC,o
229,0211-699501013259,337,o
229,0211-699501013259,363,o
229,0211-699501013259,p,o
229,0211-699501013259,005,o
229,0211-699501013259,Conclusion,o
229,0211-699501013259,Tras,o
229,0211-699501013259,suplementacion,i
229,0211-699501013259,con,o
229,0211-699501013259,acido,i
229,0211-699501013259,folico,i
229,0211-699501013259,y,o
229,0211-699501013259,vitamina,i
229,0211-699501013259,B6,i
229,0211-699501013259,aunque,o
229,0211-699501013259,inicialmente,o
229,0211-699501013259,se,o
229,0211-699501013259,reduce,o
229,0211-699501013259,la,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,esta,o
229,0211-699501013259,respuesta,o
229,0211-699501013259,se,o
229,0211-699501013259,hace,o
229,0211-699501013259,refractaria,o
229,0211-699501013259,correlacionandose,o
229,0211-699501013259,directamente,o
229,0211-699501013259,la,o
229,0211-699501013259,tHcy,i
229,0211-699501013259,con,o
229,0211-699501013259,la,o
229,0211-699501013259,albumina,i
229,0211-699501013259,plasmatica,i
229,0211-699501013259,La,o
229,0211-699501013259,interpretacion,o
229,0211-699501013259,de,o
229,0211-699501013259,los,o
229,0211-699501013259,niveles,i
229,0211-699501013259,de,i
229,0211-699501013259,tHcy,i
229,0211-699501013259,debe,o
229,0211-699501013259,tener,o
229,0211-699501013259,en,o
229,0211-699501013259,cuenta,o
229,0211-699501013259,la,o
229,0211-699501013259,concentracion,i
229,0211-699501013259,de,i
229,0211-699501013259,albumina,i
230,0211-699501013259,Efecto,o
230,0211-699501013259,de,o
230,0211-699501013259,la,o
230,0211-699501013259,suplementacion,i
230,0211-699501013259,con,o
230,0211-699501013259,acido,i
230,0211-699501013259,folico,i
230,0211-699501013259,sobre,o
230,0211-699501013259,los,o
230,0211-699501013259,niveles,i
230,0211-699501013259,de,i
230,0211-699501013259,homocisteina,i
230,0211-699501013259,total,o
230,0211-699501013259,en,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,en,o
230,0211-699501013259,hemodialisis,i
230,0211-699501013259,La,o
230,0211-699501013259,hiperhomocisteinemia,i
230,0211-699501013259,es,o
230,0211-699501013259,un,o
230,0211-699501013259,marcador,o
230,0211-699501013259,de,o
230,0211-699501013259,riesgo,o
230,0211-699501013259,independiente,o
230,0211-699501013259,de,o
230,0211-699501013259,morbimortalidad,o
230,0211-699501013259,cardiovascular,i
230,0211-699501013259,Hemos,o
230,0211-699501013259,intentado,o
230,0211-699501013259,prospectivamente,o
230,0211-699501013259,reducir,o
230,0211-699501013259,los,o
230,0211-699501013259,niveles,i
230,0211-699501013259,de,i
230,0211-699501013259,homocisteina,i
230,0211-699501013259,total,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,mediante,o
230,0211-699501013259,suplemento,o
230,0211-699501013259,con,o
230,0211-699501013259,acido,i
230,0211-699501013259,folico,i
230,0211-699501013259,y,o
230,0211-699501013259,vitamina,i
230,0211-699501013259,B6,i
230,0211-699501013259,pp,i
230,0211-699501013259,valorando,o
230,0211-699501013259,su,o
230,0211-699501013259,posible,o
230,0211-699501013259,correlacion,o
230,0211-699501013259,con,o
230,0211-699501013259,dosis,o
230,0211-699501013259,de,o
230,0211-699501013259,dialisis,i
230,0211-699501013259,funcion,i
230,0211-699501013259,residual,i
230,0211-699501013259,y,o
230,0211-699501013259,parametros,o
230,0211-699501013259,nutricionales,o
230,0211-699501013259,Metodos,o
230,0211-699501013259,Todos,o
230,0211-699501013259,los,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,en,o
230,0211-699501013259,hemodialisis,i
230,0211-699501013259,al,o
230,0211-699501013259,comienzo,o
230,0211-699501013259,del,o
230,0211-699501013259,estudio,o
230,0211-699501013259,que,o
230,0211-699501013259,no,o
230,0211-699501013259,recibian,o
230,0211-699501013259,acido,i
230,0211-699501013259,folico,i
230,0211-699501013259,ni,o
230,0211-699501013259,vitamina,i
230,0211-699501013259,B6,i
230,0211-699501013259,asi,o
230,0211-699501013259,como,o
230,0211-699501013259,los,o
230,0211-699501013259,incorporados,o
230,0211-699501013259,posteriormente,o
230,0211-699501013259,a,o
230,0211-699501013259,partir,o
230,0211-699501013259,de,o
230,0211-699501013259,su,o
230,0211-699501013259,tercer,o
230,0211-699501013259,mes,o
230,0211-699501013259,en,o
230,0211-699501013259,hemodialisis,i
230,0211-699501013259,recibieron,o
230,0211-699501013259,5,o
230,0211-699501013259,mg,o
230,0211-699501013259,orales,o
230,0211-699501013259,de,o
230,0211-699501013259,acido,i
230,0211-699501013259,folico,i
230,0211-699501013259,cada,o
230,0211-699501013259,48,o
230,0211-699501013259,horas,o
230,0211-699501013259,y,o
230,0211-699501013259,40,o
230,0211-699501013259,mg,o
230,0211-699501013259,orales,o
230,0211-699501013259,de,o
230,0211-699501013259,vitamina,i
230,0211-699501013259,B6,i
230,0211-699501013259,cada,o
230,0211-699501013259,semana,o
230,0211-699501013259,Se,o
230,0211-699501013259,determinaron,o
230,0211-699501013259,al,o
230,0211-699501013259,comienzo,o
230,0211-699501013259,del,o
230,0211-699501013259,estudio,o
230,0211-699501013259,y,o
230,0211-699501013259,cada,o
230,0211-699501013259,2,o
230,0211-699501013259,meses,o
230,0211-699501013259,niveles,i
230,0211-699501013259,de,i
230,0211-699501013259,folato,i
230,0211-699501013259,vitamina,i
230,0211-699501013259,B12,i
230,0211-699501013259,inmunoensayo,i
230,0211-699501013259,albumina,i
230,0211-699501013259,y,o
230,0211-699501013259,cinetica,o
230,0211-699501013259,de,o
230,0211-699501013259,la,o
230,0211-699501013259,urea,i
230,0211-699501013259,KTV,o
230,0211-699501013259,KRU,o
230,0211-699501013259,PCRn,o
230,0211-699501013259,y,o
230,0211-699501013259,cada,o
230,0211-699501013259,6,o
230,0211-699501013259,meses,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,HPLC,i
230,0211-699501013259,y,o
230,0211-699501013259,pp,i
230,0211-699501013259,RIA,i
230,0211-699501013259,Resultados,o
230,0211-699501013259,80,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,fueron,o
230,0211-699501013259,incluidos,o
230,0211-699501013259,en,o
230,0211-699501013259,el,o
230,0211-699501013259,estudio,o
230,0211-699501013259,basal,o
230,0211-699501013259,con,o
230,0211-699501013259,una,o
230,0211-699501013259,prevalencia,o
230,0211-699501013259,de,o
230,0211-699501013259,hiperhomocisteinemia,i
230,0211-699501013259,del,o
230,0211-699501013259,844,o
230,0211-699501013259,deficit,i
230,0211-699501013259,de,i
230,0211-699501013259,pp,i
230,0211-699501013259,en,o
230,0211-699501013259,el,o
230,0211-699501013259,32,o
230,0211-699501013259,y,o
230,0211-699501013259,folato,i
230,0211-699501013259,en,o
230,0211-699501013259,el,o
230,0211-699501013259,rango,o
230,0211-699501013259,normal,o
230,0211-699501013259,bajo,o
230,0211-699501013259,los,o
230,0211-699501013259,niveles,i
230,0211-699501013259,de,i
230,0211-699501013259,tHcy,i
230,0211-699501013259,se,o
230,0211-699501013259,correlacionaban,o
230,0211-699501013259,inversamente,o
230,0211-699501013259,con,o
230,0211-699501013259,los,o
230,0211-699501013259,del,o
230,0211-699501013259,folato,i
230,0211-699501013259,r,o
230,0211-699501013259,0336,o
230,0211-699501013259,p,o
230,0211-699501013259,001,o
230,0211-699501013259,pero,o
230,0211-699501013259,no,o
230,0211-699501013259,con,o
230,0211-699501013259,pp,i
230,0211-699501013259,B12,i
230,0211-699501013259,edad,o
230,0211-699501013259,albumina,i
230,0211-699501013259,KTV,o
230,0211-699501013259,KRU,o
230,0211-699501013259,PCRn,o
230,0211-699501013259,Cincuenta,o
230,0211-699501013259,y,o
230,0211-699501013259,ocho,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,recibieron,o
230,0211-699501013259,seis,o
230,0211-699501013259,meses,o
230,0211-699501013259,de,o
230,0211-699501013259,suplementacion,i
230,0211-699501013259,con,o
230,0211-699501013259,normalizacion,o
230,0211-699501013259,del,o
230,0211-699501013259,pp,i
230,0211-699501013259,aumento,o
230,0211-699501013259,del,o
230,0211-699501013259,folato,i
230,0211-699501013259,703,o
230,0211-699501013259,IC,o
230,0211-699501013259,638,o
230,0211-699501013259,795,o
230,0211-699501013259,vs,o
230,0211-699501013259,6181,o
230,0211-699501013259,IC,o
230,0211-699501013259,4447,o
230,0211-699501013259,7811,o
230,0211-699501013259,p,o
230,0211-699501013259,0001,o
230,0211-699501013259,y,o
230,0211-699501013259,descenso,o
230,0211-699501013259,de,o
230,0211-699501013259,la,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,240,o
230,0211-699501013259,IC,o
230,0211-699501013259,213,o
230,0211-699501013259,264,o
230,0211-699501013259,vs,o
230,0211-699501013259,199,o
230,0211-699501013259,IC,o
230,0211-699501013259,175,o
230,0211-699501013259,224,o
230,0211-699501013259,p,o
230,0211-699501013259,005,o
230,0211-699501013259,Han,o
230,0211-699501013259,recibido,o
230,0211-699501013259,suplementacion,i
230,0211-699501013259,durante,o
230,0211-699501013259,12,o
230,0211-699501013259,meses,o
230,0211-699501013259,33,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,pero,o
230,0211-699501013259,a,o
230,0211-699501013259,pesar,o
230,0211-699501013259,de,o
230,0211-699501013259,un,o
230,0211-699501013259,continuo,o
230,0211-699501013259,aumento,o
230,0211-699501013259,del,o
230,0211-699501013259,folato,i
230,0211-699501013259,10078,o
230,0211-699501013259,IC,o
230,0211-699501013259,7481,o
230,0211-699501013259,12674,o
230,0211-699501013259,p,o
230,0211-699501013259,0001,o
230,0211-699501013259,solo,o
230,0211-699501013259,3,o
230,0211-699501013259,pacientes,o
230,0211-699501013259,presentan,o
230,0211-699501013259,niveles,o
230,0211-699501013259,normales,o
230,0211-699501013259,de,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,correlacionandose,o
230,0211-699501013259,directamente,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,con,o
230,0211-699501013259,la,o
230,0211-699501013259,albumina,i
230,0211-699501013259,r,o
230,0211-699501013259,056,o
230,0211-699501013259,p,o
230,0211-699501013259,0001,o
230,0211-699501013259,que,o
230,0211-699501013259,se,o
230,0211-699501013259,elevo,o
230,0211-699501013259,con,o
230,0211-699501013259,respecto,o
230,0211-699501013259,al,o
230,0211-699501013259,inicio,o
230,0211-699501013259,337,o
230,0211-699501013259,IC,o
230,0211-699501013259,327,o
230,0211-699501013259,346,o
230,0211-699501013259,vs,o
230,0211-699501013259,350,o
230,0211-699501013259,IC,o
230,0211-699501013259,337,o
230,0211-699501013259,363,o
230,0211-699501013259,p,o
230,0211-699501013259,005,o
230,0211-699501013259,Conclusion,o
230,0211-699501013259,Tras,o
230,0211-699501013259,suplementacion,i
230,0211-699501013259,con,o
230,0211-699501013259,acido,i
230,0211-699501013259,folico,i
230,0211-699501013259,y,o
230,0211-699501013259,vitamina,i
230,0211-699501013259,B6,i
230,0211-699501013259,aunque,o
230,0211-699501013259,inicialmente,o
230,0211-699501013259,se,o
230,0211-699501013259,reduce,o
230,0211-699501013259,la,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,esta,o
230,0211-699501013259,respuesta,o
230,0211-699501013259,se,o
230,0211-699501013259,hace,o
230,0211-699501013259,refractaria,o
230,0211-699501013259,correlacionandose,o
230,0211-699501013259,directamente,o
230,0211-699501013259,la,o
230,0211-699501013259,tHcy,i
230,0211-699501013259,con,o
230,0211-699501013259,la,o
230,0211-699501013259,albumina,i
230,0211-699501013259,plasmatica,i
230,0211-699501013259,La,o
230,0211-699501013259,interpretacion,o
230,0211-699501013259,de,o
230,0211-699501013259,los,o
230,0211-699501013259,niveles,i
230,0211-699501013259,de,i
230,0211-699501013259,tHcy,i
230,0211-699501013259,debe,o
230,0211-699501013259,tener,o
230,0211-699501013259,en,o
230,0211-699501013259,cuenta,o
230,0211-699501013259,la,o
230,0211-699501013259,concentracion,i
230,0211-699501013259,de,i
230,0211-699501013259,albumina,i
231,0211-699501013259,Efecto,o
231,0211-699501013259,de,o
231,0211-699501013259,la,o
231,0211-699501013259,suplementacion,i
231,0211-699501013259,con,o
231,0211-699501013259,acido,i
231,0211-699501013259,folico,i
231,0211-699501013259,sobre,o
231,0211-699501013259,los,o
231,0211-699501013259,niveles,i
231,0211-699501013259,de,i
231,0211-699501013259,homocisteina,i
231,0211-699501013259,total,o
231,0211-699501013259,en,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,en,o
231,0211-699501013259,hemodialisis,i
231,0211-699501013259,La,o
231,0211-699501013259,hiperhomocisteinemia,i
231,0211-699501013259,es,o
231,0211-699501013259,un,o
231,0211-699501013259,marcador,o
231,0211-699501013259,de,o
231,0211-699501013259,riesgo,o
231,0211-699501013259,independiente,o
231,0211-699501013259,de,o
231,0211-699501013259,morbimortalidad,o
231,0211-699501013259,cardiovascular,i
231,0211-699501013259,Hemos,o
231,0211-699501013259,intentado,o
231,0211-699501013259,prospectivamente,o
231,0211-699501013259,reducir,o
231,0211-699501013259,los,o
231,0211-699501013259,niveles,i
231,0211-699501013259,de,i
231,0211-699501013259,homocisteina,i
231,0211-699501013259,total,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,mediante,o
231,0211-699501013259,suplemento,o
231,0211-699501013259,con,o
231,0211-699501013259,acido,i
231,0211-699501013259,folico,i
231,0211-699501013259,y,o
231,0211-699501013259,vitamina,i
231,0211-699501013259,B6,i
231,0211-699501013259,pp,i
231,0211-699501013259,valorando,o
231,0211-699501013259,su,o
231,0211-699501013259,posible,o
231,0211-699501013259,correlacion,o
231,0211-699501013259,con,o
231,0211-699501013259,dosis,o
231,0211-699501013259,de,o
231,0211-699501013259,dialisis,i
231,0211-699501013259,funcion,i
231,0211-699501013259,residual,i
231,0211-699501013259,y,o
231,0211-699501013259,parametros,o
231,0211-699501013259,nutricionales,o
231,0211-699501013259,Metodos,o
231,0211-699501013259,Todos,o
231,0211-699501013259,los,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,en,o
231,0211-699501013259,hemodialisis,i
231,0211-699501013259,al,o
231,0211-699501013259,comienzo,o
231,0211-699501013259,del,o
231,0211-699501013259,estudio,o
231,0211-699501013259,que,o
231,0211-699501013259,no,o
231,0211-699501013259,recibian,o
231,0211-699501013259,acido,i
231,0211-699501013259,folico,i
231,0211-699501013259,ni,o
231,0211-699501013259,vitamina,i
231,0211-699501013259,B6,i
231,0211-699501013259,asi,o
231,0211-699501013259,como,o
231,0211-699501013259,los,o
231,0211-699501013259,incorporados,o
231,0211-699501013259,posteriormente,o
231,0211-699501013259,a,o
231,0211-699501013259,partir,o
231,0211-699501013259,de,o
231,0211-699501013259,su,o
231,0211-699501013259,tercer,o
231,0211-699501013259,mes,o
231,0211-699501013259,en,o
231,0211-699501013259,hemodialisis,i
231,0211-699501013259,recibieron,o
231,0211-699501013259,5,o
231,0211-699501013259,mg,o
231,0211-699501013259,orales,o
231,0211-699501013259,de,o
231,0211-699501013259,acido,i
231,0211-699501013259,folico,i
231,0211-699501013259,cada,o
231,0211-699501013259,48,o
231,0211-699501013259,horas,o
231,0211-699501013259,y,o
231,0211-699501013259,40,o
231,0211-699501013259,mg,o
231,0211-699501013259,orales,o
231,0211-699501013259,de,o
231,0211-699501013259,vitamina,i
231,0211-699501013259,B6,i
231,0211-699501013259,cada,o
231,0211-699501013259,semana,o
231,0211-699501013259,Se,o
231,0211-699501013259,determinaron,o
231,0211-699501013259,al,o
231,0211-699501013259,comienzo,o
231,0211-699501013259,del,o
231,0211-699501013259,estudio,o
231,0211-699501013259,y,o
231,0211-699501013259,cada,o
231,0211-699501013259,2,o
231,0211-699501013259,meses,o
231,0211-699501013259,niveles,i
231,0211-699501013259,de,i
231,0211-699501013259,folato,i
231,0211-699501013259,vitamina,i
231,0211-699501013259,B12,i
231,0211-699501013259,inmunoensayo,i
231,0211-699501013259,albumina,i
231,0211-699501013259,y,o
231,0211-699501013259,cinetica,o
231,0211-699501013259,de,o
231,0211-699501013259,la,o
231,0211-699501013259,urea,i
231,0211-699501013259,KTV,o
231,0211-699501013259,KRU,o
231,0211-699501013259,PCRn,o
231,0211-699501013259,y,o
231,0211-699501013259,cada,o
231,0211-699501013259,6,o
231,0211-699501013259,meses,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,HPLC,i
231,0211-699501013259,y,o
231,0211-699501013259,pp,i
231,0211-699501013259,RIA,i
231,0211-699501013259,Resultados,o
231,0211-699501013259,80,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,fueron,o
231,0211-699501013259,incluidos,o
231,0211-699501013259,en,o
231,0211-699501013259,el,o
231,0211-699501013259,estudio,o
231,0211-699501013259,basal,o
231,0211-699501013259,con,o
231,0211-699501013259,una,o
231,0211-699501013259,prevalencia,o
231,0211-699501013259,de,o
231,0211-699501013259,hiperhomocisteinemia,i
231,0211-699501013259,del,o
231,0211-699501013259,844,o
231,0211-699501013259,deficit,i
231,0211-699501013259,de,i
231,0211-699501013259,pp,i
231,0211-699501013259,en,o
231,0211-699501013259,el,o
231,0211-699501013259,32,o
231,0211-699501013259,y,o
231,0211-699501013259,folato,i
231,0211-699501013259,en,o
231,0211-699501013259,el,o
231,0211-699501013259,rango,o
231,0211-699501013259,normal,o
231,0211-699501013259,bajo,o
231,0211-699501013259,los,o
231,0211-699501013259,niveles,i
231,0211-699501013259,de,i
231,0211-699501013259,tHcy,i
231,0211-699501013259,se,o
231,0211-699501013259,correlacionaban,o
231,0211-699501013259,inversamente,o
231,0211-699501013259,con,o
231,0211-699501013259,los,o
231,0211-699501013259,del,o
231,0211-699501013259,folato,i
231,0211-699501013259,r,o
231,0211-699501013259,0336,o
231,0211-699501013259,p,o
231,0211-699501013259,001,o
231,0211-699501013259,pero,o
231,0211-699501013259,no,o
231,0211-699501013259,con,o
231,0211-699501013259,pp,i
231,0211-699501013259,B12,i
231,0211-699501013259,edad,o
231,0211-699501013259,albumina,i
231,0211-699501013259,KTV,o
231,0211-699501013259,KRU,o
231,0211-699501013259,PCRn,o
231,0211-699501013259,Cincuenta,o
231,0211-699501013259,y,o
231,0211-699501013259,ocho,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,recibieron,o
231,0211-699501013259,seis,o
231,0211-699501013259,meses,o
231,0211-699501013259,de,o
231,0211-699501013259,suplementacion,i
231,0211-699501013259,con,o
231,0211-699501013259,normalizacion,o
231,0211-699501013259,del,o
231,0211-699501013259,pp,i
231,0211-699501013259,aumento,o
231,0211-699501013259,del,o
231,0211-699501013259,folato,i
231,0211-699501013259,703,o
231,0211-699501013259,IC,o
231,0211-699501013259,638,o
231,0211-699501013259,795,o
231,0211-699501013259,vs,o
231,0211-699501013259,6181,o
231,0211-699501013259,IC,o
231,0211-699501013259,4447,o
231,0211-699501013259,7811,o
231,0211-699501013259,p,o
231,0211-699501013259,0001,o
231,0211-699501013259,y,o
231,0211-699501013259,descenso,o
231,0211-699501013259,de,o
231,0211-699501013259,la,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,240,o
231,0211-699501013259,IC,o
231,0211-699501013259,213,o
231,0211-699501013259,264,o
231,0211-699501013259,vs,o
231,0211-699501013259,199,o
231,0211-699501013259,IC,o
231,0211-699501013259,175,o
231,0211-699501013259,224,o
231,0211-699501013259,p,o
231,0211-699501013259,005,o
231,0211-699501013259,Han,o
231,0211-699501013259,recibido,o
231,0211-699501013259,suplementacion,i
231,0211-699501013259,durante,o
231,0211-699501013259,12,o
231,0211-699501013259,meses,o
231,0211-699501013259,33,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,pero,o
231,0211-699501013259,a,o
231,0211-699501013259,pesar,o
231,0211-699501013259,de,o
231,0211-699501013259,un,o
231,0211-699501013259,continuo,o
231,0211-699501013259,aumento,o
231,0211-699501013259,del,o
231,0211-699501013259,folato,i
231,0211-699501013259,10078,o
231,0211-699501013259,IC,o
231,0211-699501013259,7481,o
231,0211-699501013259,12674,o
231,0211-699501013259,p,o
231,0211-699501013259,0001,o
231,0211-699501013259,solo,o
231,0211-699501013259,3,o
231,0211-699501013259,pacientes,o
231,0211-699501013259,presentan,o
231,0211-699501013259,niveles,o
231,0211-699501013259,normales,o
231,0211-699501013259,de,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,correlacionandose,o
231,0211-699501013259,directamente,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,con,o
231,0211-699501013259,la,o
231,0211-699501013259,albumina,i
231,0211-699501013259,r,o
231,0211-699501013259,056,o
231,0211-699501013259,p,o
231,0211-699501013259,0001,o
231,0211-699501013259,que,o
231,0211-699501013259,se,o
231,0211-699501013259,elevo,o
231,0211-699501013259,con,o
231,0211-699501013259,respecto,o
231,0211-699501013259,al,o
231,0211-699501013259,inicio,o
231,0211-699501013259,337,o
231,0211-699501013259,IC,o
231,0211-699501013259,327,o
231,0211-699501013259,346,o
231,0211-699501013259,vs,o
231,0211-699501013259,350,o
231,0211-699501013259,IC,o
231,0211-699501013259,337,o
231,0211-699501013259,363,o
231,0211-699501013259,p,o
231,0211-699501013259,005,o
231,0211-699501013259,Conclusion,o
231,0211-699501013259,Tras,o
231,0211-699501013259,suplementacion,i
231,0211-699501013259,con,o
231,0211-699501013259,acido,i
231,0211-699501013259,folico,i
231,0211-699501013259,y,o
231,0211-699501013259,vitamina,i
231,0211-699501013259,B6,i
231,0211-699501013259,aunque,o
231,0211-699501013259,inicialmente,o
231,0211-699501013259,se,o
231,0211-699501013259,reduce,o
231,0211-699501013259,la,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,esta,o
231,0211-699501013259,respuesta,o
231,0211-699501013259,se,o
231,0211-699501013259,hace,o
231,0211-699501013259,refractaria,o
231,0211-699501013259,correlacionandose,o
231,0211-699501013259,directamente,o
231,0211-699501013259,la,o
231,0211-699501013259,tHcy,i
231,0211-699501013259,con,o
231,0211-699501013259,la,o
231,0211-699501013259,albumina,i
231,0211-699501013259,plasmatica,i
231,0211-699501013259,La,o
231,0211-699501013259,interpretacion,o
231,0211-699501013259,de,o
231,0211-699501013259,los,o
231,0211-699501013259,niveles,i
231,0211-699501013259,de,i
231,0211-699501013259,tHcy,i
231,0211-699501013259,debe,o
231,0211-699501013259,tener,o
231,0211-699501013259,en,o
231,0211-699501013259,cuenta,o
231,0211-699501013259,la,o
231,0211-699501013259,concentracion,i
231,0211-699501013259,de,i
231,0211-699501013259,albumina,i
232,0211-699501013259,Efecto,o
232,0211-699501013259,de,o
232,0211-699501013259,la,o
232,0211-699501013259,suplementacion,i
232,0211-699501013259,con,o
232,0211-699501013259,acido,i
232,0211-699501013259,folico,i
232,0211-699501013259,sobre,o
232,0211-699501013259,los,o
232,0211-699501013259,niveles,i
232,0211-699501013259,de,i
232,0211-699501013259,homocisteina,i
232,0211-699501013259,total,o
232,0211-699501013259,en,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,en,o
232,0211-699501013259,hemodialisis,i
232,0211-699501013259,La,o
232,0211-699501013259,hiperhomocisteinemia,i
232,0211-699501013259,es,o
232,0211-699501013259,un,o
232,0211-699501013259,marcador,o
232,0211-699501013259,de,o
232,0211-699501013259,riesgo,o
232,0211-699501013259,independiente,o
232,0211-699501013259,de,o
232,0211-699501013259,morbimortalidad,o
232,0211-699501013259,cardiovascular,i
232,0211-699501013259,Hemos,o
232,0211-699501013259,intentado,o
232,0211-699501013259,prospectivamente,o
232,0211-699501013259,reducir,o
232,0211-699501013259,los,o
232,0211-699501013259,niveles,i
232,0211-699501013259,de,i
232,0211-699501013259,homocisteina,i
232,0211-699501013259,total,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,mediante,o
232,0211-699501013259,suplemento,o
232,0211-699501013259,con,o
232,0211-699501013259,acido,i
232,0211-699501013259,folico,i
232,0211-699501013259,y,o
232,0211-699501013259,vitamina,i
232,0211-699501013259,B6,i
232,0211-699501013259,pp,i
232,0211-699501013259,valorando,o
232,0211-699501013259,su,o
232,0211-699501013259,posible,o
232,0211-699501013259,correlacion,o
232,0211-699501013259,con,o
232,0211-699501013259,dosis,o
232,0211-699501013259,de,o
232,0211-699501013259,dialisis,i
232,0211-699501013259,funcion,i
232,0211-699501013259,residual,i
232,0211-699501013259,y,o
232,0211-699501013259,parametros,o
232,0211-699501013259,nutricionales,o
232,0211-699501013259,Metodos,o
232,0211-699501013259,Todos,o
232,0211-699501013259,los,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,en,o
232,0211-699501013259,hemodialisis,i
232,0211-699501013259,al,o
232,0211-699501013259,comienzo,o
232,0211-699501013259,del,o
232,0211-699501013259,estudio,o
232,0211-699501013259,que,o
232,0211-699501013259,no,o
232,0211-699501013259,recibian,o
232,0211-699501013259,acido,i
232,0211-699501013259,folico,i
232,0211-699501013259,ni,o
232,0211-699501013259,vitamina,i
232,0211-699501013259,B6,i
232,0211-699501013259,asi,o
232,0211-699501013259,como,o
232,0211-699501013259,los,o
232,0211-699501013259,incorporados,o
232,0211-699501013259,posteriormente,o
232,0211-699501013259,a,o
232,0211-699501013259,partir,o
232,0211-699501013259,de,o
232,0211-699501013259,su,o
232,0211-699501013259,tercer,o
232,0211-699501013259,mes,o
232,0211-699501013259,en,o
232,0211-699501013259,hemodialisis,i
232,0211-699501013259,recibieron,o
232,0211-699501013259,5,o
232,0211-699501013259,mg,o
232,0211-699501013259,orales,o
232,0211-699501013259,de,o
232,0211-699501013259,acido,i
232,0211-699501013259,folico,i
232,0211-699501013259,cada,o
232,0211-699501013259,48,o
232,0211-699501013259,horas,o
232,0211-699501013259,y,o
232,0211-699501013259,40,o
232,0211-699501013259,mg,o
232,0211-699501013259,orales,o
232,0211-699501013259,de,o
232,0211-699501013259,vitamina,i
232,0211-699501013259,B6,i
232,0211-699501013259,cada,o
232,0211-699501013259,semana,o
232,0211-699501013259,Se,o
232,0211-699501013259,determinaron,o
232,0211-699501013259,al,o
232,0211-699501013259,comienzo,o
232,0211-699501013259,del,o
232,0211-699501013259,estudio,o
232,0211-699501013259,y,o
232,0211-699501013259,cada,o
232,0211-699501013259,2,o
232,0211-699501013259,meses,o
232,0211-699501013259,niveles,i
232,0211-699501013259,de,i
232,0211-699501013259,folato,i
232,0211-699501013259,vitamina,i
232,0211-699501013259,B12,i
232,0211-699501013259,inmunoensayo,i
232,0211-699501013259,albumina,i
232,0211-699501013259,y,o
232,0211-699501013259,cinetica,o
232,0211-699501013259,de,o
232,0211-699501013259,la,o
232,0211-699501013259,urea,i
232,0211-699501013259,KTV,o
232,0211-699501013259,KRU,o
232,0211-699501013259,PCRn,o
232,0211-699501013259,y,o
232,0211-699501013259,cada,o
232,0211-699501013259,6,o
232,0211-699501013259,meses,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,HPLC,i
232,0211-699501013259,y,o
232,0211-699501013259,pp,i
232,0211-699501013259,RIA,i
232,0211-699501013259,Resultados,o
232,0211-699501013259,80,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,fueron,o
232,0211-699501013259,incluidos,o
232,0211-699501013259,en,o
232,0211-699501013259,el,o
232,0211-699501013259,estudio,o
232,0211-699501013259,basal,o
232,0211-699501013259,con,o
232,0211-699501013259,una,o
232,0211-699501013259,prevalencia,o
232,0211-699501013259,de,o
232,0211-699501013259,hiperhomocisteinemia,i
232,0211-699501013259,del,o
232,0211-699501013259,844,o
232,0211-699501013259,deficit,i
232,0211-699501013259,de,i
232,0211-699501013259,pp,i
232,0211-699501013259,en,o
232,0211-699501013259,el,o
232,0211-699501013259,32,o
232,0211-699501013259,y,o
232,0211-699501013259,folato,i
232,0211-699501013259,en,o
232,0211-699501013259,el,o
232,0211-699501013259,rango,o
232,0211-699501013259,normal,o
232,0211-699501013259,bajo,o
232,0211-699501013259,los,o
232,0211-699501013259,niveles,i
232,0211-699501013259,de,i
232,0211-699501013259,tHcy,i
232,0211-699501013259,se,o
232,0211-699501013259,correlacionaban,o
232,0211-699501013259,inversamente,o
232,0211-699501013259,con,o
232,0211-699501013259,los,o
232,0211-699501013259,del,o
232,0211-699501013259,folato,i
232,0211-699501013259,r,o
232,0211-699501013259,0336,o
232,0211-699501013259,p,o
232,0211-699501013259,001,o
232,0211-699501013259,pero,o
232,0211-699501013259,no,o
232,0211-699501013259,con,o
232,0211-699501013259,pp,i
232,0211-699501013259,B12,i
232,0211-699501013259,edad,o
232,0211-699501013259,albumina,i
232,0211-699501013259,KTV,o
232,0211-699501013259,KRU,o
232,0211-699501013259,PCRn,o
232,0211-699501013259,Cincuenta,o
232,0211-699501013259,y,o
232,0211-699501013259,ocho,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,recibieron,o
232,0211-699501013259,seis,o
232,0211-699501013259,meses,o
232,0211-699501013259,de,o
232,0211-699501013259,suplementacion,i
232,0211-699501013259,con,o
232,0211-699501013259,normalizacion,o
232,0211-699501013259,del,o
232,0211-699501013259,pp,i
232,0211-699501013259,aumento,o
232,0211-699501013259,del,o
232,0211-699501013259,folato,i
232,0211-699501013259,703,o
232,0211-699501013259,IC,o
232,0211-699501013259,638,o
232,0211-699501013259,795,o
232,0211-699501013259,vs,o
232,0211-699501013259,6181,o
232,0211-699501013259,IC,o
232,0211-699501013259,4447,o
232,0211-699501013259,7811,o
232,0211-699501013259,p,o
232,0211-699501013259,0001,o
232,0211-699501013259,y,o
232,0211-699501013259,descenso,o
232,0211-699501013259,de,o
232,0211-699501013259,la,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,240,o
232,0211-699501013259,IC,o
232,0211-699501013259,213,o
232,0211-699501013259,264,o
232,0211-699501013259,vs,o
232,0211-699501013259,199,o
232,0211-699501013259,IC,o
232,0211-699501013259,175,o
232,0211-699501013259,224,o
232,0211-699501013259,p,o
232,0211-699501013259,005,o
232,0211-699501013259,Han,o
232,0211-699501013259,recibido,o
232,0211-699501013259,suplementacion,i
232,0211-699501013259,durante,o
232,0211-699501013259,12,o
232,0211-699501013259,meses,o
232,0211-699501013259,33,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,pero,o
232,0211-699501013259,a,o
232,0211-699501013259,pesar,o
232,0211-699501013259,de,o
232,0211-699501013259,un,o
232,0211-699501013259,continuo,o
232,0211-699501013259,aumento,o
232,0211-699501013259,del,o
232,0211-699501013259,folato,i
232,0211-699501013259,10078,o
232,0211-699501013259,IC,o
232,0211-699501013259,7481,o
232,0211-699501013259,12674,o
232,0211-699501013259,p,o
232,0211-699501013259,0001,o
232,0211-699501013259,solo,o
232,0211-699501013259,3,o
232,0211-699501013259,pacientes,o
232,0211-699501013259,presentan,o
232,0211-699501013259,niveles,o
232,0211-699501013259,normales,o
232,0211-699501013259,de,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,correlacionandose,o
232,0211-699501013259,directamente,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,con,o
232,0211-699501013259,la,o
232,0211-699501013259,albumina,i
232,0211-699501013259,r,o
232,0211-699501013259,056,o
232,0211-699501013259,p,o
232,0211-699501013259,0001,o
232,0211-699501013259,que,o
232,0211-699501013259,se,o
232,0211-699501013259,elevo,o
232,0211-699501013259,con,o
232,0211-699501013259,respecto,o
232,0211-699501013259,al,o
232,0211-699501013259,inicio,o
232,0211-699501013259,337,o
232,0211-699501013259,IC,o
232,0211-699501013259,327,o
232,0211-699501013259,346,o
232,0211-699501013259,vs,o
232,0211-699501013259,350,o
232,0211-699501013259,IC,o
232,0211-699501013259,337,o
232,0211-699501013259,363,o
232,0211-699501013259,p,o
232,0211-699501013259,005,o
232,0211-699501013259,Conclusion,o
232,0211-699501013259,Tras,o
232,0211-699501013259,suplementacion,i
232,0211-699501013259,con,o
232,0211-699501013259,acido,i
232,0211-699501013259,folico,i
232,0211-699501013259,y,o
232,0211-699501013259,vitamina,i
232,0211-699501013259,B6,i
232,0211-699501013259,aunque,o
232,0211-699501013259,inicialmente,o
232,0211-699501013259,se,o
232,0211-699501013259,reduce,o
232,0211-699501013259,la,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,esta,o
232,0211-699501013259,respuesta,o
232,0211-699501013259,se,o
232,0211-699501013259,hace,o
232,0211-699501013259,refractaria,o
232,0211-699501013259,correlacionandose,o
232,0211-699501013259,directamente,o
232,0211-699501013259,la,o
232,0211-699501013259,tHcy,i
232,0211-699501013259,con,o
232,0211-699501013259,la,o
232,0211-699501013259,albumina,i
232,0211-699501013259,plasmatica,i
232,0211-699501013259,La,o
232,0211-699501013259,interpretacion,o
232,0211-699501013259,de,o
232,0211-699501013259,los,o
232,0211-699501013259,niveles,i
232,0211-699501013259,de,i
232,0211-699501013259,tHcy,i
232,0211-699501013259,debe,o
232,0211-699501013259,tener,o
232,0211-699501013259,en,o
232,0211-699501013259,cuenta,o
232,0211-699501013259,la,o
232,0211-699501013259,concentracion,i
232,0211-699501013259,de,i
232,0211-699501013259,albumina,i
233,0211-699501013259,Efecto,o
233,0211-699501013259,de,o
233,0211-699501013259,la,o
233,0211-699501013259,suplementacion,i
233,0211-699501013259,con,o
233,0211-699501013259,acido,i
233,0211-699501013259,folico,i
233,0211-699501013259,sobre,o
233,0211-699501013259,los,o
233,0211-699501013259,niveles,i
233,0211-699501013259,de,i
233,0211-699501013259,homocisteina,i
233,0211-699501013259,total,o
233,0211-699501013259,en,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,en,o
233,0211-699501013259,hemodialisis,i
233,0211-699501013259,La,o
233,0211-699501013259,hiperhomocisteinemia,i
233,0211-699501013259,es,o
233,0211-699501013259,un,o
233,0211-699501013259,marcador,o
233,0211-699501013259,de,o
233,0211-699501013259,riesgo,o
233,0211-699501013259,independiente,o
233,0211-699501013259,de,o
233,0211-699501013259,morbimortalidad,o
233,0211-699501013259,cardiovascular,i
233,0211-699501013259,Hemos,o
233,0211-699501013259,intentado,o
233,0211-699501013259,prospectivamente,o
233,0211-699501013259,reducir,o
233,0211-699501013259,los,o
233,0211-699501013259,niveles,i
233,0211-699501013259,de,i
233,0211-699501013259,homocisteina,i
233,0211-699501013259,total,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,mediante,o
233,0211-699501013259,suplemento,o
233,0211-699501013259,con,o
233,0211-699501013259,acido,i
233,0211-699501013259,folico,i
233,0211-699501013259,y,o
233,0211-699501013259,vitamina,i
233,0211-699501013259,B6,i
233,0211-699501013259,pp,i
233,0211-699501013259,valorando,o
233,0211-699501013259,su,o
233,0211-699501013259,posible,o
233,0211-699501013259,correlacion,o
233,0211-699501013259,con,o
233,0211-699501013259,dosis,o
233,0211-699501013259,de,o
233,0211-699501013259,dialisis,i
233,0211-699501013259,funcion,i
233,0211-699501013259,residual,i
233,0211-699501013259,y,o
233,0211-699501013259,parametros,o
233,0211-699501013259,nutricionales,o
233,0211-699501013259,Metodos,o
233,0211-699501013259,Todos,o
233,0211-699501013259,los,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,en,o
233,0211-699501013259,hemodialisis,i
233,0211-699501013259,al,o
233,0211-699501013259,comienzo,o
233,0211-699501013259,del,o
233,0211-699501013259,estudio,o
233,0211-699501013259,que,o
233,0211-699501013259,no,o
233,0211-699501013259,recibian,o
233,0211-699501013259,acido,i
233,0211-699501013259,folico,i
233,0211-699501013259,ni,o
233,0211-699501013259,vitamina,i
233,0211-699501013259,B6,i
233,0211-699501013259,asi,o
233,0211-699501013259,como,o
233,0211-699501013259,los,o
233,0211-699501013259,incorporados,o
233,0211-699501013259,posteriormente,o
233,0211-699501013259,a,o
233,0211-699501013259,partir,o
233,0211-699501013259,de,o
233,0211-699501013259,su,o
233,0211-699501013259,tercer,o
233,0211-699501013259,mes,o
233,0211-699501013259,en,o
233,0211-699501013259,hemodialisis,i
233,0211-699501013259,recibieron,o
233,0211-699501013259,5,o
233,0211-699501013259,mg,o
233,0211-699501013259,orales,o
233,0211-699501013259,de,o
233,0211-699501013259,acido,i
233,0211-699501013259,folico,i
233,0211-699501013259,cada,o
233,0211-699501013259,48,o
233,0211-699501013259,horas,o
233,0211-699501013259,y,o
233,0211-699501013259,40,o
233,0211-699501013259,mg,o
233,0211-699501013259,orales,o
233,0211-699501013259,de,o
233,0211-699501013259,vitamina,i
233,0211-699501013259,B6,i
233,0211-699501013259,cada,o
233,0211-699501013259,semana,o
233,0211-699501013259,Se,o
233,0211-699501013259,determinaron,o
233,0211-699501013259,al,o
233,0211-699501013259,comienzo,o
233,0211-699501013259,del,o
233,0211-699501013259,estudio,o
233,0211-699501013259,y,o
233,0211-699501013259,cada,o
233,0211-699501013259,2,o
233,0211-699501013259,meses,o
233,0211-699501013259,niveles,i
233,0211-699501013259,de,i
233,0211-699501013259,folato,i
233,0211-699501013259,vitamina,i
233,0211-699501013259,B12,i
233,0211-699501013259,inmunoensayo,i
233,0211-699501013259,albumina,i
233,0211-699501013259,y,o
233,0211-699501013259,cinetica,o
233,0211-699501013259,de,o
233,0211-699501013259,la,o
233,0211-699501013259,urea,i
233,0211-699501013259,KTV,o
233,0211-699501013259,KRU,o
233,0211-699501013259,PCRn,o
233,0211-699501013259,y,o
233,0211-699501013259,cada,o
233,0211-699501013259,6,o
233,0211-699501013259,meses,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,HPLC,i
233,0211-699501013259,y,o
233,0211-699501013259,pp,i
233,0211-699501013259,RIA,i
233,0211-699501013259,Resultados,o
233,0211-699501013259,80,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,fueron,o
233,0211-699501013259,incluidos,o
233,0211-699501013259,en,o
233,0211-699501013259,el,o
233,0211-699501013259,estudio,o
233,0211-699501013259,basal,o
233,0211-699501013259,con,o
233,0211-699501013259,una,o
233,0211-699501013259,prevalencia,o
233,0211-699501013259,de,o
233,0211-699501013259,hiperhomocisteinemia,i
233,0211-699501013259,del,o
233,0211-699501013259,844,o
233,0211-699501013259,deficit,i
233,0211-699501013259,de,i
233,0211-699501013259,pp,i
233,0211-699501013259,en,o
233,0211-699501013259,el,o
233,0211-699501013259,32,o
233,0211-699501013259,y,o
233,0211-699501013259,folato,i
233,0211-699501013259,en,o
233,0211-699501013259,el,o
233,0211-699501013259,rango,o
233,0211-699501013259,normal,o
233,0211-699501013259,bajo,o
233,0211-699501013259,los,o
233,0211-699501013259,niveles,i
233,0211-699501013259,de,i
233,0211-699501013259,tHcy,i
233,0211-699501013259,se,o
233,0211-699501013259,correlacionaban,o
233,0211-699501013259,inversamente,o
233,0211-699501013259,con,o
233,0211-699501013259,los,o
233,0211-699501013259,del,o
233,0211-699501013259,folato,i
233,0211-699501013259,r,o
233,0211-699501013259,0336,o
233,0211-699501013259,p,o
233,0211-699501013259,001,o
233,0211-699501013259,pero,o
233,0211-699501013259,no,o
233,0211-699501013259,con,o
233,0211-699501013259,pp,i
233,0211-699501013259,B12,i
233,0211-699501013259,edad,o
233,0211-699501013259,albumina,i
233,0211-699501013259,KTV,o
233,0211-699501013259,KRU,o
233,0211-699501013259,PCRn,o
233,0211-699501013259,Cincuenta,o
233,0211-699501013259,y,o
233,0211-699501013259,ocho,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,recibieron,o
233,0211-699501013259,seis,o
233,0211-699501013259,meses,o
233,0211-699501013259,de,o
233,0211-699501013259,suplementacion,i
233,0211-699501013259,con,o
233,0211-699501013259,normalizacion,o
233,0211-699501013259,del,o
233,0211-699501013259,pp,i
233,0211-699501013259,aumento,o
233,0211-699501013259,del,o
233,0211-699501013259,folato,i
233,0211-699501013259,703,o
233,0211-699501013259,IC,o
233,0211-699501013259,638,o
233,0211-699501013259,795,o
233,0211-699501013259,vs,o
233,0211-699501013259,6181,o
233,0211-699501013259,IC,o
233,0211-699501013259,4447,o
233,0211-699501013259,7811,o
233,0211-699501013259,p,o
233,0211-699501013259,0001,o
233,0211-699501013259,y,o
233,0211-699501013259,descenso,o
233,0211-699501013259,de,o
233,0211-699501013259,la,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,240,o
233,0211-699501013259,IC,o
233,0211-699501013259,213,o
233,0211-699501013259,264,o
233,0211-699501013259,vs,o
233,0211-699501013259,199,o
233,0211-699501013259,IC,o
233,0211-699501013259,175,o
233,0211-699501013259,224,o
233,0211-699501013259,p,o
233,0211-699501013259,005,o
233,0211-699501013259,Han,o
233,0211-699501013259,recibido,o
233,0211-699501013259,suplementacion,i
233,0211-699501013259,durante,o
233,0211-699501013259,12,o
233,0211-699501013259,meses,o
233,0211-699501013259,33,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,pero,o
233,0211-699501013259,a,o
233,0211-699501013259,pesar,o
233,0211-699501013259,de,o
233,0211-699501013259,un,o
233,0211-699501013259,continuo,o
233,0211-699501013259,aumento,o
233,0211-699501013259,del,o
233,0211-699501013259,folato,i
233,0211-699501013259,10078,o
233,0211-699501013259,IC,o
233,0211-699501013259,7481,o
233,0211-699501013259,12674,o
233,0211-699501013259,p,o
233,0211-699501013259,0001,o
233,0211-699501013259,solo,o
233,0211-699501013259,3,o
233,0211-699501013259,pacientes,o
233,0211-699501013259,presentan,o
233,0211-699501013259,niveles,o
233,0211-699501013259,normales,o
233,0211-699501013259,de,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,correlacionandose,o
233,0211-699501013259,directamente,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,con,o
233,0211-699501013259,la,o
233,0211-699501013259,albumina,i
233,0211-699501013259,r,o
233,0211-699501013259,056,o
233,0211-699501013259,p,o
233,0211-699501013259,0001,o
233,0211-699501013259,que,o
233,0211-699501013259,se,o
233,0211-699501013259,elevo,o
233,0211-699501013259,con,o
233,0211-699501013259,respecto,o
233,0211-699501013259,al,o
233,0211-699501013259,inicio,o
233,0211-699501013259,337,o
233,0211-699501013259,IC,o
233,0211-699501013259,327,o
233,0211-699501013259,346,o
233,0211-699501013259,vs,o
233,0211-699501013259,350,o
233,0211-699501013259,IC,o
233,0211-699501013259,337,o
233,0211-699501013259,363,o
233,0211-699501013259,p,o
233,0211-699501013259,005,o
233,0211-699501013259,Conclusion,o
233,0211-699501013259,Tras,o
233,0211-699501013259,suplementacion,i
233,0211-699501013259,con,o
233,0211-699501013259,acido,i
233,0211-699501013259,folico,i
233,0211-699501013259,y,o
233,0211-699501013259,vitamina,i
233,0211-699501013259,B6,i
233,0211-699501013259,aunque,o
233,0211-699501013259,inicialmente,o
233,0211-699501013259,se,o
233,0211-699501013259,reduce,o
233,0211-699501013259,la,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,esta,o
233,0211-699501013259,respuesta,o
233,0211-699501013259,se,o
233,0211-699501013259,hace,o
233,0211-699501013259,refractaria,o
233,0211-699501013259,correlacionandose,o
233,0211-699501013259,directamente,o
233,0211-699501013259,la,o
233,0211-699501013259,tHcy,i
233,0211-699501013259,con,o
233,0211-699501013259,la,o
233,0211-699501013259,albumina,i
233,0211-699501013259,plasmatica,i
233,0211-699501013259,La,o
233,0211-699501013259,interpretacion,o
233,0211-699501013259,de,o
233,0211-699501013259,los,o
233,0211-699501013259,niveles,i
233,0211-699501013259,de,i
233,0211-699501013259,tHcy,i
233,0211-699501013259,debe,o
233,0211-699501013259,tener,o
233,0211-699501013259,en,o
233,0211-699501013259,cuenta,o
233,0211-699501013259,la,o
233,0211-699501013259,concentracion,i
233,0211-699501013259,de,i
233,0211-699501013259,albumina,i
234,0211-699501013259,Efecto,o
234,0211-699501013259,de,o
234,0211-699501013259,la,o
234,0211-699501013259,suplementacion,i
234,0211-699501013259,con,o
234,0211-699501013259,acido,i
234,0211-699501013259,folico,i
234,0211-699501013259,sobre,o
234,0211-699501013259,los,o
234,0211-699501013259,niveles,i
234,0211-699501013259,de,i
234,0211-699501013259,homocisteina,i
234,0211-699501013259,total,o
234,0211-699501013259,en,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,en,o
234,0211-699501013259,hemodialisis,i
234,0211-699501013259,La,o
234,0211-699501013259,hiperhomocisteinemia,i
234,0211-699501013259,es,o
234,0211-699501013259,un,o
234,0211-699501013259,marcador,o
234,0211-699501013259,de,o
234,0211-699501013259,riesgo,o
234,0211-699501013259,independiente,o
234,0211-699501013259,de,o
234,0211-699501013259,morbimortalidad,o
234,0211-699501013259,cardiovascular,i
234,0211-699501013259,Hemos,o
234,0211-699501013259,intentado,o
234,0211-699501013259,prospectivamente,o
234,0211-699501013259,reducir,o
234,0211-699501013259,los,o
234,0211-699501013259,niveles,i
234,0211-699501013259,de,i
234,0211-699501013259,homocisteina,i
234,0211-699501013259,total,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,mediante,o
234,0211-699501013259,suplemento,o
234,0211-699501013259,con,o
234,0211-699501013259,acido,i
234,0211-699501013259,folico,i
234,0211-699501013259,y,o
234,0211-699501013259,vitamina,i
234,0211-699501013259,B6,i
234,0211-699501013259,pp,i
234,0211-699501013259,valorando,o
234,0211-699501013259,su,o
234,0211-699501013259,posible,o
234,0211-699501013259,correlacion,o
234,0211-699501013259,con,o
234,0211-699501013259,dosis,o
234,0211-699501013259,de,o
234,0211-699501013259,dialisis,i
234,0211-699501013259,funcion,i
234,0211-699501013259,residual,i
234,0211-699501013259,y,o
234,0211-699501013259,parametros,o
234,0211-699501013259,nutricionales,o
234,0211-699501013259,Metodos,o
234,0211-699501013259,Todos,o
234,0211-699501013259,los,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,en,o
234,0211-699501013259,hemodialisis,i
234,0211-699501013259,al,o
234,0211-699501013259,comienzo,o
234,0211-699501013259,del,o
234,0211-699501013259,estudio,o
234,0211-699501013259,que,o
234,0211-699501013259,no,o
234,0211-699501013259,recibian,o
234,0211-699501013259,acido,i
234,0211-699501013259,folico,i
234,0211-699501013259,ni,o
234,0211-699501013259,vitamina,i
234,0211-699501013259,B6,i
234,0211-699501013259,asi,o
234,0211-699501013259,como,o
234,0211-699501013259,los,o
234,0211-699501013259,incorporados,o
234,0211-699501013259,posteriormente,o
234,0211-699501013259,a,o
234,0211-699501013259,partir,o
234,0211-699501013259,de,o
234,0211-699501013259,su,o
234,0211-699501013259,tercer,o
234,0211-699501013259,mes,o
234,0211-699501013259,en,o
234,0211-699501013259,hemodialisis,i
234,0211-699501013259,recibieron,o
234,0211-699501013259,5,o
234,0211-699501013259,mg,o
234,0211-699501013259,orales,o
234,0211-699501013259,de,o
234,0211-699501013259,acido,i
234,0211-699501013259,folico,i
234,0211-699501013259,cada,o
234,0211-699501013259,48,o
234,0211-699501013259,horas,o
234,0211-699501013259,y,o
234,0211-699501013259,40,o
234,0211-699501013259,mg,o
234,0211-699501013259,orales,o
234,0211-699501013259,de,o
234,0211-699501013259,vitamina,i
234,0211-699501013259,B6,i
234,0211-699501013259,cada,o
234,0211-699501013259,semana,o
234,0211-699501013259,Se,o
234,0211-699501013259,determinaron,o
234,0211-699501013259,al,o
234,0211-699501013259,comienzo,o
234,0211-699501013259,del,o
234,0211-699501013259,estudio,o
234,0211-699501013259,y,o
234,0211-699501013259,cada,o
234,0211-699501013259,2,o
234,0211-699501013259,meses,o
234,0211-699501013259,niveles,i
234,0211-699501013259,de,i
234,0211-699501013259,folato,i
234,0211-699501013259,vitamina,i
234,0211-699501013259,B12,i
234,0211-699501013259,inmunoensayo,i
234,0211-699501013259,albumina,i
234,0211-699501013259,y,o
234,0211-699501013259,cinetica,o
234,0211-699501013259,de,o
234,0211-699501013259,la,o
234,0211-699501013259,urea,i
234,0211-699501013259,KTV,o
234,0211-699501013259,KRU,o
234,0211-699501013259,PCRn,o
234,0211-699501013259,y,o
234,0211-699501013259,cada,o
234,0211-699501013259,6,o
234,0211-699501013259,meses,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,HPLC,i
234,0211-699501013259,y,o
234,0211-699501013259,pp,i
234,0211-699501013259,RIA,i
234,0211-699501013259,Resultados,o
234,0211-699501013259,80,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,fueron,o
234,0211-699501013259,incluidos,o
234,0211-699501013259,en,o
234,0211-699501013259,el,o
234,0211-699501013259,estudio,o
234,0211-699501013259,basal,o
234,0211-699501013259,con,o
234,0211-699501013259,una,o
234,0211-699501013259,prevalencia,o
234,0211-699501013259,de,o
234,0211-699501013259,hiperhomocisteinemia,i
234,0211-699501013259,del,o
234,0211-699501013259,844,o
234,0211-699501013259,deficit,i
234,0211-699501013259,de,i
234,0211-699501013259,pp,i
234,0211-699501013259,en,o
234,0211-699501013259,el,o
234,0211-699501013259,32,o
234,0211-699501013259,y,o
234,0211-699501013259,folato,i
234,0211-699501013259,en,o
234,0211-699501013259,el,o
234,0211-699501013259,rango,o
234,0211-699501013259,normal,o
234,0211-699501013259,bajo,o
234,0211-699501013259,los,o
234,0211-699501013259,niveles,i
234,0211-699501013259,de,i
234,0211-699501013259,tHcy,i
234,0211-699501013259,se,o
234,0211-699501013259,correlacionaban,o
234,0211-699501013259,inversamente,o
234,0211-699501013259,con,o
234,0211-699501013259,los,o
234,0211-699501013259,del,o
234,0211-699501013259,folato,i
234,0211-699501013259,r,o
234,0211-699501013259,0336,o
234,0211-699501013259,p,o
234,0211-699501013259,001,o
234,0211-699501013259,pero,o
234,0211-699501013259,no,o
234,0211-699501013259,con,o
234,0211-699501013259,pp,i
234,0211-699501013259,B12,i
234,0211-699501013259,edad,o
234,0211-699501013259,albumina,i
234,0211-699501013259,KTV,o
234,0211-699501013259,KRU,o
234,0211-699501013259,PCRn,o
234,0211-699501013259,Cincuenta,o
234,0211-699501013259,y,o
234,0211-699501013259,ocho,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,recibieron,o
234,0211-699501013259,seis,o
234,0211-699501013259,meses,o
234,0211-699501013259,de,o
234,0211-699501013259,suplementacion,i
234,0211-699501013259,con,o
234,0211-699501013259,normalizacion,o
234,0211-699501013259,del,o
234,0211-699501013259,pp,i
234,0211-699501013259,aumento,o
234,0211-699501013259,del,o
234,0211-699501013259,folato,i
234,0211-699501013259,703,o
234,0211-699501013259,IC,o
234,0211-699501013259,638,o
234,0211-699501013259,795,o
234,0211-699501013259,vs,o
234,0211-699501013259,6181,o
234,0211-699501013259,IC,o
234,0211-699501013259,4447,o
234,0211-699501013259,7811,o
234,0211-699501013259,p,o
234,0211-699501013259,0001,o
234,0211-699501013259,y,o
234,0211-699501013259,descenso,o
234,0211-699501013259,de,o
234,0211-699501013259,la,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,240,o
234,0211-699501013259,IC,o
234,0211-699501013259,213,o
234,0211-699501013259,264,o
234,0211-699501013259,vs,o
234,0211-699501013259,199,o
234,0211-699501013259,IC,o
234,0211-699501013259,175,o
234,0211-699501013259,224,o
234,0211-699501013259,p,o
234,0211-699501013259,005,o
234,0211-699501013259,Han,o
234,0211-699501013259,recibido,o
234,0211-699501013259,suplementacion,i
234,0211-699501013259,durante,o
234,0211-699501013259,12,o
234,0211-699501013259,meses,o
234,0211-699501013259,33,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,pero,o
234,0211-699501013259,a,o
234,0211-699501013259,pesar,o
234,0211-699501013259,de,o
234,0211-699501013259,un,o
234,0211-699501013259,continuo,o
234,0211-699501013259,aumento,o
234,0211-699501013259,del,o
234,0211-699501013259,folato,i
234,0211-699501013259,10078,o
234,0211-699501013259,IC,o
234,0211-699501013259,7481,o
234,0211-699501013259,12674,o
234,0211-699501013259,p,o
234,0211-699501013259,0001,o
234,0211-699501013259,solo,o
234,0211-699501013259,3,o
234,0211-699501013259,pacientes,o
234,0211-699501013259,presentan,o
234,0211-699501013259,niveles,o
234,0211-699501013259,normales,o
234,0211-699501013259,de,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,correlacionandose,o
234,0211-699501013259,directamente,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,con,o
234,0211-699501013259,la,o
234,0211-699501013259,albumina,i
234,0211-699501013259,r,o
234,0211-699501013259,056,o
234,0211-699501013259,p,o
234,0211-699501013259,0001,o
234,0211-699501013259,que,o
234,0211-699501013259,se,o
234,0211-699501013259,elevo,o
234,0211-699501013259,con,o
234,0211-699501013259,respecto,o
234,0211-699501013259,al,o
234,0211-699501013259,inicio,o
234,0211-699501013259,337,o
234,0211-699501013259,IC,o
234,0211-699501013259,327,o
234,0211-699501013259,346,o
234,0211-699501013259,vs,o
234,0211-699501013259,350,o
234,0211-699501013259,IC,o
234,0211-699501013259,337,o
234,0211-699501013259,363,o
234,0211-699501013259,p,o
234,0211-699501013259,005,o
234,0211-699501013259,Conclusion,o
234,0211-699501013259,Tras,o
234,0211-699501013259,suplementacion,i
234,0211-699501013259,con,o
234,0211-699501013259,acido,i
234,0211-699501013259,folico,i
234,0211-699501013259,y,o
234,0211-699501013259,vitamina,i
234,0211-699501013259,B6,i
234,0211-699501013259,aunque,o
234,0211-699501013259,inicialmente,o
234,0211-699501013259,se,o
234,0211-699501013259,reduce,o
234,0211-699501013259,la,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,esta,o
234,0211-699501013259,respuesta,o
234,0211-699501013259,se,o
234,0211-699501013259,hace,o
234,0211-699501013259,refractaria,o
234,0211-699501013259,correlacionandose,o
234,0211-699501013259,directamente,o
234,0211-699501013259,la,o
234,0211-699501013259,tHcy,i
234,0211-699501013259,con,o
234,0211-699501013259,la,o
234,0211-699501013259,albumina,i
234,0211-699501013259,plasmatica,i
234,0211-699501013259,La,o
234,0211-699501013259,interpretacion,o
234,0211-699501013259,de,o
234,0211-699501013259,los,o
234,0211-699501013259,niveles,i
234,0211-699501013259,de,i
234,0211-699501013259,tHcy,i
234,0211-699501013259,debe,o
234,0211-699501013259,tener,o
234,0211-699501013259,en,o
234,0211-699501013259,cuenta,o
234,0211-699501013259,la,o
234,0211-699501013259,concentracion,i
234,0211-699501013259,de,i
234,0211-699501013259,albumina,i
235,0211-699501013259,Efecto,o
235,0211-699501013259,de,o
235,0211-699501013259,la,o
235,0211-699501013259,suplementacion,i
235,0211-699501013259,con,o
235,0211-699501013259,acido,i
235,0211-699501013259,folico,i
235,0211-699501013259,sobre,o
235,0211-699501013259,los,o
235,0211-699501013259,niveles,i
235,0211-699501013259,de,i
235,0211-699501013259,homocisteina,i
235,0211-699501013259,total,o
235,0211-699501013259,en,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,en,o
235,0211-699501013259,hemodialisis,i
235,0211-699501013259,La,o
235,0211-699501013259,hiperhomocisteinemia,i
235,0211-699501013259,es,o
235,0211-699501013259,un,o
235,0211-699501013259,marcador,o
235,0211-699501013259,de,o
235,0211-699501013259,riesgo,o
235,0211-699501013259,independiente,o
235,0211-699501013259,de,o
235,0211-699501013259,morbimortalidad,o
235,0211-699501013259,cardiovascular,i
235,0211-699501013259,Hemos,o
235,0211-699501013259,intentado,o
235,0211-699501013259,prospectivamente,o
235,0211-699501013259,reducir,o
235,0211-699501013259,los,o
235,0211-699501013259,niveles,i
235,0211-699501013259,de,i
235,0211-699501013259,homocisteina,i
235,0211-699501013259,total,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,mediante,o
235,0211-699501013259,suplemento,o
235,0211-699501013259,con,o
235,0211-699501013259,acido,i
235,0211-699501013259,folico,i
235,0211-699501013259,y,o
235,0211-699501013259,vitamina,i
235,0211-699501013259,B6,i
235,0211-699501013259,pp,i
235,0211-699501013259,valorando,o
235,0211-699501013259,su,o
235,0211-699501013259,posible,o
235,0211-699501013259,correlacion,o
235,0211-699501013259,con,o
235,0211-699501013259,dosis,o
235,0211-699501013259,de,o
235,0211-699501013259,dialisis,i
235,0211-699501013259,funcion,i
235,0211-699501013259,residual,i
235,0211-699501013259,y,o
235,0211-699501013259,parametros,o
235,0211-699501013259,nutricionales,o
235,0211-699501013259,Metodos,o
235,0211-699501013259,Todos,o
235,0211-699501013259,los,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,en,o
235,0211-699501013259,hemodialisis,i
235,0211-699501013259,al,o
235,0211-699501013259,comienzo,o
235,0211-699501013259,del,o
235,0211-699501013259,estudio,o
235,0211-699501013259,que,o
235,0211-699501013259,no,o
235,0211-699501013259,recibian,o
235,0211-699501013259,acido,i
235,0211-699501013259,folico,i
235,0211-699501013259,ni,o
235,0211-699501013259,vitamina,i
235,0211-699501013259,B6,i
235,0211-699501013259,asi,o
235,0211-699501013259,como,o
235,0211-699501013259,los,o
235,0211-699501013259,incorporados,o
235,0211-699501013259,posteriormente,o
235,0211-699501013259,a,o
235,0211-699501013259,partir,o
235,0211-699501013259,de,o
235,0211-699501013259,su,o
235,0211-699501013259,tercer,o
235,0211-699501013259,mes,o
235,0211-699501013259,en,o
235,0211-699501013259,hemodialisis,i
235,0211-699501013259,recibieron,o
235,0211-699501013259,5,o
235,0211-699501013259,mg,o
235,0211-699501013259,orales,o
235,0211-699501013259,de,o
235,0211-699501013259,acido,i
235,0211-699501013259,folico,i
235,0211-699501013259,cada,o
235,0211-699501013259,48,o
235,0211-699501013259,horas,o
235,0211-699501013259,y,o
235,0211-699501013259,40,o
235,0211-699501013259,mg,o
235,0211-699501013259,orales,o
235,0211-699501013259,de,o
235,0211-699501013259,vitamina,i
235,0211-699501013259,B6,i
235,0211-699501013259,cada,o
235,0211-699501013259,semana,o
235,0211-699501013259,Se,o
235,0211-699501013259,determinaron,o
235,0211-699501013259,al,o
235,0211-699501013259,comienzo,o
235,0211-699501013259,del,o
235,0211-699501013259,estudio,o
235,0211-699501013259,y,o
235,0211-699501013259,cada,o
235,0211-699501013259,2,o
235,0211-699501013259,meses,o
235,0211-699501013259,niveles,i
235,0211-699501013259,de,i
235,0211-699501013259,folato,i
235,0211-699501013259,vitamina,i
235,0211-699501013259,B12,i
235,0211-699501013259,inmunoensayo,i
235,0211-699501013259,albumina,i
235,0211-699501013259,y,o
235,0211-699501013259,cinetica,o
235,0211-699501013259,de,o
235,0211-699501013259,la,o
235,0211-699501013259,urea,i
235,0211-699501013259,KTV,o
235,0211-699501013259,KRU,o
235,0211-699501013259,PCRn,o
235,0211-699501013259,y,o
235,0211-699501013259,cada,o
235,0211-699501013259,6,o
235,0211-699501013259,meses,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,HPLC,i
235,0211-699501013259,y,o
235,0211-699501013259,pp,i
235,0211-699501013259,RIA,i
235,0211-699501013259,Resultados,o
235,0211-699501013259,80,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,fueron,o
235,0211-699501013259,incluidos,o
235,0211-699501013259,en,o
235,0211-699501013259,el,o
235,0211-699501013259,estudio,o
235,0211-699501013259,basal,o
235,0211-699501013259,con,o
235,0211-699501013259,una,o
235,0211-699501013259,prevalencia,o
235,0211-699501013259,de,o
235,0211-699501013259,hiperhomocisteinemia,i
235,0211-699501013259,del,o
235,0211-699501013259,844,o
235,0211-699501013259,deficit,i
235,0211-699501013259,de,i
235,0211-699501013259,pp,i
235,0211-699501013259,en,o
235,0211-699501013259,el,o
235,0211-699501013259,32,o
235,0211-699501013259,y,o
235,0211-699501013259,folato,i
235,0211-699501013259,en,o
235,0211-699501013259,el,o
235,0211-699501013259,rango,o
235,0211-699501013259,normal,o
235,0211-699501013259,bajo,o
235,0211-699501013259,los,o
235,0211-699501013259,niveles,i
235,0211-699501013259,de,i
235,0211-699501013259,tHcy,i
235,0211-699501013259,se,o
235,0211-699501013259,correlacionaban,o
235,0211-699501013259,inversamente,o
235,0211-699501013259,con,o
235,0211-699501013259,los,o
235,0211-699501013259,del,o
235,0211-699501013259,folato,i
235,0211-699501013259,r,o
235,0211-699501013259,0336,o
235,0211-699501013259,p,o
235,0211-699501013259,001,o
235,0211-699501013259,pero,o
235,0211-699501013259,no,o
235,0211-699501013259,con,o
235,0211-699501013259,pp,i
235,0211-699501013259,B12,i
235,0211-699501013259,edad,o
235,0211-699501013259,albumina,i
235,0211-699501013259,KTV,o
235,0211-699501013259,KRU,o
235,0211-699501013259,PCRn,o
235,0211-699501013259,Cincuenta,o
235,0211-699501013259,y,o
235,0211-699501013259,ocho,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,recibieron,o
235,0211-699501013259,seis,o
235,0211-699501013259,meses,o
235,0211-699501013259,de,o
235,0211-699501013259,suplementacion,i
235,0211-699501013259,con,o
235,0211-699501013259,normalizacion,o
235,0211-699501013259,del,o
235,0211-699501013259,pp,i
235,0211-699501013259,aumento,o
235,0211-699501013259,del,o
235,0211-699501013259,folato,i
235,0211-699501013259,703,o
235,0211-699501013259,IC,o
235,0211-699501013259,638,o
235,0211-699501013259,795,o
235,0211-699501013259,vs,o
235,0211-699501013259,6181,o
235,0211-699501013259,IC,o
235,0211-699501013259,4447,o
235,0211-699501013259,7811,o
235,0211-699501013259,p,o
235,0211-699501013259,0001,o
235,0211-699501013259,y,o
235,0211-699501013259,descenso,o
235,0211-699501013259,de,o
235,0211-699501013259,la,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,240,o
235,0211-699501013259,IC,o
235,0211-699501013259,213,o
235,0211-699501013259,264,o
235,0211-699501013259,vs,o
235,0211-699501013259,199,o
235,0211-699501013259,IC,o
235,0211-699501013259,175,o
235,0211-699501013259,224,o
235,0211-699501013259,p,o
235,0211-699501013259,005,o
235,0211-699501013259,Han,o
235,0211-699501013259,recibido,o
235,0211-699501013259,suplementacion,i
235,0211-699501013259,durante,o
235,0211-699501013259,12,o
235,0211-699501013259,meses,o
235,0211-699501013259,33,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,pero,o
235,0211-699501013259,a,o
235,0211-699501013259,pesar,o
235,0211-699501013259,de,o
235,0211-699501013259,un,o
235,0211-699501013259,continuo,o
235,0211-699501013259,aumento,o
235,0211-699501013259,del,o
235,0211-699501013259,folato,i
235,0211-699501013259,10078,o
235,0211-699501013259,IC,o
235,0211-699501013259,7481,o
235,0211-699501013259,12674,o
235,0211-699501013259,p,o
235,0211-699501013259,0001,o
235,0211-699501013259,solo,o
235,0211-699501013259,3,o
235,0211-699501013259,pacientes,o
235,0211-699501013259,presentan,o
235,0211-699501013259,niveles,o
235,0211-699501013259,normales,o
235,0211-699501013259,de,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,correlacionandose,o
235,0211-699501013259,directamente,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,con,o
235,0211-699501013259,la,o
235,0211-699501013259,albumina,i
235,0211-699501013259,r,o
235,0211-699501013259,056,o
235,0211-699501013259,p,o
235,0211-699501013259,0001,o
235,0211-699501013259,que,o
235,0211-699501013259,se,o
235,0211-699501013259,elevo,o
235,0211-699501013259,con,o
235,0211-699501013259,respecto,o
235,0211-699501013259,al,o
235,0211-699501013259,inicio,o
235,0211-699501013259,337,o
235,0211-699501013259,IC,o
235,0211-699501013259,327,o
235,0211-699501013259,346,o
235,0211-699501013259,vs,o
235,0211-699501013259,350,o
235,0211-699501013259,IC,o
235,0211-699501013259,337,o
235,0211-699501013259,363,o
235,0211-699501013259,p,o
235,0211-699501013259,005,o
235,0211-699501013259,Conclusion,o
235,0211-699501013259,Tras,o
235,0211-699501013259,suplementacion,i
235,0211-699501013259,con,o
235,0211-699501013259,acido,i
235,0211-699501013259,folico,i
235,0211-699501013259,y,o
235,0211-699501013259,vitamina,i
235,0211-699501013259,B6,i
235,0211-699501013259,aunque,o
235,0211-699501013259,inicialmente,o
235,0211-699501013259,se,o
235,0211-699501013259,reduce,o
235,0211-699501013259,la,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,esta,o
235,0211-699501013259,respuesta,o
235,0211-699501013259,se,o
235,0211-699501013259,hace,o
235,0211-699501013259,refractaria,o
235,0211-699501013259,correlacionandose,o
235,0211-699501013259,directamente,o
235,0211-699501013259,la,o
235,0211-699501013259,tHcy,i
235,0211-699501013259,con,o
235,0211-699501013259,la,o
235,0211-699501013259,albumina,i
235,0211-699501013259,plasmatica,i
235,0211-699501013259,La,o
235,0211-699501013259,interpretacion,o
235,0211-699501013259,de,o
235,0211-699501013259,los,o
235,0211-699501013259,niveles,i
235,0211-699501013259,de,i
235,0211-699501013259,tHcy,i
235,0211-699501013259,debe,o
235,0211-699501013259,tener,o
235,0211-699501013259,en,o
235,0211-699501013259,cuenta,o
235,0211-699501013259,la,o
235,0211-699501013259,concentracion,i
235,0211-699501013259,de,i
235,0211-699501013259,albumina,i
236,0211-699501013259,Efecto,o
236,0211-699501013259,de,o
236,0211-699501013259,la,o
236,0211-699501013259,suplementacion,i
236,0211-699501013259,con,o
236,0211-699501013259,acido,i
236,0211-699501013259,folico,i
236,0211-699501013259,sobre,o
236,0211-699501013259,los,o
236,0211-699501013259,niveles,i
236,0211-699501013259,de,i
236,0211-699501013259,homocisteina,i
236,0211-699501013259,total,o
236,0211-699501013259,en,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,en,o
236,0211-699501013259,hemodialisis,i
236,0211-699501013259,La,o
236,0211-699501013259,hiperhomocisteinemia,i
236,0211-699501013259,es,o
236,0211-699501013259,un,o
236,0211-699501013259,marcador,o
236,0211-699501013259,de,o
236,0211-699501013259,riesgo,o
236,0211-699501013259,independiente,o
236,0211-699501013259,de,o
236,0211-699501013259,morbimortalidad,o
236,0211-699501013259,cardiovascular,i
236,0211-699501013259,Hemos,o
236,0211-699501013259,intentado,o
236,0211-699501013259,prospectivamente,o
236,0211-699501013259,reducir,o
236,0211-699501013259,los,o
236,0211-699501013259,niveles,i
236,0211-699501013259,de,i
236,0211-699501013259,homocisteina,i
236,0211-699501013259,total,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,mediante,o
236,0211-699501013259,suplemento,o
236,0211-699501013259,con,o
236,0211-699501013259,acido,i
236,0211-699501013259,folico,i
236,0211-699501013259,y,o
236,0211-699501013259,vitamina,i
236,0211-699501013259,B6,i
236,0211-699501013259,pp,i
236,0211-699501013259,valorando,o
236,0211-699501013259,su,o
236,0211-699501013259,posible,o
236,0211-699501013259,correlacion,o
236,0211-699501013259,con,o
236,0211-699501013259,dosis,o
236,0211-699501013259,de,o
236,0211-699501013259,dialisis,i
236,0211-699501013259,funcion,i
236,0211-699501013259,residual,i
236,0211-699501013259,y,o
236,0211-699501013259,parametros,o
236,0211-699501013259,nutricionales,o
236,0211-699501013259,Metodos,o
236,0211-699501013259,Todos,o
236,0211-699501013259,los,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,en,o
236,0211-699501013259,hemodialisis,i
236,0211-699501013259,al,o
236,0211-699501013259,comienzo,o
236,0211-699501013259,del,o
236,0211-699501013259,estudio,o
236,0211-699501013259,que,o
236,0211-699501013259,no,o
236,0211-699501013259,recibian,o
236,0211-699501013259,acido,i
236,0211-699501013259,folico,i
236,0211-699501013259,ni,o
236,0211-699501013259,vitamina,i
236,0211-699501013259,B6,i
236,0211-699501013259,asi,o
236,0211-699501013259,como,o
236,0211-699501013259,los,o
236,0211-699501013259,incorporados,o
236,0211-699501013259,posteriormente,o
236,0211-699501013259,a,o
236,0211-699501013259,partir,o
236,0211-699501013259,de,o
236,0211-699501013259,su,o
236,0211-699501013259,tercer,o
236,0211-699501013259,mes,o
236,0211-699501013259,en,o
236,0211-699501013259,hemodialisis,i
236,0211-699501013259,recibieron,o
236,0211-699501013259,5,o
236,0211-699501013259,mg,o
236,0211-699501013259,orales,o
236,0211-699501013259,de,o
236,0211-699501013259,acido,i
236,0211-699501013259,folico,i
236,0211-699501013259,cada,o
236,0211-699501013259,48,o
236,0211-699501013259,horas,o
236,0211-699501013259,y,o
236,0211-699501013259,40,o
236,0211-699501013259,mg,o
236,0211-699501013259,orales,o
236,0211-699501013259,de,o
236,0211-699501013259,vitamina,i
236,0211-699501013259,B6,i
236,0211-699501013259,cada,o
236,0211-699501013259,semana,o
236,0211-699501013259,Se,o
236,0211-699501013259,determinaron,o
236,0211-699501013259,al,o
236,0211-699501013259,comienzo,o
236,0211-699501013259,del,o
236,0211-699501013259,estudio,o
236,0211-699501013259,y,o
236,0211-699501013259,cada,o
236,0211-699501013259,2,o
236,0211-699501013259,meses,o
236,0211-699501013259,niveles,i
236,0211-699501013259,de,i
236,0211-699501013259,folato,i
236,0211-699501013259,vitamina,i
236,0211-699501013259,B12,i
236,0211-699501013259,inmunoensayo,i
236,0211-699501013259,albumina,i
236,0211-699501013259,y,o
236,0211-699501013259,cinetica,o
236,0211-699501013259,de,o
236,0211-699501013259,la,o
236,0211-699501013259,urea,i
236,0211-699501013259,KTV,o
236,0211-699501013259,KRU,o
236,0211-699501013259,PCRn,o
236,0211-699501013259,y,o
236,0211-699501013259,cada,o
236,0211-699501013259,6,o
236,0211-699501013259,meses,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,HPLC,i
236,0211-699501013259,y,o
236,0211-699501013259,pp,i
236,0211-699501013259,RIA,i
236,0211-699501013259,Resultados,o
236,0211-699501013259,80,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,fueron,o
236,0211-699501013259,incluidos,o
236,0211-699501013259,en,o
236,0211-699501013259,el,o
236,0211-699501013259,estudio,o
236,0211-699501013259,basal,o
236,0211-699501013259,con,o
236,0211-699501013259,una,o
236,0211-699501013259,prevalencia,o
236,0211-699501013259,de,o
236,0211-699501013259,hiperhomocisteinemia,i
236,0211-699501013259,del,o
236,0211-699501013259,844,o
236,0211-699501013259,deficit,i
236,0211-699501013259,de,i
236,0211-699501013259,pp,i
236,0211-699501013259,en,o
236,0211-699501013259,el,o
236,0211-699501013259,32,o
236,0211-699501013259,y,o
236,0211-699501013259,folato,i
236,0211-699501013259,en,o
236,0211-699501013259,el,o
236,0211-699501013259,rango,o
236,0211-699501013259,normal,o
236,0211-699501013259,bajo,o
236,0211-699501013259,los,o
236,0211-699501013259,niveles,i
236,0211-699501013259,de,i
236,0211-699501013259,tHcy,i
236,0211-699501013259,se,o
236,0211-699501013259,correlacionaban,o
236,0211-699501013259,inversamente,o
236,0211-699501013259,con,o
236,0211-699501013259,los,o
236,0211-699501013259,del,o
236,0211-699501013259,folato,i
236,0211-699501013259,r,o
236,0211-699501013259,0336,o
236,0211-699501013259,p,o
236,0211-699501013259,001,o
236,0211-699501013259,pero,o
236,0211-699501013259,no,o
236,0211-699501013259,con,o
236,0211-699501013259,pp,i
236,0211-699501013259,B12,i
236,0211-699501013259,edad,o
236,0211-699501013259,albumina,i
236,0211-699501013259,KTV,o
236,0211-699501013259,KRU,o
236,0211-699501013259,PCRn,o
236,0211-699501013259,Cincuenta,o
236,0211-699501013259,y,o
236,0211-699501013259,ocho,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,recibieron,o
236,0211-699501013259,seis,o
236,0211-699501013259,meses,o
236,0211-699501013259,de,o
236,0211-699501013259,suplementacion,i
236,0211-699501013259,con,o
236,0211-699501013259,normalizacion,o
236,0211-699501013259,del,o
236,0211-699501013259,pp,i
236,0211-699501013259,aumento,o
236,0211-699501013259,del,o
236,0211-699501013259,folato,i
236,0211-699501013259,703,o
236,0211-699501013259,IC,o
236,0211-699501013259,638,o
236,0211-699501013259,795,o
236,0211-699501013259,vs,o
236,0211-699501013259,6181,o
236,0211-699501013259,IC,o
236,0211-699501013259,4447,o
236,0211-699501013259,7811,o
236,0211-699501013259,p,o
236,0211-699501013259,0001,o
236,0211-699501013259,y,o
236,0211-699501013259,descenso,o
236,0211-699501013259,de,o
236,0211-699501013259,la,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,240,o
236,0211-699501013259,IC,o
236,0211-699501013259,213,o
236,0211-699501013259,264,o
236,0211-699501013259,vs,o
236,0211-699501013259,199,o
236,0211-699501013259,IC,o
236,0211-699501013259,175,o
236,0211-699501013259,224,o
236,0211-699501013259,p,o
236,0211-699501013259,005,o
236,0211-699501013259,Han,o
236,0211-699501013259,recibido,o
236,0211-699501013259,suplementacion,i
236,0211-699501013259,durante,o
236,0211-699501013259,12,o
236,0211-699501013259,meses,o
236,0211-699501013259,33,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,pero,o
236,0211-699501013259,a,o
236,0211-699501013259,pesar,o
236,0211-699501013259,de,o
236,0211-699501013259,un,o
236,0211-699501013259,continuo,o
236,0211-699501013259,aumento,o
236,0211-699501013259,del,o
236,0211-699501013259,folato,i
236,0211-699501013259,10078,o
236,0211-699501013259,IC,o
236,0211-699501013259,7481,o
236,0211-699501013259,12674,o
236,0211-699501013259,p,o
236,0211-699501013259,0001,o
236,0211-699501013259,solo,o
236,0211-699501013259,3,o
236,0211-699501013259,pacientes,o
236,0211-699501013259,presentan,o
236,0211-699501013259,niveles,o
236,0211-699501013259,normales,o
236,0211-699501013259,de,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,correlacionandose,o
236,0211-699501013259,directamente,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,con,o
236,0211-699501013259,la,o
236,0211-699501013259,albumina,i
236,0211-699501013259,r,o
236,0211-699501013259,056,o
236,0211-699501013259,p,o
236,0211-699501013259,0001,o
236,0211-699501013259,que,o
236,0211-699501013259,se,o
236,0211-699501013259,elevo,o
236,0211-699501013259,con,o
236,0211-699501013259,respecto,o
236,0211-699501013259,al,o
236,0211-699501013259,inicio,o
236,0211-699501013259,337,o
236,0211-699501013259,IC,o
236,0211-699501013259,327,o
236,0211-699501013259,346,o
236,0211-699501013259,vs,o
236,0211-699501013259,350,o
236,0211-699501013259,IC,o
236,0211-699501013259,337,o
236,0211-699501013259,363,o
236,0211-699501013259,p,o
236,0211-699501013259,005,o
236,0211-699501013259,Conclusion,o
236,0211-699501013259,Tras,o
236,0211-699501013259,suplementacion,i
236,0211-699501013259,con,o
236,0211-699501013259,acido,i
236,0211-699501013259,folico,i
236,0211-699501013259,y,o
236,0211-699501013259,vitamina,i
236,0211-699501013259,B6,i
236,0211-699501013259,aunque,o
236,0211-699501013259,inicialmente,o
236,0211-699501013259,se,o
236,0211-699501013259,reduce,o
236,0211-699501013259,la,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,esta,o
236,0211-699501013259,respuesta,o
236,0211-699501013259,se,o
236,0211-699501013259,hace,o
236,0211-699501013259,refractaria,o
236,0211-699501013259,correlacionandose,o
236,0211-699501013259,directamente,o
236,0211-699501013259,la,o
236,0211-699501013259,tHcy,i
236,0211-699501013259,con,o
236,0211-699501013259,la,o
236,0211-699501013259,albumina,i
236,0211-699501013259,plasmatica,i
236,0211-699501013259,La,o
236,0211-699501013259,interpretacion,o
236,0211-699501013259,de,o
236,0211-699501013259,los,o
236,0211-699501013259,niveles,i
236,0211-699501013259,de,i
236,0211-699501013259,tHcy,i
236,0211-699501013259,debe,o
236,0211-699501013259,tener,o
236,0211-699501013259,en,o
236,0211-699501013259,cuenta,o
236,0211-699501013259,la,o
236,0211-699501013259,concentracion,i
236,0211-699501013259,de,i
236,0211-699501013259,albumina,i
237,0211-699501013259,Efecto,o
237,0211-699501013259,de,o
237,0211-699501013259,la,o
237,0211-699501013259,suplementacion,i
237,0211-699501013259,con,o
237,0211-699501013259,acido,i
237,0211-699501013259,folico,i
237,0211-699501013259,sobre,o
237,0211-699501013259,los,o
237,0211-699501013259,niveles,i
237,0211-699501013259,de,i
237,0211-699501013259,homocisteina,i
237,0211-699501013259,total,o
237,0211-699501013259,en,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,en,o
237,0211-699501013259,hemodialisis,i
237,0211-699501013259,La,o
237,0211-699501013259,hiperhomocisteinemia,i
237,0211-699501013259,es,o
237,0211-699501013259,un,o
237,0211-699501013259,marcador,o
237,0211-699501013259,de,o
237,0211-699501013259,riesgo,o
237,0211-699501013259,independiente,o
237,0211-699501013259,de,o
237,0211-699501013259,morbimortalidad,o
237,0211-699501013259,cardiovascular,i
237,0211-699501013259,Hemos,o
237,0211-699501013259,intentado,o
237,0211-699501013259,prospectivamente,o
237,0211-699501013259,reducir,o
237,0211-699501013259,los,o
237,0211-699501013259,niveles,i
237,0211-699501013259,de,i
237,0211-699501013259,homocisteina,i
237,0211-699501013259,total,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,mediante,o
237,0211-699501013259,suplemento,o
237,0211-699501013259,con,o
237,0211-699501013259,acido,i
237,0211-699501013259,folico,i
237,0211-699501013259,y,o
237,0211-699501013259,vitamina,i
237,0211-699501013259,B6,i
237,0211-699501013259,pp,i
237,0211-699501013259,valorando,o
237,0211-699501013259,su,o
237,0211-699501013259,posible,o
237,0211-699501013259,correlacion,o
237,0211-699501013259,con,o
237,0211-699501013259,dosis,o
237,0211-699501013259,de,o
237,0211-699501013259,dialisis,i
237,0211-699501013259,funcion,i
237,0211-699501013259,residual,i
237,0211-699501013259,y,o
237,0211-699501013259,parametros,o
237,0211-699501013259,nutricionales,o
237,0211-699501013259,Metodos,o
237,0211-699501013259,Todos,o
237,0211-699501013259,los,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,en,o
237,0211-699501013259,hemodialisis,i
237,0211-699501013259,al,o
237,0211-699501013259,comienzo,o
237,0211-699501013259,del,o
237,0211-699501013259,estudio,o
237,0211-699501013259,que,o
237,0211-699501013259,no,o
237,0211-699501013259,recibian,o
237,0211-699501013259,acido,i
237,0211-699501013259,folico,i
237,0211-699501013259,ni,o
237,0211-699501013259,vitamina,i
237,0211-699501013259,B6,i
237,0211-699501013259,asi,o
237,0211-699501013259,como,o
237,0211-699501013259,los,o
237,0211-699501013259,incorporados,o
237,0211-699501013259,posteriormente,o
237,0211-699501013259,a,o
237,0211-699501013259,partir,o
237,0211-699501013259,de,o
237,0211-699501013259,su,o
237,0211-699501013259,tercer,o
237,0211-699501013259,mes,o
237,0211-699501013259,en,o
237,0211-699501013259,hemodialisis,i
237,0211-699501013259,recibieron,o
237,0211-699501013259,5,o
237,0211-699501013259,mg,o
237,0211-699501013259,orales,o
237,0211-699501013259,de,o
237,0211-699501013259,acido,i
237,0211-699501013259,folico,i
237,0211-699501013259,cada,o
237,0211-699501013259,48,o
237,0211-699501013259,horas,o
237,0211-699501013259,y,o
237,0211-699501013259,40,o
237,0211-699501013259,mg,o
237,0211-699501013259,orales,o
237,0211-699501013259,de,o
237,0211-699501013259,vitamina,i
237,0211-699501013259,B6,i
237,0211-699501013259,cada,o
237,0211-699501013259,semana,o
237,0211-699501013259,Se,o
237,0211-699501013259,determinaron,o
237,0211-699501013259,al,o
237,0211-699501013259,comienzo,o
237,0211-699501013259,del,o
237,0211-699501013259,estudio,o
237,0211-699501013259,y,o
237,0211-699501013259,cada,o
237,0211-699501013259,2,o
237,0211-699501013259,meses,o
237,0211-699501013259,niveles,i
237,0211-699501013259,de,i
237,0211-699501013259,folato,i
237,0211-699501013259,vitamina,i
237,0211-699501013259,B12,i
237,0211-699501013259,inmunoensayo,i
237,0211-699501013259,albumina,i
237,0211-699501013259,y,o
237,0211-699501013259,cinetica,o
237,0211-699501013259,de,o
237,0211-699501013259,la,o
237,0211-699501013259,urea,i
237,0211-699501013259,KTV,o
237,0211-699501013259,KRU,o
237,0211-699501013259,PCRn,o
237,0211-699501013259,y,o
237,0211-699501013259,cada,o
237,0211-699501013259,6,o
237,0211-699501013259,meses,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,HPLC,i
237,0211-699501013259,y,o
237,0211-699501013259,pp,i
237,0211-699501013259,RIA,i
237,0211-699501013259,Resultados,o
237,0211-699501013259,80,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,fueron,o
237,0211-699501013259,incluidos,o
237,0211-699501013259,en,o
237,0211-699501013259,el,o
237,0211-699501013259,estudio,o
237,0211-699501013259,basal,o
237,0211-699501013259,con,o
237,0211-699501013259,una,o
237,0211-699501013259,prevalencia,o
237,0211-699501013259,de,o
237,0211-699501013259,hiperhomocisteinemia,i
237,0211-699501013259,del,o
237,0211-699501013259,844,o
237,0211-699501013259,deficit,i
237,0211-699501013259,de,i
237,0211-699501013259,pp,i
237,0211-699501013259,en,o
237,0211-699501013259,el,o
237,0211-699501013259,32,o
237,0211-699501013259,y,o
237,0211-699501013259,folato,i
237,0211-699501013259,en,o
237,0211-699501013259,el,o
237,0211-699501013259,rango,o
237,0211-699501013259,normal,o
237,0211-699501013259,bajo,o
237,0211-699501013259,los,o
237,0211-699501013259,niveles,i
237,0211-699501013259,de,i
237,0211-699501013259,tHcy,i
237,0211-699501013259,se,o
237,0211-699501013259,correlacionaban,o
237,0211-699501013259,inversamente,o
237,0211-699501013259,con,o
237,0211-699501013259,los,o
237,0211-699501013259,del,o
237,0211-699501013259,folato,i
237,0211-699501013259,r,o
237,0211-699501013259,0336,o
237,0211-699501013259,p,o
237,0211-699501013259,001,o
237,0211-699501013259,pero,o
237,0211-699501013259,no,o
237,0211-699501013259,con,o
237,0211-699501013259,pp,i
237,0211-699501013259,B12,i
237,0211-699501013259,edad,o
237,0211-699501013259,albumina,i
237,0211-699501013259,KTV,o
237,0211-699501013259,KRU,o
237,0211-699501013259,PCRn,o
237,0211-699501013259,Cincuenta,o
237,0211-699501013259,y,o
237,0211-699501013259,ocho,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,recibieron,o
237,0211-699501013259,seis,o
237,0211-699501013259,meses,o
237,0211-699501013259,de,o
237,0211-699501013259,suplementacion,i
237,0211-699501013259,con,o
237,0211-699501013259,normalizacion,o
237,0211-699501013259,del,o
237,0211-699501013259,pp,i
237,0211-699501013259,aumento,o
237,0211-699501013259,del,o
237,0211-699501013259,folato,i
237,0211-699501013259,703,o
237,0211-699501013259,IC,o
237,0211-699501013259,638,o
237,0211-699501013259,795,o
237,0211-699501013259,vs,o
237,0211-699501013259,6181,o
237,0211-699501013259,IC,o
237,0211-699501013259,4447,o
237,0211-699501013259,7811,o
237,0211-699501013259,p,o
237,0211-699501013259,0001,o
237,0211-699501013259,y,o
237,0211-699501013259,descenso,o
237,0211-699501013259,de,o
237,0211-699501013259,la,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,240,o
237,0211-699501013259,IC,o
237,0211-699501013259,213,o
237,0211-699501013259,264,o
237,0211-699501013259,vs,o
237,0211-699501013259,199,o
237,0211-699501013259,IC,o
237,0211-699501013259,175,o
237,0211-699501013259,224,o
237,0211-699501013259,p,o
237,0211-699501013259,005,o
237,0211-699501013259,Han,o
237,0211-699501013259,recibido,o
237,0211-699501013259,suplementacion,i
237,0211-699501013259,durante,o
237,0211-699501013259,12,o
237,0211-699501013259,meses,o
237,0211-699501013259,33,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,pero,o
237,0211-699501013259,a,o
237,0211-699501013259,pesar,o
237,0211-699501013259,de,o
237,0211-699501013259,un,o
237,0211-699501013259,continuo,o
237,0211-699501013259,aumento,o
237,0211-699501013259,del,o
237,0211-699501013259,folato,i
237,0211-699501013259,10078,o
237,0211-699501013259,IC,o
237,0211-699501013259,7481,o
237,0211-699501013259,12674,o
237,0211-699501013259,p,o
237,0211-699501013259,0001,o
237,0211-699501013259,solo,o
237,0211-699501013259,3,o
237,0211-699501013259,pacientes,o
237,0211-699501013259,presentan,o
237,0211-699501013259,niveles,o
237,0211-699501013259,normales,o
237,0211-699501013259,de,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,correlacionandose,o
237,0211-699501013259,directamente,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,con,o
237,0211-699501013259,la,o
237,0211-699501013259,albumina,i
237,0211-699501013259,r,o
237,0211-699501013259,056,o
237,0211-699501013259,p,o
237,0211-699501013259,0001,o
237,0211-699501013259,que,o
237,0211-699501013259,se,o
237,0211-699501013259,elevo,o
237,0211-699501013259,con,o
237,0211-699501013259,respecto,o
237,0211-699501013259,al,o
237,0211-699501013259,inicio,o
237,0211-699501013259,337,o
237,0211-699501013259,IC,o
237,0211-699501013259,327,o
237,0211-699501013259,346,o
237,0211-699501013259,vs,o
237,0211-699501013259,350,o
237,0211-699501013259,IC,o
237,0211-699501013259,337,o
237,0211-699501013259,363,o
237,0211-699501013259,p,o
237,0211-699501013259,005,o
237,0211-699501013259,Conclusion,o
237,0211-699501013259,Tras,o
237,0211-699501013259,suplementacion,i
237,0211-699501013259,con,o
237,0211-699501013259,acido,i
237,0211-699501013259,folico,i
237,0211-699501013259,y,o
237,0211-699501013259,vitamina,i
237,0211-699501013259,B6,i
237,0211-699501013259,aunque,o
237,0211-699501013259,inicialmente,o
237,0211-699501013259,se,o
237,0211-699501013259,reduce,o
237,0211-699501013259,la,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,esta,o
237,0211-699501013259,respuesta,o
237,0211-699501013259,se,o
237,0211-699501013259,hace,o
237,0211-699501013259,refractaria,o
237,0211-699501013259,correlacionandose,o
237,0211-699501013259,directamente,o
237,0211-699501013259,la,o
237,0211-699501013259,tHcy,i
237,0211-699501013259,con,o
237,0211-699501013259,la,o
237,0211-699501013259,albumina,i
237,0211-699501013259,plasmatica,i
237,0211-699501013259,La,o
237,0211-699501013259,interpretacion,o
237,0211-699501013259,de,o
237,0211-699501013259,los,o
237,0211-699501013259,niveles,i
237,0211-699501013259,de,i
237,0211-699501013259,tHcy,i
237,0211-699501013259,debe,o
237,0211-699501013259,tener,o
237,0211-699501013259,en,o
237,0211-699501013259,cuenta,o
237,0211-699501013259,la,o
237,0211-699501013259,concentracion,i
237,0211-699501013259,de,i
237,0211-699501013259,albumina,i
238,0211-699501013259,Efecto,o
238,0211-699501013259,de,o
238,0211-699501013259,la,o
238,0211-699501013259,suplementacion,i
238,0211-699501013259,con,o
238,0211-699501013259,acido,i
238,0211-699501013259,folico,i
238,0211-699501013259,sobre,o
238,0211-699501013259,los,o
238,0211-699501013259,niveles,i
238,0211-699501013259,de,i
238,0211-699501013259,homocisteina,i
238,0211-699501013259,total,o
238,0211-699501013259,en,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,en,o
238,0211-699501013259,hemodialisis,i
238,0211-699501013259,La,o
238,0211-699501013259,hiperhomocisteinemia,i
238,0211-699501013259,es,o
238,0211-699501013259,un,o
238,0211-699501013259,marcador,o
238,0211-699501013259,de,o
238,0211-699501013259,riesgo,o
238,0211-699501013259,independiente,o
238,0211-699501013259,de,o
238,0211-699501013259,morbimortalidad,o
238,0211-699501013259,cardiovascular,i
238,0211-699501013259,Hemos,o
238,0211-699501013259,intentado,o
238,0211-699501013259,prospectivamente,o
238,0211-699501013259,reducir,o
238,0211-699501013259,los,o
238,0211-699501013259,niveles,i
238,0211-699501013259,de,i
238,0211-699501013259,homocisteina,i
238,0211-699501013259,total,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,mediante,o
238,0211-699501013259,suplemento,o
238,0211-699501013259,con,o
238,0211-699501013259,acido,i
238,0211-699501013259,folico,i
238,0211-699501013259,y,o
238,0211-699501013259,vitamina,i
238,0211-699501013259,B6,i
238,0211-699501013259,pp,i
238,0211-699501013259,valorando,o
238,0211-699501013259,su,o
238,0211-699501013259,posible,o
238,0211-699501013259,correlacion,o
238,0211-699501013259,con,o
238,0211-699501013259,dosis,o
238,0211-699501013259,de,o
238,0211-699501013259,dialisis,i
238,0211-699501013259,funcion,i
238,0211-699501013259,residual,i
238,0211-699501013259,y,o
238,0211-699501013259,parametros,o
238,0211-699501013259,nutricionales,o
238,0211-699501013259,Metodos,o
238,0211-699501013259,Todos,o
238,0211-699501013259,los,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,en,o
238,0211-699501013259,hemodialisis,i
238,0211-699501013259,al,o
238,0211-699501013259,comienzo,o
238,0211-699501013259,del,o
238,0211-699501013259,estudio,o
238,0211-699501013259,que,o
238,0211-699501013259,no,o
238,0211-699501013259,recibian,o
238,0211-699501013259,acido,i
238,0211-699501013259,folico,i
238,0211-699501013259,ni,o
238,0211-699501013259,vitamina,i
238,0211-699501013259,B6,i
238,0211-699501013259,asi,o
238,0211-699501013259,como,o
238,0211-699501013259,los,o
238,0211-699501013259,incorporados,o
238,0211-699501013259,posteriormente,o
238,0211-699501013259,a,o
238,0211-699501013259,partir,o
238,0211-699501013259,de,o
238,0211-699501013259,su,o
238,0211-699501013259,tercer,o
238,0211-699501013259,mes,o
238,0211-699501013259,en,o
238,0211-699501013259,hemodialisis,i
238,0211-699501013259,recibieron,o
238,0211-699501013259,5,o
238,0211-699501013259,mg,o
238,0211-699501013259,orales,o
238,0211-699501013259,de,o
238,0211-699501013259,acido,i
238,0211-699501013259,folico,i
238,0211-699501013259,cada,o
238,0211-699501013259,48,o
238,0211-699501013259,horas,o
238,0211-699501013259,y,o
238,0211-699501013259,40,o
238,0211-699501013259,mg,o
238,0211-699501013259,orales,o
238,0211-699501013259,de,o
238,0211-699501013259,vitamina,i
238,0211-699501013259,B6,i
238,0211-699501013259,cada,o
238,0211-699501013259,semana,o
238,0211-699501013259,Se,o
238,0211-699501013259,determinaron,o
238,0211-699501013259,al,o
238,0211-699501013259,comienzo,o
238,0211-699501013259,del,o
238,0211-699501013259,estudio,o
238,0211-699501013259,y,o
238,0211-699501013259,cada,o
238,0211-699501013259,2,o
238,0211-699501013259,meses,o
238,0211-699501013259,niveles,i
238,0211-699501013259,de,i
238,0211-699501013259,folato,i
238,0211-699501013259,vitamina,i
238,0211-699501013259,B12,i
238,0211-699501013259,inmunoensayo,i
238,0211-699501013259,albumina,i
238,0211-699501013259,y,o
238,0211-699501013259,cinetica,o
238,0211-699501013259,de,o
238,0211-699501013259,la,o
238,0211-699501013259,urea,i
238,0211-699501013259,KTV,o
238,0211-699501013259,KRU,o
238,0211-699501013259,PCRn,o
238,0211-699501013259,y,o
238,0211-699501013259,cada,o
238,0211-699501013259,6,o
238,0211-699501013259,meses,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,HPLC,i
238,0211-699501013259,y,o
238,0211-699501013259,pp,i
238,0211-699501013259,RIA,i
238,0211-699501013259,Resultados,o
238,0211-699501013259,80,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,fueron,o
238,0211-699501013259,incluidos,o
238,0211-699501013259,en,o
238,0211-699501013259,el,o
238,0211-699501013259,estudio,o
238,0211-699501013259,basal,o
238,0211-699501013259,con,o
238,0211-699501013259,una,o
238,0211-699501013259,prevalencia,o
238,0211-699501013259,de,o
238,0211-699501013259,hiperhomocisteinemia,i
238,0211-699501013259,del,o
238,0211-699501013259,844,o
238,0211-699501013259,deficit,i
238,0211-699501013259,de,i
238,0211-699501013259,pp,i
238,0211-699501013259,en,o
238,0211-699501013259,el,o
238,0211-699501013259,32,o
238,0211-699501013259,y,o
238,0211-699501013259,folato,i
238,0211-699501013259,en,o
238,0211-699501013259,el,o
238,0211-699501013259,rango,o
238,0211-699501013259,normal,o
238,0211-699501013259,bajo,o
238,0211-699501013259,los,o
238,0211-699501013259,niveles,i
238,0211-699501013259,de,i
238,0211-699501013259,tHcy,i
238,0211-699501013259,se,o
238,0211-699501013259,correlacionaban,o
238,0211-699501013259,inversamente,o
238,0211-699501013259,con,o
238,0211-699501013259,los,o
238,0211-699501013259,del,o
238,0211-699501013259,folato,i
238,0211-699501013259,r,o
238,0211-699501013259,0336,o
238,0211-699501013259,p,o
238,0211-699501013259,001,o
238,0211-699501013259,pero,o
238,0211-699501013259,no,o
238,0211-699501013259,con,o
238,0211-699501013259,pp,i
238,0211-699501013259,B12,i
238,0211-699501013259,edad,o
238,0211-699501013259,albumina,i
238,0211-699501013259,KTV,o
238,0211-699501013259,KRU,o
238,0211-699501013259,PCRn,o
238,0211-699501013259,Cincuenta,o
238,0211-699501013259,y,o
238,0211-699501013259,ocho,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,recibieron,o
238,0211-699501013259,seis,o
238,0211-699501013259,meses,o
238,0211-699501013259,de,o
238,0211-699501013259,suplementacion,i
238,0211-699501013259,con,o
238,0211-699501013259,normalizacion,o
238,0211-699501013259,del,o
238,0211-699501013259,pp,i
238,0211-699501013259,aumento,o
238,0211-699501013259,del,o
238,0211-699501013259,folato,i
238,0211-699501013259,703,o
238,0211-699501013259,IC,o
238,0211-699501013259,638,o
238,0211-699501013259,795,o
238,0211-699501013259,vs,o
238,0211-699501013259,6181,o
238,0211-699501013259,IC,o
238,0211-699501013259,4447,o
238,0211-699501013259,7811,o
238,0211-699501013259,p,o
238,0211-699501013259,0001,o
238,0211-699501013259,y,o
238,0211-699501013259,descenso,o
238,0211-699501013259,de,o
238,0211-699501013259,la,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,240,o
238,0211-699501013259,IC,o
238,0211-699501013259,213,o
238,0211-699501013259,264,o
238,0211-699501013259,vs,o
238,0211-699501013259,199,o
238,0211-699501013259,IC,o
238,0211-699501013259,175,o
238,0211-699501013259,224,o
238,0211-699501013259,p,o
238,0211-699501013259,005,o
238,0211-699501013259,Han,o
238,0211-699501013259,recibido,o
238,0211-699501013259,suplementacion,i
238,0211-699501013259,durante,o
238,0211-699501013259,12,o
238,0211-699501013259,meses,o
238,0211-699501013259,33,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,pero,o
238,0211-699501013259,a,o
238,0211-699501013259,pesar,o
238,0211-699501013259,de,o
238,0211-699501013259,un,o
238,0211-699501013259,continuo,o
238,0211-699501013259,aumento,o
238,0211-699501013259,del,o
238,0211-699501013259,folato,i
238,0211-699501013259,10078,o
238,0211-699501013259,IC,o
238,0211-699501013259,7481,o
238,0211-699501013259,12674,o
238,0211-699501013259,p,o
238,0211-699501013259,0001,o
238,0211-699501013259,solo,o
238,0211-699501013259,3,o
238,0211-699501013259,pacientes,o
238,0211-699501013259,presentan,o
238,0211-699501013259,niveles,o
238,0211-699501013259,normales,o
238,0211-699501013259,de,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,correlacionandose,o
238,0211-699501013259,directamente,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,con,o
238,0211-699501013259,la,o
238,0211-699501013259,albumina,i
238,0211-699501013259,r,o
238,0211-699501013259,056,o
238,0211-699501013259,p,o
238,0211-699501013259,0001,o
238,0211-699501013259,que,o
238,0211-699501013259,se,o
238,0211-699501013259,elevo,o
238,0211-699501013259,con,o
238,0211-699501013259,respecto,o
238,0211-699501013259,al,o
238,0211-699501013259,inicio,o
238,0211-699501013259,337,o
238,0211-699501013259,IC,o
238,0211-699501013259,327,o
238,0211-699501013259,346,o
238,0211-699501013259,vs,o
238,0211-699501013259,350,o
238,0211-699501013259,IC,o
238,0211-699501013259,337,o
238,0211-699501013259,363,o
238,0211-699501013259,p,o
238,0211-699501013259,005,o
238,0211-699501013259,Conclusion,o
238,0211-699501013259,Tras,o
238,0211-699501013259,suplementacion,i
238,0211-699501013259,con,o
238,0211-699501013259,acido,i
238,0211-699501013259,folico,i
238,0211-699501013259,y,o
238,0211-699501013259,vitamina,i
238,0211-699501013259,B6,i
238,0211-699501013259,aunque,o
238,0211-699501013259,inicialmente,o
238,0211-699501013259,se,o
238,0211-699501013259,reduce,o
238,0211-699501013259,la,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,esta,o
238,0211-699501013259,respuesta,o
238,0211-699501013259,se,o
238,0211-699501013259,hace,o
238,0211-699501013259,refractaria,o
238,0211-699501013259,correlacionandose,o
238,0211-699501013259,directamente,o
238,0211-699501013259,la,o
238,0211-699501013259,tHcy,i
238,0211-699501013259,con,o
238,0211-699501013259,la,o
238,0211-699501013259,albumina,i
238,0211-699501013259,plasmatica,i
238,0211-699501013259,La,o
238,0211-699501013259,interpretacion,o
238,0211-699501013259,de,o
238,0211-699501013259,los,o
238,0211-699501013259,niveles,i
238,0211-699501013259,de,i
238,0211-699501013259,tHcy,i
238,0211-699501013259,debe,o
238,0211-699501013259,tener,o
238,0211-699501013259,en,o
238,0211-699501013259,cuenta,o
238,0211-699501013259,la,o
238,0211-699501013259,concentracion,i
238,0211-699501013259,de,i
238,0211-699501013259,albumina,i
239,0211-699501013259,Efecto,o
239,0211-699501013259,de,o
239,0211-699501013259,la,o
239,0211-699501013259,suplementacion,i
239,0211-699501013259,con,o
239,0211-699501013259,acido,i
239,0211-699501013259,folico,i
239,0211-699501013259,sobre,o
239,0211-699501013259,los,o
239,0211-699501013259,niveles,i
239,0211-699501013259,de,i
239,0211-699501013259,homocisteina,i
239,0211-699501013259,total,o
239,0211-699501013259,en,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,en,o
239,0211-699501013259,hemodialisis,i
239,0211-699501013259,La,o
239,0211-699501013259,hiperhomocisteinemia,i
239,0211-699501013259,es,o
239,0211-699501013259,un,o
239,0211-699501013259,marcador,o
239,0211-699501013259,de,o
239,0211-699501013259,riesgo,o
239,0211-699501013259,independiente,o
239,0211-699501013259,de,o
239,0211-699501013259,morbimortalidad,o
239,0211-699501013259,cardiovascular,i
239,0211-699501013259,Hemos,o
239,0211-699501013259,intentado,o
239,0211-699501013259,prospectivamente,o
239,0211-699501013259,reducir,o
239,0211-699501013259,los,o
239,0211-699501013259,niveles,i
239,0211-699501013259,de,i
239,0211-699501013259,homocisteina,i
239,0211-699501013259,total,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,mediante,o
239,0211-699501013259,suplemento,o
239,0211-699501013259,con,o
239,0211-699501013259,acido,i
239,0211-699501013259,folico,i
239,0211-699501013259,y,o
239,0211-699501013259,vitamina,i
239,0211-699501013259,B6,i
239,0211-699501013259,pp,i
239,0211-699501013259,valorando,o
239,0211-699501013259,su,o
239,0211-699501013259,posible,o
239,0211-699501013259,correlacion,o
239,0211-699501013259,con,o
239,0211-699501013259,dosis,o
239,0211-699501013259,de,o
239,0211-699501013259,dialisis,i
239,0211-699501013259,funcion,i
239,0211-699501013259,residual,i
239,0211-699501013259,y,o
239,0211-699501013259,parametros,o
239,0211-699501013259,nutricionales,o
239,0211-699501013259,Metodos,o
239,0211-699501013259,Todos,o
239,0211-699501013259,los,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,en,o
239,0211-699501013259,hemodialisis,i
239,0211-699501013259,al,o
239,0211-699501013259,comienzo,o
239,0211-699501013259,del,o
239,0211-699501013259,estudio,o
239,0211-699501013259,que,o
239,0211-699501013259,no,o
239,0211-699501013259,recibian,o
239,0211-699501013259,acido,i
239,0211-699501013259,folico,i
239,0211-699501013259,ni,o
239,0211-699501013259,vitamina,i
239,0211-699501013259,B6,i
239,0211-699501013259,asi,o
239,0211-699501013259,como,o
239,0211-699501013259,los,o
239,0211-699501013259,incorporados,o
239,0211-699501013259,posteriormente,o
239,0211-699501013259,a,o
239,0211-699501013259,partir,o
239,0211-699501013259,de,o
239,0211-699501013259,su,o
239,0211-699501013259,tercer,o
239,0211-699501013259,mes,o
239,0211-699501013259,en,o
239,0211-699501013259,hemodialisis,i
239,0211-699501013259,recibieron,o
239,0211-699501013259,5,o
239,0211-699501013259,mg,o
239,0211-699501013259,orales,o
239,0211-699501013259,de,o
239,0211-699501013259,acido,i
239,0211-699501013259,folico,i
239,0211-699501013259,cada,o
239,0211-699501013259,48,o
239,0211-699501013259,horas,o
239,0211-699501013259,y,o
239,0211-699501013259,40,o
239,0211-699501013259,mg,o
239,0211-699501013259,orales,o
239,0211-699501013259,de,o
239,0211-699501013259,vitamina,i
239,0211-699501013259,B6,i
239,0211-699501013259,cada,o
239,0211-699501013259,semana,o
239,0211-699501013259,Se,o
239,0211-699501013259,determinaron,o
239,0211-699501013259,al,o
239,0211-699501013259,comienzo,o
239,0211-699501013259,del,o
239,0211-699501013259,estudio,o
239,0211-699501013259,y,o
239,0211-699501013259,cada,o
239,0211-699501013259,2,o
239,0211-699501013259,meses,o
239,0211-699501013259,niveles,i
239,0211-699501013259,de,i
239,0211-699501013259,folato,i
239,0211-699501013259,vitamina,i
239,0211-699501013259,B12,i
239,0211-699501013259,inmunoensayo,i
239,0211-699501013259,albumina,i
239,0211-699501013259,y,o
239,0211-699501013259,cinetica,o
239,0211-699501013259,de,o
239,0211-699501013259,la,o
239,0211-699501013259,urea,i
239,0211-699501013259,KTV,o
239,0211-699501013259,KRU,o
239,0211-699501013259,PCRn,o
239,0211-699501013259,y,o
239,0211-699501013259,cada,o
239,0211-699501013259,6,o
239,0211-699501013259,meses,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,HPLC,i
239,0211-699501013259,y,o
239,0211-699501013259,pp,i
239,0211-699501013259,RIA,i
239,0211-699501013259,Resultados,o
239,0211-699501013259,80,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,fueron,o
239,0211-699501013259,incluidos,o
239,0211-699501013259,en,o
239,0211-699501013259,el,o
239,0211-699501013259,estudio,o
239,0211-699501013259,basal,o
239,0211-699501013259,con,o
239,0211-699501013259,una,o
239,0211-699501013259,prevalencia,o
239,0211-699501013259,de,o
239,0211-699501013259,hiperhomocisteinemia,i
239,0211-699501013259,del,o
239,0211-699501013259,844,o
239,0211-699501013259,deficit,i
239,0211-699501013259,de,i
239,0211-699501013259,pp,i
239,0211-699501013259,en,o
239,0211-699501013259,el,o
239,0211-699501013259,32,o
239,0211-699501013259,y,o
239,0211-699501013259,folato,i
239,0211-699501013259,en,o
239,0211-699501013259,el,o
239,0211-699501013259,rango,o
239,0211-699501013259,normal,o
239,0211-699501013259,bajo,o
239,0211-699501013259,los,o
239,0211-699501013259,niveles,i
239,0211-699501013259,de,i
239,0211-699501013259,tHcy,i
239,0211-699501013259,se,o
239,0211-699501013259,correlacionaban,o
239,0211-699501013259,inversamente,o
239,0211-699501013259,con,o
239,0211-699501013259,los,o
239,0211-699501013259,del,o
239,0211-699501013259,folato,i
239,0211-699501013259,r,o
239,0211-699501013259,0336,o
239,0211-699501013259,p,o
239,0211-699501013259,001,o
239,0211-699501013259,pero,o
239,0211-699501013259,no,o
239,0211-699501013259,con,o
239,0211-699501013259,pp,i
239,0211-699501013259,B12,i
239,0211-699501013259,edad,o
239,0211-699501013259,albumina,i
239,0211-699501013259,KTV,o
239,0211-699501013259,KRU,o
239,0211-699501013259,PCRn,o
239,0211-699501013259,Cincuenta,o
239,0211-699501013259,y,o
239,0211-699501013259,ocho,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,recibieron,o
239,0211-699501013259,seis,o
239,0211-699501013259,meses,o
239,0211-699501013259,de,o
239,0211-699501013259,suplementacion,i
239,0211-699501013259,con,o
239,0211-699501013259,normalizacion,o
239,0211-699501013259,del,o
239,0211-699501013259,pp,i
239,0211-699501013259,aumento,o
239,0211-699501013259,del,o
239,0211-699501013259,folato,i
239,0211-699501013259,703,o
239,0211-699501013259,IC,o
239,0211-699501013259,638,o
239,0211-699501013259,795,o
239,0211-699501013259,vs,o
239,0211-699501013259,6181,o
239,0211-699501013259,IC,o
239,0211-699501013259,4447,o
239,0211-699501013259,7811,o
239,0211-699501013259,p,o
239,0211-699501013259,0001,o
239,0211-699501013259,y,o
239,0211-699501013259,descenso,o
239,0211-699501013259,de,o
239,0211-699501013259,la,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,240,o
239,0211-699501013259,IC,o
239,0211-699501013259,213,o
239,0211-699501013259,264,o
239,0211-699501013259,vs,o
239,0211-699501013259,199,o
239,0211-699501013259,IC,o
239,0211-699501013259,175,o
239,0211-699501013259,224,o
239,0211-699501013259,p,o
239,0211-699501013259,005,o
239,0211-699501013259,Han,o
239,0211-699501013259,recibido,o
239,0211-699501013259,suplementacion,i
239,0211-699501013259,durante,o
239,0211-699501013259,12,o
239,0211-699501013259,meses,o
239,0211-699501013259,33,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,pero,o
239,0211-699501013259,a,o
239,0211-699501013259,pesar,o
239,0211-699501013259,de,o
239,0211-699501013259,un,o
239,0211-699501013259,continuo,o
239,0211-699501013259,aumento,o
239,0211-699501013259,del,o
239,0211-699501013259,folato,i
239,0211-699501013259,10078,o
239,0211-699501013259,IC,o
239,0211-699501013259,7481,o
239,0211-699501013259,12674,o
239,0211-699501013259,p,o
239,0211-699501013259,0001,o
239,0211-699501013259,solo,o
239,0211-699501013259,3,o
239,0211-699501013259,pacientes,o
239,0211-699501013259,presentan,o
239,0211-699501013259,niveles,o
239,0211-699501013259,normales,o
239,0211-699501013259,de,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,correlacionandose,o
239,0211-699501013259,directamente,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,con,o
239,0211-699501013259,la,o
239,0211-699501013259,albumina,i
239,0211-699501013259,r,o
239,0211-699501013259,056,o
239,0211-699501013259,p,o
239,0211-699501013259,0001,o
239,0211-699501013259,que,o
239,0211-699501013259,se,o
239,0211-699501013259,elevo,o
239,0211-699501013259,con,o
239,0211-699501013259,respecto,o
239,0211-699501013259,al,o
239,0211-699501013259,inicio,o
239,0211-699501013259,337,o
239,0211-699501013259,IC,o
239,0211-699501013259,327,o
239,0211-699501013259,346,o
239,0211-699501013259,vs,o
239,0211-699501013259,350,o
239,0211-699501013259,IC,o
239,0211-699501013259,337,o
239,0211-699501013259,363,o
239,0211-699501013259,p,o
239,0211-699501013259,005,o
239,0211-699501013259,Conclusion,o
239,0211-699501013259,Tras,o
239,0211-699501013259,suplementacion,i
239,0211-699501013259,con,o
239,0211-699501013259,acido,i
239,0211-699501013259,folico,i
239,0211-699501013259,y,o
239,0211-699501013259,vitamina,i
239,0211-699501013259,B6,i
239,0211-699501013259,aunque,o
239,0211-699501013259,inicialmente,o
239,0211-699501013259,se,o
239,0211-699501013259,reduce,o
239,0211-699501013259,la,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,esta,o
239,0211-699501013259,respuesta,o
239,0211-699501013259,se,o
239,0211-699501013259,hace,o
239,0211-699501013259,refractaria,o
239,0211-699501013259,correlacionandose,o
239,0211-699501013259,directamente,o
239,0211-699501013259,la,o
239,0211-699501013259,tHcy,i
239,0211-699501013259,con,o
239,0211-699501013259,la,o
239,0211-699501013259,albumina,i
239,0211-699501013259,plasmatica,i
239,0211-699501013259,La,o
239,0211-699501013259,interpretacion,o
239,0211-699501013259,de,o
239,0211-699501013259,los,o
239,0211-699501013259,niveles,i
239,0211-699501013259,de,i
239,0211-699501013259,tHcy,i
239,0211-699501013259,debe,o
239,0211-699501013259,tener,o
239,0211-699501013259,en,o
239,0211-699501013259,cuenta,o
239,0211-699501013259,la,o
239,0211-699501013259,concentracion,i
239,0211-699501013259,de,i
239,0211-699501013259,albumina,i
240,0211-699501013259,Efecto,o
240,0211-699501013259,de,o
240,0211-699501013259,la,o
240,0211-699501013259,suplementacion,i
240,0211-699501013259,con,o
240,0211-699501013259,acido,i
240,0211-699501013259,folico,i
240,0211-699501013259,sobre,o
240,0211-699501013259,los,o
240,0211-699501013259,niveles,i
240,0211-699501013259,de,i
240,0211-699501013259,homocisteina,i
240,0211-699501013259,total,o
240,0211-699501013259,en,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,en,o
240,0211-699501013259,hemodialisis,i
240,0211-699501013259,La,o
240,0211-699501013259,hiperhomocisteinemia,i
240,0211-699501013259,es,o
240,0211-699501013259,un,o
240,0211-699501013259,marcador,o
240,0211-699501013259,de,o
240,0211-699501013259,riesgo,o
240,0211-699501013259,independiente,o
240,0211-699501013259,de,o
240,0211-699501013259,morbimortalidad,o
240,0211-699501013259,cardiovascular,i
240,0211-699501013259,Hemos,o
240,0211-699501013259,intentado,o
240,0211-699501013259,prospectivamente,o
240,0211-699501013259,reducir,o
240,0211-699501013259,los,o
240,0211-699501013259,niveles,i
240,0211-699501013259,de,i
240,0211-699501013259,homocisteina,i
240,0211-699501013259,total,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,mediante,o
240,0211-699501013259,suplemento,o
240,0211-699501013259,con,o
240,0211-699501013259,acido,i
240,0211-699501013259,folico,i
240,0211-699501013259,y,o
240,0211-699501013259,vitamina,i
240,0211-699501013259,B6,i
240,0211-699501013259,pp,i
240,0211-699501013259,valorando,o
240,0211-699501013259,su,o
240,0211-699501013259,posible,o
240,0211-699501013259,correlacion,o
240,0211-699501013259,con,o
240,0211-699501013259,dosis,o
240,0211-699501013259,de,o
240,0211-699501013259,dialisis,i
240,0211-699501013259,funcion,i
240,0211-699501013259,residual,i
240,0211-699501013259,y,o
240,0211-699501013259,parametros,o
240,0211-699501013259,nutricionales,o
240,0211-699501013259,Metodos,o
240,0211-699501013259,Todos,o
240,0211-699501013259,los,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,en,o
240,0211-699501013259,hemodialisis,i
240,0211-699501013259,al,o
240,0211-699501013259,comienzo,o
240,0211-699501013259,del,o
240,0211-699501013259,estudio,o
240,0211-699501013259,que,o
240,0211-699501013259,no,o
240,0211-699501013259,recibian,o
240,0211-699501013259,acido,i
240,0211-699501013259,folico,i
240,0211-699501013259,ni,o
240,0211-699501013259,vitamina,i
240,0211-699501013259,B6,i
240,0211-699501013259,asi,o
240,0211-699501013259,como,o
240,0211-699501013259,los,o
240,0211-699501013259,incorporados,o
240,0211-699501013259,posteriormente,o
240,0211-699501013259,a,o
240,0211-699501013259,partir,o
240,0211-699501013259,de,o
240,0211-699501013259,su,o
240,0211-699501013259,tercer,o
240,0211-699501013259,mes,o
240,0211-699501013259,en,o
240,0211-699501013259,hemodialisis,i
240,0211-699501013259,recibieron,o
240,0211-699501013259,5,o
240,0211-699501013259,mg,o
240,0211-699501013259,orales,o
240,0211-699501013259,de,o
240,0211-699501013259,acido,i
240,0211-699501013259,folico,i
240,0211-699501013259,cada,o
240,0211-699501013259,48,o
240,0211-699501013259,horas,o
240,0211-699501013259,y,o
240,0211-699501013259,40,o
240,0211-699501013259,mg,o
240,0211-699501013259,orales,o
240,0211-699501013259,de,o
240,0211-699501013259,vitamina,i
240,0211-699501013259,B6,i
240,0211-699501013259,cada,o
240,0211-699501013259,semana,o
240,0211-699501013259,Se,o
240,0211-699501013259,determinaron,o
240,0211-699501013259,al,o
240,0211-699501013259,comienzo,o
240,0211-699501013259,del,o
240,0211-699501013259,estudio,o
240,0211-699501013259,y,o
240,0211-699501013259,cada,o
240,0211-699501013259,2,o
240,0211-699501013259,meses,o
240,0211-699501013259,niveles,i
240,0211-699501013259,de,i
240,0211-699501013259,folato,i
240,0211-699501013259,vitamina,i
240,0211-699501013259,B12,i
240,0211-699501013259,inmunoensayo,i
240,0211-699501013259,albumina,i
240,0211-699501013259,y,o
240,0211-699501013259,cinetica,o
240,0211-699501013259,de,o
240,0211-699501013259,la,o
240,0211-699501013259,urea,i
240,0211-699501013259,KTV,o
240,0211-699501013259,KRU,o
240,0211-699501013259,PCRn,o
240,0211-699501013259,y,o
240,0211-699501013259,cada,o
240,0211-699501013259,6,o
240,0211-699501013259,meses,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,HPLC,i
240,0211-699501013259,y,o
240,0211-699501013259,pp,i
240,0211-699501013259,RIA,i
240,0211-699501013259,Resultados,o
240,0211-699501013259,80,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,fueron,o
240,0211-699501013259,incluidos,o
240,0211-699501013259,en,o
240,0211-699501013259,el,o
240,0211-699501013259,estudio,o
240,0211-699501013259,basal,o
240,0211-699501013259,con,o
240,0211-699501013259,una,o
240,0211-699501013259,prevalencia,o
240,0211-699501013259,de,o
240,0211-699501013259,hiperhomocisteinemia,i
240,0211-699501013259,del,o
240,0211-699501013259,844,o
240,0211-699501013259,deficit,i
240,0211-699501013259,de,i
240,0211-699501013259,pp,i
240,0211-699501013259,en,o
240,0211-699501013259,el,o
240,0211-699501013259,32,o
240,0211-699501013259,y,o
240,0211-699501013259,folato,i
240,0211-699501013259,en,o
240,0211-699501013259,el,o
240,0211-699501013259,rango,o
240,0211-699501013259,normal,o
240,0211-699501013259,bajo,o
240,0211-699501013259,los,o
240,0211-699501013259,niveles,i
240,0211-699501013259,de,i
240,0211-699501013259,tHcy,i
240,0211-699501013259,se,o
240,0211-699501013259,correlacionaban,o
240,0211-699501013259,inversamente,o
240,0211-699501013259,con,o
240,0211-699501013259,los,o
240,0211-699501013259,del,o
240,0211-699501013259,folato,i
240,0211-699501013259,r,o
240,0211-699501013259,0336,o
240,0211-699501013259,p,o
240,0211-699501013259,001,o
240,0211-699501013259,pero,o
240,0211-699501013259,no,o
240,0211-699501013259,con,o
240,0211-699501013259,pp,i
240,0211-699501013259,B12,i
240,0211-699501013259,edad,o
240,0211-699501013259,albumina,i
240,0211-699501013259,KTV,o
240,0211-699501013259,KRU,o
240,0211-699501013259,PCRn,o
240,0211-699501013259,Cincuenta,o
240,0211-699501013259,y,o
240,0211-699501013259,ocho,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,recibieron,o
240,0211-699501013259,seis,o
240,0211-699501013259,meses,o
240,0211-699501013259,de,o
240,0211-699501013259,suplementacion,i
240,0211-699501013259,con,o
240,0211-699501013259,normalizacion,o
240,0211-699501013259,del,o
240,0211-699501013259,pp,i
240,0211-699501013259,aumento,o
240,0211-699501013259,del,o
240,0211-699501013259,folato,i
240,0211-699501013259,703,o
240,0211-699501013259,IC,o
240,0211-699501013259,638,o
240,0211-699501013259,795,o
240,0211-699501013259,vs,o
240,0211-699501013259,6181,o
240,0211-699501013259,IC,o
240,0211-699501013259,4447,o
240,0211-699501013259,7811,o
240,0211-699501013259,p,o
240,0211-699501013259,0001,o
240,0211-699501013259,y,o
240,0211-699501013259,descenso,o
240,0211-699501013259,de,o
240,0211-699501013259,la,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,240,o
240,0211-699501013259,IC,o
240,0211-699501013259,213,o
240,0211-699501013259,264,o
240,0211-699501013259,vs,o
240,0211-699501013259,199,o
240,0211-699501013259,IC,o
240,0211-699501013259,175,o
240,0211-699501013259,224,o
240,0211-699501013259,p,o
240,0211-699501013259,005,o
240,0211-699501013259,Han,o
240,0211-699501013259,recibido,o
240,0211-699501013259,suplementacion,i
240,0211-699501013259,durante,o
240,0211-699501013259,12,o
240,0211-699501013259,meses,o
240,0211-699501013259,33,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,pero,o
240,0211-699501013259,a,o
240,0211-699501013259,pesar,o
240,0211-699501013259,de,o
240,0211-699501013259,un,o
240,0211-699501013259,continuo,o
240,0211-699501013259,aumento,o
240,0211-699501013259,del,o
240,0211-699501013259,folato,i
240,0211-699501013259,10078,o
240,0211-699501013259,IC,o
240,0211-699501013259,7481,o
240,0211-699501013259,12674,o
240,0211-699501013259,p,o
240,0211-699501013259,0001,o
240,0211-699501013259,solo,o
240,0211-699501013259,3,o
240,0211-699501013259,pacientes,o
240,0211-699501013259,presentan,o
240,0211-699501013259,niveles,o
240,0211-699501013259,normales,o
240,0211-699501013259,de,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,correlacionandose,o
240,0211-699501013259,directamente,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,con,o
240,0211-699501013259,la,o
240,0211-699501013259,albumina,i
240,0211-699501013259,r,o
240,0211-699501013259,056,o
240,0211-699501013259,p,o
240,0211-699501013259,0001,o
240,0211-699501013259,que,o
240,0211-699501013259,se,o
240,0211-699501013259,elevo,o
240,0211-699501013259,con,o
240,0211-699501013259,respecto,o
240,0211-699501013259,al,o
240,0211-699501013259,inicio,o
240,0211-699501013259,337,o
240,0211-699501013259,IC,o
240,0211-699501013259,327,o
240,0211-699501013259,346,o
240,0211-699501013259,vs,o
240,0211-699501013259,350,o
240,0211-699501013259,IC,o
240,0211-699501013259,337,o
240,0211-699501013259,363,o
240,0211-699501013259,p,o
240,0211-699501013259,005,o
240,0211-699501013259,Conclusion,o
240,0211-699501013259,Tras,o
240,0211-699501013259,suplementacion,i
240,0211-699501013259,con,o
240,0211-699501013259,acido,i
240,0211-699501013259,folico,i
240,0211-699501013259,y,o
240,0211-699501013259,vitamina,i
240,0211-699501013259,B6,i
240,0211-699501013259,aunque,o
240,0211-699501013259,inicialmente,o
240,0211-699501013259,se,o
240,0211-699501013259,reduce,o
240,0211-699501013259,la,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,esta,o
240,0211-699501013259,respuesta,o
240,0211-699501013259,se,o
240,0211-699501013259,hace,o
240,0211-699501013259,refractaria,o
240,0211-699501013259,correlacionandose,o
240,0211-699501013259,directamente,o
240,0211-699501013259,la,o
240,0211-699501013259,tHcy,i
240,0211-699501013259,con,o
240,0211-699501013259,la,o
240,0211-699501013259,albumina,i
240,0211-699501013259,plasmatica,i
240,0211-699501013259,La,o
240,0211-699501013259,interpretacion,o
240,0211-699501013259,de,o
240,0211-699501013259,los,o
240,0211-699501013259,niveles,i
240,0211-699501013259,de,i
240,0211-699501013259,tHcy,i
240,0211-699501013259,debe,o
240,0211-699501013259,tener,o
240,0211-699501013259,en,o
240,0211-699501013259,cuenta,o
240,0211-699501013259,la,o
240,0211-699501013259,concentracion,i
240,0211-699501013259,de,i
240,0211-699501013259,albumina,i
241,0211-699501013259,Efecto,o
241,0211-699501013259,de,o
241,0211-699501013259,la,o
241,0211-699501013259,suplementacion,i
241,0211-699501013259,con,o
241,0211-699501013259,acido,i
241,0211-699501013259,folico,i
241,0211-699501013259,sobre,o
241,0211-699501013259,los,o
241,0211-699501013259,niveles,i
241,0211-699501013259,de,i
241,0211-699501013259,homocisteina,i
241,0211-699501013259,total,o
241,0211-699501013259,en,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,en,o
241,0211-699501013259,hemodialisis,i
241,0211-699501013259,La,o
241,0211-699501013259,hiperhomocisteinemia,i
241,0211-699501013259,es,o
241,0211-699501013259,un,o
241,0211-699501013259,marcador,o
241,0211-699501013259,de,o
241,0211-699501013259,riesgo,o
241,0211-699501013259,independiente,o
241,0211-699501013259,de,o
241,0211-699501013259,morbimortalidad,o
241,0211-699501013259,cardiovascular,i
241,0211-699501013259,Hemos,o
241,0211-699501013259,intentado,o
241,0211-699501013259,prospectivamente,o
241,0211-699501013259,reducir,o
241,0211-699501013259,los,o
241,0211-699501013259,niveles,i
241,0211-699501013259,de,i
241,0211-699501013259,homocisteina,i
241,0211-699501013259,total,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,mediante,o
241,0211-699501013259,suplemento,o
241,0211-699501013259,con,o
241,0211-699501013259,acido,i
241,0211-699501013259,folico,i
241,0211-699501013259,y,o
241,0211-699501013259,vitamina,i
241,0211-699501013259,B6,i
241,0211-699501013259,pp,i
241,0211-699501013259,valorando,o
241,0211-699501013259,su,o
241,0211-699501013259,posible,o
241,0211-699501013259,correlacion,o
241,0211-699501013259,con,o
241,0211-699501013259,dosis,o
241,0211-699501013259,de,o
241,0211-699501013259,dialisis,i
241,0211-699501013259,funcion,i
241,0211-699501013259,residual,i
241,0211-699501013259,y,o
241,0211-699501013259,parametros,o
241,0211-699501013259,nutricionales,o
241,0211-699501013259,Metodos,o
241,0211-699501013259,Todos,o
241,0211-699501013259,los,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,en,o
241,0211-699501013259,hemodialisis,i
241,0211-699501013259,al,o
241,0211-699501013259,comienzo,o
241,0211-699501013259,del,o
241,0211-699501013259,estudio,o
241,0211-699501013259,que,o
241,0211-699501013259,no,o
241,0211-699501013259,recibian,o
241,0211-699501013259,acido,i
241,0211-699501013259,folico,i
241,0211-699501013259,ni,o
241,0211-699501013259,vitamina,i
241,0211-699501013259,B6,i
241,0211-699501013259,asi,o
241,0211-699501013259,como,o
241,0211-699501013259,los,o
241,0211-699501013259,incorporados,o
241,0211-699501013259,posteriormente,o
241,0211-699501013259,a,o
241,0211-699501013259,partir,o
241,0211-699501013259,de,o
241,0211-699501013259,su,o
241,0211-699501013259,tercer,o
241,0211-699501013259,mes,o
241,0211-699501013259,en,o
241,0211-699501013259,hemodialisis,i
241,0211-699501013259,recibieron,o
241,0211-699501013259,5,o
241,0211-699501013259,mg,o
241,0211-699501013259,orales,o
241,0211-699501013259,de,o
241,0211-699501013259,acido,i
241,0211-699501013259,folico,i
241,0211-699501013259,cada,o
241,0211-699501013259,48,o
241,0211-699501013259,horas,o
241,0211-699501013259,y,o
241,0211-699501013259,40,o
241,0211-699501013259,mg,o
241,0211-699501013259,orales,o
241,0211-699501013259,de,o
241,0211-699501013259,vitamina,i
241,0211-699501013259,B6,i
241,0211-699501013259,cada,o
241,0211-699501013259,semana,o
241,0211-699501013259,Se,o
241,0211-699501013259,determinaron,o
241,0211-699501013259,al,o
241,0211-699501013259,comienzo,o
241,0211-699501013259,del,o
241,0211-699501013259,estudio,o
241,0211-699501013259,y,o
241,0211-699501013259,cada,o
241,0211-699501013259,2,o
241,0211-699501013259,meses,o
241,0211-699501013259,niveles,i
241,0211-699501013259,de,i
241,0211-699501013259,folato,i
241,0211-699501013259,vitamina,i
241,0211-699501013259,B12,i
241,0211-699501013259,inmunoensayo,i
241,0211-699501013259,albumina,i
241,0211-699501013259,y,o
241,0211-699501013259,cinetica,o
241,0211-699501013259,de,o
241,0211-699501013259,la,o
241,0211-699501013259,urea,i
241,0211-699501013259,KTV,o
241,0211-699501013259,KRU,o
241,0211-699501013259,PCRn,o
241,0211-699501013259,y,o
241,0211-699501013259,cada,o
241,0211-699501013259,6,o
241,0211-699501013259,meses,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,HPLC,i
241,0211-699501013259,y,o
241,0211-699501013259,pp,i
241,0211-699501013259,RIA,i
241,0211-699501013259,Resultados,o
241,0211-699501013259,80,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,fueron,o
241,0211-699501013259,incluidos,o
241,0211-699501013259,en,o
241,0211-699501013259,el,o
241,0211-699501013259,estudio,o
241,0211-699501013259,basal,o
241,0211-699501013259,con,o
241,0211-699501013259,una,o
241,0211-699501013259,prevalencia,o
241,0211-699501013259,de,o
241,0211-699501013259,hiperhomocisteinemia,i
241,0211-699501013259,del,o
241,0211-699501013259,844,o
241,0211-699501013259,deficit,i
241,0211-699501013259,de,i
241,0211-699501013259,pp,i
241,0211-699501013259,en,o
241,0211-699501013259,el,o
241,0211-699501013259,32,o
241,0211-699501013259,y,o
241,0211-699501013259,folato,i
241,0211-699501013259,en,o
241,0211-699501013259,el,o
241,0211-699501013259,rango,o
241,0211-699501013259,normal,o
241,0211-699501013259,bajo,o
241,0211-699501013259,los,o
241,0211-699501013259,niveles,i
241,0211-699501013259,de,i
241,0211-699501013259,tHcy,i
241,0211-699501013259,se,o
241,0211-699501013259,correlacionaban,o
241,0211-699501013259,inversamente,o
241,0211-699501013259,con,o
241,0211-699501013259,los,o
241,0211-699501013259,del,o
241,0211-699501013259,folato,i
241,0211-699501013259,r,o
241,0211-699501013259,0336,o
241,0211-699501013259,p,o
241,0211-699501013259,001,o
241,0211-699501013259,pero,o
241,0211-699501013259,no,o
241,0211-699501013259,con,o
241,0211-699501013259,pp,i
241,0211-699501013259,B12,i
241,0211-699501013259,edad,o
241,0211-699501013259,albumina,i
241,0211-699501013259,KTV,o
241,0211-699501013259,KRU,o
241,0211-699501013259,PCRn,o
241,0211-699501013259,Cincuenta,o
241,0211-699501013259,y,o
241,0211-699501013259,ocho,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,recibieron,o
241,0211-699501013259,seis,o
241,0211-699501013259,meses,o
241,0211-699501013259,de,o
241,0211-699501013259,suplementacion,i
241,0211-699501013259,con,o
241,0211-699501013259,normalizacion,o
241,0211-699501013259,del,o
241,0211-699501013259,pp,i
241,0211-699501013259,aumento,o
241,0211-699501013259,del,o
241,0211-699501013259,folato,i
241,0211-699501013259,703,o
241,0211-699501013259,IC,o
241,0211-699501013259,638,o
241,0211-699501013259,795,o
241,0211-699501013259,vs,o
241,0211-699501013259,6181,o
241,0211-699501013259,IC,o
241,0211-699501013259,4447,o
241,0211-699501013259,7811,o
241,0211-699501013259,p,o
241,0211-699501013259,0001,o
241,0211-699501013259,y,o
241,0211-699501013259,descenso,o
241,0211-699501013259,de,o
241,0211-699501013259,la,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,240,o
241,0211-699501013259,IC,o
241,0211-699501013259,213,o
241,0211-699501013259,264,o
241,0211-699501013259,vs,o
241,0211-699501013259,199,o
241,0211-699501013259,IC,o
241,0211-699501013259,175,o
241,0211-699501013259,224,o
241,0211-699501013259,p,o
241,0211-699501013259,005,o
241,0211-699501013259,Han,o
241,0211-699501013259,recibido,o
241,0211-699501013259,suplementacion,i
241,0211-699501013259,durante,o
241,0211-699501013259,12,o
241,0211-699501013259,meses,o
241,0211-699501013259,33,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,pero,o
241,0211-699501013259,a,o
241,0211-699501013259,pesar,o
241,0211-699501013259,de,o
241,0211-699501013259,un,o
241,0211-699501013259,continuo,o
241,0211-699501013259,aumento,o
241,0211-699501013259,del,o
241,0211-699501013259,folato,i
241,0211-699501013259,10078,o
241,0211-699501013259,IC,o
241,0211-699501013259,7481,o
241,0211-699501013259,12674,o
241,0211-699501013259,p,o
241,0211-699501013259,0001,o
241,0211-699501013259,solo,o
241,0211-699501013259,3,o
241,0211-699501013259,pacientes,o
241,0211-699501013259,presentan,o
241,0211-699501013259,niveles,o
241,0211-699501013259,normales,o
241,0211-699501013259,de,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,correlacionandose,o
241,0211-699501013259,directamente,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,con,o
241,0211-699501013259,la,o
241,0211-699501013259,albumina,i
241,0211-699501013259,r,o
241,0211-699501013259,056,o
241,0211-699501013259,p,o
241,0211-699501013259,0001,o
241,0211-699501013259,que,o
241,0211-699501013259,se,o
241,0211-699501013259,elevo,o
241,0211-699501013259,con,o
241,0211-699501013259,respecto,o
241,0211-699501013259,al,o
241,0211-699501013259,inicio,o
241,0211-699501013259,337,o
241,0211-699501013259,IC,o
241,0211-699501013259,327,o
241,0211-699501013259,346,o
241,0211-699501013259,vs,o
241,0211-699501013259,350,o
241,0211-699501013259,IC,o
241,0211-699501013259,337,o
241,0211-699501013259,363,o
241,0211-699501013259,p,o
241,0211-699501013259,005,o
241,0211-699501013259,Conclusion,o
241,0211-699501013259,Tras,o
241,0211-699501013259,suplementacion,i
241,0211-699501013259,con,o
241,0211-699501013259,acido,i
241,0211-699501013259,folico,i
241,0211-699501013259,y,o
241,0211-699501013259,vitamina,i
241,0211-699501013259,B6,i
241,0211-699501013259,aunque,o
241,0211-699501013259,inicialmente,o
241,0211-699501013259,se,o
241,0211-699501013259,reduce,o
241,0211-699501013259,la,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,esta,o
241,0211-699501013259,respuesta,o
241,0211-699501013259,se,o
241,0211-699501013259,hace,o
241,0211-699501013259,refractaria,o
241,0211-699501013259,correlacionandose,o
241,0211-699501013259,directamente,o
241,0211-699501013259,la,o
241,0211-699501013259,tHcy,i
241,0211-699501013259,con,o
241,0211-699501013259,la,o
241,0211-699501013259,albumina,i
241,0211-699501013259,plasmatica,i
241,0211-699501013259,La,o
241,0211-699501013259,interpretacion,o
241,0211-699501013259,de,o
241,0211-699501013259,los,o
241,0211-699501013259,niveles,i
241,0211-699501013259,de,i
241,0211-699501013259,tHcy,i
241,0211-699501013259,debe,o
241,0211-699501013259,tener,o
241,0211-699501013259,en,o
241,0211-699501013259,cuenta,o
241,0211-699501013259,la,o
241,0211-699501013259,concentracion,i
241,0211-699501013259,de,i
241,0211-699501013259,albumina,i
242,0211-699501013259,Efecto,o
242,0211-699501013259,de,o
242,0211-699501013259,la,o
242,0211-699501013259,suplementacion,i
242,0211-699501013259,con,o
242,0211-699501013259,acido,i
242,0211-699501013259,folico,i
242,0211-699501013259,sobre,o
242,0211-699501013259,los,o
242,0211-699501013259,niveles,i
242,0211-699501013259,de,i
242,0211-699501013259,homocisteina,i
242,0211-699501013259,total,o
242,0211-699501013259,en,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,en,o
242,0211-699501013259,hemodialisis,i
242,0211-699501013259,La,o
242,0211-699501013259,hiperhomocisteinemia,i
242,0211-699501013259,es,o
242,0211-699501013259,un,o
242,0211-699501013259,marcador,o
242,0211-699501013259,de,o
242,0211-699501013259,riesgo,o
242,0211-699501013259,independiente,o
242,0211-699501013259,de,o
242,0211-699501013259,morbimortalidad,o
242,0211-699501013259,cardiovascular,i
242,0211-699501013259,Hemos,o
242,0211-699501013259,intentado,o
242,0211-699501013259,prospectivamente,o
242,0211-699501013259,reducir,o
242,0211-699501013259,los,o
242,0211-699501013259,niveles,i
242,0211-699501013259,de,i
242,0211-699501013259,homocisteina,i
242,0211-699501013259,total,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,mediante,o
242,0211-699501013259,suplemento,o
242,0211-699501013259,con,o
242,0211-699501013259,acido,i
242,0211-699501013259,folico,i
242,0211-699501013259,y,o
242,0211-699501013259,vitamina,i
242,0211-699501013259,B6,i
242,0211-699501013259,pp,i
242,0211-699501013259,valorando,o
242,0211-699501013259,su,o
242,0211-699501013259,posible,o
242,0211-699501013259,correlacion,o
242,0211-699501013259,con,o
242,0211-699501013259,dosis,o
242,0211-699501013259,de,o
242,0211-699501013259,dialisis,i
242,0211-699501013259,funcion,i
242,0211-699501013259,residual,i
242,0211-699501013259,y,o
242,0211-699501013259,parametros,o
242,0211-699501013259,nutricionales,o
242,0211-699501013259,Metodos,o
242,0211-699501013259,Todos,o
242,0211-699501013259,los,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,en,o
242,0211-699501013259,hemodialisis,i
242,0211-699501013259,al,o
242,0211-699501013259,comienzo,o
242,0211-699501013259,del,o
242,0211-699501013259,estudio,o
242,0211-699501013259,que,o
242,0211-699501013259,no,o
242,0211-699501013259,recibian,o
242,0211-699501013259,acido,i
242,0211-699501013259,folico,i
242,0211-699501013259,ni,o
242,0211-699501013259,vitamina,i
242,0211-699501013259,B6,i
242,0211-699501013259,asi,o
242,0211-699501013259,como,o
242,0211-699501013259,los,o
242,0211-699501013259,incorporados,o
242,0211-699501013259,posteriormente,o
242,0211-699501013259,a,o
242,0211-699501013259,partir,o
242,0211-699501013259,de,o
242,0211-699501013259,su,o
242,0211-699501013259,tercer,o
242,0211-699501013259,mes,o
242,0211-699501013259,en,o
242,0211-699501013259,hemodialisis,i
242,0211-699501013259,recibieron,o
242,0211-699501013259,5,o
242,0211-699501013259,mg,o
242,0211-699501013259,orales,o
242,0211-699501013259,de,o
242,0211-699501013259,acido,i
242,0211-699501013259,folico,i
242,0211-699501013259,cada,o
242,0211-699501013259,48,o
242,0211-699501013259,horas,o
242,0211-699501013259,y,o
242,0211-699501013259,40,o
242,0211-699501013259,mg,o
242,0211-699501013259,orales,o
242,0211-699501013259,de,o
242,0211-699501013259,vitamina,i
242,0211-699501013259,B6,i
242,0211-699501013259,cada,o
242,0211-699501013259,semana,o
242,0211-699501013259,Se,o
242,0211-699501013259,determinaron,o
242,0211-699501013259,al,o
242,0211-699501013259,comienzo,o
242,0211-699501013259,del,o
242,0211-699501013259,estudio,o
242,0211-699501013259,y,o
242,0211-699501013259,cada,o
242,0211-699501013259,2,o
242,0211-699501013259,meses,o
242,0211-699501013259,niveles,i
242,0211-699501013259,de,i
242,0211-699501013259,folato,i
242,0211-699501013259,vitamina,i
242,0211-699501013259,B12,i
242,0211-699501013259,inmunoensayo,i
242,0211-699501013259,albumina,i
242,0211-699501013259,y,o
242,0211-699501013259,cinetica,o
242,0211-699501013259,de,o
242,0211-699501013259,la,o
242,0211-699501013259,urea,i
242,0211-699501013259,KTV,o
242,0211-699501013259,KRU,o
242,0211-699501013259,PCRn,o
242,0211-699501013259,y,o
242,0211-699501013259,cada,o
242,0211-699501013259,6,o
242,0211-699501013259,meses,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,HPLC,i
242,0211-699501013259,y,o
242,0211-699501013259,pp,i
242,0211-699501013259,RIA,i
242,0211-699501013259,Resultados,o
242,0211-699501013259,80,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,fueron,o
242,0211-699501013259,incluidos,o
242,0211-699501013259,en,o
242,0211-699501013259,el,o
242,0211-699501013259,estudio,o
242,0211-699501013259,basal,o
242,0211-699501013259,con,o
242,0211-699501013259,una,o
242,0211-699501013259,prevalencia,o
242,0211-699501013259,de,o
242,0211-699501013259,hiperhomocisteinemia,i
242,0211-699501013259,del,o
242,0211-699501013259,844,o
242,0211-699501013259,deficit,i
242,0211-699501013259,de,i
242,0211-699501013259,pp,i
242,0211-699501013259,en,o
242,0211-699501013259,el,o
242,0211-699501013259,32,o
242,0211-699501013259,y,o
242,0211-699501013259,folato,i
242,0211-699501013259,en,o
242,0211-699501013259,el,o
242,0211-699501013259,rango,o
242,0211-699501013259,normal,o
242,0211-699501013259,bajo,o
242,0211-699501013259,los,o
242,0211-699501013259,niveles,i
242,0211-699501013259,de,i
242,0211-699501013259,tHcy,i
242,0211-699501013259,se,o
242,0211-699501013259,correlacionaban,o
242,0211-699501013259,inversamente,o
242,0211-699501013259,con,o
242,0211-699501013259,los,o
242,0211-699501013259,del,o
242,0211-699501013259,folato,i
242,0211-699501013259,r,o
242,0211-699501013259,0336,o
242,0211-699501013259,p,o
242,0211-699501013259,001,o
242,0211-699501013259,pero,o
242,0211-699501013259,no,o
242,0211-699501013259,con,o
242,0211-699501013259,pp,i
242,0211-699501013259,B12,i
242,0211-699501013259,edad,o
242,0211-699501013259,albumina,i
242,0211-699501013259,KTV,o
242,0211-699501013259,KRU,o
242,0211-699501013259,PCRn,o
242,0211-699501013259,Cincuenta,o
242,0211-699501013259,y,o
242,0211-699501013259,ocho,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,recibieron,o
242,0211-699501013259,seis,o
242,0211-699501013259,meses,o
242,0211-699501013259,de,o
242,0211-699501013259,suplementacion,i
242,0211-699501013259,con,o
242,0211-699501013259,normalizacion,o
242,0211-699501013259,del,o
242,0211-699501013259,pp,i
242,0211-699501013259,aumento,o
242,0211-699501013259,del,o
242,0211-699501013259,folato,i
242,0211-699501013259,703,o
242,0211-699501013259,IC,o
242,0211-699501013259,638,o
242,0211-699501013259,795,o
242,0211-699501013259,vs,o
242,0211-699501013259,6181,o
242,0211-699501013259,IC,o
242,0211-699501013259,4447,o
242,0211-699501013259,7811,o
242,0211-699501013259,p,o
242,0211-699501013259,0001,o
242,0211-699501013259,y,o
242,0211-699501013259,descenso,o
242,0211-699501013259,de,o
242,0211-699501013259,la,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,240,o
242,0211-699501013259,IC,o
242,0211-699501013259,213,o
242,0211-699501013259,264,o
242,0211-699501013259,vs,o
242,0211-699501013259,199,o
242,0211-699501013259,IC,o
242,0211-699501013259,175,o
242,0211-699501013259,224,o
242,0211-699501013259,p,o
242,0211-699501013259,005,o
242,0211-699501013259,Han,o
242,0211-699501013259,recibido,o
242,0211-699501013259,suplementacion,i
242,0211-699501013259,durante,o
242,0211-699501013259,12,o
242,0211-699501013259,meses,o
242,0211-699501013259,33,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,pero,o
242,0211-699501013259,a,o
242,0211-699501013259,pesar,o
242,0211-699501013259,de,o
242,0211-699501013259,un,o
242,0211-699501013259,continuo,o
242,0211-699501013259,aumento,o
242,0211-699501013259,del,o
242,0211-699501013259,folato,i
242,0211-699501013259,10078,o
242,0211-699501013259,IC,o
242,0211-699501013259,7481,o
242,0211-699501013259,12674,o
242,0211-699501013259,p,o
242,0211-699501013259,0001,o
242,0211-699501013259,solo,o
242,0211-699501013259,3,o
242,0211-699501013259,pacientes,o
242,0211-699501013259,presentan,o
242,0211-699501013259,niveles,o
242,0211-699501013259,normales,o
242,0211-699501013259,de,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,correlacionandose,o
242,0211-699501013259,directamente,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,con,o
242,0211-699501013259,la,o
242,0211-699501013259,albumina,i
242,0211-699501013259,r,o
242,0211-699501013259,056,o
242,0211-699501013259,p,o
242,0211-699501013259,0001,o
242,0211-699501013259,que,o
242,0211-699501013259,se,o
242,0211-699501013259,elevo,o
242,0211-699501013259,con,o
242,0211-699501013259,respecto,o
242,0211-699501013259,al,o
242,0211-699501013259,inicio,o
242,0211-699501013259,337,o
242,0211-699501013259,IC,o
242,0211-699501013259,327,o
242,0211-699501013259,346,o
242,0211-699501013259,vs,o
242,0211-699501013259,350,o
242,0211-699501013259,IC,o
242,0211-699501013259,337,o
242,0211-699501013259,363,o
242,0211-699501013259,p,o
242,0211-699501013259,005,o
242,0211-699501013259,Conclusion,o
242,0211-699501013259,Tras,o
242,0211-699501013259,suplementacion,i
242,0211-699501013259,con,o
242,0211-699501013259,acido,i
242,0211-699501013259,folico,i
242,0211-699501013259,y,o
242,0211-699501013259,vitamina,i
242,0211-699501013259,B6,i
242,0211-699501013259,aunque,o
242,0211-699501013259,inicialmente,o
242,0211-699501013259,se,o
242,0211-699501013259,reduce,o
242,0211-699501013259,la,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,esta,o
242,0211-699501013259,respuesta,o
242,0211-699501013259,se,o
242,0211-699501013259,hace,o
242,0211-699501013259,refractaria,o
242,0211-699501013259,correlacionandose,o
242,0211-699501013259,directamente,o
242,0211-699501013259,la,o
242,0211-699501013259,tHcy,i
242,0211-699501013259,con,o
242,0211-699501013259,la,o
242,0211-699501013259,albumina,i
242,0211-699501013259,plasmatica,i
242,0211-699501013259,La,o
242,0211-699501013259,interpretacion,o
242,0211-699501013259,de,o
242,0211-699501013259,los,o
242,0211-699501013259,niveles,i
242,0211-699501013259,de,i
242,0211-699501013259,tHcy,i
242,0211-699501013259,debe,o
242,0211-699501013259,tener,o
242,0211-699501013259,en,o
242,0211-699501013259,cuenta,o
242,0211-699501013259,la,o
242,0211-699501013259,concentracion,i
242,0211-699501013259,de,i
242,0211-699501013259,albumina,i
243,0211-699501013259,Efecto,o
243,0211-699501013259,de,o
243,0211-699501013259,la,o
243,0211-699501013259,suplementacion,i
243,0211-699501013259,con,o
243,0211-699501013259,acido,i
243,0211-699501013259,folico,i
243,0211-699501013259,sobre,o
243,0211-699501013259,los,o
243,0211-699501013259,niveles,i
243,0211-699501013259,de,i
243,0211-699501013259,homocisteina,i
243,0211-699501013259,total,o
243,0211-699501013259,en,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,en,o
243,0211-699501013259,hemodialisis,i
243,0211-699501013259,La,o
243,0211-699501013259,hiperhomocisteinemia,i
243,0211-699501013259,es,o
243,0211-699501013259,un,o
243,0211-699501013259,marcador,o
243,0211-699501013259,de,o
243,0211-699501013259,riesgo,o
243,0211-699501013259,independiente,o
243,0211-699501013259,de,o
243,0211-699501013259,morbimortalidad,o
243,0211-699501013259,cardiovascular,i
243,0211-699501013259,Hemos,o
243,0211-699501013259,intentado,o
243,0211-699501013259,prospectivamente,o
243,0211-699501013259,reducir,o
243,0211-699501013259,los,o
243,0211-699501013259,niveles,i
243,0211-699501013259,de,i
243,0211-699501013259,homocisteina,i
243,0211-699501013259,total,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,mediante,o
243,0211-699501013259,suplemento,o
243,0211-699501013259,con,o
243,0211-699501013259,acido,i
243,0211-699501013259,folico,i
243,0211-699501013259,y,o
243,0211-699501013259,vitamina,i
243,0211-699501013259,B6,i
243,0211-699501013259,pp,i
243,0211-699501013259,valorando,o
243,0211-699501013259,su,o
243,0211-699501013259,posible,o
243,0211-699501013259,correlacion,o
243,0211-699501013259,con,o
243,0211-699501013259,dosis,o
243,0211-699501013259,de,o
243,0211-699501013259,dialisis,i
243,0211-699501013259,funcion,i
243,0211-699501013259,residual,i
243,0211-699501013259,y,o
243,0211-699501013259,parametros,o
243,0211-699501013259,nutricionales,o
243,0211-699501013259,Metodos,o
243,0211-699501013259,Todos,o
243,0211-699501013259,los,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,en,o
243,0211-699501013259,hemodialisis,i
243,0211-699501013259,al,o
243,0211-699501013259,comienzo,o
243,0211-699501013259,del,o
243,0211-699501013259,estudio,o
243,0211-699501013259,que,o
243,0211-699501013259,no,o
243,0211-699501013259,recibian,o
243,0211-699501013259,acido,i
243,0211-699501013259,folico,i
243,0211-699501013259,ni,o
243,0211-699501013259,vitamina,i
243,0211-699501013259,B6,i
243,0211-699501013259,asi,o
243,0211-699501013259,como,o
243,0211-699501013259,los,o
243,0211-699501013259,incorporados,o
243,0211-699501013259,posteriormente,o
243,0211-699501013259,a,o
243,0211-699501013259,partir,o
243,0211-699501013259,de,o
243,0211-699501013259,su,o
243,0211-699501013259,tercer,o
243,0211-699501013259,mes,o
243,0211-699501013259,en,o
243,0211-699501013259,hemodialisis,i
243,0211-699501013259,recibieron,o
243,0211-699501013259,5,o
243,0211-699501013259,mg,o
243,0211-699501013259,orales,o
243,0211-699501013259,de,o
243,0211-699501013259,acido,i
243,0211-699501013259,folico,i
243,0211-699501013259,cada,o
243,0211-699501013259,48,o
243,0211-699501013259,horas,o
243,0211-699501013259,y,o
243,0211-699501013259,40,o
243,0211-699501013259,mg,o
243,0211-699501013259,orales,o
243,0211-699501013259,de,o
243,0211-699501013259,vitamina,i
243,0211-699501013259,B6,i
243,0211-699501013259,cada,o
243,0211-699501013259,semana,o
243,0211-699501013259,Se,o
243,0211-699501013259,determinaron,o
243,0211-699501013259,al,o
243,0211-699501013259,comienzo,o
243,0211-699501013259,del,o
243,0211-699501013259,estudio,o
243,0211-699501013259,y,o
243,0211-699501013259,cada,o
243,0211-699501013259,2,o
243,0211-699501013259,meses,o
243,0211-699501013259,niveles,i
243,0211-699501013259,de,i
243,0211-699501013259,folato,i
243,0211-699501013259,vitamina,i
243,0211-699501013259,B12,i
243,0211-699501013259,inmunoensayo,i
243,0211-699501013259,albumina,i
243,0211-699501013259,y,o
243,0211-699501013259,cinetica,o
243,0211-699501013259,de,o
243,0211-699501013259,la,o
243,0211-699501013259,urea,i
243,0211-699501013259,KTV,o
243,0211-699501013259,KRU,o
243,0211-699501013259,PCRn,o
243,0211-699501013259,y,o
243,0211-699501013259,cada,o
243,0211-699501013259,6,o
243,0211-699501013259,meses,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,HPLC,i
243,0211-699501013259,y,o
243,0211-699501013259,pp,i
243,0211-699501013259,RIA,i
243,0211-699501013259,Resultados,o
243,0211-699501013259,80,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,fueron,o
243,0211-699501013259,incluidos,o
243,0211-699501013259,en,o
243,0211-699501013259,el,o
243,0211-699501013259,estudio,o
243,0211-699501013259,basal,o
243,0211-699501013259,con,o
243,0211-699501013259,una,o
243,0211-699501013259,prevalencia,o
243,0211-699501013259,de,o
243,0211-699501013259,hiperhomocisteinemia,i
243,0211-699501013259,del,o
243,0211-699501013259,844,o
243,0211-699501013259,deficit,i
243,0211-699501013259,de,i
243,0211-699501013259,pp,i
243,0211-699501013259,en,o
243,0211-699501013259,el,o
243,0211-699501013259,32,o
243,0211-699501013259,y,o
243,0211-699501013259,folato,i
243,0211-699501013259,en,o
243,0211-699501013259,el,o
243,0211-699501013259,rango,o
243,0211-699501013259,normal,o
243,0211-699501013259,bajo,o
243,0211-699501013259,los,o
243,0211-699501013259,niveles,i
243,0211-699501013259,de,i
243,0211-699501013259,tHcy,i
243,0211-699501013259,se,o
243,0211-699501013259,correlacionaban,o
243,0211-699501013259,inversamente,o
243,0211-699501013259,con,o
243,0211-699501013259,los,o
243,0211-699501013259,del,o
243,0211-699501013259,folato,i
243,0211-699501013259,r,o
243,0211-699501013259,0336,o
243,0211-699501013259,p,o
243,0211-699501013259,001,o
243,0211-699501013259,pero,o
243,0211-699501013259,no,o
243,0211-699501013259,con,o
243,0211-699501013259,pp,i
243,0211-699501013259,B12,i
243,0211-699501013259,edad,o
243,0211-699501013259,albumina,i
243,0211-699501013259,KTV,o
243,0211-699501013259,KRU,o
243,0211-699501013259,PCRn,o
243,0211-699501013259,Cincuenta,o
243,0211-699501013259,y,o
243,0211-699501013259,ocho,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,recibieron,o
243,0211-699501013259,seis,o
243,0211-699501013259,meses,o
243,0211-699501013259,de,o
243,0211-699501013259,suplementacion,i
243,0211-699501013259,con,o
243,0211-699501013259,normalizacion,o
243,0211-699501013259,del,o
243,0211-699501013259,pp,i
243,0211-699501013259,aumento,o
243,0211-699501013259,del,o
243,0211-699501013259,folato,i
243,0211-699501013259,703,o
243,0211-699501013259,IC,o
243,0211-699501013259,638,o
243,0211-699501013259,795,o
243,0211-699501013259,vs,o
243,0211-699501013259,6181,o
243,0211-699501013259,IC,o
243,0211-699501013259,4447,o
243,0211-699501013259,7811,o
243,0211-699501013259,p,o
243,0211-699501013259,0001,o
243,0211-699501013259,y,o
243,0211-699501013259,descenso,o
243,0211-699501013259,de,o
243,0211-699501013259,la,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,240,o
243,0211-699501013259,IC,o
243,0211-699501013259,213,o
243,0211-699501013259,264,o
243,0211-699501013259,vs,o
243,0211-699501013259,199,o
243,0211-699501013259,IC,o
243,0211-699501013259,175,o
243,0211-699501013259,224,o
243,0211-699501013259,p,o
243,0211-699501013259,005,o
243,0211-699501013259,Han,o
243,0211-699501013259,recibido,o
243,0211-699501013259,suplementacion,i
243,0211-699501013259,durante,o
243,0211-699501013259,12,o
243,0211-699501013259,meses,o
243,0211-699501013259,33,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,pero,o
243,0211-699501013259,a,o
243,0211-699501013259,pesar,o
243,0211-699501013259,de,o
243,0211-699501013259,un,o
243,0211-699501013259,continuo,o
243,0211-699501013259,aumento,o
243,0211-699501013259,del,o
243,0211-699501013259,folato,i
243,0211-699501013259,10078,o
243,0211-699501013259,IC,o
243,0211-699501013259,7481,o
243,0211-699501013259,12674,o
243,0211-699501013259,p,o
243,0211-699501013259,0001,o
243,0211-699501013259,solo,o
243,0211-699501013259,3,o
243,0211-699501013259,pacientes,o
243,0211-699501013259,presentan,o
243,0211-699501013259,niveles,o
243,0211-699501013259,normales,o
243,0211-699501013259,de,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,correlacionandose,o
243,0211-699501013259,directamente,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,con,o
243,0211-699501013259,la,o
243,0211-699501013259,albumina,i
243,0211-699501013259,r,o
243,0211-699501013259,056,o
243,0211-699501013259,p,o
243,0211-699501013259,0001,o
243,0211-699501013259,que,o
243,0211-699501013259,se,o
243,0211-699501013259,elevo,o
243,0211-699501013259,con,o
243,0211-699501013259,respecto,o
243,0211-699501013259,al,o
243,0211-699501013259,inicio,o
243,0211-699501013259,337,o
243,0211-699501013259,IC,o
243,0211-699501013259,327,o
243,0211-699501013259,346,o
243,0211-699501013259,vs,o
243,0211-699501013259,350,o
243,0211-699501013259,IC,o
243,0211-699501013259,337,o
243,0211-699501013259,363,o
243,0211-699501013259,p,o
243,0211-699501013259,005,o
243,0211-699501013259,Conclusion,o
243,0211-699501013259,Tras,o
243,0211-699501013259,suplementacion,i
243,0211-699501013259,con,o
243,0211-699501013259,acido,i
243,0211-699501013259,folico,i
243,0211-699501013259,y,o
243,0211-699501013259,vitamina,i
243,0211-699501013259,B6,i
243,0211-699501013259,aunque,o
243,0211-699501013259,inicialmente,o
243,0211-699501013259,se,o
243,0211-699501013259,reduce,o
243,0211-699501013259,la,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,esta,o
243,0211-699501013259,respuesta,o
243,0211-699501013259,se,o
243,0211-699501013259,hace,o
243,0211-699501013259,refractaria,o
243,0211-699501013259,correlacionandose,o
243,0211-699501013259,directamente,o
243,0211-699501013259,la,o
243,0211-699501013259,tHcy,i
243,0211-699501013259,con,o
243,0211-699501013259,la,o
243,0211-699501013259,albumina,i
243,0211-699501013259,plasmatica,i
243,0211-699501013259,La,o
243,0211-699501013259,interpretacion,o
243,0211-699501013259,de,o
243,0211-699501013259,los,o
243,0211-699501013259,niveles,i
243,0211-699501013259,de,i
243,0211-699501013259,tHcy,i
243,0211-699501013259,debe,o
243,0211-699501013259,tener,o
243,0211-699501013259,en,o
243,0211-699501013259,cuenta,o
243,0211-699501013259,la,o
243,0211-699501013259,concentracion,i
243,0211-699501013259,de,i
243,0211-699501013259,albumina,i
244,0211-699501013259,Efecto,o
244,0211-699501013259,de,o
244,0211-699501013259,la,o
244,0211-699501013259,suplementacion,i
244,0211-699501013259,con,o
244,0211-699501013259,acido,i
244,0211-699501013259,folico,i
244,0211-699501013259,sobre,o
244,0211-699501013259,los,o
244,0211-699501013259,niveles,i
244,0211-699501013259,de,i
244,0211-699501013259,homocisteina,i
244,0211-699501013259,total,o
244,0211-699501013259,en,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,en,o
244,0211-699501013259,hemodialisis,i
244,0211-699501013259,La,o
244,0211-699501013259,hiperhomocisteinemia,i
244,0211-699501013259,es,o
244,0211-699501013259,un,o
244,0211-699501013259,marcador,o
244,0211-699501013259,de,o
244,0211-699501013259,riesgo,o
244,0211-699501013259,independiente,o
244,0211-699501013259,de,o
244,0211-699501013259,morbimortalidad,o
244,0211-699501013259,cardiovascular,i
244,0211-699501013259,Hemos,o
244,0211-699501013259,intentado,o
244,0211-699501013259,prospectivamente,o
244,0211-699501013259,reducir,o
244,0211-699501013259,los,o
244,0211-699501013259,niveles,i
244,0211-699501013259,de,i
244,0211-699501013259,homocisteina,i
244,0211-699501013259,total,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,mediante,o
244,0211-699501013259,suplemento,o
244,0211-699501013259,con,o
244,0211-699501013259,acido,i
244,0211-699501013259,folico,i
244,0211-699501013259,y,o
244,0211-699501013259,vitamina,i
244,0211-699501013259,B6,i
244,0211-699501013259,pp,i
244,0211-699501013259,valorando,o
244,0211-699501013259,su,o
244,0211-699501013259,posible,o
244,0211-699501013259,correlacion,o
244,0211-699501013259,con,o
244,0211-699501013259,dosis,o
244,0211-699501013259,de,o
244,0211-699501013259,dialisis,i
244,0211-699501013259,funcion,i
244,0211-699501013259,residual,i
244,0211-699501013259,y,o
244,0211-699501013259,parametros,o
244,0211-699501013259,nutricionales,o
244,0211-699501013259,Metodos,o
244,0211-699501013259,Todos,o
244,0211-699501013259,los,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,en,o
244,0211-699501013259,hemodialisis,i
244,0211-699501013259,al,o
244,0211-699501013259,comienzo,o
244,0211-699501013259,del,o
244,0211-699501013259,estudio,o
244,0211-699501013259,que,o
244,0211-699501013259,no,o
244,0211-699501013259,recibian,o
244,0211-699501013259,acido,i
244,0211-699501013259,folico,i
244,0211-699501013259,ni,o
244,0211-699501013259,vitamina,i
244,0211-699501013259,B6,i
244,0211-699501013259,asi,o
244,0211-699501013259,como,o
244,0211-699501013259,los,o
244,0211-699501013259,incorporados,o
244,0211-699501013259,posteriormente,o
244,0211-699501013259,a,o
244,0211-699501013259,partir,o
244,0211-699501013259,de,o
244,0211-699501013259,su,o
244,0211-699501013259,tercer,o
244,0211-699501013259,mes,o
244,0211-699501013259,en,o
244,0211-699501013259,hemodialisis,i
244,0211-699501013259,recibieron,o
244,0211-699501013259,5,o
244,0211-699501013259,mg,o
244,0211-699501013259,orales,o
244,0211-699501013259,de,o
244,0211-699501013259,acido,i
244,0211-699501013259,folico,i
244,0211-699501013259,cada,o
244,0211-699501013259,48,o
244,0211-699501013259,horas,o
244,0211-699501013259,y,o
244,0211-699501013259,40,o
244,0211-699501013259,mg,o
244,0211-699501013259,orales,o
244,0211-699501013259,de,o
244,0211-699501013259,vitamina,i
244,0211-699501013259,B6,i
244,0211-699501013259,cada,o
244,0211-699501013259,semana,o
244,0211-699501013259,Se,o
244,0211-699501013259,determinaron,o
244,0211-699501013259,al,o
244,0211-699501013259,comienzo,o
244,0211-699501013259,del,o
244,0211-699501013259,estudio,o
244,0211-699501013259,y,o
244,0211-699501013259,cada,o
244,0211-699501013259,2,o
244,0211-699501013259,meses,o
244,0211-699501013259,niveles,i
244,0211-699501013259,de,i
244,0211-699501013259,folato,i
244,0211-699501013259,vitamina,i
244,0211-699501013259,B12,i
244,0211-699501013259,inmunoensayo,i
244,0211-699501013259,albumina,i
244,0211-699501013259,y,o
244,0211-699501013259,cinetica,o
244,0211-699501013259,de,o
244,0211-699501013259,la,o
244,0211-699501013259,urea,i
244,0211-699501013259,KTV,o
244,0211-699501013259,KRU,o
244,0211-699501013259,PCRn,o
244,0211-699501013259,y,o
244,0211-699501013259,cada,o
244,0211-699501013259,6,o
244,0211-699501013259,meses,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,HPLC,i
244,0211-699501013259,y,o
244,0211-699501013259,pp,i
244,0211-699501013259,RIA,i
244,0211-699501013259,Resultados,o
244,0211-699501013259,80,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,fueron,o
244,0211-699501013259,incluidos,o
244,0211-699501013259,en,o
244,0211-699501013259,el,o
244,0211-699501013259,estudio,o
244,0211-699501013259,basal,o
244,0211-699501013259,con,o
244,0211-699501013259,una,o
244,0211-699501013259,prevalencia,o
244,0211-699501013259,de,o
244,0211-699501013259,hiperhomocisteinemia,i
244,0211-699501013259,del,o
244,0211-699501013259,844,o
244,0211-699501013259,deficit,i
244,0211-699501013259,de,i
244,0211-699501013259,pp,i
244,0211-699501013259,en,o
244,0211-699501013259,el,o
244,0211-699501013259,32,o
244,0211-699501013259,y,o
244,0211-699501013259,folato,i
244,0211-699501013259,en,o
244,0211-699501013259,el,o
244,0211-699501013259,rango,o
244,0211-699501013259,normal,o
244,0211-699501013259,bajo,o
244,0211-699501013259,los,o
244,0211-699501013259,niveles,i
244,0211-699501013259,de,i
244,0211-699501013259,tHcy,i
244,0211-699501013259,se,o
244,0211-699501013259,correlacionaban,o
244,0211-699501013259,inversamente,o
244,0211-699501013259,con,o
244,0211-699501013259,los,o
244,0211-699501013259,del,o
244,0211-699501013259,folato,i
244,0211-699501013259,r,o
244,0211-699501013259,0336,o
244,0211-699501013259,p,o
244,0211-699501013259,001,o
244,0211-699501013259,pero,o
244,0211-699501013259,no,o
244,0211-699501013259,con,o
244,0211-699501013259,pp,i
244,0211-699501013259,B12,i
244,0211-699501013259,edad,o
244,0211-699501013259,albumina,i
244,0211-699501013259,KTV,o
244,0211-699501013259,KRU,o
244,0211-699501013259,PCRn,o
244,0211-699501013259,Cincuenta,o
244,0211-699501013259,y,o
244,0211-699501013259,ocho,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,recibieron,o
244,0211-699501013259,seis,o
244,0211-699501013259,meses,o
244,0211-699501013259,de,o
244,0211-699501013259,suplementacion,i
244,0211-699501013259,con,o
244,0211-699501013259,normalizacion,o
244,0211-699501013259,del,o
244,0211-699501013259,pp,i
244,0211-699501013259,aumento,o
244,0211-699501013259,del,o
244,0211-699501013259,folato,i
244,0211-699501013259,703,o
244,0211-699501013259,IC,o
244,0211-699501013259,638,o
244,0211-699501013259,795,o
244,0211-699501013259,vs,o
244,0211-699501013259,6181,o
244,0211-699501013259,IC,o
244,0211-699501013259,4447,o
244,0211-699501013259,7811,o
244,0211-699501013259,p,o
244,0211-699501013259,0001,o
244,0211-699501013259,y,o
244,0211-699501013259,descenso,o
244,0211-699501013259,de,o
244,0211-699501013259,la,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,240,o
244,0211-699501013259,IC,o
244,0211-699501013259,213,o
244,0211-699501013259,264,o
244,0211-699501013259,vs,o
244,0211-699501013259,199,o
244,0211-699501013259,IC,o
244,0211-699501013259,175,o
244,0211-699501013259,224,o
244,0211-699501013259,p,o
244,0211-699501013259,005,o
244,0211-699501013259,Han,o
244,0211-699501013259,recibido,o
244,0211-699501013259,suplementacion,i
244,0211-699501013259,durante,o
244,0211-699501013259,12,o
244,0211-699501013259,meses,o
244,0211-699501013259,33,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,pero,o
244,0211-699501013259,a,o
244,0211-699501013259,pesar,o
244,0211-699501013259,de,o
244,0211-699501013259,un,o
244,0211-699501013259,continuo,o
244,0211-699501013259,aumento,o
244,0211-699501013259,del,o
244,0211-699501013259,folato,i
244,0211-699501013259,10078,o
244,0211-699501013259,IC,o
244,0211-699501013259,7481,o
244,0211-699501013259,12674,o
244,0211-699501013259,p,o
244,0211-699501013259,0001,o
244,0211-699501013259,solo,o
244,0211-699501013259,3,o
244,0211-699501013259,pacientes,o
244,0211-699501013259,presentan,o
244,0211-699501013259,niveles,o
244,0211-699501013259,normales,o
244,0211-699501013259,de,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,correlacionandose,o
244,0211-699501013259,directamente,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,con,o
244,0211-699501013259,la,o
244,0211-699501013259,albumina,i
244,0211-699501013259,r,o
244,0211-699501013259,056,o
244,0211-699501013259,p,o
244,0211-699501013259,0001,o
244,0211-699501013259,que,o
244,0211-699501013259,se,o
244,0211-699501013259,elevo,o
244,0211-699501013259,con,o
244,0211-699501013259,respecto,o
244,0211-699501013259,al,o
244,0211-699501013259,inicio,o
244,0211-699501013259,337,o
244,0211-699501013259,IC,o
244,0211-699501013259,327,o
244,0211-699501013259,346,o
244,0211-699501013259,vs,o
244,0211-699501013259,350,o
244,0211-699501013259,IC,o
244,0211-699501013259,337,o
244,0211-699501013259,363,o
244,0211-699501013259,p,o
244,0211-699501013259,005,o
244,0211-699501013259,Conclusion,o
244,0211-699501013259,Tras,o
244,0211-699501013259,suplementacion,i
244,0211-699501013259,con,o
244,0211-699501013259,acido,i
244,0211-699501013259,folico,i
244,0211-699501013259,y,o
244,0211-699501013259,vitamina,i
244,0211-699501013259,B6,i
244,0211-699501013259,aunque,o
244,0211-699501013259,inicialmente,o
244,0211-699501013259,se,o
244,0211-699501013259,reduce,o
244,0211-699501013259,la,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,esta,o
244,0211-699501013259,respuesta,o
244,0211-699501013259,se,o
244,0211-699501013259,hace,o
244,0211-699501013259,refractaria,o
244,0211-699501013259,correlacionandose,o
244,0211-699501013259,directamente,o
244,0211-699501013259,la,o
244,0211-699501013259,tHcy,i
244,0211-699501013259,con,o
244,0211-699501013259,la,o
244,0211-699501013259,albumina,i
244,0211-699501013259,plasmatica,i
244,0211-699501013259,La,o
244,0211-699501013259,interpretacion,o
244,0211-699501013259,de,o
244,0211-699501013259,los,o
244,0211-699501013259,niveles,i
244,0211-699501013259,de,i
244,0211-699501013259,tHcy,i
244,0211-699501013259,debe,o
244,0211-699501013259,tener,o
244,0211-699501013259,en,o
244,0211-699501013259,cuenta,o
244,0211-699501013259,la,o
244,0211-699501013259,concentracion,i
244,0211-699501013259,de,i
244,0211-699501013259,albumina,i
245,0211-699501013259,Efecto,o
245,0211-699501013259,de,o
245,0211-699501013259,la,o
245,0211-699501013259,suplementacion,i
245,0211-699501013259,con,o
245,0211-699501013259,acido,i
245,0211-699501013259,folico,i
245,0211-699501013259,sobre,o
245,0211-699501013259,los,o
245,0211-699501013259,niveles,i
245,0211-699501013259,de,i
245,0211-699501013259,homocisteina,i
245,0211-699501013259,total,o
245,0211-699501013259,en,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,en,o
245,0211-699501013259,hemodialisis,i
245,0211-699501013259,La,o
245,0211-699501013259,hiperhomocisteinemia,i
245,0211-699501013259,es,o
245,0211-699501013259,un,o
245,0211-699501013259,marcador,o
245,0211-699501013259,de,o
245,0211-699501013259,riesgo,o
245,0211-699501013259,independiente,o
245,0211-699501013259,de,o
245,0211-699501013259,morbimortalidad,o
245,0211-699501013259,cardiovascular,i
245,0211-699501013259,Hemos,o
245,0211-699501013259,intentado,o
245,0211-699501013259,prospectivamente,o
245,0211-699501013259,reducir,o
245,0211-699501013259,los,o
245,0211-699501013259,niveles,i
245,0211-699501013259,de,i
245,0211-699501013259,homocisteina,i
245,0211-699501013259,total,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,mediante,o
245,0211-699501013259,suplemento,o
245,0211-699501013259,con,o
245,0211-699501013259,acido,i
245,0211-699501013259,folico,i
245,0211-699501013259,y,o
245,0211-699501013259,vitamina,i
245,0211-699501013259,B6,i
245,0211-699501013259,pp,i
245,0211-699501013259,valorando,o
245,0211-699501013259,su,o
245,0211-699501013259,posible,o
245,0211-699501013259,correlacion,o
245,0211-699501013259,con,o
245,0211-699501013259,dosis,o
245,0211-699501013259,de,o
245,0211-699501013259,dialisis,i
245,0211-699501013259,funcion,i
245,0211-699501013259,residual,i
245,0211-699501013259,y,o
245,0211-699501013259,parametros,o
245,0211-699501013259,nutricionales,o
245,0211-699501013259,Metodos,o
245,0211-699501013259,Todos,o
245,0211-699501013259,los,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,en,o
245,0211-699501013259,hemodialisis,i
245,0211-699501013259,al,o
245,0211-699501013259,comienzo,o
245,0211-699501013259,del,o
245,0211-699501013259,estudio,o
245,0211-699501013259,que,o
245,0211-699501013259,no,o
245,0211-699501013259,recibian,o
245,0211-699501013259,acido,i
245,0211-699501013259,folico,i
245,0211-699501013259,ni,o
245,0211-699501013259,vitamina,i
245,0211-699501013259,B6,i
245,0211-699501013259,asi,o
245,0211-699501013259,como,o
245,0211-699501013259,los,o
245,0211-699501013259,incorporados,o
245,0211-699501013259,posteriormente,o
245,0211-699501013259,a,o
245,0211-699501013259,partir,o
245,0211-699501013259,de,o
245,0211-699501013259,su,o
245,0211-699501013259,tercer,o
245,0211-699501013259,mes,o
245,0211-699501013259,en,o
245,0211-699501013259,hemodialisis,i
245,0211-699501013259,recibieron,o
245,0211-699501013259,5,o
245,0211-699501013259,mg,o
245,0211-699501013259,orales,o
245,0211-699501013259,de,o
245,0211-699501013259,acido,i
245,0211-699501013259,folico,i
245,0211-699501013259,cada,o
245,0211-699501013259,48,o
245,0211-699501013259,horas,o
245,0211-699501013259,y,o
245,0211-699501013259,40,o
245,0211-699501013259,mg,o
245,0211-699501013259,orales,o
245,0211-699501013259,de,o
245,0211-699501013259,vitamina,i
245,0211-699501013259,B6,i
245,0211-699501013259,cada,o
245,0211-699501013259,semana,o
245,0211-699501013259,Se,o
245,0211-699501013259,determinaron,o
245,0211-699501013259,al,o
245,0211-699501013259,comienzo,o
245,0211-699501013259,del,o
245,0211-699501013259,estudio,o
245,0211-699501013259,y,o
245,0211-699501013259,cada,o
245,0211-699501013259,2,o
245,0211-699501013259,meses,o
245,0211-699501013259,niveles,i
245,0211-699501013259,de,i
245,0211-699501013259,folato,i
245,0211-699501013259,vitamina,i
245,0211-699501013259,B12,i
245,0211-699501013259,inmunoensayo,i
245,0211-699501013259,albumina,i
245,0211-699501013259,y,o
245,0211-699501013259,cinetica,o
245,0211-699501013259,de,o
245,0211-699501013259,la,o
245,0211-699501013259,urea,i
245,0211-699501013259,KTV,o
245,0211-699501013259,KRU,o
245,0211-699501013259,PCRn,o
245,0211-699501013259,y,o
245,0211-699501013259,cada,o
245,0211-699501013259,6,o
245,0211-699501013259,meses,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,HPLC,i
245,0211-699501013259,y,o
245,0211-699501013259,pp,i
245,0211-699501013259,RIA,i
245,0211-699501013259,Resultados,o
245,0211-699501013259,80,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,fueron,o
245,0211-699501013259,incluidos,o
245,0211-699501013259,en,o
245,0211-699501013259,el,o
245,0211-699501013259,estudio,o
245,0211-699501013259,basal,o
245,0211-699501013259,con,o
245,0211-699501013259,una,o
245,0211-699501013259,prevalencia,o
245,0211-699501013259,de,o
245,0211-699501013259,hiperhomocisteinemia,i
245,0211-699501013259,del,o
245,0211-699501013259,844,o
245,0211-699501013259,deficit,i
245,0211-699501013259,de,i
245,0211-699501013259,pp,i
245,0211-699501013259,en,o
245,0211-699501013259,el,o
245,0211-699501013259,32,o
245,0211-699501013259,y,o
245,0211-699501013259,folato,i
245,0211-699501013259,en,o
245,0211-699501013259,el,o
245,0211-699501013259,rango,o
245,0211-699501013259,normal,o
245,0211-699501013259,bajo,o
245,0211-699501013259,los,o
245,0211-699501013259,niveles,i
245,0211-699501013259,de,i
245,0211-699501013259,tHcy,i
245,0211-699501013259,se,o
245,0211-699501013259,correlacionaban,o
245,0211-699501013259,inversamente,o
245,0211-699501013259,con,o
245,0211-699501013259,los,o
245,0211-699501013259,del,o
245,0211-699501013259,folato,i
245,0211-699501013259,r,o
245,0211-699501013259,0336,o
245,0211-699501013259,p,o
245,0211-699501013259,001,o
245,0211-699501013259,pero,o
245,0211-699501013259,no,o
245,0211-699501013259,con,o
245,0211-699501013259,pp,i
245,0211-699501013259,B12,i
245,0211-699501013259,edad,o
245,0211-699501013259,albumina,i
245,0211-699501013259,KTV,o
245,0211-699501013259,KRU,o
245,0211-699501013259,PCRn,o
245,0211-699501013259,Cincuenta,o
245,0211-699501013259,y,o
245,0211-699501013259,ocho,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,recibieron,o
245,0211-699501013259,seis,o
245,0211-699501013259,meses,o
245,0211-699501013259,de,o
245,0211-699501013259,suplementacion,i
245,0211-699501013259,con,o
245,0211-699501013259,normalizacion,o
245,0211-699501013259,del,o
245,0211-699501013259,pp,i
245,0211-699501013259,aumento,o
245,0211-699501013259,del,o
245,0211-699501013259,folato,i
245,0211-699501013259,703,o
245,0211-699501013259,IC,o
245,0211-699501013259,638,o
245,0211-699501013259,795,o
245,0211-699501013259,vs,o
245,0211-699501013259,6181,o
245,0211-699501013259,IC,o
245,0211-699501013259,4447,o
245,0211-699501013259,7811,o
245,0211-699501013259,p,o
245,0211-699501013259,0001,o
245,0211-699501013259,y,o
245,0211-699501013259,descenso,o
245,0211-699501013259,de,o
245,0211-699501013259,la,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,240,o
245,0211-699501013259,IC,o
245,0211-699501013259,213,o
245,0211-699501013259,264,o
245,0211-699501013259,vs,o
245,0211-699501013259,199,o
245,0211-699501013259,IC,o
245,0211-699501013259,175,o
245,0211-699501013259,224,o
245,0211-699501013259,p,o
245,0211-699501013259,005,o
245,0211-699501013259,Han,o
245,0211-699501013259,recibido,o
245,0211-699501013259,suplementacion,i
245,0211-699501013259,durante,o
245,0211-699501013259,12,o
245,0211-699501013259,meses,o
245,0211-699501013259,33,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,pero,o
245,0211-699501013259,a,o
245,0211-699501013259,pesar,o
245,0211-699501013259,de,o
245,0211-699501013259,un,o
245,0211-699501013259,continuo,o
245,0211-699501013259,aumento,o
245,0211-699501013259,del,o
245,0211-699501013259,folato,i
245,0211-699501013259,10078,o
245,0211-699501013259,IC,o
245,0211-699501013259,7481,o
245,0211-699501013259,12674,o
245,0211-699501013259,p,o
245,0211-699501013259,0001,o
245,0211-699501013259,solo,o
245,0211-699501013259,3,o
245,0211-699501013259,pacientes,o
245,0211-699501013259,presentan,o
245,0211-699501013259,niveles,o
245,0211-699501013259,normales,o
245,0211-699501013259,de,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,correlacionandose,o
245,0211-699501013259,directamente,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,con,o
245,0211-699501013259,la,o
245,0211-699501013259,albumina,i
245,0211-699501013259,r,o
245,0211-699501013259,056,o
245,0211-699501013259,p,o
245,0211-699501013259,0001,o
245,0211-699501013259,que,o
245,0211-699501013259,se,o
245,0211-699501013259,elevo,o
245,0211-699501013259,con,o
245,0211-699501013259,respecto,o
245,0211-699501013259,al,o
245,0211-699501013259,inicio,o
245,0211-699501013259,337,o
245,0211-699501013259,IC,o
245,0211-699501013259,327,o
245,0211-699501013259,346,o
245,0211-699501013259,vs,o
245,0211-699501013259,350,o
245,0211-699501013259,IC,o
245,0211-699501013259,337,o
245,0211-699501013259,363,o
245,0211-699501013259,p,o
245,0211-699501013259,005,o
245,0211-699501013259,Conclusion,o
245,0211-699501013259,Tras,o
245,0211-699501013259,suplementacion,i
245,0211-699501013259,con,o
245,0211-699501013259,acido,i
245,0211-699501013259,folico,i
245,0211-699501013259,y,o
245,0211-699501013259,vitamina,i
245,0211-699501013259,B6,i
245,0211-699501013259,aunque,o
245,0211-699501013259,inicialmente,o
245,0211-699501013259,se,o
245,0211-699501013259,reduce,o
245,0211-699501013259,la,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,esta,o
245,0211-699501013259,respuesta,o
245,0211-699501013259,se,o
245,0211-699501013259,hace,o
245,0211-699501013259,refractaria,o
245,0211-699501013259,correlacionandose,o
245,0211-699501013259,directamente,o
245,0211-699501013259,la,o
245,0211-699501013259,tHcy,i
245,0211-699501013259,con,o
245,0211-699501013259,la,o
245,0211-699501013259,albumina,i
245,0211-699501013259,plasmatica,i
245,0211-699501013259,La,o
245,0211-699501013259,interpretacion,o
245,0211-699501013259,de,o
245,0211-699501013259,los,o
245,0211-699501013259,niveles,i
245,0211-699501013259,de,i
245,0211-699501013259,tHcy,i
245,0211-699501013259,debe,o
245,0211-699501013259,tener,o
245,0211-699501013259,en,o
245,0211-699501013259,cuenta,o
245,0211-699501013259,la,o
245,0211-699501013259,concentracion,i
245,0211-699501013259,de,i
245,0211-699501013259,albumina,i
246,0211-699501013259,Efecto,o
246,0211-699501013259,de,o
246,0211-699501013259,la,o
246,0211-699501013259,suplementacion,i
246,0211-699501013259,con,o
246,0211-699501013259,acido,i
246,0211-699501013259,folico,i
246,0211-699501013259,sobre,o
246,0211-699501013259,los,o
246,0211-699501013259,niveles,i
246,0211-699501013259,de,i
246,0211-699501013259,homocisteina,i
246,0211-699501013259,total,o
246,0211-699501013259,en,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,en,o
246,0211-699501013259,hemodialisis,i
246,0211-699501013259,La,o
246,0211-699501013259,hiperhomocisteinemia,i
246,0211-699501013259,es,o
246,0211-699501013259,un,o
246,0211-699501013259,marcador,o
246,0211-699501013259,de,o
246,0211-699501013259,riesgo,o
246,0211-699501013259,independiente,o
246,0211-699501013259,de,o
246,0211-699501013259,morbimortalidad,o
246,0211-699501013259,cardiovascular,i
246,0211-699501013259,Hemos,o
246,0211-699501013259,intentado,o
246,0211-699501013259,prospectivamente,o
246,0211-699501013259,reducir,o
246,0211-699501013259,los,o
246,0211-699501013259,niveles,i
246,0211-699501013259,de,i
246,0211-699501013259,homocisteina,i
246,0211-699501013259,total,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,mediante,o
246,0211-699501013259,suplemento,o
246,0211-699501013259,con,o
246,0211-699501013259,acido,i
246,0211-699501013259,folico,i
246,0211-699501013259,y,o
246,0211-699501013259,vitamina,i
246,0211-699501013259,B6,i
246,0211-699501013259,pp,i
246,0211-699501013259,valorando,o
246,0211-699501013259,su,o
246,0211-699501013259,posible,o
246,0211-699501013259,correlacion,o
246,0211-699501013259,con,o
246,0211-699501013259,dosis,o
246,0211-699501013259,de,o
246,0211-699501013259,dialisis,i
246,0211-699501013259,funcion,i
246,0211-699501013259,residual,i
246,0211-699501013259,y,o
246,0211-699501013259,parametros,o
246,0211-699501013259,nutricionales,o
246,0211-699501013259,Metodos,o
246,0211-699501013259,Todos,o
246,0211-699501013259,los,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,en,o
246,0211-699501013259,hemodialisis,i
246,0211-699501013259,al,o
246,0211-699501013259,comienzo,o
246,0211-699501013259,del,o
246,0211-699501013259,estudio,o
246,0211-699501013259,que,o
246,0211-699501013259,no,o
246,0211-699501013259,recibian,o
246,0211-699501013259,acido,i
246,0211-699501013259,folico,i
246,0211-699501013259,ni,o
246,0211-699501013259,vitamina,i
246,0211-699501013259,B6,i
246,0211-699501013259,asi,o
246,0211-699501013259,como,o
246,0211-699501013259,los,o
246,0211-699501013259,incorporados,o
246,0211-699501013259,posteriormente,o
246,0211-699501013259,a,o
246,0211-699501013259,partir,o
246,0211-699501013259,de,o
246,0211-699501013259,su,o
246,0211-699501013259,tercer,o
246,0211-699501013259,mes,o
246,0211-699501013259,en,o
246,0211-699501013259,hemodialisis,i
246,0211-699501013259,recibieron,o
246,0211-699501013259,5,o
246,0211-699501013259,mg,o
246,0211-699501013259,orales,o
246,0211-699501013259,de,o
246,0211-699501013259,acido,i
246,0211-699501013259,folico,i
246,0211-699501013259,cada,o
246,0211-699501013259,48,o
246,0211-699501013259,horas,o
246,0211-699501013259,y,o
246,0211-699501013259,40,o
246,0211-699501013259,mg,o
246,0211-699501013259,orales,o
246,0211-699501013259,de,o
246,0211-699501013259,vitamina,i
246,0211-699501013259,B6,i
246,0211-699501013259,cada,o
246,0211-699501013259,semana,o
246,0211-699501013259,Se,o
246,0211-699501013259,determinaron,o
246,0211-699501013259,al,o
246,0211-699501013259,comienzo,o
246,0211-699501013259,del,o
246,0211-699501013259,estudio,o
246,0211-699501013259,y,o
246,0211-699501013259,cada,o
246,0211-699501013259,2,o
246,0211-699501013259,meses,o
246,0211-699501013259,niveles,i
246,0211-699501013259,de,i
246,0211-699501013259,folato,i
246,0211-699501013259,vitamina,i
246,0211-699501013259,B12,i
246,0211-699501013259,inmunoensayo,i
246,0211-699501013259,albumina,i
246,0211-699501013259,y,o
246,0211-699501013259,cinetica,o
246,0211-699501013259,de,o
246,0211-699501013259,la,o
246,0211-699501013259,urea,i
246,0211-699501013259,KTV,o
246,0211-699501013259,KRU,o
246,0211-699501013259,PCRn,o
246,0211-699501013259,y,o
246,0211-699501013259,cada,o
246,0211-699501013259,6,o
246,0211-699501013259,meses,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,HPLC,i
246,0211-699501013259,y,o
246,0211-699501013259,pp,i
246,0211-699501013259,RIA,i
246,0211-699501013259,Resultados,o
246,0211-699501013259,80,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,fueron,o
246,0211-699501013259,incluidos,o
246,0211-699501013259,en,o
246,0211-699501013259,el,o
246,0211-699501013259,estudio,o
246,0211-699501013259,basal,o
246,0211-699501013259,con,o
246,0211-699501013259,una,o
246,0211-699501013259,prevalencia,o
246,0211-699501013259,de,o
246,0211-699501013259,hiperhomocisteinemia,i
246,0211-699501013259,del,o
246,0211-699501013259,844,o
246,0211-699501013259,deficit,i
246,0211-699501013259,de,i
246,0211-699501013259,pp,i
246,0211-699501013259,en,o
246,0211-699501013259,el,o
246,0211-699501013259,32,o
246,0211-699501013259,y,o
246,0211-699501013259,folato,i
246,0211-699501013259,en,o
246,0211-699501013259,el,o
246,0211-699501013259,rango,o
246,0211-699501013259,normal,o
246,0211-699501013259,bajo,o
246,0211-699501013259,los,o
246,0211-699501013259,niveles,i
246,0211-699501013259,de,i
246,0211-699501013259,tHcy,i
246,0211-699501013259,se,o
246,0211-699501013259,correlacionaban,o
246,0211-699501013259,inversamente,o
246,0211-699501013259,con,o
246,0211-699501013259,los,o
246,0211-699501013259,del,o
246,0211-699501013259,folato,i
246,0211-699501013259,r,o
246,0211-699501013259,0336,o
246,0211-699501013259,p,o
246,0211-699501013259,001,o
246,0211-699501013259,pero,o
246,0211-699501013259,no,o
246,0211-699501013259,con,o
246,0211-699501013259,pp,i
246,0211-699501013259,B12,i
246,0211-699501013259,edad,o
246,0211-699501013259,albumina,i
246,0211-699501013259,KTV,o
246,0211-699501013259,KRU,o
246,0211-699501013259,PCRn,o
246,0211-699501013259,Cincuenta,o
246,0211-699501013259,y,o
246,0211-699501013259,ocho,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,recibieron,o
246,0211-699501013259,seis,o
246,0211-699501013259,meses,o
246,0211-699501013259,de,o
246,0211-699501013259,suplementacion,i
246,0211-699501013259,con,o
246,0211-699501013259,normalizacion,o
246,0211-699501013259,del,o
246,0211-699501013259,pp,i
246,0211-699501013259,aumento,o
246,0211-699501013259,del,o
246,0211-699501013259,folato,i
246,0211-699501013259,703,o
246,0211-699501013259,IC,o
246,0211-699501013259,638,o
246,0211-699501013259,795,o
246,0211-699501013259,vs,o
246,0211-699501013259,6181,o
246,0211-699501013259,IC,o
246,0211-699501013259,4447,o
246,0211-699501013259,7811,o
246,0211-699501013259,p,o
246,0211-699501013259,0001,o
246,0211-699501013259,y,o
246,0211-699501013259,descenso,o
246,0211-699501013259,de,o
246,0211-699501013259,la,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,240,o
246,0211-699501013259,IC,o
246,0211-699501013259,213,o
246,0211-699501013259,264,o
246,0211-699501013259,vs,o
246,0211-699501013259,199,o
246,0211-699501013259,IC,o
246,0211-699501013259,175,o
246,0211-699501013259,224,o
246,0211-699501013259,p,o
246,0211-699501013259,005,o
246,0211-699501013259,Han,o
246,0211-699501013259,recibido,o
246,0211-699501013259,suplementacion,i
246,0211-699501013259,durante,o
246,0211-699501013259,12,o
246,0211-699501013259,meses,o
246,0211-699501013259,33,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,pero,o
246,0211-699501013259,a,o
246,0211-699501013259,pesar,o
246,0211-699501013259,de,o
246,0211-699501013259,un,o
246,0211-699501013259,continuo,o
246,0211-699501013259,aumento,o
246,0211-699501013259,del,o
246,0211-699501013259,folato,i
246,0211-699501013259,10078,o
246,0211-699501013259,IC,o
246,0211-699501013259,7481,o
246,0211-699501013259,12674,o
246,0211-699501013259,p,o
246,0211-699501013259,0001,o
246,0211-699501013259,solo,o
246,0211-699501013259,3,o
246,0211-699501013259,pacientes,o
246,0211-699501013259,presentan,o
246,0211-699501013259,niveles,o
246,0211-699501013259,normales,o
246,0211-699501013259,de,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,correlacionandose,o
246,0211-699501013259,directamente,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,con,o
246,0211-699501013259,la,o
246,0211-699501013259,albumina,i
246,0211-699501013259,r,o
246,0211-699501013259,056,o
246,0211-699501013259,p,o
246,0211-699501013259,0001,o
246,0211-699501013259,que,o
246,0211-699501013259,se,o
246,0211-699501013259,elevo,o
246,0211-699501013259,con,o
246,0211-699501013259,respecto,o
246,0211-699501013259,al,o
246,0211-699501013259,inicio,o
246,0211-699501013259,337,o
246,0211-699501013259,IC,o
246,0211-699501013259,327,o
246,0211-699501013259,346,o
246,0211-699501013259,vs,o
246,0211-699501013259,350,o
246,0211-699501013259,IC,o
246,0211-699501013259,337,o
246,0211-699501013259,363,o
246,0211-699501013259,p,o
246,0211-699501013259,005,o
246,0211-699501013259,Conclusion,o
246,0211-699501013259,Tras,o
246,0211-699501013259,suplementacion,i
246,0211-699501013259,con,o
246,0211-699501013259,acido,i
246,0211-699501013259,folico,i
246,0211-699501013259,y,o
246,0211-699501013259,vitamina,i
246,0211-699501013259,B6,i
246,0211-699501013259,aunque,o
246,0211-699501013259,inicialmente,o
246,0211-699501013259,se,o
246,0211-699501013259,reduce,o
246,0211-699501013259,la,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,esta,o
246,0211-699501013259,respuesta,o
246,0211-699501013259,se,o
246,0211-699501013259,hace,o
246,0211-699501013259,refractaria,o
246,0211-699501013259,correlacionandose,o
246,0211-699501013259,directamente,o
246,0211-699501013259,la,o
246,0211-699501013259,tHcy,i
246,0211-699501013259,con,o
246,0211-699501013259,la,o
246,0211-699501013259,albumina,i
246,0211-699501013259,plasmatica,i
246,0211-699501013259,La,o
246,0211-699501013259,interpretacion,o
246,0211-699501013259,de,o
246,0211-699501013259,los,o
246,0211-699501013259,niveles,i
246,0211-699501013259,de,i
246,0211-699501013259,tHcy,i
246,0211-699501013259,debe,o
246,0211-699501013259,tener,o
246,0211-699501013259,en,o
246,0211-699501013259,cuenta,o
246,0211-699501013259,la,o
246,0211-699501013259,concentracion,i
246,0211-699501013259,de,i
246,0211-699501013259,albumina,i
247,0211-699501013259,Efecto,o
247,0211-699501013259,de,o
247,0211-699501013259,la,o
247,0211-699501013259,suplementacion,i
247,0211-699501013259,con,o
247,0211-699501013259,acido,i
247,0211-699501013259,folico,i
247,0211-699501013259,sobre,o
247,0211-699501013259,los,o
247,0211-699501013259,niveles,i
247,0211-699501013259,de,i
247,0211-699501013259,homocisteina,i
247,0211-699501013259,total,o
247,0211-699501013259,en,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,en,o
247,0211-699501013259,hemodialisis,i
247,0211-699501013259,La,o
247,0211-699501013259,hiperhomocisteinemia,i
247,0211-699501013259,es,o
247,0211-699501013259,un,o
247,0211-699501013259,marcador,o
247,0211-699501013259,de,o
247,0211-699501013259,riesgo,o
247,0211-699501013259,independiente,o
247,0211-699501013259,de,o
247,0211-699501013259,morbimortalidad,o
247,0211-699501013259,cardiovascular,i
247,0211-699501013259,Hemos,o
247,0211-699501013259,intentado,o
247,0211-699501013259,prospectivamente,o
247,0211-699501013259,reducir,o
247,0211-699501013259,los,o
247,0211-699501013259,niveles,i
247,0211-699501013259,de,i
247,0211-699501013259,homocisteina,i
247,0211-699501013259,total,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,mediante,o
247,0211-699501013259,suplemento,o
247,0211-699501013259,con,o
247,0211-699501013259,acido,i
247,0211-699501013259,folico,i
247,0211-699501013259,y,o
247,0211-699501013259,vitamina,i
247,0211-699501013259,B6,i
247,0211-699501013259,pp,i
247,0211-699501013259,valorando,o
247,0211-699501013259,su,o
247,0211-699501013259,posible,o
247,0211-699501013259,correlacion,o
247,0211-699501013259,con,o
247,0211-699501013259,dosis,o
247,0211-699501013259,de,o
247,0211-699501013259,dialisis,i
247,0211-699501013259,funcion,i
247,0211-699501013259,residual,i
247,0211-699501013259,y,o
247,0211-699501013259,parametros,o
247,0211-699501013259,nutricionales,o
247,0211-699501013259,Metodos,o
247,0211-699501013259,Todos,o
247,0211-699501013259,los,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,en,o
247,0211-699501013259,hemodialisis,i
247,0211-699501013259,al,o
247,0211-699501013259,comienzo,o
247,0211-699501013259,del,o
247,0211-699501013259,estudio,o
247,0211-699501013259,que,o
247,0211-699501013259,no,o
247,0211-699501013259,recibian,o
247,0211-699501013259,acido,i
247,0211-699501013259,folico,i
247,0211-699501013259,ni,o
247,0211-699501013259,vitamina,i
247,0211-699501013259,B6,i
247,0211-699501013259,asi,o
247,0211-699501013259,como,o
247,0211-699501013259,los,o
247,0211-699501013259,incorporados,o
247,0211-699501013259,posteriormente,o
247,0211-699501013259,a,o
247,0211-699501013259,partir,o
247,0211-699501013259,de,o
247,0211-699501013259,su,o
247,0211-699501013259,tercer,o
247,0211-699501013259,mes,o
247,0211-699501013259,en,o
247,0211-699501013259,hemodialisis,i
247,0211-699501013259,recibieron,o
247,0211-699501013259,5,o
247,0211-699501013259,mg,o
247,0211-699501013259,orales,o
247,0211-699501013259,de,o
247,0211-699501013259,acido,i
247,0211-699501013259,folico,i
247,0211-699501013259,cada,o
247,0211-699501013259,48,o
247,0211-699501013259,horas,o
247,0211-699501013259,y,o
247,0211-699501013259,40,o
247,0211-699501013259,mg,o
247,0211-699501013259,orales,o
247,0211-699501013259,de,o
247,0211-699501013259,vitamina,i
247,0211-699501013259,B6,i
247,0211-699501013259,cada,o
247,0211-699501013259,semana,o
247,0211-699501013259,Se,o
247,0211-699501013259,determinaron,o
247,0211-699501013259,al,o
247,0211-699501013259,comienzo,o
247,0211-699501013259,del,o
247,0211-699501013259,estudio,o
247,0211-699501013259,y,o
247,0211-699501013259,cada,o
247,0211-699501013259,2,o
247,0211-699501013259,meses,o
247,0211-699501013259,niveles,i
247,0211-699501013259,de,i
247,0211-699501013259,folato,i
247,0211-699501013259,vitamina,i
247,0211-699501013259,B12,i
247,0211-699501013259,inmunoensayo,i
247,0211-699501013259,albumina,i
247,0211-699501013259,y,o
247,0211-699501013259,cinetica,o
247,0211-699501013259,de,o
247,0211-699501013259,la,o
247,0211-699501013259,urea,i
247,0211-699501013259,KTV,o
247,0211-699501013259,KRU,o
247,0211-699501013259,PCRn,o
247,0211-699501013259,y,o
247,0211-699501013259,cada,o
247,0211-699501013259,6,o
247,0211-699501013259,meses,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,HPLC,i
247,0211-699501013259,y,o
247,0211-699501013259,pp,i
247,0211-699501013259,RIA,i
247,0211-699501013259,Resultados,o
247,0211-699501013259,80,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,fueron,o
247,0211-699501013259,incluidos,o
247,0211-699501013259,en,o
247,0211-699501013259,el,o
247,0211-699501013259,estudio,o
247,0211-699501013259,basal,o
247,0211-699501013259,con,o
247,0211-699501013259,una,o
247,0211-699501013259,prevalencia,o
247,0211-699501013259,de,o
247,0211-699501013259,hiperhomocisteinemia,i
247,0211-699501013259,del,o
247,0211-699501013259,844,o
247,0211-699501013259,deficit,i
247,0211-699501013259,de,i
247,0211-699501013259,pp,i
247,0211-699501013259,en,o
247,0211-699501013259,el,o
247,0211-699501013259,32,o
247,0211-699501013259,y,o
247,0211-699501013259,folato,i
247,0211-699501013259,en,o
247,0211-699501013259,el,o
247,0211-699501013259,rango,o
247,0211-699501013259,normal,o
247,0211-699501013259,bajo,o
247,0211-699501013259,los,o
247,0211-699501013259,niveles,i
247,0211-699501013259,de,i
247,0211-699501013259,tHcy,i
247,0211-699501013259,se,o
247,0211-699501013259,correlacionaban,o
247,0211-699501013259,inversamente,o
247,0211-699501013259,con,o
247,0211-699501013259,los,o
247,0211-699501013259,del,o
247,0211-699501013259,folato,i
247,0211-699501013259,r,o
247,0211-699501013259,0336,o
247,0211-699501013259,p,o
247,0211-699501013259,001,o
247,0211-699501013259,pero,o
247,0211-699501013259,no,o
247,0211-699501013259,con,o
247,0211-699501013259,pp,i
247,0211-699501013259,B12,i
247,0211-699501013259,edad,o
247,0211-699501013259,albumina,i
247,0211-699501013259,KTV,o
247,0211-699501013259,KRU,o
247,0211-699501013259,PCRn,o
247,0211-699501013259,Cincuenta,o
247,0211-699501013259,y,o
247,0211-699501013259,ocho,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,recibieron,o
247,0211-699501013259,seis,o
247,0211-699501013259,meses,o
247,0211-699501013259,de,o
247,0211-699501013259,suplementacion,i
247,0211-699501013259,con,o
247,0211-699501013259,normalizacion,o
247,0211-699501013259,del,o
247,0211-699501013259,pp,i
247,0211-699501013259,aumento,o
247,0211-699501013259,del,o
247,0211-699501013259,folato,i
247,0211-699501013259,703,o
247,0211-699501013259,IC,o
247,0211-699501013259,638,o
247,0211-699501013259,795,o
247,0211-699501013259,vs,o
247,0211-699501013259,6181,o
247,0211-699501013259,IC,o
247,0211-699501013259,4447,o
247,0211-699501013259,7811,o
247,0211-699501013259,p,o
247,0211-699501013259,0001,o
247,0211-699501013259,y,o
247,0211-699501013259,descenso,o
247,0211-699501013259,de,o
247,0211-699501013259,la,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,240,o
247,0211-699501013259,IC,o
247,0211-699501013259,213,o
247,0211-699501013259,264,o
247,0211-699501013259,vs,o
247,0211-699501013259,199,o
247,0211-699501013259,IC,o
247,0211-699501013259,175,o
247,0211-699501013259,224,o
247,0211-699501013259,p,o
247,0211-699501013259,005,o
247,0211-699501013259,Han,o
247,0211-699501013259,recibido,o
247,0211-699501013259,suplementacion,i
247,0211-699501013259,durante,o
247,0211-699501013259,12,o
247,0211-699501013259,meses,o
247,0211-699501013259,33,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,pero,o
247,0211-699501013259,a,o
247,0211-699501013259,pesar,o
247,0211-699501013259,de,o
247,0211-699501013259,un,o
247,0211-699501013259,continuo,o
247,0211-699501013259,aumento,o
247,0211-699501013259,del,o
247,0211-699501013259,folato,i
247,0211-699501013259,10078,o
247,0211-699501013259,IC,o
247,0211-699501013259,7481,o
247,0211-699501013259,12674,o
247,0211-699501013259,p,o
247,0211-699501013259,0001,o
247,0211-699501013259,solo,o
247,0211-699501013259,3,o
247,0211-699501013259,pacientes,o
247,0211-699501013259,presentan,o
247,0211-699501013259,niveles,o
247,0211-699501013259,normales,o
247,0211-699501013259,de,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,correlacionandose,o
247,0211-699501013259,directamente,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,con,o
247,0211-699501013259,la,o
247,0211-699501013259,albumina,i
247,0211-699501013259,r,o
247,0211-699501013259,056,o
247,0211-699501013259,p,o
247,0211-699501013259,0001,o
247,0211-699501013259,que,o
247,0211-699501013259,se,o
247,0211-699501013259,elevo,o
247,0211-699501013259,con,o
247,0211-699501013259,respecto,o
247,0211-699501013259,al,o
247,0211-699501013259,inicio,o
247,0211-699501013259,337,o
247,0211-699501013259,IC,o
247,0211-699501013259,327,o
247,0211-699501013259,346,o
247,0211-699501013259,vs,o
247,0211-699501013259,350,o
247,0211-699501013259,IC,o
247,0211-699501013259,337,o
247,0211-699501013259,363,o
247,0211-699501013259,p,o
247,0211-699501013259,005,o
247,0211-699501013259,Conclusion,o
247,0211-699501013259,Tras,o
247,0211-699501013259,suplementacion,i
247,0211-699501013259,con,o
247,0211-699501013259,acido,i
247,0211-699501013259,folico,i
247,0211-699501013259,y,o
247,0211-699501013259,vitamina,i
247,0211-699501013259,B6,i
247,0211-699501013259,aunque,o
247,0211-699501013259,inicialmente,o
247,0211-699501013259,se,o
247,0211-699501013259,reduce,o
247,0211-699501013259,la,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,esta,o
247,0211-699501013259,respuesta,o
247,0211-699501013259,se,o
247,0211-699501013259,hace,o
247,0211-699501013259,refractaria,o
247,0211-699501013259,correlacionandose,o
247,0211-699501013259,directamente,o
247,0211-699501013259,la,o
247,0211-699501013259,tHcy,i
247,0211-699501013259,con,o
247,0211-699501013259,la,o
247,0211-699501013259,albumina,i
247,0211-699501013259,plasmatica,i
247,0211-699501013259,La,o
247,0211-699501013259,interpretacion,o
247,0211-699501013259,de,o
247,0211-699501013259,los,o
247,0211-699501013259,niveles,i
247,0211-699501013259,de,i
247,0211-699501013259,tHcy,i
247,0211-699501013259,debe,o
247,0211-699501013259,tener,o
247,0211-699501013259,en,o
247,0211-699501013259,cuenta,o
247,0211-699501013259,la,o
247,0211-699501013259,concentracion,i
247,0211-699501013259,de,i
247,0211-699501013259,albumina,i
248,0211-699501013259,Efecto,o
248,0211-699501013259,de,o
248,0211-699501013259,la,o
248,0211-699501013259,suplementacion,i
248,0211-699501013259,con,o
248,0211-699501013259,acido,i
248,0211-699501013259,folico,i
248,0211-699501013259,sobre,o
248,0211-699501013259,los,o
248,0211-699501013259,niveles,i
248,0211-699501013259,de,i
248,0211-699501013259,homocisteina,i
248,0211-699501013259,total,o
248,0211-699501013259,en,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,en,o
248,0211-699501013259,hemodialisis,i
248,0211-699501013259,La,o
248,0211-699501013259,hiperhomocisteinemia,i
248,0211-699501013259,es,o
248,0211-699501013259,un,o
248,0211-699501013259,marcador,o
248,0211-699501013259,de,o
248,0211-699501013259,riesgo,o
248,0211-699501013259,independiente,o
248,0211-699501013259,de,o
248,0211-699501013259,morbimortalidad,o
248,0211-699501013259,cardiovascular,i
248,0211-699501013259,Hemos,o
248,0211-699501013259,intentado,o
248,0211-699501013259,prospectivamente,o
248,0211-699501013259,reducir,o
248,0211-699501013259,los,o
248,0211-699501013259,niveles,i
248,0211-699501013259,de,i
248,0211-699501013259,homocisteina,i
248,0211-699501013259,total,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,mediante,o
248,0211-699501013259,suplemento,o
248,0211-699501013259,con,o
248,0211-699501013259,acido,i
248,0211-699501013259,folico,i
248,0211-699501013259,y,o
248,0211-699501013259,vitamina,i
248,0211-699501013259,B6,i
248,0211-699501013259,pp,i
248,0211-699501013259,valorando,o
248,0211-699501013259,su,o
248,0211-699501013259,posible,o
248,0211-699501013259,correlacion,o
248,0211-699501013259,con,o
248,0211-699501013259,dosis,o
248,0211-699501013259,de,o
248,0211-699501013259,dialisis,i
248,0211-699501013259,funcion,i
248,0211-699501013259,residual,i
248,0211-699501013259,y,o
248,0211-699501013259,parametros,o
248,0211-699501013259,nutricionales,o
248,0211-699501013259,Metodos,o
248,0211-699501013259,Todos,o
248,0211-699501013259,los,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,en,o
248,0211-699501013259,hemodialisis,i
248,0211-699501013259,al,o
248,0211-699501013259,comienzo,o
248,0211-699501013259,del,o
248,0211-699501013259,estudio,o
248,0211-699501013259,que,o
248,0211-699501013259,no,o
248,0211-699501013259,recibian,o
248,0211-699501013259,acido,i
248,0211-699501013259,folico,i
248,0211-699501013259,ni,o
248,0211-699501013259,vitamina,i
248,0211-699501013259,B6,i
248,0211-699501013259,asi,o
248,0211-699501013259,como,o
248,0211-699501013259,los,o
248,0211-699501013259,incorporados,o
248,0211-699501013259,posteriormente,o
248,0211-699501013259,a,o
248,0211-699501013259,partir,o
248,0211-699501013259,de,o
248,0211-699501013259,su,o
248,0211-699501013259,tercer,o
248,0211-699501013259,mes,o
248,0211-699501013259,en,o
248,0211-699501013259,hemodialisis,i
248,0211-699501013259,recibieron,o
248,0211-699501013259,5,o
248,0211-699501013259,mg,o
248,0211-699501013259,orales,o
248,0211-699501013259,de,o
248,0211-699501013259,acido,i
248,0211-699501013259,folico,i
248,0211-699501013259,cada,o
248,0211-699501013259,48,o
248,0211-699501013259,horas,o
248,0211-699501013259,y,o
248,0211-699501013259,40,o
248,0211-699501013259,mg,o
248,0211-699501013259,orales,o
248,0211-699501013259,de,o
248,0211-699501013259,vitamina,i
248,0211-699501013259,B6,i
248,0211-699501013259,cada,o
248,0211-699501013259,semana,o
248,0211-699501013259,Se,o
248,0211-699501013259,determinaron,o
248,0211-699501013259,al,o
248,0211-699501013259,comienzo,o
248,0211-699501013259,del,o
248,0211-699501013259,estudio,o
248,0211-699501013259,y,o
248,0211-699501013259,cada,o
248,0211-699501013259,2,o
248,0211-699501013259,meses,o
248,0211-699501013259,niveles,i
248,0211-699501013259,de,i
248,0211-699501013259,folato,i
248,0211-699501013259,vitamina,i
248,0211-699501013259,B12,i
248,0211-699501013259,inmunoensayo,i
248,0211-699501013259,albumina,i
248,0211-699501013259,y,o
248,0211-699501013259,cinetica,o
248,0211-699501013259,de,o
248,0211-699501013259,la,o
248,0211-699501013259,urea,i
248,0211-699501013259,KTV,o
248,0211-699501013259,KRU,o
248,0211-699501013259,PCRn,o
248,0211-699501013259,y,o
248,0211-699501013259,cada,o
248,0211-699501013259,6,o
248,0211-699501013259,meses,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,HPLC,i
248,0211-699501013259,y,o
248,0211-699501013259,pp,i
248,0211-699501013259,RIA,i
248,0211-699501013259,Resultados,o
248,0211-699501013259,80,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,fueron,o
248,0211-699501013259,incluidos,o
248,0211-699501013259,en,o
248,0211-699501013259,el,o
248,0211-699501013259,estudio,o
248,0211-699501013259,basal,o
248,0211-699501013259,con,o
248,0211-699501013259,una,o
248,0211-699501013259,prevalencia,o
248,0211-699501013259,de,o
248,0211-699501013259,hiperhomocisteinemia,i
248,0211-699501013259,del,o
248,0211-699501013259,844,o
248,0211-699501013259,deficit,i
248,0211-699501013259,de,i
248,0211-699501013259,pp,i
248,0211-699501013259,en,o
248,0211-699501013259,el,o
248,0211-699501013259,32,o
248,0211-699501013259,y,o
248,0211-699501013259,folato,i
248,0211-699501013259,en,o
248,0211-699501013259,el,o
248,0211-699501013259,rango,o
248,0211-699501013259,normal,o
248,0211-699501013259,bajo,o
248,0211-699501013259,los,o
248,0211-699501013259,niveles,i
248,0211-699501013259,de,i
248,0211-699501013259,tHcy,i
248,0211-699501013259,se,o
248,0211-699501013259,correlacionaban,o
248,0211-699501013259,inversamente,o
248,0211-699501013259,con,o
248,0211-699501013259,los,o
248,0211-699501013259,del,o
248,0211-699501013259,folato,i
248,0211-699501013259,r,o
248,0211-699501013259,0336,o
248,0211-699501013259,p,o
248,0211-699501013259,001,o
248,0211-699501013259,pero,o
248,0211-699501013259,no,o
248,0211-699501013259,con,o
248,0211-699501013259,pp,i
248,0211-699501013259,B12,i
248,0211-699501013259,edad,o
248,0211-699501013259,albumina,i
248,0211-699501013259,KTV,o
248,0211-699501013259,KRU,o
248,0211-699501013259,PCRn,o
248,0211-699501013259,Cincuenta,o
248,0211-699501013259,y,o
248,0211-699501013259,ocho,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,recibieron,o
248,0211-699501013259,seis,o
248,0211-699501013259,meses,o
248,0211-699501013259,de,o
248,0211-699501013259,suplementacion,i
248,0211-699501013259,con,o
248,0211-699501013259,normalizacion,o
248,0211-699501013259,del,o
248,0211-699501013259,pp,i
248,0211-699501013259,aumento,o
248,0211-699501013259,del,o
248,0211-699501013259,folato,i
248,0211-699501013259,703,o
248,0211-699501013259,IC,o
248,0211-699501013259,638,o
248,0211-699501013259,795,o
248,0211-699501013259,vs,o
248,0211-699501013259,6181,o
248,0211-699501013259,IC,o
248,0211-699501013259,4447,o
248,0211-699501013259,7811,o
248,0211-699501013259,p,o
248,0211-699501013259,0001,o
248,0211-699501013259,y,o
248,0211-699501013259,descenso,o
248,0211-699501013259,de,o
248,0211-699501013259,la,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,240,o
248,0211-699501013259,IC,o
248,0211-699501013259,213,o
248,0211-699501013259,264,o
248,0211-699501013259,vs,o
248,0211-699501013259,199,o
248,0211-699501013259,IC,o
248,0211-699501013259,175,o
248,0211-699501013259,224,o
248,0211-699501013259,p,o
248,0211-699501013259,005,o
248,0211-699501013259,Han,o
248,0211-699501013259,recibido,o
248,0211-699501013259,suplementacion,i
248,0211-699501013259,durante,o
248,0211-699501013259,12,o
248,0211-699501013259,meses,o
248,0211-699501013259,33,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,pero,o
248,0211-699501013259,a,o
248,0211-699501013259,pesar,o
248,0211-699501013259,de,o
248,0211-699501013259,un,o
248,0211-699501013259,continuo,o
248,0211-699501013259,aumento,o
248,0211-699501013259,del,o
248,0211-699501013259,folato,i
248,0211-699501013259,10078,o
248,0211-699501013259,IC,o
248,0211-699501013259,7481,o
248,0211-699501013259,12674,o
248,0211-699501013259,p,o
248,0211-699501013259,0001,o
248,0211-699501013259,solo,o
248,0211-699501013259,3,o
248,0211-699501013259,pacientes,o
248,0211-699501013259,presentan,o
248,0211-699501013259,niveles,o
248,0211-699501013259,normales,o
248,0211-699501013259,de,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,correlacionandose,o
248,0211-699501013259,directamente,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,con,o
248,0211-699501013259,la,o
248,0211-699501013259,albumina,i
248,0211-699501013259,r,o
248,0211-699501013259,056,o
248,0211-699501013259,p,o
248,0211-699501013259,0001,o
248,0211-699501013259,que,o
248,0211-699501013259,se,o
248,0211-699501013259,elevo,o
248,0211-699501013259,con,o
248,0211-699501013259,respecto,o
248,0211-699501013259,al,o
248,0211-699501013259,inicio,o
248,0211-699501013259,337,o
248,0211-699501013259,IC,o
248,0211-699501013259,327,o
248,0211-699501013259,346,o
248,0211-699501013259,vs,o
248,0211-699501013259,350,o
248,0211-699501013259,IC,o
248,0211-699501013259,337,o
248,0211-699501013259,363,o
248,0211-699501013259,p,o
248,0211-699501013259,005,o
248,0211-699501013259,Conclusion,o
248,0211-699501013259,Tras,o
248,0211-699501013259,suplementacion,i
248,0211-699501013259,con,o
248,0211-699501013259,acido,i
248,0211-699501013259,folico,i
248,0211-699501013259,y,o
248,0211-699501013259,vitamina,i
248,0211-699501013259,B6,i
248,0211-699501013259,aunque,o
248,0211-699501013259,inicialmente,o
248,0211-699501013259,se,o
248,0211-699501013259,reduce,o
248,0211-699501013259,la,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,esta,o
248,0211-699501013259,respuesta,o
248,0211-699501013259,se,o
248,0211-699501013259,hace,o
248,0211-699501013259,refractaria,o
248,0211-699501013259,correlacionandose,o
248,0211-699501013259,directamente,o
248,0211-699501013259,la,o
248,0211-699501013259,tHcy,i
248,0211-699501013259,con,o
248,0211-699501013259,la,o
248,0211-699501013259,albumina,i
248,0211-699501013259,plasmatica,i
248,0211-699501013259,La,o
248,0211-699501013259,interpretacion,o
248,0211-699501013259,de,o
248,0211-699501013259,los,o
248,0211-699501013259,niveles,i
248,0211-699501013259,de,i
248,0211-699501013259,tHcy,i
248,0211-699501013259,debe,o
248,0211-699501013259,tener,o
248,0211-699501013259,en,o
248,0211-699501013259,cuenta,o
248,0211-699501013259,la,o
248,0211-699501013259,concentracion,i
248,0211-699501013259,de,i
248,0211-699501013259,albumina,i
249,0211-699501013259,Efecto,o
249,0211-699501013259,de,o
249,0211-699501013259,la,o
249,0211-699501013259,suplementacion,i
249,0211-699501013259,con,o
249,0211-699501013259,acido,i
249,0211-699501013259,folico,i
249,0211-699501013259,sobre,o
249,0211-699501013259,los,o
249,0211-699501013259,niveles,i
249,0211-699501013259,de,i
249,0211-699501013259,homocisteina,i
249,0211-699501013259,total,o
249,0211-699501013259,en,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,en,o
249,0211-699501013259,hemodialisis,i
249,0211-699501013259,La,o
249,0211-699501013259,hiperhomocisteinemia,i
249,0211-699501013259,es,o
249,0211-699501013259,un,o
249,0211-699501013259,marcador,o
249,0211-699501013259,de,o
249,0211-699501013259,riesgo,o
249,0211-699501013259,independiente,o
249,0211-699501013259,de,o
249,0211-699501013259,morbimortalidad,o
249,0211-699501013259,cardiovascular,i
249,0211-699501013259,Hemos,o
249,0211-699501013259,intentado,o
249,0211-699501013259,prospectivamente,o
249,0211-699501013259,reducir,o
249,0211-699501013259,los,o
249,0211-699501013259,niveles,i
249,0211-699501013259,de,i
249,0211-699501013259,homocisteina,i
249,0211-699501013259,total,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,mediante,o
249,0211-699501013259,suplemento,o
249,0211-699501013259,con,o
249,0211-699501013259,acido,i
249,0211-699501013259,folico,i
249,0211-699501013259,y,o
249,0211-699501013259,vitamina,i
249,0211-699501013259,B6,i
249,0211-699501013259,pp,i
249,0211-699501013259,valorando,o
249,0211-699501013259,su,o
249,0211-699501013259,posible,o
249,0211-699501013259,correlacion,o
249,0211-699501013259,con,o
249,0211-699501013259,dosis,o
249,0211-699501013259,de,o
249,0211-699501013259,dialisis,i
249,0211-699501013259,funcion,i
249,0211-699501013259,residual,i
249,0211-699501013259,y,o
249,0211-699501013259,parametros,o
249,0211-699501013259,nutricionales,o
249,0211-699501013259,Metodos,o
249,0211-699501013259,Todos,o
249,0211-699501013259,los,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,en,o
249,0211-699501013259,hemodialisis,i
249,0211-699501013259,al,o
249,0211-699501013259,comienzo,o
249,0211-699501013259,del,o
249,0211-699501013259,estudio,o
249,0211-699501013259,que,o
249,0211-699501013259,no,o
249,0211-699501013259,recibian,o
249,0211-699501013259,acido,i
249,0211-699501013259,folico,i
249,0211-699501013259,ni,o
249,0211-699501013259,vitamina,i
249,0211-699501013259,B6,i
249,0211-699501013259,asi,o
249,0211-699501013259,como,o
249,0211-699501013259,los,o
249,0211-699501013259,incorporados,o
249,0211-699501013259,posteriormente,o
249,0211-699501013259,a,o
249,0211-699501013259,partir,o
249,0211-699501013259,de,o
249,0211-699501013259,su,o
249,0211-699501013259,tercer,o
249,0211-699501013259,mes,o
249,0211-699501013259,en,o
249,0211-699501013259,hemodialisis,i
249,0211-699501013259,recibieron,o
249,0211-699501013259,5,o
249,0211-699501013259,mg,o
249,0211-699501013259,orales,o
249,0211-699501013259,de,o
249,0211-699501013259,acido,i
249,0211-699501013259,folico,i
249,0211-699501013259,cada,o
249,0211-699501013259,48,o
249,0211-699501013259,horas,o
249,0211-699501013259,y,o
249,0211-699501013259,40,o
249,0211-699501013259,mg,o
249,0211-699501013259,orales,o
249,0211-699501013259,de,o
249,0211-699501013259,vitamina,i
249,0211-699501013259,B6,i
249,0211-699501013259,cada,o
249,0211-699501013259,semana,o
249,0211-699501013259,Se,o
249,0211-699501013259,determinaron,o
249,0211-699501013259,al,o
249,0211-699501013259,comienzo,o
249,0211-699501013259,del,o
249,0211-699501013259,estudio,o
249,0211-699501013259,y,o
249,0211-699501013259,cada,o
249,0211-699501013259,2,o
249,0211-699501013259,meses,o
249,0211-699501013259,niveles,i
249,0211-699501013259,de,i
249,0211-699501013259,folato,i
249,0211-699501013259,vitamina,i
249,0211-699501013259,B12,i
249,0211-699501013259,inmunoensayo,i
249,0211-699501013259,albumina,i
249,0211-699501013259,y,o
249,0211-699501013259,cinetica,o
249,0211-699501013259,de,o
249,0211-699501013259,la,o
249,0211-699501013259,urea,i
249,0211-699501013259,KTV,o
249,0211-699501013259,KRU,o
249,0211-699501013259,PCRn,o
249,0211-699501013259,y,o
249,0211-699501013259,cada,o
249,0211-699501013259,6,o
249,0211-699501013259,meses,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,HPLC,i
249,0211-699501013259,y,o
249,0211-699501013259,pp,i
249,0211-699501013259,RIA,i
249,0211-699501013259,Resultados,o
249,0211-699501013259,80,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,fueron,o
249,0211-699501013259,incluidos,o
249,0211-699501013259,en,o
249,0211-699501013259,el,o
249,0211-699501013259,estudio,o
249,0211-699501013259,basal,o
249,0211-699501013259,con,o
249,0211-699501013259,una,o
249,0211-699501013259,prevalencia,o
249,0211-699501013259,de,o
249,0211-699501013259,hiperhomocisteinemia,i
249,0211-699501013259,del,o
249,0211-699501013259,844,o
249,0211-699501013259,deficit,i
249,0211-699501013259,de,i
249,0211-699501013259,pp,i
249,0211-699501013259,en,o
249,0211-699501013259,el,o
249,0211-699501013259,32,o
249,0211-699501013259,y,o
249,0211-699501013259,folato,i
249,0211-699501013259,en,o
249,0211-699501013259,el,o
249,0211-699501013259,rango,o
249,0211-699501013259,normal,o
249,0211-699501013259,bajo,o
249,0211-699501013259,los,o
249,0211-699501013259,niveles,i
249,0211-699501013259,de,i
249,0211-699501013259,tHcy,i
249,0211-699501013259,se,o
249,0211-699501013259,correlacionaban,o
249,0211-699501013259,inversamente,o
249,0211-699501013259,con,o
249,0211-699501013259,los,o
249,0211-699501013259,del,o
249,0211-699501013259,folato,i
249,0211-699501013259,r,o
249,0211-699501013259,0336,o
249,0211-699501013259,p,o
249,0211-699501013259,001,o
249,0211-699501013259,pero,o
249,0211-699501013259,no,o
249,0211-699501013259,con,o
249,0211-699501013259,pp,i
249,0211-699501013259,B12,i
249,0211-699501013259,edad,o
249,0211-699501013259,albumina,i
249,0211-699501013259,KTV,o
249,0211-699501013259,KRU,o
249,0211-699501013259,PCRn,o
249,0211-699501013259,Cincuenta,o
249,0211-699501013259,y,o
249,0211-699501013259,ocho,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,recibieron,o
249,0211-699501013259,seis,o
249,0211-699501013259,meses,o
249,0211-699501013259,de,o
249,0211-699501013259,suplementacion,i
249,0211-699501013259,con,o
249,0211-699501013259,normalizacion,o
249,0211-699501013259,del,o
249,0211-699501013259,pp,i
249,0211-699501013259,aumento,o
249,0211-699501013259,del,o
249,0211-699501013259,folato,i
249,0211-699501013259,703,o
249,0211-699501013259,IC,o
249,0211-699501013259,638,o
249,0211-699501013259,795,o
249,0211-699501013259,vs,o
249,0211-699501013259,6181,o
249,0211-699501013259,IC,o
249,0211-699501013259,4447,o
249,0211-699501013259,7811,o
249,0211-699501013259,p,o
249,0211-699501013259,0001,o
249,0211-699501013259,y,o
249,0211-699501013259,descenso,o
249,0211-699501013259,de,o
249,0211-699501013259,la,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,240,o
249,0211-699501013259,IC,o
249,0211-699501013259,213,o
249,0211-699501013259,264,o
249,0211-699501013259,vs,o
249,0211-699501013259,199,o
249,0211-699501013259,IC,o
249,0211-699501013259,175,o
249,0211-699501013259,224,o
249,0211-699501013259,p,o
249,0211-699501013259,005,o
249,0211-699501013259,Han,o
249,0211-699501013259,recibido,o
249,0211-699501013259,suplementacion,i
249,0211-699501013259,durante,o
249,0211-699501013259,12,o
249,0211-699501013259,meses,o
249,0211-699501013259,33,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,pero,o
249,0211-699501013259,a,o
249,0211-699501013259,pesar,o
249,0211-699501013259,de,o
249,0211-699501013259,un,o
249,0211-699501013259,continuo,o
249,0211-699501013259,aumento,o
249,0211-699501013259,del,o
249,0211-699501013259,folato,i
249,0211-699501013259,10078,o
249,0211-699501013259,IC,o
249,0211-699501013259,7481,o
249,0211-699501013259,12674,o
249,0211-699501013259,p,o
249,0211-699501013259,0001,o
249,0211-699501013259,solo,o
249,0211-699501013259,3,o
249,0211-699501013259,pacientes,o
249,0211-699501013259,presentan,o
249,0211-699501013259,niveles,o
249,0211-699501013259,normales,o
249,0211-699501013259,de,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,correlacionandose,o
249,0211-699501013259,directamente,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,con,o
249,0211-699501013259,la,o
249,0211-699501013259,albumina,i
249,0211-699501013259,r,o
249,0211-699501013259,056,o
249,0211-699501013259,p,o
249,0211-699501013259,0001,o
249,0211-699501013259,que,o
249,0211-699501013259,se,o
249,0211-699501013259,elevo,o
249,0211-699501013259,con,o
249,0211-699501013259,respecto,o
249,0211-699501013259,al,o
249,0211-699501013259,inicio,o
249,0211-699501013259,337,o
249,0211-699501013259,IC,o
249,0211-699501013259,327,o
249,0211-699501013259,346,o
249,0211-699501013259,vs,o
249,0211-699501013259,350,o
249,0211-699501013259,IC,o
249,0211-699501013259,337,o
249,0211-699501013259,363,o
249,0211-699501013259,p,o
249,0211-699501013259,005,o
249,0211-699501013259,Conclusion,o
249,0211-699501013259,Tras,o
249,0211-699501013259,suplementacion,i
249,0211-699501013259,con,o
249,0211-699501013259,acido,i
249,0211-699501013259,folico,i
249,0211-699501013259,y,o
249,0211-699501013259,vitamina,i
249,0211-699501013259,B6,i
249,0211-699501013259,aunque,o
249,0211-699501013259,inicialmente,o
249,0211-699501013259,se,o
249,0211-699501013259,reduce,o
249,0211-699501013259,la,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,esta,o
249,0211-699501013259,respuesta,o
249,0211-699501013259,se,o
249,0211-699501013259,hace,o
249,0211-699501013259,refractaria,o
249,0211-699501013259,correlacionandose,o
249,0211-699501013259,directamente,o
249,0211-699501013259,la,o
249,0211-699501013259,tHcy,i
249,0211-699501013259,con,o
249,0211-699501013259,la,o
249,0211-699501013259,albumina,i
249,0211-699501013259,plasmatica,i
249,0211-699501013259,La,o
249,0211-699501013259,interpretacion,o
249,0211-699501013259,de,o
249,0211-699501013259,los,o
249,0211-699501013259,niveles,i
249,0211-699501013259,de,i
249,0211-699501013259,tHcy,i
249,0211-699501013259,debe,o
249,0211-699501013259,tener,o
249,0211-699501013259,en,o
249,0211-699501013259,cuenta,o
249,0211-699501013259,la,o
249,0211-699501013259,concentracion,i
249,0211-699501013259,de,i
249,0211-699501013259,albumina,i
250,0211-699501013259,Efecto,o
250,0211-699501013259,de,o
250,0211-699501013259,la,o
250,0211-699501013259,suplementacion,i
250,0211-699501013259,con,o
250,0211-699501013259,acido,i
250,0211-699501013259,folico,i
250,0211-699501013259,sobre,o
250,0211-699501013259,los,o
250,0211-699501013259,niveles,i
250,0211-699501013259,de,i
250,0211-699501013259,homocisteina,i
250,0211-699501013259,total,o
250,0211-699501013259,en,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,en,o
250,0211-699501013259,hemodialisis,i
250,0211-699501013259,La,o
250,0211-699501013259,hiperhomocisteinemia,i
250,0211-699501013259,es,o
250,0211-699501013259,un,o
250,0211-699501013259,marcador,o
250,0211-699501013259,de,o
250,0211-699501013259,riesgo,o
250,0211-699501013259,independiente,o
250,0211-699501013259,de,o
250,0211-699501013259,morbimortalidad,o
250,0211-699501013259,cardiovascular,i
250,0211-699501013259,Hemos,o
250,0211-699501013259,intentado,o
250,0211-699501013259,prospectivamente,o
250,0211-699501013259,reducir,o
250,0211-699501013259,los,o
250,0211-699501013259,niveles,i
250,0211-699501013259,de,i
250,0211-699501013259,homocisteina,i
250,0211-699501013259,total,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,mediante,o
250,0211-699501013259,suplemento,o
250,0211-699501013259,con,o
250,0211-699501013259,acido,i
250,0211-699501013259,folico,i
250,0211-699501013259,y,o
250,0211-699501013259,vitamina,i
250,0211-699501013259,B6,i
250,0211-699501013259,pp,i
250,0211-699501013259,valorando,o
250,0211-699501013259,su,o
250,0211-699501013259,posible,o
250,0211-699501013259,correlacion,o
250,0211-699501013259,con,o
250,0211-699501013259,dosis,o
250,0211-699501013259,de,o
250,0211-699501013259,dialisis,i
250,0211-699501013259,funcion,i
250,0211-699501013259,residual,i
250,0211-699501013259,y,o
250,0211-699501013259,parametros,o
250,0211-699501013259,nutricionales,o
250,0211-699501013259,Metodos,o
250,0211-699501013259,Todos,o
250,0211-699501013259,los,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,en,o
250,0211-699501013259,hemodialisis,i
250,0211-699501013259,al,o
250,0211-699501013259,comienzo,o
250,0211-699501013259,del,o
250,0211-699501013259,estudio,o
250,0211-699501013259,que,o
250,0211-699501013259,no,o
250,0211-699501013259,recibian,o
250,0211-699501013259,acido,i
250,0211-699501013259,folico,i
250,0211-699501013259,ni,o
250,0211-699501013259,vitamina,i
250,0211-699501013259,B6,i
250,0211-699501013259,asi,o
250,0211-699501013259,como,o
250,0211-699501013259,los,o
250,0211-699501013259,incorporados,o
250,0211-699501013259,posteriormente,o
250,0211-699501013259,a,o
250,0211-699501013259,partir,o
250,0211-699501013259,de,o
250,0211-699501013259,su,o
250,0211-699501013259,tercer,o
250,0211-699501013259,mes,o
250,0211-699501013259,en,o
250,0211-699501013259,hemodialisis,i
250,0211-699501013259,recibieron,o
250,0211-699501013259,5,o
250,0211-699501013259,mg,o
250,0211-699501013259,orales,o
250,0211-699501013259,de,o
250,0211-699501013259,acido,i
250,0211-699501013259,folico,i
250,0211-699501013259,cada,o
250,0211-699501013259,48,o
250,0211-699501013259,horas,o
250,0211-699501013259,y,o
250,0211-699501013259,40,o
250,0211-699501013259,mg,o
250,0211-699501013259,orales,o
250,0211-699501013259,de,o
250,0211-699501013259,vitamina,i
250,0211-699501013259,B6,i
250,0211-699501013259,cada,o
250,0211-699501013259,semana,o
250,0211-699501013259,Se,o
250,0211-699501013259,determinaron,o
250,0211-699501013259,al,o
250,0211-699501013259,comienzo,o
250,0211-699501013259,del,o
250,0211-699501013259,estudio,o
250,0211-699501013259,y,o
250,0211-699501013259,cada,o
250,0211-699501013259,2,o
250,0211-699501013259,meses,o
250,0211-699501013259,niveles,i
250,0211-699501013259,de,i
250,0211-699501013259,folato,i
250,0211-699501013259,vitamina,i
250,0211-699501013259,B12,i
250,0211-699501013259,inmunoensayo,i
250,0211-699501013259,albumina,i
250,0211-699501013259,y,o
250,0211-699501013259,cinetica,o
250,0211-699501013259,de,o
250,0211-699501013259,la,o
250,0211-699501013259,urea,i
250,0211-699501013259,KTV,o
250,0211-699501013259,KRU,o
250,0211-699501013259,PCRn,o
250,0211-699501013259,y,o
250,0211-699501013259,cada,o
250,0211-699501013259,6,o
250,0211-699501013259,meses,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,HPLC,i
250,0211-699501013259,y,o
250,0211-699501013259,pp,i
250,0211-699501013259,RIA,i
250,0211-699501013259,Resultados,o
250,0211-699501013259,80,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,fueron,o
250,0211-699501013259,incluidos,o
250,0211-699501013259,en,o
250,0211-699501013259,el,o
250,0211-699501013259,estudio,o
250,0211-699501013259,basal,o
250,0211-699501013259,con,o
250,0211-699501013259,una,o
250,0211-699501013259,prevalencia,o
250,0211-699501013259,de,o
250,0211-699501013259,hiperhomocisteinemia,i
250,0211-699501013259,del,o
250,0211-699501013259,844,o
250,0211-699501013259,deficit,i
250,0211-699501013259,de,i
250,0211-699501013259,pp,i
250,0211-699501013259,en,o
250,0211-699501013259,el,o
250,0211-699501013259,32,o
250,0211-699501013259,y,o
250,0211-699501013259,folato,i
250,0211-699501013259,en,o
250,0211-699501013259,el,o
250,0211-699501013259,rango,o
250,0211-699501013259,normal,o
250,0211-699501013259,bajo,o
250,0211-699501013259,los,o
250,0211-699501013259,niveles,i
250,0211-699501013259,de,i
250,0211-699501013259,tHcy,i
250,0211-699501013259,se,o
250,0211-699501013259,correlacionaban,o
250,0211-699501013259,inversamente,o
250,0211-699501013259,con,o
250,0211-699501013259,los,o
250,0211-699501013259,del,o
250,0211-699501013259,folato,i
250,0211-699501013259,r,o
250,0211-699501013259,0336,o
250,0211-699501013259,p,o
250,0211-699501013259,001,o
250,0211-699501013259,pero,o
250,0211-699501013259,no,o
250,0211-699501013259,con,o
250,0211-699501013259,pp,i
250,0211-699501013259,B12,i
250,0211-699501013259,edad,o
250,0211-699501013259,albumina,i
250,0211-699501013259,KTV,o
250,0211-699501013259,KRU,o
250,0211-699501013259,PCRn,o
250,0211-699501013259,Cincuenta,o
250,0211-699501013259,y,o
250,0211-699501013259,ocho,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,recibieron,o
250,0211-699501013259,seis,o
250,0211-699501013259,meses,o
250,0211-699501013259,de,o
250,0211-699501013259,suplementacion,i
250,0211-699501013259,con,o
250,0211-699501013259,normalizacion,o
250,0211-699501013259,del,o
250,0211-699501013259,pp,i
250,0211-699501013259,aumento,o
250,0211-699501013259,del,o
250,0211-699501013259,folato,i
250,0211-699501013259,703,o
250,0211-699501013259,IC,o
250,0211-699501013259,638,o
250,0211-699501013259,795,o
250,0211-699501013259,vs,o
250,0211-699501013259,6181,o
250,0211-699501013259,IC,o
250,0211-699501013259,4447,o
250,0211-699501013259,7811,o
250,0211-699501013259,p,o
250,0211-699501013259,0001,o
250,0211-699501013259,y,o
250,0211-699501013259,descenso,o
250,0211-699501013259,de,o
250,0211-699501013259,la,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,240,o
250,0211-699501013259,IC,o
250,0211-699501013259,213,o
250,0211-699501013259,264,o
250,0211-699501013259,vs,o
250,0211-699501013259,199,o
250,0211-699501013259,IC,o
250,0211-699501013259,175,o
250,0211-699501013259,224,o
250,0211-699501013259,p,o
250,0211-699501013259,005,o
250,0211-699501013259,Han,o
250,0211-699501013259,recibido,o
250,0211-699501013259,suplementacion,i
250,0211-699501013259,durante,o
250,0211-699501013259,12,o
250,0211-699501013259,meses,o
250,0211-699501013259,33,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,pero,o
250,0211-699501013259,a,o
250,0211-699501013259,pesar,o
250,0211-699501013259,de,o
250,0211-699501013259,un,o
250,0211-699501013259,continuo,o
250,0211-699501013259,aumento,o
250,0211-699501013259,del,o
250,0211-699501013259,folato,i
250,0211-699501013259,10078,o
250,0211-699501013259,IC,o
250,0211-699501013259,7481,o
250,0211-699501013259,12674,o
250,0211-699501013259,p,o
250,0211-699501013259,0001,o
250,0211-699501013259,solo,o
250,0211-699501013259,3,o
250,0211-699501013259,pacientes,o
250,0211-699501013259,presentan,o
250,0211-699501013259,niveles,o
250,0211-699501013259,normales,o
250,0211-699501013259,de,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,correlacionandose,o
250,0211-699501013259,directamente,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,con,o
250,0211-699501013259,la,o
250,0211-699501013259,albumina,i
250,0211-699501013259,r,o
250,0211-699501013259,056,o
250,0211-699501013259,p,o
250,0211-699501013259,0001,o
250,0211-699501013259,que,o
250,0211-699501013259,se,o
250,0211-699501013259,elevo,o
250,0211-699501013259,con,o
250,0211-699501013259,respecto,o
250,0211-699501013259,al,o
250,0211-699501013259,inicio,o
250,0211-699501013259,337,o
250,0211-699501013259,IC,o
250,0211-699501013259,327,o
250,0211-699501013259,346,o
250,0211-699501013259,vs,o
250,0211-699501013259,350,o
250,0211-699501013259,IC,o
250,0211-699501013259,337,o
250,0211-699501013259,363,o
250,0211-699501013259,p,o
250,0211-699501013259,005,o
250,0211-699501013259,Conclusion,o
250,0211-699501013259,Tras,o
250,0211-699501013259,suplementacion,i
250,0211-699501013259,con,o
250,0211-699501013259,acido,i
250,0211-699501013259,folico,i
250,0211-699501013259,y,o
250,0211-699501013259,vitamina,i
250,0211-699501013259,B6,i
250,0211-699501013259,aunque,o
250,0211-699501013259,inicialmente,o
250,0211-699501013259,se,o
250,0211-699501013259,reduce,o
250,0211-699501013259,la,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,esta,o
250,0211-699501013259,respuesta,o
250,0211-699501013259,se,o
250,0211-699501013259,hace,o
250,0211-699501013259,refractaria,o
250,0211-699501013259,correlacionandose,o
250,0211-699501013259,directamente,o
250,0211-699501013259,la,o
250,0211-699501013259,tHcy,i
250,0211-699501013259,con,o
250,0211-699501013259,la,o
250,0211-699501013259,albumina,i
250,0211-699501013259,plasmatica,i
250,0211-699501013259,La,o
250,0211-699501013259,interpretacion,o
250,0211-699501013259,de,o
250,0211-699501013259,los,o
250,0211-699501013259,niveles,i
250,0211-699501013259,de,i
250,0211-699501013259,tHcy,i
250,0211-699501013259,debe,o
250,0211-699501013259,tener,o
250,0211-699501013259,en,o
250,0211-699501013259,cuenta,o
250,0211-699501013259,la,o
250,0211-699501013259,concentracion,i
250,0211-699501013259,de,i
250,0211-699501013259,albumina,i
251,0211-699501013259,Efecto,o
251,0211-699501013259,de,o
251,0211-699501013259,la,o
251,0211-699501013259,suplementacion,i
251,0211-699501013259,con,o
251,0211-699501013259,acido,i
251,0211-699501013259,folico,i
251,0211-699501013259,sobre,o
251,0211-699501013259,los,o
251,0211-699501013259,niveles,i
251,0211-699501013259,de,i
251,0211-699501013259,homocisteina,i
251,0211-699501013259,total,o
251,0211-699501013259,en,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,en,o
251,0211-699501013259,hemodialisis,i
251,0211-699501013259,La,o
251,0211-699501013259,hiperhomocisteinemia,i
251,0211-699501013259,es,o
251,0211-699501013259,un,o
251,0211-699501013259,marcador,o
251,0211-699501013259,de,o
251,0211-699501013259,riesgo,o
251,0211-699501013259,independiente,o
251,0211-699501013259,de,o
251,0211-699501013259,morbimortalidad,o
251,0211-699501013259,cardiovascular,i
251,0211-699501013259,Hemos,o
251,0211-699501013259,intentado,o
251,0211-699501013259,prospectivamente,o
251,0211-699501013259,reducir,o
251,0211-699501013259,los,o
251,0211-699501013259,niveles,i
251,0211-699501013259,de,i
251,0211-699501013259,homocisteina,i
251,0211-699501013259,total,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,mediante,o
251,0211-699501013259,suplemento,o
251,0211-699501013259,con,o
251,0211-699501013259,acido,i
251,0211-699501013259,folico,i
251,0211-699501013259,y,o
251,0211-699501013259,vitamina,i
251,0211-699501013259,B6,i
251,0211-699501013259,pp,i
251,0211-699501013259,valorando,o
251,0211-699501013259,su,o
251,0211-699501013259,posible,o
251,0211-699501013259,correlacion,o
251,0211-699501013259,con,o
251,0211-699501013259,dosis,o
251,0211-699501013259,de,o
251,0211-699501013259,dialisis,i
251,0211-699501013259,funcion,i
251,0211-699501013259,residual,i
251,0211-699501013259,y,o
251,0211-699501013259,parametros,o
251,0211-699501013259,nutricionales,o
251,0211-699501013259,Metodos,o
251,0211-699501013259,Todos,o
251,0211-699501013259,los,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,en,o
251,0211-699501013259,hemodialisis,i
251,0211-699501013259,al,o
251,0211-699501013259,comienzo,o
251,0211-699501013259,del,o
251,0211-699501013259,estudio,o
251,0211-699501013259,que,o
251,0211-699501013259,no,o
251,0211-699501013259,recibian,o
251,0211-699501013259,acido,i
251,0211-699501013259,folico,i
251,0211-699501013259,ni,o
251,0211-699501013259,vitamina,i
251,0211-699501013259,B6,i
251,0211-699501013259,asi,o
251,0211-699501013259,como,o
251,0211-699501013259,los,o
251,0211-699501013259,incorporados,o
251,0211-699501013259,posteriormente,o
251,0211-699501013259,a,o
251,0211-699501013259,partir,o
251,0211-699501013259,de,o
251,0211-699501013259,su,o
251,0211-699501013259,tercer,o
251,0211-699501013259,mes,o
251,0211-699501013259,en,o
251,0211-699501013259,hemodialisis,i
251,0211-699501013259,recibieron,o
251,0211-699501013259,5,o
251,0211-699501013259,mg,o
251,0211-699501013259,orales,o
251,0211-699501013259,de,o
251,0211-699501013259,acido,i
251,0211-699501013259,folico,i
251,0211-699501013259,cada,o
251,0211-699501013259,48,o
251,0211-699501013259,horas,o
251,0211-699501013259,y,o
251,0211-699501013259,40,o
251,0211-699501013259,mg,o
251,0211-699501013259,orales,o
251,0211-699501013259,de,o
251,0211-699501013259,vitamina,i
251,0211-699501013259,B6,i
251,0211-699501013259,cada,o
251,0211-699501013259,semana,o
251,0211-699501013259,Se,o
251,0211-699501013259,determinaron,o
251,0211-699501013259,al,o
251,0211-699501013259,comienzo,o
251,0211-699501013259,del,o
251,0211-699501013259,estudio,o
251,0211-699501013259,y,o
251,0211-699501013259,cada,o
251,0211-699501013259,2,o
251,0211-699501013259,meses,o
251,0211-699501013259,niveles,i
251,0211-699501013259,de,i
251,0211-699501013259,folato,i
251,0211-699501013259,vitamina,i
251,0211-699501013259,B12,i
251,0211-699501013259,inmunoensayo,i
251,0211-699501013259,albumina,i
251,0211-699501013259,y,o
251,0211-699501013259,cinetica,o
251,0211-699501013259,de,o
251,0211-699501013259,la,o
251,0211-699501013259,urea,i
251,0211-699501013259,KTV,o
251,0211-699501013259,KRU,o
251,0211-699501013259,PCRn,o
251,0211-699501013259,y,o
251,0211-699501013259,cada,o
251,0211-699501013259,6,o
251,0211-699501013259,meses,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,HPLC,i
251,0211-699501013259,y,o
251,0211-699501013259,pp,i
251,0211-699501013259,RIA,i
251,0211-699501013259,Resultados,o
251,0211-699501013259,80,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,fueron,o
251,0211-699501013259,incluidos,o
251,0211-699501013259,en,o
251,0211-699501013259,el,o
251,0211-699501013259,estudio,o
251,0211-699501013259,basal,o
251,0211-699501013259,con,o
251,0211-699501013259,una,o
251,0211-699501013259,prevalencia,o
251,0211-699501013259,de,o
251,0211-699501013259,hiperhomocisteinemia,i
251,0211-699501013259,del,o
251,0211-699501013259,844,o
251,0211-699501013259,deficit,i
251,0211-699501013259,de,i
251,0211-699501013259,pp,i
251,0211-699501013259,en,o
251,0211-699501013259,el,o
251,0211-699501013259,32,o
251,0211-699501013259,y,o
251,0211-699501013259,folato,i
251,0211-699501013259,en,o
251,0211-699501013259,el,o
251,0211-699501013259,rango,o
251,0211-699501013259,normal,o
251,0211-699501013259,bajo,o
251,0211-699501013259,los,o
251,0211-699501013259,niveles,i
251,0211-699501013259,de,i
251,0211-699501013259,tHcy,i
251,0211-699501013259,se,o
251,0211-699501013259,correlacionaban,o
251,0211-699501013259,inversamente,o
251,0211-699501013259,con,o
251,0211-699501013259,los,o
251,0211-699501013259,del,o
251,0211-699501013259,folato,i
251,0211-699501013259,r,o
251,0211-699501013259,0336,o
251,0211-699501013259,p,o
251,0211-699501013259,001,o
251,0211-699501013259,pero,o
251,0211-699501013259,no,o
251,0211-699501013259,con,o
251,0211-699501013259,pp,i
251,0211-699501013259,B12,i
251,0211-699501013259,edad,o
251,0211-699501013259,albumina,i
251,0211-699501013259,KTV,o
251,0211-699501013259,KRU,o
251,0211-699501013259,PCRn,o
251,0211-699501013259,Cincuenta,o
251,0211-699501013259,y,o
251,0211-699501013259,ocho,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,recibieron,o
251,0211-699501013259,seis,o
251,0211-699501013259,meses,o
251,0211-699501013259,de,o
251,0211-699501013259,suplementacion,i
251,0211-699501013259,con,o
251,0211-699501013259,normalizacion,o
251,0211-699501013259,del,o
251,0211-699501013259,pp,i
251,0211-699501013259,aumento,o
251,0211-699501013259,del,o
251,0211-699501013259,folato,i
251,0211-699501013259,703,o
251,0211-699501013259,IC,o
251,0211-699501013259,638,o
251,0211-699501013259,795,o
251,0211-699501013259,vs,o
251,0211-699501013259,6181,o
251,0211-699501013259,IC,o
251,0211-699501013259,4447,o
251,0211-699501013259,7811,o
251,0211-699501013259,p,o
251,0211-699501013259,0001,o
251,0211-699501013259,y,o
251,0211-699501013259,descenso,o
251,0211-699501013259,de,o
251,0211-699501013259,la,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,240,o
251,0211-699501013259,IC,o
251,0211-699501013259,213,o
251,0211-699501013259,264,o
251,0211-699501013259,vs,o
251,0211-699501013259,199,o
251,0211-699501013259,IC,o
251,0211-699501013259,175,o
251,0211-699501013259,224,o
251,0211-699501013259,p,o
251,0211-699501013259,005,o
251,0211-699501013259,Han,o
251,0211-699501013259,recibido,o
251,0211-699501013259,suplementacion,i
251,0211-699501013259,durante,o
251,0211-699501013259,12,o
251,0211-699501013259,meses,o
251,0211-699501013259,33,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,pero,o
251,0211-699501013259,a,o
251,0211-699501013259,pesar,o
251,0211-699501013259,de,o
251,0211-699501013259,un,o
251,0211-699501013259,continuo,o
251,0211-699501013259,aumento,o
251,0211-699501013259,del,o
251,0211-699501013259,folato,i
251,0211-699501013259,10078,o
251,0211-699501013259,IC,o
251,0211-699501013259,7481,o
251,0211-699501013259,12674,o
251,0211-699501013259,p,o
251,0211-699501013259,0001,o
251,0211-699501013259,solo,o
251,0211-699501013259,3,o
251,0211-699501013259,pacientes,o
251,0211-699501013259,presentan,o
251,0211-699501013259,niveles,o
251,0211-699501013259,normales,o
251,0211-699501013259,de,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,correlacionandose,o
251,0211-699501013259,directamente,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,con,o
251,0211-699501013259,la,o
251,0211-699501013259,albumina,i
251,0211-699501013259,r,o
251,0211-699501013259,056,o
251,0211-699501013259,p,o
251,0211-699501013259,0001,o
251,0211-699501013259,que,o
251,0211-699501013259,se,o
251,0211-699501013259,elevo,o
251,0211-699501013259,con,o
251,0211-699501013259,respecto,o
251,0211-699501013259,al,o
251,0211-699501013259,inicio,o
251,0211-699501013259,337,o
251,0211-699501013259,IC,o
251,0211-699501013259,327,o
251,0211-699501013259,346,o
251,0211-699501013259,vs,o
251,0211-699501013259,350,o
251,0211-699501013259,IC,o
251,0211-699501013259,337,o
251,0211-699501013259,363,o
251,0211-699501013259,p,o
251,0211-699501013259,005,o
251,0211-699501013259,Conclusion,o
251,0211-699501013259,Tras,o
251,0211-699501013259,suplementacion,i
251,0211-699501013259,con,o
251,0211-699501013259,acido,i
251,0211-699501013259,folico,i
251,0211-699501013259,y,o
251,0211-699501013259,vitamina,i
251,0211-699501013259,B6,i
251,0211-699501013259,aunque,o
251,0211-699501013259,inicialmente,o
251,0211-699501013259,se,o
251,0211-699501013259,reduce,o
251,0211-699501013259,la,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,esta,o
251,0211-699501013259,respuesta,o
251,0211-699501013259,se,o
251,0211-699501013259,hace,o
251,0211-699501013259,refractaria,o
251,0211-699501013259,correlacionandose,o
251,0211-699501013259,directamente,o
251,0211-699501013259,la,o
251,0211-699501013259,tHcy,i
251,0211-699501013259,con,o
251,0211-699501013259,la,o
251,0211-699501013259,albumina,i
251,0211-699501013259,plasmatica,i
251,0211-699501013259,La,o
251,0211-699501013259,interpretacion,o
251,0211-699501013259,de,o
251,0211-699501013259,los,o
251,0211-699501013259,niveles,i
251,0211-699501013259,de,i
251,0211-699501013259,tHcy,i
251,0211-699501013259,debe,o
251,0211-699501013259,tener,o
251,0211-699501013259,en,o
251,0211-699501013259,cuenta,o
251,0211-699501013259,la,o
251,0211-699501013259,concentracion,i
251,0211-699501013259,de,i
251,0211-699501013259,albumina,i
252,0211-699501013259,Efecto,o
252,0211-699501013259,de,o
252,0211-699501013259,la,o
252,0211-699501013259,suplementacion,i
252,0211-699501013259,con,o
252,0211-699501013259,acido,i
252,0211-699501013259,folico,i
252,0211-699501013259,sobre,o
252,0211-699501013259,los,o
252,0211-699501013259,niveles,i
252,0211-699501013259,de,i
252,0211-699501013259,homocisteina,i
252,0211-699501013259,total,o
252,0211-699501013259,en,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,en,o
252,0211-699501013259,hemodialisis,i
252,0211-699501013259,La,o
252,0211-699501013259,hiperhomocisteinemia,i
252,0211-699501013259,es,o
252,0211-699501013259,un,o
252,0211-699501013259,marcador,o
252,0211-699501013259,de,o
252,0211-699501013259,riesgo,o
252,0211-699501013259,independiente,o
252,0211-699501013259,de,o
252,0211-699501013259,morbimortalidad,o
252,0211-699501013259,cardiovascular,i
252,0211-699501013259,Hemos,o
252,0211-699501013259,intentado,o
252,0211-699501013259,prospectivamente,o
252,0211-699501013259,reducir,o
252,0211-699501013259,los,o
252,0211-699501013259,niveles,i
252,0211-699501013259,de,i
252,0211-699501013259,homocisteina,i
252,0211-699501013259,total,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,mediante,o
252,0211-699501013259,suplemento,o
252,0211-699501013259,con,o
252,0211-699501013259,acido,i
252,0211-699501013259,folico,i
252,0211-699501013259,y,o
252,0211-699501013259,vitamina,i
252,0211-699501013259,B6,i
252,0211-699501013259,pp,i
252,0211-699501013259,valorando,o
252,0211-699501013259,su,o
252,0211-699501013259,posible,o
252,0211-699501013259,correlacion,o
252,0211-699501013259,con,o
252,0211-699501013259,dosis,o
252,0211-699501013259,de,o
252,0211-699501013259,dialisis,i
252,0211-699501013259,funcion,i
252,0211-699501013259,residual,i
252,0211-699501013259,y,o
252,0211-699501013259,parametros,o
252,0211-699501013259,nutricionales,o
252,0211-699501013259,Metodos,o
252,0211-699501013259,Todos,o
252,0211-699501013259,los,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,en,o
252,0211-699501013259,hemodialisis,i
252,0211-699501013259,al,o
252,0211-699501013259,comienzo,o
252,0211-699501013259,del,o
252,0211-699501013259,estudio,o
252,0211-699501013259,que,o
252,0211-699501013259,no,o
252,0211-699501013259,recibian,o
252,0211-699501013259,acido,i
252,0211-699501013259,folico,i
252,0211-699501013259,ni,o
252,0211-699501013259,vitamina,i
252,0211-699501013259,B6,i
252,0211-699501013259,asi,o
252,0211-699501013259,como,o
252,0211-699501013259,los,o
252,0211-699501013259,incorporados,o
252,0211-699501013259,posteriormente,o
252,0211-699501013259,a,o
252,0211-699501013259,partir,o
252,0211-699501013259,de,o
252,0211-699501013259,su,o
252,0211-699501013259,tercer,o
252,0211-699501013259,mes,o
252,0211-699501013259,en,o
252,0211-699501013259,hemodialisis,i
252,0211-699501013259,recibieron,o
252,0211-699501013259,5,o
252,0211-699501013259,mg,o
252,0211-699501013259,orales,o
252,0211-699501013259,de,o
252,0211-699501013259,acido,i
252,0211-699501013259,folico,i
252,0211-699501013259,cada,o
252,0211-699501013259,48,o
252,0211-699501013259,horas,o
252,0211-699501013259,y,o
252,0211-699501013259,40,o
252,0211-699501013259,mg,o
252,0211-699501013259,orales,o
252,0211-699501013259,de,o
252,0211-699501013259,vitamina,i
252,0211-699501013259,B6,i
252,0211-699501013259,cada,o
252,0211-699501013259,semana,o
252,0211-699501013259,Se,o
252,0211-699501013259,determinaron,o
252,0211-699501013259,al,o
252,0211-699501013259,comienzo,o
252,0211-699501013259,del,o
252,0211-699501013259,estudio,o
252,0211-699501013259,y,o
252,0211-699501013259,cada,o
252,0211-699501013259,2,o
252,0211-699501013259,meses,o
252,0211-699501013259,niveles,i
252,0211-699501013259,de,i
252,0211-699501013259,folato,i
252,0211-699501013259,vitamina,i
252,0211-699501013259,B12,i
252,0211-699501013259,inmunoensayo,i
252,0211-699501013259,albumina,i
252,0211-699501013259,y,o
252,0211-699501013259,cinetica,o
252,0211-699501013259,de,o
252,0211-699501013259,la,o
252,0211-699501013259,urea,i
252,0211-699501013259,KTV,o
252,0211-699501013259,KRU,o
252,0211-699501013259,PCRn,o
252,0211-699501013259,y,o
252,0211-699501013259,cada,o
252,0211-699501013259,6,o
252,0211-699501013259,meses,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,HPLC,i
252,0211-699501013259,y,o
252,0211-699501013259,pp,i
252,0211-699501013259,RIA,i
252,0211-699501013259,Resultados,o
252,0211-699501013259,80,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,fueron,o
252,0211-699501013259,incluidos,o
252,0211-699501013259,en,o
252,0211-699501013259,el,o
252,0211-699501013259,estudio,o
252,0211-699501013259,basal,o
252,0211-699501013259,con,o
252,0211-699501013259,una,o
252,0211-699501013259,prevalencia,o
252,0211-699501013259,de,o
252,0211-699501013259,hiperhomocisteinemia,i
252,0211-699501013259,del,o
252,0211-699501013259,844,o
252,0211-699501013259,deficit,i
252,0211-699501013259,de,i
252,0211-699501013259,pp,i
252,0211-699501013259,en,o
252,0211-699501013259,el,o
252,0211-699501013259,32,o
252,0211-699501013259,y,o
252,0211-699501013259,folato,i
252,0211-699501013259,en,o
252,0211-699501013259,el,o
252,0211-699501013259,rango,o
252,0211-699501013259,normal,o
252,0211-699501013259,bajo,o
252,0211-699501013259,los,o
252,0211-699501013259,niveles,i
252,0211-699501013259,de,i
252,0211-699501013259,tHcy,i
252,0211-699501013259,se,o
252,0211-699501013259,correlacionaban,o
252,0211-699501013259,inversamente,o
252,0211-699501013259,con,o
252,0211-699501013259,los,o
252,0211-699501013259,del,o
252,0211-699501013259,folato,i
252,0211-699501013259,r,o
252,0211-699501013259,0336,o
252,0211-699501013259,p,o
252,0211-699501013259,001,o
252,0211-699501013259,pero,o
252,0211-699501013259,no,o
252,0211-699501013259,con,o
252,0211-699501013259,pp,i
252,0211-699501013259,B12,i
252,0211-699501013259,edad,o
252,0211-699501013259,albumina,i
252,0211-699501013259,KTV,o
252,0211-699501013259,KRU,o
252,0211-699501013259,PCRn,o
252,0211-699501013259,Cincuenta,o
252,0211-699501013259,y,o
252,0211-699501013259,ocho,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,recibieron,o
252,0211-699501013259,seis,o
252,0211-699501013259,meses,o
252,0211-699501013259,de,o
252,0211-699501013259,suplementacion,i
252,0211-699501013259,con,o
252,0211-699501013259,normalizacion,o
252,0211-699501013259,del,o
252,0211-699501013259,pp,i
252,0211-699501013259,aumento,o
252,0211-699501013259,del,o
252,0211-699501013259,folato,i
252,0211-699501013259,703,o
252,0211-699501013259,IC,o
252,0211-699501013259,638,o
252,0211-699501013259,795,o
252,0211-699501013259,vs,o
252,0211-699501013259,6181,o
252,0211-699501013259,IC,o
252,0211-699501013259,4447,o
252,0211-699501013259,7811,o
252,0211-699501013259,p,o
252,0211-699501013259,0001,o
252,0211-699501013259,y,o
252,0211-699501013259,descenso,o
252,0211-699501013259,de,o
252,0211-699501013259,la,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,240,o
252,0211-699501013259,IC,o
252,0211-699501013259,213,o
252,0211-699501013259,264,o
252,0211-699501013259,vs,o
252,0211-699501013259,199,o
252,0211-699501013259,IC,o
252,0211-699501013259,175,o
252,0211-699501013259,224,o
252,0211-699501013259,p,o
252,0211-699501013259,005,o
252,0211-699501013259,Han,o
252,0211-699501013259,recibido,o
252,0211-699501013259,suplementacion,i
252,0211-699501013259,durante,o
252,0211-699501013259,12,o
252,0211-699501013259,meses,o
252,0211-699501013259,33,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,pero,o
252,0211-699501013259,a,o
252,0211-699501013259,pesar,o
252,0211-699501013259,de,o
252,0211-699501013259,un,o
252,0211-699501013259,continuo,o
252,0211-699501013259,aumento,o
252,0211-699501013259,del,o
252,0211-699501013259,folato,i
252,0211-699501013259,10078,o
252,0211-699501013259,IC,o
252,0211-699501013259,7481,o
252,0211-699501013259,12674,o
252,0211-699501013259,p,o
252,0211-699501013259,0001,o
252,0211-699501013259,solo,o
252,0211-699501013259,3,o
252,0211-699501013259,pacientes,o
252,0211-699501013259,presentan,o
252,0211-699501013259,niveles,o
252,0211-699501013259,normales,o
252,0211-699501013259,de,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,correlacionandose,o
252,0211-699501013259,directamente,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,con,o
252,0211-699501013259,la,o
252,0211-699501013259,albumina,i
252,0211-699501013259,r,o
252,0211-699501013259,056,o
252,0211-699501013259,p,o
252,0211-699501013259,0001,o
252,0211-699501013259,que,o
252,0211-699501013259,se,o
252,0211-699501013259,elevo,o
252,0211-699501013259,con,o
252,0211-699501013259,respecto,o
252,0211-699501013259,al,o
252,0211-699501013259,inicio,o
252,0211-699501013259,337,o
252,0211-699501013259,IC,o
252,0211-699501013259,327,o
252,0211-699501013259,346,o
252,0211-699501013259,vs,o
252,0211-699501013259,350,o
252,0211-699501013259,IC,o
252,0211-699501013259,337,o
252,0211-699501013259,363,o
252,0211-699501013259,p,o
252,0211-699501013259,005,o
252,0211-699501013259,Conclusion,o
252,0211-699501013259,Tras,o
252,0211-699501013259,suplementacion,i
252,0211-699501013259,con,o
252,0211-699501013259,acido,i
252,0211-699501013259,folico,i
252,0211-699501013259,y,o
252,0211-699501013259,vitamina,i
252,0211-699501013259,B6,i
252,0211-699501013259,aunque,o
252,0211-699501013259,inicialmente,o
252,0211-699501013259,se,o
252,0211-699501013259,reduce,o
252,0211-699501013259,la,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,esta,o
252,0211-699501013259,respuesta,o
252,0211-699501013259,se,o
252,0211-699501013259,hace,o
252,0211-699501013259,refractaria,o
252,0211-699501013259,correlacionandose,o
252,0211-699501013259,directamente,o
252,0211-699501013259,la,o
252,0211-699501013259,tHcy,i
252,0211-699501013259,con,o
252,0211-699501013259,la,o
252,0211-699501013259,albumina,i
252,0211-699501013259,plasmatica,i
252,0211-699501013259,La,o
252,0211-699501013259,interpretacion,o
252,0211-699501013259,de,o
252,0211-699501013259,los,o
252,0211-699501013259,niveles,i
252,0211-699501013259,de,i
252,0211-699501013259,tHcy,i
252,0211-699501013259,debe,o
252,0211-699501013259,tener,o
252,0211-699501013259,en,o
252,0211-699501013259,cuenta,o
252,0211-699501013259,la,o
252,0211-699501013259,concentracion,i
252,0211-699501013259,de,i
252,0211-699501013259,albumina,i
253,0211-699501013259,Efecto,o
253,0211-699501013259,de,o
253,0211-699501013259,la,o
253,0211-699501013259,suplementacion,i
253,0211-699501013259,con,o
253,0211-699501013259,acido,i
253,0211-699501013259,folico,i
253,0211-699501013259,sobre,o
253,0211-699501013259,los,o
253,0211-699501013259,niveles,i
253,0211-699501013259,de,i
253,0211-699501013259,homocisteina,i
253,0211-699501013259,total,o
253,0211-699501013259,en,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,en,o
253,0211-699501013259,hemodialisis,i
253,0211-699501013259,La,o
253,0211-699501013259,hiperhomocisteinemia,i
253,0211-699501013259,es,o
253,0211-699501013259,un,o
253,0211-699501013259,marcador,o
253,0211-699501013259,de,o
253,0211-699501013259,riesgo,o
253,0211-699501013259,independiente,o
253,0211-699501013259,de,o
253,0211-699501013259,morbimortalidad,o
253,0211-699501013259,cardiovascular,i
253,0211-699501013259,Hemos,o
253,0211-699501013259,intentado,o
253,0211-699501013259,prospectivamente,o
253,0211-699501013259,reducir,o
253,0211-699501013259,los,o
253,0211-699501013259,niveles,i
253,0211-699501013259,de,i
253,0211-699501013259,homocisteina,i
253,0211-699501013259,total,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,mediante,o
253,0211-699501013259,suplemento,o
253,0211-699501013259,con,o
253,0211-699501013259,acido,i
253,0211-699501013259,folico,i
253,0211-699501013259,y,o
253,0211-699501013259,vitamina,i
253,0211-699501013259,B6,i
253,0211-699501013259,pp,i
253,0211-699501013259,valorando,o
253,0211-699501013259,su,o
253,0211-699501013259,posible,o
253,0211-699501013259,correlacion,o
253,0211-699501013259,con,o
253,0211-699501013259,dosis,o
253,0211-699501013259,de,o
253,0211-699501013259,dialisis,i
253,0211-699501013259,funcion,i
253,0211-699501013259,residual,i
253,0211-699501013259,y,o
253,0211-699501013259,parametros,o
253,0211-699501013259,nutricionales,o
253,0211-699501013259,Metodos,o
253,0211-699501013259,Todos,o
253,0211-699501013259,los,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,en,o
253,0211-699501013259,hemodialisis,i
253,0211-699501013259,al,o
253,0211-699501013259,comienzo,o
253,0211-699501013259,del,o
253,0211-699501013259,estudio,o
253,0211-699501013259,que,o
253,0211-699501013259,no,o
253,0211-699501013259,recibian,o
253,0211-699501013259,acido,i
253,0211-699501013259,folico,i
253,0211-699501013259,ni,o
253,0211-699501013259,vitamina,i
253,0211-699501013259,B6,i
253,0211-699501013259,asi,o
253,0211-699501013259,como,o
253,0211-699501013259,los,o
253,0211-699501013259,incorporados,o
253,0211-699501013259,posteriormente,o
253,0211-699501013259,a,o
253,0211-699501013259,partir,o
253,0211-699501013259,de,o
253,0211-699501013259,su,o
253,0211-699501013259,tercer,o
253,0211-699501013259,mes,o
253,0211-699501013259,en,o
253,0211-699501013259,hemodialisis,i
253,0211-699501013259,recibieron,o
253,0211-699501013259,5,o
253,0211-699501013259,mg,o
253,0211-699501013259,orales,o
253,0211-699501013259,de,o
253,0211-699501013259,acido,i
253,0211-699501013259,folico,i
253,0211-699501013259,cada,o
253,0211-699501013259,48,o
253,0211-699501013259,horas,o
253,0211-699501013259,y,o
253,0211-699501013259,40,o
253,0211-699501013259,mg,o
253,0211-699501013259,orales,o
253,0211-699501013259,de,o
253,0211-699501013259,vitamina,i
253,0211-699501013259,B6,i
253,0211-699501013259,cada,o
253,0211-699501013259,semana,o
253,0211-699501013259,Se,o
253,0211-699501013259,determinaron,o
253,0211-699501013259,al,o
253,0211-699501013259,comienzo,o
253,0211-699501013259,del,o
253,0211-699501013259,estudio,o
253,0211-699501013259,y,o
253,0211-699501013259,cada,o
253,0211-699501013259,2,o
253,0211-699501013259,meses,o
253,0211-699501013259,niveles,i
253,0211-699501013259,de,i
253,0211-699501013259,folato,i
253,0211-699501013259,vitamina,i
253,0211-699501013259,B12,i
253,0211-699501013259,inmunoensayo,i
253,0211-699501013259,albumina,i
253,0211-699501013259,y,o
253,0211-699501013259,cinetica,o
253,0211-699501013259,de,o
253,0211-699501013259,la,o
253,0211-699501013259,urea,i
253,0211-699501013259,KTV,o
253,0211-699501013259,KRU,o
253,0211-699501013259,PCRn,o
253,0211-699501013259,y,o
253,0211-699501013259,cada,o
253,0211-699501013259,6,o
253,0211-699501013259,meses,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,HPLC,i
253,0211-699501013259,y,o
253,0211-699501013259,pp,i
253,0211-699501013259,RIA,i
253,0211-699501013259,Resultados,o
253,0211-699501013259,80,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,fueron,o
253,0211-699501013259,incluidos,o
253,0211-699501013259,en,o
253,0211-699501013259,el,o
253,0211-699501013259,estudio,o
253,0211-699501013259,basal,o
253,0211-699501013259,con,o
253,0211-699501013259,una,o
253,0211-699501013259,prevalencia,o
253,0211-699501013259,de,o
253,0211-699501013259,hiperhomocisteinemia,i
253,0211-699501013259,del,o
253,0211-699501013259,844,o
253,0211-699501013259,deficit,i
253,0211-699501013259,de,i
253,0211-699501013259,pp,i
253,0211-699501013259,en,o
253,0211-699501013259,el,o
253,0211-699501013259,32,o
253,0211-699501013259,y,o
253,0211-699501013259,folato,i
253,0211-699501013259,en,o
253,0211-699501013259,el,o
253,0211-699501013259,rango,o
253,0211-699501013259,normal,o
253,0211-699501013259,bajo,o
253,0211-699501013259,los,o
253,0211-699501013259,niveles,i
253,0211-699501013259,de,i
253,0211-699501013259,tHcy,i
253,0211-699501013259,se,o
253,0211-699501013259,correlacionaban,o
253,0211-699501013259,inversamente,o
253,0211-699501013259,con,o
253,0211-699501013259,los,o
253,0211-699501013259,del,o
253,0211-699501013259,folato,i
253,0211-699501013259,r,o
253,0211-699501013259,0336,o
253,0211-699501013259,p,o
253,0211-699501013259,001,o
253,0211-699501013259,pero,o
253,0211-699501013259,no,o
253,0211-699501013259,con,o
253,0211-699501013259,pp,i
253,0211-699501013259,B12,i
253,0211-699501013259,edad,o
253,0211-699501013259,albumina,i
253,0211-699501013259,KTV,o
253,0211-699501013259,KRU,o
253,0211-699501013259,PCRn,o
253,0211-699501013259,Cincuenta,o
253,0211-699501013259,y,o
253,0211-699501013259,ocho,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,recibieron,o
253,0211-699501013259,seis,o
253,0211-699501013259,meses,o
253,0211-699501013259,de,o
253,0211-699501013259,suplementacion,i
253,0211-699501013259,con,o
253,0211-699501013259,normalizacion,o
253,0211-699501013259,del,o
253,0211-699501013259,pp,i
253,0211-699501013259,aumento,o
253,0211-699501013259,del,o
253,0211-699501013259,folato,i
253,0211-699501013259,703,o
253,0211-699501013259,IC,o
253,0211-699501013259,638,o
253,0211-699501013259,795,o
253,0211-699501013259,vs,o
253,0211-699501013259,6181,o
253,0211-699501013259,IC,o
253,0211-699501013259,4447,o
253,0211-699501013259,7811,o
253,0211-699501013259,p,o
253,0211-699501013259,0001,o
253,0211-699501013259,y,o
253,0211-699501013259,descenso,o
253,0211-699501013259,de,o
253,0211-699501013259,la,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,240,o
253,0211-699501013259,IC,o
253,0211-699501013259,213,o
253,0211-699501013259,264,o
253,0211-699501013259,vs,o
253,0211-699501013259,199,o
253,0211-699501013259,IC,o
253,0211-699501013259,175,o
253,0211-699501013259,224,o
253,0211-699501013259,p,o
253,0211-699501013259,005,o
253,0211-699501013259,Han,o
253,0211-699501013259,recibido,o
253,0211-699501013259,suplementacion,i
253,0211-699501013259,durante,o
253,0211-699501013259,12,o
253,0211-699501013259,meses,o
253,0211-699501013259,33,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,pero,o
253,0211-699501013259,a,o
253,0211-699501013259,pesar,o
253,0211-699501013259,de,o
253,0211-699501013259,un,o
253,0211-699501013259,continuo,o
253,0211-699501013259,aumento,o
253,0211-699501013259,del,o
253,0211-699501013259,folato,i
253,0211-699501013259,10078,o
253,0211-699501013259,IC,o
253,0211-699501013259,7481,o
253,0211-699501013259,12674,o
253,0211-699501013259,p,o
253,0211-699501013259,0001,o
253,0211-699501013259,solo,o
253,0211-699501013259,3,o
253,0211-699501013259,pacientes,o
253,0211-699501013259,presentan,o
253,0211-699501013259,niveles,o
253,0211-699501013259,normales,o
253,0211-699501013259,de,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,correlacionandose,o
253,0211-699501013259,directamente,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,con,o
253,0211-699501013259,la,o
253,0211-699501013259,albumina,i
253,0211-699501013259,r,o
253,0211-699501013259,056,o
253,0211-699501013259,p,o
253,0211-699501013259,0001,o
253,0211-699501013259,que,o
253,0211-699501013259,se,o
253,0211-699501013259,elevo,o
253,0211-699501013259,con,o
253,0211-699501013259,respecto,o
253,0211-699501013259,al,o
253,0211-699501013259,inicio,o
253,0211-699501013259,337,o
253,0211-699501013259,IC,o
253,0211-699501013259,327,o
253,0211-699501013259,346,o
253,0211-699501013259,vs,o
253,0211-699501013259,350,o
253,0211-699501013259,IC,o
253,0211-699501013259,337,o
253,0211-699501013259,363,o
253,0211-699501013259,p,o
253,0211-699501013259,005,o
253,0211-699501013259,Conclusion,o
253,0211-699501013259,Tras,o
253,0211-699501013259,suplementacion,i
253,0211-699501013259,con,o
253,0211-699501013259,acido,i
253,0211-699501013259,folico,i
253,0211-699501013259,y,o
253,0211-699501013259,vitamina,i
253,0211-699501013259,B6,i
253,0211-699501013259,aunque,o
253,0211-699501013259,inicialmente,o
253,0211-699501013259,se,o
253,0211-699501013259,reduce,o
253,0211-699501013259,la,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,esta,o
253,0211-699501013259,respuesta,o
253,0211-699501013259,se,o
253,0211-699501013259,hace,o
253,0211-699501013259,refractaria,o
253,0211-699501013259,correlacionandose,o
253,0211-699501013259,directamente,o
253,0211-699501013259,la,o
253,0211-699501013259,tHcy,i
253,0211-699501013259,con,o
253,0211-699501013259,la,o
253,0211-699501013259,albumina,i
253,0211-699501013259,plasmatica,i
253,0211-699501013259,La,o
253,0211-699501013259,interpretacion,o
253,0211-699501013259,de,o
253,0211-699501013259,los,o
253,0211-699501013259,niveles,i
253,0211-699501013259,de,i
253,0211-699501013259,tHcy,i
253,0211-699501013259,debe,o
253,0211-699501013259,tener,o
253,0211-699501013259,en,o
253,0211-699501013259,cuenta,o
253,0211-699501013259,la,o
253,0211-699501013259,concentracion,i
253,0211-699501013259,de,i
253,0211-699501013259,albumina,i
254,0211-699501013259,Efecto,o
254,0211-699501013259,de,o
254,0211-699501013259,la,o
254,0211-699501013259,suplementacion,i
254,0211-699501013259,con,o
254,0211-699501013259,acido,i
254,0211-699501013259,folico,i
254,0211-699501013259,sobre,o
254,0211-699501013259,los,o
254,0211-699501013259,niveles,i
254,0211-699501013259,de,i
254,0211-699501013259,homocisteina,i
254,0211-699501013259,total,o
254,0211-699501013259,en,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,en,o
254,0211-699501013259,hemodialisis,i
254,0211-699501013259,La,o
254,0211-699501013259,hiperhomocisteinemia,i
254,0211-699501013259,es,o
254,0211-699501013259,un,o
254,0211-699501013259,marcador,o
254,0211-699501013259,de,o
254,0211-699501013259,riesgo,o
254,0211-699501013259,independiente,o
254,0211-699501013259,de,o
254,0211-699501013259,morbimortalidad,o
254,0211-699501013259,cardiovascular,i
254,0211-699501013259,Hemos,o
254,0211-699501013259,intentado,o
254,0211-699501013259,prospectivamente,o
254,0211-699501013259,reducir,o
254,0211-699501013259,los,o
254,0211-699501013259,niveles,i
254,0211-699501013259,de,i
254,0211-699501013259,homocisteina,i
254,0211-699501013259,total,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,mediante,o
254,0211-699501013259,suplemento,o
254,0211-699501013259,con,o
254,0211-699501013259,acido,i
254,0211-699501013259,folico,i
254,0211-699501013259,y,o
254,0211-699501013259,vitamina,i
254,0211-699501013259,B6,i
254,0211-699501013259,pp,i
254,0211-699501013259,valorando,o
254,0211-699501013259,su,o
254,0211-699501013259,posible,o
254,0211-699501013259,correlacion,o
254,0211-699501013259,con,o
254,0211-699501013259,dosis,o
254,0211-699501013259,de,o
254,0211-699501013259,dialisis,i
254,0211-699501013259,funcion,i
254,0211-699501013259,residual,i
254,0211-699501013259,y,o
254,0211-699501013259,parametros,o
254,0211-699501013259,nutricionales,o
254,0211-699501013259,Metodos,o
254,0211-699501013259,Todos,o
254,0211-699501013259,los,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,en,o
254,0211-699501013259,hemodialisis,i
254,0211-699501013259,al,o
254,0211-699501013259,comienzo,o
254,0211-699501013259,del,o
254,0211-699501013259,estudio,o
254,0211-699501013259,que,o
254,0211-699501013259,no,o
254,0211-699501013259,recibian,o
254,0211-699501013259,acido,i
254,0211-699501013259,folico,i
254,0211-699501013259,ni,o
254,0211-699501013259,vitamina,i
254,0211-699501013259,B6,i
254,0211-699501013259,asi,o
254,0211-699501013259,como,o
254,0211-699501013259,los,o
254,0211-699501013259,incorporados,o
254,0211-699501013259,posteriormente,o
254,0211-699501013259,a,o
254,0211-699501013259,partir,o
254,0211-699501013259,de,o
254,0211-699501013259,su,o
254,0211-699501013259,tercer,o
254,0211-699501013259,mes,o
254,0211-699501013259,en,o
254,0211-699501013259,hemodialisis,i
254,0211-699501013259,recibieron,o
254,0211-699501013259,5,o
254,0211-699501013259,mg,o
254,0211-699501013259,orales,o
254,0211-699501013259,de,o
254,0211-699501013259,acido,i
254,0211-699501013259,folico,i
254,0211-699501013259,cada,o
254,0211-699501013259,48,o
254,0211-699501013259,horas,o
254,0211-699501013259,y,o
254,0211-699501013259,40,o
254,0211-699501013259,mg,o
254,0211-699501013259,orales,o
254,0211-699501013259,de,o
254,0211-699501013259,vitamina,i
254,0211-699501013259,B6,i
254,0211-699501013259,cada,o
254,0211-699501013259,semana,o
254,0211-699501013259,Se,o
254,0211-699501013259,determinaron,o
254,0211-699501013259,al,o
254,0211-699501013259,comienzo,o
254,0211-699501013259,del,o
254,0211-699501013259,estudio,o
254,0211-699501013259,y,o
254,0211-699501013259,cada,o
254,0211-699501013259,2,o
254,0211-699501013259,meses,o
254,0211-699501013259,niveles,i
254,0211-699501013259,de,i
254,0211-699501013259,folato,i
254,0211-699501013259,vitamina,i
254,0211-699501013259,B12,i
254,0211-699501013259,inmunoensayo,i
254,0211-699501013259,albumina,i
254,0211-699501013259,y,o
254,0211-699501013259,cinetica,o
254,0211-699501013259,de,o
254,0211-699501013259,la,o
254,0211-699501013259,urea,i
254,0211-699501013259,KTV,o
254,0211-699501013259,KRU,o
254,0211-699501013259,PCRn,o
254,0211-699501013259,y,o
254,0211-699501013259,cada,o
254,0211-699501013259,6,o
254,0211-699501013259,meses,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,HPLC,i
254,0211-699501013259,y,o
254,0211-699501013259,pp,i
254,0211-699501013259,RIA,i
254,0211-699501013259,Resultados,o
254,0211-699501013259,80,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,fueron,o
254,0211-699501013259,incluidos,o
254,0211-699501013259,en,o
254,0211-699501013259,el,o
254,0211-699501013259,estudio,o
254,0211-699501013259,basal,o
254,0211-699501013259,con,o
254,0211-699501013259,una,o
254,0211-699501013259,prevalencia,o
254,0211-699501013259,de,o
254,0211-699501013259,hiperhomocisteinemia,i
254,0211-699501013259,del,o
254,0211-699501013259,844,o
254,0211-699501013259,deficit,i
254,0211-699501013259,de,i
254,0211-699501013259,pp,i
254,0211-699501013259,en,o
254,0211-699501013259,el,o
254,0211-699501013259,32,o
254,0211-699501013259,y,o
254,0211-699501013259,folato,i
254,0211-699501013259,en,o
254,0211-699501013259,el,o
254,0211-699501013259,rango,o
254,0211-699501013259,normal,o
254,0211-699501013259,bajo,o
254,0211-699501013259,los,o
254,0211-699501013259,niveles,i
254,0211-699501013259,de,i
254,0211-699501013259,tHcy,i
254,0211-699501013259,se,o
254,0211-699501013259,correlacionaban,o
254,0211-699501013259,inversamente,o
254,0211-699501013259,con,o
254,0211-699501013259,los,o
254,0211-699501013259,del,o
254,0211-699501013259,folato,i
254,0211-699501013259,r,o
254,0211-699501013259,0336,o
254,0211-699501013259,p,o
254,0211-699501013259,001,o
254,0211-699501013259,pero,o
254,0211-699501013259,no,o
254,0211-699501013259,con,o
254,0211-699501013259,pp,i
254,0211-699501013259,B12,i
254,0211-699501013259,edad,o
254,0211-699501013259,albumina,i
254,0211-699501013259,KTV,o
254,0211-699501013259,KRU,o
254,0211-699501013259,PCRn,o
254,0211-699501013259,Cincuenta,o
254,0211-699501013259,y,o
254,0211-699501013259,ocho,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,recibieron,o
254,0211-699501013259,seis,o
254,0211-699501013259,meses,o
254,0211-699501013259,de,o
254,0211-699501013259,suplementacion,i
254,0211-699501013259,con,o
254,0211-699501013259,normalizacion,o
254,0211-699501013259,del,o
254,0211-699501013259,pp,i
254,0211-699501013259,aumento,o
254,0211-699501013259,del,o
254,0211-699501013259,folato,i
254,0211-699501013259,703,o
254,0211-699501013259,IC,o
254,0211-699501013259,638,o
254,0211-699501013259,795,o
254,0211-699501013259,vs,o
254,0211-699501013259,6181,o
254,0211-699501013259,IC,o
254,0211-699501013259,4447,o
254,0211-699501013259,7811,o
254,0211-699501013259,p,o
254,0211-699501013259,0001,o
254,0211-699501013259,y,o
254,0211-699501013259,descenso,o
254,0211-699501013259,de,o
254,0211-699501013259,la,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,240,o
254,0211-699501013259,IC,o
254,0211-699501013259,213,o
254,0211-699501013259,264,o
254,0211-699501013259,vs,o
254,0211-699501013259,199,o
254,0211-699501013259,IC,o
254,0211-699501013259,175,o
254,0211-699501013259,224,o
254,0211-699501013259,p,o
254,0211-699501013259,005,o
254,0211-699501013259,Han,o
254,0211-699501013259,recibido,o
254,0211-699501013259,suplementacion,i
254,0211-699501013259,durante,o
254,0211-699501013259,12,o
254,0211-699501013259,meses,o
254,0211-699501013259,33,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,pero,o
254,0211-699501013259,a,o
254,0211-699501013259,pesar,o
254,0211-699501013259,de,o
254,0211-699501013259,un,o
254,0211-699501013259,continuo,o
254,0211-699501013259,aumento,o
254,0211-699501013259,del,o
254,0211-699501013259,folato,i
254,0211-699501013259,10078,o
254,0211-699501013259,IC,o
254,0211-699501013259,7481,o
254,0211-699501013259,12674,o
254,0211-699501013259,p,o
254,0211-699501013259,0001,o
254,0211-699501013259,solo,o
254,0211-699501013259,3,o
254,0211-699501013259,pacientes,o
254,0211-699501013259,presentan,o
254,0211-699501013259,niveles,o
254,0211-699501013259,normales,o
254,0211-699501013259,de,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,correlacionandose,o
254,0211-699501013259,directamente,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,con,o
254,0211-699501013259,la,o
254,0211-699501013259,albumina,i
254,0211-699501013259,r,o
254,0211-699501013259,056,o
254,0211-699501013259,p,o
254,0211-699501013259,0001,o
254,0211-699501013259,que,o
254,0211-699501013259,se,o
254,0211-699501013259,elevo,o
254,0211-699501013259,con,o
254,0211-699501013259,respecto,o
254,0211-699501013259,al,o
254,0211-699501013259,inicio,o
254,0211-699501013259,337,o
254,0211-699501013259,IC,o
254,0211-699501013259,327,o
254,0211-699501013259,346,o
254,0211-699501013259,vs,o
254,0211-699501013259,350,o
254,0211-699501013259,IC,o
254,0211-699501013259,337,o
254,0211-699501013259,363,o
254,0211-699501013259,p,o
254,0211-699501013259,005,o
254,0211-699501013259,Conclusion,o
254,0211-699501013259,Tras,o
254,0211-699501013259,suplementacion,i
254,0211-699501013259,con,o
254,0211-699501013259,acido,i
254,0211-699501013259,folico,i
254,0211-699501013259,y,o
254,0211-699501013259,vitamina,i
254,0211-699501013259,B6,i
254,0211-699501013259,aunque,o
254,0211-699501013259,inicialmente,o
254,0211-699501013259,se,o
254,0211-699501013259,reduce,o
254,0211-699501013259,la,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,esta,o
254,0211-699501013259,respuesta,o
254,0211-699501013259,se,o
254,0211-699501013259,hace,o
254,0211-699501013259,refractaria,o
254,0211-699501013259,correlacionandose,o
254,0211-699501013259,directamente,o
254,0211-699501013259,la,o
254,0211-699501013259,tHcy,i
254,0211-699501013259,con,o
254,0211-699501013259,la,o
254,0211-699501013259,albumina,i
254,0211-699501013259,plasmatica,i
254,0211-699501013259,La,o
254,0211-699501013259,interpretacion,o
254,0211-699501013259,de,o
254,0211-699501013259,los,o
254,0211-699501013259,niveles,i
254,0211-699501013259,de,i
254,0211-699501013259,tHcy,i
254,0211-699501013259,debe,o
254,0211-699501013259,tener,o
254,0211-699501013259,en,o
254,0211-699501013259,cuenta,o
254,0211-699501013259,la,o
254,0211-699501013259,concentracion,i
254,0211-699501013259,de,i
254,0211-699501013259,albumina,i
255,0211-699501013259,Efecto,o
255,0211-699501013259,de,o
255,0211-699501013259,la,o
255,0211-699501013259,suplementacion,i
255,0211-699501013259,con,o
255,0211-699501013259,acido,i
255,0211-699501013259,folico,i
255,0211-699501013259,sobre,o
255,0211-699501013259,los,o
255,0211-699501013259,niveles,i
255,0211-699501013259,de,i
255,0211-699501013259,homocisteina,i
255,0211-699501013259,total,o
255,0211-699501013259,en,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,en,o
255,0211-699501013259,hemodialisis,i
255,0211-699501013259,La,o
255,0211-699501013259,hiperhomocisteinemia,i
255,0211-699501013259,es,o
255,0211-699501013259,un,o
255,0211-699501013259,marcador,o
255,0211-699501013259,de,o
255,0211-699501013259,riesgo,o
255,0211-699501013259,independiente,o
255,0211-699501013259,de,o
255,0211-699501013259,morbimortalidad,o
255,0211-699501013259,cardiovascular,i
255,0211-699501013259,Hemos,o
255,0211-699501013259,intentado,o
255,0211-699501013259,prospectivamente,o
255,0211-699501013259,reducir,o
255,0211-699501013259,los,o
255,0211-699501013259,niveles,i
255,0211-699501013259,de,i
255,0211-699501013259,homocisteina,i
255,0211-699501013259,total,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,mediante,o
255,0211-699501013259,suplemento,o
255,0211-699501013259,con,o
255,0211-699501013259,acido,i
255,0211-699501013259,folico,i
255,0211-699501013259,y,o
255,0211-699501013259,vitamina,i
255,0211-699501013259,B6,i
255,0211-699501013259,pp,i
255,0211-699501013259,valorando,o
255,0211-699501013259,su,o
255,0211-699501013259,posible,o
255,0211-699501013259,correlacion,o
255,0211-699501013259,con,o
255,0211-699501013259,dosis,o
255,0211-699501013259,de,o
255,0211-699501013259,dialisis,i
255,0211-699501013259,funcion,i
255,0211-699501013259,residual,i
255,0211-699501013259,y,o
255,0211-699501013259,parametros,o
255,0211-699501013259,nutricionales,o
255,0211-699501013259,Metodos,o
255,0211-699501013259,Todos,o
255,0211-699501013259,los,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,en,o
255,0211-699501013259,hemodialisis,i
255,0211-699501013259,al,o
255,0211-699501013259,comienzo,o
255,0211-699501013259,del,o
255,0211-699501013259,estudio,o
255,0211-699501013259,que,o
255,0211-699501013259,no,o
255,0211-699501013259,recibian,o
255,0211-699501013259,acido,i
255,0211-699501013259,folico,i
255,0211-699501013259,ni,o
255,0211-699501013259,vitamina,i
255,0211-699501013259,B6,i
255,0211-699501013259,asi,o
255,0211-699501013259,como,o
255,0211-699501013259,los,o
255,0211-699501013259,incorporados,o
255,0211-699501013259,posteriormente,o
255,0211-699501013259,a,o
255,0211-699501013259,partir,o
255,0211-699501013259,de,o
255,0211-699501013259,su,o
255,0211-699501013259,tercer,o
255,0211-699501013259,mes,o
255,0211-699501013259,en,o
255,0211-699501013259,hemodialisis,i
255,0211-699501013259,recibieron,o
255,0211-699501013259,5,o
255,0211-699501013259,mg,o
255,0211-699501013259,orales,o
255,0211-699501013259,de,o
255,0211-699501013259,acido,i
255,0211-699501013259,folico,i
255,0211-699501013259,cada,o
255,0211-699501013259,48,o
255,0211-699501013259,horas,o
255,0211-699501013259,y,o
255,0211-699501013259,40,o
255,0211-699501013259,mg,o
255,0211-699501013259,orales,o
255,0211-699501013259,de,o
255,0211-699501013259,vitamina,i
255,0211-699501013259,B6,i
255,0211-699501013259,cada,o
255,0211-699501013259,semana,o
255,0211-699501013259,Se,o
255,0211-699501013259,determinaron,o
255,0211-699501013259,al,o
255,0211-699501013259,comienzo,o
255,0211-699501013259,del,o
255,0211-699501013259,estudio,o
255,0211-699501013259,y,o
255,0211-699501013259,cada,o
255,0211-699501013259,2,o
255,0211-699501013259,meses,o
255,0211-699501013259,niveles,i
255,0211-699501013259,de,i
255,0211-699501013259,folato,i
255,0211-699501013259,vitamina,i
255,0211-699501013259,B12,i
255,0211-699501013259,inmunoensayo,i
255,0211-699501013259,albumina,i
255,0211-699501013259,y,o
255,0211-699501013259,cinetica,o
255,0211-699501013259,de,o
255,0211-699501013259,la,o
255,0211-699501013259,urea,i
255,0211-699501013259,KTV,o
255,0211-699501013259,KRU,o
255,0211-699501013259,PCRn,o
255,0211-699501013259,y,o
255,0211-699501013259,cada,o
255,0211-699501013259,6,o
255,0211-699501013259,meses,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,HPLC,i
255,0211-699501013259,y,o
255,0211-699501013259,pp,i
255,0211-699501013259,RIA,i
255,0211-699501013259,Resultados,o
255,0211-699501013259,80,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,fueron,o
255,0211-699501013259,incluidos,o
255,0211-699501013259,en,o
255,0211-699501013259,el,o
255,0211-699501013259,estudio,o
255,0211-699501013259,basal,o
255,0211-699501013259,con,o
255,0211-699501013259,una,o
255,0211-699501013259,prevalencia,o
255,0211-699501013259,de,o
255,0211-699501013259,hiperhomocisteinemia,i
255,0211-699501013259,del,o
255,0211-699501013259,844,o
255,0211-699501013259,deficit,i
255,0211-699501013259,de,i
255,0211-699501013259,pp,i
255,0211-699501013259,en,o
255,0211-699501013259,el,o
255,0211-699501013259,32,o
255,0211-699501013259,y,o
255,0211-699501013259,folato,i
255,0211-699501013259,en,o
255,0211-699501013259,el,o
255,0211-699501013259,rango,o
255,0211-699501013259,normal,o
255,0211-699501013259,bajo,o
255,0211-699501013259,los,o
255,0211-699501013259,niveles,i
255,0211-699501013259,de,i
255,0211-699501013259,tHcy,i
255,0211-699501013259,se,o
255,0211-699501013259,correlacionaban,o
255,0211-699501013259,inversamente,o
255,0211-699501013259,con,o
255,0211-699501013259,los,o
255,0211-699501013259,del,o
255,0211-699501013259,folato,i
255,0211-699501013259,r,o
255,0211-699501013259,0336,o
255,0211-699501013259,p,o
255,0211-699501013259,001,o
255,0211-699501013259,pero,o
255,0211-699501013259,no,o
255,0211-699501013259,con,o
255,0211-699501013259,pp,i
255,0211-699501013259,B12,i
255,0211-699501013259,edad,o
255,0211-699501013259,albumina,i
255,0211-699501013259,KTV,o
255,0211-699501013259,KRU,o
255,0211-699501013259,PCRn,o
255,0211-699501013259,Cincuenta,o
255,0211-699501013259,y,o
255,0211-699501013259,ocho,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,recibieron,o
255,0211-699501013259,seis,o
255,0211-699501013259,meses,o
255,0211-699501013259,de,o
255,0211-699501013259,suplementacion,i
255,0211-699501013259,con,o
255,0211-699501013259,normalizacion,o
255,0211-699501013259,del,o
255,0211-699501013259,pp,i
255,0211-699501013259,aumento,o
255,0211-699501013259,del,o
255,0211-699501013259,folato,i
255,0211-699501013259,703,o
255,0211-699501013259,IC,o
255,0211-699501013259,638,o
255,0211-699501013259,795,o
255,0211-699501013259,vs,o
255,0211-699501013259,6181,o
255,0211-699501013259,IC,o
255,0211-699501013259,4447,o
255,0211-699501013259,7811,o
255,0211-699501013259,p,o
255,0211-699501013259,0001,o
255,0211-699501013259,y,o
255,0211-699501013259,descenso,o
255,0211-699501013259,de,o
255,0211-699501013259,la,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,240,o
255,0211-699501013259,IC,o
255,0211-699501013259,213,o
255,0211-699501013259,264,o
255,0211-699501013259,vs,o
255,0211-699501013259,199,o
255,0211-699501013259,IC,o
255,0211-699501013259,175,o
255,0211-699501013259,224,o
255,0211-699501013259,p,o
255,0211-699501013259,005,o
255,0211-699501013259,Han,o
255,0211-699501013259,recibido,o
255,0211-699501013259,suplementacion,i
255,0211-699501013259,durante,o
255,0211-699501013259,12,o
255,0211-699501013259,meses,o
255,0211-699501013259,33,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,pero,o
255,0211-699501013259,a,o
255,0211-699501013259,pesar,o
255,0211-699501013259,de,o
255,0211-699501013259,un,o
255,0211-699501013259,continuo,o
255,0211-699501013259,aumento,o
255,0211-699501013259,del,o
255,0211-699501013259,folato,i
255,0211-699501013259,10078,o
255,0211-699501013259,IC,o
255,0211-699501013259,7481,o
255,0211-699501013259,12674,o
255,0211-699501013259,p,o
255,0211-699501013259,0001,o
255,0211-699501013259,solo,o
255,0211-699501013259,3,o
255,0211-699501013259,pacientes,o
255,0211-699501013259,presentan,o
255,0211-699501013259,niveles,o
255,0211-699501013259,normales,o
255,0211-699501013259,de,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,correlacionandose,o
255,0211-699501013259,directamente,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,con,o
255,0211-699501013259,la,o
255,0211-699501013259,albumina,i
255,0211-699501013259,r,o
255,0211-699501013259,056,o
255,0211-699501013259,p,o
255,0211-699501013259,0001,o
255,0211-699501013259,que,o
255,0211-699501013259,se,o
255,0211-699501013259,elevo,o
255,0211-699501013259,con,o
255,0211-699501013259,respecto,o
255,0211-699501013259,al,o
255,0211-699501013259,inicio,o
255,0211-699501013259,337,o
255,0211-699501013259,IC,o
255,0211-699501013259,327,o
255,0211-699501013259,346,o
255,0211-699501013259,vs,o
255,0211-699501013259,350,o
255,0211-699501013259,IC,o
255,0211-699501013259,337,o
255,0211-699501013259,363,o
255,0211-699501013259,p,o
255,0211-699501013259,005,o
255,0211-699501013259,Conclusion,o
255,0211-699501013259,Tras,o
255,0211-699501013259,suplementacion,i
255,0211-699501013259,con,o
255,0211-699501013259,acido,i
255,0211-699501013259,folico,i
255,0211-699501013259,y,o
255,0211-699501013259,vitamina,i
255,0211-699501013259,B6,i
255,0211-699501013259,aunque,o
255,0211-699501013259,inicialmente,o
255,0211-699501013259,se,o
255,0211-699501013259,reduce,o
255,0211-699501013259,la,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,esta,o
255,0211-699501013259,respuesta,o
255,0211-699501013259,se,o
255,0211-699501013259,hace,o
255,0211-699501013259,refractaria,o
255,0211-699501013259,correlacionandose,o
255,0211-699501013259,directamente,o
255,0211-699501013259,la,o
255,0211-699501013259,tHcy,i
255,0211-699501013259,con,o
255,0211-699501013259,la,o
255,0211-699501013259,albumina,i
255,0211-699501013259,plasmatica,i
255,0211-699501013259,La,o
255,0211-699501013259,interpretacion,o
255,0211-699501013259,de,o
255,0211-699501013259,los,o
255,0211-699501013259,niveles,i
255,0211-699501013259,de,i
255,0211-699501013259,tHcy,i
255,0211-699501013259,debe,o
255,0211-699501013259,tener,o
255,0211-699501013259,en,o
255,0211-699501013259,cuenta,o
255,0211-699501013259,la,o
255,0211-699501013259,concentracion,i
255,0211-699501013259,de,i
255,0211-699501013259,albumina,i
256,0211-699501013259,Efecto,o
256,0211-699501013259,de,o
256,0211-699501013259,la,o
256,0211-699501013259,suplementacion,i
256,0211-699501013259,con,o
256,0211-699501013259,acido,i
256,0211-699501013259,folico,i
256,0211-699501013259,sobre,o
256,0211-699501013259,los,o
256,0211-699501013259,niveles,i
256,0211-699501013259,de,i
256,0211-699501013259,homocisteina,i
256,0211-699501013259,total,o
256,0211-699501013259,en,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,en,o
256,0211-699501013259,hemodialisis,i
256,0211-699501013259,La,o
256,0211-699501013259,hiperhomocisteinemia,i
256,0211-699501013259,es,o
256,0211-699501013259,un,o
256,0211-699501013259,marcador,o
256,0211-699501013259,de,o
256,0211-699501013259,riesgo,o
256,0211-699501013259,independiente,o
256,0211-699501013259,de,o
256,0211-699501013259,morbimortalidad,o
256,0211-699501013259,cardiovascular,i
256,0211-699501013259,Hemos,o
256,0211-699501013259,intentado,o
256,0211-699501013259,prospectivamente,o
256,0211-699501013259,reducir,o
256,0211-699501013259,los,o
256,0211-699501013259,niveles,i
256,0211-699501013259,de,i
256,0211-699501013259,homocisteina,i
256,0211-699501013259,total,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,mediante,o
256,0211-699501013259,suplemento,o
256,0211-699501013259,con,o
256,0211-699501013259,acido,i
256,0211-699501013259,folico,i
256,0211-699501013259,y,o
256,0211-699501013259,vitamina,i
256,0211-699501013259,B6,i
256,0211-699501013259,pp,i
256,0211-699501013259,valorando,o
256,0211-699501013259,su,o
256,0211-699501013259,posible,o
256,0211-699501013259,correlacion,o
256,0211-699501013259,con,o
256,0211-699501013259,dosis,o
256,0211-699501013259,de,o
256,0211-699501013259,dialisis,i
256,0211-699501013259,funcion,i
256,0211-699501013259,residual,i
256,0211-699501013259,y,o
256,0211-699501013259,parametros,o
256,0211-699501013259,nutricionales,o
256,0211-699501013259,Metodos,o
256,0211-699501013259,Todos,o
256,0211-699501013259,los,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,en,o
256,0211-699501013259,hemodialisis,i
256,0211-699501013259,al,o
256,0211-699501013259,comienzo,o
256,0211-699501013259,del,o
256,0211-699501013259,estudio,o
256,0211-699501013259,que,o
256,0211-699501013259,no,o
256,0211-699501013259,recibian,o
256,0211-699501013259,acido,i
256,0211-699501013259,folico,i
256,0211-699501013259,ni,o
256,0211-699501013259,vitamina,i
256,0211-699501013259,B6,i
256,0211-699501013259,asi,o
256,0211-699501013259,como,o
256,0211-699501013259,los,o
256,0211-699501013259,incorporados,o
256,0211-699501013259,posteriormente,o
256,0211-699501013259,a,o
256,0211-699501013259,partir,o
256,0211-699501013259,de,o
256,0211-699501013259,su,o
256,0211-699501013259,tercer,o
256,0211-699501013259,mes,o
256,0211-699501013259,en,o
256,0211-699501013259,hemodialisis,i
256,0211-699501013259,recibieron,o
256,0211-699501013259,5,o
256,0211-699501013259,mg,o
256,0211-699501013259,orales,o
256,0211-699501013259,de,o
256,0211-699501013259,acido,i
256,0211-699501013259,folico,i
256,0211-699501013259,cada,o
256,0211-699501013259,48,o
256,0211-699501013259,horas,o
256,0211-699501013259,y,o
256,0211-699501013259,40,o
256,0211-699501013259,mg,o
256,0211-699501013259,orales,o
256,0211-699501013259,de,o
256,0211-699501013259,vitamina,i
256,0211-699501013259,B6,i
256,0211-699501013259,cada,o
256,0211-699501013259,semana,o
256,0211-699501013259,Se,o
256,0211-699501013259,determinaron,o
256,0211-699501013259,al,o
256,0211-699501013259,comienzo,o
256,0211-699501013259,del,o
256,0211-699501013259,estudio,o
256,0211-699501013259,y,o
256,0211-699501013259,cada,o
256,0211-699501013259,2,o
256,0211-699501013259,meses,o
256,0211-699501013259,niveles,i
256,0211-699501013259,de,i
256,0211-699501013259,folato,i
256,0211-699501013259,vitamina,i
256,0211-699501013259,B12,i
256,0211-699501013259,inmunoensayo,i
256,0211-699501013259,albumina,i
256,0211-699501013259,y,o
256,0211-699501013259,cinetica,o
256,0211-699501013259,de,o
256,0211-699501013259,la,o
256,0211-699501013259,urea,i
256,0211-699501013259,KTV,o
256,0211-699501013259,KRU,o
256,0211-699501013259,PCRn,o
256,0211-699501013259,y,o
256,0211-699501013259,cada,o
256,0211-699501013259,6,o
256,0211-699501013259,meses,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,HPLC,i
256,0211-699501013259,y,o
256,0211-699501013259,pp,i
256,0211-699501013259,RIA,i
256,0211-699501013259,Resultados,o
256,0211-699501013259,80,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,fueron,o
256,0211-699501013259,incluidos,o
256,0211-699501013259,en,o
256,0211-699501013259,el,o
256,0211-699501013259,estudio,o
256,0211-699501013259,basal,o
256,0211-699501013259,con,o
256,0211-699501013259,una,o
256,0211-699501013259,prevalencia,o
256,0211-699501013259,de,o
256,0211-699501013259,hiperhomocisteinemia,i
256,0211-699501013259,del,o
256,0211-699501013259,844,o
256,0211-699501013259,deficit,i
256,0211-699501013259,de,i
256,0211-699501013259,pp,i
256,0211-699501013259,en,o
256,0211-699501013259,el,o
256,0211-699501013259,32,o
256,0211-699501013259,y,o
256,0211-699501013259,folato,i
256,0211-699501013259,en,o
256,0211-699501013259,el,o
256,0211-699501013259,rango,o
256,0211-699501013259,normal,o
256,0211-699501013259,bajo,o
256,0211-699501013259,los,o
256,0211-699501013259,niveles,i
256,0211-699501013259,de,i
256,0211-699501013259,tHcy,i
256,0211-699501013259,se,o
256,0211-699501013259,correlacionaban,o
256,0211-699501013259,inversamente,o
256,0211-699501013259,con,o
256,0211-699501013259,los,o
256,0211-699501013259,del,o
256,0211-699501013259,folato,i
256,0211-699501013259,r,o
256,0211-699501013259,0336,o
256,0211-699501013259,p,o
256,0211-699501013259,001,o
256,0211-699501013259,pero,o
256,0211-699501013259,no,o
256,0211-699501013259,con,o
256,0211-699501013259,pp,i
256,0211-699501013259,B12,i
256,0211-699501013259,edad,o
256,0211-699501013259,albumina,i
256,0211-699501013259,KTV,o
256,0211-699501013259,KRU,o
256,0211-699501013259,PCRn,o
256,0211-699501013259,Cincuenta,o
256,0211-699501013259,y,o
256,0211-699501013259,ocho,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,recibieron,o
256,0211-699501013259,seis,o
256,0211-699501013259,meses,o
256,0211-699501013259,de,o
256,0211-699501013259,suplementacion,i
256,0211-699501013259,con,o
256,0211-699501013259,normalizacion,o
256,0211-699501013259,del,o
256,0211-699501013259,pp,i
256,0211-699501013259,aumento,o
256,0211-699501013259,del,o
256,0211-699501013259,folato,i
256,0211-699501013259,703,o
256,0211-699501013259,IC,o
256,0211-699501013259,638,o
256,0211-699501013259,795,o
256,0211-699501013259,vs,o
256,0211-699501013259,6181,o
256,0211-699501013259,IC,o
256,0211-699501013259,4447,o
256,0211-699501013259,7811,o
256,0211-699501013259,p,o
256,0211-699501013259,0001,o
256,0211-699501013259,y,o
256,0211-699501013259,descenso,o
256,0211-699501013259,de,o
256,0211-699501013259,la,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,240,o
256,0211-699501013259,IC,o
256,0211-699501013259,213,o
256,0211-699501013259,264,o
256,0211-699501013259,vs,o
256,0211-699501013259,199,o
256,0211-699501013259,IC,o
256,0211-699501013259,175,o
256,0211-699501013259,224,o
256,0211-699501013259,p,o
256,0211-699501013259,005,o
256,0211-699501013259,Han,o
256,0211-699501013259,recibido,o
256,0211-699501013259,suplementacion,i
256,0211-699501013259,durante,o
256,0211-699501013259,12,o
256,0211-699501013259,meses,o
256,0211-699501013259,33,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,pero,o
256,0211-699501013259,a,o
256,0211-699501013259,pesar,o
256,0211-699501013259,de,o
256,0211-699501013259,un,o
256,0211-699501013259,continuo,o
256,0211-699501013259,aumento,o
256,0211-699501013259,del,o
256,0211-699501013259,folato,i
256,0211-699501013259,10078,o
256,0211-699501013259,IC,o
256,0211-699501013259,7481,o
256,0211-699501013259,12674,o
256,0211-699501013259,p,o
256,0211-699501013259,0001,o
256,0211-699501013259,solo,o
256,0211-699501013259,3,o
256,0211-699501013259,pacientes,o
256,0211-699501013259,presentan,o
256,0211-699501013259,niveles,o
256,0211-699501013259,normales,o
256,0211-699501013259,de,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,correlacionandose,o
256,0211-699501013259,directamente,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,con,o
256,0211-699501013259,la,o
256,0211-699501013259,albumina,i
256,0211-699501013259,r,o
256,0211-699501013259,056,o
256,0211-699501013259,p,o
256,0211-699501013259,0001,o
256,0211-699501013259,que,o
256,0211-699501013259,se,o
256,0211-699501013259,elevo,o
256,0211-699501013259,con,o
256,0211-699501013259,respecto,o
256,0211-699501013259,al,o
256,0211-699501013259,inicio,o
256,0211-699501013259,337,o
256,0211-699501013259,IC,o
256,0211-699501013259,327,o
256,0211-699501013259,346,o
256,0211-699501013259,vs,o
256,0211-699501013259,350,o
256,0211-699501013259,IC,o
256,0211-699501013259,337,o
256,0211-699501013259,363,o
256,0211-699501013259,p,o
256,0211-699501013259,005,o
256,0211-699501013259,Conclusion,o
256,0211-699501013259,Tras,o
256,0211-699501013259,suplementacion,i
256,0211-699501013259,con,o
256,0211-699501013259,acido,i
256,0211-699501013259,folico,i
256,0211-699501013259,y,o
256,0211-699501013259,vitamina,i
256,0211-699501013259,B6,i
256,0211-699501013259,aunque,o
256,0211-699501013259,inicialmente,o
256,0211-699501013259,se,o
256,0211-699501013259,reduce,o
256,0211-699501013259,la,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,esta,o
256,0211-699501013259,respuesta,o
256,0211-699501013259,se,o
256,0211-699501013259,hace,o
256,0211-699501013259,refractaria,o
256,0211-699501013259,correlacionandose,o
256,0211-699501013259,directamente,o
256,0211-699501013259,la,o
256,0211-699501013259,tHcy,i
256,0211-699501013259,con,o
256,0211-699501013259,la,o
256,0211-699501013259,albumina,i
256,0211-699501013259,plasmatica,i
256,0211-699501013259,La,o
256,0211-699501013259,interpretacion,o
256,0211-699501013259,de,o
256,0211-699501013259,los,o
256,0211-699501013259,niveles,i
256,0211-699501013259,de,i
256,0211-699501013259,tHcy,i
256,0211-699501013259,debe,o
256,0211-699501013259,tener,o
256,0211-699501013259,en,o
256,0211-699501013259,cuenta,o
256,0211-699501013259,la,o
256,0211-699501013259,concentracion,i
256,0211-699501013259,de,i
256,0211-699501013259,albumina,i
257,0211-699501013259,Efecto,o
257,0211-699501013259,de,o
257,0211-699501013259,la,o
257,0211-699501013259,suplementacion,i
257,0211-699501013259,con,o
257,0211-699501013259,acido,i
257,0211-699501013259,folico,i
257,0211-699501013259,sobre,o
257,0211-699501013259,los,o
257,0211-699501013259,niveles,i
257,0211-699501013259,de,i
257,0211-699501013259,homocisteina,i
257,0211-699501013259,total,o
257,0211-699501013259,en,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,en,o
257,0211-699501013259,hemodialisis,i
257,0211-699501013259,La,o
257,0211-699501013259,hiperhomocisteinemia,i
257,0211-699501013259,es,o
257,0211-699501013259,un,o
257,0211-699501013259,marcador,o
257,0211-699501013259,de,o
257,0211-699501013259,riesgo,o
257,0211-699501013259,independiente,o
257,0211-699501013259,de,o
257,0211-699501013259,morbimortalidad,o
257,0211-699501013259,cardiovascular,i
257,0211-699501013259,Hemos,o
257,0211-699501013259,intentado,o
257,0211-699501013259,prospectivamente,o
257,0211-699501013259,reducir,o
257,0211-699501013259,los,o
257,0211-699501013259,niveles,i
257,0211-699501013259,de,i
257,0211-699501013259,homocisteina,i
257,0211-699501013259,total,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,mediante,o
257,0211-699501013259,suplemento,o
257,0211-699501013259,con,o
257,0211-699501013259,acido,i
257,0211-699501013259,folico,i
257,0211-699501013259,y,o
257,0211-699501013259,vitamina,i
257,0211-699501013259,B6,i
257,0211-699501013259,pp,i
257,0211-699501013259,valorando,o
257,0211-699501013259,su,o
257,0211-699501013259,posible,o
257,0211-699501013259,correlacion,o
257,0211-699501013259,con,o
257,0211-699501013259,dosis,o
257,0211-699501013259,de,o
257,0211-699501013259,dialisis,i
257,0211-699501013259,funcion,i
257,0211-699501013259,residual,i
257,0211-699501013259,y,o
257,0211-699501013259,parametros,o
257,0211-699501013259,nutricionales,o
257,0211-699501013259,Metodos,o
257,0211-699501013259,Todos,o
257,0211-699501013259,los,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,en,o
257,0211-699501013259,hemodialisis,i
257,0211-699501013259,al,o
257,0211-699501013259,comienzo,o
257,0211-699501013259,del,o
257,0211-699501013259,estudio,o
257,0211-699501013259,que,o
257,0211-699501013259,no,o
257,0211-699501013259,recibian,o
257,0211-699501013259,acido,i
257,0211-699501013259,folico,i
257,0211-699501013259,ni,o
257,0211-699501013259,vitamina,i
257,0211-699501013259,B6,i
257,0211-699501013259,asi,o
257,0211-699501013259,como,o
257,0211-699501013259,los,o
257,0211-699501013259,incorporados,o
257,0211-699501013259,posteriormente,o
257,0211-699501013259,a,o
257,0211-699501013259,partir,o
257,0211-699501013259,de,o
257,0211-699501013259,su,o
257,0211-699501013259,tercer,o
257,0211-699501013259,mes,o
257,0211-699501013259,en,o
257,0211-699501013259,hemodialisis,i
257,0211-699501013259,recibieron,o
257,0211-699501013259,5,o
257,0211-699501013259,mg,o
257,0211-699501013259,orales,o
257,0211-699501013259,de,o
257,0211-699501013259,acido,i
257,0211-699501013259,folico,i
257,0211-699501013259,cada,o
257,0211-699501013259,48,o
257,0211-699501013259,horas,o
257,0211-699501013259,y,o
257,0211-699501013259,40,o
257,0211-699501013259,mg,o
257,0211-699501013259,orales,o
257,0211-699501013259,de,o
257,0211-699501013259,vitamina,i
257,0211-699501013259,B6,i
257,0211-699501013259,cada,o
257,0211-699501013259,semana,o
257,0211-699501013259,Se,o
257,0211-699501013259,determinaron,o
257,0211-699501013259,al,o
257,0211-699501013259,comienzo,o
257,0211-699501013259,del,o
257,0211-699501013259,estudio,o
257,0211-699501013259,y,o
257,0211-699501013259,cada,o
257,0211-699501013259,2,o
257,0211-699501013259,meses,o
257,0211-699501013259,niveles,i
257,0211-699501013259,de,i
257,0211-699501013259,folato,i
257,0211-699501013259,vitamina,i
257,0211-699501013259,B12,i
257,0211-699501013259,inmunoensayo,i
257,0211-699501013259,albumina,i
257,0211-699501013259,y,o
257,0211-699501013259,cinetica,o
257,0211-699501013259,de,o
257,0211-699501013259,la,o
257,0211-699501013259,urea,i
257,0211-699501013259,KTV,o
257,0211-699501013259,KRU,o
257,0211-699501013259,PCRn,o
257,0211-699501013259,y,o
257,0211-699501013259,cada,o
257,0211-699501013259,6,o
257,0211-699501013259,meses,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,HPLC,i
257,0211-699501013259,y,o
257,0211-699501013259,pp,i
257,0211-699501013259,RIA,i
257,0211-699501013259,Resultados,o
257,0211-699501013259,80,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,fueron,o
257,0211-699501013259,incluidos,o
257,0211-699501013259,en,o
257,0211-699501013259,el,o
257,0211-699501013259,estudio,o
257,0211-699501013259,basal,o
257,0211-699501013259,con,o
257,0211-699501013259,una,o
257,0211-699501013259,prevalencia,o
257,0211-699501013259,de,o
257,0211-699501013259,hiperhomocisteinemia,i
257,0211-699501013259,del,o
257,0211-699501013259,844,o
257,0211-699501013259,deficit,i
257,0211-699501013259,de,i
257,0211-699501013259,pp,i
257,0211-699501013259,en,o
257,0211-699501013259,el,o
257,0211-699501013259,32,o
257,0211-699501013259,y,o
257,0211-699501013259,folato,i
257,0211-699501013259,en,o
257,0211-699501013259,el,o
257,0211-699501013259,rango,o
257,0211-699501013259,normal,o
257,0211-699501013259,bajo,o
257,0211-699501013259,los,o
257,0211-699501013259,niveles,i
257,0211-699501013259,de,i
257,0211-699501013259,tHcy,i
257,0211-699501013259,se,o
257,0211-699501013259,correlacionaban,o
257,0211-699501013259,inversamente,o
257,0211-699501013259,con,o
257,0211-699501013259,los,o
257,0211-699501013259,del,o
257,0211-699501013259,folato,i
257,0211-699501013259,r,o
257,0211-699501013259,0336,o
257,0211-699501013259,p,o
257,0211-699501013259,001,o
257,0211-699501013259,pero,o
257,0211-699501013259,no,o
257,0211-699501013259,con,o
257,0211-699501013259,pp,i
257,0211-699501013259,B12,i
257,0211-699501013259,edad,o
257,0211-699501013259,albumina,i
257,0211-699501013259,KTV,o
257,0211-699501013259,KRU,o
257,0211-699501013259,PCRn,o
257,0211-699501013259,Cincuenta,o
257,0211-699501013259,y,o
257,0211-699501013259,ocho,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,recibieron,o
257,0211-699501013259,seis,o
257,0211-699501013259,meses,o
257,0211-699501013259,de,o
257,0211-699501013259,suplementacion,i
257,0211-699501013259,con,o
257,0211-699501013259,normalizacion,o
257,0211-699501013259,del,o
257,0211-699501013259,pp,i
257,0211-699501013259,aumento,o
257,0211-699501013259,del,o
257,0211-699501013259,folato,i
257,0211-699501013259,703,o
257,0211-699501013259,IC,o
257,0211-699501013259,638,o
257,0211-699501013259,795,o
257,0211-699501013259,vs,o
257,0211-699501013259,6181,o
257,0211-699501013259,IC,o
257,0211-699501013259,4447,o
257,0211-699501013259,7811,o
257,0211-699501013259,p,o
257,0211-699501013259,0001,o
257,0211-699501013259,y,o
257,0211-699501013259,descenso,o
257,0211-699501013259,de,o
257,0211-699501013259,la,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,240,o
257,0211-699501013259,IC,o
257,0211-699501013259,213,o
257,0211-699501013259,264,o
257,0211-699501013259,vs,o
257,0211-699501013259,199,o
257,0211-699501013259,IC,o
257,0211-699501013259,175,o
257,0211-699501013259,224,o
257,0211-699501013259,p,o
257,0211-699501013259,005,o
257,0211-699501013259,Han,o
257,0211-699501013259,recibido,o
257,0211-699501013259,suplementacion,i
257,0211-699501013259,durante,o
257,0211-699501013259,12,o
257,0211-699501013259,meses,o
257,0211-699501013259,33,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,pero,o
257,0211-699501013259,a,o
257,0211-699501013259,pesar,o
257,0211-699501013259,de,o
257,0211-699501013259,un,o
257,0211-699501013259,continuo,o
257,0211-699501013259,aumento,o
257,0211-699501013259,del,o
257,0211-699501013259,folato,i
257,0211-699501013259,10078,o
257,0211-699501013259,IC,o
257,0211-699501013259,7481,o
257,0211-699501013259,12674,o
257,0211-699501013259,p,o
257,0211-699501013259,0001,o
257,0211-699501013259,solo,o
257,0211-699501013259,3,o
257,0211-699501013259,pacientes,o
257,0211-699501013259,presentan,o
257,0211-699501013259,niveles,o
257,0211-699501013259,normales,o
257,0211-699501013259,de,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,correlacionandose,o
257,0211-699501013259,directamente,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,con,o
257,0211-699501013259,la,o
257,0211-699501013259,albumina,i
257,0211-699501013259,r,o
257,0211-699501013259,056,o
257,0211-699501013259,p,o
257,0211-699501013259,0001,o
257,0211-699501013259,que,o
257,0211-699501013259,se,o
257,0211-699501013259,elevo,o
257,0211-699501013259,con,o
257,0211-699501013259,respecto,o
257,0211-699501013259,al,o
257,0211-699501013259,inicio,o
257,0211-699501013259,337,o
257,0211-699501013259,IC,o
257,0211-699501013259,327,o
257,0211-699501013259,346,o
257,0211-699501013259,vs,o
257,0211-699501013259,350,o
257,0211-699501013259,IC,o
257,0211-699501013259,337,o
257,0211-699501013259,363,o
257,0211-699501013259,p,o
257,0211-699501013259,005,o
257,0211-699501013259,Conclusion,o
257,0211-699501013259,Tras,o
257,0211-699501013259,suplementacion,i
257,0211-699501013259,con,o
257,0211-699501013259,acido,i
257,0211-699501013259,folico,i
257,0211-699501013259,y,o
257,0211-699501013259,vitamina,i
257,0211-699501013259,B6,i
257,0211-699501013259,aunque,o
257,0211-699501013259,inicialmente,o
257,0211-699501013259,se,o
257,0211-699501013259,reduce,o
257,0211-699501013259,la,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,esta,o
257,0211-699501013259,respuesta,o
257,0211-699501013259,se,o
257,0211-699501013259,hace,o
257,0211-699501013259,refractaria,o
257,0211-699501013259,correlacionandose,o
257,0211-699501013259,directamente,o
257,0211-699501013259,la,o
257,0211-699501013259,tHcy,i
257,0211-699501013259,con,o
257,0211-699501013259,la,o
257,0211-699501013259,albumina,i
257,0211-699501013259,plasmatica,i
257,0211-699501013259,La,o
257,0211-699501013259,interpretacion,o
257,0211-699501013259,de,o
257,0211-699501013259,los,o
257,0211-699501013259,niveles,i
257,0211-699501013259,de,i
257,0211-699501013259,tHcy,i
257,0211-699501013259,debe,o
257,0211-699501013259,tener,o
257,0211-699501013259,en,o
257,0211-699501013259,cuenta,o
257,0211-699501013259,la,o
257,0211-699501013259,concentracion,i
257,0211-699501013259,de,i
257,0211-699501013259,albumina,i
258,0211-699501013259,Efecto,o
258,0211-699501013259,de,o
258,0211-699501013259,la,o
258,0211-699501013259,suplementacion,i
258,0211-699501013259,con,o
258,0211-699501013259,acido,i
258,0211-699501013259,folico,i
258,0211-699501013259,sobre,o
258,0211-699501013259,los,o
258,0211-699501013259,niveles,i
258,0211-699501013259,de,i
258,0211-699501013259,homocisteina,i
258,0211-699501013259,total,o
258,0211-699501013259,en,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,en,o
258,0211-699501013259,hemodialisis,i
258,0211-699501013259,La,o
258,0211-699501013259,hiperhomocisteinemia,i
258,0211-699501013259,es,o
258,0211-699501013259,un,o
258,0211-699501013259,marcador,o
258,0211-699501013259,de,o
258,0211-699501013259,riesgo,o
258,0211-699501013259,independiente,o
258,0211-699501013259,de,o
258,0211-699501013259,morbimortalidad,o
258,0211-699501013259,cardiovascular,i
258,0211-699501013259,Hemos,o
258,0211-699501013259,intentado,o
258,0211-699501013259,prospectivamente,o
258,0211-699501013259,reducir,o
258,0211-699501013259,los,o
258,0211-699501013259,niveles,i
258,0211-699501013259,de,i
258,0211-699501013259,homocisteina,i
258,0211-699501013259,total,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,mediante,o
258,0211-699501013259,suplemento,o
258,0211-699501013259,con,o
258,0211-699501013259,acido,i
258,0211-699501013259,folico,i
258,0211-699501013259,y,o
258,0211-699501013259,vitamina,i
258,0211-699501013259,B6,i
258,0211-699501013259,pp,i
258,0211-699501013259,valorando,o
258,0211-699501013259,su,o
258,0211-699501013259,posible,o
258,0211-699501013259,correlacion,o
258,0211-699501013259,con,o
258,0211-699501013259,dosis,o
258,0211-699501013259,de,o
258,0211-699501013259,dialisis,i
258,0211-699501013259,funcion,i
258,0211-699501013259,residual,i
258,0211-699501013259,y,o
258,0211-699501013259,parametros,o
258,0211-699501013259,nutricionales,o
258,0211-699501013259,Metodos,o
258,0211-699501013259,Todos,o
258,0211-699501013259,los,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,en,o
258,0211-699501013259,hemodialisis,i
258,0211-699501013259,al,o
258,0211-699501013259,comienzo,o
258,0211-699501013259,del,o
258,0211-699501013259,estudio,o
258,0211-699501013259,que,o
258,0211-699501013259,no,o
258,0211-699501013259,recibian,o
258,0211-699501013259,acido,i
258,0211-699501013259,folico,i
258,0211-699501013259,ni,o
258,0211-699501013259,vitamina,i
258,0211-699501013259,B6,i
258,0211-699501013259,asi,o
258,0211-699501013259,como,o
258,0211-699501013259,los,o
258,0211-699501013259,incorporados,o
258,0211-699501013259,posteriormente,o
258,0211-699501013259,a,o
258,0211-699501013259,partir,o
258,0211-699501013259,de,o
258,0211-699501013259,su,o
258,0211-699501013259,tercer,o
258,0211-699501013259,mes,o
258,0211-699501013259,en,o
258,0211-699501013259,hemodialisis,i
258,0211-699501013259,recibieron,o
258,0211-699501013259,5,o
258,0211-699501013259,mg,o
258,0211-699501013259,orales,o
258,0211-699501013259,de,o
258,0211-699501013259,acido,i
258,0211-699501013259,folico,i
258,0211-699501013259,cada,o
258,0211-699501013259,48,o
258,0211-699501013259,horas,o
258,0211-699501013259,y,o
258,0211-699501013259,40,o
258,0211-699501013259,mg,o
258,0211-699501013259,orales,o
258,0211-699501013259,de,o
258,0211-699501013259,vitamina,i
258,0211-699501013259,B6,i
258,0211-699501013259,cada,o
258,0211-699501013259,semana,o
258,0211-699501013259,Se,o
258,0211-699501013259,determinaron,o
258,0211-699501013259,al,o
258,0211-699501013259,comienzo,o
258,0211-699501013259,del,o
258,0211-699501013259,estudio,o
258,0211-699501013259,y,o
258,0211-699501013259,cada,o
258,0211-699501013259,2,o
258,0211-699501013259,meses,o
258,0211-699501013259,niveles,i
258,0211-699501013259,de,i
258,0211-699501013259,folato,i
258,0211-699501013259,vitamina,i
258,0211-699501013259,B12,i
258,0211-699501013259,inmunoensayo,i
258,0211-699501013259,albumina,i
258,0211-699501013259,y,o
258,0211-699501013259,cinetica,o
258,0211-699501013259,de,o
258,0211-699501013259,la,o
258,0211-699501013259,urea,i
258,0211-699501013259,KTV,o
258,0211-699501013259,KRU,o
258,0211-699501013259,PCRn,o
258,0211-699501013259,y,o
258,0211-699501013259,cada,o
258,0211-699501013259,6,o
258,0211-699501013259,meses,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,HPLC,i
258,0211-699501013259,y,o
258,0211-699501013259,pp,i
258,0211-699501013259,RIA,i
258,0211-699501013259,Resultados,o
258,0211-699501013259,80,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,fueron,o
258,0211-699501013259,incluidos,o
258,0211-699501013259,en,o
258,0211-699501013259,el,o
258,0211-699501013259,estudio,o
258,0211-699501013259,basal,o
258,0211-699501013259,con,o
258,0211-699501013259,una,o
258,0211-699501013259,prevalencia,o
258,0211-699501013259,de,o
258,0211-699501013259,hiperhomocisteinemia,i
258,0211-699501013259,del,o
258,0211-699501013259,844,o
258,0211-699501013259,deficit,i
258,0211-699501013259,de,i
258,0211-699501013259,pp,i
258,0211-699501013259,en,o
258,0211-699501013259,el,o
258,0211-699501013259,32,o
258,0211-699501013259,y,o
258,0211-699501013259,folato,i
258,0211-699501013259,en,o
258,0211-699501013259,el,o
258,0211-699501013259,rango,o
258,0211-699501013259,normal,o
258,0211-699501013259,bajo,o
258,0211-699501013259,los,o
258,0211-699501013259,niveles,i
258,0211-699501013259,de,i
258,0211-699501013259,tHcy,i
258,0211-699501013259,se,o
258,0211-699501013259,correlacionaban,o
258,0211-699501013259,inversamente,o
258,0211-699501013259,con,o
258,0211-699501013259,los,o
258,0211-699501013259,del,o
258,0211-699501013259,folato,i
258,0211-699501013259,r,o
258,0211-699501013259,0336,o
258,0211-699501013259,p,o
258,0211-699501013259,001,o
258,0211-699501013259,pero,o
258,0211-699501013259,no,o
258,0211-699501013259,con,o
258,0211-699501013259,pp,i
258,0211-699501013259,B12,i
258,0211-699501013259,edad,o
258,0211-699501013259,albumina,i
258,0211-699501013259,KTV,o
258,0211-699501013259,KRU,o
258,0211-699501013259,PCRn,o
258,0211-699501013259,Cincuenta,o
258,0211-699501013259,y,o
258,0211-699501013259,ocho,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,recibieron,o
258,0211-699501013259,seis,o
258,0211-699501013259,meses,o
258,0211-699501013259,de,o
258,0211-699501013259,suplementacion,i
258,0211-699501013259,con,o
258,0211-699501013259,normalizacion,o
258,0211-699501013259,del,o
258,0211-699501013259,pp,i
258,0211-699501013259,aumento,o
258,0211-699501013259,del,o
258,0211-699501013259,folato,i
258,0211-699501013259,703,o
258,0211-699501013259,IC,o
258,0211-699501013259,638,o
258,0211-699501013259,795,o
258,0211-699501013259,vs,o
258,0211-699501013259,6181,o
258,0211-699501013259,IC,o
258,0211-699501013259,4447,o
258,0211-699501013259,7811,o
258,0211-699501013259,p,o
258,0211-699501013259,0001,o
258,0211-699501013259,y,o
258,0211-699501013259,descenso,o
258,0211-699501013259,de,o
258,0211-699501013259,la,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,240,o
258,0211-699501013259,IC,o
258,0211-699501013259,213,o
258,0211-699501013259,264,o
258,0211-699501013259,vs,o
258,0211-699501013259,199,o
258,0211-699501013259,IC,o
258,0211-699501013259,175,o
258,0211-699501013259,224,o
258,0211-699501013259,p,o
258,0211-699501013259,005,o
258,0211-699501013259,Han,o
258,0211-699501013259,recibido,o
258,0211-699501013259,suplementacion,i
258,0211-699501013259,durante,o
258,0211-699501013259,12,o
258,0211-699501013259,meses,o
258,0211-699501013259,33,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,pero,o
258,0211-699501013259,a,o
258,0211-699501013259,pesar,o
258,0211-699501013259,de,o
258,0211-699501013259,un,o
258,0211-699501013259,continuo,o
258,0211-699501013259,aumento,o
258,0211-699501013259,del,o
258,0211-699501013259,folato,i
258,0211-699501013259,10078,o
258,0211-699501013259,IC,o
258,0211-699501013259,7481,o
258,0211-699501013259,12674,o
258,0211-699501013259,p,o
258,0211-699501013259,0001,o
258,0211-699501013259,solo,o
258,0211-699501013259,3,o
258,0211-699501013259,pacientes,o
258,0211-699501013259,presentan,o
258,0211-699501013259,niveles,o
258,0211-699501013259,normales,o
258,0211-699501013259,de,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,correlacionandose,o
258,0211-699501013259,directamente,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,con,o
258,0211-699501013259,la,o
258,0211-699501013259,albumina,i
258,0211-699501013259,r,o
258,0211-699501013259,056,o
258,0211-699501013259,p,o
258,0211-699501013259,0001,o
258,0211-699501013259,que,o
258,0211-699501013259,se,o
258,0211-699501013259,elevo,o
258,0211-699501013259,con,o
258,0211-699501013259,respecto,o
258,0211-699501013259,al,o
258,0211-699501013259,inicio,o
258,0211-699501013259,337,o
258,0211-699501013259,IC,o
258,0211-699501013259,327,o
258,0211-699501013259,346,o
258,0211-699501013259,vs,o
258,0211-699501013259,350,o
258,0211-699501013259,IC,o
258,0211-699501013259,337,o
258,0211-699501013259,363,o
258,0211-699501013259,p,o
258,0211-699501013259,005,o
258,0211-699501013259,Conclusion,o
258,0211-699501013259,Tras,o
258,0211-699501013259,suplementacion,i
258,0211-699501013259,con,o
258,0211-699501013259,acido,i
258,0211-699501013259,folico,i
258,0211-699501013259,y,o
258,0211-699501013259,vitamina,i
258,0211-699501013259,B6,i
258,0211-699501013259,aunque,o
258,0211-699501013259,inicialmente,o
258,0211-699501013259,se,o
258,0211-699501013259,reduce,o
258,0211-699501013259,la,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,esta,o
258,0211-699501013259,respuesta,o
258,0211-699501013259,se,o
258,0211-699501013259,hace,o
258,0211-699501013259,refractaria,o
258,0211-699501013259,correlacionandose,o
258,0211-699501013259,directamente,o
258,0211-699501013259,la,o
258,0211-699501013259,tHcy,i
258,0211-699501013259,con,o
258,0211-699501013259,la,o
258,0211-699501013259,albumina,i
258,0211-699501013259,plasmatica,i
258,0211-699501013259,La,o
258,0211-699501013259,interpretacion,o
258,0211-699501013259,de,o
258,0211-699501013259,los,o
258,0211-699501013259,niveles,i
258,0211-699501013259,de,i
258,0211-699501013259,tHcy,i
258,0211-699501013259,debe,o
258,0211-699501013259,tener,o
258,0211-699501013259,en,o
258,0211-699501013259,cuenta,o
258,0211-699501013259,la,o
258,0211-699501013259,concentracion,i
258,0211-699501013259,de,i
258,0211-699501013259,albumina,i
259,0211-699501013259,Efecto,o
259,0211-699501013259,de,o
259,0211-699501013259,la,o
259,0211-699501013259,suplementacion,i
259,0211-699501013259,con,o
259,0211-699501013259,acido,i
259,0211-699501013259,folico,i
259,0211-699501013259,sobre,o
259,0211-699501013259,los,o
259,0211-699501013259,niveles,i
259,0211-699501013259,de,i
259,0211-699501013259,homocisteina,i
259,0211-699501013259,total,o
259,0211-699501013259,en,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,en,o
259,0211-699501013259,hemodialisis,i
259,0211-699501013259,La,o
259,0211-699501013259,hiperhomocisteinemia,i
259,0211-699501013259,es,o
259,0211-699501013259,un,o
259,0211-699501013259,marcador,o
259,0211-699501013259,de,o
259,0211-699501013259,riesgo,o
259,0211-699501013259,independiente,o
259,0211-699501013259,de,o
259,0211-699501013259,morbimortalidad,o
259,0211-699501013259,cardiovascular,i
259,0211-699501013259,Hemos,o
259,0211-699501013259,intentado,o
259,0211-699501013259,prospectivamente,o
259,0211-699501013259,reducir,o
259,0211-699501013259,los,o
259,0211-699501013259,niveles,i
259,0211-699501013259,de,i
259,0211-699501013259,homocisteina,i
259,0211-699501013259,total,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,mediante,o
259,0211-699501013259,suplemento,o
259,0211-699501013259,con,o
259,0211-699501013259,acido,i
259,0211-699501013259,folico,i
259,0211-699501013259,y,o
259,0211-699501013259,vitamina,i
259,0211-699501013259,B6,i
259,0211-699501013259,pp,i
259,0211-699501013259,valorando,o
259,0211-699501013259,su,o
259,0211-699501013259,posible,o
259,0211-699501013259,correlacion,o
259,0211-699501013259,con,o
259,0211-699501013259,dosis,o
259,0211-699501013259,de,o
259,0211-699501013259,dialisis,i
259,0211-699501013259,funcion,i
259,0211-699501013259,residual,i
259,0211-699501013259,y,o
259,0211-699501013259,parametros,o
259,0211-699501013259,nutricionales,o
259,0211-699501013259,Metodos,o
259,0211-699501013259,Todos,o
259,0211-699501013259,los,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,en,o
259,0211-699501013259,hemodialisis,i
259,0211-699501013259,al,o
259,0211-699501013259,comienzo,o
259,0211-699501013259,del,o
259,0211-699501013259,estudio,o
259,0211-699501013259,que,o
259,0211-699501013259,no,o
259,0211-699501013259,recibian,o
259,0211-699501013259,acido,i
259,0211-699501013259,folico,i
259,0211-699501013259,ni,o
259,0211-699501013259,vitamina,i
259,0211-699501013259,B6,i
259,0211-699501013259,asi,o
259,0211-699501013259,como,o
259,0211-699501013259,los,o
259,0211-699501013259,incorporados,o
259,0211-699501013259,posteriormente,o
259,0211-699501013259,a,o
259,0211-699501013259,partir,o
259,0211-699501013259,de,o
259,0211-699501013259,su,o
259,0211-699501013259,tercer,o
259,0211-699501013259,mes,o
259,0211-699501013259,en,o
259,0211-699501013259,hemodialisis,i
259,0211-699501013259,recibieron,o
259,0211-699501013259,5,o
259,0211-699501013259,mg,o
259,0211-699501013259,orales,o
259,0211-699501013259,de,o
259,0211-699501013259,acido,i
259,0211-699501013259,folico,i
259,0211-699501013259,cada,o
259,0211-699501013259,48,o
259,0211-699501013259,horas,o
259,0211-699501013259,y,o
259,0211-699501013259,40,o
259,0211-699501013259,mg,o
259,0211-699501013259,orales,o
259,0211-699501013259,de,o
259,0211-699501013259,vitamina,i
259,0211-699501013259,B6,i
259,0211-699501013259,cada,o
259,0211-699501013259,semana,o
259,0211-699501013259,Se,o
259,0211-699501013259,determinaron,o
259,0211-699501013259,al,o
259,0211-699501013259,comienzo,o
259,0211-699501013259,del,o
259,0211-699501013259,estudio,o
259,0211-699501013259,y,o
259,0211-699501013259,cada,o
259,0211-699501013259,2,o
259,0211-699501013259,meses,o
259,0211-699501013259,niveles,i
259,0211-699501013259,de,i
259,0211-699501013259,folato,i
259,0211-699501013259,vitamina,i
259,0211-699501013259,B12,i
259,0211-699501013259,inmunoensayo,i
259,0211-699501013259,albumina,i
259,0211-699501013259,y,o
259,0211-699501013259,cinetica,o
259,0211-699501013259,de,o
259,0211-699501013259,la,o
259,0211-699501013259,urea,i
259,0211-699501013259,KTV,o
259,0211-699501013259,KRU,o
259,0211-699501013259,PCRn,o
259,0211-699501013259,y,o
259,0211-699501013259,cada,o
259,0211-699501013259,6,o
259,0211-699501013259,meses,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,HPLC,i
259,0211-699501013259,y,o
259,0211-699501013259,pp,i
259,0211-699501013259,RIA,i
259,0211-699501013259,Resultados,o
259,0211-699501013259,80,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,fueron,o
259,0211-699501013259,incluidos,o
259,0211-699501013259,en,o
259,0211-699501013259,el,o
259,0211-699501013259,estudio,o
259,0211-699501013259,basal,o
259,0211-699501013259,con,o
259,0211-699501013259,una,o
259,0211-699501013259,prevalencia,o
259,0211-699501013259,de,o
259,0211-699501013259,hiperhomocisteinemia,i
259,0211-699501013259,del,o
259,0211-699501013259,844,o
259,0211-699501013259,deficit,i
259,0211-699501013259,de,i
259,0211-699501013259,pp,i
259,0211-699501013259,en,o
259,0211-699501013259,el,o
259,0211-699501013259,32,o
259,0211-699501013259,y,o
259,0211-699501013259,folato,i
259,0211-699501013259,en,o
259,0211-699501013259,el,o
259,0211-699501013259,rango,o
259,0211-699501013259,normal,o
259,0211-699501013259,bajo,o
259,0211-699501013259,los,o
259,0211-699501013259,niveles,i
259,0211-699501013259,de,i
259,0211-699501013259,tHcy,i
259,0211-699501013259,se,o
259,0211-699501013259,correlacionaban,o
259,0211-699501013259,inversamente,o
259,0211-699501013259,con,o
259,0211-699501013259,los,o
259,0211-699501013259,del,o
259,0211-699501013259,folato,i
259,0211-699501013259,r,o
259,0211-699501013259,0336,o
259,0211-699501013259,p,o
259,0211-699501013259,001,o
259,0211-699501013259,pero,o
259,0211-699501013259,no,o
259,0211-699501013259,con,o
259,0211-699501013259,pp,i
259,0211-699501013259,B12,i
259,0211-699501013259,edad,o
259,0211-699501013259,albumina,i
259,0211-699501013259,KTV,o
259,0211-699501013259,KRU,o
259,0211-699501013259,PCRn,o
259,0211-699501013259,Cincuenta,o
259,0211-699501013259,y,o
259,0211-699501013259,ocho,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,recibieron,o
259,0211-699501013259,seis,o
259,0211-699501013259,meses,o
259,0211-699501013259,de,o
259,0211-699501013259,suplementacion,i
259,0211-699501013259,con,o
259,0211-699501013259,normalizacion,o
259,0211-699501013259,del,o
259,0211-699501013259,pp,i
259,0211-699501013259,aumento,o
259,0211-699501013259,del,o
259,0211-699501013259,folato,i
259,0211-699501013259,703,o
259,0211-699501013259,IC,o
259,0211-699501013259,638,o
259,0211-699501013259,795,o
259,0211-699501013259,vs,o
259,0211-699501013259,6181,o
259,0211-699501013259,IC,o
259,0211-699501013259,4447,o
259,0211-699501013259,7811,o
259,0211-699501013259,p,o
259,0211-699501013259,0001,o
259,0211-699501013259,y,o
259,0211-699501013259,descenso,o
259,0211-699501013259,de,o
259,0211-699501013259,la,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,240,o
259,0211-699501013259,IC,o
259,0211-699501013259,213,o
259,0211-699501013259,264,o
259,0211-699501013259,vs,o
259,0211-699501013259,199,o
259,0211-699501013259,IC,o
259,0211-699501013259,175,o
259,0211-699501013259,224,o
259,0211-699501013259,p,o
259,0211-699501013259,005,o
259,0211-699501013259,Han,o
259,0211-699501013259,recibido,o
259,0211-699501013259,suplementacion,i
259,0211-699501013259,durante,o
259,0211-699501013259,12,o
259,0211-699501013259,meses,o
259,0211-699501013259,33,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,pero,o
259,0211-699501013259,a,o
259,0211-699501013259,pesar,o
259,0211-699501013259,de,o
259,0211-699501013259,un,o
259,0211-699501013259,continuo,o
259,0211-699501013259,aumento,o
259,0211-699501013259,del,o
259,0211-699501013259,folato,i
259,0211-699501013259,10078,o
259,0211-699501013259,IC,o
259,0211-699501013259,7481,o
259,0211-699501013259,12674,o
259,0211-699501013259,p,o
259,0211-699501013259,0001,o
259,0211-699501013259,solo,o
259,0211-699501013259,3,o
259,0211-699501013259,pacientes,o
259,0211-699501013259,presentan,o
259,0211-699501013259,niveles,o
259,0211-699501013259,normales,o
259,0211-699501013259,de,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,correlacionandose,o
259,0211-699501013259,directamente,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,con,o
259,0211-699501013259,la,o
259,0211-699501013259,albumina,i
259,0211-699501013259,r,o
259,0211-699501013259,056,o
259,0211-699501013259,p,o
259,0211-699501013259,0001,o
259,0211-699501013259,que,o
259,0211-699501013259,se,o
259,0211-699501013259,elevo,o
259,0211-699501013259,con,o
259,0211-699501013259,respecto,o
259,0211-699501013259,al,o
259,0211-699501013259,inicio,o
259,0211-699501013259,337,o
259,0211-699501013259,IC,o
259,0211-699501013259,327,o
259,0211-699501013259,346,o
259,0211-699501013259,vs,o
259,0211-699501013259,350,o
259,0211-699501013259,IC,o
259,0211-699501013259,337,o
259,0211-699501013259,363,o
259,0211-699501013259,p,o
259,0211-699501013259,005,o
259,0211-699501013259,Conclusion,o
259,0211-699501013259,Tras,o
259,0211-699501013259,suplementacion,i
259,0211-699501013259,con,o
259,0211-699501013259,acido,i
259,0211-699501013259,folico,i
259,0211-699501013259,y,o
259,0211-699501013259,vitamina,i
259,0211-699501013259,B6,i
259,0211-699501013259,aunque,o
259,0211-699501013259,inicialmente,o
259,0211-699501013259,se,o
259,0211-699501013259,reduce,o
259,0211-699501013259,la,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,esta,o
259,0211-699501013259,respuesta,o
259,0211-699501013259,se,o
259,0211-699501013259,hace,o
259,0211-699501013259,refractaria,o
259,0211-699501013259,correlacionandose,o
259,0211-699501013259,directamente,o
259,0211-699501013259,la,o
259,0211-699501013259,tHcy,i
259,0211-699501013259,con,o
259,0211-699501013259,la,o
259,0211-699501013259,albumina,i
259,0211-699501013259,plasmatica,i
259,0211-699501013259,La,o
259,0211-699501013259,interpretacion,o
259,0211-699501013259,de,o
259,0211-699501013259,los,o
259,0211-699501013259,niveles,i
259,0211-699501013259,de,i
259,0211-699501013259,tHcy,i
259,0211-699501013259,debe,o
259,0211-699501013259,tener,o
259,0211-699501013259,en,o
259,0211-699501013259,cuenta,o
259,0211-699501013259,la,o
259,0211-699501013259,concentracion,i
259,0211-699501013259,de,i
259,0211-699501013259,albumina,i
260,0211-699501013259,Efecto,o
260,0211-699501013259,de,o
260,0211-699501013259,la,o
260,0211-699501013259,suplementacion,i
260,0211-699501013259,con,o
260,0211-699501013259,acido,i
260,0211-699501013259,folico,i
260,0211-699501013259,sobre,o
260,0211-699501013259,los,o
260,0211-699501013259,niveles,i
260,0211-699501013259,de,i
260,0211-699501013259,homocisteina,i
260,0211-699501013259,total,o
260,0211-699501013259,en,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,en,o
260,0211-699501013259,hemodialisis,i
260,0211-699501013259,La,o
260,0211-699501013259,hiperhomocisteinemia,i
260,0211-699501013259,es,o
260,0211-699501013259,un,o
260,0211-699501013259,marcador,o
260,0211-699501013259,de,o
260,0211-699501013259,riesgo,o
260,0211-699501013259,independiente,o
260,0211-699501013259,de,o
260,0211-699501013259,morbimortalidad,o
260,0211-699501013259,cardiovascular,i
260,0211-699501013259,Hemos,o
260,0211-699501013259,intentado,o
260,0211-699501013259,prospectivamente,o
260,0211-699501013259,reducir,o
260,0211-699501013259,los,o
260,0211-699501013259,niveles,i
260,0211-699501013259,de,i
260,0211-699501013259,homocisteina,i
260,0211-699501013259,total,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,mediante,o
260,0211-699501013259,suplemento,o
260,0211-699501013259,con,o
260,0211-699501013259,acido,i
260,0211-699501013259,folico,i
260,0211-699501013259,y,o
260,0211-699501013259,vitamina,i
260,0211-699501013259,B6,i
260,0211-699501013259,pp,i
260,0211-699501013259,valorando,o
260,0211-699501013259,su,o
260,0211-699501013259,posible,o
260,0211-699501013259,correlacion,o
260,0211-699501013259,con,o
260,0211-699501013259,dosis,o
260,0211-699501013259,de,o
260,0211-699501013259,dialisis,i
260,0211-699501013259,funcion,i
260,0211-699501013259,residual,i
260,0211-699501013259,y,o
260,0211-699501013259,parametros,o
260,0211-699501013259,nutricionales,o
260,0211-699501013259,Metodos,o
260,0211-699501013259,Todos,o
260,0211-699501013259,los,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,en,o
260,0211-699501013259,hemodialisis,i
260,0211-699501013259,al,o
260,0211-699501013259,comienzo,o
260,0211-699501013259,del,o
260,0211-699501013259,estudio,o
260,0211-699501013259,que,o
260,0211-699501013259,no,o
260,0211-699501013259,recibian,o
260,0211-699501013259,acido,i
260,0211-699501013259,folico,i
260,0211-699501013259,ni,o
260,0211-699501013259,vitamina,i
260,0211-699501013259,B6,i
260,0211-699501013259,asi,o
260,0211-699501013259,como,o
260,0211-699501013259,los,o
260,0211-699501013259,incorporados,o
260,0211-699501013259,posteriormente,o
260,0211-699501013259,a,o
260,0211-699501013259,partir,o
260,0211-699501013259,de,o
260,0211-699501013259,su,o
260,0211-699501013259,tercer,o
260,0211-699501013259,mes,o
260,0211-699501013259,en,o
260,0211-699501013259,hemodialisis,i
260,0211-699501013259,recibieron,o
260,0211-699501013259,5,o
260,0211-699501013259,mg,o
260,0211-699501013259,orales,o
260,0211-699501013259,de,o
260,0211-699501013259,acido,i
260,0211-699501013259,folico,i
260,0211-699501013259,cada,o
260,0211-699501013259,48,o
260,0211-699501013259,horas,o
260,0211-699501013259,y,o
260,0211-699501013259,40,o
260,0211-699501013259,mg,o
260,0211-699501013259,orales,o
260,0211-699501013259,de,o
260,0211-699501013259,vitamina,i
260,0211-699501013259,B6,i
260,0211-699501013259,cada,o
260,0211-699501013259,semana,o
260,0211-699501013259,Se,o
260,0211-699501013259,determinaron,o
260,0211-699501013259,al,o
260,0211-699501013259,comienzo,o
260,0211-699501013259,del,o
260,0211-699501013259,estudio,o
260,0211-699501013259,y,o
260,0211-699501013259,cada,o
260,0211-699501013259,2,o
260,0211-699501013259,meses,o
260,0211-699501013259,niveles,i
260,0211-699501013259,de,i
260,0211-699501013259,folato,i
260,0211-699501013259,vitamina,i
260,0211-699501013259,B12,i
260,0211-699501013259,inmunoensayo,i
260,0211-699501013259,albumina,i
260,0211-699501013259,y,o
260,0211-699501013259,cinetica,o
260,0211-699501013259,de,o
260,0211-699501013259,la,o
260,0211-699501013259,urea,i
260,0211-699501013259,KTV,o
260,0211-699501013259,KRU,o
260,0211-699501013259,PCRn,o
260,0211-699501013259,y,o
260,0211-699501013259,cada,o
260,0211-699501013259,6,o
260,0211-699501013259,meses,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,HPLC,i
260,0211-699501013259,y,o
260,0211-699501013259,pp,i
260,0211-699501013259,RIA,i
260,0211-699501013259,Resultados,o
260,0211-699501013259,80,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,fueron,o
260,0211-699501013259,incluidos,o
260,0211-699501013259,en,o
260,0211-699501013259,el,o
260,0211-699501013259,estudio,o
260,0211-699501013259,basal,o
260,0211-699501013259,con,o
260,0211-699501013259,una,o
260,0211-699501013259,prevalencia,o
260,0211-699501013259,de,o
260,0211-699501013259,hiperhomocisteinemia,i
260,0211-699501013259,del,o
260,0211-699501013259,844,o
260,0211-699501013259,deficit,i
260,0211-699501013259,de,i
260,0211-699501013259,pp,i
260,0211-699501013259,en,o
260,0211-699501013259,el,o
260,0211-699501013259,32,o
260,0211-699501013259,y,o
260,0211-699501013259,folato,i
260,0211-699501013259,en,o
260,0211-699501013259,el,o
260,0211-699501013259,rango,o
260,0211-699501013259,normal,o
260,0211-699501013259,bajo,o
260,0211-699501013259,los,o
260,0211-699501013259,niveles,i
260,0211-699501013259,de,i
260,0211-699501013259,tHcy,i
260,0211-699501013259,se,o
260,0211-699501013259,correlacionaban,o
260,0211-699501013259,inversamente,o
260,0211-699501013259,con,o
260,0211-699501013259,los,o
260,0211-699501013259,del,o
260,0211-699501013259,folato,i
260,0211-699501013259,r,o
260,0211-699501013259,0336,o
260,0211-699501013259,p,o
260,0211-699501013259,001,o
260,0211-699501013259,pero,o
260,0211-699501013259,no,o
260,0211-699501013259,con,o
260,0211-699501013259,pp,i
260,0211-699501013259,B12,i
260,0211-699501013259,edad,o
260,0211-699501013259,albumina,i
260,0211-699501013259,KTV,o
260,0211-699501013259,KRU,o
260,0211-699501013259,PCRn,o
260,0211-699501013259,Cincuenta,o
260,0211-699501013259,y,o
260,0211-699501013259,ocho,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,recibieron,o
260,0211-699501013259,seis,o
260,0211-699501013259,meses,o
260,0211-699501013259,de,o
260,0211-699501013259,suplementacion,i
260,0211-699501013259,con,o
260,0211-699501013259,normalizacion,o
260,0211-699501013259,del,o
260,0211-699501013259,pp,i
260,0211-699501013259,aumento,o
260,0211-699501013259,del,o
260,0211-699501013259,folato,i
260,0211-699501013259,703,o
260,0211-699501013259,IC,o
260,0211-699501013259,638,o
260,0211-699501013259,795,o
260,0211-699501013259,vs,o
260,0211-699501013259,6181,o
260,0211-699501013259,IC,o
260,0211-699501013259,4447,o
260,0211-699501013259,7811,o
260,0211-699501013259,p,o
260,0211-699501013259,0001,o
260,0211-699501013259,y,o
260,0211-699501013259,descenso,o
260,0211-699501013259,de,o
260,0211-699501013259,la,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,240,o
260,0211-699501013259,IC,o
260,0211-699501013259,213,o
260,0211-699501013259,264,o
260,0211-699501013259,vs,o
260,0211-699501013259,199,o
260,0211-699501013259,IC,o
260,0211-699501013259,175,o
260,0211-699501013259,224,o
260,0211-699501013259,p,o
260,0211-699501013259,005,o
260,0211-699501013259,Han,o
260,0211-699501013259,recibido,o
260,0211-699501013259,suplementacion,i
260,0211-699501013259,durante,o
260,0211-699501013259,12,o
260,0211-699501013259,meses,o
260,0211-699501013259,33,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,pero,o
260,0211-699501013259,a,o
260,0211-699501013259,pesar,o
260,0211-699501013259,de,o
260,0211-699501013259,un,o
260,0211-699501013259,continuo,o
260,0211-699501013259,aumento,o
260,0211-699501013259,del,o
260,0211-699501013259,folato,i
260,0211-699501013259,10078,o
260,0211-699501013259,IC,o
260,0211-699501013259,7481,o
260,0211-699501013259,12674,o
260,0211-699501013259,p,o
260,0211-699501013259,0001,o
260,0211-699501013259,solo,o
260,0211-699501013259,3,o
260,0211-699501013259,pacientes,o
260,0211-699501013259,presentan,o
260,0211-699501013259,niveles,o
260,0211-699501013259,normales,o
260,0211-699501013259,de,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,correlacionandose,o
260,0211-699501013259,directamente,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,con,o
260,0211-699501013259,la,o
260,0211-699501013259,albumina,i
260,0211-699501013259,r,o
260,0211-699501013259,056,o
260,0211-699501013259,p,o
260,0211-699501013259,0001,o
260,0211-699501013259,que,o
260,0211-699501013259,se,o
260,0211-699501013259,elevo,o
260,0211-699501013259,con,o
260,0211-699501013259,respecto,o
260,0211-699501013259,al,o
260,0211-699501013259,inicio,o
260,0211-699501013259,337,o
260,0211-699501013259,IC,o
260,0211-699501013259,327,o
260,0211-699501013259,346,o
260,0211-699501013259,vs,o
260,0211-699501013259,350,o
260,0211-699501013259,IC,o
260,0211-699501013259,337,o
260,0211-699501013259,363,o
260,0211-699501013259,p,o
260,0211-699501013259,005,o
260,0211-699501013259,Conclusion,o
260,0211-699501013259,Tras,o
260,0211-699501013259,suplementacion,i
260,0211-699501013259,con,o
260,0211-699501013259,acido,i
260,0211-699501013259,folico,i
260,0211-699501013259,y,o
260,0211-699501013259,vitamina,i
260,0211-699501013259,B6,i
260,0211-699501013259,aunque,o
260,0211-699501013259,inicialmente,o
260,0211-699501013259,se,o
260,0211-699501013259,reduce,o
260,0211-699501013259,la,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,esta,o
260,0211-699501013259,respuesta,o
260,0211-699501013259,se,o
260,0211-699501013259,hace,o
260,0211-699501013259,refractaria,o
260,0211-699501013259,correlacionandose,o
260,0211-699501013259,directamente,o
260,0211-699501013259,la,o
260,0211-699501013259,tHcy,i
260,0211-699501013259,con,o
260,0211-699501013259,la,o
260,0211-699501013259,albumina,i
260,0211-699501013259,plasmatica,i
260,0211-699501013259,La,o
260,0211-699501013259,interpretacion,o
260,0211-699501013259,de,o
260,0211-699501013259,los,o
260,0211-699501013259,niveles,i
260,0211-699501013259,de,i
260,0211-699501013259,tHcy,i
260,0211-699501013259,debe,o
260,0211-699501013259,tener,o
260,0211-699501013259,en,o
260,0211-699501013259,cuenta,o
260,0211-699501013259,la,o
260,0211-699501013259,concentracion,i
260,0211-699501013259,de,i
260,0211-699501013259,albumina,i
261,0211-699501013259,Efecto,o
261,0211-699501013259,de,o
261,0211-699501013259,la,o
261,0211-699501013259,suplementacion,i
261,0211-699501013259,con,o
261,0211-699501013259,acido,i
261,0211-699501013259,folico,i
261,0211-699501013259,sobre,o
261,0211-699501013259,los,o
261,0211-699501013259,niveles,i
261,0211-699501013259,de,i
261,0211-699501013259,homocisteina,i
261,0211-699501013259,total,o
261,0211-699501013259,en,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,en,o
261,0211-699501013259,hemodialisis,i
261,0211-699501013259,La,o
261,0211-699501013259,hiperhomocisteinemia,i
261,0211-699501013259,es,o
261,0211-699501013259,un,o
261,0211-699501013259,marcador,o
261,0211-699501013259,de,o
261,0211-699501013259,riesgo,o
261,0211-699501013259,independiente,o
261,0211-699501013259,de,o
261,0211-699501013259,morbimortalidad,o
261,0211-699501013259,cardiovascular,i
261,0211-699501013259,Hemos,o
261,0211-699501013259,intentado,o
261,0211-699501013259,prospectivamente,o
261,0211-699501013259,reducir,o
261,0211-699501013259,los,o
261,0211-699501013259,niveles,i
261,0211-699501013259,de,i
261,0211-699501013259,homocisteina,i
261,0211-699501013259,total,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,mediante,o
261,0211-699501013259,suplemento,o
261,0211-699501013259,con,o
261,0211-699501013259,acido,i
261,0211-699501013259,folico,i
261,0211-699501013259,y,o
261,0211-699501013259,vitamina,i
261,0211-699501013259,B6,i
261,0211-699501013259,pp,i
261,0211-699501013259,valorando,o
261,0211-699501013259,su,o
261,0211-699501013259,posible,o
261,0211-699501013259,correlacion,o
261,0211-699501013259,con,o
261,0211-699501013259,dosis,o
261,0211-699501013259,de,o
261,0211-699501013259,dialisis,i
261,0211-699501013259,funcion,i
261,0211-699501013259,residual,i
261,0211-699501013259,y,o
261,0211-699501013259,parametros,o
261,0211-699501013259,nutricionales,o
261,0211-699501013259,Metodos,o
261,0211-699501013259,Todos,o
261,0211-699501013259,los,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,en,o
261,0211-699501013259,hemodialisis,i
261,0211-699501013259,al,o
261,0211-699501013259,comienzo,o
261,0211-699501013259,del,o
261,0211-699501013259,estudio,o
261,0211-699501013259,que,o
261,0211-699501013259,no,o
261,0211-699501013259,recibian,o
261,0211-699501013259,acido,i
261,0211-699501013259,folico,i
261,0211-699501013259,ni,o
261,0211-699501013259,vitamina,i
261,0211-699501013259,B6,i
261,0211-699501013259,asi,o
261,0211-699501013259,como,o
261,0211-699501013259,los,o
261,0211-699501013259,incorporados,o
261,0211-699501013259,posteriormente,o
261,0211-699501013259,a,o
261,0211-699501013259,partir,o
261,0211-699501013259,de,o
261,0211-699501013259,su,o
261,0211-699501013259,tercer,o
261,0211-699501013259,mes,o
261,0211-699501013259,en,o
261,0211-699501013259,hemodialisis,i
261,0211-699501013259,recibieron,o
261,0211-699501013259,5,o
261,0211-699501013259,mg,o
261,0211-699501013259,orales,o
261,0211-699501013259,de,o
261,0211-699501013259,acido,i
261,0211-699501013259,folico,i
261,0211-699501013259,cada,o
261,0211-699501013259,48,o
261,0211-699501013259,horas,o
261,0211-699501013259,y,o
261,0211-699501013259,40,o
261,0211-699501013259,mg,o
261,0211-699501013259,orales,o
261,0211-699501013259,de,o
261,0211-699501013259,vitamina,i
261,0211-699501013259,B6,i
261,0211-699501013259,cada,o
261,0211-699501013259,semana,o
261,0211-699501013259,Se,o
261,0211-699501013259,determinaron,o
261,0211-699501013259,al,o
261,0211-699501013259,comienzo,o
261,0211-699501013259,del,o
261,0211-699501013259,estudio,o
261,0211-699501013259,y,o
261,0211-699501013259,cada,o
261,0211-699501013259,2,o
261,0211-699501013259,meses,o
261,0211-699501013259,niveles,i
261,0211-699501013259,de,i
261,0211-699501013259,folato,i
261,0211-699501013259,vitamina,i
261,0211-699501013259,B12,i
261,0211-699501013259,inmunoensayo,i
261,0211-699501013259,albumina,i
261,0211-699501013259,y,o
261,0211-699501013259,cinetica,o
261,0211-699501013259,de,o
261,0211-699501013259,la,o
261,0211-699501013259,urea,i
261,0211-699501013259,KTV,o
261,0211-699501013259,KRU,o
261,0211-699501013259,PCRn,o
261,0211-699501013259,y,o
261,0211-699501013259,cada,o
261,0211-699501013259,6,o
261,0211-699501013259,meses,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,HPLC,i
261,0211-699501013259,y,o
261,0211-699501013259,pp,i
261,0211-699501013259,RIA,i
261,0211-699501013259,Resultados,o
261,0211-699501013259,80,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,fueron,o
261,0211-699501013259,incluidos,o
261,0211-699501013259,en,o
261,0211-699501013259,el,o
261,0211-699501013259,estudio,o
261,0211-699501013259,basal,o
261,0211-699501013259,con,o
261,0211-699501013259,una,o
261,0211-699501013259,prevalencia,o
261,0211-699501013259,de,o
261,0211-699501013259,hiperhomocisteinemia,i
261,0211-699501013259,del,o
261,0211-699501013259,844,o
261,0211-699501013259,deficit,i
261,0211-699501013259,de,i
261,0211-699501013259,pp,i
261,0211-699501013259,en,o
261,0211-699501013259,el,o
261,0211-699501013259,32,o
261,0211-699501013259,y,o
261,0211-699501013259,folato,i
261,0211-699501013259,en,o
261,0211-699501013259,el,o
261,0211-699501013259,rango,o
261,0211-699501013259,normal,o
261,0211-699501013259,bajo,o
261,0211-699501013259,los,o
261,0211-699501013259,niveles,i
261,0211-699501013259,de,i
261,0211-699501013259,tHcy,i
261,0211-699501013259,se,o
261,0211-699501013259,correlacionaban,o
261,0211-699501013259,inversamente,o
261,0211-699501013259,con,o
261,0211-699501013259,los,o
261,0211-699501013259,del,o
261,0211-699501013259,folato,i
261,0211-699501013259,r,o
261,0211-699501013259,0336,o
261,0211-699501013259,p,o
261,0211-699501013259,001,o
261,0211-699501013259,pero,o
261,0211-699501013259,no,o
261,0211-699501013259,con,o
261,0211-699501013259,pp,i
261,0211-699501013259,B12,i
261,0211-699501013259,edad,o
261,0211-699501013259,albumina,i
261,0211-699501013259,KTV,o
261,0211-699501013259,KRU,o
261,0211-699501013259,PCRn,o
261,0211-699501013259,Cincuenta,o
261,0211-699501013259,y,o
261,0211-699501013259,ocho,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,recibieron,o
261,0211-699501013259,seis,o
261,0211-699501013259,meses,o
261,0211-699501013259,de,o
261,0211-699501013259,suplementacion,i
261,0211-699501013259,con,o
261,0211-699501013259,normalizacion,o
261,0211-699501013259,del,o
261,0211-699501013259,pp,i
261,0211-699501013259,aumento,o
261,0211-699501013259,del,o
261,0211-699501013259,folato,i
261,0211-699501013259,703,o
261,0211-699501013259,IC,o
261,0211-699501013259,638,o
261,0211-699501013259,795,o
261,0211-699501013259,vs,o
261,0211-699501013259,6181,o
261,0211-699501013259,IC,o
261,0211-699501013259,4447,o
261,0211-699501013259,7811,o
261,0211-699501013259,p,o
261,0211-699501013259,0001,o
261,0211-699501013259,y,o
261,0211-699501013259,descenso,o
261,0211-699501013259,de,o
261,0211-699501013259,la,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,240,o
261,0211-699501013259,IC,o
261,0211-699501013259,213,o
261,0211-699501013259,264,o
261,0211-699501013259,vs,o
261,0211-699501013259,199,o
261,0211-699501013259,IC,o
261,0211-699501013259,175,o
261,0211-699501013259,224,o
261,0211-699501013259,p,o
261,0211-699501013259,005,o
261,0211-699501013259,Han,o
261,0211-699501013259,recibido,o
261,0211-699501013259,suplementacion,i
261,0211-699501013259,durante,o
261,0211-699501013259,12,o
261,0211-699501013259,meses,o
261,0211-699501013259,33,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,pero,o
261,0211-699501013259,a,o
261,0211-699501013259,pesar,o
261,0211-699501013259,de,o
261,0211-699501013259,un,o
261,0211-699501013259,continuo,o
261,0211-699501013259,aumento,o
261,0211-699501013259,del,o
261,0211-699501013259,folato,i
261,0211-699501013259,10078,o
261,0211-699501013259,IC,o
261,0211-699501013259,7481,o
261,0211-699501013259,12674,o
261,0211-699501013259,p,o
261,0211-699501013259,0001,o
261,0211-699501013259,solo,o
261,0211-699501013259,3,o
261,0211-699501013259,pacientes,o
261,0211-699501013259,presentan,o
261,0211-699501013259,niveles,o
261,0211-699501013259,normales,o
261,0211-699501013259,de,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,correlacionandose,o
261,0211-699501013259,directamente,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,con,o
261,0211-699501013259,la,o
261,0211-699501013259,albumina,i
261,0211-699501013259,r,o
261,0211-699501013259,056,o
261,0211-699501013259,p,o
261,0211-699501013259,0001,o
261,0211-699501013259,que,o
261,0211-699501013259,se,o
261,0211-699501013259,elevo,o
261,0211-699501013259,con,o
261,0211-699501013259,respecto,o
261,0211-699501013259,al,o
261,0211-699501013259,inicio,o
261,0211-699501013259,337,o
261,0211-699501013259,IC,o
261,0211-699501013259,327,o
261,0211-699501013259,346,o
261,0211-699501013259,vs,o
261,0211-699501013259,350,o
261,0211-699501013259,IC,o
261,0211-699501013259,337,o
261,0211-699501013259,363,o
261,0211-699501013259,p,o
261,0211-699501013259,005,o
261,0211-699501013259,Conclusion,o
261,0211-699501013259,Tras,o
261,0211-699501013259,suplementacion,i
261,0211-699501013259,con,o
261,0211-699501013259,acido,i
261,0211-699501013259,folico,i
261,0211-699501013259,y,o
261,0211-699501013259,vitamina,i
261,0211-699501013259,B6,i
261,0211-699501013259,aunque,o
261,0211-699501013259,inicialmente,o
261,0211-699501013259,se,o
261,0211-699501013259,reduce,o
261,0211-699501013259,la,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,esta,o
261,0211-699501013259,respuesta,o
261,0211-699501013259,se,o
261,0211-699501013259,hace,o
261,0211-699501013259,refractaria,o
261,0211-699501013259,correlacionandose,o
261,0211-699501013259,directamente,o
261,0211-699501013259,la,o
261,0211-699501013259,tHcy,i
261,0211-699501013259,con,o
261,0211-699501013259,la,o
261,0211-699501013259,albumina,i
261,0211-699501013259,plasmatica,i
261,0211-699501013259,La,o
261,0211-699501013259,interpretacion,o
261,0211-699501013259,de,o
261,0211-699501013259,los,o
261,0211-699501013259,niveles,i
261,0211-699501013259,de,i
261,0211-699501013259,tHcy,i
261,0211-699501013259,debe,o
261,0211-699501013259,tener,o
261,0211-699501013259,en,o
261,0211-699501013259,cuenta,o
261,0211-699501013259,la,o
261,0211-699501013259,concentracion,i
261,0211-699501013259,de,i
261,0211-699501013259,albumina,i
262,0211-699501013259,Efecto,o
262,0211-699501013259,de,o
262,0211-699501013259,la,o
262,0211-699501013259,suplementacion,i
262,0211-699501013259,con,o
262,0211-699501013259,acido,i
262,0211-699501013259,folico,i
262,0211-699501013259,sobre,o
262,0211-699501013259,los,o
262,0211-699501013259,niveles,i
262,0211-699501013259,de,i
262,0211-699501013259,homocisteina,i
262,0211-699501013259,total,o
262,0211-699501013259,en,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,en,o
262,0211-699501013259,hemodialisis,i
262,0211-699501013259,La,o
262,0211-699501013259,hiperhomocisteinemia,i
262,0211-699501013259,es,o
262,0211-699501013259,un,o
262,0211-699501013259,marcador,o
262,0211-699501013259,de,o
262,0211-699501013259,riesgo,o
262,0211-699501013259,independiente,o
262,0211-699501013259,de,o
262,0211-699501013259,morbimortalidad,o
262,0211-699501013259,cardiovascular,i
262,0211-699501013259,Hemos,o
262,0211-699501013259,intentado,o
262,0211-699501013259,prospectivamente,o
262,0211-699501013259,reducir,o
262,0211-699501013259,los,o
262,0211-699501013259,niveles,i
262,0211-699501013259,de,i
262,0211-699501013259,homocisteina,i
262,0211-699501013259,total,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,mediante,o
262,0211-699501013259,suplemento,o
262,0211-699501013259,con,o
262,0211-699501013259,acido,i
262,0211-699501013259,folico,i
262,0211-699501013259,y,o
262,0211-699501013259,vitamina,i
262,0211-699501013259,B6,i
262,0211-699501013259,pp,i
262,0211-699501013259,valorando,o
262,0211-699501013259,su,o
262,0211-699501013259,posible,o
262,0211-699501013259,correlacion,o
262,0211-699501013259,con,o
262,0211-699501013259,dosis,o
262,0211-699501013259,de,o
262,0211-699501013259,dialisis,i
262,0211-699501013259,funcion,i
262,0211-699501013259,residual,i
262,0211-699501013259,y,o
262,0211-699501013259,parametros,o
262,0211-699501013259,nutricionales,o
262,0211-699501013259,Metodos,o
262,0211-699501013259,Todos,o
262,0211-699501013259,los,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,en,o
262,0211-699501013259,hemodialisis,i
262,0211-699501013259,al,o
262,0211-699501013259,comienzo,o
262,0211-699501013259,del,o
262,0211-699501013259,estudio,o
262,0211-699501013259,que,o
262,0211-699501013259,no,o
262,0211-699501013259,recibian,o
262,0211-699501013259,acido,i
262,0211-699501013259,folico,i
262,0211-699501013259,ni,o
262,0211-699501013259,vitamina,i
262,0211-699501013259,B6,i
262,0211-699501013259,asi,o
262,0211-699501013259,como,o
262,0211-699501013259,los,o
262,0211-699501013259,incorporados,o
262,0211-699501013259,posteriormente,o
262,0211-699501013259,a,o
262,0211-699501013259,partir,o
262,0211-699501013259,de,o
262,0211-699501013259,su,o
262,0211-699501013259,tercer,o
262,0211-699501013259,mes,o
262,0211-699501013259,en,o
262,0211-699501013259,hemodialisis,i
262,0211-699501013259,recibieron,o
262,0211-699501013259,5,o
262,0211-699501013259,mg,o
262,0211-699501013259,orales,o
262,0211-699501013259,de,o
262,0211-699501013259,acido,i
262,0211-699501013259,folico,i
262,0211-699501013259,cada,o
262,0211-699501013259,48,o
262,0211-699501013259,horas,o
262,0211-699501013259,y,o
262,0211-699501013259,40,o
262,0211-699501013259,mg,o
262,0211-699501013259,orales,o
262,0211-699501013259,de,o
262,0211-699501013259,vitamina,i
262,0211-699501013259,B6,i
262,0211-699501013259,cada,o
262,0211-699501013259,semana,o
262,0211-699501013259,Se,o
262,0211-699501013259,determinaron,o
262,0211-699501013259,al,o
262,0211-699501013259,comienzo,o
262,0211-699501013259,del,o
262,0211-699501013259,estudio,o
262,0211-699501013259,y,o
262,0211-699501013259,cada,o
262,0211-699501013259,2,o
262,0211-699501013259,meses,o
262,0211-699501013259,niveles,i
262,0211-699501013259,de,i
262,0211-699501013259,folato,i
262,0211-699501013259,vitamina,i
262,0211-699501013259,B12,i
262,0211-699501013259,inmunoensayo,i
262,0211-699501013259,albumina,i
262,0211-699501013259,y,o
262,0211-699501013259,cinetica,o
262,0211-699501013259,de,o
262,0211-699501013259,la,o
262,0211-699501013259,urea,i
262,0211-699501013259,KTV,o
262,0211-699501013259,KRU,o
262,0211-699501013259,PCRn,o
262,0211-699501013259,y,o
262,0211-699501013259,cada,o
262,0211-699501013259,6,o
262,0211-699501013259,meses,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,HPLC,i
262,0211-699501013259,y,o
262,0211-699501013259,pp,i
262,0211-699501013259,RIA,i
262,0211-699501013259,Resultados,o
262,0211-699501013259,80,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,fueron,o
262,0211-699501013259,incluidos,o
262,0211-699501013259,en,o
262,0211-699501013259,el,o
262,0211-699501013259,estudio,o
262,0211-699501013259,basal,o
262,0211-699501013259,con,o
262,0211-699501013259,una,o
262,0211-699501013259,prevalencia,o
262,0211-699501013259,de,o
262,0211-699501013259,hiperhomocisteinemia,i
262,0211-699501013259,del,o
262,0211-699501013259,844,o
262,0211-699501013259,deficit,i
262,0211-699501013259,de,i
262,0211-699501013259,pp,i
262,0211-699501013259,en,o
262,0211-699501013259,el,o
262,0211-699501013259,32,o
262,0211-699501013259,y,o
262,0211-699501013259,folato,i
262,0211-699501013259,en,o
262,0211-699501013259,el,o
262,0211-699501013259,rango,o
262,0211-699501013259,normal,o
262,0211-699501013259,bajo,o
262,0211-699501013259,los,o
262,0211-699501013259,niveles,i
262,0211-699501013259,de,i
262,0211-699501013259,tHcy,i
262,0211-699501013259,se,o
262,0211-699501013259,correlacionaban,o
262,0211-699501013259,inversamente,o
262,0211-699501013259,con,o
262,0211-699501013259,los,o
262,0211-699501013259,del,o
262,0211-699501013259,folato,i
262,0211-699501013259,r,o
262,0211-699501013259,0336,o
262,0211-699501013259,p,o
262,0211-699501013259,001,o
262,0211-699501013259,pero,o
262,0211-699501013259,no,o
262,0211-699501013259,con,o
262,0211-699501013259,pp,i
262,0211-699501013259,B12,i
262,0211-699501013259,edad,o
262,0211-699501013259,albumina,i
262,0211-699501013259,KTV,o
262,0211-699501013259,KRU,o
262,0211-699501013259,PCRn,o
262,0211-699501013259,Cincuenta,o
262,0211-699501013259,y,o
262,0211-699501013259,ocho,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,recibieron,o
262,0211-699501013259,seis,o
262,0211-699501013259,meses,o
262,0211-699501013259,de,o
262,0211-699501013259,suplementacion,i
262,0211-699501013259,con,o
262,0211-699501013259,normalizacion,o
262,0211-699501013259,del,o
262,0211-699501013259,pp,i
262,0211-699501013259,aumento,o
262,0211-699501013259,del,o
262,0211-699501013259,folato,i
262,0211-699501013259,703,o
262,0211-699501013259,IC,o
262,0211-699501013259,638,o
262,0211-699501013259,795,o
262,0211-699501013259,vs,o
262,0211-699501013259,6181,o
262,0211-699501013259,IC,o
262,0211-699501013259,4447,o
262,0211-699501013259,7811,o
262,0211-699501013259,p,o
262,0211-699501013259,0001,o
262,0211-699501013259,y,o
262,0211-699501013259,descenso,o
262,0211-699501013259,de,o
262,0211-699501013259,la,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,240,o
262,0211-699501013259,IC,o
262,0211-699501013259,213,o
262,0211-699501013259,264,o
262,0211-699501013259,vs,o
262,0211-699501013259,199,o
262,0211-699501013259,IC,o
262,0211-699501013259,175,o
262,0211-699501013259,224,o
262,0211-699501013259,p,o
262,0211-699501013259,005,o
262,0211-699501013259,Han,o
262,0211-699501013259,recibido,o
262,0211-699501013259,suplementacion,i
262,0211-699501013259,durante,o
262,0211-699501013259,12,o
262,0211-699501013259,meses,o
262,0211-699501013259,33,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,pero,o
262,0211-699501013259,a,o
262,0211-699501013259,pesar,o
262,0211-699501013259,de,o
262,0211-699501013259,un,o
262,0211-699501013259,continuo,o
262,0211-699501013259,aumento,o
262,0211-699501013259,del,o
262,0211-699501013259,folato,i
262,0211-699501013259,10078,o
262,0211-699501013259,IC,o
262,0211-699501013259,7481,o
262,0211-699501013259,12674,o
262,0211-699501013259,p,o
262,0211-699501013259,0001,o
262,0211-699501013259,solo,o
262,0211-699501013259,3,o
262,0211-699501013259,pacientes,o
262,0211-699501013259,presentan,o
262,0211-699501013259,niveles,o
262,0211-699501013259,normales,o
262,0211-699501013259,de,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,correlacionandose,o
262,0211-699501013259,directamente,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,con,o
262,0211-699501013259,la,o
262,0211-699501013259,albumina,i
262,0211-699501013259,r,o
262,0211-699501013259,056,o
262,0211-699501013259,p,o
262,0211-699501013259,0001,o
262,0211-699501013259,que,o
262,0211-699501013259,se,o
262,0211-699501013259,elevo,o
262,0211-699501013259,con,o
262,0211-699501013259,respecto,o
262,0211-699501013259,al,o
262,0211-699501013259,inicio,o
262,0211-699501013259,337,o
262,0211-699501013259,IC,o
262,0211-699501013259,327,o
262,0211-699501013259,346,o
262,0211-699501013259,vs,o
262,0211-699501013259,350,o
262,0211-699501013259,IC,o
262,0211-699501013259,337,o
262,0211-699501013259,363,o
262,0211-699501013259,p,o
262,0211-699501013259,005,o
262,0211-699501013259,Conclusion,o
262,0211-699501013259,Tras,o
262,0211-699501013259,suplementacion,i
262,0211-699501013259,con,o
262,0211-699501013259,acido,i
262,0211-699501013259,folico,i
262,0211-699501013259,y,o
262,0211-699501013259,vitamina,i
262,0211-699501013259,B6,i
262,0211-699501013259,aunque,o
262,0211-699501013259,inicialmente,o
262,0211-699501013259,se,o
262,0211-699501013259,reduce,o
262,0211-699501013259,la,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,esta,o
262,0211-699501013259,respuesta,o
262,0211-699501013259,se,o
262,0211-699501013259,hace,o
262,0211-699501013259,refractaria,o
262,0211-699501013259,correlacionandose,o
262,0211-699501013259,directamente,o
262,0211-699501013259,la,o
262,0211-699501013259,tHcy,i
262,0211-699501013259,con,o
262,0211-699501013259,la,o
262,0211-699501013259,albumina,i
262,0211-699501013259,plasmatica,i
262,0211-699501013259,La,o
262,0211-699501013259,interpretacion,o
262,0211-699501013259,de,o
262,0211-699501013259,los,o
262,0211-699501013259,niveles,i
262,0211-699501013259,de,i
262,0211-699501013259,tHcy,i
262,0211-699501013259,debe,o
262,0211-699501013259,tener,o
262,0211-699501013259,en,o
262,0211-699501013259,cuenta,o
262,0211-699501013259,la,o
262,0211-699501013259,concentracion,i
262,0211-699501013259,de,i
262,0211-699501013259,albumina,i
263,0211-699501013259,Efecto,o
263,0211-699501013259,de,o
263,0211-699501013259,la,o
263,0211-699501013259,suplementacion,i
263,0211-699501013259,con,o
263,0211-699501013259,acido,i
263,0211-699501013259,folico,i
263,0211-699501013259,sobre,o
263,0211-699501013259,los,o
263,0211-699501013259,niveles,i
263,0211-699501013259,de,i
263,0211-699501013259,homocisteina,i
263,0211-699501013259,total,o
263,0211-699501013259,en,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,en,o
263,0211-699501013259,hemodialisis,i
263,0211-699501013259,La,o
263,0211-699501013259,hiperhomocisteinemia,i
263,0211-699501013259,es,o
263,0211-699501013259,un,o
263,0211-699501013259,marcador,o
263,0211-699501013259,de,o
263,0211-699501013259,riesgo,o
263,0211-699501013259,independiente,o
263,0211-699501013259,de,o
263,0211-699501013259,morbimortalidad,o
263,0211-699501013259,cardiovascular,i
263,0211-699501013259,Hemos,o
263,0211-699501013259,intentado,o
263,0211-699501013259,prospectivamente,o
263,0211-699501013259,reducir,o
263,0211-699501013259,los,o
263,0211-699501013259,niveles,i
263,0211-699501013259,de,i
263,0211-699501013259,homocisteina,i
263,0211-699501013259,total,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,mediante,o
263,0211-699501013259,suplemento,o
263,0211-699501013259,con,o
263,0211-699501013259,acido,i
263,0211-699501013259,folico,i
263,0211-699501013259,y,o
263,0211-699501013259,vitamina,i
263,0211-699501013259,B6,i
263,0211-699501013259,pp,i
263,0211-699501013259,valorando,o
263,0211-699501013259,su,o
263,0211-699501013259,posible,o
263,0211-699501013259,correlacion,o
263,0211-699501013259,con,o
263,0211-699501013259,dosis,o
263,0211-699501013259,de,o
263,0211-699501013259,dialisis,i
263,0211-699501013259,funcion,i
263,0211-699501013259,residual,i
263,0211-699501013259,y,o
263,0211-699501013259,parametros,o
263,0211-699501013259,nutricionales,o
263,0211-699501013259,Metodos,o
263,0211-699501013259,Todos,o
263,0211-699501013259,los,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,en,o
263,0211-699501013259,hemodialisis,i
263,0211-699501013259,al,o
263,0211-699501013259,comienzo,o
263,0211-699501013259,del,o
263,0211-699501013259,estudio,o
263,0211-699501013259,que,o
263,0211-699501013259,no,o
263,0211-699501013259,recibian,o
263,0211-699501013259,acido,i
263,0211-699501013259,folico,i
263,0211-699501013259,ni,o
263,0211-699501013259,vitamina,i
263,0211-699501013259,B6,i
263,0211-699501013259,asi,o
263,0211-699501013259,como,o
263,0211-699501013259,los,o
263,0211-699501013259,incorporados,o
263,0211-699501013259,posteriormente,o
263,0211-699501013259,a,o
263,0211-699501013259,partir,o
263,0211-699501013259,de,o
263,0211-699501013259,su,o
263,0211-699501013259,tercer,o
263,0211-699501013259,mes,o
263,0211-699501013259,en,o
263,0211-699501013259,hemodialisis,i
263,0211-699501013259,recibieron,o
263,0211-699501013259,5,o
263,0211-699501013259,mg,o
263,0211-699501013259,orales,o
263,0211-699501013259,de,o
263,0211-699501013259,acido,i
263,0211-699501013259,folico,i
263,0211-699501013259,cada,o
263,0211-699501013259,48,o
263,0211-699501013259,horas,o
263,0211-699501013259,y,o
263,0211-699501013259,40,o
263,0211-699501013259,mg,o
263,0211-699501013259,orales,o
263,0211-699501013259,de,o
263,0211-699501013259,vitamina,i
263,0211-699501013259,B6,i
263,0211-699501013259,cada,o
263,0211-699501013259,semana,o
263,0211-699501013259,Se,o
263,0211-699501013259,determinaron,o
263,0211-699501013259,al,o
263,0211-699501013259,comienzo,o
263,0211-699501013259,del,o
263,0211-699501013259,estudio,o
263,0211-699501013259,y,o
263,0211-699501013259,cada,o
263,0211-699501013259,2,o
263,0211-699501013259,meses,o
263,0211-699501013259,niveles,i
263,0211-699501013259,de,i
263,0211-699501013259,folato,i
263,0211-699501013259,vitamina,i
263,0211-699501013259,B12,i
263,0211-699501013259,inmunoensayo,i
263,0211-699501013259,albumina,i
263,0211-699501013259,y,o
263,0211-699501013259,cinetica,o
263,0211-699501013259,de,o
263,0211-699501013259,la,o
263,0211-699501013259,urea,i
263,0211-699501013259,KTV,o
263,0211-699501013259,KRU,o
263,0211-699501013259,PCRn,o
263,0211-699501013259,y,o
263,0211-699501013259,cada,o
263,0211-699501013259,6,o
263,0211-699501013259,meses,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,HPLC,i
263,0211-699501013259,y,o
263,0211-699501013259,pp,i
263,0211-699501013259,RIA,i
263,0211-699501013259,Resultados,o
263,0211-699501013259,80,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,fueron,o
263,0211-699501013259,incluidos,o
263,0211-699501013259,en,o
263,0211-699501013259,el,o
263,0211-699501013259,estudio,o
263,0211-699501013259,basal,o
263,0211-699501013259,con,o
263,0211-699501013259,una,o
263,0211-699501013259,prevalencia,o
263,0211-699501013259,de,o
263,0211-699501013259,hiperhomocisteinemia,i
263,0211-699501013259,del,o
263,0211-699501013259,844,o
263,0211-699501013259,deficit,i
263,0211-699501013259,de,i
263,0211-699501013259,pp,i
263,0211-699501013259,en,o
263,0211-699501013259,el,o
263,0211-699501013259,32,o
263,0211-699501013259,y,o
263,0211-699501013259,folato,i
263,0211-699501013259,en,o
263,0211-699501013259,el,o
263,0211-699501013259,rango,o
263,0211-699501013259,normal,o
263,0211-699501013259,bajo,o
263,0211-699501013259,los,o
263,0211-699501013259,niveles,i
263,0211-699501013259,de,i
263,0211-699501013259,tHcy,i
263,0211-699501013259,se,o
263,0211-699501013259,correlacionaban,o
263,0211-699501013259,inversamente,o
263,0211-699501013259,con,o
263,0211-699501013259,los,o
263,0211-699501013259,del,o
263,0211-699501013259,folato,i
263,0211-699501013259,r,o
263,0211-699501013259,0336,o
263,0211-699501013259,p,o
263,0211-699501013259,001,o
263,0211-699501013259,pero,o
263,0211-699501013259,no,o
263,0211-699501013259,con,o
263,0211-699501013259,pp,i
263,0211-699501013259,B12,i
263,0211-699501013259,edad,o
263,0211-699501013259,albumina,i
263,0211-699501013259,KTV,o
263,0211-699501013259,KRU,o
263,0211-699501013259,PCRn,o
263,0211-699501013259,Cincuenta,o
263,0211-699501013259,y,o
263,0211-699501013259,ocho,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,recibieron,o
263,0211-699501013259,seis,o
263,0211-699501013259,meses,o
263,0211-699501013259,de,o
263,0211-699501013259,suplementacion,i
263,0211-699501013259,con,o
263,0211-699501013259,normalizacion,o
263,0211-699501013259,del,o
263,0211-699501013259,pp,i
263,0211-699501013259,aumento,o
263,0211-699501013259,del,o
263,0211-699501013259,folato,i
263,0211-699501013259,703,o
263,0211-699501013259,IC,o
263,0211-699501013259,638,o
263,0211-699501013259,795,o
263,0211-699501013259,vs,o
263,0211-699501013259,6181,o
263,0211-699501013259,IC,o
263,0211-699501013259,4447,o
263,0211-699501013259,7811,o
263,0211-699501013259,p,o
263,0211-699501013259,0001,o
263,0211-699501013259,y,o
263,0211-699501013259,descenso,o
263,0211-699501013259,de,o
263,0211-699501013259,la,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,240,o
263,0211-699501013259,IC,o
263,0211-699501013259,213,o
263,0211-699501013259,264,o
263,0211-699501013259,vs,o
263,0211-699501013259,199,o
263,0211-699501013259,IC,o
263,0211-699501013259,175,o
263,0211-699501013259,224,o
263,0211-699501013259,p,o
263,0211-699501013259,005,o
263,0211-699501013259,Han,o
263,0211-699501013259,recibido,o
263,0211-699501013259,suplementacion,i
263,0211-699501013259,durante,o
263,0211-699501013259,12,o
263,0211-699501013259,meses,o
263,0211-699501013259,33,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,pero,o
263,0211-699501013259,a,o
263,0211-699501013259,pesar,o
263,0211-699501013259,de,o
263,0211-699501013259,un,o
263,0211-699501013259,continuo,o
263,0211-699501013259,aumento,o
263,0211-699501013259,del,o
263,0211-699501013259,folato,i
263,0211-699501013259,10078,o
263,0211-699501013259,IC,o
263,0211-699501013259,7481,o
263,0211-699501013259,12674,o
263,0211-699501013259,p,o
263,0211-699501013259,0001,o
263,0211-699501013259,solo,o
263,0211-699501013259,3,o
263,0211-699501013259,pacientes,o
263,0211-699501013259,presentan,o
263,0211-699501013259,niveles,o
263,0211-699501013259,normales,o
263,0211-699501013259,de,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,correlacionandose,o
263,0211-699501013259,directamente,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,con,o
263,0211-699501013259,la,o
263,0211-699501013259,albumina,i
263,0211-699501013259,r,o
263,0211-699501013259,056,o
263,0211-699501013259,p,o
263,0211-699501013259,0001,o
263,0211-699501013259,que,o
263,0211-699501013259,se,o
263,0211-699501013259,elevo,o
263,0211-699501013259,con,o
263,0211-699501013259,respecto,o
263,0211-699501013259,al,o
263,0211-699501013259,inicio,o
263,0211-699501013259,337,o
263,0211-699501013259,IC,o
263,0211-699501013259,327,o
263,0211-699501013259,346,o
263,0211-699501013259,vs,o
263,0211-699501013259,350,o
263,0211-699501013259,IC,o
263,0211-699501013259,337,o
263,0211-699501013259,363,o
263,0211-699501013259,p,o
263,0211-699501013259,005,o
263,0211-699501013259,Conclusion,o
263,0211-699501013259,Tras,o
263,0211-699501013259,suplementacion,i
263,0211-699501013259,con,o
263,0211-699501013259,acido,i
263,0211-699501013259,folico,i
263,0211-699501013259,y,o
263,0211-699501013259,vitamina,i
263,0211-699501013259,B6,i
263,0211-699501013259,aunque,o
263,0211-699501013259,inicialmente,o
263,0211-699501013259,se,o
263,0211-699501013259,reduce,o
263,0211-699501013259,la,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,esta,o
263,0211-699501013259,respuesta,o
263,0211-699501013259,se,o
263,0211-699501013259,hace,o
263,0211-699501013259,refractaria,o
263,0211-699501013259,correlacionandose,o
263,0211-699501013259,directamente,o
263,0211-699501013259,la,o
263,0211-699501013259,tHcy,i
263,0211-699501013259,con,o
263,0211-699501013259,la,o
263,0211-699501013259,albumina,i
263,0211-699501013259,plasmatica,i
263,0211-699501013259,La,o
263,0211-699501013259,interpretacion,o
263,0211-699501013259,de,o
263,0211-699501013259,los,o
263,0211-699501013259,niveles,i
263,0211-699501013259,de,i
263,0211-699501013259,tHcy,i
263,0211-699501013259,debe,o
263,0211-699501013259,tener,o
263,0211-699501013259,en,o
263,0211-699501013259,cuenta,o
263,0211-699501013259,la,o
263,0211-699501013259,concentracion,i
263,0211-699501013259,de,i
263,0211-699501013259,albumina,i
264,0211-699501013259,Efecto,o
264,0211-699501013259,de,o
264,0211-699501013259,la,o
264,0211-699501013259,suplementacion,i
264,0211-699501013259,con,o
264,0211-699501013259,acido,i
264,0211-699501013259,folico,i
264,0211-699501013259,sobre,o
264,0211-699501013259,los,o
264,0211-699501013259,niveles,i
264,0211-699501013259,de,i
264,0211-699501013259,homocisteina,i
264,0211-699501013259,total,o
264,0211-699501013259,en,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,en,o
264,0211-699501013259,hemodialisis,i
264,0211-699501013259,La,o
264,0211-699501013259,hiperhomocisteinemia,i
264,0211-699501013259,es,o
264,0211-699501013259,un,o
264,0211-699501013259,marcador,o
264,0211-699501013259,de,o
264,0211-699501013259,riesgo,o
264,0211-699501013259,independiente,o
264,0211-699501013259,de,o
264,0211-699501013259,morbimortalidad,o
264,0211-699501013259,cardiovascular,i
264,0211-699501013259,Hemos,o
264,0211-699501013259,intentado,o
264,0211-699501013259,prospectivamente,o
264,0211-699501013259,reducir,o
264,0211-699501013259,los,o
264,0211-699501013259,niveles,i
264,0211-699501013259,de,i
264,0211-699501013259,homocisteina,i
264,0211-699501013259,total,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,mediante,o
264,0211-699501013259,suplemento,o
264,0211-699501013259,con,o
264,0211-699501013259,acido,i
264,0211-699501013259,folico,i
264,0211-699501013259,y,o
264,0211-699501013259,vitamina,i
264,0211-699501013259,B6,i
264,0211-699501013259,pp,i
264,0211-699501013259,valorando,o
264,0211-699501013259,su,o
264,0211-699501013259,posible,o
264,0211-699501013259,correlacion,o
264,0211-699501013259,con,o
264,0211-699501013259,dosis,o
264,0211-699501013259,de,o
264,0211-699501013259,dialisis,i
264,0211-699501013259,funcion,i
264,0211-699501013259,residual,i
264,0211-699501013259,y,o
264,0211-699501013259,parametros,o
264,0211-699501013259,nutricionales,o
264,0211-699501013259,Metodos,o
264,0211-699501013259,Todos,o
264,0211-699501013259,los,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,en,o
264,0211-699501013259,hemodialisis,i
264,0211-699501013259,al,o
264,0211-699501013259,comienzo,o
264,0211-699501013259,del,o
264,0211-699501013259,estudio,o
264,0211-699501013259,que,o
264,0211-699501013259,no,o
264,0211-699501013259,recibian,o
264,0211-699501013259,acido,i
264,0211-699501013259,folico,i
264,0211-699501013259,ni,o
264,0211-699501013259,vitamina,i
264,0211-699501013259,B6,i
264,0211-699501013259,asi,o
264,0211-699501013259,como,o
264,0211-699501013259,los,o
264,0211-699501013259,incorporados,o
264,0211-699501013259,posteriormente,o
264,0211-699501013259,a,o
264,0211-699501013259,partir,o
264,0211-699501013259,de,o
264,0211-699501013259,su,o
264,0211-699501013259,tercer,o
264,0211-699501013259,mes,o
264,0211-699501013259,en,o
264,0211-699501013259,hemodialisis,i
264,0211-699501013259,recibieron,o
264,0211-699501013259,5,o
264,0211-699501013259,mg,o
264,0211-699501013259,orales,o
264,0211-699501013259,de,o
264,0211-699501013259,acido,i
264,0211-699501013259,folico,i
264,0211-699501013259,cada,o
264,0211-699501013259,48,o
264,0211-699501013259,horas,o
264,0211-699501013259,y,o
264,0211-699501013259,40,o
264,0211-699501013259,mg,o
264,0211-699501013259,orales,o
264,0211-699501013259,de,o
264,0211-699501013259,vitamina,i
264,0211-699501013259,B6,i
264,0211-699501013259,cada,o
264,0211-699501013259,semana,o
264,0211-699501013259,Se,o
264,0211-699501013259,determinaron,o
264,0211-699501013259,al,o
264,0211-699501013259,comienzo,o
264,0211-699501013259,del,o
264,0211-699501013259,estudio,o
264,0211-699501013259,y,o
264,0211-699501013259,cada,o
264,0211-699501013259,2,o
264,0211-699501013259,meses,o
264,0211-699501013259,niveles,i
264,0211-699501013259,de,i
264,0211-699501013259,folato,i
264,0211-699501013259,vitamina,i
264,0211-699501013259,B12,i
264,0211-699501013259,inmunoensayo,i
264,0211-699501013259,albumina,i
264,0211-699501013259,y,o
264,0211-699501013259,cinetica,o
264,0211-699501013259,de,o
264,0211-699501013259,la,o
264,0211-699501013259,urea,i
264,0211-699501013259,KTV,o
264,0211-699501013259,KRU,o
264,0211-699501013259,PCRn,o
264,0211-699501013259,y,o
264,0211-699501013259,cada,o
264,0211-699501013259,6,o
264,0211-699501013259,meses,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,HPLC,i
264,0211-699501013259,y,o
264,0211-699501013259,pp,i
264,0211-699501013259,RIA,i
264,0211-699501013259,Resultados,o
264,0211-699501013259,80,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,fueron,o
264,0211-699501013259,incluidos,o
264,0211-699501013259,en,o
264,0211-699501013259,el,o
264,0211-699501013259,estudio,o
264,0211-699501013259,basal,o
264,0211-699501013259,con,o
264,0211-699501013259,una,o
264,0211-699501013259,prevalencia,o
264,0211-699501013259,de,o
264,0211-699501013259,hiperhomocisteinemia,i
264,0211-699501013259,del,o
264,0211-699501013259,844,o
264,0211-699501013259,deficit,i
264,0211-699501013259,de,i
264,0211-699501013259,pp,i
264,0211-699501013259,en,o
264,0211-699501013259,el,o
264,0211-699501013259,32,o
264,0211-699501013259,y,o
264,0211-699501013259,folato,i
264,0211-699501013259,en,o
264,0211-699501013259,el,o
264,0211-699501013259,rango,o
264,0211-699501013259,normal,o
264,0211-699501013259,bajo,o
264,0211-699501013259,los,o
264,0211-699501013259,niveles,i
264,0211-699501013259,de,i
264,0211-699501013259,tHcy,i
264,0211-699501013259,se,o
264,0211-699501013259,correlacionaban,o
264,0211-699501013259,inversamente,o
264,0211-699501013259,con,o
264,0211-699501013259,los,o
264,0211-699501013259,del,o
264,0211-699501013259,folato,i
264,0211-699501013259,r,o
264,0211-699501013259,0336,o
264,0211-699501013259,p,o
264,0211-699501013259,001,o
264,0211-699501013259,pero,o
264,0211-699501013259,no,o
264,0211-699501013259,con,o
264,0211-699501013259,pp,i
264,0211-699501013259,B12,i
264,0211-699501013259,edad,o
264,0211-699501013259,albumina,i
264,0211-699501013259,KTV,o
264,0211-699501013259,KRU,o
264,0211-699501013259,PCRn,o
264,0211-699501013259,Cincuenta,o
264,0211-699501013259,y,o
264,0211-699501013259,ocho,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,recibieron,o
264,0211-699501013259,seis,o
264,0211-699501013259,meses,o
264,0211-699501013259,de,o
264,0211-699501013259,suplementacion,i
264,0211-699501013259,con,o
264,0211-699501013259,normalizacion,o
264,0211-699501013259,del,o
264,0211-699501013259,pp,i
264,0211-699501013259,aumento,o
264,0211-699501013259,del,o
264,0211-699501013259,folato,i
264,0211-699501013259,703,o
264,0211-699501013259,IC,o
264,0211-699501013259,638,o
264,0211-699501013259,795,o
264,0211-699501013259,vs,o
264,0211-699501013259,6181,o
264,0211-699501013259,IC,o
264,0211-699501013259,4447,o
264,0211-699501013259,7811,o
264,0211-699501013259,p,o
264,0211-699501013259,0001,o
264,0211-699501013259,y,o
264,0211-699501013259,descenso,o
264,0211-699501013259,de,o
264,0211-699501013259,la,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,240,o
264,0211-699501013259,IC,o
264,0211-699501013259,213,o
264,0211-699501013259,264,o
264,0211-699501013259,vs,o
264,0211-699501013259,199,o
264,0211-699501013259,IC,o
264,0211-699501013259,175,o
264,0211-699501013259,224,o
264,0211-699501013259,p,o
264,0211-699501013259,005,o
264,0211-699501013259,Han,o
264,0211-699501013259,recibido,o
264,0211-699501013259,suplementacion,i
264,0211-699501013259,durante,o
264,0211-699501013259,12,o
264,0211-699501013259,meses,o
264,0211-699501013259,33,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,pero,o
264,0211-699501013259,a,o
264,0211-699501013259,pesar,o
264,0211-699501013259,de,o
264,0211-699501013259,un,o
264,0211-699501013259,continuo,o
264,0211-699501013259,aumento,o
264,0211-699501013259,del,o
264,0211-699501013259,folato,i
264,0211-699501013259,10078,o
264,0211-699501013259,IC,o
264,0211-699501013259,7481,o
264,0211-699501013259,12674,o
264,0211-699501013259,p,o
264,0211-699501013259,0001,o
264,0211-699501013259,solo,o
264,0211-699501013259,3,o
264,0211-699501013259,pacientes,o
264,0211-699501013259,presentan,o
264,0211-699501013259,niveles,o
264,0211-699501013259,normales,o
264,0211-699501013259,de,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,correlacionandose,o
264,0211-699501013259,directamente,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,con,o
264,0211-699501013259,la,o
264,0211-699501013259,albumina,i
264,0211-699501013259,r,o
264,0211-699501013259,056,o
264,0211-699501013259,p,o
264,0211-699501013259,0001,o
264,0211-699501013259,que,o
264,0211-699501013259,se,o
264,0211-699501013259,elevo,o
264,0211-699501013259,con,o
264,0211-699501013259,respecto,o
264,0211-699501013259,al,o
264,0211-699501013259,inicio,o
264,0211-699501013259,337,o
264,0211-699501013259,IC,o
264,0211-699501013259,327,o
264,0211-699501013259,346,o
264,0211-699501013259,vs,o
264,0211-699501013259,350,o
264,0211-699501013259,IC,o
264,0211-699501013259,337,o
264,0211-699501013259,363,o
264,0211-699501013259,p,o
264,0211-699501013259,005,o
264,0211-699501013259,Conclusion,o
264,0211-699501013259,Tras,o
264,0211-699501013259,suplementacion,i
264,0211-699501013259,con,o
264,0211-699501013259,acido,i
264,0211-699501013259,folico,i
264,0211-699501013259,y,o
264,0211-699501013259,vitamina,i
264,0211-699501013259,B6,i
264,0211-699501013259,aunque,o
264,0211-699501013259,inicialmente,o
264,0211-699501013259,se,o
264,0211-699501013259,reduce,o
264,0211-699501013259,la,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,esta,o
264,0211-699501013259,respuesta,o
264,0211-699501013259,se,o
264,0211-699501013259,hace,o
264,0211-699501013259,refractaria,o
264,0211-699501013259,correlacionandose,o
264,0211-699501013259,directamente,o
264,0211-699501013259,la,o
264,0211-699501013259,tHcy,i
264,0211-699501013259,con,o
264,0211-699501013259,la,o
264,0211-699501013259,albumina,i
264,0211-699501013259,plasmatica,i
264,0211-699501013259,La,o
264,0211-699501013259,interpretacion,o
264,0211-699501013259,de,o
264,0211-699501013259,los,o
264,0211-699501013259,niveles,i
264,0211-699501013259,de,i
264,0211-699501013259,tHcy,i
264,0211-699501013259,debe,o
264,0211-699501013259,tener,o
264,0211-699501013259,en,o
264,0211-699501013259,cuenta,o
264,0211-699501013259,la,o
264,0211-699501013259,concentracion,i
264,0211-699501013259,de,i
264,0211-699501013259,albumina,i
265,0211-699501013259,Efecto,o
265,0211-699501013259,de,o
265,0211-699501013259,la,o
265,0211-699501013259,suplementacion,i
265,0211-699501013259,con,o
265,0211-699501013259,acido,i
265,0211-699501013259,folico,i
265,0211-699501013259,sobre,o
265,0211-699501013259,los,o
265,0211-699501013259,niveles,i
265,0211-699501013259,de,i
265,0211-699501013259,homocisteina,i
265,0211-699501013259,total,o
265,0211-699501013259,en,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,en,o
265,0211-699501013259,hemodialisis,i
265,0211-699501013259,La,o
265,0211-699501013259,hiperhomocisteinemia,i
265,0211-699501013259,es,o
265,0211-699501013259,un,o
265,0211-699501013259,marcador,o
265,0211-699501013259,de,o
265,0211-699501013259,riesgo,o
265,0211-699501013259,independiente,o
265,0211-699501013259,de,o
265,0211-699501013259,morbimortalidad,o
265,0211-699501013259,cardiovascular,i
265,0211-699501013259,Hemos,o
265,0211-699501013259,intentado,o
265,0211-699501013259,prospectivamente,o
265,0211-699501013259,reducir,o
265,0211-699501013259,los,o
265,0211-699501013259,niveles,i
265,0211-699501013259,de,i
265,0211-699501013259,homocisteina,i
265,0211-699501013259,total,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,mediante,o
265,0211-699501013259,suplemento,o
265,0211-699501013259,con,o
265,0211-699501013259,acido,i
265,0211-699501013259,folico,i
265,0211-699501013259,y,o
265,0211-699501013259,vitamina,i
265,0211-699501013259,B6,i
265,0211-699501013259,pp,i
265,0211-699501013259,valorando,o
265,0211-699501013259,su,o
265,0211-699501013259,posible,o
265,0211-699501013259,correlacion,o
265,0211-699501013259,con,o
265,0211-699501013259,dosis,o
265,0211-699501013259,de,o
265,0211-699501013259,dialisis,i
265,0211-699501013259,funcion,i
265,0211-699501013259,residual,i
265,0211-699501013259,y,o
265,0211-699501013259,parametros,o
265,0211-699501013259,nutricionales,o
265,0211-699501013259,Metodos,o
265,0211-699501013259,Todos,o
265,0211-699501013259,los,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,en,o
265,0211-699501013259,hemodialisis,i
265,0211-699501013259,al,o
265,0211-699501013259,comienzo,o
265,0211-699501013259,del,o
265,0211-699501013259,estudio,o
265,0211-699501013259,que,o
265,0211-699501013259,no,o
265,0211-699501013259,recibian,o
265,0211-699501013259,acido,i
265,0211-699501013259,folico,i
265,0211-699501013259,ni,o
265,0211-699501013259,vitamina,i
265,0211-699501013259,B6,i
265,0211-699501013259,asi,o
265,0211-699501013259,como,o
265,0211-699501013259,los,o
265,0211-699501013259,incorporados,o
265,0211-699501013259,posteriormente,o
265,0211-699501013259,a,o
265,0211-699501013259,partir,o
265,0211-699501013259,de,o
265,0211-699501013259,su,o
265,0211-699501013259,tercer,o
265,0211-699501013259,mes,o
265,0211-699501013259,en,o
265,0211-699501013259,hemodialisis,i
265,0211-699501013259,recibieron,o
265,0211-699501013259,5,o
265,0211-699501013259,mg,o
265,0211-699501013259,orales,o
265,0211-699501013259,de,o
265,0211-699501013259,acido,i
265,0211-699501013259,folico,i
265,0211-699501013259,cada,o
265,0211-699501013259,48,o
265,0211-699501013259,horas,o
265,0211-699501013259,y,o
265,0211-699501013259,40,o
265,0211-699501013259,mg,o
265,0211-699501013259,orales,o
265,0211-699501013259,de,o
265,0211-699501013259,vitamina,i
265,0211-699501013259,B6,i
265,0211-699501013259,cada,o
265,0211-699501013259,semana,o
265,0211-699501013259,Se,o
265,0211-699501013259,determinaron,o
265,0211-699501013259,al,o
265,0211-699501013259,comienzo,o
265,0211-699501013259,del,o
265,0211-699501013259,estudio,o
265,0211-699501013259,y,o
265,0211-699501013259,cada,o
265,0211-699501013259,2,o
265,0211-699501013259,meses,o
265,0211-699501013259,niveles,i
265,0211-699501013259,de,i
265,0211-699501013259,folato,i
265,0211-699501013259,vitamina,i
265,0211-699501013259,B12,i
265,0211-699501013259,inmunoensayo,i
265,0211-699501013259,albumina,i
265,0211-699501013259,y,o
265,0211-699501013259,cinetica,o
265,0211-699501013259,de,o
265,0211-699501013259,la,o
265,0211-699501013259,urea,i
265,0211-699501013259,KTV,o
265,0211-699501013259,KRU,o
265,0211-699501013259,PCRn,o
265,0211-699501013259,y,o
265,0211-699501013259,cada,o
265,0211-699501013259,6,o
265,0211-699501013259,meses,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,HPLC,i
265,0211-699501013259,y,o
265,0211-699501013259,pp,i
265,0211-699501013259,RIA,i
265,0211-699501013259,Resultados,o
265,0211-699501013259,80,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,fueron,o
265,0211-699501013259,incluidos,o
265,0211-699501013259,en,o
265,0211-699501013259,el,o
265,0211-699501013259,estudio,o
265,0211-699501013259,basal,o
265,0211-699501013259,con,o
265,0211-699501013259,una,o
265,0211-699501013259,prevalencia,o
265,0211-699501013259,de,o
265,0211-699501013259,hiperhomocisteinemia,i
265,0211-699501013259,del,o
265,0211-699501013259,844,o
265,0211-699501013259,deficit,i
265,0211-699501013259,de,i
265,0211-699501013259,pp,i
265,0211-699501013259,en,o
265,0211-699501013259,el,o
265,0211-699501013259,32,o
265,0211-699501013259,y,o
265,0211-699501013259,folato,i
265,0211-699501013259,en,o
265,0211-699501013259,el,o
265,0211-699501013259,rango,o
265,0211-699501013259,normal,o
265,0211-699501013259,bajo,o
265,0211-699501013259,los,o
265,0211-699501013259,niveles,i
265,0211-699501013259,de,i
265,0211-699501013259,tHcy,i
265,0211-699501013259,se,o
265,0211-699501013259,correlacionaban,o
265,0211-699501013259,inversamente,o
265,0211-699501013259,con,o
265,0211-699501013259,los,o
265,0211-699501013259,del,o
265,0211-699501013259,folato,i
265,0211-699501013259,r,o
265,0211-699501013259,0336,o
265,0211-699501013259,p,o
265,0211-699501013259,001,o
265,0211-699501013259,pero,o
265,0211-699501013259,no,o
265,0211-699501013259,con,o
265,0211-699501013259,pp,i
265,0211-699501013259,B12,i
265,0211-699501013259,edad,o
265,0211-699501013259,albumina,i
265,0211-699501013259,KTV,o
265,0211-699501013259,KRU,o
265,0211-699501013259,PCRn,o
265,0211-699501013259,Cincuenta,o
265,0211-699501013259,y,o
265,0211-699501013259,ocho,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,recibieron,o
265,0211-699501013259,seis,o
265,0211-699501013259,meses,o
265,0211-699501013259,de,o
265,0211-699501013259,suplementacion,i
265,0211-699501013259,con,o
265,0211-699501013259,normalizacion,o
265,0211-699501013259,del,o
265,0211-699501013259,pp,i
265,0211-699501013259,aumento,o
265,0211-699501013259,del,o
265,0211-699501013259,folato,i
265,0211-699501013259,703,o
265,0211-699501013259,IC,o
265,0211-699501013259,638,o
265,0211-699501013259,795,o
265,0211-699501013259,vs,o
265,0211-699501013259,6181,o
265,0211-699501013259,IC,o
265,0211-699501013259,4447,o
265,0211-699501013259,7811,o
265,0211-699501013259,p,o
265,0211-699501013259,0001,o
265,0211-699501013259,y,o
265,0211-699501013259,descenso,o
265,0211-699501013259,de,o
265,0211-699501013259,la,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,240,o
265,0211-699501013259,IC,o
265,0211-699501013259,213,o
265,0211-699501013259,264,o
265,0211-699501013259,vs,o
265,0211-699501013259,199,o
265,0211-699501013259,IC,o
265,0211-699501013259,175,o
265,0211-699501013259,224,o
265,0211-699501013259,p,o
265,0211-699501013259,005,o
265,0211-699501013259,Han,o
265,0211-699501013259,recibido,o
265,0211-699501013259,suplementacion,i
265,0211-699501013259,durante,o
265,0211-699501013259,12,o
265,0211-699501013259,meses,o
265,0211-699501013259,33,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,pero,o
265,0211-699501013259,a,o
265,0211-699501013259,pesar,o
265,0211-699501013259,de,o
265,0211-699501013259,un,o
265,0211-699501013259,continuo,o
265,0211-699501013259,aumento,o
265,0211-699501013259,del,o
265,0211-699501013259,folato,i
265,0211-699501013259,10078,o
265,0211-699501013259,IC,o
265,0211-699501013259,7481,o
265,0211-699501013259,12674,o
265,0211-699501013259,p,o
265,0211-699501013259,0001,o
265,0211-699501013259,solo,o
265,0211-699501013259,3,o
265,0211-699501013259,pacientes,o
265,0211-699501013259,presentan,o
265,0211-699501013259,niveles,o
265,0211-699501013259,normales,o
265,0211-699501013259,de,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,correlacionandose,o
265,0211-699501013259,directamente,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,con,o
265,0211-699501013259,la,o
265,0211-699501013259,albumina,i
265,0211-699501013259,r,o
265,0211-699501013259,056,o
265,0211-699501013259,p,o
265,0211-699501013259,0001,o
265,0211-699501013259,que,o
265,0211-699501013259,se,o
265,0211-699501013259,elevo,o
265,0211-699501013259,con,o
265,0211-699501013259,respecto,o
265,0211-699501013259,al,o
265,0211-699501013259,inicio,o
265,0211-699501013259,337,o
265,0211-699501013259,IC,o
265,0211-699501013259,327,o
265,0211-699501013259,346,o
265,0211-699501013259,vs,o
265,0211-699501013259,350,o
265,0211-699501013259,IC,o
265,0211-699501013259,337,o
265,0211-699501013259,363,o
265,0211-699501013259,p,o
265,0211-699501013259,005,o
265,0211-699501013259,Conclusion,o
265,0211-699501013259,Tras,o
265,0211-699501013259,suplementacion,i
265,0211-699501013259,con,o
265,0211-699501013259,acido,i
265,0211-699501013259,folico,i
265,0211-699501013259,y,o
265,0211-699501013259,vitamina,i
265,0211-699501013259,B6,i
265,0211-699501013259,aunque,o
265,0211-699501013259,inicialmente,o
265,0211-699501013259,se,o
265,0211-699501013259,reduce,o
265,0211-699501013259,la,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,esta,o
265,0211-699501013259,respuesta,o
265,0211-699501013259,se,o
265,0211-699501013259,hace,o
265,0211-699501013259,refractaria,o
265,0211-699501013259,correlacionandose,o
265,0211-699501013259,directamente,o
265,0211-699501013259,la,o
265,0211-699501013259,tHcy,i
265,0211-699501013259,con,o
265,0211-699501013259,la,o
265,0211-699501013259,albumina,i
265,0211-699501013259,plasmatica,i
265,0211-699501013259,La,o
265,0211-699501013259,interpretacion,o
265,0211-699501013259,de,o
265,0211-699501013259,los,o
265,0211-699501013259,niveles,i
265,0211-699501013259,de,i
265,0211-699501013259,tHcy,i
265,0211-699501013259,debe,o
265,0211-699501013259,tener,o
265,0211-699501013259,en,o
265,0211-699501013259,cuenta,o
265,0211-699501013259,la,o
265,0211-699501013259,concentracion,i
265,0211-699501013259,de,i
265,0211-699501013259,albumina,i
266,0211-699501013259,Efecto,o
266,0211-699501013259,de,o
266,0211-699501013259,la,o
266,0211-699501013259,suplementacion,i
266,0211-699501013259,con,o
266,0211-699501013259,acido,i
266,0211-699501013259,folico,i
266,0211-699501013259,sobre,o
266,0211-699501013259,los,o
266,0211-699501013259,niveles,i
266,0211-699501013259,de,i
266,0211-699501013259,homocisteina,i
266,0211-699501013259,total,o
266,0211-699501013259,en,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,en,o
266,0211-699501013259,hemodialisis,i
266,0211-699501013259,La,o
266,0211-699501013259,hiperhomocisteinemia,i
266,0211-699501013259,es,o
266,0211-699501013259,un,o
266,0211-699501013259,marcador,o
266,0211-699501013259,de,o
266,0211-699501013259,riesgo,o
266,0211-699501013259,independiente,o
266,0211-699501013259,de,o
266,0211-699501013259,morbimortalidad,o
266,0211-699501013259,cardiovascular,i
266,0211-699501013259,Hemos,o
266,0211-699501013259,intentado,o
266,0211-699501013259,prospectivamente,o
266,0211-699501013259,reducir,o
266,0211-699501013259,los,o
266,0211-699501013259,niveles,i
266,0211-699501013259,de,i
266,0211-699501013259,homocisteina,i
266,0211-699501013259,total,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,mediante,o
266,0211-699501013259,suplemento,o
266,0211-699501013259,con,o
266,0211-699501013259,acido,i
266,0211-699501013259,folico,i
266,0211-699501013259,y,o
266,0211-699501013259,vitamina,i
266,0211-699501013259,B6,i
266,0211-699501013259,pp,i
266,0211-699501013259,valorando,o
266,0211-699501013259,su,o
266,0211-699501013259,posible,o
266,0211-699501013259,correlacion,o
266,0211-699501013259,con,o
266,0211-699501013259,dosis,o
266,0211-699501013259,de,o
266,0211-699501013259,dialisis,i
266,0211-699501013259,funcion,i
266,0211-699501013259,residual,i
266,0211-699501013259,y,o
266,0211-699501013259,parametros,o
266,0211-699501013259,nutricionales,o
266,0211-699501013259,Metodos,o
266,0211-699501013259,Todos,o
266,0211-699501013259,los,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,en,o
266,0211-699501013259,hemodialisis,i
266,0211-699501013259,al,o
266,0211-699501013259,comienzo,o
266,0211-699501013259,del,o
266,0211-699501013259,estudio,o
266,0211-699501013259,que,o
266,0211-699501013259,no,o
266,0211-699501013259,recibian,o
266,0211-699501013259,acido,i
266,0211-699501013259,folico,i
266,0211-699501013259,ni,o
266,0211-699501013259,vitamina,i
266,0211-699501013259,B6,i
266,0211-699501013259,asi,o
266,0211-699501013259,como,o
266,0211-699501013259,los,o
266,0211-699501013259,incorporados,o
266,0211-699501013259,posteriormente,o
266,0211-699501013259,a,o
266,0211-699501013259,partir,o
266,0211-699501013259,de,o
266,0211-699501013259,su,o
266,0211-699501013259,tercer,o
266,0211-699501013259,mes,o
266,0211-699501013259,en,o
266,0211-699501013259,hemodialisis,i
266,0211-699501013259,recibieron,o
266,0211-699501013259,5,o
266,0211-699501013259,mg,o
266,0211-699501013259,orales,o
266,0211-699501013259,de,o
266,0211-699501013259,acido,i
266,0211-699501013259,folico,i
266,0211-699501013259,cada,o
266,0211-699501013259,48,o
266,0211-699501013259,horas,o
266,0211-699501013259,y,o
266,0211-699501013259,40,o
266,0211-699501013259,mg,o
266,0211-699501013259,orales,o
266,0211-699501013259,de,o
266,0211-699501013259,vitamina,i
266,0211-699501013259,B6,i
266,0211-699501013259,cada,o
266,0211-699501013259,semana,o
266,0211-699501013259,Se,o
266,0211-699501013259,determinaron,o
266,0211-699501013259,al,o
266,0211-699501013259,comienzo,o
266,0211-699501013259,del,o
266,0211-699501013259,estudio,o
266,0211-699501013259,y,o
266,0211-699501013259,cada,o
266,0211-699501013259,2,o
266,0211-699501013259,meses,o
266,0211-699501013259,niveles,i
266,0211-699501013259,de,i
266,0211-699501013259,folato,i
266,0211-699501013259,vitamina,i
266,0211-699501013259,B12,i
266,0211-699501013259,inmunoensayo,i
266,0211-699501013259,albumina,i
266,0211-699501013259,y,o
266,0211-699501013259,cinetica,o
266,0211-699501013259,de,o
266,0211-699501013259,la,o
266,0211-699501013259,urea,i
266,0211-699501013259,KTV,o
266,0211-699501013259,KRU,o
266,0211-699501013259,PCRn,o
266,0211-699501013259,y,o
266,0211-699501013259,cada,o
266,0211-699501013259,6,o
266,0211-699501013259,meses,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,HPLC,i
266,0211-699501013259,y,o
266,0211-699501013259,pp,i
266,0211-699501013259,RIA,i
266,0211-699501013259,Resultados,o
266,0211-699501013259,80,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,fueron,o
266,0211-699501013259,incluidos,o
266,0211-699501013259,en,o
266,0211-699501013259,el,o
266,0211-699501013259,estudio,o
266,0211-699501013259,basal,o
266,0211-699501013259,con,o
266,0211-699501013259,una,o
266,0211-699501013259,prevalencia,o
266,0211-699501013259,de,o
266,0211-699501013259,hiperhomocisteinemia,i
266,0211-699501013259,del,o
266,0211-699501013259,844,o
266,0211-699501013259,deficit,i
266,0211-699501013259,de,i
266,0211-699501013259,pp,i
266,0211-699501013259,en,o
266,0211-699501013259,el,o
266,0211-699501013259,32,o
266,0211-699501013259,y,o
266,0211-699501013259,folato,i
266,0211-699501013259,en,o
266,0211-699501013259,el,o
266,0211-699501013259,rango,o
266,0211-699501013259,normal,o
266,0211-699501013259,bajo,o
266,0211-699501013259,los,o
266,0211-699501013259,niveles,i
266,0211-699501013259,de,i
266,0211-699501013259,tHcy,i
266,0211-699501013259,se,o
266,0211-699501013259,correlacionaban,o
266,0211-699501013259,inversamente,o
266,0211-699501013259,con,o
266,0211-699501013259,los,o
266,0211-699501013259,del,o
266,0211-699501013259,folato,i
266,0211-699501013259,r,o
266,0211-699501013259,0336,o
266,0211-699501013259,p,o
266,0211-699501013259,001,o
266,0211-699501013259,pero,o
266,0211-699501013259,no,o
266,0211-699501013259,con,o
266,0211-699501013259,pp,i
266,0211-699501013259,B12,i
266,0211-699501013259,edad,o
266,0211-699501013259,albumina,i
266,0211-699501013259,KTV,o
266,0211-699501013259,KRU,o
266,0211-699501013259,PCRn,o
266,0211-699501013259,Cincuenta,o
266,0211-699501013259,y,o
266,0211-699501013259,ocho,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,recibieron,o
266,0211-699501013259,seis,o
266,0211-699501013259,meses,o
266,0211-699501013259,de,o
266,0211-699501013259,suplementacion,i
266,0211-699501013259,con,o
266,0211-699501013259,normalizacion,o
266,0211-699501013259,del,o
266,0211-699501013259,pp,i
266,0211-699501013259,aumento,o
266,0211-699501013259,del,o
266,0211-699501013259,folato,i
266,0211-699501013259,703,o
266,0211-699501013259,IC,o
266,0211-699501013259,638,o
266,0211-699501013259,795,o
266,0211-699501013259,vs,o
266,0211-699501013259,6181,o
266,0211-699501013259,IC,o
266,0211-699501013259,4447,o
266,0211-699501013259,7811,o
266,0211-699501013259,p,o
266,0211-699501013259,0001,o
266,0211-699501013259,y,o
266,0211-699501013259,descenso,o
266,0211-699501013259,de,o
266,0211-699501013259,la,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,240,o
266,0211-699501013259,IC,o
266,0211-699501013259,213,o
266,0211-699501013259,264,o
266,0211-699501013259,vs,o
266,0211-699501013259,199,o
266,0211-699501013259,IC,o
266,0211-699501013259,175,o
266,0211-699501013259,224,o
266,0211-699501013259,p,o
266,0211-699501013259,005,o
266,0211-699501013259,Han,o
266,0211-699501013259,recibido,o
266,0211-699501013259,suplementacion,i
266,0211-699501013259,durante,o
266,0211-699501013259,12,o
266,0211-699501013259,meses,o
266,0211-699501013259,33,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,pero,o
266,0211-699501013259,a,o
266,0211-699501013259,pesar,o
266,0211-699501013259,de,o
266,0211-699501013259,un,o
266,0211-699501013259,continuo,o
266,0211-699501013259,aumento,o
266,0211-699501013259,del,o
266,0211-699501013259,folato,i
266,0211-699501013259,10078,o
266,0211-699501013259,IC,o
266,0211-699501013259,7481,o
266,0211-699501013259,12674,o
266,0211-699501013259,p,o
266,0211-699501013259,0001,o
266,0211-699501013259,solo,o
266,0211-699501013259,3,o
266,0211-699501013259,pacientes,o
266,0211-699501013259,presentan,o
266,0211-699501013259,niveles,o
266,0211-699501013259,normales,o
266,0211-699501013259,de,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,correlacionandose,o
266,0211-699501013259,directamente,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,con,o
266,0211-699501013259,la,o
266,0211-699501013259,albumina,i
266,0211-699501013259,r,o
266,0211-699501013259,056,o
266,0211-699501013259,p,o
266,0211-699501013259,0001,o
266,0211-699501013259,que,o
266,0211-699501013259,se,o
266,0211-699501013259,elevo,o
266,0211-699501013259,con,o
266,0211-699501013259,respecto,o
266,0211-699501013259,al,o
266,0211-699501013259,inicio,o
266,0211-699501013259,337,o
266,0211-699501013259,IC,o
266,0211-699501013259,327,o
266,0211-699501013259,346,o
266,0211-699501013259,vs,o
266,0211-699501013259,350,o
266,0211-699501013259,IC,o
266,0211-699501013259,337,o
266,0211-699501013259,363,o
266,0211-699501013259,p,o
266,0211-699501013259,005,o
266,0211-699501013259,Conclusion,o
266,0211-699501013259,Tras,o
266,0211-699501013259,suplementacion,i
266,0211-699501013259,con,o
266,0211-699501013259,acido,i
266,0211-699501013259,folico,i
266,0211-699501013259,y,o
266,0211-699501013259,vitamina,i
266,0211-699501013259,B6,i
266,0211-699501013259,aunque,o
266,0211-699501013259,inicialmente,o
266,0211-699501013259,se,o
266,0211-699501013259,reduce,o
266,0211-699501013259,la,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,esta,o
266,0211-699501013259,respuesta,o
266,0211-699501013259,se,o
266,0211-699501013259,hace,o
266,0211-699501013259,refractaria,o
266,0211-699501013259,correlacionandose,o
266,0211-699501013259,directamente,o
266,0211-699501013259,la,o
266,0211-699501013259,tHcy,i
266,0211-699501013259,con,o
266,0211-699501013259,la,o
266,0211-699501013259,albumina,i
266,0211-699501013259,plasmatica,i
266,0211-699501013259,La,o
266,0211-699501013259,interpretacion,o
266,0211-699501013259,de,o
266,0211-699501013259,los,o
266,0211-699501013259,niveles,i
266,0211-699501013259,de,i
266,0211-699501013259,tHcy,i
266,0211-699501013259,debe,o
266,0211-699501013259,tener,o
266,0211-699501013259,en,o
266,0211-699501013259,cuenta,o
266,0211-699501013259,la,o
266,0211-699501013259,concentracion,i
266,0211-699501013259,de,i
266,0211-699501013259,albumina,i
267,0211-699501013259,Efecto,o
267,0211-699501013259,de,o
267,0211-699501013259,la,o
267,0211-699501013259,suplementacion,i
267,0211-699501013259,con,o
267,0211-699501013259,acido,i
267,0211-699501013259,folico,i
267,0211-699501013259,sobre,o
267,0211-699501013259,los,o
267,0211-699501013259,niveles,i
267,0211-699501013259,de,i
267,0211-699501013259,homocisteina,i
267,0211-699501013259,total,o
267,0211-699501013259,en,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,en,o
267,0211-699501013259,hemodialisis,i
267,0211-699501013259,La,o
267,0211-699501013259,hiperhomocisteinemia,i
267,0211-699501013259,es,o
267,0211-699501013259,un,o
267,0211-699501013259,marcador,o
267,0211-699501013259,de,o
267,0211-699501013259,riesgo,o
267,0211-699501013259,independiente,o
267,0211-699501013259,de,o
267,0211-699501013259,morbimortalidad,o
267,0211-699501013259,cardiovascular,i
267,0211-699501013259,Hemos,o
267,0211-699501013259,intentado,o
267,0211-699501013259,prospectivamente,o
267,0211-699501013259,reducir,o
267,0211-699501013259,los,o
267,0211-699501013259,niveles,i
267,0211-699501013259,de,i
267,0211-699501013259,homocisteina,i
267,0211-699501013259,total,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,mediante,o
267,0211-699501013259,suplemento,o
267,0211-699501013259,con,o
267,0211-699501013259,acido,i
267,0211-699501013259,folico,i
267,0211-699501013259,y,o
267,0211-699501013259,vitamina,i
267,0211-699501013259,B6,i
267,0211-699501013259,pp,i
267,0211-699501013259,valorando,o
267,0211-699501013259,su,o
267,0211-699501013259,posible,o
267,0211-699501013259,correlacion,o
267,0211-699501013259,con,o
267,0211-699501013259,dosis,o
267,0211-699501013259,de,o
267,0211-699501013259,dialisis,i
267,0211-699501013259,funcion,i
267,0211-699501013259,residual,i
267,0211-699501013259,y,o
267,0211-699501013259,parametros,o
267,0211-699501013259,nutricionales,o
267,0211-699501013259,Metodos,o
267,0211-699501013259,Todos,o
267,0211-699501013259,los,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,en,o
267,0211-699501013259,hemodialisis,i
267,0211-699501013259,al,o
267,0211-699501013259,comienzo,o
267,0211-699501013259,del,o
267,0211-699501013259,estudio,o
267,0211-699501013259,que,o
267,0211-699501013259,no,o
267,0211-699501013259,recibian,o
267,0211-699501013259,acido,i
267,0211-699501013259,folico,i
267,0211-699501013259,ni,o
267,0211-699501013259,vitamina,i
267,0211-699501013259,B6,i
267,0211-699501013259,asi,o
267,0211-699501013259,como,o
267,0211-699501013259,los,o
267,0211-699501013259,incorporados,o
267,0211-699501013259,posteriormente,o
267,0211-699501013259,a,o
267,0211-699501013259,partir,o
267,0211-699501013259,de,o
267,0211-699501013259,su,o
267,0211-699501013259,tercer,o
267,0211-699501013259,mes,o
267,0211-699501013259,en,o
267,0211-699501013259,hemodialisis,i
267,0211-699501013259,recibieron,o
267,0211-699501013259,5,o
267,0211-699501013259,mg,o
267,0211-699501013259,orales,o
267,0211-699501013259,de,o
267,0211-699501013259,acido,i
267,0211-699501013259,folico,i
267,0211-699501013259,cada,o
267,0211-699501013259,48,o
267,0211-699501013259,horas,o
267,0211-699501013259,y,o
267,0211-699501013259,40,o
267,0211-699501013259,mg,o
267,0211-699501013259,orales,o
267,0211-699501013259,de,o
267,0211-699501013259,vitamina,i
267,0211-699501013259,B6,i
267,0211-699501013259,cada,o
267,0211-699501013259,semana,o
267,0211-699501013259,Se,o
267,0211-699501013259,determinaron,o
267,0211-699501013259,al,o
267,0211-699501013259,comienzo,o
267,0211-699501013259,del,o
267,0211-699501013259,estudio,o
267,0211-699501013259,y,o
267,0211-699501013259,cada,o
267,0211-699501013259,2,o
267,0211-699501013259,meses,o
267,0211-699501013259,niveles,i
267,0211-699501013259,de,i
267,0211-699501013259,folato,i
267,0211-699501013259,vitamina,i
267,0211-699501013259,B12,i
267,0211-699501013259,inmunoensayo,i
267,0211-699501013259,albumina,i
267,0211-699501013259,y,o
267,0211-699501013259,cinetica,o
267,0211-699501013259,de,o
267,0211-699501013259,la,o
267,0211-699501013259,urea,i
267,0211-699501013259,KTV,o
267,0211-699501013259,KRU,o
267,0211-699501013259,PCRn,o
267,0211-699501013259,y,o
267,0211-699501013259,cada,o
267,0211-699501013259,6,o
267,0211-699501013259,meses,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,HPLC,i
267,0211-699501013259,y,o
267,0211-699501013259,pp,i
267,0211-699501013259,RIA,i
267,0211-699501013259,Resultados,o
267,0211-699501013259,80,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,fueron,o
267,0211-699501013259,incluidos,o
267,0211-699501013259,en,o
267,0211-699501013259,el,o
267,0211-699501013259,estudio,o
267,0211-699501013259,basal,o
267,0211-699501013259,con,o
267,0211-699501013259,una,o
267,0211-699501013259,prevalencia,o
267,0211-699501013259,de,o
267,0211-699501013259,hiperhomocisteinemia,i
267,0211-699501013259,del,o
267,0211-699501013259,844,o
267,0211-699501013259,deficit,i
267,0211-699501013259,de,i
267,0211-699501013259,pp,i
267,0211-699501013259,en,o
267,0211-699501013259,el,o
267,0211-699501013259,32,o
267,0211-699501013259,y,o
267,0211-699501013259,folato,i
267,0211-699501013259,en,o
267,0211-699501013259,el,o
267,0211-699501013259,rango,o
267,0211-699501013259,normal,o
267,0211-699501013259,bajo,o
267,0211-699501013259,los,o
267,0211-699501013259,niveles,i
267,0211-699501013259,de,i
267,0211-699501013259,tHcy,i
267,0211-699501013259,se,o
267,0211-699501013259,correlacionaban,o
267,0211-699501013259,inversamente,o
267,0211-699501013259,con,o
267,0211-699501013259,los,o
267,0211-699501013259,del,o
267,0211-699501013259,folato,i
267,0211-699501013259,r,o
267,0211-699501013259,0336,o
267,0211-699501013259,p,o
267,0211-699501013259,001,o
267,0211-699501013259,pero,o
267,0211-699501013259,no,o
267,0211-699501013259,con,o
267,0211-699501013259,pp,i
267,0211-699501013259,B12,i
267,0211-699501013259,edad,o
267,0211-699501013259,albumina,i
267,0211-699501013259,KTV,o
267,0211-699501013259,KRU,o
267,0211-699501013259,PCRn,o
267,0211-699501013259,Cincuenta,o
267,0211-699501013259,y,o
267,0211-699501013259,ocho,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,recibieron,o
267,0211-699501013259,seis,o
267,0211-699501013259,meses,o
267,0211-699501013259,de,o
267,0211-699501013259,suplementacion,i
267,0211-699501013259,con,o
267,0211-699501013259,normalizacion,o
267,0211-699501013259,del,o
267,0211-699501013259,pp,i
267,0211-699501013259,aumento,o
267,0211-699501013259,del,o
267,0211-699501013259,folato,i
267,0211-699501013259,703,o
267,0211-699501013259,IC,o
267,0211-699501013259,638,o
267,0211-699501013259,795,o
267,0211-699501013259,vs,o
267,0211-699501013259,6181,o
267,0211-699501013259,IC,o
267,0211-699501013259,4447,o
267,0211-699501013259,7811,o
267,0211-699501013259,p,o
267,0211-699501013259,0001,o
267,0211-699501013259,y,o
267,0211-699501013259,descenso,o
267,0211-699501013259,de,o
267,0211-699501013259,la,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,240,o
267,0211-699501013259,IC,o
267,0211-699501013259,213,o
267,0211-699501013259,264,o
267,0211-699501013259,vs,o
267,0211-699501013259,199,o
267,0211-699501013259,IC,o
267,0211-699501013259,175,o
267,0211-699501013259,224,o
267,0211-699501013259,p,o
267,0211-699501013259,005,o
267,0211-699501013259,Han,o
267,0211-699501013259,recibido,o
267,0211-699501013259,suplementacion,i
267,0211-699501013259,durante,o
267,0211-699501013259,12,o
267,0211-699501013259,meses,o
267,0211-699501013259,33,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,pero,o
267,0211-699501013259,a,o
267,0211-699501013259,pesar,o
267,0211-699501013259,de,o
267,0211-699501013259,un,o
267,0211-699501013259,continuo,o
267,0211-699501013259,aumento,o
267,0211-699501013259,del,o
267,0211-699501013259,folato,i
267,0211-699501013259,10078,o
267,0211-699501013259,IC,o
267,0211-699501013259,7481,o
267,0211-699501013259,12674,o
267,0211-699501013259,p,o
267,0211-699501013259,0001,o
267,0211-699501013259,solo,o
267,0211-699501013259,3,o
267,0211-699501013259,pacientes,o
267,0211-699501013259,presentan,o
267,0211-699501013259,niveles,o
267,0211-699501013259,normales,o
267,0211-699501013259,de,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,correlacionandose,o
267,0211-699501013259,directamente,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,con,o
267,0211-699501013259,la,o
267,0211-699501013259,albumina,i
267,0211-699501013259,r,o
267,0211-699501013259,056,o
267,0211-699501013259,p,o
267,0211-699501013259,0001,o
267,0211-699501013259,que,o
267,0211-699501013259,se,o
267,0211-699501013259,elevo,o
267,0211-699501013259,con,o
267,0211-699501013259,respecto,o
267,0211-699501013259,al,o
267,0211-699501013259,inicio,o
267,0211-699501013259,337,o
267,0211-699501013259,IC,o
267,0211-699501013259,327,o
267,0211-699501013259,346,o
267,0211-699501013259,vs,o
267,0211-699501013259,350,o
267,0211-699501013259,IC,o
267,0211-699501013259,337,o
267,0211-699501013259,363,o
267,0211-699501013259,p,o
267,0211-699501013259,005,o
267,0211-699501013259,Conclusion,o
267,0211-699501013259,Tras,o
267,0211-699501013259,suplementacion,i
267,0211-699501013259,con,o
267,0211-699501013259,acido,i
267,0211-699501013259,folico,i
267,0211-699501013259,y,o
267,0211-699501013259,vitamina,i
267,0211-699501013259,B6,i
267,0211-699501013259,aunque,o
267,0211-699501013259,inicialmente,o
267,0211-699501013259,se,o
267,0211-699501013259,reduce,o
267,0211-699501013259,la,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,esta,o
267,0211-699501013259,respuesta,o
267,0211-699501013259,se,o
267,0211-699501013259,hace,o
267,0211-699501013259,refractaria,o
267,0211-699501013259,correlacionandose,o
267,0211-699501013259,directamente,o
267,0211-699501013259,la,o
267,0211-699501013259,tHcy,i
267,0211-699501013259,con,o
267,0211-699501013259,la,o
267,0211-699501013259,albumina,i
267,0211-699501013259,plasmatica,i
267,0211-699501013259,La,o
267,0211-699501013259,interpretacion,o
267,0211-699501013259,de,o
267,0211-699501013259,los,o
267,0211-699501013259,niveles,i
267,0211-699501013259,de,i
267,0211-699501013259,tHcy,i
267,0211-699501013259,debe,o
267,0211-699501013259,tener,o
267,0211-699501013259,en,o
267,0211-699501013259,cuenta,o
267,0211-699501013259,la,o
267,0211-699501013259,concentracion,i
267,0211-699501013259,de,i
267,0211-699501013259,albumina,i
268,0211-699501013259,Efecto,o
268,0211-699501013259,de,o
268,0211-699501013259,la,o
268,0211-699501013259,suplementacion,i
268,0211-699501013259,con,o
268,0211-699501013259,acido,i
268,0211-699501013259,folico,i
268,0211-699501013259,sobre,o
268,0211-699501013259,los,o
268,0211-699501013259,niveles,i
268,0211-699501013259,de,i
268,0211-699501013259,homocisteina,i
268,0211-699501013259,total,o
268,0211-699501013259,en,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,en,o
268,0211-699501013259,hemodialisis,i
268,0211-699501013259,La,o
268,0211-699501013259,hiperhomocisteinemia,i
268,0211-699501013259,es,o
268,0211-699501013259,un,o
268,0211-699501013259,marcador,o
268,0211-699501013259,de,o
268,0211-699501013259,riesgo,o
268,0211-699501013259,independiente,o
268,0211-699501013259,de,o
268,0211-699501013259,morbimortalidad,o
268,0211-699501013259,cardiovascular,i
268,0211-699501013259,Hemos,o
268,0211-699501013259,intentado,o
268,0211-699501013259,prospectivamente,o
268,0211-699501013259,reducir,o
268,0211-699501013259,los,o
268,0211-699501013259,niveles,i
268,0211-699501013259,de,i
268,0211-699501013259,homocisteina,i
268,0211-699501013259,total,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,mediante,o
268,0211-699501013259,suplemento,o
268,0211-699501013259,con,o
268,0211-699501013259,acido,i
268,0211-699501013259,folico,i
268,0211-699501013259,y,o
268,0211-699501013259,vitamina,i
268,0211-699501013259,B6,i
268,0211-699501013259,pp,i
268,0211-699501013259,valorando,o
268,0211-699501013259,su,o
268,0211-699501013259,posible,o
268,0211-699501013259,correlacion,o
268,0211-699501013259,con,o
268,0211-699501013259,dosis,o
268,0211-699501013259,de,o
268,0211-699501013259,dialisis,i
268,0211-699501013259,funcion,i
268,0211-699501013259,residual,i
268,0211-699501013259,y,o
268,0211-699501013259,parametros,o
268,0211-699501013259,nutricionales,o
268,0211-699501013259,Metodos,o
268,0211-699501013259,Todos,o
268,0211-699501013259,los,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,en,o
268,0211-699501013259,hemodialisis,i
268,0211-699501013259,al,o
268,0211-699501013259,comienzo,o
268,0211-699501013259,del,o
268,0211-699501013259,estudio,o
268,0211-699501013259,que,o
268,0211-699501013259,no,o
268,0211-699501013259,recibian,o
268,0211-699501013259,acido,i
268,0211-699501013259,folico,i
268,0211-699501013259,ni,o
268,0211-699501013259,vitamina,i
268,0211-699501013259,B6,i
268,0211-699501013259,asi,o
268,0211-699501013259,como,o
268,0211-699501013259,los,o
268,0211-699501013259,incorporados,o
268,0211-699501013259,posteriormente,o
268,0211-699501013259,a,o
268,0211-699501013259,partir,o
268,0211-699501013259,de,o
268,0211-699501013259,su,o
268,0211-699501013259,tercer,o
268,0211-699501013259,mes,o
268,0211-699501013259,en,o
268,0211-699501013259,hemodialisis,i
268,0211-699501013259,recibieron,o
268,0211-699501013259,5,o
268,0211-699501013259,mg,o
268,0211-699501013259,orales,o
268,0211-699501013259,de,o
268,0211-699501013259,acido,i
268,0211-699501013259,folico,i
268,0211-699501013259,cada,o
268,0211-699501013259,48,o
268,0211-699501013259,horas,o
268,0211-699501013259,y,o
268,0211-699501013259,40,o
268,0211-699501013259,mg,o
268,0211-699501013259,orales,o
268,0211-699501013259,de,o
268,0211-699501013259,vitamina,i
268,0211-699501013259,B6,i
268,0211-699501013259,cada,o
268,0211-699501013259,semana,o
268,0211-699501013259,Se,o
268,0211-699501013259,determinaron,o
268,0211-699501013259,al,o
268,0211-699501013259,comienzo,o
268,0211-699501013259,del,o
268,0211-699501013259,estudio,o
268,0211-699501013259,y,o
268,0211-699501013259,cada,o
268,0211-699501013259,2,o
268,0211-699501013259,meses,o
268,0211-699501013259,niveles,i
268,0211-699501013259,de,i
268,0211-699501013259,folato,i
268,0211-699501013259,vitamina,i
268,0211-699501013259,B12,i
268,0211-699501013259,inmunoensayo,i
268,0211-699501013259,albumina,i
268,0211-699501013259,y,o
268,0211-699501013259,cinetica,o
268,0211-699501013259,de,o
268,0211-699501013259,la,o
268,0211-699501013259,urea,i
268,0211-699501013259,KTV,o
268,0211-699501013259,KRU,o
268,0211-699501013259,PCRn,o
268,0211-699501013259,y,o
268,0211-699501013259,cada,o
268,0211-699501013259,6,o
268,0211-699501013259,meses,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,HPLC,i
268,0211-699501013259,y,o
268,0211-699501013259,pp,i
268,0211-699501013259,RIA,i
268,0211-699501013259,Resultados,o
268,0211-699501013259,80,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,fueron,o
268,0211-699501013259,incluidos,o
268,0211-699501013259,en,o
268,0211-699501013259,el,o
268,0211-699501013259,estudio,o
268,0211-699501013259,basal,o
268,0211-699501013259,con,o
268,0211-699501013259,una,o
268,0211-699501013259,prevalencia,o
268,0211-699501013259,de,o
268,0211-699501013259,hiperhomocisteinemia,i
268,0211-699501013259,del,o
268,0211-699501013259,844,o
268,0211-699501013259,deficit,i
268,0211-699501013259,de,i
268,0211-699501013259,pp,i
268,0211-699501013259,en,o
268,0211-699501013259,el,o
268,0211-699501013259,32,o
268,0211-699501013259,y,o
268,0211-699501013259,folato,i
268,0211-699501013259,en,o
268,0211-699501013259,el,o
268,0211-699501013259,rango,o
268,0211-699501013259,normal,o
268,0211-699501013259,bajo,o
268,0211-699501013259,los,o
268,0211-699501013259,niveles,i
268,0211-699501013259,de,i
268,0211-699501013259,tHcy,i
268,0211-699501013259,se,o
268,0211-699501013259,correlacionaban,o
268,0211-699501013259,inversamente,o
268,0211-699501013259,con,o
268,0211-699501013259,los,o
268,0211-699501013259,del,o
268,0211-699501013259,folato,i
268,0211-699501013259,r,o
268,0211-699501013259,0336,o
268,0211-699501013259,p,o
268,0211-699501013259,001,o
268,0211-699501013259,pero,o
268,0211-699501013259,no,o
268,0211-699501013259,con,o
268,0211-699501013259,pp,i
268,0211-699501013259,B12,i
268,0211-699501013259,edad,o
268,0211-699501013259,albumina,i
268,0211-699501013259,KTV,o
268,0211-699501013259,KRU,o
268,0211-699501013259,PCRn,o
268,0211-699501013259,Cincuenta,o
268,0211-699501013259,y,o
268,0211-699501013259,ocho,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,recibieron,o
268,0211-699501013259,seis,o
268,0211-699501013259,meses,o
268,0211-699501013259,de,o
268,0211-699501013259,suplementacion,i
268,0211-699501013259,con,o
268,0211-699501013259,normalizacion,o
268,0211-699501013259,del,o
268,0211-699501013259,pp,i
268,0211-699501013259,aumento,o
268,0211-699501013259,del,o
268,0211-699501013259,folato,i
268,0211-699501013259,703,o
268,0211-699501013259,IC,o
268,0211-699501013259,638,o
268,0211-699501013259,795,o
268,0211-699501013259,vs,o
268,0211-699501013259,6181,o
268,0211-699501013259,IC,o
268,0211-699501013259,4447,o
268,0211-699501013259,7811,o
268,0211-699501013259,p,o
268,0211-699501013259,0001,o
268,0211-699501013259,y,o
268,0211-699501013259,descenso,o
268,0211-699501013259,de,o
268,0211-699501013259,la,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,240,o
268,0211-699501013259,IC,o
268,0211-699501013259,213,o
268,0211-699501013259,264,o
268,0211-699501013259,vs,o
268,0211-699501013259,199,o
268,0211-699501013259,IC,o
268,0211-699501013259,175,o
268,0211-699501013259,224,o
268,0211-699501013259,p,o
268,0211-699501013259,005,o
268,0211-699501013259,Han,o
268,0211-699501013259,recibido,o
268,0211-699501013259,suplementacion,i
268,0211-699501013259,durante,o
268,0211-699501013259,12,o
268,0211-699501013259,meses,o
268,0211-699501013259,33,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,pero,o
268,0211-699501013259,a,o
268,0211-699501013259,pesar,o
268,0211-699501013259,de,o
268,0211-699501013259,un,o
268,0211-699501013259,continuo,o
268,0211-699501013259,aumento,o
268,0211-699501013259,del,o
268,0211-699501013259,folato,i
268,0211-699501013259,10078,o
268,0211-699501013259,IC,o
268,0211-699501013259,7481,o
268,0211-699501013259,12674,o
268,0211-699501013259,p,o
268,0211-699501013259,0001,o
268,0211-699501013259,solo,o
268,0211-699501013259,3,o
268,0211-699501013259,pacientes,o
268,0211-699501013259,presentan,o
268,0211-699501013259,niveles,o
268,0211-699501013259,normales,o
268,0211-699501013259,de,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,correlacionandose,o
268,0211-699501013259,directamente,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,con,o
268,0211-699501013259,la,o
268,0211-699501013259,albumina,i
268,0211-699501013259,r,o
268,0211-699501013259,056,o
268,0211-699501013259,p,o
268,0211-699501013259,0001,o
268,0211-699501013259,que,o
268,0211-699501013259,se,o
268,0211-699501013259,elevo,o
268,0211-699501013259,con,o
268,0211-699501013259,respecto,o
268,0211-699501013259,al,o
268,0211-699501013259,inicio,o
268,0211-699501013259,337,o
268,0211-699501013259,IC,o
268,0211-699501013259,327,o
268,0211-699501013259,346,o
268,0211-699501013259,vs,o
268,0211-699501013259,350,o
268,0211-699501013259,IC,o
268,0211-699501013259,337,o
268,0211-699501013259,363,o
268,0211-699501013259,p,o
268,0211-699501013259,005,o
268,0211-699501013259,Conclusion,o
268,0211-699501013259,Tras,o
268,0211-699501013259,suplementacion,i
268,0211-699501013259,con,o
268,0211-699501013259,acido,i
268,0211-699501013259,folico,i
268,0211-699501013259,y,o
268,0211-699501013259,vitamina,i
268,0211-699501013259,B6,i
268,0211-699501013259,aunque,o
268,0211-699501013259,inicialmente,o
268,0211-699501013259,se,o
268,0211-699501013259,reduce,o
268,0211-699501013259,la,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,esta,o
268,0211-699501013259,respuesta,o
268,0211-699501013259,se,o
268,0211-699501013259,hace,o
268,0211-699501013259,refractaria,o
268,0211-699501013259,correlacionandose,o
268,0211-699501013259,directamente,o
268,0211-699501013259,la,o
268,0211-699501013259,tHcy,i
268,0211-699501013259,con,o
268,0211-699501013259,la,o
268,0211-699501013259,albumina,i
268,0211-699501013259,plasmatica,i
268,0211-699501013259,La,o
268,0211-699501013259,interpretacion,o
268,0211-699501013259,de,o
268,0211-699501013259,los,o
268,0211-699501013259,niveles,i
268,0211-699501013259,de,i
268,0211-699501013259,tHcy,i
268,0211-699501013259,debe,o
268,0211-699501013259,tener,o
268,0211-699501013259,en,o
268,0211-699501013259,cuenta,o
268,0211-699501013259,la,o
268,0211-699501013259,concentracion,i
268,0211-699501013259,de,i
268,0211-699501013259,albumina,i
269,0211-699501013259,Efecto,o
269,0211-699501013259,de,o
269,0211-699501013259,la,o
269,0211-699501013259,suplementacion,i
269,0211-699501013259,con,o
269,0211-699501013259,acido,i
269,0211-699501013259,folico,i
269,0211-699501013259,sobre,o
269,0211-699501013259,los,o
269,0211-699501013259,niveles,i
269,0211-699501013259,de,i
269,0211-699501013259,homocisteina,i
269,0211-699501013259,total,o
269,0211-699501013259,en,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,en,o
269,0211-699501013259,hemodialisis,i
269,0211-699501013259,La,o
269,0211-699501013259,hiperhomocisteinemia,i
269,0211-699501013259,es,o
269,0211-699501013259,un,o
269,0211-699501013259,marcador,o
269,0211-699501013259,de,o
269,0211-699501013259,riesgo,o
269,0211-699501013259,independiente,o
269,0211-699501013259,de,o
269,0211-699501013259,morbimortalidad,o
269,0211-699501013259,cardiovascular,i
269,0211-699501013259,Hemos,o
269,0211-699501013259,intentado,o
269,0211-699501013259,prospectivamente,o
269,0211-699501013259,reducir,o
269,0211-699501013259,los,o
269,0211-699501013259,niveles,i
269,0211-699501013259,de,i
269,0211-699501013259,homocisteina,i
269,0211-699501013259,total,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,mediante,o
269,0211-699501013259,suplemento,o
269,0211-699501013259,con,o
269,0211-699501013259,acido,i
269,0211-699501013259,folico,i
269,0211-699501013259,y,o
269,0211-699501013259,vitamina,i
269,0211-699501013259,B6,i
269,0211-699501013259,pp,i
269,0211-699501013259,valorando,o
269,0211-699501013259,su,o
269,0211-699501013259,posible,o
269,0211-699501013259,correlacion,o
269,0211-699501013259,con,o
269,0211-699501013259,dosis,o
269,0211-699501013259,de,o
269,0211-699501013259,dialisis,i
269,0211-699501013259,funcion,i
269,0211-699501013259,residual,i
269,0211-699501013259,y,o
269,0211-699501013259,parametros,o
269,0211-699501013259,nutricionales,o
269,0211-699501013259,Metodos,o
269,0211-699501013259,Todos,o
269,0211-699501013259,los,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,en,o
269,0211-699501013259,hemodialisis,i
269,0211-699501013259,al,o
269,0211-699501013259,comienzo,o
269,0211-699501013259,del,o
269,0211-699501013259,estudio,o
269,0211-699501013259,que,o
269,0211-699501013259,no,o
269,0211-699501013259,recibian,o
269,0211-699501013259,acido,i
269,0211-699501013259,folico,i
269,0211-699501013259,ni,o
269,0211-699501013259,vitamina,i
269,0211-699501013259,B6,i
269,0211-699501013259,asi,o
269,0211-699501013259,como,o
269,0211-699501013259,los,o
269,0211-699501013259,incorporados,o
269,0211-699501013259,posteriormente,o
269,0211-699501013259,a,o
269,0211-699501013259,partir,o
269,0211-699501013259,de,o
269,0211-699501013259,su,o
269,0211-699501013259,tercer,o
269,0211-699501013259,mes,o
269,0211-699501013259,en,o
269,0211-699501013259,hemodialisis,i
269,0211-699501013259,recibieron,o
269,0211-699501013259,5,o
269,0211-699501013259,mg,o
269,0211-699501013259,orales,o
269,0211-699501013259,de,o
269,0211-699501013259,acido,i
269,0211-699501013259,folico,i
269,0211-699501013259,cada,o
269,0211-699501013259,48,o
269,0211-699501013259,horas,o
269,0211-699501013259,y,o
269,0211-699501013259,40,o
269,0211-699501013259,mg,o
269,0211-699501013259,orales,o
269,0211-699501013259,de,o
269,0211-699501013259,vitamina,i
269,0211-699501013259,B6,i
269,0211-699501013259,cada,o
269,0211-699501013259,semana,o
269,0211-699501013259,Se,o
269,0211-699501013259,determinaron,o
269,0211-699501013259,al,o
269,0211-699501013259,comienzo,o
269,0211-699501013259,del,o
269,0211-699501013259,estudio,o
269,0211-699501013259,y,o
269,0211-699501013259,cada,o
269,0211-699501013259,2,o
269,0211-699501013259,meses,o
269,0211-699501013259,niveles,i
269,0211-699501013259,de,i
269,0211-699501013259,folato,i
269,0211-699501013259,vitamina,i
269,0211-699501013259,B12,i
269,0211-699501013259,inmunoensayo,i
269,0211-699501013259,albumina,i
269,0211-699501013259,y,o
269,0211-699501013259,cinetica,o
269,0211-699501013259,de,o
269,0211-699501013259,la,o
269,0211-699501013259,urea,i
269,0211-699501013259,KTV,o
269,0211-699501013259,KRU,o
269,0211-699501013259,PCRn,o
269,0211-699501013259,y,o
269,0211-699501013259,cada,o
269,0211-699501013259,6,o
269,0211-699501013259,meses,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,HPLC,i
269,0211-699501013259,y,o
269,0211-699501013259,pp,i
269,0211-699501013259,RIA,i
269,0211-699501013259,Resultados,o
269,0211-699501013259,80,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,fueron,o
269,0211-699501013259,incluidos,o
269,0211-699501013259,en,o
269,0211-699501013259,el,o
269,0211-699501013259,estudio,o
269,0211-699501013259,basal,o
269,0211-699501013259,con,o
269,0211-699501013259,una,o
269,0211-699501013259,prevalencia,o
269,0211-699501013259,de,o
269,0211-699501013259,hiperhomocisteinemia,i
269,0211-699501013259,del,o
269,0211-699501013259,844,o
269,0211-699501013259,deficit,i
269,0211-699501013259,de,i
269,0211-699501013259,pp,i
269,0211-699501013259,en,o
269,0211-699501013259,el,o
269,0211-699501013259,32,o
269,0211-699501013259,y,o
269,0211-699501013259,folato,i
269,0211-699501013259,en,o
269,0211-699501013259,el,o
269,0211-699501013259,rango,o
269,0211-699501013259,normal,o
269,0211-699501013259,bajo,o
269,0211-699501013259,los,o
269,0211-699501013259,niveles,i
269,0211-699501013259,de,i
269,0211-699501013259,tHcy,i
269,0211-699501013259,se,o
269,0211-699501013259,correlacionaban,o
269,0211-699501013259,inversamente,o
269,0211-699501013259,con,o
269,0211-699501013259,los,o
269,0211-699501013259,del,o
269,0211-699501013259,folato,i
269,0211-699501013259,r,o
269,0211-699501013259,0336,o
269,0211-699501013259,p,o
269,0211-699501013259,001,o
269,0211-699501013259,pero,o
269,0211-699501013259,no,o
269,0211-699501013259,con,o
269,0211-699501013259,pp,i
269,0211-699501013259,B12,i
269,0211-699501013259,edad,o
269,0211-699501013259,albumina,i
269,0211-699501013259,KTV,o
269,0211-699501013259,KRU,o
269,0211-699501013259,PCRn,o
269,0211-699501013259,Cincuenta,o
269,0211-699501013259,y,o
269,0211-699501013259,ocho,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,recibieron,o
269,0211-699501013259,seis,o
269,0211-699501013259,meses,o
269,0211-699501013259,de,o
269,0211-699501013259,suplementacion,i
269,0211-699501013259,con,o
269,0211-699501013259,normalizacion,o
269,0211-699501013259,del,o
269,0211-699501013259,pp,i
269,0211-699501013259,aumento,o
269,0211-699501013259,del,o
269,0211-699501013259,folato,i
269,0211-699501013259,703,o
269,0211-699501013259,IC,o
269,0211-699501013259,638,o
269,0211-699501013259,795,o
269,0211-699501013259,vs,o
269,0211-699501013259,6181,o
269,0211-699501013259,IC,o
269,0211-699501013259,4447,o
269,0211-699501013259,7811,o
269,0211-699501013259,p,o
269,0211-699501013259,0001,o
269,0211-699501013259,y,o
269,0211-699501013259,descenso,o
269,0211-699501013259,de,o
269,0211-699501013259,la,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,240,o
269,0211-699501013259,IC,o
269,0211-699501013259,213,o
269,0211-699501013259,264,o
269,0211-699501013259,vs,o
269,0211-699501013259,199,o
269,0211-699501013259,IC,o
269,0211-699501013259,175,o
269,0211-699501013259,224,o
269,0211-699501013259,p,o
269,0211-699501013259,005,o
269,0211-699501013259,Han,o
269,0211-699501013259,recibido,o
269,0211-699501013259,suplementacion,i
269,0211-699501013259,durante,o
269,0211-699501013259,12,o
269,0211-699501013259,meses,o
269,0211-699501013259,33,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,pero,o
269,0211-699501013259,a,o
269,0211-699501013259,pesar,o
269,0211-699501013259,de,o
269,0211-699501013259,un,o
269,0211-699501013259,continuo,o
269,0211-699501013259,aumento,o
269,0211-699501013259,del,o
269,0211-699501013259,folato,i
269,0211-699501013259,10078,o
269,0211-699501013259,IC,o
269,0211-699501013259,7481,o
269,0211-699501013259,12674,o
269,0211-699501013259,p,o
269,0211-699501013259,0001,o
269,0211-699501013259,solo,o
269,0211-699501013259,3,o
269,0211-699501013259,pacientes,o
269,0211-699501013259,presentan,o
269,0211-699501013259,niveles,o
269,0211-699501013259,normales,o
269,0211-699501013259,de,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,correlacionandose,o
269,0211-699501013259,directamente,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,con,o
269,0211-699501013259,la,o
269,0211-699501013259,albumina,i
269,0211-699501013259,r,o
269,0211-699501013259,056,o
269,0211-699501013259,p,o
269,0211-699501013259,0001,o
269,0211-699501013259,que,o
269,0211-699501013259,se,o
269,0211-699501013259,elevo,o
269,0211-699501013259,con,o
269,0211-699501013259,respecto,o
269,0211-699501013259,al,o
269,0211-699501013259,inicio,o
269,0211-699501013259,337,o
269,0211-699501013259,IC,o
269,0211-699501013259,327,o
269,0211-699501013259,346,o
269,0211-699501013259,vs,o
269,0211-699501013259,350,o
269,0211-699501013259,IC,o
269,0211-699501013259,337,o
269,0211-699501013259,363,o
269,0211-699501013259,p,o
269,0211-699501013259,005,o
269,0211-699501013259,Conclusion,o
269,0211-699501013259,Tras,o
269,0211-699501013259,suplementacion,i
269,0211-699501013259,con,o
269,0211-699501013259,acido,i
269,0211-699501013259,folico,i
269,0211-699501013259,y,o
269,0211-699501013259,vitamina,i
269,0211-699501013259,B6,i
269,0211-699501013259,aunque,o
269,0211-699501013259,inicialmente,o
269,0211-699501013259,se,o
269,0211-699501013259,reduce,o
269,0211-699501013259,la,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,esta,o
269,0211-699501013259,respuesta,o
269,0211-699501013259,se,o
269,0211-699501013259,hace,o
269,0211-699501013259,refractaria,o
269,0211-699501013259,correlacionandose,o
269,0211-699501013259,directamente,o
269,0211-699501013259,la,o
269,0211-699501013259,tHcy,i
269,0211-699501013259,con,o
269,0211-699501013259,la,o
269,0211-699501013259,albumina,i
269,0211-699501013259,plasmatica,i
269,0211-699501013259,La,o
269,0211-699501013259,interpretacion,o
269,0211-699501013259,de,o
269,0211-699501013259,los,o
269,0211-699501013259,niveles,i
269,0211-699501013259,de,i
269,0211-699501013259,tHcy,i
269,0211-699501013259,debe,o
269,0211-699501013259,tener,o
269,0211-699501013259,en,o
269,0211-699501013259,cuenta,o
269,0211-699501013259,la,o
269,0211-699501013259,concentracion,i
269,0211-699501013259,de,i
269,0211-699501013259,albumina,i
270,0211-699501013259,Efecto,o
270,0211-699501013259,de,o
270,0211-699501013259,la,o
270,0211-699501013259,suplementacion,i
270,0211-699501013259,con,o
270,0211-699501013259,acido,i
270,0211-699501013259,folico,i
270,0211-699501013259,sobre,o
270,0211-699501013259,los,o
270,0211-699501013259,niveles,i
270,0211-699501013259,de,i
270,0211-699501013259,homocisteina,i
270,0211-699501013259,total,o
270,0211-699501013259,en,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,en,o
270,0211-699501013259,hemodialisis,i
270,0211-699501013259,La,o
270,0211-699501013259,hiperhomocisteinemia,i
270,0211-699501013259,es,o
270,0211-699501013259,un,o
270,0211-699501013259,marcador,o
270,0211-699501013259,de,o
270,0211-699501013259,riesgo,o
270,0211-699501013259,independiente,o
270,0211-699501013259,de,o
270,0211-699501013259,morbimortalidad,o
270,0211-699501013259,cardiovascular,i
270,0211-699501013259,Hemos,o
270,0211-699501013259,intentado,o
270,0211-699501013259,prospectivamente,o
270,0211-699501013259,reducir,o
270,0211-699501013259,los,o
270,0211-699501013259,niveles,i
270,0211-699501013259,de,i
270,0211-699501013259,homocisteina,i
270,0211-699501013259,total,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,mediante,o
270,0211-699501013259,suplemento,o
270,0211-699501013259,con,o
270,0211-699501013259,acido,i
270,0211-699501013259,folico,i
270,0211-699501013259,y,o
270,0211-699501013259,vitamina,i
270,0211-699501013259,B6,i
270,0211-699501013259,pp,i
270,0211-699501013259,valorando,o
270,0211-699501013259,su,o
270,0211-699501013259,posible,o
270,0211-699501013259,correlacion,o
270,0211-699501013259,con,o
270,0211-699501013259,dosis,o
270,0211-699501013259,de,o
270,0211-699501013259,dialisis,i
270,0211-699501013259,funcion,i
270,0211-699501013259,residual,i
270,0211-699501013259,y,o
270,0211-699501013259,parametros,o
270,0211-699501013259,nutricionales,o
270,0211-699501013259,Metodos,o
270,0211-699501013259,Todos,o
270,0211-699501013259,los,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,en,o
270,0211-699501013259,hemodialisis,i
270,0211-699501013259,al,o
270,0211-699501013259,comienzo,o
270,0211-699501013259,del,o
270,0211-699501013259,estudio,o
270,0211-699501013259,que,o
270,0211-699501013259,no,o
270,0211-699501013259,recibian,o
270,0211-699501013259,acido,i
270,0211-699501013259,folico,i
270,0211-699501013259,ni,o
270,0211-699501013259,vitamina,i
270,0211-699501013259,B6,i
270,0211-699501013259,asi,o
270,0211-699501013259,como,o
270,0211-699501013259,los,o
270,0211-699501013259,incorporados,o
270,0211-699501013259,posteriormente,o
270,0211-699501013259,a,o
270,0211-699501013259,partir,o
270,0211-699501013259,de,o
270,0211-699501013259,su,o
270,0211-699501013259,tercer,o
270,0211-699501013259,mes,o
270,0211-699501013259,en,o
270,0211-699501013259,hemodialisis,i
270,0211-699501013259,recibieron,o
270,0211-699501013259,5,o
270,0211-699501013259,mg,o
270,0211-699501013259,orales,o
270,0211-699501013259,de,o
270,0211-699501013259,acido,i
270,0211-699501013259,folico,i
270,0211-699501013259,cada,o
270,0211-699501013259,48,o
270,0211-699501013259,horas,o
270,0211-699501013259,y,o
270,0211-699501013259,40,o
270,0211-699501013259,mg,o
270,0211-699501013259,orales,o
270,0211-699501013259,de,o
270,0211-699501013259,vitamina,i
270,0211-699501013259,B6,i
270,0211-699501013259,cada,o
270,0211-699501013259,semana,o
270,0211-699501013259,Se,o
270,0211-699501013259,determinaron,o
270,0211-699501013259,al,o
270,0211-699501013259,comienzo,o
270,0211-699501013259,del,o
270,0211-699501013259,estudio,o
270,0211-699501013259,y,o
270,0211-699501013259,cada,o
270,0211-699501013259,2,o
270,0211-699501013259,meses,o
270,0211-699501013259,niveles,i
270,0211-699501013259,de,i
270,0211-699501013259,folato,i
270,0211-699501013259,vitamina,i
270,0211-699501013259,B12,i
270,0211-699501013259,inmunoensayo,i
270,0211-699501013259,albumina,i
270,0211-699501013259,y,o
270,0211-699501013259,cinetica,o
270,0211-699501013259,de,o
270,0211-699501013259,la,o
270,0211-699501013259,urea,i
270,0211-699501013259,KTV,o
270,0211-699501013259,KRU,o
270,0211-699501013259,PCRn,o
270,0211-699501013259,y,o
270,0211-699501013259,cada,o
270,0211-699501013259,6,o
270,0211-699501013259,meses,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,HPLC,i
270,0211-699501013259,y,o
270,0211-699501013259,pp,i
270,0211-699501013259,RIA,i
270,0211-699501013259,Resultados,o
270,0211-699501013259,80,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,fueron,o
270,0211-699501013259,incluidos,o
270,0211-699501013259,en,o
270,0211-699501013259,el,o
270,0211-699501013259,estudio,o
270,0211-699501013259,basal,o
270,0211-699501013259,con,o
270,0211-699501013259,una,o
270,0211-699501013259,prevalencia,o
270,0211-699501013259,de,o
270,0211-699501013259,hiperhomocisteinemia,i
270,0211-699501013259,del,o
270,0211-699501013259,844,o
270,0211-699501013259,deficit,i
270,0211-699501013259,de,i
270,0211-699501013259,pp,i
270,0211-699501013259,en,o
270,0211-699501013259,el,o
270,0211-699501013259,32,o
270,0211-699501013259,y,o
270,0211-699501013259,folato,i
270,0211-699501013259,en,o
270,0211-699501013259,el,o
270,0211-699501013259,rango,o
270,0211-699501013259,normal,o
270,0211-699501013259,bajo,o
270,0211-699501013259,los,o
270,0211-699501013259,niveles,i
270,0211-699501013259,de,i
270,0211-699501013259,tHcy,i
270,0211-699501013259,se,o
270,0211-699501013259,correlacionaban,o
270,0211-699501013259,inversamente,o
270,0211-699501013259,con,o
270,0211-699501013259,los,o
270,0211-699501013259,del,o
270,0211-699501013259,folato,i
270,0211-699501013259,r,o
270,0211-699501013259,0336,o
270,0211-699501013259,p,o
270,0211-699501013259,001,o
270,0211-699501013259,pero,o
270,0211-699501013259,no,o
270,0211-699501013259,con,o
270,0211-699501013259,pp,i
270,0211-699501013259,B12,i
270,0211-699501013259,edad,o
270,0211-699501013259,albumina,i
270,0211-699501013259,KTV,o
270,0211-699501013259,KRU,o
270,0211-699501013259,PCRn,o
270,0211-699501013259,Cincuenta,o
270,0211-699501013259,y,o
270,0211-699501013259,ocho,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,recibieron,o
270,0211-699501013259,seis,o
270,0211-699501013259,meses,o
270,0211-699501013259,de,o
270,0211-699501013259,suplementacion,i
270,0211-699501013259,con,o
270,0211-699501013259,normalizacion,o
270,0211-699501013259,del,o
270,0211-699501013259,pp,i
270,0211-699501013259,aumento,o
270,0211-699501013259,del,o
270,0211-699501013259,folato,i
270,0211-699501013259,703,o
270,0211-699501013259,IC,o
270,0211-699501013259,638,o
270,0211-699501013259,795,o
270,0211-699501013259,vs,o
270,0211-699501013259,6181,o
270,0211-699501013259,IC,o
270,0211-699501013259,4447,o
270,0211-699501013259,7811,o
270,0211-699501013259,p,o
270,0211-699501013259,0001,o
270,0211-699501013259,y,o
270,0211-699501013259,descenso,o
270,0211-699501013259,de,o
270,0211-699501013259,la,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,240,o
270,0211-699501013259,IC,o
270,0211-699501013259,213,o
270,0211-699501013259,264,o
270,0211-699501013259,vs,o
270,0211-699501013259,199,o
270,0211-699501013259,IC,o
270,0211-699501013259,175,o
270,0211-699501013259,224,o
270,0211-699501013259,p,o
270,0211-699501013259,005,o
270,0211-699501013259,Han,o
270,0211-699501013259,recibido,o
270,0211-699501013259,suplementacion,i
270,0211-699501013259,durante,o
270,0211-699501013259,12,o
270,0211-699501013259,meses,o
270,0211-699501013259,33,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,pero,o
270,0211-699501013259,a,o
270,0211-699501013259,pesar,o
270,0211-699501013259,de,o
270,0211-699501013259,un,o
270,0211-699501013259,continuo,o
270,0211-699501013259,aumento,o
270,0211-699501013259,del,o
270,0211-699501013259,folato,i
270,0211-699501013259,10078,o
270,0211-699501013259,IC,o
270,0211-699501013259,7481,o
270,0211-699501013259,12674,o
270,0211-699501013259,p,o
270,0211-699501013259,0001,o
270,0211-699501013259,solo,o
270,0211-699501013259,3,o
270,0211-699501013259,pacientes,o
270,0211-699501013259,presentan,o
270,0211-699501013259,niveles,o
270,0211-699501013259,normales,o
270,0211-699501013259,de,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,correlacionandose,o
270,0211-699501013259,directamente,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,con,o
270,0211-699501013259,la,o
270,0211-699501013259,albumina,i
270,0211-699501013259,r,o
270,0211-699501013259,056,o
270,0211-699501013259,p,o
270,0211-699501013259,0001,o
270,0211-699501013259,que,o
270,0211-699501013259,se,o
270,0211-699501013259,elevo,o
270,0211-699501013259,con,o
270,0211-699501013259,respecto,o
270,0211-699501013259,al,o
270,0211-699501013259,inicio,o
270,0211-699501013259,337,o
270,0211-699501013259,IC,o
270,0211-699501013259,327,o
270,0211-699501013259,346,o
270,0211-699501013259,vs,o
270,0211-699501013259,350,o
270,0211-699501013259,IC,o
270,0211-699501013259,337,o
270,0211-699501013259,363,o
270,0211-699501013259,p,o
270,0211-699501013259,005,o
270,0211-699501013259,Conclusion,o
270,0211-699501013259,Tras,o
270,0211-699501013259,suplementacion,i
270,0211-699501013259,con,o
270,0211-699501013259,acido,i
270,0211-699501013259,folico,i
270,0211-699501013259,y,o
270,0211-699501013259,vitamina,i
270,0211-699501013259,B6,i
270,0211-699501013259,aunque,o
270,0211-699501013259,inicialmente,o
270,0211-699501013259,se,o
270,0211-699501013259,reduce,o
270,0211-699501013259,la,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,esta,o
270,0211-699501013259,respuesta,o
270,0211-699501013259,se,o
270,0211-699501013259,hace,o
270,0211-699501013259,refractaria,o
270,0211-699501013259,correlacionandose,o
270,0211-699501013259,directamente,o
270,0211-699501013259,la,o
270,0211-699501013259,tHcy,i
270,0211-699501013259,con,o
270,0211-699501013259,la,o
270,0211-699501013259,albumina,i
270,0211-699501013259,plasmatica,i
270,0211-699501013259,La,o
270,0211-699501013259,interpretacion,o
270,0211-699501013259,de,o
270,0211-699501013259,los,o
270,0211-699501013259,niveles,i
270,0211-699501013259,de,i
270,0211-699501013259,tHcy,i
270,0211-699501013259,debe,o
270,0211-699501013259,tener,o
270,0211-699501013259,en,o
270,0211-699501013259,cuenta,o
270,0211-699501013259,la,o
270,0211-699501013259,concentracion,i
270,0211-699501013259,de,i
270,0211-699501013259,albumina,i
271,0211-699501013259,Efecto,o
271,0211-699501013259,de,o
271,0211-699501013259,la,o
271,0211-699501013259,suplementacion,i
271,0211-699501013259,con,o
271,0211-699501013259,acido,i
271,0211-699501013259,folico,i
271,0211-699501013259,sobre,o
271,0211-699501013259,los,o
271,0211-699501013259,niveles,i
271,0211-699501013259,de,i
271,0211-699501013259,homocisteina,i
271,0211-699501013259,total,o
271,0211-699501013259,en,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,en,o
271,0211-699501013259,hemodialisis,i
271,0211-699501013259,La,o
271,0211-699501013259,hiperhomocisteinemia,i
271,0211-699501013259,es,o
271,0211-699501013259,un,o
271,0211-699501013259,marcador,o
271,0211-699501013259,de,o
271,0211-699501013259,riesgo,o
271,0211-699501013259,independiente,o
271,0211-699501013259,de,o
271,0211-699501013259,morbimortalidad,o
271,0211-699501013259,cardiovascular,i
271,0211-699501013259,Hemos,o
271,0211-699501013259,intentado,o
271,0211-699501013259,prospectivamente,o
271,0211-699501013259,reducir,o
271,0211-699501013259,los,o
271,0211-699501013259,niveles,i
271,0211-699501013259,de,i
271,0211-699501013259,homocisteina,i
271,0211-699501013259,total,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,mediante,o
271,0211-699501013259,suplemento,o
271,0211-699501013259,con,o
271,0211-699501013259,acido,i
271,0211-699501013259,folico,i
271,0211-699501013259,y,o
271,0211-699501013259,vitamina,i
271,0211-699501013259,B6,i
271,0211-699501013259,pp,i
271,0211-699501013259,valorando,o
271,0211-699501013259,su,o
271,0211-699501013259,posible,o
271,0211-699501013259,correlacion,o
271,0211-699501013259,con,o
271,0211-699501013259,dosis,o
271,0211-699501013259,de,o
271,0211-699501013259,dialisis,i
271,0211-699501013259,funcion,i
271,0211-699501013259,residual,i
271,0211-699501013259,y,o
271,0211-699501013259,parametros,o
271,0211-699501013259,nutricionales,o
271,0211-699501013259,Metodos,o
271,0211-699501013259,Todos,o
271,0211-699501013259,los,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,en,o
271,0211-699501013259,hemodialisis,i
271,0211-699501013259,al,o
271,0211-699501013259,comienzo,o
271,0211-699501013259,del,o
271,0211-699501013259,estudio,o
271,0211-699501013259,que,o
271,0211-699501013259,no,o
271,0211-699501013259,recibian,o
271,0211-699501013259,acido,i
271,0211-699501013259,folico,i
271,0211-699501013259,ni,o
271,0211-699501013259,vitamina,i
271,0211-699501013259,B6,i
271,0211-699501013259,asi,o
271,0211-699501013259,como,o
271,0211-699501013259,los,o
271,0211-699501013259,incorporados,o
271,0211-699501013259,posteriormente,o
271,0211-699501013259,a,o
271,0211-699501013259,partir,o
271,0211-699501013259,de,o
271,0211-699501013259,su,o
271,0211-699501013259,tercer,o
271,0211-699501013259,mes,o
271,0211-699501013259,en,o
271,0211-699501013259,hemodialisis,i
271,0211-699501013259,recibieron,o
271,0211-699501013259,5,o
271,0211-699501013259,mg,o
271,0211-699501013259,orales,o
271,0211-699501013259,de,o
271,0211-699501013259,acido,i
271,0211-699501013259,folico,i
271,0211-699501013259,cada,o
271,0211-699501013259,48,o
271,0211-699501013259,horas,o
271,0211-699501013259,y,o
271,0211-699501013259,40,o
271,0211-699501013259,mg,o
271,0211-699501013259,orales,o
271,0211-699501013259,de,o
271,0211-699501013259,vitamina,i
271,0211-699501013259,B6,i
271,0211-699501013259,cada,o
271,0211-699501013259,semana,o
271,0211-699501013259,Se,o
271,0211-699501013259,determinaron,o
271,0211-699501013259,al,o
271,0211-699501013259,comienzo,o
271,0211-699501013259,del,o
271,0211-699501013259,estudio,o
271,0211-699501013259,y,o
271,0211-699501013259,cada,o
271,0211-699501013259,2,o
271,0211-699501013259,meses,o
271,0211-699501013259,niveles,i
271,0211-699501013259,de,i
271,0211-699501013259,folato,i
271,0211-699501013259,vitamina,i
271,0211-699501013259,B12,i
271,0211-699501013259,inmunoensayo,i
271,0211-699501013259,albumina,i
271,0211-699501013259,y,o
271,0211-699501013259,cinetica,o
271,0211-699501013259,de,o
271,0211-699501013259,la,o
271,0211-699501013259,urea,i
271,0211-699501013259,KTV,o
271,0211-699501013259,KRU,o
271,0211-699501013259,PCRn,o
271,0211-699501013259,y,o
271,0211-699501013259,cada,o
271,0211-699501013259,6,o
271,0211-699501013259,meses,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,HPLC,i
271,0211-699501013259,y,o
271,0211-699501013259,pp,i
271,0211-699501013259,RIA,i
271,0211-699501013259,Resultados,o
271,0211-699501013259,80,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,fueron,o
271,0211-699501013259,incluidos,o
271,0211-699501013259,en,o
271,0211-699501013259,el,o
271,0211-699501013259,estudio,o
271,0211-699501013259,basal,o
271,0211-699501013259,con,o
271,0211-699501013259,una,o
271,0211-699501013259,prevalencia,o
271,0211-699501013259,de,o
271,0211-699501013259,hiperhomocisteinemia,i
271,0211-699501013259,del,o
271,0211-699501013259,844,o
271,0211-699501013259,deficit,i
271,0211-699501013259,de,i
271,0211-699501013259,pp,i
271,0211-699501013259,en,o
271,0211-699501013259,el,o
271,0211-699501013259,32,o
271,0211-699501013259,y,o
271,0211-699501013259,folato,i
271,0211-699501013259,en,o
271,0211-699501013259,el,o
271,0211-699501013259,rango,o
271,0211-699501013259,normal,o
271,0211-699501013259,bajo,o
271,0211-699501013259,los,o
271,0211-699501013259,niveles,i
271,0211-699501013259,de,i
271,0211-699501013259,tHcy,i
271,0211-699501013259,se,o
271,0211-699501013259,correlacionaban,o
271,0211-699501013259,inversamente,o
271,0211-699501013259,con,o
271,0211-699501013259,los,o
271,0211-699501013259,del,o
271,0211-699501013259,folato,i
271,0211-699501013259,r,o
271,0211-699501013259,0336,o
271,0211-699501013259,p,o
271,0211-699501013259,001,o
271,0211-699501013259,pero,o
271,0211-699501013259,no,o
271,0211-699501013259,con,o
271,0211-699501013259,pp,i
271,0211-699501013259,B12,i
271,0211-699501013259,edad,o
271,0211-699501013259,albumina,i
271,0211-699501013259,KTV,o
271,0211-699501013259,KRU,o
271,0211-699501013259,PCRn,o
271,0211-699501013259,Cincuenta,o
271,0211-699501013259,y,o
271,0211-699501013259,ocho,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,recibieron,o
271,0211-699501013259,seis,o
271,0211-699501013259,meses,o
271,0211-699501013259,de,o
271,0211-699501013259,suplementacion,i
271,0211-699501013259,con,o
271,0211-699501013259,normalizacion,o
271,0211-699501013259,del,o
271,0211-699501013259,pp,i
271,0211-699501013259,aumento,o
271,0211-699501013259,del,o
271,0211-699501013259,folato,i
271,0211-699501013259,703,o
271,0211-699501013259,IC,o
271,0211-699501013259,638,o
271,0211-699501013259,795,o
271,0211-699501013259,vs,o
271,0211-699501013259,6181,o
271,0211-699501013259,IC,o
271,0211-699501013259,4447,o
271,0211-699501013259,7811,o
271,0211-699501013259,p,o
271,0211-699501013259,0001,o
271,0211-699501013259,y,o
271,0211-699501013259,descenso,o
271,0211-699501013259,de,o
271,0211-699501013259,la,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,240,o
271,0211-699501013259,IC,o
271,0211-699501013259,213,o
271,0211-699501013259,264,o
271,0211-699501013259,vs,o
271,0211-699501013259,199,o
271,0211-699501013259,IC,o
271,0211-699501013259,175,o
271,0211-699501013259,224,o
271,0211-699501013259,p,o
271,0211-699501013259,005,o
271,0211-699501013259,Han,o
271,0211-699501013259,recibido,o
271,0211-699501013259,suplementacion,i
271,0211-699501013259,durante,o
271,0211-699501013259,12,o
271,0211-699501013259,meses,o
271,0211-699501013259,33,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,pero,o
271,0211-699501013259,a,o
271,0211-699501013259,pesar,o
271,0211-699501013259,de,o
271,0211-699501013259,un,o
271,0211-699501013259,continuo,o
271,0211-699501013259,aumento,o
271,0211-699501013259,del,o
271,0211-699501013259,folato,i
271,0211-699501013259,10078,o
271,0211-699501013259,IC,o
271,0211-699501013259,7481,o
271,0211-699501013259,12674,o
271,0211-699501013259,p,o
271,0211-699501013259,0001,o
271,0211-699501013259,solo,o
271,0211-699501013259,3,o
271,0211-699501013259,pacientes,o
271,0211-699501013259,presentan,o
271,0211-699501013259,niveles,o
271,0211-699501013259,normales,o
271,0211-699501013259,de,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,correlacionandose,o
271,0211-699501013259,directamente,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,con,o
271,0211-699501013259,la,o
271,0211-699501013259,albumina,i
271,0211-699501013259,r,o
271,0211-699501013259,056,o
271,0211-699501013259,p,o
271,0211-699501013259,0001,o
271,0211-699501013259,que,o
271,0211-699501013259,se,o
271,0211-699501013259,elevo,o
271,0211-699501013259,con,o
271,0211-699501013259,respecto,o
271,0211-699501013259,al,o
271,0211-699501013259,inicio,o
271,0211-699501013259,337,o
271,0211-699501013259,IC,o
271,0211-699501013259,327,o
271,0211-699501013259,346,o
271,0211-699501013259,vs,o
271,0211-699501013259,350,o
271,0211-699501013259,IC,o
271,0211-699501013259,337,o
271,0211-699501013259,363,o
271,0211-699501013259,p,o
271,0211-699501013259,005,o
271,0211-699501013259,Conclusion,o
271,0211-699501013259,Tras,o
271,0211-699501013259,suplementacion,i
271,0211-699501013259,con,o
271,0211-699501013259,acido,i
271,0211-699501013259,folico,i
271,0211-699501013259,y,o
271,0211-699501013259,vitamina,i
271,0211-699501013259,B6,i
271,0211-699501013259,aunque,o
271,0211-699501013259,inicialmente,o
271,0211-699501013259,se,o
271,0211-699501013259,reduce,o
271,0211-699501013259,la,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,esta,o
271,0211-699501013259,respuesta,o
271,0211-699501013259,se,o
271,0211-699501013259,hace,o
271,0211-699501013259,refractaria,o
271,0211-699501013259,correlacionandose,o
271,0211-699501013259,directamente,o
271,0211-699501013259,la,o
271,0211-699501013259,tHcy,i
271,0211-699501013259,con,o
271,0211-699501013259,la,o
271,0211-699501013259,albumina,i
271,0211-699501013259,plasmatica,i
271,0211-699501013259,La,o
271,0211-699501013259,interpretacion,o
271,0211-699501013259,de,o
271,0211-699501013259,los,o
271,0211-699501013259,niveles,i
271,0211-699501013259,de,i
271,0211-699501013259,tHcy,i
271,0211-699501013259,debe,o
271,0211-699501013259,tener,o
271,0211-699501013259,en,o
271,0211-699501013259,cuenta,o
271,0211-699501013259,la,o
271,0211-699501013259,concentracion,i
271,0211-699501013259,de,i
271,0211-699501013259,albumina,i
272,0211-699501013259,Efecto,o
272,0211-699501013259,de,o
272,0211-699501013259,la,o
272,0211-699501013259,suplementacion,i
272,0211-699501013259,con,o
272,0211-699501013259,acido,i
272,0211-699501013259,folico,i
272,0211-699501013259,sobre,o
272,0211-699501013259,los,o
272,0211-699501013259,niveles,i
272,0211-699501013259,de,i
272,0211-699501013259,homocisteina,i
272,0211-699501013259,total,o
272,0211-699501013259,en,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,en,o
272,0211-699501013259,hemodialisis,i
272,0211-699501013259,La,o
272,0211-699501013259,hiperhomocisteinemia,i
272,0211-699501013259,es,o
272,0211-699501013259,un,o
272,0211-699501013259,marcador,o
272,0211-699501013259,de,o
272,0211-699501013259,riesgo,o
272,0211-699501013259,independiente,o
272,0211-699501013259,de,o
272,0211-699501013259,morbimortalidad,o
272,0211-699501013259,cardiovascular,i
272,0211-699501013259,Hemos,o
272,0211-699501013259,intentado,o
272,0211-699501013259,prospectivamente,o
272,0211-699501013259,reducir,o
272,0211-699501013259,los,o
272,0211-699501013259,niveles,i
272,0211-699501013259,de,i
272,0211-699501013259,homocisteina,i
272,0211-699501013259,total,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,mediante,o
272,0211-699501013259,suplemento,o
272,0211-699501013259,con,o
272,0211-699501013259,acido,i
272,0211-699501013259,folico,i
272,0211-699501013259,y,o
272,0211-699501013259,vitamina,i
272,0211-699501013259,B6,i
272,0211-699501013259,pp,i
272,0211-699501013259,valorando,o
272,0211-699501013259,su,o
272,0211-699501013259,posible,o
272,0211-699501013259,correlacion,o
272,0211-699501013259,con,o
272,0211-699501013259,dosis,o
272,0211-699501013259,de,o
272,0211-699501013259,dialisis,i
272,0211-699501013259,funcion,i
272,0211-699501013259,residual,i
272,0211-699501013259,y,o
272,0211-699501013259,parametros,o
272,0211-699501013259,nutricionales,o
272,0211-699501013259,Metodos,o
272,0211-699501013259,Todos,o
272,0211-699501013259,los,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,en,o
272,0211-699501013259,hemodialisis,i
272,0211-699501013259,al,o
272,0211-699501013259,comienzo,o
272,0211-699501013259,del,o
272,0211-699501013259,estudio,o
272,0211-699501013259,que,o
272,0211-699501013259,no,o
272,0211-699501013259,recibian,o
272,0211-699501013259,acido,i
272,0211-699501013259,folico,i
272,0211-699501013259,ni,o
272,0211-699501013259,vitamina,i
272,0211-699501013259,B6,i
272,0211-699501013259,asi,o
272,0211-699501013259,como,o
272,0211-699501013259,los,o
272,0211-699501013259,incorporados,o
272,0211-699501013259,posteriormente,o
272,0211-699501013259,a,o
272,0211-699501013259,partir,o
272,0211-699501013259,de,o
272,0211-699501013259,su,o
272,0211-699501013259,tercer,o
272,0211-699501013259,mes,o
272,0211-699501013259,en,o
272,0211-699501013259,hemodialisis,i
272,0211-699501013259,recibieron,o
272,0211-699501013259,5,o
272,0211-699501013259,mg,o
272,0211-699501013259,orales,o
272,0211-699501013259,de,o
272,0211-699501013259,acido,i
272,0211-699501013259,folico,i
272,0211-699501013259,cada,o
272,0211-699501013259,48,o
272,0211-699501013259,horas,o
272,0211-699501013259,y,o
272,0211-699501013259,40,o
272,0211-699501013259,mg,o
272,0211-699501013259,orales,o
272,0211-699501013259,de,o
272,0211-699501013259,vitamina,i
272,0211-699501013259,B6,i
272,0211-699501013259,cada,o
272,0211-699501013259,semana,o
272,0211-699501013259,Se,o
272,0211-699501013259,determinaron,o
272,0211-699501013259,al,o
272,0211-699501013259,comienzo,o
272,0211-699501013259,del,o
272,0211-699501013259,estudio,o
272,0211-699501013259,y,o
272,0211-699501013259,cada,o
272,0211-699501013259,2,o
272,0211-699501013259,meses,o
272,0211-699501013259,niveles,i
272,0211-699501013259,de,i
272,0211-699501013259,folato,i
272,0211-699501013259,vitamina,i
272,0211-699501013259,B12,i
272,0211-699501013259,inmunoensayo,i
272,0211-699501013259,albumina,i
272,0211-699501013259,y,o
272,0211-699501013259,cinetica,o
272,0211-699501013259,de,o
272,0211-699501013259,la,o
272,0211-699501013259,urea,i
272,0211-699501013259,KTV,o
272,0211-699501013259,KRU,o
272,0211-699501013259,PCRn,o
272,0211-699501013259,y,o
272,0211-699501013259,cada,o
272,0211-699501013259,6,o
272,0211-699501013259,meses,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,HPLC,i
272,0211-699501013259,y,o
272,0211-699501013259,pp,i
272,0211-699501013259,RIA,i
272,0211-699501013259,Resultados,o
272,0211-699501013259,80,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,fueron,o
272,0211-699501013259,incluidos,o
272,0211-699501013259,en,o
272,0211-699501013259,el,o
272,0211-699501013259,estudio,o
272,0211-699501013259,basal,o
272,0211-699501013259,con,o
272,0211-699501013259,una,o
272,0211-699501013259,prevalencia,o
272,0211-699501013259,de,o
272,0211-699501013259,hiperhomocisteinemia,i
272,0211-699501013259,del,o
272,0211-699501013259,844,o
272,0211-699501013259,deficit,i
272,0211-699501013259,de,i
272,0211-699501013259,pp,i
272,0211-699501013259,en,o
272,0211-699501013259,el,o
272,0211-699501013259,32,o
272,0211-699501013259,y,o
272,0211-699501013259,folato,i
272,0211-699501013259,en,o
272,0211-699501013259,el,o
272,0211-699501013259,rango,o
272,0211-699501013259,normal,o
272,0211-699501013259,bajo,o
272,0211-699501013259,los,o
272,0211-699501013259,niveles,i
272,0211-699501013259,de,i
272,0211-699501013259,tHcy,i
272,0211-699501013259,se,o
272,0211-699501013259,correlacionaban,o
272,0211-699501013259,inversamente,o
272,0211-699501013259,con,o
272,0211-699501013259,los,o
272,0211-699501013259,del,o
272,0211-699501013259,folato,i
272,0211-699501013259,r,o
272,0211-699501013259,0336,o
272,0211-699501013259,p,o
272,0211-699501013259,001,o
272,0211-699501013259,pero,o
272,0211-699501013259,no,o
272,0211-699501013259,con,o
272,0211-699501013259,pp,i
272,0211-699501013259,B12,i
272,0211-699501013259,edad,o
272,0211-699501013259,albumina,i
272,0211-699501013259,KTV,o
272,0211-699501013259,KRU,o
272,0211-699501013259,PCRn,o
272,0211-699501013259,Cincuenta,o
272,0211-699501013259,y,o
272,0211-699501013259,ocho,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,recibieron,o
272,0211-699501013259,seis,o
272,0211-699501013259,meses,o
272,0211-699501013259,de,o
272,0211-699501013259,suplementacion,i
272,0211-699501013259,con,o
272,0211-699501013259,normalizacion,o
272,0211-699501013259,del,o
272,0211-699501013259,pp,i
272,0211-699501013259,aumento,o
272,0211-699501013259,del,o
272,0211-699501013259,folato,i
272,0211-699501013259,703,o
272,0211-699501013259,IC,o
272,0211-699501013259,638,o
272,0211-699501013259,795,o
272,0211-699501013259,vs,o
272,0211-699501013259,6181,o
272,0211-699501013259,IC,o
272,0211-699501013259,4447,o
272,0211-699501013259,7811,o
272,0211-699501013259,p,o
272,0211-699501013259,0001,o
272,0211-699501013259,y,o
272,0211-699501013259,descenso,o
272,0211-699501013259,de,o
272,0211-699501013259,la,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,240,o
272,0211-699501013259,IC,o
272,0211-699501013259,213,o
272,0211-699501013259,264,o
272,0211-699501013259,vs,o
272,0211-699501013259,199,o
272,0211-699501013259,IC,o
272,0211-699501013259,175,o
272,0211-699501013259,224,o
272,0211-699501013259,p,o
272,0211-699501013259,005,o
272,0211-699501013259,Han,o
272,0211-699501013259,recibido,o
272,0211-699501013259,suplementacion,i
272,0211-699501013259,durante,o
272,0211-699501013259,12,o
272,0211-699501013259,meses,o
272,0211-699501013259,33,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,pero,o
272,0211-699501013259,a,o
272,0211-699501013259,pesar,o
272,0211-699501013259,de,o
272,0211-699501013259,un,o
272,0211-699501013259,continuo,o
272,0211-699501013259,aumento,o
272,0211-699501013259,del,o
272,0211-699501013259,folato,i
272,0211-699501013259,10078,o
272,0211-699501013259,IC,o
272,0211-699501013259,7481,o
272,0211-699501013259,12674,o
272,0211-699501013259,p,o
272,0211-699501013259,0001,o
272,0211-699501013259,solo,o
272,0211-699501013259,3,o
272,0211-699501013259,pacientes,o
272,0211-699501013259,presentan,o
272,0211-699501013259,niveles,o
272,0211-699501013259,normales,o
272,0211-699501013259,de,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,correlacionandose,o
272,0211-699501013259,directamente,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,con,o
272,0211-699501013259,la,o
272,0211-699501013259,albumina,i
272,0211-699501013259,r,o
272,0211-699501013259,056,o
272,0211-699501013259,p,o
272,0211-699501013259,0001,o
272,0211-699501013259,que,o
272,0211-699501013259,se,o
272,0211-699501013259,elevo,o
272,0211-699501013259,con,o
272,0211-699501013259,respecto,o
272,0211-699501013259,al,o
272,0211-699501013259,inicio,o
272,0211-699501013259,337,o
272,0211-699501013259,IC,o
272,0211-699501013259,327,o
272,0211-699501013259,346,o
272,0211-699501013259,vs,o
272,0211-699501013259,350,o
272,0211-699501013259,IC,o
272,0211-699501013259,337,o
272,0211-699501013259,363,o
272,0211-699501013259,p,o
272,0211-699501013259,005,o
272,0211-699501013259,Conclusion,o
272,0211-699501013259,Tras,o
272,0211-699501013259,suplementacion,i
272,0211-699501013259,con,o
272,0211-699501013259,acido,i
272,0211-699501013259,folico,i
272,0211-699501013259,y,o
272,0211-699501013259,vitamina,i
272,0211-699501013259,B6,i
272,0211-699501013259,aunque,o
272,0211-699501013259,inicialmente,o
272,0211-699501013259,se,o
272,0211-699501013259,reduce,o
272,0211-699501013259,la,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,esta,o
272,0211-699501013259,respuesta,o
272,0211-699501013259,se,o
272,0211-699501013259,hace,o
272,0211-699501013259,refractaria,o
272,0211-699501013259,correlacionandose,o
272,0211-699501013259,directamente,o
272,0211-699501013259,la,o
272,0211-699501013259,tHcy,i
272,0211-699501013259,con,o
272,0211-699501013259,la,o
272,0211-699501013259,albumina,i
272,0211-699501013259,plasmatica,i
272,0211-699501013259,La,o
272,0211-699501013259,interpretacion,o
272,0211-699501013259,de,o
272,0211-699501013259,los,o
272,0211-699501013259,niveles,i
272,0211-699501013259,de,i
272,0211-699501013259,tHcy,i
272,0211-699501013259,debe,o
272,0211-699501013259,tener,o
272,0211-699501013259,en,o
272,0211-699501013259,cuenta,o
272,0211-699501013259,la,o
272,0211-699501013259,concentracion,i
272,0211-699501013259,de,i
272,0211-699501013259,albumina,i
273,0211-699501013259,Efecto,o
273,0211-699501013259,de,o
273,0211-699501013259,la,o
273,0211-699501013259,suplementacion,i
273,0211-699501013259,con,o
273,0211-699501013259,acido,i
273,0211-699501013259,folico,i
273,0211-699501013259,sobre,o
273,0211-699501013259,los,o
273,0211-699501013259,niveles,i
273,0211-699501013259,de,i
273,0211-699501013259,homocisteina,i
273,0211-699501013259,total,o
273,0211-699501013259,en,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,en,o
273,0211-699501013259,hemodialisis,i
273,0211-699501013259,La,o
273,0211-699501013259,hiperhomocisteinemia,i
273,0211-699501013259,es,o
273,0211-699501013259,un,o
273,0211-699501013259,marcador,o
273,0211-699501013259,de,o
273,0211-699501013259,riesgo,o
273,0211-699501013259,independiente,o
273,0211-699501013259,de,o
273,0211-699501013259,morbimortalidad,o
273,0211-699501013259,cardiovascular,i
273,0211-699501013259,Hemos,o
273,0211-699501013259,intentado,o
273,0211-699501013259,prospectivamente,o
273,0211-699501013259,reducir,o
273,0211-699501013259,los,o
273,0211-699501013259,niveles,i
273,0211-699501013259,de,i
273,0211-699501013259,homocisteina,i
273,0211-699501013259,total,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,mediante,o
273,0211-699501013259,suplemento,o
273,0211-699501013259,con,o
273,0211-699501013259,acido,i
273,0211-699501013259,folico,i
273,0211-699501013259,y,o
273,0211-699501013259,vitamina,i
273,0211-699501013259,B6,i
273,0211-699501013259,pp,i
273,0211-699501013259,valorando,o
273,0211-699501013259,su,o
273,0211-699501013259,posible,o
273,0211-699501013259,correlacion,o
273,0211-699501013259,con,o
273,0211-699501013259,dosis,o
273,0211-699501013259,de,o
273,0211-699501013259,dialisis,i
273,0211-699501013259,funcion,i
273,0211-699501013259,residual,i
273,0211-699501013259,y,o
273,0211-699501013259,parametros,o
273,0211-699501013259,nutricionales,o
273,0211-699501013259,Metodos,o
273,0211-699501013259,Todos,o
273,0211-699501013259,los,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,en,o
273,0211-699501013259,hemodialisis,i
273,0211-699501013259,al,o
273,0211-699501013259,comienzo,o
273,0211-699501013259,del,o
273,0211-699501013259,estudio,o
273,0211-699501013259,que,o
273,0211-699501013259,no,o
273,0211-699501013259,recibian,o
273,0211-699501013259,acido,i
273,0211-699501013259,folico,i
273,0211-699501013259,ni,o
273,0211-699501013259,vitamina,i
273,0211-699501013259,B6,i
273,0211-699501013259,asi,o
273,0211-699501013259,como,o
273,0211-699501013259,los,o
273,0211-699501013259,incorporados,o
273,0211-699501013259,posteriormente,o
273,0211-699501013259,a,o
273,0211-699501013259,partir,o
273,0211-699501013259,de,o
273,0211-699501013259,su,o
273,0211-699501013259,tercer,o
273,0211-699501013259,mes,o
273,0211-699501013259,en,o
273,0211-699501013259,hemodialisis,i
273,0211-699501013259,recibieron,o
273,0211-699501013259,5,o
273,0211-699501013259,mg,o
273,0211-699501013259,orales,o
273,0211-699501013259,de,o
273,0211-699501013259,acido,i
273,0211-699501013259,folico,i
273,0211-699501013259,cada,o
273,0211-699501013259,48,o
273,0211-699501013259,horas,o
273,0211-699501013259,y,o
273,0211-699501013259,40,o
273,0211-699501013259,mg,o
273,0211-699501013259,orales,o
273,0211-699501013259,de,o
273,0211-699501013259,vitamina,i
273,0211-699501013259,B6,i
273,0211-699501013259,cada,o
273,0211-699501013259,semana,o
273,0211-699501013259,Se,o
273,0211-699501013259,determinaron,o
273,0211-699501013259,al,o
273,0211-699501013259,comienzo,o
273,0211-699501013259,del,o
273,0211-699501013259,estudio,o
273,0211-699501013259,y,o
273,0211-699501013259,cada,o
273,0211-699501013259,2,o
273,0211-699501013259,meses,o
273,0211-699501013259,niveles,i
273,0211-699501013259,de,i
273,0211-699501013259,folato,i
273,0211-699501013259,vitamina,i
273,0211-699501013259,B12,i
273,0211-699501013259,inmunoensayo,i
273,0211-699501013259,albumina,i
273,0211-699501013259,y,o
273,0211-699501013259,cinetica,o
273,0211-699501013259,de,o
273,0211-699501013259,la,o
273,0211-699501013259,urea,i
273,0211-699501013259,KTV,o
273,0211-699501013259,KRU,o
273,0211-699501013259,PCRn,o
273,0211-699501013259,y,o
273,0211-699501013259,cada,o
273,0211-699501013259,6,o
273,0211-699501013259,meses,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,HPLC,i
273,0211-699501013259,y,o
273,0211-699501013259,pp,i
273,0211-699501013259,RIA,i
273,0211-699501013259,Resultados,o
273,0211-699501013259,80,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,fueron,o
273,0211-699501013259,incluidos,o
273,0211-699501013259,en,o
273,0211-699501013259,el,o
273,0211-699501013259,estudio,o
273,0211-699501013259,basal,o
273,0211-699501013259,con,o
273,0211-699501013259,una,o
273,0211-699501013259,prevalencia,o
273,0211-699501013259,de,o
273,0211-699501013259,hiperhomocisteinemia,i
273,0211-699501013259,del,o
273,0211-699501013259,844,o
273,0211-699501013259,deficit,i
273,0211-699501013259,de,i
273,0211-699501013259,pp,i
273,0211-699501013259,en,o
273,0211-699501013259,el,o
273,0211-699501013259,32,o
273,0211-699501013259,y,o
273,0211-699501013259,folato,i
273,0211-699501013259,en,o
273,0211-699501013259,el,o
273,0211-699501013259,rango,o
273,0211-699501013259,normal,o
273,0211-699501013259,bajo,o
273,0211-699501013259,los,o
273,0211-699501013259,niveles,i
273,0211-699501013259,de,i
273,0211-699501013259,tHcy,i
273,0211-699501013259,se,o
273,0211-699501013259,correlacionaban,o
273,0211-699501013259,inversamente,o
273,0211-699501013259,con,o
273,0211-699501013259,los,o
273,0211-699501013259,del,o
273,0211-699501013259,folato,i
273,0211-699501013259,r,o
273,0211-699501013259,0336,o
273,0211-699501013259,p,o
273,0211-699501013259,001,o
273,0211-699501013259,pero,o
273,0211-699501013259,no,o
273,0211-699501013259,con,o
273,0211-699501013259,pp,i
273,0211-699501013259,B12,i
273,0211-699501013259,edad,o
273,0211-699501013259,albumina,i
273,0211-699501013259,KTV,o
273,0211-699501013259,KRU,o
273,0211-699501013259,PCRn,o
273,0211-699501013259,Cincuenta,o
273,0211-699501013259,y,o
273,0211-699501013259,ocho,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,recibieron,o
273,0211-699501013259,seis,o
273,0211-699501013259,meses,o
273,0211-699501013259,de,o
273,0211-699501013259,suplementacion,i
273,0211-699501013259,con,o
273,0211-699501013259,normalizacion,o
273,0211-699501013259,del,o
273,0211-699501013259,pp,i
273,0211-699501013259,aumento,o
273,0211-699501013259,del,o
273,0211-699501013259,folato,i
273,0211-699501013259,703,o
273,0211-699501013259,IC,o
273,0211-699501013259,638,o
273,0211-699501013259,795,o
273,0211-699501013259,vs,o
273,0211-699501013259,6181,o
273,0211-699501013259,IC,o
273,0211-699501013259,4447,o
273,0211-699501013259,7811,o
273,0211-699501013259,p,o
273,0211-699501013259,0001,o
273,0211-699501013259,y,o
273,0211-699501013259,descenso,o
273,0211-699501013259,de,o
273,0211-699501013259,la,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,240,o
273,0211-699501013259,IC,o
273,0211-699501013259,213,o
273,0211-699501013259,264,o
273,0211-699501013259,vs,o
273,0211-699501013259,199,o
273,0211-699501013259,IC,o
273,0211-699501013259,175,o
273,0211-699501013259,224,o
273,0211-699501013259,p,o
273,0211-699501013259,005,o
273,0211-699501013259,Han,o
273,0211-699501013259,recibido,o
273,0211-699501013259,suplementacion,i
273,0211-699501013259,durante,o
273,0211-699501013259,12,o
273,0211-699501013259,meses,o
273,0211-699501013259,33,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,pero,o
273,0211-699501013259,a,o
273,0211-699501013259,pesar,o
273,0211-699501013259,de,o
273,0211-699501013259,un,o
273,0211-699501013259,continuo,o
273,0211-699501013259,aumento,o
273,0211-699501013259,del,o
273,0211-699501013259,folato,i
273,0211-699501013259,10078,o
273,0211-699501013259,IC,o
273,0211-699501013259,7481,o
273,0211-699501013259,12674,o
273,0211-699501013259,p,o
273,0211-699501013259,0001,o
273,0211-699501013259,solo,o
273,0211-699501013259,3,o
273,0211-699501013259,pacientes,o
273,0211-699501013259,presentan,o
273,0211-699501013259,niveles,o
273,0211-699501013259,normales,o
273,0211-699501013259,de,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,correlacionandose,o
273,0211-699501013259,directamente,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,con,o
273,0211-699501013259,la,o
273,0211-699501013259,albumina,i
273,0211-699501013259,r,o
273,0211-699501013259,056,o
273,0211-699501013259,p,o
273,0211-699501013259,0001,o
273,0211-699501013259,que,o
273,0211-699501013259,se,o
273,0211-699501013259,elevo,o
273,0211-699501013259,con,o
273,0211-699501013259,respecto,o
273,0211-699501013259,al,o
273,0211-699501013259,inicio,o
273,0211-699501013259,337,o
273,0211-699501013259,IC,o
273,0211-699501013259,327,o
273,0211-699501013259,346,o
273,0211-699501013259,vs,o
273,0211-699501013259,350,o
273,0211-699501013259,IC,o
273,0211-699501013259,337,o
273,0211-699501013259,363,o
273,0211-699501013259,p,o
273,0211-699501013259,005,o
273,0211-699501013259,Conclusion,o
273,0211-699501013259,Tras,o
273,0211-699501013259,suplementacion,i
273,0211-699501013259,con,o
273,0211-699501013259,acido,i
273,0211-699501013259,folico,i
273,0211-699501013259,y,o
273,0211-699501013259,vitamina,i
273,0211-699501013259,B6,i
273,0211-699501013259,aunque,o
273,0211-699501013259,inicialmente,o
273,0211-699501013259,se,o
273,0211-699501013259,reduce,o
273,0211-699501013259,la,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,esta,o
273,0211-699501013259,respuesta,o
273,0211-699501013259,se,o
273,0211-699501013259,hace,o
273,0211-699501013259,refractaria,o
273,0211-699501013259,correlacionandose,o
273,0211-699501013259,directamente,o
273,0211-699501013259,la,o
273,0211-699501013259,tHcy,i
273,0211-699501013259,con,o
273,0211-699501013259,la,o
273,0211-699501013259,albumina,i
273,0211-699501013259,plasmatica,i
273,0211-699501013259,La,o
273,0211-699501013259,interpretacion,o
273,0211-699501013259,de,o
273,0211-699501013259,los,o
273,0211-699501013259,niveles,i
273,0211-699501013259,de,i
273,0211-699501013259,tHcy,i
273,0211-699501013259,debe,o
273,0211-699501013259,tener,o
273,0211-699501013259,en,o
273,0211-699501013259,cuenta,o
273,0211-699501013259,la,o
273,0211-699501013259,concentracion,i
273,0211-699501013259,de,i
273,0211-699501013259,albumina,i
274,0211-699501013259,Efecto,o
274,0211-699501013259,de,o
274,0211-699501013259,la,o
274,0211-699501013259,suplementacion,i
274,0211-699501013259,con,o
274,0211-699501013259,acido,i
274,0211-699501013259,folico,i
274,0211-699501013259,sobre,o
274,0211-699501013259,los,o
274,0211-699501013259,niveles,i
274,0211-699501013259,de,i
274,0211-699501013259,homocisteina,i
274,0211-699501013259,total,o
274,0211-699501013259,en,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,en,o
274,0211-699501013259,hemodialisis,i
274,0211-699501013259,La,o
274,0211-699501013259,hiperhomocisteinemia,i
274,0211-699501013259,es,o
274,0211-699501013259,un,o
274,0211-699501013259,marcador,o
274,0211-699501013259,de,o
274,0211-699501013259,riesgo,o
274,0211-699501013259,independiente,o
274,0211-699501013259,de,o
274,0211-699501013259,morbimortalidad,o
274,0211-699501013259,cardiovascular,i
274,0211-699501013259,Hemos,o
274,0211-699501013259,intentado,o
274,0211-699501013259,prospectivamente,o
274,0211-699501013259,reducir,o
274,0211-699501013259,los,o
274,0211-699501013259,niveles,i
274,0211-699501013259,de,i
274,0211-699501013259,homocisteina,i
274,0211-699501013259,total,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,mediante,o
274,0211-699501013259,suplemento,o
274,0211-699501013259,con,o
274,0211-699501013259,acido,i
274,0211-699501013259,folico,i
274,0211-699501013259,y,o
274,0211-699501013259,vitamina,i
274,0211-699501013259,B6,i
274,0211-699501013259,pp,i
274,0211-699501013259,valorando,o
274,0211-699501013259,su,o
274,0211-699501013259,posible,o
274,0211-699501013259,correlacion,o
274,0211-699501013259,con,o
274,0211-699501013259,dosis,o
274,0211-699501013259,de,o
274,0211-699501013259,dialisis,i
274,0211-699501013259,funcion,i
274,0211-699501013259,residual,i
274,0211-699501013259,y,o
274,0211-699501013259,parametros,o
274,0211-699501013259,nutricionales,o
274,0211-699501013259,Metodos,o
274,0211-699501013259,Todos,o
274,0211-699501013259,los,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,en,o
274,0211-699501013259,hemodialisis,i
274,0211-699501013259,al,o
274,0211-699501013259,comienzo,o
274,0211-699501013259,del,o
274,0211-699501013259,estudio,o
274,0211-699501013259,que,o
274,0211-699501013259,no,o
274,0211-699501013259,recibian,o
274,0211-699501013259,acido,i
274,0211-699501013259,folico,i
274,0211-699501013259,ni,o
274,0211-699501013259,vitamina,i
274,0211-699501013259,B6,i
274,0211-699501013259,asi,o
274,0211-699501013259,como,o
274,0211-699501013259,los,o
274,0211-699501013259,incorporados,o
274,0211-699501013259,posteriormente,o
274,0211-699501013259,a,o
274,0211-699501013259,partir,o
274,0211-699501013259,de,o
274,0211-699501013259,su,o
274,0211-699501013259,tercer,o
274,0211-699501013259,mes,o
274,0211-699501013259,en,o
274,0211-699501013259,hemodialisis,i
274,0211-699501013259,recibieron,o
274,0211-699501013259,5,o
274,0211-699501013259,mg,o
274,0211-699501013259,orales,o
274,0211-699501013259,de,o
274,0211-699501013259,acido,i
274,0211-699501013259,folico,i
274,0211-699501013259,cada,o
274,0211-699501013259,48,o
274,0211-699501013259,horas,o
274,0211-699501013259,y,o
274,0211-699501013259,40,o
274,0211-699501013259,mg,o
274,0211-699501013259,orales,o
274,0211-699501013259,de,o
274,0211-699501013259,vitamina,i
274,0211-699501013259,B6,i
274,0211-699501013259,cada,o
274,0211-699501013259,semana,o
274,0211-699501013259,Se,o
274,0211-699501013259,determinaron,o
274,0211-699501013259,al,o
274,0211-699501013259,comienzo,o
274,0211-699501013259,del,o
274,0211-699501013259,estudio,o
274,0211-699501013259,y,o
274,0211-699501013259,cada,o
274,0211-699501013259,2,o
274,0211-699501013259,meses,o
274,0211-699501013259,niveles,i
274,0211-699501013259,de,i
274,0211-699501013259,folato,i
274,0211-699501013259,vitamina,i
274,0211-699501013259,B12,i
274,0211-699501013259,inmunoensayo,i
274,0211-699501013259,albumina,i
274,0211-699501013259,y,o
274,0211-699501013259,cinetica,o
274,0211-699501013259,de,o
274,0211-699501013259,la,o
274,0211-699501013259,urea,i
274,0211-699501013259,KTV,o
274,0211-699501013259,KRU,o
274,0211-699501013259,PCRn,o
274,0211-699501013259,y,o
274,0211-699501013259,cada,o
274,0211-699501013259,6,o
274,0211-699501013259,meses,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,HPLC,i
274,0211-699501013259,y,o
274,0211-699501013259,pp,i
274,0211-699501013259,RIA,i
274,0211-699501013259,Resultados,o
274,0211-699501013259,80,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,fueron,o
274,0211-699501013259,incluidos,o
274,0211-699501013259,en,o
274,0211-699501013259,el,o
274,0211-699501013259,estudio,o
274,0211-699501013259,basal,o
274,0211-699501013259,con,o
274,0211-699501013259,una,o
274,0211-699501013259,prevalencia,o
274,0211-699501013259,de,o
274,0211-699501013259,hiperhomocisteinemia,i
274,0211-699501013259,del,o
274,0211-699501013259,844,o
274,0211-699501013259,deficit,i
274,0211-699501013259,de,i
274,0211-699501013259,pp,i
274,0211-699501013259,en,o
274,0211-699501013259,el,o
274,0211-699501013259,32,o
274,0211-699501013259,y,o
274,0211-699501013259,folato,i
274,0211-699501013259,en,o
274,0211-699501013259,el,o
274,0211-699501013259,rango,o
274,0211-699501013259,normal,o
274,0211-699501013259,bajo,o
274,0211-699501013259,los,o
274,0211-699501013259,niveles,i
274,0211-699501013259,de,i
274,0211-699501013259,tHcy,i
274,0211-699501013259,se,o
274,0211-699501013259,correlacionaban,o
274,0211-699501013259,inversamente,o
274,0211-699501013259,con,o
274,0211-699501013259,los,o
274,0211-699501013259,del,o
274,0211-699501013259,folato,i
274,0211-699501013259,r,o
274,0211-699501013259,0336,o
274,0211-699501013259,p,o
274,0211-699501013259,001,o
274,0211-699501013259,pero,o
274,0211-699501013259,no,o
274,0211-699501013259,con,o
274,0211-699501013259,pp,i
274,0211-699501013259,B12,i
274,0211-699501013259,edad,o
274,0211-699501013259,albumina,i
274,0211-699501013259,KTV,o
274,0211-699501013259,KRU,o
274,0211-699501013259,PCRn,o
274,0211-699501013259,Cincuenta,o
274,0211-699501013259,y,o
274,0211-699501013259,ocho,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,recibieron,o
274,0211-699501013259,seis,o
274,0211-699501013259,meses,o
274,0211-699501013259,de,o
274,0211-699501013259,suplementacion,i
274,0211-699501013259,con,o
274,0211-699501013259,normalizacion,o
274,0211-699501013259,del,o
274,0211-699501013259,pp,i
274,0211-699501013259,aumento,o
274,0211-699501013259,del,o
274,0211-699501013259,folato,i
274,0211-699501013259,703,o
274,0211-699501013259,IC,o
274,0211-699501013259,638,o
274,0211-699501013259,795,o
274,0211-699501013259,vs,o
274,0211-699501013259,6181,o
274,0211-699501013259,IC,o
274,0211-699501013259,4447,o
274,0211-699501013259,7811,o
274,0211-699501013259,p,o
274,0211-699501013259,0001,o
274,0211-699501013259,y,o
274,0211-699501013259,descenso,o
274,0211-699501013259,de,o
274,0211-699501013259,la,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,240,o
274,0211-699501013259,IC,o
274,0211-699501013259,213,o
274,0211-699501013259,264,o
274,0211-699501013259,vs,o
274,0211-699501013259,199,o
274,0211-699501013259,IC,o
274,0211-699501013259,175,o
274,0211-699501013259,224,o
274,0211-699501013259,p,o
274,0211-699501013259,005,o
274,0211-699501013259,Han,o
274,0211-699501013259,recibido,o
274,0211-699501013259,suplementacion,i
274,0211-699501013259,durante,o
274,0211-699501013259,12,o
274,0211-699501013259,meses,o
274,0211-699501013259,33,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,pero,o
274,0211-699501013259,a,o
274,0211-699501013259,pesar,o
274,0211-699501013259,de,o
274,0211-699501013259,un,o
274,0211-699501013259,continuo,o
274,0211-699501013259,aumento,o
274,0211-699501013259,del,o
274,0211-699501013259,folato,i
274,0211-699501013259,10078,o
274,0211-699501013259,IC,o
274,0211-699501013259,7481,o
274,0211-699501013259,12674,o
274,0211-699501013259,p,o
274,0211-699501013259,0001,o
274,0211-699501013259,solo,o
274,0211-699501013259,3,o
274,0211-699501013259,pacientes,o
274,0211-699501013259,presentan,o
274,0211-699501013259,niveles,o
274,0211-699501013259,normales,o
274,0211-699501013259,de,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,correlacionandose,o
274,0211-699501013259,directamente,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,con,o
274,0211-699501013259,la,o
274,0211-699501013259,albumina,i
274,0211-699501013259,r,o
274,0211-699501013259,056,o
274,0211-699501013259,p,o
274,0211-699501013259,0001,o
274,0211-699501013259,que,o
274,0211-699501013259,se,o
274,0211-699501013259,elevo,o
274,0211-699501013259,con,o
274,0211-699501013259,respecto,o
274,0211-699501013259,al,o
274,0211-699501013259,inicio,o
274,0211-699501013259,337,o
274,0211-699501013259,IC,o
274,0211-699501013259,327,o
274,0211-699501013259,346,o
274,0211-699501013259,vs,o
274,0211-699501013259,350,o
274,0211-699501013259,IC,o
274,0211-699501013259,337,o
274,0211-699501013259,363,o
274,0211-699501013259,p,o
274,0211-699501013259,005,o
274,0211-699501013259,Conclusion,o
274,0211-699501013259,Tras,o
274,0211-699501013259,suplementacion,i
274,0211-699501013259,con,o
274,0211-699501013259,acido,i
274,0211-699501013259,folico,i
274,0211-699501013259,y,o
274,0211-699501013259,vitamina,i
274,0211-699501013259,B6,i
274,0211-699501013259,aunque,o
274,0211-699501013259,inicialmente,o
274,0211-699501013259,se,o
274,0211-699501013259,reduce,o
274,0211-699501013259,la,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,esta,o
274,0211-699501013259,respuesta,o
274,0211-699501013259,se,o
274,0211-699501013259,hace,o
274,0211-699501013259,refractaria,o
274,0211-699501013259,correlacionandose,o
274,0211-699501013259,directamente,o
274,0211-699501013259,la,o
274,0211-699501013259,tHcy,i
274,0211-699501013259,con,o
274,0211-699501013259,la,o
274,0211-699501013259,albumina,i
274,0211-699501013259,plasmatica,i
274,0211-699501013259,La,o
274,0211-699501013259,interpretacion,o
274,0211-699501013259,de,o
274,0211-699501013259,los,o
274,0211-699501013259,niveles,i
274,0211-699501013259,de,i
274,0211-699501013259,tHcy,i
274,0211-699501013259,debe,o
274,0211-699501013259,tener,o
274,0211-699501013259,en,o
274,0211-699501013259,cuenta,o
274,0211-699501013259,la,o
274,0211-699501013259,concentracion,i
274,0211-699501013259,de,i
274,0211-699501013259,albumina,i
275,0211-699501013259,Efecto,o
275,0211-699501013259,de,o
275,0211-699501013259,la,o
275,0211-699501013259,suplementacion,i
275,0211-699501013259,con,o
275,0211-699501013259,acido,i
275,0211-699501013259,folico,i
275,0211-699501013259,sobre,o
275,0211-699501013259,los,o
275,0211-699501013259,niveles,i
275,0211-699501013259,de,i
275,0211-699501013259,homocisteina,i
275,0211-699501013259,total,o
275,0211-699501013259,en,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,en,o
275,0211-699501013259,hemodialisis,i
275,0211-699501013259,La,o
275,0211-699501013259,hiperhomocisteinemia,i
275,0211-699501013259,es,o
275,0211-699501013259,un,o
275,0211-699501013259,marcador,o
275,0211-699501013259,de,o
275,0211-699501013259,riesgo,o
275,0211-699501013259,independiente,o
275,0211-699501013259,de,o
275,0211-699501013259,morbimortalidad,o
275,0211-699501013259,cardiovascular,i
275,0211-699501013259,Hemos,o
275,0211-699501013259,intentado,o
275,0211-699501013259,prospectivamente,o
275,0211-699501013259,reducir,o
275,0211-699501013259,los,o
275,0211-699501013259,niveles,i
275,0211-699501013259,de,i
275,0211-699501013259,homocisteina,i
275,0211-699501013259,total,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,mediante,o
275,0211-699501013259,suplemento,o
275,0211-699501013259,con,o
275,0211-699501013259,acido,i
275,0211-699501013259,folico,i
275,0211-699501013259,y,o
275,0211-699501013259,vitamina,i
275,0211-699501013259,B6,i
275,0211-699501013259,pp,i
275,0211-699501013259,valorando,o
275,0211-699501013259,su,o
275,0211-699501013259,posible,o
275,0211-699501013259,correlacion,o
275,0211-699501013259,con,o
275,0211-699501013259,dosis,o
275,0211-699501013259,de,o
275,0211-699501013259,dialisis,i
275,0211-699501013259,funcion,i
275,0211-699501013259,residual,i
275,0211-699501013259,y,o
275,0211-699501013259,parametros,o
275,0211-699501013259,nutricionales,o
275,0211-699501013259,Metodos,o
275,0211-699501013259,Todos,o
275,0211-699501013259,los,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,en,o
275,0211-699501013259,hemodialisis,i
275,0211-699501013259,al,o
275,0211-699501013259,comienzo,o
275,0211-699501013259,del,o
275,0211-699501013259,estudio,o
275,0211-699501013259,que,o
275,0211-699501013259,no,o
275,0211-699501013259,recibian,o
275,0211-699501013259,acido,i
275,0211-699501013259,folico,i
275,0211-699501013259,ni,o
275,0211-699501013259,vitamina,i
275,0211-699501013259,B6,i
275,0211-699501013259,asi,o
275,0211-699501013259,como,o
275,0211-699501013259,los,o
275,0211-699501013259,incorporados,o
275,0211-699501013259,posteriormente,o
275,0211-699501013259,a,o
275,0211-699501013259,partir,o
275,0211-699501013259,de,o
275,0211-699501013259,su,o
275,0211-699501013259,tercer,o
275,0211-699501013259,mes,o
275,0211-699501013259,en,o
275,0211-699501013259,hemodialisis,i
275,0211-699501013259,recibieron,o
275,0211-699501013259,5,o
275,0211-699501013259,mg,o
275,0211-699501013259,orales,o
275,0211-699501013259,de,o
275,0211-699501013259,acido,i
275,0211-699501013259,folico,i
275,0211-699501013259,cada,o
275,0211-699501013259,48,o
275,0211-699501013259,horas,o
275,0211-699501013259,y,o
275,0211-699501013259,40,o
275,0211-699501013259,mg,o
275,0211-699501013259,orales,o
275,0211-699501013259,de,o
275,0211-699501013259,vitamina,i
275,0211-699501013259,B6,i
275,0211-699501013259,cada,o
275,0211-699501013259,semana,o
275,0211-699501013259,Se,o
275,0211-699501013259,determinaron,o
275,0211-699501013259,al,o
275,0211-699501013259,comienzo,o
275,0211-699501013259,del,o
275,0211-699501013259,estudio,o
275,0211-699501013259,y,o
275,0211-699501013259,cada,o
275,0211-699501013259,2,o
275,0211-699501013259,meses,o
275,0211-699501013259,niveles,i
275,0211-699501013259,de,i
275,0211-699501013259,folato,i
275,0211-699501013259,vitamina,i
275,0211-699501013259,B12,i
275,0211-699501013259,inmunoensayo,i
275,0211-699501013259,albumina,i
275,0211-699501013259,y,o
275,0211-699501013259,cinetica,o
275,0211-699501013259,de,o
275,0211-699501013259,la,o
275,0211-699501013259,urea,i
275,0211-699501013259,KTV,o
275,0211-699501013259,KRU,o
275,0211-699501013259,PCRn,o
275,0211-699501013259,y,o
275,0211-699501013259,cada,o
275,0211-699501013259,6,o
275,0211-699501013259,meses,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,HPLC,i
275,0211-699501013259,y,o
275,0211-699501013259,pp,i
275,0211-699501013259,RIA,i
275,0211-699501013259,Resultados,o
275,0211-699501013259,80,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,fueron,o
275,0211-699501013259,incluidos,o
275,0211-699501013259,en,o
275,0211-699501013259,el,o
275,0211-699501013259,estudio,o
275,0211-699501013259,basal,o
275,0211-699501013259,con,o
275,0211-699501013259,una,o
275,0211-699501013259,prevalencia,o
275,0211-699501013259,de,o
275,0211-699501013259,hiperhomocisteinemia,i
275,0211-699501013259,del,o
275,0211-699501013259,844,o
275,0211-699501013259,deficit,i
275,0211-699501013259,de,i
275,0211-699501013259,pp,i
275,0211-699501013259,en,o
275,0211-699501013259,el,o
275,0211-699501013259,32,o
275,0211-699501013259,y,o
275,0211-699501013259,folato,i
275,0211-699501013259,en,o
275,0211-699501013259,el,o
275,0211-699501013259,rango,o
275,0211-699501013259,normal,o
275,0211-699501013259,bajo,o
275,0211-699501013259,los,o
275,0211-699501013259,niveles,i
275,0211-699501013259,de,i
275,0211-699501013259,tHcy,i
275,0211-699501013259,se,o
275,0211-699501013259,correlacionaban,o
275,0211-699501013259,inversamente,o
275,0211-699501013259,con,o
275,0211-699501013259,los,o
275,0211-699501013259,del,o
275,0211-699501013259,folato,i
275,0211-699501013259,r,o
275,0211-699501013259,0336,o
275,0211-699501013259,p,o
275,0211-699501013259,001,o
275,0211-699501013259,pero,o
275,0211-699501013259,no,o
275,0211-699501013259,con,o
275,0211-699501013259,pp,i
275,0211-699501013259,B12,i
275,0211-699501013259,edad,o
275,0211-699501013259,albumina,i
275,0211-699501013259,KTV,o
275,0211-699501013259,KRU,o
275,0211-699501013259,PCRn,o
275,0211-699501013259,Cincuenta,o
275,0211-699501013259,y,o
275,0211-699501013259,ocho,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,recibieron,o
275,0211-699501013259,seis,o
275,0211-699501013259,meses,o
275,0211-699501013259,de,o
275,0211-699501013259,suplementacion,i
275,0211-699501013259,con,o
275,0211-699501013259,normalizacion,o
275,0211-699501013259,del,o
275,0211-699501013259,pp,i
275,0211-699501013259,aumento,o
275,0211-699501013259,del,o
275,0211-699501013259,folato,i
275,0211-699501013259,703,o
275,0211-699501013259,IC,o
275,0211-699501013259,638,o
275,0211-699501013259,795,o
275,0211-699501013259,vs,o
275,0211-699501013259,6181,o
275,0211-699501013259,IC,o
275,0211-699501013259,4447,o
275,0211-699501013259,7811,o
275,0211-699501013259,p,o
275,0211-699501013259,0001,o
275,0211-699501013259,y,o
275,0211-699501013259,descenso,o
275,0211-699501013259,de,o
275,0211-699501013259,la,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,240,o
275,0211-699501013259,IC,o
275,0211-699501013259,213,o
275,0211-699501013259,264,o
275,0211-699501013259,vs,o
275,0211-699501013259,199,o
275,0211-699501013259,IC,o
275,0211-699501013259,175,o
275,0211-699501013259,224,o
275,0211-699501013259,p,o
275,0211-699501013259,005,o
275,0211-699501013259,Han,o
275,0211-699501013259,recibido,o
275,0211-699501013259,suplementacion,i
275,0211-699501013259,durante,o
275,0211-699501013259,12,o
275,0211-699501013259,meses,o
275,0211-699501013259,33,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,pero,o
275,0211-699501013259,a,o
275,0211-699501013259,pesar,o
275,0211-699501013259,de,o
275,0211-699501013259,un,o
275,0211-699501013259,continuo,o
275,0211-699501013259,aumento,o
275,0211-699501013259,del,o
275,0211-699501013259,folato,i
275,0211-699501013259,10078,o
275,0211-699501013259,IC,o
275,0211-699501013259,7481,o
275,0211-699501013259,12674,o
275,0211-699501013259,p,o
275,0211-699501013259,0001,o
275,0211-699501013259,solo,o
275,0211-699501013259,3,o
275,0211-699501013259,pacientes,o
275,0211-699501013259,presentan,o
275,0211-699501013259,niveles,o
275,0211-699501013259,normales,o
275,0211-699501013259,de,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,correlacionandose,o
275,0211-699501013259,directamente,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,con,o
275,0211-699501013259,la,o
275,0211-699501013259,albumina,i
275,0211-699501013259,r,o
275,0211-699501013259,056,o
275,0211-699501013259,p,o
275,0211-699501013259,0001,o
275,0211-699501013259,que,o
275,0211-699501013259,se,o
275,0211-699501013259,elevo,o
275,0211-699501013259,con,o
275,0211-699501013259,respecto,o
275,0211-699501013259,al,o
275,0211-699501013259,inicio,o
275,0211-699501013259,337,o
275,0211-699501013259,IC,o
275,0211-699501013259,327,o
275,0211-699501013259,346,o
275,0211-699501013259,vs,o
275,0211-699501013259,350,o
275,0211-699501013259,IC,o
275,0211-699501013259,337,o
275,0211-699501013259,363,o
275,0211-699501013259,p,o
275,0211-699501013259,005,o
275,0211-699501013259,Conclusion,o
275,0211-699501013259,Tras,o
275,0211-699501013259,suplementacion,i
275,0211-699501013259,con,o
275,0211-699501013259,acido,i
275,0211-699501013259,folico,i
275,0211-699501013259,y,o
275,0211-699501013259,vitamina,i
275,0211-699501013259,B6,i
275,0211-699501013259,aunque,o
275,0211-699501013259,inicialmente,o
275,0211-699501013259,se,o
275,0211-699501013259,reduce,o
275,0211-699501013259,la,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,esta,o
275,0211-699501013259,respuesta,o
275,0211-699501013259,se,o
275,0211-699501013259,hace,o
275,0211-699501013259,refractaria,o
275,0211-699501013259,correlacionandose,o
275,0211-699501013259,directamente,o
275,0211-699501013259,la,o
275,0211-699501013259,tHcy,i
275,0211-699501013259,con,o
275,0211-699501013259,la,o
275,0211-699501013259,albumina,i
275,0211-699501013259,plasmatica,i
275,0211-699501013259,La,o
275,0211-699501013259,interpretacion,o
275,0211-699501013259,de,o
275,0211-699501013259,los,o
275,0211-699501013259,niveles,i
275,0211-699501013259,de,i
275,0211-699501013259,tHcy,i
275,0211-699501013259,debe,o
275,0211-699501013259,tener,o
275,0211-699501013259,en,o
275,0211-699501013259,cuenta,o
275,0211-699501013259,la,o
275,0211-699501013259,concentracion,i
275,0211-699501013259,de,i
275,0211-699501013259,albumina,i
276,0211-699501013259,Efecto,o
276,0211-699501013259,de,o
276,0211-699501013259,la,o
276,0211-699501013259,suplementacion,i
276,0211-699501013259,con,o
276,0211-699501013259,acido,i
276,0211-699501013259,folico,i
276,0211-699501013259,sobre,o
276,0211-699501013259,los,o
276,0211-699501013259,niveles,i
276,0211-699501013259,de,i
276,0211-699501013259,homocisteina,i
276,0211-699501013259,total,o
276,0211-699501013259,en,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,en,o
276,0211-699501013259,hemodialisis,i
276,0211-699501013259,La,o
276,0211-699501013259,hiperhomocisteinemia,i
276,0211-699501013259,es,o
276,0211-699501013259,un,o
276,0211-699501013259,marcador,o
276,0211-699501013259,de,o
276,0211-699501013259,riesgo,o
276,0211-699501013259,independiente,o
276,0211-699501013259,de,o
276,0211-699501013259,morbimortalidad,o
276,0211-699501013259,cardiovascular,i
276,0211-699501013259,Hemos,o
276,0211-699501013259,intentado,o
276,0211-699501013259,prospectivamente,o
276,0211-699501013259,reducir,o
276,0211-699501013259,los,o
276,0211-699501013259,niveles,i
276,0211-699501013259,de,i
276,0211-699501013259,homocisteina,i
276,0211-699501013259,total,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,mediante,o
276,0211-699501013259,suplemento,o
276,0211-699501013259,con,o
276,0211-699501013259,acido,i
276,0211-699501013259,folico,i
276,0211-699501013259,y,o
276,0211-699501013259,vitamina,i
276,0211-699501013259,B6,i
276,0211-699501013259,pp,i
276,0211-699501013259,valorando,o
276,0211-699501013259,su,o
276,0211-699501013259,posible,o
276,0211-699501013259,correlacion,o
276,0211-699501013259,con,o
276,0211-699501013259,dosis,o
276,0211-699501013259,de,o
276,0211-699501013259,dialisis,i
276,0211-699501013259,funcion,i
276,0211-699501013259,residual,i
276,0211-699501013259,y,o
276,0211-699501013259,parametros,o
276,0211-699501013259,nutricionales,o
276,0211-699501013259,Metodos,o
276,0211-699501013259,Todos,o
276,0211-699501013259,los,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,en,o
276,0211-699501013259,hemodialisis,i
276,0211-699501013259,al,o
276,0211-699501013259,comienzo,o
276,0211-699501013259,del,o
276,0211-699501013259,estudio,o
276,0211-699501013259,que,o
276,0211-699501013259,no,o
276,0211-699501013259,recibian,o
276,0211-699501013259,acido,i
276,0211-699501013259,folico,i
276,0211-699501013259,ni,o
276,0211-699501013259,vitamina,i
276,0211-699501013259,B6,i
276,0211-699501013259,asi,o
276,0211-699501013259,como,o
276,0211-699501013259,los,o
276,0211-699501013259,incorporados,o
276,0211-699501013259,posteriormente,o
276,0211-699501013259,a,o
276,0211-699501013259,partir,o
276,0211-699501013259,de,o
276,0211-699501013259,su,o
276,0211-699501013259,tercer,o
276,0211-699501013259,mes,o
276,0211-699501013259,en,o
276,0211-699501013259,hemodialisis,i
276,0211-699501013259,recibieron,o
276,0211-699501013259,5,o
276,0211-699501013259,mg,o
276,0211-699501013259,orales,o
276,0211-699501013259,de,o
276,0211-699501013259,acido,i
276,0211-699501013259,folico,i
276,0211-699501013259,cada,o
276,0211-699501013259,48,o
276,0211-699501013259,horas,o
276,0211-699501013259,y,o
276,0211-699501013259,40,o
276,0211-699501013259,mg,o
276,0211-699501013259,orales,o
276,0211-699501013259,de,o
276,0211-699501013259,vitamina,i
276,0211-699501013259,B6,i
276,0211-699501013259,cada,o
276,0211-699501013259,semana,o
276,0211-699501013259,Se,o
276,0211-699501013259,determinaron,o
276,0211-699501013259,al,o
276,0211-699501013259,comienzo,o
276,0211-699501013259,del,o
276,0211-699501013259,estudio,o
276,0211-699501013259,y,o
276,0211-699501013259,cada,o
276,0211-699501013259,2,o
276,0211-699501013259,meses,o
276,0211-699501013259,niveles,i
276,0211-699501013259,de,i
276,0211-699501013259,folato,i
276,0211-699501013259,vitamina,i
276,0211-699501013259,B12,i
276,0211-699501013259,inmunoensayo,i
276,0211-699501013259,albumina,i
276,0211-699501013259,y,o
276,0211-699501013259,cinetica,o
276,0211-699501013259,de,o
276,0211-699501013259,la,o
276,0211-699501013259,urea,i
276,0211-699501013259,KTV,o
276,0211-699501013259,KRU,o
276,0211-699501013259,PCRn,o
276,0211-699501013259,y,o
276,0211-699501013259,cada,o
276,0211-699501013259,6,o
276,0211-699501013259,meses,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,HPLC,i
276,0211-699501013259,y,o
276,0211-699501013259,pp,i
276,0211-699501013259,RIA,i
276,0211-699501013259,Resultados,o
276,0211-699501013259,80,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,fueron,o
276,0211-699501013259,incluidos,o
276,0211-699501013259,en,o
276,0211-699501013259,el,o
276,0211-699501013259,estudio,o
276,0211-699501013259,basal,o
276,0211-699501013259,con,o
276,0211-699501013259,una,o
276,0211-699501013259,prevalencia,o
276,0211-699501013259,de,o
276,0211-699501013259,hiperhomocisteinemia,i
276,0211-699501013259,del,o
276,0211-699501013259,844,o
276,0211-699501013259,deficit,i
276,0211-699501013259,de,i
276,0211-699501013259,pp,i
276,0211-699501013259,en,o
276,0211-699501013259,el,o
276,0211-699501013259,32,o
276,0211-699501013259,y,o
276,0211-699501013259,folato,i
276,0211-699501013259,en,o
276,0211-699501013259,el,o
276,0211-699501013259,rango,o
276,0211-699501013259,normal,o
276,0211-699501013259,bajo,o
276,0211-699501013259,los,o
276,0211-699501013259,niveles,i
276,0211-699501013259,de,i
276,0211-699501013259,tHcy,i
276,0211-699501013259,se,o
276,0211-699501013259,correlacionaban,o
276,0211-699501013259,inversamente,o
276,0211-699501013259,con,o
276,0211-699501013259,los,o
276,0211-699501013259,del,o
276,0211-699501013259,folato,i
276,0211-699501013259,r,o
276,0211-699501013259,0336,o
276,0211-699501013259,p,o
276,0211-699501013259,001,o
276,0211-699501013259,pero,o
276,0211-699501013259,no,o
276,0211-699501013259,con,o
276,0211-699501013259,pp,i
276,0211-699501013259,B12,i
276,0211-699501013259,edad,o
276,0211-699501013259,albumina,i
276,0211-699501013259,KTV,o
276,0211-699501013259,KRU,o
276,0211-699501013259,PCRn,o
276,0211-699501013259,Cincuenta,o
276,0211-699501013259,y,o
276,0211-699501013259,ocho,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,recibieron,o
276,0211-699501013259,seis,o
276,0211-699501013259,meses,o
276,0211-699501013259,de,o
276,0211-699501013259,suplementacion,i
276,0211-699501013259,con,o
276,0211-699501013259,normalizacion,o
276,0211-699501013259,del,o
276,0211-699501013259,pp,i
276,0211-699501013259,aumento,o
276,0211-699501013259,del,o
276,0211-699501013259,folato,i
276,0211-699501013259,703,o
276,0211-699501013259,IC,o
276,0211-699501013259,638,o
276,0211-699501013259,795,o
276,0211-699501013259,vs,o
276,0211-699501013259,6181,o
276,0211-699501013259,IC,o
276,0211-699501013259,4447,o
276,0211-699501013259,7811,o
276,0211-699501013259,p,o
276,0211-699501013259,0001,o
276,0211-699501013259,y,o
276,0211-699501013259,descenso,o
276,0211-699501013259,de,o
276,0211-699501013259,la,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,240,o
276,0211-699501013259,IC,o
276,0211-699501013259,213,o
276,0211-699501013259,264,o
276,0211-699501013259,vs,o
276,0211-699501013259,199,o
276,0211-699501013259,IC,o
276,0211-699501013259,175,o
276,0211-699501013259,224,o
276,0211-699501013259,p,o
276,0211-699501013259,005,o
276,0211-699501013259,Han,o
276,0211-699501013259,recibido,o
276,0211-699501013259,suplementacion,i
276,0211-699501013259,durante,o
276,0211-699501013259,12,o
276,0211-699501013259,meses,o
276,0211-699501013259,33,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,pero,o
276,0211-699501013259,a,o
276,0211-699501013259,pesar,o
276,0211-699501013259,de,o
276,0211-699501013259,un,o
276,0211-699501013259,continuo,o
276,0211-699501013259,aumento,o
276,0211-699501013259,del,o
276,0211-699501013259,folato,i
276,0211-699501013259,10078,o
276,0211-699501013259,IC,o
276,0211-699501013259,7481,o
276,0211-699501013259,12674,o
276,0211-699501013259,p,o
276,0211-699501013259,0001,o
276,0211-699501013259,solo,o
276,0211-699501013259,3,o
276,0211-699501013259,pacientes,o
276,0211-699501013259,presentan,o
276,0211-699501013259,niveles,o
276,0211-699501013259,normales,o
276,0211-699501013259,de,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,correlacionandose,o
276,0211-699501013259,directamente,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,con,o
276,0211-699501013259,la,o
276,0211-699501013259,albumina,i
276,0211-699501013259,r,o
276,0211-699501013259,056,o
276,0211-699501013259,p,o
276,0211-699501013259,0001,o
276,0211-699501013259,que,o
276,0211-699501013259,se,o
276,0211-699501013259,elevo,o
276,0211-699501013259,con,o
276,0211-699501013259,respecto,o
276,0211-699501013259,al,o
276,0211-699501013259,inicio,o
276,0211-699501013259,337,o
276,0211-699501013259,IC,o
276,0211-699501013259,327,o
276,0211-699501013259,346,o
276,0211-699501013259,vs,o
276,0211-699501013259,350,o
276,0211-699501013259,IC,o
276,0211-699501013259,337,o
276,0211-699501013259,363,o
276,0211-699501013259,p,o
276,0211-699501013259,005,o
276,0211-699501013259,Conclusion,o
276,0211-699501013259,Tras,o
276,0211-699501013259,suplementacion,i
276,0211-699501013259,con,o
276,0211-699501013259,acido,i
276,0211-699501013259,folico,i
276,0211-699501013259,y,o
276,0211-699501013259,vitamina,i
276,0211-699501013259,B6,i
276,0211-699501013259,aunque,o
276,0211-699501013259,inicialmente,o
276,0211-699501013259,se,o
276,0211-699501013259,reduce,o
276,0211-699501013259,la,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,esta,o
276,0211-699501013259,respuesta,o
276,0211-699501013259,se,o
276,0211-699501013259,hace,o
276,0211-699501013259,refractaria,o
276,0211-699501013259,correlacionandose,o
276,0211-699501013259,directamente,o
276,0211-699501013259,la,o
276,0211-699501013259,tHcy,i
276,0211-699501013259,con,o
276,0211-699501013259,la,o
276,0211-699501013259,albumina,i
276,0211-699501013259,plasmatica,i
276,0211-699501013259,La,o
276,0211-699501013259,interpretacion,o
276,0211-699501013259,de,o
276,0211-699501013259,los,o
276,0211-699501013259,niveles,i
276,0211-699501013259,de,i
276,0211-699501013259,tHcy,i
276,0211-699501013259,debe,o
276,0211-699501013259,tener,o
276,0211-699501013259,en,o
276,0211-699501013259,cuenta,o
276,0211-699501013259,la,o
276,0211-699501013259,concentracion,i
276,0211-699501013259,de,i
276,0211-699501013259,albumina,i
277,0211-699501013259,Efecto,o
277,0211-699501013259,de,o
277,0211-699501013259,la,o
277,0211-699501013259,suplementacion,i
277,0211-699501013259,con,o
277,0211-699501013259,acido,i
277,0211-699501013259,folico,i
277,0211-699501013259,sobre,o
277,0211-699501013259,los,o
277,0211-699501013259,niveles,i
277,0211-699501013259,de,i
277,0211-699501013259,homocisteina,i
277,0211-699501013259,total,o
277,0211-699501013259,en,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,en,o
277,0211-699501013259,hemodialisis,i
277,0211-699501013259,La,o
277,0211-699501013259,hiperhomocisteinemia,i
277,0211-699501013259,es,o
277,0211-699501013259,un,o
277,0211-699501013259,marcador,o
277,0211-699501013259,de,o
277,0211-699501013259,riesgo,o
277,0211-699501013259,independiente,o
277,0211-699501013259,de,o
277,0211-699501013259,morbimortalidad,o
277,0211-699501013259,cardiovascular,i
277,0211-699501013259,Hemos,o
277,0211-699501013259,intentado,o
277,0211-699501013259,prospectivamente,o
277,0211-699501013259,reducir,o
277,0211-699501013259,los,o
277,0211-699501013259,niveles,i
277,0211-699501013259,de,i
277,0211-699501013259,homocisteina,i
277,0211-699501013259,total,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,mediante,o
277,0211-699501013259,suplemento,o
277,0211-699501013259,con,o
277,0211-699501013259,acido,i
277,0211-699501013259,folico,i
277,0211-699501013259,y,o
277,0211-699501013259,vitamina,i
277,0211-699501013259,B6,i
277,0211-699501013259,pp,i
277,0211-699501013259,valorando,o
277,0211-699501013259,su,o
277,0211-699501013259,posible,o
277,0211-699501013259,correlacion,o
277,0211-699501013259,con,o
277,0211-699501013259,dosis,o
277,0211-699501013259,de,o
277,0211-699501013259,dialisis,i
277,0211-699501013259,funcion,i
277,0211-699501013259,residual,i
277,0211-699501013259,y,o
277,0211-699501013259,parametros,o
277,0211-699501013259,nutricionales,o
277,0211-699501013259,Metodos,o
277,0211-699501013259,Todos,o
277,0211-699501013259,los,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,en,o
277,0211-699501013259,hemodialisis,i
277,0211-699501013259,al,o
277,0211-699501013259,comienzo,o
277,0211-699501013259,del,o
277,0211-699501013259,estudio,o
277,0211-699501013259,que,o
277,0211-699501013259,no,o
277,0211-699501013259,recibian,o
277,0211-699501013259,acido,i
277,0211-699501013259,folico,i
277,0211-699501013259,ni,o
277,0211-699501013259,vitamina,i
277,0211-699501013259,B6,i
277,0211-699501013259,asi,o
277,0211-699501013259,como,o
277,0211-699501013259,los,o
277,0211-699501013259,incorporados,o
277,0211-699501013259,posteriormente,o
277,0211-699501013259,a,o
277,0211-699501013259,partir,o
277,0211-699501013259,de,o
277,0211-699501013259,su,o
277,0211-699501013259,tercer,o
277,0211-699501013259,mes,o
277,0211-699501013259,en,o
277,0211-699501013259,hemodialisis,i
277,0211-699501013259,recibieron,o
277,0211-699501013259,5,o
277,0211-699501013259,mg,o
277,0211-699501013259,orales,o
277,0211-699501013259,de,o
277,0211-699501013259,acido,i
277,0211-699501013259,folico,i
277,0211-699501013259,cada,o
277,0211-699501013259,48,o
277,0211-699501013259,horas,o
277,0211-699501013259,y,o
277,0211-699501013259,40,o
277,0211-699501013259,mg,o
277,0211-699501013259,orales,o
277,0211-699501013259,de,o
277,0211-699501013259,vitamina,i
277,0211-699501013259,B6,i
277,0211-699501013259,cada,o
277,0211-699501013259,semana,o
277,0211-699501013259,Se,o
277,0211-699501013259,determinaron,o
277,0211-699501013259,al,o
277,0211-699501013259,comienzo,o
277,0211-699501013259,del,o
277,0211-699501013259,estudio,o
277,0211-699501013259,y,o
277,0211-699501013259,cada,o
277,0211-699501013259,2,o
277,0211-699501013259,meses,o
277,0211-699501013259,niveles,i
277,0211-699501013259,de,i
277,0211-699501013259,folato,i
277,0211-699501013259,vitamina,i
277,0211-699501013259,B12,i
277,0211-699501013259,inmunoensayo,i
277,0211-699501013259,albumina,i
277,0211-699501013259,y,o
277,0211-699501013259,cinetica,o
277,0211-699501013259,de,o
277,0211-699501013259,la,o
277,0211-699501013259,urea,i
277,0211-699501013259,KTV,o
277,0211-699501013259,KRU,o
277,0211-699501013259,PCRn,o
277,0211-699501013259,y,o
277,0211-699501013259,cada,o
277,0211-699501013259,6,o
277,0211-699501013259,meses,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,HPLC,i
277,0211-699501013259,y,o
277,0211-699501013259,pp,i
277,0211-699501013259,RIA,i
277,0211-699501013259,Resultados,o
277,0211-699501013259,80,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,fueron,o
277,0211-699501013259,incluidos,o
277,0211-699501013259,en,o
277,0211-699501013259,el,o
277,0211-699501013259,estudio,o
277,0211-699501013259,basal,o
277,0211-699501013259,con,o
277,0211-699501013259,una,o
277,0211-699501013259,prevalencia,o
277,0211-699501013259,de,o
277,0211-699501013259,hiperhomocisteinemia,i
277,0211-699501013259,del,o
277,0211-699501013259,844,o
277,0211-699501013259,deficit,i
277,0211-699501013259,de,i
277,0211-699501013259,pp,i
277,0211-699501013259,en,o
277,0211-699501013259,el,o
277,0211-699501013259,32,o
277,0211-699501013259,y,o
277,0211-699501013259,folato,i
277,0211-699501013259,en,o
277,0211-699501013259,el,o
277,0211-699501013259,rango,o
277,0211-699501013259,normal,o
277,0211-699501013259,bajo,o
277,0211-699501013259,los,o
277,0211-699501013259,niveles,i
277,0211-699501013259,de,i
277,0211-699501013259,tHcy,i
277,0211-699501013259,se,o
277,0211-699501013259,correlacionaban,o
277,0211-699501013259,inversamente,o
277,0211-699501013259,con,o
277,0211-699501013259,los,o
277,0211-699501013259,del,o
277,0211-699501013259,folato,i
277,0211-699501013259,r,o
277,0211-699501013259,0336,o
277,0211-699501013259,p,o
277,0211-699501013259,001,o
277,0211-699501013259,pero,o
277,0211-699501013259,no,o
277,0211-699501013259,con,o
277,0211-699501013259,pp,i
277,0211-699501013259,B12,i
277,0211-699501013259,edad,o
277,0211-699501013259,albumina,i
277,0211-699501013259,KTV,o
277,0211-699501013259,KRU,o
277,0211-699501013259,PCRn,o
277,0211-699501013259,Cincuenta,o
277,0211-699501013259,y,o
277,0211-699501013259,ocho,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,recibieron,o
277,0211-699501013259,seis,o
277,0211-699501013259,meses,o
277,0211-699501013259,de,o
277,0211-699501013259,suplementacion,i
277,0211-699501013259,con,o
277,0211-699501013259,normalizacion,o
277,0211-699501013259,del,o
277,0211-699501013259,pp,i
277,0211-699501013259,aumento,o
277,0211-699501013259,del,o
277,0211-699501013259,folato,i
277,0211-699501013259,703,o
277,0211-699501013259,IC,o
277,0211-699501013259,638,o
277,0211-699501013259,795,o
277,0211-699501013259,vs,o
277,0211-699501013259,6181,o
277,0211-699501013259,IC,o
277,0211-699501013259,4447,o
277,0211-699501013259,7811,o
277,0211-699501013259,p,o
277,0211-699501013259,0001,o
277,0211-699501013259,y,o
277,0211-699501013259,descenso,o
277,0211-699501013259,de,o
277,0211-699501013259,la,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,240,o
277,0211-699501013259,IC,o
277,0211-699501013259,213,o
277,0211-699501013259,264,o
277,0211-699501013259,vs,o
277,0211-699501013259,199,o
277,0211-699501013259,IC,o
277,0211-699501013259,175,o
277,0211-699501013259,224,o
277,0211-699501013259,p,o
277,0211-699501013259,005,o
277,0211-699501013259,Han,o
277,0211-699501013259,recibido,o
277,0211-699501013259,suplementacion,i
277,0211-699501013259,durante,o
277,0211-699501013259,12,o
277,0211-699501013259,meses,o
277,0211-699501013259,33,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,pero,o
277,0211-699501013259,a,o
277,0211-699501013259,pesar,o
277,0211-699501013259,de,o
277,0211-699501013259,un,o
277,0211-699501013259,continuo,o
277,0211-699501013259,aumento,o
277,0211-699501013259,del,o
277,0211-699501013259,folato,i
277,0211-699501013259,10078,o
277,0211-699501013259,IC,o
277,0211-699501013259,7481,o
277,0211-699501013259,12674,o
277,0211-699501013259,p,o
277,0211-699501013259,0001,o
277,0211-699501013259,solo,o
277,0211-699501013259,3,o
277,0211-699501013259,pacientes,o
277,0211-699501013259,presentan,o
277,0211-699501013259,niveles,o
277,0211-699501013259,normales,o
277,0211-699501013259,de,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,correlacionandose,o
277,0211-699501013259,directamente,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,con,o
277,0211-699501013259,la,o
277,0211-699501013259,albumina,i
277,0211-699501013259,r,o
277,0211-699501013259,056,o
277,0211-699501013259,p,o
277,0211-699501013259,0001,o
277,0211-699501013259,que,o
277,0211-699501013259,se,o
277,0211-699501013259,elevo,o
277,0211-699501013259,con,o
277,0211-699501013259,respecto,o
277,0211-699501013259,al,o
277,0211-699501013259,inicio,o
277,0211-699501013259,337,o
277,0211-699501013259,IC,o
277,0211-699501013259,327,o
277,0211-699501013259,346,o
277,0211-699501013259,vs,o
277,0211-699501013259,350,o
277,0211-699501013259,IC,o
277,0211-699501013259,337,o
277,0211-699501013259,363,o
277,0211-699501013259,p,o
277,0211-699501013259,005,o
277,0211-699501013259,Conclusion,o
277,0211-699501013259,Tras,o
277,0211-699501013259,suplementacion,i
277,0211-699501013259,con,o
277,0211-699501013259,acido,i
277,0211-699501013259,folico,i
277,0211-699501013259,y,o
277,0211-699501013259,vitamina,i
277,0211-699501013259,B6,i
277,0211-699501013259,aunque,o
277,0211-699501013259,inicialmente,o
277,0211-699501013259,se,o
277,0211-699501013259,reduce,o
277,0211-699501013259,la,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,esta,o
277,0211-699501013259,respuesta,o
277,0211-699501013259,se,o
277,0211-699501013259,hace,o
277,0211-699501013259,refractaria,o
277,0211-699501013259,correlacionandose,o
277,0211-699501013259,directamente,o
277,0211-699501013259,la,o
277,0211-699501013259,tHcy,i
277,0211-699501013259,con,o
277,0211-699501013259,la,o
277,0211-699501013259,albumina,i
277,0211-699501013259,plasmatica,i
277,0211-699501013259,La,o
277,0211-699501013259,interpretacion,o
277,0211-699501013259,de,o
277,0211-699501013259,los,o
277,0211-699501013259,niveles,i
277,0211-699501013259,de,i
277,0211-699501013259,tHcy,i
277,0211-699501013259,debe,o
277,0211-699501013259,tener,o
277,0211-699501013259,en,o
277,0211-699501013259,cuenta,o
277,0211-699501013259,la,o
277,0211-699501013259,concentracion,i
277,0211-699501013259,de,i
277,0211-699501013259,albumina,i
278,0211-699501013259,Efecto,o
278,0211-699501013259,de,o
278,0211-699501013259,la,o
278,0211-699501013259,suplementacion,i
278,0211-699501013259,con,o
278,0211-699501013259,acido,i
278,0211-699501013259,folico,i
278,0211-699501013259,sobre,o
278,0211-699501013259,los,o
278,0211-699501013259,niveles,i
278,0211-699501013259,de,i
278,0211-699501013259,homocisteina,i
278,0211-699501013259,total,o
278,0211-699501013259,en,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,en,o
278,0211-699501013259,hemodialisis,i
278,0211-699501013259,La,o
278,0211-699501013259,hiperhomocisteinemia,i
278,0211-699501013259,es,o
278,0211-699501013259,un,o
278,0211-699501013259,marcador,o
278,0211-699501013259,de,o
278,0211-699501013259,riesgo,o
278,0211-699501013259,independiente,o
278,0211-699501013259,de,o
278,0211-699501013259,morbimortalidad,o
278,0211-699501013259,cardiovascular,i
278,0211-699501013259,Hemos,o
278,0211-699501013259,intentado,o
278,0211-699501013259,prospectivamente,o
278,0211-699501013259,reducir,o
278,0211-699501013259,los,o
278,0211-699501013259,niveles,i
278,0211-699501013259,de,i
278,0211-699501013259,homocisteina,i
278,0211-699501013259,total,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,mediante,o
278,0211-699501013259,suplemento,o
278,0211-699501013259,con,o
278,0211-699501013259,acido,i
278,0211-699501013259,folico,i
278,0211-699501013259,y,o
278,0211-699501013259,vitamina,i
278,0211-699501013259,B6,i
278,0211-699501013259,pp,i
278,0211-699501013259,valorando,o
278,0211-699501013259,su,o
278,0211-699501013259,posible,o
278,0211-699501013259,correlacion,o
278,0211-699501013259,con,o
278,0211-699501013259,dosis,o
278,0211-699501013259,de,o
278,0211-699501013259,dialisis,i
278,0211-699501013259,funcion,i
278,0211-699501013259,residual,i
278,0211-699501013259,y,o
278,0211-699501013259,parametros,o
278,0211-699501013259,nutricionales,o
278,0211-699501013259,Metodos,o
278,0211-699501013259,Todos,o
278,0211-699501013259,los,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,en,o
278,0211-699501013259,hemodialisis,i
278,0211-699501013259,al,o
278,0211-699501013259,comienzo,o
278,0211-699501013259,del,o
278,0211-699501013259,estudio,o
278,0211-699501013259,que,o
278,0211-699501013259,no,o
278,0211-699501013259,recibian,o
278,0211-699501013259,acido,i
278,0211-699501013259,folico,i
278,0211-699501013259,ni,o
278,0211-699501013259,vitamina,i
278,0211-699501013259,B6,i
278,0211-699501013259,asi,o
278,0211-699501013259,como,o
278,0211-699501013259,los,o
278,0211-699501013259,incorporados,o
278,0211-699501013259,posteriormente,o
278,0211-699501013259,a,o
278,0211-699501013259,partir,o
278,0211-699501013259,de,o
278,0211-699501013259,su,o
278,0211-699501013259,tercer,o
278,0211-699501013259,mes,o
278,0211-699501013259,en,o
278,0211-699501013259,hemodialisis,i
278,0211-699501013259,recibieron,o
278,0211-699501013259,5,o
278,0211-699501013259,mg,o
278,0211-699501013259,orales,o
278,0211-699501013259,de,o
278,0211-699501013259,acido,i
278,0211-699501013259,folico,i
278,0211-699501013259,cada,o
278,0211-699501013259,48,o
278,0211-699501013259,horas,o
278,0211-699501013259,y,o
278,0211-699501013259,40,o
278,0211-699501013259,mg,o
278,0211-699501013259,orales,o
278,0211-699501013259,de,o
278,0211-699501013259,vitamina,i
278,0211-699501013259,B6,i
278,0211-699501013259,cada,o
278,0211-699501013259,semana,o
278,0211-699501013259,Se,o
278,0211-699501013259,determinaron,o
278,0211-699501013259,al,o
278,0211-699501013259,comienzo,o
278,0211-699501013259,del,o
278,0211-699501013259,estudio,o
278,0211-699501013259,y,o
278,0211-699501013259,cada,o
278,0211-699501013259,2,o
278,0211-699501013259,meses,o
278,0211-699501013259,niveles,i
278,0211-699501013259,de,i
278,0211-699501013259,folato,i
278,0211-699501013259,vitamina,i
278,0211-699501013259,B12,i
278,0211-699501013259,inmunoensayo,i
278,0211-699501013259,albumina,i
278,0211-699501013259,y,o
278,0211-699501013259,cinetica,o
278,0211-699501013259,de,o
278,0211-699501013259,la,o
278,0211-699501013259,urea,i
278,0211-699501013259,KTV,o
278,0211-699501013259,KRU,o
278,0211-699501013259,PCRn,o
278,0211-699501013259,y,o
278,0211-699501013259,cada,o
278,0211-699501013259,6,o
278,0211-699501013259,meses,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,HPLC,i
278,0211-699501013259,y,o
278,0211-699501013259,pp,i
278,0211-699501013259,RIA,i
278,0211-699501013259,Resultados,o
278,0211-699501013259,80,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,fueron,o
278,0211-699501013259,incluidos,o
278,0211-699501013259,en,o
278,0211-699501013259,el,o
278,0211-699501013259,estudio,o
278,0211-699501013259,basal,o
278,0211-699501013259,con,o
278,0211-699501013259,una,o
278,0211-699501013259,prevalencia,o
278,0211-699501013259,de,o
278,0211-699501013259,hiperhomocisteinemia,i
278,0211-699501013259,del,o
278,0211-699501013259,844,o
278,0211-699501013259,deficit,i
278,0211-699501013259,de,i
278,0211-699501013259,pp,i
278,0211-699501013259,en,o
278,0211-699501013259,el,o
278,0211-699501013259,32,o
278,0211-699501013259,y,o
278,0211-699501013259,folato,i
278,0211-699501013259,en,o
278,0211-699501013259,el,o
278,0211-699501013259,rango,o
278,0211-699501013259,normal,o
278,0211-699501013259,bajo,o
278,0211-699501013259,los,o
278,0211-699501013259,niveles,i
278,0211-699501013259,de,i
278,0211-699501013259,tHcy,i
278,0211-699501013259,se,o
278,0211-699501013259,correlacionaban,o
278,0211-699501013259,inversamente,o
278,0211-699501013259,con,o
278,0211-699501013259,los,o
278,0211-699501013259,del,o
278,0211-699501013259,folato,i
278,0211-699501013259,r,o
278,0211-699501013259,0336,o
278,0211-699501013259,p,o
278,0211-699501013259,001,o
278,0211-699501013259,pero,o
278,0211-699501013259,no,o
278,0211-699501013259,con,o
278,0211-699501013259,pp,i
278,0211-699501013259,B12,i
278,0211-699501013259,edad,o
278,0211-699501013259,albumina,i
278,0211-699501013259,KTV,o
278,0211-699501013259,KRU,o
278,0211-699501013259,PCRn,o
278,0211-699501013259,Cincuenta,o
278,0211-699501013259,y,o
278,0211-699501013259,ocho,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,recibieron,o
278,0211-699501013259,seis,o
278,0211-699501013259,meses,o
278,0211-699501013259,de,o
278,0211-699501013259,suplementacion,i
278,0211-699501013259,con,o
278,0211-699501013259,normalizacion,o
278,0211-699501013259,del,o
278,0211-699501013259,pp,i
278,0211-699501013259,aumento,o
278,0211-699501013259,del,o
278,0211-699501013259,folato,i
278,0211-699501013259,703,o
278,0211-699501013259,IC,o
278,0211-699501013259,638,o
278,0211-699501013259,795,o
278,0211-699501013259,vs,o
278,0211-699501013259,6181,o
278,0211-699501013259,IC,o
278,0211-699501013259,4447,o
278,0211-699501013259,7811,o
278,0211-699501013259,p,o
278,0211-699501013259,0001,o
278,0211-699501013259,y,o
278,0211-699501013259,descenso,o
278,0211-699501013259,de,o
278,0211-699501013259,la,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,240,o
278,0211-699501013259,IC,o
278,0211-699501013259,213,o
278,0211-699501013259,264,o
278,0211-699501013259,vs,o
278,0211-699501013259,199,o
278,0211-699501013259,IC,o
278,0211-699501013259,175,o
278,0211-699501013259,224,o
278,0211-699501013259,p,o
278,0211-699501013259,005,o
278,0211-699501013259,Han,o
278,0211-699501013259,recibido,o
278,0211-699501013259,suplementacion,i
278,0211-699501013259,durante,o
278,0211-699501013259,12,o
278,0211-699501013259,meses,o
278,0211-699501013259,33,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,pero,o
278,0211-699501013259,a,o
278,0211-699501013259,pesar,o
278,0211-699501013259,de,o
278,0211-699501013259,un,o
278,0211-699501013259,continuo,o
278,0211-699501013259,aumento,o
278,0211-699501013259,del,o
278,0211-699501013259,folato,i
278,0211-699501013259,10078,o
278,0211-699501013259,IC,o
278,0211-699501013259,7481,o
278,0211-699501013259,12674,o
278,0211-699501013259,p,o
278,0211-699501013259,0001,o
278,0211-699501013259,solo,o
278,0211-699501013259,3,o
278,0211-699501013259,pacientes,o
278,0211-699501013259,presentan,o
278,0211-699501013259,niveles,o
278,0211-699501013259,normales,o
278,0211-699501013259,de,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,correlacionandose,o
278,0211-699501013259,directamente,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,con,o
278,0211-699501013259,la,o
278,0211-699501013259,albumina,i
278,0211-699501013259,r,o
278,0211-699501013259,056,o
278,0211-699501013259,p,o
278,0211-699501013259,0001,o
278,0211-699501013259,que,o
278,0211-699501013259,se,o
278,0211-699501013259,elevo,o
278,0211-699501013259,con,o
278,0211-699501013259,respecto,o
278,0211-699501013259,al,o
278,0211-699501013259,inicio,o
278,0211-699501013259,337,o
278,0211-699501013259,IC,o
278,0211-699501013259,327,o
278,0211-699501013259,346,o
278,0211-699501013259,vs,o
278,0211-699501013259,350,o
278,0211-699501013259,IC,o
278,0211-699501013259,337,o
278,0211-699501013259,363,o
278,0211-699501013259,p,o
278,0211-699501013259,005,o
278,0211-699501013259,Conclusion,o
278,0211-699501013259,Tras,o
278,0211-699501013259,suplementacion,i
278,0211-699501013259,con,o
278,0211-699501013259,acido,i
278,0211-699501013259,folico,i
278,0211-699501013259,y,o
278,0211-699501013259,vitamina,i
278,0211-699501013259,B6,i
278,0211-699501013259,aunque,o
278,0211-699501013259,inicialmente,o
278,0211-699501013259,se,o
278,0211-699501013259,reduce,o
278,0211-699501013259,la,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,esta,o
278,0211-699501013259,respuesta,o
278,0211-699501013259,se,o
278,0211-699501013259,hace,o
278,0211-699501013259,refractaria,o
278,0211-699501013259,correlacionandose,o
278,0211-699501013259,directamente,o
278,0211-699501013259,la,o
278,0211-699501013259,tHcy,i
278,0211-699501013259,con,o
278,0211-699501013259,la,o
278,0211-699501013259,albumina,i
278,0211-699501013259,plasmatica,i
278,0211-699501013259,La,o
278,0211-699501013259,interpretacion,o
278,0211-699501013259,de,o
278,0211-699501013259,los,o
278,0211-699501013259,niveles,i
278,0211-699501013259,de,i
278,0211-699501013259,tHcy,i
278,0211-699501013259,debe,o
278,0211-699501013259,tener,o
278,0211-699501013259,en,o
278,0211-699501013259,cuenta,o
278,0211-699501013259,la,o
278,0211-699501013259,concentracion,i
278,0211-699501013259,de,i
278,0211-699501013259,albumina,i
279,0211-699501013259,Efecto,o
279,0211-699501013259,de,o
279,0211-699501013259,la,o
279,0211-699501013259,suplementacion,i
279,0211-699501013259,con,o
279,0211-699501013259,acido,i
279,0211-699501013259,folico,i
279,0211-699501013259,sobre,o
279,0211-699501013259,los,o
279,0211-699501013259,niveles,i
279,0211-699501013259,de,i
279,0211-699501013259,homocisteina,i
279,0211-699501013259,total,o
279,0211-699501013259,en,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,en,o
279,0211-699501013259,hemodialisis,i
279,0211-699501013259,La,o
279,0211-699501013259,hiperhomocisteinemia,i
279,0211-699501013259,es,o
279,0211-699501013259,un,o
279,0211-699501013259,marcador,o
279,0211-699501013259,de,o
279,0211-699501013259,riesgo,o
279,0211-699501013259,independiente,o
279,0211-699501013259,de,o
279,0211-699501013259,morbimortalidad,o
279,0211-699501013259,cardiovascular,i
279,0211-699501013259,Hemos,o
279,0211-699501013259,intentado,o
279,0211-699501013259,prospectivamente,o
279,0211-699501013259,reducir,o
279,0211-699501013259,los,o
279,0211-699501013259,niveles,i
279,0211-699501013259,de,i
279,0211-699501013259,homocisteina,i
279,0211-699501013259,total,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,mediante,o
279,0211-699501013259,suplemento,o
279,0211-699501013259,con,o
279,0211-699501013259,acido,i
279,0211-699501013259,folico,i
279,0211-699501013259,y,o
279,0211-699501013259,vitamina,i
279,0211-699501013259,B6,i
279,0211-699501013259,pp,i
279,0211-699501013259,valorando,o
279,0211-699501013259,su,o
279,0211-699501013259,posible,o
279,0211-699501013259,correlacion,o
279,0211-699501013259,con,o
279,0211-699501013259,dosis,o
279,0211-699501013259,de,o
279,0211-699501013259,dialisis,i
279,0211-699501013259,funcion,i
279,0211-699501013259,residual,i
279,0211-699501013259,y,o
279,0211-699501013259,parametros,o
279,0211-699501013259,nutricionales,o
279,0211-699501013259,Metodos,o
279,0211-699501013259,Todos,o
279,0211-699501013259,los,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,en,o
279,0211-699501013259,hemodialisis,i
279,0211-699501013259,al,o
279,0211-699501013259,comienzo,o
279,0211-699501013259,del,o
279,0211-699501013259,estudio,o
279,0211-699501013259,que,o
279,0211-699501013259,no,o
279,0211-699501013259,recibian,o
279,0211-699501013259,acido,i
279,0211-699501013259,folico,i
279,0211-699501013259,ni,o
279,0211-699501013259,vitamina,i
279,0211-699501013259,B6,i
279,0211-699501013259,asi,o
279,0211-699501013259,como,o
279,0211-699501013259,los,o
279,0211-699501013259,incorporados,o
279,0211-699501013259,posteriormente,o
279,0211-699501013259,a,o
279,0211-699501013259,partir,o
279,0211-699501013259,de,o
279,0211-699501013259,su,o
279,0211-699501013259,tercer,o
279,0211-699501013259,mes,o
279,0211-699501013259,en,o
279,0211-699501013259,hemodialisis,i
279,0211-699501013259,recibieron,o
279,0211-699501013259,5,o
279,0211-699501013259,mg,o
279,0211-699501013259,orales,o
279,0211-699501013259,de,o
279,0211-699501013259,acido,i
279,0211-699501013259,folico,i
279,0211-699501013259,cada,o
279,0211-699501013259,48,o
279,0211-699501013259,horas,o
279,0211-699501013259,y,o
279,0211-699501013259,40,o
279,0211-699501013259,mg,o
279,0211-699501013259,orales,o
279,0211-699501013259,de,o
279,0211-699501013259,vitamina,i
279,0211-699501013259,B6,i
279,0211-699501013259,cada,o
279,0211-699501013259,semana,o
279,0211-699501013259,Se,o
279,0211-699501013259,determinaron,o
279,0211-699501013259,al,o
279,0211-699501013259,comienzo,o
279,0211-699501013259,del,o
279,0211-699501013259,estudio,o
279,0211-699501013259,y,o
279,0211-699501013259,cada,o
279,0211-699501013259,2,o
279,0211-699501013259,meses,o
279,0211-699501013259,niveles,i
279,0211-699501013259,de,i
279,0211-699501013259,folato,i
279,0211-699501013259,vitamina,i
279,0211-699501013259,B12,i
279,0211-699501013259,inmunoensayo,i
279,0211-699501013259,albumina,i
279,0211-699501013259,y,o
279,0211-699501013259,cinetica,o
279,0211-699501013259,de,o
279,0211-699501013259,la,o
279,0211-699501013259,urea,i
279,0211-699501013259,KTV,o
279,0211-699501013259,KRU,o
279,0211-699501013259,PCRn,o
279,0211-699501013259,y,o
279,0211-699501013259,cada,o
279,0211-699501013259,6,o
279,0211-699501013259,meses,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,HPLC,i
279,0211-699501013259,y,o
279,0211-699501013259,pp,i
279,0211-699501013259,RIA,i
279,0211-699501013259,Resultados,o
279,0211-699501013259,80,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,fueron,o
279,0211-699501013259,incluidos,o
279,0211-699501013259,en,o
279,0211-699501013259,el,o
279,0211-699501013259,estudio,o
279,0211-699501013259,basal,o
279,0211-699501013259,con,o
279,0211-699501013259,una,o
279,0211-699501013259,prevalencia,o
279,0211-699501013259,de,o
279,0211-699501013259,hiperhomocisteinemia,i
279,0211-699501013259,del,o
279,0211-699501013259,844,o
279,0211-699501013259,deficit,i
279,0211-699501013259,de,i
279,0211-699501013259,pp,i
279,0211-699501013259,en,o
279,0211-699501013259,el,o
279,0211-699501013259,32,o
279,0211-699501013259,y,o
279,0211-699501013259,folato,i
279,0211-699501013259,en,o
279,0211-699501013259,el,o
279,0211-699501013259,rango,o
279,0211-699501013259,normal,o
279,0211-699501013259,bajo,o
279,0211-699501013259,los,o
279,0211-699501013259,niveles,i
279,0211-699501013259,de,i
279,0211-699501013259,tHcy,i
279,0211-699501013259,se,o
279,0211-699501013259,correlacionaban,o
279,0211-699501013259,inversamente,o
279,0211-699501013259,con,o
279,0211-699501013259,los,o
279,0211-699501013259,del,o
279,0211-699501013259,folato,i
279,0211-699501013259,r,o
279,0211-699501013259,0336,o
279,0211-699501013259,p,o
279,0211-699501013259,001,o
279,0211-699501013259,pero,o
279,0211-699501013259,no,o
279,0211-699501013259,con,o
279,0211-699501013259,pp,i
279,0211-699501013259,B12,i
279,0211-699501013259,edad,o
279,0211-699501013259,albumina,i
279,0211-699501013259,KTV,o
279,0211-699501013259,KRU,o
279,0211-699501013259,PCRn,o
279,0211-699501013259,Cincuenta,o
279,0211-699501013259,y,o
279,0211-699501013259,ocho,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,recibieron,o
279,0211-699501013259,seis,o
279,0211-699501013259,meses,o
279,0211-699501013259,de,o
279,0211-699501013259,suplementacion,i
279,0211-699501013259,con,o
279,0211-699501013259,normalizacion,o
279,0211-699501013259,del,o
279,0211-699501013259,pp,i
279,0211-699501013259,aumento,o
279,0211-699501013259,del,o
279,0211-699501013259,folato,i
279,0211-699501013259,703,o
279,0211-699501013259,IC,o
279,0211-699501013259,638,o
279,0211-699501013259,795,o
279,0211-699501013259,vs,o
279,0211-699501013259,6181,o
279,0211-699501013259,IC,o
279,0211-699501013259,4447,o
279,0211-699501013259,7811,o
279,0211-699501013259,p,o
279,0211-699501013259,0001,o
279,0211-699501013259,y,o
279,0211-699501013259,descenso,o
279,0211-699501013259,de,o
279,0211-699501013259,la,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,240,o
279,0211-699501013259,IC,o
279,0211-699501013259,213,o
279,0211-699501013259,264,o
279,0211-699501013259,vs,o
279,0211-699501013259,199,o
279,0211-699501013259,IC,o
279,0211-699501013259,175,o
279,0211-699501013259,224,o
279,0211-699501013259,p,o
279,0211-699501013259,005,o
279,0211-699501013259,Han,o
279,0211-699501013259,recibido,o
279,0211-699501013259,suplementacion,i
279,0211-699501013259,durante,o
279,0211-699501013259,12,o
279,0211-699501013259,meses,o
279,0211-699501013259,33,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,pero,o
279,0211-699501013259,a,o
279,0211-699501013259,pesar,o
279,0211-699501013259,de,o
279,0211-699501013259,un,o
279,0211-699501013259,continuo,o
279,0211-699501013259,aumento,o
279,0211-699501013259,del,o
279,0211-699501013259,folato,i
279,0211-699501013259,10078,o
279,0211-699501013259,IC,o
279,0211-699501013259,7481,o
279,0211-699501013259,12674,o
279,0211-699501013259,p,o
279,0211-699501013259,0001,o
279,0211-699501013259,solo,o
279,0211-699501013259,3,o
279,0211-699501013259,pacientes,o
279,0211-699501013259,presentan,o
279,0211-699501013259,niveles,o
279,0211-699501013259,normales,o
279,0211-699501013259,de,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,correlacionandose,o
279,0211-699501013259,directamente,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,con,o
279,0211-699501013259,la,o
279,0211-699501013259,albumina,i
279,0211-699501013259,r,o
279,0211-699501013259,056,o
279,0211-699501013259,p,o
279,0211-699501013259,0001,o
279,0211-699501013259,que,o
279,0211-699501013259,se,o
279,0211-699501013259,elevo,o
279,0211-699501013259,con,o
279,0211-699501013259,respecto,o
279,0211-699501013259,al,o
279,0211-699501013259,inicio,o
279,0211-699501013259,337,o
279,0211-699501013259,IC,o
279,0211-699501013259,327,o
279,0211-699501013259,346,o
279,0211-699501013259,vs,o
279,0211-699501013259,350,o
279,0211-699501013259,IC,o
279,0211-699501013259,337,o
279,0211-699501013259,363,o
279,0211-699501013259,p,o
279,0211-699501013259,005,o
279,0211-699501013259,Conclusion,o
279,0211-699501013259,Tras,o
279,0211-699501013259,suplementacion,i
279,0211-699501013259,con,o
279,0211-699501013259,acido,i
279,0211-699501013259,folico,i
279,0211-699501013259,y,o
279,0211-699501013259,vitamina,i
279,0211-699501013259,B6,i
279,0211-699501013259,aunque,o
279,0211-699501013259,inicialmente,o
279,0211-699501013259,se,o
279,0211-699501013259,reduce,o
279,0211-699501013259,la,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,esta,o
279,0211-699501013259,respuesta,o
279,0211-699501013259,se,o
279,0211-699501013259,hace,o
279,0211-699501013259,refractaria,o
279,0211-699501013259,correlacionandose,o
279,0211-699501013259,directamente,o
279,0211-699501013259,la,o
279,0211-699501013259,tHcy,i
279,0211-699501013259,con,o
279,0211-699501013259,la,o
279,0211-699501013259,albumina,i
279,0211-699501013259,plasmatica,i
279,0211-699501013259,La,o
279,0211-699501013259,interpretacion,o
279,0211-699501013259,de,o
279,0211-699501013259,los,o
279,0211-699501013259,niveles,i
279,0211-699501013259,de,i
279,0211-699501013259,tHcy,i
279,0211-699501013259,debe,o
279,0211-699501013259,tener,o
279,0211-699501013259,en,o
279,0211-699501013259,cuenta,o
279,0211-699501013259,la,o
279,0211-699501013259,concentracion,i
279,0211-699501013259,de,i
279,0211-699501013259,albumina,i
280,0211-699501013259,Efecto,o
280,0211-699501013259,de,o
280,0211-699501013259,la,o
280,0211-699501013259,suplementacion,i
280,0211-699501013259,con,o
280,0211-699501013259,acido,i
280,0211-699501013259,folico,i
280,0211-699501013259,sobre,o
280,0211-699501013259,los,o
280,0211-699501013259,niveles,i
280,0211-699501013259,de,i
280,0211-699501013259,homocisteina,i
280,0211-699501013259,total,o
280,0211-699501013259,en,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,en,o
280,0211-699501013259,hemodialisis,i
280,0211-699501013259,La,o
280,0211-699501013259,hiperhomocisteinemia,i
280,0211-699501013259,es,o
280,0211-699501013259,un,o
280,0211-699501013259,marcador,o
280,0211-699501013259,de,o
280,0211-699501013259,riesgo,o
280,0211-699501013259,independiente,o
280,0211-699501013259,de,o
280,0211-699501013259,morbimortalidad,o
280,0211-699501013259,cardiovascular,i
280,0211-699501013259,Hemos,o
280,0211-699501013259,intentado,o
280,0211-699501013259,prospectivamente,o
280,0211-699501013259,reducir,o
280,0211-699501013259,los,o
280,0211-699501013259,niveles,i
280,0211-699501013259,de,i
280,0211-699501013259,homocisteina,i
280,0211-699501013259,total,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,mediante,o
280,0211-699501013259,suplemento,o
280,0211-699501013259,con,o
280,0211-699501013259,acido,i
280,0211-699501013259,folico,i
280,0211-699501013259,y,o
280,0211-699501013259,vitamina,i
280,0211-699501013259,B6,i
280,0211-699501013259,pp,i
280,0211-699501013259,valorando,o
280,0211-699501013259,su,o
280,0211-699501013259,posible,o
280,0211-699501013259,correlacion,o
280,0211-699501013259,con,o
280,0211-699501013259,dosis,o
280,0211-699501013259,de,o
280,0211-699501013259,dialisis,i
280,0211-699501013259,funcion,i
280,0211-699501013259,residual,i
280,0211-699501013259,y,o
280,0211-699501013259,parametros,o
280,0211-699501013259,nutricionales,o
280,0211-699501013259,Metodos,o
280,0211-699501013259,Todos,o
280,0211-699501013259,los,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,en,o
280,0211-699501013259,hemodialisis,i
280,0211-699501013259,al,o
280,0211-699501013259,comienzo,o
280,0211-699501013259,del,o
280,0211-699501013259,estudio,o
280,0211-699501013259,que,o
280,0211-699501013259,no,o
280,0211-699501013259,recibian,o
280,0211-699501013259,acido,i
280,0211-699501013259,folico,i
280,0211-699501013259,ni,o
280,0211-699501013259,vitamina,i
280,0211-699501013259,B6,i
280,0211-699501013259,asi,o
280,0211-699501013259,como,o
280,0211-699501013259,los,o
280,0211-699501013259,incorporados,o
280,0211-699501013259,posteriormente,o
280,0211-699501013259,a,o
280,0211-699501013259,partir,o
280,0211-699501013259,de,o
280,0211-699501013259,su,o
280,0211-699501013259,tercer,o
280,0211-699501013259,mes,o
280,0211-699501013259,en,o
280,0211-699501013259,hemodialisis,i
280,0211-699501013259,recibieron,o
280,0211-699501013259,5,o
280,0211-699501013259,mg,o
280,0211-699501013259,orales,o
280,0211-699501013259,de,o
280,0211-699501013259,acido,i
280,0211-699501013259,folico,i
280,0211-699501013259,cada,o
280,0211-699501013259,48,o
280,0211-699501013259,horas,o
280,0211-699501013259,y,o
280,0211-699501013259,40,o
280,0211-699501013259,mg,o
280,0211-699501013259,orales,o
280,0211-699501013259,de,o
280,0211-699501013259,vitamina,i
280,0211-699501013259,B6,i
280,0211-699501013259,cada,o
280,0211-699501013259,semana,o
280,0211-699501013259,Se,o
280,0211-699501013259,determinaron,o
280,0211-699501013259,al,o
280,0211-699501013259,comienzo,o
280,0211-699501013259,del,o
280,0211-699501013259,estudio,o
280,0211-699501013259,y,o
280,0211-699501013259,cada,o
280,0211-699501013259,2,o
280,0211-699501013259,meses,o
280,0211-699501013259,niveles,i
280,0211-699501013259,de,i
280,0211-699501013259,folato,i
280,0211-699501013259,vitamina,i
280,0211-699501013259,B12,i
280,0211-699501013259,inmunoensayo,i
280,0211-699501013259,albumina,i
280,0211-699501013259,y,o
280,0211-699501013259,cinetica,o
280,0211-699501013259,de,o
280,0211-699501013259,la,o
280,0211-699501013259,urea,i
280,0211-699501013259,KTV,o
280,0211-699501013259,KRU,o
280,0211-699501013259,PCRn,o
280,0211-699501013259,y,o
280,0211-699501013259,cada,o
280,0211-699501013259,6,o
280,0211-699501013259,meses,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,HPLC,i
280,0211-699501013259,y,o
280,0211-699501013259,pp,i
280,0211-699501013259,RIA,i
280,0211-699501013259,Resultados,o
280,0211-699501013259,80,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,fueron,o
280,0211-699501013259,incluidos,o
280,0211-699501013259,en,o
280,0211-699501013259,el,o
280,0211-699501013259,estudio,o
280,0211-699501013259,basal,o
280,0211-699501013259,con,o
280,0211-699501013259,una,o
280,0211-699501013259,prevalencia,o
280,0211-699501013259,de,o
280,0211-699501013259,hiperhomocisteinemia,i
280,0211-699501013259,del,o
280,0211-699501013259,844,o
280,0211-699501013259,deficit,i
280,0211-699501013259,de,i
280,0211-699501013259,pp,i
280,0211-699501013259,en,o
280,0211-699501013259,el,o
280,0211-699501013259,32,o
280,0211-699501013259,y,o
280,0211-699501013259,folato,i
280,0211-699501013259,en,o
280,0211-699501013259,el,o
280,0211-699501013259,rango,o
280,0211-699501013259,normal,o
280,0211-699501013259,bajo,o
280,0211-699501013259,los,o
280,0211-699501013259,niveles,i
280,0211-699501013259,de,i
280,0211-699501013259,tHcy,i
280,0211-699501013259,se,o
280,0211-699501013259,correlacionaban,o
280,0211-699501013259,inversamente,o
280,0211-699501013259,con,o
280,0211-699501013259,los,o
280,0211-699501013259,del,o
280,0211-699501013259,folato,i
280,0211-699501013259,r,o
280,0211-699501013259,0336,o
280,0211-699501013259,p,o
280,0211-699501013259,001,o
280,0211-699501013259,pero,o
280,0211-699501013259,no,o
280,0211-699501013259,con,o
280,0211-699501013259,pp,i
280,0211-699501013259,B12,i
280,0211-699501013259,edad,o
280,0211-699501013259,albumina,i
280,0211-699501013259,KTV,o
280,0211-699501013259,KRU,o
280,0211-699501013259,PCRn,o
280,0211-699501013259,Cincuenta,o
280,0211-699501013259,y,o
280,0211-699501013259,ocho,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,recibieron,o
280,0211-699501013259,seis,o
280,0211-699501013259,meses,o
280,0211-699501013259,de,o
280,0211-699501013259,suplementacion,i
280,0211-699501013259,con,o
280,0211-699501013259,normalizacion,o
280,0211-699501013259,del,o
280,0211-699501013259,pp,i
280,0211-699501013259,aumento,o
280,0211-699501013259,del,o
280,0211-699501013259,folato,i
280,0211-699501013259,703,o
280,0211-699501013259,IC,o
280,0211-699501013259,638,o
280,0211-699501013259,795,o
280,0211-699501013259,vs,o
280,0211-699501013259,6181,o
280,0211-699501013259,IC,o
280,0211-699501013259,4447,o
280,0211-699501013259,7811,o
280,0211-699501013259,p,o
280,0211-699501013259,0001,o
280,0211-699501013259,y,o
280,0211-699501013259,descenso,o
280,0211-699501013259,de,o
280,0211-699501013259,la,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,240,o
280,0211-699501013259,IC,o
280,0211-699501013259,213,o
280,0211-699501013259,264,o
280,0211-699501013259,vs,o
280,0211-699501013259,199,o
280,0211-699501013259,IC,o
280,0211-699501013259,175,o
280,0211-699501013259,224,o
280,0211-699501013259,p,o
280,0211-699501013259,005,o
280,0211-699501013259,Han,o
280,0211-699501013259,recibido,o
280,0211-699501013259,suplementacion,i
280,0211-699501013259,durante,o
280,0211-699501013259,12,o
280,0211-699501013259,meses,o
280,0211-699501013259,33,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,pero,o
280,0211-699501013259,a,o
280,0211-699501013259,pesar,o
280,0211-699501013259,de,o
280,0211-699501013259,un,o
280,0211-699501013259,continuo,o
280,0211-699501013259,aumento,o
280,0211-699501013259,del,o
280,0211-699501013259,folato,i
280,0211-699501013259,10078,o
280,0211-699501013259,IC,o
280,0211-699501013259,7481,o
280,0211-699501013259,12674,o
280,0211-699501013259,p,o
280,0211-699501013259,0001,o
280,0211-699501013259,solo,o
280,0211-699501013259,3,o
280,0211-699501013259,pacientes,o
280,0211-699501013259,presentan,o
280,0211-699501013259,niveles,o
280,0211-699501013259,normales,o
280,0211-699501013259,de,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,correlacionandose,o
280,0211-699501013259,directamente,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,con,o
280,0211-699501013259,la,o
280,0211-699501013259,albumina,i
280,0211-699501013259,r,o
280,0211-699501013259,056,o
280,0211-699501013259,p,o
280,0211-699501013259,0001,o
280,0211-699501013259,que,o
280,0211-699501013259,se,o
280,0211-699501013259,elevo,o
280,0211-699501013259,con,o
280,0211-699501013259,respecto,o
280,0211-699501013259,al,o
280,0211-699501013259,inicio,o
280,0211-699501013259,337,o
280,0211-699501013259,IC,o
280,0211-699501013259,327,o
280,0211-699501013259,346,o
280,0211-699501013259,vs,o
280,0211-699501013259,350,o
280,0211-699501013259,IC,o
280,0211-699501013259,337,o
280,0211-699501013259,363,o
280,0211-699501013259,p,o
280,0211-699501013259,005,o
280,0211-699501013259,Conclusion,o
280,0211-699501013259,Tras,o
280,0211-699501013259,suplementacion,i
280,0211-699501013259,con,o
280,0211-699501013259,acido,i
280,0211-699501013259,folico,i
280,0211-699501013259,y,o
280,0211-699501013259,vitamina,i
280,0211-699501013259,B6,i
280,0211-699501013259,aunque,o
280,0211-699501013259,inicialmente,o
280,0211-699501013259,se,o
280,0211-699501013259,reduce,o
280,0211-699501013259,la,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,esta,o
280,0211-699501013259,respuesta,o
280,0211-699501013259,se,o
280,0211-699501013259,hace,o
280,0211-699501013259,refractaria,o
280,0211-699501013259,correlacionandose,o
280,0211-699501013259,directamente,o
280,0211-699501013259,la,o
280,0211-699501013259,tHcy,i
280,0211-699501013259,con,o
280,0211-699501013259,la,o
280,0211-699501013259,albumina,i
280,0211-699501013259,plasmatica,i
280,0211-699501013259,La,o
280,0211-699501013259,interpretacion,o
280,0211-699501013259,de,o
280,0211-699501013259,los,o
280,0211-699501013259,niveles,i
280,0211-699501013259,de,i
280,0211-699501013259,tHcy,i
280,0211-699501013259,debe,o
280,0211-699501013259,tener,o
280,0211-699501013259,en,o
280,0211-699501013259,cuenta,o
280,0211-699501013259,la,o
280,0211-699501013259,concentracion,i
280,0211-699501013259,de,i
280,0211-699501013259,albumina,i
281,0211-699501013259,Efecto,o
281,0211-699501013259,de,o
281,0211-699501013259,la,o
281,0211-699501013259,suplementacion,i
281,0211-699501013259,con,o
281,0211-699501013259,acido,i
281,0211-699501013259,folico,i
281,0211-699501013259,sobre,o
281,0211-699501013259,los,o
281,0211-699501013259,niveles,i
281,0211-699501013259,de,i
281,0211-699501013259,homocisteina,i
281,0211-699501013259,total,o
281,0211-699501013259,en,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,en,o
281,0211-699501013259,hemodialisis,i
281,0211-699501013259,La,o
281,0211-699501013259,hiperhomocisteinemia,i
281,0211-699501013259,es,o
281,0211-699501013259,un,o
281,0211-699501013259,marcador,o
281,0211-699501013259,de,o
281,0211-699501013259,riesgo,o
281,0211-699501013259,independiente,o
281,0211-699501013259,de,o
281,0211-699501013259,morbimortalidad,o
281,0211-699501013259,cardiovascular,i
281,0211-699501013259,Hemos,o
281,0211-699501013259,intentado,o
281,0211-699501013259,prospectivamente,o
281,0211-699501013259,reducir,o
281,0211-699501013259,los,o
281,0211-699501013259,niveles,i
281,0211-699501013259,de,i
281,0211-699501013259,homocisteina,i
281,0211-699501013259,total,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,mediante,o
281,0211-699501013259,suplemento,o
281,0211-699501013259,con,o
281,0211-699501013259,acido,i
281,0211-699501013259,folico,i
281,0211-699501013259,y,o
281,0211-699501013259,vitamina,i
281,0211-699501013259,B6,i
281,0211-699501013259,pp,i
281,0211-699501013259,valorando,o
281,0211-699501013259,su,o
281,0211-699501013259,posible,o
281,0211-699501013259,correlacion,o
281,0211-699501013259,con,o
281,0211-699501013259,dosis,o
281,0211-699501013259,de,o
281,0211-699501013259,dialisis,i
281,0211-699501013259,funcion,i
281,0211-699501013259,residual,i
281,0211-699501013259,y,o
281,0211-699501013259,parametros,o
281,0211-699501013259,nutricionales,o
281,0211-699501013259,Metodos,o
281,0211-699501013259,Todos,o
281,0211-699501013259,los,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,en,o
281,0211-699501013259,hemodialisis,i
281,0211-699501013259,al,o
281,0211-699501013259,comienzo,o
281,0211-699501013259,del,o
281,0211-699501013259,estudio,o
281,0211-699501013259,que,o
281,0211-699501013259,no,o
281,0211-699501013259,recibian,o
281,0211-699501013259,acido,i
281,0211-699501013259,folico,i
281,0211-699501013259,ni,o
281,0211-699501013259,vitamina,i
281,0211-699501013259,B6,i
281,0211-699501013259,asi,o
281,0211-699501013259,como,o
281,0211-699501013259,los,o
281,0211-699501013259,incorporados,o
281,0211-699501013259,posteriormente,o
281,0211-699501013259,a,o
281,0211-699501013259,partir,o
281,0211-699501013259,de,o
281,0211-699501013259,su,o
281,0211-699501013259,tercer,o
281,0211-699501013259,mes,o
281,0211-699501013259,en,o
281,0211-699501013259,hemodialisis,i
281,0211-699501013259,recibieron,o
281,0211-699501013259,5,o
281,0211-699501013259,mg,o
281,0211-699501013259,orales,o
281,0211-699501013259,de,o
281,0211-699501013259,acido,i
281,0211-699501013259,folico,i
281,0211-699501013259,cada,o
281,0211-699501013259,48,o
281,0211-699501013259,horas,o
281,0211-699501013259,y,o
281,0211-699501013259,40,o
281,0211-699501013259,mg,o
281,0211-699501013259,orales,o
281,0211-699501013259,de,o
281,0211-699501013259,vitamina,i
281,0211-699501013259,B6,i
281,0211-699501013259,cada,o
281,0211-699501013259,semana,o
281,0211-699501013259,Se,o
281,0211-699501013259,determinaron,o
281,0211-699501013259,al,o
281,0211-699501013259,comienzo,o
281,0211-699501013259,del,o
281,0211-699501013259,estudio,o
281,0211-699501013259,y,o
281,0211-699501013259,cada,o
281,0211-699501013259,2,o
281,0211-699501013259,meses,o
281,0211-699501013259,niveles,i
281,0211-699501013259,de,i
281,0211-699501013259,folato,i
281,0211-699501013259,vitamina,i
281,0211-699501013259,B12,i
281,0211-699501013259,inmunoensayo,i
281,0211-699501013259,albumina,i
281,0211-699501013259,y,o
281,0211-699501013259,cinetica,o
281,0211-699501013259,de,o
281,0211-699501013259,la,o
281,0211-699501013259,urea,i
281,0211-699501013259,KTV,o
281,0211-699501013259,KRU,o
281,0211-699501013259,PCRn,o
281,0211-699501013259,y,o
281,0211-699501013259,cada,o
281,0211-699501013259,6,o
281,0211-699501013259,meses,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,HPLC,i
281,0211-699501013259,y,o
281,0211-699501013259,pp,i
281,0211-699501013259,RIA,i
281,0211-699501013259,Resultados,o
281,0211-699501013259,80,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,fueron,o
281,0211-699501013259,incluidos,o
281,0211-699501013259,en,o
281,0211-699501013259,el,o
281,0211-699501013259,estudio,o
281,0211-699501013259,basal,o
281,0211-699501013259,con,o
281,0211-699501013259,una,o
281,0211-699501013259,prevalencia,o
281,0211-699501013259,de,o
281,0211-699501013259,hiperhomocisteinemia,i
281,0211-699501013259,del,o
281,0211-699501013259,844,o
281,0211-699501013259,deficit,i
281,0211-699501013259,de,i
281,0211-699501013259,pp,i
281,0211-699501013259,en,o
281,0211-699501013259,el,o
281,0211-699501013259,32,o
281,0211-699501013259,y,o
281,0211-699501013259,folato,i
281,0211-699501013259,en,o
281,0211-699501013259,el,o
281,0211-699501013259,rango,o
281,0211-699501013259,normal,o
281,0211-699501013259,bajo,o
281,0211-699501013259,los,o
281,0211-699501013259,niveles,i
281,0211-699501013259,de,i
281,0211-699501013259,tHcy,i
281,0211-699501013259,se,o
281,0211-699501013259,correlacionaban,o
281,0211-699501013259,inversamente,o
281,0211-699501013259,con,o
281,0211-699501013259,los,o
281,0211-699501013259,del,o
281,0211-699501013259,folato,i
281,0211-699501013259,r,o
281,0211-699501013259,0336,o
281,0211-699501013259,p,o
281,0211-699501013259,001,o
281,0211-699501013259,pero,o
281,0211-699501013259,no,o
281,0211-699501013259,con,o
281,0211-699501013259,pp,i
281,0211-699501013259,B12,i
281,0211-699501013259,edad,o
281,0211-699501013259,albumina,i
281,0211-699501013259,KTV,o
281,0211-699501013259,KRU,o
281,0211-699501013259,PCRn,o
281,0211-699501013259,Cincuenta,o
281,0211-699501013259,y,o
281,0211-699501013259,ocho,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,recibieron,o
281,0211-699501013259,seis,o
281,0211-699501013259,meses,o
281,0211-699501013259,de,o
281,0211-699501013259,suplementacion,i
281,0211-699501013259,con,o
281,0211-699501013259,normalizacion,o
281,0211-699501013259,del,o
281,0211-699501013259,pp,i
281,0211-699501013259,aumento,o
281,0211-699501013259,del,o
281,0211-699501013259,folato,i
281,0211-699501013259,703,o
281,0211-699501013259,IC,o
281,0211-699501013259,638,o
281,0211-699501013259,795,o
281,0211-699501013259,vs,o
281,0211-699501013259,6181,o
281,0211-699501013259,IC,o
281,0211-699501013259,4447,o
281,0211-699501013259,7811,o
281,0211-699501013259,p,o
281,0211-699501013259,0001,o
281,0211-699501013259,y,o
281,0211-699501013259,descenso,o
281,0211-699501013259,de,o
281,0211-699501013259,la,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,240,o
281,0211-699501013259,IC,o
281,0211-699501013259,213,o
281,0211-699501013259,264,o
281,0211-699501013259,vs,o
281,0211-699501013259,199,o
281,0211-699501013259,IC,o
281,0211-699501013259,175,o
281,0211-699501013259,224,o
281,0211-699501013259,p,o
281,0211-699501013259,005,o
281,0211-699501013259,Han,o
281,0211-699501013259,recibido,o
281,0211-699501013259,suplementacion,i
281,0211-699501013259,durante,o
281,0211-699501013259,12,o
281,0211-699501013259,meses,o
281,0211-699501013259,33,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,pero,o
281,0211-699501013259,a,o
281,0211-699501013259,pesar,o
281,0211-699501013259,de,o
281,0211-699501013259,un,o
281,0211-699501013259,continuo,o
281,0211-699501013259,aumento,o
281,0211-699501013259,del,o
281,0211-699501013259,folato,i
281,0211-699501013259,10078,o
281,0211-699501013259,IC,o
281,0211-699501013259,7481,o
281,0211-699501013259,12674,o
281,0211-699501013259,p,o
281,0211-699501013259,0001,o
281,0211-699501013259,solo,o
281,0211-699501013259,3,o
281,0211-699501013259,pacientes,o
281,0211-699501013259,presentan,o
281,0211-699501013259,niveles,o
281,0211-699501013259,normales,o
281,0211-699501013259,de,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,correlacionandose,o
281,0211-699501013259,directamente,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,con,o
281,0211-699501013259,la,o
281,0211-699501013259,albumina,i
281,0211-699501013259,r,o
281,0211-699501013259,056,o
281,0211-699501013259,p,o
281,0211-699501013259,0001,o
281,0211-699501013259,que,o
281,0211-699501013259,se,o
281,0211-699501013259,elevo,o
281,0211-699501013259,con,o
281,0211-699501013259,respecto,o
281,0211-699501013259,al,o
281,0211-699501013259,inicio,o
281,0211-699501013259,337,o
281,0211-699501013259,IC,o
281,0211-699501013259,327,o
281,0211-699501013259,346,o
281,0211-699501013259,vs,o
281,0211-699501013259,350,o
281,0211-699501013259,IC,o
281,0211-699501013259,337,o
281,0211-699501013259,363,o
281,0211-699501013259,p,o
281,0211-699501013259,005,o
281,0211-699501013259,Conclusion,o
281,0211-699501013259,Tras,o
281,0211-699501013259,suplementacion,i
281,0211-699501013259,con,o
281,0211-699501013259,acido,i
281,0211-699501013259,folico,i
281,0211-699501013259,y,o
281,0211-699501013259,vitamina,i
281,0211-699501013259,B6,i
281,0211-699501013259,aunque,o
281,0211-699501013259,inicialmente,o
281,0211-699501013259,se,o
281,0211-699501013259,reduce,o
281,0211-699501013259,la,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,esta,o
281,0211-699501013259,respuesta,o
281,0211-699501013259,se,o
281,0211-699501013259,hace,o
281,0211-699501013259,refractaria,o
281,0211-699501013259,correlacionandose,o
281,0211-699501013259,directamente,o
281,0211-699501013259,la,o
281,0211-699501013259,tHcy,i
281,0211-699501013259,con,o
281,0211-699501013259,la,o
281,0211-699501013259,albumina,i
281,0211-699501013259,plasmatica,i
281,0211-699501013259,La,o
281,0211-699501013259,interpretacion,o
281,0211-699501013259,de,o
281,0211-699501013259,los,o
281,0211-699501013259,niveles,i
281,0211-699501013259,de,i
281,0211-699501013259,tHcy,i
281,0211-699501013259,debe,o
281,0211-699501013259,tener,o
281,0211-699501013259,en,o
281,0211-699501013259,cuenta,o
281,0211-699501013259,la,o
281,0211-699501013259,concentracion,i
281,0211-699501013259,de,i
281,0211-699501013259,albumina,i
282,0211-699501013259,Efecto,o
282,0211-699501013259,de,o
282,0211-699501013259,la,o
282,0211-699501013259,suplementacion,i
282,0211-699501013259,con,o
282,0211-699501013259,acido,i
282,0211-699501013259,folico,i
282,0211-699501013259,sobre,o
282,0211-699501013259,los,o
282,0211-699501013259,niveles,i
282,0211-699501013259,de,i
282,0211-699501013259,homocisteina,i
282,0211-699501013259,total,o
282,0211-699501013259,en,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,en,o
282,0211-699501013259,hemodialisis,i
282,0211-699501013259,La,o
282,0211-699501013259,hiperhomocisteinemia,i
282,0211-699501013259,es,o
282,0211-699501013259,un,o
282,0211-699501013259,marcador,o
282,0211-699501013259,de,o
282,0211-699501013259,riesgo,o
282,0211-699501013259,independiente,o
282,0211-699501013259,de,o
282,0211-699501013259,morbimortalidad,o
282,0211-699501013259,cardiovascular,i
282,0211-699501013259,Hemos,o
282,0211-699501013259,intentado,o
282,0211-699501013259,prospectivamente,o
282,0211-699501013259,reducir,o
282,0211-699501013259,los,o
282,0211-699501013259,niveles,i
282,0211-699501013259,de,i
282,0211-699501013259,homocisteina,i
282,0211-699501013259,total,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,mediante,o
282,0211-699501013259,suplemento,o
282,0211-699501013259,con,o
282,0211-699501013259,acido,i
282,0211-699501013259,folico,i
282,0211-699501013259,y,o
282,0211-699501013259,vitamina,i
282,0211-699501013259,B6,i
282,0211-699501013259,pp,i
282,0211-699501013259,valorando,o
282,0211-699501013259,su,o
282,0211-699501013259,posible,o
282,0211-699501013259,correlacion,o
282,0211-699501013259,con,o
282,0211-699501013259,dosis,o
282,0211-699501013259,de,o
282,0211-699501013259,dialisis,i
282,0211-699501013259,funcion,i
282,0211-699501013259,residual,i
282,0211-699501013259,y,o
282,0211-699501013259,parametros,o
282,0211-699501013259,nutricionales,o
282,0211-699501013259,Metodos,o
282,0211-699501013259,Todos,o
282,0211-699501013259,los,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,en,o
282,0211-699501013259,hemodialisis,i
282,0211-699501013259,al,o
282,0211-699501013259,comienzo,o
282,0211-699501013259,del,o
282,0211-699501013259,estudio,o
282,0211-699501013259,que,o
282,0211-699501013259,no,o
282,0211-699501013259,recibian,o
282,0211-699501013259,acido,i
282,0211-699501013259,folico,i
282,0211-699501013259,ni,o
282,0211-699501013259,vitamina,i
282,0211-699501013259,B6,i
282,0211-699501013259,asi,o
282,0211-699501013259,como,o
282,0211-699501013259,los,o
282,0211-699501013259,incorporados,o
282,0211-699501013259,posteriormente,o
282,0211-699501013259,a,o
282,0211-699501013259,partir,o
282,0211-699501013259,de,o
282,0211-699501013259,su,o
282,0211-699501013259,tercer,o
282,0211-699501013259,mes,o
282,0211-699501013259,en,o
282,0211-699501013259,hemodialisis,i
282,0211-699501013259,recibieron,o
282,0211-699501013259,5,o
282,0211-699501013259,mg,o
282,0211-699501013259,orales,o
282,0211-699501013259,de,o
282,0211-699501013259,acido,i
282,0211-699501013259,folico,i
282,0211-699501013259,cada,o
282,0211-699501013259,48,o
282,0211-699501013259,horas,o
282,0211-699501013259,y,o
282,0211-699501013259,40,o
282,0211-699501013259,mg,o
282,0211-699501013259,orales,o
282,0211-699501013259,de,o
282,0211-699501013259,vitamina,i
282,0211-699501013259,B6,i
282,0211-699501013259,cada,o
282,0211-699501013259,semana,o
282,0211-699501013259,Se,o
282,0211-699501013259,determinaron,o
282,0211-699501013259,al,o
282,0211-699501013259,comienzo,o
282,0211-699501013259,del,o
282,0211-699501013259,estudio,o
282,0211-699501013259,y,o
282,0211-699501013259,cada,o
282,0211-699501013259,2,o
282,0211-699501013259,meses,o
282,0211-699501013259,niveles,i
282,0211-699501013259,de,i
282,0211-699501013259,folato,i
282,0211-699501013259,vitamina,i
282,0211-699501013259,B12,i
282,0211-699501013259,inmunoensayo,i
282,0211-699501013259,albumina,i
282,0211-699501013259,y,o
282,0211-699501013259,cinetica,o
282,0211-699501013259,de,o
282,0211-699501013259,la,o
282,0211-699501013259,urea,i
282,0211-699501013259,KTV,o
282,0211-699501013259,KRU,o
282,0211-699501013259,PCRn,o
282,0211-699501013259,y,o
282,0211-699501013259,cada,o
282,0211-699501013259,6,o
282,0211-699501013259,meses,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,HPLC,i
282,0211-699501013259,y,o
282,0211-699501013259,pp,i
282,0211-699501013259,RIA,i
282,0211-699501013259,Resultados,o
282,0211-699501013259,80,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,fueron,o
282,0211-699501013259,incluidos,o
282,0211-699501013259,en,o
282,0211-699501013259,el,o
282,0211-699501013259,estudio,o
282,0211-699501013259,basal,o
282,0211-699501013259,con,o
282,0211-699501013259,una,o
282,0211-699501013259,prevalencia,o
282,0211-699501013259,de,o
282,0211-699501013259,hiperhomocisteinemia,i
282,0211-699501013259,del,o
282,0211-699501013259,844,o
282,0211-699501013259,deficit,i
282,0211-699501013259,de,i
282,0211-699501013259,pp,i
282,0211-699501013259,en,o
282,0211-699501013259,el,o
282,0211-699501013259,32,o
282,0211-699501013259,y,o
282,0211-699501013259,folato,i
282,0211-699501013259,en,o
282,0211-699501013259,el,o
282,0211-699501013259,rango,o
282,0211-699501013259,normal,o
282,0211-699501013259,bajo,o
282,0211-699501013259,los,o
282,0211-699501013259,niveles,i
282,0211-699501013259,de,i
282,0211-699501013259,tHcy,i
282,0211-699501013259,se,o
282,0211-699501013259,correlacionaban,o
282,0211-699501013259,inversamente,o
282,0211-699501013259,con,o
282,0211-699501013259,los,o
282,0211-699501013259,del,o
282,0211-699501013259,folato,i
282,0211-699501013259,r,o
282,0211-699501013259,0336,o
282,0211-699501013259,p,o
282,0211-699501013259,001,o
282,0211-699501013259,pero,o
282,0211-699501013259,no,o
282,0211-699501013259,con,o
282,0211-699501013259,pp,i
282,0211-699501013259,B12,i
282,0211-699501013259,edad,o
282,0211-699501013259,albumina,i
282,0211-699501013259,KTV,o
282,0211-699501013259,KRU,o
282,0211-699501013259,PCRn,o
282,0211-699501013259,Cincuenta,o
282,0211-699501013259,y,o
282,0211-699501013259,ocho,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,recibieron,o
282,0211-699501013259,seis,o
282,0211-699501013259,meses,o
282,0211-699501013259,de,o
282,0211-699501013259,suplementacion,i
282,0211-699501013259,con,o
282,0211-699501013259,normalizacion,o
282,0211-699501013259,del,o
282,0211-699501013259,pp,i
282,0211-699501013259,aumento,o
282,0211-699501013259,del,o
282,0211-699501013259,folato,i
282,0211-699501013259,703,o
282,0211-699501013259,IC,o
282,0211-699501013259,638,o
282,0211-699501013259,795,o
282,0211-699501013259,vs,o
282,0211-699501013259,6181,o
282,0211-699501013259,IC,o
282,0211-699501013259,4447,o
282,0211-699501013259,7811,o
282,0211-699501013259,p,o
282,0211-699501013259,0001,o
282,0211-699501013259,y,o
282,0211-699501013259,descenso,o
282,0211-699501013259,de,o
282,0211-699501013259,la,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,240,o
282,0211-699501013259,IC,o
282,0211-699501013259,213,o
282,0211-699501013259,264,o
282,0211-699501013259,vs,o
282,0211-699501013259,199,o
282,0211-699501013259,IC,o
282,0211-699501013259,175,o
282,0211-699501013259,224,o
282,0211-699501013259,p,o
282,0211-699501013259,005,o
282,0211-699501013259,Han,o
282,0211-699501013259,recibido,o
282,0211-699501013259,suplementacion,i
282,0211-699501013259,durante,o
282,0211-699501013259,12,o
282,0211-699501013259,meses,o
282,0211-699501013259,33,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,pero,o
282,0211-699501013259,a,o
282,0211-699501013259,pesar,o
282,0211-699501013259,de,o
282,0211-699501013259,un,o
282,0211-699501013259,continuo,o
282,0211-699501013259,aumento,o
282,0211-699501013259,del,o
282,0211-699501013259,folato,i
282,0211-699501013259,10078,o
282,0211-699501013259,IC,o
282,0211-699501013259,7481,o
282,0211-699501013259,12674,o
282,0211-699501013259,p,o
282,0211-699501013259,0001,o
282,0211-699501013259,solo,o
282,0211-699501013259,3,o
282,0211-699501013259,pacientes,o
282,0211-699501013259,presentan,o
282,0211-699501013259,niveles,o
282,0211-699501013259,normales,o
282,0211-699501013259,de,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,correlacionandose,o
282,0211-699501013259,directamente,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,con,o
282,0211-699501013259,la,o
282,0211-699501013259,albumina,i
282,0211-699501013259,r,o
282,0211-699501013259,056,o
282,0211-699501013259,p,o
282,0211-699501013259,0001,o
282,0211-699501013259,que,o
282,0211-699501013259,se,o
282,0211-699501013259,elevo,o
282,0211-699501013259,con,o
282,0211-699501013259,respecto,o
282,0211-699501013259,al,o
282,0211-699501013259,inicio,o
282,0211-699501013259,337,o
282,0211-699501013259,IC,o
282,0211-699501013259,327,o
282,0211-699501013259,346,o
282,0211-699501013259,vs,o
282,0211-699501013259,350,o
282,0211-699501013259,IC,o
282,0211-699501013259,337,o
282,0211-699501013259,363,o
282,0211-699501013259,p,o
282,0211-699501013259,005,o
282,0211-699501013259,Conclusion,o
282,0211-699501013259,Tras,o
282,0211-699501013259,suplementacion,i
282,0211-699501013259,con,o
282,0211-699501013259,acido,i
282,0211-699501013259,folico,i
282,0211-699501013259,y,o
282,0211-699501013259,vitamina,i
282,0211-699501013259,B6,i
282,0211-699501013259,aunque,o
282,0211-699501013259,inicialmente,o
282,0211-699501013259,se,o
282,0211-699501013259,reduce,o
282,0211-699501013259,la,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,esta,o
282,0211-699501013259,respuesta,o
282,0211-699501013259,se,o
282,0211-699501013259,hace,o
282,0211-699501013259,refractaria,o
282,0211-699501013259,correlacionandose,o
282,0211-699501013259,directamente,o
282,0211-699501013259,la,o
282,0211-699501013259,tHcy,i
282,0211-699501013259,con,o
282,0211-699501013259,la,o
282,0211-699501013259,albumina,i
282,0211-699501013259,plasmatica,i
282,0211-699501013259,La,o
282,0211-699501013259,interpretacion,o
282,0211-699501013259,de,o
282,0211-699501013259,los,o
282,0211-699501013259,niveles,i
282,0211-699501013259,de,i
282,0211-699501013259,tHcy,i
282,0211-699501013259,debe,o
282,0211-699501013259,tener,o
282,0211-699501013259,en,o
282,0211-699501013259,cuenta,o
282,0211-699501013259,la,o
282,0211-699501013259,concentracion,i
282,0211-699501013259,de,i
282,0211-699501013259,albumina,i
283,0211-699501013259,Efecto,o
283,0211-699501013259,de,o
283,0211-699501013259,la,o
283,0211-699501013259,suplementacion,i
283,0211-699501013259,con,o
283,0211-699501013259,acido,i
283,0211-699501013259,folico,i
283,0211-699501013259,sobre,o
283,0211-699501013259,los,o
283,0211-699501013259,niveles,i
283,0211-699501013259,de,i
283,0211-699501013259,homocisteina,i
283,0211-699501013259,total,o
283,0211-699501013259,en,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,en,o
283,0211-699501013259,hemodialisis,i
283,0211-699501013259,La,o
283,0211-699501013259,hiperhomocisteinemia,i
283,0211-699501013259,es,o
283,0211-699501013259,un,o
283,0211-699501013259,marcador,o
283,0211-699501013259,de,o
283,0211-699501013259,riesgo,o
283,0211-699501013259,independiente,o
283,0211-699501013259,de,o
283,0211-699501013259,morbimortalidad,o
283,0211-699501013259,cardiovascular,i
283,0211-699501013259,Hemos,o
283,0211-699501013259,intentado,o
283,0211-699501013259,prospectivamente,o
283,0211-699501013259,reducir,o
283,0211-699501013259,los,o
283,0211-699501013259,niveles,i
283,0211-699501013259,de,i
283,0211-699501013259,homocisteina,i
283,0211-699501013259,total,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,mediante,o
283,0211-699501013259,suplemento,o
283,0211-699501013259,con,o
283,0211-699501013259,acido,i
283,0211-699501013259,folico,i
283,0211-699501013259,y,o
283,0211-699501013259,vitamina,i
283,0211-699501013259,B6,i
283,0211-699501013259,pp,i
283,0211-699501013259,valorando,o
283,0211-699501013259,su,o
283,0211-699501013259,posible,o
283,0211-699501013259,correlacion,o
283,0211-699501013259,con,o
283,0211-699501013259,dosis,o
283,0211-699501013259,de,o
283,0211-699501013259,dialisis,i
283,0211-699501013259,funcion,i
283,0211-699501013259,residual,i
283,0211-699501013259,y,o
283,0211-699501013259,parametros,o
283,0211-699501013259,nutricionales,o
283,0211-699501013259,Metodos,o
283,0211-699501013259,Todos,o
283,0211-699501013259,los,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,en,o
283,0211-699501013259,hemodialisis,i
283,0211-699501013259,al,o
283,0211-699501013259,comienzo,o
283,0211-699501013259,del,o
283,0211-699501013259,estudio,o
283,0211-699501013259,que,o
283,0211-699501013259,no,o
283,0211-699501013259,recibian,o
283,0211-699501013259,acido,i
283,0211-699501013259,folico,i
283,0211-699501013259,ni,o
283,0211-699501013259,vitamina,i
283,0211-699501013259,B6,i
283,0211-699501013259,asi,o
283,0211-699501013259,como,o
283,0211-699501013259,los,o
283,0211-699501013259,incorporados,o
283,0211-699501013259,posteriormente,o
283,0211-699501013259,a,o
283,0211-699501013259,partir,o
283,0211-699501013259,de,o
283,0211-699501013259,su,o
283,0211-699501013259,tercer,o
283,0211-699501013259,mes,o
283,0211-699501013259,en,o
283,0211-699501013259,hemodialisis,i
283,0211-699501013259,recibieron,o
283,0211-699501013259,5,o
283,0211-699501013259,mg,o
283,0211-699501013259,orales,o
283,0211-699501013259,de,o
283,0211-699501013259,acido,i
283,0211-699501013259,folico,i
283,0211-699501013259,cada,o
283,0211-699501013259,48,o
283,0211-699501013259,horas,o
283,0211-699501013259,y,o
283,0211-699501013259,40,o
283,0211-699501013259,mg,o
283,0211-699501013259,orales,o
283,0211-699501013259,de,o
283,0211-699501013259,vitamina,i
283,0211-699501013259,B6,i
283,0211-699501013259,cada,o
283,0211-699501013259,semana,o
283,0211-699501013259,Se,o
283,0211-699501013259,determinaron,o
283,0211-699501013259,al,o
283,0211-699501013259,comienzo,o
283,0211-699501013259,del,o
283,0211-699501013259,estudio,o
283,0211-699501013259,y,o
283,0211-699501013259,cada,o
283,0211-699501013259,2,o
283,0211-699501013259,meses,o
283,0211-699501013259,niveles,i
283,0211-699501013259,de,i
283,0211-699501013259,folato,i
283,0211-699501013259,vitamina,i
283,0211-699501013259,B12,i
283,0211-699501013259,inmunoensayo,i
283,0211-699501013259,albumina,i
283,0211-699501013259,y,o
283,0211-699501013259,cinetica,o
283,0211-699501013259,de,o
283,0211-699501013259,la,o
283,0211-699501013259,urea,i
283,0211-699501013259,KTV,o
283,0211-699501013259,KRU,o
283,0211-699501013259,PCRn,o
283,0211-699501013259,y,o
283,0211-699501013259,cada,o
283,0211-699501013259,6,o
283,0211-699501013259,meses,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,HPLC,i
283,0211-699501013259,y,o
283,0211-699501013259,pp,i
283,0211-699501013259,RIA,i
283,0211-699501013259,Resultados,o
283,0211-699501013259,80,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,fueron,o
283,0211-699501013259,incluidos,o
283,0211-699501013259,en,o
283,0211-699501013259,el,o
283,0211-699501013259,estudio,o
283,0211-699501013259,basal,o
283,0211-699501013259,con,o
283,0211-699501013259,una,o
283,0211-699501013259,prevalencia,o
283,0211-699501013259,de,o
283,0211-699501013259,hiperhomocisteinemia,i
283,0211-699501013259,del,o
283,0211-699501013259,844,o
283,0211-699501013259,deficit,i
283,0211-699501013259,de,i
283,0211-699501013259,pp,i
283,0211-699501013259,en,o
283,0211-699501013259,el,o
283,0211-699501013259,32,o
283,0211-699501013259,y,o
283,0211-699501013259,folato,i
283,0211-699501013259,en,o
283,0211-699501013259,el,o
283,0211-699501013259,rango,o
283,0211-699501013259,normal,o
283,0211-699501013259,bajo,o
283,0211-699501013259,los,o
283,0211-699501013259,niveles,i
283,0211-699501013259,de,i
283,0211-699501013259,tHcy,i
283,0211-699501013259,se,o
283,0211-699501013259,correlacionaban,o
283,0211-699501013259,inversamente,o
283,0211-699501013259,con,o
283,0211-699501013259,los,o
283,0211-699501013259,del,o
283,0211-699501013259,folato,i
283,0211-699501013259,r,o
283,0211-699501013259,0336,o
283,0211-699501013259,p,o
283,0211-699501013259,001,o
283,0211-699501013259,pero,o
283,0211-699501013259,no,o
283,0211-699501013259,con,o
283,0211-699501013259,pp,i
283,0211-699501013259,B12,i
283,0211-699501013259,edad,o
283,0211-699501013259,albumina,i
283,0211-699501013259,KTV,o
283,0211-699501013259,KRU,o
283,0211-699501013259,PCRn,o
283,0211-699501013259,Cincuenta,o
283,0211-699501013259,y,o
283,0211-699501013259,ocho,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,recibieron,o
283,0211-699501013259,seis,o
283,0211-699501013259,meses,o
283,0211-699501013259,de,o
283,0211-699501013259,suplementacion,i
283,0211-699501013259,con,o
283,0211-699501013259,normalizacion,o
283,0211-699501013259,del,o
283,0211-699501013259,pp,i
283,0211-699501013259,aumento,o
283,0211-699501013259,del,o
283,0211-699501013259,folato,i
283,0211-699501013259,703,o
283,0211-699501013259,IC,o
283,0211-699501013259,638,o
283,0211-699501013259,795,o
283,0211-699501013259,vs,o
283,0211-699501013259,6181,o
283,0211-699501013259,IC,o
283,0211-699501013259,4447,o
283,0211-699501013259,7811,o
283,0211-699501013259,p,o
283,0211-699501013259,0001,o
283,0211-699501013259,y,o
283,0211-699501013259,descenso,o
283,0211-699501013259,de,o
283,0211-699501013259,la,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,240,o
283,0211-699501013259,IC,o
283,0211-699501013259,213,o
283,0211-699501013259,264,o
283,0211-699501013259,vs,o
283,0211-699501013259,199,o
283,0211-699501013259,IC,o
283,0211-699501013259,175,o
283,0211-699501013259,224,o
283,0211-699501013259,p,o
283,0211-699501013259,005,o
283,0211-699501013259,Han,o
283,0211-699501013259,recibido,o
283,0211-699501013259,suplementacion,i
283,0211-699501013259,durante,o
283,0211-699501013259,12,o
283,0211-699501013259,meses,o
283,0211-699501013259,33,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,pero,o
283,0211-699501013259,a,o
283,0211-699501013259,pesar,o
283,0211-699501013259,de,o
283,0211-699501013259,un,o
283,0211-699501013259,continuo,o
283,0211-699501013259,aumento,o
283,0211-699501013259,del,o
283,0211-699501013259,folato,i
283,0211-699501013259,10078,o
283,0211-699501013259,IC,o
283,0211-699501013259,7481,o
283,0211-699501013259,12674,o
283,0211-699501013259,p,o
283,0211-699501013259,0001,o
283,0211-699501013259,solo,o
283,0211-699501013259,3,o
283,0211-699501013259,pacientes,o
283,0211-699501013259,presentan,o
283,0211-699501013259,niveles,o
283,0211-699501013259,normales,o
283,0211-699501013259,de,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,correlacionandose,o
283,0211-699501013259,directamente,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,con,o
283,0211-699501013259,la,o
283,0211-699501013259,albumina,i
283,0211-699501013259,r,o
283,0211-699501013259,056,o
283,0211-699501013259,p,o
283,0211-699501013259,0001,o
283,0211-699501013259,que,o
283,0211-699501013259,se,o
283,0211-699501013259,elevo,o
283,0211-699501013259,con,o
283,0211-699501013259,respecto,o
283,0211-699501013259,al,o
283,0211-699501013259,inicio,o
283,0211-699501013259,337,o
283,0211-699501013259,IC,o
283,0211-699501013259,327,o
283,0211-699501013259,346,o
283,0211-699501013259,vs,o
283,0211-699501013259,350,o
283,0211-699501013259,IC,o
283,0211-699501013259,337,o
283,0211-699501013259,363,o
283,0211-699501013259,p,o
283,0211-699501013259,005,o
283,0211-699501013259,Conclusion,o
283,0211-699501013259,Tras,o
283,0211-699501013259,suplementacion,i
283,0211-699501013259,con,o
283,0211-699501013259,acido,i
283,0211-699501013259,folico,i
283,0211-699501013259,y,o
283,0211-699501013259,vitamina,i
283,0211-699501013259,B6,i
283,0211-699501013259,aunque,o
283,0211-699501013259,inicialmente,o
283,0211-699501013259,se,o
283,0211-699501013259,reduce,o
283,0211-699501013259,la,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,esta,o
283,0211-699501013259,respuesta,o
283,0211-699501013259,se,o
283,0211-699501013259,hace,o
283,0211-699501013259,refractaria,o
283,0211-699501013259,correlacionandose,o
283,0211-699501013259,directamente,o
283,0211-699501013259,la,o
283,0211-699501013259,tHcy,i
283,0211-699501013259,con,o
283,0211-699501013259,la,o
283,0211-699501013259,albumina,i
283,0211-699501013259,plasmatica,i
283,0211-699501013259,La,o
283,0211-699501013259,interpretacion,o
283,0211-699501013259,de,o
283,0211-699501013259,los,o
283,0211-699501013259,niveles,i
283,0211-699501013259,de,i
283,0211-699501013259,tHcy,i
283,0211-699501013259,debe,o
283,0211-699501013259,tener,o
283,0211-699501013259,en,o
283,0211-699501013259,cuenta,o
283,0211-699501013259,la,o
283,0211-699501013259,concentracion,i
283,0211-699501013259,de,i
283,0211-699501013259,albumina,i
284,0211-699501013259,Efecto,o
284,0211-699501013259,de,o
284,0211-699501013259,la,o
284,0211-699501013259,suplementacion,i
284,0211-699501013259,con,o
284,0211-699501013259,acido,i
284,0211-699501013259,folico,i
284,0211-699501013259,sobre,o
284,0211-699501013259,los,o
284,0211-699501013259,niveles,i
284,0211-699501013259,de,i
284,0211-699501013259,homocisteina,i
284,0211-699501013259,total,o
284,0211-699501013259,en,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,en,o
284,0211-699501013259,hemodialisis,i
284,0211-699501013259,La,o
284,0211-699501013259,hiperhomocisteinemia,i
284,0211-699501013259,es,o
284,0211-699501013259,un,o
284,0211-699501013259,marcador,o
284,0211-699501013259,de,o
284,0211-699501013259,riesgo,o
284,0211-699501013259,independiente,o
284,0211-699501013259,de,o
284,0211-699501013259,morbimortalidad,o
284,0211-699501013259,cardiovascular,i
284,0211-699501013259,Hemos,o
284,0211-699501013259,intentado,o
284,0211-699501013259,prospectivamente,o
284,0211-699501013259,reducir,o
284,0211-699501013259,los,o
284,0211-699501013259,niveles,i
284,0211-699501013259,de,i
284,0211-699501013259,homocisteina,i
284,0211-699501013259,total,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,mediante,o
284,0211-699501013259,suplemento,o
284,0211-699501013259,con,o
284,0211-699501013259,acido,i
284,0211-699501013259,folico,i
284,0211-699501013259,y,o
284,0211-699501013259,vitamina,i
284,0211-699501013259,B6,i
284,0211-699501013259,pp,i
284,0211-699501013259,valorando,o
284,0211-699501013259,su,o
284,0211-699501013259,posible,o
284,0211-699501013259,correlacion,o
284,0211-699501013259,con,o
284,0211-699501013259,dosis,o
284,0211-699501013259,de,o
284,0211-699501013259,dialisis,i
284,0211-699501013259,funcion,i
284,0211-699501013259,residual,i
284,0211-699501013259,y,o
284,0211-699501013259,parametros,o
284,0211-699501013259,nutricionales,o
284,0211-699501013259,Metodos,o
284,0211-699501013259,Todos,o
284,0211-699501013259,los,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,en,o
284,0211-699501013259,hemodialisis,i
284,0211-699501013259,al,o
284,0211-699501013259,comienzo,o
284,0211-699501013259,del,o
284,0211-699501013259,estudio,o
284,0211-699501013259,que,o
284,0211-699501013259,no,o
284,0211-699501013259,recibian,o
284,0211-699501013259,acido,i
284,0211-699501013259,folico,i
284,0211-699501013259,ni,o
284,0211-699501013259,vitamina,i
284,0211-699501013259,B6,i
284,0211-699501013259,asi,o
284,0211-699501013259,como,o
284,0211-699501013259,los,o
284,0211-699501013259,incorporados,o
284,0211-699501013259,posteriormente,o
284,0211-699501013259,a,o
284,0211-699501013259,partir,o
284,0211-699501013259,de,o
284,0211-699501013259,su,o
284,0211-699501013259,tercer,o
284,0211-699501013259,mes,o
284,0211-699501013259,en,o
284,0211-699501013259,hemodialisis,i
284,0211-699501013259,recibieron,o
284,0211-699501013259,5,o
284,0211-699501013259,mg,o
284,0211-699501013259,orales,o
284,0211-699501013259,de,o
284,0211-699501013259,acido,i
284,0211-699501013259,folico,i
284,0211-699501013259,cada,o
284,0211-699501013259,48,o
284,0211-699501013259,horas,o
284,0211-699501013259,y,o
284,0211-699501013259,40,o
284,0211-699501013259,mg,o
284,0211-699501013259,orales,o
284,0211-699501013259,de,o
284,0211-699501013259,vitamina,i
284,0211-699501013259,B6,i
284,0211-699501013259,cada,o
284,0211-699501013259,semana,o
284,0211-699501013259,Se,o
284,0211-699501013259,determinaron,o
284,0211-699501013259,al,o
284,0211-699501013259,comienzo,o
284,0211-699501013259,del,o
284,0211-699501013259,estudio,o
284,0211-699501013259,y,o
284,0211-699501013259,cada,o
284,0211-699501013259,2,o
284,0211-699501013259,meses,o
284,0211-699501013259,niveles,i
284,0211-699501013259,de,i
284,0211-699501013259,folato,i
284,0211-699501013259,vitamina,i
284,0211-699501013259,B12,i
284,0211-699501013259,inmunoensayo,i
284,0211-699501013259,albumina,i
284,0211-699501013259,y,o
284,0211-699501013259,cinetica,o
284,0211-699501013259,de,o
284,0211-699501013259,la,o
284,0211-699501013259,urea,i
284,0211-699501013259,KTV,o
284,0211-699501013259,KRU,o
284,0211-699501013259,PCRn,o
284,0211-699501013259,y,o
284,0211-699501013259,cada,o
284,0211-699501013259,6,o
284,0211-699501013259,meses,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,HPLC,i
284,0211-699501013259,y,o
284,0211-699501013259,pp,i
284,0211-699501013259,RIA,i
284,0211-699501013259,Resultados,o
284,0211-699501013259,80,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,fueron,o
284,0211-699501013259,incluidos,o
284,0211-699501013259,en,o
284,0211-699501013259,el,o
284,0211-699501013259,estudio,o
284,0211-699501013259,basal,o
284,0211-699501013259,con,o
284,0211-699501013259,una,o
284,0211-699501013259,prevalencia,o
284,0211-699501013259,de,o
284,0211-699501013259,hiperhomocisteinemia,i
284,0211-699501013259,del,o
284,0211-699501013259,844,o
284,0211-699501013259,deficit,i
284,0211-699501013259,de,i
284,0211-699501013259,pp,i
284,0211-699501013259,en,o
284,0211-699501013259,el,o
284,0211-699501013259,32,o
284,0211-699501013259,y,o
284,0211-699501013259,folato,i
284,0211-699501013259,en,o
284,0211-699501013259,el,o
284,0211-699501013259,rango,o
284,0211-699501013259,normal,o
284,0211-699501013259,bajo,o
284,0211-699501013259,los,o
284,0211-699501013259,niveles,i
284,0211-699501013259,de,i
284,0211-699501013259,tHcy,i
284,0211-699501013259,se,o
284,0211-699501013259,correlacionaban,o
284,0211-699501013259,inversamente,o
284,0211-699501013259,con,o
284,0211-699501013259,los,o
284,0211-699501013259,del,o
284,0211-699501013259,folato,i
284,0211-699501013259,r,o
284,0211-699501013259,0336,o
284,0211-699501013259,p,o
284,0211-699501013259,001,o
284,0211-699501013259,pero,o
284,0211-699501013259,no,o
284,0211-699501013259,con,o
284,0211-699501013259,pp,i
284,0211-699501013259,B12,i
284,0211-699501013259,edad,o
284,0211-699501013259,albumina,i
284,0211-699501013259,KTV,o
284,0211-699501013259,KRU,o
284,0211-699501013259,PCRn,o
284,0211-699501013259,Cincuenta,o
284,0211-699501013259,y,o
284,0211-699501013259,ocho,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,recibieron,o
284,0211-699501013259,seis,o
284,0211-699501013259,meses,o
284,0211-699501013259,de,o
284,0211-699501013259,suplementacion,i
284,0211-699501013259,con,o
284,0211-699501013259,normalizacion,o
284,0211-699501013259,del,o
284,0211-699501013259,pp,i
284,0211-699501013259,aumento,o
284,0211-699501013259,del,o
284,0211-699501013259,folato,i
284,0211-699501013259,703,o
284,0211-699501013259,IC,o
284,0211-699501013259,638,o
284,0211-699501013259,795,o
284,0211-699501013259,vs,o
284,0211-699501013259,6181,o
284,0211-699501013259,IC,o
284,0211-699501013259,4447,o
284,0211-699501013259,7811,o
284,0211-699501013259,p,o
284,0211-699501013259,0001,o
284,0211-699501013259,y,o
284,0211-699501013259,descenso,o
284,0211-699501013259,de,o
284,0211-699501013259,la,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,240,o
284,0211-699501013259,IC,o
284,0211-699501013259,213,o
284,0211-699501013259,264,o
284,0211-699501013259,vs,o
284,0211-699501013259,199,o
284,0211-699501013259,IC,o
284,0211-699501013259,175,o
284,0211-699501013259,224,o
284,0211-699501013259,p,o
284,0211-699501013259,005,o
284,0211-699501013259,Han,o
284,0211-699501013259,recibido,o
284,0211-699501013259,suplementacion,i
284,0211-699501013259,durante,o
284,0211-699501013259,12,o
284,0211-699501013259,meses,o
284,0211-699501013259,33,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,pero,o
284,0211-699501013259,a,o
284,0211-699501013259,pesar,o
284,0211-699501013259,de,o
284,0211-699501013259,un,o
284,0211-699501013259,continuo,o
284,0211-699501013259,aumento,o
284,0211-699501013259,del,o
284,0211-699501013259,folato,i
284,0211-699501013259,10078,o
284,0211-699501013259,IC,o
284,0211-699501013259,7481,o
284,0211-699501013259,12674,o
284,0211-699501013259,p,o
284,0211-699501013259,0001,o
284,0211-699501013259,solo,o
284,0211-699501013259,3,o
284,0211-699501013259,pacientes,o
284,0211-699501013259,presentan,o
284,0211-699501013259,niveles,o
284,0211-699501013259,normales,o
284,0211-699501013259,de,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,correlacionandose,o
284,0211-699501013259,directamente,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,con,o
284,0211-699501013259,la,o
284,0211-699501013259,albumina,i
284,0211-699501013259,r,o
284,0211-699501013259,056,o
284,0211-699501013259,p,o
284,0211-699501013259,0001,o
284,0211-699501013259,que,o
284,0211-699501013259,se,o
284,0211-699501013259,elevo,o
284,0211-699501013259,con,o
284,0211-699501013259,respecto,o
284,0211-699501013259,al,o
284,0211-699501013259,inicio,o
284,0211-699501013259,337,o
284,0211-699501013259,IC,o
284,0211-699501013259,327,o
284,0211-699501013259,346,o
284,0211-699501013259,vs,o
284,0211-699501013259,350,o
284,0211-699501013259,IC,o
284,0211-699501013259,337,o
284,0211-699501013259,363,o
284,0211-699501013259,p,o
284,0211-699501013259,005,o
284,0211-699501013259,Conclusion,o
284,0211-699501013259,Tras,o
284,0211-699501013259,suplementacion,i
284,0211-699501013259,con,o
284,0211-699501013259,acido,i
284,0211-699501013259,folico,i
284,0211-699501013259,y,o
284,0211-699501013259,vitamina,i
284,0211-699501013259,B6,i
284,0211-699501013259,aunque,o
284,0211-699501013259,inicialmente,o
284,0211-699501013259,se,o
284,0211-699501013259,reduce,o
284,0211-699501013259,la,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,esta,o
284,0211-699501013259,respuesta,o
284,0211-699501013259,se,o
284,0211-699501013259,hace,o
284,0211-699501013259,refractaria,o
284,0211-699501013259,correlacionandose,o
284,0211-699501013259,directamente,o
284,0211-699501013259,la,o
284,0211-699501013259,tHcy,i
284,0211-699501013259,con,o
284,0211-699501013259,la,o
284,0211-699501013259,albumina,i
284,0211-699501013259,plasmatica,i
284,0211-699501013259,La,o
284,0211-699501013259,interpretacion,o
284,0211-699501013259,de,o
284,0211-699501013259,los,o
284,0211-699501013259,niveles,i
284,0211-699501013259,de,i
284,0211-699501013259,tHcy,i
284,0211-699501013259,debe,o
284,0211-699501013259,tener,o
284,0211-699501013259,en,o
284,0211-699501013259,cuenta,o
284,0211-699501013259,la,o
284,0211-699501013259,concentracion,i
284,0211-699501013259,de,i
284,0211-699501013259,albumina,i
285,0211-699501013259,Efecto,o
285,0211-699501013259,de,o
285,0211-699501013259,la,o
285,0211-699501013259,suplementacion,i
285,0211-699501013259,con,o
285,0211-699501013259,acido,i
285,0211-699501013259,folico,i
285,0211-699501013259,sobre,o
285,0211-699501013259,los,o
285,0211-699501013259,niveles,i
285,0211-699501013259,de,i
285,0211-699501013259,homocisteina,i
285,0211-699501013259,total,o
285,0211-699501013259,en,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,en,o
285,0211-699501013259,hemodialisis,i
285,0211-699501013259,La,o
285,0211-699501013259,hiperhomocisteinemia,i
285,0211-699501013259,es,o
285,0211-699501013259,un,o
285,0211-699501013259,marcador,o
285,0211-699501013259,de,o
285,0211-699501013259,riesgo,o
285,0211-699501013259,independiente,o
285,0211-699501013259,de,o
285,0211-699501013259,morbimortalidad,o
285,0211-699501013259,cardiovascular,i
285,0211-699501013259,Hemos,o
285,0211-699501013259,intentado,o
285,0211-699501013259,prospectivamente,o
285,0211-699501013259,reducir,o
285,0211-699501013259,los,o
285,0211-699501013259,niveles,i
285,0211-699501013259,de,i
285,0211-699501013259,homocisteina,i
285,0211-699501013259,total,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,mediante,o
285,0211-699501013259,suplemento,o
285,0211-699501013259,con,o
285,0211-699501013259,acido,i
285,0211-699501013259,folico,i
285,0211-699501013259,y,o
285,0211-699501013259,vitamina,i
285,0211-699501013259,B6,i
285,0211-699501013259,pp,i
285,0211-699501013259,valorando,o
285,0211-699501013259,su,o
285,0211-699501013259,posible,o
285,0211-699501013259,correlacion,o
285,0211-699501013259,con,o
285,0211-699501013259,dosis,o
285,0211-699501013259,de,o
285,0211-699501013259,dialisis,i
285,0211-699501013259,funcion,i
285,0211-699501013259,residual,i
285,0211-699501013259,y,o
285,0211-699501013259,parametros,o
285,0211-699501013259,nutricionales,o
285,0211-699501013259,Metodos,o
285,0211-699501013259,Todos,o
285,0211-699501013259,los,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,en,o
285,0211-699501013259,hemodialisis,i
285,0211-699501013259,al,o
285,0211-699501013259,comienzo,o
285,0211-699501013259,del,o
285,0211-699501013259,estudio,o
285,0211-699501013259,que,o
285,0211-699501013259,no,o
285,0211-699501013259,recibian,o
285,0211-699501013259,acido,i
285,0211-699501013259,folico,i
285,0211-699501013259,ni,o
285,0211-699501013259,vitamina,i
285,0211-699501013259,B6,i
285,0211-699501013259,asi,o
285,0211-699501013259,como,o
285,0211-699501013259,los,o
285,0211-699501013259,incorporados,o
285,0211-699501013259,posteriormente,o
285,0211-699501013259,a,o
285,0211-699501013259,partir,o
285,0211-699501013259,de,o
285,0211-699501013259,su,o
285,0211-699501013259,tercer,o
285,0211-699501013259,mes,o
285,0211-699501013259,en,o
285,0211-699501013259,hemodialisis,i
285,0211-699501013259,recibieron,o
285,0211-699501013259,5,o
285,0211-699501013259,mg,o
285,0211-699501013259,orales,o
285,0211-699501013259,de,o
285,0211-699501013259,acido,i
285,0211-699501013259,folico,i
285,0211-699501013259,cada,o
285,0211-699501013259,48,o
285,0211-699501013259,horas,o
285,0211-699501013259,y,o
285,0211-699501013259,40,o
285,0211-699501013259,mg,o
285,0211-699501013259,orales,o
285,0211-699501013259,de,o
285,0211-699501013259,vitamina,i
285,0211-699501013259,B6,i
285,0211-699501013259,cada,o
285,0211-699501013259,semana,o
285,0211-699501013259,Se,o
285,0211-699501013259,determinaron,o
285,0211-699501013259,al,o
285,0211-699501013259,comienzo,o
285,0211-699501013259,del,o
285,0211-699501013259,estudio,o
285,0211-699501013259,y,o
285,0211-699501013259,cada,o
285,0211-699501013259,2,o
285,0211-699501013259,meses,o
285,0211-699501013259,niveles,i
285,0211-699501013259,de,i
285,0211-699501013259,folato,i
285,0211-699501013259,vitamina,i
285,0211-699501013259,B12,i
285,0211-699501013259,inmunoensayo,i
285,0211-699501013259,albumina,i
285,0211-699501013259,y,o
285,0211-699501013259,cinetica,o
285,0211-699501013259,de,o
285,0211-699501013259,la,o
285,0211-699501013259,urea,i
285,0211-699501013259,KTV,o
285,0211-699501013259,KRU,o
285,0211-699501013259,PCRn,o
285,0211-699501013259,y,o
285,0211-699501013259,cada,o
285,0211-699501013259,6,o
285,0211-699501013259,meses,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,HPLC,i
285,0211-699501013259,y,o
285,0211-699501013259,pp,i
285,0211-699501013259,RIA,i
285,0211-699501013259,Resultados,o
285,0211-699501013259,80,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,fueron,o
285,0211-699501013259,incluidos,o
285,0211-699501013259,en,o
285,0211-699501013259,el,o
285,0211-699501013259,estudio,o
285,0211-699501013259,basal,o
285,0211-699501013259,con,o
285,0211-699501013259,una,o
285,0211-699501013259,prevalencia,o
285,0211-699501013259,de,o
285,0211-699501013259,hiperhomocisteinemia,i
285,0211-699501013259,del,o
285,0211-699501013259,844,o
285,0211-699501013259,deficit,i
285,0211-699501013259,de,i
285,0211-699501013259,pp,i
285,0211-699501013259,en,o
285,0211-699501013259,el,o
285,0211-699501013259,32,o
285,0211-699501013259,y,o
285,0211-699501013259,folato,i
285,0211-699501013259,en,o
285,0211-699501013259,el,o
285,0211-699501013259,rango,o
285,0211-699501013259,normal,o
285,0211-699501013259,bajo,o
285,0211-699501013259,los,o
285,0211-699501013259,niveles,i
285,0211-699501013259,de,i
285,0211-699501013259,tHcy,i
285,0211-699501013259,se,o
285,0211-699501013259,correlacionaban,o
285,0211-699501013259,inversamente,o
285,0211-699501013259,con,o
285,0211-699501013259,los,o
285,0211-699501013259,del,o
285,0211-699501013259,folato,i
285,0211-699501013259,r,o
285,0211-699501013259,0336,o
285,0211-699501013259,p,o
285,0211-699501013259,001,o
285,0211-699501013259,pero,o
285,0211-699501013259,no,o
285,0211-699501013259,con,o
285,0211-699501013259,pp,i
285,0211-699501013259,B12,i
285,0211-699501013259,edad,o
285,0211-699501013259,albumina,i
285,0211-699501013259,KTV,o
285,0211-699501013259,KRU,o
285,0211-699501013259,PCRn,o
285,0211-699501013259,Cincuenta,o
285,0211-699501013259,y,o
285,0211-699501013259,ocho,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,recibieron,o
285,0211-699501013259,seis,o
285,0211-699501013259,meses,o
285,0211-699501013259,de,o
285,0211-699501013259,suplementacion,i
285,0211-699501013259,con,o
285,0211-699501013259,normalizacion,o
285,0211-699501013259,del,o
285,0211-699501013259,pp,i
285,0211-699501013259,aumento,o
285,0211-699501013259,del,o
285,0211-699501013259,folato,i
285,0211-699501013259,703,o
285,0211-699501013259,IC,o
285,0211-699501013259,638,o
285,0211-699501013259,795,o
285,0211-699501013259,vs,o
285,0211-699501013259,6181,o
285,0211-699501013259,IC,o
285,0211-699501013259,4447,o
285,0211-699501013259,7811,o
285,0211-699501013259,p,o
285,0211-699501013259,0001,o
285,0211-699501013259,y,o
285,0211-699501013259,descenso,o
285,0211-699501013259,de,o
285,0211-699501013259,la,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,240,o
285,0211-699501013259,IC,o
285,0211-699501013259,213,o
285,0211-699501013259,264,o
285,0211-699501013259,vs,o
285,0211-699501013259,199,o
285,0211-699501013259,IC,o
285,0211-699501013259,175,o
285,0211-699501013259,224,o
285,0211-699501013259,p,o
285,0211-699501013259,005,o
285,0211-699501013259,Han,o
285,0211-699501013259,recibido,o
285,0211-699501013259,suplementacion,i
285,0211-699501013259,durante,o
285,0211-699501013259,12,o
285,0211-699501013259,meses,o
285,0211-699501013259,33,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,pero,o
285,0211-699501013259,a,o
285,0211-699501013259,pesar,o
285,0211-699501013259,de,o
285,0211-699501013259,un,o
285,0211-699501013259,continuo,o
285,0211-699501013259,aumento,o
285,0211-699501013259,del,o
285,0211-699501013259,folato,i
285,0211-699501013259,10078,o
285,0211-699501013259,IC,o
285,0211-699501013259,7481,o
285,0211-699501013259,12674,o
285,0211-699501013259,p,o
285,0211-699501013259,0001,o
285,0211-699501013259,solo,o
285,0211-699501013259,3,o
285,0211-699501013259,pacientes,o
285,0211-699501013259,presentan,o
285,0211-699501013259,niveles,o
285,0211-699501013259,normales,o
285,0211-699501013259,de,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,correlacionandose,o
285,0211-699501013259,directamente,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,con,o
285,0211-699501013259,la,o
285,0211-699501013259,albumina,i
285,0211-699501013259,r,o
285,0211-699501013259,056,o
285,0211-699501013259,p,o
285,0211-699501013259,0001,o
285,0211-699501013259,que,o
285,0211-699501013259,se,o
285,0211-699501013259,elevo,o
285,0211-699501013259,con,o
285,0211-699501013259,respecto,o
285,0211-699501013259,al,o
285,0211-699501013259,inicio,o
285,0211-699501013259,337,o
285,0211-699501013259,IC,o
285,0211-699501013259,327,o
285,0211-699501013259,346,o
285,0211-699501013259,vs,o
285,0211-699501013259,350,o
285,0211-699501013259,IC,o
285,0211-699501013259,337,o
285,0211-699501013259,363,o
285,0211-699501013259,p,o
285,0211-699501013259,005,o
285,0211-699501013259,Conclusion,o
285,0211-699501013259,Tras,o
285,0211-699501013259,suplementacion,i
285,0211-699501013259,con,o
285,0211-699501013259,acido,i
285,0211-699501013259,folico,i
285,0211-699501013259,y,o
285,0211-699501013259,vitamina,i
285,0211-699501013259,B6,i
285,0211-699501013259,aunque,o
285,0211-699501013259,inicialmente,o
285,0211-699501013259,se,o
285,0211-699501013259,reduce,o
285,0211-699501013259,la,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,esta,o
285,0211-699501013259,respuesta,o
285,0211-699501013259,se,o
285,0211-699501013259,hace,o
285,0211-699501013259,refractaria,o
285,0211-699501013259,correlacionandose,o
285,0211-699501013259,directamente,o
285,0211-699501013259,la,o
285,0211-699501013259,tHcy,i
285,0211-699501013259,con,o
285,0211-699501013259,la,o
285,0211-699501013259,albumina,i
285,0211-699501013259,plasmatica,i
285,0211-699501013259,La,o
285,0211-699501013259,interpretacion,o
285,0211-699501013259,de,o
285,0211-699501013259,los,o
285,0211-699501013259,niveles,i
285,0211-699501013259,de,i
285,0211-699501013259,tHcy,i
285,0211-699501013259,debe,o
285,0211-699501013259,tener,o
285,0211-699501013259,en,o
285,0211-699501013259,cuenta,o
285,0211-699501013259,la,o
285,0211-699501013259,concentracion,i
285,0211-699501013259,de,i
285,0211-699501013259,albumina,i
286,0211-699501013259,Efecto,o
286,0211-699501013259,de,o
286,0211-699501013259,la,o
286,0211-699501013259,suplementacion,i
286,0211-699501013259,con,o
286,0211-699501013259,acido,i
286,0211-699501013259,folico,i
286,0211-699501013259,sobre,o
286,0211-699501013259,los,o
286,0211-699501013259,niveles,i
286,0211-699501013259,de,i
286,0211-699501013259,homocisteina,i
286,0211-699501013259,total,o
286,0211-699501013259,en,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,en,o
286,0211-699501013259,hemodialisis,i
286,0211-699501013259,La,o
286,0211-699501013259,hiperhomocisteinemia,i
286,0211-699501013259,es,o
286,0211-699501013259,un,o
286,0211-699501013259,marcador,o
286,0211-699501013259,de,o
286,0211-699501013259,riesgo,o
286,0211-699501013259,independiente,o
286,0211-699501013259,de,o
286,0211-699501013259,morbimortalidad,o
286,0211-699501013259,cardiovascular,i
286,0211-699501013259,Hemos,o
286,0211-699501013259,intentado,o
286,0211-699501013259,prospectivamente,o
286,0211-699501013259,reducir,o
286,0211-699501013259,los,o
286,0211-699501013259,niveles,i
286,0211-699501013259,de,i
286,0211-699501013259,homocisteina,i
286,0211-699501013259,total,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,mediante,o
286,0211-699501013259,suplemento,o
286,0211-699501013259,con,o
286,0211-699501013259,acido,i
286,0211-699501013259,folico,i
286,0211-699501013259,y,o
286,0211-699501013259,vitamina,i
286,0211-699501013259,B6,i
286,0211-699501013259,pp,i
286,0211-699501013259,valorando,o
286,0211-699501013259,su,o
286,0211-699501013259,posible,o
286,0211-699501013259,correlacion,o
286,0211-699501013259,con,o
286,0211-699501013259,dosis,o
286,0211-699501013259,de,o
286,0211-699501013259,dialisis,i
286,0211-699501013259,funcion,i
286,0211-699501013259,residual,i
286,0211-699501013259,y,o
286,0211-699501013259,parametros,o
286,0211-699501013259,nutricionales,o
286,0211-699501013259,Metodos,o
286,0211-699501013259,Todos,o
286,0211-699501013259,los,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,en,o
286,0211-699501013259,hemodialisis,i
286,0211-699501013259,al,o
286,0211-699501013259,comienzo,o
286,0211-699501013259,del,o
286,0211-699501013259,estudio,o
286,0211-699501013259,que,o
286,0211-699501013259,no,o
286,0211-699501013259,recibian,o
286,0211-699501013259,acido,i
286,0211-699501013259,folico,i
286,0211-699501013259,ni,o
286,0211-699501013259,vitamina,i
286,0211-699501013259,B6,i
286,0211-699501013259,asi,o
286,0211-699501013259,como,o
286,0211-699501013259,los,o
286,0211-699501013259,incorporados,o
286,0211-699501013259,posteriormente,o
286,0211-699501013259,a,o
286,0211-699501013259,partir,o
286,0211-699501013259,de,o
286,0211-699501013259,su,o
286,0211-699501013259,tercer,o
286,0211-699501013259,mes,o
286,0211-699501013259,en,o
286,0211-699501013259,hemodialisis,i
286,0211-699501013259,recibieron,o
286,0211-699501013259,5,o
286,0211-699501013259,mg,o
286,0211-699501013259,orales,o
286,0211-699501013259,de,o
286,0211-699501013259,acido,i
286,0211-699501013259,folico,i
286,0211-699501013259,cada,o
286,0211-699501013259,48,o
286,0211-699501013259,horas,o
286,0211-699501013259,y,o
286,0211-699501013259,40,o
286,0211-699501013259,mg,o
286,0211-699501013259,orales,o
286,0211-699501013259,de,o
286,0211-699501013259,vitamina,i
286,0211-699501013259,B6,i
286,0211-699501013259,cada,o
286,0211-699501013259,semana,o
286,0211-699501013259,Se,o
286,0211-699501013259,determinaron,o
286,0211-699501013259,al,o
286,0211-699501013259,comienzo,o
286,0211-699501013259,del,o
286,0211-699501013259,estudio,o
286,0211-699501013259,y,o
286,0211-699501013259,cada,o
286,0211-699501013259,2,o
286,0211-699501013259,meses,o
286,0211-699501013259,niveles,i
286,0211-699501013259,de,i
286,0211-699501013259,folato,i
286,0211-699501013259,vitamina,i
286,0211-699501013259,B12,i
286,0211-699501013259,inmunoensayo,i
286,0211-699501013259,albumina,i
286,0211-699501013259,y,o
286,0211-699501013259,cinetica,o
286,0211-699501013259,de,o
286,0211-699501013259,la,o
286,0211-699501013259,urea,i
286,0211-699501013259,KTV,o
286,0211-699501013259,KRU,o
286,0211-699501013259,PCRn,o
286,0211-699501013259,y,o
286,0211-699501013259,cada,o
286,0211-699501013259,6,o
286,0211-699501013259,meses,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,HPLC,i
286,0211-699501013259,y,o
286,0211-699501013259,pp,i
286,0211-699501013259,RIA,i
286,0211-699501013259,Resultados,o
286,0211-699501013259,80,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,fueron,o
286,0211-699501013259,incluidos,o
286,0211-699501013259,en,o
286,0211-699501013259,el,o
286,0211-699501013259,estudio,o
286,0211-699501013259,basal,o
286,0211-699501013259,con,o
286,0211-699501013259,una,o
286,0211-699501013259,prevalencia,o
286,0211-699501013259,de,o
286,0211-699501013259,hiperhomocisteinemia,i
286,0211-699501013259,del,o
286,0211-699501013259,844,o
286,0211-699501013259,deficit,i
286,0211-699501013259,de,i
286,0211-699501013259,pp,i
286,0211-699501013259,en,o
286,0211-699501013259,el,o
286,0211-699501013259,32,o
286,0211-699501013259,y,o
286,0211-699501013259,folato,i
286,0211-699501013259,en,o
286,0211-699501013259,el,o
286,0211-699501013259,rango,o
286,0211-699501013259,normal,o
286,0211-699501013259,bajo,o
286,0211-699501013259,los,o
286,0211-699501013259,niveles,i
286,0211-699501013259,de,i
286,0211-699501013259,tHcy,i
286,0211-699501013259,se,o
286,0211-699501013259,correlacionaban,o
286,0211-699501013259,inversamente,o
286,0211-699501013259,con,o
286,0211-699501013259,los,o
286,0211-699501013259,del,o
286,0211-699501013259,folato,i
286,0211-699501013259,r,o
286,0211-699501013259,0336,o
286,0211-699501013259,p,o
286,0211-699501013259,001,o
286,0211-699501013259,pero,o
286,0211-699501013259,no,o
286,0211-699501013259,con,o
286,0211-699501013259,pp,i
286,0211-699501013259,B12,i
286,0211-699501013259,edad,o
286,0211-699501013259,albumina,i
286,0211-699501013259,KTV,o
286,0211-699501013259,KRU,o
286,0211-699501013259,PCRn,o
286,0211-699501013259,Cincuenta,o
286,0211-699501013259,y,o
286,0211-699501013259,ocho,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,recibieron,o
286,0211-699501013259,seis,o
286,0211-699501013259,meses,o
286,0211-699501013259,de,o
286,0211-699501013259,suplementacion,i
286,0211-699501013259,con,o
286,0211-699501013259,normalizacion,o
286,0211-699501013259,del,o
286,0211-699501013259,pp,i
286,0211-699501013259,aumento,o
286,0211-699501013259,del,o
286,0211-699501013259,folato,i
286,0211-699501013259,703,o
286,0211-699501013259,IC,o
286,0211-699501013259,638,o
286,0211-699501013259,795,o
286,0211-699501013259,vs,o
286,0211-699501013259,6181,o
286,0211-699501013259,IC,o
286,0211-699501013259,4447,o
286,0211-699501013259,7811,o
286,0211-699501013259,p,o
286,0211-699501013259,0001,o
286,0211-699501013259,y,o
286,0211-699501013259,descenso,o
286,0211-699501013259,de,o
286,0211-699501013259,la,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,240,o
286,0211-699501013259,IC,o
286,0211-699501013259,213,o
286,0211-699501013259,264,o
286,0211-699501013259,vs,o
286,0211-699501013259,199,o
286,0211-699501013259,IC,o
286,0211-699501013259,175,o
286,0211-699501013259,224,o
286,0211-699501013259,p,o
286,0211-699501013259,005,o
286,0211-699501013259,Han,o
286,0211-699501013259,recibido,o
286,0211-699501013259,suplementacion,i
286,0211-699501013259,durante,o
286,0211-699501013259,12,o
286,0211-699501013259,meses,o
286,0211-699501013259,33,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,pero,o
286,0211-699501013259,a,o
286,0211-699501013259,pesar,o
286,0211-699501013259,de,o
286,0211-699501013259,un,o
286,0211-699501013259,continuo,o
286,0211-699501013259,aumento,o
286,0211-699501013259,del,o
286,0211-699501013259,folato,i
286,0211-699501013259,10078,o
286,0211-699501013259,IC,o
286,0211-699501013259,7481,o
286,0211-699501013259,12674,o
286,0211-699501013259,p,o
286,0211-699501013259,0001,o
286,0211-699501013259,solo,o
286,0211-699501013259,3,o
286,0211-699501013259,pacientes,o
286,0211-699501013259,presentan,o
286,0211-699501013259,niveles,o
286,0211-699501013259,normales,o
286,0211-699501013259,de,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,correlacionandose,o
286,0211-699501013259,directamente,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,con,o
286,0211-699501013259,la,o
286,0211-699501013259,albumina,i
286,0211-699501013259,r,o
286,0211-699501013259,056,o
286,0211-699501013259,p,o
286,0211-699501013259,0001,o
286,0211-699501013259,que,o
286,0211-699501013259,se,o
286,0211-699501013259,elevo,o
286,0211-699501013259,con,o
286,0211-699501013259,respecto,o
286,0211-699501013259,al,o
286,0211-699501013259,inicio,o
286,0211-699501013259,337,o
286,0211-699501013259,IC,o
286,0211-699501013259,327,o
286,0211-699501013259,346,o
286,0211-699501013259,vs,o
286,0211-699501013259,350,o
286,0211-699501013259,IC,o
286,0211-699501013259,337,o
286,0211-699501013259,363,o
286,0211-699501013259,p,o
286,0211-699501013259,005,o
286,0211-699501013259,Conclusion,o
286,0211-699501013259,Tras,o
286,0211-699501013259,suplementacion,i
286,0211-699501013259,con,o
286,0211-699501013259,acido,i
286,0211-699501013259,folico,i
286,0211-699501013259,y,o
286,0211-699501013259,vitamina,i
286,0211-699501013259,B6,i
286,0211-699501013259,aunque,o
286,0211-699501013259,inicialmente,o
286,0211-699501013259,se,o
286,0211-699501013259,reduce,o
286,0211-699501013259,la,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,esta,o
286,0211-699501013259,respuesta,o
286,0211-699501013259,se,o
286,0211-699501013259,hace,o
286,0211-699501013259,refractaria,o
286,0211-699501013259,correlacionandose,o
286,0211-699501013259,directamente,o
286,0211-699501013259,la,o
286,0211-699501013259,tHcy,i
286,0211-699501013259,con,o
286,0211-699501013259,la,o
286,0211-699501013259,albumina,i
286,0211-699501013259,plasmatica,i
286,0211-699501013259,La,o
286,0211-699501013259,interpretacion,o
286,0211-699501013259,de,o
286,0211-699501013259,los,o
286,0211-699501013259,niveles,i
286,0211-699501013259,de,i
286,0211-699501013259,tHcy,i
286,0211-699501013259,debe,o
286,0211-699501013259,tener,o
286,0211-699501013259,en,o
286,0211-699501013259,cuenta,o
286,0211-699501013259,la,o
286,0211-699501013259,concentracion,i
286,0211-699501013259,de,i
286,0211-699501013259,albumina,i
287,0211-699501013259,Efecto,o
287,0211-699501013259,de,o
287,0211-699501013259,la,o
287,0211-699501013259,suplementacion,i
287,0211-699501013259,con,o
287,0211-699501013259,acido,i
287,0211-699501013259,folico,i
287,0211-699501013259,sobre,o
287,0211-699501013259,los,o
287,0211-699501013259,niveles,i
287,0211-699501013259,de,i
287,0211-699501013259,homocisteina,i
287,0211-699501013259,total,o
287,0211-699501013259,en,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,en,o
287,0211-699501013259,hemodialisis,i
287,0211-699501013259,La,o
287,0211-699501013259,hiperhomocisteinemia,i
287,0211-699501013259,es,o
287,0211-699501013259,un,o
287,0211-699501013259,marcador,o
287,0211-699501013259,de,o
287,0211-699501013259,riesgo,o
287,0211-699501013259,independiente,o
287,0211-699501013259,de,o
287,0211-699501013259,morbimortalidad,o
287,0211-699501013259,cardiovascular,i
287,0211-699501013259,Hemos,o
287,0211-699501013259,intentado,o
287,0211-699501013259,prospectivamente,o
287,0211-699501013259,reducir,o
287,0211-699501013259,los,o
287,0211-699501013259,niveles,i
287,0211-699501013259,de,i
287,0211-699501013259,homocisteina,i
287,0211-699501013259,total,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,mediante,o
287,0211-699501013259,suplemento,o
287,0211-699501013259,con,o
287,0211-699501013259,acido,i
287,0211-699501013259,folico,i
287,0211-699501013259,y,o
287,0211-699501013259,vitamina,i
287,0211-699501013259,B6,i
287,0211-699501013259,pp,i
287,0211-699501013259,valorando,o
287,0211-699501013259,su,o
287,0211-699501013259,posible,o
287,0211-699501013259,correlacion,o
287,0211-699501013259,con,o
287,0211-699501013259,dosis,o
287,0211-699501013259,de,o
287,0211-699501013259,dialisis,i
287,0211-699501013259,funcion,i
287,0211-699501013259,residual,i
287,0211-699501013259,y,o
287,0211-699501013259,parametros,o
287,0211-699501013259,nutricionales,o
287,0211-699501013259,Metodos,o
287,0211-699501013259,Todos,o
287,0211-699501013259,los,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,en,o
287,0211-699501013259,hemodialisis,i
287,0211-699501013259,al,o
287,0211-699501013259,comienzo,o
287,0211-699501013259,del,o
287,0211-699501013259,estudio,o
287,0211-699501013259,que,o
287,0211-699501013259,no,o
287,0211-699501013259,recibian,o
287,0211-699501013259,acido,i
287,0211-699501013259,folico,i
287,0211-699501013259,ni,o
287,0211-699501013259,vitamina,i
287,0211-699501013259,B6,i
287,0211-699501013259,asi,o
287,0211-699501013259,como,o
287,0211-699501013259,los,o
287,0211-699501013259,incorporados,o
287,0211-699501013259,posteriormente,o
287,0211-699501013259,a,o
287,0211-699501013259,partir,o
287,0211-699501013259,de,o
287,0211-699501013259,su,o
287,0211-699501013259,tercer,o
287,0211-699501013259,mes,o
287,0211-699501013259,en,o
287,0211-699501013259,hemodialisis,i
287,0211-699501013259,recibieron,o
287,0211-699501013259,5,o
287,0211-699501013259,mg,o
287,0211-699501013259,orales,o
287,0211-699501013259,de,o
287,0211-699501013259,acido,i
287,0211-699501013259,folico,i
287,0211-699501013259,cada,o
287,0211-699501013259,48,o
287,0211-699501013259,horas,o
287,0211-699501013259,y,o
287,0211-699501013259,40,o
287,0211-699501013259,mg,o
287,0211-699501013259,orales,o
287,0211-699501013259,de,o
287,0211-699501013259,vitamina,i
287,0211-699501013259,B6,i
287,0211-699501013259,cada,o
287,0211-699501013259,semana,o
287,0211-699501013259,Se,o
287,0211-699501013259,determinaron,o
287,0211-699501013259,al,o
287,0211-699501013259,comienzo,o
287,0211-699501013259,del,o
287,0211-699501013259,estudio,o
287,0211-699501013259,y,o
287,0211-699501013259,cada,o
287,0211-699501013259,2,o
287,0211-699501013259,meses,o
287,0211-699501013259,niveles,i
287,0211-699501013259,de,i
287,0211-699501013259,folato,i
287,0211-699501013259,vitamina,i
287,0211-699501013259,B12,i
287,0211-699501013259,inmunoensayo,i
287,0211-699501013259,albumina,i
287,0211-699501013259,y,o
287,0211-699501013259,cinetica,o
287,0211-699501013259,de,o
287,0211-699501013259,la,o
287,0211-699501013259,urea,i
287,0211-699501013259,KTV,o
287,0211-699501013259,KRU,o
287,0211-699501013259,PCRn,o
287,0211-699501013259,y,o
287,0211-699501013259,cada,o
287,0211-699501013259,6,o
287,0211-699501013259,meses,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,HPLC,i
287,0211-699501013259,y,o
287,0211-699501013259,pp,i
287,0211-699501013259,RIA,i
287,0211-699501013259,Resultados,o
287,0211-699501013259,80,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,fueron,o
287,0211-699501013259,incluidos,o
287,0211-699501013259,en,o
287,0211-699501013259,el,o
287,0211-699501013259,estudio,o
287,0211-699501013259,basal,o
287,0211-699501013259,con,o
287,0211-699501013259,una,o
287,0211-699501013259,prevalencia,o
287,0211-699501013259,de,o
287,0211-699501013259,hiperhomocisteinemia,i
287,0211-699501013259,del,o
287,0211-699501013259,844,o
287,0211-699501013259,deficit,i
287,0211-699501013259,de,i
287,0211-699501013259,pp,i
287,0211-699501013259,en,o
287,0211-699501013259,el,o
287,0211-699501013259,32,o
287,0211-699501013259,y,o
287,0211-699501013259,folato,i
287,0211-699501013259,en,o
287,0211-699501013259,el,o
287,0211-699501013259,rango,o
287,0211-699501013259,normal,o
287,0211-699501013259,bajo,o
287,0211-699501013259,los,o
287,0211-699501013259,niveles,i
287,0211-699501013259,de,i
287,0211-699501013259,tHcy,i
287,0211-699501013259,se,o
287,0211-699501013259,correlacionaban,o
287,0211-699501013259,inversamente,o
287,0211-699501013259,con,o
287,0211-699501013259,los,o
287,0211-699501013259,del,o
287,0211-699501013259,folato,i
287,0211-699501013259,r,o
287,0211-699501013259,0336,o
287,0211-699501013259,p,o
287,0211-699501013259,001,o
287,0211-699501013259,pero,o
287,0211-699501013259,no,o
287,0211-699501013259,con,o
287,0211-699501013259,pp,i
287,0211-699501013259,B12,i
287,0211-699501013259,edad,o
287,0211-699501013259,albumina,i
287,0211-699501013259,KTV,o
287,0211-699501013259,KRU,o
287,0211-699501013259,PCRn,o
287,0211-699501013259,Cincuenta,o
287,0211-699501013259,y,o
287,0211-699501013259,ocho,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,recibieron,o
287,0211-699501013259,seis,o
287,0211-699501013259,meses,o
287,0211-699501013259,de,o
287,0211-699501013259,suplementacion,i
287,0211-699501013259,con,o
287,0211-699501013259,normalizacion,o
287,0211-699501013259,del,o
287,0211-699501013259,pp,i
287,0211-699501013259,aumento,o
287,0211-699501013259,del,o
287,0211-699501013259,folato,i
287,0211-699501013259,703,o
287,0211-699501013259,IC,o
287,0211-699501013259,638,o
287,0211-699501013259,795,o
287,0211-699501013259,vs,o
287,0211-699501013259,6181,o
287,0211-699501013259,IC,o
287,0211-699501013259,4447,o
287,0211-699501013259,7811,o
287,0211-699501013259,p,o
287,0211-699501013259,0001,o
287,0211-699501013259,y,o
287,0211-699501013259,descenso,o
287,0211-699501013259,de,o
287,0211-699501013259,la,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,240,o
287,0211-699501013259,IC,o
287,0211-699501013259,213,o
287,0211-699501013259,264,o
287,0211-699501013259,vs,o
287,0211-699501013259,199,o
287,0211-699501013259,IC,o
287,0211-699501013259,175,o
287,0211-699501013259,224,o
287,0211-699501013259,p,o
287,0211-699501013259,005,o
287,0211-699501013259,Han,o
287,0211-699501013259,recibido,o
287,0211-699501013259,suplementacion,i
287,0211-699501013259,durante,o
287,0211-699501013259,12,o
287,0211-699501013259,meses,o
287,0211-699501013259,33,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,pero,o
287,0211-699501013259,a,o
287,0211-699501013259,pesar,o
287,0211-699501013259,de,o
287,0211-699501013259,un,o
287,0211-699501013259,continuo,o
287,0211-699501013259,aumento,o
287,0211-699501013259,del,o
287,0211-699501013259,folato,i
287,0211-699501013259,10078,o
287,0211-699501013259,IC,o
287,0211-699501013259,7481,o
287,0211-699501013259,12674,o
287,0211-699501013259,p,o
287,0211-699501013259,0001,o
287,0211-699501013259,solo,o
287,0211-699501013259,3,o
287,0211-699501013259,pacientes,o
287,0211-699501013259,presentan,o
287,0211-699501013259,niveles,o
287,0211-699501013259,normales,o
287,0211-699501013259,de,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,correlacionandose,o
287,0211-699501013259,directamente,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,con,o
287,0211-699501013259,la,o
287,0211-699501013259,albumina,i
287,0211-699501013259,r,o
287,0211-699501013259,056,o
287,0211-699501013259,p,o
287,0211-699501013259,0001,o
287,0211-699501013259,que,o
287,0211-699501013259,se,o
287,0211-699501013259,elevo,o
287,0211-699501013259,con,o
287,0211-699501013259,respecto,o
287,0211-699501013259,al,o
287,0211-699501013259,inicio,o
287,0211-699501013259,337,o
287,0211-699501013259,IC,o
287,0211-699501013259,327,o
287,0211-699501013259,346,o
287,0211-699501013259,vs,o
287,0211-699501013259,350,o
287,0211-699501013259,IC,o
287,0211-699501013259,337,o
287,0211-699501013259,363,o
287,0211-699501013259,p,o
287,0211-699501013259,005,o
287,0211-699501013259,Conclusion,o
287,0211-699501013259,Tras,o
287,0211-699501013259,suplementacion,i
287,0211-699501013259,con,o
287,0211-699501013259,acido,i
287,0211-699501013259,folico,i
287,0211-699501013259,y,o
287,0211-699501013259,vitamina,i
287,0211-699501013259,B6,i
287,0211-699501013259,aunque,o
287,0211-699501013259,inicialmente,o
287,0211-699501013259,se,o
287,0211-699501013259,reduce,o
287,0211-699501013259,la,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,esta,o
287,0211-699501013259,respuesta,o
287,0211-699501013259,se,o
287,0211-699501013259,hace,o
287,0211-699501013259,refractaria,o
287,0211-699501013259,correlacionandose,o
287,0211-699501013259,directamente,o
287,0211-699501013259,la,o
287,0211-699501013259,tHcy,i
287,0211-699501013259,con,o
287,0211-699501013259,la,o
287,0211-699501013259,albumina,i
287,0211-699501013259,plasmatica,i
287,0211-699501013259,La,o
287,0211-699501013259,interpretacion,o
287,0211-699501013259,de,o
287,0211-699501013259,los,o
287,0211-699501013259,niveles,i
287,0211-699501013259,de,i
287,0211-699501013259,tHcy,i
287,0211-699501013259,debe,o
287,0211-699501013259,tener,o
287,0211-699501013259,en,o
287,0211-699501013259,cuenta,o
287,0211-699501013259,la,o
287,0211-699501013259,concentracion,i
287,0211-699501013259,de,i
287,0211-699501013259,albumina,i
288,0211-699501013259,Efecto,o
288,0211-699501013259,de,o
288,0211-699501013259,la,o
288,0211-699501013259,suplementacion,i
288,0211-699501013259,con,o
288,0211-699501013259,acido,i
288,0211-699501013259,folico,i
288,0211-699501013259,sobre,o
288,0211-699501013259,los,o
288,0211-699501013259,niveles,i
288,0211-699501013259,de,i
288,0211-699501013259,homocisteina,i
288,0211-699501013259,total,o
288,0211-699501013259,en,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,en,o
288,0211-699501013259,hemodialisis,i
288,0211-699501013259,La,o
288,0211-699501013259,hiperhomocisteinemia,i
288,0211-699501013259,es,o
288,0211-699501013259,un,o
288,0211-699501013259,marcador,o
288,0211-699501013259,de,o
288,0211-699501013259,riesgo,o
288,0211-699501013259,independiente,o
288,0211-699501013259,de,o
288,0211-699501013259,morbimortalidad,o
288,0211-699501013259,cardiovascular,i
288,0211-699501013259,Hemos,o
288,0211-699501013259,intentado,o
288,0211-699501013259,prospectivamente,o
288,0211-699501013259,reducir,o
288,0211-699501013259,los,o
288,0211-699501013259,niveles,i
288,0211-699501013259,de,i
288,0211-699501013259,homocisteina,i
288,0211-699501013259,total,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,mediante,o
288,0211-699501013259,suplemento,o
288,0211-699501013259,con,o
288,0211-699501013259,acido,i
288,0211-699501013259,folico,i
288,0211-699501013259,y,o
288,0211-699501013259,vitamina,i
288,0211-699501013259,B6,i
288,0211-699501013259,pp,i
288,0211-699501013259,valorando,o
288,0211-699501013259,su,o
288,0211-699501013259,posible,o
288,0211-699501013259,correlacion,o
288,0211-699501013259,con,o
288,0211-699501013259,dosis,o
288,0211-699501013259,de,o
288,0211-699501013259,dialisis,i
288,0211-699501013259,funcion,i
288,0211-699501013259,residual,i
288,0211-699501013259,y,o
288,0211-699501013259,parametros,o
288,0211-699501013259,nutricionales,o
288,0211-699501013259,Metodos,o
288,0211-699501013259,Todos,o
288,0211-699501013259,los,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,en,o
288,0211-699501013259,hemodialisis,i
288,0211-699501013259,al,o
288,0211-699501013259,comienzo,o
288,0211-699501013259,del,o
288,0211-699501013259,estudio,o
288,0211-699501013259,que,o
288,0211-699501013259,no,o
288,0211-699501013259,recibian,o
288,0211-699501013259,acido,i
288,0211-699501013259,folico,i
288,0211-699501013259,ni,o
288,0211-699501013259,vitamina,i
288,0211-699501013259,B6,i
288,0211-699501013259,asi,o
288,0211-699501013259,como,o
288,0211-699501013259,los,o
288,0211-699501013259,incorporados,o
288,0211-699501013259,posteriormente,o
288,0211-699501013259,a,o
288,0211-699501013259,partir,o
288,0211-699501013259,de,o
288,0211-699501013259,su,o
288,0211-699501013259,tercer,o
288,0211-699501013259,mes,o
288,0211-699501013259,en,o
288,0211-699501013259,hemodialisis,i
288,0211-699501013259,recibieron,o
288,0211-699501013259,5,o
288,0211-699501013259,mg,o
288,0211-699501013259,orales,o
288,0211-699501013259,de,o
288,0211-699501013259,acido,i
288,0211-699501013259,folico,i
288,0211-699501013259,cada,o
288,0211-699501013259,48,o
288,0211-699501013259,horas,o
288,0211-699501013259,y,o
288,0211-699501013259,40,o
288,0211-699501013259,mg,o
288,0211-699501013259,orales,o
288,0211-699501013259,de,o
288,0211-699501013259,vitamina,i
288,0211-699501013259,B6,i
288,0211-699501013259,cada,o
288,0211-699501013259,semana,o
288,0211-699501013259,Se,o
288,0211-699501013259,determinaron,o
288,0211-699501013259,al,o
288,0211-699501013259,comienzo,o
288,0211-699501013259,del,o
288,0211-699501013259,estudio,o
288,0211-699501013259,y,o
288,0211-699501013259,cada,o
288,0211-699501013259,2,o
288,0211-699501013259,meses,o
288,0211-699501013259,niveles,i
288,0211-699501013259,de,i
288,0211-699501013259,folato,i
288,0211-699501013259,vitamina,i
288,0211-699501013259,B12,i
288,0211-699501013259,inmunoensayo,i
288,0211-699501013259,albumina,i
288,0211-699501013259,y,o
288,0211-699501013259,cinetica,o
288,0211-699501013259,de,o
288,0211-699501013259,la,o
288,0211-699501013259,urea,i
288,0211-699501013259,KTV,o
288,0211-699501013259,KRU,o
288,0211-699501013259,PCRn,o
288,0211-699501013259,y,o
288,0211-699501013259,cada,o
288,0211-699501013259,6,o
288,0211-699501013259,meses,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,HPLC,i
288,0211-699501013259,y,o
288,0211-699501013259,pp,i
288,0211-699501013259,RIA,i
288,0211-699501013259,Resultados,o
288,0211-699501013259,80,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,fueron,o
288,0211-699501013259,incluidos,o
288,0211-699501013259,en,o
288,0211-699501013259,el,o
288,0211-699501013259,estudio,o
288,0211-699501013259,basal,o
288,0211-699501013259,con,o
288,0211-699501013259,una,o
288,0211-699501013259,prevalencia,o
288,0211-699501013259,de,o
288,0211-699501013259,hiperhomocisteinemia,i
288,0211-699501013259,del,o
288,0211-699501013259,844,o
288,0211-699501013259,deficit,i
288,0211-699501013259,de,i
288,0211-699501013259,pp,i
288,0211-699501013259,en,o
288,0211-699501013259,el,o
288,0211-699501013259,32,o
288,0211-699501013259,y,o
288,0211-699501013259,folato,i
288,0211-699501013259,en,o
288,0211-699501013259,el,o
288,0211-699501013259,rango,o
288,0211-699501013259,normal,o
288,0211-699501013259,bajo,o
288,0211-699501013259,los,o
288,0211-699501013259,niveles,i
288,0211-699501013259,de,i
288,0211-699501013259,tHcy,i
288,0211-699501013259,se,o
288,0211-699501013259,correlacionaban,o
288,0211-699501013259,inversamente,o
288,0211-699501013259,con,o
288,0211-699501013259,los,o
288,0211-699501013259,del,o
288,0211-699501013259,folato,i
288,0211-699501013259,r,o
288,0211-699501013259,0336,o
288,0211-699501013259,p,o
288,0211-699501013259,001,o
288,0211-699501013259,pero,o
288,0211-699501013259,no,o
288,0211-699501013259,con,o
288,0211-699501013259,pp,i
288,0211-699501013259,B12,i
288,0211-699501013259,edad,o
288,0211-699501013259,albumina,i
288,0211-699501013259,KTV,o
288,0211-699501013259,KRU,o
288,0211-699501013259,PCRn,o
288,0211-699501013259,Cincuenta,o
288,0211-699501013259,y,o
288,0211-699501013259,ocho,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,recibieron,o
288,0211-699501013259,seis,o
288,0211-699501013259,meses,o
288,0211-699501013259,de,o
288,0211-699501013259,suplementacion,i
288,0211-699501013259,con,o
288,0211-699501013259,normalizacion,o
288,0211-699501013259,del,o
288,0211-699501013259,pp,i
288,0211-699501013259,aumento,o
288,0211-699501013259,del,o
288,0211-699501013259,folato,i
288,0211-699501013259,703,o
288,0211-699501013259,IC,o
288,0211-699501013259,638,o
288,0211-699501013259,795,o
288,0211-699501013259,vs,o
288,0211-699501013259,6181,o
288,0211-699501013259,IC,o
288,0211-699501013259,4447,o
288,0211-699501013259,7811,o
288,0211-699501013259,p,o
288,0211-699501013259,0001,o
288,0211-699501013259,y,o
288,0211-699501013259,descenso,o
288,0211-699501013259,de,o
288,0211-699501013259,la,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,240,o
288,0211-699501013259,IC,o
288,0211-699501013259,213,o
288,0211-699501013259,264,o
288,0211-699501013259,vs,o
288,0211-699501013259,199,o
288,0211-699501013259,IC,o
288,0211-699501013259,175,o
288,0211-699501013259,224,o
288,0211-699501013259,p,o
288,0211-699501013259,005,o
288,0211-699501013259,Han,o
288,0211-699501013259,recibido,o
288,0211-699501013259,suplementacion,i
288,0211-699501013259,durante,o
288,0211-699501013259,12,o
288,0211-699501013259,meses,o
288,0211-699501013259,33,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,pero,o
288,0211-699501013259,a,o
288,0211-699501013259,pesar,o
288,0211-699501013259,de,o
288,0211-699501013259,un,o
288,0211-699501013259,continuo,o
288,0211-699501013259,aumento,o
288,0211-699501013259,del,o
288,0211-699501013259,folato,i
288,0211-699501013259,10078,o
288,0211-699501013259,IC,o
288,0211-699501013259,7481,o
288,0211-699501013259,12674,o
288,0211-699501013259,p,o
288,0211-699501013259,0001,o
288,0211-699501013259,solo,o
288,0211-699501013259,3,o
288,0211-699501013259,pacientes,o
288,0211-699501013259,presentan,o
288,0211-699501013259,niveles,o
288,0211-699501013259,normales,o
288,0211-699501013259,de,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,correlacionandose,o
288,0211-699501013259,directamente,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,con,o
288,0211-699501013259,la,o
288,0211-699501013259,albumina,i
288,0211-699501013259,r,o
288,0211-699501013259,056,o
288,0211-699501013259,p,o
288,0211-699501013259,0001,o
288,0211-699501013259,que,o
288,0211-699501013259,se,o
288,0211-699501013259,elevo,o
288,0211-699501013259,con,o
288,0211-699501013259,respecto,o
288,0211-699501013259,al,o
288,0211-699501013259,inicio,o
288,0211-699501013259,337,o
288,0211-699501013259,IC,o
288,0211-699501013259,327,o
288,0211-699501013259,346,o
288,0211-699501013259,vs,o
288,0211-699501013259,350,o
288,0211-699501013259,IC,o
288,0211-699501013259,337,o
288,0211-699501013259,363,o
288,0211-699501013259,p,o
288,0211-699501013259,005,o
288,0211-699501013259,Conclusion,o
288,0211-699501013259,Tras,o
288,0211-699501013259,suplementacion,i
288,0211-699501013259,con,o
288,0211-699501013259,acido,i
288,0211-699501013259,folico,i
288,0211-699501013259,y,o
288,0211-699501013259,vitamina,i
288,0211-699501013259,B6,i
288,0211-699501013259,aunque,o
288,0211-699501013259,inicialmente,o
288,0211-699501013259,se,o
288,0211-699501013259,reduce,o
288,0211-699501013259,la,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,esta,o
288,0211-699501013259,respuesta,o
288,0211-699501013259,se,o
288,0211-699501013259,hace,o
288,0211-699501013259,refractaria,o
288,0211-699501013259,correlacionandose,o
288,0211-699501013259,directamente,o
288,0211-699501013259,la,o
288,0211-699501013259,tHcy,i
288,0211-699501013259,con,o
288,0211-699501013259,la,o
288,0211-699501013259,albumina,i
288,0211-699501013259,plasmatica,i
288,0211-699501013259,La,o
288,0211-699501013259,interpretacion,o
288,0211-699501013259,de,o
288,0211-699501013259,los,o
288,0211-699501013259,niveles,i
288,0211-699501013259,de,i
288,0211-699501013259,tHcy,i
288,0211-699501013259,debe,o
288,0211-699501013259,tener,o
288,0211-699501013259,en,o
288,0211-699501013259,cuenta,o
288,0211-699501013259,la,o
288,0211-699501013259,concentracion,i
288,0211-699501013259,de,i
288,0211-699501013259,albumina,i
289,0211-699501013259,Efecto,o
289,0211-699501013259,de,o
289,0211-699501013259,la,o
289,0211-699501013259,suplementacion,i
289,0211-699501013259,con,o
289,0211-699501013259,acido,i
289,0211-699501013259,folico,i
289,0211-699501013259,sobre,o
289,0211-699501013259,los,o
289,0211-699501013259,niveles,i
289,0211-699501013259,de,i
289,0211-699501013259,homocisteina,i
289,0211-699501013259,total,o
289,0211-699501013259,en,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,en,o
289,0211-699501013259,hemodialisis,i
289,0211-699501013259,La,o
289,0211-699501013259,hiperhomocisteinemia,i
289,0211-699501013259,es,o
289,0211-699501013259,un,o
289,0211-699501013259,marcador,o
289,0211-699501013259,de,o
289,0211-699501013259,riesgo,o
289,0211-699501013259,independiente,o
289,0211-699501013259,de,o
289,0211-699501013259,morbimortalidad,o
289,0211-699501013259,cardiovascular,i
289,0211-699501013259,Hemos,o
289,0211-699501013259,intentado,o
289,0211-699501013259,prospectivamente,o
289,0211-699501013259,reducir,o
289,0211-699501013259,los,o
289,0211-699501013259,niveles,i
289,0211-699501013259,de,i
289,0211-699501013259,homocisteina,i
289,0211-699501013259,total,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,mediante,o
289,0211-699501013259,suplemento,o
289,0211-699501013259,con,o
289,0211-699501013259,acido,i
289,0211-699501013259,folico,i
289,0211-699501013259,y,o
289,0211-699501013259,vitamina,i
289,0211-699501013259,B6,i
289,0211-699501013259,pp,i
289,0211-699501013259,valorando,o
289,0211-699501013259,su,o
289,0211-699501013259,posible,o
289,0211-699501013259,correlacion,o
289,0211-699501013259,con,o
289,0211-699501013259,dosis,o
289,0211-699501013259,de,o
289,0211-699501013259,dialisis,i
289,0211-699501013259,funcion,i
289,0211-699501013259,residual,i
289,0211-699501013259,y,o
289,0211-699501013259,parametros,o
289,0211-699501013259,nutricionales,o
289,0211-699501013259,Metodos,o
289,0211-699501013259,Todos,o
289,0211-699501013259,los,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,en,o
289,0211-699501013259,hemodialisis,i
289,0211-699501013259,al,o
289,0211-699501013259,comienzo,o
289,0211-699501013259,del,o
289,0211-699501013259,estudio,o
289,0211-699501013259,que,o
289,0211-699501013259,no,o
289,0211-699501013259,recibian,o
289,0211-699501013259,acido,i
289,0211-699501013259,folico,i
289,0211-699501013259,ni,o
289,0211-699501013259,vitamina,i
289,0211-699501013259,B6,i
289,0211-699501013259,asi,o
289,0211-699501013259,como,o
289,0211-699501013259,los,o
289,0211-699501013259,incorporados,o
289,0211-699501013259,posteriormente,o
289,0211-699501013259,a,o
289,0211-699501013259,partir,o
289,0211-699501013259,de,o
289,0211-699501013259,su,o
289,0211-699501013259,tercer,o
289,0211-699501013259,mes,o
289,0211-699501013259,en,o
289,0211-699501013259,hemodialisis,i
289,0211-699501013259,recibieron,o
289,0211-699501013259,5,o
289,0211-699501013259,mg,o
289,0211-699501013259,orales,o
289,0211-699501013259,de,o
289,0211-699501013259,acido,i
289,0211-699501013259,folico,i
289,0211-699501013259,cada,o
289,0211-699501013259,48,o
289,0211-699501013259,horas,o
289,0211-699501013259,y,o
289,0211-699501013259,40,o
289,0211-699501013259,mg,o
289,0211-699501013259,orales,o
289,0211-699501013259,de,o
289,0211-699501013259,vitamina,i
289,0211-699501013259,B6,i
289,0211-699501013259,cada,o
289,0211-699501013259,semana,o
289,0211-699501013259,Se,o
289,0211-699501013259,determinaron,o
289,0211-699501013259,al,o
289,0211-699501013259,comienzo,o
289,0211-699501013259,del,o
289,0211-699501013259,estudio,o
289,0211-699501013259,y,o
289,0211-699501013259,cada,o
289,0211-699501013259,2,o
289,0211-699501013259,meses,o
289,0211-699501013259,niveles,i
289,0211-699501013259,de,i
289,0211-699501013259,folato,i
289,0211-699501013259,vitamina,i
289,0211-699501013259,B12,i
289,0211-699501013259,inmunoensayo,i
289,0211-699501013259,albumina,i
289,0211-699501013259,y,o
289,0211-699501013259,cinetica,o
289,0211-699501013259,de,o
289,0211-699501013259,la,o
289,0211-699501013259,urea,i
289,0211-699501013259,KTV,o
289,0211-699501013259,KRU,o
289,0211-699501013259,PCRn,o
289,0211-699501013259,y,o
289,0211-699501013259,cada,o
289,0211-699501013259,6,o
289,0211-699501013259,meses,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,HPLC,i
289,0211-699501013259,y,o
289,0211-699501013259,pp,i
289,0211-699501013259,RIA,i
289,0211-699501013259,Resultados,o
289,0211-699501013259,80,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,fueron,o
289,0211-699501013259,incluidos,o
289,0211-699501013259,en,o
289,0211-699501013259,el,o
289,0211-699501013259,estudio,o
289,0211-699501013259,basal,o
289,0211-699501013259,con,o
289,0211-699501013259,una,o
289,0211-699501013259,prevalencia,o
289,0211-699501013259,de,o
289,0211-699501013259,hiperhomocisteinemia,i
289,0211-699501013259,del,o
289,0211-699501013259,844,o
289,0211-699501013259,deficit,i
289,0211-699501013259,de,i
289,0211-699501013259,pp,i
289,0211-699501013259,en,o
289,0211-699501013259,el,o
289,0211-699501013259,32,o
289,0211-699501013259,y,o
289,0211-699501013259,folato,i
289,0211-699501013259,en,o
289,0211-699501013259,el,o
289,0211-699501013259,rango,o
289,0211-699501013259,normal,o
289,0211-699501013259,bajo,o
289,0211-699501013259,los,o
289,0211-699501013259,niveles,i
289,0211-699501013259,de,i
289,0211-699501013259,tHcy,i
289,0211-699501013259,se,o
289,0211-699501013259,correlacionaban,o
289,0211-699501013259,inversamente,o
289,0211-699501013259,con,o
289,0211-699501013259,los,o
289,0211-699501013259,del,o
289,0211-699501013259,folato,i
289,0211-699501013259,r,o
289,0211-699501013259,0336,o
289,0211-699501013259,p,o
289,0211-699501013259,001,o
289,0211-699501013259,pero,o
289,0211-699501013259,no,o
289,0211-699501013259,con,o
289,0211-699501013259,pp,i
289,0211-699501013259,B12,i
289,0211-699501013259,edad,o
289,0211-699501013259,albumina,i
289,0211-699501013259,KTV,o
289,0211-699501013259,KRU,o
289,0211-699501013259,PCRn,o
289,0211-699501013259,Cincuenta,o
289,0211-699501013259,y,o
289,0211-699501013259,ocho,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,recibieron,o
289,0211-699501013259,seis,o
289,0211-699501013259,meses,o
289,0211-699501013259,de,o
289,0211-699501013259,suplementacion,i
289,0211-699501013259,con,o
289,0211-699501013259,normalizacion,o
289,0211-699501013259,del,o
289,0211-699501013259,pp,i
289,0211-699501013259,aumento,o
289,0211-699501013259,del,o
289,0211-699501013259,folato,i
289,0211-699501013259,703,o
289,0211-699501013259,IC,o
289,0211-699501013259,638,o
289,0211-699501013259,795,o
289,0211-699501013259,vs,o
289,0211-699501013259,6181,o
289,0211-699501013259,IC,o
289,0211-699501013259,4447,o
289,0211-699501013259,7811,o
289,0211-699501013259,p,o
289,0211-699501013259,0001,o
289,0211-699501013259,y,o
289,0211-699501013259,descenso,o
289,0211-699501013259,de,o
289,0211-699501013259,la,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,240,o
289,0211-699501013259,IC,o
289,0211-699501013259,213,o
289,0211-699501013259,264,o
289,0211-699501013259,vs,o
289,0211-699501013259,199,o
289,0211-699501013259,IC,o
289,0211-699501013259,175,o
289,0211-699501013259,224,o
289,0211-699501013259,p,o
289,0211-699501013259,005,o
289,0211-699501013259,Han,o
289,0211-699501013259,recibido,o
289,0211-699501013259,suplementacion,i
289,0211-699501013259,durante,o
289,0211-699501013259,12,o
289,0211-699501013259,meses,o
289,0211-699501013259,33,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,pero,o
289,0211-699501013259,a,o
289,0211-699501013259,pesar,o
289,0211-699501013259,de,o
289,0211-699501013259,un,o
289,0211-699501013259,continuo,o
289,0211-699501013259,aumento,o
289,0211-699501013259,del,o
289,0211-699501013259,folato,i
289,0211-699501013259,10078,o
289,0211-699501013259,IC,o
289,0211-699501013259,7481,o
289,0211-699501013259,12674,o
289,0211-699501013259,p,o
289,0211-699501013259,0001,o
289,0211-699501013259,solo,o
289,0211-699501013259,3,o
289,0211-699501013259,pacientes,o
289,0211-699501013259,presentan,o
289,0211-699501013259,niveles,o
289,0211-699501013259,normales,o
289,0211-699501013259,de,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,correlacionandose,o
289,0211-699501013259,directamente,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,con,o
289,0211-699501013259,la,o
289,0211-699501013259,albumina,i
289,0211-699501013259,r,o
289,0211-699501013259,056,o
289,0211-699501013259,p,o
289,0211-699501013259,0001,o
289,0211-699501013259,que,o
289,0211-699501013259,se,o
289,0211-699501013259,elevo,o
289,0211-699501013259,con,o
289,0211-699501013259,respecto,o
289,0211-699501013259,al,o
289,0211-699501013259,inicio,o
289,0211-699501013259,337,o
289,0211-699501013259,IC,o
289,0211-699501013259,327,o
289,0211-699501013259,346,o
289,0211-699501013259,vs,o
289,0211-699501013259,350,o
289,0211-699501013259,IC,o
289,0211-699501013259,337,o
289,0211-699501013259,363,o
289,0211-699501013259,p,o
289,0211-699501013259,005,o
289,0211-699501013259,Conclusion,o
289,0211-699501013259,Tras,o
289,0211-699501013259,suplementacion,i
289,0211-699501013259,con,o
289,0211-699501013259,acido,i
289,0211-699501013259,folico,i
289,0211-699501013259,y,o
289,0211-699501013259,vitamina,i
289,0211-699501013259,B6,i
289,0211-699501013259,aunque,o
289,0211-699501013259,inicialmente,o
289,0211-699501013259,se,o
289,0211-699501013259,reduce,o
289,0211-699501013259,la,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,esta,o
289,0211-699501013259,respuesta,o
289,0211-699501013259,se,o
289,0211-699501013259,hace,o
289,0211-699501013259,refractaria,o
289,0211-699501013259,correlacionandose,o
289,0211-699501013259,directamente,o
289,0211-699501013259,la,o
289,0211-699501013259,tHcy,i
289,0211-699501013259,con,o
289,0211-699501013259,la,o
289,0211-699501013259,albumina,i
289,0211-699501013259,plasmatica,i
289,0211-699501013259,La,o
289,0211-699501013259,interpretacion,o
289,0211-699501013259,de,o
289,0211-699501013259,los,o
289,0211-699501013259,niveles,i
289,0211-699501013259,de,i
289,0211-699501013259,tHcy,i
289,0211-699501013259,debe,o
289,0211-699501013259,tener,o
289,0211-699501013259,en,o
289,0211-699501013259,cuenta,o
289,0211-699501013259,la,o
289,0211-699501013259,concentracion,i
289,0211-699501013259,de,i
289,0211-699501013259,albumina,i
290,0211-699501013259,Efecto,o
290,0211-699501013259,de,o
290,0211-699501013259,la,o
290,0211-699501013259,suplementacion,i
290,0211-699501013259,con,o
290,0211-699501013259,acido,i
290,0211-699501013259,folico,i
290,0211-699501013259,sobre,o
290,0211-699501013259,los,o
290,0211-699501013259,niveles,i
290,0211-699501013259,de,i
290,0211-699501013259,homocisteina,i
290,0211-699501013259,total,o
290,0211-699501013259,en,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,en,o
290,0211-699501013259,hemodialisis,i
290,0211-699501013259,La,o
290,0211-699501013259,hiperhomocisteinemia,i
290,0211-699501013259,es,o
290,0211-699501013259,un,o
290,0211-699501013259,marcador,o
290,0211-699501013259,de,o
290,0211-699501013259,riesgo,o
290,0211-699501013259,independiente,o
290,0211-699501013259,de,o
290,0211-699501013259,morbimortalidad,o
290,0211-699501013259,cardiovascular,i
290,0211-699501013259,Hemos,o
290,0211-699501013259,intentado,o
290,0211-699501013259,prospectivamente,o
290,0211-699501013259,reducir,o
290,0211-699501013259,los,o
290,0211-699501013259,niveles,i
290,0211-699501013259,de,i
290,0211-699501013259,homocisteina,i
290,0211-699501013259,total,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,mediante,o
290,0211-699501013259,suplemento,o
290,0211-699501013259,con,o
290,0211-699501013259,acido,i
290,0211-699501013259,folico,i
290,0211-699501013259,y,o
290,0211-699501013259,vitamina,i
290,0211-699501013259,B6,i
290,0211-699501013259,pp,i
290,0211-699501013259,valorando,o
290,0211-699501013259,su,o
290,0211-699501013259,posible,o
290,0211-699501013259,correlacion,o
290,0211-699501013259,con,o
290,0211-699501013259,dosis,o
290,0211-699501013259,de,o
290,0211-699501013259,dialisis,i
290,0211-699501013259,funcion,i
290,0211-699501013259,residual,i
290,0211-699501013259,y,o
290,0211-699501013259,parametros,o
290,0211-699501013259,nutricionales,o
290,0211-699501013259,Metodos,o
290,0211-699501013259,Todos,o
290,0211-699501013259,los,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,en,o
290,0211-699501013259,hemodialisis,i
290,0211-699501013259,al,o
290,0211-699501013259,comienzo,o
290,0211-699501013259,del,o
290,0211-699501013259,estudio,o
290,0211-699501013259,que,o
290,0211-699501013259,no,o
290,0211-699501013259,recibian,o
290,0211-699501013259,acido,i
290,0211-699501013259,folico,i
290,0211-699501013259,ni,o
290,0211-699501013259,vitamina,i
290,0211-699501013259,B6,i
290,0211-699501013259,asi,o
290,0211-699501013259,como,o
290,0211-699501013259,los,o
290,0211-699501013259,incorporados,o
290,0211-699501013259,posteriormente,o
290,0211-699501013259,a,o
290,0211-699501013259,partir,o
290,0211-699501013259,de,o
290,0211-699501013259,su,o
290,0211-699501013259,tercer,o
290,0211-699501013259,mes,o
290,0211-699501013259,en,o
290,0211-699501013259,hemodialisis,i
290,0211-699501013259,recibieron,o
290,0211-699501013259,5,o
290,0211-699501013259,mg,o
290,0211-699501013259,orales,o
290,0211-699501013259,de,o
290,0211-699501013259,acido,i
290,0211-699501013259,folico,i
290,0211-699501013259,cada,o
290,0211-699501013259,48,o
290,0211-699501013259,horas,o
290,0211-699501013259,y,o
290,0211-699501013259,40,o
290,0211-699501013259,mg,o
290,0211-699501013259,orales,o
290,0211-699501013259,de,o
290,0211-699501013259,vitamina,i
290,0211-699501013259,B6,i
290,0211-699501013259,cada,o
290,0211-699501013259,semana,o
290,0211-699501013259,Se,o
290,0211-699501013259,determinaron,o
290,0211-699501013259,al,o
290,0211-699501013259,comienzo,o
290,0211-699501013259,del,o
290,0211-699501013259,estudio,o
290,0211-699501013259,y,o
290,0211-699501013259,cada,o
290,0211-699501013259,2,o
290,0211-699501013259,meses,o
290,0211-699501013259,niveles,i
290,0211-699501013259,de,i
290,0211-699501013259,folato,i
290,0211-699501013259,vitamina,i
290,0211-699501013259,B12,i
290,0211-699501013259,inmunoensayo,i
290,0211-699501013259,albumina,i
290,0211-699501013259,y,o
290,0211-699501013259,cinetica,o
290,0211-699501013259,de,o
290,0211-699501013259,la,o
290,0211-699501013259,urea,i
290,0211-699501013259,KTV,o
290,0211-699501013259,KRU,o
290,0211-699501013259,PCRn,o
290,0211-699501013259,y,o
290,0211-699501013259,cada,o
290,0211-699501013259,6,o
290,0211-699501013259,meses,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,HPLC,i
290,0211-699501013259,y,o
290,0211-699501013259,pp,i
290,0211-699501013259,RIA,i
290,0211-699501013259,Resultados,o
290,0211-699501013259,80,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,fueron,o
290,0211-699501013259,incluidos,o
290,0211-699501013259,en,o
290,0211-699501013259,el,o
290,0211-699501013259,estudio,o
290,0211-699501013259,basal,o
290,0211-699501013259,con,o
290,0211-699501013259,una,o
290,0211-699501013259,prevalencia,o
290,0211-699501013259,de,o
290,0211-699501013259,hiperhomocisteinemia,i
290,0211-699501013259,del,o
290,0211-699501013259,844,o
290,0211-699501013259,deficit,i
290,0211-699501013259,de,i
290,0211-699501013259,pp,i
290,0211-699501013259,en,o
290,0211-699501013259,el,o
290,0211-699501013259,32,o
290,0211-699501013259,y,o
290,0211-699501013259,folato,i
290,0211-699501013259,en,o
290,0211-699501013259,el,o
290,0211-699501013259,rango,o
290,0211-699501013259,normal,o
290,0211-699501013259,bajo,o
290,0211-699501013259,los,o
290,0211-699501013259,niveles,i
290,0211-699501013259,de,i
290,0211-699501013259,tHcy,i
290,0211-699501013259,se,o
290,0211-699501013259,correlacionaban,o
290,0211-699501013259,inversamente,o
290,0211-699501013259,con,o
290,0211-699501013259,los,o
290,0211-699501013259,del,o
290,0211-699501013259,folato,i
290,0211-699501013259,r,o
290,0211-699501013259,0336,o
290,0211-699501013259,p,o
290,0211-699501013259,001,o
290,0211-699501013259,pero,o
290,0211-699501013259,no,o
290,0211-699501013259,con,o
290,0211-699501013259,pp,i
290,0211-699501013259,B12,i
290,0211-699501013259,edad,o
290,0211-699501013259,albumina,i
290,0211-699501013259,KTV,o
290,0211-699501013259,KRU,o
290,0211-699501013259,PCRn,o
290,0211-699501013259,Cincuenta,o
290,0211-699501013259,y,o
290,0211-699501013259,ocho,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,recibieron,o
290,0211-699501013259,seis,o
290,0211-699501013259,meses,o
290,0211-699501013259,de,o
290,0211-699501013259,suplementacion,i
290,0211-699501013259,con,o
290,0211-699501013259,normalizacion,o
290,0211-699501013259,del,o
290,0211-699501013259,pp,i
290,0211-699501013259,aumento,o
290,0211-699501013259,del,o
290,0211-699501013259,folato,i
290,0211-699501013259,703,o
290,0211-699501013259,IC,o
290,0211-699501013259,638,o
290,0211-699501013259,795,o
290,0211-699501013259,vs,o
290,0211-699501013259,6181,o
290,0211-699501013259,IC,o
290,0211-699501013259,4447,o
290,0211-699501013259,7811,o
290,0211-699501013259,p,o
290,0211-699501013259,0001,o
290,0211-699501013259,y,o
290,0211-699501013259,descenso,o
290,0211-699501013259,de,o
290,0211-699501013259,la,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,240,o
290,0211-699501013259,IC,o
290,0211-699501013259,213,o
290,0211-699501013259,264,o
290,0211-699501013259,vs,o
290,0211-699501013259,199,o
290,0211-699501013259,IC,o
290,0211-699501013259,175,o
290,0211-699501013259,224,o
290,0211-699501013259,p,o
290,0211-699501013259,005,o
290,0211-699501013259,Han,o
290,0211-699501013259,recibido,o
290,0211-699501013259,suplementacion,i
290,0211-699501013259,durante,o
290,0211-699501013259,12,o
290,0211-699501013259,meses,o
290,0211-699501013259,33,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,pero,o
290,0211-699501013259,a,o
290,0211-699501013259,pesar,o
290,0211-699501013259,de,o
290,0211-699501013259,un,o
290,0211-699501013259,continuo,o
290,0211-699501013259,aumento,o
290,0211-699501013259,del,o
290,0211-699501013259,folato,i
290,0211-699501013259,10078,o
290,0211-699501013259,IC,o
290,0211-699501013259,7481,o
290,0211-699501013259,12674,o
290,0211-699501013259,p,o
290,0211-699501013259,0001,o
290,0211-699501013259,solo,o
290,0211-699501013259,3,o
290,0211-699501013259,pacientes,o
290,0211-699501013259,presentan,o
290,0211-699501013259,niveles,o
290,0211-699501013259,normales,o
290,0211-699501013259,de,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,correlacionandose,o
290,0211-699501013259,directamente,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,con,o
290,0211-699501013259,la,o
290,0211-699501013259,albumina,i
290,0211-699501013259,r,o
290,0211-699501013259,056,o
290,0211-699501013259,p,o
290,0211-699501013259,0001,o
290,0211-699501013259,que,o
290,0211-699501013259,se,o
290,0211-699501013259,elevo,o
290,0211-699501013259,con,o
290,0211-699501013259,respecto,o
290,0211-699501013259,al,o
290,0211-699501013259,inicio,o
290,0211-699501013259,337,o
290,0211-699501013259,IC,o
290,0211-699501013259,327,o
290,0211-699501013259,346,o
290,0211-699501013259,vs,o
290,0211-699501013259,350,o
290,0211-699501013259,IC,o
290,0211-699501013259,337,o
290,0211-699501013259,363,o
290,0211-699501013259,p,o
290,0211-699501013259,005,o
290,0211-699501013259,Conclusion,o
290,0211-699501013259,Tras,o
290,0211-699501013259,suplementacion,i
290,0211-699501013259,con,o
290,0211-699501013259,acido,i
290,0211-699501013259,folico,i
290,0211-699501013259,y,o
290,0211-699501013259,vitamina,i
290,0211-699501013259,B6,i
290,0211-699501013259,aunque,o
290,0211-699501013259,inicialmente,o
290,0211-699501013259,se,o
290,0211-699501013259,reduce,o
290,0211-699501013259,la,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,esta,o
290,0211-699501013259,respuesta,o
290,0211-699501013259,se,o
290,0211-699501013259,hace,o
290,0211-699501013259,refractaria,o
290,0211-699501013259,correlacionandose,o
290,0211-699501013259,directamente,o
290,0211-699501013259,la,o
290,0211-699501013259,tHcy,i
290,0211-699501013259,con,o
290,0211-699501013259,la,o
290,0211-699501013259,albumina,i
290,0211-699501013259,plasmatica,i
290,0211-699501013259,La,o
290,0211-699501013259,interpretacion,o
290,0211-699501013259,de,o
290,0211-699501013259,los,o
290,0211-699501013259,niveles,i
290,0211-699501013259,de,i
290,0211-699501013259,tHcy,i
290,0211-699501013259,debe,o
290,0211-699501013259,tener,o
290,0211-699501013259,en,o
290,0211-699501013259,cuenta,o
290,0211-699501013259,la,o
290,0211-699501013259,concentracion,i
290,0211-699501013259,de,i
290,0211-699501013259,albumina,i
291,0211-699501013259,Efecto,o
291,0211-699501013259,de,o
291,0211-699501013259,la,o
291,0211-699501013259,suplementacion,i
291,0211-699501013259,con,o
291,0211-699501013259,acido,i
291,0211-699501013259,folico,i
291,0211-699501013259,sobre,o
291,0211-699501013259,los,o
291,0211-699501013259,niveles,i
291,0211-699501013259,de,i
291,0211-699501013259,homocisteina,i
291,0211-699501013259,total,o
291,0211-699501013259,en,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,en,o
291,0211-699501013259,hemodialisis,i
291,0211-699501013259,La,o
291,0211-699501013259,hiperhomocisteinemia,i
291,0211-699501013259,es,o
291,0211-699501013259,un,o
291,0211-699501013259,marcador,o
291,0211-699501013259,de,o
291,0211-699501013259,riesgo,o
291,0211-699501013259,independiente,o
291,0211-699501013259,de,o
291,0211-699501013259,morbimortalidad,o
291,0211-699501013259,cardiovascular,i
291,0211-699501013259,Hemos,o
291,0211-699501013259,intentado,o
291,0211-699501013259,prospectivamente,o
291,0211-699501013259,reducir,o
291,0211-699501013259,los,o
291,0211-699501013259,niveles,i
291,0211-699501013259,de,i
291,0211-699501013259,homocisteina,i
291,0211-699501013259,total,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,mediante,o
291,0211-699501013259,suplemento,o
291,0211-699501013259,con,o
291,0211-699501013259,acido,i
291,0211-699501013259,folico,i
291,0211-699501013259,y,o
291,0211-699501013259,vitamina,i
291,0211-699501013259,B6,i
291,0211-699501013259,pp,i
291,0211-699501013259,valorando,o
291,0211-699501013259,su,o
291,0211-699501013259,posible,o
291,0211-699501013259,correlacion,o
291,0211-699501013259,con,o
291,0211-699501013259,dosis,o
291,0211-699501013259,de,o
291,0211-699501013259,dialisis,i
291,0211-699501013259,funcion,i
291,0211-699501013259,residual,i
291,0211-699501013259,y,o
291,0211-699501013259,parametros,o
291,0211-699501013259,nutricionales,o
291,0211-699501013259,Metodos,o
291,0211-699501013259,Todos,o
291,0211-699501013259,los,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,en,o
291,0211-699501013259,hemodialisis,i
291,0211-699501013259,al,o
291,0211-699501013259,comienzo,o
291,0211-699501013259,del,o
291,0211-699501013259,estudio,o
291,0211-699501013259,que,o
291,0211-699501013259,no,o
291,0211-699501013259,recibian,o
291,0211-699501013259,acido,i
291,0211-699501013259,folico,i
291,0211-699501013259,ni,o
291,0211-699501013259,vitamina,i
291,0211-699501013259,B6,i
291,0211-699501013259,asi,o
291,0211-699501013259,como,o
291,0211-699501013259,los,o
291,0211-699501013259,incorporados,o
291,0211-699501013259,posteriormente,o
291,0211-699501013259,a,o
291,0211-699501013259,partir,o
291,0211-699501013259,de,o
291,0211-699501013259,su,o
291,0211-699501013259,tercer,o
291,0211-699501013259,mes,o
291,0211-699501013259,en,o
291,0211-699501013259,hemodialisis,i
291,0211-699501013259,recibieron,o
291,0211-699501013259,5,o
291,0211-699501013259,mg,o
291,0211-699501013259,orales,o
291,0211-699501013259,de,o
291,0211-699501013259,acido,i
291,0211-699501013259,folico,i
291,0211-699501013259,cada,o
291,0211-699501013259,48,o
291,0211-699501013259,horas,o
291,0211-699501013259,y,o
291,0211-699501013259,40,o
291,0211-699501013259,mg,o
291,0211-699501013259,orales,o
291,0211-699501013259,de,o
291,0211-699501013259,vitamina,i
291,0211-699501013259,B6,i
291,0211-699501013259,cada,o
291,0211-699501013259,semana,o
291,0211-699501013259,Se,o
291,0211-699501013259,determinaron,o
291,0211-699501013259,al,o
291,0211-699501013259,comienzo,o
291,0211-699501013259,del,o
291,0211-699501013259,estudio,o
291,0211-699501013259,y,o
291,0211-699501013259,cada,o
291,0211-699501013259,2,o
291,0211-699501013259,meses,o
291,0211-699501013259,niveles,i
291,0211-699501013259,de,i
291,0211-699501013259,folato,i
291,0211-699501013259,vitamina,i
291,0211-699501013259,B12,i
291,0211-699501013259,inmunoensayo,i
291,0211-699501013259,albumina,i
291,0211-699501013259,y,o
291,0211-699501013259,cinetica,o
291,0211-699501013259,de,o
291,0211-699501013259,la,o
291,0211-699501013259,urea,i
291,0211-699501013259,KTV,o
291,0211-699501013259,KRU,o
291,0211-699501013259,PCRn,o
291,0211-699501013259,y,o
291,0211-699501013259,cada,o
291,0211-699501013259,6,o
291,0211-699501013259,meses,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,HPLC,i
291,0211-699501013259,y,o
291,0211-699501013259,pp,i
291,0211-699501013259,RIA,i
291,0211-699501013259,Resultados,o
291,0211-699501013259,80,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,fueron,o
291,0211-699501013259,incluidos,o
291,0211-699501013259,en,o
291,0211-699501013259,el,o
291,0211-699501013259,estudio,o
291,0211-699501013259,basal,o
291,0211-699501013259,con,o
291,0211-699501013259,una,o
291,0211-699501013259,prevalencia,o
291,0211-699501013259,de,o
291,0211-699501013259,hiperhomocisteinemia,i
291,0211-699501013259,del,o
291,0211-699501013259,844,o
291,0211-699501013259,deficit,i
291,0211-699501013259,de,i
291,0211-699501013259,pp,i
291,0211-699501013259,en,o
291,0211-699501013259,el,o
291,0211-699501013259,32,o
291,0211-699501013259,y,o
291,0211-699501013259,folato,i
291,0211-699501013259,en,o
291,0211-699501013259,el,o
291,0211-699501013259,rango,o
291,0211-699501013259,normal,o
291,0211-699501013259,bajo,o
291,0211-699501013259,los,o
291,0211-699501013259,niveles,i
291,0211-699501013259,de,i
291,0211-699501013259,tHcy,i
291,0211-699501013259,se,o
291,0211-699501013259,correlacionaban,o
291,0211-699501013259,inversamente,o
291,0211-699501013259,con,o
291,0211-699501013259,los,o
291,0211-699501013259,del,o
291,0211-699501013259,folato,i
291,0211-699501013259,r,o
291,0211-699501013259,0336,o
291,0211-699501013259,p,o
291,0211-699501013259,001,o
291,0211-699501013259,pero,o
291,0211-699501013259,no,o
291,0211-699501013259,con,o
291,0211-699501013259,pp,i
291,0211-699501013259,B12,i
291,0211-699501013259,edad,o
291,0211-699501013259,albumina,i
291,0211-699501013259,KTV,o
291,0211-699501013259,KRU,o
291,0211-699501013259,PCRn,o
291,0211-699501013259,Cincuenta,o
291,0211-699501013259,y,o
291,0211-699501013259,ocho,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,recibieron,o
291,0211-699501013259,seis,o
291,0211-699501013259,meses,o
291,0211-699501013259,de,o
291,0211-699501013259,suplementacion,i
291,0211-699501013259,con,o
291,0211-699501013259,normalizacion,o
291,0211-699501013259,del,o
291,0211-699501013259,pp,i
291,0211-699501013259,aumento,o
291,0211-699501013259,del,o
291,0211-699501013259,folato,i
291,0211-699501013259,703,o
291,0211-699501013259,IC,o
291,0211-699501013259,638,o
291,0211-699501013259,795,o
291,0211-699501013259,vs,o
291,0211-699501013259,6181,o
291,0211-699501013259,IC,o
291,0211-699501013259,4447,o
291,0211-699501013259,7811,o
291,0211-699501013259,p,o
291,0211-699501013259,0001,o
291,0211-699501013259,y,o
291,0211-699501013259,descenso,o
291,0211-699501013259,de,o
291,0211-699501013259,la,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,240,o
291,0211-699501013259,IC,o
291,0211-699501013259,213,o
291,0211-699501013259,264,o
291,0211-699501013259,vs,o
291,0211-699501013259,199,o
291,0211-699501013259,IC,o
291,0211-699501013259,175,o
291,0211-699501013259,224,o
291,0211-699501013259,p,o
291,0211-699501013259,005,o
291,0211-699501013259,Han,o
291,0211-699501013259,recibido,o
291,0211-699501013259,suplementacion,i
291,0211-699501013259,durante,o
291,0211-699501013259,12,o
291,0211-699501013259,meses,o
291,0211-699501013259,33,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,pero,o
291,0211-699501013259,a,o
291,0211-699501013259,pesar,o
291,0211-699501013259,de,o
291,0211-699501013259,un,o
291,0211-699501013259,continuo,o
291,0211-699501013259,aumento,o
291,0211-699501013259,del,o
291,0211-699501013259,folato,i
291,0211-699501013259,10078,o
291,0211-699501013259,IC,o
291,0211-699501013259,7481,o
291,0211-699501013259,12674,o
291,0211-699501013259,p,o
291,0211-699501013259,0001,o
291,0211-699501013259,solo,o
291,0211-699501013259,3,o
291,0211-699501013259,pacientes,o
291,0211-699501013259,presentan,o
291,0211-699501013259,niveles,o
291,0211-699501013259,normales,o
291,0211-699501013259,de,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,correlacionandose,o
291,0211-699501013259,directamente,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,con,o
291,0211-699501013259,la,o
291,0211-699501013259,albumina,i
291,0211-699501013259,r,o
291,0211-699501013259,056,o
291,0211-699501013259,p,o
291,0211-699501013259,0001,o
291,0211-699501013259,que,o
291,0211-699501013259,se,o
291,0211-699501013259,elevo,o
291,0211-699501013259,con,o
291,0211-699501013259,respecto,o
291,0211-699501013259,al,o
291,0211-699501013259,inicio,o
291,0211-699501013259,337,o
291,0211-699501013259,IC,o
291,0211-699501013259,327,o
291,0211-699501013259,346,o
291,0211-699501013259,vs,o
291,0211-699501013259,350,o
291,0211-699501013259,IC,o
291,0211-699501013259,337,o
291,0211-699501013259,363,o
291,0211-699501013259,p,o
291,0211-699501013259,005,o
291,0211-699501013259,Conclusion,o
291,0211-699501013259,Tras,o
291,0211-699501013259,suplementacion,i
291,0211-699501013259,con,o
291,0211-699501013259,acido,i
291,0211-699501013259,folico,i
291,0211-699501013259,y,o
291,0211-699501013259,vitamina,i
291,0211-699501013259,B6,i
291,0211-699501013259,aunque,o
291,0211-699501013259,inicialmente,o
291,0211-699501013259,se,o
291,0211-699501013259,reduce,o
291,0211-699501013259,la,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,esta,o
291,0211-699501013259,respuesta,o
291,0211-699501013259,se,o
291,0211-699501013259,hace,o
291,0211-699501013259,refractaria,o
291,0211-699501013259,correlacionandose,o
291,0211-699501013259,directamente,o
291,0211-699501013259,la,o
291,0211-699501013259,tHcy,i
291,0211-699501013259,con,o
291,0211-699501013259,la,o
291,0211-699501013259,albumina,i
291,0211-699501013259,plasmatica,i
291,0211-699501013259,La,o
291,0211-699501013259,interpretacion,o
291,0211-699501013259,de,o
291,0211-699501013259,los,o
291,0211-699501013259,niveles,i
291,0211-699501013259,de,i
291,0211-699501013259,tHcy,i
291,0211-699501013259,debe,o
291,0211-699501013259,tener,o
291,0211-699501013259,en,o
291,0211-699501013259,cuenta,o
291,0211-699501013259,la,o
291,0211-699501013259,concentracion,i
291,0211-699501013259,de,i
291,0211-699501013259,albumina,i
292,0211-699501013259,Efecto,o
292,0211-699501013259,de,o
292,0211-699501013259,la,o
292,0211-699501013259,suplementacion,i
292,0211-699501013259,con,o
292,0211-699501013259,acido,i
292,0211-699501013259,folico,i
292,0211-699501013259,sobre,o
292,0211-699501013259,los,o
292,0211-699501013259,niveles,i
292,0211-699501013259,de,i
292,0211-699501013259,homocisteina,i
292,0211-699501013259,total,o
292,0211-699501013259,en,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,en,o
292,0211-699501013259,hemodialisis,i
292,0211-699501013259,La,o
292,0211-699501013259,hiperhomocisteinemia,i
292,0211-699501013259,es,o
292,0211-699501013259,un,o
292,0211-699501013259,marcador,o
292,0211-699501013259,de,o
292,0211-699501013259,riesgo,o
292,0211-699501013259,independiente,o
292,0211-699501013259,de,o
292,0211-699501013259,morbimortalidad,o
292,0211-699501013259,cardiovascular,i
292,0211-699501013259,Hemos,o
292,0211-699501013259,intentado,o
292,0211-699501013259,prospectivamente,o
292,0211-699501013259,reducir,o
292,0211-699501013259,los,o
292,0211-699501013259,niveles,i
292,0211-699501013259,de,i
292,0211-699501013259,homocisteina,i
292,0211-699501013259,total,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,mediante,o
292,0211-699501013259,suplemento,o
292,0211-699501013259,con,o
292,0211-699501013259,acido,i
292,0211-699501013259,folico,i
292,0211-699501013259,y,o
292,0211-699501013259,vitamina,i
292,0211-699501013259,B6,i
292,0211-699501013259,pp,i
292,0211-699501013259,valorando,o
292,0211-699501013259,su,o
292,0211-699501013259,posible,o
292,0211-699501013259,correlacion,o
292,0211-699501013259,con,o
292,0211-699501013259,dosis,o
292,0211-699501013259,de,o
292,0211-699501013259,dialisis,i
292,0211-699501013259,funcion,i
292,0211-699501013259,residual,i
292,0211-699501013259,y,o
292,0211-699501013259,parametros,o
292,0211-699501013259,nutricionales,o
292,0211-699501013259,Metodos,o
292,0211-699501013259,Todos,o
292,0211-699501013259,los,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,en,o
292,0211-699501013259,hemodialisis,i
292,0211-699501013259,al,o
292,0211-699501013259,comienzo,o
292,0211-699501013259,del,o
292,0211-699501013259,estudio,o
292,0211-699501013259,que,o
292,0211-699501013259,no,o
292,0211-699501013259,recibian,o
292,0211-699501013259,acido,i
292,0211-699501013259,folico,i
292,0211-699501013259,ni,o
292,0211-699501013259,vitamina,i
292,0211-699501013259,B6,i
292,0211-699501013259,asi,o
292,0211-699501013259,como,o
292,0211-699501013259,los,o
292,0211-699501013259,incorporados,o
292,0211-699501013259,posteriormente,o
292,0211-699501013259,a,o
292,0211-699501013259,partir,o
292,0211-699501013259,de,o
292,0211-699501013259,su,o
292,0211-699501013259,tercer,o
292,0211-699501013259,mes,o
292,0211-699501013259,en,o
292,0211-699501013259,hemodialisis,i
292,0211-699501013259,recibieron,o
292,0211-699501013259,5,o
292,0211-699501013259,mg,o
292,0211-699501013259,orales,o
292,0211-699501013259,de,o
292,0211-699501013259,acido,i
292,0211-699501013259,folico,i
292,0211-699501013259,cada,o
292,0211-699501013259,48,o
292,0211-699501013259,horas,o
292,0211-699501013259,y,o
292,0211-699501013259,40,o
292,0211-699501013259,mg,o
292,0211-699501013259,orales,o
292,0211-699501013259,de,o
292,0211-699501013259,vitamina,i
292,0211-699501013259,B6,i
292,0211-699501013259,cada,o
292,0211-699501013259,semana,o
292,0211-699501013259,Se,o
292,0211-699501013259,determinaron,o
292,0211-699501013259,al,o
292,0211-699501013259,comienzo,o
292,0211-699501013259,del,o
292,0211-699501013259,estudio,o
292,0211-699501013259,y,o
292,0211-699501013259,cada,o
292,0211-699501013259,2,o
292,0211-699501013259,meses,o
292,0211-699501013259,niveles,i
292,0211-699501013259,de,i
292,0211-699501013259,folato,i
292,0211-699501013259,vitamina,i
292,0211-699501013259,B12,i
292,0211-699501013259,inmunoensayo,i
292,0211-699501013259,albumina,i
292,0211-699501013259,y,o
292,0211-699501013259,cinetica,o
292,0211-699501013259,de,o
292,0211-699501013259,la,o
292,0211-699501013259,urea,i
292,0211-699501013259,KTV,o
292,0211-699501013259,KRU,o
292,0211-699501013259,PCRn,o
292,0211-699501013259,y,o
292,0211-699501013259,cada,o
292,0211-699501013259,6,o
292,0211-699501013259,meses,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,HPLC,i
292,0211-699501013259,y,o
292,0211-699501013259,pp,i
292,0211-699501013259,RIA,i
292,0211-699501013259,Resultados,o
292,0211-699501013259,80,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,fueron,o
292,0211-699501013259,incluidos,o
292,0211-699501013259,en,o
292,0211-699501013259,el,o
292,0211-699501013259,estudio,o
292,0211-699501013259,basal,o
292,0211-699501013259,con,o
292,0211-699501013259,una,o
292,0211-699501013259,prevalencia,o
292,0211-699501013259,de,o
292,0211-699501013259,hiperhomocisteinemia,i
292,0211-699501013259,del,o
292,0211-699501013259,844,o
292,0211-699501013259,deficit,i
292,0211-699501013259,de,i
292,0211-699501013259,pp,i
292,0211-699501013259,en,o
292,0211-699501013259,el,o
292,0211-699501013259,32,o
292,0211-699501013259,y,o
292,0211-699501013259,folato,i
292,0211-699501013259,en,o
292,0211-699501013259,el,o
292,0211-699501013259,rango,o
292,0211-699501013259,normal,o
292,0211-699501013259,bajo,o
292,0211-699501013259,los,o
292,0211-699501013259,niveles,i
292,0211-699501013259,de,i
292,0211-699501013259,tHcy,i
292,0211-699501013259,se,o
292,0211-699501013259,correlacionaban,o
292,0211-699501013259,inversamente,o
292,0211-699501013259,con,o
292,0211-699501013259,los,o
292,0211-699501013259,del,o
292,0211-699501013259,folato,i
292,0211-699501013259,r,o
292,0211-699501013259,0336,o
292,0211-699501013259,p,o
292,0211-699501013259,001,o
292,0211-699501013259,pero,o
292,0211-699501013259,no,o
292,0211-699501013259,con,o
292,0211-699501013259,pp,i
292,0211-699501013259,B12,i
292,0211-699501013259,edad,o
292,0211-699501013259,albumina,i
292,0211-699501013259,KTV,o
292,0211-699501013259,KRU,o
292,0211-699501013259,PCRn,o
292,0211-699501013259,Cincuenta,o
292,0211-699501013259,y,o
292,0211-699501013259,ocho,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,recibieron,o
292,0211-699501013259,seis,o
292,0211-699501013259,meses,o
292,0211-699501013259,de,o
292,0211-699501013259,suplementacion,i
292,0211-699501013259,con,o
292,0211-699501013259,normalizacion,o
292,0211-699501013259,del,o
292,0211-699501013259,pp,i
292,0211-699501013259,aumento,o
292,0211-699501013259,del,o
292,0211-699501013259,folato,i
292,0211-699501013259,703,o
292,0211-699501013259,IC,o
292,0211-699501013259,638,o
292,0211-699501013259,795,o
292,0211-699501013259,vs,o
292,0211-699501013259,6181,o
292,0211-699501013259,IC,o
292,0211-699501013259,4447,o
292,0211-699501013259,7811,o
292,0211-699501013259,p,o
292,0211-699501013259,0001,o
292,0211-699501013259,y,o
292,0211-699501013259,descenso,o
292,0211-699501013259,de,o
292,0211-699501013259,la,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,240,o
292,0211-699501013259,IC,o
292,0211-699501013259,213,o
292,0211-699501013259,264,o
292,0211-699501013259,vs,o
292,0211-699501013259,199,o
292,0211-699501013259,IC,o
292,0211-699501013259,175,o
292,0211-699501013259,224,o
292,0211-699501013259,p,o
292,0211-699501013259,005,o
292,0211-699501013259,Han,o
292,0211-699501013259,recibido,o
292,0211-699501013259,suplementacion,i
292,0211-699501013259,durante,o
292,0211-699501013259,12,o
292,0211-699501013259,meses,o
292,0211-699501013259,33,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,pero,o
292,0211-699501013259,a,o
292,0211-699501013259,pesar,o
292,0211-699501013259,de,o
292,0211-699501013259,un,o
292,0211-699501013259,continuo,o
292,0211-699501013259,aumento,o
292,0211-699501013259,del,o
292,0211-699501013259,folato,i
292,0211-699501013259,10078,o
292,0211-699501013259,IC,o
292,0211-699501013259,7481,o
292,0211-699501013259,12674,o
292,0211-699501013259,p,o
292,0211-699501013259,0001,o
292,0211-699501013259,solo,o
292,0211-699501013259,3,o
292,0211-699501013259,pacientes,o
292,0211-699501013259,presentan,o
292,0211-699501013259,niveles,o
292,0211-699501013259,normales,o
292,0211-699501013259,de,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,correlacionandose,o
292,0211-699501013259,directamente,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,con,o
292,0211-699501013259,la,o
292,0211-699501013259,albumina,i
292,0211-699501013259,r,o
292,0211-699501013259,056,o
292,0211-699501013259,p,o
292,0211-699501013259,0001,o
292,0211-699501013259,que,o
292,0211-699501013259,se,o
292,0211-699501013259,elevo,o
292,0211-699501013259,con,o
292,0211-699501013259,respecto,o
292,0211-699501013259,al,o
292,0211-699501013259,inicio,o
292,0211-699501013259,337,o
292,0211-699501013259,IC,o
292,0211-699501013259,327,o
292,0211-699501013259,346,o
292,0211-699501013259,vs,o
292,0211-699501013259,350,o
292,0211-699501013259,IC,o
292,0211-699501013259,337,o
292,0211-699501013259,363,o
292,0211-699501013259,p,o
292,0211-699501013259,005,o
292,0211-699501013259,Conclusion,o
292,0211-699501013259,Tras,o
292,0211-699501013259,suplementacion,i
292,0211-699501013259,con,o
292,0211-699501013259,acido,i
292,0211-699501013259,folico,i
292,0211-699501013259,y,o
292,0211-699501013259,vitamina,i
292,0211-699501013259,B6,i
292,0211-699501013259,aunque,o
292,0211-699501013259,inicialmente,o
292,0211-699501013259,se,o
292,0211-699501013259,reduce,o
292,0211-699501013259,la,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,esta,o
292,0211-699501013259,respuesta,o
292,0211-699501013259,se,o
292,0211-699501013259,hace,o
292,0211-699501013259,refractaria,o
292,0211-699501013259,correlacionandose,o
292,0211-699501013259,directamente,o
292,0211-699501013259,la,o
292,0211-699501013259,tHcy,i
292,0211-699501013259,con,o
292,0211-699501013259,la,o
292,0211-699501013259,albumina,i
292,0211-699501013259,plasmatica,i
292,0211-699501013259,La,o
292,0211-699501013259,interpretacion,o
292,0211-699501013259,de,o
292,0211-699501013259,los,o
292,0211-699501013259,niveles,i
292,0211-699501013259,de,i
292,0211-699501013259,tHcy,i
292,0211-699501013259,debe,o
292,0211-699501013259,tener,o
292,0211-699501013259,en,o
292,0211-699501013259,cuenta,o
292,0211-699501013259,la,o
292,0211-699501013259,concentracion,i
292,0211-699501013259,de,i
292,0211-699501013259,albumina,i
293,0211-699501013259,Efecto,o
293,0211-699501013259,de,o
293,0211-699501013259,la,o
293,0211-699501013259,suplementacion,i
293,0211-699501013259,con,o
293,0211-699501013259,acido,i
293,0211-699501013259,folico,i
293,0211-699501013259,sobre,o
293,0211-699501013259,los,o
293,0211-699501013259,niveles,i
293,0211-699501013259,de,i
293,0211-699501013259,homocisteina,i
293,0211-699501013259,total,o
293,0211-699501013259,en,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,en,o
293,0211-699501013259,hemodialisis,i
293,0211-699501013259,La,o
293,0211-699501013259,hiperhomocisteinemia,i
293,0211-699501013259,es,o
293,0211-699501013259,un,o
293,0211-699501013259,marcador,o
293,0211-699501013259,de,o
293,0211-699501013259,riesgo,o
293,0211-699501013259,independiente,o
293,0211-699501013259,de,o
293,0211-699501013259,morbimortalidad,o
293,0211-699501013259,cardiovascular,i
293,0211-699501013259,Hemos,o
293,0211-699501013259,intentado,o
293,0211-699501013259,prospectivamente,o
293,0211-699501013259,reducir,o
293,0211-699501013259,los,o
293,0211-699501013259,niveles,i
293,0211-699501013259,de,i
293,0211-699501013259,homocisteina,i
293,0211-699501013259,total,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,mediante,o
293,0211-699501013259,suplemento,o
293,0211-699501013259,con,o
293,0211-699501013259,acido,i
293,0211-699501013259,folico,i
293,0211-699501013259,y,o
293,0211-699501013259,vitamina,i
293,0211-699501013259,B6,i
293,0211-699501013259,pp,i
293,0211-699501013259,valorando,o
293,0211-699501013259,su,o
293,0211-699501013259,posible,o
293,0211-699501013259,correlacion,o
293,0211-699501013259,con,o
293,0211-699501013259,dosis,o
293,0211-699501013259,de,o
293,0211-699501013259,dialisis,i
293,0211-699501013259,funcion,i
293,0211-699501013259,residual,i
293,0211-699501013259,y,o
293,0211-699501013259,parametros,o
293,0211-699501013259,nutricionales,o
293,0211-699501013259,Metodos,o
293,0211-699501013259,Todos,o
293,0211-699501013259,los,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,en,o
293,0211-699501013259,hemodialisis,i
293,0211-699501013259,al,o
293,0211-699501013259,comienzo,o
293,0211-699501013259,del,o
293,0211-699501013259,estudio,o
293,0211-699501013259,que,o
293,0211-699501013259,no,o
293,0211-699501013259,recibian,o
293,0211-699501013259,acido,i
293,0211-699501013259,folico,i
293,0211-699501013259,ni,o
293,0211-699501013259,vitamina,i
293,0211-699501013259,B6,i
293,0211-699501013259,asi,o
293,0211-699501013259,como,o
293,0211-699501013259,los,o
293,0211-699501013259,incorporados,o
293,0211-699501013259,posteriormente,o
293,0211-699501013259,a,o
293,0211-699501013259,partir,o
293,0211-699501013259,de,o
293,0211-699501013259,su,o
293,0211-699501013259,tercer,o
293,0211-699501013259,mes,o
293,0211-699501013259,en,o
293,0211-699501013259,hemodialisis,i
293,0211-699501013259,recibieron,o
293,0211-699501013259,5,o
293,0211-699501013259,mg,o
293,0211-699501013259,orales,o
293,0211-699501013259,de,o
293,0211-699501013259,acido,i
293,0211-699501013259,folico,i
293,0211-699501013259,cada,o
293,0211-699501013259,48,o
293,0211-699501013259,horas,o
293,0211-699501013259,y,o
293,0211-699501013259,40,o
293,0211-699501013259,mg,o
293,0211-699501013259,orales,o
293,0211-699501013259,de,o
293,0211-699501013259,vitamina,i
293,0211-699501013259,B6,i
293,0211-699501013259,cada,o
293,0211-699501013259,semana,o
293,0211-699501013259,Se,o
293,0211-699501013259,determinaron,o
293,0211-699501013259,al,o
293,0211-699501013259,comienzo,o
293,0211-699501013259,del,o
293,0211-699501013259,estudio,o
293,0211-699501013259,y,o
293,0211-699501013259,cada,o
293,0211-699501013259,2,o
293,0211-699501013259,meses,o
293,0211-699501013259,niveles,i
293,0211-699501013259,de,i
293,0211-699501013259,folato,i
293,0211-699501013259,vitamina,i
293,0211-699501013259,B12,i
293,0211-699501013259,inmunoensayo,i
293,0211-699501013259,albumina,i
293,0211-699501013259,y,o
293,0211-699501013259,cinetica,o
293,0211-699501013259,de,o
293,0211-699501013259,la,o
293,0211-699501013259,urea,i
293,0211-699501013259,KTV,o
293,0211-699501013259,KRU,o
293,0211-699501013259,PCRn,o
293,0211-699501013259,y,o
293,0211-699501013259,cada,o
293,0211-699501013259,6,o
293,0211-699501013259,meses,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,HPLC,i
293,0211-699501013259,y,o
293,0211-699501013259,pp,i
293,0211-699501013259,RIA,i
293,0211-699501013259,Resultados,o
293,0211-699501013259,80,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,fueron,o
293,0211-699501013259,incluidos,o
293,0211-699501013259,en,o
293,0211-699501013259,el,o
293,0211-699501013259,estudio,o
293,0211-699501013259,basal,o
293,0211-699501013259,con,o
293,0211-699501013259,una,o
293,0211-699501013259,prevalencia,o
293,0211-699501013259,de,o
293,0211-699501013259,hiperhomocisteinemia,i
293,0211-699501013259,del,o
293,0211-699501013259,844,o
293,0211-699501013259,deficit,i
293,0211-699501013259,de,i
293,0211-699501013259,pp,i
293,0211-699501013259,en,o
293,0211-699501013259,el,o
293,0211-699501013259,32,o
293,0211-699501013259,y,o
293,0211-699501013259,folato,i
293,0211-699501013259,en,o
293,0211-699501013259,el,o
293,0211-699501013259,rango,o
293,0211-699501013259,normal,o
293,0211-699501013259,bajo,o
293,0211-699501013259,los,o
293,0211-699501013259,niveles,i
293,0211-699501013259,de,i
293,0211-699501013259,tHcy,i
293,0211-699501013259,se,o
293,0211-699501013259,correlacionaban,o
293,0211-699501013259,inversamente,o
293,0211-699501013259,con,o
293,0211-699501013259,los,o
293,0211-699501013259,del,o
293,0211-699501013259,folato,i
293,0211-699501013259,r,o
293,0211-699501013259,0336,o
293,0211-699501013259,p,o
293,0211-699501013259,001,o
293,0211-699501013259,pero,o
293,0211-699501013259,no,o
293,0211-699501013259,con,o
293,0211-699501013259,pp,i
293,0211-699501013259,B12,i
293,0211-699501013259,edad,o
293,0211-699501013259,albumina,i
293,0211-699501013259,KTV,o
293,0211-699501013259,KRU,o
293,0211-699501013259,PCRn,o
293,0211-699501013259,Cincuenta,o
293,0211-699501013259,y,o
293,0211-699501013259,ocho,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,recibieron,o
293,0211-699501013259,seis,o
293,0211-699501013259,meses,o
293,0211-699501013259,de,o
293,0211-699501013259,suplementacion,i
293,0211-699501013259,con,o
293,0211-699501013259,normalizacion,o
293,0211-699501013259,del,o
293,0211-699501013259,pp,i
293,0211-699501013259,aumento,o
293,0211-699501013259,del,o
293,0211-699501013259,folato,i
293,0211-699501013259,703,o
293,0211-699501013259,IC,o
293,0211-699501013259,638,o
293,0211-699501013259,795,o
293,0211-699501013259,vs,o
293,0211-699501013259,6181,o
293,0211-699501013259,IC,o
293,0211-699501013259,4447,o
293,0211-699501013259,7811,o
293,0211-699501013259,p,o
293,0211-699501013259,0001,o
293,0211-699501013259,y,o
293,0211-699501013259,descenso,o
293,0211-699501013259,de,o
293,0211-699501013259,la,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,240,o
293,0211-699501013259,IC,o
293,0211-699501013259,213,o
293,0211-699501013259,264,o
293,0211-699501013259,vs,o
293,0211-699501013259,199,o
293,0211-699501013259,IC,o
293,0211-699501013259,175,o
293,0211-699501013259,224,o
293,0211-699501013259,p,o
293,0211-699501013259,005,o
293,0211-699501013259,Han,o
293,0211-699501013259,recibido,o
293,0211-699501013259,suplementacion,i
293,0211-699501013259,durante,o
293,0211-699501013259,12,o
293,0211-699501013259,meses,o
293,0211-699501013259,33,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,pero,o
293,0211-699501013259,a,o
293,0211-699501013259,pesar,o
293,0211-699501013259,de,o
293,0211-699501013259,un,o
293,0211-699501013259,continuo,o
293,0211-699501013259,aumento,o
293,0211-699501013259,del,o
293,0211-699501013259,folato,i
293,0211-699501013259,10078,o
293,0211-699501013259,IC,o
293,0211-699501013259,7481,o
293,0211-699501013259,12674,o
293,0211-699501013259,p,o
293,0211-699501013259,0001,o
293,0211-699501013259,solo,o
293,0211-699501013259,3,o
293,0211-699501013259,pacientes,o
293,0211-699501013259,presentan,o
293,0211-699501013259,niveles,o
293,0211-699501013259,normales,o
293,0211-699501013259,de,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,correlacionandose,o
293,0211-699501013259,directamente,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,con,o
293,0211-699501013259,la,o
293,0211-699501013259,albumina,i
293,0211-699501013259,r,o
293,0211-699501013259,056,o
293,0211-699501013259,p,o
293,0211-699501013259,0001,o
293,0211-699501013259,que,o
293,0211-699501013259,se,o
293,0211-699501013259,elevo,o
293,0211-699501013259,con,o
293,0211-699501013259,respecto,o
293,0211-699501013259,al,o
293,0211-699501013259,inicio,o
293,0211-699501013259,337,o
293,0211-699501013259,IC,o
293,0211-699501013259,327,o
293,0211-699501013259,346,o
293,0211-699501013259,vs,o
293,0211-699501013259,350,o
293,0211-699501013259,IC,o
293,0211-699501013259,337,o
293,0211-699501013259,363,o
293,0211-699501013259,p,o
293,0211-699501013259,005,o
293,0211-699501013259,Conclusion,o
293,0211-699501013259,Tras,o
293,0211-699501013259,suplementacion,i
293,0211-699501013259,con,o
293,0211-699501013259,acido,i
293,0211-699501013259,folico,i
293,0211-699501013259,y,o
293,0211-699501013259,vitamina,i
293,0211-699501013259,B6,i
293,0211-699501013259,aunque,o
293,0211-699501013259,inicialmente,o
293,0211-699501013259,se,o
293,0211-699501013259,reduce,o
293,0211-699501013259,la,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,esta,o
293,0211-699501013259,respuesta,o
293,0211-699501013259,se,o
293,0211-699501013259,hace,o
293,0211-699501013259,refractaria,o
293,0211-699501013259,correlacionandose,o
293,0211-699501013259,directamente,o
293,0211-699501013259,la,o
293,0211-699501013259,tHcy,i
293,0211-699501013259,con,o
293,0211-699501013259,la,o
293,0211-699501013259,albumina,i
293,0211-699501013259,plasmatica,i
293,0211-699501013259,La,o
293,0211-699501013259,interpretacion,o
293,0211-699501013259,de,o
293,0211-699501013259,los,o
293,0211-699501013259,niveles,i
293,0211-699501013259,de,i
293,0211-699501013259,tHcy,i
293,0211-699501013259,debe,o
293,0211-699501013259,tener,o
293,0211-699501013259,en,o
293,0211-699501013259,cuenta,o
293,0211-699501013259,la,o
293,0211-699501013259,concentracion,i
293,0211-699501013259,de,i
293,0211-699501013259,albumina,i
294,0211-699501013259,Efecto,o
294,0211-699501013259,de,o
294,0211-699501013259,la,o
294,0211-699501013259,suplementacion,i
294,0211-699501013259,con,o
294,0211-699501013259,acido,i
294,0211-699501013259,folico,i
294,0211-699501013259,sobre,o
294,0211-699501013259,los,o
294,0211-699501013259,niveles,i
294,0211-699501013259,de,i
294,0211-699501013259,homocisteina,i
294,0211-699501013259,total,o
294,0211-699501013259,en,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,en,o
294,0211-699501013259,hemodialisis,i
294,0211-699501013259,La,o
294,0211-699501013259,hiperhomocisteinemia,i
294,0211-699501013259,es,o
294,0211-699501013259,un,o
294,0211-699501013259,marcador,o
294,0211-699501013259,de,o
294,0211-699501013259,riesgo,o
294,0211-699501013259,independiente,o
294,0211-699501013259,de,o
294,0211-699501013259,morbimortalidad,o
294,0211-699501013259,cardiovascular,i
294,0211-699501013259,Hemos,o
294,0211-699501013259,intentado,o
294,0211-699501013259,prospectivamente,o
294,0211-699501013259,reducir,o
294,0211-699501013259,los,o
294,0211-699501013259,niveles,i
294,0211-699501013259,de,i
294,0211-699501013259,homocisteina,i
294,0211-699501013259,total,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,mediante,o
294,0211-699501013259,suplemento,o
294,0211-699501013259,con,o
294,0211-699501013259,acido,i
294,0211-699501013259,folico,i
294,0211-699501013259,y,o
294,0211-699501013259,vitamina,i
294,0211-699501013259,B6,i
294,0211-699501013259,pp,i
294,0211-699501013259,valorando,o
294,0211-699501013259,su,o
294,0211-699501013259,posible,o
294,0211-699501013259,correlacion,o
294,0211-699501013259,con,o
294,0211-699501013259,dosis,o
294,0211-699501013259,de,o
294,0211-699501013259,dialisis,i
294,0211-699501013259,funcion,i
294,0211-699501013259,residual,i
294,0211-699501013259,y,o
294,0211-699501013259,parametros,o
294,0211-699501013259,nutricionales,o
294,0211-699501013259,Metodos,o
294,0211-699501013259,Todos,o
294,0211-699501013259,los,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,en,o
294,0211-699501013259,hemodialisis,i
294,0211-699501013259,al,o
294,0211-699501013259,comienzo,o
294,0211-699501013259,del,o
294,0211-699501013259,estudio,o
294,0211-699501013259,que,o
294,0211-699501013259,no,o
294,0211-699501013259,recibian,o
294,0211-699501013259,acido,i
294,0211-699501013259,folico,i
294,0211-699501013259,ni,o
294,0211-699501013259,vitamina,i
294,0211-699501013259,B6,i
294,0211-699501013259,asi,o
294,0211-699501013259,como,o
294,0211-699501013259,los,o
294,0211-699501013259,incorporados,o
294,0211-699501013259,posteriormente,o
294,0211-699501013259,a,o
294,0211-699501013259,partir,o
294,0211-699501013259,de,o
294,0211-699501013259,su,o
294,0211-699501013259,tercer,o
294,0211-699501013259,mes,o
294,0211-699501013259,en,o
294,0211-699501013259,hemodialisis,i
294,0211-699501013259,recibieron,o
294,0211-699501013259,5,o
294,0211-699501013259,mg,o
294,0211-699501013259,orales,o
294,0211-699501013259,de,o
294,0211-699501013259,acido,i
294,0211-699501013259,folico,i
294,0211-699501013259,cada,o
294,0211-699501013259,48,o
294,0211-699501013259,horas,o
294,0211-699501013259,y,o
294,0211-699501013259,40,o
294,0211-699501013259,mg,o
294,0211-699501013259,orales,o
294,0211-699501013259,de,o
294,0211-699501013259,vitamina,i
294,0211-699501013259,B6,i
294,0211-699501013259,cada,o
294,0211-699501013259,semana,o
294,0211-699501013259,Se,o
294,0211-699501013259,determinaron,o
294,0211-699501013259,al,o
294,0211-699501013259,comienzo,o
294,0211-699501013259,del,o
294,0211-699501013259,estudio,o
294,0211-699501013259,y,o
294,0211-699501013259,cada,o
294,0211-699501013259,2,o
294,0211-699501013259,meses,o
294,0211-699501013259,niveles,i
294,0211-699501013259,de,i
294,0211-699501013259,folato,i
294,0211-699501013259,vitamina,i
294,0211-699501013259,B12,i
294,0211-699501013259,inmunoensayo,i
294,0211-699501013259,albumina,i
294,0211-699501013259,y,o
294,0211-699501013259,cinetica,o
294,0211-699501013259,de,o
294,0211-699501013259,la,o
294,0211-699501013259,urea,i
294,0211-699501013259,KTV,o
294,0211-699501013259,KRU,o
294,0211-699501013259,PCRn,o
294,0211-699501013259,y,o
294,0211-699501013259,cada,o
294,0211-699501013259,6,o
294,0211-699501013259,meses,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,HPLC,i
294,0211-699501013259,y,o
294,0211-699501013259,pp,i
294,0211-699501013259,RIA,i
294,0211-699501013259,Resultados,o
294,0211-699501013259,80,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,fueron,o
294,0211-699501013259,incluidos,o
294,0211-699501013259,en,o
294,0211-699501013259,el,o
294,0211-699501013259,estudio,o
294,0211-699501013259,basal,o
294,0211-699501013259,con,o
294,0211-699501013259,una,o
294,0211-699501013259,prevalencia,o
294,0211-699501013259,de,o
294,0211-699501013259,hiperhomocisteinemia,i
294,0211-699501013259,del,o
294,0211-699501013259,844,o
294,0211-699501013259,deficit,i
294,0211-699501013259,de,i
294,0211-699501013259,pp,i
294,0211-699501013259,en,o
294,0211-699501013259,el,o
294,0211-699501013259,32,o
294,0211-699501013259,y,o
294,0211-699501013259,folato,i
294,0211-699501013259,en,o
294,0211-699501013259,el,o
294,0211-699501013259,rango,o
294,0211-699501013259,normal,o
294,0211-699501013259,bajo,o
294,0211-699501013259,los,o
294,0211-699501013259,niveles,i
294,0211-699501013259,de,i
294,0211-699501013259,tHcy,i
294,0211-699501013259,se,o
294,0211-699501013259,correlacionaban,o
294,0211-699501013259,inversamente,o
294,0211-699501013259,con,o
294,0211-699501013259,los,o
294,0211-699501013259,del,o
294,0211-699501013259,folato,i
294,0211-699501013259,r,o
294,0211-699501013259,0336,o
294,0211-699501013259,p,o
294,0211-699501013259,001,o
294,0211-699501013259,pero,o
294,0211-699501013259,no,o
294,0211-699501013259,con,o
294,0211-699501013259,pp,i
294,0211-699501013259,B12,i
294,0211-699501013259,edad,o
294,0211-699501013259,albumina,i
294,0211-699501013259,KTV,o
294,0211-699501013259,KRU,o
294,0211-699501013259,PCRn,o
294,0211-699501013259,Cincuenta,o
294,0211-699501013259,y,o
294,0211-699501013259,ocho,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,recibieron,o
294,0211-699501013259,seis,o
294,0211-699501013259,meses,o
294,0211-699501013259,de,o
294,0211-699501013259,suplementacion,i
294,0211-699501013259,con,o
294,0211-699501013259,normalizacion,o
294,0211-699501013259,del,o
294,0211-699501013259,pp,i
294,0211-699501013259,aumento,o
294,0211-699501013259,del,o
294,0211-699501013259,folato,i
294,0211-699501013259,703,o
294,0211-699501013259,IC,o
294,0211-699501013259,638,o
294,0211-699501013259,795,o
294,0211-699501013259,vs,o
294,0211-699501013259,6181,o
294,0211-699501013259,IC,o
294,0211-699501013259,4447,o
294,0211-699501013259,7811,o
294,0211-699501013259,p,o
294,0211-699501013259,0001,o
294,0211-699501013259,y,o
294,0211-699501013259,descenso,o
294,0211-699501013259,de,o
294,0211-699501013259,la,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,240,o
294,0211-699501013259,IC,o
294,0211-699501013259,213,o
294,0211-699501013259,264,o
294,0211-699501013259,vs,o
294,0211-699501013259,199,o
294,0211-699501013259,IC,o
294,0211-699501013259,175,o
294,0211-699501013259,224,o
294,0211-699501013259,p,o
294,0211-699501013259,005,o
294,0211-699501013259,Han,o
294,0211-699501013259,recibido,o
294,0211-699501013259,suplementacion,i
294,0211-699501013259,durante,o
294,0211-699501013259,12,o
294,0211-699501013259,meses,o
294,0211-699501013259,33,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,pero,o
294,0211-699501013259,a,o
294,0211-699501013259,pesar,o
294,0211-699501013259,de,o
294,0211-699501013259,un,o
294,0211-699501013259,continuo,o
294,0211-699501013259,aumento,o
294,0211-699501013259,del,o
294,0211-699501013259,folato,i
294,0211-699501013259,10078,o
294,0211-699501013259,IC,o
294,0211-699501013259,7481,o
294,0211-699501013259,12674,o
294,0211-699501013259,p,o
294,0211-699501013259,0001,o
294,0211-699501013259,solo,o
294,0211-699501013259,3,o
294,0211-699501013259,pacientes,o
294,0211-699501013259,presentan,o
294,0211-699501013259,niveles,o
294,0211-699501013259,normales,o
294,0211-699501013259,de,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,correlacionandose,o
294,0211-699501013259,directamente,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,con,o
294,0211-699501013259,la,o
294,0211-699501013259,albumina,i
294,0211-699501013259,r,o
294,0211-699501013259,056,o
294,0211-699501013259,p,o
294,0211-699501013259,0001,o
294,0211-699501013259,que,o
294,0211-699501013259,se,o
294,0211-699501013259,elevo,o
294,0211-699501013259,con,o
294,0211-699501013259,respecto,o
294,0211-699501013259,al,o
294,0211-699501013259,inicio,o
294,0211-699501013259,337,o
294,0211-699501013259,IC,o
294,0211-699501013259,327,o
294,0211-699501013259,346,o
294,0211-699501013259,vs,o
294,0211-699501013259,350,o
294,0211-699501013259,IC,o
294,0211-699501013259,337,o
294,0211-699501013259,363,o
294,0211-699501013259,p,o
294,0211-699501013259,005,o
294,0211-699501013259,Conclusion,o
294,0211-699501013259,Tras,o
294,0211-699501013259,suplementacion,i
294,0211-699501013259,con,o
294,0211-699501013259,acido,i
294,0211-699501013259,folico,i
294,0211-699501013259,y,o
294,0211-699501013259,vitamina,i
294,0211-699501013259,B6,i
294,0211-699501013259,aunque,o
294,0211-699501013259,inicialmente,o
294,0211-699501013259,se,o
294,0211-699501013259,reduce,o
294,0211-699501013259,la,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,esta,o
294,0211-699501013259,respuesta,o
294,0211-699501013259,se,o
294,0211-699501013259,hace,o
294,0211-699501013259,refractaria,o
294,0211-699501013259,correlacionandose,o
294,0211-699501013259,directamente,o
294,0211-699501013259,la,o
294,0211-699501013259,tHcy,i
294,0211-699501013259,con,o
294,0211-699501013259,la,o
294,0211-699501013259,albumina,i
294,0211-699501013259,plasmatica,i
294,0211-699501013259,La,o
294,0211-699501013259,interpretacion,o
294,0211-699501013259,de,o
294,0211-699501013259,los,o
294,0211-699501013259,niveles,i
294,0211-699501013259,de,i
294,0211-699501013259,tHcy,i
294,0211-699501013259,debe,o
294,0211-699501013259,tener,o
294,0211-699501013259,en,o
294,0211-699501013259,cuenta,o
294,0211-699501013259,la,o
294,0211-699501013259,concentracion,i
294,0211-699501013259,de,i
294,0211-699501013259,albumina,i
295,0211-699501013259,Efecto,o
295,0211-699501013259,de,o
295,0211-699501013259,la,o
295,0211-699501013259,suplementacion,i
295,0211-699501013259,con,o
295,0211-699501013259,acido,i
295,0211-699501013259,folico,i
295,0211-699501013259,sobre,o
295,0211-699501013259,los,o
295,0211-699501013259,niveles,i
295,0211-699501013259,de,i
295,0211-699501013259,homocisteina,i
295,0211-699501013259,total,o
295,0211-699501013259,en,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,en,o
295,0211-699501013259,hemodialisis,i
295,0211-699501013259,La,o
295,0211-699501013259,hiperhomocisteinemia,i
295,0211-699501013259,es,o
295,0211-699501013259,un,o
295,0211-699501013259,marcador,o
295,0211-699501013259,de,o
295,0211-699501013259,riesgo,o
295,0211-699501013259,independiente,o
295,0211-699501013259,de,o
295,0211-699501013259,morbimortalidad,o
295,0211-699501013259,cardiovascular,i
295,0211-699501013259,Hemos,o
295,0211-699501013259,intentado,o
295,0211-699501013259,prospectivamente,o
295,0211-699501013259,reducir,o
295,0211-699501013259,los,o
295,0211-699501013259,niveles,i
295,0211-699501013259,de,i
295,0211-699501013259,homocisteina,i
295,0211-699501013259,total,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,mediante,o
295,0211-699501013259,suplemento,o
295,0211-699501013259,con,o
295,0211-699501013259,acido,i
295,0211-699501013259,folico,i
295,0211-699501013259,y,o
295,0211-699501013259,vitamina,i
295,0211-699501013259,B6,i
295,0211-699501013259,pp,i
295,0211-699501013259,valorando,o
295,0211-699501013259,su,o
295,0211-699501013259,posible,o
295,0211-699501013259,correlacion,o
295,0211-699501013259,con,o
295,0211-699501013259,dosis,o
295,0211-699501013259,de,o
295,0211-699501013259,dialisis,i
295,0211-699501013259,funcion,i
295,0211-699501013259,residual,i
295,0211-699501013259,y,o
295,0211-699501013259,parametros,o
295,0211-699501013259,nutricionales,o
295,0211-699501013259,Metodos,o
295,0211-699501013259,Todos,o
295,0211-699501013259,los,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,en,o
295,0211-699501013259,hemodialisis,i
295,0211-699501013259,al,o
295,0211-699501013259,comienzo,o
295,0211-699501013259,del,o
295,0211-699501013259,estudio,o
295,0211-699501013259,que,o
295,0211-699501013259,no,o
295,0211-699501013259,recibian,o
295,0211-699501013259,acido,i
295,0211-699501013259,folico,i
295,0211-699501013259,ni,o
295,0211-699501013259,vitamina,i
295,0211-699501013259,B6,i
295,0211-699501013259,asi,o
295,0211-699501013259,como,o
295,0211-699501013259,los,o
295,0211-699501013259,incorporados,o
295,0211-699501013259,posteriormente,o
295,0211-699501013259,a,o
295,0211-699501013259,partir,o
295,0211-699501013259,de,o
295,0211-699501013259,su,o
295,0211-699501013259,tercer,o
295,0211-699501013259,mes,o
295,0211-699501013259,en,o
295,0211-699501013259,hemodialisis,i
295,0211-699501013259,recibieron,o
295,0211-699501013259,5,o
295,0211-699501013259,mg,o
295,0211-699501013259,orales,o
295,0211-699501013259,de,o
295,0211-699501013259,acido,i
295,0211-699501013259,folico,i
295,0211-699501013259,cada,o
295,0211-699501013259,48,o
295,0211-699501013259,horas,o
295,0211-699501013259,y,o
295,0211-699501013259,40,o
295,0211-699501013259,mg,o
295,0211-699501013259,orales,o
295,0211-699501013259,de,o
295,0211-699501013259,vitamina,i
295,0211-699501013259,B6,i
295,0211-699501013259,cada,o
295,0211-699501013259,semana,o
295,0211-699501013259,Se,o
295,0211-699501013259,determinaron,o
295,0211-699501013259,al,o
295,0211-699501013259,comienzo,o
295,0211-699501013259,del,o
295,0211-699501013259,estudio,o
295,0211-699501013259,y,o
295,0211-699501013259,cada,o
295,0211-699501013259,2,o
295,0211-699501013259,meses,o
295,0211-699501013259,niveles,i
295,0211-699501013259,de,i
295,0211-699501013259,folato,i
295,0211-699501013259,vitamina,i
295,0211-699501013259,B12,i
295,0211-699501013259,inmunoensayo,i
295,0211-699501013259,albumina,i
295,0211-699501013259,y,o
295,0211-699501013259,cinetica,o
295,0211-699501013259,de,o
295,0211-699501013259,la,o
295,0211-699501013259,urea,i
295,0211-699501013259,KTV,o
295,0211-699501013259,KRU,o
295,0211-699501013259,PCRn,o
295,0211-699501013259,y,o
295,0211-699501013259,cada,o
295,0211-699501013259,6,o
295,0211-699501013259,meses,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,HPLC,i
295,0211-699501013259,y,o
295,0211-699501013259,pp,i
295,0211-699501013259,RIA,i
295,0211-699501013259,Resultados,o
295,0211-699501013259,80,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,fueron,o
295,0211-699501013259,incluidos,o
295,0211-699501013259,en,o
295,0211-699501013259,el,o
295,0211-699501013259,estudio,o
295,0211-699501013259,basal,o
295,0211-699501013259,con,o
295,0211-699501013259,una,o
295,0211-699501013259,prevalencia,o
295,0211-699501013259,de,o
295,0211-699501013259,hiperhomocisteinemia,i
295,0211-699501013259,del,o
295,0211-699501013259,844,o
295,0211-699501013259,deficit,i
295,0211-699501013259,de,i
295,0211-699501013259,pp,i
295,0211-699501013259,en,o
295,0211-699501013259,el,o
295,0211-699501013259,32,o
295,0211-699501013259,y,o
295,0211-699501013259,folato,i
295,0211-699501013259,en,o
295,0211-699501013259,el,o
295,0211-699501013259,rango,o
295,0211-699501013259,normal,o
295,0211-699501013259,bajo,o
295,0211-699501013259,los,o
295,0211-699501013259,niveles,i
295,0211-699501013259,de,i
295,0211-699501013259,tHcy,i
295,0211-699501013259,se,o
295,0211-699501013259,correlacionaban,o
295,0211-699501013259,inversamente,o
295,0211-699501013259,con,o
295,0211-699501013259,los,o
295,0211-699501013259,del,o
295,0211-699501013259,folato,i
295,0211-699501013259,r,o
295,0211-699501013259,0336,o
295,0211-699501013259,p,o
295,0211-699501013259,001,o
295,0211-699501013259,pero,o
295,0211-699501013259,no,o
295,0211-699501013259,con,o
295,0211-699501013259,pp,i
295,0211-699501013259,B12,i
295,0211-699501013259,edad,o
295,0211-699501013259,albumina,i
295,0211-699501013259,KTV,o
295,0211-699501013259,KRU,o
295,0211-699501013259,PCRn,o
295,0211-699501013259,Cincuenta,o
295,0211-699501013259,y,o
295,0211-699501013259,ocho,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,recibieron,o
295,0211-699501013259,seis,o
295,0211-699501013259,meses,o
295,0211-699501013259,de,o
295,0211-699501013259,suplementacion,i
295,0211-699501013259,con,o
295,0211-699501013259,normalizacion,o
295,0211-699501013259,del,o
295,0211-699501013259,pp,i
295,0211-699501013259,aumento,o
295,0211-699501013259,del,o
295,0211-699501013259,folato,i
295,0211-699501013259,703,o
295,0211-699501013259,IC,o
295,0211-699501013259,638,o
295,0211-699501013259,795,o
295,0211-699501013259,vs,o
295,0211-699501013259,6181,o
295,0211-699501013259,IC,o
295,0211-699501013259,4447,o
295,0211-699501013259,7811,o
295,0211-699501013259,p,o
295,0211-699501013259,0001,o
295,0211-699501013259,y,o
295,0211-699501013259,descenso,o
295,0211-699501013259,de,o
295,0211-699501013259,la,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,240,o
295,0211-699501013259,IC,o
295,0211-699501013259,213,o
295,0211-699501013259,264,o
295,0211-699501013259,vs,o
295,0211-699501013259,199,o
295,0211-699501013259,IC,o
295,0211-699501013259,175,o
295,0211-699501013259,224,o
295,0211-699501013259,p,o
295,0211-699501013259,005,o
295,0211-699501013259,Han,o
295,0211-699501013259,recibido,o
295,0211-699501013259,suplementacion,i
295,0211-699501013259,durante,o
295,0211-699501013259,12,o
295,0211-699501013259,meses,o
295,0211-699501013259,33,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,pero,o
295,0211-699501013259,a,o
295,0211-699501013259,pesar,o
295,0211-699501013259,de,o
295,0211-699501013259,un,o
295,0211-699501013259,continuo,o
295,0211-699501013259,aumento,o
295,0211-699501013259,del,o
295,0211-699501013259,folato,i
295,0211-699501013259,10078,o
295,0211-699501013259,IC,o
295,0211-699501013259,7481,o
295,0211-699501013259,12674,o
295,0211-699501013259,p,o
295,0211-699501013259,0001,o
295,0211-699501013259,solo,o
295,0211-699501013259,3,o
295,0211-699501013259,pacientes,o
295,0211-699501013259,presentan,o
295,0211-699501013259,niveles,o
295,0211-699501013259,normales,o
295,0211-699501013259,de,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,correlacionandose,o
295,0211-699501013259,directamente,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,con,o
295,0211-699501013259,la,o
295,0211-699501013259,albumina,i
295,0211-699501013259,r,o
295,0211-699501013259,056,o
295,0211-699501013259,p,o
295,0211-699501013259,0001,o
295,0211-699501013259,que,o
295,0211-699501013259,se,o
295,0211-699501013259,elevo,o
295,0211-699501013259,con,o
295,0211-699501013259,respecto,o
295,0211-699501013259,al,o
295,0211-699501013259,inicio,o
295,0211-699501013259,337,o
295,0211-699501013259,IC,o
295,0211-699501013259,327,o
295,0211-699501013259,346,o
295,0211-699501013259,vs,o
295,0211-699501013259,350,o
295,0211-699501013259,IC,o
295,0211-699501013259,337,o
295,0211-699501013259,363,o
295,0211-699501013259,p,o
295,0211-699501013259,005,o
295,0211-699501013259,Conclusion,o
295,0211-699501013259,Tras,o
295,0211-699501013259,suplementacion,i
295,0211-699501013259,con,o
295,0211-699501013259,acido,i
295,0211-699501013259,folico,i
295,0211-699501013259,y,o
295,0211-699501013259,vitamina,i
295,0211-699501013259,B6,i
295,0211-699501013259,aunque,o
295,0211-699501013259,inicialmente,o
295,0211-699501013259,se,o
295,0211-699501013259,reduce,o
295,0211-699501013259,la,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,esta,o
295,0211-699501013259,respuesta,o
295,0211-699501013259,se,o
295,0211-699501013259,hace,o
295,0211-699501013259,refractaria,o
295,0211-699501013259,correlacionandose,o
295,0211-699501013259,directamente,o
295,0211-699501013259,la,o
295,0211-699501013259,tHcy,i
295,0211-699501013259,con,o
295,0211-699501013259,la,o
295,0211-699501013259,albumina,i
295,0211-699501013259,plasmatica,i
295,0211-699501013259,La,o
295,0211-699501013259,interpretacion,o
295,0211-699501013259,de,o
295,0211-699501013259,los,o
295,0211-699501013259,niveles,i
295,0211-699501013259,de,i
295,0211-699501013259,tHcy,i
295,0211-699501013259,debe,o
295,0211-699501013259,tener,o
295,0211-699501013259,en,o
295,0211-699501013259,cuenta,o
295,0211-699501013259,la,o
295,0211-699501013259,concentracion,i
295,0211-699501013259,de,i
295,0211-699501013259,albumina,i
296,0211-699501013259,Efecto,o
296,0211-699501013259,de,o
296,0211-699501013259,la,o
296,0211-699501013259,suplementacion,i
296,0211-699501013259,con,o
296,0211-699501013259,acido,i
296,0211-699501013259,folico,i
296,0211-699501013259,sobre,o
296,0211-699501013259,los,o
296,0211-699501013259,niveles,i
296,0211-699501013259,de,i
296,0211-699501013259,homocisteina,i
296,0211-699501013259,total,o
296,0211-699501013259,en,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,en,o
296,0211-699501013259,hemodialisis,i
296,0211-699501013259,La,o
296,0211-699501013259,hiperhomocisteinemia,i
296,0211-699501013259,es,o
296,0211-699501013259,un,o
296,0211-699501013259,marcador,o
296,0211-699501013259,de,o
296,0211-699501013259,riesgo,o
296,0211-699501013259,independiente,o
296,0211-699501013259,de,o
296,0211-699501013259,morbimortalidad,o
296,0211-699501013259,cardiovascular,i
296,0211-699501013259,Hemos,o
296,0211-699501013259,intentado,o
296,0211-699501013259,prospectivamente,o
296,0211-699501013259,reducir,o
296,0211-699501013259,los,o
296,0211-699501013259,niveles,i
296,0211-699501013259,de,i
296,0211-699501013259,homocisteina,i
296,0211-699501013259,total,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,mediante,o
296,0211-699501013259,suplemento,o
296,0211-699501013259,con,o
296,0211-699501013259,acido,i
296,0211-699501013259,folico,i
296,0211-699501013259,y,o
296,0211-699501013259,vitamina,i
296,0211-699501013259,B6,i
296,0211-699501013259,pp,i
296,0211-699501013259,valorando,o
296,0211-699501013259,su,o
296,0211-699501013259,posible,o
296,0211-699501013259,correlacion,o
296,0211-699501013259,con,o
296,0211-699501013259,dosis,o
296,0211-699501013259,de,o
296,0211-699501013259,dialisis,i
296,0211-699501013259,funcion,i
296,0211-699501013259,residual,i
296,0211-699501013259,y,o
296,0211-699501013259,parametros,o
296,0211-699501013259,nutricionales,o
296,0211-699501013259,Metodos,o
296,0211-699501013259,Todos,o
296,0211-699501013259,los,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,en,o
296,0211-699501013259,hemodialisis,i
296,0211-699501013259,al,o
296,0211-699501013259,comienzo,o
296,0211-699501013259,del,o
296,0211-699501013259,estudio,o
296,0211-699501013259,que,o
296,0211-699501013259,no,o
296,0211-699501013259,recibian,o
296,0211-699501013259,acido,i
296,0211-699501013259,folico,i
296,0211-699501013259,ni,o
296,0211-699501013259,vitamina,i
296,0211-699501013259,B6,i
296,0211-699501013259,asi,o
296,0211-699501013259,como,o
296,0211-699501013259,los,o
296,0211-699501013259,incorporados,o
296,0211-699501013259,posteriormente,o
296,0211-699501013259,a,o
296,0211-699501013259,partir,o
296,0211-699501013259,de,o
296,0211-699501013259,su,o
296,0211-699501013259,tercer,o
296,0211-699501013259,mes,o
296,0211-699501013259,en,o
296,0211-699501013259,hemodialisis,i
296,0211-699501013259,recibieron,o
296,0211-699501013259,5,o
296,0211-699501013259,mg,o
296,0211-699501013259,orales,o
296,0211-699501013259,de,o
296,0211-699501013259,acido,i
296,0211-699501013259,folico,i
296,0211-699501013259,cada,o
296,0211-699501013259,48,o
296,0211-699501013259,horas,o
296,0211-699501013259,y,o
296,0211-699501013259,40,o
296,0211-699501013259,mg,o
296,0211-699501013259,orales,o
296,0211-699501013259,de,o
296,0211-699501013259,vitamina,i
296,0211-699501013259,B6,i
296,0211-699501013259,cada,o
296,0211-699501013259,semana,o
296,0211-699501013259,Se,o
296,0211-699501013259,determinaron,o
296,0211-699501013259,al,o
296,0211-699501013259,comienzo,o
296,0211-699501013259,del,o
296,0211-699501013259,estudio,o
296,0211-699501013259,y,o
296,0211-699501013259,cada,o
296,0211-699501013259,2,o
296,0211-699501013259,meses,o
296,0211-699501013259,niveles,i
296,0211-699501013259,de,i
296,0211-699501013259,folato,i
296,0211-699501013259,vitamina,i
296,0211-699501013259,B12,i
296,0211-699501013259,inmunoensayo,i
296,0211-699501013259,albumina,i
296,0211-699501013259,y,o
296,0211-699501013259,cinetica,o
296,0211-699501013259,de,o
296,0211-699501013259,la,o
296,0211-699501013259,urea,i
296,0211-699501013259,KTV,o
296,0211-699501013259,KRU,o
296,0211-699501013259,PCRn,o
296,0211-699501013259,y,o
296,0211-699501013259,cada,o
296,0211-699501013259,6,o
296,0211-699501013259,meses,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,HPLC,i
296,0211-699501013259,y,o
296,0211-699501013259,pp,i
296,0211-699501013259,RIA,i
296,0211-699501013259,Resultados,o
296,0211-699501013259,80,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,fueron,o
296,0211-699501013259,incluidos,o
296,0211-699501013259,en,o
296,0211-699501013259,el,o
296,0211-699501013259,estudio,o
296,0211-699501013259,basal,o
296,0211-699501013259,con,o
296,0211-699501013259,una,o
296,0211-699501013259,prevalencia,o
296,0211-699501013259,de,o
296,0211-699501013259,hiperhomocisteinemia,i
296,0211-699501013259,del,o
296,0211-699501013259,844,o
296,0211-699501013259,deficit,i
296,0211-699501013259,de,i
296,0211-699501013259,pp,i
296,0211-699501013259,en,o
296,0211-699501013259,el,o
296,0211-699501013259,32,o
296,0211-699501013259,y,o
296,0211-699501013259,folato,i
296,0211-699501013259,en,o
296,0211-699501013259,el,o
296,0211-699501013259,rango,o
296,0211-699501013259,normal,o
296,0211-699501013259,bajo,o
296,0211-699501013259,los,o
296,0211-699501013259,niveles,i
296,0211-699501013259,de,i
296,0211-699501013259,tHcy,i
296,0211-699501013259,se,o
296,0211-699501013259,correlacionaban,o
296,0211-699501013259,inversamente,o
296,0211-699501013259,con,o
296,0211-699501013259,los,o
296,0211-699501013259,del,o
296,0211-699501013259,folato,i
296,0211-699501013259,r,o
296,0211-699501013259,0336,o
296,0211-699501013259,p,o
296,0211-699501013259,001,o
296,0211-699501013259,pero,o
296,0211-699501013259,no,o
296,0211-699501013259,con,o
296,0211-699501013259,pp,i
296,0211-699501013259,B12,i
296,0211-699501013259,edad,o
296,0211-699501013259,albumina,i
296,0211-699501013259,KTV,o
296,0211-699501013259,KRU,o
296,0211-699501013259,PCRn,o
296,0211-699501013259,Cincuenta,o
296,0211-699501013259,y,o
296,0211-699501013259,ocho,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,recibieron,o
296,0211-699501013259,seis,o
296,0211-699501013259,meses,o
296,0211-699501013259,de,o
296,0211-699501013259,suplementacion,i
296,0211-699501013259,con,o
296,0211-699501013259,normalizacion,o
296,0211-699501013259,del,o
296,0211-699501013259,pp,i
296,0211-699501013259,aumento,o
296,0211-699501013259,del,o
296,0211-699501013259,folato,i
296,0211-699501013259,703,o
296,0211-699501013259,IC,o
296,0211-699501013259,638,o
296,0211-699501013259,795,o
296,0211-699501013259,vs,o
296,0211-699501013259,6181,o
296,0211-699501013259,IC,o
296,0211-699501013259,4447,o
296,0211-699501013259,7811,o
296,0211-699501013259,p,o
296,0211-699501013259,0001,o
296,0211-699501013259,y,o
296,0211-699501013259,descenso,o
296,0211-699501013259,de,o
296,0211-699501013259,la,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,240,o
296,0211-699501013259,IC,o
296,0211-699501013259,213,o
296,0211-699501013259,264,o
296,0211-699501013259,vs,o
296,0211-699501013259,199,o
296,0211-699501013259,IC,o
296,0211-699501013259,175,o
296,0211-699501013259,224,o
296,0211-699501013259,p,o
296,0211-699501013259,005,o
296,0211-699501013259,Han,o
296,0211-699501013259,recibido,o
296,0211-699501013259,suplementacion,i
296,0211-699501013259,durante,o
296,0211-699501013259,12,o
296,0211-699501013259,meses,o
296,0211-699501013259,33,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,pero,o
296,0211-699501013259,a,o
296,0211-699501013259,pesar,o
296,0211-699501013259,de,o
296,0211-699501013259,un,o
296,0211-699501013259,continuo,o
296,0211-699501013259,aumento,o
296,0211-699501013259,del,o
296,0211-699501013259,folato,i
296,0211-699501013259,10078,o
296,0211-699501013259,IC,o
296,0211-699501013259,7481,o
296,0211-699501013259,12674,o
296,0211-699501013259,p,o
296,0211-699501013259,0001,o
296,0211-699501013259,solo,o
296,0211-699501013259,3,o
296,0211-699501013259,pacientes,o
296,0211-699501013259,presentan,o
296,0211-699501013259,niveles,o
296,0211-699501013259,normales,o
296,0211-699501013259,de,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,correlacionandose,o
296,0211-699501013259,directamente,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,con,o
296,0211-699501013259,la,o
296,0211-699501013259,albumina,i
296,0211-699501013259,r,o
296,0211-699501013259,056,o
296,0211-699501013259,p,o
296,0211-699501013259,0001,o
296,0211-699501013259,que,o
296,0211-699501013259,se,o
296,0211-699501013259,elevo,o
296,0211-699501013259,con,o
296,0211-699501013259,respecto,o
296,0211-699501013259,al,o
296,0211-699501013259,inicio,o
296,0211-699501013259,337,o
296,0211-699501013259,IC,o
296,0211-699501013259,327,o
296,0211-699501013259,346,o
296,0211-699501013259,vs,o
296,0211-699501013259,350,o
296,0211-699501013259,IC,o
296,0211-699501013259,337,o
296,0211-699501013259,363,o
296,0211-699501013259,p,o
296,0211-699501013259,005,o
296,0211-699501013259,Conclusion,o
296,0211-699501013259,Tras,o
296,0211-699501013259,suplementacion,i
296,0211-699501013259,con,o
296,0211-699501013259,acido,i
296,0211-699501013259,folico,i
296,0211-699501013259,y,o
296,0211-699501013259,vitamina,i
296,0211-699501013259,B6,i
296,0211-699501013259,aunque,o
296,0211-699501013259,inicialmente,o
296,0211-699501013259,se,o
296,0211-699501013259,reduce,o
296,0211-699501013259,la,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,esta,o
296,0211-699501013259,respuesta,o
296,0211-699501013259,se,o
296,0211-699501013259,hace,o
296,0211-699501013259,refractaria,o
296,0211-699501013259,correlacionandose,o
296,0211-699501013259,directamente,o
296,0211-699501013259,la,o
296,0211-699501013259,tHcy,i
296,0211-699501013259,con,o
296,0211-699501013259,la,o
296,0211-699501013259,albumina,i
296,0211-699501013259,plasmatica,i
296,0211-699501013259,La,o
296,0211-699501013259,interpretacion,o
296,0211-699501013259,de,o
296,0211-699501013259,los,o
296,0211-699501013259,niveles,i
296,0211-699501013259,de,i
296,0211-699501013259,tHcy,i
296,0211-699501013259,debe,o
296,0211-699501013259,tener,o
296,0211-699501013259,en,o
296,0211-699501013259,cuenta,o
296,0211-699501013259,la,o
296,0211-699501013259,concentracion,i
296,0211-699501013259,de,i
296,0211-699501013259,albumina,i
297,0211-699501013259,Efecto,o
297,0211-699501013259,de,o
297,0211-699501013259,la,o
297,0211-699501013259,suplementacion,i
297,0211-699501013259,con,o
297,0211-699501013259,acido,i
297,0211-699501013259,folico,i
297,0211-699501013259,sobre,o
297,0211-699501013259,los,o
297,0211-699501013259,niveles,i
297,0211-699501013259,de,i
297,0211-699501013259,homocisteina,i
297,0211-699501013259,total,o
297,0211-699501013259,en,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,en,o
297,0211-699501013259,hemodialisis,i
297,0211-699501013259,La,o
297,0211-699501013259,hiperhomocisteinemia,i
297,0211-699501013259,es,o
297,0211-699501013259,un,o
297,0211-699501013259,marcador,o
297,0211-699501013259,de,o
297,0211-699501013259,riesgo,o
297,0211-699501013259,independiente,o
297,0211-699501013259,de,o
297,0211-699501013259,morbimortalidad,o
297,0211-699501013259,cardiovascular,i
297,0211-699501013259,Hemos,o
297,0211-699501013259,intentado,o
297,0211-699501013259,prospectivamente,o
297,0211-699501013259,reducir,o
297,0211-699501013259,los,o
297,0211-699501013259,niveles,i
297,0211-699501013259,de,i
297,0211-699501013259,homocisteina,i
297,0211-699501013259,total,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,mediante,o
297,0211-699501013259,suplemento,o
297,0211-699501013259,con,o
297,0211-699501013259,acido,i
297,0211-699501013259,folico,i
297,0211-699501013259,y,o
297,0211-699501013259,vitamina,i
297,0211-699501013259,B6,i
297,0211-699501013259,pp,i
297,0211-699501013259,valorando,o
297,0211-699501013259,su,o
297,0211-699501013259,posible,o
297,0211-699501013259,correlacion,o
297,0211-699501013259,con,o
297,0211-699501013259,dosis,o
297,0211-699501013259,de,o
297,0211-699501013259,dialisis,i
297,0211-699501013259,funcion,i
297,0211-699501013259,residual,i
297,0211-699501013259,y,o
297,0211-699501013259,parametros,o
297,0211-699501013259,nutricionales,o
297,0211-699501013259,Metodos,o
297,0211-699501013259,Todos,o
297,0211-699501013259,los,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,en,o
297,0211-699501013259,hemodialisis,i
297,0211-699501013259,al,o
297,0211-699501013259,comienzo,o
297,0211-699501013259,del,o
297,0211-699501013259,estudio,o
297,0211-699501013259,que,o
297,0211-699501013259,no,o
297,0211-699501013259,recibian,o
297,0211-699501013259,acido,i
297,0211-699501013259,folico,i
297,0211-699501013259,ni,o
297,0211-699501013259,vitamina,i
297,0211-699501013259,B6,i
297,0211-699501013259,asi,o
297,0211-699501013259,como,o
297,0211-699501013259,los,o
297,0211-699501013259,incorporados,o
297,0211-699501013259,posteriormente,o
297,0211-699501013259,a,o
297,0211-699501013259,partir,o
297,0211-699501013259,de,o
297,0211-699501013259,su,o
297,0211-699501013259,tercer,o
297,0211-699501013259,mes,o
297,0211-699501013259,en,o
297,0211-699501013259,hemodialisis,i
297,0211-699501013259,recibieron,o
297,0211-699501013259,5,o
297,0211-699501013259,mg,o
297,0211-699501013259,orales,o
297,0211-699501013259,de,o
297,0211-699501013259,acido,i
297,0211-699501013259,folico,i
297,0211-699501013259,cada,o
297,0211-699501013259,48,o
297,0211-699501013259,horas,o
297,0211-699501013259,y,o
297,0211-699501013259,40,o
297,0211-699501013259,mg,o
297,0211-699501013259,orales,o
297,0211-699501013259,de,o
297,0211-699501013259,vitamina,i
297,0211-699501013259,B6,i
297,0211-699501013259,cada,o
297,0211-699501013259,semana,o
297,0211-699501013259,Se,o
297,0211-699501013259,determinaron,o
297,0211-699501013259,al,o
297,0211-699501013259,comienzo,o
297,0211-699501013259,del,o
297,0211-699501013259,estudio,o
297,0211-699501013259,y,o
297,0211-699501013259,cada,o
297,0211-699501013259,2,o
297,0211-699501013259,meses,o
297,0211-699501013259,niveles,i
297,0211-699501013259,de,i
297,0211-699501013259,folato,i
297,0211-699501013259,vitamina,i
297,0211-699501013259,B12,i
297,0211-699501013259,inmunoensayo,i
297,0211-699501013259,albumina,i
297,0211-699501013259,y,o
297,0211-699501013259,cinetica,o
297,0211-699501013259,de,o
297,0211-699501013259,la,o
297,0211-699501013259,urea,i
297,0211-699501013259,KTV,o
297,0211-699501013259,KRU,o
297,0211-699501013259,PCRn,o
297,0211-699501013259,y,o
297,0211-699501013259,cada,o
297,0211-699501013259,6,o
297,0211-699501013259,meses,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,HPLC,i
297,0211-699501013259,y,o
297,0211-699501013259,pp,i
297,0211-699501013259,RIA,i
297,0211-699501013259,Resultados,o
297,0211-699501013259,80,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,fueron,o
297,0211-699501013259,incluidos,o
297,0211-699501013259,en,o
297,0211-699501013259,el,o
297,0211-699501013259,estudio,o
297,0211-699501013259,basal,o
297,0211-699501013259,con,o
297,0211-699501013259,una,o
297,0211-699501013259,prevalencia,o
297,0211-699501013259,de,o
297,0211-699501013259,hiperhomocisteinemia,i
297,0211-699501013259,del,o
297,0211-699501013259,844,o
297,0211-699501013259,deficit,i
297,0211-699501013259,de,i
297,0211-699501013259,pp,i
297,0211-699501013259,en,o
297,0211-699501013259,el,o
297,0211-699501013259,32,o
297,0211-699501013259,y,o
297,0211-699501013259,folato,i
297,0211-699501013259,en,o
297,0211-699501013259,el,o
297,0211-699501013259,rango,o
297,0211-699501013259,normal,o
297,0211-699501013259,bajo,o
297,0211-699501013259,los,o
297,0211-699501013259,niveles,i
297,0211-699501013259,de,i
297,0211-699501013259,tHcy,i
297,0211-699501013259,se,o
297,0211-699501013259,correlacionaban,o
297,0211-699501013259,inversamente,o
297,0211-699501013259,con,o
297,0211-699501013259,los,o
297,0211-699501013259,del,o
297,0211-699501013259,folato,i
297,0211-699501013259,r,o
297,0211-699501013259,0336,o
297,0211-699501013259,p,o
297,0211-699501013259,001,o
297,0211-699501013259,pero,o
297,0211-699501013259,no,o
297,0211-699501013259,con,o
297,0211-699501013259,pp,i
297,0211-699501013259,B12,i
297,0211-699501013259,edad,o
297,0211-699501013259,albumina,i
297,0211-699501013259,KTV,o
297,0211-699501013259,KRU,o
297,0211-699501013259,PCRn,o
297,0211-699501013259,Cincuenta,o
297,0211-699501013259,y,o
297,0211-699501013259,ocho,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,recibieron,o
297,0211-699501013259,seis,o
297,0211-699501013259,meses,o
297,0211-699501013259,de,o
297,0211-699501013259,suplementacion,i
297,0211-699501013259,con,o
297,0211-699501013259,normalizacion,o
297,0211-699501013259,del,o
297,0211-699501013259,pp,i
297,0211-699501013259,aumento,o
297,0211-699501013259,del,o
297,0211-699501013259,folato,i
297,0211-699501013259,703,o
297,0211-699501013259,IC,o
297,0211-699501013259,638,o
297,0211-699501013259,795,o
297,0211-699501013259,vs,o
297,0211-699501013259,6181,o
297,0211-699501013259,IC,o
297,0211-699501013259,4447,o
297,0211-699501013259,7811,o
297,0211-699501013259,p,o
297,0211-699501013259,0001,o
297,0211-699501013259,y,o
297,0211-699501013259,descenso,o
297,0211-699501013259,de,o
297,0211-699501013259,la,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,240,o
297,0211-699501013259,IC,o
297,0211-699501013259,213,o
297,0211-699501013259,264,o
297,0211-699501013259,vs,o
297,0211-699501013259,199,o
297,0211-699501013259,IC,o
297,0211-699501013259,175,o
297,0211-699501013259,224,o
297,0211-699501013259,p,o
297,0211-699501013259,005,o
297,0211-699501013259,Han,o
297,0211-699501013259,recibido,o
297,0211-699501013259,suplementacion,i
297,0211-699501013259,durante,o
297,0211-699501013259,12,o
297,0211-699501013259,meses,o
297,0211-699501013259,33,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,pero,o
297,0211-699501013259,a,o
297,0211-699501013259,pesar,o
297,0211-699501013259,de,o
297,0211-699501013259,un,o
297,0211-699501013259,continuo,o
297,0211-699501013259,aumento,o
297,0211-699501013259,del,o
297,0211-699501013259,folato,i
297,0211-699501013259,10078,o
297,0211-699501013259,IC,o
297,0211-699501013259,7481,o
297,0211-699501013259,12674,o
297,0211-699501013259,p,o
297,0211-699501013259,0001,o
297,0211-699501013259,solo,o
297,0211-699501013259,3,o
297,0211-699501013259,pacientes,o
297,0211-699501013259,presentan,o
297,0211-699501013259,niveles,o
297,0211-699501013259,normales,o
297,0211-699501013259,de,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,correlacionandose,o
297,0211-699501013259,directamente,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,con,o
297,0211-699501013259,la,o
297,0211-699501013259,albumina,i
297,0211-699501013259,r,o
297,0211-699501013259,056,o
297,0211-699501013259,p,o
297,0211-699501013259,0001,o
297,0211-699501013259,que,o
297,0211-699501013259,se,o
297,0211-699501013259,elevo,o
297,0211-699501013259,con,o
297,0211-699501013259,respecto,o
297,0211-699501013259,al,o
297,0211-699501013259,inicio,o
297,0211-699501013259,337,o
297,0211-699501013259,IC,o
297,0211-699501013259,327,o
297,0211-699501013259,346,o
297,0211-699501013259,vs,o
297,0211-699501013259,350,o
297,0211-699501013259,IC,o
297,0211-699501013259,337,o
297,0211-699501013259,363,o
297,0211-699501013259,p,o
297,0211-699501013259,005,o
297,0211-699501013259,Conclusion,o
297,0211-699501013259,Tras,o
297,0211-699501013259,suplementacion,i
297,0211-699501013259,con,o
297,0211-699501013259,acido,i
297,0211-699501013259,folico,i
297,0211-699501013259,y,o
297,0211-699501013259,vitamina,i
297,0211-699501013259,B6,i
297,0211-699501013259,aunque,o
297,0211-699501013259,inicialmente,o
297,0211-699501013259,se,o
297,0211-699501013259,reduce,o
297,0211-699501013259,la,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,esta,o
297,0211-699501013259,respuesta,o
297,0211-699501013259,se,o
297,0211-699501013259,hace,o
297,0211-699501013259,refractaria,o
297,0211-699501013259,correlacionandose,o
297,0211-699501013259,directamente,o
297,0211-699501013259,la,o
297,0211-699501013259,tHcy,i
297,0211-699501013259,con,o
297,0211-699501013259,la,o
297,0211-699501013259,albumina,i
297,0211-699501013259,plasmatica,i
297,0211-699501013259,La,o
297,0211-699501013259,interpretacion,o
297,0211-699501013259,de,o
297,0211-699501013259,los,o
297,0211-699501013259,niveles,i
297,0211-699501013259,de,i
297,0211-699501013259,tHcy,i
297,0211-699501013259,debe,o
297,0211-699501013259,tener,o
297,0211-699501013259,en,o
297,0211-699501013259,cuenta,o
297,0211-699501013259,la,o
297,0211-699501013259,concentracion,i
297,0211-699501013259,de,i
297,0211-699501013259,albumina,i
298,0211-699501013259,Efecto,o
298,0211-699501013259,de,o
298,0211-699501013259,la,o
298,0211-699501013259,suplementacion,i
298,0211-699501013259,con,o
298,0211-699501013259,acido,i
298,0211-699501013259,folico,i
298,0211-699501013259,sobre,o
298,0211-699501013259,los,o
298,0211-699501013259,niveles,i
298,0211-699501013259,de,i
298,0211-699501013259,homocisteina,i
298,0211-699501013259,total,o
298,0211-699501013259,en,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,en,o
298,0211-699501013259,hemodialisis,i
298,0211-699501013259,La,o
298,0211-699501013259,hiperhomocisteinemia,i
298,0211-699501013259,es,o
298,0211-699501013259,un,o
298,0211-699501013259,marcador,o
298,0211-699501013259,de,o
298,0211-699501013259,riesgo,o
298,0211-699501013259,independiente,o
298,0211-699501013259,de,o
298,0211-699501013259,morbimortalidad,o
298,0211-699501013259,cardiovascular,i
298,0211-699501013259,Hemos,o
298,0211-699501013259,intentado,o
298,0211-699501013259,prospectivamente,o
298,0211-699501013259,reducir,o
298,0211-699501013259,los,o
298,0211-699501013259,niveles,i
298,0211-699501013259,de,i
298,0211-699501013259,homocisteina,i
298,0211-699501013259,total,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,mediante,o
298,0211-699501013259,suplemento,o
298,0211-699501013259,con,o
298,0211-699501013259,acido,i
298,0211-699501013259,folico,i
298,0211-699501013259,y,o
298,0211-699501013259,vitamina,i
298,0211-699501013259,B6,i
298,0211-699501013259,pp,i
298,0211-699501013259,valorando,o
298,0211-699501013259,su,o
298,0211-699501013259,posible,o
298,0211-699501013259,correlacion,o
298,0211-699501013259,con,o
298,0211-699501013259,dosis,o
298,0211-699501013259,de,o
298,0211-699501013259,dialisis,i
298,0211-699501013259,funcion,i
298,0211-699501013259,residual,i
298,0211-699501013259,y,o
298,0211-699501013259,parametros,o
298,0211-699501013259,nutricionales,o
298,0211-699501013259,Metodos,o
298,0211-699501013259,Todos,o
298,0211-699501013259,los,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,en,o
298,0211-699501013259,hemodialisis,i
298,0211-699501013259,al,o
298,0211-699501013259,comienzo,o
298,0211-699501013259,del,o
298,0211-699501013259,estudio,o
298,0211-699501013259,que,o
298,0211-699501013259,no,o
298,0211-699501013259,recibian,o
298,0211-699501013259,acido,i
298,0211-699501013259,folico,i
298,0211-699501013259,ni,o
298,0211-699501013259,vitamina,i
298,0211-699501013259,B6,i
298,0211-699501013259,asi,o
298,0211-699501013259,como,o
298,0211-699501013259,los,o
298,0211-699501013259,incorporados,o
298,0211-699501013259,posteriormente,o
298,0211-699501013259,a,o
298,0211-699501013259,partir,o
298,0211-699501013259,de,o
298,0211-699501013259,su,o
298,0211-699501013259,tercer,o
298,0211-699501013259,mes,o
298,0211-699501013259,en,o
298,0211-699501013259,hemodialisis,i
298,0211-699501013259,recibieron,o
298,0211-699501013259,5,o
298,0211-699501013259,mg,o
298,0211-699501013259,orales,o
298,0211-699501013259,de,o
298,0211-699501013259,acido,i
298,0211-699501013259,folico,i
298,0211-699501013259,cada,o
298,0211-699501013259,48,o
298,0211-699501013259,horas,o
298,0211-699501013259,y,o
298,0211-699501013259,40,o
298,0211-699501013259,mg,o
298,0211-699501013259,orales,o
298,0211-699501013259,de,o
298,0211-699501013259,vitamina,i
298,0211-699501013259,B6,i
298,0211-699501013259,cada,o
298,0211-699501013259,semana,o
298,0211-699501013259,Se,o
298,0211-699501013259,determinaron,o
298,0211-699501013259,al,o
298,0211-699501013259,comienzo,o
298,0211-699501013259,del,o
298,0211-699501013259,estudio,o
298,0211-699501013259,y,o
298,0211-699501013259,cada,o
298,0211-699501013259,2,o
298,0211-699501013259,meses,o
298,0211-699501013259,niveles,i
298,0211-699501013259,de,i
298,0211-699501013259,folato,i
298,0211-699501013259,vitamina,i
298,0211-699501013259,B12,i
298,0211-699501013259,inmunoensayo,i
298,0211-699501013259,albumina,i
298,0211-699501013259,y,o
298,0211-699501013259,cinetica,o
298,0211-699501013259,de,o
298,0211-699501013259,la,o
298,0211-699501013259,urea,i
298,0211-699501013259,KTV,o
298,0211-699501013259,KRU,o
298,0211-699501013259,PCRn,o
298,0211-699501013259,y,o
298,0211-699501013259,cada,o
298,0211-699501013259,6,o
298,0211-699501013259,meses,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,HPLC,i
298,0211-699501013259,y,o
298,0211-699501013259,pp,i
298,0211-699501013259,RIA,i
298,0211-699501013259,Resultados,o
298,0211-699501013259,80,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,fueron,o
298,0211-699501013259,incluidos,o
298,0211-699501013259,en,o
298,0211-699501013259,el,o
298,0211-699501013259,estudio,o
298,0211-699501013259,basal,o
298,0211-699501013259,con,o
298,0211-699501013259,una,o
298,0211-699501013259,prevalencia,o
298,0211-699501013259,de,o
298,0211-699501013259,hiperhomocisteinemia,i
298,0211-699501013259,del,o
298,0211-699501013259,844,o
298,0211-699501013259,deficit,i
298,0211-699501013259,de,i
298,0211-699501013259,pp,i
298,0211-699501013259,en,o
298,0211-699501013259,el,o
298,0211-699501013259,32,o
298,0211-699501013259,y,o
298,0211-699501013259,folato,i
298,0211-699501013259,en,o
298,0211-699501013259,el,o
298,0211-699501013259,rango,o
298,0211-699501013259,normal,o
298,0211-699501013259,bajo,o
298,0211-699501013259,los,o
298,0211-699501013259,niveles,i
298,0211-699501013259,de,i
298,0211-699501013259,tHcy,i
298,0211-699501013259,se,o
298,0211-699501013259,correlacionaban,o
298,0211-699501013259,inversamente,o
298,0211-699501013259,con,o
298,0211-699501013259,los,o
298,0211-699501013259,del,o
298,0211-699501013259,folato,i
298,0211-699501013259,r,o
298,0211-699501013259,0336,o
298,0211-699501013259,p,o
298,0211-699501013259,001,o
298,0211-699501013259,pero,o
298,0211-699501013259,no,o
298,0211-699501013259,con,o
298,0211-699501013259,pp,i
298,0211-699501013259,B12,i
298,0211-699501013259,edad,o
298,0211-699501013259,albumina,i
298,0211-699501013259,KTV,o
298,0211-699501013259,KRU,o
298,0211-699501013259,PCRn,o
298,0211-699501013259,Cincuenta,o
298,0211-699501013259,y,o
298,0211-699501013259,ocho,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,recibieron,o
298,0211-699501013259,seis,o
298,0211-699501013259,meses,o
298,0211-699501013259,de,o
298,0211-699501013259,suplementacion,i
298,0211-699501013259,con,o
298,0211-699501013259,normalizacion,o
298,0211-699501013259,del,o
298,0211-699501013259,pp,i
298,0211-699501013259,aumento,o
298,0211-699501013259,del,o
298,0211-699501013259,folato,i
298,0211-699501013259,703,o
298,0211-699501013259,IC,o
298,0211-699501013259,638,o
298,0211-699501013259,795,o
298,0211-699501013259,vs,o
298,0211-699501013259,6181,o
298,0211-699501013259,IC,o
298,0211-699501013259,4447,o
298,0211-699501013259,7811,o
298,0211-699501013259,p,o
298,0211-699501013259,0001,o
298,0211-699501013259,y,o
298,0211-699501013259,descenso,o
298,0211-699501013259,de,o
298,0211-699501013259,la,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,240,o
298,0211-699501013259,IC,o
298,0211-699501013259,213,o
298,0211-699501013259,264,o
298,0211-699501013259,vs,o
298,0211-699501013259,199,o
298,0211-699501013259,IC,o
298,0211-699501013259,175,o
298,0211-699501013259,224,o
298,0211-699501013259,p,o
298,0211-699501013259,005,o
298,0211-699501013259,Han,o
298,0211-699501013259,recibido,o
298,0211-699501013259,suplementacion,i
298,0211-699501013259,durante,o
298,0211-699501013259,12,o
298,0211-699501013259,meses,o
298,0211-699501013259,33,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,pero,o
298,0211-699501013259,a,o
298,0211-699501013259,pesar,o
298,0211-699501013259,de,o
298,0211-699501013259,un,o
298,0211-699501013259,continuo,o
298,0211-699501013259,aumento,o
298,0211-699501013259,del,o
298,0211-699501013259,folato,i
298,0211-699501013259,10078,o
298,0211-699501013259,IC,o
298,0211-699501013259,7481,o
298,0211-699501013259,12674,o
298,0211-699501013259,p,o
298,0211-699501013259,0001,o
298,0211-699501013259,solo,o
298,0211-699501013259,3,o
298,0211-699501013259,pacientes,o
298,0211-699501013259,presentan,o
298,0211-699501013259,niveles,o
298,0211-699501013259,normales,o
298,0211-699501013259,de,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,correlacionandose,o
298,0211-699501013259,directamente,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,con,o
298,0211-699501013259,la,o
298,0211-699501013259,albumina,i
298,0211-699501013259,r,o
298,0211-699501013259,056,o
298,0211-699501013259,p,o
298,0211-699501013259,0001,o
298,0211-699501013259,que,o
298,0211-699501013259,se,o
298,0211-699501013259,elevo,o
298,0211-699501013259,con,o
298,0211-699501013259,respecto,o
298,0211-699501013259,al,o
298,0211-699501013259,inicio,o
298,0211-699501013259,337,o
298,0211-699501013259,IC,o
298,0211-699501013259,327,o
298,0211-699501013259,346,o
298,0211-699501013259,vs,o
298,0211-699501013259,350,o
298,0211-699501013259,IC,o
298,0211-699501013259,337,o
298,0211-699501013259,363,o
298,0211-699501013259,p,o
298,0211-699501013259,005,o
298,0211-699501013259,Conclusion,o
298,0211-699501013259,Tras,o
298,0211-699501013259,suplementacion,i
298,0211-699501013259,con,o
298,0211-699501013259,acido,i
298,0211-699501013259,folico,i
298,0211-699501013259,y,o
298,0211-699501013259,vitamina,i
298,0211-699501013259,B6,i
298,0211-699501013259,aunque,o
298,0211-699501013259,inicialmente,o
298,0211-699501013259,se,o
298,0211-699501013259,reduce,o
298,0211-699501013259,la,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,esta,o
298,0211-699501013259,respuesta,o
298,0211-699501013259,se,o
298,0211-699501013259,hace,o
298,0211-699501013259,refractaria,o
298,0211-699501013259,correlacionandose,o
298,0211-699501013259,directamente,o
298,0211-699501013259,la,o
298,0211-699501013259,tHcy,i
298,0211-699501013259,con,o
298,0211-699501013259,la,o
298,0211-699501013259,albumina,i
298,0211-699501013259,plasmatica,i
298,0211-699501013259,La,o
298,0211-699501013259,interpretacion,o
298,0211-699501013259,de,o
298,0211-699501013259,los,o
298,0211-699501013259,niveles,i
298,0211-699501013259,de,i
298,0211-699501013259,tHcy,i
298,0211-699501013259,debe,o
298,0211-699501013259,tener,o
298,0211-699501013259,en,o
298,0211-699501013259,cuenta,o
298,0211-699501013259,la,o
298,0211-699501013259,concentracion,i
298,0211-699501013259,de,i
298,0211-699501013259,albumina,i
299,0211-699501013259,Efecto,o
299,0211-699501013259,de,o
299,0211-699501013259,la,o
299,0211-699501013259,suplementacion,i
299,0211-699501013259,con,o
299,0211-699501013259,acido,i
299,0211-699501013259,folico,i
299,0211-699501013259,sobre,o
299,0211-699501013259,los,o
299,0211-699501013259,niveles,i
299,0211-699501013259,de,i
299,0211-699501013259,homocisteina,i
299,0211-699501013259,total,o
299,0211-699501013259,en,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,en,o
299,0211-699501013259,hemodialisis,i
299,0211-699501013259,La,o
299,0211-699501013259,hiperhomocisteinemia,i
299,0211-699501013259,es,o
299,0211-699501013259,un,o
299,0211-699501013259,marcador,o
299,0211-699501013259,de,o
299,0211-699501013259,riesgo,o
299,0211-699501013259,independiente,o
299,0211-699501013259,de,o
299,0211-699501013259,morbimortalidad,o
299,0211-699501013259,cardiovascular,i
299,0211-699501013259,Hemos,o
299,0211-699501013259,intentado,o
299,0211-699501013259,prospectivamente,o
299,0211-699501013259,reducir,o
299,0211-699501013259,los,o
299,0211-699501013259,niveles,i
299,0211-699501013259,de,i
299,0211-699501013259,homocisteina,i
299,0211-699501013259,total,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,mediante,o
299,0211-699501013259,suplemento,o
299,0211-699501013259,con,o
299,0211-699501013259,acido,i
299,0211-699501013259,folico,i
299,0211-699501013259,y,o
299,0211-699501013259,vitamina,i
299,0211-699501013259,B6,i
299,0211-699501013259,pp,i
299,0211-699501013259,valorando,o
299,0211-699501013259,su,o
299,0211-699501013259,posible,o
299,0211-699501013259,correlacion,o
299,0211-699501013259,con,o
299,0211-699501013259,dosis,o
299,0211-699501013259,de,o
299,0211-699501013259,dialisis,i
299,0211-699501013259,funcion,i
299,0211-699501013259,residual,i
299,0211-699501013259,y,o
299,0211-699501013259,parametros,o
299,0211-699501013259,nutricionales,o
299,0211-699501013259,Metodos,o
299,0211-699501013259,Todos,o
299,0211-699501013259,los,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,en,o
299,0211-699501013259,hemodialisis,i
299,0211-699501013259,al,o
299,0211-699501013259,comienzo,o
299,0211-699501013259,del,o
299,0211-699501013259,estudio,o
299,0211-699501013259,que,o
299,0211-699501013259,no,o
299,0211-699501013259,recibian,o
299,0211-699501013259,acido,i
299,0211-699501013259,folico,i
299,0211-699501013259,ni,o
299,0211-699501013259,vitamina,i
299,0211-699501013259,B6,i
299,0211-699501013259,asi,o
299,0211-699501013259,como,o
299,0211-699501013259,los,o
299,0211-699501013259,incorporados,o
299,0211-699501013259,posteriormente,o
299,0211-699501013259,a,o
299,0211-699501013259,partir,o
299,0211-699501013259,de,o
299,0211-699501013259,su,o
299,0211-699501013259,tercer,o
299,0211-699501013259,mes,o
299,0211-699501013259,en,o
299,0211-699501013259,hemodialisis,i
299,0211-699501013259,recibieron,o
299,0211-699501013259,5,o
299,0211-699501013259,mg,o
299,0211-699501013259,orales,o
299,0211-699501013259,de,o
299,0211-699501013259,acido,i
299,0211-699501013259,folico,i
299,0211-699501013259,cada,o
299,0211-699501013259,48,o
299,0211-699501013259,horas,o
299,0211-699501013259,y,o
299,0211-699501013259,40,o
299,0211-699501013259,mg,o
299,0211-699501013259,orales,o
299,0211-699501013259,de,o
299,0211-699501013259,vitamina,i
299,0211-699501013259,B6,i
299,0211-699501013259,cada,o
299,0211-699501013259,semana,o
299,0211-699501013259,Se,o
299,0211-699501013259,determinaron,o
299,0211-699501013259,al,o
299,0211-699501013259,comienzo,o
299,0211-699501013259,del,o
299,0211-699501013259,estudio,o
299,0211-699501013259,y,o
299,0211-699501013259,cada,o
299,0211-699501013259,2,o
299,0211-699501013259,meses,o
299,0211-699501013259,niveles,i
299,0211-699501013259,de,i
299,0211-699501013259,folato,i
299,0211-699501013259,vitamina,i
299,0211-699501013259,B12,i
299,0211-699501013259,inmunoensayo,i
299,0211-699501013259,albumina,i
299,0211-699501013259,y,o
299,0211-699501013259,cinetica,o
299,0211-699501013259,de,o
299,0211-699501013259,la,o
299,0211-699501013259,urea,i
299,0211-699501013259,KTV,o
299,0211-699501013259,KRU,o
299,0211-699501013259,PCRn,o
299,0211-699501013259,y,o
299,0211-699501013259,cada,o
299,0211-699501013259,6,o
299,0211-699501013259,meses,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,HPLC,i
299,0211-699501013259,y,o
299,0211-699501013259,pp,i
299,0211-699501013259,RIA,i
299,0211-699501013259,Resultados,o
299,0211-699501013259,80,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,fueron,o
299,0211-699501013259,incluidos,o
299,0211-699501013259,en,o
299,0211-699501013259,el,o
299,0211-699501013259,estudio,o
299,0211-699501013259,basal,o
299,0211-699501013259,con,o
299,0211-699501013259,una,o
299,0211-699501013259,prevalencia,o
299,0211-699501013259,de,o
299,0211-699501013259,hiperhomocisteinemia,i
299,0211-699501013259,del,o
299,0211-699501013259,844,o
299,0211-699501013259,deficit,i
299,0211-699501013259,de,i
299,0211-699501013259,pp,i
299,0211-699501013259,en,o
299,0211-699501013259,el,o
299,0211-699501013259,32,o
299,0211-699501013259,y,o
299,0211-699501013259,folato,i
299,0211-699501013259,en,o
299,0211-699501013259,el,o
299,0211-699501013259,rango,o
299,0211-699501013259,normal,o
299,0211-699501013259,bajo,o
299,0211-699501013259,los,o
299,0211-699501013259,niveles,i
299,0211-699501013259,de,i
299,0211-699501013259,tHcy,i
299,0211-699501013259,se,o
299,0211-699501013259,correlacionaban,o
299,0211-699501013259,inversamente,o
299,0211-699501013259,con,o
299,0211-699501013259,los,o
299,0211-699501013259,del,o
299,0211-699501013259,folato,i
299,0211-699501013259,r,o
299,0211-699501013259,0336,o
299,0211-699501013259,p,o
299,0211-699501013259,001,o
299,0211-699501013259,pero,o
299,0211-699501013259,no,o
299,0211-699501013259,con,o
299,0211-699501013259,pp,i
299,0211-699501013259,B12,i
299,0211-699501013259,edad,o
299,0211-699501013259,albumina,i
299,0211-699501013259,KTV,o
299,0211-699501013259,KRU,o
299,0211-699501013259,PCRn,o
299,0211-699501013259,Cincuenta,o
299,0211-699501013259,y,o
299,0211-699501013259,ocho,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,recibieron,o
299,0211-699501013259,seis,o
299,0211-699501013259,meses,o
299,0211-699501013259,de,o
299,0211-699501013259,suplementacion,i
299,0211-699501013259,con,o
299,0211-699501013259,normalizacion,o
299,0211-699501013259,del,o
299,0211-699501013259,pp,i
299,0211-699501013259,aumento,o
299,0211-699501013259,del,o
299,0211-699501013259,folato,i
299,0211-699501013259,703,o
299,0211-699501013259,IC,o
299,0211-699501013259,638,o
299,0211-699501013259,795,o
299,0211-699501013259,vs,o
299,0211-699501013259,6181,o
299,0211-699501013259,IC,o
299,0211-699501013259,4447,o
299,0211-699501013259,7811,o
299,0211-699501013259,p,o
299,0211-699501013259,0001,o
299,0211-699501013259,y,o
299,0211-699501013259,descenso,o
299,0211-699501013259,de,o
299,0211-699501013259,la,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,240,o
299,0211-699501013259,IC,o
299,0211-699501013259,213,o
299,0211-699501013259,264,o
299,0211-699501013259,vs,o
299,0211-699501013259,199,o
299,0211-699501013259,IC,o
299,0211-699501013259,175,o
299,0211-699501013259,224,o
299,0211-699501013259,p,o
299,0211-699501013259,005,o
299,0211-699501013259,Han,o
299,0211-699501013259,recibido,o
299,0211-699501013259,suplementacion,i
299,0211-699501013259,durante,o
299,0211-699501013259,12,o
299,0211-699501013259,meses,o
299,0211-699501013259,33,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,pero,o
299,0211-699501013259,a,o
299,0211-699501013259,pesar,o
299,0211-699501013259,de,o
299,0211-699501013259,un,o
299,0211-699501013259,continuo,o
299,0211-699501013259,aumento,o
299,0211-699501013259,del,o
299,0211-699501013259,folato,i
299,0211-699501013259,10078,o
299,0211-699501013259,IC,o
299,0211-699501013259,7481,o
299,0211-699501013259,12674,o
299,0211-699501013259,p,o
299,0211-699501013259,0001,o
299,0211-699501013259,solo,o
299,0211-699501013259,3,o
299,0211-699501013259,pacientes,o
299,0211-699501013259,presentan,o
299,0211-699501013259,niveles,o
299,0211-699501013259,normales,o
299,0211-699501013259,de,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,correlacionandose,o
299,0211-699501013259,directamente,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,con,o
299,0211-699501013259,la,o
299,0211-699501013259,albumina,i
299,0211-699501013259,r,o
299,0211-699501013259,056,o
299,0211-699501013259,p,o
299,0211-699501013259,0001,o
299,0211-699501013259,que,o
299,0211-699501013259,se,o
299,0211-699501013259,elevo,o
299,0211-699501013259,con,o
299,0211-699501013259,respecto,o
299,0211-699501013259,al,o
299,0211-699501013259,inicio,o
299,0211-699501013259,337,o
299,0211-699501013259,IC,o
299,0211-699501013259,327,o
299,0211-699501013259,346,o
299,0211-699501013259,vs,o
299,0211-699501013259,350,o
299,0211-699501013259,IC,o
299,0211-699501013259,337,o
299,0211-699501013259,363,o
299,0211-699501013259,p,o
299,0211-699501013259,005,o
299,0211-699501013259,Conclusion,o
299,0211-699501013259,Tras,o
299,0211-699501013259,suplementacion,i
299,0211-699501013259,con,o
299,0211-699501013259,acido,i
299,0211-699501013259,folico,i
299,0211-699501013259,y,o
299,0211-699501013259,vitamina,i
299,0211-699501013259,B6,i
299,0211-699501013259,aunque,o
299,0211-699501013259,inicialmente,o
299,0211-699501013259,se,o
299,0211-699501013259,reduce,o
299,0211-699501013259,la,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,esta,o
299,0211-699501013259,respuesta,o
299,0211-699501013259,se,o
299,0211-699501013259,hace,o
299,0211-699501013259,refractaria,o
299,0211-699501013259,correlacionandose,o
299,0211-699501013259,directamente,o
299,0211-699501013259,la,o
299,0211-699501013259,tHcy,i
299,0211-699501013259,con,o
299,0211-699501013259,la,o
299,0211-699501013259,albumina,i
299,0211-699501013259,plasmatica,i
299,0211-699501013259,La,o
299,0211-699501013259,interpretacion,o
299,0211-699501013259,de,o
299,0211-699501013259,los,o
299,0211-699501013259,niveles,i
299,0211-699501013259,de,i
299,0211-699501013259,tHcy,i
299,0211-699501013259,debe,o
299,0211-699501013259,tener,o
299,0211-699501013259,en,o
299,0211-699501013259,cuenta,o
299,0211-699501013259,la,o
299,0211-699501013259,concentracion,i
299,0211-699501013259,de,i
299,0211-699501013259,albumina,i
